PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	EA	PG	WC	SC	GA	UT	PM	OA	HC	HP	DA
J	Bar-Or, D; Rael, LT; Madayag, RM; Banton, KL; Tanner, A; Acuna, DL; Lieser, MJ; Marshall, GT; Mains, CW; Brody, E				Bar-Or, David; Rael, Leonard T.; Madayag, Robert M.; Banton, Kaysie L.; Tanner, Allen, II; Acuna, David L.; Lieser, Mark J.; Marshall, Gary T.; Mains, Charles W.; Brody, Edward			Stress Hyperglycemia in Critically Ill Patients: Insight Into Possible Molecular Pathways	FRONTIERS IN MEDICINE			English	Article						sepsis; Warburg effect; hyperglycemia; glycolysis; oxidative phosphorylation; dipeptidyl peptidase IV	INTENSIVE INSULIN THERAPY; CD26/DIPEPTIDYL PEPTIDASE IV; GLUCOSE-METABOLISM; LACTATE; MORTALITY; DYSFUNCTION; INHIBITION; GLYCOLYSIS; EXPRESSION; SUCCINATE	Severe sepsis, systemic inflammatory response syndrome (SIRS), and traumatic brain injury are frequently associated with hyperglycemia in non-diabetic patients. In patients suffering from any of these conditions, hyperglycemia at admission to an intensive care unit (ICU) is directly correlated with increased mortality or morbidity. Although there was initial enthusiasm for insulin treatment to blood glucose levels below 110 mg/dL in these patients, recent understanding suggests that the potential for hypoglycemic complications make this approach potentially dangerous. More moderate glucose control seems to be more beneficial than the aggressive glucose lowering initially suggested. An important publication has shown that hyperlactatemia accompanying hyperglycemia could be the real culprit in bad outcomes. This suggests that coupling moderate glucose lowering with therapeutic agents which might treat the underlying metabolic disturbances in these conditions may be a better strategy. The key metabolic disturbance in these three conditions seems to be persistent glycolysis as an energy source even in the presence of adequate tissue oxygenation (the Warburg Effect). We look at recent advances in understanding aerobic glycolysis and possibly the action of DPP4 on incretins resulting in insulin dysregulation and suggest key metabolic pathways involved in hyperglycemia regulation.	[Bar-Or, David; Rael, Leonard T.; Banton, Kaysie L.] Swedish Med Ctr, Trauma Res Lab, Englewood, CO 80110 USA; [Bar-Or, David; Madayag, Robert M.; Mains, Charles W.] St Anthony Hosp, Lakewood, CO 80228 USA; [Bar-Or, David; Tanner, Allen, II] Penrose Community Hosp, Colorado Springs, CO 80907 USA; [Bar-Or, David; Acuna, David L.] Wesley Med Ctr, Wichita, KS 67214 USA; [Bar-Or, David; Lieser, Mark J.] Res Med Ctr, Kansas City, MO 64132 USA; [Bar-Or, David; Marshall, Gary T.] Med City Plano Hosp, Plano, TX 75075 USA; [Brody, Edward] SomaLogic Inc, Boulder, CO USA	Bar-Or, D (corresponding author), Swedish Med Ctr, Trauma Res Lab, Englewood, CO 80110 USA.; Bar-Or, D (corresponding author), St Anthony Hosp, Lakewood, CO 80228 USA.; Bar-Or, D (corresponding author), Penrose Community Hosp, Colorado Springs, CO 80907 USA.; Bar-Or, D (corresponding author), Wesley Med Ctr, Wichita, KS 67214 USA.; Bar-Or, D (corresponding author), Res Med Ctr, Kansas City, MO 64132 USA.; Bar-Or, D (corresponding author), Med City Plano Hosp, Plano, TX 75075 USA.	davidbme49@gmail.com	Bar-Or, David/AAE-9328-2020				Abrahami D, 2018, BMJ-BRIT MED J, V360, DOI 10.1136/bmj.k872; Bar-Or D, 2018, J CRIT CARE, V43, P197, DOI 10.1016/j.jcrc.2017.09.012; Barth E, 2007, CRIT CARE MED, V35, pS508, DOI 10.1097/01.CCM.0000278047.06965.20; Bochicchio Grant V, 2008, Adv Surg, V42, P261, DOI 10.1016/j.yasu.2008.03.006; Brunkhorst FM, 2008, NEW ENGL J MED, V358, P125, DOI 10.1056/NEJMoa070716; Capes SE, 2000, LANCET, V355, P773, DOI 10.1016/S0140-6736(99)08415-9; Chen J, 2011, ONCOGENE, V30, P4297, DOI 10.1038/onc.2011.137; Choi CS, 2002, AM J PHYSIOL-ENDOC M, V283, pE233, DOI 10.1152/ajpendo.00557.2001; Cochran A, 2003, J TRAUMA, V55, P1035, DOI 10.1097/01.TA.0000031175.96507.48; Dienel GA, 2012, J CEREBR BLOOD F MET, V32, P1107, DOI 10.1038/jcbfm.2011.175; Douzinas EE, 1997, AM J RESP CRIT CARE, V155, P53, DOI 10.1164/ajrccm.155.1.9001289; Durinx C, 2000, EUR J BIOCHEM, V267, P5608, DOI 10.1046/j.1432-1327.2000.01634.x; Finfer S, 2009, NEW ENGL J MED, V360, P1283, DOI 10.1056/NEJMoa0810625; FLENTKE GR, 1991, P NATL ACAD SCI USA, V88, P1556, DOI 10.1073/pnas.88.4.1556; Flierl MA, 2007, NATURE, V449, P721, DOI 10.1038/nature06185; Green JP, 2012, ACAD EMERG MED, V19, P1268, DOI 10.1111/acem.12015; Hatwal Amitabh, 2012, Indian J Endocrinol Metab, V16, pS239, DOI 10.4103/2230-8210.104049; Kelly B, 2015, CELL RES, V25, P771, DOI 10.1038/cr.2015.68; Kim SC, 2015, ANN RHEUM DIS, V74, P1968, DOI 10.1136/annrheumdis-2014-205216; Koivunen P, 2007, J BIOL CHEM, V282, P4524, DOI 10.1074/jbc.M610415200; Koska Juraj, 2012, Cardiovascular & Hematological Agents in Medicinal Chemistry, V10, P295; Laird AM, 2004, J TRAUMA, V56, P1058, DOI 10.1097/01.TA.0000123267.39011.9F; Levraut J, 2003, CRIT CARE MED, V31, P705, DOI 10.1097/01.CCM.0000045561.85810.45; Levy B, 2006, CURR OPIN CRIT CARE, V12, P315, DOI 10.1097/01.ccx.0000235208.77450.15; Lombardi AM, 1999, AM J PHYSIOL-ENDOC M, V276, pE922; Nemoto E, 1999, INFECT IMMUN, V67, P6225; Osterbur K, 2014, J VET INTERN MED, V28, P1141, DOI 10.1111/jvim.12364; Revelly JP, 2005, CRIT CARE MED, V33, P2235, DOI 10.1097/01.CCM.0000181525.99295.8F; Rovlias A, 2000, NEUROSURGERY, V46, P335, DOI 10.1097/00006123-200002000-00015; Selak MA, 2005, CANCER CELL, V7, P77, DOI 10.1016/j.ccr.2004.11.022; Shestov AA, 2014, ELIFE, V3, DOI 10.7554/eLife.03342; Shi J, 2016, ONCOTARGET, V7, P71052, DOI 10.18632/oncotarget.11958; Simpson IA, 2007, J CEREBR BLOOD F MET, V27, P1766, DOI 10.1038/sj.jcbfm.9600521; Sperry JL, 2007, J TRAUMA, V63, P487, DOI 10.1097/TA.0b013e31812e51fc; Stapleton RD, 2018, GLYCEMIC CONTROL INT; Tannahill GM, 2013, NATURE, V496, P238, DOI 10.1038/nature11986; Van den Berghe G, 2006, NEW ENGL J MED, V354, P449, DOI 10.1056/NEJMoa052521; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; van Niekerk G, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1775-1; Whitcomb BW, 2005, CRIT CARE MED, V33, P2772, DOI 10.1097/01.CCM.0000189741.44071.25; Yang LC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5436	41	18	18	0	2	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		2296-858X		FRONT MED-LAUSANNE	Front. Med.	MAR 27	2019	6								54	10.3389/fmed.2019.00054			6	Medicine, General & Internal	General & Internal Medicine	HQ8DP	WOS:000462654500002	30972338	DOAJ Gold, Green Published			2021-06-18	
J	Jak, AJ; Jurick, S; Crocker, LD; Sanderson-Cimino, M; Aupperle, R; Rodgers, CS; Thomas, KR; Boyd, B; Norman, SB; Lang, AJ; Keller, AV; Schiehser, DM; Twamley, EW				Jak, Amy J.; Jurick, Sarah; Crocker, Laura D.; Sanderson-Cimino, Mark; Aupperle, Robin; Rodgers, Carie S.; Thomas, Kelsey R.; Boyd, Briana; Norman, Sonya B.; Lang, Ariel J.; Keller, Amber V.; Schiehser, Dawn M.; Twamley, Elizabeth W.			SMART-CPT for veterans with comorbid post-traumatic stress disorder and history of traumatic brain injury: a randomised controlled trial	JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY			English	Article							COGNITIVE PROCESSING THERAPY; PERSISTENT POSTCONCUSSION SYNDROME; PTSD; AFGHANISTAN; SYMPTOMS; DROPOUT; IRAQ; PERFORMANCE; PREVALENCE; COMPLAINTS	Objective To better concurrently address emotional and neuropsychological symptoms common in veterans with comorbid post-traumatic stress disorder (PTSD) and history of traumatic brain injury (TBI), we integrated components of compensatory cognitive training from the Cognitive Symptom Management and Rehabilitation Therapy (CogSMART) programme into cognitive processing therapy (CPT) for PTSD to create a hybrid treatment, SMART-CPT (CogSMART+CPT). This study compared the efficacy of standard CPT with SMART-CPT for treatment of veterans with comorbid PTSD and history of TBI reporting cognitive symptoms. Methods One hundred veterans with PTSD, a history of mild to moderate TBI and current cognitive complaints were randomised and received individually delivered CPT or SMART-CPT for 12 weeks. Participants underwent psychological, neurobehavioural and neuropsychological assessments at baseline, on completion of treatment and 3 months after treatment. Results Both CPT and SMART-CPT resulted in clinically significant reductions in PTSD and postconcussive symptomatology and improvements in quality of life. SMART-CPT resulted in additional improvements in the neuropsychological domains of attention/working memory, verbal learning/memory and novel problem solving. Conclusion SMART-CPT, a mental health intervention for PTSD, combined with compensatory cognitive training strategies, reduces PTSD and neurobehavioural symptoms and also provides added value by improving cognitive functioning.	[Jak, Amy J.; Thomas, Kelsey R.; Norman, Sonya B.] VA San Diego Healthcare Syst, Psychol Serv, San Diego, CA 92161 USA; [Jak, Amy J.; Jurick, Sarah; Crocker, Laura D.; Norman, Sonya B.; Lang, Ariel J.; Schiehser, Dawn M.; Twamley, Elizabeth W.] VA San Diego Healthcare Syst, Ctr Excellence Stress & Mental Hlth, San Diego, CA USA; [Jak, Amy J.; Crocker, Laura D.; Boyd, Briana; Keller, Amber V.; Schiehser, Dawn M.] VA San Diego Healthcare Syst, Res Serv, San Diego, CA USA; [Jak, Amy J.; Jurick, Sarah; Sanderson-Cimino, Mark; Thomas, Kelsey R.; Norman, Sonya B.; Lang, Ariel J.; Schiehser, Dawn M.; Twamley, Elizabeth W.] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA; [Aupperle, Robin] Univ Tulsa, Laureate Inst Brain Res, Tulsa, OK 74104 USA; [Rodgers, Carie S.] PsychArmor Inst, San Diego, CA USA; [Norman, Sonya B.] Natl Ctr PTSD, White River Jct, VT USA	Jak, AJ (corresponding author), VA San Diego Healthcare Syst, Psychol Serv, San Diego, CA 92161 USA.	ajak@ucsd.edu	Aupperle, Robin/AAU-8550-2020	Sanderson-Cimino, Mark/0000-0002-5872-3186; Keller, Amber/0000-0002-2972-784X; Thomas, Kelsey/0000-0003-4277-8876	Department of DefenseUnited States Department of Defense [W81XWH-11-1-0641]; VA Interprofessional Polytrauma and TBI Fellowship and Career Development from the VA Rehabilitation Research & Development (RR D) Service [IK2 RX002459]; VA RR D MERIT [1 I01 RX001691]; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [K23MH108707] Funding Source: NIH RePORTER	Funding was provided by the Department of Defense (award W81XWH-11-1-0641). LDC received salary support during this work from the VA Interprofessional Polytrauma and TBI Fellowship and Career Development (award number IK2 RX002459) from the VA Rehabilitation Research & Development (RR& D) Service. DMS received salary support from VA RR& D MERIT (award 1 I01 RX001691).	Aupperle RL, 2012, NEUROPHARMACOLOGY, V62, P686, DOI 10.1016/j.neuropharm.2011.02.008; Belanger HG, 2013, CLIN NEUROPSYCHOL, V27, P159, DOI 10.1080/13854046.2012.758780; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P194, DOI 10.1017/S1355617709990841; Boyd B, 2016, COGN BEHAV PRACT, V23, P173, DOI 10.1016/j.cbpra.2015.10.001; Bryant RA, 2012, PTSD TRAUMATIC BRAIN; Bryant RA, 2012, PTSD MILD TRAUMATIC; Chard KM, 2011, J TRAUMA STRESS, V24, P347, DOI 10.1002/jts.20644; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Cook JM, 2014, PROF PSYCHOL-RES PR, V45, P136, DOI 10.1037/a0036183; Davis JJ, 2013, REHABIL PSYCHOL, V58, P36, DOI 10.1037/a0031525; Drag LL, 2012, J INT NEUROPSYCH SOC, V18, P576, DOI 10.1017/S1355617712000203; Fulton JJ, 2015, J ANXIETY DISORD, V31, P98, DOI 10.1016/j.janxdis.2015.02.003; Galovski TE, 2012, J CONSULT CLIN PSYCH, V80, P968, DOI 10.1037/a0030600; Garcia HA, 2011, PSYCHOL SERV, V8, P1, DOI 10.1037/a0022705; Geuze E, 2009, DEPRESS ANXIETY, V26, P7, DOI 10.1002/da.20476; Goetter EM, 2015, J TRAUMA STRESS, V28, P401, DOI 10.1002/jts.22038; Institute of Medicine, 2014, TREATM POSTTR STRESS; Iverson GL, 2006, ARCH CLIN NEUROPSYCH, V21, P303, DOI 10.1016/j.acn.2005.12.008; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Jak AJ, 2018, CURR TOP BEHAV NEURO, V38, P93, DOI 10.1007/7854_2016_62; Jak AJ, 2015, CONTEMP CLIN TRIALS, V45, P210, DOI 10.1016/j.cct.2015.10.009; Kehle-Forbes SM, 2016, PSYCHOL TRAUMA-US, V8, P107, DOI 10.1037/tra0000065; Kilmer B, 2011, PSYCHOL TRAUMA-US, V3, P201, DOI 10.1037/a0020592; LaFrance WC, 2014, JAMA PSYCHIAT, V71, P997, DOI 10.1001/jamapsychiatry.2014.817; Lehman A, 1994, TOOLKIT EVALUATING Q; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; McCrea M, 2008, MILD TRAUMATIC BRAIN; O'Neil ME, 2017, ACM T MATH SOF UNPUB, P1; Pape TLB, 2016, J HEAD TRAUMA REHAB, V31, pE10, DOI 10.1097/HTR.0000000000000220; Schottenbauer MA, 2008, PSYCHIATRY, V71, P134, DOI 10.1521/psyc.2008.71.2.134; Scott JC, 2015, PSYCHOL BULL, V141, P105, DOI 10.1037/a0038039; Singer J.D., 2003, APPL LONGITUDINAL DA; Stein MB, 2015, AM J PSYCHIAT, V172, P1101, DOI 10.1176/appi.ajp.2015.14121572; Stein MB, 2009, AM J PSYCHIAT, V166, P768, DOI 10.1176/appi.ajp.2009.08101604; Storzbach D, 2017, J HEAD TRAUMA REHAB, V32, P16, DOI 10.1097/HTR.0000000000000228; Stroupe KT, 2013, J REHABIL RES DEV, V50, P1047, DOI 10.1682/JRRD.2012.06.0107; Suris A, 2013, J TRAUMA STRESS, V26, P28, DOI 10.1002/jts.21765; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Twamley EW, 2014, J REHABIL RES DEV, V51, P59, DOI 10.1682/JRRD.2013.01.0020; VA/DoD, 2010, VA DOD CLIN PRACT GU; VA/DoD, 2016, VA DOD CLIN PRACT GU; Walter KH, 2012, REHABIL PSYCHOL, V57, P13, DOI 10.1037/a0026254; Wolf GK, 2018, J HEAD TRAUMA REHAB, V33, pE53, DOI 10.1097/HTR.0000000000000344; Wrocklage KM, 2016, J INT NEUROPSYCH SOC, V22, P399, DOI 10.1017/S1355617716000059; Yurgil KA, 2014, JAMA PSYCHIAT, V71, P149, DOI 10.1001/jamapsychiatry.2013.3080	46	18	18	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0022-3050	1468-330X		J NEUROL NEUROSUR PS	J. Neurol. Neurosurg. Psychiatry	MAR	2019	90	3					333	341		10.1136/jnnp-2018-319315			9	Clinical Neurology; Psychiatry; Surgery	Neurosciences & Neurology; Psychiatry; Surgery	IC7UC	WOS:000471181900183	30554135				2021-06-18	
J	Kumar, A; Henry, RJ; Stoica, BA; Loane, DJ; Abulwerdi, G; Bhat, SA; Faden, AI				Kumar, Asit; Henry, Rebecca J.; Stoica, Bogdan A.; Loane, David J.; Abulwerdi, Gelareh; Bhat, Shahnawaz A.; Faden, Alan, I			Neutral Sphingomyelinase Inhibition Alleviates LPS-Induced Microglia Activation and Neuroinflammation after Experimental Traumatic Brain Injury	JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS			English	Article							IMPROVES FUNCTIONAL RECOVERY; MAPK SIGNALING PATHWAYS; DENDRITIC CELLS; DOWN-REGULATION; TNF-ALPHA; INFLAMMATION; RELEASE; DISEASE; DEATH; NEURODEGENERATION	Neuroinflammation is one of the key secondary injury mechanisms triggered by traumatic brain injury (TBI). Microglial activation, a hallmark of brain neuroinflammation, plays a critical role in regulating immune responses after TBI and contributes to progressive neurodegeneration and neurologic deficits following brain trauma. Here we evaluated the role of neutral sphingomyelinase (nSMase) in microglial activation by examining the effects of the nSMase inhibitors altenusin and GW4869 in vitro (using BV2 microglia cells and primary microglia), as well as in a controlled cortical injury (CCI) model in adult male C57BL/6 mice. Pretreatment of altenusin or GW4869 prior to lipopolysaccharide (LPS) stimulation for 4 or 24 hours, significantly downregulated gene expression of the pro-inflammatory mediators TNF-alpha, IL-1 beta, IL-6, iNOS, and CCL2 in microglia and reduced the release of nitric oxide and TNF-alpha. These nSMase inhibitors also attenuated the release of microparticles and phosphorylation of p38 MAPK and ERK1/2. In addition, altenusin pretreatment also reduced the gene expression of multiple inflammatory markers associated with microglial activation after experimental TBI, including TNF-alpha, IL-1 beta, IL-6, iNOS, CCL2, CD68, NOX2, and p22(phox). Overall, our data demonstrate that nSMase inhibitors attenuate multiple inflammatory pathways associated with microglial activation in vitro and after experimental TBI. Thus, nSMase inhibitors may represent promising therapeutics agents targeting neuroinflammation.	[Kumar, Asit; Henry, Rebecca J.; Stoica, Bogdan A.; Loane, David J.; Abulwerdi, Gelareh; Bhat, Shahnawaz A.; Faden, Alan, I] Univ Maryland, Sch Med, Dept Anesthesiol & Shock, Trauma & Anesthesiol Res STAR Ctr, Baltimore, MD 21201 USA; [Kumar, Asit] Johns Hopkins Univ, Dept Neurol, Richard T Johnson Div Neuroimmunol & Neurol Infec, Baltimore, MD 21218 USA	Kumar, A (corresponding author), Univ Maryland, Sch Med, Dept Anesthesiol & Shock, Trauma & Anesthesiol Res STAR Ctr, Baltimore, MD 21201 USA.; Faden, AI (corresponding author), Univ Maryland, Sch Med, Dept Anesthesiol Anat & Neurobiol, Baltimore, MD 21201 USA.; Faden, AI (corresponding author), Univ Maryland, Sch Med, Dept Neurosurg, Baltimore, MD 21201 USA.; Faden, AI (corresponding author), Univ Maryland, Sch Med, Dept Neurol, Baltimore, MD 21201 USA.; Faden, AI (corresponding author), Univ Maryland, Sch Med, Ctr Shock Trauma & Anesthesiol Res STAR, Baltimore, MD 21201 USA.	asitkumar14@gmail.com; afaden1@som.umaryland.edu	Kumar, Asit/AAG-3916-2021	Kumar, Asit/0000-0003-1735-7033; Faden, Alan I./0000-0003-0128-2348; Henry, Rebecca/0000-0001-8548-1170; Vinueza, Gelareh/0000-0002-1036-6378; Loane, David/0000-0003-0393-3503	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01NS037313, R01NS082308, R01NS096002]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS096002, R01NS037313] Funding Source: NIH RePORTER	This work was supported by the National Institutes of Health [Grant Number R01NS037313 (A.I.F.), R01NS082308 (D.J.L.), and R01NS096002 (B.A.S.)].	Aly AH, 2008, J NAT PROD, V71, P972, DOI 10.1021/np070447m; Bachstetter AD, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-79; Balusu S, 2016, EMBO MOL MED, V8, P1162, DOI 10.15252/emmm.201606271; Beneventano M, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00812; Bianco F, 2005, J IMMUNOL, V174, P7268, DOI 10.4049/jimmunol.174.11.7268; Bianco F, 2009, EMBO J, V28, P1043, DOI 10.1038/emboj.2009.45; Bilousova T, 2018, BIOCHEM BIOPH RES CO, V499, P751, DOI 10.1016/j.bbrc.2018.03.209; Bohman LE, 2016, J NEUROTRAUM, V33, P168, DOI 10.1089/neu.2015.3885; Brann AB, 2002, J BIOL CHEM, V277, P9812, DOI 10.1074/jbc.M109862200; Brites D, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00476; Butovsky O, 2015, ANN NEUROL, V77, P75, DOI 10.1002/ana.24304; Byrnes KR, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-43; Caballero-Garrido E, 2015, J NEUROSCI, V35, P12446, DOI 10.1523/JNEUROSCI.1641-15.2015; Cardoso AL, 2012, IMMUNOLOGY, V135, P73, DOI 10.1111/j.1365-2567.2011.03514.x; Pena-Philippides JC, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0753-x; Chua SW, 2017, ACS CHEM NEUROSCI, V8, P743, DOI 10.1021/acschemneuro.6b00433; Clarke CJ, 2007, J BIOL CHEM, V282, P1384, DOI 10.1074/jbc.M609216200; Clarke CJ, 2011, BIOCHEM J, V435, P381, DOI 10.1042/BJ20101752; Dickens AM, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aai7696; Dinkins MB, 2016, J NEUROSCI, V36, P8653, DOI 10.1523/JNEUROSCI.1429-16.2016; Essandoh K, 2015, BBA-MOL BASIS DIS, V1852, P2362, DOI 10.1016/j.bbadis.2015.08.010; Fenn AM, 2014, BIOL PSYCHIAT, V76, P575, DOI 10.1016/j.biopsych.2013.10.014; Figuera-Losada M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124481; Filosto S, 2010, J BIOL CHEM, V285, P10213, DOI 10.1074/jbc.M109.069963; Fu RY, 2014, MOL NEUROBIOL, V49, P1422, DOI 10.1007/s12035-013-8620-6; Gao HM, 2012, TRENDS PHARMACOL SCI, V33, P295, DOI 10.1016/j.tips.2012.03.008; Gao W, 2016, J CELL MOL MED, V20, P2318, DOI 10.1111/jcmm.12923; Gu LZ, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-109; Guedes J, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/186872; Guedes JR, 2014, HUM MOL GENET, V23, P6286, DOI 10.1093/hmg/ddu348; Guo BB, 2015, J BIOL CHEM, V290, P3455, DOI 10.1074/jbc.M114.605253; Hanisch UK, 2002, GLIA, V40, P140, DOI 10.1002/glia.10161; Harrison EB, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00228; Harrison EB, 2016, FEBS OPEN BIO, V6, P835, DOI 10.1002/2211-5463.12092; Harrison-Brown M, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17122030; Hazelton I, 2018, J NEUROTRAUM, V35, P639, DOI 10.1089/neu.2017.5049; Henry RJ, 2019, NEUROTHERAPEUTICS, V16, P216, DOI 10.1007/s13311-018-0665-9; Hide I, 2000, J NEUROCHEM, V75, P965, DOI 10.1046/j.1471-4159.2000.0750965.x; Huang YL, 2018, CELL DISCOV, V4, DOI 10.1038/s41421-018-0017-2; Hulsmans M, 2013, CARDIOVASC RES, V100, P7, DOI 10.1093/cvr/cvt161; Hung TH, 2017, ONCOTARGET, V8, P103236, DOI 10.18632/oncotarget.21139; Iguchi Y, 2016, BRAIN, V139, P3187, DOI 10.1093/brain/aww237; Jayadev S, 2013, J NEUROCHEM, V127, P592, DOI 10.1111/jnc.12400; Kabadi SV, 2012, NEUROTHERAPEUTICS, V9, P405, DOI 10.1007/s13311-011-0095-4; Kaminska B, 2005, BBA-PROTEINS PROTEOM, V1754, P253, DOI 10.1016/j.bbapap.2005.08.017; Kaminska B, 2009, ANAT REC, V292, P1902, DOI 10.1002/ar.21047; Kim EK, 2010, BBA-MOL BASIS DIS, V1802, P396, DOI 10.1016/j.bbadis.2009.12.009; Kopitar-Jerata N, 2015, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00073; Kumar A, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0819-4; Kumar A, 2016, BRAIN BEHAV IMMUN, V58, P291, DOI 10.1016/j.bbi.2016.07.158; Kumar A, 2016, J NEUROTRAUM, V33, P1732, DOI 10.1089/neu.2015.4268; Kumar A, 2015, J NEUROCHEM, V135, P1189, DOI 10.1111/jnc.13364; Lee JT, 2004, J CELL BIOL, V164, P123, DOI 10.1083/jcb.200307017; Li J, 2017, PURINERG SIGNAL, V13, P13, DOI 10.1007/s11302-016-9537-0; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loane DJ, 2016, EXP NEUROL, V275, P316, DOI 10.1016/j.expneurol.2015.08.018; Loane D, 2014, NEUROTHERAPEUTICS, V11, P857, DOI 10.1007/s13311-014-0298-6; Loane DJ, 2014, J NEUROPATH EXP NEUR, V73, P14, DOI 10.1097/NEN.0000000000000021; Loane DJ, 2013, J NEUROTRAUM, V30, P403, DOI 10.1089/neu.2012.2589; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Loane DJ, 2009, J BIOL CHEM, V284, P15629, DOI 10.1074/jbc.M806139200; Luberto C, 2002, J BIOL CHEM, V277, P41128, DOI 10.1074/jbc.M206747200; Mao SS, 2012, J NEUROTRAUM, V29, P1941, DOI 10.1089/neu.2011.2244; Martinez TN, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-45; Menck K, 2017, J EXTRACELL VESICLES, V6, DOI 10.1080/20013078.2017.1378056; Montecalvo A, 2012, BLOOD, V119, P756, DOI 10.1182/blood-2011-02-338004; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nigro A, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00017; Novgorodov SA, 2014, J BIOL CHEM, V289, P13142, DOI 10.1074/jbc.M113.530311; Olajide OA, 2014, MOL NUTR FOOD RES, V58, P1843, DOI 10.1002/mnfr.201400163; Paolicelli RC, 2018, NEUROSCIENCE, DOI [10.1016/j.neurosci-ence.2018.04.003, DOI 10.1016/J.NEUROSCI-ENCE.2018.04.003]; Perry VH, 2010, NAT REV NEUROL, V6, P193, DOI 10.1038/nrneurol.2010.17; Pieragostino D, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21497-5; Poncelet P, 2015, TRANSFUS APHER SCI, V53, P110, DOI 10.1016/j.transci.2015.10.008; Ponomarev ED, 2011, NAT MED, V17, P64, DOI 10.1038/nm.2266; Prinz M, 2014, NAT REV NEUROSCI, V15, P300, DOI 10.1038/nrn3722; Saba R, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00578; Saba R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030832; Sabirzhanov B, 2018, J NEUROTRAUM, V35, P2462, DOI 10.1089/neu.2017.5572; Sabirzhanov B, 2014, J NEUROSCI, V34, P10055, DOI 10.1523/JNEUROSCI.1260-14.2014; Shieh CH, 2014, GLIA, V62, P592, DOI 10.1002/glia.22628; Shih RH, 2015, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00077; Singh V, 2014, NEUROSCIENCE, V265, P147, DOI 10.1016/j.neuroscience.2014.01.037; Sobue A, 2018, GLIA, V66, P1034, DOI 10.1002/glia.23299; Song L, 2011, J LIPID RES, V52, P1542, DOI 10.1194/jlr.M015412; Stoica BA, 2014, J NEUROTRAUM, V31, P758, DOI 10.1089/neu.2013.3194; Tabatadze N, 2010, J NEUROSCI RES, V88, P2940, DOI 10.1002/jnr.22438; Tan LHR, 2018, MOL NEUROBIOL, V55, P5741, DOI 10.1007/s12035-017-0784-z; Taylor DD, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0503; Thelin EP, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00351; Tian Y, 2015, BLOOD, V125, P2151, DOI 10.1182/blood-2014-09-598805; Uchida R, 1999, J ANTIBIOT, V52, P572, DOI 10.7164/antibiotics.52.572; Velagapudi R, 2017, INT IMMUNOPHARMACOL, V48, P17, DOI 10.1016/j.intimp.2017.04.018; Walker DG, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0139-9; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Wu BX, 2010, J BIOL CHEM, V285, P17993, DOI 10.1074/jbc.M110.102988; Wu M, 2005, INT J CANCER, V117, P340, DOI 10.1002/ijc.21238; Xiao CC, 2018, CIRC RES, V123, P564, DOI 10.1161/CIRCRESAHA.118.312758; Xiao TT, 2017, TRANSL NEURODEGENER, V6, DOI [10.1186/s40035-017-0072-x, 10.1186/s40035-017-0081-9]; Yang YY, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1204-7; Yin HY, 2017, J INFLAMM-LOND, V14, DOI 10.1186/s12950-017-0162-7; Yuan YM, 2015, BRAIN BEHAV IMMUN, V48, P287, DOI 10.1016/j.bbi.2015.04.008; Zeng C, 2005, J NEUROCHEM, V94, P703, DOI 10.1111/j.1471-4159.2005.03217.x; Zhao L, 2017, CARDIOLOGY, V137, P43, DOI 10.1159/000453544; Zheng ZH, 2017, MOL PHARMACOL, V92, P425, DOI 10.1124/mol.117.108829	105	18	18	0	7	AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3995 USA	0022-3565	1521-0103		J PHARMACOL EXP THER	J. Pharmacol. Exp. Ther.	MAR 1	2019	368	3					338	352		10.1124/jpet.118.253955			15	Pharmacology & Pharmacy	Pharmacology & Pharmacy	HM1AI	WOS:000459179300002	30563941	Bronze, Green Published			2021-06-18	
J	Migueis, GFJ; Fernandes, FAO; Ptak, M; Ratajczak, M; de Sousa, RJA				Migueis, G. F. J.; Fernandes, F. A. O.; Ptak, M.; Ratajczak, M.; Alves de Sousa, R. J.			Detection of bridging veins rupture and subdural haematoma onset using a finite element head model	CLINICAL BIOMECHANICS			English	Article						Biomechanics; Finite elements; Bridging veins; Subdural haematoma; Head model; Damage modeling	INJURY; BIOMECHANICS; BRAIN	Background: One of the most severe traumatic brain injuries, the subdural haematoma, is related to damage and rupture of the bridging veins, generating an abnormal collection of blood between the dura mater and arachnoid mater. Current numerical models of these vessels rely on very simple geometries and material laws, limiting its accuracy and bio-fidelity. Methods: In this work, departing from an existing human head numerical model, a realistic geometry for the bridging veins was developed, devoting special attention to the finite elements type employed. A novel and adequate constitutive model including damage behavior was also successfully implemented. Findings: Results attest that vessel tearing onset was correctly captured, after comparison against experiments on cadavers. Interpretation: Doing so, the model allow to precisely predict the individual influence of kinematic parameters such as the pulse duration, linear and rotational accelerations in promoting vessel tearing.	[Migueis, G. F. J.; Fernandes, F. A. O.; Alves de Sousa, R. J.] Univ Aveiro, Dept Mech Engn, TEMA Ctr Mech Technol & Automat, Aveiro, Portugal; [Ptak, M.] Wroclaw Univ Sci & Technol, Fac Mech Engn, Lukasiewicza 7-9, PL-50371 Wroclaw, Poland; [Ratajczak, M.] Univ Zielona Gora, Fac Mech Engn, Prof Z Szafrana 4, PL-65516 Zielona Gora, Poland	de Sousa, RJA (corresponding author), Univ Aveiro, Campus Santiago, P-3810193 Aveiro, Portugal.	rsousa@ua.pt	Ratajczak, Monika/AAV-6979-2020; de Sousa, Ricardo Alves/E-4405-2010; Fernandes, Fabio A.O./H-2680-2012; Ptak, Mariusz/B-1493-2013	Ratajczak, Monika/0000-0001-6980-315X; de Sousa, Ricardo Alves/0000-0002-5848-6424; Fernandes, Fabio A.O./0000-0001-9751-8807; Ptak, Mariusz/0000-0001-8081-8336	Fundacao para a Cincia e Tecnologia (FCT)Portuguese Foundation for Science and Technology [CEECIND/01192/2017];  [UID/EMS/00481/2013-FCT];  [CENTRO-01-0145-FEDER-022083]	Center of Mechanical Technology and Automation (TEMA, University of Aveiro) is supported by grants UID/EMS/00481/2013-FCT and CENTRO-01-0145-FEDER-022083. Medical images provided by Hospital Sao Joao (Porto, Portugal) are gratefully acknowledged. Fabio Fernandes is supported by individual grant CEECIND/01192/2017, Fundacao para a Cincia e Tecnologia (FCT)	Asiminei A., 2011, P IRCOBI C WARS, P36; Bandak FA, 1997, NATO ADV SCI I E-APP, V332, P53; Besenski N., 2006, IMAGING HEAD INJURIE, P99; Dassault Systemes, 2017, AB AN US MAN; Delye Hans, 2006, Stapp Car Crash J, V50, P625; Depreitere B, 2006, J NEUROSURG, V104, P950, DOI 10.3171/jns.2006.104.6.950; Famaey N, 2015, J MECH BEHAV BIOMED, V41, P222, DOI 10.1016/j.jmbbm.2014.06.009; Fernandes FAO, 2018, SPRINGERBR APPL SCI, P1, DOI 10.1007/978-3-319-89926-8_1; Fernandes FAO, 2018, SPRINGERBR APPL SCI, P41, DOI 10.1007/978-3-319-89926-8_3; Fernandes FAO, 2018, ENG COMPUTATION, V35, P477, DOI 10.1108/EC-09-2016-0321; Fernandes FAO, 2015, P I MECH ENG H, V229, P592, DOI 10.1177/0954411915592906; Gennarelli T A, 1983, Acta Neurochir Suppl (Wien), V32, P1; GENNARELLI TA, 1982, J TRAUMA, V22, P680, DOI 10.1097/00005373-198208000-00005; Han H, 2007, NEURORADIOLOGY, V49, P169, DOI 10.1007/s00234-006-0175-z; Hardy WN, 2007, STAPP CAR CRASH JO, V51, P17; Ho J, 2008, THESIS; Ho J, 2007, J BIOMECH, V40, P3006, DOI 10.1016/j.jbiomech.2007.02.011; Kilic Turker, 2008, Front Neurol Neurosci, V23, P4; Kleiven S., 2002, THESIS; LEE MC, 1989, J BIOMECH, V22, P537, DOI 10.1016/0021-9290(89)90005-5; Li WG, 2016, J MED BIOL ENG, V36, P285, DOI 10.1007/s40846-016-0132-1; LOWENHIELM P, 1978, J BIOENG, V2, P501; Monea AG, 2014, J MECH BEHAV BIOMED, V32, P155, DOI 10.1016/j.jmbbm.2013.12.007; Monson KL, 2005, J BIOMECH, V38, P737, DOI 10.1016/j.jbiomech.2004.05.004; Nahum AM., 1977, P 21 STAPP CAR CRASH, P339, DOI [10.4271/770922., DOI 10.4271/770922]; Nowinski W., 2016, HUMAN BRAIN HEAD NEC; OKA K, 1985, NEUROSURGERY, V17, P711, DOI 10.1227/00006123-198511000-00003; Prantl A., 2013, 2013 SIMULIA COMM C; Ratajczak M, 2016, ACTA BIOENG BIOMECH, V18, P21, DOI 10.5277/ABB-00552-2016-02; Richter M, 2001, J TRAUMA, V51, P949, DOI 10.1097/00005373-200111000-00021; SAHUQUILLOBARRIS J, 1988, J NEUROSURG, V68, P894, DOI 10.3171/jns.1988.68.6.0894; Sampei T, 1996, NEUROSURGERY, V38, P971, DOI 10.1097/00006123-199605000-00024; Vignes JR, 2007, J NEUROSURG, V107, P1205, DOI 10.3171/JNS-07/12/1205; YAMASHIMA T, 1984, J NEUROL NEUROSUR PS, V47, P121, DOI 10.1136/jnnp.47.2.121; Zhang L, 2001, Stapp Car Crash J, V45, P369	35	18	18	0	6	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0268-0033	1879-1271		CLIN BIOMECH	Clin. Biomech.	MAR	2019	63						104	111		10.1016/j.clinbiomech.2019.02.010			8	Engineering, Biomedical; Orthopedics; Sport Sciences	Engineering; Orthopedics; Sport Sciences	HW6UZ	WOS:000466827500015	30851565				2021-06-18	
J	Zhang, T; Ni, SF; Luo, ZX; Lang, Y; Hu, JZ; Lu, HB				Zhang, Tao; Ni, Shuangfei; Luo, Zixiang; Lang, Ye; Hu, Jianzhong; Lu, Hongbin			The protective effect of microRNA-21 in neurons after spinal cord injury	SPINAL CORD			English	Article							TRAUMATIC BRAIN-INJURY; RAT-HEART; APOPTOSIS; MIR-21; EXPRESSION; IDENTIFICATION; CELLS	Study design Experimental animal study. Objectives To validate the anti-apoptosis effect of microRNA-21 in neurons after spinal cord injury (SCI) and explore the mechanism. Setting Xiangya Hospital, Central South University, Changsha, Hunan, People's Republic of China. Methods In situ hybridization was used to detect the expression of miR-21 in spinal cord neurons (n = 24). In a rat contusion SCI model (n = 48), we upregulated the miR-21 level around the injured area using miR-21 lentiviral vectors and evaluated the therapeutic effect with histology and behavioural scores. In neuronal cells, oxygen-glucose deprivation (OGD) was exerted to imitate SCI, and we explored the biomechanism using molecular biology and a dual-luciferase reporter assay. Results miR-21 was expressed in spinal cord neurons and was found to improve neuronal survival and promote functional recovery in rat SCI models. The in vitro results in PC-12 cells revealed that the augmentation of endogenous miR-21 was able to reduce neuronal cell death after OGD. In addition, overexpression of miR-21 was able to reduce cellular apoptosis via decreasing PDCD4 protein levels, and caspase-3 activity was also influenced. Transfection of miR-21 into 293T cells was able to decrease luciferase activity in a reporter assay system, including the 3' untranslated region of PDCD4. Conclusions miR-21 may have a protective role in neuronal apoptosis after SCI. PDCD4 may be a functional target gene involved in the miR-21-mediated anti-apoptotic effect through an miR-21/PDCD4/caspase-3 pathway.	[Zhang, Tao; Lu, Hongbin] Cent S Univ, Xiangya Hosp, Res Ctr Sports Med, Dept Sports Med, Changsha, Hunan, Peoples R China; [Zhang, Tao; Hu, Jianzhong; Lu, Hongbin] Key Lab Organ Injury Aging & Regenerat Med Hunan, Changsha, Hunan, Peoples R China; [Ni, Shuangfei; Luo, Zixiang; Lang, Ye; Hu, Jianzhong] Cent S Univ, Xiangya Hosp, Dept Spine Surg, Changsha, Hunan, Peoples R China	Lu, HB (corresponding author), Cent S Univ, Xiangya Hosp, Res Ctr Sports Med, Dept Sports Med, Changsha, Hunan, Peoples R China.; Lu, HB (corresponding author), Key Lab Organ Injury Aging & Regenerat Med Hunan, Changsha, Hunan, Peoples R China.	hongbinlu@hotmail.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81371956, 81171698, 81672174]	This work was supported by the National Natural Science Foundation of China (No. 81371956, No. 81171698 and No. 81672174).	BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Ben Borgens R, 2012, Q REV BIOL, V87, P89, DOI 10.1086/665457; Bhalala OG, 2013, NAT REV NEUROL, V9, P328, DOI 10.1038/nrneurol.2013.67; Bhalala OG, 2012, J NEUROSCI, V32, P17935, DOI 10.1523/JNEUROSCI.3860-12.2012; Buller B, 2010, FEBS J, V277, P4299, DOI 10.1111/j.1742-4658.2010.07818.x; Cheng YH, 2010, CARDIOVASC RES, V87, P431, DOI 10.1093/cvr/cvq082; Cheng YH, 2009, J MOL CELL CARDIOL, V47, P5, DOI 10.1016/j.yjmcc.2009.01.008; Dong J, 2014, NEUROL SCI, V35, P1663, DOI 10.1007/s10072-014-1940-0; Duan X, 2012, CARDIOLOGY, V122, P36, DOI 10.1159/000338149; Eto K, 2012, CELL DEATH DIFFER, V19, P573, DOI 10.1038/cdd.2011.126; Ge XT, 2015, BRAIN RES, V1603, P150, DOI 10.1016/j.brainres.2015.01.009; Godwin JG, 2010, P NATL ACAD SCI USA, V107, P14339, DOI 10.1073/pnas.0912701107; Hannan JL, 2016, SCI REP-UK, V6, DOI 10.1038/srep29416; Hao N, 2014, NEUROSCI LETT, V564, P37, DOI 10.1016/j.neulet.2013.12.050; Harrison EB, 2016, FEBS OPEN BIO, V6, P835, DOI 10.1002/2211-5463.12092; Hu JZ, 2013, J NEUROTRAUM, V30, P1349, DOI 10.1089/neu.2012.2748; Jiang LP, 2017, ONCOTARGET, V8, P23675, DOI 10.18632/oncotarget.15644; Kosik KS, 2006, NAT REV NEUROSCI, V7, P911, DOI 10.1038/nrn2037; Kutner RH, 2009, NAT PROTOC, V4, P495, DOI 10.1038/nprot.2009.22; Lei P, 2009, BRAIN RES, V1284, P191, DOI 10.1016/j.brainres.2009.05.074; Liu G, 2010, EXP NEUROL, V226, P200, DOI 10.1016/j.expneurol.2010.08.032; Liu XS, 2009, J BIOL CHEM, V284, P22680, DOI 10.1074/jbc.M109.006551; Nardone R, 2016, DRUG DISCOV TODAY, V21, P1632, DOI 10.1016/j.drudis.2016.06.015; Ruan QG, 2011, P NATL ACAD SCI USA, V108, P12030, DOI 10.1073/pnas.1101450108; Shen ZL, 2017, NEUROCHEM RES, V42, P2336, DOI 10.1007/s11064-017-2251-7; Tian R, 2017, J NEUROCHEM, V141, P708, DOI 10.1111/jnc.14025; van den Bogaart G, 2011, NATURE, V479, P552, DOI 10.1038/nature10545; Wang G, 2015, ARCH BIOCHEM BIOPHYS, V580, P64, DOI 10.1016/j.abb.2015.07.001; White K, 2014, HYPERTENSION, V64, P185, DOI 10.1161/HYPERTENSIONAHA.113.03037; Xiang MQ, 2014, BIOCHEM BIOPH RES CO, V454, P210, DOI 10.1016/j.bbrc.2014.10.064; Yip PK, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-6; Zhang L, 2012, GLIA, V60, P1888, DOI 10.1002/glia.22404; Zhu JB, 2016, CELL PHYSIOL BIOCHEM, V39, P2364, DOI 10.1159/000452506	33	18	19	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1362-4393	1476-5624		SPINAL CORD	Spinal Cord	FEB	2019	57	2					141	149		10.1038/s41393-018-0180-1			9	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	HJ8PV	WOS:000457462800009	30089893	Green Published, Other Gold			2021-06-18	
J	Li, LX; Ismael, S; Nasoohi, S; Sakata, K; Liao, FF; McDonald, MP; Ishrat, T				Li, Lexiao; Ismael, Saifudeen; Nasoohi, Sanaz; Sakata, Kazuko; Liao, Francesca-Fang; McDonald, Michael P.; Ishrat, Tauheed			Thioredoxin-Interacting Protein (TXNIP) Associated NLRP3 Inflammasome Activation in Human Alzheimer's Disease Brain	JOURNAL OF ALZHEIMERS DISEASE			English	Article						Alzheimer's disease; amyloid plaques; hyperphosphorylated tau; NLRP3 inflammasome interlukin-1; thioredoxin-interacting protein	OXIDATIVE STRESS; GENE-EXPRESSION; TRANSGENIC MICE; NEUROINFLAMMATION; CONTRIBUTES; STROKE	Alzheimer's disease (AD) is the most common form of age-associated dementia characterized by amyloid-beta plaques and neurofibrillary tangles. Recent studies have demonstrated that thioredoxin-interacting protein (TXNIP), an endogenous regulator of redox/glucose induced stress and inflammation, is now known to be upregulated in stroke, traumatic brain injury, diabetes and AD. We hypothesized that TXNIP overexpression sustains neurodegeneration through activation of the nucleotide binding and oligomerization domain-like receptor protein 3 in human AD brains. We analyzed TXNIP and the components of the NLRP3 inflammasome in the cortex of postmortem human brain samples by western blotting, real-time PCR, and immunohistochemical techniques in comparison with age-matched non-demented controls. Our results demonstrate that TXNIP protein as well as its mRNA levels in the cortex was significantly upregulated in AD compared to control brains. Moreover, using double immunofluorescence staining, TXNIP and interlukin-1 beta (IL-1 beta) were co-localized near A beta plaques and p-tau. These results suggest an association between TXNIP overexpression levels and AD pathogenesis. Further, a significant increased expression of cleaved caspase-1 and IL-1 beta, the products of inflammasome activation, was detected in the cortex of AD brains. Together, these findings suggest that TXNIP, an upstream promising new therapeutic target, is a molecular link between inflammation and AD. The significant contribution of TXNIP to AD pathology suggests that strategies focusing on specific targeting of the TXNIP-NLRP3 inflammasome may lead to novel therapies for the management of AD and other age-related dementias.	[Li, Lexiao; Ismael, Saifudeen; Nasoohi, Sanaz; McDonald, Michael P.; Ishrat, Tauheed] Univ Tennessee, Ctr Hlth Sci, Coll Med, Dept Anat & Neurobiol, 875 Monroe Ave,Wittenborg Bldg,Room 231, Memphis, TN 38163 USA; [Sakata, Kazuko; Liao, Francesca-Fang] Univ Tennessee, Ctr Hlth Sci, Coll Med, Dept Pharmacol, Memphis, TN 38163 USA; [Sakata, Kazuko; Liao, Francesca-Fang; McDonald, Michael P.] Univ Tennessee, Ctr Hlth Sci, Coll Med, Dept Neurol, Memphis, TN 38163 USA; [Nasoohi, Sanaz] Shahid Beheshti Univ Med Sci, Neurosci Res Ctr, Tehran, Iran; [McDonald, Michael P.; Ishrat, Tauheed] Univ Tennessee, Ctr Hlth Sci, Inst Neurosci, Memphis, TN 38163 USA	Ishrat, T (corresponding author), Univ Tennessee, Ctr Hlth Sci, Coll Med, Dept Anat & Neurobiol, 875 Monroe Ave,Wittenborg Bldg,Room 231, Memphis, TN 38163 USA.	tishrat@uthsc.edu	Ismael, Saifudeen/AAE-1679-2021; Ismael, Saifudeen/AAR-2031-2021; Sakata, Kazuko/I-2351-2017	Li, Lexiao/0000-0002-3693-5452	Department of Anatomy Neurobiology, UTHSC Memphis TN; National Institute of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01-NS097800, R01-NS094595, R01-AG054562, R01AG049772]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS094595, R01NS097800] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [RF1AG058467, R01AG054562, R01AG049772] Funding Source: NIH RePORTER	This work was supported by startup funds: Department of Anatomy Neurobiology, UTHSC Memphis TN (TI) and National Institute of Health: R01-NS097800 (TI), R01-NS094595 (MPM), R01-AG054562 (MPM), R01AG049772 (FFL). We thank Dr. Peter T. Nelson (University of Kentucky Sanders-Brown Center on Aging) for providing human brain specimens from the University of Kentucky AD Center (UK-ADC) cohort. Authors are also grateful for Dr. Asgar Zaheer, Department of Neurology, University of Missouri, Columbia, MO, USA, for providing human brain sections for immunostaining.	Abais JM, 2015, ANTIOXID REDOX SIGN, V22, P1111, DOI 10.1089/ars.2014.5994; Agostinho P, 2010, CURR PHARM DESIGN, V16, P2766, DOI 10.2174/138161210793176572; Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Alzheimer's Association, 2018, ALZHEIMERS DEMENT, V13, P325; Apelt J, 2001, BRAIN RES, V894, P21, DOI 10.1016/S0006-8993(00)03176-0; Arodin L, 2014, J ALZHEIMERS DIS, V39, P787, DOI 10.3233/JAD-131814; Brooks WM, 2007, BRAIN RES, V1127, P127, DOI 10.1016/j.brainres.2006.09.106; Chen JJ, 2016, J FUNCT FOODS, V22, P463, DOI 10.1016/j.jff.2016.01.036; Clausen BH, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-46; Colangelo V, 2002, J NEUROSCI RES, V70, P462, DOI 10.1002/jnr.10351; Craft JM, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-15; Denes A, 2011, CEREBROVASC DIS, V32, P517, DOI 10.1159/000332205; El-Azab MF, 2014, BRIT J PHARMACOL, V171, P1299, DOI 10.1111/bph.12535; Gouget T., 2011, ALZHEIMERS DEMENT, V7, pS684; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Heneka MT, 2013, NATURE, V493, P674, DOI 10.1038/nature11729; Hokama M, 2014, CEREB CORTEX, V24, P2476, DOI 10.1093/cercor/bht101; Horie K, 1997, BIOCHEM BIOPH RES CO, V236, P327, DOI 10.1006/bbrc.1997.6944; Hui STY, 2008, P NATL ACAD SCI USA, V105, P3921, DOI 10.1073/pnas.0800293105; Ishrat T, 2015, MOL NEUROBIOL, V51, P766, DOI 10.1007/s12035-014-8766-x; Ismael S, 2018, J NEUROTRAUM, V35, P1294, DOI 10.1089/neu.2017.5344; Jing G, 2014, J BIOL CHEM, V289, P11807, DOI 10.1074/jbc.M113.525022; Kim E, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006849; Lane T, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00050; Lovell MA, 2000, FREE RADICAL BIO MED, V28, P418, DOI 10.1016/S0891-5849(99)00258-0; Lue LF, 2001, GLIA, V35, P72, DOI 10.1002/glia.1072; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Melone MAB, 2018, PHARM RES-DORDR, V35, DOI 10.1007/s11095-017-2276-2; Mohamed IN, 2015, ANTIOXID REDOX SIGN, V22, P1188, DOI 10.1089/ars.2014.6126; Mohamed IN, 2014, DIABETOLOGIA, V57, P413, DOI 10.1007/s00125-013-3101-z; Mullins RJ, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00118; Nasoohi S, 2018, MOL NEUROBIOL, V55, P7900, DOI 10.1007/s12035-018-0917-z; Nelson PT, 2010, BRAIN PATHOL, V20, P66, DOI 10.1111/j.1750-3639.2008.00244.x; Nelson PT, 2009, J NEUROPATH EXP NEUR, V68, P774, DOI 10.1097/NEN.0b013e3181aacbe9; Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006; Panse M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198016; Papadia S, 2008, NAT NEUROSCI, V11, P476, DOI 10.1038/nn2071; Parachikova A, 2007, NEUROBIOL AGING, V28, P1821, DOI 10.1016/j.neurobiolaging.2006.08.014; Pelicano H, 2006, J CELL BIOL, V175, P913, DOI 10.1083/jcb.200512100; Perl DP, 2010, MT SINAI J MED, V77, P32, DOI 10.1002/msj.20157; Perrone Lorena, 2012, Int J Alzheimers Dis, V2012, P734956, DOI 10.1155/2012/734956; Ping LY, 2018, SCI DATA, V5, DOI 10.1038/sdata.2018.36; Pohanka M, 2014, CURR MED CHEM, V21, P356; Sand J, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0009-4; Saresella M, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0088-1; Sastre M, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-25; Schmitt FA, 2012, CURR ALZHEIMER RES, V9, P724; Shaftel SS, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-7; Shi JQ, 2013, CNS NEUROSCI THER, V19, P262, DOI 10.1111/cns.12066; Styr B, 2018, NAT NEUROSCI, V21, P463, DOI 10.1038/s41593-018-0080-x; Tan MG, 2010, J NEUROSCI RES, V88, P1157, DOI 10.1002/jnr.22290; Verdile G, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/105828; Watanabe R, 2010, PHARMACOL THERAPEUT, V127, P261, DOI 10.1016/j.pharmthera.2010.04.004; Ye XC, 2016, BIOCHEM BIOPH RES CO, V480, P69, DOI 10.1016/j.bbrc.2016.10.007; Yin J, 2018, MOL NEUROBIOL, V55, P1977, DOI 10.1007/s12035-017-0467-9; Yoshihara E, 2014, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00514; Zhou KR, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/9238290; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831	58	18	18	2	18	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1387-2877	1875-8908		J ALZHEIMERS DIS	J. Alzheimers Dis.		2019	68	1					255	265		10.3233/JAD-180814			11	Neurosciences	Neurosciences & Neurology	HO6PC	WOS:000461051200021	30741672				2021-06-18	
J	Asken, BM; Bauer, RM; DeKosky, ST; Houck, ZM; Moreno, CC; Jaffee, MS; Weber, AG; Clugston, JR				Asken, Breton M.; Bauer, Russell M.; DeKosky, Steven T.; Houck, Zachary M.; Moreno, Charles C.; Jaffee, Michael S.; Weber, Arthur G.; Clugston, James R.			Concussion Biomarkers Assessed in Collegiate Student-Athletes (BASICS) I Normative study	NEUROLOGY			English	Article							BRAIN-INJURY; SERUM-LEVELS; MARKERS; STRESS	Objective To describe variability in concussion biomarker concentrations collected from serum in a sample of healthy collegiate athletes, as well as report reliability metrics in a subsample of female athletes. Methods In this observational cohort study, beta-amyloid peptide 42 (A beta(42)), total tau, S100 calcium binding protein B (S100B), ubiquitin carboxy-terminal hydrolyzing enzyme L1 (UCH-L1), glial fibrillary acidic protein, microtubule associated protein 2, and 29,39-cyclic-nucleotide 39-phosphodiesterase (CNPase) serum concentrations were measured in 415 (61% male, 40% white, aged 19.0 +/- 1.2 years) nonconcussed collegiate athletes without recent exposure to head impacts. Standardized normative distributions are reported for each biomarker. We evaluated main effects (analyses of variance) of sex and race, reporting demographic-specific normative metrics when appropriate. In a subset of 31 female participants, test-retest reliability (Pearson r) and reliable change indices (80%, 90%, and 95% confidence intervals) across a 6- to 12-month interval are reported for A beta(42), total tau, S100B, and UCH-L1. Results Males exhibited higher UCH-L1 (p < 0.001, Cohen d = 0.75) and S100B (p < 0.001, d = 0.56) than females, while females had higher CNPase (p < 0.001, d = 0.43). Regarding race, black participants had higher baseline levels of UCH-L1 (p < 0.001, d = 0.61) and S100B (p < 0.001, d = 1.1) than white participants. Conversely, white participants had higher baseline levels of A beta(42) (p = 0.005, d = 0.28) and CNPase (p < 0.001, d = 0.46). Test-retest reliability was generally poor, ranging from -0.02 to 0.40, and A beta(42) significantly increased from time 1 to time 2. Conclusion Healthy collegiate athletes express concussion-related serum biomarkers in variable concentrations. Accounting for demographic factors such as sex and race is essential. Evidence suggested poor reliability for serum biomarkers; however, understanding how other factors influence biomarker expression, as well as knowledge of reliable change metrics, may improve clinical interpretation and future study designs.	[Asken, Breton M.; Houck, Zachary M.; Moreno, Charles C.] Univ Florida, Dept Clin & Hlth Psychol, Gainesville, FL 32611 USA; [Bauer, Russell M.; DeKosky, Steven T.; Jaffee, Michael S.; Clugston, James R.] Univ Florida, Dept Neurol, Gainesville, FL USA; [Clugston, James R.] Univ Florida, Dept Community Hlth & Family Med, Gainesville, FL USA; [Clugston, James R.] Univ Florida, Univ Athlet Assoc, Gainesville, FL USA; [Weber, Arthur G.] Banyan Biomarkers Inc, Alachua, FL USA	Asken, BM (corresponding author), Univ Florida, Dept Clin & Hlth Psychol, Gainesville, FL 32611 USA.	basken8@phhp.ufl.edu		Asken, Breton/0000-0001-8419-142X; DeKosky, Steven/0000-0003-3743-2758; Clugston, James/0000-0002-2103-1039	GE; Banyan Biomarkers, Inc.; U.S. Army Medical Research and Material Command (USAMRMC)U.S. Army Medical Research & Materiel Command (USAMRMC) [W81XWH-06-1-0517]; NFL; University of FloridaUniversity of Florida	This work was primarily supported by funds provided in a grant from the Head Health Initiative, a collaboration between GE and the NFL, Banyan Biomarkers, Inc., and the U.S. Army Medical Research and Material Command (USAMRMC) under contract W81XWH-06-1-0517. The University of Florida owns stock in Banyan Biomarkers, Inc., which is the sponsor of the study. In addition, the university has licensed technology to Banyan concerning blood biomarkers or proteins thereby allowing Banyan to use the technology. The company is interested in making a biomarker test for traumatic brain injury. If the biomarker test is sold commercially, then the University of Florida could benefit financially. Please feel free to ask any further questions you might have about this matter.	Asken BM, 2018, NEUROLOGY, V91, pE2123, DOI 10.1212/WNL.0000000000006616; Ben Abdesselam O, 2003, CLIN CHEM, V49, P836, DOI 10.1373/49.5.836; Biberthaler P, 2006, SHOCK, V25, P446, DOI 10.1097/01.shk.0000209534.61058.35; Brooks BL, 2017, ARCH CLIN NEUROPSYCH, V32, P1001, DOI 10.1093/arclin/acx028; Brooks BL, 2016, ARCH CLIN NEUROPSYCH, V31, P1026, DOI 10.1093/arclin/acw079; Chelune GJ, 1993, NEUROPSYCHOLOGY, V7, P41, DOI DOI 10.1037/0894-4105.7.1.41; Hasselblatt M, 2004, NEUROLOGY, V62, P1634, DOI 10.1212/01.WNL.0000123092.97047.B1; Hutchison MG, 2017, J HEAD TRAUMA REHAB, V32, pE38, DOI 10.1097/HTR.0000000000000252; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; Jessen NA, 2015, NEUROCHEM RES, V40, P2583, DOI 10.1007/s11064-015-1581-6; Jeter CB, 2013, J NEUROTRAUM, V30, P657, DOI 10.1089/neu.2012.2439; Kamins J, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097464; Kiechle K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084977; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Marchi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056805; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrea M, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097447; McCrea M, 2015, BRAIN INJURY, V29, P276, DOI 10.3109/02699052.2014.965216; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Meier TB, 2017, J NEUROTRAUM, V34, P3134, DOI 10.1089/neu.2017.5046; Meier TB, 2016, HUM BRAIN MAPP, V37, P833, DOI 10.1002/hbm.23072; Mondello S, 2012, NEUROSURGERY, V70, P666, DOI 10.1227/NEU.0b013e318236a809; Neselius S, 2013, BRAIN INJURY, V27, P425, DOI 10.3109/02699052.2012.750752; Nygaard O, 1997, CLIN CHEM, V43, P541; Otto M, 2000, INT J SPORTS MED, V21, P551, DOI 10.1055/s-2000-8480; Papa L, 2015, J NEUROTRAUM, V32, P661, DOI 10.1089/neu.2014.3655; Puvenna V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096296; Rissin DM, 2010, NAT BIOTECHNOL, V28, P595, DOI 10.1038/nbt.1641; Scaccianoce S, 2004, BRAIN RES, V1004, P208, DOI 10.1016/j.brainres.2004.01.028; Shahim P, 2014, JAMA NEUROL, V71, P684, DOI 10.1001/jamaneurol.2014.367; Unden J, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-50; Wiesmann M, 1998, CLIN CHEM, V44, P1056	32	18	18	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0028-3878	1526-632X		NEUROLOGY	Neurology	DEC 4	2018	91	23					E2109	E2122		10.1212/WNL.0000000000006613			14	Clinical Neurology	Neurosciences & Neurology	HK3XY	WOS:000457854000001	30404785	Green Published			2021-06-18	
J	Brickler, TR; Hazy, A; Correa, FG; Dai, RJ; Kowalski, EJA; Dickerson, R; Chen, J; Wang, X; Morton, PD; Whittington, A; Ahmed, A; Theus, MH				Brickler, Thomas R.; Hazy, Amanda; Correa, Fernanda Guilhaume; Dai, Rujuan; Kowalski, Elizabeth J. A.; Dickerson, Ross; Chen, Jiang; Wang, Xia; Morton, Paul D.; Whittington, Abby; Ahmed, Ansar; Theus, Michelle H.			Angiopoietin/Tie2 Axis Regulates the Age-at-Injury Cerebrovascular Response to Traumatic Brain Injury	JOURNAL OF NEUROSCIENCE			English	Article						angiopoietin; blood-brain barrier; cerebral blood flow; juvenile; miRNA; Tie2 receptor	GLUT1 GLUCOSE-TRANSPORTER; DIFFUSE AXONAL INJURY; IN-VITRO; CEREBRAL MICROBLEEDS; SUBVENTRICULAR ZONE; MICRORNA EXPRESSION; ENDOTHELIAL-CELLS; KETOGENIC DIET; PIGLET BRAIN; BLOOD-FLOW	Although age-at-injury influences chronic recovery from traumatic brain injury (TBI), the differential effects of age on early outcome remain understudied. Using a male murine model of moderate contusion injury, we investigated the underlying mechanism(s) regulating the distinct response between juvenile and adult TBI. We demonstrate similar biomechanical and physical properties of naive juvenile and adult brains. However, following controlled cortical impact (CCI), juvenile mice displayed reduced cortical lesion formation, cell death, and behavioral deficits at 4 and 14 d. Analysis of high-resolution laser Doppler imaging showed a similar loss of cerebral blood flow (CBF) in the ipsilateral cortex at 3 and 24 h post-CCI, whereas juvenile mice showed enhanced subsequent restoration at 2-4 d compared with adults. These findings correlated with reduced blood-brain barrier (BBB) disruption and increased perilesional vessel density. To address whether an age-dependent endothelial cell (EC) response affects vessel stability and tissue outcome, we magnetically isolated CD31(+) ECs from sham and injured cortices and evaluated mRNA expression. Interestingly, we found increased transcripts for BBB stability-related genes and reduced expression of BBB-disrupting genes in juveniles compared with adults. These differences were concomitant with significant changes in miRNA-21-5p and miR-148a levels. Accompanying these findings was robust GFAP immunoreactivity, which was not resolved by day 35. Importantly, pharmacological inhibition of EC-specific Tie2 signaling abolished the juvenile protective effects. These findings shed new mechanistic light on the divergent effects that age plays on acute TBI outcome that are both spatial and temporal dependent.	[Brickler, Thomas R.; Hazy, Amanda; Dai, Rujuan; Kowalski, Elizabeth J. A.; Chen, Jiang; Wang, Xia; Morton, Paul D.; Ahmed, Ansar; Theus, Michelle H.] Virginia Polytech Inst & State Univ, Dept Biomed Sci & Pathobiol, Coll Vet Med, Roanoke, VA 24061 USA; [Correa, Fernanda Guilhaume] Virginia Polytech Inst & State Univ, Translat Biol Med & Hlth Grad Program, Sch Med, Roanoke, VA 24061 USA; [Dickerson, Ross; Whittington, Abby] Virginia Polytech Inst & State Univ, Dept Chem Engn, Sch Biomed Engn & Sci, Roanoke, VA 24061 USA	Theus, MH (corresponding author), Virginia Tech, Dept Biomed Sci & Pathobiol, Coll Vet Med, 970 Washington St SW,MC0910, Blacksburg, VA 24061 USA.	mtheus@vt.edu		Guilhaume Correa, Fernanda/0000-0002-3878-5283	National Institute of Neurological Disorders and Stroke of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS096281]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS096281] Funding Source: NIH RePORTER	This work was supported by the National Institute of Neurological Disorders and Stroke of the National Institutes of Health (Grant R01NS096281 to M.H.T.). We thank the Regenerative Medicine-Interdisciplinary Graduate Education Program at Virginia Tech and Institute of Critical Technology and Applied Sciences Programs for student support T.R.B., A.H.), the Virginia-Maryland Regional College of Veterinary Medicine, and Dr. William Huckle for the generous gift of qRT-PCR primers.	Abbott NJ, 2002, J ANAT, V200, P629, DOI 10.1046/j.1469-7580.2002.00064.x; Abdul-Muneer PM, 2016, CNS NEUROSCI THER, V22, P543, DOI 10.1111/cns.12579; Adelson PD, 1997, PEDIATR NEUROSURG, V26, P200; Adlakha YK, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-33; Allen CL, 2009, INT J STROKE, V4, P461, DOI 10.1111/j.1747-4949.2009.00387.x; Appelberg KS, 2009, J NEUROTRAUM, V26, P497, DOI 10.1089/neu.2008.0664; Armstead WM, 1999, EXP TOXICOL PATHOL, V51, P137, DOI 10.1016/S0940-2993(99)80087-6; Assis-Nascimento P, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0016-5; Baumann G, 2013, EXP BIOL MED, V238, P830, DOI 10.1177/1535370213494558; Belanger Mireille, 2009, Dialogues Clin Neurosci, V11, P281; Bhalala OG, 2013, NAT REV NEUROL, V9, P328, DOI 10.1038/nrneurol.2013.67; Blaiss CA, 2011, J NEUROSCI, V31, P4906, DOI 10.1523/JNEUROSCI.5265-10.2011; BOADO RJ, 1994, MOL BRAIN RES, V22, P259, DOI 10.1016/0169-328X(94)90054-X; Bouet V, 2007, EXP NEUROL, V203, P555, DOI 10.1016/j.expneurol.2006.09.006; Brickler T, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/6373506; Brindle NPJ, 2006, CIRC RES, V98, P1014, DOI 10.1161/01.RES.0000218275.54089.12; Burda JE, 2016, EXP NEUROL, V275, P305, DOI 10.1016/j.expneurol.2015.03.020; Chamorro-Jorganes A, 2013, PHARMACOL RES, V75, P15, DOI 10.1016/j.phrs.2013.04.002; Chen YM, 2003, J CEREBR BLOOD F MET, V23, P137, DOI 10.1097/01.WCB.0000044631.80210.3C; Chittiboina Prashant, 2013, Pathophysiology, V20, P15, DOI 10.1016/j.pathophys.2012.02.004; Clark RE, 2000, J NEUROSCI, V20, P8853; Claus CP, 2010, DEV NEUROSCI-BASEL, V32, P454, DOI 10.1159/000316805; Curvello V, 2017, PEDIATR RES, V82, P108, DOI 10.1038/pr.2017.83; Dai RJ, 2013, BIOL SEX DIFFER, V4, DOI 10.1186/2042-6410-4-19; Dai RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014302; de la Plata CAM, 2008, ARCH PHYS MED REHAB, V89, P896, DOI 10.1016/j.apmr.2007.12.030; Deng-Bryant Y, 2011, J NEUROTRAUM, V28, P1813, DOI 10.1089/neu.2011.1822; Devraj K, 2011, J NEUROSCI RES, V89, P1913, DOI 10.1002/jnr.22738; Dixon KJ, 2015, J NEUROTRAUM, V32, P753, DOI 10.1089/neu.2014.3390; Duhaime AC, 2003, J NEUROSURG, V99, P542, DOI 10.3171/jns.2003.99.3.0542; Duhaime AC, 2000, J NEUROSURG, V93, P455, DOI 10.3171/jns.2000.93.3.0455; Durham SR, 2000, PEDIATR NEUROSURG, V33, P76, DOI 10.1159/000028980; Engelhardt B, 2014, CELL TISSUE RES, V355, P687, DOI 10.1007/s00441-014-1811-2; ESTRADA C, 1990, J NEUROPATH EXP NEUR, V49, P539, DOI 10.1097/00005072-199011000-00001; Fan P, 2003, J NEUROTRAUM, V20, P437, DOI 10.1089/089771503765355513; Fiedler U, 2006, TRENDS IMMUNOL, V27, P552, DOI 10.1016/j.it.2006.10.004; FitzGerald A, 2010, BRAIN INJURY, V24, P1311, DOI 10.3109/02699052.2010.506864; Fukuhara S, 2009, EXP MOL MED, V41, P133, DOI 10.3858/emm.2009.41.3.016; Ge XT, 2014, SCI REP-UK, V4, DOI 10.1038/srep06718; Ge XT, 2019, J NEUROTRAUM, V36, P1291, DOI 10.1089/neu.2018.5728; Ge XT, 2016, BRAIN RES, V1650, P31, DOI 10.1016/j.brainres.2016.07.015; Giza CC, 2006, DEV NEUROSCI-BASEL, V28, P364, DOI 10.1159/000094163; Goldstein G W, 1987, Mead Johnson Symp Perinat Dev Med, P15; Gu H, 2016, INT NEUROUROL J, V20, P288, DOI 10.5213/inj.1632692.346; Gurnik S, 2016, ACTA NEUROPATHOL, V131, P753, DOI 10.1007/s00401-016-1551-3; Han ZL, 2015, DNA CELL BIOL, V34, P703, DOI 10.1089/dna.2015.2800; Han ZL, 2014, BRAIN RES, V1582, P12, DOI 10.1016/j.brainres.2014.07.045; Hashimoto T, 2004, ENDOTHELIUM-J ENDOTH, V11, P207, DOI 10.1080/10623320490512417; Huang Y, 2012, P NATL ACAD SCI USA, V109, P17478, DOI 10.1073/pnas.1209281109; JANE JA, 1985, J NEUROSURG, V62, P96, DOI 10.3171/jns.1985.62.1.0096; JONES BJ, 1968, J PHARM PHARMACOL, V20, P302, DOI 10.1111/j.2042-7158.1968.tb09743.x; Kamper JE, 2013, EXP NEUROL, V250, P8, DOI 10.1016/j.expneurol.2013.09.016; Kanehisa M, 2017, NUCLEIC ACIDS RES, V45, pD353, DOI 10.1093/nar/gkw1092; Kim I, 2000, ONCOGENE, V19, P4549, DOI 10.1038/sj.onc.1203800; Leger M, 2013, NAT PROTOC, V8, P2531, DOI 10.1038/nprot.2013.155; Lei P, 2009, BRAIN RES, V1284, P191, DOI 10.1016/j.brainres.2009.05.074; Liu J, 2014, NEURAL REGEN RES, V9, P1222, DOI 10.4103/1673-5374.135330; Liu YL, 2017, ACTA PHARMACOL SIN, V38, P1445, DOI 10.1038/aps.2017.103; Logsdon AF, 2015, COMPR PHYSIOL, V5, P1147, DOI 10.1002/cphy.c140057; Lu TP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042390; Marin JR, 2014, JAMA-J AM MED ASSOC, V311, P1917, DOI 10.1001/jama.2014.3979; McGinn MJ, 2016, NEUROSURG CLIN N AM, V27, P397, DOI 10.1016/j.nec.2016.06.002; McGraw J, 2001, J NEUROSCI RES, V63, P109, DOI 10.1002/1097-4547(20010115)63:2<109::AID-JNR1002>3.0.CO;2-J; Meissner L, 2016, J NEUROTRAUM, V33, P713, DOI 10.1089/neu.2015.4077; Mi HY, 2001, J NEUROSCI, V21, P1538; Milam KE, 2015, TISSUE BARRIERS, V3, DOI 10.4161/21688362.2014.957508; Missios S, 2009, J NEUROTRAUM, V26, P1943, DOI [10.1089/neu.2009.0956, 10.1089/neu.2009-0956]; Morales Sara, 2017, BioMolecular Concepts, V8, P203, DOI 10.1515/bmc-2017-0024; Moretti R, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00040; Myer DJ, 2006, BRAIN, V129, P2761, DOI 10.1093/brain/awl165; Ojo JO, 2016, J NEUROPATH EXP NEUR, V75, P636, DOI 10.1093/jnen/nlw035; Okyere B, 2018, J NEUROSCI METH, V293, P86, DOI 10.1016/j.jneumeth.2017.09.010; Okyere B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159930; OPPENHEI.DR, 1968, J NEUROL NEUROSUR PS, V31, P299, DOI 10.1136/jnnp.31.4.299; Park JH, 2009, J KOREAN NEUROSURG S, V46, P365, DOI 10.3340/jkns.2009.46.4.365; Passineau MJ, 2000, AM J PHYSIOL-HEART C, V279, pH924; Pearn ML, 2017, CELL MOL NEUROBIOL, V37, P571, DOI 10.1007/s10571-016-0400-1; Pop V, 2013, J CEREBR BLOOD F MET, V33, P205, DOI 10.1038/jcbfm.2012.154; POVLISHOCK JT, 1993, ANN EMERG MED, V22, P980, DOI 10.1016/S0196-0644(05)82738-6; POVLISHOCK JT, 1983, J NEUROPATH EXP NEUR, V42, P225, DOI 10.1097/00005072-198305000-00002; Price L., 2016, TRANSLATIONAL RES TR; Prins ML, 2005, J NEUROSCI RES, V82, P413, DOI 10.1002/jnr.20633; Prins ML, 2004, J NEUROCHEM, V90, P666, DOI 10.1111/j.1471-4159.2004.02542.x; Redell JB, 2011, J NEUROSCI RES, V89, P212, DOI 10.1002/jnr.22539; Reis C, 2015, INT J MOL SCI, V16, P11903, DOI 10.3390/ijms160611903; Salehi A, 2017, J CEREBR BLOOD F MET, V37, P2320, DOI 10.1177/0271678X17701460; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; Spoerri PE, 1997, DEV BRAIN RES, V104, P205, DOI 10.1016/S0165-3806(97)00173-9; Teichert-Kuliszewska K, 2001, CARDIOVASC RES, V49, P659, DOI 10.1016/S0008-6363(00)00231-5; Theus MH, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.165; Theus MH, 2010, STEM CELLS, V28, P1231, DOI 10.1002/stem.449; Thomas S, 2000, J NEUROTRAUM, V17, P649, DOI 10.1089/089771500415409; Thurman DJ, 2016, J CHILD NEUROL, V31, P20, DOI 10.1177/0883073814544363; Tong KA, 2003, RADIOLOGY, V227, P332, DOI 10.1148/radiol.2272020176; van der Horn HJ, 2018, BRAIN IMAGING BEHAV, V12, P912, DOI 10.1007/s11682-017-9743-6; Walchli T, 2015, NAT PROTOC, V10, P53, DOI 10.1038/nprot.2015.002; Wagner S, 2000, NEUROSCI LETT, V284, P105, DOI 10.1016/S0304-3940(00)00987-3; Wang JD, 2016, MOL PHARMACEUT, V13, P895, DOI 10.1021/acs.molpharmaceut.5b00805; Wang Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep37098; Zeller K, 1996, DEV BRAIN RES, V91, P200, DOI 10.1016/0165-3806(95)00177-8; Zhang J, 2014, BRAIN RES, V1583, P193, DOI 10.1016/j.brainres.2014.06.014; Zhao ZR, 2012, J NEUROTRAUM, V29, P2475, DOI 10.1089/neu.2012.2511	102	18	19	0	1	SOC NEUROSCIENCE	WASHINGTON	11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA	0270-6474	1529-2401		J NEUROSCI	J. Neurosci.	NOV 7	2018	38	45					9618	9634		10.1523/JNEUROSCI.0914-18.2018			17	Neurosciences	Neurosciences & Neurology	GZ4HM	WOS:000449355600002	30242049	Bronze, Green Published			2021-06-18	
J	Erdodi, LA; Abeare, CA; Medoff, B; Seke, KR; Sagar, S; Kirsch, NL				Erdodi, Laszlo A.; Abeare, Christopher A.; Medoff, Brent; Seke, Kristian R.; Sagar, Sanya; Kirsch, Ned L.			A Single Error Is One Too Many: The Forced Choice Recognition Trial of the CVLT-II as a Measure of Performance Validity in Adults with TBI	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						CVLT-II; Forced choice recognition; Traumatic brain injury; Performance validity assessment; Alternative cutoffs	TRAUMATIC BRAIN-INJURY; VERBAL-LEARNING TEST; CARD SORTING TEST; SYMPTOM VALIDITY; MEMORY TEST; RESPONSE BIAS; NEUROPSYCHOLOGICAL ASSESSMENT; DEPRESSIVE SYMPTOMS; INVALID PERFORMANCE; AMERICAN ACADEMY	Objective: The Forced Choice Recognition (FCR) trial of the California Verbal Learning Test-Second Edition (CVLT-II) was designed to serve as a performance validity test (PVT). The present study was designed to compare the classification accuracy of a more liberal alternative (<= 15) to the de facto FCR cutoff (<= 14). Method: The classification accuracy of the two cutoffs was computed in reference to psychometrically defined invalid performance, across various criterion measures, in a sample of 104 adults with TBI clinically referred for neuropsychological assessment. Results: The FCR was highly predictive (AUC: .71-.83) of Pass/Fail status on reference PVTs, but unrelated to performance on measures known to be sensitive to TBI. On average, FCR <= 15 correctly identified an additional 6% of invalid response sets compared to FCR <= 14, while maintaining .92 specificity. Patients who failed the FCR reported higher levels of emotional distress. Conclusions: Results suggest that even a single error on the FCR is a reliable indicator of invalid responding. Further research is needed to investigate the clinical significance of the relationship between failing the FCR and level of self-reported psychiatric symptoms.	[Erdodi, Laszlo A.] Univ Windsor, Dept Psychol, 168 Chrysler Hall South, Windsor, ON N9B 3P4, Canada; [Abeare, Christopher A.] Univ Windsor, Dept Psychol, 170 Chrysler Hall South, Windsor, ON N9B 3P4, Canada; [Medoff, Brent] Commonwealth Med Coll, 525 Pine St, Scranton, PA 18509 USA; [Seke, Kristian R.] Univ Windsor, Brain Cognit Neurosci Program, G105 Chrysler Hall North, Windsor, ON N9B 3P4, Canada; [Sagar, Sanya] Univ Windsor, Dept Psychol, 109 Chrysler Hall North, Windsor, ON N9B 3P4, Canada; [Kirsch, Ned L.] Univ Michigan, Dept Phys Med & Rehabil, Briarwood Circle 4, Ann Arbor, MI 48108 USA	Erdodi, LA (corresponding author), Univ Windsor, Dept Psychol, 168 Chrysler Hall South, Windsor, ON N9B 3P4, Canada.	lerdodi@gmail.com		Abeare, Christopher/0000-0002-7163-7434; Sagar, Sanya/0000-0001-7381-0803			American Psychiatric Association, 1996, Diagnostic and statistical manual of mental disorders, V4th; An KY, 2017, CLIN NEUROPSYCHOL, V31, P193, DOI 10.1080/13854046.2016.1217046; An KY, 2012, ARCH CLIN NEUROPSYCH, V27, P849, DOI 10.1093/arclin/acs085; Arnold G, 2005, CLIN NEUROPSYCHOL, V19, P105, DOI 10.1080/13854040490888567; Ashendorf L, 2004, ARCH CLIN NEUROPSYCH, V19, P125, DOI 10.1016/S0887-6177(02)00218-4; Axelrod BN, 2006, CLIN NEUROPSYCHOL, V20, P513, DOI 10.1080/13854040590967117; Baker KA, 1998, REHABIL PSYCHOL, V43, P30, DOI 10.1037/0090-5550.43.1.30; Baldo JV, 2002, J INT NEUROPSYCH SOC, V8, P539, DOI 10.1017/S135561770281428X; Bauer L, 2005, APPL NEUROPSYCHOL, V12, P202, DOI 10.1207/s15324826an1204_3; Bearden CE, 2006, PSYCHIAT RES, V142, P139, DOI 10.1016/j.psychres.2005.08.010; Beck A. T., 1996, BECK DEPRESSION INVE, VII; Bigler ED, 2015, BRAIN IMAGING BEHAV, V9, P421, DOI 10.1007/s11682-015-9409-1; Bigler ED, 2012, J INT NEUROPSYCH SOC, V18, P632, DOI 10.1017/S1355617712000252; Boone K. B., 2013, CLIN PRACTICE FORENS; Boone KB, 2009, CLIN NEUROPSYCHOL, V23, P729, DOI 10.1080/13854040802427803; Bortnik KE, 2010, CLIN NEUROPSYCHOL, V24, P344, DOI 10.1080/13854040903307268; Carone DA, 2008, BRAIN INJURY, V22, P960, DOI 10.1080/02699050802491297; Chafetz MD, 2015, CLIN NEUROPSYCHOL, V29, P723, DOI 10.1080/13854046.2015.1099738; Clark LR, 2012, CLIN NEUROPSYCHOL, V26, P1201, DOI 10.1080/13854046.2012.728626; Coleman RD, 1998, J CLIN EXP NEUROPSYC, V20, P201, DOI 10.1076/jcen.20.2.201.1164; Connor D. J., 1997, AM AC NEUR BOST; Considine CM, 2011, ARCH CLIN NEUROPSYCH, V26, P445, DOI 10.1093/arclin/acr041; Constantinou M, 2005, ARCH CLIN NEUROPSYCH, V20, P191, DOI 10.1016/j.acn.2004.06.002; Delis DC, 2000, CALIFORNIA VERBAL LE; Delis DC, 2007, ARCH CLIN NEUROPSYCH, V22, P589, DOI 10.1016/j.acn.2007.04.001; Derogatis L.R., 1994, SCL 90 R ADM SCORING, V3rd; Donders J, 2011, CLIN NEUROPSYCHOL, V25, P173, DOI 10.1080/13854046.2010.536781; Egeland J, 2005, ACTA PSYCHIAT SCAND, V112, P434, DOI 10.1111/j.1600-0447.2005.00599.x; Erdodi LA, 2019, APPL NEUROPSYCH-ADUL, V26, P155, DOI 10.1080/23279095.2017.1384925; Erdodi LA, 2018, APPL NEUROPSYCH-ADUL, V25, P327, DOI 10.1080/23279095.2017.1298600; Erdodi LA, 2018, PSYCHOL ASSESSMENT, V30, P755, DOI 10.1037/pas0000525; Erdodi LA, 2017, BRAIN INJURY, V31, P1362, DOI 10.1080/02699052.2017.1332386; Erdodi LA, 2017, J CLIN EXP NEUROPSYC, V39, P369, DOI 10.1080/13803395.2016.1230181; Erdodi LA, 2016, PSYCHOL INJ LAW, V9, P112, DOI 10.1007/s12207-016-9254-6; Erdodi LA, 2014, PSYCHOL INJ LAW, V7, P255, DOI 10.1007/s12207-014-9197-8; Erdodi LA, 2014, ARCH CLIN NEUROPSYCH, V29, P456, DOI 10.1093/arclin/acu026; Frederick R. I., 2003, VIP VALIDITY INDICAT; GRANT I, 1996, NEUROPSYCHOLOGICAL A; Green P, 2009, BRAIN INJURY, V23, P741, DOI 10.1080/02699050903133962; Green P, 1999, BRAIN INJURY, V13, P813, DOI 10.1080/026990599121205; Green P., 2003, GREENS WORD MEMORY T; Green P., 2007, ASSESSMENT FEIGNED C, P50; Greiffenstein M.F., 1994, PSYCHOL ASSESSMENT, V6, P218, DOI [https://doi.org/10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Greve KW, 2004, ARCH CLIN NEUROPSYCH, V19, P533, DOI 10.1016/j.acn.2003.08.002; Greve KW, 2002, CLIN NEUROPSYCHOL, V16, P179, DOI 10.1076/clin.16.2.179.13241; Heaton RK, 2004, REVISED COMPREHENSIV; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Hoofien D, 2005, APPL NEUROPSYCHOL, V12, P30, DOI 10.1207/s15324826an1201_6; ILSLEY JE, 1995, J AFFECT DISORDERS, V35, P1, DOI 10.1016/0165-0327(95)00032-I; Iverson GL, 2003, HANDBOOK OF FORENSIC NEUROPSYCHOLOGY, P137; Keiski MA, 2007, CLIN NEUROPSYCHOL, V21, P744, DOI 10.1080/13854040600775346; Kessels RPC, 2007, CLIN NEUROL NEUROSUR, V109, P323, DOI 10.1016/j.clineuro.2006.12.009; Lange RT, 2013, PSYCHOL ASSESSMENT, V25, P339, DOI 10.1037/a0030915; Langenecker SA, 2005, J CLIN EXP NEUROPSYC, V27, P320, DOI 10.1080/13803390490490515720; Larrabee G.J., 2012, FORENSIC NEUROPSYCHO; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; Leighton A, 2014, J INT NEUROPSYCH SOC, V20, P873, DOI 10.1017/S135561771400085X; Lichtenstein JD, 2017, CHILD NEUROPSYCHOL, V23, P284, DOI 10.1080/09297049.2015.1135422; Marschark M, 2000, J HEAD TRAUMA REHAB, V15, P1227, DOI 10.1097/00001199-200012000-00004; Marshall P, 2007, CLIN NEUROPSYCHOL, V21, P826, DOI 10.1080/13854040600801001; Millis SR., 2001, J FORENSIC NEUROPSYC, V2, P1, DOI [10.1300/J151v02n01_01, DOI 10.1300/J151V02N01_]; Moore BA, 2004, BRAIN INJURY, V18, P975, DOI 10.1080/02699050410001672350; Ord JS, 2010, J CLIN EXP NEUROPSYC, V32, P380, DOI 10.1080/13803390903066881; Palav A, 2001, J HEAD TRAUMA REHAB, V16, P275, DOI 10.1097/00001199-200106000-00006; Pearson, 2009, ADV CLIN SOL WAIS 4; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Raskin SA, 1998, CLIN NEUROPSYCHOL, V12, P21, DOI 10.1076/clin.12.1.21.1724; Rees LM, 2001, ARCH CLIN NEUROPSYCH, V16, P501, DOI 10.1016/S0887-6177(00)00064-0; Reese CS, 2012, ARCH CLIN NEUROPSYCH, V27, P176, DOI 10.1093/arclin/acr117; Reznek L, 2005, BRAIN INJURY, V19, P539, DOI 10.1080/02699050400005242; Rohling ML, 2002, ARCH CLIN NEUROPSYCH, V17, P205, DOI 10.1016/S0887-6177(01)00109-3; Root JC, 2006, J INT NEUROPSYCH SOC, V12, P688, DOI 10.1017/S1355617706060838; Ross TP, 2016, ARCH CLIN NEUROPSYCH, V31, P97, DOI 10.1093/arclin/acv062; Roth R.M., 2017, PSYCHOL NEUROSCI, V10, DOI [https//doi.org/10.1037/pne0000103, DOI 10.1037/PNE0000103]; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; Santos OA, 2014, ARCH CLIN NEUROPSYCH, V29, P609, DOI 10.1093/arclin/acu039; Schwartz ES, 2016, J INT NEUROPSYCH SOC, V22, P851, DOI 10.1017/S1355617716000746; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Spencer RJ, 2013, CLIN NEUROPSYCHOL, V27, P1362, DOI 10.1080/13854046.2013.845248; Sprinkle SD, 2002, J COUNS PSYCHOL, V49, P381, DOI 10.1037//0022-0167.49.3.381; Storch EA, 2004, DEPRESS ANXIETY, V19, P187, DOI 10.1002/da.20002; Sugarman MA, 2015, APPL NEUROPSYCH-ADUL, V22, P141, DOI 10.1080/23279095.2013.873439; Suhr J, 1997, J CLIN EXP NEUROPSYC, V19, P500, DOI 10.1080/01688639708403740; Suhr JA, 1999, J CLIN EXP NEUROPSYC, V21, P701, DOI 10.1076/jcen.21.5.701.868; Sweet JJ, 2013, BEHAV SCI LAW, V31, P756, DOI 10.1002/bsl.2088; Tombaugh TN, 1996, TEST MEMORY MALINGER; TRUEBLOOD W, 1994, J CLIN EXP NEUROPSYC, V16, P597, DOI 10.1080/01688639408402671; Van Dyke SA, 2013, CLIN NEUROPSYCHOL, V27, P1234, DOI 10.1080/13854046.2013.835447; Westcott MC, 2005, BRAIN INJURY, V19, P1261, DOI 10.1080/02699050500150104; Wolfe PL, 2010, CLIN NEUROPSYCHOL, V24, P153, DOI 10.1080/13854040903107791	90	18	18	0	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	NOV	2018	33	7					845	860		10.1093/acn/acx110			16	Psychology, Clinical; Psychology	Psychology	HG9KC	WOS:000455325500005	29293900				2021-06-18	
J	Hsu, WC; Sugiarto, T; Lin, YJ; Yang, FC; Lin, ZY; Sun, CT; Hsu, CL; Chou, KN				Hsu, Wei-Chun; Sugiarto, Tommy; Lin, Yi-Jia; Yang, Fu-Chi; Lin, Zheng-Yi; Sun, Chi-Tien; Hsu, Chun-Lung; Chou, Kuan-Nien			Multiple-Wearable-Sensor-Based Gait Classification and Analysis in Patients with Neurological Disorders	SENSORS			English	Article						wearable device; gait analysis; IMU sensors; gait classification; stroke patients; neurological disorders	PHYSICAL-ACTIVITY; TRIAXIAL ACCELEROMETER; AMBULATORY SYSTEM; INERTIAL SENSORS; PARAMETERS; STABILITY; SUPPORT; HARMONY; EVENTS	The aim of this study was to conduct a comprehensive analysis of the placement of multiple wearable sensors for the purpose of analyzing and classifying the gaits of patients with neurological disorders. Seven inertial measurement unit (IMU) sensors were placed at seven locations: the lower back (L5) and both sides of the thigh, distal tibia (shank), and foot. The 20 subjects selected to participate in this study were separated into two groups: stroke patients (11) and patients with neurological disorders other than stroke (brain concussion, spinal injury, or brain hemorrhage) (9). The temporal parameters of gait were calculated using a wearable device, and various features and sensor configurations were examined to establish the ideal accuracy for classifying different groups. A comparison of the various methods and features for classifying the three groups revealed that a combination of time domain and gait temporal feature-based classification with the Multilayer Perceptron (MLP) algorithm outperformed the other methods of feature-based classification. The classification results of different sensor placements revealed that the sensor placed on the shank achieved higher accuracy than the other sensor placements (L5, foot, and thigh). The placement-based classification of the shank sensor achieved 89.13% testing accuracy with the Decision Tree (DT) classifier algorithm. The results of this study indicate that the wearable IMU device is capable of differentiating between the gait patterns of healthy patients, patients with stroke, and patients with other neurological disorders. Moreover, the most favorable results were reported for the classification that used the combination of time domain and gait temporal features as the model input and the shank location for sensor placement.	[Hsu, Wei-Chun; Sugiarto, Tommy; Lin, Yi-Jia] Natl Taiwan Univ Sci & Technol, Grad Inst Biomed Engn, Taipei 10607, Taiwan; [Hsu, Wei-Chun; Sugiarto, Tommy] Natl Taiwan Univ Sci & Technol, Grad Inst Appl Sci & Technol, Taipei 10607, Taiwan; [Hsu, Wei-Chun] Natl Def Med Ctr, Dept Biomed Engn, Taipei 11490, Taiwan; [Sun, Chi-Tien; Hsu, Chun-Lung] Ind Technol Res Inst, Div Embedded Syst & SoC Technol, Syst Integrat & Applicat Dept, Informat & Commun Res Lab, Hsinchu 31057, Taiwan; [Yang, Fu-Chi] Triserv Gen Hosp, Dept Neurol, Natl Def Med Ctr, Taipei 11490, Taiwan; [Lin, Zheng-Yi] Taipei City Hosp, Dept Phys Med & Rehabil, Zhongxing Branch, Taipei 10341, Taiwan; [Chou, Kuan-Nien] Triserv Gen Hosp, Neurosurg Dept, Taipei 11490, Taiwan	Hsu, WC (corresponding author), Natl Taiwan Univ Sci & Technol, Grad Inst Biomed Engn, Taipei 10607, Taiwan.; Hsu, WC (corresponding author), Natl Taiwan Univ Sci & Technol, Grad Inst Appl Sci & Technol, Taipei 10607, Taiwan.; Hsu, WC (corresponding author), Natl Def Med Ctr, Dept Biomed Engn, Taipei 11490, Taiwan.; Chou, KN (corresponding author), Triserv Gen Hosp, Neurosurg Dept, Taipei 11490, Taiwan.	wchsu@mail.ntust.edu.tw; d10622817@mail.ntust.edu.tw; jiajia527@gmail.com; Fuji-yang@yahoo.com.tw; DAP52@tpech.gov.tw; ctsun@itri.org.tw; clh@itri.org.tw; choukuannien@gmail.com	Sugiarto, Tommy/W-8465-2019	Sugiarto, Tommy/0000-0002-8814-1275; Yang, Fu-Chi/0000-0001-6831-3634; Lin, C. Delmar/0000-0003-0720-7584	Ministry of Science and Technology, TaiwanMinistry of Science and Technology, Taiwan [MOST104-2628-E-011-006-MY3]; National Taiwan University of Science and Technology [TSGH-NTUST-104-05]; Tri-Service General Hospital [TSGH-NTUST-107-04]; Industrial Technology Research Institute [107A02104]	The authors gratefully acknowledge financial support from the grant from the Ministry of Science and Technology, Taiwan (MOST104-2628-E-011-006-MY3 to W.-C.H., the corresponding author Wei-Chun Hsu), the National Taiwan University of Science and Technology (TSGH-NTUST-104-05), the Tri-Service General Hospital (TSGH-NTUST-107-04), and Industrial Technology Research Institute (107A02104).	Aminian K, 2002, J BIOMECH, V35, P689, DOI 10.1016/S0021-9290(02)00008-8; Anwary AR, 2018, IEEE SENS J, V18, P2555, DOI 10.1109/JSEN.2017.2786587; Begg RK, 2005, IEEE T BIO-MED ENG, V52, P828, DOI 10.1109/TBME.2005.845241; Bishop CM., 1995, NEURAL NETWORKS PATT; Carcreff L, 2018, SENSORS-BASEL, V18, DOI 10.3390/s18020394; Coley B, 2005, GAIT POSTURE, V22, P287, DOI 10.1016/j.gaitpost.2004.08.008; Daliri MR, 2012, MEASUREMENT, V45, P1729, DOI 10.1016/j.measurement.2012.04.013; De Vroey H, 2018, CLIN BIOMECH, V54, P22, DOI 10.1016/j.clinbiomech.2018.03.002; Del Din S, 2016, IEEE J BIOMED HEALTH, V20, P838, DOI 10.1109/JBHI.2015.2419317; Freund Y, 1997, J COMPUT SYST SCI, V55, P119, DOI 10.1006/jcss.1997.1504; Godfrey A, 2014, IEEE ENG MED BIO, P5892, DOI 10.1109/EMBC.2014.6944969; Iosa M, 2016, J MED BIOL ENG, V36, P635, DOI 10.1007/s40846-016-0178-0; Iosa M, 2016, EXPERT REV MED DEVIC, V13, P641, DOI 10.1080/17434440.2016.1198694; Iosa M, 2014, J REHABIL RES DEV, V51, P623, DOI 10.1682/JRRD.2013.07.0162; Iosa M, 2012, RES DEV DISABIL, V33, P129, DOI 10.1016/j.ridd.2011.08.031; Jasiewicz JM, 2006, GAIT POSTURE, V24, P502, DOI 10.1016/j.gaitpost.2005.12.017; Kavanagh JJ, 2006, J BIOMECH, V39, P2863, DOI 10.1016/j.jbiomech.2005.09.012; Khandelwal S, 2018, GAIT POSTURE, V59, P278, DOI 10.1016/j.gaitpost.2017.07.030; Long X, 2009, IEEE ENG MED BIO, P6107, DOI 10.1109/IEMBS.2009.5334925; Mannini A, 2016, SENSORS-BASEL, V16, DOI 10.3390/s16010134; Mannini A, 2010, SENSORS-BASEL, V10, P1154, DOI 10.3390/s100201154; Patterson KK, 2010, GAIT POSTURE, V31, P241, DOI 10.1016/j.gaitpost.2009.10.014; Plasqui G, 2007, OBESITY, V15, P2371, DOI 10.1038/oby.2007.281; Pogorelc B, 2012, MULTIMED TOOLS APPL, V58, P333, DOI 10.1007/s11042-011-0786-1; Rowlands AV, 2004, MED SCI SPORT EXER, V36, P518, DOI 10.1249/01.MSS.0000117158.14542.E7; Salarian A, 2004, IEEE T BIO-MED ENG, V51, P1434, DOI 10.1109/TBME.2004.827933; Salarian A, 2013, IEEE T BIO-MED ENG, V60, P72, DOI 10.1109/TBME.2012.2223465; Salatino G., 2016, GAIT POSTURE, V49, pS16, DOI [10.1016/j.gaitpost.2016.07.046, DOI 10.1016/J.GAITPOST.2016.07.046]; Sejdic E, 2014, IEEE T NEUR SYS REH, V22, P603, DOI 10.1109/TNSRE.2013.2265887; Sinclair J, 2013, J APPL BIOMECH, V29, P118, DOI 10.1123/jab.29.1.118; Steele BG, 2000, CHEST, V117, P1359, DOI 10.1378/chest.117.5.1359; Taraldsen K, 2012, MATURITAS, V71, P13, DOI 10.1016/j.maturitas.2011.11.003; Trojaniello D, 2014, GAIT POSTURE, V40, P487, DOI 10.1016/j.gaitpost.2014.07.007; Vienne A, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00817; Weiss A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096675; Zhang H., 2004, P 17 INT FLOR ART IN; Zhang J, 2014, ANN BIOMED ENG, V42, P600, DOI 10.1007/s10439-013-0917-0; Zheng HR, 2009, STUD COMPUT INTELL, V189, P57	38	18	19	0	7	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND	1424-8220			SENSORS-BASEL	Sensors	OCT	2018	18	10							3397	10.3390/s18103397			17	Chemistry, Analytical; Engineering, Electrical & Electronic; Instruments & Instrumentation	Chemistry; Engineering; Instruments & Instrumentation	GY5YX	WOS:000448661500225	30314269	DOAJ Gold, Green Published			2021-06-18	
J	Li, ZZ; Zeng, G; Zheng, XW; Wang, WB; Ling, Y; Tang, HM; Zhang, JF				Li, Zhengzhao; Zeng, Guang; Zheng, Xiaowen; Wang, Wenbo; Ling, Yun; Tang, Huamin; Zhang, Jianfeng			Neuroprotective effect of formononetin against TBI in rats via suppressing inflammatory reaction in cortical neurons	BIOMEDICINE & PHARMACOTHERAPY			English	Article						Formononetin; Traumatic brain injury; Interleukin-10; Inflammation	TRAUMATIC BRAIN-INJURY; INTERLEUKIN-10; APOPTOSIS; CALYCOSIN; PATHWAY; STRESS; CELLS	Traumatic brain injury (TBI) refers to external force-induced brain damage, characterized with necrosis and cell loss in cerebral cortex. Interestingly, a plant-extract named formononetin (FN) is found to possess promising pharmacological activities, including cellular neuroprotection. Thus, we propose that FN may exert biological protection against TBI and discuss the underlying mechanism. In the current study, a rat TBI model was established via Feeney's classical method, followed by different concentrations of FN treatment. Nissl-special and DAPI-labeled stains were utilized to assess the proliferation of cortical neurons nearing lesioned tissue. The contents of interleukin-6 (IL6), tumor necrosis factor (TNF-alpha), and interleukin-10 (IL10) in serum and the cortical neurons were determined by ELISA. Further, intracephalic IL10 expression levels were detected through immunoassay and RT-PCR. Interestingly, the results exhibited within the FN-treated TBI rat model indicated elevated cortical proliferation. The levels of IL10 in serum and the cortical neurons were increased following FN treatments, while TNF-alpha and IL6 levels in the blood were decreased. In addition, both mRNA and protein expression levels of IL10 in the FN-treated TBI rat model were up-regulated in a dose-dependent manner. Collectively, our present findings indicate that FN provides effective neuroprotection against TBI, likely by activating IL10 expression in cortical neurons nearing lesioned tissue to inhibit neuroinflammatory reaction.	[Li, Zhengzhao; Zeng, Guang; Zheng, Xiaowen; Ling, Yun; Tang, Huamin; Zhang, Jianfeng] Guangxi Med Univ, Affiliated Hosp 2, Dept Emergency, 166 Daxuedonglu Rd, Nanning 530007, Peoples R China; [Wang, Wenbo] Guilin Med Univ, Affiliated Hosp, Dept Neurosurg, Guilin 541001, Peoples R China	Zhang, JF (corresponding author), Guangxi Med Univ, Affiliated Hosp 2, Dept Emergency, 166 Daxuedonglu Rd, Nanning 530007, Peoples R China.	jf_zhang68@126.com		Zhang, Jianfeng/0000-0003-4213-9310	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81460211, 81560378]; Guangxi Emergency and Medical Rescue Talent Highland [GXJZ201506]	Our present study was supported by the National Natural Science Foundation of China (81460211, 81560378) and the Guangxi Emergency and Medical Rescue Talent Highland (GXJZ201506).	Berti FCB, 2017, CYTOKINE GROWTH F R, V34, P1, DOI 10.1016/j.cytogfr.2017.03.002; Brogan RJ, 2017, BRAIN INJURY, V31, P581, DOI 10.1080/02699052.2017.1287956; Chen J, 2015, FOOD FUNCT, V6, P3091, DOI [10.1039/c5fo00374a, 10.1039/C5FO00374A]; Durand E., 2017, ANN PHYS REHABIL MED; Eme R, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7050046; Fouda AY, 2017, EUR J PHARMACOL, V799, P128, DOI 10.1016/j.ejphar.2017.02.016; Garcia JM, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00244; Ge B, 2018, INT IMMUNOPHARMACOL, V54, P139, DOI 10.1016/j.intimp.2017.11.010; Greene N. H., 2017, J BURN CARE RES, V60, P95; Greene NH, 2014, ARCH PHYS MED REHAB, V95, P1148, DOI 10.1016/j.apmr.2014.02.020; Larsson J, 2013, J REHABIL MED, V45, P765, DOI 10.2340/16501977-1184; Latina V, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00068; Li R, 2016, GENE, V595, P168, DOI 10.1016/j.gene.2016.09.036; Li R, 2013, BRAIN RES, V1517, P28, DOI 10.1016/j.brainres.2013.04.013; Li ZZ, 2014, J NEUROL SCI, V338, P112, DOI 10.1016/j.jns.2013.12.027; Qiu GZ, 2017, EXP BIOL MED, V242, P223, DOI 10.1177/1535370216657445; Sarkaki A, 2015, CAN J PHYSIOL PHARM, V93, P687, DOI 10.1139/cjpp-2014-0546; Stabile A, 2016, BIOL CHEM, V397, P157, DOI 10.1515/hsz-2015-0208; Suryanarayanan A, 2016, NEUROPHARMACOLOGY, V107, P181, DOI 10.1016/j.neuropharm.2016.03.027; Tian J, 2017, J EXP CLIN CANC RES, V36, DOI 10.1186/s13046-017-0625-y; Wang Y, 2018, CELL PHYSIOL BIOCHEM, V45, P537, DOI 10.1159/000487031; Wu K, 2017, CELL PHYSIOL BIOCHEM, V43, P1562, DOI 10.1159/000482003; Wu XO, 2017, ENVIRON SCI POLLUT R, V24, P24201, DOI 10.1007/s11356-017-0072-5; Wu YY, 2017, FOOD FUNCT, V8, P1061, DOI 10.1039/c6fo01535b; Zhu Y, 2017, INT IMMUNOPHARMACOL, V50, P353, DOI 10.1016/j.intimp.2017.07.017	25	18	21	1	9	ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	ISSY-LES-MOULINEAUX	65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE	0753-3322	1950-6007		BIOMED PHARMACOTHER	Biomed. Pharmacother.	OCT	2018	106						349	354		10.1016/j.biopha.2018.06.041			6	Medicine, Research & Experimental; Pharmacology & Pharmacy	Research & Experimental Medicine; Pharmacology & Pharmacy	GR4QO	WOS:000442600300044	29966980				2021-06-18	
J	Schulte, F; Brinkman, TM; Li, CH; Fay-McClymont, T; Srivastava, DK; Ness, KK; Howell, RM; Mueller, S; Wells, E; Strother, D; Lafay-Cousin, L; Leisenring, W; Robison, LL; Armstrong, GT; Krull, KR				Schulte, Fiona; Brinkman, Tara M.; Li, Chenghong; Fay-McClymont, Taryn; Srivastava, Deo Kumar; Ness, Kirsten K.; Howell, Rebecca M.; Mueller, Sabine; Wells, Elizabeth; Strother, Douglas; Lafay-Cousin, Lucie; Leisenring, Wendy; Robison, Leslie L.; Armstrong, Gregory T.; Krull, Kevin R.			Social adjustment in adolescent survivors of pediatric central nervous system tumors: A report from the Childhood Cancer Survivor Study	CANCER			English	Article						adolescent; brain neoplasms; cognition; social adjustment; survivors	FACIAL EXPRESSION RECOGNITION; TRAUMATIC BRAIN-INJURY; LONG-TERM SURVIVORS; DEVELOPMENTAL-PSYCHOLOGY; NEUROCOGNITIVE SEQUELAE; PEER RELATIONSHIPS; ADULT SURVIVORS; OUTCOMES; CHILDREN; SKILLS	BACKGROUND: The purpose of this study was to examine the prevalence and predictors of social difficulties in adolescent survivors of central nervous system (CNS) tumors. METHODS: Six hundred sixty-five survivors of CNS tumors (53.8% male and 51.7% treated with cranial radiation therapy [CRT]), who had a current median age of 15.0 years (range, 2.0-17.0 years) and were a median of 12.1 years (range, 8.0-17.7 years) from their diagnosis, were compared with 1376 survivors of solid tumors (50.4% male), who had a median age of 15.0 years (range, 12.0-17.0 years) and were a median of 13.2 years (range, 8.3-17.9 years) from their diagnosis, and 726 siblings (52.2% male), who had a median age of 15.0 years (range, 12.0-17.0 years). Social adjustment was measured with parent-proxy responses to the Behavior Problems Index. Latent profile analysis defined social classes. Multinomial logistic regression, adjusted for age, sex, and age at diagnosis, identified predictors of class membership. Path analyses tested mediating effects of physical limitations, sensory loss, and cognitive impairment on social outcomes. RESULTS: Caregivers reported that survivors of CNS tumors were more likely to have 0 friends (15.3%) and to interact with friends less than once per week (41.0%) in comparison with survivors of solid tumors (2.9% and 13.6%, respectively) and siblings (2.3% and 8.7%, respectively). Latent profile analysis identified 3 social classes for survivors of CNS tumors: well-adjusted (53.4%), social deficits (16.2%), and poor peer relationships (30.4%). However, 2 classes were identified for survivors of solid tumors and siblings: well-adjusted (86.2% and 91.1%, respectively) and social deficits (13.8% and 8.9%, respectively). CRT predicted class membership for CNS survivors (odds ratio [OR] for poor peer relationships, 1.16/10 Gy; 95% confidence interval [CI], 1.08-1.25; OR for social deficits 1.14/10 Gy; 95% CI, 1.04-1.25; reference, well-adjusted). Cognitive impairment mediated the association between all social outcomes and CRT (P values < .001). CONCLUSION: Almost 50% of survivors of CNS tumors experience social difficulties; the pattern is unique in comparison with solid tumor and sibling groups. Cognitive impairment is associated with increased risk, and this highlights the need for multitargeted interventions. (c) 2018 American Cancer Society.	[Schulte, Fiona; Fay-McClymont, Taryn; Strother, Douglas; Lafay-Cousin, Lucie] Univ Calgary, Calgary, AB, Canada; [Schulte, Fiona; Fay-McClymont, Taryn; Strother, Douglas; Lafay-Cousin, Lucie] Alberta Childrens Prov Gen Hosp, Calgary, AB, Canada; [Brinkman, Tara M.; Li, Chenghong; Srivastava, Deo Kumar; Ness, Kirsten K.; Robison, Leslie L.; Armstrong, Gregory T.; Krull, Kevin R.] St Jude Childrens Res Hosp, 332 N Lauderdale St, Memphis, TN 38105 USA; [Howell, Rebecca M.] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Mueller, Sabine] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Wells, Elizabeth] Childrens Natl Med Ctr, Washington, DC 20010 USA; [Leisenring, Wendy] Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA	Schulte, F (corresponding author), Univ Calgary, Div Psychosocial Oncol, Dept Oncol, Cumming Sch Med, 2202 2nd St Southwest, Calgary, AB T2S 3C3, Canada.	fiona.schulte@ahs.ca	Armstrong, Gregory/N-8096-2018; Schulte, Fiona/AAK-7619-2020; Krull, Kevin R/N-3882-2018; Ness, Kirsten K/N-2550-2018; Srivastava, Deo Kumar/P-2435-2017	Schulte, Fiona/0000-0002-3076-9676; Krull, Kevin R/0000-0002-0476-7001; Ness, Kirsten K/0000-0002-2084-1507; Srivastava, Deo Kumar/0000-0001-6693-8120; Fay-McClymont, Taryn/0000-0002-2706-6179; Leisenring, Wendy/0000-0001-7405-0906	National Cancer InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [CA55727]; St. Jude Children's Research Hospital through a Cancer Center Support (CORE) Grant [CA21765]; American Lebanese Syrian Associated CharitiesAmerican Lebanese Syrian Associated Charities (ALSAC); National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [P30 CA016672]; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [U24CA055727, P30CA021765] Funding Source: NIH RePORTER	This work was supported by the National Cancer Institute (CA55727; principal investigator Gregory T. Armstrong). Support was also provided to St. Jude Children's Research Hospital through a Cancer Center Support (CORE) Grant (CA21765; principal investigator Charles W. M. Roberts) and by the American Lebanese Syrian Associated Charities. The University of TexasMD Anderson Cancer Center is supported by the National Institutes of Health (grant P30 CA016672).	Achenbach T. M., 1991, MANUAL CHILD BEHAV C; Alderfer MA, 2010, PSYCHO-ONCOLOGY, V19, P789, DOI 10.1002/pon.1638; Anderson V, 2013, J INT NEUROPSYCH SOC, V19, P539, DOI 10.1017/S1355617712001543; Armstrong GT, 2007, J CLIN ONCOL, V25, P4477, DOI 10.1200/JCO.2007.11.2003; Askins MA, 2009, J PEDIATR PSYCHOL, V34, P551, DOI 10.1093/jpepsy/jsn124; Barakat LP, 2003, J PEDIATR PSYCHOL, V28, P299, DOI 10.1093/jpepsy/jsg019; Barrera M, 2009, J PEDIATR PSYCHOL, V34, P1108, DOI 10.1093/jpepsy/jsp018; Barrera M, 2018, PSYCHO-ONCOLOGY, V27, P91, DOI 10.1002/pon.4385; Bonner MJ, 2008, J PEDIATR PSYCHOL, V33, P1142, DOI 10.1093/jpepsy/jsn035; Brinkman TM, 2013, J NEURO-ONCOL, V111, P195, DOI 10.1007/s11060-012-1001-6; Brinkman TM, 2012, J CLIN ONCOL, V30, P4134, DOI 10.1200/JCO.2011.40.6702; Butler RW, 2008, DEV DISABIL RES REV, V14, P251, DOI 10.1002/ddrr.33; Campbell LK, 2007, PEDIATR BLOOD CANCER, V49, P65, DOI 10.1002/pbc.20860; Conklin HM, 2015, J CLIN ONCOL, V33, P3894, DOI 10.1200/JCO.2015.61.6672; Conklin HM, 2010, J CLIN ONCOL, V28, P4465, DOI 10.1200/JCO.2010.28.4026; Devine KA, 2016, J DEV BEHAV PEDIATR, V37, P475, DOI 10.1097/DBP.0000000000000315; DieTrill M, 1996, J PSYCHOSOC ONCOL, V14, P23, DOI 10.1300/J077v14n02_02; Gurney JG, 2009, J CLIN ONCOL, V27, P2390, DOI 10.1200/JCO.2008.21.1458; Hocking MC, 2015, PEDIATR BLOOD CANCER, V62, P375, DOI 10.1002/pbc.25300; Iyer NS, 2015, BLOOD, V126, P346, DOI 10.1182/blood-2015-02-627414; Mabbott DJ, 2005, J CLIN ONCOL, V23, P2256, DOI 10.1200/JCO.2005.01.158; MASTEN AS, 1985, DEV PSYCHOL, V21, P523, DOI 10.1037/0012-1649.21.3.523; Moyer KH, 2012, PEDIATR BLOOD CANCER, V59, P1290, DOI 10.1002/pbc.24256; Mulhern RK, 2004, LANCET ONCOL, V5, P399, DOI 10.1016/S1470-2045(04)01507-4; Ness KK, 2010, CANCER-AM CANCER SOC, V116, P3034, DOI 10.1002/cncr.25051; NOLL RB, 1990, J PEDIATR PSYCHOL, V15, P43, DOI 10.1093/jpepsy/15.1.43; Noll RB, 2007, CHILD NEUROPSYCHOL, V13, P173, DOI 10.1080/09297040500473706; Piscione PJ, 2014, NEURO-ONCOLOGY, V16, P147, DOI 10.1093/neuonc/not138; Poggi G, 2005, PSYCHO-ONCOLOGY, V14, P386, DOI 10.1002/pon.855; Reddick WE, 2003, CANCER-AM CANCER SOC, V97, P2512, DOI 10.1002/cncr.11355; Robison LL, 2009, J CLIN ONCOL, V27, P2308, DOI 10.1200/JCO.2009.22.3339; Robison LL, 2002, MED PEDIATR ONCOL, V38, P229, DOI 10.1002/mpo.1316; Roelofs RL, 2017, BRAIN IMPAIR, V18, P138, DOI 10.1017/BrImp.2016.31; Schulte F, 2015, CURR OPIN ONCOL, V27, P306, DOI 10.1097/CCO.0000000000000193; Schulte F, 2010, SUPPORT CARE CANCER, V18, P1499, DOI 10.1007/s00520-010-0963-1; Schultz KAP, 2007, J CLIN ONCOL, V25, P3649, DOI 10.1200/JCO.2006.09.2486; Stovall M, 2006, RADIAT RES, V166, P141, DOI 10.1667/RR3525.1; Vannatta K, 1998, J PEDIATR PSYCHOL, V23, P279, DOI 10.1093/jpepsy/23.5.279; Vannatta K, 2007, PEDIATR BLOOD CANCER, V49, P716, DOI 10.1002/pbc.21062; Ward E, 2014, CA-CANCER J CLIN, V64, P83, DOI 10.3322/caac.21219; Ware J, 2003, VERSION 2 SF 36 HLTH; Willard VW, 2017, CHILD HEALTH CARE, V46, P181, DOI 10.1080/02739615.2015.1124769; Willard VW, 2009, PSYCHO-ONCOLOGY, V18, P893, DOI 10.1002/pon.1502; Yeates KO, 2007, PSYCHOL BULL, V133, P535, DOI 10.1037/0033-2909.133.3.535; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093; Zebrack BJ, 2004, J CLIN ONCOL, V22, P999, DOI 10.1200/JCO.2004.06.148; Zebrack BJ, 2007, PEDIATR BLOOD CANCER, V49, P47, DOI 10.1002/pbc.20914; Zill N., 1986, BEHAV PROBLEMS INDEX	48	18	19	0	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0008-543X	1097-0142		CANCER-AM CANCER SOC	Cancer	SEP 1	2018	124	17					3596	3608		10.1002/cncr.31593			13	Oncology	Oncology	GX0CI	WOS:000447376600016	30067866	Bronze, Green Accepted			2021-06-18	
J	St Ivany, A; Bullock, L; Schminkey, D; Wells, K; Sharps, P; Kools, S				St Ivany, Amanda; Bullock, Linda; Schminkey, Donna; Wells, Kristen; Sharps, Phyllis; Kools, Susan			Living in Fear and Prioritizing Safety: Exploring Women's Lives After Traumatic Brain Injury From Intimate Partner Violence	QUALITATIVE HEALTH RESEARCH			English	Article						domestic; abuse; violence against women; structural violence; brain injury; community and public health; qualitative; grounded theory; situational analysis; United States	ABUSED WOMEN; INTERSECTIONALITY; FRAMEWORK; OUTCOMES; HEALTH	There is increasing evidence that women are receiving a traumatic brain injury (TBI) during episodes of intimate partner violence (IPV), but little qualitative research exists around how surviving this experience impacts the lives of women. Primary and secondary data (N = 19) were used with a constructivist grounded theory approach to explore the lives of women aged 18 to 44 years, who were living with a TBI from IPV. Women described multiple aspects of living in fear that shaped their daily lives and ability to seek help and access resources. The central process of prioritizing safety emerged, with salient dimensions of maintaining a present orientation, exhibiting hyperprotection of children, invoking isolation as protection, and calculating risk of death. These findings add to the growing body of knowledge that women living with IPV are at high risk for receiving a TBI and are therefore a subgroup in need of more prevention and treatment resources.	[St Ivany, Amanda] Univ Virginia, Charlottesville, VA USA; [Bullock, Linda] Univ Virginia, Sch Nursing, Charlottesville, VA 22903 USA; [Schminkey, Donna] Univ Virginia, Sch Nursing, Acute & Specialty Care Dept, Charlottesville, VA 22903 USA; [Wells, Kristen] Univ Virginia, Dept Publ Hlth Sci, Charlottesville, VA USA; [Kools, Susan] Univ Virginia, Nursing, Charlottesville, VA USA; [St Ivany, Amanda] Dartmouth Hitchcock Med Ctr, 1 Med Ctr Dr, Lebanon, NH 03766 USA; [Sharps, Phyllis] Johns Hopkins Univ, Nursing, Baltimore, MD USA; [Sharps, Phyllis] Johns Hopkins Univ, Community Programs & Initiat, Baltimore, MD USA	St Ivany, A (corresponding author), Dartmouth Hitchcock Med Ctr, 1 Med Ctr Dr, Lebanon, NH 03766 USA.	Amanda.R.St.Ivany@dartmouth.edu	St Ivany, Amanda/AAC-6228-2019	Sharps, Phyllis/0000-0002-8508-5087	NATIONAL INSTITUTE OF NURSING RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [R01NR009093] Funding Source: NIH RePORTER; NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [T32HP30036] Funding Source: Medline; NINR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [R01 NR009093] Funding Source: Medline		Anderson JC, 2015, J EMERG NURS, V41, P36, DOI 10.1016/j.jen.2014.01.015; Black M.C., 2011, NATL INTIMATE PARTNE; Bowleg L, 2012, AM J PUBLIC HEALTH, V102, P1267, DOI 10.2105/AJPH.2012.300750; Campbell JC, 2002, LANCET, V359, P1331, DOI 10.1016/S0140-6736(02)08336-8; Charmaz K., 2014, CONSTRUCTING GROUNDE; Clarke A.E., 2017, SITUATIONAL ANAL GRO; Collins PH, 2015, ANNU REV SOCIOL, V41, P1, DOI 10.1146/annurev-soc-073014-112142; Corbin J., 2009, DEV GROUNDED THEORY, P35; Corrigan John D., 2003, American Journal of Obstetrics and Gynecology, V188, pS71, DOI 10.1067/mob.2003.404; Crenshaw K., 1991, STANFORD LAW REV, V43, P1241, DOI [DOI 10.2307/1229039, 10.2307/1229039]; Davis A, 2014, J TRAUMA NURS, V21, P300, DOI 10.1097/JTN.0000000000000086; Farmer PE, 2006, PLOS MED, V3, P1686, DOI 10.1371/journal.pmed.0030449; Feder GS, 2006, ARCH INTERN MED, V166, P22, DOI 10.1001/archinte.166.1.22; Ford-Gilboe M, 2011, FAMILY VIOLENCE NURS, P115; GALTUNG J, 1969, J PEACE RES, P167; Iverson KM, 2015, MED CARE, V53, pS112, DOI 10.1097/MLR.0000000000000263; Kelly UA, 2011, ADV NURS SCI, V34, pE29, DOI 10.1097/ANS.0b013e3182272388; Kools S, 1996, QUAL HEALTH RES, V6, P312, DOI 10.1177/104973239600600302; Kwako LE, 2011, TRAUMA VIOLENCE ABUS, V12, P115, DOI 10.1177/1524838011404251; Nash JC, 2008, FEMINIST REV, P1, DOI 10.1057/fr.2008.4; Pawluch D., 2010, SAGE HDB QUALITATIVE, P174; Rich K, 2014, AFFILIA J WOM SOC WO, V29, P418, DOI 10.1177/0886109914522626; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Sharps P, 2013, PEDIATRICS, V132, pS134, DOI 10.1542/peds.2013-1021L; St Ivany A, 2016, FAM COMMUNITY HEALTH, V39, P129, DOI 10.1097/FCH.0000000000000094; Strauss A, 1990, BASICS QUALITATIVE R, V15; Zieman G, 2017, J NEUROTRAUM, V34, P876, DOI 10.1089/neu.2016.4579	27	18	18	0	17	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1049-7323	1552-7557		QUAL HEALTH RES	Qual. Health Res.	SEP	2018	28	11			SI		1708	1718		10.1177/1049732318786705			11	Information Science & Library Science; Social Sciences, Interdisciplinary; Social Sciences, Biomedical	Information Science & Library Science; Social Sciences - Other Topics; Biomedical Social Sciences	GR2NN	WOS:000442412400003	30027811	Green Accepted			2021-06-18	
J	Logsdon, AF; Meabon, JS; Cline, MM; Bullock, KM; Raskind, MA; Peskind, ER; Banks, WA; Cook, DG				Logsdon, Aric F.; Meabon, James S.; Cline, Marcella M.; Bullock, Kristin M.; Raskind, Murray A.; Peskind, Elaine R.; Banks, William A.; Cook, David G.			Blast exposure elicits blood-brain barrier disruption and repair mediated by tight junction integrity and nitric oxide dependent processes	SCIENTIFIC REPORTS			English	Article							CHRONIC TRAUMATIC ENCEPHALOPATHY; CEREBRAL-ARTERY OCCLUSION; OPERATION IRAQI FREEDOM; ESTER L-NAME; L-ARGININE; OXIDATIVE STRESS; ALZHEIMERS-DISEASE; REPERFUSION INJURY; NEUROVASCULAR UNIT; HEAD-INJURY	Mild blast-induced traumatic brain injury (TBI) is associated with blood-brain barrier (BBB) disruption. However, the mechanisms whereby blast disrupts BBB integrity are not well understood. To address this issue BBB permeability to peripherally injected C-14-sucrose and Tc-99m-albumin was quantified in ten brain regions at time points ranging from 0.25 to 72 hours. In mice, repetitive (2X) blast provoked BBB permeability to C-14-sucrose that persisted in specific brain regions from 0.25 to 72 hours. However, Tc-99m-albumin revealed biphasic BBB disruption (open-closed-open) over the same interval, which was most pronounced in frontal cortex and hippocampus. This indicates that blast initiates interacting BBB disruption and reparative processes in specific brain regions. Further investigation of delayed (72 hour) BBB disruption revealed that claudin-5 (CLD5) expression was disrupted specifically in the hippocampus, but not in dorsal striatum, a brain region that showed no blast-induced BBB permeability to sucrose or albumin. In addition, we found that delayed BBB permeability and disrupted CLD5 expression were blocked by the nitric oxide synthase inhibitor N(G)-nitro-L-arginine methyl ester (L-NAME). These data argue that latent nitric oxide-dependent signaling pathways initiate processes that result in delayed BBB disruption, which are manifested in a brain-region specific manner.	[Logsdon, Aric F.; Cline, Marcella M.; Bullock, Kristin M.; Banks, William A.; Cook, David G.] Vet Affairs Puget Sound Hlth Care Syst, GRECC, Seattle, WA 98108 USA; [Logsdon, Aric F.; Banks, William A.; Cook, David G.] Univ Washington, Sch Med, Dept Med, Div Gerontol & Geriatr Med, Seattle, WA 98195 USA; [Meabon, James S.; Raskind, Murray A.; Peskind, Elaine R.] Vet Affairs Puget Sound Hlth Care Syst, Mental Illness Res Educ & Clin Ctr, Vet Affairs Northwest Network, Seattle, WA 98108 USA; [Meabon, James S.; Raskind, Murray A.; Peskind, Elaine R.] Univ Washington, Sch Med, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Cline, Marcella M.] Univ Washington, Dept Mol & Cellular Biol, Seattle, WA 98195 USA	Cook, DG (corresponding author), Vet Affairs Puget Sound Hlth Care Syst, GRECC, Seattle, WA 98108 USA.; Cook, DG (corresponding author), Univ Washington, Sch Med, Dept Med, Div Gerontol & Geriatr Med, Seattle, WA 98195 USA.	dgcook@u.washington.edu		Cline, Marcella/0000-0002-9590-3725	VA Puget Sound Health Care System Seed Grant; Department of Veterans Affairs Office of Research and Development Medical Research Service RDIS [0005]; Veterans Affairs Rehabilitation Research and Development Service Merit Review Grant [B77421]; University of Washington Friends of Alzheimer's Research; University of Washington Royalty Research FundUniversity of Washington; Northwest Network Mental Illness Research Education and Clinical Center;  [R01AG046619];  [T32AG052354]; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG046619, T32AG052354] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [I01BX002311, I01RX001612] Funding Source: NIH RePORTER	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: These studies were supported by R01AG046619 (WAB), and T32AG052354 (A.F.L.), VA Puget Sound Health Care System Seed Grant (J.S.M.), Department of Veterans Affairs Office of Research and Development Medical Research Service RDIS# 0005 (D.G.C.), Veterans Affairs Rehabilitation Research and Development Service Merit Review Grant #B77421 (E.R.P.), University of Washington Friends of Alzheimer's Research (D.G.C., E.R.P.), University of Washington Royalty Research Fund (D.G.C.), Northwest Network Mental Illness Research Education and Clinical Center (J.S.M., E.R.P., M.A.R.).	Abdul-Muneer PM, 2013, FREE RADICAL BIO MED, V60, P282, DOI 10.1016/j.freeradbiomed.2013.02.029; Argaw AT, 2012, J CLIN INVEST, V122, P2454, DOI 10.1172/JCI60842; Argaw AT, 2009, P NATL ACAD SCI USA, V106, P1977, DOI 10.1073/pnas.0808698106; Badaut J, 2015, NEUROSCIENCE, V285, P215, DOI 10.1016/j.neuroscience.2014.10.035; Baldwin SA, 1996, J NEUROSURG, V85, P476, DOI 10.3171/jns.1996.85.3.0476; Ballabh P, 2004, NEUROBIOL DIS, V16, P1, DOI 10.1016/j.nbd.2003.12.016; Banks WA, 2008, ENDOCRINOLOGY, V149, P1514, DOI 10.1210/en.2007-1091; Banks WA, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0434-1; Baskaya MK, 1997, NEUROSCI LETT, V226, P33; Belayev L, 1996, BRAIN RES, V739, P88, DOI 10.1016/S0006-8993(96)00815-3; Bell RS, 2009, J TRAUMA, V66, pS104, DOI 10.1097/TA.0b013e31819d88c8; BLASBERG RG, 1983, J CEREBR BLOOD F MET, V3, P8, DOI 10.1038/jcbfm.1983.2; Chip S, 2013, J CEREBR BLOOD F MET, V33, P508, DOI 10.1038/jcbfm.2012.190; Clark PR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120075; Cooper I, 2011, METHODS MOL BIOL, V762, P347, DOI 10.1007/978-1-61779-185-7_25; Del Razo MJ, 2016, SIAM J SCI COMPUT, V38, pB347, DOI 10.1137/15M1010750; Elder GA, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00048; Eskridge SL, 2012, INJURY, V43, P1678, DOI 10.1016/j.injury.2012.05.027; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; Gahm C, 2005, NEUROSURGERY, V57, P1272, DOI 10.1227/01.NEU.0000187317.32529.06; Gardner RC, 2014, JAMA NEUROL, V71, P1490, DOI 10.1001/jamaneurol.2014.2668; Garman RH, 2011, J NEUROTRAUM, V28, P947, DOI 10.1089/neu.2010.1540; Glushakova OY, 2014, J NEUROTRAUM, V31, P1180, DOI 10.1089/neu.2013.3080; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Gu Y, 2012, J NEUROCHEM, V120, P147, DOI 10.1111/j.1471-4159.2011.07542.x; Hall AA, 2017, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.00104; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Huber BR, 2016, NEUROSCIENCE, V319, P206, DOI 10.1016/j.neuroscience.2016.01.022; Huber BR, 2013, J ALZHEIMERS DIS, V37, P309, DOI 10.3233/JAD-130182; Hue CD, 2016, J NEUROTRAUM, V33, P1202, DOI 10.1089/neu.2015.4067; Jorge RE, 2012, AM J PSYCHIAT, V169, P1284, DOI 10.1176/appi.ajp.2012.12050600; Khaldi A, 2002, ANN NY ACAD SCI, V962, P53, DOI 10.1111/j.1749-6632.2002.tb04055.x; Kondo A, 2015, NATURE, V523, P431, DOI 10.1038/nature14658; Kuraikose M., 2018, SCI REPORTS, V8; KUROIWA T, 1985, ACTA NEUROPATHOL, V68, P122, DOI 10.1007/BF00688633; Lee YK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062422; LEVIN VA, 1970, AM J PHYSIOL, V219, P1528; Liu J, 2012, J NEUROSCI, V32, P3044, DOI 10.1523/JNEUROSCI.6409-11.2012; Logsdon AE, 2016, BRAIN RES, V1643, P140, DOI 10.1016/j.brainres.2016.04.063; Logsdon AF, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00421; Lowenstein CJ, 1996, J CLIN INVEST, V97, P1837, DOI 10.1172/JCI118613; Lucke-Wold BP, 2015, MOL NEUROBIOL, V52, P1119, DOI 10.1007/s12035-014-8902-7; Lucke-Wold BP, 2014, J NEUROTRAUM, V31, P1129, DOI 10.1089/neu.2013.3303; Macdonald A, 2011, J TRAUMA STRESS, V24, P268, DOI 10.1002/jts.20642; MacDonald Christine L, 2014, J Neurotrauma, V31, P889, DOI 10.1089/neu.2013.3173; MacGregor AJ, 2011, J REHABIL RES DEV, V48, P1269, DOI 10.1682/JRRD.2011.01.0013; MAYHAN WG, 1985, AM J PHYSIOL, V248, pH712; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Meabon JS, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaa9585; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Mishra V, 2016, SCI REP-UK, V6, DOI 10.1038/srep26992; MULSCH A, 1990, N-S ARCH PHARMACOL, V341, P143; Nakaizumi A, 2012, CELL MOL NEUROBIOL, V32, P95, DOI 10.1007/s10571-011-9739-5; Nitta T, 2003, J CELL BIOL, V161, P653, DOI 10.1083/jcb.200302070; Nordstrom P, 2014, ANN NEUROL, V75, P374, DOI 10.1002/ana.24101; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; PATLAK CS, 1983, J CEREBR BLOOD F MET, V3, P1, DOI 10.1038/jcbfm.1983.1; Petrie EC, 2014, J NEUROTRAUM, V31, P425, DOI [10.1089/NEU.2013.2952, 10.1089/neu.2013.2952]; Pfeiffer S, 1996, BRIT J PHARMACOL, V118, P1433, DOI 10.1111/j.1476-5381.1996.tb15557.x; Pillai DR, 2009, J CEREBR BLOOD F MET, V29, P1846, DOI 10.1038/jcbfm.2009.106; Rao VLR, 1999, J NEUROTRAUM, V16, P865, DOI 10.1089/neu.1999.16.865; Readnower RD, 2010, J NEUROSCI RES, V88, P3530, DOI 10.1002/jnr.22510; REES DD, 1989, P NATL ACAD SCI USA, V86, P3375, DOI 10.1073/pnas.86.9.3375; REES DD, 1989, BRIT J PHARMACOL, V96, P418, DOI 10.1111/j.1476-5381.1989.tb11833.x; RUBIN LL, 1991, J CELL BIOL, V115, P1725, DOI 10.1083/jcb.115.6.1725; Schindler AG, 2017, NEUROBIOL DIS, V106, P23, DOI 10.1016/j.nbd.2017.06.004; Schofield PW, 1997, J NEUROL NEUROSUR PS, V62, P119, DOI 10.1136/jnnp.62.2.119; Schubert W, 2002, J BIOL CHEM, V277, P40091, DOI 10.1074/jbc.M205948200; Shetty AK, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00232; Stamatovic SM, 2009, J BIOL CHEM, V284, P19053, DOI 10.1074/jbc.M109.000521; Terpolilli NA, 2009, J NEUROTRAUM, V26, P1963, DOI 10.1089/neu.2008.0853; Theas S, 2001, NEUROENDOCRINOLOGY, V74, P82, DOI 10.1159/000054673; Tweedie D, 2013, NEUROBIOL DIS, V54, P1, DOI 10.1016/j.nbd.2013.02.006; Wada K, 1999, J NEUROTRAUM, V16, P203, DOI 10.1089/neu.1999.16.203; Willis CL, 2013, NEUROSCIENCE, V250, P773, DOI 10.1016/j.neuroscience.2013.06.061; Winger RC, 2014, J IMMUNOL, V193, P2427, DOI 10.4049/jimmunol.1400700; Xaio HP, 2001, BRAIN RES, V896, P36, DOI 10.1016/S0006-8993(00)03247-9; Yamaguchi H, 2008, MOL CELL BIOCHEM, V312, P103, DOI 10.1007/s11010-008-9725-5; Yang Y, 2007, J CEREBR BLOOD F MET, V27, P697, DOI 10.1038/sj.jcbfm.9600375; Yeoh S, 2013, ANN BIOMED ENG, V41, P2206, DOI 10.1007/s10439-013-0805-7; ZIYLAN YZ, 1984, AM J PHYSIOL, V247, pR634; Zlokovic BV, 2005, TRENDS NEUROSCI, V28, P202, DOI 10.1016/j.tins.2005.02.001	83	18	19	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	JUL 27	2018	8								11344	10.1038/s41598-018-29341-6			13	Multidisciplinary Sciences	Science & Technology - Other Topics	GO4HC	WOS:000439965200037	30054495	DOAJ Gold, Green Published			2021-06-18	
J	Langdon, C; Lehrer, E; Berenguer, J; Laxe, S; Alobid, I; Quint, L; Mario-Snchez, F; Bernabeu, M; Marin, C; Mullol, J				Langdon, Cristobal; Lehrer, Eduardo; Berenguer, Joan; Laxe, Sara; Alobid, Isam; Quinto, Llorenc; Marino-Sanchez, Franklin; Bernabeu, Montserrat; Marin, Concepcio; Mullol, Joaquim			Olfactory Training in Post-Traumatic Smell Impairment: Mild Improvement in Threshold Performances: Results from a Randomized Controlled Trial	JOURNAL OF NEUROTRAUMA			English	Article						BAST-24; MRI; olfaction; OT; smell loss; TBI	TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; TERM-FOLLOW-UP; BULB VOLUME; HEAD-INJURY; DYSFUNCTION; ANOSMIA; DISCRIMINATION; ORGANIZATION; RECOVERY	Traumatic Brain Injury (TBI) can be associated with partial or total smell loss. Recent studies have suggested that olfactory outcome can be positively modulated after olfactory training (OT). This study's aim was to investigate OT's potential role in smell recovery after TBI-induced olfactory loss. A prospective, randomized, and controlled study was developed. Patients with TBI-induced olfactory dysfunction (n = 42) were randomized into an experimental group with OT and a control group without (nOT). OT was performed twice daily with a six odor training set during 12 weeks. Olfactory loss was assessed using subjective olfactometry (Barcelona Smell Test [BAST] 24), a visual analogue scale (VAS), and n-butanol threshold (n-BTt) at baseline at 4, 12, and 24 weeks. Additionally, patients underwent MRI of the olfactory brain and olfactory bulbs (OB). Based on the MRI results, an overall score (0-16) was developed to associate the structural neurological damage with olfactory outcomes. The primary outcome was the change in olfactory measurements (VAS and BAST-24) between baseline and 12 weeks. The secondary outcome was the association of the MRI score with olfactory outcomes at baseline, and the impact on quality of life (QoL). After 12 weeks of training, OT patients showed a significant improvement in n-BTt (0.6 +/- 1.7 OT vs. -0.6 +/- 1.8 nOT, p < 0.05), but not in the smell VAS and BAST-24 scores. Olfactory outcomes (VAS, BAST-24, and n-BTt) were significantly associated with MRI structural findings (p < 0.001), but not with the OB volume or olfactory sulcus length. The present study suggests that 12 weeks of OT mildly improves the olfactory threshold in TBI, whereas the overall MRI score may be used as an imaging marker of olfactory dysfunction and disease severity in TBI patients.	[Langdon, Cristobal; Lehrer, Eduardo; Alobid, Isam; Mullol, Joaquim] Hosp Clin Barcelona, ENT Dept, Rhinol Unit, Barcelona, Catalonia, Spain; [Langdon, Cristobal; Lehrer, Eduardo; Alobid, Isam; Mullol, Joaquim] Hosp Clin Barcelona, ENT Dept, Smell Clin, Barcelona, Catalonia, Spain; [Berenguer, Joan] Hosp Clin Barcelona, Dept Radiol, Neuroradiol Unit, Barcelona, Catalonia, Spain; [Berenguer, Joan] Hosp Clin Barcelona, Imaging Diagnost Ctr, Barcelona, Catalonia, Spain; [Langdon, Cristobal; Lehrer, Eduardo; Berenguer, Joan; Alobid, Isam; Marino-Sanchez, Franklin; Marin, Concepcio; Mullol, Joaquim] August Pi i Sunyer Biomed Res Inst IDIBAPS, Clin & Expt Resp Immunoallergy IRCE, Barcelona, Catalonia, Spain; [Laxe, Sara; Bernabeu, Montserrat] Autonomous Univ Barcelona, Guttmann Inst Fdn, Brain Injury Unit, Barcelona, Catalonia, Spain; [Laxe, Sara; Bernabeu, Montserrat] Autonomous Univ Barcelona, Neurorehabil Hosp, Barcelona, Catalonia, Spain; [Laxe, Sara; Bernabeu, Montserrat] Germans Trias & Pujol Sci Hlth Inst Fdn, Barcelona, Catalonia, Spain; [Alobid, Isam; Marino-Sanchez, Franklin] Ctr Biomed Res Network Resp Dis CIBERES, Barcelona, Catalonia, Spain; [Quinto, Llorenc; Mullol, Joaquim] Univ Barcelona, Hosp Clin, Barcelona Inst Global Hlth, Barcelona, Catalonia, Spain	Mullol, J (corresponding author), Hosp Clin & Univ, Clin & Expt Resp Immunoallergy, ENT Dept, IDIBAPS, C Villarroel 170, Barcelona 08036, Catalonia, Spain.	jmullol@clinic.cat	Lehrer, Eduardo/AAE-9945-2021; Marino Sanchez, Franklin Santiago/L-9210-2018	Lehrer, Eduardo/0000-0002-4591-2607; Marino Sanchez, Franklin Santiago/0000-0002-4328-0925; Quinto, Llorenc/0000-0001-9992-6951	Fundacio La Marato de TV3 [201106-10]	This study was sponsored by a research grant (No. 201106-10) from Fundacio La Marato de TV3.	Altundag A, 2015, LARYNGOSCOPE, V125, P1763, DOI 10.1002/lary.25245; Bernert S, 2009, VALUE HEALTH, V12, P750, DOI 10.1111/j.1524-4733.2009.00509.x; Bousquet J, 2008, ALLERGY, V63, P8, DOI 10.1111/j.1398-9995.2007.01620.x; Brazinova A, 2021, J NEUROTRAUM, V38, P1411, DOI 10.1089/neu.2015.4126; Callahan CD, 2002, J HEAD TRAUMA REHAB, V17, P251, DOI 10.1097/00001199-200206000-00006; Callahan CD, 1999, J HEAD TRAUMA REHAB, V14, P581, DOI 10.1097/00001199-199912000-00006; Cardesin A, 2006, RHINOLOGY, V44, P83; Costanzo RM, 2006, ADV OTO-RHINO-LARYNG, V63, P99, DOI 10.1159/000093753; Damm M, 2014, LARYNGOSCOPE, V124, P826, DOI 10.1002/lary.24340; De Guise E, 2005, BRAIN INJURY, V19, P1087, DOI 10.1080/02699050500149882; de Kruijk JR, 2003, BRAIN INJURY, V17, P73, DOI 10.1080/0269905021000010221; Doty RL, 1997, ARCH NEUROL-CHICAGO, V54, P1131, DOI 10.1001/archneur.1997.00550210061014; DUNCAN HJ, 1995, ARCH OTOLARYNGOL, V121, P1183; Erskine SE, 2017, CLIN OTOLARYNGOL, V42, P81, DOI 10.1111/coa.12667; Escanilla O, 2008, PHYSIOL BEHAV, V94, P621, DOI 10.1016/j.physbeh.2008.03.008; Escanilla O, 2009, BEHAV NEUROSCI, V123, P828, DOI 10.1037/a0015855; Fleiner F, 2012, ENT-EAR NOSE THROAT, V91, P198, DOI 10.1177/014556131209100508; Fokkens WJ, 2012, RHINOLOGY, V50, P1; Formisano R, 2017, NEUROL SCI, V38, P279, DOI 10.1007/s10072-016-2755-y; Fortin A, 2010, BRAIN INJURY, V24, P27, DOI 10.3109/02699050903446815; Frasnelli J, 2005, EUR ARCH OTO-RHINO-L, V262, P231, DOI 10.1007/s00405-004-0796-y; Frasnelli J, 2016, CLIN NEUROL NEUROSUR, V140, P68, DOI 10.1016/j.clineuro.2015.11.013; Gautschi OP, 2013, CLIN NEUROL NEUROSUR, V115, P2482, DOI 10.1016/j.clineuro.2013.09.038; Gillett S, 2009, CLIN OTOLARYNGOL, V34, P467, DOI 10.1111/j.1749-4486.2009.01975.x; Green P, 2003, BRAIN INJURY, V17, P479, DOI 10.1080/0269905031000070242; Green P, 2001, NEUROREHABILITATION, V16, P237; Gudziol V, 2014, EUR ARCH OTO-RHINO-L, V271, P1533, DOI 10.1007/s00405-013-2687-6; Haxel BR, 2008, J HEAD TRAUMA REHAB, V23, P407, DOI 10.1097/01.HTR.0000341437.59627.ec; Herdman M, 2001, Aten Primaria, V28, P425; Hummel T, 2017, RHINOLOGY; Hummel T, 2009, LARYNGOSCOPE, V119, P496, DOI 10.1002/lary.20101; Jaracz K, 2008, NEUROL NEUROCHIR POL, V42, P525; Kalinowski B, 1969, Otolaryngol Pol, V23, P80; Knudsen K, 2015, ACTA NEUROL SCAND, V132, P395, DOI 10.1111/ane.12406; Kobal G., 1996, Rhinology (Utrecht), V34, P222; Konstantinidis I, 2016, RHINOLOGY, V54, P170, DOI [10.4193/Rhin15.264, 10.4193/Rhino15.264]; Konstantinidis I, 2013, LARYNGOSCOPE, V123, pE85, DOI 10.1002/lary.24390; Landis BN, 2003, CHEM SENSES, V28, P691, DOI 10.1093/chemse/bjg061; LEVIN HS, 1985, BRAIN, V108, P579, DOI 10.1093/brain/108.3.579; Lotsch J, 2015, RHINOLOGY, V53, P365, DOI 10.4193/Rhino15.010; London B, 2008, ANN NEUROL, V63, P159, DOI 10.1002/ana.21293; Marino-Sanchez FS, 2010, RHINOLOGY, V48, P273, DOI [10.4193/Rhin09.206, 10.4193/Rhino09.206]; Miao XT, 2015, EUR ARCH OTO-RHINO-L, V272, P1945, DOI 10.1007/s00405-014-3278-x; Ministerio de Sanidad  Servicios Sociales e Igualdad . Encuesta Nacional de Salud, 2014, SERIE INFORMES MONOG, V3; Mullol J, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001256; Negoias S., 2016, BRAIN IMAGING BEHAV; Pekala K, 2016, INT FORUM ALLERGY RH, V6, P299, DOI 10.1002/alr.21669; Proskynitopoulos Phileas J, 2016, Surg Neurol Int, V7, pS263, DOI 10.4103/2152-7806.181981; Reden J, 2006, ARCH OTOLARYNGOL, V132, P265, DOI 10.1001/archotol.132.3.265; Rombaux P, 2009, B-ENT, P53; Rombaux P, 2006, LARYNGOSCOPE, V116, P901, DOI 10.1097/01.mlg.0000217533.60311.e7; Rombaux P, 2012, OTOLARYNG HEAD NECK, V147, P1136, DOI 10.1177/0194599812459704; Savic I, 2005, CHEM SENSES, V30, pI222, DOI 10.1093/chemse/bjh194; Schofield PW, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00005; Seiden AM, 2004, OTOLARYNG CLIN N AM, V37, P1159, DOI 10.1016/j.otc.2004.06.007; Sorokowska A, 2017, RHINOLOGY, V55, P17, DOI 10.4193/Rhin16.195; Toledano A, 2003, Acta Otorrinolaringol Esp, V54, P678; Walker WC, 2010, J NEUROL NEUROSUR PS, V81, P87, DOI 10.1136/jnnp.2008.161570; Welge-Lussen A, 2012, RHINOLOGY, V50, P67, DOI 10.4193/Rhino11.141; Yousem DM, 1996, AM J NEURORADIOL, V17, P1171	60	18	18	1	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	NOV	2018	35	22					2641	2652		10.1089/neu.2017.5230		JUL 2018	12	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	GZ0MO	WOS:000439636800001	29790420				2021-06-18	
J	Lyons, DN; Vekaria, H; Macheda, T; Bakshi, V; Powell, DK; Gold, BT; Lin, AL; Sullivan, PG; Bachstetter, AD				Lyons, Danielle N.; Vekaria, Hemendra; Macheda, Teresa; Bakshi, Vikas; Powell, David K.; Gold, Brian T.; Lin, Ai-Ling; Sullivan, Patrick G.; Bachstetter, Adam D.			A Mild Traumatic Brain Injury in Mice Produces Lasting Deficits in Brain Metabolism	JOURNAL OF NEUROTRAUMA			English	Article						arterial spin labeling; biomarkers; concussion; magnetic resonance spectroscopy; mitochondria	CEREBRAL-BLOOD-FLOW; MITOCHONDRIAL BIOENERGETICS; MOUSE MODEL; SYNAPTIC MITOCHONDRIA; DAMAGE; DYSFUNCTION; CONCUSSION	Metabolic uncoupling has been well-characterized during the first minutes-to-days after a traumatic brain injury (TBI), yet mitochondrial bioenergetics during the weeks-to-months after a brain injury is poorly defined, particularly after a mild TBI. We hypothesized that a closed head injury (CHI) would be associated with deficits in mitochondrial bioenergetics at one month after the injury. A significant decrease in state-III (adenosine triphosphate production) and state-V (complex-I) driven mitochondrial respiration was found at one month post-injury in adult C57Bl/6J mice. Isolation of synaptic mitochondria demonstrated that the deficit in state-III and state-V was primarily neuronal. Injured mice had a temporally consistent deficit in memory recall at one month post-injury. Using proton magnetic resonance spectroscopy (H-1 MRS) at 7-Tesla, we found significant decreases in phosphocreatine, N-Acetylaspartic acid, and total choline. We also found regional variations in cerebral blood flow, including both hypo- and hyperperfusion, as measured by a pseudocontinuous arterial spin labeling MR sequence. Our results highlight a chronic deficit in mitochondrial bioenergetics associated with a CHI that may lead toward a novel approach for neurorestoration after a mild TBI. MRS provides a potential biomarker for assessing the efficacy of candidate treatments targeted at improving mitochondrial bioenergetics.	[Lyons, Danielle N.; Vekaria, Hemendra; Macheda, Teresa; Sullivan, Patrick G.; Bachstetter, Adam D.] Univ Kentucky, Spinal Cord & Brain Injury Res Ctr, Lexington, KY 40536 USA; [Lyons, Danielle N.; Vekaria, Hemendra; Macheda, Teresa; Powell, David K.; Gold, Brian T.; Sullivan, Patrick G.; Bachstetter, Adam D.] Univ Kentucky, Dept Neurosci, Lexington, KY 40536 USA; [Powell, David K.] Univ Kentucky, Dept Biomed Engn, Lexington, KY 40536 USA; [Bakshi, Vikas; Lin, Ai-Ling] Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40536 USA; [Bakshi, Vikas; Lin, Ai-Ling] Univ Kentucky, Dept Pharmacol & Nutr Sci, Lexington, KY 40536 USA	Bachstetter, AD (corresponding author), Univ Kentucky, Coll Med, 741 S Limestone St, Lexington, KY 40536 USA.	adam.bachstetter@uky.edu	Vekaria, Hemendra/AAH-2100-2021; Vekaria, Hemendra/AAQ-7450-2020	Vekaria, Hemendra/0000-0001-5945-5235; Vekaria, Hemendra/0000-0001-5945-5235	Kentucky Spinal and Head Injury Trust trainee fellowship; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R00 AG044445, P30 GM110787]; University of Kentucky; United States Department of Veterans Affairs Biomedical Laboratory Research and Development Program [I01BX003405]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P30GM110787] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R00AG044445, R01AG054459] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [I01BX003405] Funding Source: NIH RePORTER	The corresponding author, Adam Bachstetter, PhD, had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. DNL was supported in part by a Kentucky Spinal and Head Injury Trust trainee fellowship. Research reported in this publication was supported by National Institutes of Health under award numbers R00 AG044445 (ADB) and P30 GM110787 (ADB), and pilot grant funding from the University of Kentucky (ADB). This work was supported in part by a Merit Review Award # I01BX003405 to (PGS) from the United States Department of Veterans Affairs Biomedical Laboratory Research and Development Program. The content is solely the responsibility of the authors and does not represent the official views of the funding organizations.	Adam O, 2015, NEUROLOGY, V85, P219, DOI 10.1212/WNL.0000000000001758; Alamed J, 2006, NAT PROTOC, V1, P1671, DOI 10.1038/nprot.2006.275; Alsop DC, 2015, MAGN RESON MED, V73, P102, DOI 10.1002/mrm.25197; Bachstetter AD, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0289-5; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Barnes DE, 2014, NEUROLOGY, V83, P312, DOI 10.1212/WNL.0000000000000616; Bouzat P, 2016, ANESTHESIOLOGY, V125, P346, DOI 10.1097/ALN.0000000000001165; Brody DL, 2007, J NEUROTRAUM, V24, P657, DOI 10.1089/neu.2006.0011; Brown MR, 2006, J BIOL CHEM, V281, P11658, DOI 10.1074/jbc.M510303200; CDC, 2003, REP C MILD TRAUM BRA; Deelchand DK, 2015, MAGN RESON MED, V73, P1718, DOI 10.1002/mrm.25295; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; George EO, 2014, J NEUROTRAUM, V31, P1018, DOI 10.1089/neu.2013.3224; Govind V, 2010, J NEUROTRAUM, V27, P483, DOI 10.1089/neu.2009.1159; Govindaraju V, 2004, AM J NEURORADIOL, V25, P730; Goyal MS, 2017, CELL METAB, V26, P353, DOI 10.1016/j.cmet.2017.07.010; Graaf R. A. d., 2007, IN VIVO NMR SPECTROS; Guo J, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00213; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; Harris JL, 2012, J CEREBR BLOOD F MET, V32, P2122, DOI 10.1038/jcbfm.2012.114; Hong X, 2015, MAGN RESON IMAGING, V33, P1098, DOI 10.1016/j.mri.2015.06.010; Janowitz T, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000330; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Kulbe JR, 2017, J NEUROTRAUM, V34, P1291, DOI 10.1089/neu.2016.4628; Lin CM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149109; Martin NA, 1997, J NEUROSURG, V87, P9, DOI 10.3171/jns.1997.87.1.0009; Maudsley AA, 2015, J NEUROTRAUM, V32, P1056, DOI 10.1089/neu.2014.3505; Opii WO, 2007, J NEUROTRAUM, V24, P772, DOI 10.1089/neu.2006.0229; Oz G, 2010, J NEUROSCI, V30, P3831, DOI 10.1523/JNEUROSCI.5612-09.2010; Pandya JD, 2016, NEUROBIOL AGING, V42, P25, DOI 10.1016/j.neurobiolaging.2016.02.027; Pandya JD, 2015, NEUROBIOL AGING, V36, P1903, DOI 10.1016/j.neurobiolaging.2015.01.018; Pandya JD, 2014, EXP NEUROL, V257, P106, DOI 10.1016/j.expneurol.2014.04.020; Pandya Jignesh D, 2013, Front Neuroenergetics, V5, P10, DOI 10.3389/fnene.2013.00010; Parikh I, 2016, AGING-US, V8, P2814, DOI 10.18632/aging.101094; Peng SP, 2016, NEURAL REGEN RES, V11, P257, DOI 10.4103/1673-5374.177733; Poole VN, 2015, DEV NEUROPSYCHOL, V40, P12, DOI 10.1080/87565641.2014.984810; PROVENCHER SW, 1993, MAGNET RESON MED, V30, P672, DOI 10.1002/mrm.1910300604; Roe C, 2009, DISABIL REHABIL, V31, P1235, DOI 10.1080/09638280802532720; Sauerbeck A, 2012, EXP NEUROL, V234, P85, DOI 10.1016/j.expneurol.2011.12.012; Sauerbeck A, 2011, J NEUROSCI METH, V198, P36, DOI 10.1016/j.jneumeth.2011.03.007; Schlattner U, 2006, BBA-MOL BASIS DIS, V1762, P164, DOI 10.1016/j.bbadis.2005.09.004; Singh IN, 2006, J CEREBR BLOOD F MET, V26, P1407, DOI 10.1038/sj.jcbfm.9600297; Sosunov SA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120456; Sullivan PG, 2005, PROG NEURO-PSYCHOPH, V29, P407, DOI 10.1016/j.pnpbp.2004.12.007; Sullivan PG, 1998, J NEUROTRAUM, V15, P789, DOI 10.1089/neu.1998.15.789; Vagnozzi R, 2008, NEUROSURGERY, V62, P1286, DOI 10.1227/01.neu.0000333300.34189.74; Vagnozzi R, 2010, BRAIN, V133, P3232, DOI 10.1093/brain/awq200; Wang XK, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00012; Wang Y, 2016, J NEUROTRAUM, V33, P1227, DOI 10.1089/neu.2015.4072; Warach SJ, 2016, STROKE, V47, P1389, DOI 10.1161/STROKEAHA.115.012364; Webster SJ, 2015, J NEUROSCI, V35, P6554, DOI 10.1523/JNEUROSCI.0291-15.2015; Williams WH, 2010, J NEUROL NEUROSUR PS, V81, P1116, DOI 10.1136/jnnp.2008.171298; Wintermark M, 2013, STROKE, V44, P2628, DOI 10.1161/STROKEAHA.113.002015; Wright DK, 2016, SCI REP-UK, V6, DOI 10.1038/srep28713; Wu X, 2016, RADIOLOGY, V279, P693, DOI 10.1148/radiol.16142535; Yonutas HM, 2016, BRAIN RES, V1640, P77, DOI 10.1016/j.brainres.2016.02.007; Zhou YL, 2010, STROKE, V41, P1521, DOI 10.1161/STROKEAHA.110.583757; Zhou YX, 2013, RADIOLOGY, V267, P880, DOI 10.1148/radiol.13122542	59	18	19	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT	2018	35	20					2435	2447		10.1089/neu.2018.5663		JUL 2018	13	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	GV6DE	WOS:000437231600001	29808778	Green Published, Other Gold			2021-06-18	
J	Olah, E; Poto, L; Hegyi, P; Szabo, I; Hartmann, P; Solymar, M; Petervari, E; Balasko, M; Habon, T; Rumbus, Z; Tenk, J; Rostas, I; Weinberg, J; Romanovsky, AA; Garami, A				Olah, Emoke; Poto, Laszlo; Hegyi, Peter; Szabo, Imre; Hartmann, Petra; Solymar, Margit; Petervari, Erika; Balasko, Marta; Habon, Tamas; Rumbus, Zoltan; Tenk, Judit; Rostas, Ildiko; Weinberg, Jordan; Romanovsky, Andrej A.; Garami, Andras			Therapeutic Whole-Body Hypothermia Reduces Death in Severe Traumatic Brain Injury if the Cooling Index Is Sufficiently High: Meta-Analyses of the Effect of Single Cooling Parameters and Their Integrated Measure	JOURNAL OF NEUROTRAUMA			English	Article						induced hypothermia; meta-analysis; mortality; thermoregulation; traumatic brain injury	RANDOMIZED CONTROLLED-TRIAL; TERM MILD HYPOTHERMIA; MODERATE HYPOTHERMIA; FEVER CONTROL; POSTTRAUMATIC HYPOTHERMIA; PREHOSPITAL HYPOTHERMIA; TEMPERATURE MANAGEMENT; CEREBRAL HYPOTHERMIA; AXONAL INJURY; HEAD	Therapeutic hypothermia was investigated repeatedly as a tool to improve the outcome of severe traumatic brain injury (TBI), but previous clinical trials and meta-analyses found contradictory results. We aimed to determine the effectiveness of therapeutic whole-body hypothermia on the deaths of adult patients with severe TBI by using a novel approach of meta-analysis. We searched the PubMed, EMBASE, and Cochrane Library databases from inception to February 2017. The identified human studies were evaluated regarding statistical, clinical, and methodological designs to ensure interstudy homogeneity. We extracted data on TBI severity, body temperature, death, and cooling parameters; then we calculated the cooling index, an integrated measure of therapeutic hypothermia. Forest plot of all identified studies showed no difference in the outcome of TBI between cooled and not cooled patients, but interstudy heterogeneity was high. On the contrary, by meta-analysis of randomized clinical trials that were homogenous with regard to statistical, clinical designs, and precisely reported the cooling protocol, we showed decreased odds ratio for death in therapeutic hypothermia compared with no cooling. As independent factors, milder and longer cooling, and rewarming at <0.25 degrees C/h were associated with better outcome. Therapeutic hypothermia was beneficial only if the cooling index (measure of combination of cooling parameters) was sufficiently high. We conclude that high methodological and statistical interstudy heterogeneity could underlie the contradictory results obtained in previous studies. By analyzing methodologically homogenous studies, we show that cooling improves the outcome of severe TBI, and this beneficial effect depends on certain cooling parameters and on their integrated measure, the cooling index.	[Olah, Emoke; Hegyi, Peter; Solymar, Margit; Petervari, Erika; Balasko, Marta; Rumbus, Zoltan; Tenk, Judit; Rostas, Ildiko; Garami, Andras] Univ Pecs, Inst Translat Med, Med Sch, 12 Szigeti St, H-7624 Pecs, Hungary; [Poto, Laszlo] Univ Pecs, Inst Bioanal, Med Sch, Pecs, Hungary; [Hegyi, Peter; Szabo, Imre] Univ Pecs, Med Sch, Div Gastroenterol, Dept Med 1, Pecs, Hungary; [Hegyi, Peter] Univ Szeged, Hungarian Acad Sci, Momentum Gastroenterol Multidisciplinary Res Grp, Szeged, Hungary; [Hartmann, Petra] Univ Szeged, Inst Surg Res, Szeged, Hungary; [Habon, Tamas] Univ Pecs, Med Sch, Dept Med 1, Dept Cardiol & Angiol, Pecs, Hungary; [Weinberg, Jordan; Romanovsky, Andrej A.] St Josephs Hosp, Trauma Res, Phoenix, AZ USA	Garami, A (corresponding author), Univ Pecs, Inst Translat Med, Med Sch, 12 Szigeti St, H-7624 Pecs, Hungary.	andras.garami@aok.pte.hu	Habon, Tamas/S-9289-2019	Habon, Tamas/0000-0002-4816-857X; Romanovsky, Andrej/0000-0003-3772-8575; Garami, Andras/0000-0003-2493-0571; Hartmann, Petra/0000-0002-4746-9792	National Research, Development and Innovation OfficeNational Research, Development & Innovation Office (NRDIO) - Hungary [FK 124483]; New National Excellence Program of the Hungarian Ministry of Human Capacities [UNKP-17-4-III-PTE-33]; GINOP STAY ALIVE [2.3.2-15-2016-00048]; EFOP LIVE LONGER [3.6.2-16-2017-00006]	This research has been supported by the National Research, Development and Innovation Office (grant FK 124483), the New National Excellence Program of the Hungarian Ministry of Human Capacities (UNKP-17-4-III-PTE-33), GINOP STAY ALIVE (grant 2.3.2-15-2016-00048), and EFOP LIVE LONGER (grant 3.6.2-16-2017-00006).	Andrews PJD, 2015, NEW ENGL J MED, V373, P2403, DOI 10.1056/NEJMoa1507581; Balvers Kirsten, 2016, J Emerg Trauma Shock, V9, P97, DOI 10.4103/0974-2700.185276; Bramlett HM, 2012, THER HYPOTHERMIA TEM, V2, P14, DOI 10.1089/ther.2012.0002; Bukur M, 2012, J TRAUMA ACUTE CARE, V73, P1195, DOI 10.1097/TA.0b013e31826fc7d9; Bukur M, 2012, J SURG RES, V175, P24, DOI 10.1016/j.jss.2011.07.003; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; CLIFTON GL, 1993, J NEUROTRAUM, V10, P263, DOI 10.1089/neu.1993.10.263; Clifton GL, 2011, LANCET NEUROL, V10, P131, DOI 10.1016/S1474-4422(10)70300-8; Crompton EM, 2017, CRIT CARE MED, V45, P575, DOI 10.1097/CCM.0000000000002205; Dietrich WD, 2009, J NEUROTRAUM, V26, P301, DOI 10.1089/neu.2008.0806; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Fay T, 1943, RES PUBL ASSOC RES N, V24, P611; Feng JF, 2010, NEUROSURGERY, V67, P730, DOI 10.1227/01.NEU.0000378023.81727.6E; Finfer SR, 2001, RESUSCITATION, V48, P77, DOI 10.1016/S0300-9572(00)00321-X; Fonseca JE, 2009, AUTOIMMUN REV, V8, P538, DOI 10.1016/j.autrev.2009.01.012; Garami A., 2018, ACTA PHYSL OXF, pprint; Harris OA, 2002, ARCH NEUROL-CHICAGO, V59, P1077, DOI 10.1001/archneur.59.7.1077; Harris OA, 2009, J NEUROSURG, V110, P1256, DOI 10.3171/2009.1.JNS081320; Hashiguchi N, 2003, J TRAUMA, V55, P1054, DOI 10.1097/01.TA.0000033252.43742.8B; Henderson WR, 2003, INTENS CARE MED, V29, P1637, DOI 10.1007/s00134-003-1848-2; Hifumi T, 2016, J NEUROTRAUM, V33, P1047, DOI 10.1089/neu.2015.4033; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Jiang JY, 2000, J NEUROSURG, V93, P546, DOI 10.3171/jns.2000.93.4.0546; Jiang JY, 2006, J CEREBR BLOOD F MET, V26, P771, DOI 10.1038/sj.jcbfm.9600253; Lee BH, 2012, CRIT CARE, V16, DOI 10.1186/cc11211; Lee HC, 2010, WORLD NEUROSURG, V74, P654, DOI 10.1016/j.wneu.2010.06.019; Lei J, 2015, CONTEMP CLIN TRIALS, V40, P9, DOI 10.1016/j.cct.2014.11.008; Li PC, 2014, BRAIN INJURY, V28, P1036, DOI 10.3109/02699052.2014.910609; Liu WG, 2006, J INT MED RES, V34, P58, DOI 10.1177/147323000603400107; Liu YH, 2015, EXP THER MED, V9, P464, DOI 10.3892/etm.2014.2130; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Maekawa T, 2015, J NEUROTRAUM, V32, P422, DOI 10.1089/neu.2013.3197; Marion D, 2009, J NEUROTRAUM, V26, P455, DOI 10.1089/neu.2008.0582; Marion DW, 2014, CRIT CARE, V18, DOI 10.1186/cc13955; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; McGinn MJ, 2016, NEUROSURG CLIN N AM, V27, P397, DOI 10.1016/j.nec.2016.06.002; McIntyre LA, 2003, JAMA-J AM MED ASSOC, V289, P2992, DOI 10.1001/jama.289.22.2992; Moher D, 2016, REV ESP NUTR HUM DIE, V20, P148, DOI [10.1186/2046-4053-4-1, 10.14306/renhyd.20.2.223]; Nichol A, 2015, CRIT CARE RESUSC, V17, P92; Peterson K, 2008, J NEUROTRAUM, V25, P62, DOI 10.1089/neu.2007.0424; Polderman KH, 2008, LANCET, V371, P1955, DOI 10.1016/S0140-6736(08)60837-5; Polderman KH, 2015, CIRCULATION, V132, P152, DOI 10.1161/CIRCULATIONAHA.115.017350; Polderman KH, 2009, CRIT CARE MED, V37, pS186, DOI 10.1097/CCM.0b013e3181aa5241; Polderman KH, 2002, INTENS CARE MED, V28, P1563, DOI 10.1007/s00134-002-1511-3; Povlishock JT, 2009, J NEUROTRAUM, V26, P333, DOI 10.1089/neu.2008.0604; Qiu W, 2007, J CRIT CARE, V22, P229, DOI 10.1016/j.jcrc.2006.06.011; Qiu WS, 2006, J CLIN NEUROSCI, V13, P995, DOI 10.1016/j.jocn.2006.02.027; Rincon F, 2014, J NEUROSURG, V121, P950, DOI 10.3171/2014.7.JNS132470; Rumbus Z, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170152; Sahuquillo J, 2007, CURR PHARM DESIGN, V13, P2310; Schwab S, 1998, STROKE, V29, P2461, DOI 10.1161/01.STR.29.12.2461; Shaefi Shahzad, 2016, Surg Neurol Int, V7, P103, DOI 10.4103/2152-7806.194816; Sheriff FG, 2015, SEMIN NEUROL, V35, P42, DOI 10.1055/s-0035-1544238; SHIOZAKI T, 1993, J NEUROSURG, V79, P363, DOI 10.3171/jns.1993.79.3.0363; Shiozaki T, 2001, J NEUROSURG, V94, P50, DOI 10.3171/jns.2001.94.1.0050; Smrcka M, 2005, ACT NEUR S, V95, P273; Steiner T, 2001, STROKE, V32, P2833, DOI 10.1161/hs1201.99511; Stocchetti N, 2017, LANCET NEUROL, V16, P452, DOI 10.1016/S1474-4422(17)30118-7; Suehiro E, 2003, J NEUROTRAUM, V20, P381, DOI 10.1089/089771503765172336; Suehiro E, 2001, J NEUROSURG, V94, P493, DOI 10.3171/jns.2001.94.3.0493; Suehiro E, 2015, J NEUROTRAUM, V32, P353, DOI 10.1089/neu.2014.3584; Suehiro E, 2014, J NEUROTRAUM, V31, P315, DOI 10.1089/neu.2013.3057; Tang CH, 2017, J CRIT CARE, V39, P267, DOI 10.1016/j.jcrc.2016.12.012; Taylor CA, 2015, J HEAD TRAUMA REHAB, V30, P150, DOI 10.1097/HTR.0000000000000105; Tohme S, 2014, SCAND J TRAUMA RESUS, V22, DOI 10.1186/1757-7241-22-1; Westermaier T, 2017, J NEUROL SURG PART A, V78, P397, DOI 10.1055/s-0036-1596057; Yokobori S, 2016, J INTENSIVE CARE, V4, DOI 10.1186/s40560-016-0137-4; Zhao QJ, 2011, J CRIT CARE, V26, P311, DOI 10.1016/j.jcrc.2010.08.014; Zhao WY, 2017, BRAIN RES, V1669, P141, DOI 10.1016/j.brainres.2017.06.006; Zhi DS, 2003, SURG NEUROL, V59, P381, DOI 10.1016/S0090-3019(03)00148-4; Zhu YF, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-2391-2	73	18	19	1	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT	2018	35	20					2407	2417		10.1089/neu.2018.5649		JUL 2018	11	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	GV6DE	WOS:000437231000001	29681213	Green Accepted			2021-06-18	
J	Schumacher, DJ; Holmboe, ES; van der Vleuten, C; Busari, JO; Carraccio, C				Schumacher, Daniel J.; Holmboe, Eric S.; van der Vleuten, Cees; Busari, Jamiu O.; Carraccio, Carol			Developing Resident-Sensitive Quality Measures: A Model From Pediatric Emergency Medicine	ACADEMIC MEDICINE			English	Article							PATIENT OUTCOMES; EDUCATION; CARE; PERFORMANCE; IMPROVEMENT; PROGRAMS	Purpose To begin closing the gap with respect to quality measures available for use among residents, the authors sought to identify and develop resident-sensitive quality measures (RSQMs) for use in the pediatric emergency department (PED) setting. Method In May 2016, the authors reviewed National Quality Measures Clearinghouse (NQMC) measures to identify resident-sensitive measures. To create additional measures focused on common, acute illnesses (acute asthma exacerbation, bronchiolitis, closed head injury [CHI]) in the PED, the authors used a nominal group technique (NGT) and Delphi process from September to December 2016. To achieve a local focus for developing these measures, all NGT and Delphi participants were from Cincinnati Children's Hospital Medical Center. Delphi participants rated measures developed through the NGT in two areas: importance of measure to quality care and likelihood that measure represents the work of a resident. Result The review of NQMC measures identified 28 of 183 as being potentially resident sensitive. The NGT produced 67 measures for asthma, 46 for bronchiolitis, and 48 for CHI. These were used in the first round of the Delphi process. After two rounds, 18 measures for asthma, 21 for bronchiolitis, and 21 for CHI met automatic inclusion criteria. In round three, participants categorized the potential final measures by their top 10 and next 5. Conclusions This study describes a template for identifying and developing RSQMs that may promote high-quality care delivery during and following training. Next steps should include implementing and seeking validity evidence for the locally developed measures.	[Schumacher, Daniel J.] Cincinnati Childrens Hosp Med Ctr, Div Emergency Med, MLC 2008,3333 Burnet Ave, Cincinnati, OH 45226 USA; [Holmboe, Eric S.] Accreditat Council Grad Med Educ, Milestones Dev & Evaluat, Chicago, IL USA; [van der Vleuten, Cees] Maastricht Univ, Dept Educ Dev & Res, Fac Hlth Med & Life Sci, Educ, Maastricht, Netherlands; [van der Vleuten, Cees] Maastricht Univ, Sch Hlth Profess Educ, Maastricht, Netherlands; [Busari, Jamiu O.] Maastricht Univ, Maastricht, Netherlands; [Busari, Jamiu O.] Maastricht Univ, Med Educ, Maastricht, Netherlands; [Carraccio, Carol] Amer Board Pediat Inc, Competency Based Assessment, Chapel Hill, NC USA	Schumacher, DJ (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Emergency Med, MLC 2008,3333 Burnet Ave, Cincinnati, OH 45226 USA.	daniel.schumacher@cchmc.org	Busari, JO/AAI-1935-2020; Busari, Jamiu/C-9425-2018	Busari, Jamiu/0000-0002-8616-5564	Division of Emergency Medicine at Cincinnati Children's Hospital Medical Center	This study was supported by the Division of Emergency Medicine at Cincinnati Children's Hospital Medical Center.	Agency for Healthcare Research and Quality, SEARCH RES EM DEP; Asch DA, 2009, JAMA-J AM MED ASSOC, V302, P1277, DOI 10.1001/jama.2009.1356; Bansal N, 2016, JAMA SURG, V151, P111, DOI 10.1001/jamasurg.2015.3637; Berenson R. A., 2013, ACHIEVING POTENTIAL; Butler JM, 2017, ACAD MED, V92, P984, DOI 10.1097/ACM.0000000000001474; Chen C, 2014, JAMA-J AM MED ASSOC, V312, P2385, DOI 10.1001/jama.2014.15973; Committee on the Governance and Financing of Graduate Medical Education Board on Health Care Services Institute of Medicine., 2014, GRAD MED ED MEETS NA; Cook DA, 2013, ACAD MED, V88, P162, DOI 10.1097/ACM.0b013e31827c3d78; CORDASCO KM, 2009, ARE RESIDENCY PROGRA, P43990; Englesbe MJ, 2007, ANN SURG, V246, P456, DOI 10.1097/SLA.0b013e31814855f2; Haan CK, 2008, ACAD MED, V83, P574, DOI 10.1097/ACM.0b013e318172318d; Hsu C-C, 2007, PRACT ASSESS RES EVA, V12; Humphrey-Murto S, 2017, ACAD MED, V92, P1491, DOI 10.1097/ACM.0000000000001812; Inaba K, 2010, J TRAUMA, V68, P19, DOI 10.1097/TA.0b013e3181b88dfe; Kalet AL, 2010, ACAD MED, V85, P844, DOI 10.1097/ACM.0b013e3181d734a5; Kauvar DS, 2006, J SURG RES, V132, P159, DOI 10.1016/j.jss.2005.11.578; Medicare Payment Advisory Commission, 2009, C IMPR INC MED PROGR; MedPAC (Payment Advisory Commission), 2010, REP C AL INC MED, P103; Mittiga Matthew R, 2010, J Grad Med Educ, V2, P571, DOI 10.4300/JGME-D-10-00106.1; Moreau KA, 2015, MED TEACH, V37, P1060, DOI 10.3109/0142159X.2015.1060307; Phillips DP, 2010, J GEN INTERN MED, V25, P774, DOI 10.1007/s11606-010-1356-3; Resnick AS, 2008, J SURG EDUC, V65, P243, DOI 10.1016/j.jsurg.2008.01.005; Sandars J, 2011, MED TEACH, V33, P875, DOI 10.3109/0142159X.2011.595434; Schon D.A., 1983, REFLECTIVE PRACTITIO; Swing SR, 2007, ACAD EMERG MED, V14, P463, DOI 10.1197/j.aem.2006.12.011; van der Leeuw RM, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-65; Van Melle E, 2017, ACAD MED, V92, P752, DOI 10.1097/ACM.0000000000001479; Wiest FC, 2002, JAMA-J AM MED ASSOC, V288, P2609, DOI 10.1001/jama.288.20.2609; Yin HS, 2015, J GEN INTERN MED, V30, P1363, DOI 10.1007/s11606-015-3329-z	29	18	18	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1040-2446	1938-808X		ACAD MED	Acad. Med.	JUL	2018	93	7					1071	1078		10.1097/ACM.0000000000002093			8	Education, Scientific Disciplines; Health Care Sciences & Services	Education & Educational Research; Health Care Sciences & Services	GL5WU	WOS:000437245700030	29215378	Bronze			2021-06-18	
J	Tolonen, A; Sarkela, MOK; Takala, RSK; Katila, A; Frantzen, J; Posti, JP; Muller, M; van Gils, M; Tenovuo, O				Tolonen, Antti; Sarkela, Mika O. K.; Takala, Riikka S. K.; Katila, Ari; Frantzen, Janek; Posti, Jussi P.; Muller, Markus; van Gils, Mark; Tenovuo, Olli			Quantitative EEG Parameters for Prediction of Outcome in Severe Traumatic Brain Injury: Development Study	CLINICAL EEG AND NEUROSCIENCE			English	Article						traumatic brain injury; continuous electroencephalography; quantitative electroencephalography; prognosis; outcome	SOMATOSENSORY-EVOKED POTENTIALS; PERCENT-ALPHA-VARIABILITY; CONTINUOUS ELECTROENCEPHALOGRAPHY; CONSENSUS STATEMENT; QUANTIFICATION	Monitoring of quantitative EEG (QEEG) parameters in the intensive care unit (ICU) can aid in the treatment of traumatic brain injury (TBI) patients by complementing visual EEG review done by an expert. We performed an explorative study investigating the prognostic value of 59 QEEG parameters in predicting the outcome of patients with severe TBI. Continuous EEG recordings were done on 28 patients with severe TBI in the ICU of Turku University Hospital. We computed a set of QEEG parameters for each patient, and correlated these to patient outcome, measured by dichotomized Glasgow Outcome Scale (GOS) at a follow-up visit between 6 and 12 months, using area under receiver operating characteristic curve (AUC) as a nonlinear correlation measure. For 17 of the 59 QEEG parameters (28.8%), the AUC differed significantly from 0.5, most of these parameters measured EEG power or variability. The best QEEG parameters for outcome prediction were alpha power (AUC = 0.87, P < .01) and variability of the relative fast theta power (AUC = 0.84, P < .01). The results of this study indicate that QEEG parameters provide useful information for predicting outcome in severe TBI. Novel QEEG parameters with potential in outcome prediction were found, the prognostic value of these parameters should be confirmed in later studies. The results also provide further evidence of the usefulness of parameters studied in preexisting studies.	[Tolonen, Antti; van Gils, Mark] VTT Tech Res Ctr Finland Ltd, Tekniikankatu 1,POB 1300, FI-33101 Tampere, Finland; [Sarkela, Mika O. K.; Posti, Jussi P.] GE Healthcare Finland Oy, Helsinki, Finland; [Takala, Riikka S. K.; Katila, Ari; Posti, Jussi P.; Tenovuo, Olli] Univ Turku, Turku, Finland; [Takala, Riikka S. K.; Katila, Ari; Frantzen, Janek; Posti, Jussi P.; Muller, Markus; Tenovuo, Olli] Turku Univ Hosp, Turku, Finland	Tolonen, A (corresponding author), VTT Tech Res Ctr Finland Ltd, Tekniikankatu 1,POB 1300, FI-33101 Tampere, Finland.	antti.tolonen@vtt.fi	Sarkela, Mika/AAJ-6496-2020; Posti, Jussi P./Y-2908-2019	Sarkela, Mika/0000-0001-6817-2093; Posti, Jussi P./0000-0002-5925-5193; van Gils, Mark/0000-0002-0029-1771			[Anonymous], 2008, BMJ-BRIT MED J, V336, P425, DOI DOI 10.1136/bmj.39461.643438.25; BRICOLO A, 1978, ELECTROEN CLIN NEURO, V45, P211, DOI 10.1016/0013-4694(78)90005-6; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Carter BG, 2005, INTENS CARE MED, V31, P765, DOI 10.1007/s00134-005-2633-1; Carter BG, 2001, CRIT CARE MED, V29, P178, DOI 10.1097/00003246-200101000-00036; Claassen J, 2013, INTENS CARE MED, V39, P1337, DOI 10.1007/s00134-013-2938-4; Dunham CM, 2006, CRIT CARE, V10, DOI 10.1186/cc5097; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Friedman D, 2009, ANESTH ANALG, V109, P506, DOI 10.1213/ane.0b013e3181a9d8b5; Hebb MO, 2007, J NEUROTRAUM, V24, P579, DOI 10.1089/neu.2006.0146; Herman ST, 2015, J CLIN NEUROPHYSIOL, V32, P96, DOI 10.1097/WNP.0000000000000165; INOUYE T, 1991, ELECTROEN CLIN NEURO, V79, P204, DOI 10.1016/0013-4694(91)90138-T; Kaplan PW, 1999, CLIN NEUROPHYSIOL, V110, P205, DOI 10.1016/S1388-2457(98)00046-7; Kirkman Matthew A, 2012, Anesthesiol Clin, V30, P269, DOI 10.1016/j.anclin.2012.05.007; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; MOULTON RJ, 1988, CAN J NEUROL SCI, V15, P82, DOI 10.1017/S0317167100027244; Moulton RJ, 1997, HEAD INJURY PATHOPHY, V1997, P229; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Sarkela Mika, 2002, J Clin Monit Comput, V17, P125, DOI 10.1023/A:1016393904439; Sarkela MOK, 2007, ANESTHESIOLOGY, V107, P928; Steudel W I, 1979, Acta Neurochir Suppl (Wien), V28, P40; Stewart J, 2014, LIVER TRANSPLANT, V20, P1256, DOI 10.1002/lt.23944; Tanner AEJ, 2014, J CLIN NEUROPHYSIOL, V31, P181, DOI 10.1097/WNP.0000000000000049; Thatcher R W, 1991, Ann N Y Acad Sci, V620, P82, DOI 10.1111/j.1749-6632.1991.tb51576.x; van Putten MJAM, 2007, CLIN NEUROPHYSIOL, V118, P2362, DOI 10.1016/j.clinph.2007.07.019; Vespa PM, 2002, J NEUROSURG, V97, P84, DOI 10.3171/jns.2002.97.1.0084; Wallace BE, 2001, J HEAD TRAUMA REHAB, V16, P165, DOI 10.1097/00001199-200104000-00006; Young GB, 2006, CLIN NEUROPHYSIOL, V117, P1376, DOI 10.1016/j.clinph.2006.02.006; Young GB, 2000, J CLIN NEUROPHYSIOL, V17, P473, DOI 10.1097/00004691-200009000-00006	29	18	20	1	7	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1550-0594	2169-5202		CLIN EEG NEUROSCI	Clin. EEG Neurosci.	JUL	2018	49	4					248	257		10.1177/1550059417742232			10	Clinical Neurology; Neurosciences; Neuroimaging; Psychiatry; Psychology	Neurosciences & Neurology; Psychiatry; Psychology	GH6DZ	WOS:000433534500004	29172703				2021-06-18	
J	Worts, PR; Schatz, P; Burkhart, SO				Worts, Phillip R.; Schatz, Philip; Burkhart, Scott O.			Test Performance and Test-Retest Reliability of the Vestibular/Ocular Motor Screening and King-Devick Test in Adolescent Athletes During a Competitive Sport Season	AMERICAN JOURNAL OF SPORTS MEDICINE			English	Article						high school; concussion; ocular; vestibular; sports; sideline; acute	ERROR SCORING SYSTEM; STANDARDIZED ASSESSMENT; POSTURAL CONTROL; BASE-LINE; CONCUSSION; EXERCISE; DEFICITS; TOOL	Background: The Vestibular/Ocular Motor Screening (VOMS) and King-Devick (K-D) test are tools designed to assess ocular or vestibular function after a sport-related concussion. Purpose: To determine the test-retestre iability and rate of false-positive results of the VOMS and K-D test in a healthy athlete sample. Study Design: Cohort study (diagnosis); Level of evidence, 2. Methods: Forty-five healthy high school student-athletes (mean age, 16.11 +/- 1.43 years) completed self-reported demographics and medical history and were administered the VOMS and K-D test during rest on day 1 (baseline). The VOMS and K-D test were administered again once during rest (prepractice) and once within 5 minutes of removal from sport practice on day 2 (removal). The Borg rating of perceived exertion scale was administered at removal. Intraclass correlation coefficients were used to determine test-retest reliability on the K-D test and the average near point of convergence (NPC) distance on the VOMS. Level of agreement was used to examine VOMS symptom provocation over the 3 administration times. Multivariate base rates were used to determine the rate of false-positive results when simultaneously considering multiple clinical cutoffs. Results: Test-retest reliability of total time on the K-D test (0.91 [95% CI, 0.86-0.95]) and NPC distance (0.91 [95% CI, 0.85-0.95]) was high across the 3 administration times. Level of agreement ranged from 48.9% to 88.9% across all 3 times for the VOMS items. Using established clinical cutoffs, false-positive results occurred in 2% of the sample using the VOMS at removal and 36% using the K-D test. Conclusion: The VOMS displayed a false-positive rate of 2% in this high school student-athlete cohort. The K-D test's false-positive rate was 36% while maintaining a high level of test-retest reliability (0.91). Results from this study support future investigation of VOMS administration in an acutely injured high school athletic sample. Going forward, the VOMS may be more stable than other neurological and symptom report screening measures and less vulnerable to false-positive results than the K-D test.	[Worts, Phillip R.; Schatz, Philip; Burkhart, Scott O.] Florida State Univ, Tallahassee, FL 32306 USA; [Burkhart, Scott O.] Childrens Hlth Andrews Inst Orthopaed & Sports Me, 7211 Preston Rd,Suite 1400, Plano, TX 75024 USA; [Worts, Phillip R.] Florida State Univ, Coll Human Sci, Dept Nutr Food & Exercise Sci, Tallahassee, FL 32306 USA; [Worts, Phillip R.] Tallahassee Orthoped Clin, Tallahassee, FL USA; [Schatz, Philip] St Josephs Univ, Dept Psychol, Philadelphia, PA 19131 USA	Burkhart, SO (corresponding author), Childrens Hlth Andrews Inst Orthopaed & Sports Me, 7211 Preston Rd,Suite 1400, Plano, TX 75024 USA.	scott.burkhart@childrens.com	Worts, Phillip Robert/J-9063-2019				BORG G, 1970, Scandinavian Journal of Rehabilitation Medicine, V2, P92; Chelune GJ, 1993, NEUROPSYCHOLOGY, V7, P41, DOI DOI 10.1037/0894-4105.7.1.41; Corwin DJ, 2015, J PEDIATR-US, V166, P1221, DOI 10.1016/j.jpeds.2015.01.039; Covassin T, 2007, BRIT J SPORT MED, V41, P370, DOI 10.1136/bjsm.2006.032334; Docherty CL, 2006, CLIN J SPORT MED, V16, P203, DOI 10.1097/00042752-200605000-00003; Erkmen N, 2009, ISOKINET EXERC SCI, V17, P121, DOI 10.3233/IES-2009-0343; Fox ZG, 2008, J ATHL TRAINING, V43, P456, DOI 10.4085/1062-6050-43.5.456; Galetta KM, 2011, NEUROLOGY, V76, P1456, DOI 10.1212/WNL.0b013e31821184c9; Galetta KM, 2011, J NEUROL SCI, V309, P34, DOI 10.1016/j.jns.2011.07.039; Iverson GL, 2015, BRAIN INJURY, V29, P263, DOI 10.3109/02699052.2014.965214; King D, 2013, J NEUROL SCI, V326, P59, DOI 10.1016/j.jns.2013.01.012; Koscs M, 2009, ATHL TRAIN SPORTS HL, V1, P24; Leong Danielle F, 2015, J Optom, V8, P131, DOI 10.1016/j.optom.2014.12.005; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; McCrea M, 1997, NEUROLOGY, V48, P586, DOI 10.1212/WNL.48.3.586; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; McCrea M, 2002, NEUROSURGERY, V50, P1032, DOI 10.1097/00006123-200205000-00017; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Oberlander TJ, 2017, J ATHL TRAINING, V52, P439, DOI 10.4085/1062-6050-52.2.12; Rahn C, 2015, CLIN J SPORT MED, V25, P248, DOI 10.1097/JSM.0000000000000141; Schatz P, 2010, AM J SPORT MED, V38, P47, DOI 10.1177/0363546509343805; SELL KE, 1994, J ORTHOP SPORT PHYS, V19, P162, DOI 10.2519/jospt.1994.19.3.162; Spradley B, 2014, SPORT J, V201419, P1; Sufrinko AM, 2017, AM J SPORT MED, V45, P1187, DOI 10.1177/0363546516685061; Sullivan SJ, 2011, BRIT J SPORT MED, V45, P46, DOI 10.1136/bjsm.2009.071225; Susco TM, 2004, J ATHL TRAINING, V39, P241; Ventura RE, 2014, LANCET NEUROL, V13, P1006, DOI 10.1016/S1474-4422(14)70111-5; Weber AF, 2013, J ATHL TRAINING, V48, P153, DOI 10.4085/1062-6050-48.1.07; Wilkins JC, 2004, J ATHL TRAINING, V39, P156; Yorke AM, 2017, SPORTS HEALTH, V9, P174, DOI 10.1177/1941738116678411	31	18	18	2	3	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0363-5465	1552-3365		AM J SPORT MED	Am. J. Sports Med.	JUL	2018	46	8					2004	2010		10.1177/0363546518768750			7	Orthopedics; Sport Sciences	Orthopedics; Sport Sciences	GN0AK	WOS:000438619500031	29741916				2021-06-18	
J	Beckwith, J; Zhao, W; Ji, SB; Ajamil, A; Bolander, R; Chu, J; McAllister, T; Crisco, J; Duma, S; Rowson, S; Broglio, S; Guskiewicz, K; Mihalik, J; Anderson, S; Schnebel, B; Gunnar Brolinson, P; Collins, M; Greenwald, R				Beckwith, Jonathan G.; Zhao, Wei; Ji, Songbai; Ajamil, Amaris G.; Bolander, Richard P.; Chu, Jeffrey J.; McAllister, Thomas W.; Crisco, Joseph J.; Duma, Stefan M.; Rowson, Steven; Broglio, Steven P.; Guskiewicz, Kevin M.; Mihalik, Jason P.; Anderson, Scott; Schnebel, Brock; Gunnar Brolinson, P.; Collins, Michael W.; Greenwald, Richard M.			Estimated Brain Tissue Response Following Impacts Associated With and Without Diagnosed Concussion	ANNALS OF BIOMEDICAL ENGINEERING			English	Article						Finite element model; Sports concussion; Mild traumatic brain injury; Head impact; Brain tissue response; HIT System	COLLEGIATE FOOTBALL PLAYERS; MAXIMUM PRINCIPAL STRAIN; WHITE-MATTER; HEAD ACCELERATION; INJURY; EXPOSURE; PREDICTORS; KINEMATICS; LOCATION; HELMETS	Kinematic measurements of head impacts are sensitive to sports concussion, but not highly specific. One potential reason is these measures reflect input conditions only and may have varying degrees of correlation to regional brain tissue deformation. In this study, previously reported head impact data recorded in the field from high school and collegiate football players were analyzed using two finite element head models (FEHM). Forty-five impacts associated with immediately diagnosed concussion were simulated along with 532 control impacts without identified concussion obtained from the same players. For each simulation, intracranial response measures (max principal strain, strain rate, von Mises stress, and pressure) were obtained for the whole brain and within four regions of interest (ROI; cerebrum, cerebellum, brain stem, corpus callosum). All response measures were sensitive to diagnosed concussion; however, large inter-athlete variability was observed and sensitivity strength depended on measure, ROI, and FEHM. Interestingly, peak linear acceleration was more sensitive to diagnosed concussion than all intracranial response measures except pressure. These findings suggest FEHM may provide unique and potentially important information on brain injury mechanisms, but estimations of concussion risk based on individual intracranial response measures evaluated in this study did not improve upon those derived from input kinematics alone.	[Beckwith, Jonathan G.; Ajamil, Amaris G.; Bolander, Richard P.; Chu, Jeffrey J.; Greenwald, Richard M.] Simbex, 10 Water St Suite 410, Lebanon, NH 03748 USA; [Zhao, Wei; Ji, Songbai] Worcester Polytech Inst, Dept Biomed Engn, Worcester, MA 01609 USA; [Ji, Songbai; Greenwald, Richard M.] Dartmouth Coll, Thayer Sch Engn, Hanover, NH 03755 USA; [McAllister, Thomas W.] Indiana Sch Med, Dept Psychiat, Indianapolis, IA USA; [Crisco, Joseph J.] Brown Univ, Alpert Med Sch, Dept Orthopaed, Providence, RI 02912 USA; [Crisco, Joseph J.] Rhode Isl Hosp, Providence, RI USA; [Duma, Stefan M.; Rowson, Steven] Virginia Tech, Dept Biomed Engn & Mech, Blacksburg, VA USA; [Broglio, Steven P.] Univ Michigan, NeuroTrauma Res Lab, Ann Arbor, MI 48109 USA; [Guskiewicz, Kevin M.; Mihalik, Jason P.] Univ N Carolina, Matthew Gfeller Sport Related Traumat Brain Injur, Chapel Hill, NC USA; [Anderson, Scott] Univ Oklahoma, Dept Intercollegiate Athlet, Norman, OK 73019 USA; [Schnebel, Brock] Univ Oklahoma, Dept Orthoped, Norman, OK 73019 USA; [Schnebel, Brock] Univ Oklahoma, Dept Athlet, Norman, OK 73019 USA; [Gunnar Brolinson, P.] Edward Via Coll Osteopath Med, Blacksburg, VA USA; [Collins, Michael W.] Univ Pittsburgh, Med Ctr, Dept Orthopaed Surg, Pittsburgh, PA USA; [Collins, Michael W.] Univ Pittsburgh, Med Ctr, Dept Neurol Surg, Pittsburgh, PA USA	Beckwith, J (corresponding author), Simbex, 10 Water St Suite 410, Lebanon, NH 03748 USA.	jbeckwith@simbex.com	Rowson, Steven/B-1270-2012	Rowson, Steven/0000-0002-3227-0596	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01HD048638, R01NS094410, R01NS055020, R01NS092853, R21NS088781]; Centers for Disease Control and PreventionUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R01CE001254, 5R49CE000196]; NOCSAE [07-04, 14-19]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R44HD40473]; Riddell, Inc. (Chicago, IL); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD048638] Funding Source: NIH RePORTER; NATIONAL CENTER FOR INJURY PREVENTION AND CONTROLUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49CE000196, R01CE001254] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS092853, R01NS055020, R21NS088781, R01NS094410] Funding Source: NIH RePORTER	This work was supported in part by awards R01HD048638, R01NS094410, R01NS055020, R01NS092853, and R21NS088781 from the National Institutes of Health, R01CE001254 and 5R49CE000196 from the Centers for Disease Control and Prevention, and NOCSAE (07-04, 14-19). HIT System technology was developed in part under NIH R44HD40473 and research and development support from Riddell, Inc. (Chicago, IL). We thank the researchers and institutions from which the data were collected: Mike Goforth MS, ATC, Virginia Tech Sports Medicine; Dave Dieter MS, ATC, Virginia Tech Sports Medicine; Russell Fiore ATC, Brown University Sports Medicine; Bethany Wilcox PhD, Brown University; Ron Gatlin ATC, Casady HS; Jeff Frechette ATC and Scott Roy ATC, Dartmouth College Sports Medicine; Dean Kleinschmidt ATC and Brian Lund, University of Indiana Sports Medicine; Jesse Townsend ATC, Greensburg Salam HS; Jeff Cienick ATC, Blackhawk HS; John Burnett ATC, Karns City HS; Chris Ashton ATC, University of Minnesota Sports Medicine; Scott Hamilton, Unity HS; Scott Oliaro, Scott Trulock, and Doug Halverson, UNC-Chapel Hill Sports Medicine. Additionally, we would like to especially thank Lindley Brainard and Wendy Chamberlin, Simbex for coordination of data collection from Dartmouth College, Brown University, and Virginia Tech, and Rema Raman PhD and Sonia Jain PhD, University of California San Diego, for review of the statistical analysis.	Beckwith JG, 2013, MED SCI SPORT EXER, V45, P737, DOI 10.1249/MSS.0b013e3182792ed7; Beckwith JG, 2013, MED SCI SPORT EXER, V45, P747, DOI 10.1249/MSS.0b013e3182793067; Beckwith JG, 2012, ANN BIOMED ENG, V40, P237, DOI 10.1007/s10439-011-0422-2; Broglio SP, 2010, MED SCI SPORT EXER, V42, P2064, DOI 10.1249/MSS.0b013e3181dd9156; Brolinson P Gunnar, 2006, Curr Sports Med Rep, V5, P23; Chu JJ, 2006, J BIOMECH S1, V39, pS534; Crisco JJ, 2004, J BIOMECH ENG-T ASME, V126, P849, DOI 10.1115/1.1824135; Crisco JJ, 2011, J BIOMECH, V44, P2673, DOI 10.1016/j.jbiomech.2011.08.003; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; Duhaime AC, 2012, J NEUROSURG, V117, P1092, DOI 10.3171/2012.8.JNS112298; Duma SM, 2005, CLIN J SPORT MED, V15, P3, DOI 10.1097/00042752-200501000-00002; Fournier E., 2000, IRCOBI INT RES COUNC, V2000, P223; Gennarelli T. A., 1972, SAE TECHNICAL PAPER, P296; Giordano C, 2014, STAPP CAR CRASH J, V58, P1; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; GURDJIAN ES, 1966, J TRAUM, V6, P600, DOI 10.1097/00005373-196609000-00005; GURDJIAN ES, 1955, SURG GYNECOL OBSTET, V101, P680; Hernandez F, 2015, ANN BIOMED ENG, V43, P1918, DOI 10.1007/s10439-014-1212-4; Ji SB, 2015, J NEUROTRAUM, V32, P441, DOI 10.1089/neu.2013.3268; Ji SB, 2014, BIOMECH MODEL MECHAN, V13, P1121, DOI 10.1007/s10237-014-0562-z; Ji SB, 2014, ANN BIOMED ENG, V42, P11, DOI 10.1007/s10439-013-0907-2; Kimpara H, 2012, ANN BIOMED ENG, V40, P114, DOI 10.1007/s10439-011-0414-2; King A.I., 2003, IRCOBI C LISB PORT, P1; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Manoogian S, 2006, BIOMED SCI INSTRUM, V42, P383; McAllister TW, 2012, NEUROLOGY, V78, P1777, DOI 10.1212/WNL.0b013e3182582fe7; McAllister TW, 2012, ANN BIOMED ENG, V40, P127, DOI 10.1007/s10439-011-0402-6; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; MEANEY DF, 1995, J NEUROTRAUM, V12, P689, DOI 10.1089/neu.1995.12.689; Newman JA, 2005, J BIOMECH, V38, P1469, DOI 10.1016/j.jbiomech.2004.06.025; Patton DA, 2013, J APPL BIOMECH, V29, P721, DOI 10.1123/jab.29.6.721; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Sabet AA, 2008, J BIOMECH, V41, P307, DOI 10.1016/j.jbiomech.2007.09.016; Schnebel B, 2007, NEUROSURGERY, V60, P490, DOI 10.1227/01.NEU.0000249286.92255.7F; Takhounts EG, 2008, STAPP CAR C, V52, P1; Viano DC, 2005, NEUROSURGERY, V57, P891, DOI 10.1227/01.NEU.0000186950.54075.3B; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zhao W, 2017, BIOMECH MODEL MECHAN, V16, P1709, DOI 10.1007/s10237-017-0915-5	38	18	19	1	13	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0090-6964	1573-9686		ANN BIOMED ENG	Ann. Biomed. Eng.	JUN	2018	46	6					819	830		10.1007/s10439-018-1999-5			12	Engineering, Biomedical	Engineering	GE7LD	WOS:000431413700004	29470745	Green Accepted			2021-06-18	
J	Faig, J; Haughton, M; Taylor, RC; D'Agostino, RB; Whelen, MJ; Rodriguez, KAP; Bonomi, M; Murea, M; Porosnicu, M				Faig, Jennifer; Haughton, Michael; Taylor, Richard C.; D'Agostino, Ralph B., Jr.; Whelen, Megan J.; Rodriguez, Kori A. Porosnicu; Bonomi, Marcelo; Murea, Mariana; Porosnicu, Mercedes			Retrospective Analysis of Cisplatin Nephrotoxicity in Patients With Head and Neck Cancer Receiving Outpatient Treatment With Concurrent High-dose Cisplatin and Radiotherapy	AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS			English	Article						head and neck cancer; cisplatin; radiotherapy; nephrotoxicity; acute kidney injury; chronic kidney disease	SQUAMOUS-CELL CARCINOMA; LOCALLY ADVANCED HEAD; LUNG-CANCER; RADIATION-THERAPY; CHEMOTHERAPY; MAGNESIUM; HYDRATION; PREVENTION; MANNITOL	Objectives: Cisplatin remains the pivotal chemotherapy in squamous cell carcinoma of the head and neck (SCCHN), with nephrotoxicity considered the dose-limiting toxicity. The purpose of our study was to propose an outpatient high-dose cisplatin protocol aimed at preventing nephrotoxicity and to analyze the results of its utilization in patients with SCCHN treated with concurrent radiotherapy. Materials and Methods: We retrospectively evaluated 82 SCCHN patients treated with outpatient high-dose cisplatin concurrent with radiotherapy at our institution. Acute kidney injury (AKI) and chronic kidney disease were defined by Kidney Disease Improving Global Outcomes criteria. Associated factors were identified using analysis of covariance models for categorical variables and adjusted Pearson correlations for continuous variables. Results: The incidence of AKI during treatment was 34.2%. With a median follow-up of 25.7 months, the average decrease in estimated glomerular filtration rate was 12.57 mL/min/1.73 m(2) (SD=18.58). At 1 year and at last follow-up, 5.4% and 4.4% of patients had estimated glomerular filtration rate <60 mL/min/1.73 m(2). Predictors associated with AKI and chronic kidney disease were: lower baseline weight and creatinine, higher baseline creatinine clearance, smoking, female sex, African American race, hypertension, and increased hydration and magnesium replacement requirements. Conclusions: We encountered limited early and late nephrotoxicity. Importantly, nephrotoxicity was not the main dose-limiting toxicity. Our results emphasize the importance of close monitoring and additional replacement of water and electrolytes as needed. A consistent method of measuring and reporting chemotherapy-induced nephrotoxicity would be a valuable contribution to the literature.	[Faig, Jennifer] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Rodriguez, Kori A. Porosnicu] Wake Forest Sch Med, Med Ctr Blvd, Winston Salem, NC USA; [Haughton, Michael; Bonomi, Marcelo; Porosnicu, Mercedes] Wake Forest Sch Med, Dept Internal Med, Sect Hematol & Oncol, Med Ctr Blvd, Winston Salem, NC USA; [Taylor, Richard C.] Wake Forest Sch Med, Dept Internal Med, Med Ctr Blvd, Winston Salem, NC USA; [Murea, Mariana] Wake Forest Sch Med, Dept Nephrol, Med Ctr Blvd, Winston Salem, NC USA; [D'Agostino, Ralph B., Jr.] Wake Forest Univ Hlth Sci, Div Publ Hlth Sci, Dept Biostat Sci, Med Ctr Blvd, Winston Salem, NC USA; [Whelen, Megan J.] Wake Forest Univ, Comprehens Canc Ctr, Med Ctr Blvd, Winston Salem, NC 27109 USA; [Faig, Jennifer] Icahn Sch Med Mt Sinai, One Gustave L Levy Pl, New York, NY 10029 USA; [Rodriguez, Kori A. Porosnicu] Columbia Univ, 116th St & Broadway, New York, NY 10027 USA	Porosnicu, M (corresponding author), Med Ctr Blvd, Winston Salem, NC 27157 USA.	mporosni@wakehealth.edu	porosnicu, mercedes/N-5745-2019	Porosnicu Rodriguez, Kori/0000-0003-3770-1479	Comprehensive Cancer Center of Wake Forest University NCI CCSG [P30CA012197]; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [P30CA012197] Funding Source: NIH RePORTER	Biostatistical services supported by the Comprehensive Cancer Center of Wake Forest University NCI CCSG P30CA012197 grant.	Adelstein DJ, 2003, J CLIN ONCOL, V21, P92, DOI 10.1200/JCO.2003.01.008; Ali BH, 2006, FOOD CHEM TOXICOL, V44, P1173, DOI 10.1016/j.fct.2006.01.013; Bernier J, 2004, NEW ENGL J MED, V350, P1945, DOI 10.1056/NEJMoa032641; Bodnar L, 2008, EUR J CANCER, V44, P2608, DOI 10.1016/j.ejca.2008.08.005; Cooper JS, 2012, INT J RADIAT ONCOL, V84, P1198, DOI 10.1016/j.ijrobp.2012.05.008; Cooper JS, 2004, NEW ENGL J MED, V350, P1937, DOI 10.1056/NEJMoa032646; Cubillo A, 2001, AM J CLIN ONCOL-CANC, V24, P192, DOI 10.1097/00000421-200104000-00018; Espeli V, 2012, ORAL ONCOL, V48, P266, DOI 10.1016/j.oraloncology.2011.10.005; Forastiere AA, 2003, NEW ENGL J MED, V349, P2091, DOI 10.1056/NEJMoa031317; Fujieda M, 2011, HUM EXP TOXICOL, V30, P603, DOI 10.1177/0960327110376551; Furukawa N, 2012, EUR J CANCER CARE, V21, P436, DOI 10.1111/j.1365-2354.2011.01284.x; Goren MP, 2003, MED PEDIATR ONCOL, V41, P186, DOI 10.1002/mpo.10335; dos Santos NAG, 2012, ARCH TOXICOL, V86, P1233, DOI 10.1007/s00204-012-0821-7; Hanigan MH, 2005, AM J PHYSIOL-RENAL, V288, pF125, DOI 10.1152/ajprenal.00041.2003; HANSEN SW, 1988, J CLIN ONCOL, V6, P1728, DOI 10.1200/JCO.1988.6.11.1728; Hartmann JT, 1999, INT J CANCER, V83, P866, DOI 10.1002/(SICI)1097-0215(19991210)83:6<866::AID-IJC34>3.3.CO;2-0; Hotta K, 2013, JPN J CLIN ONCOL, V43, P1115, DOI 10.1093/jjco/hyt128; Lajer H, 2005, CANCER CHEMOTH PHARM, V56, P535, DOI 10.1007/s00280-005-1010-7; Launay-Vacher V, 2008, CANCER CHEMOTH PHARM, V61, P903, DOI 10.1007/s00280-008-0711-0; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levin A, 2013, KIDNEY INT SUPPL, V3, P5, DOI 10.1038/kisup.2012.77; Lin A, 2005, INT J RADIAT ONCOL, V63, P1413, DOI 10.1016/j.ijrobp.2005.05.012; LOEHRER PJ, 1984, ANN INTERN MED, V100, P704, DOI 10.7326/0003-4819-100-5-704; Mathe C, 2011, EUR RESPIR J, V37, P888, DOI 10.1183/09031936.00055110; Miller RP, 2010, TOXINS, V2, P2490, DOI 10.3390/toxins2112490; Morgan KP, 2012, ANN PHARMACOTHER, V46, P276, DOI 10.1345/aph.1Q333; Okusa MD, 2014, KIDNEY INT, V85, P39, DOI 10.1038/ki.2013.378; Polycarpe E, 2004, INT J CANCER, V111, P131, DOI 10.1002/ijc.20202; Razzaque MS, 2007, NEPHROL DIAL TRANSPL, V22, P2112, DOI 10.1093/ndt/gfm378; Saleh S, 2009, CHEMOTHERAPY, V55, P399, DOI 10.1159/000262453; Santoso JT, 2003, CANCER CHEMOTH PHARM, V52, P13, DOI 10.1007/s00280-003-0620-1; SCHILSKY RL, 1982, CANCER TREAT REP, V66, P1767; Shord SS, 2006, ANTI-CANCER DRUG, V17, P207, DOI 10.1097/00001813-200602000-00013; Tiseo M, 2007, TUMORI, V93, P138	34	18	18	1	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0277-3732	1537-453X		AM J CLIN ONCOL-CANC	Am. J. Clin. Oncol.-Cancer Clin. Trials	MAY	2018	41	5					432	440		10.1097/COC.0000000000000301			9	Oncology	Oncology	GE3HI	WOS:000431104000002	27281266	Green Accepted			2021-06-18	
J	Narad, ME; Kennelly, M; Zhang, NH; Wade, SL; Yeates, KO; Taylor, HG; Epstein, JN; Kurowski, BG				Narad, Megan E.; Kennelly, Megan; Zhang, Nanhua; Wade, Shari L.; Yeates, Keith Owen; Taylor, H. Gerry; Epstein, Jeffery N.; Kurowski, Brad G.			Secondary Attention-Deficit/Hyperactivity Disorder in Children and Adolescents 5 to 10 Years After Traumatic Brain Injury	JAMA PEDIATRICS			English	Article							DEFICIT HYPERACTIVITY DISORDER; TERM BEHAVIOR PROBLEMS; YOUNG-CHILDREN; OUTCOMES; PREDICTORS; CHILDHOOD; PREVALENCE; ADHD; ACHIEVEMENT; ADAPTATION	IMPORTANCE After traumatic brain injury (TBI), children often experience impairment when faced with tasks and situations of increasing complexity. Studies have failed to consider the potential for attention problems to develop many years after TBI or factors that may predict the development of secondary attention-deficit/hyperactivity disorder (SADHD). Understanding these patterns will aid in timely identification of clinically significant problems and appropriate initiation of treatment with the hope of limiting additional functional impairment. OBJECTIVE To examine the development of SADHD during the 5 to 10 years after TBI and individual (sex, age at injury, and injury characteristics) and environmental (socioeconomic status and family functioning) factors that may be associated with SADHD. DESIGN, SETTING, AND PARTICIPANTS Concurrent cohort/prospective study of children aged 3 to 7 years hospitalized overnight for TBI or orthopedic injury (OI; used as control group) who were screened at 3 tertiary care children's hospitals and 1 general hospital in Ohio from January 2003 to June 2008. Parents completed assessments at baseline (0-3 months), 6 months, 12 months, 18 months, 3.4 years, and 6.8 years after injury. A total of 187 children and adolescents were included in the analyses: 81 in the TBI group and 106 in the OI group. MAIN OUTCOMES AND MEASURES Diagnosis of SADHD was the primary outcome. Assessments were all completed by parents. Secondary ADHD was defined as an elevated T score on the DSM-Oriented Attention-Deficit/Hyperactivity Problems Scale of the parent-reported Child Behavior Checklist, report of an ADHD diagnosis, and/or current treatment with stimulant medication not present at the baseline assessment. The Family Assessment Device-Global Functioning measurement was used to assess family functioning; scores ranged from 1 to 4, with greater scores indicating poorer family functioning. RESULTS The analyzed sample included 187 children with no preinjury ADHD. Mean (SD) age was 5.1 (1.1) years; 108 (57.8%) were male, and 50 (26.7%) were of nonwhite race/ethnicity. Of the 187 children, 48 (25.7%) met our definition of SADHD. Severe TBI (hazard ratio [HR], 3.62; 95% CI, 1.59-8.26) was associated with SADHD compared with the OI group. Higher levels of maternal education (HR, 0.33; 95% CI, 0.17-0.62) were associated with a lower risk of SADHD. Family dysfunction was associated with increased risk of SADHD within the TBI group (HR, 4.24; 95% CI, 1.91-9.43), with minimal association within the OI group (HR, 1.32; 95% CI, 0.36-4.91). CONCLUSIONS AND RELEVANCE Early childhood TBI was associated with increased risk for SADHD. This finding supports the need for postinjury monitoring for attention problems. Consideration of factors that may interact with injury characteristics, such as family functioning, will be important in planning clinical follow-up of children with TBI.	[Narad, Megan E.; Kennelly, Megan; Wade, Shari L.; Kurowski, Brad G.] Cincinnati Childrens Hosp Med Ctr, Div Phys Med & Rehabil, 3333 Burnet Ave, Cincinnati, OH 45229 USA; [Kennelly, Megan] Univ Cincinnati, Coll Med, Cincinnati, OH USA; [Kennelly, Megan; Zhang, Nanhua; Wade, Shari L.; Epstein, Jeffery N.; Kurowski, Brad G.] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA; [Zhang, Nanhua] Cincinnati Childrens Hosp Med Ctr, Div Biostat & Epidemiol, Cincinnati, OH 45229 USA; [Yeates, Keith Owen] Univ Calgary, Dept Psychol, Calgary, AB, Canada; [Yeates, Keith Owen] Univ Calgary, Alberta Childrens Hosp, Res Inst, Calgary, AB, Canada; [Yeates, Keith Owen] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada; [Taylor, H. Gerry] Nationwide Childrens Hosp, Biobehav Hlth Ctr, Res Inst, Columbus, OH USA; [Taylor, H. Gerry] Ohio State Univ, Dept Pediat, Columbus, OH 43210 USA; [Epstein, Jeffery N.] Cincinnati Childrens Hosp Med Ctr, Div Behav Med & Clin Psychol, Cincinnati, OH 45229 USA; [Kurowski, Brad G.] Univ Cincinnati, Coll Med, Dept Neurol & Rehabil Med, Cincinnati, OH USA	Narad, ME (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Phys Med & Rehabil, 3333 Burnet Ave, Cincinnati, OH 45229 USA.	megan.narad@cchmc.org	Yeates, Keith/AAJ-4223-2020	Zhang, Nanhua/0000-0001-5796-3404; Yeates, Keith/0000-0001-7680-2892	Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01 HD42729]; Trauma Research Grant from the State of Ohio Emergency Medical Services; National Center for Advancing Translational Sciences of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [8 UL1 TR000077]; NICHDUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [1F32HD088011-01, K23 HD07468303]; Rehabilitation Research Experience for Medical Students; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [F32HD088011] Funding Source: NIH RePORTER	This publication was supported by grant R01 HD42729 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and a Trauma Research Grant from the State of Ohio Emergency Medical Services. Additional support was provided through grant 8 UL1 TR000077 from the National Center for Advancing Translational Sciences of the National Institutes of Health. Dr Narad was supported by grant 1F32HD088011-01 from the NICHD. Ms Kennelly was supported by a grant from the Rehabilitation Research Experience for Medical Students. Dr Kurowski was supported by Mentored Patient-Oriented Research Career Development Award K23 HD07468303 from the NICHD.	Achenbach TM, 2001, MANUAL ASEBA SCH AGE; American Psychiatric Association, 2013, DIAGN STAT MAN MENT, V5, DOI [10.1176/appi.books.9780890425596., DOI 10.1176/APPI.BOOKS.9780890425596, 10.1176/appi.books.9780890425596]; Anderson V, 2012, PEDIATRICS, V129, pE254, DOI 10.1542/peds.2011-0311; Backeljauw B, 2014, PM&R, V6, P814, DOI 10.1016/j.pmrj.2014.04.004; Blakemore SJ, 2006, J CHILD PSYCHOL PSYC, V47, P296, DOI 10.1111/j.1469-7610.2006.01611.x; Chapman LA, 2010, REHABIL PSYCHOL, V55, P48, DOI 10.1037/a0018418; DiScala C, 1998, PEDIATRICS, V102, P1415, DOI 10.1542/peds.102.6.1415; Emery CA, 2016, CAN J PSYCHIAT, V61, P259, DOI 10.1177/0706743716643741; EPSTEIN NB, 1983, J MARITAL FAM THER, V9, P171, DOI 10.1111/j.1752-0606.1983.tb01497.x; Ewing-Cobbs L, 2004, DEV NEUROPSYCHOL, V25, P107, DOI 10.1207/s15326942dn2501&2_7; Froehlich TE, 2007, ARCH PEDIAT ADOL MED, V161, P857, DOI 10.1001/archpedi.161.9.857; Gerring JP, 1998, J AM ACAD CHILD PSY, V37, P647, DOI 10.1097/00004583-199806000-00015; Karver CL, 2012, REHABIL PSYCHOL, V57, P256, DOI 10.1037/a0029522; Kurowski BG, 2011, PM&R, V3, P836, DOI 10.1016/j.pmrj.2011.05.016; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Max JE, 1998, J AM ACAD CHILD PSY, V37, P841, DOI 10.1097/00004583-199808000-00014; Max JE, 2005, J AM ACAD CHILD PSY, V44, P1032, DOI 10.1097/01.chi.0000173293.05817.b1; Max JE, 2005, J AM ACAD CHILD PSY, V44, P1041, DOI 10.1097/01.chi.0000173292.05817.f8; Max JE, 2004, DEV NEUROPSYCHOL, V25, P159, DOI 10.1207/s15326942dn2501&2_9; Max JE, 2012, PEDIAT FORENSIC NEUR, P258; Max JE, 2012, J NEUROPSYCH CLIN N, V24, P427, DOI 10.1176/appi.neuropsych.12060149; Schwartz L, 2003, J PEDIATR PSYCHOL, V28, P251, DOI 10.1093/jpepsy/jsg013; Slomine BS, 2005, J INT NEUROPSYCH SOC, V11, P645, DOI 10.1017/S1355617705050769; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; Taylor HG, 2001, J INT NEUROPSYCH SOC, V7, P755, DOI 10.1017/S1355617701766118; Visser SN, 2014, J AM ACAD CHILD ADOL, V53, pe2; Wade SL, 2016, JAMA PEDIATR, V170, P343, DOI 10.1001/jamapediatrics.2015.4485; Wade SL, 2011, DEV PSYCHOL, V47, P119, DOI 10.1037/a0021028; Wade SL, 2003, J HEAD TRAUMA REHAB, V18, P164, DOI 10.1097/00001199-200303000-00007; Wade SL, 1998, PEDIATRICS, V102, P110, DOI 10.1542/peds.102.1.110; Wassenberg R, 2004, BRAIN INJURY, V18, P751, DOI 10.1080/02699050410001671775; Yang LY, 2016, PEDIATR RES, V80, P356, DOI 10.1038/pr.2016.85; Yeates K O, 1997, J Int Neuropsychol Soc, V3, P617; Yeates KO, 2010, NEUROPSYCHOLOGY, V24, P345, DOI 10.1037/a0018387; Yeates KO, 2005, J AM ACAD CHILD PSY, V44, P574, DOI 10.1097/01.chi.0000159947.50523.64	36	18	18	0	19	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	2168-6203	2168-6211		JAMA PEDIATR	JAMA Pediatr.	MAY	2018	172	5					437	443		10.1001/jamapediatrics.2017.5746			7	Pediatrics	Pediatrics	GF0RO	WOS:000431638900012	29554197	Bronze, Green Published			2021-06-18	
J	Xu, XP; Zhi, TL; Chao, HL; Jiang, K; Liu, YL; Bao, ZY; Fan, L; Wang, D; Li, Z; Liu, N; Ji, J				Xu, Xiupeng; Zhi, Tongle; Chao, Honglu; Jiang, Kuan; Liu, Yinlong; Bao, Zhongyuan; Fan, Liang; Wang, Dong; Li, Zheng; Liu, Ning; Ji, Jing			ERK1/2/mTOR/Stat3 pathway-mediated autophagy brain injury-induced acute lung injury	BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE			English	Article						Traumatic brain injury; Acute lung injury; Autophagy; Apoptosis; Inflammation; Oxidative stress	SIGNALING PATHWAY; INFLAMMATORY RESPONSE; NLRP3 INFLAMMASOME; ORGAN DYSFUNCTION; ACTIVATION; CELLS; APOPTOSIS; RECEPTOR; DAMAGE; MICE	Acute lung injury (ALI) is one of several complications in patients with traumatic brain injury (TBI). Autophagy is a primary homeostatic process that promotes cell survival under stress. Accumulating evidence implicates autophagy in the pathogenesis of ALI under various conditions. However, the role of autophagy in TBI-induced ALI remains unknown. The aim of this study was to adjust autophagy with pharmacological agents to determine its functional significance in TBI-induced ALI. Rats were preconditioned with autophagy promoter rapamycin or inhibitor 3-methyladenine before they were challenged with TBI. Extracellular signal-regulated kinase 1/2 (ERK1/2) inhibitor U0126, mechanistic target of rapamycin (mTOR) inhibitor rapamycin, and signal transducer and activator of transcription 3 (Stat3) inhibitor S31-201 were used to test the role of ERK1/2/mTOR/Stat3 signaling pathway in regulating autophagy. Autophagy is activated in lung tissues after TBI. Enhancement of autophagy suppressed apoptosis, inflammation and oxidative stress in lung tissues, which were activated after TBI, whereas inhibition of autophagy aggravated these critical pathological changes. Autophagy also improved TBI-induced impairment in pulmonary barrier function, oxygenation function and static compliance. Furthermore, TBI-induced autophagy was mediated by ERK1/2/mTOR/Stat3 pathway, which may serve to reduce ALI and improve pulmonary barrier function, oxygenation function and static compliance. These findings are important for the prevention and treatment of TBI-induced ALI.	[Xu, Xiupeng; Zhi, Tongle; Chao, Honglu; Bao, Zhongyuan; Fan, Liang; Wang, Dong; Li, Zheng; Liu, Ning; Ji, Jing] Nanjing Med Univ, Affiliated Hosp 1, Dept Neurosurg, Guangzhou Rd 300, Nanjing, Jiangsu, Peoples R China; [Jiang, Kuan] Yixing Peoples Hosp, Dept Neurosurg, Yixing, Jiangsu, Peoples R China; [Liu, Yinlong] Suzhou Municipal Hosp, Dept Neurosurg, Suzhou, Jiangsu, Peoples R China	Ji, J (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Neurosurg, Guangzhou Rd 300, Nanjing, Jiangsu, Peoples R China.	jijing@njmu.edu.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81300998, 81471269]; National Natural Science Foundation of Jiangsu ProvinceNatural Science Foundation of Jiangsu Province [BK20131022, BK20160047]; Jiangsu Province's Key Discipline of Medicine [XK201117]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Specially Appointed Professor Foundation of Jiangsu Province [ky216r201307]	This work was supported by the National Natural Science Foundation of China (81300998 and 81471269), National Natural Science Foundation of Jiangsu Province (BK20131022 and BK20160047), Jiangsu Province's Key Discipline of Medicine (XK201117), the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD), and the Specially Appointed Professor Foundation of Jiangsu Province (ky216r201307).	Aisiku IP, 2016, J TRAUMA ACUTE CARE, V80, P308, DOI 10.1097/TA.0000000000000903; Antonioli M, 2017, TRENDS BIOCHEM SCI, V42, P28, DOI 10.1016/j.tibs.2016.09.008; Bethea JR, 1998, J NEUROSCI, V18, P3251; Carriere A, 2011, J BIOL CHEM, V286, P567, DOI 10.1074/jbc.M110.159046; Cercone MA, 2009, AM J PHYSIOL-LUNG C, V297, pL856, DOI 10.1152/ajplung.00118.2009; Chen GS, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/729831; Chi W, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0360-2; Davison DL, 2012, CHEST, V141, P793, DOI 10.1378/chest.11-0789; Diao MY, 2016, INFLAMMATION, V39, P2029, DOI 10.1007/s10753-016-0440-1; Frank MG, 2016, BRAIN BEHAV IMMUN, V55, P215, DOI 10.1016/j.bbi.2015.10.009; Gao YY, 2016, J SURG RES, V206, P67, DOI 10.1016/j.jss.2016.07.014; Grailer JJ, 2014, J IMMUNOL, V192, P5974, DOI 10.4049/jimmunol.1400368; Granato M, 2017, J NUTR BIOCHEM, V41, P124, DOI 10.1016/j.jnutbio.2016.12.011; Harris J, 2011, CYTOKINE, V56, P140, DOI 10.1016/j.cyto.2011.08.022; Holland MC, 2003, J TRAUMA, V55, P106, DOI 10.1097/01.TA.0000071620.27375.BE; Hu R, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.274; Hu Y, 2016, AUTOPHAGY, V12, P2286, DOI 10.1080/15548627.2016.1230584; Hu Y, 2014, MICROBES INFECT, V16, P727, DOI 10.1016/j.micinf.2014.07.005; Ji J, 2012, NAT NEUROSCI, V15, P1407, DOI 10.1038/nn.3195; Ji J, 2012, J NEUROTRAUM, V29, P776, DOI 10.1089/neu.2010.1602; Jin W, 2008, ANN CLIN LAB SCI, V38, P221; Jin W, 2011, J TRAUMA, V71, P680, DOI 10.1097/TA.0b013e3181f6b984; Jin W, 2009, EXP BIOL MED, V234, P181, DOI 10.3181/0807-RM-232; Kagan VE, 2016, CELL DEATH DIFFER, V23, P1140, DOI 10.1038/cdd.2015.160; Kalsotra A, 2007, J CEREBR BLOOD F MET, V27, P963, DOI 10.1038/sj.jcbfm.9600396; Kang R, 2012, P NATL ACAD SCI USA, V109, P7031, DOI 10.1073/pnas.1113865109; Kemp CD, 2008, AM SURGEON, V74, P866; Li DD, 2016, SCI REP-UK, V6, DOI 10.1038/srep37751; Liu YL, 2017, J NEUROTRAUM, V34, P2119, DOI 10.1089/neu.2016.4764; Maddahi A, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-85; Matute-Bello G, 2011, AM J RESP CELL MOL, V44, P725, DOI 10.1165/rcmb.2009-0210ST; Mir SA, 2012, J BIOL CHEM, V287, P2666, DOI 10.1074/jbc.M111.246173; Mizumura K, 2012, CHEST, V142, P1289, DOI 10.1378/chest.12-0809; Oddo M, 2010, NEUROSURGERY, V67, P338, DOI 10.1227/01.NEU.0000371979.48809.D9; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Sun L., 2017, AUTOPHAGY; Tian Y, 2015, BLOOD, V125, P2151, DOI 10.1182/blood-2014-09-598805; Viscomi MT, 2012, AUTOPHAGY, V8, P222, DOI 10.4161/auto.8.2.18599; Wang JR, 2009, J BIOL CHEM, V284, P21412, DOI 10.1074/jbc.M109.026013; Weaver LC, 2015, EXP NEUROL, V271, P409, DOI 10.1016/j.expneurol.2015.07.003; Weber DJ, 2014, SCI TRANSL MED, V6, P252; Wen ZM, 2014, J IMMUNOL, V193, P4623, DOI 10.4049/jimmunol.1400899; Xiao YZ, 2016, DIABETES, V65, P393, DOI 10.2337/db15-1024; Xu XP, 2016, BRAIN RES BULL, V124, P214, DOI 10.1016/j.brainresbull.2016.05.010; Yang SQ, 2016, INT IMMUNOPHARMACOL, V40, P219, DOI 10.1016/j.intimp.2016.08.041; Yasui H, 2016, AM J PHYSIOL-LUNG C, V311, pL74, DOI 10.1152/ajplung.00429.2015; Yoon S, 2010, AUTOPHAGY, V6, P1125, DOI 10.4161/auto.6.8.13547; Zhang D, 2015, J HEART LUNG TRANSPL, V34, P746, DOI 10.1016/j.healun.2014.12.008; Zhang Y, 2013, FASEB J, V27, P4041, DOI 10.1096/fj.13-231225; Zhao HL, 2017, AM J PHYSIOL-LUNG C, V312, pL155, DOI 10.1152/ajplung.00449.2016; Zou MJ, 2015, MOL CARCINOGEN, V54, P1363, DOI 10.1002/mc.22212; Zygun DA, 2005, CRIT CARE MED, V33, P654, DOI 10.1097/01.ccm.0000155911.01844.54	52	18	22	0	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0925-4439	1879-260X		BBA-MOL BASIS DIS	Biochim. Biophys. Acta-Mol. Basis Dis.	MAY	2018	1864	5	A				1663	1674		10.1016/j.bbadis.2018.02.011			12	Biochemistry & Molecular Biology; Biophysics; Cell Biology	Biochemistry & Molecular Biology; Biophysics; Cell Biology	GE0DB	WOS:000430883100012	29466698	Bronze			2021-06-18	
J	Townsend, JM; Andrews, BT; Feng, Y; Wang, JX; Nudo, RJ; Van Kampen, E; Gehrke, SH; Berkland, CJ; Detamore, MS				Townsend, Jakob M.; Andrews, Brian T.; Feng, Yi; Wang, Jinxi; Nudo, Randolph J.; Van Kampen, Erik; Gehrke, Stevin H.; Berkland, Cory J.; Detamore, Michael S.			Superior calvarial bone regeneration using pentenoate-functionalized hyaluronic acid hydrogels with devitalized tendon particles	ACTA BIOMATERIALIA			English	Article						Bone; Calvarial; Hyaluronic acid; In situ; Hydrogel; Traumatic brain injury	TRAUMATIC BRAIN-INJURY; DECOMPRESSIVE CRANIECTOMY; COLLOIDAL GELS; MATRIX PARTICLES; BIOMATERIALS; CARTILAGE; GELATIN; SCAFFOLDS; BEHAVIOR; DEFECTS	Traumatic brain injury (TBI) is a life-threatening condition defined by internal brain herniation. Severe TBI is commonly treated by a two-stage surgical intervention, where decompressive craniectomy is first conducted to remove a large portion of calvarial bone and allow unimpeded brain swelling. In the second surgery, spaced weeks to months after the first, cranioplasty is performed to restore the cranial bone. Hydrogels with paste-like precursor solutions for surgical placement may potentially revolutionize TBI treatment by permitting a single-stage surgical intervention, capable of being implanted with the initial surgery, remaining pliable during brain swelling, and tuned to regenerate calvarial bone after brain swelling has subsided. The current study evaluated the use of photocrosslinkable pentenoate-functionalized hyaluronic acid (PHA) and non-crosslinking hyaluronic acid (HA) hydrogels encapsulating naturally derived tissue particles of demineralized bone matrix (DBM), devitalized cartilage (DVC), devitalized meniscus (DVM), or devitalized tendon (DVT) for bone regeneration in critical-size rat calvarial defects. All hydrogel precursors exhibited a yield stress for placement and addition of particles increased the average material compressive modulus. The HA-DBM (4-30%), PHA (4%), and PHA-DVT (4-30%) groups had 5 (p < 0.0001), 3.1, and 3.2 (p < 0.05) times greater regenerated bone volume compared to the sham (untreated defect) group, respectively. In vitro cell studies suggested that the PHA-DVT (4-10%) group would have the most desirable performance. Overall, hydrogels containing DVT particles outperformed other materials in terms of bone regeneration in vivo and calcium deposition in vitro. Hydrogels containing DVT will be further evaluated in future rat TBI studies. (C) 2018 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.	[Townsend, Jakob M.; Detamore, Michael S.] Univ Oklahoma, Stephenson Sch Biomed Engn, Norman, OK 73019 USA; [Andrews, Brian T.] Univ Kansas, Med Ctr, Dept Plast Surg, Kansas City, KS 66160 USA; [Feng, Yi; Wang, Jinxi] Univ Kansas, Med Ctr, Dept Orthoped Surg, Kansas City, KS 66160 USA; [Nudo, Randolph J.] Univ Kansas, Med Ctr, Dept Rehabil Med, Kansas City, KS 66160 USA; [Van Kampen, Erik; Gehrke, Stevin H.] Univ Kansas, Dept Chem & Petr Engn, Lawrence, KS 66047 USA; [Berkland, Cory J.] Univ Kansas, Dept Pharmaceut Chem, Lawrence, KS 66047 USA	Detamore, MS (corresponding author), Univ Oklahoma, 101 David L Boren Blvd, Norman, OK 73019 USA.	Detamore@ou.edu	Gehrke, Stevin H/A-5265-2014; Townsend, Jakob/AAH-9637-2019		Stephenson Graduate Fellowship; National Institute of Dental and Craniofacial Research of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR) [R01 DE022472, R03 DE025906]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR) [R03DE025906, R01DE022472] Funding Source: NIH RePORTER	The authors would like to thank Dr. Hong Liu and Dr. Di Wu for help in conducting the mu CT scans. We would like to thank Alysa Crum for creation of the graphical abstract. We would like to recognize funding from the Stephenson Graduate Fellowship. Research reported in the current publication was supported by the National Institute of Dental and Craniofacial Research of the National Institutes of Health under award number R01 DE022472 and R03 DE025906. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. No industry funding or support was provided for the current study.	Beck EC, 2016, ANN BIOMED ENG, V44, P1863, DOI 10.1007/s10439-015-1547-5; Beck EC, 2016, TISSUE ENG PT A, V22, P665, DOI [10.1089/ten.tea.2015.0546, 10.1089/ten.TEA.2015.0546]; Beck EC, 2015, ANN BIOMED ENG, V43, P2569, DOI 10.1007/s10439-015-1277-8; Bencherif SA, 2008, BIOMATERIALS, V29, P1739, DOI 10.1016/j.biomaterials.2007.11.047; Burdick JA, 2005, BIOMACROMOLECULES, V6, P386, DOI 10.1021/bm049508a; Choy DKS, 2013, TISSUE ENG PT A, V19, P2382, DOI [10.1089/ten.tea.2012.0733, 10.1089/ten.TEA.2012.0733]; Chung C, 2009, TISSUE ENG PT A, V15, P243, DOI 10.1089/ten.tea.2008.0067; Cunniffe GM, 2015, EUR POLYM J, V72, P464, DOI 10.1016/j.eurpolymj.2015.07.021; Cunniffe GM, 2015, ACTA BIOMATER, V23, P82, DOI 10.1016/j.actbio.2015.05.031; Dennis SC, 2017, LANGMUIR, V33, P206, DOI 10.1021/acs.langmuir.6b03529; Dennis SC, 2015, TISSUE ENG PART B-RE, V21, P247, DOI [10.1089/ten.TEB.2014.0419, 10.1089/ten.teb.2014.0419]; Dujovny M, 1999, CRIT REV NEUROSURG, V9, P271, DOI 10.1007/s003290050143; Gawlitta D, 2015, TISSUE ENG PT A, V21, P694, DOI [10.1089/ten.tea.2014.0117, 10.1089/ten.TEA.2014.0117]; Holloway JL, 2015, MACROMOL BIOSCI, V15, P1218, DOI 10.1002/mabi.201500178; Honeybul S, 2017, J REHABIL MED, V49, P204, DOI 10.2340/16501977-2209; Khader BA, 2016, MAT SCI ENG C-MATER, V66, P315, DOI 10.1016/j.msec.2016.04.101; Ko E, 2016, ACS APPL MATER INTER, V8, P22819, DOI 10.1021/acsami.6b05358; Kretlow JD, 2009, ADV MATER, V21, P3368, DOI 10.1002/adma.200802009; Kurland DB, 2015, NEUROCRIT CARE, V23, P292, DOI 10.1007/s12028-015-0144-7; Lang J, 2016, IDEGGYOGY SZEMLE, V69, P227, DOI 10.18071/isz.69.0227; Martin KD, 2014, ACTA NEUROCHIR, V156, P813, DOI 10.1007/s00701-014-2021-0; Mergy J, 2012, J POLYM SCI POL CHEM, V50, P4019, DOI 10.1002/pola.26201; Motherway JA, 2009, J BIOMECH, V42, P2129, DOI 10.1016/j.jbiomech.2009.05.030; Oladunjoye AO, 2013, J NEUROSURG, V118, P776, DOI 10.3171/2013.1.JNS121475; Omary R, 2013, J MOL NEUROSCI, V49, P157, DOI 10.1007/s12031-012-9922-2; Oudshoorn MHM, 2007, POLYMER, V48, P1915, DOI 10.1016/j.polymer.2007.01.068; Poldervaart MT, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177628; Roughley Peter J, 2014, J Exp Orthop, V1, P8, DOI 10.1186/s40634-014-0008-7; Samaniuk JR, 2014, AICHE J, V60, P1523, DOI 10.1002/aic.14329; Schiffer J, 1997, SURG NEUROL, V47, P231, DOI 10.1016/S0090-3019(96)00376-X; Tate MC, 2001, BIOMATERIALS, V22, P1113, DOI 10.1016/S0142-9612(00)00348-3; Tian WM, 2005, TISSUE ENG, V11, P513, DOI 10.1089/ten.2005.11.513; Townsend JM, 2017, AAPS J, V19, P703, DOI 10.1208/s12248-017-0045-0; VanKampen E, 2016, CONTROLLING PROTEIN; Visser J, 2015, BIOMATERIALS, V37, P174, DOI 10.1016/j.biomaterials.2014.10.020; Wang Q, 2013, TISSUE ENG PT A, V19, P2586, DOI [10.1089/ten.tea.2013.0075, 10.1089/ten.TEA.2013.0075]; Wong DY, 2007, TISSUE ENG, V13, P2515, DOI 10.1089/ten.2006.0440; Zhang T, 2007, J BIOACT COMPAT POL, V22, P19, DOI 10.1177/0883911506074025	38	18	18	5	44	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1742-7061	1878-7568		ACTA BIOMATER	Acta Biomater.	APR 15	2018	71						148	155		10.1016/j.actbio.2018.02.013			8	Engineering, Biomedical; Materials Science, Biomaterials	Engineering; Materials Science	GE8GN	WOS:000431470300012	29496620	Green Accepted			2021-06-18	
J	Grauwmeijer, E; Heijenbrok-Kal, MH; Peppel, LD; Hartjes, CJ; Haitsma, IK; de Koning, I; Ribbers, GM				Grauwmeijer, Erik; Heijenbrok-Kal, Majanka H.; Peppel, Lianne D.; Hartjes, Chantalle J.; Haitsma, Iain K.; de Koning, Inge; Ribbers, Gerard M.			Cognition, Health-Related Quality of Life, and Depression Ten Years after Moderate to Severe Traumatic Brain Injury: A Prospective Cohort Study	JOURNAL OF NEUROTRAUMA			English	Article						outcome measures; prospective studies; rehabilitation; TBI	PREDICTORS; DISABILITY; SF-36; REHABILITATION; QUESTIONNAIRE; EPIDEMIOLOGY; COMMUNITY; OUTCOMES; DISEASE; IMPACT	The aim of this study was to evaluate cognitive function 10 years after moderate-severe traumatic brain injury (TBI) and to investigate the associations among cognitive function, depression, and health-related quality of life (HRQoL). In this prospective cohort study, with measurements at 3, 6, 12, 18, 24, 36, and 120 months post-TBI, patients 18-67 years of age (n=113) with moderate-severe TBI were recruited. Main outcome measures were depression (Center for Epidemiologic Studies-Depression Scale [CES-D]), subjective cognitive functioning (Cognitive Failure Questionnaire [CFQ]), objective cognitive functioning, and HRQoL (Medical Outcomes Study 36-Item Short Form Health Survey [SF-36]). Fifty of the initial 113 patients completed the 10 year follow-up. Twenty percent showed symptoms of depression (CES-D 16). These patients had more psychiatric symptoms at hospital discharge (p=0.048) and were more often referred to rehabilitation or nursing homes (p=0.015) than non-depressed patients. Further, they also had significantly lower scores in six of the eight subdomains of the SF-36. The non-depressed patients had equivalent scores to those of the Dutch norm-population on all subdomains of the SF-36. Cognitive problems at hospital discharge were related with worse cognitive outcome 10 years post-TBI, but not with depression or HRQoL. Ten years after moderate-severe TBI, only weak associations (p<0.05) between depression scores and two objective cognitive functioning scores were found. However, there were moderate associations (p<0.01) among depression scores, HRQoL, and subjective cognitive functioning. Therefore, signaling and treatment of depressive symptoms after moderate-severe TBI may be of major importance for optimizing HRQoL in the long term. We did not find strong evidence for associations between depression and objective cognitive functioning in the long term post-TBI. Disease awareness and selective dropping out may play a role in long-term follow-up studies in moderate-severe TBI. More long-term research is needed in this field.	[Grauwmeijer, Erik; Heijenbrok-Kal, Majanka H.; Peppel, Lianne D.; Hartjes, Chantalle J.; de Koning, Inge; Ribbers, Gerard M.] Rijndam Rehabil, Rotterdam, Netherlands; [Grauwmeijer, Erik; Heijenbrok-Kal, Majanka H.; Peppel, Lianne D.; Ribbers, Gerard M.] Erasmus Univ, Med Ctr, Dept Rehabil Med, Rotterdam, Netherlands; [Haitsma, Iain K.] Erasmus Univ, Med Ctr, Dept Neurosurg, Rotterdam, Netherlands	Grauwmeijer, E (corresponding author), Rotterdam Neurorehabil Res RoNeRes, Rijndam Rehabil Ctr, POB 23181, NL-3001 KD Rotterdam, Netherlands.	egrauwmeijer@rijndam.nl	Ribbers, Gerard M/C-1454-2014; Ribbers, Gerard/N-3623-2019	Ribbers, Gerard M/0000-0002-6114-349X; Heijenbrok-Kal, Majanka H./0000-0002-2982-4404	Netherlands Organisation for Health Research and DevelopmentNetherlands Organization for Health Research and Development [1435.0020]	This study was financially supported by the Netherlands Organisation for Health Research and Development (project no.: 1435.0020).	Aaronson NK, 1998, J CLIN EPIDEMIOL, V51, P1055, DOI 10.1016/S0895-4356(98)00097-3; Bogner JA, 2017, J HEAD TRAUMA REHAB, V32, pE1, DOI 10.1097/HTR.0000000000000291; Bouma A., 2012, NEUROPSYCHLOGICAL AS; Brickenkamp R., 1998, D2 TEST ATTENTION H; BROADBENT DE, 1982, BRIT J CLIN PSYCHOL, V21, P1, DOI 10.1111/j.2044-8260.1982.tb01421.x; Cieza A, 2005, QUAL LIFE RES, V14, P1225, DOI 10.1007/s11136-004-4773-0; Coughlan AK, 1988, CLIN REHABIL, V2, P207, DOI DOI 10.1177/026921558800200305; Dahm J, 2015, J REHABIL MED, V47, P932, DOI 10.2340/16501977-2016; Diaz AP, 2012, J NEUROTRAUM, V29, P1029, DOI 10.1089/neu.2011.2089; Dijkers MP, 2004, ARCH PHYS MED REHAB, V85, pS21, DOI 10.1016/j.apmr.2003.08.119; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Failla MD, 2016, J HEAD TRAUMA REHAB, V31, pE62, DOI 10.1097/HTR.0000000000000214; Findler M, 2001, BRAIN INJURY, V15, P715, DOI 10.1080/02699050010013941; Grauwmeijer E, 2017, J NEUROTRAUM, V34, P2575, DOI 10.1089/neu.2016.4846; Grauwmeijer E, 2014, ARCH PHYS MED REHAB, V95, P1268, DOI 10.1016/j.apmr.2014.02.002; Haagsma JA, 2015, J NEUROTRAUM, V32, P853, DOI 10.1089/neu.2013.3283; Hammond FM, 2004, NEUROREHABILITATION, V19, P25; Hammond FM, 2004, J HEAD TRAUMA REHAB, V19, P314, DOI 10.1097/00001199-200407000-00006; Harrison-Felix C, 2015, J NEUROTRAUM, V32, P1893, DOI 10.1089/neu.2014.3353; Hoofien D, 2001, BRAIN INJURY, V15, P189; Lin MR, 2010, ARCH PHYS MED REHAB, V91, P474, DOI 10.1016/j.apmr.2009.10.031; Majdan M, 2016, LANCET PUBLIC HEALTH, V1, pE76, DOI 10.1016/S2468-2667(16)30017-2; Marsh NV, 2016, NEUROREHABILITATION, V38, P71, DOI 10.3233/NRE-151297; Moretti L, 2012, LANCET NEUROL, V11, P1103, DOI 10.1016/S1474-4422(12)70226-0; Osborn AJ, 2014, NEUROSCI BIOBEHAV R, V47, P1, DOI 10.1016/j.neubiorev.2014.07.007; Pagulayan KF, 2006, ARCH PHYS MED REHAB, V87, P611, DOI 10.1016/j.apmr.2006.01.018; Peeters W, 2017, NEUROEPIDEMIOLOGY, V48, P63, DOI 10.1159/000471877; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Ponds R., 2006, TIJDSCHRIFT NEUROPSY, V1, P37; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Reitan RM., 1985, HALSTEAD REITAN NEUR; Rey A, 1964, EXAMEN CLIN PSYCHOL; Riihimaki K, 2016, EUR PSYCHIAT, V37, P28, DOI 10.1016/j.eurpsy.2016.04.008; Scholten AC, 2016, J NEUROTRAUM, V33, P1969, DOI 10.1089/neu.2015.4252; Seel RT, 2003, ARCH PHYS MED REHAB, V84, P177, DOI 10.1053/apmr.2003.50106; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Sigurdardottir S, 2015, J HEAD TRAUMA REHAB, V30, pE1, DOI 10.1097/HTR.0000000000000039; Skandsen T, 2008, CLIN REHABIL, V22, P653, DOI 10.1177/0269215508089067; Spitz G, 2012, NEUROPSYCHOLOGY, V26, P604, DOI 10.1037/a0029239; Stenberg M, 2015, BEHAV NEUROL, V2015, DOI 10.1155/2015/680308; Valk-Kleibeuker L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087414; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Ware JE., 1993, SF 36 HLTH SURVEY MA; Ware JE., 1994, SF 36 PHYS MENTAL HL, V1st; Wechsler D, 1997, WAIS 3 ADM SCORING M; Willemse-Van Son AHP, 2009, J REHABIL MED, V41, P521, DOI 10.2340/16501977-0377; Williamson MLC, 2013, BRAIN INJURY, V27, P992, DOI 10.3109/02699052.2013.801512; Wilson BA, 1998, NEUROPSYCHOL REHABIL, V8, P213, DOI 10.1080/713755570; Yue JK, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7080093; Zgaljardic DJ, 2015, J NEUROTRAUM, V32, P1911, DOI 10.1089/neu.2014.3569	54	18	18	0	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL	2018	35	13					1543	1551		10.1089/neu.2017.5404		APR 2018	9	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	GJ4CQ	WOS:000429541100001	29343203				2021-06-18	
J	Kim, JA; Boyle, EJ; Wu, AC; Cole, AJ; Staley, KJ; Zafar, S; Cash, SS; Westover, MB				Kim, Jennifer A.; Boyle, Emily J.; Wu, Alexander C.; Cole, Andrew J.; Staley, Kevin J.; Zafar, Sahar; Cash, Sydney S.; Westover, M. Brandon			Epileptiform activity in traumatic brain injury predicts post-traumatic epilepsy	ANNALS OF NEUROLOGY			English	Article							RISK-FACTORS; SEIZURES; EEG; ABNORMALITIES; ADULTS	We hypothesize that epileptiform abnormalities (EAs) in the electroencephalogram (EEG) during the acute period following traumatic brain injury (TBI) independently predict first-year post-traumatic epilepsy (PTE1). We analyze PTE1 risk factors in two cohorts matched for TBI severity and age (n=50). EAs independently predict risk for PTE1 (odds ratio [OR], 3.16 [0.99, 11.68]); subdural hematoma is another independent risk factor (OR, 4.13 [1.18, 39.33]). Differences in EA rates are apparent within 5 days following TBI. Our results suggest that increased EA prevalence identifies patients at increased risk for PTE1, and that EAs acutely post-TBI can identify patients most likely to benefit from antiepileptogenesis drug trials. Ann Neurol 2018;83:858-862	[Kim, Jennifer A.; Boyle, Emily J.; Cole, Andrew J.; Staley, Kevin J.; Zafar, Sahar; Cash, Sydney S.; Westover, M. Brandon] Massachusetts Gen Hosp, Dept Neurol, 15 Parkman St,Wang ACC 739 L, Boston, MA 02114 USA; [Kim, Jennifer A.; Zafar, Sahar] Massachusetts Gen Hosp, Dept Emergency Neurol & Neurocrit Care, Boston, MA 02114 USA; [Wu, Alexander C.] Harvard Univ, Harvard TH Chan Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA	Westover, MB (corresponding author), Massachusetts Gen Hosp, Dept Neurol, 15 Parkman St,Wang ACC 739 L, Boston, MA 02114 USA.	mwestover@mgh.harvard.edu		Cole, Andrew/0000-0002-0828-826X	NIH-NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R25NS065743, 1K23NS090900, R01NS086364]; Bee Foundation; Andrew David Heitman Neuroendovascular Research Fund; CDC-NIOSH ERC training-grant [T42 OH008416]; NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTHUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH) [T42OH008416] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K23NS090900, R01NS086364, R25NS065743] Funding Source: NIH RePORTER	J.A.K. received funding from NIH-NINDS (R25NS065743) and the Bee Foundation W. M.B.W. received funding from NIH-NINDS (1K23NS090900) and the Andrew David Heitman Neuroendovascular Research Fund. A.C.W. is supported by the CDC-NIOSH ERC training-grant (T42 OH008416). K.J.S. received funding from NIH-NINDS (R01NS086364).	ANNEGERS JF, 1980, NEUROLOGY, V30, P683, DOI 10.1212/WNL.30.7.683; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Curia G., 2016, TRANSLATIONAL RES TR; Hirsch LJ, 2013, J CLIN NEUROPHYSIOL, V30, P1, DOI 10.1097/WNP.0b013e3182784729; Klein P, 2017, EPILEPSY BEHAV, V72, P188, DOI 10.1016/j.yebeh.2017.05.024; KOUFEN H, 1978, FORTSCHR NEUROL PSYC, V46, P165; Liesemer K, 2011, J NEUROTRAUM, V28, P755, DOI 10.1089/neu.2010.1518; Piccenna Loretta, 2017, Epilepsia Open, V2, P123, DOI 10.1002/epi4.12049; Ritter AC, 2016, EPILEPSIA, V57, P1968, DOI 10.1111/epi.13582; Ruiz AR, 2017, JAMA NEUROL, V74, P181, DOI 10.1001/jamaneurol.2016.4990; Schmidt D, 2014, NEUROTHERAPEUTICS, V11, P401, DOI 10.1007/s13311-013-0252-z; Shafi MM, 2012, NEUROLOGY, V79, P1796, DOI 10.1212/WNL.0b013e3182703fbc; Terrone G, 2016, PHARMACOL RES, V110, P96, DOI 10.1016/j.phrs.2016.05.009; Tomkins O, 2008, J NEUROL NEUROSUR PS, V79, P774, DOI 10.1136/jnnp.2007.126425; Vespa P, 2016, ANN NEUROL, V79, P579, DOI 10.1002/ana.24606; Wang ML, 2016, J NEUROL SCI, V370, P244, DOI 10.1016/j.jns.2016.09.049; Westover MB, 2015, CLIN NEUROPHYSIOL, V126, P463, DOI 10.1016/j.clinph.2014.05.037; Xu T, 2017, EPILEPSY BEHAV, V67, P1, DOI 10.1016/j.yebeh.2016.10.026; Yeh CC, 2013, J NEUROL NEUROSUR PS, V84, P441, DOI 10.1136/jnnp-2012-302547	19	18	19	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0364-5134	1531-8249		ANN NEUROL	Ann. Neurol.	APR	2018	83	4					858	862		10.1002/ana.25211			5	Clinical Neurology; Neurosciences	Neurosciences & Neurology	GD7BA	WOS:000430662400021	29537656	Green Accepted			2021-06-18	
J	Kimbrel, NA; Meyer, EC; DeBeer, BB; Gulliver, SB; Morissette, SB				Kimbrel, Nathan A.; Meyer, Eric C.; DeBeer, Bryann B.; Gulliver, Suzy B.; Morissette, Sandra B.			The Impact of Cannabis Use Disorder on Suicidal and Nonsuicidal Self-Injury in Iraq/Afghanistan-Era Veterans with and without Mental Health Disorders	SUICIDE AND LIFE-THREATENING BEHAVIOR			English	Article							POSTTRAUMATIC-STRESS-DISORDER; WAR VETERANS; PTSD; SCALE; HARM; COMORBIDITY; PREVALENCE; DEPRESSION; PREDICTOR; MARIJUANA	The objective of this study was to assess the association between cannabis use disorder (CUD) and self-injury among veterans. As expected, after adjusting for sex, age, sexual orientation, combat exposure, traumatic life events, traumatic brain injury, posttraumatic stress disorder, depression, alcohol use disorder, and noncannabis drug use disorder, CUD was significantly associated with both suicidal (OR=3.10, p=.045) and nonsuicidal (OR=5.12, p=.009) self-injury. CUD was the only variable significantly associated with self-injury in all three models examined. These findings are consistent with prior research among civilians and suggest that CUD may also increase veterans' risk for self-injurious behavior.	[Kimbrel, Nathan A.] Durham Vet Affairs Med Ctr, 508 Fulton St, Durham, NC 27705 USA; [Kimbrel, Nathan A.] VA Mid Atlantic Mental Illness Res Educ & Clin Ct, Durham, NC USA; [Kimbrel, Nathan A.] Duke Univ, Med Ctr, Durham, NC USA; [Meyer, Eric C.; DeBeer, Bryann B.] VISN 17 Ctr Excellence Res Returning War Vet, Waco, TX USA; [Meyer, Eric C.; DeBeer, Bryann B.] Cent Texas Vet Hlth Care Syst, Temple, TX USA; [Meyer, Eric C.; DeBeer, Bryann B.] Texas A&M Univ, Hlth Sci Ctr, College Stn, TX USA; [Gulliver, Suzy B.] Baylor Scott & White Healthcare Syst, Warriors Res Inst, Waco, TX USA; [Morissette, Sandra B.] Univ Texas San Antonio, San Antonio, TX USA	Kimbrel, NA (corresponding author), Durham Vet Affairs Med Ctr, 508 Fulton St, Durham, NC 27705 USA.	Nathan.Kimbrel@va.gov	Gulliver, Suzy/X-9776-2019; Kimbrel, Nathan/P-3109-2016	Kimbrel, Nathan/0000-0001-7218-1005; Gulliver, Suzy Bird/0000-0002-6476-9447	Rehabilitation Research and Development (RR&D) Service of the Department of Veterans Affairs (VA) Office of Research and Development (ORD) [I01RX000304]; RR&D Service of VA ORD [I01RX000304-04]; Clinical Science Research and Development (CSR&D) Service of VA ORD [I01 CX001486]; CSR&D Service of VA ORD [IK2 CX000525]; VA VISN 17 Center of Excellence for Research on Returning War Veterans; Central Texas Veterans Health Care System; VA Mid-Atlantic Mental Illness Research, Education, and Clinical Center; Research & Development and Mental Health Services of the Durham VA Medical Center; Veterans AffairsUS Department of Veterans Affairs [I01CX001486, IK2CX000525, I01RX000304] Funding Source: NIH RePORTER	This work was supported by Merit Award #I01RX000304 to Dr. Morissette from the Rehabilitation Research and Development (RR&D) Service of the Department of Veterans Affairs (VA) Office of Research and Development (ORD), Merit Award #I01RX000304-04 to Dr. Meyer from the RR&D Service of VA ORD, and Merit Award #I01 CX001486 to Dr. Kimbrel from the Clinical Science Research and Development (CSR&D) Service of VA ORD. Dr. Kimbrel was also supported by a Career Development Award (#IK2 CX000525) from the CSR&D Service of VA ORD. This research was also supported by the VA VISN 17 Center of Excellence for Research on Returning War Veterans, the Central Texas Veterans Health Care System, the VA Mid-Atlantic Mental Illness Research, Education, and Clinical Center, and the Research & Development and Mental Health Services of the Durham VA Medical Center. The views expressed in this article are those of the authors and do not necessarily reflect the position or policy of the Department of Veterans Affairs or the U.S. government.	Belendiuk KA, 2015, ADDICT SCI CLIN PRAC, V10, DOI 10.1186/s13722-015-0032-7; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1002/jts.2490080106; Boden MT, 2013, AM J ADDICTION, V22, P277, DOI 10.1111/j.1521-0391.2012.12018.x; Bonn-Miller MO, 2007, J TRAUMA STRESS, V20, P577, DOI 10.1002/jts.20243; Bonn-Miller MO, 2012, PSYCHOL SERV, V9, P404, DOI 10.1037/a0027622; Borges G, 2016, J AFFECT DISORDERS, V195, P63, DOI 10.1016/j.jad.2016.02.007; Bremner JD, 1996, AM J PSYCHIAT, V153, P369; Bryan CJ, 2015, COMPR PSYCHIAT, V59, P1, DOI 10.1016/j.comppsych.2014.07.009; BULLMAN TA, 1994, J NERV MENT DIS, V182, P604, DOI 10.1097/00005053-199411000-00002; Chapman AL, 2006, BEHAV RES THER, V44, P371, DOI 10.1016/j.brat.2005.03.005; Cheung JTW, 2010, AM J DRUG ALCOHOL AB, V36, P118, DOI 10.3109/00952991003713784; Curran HV, 2016, NAT REV NEUROSCI, V17, P293, DOI 10.1038/nrn.2016.28; Delforterie MJ, 2015, DRUG ALCOHOL DEPEN, V150, P98, DOI 10.1016/j.drugalcdep.2015.02.019; Few LR, 2016, J STUD ALCOHOL DRUGS, V77, P873, DOI 10.15288/jsad.2016.77.873; First M.B., 1994, STRUCTURAL CLIN INTE; Gentes EL, 2016, PSYCHOL ADDICT BEHAV, V30, P415, DOI 10.1037/adb0000154; Giletta M, 2012, PSYCHIAT RES, V197, P66, DOI 10.1016/j.psychres.2012.02.009; Goldman M, 2010, J ADDICT MED, V4, P47, DOI 10.1097/ADM.0b013e3181b18782; Gratz KL, 2015, ASSESSMENT, V22, P527, DOI 10.1177/1073191114565878; Hall W, 2004, DRUG ALCOHOL REV, V23, P433, DOI 10.1080/09595230412331324554; Hoch E, 2015, DTSCH ARZTEBL INT, V112, P271, DOI 10.3238/arztebl.2015.0271; Joshi M, 2014, CURR OPIN PULM MED, V20, P173, DOI 10.1097/MCP.0000000000000026; Kimbrel NA, 2017, WORLD PSYCHIATRY, V16, P108, DOI 10.1002/wps.20358; Kimbrel NA, 2016, PSYCHIAT RES, V243, P232, DOI 10.1016/j.psychres.2016.06.039; Kimbrel NA, 2016, PSYCHIAT RES, V243, P97, DOI 10.1016/j.psychres.2016.06.011; Kimbrel NA, 2015, PSYCHIAT RES, V227, P360, DOI 10.1016/j.psychres.2015.03.026; Kimbrel NA, 2014, PSYCHIAT RES, V220, P1118, DOI 10.1016/j.psychres.2014.08.053; Kimbrel NA, 2014, PSYCHIAT RES, V220, P397, DOI 10.1016/j.psychres.2014.07.064; Kimbrel NA, 2014, J TRAUMA STRESS, V27, P474, DOI 10.1002/jts.21932; Klonsky ED, 2011, PSYCHOL MED, V41, P1981, DOI 10.1017/S0033291710002497; Kubany ES, 2000, PSYCHOL ASSESSMENT, V12, P210, DOI 10.1037//1040-3590.12.2.210; Moller CI, 2013, ADDICTION, V108, P211, DOI 10.1111/j.1360-0443.2012.04021.x; Posner K, 2011, AM J PSYCHIAT, V168, P1266, DOI 10.1176/appi.ajp.2011.10111704; Selby EA, 2015, CLIN PSYCHOL REV, V38, P79, DOI 10.1016/j.cpr.2015.03.003; Selby EA, 2012, PERSONAL DISORD, V3, P167, DOI 10.1037/a0024405; Sherman BJ, 2016, PHARMACOTHERAPY, V36, P511, DOI 10.1002/phar.1747; United Nations Office on Drugs and Crime, 2014, WORLD DRUG REP 2014; van Ours JC, 2013, J HEALTH ECON, V32, P524, DOI 10.1016/j.jhealeco.2013.02.002; Vasterling J. J., 2008, TBI SCREENING UNPUB	39	18	18	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0363-0234	1943-278X		SUICIDE LIFE-THREAT	Suicide Life-Threat. Behav.	APR	2018	48	2					140	148		10.1111/sltb.12345			9	Psychiatry; Psychology, Multidisciplinary	Psychiatry; Psychology	GC8QX	WOS:000430062400002	28295524	Green Accepted			2021-06-18	
J	de Campos, JRM; White, TW				Milanez de Campos, Jose Ribas; White, Thomas W.			Chest wall stabilization in trauma patients: why, when, and how?	JOURNAL OF THORACIC DISEASE			English	Article; Proceedings Paper	26th European Conference on General Thoracic Surgery of the European-Society-of-Thoracic-Surgeons (ESTS)	MAY 26-30, 2018	Ljubljana, SLOVENIA	European Soc Thorac Surg		Flail chest; chest wall stabilization (CWS); rib fracture; plating systems	SEVERE RIB FRACTURES; SURGICAL STABILIZATION; FLAIL CHEST; RETAINED HEMOTHORAX; DECREASES INCIDENCE; MANAGEMENT; FIXATION; OUTCOMES; METAANALYSIS; INJURIES	Blunt trauma to the chest wall and rib fractures are remarkably frequent and are the basis of considerable morbidity and possible mortality. Surgical remedies for highly displaced rib fractures, especially in cases of flail chest, have been undertaken intermittently for more than 50 years. Rib-specific plating systems have started to be used in the last 10 years. These have ushered in the modern era of rib repair with chest wall stabilization (CWS) techniques that are safer, easier to perform, and more efficient. Recent consensus statements have sought to define the indications and contraindications, as well as the when, the how, and the technical details of CWS. Repair should be considered for patients who have three or more displaced rib fractures or a flail chest, whether or not mechanical ventilation is required. Additional candidates include patients who fail non-operative management irrespective of fracture pattern and those with rib fractures who need thoracic procedures for other reasons. Traditionally, unstable spine fracture and severe traumatic brain injury are definite contraindications. Pulmonary contusion's role in the decision to perform CWS remains controversial. A range of rib-specific plating systems are now commercially available.	[Milanez de Campos, Jose Ribas] Univ Sao Paulo, Div Thorac Surg, Sao Paulo, Brazil; [White, Thomas W.] Intermt Med Ctr, Trauma & Surg Crit Care, Salt Lake City, UT USA	de Campos, JRM (corresponding author), Univ Sao Paulo, Div Thorac Surg, Sao Paulo, Brazil.	jribas@usp.br					Bemelman Michael, 2017, Korean J Thorac Cardiovasc Surg, V50, P229, DOI 10.5090/kjtcs.2017.50.4.229; Caragounis EC, 2016, WORLD J EMERG SURG, V11, DOI 10.1186/s13017-016-0085-2; Chien CY, 2017, SCAND J TRAUMA RESUS, V25, DOI 10.1186/s13049-017-0368-y; Coughlin TA, 2016, BONE JOINT J, V98B, P1119, DOI 10.1302/0301-620X.98B8.37282; Dehghan N, 2014, J TRAUMA ACUTE CARE, V76, P462, DOI 10.1097/TA.0000000000000086; Dent DL, 2015, AM J SURG, V210, P1116; Farquhar J, 2017, CAN J SURG, V60, P7; Fitzgerald MT, 2017, J TRAUMA ACUTE CARE, V82, P524, DOI 10.1097/TA.0000000000001330; Kaplan DJ, 2017, J ORTHOP TRAUMA, V31, pS34, DOI 10.1097/BOT.0000000000000910; Kocher GJ, 2017, EUR J CARDIO-THORAC, V51, P696, DOI 10.1093/ejcts/ezw365; Majak P, 2016, CURR OPIN CRIT CARE, V22, P572, DOI 10.1097/MCC.0000000000000364; Majercik S, 2015, AM J SURG, V210, P1112, DOI 10.1016/j.amjsurg.2015.08.008; Majercik S, 2015, J TRAUMA ACUTE CARE, V79, P533, DOI 10.1097/TA.0000000000000820; Marasco S, 2014, J TRAUMA ACUTE CARE, V77, P452, DOI 10.1097/TA.0000000000000375; Nickerson TP, 2016, WORLD J SURG, V40, P236, DOI 10.1007/s00268-015-3169-3; Olsen MF, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0322-4; Pieracci Fredric M, 2015, Trauma Case Rep, V1, P39, DOI 10.1016/j.tcr.2015.10.001; Pieracci FM, 2018, J TRAUMA ACUTE CARE, V84, P1, DOI 10.1097/TA.0000000000001729; Pieracci FM, 2017, INJURY, V48, P307, DOI 10.1016/j.injury.2016.11.026; Pieracci FM, 2016, J TRAUMA ACUTE CARE, V80, P187, DOI 10.1097/TA.0000000000000925; Skedros JG, 2014, INT J SURG CASE REP, V5, P750, DOI 10.1016/j.ijscr.2014.08.023; Swart E, 2017, J ORTHOP TRAUMA, V31, P64, DOI 10.1097/BOT.0000000000000750; Uchida K, 2017, EUR J TRAUMA EMERG S, V43, P541, DOI 10.1007/s00068-016-0687-0	23	18	18	0	3	AME PUBL CO	SHATIN	FLAT-RM C 16F, KINGS WING PLAZA 1, NO 3 KWAN ST, SHATIN, HONG KONG 00000, PEOPLES R CHINA	2072-1439	2077-6624		J THORAC DIS	J. Thorac. Dis.	APR	2018	10			8	SI		S951	S962		10.21037/jtd.2018.04.69			12	Respiratory System	Respiratory System	GF1HP	WOS:000431685100006	29744222	Green Published, Other Gold			2021-06-18	
J	Stolp, HB; Ball, G; So, PW; Tournier, JD; Jones, M; Thornton, C; Edwards, AD				Stolp, H. B.; Ball, G.; So, P. -W.; Tournier, J. -D.; Jones, M.; Thornton, C.; Edwards, A. D.			Voxel-wise comparisons of cellular microstructure and diffusion-MRI in mouse hippocampus using 3D Bridging of Optically-clear histology with Neuroimaging Data (3D-BOND)	SCIENTIFIC REPORTS			English	Article							TRAUMATIC BRAIN-INJURY; WHITE-MATTER INTEGRITY; SPHERICAL DECONVOLUTION; DTI MEASURES; TISSUE; RECONSTRUCTION; MICROSCOPY; REGISTRATION; TRACTOGRAPHY; VALIDATION	A key challenge in medical imaging is determining a precise correspondence between image properties and tissue microstructure. This comparison is hindered by disparate scales and resolutions between medical imaging and histology. We present a new technique, 3D Bridging of Optically-clear histology with Neuroimaging Data (3D-BOND), for registering medical images with 3D histology to overcome these limitations. Ex vivo 120 x 120 x 200 mu m resolution diffusion-MRI (dMRI) data was acquired at 7 T from adult C57Bl/6 mouse hippocampus. Tissue was then optically cleared using CLARITY and stained with cellular markers and confocal microscopy used to produce high-resolution images of the 3D-tissue microstructure. For each sample, a dense array of hippocampal landmarks was used to drive registration between upsampled dMRI data and the corresponding confocal images. The cell population in each MRI voxel was determined within hippocampal subregions and compared to MRI-derived metrics. 3D-BOND provided robust voxel-wise, cellular correlates of dMRI data. CA1 pyramidal and dentate gyrus granular layers had significantly different mean diffusivity (p > 0.001), which was related to microstructural features. Overall, mean and radial diffusivity correlated with cell and axon density and fractional anisotropy with astrocyte density, while apparent fibre density correlated negatively with axon density. Astrocytes, axons and blood vessels correlated to tensor orientation.	[Stolp, H. B.; Ball, G.; Tournier, J. -D.; Jones, M.; Thornton, C.; Edwards, A. D.] St Thomas Hosp, Kings Coll London, Sch Biomed Engn & Imaging Sci, Ctr Developing Brain, London SE1 7EH, England; [So, P. -W.] Kings Coll London, Inst Psychiat Psychol & Neurosci, Maurice Wohl Clin Neurosci Inst, Dept Neuroimaging, London SE5 9NU, England; [Ball, G.] Murdoch Childrens Res Inst, Dev Imaging, Clin Sci, Melbourne, Vic 3052, Australia; [Stolp, H. B.] Royal Vet Coll, Dept Comparat Biomed Sci, London NW1 0TU, England	Thornton, C (corresponding author), St Thomas Hosp, Kings Coll London, Sch Biomed Engn & Imaging Sci, Ctr Developing Brain, London SE1 7EH, England.	claire.thornton@kcl.ac.uk	Thornton, Claire/AAF-7481-2019; So, Po-Wah/AAJ-5501-2020	Thornton, Claire/0000-0001-7676-3272; So, Po-Wah/0000-0003-3449-8532; Ball, Gareth/0000-0003-3509-1435; Tournier, Jacques-Donald/0000-0001-5591-7383; Edwards, Anthony David/0000-0003-4801-7066	Department of Perinatal Imaging and Health; King's Health Partners Research & Development Challenge Fund; Medical Research Council, United KingdomUK Research & Innovation (UKRI)Medical Research Council UK (MRC); Department of Health via the National Institute for Health Research (NIHR) Comprehensive Biomedical Research Centre Award to Guy's & St Thomas' NHS Foundation Trust; King's College London and King's College Hospital NHS Foundation Trust; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [MC_PC_16048, MR/K006355/1, MC_PC_15031] Funding Source: researchfish	We gratefully acknowledge the support of the Department of Perinatal Imaging and Health, in particular Henrik Hagberg, Pierre Gressens, Jo Hajnal, Paul Aljabar and Serena Counsell for their thoughtful comments and discussions. Financial support for this work was provided by King's Health Partners Research & Development Challenge Fund and the Medical Research Council, United Kingdom. We thank the British Heart Foundation for supporting the 7T MRI scanner (Preclinical Imaging Unit, King's College London) used in this study. In addition, the authors acknowledge financial support from the Department of Health via the National Institute for Health Research (NIHR) Comprehensive Biomedical Research Centre Award to Guy's & St Thomas' NHS Foundation Trust in partnership with King's College London and King's College Hospital NHS Foundation Trust.	Aggarwal M, 2014, MAGN RESON MED, V72, P829, DOI 10.1002/mrm.24956; Becker K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033916; Blumenfeld-Katzir T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020678; Bruce IP, 2017, NEUROIMAGE, V159, P46, DOI 10.1016/j.neuroimage.2017.07.035; Budde MD, 2011, BRAIN, V134, P2248, DOI 10.1093/brain/awr161; Chang EH, 2017, NEUROIMAGE, V147, P253, DOI 10.1016/j.neuroimage.2016.11.068; Chung K, 2013, NATURE, V497, P332, DOI 10.1038/nature12107; Dodt HU, 2007, NAT METHODS, V4, P331, DOI 10.1038/NMETH1036; Dyrby TB, 2011, HUM BRAIN MAPP, V32, P544, DOI 10.1002/hbm.21043; Errico C, 2015, NATURE, V527, P499, DOI 10.1038/nature16066; Erturk A, 2012, NAT PROTOC, V7, P1983, DOI 10.1038/nprot.2012.119; Feng L, 2017, BRAIN STRUCT FUNCT, V222, P4131, DOI 10.1007/s00429-017-1463-6; Goubran M, 2016, HUM BRAIN MAPP, V37, P1103, DOI 10.1002/hbm.23090; Hama H, 2011, NAT NEUROSCI, V14, P1481, DOI 10.1038/nn.2928; Hutchinson E. B., 2017, J NEUROSCI RES; Jacobs MA, 1999, MED PHYS, V26, P1568, DOI 10.1118/1.598671; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Jeurissen B, 2014, NEUROIMAGE, V103, P411, DOI 10.1016/j.neuroimage.2014.07.061; Jones DK, 2013, NEUROIMAGE, V73, P239, DOI 10.1016/j.neuroimage.2012.06.081; Ke MT, 2013, NAT NEUROSCI, V16, P1154, DOI 10.1038/nn.3447; Khan A. U., 2015, QUAL QUANT, V2015, P1, DOI DOI 10.1016/J.IJHCS.2015.07.001; Labate A, 2015, EPILEPSIA, V56, P1109, DOI 10.1111/epi.13027; Lee SP, 1999, MAGNET RESON MED, V42, P919, DOI 10.1002/(SICI)1522-2594(199911)42:5<919::AID-MRM12>3.0.CO;2-8; Mandl RCW, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00817; Manjon J. V., 2010, INT J BIOMED IMAGING, V2010, DOI DOI 10.1155/2010/425891; Manjon JV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073021; Manjon JV, 2012, MED IMAGE ANAL, V16, P18, DOI 10.1016/j.media.2011.04.003; Mollink J, 2017, NEUROIMAGE; Nir TM, 2013, NEUROIMAGE-CLIN, V3, P180, DOI 10.1016/j.nicl.2013.07.006; Renier N, 2014, CELL, V159, P896, DOI 10.1016/j.cell.2014.10.010; Rueckert D, 2003, IEEE T MED IMAGING, V22, P1014, DOI 10.1109/TMI.2003.815865; Schilling K, 2016, NEUROIMAGE, V129, P185, DOI 10.1016/j.neuroimage.2016.01.022; Seehaus A, 2015, FRONT NEUROANAT, V9, DOI 10.3389/fnana.2015.00098; Sepehrband F, 2015, HUM BRAIN MAPP, V36, P3687, DOI 10.1002/hbm.22872; Silva AC, 1997, MAGNET RESON MED, V38, P232, DOI 10.1002/mrm.1910380211; Singh K, 2016, EXP NEUROL, V275, P427, DOI 10.1016/j.expneurol.2015.07.016; Susaki EA, 2015, NAT PROTOC, V10, P1709, DOI 10.1038/nprot.2015.085; Tomer R, 2014, NAT PROTOC, V9, P1682, DOI 10.1038/nprot.2014.123; Tournier JD, 2007, NEUROIMAGE, V35, P1459, DOI 10.1016/j.neuroimage.2007.02.016; Trojsi F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119045; Wells JA, 2015, NEUROIMAGE, V111, P369, DOI 10.1016/j.neuroimage.2015.02.023; Wu D, 2016, NEUROIMAGE, V125, P84, DOI 10.1016/j.neuroimage.2015.10.051; Xu G, 2014, CEREB CORTEX, V24, P579, DOI 10.1093/cercor/bhs330; Yang B, 2014, CELL, V158, P945, DOI 10.1016/j.cell.2014.07.017; Zhang B, 2014, CNS NEUROSCI THER, V20, P3, DOI 10.1111/cns.12166; Zhang H, 2012, NEUROIMAGE, V61, P1000, DOI 10.1016/j.neuroimage.2012.03.072	46	18	18	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	MAR 5	2018	8								4011	10.1038/s41598-018-22295-9			12	Multidisciplinary Sciences	Science & Technology - Other Topics	FY0ZI	WOS:000426540800044	29507311	DOAJ Gold, Green Published, Green Accepted			2021-06-18	
J	Bonow, RH; Barber, J; Temkin, NR; Videtta, W; Rondina, C; Petroni, G; Lujan, S; Alanis, V; La Fuente, G; Lavadenz, A; Merida, R; Jibaja, M; Gonzales, L; Falcao, A; Romero, R; Dikmen, S; Pridgeon, J; Chesnut, RM				Bonow, Robert H.; Barber, Jason; Temkin, Nancy R.; Videtta, Walter; Rondina, Carlos; Petroni, Gustavo; Lujan, Silvia; Alanis, Victor; La Fuente, Gustavo; Lavadenz, Arturo; Merida, Roberto; Jibaja, Manuel; Gonzales, Luis; Falcao, Antonio; Romero, Ricardo; Dikmen, Sureyya; Pridgeon, James; Chesnut, Randall M.		Global Neurotrauma Res Grp	The Outcome of Severe Traumatic Brain Injury in Latin America	WORLD NEUROSURGERY			English	Article						Global health; Social determinants of health; Traumatic brain injury	HEAD-INJURY; PROGNOSTIC VALUE; DIRECT TRANSPORT; LOW-INCOME; MORTALITY; HYPOTENSION; PRESSURE; CENTERS; SYSTEM; IMPACT	BACKGROUND: Traumatic brain injury (TBI) disproportionately affects lower-and middle-income countries (LMIC). The factors influencing outcomes in LMIC have not been examined as rigorously as in higher-income countries. METHODS: This study was conducted to examine clinical and demographic factors influencing TBI outcomes in Latin American LMIC. Data were prospectively collected during a randomized trial of intracranial pressure monitoring in severe TBI and a companion observational study. Participants were aged >= 13 years and admitted to study hospitals with Glasgow Coma Scale score <= 8. The primary outcome was Glasgow Outcome Scale, Extended (GOS-E) score at 6 months. Predictors were analyzed using a multivariable proportional odds model created by forward stepwise selection. RESULTS: A total of 550 patients were identified. Six-month outcomes were available for 88%, of whom 37% had died and 44% had achieved a GOS-E score of 5-8. In multivariable proportional odds modeling, higher Glasgow Coma Scale motor score (odds ratio [OR], 1.41 per point; 95% confidence interval [CI], 1.23-1.61) and epidural hematoma (OR, 1.83; 95% CI, 1.17-2.86) were significant predictors of higher GOS-E score, whereas advanced age (OR, 0.65 per 10 years; 95% CI, 0.57-0.73) and cisternal effacement (P < 0.001) were associated with lower GOS-E score. Study site (P < 0.001) and race (P = 0.004) significantly predicted outcome, outweighing clinical variables such as hypotension and pupillary examination. CONCLUSIONS: Mortality from severe TBI is high in Latin American LMIC, although the rate of favorable recovery is similar to that of high-income countries. Demographic factors such as race and study site played an outsized role in predicting outcome; further research is required to understand these associations.	[Bonow, Robert H.; Barber, Jason; Temkin, Nancy R.; Pridgeon, James; Chesnut, Randall M.] Univ Washington, Dept Neurol Surg, Seattle, WA 98195 USA; [Videtta, Walter] Hosp Posadas, Buenos Aires, DF, Argentina; [Rondina, Carlos] Fdn ALAS, Buenos Aires, DF, Argentina; [Petroni, Gustavo; Lujan, Silvia] Hosp Emergencias Dr Clemente Alvarez, Rosario, Santa Fe, Argentina; [Alanis, Victor] Univ Hosp San Juan Dios, Santa Cruz, Bolivia; [La Fuente, Gustavo] Hosp Japones, Santa Cruz, Bolivia; [Lavadenz, Arturo] Hosp Viedma, Cochabamba, Bolivia; [Merida, Roberto] San Juan Dios Hosp, Tarija, Bolivia; [Jibaja, Manuel] Espejo Hosp, Quito, Ecuador; [Gonzales, Luis] Vernaza Hosp, Guayaquil, Ecuador; [Falcao, Antonio] Univ Estadual Campinas, Campinas, SP, Brazil; [Romero, Ricardo] Fdn Clin Campbell, Barranquilla, Colombia; [Dikmen, Sureyya] Univ Washington, Dept Rehabil Med, Seattle, WA 98195 USA	Bonow, RH (corresponding author), Univ Washington, Dept Neurol Surg, Seattle, WA 98195 USA.	rbonow@uw.edu		Chesnut, Randall/0000-0001-6377-3666; ROMERO FIGUEROA, RICARDO LUIS/0000-0002-3124-8717; Falcao, Antonio/0000-0002-1630-7889	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS058302] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS080648, R01 NS058302] Funding Source: Medline		Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Butcher I, 2007, J NEUROTRAUM, V24, P294, DOI 10.1089/neu.2006.0032; Canadian Association for Community Living, 1997, INT PERS DIS PROD WO; Carney N, 2012, J NEUROTRAUM, V29, P2022, DOI 10.1089/neu.2011.2019; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; CHESNUT RM, 1993, ACTA NEUROCHIR, P121; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; COLOHAN ART, 1989, J NEUROSURG, V71, P202, DOI 10.3171/jns.1989.71.2.0202; De Ferranti D., 2004, INEQUALITY LATIN AM; De Silva MJ, 2009, INT J EPIDEMIOL, V38, P452, DOI 10.1093/ije/dyn189; Dudzik P, 2000, DISABILITY POLICIES, P1; FEARNSIDE MR, 1993, BRIT J NEUROSURG, V7, P267, DOI 10.3109/02688699309023809; Hartl R, 2006, J TRAUMA, V60, P1250, DOI 10.1097/01.ta.0000203717.57821.8d; Hofman K, 2005, AM J PUBLIC HEALTH, V95, P13, DOI 10.2105/AJPH.2004.039354; Hukkelhoven CWPM, 2005, J NEUROTRAUM, V22, P1025, DOI 10.1089/neu.2005.22.1025; Hukkelhoven CWPM, 2002, J NEUROSURG, V97, P549, DOI 10.3171/jns.2002.97.3.0549; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Leipziger DM, 2001, FINANCE DEV, V38; Lingsma HF, 2011, NEUROSURGERY, V68, P601, DOI 10.1227/NEU.0b013e318209333b; Lu J, 2005, ACT NEUR S, V95, P281; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; MARSHALL LF, 1991, J NEUROSURG, V75, pS28, DOI 10.3171/sup.1991.75.1s.0s28; Mullins RJ, 1996, J TRAUMA, V40, P536, DOI 10.1097/00005373-199604000-00004; Mullins RJ, 1996, J TRAUMA, V40, P545; Murray CJL, 1996, GLOBAL BURDEN DIS CO; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; Mushkudiani NA, 2007, J NEUROTRAUM, V24, P259, DOI 10.1089/neu.2006.0028; Pan American Health Organization, 2013, ROAD SAF FACTS REG A; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Perel Pablo, 2006, BMC Med Inform Decis Mak, V6, P38, DOI 10.1186/1472-6947-6-38; PIETROPAOLI JA, 1992, J TRAUMA, V33, P403, DOI 10.1097/00005373-199209000-00011; Puvanachandra P., 2009, PAK J NEUROL SCI, V4, P27; Puvanachandra P, 2008, SALUD PUBLICA MEXICO, V50, pS3; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Rubiano AM, 2013, BRAIN INJURY, V27, P262, DOI 10.3109/02699052.2012.750742; Sampalis JS, 1997, J TRAUMA, V43, P288, DOI 10.1097/00005373-199708000-00014; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; Stocchetti N, 1996, J TRAUMA, V40, P764, DOI 10.1097/00005373-199605000-00014; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	41	18	20	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	MAR	2018	111						E82	E90		10.1016/j.wneu.2017.11.171			9	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	GG7WI	WOS:000432908700012	29229352	Green Accepted			2021-06-18	
J	Erdodi, LA; Dunn, AG; Seke, KR; Charron, C; McDermott, A; Enache, A; Maytham, C; Hurtubise, JL				Erdodi, Laszlo A.; Dunn, Alexa G.; Seke, Kristian R.; Charron, Carly; McDermott, Abigail; Enache, Anca; Maytham, Charlotte; Hurtubise, Jessica L.			The Boston Naming Test as a Measure of Performance Validity	PSYCHOLOGICAL INJURY & LAW			English	Article						Boston Naming Test; Performance validity; Embedded validity indicators	TRAUMATIC BRAIN-INJURY; FORCED-CHOICE RECOGNITION; VERBAL-LEARNING TEST; COMPLEX IDEATIONAL MATERIAL; MEMORY-MALINGERING TOMM; CLASSIFICATION ACCURACY; TRIAL 1; INVALID PERFORMANCE; CROSS-VALIDATION; SUSPECT EFFORT	This study was designed to evaluate the potential of the Boston Naming Test (BNT) as a performance validity test (PVT). The classification accuracy of the BNT was examined against several criterion PVTs in a mixed clinical sample of 214 adult outpatients physician referred for neuropsychological assessment. Mean age was 46.7 (SD = 12.5); mean education was 13.5 (SD = 2.5). All participants were native speakers of English. A BNT raw score = 50 produced high specificity (.87-.95), but low and variable sensitivity (.15-.41). Similarly, a T score <= 37 was specific (.87-.95), but not very sensitive (.15-.35) to psychometrically defined non-credible responding. Ipsative analyses (i.e., case-by-case review of individual PVT profiles) suggest that failing these cutoffs was associated with zero false positives when all available PVTs were taken into account. Results are consistent with previous reports that the validity cutoffs on the BNT have high positive predictive power, but low negative predictive power. As such, they are useful in ruling in invalid performance, but they cannot be used to rule it out.	[Erdodi, Laszlo A.; Dunn, Alexa G.; Seke, Kristian R.; Charron, Carly; McDermott, Abigail; Enache, Anca; Maytham, Charlotte; Hurtubise, Jessica L.] Univ Windsor, Dept Psychol, 168 Chrysler Hall South,401 Sunset Ave, Windsor, ON N9B 3P4, Canada	Erdodi, LA (corresponding author), Univ Windsor, Dept Psychol, 168 Chrysler Hall South,401 Sunset Ave, Windsor, ON N9B 3P4, Canada.	lerdodi@gmail.com		Charron, Carly/0000-0001-5647-6903			Arnold G, 2005, CLIN NEUROPSYCHOL, V19, P105, DOI 10.1080/13854040490888567; Ashendorf L, 2017, CLIN NEUROPSYCHOL, V31, P857, DOI 10.1080/13854046.2017.1285961; Axelrod BN, 2014, CLIN NEUROPSYCHOL, V28, P876, DOI 10.1080/13854046.2014.907583; BALDESSARINI RJ, 1983, ARCH GEN PSYCHIAT, V40, P569; Bauer L, 2005, APPL NEUROPSYCHOL, V12, P202, DOI 10.1207/s15324826an1204_3; Bigler ED, 2012, J INT NEUROPSYCH SOC, V18, P632, DOI 10.1017/S1355617712000252; Boone K. B., 2013, CLIN PRACTICE FORENS; Boone KB, 2007, ARCH CLIN NEUROPSYCH, V22, P355, DOI 10.1016/j.acn.2007.01.010; Boone KB, 2009, CLIN NEUROPSYCHOL, V23, P729, DOI 10.1080/13854040802427803; Bortnik KE, 2010, CLIN NEUROPSYCHOL, V24, P344, DOI 10.1080/13854040903307268; Busse M, 2012, CLIN NEUROPSYCHOL, V26, P675, DOI 10.1080/13854046.2012.679623; Cottingham ME, 2014, CLIN NEUROPSYCHOL, V28, P1030, DOI 10.1080/13854046.2014.951397; Curtis KL, 2008, CLIN NEUROPSYCHOL, V22, P930, DOI 10.1080/13854040701563591; Davis JJ, 2014, CLIN NEUROPSYCHOL, V28, P199, DOI 10.1080/13854046.2014.884633; Denning JH, 2012, ARCH CLIN NEUROPSYCH, V27, P417, DOI 10.1093/arclin/acs044; Denning JH, 2014, APPL NEUROPSYCH-ADUL, V21, P269, DOI 10.1080/23279095.2013.811076; Erdodi L. A., 2017, APPL NEUROPSYCHOLOGY; Erdodi L, 2017, APPL NEUROPSYCH-ADUL, V24, P264, DOI 10.1080/23279095.2016.1154856; Erdodi LA, 2018, PSYCHOL ASSESSMENT, V30, P755, DOI 10.1037/pas0000525; Erdodi LA, 2017, BRAIN INJURY, V31, P1362, DOI 10.1080/02699052.2017.1332386; Erdodi LA, 2018, APPL NEUROPSYCH-ADUL, V25, P19, DOI 10.1080/23279095.2016.1232262; Erdodi LA, 2017, J CLIN EXP NEUROPSYC, V39, P369, DOI 10.1080/13803395.2016.1230181; Erdodi LA, 2016, PSYCHOL INJ LAW, V9, P112, DOI 10.1007/s12207-016-9254-6; Erdodi LA, 2017, PSYCHOL ASSESSMENT, V29, P148, DOI 10.1037/pas0000319; Erdodi LA, 2017, CLIN NEUROPSYCHOL, V31, P168, DOI 10.1080/13854046.2016.1224392; Erdodi LA, 2014, PSYCHOL INJ LAW, V7, P255, DOI 10.1007/s12207-014-9197-8; Erdodi LA, 2014, ARCH CLIN NEUROPSYCH, V29, P456, DOI 10.1093/arclin/acu026; Etherton JL, 2006, J CLIN EXP NEUROPSYC, V28, P1218, DOI 10.1080/13803390500346595; Goodglass H, 1972, THE ASSESSMENT OF AP; Greiffenstein M.F., 1994, PSYCHOL ASSESSMENT, V6, P218, DOI [https://doi.org/10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; HAYWARD L, 1987, AUST NZ J PSYCHIAT, V21, P87, DOI 10.3109/00048678709160904; HEATON RK, 1978, J CONSULT CLIN PSYCH, V46, P892, DOI 10.1037/0022-006X.46.5.892; Heaton RK, 2004, REVISED COMPREHENSIV; Hilsabeck RC, 2011, CLIN NEUROPSYCHOL, V25, P1228, DOI 10.1080/13854046.2011.589409; Iverson GL, 2002, CLIN NEUROPSYCHOL, V16, P398, DOI 10.1076/clin.16.3.398.13861; Jones A, 2013, CLIN NEUROPSYCHOL, V27, P1043, DOI 10.1080/13854046.2013.804949; Kaplan E, 1978, BOSTON NAMING TEST E, V2nd; Kim N, 2010, ARCH CLIN NEUROPSYCH, V25, P420, DOI 10.1093/arclin/acq040; Kulas JF, 2014, PSYCHOL INJ LAW, V7, P236, DOI 10.1007/s12207-014-9200-4; Larrabee G. J., 2012, FORENSIC NEUROPSYCHO, P117; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; Larrabee GJ, 2008, CLIN NEUROPSYCHOL, V22, P666, DOI 10.1080/13854040701494987; Lezak M., 2012, NEUROPSYCHOLOGICAL A, V5th; Lichtenstein JD, 2017, CHILD NEUROPSYCHOL, V23, P284, DOI 10.1080/09297049.2015.1135422; Lu PH, 2003, CLIN NEUROPSYCHOL, V17, P426, DOI 10.1076/clin.17.3.426.18083; Moore BA, 2004, BRAIN INJURY, V18, P975, DOI 10.1080/02699050410001672350; O'Bryant SE, 2008, APPL NEUROPSYCHOL, V15, P113, DOI 10.1080/09084280802083921; Pearson, 2009, ADV CLIN SOL WAIS 4; Pedraza O, 2009, J INT NEUROPSYCH SOC, V15, P758, DOI 10.1017/S1355617709990361; Reedy SD, 2013, ARCH CLIN NEUROPSYCH, V28, P30, DOI 10.1093/arclin/acs106; Robles L, 2015, J CLIN EXP NEUROPSYC, V37, P614, DOI 10.1080/13803395.2015.1039961; Root JC, 2006, J INT NEUROPSYCH SOC, V12, P688, DOI 10.1017/S1355617706060838; Roth R.M., 2017, PSYCHOL NEUROSCI, V10, DOI [https//doi.org/10.1037/pne0000103, DOI 10.1037/PNE0000103]; Schwartz ES, 2016, J INT NEUROPSYCH SOC, V22, P851, DOI 10.1017/S1355617716000746; Shura RD, 2016, APPL NEUROPSYCH-ADUL, V23, P94, DOI 10.1080/23279095.2015.1014556; Sugarman MA, 2015, APPL NEUROPSYCH-ADUL, V22, P141, DOI 10.1080/23279095.2013.873439; Suhr JA, 1999, J CLIN EXP NEUROPSYC, V21, P701, DOI 10.1076/jcen.21.5.701.868; Tombaugh TN, 1996, TEST MEMORY MALINGER; Trueblood W., 1994, J CLIN EXPT NEUROPSY, V4, P697, DOI DOI 10.1080/01688639408402671; Whiteside DM, 2015, J CLIN EXP NEUROPSYC, V37, P220, DOI 10.1080/13803395.2014.1002758; Young G, 2015, PSYCHOL INJ LAW, V8, P188, DOI 10.1007/s12207-015-9232-4	61	18	18	0	5	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1938-971X	1938-9728		PSYCHOL INJ LAW	Psychol. Inj. Law	MAR	2018	11	1					1	8		10.1007/s12207-017-9309-3			8	Psychology, Clinical	Psychology	FX8UX	WOS:000426372200001					2021-06-18	
J	Guertler, CA; Okamoto, RJ; Schmidt, JL; Badachhape, AA; Johnson, CL; Bayly, PV				Guertler, Charlotte A.; Okamoto, Ruth J.; Schmidt, John L.; Badachhape, Andrew A.; Johnson, Curtis L.; Bayly, Philip V.			Mechanical properties of porcine brain tissue in vivo and ex vivo estimated by MR elastography	JOURNAL OF BIOMECHANICS			English	Article						Magnetic resonance elastography; Brain tissue stiffness; Shear modulus; Post-mortem tissue changes; Porcine brain	MAGNETIC-RESONANCE ELASTOGRAPHY; TRANSVERSELY ISOTROPIC MATERIAL; FAST SHEAR-WAVES; VISCOELASTIC PROPERTIES; NONINVASIVE ASSESSMENT; HEAD-INJURY; BEHAVIOR; ELASTICITY; PARAMETERS; IMPACT	The mechanical properties of brain tissue in vivo determine the response of the brain to rapid skull acceleration. These properties are thus of great interest to the developers of mathematical models of traumatic brain injury (TBI) or neurosurgical simulations. Animal models provide valuable insight that can improve TBI modeling. In this study we compare estimates of mechanical properties of the Yucatan mini-pig brain in vivo and ex vivo using magnetic resonance elastography (MRE) at multiple frequencies. MRE allows estimations of properties in soft tissue, either in vivo or ex vivo, by imaging harmonic shear wave propagation. Most direct measurements of brain mechanical properties have been performed using samples of brain tissue ex vivo. It has been observed that direct estimates of brain mechanical properties depend on the frequency and amplitude of loading, as well as the time post-mortem and condition of the sample. Using MRE in the same animals at overlapping frequencies, we observe that porcine brain tissue in vivo appears stiffer than porcine brain tissue samples ex vivo at frequencies of 100 Hz and 125 Hz, but measurements show closer agreement at lower frequencies. (C) 2018 Elsevier Ltd. All rights reserved.	[Guertler, Charlotte A.; Okamoto, Ruth J.; Schmidt, John L.; Bayly, Philip V.] Washington Univ, Mech Engn & Mat Sci, Urbauer 319,Campus Box 1185,1 Brookings Dr, St Louis, MO 63130 USA; [Badachhape, Andrew A.; Bayly, Philip V.] Washington Univ, Biomed Engn, St Louis, MO 63130 USA; [Johnson, Curtis L.] Univ Delaware, Biomed Engn, Newark, DE 19716 USA	Guertler, CA (corresponding author), Washington Univ, Mech Engn & Mat Sci, Urbauer 319,Campus Box 1185,1 Brookings Dr, St Louis, MO 63130 USA.	charlotte.guertler@wustl.edu	Johnson, Curtis/U-8372-2019	Badachhape, Andrew/0000-0002-5857-9495; Okamoto, Ruth/0000-0002-3085-3878	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS055951]; NSFNational Science Foundation (NSF) [CMMI-1332433]; ONROffice of Naval Research [N00014-15-C-5160]; Imaging Sciences Pathway Fellowship [NIH 5T32EB01485505]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [T32EB014855] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS055951] Funding Source: NIH RePORTER	This study was performed with funding from NIH Grant R01 NS055951, NSF Grant CMMI-1332433, ONR Grant N00014-15-C-5160, and Imaging Sciences Pathway Fellowship NIH 5T32EB01485505. Technical assistance from Linda Hood in MR image acquisition is gratefully acknowledged.	Anderson AT, 2016, J MECH BEHAV BIOMED, V59, P538, DOI 10.1016/j.jmbbm.2016.03.005; Arbogast KB, 1998, J BIOMECH, V31, P801, DOI 10.1016/S0021-9290(98)00068-2; ARBOGAST KB, 1997, P 41 STAPP CAR CRASH, P293; Atay SM, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2899575; Badachhape AA, 2017, J BIOMECH ENG-T ASME, V139, DOI 10.1115/1.4036146; Bilston LE, 1997, BIORHEOLOGY, V34, P377, DOI 10.1016/S0006-355X(98)00022-5; Bilston LE, 2001, BIORHEOLOGY, V38, P335; Brands D W, 2000, Stapp Car Crash J, V44, P249; Chatelin S, 2010, BIORHEOLOGY, V47, P255, DOI 10.3233/BIR-2010-0576; Clayton EH, 2011, PHYS MED BIOL, V56, P2391, DOI 10.1088/0031-9155/56/8/005; Clayton EH, 2012, J R SOC INTERFACE, V9, P2899, DOI 10.1098/rsif.2012.0325; Feng Y, 2013, J BIOMECH, V46, P863, DOI 10.1016/j.jbiomech.2012.12.024; Feng Y, 2013, J MECH BEHAV BIOMED, V23, P117, DOI 10.1016/j.jmbbm.2013.04.007; Gefen A, 2004, J BIOMECH, V37, P1339, DOI 10.1016/j.jbiomech.2003.12.032; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Holbourn AHS, 1943, LANCET, V2, P438; Hrapko M, 2006, BIORHEOLOGY, V43, P623; Hrapko M, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2907746; Johnson CL, 2016, HUM BRAIN MAPP, V37, P4221, DOI 10.1002/hbm.23314; Johnson CL, 2013, MAGN RESON MED, V70, P404, DOI 10.1002/mrm.24473; Klatt D, 2007, PHYS MED BIOL, V52, P7281, DOI 10.1088/0031-9155/52/24/006; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Manduca A, 2001, MED IMAGE ANAL, V5, P237, DOI 10.1016/S1361-8415(00)00039-6; Miller K, 2000, J BIOMECH, V33, P1369, DOI 10.1016/S0021-9290(00)00120-2; MUTHUPILLAI R, 1995, SCIENCE, V269, P1854, DOI 10.1126/science.7569924; Nicolle Stephane, 2004, Stapp Car Crash J, V48, P239; Okamoto RJ, 2011, PHYS MED BIOL, V56, P6379, DOI 10.1088/0031-9155/56/19/014; OMMAYA A K, 1968, Journal of Biomechanics, V1, P127, DOI 10.1016/0021-9290(68)90015-8; Papazoglou S, 2008, PHYS MED BIOL, V53, P3147, DOI 10.1088/0031-9155/53/12/005; Rashid B, 2012, J MECH BEHAV BIOMED, V10, P23, DOI 10.1016/j.jmbbm.2012.01.022; Riek K, 2011, J BIOMECH, V44, P1380, DOI 10.1016/j.jbiomech.2010.12.031; Sack I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023451; Sack I, 2009, NEUROIMAGE, V46, P652, DOI 10.1016/j.neuroimage.2009.02.040; Sack I, 2009, MAGN RESON MED, V61, P668, DOI 10.1002/mrm.21878; Schmidt JL, 2016, J BIOMECH, V49, P1042, DOI 10.1016/j.jbiomech.2016.02.018; Schregel K, 2012, P NATL ACAD SCI USA, V109, P6650, DOI 10.1073/pnas.1200151109; Shen F, 2006, J BIOMECH ENG-T ASME, V128, P797, DOI 10.1115/1.2264393; Sierra H, 2015, J INVEST DERMATOL, V135, P612, DOI 10.1038/jid.2014.371; Sinkus R, 2005, MAGN RESON IMAGING, V23, P159, DOI 10.1016/j.mri.2004.11.060; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Thibault KL, 1998, J BIOMECH, V31, P1119, DOI 10.1016/S0021-9290(98)00122-5; Tweten DJ, 2015, J BIOMECH, V48, P4002, DOI 10.1016/j.jbiomech.2015.09.009; van Dommelen JAW, 2010, J MECH BEHAV BIOMED, V3, P158, DOI 10.1016/j.jmbbm.2009.09.001; Vappou J, 2008, J BIOMECH, V41, P2954, DOI 10.1016/j.jbiomech.2008.07.034; Vappou J, 2007, MAGN RESON MATER PHY, V20, P273, DOI 10.1007/s10334-007-0098-7	45	18	18	0	12	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0021-9290	1873-2380		J BIOMECH	J. Biomech.	MAR 1	2018	69						10	18		10.1016/j.jbiomech.2018.01.016			9	Biophysics; Engineering, Biomedical	Biophysics; Engineering	FX6WZ	WOS:000426229300002	29395225	Green Accepted, Bronze			2021-06-18	
J	Heimesaat, MM; Giladi, E; Kuhl, AA; Bereswill, S; Gozes, I				Heimesaat, Markus M.; Giladi, Eliezer; Kuehl, Anja A.; Bereswill, Stefan; Gozes, Illana			The octapetide NAP alleviates intestinal and extra-intestinal anti-inflammatory sequelae of acute experimental colitis	PEPTIDES			English	Article						NAP; Activity-dependent neuroprotective protein (ADNP); Acute colitis; Anti-inflammatory effects; Immunomodulatory properties; Bifidobacteria; Gut-brain axis	DEPENDENT NEUROPROTECTIVE PROTEIN; INFLAMMATORY-BOWEL-DISEASE; CAMPYLOBACTER-JEJUNI INFECTION; CLOSED-HEAD INJURY; TOXOPLASMA-GONDII; PEPTIDE; MICE; MODEL; MICROBIOTA; IMMUNOPATHOLOGY	The octapeptide NAP has been shown to exert neuroprotective properties and reduce neuro-inflammatory responses. The aim of the present study was to investigate if NAP provides anti-inflammatory effects in acute murine colitis. To address this, C57BL/6 j mice were challenged with 3.5% dextran sulfate sodium from day 0 until day 6 to induce colitis, either treated intraperitoneally with NAP or placebo (NaCl 0.9%) from day 1 until day 6 post-induction (p.i.) and subjected to in depth macroscopic, microscopic and immunological evaluations. Whereas NAP application did not alleviate macroscopic (i.e. clinical) sequelae of colitis, lower numbers of apoptotic, but higher counts of proliferating/regenerating colonic epithelial cells could be observed in NAP as compared to placebo treated mice at day 7 p.i. Furthermore, lower numbers of adaptive immune cells such as T lymphocytes and regulatory T cells were abundant in the colonic mucosa and lamina propria upon NAP versus placebo treatment that were accompanied by less colonic secretion of pro-inflammatory mediators including IFN-gamma and nitric oxide at day 7 p.i. In mesenteric lymph nodes, pro-inflammatory IFN-gamma, TNF and IL-6 concentrations were increased in placebo, but not NAP treated mice at day 7 p.i., whereas interestingly, elevated anti-inflammatory IL-10 levels could be observed in NAP treated mice only. The assessed anti-inflammatory properties of NAP were not restricted to the intestinal tract, given that in extra-intestinal compartments such as the kidneys, IFN-gamma levels increased in placebo, but not NAP treated mice upon colitis induction. NAP induced effects were accompanied by distinct changes in intestinal microbiota composition, given that colonic luminal loads of bifidobacteria, regarded as anti-inflammatory, "health-promoting" commensal species, were two orders of magnitude higher in NAP as compared to placebo treated mice and even naive controls. In conclusion, NAP alleviates intestinal and extra-intestinal pro-inflammatory sequelae of acute experimental colitis and may provide novel treatment options of intestinal inflammatory diseases in humans.	[Heimesaat, Markus M.; Bereswill, Stefan] Humboldt Univ, Freie Univ Berlin, Charite Univ Med Berlin, Dept Microbiol & Hyg, Berlin, Germany; [Heimesaat, Markus M.; Bereswill, Stefan] Berlin Inst Hlth, Berlin, Germany; [Giladi, Eliezer; Gozes, Illana] Tel Aviv Univ, Sackler Sch Med, Dept Human Mol Genet & Biochem, Tel Aviv, Israel; [Kuehl, Anja A.] Humboldt Univ, Freie Univ Berlin, Charite Univ Med Berlin, Dept Med Gastroenterol Infect Dis & Rheumatol 1,R, Berlin, Germany	Heimesaat, MM (corresponding author), Charite Univ Med Berlin, CC5, Dept Microbiol & Hyg, Campus Benjamin Franklin,FEM,Garystr 5, D-14195 Berlin, Germany.	markus.heimesaat@charite.de		Heimesaat, Markus/0000-0001-6399-651X; Kuhl, Anja/0000-0003-2293-5387	German Research Foundation (DFG)German Research Foundation (DFG) [SFB633]; German Federal Ministeries of Education and Research (BMBF) [PAC-Campy 01KI1725D]	This work was supported by grants from the German Research Foundation (DFG) to SB (SFB633, TP A7), AAK (SFB633, TP Z1), MMH (SFB633, TP B6) and from the German Federal Ministeries of Education and Research (BMBF) to SB and MMH (PAC-Campy 01KI1725D).	Alutis ME, 2015, EUR J MICROBIOL IMMU, V5, P256, DOI 10.1556/1886.2015.00033; ALUTIS ME, 2015, EUR J MICROBIOL IMMU, V5, P3; Ashur-Fabian O, 2003, PEPTIDES, V24, P1413, DOI 10.1016/j.peptides.2003.08.005; BASSAN M, 1999, PUBMED; BASSET C, 2002, PUBMED; BENIADANI L, 2001, PUBMED; BERESWILL S, 1921, PUBMED, DOI DOI 10.1186/1757-4749-6-19; BERESWILL S, 2011, PUBMED, DOI DOI 10.1371/J0URNAL.P0NE.0020953; BERESWILL S, 1942, PUBMED, DOI DOI 10.1371/J0URNAL.P0NE.0015099; BRAITCH M, 1959, PUBMED, DOI DOI 10.1159/000258695; BRYAN NS, 2007, PUBMED, DOI DOI 10.1016/J.FREERADBI0MED.2007.04.026; Chassaing B., 2014, PUBMED, V104; DIVINSKI I, 1974, PUBMED, DOI DOI 10.1074/JBC.M403197200; EKMEKCIU I, 1953, PUBMED, DOI DOI 10.1186/S13099-017-0168-Y; Ekmekciu I, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00167; Ekmekciu I, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00397; ERBEN U, 2014, PUBMED; ERRIDGE C, 1936, PUBMED, DOI DOI 10.1371/J0URNAL.P0NE.0009125; Fiebiger U, 2016, EUR J MICROBIOL IMMU, V6, P253, DOI 10.1556/1886.2016.00036; Gozes I, 2004, J ALZHEIMERS DIS, V6, pS37; Gozes Illana, 2005, Current Alzheimer Research, V2, P149, DOI 10.2174/1567205053585873; Greggio S, 2011, NEUROBIOL DIS, V44, P152, DOI 10.1016/j.nbd.2011.06.018; Haag L.M., 2012, PUBMED, V7; Haag L.M., 2012, PUBMED, V7, DOI DOI 10.1002/0471142735.IM1525S104; HAAG LM, 2012, PUBMED, DOI DOI 10.1371/J0URNAL.P0NE.0035988; HAAG LM, 1961, PUBMED, DOI DOI 10.1371/J0URNAL.P0NE.0040761; Heimesaat M.M., 2012, PUBMED, V7; Heimesaat MM, 2015, EUR J MICROBIOL IMMU, V5, P210, DOI 10.1556/1886.2015.00025; Heimesaat MM, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00077; Heimesaat MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040758; Heimesaat MM, 2010, GUT, V59, P1079, DOI 10.1136/gut.2009.197434; HEIMESAAT MM, 1985, PUBMED; HEIMESAAT MM, 1920, PUBMED, DOI DOI 10.1371/J0URNAL.P0NE.0105120; HEIMESAAT MM, 2007, PUBMED, DOI DOI 10.1371/J0URNAL.P0NE.0000662; HEIMESAAT MM, 2006, PUBMED, DOI DOI 10.1136/GUT.2006.104497; Herrlinger KR, 2001, ALIMENT PHARM THER, V15, P363, DOI 10.1046/j.1365-2036.2001.00940.x; Idan-Feldman A, 2011, NEUROBIOL DIS, V44, P327, DOI 10.1016/j.nbd.2011.06.020; IDANFELDMAN A, 2012, PUBMED, DOI DOI 10.1155/2012/493670; IVASHKOPACHIMA Y, 2016, PUBMED, DOI DOI 10.1038/MP.2016.255; Klijn A, 2005, FEMS MICROBIOL REV, V29, P491, DOI 10.1016/j.femsre.2005.04.010; KREISEL W, 1996, PUBMED; Leker RR, 2002, STROKE, V33, P1085, DOI 10.1161/01.STR.0000014207.05597.D7; MUNOZ M, 2010, PUBMED, DOI DOI 10.1111/J.1600-065X.2010.00992.X; Munoz M, 2009, J EXP MED, V206, P3047, DOI 10.1084/jem.20090900; Oz S, 2014, MOL PSYCHIATR, V19, P1115, DOI 10.1038/mp.2014.97; PODOLSKY D, 2002, NEW ENGL J MED, V347, P6; POKUSAEVA K, 1985, PUBMED, DOI DOI 10.1111/NM0.12904; PUBMEDPMID JPET, 1998, PUBMED; PUBMEDPMID JPET, 1971, PUBMED; PUBMEDPMID JPET, 2001, PUBMED, V28; PUBMEDPMID JPET, 1931, PUBMED; PUBMEDPMID JPET, 2009, PUBMED; QUINTANA FJ, 1969, PUBMED, DOI DOI 10.1196/ANNALS.1317.069; RANGANATHAN P, 2012, PUBMED, DOI DOI 10.1152/AJPRENAL.00702.2012; RAUSCH S, 1952, PUBMED, DOI DOI 10.1371/J0URNAL.P0NE.0074026; Rotstein M, 2006, J PHARMACOL EXP THER, V319, P332, DOI 10.1124/jpet.106.106898; SARTOR RB, 2010, PUBMED, DOI DOI 10.1053/J.GASTR0.2010.10.036; SARTOR RB, 2005, PUBMED, DOI DOI 10.1073/PNAS.0809363105; SARTOR RB, 2007, PUBMED, DOI DOI 10.1053/J.GASTR0.2007.11.059; SARTOR RB, 1995, PUBMED; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; SIEGMUND B, 2001, PUBMED; SOKOLOWSKA P, 2010, PUBMED, DOI DOI 10.1016/J.NEUR0SCIENCE.2010.10.074; STROBER W, 2016, PUBMED, DOI DOI 10.1146/ANNUREV.IMMUN0L.20.100301.064816; THOENEREINEKE C, 2006, PUBMED, DOI DOI 10.1371/J0URNAL.P0NE.0113406; TOJO R, 1966, PUBMED, DOI DOI 10.3748/WJG.V20.I41.15163; Zaltzman R, 2005, PEPTIDES, V26, P1520, DOI 10.1016/j.peptides.2005.03.014; ZAMOSTIANO R, 2000, PUBMED, DOI DOI 10.1074/JBC.M007416200; ZEMLYAK I, 2000, PUBMED, V1, P39; Zucker S, 2000, ONCOGENE, V19, P6642, DOI 10.1038/sj.onc.1204097	70	18	18	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0196-9781	1873-5169		PEPTIDES	Peptides	MAR	2018	101						1	9		10.1016/j.peptides.2017.12.023			9	Biochemistry & Molecular Biology; Endocrinology & Metabolism; Pharmacology & Pharmacy	Biochemistry & Molecular Biology; Endocrinology & Metabolism; Pharmacology & Pharmacy	FX9ST	WOS:000426446000001	29288684	Other Gold			2021-06-18	
J	Ma, MW; Wang, J; Dhandapani, KM; Brann, DW				Ma, Merry W.; Wang, Jing; Dhandapani, Krishnan M.; Brann, Darrell W.			Deletion of NADPH oxidase 4 reduces severity of traumatic brain injury	FREE RADICAL BIOLOGY AND MEDICINE			English	Article						NADPH oxidase; NOX4; Traumatic brain injury; TBI; Oxidative stress	CONTROLLED CORTICAL IMPACT; OXIDATIVE STRESS; NOX FAMILY; ANTIOXIDANT THERAPIES; CLINICAL-TRIALS; NOX/DUOX FAMILY; NEURODEGENERATION; ACTIVATION; EXPRESSION; NEUROPROTECTION	Traumatic brain injury (TBI) contributes to over 30% of injury-related deaths and is a major cause of disability without effective clinical therapies. Oxidative stress contributes to neurodegeneration, neuroinflammation, and neuronal death to amplify the primary injury after TBI. NADPH oxidase (NOX) is a major source of reactive oxygen species following brain injury. Our current study addresses the functional role of the NOX4 isoform in the damaged cortex following TBI. Adult male C57BL/6 J and NOX4(-/-) mice received a controlled cortical impact and lesion size, NOX4 expression, oxidative stress, neurodegeneration, and cell death were assessed in the injured cerebral cortex. The results revealed that NOX4 mRNA and protein expression were significantly upregulated at 1-7 days post-TBI in the injured cerebral cortex. Expression of the oxidative stress markers, 8-OHdG, 4-HNE, and nitrotyrosine was upregulated at 2 and 4 days post-TBI in the WT injured cerebral cortex, and nitrotyrosine primarily colocalized with neurons. In the NOX4(-/-) mice, expression of these oxidative stress markers, 8-OHdG, 4-HNE, and nitrotyrosine were significantly attenuated at both timepoints. In addition, examination of NOX4(-/-) mice revealed a reduced number of apoptotic (TUNEL+) and degenerating (FJB(+)) cells in the perilesional cortex after TBI, as well as a smaller lesion size compared with the WT group. The results of this study implicate a functional role for NOX4 in TBI induced oxidative damage and neurodegeneration and raise the possibility that targeting NOX4 may have therapeutic efficacy in TBI.	[Ma, Merry W.; Wang, Jing; Dhandapani, Krishnan M.; Brann, Darrell W.] Charlie Norwood VA Med Ctr, One Freedom Way, Augusta, GA 30904 USA; [Ma, Merry W.; Wang, Jing; Brann, Darrell W.] Augusta Univ, Med Coll Georgia, Dept Neurosci & Regenerat Med, Augusta, GA 30912 USA; [Dhandapani, Krishnan M.] Augusta Univ, Med Coll Georgia, Dept Neurosurg, Augusta, GA 30912 USA	Brann, DW (corresponding author), Augusta Univ, Dept Neurosci & Regenerat Med, 1120 15th St,CA-4004, Augusta, GA 30912 USA.	dbrann@augusta.edu		Dhandapani, Krishnan/0000-0001-7044-1117	VA Merit Review Award from the United States Department of Veteran's Affairs, Biomedical Laboratory Research and Development ServiceUS Department of Veterans Affairs [5l101BX001117]	The research presented in this article was conducted in partial fulfillment of the Ph.D. degree requirements set forth for Merry W. Ma and was supported by a VA Merit Review Award (5l101BX001117) from the United States Department of Veteran's Affairs, Biomedical Laboratory Research and Development Service.	Altenhofer S, 2012, CELL MOL LIFE SCI, V69, P2327, DOI 10.1007/s00018-012-1010-9; Angeloni C, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/370312; Bains M, 2012, BBA-MOL BASIS DIS, V1822, P675, DOI 10.1016/j.bbadis.2011.10.017; Barrett JP, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0843-4; Beauchamp K, 2008, MOL MED, V14, P731, DOI 10.2119/2008-00050.Beauchamp; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Birben E, 2012, WORLD ALLERGY ORGAN, V5, P9, DOI 10.1097/WOX.0b013e3182439613; Boque M C, 2000, Semin Respir Infect, V15, P280; BRIDGES RA, 1959, AMA J DIS CHILD, V97, P387, DOI 10.1001/archpedi.1959.02070010389004; Brown DI, 2009, FREE RADICAL BIO MED, V47, P1239, DOI 10.1016/j.freeradbiomed.2009.07.023; Buetler TM, 2004, NEWS PHYSIOL SCI, V19, P120, DOI 10.1152/nips.01514.2003; Cachat J, 2015, CLIN SCI, V128, P635, DOI 10.1042/CS20140635; Choi BY, 2012, BRAIN RES, V1481, P49, DOI 10.1016/j.brainres.2012.08.032; Cooney SJ, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-155; Cornelius C, 2013, ANTIOXID REDOX SIGN, V19, P836, DOI 10.1089/ars.2012.4981; Dohi K, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-41; Donat CK, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00208; Doppenberg EMR, 2004, J NEUROSURG ANESTH, V16, P87, DOI 10.1097/00008506-200401000-00019; Dziedzic T, 2004, CRIT CARE, V8, P266, DOI 10.1186/cc2828; Faden AI, 2015, NEUROTHERAPEUTICS, V12, P143, DOI 10.1007/s13311-014-0319-5; Finfer SR, 2001, RESUSCITATION, V48, P77, DOI 10.1016/S0300-9572(00)00321-X; Gaetz M, 2004, CLIN NEUROPHYSIOL, V115, P4, DOI 10.1016/S1388-2457(03)00258-X; Gao XA, 2011, J NEUROPATH EXP NEUR, V70, P183, DOI 10.1097/NEN.0b013e31820c6878; Geiszt M, 2004, J BIOL CHEM, V279, P51715, DOI 10.1074/jbc.R400024200; Hall ED, 2008, J NEUROTRAUM, V25, P235, DOI 10.1089/neu.2007.0383; Hall ED, 2012, EXP NEUROL, V238, P176, DOI 10.1016/j.expneurol.2012.08.024; Hall ED, 2010, NEUROTHERAPEUTICS, V7, P51, DOI 10.1016/j.nurt.2009.10.021; Harrison-Felix C, 2006, J HEAD TRAUMA REHAB, V21, P22, DOI 10.1097/00001199-200601000-00003; Harting MT, 2008, SURGERY, V144, P803, DOI 10.1016/j.surg.2008.05.017; Hoover RC, 2004, J NEUROTRAUM, V21, P501, DOI 10.1089/089771504774129847; Huang J, 2009, P NATL ACAD SCI USA, V106, P6226, DOI 10.1073/pnas.0811045106; Inatomi Y, 2006, INTERNAL MED, V45, P253, DOI 10.2169/internalmedicine.45.1423; Jin WN, 2017, J CEREBR BLOOD F MET, V37, P2224, DOI 10.1177/0271678X17694185; Kim GH, 2015, EXP NEUROBIOL, V24, P325, DOI 10.5607/en.2015.24.4.325; Kleinschnitz C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000479; Kourbeti IS, 2012, CLIN MICROBIOL INFEC, V18, P359, DOI 10.1111/j.1469-0691.2011.03625.x; Kumar A, 2016, BRAIN BEHAV IMMUN, V58, P291, DOI 10.1016/j.bbi.2016.07.158; Laird MD, 2010, J NEUROCHEM, V113, P637, DOI 10.1111/j.1471-4159.2010.06630.x; Leto TL, 2006, ANTIOXID REDOX SIGN, V8, P1549, DOI 10.1089/ars.2006.8.1549; Li Z, 2015, NEUROL SCI, V36, P61, DOI 10.1007/s10072-014-1909-z; Liu Z., 2016, J NEUROINTERVENTIONA; Loane DJ, 2014, J NEUROPATH EXP NEUR, V73, P14, DOI 10.1097/NEN.0000000000000021; Lotocki G, 2009, J NEUROTRAUM, V26, P1123, DOI 10.1089/neu.2008.0802; Lu XY, 2014, NEUROCHEM INT, V69, P14, DOI 10.1016/j.neuint.2014.02.006; Lucke-Wold B.P., 2015, TRANSL RES, V166; Ma MW, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/6057609; Ma MW, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0150-7; McCord JM, 2005, BIOMED PHARMACOTHER, V59, P139, DOI 10.1016/j.biopha.2005.03.005; Miller DM, 2014, J NEUROTRAUM, V31, P1194, DOI 10.1089/neu.2013.3218; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Nathoo N, 2004, J NEUROSURG, V101, P233, DOI 10.3171/jns.2004.101.2.0233; NELSON SK, 1994, FREE RADICAL BIO MED, V16, P195, DOI 10.1016/0891-5849(94)90143-0; Nizamutdinov D, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7010011; Ferreira APO, 2013, NEUROCHEM INT, V63, P583, DOI 10.1016/j.neuint.2013.09.012; Pendyala S, 2010, RESP PHYSIOL NEUROBI, V174, P265, DOI 10.1016/j.resp.2010.09.016; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; Rada Balazs, 2008, V15, P164, DOI 10.1159/000136357; Radi R, 2013, ACCOUNTS CHEM RES, V46, P550, DOI 10.1021/ar300234c; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Russo MV, 2016, SCIENCE, V353, P783, DOI 10.1126/science.aaf6260; Schiavone S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09202-4; Scott P, 1996, STROKE, V27, P1453; Segal BH, 2000, MEDICINE, V79, P170, DOI 10.1097/00005792-200005000-00004; Serrander L, 2007, BIOCHEM J, V406, P105, DOI 10.1042/BJ20061903; Shirley R, 2014, ANTIOXIDANTS-BASEL, V3, P472, DOI 10.3390/antiox3030472; Shuaib A, 2007, NEW ENGL J MED, V357, P562, DOI 10.1056/NEJMoa070240; Sirokmany G, 2016, TRENDS PHARMACOL SCI, V37, P318, DOI 10.1016/j.tips.2016.01.006; Thompson HJ, 2006, EUR J NEUROSCI, V24, P3063, DOI 10.1111/j.1460-9568.2006.05197.x; Toklu H.Z., 2015, BRAIN NEUROTRAUMA MO; Uzan M, 2006, ACTA NEUROCHIR, V148, P1157, DOI 10.1007/s00701-006-0887-1; von Leden RE, 2017, J NEUROTRAUM, V34, P755, DOI 10.1089/neu.2016.4486; Wakade C, 2010, J NEUROSURG, V113, P1195, DOI 10.3171/2010.3.JNS091212; Wang J, 2017, FREE RADICAL BIO MED, V113, P119, DOI 10.1016/j.freeradbiomed.2017.09.017; Wang RM, 2009, BRAIN RES, V1255, P32, DOI 10.1016/j.brainres.2008.12.011; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Whitaker-Lea WA, 2017, PHYS MED REH CLIN N, V28, P227, DOI 10.1016/j.pmr.2016.12.002; Yamaguchi T, 1998, STROKE, V29, P12, DOI 10.1161/01.STR.29.1.12; Zhang QG, 2008, J NEUROSCI, V28, P8430, DOI 10.1523/JNEUROSCI.2752-08.2008; Zhang QG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034504	80	18	18	1	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0891-5849	1873-4596		FREE RADICAL BIO MED	Free Radic. Biol. Med.	MAR	2018	117						66	75		10.1016/j.freeradbiomed.2018.01.031			10	Biochemistry & Molecular Biology; Endocrinology & Metabolism	Biochemistry & Molecular Biology; Endocrinology & Metabolism	FZ2PA	WOS:000427420600008	29391196	Other Gold			2021-06-18	
J	Mauri, E; Sacchetti, A; Vicario, N; Peruzzotti-Jametti, L; Rossi, F; Pluchino, S				Mauri, Emanuele; Sacchetti, Alessandro; Vicario, Nunzio; Peruzzotti-Jametti, Luca; Rossi, Filippo; Pluchino, Stefano			Evaluation of RGD functionalization in hybrid hydrogels as 3D neural stem cell culture systems	BIOMATERIALS SCIENCE			English	Article							SPINAL-CORD-INJURY; TISSUE ENGINEERING APPLICATIONS; CENTRAL-NERVOUS-SYSTEM; DRUG-DELIVERY; IN-VITRO; CLICK CHEMISTRY; BIOMATERIALS; REGENERATION; THERAPIES; DIFFERENTIATION	The use of neural stem cells (NSCs) in cell therapy has become a powerful tool used for the treatment of central nervous system diseases, including traumatic brain and spinal cord injuries. However, a significant drawback is related to the limited viability after transplantation in situ. The design of three-dimensional (3D) scaffolds that are capable of resembling the architecture and physico-chemical features of an extracellular environment could be a suitable approach to improve cell survival and preserve their cellular active phase over time. In this study, we investigated NSC adhesion and proliferation in hydrogel systems. In particular, we evaluated the effect of RGD binding domains on cell fate within the polymeric scaffold. The introduction of a tripeptide via hydrogel chemical functionalization improved the percentage of proliferating cells until 8 days after seeding when compared to the unmodified scaffold. The beneficial effects of this 3D culture system was further evident when compared to a NSC monolayer (2D) culture, resulting in an approximately 40% increase in cells in the active phases at 4 and 8 days, and maintained a difference of 25% until 21 days after seeding.	[Mauri, Emanuele; Sacchetti, Alessandro; Rossi, Filippo] Politecn Milan, Dept Chem Mat & Chem Engn Giulio Natta, Via Mancinelli 7, I-20131 Milan, Italy; [Vicario, Nunzio; Peruzzotti-Jametti, Luca; Pluchino, Stefano] Univ Cambridge, Wellcome Trust Med Res Council Stem Cell Inst, Dept Clin Neurosci, Div Stem Cell Neurobiol, Clifford Allbutt Bldg,Cambridge Biosci Campus, Cambridge CB2 0HA, England; [Vicario, Nunzio; Peruzzotti-Jametti, Luca; Pluchino, Stefano] Univ Cambridge, NIHR Biomed Res Ctr, Clifford Allbutt Bldg,Cambridge Biosci Campus, Cambridge CB2 0HA, England	Mauri, E (corresponding author), Politecn Milan, Dept Chem Mat & Chem Engn Giulio Natta, Via Mancinelli 7, I-20131 Milan, Italy.; Pluchino, S (corresponding author), Univ Cambridge, Wellcome Trust Med Res Council Stem Cell Inst, Dept Clin Neurosci, Div Stem Cell Neurobiol, Clifford Allbutt Bldg,Cambridge Biosci Campus, Cambridge CB2 0HA, England.; Pluchino, S (corresponding author), Univ Cambridge, NIHR Biomed Res Ctr, Clifford Allbutt Bldg,Cambridge Biosci Campus, Cambridge CB2 0HA, England.	emanuele.mauri@polimi.it; spp24@cam.ac.uk	Vicario, Nunzio/AAJ-4917-2020; Pluchino, Stefano/AAE-9037-2019; Rossi, Filippo/D-3679-2013; Mauri, Emanuele/B-7674-2018	Vicario, Nunzio/0000-0001-5934-3962; Pluchino, Stefano/0000-0002-6267-9472; Rossi, Filippo/0000-0003-2665-120X; Peruzzotti-Jametti, Luca/0000-0002-9396-5607; Mauri, Emanuele/0000-0002-6203-8405; sacchetti, alessandro/0000-0002-4830-0825	Wellcome TrustWellcome TrustEuropean Commission [RRZA/057 RG79423]; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission	The authors would like to thank Dr Simonetta Papa, Dr Pietro Veglianese and Stefano Rimondo for their fruitful discussions. This work was supported by a core support grant from the Wellcome Trust and Medical Research Council to the Wellcome Trust - MRC Cambridge Stem Cell Institute. LPJ was supported by a research training fellowship from the Wellcome Trust (RRZA/057 RG79423).	Assuncao-Silva RC, 2015, STEM CELLS INT, V2015, DOI 10.1155/2015/948040; Beria L, 2014, BIOMATER SCI-UK, V2, P67, DOI 10.1039/c3bm60171d; Bongio M, 2011, Eur Cell Mater, V22, P359; Caron I, 2016, BIOMATERIALS, V75, P135, DOI 10.1016/j.biomaterials.2015.10.024; Cha C, 2012, ACS NANO, V6, P9353, DOI 10.1021/nn304773b; Cossetti C, 2012, CELL TISSUE RES, V349, P321, DOI 10.1007/s00441-012-1341-8; Cusimano M, 2012, BRAIN, V135, P447, DOI 10.1093/brain/awr339; de Luca AC, 2016, J TISSUE ENG REGEN M, V10, P647, DOI 10.1002/term.1804; DiNunzio JC, 2008, DRUG DEV IND PHARM, V34, P1141, DOI [10.1080/03639040802020536, 10.1080/03639040802020536 ]; Edmondson R, 2014, ASSAY DRUG DEV TECHN, V12, P207, DOI 10.1089/adt.2014.573; Elliott Donaghue I, 2015, BIOMATER SCI-UK, V3, P65, DOI 10.1039/c4bm00311j; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Follenzi A, 2000, NAT GENET, V25, P217, DOI 10.1038/76095; Giusto E, 2014, EXP NEUROL, V260, P19, DOI 10.1016/j.expneurol.2013.03.009; Gros T, 2010, BIOMATERIALS, V31, P6719, DOI 10.1016/j.biomaterials.2010.04.035; Hadden WJ, 2017, P NATL ACAD SCI USA, V114, P5647, DOI 10.1073/pnas.1618239114; Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0; Horner PJ, 2000, NATURE, V407, P963, DOI 10.1038/35039559; Kappe CO, 2004, ANGEW CHEM INT EDIT, V43, P6250, DOI 10.1002/anie.200400655; Knight E, 2015, J ANAT, V227, P746, DOI 10.1111/joa.12257; Knowlton S, 2016, BIOMATER SCI-UK, V4, P768, DOI 10.1039/c5bm00324e; Lagunas A, 2012, NANOMED-NANOTECHNOL, V8, P432, DOI 10.1016/j.nano.2011.08.001; Li HB, 2010, ANALYST, V135, P1360, DOI 10.1039/c0an00023j; Li L, 2016, REGEN BIOMATER, V3, P99, DOI 10.1093/rb/rbw007; Li XW, 2012, PROG POLYM SCI, V37, P1105, DOI 10.1016/j.progpolymsci.2012.02.004; Lu P, 2003, EXP NEUROL, V181, P115, DOI 10.1016/S0014-4886(03)00037-2; Ma N, 2015, DRUG DES DEV THER, V9, P1585, DOI 10.2147/DDDT.S56038; Martino G, 2011, PHYSIOL REV, V91, P1281, DOI 10.1152/physrev.00032.2010; Mauri E, 2017, RSC ADV, V7, P30345, DOI 10.1039/c7ra04584k; Mauri E, 2016, MAT SCI ENG C-MATER, V61, P851, DOI 10.1016/j.msec.2016.01.022; Mekhail M, 2015, BIOMATER SCI-UK, V3, P279, DOI 10.1039/c4bm00215f; Muskovich M, 2012, ADV HEALTHC MATER, V1, P248, DOI 10.1002/adhm.201200071; Naghdi P, 2016, J TISSUE ENG REGEN M, V10, P199, DOI 10.1002/term.1958; Pego AP, 2012, J CELL MOL MED, V16, P2564, DOI 10.1111/j.1582-4934.2012.01603.x; Perale G, 2012, J CONTROL RELEASE, V159, P271, DOI 10.1016/j.jconrel.2011.12.025; Pluchino S, 2005, BRAIN RES REV, V48, P211, DOI 10.1016/j.brainresrev.2004.12.011; Pluchino S, 2003, NATURE, V422, P688, DOI 10.1038/nature01552; Rossi F, 2013, COLLOID SURFACE B, V108, P169, DOI 10.1016/j.colsurfb.2013.02.046; Rossi F, 2012, J APPL POLYM SCI, V123, P2211, DOI 10.1002/app.34731; Sacchetti A, 2014, TETRAHEDRON LETT, V55, P6817, DOI 10.1016/j.tetlet.2014.10.069; Sandner B, 2015, STEM CELLS BIOL REG, P155, DOI 10.1007/978-1-4939-1908-6_9; Santoro M, 2011, J PHYS CHEM B, V115, P2503, DOI 10.1021/jp1111394; Tabata Y, 2009, J R SOC INTERFACE, V6, pS311, DOI 10.1098/rsif.2008.0448.focus; Taddei M, 2014, J MED CHEM, V57, P2258, DOI 10.1021/jm401536b; Tsou YH, 2016, BIOACT MATER, V1, P39, DOI 10.1016/j.bioactmat.2016.05.001; Ullah F, 2015, MAT SCI ENG C-MATER, V57, P414, DOI 10.1016/j.msec.2015.07.053; Vanderburgh J, 2017, ANN BIOMED ENG, V45, P164, DOI 10.1007/s10439-016-1640-4; Varoni E, 2012, CONNECT TISSUE RES, V53, P548, DOI 10.3109/03008207.2012.712583; Xu M, 2016, ACS NANO, V10, P3267, DOI 10.1021/acsnano.6b00539; Yang RR, 2017, RSC ADV, V7, P41098, DOI 10.1039/c7ra06614g; Zako T, 2014, BIOMATER SCI-UK, V2, P951, DOI 10.1039/c4bm00026a; Zhang YS, 2017, SCIENCE, V356, DOI 10.1126/science.aaf3627; Zhu JM, 2009, BIOCONJUGATE CHEM, V20, P333, DOI 10.1021/bc800441v	53	18	19	1	34	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	2047-4830	2047-4849		BIOMATER SCI-UK	Biomater. Sci.	MAR 1	2018	6	3					501	510		10.1039/c7bm01056g			10	Materials Science, Biomaterials	Materials Science	FX9CE	WOS:000426392200005	29368775				2021-06-18	
J	Newell, EA; Todd, BP; Mahoney, J; Pieper, AA; Ferguson, PJ; Bassuk, AG				Newell, Elizabeth A.; Todd, Brittany P.; Mahoney, Jolonda; Pieper, Andrew A.; Ferguson, Polly J.; Bassuk, Alexander G.			Combined Blockade of Interleukin-1 alpha and -1 beta Signaling Protects Mice from Cognitive Dysfunction after Traumatic Brain Injury	ENEURO			English	Article						Inflammation; interleukin-1; traumatic brain injury	FLUID-PERCUSSION INJURY; RECEPTOR ANTAGONIST; NEURONAL INJURY; CEREBROSPINAL-FLUID; HEAD-INJURY; PHASE-II; IL-1-ALPHA; IL-1-BETA; NEUROINFLAMMATION; ANAKINRA	Diffuse activation of interleukin-1 inflammatory cytokine signaling after traumatic brain injury (TBI) elicits progressive neurodegeneration and neuropsychiatric dysfunction, and thus represents a potential opportunity for therapeutic intervention. Although interleukin (IL)-1 alpha and IL-1 beta both activate the common type 1 IL-1 receptor (IL-1RI), they manifest distinct injury-specific roles in some models of neurodegeneration. Despite its potential relevance to treating patients with TBI, however, the individual contributions of IL-1 alpha and IL-1 beta to TBI-pathology have not been previously investigated. To address this need, we applied genetic and pharmacologic approaches in mice to dissect the individual contributions of IL-1 alpha, IL-beta, and IL-1RI signaling to the pathophysiology of fluid percussion-mediated TBI, amodel of mixed focal and diffuse TBI. IL-1RI ablation conferred a greater protective effect on brain cytokine expression and cognitive function after TBI than did individual IL-1 alpha or IL-1 beta ablation. This protective effect was recapitulated by treatment with the drug anakinra, a recombinant naturally occurring IL-1RI antagonist. Our data thus suggest that broad targeting of IL-1RI signaling is more likely to reduce neuroinflammation and preserve cognitive function after TBI than are approaches that individually target IL-1 alpha or IL-1 beta signaling.	[Newell, Elizabeth A.; Todd, Brittany P.; Mahoney, Jolonda; Ferguson, Polly J.; Bassuk, Alexander G.] Univ Iowa, Dept Pediat, Carver Coll Med, Iowa City, IA 52242 USA; [Pieper, Andrew A.] Univ Iowa, Dept Psychiat, Carver Coll Med, Iowa City, IA 52242 USA; [Pieper, Andrew A.] Univ Iowa, Dept Neurol, Carver Coll Med, Iowa City, IA 52242 USA; [Pieper, Andrew A.] Univ Iowa, Comprehens Canc Ctr, Carver Coll Med,Dept Radiat Oncol, Dept Free Radical & Radiat,Biol Program, Iowa City, IA USA; [Pieper, Andrew A.] Univ Iowa, Carver Coll Med, Dept Vet Affairs, Iowa City, IA USA; [Pieper, Andrew A.] Univ Iowa, Pappajohn Biomed Inst, Iowa Neurosci Inst, Carver Coll Med, Iowa City, IA USA	Bassuk, AG (corresponding author), Univ Iowa, Dept Pediat, Hosp & Clin, 200 Hawkins Dr, Iowa City, IA 52242 USA.	alexander-bassuk@uiowa.edu		Newell, Elizabeth/0000-0002-1476-033X; Pieper, Andrew/0000-0001-6299-6577; Bassuk, Alexander/0000-0002-4067-2157	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [K12 HD027748, R01NS098590, 5R01AR059703]; Titan Neurology Research Fund; Brockman Medical Research Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K12HD027748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS) [R01AR059703] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS098590] Funding Source: NIH RePORTER	This work was supported by NIH grants K12 HD027748 (EAN), R01NS098590 (AGB), and 5R01AR059703 (AGB and PJF) and funds from an anonymous donor to the Mary Alice Smith Fund for Neuropsychiatry Research (AAP), the Titan Neurology Research Fund (AAP), and the Brockman Medical Research Foundation (AAP).	Alder J, 2011, JOVE-J VIS EXP, DOI 10.3791/3063; Allan SM, 2005, NAT REV IMMUNOL, V5, P629, DOI 10.1038/nri1664; Auron PE, 1998, CYTOKINE GROWTH F R, V9, P221, DOI 10.1016/S1359-6101(98)00018-5; Bastien D, 2015, J NEUROSCI, V35, P10715, DOI 10.1523/JNEUROSCI.0498-15.2015; Basu A, 2004, J NEUROSCI RES, V78, P151, DOI 10.1002/jnr.20266; Bertheloot D, 2017, CELL MOL IMMUNOL, V14, P43, DOI 10.1038/cmi.2016.34; Boutin H, 2001, J NEUROSCI, V21, P5528; Dapul HR, 2013, J NEUROTRAUM, V30, P382, DOI 10.1089/neu.2012.2536; DIETRICH WD, 1994, J NEUROTRAUM, V11, P289, DOI 10.1089/neu.1994.11.289; Emsley HCA, 2005, J NEUROL NEUROSUR PS, V76, P1366, DOI 10.1136/jnnp.2004.054882; FAN L, 1995, MOL BRAIN RES, V30, P125; Fenn AM, 2015, J NEUROTRAUM, V32, P127, DOI 10.1089/neu.2014.3514; FISHER CJ, 1994, JAMA-J AM MED ASSOC, V271, P1836, DOI 10.1001/jama.271.23.1836; Fleischmann RM, 2006, ANN RHEUM DIS, V65, P1006, DOI 10.1136/ard.2005.048371; Fox E, 2010, J NEUROIMMUNOL, V223, P138, DOI 10.1016/j.jneuroim.2010.03.022; Gadani SP, 2015, NEURON, V87, P47, DOI 10.1016/j.neuron.2015.05.019; Galea J, 2011, J CEREBR BLOOD F MET, V31, P439, DOI 10.1038/jcbfm.2010.103; Glaccum MB, 1997, J IMMUNOL, V159, P3364; Greenhalgh AD, 2010, BRIT J PHARMACOL, V160, P153, DOI 10.1111/j.1476-5381.2010.00684.x; GRIFFIN WST, 1994, NEUROSCI LETT, V176, P133, DOI 10.1016/0304-3940(94)90066-3; Gueorguieva I, 2008, BRIT J CLIN PHARMACO, V65, P317, DOI 10.1111/j.1365-2125.2007.03026.x; Helmy A, 2014, J CEREBR BLOOD F MET, V34, P845, DOI 10.1038/jcbfm.2014.23; Hicks R, 1996, ACTA NEUROPATHOL, V91, P236, DOI 10.1007/s004010050421; Horai R, 1998, J EXP MED, V187, P1463, DOI 10.1084/jem.187.9.1463; Hoshino S, 1996, BRAIN RES, V711, P73, DOI 10.1016/0006-8993(95)01329-6; Hutchinson PJ, 2007, J NEUROTRAUM, V24, P1545, DOI 10.1089/neu.2007.0295; Jin X, 2012, J SOFTWARE, V7, P6, DOI DOI 10.1371/J0URNAL.P0NE.0041892; Kelley BJ, 2006, EXP NEUROL, V198, P350, DOI 10.1016/j.expneurol.2005.12.017; Kinoshita K, 2002, NEUROSURGERY, V51, P195, DOI 10.1097/00006123-200207000-00027; Kumar A, 2016, BRAIN BEHAV IMMUN, V58, P291, DOI 10.1016/j.bbi.2016.07.158; Li R, 1998, AM J FOREN MED PATH, V19, P129, DOI 10.1097/00000433-199806000-00006; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Morales DM, 2005, NEUROSCIENCE, V136, P971, DOI 10.1016/j.neuroscience.2005.08.030; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Park E, 2007, EXP NEUROL, V204, P49, DOI 10.1016/j.expneurol.2006.09.012; Qian J, 2012, P NATL ACAD SCI USA, V109, P12189, DOI 10.1073/pnas.1205207109; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Rider P, 2011, J IMMUNOL, V187, P4835, DOI 10.4049/jimmunol.1102048; Schurman LD, 2017, NEUROSCI LETT, V653, P31, DOI 10.1016/j.neulet.2017.05.032; Simon DW, 2017, NAT REV NEUROL, V13, P171, DOI 10.1038/nrneurol.2017.13; Singh N, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-1; Singleton RH, 2004, J NEUROSCI, V24, P3543, DOI 10.1523/JNEUROSCI.5048-03.2004; Singleton RH, 2002, J NEUROSCI, V22, P791, DOI 10.1523/JNEUROSCI.22-03-00791.2002; Sinha SP, 2017, BRAIN BEHAV IMMUN, V61, P353, DOI 10.1016/j.bbi.2017.01.006; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Weber A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3105cm1	47	18	19	0	0	SOC NEUROSCIENCE	WASHINGTON	11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA		2373-2822		ENEURO	eNeuro	MAR-APR	2018	5	2							UNSP e0385-17.2018	10.1523/ENEURO.0385-17.2018			15	Neurosciences	Neurosciences & Neurology	GC8BE	WOS:000430017100003	29662944	DOAJ Gold, Green Published			2021-06-18	
J	Rabinowitz, AR; Hart, T; Whyte, J; Kim, J				Rabinowitz, Amanda R.; Hart, Tessa; Whyte, John; Kim, Junghoon			Neuropsychological Recovery Trajectories in Moderate to Severe Traumatic Brain Injury: Influence of Patient Characteristics and Diffuse Axonal Injury	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Brain injury; Neuropsychological tests; Cognition; Executive function; Verbal learning; Diffusion tensor imaging	WHITE-MATTER INTEGRITY; FOLLOW-UP; COGNITIVE FUNCTION; OUTCOME MEASURES; MILD; PREDICTORS; VARIABLES; MEMORY; ABNORMALITIES; RESERVE	Objectives: The goal of the present study was to elucidate the influence of demographic and neuropathological moderators on the longitudinal trajectory neuropsychological functions during the first year after moderate to severe traumatic brain injury (TBI). In addition to examining demographic moderators such as age and education, we included a measure of whole-brain diffuse axonal injury (DAI), and examined measures of processing speed (PS), executive function (EF), and verbal learning (VL) separately. Methods: Forty-six adults with moderate to severe TBI were examined at 3, 6, and 12 months post-injury. Participants underwent neuropsychological evaluation and neuroimaging including diffusion tensor imaging. Using linear mixed effects modeling, we examined longitudinal trajectories and moderating factors of cognitive outcomes separately for three domains: PS, VL, and EF. Results: VL and EF showed linear improvements, whereas PS exhibited a curvilinear trend characterized by initial improvements that plateaued or declined, depending on age. Age moderated the recovery trajectories of EF and PS. Education and DAI did not influence trajectory but were related to initial level of functioning for PS and EF in the case of DAI, and all three cognitive domains in the case of education. Conclusions: We found disparate recovery trajectories across cognitive domains. Younger age was associated with more favorable recovery of EF and PS. These findings have both clinical and theoretical implications. Future research with a larger sample followed over a longer time period is needed to further elucidate the factors that may influence cognitive change over the acute to chronic period after TBI.	[Rabinowitz, Amanda R.; Hart, Tessa; Whyte, John; Kim, Junghoon] Moss Rehabil Res Inst, 50 Township Line Rd, Elkins Pk, PA 19027 USA; [Rabinowitz, Amanda R.] CUNY City Coll, Sch Med, New York, NY 10031 USA	Rabinowitz, AR (corresponding author), Moss Rehabil Res Inst, 50 Township Line Rd, Elkins Pk, PA 19027 USA.	rabinowa@einstein.edu	Kim, Junghoon John/I-6702-2019	Kim, Junghoon John/0000-0001-5729-8993; Whyte, John/0000-0002-4381-1474	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01NS065980]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS065980] Funding Source: NIH RePORTER	This work was supported by the National Institutes of Health (R01NS065980; Principal Investigator, J.K.). The authors have no conflicts of interest to disclose. The authors thank JeffreyWare, M.D., for DTI image processing. We also thank Morgan Rohrbach, Sigrid Williamson, Grayce Selig, Riya Rajan, Tincy Philip, and Devon Kratchman for their contributions to participant recruitment and data collection.	Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Beglinger LJ, 2005, ARCH CLIN NEUROPSYCH, V20, P517, DOI 10.1016/j.acn.2004.12.003; Benton LA, 1994, CONTROLLED ORAL WORD; Bigler ED, 1996, NEUROPSYCHOLOGY, V10, P333, DOI 10.1037/0894-4105.10.3.333; Christensen BK, 2008, ARCH PHYS MED REHAB, V89, pS3, DOI 10.1016/j.apmr.2008.10.002; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1199, DOI 10.1016/j.apmr.2013.01.023; DAWSON DR, 1995, BRAIN INJURY, V9, P339, DOI 10.3109/02699059509005774; Delis D.C., 2001, DELIS KAPLAN EXECUTI; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Farbota KD, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00160; Green RE, 2008, ARCH PHYS MED REHAB, V89, pS16, DOI 10.1016/j.apmr.2008.09.551; Haberg AK, 2015, J NEUROSCI RES, V93, P1109, DOI 10.1002/jnr.23534; Hellawell DJ, 1999, BRAIN INJURY, V13, P489; Himanen L, 2006, NEUROLOGY, V66, P187, DOI 10.1212/01.wnl.0000194264.60150.d3; Hoofien D, 2002, BRAIN INJURY, V16, P9, DOI 10.1080/02699050110088227; HURVICH CM, 1989, BIOMETRIKA, V76, P297, DOI 10.2307/2336663; Jackson WT, 1998, ARCH PHYS MED REHAB, V79, P718, DOI 10.1016/S0003-9993(98)90051-X; Kesler SR, 2003, APPL NEUROPSYCHOL, V10, P153, DOI 10.1207/S15324826AN1003_04; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Kumar R, 2009, BRAIN INJURY, V23, P675, DOI 10.1080/02699050903014915; Lannoo E, 2001, BRAIN INJURY, V15, P1, DOI 10.1080/02699050150209084; Lezak M., 2012, NEUROPSYCHOLOGICAL A, V5th; Lezak M.D., 2004, NEUROPSYCHOLOGICAL A, Vfourth; Lipton ML, 2012, BRAIN IMAGING BEHAV, V6, P329, DOI 10.1007/s11682-012-9175-2; Mayer AR, 2014, HUM BRAIN MAPP, V35, P5457, DOI 10.1002/hbm.22563; Newcombe V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019214; Niogi SN, 2008, BRAIN, V131, P3209, DOI 10.1093/brain/awn247; Novack TA, 2001, ARCH PHYS MED REHAB, V82, P300, DOI 10.1053/apmr.2001.18222; Palacios EM, 2013, CORTEX, V49, P646, DOI 10.1016/j.cortex.2012.02.011; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; Rabinowitz A.R., 2016, GENES ENV ALZHEIMERS, P267; Reitan R.M, 1985, HALSTEAD REITAN NEUR, V4; RUFF RM, 1993, BRAIN INJURY, V7, P101, DOI 10.3109/02699059309008164; Salthouse TA, 2010, J INT NEUROPSYCH SOC, V16, P754, DOI 10.1017/S1355617710000706; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Schultz R., 2013, BRAIN IMPAIRMENT, V14; Senathi-Raja D, 2010, NEUROPSYCHOLOGY, V24, P336, DOI 10.1037/a0018239; Sherer M, 2006, BRAIN INJURY, V20, P997, DOI 10.1080/02699050600677055; Spitz G, 2013, BRAIN TOPOGR, V26, P648, DOI 10.1007/s10548-013-0283-0; Stern Y, 2002, J INT NEUROPSYCH SOC, V8, P448, DOI 10.1017/S1355617702813248; Ware, 2012, APPL LONGITUDINAL AN, V998; Ware JB, 2017, J NEUROTRAUM, V34, P2243, DOI 10.1089/neu.2016.4817; Watts R, 2014, RADIOLOGY, V272, P217, DOI 10.1148/radiol.14131856; Wechsler D., 2014, WECHSLER ADULT INTEL; White T, 2011, SCHIZOPHRENIA BULL, V37, P222, DOI 10.1093/schbul/sbp088; Whiteneck G, 2004, ARCH PHYS MED REHAB, V85, pS73, DOI 10.1016/j.apmr.2003.08.107; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Wood RLL, 2006, J INT NEUROPSYCH SOC, V12, P350, DOI 10.1017/S1355617706060498; Yuh EL, 2014, J NEUROTRAUM, V31, P1457, DOI 10.1089/neu.2013.3171	50	18	18	0	18	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	MAR	2018	24	3					237	246		10.1017/S1355617717000996			10	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Neurosciences & Neurology; Psychiatry; Psychology	FW9IX	WOS:000425650000003	29032776	Green Accepted			2021-06-18	
J	Cassilo, D; Sanderson, J				Cassilo, David; Sanderson, Jimmy			"I Don't Think It's Worth the Risk": Media Framing of the Chris Borland Retirement in Digital and Print Media	COMMUNICATION & SPORT			English	Article						media framing; football; sport and health; Chris Borland; concussions	TELEVISED NEWS; WOMENS SPORTS; COVERAGE; HEALTH; TIME; MASCULINITY; NETWORK; GENDER	Football player safety, specifically concussions, has been a growing area of debate in U.S. mainstream media. Whereas many of these discussions are centered on the health effects experienced by former players, active National Football League (NFL) players often discursively minimize concussions. However, in March 2015, 24-year-old, San Francisco 49ers player Chris Borland voluntarily retired, specifically citing concerns about the health risks associated with concussions sustained while playing football. A textual analysis of 112 digital media and 187 print media articles revealed 10 frames that were used to discuss Borland's decision. Analysis revealed that the most prominent frame used in media outlets was centered on the health risks and consequences of playing football, while other frames discussed parental choice and social mobility associated with football. The results suggest that decisions by NFL players with respect to concussions can be framed in the context of larger social and cultural issues. As this occurs, conversations around safety, masculinity, and football move beyond the microlevel of participation, capturing macrolevel elements, such as parental consent, socioeconomic status, and health prioritization that factor into football participation.	[Cassilo, David] Kent State Univ, Kent, OH 44242 USA; [Sanderson, Jimmy] Clemson Univ, 502 Old Lebanon Rd, Pendleton, SC 29670 USA	Sanderson, J (corresponding author), Clemson Univ, 502 Old Lebanon Rd, Pendleton, SC 29670 USA.	jsande6@clemson.edu					Anderson E, 2012, MEN MASC, V15, P152, DOI 10.1177/1097184X11430127; Angelini JR, 2014, HOWARD J COMMUN, V25, P115, DOI 10.1080/10646175.2014.888380; [Anonymous], 2013, LIMBAUGH USE CONCUSS; Bigman CA, 2014, HEALTH COMMUN, V29, P267, DOI 10.1080/10410236.2012.745043; Billings AC, 2003, J COMMUN, V53, P569, DOI 10.1093/joc/53.4.569; Billings AC, 2014, COMMUN RES REP, V31, P141, DOI 10.1080/08824096.2014.907142; Billings AC, 2015, J MASS COMMUN Q, V92, P142, DOI 10.1177/1077699014560516; Bills LB, 2016, RETIRES 23 CITING CO; Blain G., 2013, I WANT PROTECT CHILD; Boren C., 2016, D TRUMP NFL FOOTBALL; Braun V., 2006, QUALITATIVE RES PSYC, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706qp063oa]; Bronstein C, 2005, J MASS COMMUN Q, V82, P783, DOI 10.1177/107769900508200403; Burch LM, 2015, J BROADCAST ELECTRON, V59, P399, DOI 10.1080/08838151.2015.1054999; Butterworth ML, 2012, COMMUN CRIT-CULT STU, V9, P241, DOI 10.1080/14791420.2012.675438; Butterworth Michael L., 2014, NFL CRITICAL CULTURA, P205; Chong D, 2007, ANNU REV POLIT SCI, V10, P103, DOI 10.1146/annurev.polisci.10.072805.103054; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Cooky C, 2015, COMMUN SPORT, V3, P261, DOI 10.1177/2167479515588761; Cooky C, 2013, COMMUN SPORT, V1, P203, DOI 10.1177/2167479513476947; Cranmer GA, 2014, HOWARD J COMMUN, V25, P171, DOI 10.1080/10646175.2014.890979; Dias C., 2015, LONG TERM EFFECTS CO; ENTMAN RM, 1993, J COMMUN, V43, P51, DOI 10.1111/j.1460-2466.1993.tb01304.x; Entman RM, 2003, POLIT COMMUN, V20, P415, DOI 10.1080/10584600390244176; Fainaru S, 2013, YOUTH FOOTBALL PARTI; Fainaru-Wada M., 2015, SFS BORLAND QUITS SA; Fisher E., 2015, NFL FANTASY FOOTBALL; Florio M., 2015, NFL DOCTOR SAYS CTE; Frederick EL, 2015, COMMUN SPORT, V3, P312, DOI 10.1177/2167479513508393; Furness Z, 2016, POP COMMUN, V14, P49, DOI 10.1080/15405702.2015.1084628; Gantt D., 2014, C BORLAND NAMED NFL; Goffman E., 1974, FRAME ANAL; Herbst D., 2015, EXPERTS ALARMED 13 H; Hull K, 2015, J SPORT SOC ISSUES, V39, P78, DOI 10.1177/0193723514558928; Isidore C., 2015, NFL REVENUE HERE COM; Jhally S., 1984, CRITICAL SOCIOLOGIST, V12, P41; Jhally Sut., 1989, MEDIA SPORTS SOC, P70; Kassing JW, 2009, WESTERN J COMM, V73, P182, DOI 10.1080/10570310902856063; Kian EM, 2009, J BROADCAST ELECTRON, V53, P477, DOI 10.1080/08838150903102519; Kirk M., 2013, LEAGUE DENIAL DOCUME; Koblin J., 2013, ESPN PULLS OUT FRONT; KUYPERS JA, 2005, QUALITATIVE RES REPO, V6, P1, DOI DOI 10.1080/17459430500262083; Lee ST, 2013, HEALTH COMMUN, V28, P119, DOI 10.1080/10410236.2012.658550; Lee S, 2014, J SPORT MANAGE, V28, P176, DOI 10.1123/jsm.2012-0243; Lindlof T.R., 2011, QUALITATIVE COMMUNIC; Martin J., 2016, P WARNER ELIMINATES; MCCOMBS ME, 1972, PUBLIC OPIN QUART, V36, P176, DOI 10.1086/267990; Mcelroy K, 2014, HOWARD J COMMUN, V25, P431, DOI 10.1080/10646175.2014.955928; MESSNER MA, 1993, SOCIOL SPORT J, V10, P119, DOI 10.1123/ssj.10.2.119; Messner MA, 2014, SOCIOL SPORT J, V31, P102, DOI 10.1123/ssj.2013-0111; Miller J. A., 2013, N F L PRESSURE SAID; Nan XL, 2013, J HEALTH COMMUN, V18, P263, DOI 10.1080/10810730.2012.727957; Neuendorf K.A., 2002, DEFINING CONTENT ANA; Oates TP, 2009, SOCIOL SPORT J, V26, P31, DOI 10.1123/ssj.26.1.31; PAXTON M, 2004, J MEDIA RELIG, V3, P43, DOI DOI 10.1207/s15328415jmr0301_3; Petchesky B., 2016, H ABDULLAH RETIRES A; Petric J., 2013, THESIS; Rodgers K., 2014, NFL CRITICAL CULTURA, P142; Rosenthal G., 2015, 8 BIGGEST SURPRISES; Sabo D., 1994, ANN M NAT ATHL TRAIN; Sabo D., 2004, SPORTING BODIES DAMA, P59; Sanderson J., 2011, ITS WHOLE NEW BALLGA; Sanderson J., COMMUNICATI IN PRESS; Sanderson J, 2016, COMMUN SPORT, V4, P3, DOI 10.1177/2167479514536982; Sandomir R., 2011, ESPN EXTENDS DEAL N; Schimmel KS, 2012, INT REV SOCIOL SPORT, V47, P338, DOI 10.1177/1012690211433479; Schimmel KS, 2011, URBAN STUD, V48, P3277, DOI 10.1177/0042098011422396; Schmitt B., 2016, NFL FREE AGENT CRIBB; Schwarz A, 2016, N F L S FLAWED CONCU; Scott R., 2015, CONCUSSION; Seate AA, 2010, COMMUN RES REP, V27, P343, DOI 10.1080/08824096.2010.518917; Seltzer T., 2009, Journal of Sports Media, V4, P1, DOI 10.1353/jsm.0.0040; Sheridan B. (Producer), 2012, HEAD GAMES DOCUMENTA; Spaaij R., 2011, SPORT SOCIAL MOBILIT; Stefanik-Sidener K, 2013, HEALTH COMMUN, V28, P351, DOI 10.1080/10410236.2012.688187; Strachan M., 2015, NFL AFFLIATED DOCTOR; Wenner L.A., 1989, MEDIA SPORTS SOC, P13; Zhang Y, 2015, J MASS COMMUN Q, V92, P99, DOI 10.1177/1077699014558553	77	18	18	1	19	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	2167-4795	2167-4809		COMMUN SPORT	Commun. Sport	FEB	2018	6	1					86	110		10.1177/2167479516654513			25	Communication; Hospitality, Leisure, Sport & Tourism	Communication; Social Sciences - Other Topics	FR5TC	WOS:000419128100005					2021-06-18	
J	Merritt, VC; Rabinowitz, AR; Arnett, PA				Merritt, Victoria C.; Rabinowitz, Amanda R.; Arnett, Peter A.			The Influence of the Apolipoprotein E (APOE) Gene on Subacute Post-Concussion Neurocognitive Performance in College Athletes	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						APOE gene; Genetics; Mild traumatic brain injury; Neuropsychological tests; Performance variability; Sports-related concussion	TRAUMATIC BRAIN-INJURY; SPORTS-RELATED CONCUSSION; INTRAINDIVIDUAL VARIABILITY; ALZHEIMERS-DISEASE; HEAD-INJURY; RISK-FACTORS; E GENOTYPE; COGNITIVE PERFORMANCE; MILITARY POPULATION; PROSPECTIVE COHORT	Objective: The purpose of this study was to determine whether the epsilon 4 allele of the APOE gene influences neurocognitive outcome following sports-related concussion. It was hypothesized that participants with an epsilon 4 allele would show poorer neurocognitive performance and greater neurocognitive variability than those without an epsilon 4 allele. Method: Participants included 57 concussed collegiate athletes (77.2% male) who participated in a concussion management program at a large university. All athletes underwent a comprehensive neuropsychological assessment and provided a DNA sample for determination of their APOE genotype. The test battery included measures sensitive to concussion, covering the broad domains of learning and memory, attention, processing speed, and executive functions. Results: The sample was divided into epsilon 4 + (n = 20) and epsilon 4 -(n = 37) groups. No significant differences were found between athletes with and without an epsilon 4 allele when examining mean neurocognitive standardized scores (all p >.05; d = 0.16-0.18). However, athletes with an epsilon 4 allele were more likely to show a greater number of impaired neurocognitive scores post-injury compared to athletes without an epsilon 4 allele, chi(2)(1, N = 57) = 3.96, p = <.05, phi = 0.26. Additionally, athletes with an epsilon 4 allele demonstrated greater neurocognitive variability than athletes without an epsilon 4 allele, t(55) = -2.04, p <.05, d = 0.53. Conclusions: This research furthers our understanding of how genetic factors uniquely contribute to neurocognitive performance differences following concussion. Our findings suggest a possible relationship between the epsilon 4 allele and post-concussion impairment, as well as between the epsilon 4 allele and neurocognitive performance variability, suggesting that the epsilon 4 genotype may be a risk factor for less efficient cognitive processing in concussed athletes.	[Merritt, Victoria C.; Arnett, Peter A.] Penn State Univ, Dept Psychol, University Pk, PA 16802 USA; [Rabinowitz, Amanda R.] Moss Rehabil Res Inst, Elkins Pk, PA USA	Merritt, VC (corresponding author), Penn State Univ, Dept Psychol, University Pk, PA 16802 USA.	vcabarnes@gmail.com		Merritt, Victoria/0000-0001-5683-4168	American Psychological Foundation	This work was supported by a grant from the American Psychological Foundation (no grant number exists).	Alexander S, 2007, J NEUROTRAUM, V24, P790, DOI 10.1089/neu.2006.0133; Allen L. M., 1999, MANUAL COMPUTERIZED; Anstey KJ, 2007, NEUROPSYCHOLOGIA, V45, P1911, DOI 10.1016/j.neuropsychologia.2006.11.020; Ariza M, 2006, J NEUROL NEUROSUR PS, V77, P1191, DOI 10.1136/jnnp.2005.085167; Arnett P., 2014, CONCUSSION ATHLETICS, P35; Backman L, 2006, NEUROSCI BIOBEHAV R, V30, P791, DOI 10.1016/j.neubiorev.2006.06.005; Bartzokis G, 2006, ARCH GEN PSYCHIAT, V63, P63, DOI 10.1001/archpsyc.63.1.63; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Benedict R., 1997, BRIEF VISUOSPATIAL M; Brandt J., 2001, HOPKINS VERBAL LEARN; Burton CL, 2006, J CLIN EXP NEUROPSYC, V28, P67, DOI 10.1080/13803390490918318; Cegalis J.A., 1994, VIGIL W CONTINUOUS P; Chamelian L, 2004, BRAIN, V127, P2621, DOI 10.1093/brain/awh296; Chiang MF, 2003, ACTA NEUROCHIR, V145, P649, DOI 10.1007/s00701-003-0069-3; Christensen Helen, 2008, BMC Geriatr, V8, P14, DOI 10.1186/1471-2318-8-14; Cole VT, 2011, SCHIZOPHR RES, V129, P91, DOI 10.1016/j.schres.2011.03.007; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Crawford FC, 2002, NEUROLOGY, V58, P1115, DOI 10.1212/WNL.58.7.1115; Dardiotis E, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2009.10.FOCUS09215; Echemendia RJ, 2001, NEUROPSYCHOL REV, V11, P69, DOI 10.1023/A:1016651217141; Finnoff JT, 2011, PM&R, V3, pS452, DOI 10.1016/j.pmrj.2011.07.014; Fjell AM, 2011, J NEUROSCI, V31, P18060, DOI 10.1523/JNEUROSCI.4735-11.2011; Freeman B, 2003, BEHAV GENET, V33, P67, DOI 10.1023/A:1021055617738; Han SD, 2007, J NEUROL NEUROSUR PS, V78, P1103, DOI 10.1136/jnnp.2006.108183; Han SD, 2009, J HEAD TRAUMA REHAB, V24, P57, DOI 10.1097/HTR.0b013e3181957055; Holtzer R, 2008, JAMA-J AM MED ASSOC, V300, P823, DOI 10.1001/jama.300.7.823; Hong Eun Pyo, 2012, Genomics & Informatics, V10, P117, DOI 10.5808/GI.2012.10.2.117; Hultsch DF, 2000, NEUROPSYCHOLOGY, V14, P588, DOI 10.1037/0894-4105.14.4.588; Ingelsson M, 2003, CURRENT PROTOCOLS HU, DOI DOI 10.1002/0471142905.HG0914S38.; Iverson G. L., 2011, HDB SPORT NEUROPSYCH, P131; Iverson GL, 2006, BRAIN INJURY, V20, P245, DOI 10.1080/02699050500487910; Iverson GL, 2011, LITTLE BLACK BOOK OF NEUROPSYCHOLOGY: A SYNDROME-BASED APPROACH, P923, DOI 10.1007/978-0-387-76978-3_32; Jordan BD, 1997, JAMA-J AM MED ASSOC, V278, P136, DOI 10.1001/jama.278.2.136; Kay T., 1993, J HEAD TRAUMA REHABI, V8, P86, DOI [10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kelly AMC, 2008, NEUROIMAGE, V39, P527, DOI 10.1016/j.neuroimage.2007.08.008; Kristman VL, 2008, CLIN J SPORT MED, V18, P322, DOI 10.1097/JSM.0b013e31817e6f3e; Kutner KC, 2000, NEUROSURGERY, V47, P651, DOI 10.1097/00006123-200009000-00026; Lange RT, 2013, J NEUROTRAUM, V30, P237, DOI 10.1089/neu.2012.2685; Lau BC, 2011, AM J SPORT MED, V39, P2311, DOI 10.1177/0363546511410655; Liberman JN, 2002, NEUROLOGY, V58, P1038, DOI 10.1212/WNL.58.7.1038; Lovden M, 2007, NEUROPSYCHOLOGIA, V45, P2827, DOI 10.1016/j.neuropsychologia.2007.05.005; Lovell M. R., 2012, IMMEDIATE POSTCONCUS; Lovell MR., 2000, IMPACT IMMEDIATE POS; Mahley RW, 2006, P NATL ACAD SCI USA, V103, P5644, DOI 10.1073/pnas.0600549103; McCauley SR, 2001, J CLIN EXP NEUROPSYC, V23, P792, DOI 10.1076/jcen.23.6.792.1016; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Merritt V. C., 2016, ARCH CLIN NEUROPSYCH, V31, P1; Millar K, 2003, J NEUROL NEUROSUR PS, V74, P1047, DOI 10.1136/jnnp.74.8.1047; Moran LM, 2009, J NEUROTRAUM, V26, P1489, DOI 10.1089/neu.2008.0767; PETERSEN RC, 1995, JAMA-J AM MED ASSOC, V273, P1274, DOI 10.1001/jama.273.16.1274; Ponsford J, 2007, NEUROLOGY, V68, P619, DOI 10.1212/01.wnl.0000254609.04330.9d; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Psychological Corporation, 2001, WECHSL TEST AD READ; Rabinowitz AR, 2013, NEUROPSYCHOLOGY, V27, P481, DOI 10.1037/a0033023; Reynolds C.R., 2002, COMPREHENSIVE TRAIL; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Samatovicz RA, 2000, J HEAD TRAUMA REHAB, V15, P869, DOI 10.1097/00001199-200006000-00002; Schretlen DJ, 2003, J INT NEUROPSYCH SOC, V9, P864, DOI 10.1017/S1355617703960061; Silver JM., 2011, TXB TRAUMATIC BRAIN, V2nd ed.; Smith A., 1991, SYMBOL DIGIT MODALIT; Sundstrom A, 2004, NEUROLOGY, V62, P1963, DOI 10.1212/01.WNL.0000129268.83927.A8; Teasdale GM, 2005, BRAIN, V128, P2556, DOI 10.1093/brain/awh595; Teasdale GM, 1997, LANCET, V350, P1069, DOI 10.1016/S0140-6736(97)04318-3; Terrell TR, 2008, CLIN J SPORT MED, V18, P10, DOI 10.1097/JSM.0b013e31815c1d4c; Tierney RT, 2010, CLIN J SPORT MED, V20, P464, DOI 10.1097/JSM.0b013e3181fc0a81; Trenerry M.R., 1989, STROOP NEUROPSYCHOLO; Walhovd KB, 2007, NEUROPSYCHOLOGIA, V45, P2277, DOI 10.1016/j.neuropsychologia.2007.02.022; Wechsler D, 1997, WAIS 3 ADM SCORING M; Willemse-Van Son AHP, 2008, J NEUROL NEUROSUR PS, V79, P426, DOI 10.1136/jnnp.2007.129460; Wilson M, 2007, BRIT J ANAESTH, V99, P43, DOI 10.1093/bja/aem142	72	18	18	0	14	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	FEB	2018	33	1					36	46		10.1093/arclin/acx051			11	Psychology, Clinical; Psychology	Psychology	FU8XL	WOS:000424139500004	28541413				2021-06-18	
J	Pugh, MJ; Swan, AA; Carlson, KF; Jaramillo, CA; Eapen, BC; Dillahunt-Aspillaga, C; Amuan, ME; Delgado, RE; McConnell, K; Finley, EP; Grafman, JH				Pugh, Mary Jo; Swan, Alicia A.; Carlson, Kathleen F.; Jaramillo, Carlos A.; Eapen, Blessen C.; Dillahunt-Aspillaga, Christina; Amuan, Megan E.; Delgado, Roxana E.; McConnell, Kimberly; Finley, Erin P.; Grafman, Jordan H.		Trajectories Resilience Complex	Traumatic Brain Injury Severity, Comorbidity, Social Support, Family Functioning, and Community Reintegration Among Veterans of the Afghanistan and Iraq Wars	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injuries; Mental health; Rehabilitation; Stress disorders, post-traumatic; Veterans	QUALITY-OF-LIFE; MEDICAL-CARE; REHABILITATION; ASSOCIATIONS; PREVALENCE; OUTCOMES; HEALTH	Objective: To examine the association between traumatic brain injury (TBI) severity; social, family, and community reintegration outcomes; and return to work status among post-9/11 veterans in Department of Veterans Affairs (VA) care. Design: Retrospective observational cohort study. Setting: Mail/online survey fielded to a national sample of veterans. Participants: Sample of post-9/11 veterans with at least 3 years of VA care stratified according to TBI severity and comorbidities who completed and returned surveys (N=2023). Interventions: Not applicable. Main Outcome Measures: Deployment Risk and Resilience Inventory-2 family functioning and social support subscales; Military to Civilian Questionnaire; and employment status. Results: Bivariate analyses revealed that veterans with every classification of TBI severity reported significantly more difficulty on social, family, and community reintegration outcomes than those with no TBI. In the fully adjusted model, veterans with unclassified and moderate/severe TBI reported significantly more difficulty with community reintegration and were less likely to be employed relative to those with no TBI; those with unclassified TBI also reported significantly more difficulty with family functioning. Veterans with mild TBI also reported significantly more difficulty with community reintegration. Conclusions: This study provides insight into long-term outcomes associated with TBI in post-9/11 veterans and suggests that exposure to TBI has a negative effect on social and family functioning, community reintegration, and return to work even after controlling for comorbidity, deployment experiences, and sociodemographic characteristics. Additional research is required to explicate what appears to be complex interactions among TBI severity, psychosocial well-being, combat exposures, and socioeconomic resources in this population. Published by Elsevier Inc. on behalf of the American Congress of Rehabilitation Medicine	[Pugh, Mary Jo; Swan, Alicia A.; Jaramillo, Carlos A.; Eapen, Blessen C.; Delgado, Roxana E.; McConnell, Kimberly; Finley, Erin P.] South Texas Vet Hlth Care Syst, Vet Hlth Adm, San Antonio, TX 78229 USA; [Pugh, Mary Jo; Delgado, Roxana E.; McConnell, Kimberly] Univ Texas Hlth San Antonio, Dept Epidemiol, San Antonio, TX USA; [Pugh, Mary Jo; Delgado, Roxana E.; McConnell, Kimberly] Univ Texas Hlth San Antonio, Dept Biostat, San Antonio, TX USA; [Pugh, Mary Jo; Finley, Erin P.] Univ Texas Hlth San Antonio, Div Gen & Hosp Med, San Antonio, TX USA; [Carlson, Kathleen F.] VA Portland Hlth Care Syst, Ctr Improve Vet Involvement Care, Portland, OR USA; [Carlson, Kathleen F.] Natl Ctr Rehabil Auditory Res, Portland, OR USA; [Carlson, Kathleen F.] VA Portland Hlth Care Syst, Portland, OR USA; [Carlson, Kathleen F.] Oregon Hlth & Sci Univ, Sch Publ Hlth, Portland, OR 97201 USA; [Eapen, Blessen C.] Univ Texas Hlth San Antonio, Dept Rehabil Med, San Antonio, TX USA; [Dillahunt-Aspillaga, Christina] Univ S Florida, Dept Child & Family Studies, Rehab & Mental Hlth Counseling Program, Tampa, FL USA; [Dillahunt-Aspillaga, Christina] James A Haley Vet Hosp, Ctr Innovat Disabil & Rehabil Res, Tampa, FL USA; [Amuan, Megan E.] Edith Nourse Rogers Mem VA Hosp, Ctr Hlth Qual Outcomes & Econ Res, Bedford, MA USA; [Finley, Erin P.; Trajectories Resilience Complex] Univ Texas Hlth San Antonio, Dept Psychiat, San Antonio, TX USA; [Grafman, Jordan H.] Rehabil Inst Chicago, Chicago, IL 60611 USA; [Grafman, Jordan H.] Northwestern Univ, Weinberg Coll Arts & Sci, Feinberg Sch Med,Dept Psychiat, Dept Phys Med & Rehabil,Cognit Neurol & Alzheimer, Chicago, IL 60611 USA; [Grafman, Jordan H.] Northwestern Univ, Weinberg Coll Arts & Sci, Feinberg Sch Med, Dept Neurol,Cognit Neurol & Alzheimers Ctr,Dept P, Chicago, IL 60611 USA; [Grafman, Jordan H.] Northwestern Univ, Weinberg Coll Arts & Sci, Dept Psychol, Chicago, IL 60611 USA	Pugh, MJ (corresponding author), South Texas Vet Hlth Care Syst, 7400 Merton Minter Blvd, San Antonio, TX 78229 USA.	pughm@uthscsa.edu	Pugh, Mary Jo/K-5336-2019	Pugh, Mary Jo/0000-0003-4196-7763	Department of Veterans Affairs Health Services Research & Development ServiceUS Department of Veterans Affairs [DHI 09-237]; U.S. Army Medical Research and Material CommandU.S. Army Medical Research & Materiel Command (USAMRMC); U.S. Department of Veterans Affairs (Chronic Effects of Neurotrauma Consortium)US Department of Veterans Affairs [W81XWH-13-2-0095]; American Congress of Rehabilitation Medicine	Supported by Department of Veterans Affairs Health Services Research & Development Service (grant no. DHI 09-237); the Frankel Foundation; the United Services Automobile Association, who provided the gift card incentive to survey participants; and use of TBI algorithm developed as part of a study funded by the U.S. Army Medical Research and Material Command; and the U.S. Department of Veterans Affairs (Chronic Effects of Neurotrauma Consortium) (award no. W81XWH-13-2-0095).; Publication of this article was supported by the American Congress of Rehabilitation Medicine.	Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P194, DOI 10.1017/S1355617709990841; Brundage John F, 2015, MSMR, V22, P2; Carlson KF, 2010, J TRAUMA STRESS, V23, P17, DOI 10.1002/jts.20483; Corrigan JD, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0000000000000020; Department of Defense, 2015, POSTD HLTH ASS PDHA; Department of Defense, 2016, VA DOD CLIN PRACT GU; DIKMEN S, 1993, BRAIN INJURY, V7, P113, DOI 10.3109/02699059309008165; Dillman D.A., 2014, INTERNET PHONE MAIL; DILLMAN DA, 1991, ANNU REV SOCIOL, V17, P225, DOI 10.1146/annurev.so.17.080191.001301; Donnelly KT, 2011, J HEAD TRAUMA REHAB, V26, P439, DOI 10.1097/HTR.0b013e3182005de3; Eapen BC, 2013, CURR PHYS MED REHABI, V1, P151, DOI DOI 10.1007/S40141-013-0023-0; Falvo MJ, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1124; Jaramillo CA, 2015, BRAIN IMAGING BEHAV, V9, P445, DOI 10.1007/s11682-015-9402-8; Kalpakjian CZ, 2004, AM J PHYS MED REHAB, V83, P255, DOI 10.1097/01.PHM.0000118033.07952.8C; Kersel DA, 2001, BRAIN INJURY, V15, P683, DOI 10.1080/02699050010013662; McAndrew LM, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-73; Military Health System and the Defense Health Agency, SURV CAS DEF; Pogoda TK, 2016, J HEAD TRAUMA REHAB, V31, P191, DOI 10.1097/HTR.0000000000000092; Pugh MJ, 2016, BRAIN INJURY, V30, P1481, DOI 10.1080/02699052.2016.1219055; Pugh MJV, 2015, J HEAD TRAUMA REHAB, V30, P29, DOI 10.1097/HTR.0000000000000045; Pugh MJV, 2014, MED CARE, V52, P172, DOI 10.1097/MLR.0000000000000059; Sander AM, 2009, NEUROREHABILITATION, V24, P15, DOI 10.3233/NRE-2009-0450; Sayer NA, 2012, ANNU REV MED, V63, P405, DOI 10.1146/annurev-med-061610-154046; Sayer NA, 2011, J TRAUMA STRESS, V24, P660, DOI 10.1002/jts.20706; Sayer NA, 2010, PSYCHIAT SERV, V61, P589, DOI 10.1176/ps.2010.61.6.589; Schulz-Heik RJ, 2016, BRAIN INJURY, V30, P271, DOI 10.3109/02699052.2015.1113567; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; Temkin NR, 2009, J HEAD TRAUMA REHAB, V24, P460, DOI 10.1097/HTR.0b013e3181c13413; Vanderploeg RD, 2013, J HEAD TRAUMA REHAB, V28, P211, DOI 10.1097/HTR.0b013e31828b50db; Vogt D, 2017, SOC PSYCH PSYCH EPID, V52, P341, DOI 10.1007/s00127-016-1321-5; Vogt D, 2013, J TRAUMA STRESS, V26, P710, DOI 10.1002/jts.21868; Wood RL, 2004, BRAIN INJURY, V18, P1135, DOI 10.1080/02699050410001675906	32	18	19	0	22	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	FEB	2018	99	2		1			S40	S49		10.1016/j.apmr.2017.05.021			10	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	FU7YY	WOS:000424069900006	28648681				2021-06-18	
J	Nukolova, NV; Aleksashkin, AD; Abakumova, TO; Morozova, AY; Gubskiy, IL; Kirzhanova, EA; Abakumov, MA; Chekhonin, VP; Klyachko, NL; Kabanov, AV				Nukolova, N. V.; Aleksashkin, A. D.; Abakumova, T. O.; Morozova, A. Y.; Gubskiy, I. L.; Kirzhanova, E. A.; Abakumov, M. A.; Chekhonin, V. P.; Klyachko, N. L.; Kabanov, A. V.			Multilayer polyion complex nanoformulations of superoxide dismutase 1 for acute spinal cord injury	JOURNAL OF CONTROLLED RELEASE			English	Article						Antioxidant enzymes; Superoxide dismutase (SOD1); Spinal cord injury (SCI); BBB score; Inflammation; Nanoparticles; Double layered polyelectrolyte complex	LINKED ANTIOXIDANT NANOZYMES; OXIDATIVE STRESS; ISCHEMIC BRAIN; DELIVERY; INFLAMMATION; THERAPY; RATS; SOD; DNA	As one of the most devastating forms of trauma, spinal cord injury (SCI) remains a challenging clinical problem. The secondary processes associated with the primary injury, such as overproduction of reactive oxygen species (ROS) and inflammation, lead to concomitant compression of the injured spinal cord and neuronal death. Delivery of copper-zinc superoxide dismutase (SOD1), an efficient ROS scavenger, to the site of injury can mitigate SCI-induced oxidative stress and tissue damage. Towards this goal catalytically active nanoformulations of SOD1 ("nanozymes") are developed as a modality for treatment of SCI. Along with the cross-linked polyion complex of SOD1 with polycation poly(ethylene glycol) (PEG)-polylysine (single-coat (SC) nanozyme), we introduce for the first time the chemically cross-linked multilayer polyion complex in which SOD1 is first incorporated into a polyion complex with polycation, then coated by anionic block copolymer, PEG-polyglutamic acid (double-coat (DC) nanozyme). We developed DC nanozymes with high enzymatic activity and ability to retain and protect SOD1 under physiological conditions. Pharmacokinetic study revealed that DC nanozymes significantly prolonged circulation of active SOD1 in the blood stream compared to free SOD1 or SC nanozymes (half-life was 60 vs 6 min). Single intravenous injection of DC nanozymes (5 kU of SOD1/kg) improved the recovery of locomotor functions in rats with moderate SCI, along with reduction of swelling, concomitant compression of the spinal cord and formation of post-traumatic cysts. Thus, based on the testing in a rodent model the SOD1 DC nanozymes are promising modality for scavenging ROS, decreasing inflammation and edema, and improving recovery after SCI.	[Nukolova, N. V.; Abakumova, T. O.; Morozova, A. Y.; Chekhonin, V. P.] V Serbsky Natl Med Res Ctr Psychiat & Narcol, Dept Fundamental & Appl Neurobiol, Kropotkinskiy 23, Moscow 119034, Russia; [Aleksashkin, A. D.; Kirzhanova, E. A.; Klyachko, N. L.; Kabanov, A. V.] Moscow MV Lomonosov State Univ, Fac Chem, Lab Chem Design Bionanomat, Leninskie Gory 1, Moscow 119991, Russia; [Nukolova, N. V.; Gubskiy, I. L.; Abakumov, M. A.; Chekhonin, V. P.] NI Pirogov Russian Natl Res Med Univ, Dept Med Nanobiotechnol, Ostrovityanova St 1, Moscow 117997, Russia; [Klyachko, N. L.; Kabanov, A. V.] Univ North Carolina Chapel Hill, Eshelman Sch Pharm, Ctr Nanotechnol Drug Delivery, Div Pharmacoengn & Mol Pharmaceut, 125 Mason Farm Rd, Chapel Hill, NC 27599 USA; [Abakumov, M. A.] Natl Univ Sci & Technol MISiS, Lab Biomed Nanomat, Leninskiy Prospekt 4, Moscow 119049, Russia; [Nukolova, N. V.] MIT, Koch Inst Integrat Canc Res, 500 Main St, Cambridge, MA 02139 USA	Kabanov, AV (corresponding author), Univ North Carolina Chapel Hill, Eshelman Sch Pharm, 125 Mason Farm Rd, Chapel Hill, NC 27599 USA.	kabanov@email.unc.edu	Morozova, Anna/T-1361-2019; Aleksashkin, Anton/AAR-2723-2021; Kabanov, Alexander V/N-3356-2013; Kabanov, Alexander/AAY-5751-2020; Chekhonin, Vladimir VP/T-4511-2018; Abakumova, Tatiana/H-2431-2013; Abakumov, Maxim A/O-5728-2017; Gubskiy, Ilya/V-4376-2017	Kabanov, Alexander V/0000-0002-3665-946X; Kabanov, Alexander/0000-0002-3665-946X; Abakumov, Maxim A/0000-0003-2622-9201; Abakumova, Tatiana/0000-0002-9139-3326; Gubskiy, Ilya/0000-0003-1726-6801; Chekhonin, Vladimir P./0000-0003-4386-7897	Russian Ministry of Science and EducationMinistry of Education and Science, Russian Federation [11G34.31.0004]	This work was supported by grant 11G34.31.0004 from Russian Ministry of Science and Education (to A.V.K.). We thank our colleagues at the V. Serbsky Medical Research Center of Psychiatry and Narcology N. P. Grinenko and P. A. Melnikov for their help with cytotoxicity and confocal imaging, and K. P. Ionova, A. Kuzkina and T. Mustafina for their help with SCI modeling. We also gratefully acknowledge N. G. Balabushevich and M. A. Pechenkin (M. V. Lomonosov Moscow State University) for establishing of SOD1 activity assay in plasma. MRI and confocal microscopy were carried out using equipment located in the Center for Collective Usage "Medical nanobiotechologies" (N. I. Pirogov Russian National Research Medical University).	BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Blanco E, 2015, NAT BIOTECHNOL, V33, P941, DOI 10.1038/nbt.3330; Bracken MB, 2001, SPINE, V26, pS47, DOI 10.1097/00007632-200112151-00010; Cadotte DW, 2011, CLIN ORTHOP RELAT R, V469, P732, DOI 10.1007/s11999-010-1674-0; Cuzzocrea S, 2001, PHARMACOL REV, V53, P135; Efremenko EN, 2017, J CONTROL RELEASE, V247, P175, DOI 10.1016/j.jconrel.2016.12.037; HALL ED, 1992, J NEUROTRAUM, V9, pS425; Hausmann O, 2003, SPINAL CORD, V41, P369, DOI 10.1038/sj.sc.3101483; Hulsebosch CE, 2002, ADV PHYSIOL EDUC, V26, P238, DOI 10.1152/advan.00039.2002; IMAIZUMI S, 1990, STROKE, V21, P1312, DOI 10.1161/01.STR.21.9.1312; Jia Z, 2012, SPINAL CORD, V50, P264, DOI 10.1038/sc.2011.111; Jiang YH, 2015, J CONTROL RELEASE, V213, P36, DOI 10.1016/j.jconrel.2015.06.021; KABANOV AV, 1995, BIOCONJUGATE CHEM, V6, P7, DOI 10.1021/bc00031a002; Kataoka K, 1996, MACROMOLECULES, V29, P8556, DOI 10.1021/ma961217+; Klyachko NL, 2012, NANOMED-NANOTECHNOL, V8, P119, DOI 10.1016/j.nano.2011.05.010; Krishna V., 2013, JOVE-J VIS EXP, V78, P1; Macaya D, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/1/012001; Manickam DS, 2012, J CONTROL RELEASE, V162, P636, DOI 10.1016/j.jconrel.2012.07.044; McCord JM, 2008, DOSE-RESPONSE, V6, P223, DOI 10.2203/dose-response.08-012.McCord; Nakauchi K, 1996, J NEUROTRAUM, V13, P573, DOI 10.1089/neu.1996.13.573; OMAR BA, 1990, FREE RADICAL BIO MED, V9, P465, DOI 10.1016/0891-5849(90)90123-Z; Rabchevsky AG, 2011, PHARMACOL THERAPEUT, V132, P15, DOI 10.1016/j.pharmthera.2011.05.001; Reddy MK, 2008, APPL BIOCHEM BIOTECH, V151, P565, DOI 10.1007/s12010-008-8232-1; Reddy MK, 2009, FASEB J, V23, P1384, DOI 10.1096/fj.08-116947; Rosenbaugh EG, 2010, BIOMATERIALS, V31, P5218, DOI 10.1016/j.biomaterials.2010.03.026; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Takenaga M, 2006, J CONTROL RELEASE, V110, P283, DOI 10.1016/j.jconrel.2005.10.022; Veronese FM, 2002, ADV DRUG DELIVER REV, V54, P587, DOI 10.1016/S0169-409X(02)00029-7; Wolfert MA, 1996, HUM GENE THER, V7, P2123, DOI 10.1089/hum.1996.7.17-2123; World Health Organization, 2013, SPIN CORD INJ; Xu W, 2005, SPINAL CORD, V43, P204, DOI 10.1038/sj.sc.3101674; Yasui K, 2006, INFLAMM RES, V55, P359, DOI 10.1007/s00011-006-5195-y; Yusubalieva GM, 2010, B EXP BIOL MED+, V149, P125, DOI 10.1007/s10517-010-0890-7	33	18	19	6	57	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0168-3659	1873-4995		J CONTROL RELEASE	J. Control. Release	JAN 28	2018	270						226	236		10.1016/j.jconrel.2017.11.044			11	Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Chemistry; Pharmacology & Pharmacy	FV5VI	WOS:000424650100018	29196042				2021-06-18	
J	An, N; Xu, HM; Gao, WQ; Yang, H				An, Na; Xu, Huiming; Gao, Wei-Qiang; Yang, Hao			Direct Conversion of Somatic Cells into Induced Neurons	MOLECULAR NEUROBIOLOGY			English	Article						Cell reprogramming; Somatic cells; Induced neuron; Transdifferentiation	PLURIPOTENT STEM-CELLS; DIRECT LINEAGE CONVERSION; ADULT HUMAN FIBROBLASTS; FUNCTIONAL-NEURONS; TRANSCRIPTION FACTOR; MEDIATED CONVERSION; MOUSE FIBROBLASTS; GLIAL-CELLS; GENERATION; INDUCTION	The progressive loss and degeneration of neurons in the central nervous system (CNS), as a result of traumas or diseases including Alzheimer's, Parkinson's, Huntington's disease, stroke, and traumatic injury to the brain and spinal cord, can usually have devastating effects on quality of life. The current strategies available for treatments are described including drug delivery, surgery, electrical stimulation, and cell-based tissue engineering approaches. However, apart from cell-based therapy, other attempts are limited in improving clinical outcomes. Recently, stem cell and neural stem cell (NSC) in particular therapy has been proposed as an attractive and promising strategy for regenerative medicine due to their unique biological attributes, such as giving rise to neuronal lineage commitment in accordance with the neural development. Nevertheless, stem cell strategy still faces numerous challenges, including ethical issue, tumor formation, and graft rejection. Thus, seeking a more appropriate approach like direct reprogramming or lineage reprogramming is critical. Compared to induced pluripotent stem cells (iPSCs) and embryonic stem cells (ESCs), direct lineage reprogramming of somatic cells to generate induced neurons (iNs) without undergoing a state of pluripotent still has several advantages such as short induction cycle, high transdifferentiation efficiency, no ethical concerns, and risk of neoplasia. On the basis of these advantages, cell reprogramming will hold great promise for therapeutic cell replacement, disease modeling establishment, drug screening, and personalized medicine. Here, we systematically review recent advances in somatic lineage reprogramming into iNs, including the identification of novel reprogramming factors, the underlying molecular mechanisms and the concerns exist, as well as the major challenges in the future.	[An, Na; Xu, Huiming; Gao, Wei-Qiang; Yang, Hao] Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Renji Med Clin Stem Cell Res Ctr 10,State Key Lab, Shanghai 200127, Peoples R China	Gao, WQ; Yang, H (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Renji Med Clin Stem Cell Res Ctr 10,State Key Lab, Shanghai 200127, Peoples R China.	gao.weiqiang@sjtu.edu.cn; yanghao.71_99@yahoo.com			Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81371411, 81571208, YG2014MS45]	This work was supported by the Natural Science Foundation of China (grant nos. 81371411, 81571208, and YG2014MS45). The authors confirm that there has been no financial support for this research that could have influenced its outcome.	Ambasudhan R, 2011, CELL STEM CELL, V9, P113, DOI 10.1016/j.stem.2011.07.002; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; Caiazzo M, 2011, NATURE, V476, P224, DOI 10.1038/nature10284; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; De la Rossa A, 2013, NAT NEUROSCI, V16, P193, DOI 10.1038/nn.3299; Eggan E, 2004, NATURE, V428, P44, DOI 10.1038/nature02375; Feng GD, 2014, MOL NEUROBIOL, V50, P997, DOI 10.1007/s12035-014-8649-1; Guo ZY, 2014, CELL STEM CELL, V14, P188, DOI 10.1016/j.stem.2013.12.001; GURDON JB, 1962, DEV BIOL, V4, P256, DOI 10.1016/0012-1606(62)90043-X; Hansen KF, 2016, LEARN MEMORY, V23, P61, DOI 10.1101/lm.039578.115; Harada K, 2016, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00499; Heinrich C, 2011, NAT PROTOC, V6, P214, DOI 10.1038/nprot.2010.188; Heins N, 2002, NAT NEUROSCI, V5, P308, DOI 10.1038/nn828; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; Hu WX, 2015, CELL STEM CELL, V17, P204, DOI 10.1016/j.stem.2015.07.006; Huang YH, 2015, NEUROSCI BULL, V31, P357, DOI 10.1007/s12264-014-1517-1; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Jiang HB, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10100; Karow M, 2014, JOVE-J VIS EXP, DOI 10.3791/51433; KULESSA H, 1995, GENE DEV, V9, P1250, DOI 10.1101/gad.9.10.1250; Li X, 2015, CELL STEM CELL, V17, P195, DOI 10.1016/j.stem.2015.06.003; Li XW, 2016, BIOMATER SCI-UK, V4, P1100, DOI 10.1039/c6bm00140h; Lin TX, 2009, NAT METHODS, V6, P805, DOI [10.1038/nmeth.1393, 10.1038/NMETH.1393]; Maguire JA, 2016, STEM CELL RES, V16, P338, DOI 10.1016/j.scr.2016.02.017; Marro S, 2014, METHODS MOL BIOL, V1150, P237, DOI 10.1007/978-1-4939-0512-6_16; Marro S, 2011, CELL STEM CELL, V9, P374, DOI 10.1016/j.stem.2011.09.002; Montana CL, 2013, P NATL ACAD SCI USA, V110, P1732, DOI 10.1073/pnas.1214387110; Niu WZ, 2015, STEM CELL REP, V4, P780, DOI 10.1016/j.stemcr.2015.03.006; Pang ZPP, 2011, NATURE, V476, P220, DOI 10.1038/nature10202; Park H, 2015, BIOMATERIALS, V72, P152, DOI 10.1016/j.biomaterials.2015.09.002; Pekny M, 2005, GLIA, V50, P427, DOI 10.1002/glia.20207; Pfisterer U, 2011, P NATL ACAD SCI USA, V108, P10343, DOI 10.1073/pnas.1105135108; Rouaux C, 2013, NAT CELL BIOL, V15, P214, DOI 10.1038/ncb2660; Shen CN, 2000, NAT CELL BIOL, V2, P879; Shi ZX, 2016, J BIOL CHEM, V291, P13560, DOI 10.1074/jbc.M115.709808; Son EY, 2011, CELL STEM CELL, V9, P205, DOI 10.1016/j.stem.2011.07.014; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tantirigama MLS, 2016, J COMP NEUROL, V524, P829, DOI 10.1002/cne.23875; Torper O, 2013, P NATL ACAD SCI USA, V110, P7038, DOI 10.1073/pnas.1303829110; Torres-Padilla ME, 2013, DEVELOPMENT, V140, P487, DOI 10.1242/dev.087577; Vadodaria KC, 2016, MOL PSYCHIATR, V21, P49, DOI 10.1038/mp.2015.161; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Wapinski OL, 2013, CELL, V155, P621, DOI 10.1016/j.cell.2013.09.028; Xiao B, 2016, J NEUROL NEUROSUR PS, V87, P697, DOI 10.1136/jnnp-2015-312036; Xie HF, 2004, CELL, V117, P663, DOI 10.1016/S0092-8674(04)00419-2; Xu J, 2015, CELL STEM CELL, V16, P119, DOI 10.1016/j.stem.2015.01.013; Xu Z, 2016, MOL PSYCHIATR, V21, P62, DOI 10.1038/mp.2015.101; Yoo AS, 2011, NATURE, V476, P228, DOI 10.1038/nature10323; Zhang L, 2015, CELL STEM CELL, V17, P735, DOI 10.1016/j.stem.2015.09.012; Zhang SZ, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/2452985; Zhang XQ, 2010, CELL STEM CELL, V7, P90, DOI 10.1016/j.stem.2010.04.017; Zuryn S, 2014, SCIENCE, V345, P826, DOI 10.1126/science.1255885	55	18	19	1	26	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0893-7648	1559-1182		MOL NEUROBIOL	Mol. Neurobiol.	JAN	2018	55	1					642	651		10.1007/s12035-016-0350-0			10	Neurosciences	Neurosciences & Neurology	FV6PC	WOS:000424702600057	27981499				2021-06-18	
J	Balba, NM; Elliott, JE; Weymann, KB; Opel, RA; Duke, JW; Oken, BS; Morasco, BJ; Heinricher, MM; Lim, MM				Balba, Nadir M.; Elliott, Jonathan E.; Weymann, Kris B.; Opel, Ryan A.; Duke, Joseph W.; Oken, Barry S.; Morasco, Benjamin J.; Heinricher, Mary M.; Lim, Miranda M.			Increased Sleep Disturbances and Pain in Veterans With Comorbid Traumatic Brain Injury and Posttraumatic Stress Disorder	JOURNAL OF CLINICAL SLEEP MEDICINE			English	Article						sleep-wake disturbances; concussion; polytrauma clinical triad; insomnia; headaches; sensory sensitivity	INSOMNIA SEVERITY INDEX; POLYTRAUMA-CLINICAL-TRIAD; LONGITUDINAL RELATIONSHIPS; FUNCTIONAL STATUS; OEF/OIF VETERANS; FREEDOM VETERANS; SOMATIC SYMPTOMS; REPORTED SLEEP; PTSD; PREVALENCE	Study Objectives: Veterans are at an increased risk for traumatic brain injury (TBI) and posttraumatic stress disorder (PTSD), both of which are associated with sleep disturbances and increased pain. Furthermore, sleep disturbances and pain are reciprocally related such that each can exacerbate the other. Although both TBI and PTSD are independently linked to sleep disturbances and pain, it remains unclear whether Veterans with comorbid TBI+PTSD show worse sleep disturbances and pain compared to those with only TBI or PTSD. We hypothesized that sleep and pain would be worse in Veterans with comorbid TBI+PTSD compared to Veterans with only TBI or PTSD. Methods: Veterans (n = 639) from the VA Portland Health Care System completed overnight polysomnography and self-report questionnaires. Primary outcome variables were self-reported sleep disturbances and current pain intensity. Participants were categorized into four trauma-exposure groups: (1) neither: without TBI or PTSD (n = 383); (2) TBI: only TBI (n = 67); (3) PTSD: only PTSD (n = 126); and (4) TBI+PTSD: TBI and PTSD (n = 63). Results: The PTSD and TBI+PTSD groups reported worse sleep compared to the TBI and neither groups. The TBI+PTSD group reported the greatest pain intensity compared to the other groups. Conclusions: These data suggest sleep and pain are worst in Veterans with TBI and PTSD, and that sleep is similarly impaired in Veterans with PTSD despite not having as much pain. Thus, although this is a complex relationship, these data suggest PTSD may be driving sleep disturbances, and the added effect of TBI in the comorbid group may be driving pain in this population.	[Balba, Nadir M.; Elliott, Jonathan E.; Weymann, Kris B.; Opel, Ryan A.; Heinricher, Mary M.; Lim, Miranda M.] VA Portland Hlth Care Syst, 3710 SW US Vet Hosp Rd,Mailcode P3-RD42, Portland, OR 97239 USA; [Balba, Nadir M.; Oken, Barry S.; Heinricher, Mary M.; Lim, Miranda M.] Oregon Hlth & Sci Univ, Dept Behav Neurosci, Portland, OR 97201 USA; [Elliott, Jonathan E.; Oken, Barry S.; Lim, Miranda M.] Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR 97201 USA; [Weymann, Kris B.] Oregon Hlth & Sci Univ, Sch Nursing, Portland, OR 97201 USA; [Duke, Joseph W.] No Arizona Univ, Dept Biol Sci, Box 5640, Flagstaff, AZ 86011 USA; [Morasco, Benjamin J.] VA Portland Hlth Care Syst, Ctr Improve Vet Involvement Care, Portland, OR 97239 USA; [Morasco, Benjamin J.] Oregon Hlth & Sci Univ, Dept Psychiat, Portland, OR 97201 USA; [Heinricher, Mary M.] Oregon Hlth & Sci Univ, Dept Neurol Surg, Portland, OR 97201 USA; [Lim, Miranda M.] Oregon Hlth & Sci Univ, Dept Med, Div Pulm & Crit Care Med, Portland, OR 97201 USA; [Lim, Miranda M.] Oregon Hlth & Sci Univ, Oregon Inst Occupat Hlth Sci, Portland, OR 97201 USA	Lim, MM (corresponding author), VA Portland Hlth Care Syst, 3710 SW US Vet Hosp Rd,Mailcode P3-RD42, Portland, OR 97239 USA.	lmir@ohsu.edu			VA Career Development Award [IK2 BX002712]; NIH EXITO Institutional CoreUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [UL1GM118964]; N.I.H.United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [T32 AT 002688]; Department of Defense awardUnited States Department of Defense [D01 W81XWH-17-1-0423]; National Center for Complementary & Integrative HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [T32AT002688] Funding Source: NIH RePORTER	All authors have seen and approved this manuscript. Work for this study was performed at VA Portland Health Care System, Portland, OR. This material is the result of work supported with resources and the use of facilities at the VA Portland Health Care System, VA Career Development Award #IK2 BX002712, NIH EXITO Institutional Core, #UL1GM118964, and the Portland VA Research Foundation to M.M.L.; N.I.H. T32 AT 002688 to J.E.E.; VA OAA Post-doctoral Nursing Research Fellowship to K.B.W.; and Department of Defense award #D01 W81XWH-17-1-0423 to M.M.H. and M.M.L., awarded and administered through the US Army Medical Research Acquisition Activity, Fort Detrick, MD. Interpretations and conclusions are those of the authors and do not represent the views of the U.S. Department of Veterans Affairs or the United States Government. The authors report no conflicts of interest.	Affleck G, 1996, PAIN, V68, P363, DOI 10.1016/S0304-3959(96)03226-5; American Psychiatric Association, 2013, DIAGN STAT MAN MENT, V5, DOI [10.1176/appi.books.9780890425596., DOI 10.1176/APPI.BOOKS.9780890425596, 10.1176/appi.books.9780890425596]; ASAKURA W, 1992, GEN PHARMACOL, V23, P337, DOI 10.1016/0306-3623(92)90092-X; Asmundson GJG, 2002, CAN J PSYCHIAT, V47, P930; Bastien CH, 2001, SLEEP MED, V2, P297, DOI 10.1016/S1389-9457(00)00065-4; Beaulieu-Bonneau S, 2012, SLEEP MED, V13, P598, DOI 10.1016/j.sleep.2012.02.010; Beckham JC, 1997, J PSYCHOSOM RES, V43, P379, DOI 10.1016/S0022-3999(97)00129-3; Beetar JT, 1996, ARCH PHYS MED REHAB, V77, P1298, DOI 10.1016/S0003-9993(96)90196-3; Blevins CA, 2015, J TRAUMA STRESS, V28, P489, DOI 10.1002/jts.22059; BOHNEN N, 1991, J NEUROL, V238, P443, DOI 10.1007/BF00314651; Bryant RA, 2001, J CLIN EXP NEUROPSYC, V23, P718, DOI 10.1076/jcen.23.6.718.1024; Bryant RA, 1999, J HEAD TRAUMA REHAB, V14, P588, DOI 10.1097/00001199-199912000-00007; Burstein R, 2015, J NEUROSCI, V35, P6619, DOI 10.1523/JNEUROSCI.0373-15.2015; Call-Schmidt Tracy Ann, 2003, Pain Manag Nurs, V4, P124, DOI 10.1016/S1524-9042(02)54212-0; Callahan ML, 2018, APPL NEUROPSYCH-ADUL, V25, P126, DOI 10.1080/23279095.2016.1261867; Centers for Disease Control and Prevention, 2016, INJ PREV CONTR TRAUM; Chasens ER, 2009, SLEEP, V32, P915, DOI 10.1093/sleep/32.7.915; Dobscha SK, 2009, PAIN MED, V10, P1200, DOI 10.1111/j.1526-4637.2009.00721.x; Elliott AM, 1999, LANCET, V354, P1248, DOI 10.1016/S0140-6736(99)03057-3; Elliott JE, 2018, J CLIN SLEEP MED, V14, P1177, DOI 10.5664/jcsm.7220; Faux S, 2008, PAIN MED, V9, P1001, DOI 10.1111/j.1526-4637.2007.00404.x; Fishbain DA, 1997, CLIN J PAIN, V13, P116, DOI 10.1097/00002508-199706000-00006; Foley D, 2004, J PSYCHOSOM RES, V56, P497, DOI 10.1016/j.jpsychores.2004.02.010; Foley DJ, 1999, SLEEP, V22, pS366; Geisser ME, 2008, J PAIN, V9, P417, DOI 10.1016/j.jpain.2007.12.006; Geisser ME, 2008, PSYCHOSOMATICS, V49, P235, DOI 10.1176/appi.psy.49.3.235; Gironda RJ, 2009, REHABIL PSYCHOL, V54, P247, DOI 10.1037/a0016906; Goadsby PJ, 2017, PHYSIOL REV, V97, P553, DOI 10.1152/physrev.00034.2015; Gotlib IH, 2004, J ABNORM PSYCHOL, V113, P127, DOI 10.1037/0021-843X.113.1.121; Grima N, 2016, J CLIN SLEEP MED, V12, P419, DOI 10.5664/jcsm.5598; Hays RD, 2009, QUAL LIFE RES, V18, P873, DOI 10.1007/s11136-009-9496-9; Herman D., 1993, ANN CONV INT SOC TRA; HICKS RA, 1978, PERCEPT MOTOR SKILL, V47, P848, DOI 10.2466/pms.1978.47.3.848; HICKS RA, 1979, PERCEPT MOTOR SKILL, V48, P687, DOI 10.2466/pms.1979.48.3.687; Hoge CW, 2007, AM J PSYCHIAT, V164, P150, DOI 10.1176/appi.ajp.164.1.150; Husain AM, 2001, J CLIN NEUROPHYSIOL, V18, P148, DOI 10.1097/00004691-200103000-00005; Insana SP, 2012, BIOL PSYCHOL, V89, P570, DOI 10.1016/j.biopsycho.2012.01.001; Jaramillo CA, 2016, HEADACHE, V56, P528, DOI 10.1111/head.12726; Johannes CB, 2010, J PAIN, V11, P1230, DOI 10.1016/j.jpain.2010.07.002; Kaniecki R, 2004, STANDARDS CARE HEADA, P40; Kempf J, 2010, J NEUROL NEUROSUR PS, V81, P1402, DOI 10.1136/jnnp.2009.201913; Khazaie Habibolah, 2016, J Inj Violence Res, V8, P99, DOI 10.5249/jivr.v8i2.808; Khoury S, 2018, PROG NEURO-PSYCHOPH, V87, P224, DOI 10.1016/j.pnpbp.2017.06.007; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Lamarche LJ, 2007, J CLIN PSYCHIAT, V68, P1257, DOI 10.4088/JCP.v68n0813; Landy S, 2004, TREATMENT PRIMARY HE; Lang KP, 2014, J HEAD TRAUMA REHAB, V29, P44, DOI 10.1097/HTR.0b013e31829c85d0; Lautenbacher S, 2006, SLEEP MED REV, V10, P357, DOI 10.1016/j.smrv.2005.08.001; Lew HL, 2010, AM J PHYS MED REHAB, V89, P437, DOI 10.1097/PHM.0b013e3181ddd301; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Lewin DS, 1999, J DEV BEHAV PEDIATR, V20, P244, DOI 10.1097/00004703-199908000-00007; Macey TA, 2011, PAIN MED, V12, P1502, DOI 10.1111/j.1526-4637.2011.01226.x; Martenson ME, 2016, PAIN, V157, P868, DOI 10.1097/j.pain.0000000000000450; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; McDonald John H, 2009, HDB BIOL STAT, V2; Mellman TA, 2007, J TRAUMA STRESS, V20, P893, DOI 10.1002/jts.20246; Menefee LA, 2000, PAIN MED, V1, P156, DOI 10.1046/j.1526-4637.2000.00022.x; Morasco BJ, 2013, PAIN, V154, P609, DOI 10.1016/j.pain.2013.01.001; Morasco BJ, 2011, PAIN, V152, P488, DOI 10.1016/j.pain.2010.10.009; Morasco BJ, 2010, PAIN, V151, P625, DOI 10.1016/j.pain.2010.08.002; Morin CM, 2011, SLEEP, V34, P601, DOI 10.1093/sleep/34.5.601; Morin CM, 1998, CLIN J PAIN, V14, P311, DOI 10.1097/00002508-199812000-00007; Mysliwiec V, 2018, SLEEP MED REV, V37, P94, DOI 10.1016/j.smrv.2017.01.004; Mysliwiec V, 2014, J CLIN SLEEP MED, V10, P1143, DOI 10.5664/jcsm.4120; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Newell J, 2012, PSYCHIAT RES, V200, P795, DOI 10.1016/j.psychres.2012.07.045; Neylan TC, 1998, AM J PSYCHIAT, V155, P929, DOI 10.1176/ajp.155.7.929; Nicassio PM, 2002, PAIN, V100, P271, DOI 10.1016/S0304-3959(02)00300-7; NICASSIO PM, 1992, J ABNORM PSYCHOL, V101, P514, DOI 10.1037/0021-843X.101.3.514; Ohayon MM, 2000, COMPR PSYCHIAT, V41, P469, DOI 10.1053/comp.2000.16568; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Omachi TA, 2011, ARTHRIT CARE RES, V63, pS287, DOI 10.1002/acr.20544; Ouellet MC, 2006, J HEAD TRAUMA REHAB, V21, P199, DOI 10.1097/00001199-200605000-00001; Palermo TM, 2005, J PAIN, V6, P201, DOI 10.1016/j.jpain.2004.12.005; Pigeon WR, 2013, J PSYCHOSOM RES, V75, P546, DOI 10.1016/j.jpsychores.2013.09.004; PITMAN RK, 1989, AM J PSYCHIAT, V146, P667; Ponsford JL, 2013, NEUROREHAB NEURAL RE, V27, P613, DOI 10.1177/1545968313481283; Pugh MJV, 2014, MED CARE, V52, P172, DOI 10.1097/MLR.0000000000000059; R Development Core Team, 2016, R LANG ENV STAT COMP; Raymond I, 2001, PAIN, V92, P381, DOI 10.1016/S0304-3959(01)00282-2; ROSZELL DK, 1991, HOSP COMMUNITY PSYCH, V42, P293; Ruff RL, 2012, J REHABIL RES DEV, V49, P1305, DOI 10.1682/JRRD.2011.12.0251; Ruff RL, 2008, J REHABIL RES DEV, V45, P941, DOI 10.1682/JRRD.2008.02.0028; Sandsmark DK, 2017, SLEEP, V40, DOI 10.1093/sleep/zsx044; Savard MH, 2005, PSYCHO-ONCOLOGY, V14, P429, DOI 10.1002/pon.860; Seal KH, 2017, ARCH PHYS MED REHAB, V98, P1636, DOI 10.1016/j.apmr.2017.03.026; Shekleton JA, 2010, NEUROLOGY, V74, P1732, DOI 10.1212/WNL.0b013e3181e0438b; Smith M.T., 2003, ARTHRIT CARE RES, V49, pS184, DOI DOI 10.1002/ART.11409; Smith MT, 2007, SLEEP, V30, P494, DOI 10.1093/sleep/30.4.494; Smith MT, 2004, SLEEP MED REV, V8, P119, DOI 10.1016/S1087-0792(03)00044-3; Stojanovic MP, 2016, PAIN MED, V17, P2017, DOI 10.1093/pm/pnw042; Stone AA, 1997, ARTHRIT CARE RES, V10, P185, DOI 10.1002/art.1790100306; Suhnan AP, 2017, INT J AUDIOL, V56, P801, DOI 10.1080/14992027.2017.1346303; van Reekum R, 2000, J NEUROPSYCH CLIN N, V12, P316, DOI 10.1176/appi.neuropsych.12.3.316; Wahbeh H, 2008, NEUROLOGY, V70, P2321, DOI 10.1212/01.wnl.0000314667.16386.5e; Weaver TE, 1997, SLEEP, V20, P835; Weymann KB, 2017, CURR SLEEP MED REP, V3, P179; Williams SG, 2015, SLEEP BREATH, V19, P175, DOI 10.1007/s11325-014-0984-y; Woodward SH, 2000, BIOL PSYCHIAT, V48, P1081, DOI 10.1016/S0006-3223(00)00917-3; Woolf CJ, 2011, PAIN, V152, pS2, DOI 10.1016/j.pain.2010.09.030; Wortzel HS, 2014, NEUROREHABILITATION, V34, P613, DOI 10.3233/NRE-141086; Yesavage JA, 2012, AM J GERIAT PSYCHIAT, V20, P199, DOI 10.1097/JGP.0b013e3181e446ea; Young James A, 2007, Phys Med Rehabil Clin N Am, V18, P145, DOI 10.1016/j.pmr.2006.11.008	103	18	18	0	2	AMER ACAD SLEEP MEDICINE	DARIEN	2510 N FRONTAGE RD, DARIEN, IL 60561 USA	1550-9389	1550-9397		J CLIN SLEEP MED	J. Clin. Sleep Med.		2018	14	11					1865	1878	PII jc-18-00057	10.5664/jcsm.7482			14	Clinical Neurology	Neurosciences & Neurology	HP1GS	WOS:000461414800007	30373686	Bronze, Green Published			2021-06-18	
J	Folkerson, LE; Sloan, D; Davis, E; Kitagawa, RS; Cotton, BA; Holcomb, JB; Tomasek, JS; Wade, CE				Folkerson, Lindley E.; Sloan, Duncan; Davis, Elizabeth; Kitagawa, Ryan S.; Cotton, Bryan A.; Holcomb, John B.; Tomasek, Jeffrey S.; Wade, Charles E.			Coagulopathy as a predictor of mortality after penetrating traumatic brain injury	AMERICAN JOURNAL OF EMERGENCY MEDICINE			English	Article						Coagulopathy; Penetrating brain injury; Rapid thrombelastography; Traumatic brain injury	CIVILIAN GUNSHOT WOUNDS; GLASGOW COMA SCALE; HEAD-INJURIES; PROGNOSTIC-FACTORS; THROMBELASTOGRAPHY; RESUSCITATION; LEVEL; SCORE	Study hypothesis: Traumatic brain injury (TBI) is a leading cause ofmortalitywith penetrating TBI (p-TBI) patients having worse outcomes. These patients are more likely to be coagulopathic than blunt TBI (b-TBI) patients, thus we hypothesize that coagulopathy would be an early predictor of mortality. Methods: We identified highest-level trauma activation patients who underwent an admission head CT and had ICU admission orders from August 2009-May 2013, excluding those with polytrauma and anticoagulant use. Rapid thrombelastography (rTEG) was obtained after emergency department (ED) arrival and coagulopathy was defined as follows: ACT = 128 s, KT = 2.5 s, angle = 56 degrees, MA = 55 mm, LY-30 = 3.0% or platelet count = 150,000/mu L. Regression modeling was used to assess the association of coagulopathy on mortality. Results: 1086 patients with head CT scans performed and ICU admission orders were reviewed. After exclusion criteria were met, 347 patients with isolated TBI were analyzed-99 (29%) with p-TBI and 248 (71%) with bTBI. Patients with p-TBI had a highermortality (41% vs. 10%, p < 0.0001) and a greater incidence of coagulopathy (64% vs. 51%, p < 0.003). After dichotomizing p-TBI patients by mortality, patients who died were younger and were more coagulopathic. When adjusting for factors available on ED arrival, coagulopathy was found to be an early predictor of mortality (OR 3.99, 95% CI 1.37, 11.72, p-value = 0.012). Conclusions: This study demonstrates that p-TBI patients with significant coagulopathy have a poor prognosis. Coagulopathy, in conjunction with other factors, can be used to earlier identify p-TBI patients with worse outcomes and represents a possible area for intervention. (C) 2017 Published by Elsevier Inc.	[Folkerson, Lindley E.; Sloan, Duncan; Davis, Elizabeth; Cotton, Bryan A.; Holcomb, John B.; Tomasek, Jeffrey S.; Wade, Charles E.] Univ Texas Hlth Sci Ctr Houston, Ctr Translat Injury Res, 6431 Fannin St,MSB 5-204, Houston, TX 77030 USA; [Folkerson, Lindley E.; Sloan, Duncan; Davis, Elizabeth; Cotton, Bryan A.; Holcomb, John B.; Tomasek, Jeffrey S.; Wade, Charles E.] Univ Texas Hlth Sci Ctr Houston, Dept Surg, Houston, TX 77030 USA; [Kitagawa, Ryan S.] Univ Texas Hlth Sci Ctr Houston, Dept Neurosurg, Houston, TX 77030 USA; [Folkerson, Lindley E.] Univ Texas Hlth Sci Ctr Houston, Dept Emergency Med, Houston, TX 77030 USA	Wade, CE (corresponding author), Univ Texas Hlth Sci Ctr Houston, Ctr Translat Injury Res, 6431 Fannin St,MSB 5-204, Houston, TX 77030 USA.	Charles.E.Wade@uth.tmc.edu		holcomb, john/0000-0001-8312-9157	State of Texas Emerging Technology Fund; University of Texas Health Science Center's Center for Translational Injury Research	Support for this work was provided by The State of Texas Emerging Technology Fund and The University of Texas Health Science Center's Center for Translational Injury Research.	ALDRICH EF, 1992, SURG NEUROL, V38, P418, DOI 10.1016/0090-3019(92)90109-Z; Brohi K, 2007, CURR OPIN CRIT CARE, V13, P680, DOI 10.1097/MCC.0b013e3282f1e78f; Cohan MJ, 2007, J TRAUMA, V63, P1254, DOI 10.1097/TA.0b013e318156ee4c; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Manoel ALD, 2015, NEUROCRIT CARE, V22, P34, DOI 10.1007/s12028-014-0026-4; Demetriades D, 2004, ARCH SURG-CHICAGO, V139, P1066, DOI 10.1001/archsurg.139.10.1066; Demetriades D, 2004, J AM COLL SURGEONS, V199, P216, DOI 10.1016/j.jamcollsurg.2004.02.030; Faul M.D., 2010, TRAUMATIC BRAIN INJU; GRAHM TW, 1990, NEUROSURGERY, V27, P696, DOI 10.1227/00006123-199011000-00005; Gressot LV, 2014, J NEUROSURG, V121, P645, DOI 10.3171/2014.5.JNS131872; Greuters S, 2011, CRIT CARE, V15, DOI 10.1186/cc9399; Holcomb JB, 2012, ANN SURG, V256, P476, DOI 10.1097/SLA.0b013e3182658180; Johansson PI, 2013, TRANSFUSION, V53, P3088, DOI 10.1111/trf.12214; Johansson PI, 2009, SCAND J TRAUMA RESUS, V17, DOI 10.1186/1757-7241-17-45; Joseph B, 2014, J AM COLL SURGEONS, V218, P58, DOI 10.1016/j.jamcollsurg.2013.08.018; Joseph B, 2013, J TRAUMA ACUTE CARE, V75, P102, DOI 10.1097/TA.0b013e3182946667; Kunio NR, 2012, AM J SURG, V203, P584, DOI 10.1016/j.amjsurg.2011.12.011; Lee TH, 2014, J TRAUMA ACUTE CARE, V77, P67, DOI 10.1097/TA.0000000000000255; Martins RS, 2003, SURG NEUROL, V60, P98, DOI 10.1016/S0090-3019(03)00302-1; NAGIB MG, 1986, NEUROSURGERY, V18, P533, DOI 10.1227/00006123-198605000-00003; Peek-Asa C, 2001, BRAIN INJURY, V15, P801, DOI 10.1080/02699050010025768; Santiago LA, 2012, BRAIN INJURY, V26, P107, DOI 10.3109/02699052.2011.635363; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Sixta SL, 2012, INT J BURNS TRAUMA, V2, P158; STEIN SC, 1992, NEUROSURGERY, V30, P160, DOI 10.1227/00006123-199202000-00002; Talving P, 2009, J TRAUMA, V66, P55, DOI 10.1097/TA.0b013e318190c3c0; Tapia NM, 2013, J TRAUMA ACUTE CARE, V74, P378, DOI 10.1097/TA.0b013e31827e20e0; The American College of Surgeons Trauma Quality Improvement Program, 2015, ACS TQIP BEST PRACT; Valadka AB, 2000, J TRAUMA, V48, P296, DOI 10.1097/00005373-200002000-00017; Williams AJ, 2006, NEUROSCI LETT, V408, P183, DOI 10.1016/j.neulet.2006.08.086; Windelov NA, 2011, BLOOD COAGUL FIBRIN, V22, P416, DOI 10.1097/MBC.0b013e3283464f53	31	18	18	0	3	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0735-6757	1532-8171		AM J EMERG MED	Am. J. Emerg. Med.	JAN	2018	36	1					38	42		10.1016/j.ajem.2017.06.057			5	Emergency Medicine	Emergency Medicine	FP5CZ	WOS:000417638100008	28764996				2021-06-18	
J	Ghalaenovi, H; Fattahi, A; Koohpayehzadeh, J; Khodadost, M; Fatahi, N; Taheri, M; Azimi, A; Rohani, S; Rahatlou, H				Ghalaenovi, Hossein; Fattahi, Arash; Koohpayehzadeh, Jalil; Khodadost, Mahmoud; Fatahi, Neda; Taheri, Morteza; Azimi, Alireza; Rohani, Sadra; Rahatlou, Hessam			The effects of amantadine on traumatic brain injury outcome: a double-blind, randomized, controlled, clinical trial	BRAIN INJURY			English	Article						Traumatic brain injury; amantadine; outcome assessment; double-blind method	COGNITION; IRRITABILITY; RECEPTORS; GLUTAMATE; CHILDREN; EFFICACY; STATE	Introduction: Amantadine, as a dopamine receptor agonist, may stimulate and help the recovery of the nervous system after traumatic brain injury (TBI).Methods: We performed this study as a double-blind, randomized, controlled clinical trial with target population including all patients with TBI who scored nine or lower on the Glasgow Coma Scale (GCS), admitted to our hospital between January 2013 and April 2014. The protocol included administration of the drug (placebo or amantadine) for 6 weeks and patient evaluation using the GCS and FOUR score on the first, third and seventh days after the drug was started. After 6 months from starting study drug, the patients were evaluated on the Mini-Mental State Examination, Glasgow Outcome Study, Disability Rating Scale and Karnofsky Performance Scale.Results: We included 40 patients in the study. The mean age of the patients was 36.7718.21. As an only important finding, the amantadine group registered an important rise between the first and the seventh day of study drug (GCS7-GCS1) with p-value=0.044.Conclusion: Based on our findings during the first week and the 6months (since starting drug) follow-ups, prescribing amantadine did not lead to reportable effects on the patients' level of consciousness, memory, disability, cognition, mortality and performance.	[Ghalaenovi, Hossein; Fattahi, Arash] Iran Univ Med Sci, Dept Neurosurg, Neurosurg, Tehran, Iran; [Koohpayehzadeh, Jalil] Iran Univ Med Sci, Community Med, Tehran, Iran; [Khodadost, Mahmoud] Shahid Beheshti Univ Med Sci, Sch Publ Hlth, Dept Epidemiol, Epidemiol, Tehran, Iran; [Fatahi, Neda] Ronash Med Genet Ctr, Genet, Tehran, Iran; [Taheri, Morteza; Azimi, Alireza; Rohani, Sadra; Rahatlou, Hessam] Iran Univ Med Sci, Dept Neurosurg, Neurosurg, Tehran, Iran	Fattahi, A (corresponding author), Iran Univ Med Sci, Dept Neurosurg, Tehran, Iran.	arashmedicine@yahoo.com	Fattahi, Arash/M-3492-2017; Taheri, Morteza/AAF-8208-2019	Fattahi, Arash/0000-0002-1874-6527; Taheri, Morteza/0000-0001-5308-8040; Khodadost, Mahmoud/0000-0003-4241-4300; Rahatlou, Hessam/0000-0003-1476-8005			Andersson EE, 2011, J REHABIL MED, V43, P323, DOI 10.2340/16501977-0666; [Anonymous], 2001, SYMM AM PROD INF; Bales James W, 2010, Open Drug Discov J, V2, P119; Beers SR, 2005, J HEAD TRAUMA REHAB, V20, P450, DOI 10.1097/00001199-200509000-00006; Brown JIM, 1998, J NEUROTRAUM, V15, P253, DOI 10.1089/neu.1998.15.253; Bullock Ross, 1993, Journal of Emergency Medicine, V11, P23; Chandler M C, 1988, Brain Inj, V2, P309; Chew E, 2009, J REHABIL RES DEV, V46, P851, DOI 10.1682/JRRD.2008.09.0120; Frenette AJ, 2012, J NEUROTRAUM, V29, P1, DOI 10.1089/neu.2011.1812; Giacino JT, 2012, NEW ENGL J MED, V366, P819, DOI 10.1056/NEJMoa1102609; GUALTIERI T, 1989, CLIN NEUROPHARMACOL, V12, P258, DOI 10.1097/00002826-198908000-00003; Guerriero RM, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0545-1; Hammond FM, 2015, J NEUROTRAUM, V32, P1230, DOI 10.1089/neu.2014.3803; Hammond FM, 2014, J HEAD TRAUMA REHAB, V29, P391, DOI 10.1097/01.HTR.0000438116.56228.de; Leone H, 2005, J CLIN PHARM THER, V30, P101, DOI 10.1111/j.1365-2710.2005.00628.x; LEVIN HS, 1991, ARCH NEUROL-CHICAGO, V48, P580, DOI 10.1001/archneur.1991.00530180032013; Mathers C, 2008, GLOBAL BURDEN OF DISEASE: 2004 UPDATE, P1; McMahon MA, 2009, AM J PHYS MED REHAB, V88, P525, DOI 10.1097/PHM.0b013e3181a5ade3; Meythaler JM, 2002, J HEAD TRAUMA REHAB, V17, P300, DOI 10.1097/00001199-200208000-00004; Muzi F, 2005, TRANSPL P, V37, P1705, DOI 10.1016/j.transproceed.2005.03.077; Patrick PD, 2006, J CHILD NEUROL, V21, P879, DOI 10.1177/08830738060210100901; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Saniova B, 2004, J NEURAL TRANSM, V111, P511, DOI 10.1007/s00702-004-0112-4; Sawyer E, 2008, ANN PHARMACOTHER, V42, P247, DOI 10.1345/aph.1K284; Schneider WN, 1999, BRAIN INJURY, V13, P863; Shohami E, 2014, CNS NEUROL DISORD-DR, V13, P567, DOI 10.2174/18715273113126660196; Takahashi H, 2012, J CEREBR BLOOD F MET, V32, P1248, DOI 10.1038/jcbfm.2011.194	27	18	18	0	5	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2018	32	8			SI		1050	1055		10.1080/02699052.2018.1476733			6	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	GJ2QK	WOS:000435116400012	29790790				2021-06-18	
J	Gray, JC; MacKillop, J; Weafer, J; Hernandez, KM; Gao, JJ; Palmer, AA; de Wit, H				Gray, Joshua C.; MacKillop, James; Weafer, Jessica; Hernandez, Kyle M.; Gao, Jianjun; Palmer, Abraham A.; de Wit, Harriet			Genetic analysis of impulsive personality traits: Examination of a priori candidates and genome-wide variation	PSYCHIATRY RESEARCH			English	Article						Impulsivity; Genetics; Endophenotype; Personality traits; Serotonin	TRAUMATIC BRAIN-INJURY; ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; SEROTONIN TRANSPORTER POLYMORPHISM; ALCOHOL-DEPENDENT PATIENTS; DRUG-USE DISORDERS; SENSATION SEEKING; ENDOPHENOTYPE CONCEPT; DECISION-MAKING; ASSOCIATION; BEHAVIOR	Impulsive personality traits are heritable risk factors and putative endophenotypes for addiction and other psychiatric disorders involving disinhibition. This study examined the genetic basis of impulsive personality traits, defined as scores on the Barratt Impulsiveness Scale (BIS-11) and the UPPS-P Impulsive Behavior Scale (UPPS-P). In 983 healthy young adults of European ancestry, the study examined genetic variation in relation to a combined phenotype of seven subscales based on high phenotypic intercorrelations. The study first tested 14 a priori loci that have previously been associated impulsive personality traits or closely related constructs. Second, the study included an exploratory genome-wide scan (i.e., GWAS), acknowledging that only relatively large effects would be detectable in a sample size of similar to 1000. A priori SNP analyses revealed a significant association between the combined impulsivity phenotype and two SNPs within the 5-HT2a receptor gene (HTR2A; rs6313 and rs6311). Follow-up analyses suggested that the effects were specific to the Motor and Non-planning sub scales on the BIS-11, and also that the two loci were in linkage disequilibrium. The GWAS yielded no statistically significant findings. This study further implicates loci within HTR2A with certain forms of self-reported impulsivity and identifies candidates for future investigation from the genome-wide analyses.	[Gray, Joshua C.] Uniformed Serv Univ Hlth Sci, Ctr Deployment Psychol, Bethesda, MD 20814 USA; [Gray, Joshua C.] Univ Georgia, Dept Psychol, Athens, GA 30602 USA; [MacKillop, James] McMaster Univ, Peter Boris Ctr Addict Res, Hamilton, ON L8S 4L8, Canada; [MacKillop, James] Homewood Hlth Ctr, Homewood Res Inst, Guelph, ON N1E 6K9, Canada; [Weafer, Jessica; Gao, Jianjun; Palmer, Abraham A.; de Wit, Harriet] Univ Chicago, Dept Psychiat & Behav Neurosci, Chicago, IL 60637 USA; [Hernandez, Kyle M.] Univ Chicago, Ctr Res Informat, Chicago, IL 60637 USA; [Gao, Jianjun; Palmer, Abraham A.] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92103 USA; [Gao, Jianjun; Palmer, Abraham A.] Univ Calif San Diego, Inst Genom Med, La Jolla, CA 92103 USA	Gray, JC (corresponding author), Uniformed Serv Univ Hlth Sci, Ctr Deployment Psychol, Bethesda, MD 20814 USA.	jgray7700@gmail.com	, James/ABI-3641-2020; Hernandez, Kyle/K-2536-2019; Gray, Joshua/AAE-7733-2019	, James/0000-0002-8695-1071; Hernandez, Kyle/0000-0001-8267-644X; Gray, Joshua/0000-0002-5351-561X	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01DA032015]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISMUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [K01AA024519] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [R01DA032015] Funding Source: NIH RePORTER	Funding for this study was provided by NIH Grant R01DA032015. JM is the holder of the Peter Boris Chair in Addictions Research, which partially supported his role.	Agrawal A, 2008, ADDICTION, V103, P1069, DOI 10.1111/j.1360-0443.2008.02213.x; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Amlung M, 2017, ADDICTION, V112, P51, DOI 10.1111/add.13535; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benko A, 2010, AM J MED GENET B, V153B, P592, DOI 10.1002/ajmg.b.31025; Berg JM, 2015, PSYCHOL ASSESSMENT, V27, P1129, DOI 10.1037/pas0000111; Berman AH, 2005, EUR ADDICT RES, V11, P22, DOI 10.1159/000081413; Bevilacqua L, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0380; Cao J, 2014, HUM GENET, V133, P357, DOI 10.1007/s00439-013-1388-y; Carver CS, 2014, SOC PSYCHOL PERS SCI, V5, P730, DOI 10.1177/1948550614527116; Carver CS, 2011, PSYCHOL SCI, V22, P589, DOI 10.1177/0956797611404085; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Chester DS, 2015, BEHAV BRAIN RES, V283, P97, DOI 10.1016/j.bbr.2015.01.034; Congdon E, 2008, AM J MED GENET B, V147B, P27, DOI 10.1002/ajmg.b.30557; Coskunpinar A, 2013, DRUG ALCOHOL DEPEN, V133, P1, DOI 10.1016/j.drugalcdep.2013.05.008; Coskunpinar A, 2013, ALCOHOL CLIN EXP RES, V37, P1441, DOI 10.1111/acer.12131; Cyders MA, 2007, PSYCHOL ASSESSMENT, V19, P107, DOI 10.1037/1040-3590.19.1.107; de Wit H, 2009, ADDICT BIOL, V14, P22, DOI 10.1111/j.1369-1600.2008.00129.x; Dick DM, 2015, PERSPECT PSYCHOL SCI, V10, P37, DOI 10.1177/1745691614556682; Dick DM, 2013, TWIN RES HUM GENET, V16, P661, DOI 10.1017/thg.2013.20; Distel MA, 2008, PSYCHOL MED, V38, P1219, DOI 10.1017/S0033291707002024; Doran N, 2013, J PSYCHOACTIVE DRUGS, V45, P379, DOI 10.1080/02791072.2013.844380; Eisenberg DTA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001216; Ersche KD, 2010, BIOL PSYCHIAT, V68, P770, DOI 10.1016/j.biopsych.2010.06.015; Faraone SV, 2005, BIOL PSYCHIAT, V57, P1313, DOI 10.1016/j.biopsych.2004.11.024; Flint J, 2007, PSYCHOL MED, V37, P163, DOI 10.1017/S0033291706008750; Forbes EE, 2009, MOL PSYCHIATR, V14, P60, DOI 10.1038/sj.mp.4002086; Galesloot TE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095923; Goldman D, 2005, NAT REV GENET, V6, P521, DOI 10.1038/nrg1635; Gottesman II, 2003, AM J PSYCHIAT, V160, P636, DOI 10.1176/appi.ajp.160.4.636; Gustavson DE, 2014, PSYCHOL SCI, V25, P1178, DOI 10.1177/0956797614526260; Hadamitzky M, 2009, BEHAV PHARMACOL, V20, P415, DOI 10.1097/FBP.0b013e3283305e11; Hart AB, 2013, NEUROPSYCHOPHARMACOL, V38, P802, DOI 10.1038/npp.2012.245; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Hutchison KE, 2004, PSYCHOL BULL, V130, P66, DOI 10.1037/0033-2909.130.1.66; Jackson Jacob N S, 2016, Biol Psychiatry Cogn Neurosci Neuroimaging, V1, P316; Jakubczyk A, 2012, J PSYCHIATR RES, V46, P44, DOI 10.1016/j.jpsychires.2011.09.001; Jepsen JRM, 2018, PSYCHOL MED, V48, P604, DOI 10.1017/S0033291717001921; Jimenez E, 2014, EUR NEUROPSYCHOPHARM, V24, P510, DOI 10.1016/j.euroneuro.2014.01.005; Laas K, 2015, J PSYCHOPHARMACOL, V29, P878, DOI 10.1177/0269881115573803; Limosin F, 2003, PSYCHIAT GENET, V13, P127, DOI 10.1097/01.ypg.0000066963.66429.00; Lo MT, 2017, NAT GENET, V49, P152, DOI 10.1038/ng.3736; MacKillop J, 2016, PSYCHOPHARMACOLOGY, V233, P3361, DOI 10.1007/s00213-016-4372-0; MacKillop J, 2013, GENETIC INFLUENCES ON ADDICTION: AN INTERMEDIATE PHENOTYPE APPROACH, P1; MacKillop J, 2011, PSYCHOPHARMACOLOGY, V216, P305, DOI 10.1007/s00213-011-2229-0; Munafo MR, 2004, PSYCHIAT RES, V129, P39, DOI 10.1016/j.psychres.2004.06.011; Nemeth N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084207; Niv S, 2012, BEHAV GENET, V42, P378, DOI 10.1007/s10519-011-9518-6; Paaver M, 2007, PSYCHOPHARMACOLOGY, V194, P545, DOI 10.1007/s00213-007-0867-z; Paloyelis Y, 2010, NEUROPSYCHOPHARMACOL, V35, P2414, DOI 10.1038/npp.2010.124; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; Pe'er I, 2008, GENET EPIDEMIOL, V32, P381, DOI 10.1002/gepi.20303; Pfeifer P., 2015, ALCOHOL ALCOHOLISM; Preuss UW, 2001, NEUROPSYCHOBIOLOGY, V43, P186, DOI 10.1159/000054888; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Quinn PD, 2013, DEV PSYCHOPATHOL, V25, P223, DOI 10.1017/S0954579412000284; Quinn PD, 2011, J ABNORM PSYCHOL, V120, P543, DOI 10.1037/a0023159; Racine SE, 2009, J PSYCHIATR RES, V43, P1278, DOI 10.1016/j.jpsychires.2009.05.002; Reynolds B, 2006, PERS INDIV DIFFER, V40, P305, DOI 10.1016/j.paid.2005.03.024; Robinson ESJ, 2008, NEUROPSYCHOPHARMACOL, V33, P2398, DOI 10.1038/sj.npp.1301636; Rochat L, 2010, NEUROPSYCHOL REHABIL, V20, P778, DOI 10.1080/09602011.2010.495245; Roiser JP, 2007, INT J NEUROPSYCHOPH, V10, P449, DOI 10.1017/S146114570600705X; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Ruble CL, 2016, BMC GENET, V17, DOI 10.1186/s12863-015-0325-6; Sakado K, 2003, AM J MED GENET B, V121B, P71, DOI 10.1002/ajmg.b.20063; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Schilling C, 2014, PSYCHIAT GENET, V24, P82, DOI 10.1097/YPG.0000000000000005; Schuckit MA, 2014, J STUD ALCOHOL DRUGS, P59, DOI 10.15288/jsads.2014.s17.59; Seroczynski AD, 1999, PSYCHIAT RES, V86, P41, DOI 10.1016/S0165-1781(99)00013-X; Smith JL, 2014, DRUG ALCOHOL DEPEN, V145, P1, DOI 10.1016/j.drugalcdep.2014.08.009; Smith RM, 2014, AUTISM RES, V7, P459, DOI 10.1002/aur.1383; Smith RM, 2013, BIOL PSYCHIAT, V73, P546, DOI 10.1016/j.biopsych.2012.09.028; Soeiro-De-Souza MG, 2013, MOL MED REP, V7, P1067, DOI 10.3892/mmr.2013.1336; Stanford MS, 2009, PERS INDIV DIFFER, V47, P385, DOI 10.1016/j.paid.2009.04.008; Steinberg L, 2008, DEV PSYCHOL, V44, P1764, DOI 10.1037/a0012955; Stoltenberg Scott F, 2011, Drug Alcohol Depend, V119, pe31, DOI 10.1016/j.drugalcdep.2011.05.025; Su H, 2014, NEUROSCI LETT, V582, P16, DOI 10.1016/j.neulet.2014.08.030; Varga G, 2012, AM J MED GENET B, V159B, P281, DOI 10.1002/ajmg.b.32025; Whiteside SP, 2001, PERS INDIV DIFFER, V30, P669, DOI 10.1016/S0191-8869(00)00064-7; Wischhof L, 2011, BEHAV PHARMACOL, V22, P805, DOI 10.1097/FBP.0b013e32834d6279; Wood RL, 2013, J INT NEUROPSYCH SOC, V19, P181, DOI 10.1017/S135561771200118X; Wrzosek M, 2014, MOL BIOL REP, V41, P7223, DOI 10.1007/s11033-014-3607-6; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Zhou X, 2012, NAT GENET, V44, P821, DOI 10.1038/ng.2310	84	18	18	0	10	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0165-1781			PSYCHIAT RES	Psychiatry Res.	JAN	2018	259						398	404		10.1016/j.psychres.2017.10.047			7	Psychiatry	Psychiatry	FU1ZT	WOS:000423648700062	29120849	Green Accepted			2021-06-18	
J	Rangaprakash, D; Dretsch, MN; Venkataraman, A; Katz, JS; Denney, TS; Deshpande, G				Rangaprakash, D.; Dretsch, Michael N.; Venkataraman, Archana; Katz, Jeffrey S.; Denney, Thomas S., Jr.; Deshpande, Gopikrishna			Identifying disease foci from static and dynamic effective connectivity networks: Illustration in soldiers with trauma	HUMAN BRAIN MAPPING			English	Article						Functional MRI; effective connectivity; dynamic connectivity; disease foci; posttraumatic stress disorder; mild traumatic brain injury; machine learning	POSTTRAUMATIC-STRESS-DISORDER; RESTING-STATE; BRAIN-INJURY; FUNCTIONAL CONNECTIVITY; GRANGER CAUSALITY; PREFRONTAL CORTEX; FMRI DATA; CLASSIFICATION; METAANALYSIS; VARIABILITY	Brain connectivity studies report group differences in pairwise connection strengths. While informative, such results are difficult to interpret since our understanding of the brain relies on region-based properties, rather than on connection information. Given that large disruptions in the brain are often caused by a few pivotal sources, we propose a novel framework to identify the sources of functional disruption from effective connectivity networks. Our approach integrates static and time-varying effective connectivity modeling in a probabilistic framework, to identify aberrant foci and the corresponding aberrant connectomics network. Using resting-state fMRI, we illustrate the utility of this novel approach in U.S. Army soldiers (N=87) with posttraumatic stress disorder (PTSD), mild traumatic brain injury (mTBI) and combat controls. Additionally, we employed machine-learning classification to identify those significant connectivity features that possessed high predictive ability. We identified three disrupted foci (middle frontal gyrus [MFG], insula, hippocampus), and an aberrant prefrontal-subcortical-parietal network of information flow. We found the MFG to be the pivotal focus of network disruption, with aberrant strength and temporal-variability of effective connectivity to the insula, amygdala and hippocampus. These connectivities also possessed high predictive ability (giving a classification accuracy of 81%); and they exhibited significant associations with symptom severity and neurocognitive functioning. In summary, dysregulation originating in the MFG caused elevated and temporally less-variable connectivity in subcortical regions, followed by a similar effect on parietal memory-related regions. This mechanism likely contributes to the reduced control over traumatic memories leading to re-experiencing, hyperarousal and flashbacks observed in soldiers with PTSD and mTBI. Hum Brain Mapp 39:264-287, 2018. (c) 2017 Wiley Periodicals, Inc.	[Rangaprakash, D.; Katz, Jeffrey S.; Denney, Thomas S., Jr.; Deshpande, Gopikrishna] Auburn Univ, Dept Elect & Comp Engn, AU MRI Res Ctr, 560 Devall Dr,Suite 266D, Auburn, AL 36849 USA; [Rangaprakash, D.] Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90024 USA; [Dretsch, Michael N.] US Army Aeromed Res Lab, Ft Rucker, AL USA; [Dretsch, Michael N.] HQ TRADOC, Human Dimens Div, Ft Eustis, VA USA; [Venkataraman, Archana] Johns Hopkins Univ, Dept Elect & Comp Engn, Baltimore, MD 21218 USA; [Katz, Jeffrey S.; Denney, Thomas S., Jr.; Deshpande, Gopikrishna] Auburn Univ, Dept Psychol, Auburn, AL 36849 USA; [Katz, Jeffrey S.; Denney, Thomas S., Jr.; Deshpande, Gopikrishna] Alabama Adv Imaging Consortium, Birmingham, AL USA	Deshpande, G (corresponding author), Auburn Univ, Dept Elect & Comp Engn, AU MRI Res Ctr, 560 Devall Dr,Suite 266D, Auburn, AL 36849 USA.	gopi@auburn.edu		Deshpande, Gopikrishna/0000-0001-7471-5357; Denney, Thomas/0000-0002-6695-4777; Rangaprakash, D/0000-0001-9553-1354	U.S. Army Medical Research and Materials Command (MRMC) [00007218]	The authors acknowledge financial support for this work from the U.S. Army Medical Research and Materials Command (MRMC) (Grant # 00007218). The views, opinions, and/or findings contained in this article are those of the authors and should not be interpreted as representing the official views or policies, either expressed or implied, of the U.S. Army or the Department of Defense (DoD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors thank the personnel at the TBI clinic and behavioral health clinic, Fort Benning, GA, USA and the US Army Aeromedical Research Laboratory, Fort Rucker, AL, USA, and most of all, the soldiers who participated in the study. The authors thank Julie Rodiek and Wayne Duggan for facilitating data acquisition.	Alba-Ferrara L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028701; Amico E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100012; Bellucci G, 2017, SOC NEUROSCI-UK, V12, P124, DOI 10.1080/17470919.2016.1153518; Berlim MT, 2014, CAN J PSYCHIAT, V59, P487, DOI 10.1177/070674371405900905; Blevins CA, 2015, J TRAUMA STRESS, V28, P489, DOI 10.1002/jts.22059; Boly M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125337; Buchel C, 1998, HUM BRAIN MAPP, V6, P403; Cerullo MA, 2012, BIPOLAR DISORD, V14, P175, DOI 10.1111/j.1399-5618.2012.01002.x; Chen G, 2011, RADIOLOGY, V259, P213, DOI 10.1148/radiol.10100734; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Cisler JM, 2014, J PSYCHIATR RES, V48, P47, DOI 10.1016/j.jpsychires.2013.09.013; Costanzo ME, 2014, NEUROSCI LETT, V577, P11, DOI 10.1016/j.neulet.2014.05.054; Craddock RC, 2012, HUM BRAIN MAPP, V33, P1914, DOI 10.1002/hbm.21333; Craddock RC, 2009, MAGN RESON MED, V62, P1619, DOI 10.1002/mrm.22159; David O, 2008, PLOS BIOL, V6, P2683, DOI 10.1371/journal.pbio.0060315; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Deshpande G, 2009, P ISMRM 17 SCI M 200, P3362; Deshpande G, 2015, IEEE T CYBERNETICS, V45, P2668, DOI 10.1109/TCYB.2014.2379621; Deshpande G, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00670; Deshpande G, 2012, BRAIN CONNECT, V2, P235, DOI 10.1089/brain.2012.0091; Deshpande G, 2012, BEHAV BRAIN SCI, V35, P148, DOI 10.1017/S0140525X1100149X; Deshpande G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014277; Deshpande G, 2011, NEUROIMAGE, V54, P1043, DOI 10.1016/j.neuroimage.2010.09.024; Deshpande G, 2010, IEEE T BIO-MED ENG, V57, P1446, DOI 10.1109/TBME.2009.2037808; Dickstein B.D., 2014, ASSESSMENT; Dretsch Michael N, 2016, Open Neuroimag J, V10, P111; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Emmert K, 2016, NEUROIMAGE, V124, P806, DOI 10.1016/j.neuroimage.2015.09.042; Feng CL, 2016, HUM BRAIN MAPP, V37, P663, DOI 10.1002/hbm.23057; Friston K, 2007, STATISTICAL PARAMETRIC MAPPING: THE ANALYSIS OF FUNCTIONAL BRAIN IMAGES, P1; Garrett DD, 2013, NEUROSCI BIOBEHAV R, V37, P610, DOI 10.1016/j.neubiorev.2013.02.015; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Grant MM, 2015, NEUROPSYCHOPHARMACOL, V40, P1782, DOI 10.1038/npp.2015.28; Grant MM, 2014, HUM BRAIN MAPP, V35, P4815, DOI 10.1002/hbm.22514; Gray MJ, 2004, ASSESSMENT, V11, P330, DOI 10.1177/1073191104269954; Greiser KH, 2009, EUR J EPIDEMIOL, V24, P123, DOI 10.1007/s10654-009-9317-z; Gross J. J, 2014, HDB EMOTION REGULATI; Gualtieri CT, 2006, ARCH CLIN NEUROPSYCH, V21, P623, DOI 10.1016/j.acn.2006.05.007; Guyker WM, 2013, MIL MED, V178, P377, DOI 10.7205/MILMED-D-12-00223; Hall CN, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0348; Handwerker DA, 2004, NEUROIMAGE, V21, P1639, DOI 10.1016/j.neuroimage.2003.11.029; Hansen ECA, 2015, NEUROIMAGE, V105, P525, DOI 10.1016/j.neuroimage.2014.11.001; Hayes JP, 2012, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00089; Hillary FG, 2015, NEUROPSYCHOLOGY, V29, P59, DOI 10.1037/neu0000110; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2009, NEW ENGL J MED, V360, P1588, DOI 10.1056/NEJMp0810606; Hutcheson NL, 2015, HUM BRAIN MAPP, V36, P1442, DOI 10.1002/hbm.22714; Hutchison RM, 2013, NEUROIMAGE, V80, P360, DOI 10.1016/j.neuroimage.2013.05.079; Illari P, 2011, CAUSALITY SCI; Jia H, 2014, BRAIN CONNECT, V4, P741, DOI 10.1089/brain.2014.0300; Jin CF, 2017, HUM BRAIN MAPP, V38, P4479, DOI 10.1002/hbm.23676; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kaminski M, 2001, BIOL CYBERN, V85, P145, DOI 10.1007/s004220000235; Katwal SB, 2013, NEUROIMAGE, V66, P436, DOI 10.1016/j.neuroimage.2012.10.052; Kennis M, 2015, HUM BRAIN MAPP, V36, P99, DOI 10.1002/hbm.22615; King DW, 2003, MANUAL DEPLOYMENT RI; Kirchgassner G, 2012, INTRO MODERN TIME SE; Kriegeskorte N, 2009, NAT NEUROSCI, V12, P535, DOI 10.1038/nn.2303; Krishnan A, 2011, NEUROIMAGE, V56, P455, DOI 10.1016/j.neuroimage.2010.07.034; Lacey S, 2014, NEUROPSYCHOLOGIA, V60, P144, DOI 10.1016/j.neuropsychologia.2014.05.008; Lamichhane B, 2014, BRAIN CONNECT, V4, P619, DOI 10.1089/brain.2014.0243; Liu F, 2015, BRAIN TOPOGR, V28, P221, DOI 10.1007/s10548-014-0386-2; Lohmann G, 2012, NEUROIMAGE, V59, P2322, DOI 10.1016/j.neuroimage.2011.09.025; Marquand AF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069237; Miller RL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149849; Modinos G, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.53; Oishi K, 2015, ANN NEUROL, V77, P68, DOI 10.1002/ana.24300; Pereira F, 2009, NEUROIMAGE, V45, pS199, DOI 10.1016/j.neuroimage.2008.11.007; Pinotsis DA, 2013, NEUROIMAGE, V65, P127, DOI 10.1016/j.neuroimage.2012.10.016; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Rangaprakash D, 2017, NEUROIMAGE-CLIN, V16, P409, DOI 10.1016/j.nicl.2017.07.016; Rangaprakash D, 2017, DATA BRIEF, V14, P558, DOI 10.1016/j.dib.2017.07.072; Rangaprakash D, 2017, HUM BRAIN MAPP, V38, P2843, DOI 10.1002/hbm.23551; Rangaprakash D., 2015, P ANN M INT SOC MAGN, V23, P4402; Rangaprakash D, 2016, P ANN M INT SOC MAGN, V24, P3740; Rashid B, 2016, NEUROIMAGE, V134, P645, DOI 10.1016/j.neuroimage.2016.04.051; Reiss AL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002225; Roebroeck A, 2005, NEUROIMAGE, V25, P230, DOI 10.1016/j.neuroimage.2004.11.017; Rolls ET, 2008, NEUROIMAGE, V41, P1504, DOI 10.1016/j.neuroimage.2008.03.005; Ryali S, 2016, NEUROIMAGE, V132, P398, DOI 10.1016/j.neuroimage.2016.02.067; Ryali S, 2012, NEUROIMAGE, V59, P3852, DOI 10.1016/j.neuroimage.2011.11.054; Ryali S, 2011, NEUROIMAGE, V54, P807, DOI 10.1016/j.neuroimage.2010.09.052; Sakoglu U, 2010, MAGN RESON MATER PHY, V23, P351, DOI 10.1007/s10334-010-0197-8; Sathian K, 2013, J NEUROSCI, V33, P5387, DOI 10.1523/JNEUROSCI.3482-12.2013; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; Simmons AN, 2012, NEUROPHARMACOLOGY, V62, P598, DOI 10.1016/j.neuropharm.2011.03.016; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Spielberg JM, 2015, BIOL PSYCHIAT, V78, P210, DOI 10.1016/j.biopsych.2015.02.013; Squire LR, 2011, ANNU REV NEUROSCI, V34, P259, DOI 10.1146/annurev-neuro-061010-113720; Thayer JF, 2000, J AFFECT DISORDERS, V61, P201, DOI 10.1016/S0165-0327(00)00338-4; Vapnik V., 1995, NATURE STAT LEARNING; Vasterling JJ, 2009, CLIN PSYCHOL REV, V29, P674, DOI 10.1016/j.cpr.2009.08.004; Venkataraman A, 2013, IEEE T MED IMAGING, V32, P2078, DOI 10.1109/TMI.2013.2272976; Vergara VM, 2017, J NEUROTRAUM, V34, P1045, DOI 10.1089/neu.2016.4526; Wang L., 2005, SUPPORT VECTOR MACHI; Weathers F.W, 2015, PTSD CHECKLIST DSM 5; Wen XT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067428; Wheelock MD, 2014, NEUROIMAGE, V102, P904, DOI 10.1016/j.neuroimage.2014.08.005; White SF, 2015, NEUROIMAGE-CLIN, V7, P19, DOI 10.1016/j.nicl.2014.11.012; Woo CW, 2015, PAIN, V156, P1379, DOI 10.1097/j.pain.0000000000000223; Wu GR, 2013, MED IMAGE ANAL, V17, P365, DOI 10.1016/j.media.2013.01.003; Xia MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068910; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Yousef M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-144; Zhang J, 2016, BRAIN, V139, P2307, DOI 10.1093/brain/aww143; Zhao SN, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00211; ZUNG WWK, 1971, PSYCHOSOMATICS, V12, P371; ZUNG WWK, 1965, ARCH GEN PSYCHIAT, V13, P508, DOI 10.1001/archpsyc.1965.01730060026004	109	18	18	0	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1065-9471	1097-0193		HUM BRAIN MAPP	Hum. Brain Mapp.	JAN	2018	39	1					264	287		10.1002/hbm.23841			24	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	FP0IF	WOS:000417282000018	29058357	Green Published			2021-06-18	
J	Samadi-Dooki, A; Voyiadjis, GZ; Stout, RW				Samadi-Dooki, Aref; Voyiadjis, George Z.; Stout, Rhett W.			A combined experimental, modeling, and computational approach to interpret the viscoelastic response of the white matter brain tissue during indentation	JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS			English	Article						Monotonic indentation; Traumatic brain injury; Rate dependent behavior; Finite element modeling	MECHANICAL-PROPERTIES; IN-VIVO; STIFFNESS; DISEASE; STRAIN; TESTS	Viscoelastic properties of the white matter brain tissue are systematically studied in this paper utilizing indentation experiments, mathematical modeling, and finite element simulation. It is first demonstrated that the internal stiffness of the instrument needs to be thoroughly obtained and incorporated in the analysis as its contribution to the recorded mechanical response is significant for experiments on very compliant materials. The flat-punch monotonic indentation is then performed indirectly on sagittal plane slices with pushing a large rigid coverslip into the sample surface. The recorded load and displacement data are used for calibrating different viscoelastic models and presenting numerical values for the model elements. Consequently, the accuracy of the findings based on the theoretical models is investigated by performing finite element simulations which suggest a considerable substrate effect that causes violation of the semi-infinite half-space assumption in modeling of the material behavior. Accordingly, correction factors for adjusting the viscoelastic constants are obtained and presented. Since the Maxwell model shows a superior capability in rendering the mechanical response of the brain, an extension of this model to Multimode Maxwell viscoelastic solid is proposed for modeling the tissue behavior under a more complex load-hold-unload indentation cycle that shows acceptable agreement with experimental observations.	[Samadi-Dooki, Aref; Voyiadjis, George Z.] Louisiana State Univ, Computat Solid Mech Lab, Dept Civil & Environm Engn, Baton Rouge, LA 70803 USA; [Stout, Rhett W.] Louisiana State Univ, Sch Vet Med, Pathobiol Sci Dept, Baton Rouge, LA 70803 USA	Voyiadjis, GZ (corresponding author), Louisiana State Univ, Computat Solid Mech Lab, Dept Civil & Environm Engn, Baton Rouge, LA 70803 USA.	asamad3@lsu.edu; voyiadjis@eng.lsu.edu; rstout1@lsu.edu	Voyiadjis, George Zino/R-1476-2018	Voyiadjis, George Zino/0000-0002-7965-6592; Samadi-Dooki, Aref/0000-0001-5927-9016			Arbogast KB, 1998, J BIOMECH, V31, P801, DOI 10.1016/S0021-9290(98)00068-2; Bayly PV, 2014, J MECH BEHAV BIOMED, V29, P568, DOI 10.1016/j.jmbbm.2013.02.018; Bilston LE, 1997, BIORHEOLOGY, V34, P377, DOI 10.1016/S0006-355X(98)00022-5; Budday S, 2017, ACTA BIOMATER, V48, P319, DOI 10.1016/j.actbio.2016.10.036; Budday S, 2015, J MECH BEHAV BIOMED, V46, P318, DOI 10.1016/j.jmbbm.2015.02.024; Budday S, 2014, J MECH PHYS SOLIDS, V72, P75, DOI 10.1016/j.jmps.2014.07.010; Catani M, 2008, CORTEX, V44, P1105, DOI 10.1016/j.cortex.2008.05.004; Chatelin Simon, 2013, Journal of Biorheology, V27, P26, DOI 10.1007/s12573-012-0055-6; Chatelin S, 2010, BIORHEOLOGY, V47, P255, DOI 10.3233/BIR-2010-0576; Chen FQ, 2015, ANN BIOMED ENG, V43, P2903, DOI 10.1007/s10439-015-1350-3; Darvish K., 2003, STAPP CAR CRASH J, V47, P79; Dimitriadis EK, 2002, BIOPHYS J, V82, P2798, DOI 10.1016/S0006-3495(02)75620-8; Elkin BS, 2011, J BIOMECH ENG-T ASME, V133, DOI 10.1115/1.4004494; Feng Y, 2017, J MECH BEHAV BIOMED, V71, P407, DOI 10.1016/j.jmbbm.2017.04.008; Feng Y, 2017, J MECH BEHAV BIOMED, V65, P490, DOI 10.1016/j.jmbbm.2016.09.020; Feng Y, 2013, J MECH BEHAV BIOMED, V23, P117, DOI 10.1016/j.jmbbm.2013.04.007; Ferrer I, 2007, J NEUROPATH EXP NEUR, V66, P35, DOI 10.1097/nen.0b013e31802c3e7d; Finan JD, 2014, BIOMECH MODEL MECHAN, V13, P573, DOI 10.1007/s10237-013-0519-7; Franceschini G, 2006, J MECH PHYS SOLIDS, V54, P2592, DOI 10.1016/j.jmps.2006.05.004; Gefen A, 2004, J BIOMECH, V37, P1339, DOI 10.1016/j.jbiomech.2003.12.032; HAYES WC, 1972, J BIOMECH, V5, P541, DOI 10.1016/0021-9290(72)90010-3; Hrapko M, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2907746; Jin X, 2013, J BIOMECH, V46, P2795, DOI 10.1016/j.jbiomech.2013.09.001; Kuhl E, 2016, NAT PHYS, V12, P533; LAUN HM, 1978, RHEOL ACTA, V17, P1, DOI 10.1007/BF01567859; Liu KF, 2009, J MECH BEHAV BIOMED, V2, P355, DOI 10.1016/j.jmbbm.2008.12.001; Murphy MC, 2011, J MAGN RESON IMAGING, V34, P494, DOI 10.1002/jmri.22707; Nicolle Stephane, 2004, Stapp Car Crash J, V48, P239; OLIVER WC, 1992, J MATER RES, V7, P1564, DOI 10.1557/JMR.1992.1564; Prevost TP, 2011, ACTA BIOMATER, V7, P83, DOI 10.1016/j.actbio.2010.06.035; Ram YM, 2004, Z ANGEW MATH MECH, V84, P807, DOI 10.1002/zamm.200310137; Samadi-Dooki A, 2017, J BIOMECH ENG-T ASME, V139, DOI 10.1115/1.4036486; Sneddon I.N., 1965, INT J ENG SCI, V3, P47, DOI [DOI 10.1016/0020-7225(65)90019-4, 10.1016/0020-7225(65)90019-4]; Stewart DC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177561; Streitberger KJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029888; Streitberger KJ, 2011, NMR BIOMED, V24, P385, DOI 10.1002/nbm.1602; Tallinen T, 2016, NAT PHYS, V12, P588, DOI [10.1038/nphys3632, 10.1038/NPHYS3632]; Weickenmeier J, 2016, ACTA BIOMATER, V42, P265, DOI 10.1016/j.actbio.2016.07.040	38	18	18	0	14	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1751-6161	1878-0180		J MECH BEHAV BIOMED	J. Mech. Behav. Biomed. Mater.	JAN	2018	77						24	33		10.1016/j.jmbbm.2017.08.037			10	Engineering, Biomedical; Materials Science, Biomaterials	Engineering; Materials Science	FQ4EC	WOS:000418309500003	28888930				2021-06-18	
S	Sussman, ES; Pendharkar, AV; Ho, AL; Ghajar, J		Hainline, B; Stern, RA		Sussman, Eric S.; Pendharkar, Arjun V.; Ho, Allen L.; Ghajar, Jamshid			Mild traumatic brain injury and concussion: terminology and classification	SPORTS NEUROLOGY	Handbook of Clinical Neurology		English	Article; Book Chapter							SPORT; ENCEPHALOPATHY; EPIDEMIOLOGY; AGREEMENT	Traumatic brain injury (TBI) is a major cause of morbidity and mortality throughout the world. Mild TBI, which is typically defined by Glasgow Coma Scale score >= 13, accounts for the vast majority of all TBIs, particularly in the setting of sports-related injuries. The terms concussion and TBI are often used interchangeably, both in the medical literature and in clinical care of this patient population. However, the lack of clearly defined definitions of these terms often leads to confusion, and this confusion may lead to delayed diagnosis and inconsistent management of affected patients. Here, we review the current terminology and classification of mild TBI and concussion. We will also discuss recent efforts to stratify these injuries into clinically relevant subtypes or profiles that are both diagnostic- and treatment-targeted.	[Sussman, Eric S.; Pendharkar, Arjun V.; Ho, Allen L.; Ghajar, Jamshid] Stanford Univ, Sch Med, Dept Neurosurg, Palo Alto, CA 94304 USA	Ghajar, J (corresponding author), Stanford Neurosci Hlth Ctr, 213 Quarry Rd, Palo Alto, CA 94304 USA.	jghajar@stanford.edu					Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Bazarian JJ, 2009, J HEAD TRAUMA REHAB, V24, P439, DOI 10.1097/HTR.0b013e3181c15600; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Carney N, 2014, NEUROSURGERY, V75, pS3, DOI 10.1227/NEU.0000000000000433; Collins MW, 2016, NEUROSURGERY, V79, P912, DOI 10.1227/NEU.0000000000001447; Collins MW, 2014, KNEE SURG SPORT TR A, V22, P235, DOI 10.1007/s00167-013-2791-6; Dabek Filip J, 2016, AMIA Annu Symp Proc, V2016, P460; Ellis MJ, 2015, BRAIN INJURY, V29, P238, DOI 10.3109/02699052.2014.965207; Fitzpatrick J, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967116675272; KATZ DI, 1994, ARCH NEUROL-CHICAGO, V51, P661, DOI 10.1001/archneur.1994.00540190041013; Kay T., 1993, J HEAD TRAUMA REHABI, V8, P86, DOI [10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Management of Concussion/mTBI Working Group, 2009, J REHABILITATION RES, V46; McCrory P, 2017, BRIT J SPORT MED, V51, P877, DOI 10.1136/bjsports-2016-097393; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Saatman K. E., 2010, NEUROTRAUM, V25, P719; Sandel N, 2017, SPORT EXERC PERFORM, V6, P304, DOI 10.1037/spy0000098; TEASDALE G, 1974, LANCET, V2, P81; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Zemek R, 2014, CAN FAM PHYSICIAN, V60, P889	23	18	18	0	0	ELSEVIER	AMSTERDAM	Radarweg 29, PO Box 211, AMSTERDAM, NETHERLANDS	0072-9752		978-0-44-463955-4; 978-0-444-63954-7	HAND CLINIC			2018	158						21	24		10.1016/B978-0-444-63954-7.00003-3			4	Clinical Neurology; Sport Sciences	Neurosciences & Neurology; Sport Sciences	BP1MW	WOS:000540371100005	30482349				2021-06-18	
J	Wiesner, D; Tar, L; Linkus, B; Chandrasekar, A; Heuvel, FO; Dupuis, L; Tsao, W; Wong, PC; Ludolph, A; Roselli, F				Wiesner, Diana; Tar, Lilla; Linkus, Birgit; Chandrasekar, Akila; Heuvel, Florian Olde; Dupuis, Luc; Tsao, William; Wong, Philip C.; Ludolph, Albert; Roselli, Francesco			Reversible induction of TDP-43 granules in cortical neurons after traumatic injury	EXPERIMENTAL NEUROLOGY			English	Article						TDP-43; Cortical injury; ALS	AMYOTROPHIC-LATERAL-SCLEROSIS; FRAGILE-X-SYNDROME; HEAD-INJURY; BRAIN-INJURY; FRONTOTEMPORAL DEMENTIA; PATHOLOGICAL TDP-43; ALZHEIMERS-DISEASE; MOTOR CORTEX; MUTANT SOD1; ALS	Traumatic brain injury (TBI) has been proposed as a risk factor for neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS). To determine whether TBI might trigger or exacerbate ALS-relevant pathology, we delivered a mild stab-wound injury to the motor cortex of three different ALS mouse models expressing mutations in SOD1, TDP-43 or FUS and scrutinized the effects on the formation of phospho-TDP-43 (pTDP-43) cytoplasmic granules. Stab-injury induced the formation of cytoplasmic TDP-43 granules in wt animals, peaking at 3 dpi; a much larger response was seen in mutant TDP-43 mice, whose response peaked at 7 dpi. The pTDP-43 granules did not colocalize with the stress markers TIAR-1 and FUS but colocalized with FMRP (35%) and with p62 (65%), suggesting their involvement in transport granules and their clearance by autophagy. A similar, albeit smaller effect, was seen in mutant FUS mice. In the SOD1(G93A) mouse model, neither increase in pTDP-43 granules nor in SOD1 aggregates were detected. In all cases, pTDP-43 granules were cleared and the number of pTDP-43-positive neurons returned to baseline by 40 dpi. Neither injury-related neuronal loss nor motor performance or survival was significantly different in transgenic mice receiving injury vs sham mice. Thus, trauma can trigger ALS-related TDP-43 pathology, the extent of which is modulated by ALS-related mutations. However, the pathological findings prove reversible and do not affect disease progression and neuronal vulnerability.	[Wiesner, Diana; Tar, Lilla; Linkus, Birgit; Chandrasekar, Akila; Heuvel, Florian Olde; Ludolph, Albert; Roselli, Francesco] Univ Ulm, Sch Med, Dept Neurol, Ulm, Germany; [Dupuis, Luc] INSERM, U1118, Mecanismes Cent & Periphet Neurodegeneresce, Strasbourg, France; [Dupuis, Luc] Univ Strasbourg, Fac Med, Strasbourg, France; [Tsao, William; Wong, Philip C.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Tsao, William; Wong, Philip C.] Johns Hopkins Univ, Sch Med, Cellular & Mol Med Program, Baltimore, MD USA; [Wong, Philip C.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; [Roselli, Francesco] Univ Ulm, Sch Med, Dept Anat & Cell Biol, Ulm, Germany	Roselli, F (corresponding author), Univ Ulm, Sch Med, Dept Neurol, Ctr Biomed Res, Helmholzstr 8-2, D-89081 Ulm De, Germany.	francesco.roselli@uni-ulm.de	roselli, francesco/O-8847-2019; Dupuis, Luc/A-6981-2012	roselli, francesco/0000-0001-9935-6899; 	DFG in the "Danger Response, Disturbance Factors and Regenerative Potential after Acute Trauma" Collaborative Research Center [SFB1149-B05, SFB1149]; ERANET-NEURON "External insults to the CNS" program as part of the MICRONET consortium; Baustein Program of the Ulm University Medical Faculty [LSBN108]	F.R. is member of the Ulm Trauma Research Center and it is supported by DFG (SFB1149-B05) in the "Danger Response, Disturbance Factors and Regenerative Potential after Acute Trauma" Collaborative Research Center (SFB1149), by the ERANET-NEURON "External insults to the CNS" program as part of the MICRONET consortium and by the Baustein Program of the Ulm University Medical Faculty (LSBN108).	AI-Chalabi A, 2014, LANCET NEUROL, V13, P1108, DOI 10.1016/S1474-4422(14)70219-4; Al-Chalabi A, 2015, EPIDEMIOLOGY, V26, P821, DOI 10.1097/EDE.0000000000000381; Al-Chalabi A, 2013, NAT REV NEUROL, V9, P617, DOI 10.1038/nrneurol.2013.203; Armon C, 2012, AMYOTROPH LATERAL SC, V13, P351, DOI 10.3109/17482968.2012.660954; Braak H., 2016, ACTA NEUROPATHOL, V18; Braak H, 2013, NAT REV NEUROL, V9, P708, DOI 10.1038/nrneurol.2013.221; Brenner D., 2016, BRAIN, V5; Brettschneider J, 2014, ACTA NEUROPATHOL, V128, P423, DOI 10.1007/s00401-014-1299-6; Brettschneider J, 2013, ANN NEUROL, V74, P20, DOI 10.1002/ana.23937; Buffo A, 2008, P NATL ACAD SCI USA, V105, P3581, DOI 10.1073/pnas.0709002105; Caller TA, 2015, NEURODEGENER DIS, V15, P202, DOI 10.1159/000374117; Chen HL, 2007, AM J EPIDEMIOL, V166, P810, DOI 10.1093/aje/kwm153; Chio A, 2005, BRAIN, V128, P472, DOI 10.1093/brain/awh373; Ciura S, 2016, AUTOPHAGY, V12, P1406, DOI 10.1080/15548627.2016.1189070; Correia AS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140248; Couratier P, 2016, REV NEUROL-FRANCE, V172, P37, DOI 10.1016/j.neurol.2015.11.002; Coyne AN, 2015, HUM MOL GENET, V24, P6886, DOI 10.1093/hmg/ddv389; Dewey CM, 2011, MOL CELL BIOL, V31, P1098, DOI 10.1128/MCB.01279-10; Dictenberg JB, 2008, DEV CELL, V14, P926, DOI 10.1016/j.devcel.2008.04.003; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Fournier CN, 2015, NEUROLOGY, V84, P1788, DOI 10.1212/WNL.0000000000001522; Freischmidt A, 2015, NAT NEUROSCI, V18, P631, DOI 10.1038/nn.4000; Gal J, 2016, ACTA NEUROPATHOL, V132, P563, DOI 10.1007/s00401-016-1601-x; Goldman SM, 2006, ANN NEUROL, V60, P65, DOI 10.1002/ana.20882; Guo WR, 2011, NAT STRUCT MOL BIOL, V18, P822, DOI 10.1038/nsmb.2053; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Gyoneva S, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0443-0; Hubers A, 2015, NEUROBIOL AGING, V36, DOI 10.1016/j.neurobiolaging.2015.08.005; Johnson VE, 2011, ACTA NEUROPATHOL, V122, P715, DOI 10.1007/s00401-011-0909-9; Kalkonde YV, 2012, ALZHEIMERS DEMENT, V8, P204, DOI 10.1016/j.jalz.2011.03.011; Lee S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6791; Lehman EJ, 2012, NEUROLOGY, V79, P1970, DOI 10.1212/WNL.0b013e31826daf50; Mackenzie IRA, 2007, ANN NEUROL, V61, P427, DOI 10.1002/ana.21147; Majumder P, 2016, ACTA NEUROPATHOL, V132, P721, DOI 10.1007/s00401-016-1603-8; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; Moisse K, 2009, BRAIN RES, V1249, P202, DOI 10.1016/j.brainres.2008.10.021; Nemetz PN, 1999, AM J EPIDEMIOL, V149, P32; Neumann M, 2009, ACTA NEUROPATHOL, V117, P137, DOI 10.1007/s00401-008-0477-9; Peters TL, 2013, AMYOTROPH LAT SCL FR, V14, P267, DOI 10.3109/21678421.2012.754043; Petkau TL, 2014, TRENDS NEUROSCI, V37, P388, DOI 10.1016/j.tins.2014.04.003; Philips T, 2011, LANCET NEUROL, V10, P253, DOI 10.1016/S1474-4422(11)70015-1; Pickles S, 2013, HUM MOL GENET, V22, P3947, DOI 10.1093/hmg/ddt249; Riva N., 2016, J NEUROL, V30; Rosenbohm A, 2014, J NEUROL, V261, P283, DOI 10.1007/s00415-013-7185-7; Scekic-Zahirovic J, 2016, EMBO J, V35, P1077, DOI 10.15252/embj.201592559; Schofield PW, 1997, J NEUROL NEUROSUR PS, V62, P119, DOI 10.1136/jnnp.62.2.119; Scotter EL, 2014, J CELL SCI, V127, P1263, DOI 10.1242/jcs.140087; Shan XY, 2009, NEUROSCI LETT, V458, P70, DOI 10.1016/j.neulet.2009.04.031; Shan X, 2010, P NATL ACAD SCI USA, V107, P16325, DOI 10.1073/pnas.1003459107; Simon C, 2011, GLIA, V59, P869, DOI 10.1002/glia.21156; Soo KY, 2015, CELL DEATH DISCOV, V1, DOI 10.1038/cddiscovery.2015.30; Steinberg KM, 2015, SCI REP-UK, V5, DOI 10.1038/srep09124; Thomsen GM, 2014, J NEUROSCI, V34, P15587, DOI 10.1523/JNEUROSCI.2037-14.2014; Turner BJ, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-104; Urwin H, 2010, ACTA NEUROPATHOL, V120, P33, DOI 10.1007/s00401-010-0698-6; Valavanis A, 2014, J NEUROL, V261, P732, DOI 10.1007/s00415-014-7260-8; van Putten M, 2010, NEUROMUSCULAR DISORD, V20, P273, DOI 10.1016/j.nmd.2010.02.004; Wang HK, 2015, NEUROSCIENCE, V300, P94, DOI 10.1016/j.neuroscience.2015.05.013; Xi ZR, 2014, NEUROLOGY, V83, P1476, DOI 10.1212/WNL.0000000000000886; Ying Z, 2016, AUTOPHAGY, V12, P707, DOI 10.1080/15548627.2016.1151596	60	18	18	0	4	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.		2018	299		A				15	25		10.1016/j.expneurol.2017.09.011			11	Neurosciences	Neurosciences & Neurology	FR7PD	WOS:000419261500002	28941811				2021-06-18	
J	Xie, GG; Peng, WJ; Li, PF; Xia, Z; Zhong, YY; He, F; Tulake, Y; Feng, DD; Wang, Y; Xing, ZH				Xie, Genggeng; Peng, Weijun; Li, Pengfei; Xia, Zian; Zhong, Yuanyuan; He, Feng; Tulake, Yimingaji; Feng, Dandan; Wang, Yang; Xing, Zhihua			A Network Pharmacology Analysis to Explore the Effect of Astragali Radix-Radix Angelica Sinensis on Traumatic Brain Injury	BIOMED RESEARCH INTERNATIONAL			English	Article							TRADITIONAL CHINESE MEDICINE; SYSTEMS PHARMACOLOGY; DRUG DISCOVERY; NOGO-A; RAT; EXPRESSION; DECOCTION; RECEPTOR; NEUROPROTECTION; CALYCOSIN	Traumatic brain injury (TBI) is a critical public health and socioeconomic problem worldwide. The herb pair Astragali Radix (AR)-Radix Angelica Sinensis (RAS) is a common prescribed herbal formula or is added to other Chinese medicine prescriptions for traumatic brain injury (TBI) treatment. However, the underlying mechanisms are unclear. In this study, we aimed to explore the active ingredients and action targets of AR-RAS based on the combined methods of network pharmacology prediction and experimental verification. Furthermore, the corresponding potential mechanisms of "multicomponents, multitargets, and multipathways" were disclosed. Methods. A network pharmacology approach including ADME (absorption, distribution, metabolism, and excretion) filter analysis, target prediction, known therapeutic targets collection, Gene Ontology (GO), pathway enrichment analysis, and network construction was used in this study. Further verification experiments were performed to reveal the therapeutic effects of AR-RAS in a rat model of TBI. Results. The comprehensive systematic approach was to successfully identify 14 bioactive ingredients in AR-RAS, while 33 potential targets hit by these ingredients related to TBI. Based on GO annotation analysis, multiple biological processes were significantly regulated by AR-RAS. In addition, 89 novel signaling pathways (P<0.05) underlying the effects of AR-RAS for TBI treatment were identified by DAVID. The neurotrophin signaling pathway was suggested as the major related pathway targeted by AR-RAS to improve axonal growth. The animal experiment confirmed that AR-RAS significantly induced tissue recovery and improved neurological deficits on the 14th day (P<0.01). Treatment with ARRAS markedly reduced the protein and mRNA expression level of NogoA in the hippocampus of TBI rats. Conclusion. Our work illuminates the "multicompounds, multitargets, and multipathways" curative action of AR-RAS in the treatment of TBI by network pharmacology. The animal experiment verifies the effects of AR-RAS on neurological function improvement and axonal outgrowth via downregulation of NogoA expression, providing a theoretical basis for further research on treatment of TBI.	[Xie, Genggeng; Li, Pengfei; Xia, Zian; Zhong, Yuanyuan; Feng, Dandan; Wang, Yang; Xing, Zhihua] Cent S Univ, Xiangya Hosp, Inst Integrat Med, Changsha 410008, Hunan, Peoples R China; [Peng, Weijun] Cent S Univ, Xiangya Hosp 2, Inst Integrat Med, Changsha 410008, Hunan, Peoples R China; [He, Feng] Cent S Univ, Dept Hepatobiliary Surg, Xiangya Hosp, Changsha 410008, Hunan, Peoples R China; [Tulake, Yimingaji] Third Div Hosp, Dept Gen Surg, Xinjiang Prod & Construct Corps, Xinjiang 844000, Peoples R China	Wang, Y; Xing, ZH (corresponding author), Cent S Univ, Xiangya Hosp, Inst Integrat Med, Changsha 410008, Hunan, Peoples R China.	wangyang_xy87@csu.edu.cn; xzh_56@163.com	Peng, Weijun/M-5131-2014	Peng, Weijun/0000-0002-4506-0942	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81673719, 81874409]; Scientific Research Project of Traditional Chinese Medicine of Hunan [201527]	This project was supported by National Natural Science Foundation of China (Nos. 81673719 and 81874409) and Scientific Research Project of Traditional Chinese Medicine of Hunan (No. 201527).	Abdelhalim MAK, 2018, INT J NANOMED, V13, P2821, DOI 10.2147/IJN.S160995; Adams J H, 1983, Acta Neurochir Suppl (Wien), V32, P15; Adams JH, 2011, J NEUROTRAUM, V28, P701, DOI 10.1089/neu.2010.1733; ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; Anderson J, 2009, J NEUROTRAUM, V26, P1557, DOI [10.1089/neu.2008.0765, 10.1089/neu.2008-0765]; Chen ML, 2001, PHARMACEUT RES, V18, P1645, DOI 10.1023/A:1013319408893; Chen X, 2002, NUCLEIC ACIDS RES, V30, P412, DOI 10.1093/nar/30.1.412; Chen XP, 2013, CHIN J NAT MEDICINES, V11, P577, DOI [10.3724/SP.J.1009.2013.00577, 10.1016/S1875-5364(13)60067-9]; Cheng LL, 2011, FITOTERAPIA, V82, P1128, DOI 10.1016/j.fitote.2011.07.011; Dewan MC, 2016, WORLD NEUROSURG, V91, P497, DOI 10.1016/j.wneu.2016.03.045; Diaz AP, 2012, J NEUROTRAUM, V29, P1029, DOI 10.1089/neu.2011.2089; Dijkers MP, 2004, ARCH PHYS MED REHAB, V85, pS21, DOI 10.1016/j.apmr.2003.08.119; Fan, 2017, ONCOTARGET, V8; Feng DD, 2017, ONCOTARGET, V8, P94692, DOI 10.18632/oncotarget.21876; Gao JQ, 2014, PHARM BIOL, V52, P1217, DOI 10.3109/13880209.2013.879188; Gao L., 2016, SCI REPORTS, V6; Gong J. L. L. W. L., 2008, CHINESE ARCH TRADITI, V09, P1941; Gu JY, 2011, COMPUT BIOL CHEM, V35, P293, DOI 10.1016/j.compbiolchem.2011.07.003; Hao DC, 2014, DRUG DEVELOP RES, V75, P299, DOI 10.1002/ddr.21214; Huber AB, 2002, J NEUROSCI, V22, P3553; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Ip FCF, 2016, BMC COMPLEM ALTERN M, V16, DOI 10.1186/s12906-016-1417-1; Janowitz T, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000330; Jia Rui-zhe, 2005, Zhongguo Zhong Xi Yi Jie He Za Zhi, V25, P54; Jin KL, 2000, P NATL ACAD SCI USA, V97, P10242, DOI 10.1073/pnas.97.18.10242; Jin XY, 2008, J ETHNOPHARMACOL, V117, P473, DOI 10.1016/j.jep.2008.02.033; Lenffer J, 2006, NUCLEIC ACIDS RES, V34, pD599, DOI 10.1093/nar/gkj152; Li J, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/149762; Li JS, 2015, SCI REP-UK, V5, DOI 10.1038/srep15290; Li S, 2013, CHIN J NAT MEDICINES, V11, P110, DOI [10.1016/S1875-5364(13)60037-0, 10.3724/SP.J.1009.2013.00110]; Liang XJ, 2014, MOL BIOSYST, V10, P1014, DOI 10.1039/c3mb70507b; Liu H, 2016, EVID-BASED COMPL ALT, V2016; Mahmood A, 2014, J NEUROSURG, V120, P1147, DOI 10.3171/2013.12.JNS131362; Mahmood A, 2014, BRAIN RES, V1542, P41, DOI 10.1016/j.brainres.2013.10.045; Miao Z. S. F. P., 2013, CHINESE J EXPT TRADI, V02, P163; Pang HQ, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00165; Pernet V, 2012, CELL TISSUE RES, V349, P97, DOI 10.1007/s00441-012-1432-6; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Ran L., 2008, LISHIZHEN MED MAT ME, V7, P1554, DOI DOI 10.3969/J.ISSN.1008-0805.2008.07.004; Reza A, 2018, BRAIN INJURY, V32, P487, DOI 10.1080/02699052.2018.1429658; Ru JL, 2014, J CHEMINFORMATICS, V6, DOI 10.1186/1758-2946-6-13; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Shahzad M, 2016, CURR DRUG TARGETS, V17, P1331, DOI 10.2174/1389450116666150907104742; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Siren AL, 2001, P NATL ACAD SCI USA, V98, P4044, DOI 10.1073/pnas.051606598; Stelmaschuk S, 2015, J TRAUMA NURS, V22, P194, DOI 10.1097/JTN.0000000000000138; Tao L, 2018, BRAIN RES BULL, V140, P154, DOI 10.1016/j.brainresbull.2018.04.008; Tohda C, 2006, BRIT J PHARMACOL, V149, P532, DOI 10.1038/sj.bjp.0706865; Wang WZ, 2017, BRAIN BEHAV IMMUN, V64, P344, DOI 10.1016/j.bbi.2017.04.019; Wang WZ, 2016, MOL NEUROBIOL, V53, P4809, DOI 10.1007/s12035-015-9385-x; Wishart DS, 2006, NUCLEIC ACIDS RES, V34, pD668, DOI 10.1093/nar/gkj067; Xing ZH, 2016, SCI REP-UK, V6, DOI 10.1038/srep20040; Xiong DW, 2011, SCI TOTAL ENVIRON, V409, P1444, DOI 10.1016/j.scitotenv.2011.01.015; Xu T., 2017, J CHINESE MED MAT, V09, P2195; Xu X, 2012, INT J MOL SCI, V13, P6964, DOI 10.3390/ijms13066964; Xu YQ, 2015, CNS NEUROSCI THER, V21, P479, DOI 10.1111/cns.12387; Xu YH, 2011, J ETHNOPHARMACOL, V137, P359, DOI 10.1016/j.jep.2011.05.041; Yadav M, 2018, PHARMACOL REP, V70, P591, DOI 10.1016/j.pharep.2018.01.001; Yamashita T, 2003, NAT NEUROSCI, V6, P461, DOI 10.1038/nn1045; Yamashita T, 1999, NEURON, V24, P585, DOI 10.1016/S0896-6273(00)81114-9; Yang B, 2016, BMC COMPLEM ALTERN M, V16, DOI 10.1186/s12906-016-1076-2; Yang JF, 2013, J SURG RES, V182, pE69, DOI 10.1016/j.jss.2012.11.010; Zhao GW, 2014, J ETHNOPHARMACOL, V151, P694, DOI 10.1016/j.jep.2013.11.041	63	18	18	0	5	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	2314-6133	2314-6141		BIOMED RES INT	Biomed Res. Int.		2018	2018								3951783	10.1155/2018/3951783			13	Biotechnology & Applied Microbiology; Medicine, Research & Experimental	Biotechnology & Applied Microbiology; Research & Experimental Medicine	HE0NJ	WOS:000452963400001	30596090	DOAJ Gold, Green Published			2021-06-18	
J	Kerr, ZY; Cortes, N; Caswell, AM; Ambegaonkar, JP; Hallsmith, KR; Milbert, AF; Caswell, SV				Kerr, Zachary Y.; Cortes, Nelson; Caswell, Amanda M.; Ambegaonkar, Jatin P.; Hallsmith, Kaitlin Romm; Milbert, A. Frederick; Caswell, Shane V.			Concussion Rates in US Middle School Athletes, 2015-2016 School Year	AMERICAN JOURNAL OF PREVENTIVE MEDICINE			English	Article							SPORTS-RELATED CONCUSSION; STATES HIGH-SCHOOL; FOOTBALL PLAYERS; EPIDEMIOLOGY; INJURY; YOUTH; SYMPTOMS; TRENDS	Introduction: Concussion incidence estimates in middle school sports settings are limited. This study examines concussion incidence in nine U.S. middle schools during the 2015-2016 school year. Methods: Concussion data originated from nine public middle schools in Prince William County, Virginia, during the 2015-2016 school year. Certified athletic trainers collected concussion and athlete exposure (AE) data in school-sanctioned games and practices in boys' baseball, basketball, football, soccer, track, and wrestling; and girls' basketball, cheerleading, soccer, softball, track, and volleyball. Athletic trainers also acquired data on non-school sanctioned sport concussions. In 2017, concussion rates were calculated per 1,000 AEs. Injury rate ratios with 95% CIs compared rates between games and practices and by sex. Results: Overall, 73 concussions were reported, of which 21.9% were from non-school sanctioned sport settings. The 57 remaining game and practice concussions were reported during 76,384 AEs, for a concussion rate of 0.75/1,000 AEs. Football had the highest concussion rate (2.61/1,000 AEs). Concussion rates were higher in games versus practices (injury rate ratio = 1.83, 95% CI = 1.06, 3.15), and in girls versus boys in sex-comparable sports, i.e., baseball/softball, basketball, soccer, and track (injury rate ratio = 3.73, 95% CI = 1.24, 11.23). Conclusions: Current findings parallel those found in high school and college sports settings in that higher concussion rates were reported in girls and competitions. However, concussion rates exceeded those recently reported in high school and youth league settings, highlighting the need for continued research in the middle school sports setting. Given that one in five concussions were from non-school sanctioned sport settings, prevention efforts in middle school sports settings should consider sport and non-sport at-risk exposure. (C) 2017 American Journal of Preventive Medicine. Published by Elsevier Inc. All rights reserved.	[Kerr, Zachary Y.] Univ N Carolina, Dept Exercise & Sport Sci, Chapel Hill, NC 27599 USA; [Cortes, Nelson; Caswell, Amanda M.; Ambegaonkar, Jatin P.; Hallsmith, Kaitlin Romm; Caswell, Shane V.] George Mason Univ, Sports Med Assessment Res & Testing SMART Lab, Manassas, VA 20110 USA; [Milbert, A. Frederick] Prince William Cty Virginia, Prince William Cty Publ Sch, Manassas, VA USA	Caswell, SV (corresponding author), George Mason Univ, 10900 Univ Blvd,MS 4E5, Manassas, VA 20110 USA.	scaswell@gmu.edu		Ambegaonkar, Jatin/0000-0002-3790-915X; /0000-0001-8762-3144	Potomac Health Foundation	We greatly appreciate the collaboration of the Prince William County Public Schools and support of the middle school principals, nurses, athletic coordinators, coaches, and athletic trainers. The Middle School ACHIEVES (Advancing Healthcare Initiatives for Underserved Students) Project aims to increase access to health care for underserved communities and is made possible with grant funding from the Potomac Health Foundation, of which S. Caswell is the Principal Investigator and N. Cortes, J. Ambegaonkar, and A. Caswell are co-investigators.	Bakhos LL, 2010, PEDIATRICS, V126, pE550, DOI 10.1542/peds.2009-3101; Beachy G, 2014, J ATHL TRAINING, V49, P493, DOI 10.4085/1062-6050-49.2.19; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Buzas D, 2014, ORTHOP J SPORTS MED, V2, DOI 10.1177/2325967114528460; Comstock RD, CONVENIENCE SAMPLE S; Coronado VG, 2015, J HEAD TRAUMA REHAB, V30, P185, DOI 10.1097/HTR.0000000000000156; Dompier TP, 2015, JAMA PEDIATR, V169, P659, DOI 10.1001/jamapediatrics.2015.0210; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Jacobson NA, 2013, ORTHOP J SPORTS MED, V1, DOI 10.1177/2325967113517860; Kerr Zachary Y, 2016, Inj Epidemiol, V3, P3; Kerr ZY, 2016, JAMA PEDIATR, V170, P647, DOI 10.1001/jamapediatrics.2016.0073; Kerr ZY, 2014, BRAIN INJURY, V28, P1009, DOI 10.3109/02699052.2014.904049; Kerr ZY, 2015, ORTHOP J SPORTS MED, V3; KERR ZY, 2015, ORTHOP J SPORTS MED, V3, DOI DOI 10.1177/23259; Kontos AP, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-1633; Kontos AP, 2013, J PEDIATR-US, V163, P717, DOI 10.1016/j.jpeds.2013.04.011; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; National Academy of Medicine, SPORTS RELATED CONCU; O'Connor KL, 2017, J ATHL TRAINING, V52, P175, DOI 10.4085/1062-6050-52.1.15; O'Kane JW, 2014, JAMA PEDIATR, V168, P258, DOI 10.1001/jamapediatrics.2013.4518; Rosenthal JA, 2014, AM J SPORT MED, V42, P1710, DOI 10.1177/0363546514530091; Turbeville SD, 2003, AM J SPORT MED, V31, P276, DOI 10.1177/03635465030310022001; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	25	18	18	1	23	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0749-3797	1873-2607		AM J PREV MED	Am. J. Prev. Med.	DEC	2017	53	6					914	918		10.1016/j.amepre.2017.05.017			5	Public, Environmental & Occupational Health; Medicine, General & Internal	Public, Environmental & Occupational Health; General & Internal Medicine	FM9VP	WOS:000415620200021	28739314				2021-06-18	
J	Kramer, T; Grob, T; Menzel, L; Hirnet, T; Griemert, E; Radyushkin, K; Thal, SC; Methner, A; Schaefer, MKE				Kraemer, Tobias; Grob, Theresa; Menzel, Lutz; Hirnet, Tobias; Griemert, Eva; Radyushkin, Konstantin; Thal, Serge C.; Methner, Axel; Schaefer, Michael K. E.			Dimethyl fumarate treatment after traumatic brain injury prevents depletion of antioxidative brain glutathione and confers neuroprotection	JOURNAL OF NEUROCHEMISTRY			English	Article						fumaric acid ester derivatives; glutathione; oxidative stress; therapy; traumatic brain injury	REMITTING MULTIPLE-SCLEROSIS; CONTROLLED CORTICAL IMPACT; OXIDATIVE STRESS; IN-VITRO; CEREBRAL-ISCHEMIA; SYNAPTIC PROTEINS; DOUBLE-BLIND; ACID ESTERS; TIME-COURSE; NRF2	Dimethyl fumarate (DMF) is an immunomodulatory compound to treat multiple sclerosis and psoriasis with neuroprotective potential. Its mechanism of action involves activation of the antioxidant pathway regulator Nuclear factor erythroid 2-related factor 2 thereby increasing synthesis of the cellular antioxidant glutathione (GSH). The objective of this study was to investigate whether post-traumatic DMF treatment is beneficial after experimental traumatic brain injury (TBI). Adult C57Bl/6 mice were subjected to controlled cortical impact followed by oral administration of DMF (80mg/kg body weight) or vehicle at 3, 24, 48, and 72h after the inflicted TBI. At 4 days after lesion (dal), DMF-treated mice displayed less neurological deficits than vehicle-treated mice and reduced histopathological brain damage. At the same time, the TBI-evoked depletion of brain GSH was prevented by DMF treatment. However, nuclear factor erythroid 2-related factor 2 target gene mRNA expression involved in antioxidant and detoxifying pathways was increased in both treatment groups at 4 dal. Blood brain barrier leakage, as assessed by immunoglobulin G extravasation, inflammatory marker mRNA expression, and CD45(+) leukocyte infiltration into the perilesional brain tissue was induced by TBI but not significantly altered by DMF treatment. Collectively, our data demonstrate that post-traumatic DMF treatment improves neurological outcome and reduces brain tissue loss in a clinically relevant model of TBI. Our findings suggest that DMF treatment confers neuroprotection after TBI via preservation of brain GSH levels rather than by modulating neuroinflammation.	[Kraemer, Tobias; Grob, Theresa; Menzel, Lutz; Hirnet, Tobias; Griemert, Eva; Thal, Serge C.; Schaefer, Michael K. E.] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Anesthesiol, Langenbeckstr 1, D-55131 Mainz, Germany; [Radyushkin, Konstantin] Johannes Gutenberg Univ Mainz, Focus Program Translat Neurosci FTN, Mouse Behav Unit, Mainz, Germany; [Radyushkin, Konstantin; Thal, Serge C.; Methner, Axel; Schaefer, Michael K. E.] Johannes Gutenberg Univ Mainz, Focus Program Translat Neurosci FTN, Mainz, Germany; [Methner, Axel] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Neurol, Mainz, Germany	Schaefer, MKE (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Anesthesiol, Langenbeckstr 1, D-55131 Mainz, Germany.; Schaefer, MKE (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Focus Program Translat Neurosci FTN, Langenbeckstr 1, D-55131 Mainz, Germany.	michael.schaefer@unimedizin-mainz.de	Thal, Serge/D-6593-2011; Schaefer, Michael K.E./S-1715-2019	Thal, Serge/0000-0002-1222-8729; Schaefer, Michael K.E./0000-0001-6055-6244; Menzel, Lutz/0000-0002-3816-6255; Kramer, Tobias/0000-0001-6900-3486			Abbas K, 2011, FREE RADICAL BIO MED, V51, P107, DOI 10.1016/j.freeradbiomed.2011.03.039; Abdul-Muneer PM, 2015, MOL NEUROBIOL, V51, P966, DOI 10.1007/s12035-014-8752-3; Ahuja M, 2016, J NEUROSCI, V36, P6332, DOI 10.1523/JNEUROSCI.0426-16.2016; Albrecht P, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-163; Ansari MA, 2008, FREE RADICAL BIO MED, V45, P443, DOI 10.1016/j.freeradbiomed.2008.04.038; Ansari MA, 2008, J NEUROTRAUM, V25, P513, DOI 10.1089/neu.2007.0451; Ansari MA, 2014, FREE RADICAL BIO MED, V77, P21, DOI 10.1016/j.freeradbiomed.2014.08.025; Arnold P, 2014, CLIN PHARMACOL-ADV A, V6, P35, DOI 10.2147/CPAA.S35033; Bayir H, 2002, PEDIATR RES, V51, P571, DOI 10.1203/00006450-200205000-00005; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Brennan MS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120254; Clausen BH, 2017, EXP NEUROL, V295, P144, DOI 10.1016/j.expneurol.2017.06.011; Cole JT, 2011, J NEUROTRAUM, V28, P359, DOI 10.1089/neu.2010.1427; Cordaro M., 2016, J NEUROTRAUMA, DOI 10.1089/neu.2016.4678<original-structure ref=info:doi/10.1089/neu.2016.4678></original-structure>; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Du LN, 2016, J NEUROTRAUM, V33, P1913, DOI 10.1089/neu.2015.4342; Dubey D, 2015, EXPERT REV NEUROTHER, V15, P339, DOI 10.1586/14737175.2015.1025755; Eakin K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090617; Escartin C, 2011, J NEUROSCI, V31, P7392, DOI 10.1523/JNEUROSCI.6577-10.2011; Ghoreschi K, 2011, J EXP MED, V208, P2291, DOI 10.1084/jem.20100977; Graber DJ, 2012, J NEUROIMMUNE PHARM, V7, P266, DOI 10.1007/s11481-011-9338-8; Gruenbaum S. E., 2016, CNS DRUGS, V23, P23; Harish G, 2015, J NEUROCHEM, V134, P156, DOI 10.1111/jnc.13082; HELD KD, 1988, RADIAT RES, V115, P495, DOI 10.2307/3577299; Hiebert JB, 2015, AM J MED SCI, V350, P132, DOI 10.1097/MAJ.0000000000000506; Huang CS, 2016, GLIA, V64, P507, DOI 10.1002/glia.22944; Iniaghe LO, 2015, NEUROBIOL DIS, V82, P349, DOI 10.1016/j.nbd.2015.07.001; Jin W, 2009, J NEUROTRAUM, V26, P131, DOI 10.1089/neu.2008.0655; Jullienne A, 2013, FUTUR NEUROL, V8, P677, DOI 10.2217/FNL.13.55; Kappos L, 2008, LANCET, V372, P1463, DOI 10.1016/S0140-6736(08)61619-0; Khan M, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-78; Krug EG, 2000, AM J PUBLIC HEALTH, V90, P523, DOI 10.2105/AJPH.90.4.523; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Kunze R, 2015, EXP NEUROL, V266, P99, DOI 10.1016/j.expneurol.2015.02.022; Lee JM, 2003, J BIOL CHEM, V278, P12029, DOI 10.1074/jbc.M211558200; Lewerenz J, 2011, ANTIOXID REDOX SIGN, V14, P1449, DOI 10.1089/ars.2010.3600; Lewerenz J, 2009, J NEUROCHEM, V111, P332, DOI 10.1111/j.1471-4159.2009.06347.x; Licastro F, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00189; Lin RH, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0733-1; Lin SX, 2011, ASN NEURO, V3, DOI 10.1042/AN20100033; Linker RA, 2011, BRAIN, V134, P678, DOI 10.1093/brain/awq386; Liu YZ, 2015, J NEUROSURG, V123, P915, DOI 10.3171/2014.11.JNS132348; Mckee CA, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00556; Menzel L, 2017, GLIA, V65, P278, DOI 10.1002/glia.23091; Methner A, 2013, NAT REV NEUROL, V9, P72, DOI 10.1038/nrneurol.2012.277; Miller DM, 2014, J NEUROTRAUM, V31, P1194, DOI 10.1089/neu.2013.3218; Nathan C, 2013, NAT REV IMMUNOL, V13, P349, DOI 10.1038/nri3423; NAVARI RM, 1978, MICROVASC RES, V16, P304, DOI 10.1016/0026-2862(78)90064-X; Nelson KC, 1999, INVEST OPHTH VIS SCI, V40, P1927; NIEBOER C, 1990, DERMATOLOGICA, V181, P33, DOI 10.1159/000247856; Noack R, 2012, HUM MOL GENET, V21, P150, DOI 10.1093/hmg/ddr450; OLESEN SP, 1987, ACTA PHYSIOL SCAND, V130, P63, DOI 10.1111/j.1748-1716.1987.tb08112.x; Palle P, 2016, LAB ANIM-UK, V50, P427, DOI 10.1177/0023677216675008; Pandya JD, 2014, EXP NEUROL, V257, P106, DOI 10.1016/j.expneurol.2014.04.020; Penning TM, 2017, CHEM RES TOXICOL, V30, P162, DOI 10.1021/acs.chemrestox.6b00319; Raghupathi R, 2000, J NEUROTRAUM, V17, P927, DOI 10.1089/neu.2000.17.927; Rojo AI, 2014, ANTIOXID REDOX SIGN, V21, P1766, DOI 10.1089/ars.2013.5745; Roth TL, 2014, NATURE, V505, P223, DOI 10.1038/nature12808; Ruggieri S, 2014, THER CLIN RISK MANAG, V10, P229, DOI 10.2147/TCRM.S53285; Salmen A, 2014, EXP NEUROL, V262, P52, DOI 10.1016/j.expneurol.2014.02.015; Scannevin RH, 2012, J PHARMACOL EXP THER, V341, P274, DOI 10.1124/jpet.111.190132; Schafer M, 2014, CELL TISSUE RES, V357, P395, DOI 10.1007/s00441-014-1807-y; Schaible EV, 2014, J NEUROCHEM, V129, P940, DOI 10.1111/jnc.12708; Schulze-Topphoff U, 2016, P NATL ACAD SCI USA, V113, P4777, DOI 10.1073/pnas.1603907113; Schwarzmaier SM, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00358; Schwarzmaier SM, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-32; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Te Ao B, 2014, NEUROLOGY, V83, P1645, DOI 10.1212/WNL.0000000000000933; Thal SC, 2008, J NEUROTRAUM, V25, P785, DOI 10.1089/neu.2007.0497; Thal SC, 2014, ARCH MED RES, V45, P698, DOI 10.1016/j.arcmed.2014.11.006; Tsenter J, 2008, J NEUROTRAUM, V25, P324, DOI 10.1089/neu.2007.0452; Wang HC, 2016, WORLD NEUROSURG, V87, P463, DOI 10.1016/j.wneu.2015.10.010; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Yao Y, 2016, TRANSL STROKE RES, V7, P535, DOI 10.1007/s12975-016-0496-0; Zhang MJ, 2013, PROG NEUROBIOL, V100, P30, DOI 10.1016/j.pneurobio.2012.09.003	75	18	19	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3042	1471-4159		J NEUROCHEM	J. Neurochem.	DEC	2017	143	5					523	533		10.1111/jnc.14220			11	Biochemistry & Molecular Biology; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	FN0OG	WOS:000415677200005	28921587	Bronze			2021-06-18	
J	Reneker, JC; Hassen, A; Phillips, RS; Moughiman, MC; Donaldson, M; Moughiman, J				Reneker, J. C.; Hassen, A.; Phillips, R. S.; Moughiman, M. C.; Donaldson, M.; Moughiman, J.			Feasibility of early physical therapy for dizziness after a sports-related concussion: A randomized clinical trial	SCANDINAVIAN JOURNAL OF MEDICINE & SCIENCE IN SPORTS			English	Article						cervical spine; dizziness; head injuries; concussion; physical therapy; rehabilitation	CERVICOGENIC DIZZINESS; MANUAL THERAPY; VESTIBULAR REHABILITATION; REST; DISORDERS; STATEMENT; SYMPTOMS; RECOVERY; INJURY	The purpose of this study was to (a) assess the feasibility of recruitment/retention of participants, protocol/resource management, and participant safety, and (b) estimate the size of the effect between the experimental and control groups. This was a feasibility study conducted as a prospective pilot double-blind randomized clinical trial. Subjects aged 10-23years old with acute concussion and dizziness were enrolled from sports medicine centers. Forty-one participants were randomized into treatment and were seen for physical therapy beginning at 10days post-concussion. Subjects in the experimental group received individually tailored, pragmatically delivered progressive interventions. Subjects in the control received prescriptive sham to minimally progressive interventions. The two primary outcomes were medical clearance for return-to-play and symptomatic recovery. The median number of days to medical clearance for the experimental group was 15.5 and for the control was 26. The median number of days to symptomatic recovery was 13.5 for the experimental group and was 17 for the control. According to Cox proportional hazards regression for time to medical release for return-to-play, the experimental group demonstrated a hazard ratio of 2.91 (95% CI: 1.01, 8.43) compared to the control. For time-to-symptomatic recovery, those in the experimental group demonstrated a hazard ratio of 1.99 (95% CI: 0.95, 4.15) compared to the control. The results indicate that it is feasible and safe to complete this type of intervention study. The results provide strong support for the allocation of resources to conduct well-powered randomized clinical trials of this intervention.	[Reneker, J. C.] Univ Mississippi, Med Ctr, Sch Hlth Related Profess, Dept Phys Therapy, Jackson, MS USA; [Hassen, A.; Phillips, R. S.; Donaldson, M.] Walsh Univ, North Canton, OH USA; [Moughiman, M. C.; Moughiman, J.] Louis Stokes Cleveland Vet Adm Med Ctr, Akron, OH USA	Reneker, JC (corresponding author), Univ Mississippi, Med Ctr, Sch Hlth Related Profess, Dept Phys Therapy, Jackson, MS USA.	JReneker@UMC.edu	Reneker, Jennifer/N-2038-2016	Reneker, Jennifer/0000-0003-3617-5681	American Academy of Orthopaedic Manual Physical Therapists, Cardon Grant; Ohio Physical Therapy Association	American Academy of Orthopaedic Manual Physical Therapists, Cardon Grant; Ohio Physical Therapy Association	Ahman S, 2013, J REHABIL MED, V45, P758, DOI 10.2340/16501977-1182; Alsalaheen BA, 2013, PHYSIOTHER RES INT, V18, P100, DOI 10.1002/pri.1532; Alsalaheen BA, 2010, J NEUROL PHYS THER, V34, P87, DOI 10.1097/NPT.0b013e3181dde568; Barozzi Stefania, 2006, Int Tinnitus J, V12, P45; Brown DA, 2015, SPORTS MED, V45, P1027, DOI 10.1007/s40279-015-0335-6; Carlesso LC, 2010, J ORTHOP SPORT PHYS, V40, P455, DOI 10.2519/jospt.2010.3229; Craton N, 2014, CURR SPORT MED REP, V13, P201, DOI 10.1249/JSR.0000000000000072; DiFazio M, 2016, CLIN PEDIATR, V55, P443, DOI 10.1177/0009922815589914; Duhaime AC, 2012, J NEUROSURG, V117, P1092, DOI 10.3171/2012.8.JNS112298; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Fife Terry D, 2012, Continuum (Minneap Minn), V18, P1060, DOI 10.1212/01.CON.0000418376.80099.24; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Herdman SJ., 2014, VESTIBULAR REHABILIT, V4th edn; Howell DR, 2016, AM J SPORT MED, V44, P1040, DOI 10.1177/0363546515625045; Lau BC, 2011, AM J SPORT MED, V39, P2311, DOI 10.1177/0363546511410655; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; Makdissi M, 2010, AM J SPORT MED, V38, P464, DOI 10.1177/0363546509349491; Malmstrom EM, 2007, DISABIL REHABIL, V29, P1193, DOI 10.1080/09638280600948383; McCrory P, 2013, CLIN J SPORT MED, V23, P89, DOI 10.1097/JSM.0b013e31828b67cf; Moor HM, 2015, INT J SPORTS PHYS TH, V10, P225; Reid SA, 2005, MANUAL THER, V10, P4, DOI 10.1016/j.math.2004.03.006; Reid SA, 2015, MANUAL THER, V20, P148, DOI 10.1016/j.math.2014.08.003; Reid SA, 2014, PHYS THER, V94, P466, DOI 10.2522/ptj.20120483; Reid SA, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-201; Reneker JC, 2015, BRIT J SPORT MED, V49, P491, DOI 10.1136/bjsports-2014-093634; Schneider KJ, 2014, BRIT J SPORT MED, V48, P1294, DOI 10.1136/bjsports-2013-093267; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; Treleaven J, 2003, J REHABIL MED, V35, P36, DOI 10.1080/16501970306109; Treleaven J, 2008, MANUAL THER, V13, P266, DOI 10.1016/j.math.2007.11.002; Wells EM, 2016, J CHILD NEUROL, V31, P86, DOI 10.1177/0883073815570152	32	18	18	0	21	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0905-7188	1600-0838		SCAND J MED SCI SPOR	Scand. J. Med. Sci. Sports	DEC	2017	27	12					2009	2018		10.1111/sms.12827			10	Sport Sciences	Sport Sciences	FO0DA	WOS:000416411800051	28211600				2021-06-18	
J	Wright, AD; Smirl, JD; Bryk, K; van Donkelaar, P				Wright, Alexander D.; Smirl, Jonathan D.; Bryk, Kelsey; van Donkelaar, Paul			A Prospective Transcranial Doppler Ultrasound-Based Evaluation of the Acute and Cumulative Effects of Sport-Related Concussion on Neurovascular Coupling Response Dynamics	JOURNAL OF NEUROTRAUMA			English	Article						cerebral blood flow; neurovascular coupling; return-to-play; sport-related concussion; transcranial Doppler ultrasound	TRAUMATIC BRAIN-INJURY; CEREBRAL-BLOOD-FLOW; FOOTBALL PLAYERS; RECOVERY; PERFUSION; EXERCISE; MEMORY; MRI; AUTOREGULATION; ABNORMALITIES	Sport-related concussion has been shown to alter cerebral blood flow (CBF) both acutely and chronically, and may exert cumulative effects across multiple injuries. Such dysfunction may be mediated by trauma-induced deficits to CBF control mechanisms, though our understanding of these effects is limited, including dynamics of neurovascular coupling (NVC) responses (i.e., CBF responses to neurologic demand). A total of 179 junior-level contact sport athletes completed preseason testing; 42 reported never having experienced a concussion (Hx(-)) while 31 had endured three or more (Hx(3+)). A total of 18 athletes suffered concussions during the study period and were re-tested 3 days, 2 weeks, and 1 month post-injury. NVC dynamics were indexed via CBF velocity in the posterior (PCAv) and middle (MCAv) cerebral arteries during cycles of 20 sec eyes closed and 40 sec eyes open to a visual stimulus (reading). Acutely following concussion, peak rate of PCAv increase during the activation phase was delayed by over 50% and PCAv response magnitude was elevated by over 30%, compared with preseason. Response magnitude remained elevated at 2 weeks despite symptom resolution. Independent medical clearance for full return-to-play was inversely related to the magnitude of increase in the NVC response at 3 days post-injury. No post-injury changes were observed in MCAv, blood pressure, or end-tidal carbon dioxide levels during visual stimulation. No NVC metric differences were observed between the Hx-and Hx(3+) groups at preseason. Via multiple potential mechanisms, acute sport-related concussion may induce compensatory alterations in NVC response dynamics that may be related to clinical recovery. Such effects do not appear to be persistent across multiple injuries.	[Wright, Alexander D.; Smirl, Jonathan D.; Bryk, Kelsey; van Donkelaar, Paul] Univ British Columbia, Sch Hlth & Exercise Sci, Kelowna, BC, Canada; [Bryk, Kelsey] Univ Delaware, Dept Kinesiol & Appl Physiol, Newark, DE USA	Wright, AD (corresponding author), Univ British Columbia, Art 180-3333 Univ Way, Kelowna, BC V1V 1V7, Canada.	adwright@alumni.ubc.ca		Smirl, Jonathan/0000-0003-1054-0038	Canadian Institutes for Health Research (CIHR)Canadian Institutes of Health Research (CIHR); Canada Foundation for Innovation (CFI)Canada Foundation for Innovation; Mitacs; Vanier Canada Graduate Scholarships program; Vancouver Coastal Health-CIHR-UBC MD/PhD Studentship; Mitacs Accelerate program; Innovations in Wellness fellowship	This research was funded by grants to PvD from the Canadian Institutes for Health Research (CIHR), Canada Foundation for Innovation (CFI), and Mitacs. ADW was supported by the Vanier Canada Graduate Scholarships program and a Vancouver Coastal Health-CIHR-UBC MD/PhD Studentship. JDS was supported by the Mitacs Accelerate program and Innovations in Wellness fellowship.	Abaji JP, 2016, J NEUROTRAUM, V33, P811, DOI 10.1089/neu.2015.3989; Azevedo E, 2007, J NEUROL, V254, P236, DOI 10.1007/s00415-006-0338-1; Barlow K., 2016, J NEUROTRAUM, V9, P1; Bishop S, 2017, BRAIN INJURY, P1; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Bryer EJ, 2013, J INT NEUROPSYCH SOC, V19, P751, DOI 10.1017/S1355617713000490; Cauli B, 2004, J NEUROSCI, V24, P8940, DOI 10.1523/JNEUROSCI.3065-04.2004; Chen BR, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.000787; Chen JK, 2008, CLIN J SPORT MED, V18, P241, DOI 10.1097/JSM.0b013e318170b59d; Chen XH, 2004, AM J PATHOL, V165, P357, DOI 10.1016/S0002-9440(10)63303-2; Churchill N., 2016, J NEUROTRAUM, V33, P1; Conroy Deirdre A, 2005, J Circadian Rhythms, V3, P3, DOI 10.1186/1740-3391-3-3; Covassin T, 2016, J ATHL TRAINING, V51, P189, DOI 10.4085/1062-6050-51.3.05; Dean PJA, 2015, BRAIN BEHAV, V5, DOI 10.1002/brb3.292; Dettwiler A, 2014, J NEUROTRAUM, V31, P180, DOI 10.1089/neu.2013.2983; Doshi H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118061; Elbin RJ, 2012, BRAIN INJURY, V26, P1217, DOI 10.3109/02699052.2012.672788; Ellis MJ, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00136; Ford JH, 2013, J NEUROTRAUM, V30, P1683, DOI 10.1089/neu.2012.2535; Gall B, 2004, MED SCI SPORT EXER, V36, P1269, DOI 10.1249/01.MSS.0000135787.73757.4D; Ge YL, 2009, BRAIN INJURY, V23, P666, DOI 10.1080/02699050903014899; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Gommer ED, 2014, MED ENG PHYS, V36, P613, DOI 10.1016/j.medengphy.2014.01.006; Gosselin N, 2011, J NEUROTRAUM, V28, P329, DOI 10.1089/neu.2010.1493; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Henry LC, 2011, J NEUROTRAUM, V28, P2049, DOI 10.1089/neu.2011.1836; Hilz MJ, 2011, J NEUROTRAUM, V28, P1727, DOI 10.1089/neu.2010.1497; Howarth C, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00103; Jantzen KJ, 2004, AM J NEURORADIOL, V25, P738; Keightley ML, 2014, J NEUROTRAUM, V31, P437, DOI [10.1089/NEU.2013.3052, 10.1089/neu.2013.3052]; Kostoglou K, 2016, IEEE ENG MED BIO, P696, DOI 10.1109/EMBC.2016.7590797; La Fountaine MF, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00013; Lecrux C, 2011, ACTA PHYSIOL, V203, P47, DOI 10.1111/j.1748-1716.2011.02256.x; Liu W, 2013, NMR BIOMED, V26, P651, DOI 10.1002/nbm.2910; Lovell MR, 2007, NEUROSURGERY, V61, P352, DOI 10.1227/01.NEU.0000279985.94168.7F; Maugans TA, 2012, PEDIATRICS, V129, P28, DOI 10.1542/peds.2011-2083; Mayer AR, 2015, NEUROSCI BIOBEHAV R, V49, P8, DOI 10.1016/j.neubiorev.2014.11.016; Mayer AR, 2014, J NEUROTRAUM, V31, P189, DOI 10.1089/neu.2013.3069; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Meier TB, 2015, JAMA NEUROL, V72, P530, DOI 10.1001/jamaneurol.2014.4778; Park E, 2009, J CEREBR BLOOD F MET, V29, P575, DOI 10.1038/jcbfm.2008.151; Persidsky Y, 2006, J NEUROIMMUNE PHARM, V1, P223, DOI 10.1007/s11481-006-9025-3; Phillips AA, 2016, J CEREBR BLOOD F MET, V36, P647, DOI 10.1177/0271678X15617954; Phillips AA, 2014, J CEREBR BLOOD F MET, V34, P794, DOI 10.1038/jcbfm.2014.3; Rosenbaum SB, 2012, BRAIN IMAGING BEHAV, V6, P255, DOI 10.1007/s11682-012-9162-7; Rosenegger DG, 2015, MICROCIRCULATION, V22, P197, DOI 10.1111/micc.12184; Rosengarten B, 2003, J NEUROIMAGING, V13, P43, DOI 10.1177/1051228402239716; Rosengarten B, 2001, ULTRASOUND MED BIOL, V27, P1499, DOI 10.1016/S0301-5629(01)00464-1; Saluja RS, 2015, J NEUROTRAUM, V32, P712, DOI 10.1089/neu.2014.3470; Slobounov SM, 2010, EXP BRAIN RES, V202, P341, DOI 10.1007/s00221-009-2141-6; Smirl JD, 2016, J NEUROSCI METH, V270, P92, DOI 10.1016/j.jneumeth.2016.06.007; Tan CO, 2014, NEUROLOGY, V83, P1665, DOI 10.1212/WNL.0000000000000944; Terry DP, 2012, BRAIN INJURY, V26, P1684, DOI 10.3109/02699052.2012.722259; Vagnozzi R, 2008, NEUROSURGERY, V62, P1286, DOI 10.1227/01.neu.0000333300.34189.74; Wang Y, 2016, J NEUROTRAUM, V33, P1227, DOI 10.1089/neu.2015.4072; Wang Y, 2015, DEV NEUROPSYCHOL, V40, P40, DOI 10.1080/87565641.2014.979927; Willie CK, 2011, J NEUROSCI METH, V198, P270, DOI 10.1016/j.jneumeth.2011.03.017; Willie CK, 2011, J NEUROSCI METH, V196, P221, DOI 10.1016/j.jneumeth.2011.01.011; Willie CK, 2014, J PHYSIOL-LONDON, V592, P841, DOI 10.1113/jphysiol.2013.268953; Wright AD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150215; Yuh EL, 2014, J NEUROTRAUM, V31, P1457, DOI 10.1089/neu.2013.3171	61	18	18	0	9	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	NOV 15	2017	34	22					3097	3106		10.1089/neu.2017.5020			10	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	FL9GC	WOS:000414560000005	28627298				2021-06-18	
J	Yamakawa, GR; Lengkeek, C; Salberg, S; Spanswick, SC; Mychasiuk, R				Yamakawa, Glenn R.; Lengkeek, Connor; Salberg, Sabrina; Spanswick, Simon C.; Mychasiuk, Richelle			Behavioral and pathophysiological outcomes associated with caffeine consumption and repetitive mild traumatic brain injury (RmTBI) in adolescent rats	PLOS ONE			English	Article							SEX-DIFFERENCES; HIPPOCAMPAL NEUROGENESIS; RECEPTOR ANTAGONISTS; GENE-EXPRESSION; ENERGY DRINKS; CONCUSSION; CHILDREN; MODEL; IMPAIRMENT; SLEEP	Given that caffeine consumption is exponentially rising in adolescents and they are at increased risk for repetitive mild traumatic brain injury (RmTBI), we sought to examine the pathophysiological outcomes associated with early life caffeine consumption and RmTBI. Adolescent male and female Sprague Dawley rats received either caffeine in the drinking water or normal water and were then randomly assigned to 3 mild injuries using our lateral impact device or 3 sham procedures. Following injury induction, behavioral outcomes were measured with a test battery designed to examine symptoms consistent with clinical manifestation of PCS (balance and motor coordination, anxiety, short-term working memory, and depressive-like behaviours). In addition, pathophysiological outcomes were examined with histological measures of volume and cellular proliferation in the dentate gyrus, as well as microglia activation in the ventromedial hypothalamus. Finally, modifications to expression of 12 genes (Adora2a, App, Aqp4, Bdnf, Bmall, Clock, Cry, Gfap, Orxl, Orx2, Per, Tau), in the prefrontal cortex, hippocampus, and/or the hypothalamus were assessed. We found that chronic caffeine consumption in adolescence altered normal developmental trajectories, as well as recovery from RmTBI. Of particular importance, many of the outcomes exhibited sex-dependent responses whereby the sex of the animal modified response to caffeine, RmTBI, and the combination of the two. These results suggest that caffeine consumption in adolescents at high risk for RmTBI should be monitored.	[Yamakawa, Glenn R.; Lengkeek, Connor; Salberg, Sabrina; Spanswick, Simon C.; Mychasiuk, Richelle] Univ Calgary, Dept Psychol, Calgary, AB, Canada	Mychasiuk, R (corresponding author), Univ Calgary, Dept Psychol, Calgary, AB, Canada.	rmmychas@ucalgary.ca		Yamakawa, Glenn/0000-0003-3079-6532	University of Calgary; Alberta Children's Hospital Research Institute; O'Brien Summer Studentship Foundation	Financial support from the Integrated Concussion Research Program at the University of Calgary, the Alberta Children's Hospital Research Institute, and the O'Brien Summer Studentship Foundation. No Grant Numbers Available.; The authors would like to thank the Integrated Concussion Research Program at the University of Calgary, the Alberta Children's Hospital Research Institute, and the O'Brien Summer Studentship Foundation for their financial support. The authors would also like to thank Melinda Wang and Rose Tobias for their technical support.	Abbas K, 2015, BRAIN CONNECT, V5, P91, DOI 10.1089/brain.2014.0279; Acosta SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053376; Aepli A, 2015, BRAIN SCI, V5, P441, DOI 10.3390/brainsci5040441; Araujo LF, 2016, J ALZHEIMERS DIS, V53, P451, DOI 10.3233/JAD-160116; Ardais A, 2014, NEUROSCIENCE, V270; Ballesteros-Yanez Inmaculada, 2012, J Caffeine Res, V2, P90, DOI 10.1089/jcr.2012.0011; Behrens M, 2015, SCI REP-UK, V5, DOI 10.1038/srep10209; Benedetti MD, 2000, NEUROLOGY, V55, P1350, DOI 10.1212/WNL.55.9.1350; Bloms LP, 2016, J STRENGTH COND RES, V30, P1855, DOI 10.1519/JSC.0000000000001280; Bonefeld BE, 2008, SYNAPSE, V62, P302, DOI 10.1002/syn.20496; Boone DR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046204; Breedlove EL, 2012, J BIOMECH, V45, P1265, DOI 10.1016/j.jbiomech.2012.01.034; Broshek D, 2012, J NEUROSURG, V102, P856; Brothers HM, 2010, NEUROSCI LETT, V480, P97, DOI 10.1016/j.neulet.2010.06.013; Burke TM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac5125; Chen JF, 2007, PROG NEUROBIOL, V83, P310, DOI 10.1016/j.pneurobio.2007.09.002; Cognato GP, 2010, J NEUROCHEM, V112, P453, DOI 10.1111/j.1471-4159.2009.06465.x; Covassin T, 2007, NEUROSURGERY, V61, P345, DOI 10.1227/01.NEU.0000279972.95060.CB; Daisuke I, 1998, MOL BRAIN RES, V57, P1; De Bellis MD, 2001, CEREB CORTEX, V11, P552, DOI 10.1093/cercor/11.6.552; Dunn GA, 2011, HORM BEHAV, V59, P290, DOI 10.1016/j.yhbeh.2010.05.004; Endesfelder S, 2014, FREE RADICAL BIO MED, V67, P221, DOI 10.1016/j.freeradbiomed.2013.09.026; Gabbita SP, 2005, J NEUROTRAUM, V22, P83, DOI 10.1089/neu.2005.22.83; Ghoneim FM, 2015, INT J CLIN EXP PATHO, V8, P7710; Griesbach GS, 2009, BRAIN RES, V1288, P105, DOI 10.1016/j.brainres.2009.06.045; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Gysland SM, 2012, ANN BIOMED ENG, V40, P14, DOI 10.1007/s10439-011-0421-3; Han ME, 2007, BIOCHEM BIOPH RES CO, V356, P976, DOI 10.1016/j.bbrc.2007.03.086; Han ME, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-110; Harnack L, 1999, J AM DIET ASSOC, V99, P436, DOI 10.1016/S0002-8223(99)00106-6; Hehar H, 2016, NEUROSCIENCE, V332, P61, DOI 10.1016/j.neuroscience.2016.06.039; Howell D, 2013, MED SCI SPORT EXER, V45, P1030, DOI 10.1249/MSS.0b013e3182814595; Huang H, 2006, NEUROIMAGE, V33, P27, DOI 10.1016/j.neuroimage.2006.06.009; Itoh T, 2009, NEUROL RES, V31, P103, DOI 10.1179/016164108X323771; Kamphuis W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042823; Kolb B, 2003, P NATL ACAD SCI USA, V100, P10523, DOI 10.1073/pnas.1834271100; Lakhan SE, 2012, BRAIN BEHAV, V2, P661, DOI 10.1002/brb3.78; Landolt HP, 2004, NEUROPSYCHOPHARMACOL, V29, P1933, DOI 10.1038/sj.npp.1300526; LATINI R, 1980, J PHARM PHARMACOL, V32, P596, DOI 10.1111/j.2042-7158.1980.tb13010.x; Lohsoonthorn V, 2013, SLEEP BREATH, V17, P1017, DOI 10.1007/s11325-012-0792-1; McCarthy MM, 2009, J NEUROSCI, V29, P12815, DOI 10.1523/JNEUROSCI.3331-09.2009; McCrory C, 2017, J NUTR EDUC BEHAV, V49, P304, DOI 10.1016/j.jneb.2016.11.013; Metting Z, 2012, NEUROLOGY, V78, P1428, DOI 10.1212/WNL.0b013e318253d5c7; Minen MT, 2016, CURR NEUROL NEUROSCI, V16, DOI 10.1007/s11910-016-0697-7; Mychasiuk R, 2016, J NEUROSCI METH, V257, P168, DOI 10.1016/j.jneumeth.2015.10.002; Mychasiuk R, 2014, J NEUROTRAUM, V31, P749, DOI 10.1089/neu.2013.3132; Nowak D, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13080768; Oike H, 2011, BIOCHEM BIOPH RES CO, V410, P654, DOI 10.1016/j.bbrc.2011.06.049; Ojo JO, 2016, J NEUROPATH EXP NEUR, V75, P636, DOI 10.1093/jnen/nlw035; Papadopoulos MC, 2004, FASEB J, V18, P1291, DOI 10.1096/fj.04-1723fje; Paus T, 1999, SCIENCE, V283, P1908, DOI 10.1126/science.283.5409.1908; Perlaki G, 2011, BRAIN IMAGING BEHAV, V5, P274, DOI 10.1007/s11682-011-9131-6; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pintor A, 2004, J NEUROCHEM, V89, P152, DOI 10.1111/j.1471-4159.2003.02306.x; Prins ML, 2010, DEV NEUROSCI-BASEL, V32, P510, DOI 10.1159/000316800; Qin  Y., 2016, BEHAV BRAIN RES; Qosa H, 2012, J ALZHEIMERS DIS, V31, P151, DOI 10.3233/JAD-2012-120319; Reddy CC, 2008, PHYS MED REH CLIN N, V19, P247, DOI 10.1016/j.pmr.2007.12.002; Rivera-Oliver M, 2014, LIFE SCI, V101, P1, DOI 10.1016/j.lfs.2014.01.083; Rola R, 2006, EXP NEUROL, V202, P189, DOI 10.1016/j.expneurol.2006.05.034; Rose SC, 2015, PEDIATR NEUROL, V53, P108, DOI 10.1016/j.pediatrneurol.2015.04.003; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Schallert T., 2002, PHARM CEREBRAL ISCHE, P201; Selassie AW, 2013, ANN EPIDEMIOL, V23, P750, DOI 10.1016/j.annepidem.2013.07.022; Sherman H, 2011, INT J BIOCHEM CELL B, V43, P829, DOI 10.1016/j.biocel.2011.02.008; Shrey DW, 2011, PHYS MED REH CLIN N, V22, P577, DOI 10.1016/j.pmr.2011.08.002; Spanswick SC, 2010, LEARN MEMORY, V17, P241, DOI 10.1101/lm.1746710; Temple JL, 2009, NEUROSCI BIOBEHAV R, V33, P793, DOI 10.1016/j.neubiorev.2009.01.001; Van Batenburg-Eddes T, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00457; Viano DC, 2009, NEUROSURGERY, V64, P1162, DOI 10.1227/01.NEU.0000345863.99099.C7; Vila-Luna S, 2012, NEUROSCIENCE, V202, P384, DOI 10.1016/j.neuroscience.2011.11.053; Vynorius KC, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00188; Walf AA, 2007, NAT PROTOC, V2, P322, DOI 10.1038/nprot.2007.44; Whishaw I. Q., 2005, BEHAV LAB RAT HDB TE; Wright D, NEUROBIOLOGY D UNPUB; Wright D, 2017, ANN CLIN TRANSLATION; Wu A, 2004, J NEUROTRAUM, V21, P1457, DOI 10.1089/neu.2004.21.1457; Wu HT, 2008, J NEUROTRAUM, V25, P130, DOI 10.1089/neu.2007.0369; Xu K, 2006, J NEUROSCI, V26, P535, DOI 10.1523/JNEUROSCI.3008-05.2006; Yadid G, 2001, BRAIN RES, V896, P43, DOI 10.1016/S0006-8993(00)03248-0; Yamakawa GR, 2017, EXP NEUROL, V295, P55, DOI 10.1016/j.expneurol.2017.06.001; Zhao J, 2005, J NEUROSCI RES, V82, P499, DOI 10.1002/jnr.20649	82	18	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2017	12	11							e0187218	10.1371/journal.pone.0187218			22	Multidisciplinary Sciences	Science & Technology - Other Topics	FL7JU	WOS:000414424600019	29108016	DOAJ Gold, Green Published			2021-06-18	
J	Chen, SL; Smielewski, P; Czosnyka, M; Papadopoulos, MC; Saadoun, S				Chen, Suliang; Smielewski, Peter; Czosnyka, Marek; Papadopoulos, Marios C.; Saadoun, Samira			Continuous Monitoring and Visualization of Optimum Spinal Cord Perfusion Pressure in Patients with Acute Cord Injury	JOURNAL OF NEUROTRAUMA			English	Article						autoregulation; blood pressure; critical care; spinal cord injuries; vasopressor agents	TRAUMATIC BRAIN-INJURY; INTRASPINAL PRESSURE; INTRATHECAL PRESSURE; MICRODIALYSIS; PROFILE	The optimum spinal cord perfusion pressure (SCPP) after traumatic spinal cord injury (TSCI) is unknown. Here, we describe techniques to compute and display the optimum SCPP in real time. We recruited adults within 72 h of severe TSCI (American Spinal Injuries Association [ASIA] grades A-C). A pressure probe and a microdialysis catheter were placed on the injured cord. SCPP was computed as mean arterial pressure (MAP) minus intraspinal pressure (ISP), spinal pressure reactivity index (sPRx) as the running ISP/MAP correlation coefficient, and continuous optimum SCPP (cSCPP(opt)) as the SCPP that minimizes sPRx in a moving 4-h window. In 45 patients, we monitored ISP and blood pressure. In 14 patients, we also monitored injury site metabolism. cSCPP(opt) could be computed 45% of the time. Mean cSCPP(opt) varied by up to 60 mm Hg between patients. Each patient's cSCPP(opt) varied with time (standard deviation 10-20 mm Hg). Color-coded maps showing the sPRx/SCPP curve evolution enhanced visualization of cSCPP(opt). Periods when SCPP approximate to cSCPP(opt) were associated with low injury site glucose, high pyruvate, and high lactate. Mean SCPP deviation from cSCPP(opt) correlated with worse neurological outcome at 9-12 months: ASIA grade improved in 30% of patients with < 5mm Hg deviation, 10% of patients with 5-15 mm Hg deviation, and no one with > 15 mm Hg deviation. We conclude that real-time computation and visualization of cSCPP(opt) after TSCI are feasible. cSCPP(opt) appears to enhance glucose utilization at the injury site and varies widely between and within patients. Our data suggest that targeting cSCPP(opt) after TSCI might improve neurological outcome.	[Chen, Suliang; Papadopoulos, Marios C.; Saadoun, Samira] St Georges Univ London, Acad Neurosurg Unit, London SW17 0RE, England; [Smielewski, Peter; Czosnyka, Marek] Univ Cambridge, Addenbrookes Hosp, Dept Clin Neurosci, Brain Phys Lab, Cambridge, England; [Czosnyka, Marek] Warsaw Univ Technol, Inst Elect Syst, Warsaw, Poland	Saadoun, S (corresponding author), St Georges Univ London, Acad Neurosurg Unit, London SW17 0RE, England.	ssaadoun@sgul.ac.uk		Saadoun, Samira/0000-0002-5480-5678; Papadopoulos, Marios/0000-0001-9174-4176	Wings for Life Spinal Cord Research Foundation; Neurosciences Research Foundation; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0600986] Funding Source: researchfish	This research was supported by grants awarded to MCP and SS from Wings for Life Spinal Cord Research Foundation and to MCP from the Neurosciences Research Foundation (Fletcher Fund). We thank the neurosurgeons at St. George's Hospital, King's College Hospital, and Hurstwood Park Neurological Centre as well as the spinal orthopaedic surgeons at St. George's Hospital who helped recruit patients. The neuroanaesthetic, neurointensive care, and operating theatre staff at St. George's Hospital helped with data collection.	Aries MJH, 2016, CRIT CARE MED, V44, pE996, DOI 10.1097/CCM.0000000000001816; Aries MJH, 2012, CRIT CARE MED, V40, P2456, DOI 10.1097/CCM.0b013e3182514eb6; Burda JE, 2014, NEURON, V81, P229, DOI 10.1016/j.neuron.2013.12.034; Burns Anthony S, 2012, Handb Clin Neurol, V109, P47, DOI 10.1016/B978-0-444-52137-8.00003-6; Chen S., 2016, J NEUROCHEM; Chen SL, 2016, J NEUROCHEM, V139, P700, DOI 10.1111/jnc.13854; Cozzens JW, 2013, NEUROSURGERY, V72, P2, DOI 10.1227/NEU.0b013e3182772981; Depreitere B, 2016, ACTA NEUROCHIR SUPPL, V122, P245, DOI 10.1007/978-3-319-22533-3_49; Depreitere B, 2014, J NEUROSURG, V120, P1451, DOI 10.3171/2014.3.JNS131500; Fleming JC, 2006, BRAIN, V129, P3249, DOI 10.1093/brain/awl296; Hawryluk G, 2015, J NEUROTRAUM, V32, P1958, DOI 10.1089/neu.2014.3778; Inoue T, 2014, J NEUROTRAUM, V31, P284, DOI 10.1089/neu.2013.3061; Kwon BK, 2009, J NEUROSURG-SPINE, V10, P181, DOI 10.3171/2008.10.SPINE08217; Lee BB, 2014, SPINAL CORD, V52, P110, DOI 10.1038/sc.2012.158; Leonard AV, 2015, J NEUROTRAUM, V32, P397, DOI 10.1089/neu.2014.3543; McKinley W, 2006, J SPINAL CORD MED, V29, P501, DOI 10.1080/10790268.2006.11753899; Papadopoulos MC, 2015, NEUROSURGERY, V77, pE500, DOI 10.1227/NEU.0000000000000862; Phang I, 2016, ANN NEUROL, V80, P522, DOI 10.1002/ana.24750; Phang I, 2016, J NEUROSURG-SPINE, V25, P398, DOI 10.3171/2016.1.SPINE151317; Phang I, 2015, NEUROCRIT CARE, V23, P414, DOI 10.1007/s12028-015-0153-6; Phang I, 2015, J NEUROTRAUM, V32, P865, DOI 10.1089/neu.2014.3668; Ploumis A, 2010, SPINAL CORD, V48, P356, DOI 10.1038/sc.2009.150; Readdy WJ, 2015, J NEUROSURG-SPINE, P1; Saadoun S, 2008, BRAIN, V131, P1087, DOI 10.1093/brain/awn014; Saadoun S, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1490-3; Saadoun S, 2016, BRIT J NEUROSURG, V30, P582, DOI 10.3109/02688697.2016.1173191; Varsos GV, 2015, J NEUROSURG-SPINE, V23, P763, DOI 10.3171/2015.3.SPINE14870; Werndle MC, 2014, CRIT CARE MED, V42, P646, DOI 10.1097/CCM.0000000000000028; Werndle MC, 2012, J NEUROTRAUM, V29, P880, DOI 10.1089/neu.2011.2038	29	18	19	1	7	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	NOV 1	2017	34	21					2941	2949		10.1089/neu.2017.4982			9	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	FK6VJ	WOS:000413643000001	28351230	Green Accepted			2021-06-18	
J	Dremmen, MHG; Wagner, MW; Bosemani, T; Tekes, A; Agostino, D; Day, E; Soares, BP; Huisman, TAGM				Dremmen, M. H. G.; Wagner, M. W.; Bosemani, T.; Tekes, A.; Agostino, D.; Day, E.; Soares, B. P.; Huisman, T. A. G. M.			Does the Addition of a "Black Bone" Sequence to a Fast Multisequence Trauma MR Protocol Allow MRI to Replace CT after Traumatic Brain Injury in Children?	AMERICAN JOURNAL OF NEURORADIOLOGY			English	Article							MINOR HEAD TRAUMA; PEDIATRIC SKULL; 3-DIMENSIONAL RECONSTRUCTION; COMPUTED-TOMOGRAPHY; UNIQUE FEATURES; COMPLICATIONS; EXPERIENCE; MECHANISMS; FRACTURES; DIAGNOSIS	BACKGROUND AND PURPOSE: Head CT is the current neuroimaging tool of choice in acute evaluation of pediatric head trauma. The potential cancer risks of CT-related ionizing radiation should limit its use in children. We evaluated the role of MR imaging, including a "black bone" sequence, compared with CT in detecting skull fractures and intracranial hemorrhages in children with acute head trauma. MATERIALS AND METHODS: We performed a retrospective evaluation of 2D head CT and brain MR imaging studies including the black bone sequence of children with head trauma. Two experienced pediatric neuroradiologists in consensus created the standard of reference. Another pediatric neuroradiologist blinded to the diagnosis evaluated brain MR images and head CT images in 2 separate sessions. The presence of skull fractures and intracranial posttraumatic hemorrhages was evaluated. We calculated the sensitivity and specificity of CT and MR imaging with the black bone sequence in the diagnosis of skull fractures and intracranial hemorrhages. RESULTS: Twenty-eight children (24 boys; mean age, 4.89 years; range, 0-15.5 years) with head trauma were included. MR imaging with the black bone sequence revealed lower sensitivity (66.7% versus 100%) and specificity (87.5% versus 100%) in identifying skull fractures. Four of 6 incorrectly interpreted black bone MR imaging studies showed cranial sutures being misinterpreted as skull fractures and vice versa. CONCLUSIONS: Our preliminary results show that brain MR imaging complemented by a black bone sequence is a promising nonionizing alternative to head CT for the assessment of skull fractures in children. However, accuracy in the detection of linear fractures in young children and fractures of aerated bone remains limited.	[Dremmen, M. H. G.; Wagner, M. W.; Bosemani, T.; Tekes, A.; Agostino, D.; Day, E.; Soares, B. P.; Huisman, T. A. G. M.] Johns Hopkins Univ Hosp, Dept Radiol & Radiol Sci, Div Pediat Radiol & Pediat Neuroradiol, Sect Pediat Neuroradiol, Baltimore, MD 21287 USA; [Dremmen, M. H. G.] Erasmus Univ, Med Ctr Rotterdam, Div Pediat Radiol, Dept Radiol, Rotterdam, Netherlands; [Wagner, M. W.] Univ Hosp Zurich, Inst Diagnost & Intervent Radiol, Zurich, Switzerland	Dremmen, MHG (corresponding author), Erasmus Univ, Med Ctr Rotterdam, Dept Radiol, POB 2040, NL-3000 CA Rotterdam, Netherlands.	m.dremmen@erasmusmc.nl		Huisman, Thierry A.G.M./0000-0003-2302-6724; Wagner, Matthias W./0000-0001-6501-839X			Beauchamp MH, 2011, J NEUROTRAUM, V28, P915, DOI 10.1089/neu.2010.1712; Bonfield CM, 2014, J NEUROSURG-PEDIATR, V14, P205, DOI 10.3171/2014.5.PEDS13414; Bosemani T, 2014, J MAGN RESON IMAGING, V40, P530, DOI 10.1002/jmri.24410; Dunning J, 2006, ARCH DIS CHILD, V91, P885, DOI 10.1136/adc.2005.083980; Eley KA, 2013, DENTOMAXILLOFAC RAD, V42, DOI 10.1259/dmfr.20130236; Eley KA, 2012, BRIT J RADIOL, V85, P1457, DOI 10.1259/bjr/16830245; Eley KA, 2012, BRIT J RADIOL, V85, P272, DOI 10.1259/bjr/95110289; Eley KA, 2014, EUR RADIOL, V24, P2417, DOI 10.1007/s00330-014-3286-7; Greenes DS, 2001, PEDIATR EMERG CARE, V17, P88, DOI 10.1097/00006565-200104000-00002; Hochstadter E, 2014, NEUROCRIT CARE, V21, P505, DOI 10.1007/s12028-014-9986-7; Klassen TP, 2000, ACAD EMERG MED, V7, P739, DOI 10.1111/j.1553-2712.2000.tb02260.x; Orman G, 2015, J NEUROSURG-PEDIATR, V16, P426, DOI 10.3171/2015.3.PEDS1553; Pinto PS, 2012, J NEUROIMAGING, V22, pe18, DOI 10.1111/j.1552-6569.2011.00690.x; Pinto PS, 2012, J NEUROIMAGING, V22, pe1, DOI 10.1111/j.1552-6569.2011.00688.x; Powell EC, 2015, PEDIATRICS, V135, pE851, DOI 10.1542/peds.2014-2858; Roguski M, 2015, J NEUROSURG-PEDIATR, V15, P529, DOI 10.3171/2014.10.PEDS14128; Schmutz B, 2014, J ORAL MAXIL SURG, V72, P611, DOI 10.1016/j.joms.2013.08.030; Schutzman SA, 2001, ANN EMERG MED, V37, P65, DOI 10.1067/mem.2001.109440; Sigmund GA, 2007, PEDIATR NEUROL, V36, P217, DOI 10.1016/j.pediatrneurol.2007.01.003; Tang PH, 2009, PEDIATR RADIOL, V39, P438, DOI 10.1007/s00247-008-1083-7; Tong KA, 2004, ANN NEUROL, V56, P36, DOI 10.1002/ana.20123	21	18	18	0	2	AMER SOC NEURORADIOLOGY	DENVILLE	PO BOX 3000, DENVILLE, NJ 07834-9349 USA	0195-6108	1936-959X		AM J NEURORADIOL	Am. J. Neuroradiol.	NOV	2017	38	11					2187	2192		10.3174/ajnr.A5405			6	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	FN4SI	WOS:000415996600034	28970241	Green Published, Other Gold			2021-06-18	
J	Olczak, M; Niderla-Bielinska, J; Kwiatkowska, M; Samojlowicz, D; Tarka, S; Wierzba-Bobrowicz, T				Olczak, Mieszko; Niderla-Bielinska, Justyna; Kwiatkowska, Magdalena; Samojlowicz, Dorota; Tarka, Sylwia; Wierzba-Bobrowicz, Teresa			Tau protein (MAPT) as a possible biochemical marker of traumatic brain injury in postmortem examination	FORENSIC SCIENCE INTERNATIONAL			English	Article						Traumatic brain injury; Tau; Cerebrospinal fluid; Neuroglia pathology; Endothelial cells; Glymphatic system	CEREBROSPINAL-FLUID; RISK-FACTOR; BLOOD; DAMAGE; AMYLOID-BETA-1-42; EPIDEMIOLOGY; ASTROCYTES; BIOMARKERS; MICROGLIA; DEMENTIA	MAPT is a neuronal protein that plays an important role in axonal stabilization, neuronal development, and neuronal polarity. MAPT release into the CSF and blood has been interpreted as indicative of axonal injury as its elevated levels were observed in olympic boxers even after a mild head trauma suggesting minor CNS injuries. In our study we wanted to check the potential relevance of MAPT examination for forensic purposes. The study was carried out using cases of head injury group and cases of sudden death (cardiopulmonary failure, no injuries of the head - control group) provided by forensic pathologists at the Department of Forensic Medicine, Medical University of Warsaw. CSF and blood were collected within 24 h after death using suboccipital puncture and femoral vein puncture. Serum and cerebrospinal fluid Tau protein concentrations were compared using an enzyme-linked immunosorbent assay (elisa). Brain specimens (frontal cortex) were collected during forensic autopsies. Sections were stained histologically (hematoxylin-eosin) and immunohistochemically with anti human Tau antibody, anti glial fibrillary acid protein (GFAP), anti human macrosialin (CD68) or anti human endothelial cells (CD34). In our study we documented that elevated levels of serum and CSF MAPT may also be considered a marker for mild traumatic brain injury and traumatic brain injury (mTBI and TBI). An increase in CSF and serum levels of MAPT in the absence of visible macroscopic traumatic CNS changes indicates that even minor head injuries may result in changes at the neuronal level that could remain undiagnosed during regular forensic autopsy and routine histopathological examination. (C) 2017 Elsevier B.V. All rights reserved.	[Olczak, Mieszko; Kwiatkowska, Magdalena; Samojlowicz, Dorota; Tarka, Sylwia] Med Univ Warsaw, Dept Forens Med, 1 Oczki St, PL-02007 Warsaw, Poland; [Niderla-Bielinska, Justyna] Med Univ Warsaw, Histol & Embriol Dept, 5 Chalubinskiego St, PL-02004 Warsaw, Poland; [Tarka, Sylwia; Wierzba-Bobrowicz, Teresa] Inst Psychiat & Neurol, Dept Neuropathol, 9 Sobieskiego St, PL-02957 Warsaw, Poland	Olczak, M (corresponding author), Med Univ Warsaw, Dept Forens Med, 1 Oczki St, PL-02007 Warsaw, Poland.		Olczak, Mieszko/N-5974-2018; Samojlowicz, Dorota/Q-1895-2018	Olczak, Mieszko/0000-0001-7055-7451; Samojlowicz, Dorota/0000-0002-4917-0292; Wierzba-Bobrowicz, Teresa/0000-0003-2518-8321	Faculty of Medicine [1MB/PM11/14]	The study was carried out within a Research Project conducted in the years 2014-2015, financed from the statutory subsidy obtained by the 1st Faculty of Medicine (1MB/PM11/14).	Arendt T, 2016, BRAIN RES BULL, V126, P238, DOI 10.1016/j.brainresbull.2016.08.018; Blennow K, 2004, NEUROLOGY, V62, P159, DOI 10.1212/WNL.62.1.159; Blennow K, 2010, NAT REV NEUROL, V6, P131, DOI 10.1038/nrneurol.2010.4; Bolos M, 2016, J ALZHEIMERS DIS, V50, P77, DOI 10.3233/JAD-150704; Chauhan NB, 2014, RESTOR NEUROL NEUROS, V32, P337, DOI 10.3233/RNN-130354; Dent KA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121541; Engel S, 2000, ACTA NEUROPATHOL, V100, P313, DOI 10.1007/s004019900172; Franz G, 2003, NEUROLOGY, V60, P1457, DOI 10.1212/01.WNL.0000063313.57292.00; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Gupta R, 2016, REV NEUROSCIENCE, V27, P93, DOI 10.1515/revneuro-2015-0017; Ikegaya H, 2004, FORENSIC SCI INT, V146, P121, DOI 10.1016/j.forsciint.2004.06.024; Iliff JJ, 2014, J NEUROSCI, V34, P16180, DOI 10.1523/JNEUROSCI.3020-14.2014; Iliff JJ, 2013, J CLIN INVEST, V123, P1299, DOI 10.1172/JCI67677; Iliff JJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003748; Jeganathan S, 2008, BIOCHEMISTRY-US, V47, P10526, DOI 10.1021/bi800783d; Jessen NA, 2015, NEUROCHEM RES, V40, P2583, DOI 10.1007/s11064-015-1581-6; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; KEEP RF, 1990, DEV BRAIN RES, V56, P47, DOI 10.1016/0165-3806(90)90163-S; Loane DJ, 2016, EXP NEUROL, V275, P316, DOI 10.1016/j.expneurol.2015.08.018; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Magnoni S, 2012, BRAIN, V135, P1268, DOI 10.1093/brain/awr286; Majerova P, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0161-z; Marklund N, 2009, J NEUROSURG, V110, P1227, DOI 10.3171/2008.9.JNS08584; Mollenhauer B, 2006, CLIN CHEM LAB MED, V44, P192, DOI 10.1515/CCLM.2006.035; Mollenhauer B, 2006, DEMENT GERIATR COGN, V22, P200, DOI 10.1159/000094871; Mondello S, 2011, EXPERT REV MOL DIAGN, V11, P65, DOI 10.1586/ERM.10.104; Neselius S, 2013, BRAIN INJURY, V27, P425, DOI 10.3109/02699052.2012.750752; Neselius S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033606; Ost M, 2006, NEUROLOGY, V67, P1600, DOI 10.1212/01.wnl.0000242732.06714.0f; Plog BA, 2015, J NEUROSCI, V35, P518, DOI 10.1523/JNEUROSCI.3742-14.2015; Rodriguez-Baeza A, 2003, ANAT REC PART A, V273A, P583, DOI 10.1002/ar.a.10069; Rostami Elham, 2012, Front Neurol, V3, P115, DOI 10.3389/fneur.2012.00115; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Sakka L, 2011, EUR ANN OTORHINOLARY, V128, P309, DOI 10.1016/j.anorl.2011.03.002; Shi H, 2015, EXP NEUROL, V272, P17, DOI 10.1016/j.expneurol.2015.03.017; SHIN RW, 1991, LAB INVEST, V64, P693; Sivanandam TM, 2012, NEUROSCI BIOBEHAV R, V36, P1376, DOI 10.1016/j.neubiorev.2012.02.013; Sjogren M, 2001, CLIN CHEM, V47, P1776; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; TEASDALE G, 1974, LANCET, V2, P81; Thrane AS, 2014, TRENDS NEUROSCI, V37, P620, DOI 10.1016/j.tins.2014.08.010; TROJANOWSKI JQ, 1989, J HISTOCHEM CYTOCHEM, V37, P209, DOI 10.1177/37.2.2492045; Vajtr D, 2009, PHYSIOL RES, V58, P263, DOI 10.33549/physiolres.931253; Washington PM, 2016, EXP NEUROL, V275, P381, DOI 10.1016/j.expneurol.2015.06.015; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Zemlan FP, 1999, J NEUROCHEM, V72, P741, DOI 10.1046/j.1471-4159.1999.0720741.x; Zemlan FP, 2002, BRAIN RES, V947, P131, DOI 10.1016/S0006-8993(02)02920-7	49	18	19	0	16	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0379-0738	1872-6283		FORENSIC SCI INT	Forensic Sci.Int.	NOV	2017	280						1	7		10.1016/j.forsciint.2017.09.008			7	Medicine, Legal	Legal Medicine	FM0NO	WOS:000414663900002	28942078				2021-06-18	
J	Schwartz, JA; Connolly, EJ; Brauer, JR				Schwartz, Joseph A.; Connolly, Eric J.; Brauer, Jonathan R.			Head Injuries and Changes in Delinquency from Adolescence to Emerging Adulthood: The Importance of Self-control as a Mediating Influence	JOURNAL OF RESEARCH IN CRIME AND DELINQUENCY			English	Article						head injuries; self-control; delinquency; desistance; adolescence	TRAUMATIC BRAIN-INJURY; DECISION-MAKING; PREFRONTAL CORTEX; PARENTAL SOCIALIZATION; ANTISOCIAL-BEHAVIOR; GENETIC INFLUENCES; EXECUTIVE FUNCTION; SENSATION SEEKING; METAANALYSIS; IMPULSIVITY	Objectives: The current study examines whether head injuries suffered earlier in the life course are associated with subsequent changes in self-control and delinquency. Methods: Latent growth curve models and path analysis are used to analyze the developmental trajectories of self-control and delinquency as well as the potential associations between head injury, self-control, and delinquency among a sample of youth offenders from the pathways to desistance study. Results: The results revealed significant associations between head injuries and short-term changes in self-control and subsequent increases in aggressive delinquency. Indirect pathway models revealed that lower levels of self-control significantly mediated the association between head injuries and starting levels in aggressive delinquency. The association between head injuries and changes in aggressive delinquency was also significantly mediated by self-control, but the association was negative, indicating that youth who previously suffered head injuries desisted from aggressive delinquency at a slightly faster rate than their noninjured peers. Additional analyses revealed that, despite accelerated rates of decline, injured youth engaged in significantly higher levels of aggressive delinquency throughout the entire observation period. Conclusion: Head injuries represent one environmental factor that may influence delinquent behaviors through their influence on biological and developmental processes.	[Schwartz, Joseph A.] Univ Nebraska, Sch Criminol & Criminal Justice, 218 CPACS,6001 Dodge St, Omaha, NE 68182 USA; [Connolly, Eric J.] Penn State Univ, Dept Criminal Justice, Abington, PA USA; [Connolly, Eric J.] Sam Houston State Univ, Coll Criminal Justice, Huntsville, TX 77340 USA; [Brauer, Jonathan R.] Indiana Univ, Dept Criminal Justice, Bloomington, IN USA	Schwartz, JA (corresponding author), Univ Nebraska, Sch Criminol & Criminal Justice, 218 CPACS,6001 Dodge St, Omaha, NE 68182 USA.	jaschwartz@unomaha.edu		Connolly, Eric/0000-0003-4714-6739			Acock AC, 2005, J MARRIAGE FAM, V67, P1012, DOI 10.1111/j.1741-3737.2005.00191.x; Batts S, 2009, BEHAV SCI LAW, V27, P261, DOI 10.1002/bsl.857; Beaver KM, 2007, CRIM JUSTICE BEHAV, V34, P1345, DOI 10.1177/0093854807302049; Bechara A, 2000, BRAIN, V123, P2189, DOI 10.1093/brain/123.11.2189; Behnken MP, 2015, ROUT INT HANDB, P418; Bentler PM, 2007, PERS INDIV DIFFER, V42, P825, DOI 10.1016/j.paid.2006.09.024; Blokland AAJ, 2005, CRIMINOLOGY, V43, P919, DOI 10.1111/j.1745-9125.2005.00029.x; Boisvert D, 2013, CRIM JUSTICE BEHAV, V40, P80, DOI 10.1177/0093854812453129; Brand M, 2005, NEUROPSYCHOLOGY, V19, P267, DOI 10.1037/0894-4105.19.3.267; Brown CH, 2008, DRUG ALCOHOL DEPEN, V95, pS74, DOI 10.1016/j.drugalcdep.2007.11.013; Brown J., 2015, DENVER POST; Burt CH, 2014, CRIMINOLOGY, V52, P450, DOI 10.1111/1745-9125.12045; Burt CH, 2006, CRIMINOLOGY, V44, P353, DOI 10.1111/j.1745-9125.2006.00052.x; CAMPBELL DT, 1959, PSYCHOL BULL, V56, P81, DOI 10.1037/h0046016; Cardinal RN, 2002, NEUROSCI BIOBEHAV R, V26, P321, DOI 10.1016/S0149-7634(02)00007-6; Cristofori I, 2016, J NEUROSCI, V36, P2757, DOI 10.1523/JNEUROSCI.2975-15.2016; de Ridder DTD, 2012, PERS SOC PSYCHOL REV, V16, P76, DOI 10.1177/1088868311418749; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; DiLisi Matt, 2015, NURTURE VERSUS BIOSO, P172; Farrer TJ, 2011, PROG NEURO-PSYCHOPH, V35, P390, DOI 10.1016/j.pnpbp.2011.01.007; Fishbein D, 2016, INT J OFFENDER THER, V60, P575, DOI 10.1177/0306624X14554778; Forth A.E., 2003, HARE PSYCHOPATHY CHE; Foster SL, 1995, PSYCHOL ASSESSMENT, V7, P248, DOI 10.1037/1040-3590.7.3.248; Frost RB, 2013, NEUROEPIDEMIOLOGY, V40, P154, DOI 10.1159/000343275; Fuhrmann D, 2015, TRENDS COGN SCI, V19, P558, DOI 10.1016/j.tics.2015.07.008; Gibson CL, 2010, J RES CRIME DELINQ, V47, P31, DOI 10.1177/0022427809348903; Glenn AL, 2010, BIOL PSYCHIAT, V67, P52, DOI 10.1016/j.biopsych.2009.06.018; Gottfredson M.R., 1990, GEN THEORY CRIME, DOI DOI 10.2307/1964276; Grant JE, 2014, CNS SPECTRUMS, V19, P21, DOI 10.1017/S109285291300028X; Harden KP, 2012, DEVELOPMENTAL SCI, V15, P150, DOI 10.1111/j.1467-7687.2011.01115.x; Harden KP, 2011, DEV PSYCHOL, V47, P739, DOI 10.1037/a0023279; Hay C., 2016, SELF CONTROL CRIME L; Hay C, 2006, CRIMINOLOGY, V44, P739, DOI 10.1111/j.1745-9125.2006.00062.x; Hirschi Travis, 2004, HDB SELF REGULATION, P537; HOLLINGSHEAD AB, 1971, SOC FORCES, V49, P563, DOI 10.2307/2576737; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; HUIZINGA D, 1991, J CRIM LAW CRIM, V82, P83, DOI 10.2307/1143790; Jimura K, 2013, J NEUROSCI, V33, P344, DOI 10.1523/JNEUROSCI.0919-12.2013; Knutson KM, 2014, HUM BRAIN MAPP, V35, P943, DOI 10.1002/hbm.22225; Konicar L, 2015, SCI REP-UK, V5, DOI 10.1038/srep09426; Loughran TA, 2011, CRIMINOLOGY, V49, P1029, DOI 10.1111/j.1745-9125.2011.00251.x; Meier MH, 2008, J ABNORM PSYCHOL, V117, P377, DOI 10.1037/0021-843X.117.2.377; Meijers J, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00043; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Moffitt TE, 2011, P NATL ACAD SCI USA, V108, P2693, DOI 10.1073/pnas.1010076108; Monahan KC, 2013, DEV PSYCHOPATHOL, V25, P1093, DOI 10.1017/S0954579413000394; Mulvey E. P, 2012, ICPSR29961V2; Mulvey Edward P, 2004, Youth Violence Juv Justice, V2, P213, DOI 10.1177/1541204004265864; Muthen L.K., 1998, MPLUS USERS GUIDE, V8th; Niv S, 2012, BEHAV GENET, V42, P378, DOI 10.1007/s10519-011-9518-6; Ochsner KN, 2005, TRENDS COGN SCI, V9, P242, DOI 10.1016/j.tics.2005.03.010; Ogilvie JM, 2011, CRIMINOLOGY, V49, P1063, DOI 10.1111/j.1745-9125.2011.00252.x; Peper JS, 2007, HUM BRAIN MAPP, V28, P464, DOI 10.1002/hbm.20398; Perron B. E., 2015, INT HDB BIOSOCIAL CR; Polito MZ, 2010, J AM ACAD NURSE PRAC, V22, P504, DOI 10.1111/j.1745-7599.2010.00540.x; Pratt TC, 2004, J RES CRIME DELINQ, V41, P219, DOI 10.1177/0022427803260270; Pratt TC, 2014, CRIMINOLOGY, V52, P87, DOI 10.1111/1745-9125.12030; Rao V, 2009, J NEUROPSYCH CLIN N, V21, P420, DOI 10.1176/appi.neuropsych.21.4.420; Sariaslan A, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002103; Sariaslan A, 2016, JAMA PSYCHIAT, V73, P796, DOI 10.1001/jamapsychiatry.2016.1349; Schubert Carol A, 2004, Youth Violence Juv Justice, V2, P237, DOI 10.1177/1541204004265875; Schug RA, 2010, J NERV MENT DIS, V198, P870, DOI 10.1097/NMD.0b013e3181fe7280; Schwartz JA, 2015, INTELLIGENCE, V51, P109, DOI 10.1016/j.intell.2015.06.001; Scott C, 2015, NEUROPSYCHOLOGY, V29, P501, DOI 10.1037/neu0000074; Selner-O'Hagan MB, 1998, J CHILD PSYCHOL PSYC, V39, P215, DOI 10.1111/1469-7610.00315; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Shiroma Eric J, 2010, J Correct Health Care, V16, P147, DOI 10.1177/1078345809356538; Steinberg L, 1996, LAW HUMAN BEHAV, V20, P249, DOI 10.1007/BF01499023; Steinberg L, 2008, DEV PSYCHOL, V44, P1764, DOI 10.1037/a0012955; Steinberg L, 2008, DEV REV, V28, P78, DOI 10.1016/j.dr.2007.08.002; Steinberg L, 2010, DEV PSYCHOBIOL, V52, P216, DOI 10.1002/dev.20445; Thompson PM, 2001, NAT NEUROSCI, V4, P1253, DOI 10.1038/nn758; Thurman DJ, 2016, J CHILD NEUROL, V31, P20, DOI 10.1177/0883073814544363; Ttofi MM, 2016, J CRIM JUST, V45, P4, DOI 10.1016/j.jcrimjus.2016.02.003; Turner MG, 2005, J CRIM JUST, V33, P327, DOI 10.1016/j.jcrimjus.2005.04.003; Vazsonyi AT, 2017, J CRIM JUST, V48, P48, DOI 10.1016/j.jcrimjus.2016.10.001; Walters GD, 2014, AGGRESSIVE BEHAV, V40, P238, DOI 10.1002/ab.21514; Wechsler D., 2011, WECHLSER ABBREVIATED; WEINBERGER DA, 1990, J PERS, V58, P381, DOI 10.1111/j.1467-6494.1990.tb00235.x; Whiteside SP, 2001, PERS INDIV DIFFER, V30, P669, DOI 10.1016/S0191-8869(00)00064-7; Wiesner M, 2007, CRIMINOLOGY, V45, P835, DOI 10.1111/j.1745-9125.2007.00099.x; Wilk JE, 2012, PSYCHOSOM MED, V74, P249, DOI 10.1097/PSY.0b013e318244c604; Yancey JR, 2013, J CRIM JUST, V41, P309, DOI 10.1016/j.jcrimjus.2013.06.002; Yang YL, 2009, PSYCHIAT RES-NEUROIM, V174, P81, DOI 10.1016/j.pscychresns.2009.03.012; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093	85	18	18	0	22	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0022-4278	1552-731X		J RES CRIME DELINQ	J. Res. Crime Delinq.	NOV	2017	54	6					869	901		10.1177/0022427817710287			33	Criminology & Penology	Criminology & Penology	FJ5UQ	WOS:000412818900005					2021-06-18	
J	Espindola, D; Lee, S; Pinton, G				Espindola, David; Lee, Stephen; Pinton, Gianmarco			Shear Shock Waves Observed in the Brain	PHYSICAL REVIEW APPLIED			English	Article							MAGNETIC-RESONANCE ELASTOGRAPHY; COLLEGIATE FOOTBALL PLAYERS; TISSUE-EQUIVALENT PHANTOMS; HEAD IMPACT EXPOSURE; TRANSIENT ELASTOGRAPHY; SOFT SOLIDS; INJURY; ULTRASOUND; DEFORMATION; PROPAGATION	The internal deformation of the brain is far more complex than the rigid motion of the skull. An ultrasound imaging technique that we have developed has a combination of penetration, frame-rate, and motion-detection accuracy required to directly observe the formation and evolution of shear shock waves in the brain. Experiments at low impacts on the traumatic-brain-injury scale demonstrate that they are spontaneously generated and propagate within the porcine brain. Compared to the initially smooth impact, the acceleration at the shock front is amplified up to a factor of 8.5. This highly localized increase in acceleration suggests that shear shock waves are a previously unappreciated mechanism that could play a significant role in traumatic brain injury.	[Espindola, David] Univ North Carolina Chapel Hill, Joint Dept Biomed Engn, 109 Mason Farm Rd,CB 7575, Chapel Hill, NC 27514 USA; North Carolina State Univ, 4130 Engn Bldg 3,CB 7115, Raleigh, NC 27695 USA	Espindola, D (corresponding author), Univ North Carolina Chapel Hill, Joint Dept Biomed Engn, 109 Mason Farm Rd,CB 7575, Chapel Hill, NC 27514 USA.	david.espindola@unc.edu; gfp@unc.edu	Espindola, DAVID/M-9318-2019	Espindola, DAVID/0000-0001-6675-9560	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01-NS091195]	The authors would like to acknowledge funding from the National Institutes of Health (Grant No. R01-NS091195). They would also like to thank Gregg Trahey and Francisco Melo for their comments on the manuscript.	Bayly PV, 2005, J NEUROTRAUM, V22, P845, DOI 10.1089/neu.2005.22.845; Broglio SP, 2009, J ATHL TRAINING, V44, P342, DOI 10.4085/1062-6050-44.4.342; Burgers J. M., 1948, ADV APPL MECH, P171, DOI DOI 10.1016/S0065-2156(08)70100-5; Catheline S, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.164301; Crisco JJ, 2011, J BIOMECH, V44, P2673, DOI 10.1016/j.jbiomech.2011.08.003; Daniel RW, 2012, ANN BIOMED ENG, V40, P976, DOI 10.1007/s10439-012-0530-7; Darvish KK, 2001, MED ENG PHYS, V23, P633, DOI 10.1016/S1350-4533(01)00101-1; Donnelly BR, 1997, J BIOMECH ENG-T ASME, V119, P423, DOI 10.1115/1.2798289; Duck FA, 1990, PHYS PROPERTIES TISS; Giammarinaro B, 2016, J BIOMECH ENG-T ASME, V138, DOI 10.1115/1.4032643; Goriely A, 2016, PHYS REV LETT, V117, DOI 10.1103/PhysRevLett.117.138001; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; Guskiewicz KM, 2007, NEUROSURGERY, V61, P1244, DOI 10.1227/01.neu.0000306103.68635.1a; Hamhaber U, 2010, J MAGN RESON IMAGING, V32, P577, DOI 10.1002/jmri.22294; Johnson CL, 2013, MAGN RESON MED, V70, P404, DOI 10.1002/mrm.24473; Laksari K, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0331; Landau L., 1959, COURSE THEORETICAL P, V7; MARGULIES SS, 1992, J BIOMECH, V25, P917, DOI 10.1016/0021-9290(92)90231-O; Montaldo G, 2009, IEEE T ULTRASON FERR, V56, P489, DOI 10.1109/TUFFC.2009.1067; Moss WC, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.108702; Oppenheim A.V., 1983, SIGNALS SYSTEMS, V2; Park JH, 2015, P NATL ACAD SCI USA, V112, P9236, DOI 10.1073/pnas.1505939112; Pinton G, 2014, IEEE T ULTRASON FERR, V61, P1489, DOI 10.1109/TUFFC.2014.3063; Pinton G, 2012, IEEE INT ULTRA SYM, P142, DOI 10.1109/ULTSYM.2012.0035; Pinton G, 2010, J ACOUST SOC AM, V127, P683, DOI 10.1121/1.3277202; Pinton GF, 2006, IEEE T ULTRASON FERR, V53, P1103, DOI 10.1109/TUFFC.2006.1642509; Pinton GF, 2017, IEEE T ULTRASON FERR, V64, P537, DOI 10.1109/TUFFC.2016.2638801; Pinton GF, 2011, IEEE T ULTRASON FERR, V58, P754, DOI 10.1109/TUFFC.2011.1868; Razani M, 2014, BIOMED OPT EXPRESS, V5, P895, DOI 10.1364/BOE.5.000895; Razani M, 2012, BIOMED OPT EXPRESS, V3, P972, DOI 10.1364/BOE.3.000972; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; Rowson S, 2013, ANN BIOMED ENG, V41, P873, DOI 10.1007/s10439-012-0731-0; Rusanov V., 1970, J COMPUT PHYS, V5, P507; Song SZ, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.12.121505; Sullivan S, 2015, BIOMECH MODEL MECHAN, V14, P877, DOI 10.1007/s10237-014-0643-z; Tanter M, 2002, IEEE T ULTRASON FERR, V49, P1363, DOI 10.1109/TUFFC.2002.1041078; Whitham G. B., 1974, PURE APPL MATH; Wochner MS, 2008, J ACOUST SOC AM, V123, P2488, DOI 10.1121/1.2890739; Wright RM, 2012, BIOMECH MODEL MECHAN, V11, P245, DOI 10.1007/s10237-011-0307-1; Zabolotskaya EA, 2004, J ACOUST SOC AM, V116, P2807, DOI 10.1121/1.1802533	40	18	18	1	13	AMER PHYSICAL SOC	COLLEGE PK	ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA	2331-7019			PHYS REV APPL	Phys. Rev. Appl.	OCT 31	2017	8	4							044024	10.1103/PhysRevApplied.8.044024			9	Physics, Applied	Physics	FL2GY	WOS:000414034600001		Bronze			2021-06-18	
J	Enam, SF; Krieger, JR; Saxena, T; Watts, BE; Olingy, CE; Botchwey, EA; Bellamkonda, RV				Enam, Syed Faaiz; Krieger, Jack R.; Saxena, Tarun; Watts, Brian E.; Olingy, Claire E.; Botchwey, Edward A.; Bellamkonda, Ravi V.			Enrichment of endogenous fractalkine and anti-inflammatory cells via aptamer-functionalized hydrogels	BIOMATERIALS			English	Article						Fractalkine; Macrophage; Monocyte; Inflammation; Aptamer; Endogenous	TRAUMATIC BRAIN-INJURY; SPINAL-CORD; RECEPTOR CX(3)CR1; NONCLASSICAL MONOCYTES; CHEMOKINE FRACTALKINE; EXOGENOUS FRACTALKINE; ENDOTHELIAL-CELLS; BLOOD MONOCYTES; GROWTH-FACTORS; TISSUE-REPAIR	Early recruitment of non-classical monocytes and their macrophage derivatives is associated with augmented tissue repair and improved integration of biomaterial constructs. A promising therapeutic approach to recruit these subpopulations is by elevating local concentrations of chemoattractants such as fractalkine (FKN, CX3CL1). However, delivering recombinant or purified proteins is not ideal due to their short half-lives, suboptimal efficacy, immunogenic potential, batch variabilities, and cost. Here we report an approach to enrich endogenous FKN, obviating the need for delivery of exogenous proteins. In this study, modified FKN-binding-aptamers are integrated with poly(ethylene glycol) diacrylate to form aptamer-functionalized hydrogels ("aptagels") that localize, dramatically enrich and passively release FKN in vitro for at least one week. Implantation in a mouse model of excisional skin injury demonstrates that aptagels enrich endogenous FKN and stimulate significant local increases in Ly6C(lo)CX3CR1(hi) non-classical monocytes and CD206(+) M2-like macrophages. The results demonstrate that orchestrators of inflammation can be manipulated without delivery of foreign proteins or cells and FKN-aptamer functionalized biomaterials may be a promising approach to recruit anti-inflammatory subpopulations to sites of injury. Aptagels are readily synthesized, highly customizable and could combine different aptamers to treat complex diseases in which regulation or enrichment of multiple proteins may be therapeutic. (C) 2017 Elsevier Ltd. All rights reserved.	[Enam, Syed Faaiz; Saxena, Tarun; Bellamkonda, Ravi V.] Duke Univ, Dept Biomed Engn, Durham, NC 27708 USA; [Krieger, Jack R.; Olingy, Claire E.; Botchwey, Edward A.] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; [Krieger, Jack R.; Olingy, Claire E.; Botchwey, Edward A.] Emory Sch Med, Atlanta, GA 30332 USA; [Watts, Brian E.] Duke Univ, Duke Human Vaccine Inst, Durham, NC 27708 USA	Bellamkonda, RV (corresponding author), Duke Univ, Dept Biomed Engn, Durham, NC 27708 USA.	ravi@duke.edu		Watts, Brian/0000-0003-1731-2441; Enam, Syed Faaiz/0000-0002-5320-6809			Acquah C, 2015, ANAL CHIM ACTA, V888, P10, DOI 10.1016/j.aca.2015.05.050; Panek CA, 2015, CELL MOL IMMUNOL, V12, P669, DOI 10.1038/cmi.2014.116; Auffray C, 2009, J EXP MED, V206, P595, DOI 10.1084/jem.20081385; Awojoodu AO, 2013, P NATL ACAD SCI USA, V110, P13785, DOI 10.1073/pnas.1221309110; Battig MR, 2014, BIOMATERIALS, V35, P8040, DOI 10.1016/j.biomaterials.2014.06.001; Bazan JF, 1997, NATURE, V385, P640, DOI 10.1038/385640a0; Blazquez R, 2016, ACTA BIOMATER, V31, P221, DOI 10.1016/j.actbio.2015.11.057; Blomster LV, 2013, EXP NEUROL, V247, P226, DOI 10.1016/j.expneurol.2013.05.002; Brinks V, 2013, PHARM RES-DORDR, V30, P1719, DOI 10.1007/s11095-013-1062-z; Brown BN, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00510; Brown Larry R, 2005, Expert Opin Drug Deliv, V2, P29, DOI 10.1517/17425247.2.1.29; Carlin L.M., 2001, CURR PROTOC IMMUNOL; Cipriani R, 2011, J NEUROSCI, V31, P16327, DOI 10.1523/JNEUROSCI.3611-11.2011; Clover AJP, 2011, BURNS, V37, P1386, DOI 10.1016/j.burns.2011.08.001; Das A, 2015, BIOMATERIALS, V64, P98, DOI 10.1016/j.biomaterials.2015.06.019; Das A, 2013, BIOMATERIALS, V34, P9853, DOI 10.1016/j.biomaterials.2013.08.015; Dickey DD, 2016, METHODS, V97, P94, DOI 10.1016/j.ymeth.2015.11.020; Donohue MM, 2012, STROKE, V43, P2300, DOI 10.1161/STROKEAHA.112.657411; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Ensan S, 2016, NAT IMMUNOL, V17, P159, DOI 10.1038/ni.3343; Francos-Quijorna I, 2016, GLIA, V64, P2079, DOI 10.1002/glia.23041; Gaetani P, 2013, J NEUROSURG SCI, V57, P55; Gao SX, 2016, ANAL BIOANAL CHEM, V408, P4567, DOI 10.1007/s00216-016-9556-2; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Geissmann F, 2008, IMMUNOL CELL BIOL, V86, P398, DOI 10.1038/icb.2008.19; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Gevrey JC, 2005, J IMMUNOL, V175, P3737, DOI 10.4049/jimmunol.175.6.3737; Goda S, 2000, J IMMUNOL, V164, P4313, DOI 10.4049/jimmunol.164.8.4313; Haskell CA, 2000, J BIOL CHEM, V275, P34183, DOI 10.1074/jbc.M005731200; He M, 2009, SHOCK, V31, P33, DOI 10.1097/SHK.0b013e31817789da; Hilgendorf I, 2014, CIRC RES, V114, P1611, DOI 10.1161/CIRCRESAHA.114.303204; Hu JP, 2017, J MOL MED, V95, P249, DOI 10.1007/s00109-016-1485-1; Hu PP, 2017, INFLAMMATION, V40, P295, DOI 10.1007/s10753-016-0437-9; Imai T, 1997, CELL, V91, P521, DOI 10.1016/S0092-8674(00)80438-9; Ishida Y, 2008, J IMMUNOL, V180, P569, DOI 10.4049/jimmunol.180.1.569; Kanwar JR, 2015, CURR MED CHEM, V22, P2539, DOI 10.2174/0929867322666150227144909; Karlmark KR, 2010, HEPATOLOGY, V52, P1769, DOI 10.1002/hep.23894; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Kim MS, 2014, J COSMET DERMATOL-US, V13, P44, DOI 10.1111/jocd.12073; Kong HY, 2013, BIOMOL THER, V21, P423, DOI 10.4062/biomolther.2013.085; Krieger JR, 2016, BIOMATERIALS, V77, P280, DOI 10.1016/j.biomaterials.2015.10.045; Landsman L, 2009, BLOOD, V113, P963, DOI 10.1182/blood-2008-07-170787; Lao YH, 2015, ACS NANO, V9, P2235, DOI 10.1021/nn507494p; Lapa SA, 2016, MOL BIOTECHNOL, V58, P79, DOI 10.1007/s12033-015-9907-9; Lee MJ, 2011, CYTOTHERAPY, V13, P165, DOI 10.3109/14653249.2010.512632; Lee SI, 2010, J NEUROSCI RES, V88, P2409, DOI 10.1002/jnr.22411; Li J, 2016, INFLAMMATION, V39, P1704, DOI 10.1007/s10753-016-0405-4; Liu B, 2014, J BIOMED NANOTECHNOL, V10, P3189, DOI 10.1166/jbn.2014.1839; Moelants EAV, 2013, IMMUNOL CELL BIOL, V91, P402, DOI 10.1038/icb.2013.16; Mokarram N, 2017, P NATL ACAD SCI USA, V114, pE5077, DOI 10.1073/pnas.1705757114; Mokarram N, 2014, ANN BIOMED ENG, V42, P338, DOI 10.1007/s10439-013-0941-0; Mokarram N, 2012, BIOMATERIALS, V33, P8793, DOI 10.1016/j.biomaterials.2012.08.050; Nahrendorf M, 2007, J EXP MED, V204, P3037, DOI 10.1084/jem.20070885; Nimjee SM, 2017, ANNU REV PHARMACOL, V57, P61, DOI 10.1146/annurev-pharmtox-010716-104558; Ogle M.E., 2017, ACS BIOMATER SCI ENG; Ogle ME, 2016, EXP BIOL MED, V241, P1084, DOI 10.1177/1535370216650293; Olingy CE, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00477-1; Pabon MM, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-9; Pan Y, 1997, NATURE, V387, P611, DOI 10.1038/42491; Pastor F, 2016, PHARMACEUTICALS-BASE, V9, DOI 10.3390/ph9040064; Qin WJ, 2014, NEUROSCI LETT, V569, P80, DOI 10.1016/j.neulet.2014.03.052; Rancan M, 2004, J CEREBR BLOOD F MET, V24, P1110, DOI 10.1097/01.WCB.0000133470.91843.72; Reed JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045877; Ryu JC, 2013, CIRCULATION, V127, P710, DOI 10.1161/CIRCULATIONAHA.112.116103; San Emeterio CL, 2017, BIOMATERIALS, V117, P32, DOI 10.1016/j.biomaterials.2016.11.021; Schellekens H, 2002, CLIN THER, V24, P1720, DOI 10.1016/S0149-2918(02)80075-3; Schellekens H, 2005, NEPHROL DIAL TRANSPL, V20, P3, DOI 10.1093/ndt/gfh1092; Shastri A, 2015, NAT CHEM, V7, P447, DOI [10.1038/NCHEM.2203, 10.1038/nchem.2203]; Shechter R, 2013, IMMUNITY, V38, P555, DOI 10.1016/j.immuni.2013.02.012; Shechter R, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000113; Slusarczyk J, 2016, BIOCHEM PHARMACOL, V113, P45, DOI 10.1016/j.bcp.2016.05.008; Smith A, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/2342187; Sola RJ, 2010, BIODRUGS, V24, P9, DOI 10.2165/11530550-000000000-00000; Strohl WR, 2015, BIODRUGS, V29, P215, DOI 10.1007/s40259-015-0133-6; Truman LA, 2008, BLOOD, V112, P5026, DOI 10.1182/blood-2008-06-162404; Vasconcelos DP, 2015, BIOMATERIALS, V53, P566, DOI 10.1016/j.biomaterials.2015.02.120; Vorobyeva M, 2016, MOLECULES, V21, DOI 10.3390/molecules21121613; Vugmeyster Yulia, 2012, World J Biol Chem, V3, P73, DOI 10.4331/wjbc.v3.i4.73; Wang RE, 2011, CURR MED CHEM, V18, P4126; Waybrant B, 2014, LANGMUIR, V30, P7465, DOI 10.1021/la500403v; Waybrant B, 2012, CHEM COMMUN, V48, P10043, DOI 10.1039/c2cc34217k; Werle M, 2006, AMINO ACIDS, V30, P351, DOI 10.1007/s00726-005-0289-3; White GE, 2014, ARTERIOSCL THROM VAS, V34, P2554, DOI 10.1161/ATVBAHA.114.304717; White GE, 2012, ARTERIOSCL THROM VAS, V32, P589, DOI 10.1161/ATVBAHA.111.237412; Zhao WM, 2016, FASEB J, V30, P380, DOI 10.1096/fj.14-270090; Zheng FY, 2014, ADV MATER, V26, P7333, DOI 10.1002/adma.201403530; Zhou JH, 2017, NAT REV DRUG DISCOV, V16, P181, DOI 10.1038/nrd.2016.199	87	18	18	1	71	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0142-9612	1878-5905		BIOMATERIALS	Biomaterials	OCT	2017	142						52	61		10.1016/j.biomaterials.2017.07.013			10	Engineering, Biomedical; Materials Science, Biomaterials	Engineering; Materials Science	FE4IW	WOS:000408178600005	28727998				2021-06-18	
J	Vonder Haar, C; Martens, KM; Riparip, LK; Rosi, S; Wellington, CL; Winstanley, CA				Vonder Haar, Cole; Martens, Kris M.; Riparip, Lara-Kirstie; Rosi, Susanna; Wellington, Cheryl L.; Winstanley, Catharine A.			Frontal Traumatic Brain Injury Increases Impulsive Decision Making in Rats: A Potential Role for the Inflammatory Cytokine Interleukin-12	JOURNAL OF NEUROTRAUMA			English	Article						cognitive function; controlled cortical impact; cytokines; delay discounting; frontal cortex; inflammation	CONTROLLED CORTICAL IMPACT; ORBITOFRONTAL CORTEX; COGNITIVE DEFICITS; SELF-CONTROL; CHOICE; DOPAMINE; MODEL; NEUROINFLAMMATION; REINFORCEMENT; MODERATE	Traumatic brain injury (TBI) is associated with the development of numerous psychiatric diseases. Of particular concern for TBI patients is the impact of chronic impulsivity on daily functioning. Despite the scope of the human problem, little has been done to address impulsivity in animal models of brain injury. In the current study, we examined the effects of either a severe or a milder bilateral frontal controlled cortical impact injury on impulsivity using the Delay Discounting Task (DDT), in which preference for smaller-sooner over larger-later rewards is indicative of greater impulsive choice. Both milder and severe TBI caused a significant, chronic increase in impulsive decision making. Despite these pronounced changes in performance of the DDT, memory function, as assessed by the Morris Water Maze, was not impaired in more mildly injured rats and only transiently impacted in the severe TBI group. Whereas a significant lesion was only evident in severely injured rats, analysis of cytokine levels within the frontal cortex revealed a selective increase in interleukin (IL)-12 that was associated with the magnitude of the change in impulsive choice caused by both milder and severe TBI. These findings suggest that tissue loss alone cannot explain the increased impulsivity observed, and that inflammatory pathways mediated by IL-12 may be a contributing factor. The findings from this study highlight the sensitivity of sophisticated behavioral measures designed to assess neuropsychiatric dysfunction in the detection of TBI-induced cognitive impairments and their utility in identifying potential mechanistic pathways and therapeutic targets.	[Vonder Haar, Cole; Martens, Kris M.; Wellington, Cheryl L.; Winstanley, Catharine A.] Univ British Columbia, Djavad Mowafaghian Ctr Brain Hlth, Vancouver, BC, Canada; [Riparip, Lara-Kirstie; Rosi, Susanna] Univ Calif San Francisco, Brain & Spinal Injury Ctr, Dept Phys Therapy Rehabil Sci, San Francisco, CA 94143 USA; [Riparip, Lara-Kirstie; Rosi, Susanna] Univ Calif San Francisco, Dept Neurol Surg, Brain & Spinal Injury Ctr, San Francisco, CA 94143 USA; [Vonder Haar, Cole; Martens, Kris M.] West Virginia Univ, Dept Psychol, Injury & Recovery Lab, Morgantown, WV 26506 USA	Vonder Haar, C (corresponding author), West Virginia Univ, Dept Psychol, Injury & Recovery Lab, Morgantown, WV 26506 USA.; Vonder Haar, C (corresponding author), West Virginia Univ, Dept Psychol, POB 6040,53 Campus Dr, Morgantown, WV 26505 USA.	cole.vonderhaar@mail.wvu.edu		Vonder Haar, Cole/0000-0001-7949-2068	Djavad Mowafaghian Centre for Brain Health; Canadian Institutes of Health Research (CIHR)Canadian Institutes of Health Research (CIHR); Weston Brain Institute; National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS087458]; CIHRCanadian Institutes of Health Research (CIHR); Michael Smith Foundation for Health ResearchMichael Smith Foundation for Health Research; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS087458] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R21AG042016] Funding Source: NIH RePORTER	Funding for this project was provided by an internal grant from the Djavad Mowafaghian Centre for Brain Health to C.V., K.M., C.L.W., and C.A.W., operating grants from the Canadian Institutes of Health Research (CIHR) awarded to C.A.W. and to C.L.W., from the Weston Brain Institute to C.L.W., and the National Institute of Neurological Disorders and Stroke (R21NS087458) awarded to S.R. C.V. was supported by a (CIHR) post-doctoral fellowship. In the past 3 years, C.A.W. has received salary support from the CIHR New Investigator Award program and the Michael Smith Foundation for Health Research.	Abe K, 2016, NEUROL RES, V38, P358, DOI 10.1080/01616412.2015.1110402; Alway Y, 2016, J NEUROTRAUM, V33, P825, DOI 10.1089/neu.2015.3992; Armstrong RC, 2016, EXP NEUROL, V275, P328, DOI 10.1016/j.expneurol.2015.02.011; Aungst SL, 2014, J CEREBR BLOOD F MET, V34, P1223, DOI 10.1038/jcbfm.2014.75; Baki SGA, 2009, BRAIN RES, V1280, P98, DOI 10.1016/j.brainres.2009.05.034; Bales JW, 2009, NEUROSCI BIOBEHAV R, V33, P981, DOI 10.1016/j.neubiorev.2009.03.011; Blasio A, 2012, PSYCHOPHARMACOLOGY, V219, P377, DOI 10.1007/s00213-011-2517-8; Bondi CO, 2014, J NEUROTRAUM, V31, P926, DOI 10.1089/neu.2013.3295; Ferreira LCB, 2014, BRAIN INJURY, V28, P1311, DOI 10.3109/02699052.2014.916818; Clark KH, 2013, NEUROTOX RES, V23, P174, DOI 10.1007/s12640-012-9334-7; COGGESHALL RE, 1992, TRENDS NEUROSCI, V15, P9, DOI 10.1016/0166-2236(92)90339-A; Crean JP, 2000, EXP CLIN PSYCHOPHARM, V8, P155, DOI 10.1037/1064-1297.8.2.155; Cuthbert BN, 2014, PSYCHOPHYSIOLOGY, V51, P1205, DOI 10.1111/psyp.12342; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Dixon MR, 2005, BEHAV INTERVENT, V20, P101, DOI 10.1002/bin.173; Donegan JJ, 2014, J NEUROSCI, V34, P953, DOI 10.1523/JNEUROSCI.3968-13.2014; Evenden JL, 1996, PSYCHOPHARMACOLOGY, V128, P161, DOI 10.1007/s002130050121; Fann JR, 2005, J HEAD TRAUMA REHAB, V20, P501, DOI 10.1097/00001199-200511000-00003; Fujimoto ST, 2004, NEUROSCI BIOBEHAV R, V28, P365, DOI 10.1016/j.neubiorev.2004.06.002; Gatson JW, 2013, J TRAUMA ACUTE CARE, V74, P470, DOI 10.1097/TA.0b013e31827e1f51; Grant JE, 2014, ADDICT BEHAV, V39, P1632, DOI 10.1016/j.addbeh.2014.04.022; Greve KW, 2001, BRAIN INJURY, V15, P255; Haar CV, 2016, ACS CHEM NEUROSCI, V7, P1531, DOI 10.1021/acschemneuro.6b00166; Hehar H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139842; Hodges H, 1996, COGNITIVE BRAIN RES, V3, P167, DOI 10.1016/0926-6410(96)00004-3; Holmin S, 1999, NEUROREPORT, V10, P1889, DOI 10.1097/00001756-199906230-00017; Isung J, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.113; James LM, 2014, MIL MED, V179, P357, DOI 10.7205/MILMED-D-13-00241; Kayser AS, 2012, J NEUROSCI, V32, P9402, DOI 10.1523/JNEUROSCI.1180-12.2012; Kokjohn TA, 2013, J NEUROTRAUM, V30, P981, DOI 10.1089/neu.2012.2699; Konoeda F, 2010, BIOCHEM BIOPH RES CO, V402, P500, DOI 10.1016/j.bbrc.2010.10.058; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; Loos M, 2010, CEREB CORTEX, V20, P1064, DOI 10.1093/cercor/bhp167; Madden GJ, 1997, EXP CLIN PSYCHOPHARM, V5, P256, DOI 10.1037/1064-1297.5.3.256; Mazur J. E, 1987, ADJUSTING PROCEDURE; McHugh L, 2008, BRAIN INJURY, V22, P715, DOI 10.1080/02699050802263027; Mychasiuk R, 2015, BEHAV BRAIN RES, V286, P285, DOI 10.1016/j.bbr.2015.03.010; Najjar S, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-43; Peper JS, 2013, CEREB CORTEX, V23, P1695, DOI 10.1093/cercor/bhs163; Petraglia AL, 2014, J NEUROTRAUM, V31, P1211, DOI 10.1089/neu.2013.3255; Rochat L, 2010, NEUROPSYCHOL REHABIL, V20, P778, DOI 10.1080/09602011.2010.495245; Rossi S, 2015, NEUROPHARMACOLOGY, V96, P105, DOI 10.1016/j.neuropharm.2014.09.022; Rudebeck PH, 2006, NAT NEUROSCI, V9, P1161, DOI 10.1038/nn1756; Sellitto M, 2010, J NEUROSCI, V30, P16429, DOI 10.1523/JNEUROSCI.2516-10.2010; Stahel PF, 1998, NEUROSCI LETT, V249, P123, DOI 10.1016/S0304-3940(98)00410-8; Sundman M, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00334; Tan M, 2011, CRITICAL CARE, V15, P1; Titus DJ, 2015, EXP NEUROL, V263, P254, DOI 10.1016/j.expneurol.2014.10.020; Vaishnavi S, 2009, PSYCHOSOMATICS, V50, P198, DOI 10.1176/appi.psy.50.3.198; Vanderveldt A, 2016, J EXP PSYCHOL-ANIM L, V42, P141, DOI 10.1037/xan0000097; Vezzani A, 2015, NEUROPHARMACOLOGY, V96, P70, DOI 10.1016/j.neuropharm.2014.10.027; Vonder Haar C, 2016, J NEUROTRAUM, V33, P1892, DOI 10.1089/neu.2015.4276; Vonder Haar C, 2014, J NEUROTRAUM, V31, P1711, DOI 10.1089/neu.2014.3459; Winstanley CA, 2005, NEUROPSYCHOPHARMACOL, V30, P669, DOI 10.1038/sj.npp.1300610; WINSTANLEY CA, 2010, IMPULSIVITY BEHAV NE, P95, DOI DOI 10.1037/12069-004; Winstanley CA, 2006, CLIN PSYCHOL REV, V26, P379, DOI 10.1016/j.cpr.2006.01.001; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Yaguchi M, 2008, J NEUROSCI RES, V86, P1972, DOI 10.1002/jnr.21658; Zeeb FD, 2010, PSYCHOPHARMACOLOGY, V211, P87, DOI 10.1007/s00213-010-1871-2; Zgaljardic DJ, 2015, J NEUROTRAUM, V32, P1911, DOI 10.1089/neu.2014.3569	62	18	18	0	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT 1	2017	34	19					2790	2800		10.1089/neu.2016.4813			11	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	FI1DZ	WOS:000411672700013	28376700	Green Published			2021-06-18	
J	Benjamin, E; Recinos, G; Aiolfi, A; Inaba, K; Demetriades, D				Benjamin, Elizabeth; Recinos, Gustavo; Aiolfi, Alberto; Inaba, Kenji; Demetriades, Demetrios			Pharmacological Thromboembolic Prophylaxis in Traumatic Brain Injuries Low Molecular Weight Heparin Is Superior to Unfractionated Heparin	ANNALS OF SURGERY			English	Article; Proceedings Paper	137th Annual Meeting of the American-Surgical-Association (ASA)	APR 20-22, 2017	Philadelphia, PA	Amer Surg Assoc		pharmacological prophylaxis; thromboembolic complications; traumatic brain injury	VENOUS THROMBOEMBOLISM; ENOXAPARIN; SAFETY; EFFICACY; EDEMA; THROMBOPROPHYLAXIS; ANTICOAGULATION	Objective: We hypothesized that low molecular weight heparin (LMWH) is superior to unfractionated heparin (UH) for venous thromboembolism (VTE) prophylaxis in patients with severe traumatic brain injuries (TBI). Summary Background Data: Pharmacological VTE prophylaxis with LMWH or UH is the current standard of care in TBI. Clinical work suggests that LMWH may be more effective than UH for VTE prophylaxis in trauma patients. Experimental work shows that heparinoids may have neuroprotective properties. Methods: ACS TQIP database study including patients with blunt severe TBI (AIS >= 3), those that received LMWH or UH VTE prophylaxis. Patients with severe extracranial injuries (AIS >= 3), death within 72 hours, or hospital stay <48 hours were excluded. Demographic and clinical data on admission was collected, as well as head, thorax, and abdomen AIS, and timing of prophylaxis (within 48 hours, 49-72 hours, and >72 hours). Outcomes included VTE complications, mortality, and unplanned return to the operating room. Multivariate analysis was performed to compare outcomes between patients receiving LMWH and UH. Results: Overall, 20,417 patients met the criteria for inclusion in the study, 10,018 (49.1%) received LMWH and 10,399 (50.9%) UH. Multivariate analysis showed that LMWH was an independent protective factor against mortality and thromboembolic complications, regardless of timing of prophylaxis initiation. The type of prophylaxis had no effect on the need for unplanned return to the operating room. Conclusions: LMWH prophylaxis in severe TBI is associated with better survival and lower thromboembolic complications than UH.	[Benjamin, Elizabeth; Recinos, Gustavo; Aiolfi, Alberto; Inaba, Kenji; Demetriades, Demetrios] Univ Southern Calif, Div Acute Care Surg, Dept Surg, Los Angeles, CA USA	Benjamin, E (corresponding author), LAC USC Med Ctr, 2051 Marengo St,Inpatient Tower,C5L 100, Los Angeles, CA 90033 USA.	Elizabeth.Benjamin@med.usc.edu	Aiolfi, Alberto/ABA-7242-2020; Benjamin, Elizabeth/AAD-2457-2020	Aiolfi, Alberto/0000-0002-7764-6075			BARA L, 1993, THROMB RES, V69, P443, DOI 10.1016/0049-3848(93)90233-E; Barrera LM, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008303.pub2; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS32, DOI 10.1089/neu.2007.9991; Byrne JP, 2017, J TRAUMA ACUTE CARE, V82, P252, DOI 10.1097/TA.0000000000001321; Byrne JP, 2016, J AM COLL SURGEONS, V223, p[621, e5]; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Denson K, 2007, AM J SURG, V193, P380, DOI 10.1016/j.amjsurg.2006.12.004; Dudley RR, 2010, J NEUROTRAUM, V27, P2165, DOI 10.1089/neu.2010.1366; Ekeh AP, 2010, J TRAUMA, V68, P912, DOI 10.1097/TA.0b013e3181b21cad; Farooqui A, 2013, J NEUROSURG, V119, P1576, DOI 10.3171/2013.8.JNS13424; Frisoli Fabio, 2016, Neurosurgery, V63 Suppl 1, P171, DOI 10.1227/01.neu.0000489749.74661.15; GEERTS WH, 1994, NEW ENGL J MED, V331, P1601, DOI 10.1056/NEJM199412153312401; Geerts WH, 1996, NEW ENGL J MED, V335, P701, DOI 10.1056/NEJM199609053351003; Jamjoom AAB, 2016, BRIT J NEUROSURG, V30, P240, DOI 10.3109/02688697.2016.1161170; Jamjoom AAB, 2013, J NEUROTRAUM, V30, P503, DOI 10.1089/neu.2012.2584; Knudson MM, 2004, ANN SURG, V240, P490, DOI 10.1097/01.sla.0000137138.40116.6c; Knudson MM, 2004, ANN SURG, V240, P6; Kwiatt ME, 2012, J TRAUMA ACUTE CARE, V73, P625, DOI 10.1097/TA.0b013e318265cab9; Li S, 2016, J TRAUMAACUTE CARE S, V80, P7; Li SJ, 2016, J TRAUMA ACUTE CARE, V80, P381, DOI 10.1097/TA.0000000000000935; Li SJ, 2015, J TRAUMA ACUTE CARE, V79, P78, DOI 10.1097/TA.0000000000000697; Galan LAM, 2016, J TRAUMA ACUTE CARE, V81, P567, DOI 10.1097/TA.0000000000001134; Murphy PB, 2016, CAN J SURG, V59, P118, DOI 10.1503/cjs.010815; Phelan HA, 2012, J TRAUMA ACUTE CARE, V73, P1434, DOI 10.1097/TA.0b013e31825ac49e; Scudday T, 2011, J AM COLL SURGEONS, V213, P53; Scudday T, 2011, J AM COLL SURGEONS, V213, P148, DOI 10.1016/j.jamcollsurg.2011.02.027; Wahl F, 2000, J NEUROTRAUM, V17, P1055, DOI 10.1089/neu.2000.17.1055; YOUNG E, 1993, THROMB HAEMOSTASIS, V70, P625	29	18	18	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0003-4932	1528-1140		ANN SURG	Ann. Surg.	SEP	2017	266	3					463	469		10.1097/SLA.0000000000002359			7	Surgery	Surgery	FD2UR	WOS:000407390800008	28650361				2021-06-18	
J	Haber, M; Hutchinson, EB; Sadeghi, N; Cheng, WH; Namjoshi, D; Cripton, P; Irfanoglu, MO; Wellington, C; Diaz-Arrastia, R; Pierpaoli, C				Haber, M.; Hutchinson, E. B.; Sadeghi, N.; Cheng, W. H.; Namjoshi, D.; Cripton, P.; Irfanoglu, M. O.; Wellington, C.; Diaz-Arrastia, R.; Pierpaoli, C.			Defining an Analytic Framework to Evaluate Quantitative MRI Markers of Traumatic Axonal Injury: Preliminary Results in a Mouse Closed Head Injury Model	ENEURO			English	Article						CHIMERA; diffuse axonal injury; diffusion tensor imaging; glia; immunohistochemistry; mouse	COMMON DATA ELEMENTS; BRAIN-INJURY; DIFFEOMORPHIC REGISTRATION; DIFFUSION; DISEASE; DAMAGE; ACCELERATION; MECHANISMS; ANISOTROPY; PATHOLOGY	Diffuse axonal injury (DAI) is a hallmark of traumatic brain injury (TBI) pathology. Recently, the Closed Head Injury Model of Engineered Rotational Acceleration (CHIMERA) was developed to generate an experimental model of DAI in a mouse. The characterization of DAI using diffusion tensor magnetic resonance imaging (MRI; diffusion tensor imaging, DTI) may provide a useful set of outcome measures for preclinical and clinical studies. The objective of this study was to identify the complex neurobiological underpinnings of DTI features following DAI using a comprehensive and quantitative evaluation of DTI and histopathology in the CHIMERA mouse model. A consistent neuroanatomical pattern of pathology in specific white matter tracts was identified across ex vivo DTI maps and photomicrographs of histology. These observations were confirmed by voxelwise and regional analysis of DTI maps, demonstrating reduced fractional anisotropy (FA) in distinct regions such as the optic tract. Similar regions were identified by quantitative histology and exhibited axonal damage as well as robust gliosis. Additional analysis using a machine-learning algorithm was performed to identify regions and metrics important for injury classification in a manner free from potential user bias. This analysis found that diffusion metrics were able to identify injured brains almost with the same degree of accuracy as the histology metrics. Good agreement between regions detected as abnormal by histology and MRI was also found. The findings of this work elucidate the complexity of cellular changes that give rise to imaging abnormalities and provide a comprehensive and quantitative evaluation of the relative importance of DTI and histological measures to detect brain injury.	[Haber, M.; Diaz-Arrastia, R.] Univ Penn, Dept Neurol, Philadelphia, PA 19104 USA; [Hutchinson, E. B.; Sadeghi, N.; Irfanoglu, M. O.; Pierpaoli, C.] Natl Inst Biomed Imaging & Bioengn, Quantitat Med Imaging Sect, NIH, Bethesda, MD USA; [Hutchinson, E. B.; Sadeghi, N.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Quantitat Imaging & Tissue Sci, NIH, Bethesda, MD USA; [Cheng, W. H.; Namjoshi, D.; Wellington, C.] Univ British Columbia, Djavad Mowafaghian Ctr Brain Hlth, Pathol & Lab Med, Vancouver, BC, Canada; [Cripton, P.] Univ British Columbia, Int Collaborat Repair Discoveries, Mech Engn, Vancouver, BC, Canada; [Hutchinson, E. B.] Henry M Jackson Fdn Adv Mil Med Inc, Bethesda, MD USA	Haber, M (corresponding author), Univ Penn, 51 N 39th St,Mutch Room 417, Philadelphia, PA 19104 USA.	Margalit.haber@uphs.upenn.edu	Cripton, Peter/AAC-8268-2020; Pierpaoli, Carlo/E-1672-2011	Cripton, Peter/0000-0002-5067-0833; Pierpaoli, Carlo/0000-0001-8558-4428; Hutchinson, Elizabeth/0000-0002-3374-5469; Cheng, Wai Hang/0000-0002-3408-9184	Department of Defense in the Center for Neuroscience and Regenerative MedicineUnited States Department of Defense; Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR); Weston Brain Institute; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [ZIAEB000089] Funding Source: NIH RePORTER	This work was supported by the Department of Defense in the Center for Neuroscience and Regenerative Medicine. T.C., D.N., P.C., and C.L.W. are supported by operating grants from the Canadian Institutes of Health Research and the Weston Brain Institute.	Adam O, 2015, NEUROLOGY, V85, P219, DOI 10.1212/WNL.0000000000001758; ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI 10.1016/j.jmr.2011.09.022; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Bennett RE, 2012, NEUROSCI LETT, V513, P160, DOI 10.1016/j.neulet.2012.02.024; Bramlett HM, 2015, J NEUROTRAUM, V32, P1834, DOI 10.1089/neu.2014.3352; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Budde MD, 2011, BRAIN, V134, P2248, DOI 10.1093/brain/awr161; Budde MD, 2009, J NEUROSCI, V29, P2805, DOI 10.1523/JNEUROSCI.4605-08.2009; Centers for Disease Control and Prevention (CDC), 2010, RAT TBI REL EM DEP V; Chen ZQ, 2008, NEUROL RES, V30, P720, DOI 10.1179/174313208X297968; Chiang SR, 2016, EPILEPSY RES, V120, P37, DOI 10.1016/j.eplepsyres.2015.12.002; Davenport EM, 2014, J NEUROTRAUM, V31, P1617, DOI 10.1089/neu.2013.3233; Duhaime AC, 2010, ARCH PHYS MED REHAB, V91, P1661, DOI 10.1016/j.apmr.2010.07.238; Haacke EM, 2010, J MAGN RESON IMAGING, V32, P516, DOI 10.1002/jmri.22259; Harris NG, 2016, NEUROIMAGE, V133, P129, DOI 10.1016/j.neuroimage.2016.03.012; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Irfanoglu MO, 2016, NEUROIMAGE, V132, P439, DOI 10.1016/j.neuroimage.2016.02.066; Irfanoglu MO, 2015, NEUROIMAGE, V106, P284, DOI 10.1016/j.neuroimage.2014.11.042; Johnson GA, 2010, NEUROIMAGE, V53, P365, DOI 10.1016/j.neuroimage.2010.06.067; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kacar K, 2011, AM J NEURORADIOL, V32, P2098, DOI 10.3174/ajnr.A2864; Li SX, 2013, INT J LEGAL MED, V127, P159, DOI 10.1007/s00414-012-0712-8; Liaw A., 2002, R NEWS, V2, P18, DOI DOI 10.1177/154405910408300516; Loane C, 2016, MOVEMENT DISORD, V31, P1020, DOI 10.1002/mds.26606; Mac Donald CL, 2007, EXP NEUROL, V205, P116, DOI 10.1016/j.expneurol.2007.01.035; Mac Donald CL, 2007, J NEUROSCI, V27, P11869, DOI 10.1523/JNEUROSCI.3647-07.2007; Melah KE, 2016, J ALZHEIMERS DIS, V50, P873, DOI 10.3233/JAD-150897; Nagae LM, 2016, FRONT NEUROANAT, V10, DOI 10.3389/fnana.2016.00017; Namjoshi DR, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-55; Namjoshi DR, 2013, DIS MODEL MECH, V6, P1325, DOI 10.1242/dmm.011320; Pierpaoli C, 1996, RADIOLOGY, V201, P637, DOI 10.1148/radiology.201.3.8939209; Pierpaoli C., 2010, ISMRM 18 ANN M; Riedy G, 2016, RADIOLOGY, V279, P207, DOI 10.1148/radiol.2015150438; Robinson S, 2017, J NEUROSCI RES, V95, P1025, DOI 10.1002/jnr.23848; Roth TL, 2014, NATURE, V505, P223, DOI 10.1038/nature12808; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sener S, 2016, NEUROSURGERY, V79, P786, DOI 10.1227/NEU.0000000000001325; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Skinner NP, 2015, NMR BIOMED, V28, P1489, DOI 10.1002/nbm.3405; Team R Core, 2016, R FDN STAT COMP; Westin CF, 2002, MED IMAGE ANAL, V6, P93, DOI 10.1016/S1361-8415(02)00053-1; Xie MQ, 2010, J NEUROPATH EXP NEUR, V69, P704, DOI 10.1097/NEN.0b013e3181e3de90; Yang M, 2017, BRAIN TOPOGR, V30, P249, DOI 10.1007/s10548-016-0503-5; Yuh EL, 2014, J NEUROTRAUM, V31, P1457, DOI 10.1089/neu.2013.3171; Zhuo JC, 2012, NEUROIMAGE, V59, P467, DOI 10.1016/j.neuroimage.2011.07.050; Ziebell JM, 2015, METAB BRAIN DIS, V30, P393, DOI 10.1007/s11011-014-9539-y	50	18	18	0	1	SOC NEUROSCIENCE	WASHINGTON	11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA		2373-2822		ENEURO	eNeuro	SEP-OCT	2017	4	5							UNSP e0164-17.2017	10.1523/ENEURO.0164-17.2017			15	Neurosciences	Neurosciences & Neurology	FG8JW	WOS:000410678100004	28966972	DOAJ Gold, Green Published			2021-06-18	
J	Howell, DR; Hanson, E; Sugimoto, D; Stracciolini, A; Meehan, WP				Howell, David R.; Hanson, Emily; Sugimoto, Dai; Stracciolini, Andrea; Meehan, William P.			Assessment of the Postural Stability of Female and Male Athletes	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						posture; balance; sex; cerebral concussion	ERROR SCORING SYSTEM; GAIT BALANCE CONTROL; YOUNG-ADULTS; PERFORMANCE; CHILDREN; CONCUSSION; ADOLESCENTS; OBESITY; GENDER; INJURY	Objective: Postural stability is often affected by sport-related injuries and subsequently evaluated during postinjury examinations. Intrinsic factors, however, may also affect postural control. We sought to compare the postural control of female and male athletes as measured simultaneously by (1) the modified balance error scoring system (mBESS) and (2) a video-force plate system. Design: Cross-sectional study. Setting: Sports injury prevention center. Participants: Pediatric, adolescent, and young adult athletes who performed mBESS during an injury prevention evaluation. Independent Variables: We compared the postural control of female and male athletes. We also accounted for independent variables associated with postural stability, including age, body mass index, and history of ankle injury, concussion, and migraine headache. Main Outcome Measures: Total errors committed during the mBESS and measurements derived from integrated kinematic and kinetic data obtained by a video-force plate system. Differences between males and females were tested using analysis of covariance. Results: Participants (n = 409) ranged in age from 10 to 29 years (mean = 14.6 +/- 2.8); 60% were female. No significant differences on mBESS were detected between females and males; however, female athletes demonstrated significantly better postural stability on the video-force plate analysis during double-leg (P = 0.03, d = 0.28), single-leg (P < 0.001, d = 0.62), and tandem stances (P < 0.001, d = 0.53) when compared with males. Conclusions: Uninjured female athletes demonstrate better postural stability on video-force plate analysis than their uninjured male counterparts. These findings provide an important information assistive to clinicians during interpretation of postinjury balance tests.	[Howell, David R.; Hanson, Emily; Sugimoto, Dai; Stracciolini, Andrea; Meehan, William P.] Micheli Ctr Sports Injury Prevent, Waltham, MA USA; [Howell, David R.; Hanson, Emily; Sugimoto, Dai; Stracciolini, Andrea; Meehan, William P.] Boston Childrens Hosp, Dept Orthopaed, Div Sports Med, Boston, MA USA; [Howell, David R.; Meehan, William P.] Boston Childrens Hosp, Brain Injury Ctr, Boston, MA USA; [Sugimoto, Dai; Meehan, William P.] Harvard Med Sch, Dept Orthopaed Surg, Boston, MA USA; [Stracciolini, Andrea; Meehan, William P.] Harvard Med Sch, Dept Pediat, Boston, MA USA	Howell, DR (corresponding author), Micheli Ctr Sports Injury Prevent, ATC, 9 Hope Ave,Suite 100, Waltham, MA 02453 USA.	David.Howell2@childrens.harvard.edu			National Football League Players Association	W. P. Meehan receives royalties from ABC-Clio publishing for the sale of his book, Kids, Sports, and Concussion: A Guide for Coaches and Parents, and royalties from Wolters Kluwer for working as an author for UpToDate. He is under contract with ABC-Clio publishing for a future book entitled, Concussions, and with Springer International publishing for a future book entitled, Head and Neck Injuries in Young Athletes. His research is funded, in part, by a grant from the National Football League Players Association and by philanthropic support from the National Hockey League Alumni Association through the Corey C. Griffin ProAm Tournament. The remaining authors report no conflicts of interest.	Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; Brown HJ, 2014, MED SCI SPORT EXER, V46, P1610, DOI 10.1249/MSS.0000000000000263; Bryant EC, 2005, CLIN BIOMECH, V20, P330, DOI 10.1016/j.clinbiomech.2004.11.006; Burk JM, 2013, CLIN J SPORT MED, V23, P312, DOI 10.1097/JSM.0b013e318285633f; Carvalho GF, 2013, HEADACHE, V53, P1116, DOI 10.1111/head.12135; Condon C, 2014, PHYSIOTHER RES INT, V19, P1, DOI 10.1002/pri.1549; Doolan AW, 2012, ANN BIOMED ENG, V40, P106, DOI 10.1007/s10439-011-0413-3; Franjoine MR, 2010, PEDIATR PHYS THER, V22, P350, DOI 10.1097/PEP.0b013e3181f9d5eb; Guskiewicz Kevin M, 2003, Curr Sports Med Rep, V2, P24; Guskiewicz KM, 2013, BRIT J SPORT MED, V47, P289, DOI 10.1136/bjsports-2013-092225; Guskiewicz KM, 1997, MED SCI SPORT EXER, V29, pS213; Howell DR, 2015, AM J SPORT MED, V43, P625, DOI 10.1177/0363546514560994; Howell DR, 2013, ARCH PHYS MED REHAB, V94, P1513, DOI 10.1016/j.apmr.2013.04.015; Iverson GL, 2013, BRAIN INJURY, V27, P596, DOI 10.3109/02699052.2013.772237; King LA, 2014, ARCH PHYS MED REHAB, V95, P353, DOI 10.1016/j.apmr.2013.10.015; Lee AJY, 2007, J APPL BIOMECH, V23, P173, DOI 10.1123/jab.23.3.173; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; McGuine TA, 2000, CLIN J SPORT MED, V10, P239, DOI 10.1097/00042752-200010000-00003; Molloy CA, 2003, J AUTISM DEV DISORD, V33, P643, DOI 10.1023/B:JADD.0000006001.00667.4c; Pataky Z, 2014, OBESITY, V22, P56, DOI 10.1002/oby.20514; Paterno MV, 2013, GAIT POSTURE, V38, P136, DOI 10.1016/j.gaitpost.2012.11.001; Ponta ML, 2014, OBES SURG, V24, P1915, DOI 10.1007/s11695-014-1254-6; Rahn C, 2015, CLIN J SPORT MED, V25, P248, DOI 10.1097/JSM.0000000000000141; Sabin MJ, 2010, J STRENGTH COND RES, V24, P2073, DOI 10.1519/JSC.0b013e3181ddae13; Soltani Narjes, 2014, Asian J Sports Med, V5, P91; Torres Sarina Francescato, 2014, Fisioter. mov., V27, P399, DOI 10.1590/0103-5150.027.003.AO10; Wikstrom EA, 2010, GAIT POSTURE, V31, P407, DOI 10.1016/j.gaitpost.2010.02.004; Wilkins JC, 2004, J ATHL TRAINING, V39, P156; Zur O, 2013, RES DEV DISABIL, V34, P1951, DOI 10.1016/j.ridd.2013.03.007	29	18	18	0	30	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	SEP	2017	27	5					444	449		10.1097/JSM.0000000000000374			6	Orthopedics; Physiology; Sport Sciences	Orthopedics; Physiology; Sport Sciences	FG2HS	WOS:000409915300009	27428677				2021-06-18	
J	Liu, SJ; Shen, Y; Shultz, SR; Nguyen, A; Hovens, C; Adlard, PA; Bush, AI; Chan, JX; Kwan, P; O'Brien, TJ; Jones, NC				Liu, Shijie; Shen, Yu; Shultz, Sandy R.; Anne Nguyen; Hovens, Christopher; Adlard, Paul A.; Bush, Ashley I.; Chan, Jianxiong; Kwan, Patrick; O'Brien, Terence J.; Jones, Nigel C.			Accelerated kindling epileptogenesis in Tg4510 tau transgenic mice, but not in tau knockout mice	EPILEPSIA			English	Article						rTg4510; Tau; Animal model; Amygdala kindling; Epileptogenesis	TRAUMATIC BRAIN-INJURY; ALZHEIMERS-DISEASE; MOUSE MODEL; HYPERPHOSPHORYLATED TAU; EPILEPSY; SEIZURES; HYPEREXCITABILITY; REDUCTION; DEMENTIA	The biologic processes underlying epileptogenesis following a brain insult are not fully understood, but several lines of evidence suggest that hyperphosphorylation of tau may be an important factor in these processes. To provide further insight into the causal relationship between tau and epileptogenesis, this study applied amygdala kindling to rTg4510 mice that, concurrent with other pathologies, overexpress phosphorylated tau, tau knockout mice, or their respective wild-type controls. Mice were electrically stimulated twice daily, 5 days per week for 3 weeks. Electroencephalography was recorded to measure the primary afterdischarge duration, and the behavioral progression of kindling-induced seizures was assessed. rTg4510 mice (n = 10) had increased primary afterdischarge durations (p < 0.001), and significantly more rapid progression of kindling (p < 0.001), compared with wild-type mice (n = 10). Tau knockout mice (n = 7), however, did not differ from their wild-type counterparts (n = 8) on any of the seizure outcomes. These results suggest that Tg4510 mice are more vulnerable to epileptogenesis, but that the presence of tau itself is not necessary for kindling epileptogenesis to occur.	[Liu, Shijie; Shen, Yu; Shultz, Sandy R.; Chan, Jianxiong; Kwan, Patrick; O'Brien, Terence J.; Jones, Nigel C.] Univ Melbourne, Dept Med, Royal Melbourne Hosp, Parkville, Vic, Australia; [Anne Nguyen; Hovens, Christopher] Univ Melbourne, Dept Surg, Royal Melbourne Hosp, Parkville, Vic, Australia; [Adlard, Paul A.; Bush, Ashley I.] Florey Inst Neurosci & Mental Hlth, Parkville, Vic, Australia; [Kwan, Patrick; O'Brien, Terence J.] Univ Melbourne, Royal Melbourne Hosp, Dept Neurol, Parkville, Vic, Australia	Jones, NC (corresponding author), Univ Melbourne, Royal Melbourne Hosp, Dept Med, Melbourne Brain Ctr, Parkville, Vic 3052, Australia.	ncjones@unimelb.edu.au	Bush, Ashley/Y-2457-2019; Bush, Ashley I/A-1186-2007	Bush, Ashley/0000-0001-8259-9069; Bush, Ashley I/0000-0001-8259-9069; O'Brien, Terence/0000-0002-7198-8621; Jones, Nigel/0000-0002-1080-8439; Hovens, Christopher/0000-0002-0610-1289	Australian Research Council (ARC) Future FellowshipsAustralian Research Council [FT120100030, FT13100100]; Victorian Government's Operational Infrastructure Support Program; National Health and Medical Research Council (NHMRC)National Health and Medical Research Council of Australia [APP1006077]	PAA (FT120100030) and NCJ (FT13100100) are supported by Australian Research Council (ARC) Future Fellowships. We gratefully acknowledge the support of the Victorian Government's Operational Infrastructure Support Program, and the National Health and Medical Research Council (NHMRC) (project grant APP1006077).	Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; Chan JX, 2015, EPILEPSIA, V56, pe73, DOI 10.1111/epi.12993; Devos SL, 2013, J NEUROSCI, V33, P12887, DOI 10.1523/JNEUROSCI.2107-13.2013; Friedman D, 2012, CNS NEUROSCI THER, V18, P285, DOI 10.1111/j.1755-5949.2011.00251.x; Garcia-Cabrero AM, 2013, NEUROBIOL DIS, V58, P200, DOI 10.1016/j.nbd.2013.06.005; Gheyara AL, 2014, ANN NEUROL, V76, P443, DOI 10.1002/ana.24230; Hall AM, 2015, J NEUROSCI, V35, P6221, DOI 10.1523/JNEUROSCI.2552-14.2015; Holth JK, 2013, J NEUROSCI, V33, P1651, DOI 10.1523/JNEUROSCI.3191-12.2013; Ittner LM, 2010, CELL, V142, P387, DOI 10.1016/j.cell.2010.06.036; Jones NC, 2012, NEUROBIOL DIS, V45, P897, DOI 10.1016/j.nbd.2011.12.005; Lei P, 2012, NAT MED, V18, P291, DOI 10.1038/nm.2613; Liu SJ, 2016, BRAIN, V139, P1919, DOI 10.1093/brain/aww116; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; Shultz SR, 2015, BRAIN, V138, P1297, DOI 10.1093/brain/awv053; Tai XY, 2016, BRAIN, V139, P2441, DOI 10.1093/brain/aww187; Thom M, 2011, BRAIN, V134, P2969, DOI 10.1093/brain/awr209	17	18	18	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0013-9580	1528-1167		EPILEPSIA	Epilepsia	SEP	2017	58	9					E136	E141		10.1111/epi.13847			6	Clinical Neurology	Neurosciences & Neurology	FF9LT	WOS:000409338700003	28710841	Bronze			2021-06-18	
J	Williams, CN; Kirby, A; Piantino, J				Williams, Cydni N.; Kirby, Aileen; Piantino, Juan			If You Build It, They Will Come: Initial Experience with a Multi-Disciplinary Pediatric Neurocritical Care Follow-Up Clinic	CHILDREN-BASEL			English	Article						pediatric; critical care outcomes; brain injuries; meningitis; encephalitis; stroke	TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; INTENSIVE-CARE; BACTERIAL-MENINGITIS; FUNCTIONAL OUTCOMES; CHILDREN; DISORDERS; HEALTH; SURVIVORS; CHILDHOOD	Pediatric Neurocritical Care diagnoses account for a large proportion of intensive care admissions. Critical care survivors suffer high rates of long-term morbidity, including physical disability, cognitive impairment, and psychosocial dysfunction. To address these morbidities in Pediatric Neurocritical Care survivors, collaboration between Pediatric Neurology and Pediatric Critical Care created a multidisciplinary follow-up clinic providing specialized evaluations after discharge. Clinic referrals apply to all Pediatric Neurocritical Care patients regardless of admission severity of illness. Here, we report an initial case series, which revealed a population that is heterogenous in age, ranging from 1 month to 18 years, and in diagnoses. Traumatic brain injuries of varying severity as well as neuroinfectious and inflammatory diseases accounted for the majority of referrals. Most patients (87%) seen in the clinic had morbidities identified, requiring ongoing evaluation and expansion of the clinic. Cognitive and psychological disturbance were seen in over half of patients at the initial clinic follow-up. Sleep disturbances, daytime fatigue, headache or chronic pain, and vision or hearing concerns were also common at initial follow-up. Data from this initial population of clinic patients reiterates the need for specialized follow-up care, but also highlights the difficulties related to providing this comprehensive care and evaluating interventions to improve outcomes.	[Williams, Cydni N.; Kirby, Aileen] Oregon Hlth & Sci Univ, Div Pediat Crit Care, Dept Pediat, CDRC P, 707 SW Gaines St, Portland, OR 97239 USA; [Piantino, Juan] Oregon Hlth & Sci Univ, Div Pediat Neurol, Dept Pediat, CDRC P, 707 SW Gaines St, Portland, OR 97239 USA	Williams, CN (corresponding author), Oregon Hlth & Sci Univ, Div Pediat Crit Care, Dept Pediat, CDRC P, 707 SW Gaines St, Portland, OR 97239 USA.	willicyd@ohsu.edu; kirbya@ohsu.edu; piantino@ohsu.edu	Piantino, Juan/AAI-2184-2019	Piantino, Juan/0000-0002-8861-5709; Williams, Cydni/0000-0002-2049-7662	Agency for Healthcare Research and QualityUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality [K12HS022981]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1K12HL133115]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITYUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality [K12HS022981] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [K12HL133115] Funding Source: NIH RePORTER	Williams is supported by the Agency for Healthcare Research and Quality (grant number K12HS022981). The content is solely the responsibility of the authors and does not necessarily represent the official views of the Agency for Healthcare Research and Quality. Piantino is supported by the National Institutes of Health (grant number 1K12HL133115). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Als LC, 2013, CRIT CARE MED, V41, P1094, DOI 10.1097/CCM.0b013e318275d032; Araujo GC, 2017, J INT NEUROPSYCH SOC, V23, P529, DOI 10.1017/S1355617717000364; Babikian T, 2015, J NEUROTRAUM, V32, P1849, DOI 10.1089/neu.2015.3971; Barlow KM, 2016, J CHILD NEUROL, V31, P57, DOI 10.1177/0883073814543305; Beers SR, 2012, J NEUROTRAUM, V29, P1126, DOI 10.1089/neu.2011.2272; Bennett T. D., 2017, JAMA PEDIAT, DOI [10.1001/jamapediatrics.2017.212728846763, DOI 10.1001/JAMAPEDIATRICS.2017.212728846763]; Bennett TD, 2016, PEDIATR CRIT CARE ME, V17, P1147, DOI 10.1097/PCC.0000000000000934; Briand C, 2016, MED MALADIES INFECT, V46, P177, DOI 10.1016/j.medmal.2016.02.009; Brooks BL, 2014, ARCH CLIN NEUROPSYCH, V29, P186, DOI 10.1093/arclin/act083; Brown EA, 2016, J PEDIATR PSYCHOL, V41, P244, DOI 10.1093/jpepsy/jsv090; Buysse CMP, 2007, QUAL LIFE RES, V16, P1567, DOI 10.1007/s11136-007-9271-8; Cooper AN, 2017, PEDIATRICS, V140, DOI 10.1542/peds.2016-3870; Cunha F, 2013, PEDIATR CRIT CARE ME, V14, pE8, DOI 10.1097/PCC.0b013e31826012b4; Ebrahim S, 2013, PEDIATR CRIT CARE ME, V14, P10, DOI 10.1097/PCC.0b013e31825b64b3; Gagner C, 2015, J NEUROTRAUM, V32, P1539, DOI 10.1089/neu.2014.3753; Hopkins RO, 2015, J PEDIATR INTENSIVE, V4, P204, DOI 10.1055/s-0035-1563547; Keenan H. T., 2016, J HEAD TRAUMA REHAB, DOI [10.1097/HTR.000000000000026528489701, DOI 10.1097/HTR.000000000000026528489701]; Moreau JF, 2013, PEDIATR CRIT CARE ME, V14, P801, DOI 10.1097/PCC.0b013e31828aa71f; Namachivayam P, 2010, PEDIATR CRIT CARE ME, V11, P549, DOI 10.1097/PCC.0b013e3181ce7427; Ong C, 2016, PEDIATR CRIT CARE ME, V17, pE247, DOI 10.1097/PCC.0000000000000706; Pollack MM, 2014, PEDIATR CRIT CARE ME, V15, P821, DOI 10.1097/PCC.0000000000000250; Simonetti BG, 2015, NEUROLOGY, V84, P1941, DOI 10.1212/WNL.0000000000001555; Singh K, 2016, PEDIATR NEUROL, V60, P30, DOI 10.1016/j.pediatrneurol.2016.02.013; Tarokh L, 2016, NEUROSCI BIOBEHAV R, V70, P182, DOI 10.1016/j.neubiorev.2016.08.008; Truss K, 2017, J NEUROTRAUM, V34, P2272, DOI 10.1089/neu.2016.4842; Turel O, 2013, BALK MED J, V30, P80, DOI 10.5152/balkanmedj.2012.092; Wainwright MS, 2016, CURR OPIN CRIT CARE, V22, P106, DOI 10.1097/MCC.0000000000000288	27	18	18	0	5	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2227-9067		CHILDREN-BASEL	Children-Basel	SEP	2017	4	9							83	10.3390/children4090083			8	Pediatrics	Pediatrics	FI6BS	WOS:000412075000009	28925974	DOAJ Gold, Green Published			2021-06-18	
J	Moritz, KE; McCormack, NM; Abera, MB; Viollet, C; Yauger, YJ; Sukumar, G; Dalgard, CL; Burnett, BG				Moritz, Kasey E.; McCormack, Nikki M.; Abera, Mahlet B.; Viollet, Coralie; Yauger, Young J.; Sukumar, Gauthaman; Dalgard, Clifton L.; Burnett, Barrington G.			The role of the immunoproteasome in interferon-gamma-mediated microglial activation	SCIENTIFIC REPORTS			English	Article							TRAUMATIC BRAIN-INJURY; 26S PROTEASOME; IN-VIVO; CONSTITUTIVE PROTEASOMES; PARKINSONS-DISEASE; SUBUNIT EXPRESSION; 20S PROTEASOMES; IMMUNE-SYSTEM; NITRIC-OXIDE; CELLS	Microglia regulate the brain microenvironment by sensing damage and neutralizing potentially harmful insults. Disruption of central nervous system (CNS) homeostasis results in transition of microglia to a reactive state characterized by morphological changes and production of cytokines to prevent further damage to CNS tissue. Immunoproteasome levels are elevated in activated microglia in models of stroke, infection and traumatic brain injury, though the exact role of the immunoproteasome in neuropathology remains poorly defined. Using gene expression analysis and native gel electrophoresis we characterize the expression and assembly of the immunoproteasome in microglia following interferon-gamma exposure. Transcriptome analysis suggests that the immunoproteasome regulates multiple features of microglial activation including nitric oxide production and phagocytosis. We show that inhibiting the immunoproteasome attenuates expression of pro-inflammatory cytokines and suppresses interferon-gamma-dependent priming of microglia. These results imply that targeting immunoproteasome function following CNS injury may attenuate select microglial activity to improve the pathophysiology of neurodegenerative conditions or the progress of inflammation-mediated secondary injury following neurotrauma.	[Moritz, Kasey E.; McCormack, Nikki M.; Yauger, Young J.; Dalgard, Clifton L.; Burnett, Barrington G.] Uniformed Serv Univ Hlth Sci, F Edward Hebert Sch Med, Neurosci Program, Bethesda, MD 20814 USA; [Abera, Mahlet B.; Dalgard, Clifton L.; Burnett, Barrington G.] Uniformed Serv Univ Hlth Sci, Dept Anat Physiol & Genet, Bethesda, MD 20814 USA; [Viollet, Coralie; Sukumar, Gauthaman; Dalgard, Clifton L.] Uniformed Serv Univ Hlth Sci, Collaborat Hlth Initiat Res Program, Bethesda, MD 20814 USA; [Dalgard, Clifton L.] Uniformed Serv Univ Hlth Sci, Amer Genome Ctr, Bethesda, MD 20814 USA	Burnett, BG (corresponding author), Uniformed Serv Univ Hlth Sci, F Edward Hebert Sch Med, Neurosci Program, Bethesda, MD 20814 USA.; Burnett, BG (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Anat Physiol & Genet, Bethesda, MD 20814 USA.	barrington.burnett@usuhs.edu	Sukumar, Gauthaman/A-1697-2018	Burnett, Barrington/0000-0002-5001-3358	Department of DefenseUnited States Department of Defense	We thank Dr. Yumin Zhang for generous gift of the BV-2 cell lines, Dr. Joseph McCabe for fruitful discussions, Kelsey Voss and Michael Shaughness for technical assistance and Kimberly Byrnes for critical reading of the manuscript. These studies were supported from Intramural funds provided by new investigator startup funds from the Department of Defense.	AKIYAMA K, 1994, FEBS LETT, V343, P85, DOI 10.1016/0014-5793(94)80612-8; Aloisi F, 2001, GLIA, V36, P165, DOI 10.1002/glia.1106; Bai M, 2014, BIOMOLECULES, V4, P662, DOI 10.3390/biom4030662; Barton LF, 2002, J IMMUNOL, V169, P3046, DOI 10.4049/jimmunol.169.6.3046; Basler M, 2014, EMBO MOL MED, V6, P226, DOI 10.1002/emmm.201303543; BOJE KM, 1992, BRAIN RES, V587, P250, DOI 10.1016/0006-8993(92)91004-X; Bose S, 2004, BIOCHEM J, V378, P177, DOI 10.1042/BJ20031122; Chen FT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064262; Chen X, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2014.586; Colton CA, 2013, J NEUROIMMUNE PHARM, V8, P4, DOI 10.1007/s11481-013-9437-9; Cunningham C, 2005, J NEUROSCI, V25, P9275, DOI 10.1523/JNEUROSCI.2614-05.2005; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Deol P, 2007, J IMMUNOL, V178, P7557, DOI 10.4049/jimmunol.178.12.7557; Diaz-Hernandez M, 2003, J NEUROSCI, V23, P11653; Doty KR, 2015, BRAIN RES, V1617, P155, DOI 10.1016/j.brainres.2014.09.008; DUBIEL W, 1992, J BIOL CHEM, V267, P22369; Ebstein F, 2013, CELL, V152, P935, DOI 10.1016/j.cell.2013.02.018; Farini A, 2016, MOL THER, V24, P1898, DOI [10.1038/MT.2016.162, 10.1038/mt.2016.162]; Fine SM, 1999, J NEUROIMMUNOL, V95, P55, DOI 10.1016/S0165-5728(98)00267-7; Frakes AE, 2014, NEURON, V81, P1009, DOI 10.1016/j.neuron.2014.01.013; Frank MG, 2006, NEUROBIOL AGING, V27, P717, DOI 10.1016/j.neurobiolaging.2005.03.013; Gao HM, 2003, FASEB J, V17, DOI 10.1096/fj.03-0109fje; Godbout JP, 2005, FASEB J, V19, P1329, DOI 10.1096/fj.05-3776fje; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Hawthorne AL, 2011, NEUROTHERAPEUTICS, V8, P252, DOI 10.1007/s13311-011-0032-6; Haynes SE, 2006, NAT NEUROSCI, V9, P1512, DOI 10.1038/nn1805; Heink S, 2005, P NATL ACAD SCI USA, V102, P9241, DOI 10.1073/pnas.0501711102; Heneka MT, 2014, NAT REV IMMUNOL, V14, P463, DOI 10.1038/nri3705; Henn A, 2009, ALTEX-ALTERN TIEREXP, V26, P83; Heppner FL, 2015, NAT REV NEUROSCI, V16, P358, DOI 10.1038/nrn3880; Hirano Y, 2005, NATURE, V437, P1381, DOI 10.1038/nature04106; Huang Q, 2013, J BIOL CHEM, V288, P12161, DOI 10.1074/jbc.M113.464552; Huber EM, 2012, CELL, V148, P727, DOI 10.1016/j.cell.2011.12.030; Huh Y, 2003, NEUROSCI LETT, V349, P63, DOI 10.1016/S0304-3940(03)00743-2; Kim HY, 2003, J IMMUNOL, V171, P6072, DOI 10.4049/jimmunol.171.11.6072; Koenigsknecht-Talboo J, 2005, J NEUROSCI, V25, P8240, DOI 10.1523/JNEUROSCI.1808-05.2005; Kopec KK, 1998, J NEUROCHEM, V71, P2123; Liu B, 2006, AAPS J, V8, pE606, DOI 10.1208/aapsj080369; Livnat-Levanon N, 2014, CELL REP, V7, P1371, DOI 10.1016/j.celrep.2014.04.030; Loane DJ, 2016, EXP NEUROL, V275, P316, DOI 10.1016/j.expneurol.2015.08.018; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; MA CP, 1992, J BIOL CHEM, V267, P10515; Marques AJ, 2009, CHEM REV, V109, P1509, DOI 10.1021/cr8004857; Marshall RS, 2015, MOL CELL, V58, P1053, DOI 10.1016/j.molcel.2015.04.023; McCarthy MK, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00021; McGeer PL, 2003, ANN NEUROL, V54, P599, DOI 10.1002/ana.10728; Mi HY, 2016, NUCLEIC ACIDS RES, V44, pD336, DOI 10.1093/nar/gkv1194; Moran LB, 2004, NEUROGENETICS, V5, P95, DOI 10.1007/s10048-004-0172-5; Moran LB, 2007, J NEUROIMMUNOL, V183, P1, DOI 10.1016/j.jneuroim.2006.10.023; Mount MP, 2007, J NEUROSCI, V27, P3328, DOI 10.1523/JNEUROSCI.5321-06.2007; Muchamuel T, 2009, NAT MED, V15, P781, DOI 10.1038/nm.1978; Nathan JA, 2013, CELL, V152, P1184, DOI 10.1016/j.cell.2013.01.037; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Noda C, 2000, BIOCHEM BIOPH RES CO, V277, P348, DOI 10.1006/bbrc.2000.3676; PERRY VH, 1993, GLIA, V7, P60, DOI 10.1002/glia.440070111; Qu CS, 2010, J NEUROTRAUM, V27, P1625, DOI 10.1089/neu.2010.1359; Qureshi N, 2005, IMMUNOL RES, V31, P243, DOI 10.1385/IR:31:3:243; Qureshi N, 2012, BBA-MOL CELL RES, V1823, P2087, DOI 10.1016/j.bbamcr.2012.06.016; Ravid T, 2008, NAT REV MOL CELL BIO, V9, P679, DOI 10.1038/nrm2468; Ridnour LA, 2012, J NEUROCHEM, V123, P736, DOI 10.1111/jnc.12028; Sasaki K, 2010, MOL CELL BIOL, V30, P3864, DOI 10.1128/MCB.00216-10; Seifert U, 2010, CELL, V142, P613, DOI 10.1016/j.cell.2010.07.036; Shen J, 2006, SHOCK, V25, P472, DOI 10.1097/01.shk.0000209554.46704.64; Spencer NG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162497; Surendranathan A, 2015, PARKINSONISM RELAT D, V21, P1398, DOI 10.1016/j.parkreldis.2015.10.009; Tai H. C., 2010, FRONTIERS MOL NEUROS, V3; Tamashiro TT, 2012, JOVE-J VIS EXP, DOI 10.3791/3814; Vilchez D, 2012, NATURE, V489, P304, DOI 10.1038/nature11468; Wilcock DM, 2011, ASN NEURO, V3, DOI 10.1042/AN20110018; Wink DA, 2011, J LEUKOCYTE BIOL, V89, P873, DOI 10.1189/jlb.1010550; Witt E, 2000, J MOL BIOL, V301, P1, DOI 10.1006/jmbi.2000.3959; Xiang Z, 2006, DIS MARKERS, V22, P95, DOI 10.1155/2006/276239; Yao XL, 2008, J NEUROCHEM, V104, P353, DOI 10.1111/j.1471-4159.2007.04970.x; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134	74	18	18	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	AUG 24	2017	7								9365	10.1038/s41598-017-09715-y			16	Multidisciplinary Sciences	Science & Technology - Other Topics	FE8FS	WOS:000408441600089	28839214	DOAJ Gold, Green Published			2021-06-18	
J	Bagnato, S; Grimaldi, LME; Di Raimondo, G; Sant'Angelo, A; Boccagni, C; Virgilio, V; Andriolo, M				Bagnato, Sergio; Grimaldi, Luigi M. E.; Di Raimondo, Giorgio; Sant'Angelo, Antonino; Boccagni, Cristina; Virgilio, Vittorio; Andriolo, Maria			Prolonged Cerebrospinal Fluid Neurofilament Light Chain Increase in Patients with Post-Traumatic Disorders of Consciousness	JOURNAL OF NEUROTRAUMA			English	Article						Alzheimer's disease; axonal injury; neurofilaments; traumatic brain injury; vegetative state	TRAUMATIC BRAIN-INJURY; UNRESPONSIVE WAKEFULNESS SYNDROME; INFLAMMATION; AD	The mechanisms involved in secondary brain injury after the acute phase of severe traumatic brain injury (TBI) are largely unknown. Ongoing axonal degeneration, consequent to the initial trauma, may lead to secondary brain injury. To test this hypothesis, we evaluated the cerebrospinal fluid (CSF) level of neurofilament light chain (NF-L), a proposed marker of axonal degeneration, in 10 patients who developed a severe disorder of consciousness after a TBI, including 7 in a minimally conscious state and 3 with unresponsive wakefulness syndrome (time since brain injury, 309 - 169 days). CSF NF-L level was measured with a commercially available NF-L enzyme-linked immunosorbent assay. CSF NF-L level was very high in all 10 patients, ranging from 2.4- to 60.5-fold the upper normal limit (median value, 4458 pg/mL; range, 695 - 23,000). Moreover, NF-L level was significantly higher after a severe TBI than in a reference group of 9 patients with probable Alzheimer's disease, a population with elevated levels of CSF NF-L attributed to neuronal degeneration (median value, 1173 pg/mL; range, 670-3643; p < 0.01). CSF NF-L level was correlated with time post-TBI (p = 0.04). These results demonstrate prolonged secondary brain injury, suggesting that patients exhibit ongoing axonal degeneration up to 19 months after a severe TBI.	[Bagnato, Sergio; Sant'Angelo, Antonino; Boccagni, Cristina] Fdn Ist Giuseppe Giglio, Rehabil Dept, Unit Neurophysiol, Viale Giuseppe Giardina, I-90015 Cefalu, PA, Italy; [Bagnato, Sergio; Sant'Angelo, Antonino; Boccagni, Cristina] Fdn Ist Giuseppe Giglio, Rehabil Dept, Unit Severe Acquired Brain Injuries, Viale Giuseppe Giardina, I-90015 Cefalu, PA, Italy; [Grimaldi, Luigi M. E.; Di Raimondo, Giorgio] Fdn Ist Giuseppe Giglio, Dept Neurol, Cefalu, PA, Italy; [Virgilio, Vittorio] Fdn Ist Giuseppe Giglio, Strateg Direct, Cefalu, PA, Italy; [Andriolo, Maria] Fdn Ist Giuseppe Giglio, Clin Pathol & Microbiol Lab, Cefalu, PA, Italy	Bagnato, S (corresponding author), Fdn Ist Giuseppe Giglio, Rehabil Dept, Unit Neurophysiol, Viale Giuseppe Giardina, I-90015 Cefalu, PA, Italy.; Bagnato, S (corresponding author), Fdn Ist Giuseppe Giglio, Rehabil Dept, Unit Severe Acquired Brain Injuries, Viale Giuseppe Giardina, I-90015 Cefalu, PA, Italy.	sergiobagnato@gmail.com	Grimaldi, Luigi/L-2614-2019; Bagnato, Sergio/H-6842-2013	Bagnato, Sergio/0000-0002-6289-1887; Sant'Angelo, Antonino/0000-0001-9972-3679; Boccagni, Cristina/0000-0002-6317-015X			Al Nimer F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132177; Bagnato S, 2017, ARCH PHYS MED REHAB, V98, P665, DOI 10.1016/j.apmr.2016.09.132; Bagnato S, 2013, NEUROSCI BIOBEHAV R, V37, P2721, DOI 10.1016/j.neubiorev.2013.09.007; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Guo Z, 2000, NEUROLOGY, V54, P1316, DOI 10.1212/WNL.54.6.1316; Hall GF, 2000, CELL MOTIL CYTOSKEL, V46, P166, DOI 10.1002/1097-0169(200007)46:3<166::AID-CM2>3.0.CO;2-8; Hill CS, 2016, TRENDS NEUROSCI, V39, P311, DOI 10.1016/j.tins.2016.03.002; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Laser-Azogui A, 2015, CURR OPIN CELL BIOL, V32, P92, DOI 10.1016/j.ceb.2015.01.003; Marmarou CR, 2006, EXP NEUROL, V197, P353, DOI 10.1016/j.expneurol.2005.10.003; Medina D, 2006, NEUROBIOL AGING, V27, P663, DOI 10.1016/j.neurobiolaging.2005.03.026; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Seel RT, 2010, ARCH PHYS MED REHAB, V91, P1795, DOI 10.1016/j.apmr.2010.07.218; Smith DH, 1999, J NEUROPATH EXP NEUR, V58, P982, DOI 10.1097/00005072-199909000-00008; Zetterberg H, 2016, JAMA NEUROL, V73, P60, DOI 10.1001/jamaneurol.2015.3037; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9	16	18	18	0	7	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	AUG 15	2017	34	16					2475	2479		10.1089/neu.2016.4837			5	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	FC6RI	WOS:000406968400010	28385104				2021-06-18	
J	Abdul-Muneer, PM; Long, M; Conte, AA; Santhakumar, V; Pfister, BJ				Abdul-Muneer, P. M.; Long, Mathew; Conte, Adriano Andrea; Santhakumar, Vijayalakshmi; Pfister, Bryan J.			High Ca2+ Influx During Traumatic Brain Injury Leads to Caspase-1-Dependent Neuroinflammation and Cell Death	MOLECULAR NEUROBIOLOGY			English	Article						Traumatic brain injury; Neuronal stretch injury; Fluid percussion injury; Ca2+ influx; Caspase-1; IL-1 beta; Neuroinflammation; Apoptosis	MITOCHONDRIAL PERMEABILITY TRANSITION; MATRIX METALLOPROTEINASES; AXONAL INJURY; CEREBROSPINAL-FLUID; NLRP3 INFLAMMASOME; OXIDATIVE STRESS; SODIUM-CHANNELS; STRETCH INJURY; APOPTOSIS; MECHANISMS	We investigated the hypothesis that high Ca2+ influx during traumatic brain injury induces the activation of the caspase-1 enzyme, which triggers neuroinflammation and cell apoptosis in a cell culture model of neuronal stretch injury and an in vivo model of fluid percussion injury (FPI). We first established that stretch injury causes a rapid increase in the intracellular Ca2+ level, which activates interleukin-converting enzyme caspase-1. The increase in the intracellular Ca2+ level and subsequent caspase-1 activation culminates into neuroinflammation via the maturation of IL-1 beta. Further, we analyzed caspase-1-mediated apoptosis by TUNEL staining and PARP western blotting. The voltage-gated sodium channel blocker, tetrodotoxin, mitigated the stretch injury-induced neuroinflammation and subsequent apoptosis by blocking Ca2+ influx during the injury. The effect of tetrodotoxin was similar to the caspase-1 inhibitor, zYVAD-fmk, in neuronal culture. To validate the in vitro results, we demonstrated an increase in caspase-1 activity, neuroinflammation and neurodegeneration in fluid percussion-injured animals. Our data suggest that neuronal injury/traumatic brain injury (TBI) can induce a high influx of Ca2+ to the cells that cause neuroinflammation and cell death by activating caspase-1, IL-1 beta, and intrinsic apoptotic pathways. We conclude that excess IL-1 beta production and cell death may contribute to neuronal dysfunction and cognitive impairment associated with TBI.	[Abdul-Muneer, P. M.; Long, Mathew; Conte, Adriano Andrea; Pfister, Bryan J.] New Jersey Inst Technol, Dept Biomed Engn, Newark, NJ 07102 USA; [Abdul-Muneer, P. M.] JFK Med Ctr, Neurosci Inst, Edison, NJ 08820 USA; [Santhakumar, Vijayalakshmi] Rutgers New Jersey Med Sch, Dept Pharmacol Physiol & Neurosci, Newark, NJ 07103 USA	Abdul-Muneer, PM; Pfister, BJ (corresponding author), New Jersey Inst Technol, Dept Biomed Engn, Newark, NJ 07102 USA.; Abdul-Muneer, PM (corresponding author), JFK Med Ctr, Neurosci Inst, Edison, NJ 08820 USA.	pmamuneer@gmail.com; bryan.j.pfister@njit.edu	Santhakumar, Viji/K-4856-2019	Santhakumar, Viji/0000-0001-6278-4187; Abdul-Muneer, P. M/0000-0001-8231-4385	New Jersey Commission on Brain Injury Research [CBIR11PJT003]; NIH/NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS069861]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS069861] Funding Source: NIH RePORTER	This work was funded by New Jersey Commission on Brain Injury Research no. CBIR11PJT003 to Bryan J. Pfister and Vijayalakshmi Santhakumar and NIH/NINDS R01NS069861 to Vijayalakshmi Santhakumar. The authors gratefully acknowledge Mr. Brian Swenson, Dept of Biomedical Engineering, NJIT for the technical support in calibrating strain.	Abdul-Muneer PM, 2015, MOL NEUROBIOL, V51, P966, DOI 10.1007/s12035-014-8752-3; Abdul-Muneer PM, 2013, FREE RADICAL BIO MED, V60, P282, DOI 10.1016/j.freeradbiomed.2013.02.029; [Anonymous], 2015, MOL NEUROBIOL; Arend WP, 2008, IMMUNOL REV, V223, P20, DOI 10.1111/j.1600-065X.2008.00624.x; Beauchamp K, 2008, MOL MED, V14, P731, DOI 10.2119/2008-00050.Beauchamp; Buki A, 1999, J NEUROPATH EXP NEUR, V58, P365; Byrne AM, 1999, HEPATOLOGY, V29, P1523, DOI 10.1002/hep.510290521; Cai JY, 1998, BBA-BIOENERGETICS, V1366, P139, DOI 10.1016/S0005-2728(98)00109-1; CERRETTI DP, 1992, SCIENCE, V256, P97, DOI 10.1126/science.1373520; Clark RSB, 2000, J NEUROCHEM, V74, P740, DOI 10.1046/j.1471-4159.2000.740740.x; Clausen F, 2004, J NEUROTRAUM, V21, P1168, DOI 10.1089/neu.2004.21.1168; Cohen AS, 2007, PROG BRAIN RES, V161, P143, DOI 10.1016/S0079-6123(06)61010-8; FAN L, 1995, MOL BRAIN RES, V30, P125; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Geddes-Klein DM, 2006, J NEUROTRAUM, V23, P193, DOI 10.1089/neu.2006.23.193; Gitler D, 1998, NEURON, V20, P1123, DOI 10.1016/S0896-6273(00)80494-8; Hans VHJ, 1999, NEUROREPORT, V10, P409; Haorah J, 2008, GLIA, V56, P78, DOI 10.1002/glia.20596; Haorah J, 2007, J NEUROCHEM, V101, P566, DOI 10.1111/j.1471-4159.2006.04393.x; Harter L, 2001, J NEUROIMMUNOL, V121, P76, DOI 10.1016/S0165-5728(01)00409-X; Iwata A, 2004, J NEUROSCI, V24, P4605, DOI 10.1523/JNEUROSCI.0515-03.2004; Jia F, 2009, J NEUROTRAUM, V26, P243, DOI 10.1089/neu.2008.0670; Keller M, 2008, CELL, V132, P818, DOI 10.1016/j.cell.2007.12.040; Lamkanfi M, 2008, MOL CELL PROTEOMICS, V7, P2350, DOI 10.1074/mcp.M800132-MCP200; Lee GS, 2012, NATURE, V492, P123, DOI 10.1038/nature11588; Lemasters JJ, 1998, BBA-BIOENERGETICS, V1366, P177, DOI 10.1016/S0005-2728(98)00112-1; Li Y, 2015, NEUROBIOL DIS, V74, P240, DOI 10.1016/j.nbd.2014.11.021; Lorente L, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0485-z; Lotocki G, 2009, J NEUROTRAUM, V26, P1123, DOI 10.1089/neu.2008.0802; Lucas SM, 2006, BRIT J PHARMACOL, V147, pS232, DOI 10.1038/sj.bjp.0706400; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Magou GC, 2011, J NEUROTRAUM, V28, P2203, DOI 10.1089/neu.2010.1596; Mannello F, 2005, APOPTOSIS, V10, P19, DOI 10.1007/s10495-005-6058-7; Montal M, 1998, BBA-BIOENERGETICS, V1366, P113, DOI 10.1016/S0005-2728(98)00124-8; Morales DM, 2005, NEUROSCIENCE, V136, P971, DOI 10.1016/j.neuroscience.2005.08.030; Morrison B, 1998, J NEUROTRAUM, V15, P911, DOI 10.1089/neu.1998.15.911; Muneer PMA, 2012, ARTERIOSCL THROM VAS, V32, P1167, DOI 10.1161/ATVBAHA.112.247668; Neuberger EJ, 2014, J NEUROSCI RES, V92, P1350, DOI 10.1002/jnr.23401; Nicholson DW, 1999, CELL DEATH DIFFER, V6, P1028, DOI 10.1038/sj.cdd.4400598; POVLISHOCK JT, 1992, J NEUROTRAUM, V9, pS189; Pun PBL, 2009, FREE RADICAL RES, V43, P348, DOI 10.1080/10715760902751902; Reed JC, 1998, ONCOGENE, V17, P3225, DOI 10.1038/sj.onc.1202591; Rossol M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2339; Saikumar P, 1998, ONCOGENE, V17, P3341, DOI 10.1038/sj.onc.1202579; Shohami E, 1996, J CEREBR BLOOD F MET, V16, P378, DOI 10.1097/00004647-199605000-00004; Siesjo BK, 1999, J CEREBR BLOOD F MET, V19, P19, DOI 10.1097/00004647-199901000-00002; Skotak M, 2012, J NEUROSCI METH, V205, P159, DOI 10.1016/j.jneumeth.2012.01.001; Soares HD, 1995, J NEUROSCI, V15, P8223; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; THORNBERRY NA, 1992, NATURE, V356, P768, DOI 10.1038/356768a0; von Reyn CR, 2012, J NEUROCHEM, V121, P793, DOI 10.1111/j.1471-4159.2012.07735.x; Wahab RA, 2015, J NEUROSCI METH, V248, P16, DOI 10.1016/j.jneumeth.2015.03.010; Weber JT, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00060; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; WINSTON FK, 1989, J APPL PHYSIOL, V67, P397; Wolf JA, 2001, J NEUROSCI, V21, P1923, DOI 10.1523/JNEUROSCI.21-06-01923.2001; Yuen TJ, 2009, J NEUROSCI RES, V87, P3620, DOI 10.1002/jnr.22161; Zhang KY, 2003, NAT NEUROSCI, V6, P1064, DOI 10.1038/nn1127	59	18	19	0	8	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0893-7648	1559-1182		MOL NEUROBIOL	Mol. Neurobiol.	AUG	2017	54	6					3964	3975		10.1007/s12035-016-9949-4			12	Neurosciences	Neurosciences & Neurology	FA8QN	WOS:000405710900004	27289225				2021-06-18	
J	Arbogast, KB; Curry, AE; Metzger, KB; Kessler, RS; Bell, JM; Haarbauer-Krupa, J; Zonfrillo, MR; Breiding, MJ; Master, CL				Arbogast, Kristy B.; Curry, Allison E.; Metzger, Kristina B.; Kessler, Ronni S.; Bell, Jeneita M.; Haarbauer-Krupa, Juliet; Zonfrillo, Mark R.; Breiding, Matthew J.; Master, Christina L.			Improving Primary Care Provider Practices in Youth Concussion Management	CLINICAL PEDIATRICS			English	Article						primary care; electronic health record; clinical decision support; traumatic brain injury	CLINICAL DECISION-SUPPORT; TRAUMATIC BRAIN-INJURY; RANDOMIZED CONTROLLED-TRIAL; ELECTRONIC HEALTH RECORD; SYSTEM; KNOWLEDGE; DIAGNOSIS; SPORTS; TRENDS; RECOMMENDATIONS	Primary care providers are increasingly providing youth concussion care but report insufficient time and training, limiting adoption of best practices. We implemented a primary care-based intervention including an electronic health record-based clinical decision support tool (SmartSet) and in-person training. We evaluated consequent improvement in 2 key concussion management practices: (1) performance of a vestibular oculomotor examination and (2) discussion of return-to-learn/return-to-play (RTL/RTP) guidelines. Data were included from 7284 primary care patients aged 0 to 17 years with initial concussion visits between July 2010 and June 2014. We compared proportions of visits pre- and post-intervention in which the examination was performed or RTL/RTP guidelines provided. Examinations and RTL/RTP were documented for 1.8% and 19.0% of visits pre-intervention, respectively, compared with 71.1% and 72.9% post-intervention. A total of 95% of post-intervention examinations were documented within the SmartSet. An electronic clinical decision support tool, plus in-person training, may be key to changing primary care provider behavior around concussion care.	[Arbogast, Kristy B.; Curry, Allison E.; Metzger, Kristina B.; Kessler, Ronni S.] Childrens Hosp Philadelphia, Ctr Injury Res & Prevent, 2716 South St,Room 13471, Philadelphia, PA 19146 USA; [Arbogast, Kristy B.; Curry, Allison E.; Master, Christina L.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Bell, Jeneita M.; Haarbauer-Krupa, Juliet; Breiding, Matthew J.] Ctr Dis Control & Prevent, Natl Ctr Injury Prevent & Control, Atlanta, GA USA; [Zonfrillo, Mark R.] Brown Univ, Hasbro Childrens Hosp, Providence, RI 02912 USA; [Zonfrillo, Mark R.] Brown Univ, Alpert Med Sch, Providence, RI 02912 USA; [Master, Christina L.] Grad Hosp Philadelphia, Sport Med & Performance Ctr, Philadelphia, PA 19146 USA	Arbogast, KB (corresponding author), Childrens Hosp Philadelphia, Ctr Injury Res & Prevent, 2716 South St,Room 13471, Philadelphia, PA 19146 USA.	arbogast@email.chop.edu	Zonfrillo, Mark R./H-9403-2017	Zonfrillo, Mark R./0000-0002-0610-9563; Master, Christina/0000-0002-6717-4270; Arbogast, Kristy/0000-0002-1694-4562; Curry, Allison/0000-0001-7076-3538	US Department of Health and Human Services (DHHS); Centers for Disease Control and Prevention (CDC)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA; Children's Hospital of Philadelphia	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This research was supported by an intergovernmental personnel act agreement between the US Department of Health and Human Services (DHHS), Centers for Disease Control and Prevention (CDC), and the Children's Hospital of Philadelphia.	Anand V, 2012, PEDIATRICS, V129, pE1275, DOI 10.1542/peds.2011-2875; Arbogast KB, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.0294; Arbogast KB, 2013, CLIN PEDIATR, V52, P397, DOI 10.1177/0009922813478160; Ballard DW, 2013, ACAD EMERG MED, V20, P352, DOI 10.1111/acem.12109; Bauer NS, 2014, J AM MED INFORM ASSN, V21, P146, DOI 10.1136/amiajnl-2013-001851; Bright TJ, 2012, ANN INTERN MED, V157, P29, DOI 10.7326/0003-4819-157-1-201207030-00450; Bryan Cathy, 2008, Inform Prim Care, V16, P79; Carl RL, 2014, CLIN PEDIATR, V53, P689, DOI 10.1177/0009922814526979; Carroll AE, 2013, PEDIATRICS, V132, pE623, DOI 10.1542/peds.2013-0933; Carroll AE, 2013, J AM MED INFORM ASSN, V20, P311, DOI 10.1136/amiajnl-2011-000682; Carroll AE, 2012, PEDIAT ALLER IMM PUL, V25, P168, DOI 10.1089/ped.2012.0143; Coronado VG, 2015, J HEAD TRAUMA REHAB, V30, P185, DOI 10.1097/HTR.0000000000000156; Corwin DJ, 2015, J PEDIATR-US, V166, P1221, DOI 10.1016/j.jpeds.2015.01.039; Cresswell Kathrin, 2012, Inform Prim Care, V20, P115; Gioia GA, 2008, J HEAD TRAUMA REHAB, V23, P230, DOI 10.1097/01.HTR.0000327255.38881.ca; Guerriero RM, 2012, CURR OPIN PEDIATR, V24, P696, DOI 10.1097/MOP.0b013e3283595175; Ip IK, 2015, AM J EMERG MED, V33, P320, DOI 10.1016/j.ajem.2014.11.005; Kaye AJ, 2010, J TRAUMA, V68, P1396, DOI 10.1097/TA.0b013e3181cf7d1b; Kinnaman KA, 2014, PEDIATR EMERG CARE, V30, P458, DOI 10.1097/PEC.0000000000000161; Kitson AL, 2009, J ADV NURS, V65, P217, DOI 10.1111/j.1365-2648.2008.04864.x; Kontos AP, 2016, AM J SPORT MED, V44, P1400, DOI 10.1177/0363546516632754; Krist AH, 2015, J AM BOARD FAM MED, V28, P299, DOI 10.3122/jabfm.2015.03.150097; Master CL, 2016, CLIN PEDIATR, V55, P260, DOI 10.1177/0009922815594367; Master CL, 2012, PEDIATR ANN, V41, pE174, DOI 10.3928/00904481-20120827-08; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; Melnick Edward R, 2015, EGEMS (Wash DC), V3, P1136, DOI 10.13063/2327-9214.1136; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; National Conference of State Legislatures, 2015, TRAUM BRAIN INJ LEG; Pfister T, 2016, BRIT J SPORT MED, V50, P292, DOI 10.1136/bjsports-2015-094978; Pleacher MD, 2006, BRIT J SPORT MED, V40, DOI 10.1136/bjsm.2005.019067; Prober CG, 2013, ACAD MED, V88, P1407, DOI 10.1097/ACM.0b013e3182a368bd; Rattay KT, 2009, PEDIATRICS, V123, pS100, DOI 10.1542/peds.2008-1755J; Reisner A, 2015, CLIN PEDIATR, V54, P1031, DOI 10.1177/0009922815573468; Schwartz L, 2014, AM FED MED RES E REG; Taylor AM, 2015, J PEDIATR-US, V167, P738, DOI 10.1016/j.jpeds.2015.05.036; Zazove P, 2015, J AM BOARD FAM MED, V28, P334, DOI 10.3122/jabfm.2015.03.140149; Zonfrillo MR, 2015, ACAD EMERG MED, V22, P872, DOI 10.1111/acem.12696; Zonfrillo MR, 2012, PEDIATRICS, V130, P1120, DOI 10.1542/peds.2012-1431; Zuckerman AE, 2009, PEDIATR CLIN N AM, V56, P965, DOI 10.1016/j.pcl.2009.05.018	39	18	18	0	2	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0009-9228	1938-2707		CLIN PEDIATR	Clin. Pediatr.	AUG	2017	56	9					854	865		10.1177/0009922817709555			12	Pediatrics	Pediatrics	FB1OX	WOS:000405914200007	28521519	Green Accepted			2021-06-18	
J	Babl, FE; Dionisio, D; Davenport, L; Baylis, A; Hearps, SJC; Bressan, S; Thompson, EJ; Anderson, V; Oakley, E; Davis, GA				Babl, Franz E.; Dionisio, Diana; Davenport, Lucy; Baylis, Amy; Hearps, Stephen J. C.; Bressan, Silvia; Thompson, Emma J.; Anderson, Vicki; Oakley, Ed; Davis, Gavin A.			Accuracy of Components of SCAT to Identify Children With Concussion	PEDIATRICS			English	Article							SPORT-RELATED CONCUSSION; INTERNATIONAL-CONFERENCE; EMERGENCY-DEPARTMENT; CONSENSUS STATEMENT; MANAGEMENT; ZURICH; ADULTS	BACKGROUND: The Sport Concussion Assessment Tool version 3 (SCAT3) and its child version abstract (ChildSCAT3) are composite physical and neuropsychological scoring systems used to assess athletes after sport-related concussion. Based on limited validation data, we aimed to evaluate the ability of SCAT3 and ChildSCAT3 to differentiate children aged 5 to 16 years with concussion from controls. METHODS: Prospective observational study of children in the emergency department with concussion (CONC group) and 2 control groups ([1] upper-limb injury [ULI] and [2] Well children) with equal-sized subgroups in 3 age bands of 5 to 8, 9 to 12, and 13 to 16 years. ChildSCAT3 was used for participants aged 5 to 12 years, and SCAT3 was used for participants aged 13 to 16 years. Differences between study groups were analyzed by using analysis of variance models, adjusting for age and sex. RESULTS: We enrolled 264 children (90 CONC, 90 ULI, and 84 Well) in equal-sized age bands. The number and severity of child-and parent-reported symptom scores were significantly higher in the CONC group than either control group (P < .001). Mean double (ChildSCAT3 P < .001) and tandem stance errors (both P = .01) were also significantly higher, and immediate memory was significantly lower for the CONC group (P < .01). No statistically significant group differences were found for orientation and digit backward tasks. There were no significant differences between ULI and Well control groups. CONCLUSIONS: Overall, SCAT3 and ChildSCAT3 can differentiate concussed from nonconcussed patients, particularly in symptom number and severity.	[Babl, Franz E.; Baylis, Amy; Oakley, Ed] Royal Childrens Hosp Melbourne, Emergency Dept, Parkville, Vic, Australia; [Babl, Franz E.; Dionisio, Diana; Davenport, Lucy; Baylis, Amy; Hearps, Stephen J. C.; Bressan, Silvia; Thompson, Emma J.; Anderson, Vicki; Oakley, Ed; Davis, Gavin A.] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Babl, Franz E.; Anderson, Vicki; Oakley, Ed] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia; [Davis, Gavin A.] Austin Hlth & Cabrini Hosp, Dept Neurosurg, Malvern, Vic, Australia	Babl, FE (corresponding author), Royal Childrens Hosp, Murdoch Childrens Res Inst, Emergency Dept, Emergency Res, Flemington Rd, Parkville, Vic 3052, Australia.	franz.babl@rch.org.au	Hearps, Stephen/L-6853-2016		Murdoch Children's Research Institute in Melbourne; Victorian Government Research Infrastructure Support program; Royal Children's Hospital Foundation; Melbourne Campus Clinician Scientist Fellowship (Melbourne, Victoria, Australia); National Health and Medical Research Council Practitioner Fellowship (Canberra, Australian Capital Territory, Australia)	Funded in part by grants from the Murdoch Children's Research Institute in Melbourne and the Victorian Government Research Infrastructure Support program. Dr Babl's time was partly funded by a grant from the The Royal Children's Hospital Foundation and the Melbourne Campus Clinician Scientist Fellowship (Melbourne, Victoria, Australia) and a National Health and Medical Research Council Practitioner Fellowship (Canberra, Australian Capital Territory, Australia).	Ayr LK, 2009, J INT NEUROPSYCH SOC, V15, P19, DOI 10.1017/S1355617708090188; Bakhos LL, 2010, PEDIATRICS, V126, pE550, DOI 10.1542/peds.2009-3101; Bressan S, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009427; Chin EY, 2016, AM J SPORT MED, V44, P2276, DOI 10.1177/0363546516648141; Gioia GA, 2009, BRIT J SPORT MED, V43, pI13, DOI 10.1136/bjsm.2009.058255; Glaviano NR, 2015, CLIN J SPORT MED, V25, P373, DOI 10.1097/JSM.0000000000000154; Gorman M, 2016, APPL NEUROPSYCH-CHIL, P1; Grubenhoff JA, 2010, PEDIATRICS, V126, P688, DOI 10.1542/peds.2009-2804; Hayden MG, 2007, CHILD NERV SYST, V23, P431, DOI 10.1007/s00381-006-0277-2; Hosmer DW., 2013, APPL LOGISTIC REGRES, V3rd ed.; Jennings D, 2015, INT J SPORTS PHYS TH, V10, P667; Kirkwood MW, 2006, PEDIATRICS, V117, P1359, DOI 10.1542/peds.2005-0994; Lovell MR, 2008, CURR SPORT MED REP, V7, P12, DOI 10.1097/01.CSMR.0000308671.45558.e2; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2004, BRIT J SPORT MED, V38, P516, DOI 10.1136/bjsm.2004.014811; McCrory P, 2002, BRIT J SPORT MED, V36, P316, DOI 10.1136/bjsm.36.5.316; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Nelson LD, 2017, CLIN J SPORT MED, V27, P381, DOI 10.1097/JSM.0000000000000369; Schnadower D, 2007, CURR OPIN PEDIATR, V19, P258, DOI 10.1097/MOP.0b013e3281084e85	21	18	18	0	6	AMER ACAD PEDIATRICS	ELK GROVE VILLAGE	141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA	0031-4005	1098-4275		PEDIATRICS	Pediatrics	AUG	2017	140	2							e20163258	10.1542/peds.2016-3258			9	Pediatrics	Pediatrics	FC2IA	WOS:000406659900013		Bronze			2021-06-18	
J	Leeper, CM; Vissa, M; Cooper, JD; Malec, LM; Gaines, BA				Leeper, Christine M.; Vissa, Madhav; Cooper, James D.; Malec, Lynn M.; Gaines, Barbara A.			Venous thromboembolism in pediatric trauma patients: Ten-year experience and long-term follow-up in a tertiary care center	PEDIATRIC BLOOD & CANCER			English	Article						anticoagulants; pediatrics; trauma; venous thrombosis	DEEP-VEIN THROMBOSIS; POSTTHROMBOTIC SYNDROME; RISK-FACTORS; BRAIN-INJURY; PULMONARY-EMBOLISM; EARLY COAGULOPATHY; CHILDREN; MORTALITY; PROPHYLAXIS; ADMISSION	BackgroundPediatric trauma patients are at high risk for development of venous thromboembolism (VTE). Our objective is to describe incidence, risk factors, and timing of development of VTE, anticoagulation complications, and long-term VTE outcomes in a critically injured pediatric population. ProcedureWe did a retrospective review of pediatric (0-17 years) trauma admissions to intensive care unit from 2005 to 2014. Our center employs VTE screening and prevention protocols for high-risk patients based on hypercoagulable history, age, injuries, and medical interventions. We collected demographics, VTE prevention measures, VTE incidence, therapeutic anticoagulant use, and outcomes including postthrombotic syndrome (PTS) and clot resolution. Analysis included Wilcoxon rank-sum, Fisher exact, and logistic regression modeling. ResultsSeven hundred fifty-three subjects were analyzed. No patients on chemical prophylaxis (21/753) developed VTE. Overall incidence of deep vein thrombosis (DVT) was 8.9%; pulmonary embolism (PE) was 0%. Time to diagnosis was median (interquartile range [IQR]) 10.5 (6.5-14.5) days, with 63% of clots being symptomatic. Risk factors for VTE development included severe traumatic brain injury (TBI), acute traumatic coagulopathy (defined by elevated admission international normalized ratio), age less than or equal to 3 or age 13 years or more, injury severity, and child abuse mechanism. At a median (IQR) follow-up of 13 (6-19) months, 52.1% had persistent clot and 15.8% had PTS. Therapeutic anticoagulation was not associated with clot resolution or prevention of PTS. ConclusionTBI therapy is closely linked to the development of DVT. Coagulopathy on admission is associated with hypercoagulability in the postinjury period, suggesting a patient phenotype with systemic coagulation dysregulation. Treatment was not associated with improved VTE outcomes, suggesting that pediatric protocols should emphasize VTE prevention and prophylaxis strategies.	[Leeper, Christine M.] Univ Pittsburgh, Dept Surg, Med Ctr, Div Gen Surg & Trauma, Pittsburgh, PA USA; [Vissa, Madhav; Cooper, James D.; Malec, Lynn M.; Gaines, Barbara A.] UPMC, Childrens Hosp Pittsburgh, Pittsburgh, PA USA	Leeper, CM (corresponding author), Univ Pittsburgh, Childrens Hosp Pittsburgh, UPMC, Sch Med, 7th Floor,Fac Pavil,4401 Penn Ave, Pittsburgh, PA 15224 USA.	leepercm@upmc.edu					Askegard-Giesmann JR, 2012, J PEDIATR SURG, V47, P980, DOI 10.1016/j.jpedsurg.2012.01.060; Avila ML, 2014, BLOOD, V124, P1166, DOI 10.1182/blood-2014-04-570531; Azu MC, 2005, J TRAUMA, V59, P1345, DOI 10.1097/01.ta.0000196008.48461.47; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Candrilli SD, 2009, PEDIATR CRIT CARE ME, V10, P554, DOI 10.1097/PCC.0b013e3181a705d3; Chiaretti A, 2001, PEDIATR NEUROSURG, V34, P131, DOI 10.1159/000056008; Christiaans SC, 2014, SHOCK, V41, P476, DOI 10.1097/SHK.0000000000000151; Cohen MJ, 2012, ANN SURG, V255, P379, DOI 10.1097/SLA.0b013e318235d9e6; Connelly CR, 2016, JAMA SURG, V151, P50, DOI 10.1001/jamasurg.2015.2670; Cook A, 2005, J TRAUMA, V59, P1114, DOI 10.1097/01.ta.0000196692.40475.61; Creary S, 2012, BLOOD COAGUL FIBRIN, V23, P39, DOI 10.1097/MBC.0b013e32834bdb1c; Cyr C, 2006, ACTA HAEMATOL-BASEL, V115, P198, DOI 10.1159/000090935; Dengler BA, 2016, NEUROCRIT CARE, V25, P215, DOI 10.1007/s12028-016-0280-8; Dietch ZC, 2015, SURGERY, V158, P379, DOI 10.1016/j.surg.2015.03.052; Goldenberg NA, 2010, HAEMATOL-HEMATOL J, V95, P1952, DOI 10.3324/haematol.2010.026989; Hanson SJ, 2016, J TRAUMA ACUTE CARE, V80, P695, DOI 10.1097/TA.0000000000000962; Hanson SJ, 2010, J TRAUMA, V68, P52, DOI 10.1097/TA.0b013e3181a74652; Hollingworth W, 2007, PEDIATR CRIT CARE ME, V8, P348, DOI 10.1097/01.PCC.0000270837.66217.3B; Hymel KP, 1997, PEDIATRICS, V99, P371, DOI 10.1542/peds.99.3.371; Jenny C, 1999, JAMA-J AM MED ASSOC, V281, P621, DOI 10.1001/jama.281.7.621; Keenan HT, 2003, JAMA-J AM MED ASSOC, V290, P621, DOI 10.1001/jama.290.5.621; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Kreuz W, 2006, ARTERIOSCL THROM VAS, V26, P1901, DOI 10.1161/01.ATV.0000227510.36653.ed; Kuhle S, 2003, THROMB RES, V111, P227, DOI 10.1016/j.thromres.2003.09.008; Kumar R, 2015, THROMB RES, V135, P347, DOI 10.1016/j.thromres.2014.12.005; Kwiatt ME, 2012, J TRAUMA ACUTE CARE, V73, P625, DOI 10.1097/TA.0b013e318265cab9; Leeper CM, 2016, J TRAUMA ACUTE CARE, V81, P34, DOI 10.1097/TA.0000000000001002; Leeper CM, 2016, J TRAUMA ACUTE CARE, V80, P711, DOI 10.1097/TA.0000000000000954; Mahajerin A, 2015, HAEMATOLOGICA, V100, P1045, DOI 10.3324/haematol.2015.123455; Manco-Johnson MJ, 2006, ACTA HAEMATOL-BASEL, V115, P207, DOI 10.1159/000090937; Marton E, 2007, CHILD NERV SYST, V23, P873, DOI 10.1007/s00381-007-0314-9; MCBRIDE WJ, 1994, J TRAUMA, V37, P913, DOI 10.1097/00005373-199412000-00007; O'Brien SH, 2011, PEDIATR CRIT CARE ME, V12, P251, DOI 10.1097/PCC.0b013e3181f36bd9; Patregnani JT, 2012, PEDIATR CRIT CARE ME, V13, P273, DOI 10.1097/PCC.0b013e31822f1727; Raffini L, 2009, PEDIATRICS, V124, P1001, DOI 10.1542/peds.2009-0768; Schobess R, 2006, HAEMATOLOGICA, V91, P1701; Sharathkumar AA, 2008, J PEDIAT HEMATOL ONC, V30, P261, DOI 10.1097/MPH.0b013e318162bcf5; Shein SL, 2012, J PEDIATR-US, V161, P716, DOI 10.1016/j.jpeds.2012.03.046; Truitt AK, 2005, J PEDIATR SURG, V40, P124, DOI 10.1016/j.jpedsurg.2004.09.017; Melo JRT, 2009, CHILD NERV SYST, V25, P1077, DOI 10.1007/s00381-009-0924-5; Van Arendonk KJ, 2013, JAMA SURG, V148, P1123, DOI 10.1001/jamasurg.2013.3558; Van Ommen CH, 2003, J THROMB HAEMOST, V1, P2516, DOI 10.1046/j.1538-7836.2003.00465.x; Vavilala MS, 2002, J TRAUMA, V52, P922, DOI 10.1097/00005373-200205000-00017; Whittaker B, 2013, SHOCK, V39, P421, DOI 10.1097/SHK.0b013e31828e08cb	44	18	18	0	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1545-5009	1545-5017		PEDIATR BLOOD CANCER	Pediatr. Blood Cancer	AUG	2017	64	8							e26415	10.1002/pbc.26415			8	Oncology; Hematology; Pediatrics	Oncology; Hematology; Pediatrics	EX5ZC	WOS:000403320600007	28067012				2021-06-18	
J	Malhotra, RK				Malhotra, Raman K.			Sleep, Recovery, and Performance in Sports	NEUROLOGIC CLINICS			English	Article						Sleep deprivation; Sleep apnea; Insomnia; Jet lag; Circadian rhythm disorder; Recovery; Hypersomnia; Concussion	PROFESSIONAL FOOTBALL PLAYERS; TRAUMATIC BRAIN-INJURY; ATHLETIC PERFORMANCE; CONSENSUS STATEMENT; RECOMMENDED AMOUNT; AMERICAN ACADEMY; SERVING ACCURACY; TENNIS PLAYERS; LEAGUE; PREVALENCE	Poor sleep can lead to decreases in performance and recovery for athletes. Sleep disorders and symptoms are commonly seen in athletes, and may be unrecognized. It is important to educate athletes on adequate duration, quality, and timing of sleep. Interventions may include changes to practice times or careful planning for travel to games in different time zones. It is important to screen and treat sleep disorders such as sleep apnea and insomnia that are seen in some athletes. In patients who suffer concussion, it is important to address sleep issues, as poor sleep can prolong or exacerbate other concussion symptoms.	[Malhotra, Raman K.] St Louis Univ, Sch Med, Dept Neurol, Monteleone Hall,1438 South Grand Blvd, St Louis, MO 63104 USA	Malhotra, RK (corresponding author), St Louis Univ, Sch Med, Dept Neurol, Monteleone Hall,1438 South Grand Blvd, St Louis, MO 63104 USA.	Rmalhot1@slu.edu					Albuquerque FN, 2010, J AM COLL CARDIOL, V56, P1432, DOI 10.1016/j.jacc.2010.03.099; Atkinson G, 1998, PERCEPT MOTOR SKILL, V86, P1335, DOI 10.2466/pms.1998.86.3c.1335; Atkinson G, 1996, SPORTS MED, V21, P292, DOI 10.2165/00007256-199621040-00005; Belenky G, 2003, J SLEEP RES, V12, P1, DOI 10.1046/j.1365-2869.2003.00337.x; Benton ML, 2013, J CLIN SLEEP MED, V9, P1237, DOI 10.5664/jcsm.3256; Blumert PA, 2007, J STRENGTH COND RES, V21, P1146; Castriotta RJ, 2007, J CLIN SLEEP MED, V3, P349; Dawson D, 1997, NATURE, V388, P235, DOI 10.1038/40775; Deschodt VJ, 2004, J STRENGTH COND RES, V18, P149; Dobrosielski DA, 2016, RESP CARE, V61, P1144, DOI 10.4187/respcare.04520; Eagles A, 2004, J SPORTS MED PHYS FI; Edwards BJ, 2005, ERGONOMICS, V48, P1488, DOI 10.1080/00140130500100975; George CFP, 2003, SLEEP MED, V4, P317, DOI 10.1016/S1389-9457(03)00113-8; Grima NA, 2016, NEUROREHAB NEURAL RE, V30, P972, DOI 10.1177/1545968316650279; Juliff LE, 2015, J SCI MED SPORT, V18, P13, DOI 10.1016/j.jsams.2014.02.007; Kripke DF, 2002, ARCH GEN PSYCHIAT, V59, P131, DOI 10.1001/archpsyc.59.2.131; Kutscher S, 2013, SLEEP, V36, pA408; Lancee J, 2016, SLEEP, V39, P183, DOI 10.5665/sleep.5344; Luke A, 2011, CLIN J SPORT MED, V21, P307, DOI 10.1097/JSM.0b013e3182218f71; Mah CD, 2011, SLEEP, V34, P943, DOI 10.5665/SLEEP.1132; McClure DJ, 2014, AM J SPORT MED, V42, P472, DOI 10.1177/0363546513510389; MOUGIN F, 1990, Science and Sports, V5, P83, DOI 10.1016/S0765-1597(05)80210-2; Paruthi S, 2016, J CLIN SLEEP MED, V12, P785, DOI 10.5664/jcsm.5866; REILLY T, 1994, ERGONOMICS, V37, P107, DOI 10.1080/00140139408963628; Reyner LA, 2013, PHYSIOL BEHAV, V120, P93, DOI 10.1016/j.physbeh.2013.07.002; Rice TB, 2010, SLEEP, V33, P819, DOI 10.1093/sleep/33.6.819; Samuels C, 2008, NEUROL CLIN, V26, P169, DOI 10.1016/j.ncl.2007.11.012; Schwartz J, 2015, PHYSIOL BEHAV, V151, P541, DOI 10.1016/j.physbeh.2015.08.035; Skein M, 2013, INT J SPORT PHYSIOL, V8, P556, DOI 10.1123/ijspp.8.5.556; Smith RS, 2013, SLEEP, V36, P1999, DOI 10.5665/sleep.3248; Swinbourne R, 2016, EUR J SPORT SCI, V16, P850, DOI 10.1080/17461391.2015.1120781; vonsRosen P, 2016, SCAND J MED SCI SPOR, DOI 10.1111/sms.12735<original-structure ref = info:doi/10.1111/sms.12735></original-structure>; Vyazovskiy VV, 2014, NEUROSCIENTIST, V20, P203, DOI 10.1177/1073858413518152; Walker MP, 2005, CLIN SPORT MED, V24, P301, DOI 10.1016/j.csm.2004.11.002; Watson NF, 2015, SLEEP, V38, P843, DOI 10.5665/sleep.4716; Wheaton A. G., 2011, Morbidity and Mortality Weekly Report, V60, P239; Winter WC, 2011, SLEEP, V34, pA167	37	18	18	2	89	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0733-8619	1557-9875		NEUROL CLIN	Neurol. Clin.	AUG	2017	35	3					547	+		10.1016/j.ncl.2017.03.002			12	Clinical Neurology; Neurosciences	Neurosciences & Neurology	FC4OI	WOS:000406819500012	28673415				2021-06-18	
J	Fonda, JR; Fredman, L; Brogly, SB; McGlinchey, RE; Milberg, WP; Gradus, JL				Fonda, Jennifer R.; Fredman, Lisa; Brogly, Susan B.; McGlinchey, Regina E.; Milberg, William P.; Gradus, Jaimie L.			Traumatic Brain Injury and Attempted Suicide Among Veterans of the Wars in Iraq and Afghanistan	AMERICAN JOURNAL OF EPIDEMIOLOGY			English	Article						attempted suicide; cohort studies; traumatic brain injury; veterans	POSTTRAUMATIC-STRESS-DISORDER; OPERATIONS ENDURING FREEDOM; POSTCONCUSSIVE SYMPTOMS; SOLDIERS; PAIN; ASSOCIATION; POLYTRAUMA; DEPRESSION; DEPLOYMENT; SERVICES	Studies of the association between traumatic brain injury (TBI) and suicide attempt have yielded conflicting results. Furthermore, no studies have examined the possible mediating role of common comorbid psychiatric conditions in this association. This study used Veterans Affairs registry data to evaluate the associations between deployment-related TBI, psychiatric diagnoses, and attempted suicide among 273,591 veterans deployed in support of Operation Enduring Freedom, Operation Iraqi Freedom, and Operation New Dawn, and who received care from the Department of Veterans Affairs during 2007-2012. We performed Cox proportional hazards regression analyses, adjusting for demographic characteristics. Mediation analyses were conducted to quantify the impact of psychiatric conditions (posttraumatic stress disorder, depression, anxiety, and substance abuse) on this association. The sample was predominantly male (84%); mean age = 28.7 years. Veterans with TBI (16%) were more likely to attempt suicide than those without (0.54% vs. 0.14%): adjusted hazards ratio = 3.76, 95% confidence interval: 3.15, 4.49. This association was attenuated in mediation analyses (adjusted hazards ratio = 1.25, 95% confidence interval: 1.07, 1.46), with 83% of the association of TBI with attempted suicide mediated by co-occurring psychiatric conditions and with posttraumatic stress disorder having the largest impact. These results suggest that veterans with these conditions should be closely monitored for suicidal behavior.	[Fonda, Jennifer R.; McGlinchey, Regina E.; Milberg, William P.] VA Boston Healthcare Syst, Translat Res Ctr TBI & Stress Disorders, 150 South Huntington Ave 182 JP, Boston, MA 02130 USA; [Fonda, Jennifer R.; McGlinchey, Regina E.; Milberg, William P.] VA Boston Healthcare Syst, Geriatr Res Educ & Clin Ctr, 150 South Huntington Ave 182 JP, Boston, MA 02130 USA; [Fonda, Jennifer R.; Fredman, Lisa; Brogly, Susan B.] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Brogly, Susan B.] Queens Univ, Dept Med, Kingston, ON, Canada; [Brogly, Susan B.] Queens Univ, Dept Surg, Kingston, ON, Canada; [McGlinchey, Regina E.; Milberg, William P.] Harvard Med Sch, Dept Psychiat, Boston, MA USA; [Gradus, Jaimie L.] VA Boston Healthcare Syst, Natl Ctr PTSD, Boston, MA USA; [Gradus, Jaimie L.] Boston Univ, Sch Med, Dept Psychiat, Boston, MA 02118 USA	Fonda, JR (corresponding author), VA Boston Healthcare Syst, Translat Res Ctr TBI & Stress Disorders, 150 South Huntington Ave 182 JP, Boston, MA 02130 USA.; Fonda, JR (corresponding author), VA Boston Healthcare Syst, Geriatr Res Educ & Clin Ctr, 150 South Huntington Ave 182 JP, Boston, MA 02130 USA.	jennifer.fonda@va.gov		Brogly, Susan/0000-0002-2339-3287	Translational Research Center for TBI and Stress Disorders (TRACTS)-aVA Rehabilitation Research and Development Traumatic Brain Injury National Network Research Center [B6796-C]	This study was performed without financial support. VA Boston Healthcare System and the Translational Research Center for TBI and Stress Disorders (TRACTS)-aVA Rehabilitation Research and Development Traumatic Brain Injury National Network Research Center (grant B6796-C)-provided overall and infrastructural support.	Barnes SM, 2012, REHABIL PSYCHOL, V57, P18, DOI 10.1037/a0027007; Brenner LA, 2011, SUICIDE LIFE-THREAT, V41, P416, DOI 10.1111/j.1943-278X.2011.00041.x; Clark ME, 2007, J REHABIL RES DEV, V44, P179, DOI 10.1682/JRRD.2006.05.0057; Ding P, 2016, EPIDEMIOLOGY, V27, P368, DOI 10.1097/EDE.0000000000000457; Dobscha SK, 2009, PAIN MED, V10, P1200, DOI 10.1111/j.1526-4637.2009.00721.x; Eber S, 2013, MIL MED, V178, P966, DOI 10.7205/MILMED-D-13-00175; Epidemiology Program Post-Deployment Health Group, 2001, AN VA HLTH CAR UT OP; Fortier CB, 2014, J HEAD TRAUMA REHAB, V29, P89, DOI 10.1097/HTR.0b013e3182865859; Gawande A, 2004, NEW ENGL J MED, V351, P2471, DOI 10.1056/NEJMp048317; Gironda RJ, 2006, PAIN MED, V7, P339, DOI 10.1111/j.1526-4637.2006.00146.x; Gradus JL, 2015, J TRAUMA STRESS, V28, P361, DOI 10.1002/jts.22021; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Lange T, 2014, AM J EPIDEMIOL, V179, P513, DOI 10.1093/aje/kwt270; Lew HL, 2005, J REHABIL RES DEV, V42, pXIII, DOI 10.1682/JRRD.2005.07.0124; Lippa SM, 2015, J TRAUMA STRESS, V28, P25, DOI 10.1002/jts.21979; Management of Concussion/mTBI Working Group, 2009, CLIN PRACT GUID MAN; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; Miller EA, 2012, SOC WORK PUBLIC HLTH, V27, P379, DOI 10.1080/19371910903176197; Oquendo MA, 2004, J NERV MENT DIS, V192, P430, DOI 10.1097/01.nmd.0000126706.53615.7b; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Rochon J, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-9; Schneider AL, 2016, FRONT PSYCHIATRY, V7, DOI 10.3389/fpsyt.2016.00059; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; Simpson G, 2005, J NERV MENT DIS, V193, P680, DOI 10.1097/01.nmd.0000180743.65943.c8; Simpson G, 2002, PSYCHOL MED, V32, P687, DOI 10.1017/S0033291702005561; Tanielian T, 2008, INVISIBLE WOUNDS WAR; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; US Department of Defense and US Department of Veterans Affairs, DOD VA COMM DEF TBI; US Department of Veterans Affairs, SCREEN EV POSS TRAUM; US Department of Veterans Affairs National Center for Veterans Analysis and Statistics, UN VET US REP FY 201; VanderWeele T J, 2014, Epidemiol Methods, V2, P95; Vasterling JJ, 2012, BRIT J PSYCHIAT, V201, P186, DOI 10.1192/bjp.bp.111.096461; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004	35	18	18	0	12	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0002-9262	1476-6256		AM J EPIDEMIOL	Am. J. Epidemiol.	JUL 15	2017	186	2					220	226		10.1093/aje/kwx044			7	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	FB0XV	WOS:000405869200011	28472407	Bronze			2021-06-18	
J	Szot, P; Franklin, A; Figlewicz, DP; Beuca, TP; Bullock, K; Hansen, K; Banks, WA; Raskind, MA; Peskind, ER				Szot, Patricia; Franklin, Allyn; Figlewicz, Dianne P.; Beuca, Timothy Petru; Bullock, Kristin; Hansen, Kim; Banks, William A.; Raskind, Murray A.; Peskind, Elaine R.			MULTIPLE LIPOPOLYSACCHARIDE (LPS) INJECTIONS ALTER INTERLEUKIN 6 (IL-6), IL-7, IL-10 AND IL-6 AND IL-7 RECEPTOR MRNA IN CNS AND SPLEEN	NEUROSCIENCE			English	Article						Neuroinflammation; LPS; spleen; interleukin-6; interleukin-10; IL receptor	CENTRAL-NERVOUS-SYSTEM; RAT-BRAIN; TRANSCRIPTIONAL ACTIVATION; PROINFLAMMATORY CYTOKINE; PARKINSONS-DISEASE; EXPRESSION; MICE; LOCALIZATION; INFLAMMATION; HIPPOCAMPUS	Neuroinflammation is proposed to be an important component in the development of several central nervous system (CNS) disorders including depression, Alzheimer's disease, Parkinson's disease, and traumatic brain injury. However, exactly how neuroinflammation leads to, or contributes to, these central disorders is unclear. The objective of the study was to examine and compare the expression of mRNAs for interleukin-6 (IL-6), IL-7, IL-10 and the receptors for IL-6 (IL-6R) and IL-7 (IL-7R) using in situ hybridization in discrete brain regions and in the spleen after multiple injections of 3 mg/kg lipopolysaccharide (LPS), a model of neuroinflammation. In the spleen, LPS significantly elevated IL-6 mRNA expression, then IL-10 mRNA, with no effect on IL-7 or IL-7R mRNA, while significantly decreasing IL-6R mRNA expression. In the CNS, LPS administration had the greatest effect on IL-6 and IL-6R mRNA. LPS increased IL-6 mRNA expression only in non neuronal cells throughout the brain, but significantly elevated IL-6R mRNA in neuronal populations, where observed, except the cerebellum. LPS resulted in variable effects on IL-10 mRNA, and had no effect on IL-7 or IL-7R mRNA expression. These studies indicate that LPS-induced neuroinflammation has substantial but variable effects on the regional and cellular patterns of CNS IL-6, IL-7 and IL-10, and for IL-6R and IL-7R mRNA expression. It is apparent that administration of LPS can affect non-neuronal and neuronal cells in the brain. Further research is required to determine how CNS inflammatory changes associated with IL-6, IL-10 and IL-6R could in turn contribute to the development of CNS neurological disorders. Published by Elsevier Ltd on behalf of IBRO.	[Szot, Patricia; Franklin, Allyn; Beuca, Timothy Petru; Raskind, Murray A.; Peskind, Elaine R.] Mental Illness Res Educ & Clin Ctr, Seattle, WA USA; [Bullock, Kristin; Hansen, Kim; Banks, William A.] Univ Washington, Sch Med, Geriatr Res Educ & Clin Ctr, Seattle, WA USA; [Bullock, Kristin; Hansen, Kim; Banks, William A.] Univ Washington, Sch Med, Vet Affairs Puget Sound Hlth Care Syst, Seattle, WA USA; [Bullock, Kristin; Hansen, Kim; Banks, William A.] Univ Washington, Sch Med, Dept Med, Div Gerontol & Geriatr Med, Seattle, WA 98195 USA; [Figlewicz, Dianne P.] Vet Affairs Puget Sound Hlth Care Syst, BSR&D, Seattle, WA USA; [Figlewicz, Dianne P.] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA	Szot, P (corresponding author), VA Puget Sound Hlth Care Syst, MIRECC, 1660 S Columbian Way, Seattle, WA 98108 USA.	szot@uw.edu			Department of Veterans Affairs VISN 20 Northwest Network Mental Illness Research, Education, and Clinical Center (MIRECC); Geriatric Research, Education, and Clinical Center (University of Washington Department of Psychiatry and Behavioral Sciences)	This work was supported by Department of Veterans Affairs VISN 20 Northwest Network Mental Illness Research, Education, and Clinical Center (MIRECC; Patricia Szot, Allyn Franklin, Murray A. Raskind and Elaine R. Peskind) and Geriatric Research, Education, and Clinical Center (University of Washington Department of Psychiatry and Behavioral Sciences (Patricia Szot, Murray A. Raskind and Elaine R. Peskind). Dianne Figlewicz Lattemann is a Senior Research Career Scientist, Biomedical Laboratory Research Program, Department of Veterans Affairs Puget Sound Health Care System, Seattle, Washington.	Balschun D, 2004, FASEB J, V18, P1788, DOI 10.1096/fj.04-1625fje; Banks WA, 1999, EXP NEUROL, V156, P165, DOI 10.1006/exnr.1998.7011; Brown MA, 1994, ANN NY ACAD SCI, V840, P21; Cazareth J, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-132; Cesta MF, 2006, TOXICOL PATHOL, V34, P455, DOI 10.1080/01926230600867743; Elenkov IJ, 1999, CYTOKINE, V6, P300; Erickson MA, 2011, BRAIN BEHAV IMMUN, V25, P1637, DOI 10.1016/j.bbi.2011.06.006; Francois A, 2014, MOL BRAIN, V7, DOI 10.1186/s13041-014-0056-z; Gadient RA, 1995, ANN NY ACAD SCI, V762, P403; GADIENT RA, 1994, BRAIN RES, V637, P10, DOI 10.1016/0006-8993(94)91211-4; GADIENT RA, 1994, NEUROSCI LETT, V182, P243, DOI 10.1016/0304-3940(94)90807-9; Gadient RA, 1997, PROG NEUROBIOL, V52, P379, DOI 10.1016/S0301-0082(97)00021-X; Harden LM, 2014, PFLUG ARCH EUR J PHY, V466, P1451, DOI 10.1007/s00424-013-1371-4; Konsman JP, 2004, J COMP NEUROL, V472, P113, DOI 10.1002/cne.20052; KOPF M, 1994, NATURE, V368, P339, DOI 10.1038/368339a0; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Kuper DF, 2002, HDB TOXICOLOGICAL PA, V2, P586; Lebel E, 2000, ENDOCRINOLOGY, V141, P3749, DOI 10.1210/en.141.10.3749; Macia L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009953; McCusker RH, 2013, J EXP BIOL, V216, P84, DOI 10.1242/jeb.073411; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Morganti-Kossmann MC, 2001, SHOCK, V16, P165, DOI 10.1097/00024382-200116030-00001; O'Brien SM, 2004, HUM PSYCHOPHARM CLIN, V19, P397, DOI 10.1002/hup.609; Orr CF, 2002, PROG NEUROBIOL, V68, P325, DOI 10.1016/S0301-0082(02)00127-2; Paxinos G., 2013, MOUSE BRAIN STEREOTA; Quan N, 2014, BRAIN BEHAV IMMUN, V40, P1, DOI 10.1016/j.bbi.2014.02.006; Ramsey CP, 2014, EXP NEUROL, V256, P126, DOI 10.1016/j.expneurol.2013.05.014; Rhodes JKJ, 2002, NEUROSCI LETT, V335, P1, DOI 10.1016/S0304-3940(02)00811-X; Richwine AF, 2009, BRAIN BEHAV IMMUN, V23, P794, DOI 10.1016/j.bbi.2009.02.020; Rohleder N, 2012, ANN NY ACAD SCI, V1261, P88, DOI 10.1111/j.1749-6632.2012.06634.x; Roth J, 2004, J THERM BIOL, V29, P383, DOI 10.1016/j.jtherbio.2004.08.002; Roth J, 2004, FRONT BIOSCI-LANDMRK, V9, P290, DOI 10.2741/1241; Rummel C, 2005, J COMP NEUROL, V491, P1, DOI 10.1002/cne.20653; Rummel C, 2008, J COMP NEUROL, V511, P373, DOI 10.1002/cne.21850; Rummel C, 2016, BRAIN BEHAV IMMUN, V54, P1, DOI 10.1016/j.bbi.2015.09.003; Sabat R, 2010, CYTOKINE GROWTH F R, V21, P331, DOI 10.1016/j.cytogfr.2010.09.002; Schaper F, 2015, CYTOKINE GROWTH F R, V26, P475, DOI 10.1016/j.cytogfr.2015.07.004; Schneiders J, 2015, BRAIN BEHAV IMMUN, V48, P147, DOI 10.1016/j.bbi.2015.03.008; SCHOBITZ B, 1992, NEUROSCI LETT, V136, P189, DOI 10.1016/0304-3940(92)90046-A; SCHOBITZ B, 1993, EUR J NEUROSCI, V5, P1426, DOI 10.1111/j.1460-9568.1993.tb00210.x; SCHOBITZ B, 1993, ENDOCRINOLOGY, V132, P1569, DOI 10.1210/en.132.4.1569; Smith EM, 1999, J NEUROIMMUNOL, V100, P140, DOI 10.1016/S0165-5728(99)00206-4; Spooren A, 2011, BRAIN RES REV, V67, P157, DOI 10.1016/j.brainresrev.2011.01.002; Stoll G, 2000, J NEURAL TRANSM-SUPP, P81; Strle K, 2001, CRIT REV IMMUNOL, V21, P427; Szelenyi J, 2007, ANN NY ACAD SCI, V1113, P311, DOI 10.1196/annals.1391.026; Szot P, 1996, MOL BRAIN RES, V43, P233, DOI 10.1016/S0169-328X(96)00184-2; Vallieres L, 1999, ENDOCRINOLOGY, V140, P3890, DOI 10.1210/en.140.9.3890; Vallieres L, 1997, J NEUROCHEM, V69, P1668, DOI 10.1046/j.1471-4159.1997.69041668.x; Vitkovic L, 2000, J NEUROCHEM, V74, P457, DOI 10.1046/j.1471-4159.2000.740457.x; Williamson LL, 2013, BRAIN BEHAV IMMUN, V30, P186, DOI 10.1016/j.bbi.2013.01.077	51	18	18	1	8	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	JUL 4	2017	355						9	21		10.1016/j.neuroscience.2017.04.028			13	Neurosciences	Neurosciences & Neurology	EY6EQ	WOS:000404075700002	28456715				2021-06-18	
J	Khalili, H; Paydar, S; Safari, R; Arasteh, P; Niakan, A; Foroughi, AA				Khalili, Hosseinali; Paydar, Shahram; Safari, Rasool; Arasteh, Peyman; Niakan, Amin; Foroughi, Amin Abolhasani			Experience with Traumatic Brain Injury: Is Early Tracheostomy Associated with Better Prognosis?	WORLD NEUROSURGERY			English	Article						Brain injury; Outcome; Prognosis; Tracheostomy; Trauma	SEVERE HEAD-INJURY; MECHANICAL VENTILATION; IMPACT	OBJECTIVE: In this study we compared the effects of early tracheostomy (ET) versus late tracheostomy on traumatic brain injury (TBI)-related outcomes and prognosis. PATIENTS AND METHODS: Data on 152 TBI patients with a Glasgow Coma Scale (GCS) score of <= 8, admitted to Rajaee Hospital between March 1, 2014 and August 23, 2015, were collected. Rajaee Hospital is the main referral trauma center in southern Iran and is affiliated with Shiraz University of Medical Sciences. Patients who had tracheostomy before or at the sixth day of their admission were considered as ET, and those who had tracheostomy after the sixth day of admission were considered as late tracheostomy. RESULTS: Patients with ET had a significantly lower hospital stay (46.4 vs. 38.6 days; P = 0.048) and intensive care unit stay (34.9 vs. 26.7 days; P = 0.003). Mortality rates were not significantly different between the 2 groups (P > 0.99). Although not statistically significant, favorable outcomes (Glasgow Outcome Scale >4) were higher and ventilator-associated pneumonia rates were lower among the ET group (P = 0.346 and P = 492, respectively). Multivariate analysis showed that ET significantly improves 6-month prognosis (Glasgow Outcome Scale >4) (odds ratio = 2.535; 95% confidence interval: 1.030-6.237). Higher age was inversely associated with favorable prognosis (odds ratio = -0.958; confidence interval: 0.936-0.981). Glasgow Coma Scale and Rotterdam score did not show any effect on 6-month prognosis. CONCLUSION: Despite previous concern regarding increased mortality rates among patients who undergo ET, performing a tracheostomy for patients with severe TBI <6 days after their hospital admission, in addition to decreasing hospital and intensive care unit stays, will improve patient prognosis.	[Khalili, Hosseinali] Shiraz Univ Med Sci, Shiraz Trauma Res Ctr, Dept Neurosurg, Shiraz, Iran; [Paydar, Shahram; Arasteh, Peyman] Shiraz Univ Med Sci, Trauma Res Ctr, Shahid Rajaee Trauma Hosp, Shiraz, Iran; [Safari, Rasool] Shiraz Univ Med Sci, Student Res Comm, Shiraz, Iran; [Niakan, Amin] Shiraz Univ Med Sci, Dept Neurosurg, Shiraz, Iran; [Foroughi, Amin Abolhasani] Shiraz Univ Med Sci, Med Imaging Res Ctr, Dept Radiol, Nemazee Hosp, Shiraz, Iran; [Arasteh, Peyman] Fasa Univ Med Sci, Noncommunicable Dis Res Ctr, Fasa, Iran	Arasteh, P (corresponding author), Shiraz Univ Med Sci, Trauma Res Ctr, Shahid Rajaee Trauma Hosp, Shiraz, Iran.; Arasteh, P (corresponding author), Fasa Univ Med Sci, Noncommunicable Dis Res Ctr, Fasa, Iran.	peyman.arasteh@yahoo.com	Khalili, Hosseinali/I-1087-2016; niakan, amin/A-6818-2019; paydar, shahram/U-3074-2018; Abolhasani Foroughi, Amin/G-5474-2015	Khalili, Hosseinali/0000-0002-3390-4212; niakan, amin/0000-0003-2644-8543; paydar, shahram/0000-0002-6980-2576; Arasteh, Peyman/0000-0001-6499-9093; Safari, Rasool/0000-0002-3333-0896; Abolhasani Foroughi, Amin/0000-0001-6565-5014			Agrawal Amit, 2009, J Emerg Trauma Shock, V2, P56, DOI 10.4103/0974-2700.44687; Ahmed Nasim, 2007, Surg Infect (Larchmt), V8, P343, DOI 10.1089/sur.2006.065; Arabi Y, 2004, CRIT CARE, V8, pR347, DOI 10.1186/cc2924; Bouderka MA, 2004, J TRAUMA, V57, P251, DOI 10.1097/01.TA.0000087646.68382.9A; Chintamani, 2005, BMC EMERG MED, V5, DOI 10.1186/1471-227X-5-8; DAMELIO LF, 1994, AM SURGEON, V60, P180; Dunham CM, 2014, INT J BURNS TRAUMA, V4, P14; Durbin Charles G Jr, 2005, Respir Care, V50, P483; Durbin CG, 2010, RESP CARE, V55, P76; Gurkin MA, 2002, AM SURGEON, V68, P324; Huang YH, 2013, INJURY, V44, P1226, DOI 10.1016/j.injury.2012.12.029; Hyde GA, 2015, INJURY, V46, P110, DOI 10.1016/j.injury.2014.08.049; Jalalvandi F, 2016, GLOBAL J HLTH SCI, V8, P139; Liesemer K, 2014, PEDIATR CRIT CARE ME, V15, P554, DOI 10.1097/PCC.0000000000000150; Major KM, 2003, AM J SURG, V186, P615, DOI 10.1016/j.amjsurg.2003.08.012; Moller MG, 2005, AM J SURG, V189, P293, DOI 10.1016/j.amjsurg.2005.01.002; Paydar Shahram, 2014, Bull Emerg Trauma, V2, P136; Pinheiro BD, 2010, J BRAS PNEUMOL, V36, P84, DOI 10.1590/S1806-37132010000100014; Rizk EB, 2011, NEUROCRIT CARE, V15, P481, DOI 10.1007/s12028-011-9615-7; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Saboori M, 2009, J ISFAHAN MED SCH, V27, P211; Siddiqui Usman Tariq, 2015, Surg Neurol Int, V6, P65, DOI 10.4103/2152-7806.155757; Sugerman HJ, 1997, J TRAUMA, V43, P741, DOI 10.1097/00005373-199711000-00002; Wang F, 2011, CHEST, V140, P1456, DOI 10.1378/chest.11-2024; Wang HK, 2012, INJURY, V43, P1432, DOI 10.1016/j.injury.2011.03.059	25	18	20	1	11	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	JUL	2017	103						88	93		10.1016/j.wneu.2017.02.060			6	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	FA5JR	WOS:000405479900013	28254541				2021-06-18	
J	Yin, C; Huang, GF; Sun, XC; Guo, ZD; Zhang, JH				Yin, Cheng; Huang, Guang-fu; Sun, Xiao-chuan; Guo, Zongduo; Zhang, John H.			DLK silencing attenuated neuron apoptosis through JIP3/MA2K7/JNK pathway in early brain injury after SAH in rats	NEUROBIOLOGY OF DISEASE			English	Article						Subarachnoid hemorrhage; Early brain injury; DLK; Neuron; Apoptosis	LEUCINE-ZIPPER KINASE; ANEURYSMAL SUBARACHNOID HEMORRHAGE; SIGNALING PATHWAY; BARRIER INTEGRITY; CELL-DEATH; MODEL; REGENERATION; ACTIVATION; MIGRATION; ISCHEMIA	Objective: Dual leucine zipper kinase (DLK/MA3K12) has been reported involved in apoptosis and neuronal degeneration during neural development and traumatic brain injury. This study was designed to investigate the role of DIX with its adaptor protein JNK interacting protein-3 (JIP3), and its downstream MA2K7/JNK signaling pathway in early brain injury (EBI) after subarachnoid hemorrhage (SAH) in a rat model. Design: Controlled in vivo laboratory study. Setting: Animal research laboratory. Subjects: Two hundred and twenty-three adult male Sprague-Dawley rats weighing 280-320 g. Interventions: SAH was induced by endovascular perforation in rats. The SAH grade, neurological score, and brain water content were measured at 24 and 72 h after SAH. Immunofluorescence staining was used to detect the cells that expressed DLK. The terminal deoxynucleotid transferase-deoxyuridine triphosphate (dUTP) nick end labeling (TUNEL) was used to detect the neuronal apoptosis. In mechanism research, the expression of DLK, JIP3, phosphorylated-JNK (p-JNK)/INK, and cleaved caspase-3 (CC-3) were analyzed by western blot at 24 h after SAH. The DLK small interfering RNA (siRNA), JIP3 siRNA, MA2K7 siRNA and recombinant DLK protein which injected intracerebroventricularly were given as the interventions. Measurements and main results: The DLK expression was increased in the left cortex neurons and peaked at 24 h after SAH. DLK siRNA attenuated brain edema, reduced neuronal apoptosis, and improved the neurobehavioral functions after SAH, but the recombinant DLK protein deteriorated neurobehavioral functions and brain edema. DLK siRNA decreased and recombinant DLK protein increased the expression of MA2K7/p-INK/CC-3 at 24 h after SAH. The JIP3 siRNA reduced the level of JIP3/MA2K7/p-JNK/CC-3, combined DLK siRNA and JIP3 siRNA further decreased the expression of DLK/MA2K7/p-JNK/CC-3, and MA2K7 siRNA lowered the amount of MA2K7/p-JNK/CC-3 at 24 h after SAH. Conclusions: As a negative role, DLK was involved in EBI after SAH, possibly mediated by its adaptor protein JIP3 and MA2K7/JNK signaling pathways. To reduce the level of DLK may be a new target as intervention for SAH. (C) 2017 Elsevier Inc. All rights reserved.	[Yin, Cheng; Zhang, John H.] Loma Linda Univ, Sch Med, Dept Anesthesiol, Loma Linda, CA USA; [Yin, Cheng; Zhang, John H.] Loma Linda Univ, Sch Med, Dept Physiol, Loma Linda, CA 92350 USA; [Yin, Cheng; Huang, Guang-fu] Univ Elect Sci & Technol China, Sichuan Prov Peoples Hosp, Affiliated Hosp, Dept Neurosurg, Chengdu, Peoples R China; [Sun, Xiao-chuan; Guo, Zongduo] Chongqing Med Univ, Affiliated Hosp 1, Dept Neurosurg, Chongqing, Peoples R China	Zhang, JH (corresponding author), Loma Linda Univ, Sch Med, Dept Physiol & Pharmacol, 11041 Campus St,Risley Hall,Room 219, Loma Linda, CA 92354 USA.	jhzhang@llu.edu		sun, xiao chuan/0000-0001-6992-332X	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS081740, NS084921]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS081740, R01NS084921, P01NS082184] Funding Source: NIH RePORTER	This study is partially supported by the National Institutes of Health grants NS081740 and NS084921 to JHZ.	Ayer R, 2010, TURK NEUROSURG, V20, P159, DOI 10.5137/1019-5149.JTN.2714-09.0; Bederson JB, 1998, NEUROSURGERY, V42, P352, DOI 10.1097/00006123-199802000-00091; BEDERSON JB, 1995, STROKE, V26, P1086, DOI 10.1161/01.STR.26.6.1086; Bloom AJ, 2007, GENE DEV, V21, P2593, DOI 10.1101/gad.1592107; Broad KD, 2016, NEUROBIOL DIS, V87, P29, DOI 10.1016/j.nbd.2015.12.001; Cahill WJ, 2006, J CEREBR BLOOD F MET, V26, P1341, DOI 10.1038/sj.jcbfm.9600283; Chen QW, 2015, TRANSL STROKE RES, V6, P125, DOI 10.1007/s12975-014-0367-5; Chen S, 2014, PROG NEUROBIOL, V115, P64, DOI 10.1016/j.pneurobio.2013.09.002; Chen S, 2013, CRIT CARE MED, V41, pE466, DOI 10.1097/CCM.0b013e31829a8246; Chen XQ, 2008, J NEUROSCI, V28, P672, DOI 10.1523/JNEUROSCI.2132-07.2008; Etminan N, 2015, TRANSL STROKE RES, V6, P167, DOI 10.1007/s12975-015-0398-6; GARCIA JH, 1995, STROKE, V26, P627, DOI 10.1161/01.STR.26.4.627; Ghosh AS, 2011, J CELL BIOL, V194, P751, DOI 10.1083/jcb.201103153; Grunwald IQ, 2014, J INVASIVE CARDIOL, V26, P30; Gupta S, 1996, EMBO J, V15, P2760, DOI 10.1002/j.1460-2075.1996.tb00636.x; Hasegawa Y, 2015, TRANSL STROKE RES, V6, P458, DOI 10.1007/s12975-015-0423-9; Hirai S, 2002, DEVELOPMENT, V129, P4483; Hirai S, 2006, J NEUROSCI, V26, P11992, DOI 10.1523/JNEUROSCI.2272-06.2006; Hirai S, 2011, J NEUROSCI, V31, P6468, DOI 10.1523/JNEUROSCI.5038-10.2011; Itoh A, 2011, J NEUROSCI, V31, P7223, DOI 10.1523/JNEUROSCI.5947-10.2011; Itoh T, 2014, J NEUROSCI, V34, P10729, DOI 10.1523/JNEUROSCI.0539-14.2014; Kusaka G, 2004, J CEREBR BLOOD F MET, V24, P916, DOI 10.1097/01.WCB.0000125886.48838.7E; Li HY, 2014, TRANSL STROKE RES, V5, P618, DOI 10.1007/s12975-014-0354-x; Liu F, 2014, STROKE, V45, P3691, DOI 10.1161/STROKEAHA.114.006635; Marbacher S, 2012, J NEUROSCI METH, V208, P138, DOI 10.1016/j.jneumeth.2012.05.010; Mata M, 1996, J BIOL CHEM, V271, P16888, DOI 10.1074/jbc.271.28.16888; Merritt SE, 1999, J BIOL CHEM, V274, P10195, DOI 10.1074/jbc.274.15.10195; Nix P, 2012, NEURON, V74, P961, DOI 10.1016/j.neuron.2012.06.005; Robitaille K, 2008, CELL DEATH DIFFER, V15, P1522, DOI 10.1038/cdd.2008.77; Sherchan P, 2016, NEUROBIOL DIS, V85, P164, DOI 10.1016/j.nbd.2015.11.003; Song JP, 2015, TRANSL STROKE RES, V6, P290, DOI 10.1007/s12975-015-0396-8; Sugawara T, 2008, J NEUROSCI METH, V167, P327, DOI 10.1016/j.jneumeth.2007.08.004; Suwatcharangkoon S, 2016, JAMA NEUROL, V73, P28, DOI 10.1001/jamaneurol.2015.3188; Tang JJ, 2015, NEUROBIOL DIS, V78, P126, DOI 10.1016/j.nbd.2015.01.009; Tedeschi A, 2013, EMBO REP, V14, P605, DOI 10.1038/embor.2013.64; Thatipamula S, 2015, NEUROBIOL DIS, V75, P15, DOI 10.1016/j.nbd.2014.12.016; Topkoru BC, 2013, STROKE, V44, P3189, DOI 10.1161/STROKEAHA.113.001574; Valakh V, 2015, NEUROBIOL DIS, V77, P13, DOI 10.1016/j.nbd.2015.02.014; Watkins TA, 2013, P NATL ACAD SCI USA, V110, P4039, DOI 10.1073/pnas.1211074110; Welsbie DS, 2013, P NATL ACAD SCI USA, V110, P4045, DOI 10.1073/pnas.1211284110; Xu ZH, 2001, MOL CELL BIOL, V21, P4713, DOI 10.1128/MCB.21.14.4713-4724.2001; Yasuda J, 1999, MOL CELL BIOL, V19, P7245; Yin C, 2016, NEUROPHARMACOLOGY, V108, P316, DOI 10.1016/j.neuropharm.2016.04.013; Zhan Y, 2015, J NEUROSCI RES, V93, P94, DOI 10.1002/jnr.23475	44	18	20	0	10	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0969-9961	1095-953X		NEUROBIOL DIS	Neurobiol. Dis.	JUL	2017	103						133	143		10.1016/j.nbd.2017.04.006			11	Neurosciences	Neurosciences & Neurology	EV3TY	WOS:000401683200013	28396258	Green Accepted			2021-06-18	
J	Bressler, S; Goldberg, H; Shinn-Cunningham, B				Bressler, Scott; Goldberg, Hannah; Shinn-Cunningham, Barbara			Sensory coding and cognitive processing of sound in Veterans with blast exposure	HEARING RESEARCH			English	Article						Blast-induced traumatic brain injury; Selective attention; Envelope following response; Cochlear neuropathy; Hidden hearing loss	TRAUMATIC BRAIN-INJURY; HIDDEN HEARING-LOSS; COCHLEAR NEUROPATHY; INDIVIDUAL-DIFFERENCES; HEAD-INJURY; MILITARY; ATTENTION; SPEECH; NOISE; EEG	Recent anecdotal reports from VA audiology clinics as well as a few published studies have identified a sub-population of Service Members seeking treatment for problems communicating in everyday, noisy listening environments despite having normal to near-normal hearing thresholds. Because of their increased risk of exposure to dangerous levels of prolonged noise and transient explosive blast events, communication problems in these soldiers could be due to either hearing loss (traditional or "hidden") in the auditory sensory periphery or from blast-induced injury to cortical networks associated with attention. We found that out of the 14 blast-exposed Service Members recruited for this study, 12 had hearing thresholds in the normal to near-normal range. A majority of these participants reported having problems specifically related to failures with selective attention. Envelope following responses (EFRs) measuring neural coding fidelity of the auditory brainstem to suprathreshold sounds were similar between blast-exposed and non-blast controls. Blast-exposed subjects performed substantially worse than non-blast controls in an auditory selective attention task in which listeners classified the melodic contour (rising, falling, or "zig-zagging") of one of three simultaneous, competing tone sequences. Salient pitch and spatial differences made for easy segregation of the three concurrent melodies. Poor performance in the blast-exposed subjects was associated with weaker evoked response potentials (ERPs) in frontal EEG channels, as well as a failure of attention to enhance the neural responses evoked by a sequence when it was the target compared to when it was a distractor. These results suggest that communication problems in these listeners cannot be explained by compromised sensory representations in the auditory periphery, but rather point to lingering blast-induced damage to cortical networks implicated in the control of attention. Because all study participants also suffered from post-traumatic disorder (PTSD), follow-up studies are required to tease apart the contributions of PTSD and blast-induced injury on cognitive performance. (C) 2016 Elsevier B.V. All rights reserved.	[Bressler, Scott; Goldberg, Hannah; Shinn-Cunningham, Barbara] Boston Univ, Ctr Computat Neurosci & Neural Technol CompNet, Boston, MA 02215 USA; [Shinn-Cunningham, Barbara] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA	Shinn-Cunningham, B (corresponding author), Ctr Computat Neurosci & Neural Technol, 677 Beacon St, Boston, MA 02215 USA.	shinn@bu.edu		Shinn-Cunningham, Barbara/0000-0002-5096-5914	National Security Science and Engineering Fellowship;  [NIH RO1 DC009477]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [R01DC009477, R01DC013825] Funding Source: NIH RePORTER	The authors thank Dr. Yelena Bogdanova, Sarah I(ark, and Vivian Ho at VA Boston Healthcare System, Jamaica Plain Campus for their assistance with subject referrals. This project was supported by NIH RO1 DC009477, and by a National Security Science and Engineering Fellowship to BGSC. The authors declare no competing financial interests.	Almeida-Suhett CP, 2015, EXP NEUROL, V273, P11, DOI 10.1016/j.expneurol.2015.07.028; Arciniegas D., 2014, J NEUROPSYCHIATRY CL, V12, P77; Baugh CM, 2012, BRAIN IMAGING BEHAV, V6, P244, DOI 10.1007/s11682-012-9164-5; Bauman RA, 2009, J NEUROTRAUM, V26, P841, DOI 10.1089/neu.2009-0898; Bergemalm PO, 2005, INT J AUDIOL, V44, P39, DOI 10.1080/14992020400022546; Bernstein LR, 2002, J ACOUST SOC AM, V112, P1026, DOI 10.1121/1.1497620; Bharadwaj HM, 2015, J NEUROSCI, V35, P2161, DOI 10.1523/JNEUROSCI.3915-14.2015; Bharadwaj HM, 2014, CLIN NEUROPHYSIOL, V125, P1878, DOI 10.1016/j.clinph.2014.01.011; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Chapman JC, 2014, ALZHEIMERS DEMENT, V10, pS97, DOI 10.1016/j.jalz.2014.04.012; CHERRY EC, 1953, J ACOUST SOC AM, V25, P975, DOI 10.1121/1.1907229; Choi I, 2014, HEARING RES, V314, P10, DOI 10.1016/j.heares.2014.04.008; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Defense and Veterans Brain Injury Center DVBIC, 2016, DOD TBI WORLDW NUMB; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Demeester K, 2012, EAR HEARING, V33, P615, DOI 10.1097/AUD.0b013e31824e0ba7; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; Farmer C.M., 2016, CHARACTERISTICS TREA; Fausti SA, 2009, J REHABIL RES DEV, V46, P797, DOI 10.1682/JRRD.2008.09.0118; Fries P, 2009, ANNU REV NEUROSCI, V32, P209, DOI 10.1146/annurev.neuro.051508.135603; Furman AC, 2013, J NEUROPHYSIOL, V110, P577, DOI 10.1152/jn.00164.2013; Gallun FJ, 2012, J REHABIL RES DEV, V49, P1005, DOI 10.1682/JRRD.2012.03.0038; Giraud AL, 2012, NAT NEUROSCI, V15, P511, DOI 10.1038/nn.3063; GOBLICK TJ, 1969, J ACOUST SOC AM, V46, P924, DOI 10.1121/1.1911812; Hasenstaub A, 2005, NEURON, V47, P423, DOI 10.1016/j.neuron.2005.06.016; HINK RF, 1976, PERCEPT PSYCHOPHYS, V20, P236, DOI 10.3758/BF03199449; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoover E.C., 2015, PERSPECT HEAR HEAR D, V19; Krause MO, 2014, BRAIN INJURY, V28, P1473, DOI 10.3109/02699052.2014.920520; Kujawa SG, 2009, J NEUROSCI, V29, P14077, DOI 10.1523/JNEUROSCI.2845-09.2009; Kwok FY, 2008, BRAIN INJURY, V22, P740, DOI 10.1080/02699050802336989; Lachaux JP, 1999, HUM BRAIN MAPP, V8, P194, DOI 10.1002/(SICI)1097-0193(1999)8:4<194::AID-HBM4>3.0.CO;2-C; Lagarde E, 2014, JAMA PSYCHIAT, V71, P1032, DOI 10.1001/jamapsychiatry.2014.666; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; Lew HL, 2007, J REHABIL RES DEV, V44, P921, DOI 10.1682/JRRD.2007.09.0140; Lew HL, 2007, J REHABIL RES DEV, V44, P1027, DOI 10.1682/JRRD.2007.05.0073; Lobarinas E, 2013, HEARING RES, V302, P113, DOI 10.1016/j.heares.2013.03.012; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; Martino J, 2010, CORTEX, V46, P691, DOI 10.1016/j.cortex.2009.07.015; McKee AC, 2014, ALZHEIMERS DEMENT, V10, pS242, DOI 10.1016/j.jalz.2014.04.003; Mehraei G, 2016, J NEUROSCI, V36, P3755, DOI 10.1523/JNEUROSCI.4460-15.2016; Mesgarani N, 2012, NATURE, V485, P233, DOI 10.1038/nature11020; Mez J, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0407-7; Michalka SW, 2015, NEURON, V87, P882, DOI 10.1016/j.neuron.2015.07.028; Munjal SK, 2010, BRAIN INJURY, V24, P525, DOI 10.3109/02699050903516872; Noble W, 2013, INT J AUDIOL, V52, P409, DOI 10.3109/14992027.2013.781278; Nuwer MR, 2005, CLIN NEUROPHYSIOL, V116, P2001, DOI 10.1016/j.clinph.2005.05.008; Oleksiak M, 2012, J REHABIL RES DEV, V49, P995, DOI 10.1682/JRRD.2011.01.0001; PICTON TW, 1974, ELECTROEN CLIN NEURO, V36, P191, DOI 10.1016/0013-4694(74)90156-4; Rosenfeld JV, 2010, INJURY, V41, P437, DOI 10.1016/j.injury.2009.11.018; Ruggles D, 2012, CURR BIOL, V22, P1417, DOI 10.1016/j.cub.2012.05.025; Ruggles D, 2011, P NATL ACAD SCI USA, V108, P15516, DOI 10.1073/pnas.1108912108; Ruggles D, 2011, JARO-J ASSOC RES OTO, V12, P395, DOI 10.1007/s10162-010-0254-z; Saunders G.H., 2012, JRRD, V49; Saunders GH, 2015, J REHABIL RES DEV, V52, P343, DOI 10.1682/JRRD.2014.11.0275; Schaette R, 2011, J NEUROSCI, V31, P13452, DOI 10.1523/JNEUROSCI.2156-11.2011; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; Shaheen LA, 2015, JARO-J ASSOC RES OTO, V16, P727, DOI 10.1007/s10162-015-0539-3; Shinn-Cunningham BG, 2008, TRENDS COGN SCI, V12, P182, DOI 10.1016/j.tics.2008.02.003; Shinn-Cunningham Barbara G, 2008, Trends Amplif, V12, P283, DOI 10.1177/1084713808325306; Skoe E, 2010, EAR HEARING, V31, P302, DOI 10.1097/AUD.0b013e3181cdb272; Smetana W.R, 1999, PREDICTING HEARING H; Sosa MAG, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-51; Taber K., 2007, J NEUROPSYCHIATRY CL, V19; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; Taber KH, 2015, J HEAD TRAUMA REHAB, V30, pE15, DOI 10.1097/HTR.0000000000000030; Tanielian T, 2008, INVISIBLE WOUNDS WAR; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Uusitalo MA, 1997, MED BIOL ENG COMPUT, V35, P135, DOI 10.1007/BF02534144; Valero MD, 2016, HEARING RES, V332, P29, DOI 10.1016/j.heares.2015.11.005; Viana LM, 2015, HEARING RES, V327, P78, DOI 10.1016/j.heares.2015.04.014; Wolf JA, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00043; Zhu L, 2013, J ACOUST SOC AM, V134, P384, DOI 10.1121/1.4807498	76	18	19	0	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0378-5955	1878-5891		HEARING RES	Hear. Res.	JUN	2017	349				SI		98	110		10.1016/j.heares.2016.10.018			13	Audiology & Speech-Language Pathology; Neurosciences; Otorhinolaryngology	Audiology & Speech-Language Pathology; Neurosciences & Neurology; Otorhinolaryngology	EW2SB	WOS:000402345200013	27815131	Green Accepted, Other Gold			2021-06-18	
J	Krishnamoorthy, V; Rowhani-Rahbar, A; Chaikittisilpa, N; Gibbons, EF; Rivara, FP; Temkin, NR; Quistberg, A; Vavilala, MS				Krishnamoorthy, Vijay; Rowhani-Rahbar, Ali; Chaikittisilpa, Nophanan; Gibbons, Edward F.; Rivara, Frederick P.; Temkin, Nancy R.; Quistberg, Alex; Vavilala, Monica S.			Association of Early Hemodynamic Profile and the Development of Systolic Dysfunction Following Traumatic Brain Injury	NEUROCRITICAL CARE			English	Article						Traumatic brain injury; Stress cardiomyopathy; Echocardiography; Trauma; Hemodynamics	SUBARACHNOID HEMORRHAGE; CHAMBER QUANTIFICATION; EUROPEAN-ASSOCIATION; AMERICAN-SOCIETY; BLOOD-PRESSURE; ECHOCARDIOGRAPHY; RECOMMENDATIONS; CATECHOLAMINES	Background While systolic dysfunction has been observed following traumatic brain injury (TBI), the relationship between early hemodynamics and the development of systolic dysfunction has not been investigated. Our study aimed to determine the early hemodynamic profile that is associated with the development of systolic dysfunction after TBI. Methods We conducted a prospective cohort study among patients under 65 years old without cardiac comorbidities who sustained moderate-severe TBI. Transthoracic echocardiography was performed within the first day after TBI to assess for systolic dysfunction. Hourly systolic blood pressure (SBP), mean arterial pressure (MAP), heart rate, and confounding clinical variables (sedatives, fluid balance, vasopressors, and osmotherapy) were collected during the first 24 h following admission. Multivariable linear mixed models assessed the early hemodynamic profile in patients who developed systolic dysfunction, compared to patients who did not develop systolic dysfunction. Results Thirty-two patients were included, and 7 (22 %) developed systolic dysfunction after TBI. Patients who developed systolic dysfunction experienced early elevation of SBP, MAP, and heart rate, compared to patients who did not develop systolic dysfunction (p < 0.01 for all comparisons). Patients who developed systolic dysfunction experienced a greater rate of decrease in SBP [-10.2 mmHg (95 % CI -16.1, -4.2)] and MAP [-9.1 mmHg (95 % CI -13.9, -4.3)] over the first day of hospitalization, compared to patients who did not develop systolic dysfunction (p < 0.01 for both comparisons). All sensitivity analyses revealed no substantial changes from the primary model. Conclusion Patients who develop systolic dysfunction following TBI have a distinctive hemodynamic profile, with early hypertension and tachycardia, followed by a decrease in blood pressure over the first day after TBI. This profile suggests an early maladaptive catecholamine-excess state as a potential underlying mechanism of TBI-induced systolic dysfunction.	[Krishnamoorthy, Vijay; Vavilala, Monica S.] Univ Washington, Dept Anesthesiol & Pain Med, 1959 NE Pacific St,BB-1469, Seattle, WA 98195 USA; [Krishnamoorthy, Vijay; Rowhani-Rahbar, Ali; Rivara, Frederick P.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Gibbons, Edward F.] Univ Washington, Dept Med, Div Cardiol, Seattle, WA USA; [Rivara, Frederick P.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Temkin, Nancy R.] Univ Washington, Dept Neurosurg, Seattle, WA 98195 USA; [Temkin, Nancy R.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Krishnamoorthy, Vijay; Rowhani-Rahbar, Ali; Chaikittisilpa, Nophanan; Gibbons, Edward F.; Rivara, Frederick P.; Temkin, Nancy R.; Quistberg, Alex; Vavilala, Monica S.] Univ Washington, Harborview Injury Prevent & Res Ctr, Seattle, WA 98105 USA	Krishnamoorthy, V (corresponding author), Univ Washington, Dept Anesthesiol & Pain Med, 1959 NE Pacific St,BB-1469, Seattle, WA 98195 USA.; Krishnamoorthy, V (corresponding author), Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA.; Krishnamoorthy, V (corresponding author), Univ Washington, Harborview Injury Prevent & Res Ctr, Seattle, WA 98105 USA.	vkrish@u.washington.edu		Krishnamoorthy, Vijay/0000-0003-4153-2348	NIH-National Research Service AwardUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [T32 GM086270]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM086270] Funding Source: NIH RePORTER	NIH-National Research Service Award (T32 GM086270).	Alali AS, 2014, NEUROCRIT CARE, V20, P514, DOI 10.1007/s12028-013-9903-5; ASGEIRSSON B, 1995, ACTA ANAESTH SCAND, V39, P347, DOI 10.1111/j.1399-6576.1995.tb04075.x; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS7; Butcher I, 2007, J NEUROTRAUM, V24, P294, DOI 10.1089/neu.2006.0032; Bybee KA, 2008, CIRCULATION, V118, P397, DOI 10.1161/CIRCULATIONAHA.106.677625; HAMILL RW, 1987, ANN NEUROL, V21, P438, DOI 10.1002/ana.410210504; HUNT D, 1972, AM HEART J, V83, P232, DOI 10.1016/0002-8703(72)90142-1; Knackstedt C, 2015, J AM COLL CARDIOL, V66, P1456, DOI 10.1016/j.jacc.2015.07.052; Krishnamoorthy V, 2016, CHEST, V149, P1325, DOI 10.1016/j.chest.2015.12.014; Krishnamoorthy V, 2012, ANESTHESIOLOGY, V117, P745, DOI 10.1097/ALN.0b013e31826a7da7; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Lang RM, 2015, EUR HEART J-CARD IMG, V16, P233, DOI 10.1093/ehjci/jev014; Masuda T, 2002, STROKE, V33, P1671, DOI 10.1161/01.STR.0000016327.74392.02; Meng LZ, 2015, ANESTHESIOLOGY, V123, P1198, DOI 10.1097/ALN.0000000000000872; Moussouttas M, 2015, CEREBROVASC DIS EXTR, V5, P57, DOI 10.1159/000431155; Naredi S, 1998, INTENS CARE MED, V24, P446, DOI 10.1007/s001340050594; Prathep S, 2014, CRIT CARE MED, V42, P142, DOI 10.1097/CCM.0b013e318298a890; RIMEL RW, 1979, JACEP-J AM COLL EMER, V8, P64, DOI 10.1016/S0361-1124(79)80039-8; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Samuels MA, 2007, CIRCULATION, V116, P77, DOI 10.1161/CIRCULATIONAHA.106.678995; TEASDALE G, 1974, LANCET, V2, P81; Wittstein IS, 2005, NEW ENGL J MED, V352, P539, DOI 10.1056/NEJMoa043046; WOOLF PD, 1987, J NEUROSURG, V66, P875, DOI 10.3171/jns.1987.66.6.0875; WOOLF PD, 1992, ARCH SURG-CHICAGO, V127, P899; Zafar SN, 2011, J TRAUMA, V71, P1179, DOI 10.1097/TA.0b013e3182140d38; Zaroff JG, 2006, STROKE, V37, P1680, DOI 10.1161/01.STR.0000226461.52423.dd; Zieleskiewicz L, 2014, ANESTHESIOLOGY, V120, P906, DOI 10.1097/ALN.0000000000000102	27	18	19	0	1	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	JUN	2017	26	3					379	387		10.1007/s12028-016-0335-x			9	Critical Care Medicine; Clinical Neurology	General & Internal Medicine; Neurosciences & Neurology	EV9JA	WOS:000402101100009	28000133	Green Accepted			2021-06-18	
J	Mantua, J; Henry, OS; Garskovas, NF; Spencer, RMC				Mantua, Janna; Henry, Owen S.; Garskovas, Nolan F.; Spencer, Rebecca M. C.			Mild Traumatic Brain Injury Chronically Impairs Sleep-and Wake-Dependent Emotional Processing	SLEEP			English	Article						Sleep; traumatic brain injury; concussion; memory; emotion	SLOW-WAVE SLEEP; REM-SLEEP; UNITED-STATES; RISK-FACTORS; HEAD-INJURY; MEMORY; DEPRESSION; DISORDERS; AMYGDALA; CONSOLIDATION	Study Objectives: A single traumatic brain injury (TBI), even when mild (ie, concussion), can cause lasting consequences. Individuals with a history of chronic (> 1-year prior) mild TBI have an increased risk of mood disturbances (eg, depression, suicide). This population also has lingering sleep alterations, including poor sleep quality and changes in sleep stage proportions. Given these sleep deficits, we aimed to test whether sleep-dependent emotional memory consolidation is reduced in this population. We utilized a mild TBI group (3.7 +/- 2.9 years post injury) and an uninjured (non-TBI) population. Methods: Participants viewed negative and neutral images both before and after a 12-hour period containing sleep ("Sleep" group) or an equivalent period of time spent awake ("Wake" group). Participants rated images for valence/arousal at both sessions, and memory recognition was tested at session two. Results: The TBI group had less rapid eye movement (REM), longer REM latency, and more sleep complaints. Sleep-dependent memory consolidation of nonemotional images was present in all participants. However, consolidation of negative images was only present in the non-TBI group. A lack of differentiation between the TBI Sleep and Wake groups was due to poor performance in the sleep group and, unexpectedly, enhanced performance in the wake group. Additionally, although the non-TBI participants habituated to negative images over a waking period, the TBI participants did not. Conclusions: We propose disrupted sleep-and wake-dependent emotional processing contributes to poor emotional outcomes following chronic, mild TBI. This work has broad implications, as roughly one-third of the US population will sustain a mild TBI during their lifetime.	[Mantua, Janna; Spencer, Rebecca M. C.] Dept Psychol & Brain Sci, Neuroscience & Behav Program, Amherst, MA USA; [Henry, Owen S.] Commonwealth Honors Coll, Dept Psychol & Brain Sci, Amherst, MA USA; [Garskovas, Nolan F.; Spencer, Rebecca M. C.] Univ Massachusetts, Dept Psychol & Brain Sci, 135 Hicks Way,Tobin 419, Amherst, MA 01003 USA	Spencer, RMC (corresponding author), Univ Massachusetts, Dept Psychol & Brain Sci, 135 Hicks Way,Tobin 419, Amherst, MA 01003 USA.	rspencer@psych.umass.edu		Henry, Owen/0000-0002-2266-7768	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 AG040133]; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG040133] Funding Source: NIH RePORTER	This work was supported in part by National Institutes of Health [grant no. R01 AG040133].	Ansari MA, 2008, FREE RADICAL BIO MED, V45, P443, DOI 10.1016/j.freeradbiomed.2008.04.038; Arbour C, 2015, SLEEP MED, V16, P534, DOI 10.1016/j.sleep.2014.12.002; Ayalon L, 2007, NEUROLOGY, V68, P1136, DOI 10.1212/01.wnl.0000258672.52836.30; Baker JM, 2014, BRAIN INJURY, V28, P51, DOI 10.3109/02699052.2013.857787; Baran B, 2016, J COGNITIVE NEUROSCI, V28, P792, DOI 10.1162/jocn_a_00938; Baran B, 2012, J NEUROSCI, V32, P1035, DOI 10.1523/JNEUROSCI.2532-11.2012; Battistone M, 2008, APPL NEUROPSYCHOL, V15, P69, DOI 10.1080/09084280801917863; BENCA RM, 1992, ARCH GEN PSYCHIAT, V49, P651; Benedict C, 2009, FASEB J, V23, P3629, DOI 10.1096/fj.08-122853; Bernstein DM, 2002, J INT NEUROPSYCH SOC, V8, P673, DOI 10.1017/S1355617702801400; Boyle J, 2006, CURR MED RES OPIN, V22, P1343, DOI 10.1185/030079906X112660; BROOKS D N, 1974, Cortex, V10, P224; BROOKS D N, 1975, Cortex, V11, P329; Broughton RJ, 1989, SLEEP ALERTNESS CHRO; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Cairney SA, 2014, SLEEP, V37, P701, DOI 10.5665/sleep.3572; Chi YC, 2016, J AFFECT DISORDERS, V191, P56, DOI 10.1016/j.jad.2015.11.035; Corsi-Cabrera M, 2016, J SLEEP RES, V25, P576, DOI 10.1111/jsr.12415; Cowdin N, 2014, EXP BRAIN RES, V232, P1479, DOI 10.1007/s00221-014-3857-5; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; Ficca G, 2000, BEHAV BRAIN RES, V112, P159, DOI 10.1016/S0166-4328(00)00177-7; Fralick M, 2016, CAN MED ASSOC J, V188, P497, DOI 10.1503/cmaj.150790; Gais S, 2004, P NATL ACAD SCI USA, V101, P2140, DOI 10.1073/pnas.0305404101; Gerberding JLBS, 2003, CTR DIS CONTR PREV, P9; GILES DE, 1988, J AFFECT DISORDERS, V14, P51, DOI 10.1016/0165-0327(88)90071-7; Gosselin N, 2009, SLEEP MED, V10, P35, DOI 10.1016/j.sleep.2007.11.023; Grima N, 2016, J CLIN SLEEP MED, V12, P419, DOI 10.5664/jcsm.5598; Groch S, 2011, PSYCHONEUROENDOCRINO, V36, P1342, DOI 10.1016/j.psyneuen.2011.03.006; Grosmark AD, 2012, NEURON, V75, P1001, DOI 10.1016/j.neuron.2012.08.015; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Haboubi NHJ, 2001, DISABIL REHABIL, V23, P635; Hazlett EA, 2012, BIOL PSYCHIAT, V72, P448, DOI 10.1016/j.biopsych.2012.03.027; Hendler T, 2001, CELL MOL NEUROBIOL, V21, P733, DOI 10.1023/A:1015156222101; HORNE J A, 1976, International Journal of Chronobiology, V4, P97; Imbach LL, 2016, NEUROLOGY, V86, P1945, DOI 10.1212/WNL.0000000000002697; JOHNS MW, 1992, SLEEP, V15, P376, DOI 10.1093/sleep/15.4.376; Jones BJ, 2016, NEUROBIOL AGING, V45, P178, DOI 10.1016/j.neurobiolaging.2016.05.019; Kaiser PR, 2010, NEUROLOGY, V75, P1780, DOI 10.1212/WNL.0b013e3181fd62a2; Kerr ZY, 2012, AM J SPORT MED, V40, P2206, DOI 10.1177/0363546512456193; Konrad C, 2011, PSYCHOL MED, V41, P1197, DOI 10.1017/S0033291710001728; Lang P. J., 2005, INT AFFECTIVE PICTUR, DOI [10.1016/j.epsr.2006.03.016, DOI 10.1016/J.EPSR.2006.03.016]; Lara-Carrasco J, 2009, J SLEEP RES, V18, P178, DOI 10.1111/j.1365-2869.2008.00709.x; LEDOUX JE, 1993, BEHAV BRAIN RES, V58, P69, DOI 10.1016/0166-4328(93)90091-4; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; Mantua J, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00328; McGaugh JL, 2004, ANNU REV NEUROSCI, V27, P1, DOI 10.1146/annurev.neuro.27.070203.144157; Mellman TA, 2002, AM J PSYCHIAT, V159, P1696, DOI 10.1176/appi.ajp.159.10.1696; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Millman RP, 2005, PEDIATRICS, V115, P1774, DOI 10.1542/peds.2005-0772; Modarres Mo H., 2017, Neurobiology of Sleep and Circadian Rhythms, V2, P59, DOI 10.1016/j.nbscr.2016.06.001; Pace-Schott EF, 2011, NEUROBIOL LEARN MEM, V95, P24, DOI 10.1016/j.nlm.2010.10.006; Parcell DL, 2008, ARCH PHYS MED REHAB, V89, P843, DOI 10.1016/j.apmr.2007.09.057; Payne JD, 2008, PSYCHOL SCI, V19, P781, DOI 10.1111/j.1467-9280.2008.02157.x; Payne JD, 2015, EMOTION, V15, P176, DOI 10.1037/a0038683; Ponsford JL, 2013, NEUROREHAB NEURAL RE, V27, P613, DOI 10.1177/1545968313481283; Rao V, 2010, J NEUROPSYCH CLIN N, V22, P100, DOI 10.1176/appi.neuropsych.22.1.100; Rizvi SJ, 2013, J AFFECT DISORDERS, V151, P573, DOI 10.1016/j.jad.2013.06.050; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Schabus M, 2004, SLEEP, V27, P1479, DOI 10.1093/sleep/27.7.1479; Schatz P, 2011, NEUROSURGERY, V68, P1562, DOI 10.1227/NEU.0b013e31820e382e; Scholten AC, 2016, J NEUROTRAUM, V33, P1969, DOI 10.1089/neu.2015.4252; Shekleton JA, 2010, NEUROLOGY, V74, P1732, DOI 10.1212/WNL.0b013e3181e0438b; Silber MH, 2007, J CLIN SLEEP MED, V3, P121; Silver JM, 2005, TXB TRAUMATIC BRAIN, V293, DOI [10.1001/jama.293.17.2161-a, DOI 10.1001/JAMA.293.17.2161-A]; Sonni A, 2015, NEUROBIOL AGING, V36, P2272, DOI 10.1016/j.neurobiolaging.2015.03.010; Spira JL, 2014, J NEUROTRAUM, V31, P1823, DOI 10.1089/neu.2014.3363; St Jacques PL, 2009, PSYCHOL SCI, V20, P74, DOI 10.1111/j.1467-9280.2008.02258.x; Teasdale JD, 1988, COGNITION EMOTION, V2, P247, DOI 10.1080/02699938808410927; Tononi G, 2003, BRAIN RES BULL, V62, P143, DOI 10.1016/j.brainresbull.2003.09.004; van Noordt S, 2011, BRAIN INJURY, V25, P707, DOI 10.3109/02699052.2011.580312; Vandekerckhove M, 2010, SLEEP MED REV, V14, P219, DOI 10.1016/j.smrv.2010.01.002; Vanderploeg RD, 2007, J CLIN EXP NEUROPSYC, V29, P585, DOI 10.1080/13803390600826587; Wagner U, 2002, PSYCHOSOM MED, V64, P627, DOI 10.1097/01.PSY.0000021940.35402.51; Walker MP, 2009, PSYCHOL BULL, V135, P731, DOI 10.1037/a0016570; Warriner Erin M, 2006, Curr Psychiatry Rep, V8, P73, DOI 10.1007/s11920-006-0083-2; Wechsler D., 2008, WECHSLER ADULT INTEL, P1; Wilson JK, 2012, NEUROBIOL AGING, V33, P991, DOI 10.1016/j.neurobiolaging.2011.06.029	77	18	18	0	16	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0161-8105	1550-9109		SLEEP	Sleep	JUN	2017	40	6							zsx062	10.1093/sleep/zsx062			11	Clinical Neurology; Neurosciences	Neurosciences & Neurology	FA6VR	WOS:000405583100008	28460124	Green Published, Bronze			2021-06-18	
J	Wang, CM; Wei, ZJ; Jiang, GH; Liu, HJ				wang, Changming; Wei, Zhijie; Jiang, Guohong; Liu, Haijun			Neuroprotective mechanisms of miR-124 activating PI3K/Akt signaling pathway in ischemic stroke	EXPERIMENTAL AND THERAPEUTIC MEDICINE			English	Article						miR-124; phosphoinositide 3-kinase/Akt signaling pathway; ischemic stroke; oxygen-glucose deprivation model; apoptosis rate; Bax; Bcl-2; caspase-3	TRAUMATIC BRAIN-INJURY; MICRORNAS; APOPTOSIS; AUTOPHAGY	The neuroprotective mechanisms of miR-124 activating phosphoinositide 3-kinase (PI3K)/Akt signaling pathway in ischemic stroke were investigated. The oxygen-glucose deprivation model of nerve cells induced by PC12 cells was established in vitro, then miR-124 mimics or inhibitor was transfected and synthesized by liposome. Cells were divided into the blank control, model, mimics and inhibitor groups, and the apoptotic rate was determined using flow cytometry. Additionally, the expression levels of PI3K, Akt, Bax, Bcl-2, caspase-3 mRNA and protein were tested by quantitative PCR and western blot analysis at 0, 3, 6, 12 and 24 h, respectively. The apoptotic rate at each time-point in the blank control group was not significantly different. The apoptotic rate of the model and inhibitor groups increased over time, whereas the mimics group decreased (P<0.05). The apoptotic rate at each time-point in the mimics group was significantly lower than that of the model and inhibitor groups, and the rate of the inhibitor group was higher than that of the model group (P<0.05). PI3K, Akt and Bcl-2 mRNA and protein expression levels at the different time-points in the mimics group were significantly higher than those of the remaining groups (P<0.05). The expression levels of Bax and caspase-3 mRNA and protein in the inhibitor group were the highest, followed by the model and mimics groups, while that of the blank control group was the lowest (P<0.05). The results suggest that miR-124 participates in the neural protection of ischemic stroke by activating the PI3K/Akt signaling pathway.	[wang, Changming; Wei, Zhijie; Jiang, Guohong; Liu, Haijun] Zunyi Med Coll, Affiliated Hosp, Dept Neurol, 149 Dalian Rd, Zunyi 563003, Guizhou, Peoples R China	Jiang, GH (corresponding author), Zunyi Med Coll, Affiliated Hosp, Dept Neurol, 149 Dalian Rd, Zunyi 563003, Guizhou, Peoples R China.	gzzyyxywcm@sina.com			Zunyi Science and Technology Plan, Compliance with Zunyi City Branch [(2014) 78]	The present study was supported by the Zunyi Science and Technology Plan, Compliance with Zunyi City Branch (2014) 78. We thank all partners and staff who helped us in the process of this study.	Akerblom M, 2012, J NEUROSCI, V32, P8879, DOI 10.1523/JNEUROSCI.0558-12.2012; Bergmann A, 2007, CELL, V131, P1032, DOI 10.1016/j.cell.2007.11.027; Cheng LC, 2009, NAT NEUROSCI, V12, P399, DOI 10.1038/nn.2294; Dharap A, 2009, J CEREBR BLOOD F MET, V29, P675, DOI 10.1038/jcbfm.2008.157; Ebert MS, 2012, CELL, V149, P515, DOI 10.1016/j.cell.2012.04.005; Gao FB, 2008, TRENDS NEUROSCI, V31, P20, DOI 10.1016/j.tins.2007.10.004; Gu X, 2014, J MOL NEUROSCI, V52, P156, DOI 10.1007/s12031-013-0190-6; Kilic E, 2005, FASEB J, V19, P2026, DOI 10.1096/fj.05-3941fje; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lang QB, 2012, BIOCHEM BIOPH RES CO, V426, P247, DOI 10.1016/j.bbrc.2012.08.075; Liu X.L., 2011, FAIL ANAL PREV, V6, P124, DOI DOI 10.1371/J0URNAL.P0NE.0023461; Richardson RM, 2010, J NEUROSURG, V112, P1125, DOI 10.3171/2009.4.JNS081087; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; Wang Z, 2015, MICROSYST TECHNOL, V21, P1; Weiss JBW, 2012, AM J CARDIOVASC DIS, V2, P237; Zhang L, 2016, CELL MOL NEUROBIOL, V36, P131, DOI 10.1007/s10571-015-0227-1; Zhao SF, 2012, NEUROL RES, V34, P400, DOI 10.1179/1743132812Y.0000000025	17	18	20	0	7	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-0981	1792-1015		EXP THER MED	Exp. Ther. Med.	JUN	2017	13	6					3315	3318		10.3892/etm.2017.4424			4	Medicine, Research & Experimental	Research & Experimental Medicine	EU5NW	WOS:000401080000103	28587406	Green Published, Other Gold			2021-06-18	
J	Salo, RA; Miettinen, T; Laitinen, T; Grohn, O; Sierra, A				Salo, Raimo A.; Miettinen, Tuukka; Laitinen, Teemu; Grohn, Olli; Sierra, Alejandra			Diffusion tensor MRI shows progressive changes in the hippocampus and dentate gyrus after status epilepticus in rat - histological validation with Fourier-based analysis	NEUROIMAGE			English	Article							TEMPORAL-LOBE EPILEPSY; TRAUMATIC BRAIN-INJURY; WATER DIFFUSION; SPONTANEOUS SEIZURES; PILOCARPINE MODEL; AXONAL INJURY; TREATED RATS; MOUSE MODEL; EX-VIVO; SCLEROSIS	Imaging markers for monitoring disease progression, recovery, and treatment efficacy are a major unmet need for many neurological diseases, including epilepsy. Recent evidence suggests that diffusion tensor imaging (DTI) provides high microstructural contrast even outside major white matter tracts. We hypothesized that in vivo DTI could detect progressive microstructural changes in the dentate gyrus and the hippocampal CA3bc in the rat brain after status epilepticus (SE). To test this hypothesis, we induced SE with systemic kainic acid or pilocarpine in adult male Wistar rats and subsequently scanned them using in vivo DTI at five time-points: prior to SE, and 10, 20, 34, and 79 days post SE. In order to tie the DTI findings to changes in the tissue microstructure, myelin-and glial fibrillary acidic protein (GFAP)-stained sections from the same animals underwent Fourier analysis. We compared the Fourier analysis parameters, anisotropy index and angle of myelinated axons or astrocyte processes, to corresponding DTI parameters, fractional anisotropy (FA) and the orientation angle of the principal eigenvector. We found progressive detectable changes in DTI parameters in both the dentate gyrus (FA, axial diffusivity [D-ll], linear anisotropy [CL] and spherical anisotropy [CS], p < 0.001, linear mixed-effects model [LMEM]) and the CA3bc (FA, (ll), CS, and angle, p < 0.001, LMEM; CL and planar anisotropy [CP], p < 0.01, LMEM) post SE. The Fourier analysis revealed that both myelinated axons and astrocyte processes played a role in the water diffusion anisotropy changes detected by DTI in individual portions of the dentate gyrus (suprapyramidal blade, mid-portion, and infrapyramidal blade). In the whole dentate gyrus, myelinated axons markedly contributed to the water diffusion changes. In CA3bc as well as in CA3b and CA3c, both myelinated axons and astrocyte processes contributed to water diffusion anisotropy and orientation. Our study revealed that DTI is a promising method for noninvasive detection of microstructural alterations in the hippocampus proper. These alterations may be potential imaging markers for epileptogenesis.	[Salo, Raimo A.; Miettinen, Tuukka; Laitinen, Teemu; Grohn, Olli; Sierra, Alejandra] Univ Eastern Finland, AI Virtanen Inst Mol Sci, Dept Neurobiol, POB 1627, FI-70211 Kuopio, Finland	Sierra, A (corresponding author), Univ Eastern Finland, AI Virtanen Inst Mol Sci, Dept Neurobiol, POB 1627, FI-70211 Kuopio, Finland.	alejandra.sierralopez@uef.fi		Sierra Lopez, Alejandra/0000-0001-5399-2056	Academy of FinlandAcademy of FinlandEuropean Commission [275453]	This work was funded by the Academy of Finland (#275453). We thank Maarit Pulkkinen for providing technical assistance, M.Sc. Juhana Sorvari for his help during the scans, and M.Sc. Heikki Yli-Ollila for helping with the Fourier analysis implementation.	Aggarwal M, 2015, NEUROIMAGE, V105, P198, DOI 10.1016/j.neuroimage.2014.10.053; Arisi GM, 2007, BRAIN RES, V1165, P126, DOI 10.1016/j.brainres.2007.06.037; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI 10.1016/j.jmr.2011.09.022; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Bennett RE, 2012, NEUROSCI LETT, V513, P160, DOI 10.1016/j.neulet.2012.02.024; Bonilha L, 2012, J NEUROL NEUROSUR PS, V83, P903, DOI 10.1136/jnnp-2012-302476; Borges K, 2006, EXP NEUROL, V201, P416, DOI 10.1016/j.expneurol.2006.04.031; Budde MD, 2011, BRAIN, V134, P2248, DOI 10.1093/brain/awr161; Coras R, 2014, EPILEPSIA, V55, P2003, DOI 10.1111/epi.12828; Elkommos S, 2016, SEIZURE-EUR J EPILEP, V35, P65, DOI 10.1016/j.seizure.2016.01.007; Engel Jr J., 2006, EPILEPSY RES S1, V70; Gong G, 2008, EPILEPSIA, V49, P1941, DOI 10.1111/j.1528-1167.2008.01666.x; Howe KL, 2010, AM J NEURORADIOL, V31, P1682, DOI 10.3174/ajnr.A2154; Immonen RJ, 2009, NEUROIMAGE, V45, P1, DOI 10.1016/j.neuroimage.2008.11.022; Jelescu IO, 2016, NEUROIMAGE, V132, P104, DOI 10.1016/j.neuroimage.2016.02.004; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Khan AR, 2015, NEUROIMAGE, V111, P192, DOI 10.1016/j.neuroimage.2015.01.061; Kharatishvili I, 2006, NEUROSCIENCE, V140, P685, DOI 10.1016/j.neuroscience.2006.03.012; Kharatishvili I, 2007, BRAIN, V130, P3155, DOI 10.1093/brain/awm268; Kuo LW, 2008, NEUROIMAGE, V41, P789, DOI 10.1016/j.neuroimage.2008.03.013; Laitinen T, 2010, NEUROIMAGE, V51, P521, DOI 10.1016/j.neuroimage.2010.02.077; Le Bihan D, 2003, NAT REV NEUROSCI, V4, P469, DOI 10.1038/nrn1119; Liu M, 2013, NEUROIMAGE, V74, P128, DOI 10.1016/j.neuroimage.2013.01.069; MELLO LEAM, 1993, EPILEPSIA, V34, P985, DOI 10.1111/j.1528-1157.1993.tb02123.x; Modo M, 2016, HUM BRAIN MAPP, V37, P780, DOI 10.1002/hbm.23066; Nissinen J, 2001, HIPPOCAMPUS, V11, P299, DOI 10.1002/hipo.1044; Pajevic S, 1999, MAGNET RESON MED, V42, P526, DOI 10.1002/(SICI)1522-2594(199909)42:3<526::AID-MRM15>3.0.CO;2-J; Parekh MB, 2010, EXP NEUROL, V224, P258, DOI 10.1016/j.expneurol.2010.03.031; Perez AM, 2014, J NEUROTRAUM, V31, P1478, DOI 10.1089/neu.2013.3216; Pernot F, 2011, EPILEPSIA, V52, P2315, DOI 10.1111/j.1528-1167.2011.03273.x; Pitkanen A, 2014, NEUROTHERAPEUTICS, V11, P231, DOI 10.1007/s13311-014-0257-2; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Sayin U, 2015, NEUROSCIENCE, V288, P120, DOI 10.1016/j.neuroscience.2014.12.017; Schilling K, 2016, NEUROIMAGE, V129, P185, DOI 10.1016/j.neuroimage.2016.01.022; Schmierer K, 2007, NEUROIMAGE, V35, P467, DOI 10.1016/j.neuroimage.2006.12.010; Shepherd TM, 2006, NEUROIMAGE, V32, P1499, DOI 10.1016/j.neuroimage.2006.04.210; Sierra A, 2015, BRAIN STRUCT FUNCT, V220, P781, DOI 10.1007/s00429-013-0683-7; Sierra A, 2011, BRAIN STRUCT FUNCT, V216, P123, DOI 10.1007/s00429-010-0299-0; Suleymanova EM, 2016, NEUROSCIENCE, V315, P79, DOI 10.1016/j.neuroscience.2015.11.061; Sun SW, 2005, MAGN RESON MED, V53, P1447, DOI 10.1002/mrm.20488; Sun SW, 2003, MAGN RESON MED, V50, P743, DOI 10.1002/mrm.10605; Sutula T, 1998, J COMP NEUROL, V390, P578, DOI 10.1002/(SICI)1096-9861(19980126)390:4<578::AID-CNE9>3.0.CO;2-Y; Tejada J, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003601; van Vliet EA, 2016, EPILEPSIA, V57, P59, DOI 10.1111/epi.13246; Westin CF, 2002, MED IMAGE ANAL, V6, P93, DOI 10.1016/S1361-8415(02)00053-1; Winston GP, 2013, EPILEPSIA, V54, P1143, DOI 10.1111/epi.12193; Zhang JY, 2002, NEUROIMAGE, V15, P892, DOI 10.1006/nimg.2001.1012	49	18	21	0	13	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1053-8119	1095-9572		NEUROIMAGE	Neuroimage	MAY 15	2017	152						221	236		10.1016/j.neuroimage.2017.03.003			16	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	EW5ZH	WOS:000402584500019	28267625				2021-06-18	
J	Lavoie, S; Sechrist, S; Quach, N; Ehsanian, R; Duong, T; Gotlib, IH; Isaac, L				Lavoie, Sarah; Sechrist, Samantha; Quach, Nhung; Ehsanian, Reza; Duong, Thao; Gotlib, Ian H.; Isaac, Linda			Depression in Men and Women One Year Following Traumatic Brain Injury (TBI): A TBI Model Systems Study	FRONTIERS IN PSYCHOLOGY			English	Article						depression; mood; traumatic brain injury; concussion; gender	MAJOR DEPRESSION; SEX-DIFFERENCES; FUNCTIONAL CONNECTIVITY; GENDER-DIFFERENCES; PREVALENCE; HEALTH; DISORDERS; SEVERITY; HYPOPITUITARISM; EPIDEMIOLOGY	In the general population, females experience depression at significantly higher rates than males. Individuals with traumatic brain injury (TBI) are at substantially greater risk for depression compared to the overall population. Treatment of, and recovery from, TBI can be hindered by depression; comorbid TBI and depression can lead to adverse outcomes and negatively affect multiple aspects of individuals' lives. Gender differences in depression following TBI are not well understood, and relevant empirical findings have been mixed. Utilizing the Patient Health Questionnaire-9 (PHQ-9) 1 year after TBI, we examined whether women would experience more severe depressive symptoms, and would endorse higher levels of depression within each category of depression severity, than would men. Interestingly, and contrary to our hypothesis, men and women reported mild depression at equal rates; PHQ-9 total scores were slightly lower in women than in men. Men and women did not differ significantly in any PHQ-9 depression severity category. Item analyses, yielded significant gender differences on the following items: greater concentration difficulties (cognitive problems) in men and more sleep disturbances (psychosomatic issues) in women per uncorrected two-sample Z-test for proportions analyses; however, these results were not significant after the family-wise Bonferroni correction. Our results indicate that, in contrast to the general population, mild depression in persons with moderate to severe TBI may not be gender-specific. These findings underscore the need for early identification, active screening, and depression treatment equally for men and women to improve emotional well-being, promote recovery, and enhance quality of life following TBI.	[Lavoie, Sarah; Sechrist, Samantha; Quach, Nhung; Ehsanian, Reza; Duong, Thao; Isaac, Linda] Santa Clara Valley Med Ctr, Rehabil Res Ctr, San Jose, CA 95128 USA; [Ehsanian, Reza] Stanford Univ, Dept Neurosurg, Stanford, CA 94305 USA; [Duong, Thao; Isaac, Linda] Stanford Univ, Dept Phys Med & Rehabil, Stanford, CA 94305 USA; [Gotlib, Ian H.] Stanford Univ, Dept Psychol, Stanford, CA USA	Isaac, L (corresponding author), Santa Clara Valley Med Ctr, Rehabil Res Ctr, San Jose, CA 95128 USA.; Isaac, L (corresponding author), Stanford Univ, Dept Phys Med & Rehabil, Stanford, CA 94305 USA.	linda.Isaac@hhs.sccgov.org			National Institute on Disability, Independent Living, and Rehabilitation Research, Administration for Community Living, U.S. Department of Health and Human Services [H133A11006]	This work was funded by the National Institute on Disability, Independent Living, and Rehabilitation Research, Administration for Community Living, U.S. Department of Health and Human Services (Grant # H133A11006) to the SCVMC Rehabilitation Research Center Director and Principal Investigator, LI.	Albrecht JS, 2015, AM J GERIAT PSYCHIAT, V23, P607, DOI 10.1016/j.jagp.2014.07.006; Alexandrino-Silva C, 2013, J AFFECT DISORDERS, V147, P355, DOI 10.1016/j.jad.2012.11.041; Armed Forces Health Surveillance Center (AFHSC), 2013, MSMR, V20, P9; Association AP, 2013, DIAGN STAT MAN MENT, DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; Barker-Collo S, 2015, BRAIN INJURY, V29, P859, DOI 10.3109/02699052.2015.1004759; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Bombardier CH, 2016, J NEUROTRAUM, V33, P2115, DOI 10.1089/neu.2015.4349; Brandel MG, 2017, J NEUROTRAUM, V34, P1005, DOI 10.1089/neu.2016.4504; BRESLAU N, 1995, PSYCHIAT RES, V58, P1, DOI 10.1016/0165-1781(95)02765-O; Centers for Disease Control and Prevention, 2016, RAT TBI REL EM DEP V; CERVOSNAVARRO J, 1991, J NEUROL SCI, V103, pS3; Chapman DP, 2004, J AFFECT DISORDERS, V82, P217, DOI 10.1016/j.jad.2003.12.013; Crooks Carol Y, 2007, Phys Med Rehabil Clin N Am, V18, P681, DOI 10.1016/j.pmr.2007.06.005; Dahmer E., 1993, J HEAD TRAUMA REHAB, V8, P12, DOI [10.1097/00001199-199308020-00004, DOI 10.1097/00001199-199308020-00004]; Davis DP, 2006, J NEUROTRAUM, V23, P140, DOI 10.1089/neu.2006.23.140; Dyer JR, 2016, J HEAD TRAUMA REHAB, V31, P225, DOI 10.1097/HTR.0000000000000177; Fann JR, 2009, J NEUROTRAUM, V26, P2383, DOI 10.1089/neu.2009.1091; Fann JR, 2005, J HEAD TRAUMA REHAB, V20, P501, DOI 10.1097/00001199-200511000-00003; Fisher LB, 2016, BRAIN INJURY, V30, P1311, DOI 10.1080/02699052.2016.1195517; Foland-Ross LC, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00489; Frost RB, 2013, NEUROEPIDEMIOLOGY, V40, P154, DOI 10.1159/000343275; Ghigo E, 2005, BRAIN INJURY, V19, P711, DOI 10.1080/02699050400025315; Gordon WA, 2006, AM J PHYS MED REHAB, V85, P343, DOI 10.1097/01.phm.0000202106.01654.61; Guillamondegui OD, 2011, TRAUMATIC BRAIN INJU; Harmon KG, 2013, CLIN J SPORT MED, V23, P1, DOI 10.1097/JSM.0b013e31827f5f93; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Isaac L, 2015, BIOL PSYCHOL, V105, P20, DOI 10.1016/j.biopsycho.2014.12.011; Iverson KM, 2011, WOMEN HEALTH ISS, V21, pS210, DOI 10.1016/j.whi.2011.04.019; Jorge RE, 2005, J HEAD TRAUMA REHAB, V20, P475, DOI 10.1097/00001199-200511000-00001; Kendler KS, 2002, AM J PSYCHIAT, V159, P1133, DOI 10.1176/appi.ajp.159.7.1133; Kircanski K, 2012, WIRES COGN SCI, V3, P301, DOI 10.1002/wcs.1177; Kirkness Catherine J, 2004, Biol Res Nurs, V5, P299, DOI 10.1177/1099800404263050; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lauzier F, 2014, CRIT CARE MED, V42, P712, DOI 10.1097/CCM.0000000000000046; Ley EJ, 2013, J TRAUMA ACUTE CARE, V75, P682, DOI 10.1097/TA.0b013e31829d024f; Lukow HR, 2015, J HEAD TRAUMA REHAB, V30, P241, DOI 10.1097/HTR.0000000000000137; Mann JJ, 2005, JAMA-J AM MED ASSOC, V294, P2064, DOI 10.1001/jama.294.16.2064; Mauri MC, 2014, ASIAN J PSYCHIATR, V12, P118, DOI 10.1016/j.ajp.2014.07.003; Model Systems Knowledge Translation Center, 2016, NAT DAT STAT CTR TRA; Moreno-Lopez L, 2016, BRAIN INJURY, V30, P1319, DOI 10.1080/02699052.2016.1186839; Mushkudiani NA, 2007, J NEUROTRAUM, V24, P259, DOI 10.1089/neu.2006.0028; National Alliance on Mental Illness, 2016, DEPRESSION; Ouellet MC, 2009, J HEAD TRAUMA REHAB, V24, P262, DOI 10.1097/HTR.0b013e3181a68b73; Oyesanya TO, 2016, HEALTH CARE WOMEN IN, V37, P45, DOI 10.1080/07399332.2015.1005307; Piccinelli M, 2000, BRIT J PSYCHIAT, V177, P486, DOI 10.1192/bjp.177.6.486; Renner C, 2012, BRAIN INJURY, V26, P1360, DOI 10.3109/02699052.2012.667592; Schneider HJ, 2011, J NEUROTRAUM, V28, P1693, DOI 10.1089/neu.2011.1887; Scholten AC, 2016, J NEUROTRAUM, V33, P1969, DOI 10.1089/neu.2015.4252; Schwarzbold Marcelo, 2008, Neuropsychiatr Dis Treat, V4, P797; Sigurdardottir S, 2013, J REHABIL MED, V45, P808, DOI 10.2340/16501977-1156; Silver JM, 2009, AM J PSYCHIAT, V166, P653, DOI 10.1176/appi.ajp.2009.08111676; Silverstein B, 2013, SOC PSYCH PSYCH EPID, V48, P257, DOI 10.1007/s00127-012-0540-7; Slewa-Younan S, 2008, J NEUROL NEUROSUR PS, V79, P1197, DOI 10.1136/jnnp.2008.147983; Sullivan PF, 2000, AM J PSYCHIAT, V157, P1552, DOI 10.1176/appi.ajp.157.10.1552; Wagner AK, 2004, J NEUROTRAUM, V21, P125, DOI 10.1089/089771504322778596; WEISSMAN MM, 1984, J AFFECT DISORDERS, V7, P179, DOI 10.1016/0165-0327(84)90039-9; Xiao H, 2015, NEURAL REGEN RES, V10, P2062, DOI 10.4103/1673-5374.172328; Zaninotto AL, 2016, FRONT PSYCHIATRY, V7, DOI 10.3389/fpsyt.2016.00095	58	18	19	0	6	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-1078			FRONT PSYCHOL	Front. Psychol.	MAY 5	2017	8								634	10.3389/fpsyg.2017.00634			7	Psychology, Multidisciplinary	Psychology	EU7AG	WOS:000401186500001	28529492	DOAJ Gold, Green Published			2021-06-18	
J	Balanca, B; Meiller, A; Bezin, L; Dreier, JP; Marinesco, S; Lieutaud, T				Balanca, Baptiste; Meiller, Anne; Bezin, Laurent; Dreier, Jens P.; Marinesco, Stephane; Lieutaud, Thomas			Altered hypermetabolic response to cortical spreading depolarizations after traumatic brain injury in rats	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						Biosensors; brain trauma; brain metabolism; cerebral blood flow; energy metabolism; spreading depression; spreading depolarization	CEREBRAL-BLOOD-FLOW; ISCHEMIC NEUROLOGICAL DEFICITS; LOW EXTRACELLULAR MAGNESIUM; IN-VIVO; PERIINFARCT DEPOLARIZATIONS; ENERGY-METABOLISM; LACTATE LEVELS; SUBARACHNOID HEMORRHAGE; ANOXIC DEPOLARIZATION; EPILEPTIFORM ACTIVITY	Spreading depolarizations are waves of near-complete breakdown of neuronal transmembrane ion gradients, free energy starving, and mass depolarization. Spreading depolarizations in electrically inactive tissue are associated with poor outcome in patients with traumatic brain injury. Here, we studied changes in regional cerebral blood flow and brain oxygen (PbtO(2)), glucose ([Glc] b), and lactate ([Lac] b) concentrations in rats, using minimally invasive real-time sensors. Rats underwent either spreading depolarizations chemically triggered by KCl in naive cortex in absence of traumatic brain injury or spontaneous spreading depolarizations in the traumatic penumbra after traumatic brain injury, or a cluster of spreading depolarizations triggered chemically by KCl in a remote window from which spreading depolarizations invaded penumbral tissue. Spreading depolarizations in noninjured cortex induced a hypermetabolic response characterized by a decline in [Glc] b and monophasic increases in regional cerebral blood flow, PbtO(2), and [Lac] b, indicating transient hyperglycolysis. Following traumatic brain injury, spontaneous spreading depolarizations occurred, causing further decline in [Glc] b and reducing the increase in regional cerebral blood flow and biphasic responses of PbtO(2) and [Lac] b, followed by prolonged decline. Recovery of PbtO(2) and [Lac] b was significantly delayed in traumatized animals. Prespreading depolarization [Glc] b levels determined the metabolic response to clusters. The results suggest a compromised hypermetabolic response to spreading depolarizations and slower return to physiological conditions following traumatic brain injury-induced spreading depolarizations.	[Balanca, Baptiste; Bezin, Laurent; Marinesco, Stephane; Lieutaud, Thomas] INSERM, CNRS, Lyon Neurosci Res Ctr, U1028,UMR 5292,Team TIGER, Lyon, France; [Balanca, Baptiste] CHU Lyon, Lyon, France; [Meiller, Anne; Marinesco, Stephane] Univ Claude Bernard Lyon I, AniRA Neurochem Technol Platform, Lyon Neuroscience Res Ctr, Lyon, France; [Dreier, Jens P.] Charite Univ Med Berlin, Ctr Stroke Res Berlin, Berlin, Germany; [Dreier, Jens P.] Charite Univ Med Berlin, Dept Neurol, Berlin, Germany; [Dreier, Jens P.] Charite Univ Med Berlin, Dept Expt Neurol, Berlin, Germany	Balanca, B (corresponding author), Univ Claude Bernard, Lyon Neurosci Res Ctr CRNL, Team TIGER, 8 Ave, F-69373 Lyon 08, France.	baptiste.balanca@gmail.com	balanca, baptiste/ABG-2847-2020; Marinesco, Stephane/M-6694-2017; balanca, baptiste/W-2261-2018	balanca, baptiste/0000-0001-7917-9645; Marinesco, Stephane/0000-0003-2712-6263; balanca, baptiste/0000-0001-7917-9645	Hospices Civils de Lyon, Inserm; Fondation Gueules cassees sourire quand meme [FGC11-2013]; Ecole de l'INSERM Bettencourt Schueller; Deutsche Forschungsgemeinschaft (DFG)German Research Foundation (DFG) [323/6-1]; Bundesministerium fur Bildung und Forschung (Center for Stroke Research Berlin)Federal Ministry of Education & Research (BMBF) [01 EO 0801]; Era-Net Neuron [01EW1212]	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: Supported by the Hospices Civils de Lyon, Inserm and the Fondation Gueules cassees sourire quand meme (FGC11-2013 to SM), BB was supported by a PhD fellowship from Ecole de l'INSERM Bettencourt Schueller, Deutsche Forschungsgemeinschaft (DFG DR 323/6-1), the Bundesministerium fur Bildung und Forschung (Center for Stroke Research Berlin, 01 EO 0801) and Era-Net Neuron 01EW1212 to JPD.	ADACHI K, 1995, J CEREBR BLOOD F MET, V15, P97, DOI 10.1038/jcbfm.1995.11; Agarwal B, 2014, BBA-BIOENERGETICS, V1837, P354, DOI 10.1016/j.bbabio.2013.11.006; AVOLI M, 1991, ANN NEUROL, V30, P589, DOI 10.1002/ana.410300412; Ayata C, 2015, PHYSIOL REV, V95, P953, DOI 10.1152/physrev.00027.2014; Balanc B, 2016, J NEUROSCI RES, V94, P39, DOI 10.1002/jnr.23676; Baron JC, 2001, CEREBROVASC DIS, V11, P2, DOI 10.1159/000049119; BAUGHMAN VL, 1990, ANESTHESIOLOGY, V72, P85, DOI 10.1097/00000542-199001000-00016; Belanger M, 2011, CELL METAB, V14, P724, DOI 10.1016/j.cmet.2011.08.016; Bere Z, 2014, J CEREBR BLOOD F MET, V34, P1695, DOI 10.1038/jcbfm.2014.136; Boretius S, 2013, NEUROIMAGE, V69, P244, DOI 10.1016/j.neuroimage.2012.12.020; Claassen J, 2013, ANN NEUROL, V74, P53, DOI 10.1002/ana.23859; CORTEZ SC, 1989, BRAIN RES, V482, P271, DOI 10.1016/0006-8993(89)91190-6; Cruz NF, 1999, J CEREBR BLOOD F MET, V19, P380, DOI 10.1097/00004647-199904000-00004; Cunningham AS, 2005, BRAIN, V128, P1931, DOI 10.1093/brain/awh536; Dohmen C, 2008, ANN NEUROL, V63, P720, DOI 10.1002/ana.21390; Dreier JP, 2007, EXP BIOL MED, V232, P204; Dreier JP, 2006, BRAIN, V129, P3224, DOI 10.1093/brain/awl297; Dreier JP, 2015, NEURON, V86, P902, DOI 10.1016/j.neuron.2015.04.004; Dreier JP, 2012, BRAIN, V135, P259, DOI 10.1093/brain/awr303; Dreier JP, 2011, NAT MED, V17, P439, DOI 10.1038/nm.2333; Dreier JP, 2009, BRAIN, V132, P1866, DOI 10.1093/brain/awp102; Dreier JP, 1998, J CEREBR BLOOD F MET, V18, P978; Dreier JP, 2002, BRAIN, V125, P102, DOI 10.1093/brain/awf007; Dreier JP, 2000, J NEUROSURG, V93, P658, DOI 10.3171/jns.2000.93.4.0658; FABRICIUS M, 1993, BRAIN RES, V612, P61, DOI 10.1016/0006-8993(93)91644-8; Fabricius M, 2006, BRAIN, V129, P778, DOI 10.1093/brain/awh716; Farkas E, 2008, J CEREBR BLOOD F MET, V28, P251, DOI 10.1038/sj.jcbfm.9600569; Feuerstein D, 2016, J CEREBR BLOOD F MET, V36, P1965, DOI 10.1177/0271678X15612779; Feuerstein D, 2014, J CEREBR BLOOD F MET, V34, P1117, DOI 10.1038/jcbfm.2014.53; Feuerstein D, 2010, J CEREBR BLOOD F MET, V30, P1343, DOI 10.1038/jcbfm.2010.17; Furlan M, 1996, ANN NEUROL, V40, P216, DOI 10.1002/ana.410400213; Gobatto CA, 2001, COMP BIOCHEM PHYS A, V130, P21, DOI 10.1016/S1095-6433(01)00362-2; Goodman JC, 1999, CRIT CARE MED, V27, P1965, DOI 10.1097/00003246-199909000-00041; Gramsbergen JB, 2004, J NEUROSCI METH, V140, P93, DOI 10.1016/j.jneumeth.2004.03.027; Hadjikhani N, 2001, P NATL ACAD SCI USA, V98, P4687, DOI 10.1073/pnas.071582498; Hartings JA, 2011, LANCET NEUROL, V10, P1058, DOI 10.1016/S1474-4422(11)70243-5; Hartings JA, 2011, BRAIN, V134, P1529, DOI 10.1093/brain/awr048; Hashemi P, 2009, J CEREBR BLOOD F MET, V29, P166, DOI 10.1038/jcbfm.2008.108; Hinzman JM, 2014, BRAIN, V137, P2960, DOI 10.1093/brain/awu241; Hopwood SE, 2005, J CEREBR BLOOD F MET, V25, P391, DOI 10.1038/sj.jcbfm.9600050; Horn T, 2010, NEUROCHEM INT, V57, P940, DOI 10.1016/j.neuint.2010.09.014; Hu YB, 1997, J NEUROCHEM, V69, P1484; Hyder F, 2000, J CEREBR BLOOD F MET, V20, P485, DOI 10.1097/00004647-200003000-00007; KRUGERS HJ, 1992, J NEUROCHEM, V58, P826, DOI 10.1111/j.1471-4159.1992.tb09331.x; KUBOTA M, 1989, Neurosurgical Review, V12, P393, DOI 10.1007/BF01790681; KUHR WG, 1988, J CEREBR BLOOD F MET, V8, P848, DOI 10.1038/jcbfm.1988.142; Lauritzen M, 2011, J CEREBR BLOOD F MET, V31, P17, DOI 10.1038/jcbfm.2010.191; Linde R, 1999, ACTA PHYSIOL SCAND, V165, P395; Magistretti PJ, 1996, CEREB CORTEX, V6, P50, DOI 10.1093/cercor/6.1.50; Makaryus R, 2011, J CEREBR BLOOD F MET, V31, P1432, DOI 10.1038/jcbfm.2011.1; Mayevsky A, 1996, BRAIN RES, V740, P268, DOI 10.1016/S0006-8993(96)00874-8; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; MODY I, 1987, J NEUROPHYSIOL, V57, P869; NILSSON P, 1993, J CEREBR BLOOD F MET, V13, P183, DOI 10.1038/jcbfm.1993.22; Offenhauser N, 2011, ACTA NEUROCHIR SUPPL, V110, P119, DOI [10.1007/978-3-7091-0353-1_2l, 10.1007/978-3-7091-0353-1_21]; Ostergaard L, 2015, STROKE, V46, P1392, DOI 10.1161/STROKEAHA.114.008077; Piilgaard H, 2009, J CEREBR BLOOD F MET, V29, P1517, DOI 10.1038/jcbfm.2009.73; Poulsen PH, 1997, J NEUROSCI METH, V77, P199, DOI 10.1016/S0165-0270(97)00127-1; Rogatsky GG, 2003, J NEUROTRAUM, V20, P1315, DOI 10.1089/089771503322686111; Rogers ML, 2013, ACS CHEM NEUROSCI, V4, P799, DOI 10.1021/cn400047x; Sahuquillo J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102540; Sakowitz OW, 2013, STROKE, V44, P220, DOI 10.1161/STROKEAHA.112.672352; Sato S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082891; Shin HK, 2006, J CEREBR BLOOD F MET, V26, P1018, DOI 10.1038/sj.jcbfm.9600252; Simpson IA, 2007, J CEREBR BLOOD F MET, V27, P1766, DOI 10.1038/sj.jcbfm.9600521; Somjen GG, 2001, PHYSIOL REV, V81, P1065; Somjen GG, 2004, IONS IN THE BRAIN, P338; Sonn J, 2012, Open Neurol J, V6, P6, DOI 10.2174/1874205X01206010006; Strong AJ, 2007, BRAIN, V130, P995, DOI 10.1093/brain/awl392; Sukhotinsky I, 2008, J CEREBR BLOOD F MET, V28, P1369, DOI 10.1038/jcbfm.2008.35; Sword J, 2013, BRAIN, V136, P1446, DOI 10.1093/brain/awt026; Takagaki M, 2014, EXP NEUROL, V252, P12, DOI 10.1016/j.expneurol.2013.11.003; Takano T, 2007, NAT NEUROSCI, V10, P754, DOI 10.1038/nn1902; Timofeev I, 2011, BRAIN, V134, P484, DOI 10.1093/brain/awq353; Vasylieva N, 2013, ANAL CHEM, V85, P2507, DOI 10.1021/ac3035794; VERHAEGEN MJ, 1992, J CEREBR BLOOD F MET, V12, P230, DOI 10.1038/jcbfm.1992.33; Vespa P, 2005, J CLIN NEUROPHYSIOL, V22, P99, DOI 10.1097/01.WNP.0000154919.54202.E0; von Baumgarten L, 2008, J CEREBR BLOOD F MET, V28, P1353, DOI 10.1038/jcbfm.2008.30; von Bornstadt D, 2015, NEURON, V85, P1117, DOI 10.1016/j.neuron.2015.02.007; von Oettingen G, 2002, NEUROSURGERY, V50, P781, DOI 10.1097/00006123-200204000-00019; Wei YN, 2014, J NEUROSCI, V34, P11733, DOI 10.1523/JNEUROSCI.0516-14.2014; Woitzik J, 2013, NEUROLOGY, V80, P1095, DOI 10.1212/WNL.0b013e3182886932; Wolf T, 1997, J CEREBR BLOOD F MET, V17, P950, DOI 10.1097/00004647-199709000-00004; Wu HM, 2013, J NEUROTRAUM, V30, P352, DOI 10.1089/neu.2012.2610; Yang Y, 2017, MOL NEUROBIOL, V54, P1101, DOI 10.1007/s12035-016-9710-z; Zazulia AR, 2001, J CEREBR BLOOD F MET, V21, P804, DOI 10.1097/00004647-200107000-00005; Zhang FY, 2002, J NEUROSURG, V97, P963, DOI 10.3171/jns.2002.97.4.0963; Zhu XH, 2002, P NATL ACAD SCI USA, V99, P13194, DOI 10.1073/pnas.202471399	88	18	18	0	9	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	MAY	2017	37	5					1670	1686		10.1177/0271678X16657571			17	Endocrinology & Metabolism; Hematology; Neurosciences	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	ET8CG	WOS:000400525200009	27356551	Bronze, Green Published			2021-06-18	
J	Ogura, T; Lefor, AK; Nakamura, M; Fujizuka, K; Shiroto, K; Nakano, M				Ogura, Takayuki; Lefor, Alan Kawarai; Nakamura, Mitsunobu; Fujizuka, Kenji; Shiroto, Kousuke; Nakano, Minoru			ULTRASOUND-GUIDED RESUSCITATIVE ENDOVASCULAR BALLOON OCCLUSION OF THE AORTA IN THE RESUSCITATION AREA	JOURNAL OF EMERGENCY MEDICINE			English	Article						trauma; hemorrhage; resuscitative endovascular balloon occlusion of the aorta	ANEURYSM	Background: In trauma resuscitation with resuscitative endovascular balloon occlusion of the aorta (REBOA), urgent and accurate placement of the catheter in the resuscitation area without fluoroscopy can shorten the time from admission to REBOA, allowing rapid, temporary control of bleeding. Discussion: The experience-based protocol in our center for ultrasound-guided REBOA in the resuscitation area without fluoroscopy is as follows: the femoral artery is punctured and a guidewire inserted; sonography is used to verify that the guidewire is in the abdominal aorta; the position of the balloon is confirmed with ultrasound after estimating the distance to the clavicle, and the pressure in the radial artery and sheath is used to monitor correct positioning; connect the pressure transducer to the catheter sheath for continuous monitoring of the blood pressure in the sheath, and inflate the balloon until the blood pressure tracing at the sheath has disappeared; check the pulse in the left radial artery, and withdraw the catheter slightly if the pulse in the radial artery is not palpable or is decreased (if this pulse is not palpable or decreased, the balloon is in the aortic arch). In this retrospective review of our REBOA protocol, between April 2012 and March 2016, 34 patients were enrolled. Two patients had complications, including dissection of the femoral artery in one and difficult percutaneous vascular access in another. Median time needed to complete the procedure was 8 min. Overall, 24 of 34 patients survived more than 24 h (72%), and overall mortality was 47%. Patients who lived more than 24 h, and then died had severe traumatic brain injury or septic shock. Conclusions: Ultrasound-guided REBOA is presented. Monitoring the blood pressure in the left radial artery allows us to determine adequate positioning of the balloon, and the blood pressure in the catheter sheath located in the femoral artery should also be monitored to prevent aortic injuries caused by the overinflation of the balloon. (C) 2017 Elsevier Inc. All rights reserved.	[Ogura, Takayuki; Nakamura, Mitsunobu; Fujizuka, Kenji; Shiroto, Kousuke; Nakano, Minoru] Japan Red Cross Maebashi Hosp, Adv Med Emergency Dept, 371-0014 Asahi Cho 3-21-36, Maebashi, Gunma, Japan; [Ogura, Takayuki; Nakamura, Mitsunobu; Fujizuka, Kenji; Shiroto, Kousuke; Nakano, Minoru] Japan Red Cross Maebashi Hosp, Crit Care Ctr, 371-0014 Asahi Cho 3-21-36, Maebashi, Gunma, Japan; [Ogura, Takayuki] Jichi Med Univ, Dept Emergency Med, Shimotsuke, Tochigi, Japan; [Lefor, Alan Kawarai] Jichi Med Univ, Dept Surg, Shimotsuke, Tochigi, Japan	Ogura, T (corresponding author), Japan Red Cross Maebashi Hosp, Adv Med Emergency Dept, 371-0014 Asahi Cho 3-21-36, Maebashi, Gunma, Japan.; Ogura, T (corresponding author), Japan Red Cross Maebashi Hosp, Crit Care Ctr, 371-0014 Asahi Cho 3-21-36, Maebashi, Gunma, Japan.		; Lefor, Alan/E-9979-2012	Ogura, Takayuki/0000-0002-2525-4985; Lefor, Alan/0000-0001-6673-5630			Assar AN, 2009, J CARDIOVASC SURG, V50, P381; Brenner ML, 2013, J TRAUMA ACUTE CARE, V75, P506, DOI 10.1097/TA.0b013e31829e5416; Chaikof EL, 2009, J VASC SURG, V50, p2S, DOI 10.1016/j.jvs.2009.07.002; Guliani S, 2015, J TRAUMA ACUTE CARE, V79, P549, DOI 10.1097/TA.0000000000000818; GUPTA BK, 1989, J TRAUMA, V29, P861, DOI 10.1097/00005373-198906000-00026; Harma M, 2004, AUST NZ J OBSTET GYN, V44, P170, DOI 10.1111/j.1479-828X.2004.00181.x; Karkos CD, 2001, ANN EMERG MED, V38, P328, DOI 10.1067/mem.2001.114408; LOW RB, 1986, ANN EMERG MED, V15, P1466, DOI 10.1016/S0196-0644(86)80945-3; MAHONEY BD, 1984, ANN EMERG MED, V13, P11, DOI 10.1016/S0196-0644(84)80376-5; Martinelli T, 2010, J TRAUMA, V68, P942, DOI 10.1097/TA.0b013e3181c40579; Miura F, 2006, J GASTROINTEST SURG, V10, P519, DOI 10.1016/j.gassur.2005.09.019; Moll FL, 2011, EUR J VASC ENDOVASC, V41, pS1, DOI 10.1016/j.ejvs.2010.09.011; Morrison JJ, 2016, J TRAUMA ACUTE CARE, V80, P324, DOI 10.1097/TA.0000000000000913; Scott DJ, 2013, J TRAUMA ACUTE CARE, V75, P122, DOI 10.1097/TA.0b013e3182946746; Stannard A, 2011, J TRAUMA, V71, P1869, DOI 10.1097/TA.0b013e31823fe90c; Tayal VS, 2003, ACAD EMERG MED, V10, P867, DOI 10.1111/j.1553-2712.2003.tb00630.x	16	18	21	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0736-4679	1090-1280		J EMERG MED	J. Emerg. Med.	MAY	2017	52	5					715	722		10.1016/j.jemermed.2017.01.014			8	Emergency Medicine	Emergency Medicine	EX9HC	WOS:000403567400031	28215930				2021-06-18	
J	Struzyna, LA; Adewole, DO; Gordian-Velez, WJ; Grovola, MR; Burrell, JC; Katiyar, KS; Petrov, D; Harris, JP; Cullen, DK				Struzyna, Laura A.; Adewole, Dayo O.; Gordian-Velez, Wisberty J.; Grovola, Michael R.; Burrell, Justin C.; Katiyar, Kritika S.; Petrov, Dmitriy; Harris, James P.; Cullen, D. Kacy			Anatomically Inspired Three-dimensional Micro-tissue Engineered Neural Networks for Nervous System Reconstruction, Modulation, and Modeling	JOVE-JOURNAL OF VISUALIZED EXPERIMENTS			English	Article						Neuroscience; Issue 123; Neural tissue engineering; biomaterials; living scaffolds; neurotrauma; neuroregeneration; neuromodulation; axonal pathways; synapses	STEM-CELL TRANSPLANTATION; AXON REGENERATION; LIVING SCAFFOLDS; RAT-BRAIN; CONSTRUCTS; STRATEGIES; GROWTH; INJURY; REPAIR; CNS	Functional recovery rarely occurs following injury or disease-induced degeneration within the central nervous system (CNS) due to the inhibitory environment and the limited capacity for neurogenesis. We are developing a strategy to simultaneously address neuronal and axonal pathway loss within the damaged CNS. This manuscript presents the fabrication protocol for micro-tissue engineered neural networks (micro-TENNs), implantable constructs consisting of neurons and aligned axonal tracts spanning the extracellular matrix (ECM) lumen of a preformed hydrogel cylinder hundreds of microns in diameter that may extend centimeters in length. Neuronal aggregates are delimited to the extremes of the three-dimensional encasement and are spanned by axonal projections. Micro-TENNs are uniquely poised as a strategy for CNS reconstruction, emulating aspects of brain connectome cytoarchitecture and potentially providing means for network replacement. The neuronal aggregates may synapse with host tissue to form new functional relays to restore and/or modulate missing or damaged circuitry. These constructs may also act as pro-regenerative "living scaffolds" capable of exploiting developmental mechanisms for cell migration and axonal pathfinding, providing synergistic structural and soluble cues based on the state of regeneration. Micro-TENNs are fabricated by pouring liquid hydrogel into a cylindrical mold containing a longitudinally centered needle. Once the hydrogel has gelled, the needle is removed, leaving a hollow micro-column. An ECM solution is added to the lumen to provide an environment suitable for neuronal adhesion and axonal outgrowth. Dissociated neurons are mechanically aggregated for precise seeding within one or both ends of the micro-column. This methodology reliably produces self-contained miniature constructs with long-projecting axonal tracts that may recapitulate features of brain neuroanatomy. Synaptic immunolabeling and genetically encoded calcium indicators suggest that micro-TENNs possess extensive synaptic distribution and intrinsic electrical activity. Consequently, micro-TENNs represent a promising strategy for targeted neurosurgical reconstruction of brain pathways and may also be applied as biofidelic models to study neurobiological phenomena in vitro.	[Struzyna, Laura A.; Adewole, Dayo O.; Gordian-Velez, Wisberty J.] Univ Penn, Sch Engn & Appl Sci, Dept Bioengn, Philadelphia, PA 19104 USA; [Struzyna, Laura A.; Adewole, Dayo O.; Gordian-Velez, Wisberty J.; Grovola, Michael R.; Burrell, Justin C.; Katiyar, Kritika S.; Petrov, Dmitriy; Harris, James P.; Cullen, D. Kacy] Univ Penn, Dept Neurosurg, Perelman Sch Med, Ctr Brain Injury & Repair, Philadelphia, PA 19104 USA; [Struzyna, Laura A.; Adewole, Dayo O.; Gordian-Velez, Wisberty J.; Grovola, Michael R.; Burrell, Justin C.; Katiyar, Kritika S.; Petrov, Dmitriy; Harris, James P.; Cullen, D. Kacy] Michael J Crescenz Vet Affairs Med Ctr, Ctr Neurotrauma Neurodegenerat & Restorat, Philadelphia, PA 19104 USA; [Katiyar, Kritika S.] Drexel Univ, Sch Biomed Engn, Philadelphia, PA 19104 USA	Cullen, DK (corresponding author), Univ Penn, Dept Neurosurg, Perelman Sch Med, Ctr Brain Injury & Repair, Philadelphia, PA 19104 USA.; Cullen, DK (corresponding author), Michael J Crescenz Vet Affairs Med Ctr, Ctr Neurotrauma Neurodegenerat & Restorat, Philadelphia, PA 19104 USA.	dkacy@mail.med.upenn.edu	Burrell, Justin C./AAW-2310-2020	Burrell, Justin C./0000-0002-5361-9224; Grovola, Michael/0000-0003-4125-9329; Adewole, Dayo/0000-0003-4685-6974; Harris, James/0000-0002-8458-5434	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [U01-NS094340, T32-NS043126, F31-NS090746]; Michael J. Fox Foundation [9998]; Penn Medicine Neuroscience Center; National Science FoundationNational Science Foundation (NSF) [DGE-1321851]; Department of Veterans Affairs (RRD Merit Review)US Department of Veterans Affairs [B1097-I]; American Association of Neurological Surgeons and Congress of Neurological Surgeons; U.S. Army Medical Research and Materiel CommandU.S. Army Medical Research & Materiel Command (USAMRMC) [W81XWH-13-207004, W81XWH-15-1-0466]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U01NS094340, F31NS090746, T32NS043126] Funding Source: NIH RePORTER	Financial support was provided by the National Institutes of Health U01-NS094340 (Cullen), T32-NS043126 (Harris), and F31-NS090746 (Katiyar)), the Michael J. Fox Foundation (Therapeutic Pipeline Program #9998 (Cullen)), the Penn Medicine Neuroscience Center Pilot Award (Cullen), the National Science Foundation (Graduate Research Fellowships DGE-1321851 (Struzyna and Adewole)), the Department of Veterans Affairs (RR&D Merit Review #B1097-I (Cullen)), the American Association of Neurological Surgeons and Congress of Neurological Surgeons (2015-2016 Codman Fellowship in Neurotrauma and Critical Care (Petrov)), and the U.S. Army Medical Research and Materiel Command (#W81XWH-13-207004 (Cullen) and W81XWH-15-1-0466 (Cullen)).	Adewole Dayo O., 2016, Critical Reviews in Biomedical Engineering, V44, P123, DOI 10.1615/CritRevBiomedEng.2016017198; BENFEY M, 1982, NATURE, V296, P150, DOI 10.1038/296150a0; Benowitz LI, 2007, DEV NEUROBIOL, V67, P1148, DOI 10.1002/dneu.20515; Chen BK, 2009, J NEUROTRAUM, V26, P1759, DOI [10.1089/neu.2008.0610, 10.1089/neu.2008-0610]; Chen HI, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00001; Cheng HC, 2010, ANN NEUROL, V67, P715, DOI 10.1002/ana.21995; Chwalek K, 2015, NAT PROTOC, V10, P1362, DOI 10.1038/nprot.2015.091; Cullen DK, 2007, J NEUROSCI RES, V85, P3642, DOI 10.1002/jnr.21434; Cullen DK, 2007, ANN BIOMED ENG, V35, P835, DOI 10.1007/s10439-007-9292-z; Cullen DK, 2012, TISSUE ENG PT A, V18, P2280, DOI [10.1089/ten.tea.2011.0534, 10.1089/ten.TEA.2011.0534]; Cullen D. Kacy, 2011, Critical Reviews in Biomedical Engineering, V39, P201; Cullen D. Kacy, 2011, Critical Reviews in Biomedical Engineering, V39, P241; Cullen DK, 2010, BRAIN RES, V1359, P44, DOI 10.1016/j.brainres.2010.08.058; Cullen DK, 2008, J NEURAL ENG, V5, P374, DOI 10.1088/1741-2560/5/4/002; Curinga G, 2008, EXP NEUROL, V209, P333, DOI 10.1016/j.expneurol.2007.06.026; Dancause N, 2005, J NEUROSCI, V25, P10167, DOI 10.1523/JNEUROSCI.3256-05.2005; DAVID S, 1981, SCIENCE, V214, P931, DOI 10.1126/science.6171034; Denham M, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00011; Donaghue IE, 2014, J CONTROL RELEASE, V190, P219, DOI 10.1016/j.jconrel.2014.05.040; FAWCETT JW, 1995, EXP BRAIN RES, V106, P275; Ganguly K, 2013, NEURON, V80, P729, DOI 10.1016/j.neuron.2013.10.028; Gao YD, 2016, REGEN BIOMATER, V3, P115, DOI 10.1093/rb/rbw004; Han QQ, 2010, BIOMATERIALS, V31, P9212, DOI 10.1016/j.biomaterials.2010.08.040; Harimkar SP., 2008, LASER FABRICATION MA; Harris JP, 2016, J NEURAL ENG, V13, DOI 10.1088/1741-2560/13/1/016019; Hinman JD, 2014, CURR OPIN NEUROL, V27, P615, DOI 10.1097/WCO.0000000000000149; Horner PJ, 2000, NATURE, V407, P963, DOI 10.1038/35039559; Howard MA, 2016, J NEUROPHYSIOL, V116, P472, DOI 10.1152/jn.00321.2016; Huang JH, 2009, TISSUE ENG PT A, V15, P1677, DOI 10.1089/ten.tea.2008.0294; Huebner EA, 2009, RESULTS PROBL CELL D, V48, P339, DOI 10.1007/400_2009_19; Irons HR, 2008, J NEURAL ENG, V5, P333, DOI 10.1088/1741-2560/5/3/006; Jain A, 2006, BIOMATERIALS, V27, P497, DOI 10.1016/j.biomaterials.2005.07.008; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Katiyar K. S., 2016, J TISSUE ENG REGEN M; Kutter J. P., 2004, J MICROMECHANICS MIC, V14; LaPlaca M. C., 2010, METHODS BIOENG 3D TI; Li XW, 2012, PROG POLYM SCI, V37, P1105, DOI 10.1016/j.progpolymsci.2012.02.004; Lie DC, 2004, ANNU REV PHARMACOL, V44, P399, DOI 10.1146/annurev.pharmtox.44.101802.121631; Lu P, 2008, EXP NEUROL, V209, P313, DOI 10.1016/j.expneurol.2007.08.004; Mehta ST, 2016, EXP NEUROL, V280, P115, DOI 10.1016/j.expneurol.2016.03.004; Mine Y, 2013, NEUROBIOL DIS, V52, P191, DOI 10.1016/j.nbd.2012.12.006; Montani L, 2014, J NEUROSCI, V34, P4443, DOI 10.1523/JNEUROSCI.0320-14.2014; Moore MJ, 2006, BIOMATERIALS, V27, P419, DOI 10.1016/j.biomaterials.2005.07.045; Morrison B, 2011, STUD MECHANOBIOL TIS, V3, P247, DOI 10.1007/8415_2011_79; Pacifici M, 2012, JOVE-J VIS EXP, DOI 10.3791/3965; Ren HM, 2013, INT J CLIN EXP PATHO, V6, P230; Shoichet Molly S., 2008, P221; Silva NA, 2010, TISSUE ENG PT A, V16, P45, DOI [10.1089/ten.tea.2008.0559, 10.1089/ten.TEA.2008.0559]; Sinclair SR, 1999, EUR J NEUROSCI, V11, P4341, DOI 10.1046/j.1460-9568.1999.00867.x; Spicar-Mihalic P, 2013, J MICROMECH MICROENG, V23, DOI 10.1088/0960-1317/23/6/067003; Struzyna LA, 2015, TISSUE ENG PT A, V21, P2744, DOI [10.1089/ten.tea.2014.0557, 10.1089/ten.TEA.2014.0557]; Struzyna LA, 2015, NEURAL REGEN RES, V10, P679, DOI 10.4103/1673-5374.156943; Struzyna LA, 2014, CURR OPIN SOLID ST M, V18, P308, DOI 10.1016/j.cossms.2014.07.004; Suzuki H, 2015, MED MOL MORPHOL, V48, P214, DOI 10.1007/s00795-015-0104-5; Tallantyre EC, 2010, MULT SCLER J, V16, P406, DOI 10.1177/1352458510364992; Tam RY, 2014, NEUROPSYCHOPHARMACOL, V39, P169, DOI 10.1038/npp.2013.237; Tate CC, 2009, J TISSUE ENG REGEN M, V3, P208, DOI 10.1002/term.154; Tate MC, 2002, CELL TRANSPLANT, V11, P283; Tsai EC, 2004, J NEUROTRAUM, V21, P789, DOI 10.1089/0897715041269687; Ungrin MD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001565; Vukasinovic J, 2009, BIOMED MICRODEVICES, V11, P1155, DOI 10.1007/s10544-009-9332-6; Wernig M, 2004, J NEUROSCI, V24, P5258, DOI 10.1523/JNEUROSCI.0428-04.200; Winter CC, 2016, ACTA BIOMATER, V38, P44, DOI 10.1016/j.actbio.2016.04.021; Yiu G, 2006, NAT REV NEUROSCI, V7, P617, DOI 10.1038/nrn1956; Yoo Sang Jin, 2011, Exp Neurobiol, V20, P110, DOI 10.5607/en.2011.20.2.110	65	18	19	0	12	JOURNAL OF VISUALIZED EXPERIMENTS	CAMBRIDGE	1 ALEWIFE CENTER, STE 200, CAMBRIDGE, MA 02140 USA	1940-087X			JOVE-J VIS EXP	J. Vis. Exp.	MAY	2017		123							e55609	10.3791/55609			14	Multidisciplinary Sciences	Science & Technology - Other Topics	FB5WV	WOS:000406213900057	28605376	Green Published			2021-06-18	
J	Menyhart, A; Zolei-Szenasi, D; Puskas, T; Makra, P; Orsolya, MT; Szepes, BE; Toth, R; Ivankovits-Kiss, O; Obrenovitch, TP; Bari, F; Farkas, E				Menyhart, Akos; Zolei-Szenasi, Daniel; Puskas, Tamas; Makra, Peter; Orsolya, M. Toth; Szepes, Borbala E.; Toth, Reka; Ivankovits-Kiss, Orsolya; Obrenovitch, Tihomir P.; Bari, Ferenc; Farkas, Eszter			Spreading depolarization remarkably exacerbates ischemia-induced tissue acidosis in the young and aged rat brain	SCIENTIFIC REPORTS			English	Article							CEREBRAL-BLOOD-FLOW; INTRACELLULAR PH; HIPPOCAMPAL SLICES; PERIINFARCT DEPOLARIZATIONS; ENERGY-METABOLISM; NEUTRAL RED; IN-VIVO; DEPRESSION; LACTATE; GLUCOSE	Spreading depolarizations (SDs) occur spontaneously in the cerebral cortex of subarachnoid hemorrhage, stroke or traumatic brain injury patients. Accumulating evidence prove that SDs exacerbate focal ischemic injury by converting zones of the viable but non-functional ischemic penumbra to the core region beyond rescue. Yet the SD-related mechanisms to mediate neurodegeneration remain poorly understood. Here we show in the cerebral cortex of isoflurane-anesthetized, young and old laboratory rats, that SDs propagating under ischemic penumbra-like conditions decrease intra and- extracellular tissue pH transiently to levels, which have been recognized to cause tissue damage. Further, tissue pH after the passage of each spontaneous SD event remains acidic for over 10 minutes. Finally, the recovery from SD-related tissue acidosis is hampered further by age. We propose that accumulating acid load is an effective mechanism for SD to cause delayed cell death in the ischemic nervous tissue, particularly in the aged brain.	[Farkas, Eszter] Univ Szeged, Fac Med, Dept Med Phys & Informat, Koranyi Fasor 9, H-6720 Szeged, Hungary; Univ Szeged, Fac Sci & Informat, Koranyi Fasor 9, H-6720 Szeged, Hungary	Farkas, E (corresponding author), Univ Szeged, Fac Med, Dept Med Phys & Informat, Koranyi Fasor 9, H-6720 Szeged, Hungary.	farkas.eszter.1@med.u-szeged.hu	Puskas, Tomas/AAB-3542-2020	Menyhart, Akos/0000-0002-1355-3208; Farkas, Eszter/0000-0002-8478-9664	Hungarian Scientific Research FundOrszagos Tudomanyos Kutatasi Alapprogramok (OTKA) [K111923]; Hungarian Brain Research Program [KTIA_13_NAP-A-I/13]; Bolyai Janos Research Scholarship of the Hungarian Academy of SciencesHungarian Academy of Sciences [BO/00327/14/5]; New National Excellence Program of the Ministry of Human Capacities of Hungary [UNKP-16-2-I]; Economic Development and Innovation Operational Programme in Hungary - European Union; European Regional Development FundEuropean Commission [GINOP-2.3.2-15-2016-00006]	This work was supported by grants from the Hungarian Scientific Research Fund (Grant No. K111923); the Hungarian Brain Research Program (No. KTIA_13_NAP-A-I/13); the Bolyai Janos Research Scholarship of the Hungarian Academy of Sciences (No. BO/00327/14/5, to EF); the New National Excellence Program of the Ministry of Human Capacities of Hungary (No. UNKP-16-2-I. to OMT); and the Economic Development and Innovation Operational Programme in Hungary co-financed by the European Union and the European Regional Development Fund (No. GINOP-2.3.2-15-2016-00006).	ASTRUP J, 1977, STROKE, V8, P51, DOI 10.1161/01.STR.8.1.51; Ay H, 2005, STROKE, V36, P2632, DOI 10.1161/01.STR.0000189991.23918.01; Ayata C, 2015, PHYSIOL REV, V95, P953, DOI 10.1152/physrev.00027.2014; Back T, 2000, ANN NEUROL, V47, P485, DOI 10.1002/1531-8249(200004)47:4<485::AID-ANA12>3.3.CO;2-#; Chen G, 1998, NEUROSCIENCE, V84, P645, DOI 10.1016/S0306-4522(97)00441-7; Chen G, 2005, J NEUROPHYSIOL, V94, P1287, DOI 10.1152/jn.00224.2005; Chen RL, 2010, NAT REV NEUROL, V6, P256, DOI 10.1038/nrneurol.2010.36; CHESLER M, 1987, AM J PHYSIOL, V253, pR666; CHESLER M, 1992, TRENDS NEUROSCI, V15, P396, DOI 10.1016/0166-2236(92)90191-A; Clark D, 2014, NEUROBIOL AGING, V35, P2803, DOI 10.1016/j.neurobiolaging.2014.06.013; Domoki F, 2012, MICROVASC RES, V83, P311, DOI 10.1016/j.mvr.2012.01.003; Dreier JP, 2006, BRAIN, V129, P3224, DOI 10.1093/brain/awl297; Dreier JP, 2017, J CEREBR BLOOD F MET, V37, P1595, DOI 10.1177/0271678X16654496; Dreier JP, 2015, NEURON, V86, P902, DOI 10.1016/j.neuron.2015.04.004; Dreier JP, 2011, NAT MED, V17, P439, DOI 10.1038/nm.2333; Farkas E, 2008, J CEREBR BLOOD F MET, V28, P251, DOI 10.1038/sj.jcbfm.9600569; Farkas E, 2014, J GERONTOL A-BIOL, V69, P1363, DOI 10.1093/gerona/glu066; Feuerstein D, 2016, J CEREBR BLOOD F MET, V36, P1965, DOI 10.1177/0271678X15612779; Hartings JA, 2017, J CEREBR BLOOD F MET, V37, P1571, DOI 10.1177/0271678X16654495; Hertelendy P, 2017, J CEREBR BLOOD F MET, V37, P1763, DOI 10.1177/0271678X16643735; Hopwood SE, 2005, J CEREBR BLOOD F MET, V25, P391, DOI 10.1038/sj.jcbfm.9600050; Hossmann KA, 1996, CEREBROVAS BRAIN MET, V8, P195; KATSURA K, 1992, EUR J NEUROSCI, V4, P166, DOI 10.1111/j.1460-9568.1992.tb00863.x; KRAIG RP, 1983, J NEUROPHYSIOL, V49, P831; KRIVANEK J, 1961, J NEUROCHEM, V6, P183, DOI 10.1111/j.1471-4159.1961.tb13463.x; LAMANNA JC, 1984, ANAL BIOCHEM, V142, P117, DOI 10.1016/0003-2697(84)90525-6; Lipton P, 1999, PHYSIOL REV, V79, P1431; MAYEVSKY A, 1991, J CEREBR BLOOD F MET, V11, P829, DOI 10.1038/jcbfm.1991.142; Menyhart A, 2015, NEUROBIOL AGING, V36, P3269, DOI 10.1016/j.neurobiolaging.2015.08.014; MEYER FB, 1986, J CEREBR BLOOD F MET, V6, P71, DOI 10.1038/jcbfm.1986.9; MIES G, 1984, EXP NEUROL, V84, P249, DOI 10.1016/0014-4886(84)90222-X; MUTCH WAC, 1984, J CEREBR BLOOD F MET, V4, P17, DOI 10.1038/jcbfm.1984.3; NEDERGAARD M, 1991, J NEUROSCI, V11, P2489; Nedergaard M, 1996, ADV NEUROL, V71, P75; NOWICKI JP, 1988, J CEREBR BLOOD F MET, V8, P462, DOI 10.1038/jcbfm.1988.87; Obrenovitch TP, 2009, NEUROIMAGE, V45, P68, DOI 10.1016/j.neuroimage.2008.11.025; OBRENOVITCH TP, 1988, J CEREBR BLOOD F MET, V8, P866, DOI 10.1038/jcbfm.1988.144; Parkin MC, 2005, J CEREBR BLOOD F MET, V25, P402, DOI 10.1038/sj.jcbfm.9600051; PEEK KE, 1989, METAB BRAIN DIS, V4, P261, DOI 10.1007/BF00999772; ROSENTHAL M, 1973, J NEUROPHYSIOL, V36, P739; Sakowitz OW, 2009, STROKE, V40, pE519, DOI 10.1161/STROKEAHA.109.549303; SCHELLER D, 1992, NEUROSCI LETT, V135, P83, DOI 10.1016/0304-3940(92)90141-S; Selman WR, 2004, BRAIN RES, V999, P167, DOI 10.1016/j.brainres.2003.11.016; Shen PP, 2016, NEURAL REGEN RES, V11, P1857, DOI 10.4103/1673-5374.194759; Siesjo BK, 1996, ACT NEUR S, V66, P8; SIESJO BK, 1988, NEUROCHEM PATHOL, V9, P31; Siqueira IR, 2004, BRAIN RES, V1025, P226, DOI 10.1016/j.brainres.2004.08.005; Somjen GG, 2001, PHYSIOL REV, V81, P1065; Sun XL, 2011, NEUROIMAGE, V57, P873, DOI 10.1016/j.neuroimage.2011.05.040; Takano T, 2007, NAT NEUROSCI, V10, P754, DOI 10.1038/nn1902; TOMBAUGH GC, 1994, J NEUROSCI, V14, P5635; Varga DP, 2016, SCI REP-UK, V6, DOI 10.1038/srep31402; VOIPIO J, 1993, PFLUG ARCH EUR J PHY, V423, P193, DOI 10.1007/BF00374394; von Bornstadt D, 2015, NEURON, V85, P1117, DOI 10.1016/j.neuron.2015.02.007; WALZ W, 1988, GLIA, V1, P366, DOI 10.1002/glia.440010603; Zhou N, 2010, CEREB CORTEX, V20, P2614, DOI 10.1093/cercor/bhq018	56	18	18	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	APR 25	2017	7								1154	10.1038/s41598-017-01284-4			13	Multidisciplinary Sciences	Science & Technology - Other Topics	ET2LP	WOS:000400104700003	28442781	DOAJ Gold, Green Accepted, Green Published			2021-06-18	
J	Osborn, AJ; Mathias, JL; Fairweather-Schmidt, AK; Anstey, KJ				Osborn, A. J.; Mathias, J. L.; Fairweather-Schmidt, A. K.; Anstey, K. J.			Anxiety and comorbid depression following traumatic brain injury in a community-based sample of young, middle-aged and older adults	JOURNAL OF AFFECTIVE DISORDERS			English	Article						Traumatic brain injury; Anxiety; Depression; Community; Population; Longitudinal; Multivariate	QUALITY-OF-LIFE; PSYCHIATRIC-DISORDERS; MENTAL-HEALTH; NATIONAL-SURVEY; HEAD-INJURY; POPULATION; IDENTIFICATION; EPIDEMIOLOGY; ASSOCIATION; PREVALENCE	Background: Anxiety is common following a traumatic brain injury (TBI), but who is most at risk, and to what extent, is not well understood. Methods: Longitudinal data from a randomly-selected community sample (Wave 1: 7397, Wave 2: 6621 and Wave 3: 6042) comprising three adult cohorts (young: 20-24 years of age, middle-aged: 40-44, older: 60-64), were analysed. The association between TBI history, anxiety and comorbid depression was assessed, controlling for age, sex, marital/employment status, medical conditions, recent life events, alcohol consumption, social support and physical activity. Results: Thirteen percent of the sample had sustained a TBI by Wave 3, 35% of whom had sustained multiple TBIs. Cross-sectional analyses revealed that clinically-significant anxiety was more common in people who had sustained a TBI. Longitudinal analyses demonstrated an increased risk of anxiety post-TBI, even after controlling for potential demographic, health and psychosocial confounds. Anxiety was more common than depression, although 10% of those with a TBI experienced comorbid anxiety/depression. Limitations: TBIs were not medically confirmed and anxiety and depression were only assessed every four years by self-report, rather than clinical interview. Sample attrition resulted in the retention of healthier individuals at each wave. Conclusions: TBIs are associated with a lifelong increased risk of experiencing clinically-significant anxiety, highlighting the chronic nature of TBI sequelae. Positive lifestyle changes (e.g., increasing physical activity, reducing alcohol consumption) may decrease the risk of anxiety problems in the early years after a TBI. Comorbid anxiety and depression was common, indicating that both should be monitored and treated.	[Osborn, A. J.; Mathias, J. L.; Fairweather-Schmidt, A. K.] Univ Adelaide, Sch Psychol, Adelaide, SA, Australia; [Fairweather-Schmidt, A. K.] Flinders Univ S Australia, Sch Psychol, Bedford Pk, SA, Australia; [Fairweather-Schmidt, A. K.; Anstey, K. J.] Australian Natl Univ, Ctr Res Ageing Hlth & Wellbeing, Canberra, ACT, Australia	Mathias, JL (corresponding author), Univ Adelaide, Sch Psychol, Adelaide, SA, Australia.	jane.mathias@adelaide.edu.au	Anstey, Kaarin/AAB-4870-2020; Anstey, Kaarin J/A-3852-2008	Anstey, Kaarin/0000-0002-9706-9316			Alway Y, 2012, NEUROPSYCHOL REHABIL, V22, P374, DOI 10.1080/09602011.2011.648757; American Psychiatric Association, 2013, DIAGN STAT MAN MENT, V5, DOI [10.1176/appi.books.9780890425596., DOI 10.1176/APPI.BOOKS.9780890425596, 10.1176/appi.books.9780890425596]; Anstey KJ, 2012, INT J EPIDEMIOL, V41, P951, DOI 10.1093/ije/dyr025; Anstey KJ, 2004, J CLIN EPIDEMIOL, V57, P1202, DOI 10.1016/j.jclinepi.2003.11.011; Arnett JJ, 2000, AM PSYCHOL, V55, P469, DOI 10.1037/0003-066X.55.5.469; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; BRUGHA TS, 1990, ACTA PSYCHIAT SCAND, V82, P77, DOI 10.1111/j.1600-0447.1990.tb01360.x; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Brzuzy S, 1997, SOC WORK HEALTH CARE, V26, P77, DOI 10.1300/J010v26n01_05; Butterworth P, 2004, J CLIN EPIDEMIOL, V57, P742, DOI 10.1016/j.jclinepi.2003.10.015; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Centers for Disease Control and Prevention, 2014, REP C TRAUM BRAIN IN; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P315, DOI 10.1097/01.HTR.0000300226.67748.3e; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1940, DOI 10.1016/j.apmr.2013.05.018; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1199, DOI 10.1016/j.apmr.2013.01.023; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Demakis GJ, 2010, ARCH CLIN NEUROPSYCH, V25, P191, DOI 10.1093/arclin/acq004; Dworkin R. J., 1992, RES PERSONS MENTAL I; Eramudugolla R, 2014, J INT NEUROPSYCH SOC, V20, P444, DOI 10.1017/S1355617714000174; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; Frost RB, 2013, NEUROEPIDEMIOLOGY, V40, P154, DOI 10.1159/000343275; GOLDBERG D, 1988, BRIT MED J, V297, P897, DOI 10.1136/bmj.297.6653.897; Gould KR, 2011, PSYCHOL MED, V41, P2099, DOI 10.1017/S003329171100033X; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; JORGE RE, 1993, J NEUROPSYCH CLIN N, V5, P369; Kiely KM, 2015, PSYCHIAT RES, V225, P291, DOI 10.1016/j.psychres.2014.12.023; King NS, 2011, BRAIN INJURY, V25, P462, DOI 10.3109/02699052.2011.558042; KINSELLA G, 1988, PSYCHOL MED, V18, P57, DOI 10.1017/S0033291700001884; Lecrubier Y, 2001, J CLIN PSYCHIAT, V62, P4; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Mallya S, 2015, J NEUROTRAUM, V32, P411, DOI 10.1089/neu.2014.3504; McCabe P, 2007, BRAIN INJURY, V21, P231, DOI 10.1080/02699050701201631; McEvoy PM, 2011, AUST NZ J PSYCHIAT, V45, P957, DOI 10.3109/00048674.2011.624083; Merikangas KR, 2010, CURR TOP BEHAV NEURO, V2, P37, DOI 10.1007/7854_2009_32; Ortiz Nadia, 2004, Cogn Behav Neurol, V17, P157, DOI 10.1097/01.wnn.0000140168.25333.2b; Osborn AJ, 2016, NEUROPSYCHOLOGY, V30, P247, DOI 10.1037/neu0000221; Osborn AJ, 2014, NEUROSCI BIOBEHAV R, V47, P1, DOI 10.1016/j.neubiorev.2014.07.007; Osborn A.J., J HEAD TRAU IN PRESS; Powell J, 2002, J NEUROL NEUROSUR PS, V72, P193, DOI 10.1136/jnnp.72.2.193; Sareen J, 2005, ARCH GEN PSYCHIAT, V62, P1249, DOI 10.1001/archpsyc.62.11.1249; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; SCHUSTER TL, 1990, AM J COMMUN PSYCHOL, V18, P423, DOI 10.1007/BF00938116; Setnik L, 2007, BRAIN INJURY, V21, P1, DOI 10.1080/02699050601111419; Shahin H, 2012, J TRAUMA, V14, P233; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; Slade T, 2009, AUST NZ J PSYCHIAT, V43, P594, DOI 10.1080/00048670902970882; Truelle JL, 2010, BRAIN INJURY, V24, P1272, DOI 10.3109/02699052.2010.506865; Twisk JWR, 2004, EUR J EPIDEMIOL, V19, P769, DOI 10.1023/B:EJEP.0000036572.00663.f2; van der Horn HJ, 2013, ARCH PHYS MED REHAB, V94, P867, DOI 10.1016/j.apmr.2012.11.039; van Reekum R, 2000, J NEUROPSYCH CLIN N, V12, P316, DOI 10.1176/appi.neuropsych.12.3.316; Vanderploeg RD, 2007, J CLIN EXP NEUROPSYC, V29, P585, DOI 10.1080/13803390600826587; VanReekum R, 1996, BRAIN INJURY, V10, P319, DOI 10.1080/026990596124340; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1157, DOI 10.1089/neu.2009.1077; Whelan-Goodinson R, 2010, J HEAD TRAUMA REHAB, V25, P320, DOI 10.1097/HTR.0b013e3181c8f8e7; Whiteneck G, 2004, ARCH PHYS MED REHAB, V85, pS73, DOI 10.1016/j.apmr.2003.08.107; Wood RLL, 2006, J INT NEUROPSYCH SOC, V12, P350, DOI 10.1017/S1355617706060498	56	18	19	1	9	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-0327	1573-2517		J AFFECT DISORDERS	J. Affect. Disord.	APR 15	2017	213						214	221		10.1016/j.jad.2016.09.045			8	Clinical Neurology; Psychiatry	Neurosciences & Neurology; Psychiatry	ER5UH	WOS:000398868300031	27919428				2021-06-18	
J	Alhilali, LM; Delic, J; Fakhran, S				Alhilali, L. M.; Delic, J.; Fakhran, S.			Differences in Callosal and Forniceal Diffusion between Patients with and without Postconcussive Migraine	AMERICAN JOURNAL OF NEURORADIOLOGY			English	Article							TRAUMATIC BRAIN-INJURY; WHITE-MATTER; POSTTRAUMATIC MIGRAINE; HEADACHE; ASSOCIATIONS; SUMATRIPTAN; RECOVERY	BACKGROUND AND PURPOSE: Posttraumatic migraines are common after mild traumatic brain injury. The purpose of this study was to determine if a specific axonal injury pattern underlies posttraumatic migraines after mild traumatic brain injury utilizing Tract-Based Spatial Statistics analysis of diffusion tensor imaging. MATERIALS AND METHODS: DTI was performed in 58 patients with mild traumatic brain injury with posttraumatic migraines. Controls consisted of 17 patients with mild traumatic brain injury without posttraumatic migraines. Fractional anisotropy and diffusivity maps were generated to measure white matter integrity and were evaluated by using Tract-Based Spatial Statistics regression analysis with a general linear model. DTI findings were correlated with symptom severity, neurocognitive test scores, and time to recovery with the Pearson correlation coefficient. RESULTS: Patients with mild traumatic brain injury with posttraumatic migraines '' were not significantly different from controls in terms of age, sex, type of injury, or neurocognitive test performance. Patients with posttraumatic migraines had higher initial symptom severity (P =.01) than controls. Compared with controls, patients with mild traumatic brain injury with posttraumatic migraines had decreased fractional anisotropy in the corpus callosum (P =.03) and fornix/septohippocampal circuit (P =.045). Injury to the fornix/septohippocampal circuit correlated with decreased visual memory (r = 0.325, P =.01). Injury to corpus callosum trended toward inverse correlation with recovery (r = -0.260, P =.05). CONCLUSIONS: Injuries to the corpus callosum and fornix/septohippocampal circuit were seen in patients with mild traumatic brain injury with posttraumatic migraines, with injuries in the fornix/septohippocampal circuit correlating with decreased performance on neurocognitive testing.	[Alhilali, L. M.] Barrow Neurol Inst, Dept Neuroradiol, 350 W Thomas Rd, Phoenix, AZ 85013 USA; [Delic, J.] Univ Pittsburgh, Med Ctr, Div Neuroradiol, Dept Radiol, Pittsburgh, PA USA; [Fakhran, S.] Banner Hlth & Hosp Syst, East Valley Diagnost Imaging, Mesa, AZ USA	Alhilali, LM (corresponding author), Barrow Neurol Inst, Dept Neuroradiol, 350 W Thomas Rd, Phoenix, AZ 85013 USA.	lalhilali@sniweb.net		Alhilali, Lea/0000-0002-9059-2454			Abend NS, 2008, J CHILD NEUROL, V23, P438, DOI 10.1177/0883073807309772; Alhilali LM, 2014, RADIOLOGY, V272, P224, DOI 10.1148/radiol.14132670; Bartsch T, 2003, Curr Pain Headache Rep, V7, P371, DOI 10.1007/s11916-003-0036-y; Bashir A, 2013, NEUROLOGY, V81, P1260, DOI 10.1212/WNL.0b013e3182a6cb32; Carlson KF, 2013, HEADACHE, V53, P1573, DOI 10.1111/head.12216; Caspers S, 2013, CEREB CORTEX, V23, P615, DOI 10.1093/cercor/bhs048; D'Onofrio F, 2014, NEUROL SCI, V35, pS203, DOI 10.1007/s10072-014-1771-z; Fakhran S, 2013, RADIOLOGY, V269, P249, DOI 10.1148/radiol.13122343; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Giorgio A, 2010, NEUROIMAGE, V49, P94, DOI 10.1016/j.neuroimage.2009.08.003; Hamel E, 2007, CEPHALALGIA, V27, P1295; Harris JL, 2012, J CEREBR BLOOD F MET, V32, P2122, DOI 10.1038/jcbfm.2012.114; Hawthorne AL, 2011, J NEUROSCI, V31, P5605, DOI 10.1523/JNEUROSCI.6663-10.2011; Kontos AP, 2016, BRAIN IMAGING BEHAV, V10, P594, DOI 10.1007/s11682-015-9412-6; Kontos AP, 2013, AM J SPORT MED, V41, P1497, DOI 10.1177/0363546513488751; Li XL, 2011, HEADACHE, V51, P237, DOI 10.1111/j.1526-4610.2010.01774.x; Lucas S, 2014, CEPHALALGIA, V34, P93, DOI 10.1177/0333102413499645; McCrory P, 2005, BRIT J SPORT MED, V39, P552, DOI 10.1136/bjsm.2004.014878; Mihalik JP, 2013, AM J SPORT MED, V41, P1490, DOI 10.1177/0363546513487982; MOSKOWITZ MA, 1993, J NEUROSCI, V13, P1167, DOI 10.1523/jneurosci.13-03-01167.1993; Murphy DL, 1998, J CLIN PSYCHIAT, V59, P4; Obermann M, 2009, NEUROLOGY, V73, P978, DOI 10.1212/WNL.0b013e3181b8791a; Pacheco J, 2009, J NEUROSCI, V29, P6229, DOI 10.1523/JNEUROSCI.0896-09.2009; Packard RC, 2008, CURR PAIN HEADACHE R, V12, P67, DOI 10.1007/s11916-008-0013-6; Rocca MA, 2008, CEPHALALGIA, V28, P1061, DOI 10.1111/j.1468-2982.2008.01655.x; Sarmento E, 2009, HEADACHE, V49, P1345, DOI 10.1111/j.1526-4610.2009.01494.x; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Tang L, 2011, RADIOLOGY, V260, P831, DOI 10.1148/radiol.11110014; Yu DH, 2013, CEPHALALGIA, V33, P34, DOI 10.1177/0333102412466964	30	18	18	0	4	AMER SOC NEURORADIOLOGY	DENVILLE	PO BOX 3000, DENVILLE, NJ 07834-9349 USA	0195-6108	1936-959X		AM J NEURORADIOL	Am. J. Neuroradiol.	APR	2017	38	4					691	695		10.3174/ajnr.A5073			5	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	EQ9UD	WOS:000398429800005	28126745	Other Gold, Green Published			2021-06-18	
J	Jiang, L; Xia, QJ; Dong, XJ; Hu, Y; Chen, ZW; Chen, K; Wang, KH; Liu, J; Wang, TH				Jiang, Ling; Xia, Qing-jie; Dong, Xiu-juan; Hu, Yue; Chen, Zhi-wei; Chen, Kang; Wang, Kun-hua; Liu, Jia; Wang, Ting-hua			Neuroprotective effect of breviscapine on traumatic brain injury in rats associated with the inhibition of GSK3 beta signaling pathway	BRAIN RESEARCH			English	Article						Breviscapine; Traumatic brain injury; Neuroprotection; Glycogen synthase kinase 3 beta; Apoptosis; Synapse growth	GLYCOGEN-SYNTHASE KINASE-3-BETA; ISCHEMIA/REPERFUSION INJURY; OXIDATIVE DAMAGE; PC12 CELLS; PKC-ALPHA; ACTIVATION; SCUTELLARIN; EXPRESSION; APOPTOSIS; ISCHEMIA	Breviscapine, a standardized Chinese herbal medicine extracted from Erigeron breviscapine, has been widely used to treat cerebrovascular diseases. However, there are no reports about the neuroprotective effects and underlying molecular mechanisms of breviscapine on traumatic brain injury (TBI). Therefore, this study was aimed to investigate the effects of breviscapine on rats with TBI insult and illuminate the underlying mechanism. We created a traumatic brain-injured model with breviscapine lateral ventricle injection and evaluated the expressional changes of glycogen synthase kinase 3 beta (GSK3I3) as well as the GSK3p-involved signaling pathways including apoptosis and axonal growth. At 7, 14, 21 days after injection, we found a great reduction of motor disability in TBI rats following breviscapine treatment, which was accompanied with a notably increased expression of phospho-Ser9-GSK313(p-Ser9-GSK3(3) and decreased expression of phosphor-Try216-GSK313 (p-Try216-GSK3(3) at 7 days after injection. Concomitantly, an enhanced expression of synaptic marker synaptophysin (SYP) together with a weakened expression of pro-apoptotic caspase3 was observed after TBI rats were treated with breviscapine. Terminal deoxynucleotidyl transferase deoxy-UTP-nick end labeling (TUNEL) immunohistochemical assay and SYP immunofluorescence staining also confirmed the result. This study suggests that breviscapine inhibits the GSK3p signaling pathway to promote neurobehavioral function following neurotrauma. These events may provide a new insight into the mechanism of breviscapine treating brain injury. (C) 2017 Elsevier B.V. All rights reserved.	[Jiang, Ling; Xia, Qing-jie; Hu, Yue; Wang, Ting-hua] Sichuan Univ, Inst Neurol Dis, West China Hosp, Translat Neurosci Ctr, Chengdu 610041, Sichuan, Peoples R China; [Dong, Xiu-juan; Chen, Zhi-wei; Wang, Ting-hua] Kunming Med Univ, Inst Neurosci, Kunming, Yunnan Province, Peoples R China; [Dong, Xiu-juan; Chen, Zhi-wei; Wang, Ting-hua] Yunnan Normal Univ, Key Lab Natl Phys Fitness & Altitude Training Ada, Inst Phys Educ, Kunming 650000, Yunnan, Peoples R China; [Chen, Kang; Wang, Kun-hua] Kunming Med Univ, Dept Gastrointestinal Surg, Affiliated Hosp 1, Kunming 650032, Yunnan, Peoples R China; [Liu, Jia; Wang, Ting-hua] Kunming Med Univ, Dept Expt Zool, Kunming 650031, Yunnan, Peoples R China	Liu, J; Wang, TH (corresponding author), Kunming Med Univ, Dept Anesthesiol, Inst Neurol Dis, West China Hosp,Translat Neurosci Ctr, Chengdu 610041, Sichuan, Peoples R China.	liujiaaixuexi@126.com; tinghua_neuron@263.net			plan for Natinional Science and Technology support [2014BAI01B00]; Program for Innovation Resarch Team (In Science and Technology) in Yunnan Province; Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81471268]	This study was supported by a plan for Natinional Science and Technology support (No. 2014BAI01B00), and by Program for Innovation Resarch Team (In Science and Technology) in Yunnan Province, 2016, together with the Grant of Natural Science Foundation of China (No. 81471268).	Agrawal R, 2015, BBA-MOL BASIS DIS, V1852, P862, DOI 10.1016/j.bbadis.2015.01.018; Bhat RV, 2000, P NATL ACAD SCI USA, V97, P11074, DOI 10.1073/pnas.190297597; Carmichael J, 2002, J BIOL CHEM, V277, P33791, DOI 10.1074/jbc.m204861200; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Endo H, 2006, STROKE, V37, P2140, DOI 10.1161/01.STR.0000229888.55078.72; Erdem Y, 2015, TURK NEUROSURG, V25, P85, DOI 10.5137/1019-5149.JTN.10359-14.2; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Finnie JW, 2013, INFLAMMOPHARMACOLOGY, V21, P309, DOI 10.1007/s10787-012-0164-2; Forde JE, 2007, CELL MOL LIFE SCI, V64, P1930, DOI 10.1007/s00018-007-7045-7; Guo C, 2014, J ETHNOPHARMACOL, V151, P660, DOI 10.1016/j.jep.2013.11.026; Hong H, 2004, PLANTA MED, V70, P427, DOI 10.1055/s-2004-818970; Horiguchi K, 2006, J CELL BIOL, V174, P425, DOI 10.1083/jcb.200604031; Jia JH, 2008, ACTA CARDIOL, V63, P757, DOI 10.2143/AC.63.6.2033394; Jin Y, 2012, ACTA PHARMACOL SIN, V33, P861, DOI 10.1038/aps.2012.59; Jope RS, 2007, NEUROCHEM RES, V32, P577, DOI 10.1007/s11064-006-9128-5; Kaytor MD, 2002, CURR OPIN NEUROBIOL, V12, P275, DOI 10.1016/S0959-4388(02)00320-3; Kukreti V, 2014, J PEDIATR NEUROSCI, V9, P207, DOI 10.4103/1817-1745.147572; Kuo CY, 2015, INT J ENV RES PUB HE, V12, P4116, DOI 10.3390/ijerph120404116; ladecola C., 1995, AM J PHYSIOL, V268, pR286; Lee KY, 2007, BRAIN RES, V1129, P89, DOI 10.1016/j.brainres.2006.10.055; Li YF, 2015, J CHROMATOGR A, V1425, P8, DOI 10.1016/j.chroma.2015.10.062; Lin LL, 2007, J CARDIOVASC PHARM, V50, P327, DOI 10.1097/FJC.0b013e3180cbd0e7; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; Liu H, 2005, PHARMACOL RES, V51, P205, DOI 10.1016/j.phrs.2004.09.001; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Maggirwar SB, 1999, J NEUROCHEM, V73, P578, DOI 10.1046/j.1471-4159.1999.0730578.x; Mao X, 2015, BRAIN INJURY, V29, P86, DOI 10.3109/02699052.2014.968621; Nusse R, 2003, DEVELOPMENT, V130, P5297, DOI 10.1242/dev.00821; Park SM, 2015, BIOL PHARM BULL, V38, P184, DOI 10.1248/bpb.b14-00430; Piper DR, 2005, J BIOL CHEM, V280, P7206, DOI 10.1074/jbc.M411042200; Pop V, 2011, TRANSL STROKE RES, V2, P533, DOI 10.1007/s12975-011-0126-9; Romanova G A, 2015, Patol Fiziol Eksp Ter, V59, P112; Seira O, 2014, MOL NEUROBIOL, V49, P931, DOI 10.1007/s12035-013-8571-y; Tong N, 2001, EUR J NEUROSCI, V13, P1913, DOI 10.1046/j.0953-816x.2001.01572.x; Wang JM, 2000, BRAIN RES, V859, P381, DOI 10.1016/S0006-8993(00)02008-4; Wang J, 2015, PHARMAZIE, V70, P593, DOI 10.1691/ph.2015.5552; Wang M, 2010, ACTA DIABETOL, V47, pS209, DOI 10.1007/s00592-009-0164-x; Wu XM, 2013, INT J CLIN EXP PATHO, V6, P1282; Wu Y, 2007, APOPTOSIS, V12, P1365, DOI 10.1007/s10495-007-0065-9; Xu JG, 2014, BRAIN RES, V1582, P237, DOI 10.1016/j.brainres.2014.07.042; Yan L, 2010, J CELL BIOCHEM, V109, P1158, DOI 10.1002/jcb.22495; Zhang H, 2011, WORLD J GASTROENTERO, V17, P1825, DOI 10.3748/wjg.v17.i14.1825; Zhao SF, 2012, NEUROL RES, V34, P400, DOI 10.1179/1743132812Y.0000000025; Zhu D, 2009, NEUROL RES, V31, P200, DOI 10.1179/174313209X393915	44	18	22	1	19	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	APR 1	2017	1660						1	9		10.1016/j.brainres.2017.01.031			9	Neurosciences	Neurosciences & Neurology	EQ3XA	WOS:000398006100001	28143715				2021-06-18	
J	Vodret, S; Bortolussi, G; Jasprova, J; Vitek, L; Muro, AF				Vodret, Simone; Bortolussi, Giulia; Jasprova, Jana; Vitek, Libor; Muro, Andres F.			Inflammatory signature of cerebellar neurodegeneration during neonatal hyperbilirubinemia in Ugt1(-/-) mouse model	JOURNAL OF NEUROINFLAMMATION			English	Article						Ugt1a1; Crigler-Najjar syndrome; Astrocytes; Microglia; Oxidative stress; Autophagy; Apoptosis; ER stress	TRAUMATIC BRAIN-INJURY; UNCONJUGATED BILIRUBIN; OXIDATIVE STRESS; CELL-DEATH; GUNN RAT; GLIAL-CELLS; MOLECULAR-MECHANISMS; MACROPHAGE SUBSETS; NERVE-CELL; NEUROTOXICITY	Background: Severe hyperbilirubinemia is toxic during central nervous system development. Prolonged and uncontrolled high levels of unconjugated bilirubin lead to bilirubin- induced neurological damage and eventually death by kernicterus. Bilirubin neurotoxicity is characterized by a wide array of neurological deficits, including irreversible abnormalities in motor, sensitive and cognitive functions, due to bilirubin accumulation in the brain. Despite the abundant literature documenting the in vitro and in vivo toxic effects of bilirubin, it is unclear which molecular and cellular events actually characterize bilirubin-induced neurodegeneration in vivo. Methods: We used a mouse model of neonatal hyperbilirubinemia to temporally and spatially define the response of the developing cerebellum to the bilirubin insult. Results: We showed that the exposure of developing cerebellum to sustained bilirubin levels induces the activation of oxidative stress, ER stress and inflammatory markers at the early stages of the disease onset. In particular, we identified TNFa and NFK beta as key mediators of bilirubin- induced inflammatory response. Moreover, we reported that M1 type microglia is increasingly activated during disease progression. Failure to counteract this overwhelming stress condition resulted in the induction of the apoptotic pathway and the generation of the glial scar. Finally, bilirubin induced the autophagy pathway in the stages preceding death of the animals. Conclusions: This study demonstrates that inflammation is a key contributor to bilirubin damage that cooperates with ER stress in the onset of neurotoxicity. Pharmacological modulation of the inflammatory pathway may be a potential intervention target to ameliorate neonatal lethality in Ugt1(-/-) mice.	[Vodret, Simone; Bortolussi, Giulia; Muro, Andres F.] ICGEB, Padriciano 99, I-34149 Trieste, Italy; [Jasprova, Jana; Vitek, Libor] Charles Univ Prague, Inst Med Biochem & Lab Med, Fac Med 1, Prague 12000, Czech Republic; [Vitek, Libor] Charles Univ Prague, Fac Med 1, Dept Internal Med 4, Prague 12000, Czech Republic	Bortolussi, G; Muro, AF (corresponding author), ICGEB, Padriciano 99, I-34149 Trieste, Italy.	giulia.bortolussi@icgeb.org; muro@icgeb.org	Jasprova, Jana/H-7839-2017; vodret, simone/AAA-6348-2019; Vitek, Libor/A-2645-2008; Muro, Andres F/K-3156-2016	Jasprova, Jana/0000-0002-0579-0895; vodret, simone/0000-0003-1627-4404; Vitek, Libor/0000-0002-5318-0151; Muro, Andres F/0000-0002-9628-0494	TelethonFondazione Telethon [GGP10051]; Friuli-Venezia Giulia Regional; Beneficentia Stiftung; AXA Research; Czech Ministry of HealthMinistry of Health, Czech Republic [RVO VFN64165]; Czech Ministry of EducationMinistry of Education, Youth & Sports - Czech Republic [KONTAKT LH15097]	This work was supported by Telethon (GGP10051), by Friuli-Venezia Giulia Regional Grant and by Beneficentia Stiftung to A. F. Muro (ICGEB), by AXA Research Fund to G. Bortolussi (ICGEB), and by the Czech Ministry of Health (RVO VFN64165) and Czech Ministry of Education (KONTAKT LH15097) to L. Vitek.	Alirezaei M, 2011, EUR J NEUROSCI, V33, P197, DOI 10.1111/j.1460-9568.2010.07500.x; B'chir W, 2013, NUCLEIC ACIDS RES, V41, P7683, DOI 10.1093/nar/gkt563; Barateiro A, 2016, MOL PHARMACOL, V89, P84, DOI 10.1124/mol.115.098228; Barateiro A, 2012, NEUROMOL MED, V14, P285, DOI 10.1007/s12017-012-8187-9; Bhutani VK, 2013, J CLIN NEONATOL, V2, P61, DOI 10.4103/2249-4847.116402; Bockor L, 2016, HUM MOL GENET; Bortolussi G, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.113; Bortolussi G, 2014, DIS MODEL MECH, V7, P1057, DOI 10.1242/dmm.016535; Bortolussi G, 2012, FASEB J, V26, P1052, DOI 10.1096/fj.11-195461; Brites D, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00088; Brites D, 2011, SEMIN PERINATOL, V35, P114, DOI 10.1053/j.semperi.2011.02.004; Brito MA, 2004, BRAIN RES, V1026, P33, DOI 10.1016/j.brainres.2004.07.063; Brito MA, 2008, NEUROTOXICOLOGY, V29, P259, DOI 10.1016/j.neuro.2007.11.002; Brito MA, 2008, NEUROBIOL DIS, V29, P30, DOI 10.1016/j.nbd.2007.07.023; Calligaris R, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-543; Chaudhari N, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00213; Daood MJ, 2012, PEDIATR RES, V72, P455, DOI 10.1038/pr.2012.111; Falcao AS, 2007, NEUROSCIENCE, V144, P878, DOI 10.1016/j.neuroscience.2006.10.026; Falcao AS, 2007, J NEUROSCI RES, V85, P1229, DOI 10.1002/jnr.21227; Falcao AS, 2006, ACTA NEUROPATHOL, V112, P95, DOI 10.1007/s00401-006-0078-4; Fernandes A, 2006, J NEUROCHEM, V96, P1667, DOI 10.1111/j.1471-4159.2006.03680.x; Fernandes A, 2004, J NEUROIMMUNOL, V153, P64, DOI 10.1016/j.jneuroim.2004.04.007; Fernandes A, 2007, EUR J NEUROSCI, V25, P1058, DOI 10.1111/j.1460-9568.2007.05340.x; Fernandes A, 2009, CURR PHARM DESIGN, V15, P2915, DOI 10.2174/138161209789058165; Fernandes A, 2009, DEV NEUROBIOL, V69, P568, DOI 10.1002/dneu.20727; Fischer R, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/610813; Fujiwara R, 2010, P NATL ACAD SCI USA, V107, P5024, DOI 10.1073/pnas.0913290107; Gazzin S, 2012, PEDIATR RES, V71, P653, DOI 10.1038/pr.2012.23; Geiger AS, 2007, NEONATOLOGY, V92, P219, DOI 10.1159/000103740; Ghavami S, 2014, PROG NEUROBIOL, V112, P24, DOI 10.1016/j.pneurobio.2013.10.004; Giraudi PJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029078; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; Gordo AC, 2006, J NEUROSCI RES, V84, P194, DOI 10.1002/jnr.20857; Greco C, 2016, NEONATOLOGY, V110, P172, DOI 10.1159/000445708; Hsieh CL, 2013, EUR J IMMUNOL, V43, P2010, DOI 10.1002/eji.201243084; Inden M, 2007, J NEUROCHEM, V101, P1491, DOI 10.1111/j.1471-4159.2006.04440.x; Johnson LH, 2002, J PEDIATR-US, V140, P396, DOI 10.1067/mpd.2002.123098; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Kim HS, 2009, BEHAV BRAIN RES, V196, P168, DOI 10.1016/j.bbr.2008.09.040; Kim KH, 2010, NUCLEIC ACIDS RES, V38, P48, DOI 10.1093/nar/gkp865; Lin SZ, 2005, EUR J NEUROSCI, V22, P21, DOI 10.1111/j.1460-9568.2005.04182.x; Lin SZ, 2003, NEUROSCI LETT, V353, P209, DOI 10.1016/j.neulet.2003.09.053; Maisels MJ, 2004, PEDIATRICS, V114, P297; MIKOSHIBA K, 1980, J NEUROCHEM, V35, P1309, DOI 10.1111/j.1471-4159.1980.tb09003.x; NOTTER MFD, 1986, EXP NEUROL, V94, P670, DOI 10.1016/0014-4886(86)90246-3; Oakes GH, 2010, J BIOCHEM MOL TOXIC, V24, P73, DOI 10.1002/jbt.20313; Oakes GH, 2005, J BIOCHEM MOL TOXIC, V19, P244, DOI 10.1002/jbt.20086; Olmos G, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/861231; Olusanya BO, 2014, ARCH DIS CHILD, V99, P1117, DOI 10.1136/archdischild-2013-305506; Palmela I, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00022; Qaisiya M, 2016, ARCH TOXICOL; Qaisiya M, 2014, CELL SIGNAL, V26, P512, DOI 10.1016/j.cellsig.2013.11.029; Reichman NE, 2015, ANN EPIDEMIOL, V25, P126, DOI 10.1016/j.annepidem.2014.10.016; Rice AC, 2011, BRAIN RES, V1368, P290, DOI 10.1016/j.brainres.2010.10.052; Rodrigues CMP, 2000, MOL MED, V6, P936, DOI 10.1007/BF03401828; Sarnat HB, 1998, BRAIN DEV-JPN, V20, P88, DOI 10.1016/S0387-7604(97)00111-3; Schreuder AB, 2013, LIVER INT, V33, P1557, DOI 10.1111/liv.12219; SCHUTTA HS, 1967, J NEUROPATH EXP NEUR, V26, P377, DOI 10.1097/00005072-196707000-00003; Silva RFM, 2002, PEDIATR RES, V51, P535, DOI 10.1203/00006450-200204000-00022; Silva SL, 2012, NEUROPHARMACOLOGY, V62, P2398, DOI 10.1016/j.neuropharm.2012.02.002; Stoeckius M, 2012, J BIOL CHEM, V287, P15418, DOI 10.1074/jbc.M111.266510; Tell G, 2009, CURR PHARM DESIGN, V15, P2908, DOI 10.2174/138161209789058174; Turtzo LC, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-82; Vaz AR, 2011, MOL CELL NEUROSCI, V48, P82, DOI 10.1016/j.mcn.2011.06.008; Vodret S, 2015, SCI REP-UK, V5, DOI 10.1038/srep16203; Watchko JF, 2006, NEUROMOL MED, V8, P513, DOI 10.1385/NMM:8:4:513; Watchko JF, 2013, NEW ENGL J MED, V369, P2021, DOI 10.1056/NEJMra1308124; Whitney ER, 2008, J NEUROSCI METH, V168, P42, DOI 10.1016/j.jneumeth.2007.09.009; Wyss-Coray T, 2002, NEURON, V35, P419, DOI 10.1016/S0896-6273(02)00794-8; Yueh MF, 2014, J BIOL CHEM, V289, P4699, DOI 10.1074/jbc.M113.518613; Zhang YH, 2008, BIOCHEM BIOPH RES CO, V377, P1205, DOI 10.1016/j.bbrc.2008.10.151	71	18	19	0	7	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1742-2094			J NEUROINFLAMM	J. Neuroinflamm.	MAR 24	2017	14								64	10.1186/s12974-017-0838-1			16	Immunology; Neurosciences	Immunology; Neurosciences & Neurology	EP9BO	WOS:000397668900001	28340583	DOAJ Gold, Green Published			2021-06-18	
J	Xu, X; Lv, HY; Xia, Z; Fan, R; Zhang, CH; Wang, Y; Wang, DS				Xu, Xia; Lv, Huiying; Xia, Zian; Fan, Rong; Zhang, Chunhu; Wang, Yang; Wang, Dongsheng			Rhein exhibits antioxidative effects similar to Rhubarb in a rat model of traumatic brain injury	BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE			English	Article						Rhein; Rhubarb; Traumatic brain injury; Oxidative stress; Neuroprotective effect	TRADITIONAL CHINESE MEDICINE; OXIDATIVE STRESS	Background: The brain is secondarily harmed by pathological, physiological, and biological reactions that are caused by traumatic brain injury (TBI). Rhein, a significant composition of Rhubarb, is a well-known traditional Chinese treatment method and has a strong oxidation-resisting characteristic, but Rhein's mechanism remains unclear. Methods: This study aimed to identify Rhein in the brain tissues of TBI model of rats, and confirm whether Rhein induced an antioxidative effect similar to its parent medicine, Rhubarb. First, the ultra performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) method was applied to identify Rhein in the brain tissue of the controlled cortical impact (CCI) rats after intra-gastric administration of Rhubarb. Further, for the purpose of calculating the oxidant stress of the CCI rats, the malondialdehyde (MDA), catalase (CAT), superoxide dismutase (SOD), and glutathione disulfide (GSSG), as well as the proportion of glutathione (GSH)/GSSG were measured in the brain tissues. Results: The results showed that Rhein was absorbed in the brain tissues of CCI rats. Rhubarb and rhein elevated the SOD, CAT activities, GSH level, and GSH/GSSG ratio, and diminished the MDA and GSSG levels. Conclusion: The data demonstrated that Rhubarb and Rhein had the potential to be used as a neuroprotective drug for TBI, and that Rhein induced an antioxidative effect similar to its parent medicine, Rhubarb.	[Xu, Xia; Xia, Zian; Fan, Rong; Zhang, Chunhu; Wang, Yang; Wang, Dongsheng] Ctr South Univ, Inst Integrad Tradit Chinese & Western Med, Lab Ethnopharmacol, Changsha 410008, Peoples R China; [Lv, Huiying] Hunan Acad Agr Sci, Hunan Agr Product Processing Inst, Hunan Food Test & Analys Ctr, Changsha 410125, Peoples R China	Wang, Y; Wang, DS (corresponding author), Ctr South Univ, Inst Integrad Tradit Chinese & Western Med, Lab Ethnopharmacol, Changsha 410008, Peoples R China.	wangyang_xy87@163.com; wdsh66@aliyun.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81303074, 81673719, 81373554, 81173198]	This project was supported by the National Natural Science Foundation of China (Nos. 81303074, 81673719, 81373554 and 81173198).	Anglada JM, 2015, ACCOUNTS CHEM RES, V48, P575, DOI 10.1021/ar500412p; Ashraf A, 2015, PAK J BOT, V47, P367; Awasthi D, 1997, SURG NEUROL, V47, P575, DOI 10.1016/S0090-3019(96)00461-2; Bas O, 2007, NEUROCHEM INT, V50, P548, DOI 10.1016/j.neuint.2006.11.005; Bounda GA, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/329831; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Dincel GC, 2016, INT J IMMUNOPATH PH, V29, P226, DOI 10.1177/0394632016638668; Doulames VM, 2015, FRONT BEHAV NEUROSCI, V9, DOI [10.3389/fnbeh.2015.00369, 10.3389/fnbeh.2015.00275]; Du XP, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/4159357; Duan YQ, 2013, FOOD FUNCT, V4, P1252, DOI 10.1039/c3fo60116a; Gan L, 2015, BIOMED ENVIRON SCI, V28, P148, DOI 10.3967/bes2015.019; Gao D, 2016, MOLECULES, V21, DOI 10.3390/molecules21030298; Giustarini D, 2016, J CHROMATOGR B, V1019, P21, DOI 10.1016/j.jchromb.2016.02.015; Hu F, 2015, SCI REP-UK, V5, DOI 10.1038/srep14012; Jia D, 2014, J MOL NEUROSCI, V53, P271, DOI 10.1007/s12031-013-0217-z; Jiang BP, 2014, BRAIN RES, V1586, P1, DOI 10.1016/j.brainres.2014.08.001; Khalaj L, 2013, BRAIN RES, V1527, P117, DOI 10.1016/j.brainres.2013.06.041; Laskowski R.A., 2015, FRONTIERS NEUROENGIN; Lecoq AL, 2015, ANN ENDOCRINOL-PARIS, V76, pS10, DOI 10.1016/S0003-4266(16)30003-8; Li M, 2015, CHINESE MED J-PEKING, V128, P1072, DOI 10.4103/0366-6999.155094; Li WJ, 2011, LIFE SCI, V88, P713, DOI 10.1016/j.lfs.2011.02.010; Liang YZ, 2004, J CHROMATOGR B, V812, P53, DOI 10.1016/j.jchromb.2004.08.041; Lu K, 2015, MOL MED REP, V12, P2689, DOI 10.3892/mmr.2015.3693; Miyamoto K, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/379206; Moghbelinejad S, 2014, TOXICOL LETT, V224, P108, DOI 10.1016/j.toxlet.2013.10.010; Naini SMA, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/151979; Omrani H, 2015, ADV PHARM BULL, V5, P283, DOI 10.15171/apb.2015.039; Ribas GS, 2014, GENE, V533, P469, DOI 10.1016/j.gene.2013.10.017; Sarkar S, 2014, ECOTOX ENVIRON SAFE, V107, P1, DOI 10.1016/j.ecoenv.2014.05.012; Shia CS, 2009, PLANTA MED, V75, P1386, DOI 10.1055/s-0029-1185725; Sun DQ, 2009, CHEM-BIOL INTERACT, V179, P110, DOI 10.1016/j.cbi.2008.11.014; Sun K, 2015, ACTA PHARM SIN B, V5, P8, DOI 10.1016/j.apsb.2014.11.002; Sun WJ, 2017, SPECTROCHIM ACTA A, V171, P72, DOI 10.1016/j.saa.2016.07.039; Tang Yu-ping, 2006, Zhongguo Zhong Xi Yi Jie He Za Zhi, V26, P152; Tejada S, 2007, BRAIN RES BULL, V71, P372, DOI 10.1016/j.brainresbull.2006.10.005; Toklu HZ, 2015, FRONTIERS NEUROENGIN; Toyama T, 2014, NAT PROD COMMUN, V9, P1755; Tu QY, 2013, INT J BIOL MACROMOL, V60, P268, DOI 10.1016/j.ijbiomac.2013.05.035; Wang D, 2012, MOLECULES, V17, P9803, DOI 10.3390/molecules17089803; Wang JB, 2008, J PHARMACEUT BIOMED, V47, P765, DOI 10.1016/j.jpba.2008.03.011; Wang QS, 2005, NEUROCHEM RES, V30, P1387, DOI 10.1007/s11064-005-8391-1; Wang Y., 2012, J VIBRATION SHOCK, V9, P9, DOI DOI 10.7150/IJMS.4970]; Wang Y, 2016, MOL MED REP, V14, P3690, DOI 10.3892/mmr.2016.5720; Wang Zhi-peng, 2003, Zhongguo Zhongyao Zazhi, V28, P974; Xing ZH, 2016, SCI REP-UK, V6, DOI 10.1038/srep20040; Yang B, 2016, BMC COMPLEM ALTERN M, V16, DOI 10.1186/s12906-016-1076-2; Yu XL, 2015, FOOD FUNCT, V6, P3296, DOI 10.1039/c5fo00500k; Yu YH, 2015, PHARMACOL BIOCHEM BE, V133, P122, DOI 10.1016/j.pbb.2015.03.020; Zeraatpishe A, 2015, ASIAN J SPORTS MED, V4; Zhang W, 2015, INT J ANTENN PROPAG, V2015, P1, DOI DOI 10.1145/2820783.2820823.10; Zhang YQ, 2008, PROCEEDINGS OF THE INTERNATIONAL SYMPOSIUM ON ELECTRONIC COMMERCE AND SECURITY, P3, DOI 10.1109/ISECS.2008.227; Zhong XF, 2012, MOL MED REP, V5, P1261, DOI 10.3892/mmr.2012.793	52	18	19	0	25	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1472-6882			BMC COMPLEM ALTERN M	BMC Complement. Altern. Med.	MAR 7	2017	17								140	10.1186/s12906-017-1655-x			9	Integrative & Complementary Medicine	Integrative & Complementary Medicine	EN8TV	WOS:000396273600001	28264680	DOAJ Gold, Green Published			2021-06-18	
J	Chen, T; Yu, Y; Tang, LJ; Kong, L; Zhang, CH; Chu, HY; Yin, LW; Ma, HY				Chen, Tao; Yu, Yan; Tang, Liu-jiu; Kong, Li; Zhang, Cheng-hong; Chu, Hai-ying; Yin, Liang-wei; Ma, Hai-ying			Neural stem cells over-expressing brain-derived neurotrophic factor promote neuronal survival and cytoskeletal protein expression in traumatic brain injury sites	NEURAL REGENERATION RESEARCH			English	Article						nerve regeneration; brain-derived neurotrophic factor; neural stem cells; transfect; differentiation; traumatic brain injury; cytoskeleton; neurofilament; microtubule-associated proteins; calmodulin; Wnt/beta-catenin; neural regeneration	FUNCTIONAL RECOVERY; SPINAL-CORD; RAT MODEL; STEM/PROGENITOR CELLS; SYNAPTIC PROTEIN; TRANSPLANTATION; DIFFERENTIATION; GROWTH; REGENERATION; CALMODULIN	Cytoskeletal proteins are involved in neuronal survival. Brain-derived neurotrophic factor can increase expression of cytoskeletal proteins during regeneration after axonal injury. However, the effect of neural stem cells genetically modified by brain-derived neurotrophic factor transplantation on neuronal survival in the injury site still remains unclear. To examine this, we established a rat model of traumatic brain injury by controlled cortical impact. At 72 hours after injury, 2 x 10(7) cells/mL neural stem cells overexpressing brain-derived neurotrophic factor or naive neural stem cells (3 mL) were injected into the injured cortex. At 1-3 weeks after transplantation, expression of neurofilament 200, microtubule-associated protein 2, actin, calmodulin, and beta-catenin were remarkably increased in the injury sites. These findings confirm that brain-derived neurotrophic factor-transfected neural stem cells contribute to neuronal survival, growth, and differentiation in the injury sites. The underlying mechanisms may be associated with increased expression of cytoskeletal proteins and the Wnt/beta-catenin signaling pathway.	[Chen, Tao] Dalian Med Univ, Affiliated Hosp 1, Dept Neurosurg, Dalian, Liaoning Provin, Peoples R China; [Yu, Yan; Tang, Liu-jiu; Kong, Li; Zhang, Cheng-hong; Chu, Hai-ying; Ma, Hai-ying] Dalian Med Univ, Dept Histol & Embryol, Dalian, Liaoning Provin, Peoples R China; [Yin, Liang-wei] Dalian Cent Hosp, Dept Oncol, Dalian, Liaoning Provin, Peoples R China	Ma, HY (corresponding author), Dalian Med Univ, Dept Histol & Embryol, Dalian, Liaoning Provin, Peoples R China.; Yin, LW (corresponding author), Dalian Cent Hosp, Dept Oncol, Dalian, Liaoning Provin, Peoples R China.	Lwyin2008@163.com; hyma20060602@aliyun.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [31300812, 31371218]	This research was supported by grants from the National Natural Science Foundation of China, No. 31300812 and No. 31371218.	Arent AM, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/723060; Bonnet C, 2001, J BIOL CHEM, V276, P12839, DOI 10.1074/jbc.M011380200; Castorina A, 2015, NEURAL REGEN RES, V10, P850, DOI 10.4103/1673-5374.158352; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; Chung S, 2016, INT J MOL MED, V37, P1170, DOI 10.3892/ijmm.2016.2532; Darsalia V, 2007, EUR J NEUROSCI, V26, P605, DOI 10.1111/j.1460-9568.2007.05702.x; DAVIES AM, 1994, J NEUROBIOL, V25, P1334, DOI 10.1002/neu.480251103; Difato F, 2011, SCI REP-UK, V1, DOI 10.1038/srep00183; Fauza DO, 2008, SURGERY, V144, P367, DOI 10.1016/j.surg.2008.05.009; Galvin JE, 2000, EXP NEUROL, V165, P77, DOI 10.1006/exnr.2000.7461; Hall AC, 2000, CELL, V100, P525, DOI 10.1016/S0092-8674(00)80689-3; Huh JW, 2002, EXP NEUROL, V175, P198, DOI 10.1006/exnr.2002.7880; Ikegami K, 2006, J BIOL CHEM, V281, P30707, DOI 10.1074/jbc.M603984200; Kallur T, 2006, J NEUROSCI RES, V84, P1630, DOI 10.1002/jnr.21066; KANG HJ, 1995, SCIENCE, V267, P1658, DOI 10.1126/science.7886457; KITAMURA Y, 1995, EUR J PHARM-MOLEC PH, V289, P299, DOI 10.1016/0922-4106(95)90107-8; Larsson C, 2006, CELL SIGNAL, V18, P276, DOI 10.1016/j.cellsig.2005.07.010; Lee IS, 2015, MOL NEURODEGENER, V10, DOI 10.1186/s13024-015-0035-6; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Levinson H, 2004, WOUND REPAIR REGEN, V12, P505, DOI 10.1111/j.1067-1927.2004.012502.x; Lin W, 2016, ASIA PAC J CLIN TRIA, V1, P170; Liu WG, 2011, NEUROL RES, V33, P686, DOI 10.1179/1743132810Y.0000000031; Lou YL, 2016, ZHONGGUO ZUZHI GONGC, V20, P1474; Lv XM, 2016, NEURAL REGEN RES, V11, P652, DOI 10.4103/1673-5374.180753; Ma HY, 2012, NEUROCHEM RES, V37, P69, DOI 10.1007/s11064-011-0584-1; Ma HY, 2011, MOL MED REP, V4, P849, DOI 10.3892/mmr.2011.510; Ma XH, 2010, CRYOBIOLOGY, V60, P184, DOI 10.1016/j.cryobiol.2009.10.013; McKay R, 1997, SCIENCE, V276, P66, DOI 10.1126/science.276.5309.66; Meng XT, 2008, CELL BIOL INT, V32, P1546, DOI 10.1016/j.cellbi.2008.09.001; Mosevitsky MI, 2005, INT REV CYTOL, V245, P245, DOI 10.1016/S0074-7696(05)45007-X; Ortega F, 2013, NAT CELL BIOL, V15, P602, DOI 10.1038/ncb2736; Perrot R, 2008, MOL NEUROBIOL, V38, P27, DOI 10.1007/s12035-008-8033-0; Piccin D, 2011, STEM CELLS, V29, P528, DOI 10.1002/stem.589; PORTIER MM, 1984, DEV NEUROSCI-BASEL, V6, P335, DOI 10.1159/000112360; POSMANTUR R, 1994, J NEUROTRAUM, V11, P533, DOI 10.1089/neu.1994.11.533; Purro SA, 2008, J NEUROSCI, V28, P8644, DOI 10.1523/JNEUROSCI.2320-08.2008; Santamaria S, 2015, NEURAL REGEN RES, V10, P1574, DOI 10.4103/1673-5374.165266; Schaloske RH, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-13; Shear DA, 2011, RESTOR NEUROL NEUROS, V29, P215, DOI 10.3233/RNN-2011-0593; Shetty AK, 1995, J COMP NEUROL, V363, P581, DOI 10.1002/cne.903630406; Shetty AK, 2013, INT J DEV NEUROSCI, V31, P646, DOI 10.1016/j.ijdevneu.2013.05.006; Wang LJ, 2014, ACTA NEUROCHIR, V156, P1409, DOI 10.1007/s00701-014-2089-6; Yang JW, 2015, NEUROPEPTIDES, V54, P35, DOI 10.1016/j.npep.2015.08.005; Yao Y, 2016, NEURAL REGEN RES, V11, P1456, DOI 10.4103/1673-5374.191220; Ye LJ, 2016, NEURAL REGEN RES, V11, P1464, DOI 10.4103/1673-5374.191221; Yu B, 2011, INT J MOL MED, V28, P739, DOI 10.3892/ijmm.2011.734; Yuan LL, 2015, NEURAL REGEN RES, V10, P1516, DOI 10.4103/1673-5374.165526	47	18	19	0	6	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	1673-5374	1876-7958		NEURAL REGEN RES	Neural Regen. Res.	MAR	2017	12	3					433	439		10.4103/1673-5374.202947			7	Cell Biology; Neurosciences	Cell Biology; Neurosciences & Neurology	ES8GC	WOS:000399792000024	28469658	DOAJ Gold, Green Published			2021-06-18	
J	Farrell, K; Joshi, J; Kothapalli, CR				Farrell, Kurt; Joshi, Jyotsna; Kothapalli, Chandrasekhar R.			Injectable uncrosslinked biomimetic hydrogels as candidate scaffolds for neural stem cell delivery	JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A			English	Article						neural stem cells; hydrogels; rheology; uncrosslinked; differentiation; injectability; axonal outgrowth; extracellular matrix	HYALURONIC-ACID HYDROGELS; CENTRAL-NERVOUS-SYSTEM; TRAUMATIC BRAIN-INJURY; NEURONAL DIFFERENTIATION; IN-VITRO; RETINOIC ACID; COLLAGEN GELS; SPINAL-CORD; STEM/PROGENITOR CELLS; MECHANICAL-PROPERTIES	Mammalian central nervous system has a limited ability for self-repair under diseased or injury conditions. Repair strategies focused on exogenously delivering autologous neural stem cells (NSCs) to replace lost neuronal populations and axonal pathways in situ, and promote endogenous repair mechanisms are gaining traction. Successful outcomes are contingent on selecting an appropriate delivery vehicle for injecting cells that promotes cell retention and survival, elicits differentiation to desired lineages, and enhances axonal outgrowth upon integration into the host tissue. Hydrogels made of varying compositions of collagen, laminin, hyaluronic acid (HA), and chondroitin sulfate proteoglycan (CSPG) were developed, with no external crosslinking agents, to mimic the native extracellular matrix composition. The physical (porosity, pore-size, gel integrity, swelling ratio, and enzymatic degradation), mechanical (viscosity, storage and loss moduli, Young's modulus, creep, and stress-relaxation), and biological (cell survival, differentiation, neurite outgrowth, and integrin expression) characteristics of these hydrogels were assessed. These hydrogels exhibited excellent injectability, retained gel integrity, and matched the mechanical moduli of native brain tissue, possibly due to natural collagen fibril polymerization and physical-crosslinking between HA molecules and collagen fibrils. Depending on the composition, these hydrogels promoted cell survival, neural differentiation, and neurite outgrowth, as evident from immunostaining and western blots. These cellular outcomes were facilitated by cellular binding via (6), (1), and CD44 surface integrins to these hydrogels. Results attest to the utility of uncrosslinked, ECM-mimicking hydrogels to deliver NSCs for tissue engineering and regenerative medicine applications. (c) 2016 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 105A: 790-805, 2017.	[Farrell, Kurt; Joshi, Jyotsna; Kothapalli, Chandrasekhar R.] Cleveland State Univ, Dept Chem & Biomed Engn, Cleveland, OH 44115 USA	Kothapalli, CR (corresponding author), Cleveland State Univ, Dept Chem & Biomed Engn, Cleveland, OH 44115 USA.	c.kothapalli@csuohio.edu			Cellular and molecular medicine fellowship (CMMS); CSU	Contract grant sponsors: Cellular and molecular medicine fellowship (CMMS), dissertation research awards (DRA), CSU, Startup funds, Faculty Research Development Grant from CSU	Akita J, 2002, BRAIN RES, V954, P286, DOI 10.1016/S0006-8993(02)03356-5; Ambrosio L, 1999, J MACROMOL SCI PURE, VA36, P991, DOI 10.1081/MA-100101578; Angele P, 2004, BIOMATERIALS, V25, P2831, DOI 10.1016/j.biomaterials.2003.09.066; Banerjee A, 2009, BIOMATERIALS, V30, P4695, DOI 10.1016/j.biomaterials.2009.05.050; Barros CS, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005108; BAXTER E, 1971, ANN RHEUM DIS, V30, P419, DOI 10.1136/ard.30.4.419; Bergstrom T, 2014, BBA-GEN SUBJECTS, V1840, P2526, DOI 10.1016/j.bbagen.2014.01.021; Bilston LE, 2001, BIORHEOLOGY, V38, P335; Bjorklund A, 2000, NAT NEUROSCI, V3, P537, DOI 10.1038/75705; Brannvall K, 2007, J NEUROSCI RES, V85, P2138, DOI 10.1002/jnr.21358; Cacciatore I, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/240146; Cesaretti M, 2003, CARBOHYD POLYM, V54, P59, DOI 10.1016/S0144-8617(03)00144-9; Cheng TY, 2013, BIOMATERIALS, V34, P2005, DOI 10.1016/j.biomaterials.2012.11.043; Christie VB, 2010, J NEUROSCI METH, V193, P239, DOI 10.1016/j.jneumeth.2010.08.022; Clarke DL, 2000, SCIENCE, V288, P1660, DOI 10.1126/science.288.5471.1660; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Davidenko N, 2010, ACTA BIOMATER, V6, P3957, DOI 10.1016/j.actbio.2010.05.005; Einstein O, 2008, ARCH NEUROL-CHICAGO, V65, P452, DOI 10.1001/archneur.65.4.452; Elkin BS, 2007, J NEUROTRAUM, V24, P812, DOI 10.1089/neu.2006.0169; Farrell K, 2012, J REGENERATIVE MED, V1, P2, DOI [10.4172/23259620, DOI 10.4172/23259620]; Farrell K, 2017, J BIOMED MATER RES A, V105, P790, DOI 10.1002/jbm.a.35956; Fedoroff S, 2001, PROTOCOLS NEURAL CEL, p[xxii, 362]; Flanagan LA, 2002, NEUROREPORT, V13, P2411, DOI 10.1097/00001756-200212200-00007; Gefen A, 2004, J BIOMECH, V37, P1339, DOI 10.1016/j.jbiomech.2003.12.032; GIBBS DA, 1968, BIOPOLYMERS, V6, P777, DOI 10.1002/bip.1968.360060603; Hopkins AM, 2013, ADV FUNCT MATER, V23, P5140, DOI 10.1002/adfm.201300435; Hou SP, 2005, J NEUROSCI METH, V148, P60, DOI 10.1016/j.jneumeth.2005.04.016; Kothapalli CR, 2013, BIOMATERIALS, V34, P5995, DOI 10.1016/j.biomaterials.2013.04.042; Kothapalli CR, 2005, ACTA BIOMATER, V1, P653, DOI 10.1016/j.actbio.2005.06.005; Krebs J, 2005, SPINE, V30, pE118, DOI 10.1097/01.brs.0000154670.49227.65; Kulbatski I, 2009, J HISTOCHEM CYTOCHEM, V57, P405, DOI 10.1369/jhc.2008.951814; Laabs T, 2005, CURR OPIN NEUROBIOL, V15, P116, DOI 10.1016/j.conb.2005.01.014; Lai GL, 2008, INT J BIOL MACROMOL, V42, P285, DOI 10.1016/j.ijbiomac.2007.12.010; Leipzig ND, 2009, BIOMATERIALS, V30, P6867, DOI 10.1016/j.biomaterials.2009.09.002; Li XW, 2012, PROG POLYM SCI, V37, P1105, DOI 10.1016/j.progpolymsci.2012.02.004; Liang Y, 2013, BIOMATERIALS, V34, P5521, DOI 10.1016/j.biomaterials.2013.03.095; Liu C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117709; Liu T, 2010, J BIOMED MATER RES A, V95A, P276, DOI 10.1002/jbm.a.32831; Lopez-Garcia MDC, 2010, BIO-MED MATER ENG, V20, P361, DOI 10.3233/BME-2010-0649; Lu P, 2003, EXP NEUROL, V181, P115, DOI 10.1016/S0014-4886(03)00037-2; Ma FK, 2014, BIOMACROMOLECULES, V15, P1062, DOI 10.1021/bm500062n; Ma W, 2004, EXP NEUROL, V190, P276, DOI 10.1016/j.expneurol.2003.10.016; Mao YW, 2005, J CELL BIOL, V170, P305, DOI 10.1083/jcb.200505061; Moretti Morgana, 2014, Front Biosci (Elite Ed), V6, P341; Mothe AJ, 2013, BIOMATERIALS, V34, P3775, DOI 10.1016/j.biomaterials.2013.02.002; Muraoka M, 1996, J BIOCHEM-TOKYO, V119, P167; Naruse M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053109; Nehrer S, 1997, BIOMATERIALS, V18, P769, DOI 10.1016/S0142-9612(97)00001-X; Oliveira SM, 2008, J BIOMED MATER RES B, V87B, P49, DOI 10.1002/jbm.b.31066; Ortinau S, 2010, BIOMED ENG ONLINE, V9, DOI 10.1186/1475-925X-9-70; Pan LJ, 2009, J NEUROSCI RES, V87, P3207, DOI 10.1002/jnr.22142; Park KK, 2008, SCIENCE, V322, P963, DOI 10.1126/science.1161566; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; Rao SS, 2013, ACS APPL MATER INTER, V5, P9276, DOI 10.1021/am402097j; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Saha K, 2008, BIOPHYS J, V95, P4426, DOI 10.1529/biophysj.108.132217; Scatena R, 2007, EXPERT OPIN INV DRUG, V16, P59, DOI 10.1517/13543784.16.1.59; Schmidt CE, 2003, ANNU REV BIOMED ENG, V5, P293, DOI 10.1146/annurev.bioeng.5.011303.120731; Segura T, 2005, BIOMATERIALS, V26, P359, DOI 10.1016/j.biomaterials.2004.02.067; Seidlits SK, 2010, BIOMATERIALS, V31, P3930, DOI 10.1016/j.biomaterials.2010.01.125; Sharif-Kashani P, 2011, J BIOMECH, V44, P419, DOI 10.1016/j.jbiomech.2010.10.002; Sher F, 2008, STEM CELLS, V26, P2875, DOI 10.1634/stemcells.2008-0121; Simmers P, 2015, TISSUE ENG PT A, V21, P1455, DOI [10.1089/ten.tea.2014.0363, 10.1089/ten.TEA.2014.0363]; Siriwardane ML, 2014, BIOFABRICATION, V6, DOI 10.1088/1758-5082/6/1/015012; Stabenfeldt SE, 2010, TISSUE ENG PT A, V16, P3747, DOI [10.1089/ten.tea.2009.0837, 10.1089/ten.TEA.2009.0837]; Sundararaghavan HG, 2008, J BIOMED MATER RES A, V87A, P308, DOI 10.1002/jbm.a.31715; Takahashi J, 1999, J NEUROBIOL, V38, P65, DOI 10.1002/(SICI)1097-4695(199901)38:1<65::AID-NEU5>3.3.CO;2-H; Tate CC, 2009, J TISSUE ENG REGEN M, V3, P208, DOI 10.1002/term.154; Thonhoff JR, 2008, BRAIN RES, V1187, P42, DOI 10.1016/j.brainres.2007.10.046; Tian WM, 2005, TISSUE ENG, V11, P513, DOI 10.1089/ten.2005.11.513; Tunesi M, 2013, INT J ARTIF ORGANS, V36, P762, DOI 10.5301/ijao.5000282; Volpi N, 2014, NAT PROTOC, V9, P541, DOI 10.1038/nprot.2014.026; Wang TW, 2009, ACTA BIOMATER, V5, P2371, DOI 10.1016/j.actbio.2009.03.033; Wang Y, 2011, PHARM RES-DORDR, V28, P1406, DOI 10.1007/s11095-011-0452-3; Watanabe K, 2007, RESTOR NEUROL NEUROS, V25, P109; Wong G, 2004, EXP NEUROL, V187, P171, DOI 10.1016/j.expneurol.2004.01.009; Yamamura N, 2007, TISSUE ENG, V13, P1443, DOI 10.1089/ten.2006.0333; Zahalak GI, 2000, BIOPHYS J, V79, P2369, DOI 10.1016/S0006-3495(00)76482-4	78	18	18	1	67	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1549-3296	1552-4965		J BIOMED MATER RES A	J. Biomed. Mater. Res. Part A	MAR	2017	105	3					790	805		10.1002/jbm.a.35956			16	Engineering, Biomedical; Materials Science, Biomaterials	Engineering; Materials Science	EK5HO	WOS:000393957700011	27798959				2021-06-18	
J	Sell, SL; Johnson, K; DeWitt, DS; Prough, DS				Sell, Stacy L.; Johnson, Kathia; DeWitt, Douglas S.; Prough, Donald S.			Persistent Behavioral Deficits in Rats after Parasagittal Fluid Percussion Injury	JOURNAL OF NEUROTRAUMA			English	Article						behavior; chronic brain injury; reference memory; TBI; working memory	TRAUMATIC BRAIN-INJURY; CONTROLLED CORTICAL IMPACT; WORKING-MEMORY; WATER MAZE; SPATIAL LOCALIZATION; HIPPOCAMPAL-LESIONS; HEAD-INJURY; MODEL; OUTCOMES; CONCUSSION	Although traumatic brain injury (TBI) is now considered a chronic disease, few studies have investigated the long-term behavioral deficits elicited by a well-established rodent model of injury. Here we evaluate behavioral measures, commonly used in TBI research, to determine which tests are useful for studying long-term effects of brain injury in rats. Male Sprague-Dawley rats were handled and pre-trained to neurological, balance, and motor coordination tests prior to receiving parasagittal fluid-percussion injury (FPI), sham injury, or maintenance as naive cohorts. Rats underwent neuroscore, beam-balance, and beam-walk tests for 3 days after injury. Subsequently, in separate groups at 3, 6, or 12 months, they were re-tested on the same tasks followed by a working memory version of the Morris water maze. On post-injury days (PIDs) 1-3, significant effects of injury on neuroscore, beam-balance, and beam-walk were observed. Differences in the beam-walk task were not detectable at any of the later time-points. However, deficits persisted in beam-balance out to 3 months and neuroscore out to 6 months. Working memory deficits persisted out to 12 months, at which time a reference memory deficit was also evident. These data suggest that balance and motor coordination recovered more quickly than neurological deficits. Furthermore, while deficits in working memory remained stable over the 12-month period, the late onset of the reference memory deficit points to the progressive nature of the injury, or an age/TBI interaction. In conclusion, standard behavioral tests are useful measures of persistent behavioral deficits after parasagittal FPI and provide evidence that TBI is a chronic condition that can change over time and worsen with age.	[Sell, Stacy L.; Johnson, Kathia; DeWitt, Douglas S.; Prough, Donald S.] Univ Texas Med Branch, Dept Anesthesiol, 301 Univ Blvd, Galveston, TX 77555 USA	Sell, SL (corresponding author), Univ Texas Med Branch, Dept Anesthesiol, 301 Univ Blvd, Galveston, TX 77555 USA.	slsell@utmb.edu	Prough, Donald S/G-5793-2013	Prough, Donald S/0000-0001-7994-532X; DeWitt, Douglas/0000-0001-9810-8156	Moody Project for Translational Traumatic Brain Injury Research	These studies were completed as part of a team funded by The Moody Project for Translational Traumatic Brain Injury Research.	AGGLETON JP, 1986, BEHAV BRAIN RES, V19, P133, DOI 10.1016/0166-4328(86)90011-2; Arnold JL, 2004, ANN EMERG MED, V43, P263, DOI 10.1016/S0196-0644(03)00723-6; Beaumont A, 1999, NEUROL RES, V21, P742, DOI 10.1080/01616412.1999.11741008; BEDERSON JB, 1986, STROKE, V17, P472, DOI 10.1161/01.STR.17.3.472; BRAMLETT HM, 1995, J NEUROTRAUM, V12, P289, DOI 10.1089/neu.1995.12.289; Casson IR, 2009, PHYS MED REH CLIN N, V20, P195, DOI 10.1016/j.pmr.2008.10.006; Choi SH, 2006, J NEUROSCI METH, V156, P182, DOI 10.1016/j.jneumeth.2006.03.002; Corrigan JD, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0000000000000020; D'Hooge R, 2001, BRAIN RES REV, V36, P60, DOI 10.1016/S0165-0173(01)00067-4; DeWitt DS, 1997, J NEUROTRAUM, V14, P223, DOI 10.1089/neu.1997.14.223; DIETRICH WD, 1994, J NEUROTRAUM, V11, P289, DOI 10.1089/neu.1994.11.289; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Dixon CE, 1999, J NEUROTRAUM, V16, P109, DOI 10.1089/neu.1999.16.109; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Eskridge SL, 2012, INJURY, V43, P1678, DOI 10.1016/j.injury.2012.05.027; Faul M.D., 2010, TRAUMATIC BRAIN INJU; FEENEY DM, 1982, SCIENCE, V217, P855, DOI 10.1126/science.7100929; Franklin M., 2015, 2015 WOUNDED WARRIOR; FRICK KM, 1995, NEUROBIOL AGING, V16, P149, DOI 10.1016/0197-4580(94)00155-3; Fujimoto ST, 2004, NEUROSCI BIOBEHAV R, V28, P365, DOI 10.1016/j.neubiorev.2004.06.002; GENTILINI M, 1985, J NEUROL NEUROSUR PS, V48, P137, DOI 10.1136/jnnp.48.2.137; Gold EM, 2013, REGEN MED, V8, P483, DOI 10.2217/rme.13.41; GOLDSTEIN LB, 1990, J NEUROSCI METH, V31, P101, DOI 10.1016/0165-0270(90)90154-8; GURDJIAN ES, 1954, NEUROLOGY, V4, P674, DOI 10.1212/WNL.4.9.674; Hamm RJ, 1996, J NEUROTRAUM, V13, P317, DOI 10.1089/neu.1996.13.317; Hayes RL, 1988, J NEUROTRAUM, V5, P259, DOI 10.1089/neu.1988.5.259; Jung J., 2016, J NEUROL SCI-TURK, V30, P617; Kline AE, 2002, J NEUROTRAUM, V19, P415, DOI 10.1089/08977150252932370; KOLB B, 1983, BEHAV NEUROSCI, V97, P13, DOI 10.1037/0735-7044.97.1.13; Lindner MD, 1998, J NEUROTRAUM, V15, P199, DOI 10.1089/neu.1998.15.199; Long JB, 1996, J NEUROTRAUM, V13, P149, DOI 10.1089/neu.1996.13.149; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; McDowell S, 1997, NEUROPSYCHOLOGIA, V35, P1341, DOI 10.1016/S0028-3932(97)00082-1; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; MORRIS RGM, 1986, Q J EXP PSYCHOL-B, V38, P365; OLTON DS, 1979, BEHAV BRAIN SCI, V2, P313, DOI 10.1017/S0140525X00062713; OLTON DS, 1978, BRAIN RES, V139, P295, DOI 10.1016/0006-8993(78)90930-7; Osier ND, 2015, J NEUROTRAUM, V32, P1861, DOI 10.1089/neu.2014.3680; Pellman E, 2004, NEUROSURGERY, V55, P860, DOI 10.1227/01.NEU.0000137657.00146.7D; Perez-Polo JR, 2015, J NEUROSCI RES, V93, P549, DOI 10.1002/jnr.23513; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; Rimel R W, 1981, J Neurosurg Nurs, V13, P132; Risdall JE, 2011, PHILOS T R SOC B, V366, P241, DOI 10.1098/rstb.2010.0230; Risling Marten, 2012, Front Neurol, V3, P30, DOI 10.3389/fneur.2012.00030; RUTHERFORD WH, 1977, LANCET, V1, P1; Schallert Timothy, 2006, NeuroRx, V3, P497, DOI 10.1016/j.nurx.2006.08.001; Sell SL, 2008, ANESTHESIOLOGY, V108, P873, DOI 10.1097/ALN.0b013e31816c8a15; Sharpe W, 1922, CAN MED ASSOC J, V7, P761; SUTHERLAND RJ, 1983, BEHAV BRAIN RES, V7, P133, DOI 10.1016/0166-4328(83)90188-2; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Weicker J, 2016, NEUROPSYCHOLOGY, V30, P190, DOI 10.1037/neu0000227; Ziebell J. M., 2016, BRAIN BEHAV IMMUN	56	18	18	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAR 1	2017	34	5					1086	1096		10.1089/neu.2016.4616			11	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	EM6EI	WOS:000395405200013	27650266				2021-06-18	
J	Young, AMH; Guilfoyle, MR; Donnelly, J; Scoffings, D; Fernandes, H; Garnett, M; Agrawal, S; Hutchinson, PJ				Young, Adam M. H.; Guilfoyle, Mathew R.; Donnelly, Joseph; Scoffings, Daniel; Fernandes, Helen; Garnett, Mathew; Agrawal, Shruti; Hutchinson, Peter J.			Correlating optic nerve sheath diameter with opening intracranial pressure in pediatric traumatic brain injury	PEDIATRIC RESEARCH			English	Article							CEREBRAL PERFUSION-PRESSURE; SEVERE HEAD-INJURY; COMPUTED-TOMOGRAPHY; EMERGENCY-DEPARTMENT; SCAN; ULTRASONOGRAPHY; HYPERTENSION; ULTRASOUND	INTRODUCTION: The use of clinical markers to predict intracranial pressure (ICP) is desirable as a first-line measure to assist in decision making as to whether invasive monitoring is required. Correlations between ICP and optic nerve sheath diameter (ONSD) using CT and MRI have been observed in adult populations. However, data on this modality in children is less well documented. METHODS: ONSD was measured by independent observers and correlated with opening ICP at insertion of invasive monitoring probes in pediatric traumatic brain injury patients admitted to Addenbrookes Hospital between January 2009 and December 2013. RESULTS: Thirty-six patients with a mean age of 8.2 y were admitted to the Pediatric Intensive Care Unit (PICU) with a traumatic head injury and required invasive neurosurgical monitoring. The median ICP was 18 +/- 10 mmHg (median +/- IQR), the median right ONSD was 5.6 +/- 2.5 mm and the left was 5.9 +/- 3.2 mm. The Intraclass correlation between observers was 0.91 (P < 0.0001). The correlation of mean ONSD and max ONSD with ICP was 0.712 (P < 0.0001) and 0.713 (P < 0.0001), respectively. Area under ROC curve for both mean and max ONSD is 0.85 (95% CI: 0.73-0.98). CONCLUSION: Where pediatric patients present with an ONSD of over 6.1 mm following a traumatic brain injury (TBI), ICP monitoring should be implemented.	[Young, Adam M. H.; Guilfoyle, Mathew R.; Donnelly, Joseph; Fernandes, Helen; Garnett, Mathew; Hutchinson, Peter J.] Univ Cambridge, Addenbrookes Hosp, Div Acad Neurosurg, Dept Clin Neurosci, Cambridge, England; [Scoffings, Daniel] Univ Cambridge, Addenbrookes Hosp, Dept Neuroradiol, Cambridge, England; [Agrawal, Shruti] Univ Cambridge, Addenbrookes Hosp, Dept Pediat Intens Care, Cambridge, England	Young, AMH (corresponding author), Univ Cambridge, Addenbrookes Hosp, Div Acad Neurosurg, Dept Clin Neurosci, Cambridge, England.	ay276@cam.ac.uk	Donnelly, Joseph/E-9235-2018; Donnelly, Joseph/N-6803-2019	Donnelly, Joseph/0000-0002-6502-8069; Donnelly, Joseph/0000-0002-6502-8069	Medical Research-Council (MRC)UK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0600986 ID79068, G1002277 ID98489]; National Institute for Health Research Biomedical Research Centre (NIHR BRC) Cambridge; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0601025, G1002277] Funding Source: researchfish; National Institute for Health ResearchNational Institute for Health Research (NIHR) [12/35/57, ACF-2014-14-005, NIHR-RP-R3-12-013] Funding Source: researchfish	We gratefully acknowledge financial support as follows. Research support: the Medical Research-Council (MRC, Grant Nos. G0600986 ID79068 and G1002277 ID98489) and the National Institute for Health Research Biomedical Research Centre (NIHR BRC) Cambridge (Neuroscience Theme; Brain Injury and Repair Theme). Authors' support: P.J.H.-NIHR Research Professorship, Academy of Medical Sciences/Health Foundation Senior Surgical Scientist Fellowship and NIHR Cambridge BRC. J.D. is supported by a Woolf Fisher Scholarship. MC-NIHR BRC.	Balestreri M, 2006, NEUROCRIT CARE, V4, P8, DOI 10.1385/NCC:4:1:008; Bhardwaj G, 2010, OPHTHALMOLOGY, V117, P983, DOI 10.1016/j.ophtha.2009.09.040; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS7; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Czosnyka M, 2004, J NEUROL NEUROSUR PS, V75, P813, DOI 10.1136/jnnp.2003.033126; Dennis EL, 2015, J NEUROSCI, V35, P10202, DOI 10.1523/JNEUROSCI.1595-15.2015; Dubourg J, 2011, INTENS CARE MED, V37, P1059, DOI 10.1007/s00134-011-2224-2; Geeraerts T, 2008, INTENS CARE MED, V34, P2062, DOI 10.1007/s00134-008-1149-x; Geeraerts T, 2007, INTENS CARE MED, V33, P1704, DOI 10.1007/s00134-007-0797-6; Geeraerts T, 2008, CRIT CARE, V12, DOI 10.1186/cc7006; Hansen HC, 1997, J NEUROSURG, V87, P34, DOI 10.3171/jns.1997.87.1.0034; Harrison D, 2013, HEALTH TECHNOL ASSES, V17, P1, DOI 10.3310/hta17030; Harrison DA, 2013, HEALTH TECHNOL ASSES, V17, P1, DOI 10.3310/hta17230; Helmke K, 1996, PEDIATR RADIOL, V26, P701, DOI 10.1007/BF01383383; Hiler M, 2006, J NEUROSURG, V104, P731, DOI 10.3171/jns.2006.104.5.731; Juul N, 2000, J NEUROSURG, V92, P1, DOI 10.3171/jns.2000.92.1.0001; Kalantari H, 2013, AM J EMERG MED, V31, P1595, DOI 10.1016/j.ajem.2013.07.028; Kimberly HH, 2008, CRIT CARE, V12, DOI 10.1186/cc7008; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Launey Y, 2014, J NEUROTRAUM, V31, P984, DOI 10.1089/neu.2012.2829; Legrand A, 2013, CRIT CARE, V17, DOI 10.1186/cc12589; Miller MT, 2004, J TRAUMA, V56, P967, DOI 10.1097/01.TA.0000123699.16465.8B; Moretti R, 2011, ACTA ANAESTH SCAND, V55, P644, DOI 10.1111/j.1399-6576.2011.02432.x; Myburgh JA, 2008, J TRAUMA, V64, P854, DOI 10.1097/TA.0b013e3180340e77; Rajajee V, 2011, NEUROCRIT CARE, V15, P506, DOI 10.1007/s12028-011-9606-8; Sekhon MS, 2014, INTENS CARE MED, V40, P1267, DOI 10.1007/s00134-014-3392-7; Tayal VS, 2007, ANN EMERG MED, V49, P508, DOI 10.1016/j.annemergmed.2006.06.040; Tsung JW, 2005, PEDIATR EMERG CARE, V21, P94, DOI 10.1097/01.pec.0000159052.64930.64; Wang D, 2004, J TRAUMA, V56, P972; YOUDEN WJ, 1950, CANCER, V3, P32, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3	31	18	18	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0031-3998	1530-0447		PEDIATR RES	Pediatr. Res.	MAR	2017	81	3					443	447		10.1038/pr.2016.165			5	Pediatrics	Pediatrics	EN9BZ	WOS:000396297000014	27513519	Bronze			2021-06-18	
J	van Essen, TA; de Ruiter, GCW; Kho, KH; Peul, WC				van Essen, Thomas A.; de Ruiter, Godard C. W.; Kho, Kuan H.; Peul, Wilco C.			Neurosurgical Treatment Variation of Traumatic Brain Injury: Evaluation of Acute Subdural Hematoma Management in Belgium and The Netherlands	JOURNAL OF NEUROTRAUMA			English	Article						ASDH; TBI; treatment variation	QUALITY-OF-LIFE; DECOMPRESSIVE CRANIECTOMY; HEAD-INJURY; CLINICAL ARTICLE; CARE MANAGEMENT; CONSORTIUM; TRIALS; EPIDEMIOLOGY; NEUROTRAUMA; POPULATION	Several recent global traumatic brain injury (TBI) initiatives rely on practice variation in diagnostic and treatment methods to answer effectiveness questions. One of these scientific dilemmas, the surgical management of the traumatic acute subdural hematoma (ASDH) might be variable among countries, among centers within countries, and even among neurosurgeons within a center, and hence be amenable for a comparative effectiveness study. The aim of our questionnaire, therefore, was to explore variations in treatment for ASDH among neurosurgeons in similar centers in a densely populated geographical area. An online questionnaire, involving treatment decisions on six case vignettes of ASDH, was sent to 93 neurosurgeons in The Netherlands and Belgium. Clinical and radiological variables differed per case. Sixty neurosurgeons filled out the questionnaire (response rate 65%). For case vignettes with severe TBI and an ASDH, there was a modest variation in the decision to evacuate the hematoma and a large variation in the decision to combine the evacuation with a decompressive craniectomy. The main reasons for operating were "neurological condition'' and "mass effect.'' For ASDH and mild/moderate TBI, there was large variation in the decision of whether to operate or not, whereas "hematoma size'' was the predominant motivation for surgery. Significant inter-center variation for the decision to evacuate the hematoma was observed (p = 0.01). Most pronounced was that 1 out of 7 (14%) neurosurgeons in one region chose a surgical strategy compared with 9 out of 10 (90%) in another region for the same scenario. In conclusion, variation exists in the neurosurgical management of TBI within an otherwise homogeneous setting. This variation supports the methodology of the international Collaborative European NeuroTrauma Effectiveness Research in Traumatic Brain Injury (CENTER-TBI) initiative, and shaped the Dutch Neurotraumatology Quality Registry (Net-QuRe) initiative.	[van Essen, Thomas A.; Peul, Wilco C.] Leiden Univ, Med Ctr, Dept Neurosurg, Neurosurg Cooperat Holland, Leiden, Netherlands; [van Essen, Thomas A.; de Ruiter, Godard C. W.; Peul, Wilco C.] Med Ctr Haaglanden, Neurosurg Cooperat Holland, Dept Neurosurg, The Hague, Netherlands; [Kho, Kuan H.] Med Spectrum Twente, Dept Neurosurg, Enschede, Netherlands; [Kho, Kuan H.] Univ Hosp Leuven, Dept Neurosurg, Leuven, Belgium	van Essen, TA (corresponding author), Albinusdreef 2,J-11-R-83, NL-2333 ZA Leiden, Netherlands.	T.A.van_Essen@lumc.nl	de Ruiter, Godard/ABC-4074-2020; Kho, Kuan H/D-3263-2013	Kho, Kuan H/0000-0002-1834-0922	European UnionEuropean Commission [602150]; Hersenstichting Nederland (Dutch Brain Foundation) for Neurotraumatology Quality Registry (Net-QuRe)	The authors thank Dr. Johannes Van Loon and Prof. dr. Bart Depreitere (neurosurgeons, Department of Neurosurgery, University Hospitals Leuven, Leuven, Belgium) for their involvement in case selection, all Dutch and Belgian neurosurgeons who participated in filling out the questionnaire, and Dr. Carmen L. Vleggeert-Lankamp (neurosurgeon, Department of Neurosurgery, Leiden University Medical Center, Leiden, The Netherlands) for critical appraisal of the first draft of our manuscript. This work was supported by The European Union seventh Framework Program (grant 602150) for Collaborative European NeuroTrauma Effectiveness Research in Traumatic Brain Injury (CENTER-TBI) and Hersenstichting Nederland (Dutch Brain Foundation) for Neurotraumatology Quality Registry (Net-QuRe).	Bell RS, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.2.FOCUS1022; Brattheim BJ, 2012, EUR J VASC ENDOVASC, V44, P267, DOI 10.1016/j.ejvs.2012.04.029; Bulger EM, 2002, CRIT CARE MED, V30, P1870, DOI 10.1097/00003246-200208000-00033; Clifton GL, 2001, J NEUROSURG, V95, P751, DOI 10.3171/jns.2001.95.5.0751; Compagnone C, 2005, NEUROSURGERY, V57, P1183; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Cooper P R, 1976, Surg Neurol, V5, P25; DENT DL, 1995, J TRAUMA, V39, P36, DOI 10.1097/00005373-199507000-00005; GHAJAR J, 1995, CRIT CARE MED, V23, P560, DOI 10.1097/00003246-199503000-00023; Gregson BA, 2003, STROKE, V34, P2593, DOI 10.1161/01.STR.0000097491.82104.F3; Guerra WKW, 1999, J NEUROSURG, V90, P187, DOI 10.3171/jns.1999.90.2.0187; Honeybul S, 2013, J NEUROSURG, V119, P1566, DOI 10.3171/2013.8.JNS13857; Hukkelhoven CWPM, 2002, J NEUROSURG, V97, P549, DOI 10.3171/jns.2002.97.3.0549; JENNETT B, 1977, J NEUROL NEUROSUR PS, V40, P291, DOI 10.1136/jnnp.40.3.291; Kahneman D., 2011, THINKING FAST SLOW; Kelly ML, 2013, NEUROSURG FOCUS, V34, DOI 10.3171/2013.2.FOCUS1319; Kolias AG, 2012, ACTA NEUROCHIR, V154, P1563, DOI 10.1007/s00701-012-1349-6; Leitgeb J, 2012, J NEUROSURG, V117, P324, DOI 10.3171/2012.4.JNS111448; Li LM, 2012, ACTA NEUROCHIR, V154, P1555, DOI 10.1007/s00701-012-1428-8; Lingsma HF, 2011, NEUROSURGERY, V68, P601, DOI 10.1227/NEU.0b013e318209333b; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; Maas AIR, 2012, J NEUROTRAUM, V29, P32, DOI 10.1089/neu.2010.1599; Marion DW, 2006, NEUROSURGERY, V58, P655; MATHEW P, 1993, ACTA NEUROCHIR, V121, P100, DOI 10.1007/BF01809258; Mendelow A. D., 2015, J NEUROTRAUMA; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Nijboer JMM, 2010, INJURY, V41, P52, DOI 10.1016/j.injury.2009.05.030; Peul W. C., 2014, J NEUROTRAUM, V31, pA1; Rayan N, 2012, J TRAUMA ACUTE CARE, V72, P585, DOI 10.1097/TA.0b013e318243da4d; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Roozenbeek Bob, 2012, Clin Investig (Lond), V2, P153; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; Servadei F, 1998, J TRAUMA, V44, P868, DOI 10.1097/00005373-199805000-00021; Servadei F, 2007, CURR OPIN CRIT CARE, V13, P163, DOI 10.1097/MCC.0b013e32807f2a94; Stocchetti N, 2001, INTENS CARE MED, V27, P400, DOI 10.1007/s001340000825; Stocchetti N, 2012, J NEUROTRAUM, V29, P1119, DOI 10.1089/neu.2011.1995; Tallon JM, 2008, CAN J SURG, V51, P339; Timmons SD, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.6.FOCUS1296; Tosetti P, 2013, J NEUROTRAUM, V30, P1211, DOI 10.1089/neu.2013.2896; Ubel PA, 2005, HEALTH PSYCHOL, V24, pS57, DOI 10.1037/0278-6133.24.4.S57; von Steinbuechel N, 2005, ACTA NEUROCHIR SUPPL, V93, P43; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1167, DOI 10.1089/neu.2009.1076; Yang XF, 2008, ACTA NEUROCHIR, V150, P1241, DOI 10.1007/s00701-008-0145-9	44	18	18	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	FEB 15	2017	34	4					881	889		10.1089/neu.2016.4495			9	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	EL0XD	WOS:000394344200016	27393190				2021-06-18	
J	Weintraub, AH; Gerber, DJ; Kowalski, RG				Weintraub, Alan H.; Gerber, Donald J.; Kowalski, Robert G.			Posttraumatic Hydrocephalus as a Confounding Influence on Brain Injury Rehabilitation: Incidence, Clinical Characteristics, and Outcomes	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injuries; Cerebrospinal fluid; Hydrocephalus; Intracranial pressure; Rehabilitation; Ventriculoperitoneal shunt	NORMAL-PRESSURE HYDROCEPHALUS; SEVERE HEAD-INJURY; DECOMPRESSIVE CRANIECTOMY; RISK-FACTORS; SHUNT IMPLANTATION; CSF DYNAMICS; CONSCIOUSNESS; DISORDERS; COMPLICATIONS; COMORBIDITIES	Objective: To describe incidence, clinical characteristics, complications, and outcomes in posttraumatic hydrocephalus (PTH) after traumatic brain injury (TBI) for patients treated in an inpatient rehabilitation program. Design: Cohort study with retrospective comparative analysis. Setting: Inpatient rehabilitation hospital. Participants: All patients admitted for TBI from 2009 to 2013 diagnosed with PTH (N=59), defined as ventriculomegaly, delayed clinical recovery discordant with injury severity, hydrocephalus symptoms, or positive lumbar puncture results. Interventions: None. Main Outcome Measures: Primary measures were incidence of PTH and patient and injury characteristics. Secondary measures included frequency and timing of ventriculoperitoneal (VP) shunt, related complications, emergence from and duration of posttraumatic amnesia (PTA), Rancho Los Amigos Scale (RLAS) score, and FIM score at rehabilitation admission and discharge. Results: Of 701 patients with TBI admitted, 59 (8%) were diagnosed with PTH. Of these, the median age was 25 years, with 73% being men. At initial presentation, 52 (88%) did not follow commands. Fifty-two (90%) patients with PTH had a VP shunt placed. Median time from injury to shunt placement was 69 (range, 9-366) days. Seven (12%) patients with PTH experienced postsurgical seizure, 3 (6%) had shunt infection, and 7 (12%) had shunt malfunction. Thirty-six (61%) patients with PTH emerged from PTA during rehabilitation. Median total FIM score at rehabilitation admission was 20 (range, 18-76), and at discharge it was 43 (range, 18-118). Injury severity predicted outcome at rehabilitation admission, whereas shunt timing predicted outcome at rehabilitation discharge. Conclusions: Incidence of PTH was observed in 8% of patients with TBI in inpatient rehabilitation. Earlier shunting predicted improved outcome during rehabilitation. Future studies should prospectively examine clinical decision rules, type, and timing of intervention and the coeffectiveness of rehabilitation treatment on outcomes. (C) 2016 by the American Congress of Rehabilitation Medicine	[Weintraub, Alan H.] CNS Med Grp, Englewood, CO USA; [Weintraub, Alan H.; Gerber, Donald J.; Kowalski, Robert G.] Craig Hosp, Res Dept, Englewood, CO USA	Weintraub, AH (corresponding author), Craig Hosp, 3425 S Clarkson St, Englewood, CO 80113 USA.	AWeintraub@CraigHospital.org			Craig Hospital Foundation	Supported by the Craig Hospital Foundation.	[Anonymous], 2011, Continuum (Minneap Minn), V17, P646, DOI 10.1212/01.CON.0000399079.30556.03; Bauer DF, 2011, NEUROSURGERY, V68, P85, DOI 10.1227/NEU.0b013e3181fd85f4; Chen Z, 2014, J REHABIL MED, V46, P876, DOI 10.2340/16501977-1856; De Bonis P, 2013, CLIN NEUROL NEUROSUR, V115, P1308, DOI 10.1016/j.clineuro.2012.12.011; De Bonis P, 2013, CLIN NEUROL NEUROSUR, V115, P49, DOI 10.1016/j.clineuro.2012.04.012; De Bonis P, 2010, J NEUROTRAUM, V27, P1965, DOI 10.1089/neu.2010.1425; Denes Z, 2010, IDEGGYOGY SZEMLE, V63, P397; Ding J, 2014, ARQ NEURO-PSIQUIAT, V72, P715, DOI 10.1590/0004-282X20140106; Exposito-Tirado JA, 2003, REV NEUROLOGIA, V36, P1126, DOI 10.33588/rn.3612.2002371; Ganesh S, 2013, ARCH PHYS MED REHAB, V94, P1899, DOI 10.1016/j.apmr.2012.12.026; Giacino JT, 2012, NEW ENGL J MED, V366, P819, DOI 10.1056/NEJMoa1102609; Guyot LL, 2000, NEUROL RES, V22, P25; Hakim S, 1965, J Neurol Sci, V2, P307, DOI 10.1016/0022-510X(65)90016-X; Honeybul S, 2014, INJURY, V45, P1332, DOI 10.1016/j.injury.2014.03.007; Honeybul S, 2012, J NEUROTRAUM, V29, P1872, DOI 10.1089/neu.2012.2356; Ishikawa M, 2010, NEUROL MED-CHIR, V50, P119, DOI 10.2176/nmc.50.119; Jackson WT, 1998, ARCH PHYS MED REHAB, V79, P718, DOI 10.1016/S0003-9993(98)90051-X; Kammersgaard LP, 2013, NEUROREHABILITATION, V33, P473, DOI 10.3233/NRE-130980; Kan P, 2006, J NEUROSURG, V105, P337, DOI 10.3171/ped.2006.105.5.337; Ki HJ, 2015, J KOREAN NEUROSURG S, V58, P254, DOI 10.3340/jkns.2015.58.3.254; Kiefer M, 2012, DTSCH ARZTEBL INT, V109, P15, DOI 10.3238/arztebl.2012.0015; Lesniak MS, 2002, BRIT J NEUROSURG, V16, P555; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Linnemann M, 2014, NEUROREHABILITATION, V35, P755, DOI 10.3233/NRE-141160; Long D., 2013, DIAGNOSIS MANAGEMENT; Marmarou A, 1996, J NEUROSURG, V85, P1026, DOI 10.3171/jns.1996.85.6.1026; Mazzini L, 2003, ARCH PHYS MED REHAB, V84, P1637, DOI 10.1053/S0003-9993(03)00314-9; Missori P, 2006, NEUROSURG REV, V29, P224, DOI 10.1007/s10143-006-0027-7; Muramatsu H, 2002, AM J PHYS MED REHAB, V81, P571, DOI 10.1097/00002060-200208000-00003; Osuka S, 2010, J NEUROSURG, V112, P832, DOI 10.3171/2009.7.JNS09550; Ottenbacher KJ, 1996, ARCH PHYS MED REHAB, V77, P1226, DOI 10.1016/S0003-9993(96)90184-7; Piatt JH, 1996, NEUROSURGERY, V39, P722, DOI 10.1097/00006123-199610000-00014; Poca MA, 2005, J NEUROTRAUM, V22, P1303, DOI 10.1089/neu.2005.22.1303; Rekate HL, 2009, SEMIN PEDIATR NEUROL, V16, P9, DOI 10.1016/j.spen.2009.01.002; Seel RT, 2013, ARCH PHYS MED REHAB, V94, P1908, DOI 10.1016/j.apmr.2012.11.052; Seel RT, 2010, ARCH PHYS MED REHAB, V91, P1795, DOI 10.1016/j.apmr.2010.07.218; SELIGER G M, 1992, Brain Injury, V6, P71, DOI 10.3109/02699059209008125; SHEFFLER LR, 1994, ARCH PHYS MED REHAB, V75, P338, DOI 10.1016/0003-9993(94)90039-6; Silver B V, 1997, Pediatr Rehabil, V1, P123; Takeuchi S, 2013, J CLIN NEUROSCI, V20, P377, DOI 10.1016/j.jocn.2012.03.035; Tian HL, 2008, SURG NEUROL, V69, P241, DOI 10.1016/j.surneu.2007.02.032; Torbic H, 2013, AM J HEALTH-SYST PH, V70, P759, DOI 10.2146/ajhp120203; Tribl G, 2000, BRAIN INJURY, V14, P345; VANNESTE J, 1992, ARCH NEUROL-CHICAGO, V49, P366, DOI 10.1001/archneur.1992.00530280046021; Wen L, 2009, BRAIN INJURY, V23, P61, DOI 10.1080/02699050802635265; Whyte J, 2013, ARCH PHYS MED REHAB, V94, P1851, DOI 10.1016/j.apmr.2013.07.003; Whyte J, 2013, ARCH PHYS MED REHAB, V94, P1877, DOI 10.1016/j.apmr.2012.12.027; Whyte J, 2013, ARCH PHYS MED REHAB, V94, P1855, DOI 10.1016/j.apmr.2012.10.041	48	18	19	0	8	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	FEB	2017	98	2					312	319		10.1016/j.apmr.2016.08.478			8	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	EK4XB	WOS:000393930100015	27670926				2021-06-18	
J	van der Horn, HJ; Liemburg, EJ; Scheenen, ME; de Koning, ME; Spikman, JM; van der Naalt, J				van der Horn, Harm J.; Liemburg, Edith J.; Scheenen, Myrthe E.; de Koning, Myrthe E.; Spikman, Jacoba M.; van der Naalt, Joukje			Graph Analysis of Functional Brain Networks in Patients with Mild Traumatic Brain Injury	PLOS ONE			English	Article							POSTERIOR CINGULATE CORTEX; STRUCTURAL CONNECTIVITY; POSTTRAUMATIC-STRESS; EMOTION REGULATION; MRI; SYMPTOMS; ABNORMALITIES; DYSFUNCTION; CONCUSSION; COMPLAINTS	Mild traumatic brain injury (mTBI) is one of the most common neurological disorders worldwide. Posttraumatic complaints are frequently reported, interfering with outcome. However, a consistent neural substrate has not yet been found. We used graph analysis to further unravel the complex interactions between functional brain networks, complaints, anxiety and depression in the sub-acute stage after mTBI. This study included 54 patients with uncomplicated mTBI and 20 matched healthy controls. Posttraumatic complaints, anxiety and depression were measured at two weeks post-injury. Patients were selected based on presence (n = 34) or absence (n = 20) of complaints. Resting-state fMRI scans were made approximately four weeks post-injury. High order independent component analysis resulted in 89 neural components that were included in subsequent graph analyses. No differences in graph measures were found between patients with mTBI and healthy controls. Regarding the two patient subgroups, degree, strength, local efficiency and eigenvector centrality of the bilateral posterior cingulate/precuneus and bilateral parahippocampal gyrus were higher, and eigenvector centrality of the frontal pole/bilateral middle & superior frontal gyrus was lower in patients with complaints compared to patients without complaints. In patients with mTBI, higher degree, strength and eigenvector centrality of default mode network components were related to higher depression scores, and higher degree and eigenvector centrality of executive network components were related to lower depression scores. In patients without complaints, one extra module was found compared to patients with complaints and healthy controls, consisting of the cingulate areas. In conclusion, this research extends the knowledge of functional network connectivity after mTBI. Specifically, our results suggest that an imbalance in the function of the default mode-and executive network plays a central role in the interaction between emotion regulation and the persistence of posttraumatic complaints.	[van der Horn, Harm J.; de Koning, Myrthe E.; van der Naalt, Joukje] Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Groningen, Netherlands; [Liemburg, Edith J.] Univ Groningen, Univ Med Ctr Groningen, BCN NeuroImaging Ctr, Groningen, Netherlands; [Liemburg, Edith J.] Univ Groningen, Univ Med Ctr Groningen, Dept Neurosci, Groningen, Netherlands; [Scheenen, Myrthe E.; Spikman, Jacoba M.] Univ Groningen, Univ Med Ctr Groningen, Dept Neuropsychol, Groningen, Netherlands	van der Horn, HJ (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Groningen, Netherlands.	h.j.van.der.horn@umcg.nl		Spikman, Jacoba/0000-0002-6477-0763	Dutch Brain Foundation [Ps2012-06]	This work was supported by Dutch Brain Foundation, grant no. Ps2012-06. J.v.d.N. received the funding. The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou Elseoud A, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00037; Allen EA, 2014, CEREB CORTEX, V24, P663, DOI 10.1093/cercor/bhs352; Allen EA, 2012, NEUROIMAGE, V59, P4141, DOI 10.1016/j.neuroimage.2011.10.010; Barbey AK, 2015, CURR OPIN BEHAV SCI, V4, P92, DOI 10.1016/j.cobeha.2015.04.002; Bazarian JJ, 2006, ACAD EMERG MED, V13, P199, DOI 10.1197/j.aem.2005.07.031; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Broshek DK, 2015, BRAIN INJURY, V29, P228, DOI 10.3109/02699052.2014.974674; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Calhoun VD, 2001, HUM BRAIN MAPP, V14, P140, DOI 10.1002/hbm.1048; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS132, DOI 10.1016/j.apmr.2013.08.299; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Cole MW, 2014, NEUROSCIENTIST, V20, P652, DOI 10.1177/1073858414525995; de Koning ME, 2016, INJURY, V47, P2041, DOI 10.1016/j.injury.2016.04.036; Dischinger PC, 2009, J TRAUMA, V66, P289, DOI 10.1097/TA.0b013e3181961da2; Ettenhofer ML, 2012, J INT NEUROPSYCH SOC, V18, P451, DOI 10.1017/S1355617711001895; Fagerholm ED, 2015, BRAIN, V138, P1696, DOI 10.1093/brain/awv075; Fallani FD, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0521; Filippi M, 2013, LANCET NEUROL, V12, P1189, DOI 10.1016/S1474-4422(13)70144-3; Frank DW, 2014, NEUROSCI BIOBEHAV R, V45, P202, DOI 10.1016/j.neubiorev.2014.06.010; Geerligs L, 2015, CEREB CORTEX, V25, P1987, DOI 10.1093/cercor/bhu012; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Hillary FG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104021; Himberg J, 2004, NEUROIMAGE, V22, P1214, DOI 10.1016/j.neuroimage.2004.03.027; Hughes DG, 2004, NEURORADIOLOGY, V46, P550, DOI 10.1007/s00234-004-1227-x; Iverson GL, 2000, BRAIN INJURY, V14, P1057; Kiviniemi V, 2009, HUM BRAIN MAPP, V30, P3865, DOI 10.1002/hbm.20813; Lagarde E, 2014, JAMA PSYCHIAT, V71, P1032, DOI 10.1001/jamapsychiatry.2014.666; Leech R, 2014, BRAIN, V137, P12, DOI 10.1093/brain/awt162; Leech R, 2011, J NEUROSCI, V31, P3217, DOI 10.1523/JNEUROSCI.5626-10.2011; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Matuseviciene G, 2015, J REHABIL MED; Matuseviciene G, 2013, BRAIN INJURY, V27, P318, DOI 10.3109/02699052.2012.750740; Mayer AR, 2015, NEUROSCI BIOBEHAV R, V49, P8, DOI 10.1016/j.neubiorev.2014.11.016; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; McAllister Thomas W, 2011, Dialogues Clin Neurosci, V13, P287; MCGRAW KO, 1992, PSYCHOL BULL, V111, P361, DOI 10.1037/0033-2909.111.2.361; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; Messe A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065470; Mulders PC, 2015, NEUROSCI BIOBEHAV R, V56, P330, DOI 10.1016/j.neubiorev.2015.07.014; Nelson LD, 2016, NEUROLOGY, V86, P1856, DOI 10.1212/WNL.0000000000002679; Pandit AS, 2013, NEUROLOGY, V80, P1826, DOI 10.1212/WNL.0b013e3182929f38; Ponsford J, 2011, J NEUROTRAUM, V28, P937, DOI 10.1089/neu.2010.1516; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Power JD, 2011, NEURON, V72, P665, DOI 10.1016/j.neuron.2011.09.006; Quoidbach J, 2015, PSYCHOL BULL, V141, P655, DOI 10.1037/a0038648; Rigon A, 2015, J NEUROTRAUM, V1, P1; Rohling ML, 2011, CLIN NEUROPSYCHOL, V25, P608, DOI 10.1080/13854046.2011.565076; Rubinov M, 2011, NEUROIMAGE, V56, P2068, DOI 10.1016/j.neuroimage.2011.03.069; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Servaas MN, 2015, NEUROPSYCHOPHARMACOL, V40, P296, DOI 10.1038/npp.2014.169; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Sheline YI, 2010, P NATL ACAD SCI USA, V107, P11020, DOI 10.1073/pnas.1000446107; Sheppes G, 2015, ANNU REV CLIN PSYCHO, V11, P379, DOI 10.1146/annurev-clinpsy-032814-112739; Sours C, 2013, BRAIN RES, V1537, P201, DOI 10.1016/j.brainres.2013.08.034; Spielberg JM, 2015, BIOL PSYCHIAT, V78, P210, DOI 10.1016/j.biopsych.2015.02.013; Sporns Olaf, 2013, Dialogues Clin Neurosci, V15, P247; Stam CJ, 2014, NAT REV NEUROSCI, V15, P683, DOI 10.1038/nrn3801; Stanley ML, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00169; Stevens MC, 2012, BRAIN IMAGING BEHAV, V6, P293, DOI 10.1007/s11682-012-9157-4; Strehl A., 2003, Journal of Machine Learning Research, V3, P583, DOI 10.1162/153244303321897735; Sun Y, 2009, EPL-EUROPHYS LETT, V86, DOI 10.1209/0295-5075/86/28004; Utevsky AV, 2014, J NEUROSCI, V34, P932, DOI 10.1523/JNEUROSCI.4227-13.2014; van den Heuvel MP, 2013, TRENDS COGN SCI, V17, P683, DOI 10.1016/j.tics.2013.09.012; van der Horn HJ, 2016, HUM BRAIN MAPP, V37, P1645, DOI 10.1002/hbm.23126; van der Horn HJ, 2016, J NEUROTRAUM, V33, P1, DOI 10.1089/neu.2015.3905; Van Dijk KRA, 2010, J NEUROPHYSIOL, V103, P297, DOI 10.1152/jn.00783.2009; Vos PE, 2002, EUR J NEUROL, V9, P207, DOI 10.1046/j.1468-1331.2002.00407.x; Waljas M, 2015, J NEUROTRAUM, V32, P534, DOI 10.1089/neu.2014.3339; Ward AM, 2014, HUM BRAIN MAPP, V35, P1061, DOI 10.1002/hbm.22234; Whitfield-Gabrieli S, 2012, ANNU REV CLIN PSYCHO, V8, P49, DOI 10.1146/annurev-clinpsy-032511-143049; Yuan WH, 2015, HUM BRAIN MAPP, V36, P779, DOI 10.1002/hbm.22664; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783; Zhou YX, 2012, RADIOLOGY, V265, P882, DOI 10.1148/radiol.12120748; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	80	18	18	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2017	12	1							e0171031	10.1371/journal.pone.0171031			19	Multidisciplinary Sciences	Science & Technology - Other Topics	EN7VX	WOS:000396211400011	28129397	DOAJ Gold, Green Published			2021-06-18	
J	Rubovitch, V; Zilberstein, Y; Chapman, J; Schreiber, S; Pick, CG				Rubovitch, Vardit; Zilberstein, Yael; Chapman, Joab; Schreiber, Shaul; Pick, Chaim G.			Restoring GM1 ganglioside expression ameliorates axonal outgrowth inhibition and cognitive impairments induced by blast traumatic brain injury	SCIENTIFIC REPORTS			English	Article							MYELIN-ASSOCIATED GLYCOPROTEIN; CENTRAL-NERVOUS-SYSTEM; NOGO-A; NEURITE OUTGROWTH; MOUSE MODEL; REGENERATION; PLASTICITY; GROWTH; MEMORY; MILD	Blast induced traumatic brain injury (B-TBI) may cause various degrees of cognitive and behavioral disturbances but the exact brain pathophysiology involved is poorly understood. It was previously suggested that ganglioside alteration on the axon surface as well as axonal regenerating inhibitors (ARIs) such as myelin associated glycoprotein (MAG) were involved in axonal outgrowth inhibition (AOI), leading to brain damage. GM1 ganglioside content in the brain was significantly reduced while GD1 ganglioside was not affected. The axonal regeneration was also reduced as seen by the phosphorylated NF-H expression. Moreover, B-TBI induced a significant elevation in MAG expression in the brains of the injured mice. The blast injured mice exhibited a significant decline in spatial memory as seen by the Y-maze test. In addition, the injured mice showed pronounced damage to the visual memory (as evaluated by the Novel object recognition test). A single low dose of GM1 (2 mg/kg; IP), shortly after the injury, prevented both the cognitive and the cellular changes in the brains of the injured mice. These results enlighten part of the complicated mechanism that underlies the damage induced by B-TBI and may also suggest a potential new treatment strategy for brain injuries.	[Rubovitch, Vardit; Pick, Chaim G.] Tel Aviv Univ, Sackler Fac Med, Dept Anat & Anthropol, IL-69978 Tel Aviv, Israel; [Zilberstein, Yael] Tel Aviv Univ, Sackler Fac Med, Sackler Cellular & Mol Imaging Ctr, IL-69978 Tel Aviv, Israel; [Chapman, Joab] Chaim Sheba Med Ctr, J Sagol Neurosci Ctr, Dept Neurol, Ramat Gan, Israel; [Chapman, Joab] Tel Aviv Univ, Sackler Sch Med, Dept Neurol, Tel Aviv, Israel; [Chapman, Joab; Schreiber, Shaul; Pick, Chaim G.] Tel Aviv Univ, Sagol Sch Neurosci, Tel Aviv, Israel; [Schreiber, Shaul] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Dept Psychiat, IL-64239 Tel Aviv, Israel; [Schreiber, Shaul] Tel Aviv Univ, Sackler Fac Med, IL-64239 Tel Aviv, Israel; [Schreiber, Shaul] Tel Aviv Univ, Sackler Sch Med, Dept Psychiat, Tel Aviv, Israel	Rubovitch, V (corresponding author), Tel Aviv Univ, Sackler Fac Med, Dept Anat & Anthropol, IL-69978 Tel Aviv, Israel.	rubovitc@post.tau.ac.il	Schreiber, Shaul/E-5821-2010	Schreiber, Shaul/0000-0002-2189-0693			Aggarwal S, 2011, TRENDS CELL BIOL, V21, P585, DOI 10.1016/j.tcb.2011.06.004; Baumann N, 2001, PHYSIOL REV, V81, P871; Bradke F, 2012, NAT REV NEUROSCI, V13, P183, DOI 10.1038/nrn3176; Buss A, 2005, ACTA NEUROPATHOL, V110, P113, DOI 10.1007/s00401-004-0942-z; Chen MS, 2000, NATURE, V403, P434, DOI 10.1038/35000219; Conrad CD, 1996, BEHAV NEUROSCI, V110, P1321, DOI 10.1037/0735-7044.110.6.1321; DELLU F, 1992, BRAIN RES, V588, P132, DOI 10.1016/0006-8993(92)91352-F; Dix SL, 1999, BEHAV BRAIN RES, V99, P191, DOI 10.1016/S0166-4328(98)00079-5; Eskridge SL, 2012, INJURY, V43, P1678, DOI 10.1016/j.injury.2012.05.027; Galiano MR, 2012, CELL, V149, P1125, DOI 10.1016/j.cell.2012.03.039; Gao L, 2015, FRONT BIOSCI-LANDMRK, V20, P763, DOI 10.2741/4335; Gotow Takahiro, 2000, Medical Electron Microscopy, V33, P173, DOI 10.1007/s007950000019; Guzik-Kornacka A, 2016, BRAIN STRUCT FUNCT, V221, P317, DOI 10.1007/s00429-014-0909-3; Huber AB, 2000, BIOL CHEM, V381, P407, DOI 10.1515/BC.2000.053; Kusumi A, 2012, MOL BIOL CELL, V23, P3925, DOI 10.1091/mbc.E12-02-0159; Lee S, 2014, BIOL OPEN, V3, P974, DOI 10.1242/bio.20149779; Li L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0144219; McAllister Thomas W, 2011, Dialogues Clin Neurosci, V13, P287; MCKERRACHER L, 1994, NEURON, V13, P805, DOI 10.1016/0896-6273(94)90247-X; McKerracher L, 2015, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00051; Messier C, 1997, NEUROBIOL LEARN MEM, V67, P172, DOI 10.1006/nlme.1996.3755; Mishra V, 2016, SCI REP-UK, V6, DOI 10.1038/srep26992; Mori K, 2012, J PHYS CHEM B, V116, P5111, DOI 10.1021/jp207881k; MUKHOPADHYAY G, 1994, NEURON, V13, P757, DOI 10.1016/0896-6273(94)90042-6; Noel A, 2015, EXP NEUROL, V271, P308, DOI 10.1016/j.expneurol.2015.06.021; O'Neil ME, 2014, J INT NEUROPSYCH SOC, V20, P249, DOI [10.1017/S1355617714000204, 10.1017/S135561771300146X]; Pernet V, 2012, CELL DEATH DIFFER, V19, P1096, DOI 10.1038/cdd.2011.191; Petrasek T, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00090; Rubovitch V, 2011, EXP NEUROL, V232, P280, DOI 10.1016/j.expneurol.2011.09.018; Schnaar R L, 2003, Prog Mol Subcell Biol, V32, P125; Schnaar RL, 2016, J MOL BIOL, V428, P3325, DOI 10.1016/j.jmb.2016.05.020; Schnaar RL, 2010, FEBS LETT, V584, P1741, DOI 10.1016/j.febslet.2009.10.011; SCHNEIDER JS, 1989, EXP NEUROL, V105, P177, DOI 10.1016/0014-4886(89)90117-9; Schreiber Shaul, 2007, Am J Disaster Med, V2, P307; Schwab JM, 2005, LANCET, V365, P2055, DOI 10.1016/S0140-6736(05)66699-8; Schwab ME, 2014, CURR OPIN NEUROBIOL, V27, P53, DOI 10.1016/j.conb.2014.02.011; Shively SB, 2012, J HEAD TRAUMA REHAB, V27, P234, DOI 10.1097/HTR.0b013e318250e9dd; Tweedie D, 2016, ALZHEIMERS DEMENT, V12, P34, DOI 10.1016/j.jalz.2015.07.489; Vinson M, 2001, J BIOL CHEM, V276, P20280, DOI 10.1074/jbc.M100345200; Vyas AA, 2005, J BIOL CHEM, V280, P16305, DOI 10.1074/jbc.M500250200; Vyas AA, 2002, P NATL ACAD SCI USA, V99, P8412, DOI 10.1073/pnas.072211699; Yuan AD, 2012, J CELL SCI, V125, P3257, DOI 10.1242/jcs.104729; Zemmar A, 2014, J NEUROSCI, V34, P8685, DOI 10.1523/JNEUROSCI.3817-13.2014	43	18	19	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	JAN 23	2017	7								41269	10.1038/srep41269			12	Multidisciplinary Sciences	Science & Technology - Other Topics	EI6VX	WOS:000392636500001	28112258	DOAJ Gold, Green Published			2021-06-18	
J	Capo-Aponte, JE; Jorgensen-Wagers, KL; Sosa, JA; Walsh, DV; Goodrich, GL; Temme, LA; Riggs, DW				Capo-Aponte, Jose E.; Jorgensen-Wagers, Kendra L.; Sosa, Josue A.; Walsh, David V.; Goodrich, Gregory L.; Temme, Leonard A.; Riggs, Daniel W.			Visual Dysfunctions at Different Stages after Blast and Non-blast Mild Traumatic Brain Injury	OPTOMETRY AND VISION SCIENCE			English	Article						visual dysfunction; mild traumatic brain injury; mTBI; military; blast	POSTCONCUSSIVE SYMPTOMS; SUBACUTE STAGE; MODERATE; PROGRESSION; POPULATION; IMPAIRMENT; MECHANISMS; MILITARY; VETERANS; PROTOCOL	Purpose. To assess the prevalence of visual dysfunctions and associated symptoms in war fighters at different stages after nonYblast- or blast-induced mild traumatic brain injury (mTBI). Methods. A comprehensive retrospective review of the electronic health records of 500 U.S. military personnel with a diagnosis of deployment-related mTBI who received eye care at the Landstuhl Regional Medical Center. For analysis, the data were grouped by mechanism of injury, and each group was further divided in three subgroups based on the number of days between injury and initial eye examination. Results. The data showed a high frequency of visual symptoms and visual dysfunctions. However, the prevalence of visual symptoms and visual dysfunctions did not differ significantly between mechanism of injury and postinjury stage, except for eye pain and diplopia. Among visual symptoms, binocular dysfunctions were more common, including higher near vertical phoria, reduced negative fusional vergence break at near, receded near point of convergence, decreased stereoacuity, and reduced positive relative accommodation. Conclusions. The lack of difference in terms of visual sequelae between subgroups (blast vs. nonblast) suggests that research addressing the assessment and management of mTBI visual sequelae resulting from civilian nonblast events is relevant to military personnel where combat injury results primarily from a blast event.	[Capo-Aponte, Jose E.; Sosa, Josue A.; Walsh, David V.; Temme, Leonard A.; Riggs, Daniel W.] US Army, Visual Sci Branch, Sensory Res Div, Aeromed Res Lab, Ft Rucker, AL USA; [Capo-Aponte, Jose E.] Womack Army Med Ctr, Dept Optometry, 2817 Reilly Rd Stop A, Ft Bragg, NC 28310 USA; [Jorgensen-Wagers, Kendra L.] Landstuhl Reg Med Ctr, Traumat Brain Injury Clin, APO, Landstuhl, Germany; [Goodrich, Gregory L.] Veteran Affairs Palo Alto Hlth Care Syst, Psychol Serv, Menlo Pk, CA USA; [Goodrich, Gregory L.] Veteran Affairs Palo Alto Hlth Care Syst, Western Blind Rehabil Ctr, Menlo Pk, CA USA	Capo-Aponte, JE (corresponding author), Womack Army Med Ctr, Dept Optometry, 2817 Reilly Rd Stop A, Ft Bragg, NC 28310 USA.	jose.e.capoaponte.mil@mail.mil	Goodrich, Gregory L./AAF-7184-2019	Riggs, Daniel/0000-0002-3503-0600	Postgraduate Research Participation Program at the U.S. Army Aeromedical Research Laboratory; U.S. Department of EnergyUnited States Department of Energy (DOE); U.S. Army Medical Research and Materiel CommandU.S. Army Medical Research & Materiel Command (USAMRMC)	Sponsored in part by the appointment to the Postgraduate Research Participation Program at the U.S. Army Aeromedical Research Laboratory administered by the Oak Ridge Institute of Science and Education through an interagency agreement, the U.S. Department of Energy and the U.S. Army Medical Research and Materiel Command.	Belanger HG, 2009, J INT NEUROPSYCH SOC, V15, P1, DOI 10.1017/S1355617708090036; Brahm KD, 2009, OPTOMETRY VISION SCI, V86, P817, DOI 10.1097/OPX.0b013e3181adff2d; Capo-Aponte JE, 2012, J REHABIL RES DEV, V49, P1377, DOI 10.1682/JRRD.2011.07.0128; Capo-Aponte JE, 2012, MIL MED, V177, P804, DOI 10.7205/MILMED-D-12-00061; Carlson NB, 2004, CLIN PROCEDURES OCUL; Ciuffreda Kenneth J, 2007, Optometry, V78, P155, DOI 10.1016/j.optm.2006.11.011; Ciuffreda KJ, 2011, OPTOMETRY, V82, P61, DOI 10.1016/j.optm.2010.11.011; Ciuffreda KJ, 2007, JBO, V18, P72; Ciuffreda KJ, 2001, VISUAL VESTIBULAR CO, P77; Cockerham GC, 2013, OCUL SURF, V11, P25, DOI 10.1016/j.jtos.2012.09.004; Doble JE, 2010, PM&R, V2, P244, DOI 10.1016/j.pmrj.2010.01.011; Dougherty AL, 2011, BRAIN INJURY, V25, P8, DOI 10.3109/02699052.2010.536195; Goodrich GL, 2007, J REHABIL RES DEV, V44, P929, DOI 10.1682/JRRD.2007.01.0003; Goodrich GL, 2013, J REHABIL RES DEV, V50, P757, DOI 10.1682/JRRD.2012.10.0184; Goodrich GL, 2013, OPTOMETRY VISION SCI, V90, P105, DOI 10.1097/OPX.0b013e31827f15a1; Goss DA, 1991, CLIN PROCEDURES OPTO, P716; Greenberg G, 2008, ARCH PHYS MED REHAB, V89, pS45, DOI 10.1016/j.apmr.2008.08.211; Halbauer JD, 2009, J REHABIL RES DEV, V46, P757, DOI 10.1682/JRRD.2008.08.0119; Hellerstein L F, 1995, J Am Optom Assoc, V66, P634; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Lippa SM, 2010, J INT NEUROPSYCH SOC, V16, P856, DOI 10.1017/S1355617710000743; Lipton ML, 2009, RADIOLOGY, V252, P816, DOI 10.1148/radiol.2523081584; Luethcke CA, 2011, J INT NEUROPSYCH SOC, V17, P36, DOI 10.1017/S1355617710001207; Magone MT, 2014, J REHABIL RES DEV, V51, P71, DOI 10.1682/JRRD.2013.01.0008; Maples W C, 1988, J Am Optom Assoc, V59, P549; Matheron E, 2007, NEUROSCI LETT, V423, P236, DOI 10.1016/j.neulet.2007.07.016; Messe A, 2011, HUM BRAIN MAPP, V32, P999, DOI 10.1002/hbm.21092; Miles L, 2008, BRAIN INJURY, V22, P115, DOI 10.1080/02699050801888816; Ng K, 2008, ARCH PHYS MED REHAB, V89, pS35, DOI 10.1016/j.apmr.2008.07.006; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; RUTHERFORD WH, 1979, INJURY, V10, P225, DOI 10.1016/0020-1383(79)90015-9; Stapert S, 2006, BRAIN INJURY, V20, P161, DOI 10.1080/02699050500442949; Stelmack JA, 2009, OPTOMETRY, V80, P419, DOI 10.1016/j.optm.2009.02.011; Sutter P., 1995, TRAUMATIC BRAIN INJU, P187; U. S. Department of Defense (DoD), DEP DEF NUMB TRAUM B; U. S. Department of Defense (DoD), 2015, DEP DEF NUMB TRAUM B	36	18	18	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1040-5488	1538-9235		OPTOMETRY VISION SCI	Optom. Vis. Sci.	JAN	2017	94	1					7	15		10.1097/OPX.0000000000000825			9	Ophthalmology	Ophthalmology	EM5ZZ	WOS:000395393900003	26889821				2021-06-18	
J	Chandran, R; Sharma, A; Bhomia, M; Balakathiresan, NS; Knollmann-Ritschel, BE; Maheshwari, RK				Chandran, Raghavendar; Sharma, Anuj; Bhomia, Manish; Balakathiresan, Nagaraja S.; Knollmann-Ritschel, Barbara E.; Maheshwari, Radha K.			Differential expression of microRNAs in the brains of mice subjected to increasing grade of mild traumatic brain injury	BRAIN INJURY			English	Article						Mild traumatic brain injury; brain; microRNA (miRNA); weight-drop injury; closed head injury	NEURONAL CELL-DEATH; COGNITIVE DEFICITS; GENE-EXPRESSION; HIPPOCAMPUS; PATHWAYS; MODEL; FEAR; ACTIVATION; DIAGNOSIS; MEDIATORS	Objective: To investigate the effect of heterogeneity in mTBI on miRNA expression in mouse brain and to identify molecular pathways targeted' by the modulated miRNAs. Methods: A weight drop device was used to induce four, increasing grades of mTBI. MiRNA expression was evaluated using TaqMan rodent miRNA arrays. Bioinformatics analysis was done using the DIANA miRPath tool and Ingenuity Pathway Analysis software. Histology of brain sections was evaluated using H&E staining. Results: No histologic lesions were observed in the brains of injured mice; however, significant modulation in miRNA expression profile was observed. Global miRNA profiling, indicated a trend Of decrease in the number of modulated' miRNAs from 24 hours to day 7 post-injury, except for the most severe grade of mTBI. Canonical pathways like calcium signalling, synaptic pathways and axon guidance pathway were the major targets of the modulated miRNAs. Network correlation analyses indicated an interaction between the modulated miRNAs and putative protein biomarkers of TBI. Conclusions: The data demonstrated that varying intensities of mTBI induced a differential miRNA expression profile in the brain post-injury. Pathways such as calcium and synaptic signalling, were major targets of modulated miRNAs and may play a role in the pathophysiology of mTBI.	[Chandran, Raghavendar; Sharma, Anuj; Bhomia, Manish; Balakathiresan, Nagaraja S.; Knollmann-Ritschel, Barbara E.; Maheshwari, Radha K.] Uniformed Serv Univ Hlth Sci, Dept Pathol, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA; [Chandran, Raghavendar] Birla Inst Technol & Sci, Biol Sci Grp, Pilani, Rajasthan, India	Sharma, A (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Pathol, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	anuj.sharma.ctr@usuhs.edu	Bhomia, Manish/C-7683-2015; Balakathiresan, Nagaraja Sethuraman/O-3213-2019; Chandran, Raghavendar/AAB-9402-2019	Bhomia, Manish/0000-0003-2808-9927; Chandran, Raghavendar/0000-0002-7915-2810; Sharma, Anuj/0000-0001-6906-190X; Balakathiresan, Nagaraja Sethuraman/0000-0001-5756-6070	Defense Medical Research and Development Program (DMRDP)	The authors report no conflicts of interest. This work was supported by a grant from the Defense Medical Research and Development Program (DMRDP). The opinions expressed herein are that of the author(s) and are not necessarily representative of those of the Uniformed Services University of the Health Sciences (USUHS), the Defense Medical Research and Development Program, Birla Institute of Technology and Science, Pilani, the Department of Defense (DOD), the United States Army, Navy; or Air Force.	Almeida-Suhett CP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102627; Atkins CM, 2006, J CEREBR BLOOD F MET, V26, P1507, DOI 10.1038/sj.jcbfm.9600301; Bajwa NM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146886; Balakathiresan NS, 2014, J PSYCHIATR RES, V57, P65, DOI 10.1016/j.jpsychires.2014.05.020; Bao TH, 2014, J MOL NEUROSCI, V54, P622, DOI 10.1007/s12031-014-0344-1; Bhalala OG, 2013, NAT REV NEUROL, V9, P328, DOI 10.1038/nrneurol.2013.67; Caballero-Garrido E, 2015, J NEUROSCI, V35, P12446, DOI 10.1523/JNEUROSCI.1641-15.2015; Camkurt MA, 2015, J PSYCHIATR RES, V69, P67, DOI 10.1016/j.jpsychires.2015.07.023; Cantu D, 2015, CEREB CORTEX, V25, P2306, DOI 10.1093/cercor/bhu041; Centers for Disease Control and Prevention, 2014, C TRAUM BRAIN INJ US; Chen RL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050957; Cheng G, 2013, MED HYPOTHESES, V80, P115, DOI 10.1016/j.mehy.2012.11.004; Creed JA, 2011, J NEUROTRAUM, V28, P547, DOI 10.1089/neu.2010.1729; Curinga G, 2008, EXP NEUROL, V209, P333, DOI 10.1016/j.expneurol.2007.06.026; DeKosky ST, 2010, NEW ENGL J MED, V363, P1293, DOI 10.1056/NEJMp1007051; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P135, DOI 10.1089/neu.2013.3019; Elder GA, 2012, J NEUROTRAUM, V29, P2564, DOI 10.1089/neu.2012.2510; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Ge XT, 2014, SCI REP-UK, V4, DOI 10.1038/srep06718; Gibson CJ, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-38; Giza CC, 2002, J NEUROTRAUM, V19, P387, DOI 10.1089/08977150252932352; Henry LC, 2014, PROG NEUROL SURG, V28, P63, DOI 10.1159/000358763; Jayakumar AR, 2016, NEUROCHEM RES, V41, P307, DOI 10.1007/s11064-015-1801-0; Jeter CB, 2013, J NEUROTRAUM, V30, P657, DOI 10.1089/neu.2012.2439; Kawa L, 2015, J NEUROTRAUM, V32, P1190, DOI 10.1089/neu.2014.3669; Kekesi KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050532; Khuman J, 2011, J CEREBR BLOOD F MET, V31, P778, DOI 10.1038/jcbfm.2010.172; Kochanek PM, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00040; Lagraoui Mouna, 2012, Front Neurol, V3, P155, DOI 10.3389/fneur.2012.00155; Langham J, 2003, COCHRANE DB SYST REV; Lee DJ, 2008, NEUROSURGERY, V63, P1004, DOI 10.1227/01.NEU.0000327685.90800.F7; Lei P, 2009, BRAIN RES, V1284, P191, DOI 10.1016/j.brainres.2009.05.074; Li H, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00164; Li HH, 2004, J NEUROTRAUM, V21, P1141, DOI 10.1089/0897715041953777; Liou AKF, 2003, PROG NEUROBIOL, V69, P103, DOI 10.1016/S0301-0082(03)00005-4; Liu L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103948; Lu J, 2000, NEUROSCI LETT, V290, P89, DOI 10.1016/S0304-3940(00)01307-0; Marion DW, 2011, J NEUROTRAUM, V28, P517, DOI 10.1089/neu.2010.1638; Marshall KR, 2012, MIL MED, V177, P67, DOI 10.7205/MILMED-D-12-00110; McAllister Thomas W, 2011, Dialogues Clin Neurosci, V13, P287; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Meyer DL, 2012, EXP NEUROL, V235, P574, DOI 10.1016/j.expneurol.2012.03.012; Miao W, 2015, BRAZ J MED BIOL RES, V48, P433, DOI [10.1590/1414-431X20144012, 10.1590/1414-431x20144012]; Milman A, 2005, J NEUROTRAUM, V22, P1003, DOI 10.1089/neu.2005.22.1003; Mtchedlishvili Z, 2010, NEUROBIOL DIS, V38, P464, DOI 10.1016/j.nbd.2010.03.012; Nakamoto M, 2005, HUM MOL GENET, V14, P3813, DOI 10.1093/hmg/ddi397; Natale JE, 2003, J NEUROTRAUM, V20, P907, DOI 10.1089/089771503770195777; Noorbakhsh F, 2011, BRAIN, V134, P2703, DOI 10.1093/brain/awr200; Oliveros JC, 2007, VENNY INTERACTIVE TO; Rapp PE, 2012, J TRAUMA ACUTE CARE, V73, pS13, DOI 10.1097/TA.0b013e318260604b; Redell JB, 2013, J NEUROTRAUM, V30, P752, DOI 10.1089/neu.2012.2437; Redell JB, 2011, J NEUROSCI RES, V89, P212, DOI 10.1002/jnr.22539; Redell JB, 2009, J NEUROSCI RES, V87, P1435, DOI 10.1002/jnr.21945; Sabirzhanov B, 2014, J NEUROSCI, V34, P10055, DOI 10.1523/JNEUROSCI.1260-14.2014; Schober K, 2014, INT J LEGAL MED, V29, P29; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Sharma A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112019; Sherin Jonathan E, 2011, Dialogues Clin Neurosci, V13, P263; Shimada R, 2014, NEUROL RES, V36, P239, DOI 10.1179/1743132813Y.0000000289; Sun E, 2014, EXPT NEUROLOGY, V13; Truettner JS, 2011, J CEREBR BLOOD F MET, V31, P1897, DOI 10.1038/jcbfm.2011.33; Valiyaveettil M, 2013, CHEM-BIOL INTERACT, V203, P371, DOI 10.1016/j.cbi.2012.10.022; Verbois SL, 2000, J NEUROTRAUM, V17, P1001, DOI 10.1089/neu.2000.17.1001; Vlachos IS, 2012, NUCLEIC ACIDS RES, V40, pW498, DOI 10.1093/nar/gks494; Wagner AK, 2009, J NEUROCHEM, V108, P986, DOI 10.1111/j.1471-4159.2008.05840.x; Walker KR, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00029; Wang WX, 2015, EXP NEUROL, V265, P84, DOI 10.1016/j.expneurol.2014.12.018; Weber JT, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00060; Wei J, 2013, ACTA PHARMACOL SIN, V34, P1485, DOI 10.1038/aps.2013.160; Wen Y, 2015, MOL MED, V21, P197, DOI 10.2119/molmed.2014.00199; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Xu GZ, 2013, BRAIN RES BULL, V99, P41, DOI 10.1016/j.brainresbull.2013.09.011; Yang SH, 2013, J SURG RES, V184, P981, DOI 10.1016/j.jss.2013.03.075; Zohar O, 2003, NEUROSCIENCE, V118, P949, DOI 10.1016/S0306-4522(03)00048-4	74	18	18	0	8	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2017	31	1					106	119		10.1080/02699052.2016.1213420			14	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	EJ5KT	WOS:000393257600014	27819514	Other Gold			2021-06-18	
J	Churchill, N; Hutchison, MG; Leung, G; Graham, S; Schweizer, TA				Churchill, Nathan; Hutchison, Michael G.; Leung, General; Graham, Simon; Schweizer, Tom A.			Changes in functional connectivity of the brain associated with a history of sport concussion: A preliminary investigation	BRAIN INJURY			English	Article						Concussion; functional MRI; neuroimaging; MRI scan	DEFAULT-MODE NETWORK; PROFESSIONAL FOOTBALL PLAYERS; RESTING-STATE FMRI; RECURRENT CONCUSSION; NCAA CONCUSSION; INDIVIDUALS; PERFORMANCE; RECOVERY; ABILITY; MRI	Objective: There is evidence of long-term clinical consequences associated with a history of sport concussion. However, there remains limited information about the underlyingchanges in brain function. The goal of this study was to identify brain regions where abnormal resting-state function is associated with chronic concussion, for athletes without persistent symptoms. Methods: Functional Magnetic Resonance Imaging (fMRI) was performed on a group of athletes with prior concussion (n = 22) and a group without documented injury (n = 21). Multivariate predictive modelling was used to localize reliable changes in brain connectivity that are associated with a history of concussion and with clinical factors, including number of prior concussions and recovery time from last injury. Results: No significant differences were found between athletes with and without a history of concussion, but functional connectivity was significantly associated with clinical history. The number of prior concussions was associated with most extensive connectivity changes, particularly for elements of the visual attention network and cerebellum. Conclusion: The findings of this preliminary study indicate that functional brain abnormalities associated with chronic concussion may be significantly dependent on clinical history. In addition, elements of the visual and cerebellar systems may be most sensitive to the long-term effects of sport concussion.	[Churchill, Nathan; Schweizer, Tom A.] St Michaels Hosp, Neurosci Res Program, Toronto, ON, Canada; [Churchill, Nathan; Hutchison, Michael G.; Leung, General; Schweizer, Tom A.] St Michaels Hosp, Keenan Res Ctr Biomed Sci, Toronto, ON, Canada; [Hutchison, Michael G.] Univ Toronto, Fac Kinesiol & Phys Educ, Toronto, ON, Canada; [Leung, General] Univ Toronto, Med Imaging, Toronto, ON, Canada; [Graham, Simon] Univ Toronto, Med Biophys, Toronto, ON, Canada; [Graham, Simon] Sunnybrook Med Ctr, Toronto, ON, Canada; [Schweizer, Tom A.] Univ Toronto, Fac Med Neurosurg, Toronto, ON, Canada	Churchill, N (corresponding author), 209 Victoria St, Toronto, ON M5B 1M8, Canada.	nchurchill.research@gmail.com			Defence Research & Development Canada (DRDC); Canadian Institutes of Military and Veterans Health (CIMVHR); Siemens Canada Ltd.	This research received funding from the Defence Research & Development Canada (DRDC) and the Canadian Institutes of Military and Veterans Health (CIMVHR). This study was approved by the Canadian Forces Surgeon General's Health Research Program. This research was also conducted with partial support from Siemens Canada Ltd. The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.	Abbas K, 2015, BRAIN CONNECT, V5, P91, DOI 10.1089/brain.2014.0279; Behm DG, 2005, J STRENGTH COND RES, V19, P326; Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; Consonni V, 2010, J CHEMOMETR, V24, P194, DOI 10.1002/cem.1290; Efron B., 1994, INTRO BOOTSTRAP; Elbin RJ, 2012, BRAIN INJURY, V26, P1217, DOI 10.3109/02699052.2012.672788; Galetta KM, 2011, J NEUROL SCI, V309, P34, DOI 10.1016/j.jns.2011.07.039; Garrity AG, 2007, AM J PSYCHIAT, V164, P450, DOI 10.1176/appi.ajp.164.3.450; Giza CC, 2001, J ATHL TRAINING, V36, P228; Graham D, 2002, TRAUMA GREENFIELDS N; Grefkes C, 2008, ANN NEUROL, V63, P236, DOI 10.1002/ana.21228; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2013, BRIT J SPORT MED, V47, P289, DOI 10.1136/bjsports-2013-092225; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Hillary FG, 2015, NEUROPSYCHOLOGY, V29, P59, DOI 10.1037/neu0000110; Hrysomallis C, 2011, SPORTS MED, V41, P221, DOI 10.2165/11538560-000000000-00000; Johnson B, 2012, NEUROIMAGE, V59, P511, DOI 10.1016/j.neuroimage.2011.07.081; Manto M, 2012, CEREBELLUM, V11, P457, DOI 10.1007/s12311-011-0331-9; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2010, J HEAD TRAUMA REHAB, V25, P283, DOI 10.1097/HTR.0b013e3181e67923; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Phillips ML, 2003, BIOL PSYCHIAT, V54, P504, DOI 10.1016/S0006-3223(03)00168-9; Slobounov S, 2012, BRAIN IMAGING BEHAV, V6, P224, DOI 10.1007/s11682-012-9167-2; Smith SM, 2013, TRENDS COGN SCI, V17, P666, DOI 10.1016/j.tics.2013.09.016; Terry DP, 2012, BRAIN INJURY, V26, P1684, DOI 10.3109/02699052.2012.722259; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Zhang K, 2012, J NEUROTRAUM, V29, P756, DOI 10.1089/neu.2011.2125; Zhu DC, 2015, J NEUROTRAUM, V32, P327, DOI 10.1089/neu.2014.3413	31	18	18	1	4	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2017	31	1					39	48		10.1080/02699052.2016.1221135			10	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	EJ5KT	WOS:000393257600006	27901587				2021-06-18	
J	Fernandez-Ortega, JF; Baguley, IJ; Gates, TA; Garcia-Caballero, M; Quesada-Garcia, JG; Prieto-Palomino, MA				Fernandez-Ortega, Juan F.; Baguley, Ian J.; Gates, Thomas A.; Garcia-Caballero, Manuel; Quesada-Garcia, Juan G.; Prieto-Palomino, Miguel A.			Catecholamines and Paroxysmal Sympathetic Hyperactivity after Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						catecholamines; cortisol; hormonal influences; paroxysmal sympathetic hyperactivity; traumatic brain injury	SUBARACHNOID HEMORRHAGE; HEAD-INJURY; NOREPINEPHRINE LEVELS; AFFERENT STIMULI; ACUTE-PHASE; DYSAUTONOMIA; PLASMA; OVERRESPONSIVENESS; ACTIVATION; SYSTEM	Paroxysmal sympathetic hyperactivity (PSH) affects a significant minority of people in the intensive care unit after severe traumatic brain injury. Systematic research has yet to elucidate or quantify the extent of the role of the catecholamines or adrenocortical and thyroid axis hormonal influences in the condition. Data were prospectively collected on 80 consecutive patients, 18 of whom developed clinical signs of PSH (22.5%). Catecholamine and hormonal data were collected sequentially at 4-h intervals or during and between episodes of PSH. Evaluated variables showed 200-300% increases in catecholamines and, to a lesser extent, adrenocortical hormones during paroxysms. The majority of PSH episodes (72%) were noted to be in response to an observable triggering event. These changes were not observed in subjects without PSH. These data go some way to explain why PSH produces adverse consequences in survivors of TBI with the condition.	[Fernandez-Ortega, Juan F.; Quesada-Garcia, Juan G.; Prieto-Palomino, Miguel A.] Univ Hosp Carlos Haya, ICU Serv, C Mirador del Candado 1, Malaga 29018, Spain; [Baguley, Ian J.; Gates, Thomas A.] Westmead Hosp, Brain Injury Rehabil Serv, Sydney, NSW, Australia; [Garcia-Caballero, Manuel] Univ Malaga, Sch Med, Malaga, Spain	Fernandez-Ortega, JF (corresponding author), Univ Hosp Carlos Haya, ICU Serv, C Mirador del Candado 1, Malaga 29018, Spain.	jfezortega@gmail.com	Baguley, Ian/AAM-5828-2021				Annane D, 1999, AM J RESP CRIT CARE, V160, P458, DOI 10.1164/ajrccm.160.2.9810073; Baguley I. J., 2006, NEUROREHAB NEURAL RE, V20, P98; Baguley IJ, 2008, NEUROCRIT CARE, V8, P293, DOI 10.1007/s12028-007-9021-3; Baguley IJ, 2008, MED HYPOTHESES, V70, P26, DOI 10.1016/j.mehy.2007.04.037; Baguley IJ, 2007, BRAIN INJURY, V21, P1175, DOI 10.1080/02699050701687375; Baguley IJ, 2014, J NEUROTRAUM, V31, P1515, DOI 10.1089/neu.2013.3301; Baguley IJ, 2009, AM J PHYS MED REHAB, V88, P615, DOI 10.1097/PHM.0b013e3181aeab96; Baguley IJ, 2009, ARCH PHYS MED REHAB, V90, P580, DOI 10.1016/j.apmr.2008.10.020; Baguley IJ, 2008, SEMIN NEUROL, V28, P716, DOI 10.1055/s-0028-1105971; Baguley IJ, 1999, J NEUROL NEUROSUR PS, V67, P39, DOI 10.1136/jnnp.67.1.39; BENEDICT CR, 1978, J NEUROL NEUROSUR PS, V41, P113, DOI 10.1136/jnnp.41.2.113; CHIOLERO R, 1988, J TRAUMA, V28, P1368, DOI 10.1097/00005373-198809000-00011; CHIOLERO RL, 1989, CRIT CARE MED, V17, P328, DOI 10.1097/00003246-198904000-00006; CLIFTON GL, 1981, NEUROSURGERY, V8, P10, DOI 10.1227/00006123-198101000-00003; Dimopoulou L, 2004, CRIT CARE MED, V32, P404, DOI 10.1097/01.CCM.0000108885.37811.CA; Fernandez-Ortega JF, 2006, J TRAUMA, V61, P1129, DOI 10.1097/01.ta.0000197634.83217.80; Fernandez-Ortega JF, 2012, J NEUROTRAUM, V29, P1364, DOI 10.1089/neu.2011.2033; Goldstein DS, 2010, CLIN AUTON RES, V20, P331, DOI 10.1007/s10286-010-0065-7; HACKL JM, 1991, INTENS CARE MED, V17, P25, DOI 10.1007/BF01708405; HAHN PY, 1995, SHOCK, V4, P269, DOI 10.1097/00024382-199510000-00007; HAMILL RW, 1987, ANN NEUROL, V21, P438, DOI 10.1002/ana.410210504; Hendricks HT, 2007, CLIN REHABIL, V21, P545, DOI 10.1177/0269215507075260; Inaba K, 2008, J AM COLL SURGEONS, V206, P432, DOI 10.1016/j.jamcollsurg.2007.10.005; Inamasu J, 2012, ACTA NEUROCHIR, V154, P2179, DOI 10.1007/s00701-012-1515-x; Johansson PI, 2011, J TRAUMA, V72, P428; Koiv L, 1997, ACTA NEUROL SCAND, V96, P52; Krach LE, 1997, J NEUROL REHABIL, V11, P41; Lindgren C, 2013, ACTA ANAESTH SCAND, V57, P452, DOI 10.1111/aas.12014; Mautes AEM, 2001, ACTA NEUROCHIR, V143, P51, DOI 10.1007/s007010170138; Naredi S, 2000, STROKE, V31, P901, DOI 10.1161/01.STR.31.4.901; Naredi S, 2006, INTENS CARE MED, V32, P1955, DOI 10.1007/s00134-006-0408-y; Ostrowski SR, 2015, J CRIT CARE, V30, P90, DOI 10.1016/j.jcrc.2014.10.006; Perkes I, 2010, ANN NEUROL, V68, P126, DOI 10.1002/ana.22066; Powner DJ, 2006, NEUROCRIT CARE, V5, P61, DOI 10.1385/NCC:5:1:61; Rabinstein AA, 2007, NEUROL RES, V29, P680, DOI 10.1179/016164107X240071; Rey M, 2005, J CARDIOTHOR VASC AN, V19, P654, DOI 10.1053/j.jvca.2005.07.008; SANDEL ME, 1986, ARCH PHYS MED REHAB, V67, P469; Slewa-Younan S, 2008, BRAIN INJURY, V22, P183, DOI 10.1080/02699050801888808; Sugimoto K, 2013, NEUROSURG REV, V36, P259, DOI 10.1007/s10143-012-0424-z; Tanriverdi F, 2006, J CLIN ENDOCR METAB, V91, P2105, DOI 10.1210/jc.2005-2476; Wang HC, 2014, BRAIN INJURY, V28, P1491, DOI 10.3109/02699052.2014.943288; Wang VY, 2008, J TRAUMA, V64, P500, DOI 10.1097/TA.0b013e31804a5738; WOOLF PD, 1987, J NEUROSURG, V66, P875, DOI 10.3171/jns.1987.66.6.0875	43	18	23	1	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 1	2017	34	1					109	114		10.1089/neu.2015.4364			6	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	EF6DE	WOS:000390420100013	27251119				2021-06-18	
J	Hoffman, AN; Paode, PR; May, HG; Ortiz, JB; Kemmou, S; Lifshitz, J; Conrad, CD; Thomas, TC				Hoffman, Ann N.; Paode, Pooja R.; May, Hazel G.; Ortiz, J. Bryce; Kemmou, Salma; Lifshitz, Jonathan; Conrad, Cheryl D.; Thomas, Theresa Currier			Early and Persistent Dendritic Hypertrophy in the Basolateral Amygdala following Experimental Diffuse Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						amygdala; comorbidity; plasticity; post-traumatic stress disorder; traumatic brain injury	POSTTRAUMATIC-STRESS-DISORDER; LATERAL FLUID PERCUSSION; CONDITIONED FEAR; GLUCOSE-UTILIZATION; RAT; HIPPOCAMPAL; NEURONS; CORTEX; PLASTICITY; GLUTAMATE	In the pathophysiology of traumatic brain injury (TBI), the amygdala remains understudied, despite involvement in processing emotional and stressful stimuli associated with anxiety disorders, such as post-traumatic stress disorder (PTSD). Because the basolateral amygdala (BLA) integrates inputs from sensory and other limbic structures coordinating emotional learning and memory, injury-induced changes in circuitry may contribute to psychiatric sequelae of TBI. This study quantified temporal changes in dendritic complexity of BLA neurons after experimental diffuse TBI, modeled by midline fluid percussion injury. At post-injury days (PIDs) 1, 7, and 28, brain tissue from sham and brain-injured adult, male rats was processed for Golgi, glial fibrillary acidic protein (GFAP), or silver stain and analyzed to quantify BLA dendritic branch intersections, activated astrocytes, and regional neuropathology, respectively. Compared to sham, brain-injured rats at all PIDs showed enhanced dendritic branch intersections in both pyramidal and stellate BLA neuronal types, as evidenced by Sholl analysis. GFAP staining in the BLA was significantly increased at PID1 and 7 in comparison to sham. However, the BLA was relatively spared from neuropathology, demonstrated by an absence of argyrophilic accumulation over time, in contrast to other brain regions. These data suggest an early and persistent enhancement of dendritic complexity within the BLA after a single diffuse TBI. Increased dendritic complexity would alter information processing into and through the amygdala, contributing to emotional symptoms post-TBI, including PTSD.	[Hoffman, Ann N.; Paode, Pooja R.; Ortiz, J. Bryce; Kemmou, Salma; Lifshitz, Jonathan; Conrad, Cheryl D.] Arizona State Univ, Dept Psychol, Tempe, AZ 85287 USA; [May, Hazel G.; Lifshitz, Jonathan; Thomas, Theresa Currier] Univ Arizona, Coll Med Phoenix, Dept Child Hlth, 425 North 5th St,ABC-1 Bldg,Room 320, Phoenix, AZ 85004 USA; [May, Hazel G.; Lifshitz, Jonathan; Thomas, Theresa Currier] Phoenix Childrens Hosp, Barrow Neurol Inst, Phoenix, AZ USA; [Lifshitz, Jonathan; Thomas, Theresa Currier] Phoenix VA Healthcare Syst, Phoenix, AZ USA; [Hoffman, Ann N.] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA USA; [Hoffman, Ann N.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, Brain Injury Res Ctr, Los Angeles, CA 90095 USA; [May, Hazel G.] Univ Bath, Dept Biol & Biochem, Bath, Avon, England	Thomas, TC (corresponding author), Univ Arizona, Coll Med Phoenix, Dept Child Hlth, 425 North 5th St,ABC-1 Bldg,Room 320, Phoenix, AZ 85004 USA.	theresathomas@email.arizona.edu	Thomas, Theresa Currier/K-1979-2019	Thomas, Theresa Currier/0000-0002-9619-7666; Conrad, Cheryl/0000-0002-5924-2173	Arizona Biomedical Research Commission through the Arizona Department of Health Services [ADHS14-00003606]; National Institute of Neurological Disorders and Stroke of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS-065052]; Phoenix Children's Hospital; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS065052] Funding Source: NIH RePORTER	The authors thank Elizabeth Peck and Amanda Lisembee. Supported by the Arizona Biomedical Research Commission through the Arizona Department of Health Services (ADHS14-00003606), National Institute of Neurological Disorders and Stroke of the National Institutes of Health (R01 NS-065052), and Phoenix Children's Hospital Mission Support Funds.	Almeida-Suhett CP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102627; BOUZARTH WF, 1968, SURG GYNECOL OBSTETR, V126, P995; Bramlett HM, 2002, ACTA NEUROPATHOL, V103, P607, DOI 10.1007/s00401-001-0510-8; Casella EM, 2014, CHILD NERV SYST, V30, P1333, DOI 10.1007/s00381-014-2446-z; Elder GA, 2012, J NEUROTRAUM, V29, P2564, DOI 10.1089/neu.2012.2510; Fanselow MS, 1999, NEURON, V23, P229, DOI 10.1016/S0896-6273(00)80775-8; Fendt M, 1999, NEUROSCI BIOBEHAV R, V23, P743, DOI 10.1016/S0149-7634(99)00016-0; Gao X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024566; Grundy PL, 2001, J NEUROTRAUM, V18, P1373, DOI 10.1089/08977150152725669; Hallam TM, 2004, J NEUROTRAUM, V21, P521, DOI 10.1089/089771504774129865; Hausser M, 2000, SCIENCE, V290, P739, DOI 10.1126/science.290.5492.739; Heldt SA, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00002; Herman JP, 2003, FRONT NEUROENDOCRIN, V24, P151, DOI 10.1016/j.yfrne.2003.07.001; Herry C, 2008, NATURE, V454, P600, DOI 10.1038/nature07166; Hosseini AH, 2009, MED SCI SPORT EXER, V41, P1687, DOI 10.1249/MSS.0b013e31819fcd1b; HOVDA DA, 1991, BRAIN RES, V567, P1, DOI 10.1016/0006-8993(91)91429-5; Ip EYY, 2002, J NEUROTRAUM, V19, P573, DOI 10.1089/089771502753754055; Jasnow AM, 2013, J NEUROSCI, V33, P10396, DOI 10.1523/JNEUROSCI.5539-12.2013; KAWAMATA T, 1992, J CEREBR BLOOD F MET, V12, P12, DOI 10.1038/jcbfm.1992.3; Kim J, 2008, NEUROIMAGE, V39, P1014, DOI 10.1016/j.neuroimage.2007.10.005; KING LR, 1970, ANN SURG, V172, P975, DOI 10.1097/00000658-197012000-00008; Kou ZF, 2014, NEURAL REGEN RES, V9, P693, DOI 10.4103/1673-5374.131568; Kovesdi Erzsebet, 2012, Front Neurol, V3, P111, DOI 10.3389/fneur.2012.00111; LeDoux J, 2003, CELL MOL NEUROBIOL, V23, P727, DOI 10.1023/A:1025048802629; Lifshitz J, 2007, BEHAV BRAIN RES, V177, P347, DOI 10.1016/j.bbr.2006.11.014; Lifshitz J, 2012, BRAIN STRUCT FUNCT, V217, P49, DOI 10.1007/s00429-011-0323-z; MCDONALD A J, 1992, P67; MCDONALD AJ, 1989, NEUROSCIENCE, V30, P405, DOI 10.1016/0306-4522(89)90261-3; MCDONALD AJ, 1992, BRAIN RES BULL, V28, P179, DOI 10.1016/0361-9230(92)90177-Y; Meyer DL, 2012, EXP NEUROL, V235, P574, DOI 10.1016/j.expneurol.2012.03.012; Mitra R, 2005, P NATL ACAD SCI USA, V102, P9371, DOI 10.1073/pnas.0504011102; Moore EL, 2006, BRAIN INJURY, V20, P117, DOI 10.1080/02699050500443558; Moreno N, 2007, J ANAT, V211, P151, DOI 10.1111/j.1469-7580.2007.00780.x; Pitkanen A, 2000, ANN NY ACAD SCI, V911, P369; Ranft A, 2004, EUR J NEUROSCI, V20, P1276, DOI 10.1111/j.1460-9568.2004.03603.x; Rao V, 2000, PSYCHOSOMATICS, V41, P95, DOI 10.1176/appi.psy.41.2.95; Reger ML, 2012, BIOL PSYCHIAT, V71, P335, DOI 10.1016/j.biopsych.2011.11.007; Ridet JL, 1997, TRENDS NEUROSCI, V20, P570, DOI 10.1016/S0166-2236(97)01139-9; Roe SY, 1998, EUR J NEUROSCI, V10, P553, DOI 10.1046/j.1460-9568.1998.00064.x; Rumney B. M., 2014, 32 ANN NAT NEUR S SA; Selye H, 1998, J NEUROPSYCH CLIN N, V10, P230; Shin LM, 2006, ANN NY ACAD SCI, V1071, P67, DOI 10.1196/annals.1364.007; Snell FI, 2010, J PSYCHOSOC NURS MEN, V48, P22, DOI [10.3928/02793695-20100108-02, 10.3928/02793695-20100107-01]; Taylor SB, 2014, NEUROSCIENCE, V280, P231, DOI 10.1016/j.neuroscience.2014.09.029; Thomas TC, 2012, J NEUROTRAUM, V29, P187, DOI 10.1089/neu.2011.2091; Uylings HBM, 2002, NETWORK-COMP NEURAL, V13, P397, DOI 10.1088/0954-898X/13/3/309; Vaishnavi S, 2009, PSYCHOSOMATICS, V50, P198, DOI 10.1176/appi.psy.50.3.198; Vyas A, 2004, NEUROSCIENCE, V128, P667, DOI 10.1016/j.neuroscience.2004.07.013; Vyas A, 2002, J NEUROSCI, V22, P6810; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K; Yurgil KA, 2014, JAMA PSYCHIAT, V71, P149, DOI 10.1001/jamapsychiatry.2013.3080	51	18	18	6	11	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 1	2017	34	1					213	219		10.1089/neu.2015.4339			7	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	EF6DE	WOS:000390420100023	27306143	Green Published, Green Accepted			2021-06-18	
S	Menon, DK; Ercole, A		Wijdicks, EFM; Kramer, AH		Menon, D. K.; Ercole, A.			Critical care management of traumatic brain injury	CRITICAL CARE NEUROLOGY, PT I	Handbook of Clinical Neurology		English	Article; Book Chapter							SEVERE HEAD-INJURY; GLASGOW COMA SCALE; CEREBRAL PERFUSION-PRESSURE; FIBRILLARY ACIDIC PROTEIN; APPARENT DIFFUSION-COEFFICIENT; CORTICAL SPREADING DEPRESSION; MILD THERAPEUTIC HYPOTHERMIA; BLOOD-CELL TRANSFUSION; QUALITY-OF-LIFE; INTRACRANIAL-PRESSURE	Traumatic brain injury (TBI) is a growing global problem, which is responsible for a substantial burden of disability and death, and which generates substantial healthcare costs. High-quality intensive care can save lives and improve the quality of outcome. TBI is extremely heterogeneous in terms of clinical presentation, pathophysiology, and outcome. Current approaches to the critical care management of TBI are not underpinned by high-quality evidence, and many of the current therapies in use have not shown benefit in randomized control trials. However, observational studies have informed the development of authoritative international guidelines, and the use of multimodality monitoring may facilitate rational approaches to optimizing acute physiology, allowing clinicians to optimize the balance between benefit and risk from these interventions in individual patients. Such approaches, along with the emerging impact of advanced neuroimaging, genomics, and protein biomarkers, could lead to the development of precision medicine approaches to the intensive care management of TBI.	[Menon, D. K.; Ercole, A.] Univ Cambridge, Div Anaesthesia, Cambridge, England; [Menon, D. K.; Ercole, A.] Addenbrookes Hosp, Neurosci Trauma Crit Care Unit, Cambridge, England	Menon, DK (corresponding author), Addenbrookes Hosp, Box 93, Cambridge CB2 2QQ, England.	dkm13@cam.ac.uk	Ercole, Ari/B-6288-2009	Ercole, Ari/0000-0001-8350-8093			Adams JH, 2011, J NEUROTRAUM, V28, P701, DOI 10.1089/neu.2010.1733; Adams JH, 1999, J CLIN PATHOL, V52, P804, DOI 10.1136/jcp.52.11.804; Agrawal D, 2016, NEUROL INDIA, V64, P62, DOI 10.4103/0028-3886.173649; Aisiku IP, 2016, J TRAUMA ACUTE CARE, V80, P308, DOI 10.1097/TA.0000000000000903; Alali Aziz S, 2014, J Trauma Acute Care Surg, V76, P70, DOI 10.1097/TA.0b013e3182a8fd6a; Alali AS, 2013, J NEUROTRAUM, V30, P1737, DOI 10.1089/neu.2012.2802; Altmeyer W, 2016, MAGN RESON IMAGING C, V24, P305, DOI 10.1016/j.mric.2015.11.011; Alves JL, 2014, J NEUROSCI RES, V92, P141, DOI 10.1002/jnr.23300; Amyot F, 2015, J NEUROTRAUM, V32, P1693, DOI 10.1089/neu.2013.3306; Andelic N, 2009, ACTA NEUROL SCAND, V120, P16, DOI 10.1111/j.1600-0404.2008.01116.x; Andelic N, 2014, J NEUROTRAUM, V31, P1313, DOI 10.1089/neu.2013.3292; Andrews PJD, 2015, NEW ENGL J MED, V373, P2403, DOI 10.1056/NEJMoa1507581; Anglin CO, 2013, J NEUROSURG, V118, P676, DOI 10.3171/2012.11.JNS12622; Anke A, 2015, J HEAD TRAUMA REHAB, V30, pE38, DOI 10.1097/HTR.0000000000000080; Aries MJH, 2012, CRIT CARE MED, V40, P2456, DOI 10.1097/CCM.0b013e3182514eb6; Balestreri M, 2006, NEUROCRIT CARE, V4, P8, DOI 10.1385/NCC:4:1:008; Bao L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090956; Barbey AK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088733; Batchelor JS, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000588; Batchelor JS, 2013, BRIT J NEUROSURG, V27, P12, DOI 10.3109/02688697.2012.705361; Batchelor JS, 2012, BRIT J NEUROSURG, V26, P525, DOI 10.3109/02688697.2011.650736; Blumbergs PC, 2008, GREENFIELDS NEUROPAT; Bohmer AE, 2011, NEUROSURGERY, V68, P1624, DOI 10.1227/NEU.0b013e318214a81f; Bogner JA, 2001, AM J PHYS MED REHAB, V80, P636, DOI 10.1097/00002060-200109000-00002; BONE LB, 1989, J BONE JOINT SURG AM, V71A, P336, DOI 10.2106/00004623-198971030-00004; BOUMA GJ, 1992, J NEUROSURG, V77, P360, DOI 10.3171/jns.1992.77.3.0360; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; Bragge P, 2016, J NEUROTRAUM, V33, P1461, DOI 10.1089/neu.2015.4233; Brain Trauma Foundation, 2016, C NEUR SURG; Brenner M, 2012, J TRAUMA ACUTE CARE, V72, P1135, DOI 10.1097/TA.0b013e31824af90b; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Brown GC, 2000, ACTA PHYSIOL SCAND, V168, P667, DOI 10.1046/j.1365-201x.2000.00718.x; Brown JB, 2010, J TRAUMA, V69, P263, DOI 10.1097/TA.0b013e3181e5d72e; Bulger EM, 2002, CRIT CARE MED, V30, P1870, DOI 10.1097/00003246-200208000-00033; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Bulstrode H, 2014, ANN NEUROL, V75, P186, DOI 10.1002/ana.24116; Butcher I, 2007, J NEUROTRAUM, V24, P294, DOI 10.1089/neu.2006.0032; Carlson AP, 2012, J NEUROIMAGING, V22, P408, DOI 10.1111/j.1552-6569.2011.00621.x; Caterino JM, 2011, ACAD EMERG MED, V18, P1014, DOI 10.1111/j.1553-2712.2011.01164.x; Chang BS, 2003, NEUROLOGY, V60, P10, DOI 10.1212/01.WNL.0000031432.05543.14; Chen S, 2015, EXP NEUROL, V272, P4, DOI 10.1016/j.expneurol.2015.03.007; Chesnut RM, 2015, J NEUROTRAUM, V32, P1722, DOI 10.1089/neu.2015.3976; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Chi JH, 2006, J TRAUMA, V61, P1134, DOI 10.1097/01.ta.0000196644.64653.d8; Claassen J, 2014, NEUROCRIT CARE, V21, P129, DOI 10.1007/s12028-014-0022-8; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Clifton GL, 2011, LANCET NEUROL, V10, P131, DOI 10.1016/S1474-4422(10)70300-8; Coles JP, 2007, CRIT CARE MED, V35, P568, DOI 10.1097/01.CCM.0000254066.37187.88; Coles JP, 2004, J CEREBR BLOOD F MET, V24, P202, DOI 10.1097/01.WCB.0000103022.98348.24; Coles JP, 2002, CRIT CARE MED, V30, P1950, DOI 10.1097/00003246-200209000-00002; Conley YP, 2014, J NEUROTRAUM, V31, P34, DOI 10.1089/neu.2013.2855; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Corrigan JD, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0000000000000020; Cremer OL, 2005, CRIT CARE MED, V33, P2207, DOI 10.1097/01.CCM.0000181300.99078.B5; Cremer OL, 2001, LANCET, V357, P117, DOI 10.1016/S0140-6736(00)03547-9; Daneshvar DH, 2015, MOL CELL NEUROSCI, V66, P81, DOI 10.1016/j.mcn.2015.03.007; De Bonis P, 2011, J NEUROTRAUM, V28, P2043, DOI 10.1089/neu.2011.1889; DeKosky ST, 2013, NAT REV NEUROL, V9, P192, DOI 10.1038/nrneurol.2013.36; Dengler B, 2015, J CRIT CARE, V30, P823, DOI 10.1016/j.jcrc.2015.03.027; Dewan Y, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-87; Diamond ML, 2014, EPILEPSIA, V55, P1109, DOI 10.1111/epi.12628; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P19, DOI 10.1089/neu.2013.3040; Ding K, 2016, TRANSLATIONAL RES TR; Donkin JJ, 2010, CURR OPIN NEUROL, V23, P293, DOI 10.1097/WCO.0b013e328337f451; Elf K, 2002, CRIT CARE MED, V30, P2129, DOI 10.1097/00003246-200209000-00029; Elterman J, 2013, J TRAUMA ACUTE CARE, V75, P8, DOI 10.1097/TA.0b013e318298492e; English SW, 2013, NEUROCRIT CARE, V18, P131, DOI 10.1007/s12028-012-9748-3; Etemadrezaie H, 2007, CLIN NEUROL NEUROSUR, V109, P166, DOI 10.1016/j.clineuro.2006.09.001; EuroSafe, 2013, INJ EUR UN REP INJ S; Fabbri A, 2013, CRIT CARE, V17, DOI 10.1186/cc12575; Fabricius M, 2006, BRAIN, V129, P778, DOI 10.1093/brain/awh716; Failla MD, 2013, BRAIN INJURY, V27, P696, DOI 10.3109/02699052.2013.775481; Fakhry SM, 2004, J TRAUMA, V56, P492, DOI 10.1097/01.TA.0000115650.07193.66; Faul M.D., 2010, TRAUMATIC BRAIN INJU; FEARNSIDE MR, 1993, BRIT J NEUROSURG, V7, P267, DOI 10.3109/02688699309023809; Fehlings MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032037; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Finfer S, 2015, INTENS CARE MED, V41, P1037, DOI 10.1007/s00134-015-3757-6; Fleminger S, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003299.pub2; Fugate LP, 1997, ARCH PHYS MED REHAB, V78, P924, DOI 10.1016/S0003-9993(97)90051-4; Fuller G, 2011, J NEUROSURG ANESTH, V23, P198, DOI 10.1097/ANA.0b013e3182161816; Galanaud D, 2012, ANESTHESIOLOGY, V117, P1300, DOI 10.1097/ALN.0b013e3182755558; Giacino JT, 2014, NAT REV NEUROL, V10, P99, DOI 10.1038/nrneurol.2013.279; Giacino JT, 2012, NEW ENGL J MED, V366, P819, DOI 10.1056/NEJMoa1102609; Giacino JT, 2005, NEUROPSYCHOL REHABIL, V15, P166, DOI 10.1080/09602010443000498; Goldschlager T, 2007, J CLIN NEUROSCI, V14, P624; Goldschlager T, 2007, J CLIN NEUROSCI, V14, P618, DOI 10.1016/j.jocn.2006.02.018; GRAHAM DI, 1989, J NEUROL NEUROSUR PS, V52, P346, DOI 10.1136/jnnp.52.3.346; GRAHAM DI, 1978, J NEUROL SCI, V39, P213, DOI 10.1016/0022-510X(78)90124-7; Grande PO, 2006, INTENS CARE MED, V32, P1475, DOI 10.1007/s00134-006-0294-3; Grandhi R, 2015, J TRAUMA ACUTE CARE, V78, P614, DOI 10.1097/TA.0000000000000542; Greenwald BD, 2015, J NEUROTRAUM, V32, P1883, DOI 10.1089/neu.2014.3454; Greuters S, 2011, CRIT CARE, V15, DOI 10.1186/cc9399; Gupta AK, 1997, ANESTH ANALG, V85, P817, DOI 10.1097/00000539-199710000-00018; Hackam DG, 2012, NEUROLOGY, V79, P1862, DOI 10.1212/WNL.0b013e318271f848; Hadjigeorgiou GM, 2005, NEUROLOGY, V65, P1077, DOI 10.1212/01.wnl.0000178890.93795.0e; Hajjar LA, 2010, JAMA-J AM MED ASSOC, V304, P1559, DOI 10.1001/jama.2010.1446; Harhangi BS, 2008, ACTA NEUROCHIR, V150, P165, DOI 10.1007/s00701-007-1475-8; Harrison DA, 2013, HEALTH TECHNOL ASSES, V17, P1, DOI 10.3310/hta17230; Harrison DA, 2015, J NEUROTRAUM, V32, P1522, DOI 10.1089/neu.2014.3628; Hartings JA, 2014, ANN NEUROL, V76, P681, DOI 10.1002/ana.24256; Hartings JA, 2011, LANCET NEUROL, V10, P1058, DOI 10.1016/S1474-4422(11)70243-5; Hartings JA, 2011, BRAIN, V134, P1529, DOI 10.1093/brain/awr048; Hawryluk G, 2015, J NEUROTRAUM, V32, P1958, DOI 10.1089/neu.2014.3778; Hay JR, 2015, J NEUROPATH EXP NEUR, V74, P1147, DOI [10.1093/jnen/74.12.1147, 10.1097/NEN.0000000000000261]; Hebert PC, 1999, NEW ENGL J MED, V340, P409, DOI 10.1056/NEJM199902113400601; Hertle DN, 2012, BRAIN, V135, P2390, DOI 10.1093/brain/aws152; Hifumi T, 2016, J NEUROTRAUM, V33, P1047, DOI 10.1089/neu.2015.4033; Hill CS, 2016, TRENDS NEUROSCI, V39, P311, DOI 10.1016/j.tins.2016.03.002; HILL DA, 1993, AUST NZ J SURG, V63, P604, DOI 10.1111/j.1445-2197.1993.tb00466.x; Hinzman JM, 2016, J NEUROTRAUMA; Hoffman AN, 2008, LIFE SCI, V83, P602, DOI 10.1016/j.lfs.2008.08.007; Hoh NZ, 2010, J NEUROTRAUM, V27, P1413, DOI 10.1089/neu.2009.1256; Honda M, 2010, J TRAUMA, V69, P104, DOI 10.1097/TA.0b013e3181bbd485; Hoyt DB, 2004, SEMIN HEMATOL, V41, P40, DOI 10.1053/j.seminhematol.2003.11.009; Huber-Wagner S, 2009, LANCET, V373, P1455, DOI 10.1016/S0140-6736(09)60232-4; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Hutchinson PJ, 2015, INTENS CARE MED, V41, P1517, DOI 10.1007/s00134-015-3930-y; Hutchinson PJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1000; Hutchinson PJA, 2000, BRIT J NEUROSURG, V14, P46; Hyam JA, 2006, CRIT CARE, V10, DOI 10.1186/cc5066; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; ICNARC, 2015, ANN QUAL REP 2013 14; Inaba K, 2015, J TRAUMA ACUTE CARE, V78, P1220, DOI 10.1097/TA.0000000000000536; Jamjoom AAB, 2013, J NEUROTRAUM, V30, P503, DOI 10.1089/neu.2012.2584; Janowitz T, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000330; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Jeremitsky E, 2003, J TRAUMA, V54, P312, DOI 10.1097/01.TA.0000037876.37236.D6; JONES PA, 1994, J NEUROSURG ANESTH, V6, P4; Joseph B, 2014, J TRAUMA ACUTE CARE, V76, P817, DOI 10.1097/TA.0b013e3182aafcf0; Kamel H, 2011, CRIT CARE MED, V39, P554, DOI 10.1097/CCM.0b013e318206b9be; Karabinis A, 2004, CRIT CARE, V8, pR268, DOI 10.1186/cc2896; Kasprowicz M, 2016, BRIT J NEUROSURG, V30, P211, DOI 10.3109/02688697.2016.1161173; Kawamata T, 2000, ACTA NEUROCHIR SUPPL, V76, P9; Kawata K, 2016, NEUROSCI BIOBEHAV R, V68, P460, DOI 10.1016/j.neubiorev.2016.05.009; Kehoe A, 2015, EMERG MED J, V32, P613, DOI 10.1136/emermed-2013-203488; Kelly DF, 1996, J NEUROSURG, V85, P762, DOI 10.3171/jns.1996.85.5.0762; Kenney K, 2016, EXP NEUROL, V275, P353, DOI 10.1016/j.expneurol.2015.05.019; Kim J, 2013, J CLIN NEUROSCI, V20, P1697, DOI 10.1016/j.jocn.2013.02.021; Kirkman MA, 2013, J NEUROTRAUM, V30, P1385, DOI 10.1089/neu.2013.2881; Kline AE, 2008, NEUROSCI LETT, V448, P263, DOI 10.1016/j.neulet.2008.10.076; Kochanek PM, 2015, SEMIN NEUROL, V35, P83, DOI 10.1055/s-0035-1544237; Korley FK, 2016, J NEUROTRAUM, V33, P215, DOI 10.1089/neu.2015.3949; Krajcova A, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1112-5; Kramer AH, 2012, CRIT CARE, V16, DOI 10.1186/cc11812; Krishnamoorthy V, 2015, J INTENSIVE CARE, V3, DOI 10.1186/s40560-015-0113-4; Krishnamurthy K, 2015, CELLULAR MOL MECH SE; Krueger F, 2011, J NEUROSCI, V31, P598, DOI 10.1523/JNEUROSCI.1399-10.2011; Kucinski T, 2002, STROKE, V33, P1786, DOI 10.1161/01.STR.0000019125.80118.99; Kulbe JR, 2016, EXP NEUROL, V275, P334, DOI 10.1016/j.expneurol.2015.05.004; Laroche M, 2012, NEUROSURGERY, V70, P1334, DOI 10.1227/NEU.0b013e31824d179b; Lawrence DW, 2015, BRAIN INJURY, V29, P1018, DOI 10.3109/02699052.2015.1005131; Lazaridis C, 2014, J NEUROSURG, V120, P893, DOI 10.3171/2014.1.JNS131292; Lazaridis C, 2013, CRIT CARE MED, V41, P1353, DOI 10.1097/CCM.0b013e31827ca4b3; Le Roux P, 2014, NEUROCRIT CARE, V21, P282, DOI 10.1007/s12028-014-0077-6; Leal-Noval SR, 2016, NEUROCRIT CARE, V24, P371, DOI 10.1007/s12028-015-0220-z; Lee JH, 2001, J NEUROSURG, V95, P222, DOI 10.3171/jns.2001.95.2.0222; Lee JH, 1997, J NEUROSURG, V87, P221, DOI 10.3171/jns.1997.87.2.0221; Lequerica AH, 2007, J HEAD TRAUMA REHAB, V22, P177, DOI 10.1097/01.HTR.0000271118.96780.bc; Levy AS, 2010, J TRAUMA, V68, P886, DOI 10.1097/TA.0b013e3181d27dd5; Levy M, 2005, NEUROREHABILITATION, V20, P279; Li J, 2012, J NEUROTRAUM, V29, P96, DOI 10.1089/neu.2011.1753; Li M, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000736; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; Lipsky RH, 2005, J NEUROPSYCH CLIN N, V17, P465, DOI 10.1176/appi.neuropsych.17.4.465; Logsdon AF, 2015, COMPR PHYSIOL, V5, P1147, DOI 10.1002/cphy.c140057; Lustenberger T, 2010, INJURY, V41, P924, DOI 10.1016/j.injury.2010.04.019; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maas Andrew I R, 2015, Handb Clin Neurol, V128, P455, DOI 10.1016/B978-0-444-63521-1.00029-7; Maas AIR, 2012, J NEUROTRAUM, V29, P32, DOI 10.1089/neu.2010.1599; Macmillan CSA, 2001, J NEUROL NEUROSUR PS, V70, P101, DOI 10.1136/jnnp.70.1.101; Maegele M, 2013, TRANSFUSION, V53, p28S, DOI 10.1111/trf.12033; Maekawa T, 2015, J NEUROTRAUM, V32, P422, DOI 10.1089/neu.2013.3197; Magnoni S, 2012, CRIT CARE MED, V40, P1785, DOI 10.1097/CCM.0b013e318246bd45; Majdan M, 2013, J NEUROTRAUM, V30, P23, DOI 10.1089/neu.2012.2554; Manley G, 2001, ARCH SURG-CHICAGO, V136, P1118, DOI 10.1001/archsurg.136.10.1118; Mannion RJ, 2007, J NEUROTRAUM, V24, P128, DOI 10.1089/neu.2006.0127; Marion DW, 2006, NEUROSURGERY, V58, P655; Marmarou A, 2006, J NEUROSURG, V104, P720, DOI 10.3171/jns.2006.104.5.720; Martin NA, 1997, J NEUROSURG, V87, P9, DOI 10.3171/jns.1997.87.1.0009; Masel BE, 2015, J NEUROTRAUM, V32, P1833, DOI 10.1089/neu.2015.29004.bm; Maxwell WL, 2004, BRAIN, V127, P2470, DOI 10.1093/brain/awh294; McAllister TW, 2008, BRAIN INJURY, V22, P705, DOI 10.1080/02699050802263019; McAllister TW, 2012, J NEUROTRAUM, V29, P1111, DOI 10.1089/neu.2011.1930; McHugh GS, 2007, J NEUROTRAUM, V24, P287, DOI 10.1089/neu.2006.0031; McIntyre LA, 2006, NEUROCRIT CARE, V5, P4, DOI 10.1385/NCC:5:1:4; McMillan TM, 2014, J NEUROL NEUROSUR PS, V85, P1214, DOI 10.1136/jnnp-2013-307279; McMillan TM, 2011, J NEUROL NEUROSUR PS, V82, P931, DOI 10.1136/jnnp.2010.222232; McMillan TM, 2012, J NEUROL NEUROSUR PS, V83, P1086, DOI 10.1136/jnnp-2012-302746; Meier R, 2008, CRIT CARE, V12, DOI 10.1186/cc6974; Meierhans R, 2010, CRIT CARE, V14, DOI 10.1186/cc8869; Menon DK, 2015, NAT REV NEUROL, V11, P71, DOI 10.1038/nrneurol.2014.261; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Menon DK, 2004, CRIT CARE MED, V32, P1384, DOI 10.1097/01.CCM.0000127777.16609.08; Miller MP, 2014, AM J EMERG MED, V32, P375, DOI 10.1016/j.ajem.2013.11.044; Moen KG, 2014, J NEUROTRAUM, V31, P1486, DOI 10.1089/neu.2013.3258; Moen KG, 2012, J NEUROL NEUROSUR PS, V83, P1193, DOI 10.1136/jnnp-2012-302644; Mondello S, 2012, J NEUROTRAUM, V29, P1096, DOI 10.1089/neu.2011.2092; Mondello S, 2011, CRIT CARE, V15, DOI 10.1186/cc10286; Morrison CA, 2011, J TRAUMA, V70, P652, DOI 10.1097/TA.0b013e31820e77ea; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; Munoz-Bendix C, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1088-1; Mura E, 2014, CURR PHARM DESIGN, V20, P4121; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Narayan RK, 2008, NEUROSURGERY, V62, P776, DOI 10.1227/01.NEU.0000297095.04013.C4; National Research Council Committee for the Update of the Guide for the C Use of Laboratory A, 2011, NAT AC COLL REP FUND; Newcombe VFJ, 2007, BRIT J NEUROSURG, V21, P340, DOI 10.1080/02688690701400882; Newell DW, 1997, ACTA NEUROCHIR, V139, P804, DOI 10.1007/BF01411398; Nortje J, 2008, CRIT CARE MED, V36, P273, DOI 10.1097/01.CCM.0000292014.60835.15; Nyam TTE, 2017, NEUROCRIT C IN PRESS; O'Boynick CP, 2014, NEUROSURG FOCUS, V37, DOI 10.3171/2014.5.FOCUS1473; O'Leary R, 2016, NEW ENGL J MED, V374, P1383, DOI 10.1056/NEJMc1600339; Oddo M, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1294-5; Oddo M, 2014, NEUROCRIT CARE, V21, P103, DOI 10.1007/s12028-014-0024-6; Oddo M, 2008, CRIT CARE MED, V36, P3233, DOI 10.1097/CCM.0b013e31818f4026; Oertel M, 2005, J NEUROSURG, V103, P812, DOI 10.3171/jns.2005.103.5.0812; Okasha AS, 2014, NEUROCRIT CARE, V21, P496, DOI 10.1007/s12028-014-9995-6; Okonkwo DO, 2013, J NEUROTRAUM, V30, P1490, DOI 10.1089/neu.2013.2883; Olivecrona M, 2009, J NEUROSURG, V110, P300, DOI 10.3171/2008.4.17538; Pajoumand M, 2016, J TRAUMA ACUTE CARE, V81, P345, DOI 10.1097/TA.0000000000001069; Papa L, 2012, ANN EMERG MED, V59, P471, DOI 10.1016/j.annemergmed.2011.08.021; Pape HC, 2009, J AM ACAD ORTHOP SUR, V17, P541, DOI 10.5435/00124635-200909000-00001; Parizel PM, 2005, EUR RADIOL, V15, P569, DOI 10.1007/s00330-004-2558-z; Parkin MC, 2005, J CEREBR BLOOD F MET, V25, P402, DOI 10.1038/sj.jcbfm.9600051; Pasco A, 2006, EUR RADIOL, V16, P1501, DOI 10.1007/s00330-005-0086-0; Patel HC, 2005, LANCET, V366, P1538, DOI 10.1016/S0140-6736(05)67626-X; Patel HC, 2002, INTENS CARE MED, V28, P547, DOI 10.1007/s00134-002-1235-4; Pelinka LE, 2004, J NEUROTRAUM, V21, P1553, DOI 10.1089/0897715042441846; Perel P, 2012, HEALTH TECHNOL ASSES, V16, P1, DOI 10.3310/hta16130; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Perel Pablo, 2006, BMC Med Inform Decis Mak, V6, P38, DOI 10.1186/1472-6947-6-38; Peterson EC, 2011, J TRAUMA, V71, P1588, DOI 10.1097/TA.0b013e31822b791d; Ponsford J, 2011, J NEUROTRAUM, V28, P1683, DOI 10.1089/neu.2010.1623; Pretz CR, 2013, ARCH PHYS MED REHAB, V94, P2486, DOI 10.1016/j.apmr.2013.06.021; Price L, 2015, BLOOD BRAIN BARRIER; Pugh MJV, 2015, J HEAD TRAUMA REHAB, V30, P29, DOI 10.1097/HTR.0000000000000045; Puljula J, 2016, ANN SURG, V263, P1235, DOI 10.1097/SLA.0000000000001392; Raymont V, 2008, BRAIN, V131, P543, DOI 10.1093/brain/awm300; REILLY PL, 1975, LANCET, V2, P375; Riker RR, 2014, NEUROCRIT CARE, V21, P27, DOI 10.1007/s12028-014-0025-5; Rincon F, 2014, J NEUROL NEUROSUR PS, V85, P799, DOI 10.1136/jnnp-2013-305505; Rizk EB, 2011, NEUROCRIT CARE, V15, P481, DOI 10.1007/s12028-011-9615-7; Roberts I, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000033.pub2; Roberts I, 2011, LANCET, V377, P1096, DOI 10.1016/S0140-6736(11)60278-X; Robertson CS, 2014, JAMA-J AM MED ASSOC, V312, P36, DOI 10.1001/jama.2014.6490; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; Rockswold SB, 2013, J NEUROSURG, V118, P1317, DOI 10.3171/2013.2.JNS121468; Romner B, 1996, J NEUROSURG, V85, P90, DOI 10.3171/jns.1996.85.1.0090; Ronne-Engstrom E, 2006, ACTA NEUROL SCAND, V114, P47, DOI 10.1111/j.1600-0404.2006.00652.x; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Roozenbeek B, 2011, CRIT CARE, V15, DOI 10.1186/cc10240; Rosenthal G, 2008, CRIT CARE MED, V36, P1917, DOI 10.1097/CCM.0b013e3181743d77; Rostami E, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00114; Rostami E, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00091; Ryu JH, 2013, NEUROCRIT CARE, V19, P222, DOI 10.1007/s12028-013-9824-3; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Sacho RH, 2010, J NEUROTRAUM, V27, P2157, DOI 10.1089/neu.2010.1384; Sadaka F, 2012, NEUROCRIT CARE, V16, P95, DOI 10.1007/s12028-011-9617-5; Sanchez-Izquierdo-Riera JA, 1998, ANESTH ANALG, V86, P1219, DOI 10.1097/00000539-199806000-00016; Sarrafzadeh AS, 2001, CRIT CARE MED, V29, P1116, DOI 10.1097/00003246-200106000-00004; Savers S, 2000, J NEUROTRAUM, V17, P507; Saxena M, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006811.pub3; Schaible EV, 2013, CURR OPIN ANESTHESIO, V26, P529, DOI 10.1097/01.aco.0000432519.16586.6b; Schochl H, 2011, J NEUROTRAUM, V28, P2033, DOI 10.1089/neu.2010.1744; Seel RT, 2013, ARCH PHYS MED REHAB, V94, P1908, DOI 10.1016/j.apmr.2012.11.052; Shafer A, 1998, CRIT CARE MED, V26, P947, DOI 10.1097/00003246-199805000-00034; Shakur H, 2010, LANCET, V376, P23, DOI 10.1016/S0140-6736(10)60835-5; Sharshar T, 2014, INTENS CARE MED, V40, P484, DOI 10.1007/s00134-014-3214-y; Shen X, 2015, J HEAD TRAUMA REHAB, V30, pE29, DOI 10.1097/HTR.0000000000000077; Shively S, 2012, ARCH NEUROL-CHICAGO, V69, P1245, DOI 10.1001/archneurol.2011.3747; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Signorini DF, 1999, J NEUROL NEUROSUR PS, V66, P26, DOI 10.1136/jnnp.66.1.26; Simard JM, 2012, J CEREBR BLOOD F MET, V32, P1699, DOI 10.1038/jcbfm.2012.91; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Smith MJ, 2005, CRIT CARE MED, V33, P1104, DOI 10.1097/01.CCM.0000162685.60609.49; Sorrentino E, 2012, NEUROCRIT CARE, V16, P258, DOI 10.1007/s12028-011-9630-8; Sorrentino E, 2011, NEUROCRIT CARE, V14, P188, DOI 10.1007/s12028-010-9492-5; Spahn DR, 2013, CRIT CARE, V17, DOI 10.1186/cc12685; Stein DM, 2012, J NEUROTRAUM, V29, P1140, DOI 10.1089/neu.2011.2149; Stein DM, 2011, J TRAUMA, V71, P364, DOI 10.1097/TA.0b013e31822820da; Steiner LA, 2005, ACTA NEUROCHIR, V147, P477, DOI 10.1007/s00701-005-0510-x; Steiner LA, 2004, INTENS CARE MED, V30, P2180, DOI 10.1007/s00134-004-2463-6; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; Stevens RD, 2014, CURR OPIN CRIT CARE, V20, P168, DOI 10.1097/MCC.0000000000000069; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Stocchetti N, 1996, J TRAUMA, V40, P764, DOI 10.1097/00005373-199605000-00014; Stocchetti N, 2008, INTENS CARE MED, V34, P461, DOI 10.1007/s00134-007-0948-9; Stocchetti N, 2012, J NEUROTRAUM, V29, P1119, DOI 10.1089/neu.2011.1995; Strong AJ, 2002, STROKE, V33, P2738, DOI 10.1161/01.STR.0000043073.69602.09; Su SH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087432; Taher A, 2016, TRAUMA MON, V21, DOI 10.5812/traumamon.26772; Takano T, 2007, NAT NEUROSCI, V10, P754, DOI 10.1038/nn1902; TEASDALE G, 1974, LANCET, V2, P81; Teasdale GM, 2005, BRAIN, V128, P2556, DOI 10.1093/brain/awh595; Teasdale GM, 1997, LANCET, V350, P1069, DOI 10.1016/S0140-6736(97)04318-3; Teasdale G, 2014, LANCET NEUROL, V13, P844, DOI 10.1016/S1474-4422(14)70120-6; Tepas JJ, 2013, J TRAUMA ACUTE CARE, V74, P143, DOI 10.1097/TA.0b013e3182788b5a; Timofeev I, 2011, BRAIN, V134, P484, DOI 10.1093/brain/awq353; Turner-Stokes L, 2014, CLIN MED, V14, P4, DOI 10.7861/clinmedicine.14-1-4; Unden L, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0533-y; Uzan M, 2005, ACTA NEUROCHIR, V147, P715, DOI 10.1007/s00701-005-0529-z; Vale FL, 1997, J NEUROSURG, V87, P239, DOI 10.3171/jns.1997.87.2.0239; Vallier HA, 2013, J ORTHOP TRAUMA, V27, P543, DOI 10.1097/BOT.0b013e31829efda1; Van Beek JGM, 2007, J NEUROTRAUM, V24, P315, DOI 10.1089/neu.2006.0034; Van den Berghe G, 2005, NEUROLOGY, V64, P1348, DOI 10.1212/01.WNL.0000158442.08857.FC; Vedantam A, 2016, J NEUROSURG, V125, P1229, DOI 10.3171/2015.11.JNS151515; Veenith TV, 2014, J CEREBR BLOOD F MET, V34, P1622, DOI 10.1038/jcbfm.2014.123; Verweij BH, 2000, J NEUROSURG, V93, P815, DOI 10.3171/jns.2000.93.5.0815; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Vespa PM, 2010, NEUROLOGY, V75, P792, DOI 10.1212/WNL.0b013e3181f07334; Vespa PM, 2016, JAMA NEUROL, V73, P504, DOI 10.1001/jamaneurol.2016.0251; Vespa PM, 2003, J CEREBR BLOOD F MET, V23, P865, DOI 10.1097/01.WCB.0000076701.45782.EF; Vik A, 2008, J NEUROSURG, V109, P678, DOI 10.3171/JNS/2008/109/10/0678; Vitek MP, 2009, NEUROBIOL AGING, V30, P1350, DOI 10.1016/j.neurobiolaging.2007.11.014; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1157, DOI 10.1089/neu.2009.1077; Vos PE, 2004, NEUROLOGY, V62, P1303, DOI 10.1212/01.WNL.0000120550.00643.DC; Wafaisade A, 2010, EMERG MED J, V27, P934, DOI 10.1136/emj.2009.088484; Wafaisade A, 2010, NEUROCRIT CARE, V12, P211, DOI 10.1007/s12028-009-9281-1; Wang HK, 2012, INJURY, V43, P1432, DOI 10.1016/j.injury.2011.03.059; Warner MA, 2010, J NEUROSURG, V113, P539, DOI 10.3171/2009.12.JNS091337; Washington PM, 2016, EXP NEUROL, V275, P381, DOI 10.1016/j.expneurol.2015.06.015; Waters RJ, 2013, J NEUROTRAUM, V30, P1710, DOI 10.1089/neu.2012.2792; Wijdicks EFM, 2005, ANN NEUROL, V58, P585, DOI 10.1002/ana.20611; Willmott C, 2013, BRAIN INJURY, V27, P1281, DOI 10.3109/02699052.2013.809553; Winkler EA, 2016, NEUROGENETICS, V17, P31, DOI 10.1007/s10048-015-0467-8; World Health Organization, 2006, NEUR DIS PUBL HLTH C; Wunsch H, 2011, AM J RESP CRIT CARE, V183, P1666, DOI 10.1164/rccm.201012-1961OC; Xu J., 2016, BIOPROCESSING PLANT, P1, DOI [10.1007/978-3-319-32004-5., DOI 10.1007/978-3-319-32004-5_14-121924345]; Yamal JM, 2015, J NEUROTRAUM, V32, P1239, DOI 10.1089/neu.2014.3752; Yanamadala V, 2014, J CLIN NEUROSCI, V21, P1881, DOI 10.1016/j.jocn.2014.05.001; Yuan Q, 2015, J NEUROSURG, V122, P574, DOI 10.3171/2014.10.JNS1460; Yue JK, 2015, NEUROGENETICS, V16, P169, DOI 10.1007/s10048-015-0437-1; Zygun DA, 2009, CRIT CARE MED, V37, P1074, DOI 10.1097/CCM.0b013e318194ad22	335	18	18	0	2	ELSEVIER SCIENCE BV	AMSTERDAM	SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0072-9752		978-0-12-803563-4; 978-0-44-463600-3	HAND CLINIC			2017	140						239	274		10.1016/B978-0-444-63600-3.00014-3			36	Critical Care Medicine; Clinical Neurology	General & Internal Medicine; Neurosciences & Neurology	BJ3DL	WOS:000422931500016	28187802				2021-06-18	
J	Nakhjavan-Shahraki, B; Yousefifard, M; Oraii, A; Sarveazad, A; Hosseini, M				Nakhjavan-Shahraki, Babak; Yousefifard, Mahmoud; Oraii, Alireza; Sarveazad, Arash; Hosseini, Mostafa			META-ANALYSIS OF NEURON SPECIFIC ENOLASE IN PREDICTING PEDIATRIC BRAIN INJURY OUTCOMES	EXCLI JOURNAL			English	Article						biomarker; pediatric; traumatic brain injury	ACUTE KIDNEY INJURY; GELATINASE-ASSOCIATED LIPOCALIN; CELL TRANSPLANTATION; CEREBROSPINAL-FLUID; BIOCHEMICAL MARKERS; TREATMENT RESPONSE; DIAGNOSTIC-VALUE; HEAD TRAUMA; SERUM; BIOMARKERS	A reliable biomarker has not been identified to predict the outcome of traumatic brain injury (TBI) in children. Therefore, the present systematic review and meta-analysis aimed to assess the association between neuron specific enolase (NSE) and traumatic brain injury (TBI) in children. Two independent reviewers searched electronic databases of EMBASE, Cochrane library, Medline and Scopus and then they summarized the results and did a quality control check. At the end, standardized mean difference (SMD) with 95 % confidence interval (CI) and performance of NSE were assessed. 10 studies were included in the present meta-analysis. Average serum (SMD=1.3; 95 % CI: 0.5 to 2.1; p=0.001) and CSF levels (SMD=2.45; 95 % CI: 1.04 to 3.8; p<0.0001) of NSE biomarker were significantly higher in children with TBI with unfavorable outcome compared with other children. Serum NSE had an area under the curve, sensitivity and specificity of 0.75 (95 % CI: 0.72 to 0.79), 0.74 (95 % CI: 0.64 to 0.82) and 0.69 (95 % CI: 0.59 to 0.77), respectively in prediction outcome of TBI. Positive likelihood ratio, negative likelihood ratio and diagnostic odds ratio of serum NSE were 2.4 (95 % CI: 1.7 to 3.3), 0.38 (95 % CI: 0.26 to 0.55) and 6.0 (95 % CI: 3.0 to 12.0), respectively. The results show that the performance of NSE is in a moderate level in prediction of unfavorable outcome in children with TBI. However, data in this aspect is not sufficient and more studies are needed.	[Nakhjavan-Shahraki, Babak] Univ Tehran Med Sci, Sina Trauma & Surg Res Ctr, Tehran, Iran; [Yousefifard, Mahmoud] Iran Univ Med Sci, Fac Med, Physiol Res Ctr, Tehran, Iran; [Yousefifard, Mahmoud] Iran Univ Med Sci, Fac Med, Dept Physiol, Tehran, Iran; [Oraii, Alireza] Univ Tehran Med Sci, Sch Med, Dept Med, Tehran, Iran; [Sarveazad, Arash] Iran Univ Med Sci, Colorectal Res Ctr, Tehran, Iran; [Hosseini, Mostafa] Univ Tehran Med Sci, Sch Publ Hlth, Dept Epidemiol & Biostat, Poursina Ave, Tehran, Iran	Hosseini, M (corresponding author), Univ Tehran Med Sci, Sch Publ Hlth, Dept Epidemiol & Biostat, Poursina Ave, Tehran, Iran.	babaknakhjavanshahraki@yahoo.com; yousefifard20@gmail.com; alirezaoraii@gmail.com; arashsarveazad@gmail.com; mhossein110@yahoo.com	Yousefifard, Mahmoud/P-1621-2018; Sarveazad, Arash/L-2064-2018	Yousefifard, Mahmoud/0000-0001-5181-4985; Sarveazad, Arash/0000-0001-9273-1940; Oraii, Alireza/0000-0002-2422-2930; hosseini, mostafa/0000-0002-1334-246X			Bandyopadhyay S, 2005, ACAD EMERG MED, V12, P732, DOI 10.1197/j.aem.2005.02.017; Berger RP, 2005, J NEUROSURG, V103, P61, DOI 10.3171/ped.2005.103.1.0061; Berger RP, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e31; Cheng F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106680; Chiaretti A, 2009, NEUROLOGY, V72, P609, DOI 10.1212/01.wnl.0000342462.51073.06; Daoud H, 2014, NEUROCRIT CARE, V20, P427, DOI 10.1007/s12028-013-9879-1; Dayan PS, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-2709; DeFazio MV, 2014, WORLD NEUROSURG, V81, P151, DOI 10.1016/j.wneu.2013.01.015; Ebrahimi Ali, 2014, Tanaffos, V13, P29; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; ELSON LM, 1994, SEMIN NEUROL, V14, P8, DOI 10.1055/s-2008-1041053; Fridriksson T, 2000, ACAD EMERG MED, V7, P816, DOI 10.1111/j.1553-2712.2000.tb02276.x; Geyer C, 2009, J NEUROS-PEDIATR, V4, P339, DOI 10.3171/2009.5.PEDS08481; Ghelichkhani P, 2016, INT J PEDIATR-MASSHA, V4, P3503, DOI 10.22038/ijp.2016.7409; Haque A, 2016, METAB BRAIN DIS, V31, P487, DOI 10.1007/s11011-016-9801-6; Hassanzadeh-Rad A, 2016, J GASTROEN HEPATOL, V31, P929, DOI 10.1111/jgh.13247; Hedt BL, 2011, STAT MED, V30, P560, DOI 10.1002/sim.3920; HIGGINS JPT, 2011, COCHRANE HDB SYSTEMA, V0001; Hosseini M, 2016, J CHEM NEUROANAT, V78, P102, DOI 10.1016/j.jchemneu.2016.09.002; Hosseini M, 2015, EMERGENCY, V3, P127; Hosseini M, 2015, BIOL BLOOD MARROW TR, V21, P1537, DOI 10.1016/j.bbmt.2015.05.008; Hozo Stela Pudar, 2005, BMC Med Res Methodol, V5, P13, DOI 10.1186/1471-2288-5-13; Hrobjartsson A, 2014, INT J EPIDEMIOL, V43, P1272, DOI 10.1093/ije/dyu115; Izadi A, 2016, INT J PEDIATR-MASSHA, V4, P3875, DOI 10.22038/ijp.2016.7783; Izadi A, 2016, INT J PEDIATR-MASSHA, V4, P3815, DOI 10.22038/ijp.2016.7782; Kochanek PM, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00040; Lo TYM, 2010, J NEUROTRAUM, V27, P2139, DOI 10.1089/neu.2010.1387; McMillan T, 2016, NAT REV NEUROL, V12, P477, DOI 10.1038/nrneurol.2016.89; Menascu S, 2010, PEDIATR NEUROSURG, V46, P82, DOI 10.1159/000319004; Mercier E, 2012, CRITICAL CARE, V16, pS112; Mercier Eric, 2016, CMAJ Open, V4, pE371; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b2535, 10.1371/journal.pmed.1000097, 10.1016/j.ijsu.2010.02.007]; Nakhjavan-Shahraki B, 2017, BMC NEPHROL, V18, DOI 10.1186/s12882-017-0539-0; Papa L, 2015, NEUROCRIT CARE, V22, P52, DOI 10.1007/s12028-014-0028-2; Rahimi-Movaghar V, 2016, EMERGENCY, V4, P116; Rodriguez-Rodriguez A, 2016, NEUROL RES, V38, P130, DOI 10.1080/01616412.2016.1144410; Safari S, 2016, CLIN EXP NEPHROL, V20, P153, DOI 10.1007/s10157-015-1204-1; Shore PM, 2007, J NEUROTRAUM, V24, P75, DOI 10.1089/neu.2006.0062; Sistrom CL, 2000, AM J ROENTGENOL, V174, P1241, DOI 10.2214/ajr.174.5.1741241; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Thurman DJ, 2016, J CHILD NEUROL, V31, P20, DOI 10.1177/0883073814544363; Varma S, 2003, J NEUROTRAUM, V20, P781, DOI 10.1089/089771503767870005; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009; Wilkinson AA, 2016, PEDIATR CRIT CARE ME, V17, P638, DOI 10.1097/PCC.0000000000000752; Yousefifard M, 2016, NEUROSCIENCE, V322, P377, DOI 10.1016/j.neuroscience.2016.02.034; Yousefifard M, 2016, EMERG TEHRAN, V5, pe37; Yousefifard M, 2016, EMERGENCY, V4, P55; Yousefifard M, 2016, EMERGENCY, V4, P1; Zurek J, 2012, ACTA NEUROCHIR, V154, P93, DOI 10.1007/s00701-011-1175-2	50	18	18	0	2	EXCLI JOURNAL MANAGING OFFICE	DORTMUND	LEIBNIZ RESEARCH CENTRE WORKING ENVIRONMENT & HUMAN FACTORS EXCLI JOURNAL, ARDEYSTR 67, DORTMUND, D-44139, GERMANY	1611-2156			EXCLI J	EXCLI J.		2017	16						995	1008		10.17179/excli2017-405			14	Biology	Life Sciences & Biomedicine - Other Topics	FB6SG	WOS:000406272100028	28900380	DOAJ Gold			2021-06-18	
J	Nardone, R; Holler, Y; Langthaler, PB; Lochner, P; Golaszewski, S; Schwenker, K; Brigo, F; Trinka, E				Nardone, R.; Hoeller, Y.; Langthaler, P. B.; Lochner, P.; Golaszewski, S.; Schwenker, K.; Brigo, F.; Trinka, E.			rTMS of the prefrontal cortex has analgesic effects on neuropathic pain in subjects with spinal cord injury	SPINAL CORD			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; BRAIN ANATOMY; BACK-PAIN; DEPRESSION; MODULATION; MECHANISMS; DEPENDS; DISEASE; PLACEBO; SESSION	Study design: Repetitive transcranial magnetic stimulation study. Objectives: The analgesic effects of repetitive transcranial magnetic stimulation (rTMS) in chronic pain have been the focus of several studies. In particular, rTMS of the premotor cortex/dorsolateral prefrontal cortex (PMC/DLPFC) changes pain perception in healthy subjects and has analgesic effects in acute postoperative pain, as well as in fibromyalgia patients. However, its effect on neuropathic pain in patients with traumatic spinal cord injury (SCI) has not been assessed. Setting: Merano (Italy) and Salzburg (Austria). Methods: In this study, we performed PMC/DLPFC rTMS in subjects with SCI and neuropathic pain. Twelve subjects with chronic cervical or thoracic SCI were randomized to receive 1250 pulses at 10 Hz rTMS (n=6) or sham rTMS (n=6) treatment for 10 sessions over 2 weeks. The visual analog scale, the sensory and affective pain rating indices of the McGill Pain Questionnaire (MPQ), the Hamilton Depression Rating Scale and the Hamilton Anxiety Rating Scale were used to assed pain and mood at baseline (T0), 1 day after the first week of treatment (T1), 1 day (T2), 1 week (T3) and 1 month (T4) after the last intervention. Results: Subjects who received active rTMS had a statistically significant reduction in pain symptoms in comparison with their baseline pain, whereas sham rTMS participants had a non-significant change in daily pain from their baseline pain. Conclusion: The findings of this preliminary study in a small patient sample suggest that rTMS of the PMC/DLPFC may be effective in relieving neuropathic pain in SCI patients.	[Nardone, R.; Hoeller, Y.; Langthaler, P. B.; Golaszewski, S.; Schwenker, K.; Trinka, E.] Paracelsus Med Univ, Christian Doppler Klin, Dept Neurol, Salzburg, Austria; [Nardone, R.; Hoeller, Y.; Langthaler, P. B.; Golaszewski, S.; Schwenker, K.; Trinka, E.] Ctr Cognit Neurosci, Salzburg, Austria; [Nardone, R.; Lochner, P.; Brigo, F.] Franz Tappeiner Hosp, Dept Neurol, Merano, Italy; [Nardone, R.; Hoeller, Y.; Langthaler, P. B.; Golaszewski, S.; Schwenker, K.; Trinka, E.] Paracelsus Med Univ, Spinal Cord Injury & Tissue Regenerat Ctr, Salzburg, Austria; [Langthaler, P. B.] Paris Lodron Univ Salzburg, Dept Math, Salzburg, Austria; [Brigo, F.] Univ Verona, Dept Neurol & Movement Sci, Verona, Italy	Nardone, R (corresponding author), Franz Tappeiner Hosp, Dept Neurol, Via Rossini,5, I-39012 Merano, Italy.	raffaele.nardone@asbmeran-o.it	Holler, Yvonne/I-8928-2017; Lochner, Piergiorgio/AAB-6784-2020; Brigo, Francesco/H-6513-2013	Holler, Yvonne/0000-0002-1727-8557; Lochner, Piergiorgio/0000-0002-2101-6066; Nardone, Raffaele/0000-0001-5243-6760; Brigo, Francesco/0000-0003-0928-1577			Ahdab R, 2010, NEUROPHYSIOL CLIN, V40, P27, DOI 10.1016/j.neucli.2010.01.001; Andre-Obadia N, 2008, NEUROLOGY, V71, P833, DOI 10.1212/01.wnl.0000325481.61471.f0; Apkarian AV, 2005, EUR J PAIN, V9, P463, DOI 10.1016/j.ejpain.2004.11.001; Apkarian AV, 2004, J NEUROSCI, V24, P10410, DOI 10.1523/JNEUROSCI.2541-04.2004; Avery DH, 2007, J NERV MENT DIS, V195, P378, DOI 10.1097/NMD.0b013e31802f58d1; de Oliveira RAA, 2014, J PAIN, V15, P1271, DOI 10.1016/j.jpain.2014.09.009; Baron R, 1999, NEUROLOGY, V53, P548, DOI 10.1212/WNL.53.3.548; Boggio PS, 2005, MOVEMENT DISORD, V20, P1178, DOI 10.1002/mds.20508; Borckardt JJ, 2011, PAIN, V152, P182, DOI 10.1016/j.pain.2010.10.018; Borckardt JJ, 2008, BRAIN STIMUL, V1, P122, DOI 10.1016/j.brs.2008.04.002; Brighina F, 2011, J HEADACHE PAIN, V12, P185, DOI 10.1007/s10194-011-0322-8; Chouinard PA, 2003, J NEUROPHYSIOL, V90, P1071, DOI 10.1152/jn.01105.2002; de Andrade DC, 2014, PAIN, V155, P598, DOI 10.1016/j.pain.2013.12.022; Defrin R, 2007, ARCH PHYS MED REHAB, V88, P1574, DOI 10.1016/j.apmr.2007.07.025; Dersh J, 2002, PSYCHOSOM MED, V64, P773, DOI 10.1097/01.PSY.0000024232.11538.54; Dworkin RH, 2007, PAIN, V132, P237, DOI 10.1016/j.pain.2007.08.033; Fierro B, 2010, EXP BRAIN RES, V203, P31, DOI 10.1007/s00221-010-2206-6; Fitzgerald PB, 2009, BRAIN STIMUL, V2, P234, DOI 10.1016/j.brs.2009.03.002; Funahashi S, 2001, NEUROSCI RES, V39, P147, DOI 10.1016/S0168-0102(00)00224-8; GEORGE MS, 1994, CONVULSIVE THER, V10, P251; Gustin SM, 2010, CEREB CORTEX, V20, P1409, DOI 10.1093/cercor/bhp205; Hallett M, 2007, NEURON, V55, P187, DOI 10.1016/j.neuron.2007.06.026; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; HAMILTON M, 1959, BRIT J MED PSYCHOL, V32, P50, DOI 10.1111/j.2044-8341.1959.tb00467.x; HARDY SGP, 1985, BRAIN RES, V339, P285; HARDY SGP, 1985, BRAIN RES, V339, P281; Jette F, 2013, NEUROREHAB NEURAL RE, V27, P636, DOI 10.1177/1545968313484810; Kang BS, 2009, ARCH PHYS MED REHAB, V90, P1766, DOI 10.1016/j.apmr.2009.04.008; Klein MM, 2015, PAIN, V156, P1601, DOI 10.1097/j.pain.0000000000000210; Lefaucheur JP, 2014, CLIN NEUROPHYSIOL, V125, P2150, DOI 10.1016/j.clinph.2014.05.021; Lefaucheur JP, 2009, BRAIN STIMUL, V2, P138, DOI 10.1016/j.brs.2009.01.002; Lefaucheur JP, 2004, J NEUROL NEUROSUR PS, V75, P612, DOI 10.1136/jnnp.2003.022236; Lorenz J, 2003, BRAIN, V126, P1079, DOI 10.1093/brain/awg102; Loubinoux I, 2012, J CELL MOL MED, V16, P1961, DOI 10.1111/j.1582-4934.2012.01555.x; MELZACK R, 1975, PAIN, V1, P277, DOI 10.1016/0304-3959(75)90044-5; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Nahmias F, 2009, PAIN, V147, P224, DOI 10.1016/j.pain.2009.09.016; Noguchi K, 2012, J STAT SOFTW, V50, P1, DOI 10.18637/jss.v050.i12; Obermann M, 2013, NEUROIMAGE, V74, P352, DOI 10.1016/j.neuroimage.2013.02.029; Paus T, 2001, EUR J NEUROSCI, V14, P1405, DOI 10.1046/j.0953-816x.2001.01757.x; Petrovic P, 2002, SCIENCE, V295, P1737, DOI 10.1126/science.1067176; Pincus T, 1999, J PSYCHOSOM RES, V47, P211, DOI 10.1016/S0022-3999(99)00045-8; PRICE DD, 1988, PAIN, V34, P245, DOI 10.1016/0304-3959(88)90119-4; Rossini PM, 2015, CLIN NEUROPHYSIOL, V126, P1071, DOI 10.1016/j.clinph.2015.02.001; Rumi DO, 2005, BIOL PSYCHIAT, V57, P162, DOI 10.1016/j.biopsych.2004.10.029; Schweinhardt P, 2008, NEUROIMAGE, V40, P759, DOI 10.1016/j.neuroimage.2007.12.016; Seminowicz DA, 2011, J NEUROSCI, V31, P7540, DOI 10.1523/JNEUROSCI.5280-10.2011; Short EB, 2011, PAIN, V152, P2477, DOI 10.1016/j.pain.2011.05.033; Stanwell P, 2010, NEUROIMAGE, V53, P544, DOI 10.1016/j.neuroimage.2010.06.051; Strafella AP, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-15-j0003.2001; Tazoe T, 2015, ARCH PHYS MED REHAB, V96, pS145, DOI 10.1016/j.apmr.2014.07.418; Treede RD, 2008, NEUROLOGY, V70, P1630, DOI 10.1212/01.wnl.0000282763.29778.59; Yilmaz B, 2014, J SPINAL CORD MED, V37, P397, DOI 10.1179/2045772313Y.0000000172; Yoon EJ, 2013, BRAIN RES, V1540, P64, DOI 10.1016/j.brainres.2013.10.007	54	18	21	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1362-4393	1476-5624		SPINAL CORD	Spinal Cord	JAN	2017	55	1					20	25		10.1038/sc.2016.87			6	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	EK9XA	WOS:000394276000004	27241450	Bronze			2021-06-18	
J	Ozay, R; Turkoglu, E; Gurer, B; Dolgun, H; Evirgen, O; Erguder, BI; Hayirli, N; Gurses, L; Sekerci, Z; Yilmaz, ER				Ozay, Rafet; Turkoglu, Erhan; Gurer, Bora; Dolgun, Habibullah; Evirgen, Oya; Erguder, Berrin Imge; Hayirli, Nazli; Gurses, Levent; Sekerci, Zeki; Yilmaz, Erdal Resit			Does Decorin Protect Neuronal Tissue via Its Antioxidant and Antiinflammatory Activity from Traumatic Brain Injury? An Experimental Study	WORLD NEUROSURGERY			English	Article						Antioxidants; Apoptosis; Decorin; Methylprednisolone; Neuroprotection; Traumatic brain injury	GROWTH-FACTOR-BETA; SPINAL-CORD; OXIDATIVE STRESS; LIPID-PEROXIDATION; TGF-BETA; BLOOD; EXPRESSION; SYSTEM; DAMAGE; METHYLPREDNISOLONE	BACKGROUND: The development of secondary brain injury via oxidative stress after traumatic brain injury (TBI) is well known. Decorin (DC) inactivates transforming growth factor beta 1, complement system, and tumor necrosis factor alpha, which are related to oxidative stress and apoptosis. Consequently, the aim of the present study was to evaluate the role of DC on TBI. METHODS: A total of 24 male rats were used and divided into 4 groups as follows; control, trauma, DC, and methylprednisolone (MP). The trauma, DC, and MP groups were subjected to closed-head contusive weight-drop injuries. Rats received treatment with intraperitoneal saline, DC, or MP, respectively. All the animals were killed at the 24th hour after trauma and brain tissues were extracted. The oxidant/antioxidant parameters (malondialdehyde, glutathione peroxidase, superoxide dismutase, and NO) and caspase 3 in the cerebral tissue were analyzed, and histomorphologic evaluation of the cerebral tissue was performed. RESULTS: Levels of malondialdehyde, NO, and activity of caspase 3 were significantly reduced, and in addition glutathione peroxidase and superoxide dismutase levels were increased in the DC and MP groups compared with the trauma group. The pathology scores and the percentage of degenerated neurons were statistically lower in the DC and MP groups than in the trauma group. CONCLUSIONS: The results of the present study showed that DC inactivates transforming growth factor beta 1 and protects the brain tissue and neuronal cells after TBI.	[Ozay, Rafet; Turkoglu, Erhan; Dolgun, Habibullah; Gurses, Levent; Sekerci, Zeki; Yilmaz, Erdal Resit] Minist Hlth Diskapi Yildirim Beyazit Training & R, Neurosurg Clin, Ankara, Turkey; [Gurer, Bora] Minist Hlth Fatih Sultan Mehmet Training & Res Ho, Neurosurg Clin, Istanbul, Turkey; [Evirgen, Oya; Hayirli, Nazli] Ankara Univ, Fac Med, Dept Histol & Embryol, Ankara, Turkey; [Erguder, Berrin Imge] Ankara Univ, Fac Med, Dept Biochem, Ankara, Turkey	Ozay, R (corresponding author), Minist Hlth Diskapi Yildirim Beyazit Training & R, Neurosurg Clin, Ankara, Turkey.	rftozay@hotmail.com	dolgun, habibullah/AAF-6745-2021; Evirgen, Oya/AAH-7582-2020; Turkoglu, Erhan/AAB-6395-2020; Erguder, Imge/AAZ-5673-2020; Dolgun, Habibullah/AAL-6610-2021; Gurer, Bora/K-1177-2012	Evirgen, Oya/0000-0001-6456-1083; Dolgun, Habibullah/0000-0002-1513-2044; Gurer, Bora/0000-0003-1500-6184; /0000-0003-0628-9223			Abdul-Muneer PM, 2015, MOL NEUROBIOL, V51, P966, DOI 10.1007/s12035-014-8752-3; Alan C, 2011, ARCH MED SCI, V7, P211, DOI 10.5114/aoms.2011.22069; Albert-Weissenberger C, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00269; ANDERSON DK, 1982, J NEUROSURG, V56, P106, DOI 10.3171/jns.1982.56.1.0106; Angeloni C, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/370312; Bae James J, 2011, Int J Physiol Pathophysiol Pharmacol, V3, P9; Bains M, 2012, BBA-MOL BASIS DIS, V1822, P675, DOI 10.1016/j.bbadis.2011.10.017; Basarslan SK, 2015, ULUS TRAVMA ACIL CER, V21, P235, DOI 10.5505/tjtes.2015.66502; Bermpohl D, 2007, J CEREBR BLOOD F MET, V27, P1806, DOI 10.1038/sj.jcbfm.9600487; Boudreau HE, 2012, FREE RADICAL BIO MED, V53, P1489, DOI 10.1016/j.freeradbiomed.2012.06.016; Bracken MB, 1997, JAMA-J AM MED ASSOC, V277, P1597, DOI 10.1001/jama.277.20.1597; Brazinova A, 2021, J NEUROTRAUM, V38, P1411, DOI 10.1089/neu.2015.4126; Chen G, 2008, MEDIAT INFLAMM, V2008, DOI 10.1155/2008/716458; Cherian L, 2000, J NEUROPHYSIOL, V83, P2171; Davies JE, 2004, EUR J NEUROSCI, V19, P1226, DOI 10.1111/j.1460-9568.2004.03184.x; Deng Y, 2007, EXP NEUROL, V205, P154, DOI 10.1016/j.expneurol.2007.01.023; Durak I, 2001, ACTA ANAESTH SCAND, V45, P119, DOI 10.1034/j.1399-6576.2001.450118.x; Ferdous Z, 2007, J BIOL CHEM, V282, P35887, DOI 10.1074/jbc.M705180200; Grant DS, 2002, ONCOGENE, V21, P4765, DOI 10.1038/sj.onc.1205595; Hall ED, 1997, J NEUROSCI METH, V76, P115, DOI 10.1016/S0165-0270(97)00089-7; Hall ED, 2010, NEUROTHERAPEUTICS, V7, P51, DOI 10.1016/j.nurt.2009.10.021; Hiebert JB, 2015, AM J MED SCI, V350, P132, DOI 10.1097/MAJ.0000000000000506; Imai K, 1997, BIOCHEM J, V322, P809, DOI 10.1042/bj3220809; Jain M, 2013, J BIOL CHEM, V288, P770, DOI 10.1074/jbc.M112.431973; Jortner BS, 2006, NEUROTOXICOLOGY, V27, P628, DOI 10.1016/j.neuro.2006.03.002; Kalamajski S, 2010, MATRIX BIOL, V29, P248, DOI 10.1016/j.matbio.2010.01.001; Kappler J, 1998, BRAIN RES, V793, P328, DOI 10.1016/S0006-8993(98)00260-1; KONTOS HA, 1986, J NEUROSURG, V64, P803, DOI 10.3171/jns.1986.64.5.0803; KRUMDIECK R, 1992, J IMMUNOL, V149, P3695; Lewen A, 2001, J CEREBR BLOOD F MET, V21, P344, DOI 10.1097/00004647-200104000-00003; Liu RM, 2010, FREE RADICAL BIO MED, V48, P1, DOI 10.1016/j.freeradbiomed.2009.09.026; Liu RM, 2015, REDOX BIOL, V6, P565, DOI 10.1016/j.redox.2015.09.009; Logan A, 1999, EXP NEUROL, V159, P504, DOI 10.1006/exnr.1999.7180; Longhi L, 2008, ACTA NEUROCHIR SUPPL, V102, P381, DOI 10.1007/978-3-211-85578-2_73; Lorente L, 2015, ARCH TRAUMA RES, V4, DOI 10.5812/atr.30165; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Mecollari V, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00328; Minor KH, 2011, BRAIN, V134, P1140, DOI 10.1093/brain/awq304; Moscatello DK, 1998, J CLIN INVEST, V101, P406, DOI 10.1172/JCI846; Nichols NR, 2005, BRAIN RES REV, V48, P287, DOI 10.1016/j.brainresrev.2004.12.019; PAGLIA DE, 1967, J LAB CLIN MED, V70, P158; Reinert M, 2000, ACTA NEUROCHIR SUPPL, V76, P439; Rodriguez-Rodriguez A, 2014, CURR MED CHEM, V21, P1201, DOI 10.2174/0929867321666131217153310; Sato K, 2003, MUSCLE NERVE, V28, P365, DOI 10.1002/mus.10436; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Smith JA, 2013, NEUROCHEM INT, V62, P764, DOI 10.1016/j.neuint.2013.02.013; SMITH SL, 1994, J NEUROTRAUM, V11, P393, DOI 10.1089/neu.1994.11.393; Springer JE, 2002, J BIOCHEM MOL BIOL, V35, P94; Stahel PF, 1998, BRAIN RES REV, V27, P243, DOI 10.1016/S0165-0173(98)00015-0; Stahel PF, 2001, J NEUROTRAUM, V18, P773, DOI 10.1089/089771501316919139; Stichel CC, 1995, BRAIN RES, V704, P263, DOI 10.1016/0006-8993(95)01131-5; Suehiro E, 2004, J NEUROTRAUM, V21, P1706, DOI 10.1089/0897715042664957; SUN Y, 1988, CLIN CHEM, V34, P497; Tufvesson E, 2002, FEBS LETT, V530, P124, DOI 10.1016/S0014-5793(02)03439-7; YAMAGUCHI Y, 1990, NATURE, V346, P281, DOI 10.1038/346281a0; Yilmaz ER, 2013, ACTA NEUROCHIR, V155, P141, DOI 10.1007/s00701-012-1501-3	57	18	20	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	JAN	2017	97						407	415		10.1016/j.wneu.2016.09.115			9	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	EO1HO	WOS:000396449400055	27744073				2021-06-18	
J	Poff, AM; Kernagis, D; D'Agostino, DP				Poff, Angela M.; Kernagis, Dawn; D'Agostino, Dominic P.			Hyperbaric Environment: Oxygen and Cellular Damage versus Protection	COMPREHENSIVE PHYSIOLOGY			English	Article							GROWTH-FACTOR EXPRESSION; TRAUMATIC BRAIN-INJURY; LOW-CARBOHYDRATE DIET; ACUTE LUNG INJURY; LIPID-PEROXIDATION; OXIDATIVE STRESS; KETOGENIC DIET; NITRIC-OXIDE; DNA-DAMAGE; ISCHEMIC TOLERANCE	The elevation of tissue pO(2) induced by hyperbaric oxygen (HBO) is a physiological stimulus that elicits a variety of cellular responses. These effects are largely mediated by, or in response to, an increase in the production of reactive oxygen and nitrogen species (RONS). The major consequences of elevated RONS include increased oxidative stress and enhanced antioxidant capacity, and modulation of redox-sensitive cell signaling pathways. Interestingly, these phenomena underlie both the therapeutic and potentially toxic effects of HBO. Emerging evidence indicates that supporting mitochondrial health is a potential method of enhancing the therapeutic efficacy of, and preventing oxygen toxicity during, HBO. This review will focus on the cellular consequences of HBO, and explore how these processes mediate a delicate balance of cellular protection versus damage. (C) 2017 American Physiological Society.	[Poff, Angela M.; D'Agostino, Dominic P.] Univ S Florida, Morsani Coll Med, Dept Mol Pharmacol & Physiol, Tampa, FL 33620 USA; [Kernagis, Dawn; D'Agostino, Dominic P.] Inst Human & Machine Cognit, Pensacola, FL 32502 USA	D'Agostino, DP (corresponding author), Univ S Florida, Morsani Coll Med, Dept Mol Pharmacol & Physiol, Tampa, FL 33620 USA.; D'Agostino, DP (corresponding author), Inst Human & Machine Cognit, Pensacola, FL 32502 USA.	ddagosti@health.usf.edu					Abe M, 2012, JPN J RADIOL, V30, P340, DOI 10.1007/s11604-011-0046-3; Al-Waili NS, 2005, MED SCI MONITOR, V11, pRA279; Pereira ALA, 2014, ACTA CIR BRAS, V29, P771, DOI 10.1590/S0102-86502014001900001; Allen BW, 2009, J APPL PHYSIOL, V106, P662, DOI 10.1152/japplphysiol.91109.2008; Alleva R, 2005, BIOCHEM BIOPH RES CO, V333, P404, DOI 10.1016/j.bbrc.2005.05.119; Almzaiel AJ, 2013, LIFE SCI, V93, P125, DOI 10.1016/j.lfs.2013.06.003; Arieli Y, 2014, RESP PHYSIOL NEUROBI, V197, P29, DOI 10.1016/j.resp.2014.03.006; Asano T, 2007, CIRC J, V71, P405, DOI 10.1253/circj.71.405; Baynosa RC, 2013, J SURG RES, V183, P355, DOI 10.1016/j.jss.2013.01.004; Baynosa RC, 2012, UNDERSEA HYPERBAR M, V39, P857; Bellance N, 2009, FRONT BIOSCI-LANDMRK, V14, P4015, DOI 10.2741/3509; Benson RM, 2003, CLIN EXP IMMUNOL, V134, P57, DOI 10.1046/j.1365-2249.2003.02248.x; Bert P., 1943, BAROMETRIC PRESSURE; Bertout JA, 2008, NAT REV CANCER, V8, P967, DOI 10.1038/nrc2540; Bhutani S, 2012, INDIAN J PLAST SURG, V45, P316, DOI 10.4103/0970-0358.101309; Bitterman H, 2009, CRIT CARE, V13, DOI 10.1186/cc7151; Bitterman N, 1997, BRAIN RES, V761, P146, DOI 10.1016/S0006-8993(97)00442-3; BOADI WY, 1991, PHARMACOL TOXICOL, V68, P77, DOI 10.1111/j.1600-0773.1991.tb02039.x; Brown GC, 2012, MITOCHONDRION, V12, P1, DOI 10.1016/j.mito.2011.02.001; BUTLER FK, 1986, UNDERSEA BIOMED RES, V13, P91; Butler FK, 2004, UNDERSEA HYPERBAR M, V31, P3; CALDWELL PR, 1966, J APPL PHYSIOL, V21, P1477; Cameron L, 2012, POSTGRAD MED J, V88, P684, DOI 10.1136/postgradmedj-2012-130809; Camporesi EM, 2014, UNDERSEA HYPERBAR M, V41, P259; Chavko M, 1996, FREE RADICAL BIO MED, V20, P973, DOI 10.1016/0891-5849(95)02181-7; Chen LF, 2014, J FORMOS MED ASSOC, V113, P620, DOI 10.1016/j.jfma.2014.03.012; Chen SJ, 2007, CLIN BIOCHEM, V40, P30, DOI 10.1016/j.clinbiochem.2006.07.007; Chen X, 2014, NEUROSCIENCE, V266, P235, DOI 10.1016/j.neuroscience.2013.11.036; Cheng OM, 2011, STROKE, V42, P484, DOI 10.1161/STROKEAHA.110.604421; Ciencewicki J, 2008, J ALLERGY CLIN IMMUN, V122, P456, DOI 10.1016/j.jaci.2008.08.004; Claireaux A E, 1975, J Clin Pathol Suppl (R Coll Pathol), V9, P75; CLARK JM, 1971, PHARMACOL REV, V23, P37; COMROE JH, 1945, JAMA-J AM MED ASSOC, V128, P710, DOI 10.1001/jama.1945.02860270012004; CRAPO JD, 1986, ANNU REV PHYSIOL, V48, P721; CRAPO JD, 1980, AM REV RESPIR DIS, V122, P123; D'agostino DP, 2009, NEUROSCIENCE, V159, P1011, DOI 10.1016/j.neuroscience.2009.01.062; D'Agostino DP, 2013, AM J PHYSIOL-REG I, V304, pR829, DOI 10.1152/ajpregu.00506.2012; D'Autreaux B, 2007, NAT REV MOL CELL BIO, V8, P813, DOI 10.1038/nrm2256; Daruwalla J, 2006, WORLD J SURG, V30, P2112, DOI 10.1007/s00268-006-0190-6; DAVIES KJA, 1987, J BIOL CHEM, V262, P8220; Davis LM, 2008, J NEUROSCI RES, V86, P1812, DOI 10.1002/jnr.21628; Dean JB, 2010, J APPL PHYSIOL, V108, P1786, DOI 10.1152/japplphysiol.01337.2009; Dean JB, 2003, J APPL PHYSIOL, V95, P883, DOI 10.1152/japplphysiol.00920.2002; Dean JB, 2004, J APPL PHYSIOL, V96, P784, DOI 10.1152/japplphysiol.00892.2003; Demchenko IT, 2005, J CEREBR BLOOD F MET, V25, P1288, DOI 10.1038/sj.jcbfm.9600110; Demchenko IT, 2007, AM J PHYSIOL-LUNG C, V293, pL229, DOI 10.1152/ajplung.00450.2006; Demchenko IT, 2013, J APPL PHYSIOL, V115, P819, DOI 10.1152/japplphysiol.00625.2013; DEMPLE B, 1994, ANNU REV BIOCHEM, V63, P915, DOI 10.1146/annurev.biochem.63.1.915; Dennog C, 1999, MUTAT RES-FUND MOL M, V428, P83, DOI 10.1016/S1383-5742(99)00034-4; Dennog C, 1996, MUTAGENESIS, V11, P605, DOI 10.1093/mutage/11.6.605; DIRKS RC, 1982, BRAIN RES, V248, P355, DOI 10.1016/0006-8993(82)90594-7; DONALD K W, 1947, Br Med J, V1, ppassim; Elayan IM, 2000, J NEUROPHYSIOL, V83, P2022; Erecinska M, 2001, RESP PHYSIOL, V128, P263, DOI 10.1016/S0034-5687(01)00306-1; Feldmeier J, 2003, UNDERSEA HYPERBAR M, V30, P1; Fenech M, 1999, MUTAT RES-FUND MOL M, V428, P271, DOI 10.1016/S1383-5742(99)00053-8; Fildissis G, 2004, EUR CYTOKINE NETW, V15, P217; Forsythe CE, 2008, LIPIDS, V43, P65, DOI 10.1007/s11745-007-3132-7; FREEMAN BA, 1982, LAB INVEST, V47, P412; GABB G, 1987, CHEST, V92, P1074, DOI 10.1378/chest.92.6.1074; Gallagher KA, 2007, J CLIN INVEST, V117, P1249, DOI 10.1172/JCI29710; Garcia AJ, 2010, J APPL PHYSIOL, V109, P804, DOI 10.1152/japplphysiol.91429.2008; GERSCHMAN R, 1954, SCIENCE, V119, P623, DOI 10.1126/science.119.3097.623; Gill AL, 2004, QJM-INT J MED, V97, P385, DOI 10.1093/qjmed/hch074; Godman CA, 2010, ANN NY ACAD SCI, V1197, P178, DOI 10.1111/j.1749-6632.2009.05393.x; Groesbeck DK, 2006, DEV MED CHILD NEUROL, V48, P978, DOI 10.1111/j.1469-8749.2006.tb01269.x; Gu GJ, 2008, J APPL PHYSIOL, V104, P1185, DOI 10.1152/japplphysiol.00323.2007; Gurdol F, 2010, PHYSIOL RES, V59, P423, DOI 10.33549/physiolres.931702; Halperin EC, 2008, PRINCIPLES PRACTICE; Hartnett ME, 2013, NEW ENGL J MED, V368, P1162, DOI 10.1056/NEJMc1301021; Heyboer M, 2014, STEM CELL RES, V12, P638, DOI 10.1016/j.scr.2014.02.005; Hileman EO, 2004, CANCER CHEMOTH PHARM, V53, P209, DOI 10.1007/s00280-003-0726-5; Hite AH, 2011, NUTR CLIN PRACT, V26, P300, DOI 10.1177/0884533611405791; Hodgson JC, 2006, VET IMMUNOL IMMUNOP, V112, P12, DOI 10.1016/j.vetimm.2006.03.008; Holmstrom KM, 2014, NAT REV MOL CELL BIO, V15, P411, DOI 10.1038/nrm3801; Hu Q, 2014, STROKE, V45, P1807, DOI 10.1161/STROKEAHA.114.005116; Hu SL, 2008, ACTA NEUROCHIR SUPPL, V105, P191; Hu SL, 2010, NEUROL RES, V32, P173, DOI 10.1179/174313209X414524; Hunt TK, 2007, ANTIOXID REDOX SIGN, V9, P1115, DOI 10.1089/ars.2007.1674; Jadhav V, 2007, SURG NEUROL, V67, P15, DOI 10.1016/j.surneu.2006.07.014; Jadhav V, 2010, ACTA NEUROCHIR SUPPL, V106, P217, DOI 10.1007/978-3-211-98811-4_40; JAMIESON D, 1989, FREE RADICAL BIO MED, V7, P87, DOI 10.1016/0891-5849(89)90103-2; Jarrett SG, 2008, J NEUROCHEM, V106, P1044, DOI 10.1111/j.1471-4159.2008.05460.x; JERRETT SA, 1973, AEROSPACE MED, V44, P40; Jyonouchi H, 1998, AM J RESP CELL MOL, V19, P426, DOI 10.1165/ajrcmb.19.3.2862m; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Kang Thomas S, 2004, Arch Facial Plast Surg, V6, P31, DOI 10.1001/archfaci.6.1.31; KASHIWAYA Y, 1994, J BIOL CHEM, V269, P25502; Kashiwaya Y, 2013, NEUROBIOL AGING, V34, P1530, DOI 10.1016/j.neurobiolaging.2012.11.023; Kazzaz JA, 1996, J BIOL CHEM, V271, P15182, DOI 10.1074/jbc.271.25.15182; KERR JS, 1987, AM REV RESPIR DIS, V135, P1334; Kesl S, 2014, FASEB J S, V28, P734; Kim DY, 2007, J NEUROCHEM, V101, P1316, DOI 10.1111/j.1471-4159.2007.04483.x; Kim HR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109297; KIRINO T, 1991, J CEREBR BLOOD F MET, V11, P299, DOI 10.1038/jcbfm.1991.62; KISTLER GS, 1967, J CELL BIOL, V32, P605, DOI 10.1083/jcb.32.3.605; Korhonen K, 2000, ANN CHIR GYNAECOL, V89, P7; KOVACHICH GB, 1980, J NEUROCHEM, V35, P1449, DOI 10.1111/j.1471-4159.1980.tb09022.x; Kutlay M, 2008, NEUROSURGERY, V62, P540, DOI [10.1227/01.NEU.0000186012.95462.E5, 10.1227/01.neu.0000316257.21478.5b]; Labrouche S, 1999, THROMB RES, V96, P309, DOI 10.1016/S0049-3848(99)00107-3; Lahat N, 1995, CLIN EXP IMMUNOL, V102, P655; Lambertsen CJ, 1978, HDB PHYSL 3, P232; Leach RM, 1998, BRIT MED J, V317, P1140; Lee PJ, 1996, P NATL ACAD SCI USA, V93, P10393, DOI 10.1073/pnas.93.19.10393; Lee PJ, 2003, FREE RADICAL BIO MED, V35, P341, DOI 10.1016/S0891-5849(03)00279-X; Lee PJ, 2000, AM J PHYSIOL-LUNG C, V279, pL175; Lee SR, 2002, J BIOL CHEM, V277, P20336, DOI 10.1074/jbc.M111899200; Li HF, 2013, IRAN J PEDIATR, V23, P613; Li Y, 2005, EXP NEUROL, V191, P198, DOI 10.1016/j.expneurol.2004.08.036; Lin KC, 2012, J TRAUMA ACUTE CARE, V72, P650, DOI 10.1097/TA.0b013e31823c575f; Lin SK, 2002, BIOCHEM BIOPH RES CO, V296, P710, DOI 10.1016/S0006-291X(02)00924-5; Liu W, 2009, UNDERSEA HYPERBAR M, V36, P155; Loboda A, 2010, MOL CELLS, V29, P435, DOI 10.1007/s10059-010-0067-2; Lodhi IJ, 2014, CELL METAB, V19, P380, DOI 10.1016/j.cmet.2014.01.002; Lum JJ, 2007, GENE DEV, V21, P1037, DOI 10.1101/gad.1529107; Luongo C, 1998, CRIT CARE MED, V26, P1972, DOI 10.1097/00003246-199812000-00022; Maalouf M, 2007, NEUROSCIENCE, V145, P256, DOI 10.1016/j.neuroscience.2006.11.065; Maalouf M, 2009, BRAIN RES REV, V59, P293, DOI 10.1016/j.brainresrev.2008.09.002; Mach WJ, 2011, NURS RES PRACT, V2011, DOI 10.1155/2011/260482; Maltepe E, 2009, PEDIATR RES, V65, P261, DOI 10.1203/PDR.0b013e31818fc83f; Marin-Hernandez A, 2009, MINI-REV MED CHEM, V9, P1084, DOI 10.2174/138955709788922610; Massey PR, 2012, J SURG RES, V177, P146, DOI 10.1016/j.jss.2012.03.016; Matott MP, 2014, NEUROSCIENCE, V270, P98, DOI 10.1016/j.neuroscience.2014.03.017; Matsunami T, 2010, PHYSIOL RES, V59, P97, DOI 10.33549/physiolres.931711; Matsunami T, 2010, INT J CLIN EXP PATHO, V3, P177; Medan D, 2005, J CELL PHYSIOL, V203, P78, DOI 10.1002/jcp.20201; Mehta JL, 1999, CARDIOVASC RES, V43, P291, DOI 10.1016/S0008-6363(99)00132-7; Meng TC, 2002, MOL CELL, V9, P387, DOI 10.1016/S1097-2765(02)00445-8; Milovanova TN, 2008, MOL CELL BIOL, V28, P6248, DOI 10.1128/MCB.00795-08; Moen I, 2012, TARGET ONCOL, V7, P233, DOI 10.1007/s11523-012-0233-x; Mulkey DK, 2003, J APPL PHYSIOL, V95, P910, DOI 10.1152/japplphysiol.00864.2002; Muralidharan Vijayaragavan, 2007, HPB (Oxford), V9, P174, DOI 10.1080/13651820601175926; NARKOWICZ CK, 1993, FREE RADICAL RES COM, V19, P71, DOI 10.3109/10715769309056501; Netea MG, 2015, CELL METAB, V21, P513, DOI 10.1016/j.cmet.2015.03.012; Neuman TS, 2008, PHYSL MED HYPERBARIC; NIKI E, 1987, ANN NY ACAD SCI, V498, P186, DOI 10.1111/j.1749-6632.1987.tb23761.x; NISHIKI K, 1976, BIOCHEM J, V160, P343, DOI 10.1042/bj1600343; NOaA A, 2011, SCI DIV STAND SAF MA; Olbryt M, 2006, GENE EXPRESSION, V13, P191, DOI 10.3727/000000006783991818; Olshyk VN, 2014, CHEM PHYS LIPIDS, V177, P1, DOI 10.1016/j.chemphyslip.2013.10.010; Ostrowski RP, 2008, NEUROBIOL DIS, V29, P1, DOI 10.1016/j.nbd.2007.07.020; Ozben T, 2007, J PHARM SCI-US, V96, P2181, DOI 10.1002/jps.20874; Pagano A, 2003, ANN NY ACAD SCI, V1010, P405, DOI 10.1196/annals.1299.074; Pagano G, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/541230; Paoli A, 2013, EUR J CLIN NUTR, V67, P789, DOI 10.1038/ejcn.2013.116; Pasupathy S, 2005, ARCH SURG-CHICAGO, V140, P405, DOI 10.1001/archsurg.140.4.405; PASUPATHY S, 2005, ARCH SURG-CHICAGO, V140, P410; Patel D, 2003, J INDIAN ACAD CLIN M, V4, P234; Peng ZY, 2008, BRAIN RES, V1212, P71, DOI 10.1016/j.brainres.2008.03.027; Pesa, 2011, HBO THER SOFT TISS R; Pilla R, 2013, J APPL PHYSIOL, V114, P1009, DOI 10.1152/japplphysiol.01326.2012; Poff AM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127407; Poff AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065522; Portakal O, 2000, CLIN BIOCHEM, V33, P279, DOI 10.1016/S0009-9120(00)00067-9; Prins ML, 2009, J NEUROTRAUM, V26, P1083, DOI [10.1089/neu.2008.0769, 10.1089/neu.2008-0769]; Reczek CR, 2015, CURR OPIN CELL BIOL, V33, P8, DOI 10.1016/j.ceb.2014.09.010; Romashko J, 2003, FREE RADICAL BIO MED, V35, P978, DOI 10.1016/S0891-5849(03)00494-5; Rothfuss A, 1998, CARCINOGENESIS, V19, P1913, DOI 10.1093/carcin/19.11.1913; SAITO K, 1991, CLIN EXP IMMUNOL, V86, P322; Schroedl C, 2002, LUNC CELL MOL PHYSL, V283, P31; Semenza GL, 2001, CURR OPIN CELL BIOL, V13, P167, DOI 10.1016/S0955-0674(00)00194-0; Semenza GL, 2013, J CLIN INVEST, V123, P3664, DOI 10.1172/JCI67230; Shaikh Nissar, 2009, J Emerg Trauma Shock, V2, P180, DOI 10.4103/0974-2700.55330; Sharman MJ, 2004, CLIN SCI, V107, P365, DOI 10.1042/CS20040111; Shaw JJ, 2014, SURG INFECT, V15, P328, DOI 10.1089/sur.2012.135; Sheikh AY, 2000, ARCH SURG-CHICAGO, V135, P1293, DOI 10.1001/archsurg.135.11.1293; Shen C, 2005, J BIOL CHEM, V280, P20580, DOI 10.1074/jbc.M501894200; Shimazu T, 2013, SCIENCE, V339, P211, DOI 10.1126/science.1227166; Shinohara M, 2007, J BIOL CHEM, V282, P17640, DOI 10.1074/jbc.M609450200; Shyu KG, 2008, LIFE SCI, V83, P65, DOI 10.1016/j.lfs.2008.05.005; Smith J L, 1899, J Physiol, V24, P19; Soejima Y, 2012, MED GAS RES, V2, DOI 10.1186/2045-9912-2-9; Song Xiao-Yu, 2010, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V18, P1275; Speit G, 2000, CARCINOGENESIS, V21, P1795, DOI 10.1093/carcin/21.10.1795; Speit G, 2002, MUTAT RES-REV MUTAT, V512, P111, DOI 10.1016/S1383-5742(02)00045-5; Speit G, 1998, MUTAGENESIS, V13, P85, DOI 10.1093/mutage/13.1.85; Srivastava S, 2012, FASEB J, V26, P2351, DOI 10.1096/fj.11-200410; Stetler RA, 2014, PROG NEUROBIOL, V114, P58, DOI 10.1016/j.pneurobio.2013.11.005; Sun L, 2008, STROKE, V39, P1000, DOI 10.1161/STROKEAHA.107.490599; Sunkari VG, 2015, WOUND REPAIR REGEN, V23, P98, DOI 10.1111/wrr.12253; Thom S, 2008, INT SOC STEM CELL RE, V453, P62; Thom S.R., 1989, J INTENSIVE CARE MED, V4, P58, DOI [10.1177/088506668900400204, DOI 10.1177/088506668900400204]; Thom SR, 2006, AM J PHYSIOL-HEART C, V290, pH1378, DOI 10.1152/ajpheart.00888.2005; Thom SR, 2011, WOUND REPAIR REGEN, V19, P149, DOI 10.1111/j.1524-475X.2010.00660.x; Thom SR, 2011, PLAST RECONSTR SURG, V127, p131S, DOI 10.1097/PRS.0b013e3181fbe2bf; Thom SR, 2009, J APPL PHYSIOL, V106, P988, DOI 10.1152/japplphysiol.91004.2008; Thomson L, 2014, PAEDIATR RESPIR REV, V15, P120, DOI 10.1016/j.prrv.2014.03.003; Tibbles PM, 1996, NEW ENGL J MED, V334, P1642, DOI 10.1056/NEJM199606203342506; Torres-Gonzalez Moises, 2008, J Atheroscler Thromb, V15, P235; Trachootham D, 2006, CANCER CELL, V10, P241, DOI 10.1016/j.ccr.2006.08.009; Tyurina YY, 2010, AM J PHYSIOL-LUNG C, V299, pL73, DOI 10.1152/ajplung.00035.2010; Undersea and Hyperbaric Medicine Society (UHMS), IND HYP OX THER; Veech RL, 2004, PROSTAG LEUKOTR ESS, V70, P309, DOI 10.1016/j.plefa.2003.09.007; Wada K, 2001, NEUROSURGERY, V49, P160; Wada K, 1996, BRAIN RES, V740, P15; Wang CH, 2013, EXP BIOL MED, V238, P450, DOI 10.1177/1535370213493069; Wang J, 2008, CANCER BIOL THER, V7, P1875, DOI 10.4161/cbt.7.12.7067; Wang Y, 2014, MED GAS RES, V4, DOI 10.1186/2045-9912-4-18; Weaver LK, 2001, CHEST, V120, P1407, DOI 10.1378/chest.120.4.1407; Weaver LK, 2014, UHMS HYPERBARIC OXYG; Weih M, 1999, STROKE, V30, P1851, DOI 10.1161/01.STR.30.9.1851; Weisz G, 1997, J CLIN IMMUNOL, V17, P154, DOI 10.1023/A:1027378532003; Wheaton WW, 2011, AM J PHYSIOL-CELL PH, V300, pC385, DOI 10.1152/ajpcell.00485.2010; WOLFF SP, 1986, TRENDS BIOCHEM SCI, V11, P27, DOI 10.1016/0968-0004(86)90228-8; Wood C D, 1970, J La State Med Soc, V122, P219; Wright CJ, 2009, PEDIATR RES, V66, P3, DOI 10.1203/PDR.0b013e3181a2c184; Xu XF, 2009, OXID MED CELL LONGEV, V2, P7, DOI 10.4161/oxim.2.1.7697; Yang Y, 2014, NEUROSCI LETT, V563, P38, DOI 10.1016/j.neulet.2014.01.002; Yang YH, 2013, INT REV IMMUNOL, V32, P249, DOI 10.3109/08830185.2012.755176; Yee M, 2006, AM J PHYSIOL-LUNG C, V291, pL1101, DOI 10.1152/ajplung.00126.2006; Yin XS, 2015, J CARDIOVASC PHARM T, V20, P428, DOI 10.1177/1074248414568196; Yogaratnam JZ, 2010, CARDIOVASC REVASCULA, V11, P8, DOI 10.1016/j.carrev.2009.03.004; Yoshida Y, 2013, J CLIN BIOCHEM NUTR, V52, P9, DOI 10.3164/jcbn.12-112; Youm YH, 2015, NAT MED, V21, P263, DOI 10.1038/nm.3804; Yu SL, 2015, IRAN J BASIC MED SCI, V18, P98; Yurkova IL, 2012, RUSS CHEM REV+, V81, P175, DOI 10.1070/RC2012v081n02ABEH004205; Zaher TE, 2007, FREE RADICAL BIO MED, V42, P897, DOI 10.1016/j.freeradbiomed.2007.01.021; Zhang QX, 2008, J INVEST DERMATOL, V128, P2102, DOI 10.1038/jid.2008.53; Zhang QX, 2014, J INVEST DERMATOL, V134, P237, DOI 10.1038/jid.2013.301; Zhao Z, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-29; Zhou ZW, 2007, J NEUROSURG, V106, P687, DOI 10.3171/jns.2007.106.4.687	221	18	19	0	14	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN, NJ 07030 USA	2040-4603			COMPR PHYSIOL	Compr. Physiol.	JAN	2017	7	1					213	234		10.1002/cphy.c150032			22	Physiology	Physiology	EK8PQ	WOS:000394186300008	28135004				2021-06-18	
J	Ricciardi, MC; Bokkers, RPH; Butman, JA; Hammoud, DA; Pham, DL; Warach, S; Latour, LL				Ricciardi, Maria Chiara; Bokkers, Reinoud P. H.; Butman, John A.; Hammoud, Dima A.; Pham, Dzung L.; Warach, Steven; Latour, Lawrence L.			Trauma-Specific Brain Abnormalities in Suspected Mild Traumatic Brain Injury Patients Identified in the First 48 Hours after Injury: A Blinded Magnetic Resonance Imaging Comparative Study Including Suspected Acute Minor Stroke Patients	JOURNAL OF NEUROTRAUMA			English	Article						CT scanning; MRI; TBI	DIFFUSE AXONAL INJURY; CT; LESIONS	We assessed the utility of a brief MRI protocol, appropriate for the acute setting, to detect acute traumatic brain injury (TBI) in patients with suspected mild TBI (mTBI) and distinguish traumatic from nontraumatic brain injury by comparing trauma with nontrauma patients. Twenty-two patients with suspected mTBI were included in this exploratory study over a period of 9 months. Median time from injury to MR scanning was 5.4 h (interquartile range 3.6-15.3). To determine the specificity of certain findings for TBI, 61 patients presenting with suspected minor acute stroke were included as a comparative group using the same MRI methods. A selected series of MRI sequences (diffusion-weighted imaging, fluid attenuated inversion recovery [FLAIR], and T2* weighted) were independently evaluated by two neuroradiologists blinded to clinical diagnosis, for presence of specific findings. In a separate session, all cases in which at least one MRI sequence above was positive were classified as TBI, stroke, or indeterminate. Intracranial MRI abnormalities were observed in 47 (57%) of the 83 studied patients. Based on findings on MRI, 12 (55%) of 22 suspected mTBI patients were classified as having traumatic injury. Nine (47%) of the 19 suspected mTBI patients with a negative CT had findings on MRI. Abnormalities on MRI consistent with trauma were observed most frequently on postcontrast FLAIR (83%) and T2*-weighted (58%) sequences. We demonstrated the ability of a fast MRI protocol to identify trauma-related abnormalities not seen on CT, and differentiate acute trauma from nonspecific chronic disease in a blinded cohort of mTBI patients.	[Ricciardi, Maria Chiara; Latour, Lawrence L.] Natl Inst Neurol Disorders & Stroke, Stroke Diagnost & Therapeut Sect, Bethesda, MD USA; [Butman, John A.] NIH, Dept Diagnost Radiol, Bethesda, MD USA; [Hammoud, Dima A.] NIH, Ctr Clin, Ctr Infect Dis Imaging CIDI Radiol & Imaging Sci, Bethesda, MD 20892 USA; [Ricciardi, Maria Chiara; Butman, John A.; Pham, Dzung L.; Latour, Lawrence L.] Ctr Neurosci & Regenerat Med, Bethesda, MD USA; [Bokkers, Reinoud P. H.] Univ Groningen, Univ Med Ctr Groningen, Dept Radiol, Groningen, Netherlands; [Warach, Steven] Univ Texas Austin, Stroke Inst, Seton Dell Med Sch, Austin, TX 78712 USA	Latour, LL (corresponding author), Natl Inst Neurol Disorders & Stroke, NIH, 10 Ctr Dr,Bldg 10,Room B1D733, Bethesda, MD 20892 USA.	LatourL@ninds.nih.gov	Pham, Dzung/AAR-8263-2020; Butman, John A/A-2694-2008; Latour, Larry/AAH-5663-2021; Bokkers, Reinoud P H/ABD-2928-2020; Butman, John/J-2780-2013; Warach, Steven/R-5074-2019; Hammoud, Dima A/C-2286-2015	Latour, Larry/0000-0001-6160-5263; Bokkers, Reinoud P H/0000-0001-6130-7311; Butman, John/0000-0002-1547-9195; Hammoud, Dima/0000-0001-7406-7871	Intramural Research Program at NINDS; Department of Defense in the Center for Neuroscience and Regenerative MedicineUnited States Department of Defense; Dutch Heart FoundationNetherlands Heart Foundation [2013T047]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [ZIANS003120, ZICNS003044, ZIANS003043] Funding Source: NIH RePORTER	We are grateful to the patients and their families without whom this research would not be possible. We wish to acknowledge the staff at Suburban Hospital, and the Investigators of the Center for Neuroscience and Regenerative Medicine THINC Study. Support for this work included funding from the Intramural Research Program at NINDS and the Department of Defense in the Center for Neuroscience and Regenerative Medicine. R. P. H. Bokkers receives support from the Dutch Heart Foundation (Grant 2013T047). The contents of this article are solely the responsibility of the authors and do not represent the official views of the Department of Defense or the Center for Neuroscience and Regenerative Medicine.	Bazarian JJ, 2006, ACAD EMERG MED, V13, P31, DOI 10.1197/j.aem.2005.07.038; Belanger HG, 2007, J NEUROPSYCH CLIN N, V19, P5, DOI 10.1176/appi.neuropsych.19.1.5; Bigler ED, 2013, NEUROPSYCHOL REV, V23, P169, DOI 10.1007/s11065-013-9237-2; ESSELMAN PC, 1995, BRAIN INJURY, V9, P417, DOI 10.3109/02699059509005782; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Fujita M, 2012, J NEUROTRAUM, V29, P2172, DOI 10.1089/neu.2012.2357; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Iverson GL, 2000, BRAIN INJURY, V14, P1057; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; Kenney K, 2016, EXP NEUROL, V275, P353, DOI 10.1016/j.expneurol.2015.05.019; Kim S.C., 2014, PLOS ONE, V16, P9; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Kirov II, 2013, J NEUROL, V260, P242, DOI 10.1007/s00415-012-6626-z; Konrad C, 2011, PSYCHOL MED, V41, P1197, DOI 10.1017/S0033291710001728; Kurca E, 2006, NEURORADIOLOGY, V48, P661, DOI 10.1007/s00234-006-0109-9; Latour LL, 2004, ANN NEUROL, V56, P468, DOI 10.1002/ana.20199; Lee H, 2008, J NEUROTRAUM, V25, P1049, DOI 10.1089/neu.2008.0566; Pop V, 2011, TRANSL STROKE RES, V2, P533, DOI 10.1007/s12975-011-0126-9; Roth TL, 2014, NATURE, V505, P223, DOI 10.1038/nature12808; Sangiorgi S, 2013, J NEUROSURG, V118, P763, DOI 10.3171/2012.11.JNS12627; Scheid R, 2003, AM J NEURORADIOL, V24, P1049; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Smits M, 2005, JAMA-J AM MED ASSOC, V294, P1519, DOI 10.1001/jama.294.12.1519; Tomkins O, 2008, J NEUROL NEUROSUR PS, V79, P774, DOI 10.1136/jnnp.2007.126425; Tong KA, 2003, RADIOLOGY, V227, P332, DOI 10.1148/radiol.2272020176; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783; Zhou YX, 2013, RADIOLOGY, V267, P880, DOI 10.1148/radiol.13122542	27	18	18	0	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 1	2017	34	1					23	30		10.1089/neu.2015.4338			8	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	EF6DE	WOS:000390420100004	27215444	Green Published			2021-06-18	
J	Robitaille, N; Jackson, PL; Hebert, LJ; Mercier, C; Bouyer, LJ; Fecteau, S; Richards, CL; McFadyen, BJ				Robitaille, Nicolas; Jackson, Philip L.; Hebert, Luc J.; Mercier, Catherine; Bouyer, Laurent J.; Fecteau, Shirley; Richards, Carol L.; McFadyen, Bradford J.			A Virtual Reality avatar interaction (VRai) platform to assess residual executive dysfunction in active military personnel with previous mild traumatic brain injury: proof of concept	DISABILITY AND REHABILITATION-ASSISTIVE TECHNOLOGY			English	Article						Rehabilitation; gait; dual task walking; concussion	SERVICE MEMBERS; DUAL-TASK; CONCUSSION; GAIT; REHABILITATION; ENVIRONMENTS; POSTSTROKE; ATTENTION; LOCOMOTOR; WALKING	Purpose: This proof of concept study tested the ability of a dual task walking protocol using a recently developed avatar-based virtual reality (VR) platform to detect differences between military personnel post mild traumatic brain injury (mTBI) and healthy controls. Methods: The VR platform coordinated motion capture, an interaction and rendering system, and a projection system to present first (participant-controlled) and third person avatars within the context of a specific military patrol scene. A divided attention task was also added. A healthy control group was compared to a group with previous mTBI (both groups comprised of six military personnel) and a repeated measures ANOVA tested for differences between conditions and groups based on recognition errors, walking speed and fluidity and obstacle clearance. Results: The VR platform was well tolerated by both groups. Walking fluidity was degraded for the control group within the more complex navigational dual tasking involving avatars, and appeared greatest in the dual tasking with the interacting avatar. This navigational behaviour was not seen in the mTBI group. Conclusions: The present findings show proof of concept for using avatars, particularly more interactive avatars, to expose differences in executive functioning when applying context-specific protocols (here for the military).	[Robitaille, Nicolas; Jackson, Philip L.; Hebert, Luc J.; Mercier, Catherine; Bouyer, Laurent J.; Fecteau, Shirley; Richards, Carol L.; McFadyen, Bradford J.] Ctr Interdisciplinaire Rech Readaptat & Integrat, 525 Boul Hamel, Quebec City, PQ G1M 2S8, Canada; [Hebert, Luc J.; Mercier, Catherine; Bouyer, Laurent J.; Fecteau, Shirley; Richards, Carol L.; McFadyen, Bradford J.] Laval Univ, Fac Med, Dept Rehabil, Quebec City, PQ, Canada; [Hebert, Luc J.] Laval Univ, Fac Med, Dept Radiol, Quebec City, PQ, Canada; [Jackson, Philip L.] Laval Univ, Sch Psychol, Quebec City, PQ, Canada; [Fecteau, Shirley] Inst Univ Sante Mentale Quebec, Ctr Rech, Quebec City, PQ, Canada	McFadyen, BJ (corresponding author), Ctr Interdisciplinaire Rech Readaptat & Integrat, 525 Boul Hamel, Quebec City, PQ G1M 2S8, Canada.	Brad.McFadyen@fmed.ulaval.ca	Bouyer, Laurent J/A-9255-2010; Bouyer, Laurent/L-6471-2019	Bouyer, Laurent J/0000-0003-2034-4516; Bouyer, Laurent/0000-0003-2034-4516; Mercier, Catherine/0000-0002-2037-6916; Hebert, Luc J./0000-0001-8903-5258; Richards, Carol L./0000-0002-1824-0817; McFadyen, Bradford/0000-0003-1992-4927; Jackson, Philip/0000-0001-8991-3217	Canadian Forces Surgeon General's Health Research Program [2011-07-038-004-0002]; Fonds de recherche du Quebec - SanteFonds de la Recherche en Sante du Quebec	This work was funded from the Canadian Forces Surgeon General's Health Research Program (# 2011-07-038-004-0002). PLJ and CM were supported by a Chercheur-Boursier Senior salary award from the Fonds de recherche du Quebec - Sante and SF holds a Canada Research Chair.	Darekar A, 2015, J NEUROENG REHABIL, V12, DOI 10.1186/s12984-015-0035-3; Deutsch JE, 2007, TOP STROKE REHABIL, V14, P45, DOI 10.1310/tsr1406-45; Edwards J, 2014, APPL NEUROPSYCH-ADUL, V21, P220, DOI 10.1080/09084282.2013.796554; Fait P, 2013, J HEAD TRAUMA REHAB, V28, P293, DOI 10.1097/HTR.0b013e3182407ace; Gerin-Lajoie M, 2005, MOTOR CONTROL, V9, P242, DOI 10.1123/mcj.9.3.242; Glegg SMN, 2017, DISABIL REHABIL-ASSI, V12, P217, DOI 10.3109/17483107.2015.1111944; Holden MK, 2005, CYBERPSYCHOL BEHAV, V8, P187, DOI 10.1089/cpb.2005.8.187; Jackson PL, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00112; Kennedy R. S., 1993, Int'l. J. Aviat. Psychol., V3, P203, DOI [DOI 10.1207/S15327108IJAP0303_3, 10.1207/s15327108ijap0303_3]; Laver KE, 2015, COCHRANE DB SYST REV, V12; Lee H, 2013, J SCI MED SPORT, V16, P2, DOI 10.1016/j.jsams.2012.03.013; McCrory P, 2013, BRIT J SPORT MED, V47, P268, DOI 10.1136/bjsports-2013-092247; McFadyen BJ, 2015, NEUROPSYCHOL REHABIL, V21, P1; Moreira MC, 2013, DISABIL REHABIL-ASSI, V8, P357, DOI 10.3109/17483107.2012.749428; Register-Mihalik JK, 2013, NEUROPSYCHOL REV, V23, P300, DOI 10.1007/s11065-013-9238-1; Rizzo AA, 2004, NEUROPSYCHOL REHABIL, V14, P207, DOI 10.1080/09602010343000183; Roosink M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120251; Roosink M, 2015, J NEUROENG REHABIL, V12, DOI 10.1186/1743-0003-12-2; Rose FD, 2005, CYBERPSYCHOL BEHAV, V8, P241, DOI 10.1089/cpb.2005.8.241; Scherer MR, 2013, PHYS THER, V93, P1254, DOI 10.2522/ptj.20120143; Usoh M, 2000, PRESENCE-TELEOP VIRT, V9, P497, DOI 10.1162/105474600566989; Witmer BG, 1998, PRESENCE-TELEOP VIRT, V7, P225, DOI 10.1162/105474698565686; Yogev-Seligmann G, 2008, MOVEMENT DISORD, V23, P329, DOI 10.1002/mds.21720	23	18	19	2	16	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1748-3107	1748-3115		DISABIL REHABIL-ASSI	Disabil. Rehabil.-Assist. Technol.		2017	12	7					758	764		10.1080/17483107.2016.1229048			7	Rehabilitation	Rehabilitation	FQ6RD	WOS:000418490800013	27677827	Green Accepted			2021-06-18	
J	Rowley, DA; Rogish, M; Alexander, T; Riggs, KJ				Rowley, Dane A.; Rogish, Miles; Alexander, Timothy; Riggs, Kevin J.			Cognitive correlates of pragmatic language comprehension in adult traumatic brain injury: A systematic review and meta-analyses	BRAIN INJURY			English	Article						Cognition; communication; language; pragmatics; traumatic brain injury	DIFFUSE AXONAL INJURY; CLOSED-HEAD INJURY; NEUROPSYCHOLOGICAL EVIDENCE; EXECUTIVE DYSFUNCTION; SOCIAL-PERCEPTION; WORKING-MEMORY; INFORMATION; MIND; DISCOURSE; IMPAIRMENT	Effective pragmatic comprehension of language is critical for successful communication and interaction, but this ability is routinely impaired following Traumatic Brain Injury (TBI) (1,2). Individual studies have investigated the cognitive domains associated with impaired pragmatic comprehension, but there remains little understanding of the relative importance of these domains in contributing to pragmatic comprehension impairment following TBI. This paper presents a systematic meta-analytic review of the observed correlations between pragmatic comprehension and cognitive processes following TBI. Five meta-analyses were computed, which quantified the relationship between pragmatic comprehension and five key cognitive constructs (declarative memory; working memory; attention; executive functions; social cognition). Significant moderate-to-strong correlations were found between all cognitive measures and pragmatic comprehension, where declarative memory was the strongest correlate. Thus, our findings indicate that pragmatic comprehension in TBI is associated with an array of domain general cognitive processes, and as such deficits in these cognitive domains may underlie pragmatic comprehension difficulties following TBI. The clinical implications of these findings are discussed.	[Rowley, Dane A.; Alexander, Timothy] Univ Hull, Clin Psychol Programme, Kingston Upon Hull, N Humberside, England; [Rogish, Miles] Disabil Trust, Brain Injury Rehabil Trust, Wakefield, W Sussex, England; [Riggs, Kevin J.] Univ Hull, Dept Psychol, Fenner Bldg, Kingston Upon Hull HU6 7RX, N Humberside, England	Riggs, KJ (corresponding author), Univ Hull, Dept Psychol, Fenner Bldg, Kingston Upon Hull HU6 7RX, N Humberside, England.	k.riggs@hull.ac.uk					ADAMS JH, 1980, J CLIN PATHOL, V33, P1132, DOI 10.1136/jcp.33.12.1132; Angeleri R, 2008, BRAIN LANG, V107, P229, DOI 10.1016/j.bandl.2008.01.002; [Anonymous], 1983, CAMBRIDGE TXB LINGUI; Apperly IA, 2005, TRENDS COGN SCI, V9, P572, DOI 10.1016/j.tics.2005.10.004; Apperly IA, 2004, J COGNITIVE NEUROSCI, V16, P1773, DOI 10.1162/0898929042947928; Barbey AK, 2014, BRAIN, V137, P277, DOI 10.1093/brain/awt312; Baron-Cohen S, 2001, J CHILD PSYCHOL PSYC, V42, P241, DOI 10.1017/S0021963001006643; Barrash J, 2000, DEV NEUROPSYCHOL, V18, P355, DOI 10.1207/S1532694205Barrash; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P432, DOI 10.1080/01688639708403871; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Bracy C. A., 2005, BRAIN IMPAIR, V6, P1, DOI [10.1375/brim.6.1.1.65476., DOI 10.1375/BRIM.6.1.1.65476, DOI 10.1375/brim.6.1.1.65476]; Braun C M, 1989, Brain Inj, V3, P345, DOI 10.3109/02699058909004559; BROOKSHIRE RH, 1984, BRAIN LANG, V21, P21, DOI 10.1016/0093-934X(84)90033-6; Bryan KL., 1996, RIGHT HEMISPHERE LAN; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Channon S, 2005, BRAIN LANG, V93, P123, DOI 10.1016/j.bandl.2004.09.002; Coelho C. A., 2002, APHASIOLOGY, V16, P659, DOI [10.1080/02687030244000275, DOI 10.1080/02687030244000275]; Coelho CA, 2002, J SPEECH LANG HEAR R, V45, P1232, DOI 10.1044/1092-4388(2002/099); Davis M.H, 1980, J PERS SOC PSYCHOL, V10, P85; Delis D.C., 2001, DELIS KAPLAN EXECUTI; Delis DC, 2000, CALIFORNIA VERBAL LE; Douglas JM, 2010, J SPEECH LANG HEAR R, V53, P365, DOI 10.1044/1092-4388(2009/08-0205); Erez ABH, 2009, AM J OCCUP THER, V63, P634; Evans K, 2011, BRAIN INJURY, V25, P767, DOI 10.3109/02699052.2011.576307; Faust ME, 1996, BRAIN LANG, V53, P234, DOI 10.1006/brln.1996.0046; Felmingham KL, 2004, NEUROPSYCHOLOGY, V18, P564, DOI 10.1037/0894-4105.18.3.564; Fork M, 2005, BRAIN INJURY, V19, P101, DOI 10.1080/02699050410001726086; Gernsbacher MA, 2001, J MEM LANG, V45, P433, DOI 10.1006/jmla.2000.2782; GLOSSER G, 1993, NARRATIVE DISCOURSE IN NEUROLOGICALLY IMPAIRED AND NORMAL AGING ADULTS, P191; Grice H., 1975, SYNTAX SEMANTICS; Hagen C, 1984, LANGUAGE DISORDERS A, P245; Havet-Thomassin V, 2006, BRAIN INJURY, V20, P83, DOI 10.1080/02699050500340655; Heaton R., 1993, WISCONSIN CARD SORTI; Hinchliffe FJ, 1998, BRAIN INJURY, V12, P109, DOI 10.1080/026990598122746; Holland A., 1982, CLIN APH P C, P345; Holliday R, 2005, BRAIN LANG, V95, P74, DOI 10.1016/j.bandl.2005.07.041; Huang Y, 2007, OXFORD TXB LINGUISTI; Joanette Y., 2004, PROTOCOLE MONTREAL E; Johnson JE, 2012, BRAIN INJURY, V26, P1118, DOI 10.3109/02699052.2012.666370; LeBlanc J, 2014, INT J SPEECH-LANG PA, V16, P582, DOI 10.3109/17549507.2013.871335; Lezak M., 2012, NEUROPSYCHOLOGICAL A, V5th; Lipton ML, 2009, RADIOLOGY, V252, P816, DOI 10.1148/radiol.2523081584; Madigan NK, 2000, J HEAD TRAUMA REHAB, V15, P943, DOI 10.1097/00001199-200006000-00007; Marini A, 2014, NEUROPSYCHOLOGIA, V64, P282, DOI 10.1016/j.neuropsychologia.2014.09.042; Marini A, 2011, NEUROPSYCHOLOGIA, V49, P2904, DOI 10.1016/j.neuropsychologia.2011.06.017; Martin I, 2003, BRAIN LANG, V85, P451, DOI 10.1016/S0093-934X(03)00070-1; Martin I, 2005, APHASIOLOGY, V19, P712, DOI 10.1080/02687030500172203; Mathias JL, 2007, NEUROPSYCHOLOGY, V21, P212, DOI 10.1037/0894-4105.21.2.212; Matsuoka K, 2012, BRAIN INJURY, V26, P1723, DOI 10.3109/02699052.2012.698789; McDonald S, 2003, J HEAD TRAUMA REHAB, V18, P219, DOI 10.1097/00001199-200305000-00001; McDonald S, 2004, NEUROPSYCHOLOGY, V18, P572, DOI 10.1037/0894-4105.18.3.572; McDonald S, 2017, J NEUROPSYCHOL, V11, P291, DOI 10.1111/jnp.12086; McDonald S, 2014, NEUROPSYCHOLOGY, V28, P801, DOI 10.1037/neu0000089; McDonald S, 2011, J CLIN EXP NEUROPSYC, V33, P17, DOI 10.1080/13803391003761967; McDowell S, 1997, NEUROPSYCHOLOGIA, V35, P1341, DOI 10.1016/S0028-3932(97)00082-1; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; MENTIS M, 1991, J SPEECH HEAR RES, V34, P583, DOI 10.1044/jshr.3403.583; Milders M, 2003, J CLIN EXP NEUROPSYC, V25, P157, DOI 10.1076/jcen.25.2.157.13642; Mozeiko J, 2011, APHASIOLOGY, V25, P826, DOI 10.1080/02687038.2010.543983; Muller F, 2010, CORTEX, V46, P1088, DOI 10.1016/j.cortex.2009.08.014; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Peach RK, 2013, AM J SPEECH-LANG PAT, V22, pS285, DOI 10.1044/1058-0360(2013/12-0081); Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; Powell GE, 2001, BRAIN DAM B, P65; R Core Team, 2012, R LANG ENV STAT COMP; Rios M, 2004, BRAIN INJURY, V18, P257, DOI 10.1080/02699050310001617442; Scheid R, 2006, ARCH NEUROL-CHICAGO, V63, P418, DOI 10.1001/archneur.63.3.418; Schmitter-Edgecombe M, 2005, BRAIN LANG, V94, P331, DOI 10.1016/j.bandl.2005.01.007; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; Spikman JM, 2012, J NEUROTRAUM, V29, P101, DOI 10.1089/neu.2011.2084; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Stuss DT, 2011, CURR OPIN NEUROL, V24, P584, DOI 10.1097/WCO.0b013e32834c7eb9; The Psychological Corporation, 2008, WAIS 4 TECHN MAN; Wallesch CW, 2001, BRAIN INJURY, V15, P401, DOI 10.1080/02699050010005959; Wechsler D, 1997, WMS 3 ADM SCORING MA; Wilson D, 2005, LINGUA, V115, P1129, DOI 10.1016/j.lingua.2004.02.005; Wood RL, 2008, J INT NEUROPSYCH SOC, V14, P289, DOI 10.1017/S1355617708080326; Yang FG, 2010, NEUROPSYCHOLOGIA, V48, P1923, DOI 10.1016/j.neuropsychologia.2010.03.011; Youse KM, 2005, BRAIN INJURY, V19, P1001, DOI 10.1080/02699050500109951	79	18	18	2	9	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2017	31	12					1564	1574		10.1080/02699052.2017.1341645			11	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	FN4KB	WOS:000415973200002	28901780	Green Accepted			2021-06-18	
J	Sawyer, RJ; Testa, SM; Dux, M				Sawyer, R. John, II; Testa, S. Marc; Dux, Moira			Embedded performance validity tests within the Hopkins Verbal Learning Test - Revised and the Brief Visuospatial Memory Test - Revised	CLINICAL NEUROPSYCHOLOGIST			English	Article						Embedded performance validity tests (PVTs); sensitivity and specificity; veterans; HVLT; BVMT	TRAUMATIC BRAIN-INJURY; RESPONSE BIAS; BASE RATES; TEST-II; NEUROPSYCHOLOGICAL EVALUATION; CLINICAL NEUROPSYCHOLOGY; INCOMPLETE EFFORT; AMERICAN ACADEMY; CROSS-VALIDATION; NORMATIVE DATA	Objective: Various research studies and neuropsychology practice organizations have reiterated the importance of developing embedded performance validity tests (PVTs) to detect potentially invalid neurocognitive test data. This study investigated whether measures within the Hopkins Verbal Learning Test - Revised (HVLT-R) and the Brief Visuospatial Memory Test - Revised (BVMT-R) could accurately classify individuals who fail two or more PVTs during routine clinical assessment. Method: The present sample of 109 United States military veterans (Mean age=52.4, SD=13.3), all consisted of clinically referred patients and received a battery of neuropsychological tests. Based on performance validity findings, veterans were assigned to valid (n=86) or invalid (n=23) groups. Of the 109 patients in the overall sample, 77 were administered the HLVT-R and 75 were administered the BVMT-R, which were examined for classification accuracy. Results: The HVLT-R Recognition Discrimination Index and the BVMT-R Retention Percentage showed good to adequate discrimination with an area under the curve of .78 and .70, respectively. The HVLT-R Recognition Discrimination Index showed sensitivity of .53 with specificity of .93. The BVMT-R Retention Percentage demonstrated sensitivity of .31 with specificity of .92. Conclusions: When used in conjunction with other PVTs, these new embedded PVTs may be effective in the detection of invalid test data, although they are not intended for use in patients with dementia.	[Sawyer, R. John, II; Dux, Moira] Baltimore Vet Affairs Med Ctr, Baltimore, MD 21201 USA; [Testa, S. Marc] Sinai Hosp, Berman Brain & Spine Inst, 2401 W Belvedere Ave, Baltimore, MD 21215 USA; [Sawyer, R. John, II] Ochnser Hlth Syst, New Orleans, LA 70121 USA	Sawyer, RJ (corresponding author), Baltimore Vet Affairs Med Ctr, Baltimore, MD 21201 USA.; Sawyer, RJ (corresponding author), Ochnser Hlth Syst, New Orleans, LA 70121 USA.	robert.sawyer@ochsner.org					Ardolf BR, 2007, CLIN NEUROPSYCHOL, V21, P899, DOI 10.1080/13825580600966391; Armistead-Jehle P, 2010, APPL NEUROPSYCHOL, V17, P52, DOI 10.1080/09084280903526182; Arnold G., 2007, ASSESSMENT FEIGNED C, P178; Axelrod BN, 2010, CLIN NEUROPSYCHOL, V24, P873, DOI 10.1080/13854040903527295; Babikian T, 2006, CLIN NEUROPSYCHOL, V20, P145, DOI 10.1080/13854040590947362; Babikian T., 2007, ASSESSMENT FEIGNED C, P103; Barr W. B., 2008, NAT AC NEUR NEW YORK; Bauer L, 2005, APPL NEUROPSYCHOL, V12, P202, DOI 10.1207/s15324826an1204_3; Benedict R., 1997, BRIEF VISUOSPATIAL M; Benedict RHB, 1998, CLIN NEUROPSYCHOL, V12, P43, DOI 10.1076/clin.12.1.43.1726; Benedict RHB., 1991, HOPKINS VERBAL LEARN; Boone K. B., 2002, DOT COUNTING TEST MA; Boone KB, 2002, J CLIN EXP NEUROPSYC, V24, P561, DOI 10.1076/jcen.24.5.561.1004; Boone KB, 2009, CLIN NEUROPSYCHOL, V23, P729, DOI 10.1080/13854040802427803; Bortnik KE, 2010, CLIN NEUROPSYCHOL, V24, P344, DOI 10.1080/13854040903307268; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Chafetz MD, 2008, CLIN NEUROPSYCHOL, V22, P529, DOI 10.1080/13854040701346104; Davis JJ, 2014, CLIN NEUROPSYCHOL, V28, P1224, DOI 10.1080/13854046.2014.987167; Davis JJ, 2012, CLIN NEUROPSYCHOL, V26, P1397, DOI 10.1080/13854046.2012.728627; DeRight J, 2015, CHILD NEUROPSYCHOL, V21, P1, DOI 10.1080/09297049.2013.864383; Goldberg H. E., 2007, ASSESSMENT FEIGNED C, P281; Green, 2004, GREENS MED SYMPTOM V; Green P, 2003, WORD MEMORY TEST WIN; Greiffenstein M.F., 1994, PSYCHOL ASSESSMENT, V6, P218, DOI [https://doi.org/10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Heilbronner RL, 2007, CLIN NEUROPSYCHOL, V21, P209, DOI 10.1080/13825580601025932; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Horwitz JE, 2006, APPL NEUROPSYCHOL, V13, P175, DOI 10.1207/s15324826an1303_5; Inman TH, 2002, ARCH CLIN NEUROPSYCH, V17, P1, DOI 10.1016/S0887-6177(00)00073-1; Jones R. G., 2012, NAT AC NEURO NASHV; Kim MS, 2010, ARCH CLIN NEUROPSYCH, V25, P60, DOI 10.1093/arclin/acp088; Larrabee GJ, 2008, CLIN NEUROPSYCHOL, V22, P666, DOI 10.1080/13854040701494987; Lu P. H., 2007, ASSESSMENT FEIGNED C, P128; Meyers JE, 2003, ARCH CLIN NEUROPSYCH, V18, P261, DOI 10.1016/S0887-6177(02)00136-1; Millis SR, 1995, PSYCHOL ASSESSMENT, V7, P463; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; Nelson NW, 2010, ARCH CLIN NEUROPSYCH, V25, P713, DOI 10.1093/arclin/acq075; Novitski J, 2012, ARCH CLIN NEUROPSYCH, V27, P190, DOI 10.1093/arclin/acr119; Ord JS, 2010, J CLIN EXP NEUROPSYC, V32, P380, DOI 10.1080/13803390903066881; Proto DA, 2014, ARCH CLIN NEUROPSYCH, V29, P614, DOI 10.1093/arclin/acu044; Reedy SD, 2013, ARCH CLIN NEUROPSYCH, V28, P30, DOI 10.1093/arclin/acs106; Schroeder RW, 2011, CLIN NEUROPSYCHOL, V25, P437, DOI 10.1080/13854046.2011.556668; Schutte C., 2013, MILD TRAUMATIC BRAIN, P159; Schutte C, 2011, CLIN NEUROPSYCHOL, V25, P454, DOI 10.1080/13854046.2010.550635; Sharland MJ, 2007, ARCH CLIN NEUROPSYCH, V22, P213, DOI 10.1016/j.acn.2006.12.004; Sweet J. J., 2007, ASSESSMENT FEIGNED C, P152; Sweet JJ, 2015, CLIN NEUROPSYCHOL, V29, P1069, DOI 10.1080/13854046.2016.1140228; Sweet JJ, 2000, ARCH CLIN NEUROPSYCH, V15, P105, DOI 10.1016/S0887-6177(98)00153-X; Tombaugh TN, 1997, PSYCHOL ASSESSMENT, V9, P260, DOI 10.1037/1040-3590.9.3.260; Tombaugh TN, 1996, TEST MEMORY MALINGER; Victor T, 2009, CLIN NEUROPSYCHOL, V23, P297, DOI 10.1080/13854040802232682; Victor TL, 2004, PROF PSYCHOL-RES PR, V35, P373, DOI 10.1037/0735-7028.35.4.373; Webb JW, 2012, CLIN NEUROPSYCHOL, V26, P1377, DOI 10.1080/13854046.2012.728248; WETTER MW, 1995, PROF PSYCHOL-RES PR, V26, P474, DOI 10.1037/0735-7028.26.5.474; Wolfe PL, 2010, CLIN NEUROPSYCHOL, V24, P153, DOI 10.1080/13854040903107791; Young JC, 2016, CLIN NEUROPSYCHOL, V30, P497, DOI 10.1080/13854046.2016.1159730; Young JC, 2012, CLIN NEUROPSYCHOL, V26, P147, DOI 10.1080/13854046.2011.647083; Youngjohn J.R., 1995, ASSESSMENT, V2, DOI [https://doi.org/10.1177/1073191195002003007, DOI 10.1177/1073191195002003007]	57	18	18	0	7	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.		2017	31	1					207	218		10.1080/13854046.2016.1245787			12	Psychology, Clinical; Clinical Neurology; Psychology	Psychology; Neurosciences & Neurology	EK2VR	WOS:000393785300013	27758163				2021-06-18	
J	Tardif, PA; Moore, L; Boutin, A; Dufresne, P; Omar, M; Bourgeois, G; Bonaventure, PL; Kuimi, BLB; Turgeon, AF				Tardif, Pier-Alexandre; Moore, Lynne; Boutin, Amelie; Dufresne, Philippe; Omar, Madiba; Bourgeois, Gilles; Bonaventure, Paule Lessard; Kuimi, Brice Lionel Batomen; Turgeon, Alexis F.			Hospital length of stay following admission for traumatic brain injury in a Canadian integrated trauma system: A retrospective multicenter cohort study	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Acute care; Determinants; Intensive care; Length of stay; Traumatic brain injury	MULTIPLE IMPUTATION; CARE-UNIT; LEVEL I; MISSING DATA; OUTCOMES; COSTS; MORTALITY; IMPROVES; IMPLEMENTATION; REIMBURSEMENT	Background: Traumatic brain injury (TBI) is the leading cause of disability in children and young adults and costs CAD$3 billion annually in Canada. Stakeholders have expressed the urgent need to obtain information on resource use for TBI to improve the quality and efficiency of acute care in this patient population. We aimed to assess the components and determinants of hospital and ICU LOS for TBI admissions. Methods: We performed a retrospective multicenter cohort study on 11,199 adults admitted for TBI between 2007 and 2012 in an inclusive Canadian trauma system. Our primary outcome measure was index hospital LOS (admission to the hospital with the highest designation level). Index LOS was compared to total LOS (all consecutive admissions related to the injury). Expected LOS was calculated by matching TBI admissions to all-diagnosis hospital admissions by age, gender, and year of admission. LOS determinants were identified using multilevel linear regression. Results: Geometric mean total LOS was 1 day longer than geometric mean index LOS (12.6 versus 11.7 days). Observed index and ICU LOS were respectively 4.2 days and 2.5 days longer than that expected according to all-diagnosis admissions. The six most important determinants of LOS were discharge destination, severity of concomitant injuries, extracranial complications, GCS, TBI severity, and mechanical ventilation, accounting for 80% of explained variation. Conclusions: Results of this multicenter retrospective cohort study suggest that hospital and ICU LOS for TBI admissions are 56% and 119% longer than expected according to all-diagnosis admissions, respectively. In addition, hospital LOS is underestimated when only the index visit is considered and is largely influenced by discharge destination and extracranial complications, suggesting that improvements could be achieved with better discharge planning and interventions targeting prevention of in-hospital complications. This study highlights the importance of considering TBI patients as a distinct population when allocating resources or planning quality improvement interventions. (C) 2016 Elsevier Ltd. All rights reserved.	[Tardif, Pier-Alexandre; Moore, Lynne; Boutin, Amelie; Dufresne, Philippe; Omar, Madiba; Bonaventure, Paule Lessard; Kuimi, Brice Lionel Batomen; Turgeon, Alexis F.] Univ Laval, Trauma Emergency Crit Care Med, Populat Hlth & Optimal Hlth Practices Res Unit, CHU Quebec,Res Ctr, Quebec City, PQ, Canada; [Tardif, Pier-Alexandre; Moore, Lynne; Boutin, Amelie; Dufresne, Philippe; Omar, Madiba] Univ Laval, Dept Social & Preventat Med, Quebec City, PQ, Canada; [Bourgeois, Gilles] Inst Natl Excellence Sante & Serv Sociaux, Montreal, PQ, Canada; [Bonaventure, Paule Lessard] Univ Laval, Div Neurosurg, Dept Neurol Sci, Quebec City, PQ, Canada; [Turgeon, Alexis F.] Univ Laval, Div Crit Care Med, Dept Anesthesiol, Quebec City, PQ, Canada	Tardif, PA (corresponding author), Univ Laval, Populat Hlth & Optimal Hlth Practices Res Unit, Trauma Emergency Crit Care Med, CHU Quebec,Res Ctr,Hop Enfant Jesus, 1401,18eme Rue,Local H-012a, Quebec City, PQ G1J 1Z4, Canada.	pier-alexandre.tardif.1@ulaval.ca; lynne.moore@fmed.ulaval.ca; amelie.boutin.2@ulaval.ca; philippe.dufresne.3@ulaval.ca; madiba.omar.1@ulaval.ca; gillesbourgeois1954@gmail.com; paule.lessard.bonaventure@gmail.com; brice-lionel.batomen-kuimi.1@ulaval.ca; alexis.Turgeon@fmed.ulaval.ca	Kuimi, Brice Lionel Batomen/AAF-3970-2020	Kuimi, Brice Lionel Batomen/0000-0002-5772-120X; Tardif, Pier-Alexandre/0000-0003-3003-2399; Boutin, Amelie/0000-0003-1907-2920	Canadian Institutes of Health Research (CIHR) New Investigator AwardCanadian Institutes of Health Research (CIHR) [110996]; CIHR Best and Banting PhD Training Award; CIHR Masters Training AwardCanadian Institutes of Health Research (CIHR)	Canadian Institutes of Health Research (CIHR) New Investigator Award (LM and AFT) and research grant (LM; #110996); CIHR Best and Banting PhD Training Award (AB) and CIHR Masters Training Award (PLB). None of the funders had any role in the design or conduct of the study; collection, management, analysis, or interpretation of the data; or preparation, review, or approval of the manuscript. The authors declare no conflicts of interest.	Alkhoury F, 2011, AM SURGEON, V77, P277; American College of Surgeons Committee on Trauma, 2012, NAT TRAUM DAT BANK 2; [Anonymous], 2006, I CANADIEN INFORM SA; Arthur M, 2009, J RURAL HEALTH, V25, P182, DOI 10.1111/j.1748-0361.2009.00215.x; Bodanapally UK, 2013, INJURY, V44, P75, DOI 10.1016/j.injury.2011.10.037; Bodner TE, 2008, STRUCT EQU MODELING, V15, P651, DOI 10.1080/10705510802339072; Brehaut JC, 2005, ACAD EMERG MED, V12, P948, DOI 10.1197/j.aem.2005.04.024; Cameron CM, 2008, BRAIN INJURY, V22, P437, DOI 10.1080/02699050802060621; Caminiti C, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-14; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd; Conforti DA, 2004, AUSTRALAS J AGEING, V23, P189, DOI 10.1111/j.1741-6612.2004.00048.x; Daly L.E., 2000, INTERPRETATION USES; Dasta JF, 2005, CRIT CARE MED, V33, P1266, DOI 10.1097/01.CCM.0000164543.14619.00; de Jongh MAC, 2011, J TRAUMA, V71, pE102, DOI 10.1097/TA.0b013e31820e351f; Dutton RP, 2003, J TRAUMA, V55, P913, DOI 10.1097/01.TA.0000093395.34097.56; Eastman AB, 2006, J TRAUMA, V60, P535; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Fakhry SM, 2010, J AM COLL SURGEONS, V210, P817, DOI 10.1016/j.jamcollsurg.2010.01.030; Fakhry SM, 2004, J TRAUMA, V56, P492, DOI 10.1097/01.TA.0000115650.07193.66; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Frederickson TA, 2013, J INTENSIVE CARE MED, V28, P58, DOI 10.1177/0885066611432420; George EO, 2014, J NEUROTRAUM, V31, P1018, DOI 10.1089/neu.2013.3224; Hassan M, 2010, INT J PHARM HEALTHC, V4, P324, DOI 10.1108/17506121011095182; Jarrett Letha Ann, 2009, J Trauma Nurs, V16, P68, DOI 10.1097/JTN.0b013e3181ac91c1; Kahn JM, 2008, MED CARE, V46, P1226, DOI 10.1097/MLR.0b013e31817d9342; KALB PE, 1989, JAMA-J AM MED ASSOC, V261, P2389, DOI 10.1001/jama.261.16.2389; KNAUS WA, 1993, ANN INTERN MED, V118, P753, DOI 10.7326/0003-4819-118-10-199305150-00001; Kuimi BLB, 2015, INJURY, V46, P595, DOI 10.1016/j.injury.2015.01.006; Legorreta A P, 1993, J Assoc Acad Minor Phys, V4, P52; Liberman M, 2004, J TRAUMA, V56, P1330, DOI 10.1097/01.TA.0000071297.76727.8B; MacKenzie EJ, 2008, J BONE JOINT SURG AM, V90A, P101, DOI 10.2106/JBJS.F.01225; Mains C, 2009, J TRAUMA, V66, P1315, DOI 10.1097/TA.0b013e31819d96d8; McDonagh MS, 2000, HEALTH POLICY, V53, P157, DOI 10.1016/S0168-8510(00)00092-0; Miller Finkelstein ECP, INCIDENCE EC BURDEN; Moein H, 2006, CLIN NEUROL NEUROSUR, V108, P539, DOI 10.1016/j.clineuro.2005.09.003; Moore L, 2005, J TRAUMA, V59, P698, DOI 10.1097/01.ta.0000177700.54943.ee; Moore L, 2014, ANN SURG, V260, P179, DOI 10.1097/SLA.0000000000000624; Moore Lynne, 2009, J Emerg Trauma Shock, V2, P73, DOI 10.4103/0974-2700.44774; Moore L, 2009, J AM COLL SURGEONS, V209, P572, DOI 10.1016/j.jamcollsurg.2009.07.004; Nickrenz L, 2010, ETHOS, V38; O'Keefe GE, 1999, J TRAUMA, V46, P473, DOI 10.1097/00005373-199903000-00023; Omar M, 2016, J TRAUMA ACUTE UNPUB; Palmer S, 2001, J TRAUMA, V50, P657, DOI 10.1097/00005373-200104000-00010; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; Robinson BRH, 2008, J TRAUMA, V65, P517, DOI 10.1097/TA.0b013e318181b8f6; Rockhill CM, 2012, J NEUROTRAUM, V29, P1038, DOI 10.1089/neu.2010.1562; Rotondo MF, 2010, J AM COLL SURGEONS, V210, P821; Ruffieux C, 2000, CASEMIX Q, V2, P1; Schafer JL, 1999, STAT METHODS MED RES, V8, P3, DOI 10.1191/096228099671525676; Schulman J, 2006, J PERINATOL, V26, P243, DOI 10.1038/sj.jp.7211478; SCHWAB CW, 1988, J TRAUMA, V28, P939, DOI 10.1097/00005373-198807000-00006; Selya AS, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00111; SHWARTZ M, 2003, RISK ADJUSTMENT MEAS; SIEGEL JH, 1994, J TRAUMA, V37, P928, DOI 10.1097/00005373-199412000-00010; Solberg BCJ, 2008, CRIT CARE, V12, DOI 10.1186/cc6903; Sterne JAC, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2393; Turgeon AF, 2011, CAN MED ASSOC J, V183, P1581, DOI 10.1503/cmaj.101786; Utter GH, 2006, J TRAUMA, V60, P529, DOI 10.1097/01.ta.0000204022.36214.9e; Vitaz TW, 2003, SURG NEUROL, V60, P285, DOI 10.1016/S0090-3019(03)00378-1; Yeung Jacky T, 2013, J Emerg Trauma Shock, V6, P189, DOI 10.4103/0974-2700.115337; Yuan Q, 2012, INJURY, V43, P2094, DOI 10.1016/j.injury.2012.03.028	61	18	19	0	4	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	JAN	2017	48	1					94	100		10.1016/j.injury.2016.10.042			7	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	EF7YF	WOS:000390544600017	27839794				2021-06-18	
J	Vahidinia, Z; Alipour, N; Atlasi, MA; Naderian, H; Beyer, C; Tameh, AA				Vahidinia, Zeinab; Alipour, Nasim; Atlasi, Mohammad Ali; Naderian, Homayoun; Beyer, Cordian; Tameh, Abolfazl Azami			Gonadal steroids block the calpain-1-dependent intrinsic pathway of apoptosis in an experimental rat stroke model	NEUROLOGICAL RESEARCH			English	Article						Estrogen; Progesterone; Apoptosis; tMCAO; Calpain-1	FOCAL CEREBRAL-ISCHEMIA; TRAUMATIC BRAIN-INJURY; INDUCED CELL-DEATH; ARTERY OCCLUSION; NEURONAL DEATH; NEUROPROTECTION; ESTROGEN; CALPAIN; PROGESTERONE; MECHANISMS	Objectives: Apoptosis plays an important role in the progression of the ischemic penumbra after reperfusion. Estrogen and progesterone have neuroprotective effects against ischemic brain damage, however the exact mechanisms of neuroprotection and signaling pathways is not completely understood. In this study, we investigated the possible regulatory effects of a combined steroid treatment on extrinsic and intrinsic apoptotic signaling pathways after cerebral ischemia. Methods: Adult male Wistar rats were subjected to transient middle cerebral artery occlusion (tMCAO) using an intraluminal filament technique for 1h followed by 23h reperfusion. Estrogen and progesterone were immediately injected after tMCAO subcutaneously. Sensorimotor functional tests and the infarct volume were evaluated 24h after ischemia. Protein expression of calpain-1 and Fas receptor (FasR), key members of intrinsic and extrinsic apoptosis, were determined in the penumbra region of the ischemic brain using western blot analysis, immunohistochemistry, and TUNEL staining. Results: Neurological deficits and infarct volume were significantly reduced following hormone therapy. Calpain-1 up-regulation and caspase-3 activation were apparent 24h after ischemia in the peri-infarct area of the cerebral cortex. Steroid hormone treatment reduced infarct pathology and attenuated the induction of both proteases. FasR protein levels were not affected by ischemia and hormone application. Conclusion: We conclude that a combined steroid treatment inhibits ischemia-induced neuronal apoptosis through the regulation of intrinsic pathways.	[Vahidinia, Zeinab; Alipour, Nasim; Atlasi, Mohammad Ali; Naderian, Homayoun; Tameh, Abolfazl Azami] Kashan Univ Med Sci, Anat Sci Res Ctr, Kashan, Iran; [Beyer, Cordian] Rhein Westfal TH Aachen, Fac Med, Inst Neuroanat, Aachen, Germany; [Tameh, Abolfazl Azami] Kashan Univ Med Sci, Sch Med, Dept Anat, Kashan, Iran	Tameh, AA (corresponding author), Kashan Univ Med Sci, Anat Sci Res Ctr, Kashan, Iran.; Tameh, AA (corresponding author), Kashan Univ Med Sci, Sch Med, Dept Anat, Kashan, Iran.	aazami@kaums.ac.ir	Atlasi, Mohammad Ali/H-1786-2017; Naderian, Homayoun/H-2265-2017; Azami Tameh, Abolfazl/G-8213-2017	Atlasi, Mohammad Ali/0000-0002-5058-9111; Naderian, Homayoun/0000-0001-9427-5168; Azami Tameh, Abolfazl/0000-0002-5359-3298	Kashan University of Medical Sciences [92159]	This work was supported by Kashan University of Medical Sciences [grant number 92159].	Abumaree M, 2012, STEM CELL REV REP, V8, P375, DOI 10.1007/s12015-011-9312-0; Alkayed NJ, 2000, STROKE, V31, P161, DOI 10.1161/01.STR.31.1.161; Arnold S, 2009, J NEUROCHEM, V110, P1, DOI 10.1111/j.1471-4159.2009.06133.x; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Barone FC, 2009, CURR OPIN INVEST DR, V10, P220; BARTUS RT, 1995, J CEREBR BLOOD F MET, V15, P969, DOI 10.1038/jcbfm.1995.123; Becher B, 1998, TRENDS NEUROSCI, V21, P114, DOI 10.1016/S0166-2236(97)01180-6; Brann DW, 2007, STEROIDS, V72, P381, DOI 10.1016/j.steroids.2007.02.003; Cain K, 2002, BIOCHIMIE, V84, P203, DOI 10.1016/S0300-9084(02)01376-7; Chan SL, 1999, J NEUROSCI RES, V58, P167, DOI 10.1002/(SICI)1097-4547(19991001)58:1<167::AID-JNR16>3.3.CO;2-B; Cimarosti H, 2006, NEUROCHEM RES, V31, P483, DOI 10.1007/s11064-006-9043-9; CROALL DE, 1991, PHYSIOL REV, V71, P813; Cutler SM, 2007, J NEUROTRAUM, V24, P1475, DOI 10.1089/neu.2007.0294; Dang J, 2011, BRAIN BEHAV IMMUN, V25, P715, DOI 10.1016/j.bbi.2011.01.013; Daniel PT, 2000, LEUKEMIA, V14, P2035, DOI 10.1038/sj.leu.2401940; Donnan GA, 2008, LANCET, V371, P1612, DOI 10.1016/S0140-6736(08)60694-7; Fujimoto S, 2004, NEUROSCI RES, V50, P179, DOI 10.1016/j.neures.2004.06.013; Gao G, 2000, J CELL BIOCHEM, V80, P53; Garcia J, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-414; Garcia-Segura LM, 2009, FRONT NEUROENDOCRIN, V30, pV, DOI 10.1016/j.yfrne.2009.04.006; Goodman YD, 1996, J NEUROCHEM, V66, P1836; Guan QH, 2006, NEUROSCIENCE, V139, P609, DOI 10.1016/j.neuroscience.2005.11.067; Guan QH, 2006, BRAIN RES, V1092, P36, DOI 10.1016/j.brainres.2006.03.086; Gutierrez-Fernandez M, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0406-3; Hoffman GE, 2006, ENDOCRINE, V29, P217, DOI 10.1385/ENDO:29:2:217; HONG SC, 1994, STROKE, V25, P663, DOI 10.1161/01.STR.25.3.663; Ishrat T, 2009, BRAIN RES, V1257, P94, DOI 10.1016/j.brainres.2008.12.048; Kim R, 2006, J PATHOL, V208, P319, DOI 10.1002/path.1885; Kim YJ, 2000, J NEUROCHEM, V74, P2490, DOI 10.1046/j.1471-4159.2000.0742490.x; Lammerding L, 2016, NEUROENDOCRINOLOGY, V103, P460, DOI 10.1159/000439435; Li YG, 2013, CHINESE MED J-PEKING, V126, P4088, DOI 10.3760/cma.j.issn.0366-6999.20130800; Lipton P, 1999, PHYSIOL REV, V79, P1431; Liu M, 2010, MINERVA ENDOCRINOL, V35, P127; Liu XS, 1997, CELL, V89, P175, DOI 10.1016/S0092-8674(00)80197-X; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Lorenz L, 2009, J NEUROENDOCRINOL, V21, P841, DOI 10.1111/j.1365-2826.2009.01903.x; Markgraf CG, 1998, STROKE, V29, P152, DOI 10.1161/01.STR.29.1.152; Mehta SL, 2007, BRAIN RES REV, V54, P34, DOI 10.1016/j.brainresrev.2006.11.003; Movsesyan VA, 2004, CELL DEATH DIFFER, V11, P1121, DOI 10.1038/sj.cdd.4401442; Nilsen J, 2002, BRAIN RES, V930, P216, DOI 10.1016/S0006-8993(02)02254-0; O'Connor CA, 2007, EXP NEUROL, V205, P145, DOI 10.1016/j.expneurol.2007.01.034; Ouyang CH, 2007, NEUROSCI LETT, V420, P174, DOI 10.1016/j.neulet.2007.05.004; Rami A, 2003, NEUROBIOL DIS, V13, P75, DOI 10.1016/S0969-9961(03)00018-4; Ryang YM, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-113; Sedarous M, 2003, J BIOL CHEM, V278, P26031, DOI 10.1074/jbc.M302833200; Sribnick EA, 2004, J NEUROSCI RES, V76, P688, DOI 10.1002/jnr.20124; Sribnick EA, 2007, NEUROCHEM RES, V32, P2210, DOI 10.1007/s11064-007-9433-7; Sribnick EA, 2009, BRAIN RES, V1276, P159, DOI 10.1016/j.brainres.2009.04.022; Stein DG, 2008, BRAIN RES REV, V57, P386, DOI 10.1016/j.brainresrev.2007.06.012; Stupka N, 2001, J APPL PHYSIOL, V91, P1828; Sur P, 2003, BRAIN RES, V971, P178, DOI 10.1016/S0006-8993(03)02349-7; Suzuki S, 2009, FRONT NEUROENDOCRIN, V30, P201, DOI 10.1016/j.yfrne.2009.04.007; Tameh AA, 2013, ANN ANAT, V195, P415, DOI 10.1016/j.aanat.2013.03.004; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; Ulbrich C, 2012, J STEROID BIOCHEM, V131, P10, DOI 10.1016/j.jsbmb.2012.01.007; Vakili A, 2014, BRAIN RES, V1548, P56, DOI 10.1016/j.brainres.2013.12.019; Wang Y, 2007, LIFE SCI, V80, P2067, DOI 10.1016/j.lfs.2007.03.010; Wood DE, 1998, ONCOGENE, V17, P1069, DOI 10.1038/sj.onc.1202034; Xing BZ, 2008, STROKE, V39, P2362, DOI 10.1161/STROKEAHA.107.507939; Yang SH, 2000, STROKE, V31, P745, DOI 10.1161/01.STR.31.3.745	60	18	21	0	15	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.	JAN	2017	39	1					54	64		10.1080/01616412.2016.1250459			11	Clinical Neurology; Neurosciences	Neurosciences & Neurology	EF6HF	WOS:000390431000009	27832728				2021-06-18	
J	Alluri, H; Grimsley, M; Shaji, CA; Varghese, KP; Zhang, SYL; Peddaboina, C; Robinson, B; Beeram, MR; Huang, JH; Tharakan, B				Alluri, Himakarnika; Grimsley, Marcene; Shaji, Chinchusha Anasooya; Varghese, Kevin Paul; Zhang, Shenyuan L.; Peddaboina, Chander; Robinson, Bobby; Beeram, Madhava R.; Huang, Jason H.; Tharakan, Binu			Attenuation of Blood-Brain Barrier Breakdown and Hyperpermeability by Calpain Inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL CEREBRAL-ISCHEMIA; ENDOTHELIAL-CELLS; INJURY; PERMEABILITY; MATRIX-METALLOPROTEINASE-9; CLEAVAGE; EDEMA; DYSFUNCTION; MODULATION; INDUCTION	Blood-brain barrier (BBB) breakdown and the associated microvascular hyperpermeability followed by brain edema are hallmark features of several brain pathologies, including traumatic brain injuries (TBI). Recent studies indicate that pro-inflammatory cytokine interleukin-1 beta (IL-1 beta) that is upregulated following traumatic injuries also promotes BBB dysfunction and hyperpermeability, but the underlying mechanisms are not clearly known. The objective of this study was to determine the role of calpains in mediating BBB dysfunction and hyperpermeability and to test the effect of calpain inhibition on theBBBfollowing traumatic insults to the brain. In these studies, rat brain microvascular endothelial cell monolayers exposed to calpain inhibitors (calpain inhibitor III and calpastatin) or transfected with calpain-1 siRNA demonstrated attenuation of IL-1 beta-induced monolayer hyperpermeability. Calpain inhibition led to protection against IL-1 beta-induced loss of zonula occludens-1 (ZO-1) at the tight junctions and alterations in F-actin cytoskeletal assembly. IL-1 beta treatment had no effect on ZO-1 gene (tjp1) or protein expression. Calpain inhibition via calpain inhibitor III and calpastatin decreased IL-1 beta-induced calpain activity significantly (p < 0.05). IL-1 beta had no detectable effect on intracellular calcium mobilization or endothelial cell viability. Furthermore, calpain inhibition preserved BBB integrity/permeability in a mouse controlled cortical impact model of TBI when studied using Evans blue assay and intravital microscopy. These studies demonstrate that calpain-1 acts as a mediator of IL-1 beta-induced loss of BBB integrity and permeability by altering tight junction integrity, promoting the displacement of ZO-1, and disorganization of cytoskeletal assembly. IL-1 beta-mediated alterations in permeability are neither due to the changes in ZO-1 expression nor cell viability. Calpain inhibition has beneficial effects against TBI-induced BBB hyperpermeability.	[Alluri, Himakarnika; Shaji, Chinchusha Anasooya; Peddaboina, Chander; Robinson, Bobby; Tharakan, Binu] Texas A&M Univ, Hlth Sci Ctr, Baylor Scott & White Hlth, Dept Surg,Coll Med, 702 SW HK Dodgen Loop, Temple, TX 76504 USA; [Huang, Jason H.] Texas A&M Univ, Hlth Sci Ctr, Baylor Scott & White Hlth, Dept Neurosurg,Coll Med, Temple, TX 76504 USA; [Beeram, Madhava R.] Texas A&M Univ, Hlth Sci Ctr, Baylor Scott & White Hlth, Dept Pediat,Coll Med, Temple, TX 76504 USA; [Grimsley, Marcene] Texas Biosci Inst, Temple, TX 76502 USA; [Varghese, Kevin Paul] Univ Texas Austin, Dept Biomed Engn, Austin, TX 78712 USA; [Zhang, Shenyuan L.] Texas A&M Univ, Hlth Sci Ctr, Coll Med, Dept Med Physiol, Temple, TX 76504 USA	Tharakan, B (corresponding author), Texas A&M Univ, Hlth Sci Ctr, Baylor Scott & White Hlth, Dept Surg,Coll Med, 702 SW HK Dodgen Loop, Temple, TX 76504 USA.	btharakan@medicine.tamhsc.edu	Huang, Jason H/J-4739-2019	Huang, Jason H/0000-0002-4426-0168	Baylor Scott and White Health Academic Operations Research funds	This work was supported by Baylor Scott and White Health Academic Operations Research funds (to B. T.). The authors declare that they have no conflicts of interest with the contents of this article.	Abbott NJ, 2000, CELL MOL NEUROBIOL, V20, P131, DOI 10.1023/A:1007074420772; Ali MAM, 2012, BIOCHEM BIOPH RES CO, V423, P1, DOI 10.1016/j.bbrc.2012.05.005; Alluri H, 2015, METAB BRAIN DIS, V30, P1093, DOI 10.1007/s11011-015-9651-7; Alluri H, 2014, MICROCIRCULATION, V21, P187, DOI 10.1111/micc.12110; Anagli J, 2009, BIOCHEM BIOPH RES CO, V385, P94, DOI 10.1016/j.bbrc.2009.04.141; Blamire AM, 2000, J NEUROSCI, V20, P8153; Bralic M, 2012, COLLEGIUM ANTROPOL, V36, P1319; Bralic M, 2012, MED HYPOTHESES, V79, P358, DOI 10.1016/j.mehy.2012.05.034; Chakraborti S, 2012, INDIAN J BIOCHEM BIO, V49, P316; Chen YC, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00100; Elali A, 2011, STROKE, V42, P3238, DOI 10.1161/STROKEAHA.111.615559; Fei B, 2013, BBA-MOL CELL RES, V1833, P2153, DOI 10.1016/j.bbamcr.2013.05.010; Germano A, 2002, J NEUROTRAUM, V19, P887, DOI 10.1089/08977150260190474; Glading A, 2004, MOL CELL BIOL, V24, P2499, DOI 10.1128/MCB.24.6.2499-2512.2004; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Hannah RM, 2011, J CEREBR BLOOD F MET, V31, P1175, DOI 10.1038/jcbfm.2010.214; Hu HX, 2009, MICROVASC RES, V78, P33, DOI 10.1016/j.mvr.2009.04.005; Jeong SY, 2013, P NATL ACAD SCI USA, V110, pE4007, DOI 10.1073/pnas.1316852110; Kampfl A, 1997, J NEUROTRAUM, V14, P121, DOI 10.1089/neu.1997.14.121; Kotecki M, 2010, MICROVASC RES, V80, P339, DOI 10.1016/j.mvr.2010.07.012; Loot AE, 2013, J CARDIOVASC PHARM, V61, P528, DOI 10.1097/FJC.0b013e31828d0fa3; Ma M, 2013, NEUROBIOL DIS, V60, P61, DOI 10.1016/j.nbd.2013.08.010; Machida T, 2015, NEUROSCI LETT, V599, P109, DOI 10.1016/j.neulet.2015.05.028; Mayhan WG, 2001, MICROCIRCULATION, V8, P89, DOI 10.1038/sj.mn.7300154; Medeiros R, 2012, AM J PATHOL, V181, P616, DOI 10.1016/j.ajpath.2012.04.020; Michinaga S, 2015, INT J MOL SCI, V16, P9949, DOI 10.3390/ijms16059949; Millan J, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-11; Miyazaki T, 2011, CIRCULATION, V124, P2522, DOI 10.1161/CIRCULATIONAHA.111.021675; Murray KN, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00018; Pfaff M, 1999, FEBS LETT, V460, P17, DOI 10.1016/S0014-5793(99)01250-8; Pietsch M, 2010, CURR TOP MED CHEM, V10, P270, DOI 10.2174/156802610790725489; Prangsaengtong O, 2012, HUM CELL, V25, P36, DOI 10.1007/s13577-012-0042-7; Ranaivo HR, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-68; Ray SK, 2003, BRAIN RES REV, V42, P169, DOI 10.1016/S0165-0173(03)00152-8; Saatman KE, 2010, NEUROTHERAPEUTICS, V7, P31, DOI 10.1016/j.nurt.2009.11.002; Samantaray S, 2015, MOL NEUROBIOL, V52, P1054, DOI 10.1007/s12035-015-9255-6; Smith MA, 2012, CARDIOVASC RES, V96, P32, DOI 10.1093/cvr/cvs163; Takata F, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-106; Tejima E, 2007, J CEREBR BLOOD F MET, V27, P460, DOI 10.1038/sj.jcbfm.9600354; Thompson SN, 2010, J NEUROTRAUM, V27, P2233, DOI 10.1089/neu.2010.1474; Toba S, 2013, SCI REP-UK, V3, DOI 10.1038/srep01224; TOULMOND S, 1995, BRAIN RES, V671, P261, DOI 10.1016/0006-8993(94)01343-G; Tsubokawa T, 2006, STROKE, V37, P1888, DOI 10.1161/01.STR.0000227259.15506.24; Wang T, 2012, PART FIBRE TOXICOL, V9, DOI 10.1186/1743-8977-9-35; Wong D, 2004, EXP NEUROL, V190, P446, DOI 10.1016/j.expneurol.2004.08.008; Yuan S. Y., 2010, C SERIES INTEGRATED, P39; Zhao XR, 1998, J CEREBR BLOOD F MET, V18, P161, DOI 10.1097/00004647-199802000-00006; Zhao YZ, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.380469; Zhou MH, 2014, J BIOL CHEM, V289, P29446, DOI 10.1074/jbc.M114.578492	49	18	18	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2016	291	53					26958	26969		10.1074/jbc.M116.735365			12	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	EH2CZ	WOS:000391576300002	27875293	Green Published, Other Gold			2021-06-18	
J	Miszczuk, D; Debski, KJ; Tanila, H; Lukasiuk, K; Pitkanen, A				Miszczuk, Diana; Debski, Konrad J.; Tanila, Heikki; Lukasiuk, Katarzyna; Pitkanen, Asla			Traumatic Brain Injury Increases the Expression of Nos1, A beta Clearance, and Epileptogenesis in APP/PS1 Mouse Model of Alzheimer's Disease	MOLECULAR NEUROBIOLOGY			English	Article						Alzheimer's disease; Beta-amyloid; Epileptogenesis; Nitric oxide synthase 1; Transcriptome; Traumatic brain injury	CONTROLLED CORTICAL IMPACT; NITRIC-OXIDE; POSTTRAUMATIC EPILEPSY; COGNITIVE DEFICITS; APOLIPOPROTEIN-E; TAU; MICE; DEPOSITION; PROTEIN; HYPEREXCITABILITY	To test the hypothesis that an amyloidogenic genetic background predisposes to worsening of post-TBI outcome, we investigated whether traumatic brain injury (TBI) in http://unabridged.merriam-webster.com(APP)/PS1 mice aggravates epileptogenesis and/or enhances somatomotor and cognitive impairment. To elaborate the mechanisms of worsening outcomes, we studied changes in the expression of genes involved in APP processing and Tau pathways in the perilesional cortex, ipsilateral thalamus, and ipsilateral hippocampus 16 weeks post-TBI. Mild (mTBI) or severe TBI (sTBI) was triggered using controlled cortical impact in 3-month-old APP/PS1 mice and wild-type (Wt) littermates. Morris water-maze revealed a genotype effect on spatial learning and memory as APP/PS1-sTBI mice performed more poorly than Wt-sTBI mice (p < 0.05). Epileptogenesis was affected by genotype and TBI as 88 % of APP/PS1-sTBI mice had epilepsy compared to 11 % in Wt-sTBI (genotype effect p < 0.01) or 50 % in APP/PS1-sham groups (TBI effect p < 0.05). The higher the seizure frequency, the higher the cortical expression of Nos1 (r = 0.83, p < 0.001) and Mapk3 (r = 0.67, p < 0.001). Immunohistochemical analysis confirmed increased amount of NOS1 protein in neuronal somata and processes in the perilesional cortex in APP/PS1-sTBI mice compared to APP/PS1-sham (p < 0.05) or Wt-sTBI mice (p < 0.01). Motor impairment correlated (p < 0.001) with the increased cortical expression of genes encoding proteins related to beta-amyloid (A beta) clearance, including Clu (r = 0.83), Abca1 (r = 0.78), A2m (r = 0.76), Apoe (r = 0.70), and Ctsd (r = 0.63). Immunohistochemical analysis revealed a focal reduction in A beta load lateral to lesion core in APP/PS1-sTBI mice compared to APP/PS1-sham mice (p < 0.05). The present study provides the first comprehensive evidence of exacerbated epileptogenesis and its molecular mechanisms in Alzheimer's disease (AD)-related genetic background after TBI.	[Miszczuk, Diana; Debski, Konrad J.; Lukasiuk, Katarzyna] Polish Acad Sci, Nencki Inst Expt Biol, 3 Pasteur St, PL-02093 Warsaw, Poland; [Miszczuk, Diana; Tanila, Heikki; Pitkanen, Asla] Univ Eastern Finland, AI Virtanen Inst Mol Sci, Dept Neurobiol, POB 1627, FIN-70211 Kuopio, Finland	Pitkanen, A (corresponding author), Univ Eastern Finland, AI Virtanen Inst Mol Sci, Dept Neurobiol, POB 1627, FIN-70211 Kuopio, Finland.	asla.pitkanen@uef.fi		Lukasiuk, Katarzyna/0000-0002-1582-0920	Academy of Finland grant EuroEPINOMICSAcademy of Finland; Sigrid Juselius FoundationSigrid Juselius Foundation; CIMO (Center for International Mobility); Foundation for Polish Science grant [MPD/2009/4]; National Science Center of PolandNational Science Centre, Poland [2012/05/N/NZ/02500]; Ministry of Science and Higher EducationMinistry of Science and Higher Education, PolandEuropean Commission [DNP/N119/ESF-EuroEPINOMICS/2012]	This study was supported by the Academy of Finland grant EuroEPINOMICS (AP), The Sigrid Juselius Foundation (AP), CIMO (Center for International Mobility) (DM), Foundation for Polish Science grant MPD/2009/4 (KL), National Science Center of Poland grant 2012/05/N/NZ/02500 (DM, KL), and Ministry of Science and Higher Education grant DNP/N119/ESF-EuroEPINOMICS/2012 (KL).	Ahn MJ, 2004, J NEUROTRAUM, V21, P1431, DOI 10.1089/neu.2004.21.1431; Alexander S, 2007, J NEUROTRAUM, V24, P790, DOI 10.1089/neu.2006.0133; Andrew PJ, 1999, CARDIOVASC RES, V43, P521, DOI 10.1016/S0008-6363(99)00115-7; Bolkvadze T, 2012, J NEUROTRAUM, V29, P789, DOI 10.1089/neu.2011.1954; Bot AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076051; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Calabrese V, 2007, NAT REV NEUROSCI, V8, P766, DOI 10.1038/nrn2214; Carvalho BS, 2010, BIOINFORMATICS, V26, P2363, DOI 10.1093/bioinformatics/btq431; Cherian L, 2004, BRAIN PATHOL, V14, P195, DOI 10.1111/j.1750-3639.2004.tb00053.x; Deng Y, 2007, EXP NEUROL, V205, P154, DOI 10.1016/j.expneurol.2007.01.023; Devos SL, 2013, J NEUROSCI, V33, P12887, DOI 10.1523/JNEUROSCI.2107-13.2013; Garcia-Alloza M, 2006, NEUROBIOL DIS, V24, P516, DOI 10.1016/j.nbd.2006.08.017; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Hall ED, 2004, J NEUROTRAUM, V21, P9, DOI 10.1089/089771504772695904; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; Hawkins BE, 2013, J BIOL CHEM, V288, P17042, DOI 10.1074/jbc.M113.472746; Holth JK, 2013, J NEUROSCI, V33, P1651, DOI 10.1523/JNEUROSCI.3191-12.2013; Hong YT, 2014, JAMA NEUROL, V71, P23, DOI 10.1001/jamaneurol.2013.4847; Hoshino S, 1998, NEUROREPORT, V9, P1879, DOI 10.1097/00001756-199806010-00039; Ittner LM, 2010, CELL, V142, P387, DOI 10.1016/j.cell.2010.06.036; Jankowsky JL, 2005, J NEUROSCI, V25, P5217, DOI 10.1523/JNEUROSCI.5080-04.2005; Jankowsky JL, 2004, HUM MOL GENET, V13, P159, DOI 10.1093/hmg/ddh019; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Kawai N, 2013, BRAIN INJURY, V27, P1026, DOI 10.3109/02699052.2013.794963; Kay AD, 2003, J NEUROTRAUM, V20, P943, DOI 10.1089/089771503770195795; Mannix R, 2013, ANN NEUROL, V74, P65, DOI 10.1002/ana.23858; Mesenge C, 1996, J NEUROTRAUM, V13, P209, DOI 10.1089/neu.1996.13.209; Minkeviciene R, 2009, J NEUROSCI, V29, P3453, DOI 10.1523/JNEUROSCI.5215-08.2009; Mouzon BC, 2014, ANN NEUROL, V75, P241, DOI 10.1002/ana.24064; Nakagawa Y, 1999, J COMP NEUROL, V411, P390; Nakagawa Y, 2000, EXP NEUROL, V163, P244, DOI 10.1006/exnr.2000.7375; Nissinen J, 2000, EPILEPSY RES, V38, P177, DOI 10.1016/S0920-1211(99)00088-1; Noebels J, 2011, EPILEPSIA, V52, P39, DOI 10.1111/j.1528-1167.2010.02909.x; Pitkanen A, 2014, EPILEPSY BEHAV, V38, P19, DOI 10.1016/j.yebeh.2014.01.013; Pitkanen A, 2011, NEUROSCI LETT, V497, P163, DOI 10.1016/j.neulet.2011.02.033; R Development Core Team, 2012, R LANG ENV STAT COMP; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; Roberson ED, 2011, J NEUROSCI, V31, P700, DOI 10.1523/JNEUROSCI.4152-10.2011; ROBERTS GW, 1991, LANCET, V338, P1422, DOI 10.1016/0140-6736(91)92724-G; Rogaeva E, 2001, J ALZHEIMERS DIS, V3, P293, DOI 10.3233/JAD-2001-3304; Schellenberg G D, 2000, Curr Psychiatry Rep, V2, P158, DOI 10.1007/s11920-000-0061-z; Scherbel U, 1999, P NATL ACAD SCI USA, V96, P8721, DOI 10.1073/pnas.96.15.8721; Shemer I, 2006, EUR J NEUROSCI, V23, P2035, DOI 10.1111/j.1460-9568.2006.04733.x; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Tajiri N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078851; Teasdale GM, 1997, LANCET, V350, P1069, DOI 10.1016/S0140-6736(97)04318-3; Thom M, 2011, BRAIN, V134, P2969, DOI 10.1093/brain/awr209; Valasek MA, 2005, ADV PHYSIOL EDUC, V29, P151, DOI 10.1152/advan.00019.2005; Van Den Heuvel C, 2007, PROG BRAIN RES, V161, P303, DOI 10.1016/S0079-6123(06)61021-2; Wada K, 1999, J NEUROTRAUM, V16, P203, DOI 10.1089/neu.1999.16.203	52	18	18	1	22	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0893-7648	1559-1182		MOL NEUROBIOL	Mol. Neurobiol.	DEC	2016	53	10					7010	7027		10.1007/s12035-015-9578-3			18	Neurosciences	Neurosciences & Neurology	EC1MQ	WOS:000387870200037	26671618				2021-06-18	
J	Urban, JE; Weaver, AA; Lillie, EM; Maldjian, JA; Whitlow, CT; Stitzel, JD				Urban, Jillian E.; Weaver, Ashley A.; Lillie, Elizabeth M.; Maldjian, Joseph A.; Whitlow, Christopher T.; Stitzel, Joel D.			Evaluation of morphological changes in the adult skull with age and sex	JOURNAL OF ANATOMY			English	Article						aging; biomechanics; cranial fossa; morphometrics; skull; trauma	HYPEROSTOSIS FRONTALIS INTERNA; TRAUMATIC BRAIN-INJURY; MORPHOMETRIC-ANALYSIS; GEOMETRIC MORPHOMETRICS; INTRACRANIAL VOLUME; SHAPE CHANGES; HUMANS; FOSSA; SIZE	The morphology of the brain and skull are important in the evaluation of the aging human; however, little is known about how the skull may change with age. The objective of this study was to evaluate the morphological changes of the adult skull using three-dimensional geometric morphometric analysis of thousands of landmarks with the focus on anatomic regions that may be correlated with brain atrophy and head injury. Computed tomography data were collected between ages 20 and 100. Each scan was segmented using thresholding techniques. An atlas image of a 50th percentile skull was registered to each subject scan by computing a series of rigid, affine, and non-linear transformations between atlas space and subject space. Landmarks on the atlas skull were transformed to each subject and partitioned into the inner and outer cranial vault and the cranial fossae. A generalized Procrustes analysis was completed for the landmark sets. The coordinate locations describing the shape of each region were regressed with age to generate a model predicting the landmark location with age. Permutation testing was performed to assess significant changes with age. For the males, all anatomic regions reveal significant changes in shape with age except for the posterior cranial fossa. For the females, only the middle cranial fossa and anterior cranial fossa were found to change significantly in shape. Results of this study are important for understanding the adult skull and how shape changes may pertain to brain atrophy, aging, and injury.	[Urban, Jillian E.; Weaver, Ashley A.; Lillie, Elizabeth M.; Stitzel, Joel D.] Wake Forest Univ, Virginia Tech, Ctr Injury Biomech, Winston Salem, NC 27109 USA; [Urban, Jillian E.; Weaver, Ashley A.; Lillie, Elizabeth M.; Maldjian, Joseph A.; Whitlow, Christopher T.; Stitzel, Joel D.] Wake Forest Sch Med, Winston Salem, NC USA; [Maldjian, Joseph A.; Whitlow, Christopher T.] Wake Forest Sch Med, Dept Radiol Neuroradiol, Winston Salem, NC USA; [Whitlow, Christopher T.] Wake Forest Univ, Translat Sci Inst, Winston Salem, NC 27109 USA	Urban, JE (corresponding author), Med Ctr Blvd, Winston Salem, NC 27157 USA.	jurban@wakehealth.edu	Stitzel, Joel/B-4045-2012	Stitzel, Joel/0000-0001-9762-3033; Weaver, Ashley/0000-0002-4383-0106; Maldjian, Joseph/0000-0002-6384-1072	National Highway Traffic Safety Administration [DTN22-09-H-00242]	Funding was provided by the National Highway Traffic Safety Administration under Cooperative Agreement Number DTN22-09-H-00242. Views expressed are those of the authors and do not represent the views of NHTSA. The authors would like to thank Callistus Nguyen for assistance with image segmentation, as well as Jaclyn Caccese and Mimin Meliyani for assistance in data collection.	Avants B, 2004, NEUROIMAGE, V23, pS139, DOI 10.1016/j.neuroimage.2004.07.010; Avants BB, 2008, MED IMAGE ANAL, V12, P26, DOI 10.1016/j.media.2007.06.004; Axelsson S, 2003, EUR J ORTHODONT, V25, P185, DOI 10.1093/ejo/25.2.185; Bigler ED, 2007, NEUROPSYCHOLOGY, V21, P515, DOI 10.1037/0894-4105.21.5.515; Chen SYY, 2000, EUR J ORTHODONT, V22, P205, DOI 10.1093/ejo/22.3.205; Coronado VG, 2005, J HEAD TRAUMA REHAB, V20, P215, DOI 10.1097/00001199-200505000-00005; Crockett JC, 2011, J CELL SCI, V124, P991, DOI 10.1242/jcs.063032; Danelson KA, 2008, STAPP CAR C, V52, P59; De Groote I, 2011, J HUM EVOL, V60, P540, DOI 10.1016/j.jhevol.2010.09.009; Fakhry N, 2013, DYSPHAGIA, V28, P435, DOI 10.1007/s00455-013-9457-x; Fedorov A, 2012, MAGN RESON IMAGING, V30, P1323, DOI 10.1016/j.mri.2012.05.001; Fowles D, 2010, PROFILE OLDER AMERIC; Frost HM, 1996, BONE BIODYNAMICS, P315; Gayzik FS, 2011, ANN BIOMED ENG, V39, P2568, DOI 10.1007/s10439-011-0359-5; Gayzik FS, 2008, J BIOMECH, V41, P1545, DOI 10.1016/j.jbiomech.2008.02.006; Good P. I, 2000, SPRINGER SERIES STAT, V2; Gunz P, 2005, MODERN MORPHOMETERIC; Hadjidakis DJ, 2006, ANN NY ACAD SCI, V1092, P385, DOI 10.1196/annals.1365.035; Harvati K, 2003, AM J PHYS ANTHROPOL, V120, P323, DOI 10.1002/ajpa.10122; Kanodia G, 2012, J NEUROSCI RURAL PRA, V3, P261, DOI 10.4103/0976-3147.102602; Marcus Jeffrey R, 2008, Eplasty, V8, pe20; May H, 2012, AM J HUM BIOL, V24, P812, DOI 10.1002/ajhb.22325; May H, 2010, ANAT REC, V293, P2007, DOI 10.1002/ar.21274; McIntyre GT, 2003, EUR J ORTHODONT, V25, P231, DOI 10.1093/ejo/25.3.231; Neubauer S, 2009, J ANAT, V215, P240, DOI 10.1111/j.1469-7580.2009.01106.x; ODDIE TH, 1966, J CLIN ENDOCR METAB, V26, P425, DOI 10.1210/jcem-26-4-425; Pirouzmand F, 2008, J CRANIOFAC SURG, V19, P27, DOI 10.1097/SCS.0b013e31815ca07a; Raikos A, 2011, ANN ANAT, V193, P453, DOI 10.1016/j.aanat.2011.05.004; Royle NA, 2013, MAGN RESON IMAGING, V31, P918, DOI 10.1016/j.mri.2013.01.012; She R, 2004, ANN CLIN LAB SCI, V34, P206; Slice DE, 2004, 2004012181 SAE; Slice DE, 2005, DEV PRIMATOL-PROG PR, P1, DOI 10.1007/0-387-27614-9_1; Sowell ER, 2003, NAT NEUROSCI, V6, P309, DOI 10.1038/nn1008; Weaver AA, 2014, J MORPHOL, V275, P1284, DOI 10.1002/jmor.20302; Weaver AA, 2014, J ANAT, V225, P246, DOI 10.1111/joa.12203	35	18	18	0	14	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0021-8782	1469-7580		J ANAT	J. Anat.	DEC	2016	229	6					838	846		10.1111/joa.12247			9	Anatomy & Morphology	Anatomy & Morphology	ED2JK	WOS:000388670200009	25406956	Green Published, Bronze			2021-06-18	
J	Goodrich, JA; Kim, JH; Situ, R; Taylor, W; Westmoreland, T; Du, F; Parks, S; Ling, G; Hwang, JY; Rapuano, A; Bandak, FA; de Lanerolle, NC				Goodrich, James A.; Kim, Jung H.; Situ, Robert; Taylor, Wesley; Westmoreland, Ted; Du, Fu; Parks, Steven; Ling, Geoffrey; Hwang, Jung Y.; Rapuano, Amedeo; Bandak, Faris A.; de lanerolle, Nihal C.			Neuronal and glial changes in the brain resulting from explosive blast in an experimental model	ACTA NEUROPATHOLOGICA COMMUNICATIONS			English	Article							CHRONIC TRAUMATIC ENCEPHALOPATHY; TEMPORAL-LOBE; AXONAL INJURY; EXPOSURE; SPECTROSCOPY; DENSITY; RATS	Mild traumatic brain injury (mTBI) is the signature injury in warfighters exposed to explosive blasts. The pathology underlying mTBI is poorly understood, as this condition is rarely fatal and thus postmortem brains are difficult to obtain for neuropathological studies. Here we report on studies of an experimental model with a gyrencephalic brain that is exposed to single and multiple explosive blast pressure waves. To determine injuries to the brain resulting from the primary blast, experimental conditions were controlled to eliminate any secondary or tertiary injury from blasts. We found small but significant levels of neuronal loss in the hippocampus, a brain area that is important for cognitive functions. Furthermore, neuronal loss increased with multiple blasts and the degree of neuronal injury worsened with time post-blast. This is consistent with our findings in the blast-exposed human brain based on magnetic resonance spectroscopic imaging. The studies on this experimental model thus confirm what has been presumed to be the case with the warfighter, namely that exposure to multiple blasts causes increased brain injury. Additionally, as in other studies of both explosive blast as well as closed head mTBI, we found astrocyte activation. Activated microglia were also prominent in white matter tracts, particularly in animals exposed to multiple blasts and at long post-blast intervals, even though injured axons (i.e. beta-APP positive) were not found in these areas. Microglial activation appears to be a delayed response, though whether they may contribute to inflammation related injury mechanism at even longer post-blast times than we tested here, remains to be explored. Petechial hemorrhages or other gross signs of vascular injury were not observed in our study. These findings confirm the development of neuropathological changes due to blast exposure. The activation of astrocytes and microglia, cell types potentially involved in inflammatory processes, suggest an important area for future study.	[Goodrich, James A.] Yale Univ, Sch Med, Dept Comparat Med, New Haven, CT USA; [Kim, Jung H.; Hwang, Jung Y.] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA; [Situ, Robert; Rapuano, Amedeo; de lanerolle, Nihal C.] Yale Univ, Sch Med, Dept Neurosurg, 333 Cedar St, New Haven, CT 06520 USA; [Taylor, Wesley; Westmoreland, Ted] Adv Med Training, Mckinney, TX USA; [Du, Fu] FD NeuroTechnol Inc, Ellicott City, MD USA; [Parks, Steven] ORA Inc, Fredericksburg, VA USA; [Ling, Geoffrey; Bandak, Faris A.] Uniformed Serv Univ Hlth Sci, Edward Hebert Sch Med, Dept Neurol, Bethesda, MD 20814 USA; [Bandak, Faris A.] Integrated Serv Grp Inc, Potomac, MD USA	de Lanerolle, NC (corresponding author), Yale Univ, Sch Med, Dept Neurosurg, 333 Cedar St, New Haven, CT 06520 USA.	nihal.delanerolle@yale.edu			Defense Advanced Research Projects Agency "PREVENT" Research Program	This work was supported by a contract from Defense Advanced Research Projects Agency "PREVENT" Research Program. The views, opinions, and/or findings contained in this study are those of the authors and should not be interpreted as representing the official views or policies, either expressed or implied, of the Defense Advanced Research Projects Agency or the Department of Defense.	ABERCROMBIE M, 1946, ANAT REC, V94, P239, DOI 10.1002/ar.1090940210; ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Ahmed F, 2012, ELECTROPHORESIS, V33, P3705, DOI 10.1002/elps.201200299; Brooks WM, 2001, J HEAD TRAUMA REHAB, V16, P149, DOI 10.1097/00001199-200104000-00005; DAM AM, 1979, NEUROPATH APPL NEURO, V5, P249, DOI 10.1111/j.1365-2990.1979.tb00624.x; de Lanerolle NC, 2014, ANN CLIN TRANSL NEUR, V1, P692, DOI 10.1002/acn3.98; de Lanerolle NC, 2011, J NEUROPATH EXP NEUR, V70, P1046, DOI 10.1097/NEN.0b013e318235bef2; de No RL, 1934, J PSYCHOL NEUROL, V46, P113; Dong YS, 2001, GLIA, V36, P180, DOI 10.1002/glia.1107; Garman RH, 2011, J NEUROTRAUM, V28, P947, DOI 10.1089/neu.2010.1540; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Guidi S, 2011, BRAIN RES BULL, V85, P169, DOI 10.1016/j.brainresbull.2011.03.028; Hetherington H, 2015, Handb Clin Neurol, V127, P309, DOI 10.1016/B978-0-444-52892-6.00020-9; Hetherington HP, 2014, MAGN RESON MED, V71, P1358, DOI 10.1002/mrm.24814; Huber BR, 2013, J ALZHEIMERS DIS, V37, P309, DOI 10.3233/JAD-130182; Jelsing J, 2006, J EXP BIOL, V209, P1454, DOI 10.1242/jeb.02141; John GR, 2005, GLIA, V49, P161, DOI 10.1002/glia.20109; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; Kernie SG, 2001, J NEUROSCI RES, V66, P317, DOI 10.1002/jnr.10013; KIM JH, 1990, ACTA NEUROPATHOL, V80, P41, DOI 10.1007/BF00294220; Lakis N, 2013, NEUROL RES, V35, P290, DOI 10.1179/1743132813Y.0000000177; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Ryu J, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0153-3; Shively SB, 2016, LANCET NEUROL, V15, P944, DOI 10.1016/S1474-4422(16)30057-6; Siegel S., 1956, NONPARAMETRIC STAT B; Smith C, 2013, NEUROPATH APPL NEURO, V39, P35, DOI 10.1111/nan.12006; STEFANINI M, 1967, NATURE, V216, P173, DOI 10.1038/216173a0; URENJAK J, 1993, J NEUROSCI, V13, P981, DOI 10.1523/jneurosci.13-03-00981.1993; Zhukareva V, 2001, ACTA NEUROPATHOL, V101, P518	32	18	18	0	9	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2051-5960			ACTA NEUROPATHOL COM	Acta Neuropathol. Commun.	NOV 24	2016	4								124	10.1186/s40478-016-0395-3			11	Neurosciences	Neurosciences & Neurology	ED0EI	WOS:000388515400002	27884214	DOAJ Gold, Green Published			2021-06-18	
J	Gao, L; Smielewski, P; Czosnyka, M; Ercole, A				Gao, Lei; Smielewski, Peter; Czosnyka, Marek; Ercole, Ari			Cerebrovascular Signal Complexity Six Hours after Intensive Care Unit Admission Correlates with Outcome after Severe Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						approximate entropy; autoregulation; complexity; ICP; traumatic brain injury	CEREBRAL PERFUSION-PRESSURE; RATE MULTISCALE ENTROPY; APPROXIMATE ENTROPY; INTRACRANIAL-PRESSURE; HEART-RATE; PHYSIOLOGICAL-COMPLEXITY; CRITICAL ILLNESS; VARIABILITY; HYPERTENSION; DISEASE	Disease states are associated with a breakdown in healthy interactions and are often characterized by reduced signal complexity. We applied approximate entropy (ApEn) analysis to investigate the correlation between the complexity of heart rate (ApEn-HR), mean arterial pressure (ApEn-MAP), intracranial pressure (ApEn-ICP), and a combined ApEn-product (product of the three individual ApEns) and outcome after traumatic brain injury. In 174 severe traumatic brain injured patients, we found significant differences across groups classified by the Glasgow Outcome Score in ApEn-HR (p = 0.007), ApEn-MAP (p = 0.02), ApEn-ICP (p = 0.01), ApEn-product (p = 0.001), and pressure reactivity index (PRx) (p = 0.004) in the first 6 h. This relationship strengthened in a 24 h and 72 h analysis (ApEn-MAP continued to correlate with death but was not correlated with favorable outcome). Outcome was dichotomized as survival versus death, and favorable versus unfavorable; the ApEn-product achieved the strongest statistical significance at 6 h (F = 11.0; p = 0.001 and F = 10.5; p = 0.001, respectively) and was a significant independent predictor of mortality and favorable outcome (p < 0.001). Patients in the lowest quartile for ApEn-product were over four times more likely to die (39.5% vs. 9.3%, p < 0.001) than those in the highest quartile. ApEn-ICP was inversely correlated with PRx (r=-0.39, p < 0.000001) indicating unique information related to impaired cerebral autoregulation. Our results demonstrate that as early as 6 h into monitoring, complexity measures from easily attainable vital signs, such as HR and MAP, in addition to ICP, can help triage those who require more intensive neurological management at an early stage.	[Gao, Lei] Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, 55 Fruit St, Boston, MA 02114 USA; [Smielewski, Peter; Czosnyka, Marek] Univ Cambridge, Dept Anesthesia, Div Neurosurg, Cambridge, England; [Ercole, Ari] Univ Cambridge, Dept Anesthesia, Neurosci Crit Care Unit, Cambridge, England	Gao, L (corresponding author), Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, 55 Fruit St, Boston, MA 02114 USA.	lgao4@partners.org	Ercole, Ari/B-6288-2009; Gao, Lei/AAL-1683-2020	Ercole, Ari/0000-0001-8350-8093; Gao, Lei/0000-0003-1476-1460; Smielewski, Peter/0000-0001-5096-3938	Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0600986, G9439390] Funding Source: Medline		Abasolo D, 2005, CLIN NEUROPHYSIOL, V116, P1826, DOI 10.1016/j.clinph.2005.04.001; Aries MJH, 2012, CRIT CARE MED, V40, P2456, DOI 10.1097/CCM.0b013e3182514eb6; Bashan A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1705; Bishop SM, 2012, ANESTHESIOLOGY, V117, P810, DOI 10.1097/ALN.0b013e31826a4aa2; Brady KM, 2008, STROKE, V39, P2531, DOI 10.1161/STROKEAHA.108.514877; Buchman Timothy G, 2004, Curr Opin Crit Care, V10, P378, DOI 10.1097/01.ccx.0000139369.65817.b6; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Chon KH, 2009, IEEE ENG MED BIOL, V28, P18, DOI 10.1109/MEMB.2009.934629; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Czosnyka Marek, 2007, Neurosurg Focus, V22, pE10; Gallagher R, 1999, SCIENCE, V284, P79, DOI 10.1126/science.284.5411.79; Goldberger AL, 2002, NEUROBIOL AGING, V23, P23, DOI 10.1016/S0197-4580(01)00266-4; Goldstein B, 1998, CRIT CARE MED, V26, P352, DOI 10.1097/00003246-199802000-00040; Guiza F, 2013, CRIT CARE MED, V41, P554, DOI 10.1097/CCM.0b013e3182742d0a; Hornero R, 2006, CRIT CARE MED, V34, P87, DOI 10.1097/01.CCM.0000190426.44782.F0; Hornero R, 2005, IEEE T BIO-MED ENG, V52, P1671, DOI 10.1109/TBME.2005.855722; Hornero R, 2005, P ANN INT IEEE EMBS, P6157, DOI 10.1109/IEMBS.2005.1615900; JENNETT B, 1975, LANCET, V1, P480; LIPSITZ LA, 1992, JAMA-J AM MED ASSOC, V267, P1806, DOI 10.1001/jama.267.13.1806; Lu CW, 2012, BRAIN, V135, P2399, DOI 10.1093/brain/aws155; Menon DK, 1999, BRIT MED BULL, V55, P226, DOI 10.1258/0007142991902231; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Norris PR, 2008, J CRIT CARE, V23, P399, DOI 10.1016/j.jcrc.2007.08.001; Norris PR, 2008, SHOCK, V30, P17, DOI 10.1097/SHK.0b013e318164e4d0; Norris PR, 2009, ANN SURG, V250, P524, DOI [10.1097/SLA.0b013e181b8fb1f, 10.1097/SLA.0b013e3181b8fb1f]; Papaioannou V, 2008, J CRIT CARE, V23, P380, DOI 10.1016/j.jcrc.2007.04.006; Pincus S, 2004, P NATL ACAD SCI USA, V101, P13709, DOI 10.1073/pnas.0405168101; PINCUS SM, 1991, P NATL ACAD SCI USA, V88, P2297, DOI 10.1073/pnas.88.6.2297; Que CL, 2001, J APPL PHYSIOL, V91, P1131; Sabeti M, 2009, ARTIF INTELL MED, V47, P263, DOI 10.1016/j.artmed.2009.03.003; Smith M, 2008, ANESTH ANALG, V106, P240, DOI 10.1213/01.ane.0000297296.52006.8e; Srinivasan V, 2007, IEEE T INF TECHNOL B, V11, P288, DOI 10.1109/TITB.2006.884369; Timofeev I, 2011, BRAIN, V134, P484, DOI 10.1093/brain/awq353; van den Brink WA, 2000, NEUROSURGERY, V46, P868, DOI 10.1097/00006123-200004000-00018; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131	35	18	18	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	NOV 15	2016	33	22					2011	2018		10.1089/neu.2015.4228			8	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	EC4OL	WOS:000388112300004	26916703				2021-06-18	
J	Chen, H; Chan, YL; Nguyen, LT; Mao, YL; de Rosa, A; Beh, IT; Chee, C; Oliver, B; Herok, G; Saad, S; Gorrie, C				Chen, Hui; Chan, Yik Lung; Nguyen, Long The; Mao, Yilin; de Rosa, Alicia; Beh, Ing Tsyr; Chee, Candice; Oliver, Brian; Herok, George; Saad, Sonia; Gorrie, Catherine			Moderate traumatic brain injury is linked to acute behaviour deficits and long term mitochondrial alterations	CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY			English	Article						behavioural studies; immunohistochemistry; mitochondria; mitophagy; oxidative stress; rat brain; trauma	OXIDATIVE STRESS; NEURONAL AUTOPHAGY; CEREBRAL-ISCHEMIA; IN-VITRO; DYSFUNCTION; DISEASE; INFLAMMATION; METABOLISM; HEMORRHAGE; MITOPHAGY	Traumatic brain injury (TBI) remains one of the leading causes of death and disability worldwide. Mild TBI may lead to neuropsychiatric sequelae, including memory loss and motor impairment. Mitochondrial dysfunction and oxidative stress have a contributory role in several neurological disorders; however, their association with mitophagy in mild TBI is unclear. TBI was induced in female Sprague Dawley (SD) rats using a New York University Impactor (10 g, impactor head 2.5 mm diameter, weight drop 50 mm) and compared to sham surgery controls. The novel object recognition and error ladder tests were performed at 24 hours and for 6 weeks post injury, and the brains were examined histologically to confirm the extent of injury. Mitochondria manganese superoxide dismutase (MnSOD) and the oxidative phosphorylation (OXPHOS) complexes I-V (CI-CV), as well as mitophagy markers, dynamin related protein 1 (DRP-1), LC3A/B and PTEN-induced putative kinase 1 (PINK-1), were measured in the penumbra by western blot. At 24 hours sham rats performed as expected on a novel object recognition test while TBI rats showed cognitive deficits at the early time points. TBI rats also showed more early motor deficits on a horizontal ladder, compared with the sham rats. MnSOD, OXPHOS CI, CIII and CV protein levels were significantly lower in the TBI group at 24 hours. DRP-1, LC3A/B I and II, and PINK-1 were increased at 6 weeks suggesting abnormal mitophagy. Moderate TBI caused immediate cognitive and mild motor functional deficits in the rats that did not persist. Reduced antioxidative capacity and possibly compromised mitochondrial function may affect the long term functional recovery.	[Chen, Hui; Chan, Yik Lung; Nguyen, Long The; Mao, Yilin; de Rosa, Alicia; Beh, Ing Tsyr; Chee, Candice; Oliver, Brian; Herok, George; Saad, Sonia; Gorrie, Catherine] Univ Technol Sydney, Fac Sci, Sch Life Sci, Broadway, NSW, Australia; [Nguyen, Long The; Saad, Sonia] Univ Sydney, Kolling Inst Med Res, St Leonards, NSW, Australia; [Beh, Ing Tsyr; Chee, Candice] Singapore Polytech, Sch Chem Life Sci, Singapore, Singapore	Chen, H; Gorrie, C (corresponding author), Univ Technol Sydney, Fac Sci, Sch Life Sci, Broadway, NSW, Australia.	hui.chen-1@uts.edu.au; catherine.gorrie@uts.edu.au	Nguyen, Long/AAH-2433-2021; Chen, Hui/D-2005-2014; Chen, Hui/R-6137-2019; Gorrie, Catherine/S-6591-2019; Oliver, Brian/E-7939-2010	Chen, Hui/0000-0001-6883-3752; Chen, Hui/0000-0001-6883-3752; Oliver, Brian/0000-0002-7122-9262; Saad, Sonia/0000-0001-8067-8046; Mao, Yilin/0000-0002-3573-6486; Chan, Yik Lung/0000-0002-9605-4200; Gorrie, Catherine/0000-0001-5934-2492	Faculty of Science, University of Technology Sydney	Faculty of Science, University of Technology Sydney	Allen CL, 2009, INT J STROKE, V4, P461, DOI 10.1111/j.1747-4949.2009.00387.x; Amadoro G, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00018; Andreyev AI, 2005, BIOCHEMISTRY-MOSCOW+, V70, P200, DOI 10.1007/s10541-005-0102-7; Antunes M, 2012, COGN PROCESS, V13, P93, DOI 10.1007/s10339-011-0430-z; Bertolin G, 2013, AUTOPHAGY, V9, P1801, DOI 10.4161/auto.25884; Bhattacharyya A, 2014, PHYSIOL REV, V94, P329, DOI 10.1152/physrev.00040.2012; Brown GC, 2010, MOL NEUROBIOL, V41, P242, DOI 10.1007/s12035-010-8105-9; Cano M, 2014, FREE RADICAL BIO MED, V69, P1, DOI 10.1016/j.freeradbiomed.2014.01.004; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cavallucci V, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.511; Cooney SJ, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-155; Day NL, 2013, J NEUROTRAUM, V30, P1531, DOI 10.1089/neu.2013.2854; Eiyama A, 2015, CURR OPIN CELL BIOL, V33, P95, DOI 10.1016/j.ceb.2015.01.002; Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6; Figueiredo-Pereira ME, 2015, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00104; Gabryel B, 2012, PHARMACOL REP, V64, P1; Gajavelli S, 2015, J BIOENERG BIOMEMBR, V47, P133, DOI 10.1007/s10863-014-9589-1; Gavett BE, 2010, ALZHEIMERS RES THER, V2, DOI 10.1186/alzrt42; Gill R, 2010, FREE RADICAL BIO MED, V48, P1121, DOI 10.1016/j.freeradbiomed.2010.01.006; Gordon GRJ, 2007, GLIA, V55, P1214, DOI 10.1002/glia.20543; Gorrie CA, 2010, BRAIN RES, V1337, P8, DOI 10.1016/j.brainres.2010.04.019; Grohm J, 2012, CELL DEATH DIFFER, V19, P1446, DOI 10.1038/cdd.2012.18; Guo X, 2014, BIOCHEM J, V461, P137, DOI 10.1042/BJ20131438; Hiebert JB, 2015, AM J MED SCI, V350, P132, DOI 10.1097/MAJ.0000000000000506; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Jahani-Asl A, 2011, J BIOL CHEM, V286, P4772, DOI 10.1074/jbc.M110.167155; Knoferl MW, 2002, ANN SURG, V235, P105, DOI 10.1097/00000658-200201000-00014; Knoferl MW, 2001, AM J PHYSIOL-CELL PH, V281, pC1131, DOI 10.1152/ajpcell.2001.281.4.C1131; Lam TKT, 2007, NAT MED, V13, P171, DOI 10.1038/nm1540; Li CY, 2011, CURR ALZHEIMER RES, V8, P67; McAllister Thomas W, 2011, Dialogues Clin Neurosci, V13, P287; McDonald RPA, 1999, NEUROREPORT, V10, P1875, DOI 10.1097/00001756-199906230-00014; Metz GA, 2009, J VIS EXP; Miller DM, 2015, EXP NEUROL, V264, P103, DOI 10.1016/j.expneurol.2014.11.008; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Mizushima Y, 2000, ANN SURG, V232, P673, DOI 10.1097/00000658-200011000-00009; Nguyen LT, 2015, AM J PHYSIOL-RENAL, V308, pF689, DOI 10.1152/ajprenal.00417.2014; O'Carroll SJ, 2013, NEUROSCI RES, V75, P256, DOI 10.1016/j.neures.2013.01.004; Oberg BP, 2004, KIDNEY INT, V65, P1009, DOI 10.1111/j.1523-1755.2004.00465.x; Okatsu K, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2016; Oliveira JMA, 2010, J NEUROCHEM, V114, P1, DOI 10.1111/j.1471-4159.2010.06741.x; Ott M, 2007, APOPTOSIS, V12, P913, DOI 10.1007/s10495-007-0756-2; Owens K, 2013, TRANSL STROKE RES, V4, P618, DOI 10.1007/s12975-013-0278-x; Park J, 2013, J NEUROCHEM, V127, P221, DOI 10.1111/jnc.12361; Pekny M, 2014, NEUROSCI LETT, V565, P30, DOI 10.1016/j.neulet.2013.12.071; Schwarz K, 2014, INT J CARDIOL, V171, P134, DOI 10.1016/j.ijcard.2013.12.014; Son JH, 2012, EXP MOL MED, V44, P89, DOI 10.3858/emm.2012.44.2.031; Stangenberg S, 2015, INT J BIOCHEM CELL B, V64, P81, DOI 10.1016/j.biocel.2015.03.017; Stork C, 2005, MOL PSYCHIATR, V10, P900, DOI 10.1038/sj.mp.4001711; Sullivan PG, 1999, EXP NEUROL, V160, P226, DOI 10.1006/exnr.1999.7197; Viscomi MT, 2012, AUTOPHAGY, V8, P222, DOI 10.4161/auto.8.2.18599; Vos Melissa, 2010, Front Synaptic Neurosci, V2, P139, DOI 10.3389/fnsyn.2010.00139; Wager K, 2013, AUTOPHAGY, V9, P1693, DOI 10.4161/auto.25082; Wang WX, 2015, EXP NEUROL, V265, P84, DOI 10.1016/j.expneurol.2014.12.018; Wang XL, 2014, BBA-MOL BASIS DIS, V1842, P1240, DOI 10.1016/j.bbadis.2013.10.015; Wei WT, 2015, NEUROCHEM INT, V87, P85, DOI 10.1016/j.neuint.2015.06.003; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Yang WJ, 2015, NEUROCHEM INT, V80, P33, DOI 10.1016/j.neuint.2014.11.003; Yano M, 1998, J BIOL CHEM, V273, P26844, DOI 10.1074/jbc.273.41.26844; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028; Zhang XN, 2013, AUTOPHAGY, V9, P1321, DOI 10.4161/auto.25132	61	18	19	0	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1440-1681			CLIN EXP PHARMACOL P	Clin. Exp. Pharmacol. Physiol.	NOV	2016	43	11					1107	1114		10.1111/1440-1681.12650			8	Pharmacology & Pharmacy; Physiology	Pharmacology & Pharmacy; Physiology	EC7HI	WOS:000388307400011	27557565	Green Accepted			2021-06-18	
J	Wang, XX; Sekine, Y; Byrne, AB; Cafferty, WBJ; Hammarlund, M; Strittmatter, SM				Wang, Xingxing; Sekine, Yuichi; Byrne, Alexandra B.; Cafferty, William B. J.; Hammarlund, Marc; Strittmatter, Stephen M.			Inhibition of Poly-ADP-Ribosylation Fails to Increase Axonal Regeneration or Improve Functional Recovery after Adult Mammalian CNS Injury	ENEURO			English	Article						axon regeneration; optic nerve regeneration; PARP; poly (ADP-ribose); spinal cord injury	FC DECOY PROTEIN; SPINAL-CORD; LOCOMOTION; GROWTH; PTEN; PARP	After traumatic damage of the brain or spinal cord, many surviving neurons are disconnected, and recovery of function is limited by poor axon regeneration. Recent data have suggested that poly ADP-ribosylation plays a role in limiting axonal regrowth such that inhibition of poly (ADP-ribose) polymerase (PARP) may have therapeutic efficacy for neurological recovery after trauma. Here, we tested systemic administration of the PARP inhibitor, veliparib, and showed effective suppression of PARylation in the mouse CNS. After optic nerve crush injury or dorsal hemisection of the thoracic spinal cord in mice, treatment with veliparib at doses with pharmacodynamic action had no benefit for axonal regeneration or functional recovery. We considered whether PARP gene family specificity might play a role. In vitro mouse cerebral cortex axon regeneration experiments revealed that short hairpin RNA (shRNA)-mediated suppression of PARP1 promoted axonal regeneration, whereas suppression of other PARP isoforms either had no effect or decreased regeneration. Therefore, we examined recovery from neurological trauma in mice lacking PARP1. No increase of axonal regeneration was observed in Parp1-/-mice after optic nerve crush injury or dorsal hemisection of the thoracic spinal cord, and there was no improvement in motor function recovery. Thus, comprehensive in vivo analysis reveals no indication that clinical PARP inhibitors will on their own provide benefit for recovery from CNS trauma.	[Wang, Xingxing; Sekine, Yuichi; Byrne, Alexandra B.; Hammarlund, Marc; Strittmatter, Stephen M.] Yale Univ, Sch Med, Program Cellular Neurosci Neurodegenerat & Repair, BCMM 436,295 Congress Ave, New Haven, CT 06536 USA; [Wang, Xingxing; Sekine, Yuichi; Byrne, Alexandra B.; Hammarlund, Marc; Strittmatter, Stephen M.] Yale Univ, Sch Med, Dept Neurosci, 333 Cedar St, New Haven, CT 06520 USA; [Wang, Xingxing; Sekine, Yuichi; Cafferty, William B. J.; Strittmatter, Stephen M.] Yale Univ, Sch Med, Dept Neurol, 333 Cedar St, New Haven, CT 06520 USA; [Byrne, Alexandra B.; Hammarlund, Marc] Yale Univ, Sch Med, Dept Genet, 333 Cedar St, New Haven, CT 06520 USA	Strittmatter, SM (corresponding author), Yale Univ, Sch Med, Program Cellular Neurosci Neurodegenerat & Repair, BCMM 436,295 Congress Ave, New Haven, CT 06536 USA.	stephen.strittmatter@yale.edu	Sekine, Yuichi/S-8813-2019; Strittmatter, Stephen/F-5739-2011	Sekine, Yuichi/0000-0002-2861-603X; Strittmatter, Stephen/0000-0001-8188-3092	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; Falk Medical Research Trust; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS094219, R01NS098817, R35NS097283] Funding Source: NIH RePORTER	This work was supported by grants from NIH and Falk Medical Research Trust to S.M.S.	Ame JC, 2004, BIOESSAYS, V26, P882, DOI 10.1002/bies.20085; Basso DM, 2006, J NEUROTRAUM, V23, P635, DOI 10.1089/neu.2006.23.635; Brochier C, 2015, P NATL ACAD SCI USA, V112, P15220, DOI 10.1073/pnas.1509754112; Byrne AB, 2016, ELIFE, V5, DOI 10.7554/eLife.12734; Duffy P, 2012, P NATL ACAD SCI USA, V109, P5063, DOI 10.1073/pnas.1113953109; Erturk A, 2012, NAT MED, V18, P166, DOI 10.1038/nm.2600; Fink KL, 2015, J NEUROSCI, V35, P15403, DOI 10.1523/JNEUROSCI.3165-15.2015; Geoffroy CG, 2016, CELL REP, V15, P238, DOI 10.1016/j.celrep.2016.03.028; Geoffroy CG, 2015, J NEUROSCI, V35, P6413, DOI 10.1523/JNEUROSCI.4013-14.2015; He ZG, 2016, NEURON, V90, P437, DOI 10.1016/j.neuron.2016.04.022; Huebner EA, 2011, J BIOL CHEM, V286, P18026, DOI 10.1074/jbc.M110.208108; Jin D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9074; Liu BP, 2006, PHILOS T R SOC B, V361, P1593, DOI 10.1098/rstb.2006.1891; Liu K, 2011, ANNU REV NEUROSCI, V34, P131, DOI 10.1146/annurev-neuro-061010-113723; Park KK, 2008, SCIENCE, V322, P963, DOI 10.1126/science.1161566; Schwab ME, 2014, CURR OPIN NEUROBIOL, V27, P53, DOI 10.1016/j.conb.2014.02.011; Wahlberg E, 2012, NAT BIOTECHNOL, V30, P283, DOI 10.1038/nbt.2121; Wang XX, 2006, ANN NEUROL, V60, P540, DOI 10.1002/ana.20953; Wang XX, 2015, INVEST OPHTH VIS SCI, V56, P1357, DOI 10.1167/iovs.14-15472; Wang XX, 2014, J NEUROTRAUM, V31, P1955, DOI 10.1089/neu.2014.3355; Wang XX, 2012, EXP NEUROL, V237, P55, DOI 10.1016/j.expneurol.2012.06.009; Wang XX, 2011, ANN NEUROL, V70, P805, DOI 10.1002/ana.22527; WANG ZQ, 1995, GENE DEV, V9, P509, DOI 10.1101/gad.9.5.509; Yiu G, 2006, NAT REV NEUROSCI, V7, P617, DOI 10.1038/nrn1956; Zou YX, 2015, J NEUROSCI, V35, P10429, DOI 10.1523/JNEUROSCI.1718-15.2015	25	18	18	0	2	SOC NEUROSCIENCE	WASHINGTON	11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA		2373-2822		ENEURO	eNeuro	NOV-DEC	2016	3	6							e0270	10.1523/ENEURO.0270-16.2016			10	Neurosciences	Neurosciences & Neurology	EH7CQ	WOS:000391930900021	28032120	DOAJ Gold, Green Published			2021-06-18	
J	Drake, A; Donahue, TLH; Stansloski, M; Fox, K; Wheatley, BB; Donahue, SW				Drake, Aaron; Donahue, Tammy L. Haut; Stansloski, Mitchel; Fox, Karen; Wheatley, Benjamin B.; Donahue, Seth W.			Horn and horn core trabecular bone of bighorn sheep rams absorbs impact energy and reduces brain cavity accelerations during high impact ramming of the skull	ACTA BIOMATERIALIA			English	Article						Horn; Trabecular bone; Impact; Concussion; Bioinspired materials	FINITE-ELEMENT-ANALYSIS; MECHANICAL-PROPERTIES; COMPACT-BONE; HEAD IMPACTS; BIOLOGICAL-MATERIALS; BENDING STRENGTH; KERATIN; FOOTBALL; TISSUE; BIOMECHANICS	Bighorn sheep (Ovis canadensis) routinely experience violent impacts to the head as part of intraspecific fighting. Dynamic 3D finite element models of the skull and horns of a male bighorn sheep were developed to gain an understanding of the roles that the horn and bone materials and structure play in absorbing the impact that occurs during ramming. The geometry and volume mesh of the model were derived from CT scan images. The models included the horn, bony horn core, and bone of the skull. The horn core fills a portion of the hollow horn and consists of a thin cortical bone shell filled with foam-like trabecular bone. Two modified models were also created: one with the distal half of the horn length removed to assess the effects of the tapered spiral geometry of the horn, and one with the internal trabecular bone material of the horn core removed. The trabecular bone material stored three times more strain energy during impact than the horn material in the intact model. Removing half of the horn length had the effect of increasing translational accelerations in the brain cavity by 49%. Removing the trabecular bone in the horn core resulted in a 442% increase in rotational accelerations within the brain cavity. These findings support the investigation of novel bioinspired materials and designs that could be used in mitigating brain injuries and in other applications involving high-impact collisions. Statement of Significance Bighorn sheep routinely experience violent impacts to the head and horns without apparent negative consequences to the brain or horns. A portion of the horn is filled with a thin cortical bone shell containing foam-like trabecular bone. We developed novel dynamic finite element models of the skull and horns of bighorn sheep to gain an understanding of the roles that the horn and bone materials play in absorbing the impact that occurs during ramming. The study revealed that both horn and bone materials and the structures made from these materials (i.e., tapered spiral horns and foam-like trabecular bone struts) are important for absorbing impact energy and reducing brain cavity accelerations. (C) 2016 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.	[Drake, Aaron; Donahue, Tammy L. Haut; Stansloski, Mitchel; Wheatley, Benjamin B.; Donahue, Seth W.] Colorado State Univ, Dept Mech Engn, 300 West Drake Rd, Ft Collins, CO 80526 USA; [Fox, Karen] Wildlife Res Ctr, Colorado Div Pk & Wildlife, 317 W Prospect Rd, Ft Collins, CO 80525 USA	Donahue, SW (corresponding author), Colorado State Univ, Dept Mech Engn, 300 West Drake Rd, Ft Collins, CO 80526 USA.	seth.donahue@colostate.edu	Wheatley, Benjamin/AAF-7438-2020	Wheatley, Benjamin/0000-0002-9779-485X			Aare M, 2004, INT J CRASHWORTHINES, V9, P15, DOI 10.1533/ijcr.2004.0268; Beckstein JC, 2008, SPINE, V33, pE166, DOI 10.1097/BRS.0b013e318166e001; Bonser RHC, 1996, J ZOOL, V239, P477, DOI 10.1111/j.1469-7998.1996.tb05937.x; Broglio SP, 2009, J ATHL TRAINING, V44, P342, DOI 10.4085/1062-6050-44.4.342; Brolinson P Gunnar, 2006, Curr Sports Med Rep, V5, P23; Currey JD, 1999, J EXP BIOL, V202, P2495; Currey JD, 1999, J EXP BIOL, V202, P3285; Doherty AH, 2015, PHYSIOLOGY, V30, P17, DOI 10.1152/physiol.00022.2014; Farke AA, 2008, J EXP BIOL, V211, P3085, DOI 10.1242/jeb.019042; GEIST V, 1974, MOUNTAIN SHEEP STUDY; Gibson LJ, 2005, J BIOMECH, V38, P377, DOI 10.1016/j.jbiomech.2004.09.027; Goff MG, 2015, J BIOMECH, V48, P4142, DOI 10.1016/j.jbiomech.2015.10.023; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; Guskiewicz KM, 2007, NEUROSURGERY, V61, P1244, DOI 10.1227/01.neu.0000306103.68635.1a; Guskiewicz KM, 2011, EXERC SPORT SCI REV, V39, P4, DOI 10.1097/JES.0b013e318201f53e; Hansen U, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2838032; Hutchinson J, 1998, APPL MATH COMPUT, V96, P1, DOI 10.1016/S0096-3003(97)10106-0; JASLOW CR, 1995, J ZOOL, V235, P193; Johnson KL, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4026320; KELLER TS, 1990, J ORTHOPAED RES, V8, P592, DOI 10.1002/jor.1100080416; KEYAK JH, 1990, J BIOMED ENG, V12, P389, DOI 10.1016/0141-5425(90)90022-F; KITCHENER A, 1987, J MATER SCI, V22, P1385, DOI 10.1007/BF01233138; KITCHENER A, 1988, J ZOOL, V214, P1, DOI 10.1111/j.1469-7998.1988.tb04983.x; KITCHENER A, 1987, J MATER SCI LETT, V6, P321, DOI 10.1007/BF01729340; KITCHENER A, 1987, J ZOOL, V213, P621, DOI 10.1111/j.1469-7998.1987.tb03730.x; Knowles TPJ, 2011, NAT NANOTECHNOL, V6, P469, DOI [10.1038/nnano.2011.102, 10.1038/NNANO.2011.102]; Lee S, 2011, MAT SCI ENG C-MATER, V31, P730, DOI 10.1016/j.msec.2010.10.017; Maity P, 2011, J BIOMECH ENG-T ASME, V133, DOI 10.1115/1.4003321; Makela T., 1965, LAAKARILEHTI FINLAND, V20, P1869; MARTIN RB, 1993, J BIOMECH, V26, P1047, DOI 10.1016/S0021-9290(05)80004-1; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; MCELHANEY JH, 1966, J APPL PHYSIOL, V21, P1231; McKittrick J, 2010, MAT SCI ENG C-MATER, V30, P331, DOI 10.1016/j.msec.2010.01.011; Meyers MA, 2008, PROG MATER SCI, V53, P1, DOI 10.1016/j.pmatsci.2007.05.002; Meyers MA, 2013, SCIENCE, V339, P773, DOI 10.1126/science.1220854; Morgan Elise F., 2005, European Journal of Morphology, V42, P13, DOI 10.1080/09243860500095273; Motherway JA, 2009, J BIOMECH, V42, P2129, DOI 10.1016/j.jbiomech.2009.05.030; MULLER R, 1995, MED ENG PHYS, V17, P126, DOI 10.1016/1350-4533(95)91884-J; Nazarian A, 2007, J BIOMECH, V40, P2573, DOI 10.1016/j.jbiomech.2006.11.022; REILLY DT, 1975, J BIOMECH, V8, P393, DOI 10.1016/0021-9290(75)90075-5; Rho JY, 1998, MED ENG PHYS, V20, P92, DOI 10.1016/S1350-4533(98)00007-1; Schnebel B, 2007, NEUROSURGERY, V60, P490, DOI 10.1227/01.NEU.0000249286.92255.7F; Seki Y, 2012, J MECH BEHAV BIOMED, V9, P1, DOI 10.1016/j.jmbbm.2011.08.003; Seref-Ferlengez Z, 2015, BONEKEY REP, V4, DOI 10.1038/bonekey.2015.11; Soons J, 2012, J R SOC INTERFACE, V9, P1787, DOI 10.1098/rsif.2011.0910; Taddei F, 2007, MED ENG PHYS, V29, P973, DOI 10.1016/j.medengphy.2006.10.014; Tombolato L, 2010, ACTA BIOMATER, V6, P319, DOI 10.1016/j.actbio.2009.06.033; Trim MW, 2011, ACTA BIOMATER, V7, P1228, DOI 10.1016/j.actbio.2010.11.024; Ulrich D, 1998, J BIOMECH, V31, P1187, DOI 10.1016/S0021-9290(98)00118-3; Wang L. F., 2011, FOREIGN LANGUAGE WOR, V6, P6, DOI DOI 10.1371/J0URNAL.P0NE.0022325	50	18	18	6	58	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1742-7061	1878-7568		ACTA BIOMATER	Acta Biomater.	OCT 15	2016	44						41	50		10.1016/j.actbio.2016.08.019			10	Engineering, Biomedical; Materials Science, Biomaterials	Engineering; Materials Science	DZ1JM	WOS:000385594700004	27544811				2021-06-18	
J	Itsekson-Hayosh, Z; Shavit-Stein, E; Katzav, A; Rubovitch, V; Maggio, N; Chapman, J; Harnof, S; Pick, CG				Itsekson-Hayosh, Zeev; Shavit-Stein, Efrat; Katzav, Aviva; Rubovitch, Vardit; Maggio, Nicola; Chapman, Joab; Harnof, Sagi; Pick, Chaim G.			Minimal Traumatic Brain Injury in Mice: Protease-Activated Receptor 1 and Thrombin-Related Changes	JOURNAL OF NEUROTRAUMA			English	Article						astrocytes; mTBI; PAR-1; thrombin	EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; FLUID PERCUSSION INJURY; LONG-TERM POTENTIATION; INTRACEREBRAL HEMORRHAGE; COGNITIVE DEFICITS; MESSENGER-RNA; SERINE PROTEASES; NERVOUS-SYSTEM; UP-REGULATION; TIME-COURSE	Minimal traumatic brain injury (mTBI) is partially defined by the existence of retrograde amnesia and is associated with microscopic bleeds containing activated coagulation factors. In a previous study, we have found that mTBI immediately releases thrombin-like activity in the brain, which induces amnesia by activating protease-activated receptor 1 (PAR-1) and blocking long-term potentiation (LTP). In the present study, we assessed the effects of mTBI on thrombin and PAR-1 levels in the brain using the same model. After the immediate elevation, thrombin activity returned to baseline 1h post-trauma and increased again 72h later (42% relative to control; p<0.005). These changes were associated with a significant increase in PAR-1 levels 24 (17%; p<0.05) and 72h (20%; p<0.05) post-trauma. Interestingly, the late elevation in thrombin-like activity was also associated with elevation of the major central nervous system thrombin inhibitor, protease nexin-1, 72h post-mTBI (10%; p<0.005). When thrombin was injected into brain ventricles, an increased sensitivity to seizure-like activity was detected at 72h post-mTBI. The results are compatible with astrocyte activation post-mTBI resulting in increased thrombin secretion, PAR-1 expression, and seizure sensitivity.	[Itsekson-Hayosh, Zeev; Shavit-Stein, Efrat; Chapman, Joab] Tel Aviv Univ, Dept Physiol & Pharmacol, Sackler Fac Med, Tel Aviv, Israel; [Itsekson-Hayosh, Zeev; Shavit-Stein, Efrat; Katzav, Aviva; Maggio, Nicola; Chapman, Joab] Chaim Sheba Med Ctr, Dept Neurol, Tel Hashomer, Israel; [Itsekson-Hayosh, Zeev; Shavit-Stein, Efrat; Katzav, Aviva; Maggio, Nicola; Chapman, Joab] Chaim Sheba Med Ctr, Joseph Sagol Neurosci Ctr, Tel Hashomer, Israel; [Maggio, Nicola] Chaim Sheba Med Ctr, Talpiot Med Leadership Program, Tel Hashomer, Israel; [Rubovitch, Vardit; Pick, Chaim G.] Tel Aviv Univ, Dept Anat & Anthropol, Sackler Fac Med, Tel Aviv, Israel; [Harnof, Sagi] Chaim Sheba Med Ctr, Dept Neurosurg, IL-52621 Tel Hashomer, Israel; [Chapman, Joab] Tel Aviv Univ, Sackler Fac Med, Robert & Martha Harden Chair Mental & Neurol Dis, Tel Aviv, Israel; [Maggio, Nicola] Tel Aviv Univ, Dept Neurol, Sackler Fac Med, Tel Aviv, Israel; [Maggio, Nicola; Chapman, Joab; Pick, Chaim G.] Tel Aviv Univ, Sagol Sch Neurosci, Tel Aviv, Israel	Harnof, S (corresponding author), Chaim Sheba Med Ctr, Dept Neurosurg, IL-52621 Tel Hashomer, Israel.	sagi.harnof@sheba.health.gov.il					Akahoshi N, 2011, EPILEPSY BEHAV, V22, P659, DOI 10.1016/j.yebeh.2011.09.002; Aronovich R, 2005, IMMUNOBIOLOGY, V210, P781, DOI 10.1016/j.imbio.2005.10.010; Beilin O, 2005, J NEUROSCI RES, V79, P351, DOI 10.1002/jnr.20270; Beilin O, 2001, NEUROREPORT, V12, P2347, DOI 10.1097/00001756-200108080-00013; Beilin O, 2007, NEUROREPORT, V18, P581, DOI 10.1097/WNR.0b013e328091c1e6; Benson RR, 2012, NEUROREHABILITATION, V31, P261, DOI 10.3233/NRE-2012-0795; Chapman J, 2006, AUTOIMMUN REV, V5, P528, DOI 10.1016/j.autrev.2006.02.011; Chapman J, 2013, SEMIN THROMB HEMOST, V39, P876, DOI 10.1055/s-0033-1357482; CHOI BH, 1990, AM J PATHOL, V137, P741; Citron BA, 2000, J NEUROTRAUM, V17, P1191, DOI 10.1089/neu.2000.17.1191; D'Ambrosio R, 2005, BRAIN, V128, P174, DOI 10.1093/brain/awh337; D'Ambrosio R, 2004, CURR OPIN NEUROL, V17, P731, DOI 10.1097/00019052-200412000-00014; D'Ambrosio Raimondo, 2005, Epilepsy Curr, V5, P244, DOI 10.1111/j.1535-7511.2005.00077.x; de Lanerolle NC, 2005, EPILEPSY BEHAV, V7, P190, DOI 10.1016/j.yebeh.2005.06.003; Donovan FM, 1998, J BIOL CHEM, V273, P12746, DOI 10.1074/jbc.273.21.12746; Fan YY, 2005, J SURG RES, V129, P196, DOI 10.1016/j.jss.2005.07.041; Feinsod M, 2012, WORLD NEUROSURG, V78, P371, DOI 10.1016/j.wneu.2011.12.007; Friedmann I, 2001, J NEUROIMMUNOL, V121, P12, DOI 10.1016/S0165-5728(01)00397-6; Friedmann I, 2001, J NEUROCHEM, V76, P641, DOI 10.1046/j.1471-4159.2001.00001.x; Friedmann I, 1999, FASEB J, V13, P533; Hamilton N, 2010, GLIA, V58, P66, DOI 10.1002/glia.20902; Han KS, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-32; Itzekson Z, 2014, J MOL NEUROSCI, V53, P87, DOI 10.1007/s12031-013-0200-8; Korn A, 2005, J CLIN NEUROPHYSIOL, V22, P1, DOI 10.1097/01.WNP.0000150973.24324.A7; Laskowski A, 2007, NEUROSCI LETT, V415, P17, DOI 10.1016/j.neulet.2006.12.050; Lee CJ, 2007, J PHYSIOL-LONDON, V581, P1057, DOI 10.1113/jphysiol.2007.130377; Lee KR, 1997, J NEUROSURG, V86, P272, DOI 10.3171/jns.1997.86.2.0272; Lee KR, 1997, J NEUROSURG, V87, P73, DOI 10.3171/jns.1997.87.1.0073; Luo W, 2007, BRAIN RES REV, V56, P331, DOI 10.1016/j.brainresrev.2007.08.002; Luo WB, 2007, J BIOL CHEM, V282, P30246, DOI 10.1074/jbc.M703205200; Maggio N, 2008, J NEUROSCI, V28, P732, DOI 10.1523/JNEUROSCI.3665-07.2008; Maggio N, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00019; Mhatre M, 2004, NEUROBIOL AGING, V25, P783, DOI 10.1016/j.neurobiolaging.2003.07.007; Milman A, 2005, J NEUROTRAUM, V22, P1003, DOI 10.1089/neu.2005.22.1003; Mott TF, 2012, AM FAM PHYSICIAN, V86, P1045; Movsesyan VA, 2001, EXP NEUROL, V167, P366, DOI 10.1006/exnr.2000.7567; Niclou SP, 1998, EUR J NEUROSCI, V10, P1590, DOI 10.1046/j.1460-9568.1998.00183.x; Nicole O, 2005, J NEUROSCI, V25, P4319, DOI 10.1523/JNEUROSCI.5200-04.2005; Pan WH, 2003, EXP BRAIN RES, V149, P195, DOI 10.1007/s00221-002-1355-7; Pompili E, 2004, MOL BRAIN RES, V122, P93, DOI 10.1016/j.molbrainres.2003.12.001; POVLISHOCK JT, 1995, BRAIN PATHOL, V5, P415, DOI 10.1111/j.1750-3639.1995.tb00620.x; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; REEVES TM, 1995, EXP BRAIN RES, V106, P248; Ribeiro MD, 2006, EXP NEUROL, V198, P199, DOI 10.1016/j.expneurol.2005.11.017; Riek-Burchardt M, 2002, NEUROSCI LETT, V329, P181, DOI 10.1016/S0304-3940(02)00645-6; Rohatgi T, 2004, J NEUROSCI RES, V75, P273, DOI 10.1002/jnr.10847; Rubovitch V, 2011, EXP NEUROL, V232, P280, DOI 10.1016/j.expneurol.2011.09.018; Seifert G, 2010, BRAIN RES REV, V63, P212, DOI 10.1016/j.brainresrev.2009.10.004; Shavit E, 2011, J NEUROCHEM, V119, P460, DOI 10.1111/j.1471-4159.2011.07436.x; Stewart TH, 2010, J NEUROPHYSIOL, V104, P3345, DOI 10.1152/jn.00398.2010; Striggow F, 2000, P NATL ACAD SCI USA, V97, P2264, DOI 10.1073/pnas.040552897; Tashlykov V, 2007, BRAIN RES, V1130, P197, DOI 10.1016/j.brainres.2006.10.032; Thevenet J, 2009, J NEUROCHEM, V111, P828, DOI 10.1111/j.1471-4159.2009.06369.x; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Tweedie D, 2007, J NEUROSCI RES, V85, P805, DOI 10.1002/jnr.21160; Ucar T, 2006, J TRAUMA, V60, P558, DOI 10.1097/01.ta.0000209172.75637.db; Vergnolle N, 2001, TRENDS PHARMACOL SCI, V22, P146, DOI 10.1016/S0165-6147(00)01634-5; Webb TS, 2015, BRAIN INJURY, V29, P430, DOI 10.3109/02699052.2014.989904; Wu H, 2010, NEUROCHEM INT, V57, P248, DOI 10.1016/j.neuint.2010.06.002; Xue MZ, 2001, STROKE, V32, P2164, DOI 10.1161/hs0901.095408; Zheng GQ, 2009, NEUROSCI LETT, V459, P62, DOI 10.1016/j.neulet.2009.05.007; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016; Zohar O, 2006, NEUROSCI LETT, V394, P239, DOI 10.1016/j.neulet.2005.10.099; Zohar O, 2003, NEUROSCIENCE, V118, P949, DOI 10.1016/S0306-4522(03)00048-4	64	18	18	1	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT 15	2016	33	20					1848	1854		10.1089/neu.2015.4146			7	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	EA6YO	WOS:000386775300005	26537880				2021-06-18	
J	Ahmed, AI; Bullock, MR; Dietrich, WD				Ahmed, Aminul I.; Bullock, M. Ross; Dietrich, W. Dalton			Hypothermia in Traumatic Brain Injury	NEUROSURGERY CLINICS OF NORTH AMERICA			English	Article						Hypothermia; Traumatic brain injury; Neuroprotection; Intracranial pressure	TERM MILD HYPOTHERMIA; RANDOMIZED CONTROLLED-TRIAL; HOSPITAL CARDIAC-ARREST; THERAPEUTIC HYPOTHERMIA; INTRACRANIAL HYPERTENSION; MODERATE HYPOTHERMIA; FLUID PRESSURE; FEVER CONTROL; HYPERTHERMIA; TEMPERATURE	For over 50 years, clinicians have used hypothermia to manage traumatic brain injury (TBI). In the last two decades, numerous trials have assessed whether hypothermia is of benefit in patients. Mild to moderate hypothermia reduces the intracranial pressure (ICP). Randomized control trials for short-term hypothermia indicate no benefit in outcome after severe TBI, whereas longer-term hypothermia could be of benefit by reducing ICP. This article summarises current evidence and gives recommendations based upon the conclusions.	[Ahmed, Aminul I.; Bullock, M. Ross; Dietrich, W. Dalton] Univ Miami, Lois Pope Life Ctr, Miami Project Cure Paralysis, 1095 Northwest,14th Terrace, Miami, FL 33136 USA	Ahmed, AI (corresponding author), Univ Southampton, Southampton Univ Hosp, Clin Expt Sci, LD83,South Acad Block,Tremona Rd, Southampton SO16 6YD, Hants, England.	a.ahmed@soton.ac.uk		Ahmed, Aminul/0000-0001-6670-0438			Adelson PD, 2013, LANCET NEUROL, V12, P546, DOI 10.1016/S1474-4422(13)70077-2; Alderson P, 2004, COCHRANE DB SYST REV, DOI [DOI 10.1002/14651858.CD001048.PUB2, 10.1002/14651858.CD001048.pub2]; Andrews PJD, 2015, NEW ENGL J MED, V373, P2403, DOI 10.1056/NEJMoa1507581; Atkins CM, 2010, EUR J NEUROSCI, V32, P1912, DOI 10.1111/j.1460-9568.2010.07467.x; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; BRAMLETT HM, 1995, J NEUROTRAUM, V12, P289, DOI 10.1089/neu.1995.12.289; Bramlett HM, 1997, ACTA NEUROPATHOL, V93, P190, DOI 10.1007/s004010050602; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; BUSTO R, 1987, J CEREBR BLOOD F MET, V7, P729, DOI 10.1038/jcbfm.1987.127; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; CLIFTON GL, 1993, J NEUROTRAUM, V10, P263, DOI 10.1089/neu.1993.10.263; CLIFTON GL, 1991, J CEREBR BLOOD F MET, V11, P114, DOI 10.1038/jcbfm.1991.13; Clifton GL, 2011, THER HYPOTHERMIA TEM, V1, DOI 10.1089/ther.2011.0009; Crossley S, 2014, CRIT CARE, V18, DOI 10.1186/cc13835; Dietrich WD, 2007, PROG BRAIN RES, V162, P201, DOI 10.1016/S0079-6123(06)62011-6; Dietrich WD, 2010, NEUROTHERAPEUTICS, V7, P43, DOI 10.1016/j.nurt.2009.10.015; Dietrich WD, 1996, NEUROSURGERY, V38, P533, DOI 10.1097/00006123-199603000-00023; DIETRICH WD, 1994, ACTA NEUROPATHOL, V87, P250, DOI 10.1007/BF00296740; DIETRICH WD, 1992, J NEUROTRAUM, V9, pS475; FAY T, 1959, J NEUROSURG, V16, P239, DOI 10.3171/jns.1959.16.3.0239; Finkelstein Robert A, 2010, J Intensive Care Med, V25, P205, DOI 10.1177/0885066610366919; Flynn LMC, 2015, THER HYPOTHERMIA TEM, V5, P143, DOI 10.1089/ther.2015.0002; Fox JL, 2010, CAN J EMERG MED, V12, P355; Gebauer CM, 2006, PEDIATRICS, V117, P843, DOI 10.1542/peds.2004-1587; Gupta AK, 2002, BRIT J ANAESTH, V88, P188, DOI 10.1093/bja/88.2.188; Hartings JA, 2011, BRAIN, V134, P1529, DOI 10.1093/brain/awr048; Hutchison JS, 2008, NEW ENGL J MED, V358, P2447, DOI 10.1056/NEJMoa0706930; Inamasu J, 2010, WORLD NEUROSURG, V74, P120, DOI 10.1016/j.wneu.2010.02.065; Jiang JY, 2000, J NEUROSURG, V93, P546, DOI 10.3171/jns.2000.93.4.0546; Jiang JY, 2006, J CEREBR BLOOD F MET, V26, P771, DOI 10.1038/sj.jcbfm.9600253; Kilpatrick MM, 2000, NEUROSURGERY, V47, P850, DOI 10.1097/00006123-200010000-00011; Kramer C, 2012, NEUROLOGIST, V18, P173, DOI 10.1097/NRL.0b013e318253f8ef; Lei J, 2015, CONTEMP CLIN TRIALS, V40, P9, DOI 10.1016/j.cct.2014.11.008; LUND LO, 1965, ANESTHESIOLOGY, V26, P45, DOI 10.1097/00000542-196501000-00008; LUNDBERG N, 1965, J NEUROSURG, V22, P581, DOI 10.3171/jns.1965.22.6.0581; Maekawa T, 2015, J NEUROTRAUM, V32, P422, DOI 10.1089/neu.2013.3197; Marion D, 2009, J NEUROTRAUM, V26, P455, DOI 10.1089/neu.2008.0582; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; MARION DW, 1993, J NEUROSURG, V79, P354, DOI 10.3171/jns.1993.79.3.0354; McIntyre LA, 2003, JAMA-J AM MED ASSOC, V289, P2992, DOI 10.1001/jama.289.22.2992; Polderman KH, 2008, LANCET, V371, P1955, DOI 10.1016/S0140-6736(08)60837-5; Polderman KH, 2009, CRIT CARE MED, V37, pS186, DOI 10.1097/CCM.0b013e3181aa5241; Polderman KH, 2005, CRIT CARE MED, V33, P2744, DOI 10.1097/01.CCM.0000190427.88735.19; Povlishock JT, 2009, J NEUROTRAUM, V26, P333, DOI 10.1089/neu.2008.0604; Puccio AM, 2009, NEUROCRIT CARE, V11, P82, DOI 10.1007/s12028-009-9213-0; Qiu W, 2007, J CRIT CARE, V22, P229, DOI 10.1016/j.jcrc.2006.06.011; ROSOMOFF HL, 1959, J NEUROSURG, V16, P177, DOI 10.3171/jns.1959.16.2.0177; Sadaka F, 2012, BRAIN INJURY, V26, P899, DOI 10.3109/02699052.2012.661120; Sakurai A, 2012, J NEUROTRAUM, V29, P313, DOI 10.1089/neu.2011.2152; Sandestig A, 2014, THER HYPOTHERMIA TEM, V4, P10, DOI 10.1089/ther.2013.0024; Saxena M, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006811.pub2; Schreckinger M, 2009, NEUROCRIT CARE, V11, P427, DOI 10.1007/s12028-009-9256-2; SEDZIMIR CB, 1959, J NEUROSURG, V16, P407, DOI 10.3171/jns.1959.16.4.0407; SHIOZAKI T, 1993, J NEUROSURG, V79, P363, DOI 10.3171/jns.1993.79.3.0363; Shiozaki T, 2001, J NEUROSURG, V94, P50, DOI 10.3171/jns.2001.94.1.0050; Suehiro E, 2003, J NEUROTRAUM, V20, P381, DOI 10.1089/089771503765172336; SYDENHAM E, 2009, COCHRANE DATABASE SY; Thompson Hilaire J, 2010, J Trauma Nurs, V17, P173, DOI 10.1097/JTN.0b013e3181ff272e; Tokutomi T, 2003, NEUROSURGERY, V52, P102, DOI 10.1097/00006123-200301000-00013; Urbano LA, 2012, CURR NEUROL NEUROSCI, V12, P580, DOI 10.1007/s11910-012-0304-5	61	18	19	0	14	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1042-3680	1558-1349		NEUROSURG CLIN N AM	Neurosurg. Clin. N. Am.	OCT	2016	27	4					489	+		10.1016/j.nec.2016.05.004			10	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	DY9SQ	WOS:000385475800010	27637398				2021-06-18	
J	Aries, MJH; Wesselink, R; Elting, JWJ; Donnelly, J; Czosnyka, M; Ercole, A; Maurits, NM; Smielewski, P				Aries, Marcel J. H.; Wesselink, Robin; Elting, Jan Willem J.; Donnelly, Joseph; Czosnyka, Marek; Ercole, Ari; Maurits, Natasha M.; Smielewski, Peter			Enhanced Visualization of Optimal Cerebral Perfusion Pressure Over Time to Support Clinical Decision Making	CRITICAL CARE MEDICINE			English	Article						cerebral autoregulation; cerebral perfusion pressure management; traumatic brain injury		Objective: Cerebrovascular reactivity can provide a continuously updated individualized target for management of cerebral perfusion pressure, termed optimal cerebral perfusion pressure. The objective of this project was to find a way of improving the optimal cerebral perfusion pressure methodology by introducing a new visualization method. Data Sources: Four severe traumatic brain injury patients with intracranial pressure monitoring. Data Extraction: Data were collected and preprocessed using ICM+ software. Data Synthesis: Sequential optimal cerebral perfusion pressure curves were used to create a color-coded maps of autoregulation - cerebral perfusion pressure relationship evolution over time. Conclusions: The visualization method addresses some of the main drawbacks of the original methodology and might bring the potential for its clinical application closer.	[Aries, Marcel J. H.; Wesselink, Robin] Univ Groningen, Univ Med Ctr Groningen, Dept Intens Care, Groningen, Netherlands; [Aries, Marcel J. H.; Donnelly, Joseph; Czosnyka, Marek; Smielewski, Peter] Univ Cambridge, Addenbrookes Hosp, Dept Clin Neurosci, Brain Phys Grp, Cambridge, England; [Wesselink, Robin] Univ Twente, Dept Tech Med, Enschede, Netherlands; [Elting, Jan Willem J.; Maurits, Natasha M.] Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Groningen, Netherlands; [Ercole, Ari] Univ Cambridge, Addenbrookes Hosp, Div Anaesthesia, Dept Anaesthesia, Cambridge, England; [Maurits, Natasha M.] Univ Groningen, Res Sch Behav & Cognit Neurosci, Groningen, Netherlands	Aries, MJH (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Intens Care, Groningen, Netherlands.; Aries, MJH (corresponding author), Univ Cambridge, Addenbrookes Hosp, Dept Clin Neurosci, Brain Phys Grp, Cambridge, England.	m.j.h.aries@umcg.nl	Donnelly, Joseph/N-6803-2019; Ercole, Ari/B-6288-2009; Donnelly, Joseph/E-9235-2018	Donnelly, Joseph/0000-0002-6502-8069; Ercole, Ari/0000-0001-8350-8093; Donnelly, Joseph/0000-0002-6502-8069; Wesselink, Robin/0000-0001-5671-2531; Smielewski, Peter/0000-0001-5096-3938; Maurits, Natasha/0000-0001-6231-7044	Dutch Society of Intensive Care; Woolf Fisher Trust, New Zealand (study scholarship); Cambridge Enterprise, United Kingdom; Radboud University Nijmegen; European UnionEuropean Commission; Princess Beatrix Foundation, The NetherlandsNetherlands Government	Dr. Aries received an unrestricted grant from the Dutch Society of Intensive Care. Dr. Donnelly received funding from Woolf Fisher Trust, New Zealand (study scholarship). Dr. Czosnyka disclosed other support (Integra Life sciences Speakers Bureau - payment (sic)1,500) and received funding from Cambridge Enterprise, United Kingdom. He has a financial interest in a part of the licensing fee. Dr. Maurits received funding from Radboud University Nijmegen. Her institution received funding from the European Union and from the Princess Beatrix Foundation, The Netherlands. Dr. Smielewski disclosed other support (he has a financial interest in the part of the licensing fees of the software, ICM+, used in data collection and partial analysis for this project). The remaining authors have disclosed that they do not have any potential conflicts of interest.	Aries MJH, 2012, CRIT CARE MED, V40, P2456, DOI 10.1097/CCM.0b013e3182514eb6; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS59, DOI 10.1089/neu.2007.9990; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Czosnyka M, 1997, J NEUROL NEUROSUR PS, V63, P721, DOI 10.1136/jnnp.63.6.721; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Le Roux P, 2014, INTENS CARE MED, V40, P1189, DOI 10.1007/s00134-014-3369-6; Maas AIR, 2012, LANCET NEUROL, V11, P12, DOI 10.1016/S1474-4422(11)70267-8; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002	8	18	18	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	OCT	2016	44	10					E996	E999		10.1097/CCM.0000000000001816			4	Critical Care Medicine	General & Internal Medicine	VC9PN	WOS:000435244200011	27270178	Green Accepted			2021-06-18	
J	Abboud, A; Mi, Q; Puccio, A; Okonkwo, D; Bulige, M; Constantine, G; Vodovotz, Y				Abboud, Andrew; Mi, Qi; Puccio, Ava; Okonkwo, David; Bulige, Marius; Constantine, Gregory; Vodovotz, Yoram			Inflammation Following Traumatic Brain Injury in Humans: Insights from Data-Driven and Mechanistic Models into Survival and Death	FRONTIERS IN PHARMACOLOGY			English	Article						inflammation; TBI outcome; mathematical modeling; data-driven modeling; mortality; inflammatory mediators in CNS	REDUCED MATHEMATICAL-MODEL; IN-SILICO; CEREBROSPINAL-FLUID; SYSTEMS BIOLOGY; BLUNT TRAUMA; VIVO; INTERLEUKIN-10; DYNAMICS; STATES; MICE	Inflammation induced by traumatic brain injury (TBI) is a complex mediator of morbidity and mortality. We have previously demonstrated the utility of both data-driven and mechanistic models in settings of traumatic injury. We hypothesized that differential dynamic inflammation programs characterize TBI survivors vs. non-survivors, and sought to leverage computational modeling to derive novel insights into this life/death bifurcation. Thirteen inflammatory cytokines and chemokines were determined using Luminex (TM) in serial cerebrospinal fluid (CSF) samples from 31 TBI patients over 5 days. In this cohort, 5 were non-survivors (Glasgow Outcome Scale EGOS] score = 1) and 26 were survivors (GOS > 1). A Pearson correlation analysis of initial injury (Glasgow Coma Scale [GCS]) vs. GOS suggested that survivors and non survivors had distinct clinical response trajectories to injury. Statistically significant differences in interleukin (IL)-4, IL-5, IL-6, IL-8, IL-13, and tumor necrosis factor-alpha (INF-alpha) were observed between TBI survivors vs. non-survivors over 5 days. Principal Component Analysis and Dynamic Bayesian Network inference suggested differential roles of chemokines, INF-alpha, IL-6, and IL-10, based upon which an ordinary differential equation model of TBI was generated. This model was calibrated separately to the time course data of TBI survivors vs. non-survivors as a function of initial GCS. Analysis of parameter values in ensembles of simulations from these models suggested differences in microglial and damage responses in TBI survivors vs. non-survivors. These studies suggest the utility of combined data-driven and mechanistic models in the context of human TBI.	[Abboud, Andrew; Vodovotz, Yoram] Univ Pittsburgh, Dept Surg, Pittsburgh, PA 15260 USA; [Mi, Qi] Univ Pittsburgh, Dept Sports Med & Nutr, Pittsburgh, PA USA; [Mi, Qi; Constantine, Gregory; Vodovotz, Yoram] Univ Pittsburgh, McGowan Inst Regenerat Med, Ctr Inflammat & Regenerat Modeling, Pittsburgh, PA 15260 USA; [Puccio, Ava; Okonkwo, David] Univ Pittsburgh, Dept Neurol Surg, Pittsburgh, PA 15260 USA; [Bulige, Marius] Univ Pittsburgh, Dept Math, Bradford, PA USA; [Constantine, Gregory] Univ Pittsburgh, Dept Math, Pittsburgh, PA USA; [Constantine, Gregory] Univ Pittsburgh, Dept Stat, Pittsburgh, PA USA	Vodovotz, Y (corresponding author), Univ Pittsburgh, Dept Surg, Pittsburgh, PA 15260 USA.; Vodovotz, Y (corresponding author), Univ Pittsburgh, McGowan Inst Regenerat Med, Ctr Inflammat & Regenerat Modeling, Pittsburgh, PA 15260 USA.	vodovotzy@upmc.edu			Commonwealth of Pennsylvania grant SAP [4100068505]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [P50GM53789]; Walter Copeland Fund of the Pittsburgh Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P50GM053789] Funding Source: NIH RePORTER	This work was supported in part by Commonwealth of Pennsylvania grant SAP#4100068505 and by National Institutes of Health grant P50GM53789 to YV, and the Walter Copeland Fund of the Pittsburgh Foundation to AP.	Abboud A, 2016, CRIT CARE MED, V44, pE1074, DOI 10.1097/CCM.0000000000001951; Almahmoud K, 2015, SHOCK, V44, P101, DOI 10.1097/SHK.0000000000000395; Almahmoud K, 2015, CRIT CARE MED, V43, P1395, DOI 10.1097/CCM.0000000000000964; An G, 2014, TRANSLATIONAL SYSTEM; An G, 2012, INT J BURNS TRAUMA, V2, P1; Azhar N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078202; Bell MJ, 1997, J NEUROTRAUM, V14, P451, DOI 10.1089/neu.1997.14.451; Blaylock Russell L, 2011, Surg Neurol Int, V2, P107, DOI 10.4103/2152-7806.83391; Brown D, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3636; Chow CC, 2005, SHOCK, V24, P74, DOI 10.1097/01.shk.0000168526.97716.f3; Collins MW, 2014, KNEE SURG SPORT TR A, V22, P235, DOI 10.1007/s00167-013-2791-6; Daun S, 2008, J THEOR BIOL, V253, P843, DOI 10.1016/j.jtbi.2008.04.033; Davis BK, 2011, ANNU REV IMMUNOL, V29, P707, DOI 10.1146/annurev-immunol-031210-101405; Day J, 2006, J THEOR BIOL, V242, P237, DOI 10.1016/j.jtbi.2006.02.015; Eungdamrong NJ, 2004, BIOL CELL, V96, P355, DOI 10.1016/j.biolcel.2004.03.004; Ferrell JE, 2013, CURR OPIN CELL BIOL, V25, P676, DOI 10.1016/j.ceb.2013.07.007; Gao JX, 2015, INT J CLIN EXP MED, V8, P19881; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Kumar R, 2004, J THEOR BIOL, V230, P145, DOI 10.1016/j.jtbi.2004.04.044; Kumar R, 2008, SHOCK, V29, P104, DOI 10.1097/SHK.0b013e318067da56; Li NYK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002789; Maier B, 2001, SHOCK, V15, P421, DOI 10.1097/00024382-200115060-00002; Mi Q, 2007, WOUND REPAIR REGEN, V15, P671, DOI 10.1111/j.1524-475X.2007.00271.x; Mi Q, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019424; MorgantiKossman MC, 1997, MOL PSYCHIATR, V2, P133, DOI 10.1038/sj.mp.4000227; Namas RA, 2016, J CRIT CARE, V36, P146, DOI 10.1016/j.jcrc.2016.07.002; Namas RA, 2015, ANTIOXID REDOX SIGN, V23, P1370, DOI 10.1089/ars.2015.6398; Namas RA, 2016, ANN SURG, V263, P191, DOI 10.1097/SLA.0000000000001001; Namas RA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067419; Namas RA, 2012, MOL MED, V18, P1366, DOI 10.2119/molmed.2012.00106; Nieman G, 2012, CRIT CARE MED, V40, P1052, DOI 10.1097/CCM.0b013e31823e986a; Pearn ML, 2017, CELL MOL NEUROBIOL, V37, P571, DOI 10.1007/s10571-016-0400-1; Prince JM, 2006, MOL MED, V12, P88, DOI 10.2119/2006-00012.Prince; Reynolds A, 2006, J THEOR BIOL, V242, P220, DOI 10.1016/j.jtbi.2006.02.016; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Starzl R, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00587; Torres A, 2009, SHOCK, V32, P172, DOI 10.1097/SHK.0b013e318193cc2b; Vasudeva K, 2015, J NEUROIMMUNOL, V283, P43, DOI 10.1016/j.jneuroim.2015.04.012; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Zaaqoq AM, 2014, CRIT CARE MED, V42, P1487, DOI 10.1097/CCM.0000000000000248	40	18	18	0	3	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1663-9812			FRONT PHARMACOL	Front. Pharmacol.	SEP 27	2016	7								342	10.3389/fphar.2016.00342			12	Pharmacology & Pharmacy	Pharmacology & Pharmacy	DX3FG	WOS:000384258300001	27729864	DOAJ Gold, Green Published			2021-06-18	
J	Abdel-Aziz, AK; Mantawy, EM; Said, RS; Helwa, R				Abdel-Aziz, Aural Kamal; Mantawy, Eman M.; Said, Riham Soliman; Helwa, Reham			The tyrosine kinase inhibitor, sunitinib malate, induces cognitive impairment in vivo via dysregulating VEGFR signaling, apoptotic and autophagic machineries	EXPERIMENTAL NEUROLOGY			English	Article						Sunitinib; Cognition; VEGF; Apoptosis; Autophagy	NF-KAPPA-B; ENDOTHELIAL GROWTH-FACTOR; TRAUMATIC BRAIN-INJURY; NEURAL STEM-CELLS; PHASE-II TRIAL; HIPPOCAMPAL NEUROGENESIS; NEURODEGENERATIVE DISORDERS; ENDOMETRIAL CARCINOMA; MOLECULAR-MECHANISMS; NEURONAL APOPTOSIS	Chemobrain refers to a cluster of cognitive deficits which affects almost 4-75% of chemotherapy-treated cancer patients. Sunitinib, an FDA-approved multityrosine kinase inhibitor, is currently used in treating different types of tumors. Despite being regarded as targeted therapy which blunts sustained angiogenesis in cancer milieu through inhibiting vascular endothelial growth factor receptor 2 (VEGFR2) signaling, the latter has a cardinal role in cognition. Recent clinical reports warned that sunitinib adversely affected memory processing in cancer patients. Nevertheless, the underlying mechanisms have not been investigated yet. Hence, we explored the impact of a clinically relevant dose of sunitinib on memory processing in vivo and questioned the implication of VEGFR2 signaling, autophagy and apoptosis. Strikingly, sunitinib preferentially impaired spatial cognition as evidenced in Morris water maze, T-maze and passive avoidance task. Consistently, sunitinib degenerated cortical and hippocampal neurons as assessed by histopathological examination and toluidine blue staining. Ultra structural examination also depicted chromatin condensation, mitochondrial damage and accumulated autophagosomes. Digging deeper, central VEGF/VEGFR2/mTOR signaling was robustly suppressed. Besides, sunitinib boosted cortical and hippocampal p53 and executioner caspase-3 and decreased nuclear factor kappa B and Bcl-2 levels promoting apoptotic cell death. It also profoundly impeded neuronal autophagic flux as shown by decreased beclin-1 and AtgS and increased p62/SQTSM1 levels. To our knowledge, this is the first study to provide molecular insights into sunitinib-induced chemofog where impeded VEGFR2 signaling and autophagic and hyperactivated apoptotic machineries act in neurodegenerative concert. Importantly, our findings shed light on potential therapeutic strategies to be exploited in the management of sunitinib-induced chemobrain. (C) 2016 Elsevier Inc. All rights reserved.	[Abdel-Aziz, Aural Kamal; Mantawy, Eman M.] Ain Shams Univ, Fac Pharm, Dept Pharmacol & Toxicol, African Union Org St, Cairo 11566, Egypt; [Said, Riham Soliman] Atom Energy Author, Natl Ctr Radiat Res & Technol, Cairo, Egypt; [Helwa, Reham] Ain Shams Univ, Fac Sci, Dept Zool, Cairo, Egypt; [Abdel-Aziz, Aural Kamal] European Inst Oncol, Dept Expt Oncol, Milan, Italy	Abdel-Aziz, AK (corresponding author), Ain Shams Univ, Fac Pharm, Dept Pharmacol & Toxicol, African Union Org St, Cairo 11566, Egypt.	AmalAbdel-Aziz@pharma.asu.edu.eg	Said, Riham/AAR-1943-2021; Abdel-Aziz, Amal Kamal/AAB-9050-2019; Abdel-Aziz, Amal Kamal/AAA-1360-2021; Helwa, Reham/N-9198-2016	Abdel-Aziz, Amal Kamal/0000-0003-1709-1183; Helwa, Reham/0000-0003-1009-0786			Abdel-Aziz AK, 2014, CHEM-BIOL INTERACT, V217, P28, DOI 10.1016/j.cbi.2014.04.007; Abouantoun TJ, 2011, J NEURO-ONCOL, V101, P215, DOI 10.1007/s11060-010-0259-9; Adams VR, 2007, CLIN THER, V29, P1338, DOI 10.1016/j.clinthera.2007.07.022; Aita Y, 2012, AM J PHYSIOL-ENDOC M, V303, pE1006, DOI 10.1152/ajpendo.00156.2012; Aparicio-Gallego G, 2011, MOL CANCER THER, V10, P2215, DOI 10.1158/1535-7163.MCT-10-1124; Bachelot T, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-166; Bai D, 2009, INT J CANCER, V125, P2863, DOI 10.1002/ijc.24748; Baumann KH, 2012, ANN ONCOL, V23, P2265, DOI 10.1093/annonc/mds003; Bekinschtein P, 2007, NEUROBIOL LEARN MEM, V87, P303, DOI 10.1016/j.nlm.2006.08.007; Bordun KA, 2015, AM J PHYSIOL-HEART C, V309, pH692, DOI 10.1152/ajpheart.00172.2015; Bromley-Brits K, 2011, JOVE-J VIS EXP, DOI 10.3791/2920; Calero R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095628; Cao L, 2004, NAT GENET, V36, P827, DOI 10.1038/ng1395; Castonguay V, 2014, GYNECOL ONCOL, V134, P274, DOI 10.1016/j.ygyno.2014.05.016; Cavaletti Guido, 2015, Am Soc Clin Oncol Educ Book, pe553, DOI 10.14694/EdBook_AM.2015.35.e553; Chu TF, 2007, LANCET, V370, P2011, DOI 10.1016/S0140-6736(07)61865-0; Copetti T, 2009, AUTOPHAGY, V5, P858, DOI 10.4161/auto.8822; Correa DD, 2008, CANCER J, V14, P396, DOI 10.1097/PPO.0b013e31818d8769; Culmsee C, 2005, BIOCHEM BIOPH RES CO, V331, P761, DOI 10.1016/j.bbrc.2005.03.149; Dan HC, 2008, GENE DEV, V22, P1490, DOI 10.1101/gad.1662308; Demetri GD, 2006, LANCET, V368, P1329, DOI 10.1016/S0140-6736(06)69446-4; Faivre S, 2006, J CLIN ONCOL, V24, P25, DOI 10.1200/JCO.2005.02.2194; Ghavami S, 2014, PROG NEUROBIOL, V112, P24, DOI 10.1016/j.pneurobio.2013.10.004; Gotink KJ, 2011, CLIN CANCER RES, V17, P7337, DOI 10.1158/1078-0432.CCR-11-1667; Hanna DMF, 2015, PROG NEURO-PSYCHOPH, V60, P36, DOI 10.1016/j.pnpbp.2015.02.005; Harada H, 2001, P NATL ACAD SCI USA, V98, P9666, DOI 10.1073/pnas.171301998; Hooper C, 2007, NEUROSCI LETT, V418, P34, DOI 10.1016/j.neulet.2007.03.026; Huang H, 2015, FASEB J, V29, P227, DOI 10.1096/fj.14-250985; Inoki K, 2005, NAT GENET, V37, P19, DOI 10.1038/ng1494; Jackson GE, 2008, MED HYPOTHESES, V70, P572, DOI 10.1016/j.mehy.2007.06.019; Kaltschmidt B, 1999, P NATL ACAD SCI USA, V96, P9409, DOI 10.1073/pnas.96.16.9409; Kerkela R, 2009, CTS-CLIN TRANSL SCI, V2, P15, DOI 10.1111/j.1752-8062.2008.00090.x; Kiriakidis S, 2003, J CELL SCI, V116, P665, DOI 10.1242/jcs.00286; Kitamura Y, 2015, BEHAV BRAIN RES, V292, P184, DOI 10.1016/j.bbr.2015.06.007; Klug M, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00149; Licht T, 2011, P NATL ACAD SCI USA, V108, P5081, DOI 10.1073/pnas.1007640108; Lopergolo A, 2014, J CLIN ENDOCR METAB, V99, P498, DOI 10.1210/jc.2013-2574; Martini M, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00202; Maurer MH, 2003, NEUROSCI LETT, V344, P165, DOI 10.1016/S0304-3940(03)00407-5; Mendel DB, 2003, CLIN CANCER RES, V9, P327; Michel HE, 2013, NEUROSCI LETT, V544, P110, DOI 10.1016/j.neulet.2013.03.055; Mulder SF, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-219; Nixon RA, 2013, NAT MED, V19, P983, DOI 10.1038/nm.3232; Ortuzar N, 2013, BEHAV BRAIN RES, V246, P36, DOI 10.1016/j.bbr.2013.02.036; Pickford F, 2008, J CLIN INVEST, V118, P2190, DOI 10.1172/JCI33585; Plaschke K, 2008, EXP NEUROL, V214, P285, DOI 10.1016/j.expneurol.2008.08.014; Santoni M, 2013, BRIT J CANCER, V109, P1040, DOI 10.1038/bjc.2013.420; Saxe MD, 2006, P NATL ACAD SCI USA, V103, P17501, DOI 10.1073/pnas.0607207103; Shen Q, 2004, SCIENCE, V304, P1338, DOI 10.1126/science.1095505; Sinha S, 2008, ONCOGENE, V27, pS137, DOI 10.1038/onc.2009.51; Sorolla A, 2012, MOL ONCOL, V6, P530, DOI 10.1016/j.molonc.2012.06.006; Speed B, 2012, DRUG METAB DISPOS, V40, P539, DOI 10.1124/dmd.111.042853; Tamatani M, 1999, J BIOL CHEM, V274, P8531, DOI 10.1074/jbc.274.13.8531; van der Veldt AAM, 2007, ANN ONCOL, V18, P1747, DOI 10.1093/annonc/mdm455; Walker KR, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00029; Wang R, 2001, EUR J PHARMACOL, V421, P149, DOI 10.1016/S0014-2999(01)01030-5; Wey MCY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031522; Wrasidlo W, 2014, BRIT J PHARMACOL, V171, P5757, DOI 10.1111/bph.12875; Yamamoto K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102110; Yang FY, 2014, BEHAV BRAIN RES, V264, P82, DOI 10.1016/j.bbr.2014.02.005; Yang ZF, 2010, CURR OPIN CELL BIOL, V22, P124, DOI 10.1016/j.ceb.2009.11.014	61	18	18	0	12	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	SEP	2016	283		A				129	141		10.1016/j.expneurol.2016.06.004			13	Neurosciences	Neurosciences & Neurology	DW0EU	WOS:000383314500012	27288242				2021-06-18	
J	Mc Fie, S; Brown, J; Hendricks, S; Posthumus, M; Readhead, C; Lambert, M; September, AV; Viljoen, W				Mc Fie, Sarah; Brown, James; Hendricks, Sharief; Posthumus, Michael; Readhead, Clint; Lambert, Mike; September, Alison V.; Viljoen, Wayne			Incidence and Factors Associated With Concussion Injuries at the 2011 to 2014 South African Rugby Union Youth Week Tournaments	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						concussion; rugby union; youth; epidemiology	TRAUMATIC BRAIN-INJURY; CONSENSUS STATEMENT; HEAD-INJURIES; UNITED-STATES; RISK-FACTORS; HIGH-SCHOOL; PLAYERS; EPIDEMIOLOGY; SPORTS; COHORT	Objective:To determine the concussion incidence and to identify factors associated with concussion in South African youth rugby union players.Design:Prospective cohort study.Setting:Injury surveillance was completed at the South African Rugby Union Youth Week tournaments (under-13, under-16, and under-18 age groups).Participants:South African youth rugby union players. A total of 7216 players participated in 531 matches between 2011 and 2014.Interventions:None.Main Outcome Measures:Concussion incidence was calculated per 1000 player-match-hours with 95% CIs. Poisson regression was used to calculate the incidence rate ratio (IRR) between factors (age, time period, playing position, and activity at the time of concussion) potentially associated with concussions.Results:The concussion incidence was 6.8/1000 player-match-hours (95% CI, 5.5-8.1) across all age groups. Under-13s (IRR, 1.5; P = 0.09) and under-16s (IRR, 1.7; P = 0.03) had higher concussion incidence rates than the under-18 age group. The incidence was higher in the third (IRR, 2.1; P = 0.04) and fourth (IRR, 2.5; P = 0.01) quarters of matches compared with the first quarter. Sixty-two percent of concussions occurred in the tackle situation. The tackler had a 4-fold greater concussion rate (IRR, 4.3; P < 0.001) compared with the ball carrier. The hooker and loose forwards had higher incidence rates than several other player positions (P < 0.05).Conclusions:The reported concussion incidence falls within the broad range previously reported in youth rugby. The evidence highlighted in this study may contribute to targeted concussion prevention strategies and provide a baseline against which the effectiveness of future interventions can be measured.	[Mc Fie, Sarah; Brown, James; Hendricks, Sharief; Posthumus, Michael; Readhead, Clint; Lambert, Mike; September, Alison V.; Viljoen, Wayne] Univ Cape Town, Div Exercise Sci & Sports Med, Dept Human Biol, Fac Hlth Sci, Cape Town, South Africa; [Readhead, Clint; Viljoen, Wayne] South African Rugby Football Union, Dept Med, Cape Town, South Africa	Viljoen, W (corresponding author), SARU House,163 Uys Krige Dr,Tygerberg Pk, ZA-7500 Cape Town, South Africa.	waynev@sarugby.co.za	Hendricks, Sharief/U-3278-2019; Brown, James Craig/H-7637-2019	Hendricks, Sharief/0000-0002-3416-6266; Brown, James Craig/0000-0002-7778-7783; Viljoen, Wayne/0000-0002-9432-6153; September, Alison V/0000-0003-0950-286X	South African National Research FoundationNational Research Foundation - South Africa; University of Cape Town; Thembakazi Trust	S.M. was funded by the South African National Research Foundation and the University of Cape Town. M.P. was funded by the Thembakazi Trust. W.V. and C.R. are full-time employees of SARU.	Abrahams S, 2014, BRIT J SPORT MED, V48, P91, DOI 10.1136/bjsports-2013-092734; Bakhos LL, 2010, PEDIATRICS, V126, pE550, DOI 10.1542/peds.2009-3101; Bathgate A, 2002, BRIT J SPORT MED, V36, P265, DOI 10.1136/bjsm.36.4.265; Bird YN, 1998, BRIT J SPORT MED, V32, P319, DOI 10.1136/bjsm.32.4.319; Brooks JHM, 2008, CLIN SPORT MED, V27, P51, DOI 10.1016/j.csm.2007.09.001; Brown JC, 2012, S AFR J SPORTS MED, V24, P49; Buzzini SRR, 2006, CURR OPIN PEDIATR, V18, P376, DOI 10.1097/01.mop.0000236385.26284.ec; Collins CL, 2008, ARCH PEDIAT ADOL MED, V162, P49, DOI 10.1001/archpediatrics.2007.1; Deutsch MU, 2007, J SPORT SCI, V25, P461, DOI 10.1080/02640410600631298; Deutsch MU, 1998, J SPORT SCI, V16, P561, DOI 10.1080/026404198366524; Fuller CW, 2007, BRIT J SPORT MED, V41, P862, DOI 10.1136/bjsm.2007.037499; Fuller CW, 2007, BRIT J SPORT MED, V41, P328, DOI 10.1136/bjsm.2006.033282; Fuller CW, 2015, BRIT J SPORT MED, V49, P478, DOI 10.1136/bjsports-2013-093381; Gabbett TJ, 2008, J STRENGTH COND RES, V22, P625, DOI 10.1519/JSC.0b013e3181635a6a; Gardner AJ, 2014, SPORTS MED, V44, P1717, DOI 10.1007/s40279-014-0233-3; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Haseler CM, 2010, BRIT J SPORT MED, V44, P1093, DOI 10.1136/bjsm.2010.074021; Hendricks S, 2014, J SPORT SCI MED, V13, P715; Hollis SJ, 2011, BRIT J SPORT MED, V45, P997, DOI 10.1136/bjsm.2010.079707; Hollis SJ, 2009, AM J SPORT MED, V37, P2328, DOI 10.1177/0363546509341032; Junge A, 2004, BRIT J SPORT MED, V38, P168, DOI 10.1136/bjsm.2002.003020; Kaminsky L, 2014, ACSMS HLTH REL PHYS; Kemp SPT, 2008, CLIN J SPORT MED, V18, P227, DOI 10.1097/JSM.0b013e31816a1c9a; Kerr HA, 2008, BRIT J SPORT MED, V42, P595, DOI 10.1136/bjsm.2007.035881; King D, 2014, J SCI MED SPORT, V17, P250, DOI 10.1016/j.jsams.2013.05.007; Koh JO, 2003, BRAIN INJURY, V17, P901, DOI 10.1080/0269905031000088869; Kontos AP, 2005, FDN SPORT RELAT BRAI, P315; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lee AJ, 1996, BRIT J SPORT MED, V30, P213, DOI 10.1136/bjsm.30.3.213; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McIntosh AS, 2010, BRIT J SPORT MED, V44, P188, DOI 10.1136/bjsm.2007.041400; Ommaya AK, 2002, BRIT J NEUROSURG, V16, P220, DOI 10.1080/02688690220148824; Posthumus M., 2008, S AFR J SPORTS MED, V20, P64, DOI [10.17159/2078-516X/2008/v20i3a633, DOI 10.17159/2078-516X/2008/V20I3A633]; Reeves TM, 2005, EXP NEUROL, V196, P126, DOI 10.1016/j.expneurol.2005.07.014; Roberts S, 2014, BRIT J SPORT MED, V48, P654; Stevens Sean T, 2008, Res Sports Med, V16, P68, DOI 10.1080/15438620701879020; Tommasone BA, 2006, J ATHL TRAINING, V41, P470; VANMECHELEN W, 1992, SPORTS MED, V14, P82, DOI 10.2165/00007256-199214020-00002; Viljoen W, 2012, BRIT J SPORT MED, V46, P692, DOI 10.1136/bjsports-2012-091278; Webbe FM, 2003, CLIN SPORT MED, V22, P577, DOI 10.1016/S0278-5919(02)00103-5	40	18	18	0	17	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	SEP	2016	26	5					398	404		10.1097/JSM.0000000000000276			7	Orthopedics; Physiology; Sport Sciences	Orthopedics; Physiology; Sport Sciences	DW8LH	WOS:000383906800011	27604072				2021-06-18	
J	Walker, PH; Pock, A; Ling, CG; Kwon, KN; Vaughan, M				Walker, Patricia Hinton; Pock, Arnyce; Ling, Catherine G.; Kwon, Kyung Nancy; Vaughan, Megan			Battlefield acupuncture: Opening the door for acupuncture in Department of Defense/Veteran's Administration health care	NURSING OUTLOOK			English	Article						Battlefield acupuncture; Pain management; Military; Veterans; Interdisciplinary education; Advanced practice nurses	PAIN RATING-SCALE; VALIDATION; MANAGEMENT; DEFENSE; DVPRS	Battlefield acupuncture is a unique auricular acupuncture procedure which is being used in a number of military medical facilities throughout the Department of Defense (DOD). It has been used with anecdotal published positive impact with warriors experiencing polytrauma, post-traumatic stress disorder, and traumatic brain injury. It has also been effectively used to treat warriors with muscle and back pain from carrying heavy combat equipment in austere environments. This article highlights the history within the DoD related to the need for nonpharmacologic/opioid pain management across the continuum of care from combat situations, during evacuation, and throughout recovery and rehabilitation. The article describes the history of auricular acupuncture and details implementation procedures. Training is necessary and partially funded through DoD and Veteran's Administration (VA) internal Joint Incentive Funds grants between the DoD and the VA for multidisciplinary teams as part of a larger initiative related to the recommendations from the DoD Army Surgeon General's Pain Management Task Force. Finally, Uniformed Services University of the Health Sciences School of Medicine and Graduate School of Nursing faculty members present how this interdisciplinary training is currently being integrated into both schools for physicians and advanced practice nurses at the Uniformed Services University of the Health Sciences. Current and future research challenges and progress related to the use of acupuncture are also presented.	[Walker, Patricia Hinton] Uniformed Serv Univ Hlth Sci, Off President, Bethesda, MD 20814 USA; [Pock, Arnyce] Uniformed Serv Univ Hlth Sci, Sch Med, Bethesda, MD 20814 USA; [Ling, Catherine G.] Daniel K Inouye Grad Sch Nursing, DNP & NP Program, Bethesda, MD USA; [Kwon, Kyung Nancy] Henry Jackson Fdn, DVCIPM, Res Management, Rockville, MD USA; [Vaughan, Megan] Def Vet Ctr Pain Management DVCIPM, Rockville, MD USA	Walker, PH (corresponding author), Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA.	phintonwalker@comcast.net	Ling, Catherine/N-4969-2016	Ling, Catherine/0000-0002-4187-8683			Ahn AC, 2008, BIOELECTROMAGNETICS, V29, P245, DOI 10.1002/bem.20403; [Anonymous], 2010, 77 PAIN MAN TASK FOR; Apkarian AV, 2009, PROG NEUROBIOL, V87, P81, DOI 10.1016/j.pneurobio.2008.09.018; Brennan T., 2014, THE DAILY NEWS; Brennan T., 2014, STARS STRIPES; Buckenmaier CC, 2013, PAIN MED, V14, P110, DOI 10.1111/j.1526-4637.2012.01516.x; Buckenmaier CC, 2012, J AM ACAD ORTHOP SUR, V20, pS35, DOI 10.5435/JAAOS-20-08-S35; Buckenmaier CC, 2010, MIL MED, V175, P7, DOI 10.7205/MILMED-D-10-00172; Buckenmaier III C. C., 2011, MILITARY ADV REGIONA; Cahana A, 2013, PAIN MED, V14, P1, DOI 10.1111/pme.12042; ClinicalTrials.gov, 2016, SERV US NAT I HLTH; Dart RC, 2015, NEW ENGL J MED, V372, P241, DOI [10.1056/NEJMsa1406143, 10.1056/NEJMc1501822]; Ernst E, 2007, CAN MED ASSOC J, V176, P1307, DOI 10.1503/cmaj.1070008; Goertz CMH, 2006, MIL MED, V171, P1010, DOI 10.7205/MILMED.171.10.1010; Koffman RL, 2013, PSYCHIAT ANN, V43, P236, DOI 10.3928/00485713-20130503-09; Kukral L., 2012, PERFORMANCE TRIAD CH; Langevin HM, 2011, EVID-BASED COMPL ALT, V2011, DOI 10.1155/2011/180805; Nassif TH, 2015, PAIN MED, V16, P2152, DOI 10.1111/pme.12866; National Center for Complementary and Integrative Health, 2016, USE COMPL ALT MED US; Niemtzow RC, 2007, MED ACUPUNCT, V19, P225, DOI 10.1089/acu.2007.0603; OLESON TD, 1980, PAIN, V8, P217, DOI 10.1016/0304-3959(88)90009-7; Ramsay DJ, 1998, JAMA-J AM MED ASSOC, V280, P1518; Sherman KJ, 2003, ALTERN THER HEALTH M, V9, P54; Soliman N, 1999, Phys Med Rehabil Clin N Am, V10, P547; Spotswood S., 2014, AURICULAR ACUPUNCTUR; Vickers AJ, 2012, ARCH INTERN MED, V172, P1444, DOI 10.1001/archinternmed.2012.3654; World Health Organization, 2002, AC REV AN REP CONTR	27	18	18	2	18	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0029-6554	1528-3968		NURS OUTLOOK	Nurs. Outlook	SEP-OCT	2016	64	5			SI		491	498		10.1016/j.outlook.2016.07.008			8	Nursing	Nursing	DW6CE	WOS:000383733200012	27601311				2021-06-18	
J	Albadawi, H; Oklu, R; Malley, RER; O'Keefe, RM; Uong, TP; Cormier, NR; Watkins, MT				Albadawi, Hassan; Oklu, Rahmi; Malley, Rita Elise Raacke; O'Keefe, Ryan M.; Uong, Thuy P.; Cormier, Nicholas R.; Watkins, Michael T.			Effect of DNase I treatment and neutrophil depletion on acute limb ischemia-reperfusion injury in mice	JOURNAL OF VASCULAR SURGERY			English	Article							DEEP-VEIN THROMBOSIS; EXTRACELLULAR TRAPS; SKELETAL-MUSCLE; DEOXYRIBONUCLEASE-I; ISCHEMIA/REPERFUSION INJURY; ACTIN; HISTONES; INFLAMMATION; CHROMATIN; CELLS	Objective: Extracellular traps (ETs) consisting of DNA-protein complexes formed after tissue injury contribute to the inflammatory and thrombosis cascades, thereby exacerbating injury. Exogenous DNase I has been suggested as a therapeutic strategy to limit injury in the brain and myocardium. These studies were designed to evaluate the effects of exogenous DNase I treatment on skeletal muscle injury after acute hindlimb ischemia-reperfusion (IR) injury in mice and to determine whether neutrophils are a major source of ETs in postischemic muscle tissue. Methods: C57BL6 mice were subjected to 1.5 hours of tourniquet ischemia and 24 hours of reperfusion with and without human recombinant DNase I treatment. A separate set of mice was subjected to neutrophil depletion (ND), followed by the same intervals of IR. Laser Doppler imaging and tissue harvesting were done at 24 hours for assessment of limb perfusion, muscle fiber injury, adenosine triphosphate (ATP) level, markers of inflammation, thrombosis, and formation of ETs. Results: DNase I treatment significantly reduced detection of ETs in postischemic muscle but did not alter skeletal muscle fiber injury, levels of proinflammatory molecules, or ATP level. DNase I treatment did enhance postischemic hindlimb perfusion, decreased infiltrating inflammatory cells, and reduced the expression of thrombin-antithrombin III. ND resulted in a significant yet small reduction in ETs in the postischemic muscle. ND did not alter skeletal muscle fiber injury, hindlimb perfusion, or ATP levels. Conclusions: These data suggest that neither DNase I treatment nor ND was protective against IR injury, even though both decreased detection of ETs in skeletal muscle after IR. Neutrophils are not the only source of ETs after IR. Clinical Relevance: Acute muscle ischemia-reperfusion injury that follows a traumatic event or thrombotic occlusion of a major artery due to vascular disease in the lower extremities can lead to extensive tissue inflammation and necrosis. DNase I was recently proposed as a treatment strategy to degrade neutrophil extracellular traps, which consist of protein-DNA complexes accumulating after tissue injury or thrombosis. Investigators believe that these complexes can enhance the prothrombogenic and proinflammatory milieu in the tissue, thereby exacerbating injury. In this study, we investigate the benefit of DNase I treatment as a tool to degrade these complexes, aiming to ameliorate muscle ischemia-reperfusion injury.	[Albadawi, Hassan; Malley, Rita Elise Raacke; O'Keefe, Ryan M.; Uong, Thuy P.; Cormier, Nicholas R.; Watkins, Michael T.] Massachusetts Gen Hosp, Dept Surg, Div Vasc & Endovasc Surg, Boston, MA 02114 USA; [Oklu, Rahmi] Massachusetts Gen Hosp, Dept Radiol, Div Vasc Imaging & Intervent, Boston, MA 02114 USA; [Albadawi, Hassan; Oklu, Rahmi; Watkins, Michael T.] Harvard Med Sch, Boston, MA USA	Albadawi, H (corresponding author), Massachusetts Gen Hosp, Vasc Res Lab, Dept Surg, Div Vasc & Endovasc Surg, 70 Blossom St Edwards 301, Boston, MA 02114 USA.	halbadawi@partners.org		Albadawi, Hassan/0000-0001-5913-8571	NIAMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS) [R01 AR055843] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS) [R01AR055843] Funding Source: NIH RePORTER		Albadawi H, 2014, J SURG RES, V190, P683, DOI 10.1016/j.jss.2014.01.020; Allam R, 2014, J MOL MED, V92, P465, DOI 10.1007/s00109-014-1148-z; Allam R, 2013, EUR J IMMUNOL, V43, P3336, DOI 10.1002/eji.201243224; Allen C, 2012, J IMMUNOL, V189, P381, DOI 10.4049/jimmunol.1200409; Bareyre FM, 2001, J NEUROCHEM, V77, P173, DOI 10.1046/j.1471-4159.2001.t01-1-00215.x; Basnakian AG, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V1341000; Blaisdell FW, 2002, CARDIOVASC SURG, V10, P620, DOI 10.1016/S0967-2109(02)00070-4; Borissoff JI, 2013, ARTERIOSCL THROM VAS, V33, P2032, DOI 10.1161/ATVBAHA.113.301627; Brill A, 2012, J THROMB HAEMOST, V10, P136, DOI 10.1111/j.1538-7836.2011.04544.x; Buzder T, 2009, DNA CELL BIOL, V28, P435, DOI 10.1089/dna.2008.0850; Chow OA, 2010, CELL HOST MICROBE, V8, P445, DOI 10.1016/j.chom.2010.10.005; Crawford RS, 2007, AM J PHYSIOL-HEART C, V292, pH830, DOI 10.1152/ajpheart.00581.2006; De Meyer SF, 2012, ARTERIOSCL THROM VAS, V32, P1884, DOI 10.1161/ATVBAHA.112.250993; Enzmann G, 2013, ACTA NEUROPATHOL, V125, P395, DOI 10.1007/s00401-012-1076-3; Eulitz D, 2007, APOPTOSIS, V12, P1511, DOI 10.1007/s10495-007-0078-4; Fuchs TA, 2010, P NATL ACAD SCI USA, V107, P15880, DOI 10.1073/pnas.1005743107; HAGBERG H, 1985, PFLUG ARCH EUR J PHY, V404, P342, DOI 10.1007/BF00585346; Lam FW, 2013, THROMB RES, V132, P69, DOI 10.1016/j.thromres.2013.04.018; Liu FC, 2014, SHOCK, V41, P491, DOI 10.1097/SHK.0000000000000146; Macanovic M, 1997, CLIN EXP IMMUNOL, V108, P220, DOI 10.1046/j.1365-2249.1997.3571249.x; MALICKABLASZKIEWICZ M, 1990, Z NATURFORSCH C, V45, P1165; MANNHERZ HG, 1980, EUR J BIOCHEM, V104, P367, DOI 10.1111/j.1432-1033.1980.tb04437.x; Martinod K, 2013, P NATL ACAD SCI USA, V110, P8674, DOI 10.1073/pnas.1301059110; McCormack MC, 2008, SURGERY, V143, P126, DOI 10.1016/j.surg.2007.06.005; Oklu R, 2014, J VASC INTERV RADIOL, V25, P631, DOI 10.1016/j.jvir.2013.12.567; Oklu R, 2013, J VASC SURG, V58, P1627, DOI 10.1016/j.jvs.2013.02.241; Oklu R, 2012, J VASC INTERV RADIOL, V23, P712, DOI 10.1016/j.jvir.2012.01.072; Pisetsky DS, 2013, EUR J IMMUNOL, V43, P3163, DOI 10.1002/eji.201344175; Romero-Calvo I, 2010, ANAL BIOCHEM, V401, P318, DOI 10.1016/j.ab.2010.02.036; Savchenko AS, 2014, J THROMB HAEMOST, V12, P860, DOI 10.1111/jth.12571; Savchenko AS, 2014, BLOOD, V123, P141, DOI 10.1182/blood-2013-07-514992; SNABES MC, 1981, J BIOL CHEM, V256, P6291; Suri R, 2005, BIODRUGS, V19, P135, DOI 10.2165/00063030-200519030-00001; von Kockritz-Blickwede M, 2008, BLOOD, V111, P3070, DOI 10.1182/blood-2007-07-104018; Wildhagen KCAA, 2014, BLOOD, V123, P1098, DOI 10.1182/blood-2013-07-514984; Xu J, 2011, J IMMUNOL, V187, P2626, DOI 10.4049/jimmunol.1003930; Yao M, 1996, J MOL CELL CARDIOL, V28, P95, DOI 10.1006/jmcc.1996.0009; Yousefi S, 2008, NAT MED, V14, P949, DOI 10.1038/nm.1855	38	18	18	0	8	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0741-5214			J VASC SURG	J. Vasc. Surg.	AUG	2016	64	2					484	493		10.1016/j.jvs.2015.01.031			10	Surgery; Peripheral Vascular Disease	Surgery; Cardiovascular System & Cardiology	DS4LT	WOS:000380753300033	26704988	Green Accepted, Bronze			2021-06-18	
J	Jackson, CE; Green, JD; Bovin, MJ; Vasterling, JJ; Holowka, DW; Ranganathan, G; Rosen, RC; Keane, TM; Marx, BP				Jackson, Colleen E.; Green, Jonathan D.; Bovin, Michelle J.; Vasterling, Jennifer J.; Holowka, Darren W.; Ranganathan, Gayatri; Rosen, Raymond C.; Keane, Terence M.; Marx, Brian P.			Mild Traumatic Brain Injury, PTSD, and Psychosocial Functioning Among Male and Female US OEF/OIF Veterans	JOURNAL OF TRAUMATIC STRESS			English	Article							POSTTRAUMATIC-STRESS-DISORDER; ENDURING FREEDOM; NATIONAL-GUARD; HEALTH; AFGHANISTAN; IRAQ; ASSOCIATION; IMPAIRMENT; DISABILITY; OUTCOMES	This study examined the unique and combined relationship between mild traumatic brain injury (mTBI) and posttraumatic stress disorder (PTSD) with psychosocial functioning in a cohort of 1,312 U.S. male and female veterans of Operations Enduring Freedom (OEF) and Iraqi Freedom (OIF) enrolled in the Veterans After-Discharge Longitudinal Registry (Project VALOR). We assessed mTBI with structured screening questions reflective of current TBI classification standards and PTSD via the SCID-IV PTSD module; all other variables were assessed by self-report questionnaires. We identified significant diagnostic group differences in psychosocial functioning for both sexes. Individuals with PTSD, with or without a history of mTBI, reported significantly worse psychosocial functioning than individuals with mTBI alone or neither mTBI nor PTSD (males, (2)(p) = .11, p < .001; females, (2)(p) = .14, p < .001), even after adjusting for demographics and severity of chronic pain. The results suggested that veterans experiencing PTSD, regardless of whether they had a history of mTBI, were at increased risk for long-term psychosocial impairment. Further research examining possible benefits from improved access to resources and treatment to address these needs would be valuable. Resumen Este estudio examino la relacion unica y combinada entre la lesion cerebral traumatica leve (LCTL) y trastorno por estres postraumatico (TEPT) con el funcionamiento psicosocial en una cohorte de 1.312 hombres y mujeres veteranos de las operaciones Enduring Freedom (OEF) y Libertad Iraqui (OIF) inscritos en el Registro Longitudinal de Veteranos despues de descargos (Proyecto VALOR). Se evaluo LCTL con preguntas de screening estructuradas que reflejan los criterios de clasificacion de LCT actual y trastorno por estres postraumatico a traves del modulo de TEPT SCID-IV; todas las demas variables se evaluaron mediante cuestionarios de auto-reporte. Se identificaron diferencias significativas entre los grupos de diagnostico en el funcionamiento psicosocial para ambos sexos, de tal manera que las personas con trastorno de estres postraumatico, con o sin historial de LCTL, reportaron significativamente peor funcionamiento psicosocial en comparacion con los individuos con LCTL solo o los que no tenian LCTL ni trastorno por estres postraumatico (hombres, 2 p = 0,11, p <0,001; mujeres, 2 p = 0,14, p <0,001), incluso despues de ajustar las variables demograficas y la severidad del dolor cronico. Los resultados sugieren que los veteranos que experimentan trastorno por estres postraumatico, independientemente de si tenian un historial de LCTL, estaban en mayor riesgo de deterioro psicosocial a largo plazo. Futuras investigaciones que examinen los posibles beneficios de un acceso mejorado a los recursos y el tratamiento para dirigir estas necesidades serian valiosas.	[Jackson, Colleen E.] VA Boston Healthcare Syst, Geriatr Res Educ & Clin Ctr GRECC, Boston, MA USA; [Jackson, Colleen E.] VA Boston Healthcare Syst, Translat Res Ctr TBI & Stress Disorders TRACTS, Boston, MA USA; [Jackson, Colleen E.; Green, Jonathan D.; Bovin, Michelle J.; Vasterling, Jennifer J.; Holowka, Darren W.; Keane, Terence M.; Marx, Brian P.] Boston Univ, Sch Med, Dept Psychiat, Boston, MA 02118 USA; [Green, Jonathan D.] VA Boston Healthcare Syst, Res Serv, Boston, MA USA; [Bovin, Michelle J.; Vasterling, Jennifer J.; Holowka, Darren W.; Keane, Terence M.; Marx, Brian P.] VA Boston Healthcare Syst, Behav Sci Div, Natl Ctr PTSD, Boston, MA USA; [Ranganathan, Gayatri; Rosen, Raymond C.] New England Res Inst, 9 Galen St, Watertown, MA 02172 USA	Marx, BP (corresponding author), VA Boston Healthcare Syst 116B 4, Natl Ctr PTSD, Behav Sci Div, 150 South Huntington Ave, Boston, MA 02130 USA.	brian.marx@va.gov	Marx, Brian/AAK-5072-2020; Keane, Terence/I-8253-2014	Keane, Terence/0000-0002-0482-3149; Bovin, Michelle/0000-0002-3296-4360			Alosco ML, 2016, J HEAD TRAUMA REHAB, V31, P360, DOI 10.1097/HTR.0000000000000201; Association AP., 2000, DIAGNOSTIC STAT MANU, V4th; Bazarian JJ, 2010, J NEUROTRAUM, V27, P527, DOI 10.1089/neu.2009.1068; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P262, DOI 10.1017/S1355617709991287; Bergman S, 2005, DISABIL REHABIL, V27, P675, DOI 10.1080/09638280400009030; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Evans VC, 2014, J CLIN PSYCHIAT, V75, P1359, DOI 10.4088/JCP.13r08939; Fang SC, 2015, J WOMENS HEALTH, V24, P1038, DOI 10.1089/jwh.2014.5096; Goldberg J, 2014, QUAL LIFE RES, V23, P1579, DOI 10.1007/s11136-013-0585-4; Hanlon RE, 1999, BRAIN INJURY, V13, P873; Hayward P, 2008, LANCET NEUROL, V7, P200, DOI 10.1016/S1474-4422(08)70032-2; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Holowka D.W., 2012, OXFORD HDB TRAUMATIC, P315, DOI [10.1093/oxfordhb/9780195399066.013.0021, DOI 10.1093/OXFORDHB/9780195399066.013.0021]; Kay T., 1993, J HEAD TRAUMA REHABI, V8, P86, DOI [10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Lippa SM, 2015, J TRAUMA STRESS, V28, P25, DOI 10.1002/jts.21979; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; Marx B. P., 2013, DEV VALIDATION PTSD; Marx B. P., 2009, 25 ANN M INT SOC TRA; Marx BP, 2015, PSYCHIAT SERV, V66, P1312, DOI 10.1176/appi.ps.201400400; Pietrzak RH, 2009, J NERV MENT DIS, V197, P748, DOI 10.1097/NMD.0b013e3181b97a75; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Raggi A, 2012, J HEADACHE PAIN, V13, P595, DOI 10.1007/s10194-012-0482-1; Rodriguez P, 2012, J REHABIL RES DEV, V49, P649, DOI 10.1682/JRRD.2011.09.0162; Rohling ML, 2011, CLIN NEUROPSYCHOL, V25, P608, DOI 10.1080/13854046.2011.565076; Romesser J, 2012, J REHABIL RES DEV, V49, P1127, DOI 10.1682/JRRD.2010.12.0238; Rosen RC, 2012, INT J METH PSYCH RES, V21, P5, DOI 10.1002/mpr.355; Schiehser DM, 2015, J HEAD TRAUMA REHAB, V30, pE21, DOI 10.1097/HTR.0000000000000065; Schnurr PP, 2009, CLIN PSYCHOL REV, V29, P727, DOI 10.1016/j.cpr.2009.08.006; Shea MT, 2010, J TRAUMA STRESS, V23, P100, DOI 10.1002/jts.20497; SPITZER RL, 1992, ARCH GEN PSYCHIAT, V49, P624; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Tanielian T, 2008, INVISIBLE WOUNDS WAR; U.S. Department of Defense Task Force on Mental Health, 2007, ACH VIS REP DEP DEF; U.S. Department of Veterans Affairs, 2010, VHA DIR 2010 012 SCR; U.S. Department of Veterans Affairs, 2015, AN VA HLTH CARE UT O; Vanderploeg RD, 2007, J CLIN EXP NEUROPSYC, V29, P585, DOI 10.1080/13803390600826587; Vasterling JJ, 2012, BRIT J PSYCHIAT, V201, P186, DOI 10.1192/bjp.bp.111.096461; Walker WC, 2015, BRAIN INJURY, V29, P1581, DOI 10.3109/02699052.2015.1075151; Wisco BE, 2014, J TRAUMA STRESS, V27, P244, DOI 10.1002/jts.21900	39	18	18	0	21	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0894-9867	1573-6598		J TRAUMA STRESS	J. Trauma Stress	AUG	2016	29	4					309	316		10.1002/jts.22110			8	Psychology, Clinical; Psychiatry	Psychology; Psychiatry	DW2MW	WOS:000383477500004	27405050				2021-06-18	
J	Liu, F; Chen, MR; Liu, J; Zou, Y; Wang, TY; Zuo, YX; Wang, TH				Liu, Fei; Chen, Mei-Rong; Liu, Jia; Zou, Yu; Wang, Ting-Yong; Zuo, Yun-Xia; Wang, Ting-Hua			Propofol administration improves neurological function associated with inhibition of pro-inflammatory cytokines in adult rats after traumatic brain injury	NEUROPEPTIDES			English	Article						Traumatic brain injury; Neuroprotection; Propofol; Pro-inflammatory cytokine	CEREBRAL-ISCHEMIA; EXPRESSION; EPIDEMIOLOGY; CELLS; PATHOPHYSIOLOGY; PHARMACOLOGY; EDEMA	Background: Neurological deficits following traumatic brain injury (TBI) result in dramatic impacts on the survivors, but the effect of propofol and associated mechanism are waiting to be determined. Methods: Adult male Sprague-Dawley rats were randomly assigned into Sham, TBI, TBI + Intralipid and TBI + Propofol group. Modified Feeney method was adopted to generate TBI model from free hammer fall injury, and animals in TBI + Propofol group were immediately treated with propofol administration for 2 hours after TBI, rats after TBI without propofol treatment was used as injury control, intralipid as vehicle in propofol was injected in TBI + intralipid group. Then, neurological severity scores (NSS) were evaluated at 1, 3, 7 and 14 days. Moreover, the expressions of IL-1 beta, IL-6 and TNF-alpha mRNA and protein were examined using quantitative real time-polymerase chain reaction and Western blot, immunohistochemical staining was used to localize cytokines. Results: The NSS increased greatly in the rats induced by TBI, while propofol could effectively decreased NSS, confirming the neuroprotective effect of propofol. Moreover, the mRNA expressions of IL-1 beta, IL-6 and TNF-alpha, at 1, 3, 7 days after operation (dpo), were significantly augmented in the injured cortex, compared with sham one. But there was no difference between TBI and TBI + Intralipid group, but markedly decreased after propofol treatment. Additionally, the protein level of IL-1 beta, IL-6 and TNF-alpha in four groups determined by Western blot and immunohistochemistry showed the similar change with mRNA expression. Conclusion: Propofol treatment could elicit a robust neuroprotective response, resulting in significant neurological function improvement for TBI rats, which was independent with intralipid. The underlying molecular mechanism may be partially associated with an inhibition of pro-inflammatory cytoldnes. (C) 2016 Elsevier Ltd. All rights reserved.	[Liu, Fei; Zuo, Yun-Xia] Sichuan Univ, West China Hosp, Dept Anesthesiol, Chengdu, Sichuan Provinc, Peoples R China; [Chen, Mei-Rong; Liu, Jia; Zou, Yu; Wang, Ting-Hua] Kunming Med Univ, Inst Neurosci, Kunming 650031, Peoples R China; [Wang, Ting-Hua] Sichuan Univ, Inst Neurol Dis, West China Hosp, Translat Neurosci Ctr, Chengdu 610041, Peoples R China	Zuo, YX (corresponding author), Sichuan Univ, West China Hosp, Dept Anesthesiol, Chengdu, Sichuan Provinc, Peoples R China.; Wang, TH (corresponding author), Sichuan Univ, Inst Neurol Dis, West China Hosp, Translat Neurosci Ctr, Chengdu 610041, Peoples R China.	zuoyunxiahx@qq.com; tinghua_neuron@263.net					Andelic N, 2013, LANCET NEUROL, V12, P28, DOI 10.1016/S1474-4422(12)70294-6; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Chui J, 2014, CAN J ANESTH, V61, P347, DOI 10.1007/s12630-014-0118-9; Cordaro M., 2014, J NEUROTRAUMA; Cuthbert J.P., 2014, J HEAD TRAUMA REHABI; Ding ZY, 2013, CELL BIOCHEM BIOPHYS, V67, P615, DOI 10.1007/s12013-013-9549-0; FULTON B, 1995, DRUGS, V50, P636, DOI 10.2165/00003495-199550040-00006; Goodman JC, 2008, ACTA NEUROCHIR SUPPL, V102, P437, DOI 10.1007/978-3-211-85578-2_85; Gubata ME, 2014, J HEAD TRAUMA REHAB, V29, P65, DOI 10.1097/HTR.0b013e318295f590; Harting MT, 2008, SURGERY, V144, P803, DOI 10.1016/j.surg.2008.05.017; He BL, 2013, NEUROPEPTIDES, V47, P1, DOI 10.1016/j.npep.2012.06.001; Kabadi SV, 2014, INT J MOL SCI, V15, P1216, DOI 10.3390/ijms15011216; Kotani Y, 2008, CNS NEUROSCI THER, V14, P95, DOI 10.1111/j.1527-3458.2008.00043.x; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; Luo T, 2013, ANESTHESIOLOGY, V119, P1370, DOI 10.1097/ALN.0000000000000020; Mauritz W, 2014, WIEN KLIN WOCHENSCHR, V126, P42, DOI 10.1007/s00508-013-0456-6; Nimmo AJ, 2004, NEUROPEPTIDES, V38, P40, DOI 10.1016/j.npep.2003.12.003; Prins M, 2013, DIS MODEL MECH, V6, P1307, DOI 10.1242/dmm.011585; Scholten AC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110905; Shi SS, 2014, NEUROCHEM RES, V39, P793, DOI 10.1007/s11064-014-1272-8; Thal SC, 2014, CRIT CARE MED, V42, P129, DOI 10.1097/CCM.0b013e3182a639fd; Vasileiou I, 2009, EUR J PHARMACOL, V605, P1, DOI 10.1016/j.ejphar.2009.01.007; White TE, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-282; Xi HJ, 2011, BRAIN RES, V1410, P24, DOI 10.1016/j.brainres.2011.06.060; Yisarakun W, 2015, NEUROPEPTIDES, V51, P9, DOI 10.1016/j.npep.2015.03.008; Yu GX, 2011, SURGERY, V150, P887, DOI 10.1016/j.surg.2011.04.002; Zhang R, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-106; Zhou R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082729; Zhu HT, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-59; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	31	18	19	0	7	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0143-4179	1532-2785		NEUROPEPTIDES	Neuropeptides	AUG	2016	58						1	6		10.1016/j.npep.2016.03.004			6	Endocrinology & Metabolism; Neurosciences	Endocrinology & Metabolism; Neurosciences & Neurology	DU7SI	WOS:000382414500001	27045803				2021-06-18	
J	Wei, X; Hu, CC; Zhang, YL; Yao, SL; Mao, WK				Wei, Xin; Hu, Chen-chen; Zhang, Ya-li; Yao, Shang-long; Mao, Wei-ke			Telmisartan reduced cerebral edema by inhibiting NLRP3 inflammasome in mice with cold brain injury	JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY-MEDICAL SCIENCES			English	Article						telmisartan; traumatic brain injury; cerebral edema; NLRP3 inflammasome; inflammation	RECEPTOR ANTAGONIST TELMISARTAN; INTRACEREBRAL HEMORRHAGE; OXIDATIVE STRESS; ISCHEMIC-STROKE; ANGIOTENSIN-II; PPAR-GAMMA; RAT MODEL; INTERLEUKIN-1-BETA; TRAUMA; PATHOGENESIS	The aim of this study was to investigate the possible beneficial role of telmisartan in cerebral edema after traumatic brain injury (TBI) and the potential mechanisms related to the nucleotide-binding oligomerization domain (NOD)-like receptor (NLR) pyrin domain-containing 3 (NLRP3) inflammasome activation. TBI model was established by cold-induced brain injury. Male C57BL/6 mice were randomly assigned into 3, 6, 12, 24, 48 and 72 h survival groups to investigate cerebral edema development with time and received 0, 5, 10, 20 and 40 mg/kg telmisartan by oral gavage, 1 h prior to TBI to determine the efficient anti-edemic dose. The therapeutic window was identified by post-treating 30 min, 1 h, 2 h and 4 h after TBI. Blood-brain barrier (BBB) integrity, the neurological function and histological injury were assessed, at the same time, the mRNA and protein expression levels of NLRP3 inflammasome, IL-1 beta and IL-18 concentrations in peri-contused brain tissue were measured 24 h post TBI. The results showed that the traumatic cerebral edema occurred from 6 h, reached the peak at 24 h and recovered to the baseline 72 h after TBI. A single oral dose of 5, 10 and 20 mg/kg telmisartan could reduce cerebral edema. Post-treatment up to 2 h effectively limited the edema development. Furthermore, prophylactic administration of telmisartan markedly inhibited BBB impairment, NLRP3, apoptotic speck-containing protein (ASC) and Caspase-1 activation, as well as IL-1 beta and IL-18 maturation, subsequently improved the neurological outcomes. In conclusion, telmisartan can reduce traumatic cerebral edema by inhibiting the NLRP3 inflammasome-regulated IL-1 beta and IL-18 accumulation.	[Wei, Xin; Hu, Chen-chen; Zhang, Ya-li; Yao, Shang-long; Mao, Wei-ke] Huazhong Univ Sci & Technol, Union Hosp, Dept Anesthesiol, Tongji Med Coll, Wuhan 430022, Peoples R China	Mao, WK (corresponding author), Huazhong Univ Sci & Technol, Union Hosp, Dept Anesthesiol, Tongji Med Coll, Wuhan 430022, Peoples R China.	1004500126@qq.com; mweike@163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81270239]; Natural Science Foundation of Hubei Province of ChinaNatural Science Foundation of Hubei Province [2014CFB200]	This project was supported by grants from the National Natural Science Foundation of China (No. 81270239) and the Natural Science Foundation of Hubei Province of China (No. 2014CFB200).	Abdul-Muneer PM, 2015, MOL NEUROBIOL, V51, P966, DOI 10.1007/s12035-014-8752-3; Alves JL, 2014, J NEUROSCI RES, V92, P141, DOI 10.1002/jnr.23300; Billecke SS, 2013, VASC HEALTH RISK MAN, V9, P95, DOI 10.2147/VHRM.S40963; Chiaretti A, 2005, CHILD NERV SYST, V21, P185, DOI 10.1007/s00381-004-1032-1; Clausen F, 2009, EUR J NEUROSCI, V30, P385, DOI 10.1111/j.1460-9568.2009.06820.x; Fann DYW, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.326; Garrido-Gil P, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-38; Gohlke P, 2001, J PHARMACOL EXP THER, V298, P62; Hayakata T, 2004, SHOCK, V22, P102, DOI 10.1097/01.shk.0000131193.80038.f1; Hu XM, 2012, STROKE, V43, P3063, DOI 10.1161/STROKEAHA.112.659656; Huang LQ, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-102; Jones NC, 2005, EUR J NEUROSCI, V22, P72, DOI 10.1111/j.1460-9568.2005.04221.x; Jung KH, 2007, J PHARMACOL EXP THER, V322, P1051, DOI 10.1124/jpet.107.120097; Kahle KT, 2013, J CLIN NEUROSCI, V20, P30, DOI 10.1016/j.jocn.2012.10.004; Kaushal V, 2015, CELL DEATH DIFFER, V22, P1676, DOI 10.1038/cdd.2015.16; Kimbler DE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041229; Kono S, 2015, J STROKE CEREBROVASC, V24, P537, DOI 10.1016/j.jstrokecerebrovasdis.2014.09.037; Liu HD, 2013, NEUROCHEM RES, V38, P2072, DOI 10.1007/s11064-013-1115-z; Ma QY, 2014, ANN NEUROL, V75, P209, DOI 10.1002/ana.24070; Michinaga S, 2015, INT J MOL SCI, V16, P9949, DOI 10.3390/ijms16059949; Morita-Fujimura Y, 1999, NEUROSCIENCE, V93, P1465, DOI 10.1016/S0306-4522(99)00231-6; Panahpour H, 2014, IRAN J MED SCI, V39, P536; Panahpour Hamdollah, 2014, Iranian Biomedical Journal, V18, P232, DOI 10.6091/ibj.13672.2014; Pang T, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-102; Shiozaki T, 2005, SHOCK, V23, P406, DOI 10.1097/01.shk.0000161385.62758.24; Tan CC, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-014-0233-0; Tehranian R, 2002, J NEUROTRAUM, V19, P939, DOI 10.1089/089771502320317096; Timaru-Kast R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043829; Timaru-Kast R, 2012, CRIT CARE MED, V40, P935, DOI 10.1097/CCM.0b013e31822f08b9; V H Pushpa, 2014, J Clin Diagn Res, V8, pHC08, DOI 10.7860/JCDR/2014/9455.5061; Villapol S, 2015, BRAIN, V138, DOI 10.1093/brain/awv172; Wang J, 2014, NEUROPHARMACOLOGY, V79, P249, DOI 10.1016/j.neuropharm.2013.11.022; Yang Z, 2015, MOL IMMUNOL, V65, P267, DOI 10.1016/j.molimm.2014.12.018; Zeynalov E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136121; Zhang B, 2015, KOREAN J PHYSIOL PHA, V19, P491, DOI 10.4196/kjpp.2015.19.6.491	35	18	18	0	4	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1672-0733	1993-1352		J HUAZHONG U SCI-MED	J. Huazhong Univ. Sci. Tech.-Med.	AUG	2016	36	4					576	583		10.1007/s11596-016-1628-1			8	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	DS3ZA	WOS:000380720000018	27465336				2021-06-18	
J	Meier, TB; Savitz, J; Singh, R; Teague, TK; Bellgowan, PSF				Meier, Timothy B.; Savitz, Jonathan; Singh, Rashmi; Teague, T. Kent; Bellgowan, Patrick S. F.			Smaller Dentate Gyrus and CA2 and CA3 Volumes Are Associated with Kynurenine Metabolites in Collegiate Football Athletes	JOURNAL OF NEUROTRAUMA			English	Article						concussion; football; hippocampus; kynurenine pathway; mTBI	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; MAJOR DEPRESSIVE DISORDER; QUINOLINIC ACID; HIPPOCAMPAL SUBFIELDS; OXIDATIVE STRESS; IN-VIVO; PATHWAY; RAT; 3-HYDROXYKYNURENINE	An imbalance in kynurenine pathway metabolism is hypothesized to be associated with dysregulated glutamatergic neurotransmission, which has been proposed as a mechanism underlying the hippocampal volume loss observed in a variety of neurological disorders. Pre-clinical models suggest that the CA2-3 and dentate gyrus hippocampal subfields are particularly susceptible to excitotoxicity after experimental traumatic brain injury. We tested the hypothesis that smaller hippocampal volumes in collegiate football athletes with (n = 25) and without (n = 24) a concussion history would be most evident in the dentate gyrus and CA2-3 subfields relative to nonfootball healthy controls (n = 27). Further, we investigated whether the concentration of peripheral levels of kynurenine metabolites are altered in football athletes. Football athletes with and without a self-reported concussion history had smaller dentate gyrus (p < 0.05, p < 0.10) and CA2-3 volumes (p's < 0.05) relative to healthy controls. Football athletes with and without a concussion history had a trend toward lower (p < 0.10) and significantly lower (p < 0.05) kynurenine levels compared with healthy controls, while athletes with a concussion history had greater levels of quinolinic acid compared with athletes without a concussion history (p < 0.05). Finally, plasma levels of 3-hydroxykynurenine inversely correlated with bilateral hippocampal volumes in football athletes with a concussion history (p < 0.01), and left hippocampal volume was correlated with the ratio of kynurenic acid to quinolinic acid in football athletes without a concussion history (p < 0.05). Our results raise the possibility that abnormalities of the kynurenine metabolic pathway constitute a mechanism for hippocampal volume differences in the context of sports-related brain injury.	[Meier, Timothy B.] Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA; [Meier, Timothy B.; Savitz, Jonathan; Singh, Rashmi] Laureate Inst Brain Res, Tulsa, OK USA; [Savitz, Jonathan] Univ Tulsa, Fac Community Med, Tulsa, OK 74104 USA; [Teague, T. Kent] Univ Oklahoma, Coll Med, Dept Surg, Tulsa, OK USA; [Teague, T. Kent] Univ Oklahoma, Coll Med, Dept Psychiat, Tulsa, OK USA; [Teague, T. Kent] Univ Oklahoma, Coll Pharm, Dept Pharmaceut Sci, Tulsa, OK USA; [Teague, T. Kent] Oklahoma State Univ, Ctr Hlth Sci, Dept Biochem & Microbiol, Tulsa, OK USA; [Bellgowan, Patrick S. F.] NINDS, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA	Meier, TB (corresponding author), Med Coll Wisconsin, Neurosci Res Ctr, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	tmeier@mcw.edu	Teague, T. Kent/A-2527-2008; Savitz, Jonathan/C-3088-2009	Teague, T. Kent/0000-0002-4680-5440; Savitz, Jonathan/0000-0001-8143-182X			Agudelo LZ, 2014, CELL, V159, P33, DOI 10.1016/j.cell.2014.07.051; Amaral M, 2013, J MOL MED, V91, P705, DOI 10.1007/s00109-013-1046-9; Baldwin SA, 1997, J NEUROTRAUM, V14, P385, DOI 10.1089/neu.1997.14.385; Bay-Richter C, 2015, BRAIN BEHAV IMMUN, V43, P110, DOI 10.1016/j.bbi.2014.07.012; Bell MJ, 1999, CRIT CARE MED, V27, P493, DOI 10.1097/00003246-199903000-00023; Blaylock Russell L, 2011, Surg Neurol Int, V2, P107, DOI 10.4103/2152-7806.83391; BLIGHT AR, 1993, BRAIN RES, V632, P314, DOI 10.1016/0006-8993(93)91167-Q; Boen E, 2014, J PSYCHIATR NEUROSCI, V39, P127, DOI 10.1503/jpn.130070; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; FUKUI S, 1991, J NEUROCHEM, V56, P2007, DOI 10.1111/j.1471-4159.1991.tb03460.x; Gabbay V, 2010, PROG NEURO-PSYCHOPH, V34, P37, DOI 10.1016/j.pnpbp.2009.09.015; Grady MS, 2003, J NEUROTRAUM, V20, P929, DOI 10.1089/089771503770195786; Guidetti P, 1999, EUR J NEUROSCI, V11, P3857, DOI 10.1046/j.1460-9568.1999.00806.x; Guillemin GJ, 2003, ADV EXP MED BIOL, V527, P105; HICKS RR, 1993, J NEUROTRAUM, V10, P405, DOI 10.1089/neu.1993.10.405; HICKS RR, 1994, BRAIN RES, V655, P91, DOI 10.1016/0006-8993(94)91601-2; Kawakami R, 2003, SCIENCE, V300, P990, DOI 10.1126/science.1082609; Kraemer WJ, 2005, J STRENGTH COND RES, V19, P485; Colin-Gonzalez AL, 2013, NEUROTOXICOLOGY, V34, P189, DOI 10.1016/j.neuro.2012.11.007; Liu YT, 2007, J NEUROSCI, V27, P2846, DOI 10.1523/JNEUROSCI.0116-07.2007; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; Lugo-Huitron R, 2011, NEUROTOXICOL TERATOL, V33, P538, DOI 10.1016/j.ntt.2011.07.002; Mackay GM, 2006, EUR J NEUROL, V13, P30, DOI 10.1111/j.1468-1331.2006.01220.x; McAllister TW, 2014, NEUROLOGY, V82, P63, DOI 10.1212/01.wnl.0000438220.16190.42; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; Meier T. B., 2015, J NEUROTRAUMA; Ode JJ, 2007, MED SCI SPORT EXER, V39, P403, DOI 10.1249/01.mss.0000247008.19127.3e; Okuda S, 1998, J NEUROCHEM, V70, P299; PERKINS MN, 1982, BRAIN RES, V247, P184, DOI 10.1016/0006-8993(82)91048-4; Sandhir R, 2008, EXP NEUROL, V213, P372, DOI 10.1016/j.expneurol.2008.06.013; Savitz J, 2015, PSYCHONEUROENDOCRINO, V62, P54, DOI 10.1016/j.psyneuen.2015.07.609; Savitz J, 2015, PSYCHONEUROENDOCRINO, V52, P200, DOI 10.1016/j.psyneuen.2014.11.015; Savitz J, 2015, NEUROPSYCHOPHARMACOL, V40, P463, DOI 10.1038/npp.2014.194; SCHWARCZ R, 1983, SCIENCE, V219, P316, DOI 10.1126/science.6849138; Schwarcz R, 2012, NAT REV NEUROSCI, V13, P465, DOI 10.1038/nrn3257; Schwarz MJ, 2013, EUR ARCH PSY CLIN N, V263, P345, DOI 10.1007/s00406-012-0384-x; Shinohara Y, 2008, P NATL ACAD SCI USA, V105, P19498, DOI 10.1073/pnas.0807461105; Singh R., 2015, J NEUROL NEUROSURG P; Singh R, 2014, JAMA-J AM MED ASSOC, V311, P1883, DOI 10.1001/jama.2014.3313; Sinz EH, 1998, J CEREBR BLOOD F MET, V18, P610, DOI 10.1097/00004647-199806000-00002; SMITH DH, 1994, NEUROSCI LETT, V168, P151, DOI 10.1016/0304-3940(94)90438-3; SMITH DH, 1993, J NEUROSCI, V13, P5383; Stein MB, 1997, PSYCHOL MED, V27, P951, DOI 10.1017/S0033291797005242; Steiner J, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-94; Stone TW, 2013, BRIT J PHARMACOL, V169, P1211, DOI 10.1111/bph.12230; Suma T, 2008, NEUROL RES, V30, P420, DOI 10.1179/016164107X251745; Teicher MH, 2012, P NATL ACAD SCI USA, V109, pE563, DOI 10.1073/pnas.1115396109; Van Leemput K, 2009, HIPPOCAMPUS, V19, P549, DOI 10.1002/hipo.20615; Wang Z, 2010, ARCH GEN PSYCHIAT, V67, P296, DOI 10.1001/archgenpsychiatry.2009.205; Wierenga L, 2014, NEUROIMAGE, V96, P67, DOI 10.1016/j.neuroimage.2014.03.072; Zierhut KC, 2013, BRAIN, V136, P804, DOI 10.1093/brain/aws335	51	18	18	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL 15	2016	33	14					1349	1357		10.1089/neu.2015.4118			9	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	DQ5CX	WOS:000379223100006	26493952	Green Published			2021-06-18	
J	Skovira, JW; Kabadi, SV; Wu, JF; Zhao, ZR; DuBose, J; Rosenthal, R; Fiskum, G; Faden, AI				Skovira, Jacob W.; Kabadi, Shruti V.; Wu, Junfang; Zhao, Zaorui; DuBose, Joseph; Rosenthal, Robert; Fiskum, Gary; Faden, Alan I.			Simulated Aeromedical Evacuation Exacerbates Experimental Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						aeromedical evacuation; hypobaria; inflammation; neuronal cell death; traumatic brain injury	LIMITS MICROGLIAL ACTIVATION; NEUROINFLAMMATORY RESPONSE; IRAQI FREEDOM; NEURONAL LOSS; TRAUMA; NEURODEGENERATION; INFLAMMATION; ASSOCIATION; HYPEROXIA; OXYGEN	Aeromedical evacuation, an important component in the care of many patients with traumatic brain injury (TBI), particularly in war zones, exposes them to prolonged periods of hypobaria. The effects of such exposure on pathophysiological changes and outcome after TBI are largely unexplored. The objective of this study was to investigate whether prolonged hypobaria in rats subjected to TBI alters behavioral and histological outcomes. Adult male Sprague-Dawley rats underwent fluid percussion induced injury at 1.5-1.9 atmospheres of pressure. The effects of hypobaric exposure (6 h duration; equivalent to 0.75 atmospheres) at 6, 24, and 72 h, or 7 days after TBI were evaluated with regard to sensorimotor, cognitive, and histological changes. Additional groups were evaluated to determine the effects of two hypobaric exposures after TBI, representing primary simulated aeromedical evacuation (6 h duration at 24 h after injury) and secondary evacuation (10 h duration at 72 h after injury), as well as the effects of 100% inspired oxygen concentrations during simulated evacuation. Hypobaric exposure up to 7 days after injury significantly worsened cognitive deficits, hippocampal neuronal loss, and microglial/astrocyte activation in comparison with injured controls not exposed to hypobaria. Hyperoxia during hypobaric exposure or two exposures to prolonged hypobaric conditions further exacerbated spatial memory deficits. These findings indicate that exposure to prolonged hypobaria up to 7 days after TBI, even while maintaining physiological oxygen concentration, worsens long-term cognitive function and neuroinflammation. Multiple exposures or use of 100% oxygen further exacerbates these pathophysiological effects.	[Skovira, Jacob W.; Kabadi, Shruti V.; Wu, Junfang; Zhao, Zaorui; Fiskum, Gary; Faden, Alan I.] Univ Maryland, Sch Med, Dept Anesthesiol, Ctr Shock Trauma & Anesthesiol Res STAR, Baltimore, MD 21201 USA; [DuBose, Joseph] Univ Maryland, Sch Med, Program Trauma, Ctr Sustainment Trauma & Readiness Skills C STARS, Baltimore, MD 21201 USA; [Rosenthal, Robert] Univ Maryland, Sch Med, Dept Emergency Med, Baltimore, MD 21201 USA	Faden, AI (corresponding author), Univ Maryland, Sch Med, Dept Anesthesiol, Hlth Sci Facil HSFII 2, S247 20 Penn St, Baltimore, MD 21201 USA.; Faden, AI (corresponding author), Univ Maryland, Sch Med, Dept Anat & Neurobiol, Hlth Sci Facil HSFII 2, S247 20 Penn St, Baltimore, MD 21201 USA.; Faden, AI (corresponding author), Univ Maryland, Sch Med, Dept Neurosurg, Hlth Sci Facil HSFII 2, S247 20 Penn St, Baltimore, MD 21201 USA.; Faden, AI (corresponding author), Univ Maryland, Sch Med, Dept Neurol, Hlth Sci Facil HSFII 2, S247 20 Penn St, Baltimore, MD 21201 USA.	afaden@anes.umm.edu		Faden, Alan I./0000-0003-0128-2348			Antunes M, 2012, COGN PROCESS, V13, P93, DOI 10.1007/s10339-011-0430-z; BORSINI F, 1988, PSYCHOPHARMACOLOGY, V94, P147; Brenner M, 2012, ARCH SURG-CHICAGO, V147, P1042, DOI 10.1001/archsurg.2012.1560; Bridges E, 2010, AACN ADV CRIT CARE, V21, P260, DOI 10.1097/NCI.0b013e3181e67385; Bridges E, 2009, MIL MED, V174, P370, DOI 10.7205/MILMED-D-03-9607; Byrnes KR, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-43; Fang R, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.2.FOCUS1043; Gentleman SM, 2004, FORENSIC SCI INT, V146, P97, DOI 10.1016/j.forsciint.2004.06.027; Goodman MD, 2011, J SURG RES, V165, P30, DOI 10.1016/j.jss.2010.05.055; Hilton GD, 2008, J CEREBR BLOOD F MET, V28, P1845, DOI 10.1038/jcbfm.2008.75; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Kabadi SV, 2014, J CEREBR BLOOD F MET, V34, P502, DOI 10.1038/jcbfm.2013.228; Kabadi SV, 2010, NAT PROTOC, V5, P1552, DOI 10.1038/nprot.2010.112; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Liu YB, 1998, STROKE, V29, P1679, DOI 10.1161/01.STR.29.8.1679; Loane DJ, 2014, J NEUROPATH EXP NEUR, V73, P14, DOI 10.1097/NEN.0000000000000021; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Luo T, 2013, ANESTHESIOLOGY, V119, P1370, DOI 10.1097/ALN.0000000000000020; Nagamoto-Combs K, 2007, J NEUROTRAUM, V24, P1719, DOI 10.1089/neu.2007.0377; Nangunoori R, 2012, NEUROCRIT CARE, V17, P131, DOI 10.1007/s12028-011-9621-9; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Redish AD, 1998, NEURAL COMPUT, V10, P73, DOI 10.1162/089976698300017908; Reno J, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.2.FOCUS1023; Rincon F, 2014, J NEUROL NEUROSUR PS, V85, P799, DOI 10.1136/jnnp-2013-305505; Rosenthal RE, 2005, HOSP MED, V66, P76; Smith C, 2013, NEUROPATH APPL NEURO, V39, P654, DOI 10.1111/nan.12008; Smith C, 2013, NEUROPATH APPL NEURO, V39, P35, DOI 10.1111/nan.12006; Wu JF, 2013, NEUROTHERAPEUTICS, V10, P520, DOI 10.1007/s13311-013-0198-1	30	18	18	0	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL 15	2016	33	14					1292	1302		10.1089/neu.2015.4189			11	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	DQ5CX	WOS:000379223100002	26593382				2021-06-18	
J	Zhang, HS; Li, H; Zhang, DD; Yan, HY; Zhang, ZH; Zhou, CH; Ye, ZN; Chen, Q; Jiang, TW; Liu, JP; Hang, CH				Zhang, Hua-Sheng; Li, Hua; Zhang, Ding-Ding; Yan, Hui-Ying; Zhang, Zi-Huan; Zhou, Chen-Hui; Ye, Zhen-Nan; Chen, Qiang; Jiang, Tian-Wei; Liu, Jing-Peng; Hang, Chun-Hua			Inhibition of myeloid differentiation factor 88(MyD88) by ST2825 provides neuroprotection after experimental traumatic brain injury in mice	BRAIN RESEARCH			English	Article						Myeloid differentiation factor 88; Traumatic brain injury; Apoptosis; ST2825	CLOSED-HEAD INJURY; PROTEIN 88 MYD88; FACTOR-KAPPA-B; SIGNALING PATHWAYS; RATS; EXPRESSION; INFLAMMATION; RECRUITMENT; ACTIVATION; RECEPTORS	Myeloid differentiation factor 88(MyD88) is an endogenous adaptor protein that plays an important role in coordinating intracellular inflammatory responses induced by agonists of the Toll-like receptor and interleukin-1 receptor families. MyD88 has been reported to be essential for neuronal death in animal models and may represent a therapeutic target for pharmacologic inhibition following traumatic brain injury (TBI). The purpose of the current study was to investigate the neuroprotective effect of MyD88 specific inhibitor ST2825 in an experimental mouse model of TBI. Intracerebroventricular (ICV) injection of high concentration (20 mu g/mu L) ST2825 (15 min post TBI) attenuated the development of TBI in mice, markedly improved neurological function and reduced brain edema. Decreased neural apoptosis and increased neuronal survival were also observed. Biochemically, the high concentration of ST2825 significantly reduced the levels of MyD88, further decreased TAK1, p-TAK1, nuclear p65 and increased I kappa B-alpha. Additionally, ST2825 significantly reduced the levels of Iba-1 and inflammatory factors TNF-alpha and IL-1 beta. These data provide an experimental rationale for evaluation of MyD88 as a drug target and highlight the potential therapeutic implications of ST2825 in TBI. (c) 2016 Elsevier B.V. All rights reserved.	[Zhang, Hua-Sheng; Zhang, Ding-Ding; Yan, Hui-Ying; Zhou, Chen-Hui; Jiang, Tian-Wei; Hang, Chun-Hua] Nanjing Univ, Sch Med, Jinling Hosp, Dept Neurosurg, 305 East Zhongshan Rd, Nanjing 210002, Jiangsu, Peoples R China; [Li, Hua] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Neurosurg, Wuhan 430030, Hubei Province, Peoples R China; [Zhang, Zi-Huan] Zhongdu Hosp, Dept Neurosurg, Bengbu, Anhui, Peoples R China; [Ye, Zhen-Nan; Chen, Qiang; Liu, Jing-Peng; Hang, Chun-Hua] Southern Univ Guangzhou, Jinling Hosp, Dept Neurosurg, 305 East Zhongshan Rd, Nanjing 210002, Jiangsu, Peoples R China	Hang, CH (corresponding author), Nanjing Univ, Sch Med, Jinling Hosp, Dept Neurosurg, 305 East Zhongshan Rd, Nanjing 210002, Jiangsu, Peoples R China.	hang_neurosurgery@163.com		Li, Hua/0000-0001-5893-535X	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81171170, 81371294, 81401029]; Natural Science Foundation of Jiangsu Province, ChinaNatural Science Foundation of Jiangsu Province [BK2010459]	This work is supported by Grants from National Natural Science Foundation of China (No. 81171170, 81371294, 81401029), Natural Science Foundation of Jiangsu Province, China (BK2010459).	Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Adeleye A, 2010, EUR J PHARMACOL, V629, P25, DOI 10.1016/j.ejphar.2009.11.066; Ajibade AA, 2013, TRENDS IMMUNOL, V34, P307, DOI 10.1016/j.it.2013.03.007; Babcock AA, 2008, J IMMUNOL, V181, P6481, DOI 10.4049/jimmunol.181.9.6481; Biegon A, 2004, P NATL ACAD SCI USA, V101, P5117, DOI 10.1073/pnas.0305741101; Bjorkbacka H, 2004, NAT MED, V10, P416, DOI 10.1038/nm1008; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P135, DOI 10.1089/neu.2013.3019; Ding K, 2015, NEUROCHEM INT, V91, P46, DOI 10.1016/j.neuint.2015.10.008; Dunne A, 2003, J BIOL CHEM, V278, P41443, DOI 10.1074/jbc.M301742200; Dunne Aisling, 2003, Sci STKE, V2003, pre3, DOI 10.1126/stke.2003.171.re3; Fan D, 2011, CELL MOL NEUROBIOL, V31, P1213, DOI 10.1007/s10571-011-9723-0; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Hardiman G, 1996, ONCOGENE, V13, P2467; Hu YC, 2014, INFLAMM RES, V63, P109, DOI 10.1007/s00011-013-0677-1; Hue CD, 2015, J CEREBR BLOOD F MET, V35, P1191, DOI 10.1038/jcbfm.2015.38; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Janssens S, 2002, TRENDS BIOCHEM SCI, V27, P474, DOI 10.1016/S0968-0004(02)02145-X; Joosten LAB, 2003, J IMMUNOL, V171, P6145, DOI 10.4049/jimmunol.171.11.6145; Jungner M., 2015, MINERVA ANESTESIOL; Koedel U, 2007, AM J PATHOL, V171, P200, DOI 10.2353/ajpath.2007.060821; Krieg SM, 2015, J NEUROTRAUM, V32, P221, DOI 10.1089/neu.2013.3274; Li GZ, 2011, BRAIN RES, V1396, P96, DOI 10.1016/j.brainres.2011.04.014; Li W, 2014, MOL NEUROBIOL, V49, P187, DOI 10.1007/s12035-013-8509-4; Li W, 2013, J SURG RES, V180, P133, DOI 10.1016/j.jss.2012.10.928; Loiarro M, 2007, J LEUKOCYTE BIOL, V82, P801, DOI 10.1189/jlb.1206746; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Mao SS, 2012, J NEUROTRAUM, V29, P1941, DOI 10.1089/neu.2011.2244; Mayeux JP, 2015, BEHAV BRAIN RES, V279, P22, DOI 10.1016/j.bbr.2014.10.053; McIntosh TK, 1998, J NEUROTRAUM, V15, P731, DOI 10.1089/neu.1998.15.731; Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7; Morganti-Kossmann MC, 2001, SHOCK, V16, P165, DOI 10.1097/00024382-200116030-00001; Prinz M, 2006, J CLIN INVEST, V116, P456, DOI 10.1172/JCI26078; Roof RL, 1996, EXP NEUROL, V138, P246, DOI 10.1006/exnr.1996.0063; Sette Claudio, 2007, J Leukoc Biol, V82, P811; Soltani Z., 2015, J PHYSL BIOCH; Suzuki N, 2002, NATURE, V416, P750, DOI 10.1038/nature736; Tolias Christos M, 2004, NeuroRx, V1, P71, DOI 10.1602/neurorx.1.1.71; Van Tassell BW, 2010, J CARDIOVASC PHARM, V55, P385, DOI 10.1097/FJC.0b013e3181d3da24; Wang T., 2015, FA YI XUE ZA ZHI, V31, P92; Wen JF, 2014, EXP THER MED, V8, P881, DOI 10.3892/etm.2014.1818; Zhang D, 2013, NEUROSCIENCE, V238, P209, DOI 10.1016/j.neuroscience.2013.02.022; Zhang DD, 2014, NEUROCHEM INT, V75, P11, DOI 10.1016/j.neuint.2014.05.003; Zhou ML, 2007, J CEREBR BLOOD F MET, V27, P1583, DOI 10.1038/sj.jcbfm.9600456	43	18	20	1	12	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	JUL 15	2016	1643						130	139		10.1016/j.brainres.2016.05.003			10	Neurosciences	Neurosciences & Neurology	DP4EE	WOS:000378448200014	27155455				2021-06-18	
J	Haaland, KY; Sadek, JR; Keller, JE; Castillo, DT				Haaland, Kathleen Y.; Sadek, Joseph R.; Keller, Jenna E.; Castillo, Diane T.			Neurocognitive Correlates of Successful Treatment of PTSD in Female Veterans	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Neuropsychology; Executive functioning; Psychotherapy; Female; Trauma; PTSD; Veterans	POSTTRAUMATIC-STRESS-DISORDER; RANDOMIZED CONTROLLED-TRIAL; MEMORY MALINGERING TOMM; EXECUTIVE FUNCTION; NEUROPSYCHOLOGICAL PERFORMANCE; MODIFICATION PROGRAM; INHIBITORY CONTROL; VERBAL MEMORY; ATTENTION; DEFICITS	Background: The influence of psychotherapy on neurocognition in post-traumatic stress disorder (PTSD) has not been examined methodically. This is despite evidence that pre-treatment learning and memory has been associated with treatment success and that executive function theories emphasize weak executive functions (especially inhibition/switching) are associated with PTSD. Objectives: To determine (1) if higher pre-treatment learning/memory, inhibition/switching, or both predict treatment success; and (2) if treatment success is associated with specific improvement in inhibition/switching and not learning/memory or working memory, another aspect of executive function. Methods: Pre-treatment neurocognition and neurocognitive changes (inhibition/switching, learning/memory, working memory) were examined in female veterans with PTSD. They were evaluated before and after 16-weeks of group psychotherapy for PTSD that included three counterbalanced modules (cognitive restructuring therapy, exposure therapy, skills training) with fidelity checks for therapist adherence. Results: Only pre-treatment learning/memory predicted better treatment outcome. Treatment success was associated with improvement in inhibition/switching only, even after controlling for mild traumatic brain injury, and changes in depressive symptoms, working memory, and learning/memory. Conclusions: Our finding that learning/memory predicted treatment success is consistent with previous studies. We extended these studies by showing that the effect was restricted to learning/memory, which is contrary to the executive function theory of PTSD. In contrast, the fact that only inhibition/switching significantly improved with better treatment success is consistent with its potential importance in maintaining PTSD symptoms. Future research should determine whether inhibition/switching abilities are a risk for development and maintenance of PTSD or whether such abilities have a broader reciprocal relationship with PTSD symptom change.	[Haaland, Kathleen Y.; Sadek, Joseph R.] Univ New Mexico, Sch Med, Albuquerque, NM 87131 USA; [Haaland, Kathleen Y.; Sadek, Joseph R.; Keller, Jenna E.; Castillo, Diane T.] New Mexico Vet Affairs Healthcare Syst, Albuquerque, NM USA; [Keller, Jenna E.] Biomed Res Inst New Mexico, Albuquerque, NM USA; [Castillo, Diane T.] VISN 17 Ctr Excellence, Waco, TX USA	Haaland, KY (corresponding author), Univ New Mexico, Dept Psychiat & Behav Sci, Albuquerque, NM 87131 USA.	khaaland@unm.edu			Department of DefenseUnited States Department of Defense [PT074309, W81XWH-08-2-0022]; Department of Veterans AffairsUS Department of Veterans Affairs; Research Service at the NMVAHCS; Veterans Health AdministrationUS Department of Veterans Affairs	Study supported by the Department of Defense (D.C., grant number PT074309, Award number W81XWH-08-2-0022); Department of Veterans Affairs (K.Y.H., Career Scientist Award); and Research Service at the NMVAHCS (K.Y.H.), which approved the study design, but required no additional approvals. None of the authors had any potential conflicts of interest. This work was completed with support from the Veterans Health Administration. The views are those of the authors and do not necessarily represent the views of the Department of Veterans Affairs.	Allen JP, 1997, ALCOHOL CLIN EXP RES, V21, P613, DOI 10.1097/00000374-199706000-00008; Amir N, 2009, J ABNORM PSYCHOL, V118, P28, DOI 10.1037/a0012589; [Anonymous], 2003, VA DOD CLIN PRACT GU; Aron AR, 2004, BRAIN, V127, P1561, DOI 10.1093/brain/awh169; Aupperle RL, 2012, ARCH GEN PSYCHIAT, V69, P360, DOI 10.1001/archgenpsychiatry.2011.1539; Aupperle RL, 2012, NEUROPHARMACOLOGY, V62, P686, DOI 10.1016/j.neuropharm.2011.02.008; Beck A. T., 1996, BECK DEPRESSION INVE, VII; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1002/jts.2490080106; Brewin CR, 2007, J ABNORM PSYCHOL, V116, P448, DOI 10.1037/0021-843X.116.3.448; Castillo DT, 2016, PSYCHOL TRAUMA-US, V8, P404, DOI 10.1037/tra0000111; DeGutis J, 2015, J INT NEUROPSYCH SOC, V21, P342, DOI 10.1017/S1355617715000235; Delis D.C., 2001, DELIS KAPLAN EXECUTI; Delis D. C., 2000, CVLT 2 MANUAL; Dolan S, 2012, NEUROPSYCHOL REV, V22, P21, DOI 10.1007/s11065-012-9190-5; Eftekhari A, 2013, JAMA PSYCHIAT, V70, P949, DOI 10.1001/jamapsychiatry.2013.36; Falconer E, 2008, J PSYCHIATR NEUROSCI, V33, P413; First MB., 2002, STRUCTURED CLIN INTE; Foa EB, 2007, PROLONGED EXPOSURE T; Fortier CB, 2014, J HEAD TRAUMA REHAB, V29, P89, DOI 10.1097/HTR.0b013e3182865859; Geuze E, 2009, DEPRESS ANXIETY, V26, P7, DOI 10.1002/da.20476; Gilbertson MW, 2006, J ABNORM PSYCHOL, V115, P484, DOI 10.1037/0021-843X.115.3.484; Goodkind MS, 2016, INT J GERIATR PSYCH, V31, P334, DOI 10.1002/gps.4325; Gray MJ, 2004, ASSESSMENT, V11, P330, DOI 10.1177/1073191104269954; Hayes JP, 2009, PSYCHIAT RES-NEUROIM, V172, P7, DOI 10.1016/j.pscychresns.2008.05.005; Hilsabeck RC, 2011, CLIN NEUROPSYCHOL, V25, P1228, DOI 10.1080/13854046.2011.589409; Institutes of Medicine, 2008, TREATM POSTTR STRESS; Kuckertz JM, 2014, BEHAV RES THER, V63, P25, DOI 10.1016/j.brat.2014.09.002; Lange A. J., 1976, RESPONSIBLE ASSERTIV; Leskin LP, 2007, NEUROPSYCHOLOGY, V21, P275, DOI 10.1037/0894-4105.21.3.275; Mild Traumatic Brain Injury Committee American Congress of Rehabilitation Medicine Head Injury Interdisciplinary Special Interest Group, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Mohlman J, 2005, BEHAV RES THER, V43, P447, DOI 10.1016/j.brat.2004.03.007; Nijdam MJ, 2015, J CLIN PSYCHIAT, V76, pE1023, DOI 10.4088/JCP.14m09438; Polak AR, 2012, J AFFECT DISORDERS, V141, P11, DOI 10.1016/j.jad.2012.01.001; PsychCorp, 2001, WECHSL TEST AD READ; Qureshi SU, 2011, J NEUROPSYCH CLIN N, V23, P16, DOI 10.1176/appi.neuropsych.23.1.16; Resick P. A., 1993, COGNITIVE PROCESSING; Schnurr PP, 2007, JAMA-J AM MED ASSOC, V297, P820, DOI 10.1001/jama.297.8.820; Scott JC, 2015, PSYCHOL BULL, V141, P105, DOI 10.1037/a0038039; Shucard JL, 2008, BIOL PSYCHOL, V79, P223, DOI 10.1016/j.biopsycho.2008.05.005; Stein MB, 2002, BIOL PSYCHIAT, V52, P1079, DOI 10.1016/S0006-3223(02)01414-2; Street AE, 2009, CLIN PSYCHOL REV, V29, P685, DOI 10.1016/j.cpr.2009.08.007; Stricker NH, 2015, J TRAUMA STRESS, V28, P102, DOI 10.1002/jts.22000; Swick D, 2012, J INT NEUROPSYCH SOC, V18, P917, DOI 10.1017/S1355617712000458; Taylor CT, 2014, SOC COGN AFFECT NEUR, V9, P1379, DOI 10.1093/scan/nst128; Tombaugh TN, 1997, PSYCHOL ASSESSMENT, V9, P260, DOI 10.1037/1040-3590.9.3.260; Twamley EW, 2004, PSYCHIAT RES, V126, P265, DOI 10.1016/j.psychres.2004.01.008; Vasterling JJ, 2002, NEUROPSYCHOLOGY, V16, P5, DOI 10.1037//0894-4105.16.1.5; Vasterling JJ, 1998, NEUROPSYCHOLOGY, V12, P125, DOI 10.1037/0894-4105.12.1.125; Walter KH, 2010, J TRAUMA STRESS, V23, P292, DOI 10.1002/jts.20506; Wechsler D., 2008, WECHSLER ADULT INTEL, V4th ed; Wild J, 2008, BRIT J PSYCHIAT, V193, P254, DOI 10.1192/bjp.bp.107.045922; Wrocklage KM, 2016, J INT NEUROPSYCH SOC, V22, P399, DOI 10.1017/S1355617716000059	52	18	18	0	24	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	JUL	2016	22	6					643	651		10.1017/S1355617716000424			9	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Neurosciences & Neurology; Psychiatry; Psychology	DU8SM	WOS:000382484700007	27264618				2021-06-18	
J	King, DA; Hume, PA; Gissane, C; Clark, TN				King, Doug A.; Hume, Patria A.; Gissane, Conor; Clark, Trevor N.			Similar head impact acceleration measured using instrumented ear patches in a junior rugby union team during matches in comparison with other sports	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						injury; linear; rotational; impact; rugby union; wireless head impact sensor; trauma	COLLEGIATE FOOTBALL PLAYERS; TRAUMATIC BRAIN-INJURY; KING-DEVICK TEST; HIGH-SCHOOL; SCREENING TOOL; CONCUSSION; EXPOSURE; STATISTICS; BIOMECHANICS; MAGNITUDE	OBJECTIVE Direct impact with the head and the inertial loading of the head have been postulated as major mechanisms of head-related injuries, such as concussion. METHODS This descriptive observational study was conducted to quantify the head impact acceleration characteristics in under-9-year-old junior rugby union players in New Zealand. The impact magnitude, frequency, and location were collected with a wireless head impact sensor that was worn by 14 junior rugby players who participated in 4 matches. RESULTS A total of 721 impacts > 10g were recorded. The median (interquartile range [IQR]) number of impacts per player was 46 (IQR 37-58), resulting in 10 (IQR 4-18) impacts to the head per player per match. The median impact magnitudes recorded were 15g (IQR 12g-21g) for linear acceleration and 2296 rad/sec(2) (IQR 1352-4152 rad/sec(2)) for rotational acceleration. CONCLUSIONS There were 121 impacts (16.8%) above the rotational injury risk limit and 1 (0.1%) impact above the linear injury risk limit. The acceleration magnitude and number of head impacts in junior rugby union players were higher than those previously reported in similar age-group sports participants. The median linear acceleration for the under 9-year-old rugby players were similar to 7- to 8-year-old American football players, but lower than 9- to 12-year-old youth American football players. The median rotational accelerations measured were higher than the median and 95th percentiles in youth, high school, and collegiate American football players.	[King, Doug A.; Hume, Patria A.] Auckland Univ Technol, Fac Hlth & Environm Sci, Sch Sport & Recreat, Sports Performance Res Inst New Zealand, Auckland, New Zealand; [Gissane, Conor] St Marys Univ, Sch Sport Hlth & Appl Sci, Twickenham, Middx, England; [Clark, Trevor N.] Australian Coll Phys Educ, Fac Sport Performance, Sydney Olympic Pk, NSW, Australia	King, DA (corresponding author), Hutt Valley Dist Hlth Board, Emergency Dept, Private Bag 31-907, Lower Hutt, New Zealand.	dking@aut.ac.nz	Hume, Patria/AAN-5514-2021; Gissane, Conor/I-3661-2019	Hume, Patria/0000-0003-1847-8128; Gissane, Conor/0000-0003-4677-3853; Clark, Dr Trevor/0000-0002-2853-0068			ALTMAN DG, 1994, BRIT MED J, V308, P1552, DOI 10.1136/bmj.308.6943.1552; Broglio SP, 2012, ANN BIOMED ENG, V40, P37, DOI 10.1007/s10439-011-0396-0; Broglio SP, 2011, J NEUROTRAUM, V28, P2069, DOI 10.1089/neu.2011.1825; Broglio SP, 2010, MED SCI SPORT EXER, V42, P2064, DOI 10.1249/MSS.0b013e3181dd9156; Broglio SP, 2009, J ATHL TRAINING, V44, P342, DOI 10.4085/1062-6050-44.4.342; Cobb BR, 2013, ANN BIOMED ENG, V41, P2463, DOI 10.1007/s10439-013-0867-6; Crisco JJ, 2004, J BIOMECH ENG-T ASME, V126, P849, DOI 10.1115/1.1824135; Crisco JJ, 2011, J BIOMECH, V44, P2673, DOI 10.1016/j.jbiomech.2011.08.003; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; Daniel RW, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4027872; Daniel RW, 2012, ANN BIOMED ENG, V40, P976, DOI 10.1007/s10439-012-0530-7; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Galetta KM, 2011, NEUROLOGY, V76, P1456, DOI 10.1212/WNL.0b013e31821184c9; Galetta KM, 2011, J NEUROL SCI, V309, P34, DOI 10.1016/j.jns.2011.07.039; Goldsmith W, 2004, AM J FOREN MED PATH, V25, P89, DOI 10.1097/01.paf.0000127407.28071.63; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; Guskiewicz KM, 2007, NEUROSURGERY, V61, P1244, DOI 10.1227/01.neu.0000306103.68635.1a; Hanlon EM, 2012, MED SCI SPORT EXER, V44, P1102, DOI 10.1249/MSS.0b013e3182444d7d; Harpham JA, 2014, ANN BIOMED ENG, V42, P1, DOI 10.1007/s10439-013-0881-8; Hopkins WG, 2007, CLIN J SPORT MED, V17, P208, DOI 10.1097/JSM.0b013e3180592a68; Hopkins WG, 2009, MED SCI SPORT EXER, V41, P3, DOI 10.1249/MSS.0b013e31818cb278; King D, 2015, AM J SPORT MED, V43, P614, DOI 10.1177/0363546514560876; Krause LM, 2015, J SCI MED SPORT, V18, P358, DOI 10.1016/j.jsams.2014.05.012; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lennon A., 2015, THESIS; Leong DF, 2014, J SPORT MED PHYS FIT, V54, P70; Meehan WP, 2011, CLIN SPORT MED, V30, P133, DOI 10.1016/j.csm.2010.08.004; Mihalik JP, 2007, NEUROSURGERY, V61, P1229, DOI 10.1227/01.neu.0000306101.83882.c8; Mihalik JP, 2010, PEDIATRICS, V125, pE1394, DOI 10.1542/peds.2009-2849; Nevins D, 2015, PROCEDIA ENGINEER, V112, P175, DOI 10.1016/j.proeng.2015.07.195; Ocwieja KE, 2012, ANN BIOMED ENG, V40, P90, DOI 10.1007/s10439-011-0401-7; Ommaya AK, 2002, BRIT J NEUROSURG, V16, P220, DOI 10.1080/02688690220148824; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Tjarks BJ, 2013, J NEUROL SCI, V334, P148, DOI 10.1016/j.jns.2013.08.015; Vopat LM, 2015, IOC MANUAL OF EMERGENCY SPORTS MEDICINE, P205; Wong RH, 2014, CLIN NEUROL NEUROSUR, V118, P1, DOI 10.1016/j.clineuro.2013.11.036; Wu L.C., 2015, ANN BIOMED ENG; Young TJ, 2014, CLIN J SPORT MED, V24, P416, DOI 10.1097/JSM.0000000000000055; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446	40	18	18	1	13	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	JUL	2016	18	1					65	72		10.3171/2015.12.PEDS15605			8	Clinical Neurology; Pediatrics; Surgery	Neurosciences & Neurology; Pediatrics; Surgery	DQ1SC	WOS:000378979700010	26942267	Bronze			2021-06-18	
J	Miyashita, TL; Diakogeorgiou, E; VanderVegt, C				Miyashita, Theresa L.; Diakogeorgiou, Eleni; VanderVegt, Christina			Gender Differences in Concussion Reporting Among High School Athletes	SPORTS HEALTH-A MULTIDISCIPLINARY APPROACH			English	Article						concussion; reporting; sex; high school	SPORTS-RELATED CONCUSSION; NEUROCOGNITIVE PERFORMANCE; FOOTBALL PLAYERS; KNOWLEDGE; EDUCATION; RECOVERY; SYMPTOMS; AGE	Background: An athlete's lack of concussion knowledge could lead to significant underreporting and injury mismanagement. To provide more effective management strategies of concussions in adolescent athletes, further examination of reporting behaviors is of critical importance. Hypothesis: The hypotheses for this study were as follows: (1) Girls are more likely to report concussion, (2) girls are more likely to report future concussions after an educational intervention, and (3) a difference in rationale for not reporting concussion will be found between sexes. Study Design: Cross-sectional, cohort design. Level of Evidence: Level 3. Methods: Survey answers were collected on 454 high school athletes (212 girls, 242 boys; mean age, 15.7 +/- 1.15 years). Individual team meetings lasting approximately 30 minutes were held to collect data and provide an educational lecture. Participants were randomly provided an iClicker to submit a response to questions asked. Results: Girls were more likely to report a concussion (chi(2) = 8.32, df = 3, N = 454, P = 0.040) and more likely to report future concussions after educational intervention (chi(2) = 8.54, df = 2, N = 454, P = 0.014). There were no differences between sexes regarding rationale for not reporting a concussion (chi(2) = 6.42, df = 4, N = 454, P = 0.170). Conclusion: There is concern these athletes still fail to understand the severity and potential sequelae of concussion injury. Both sexes cited that concussion is not a serious enough injury to warrant reporting to a medical professional. Clinical Relevance: High school athletes recover more slowly from concussions compared with college athletes; therefore, educating this population and promoting the importance of being knowledgeable regarding concussion recognition may increase reporting prevalence.	[Miyashita, Theresa L.; Diakogeorgiou, Eleni] Sacred Heart Univ, 5151 Pk Ave, Fairfield, CT 06825 USA; [VanderVegt, Christina] Ben Hogan Sports Med, Arlington, TX USA	Miyashita, TL (corresponding author), Sacred Heart Univ, 5151 Pk Ave, Fairfield, CT 06825 USA.	miyashitat@sacredheart.edu					Castile L, 2012, BRIT J SPORT MED, V46, P603, DOI 10.1136/bjsports-2011-090115; Cournoyer J, 2014, J ATHL TRAINING, V49, P654, DOI 10.4085/1062-6050-49.3.34; Covassin T, 2013, AM J SPORT MED, V41, P2885, DOI 10.1177/0363546513499230; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Cripps AE, 2015, INT J ATHL THER TRAI, V20, P46, DOI 10.1123/ijatt.2014-0051; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Guskiewicz KM, 2011, PM&R, V3, P353, DOI 10.1016/j.pmrj.2010.12.006; Kostyun RO, 2015, SPORTS HEALTH, V7, P52, DOI 10.1177/1941738114555075; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; Meehan WP, 2013, CLIN J SPORT MED, V23, P339, DOI 10.1097/JSM.0b013e318291d3b3; Reddy CC, 2008, PHYS MED REH CLIN N, V19, P247, DOI 10.1016/j.pmr.2007.12.002; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Register-Mihalik JK, 2013, BRAIN INJURY, V27, P878, DOI 10.3109/02699052.2013.775508; Rivara FP, 2014, AM J SPORT MED, V42, P1197, DOI 10.1177/0363546514521774; Robbins CA, 2014, OPEN ACCESS J SPORTS, V5, P99, DOI 10.2147/OAJSM.S58005; Sye G, 2006, BRIT J SPORT MED, V40, P1003, DOI 10.1136/bjsm.2005.020511; Williamson IJS, 2006, BRIT J SPORT MED, V40, P128, DOI 10.1136/bjsm.2005.021832	17	18	18	1	14	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1941-7381	1941-0921		SPORTS HEALTH	Sports Health	JUL-AUG	2016	8	4					359	363		10.1177/1941738116651856			5	Sport Sciences	Sport Sciences	EG8CT	WOS:000391284000009	27233957	Green Published			2021-06-18	
J	Tanweer, O; Frisoli, FA; Bravate, C; Harrison, G; Pacione, D; Kondziolka, D; Huang, PP				Tanweer, Omar; Frisoli, Fabio A.; Bravate, Crystal; Harrison, Gillian; Pacione, Donato; Kondziolka, Douglas; Huang, Paul P.			Tranexamic Acid for Treatment of Residual Subdural Hematoma After Bedside Twist-Drill Evacuation	WORLD NEUROSURGERY			English	Article						Bedside evacuation; Fibrinolyisis; Subdural hematoma; Tranexamic acid; Traumatic brain injury; Venous thromboembolism	PORT SYSTEM; SINGLE INSTITUTION; EXPERIENCE; MANAGEMENT	BACKGROUND: Management of nonemergent, nonacute subdural hematomas (SDHs) ranges from observation to burr-hole evacuation or craniotomy, but recurrence rates are high. We evaluated the safety and efficacy of tranexamic acid (TXA) for the treatment of residual SDHs after bedside twist-drill evacuation. METHODS: We performed a retrospective analysis of a prospectively maintained database from November 2013 to November 2014 for all patients who underwent placement of a bedside subdural evacuating port system (SEPS) followed by treatment with oral TXA (650 mg daily). All demographics, evidence of venous thromboembolism, and volumes of pertinent computed tomography were obtained. RESULTS: Twenty subdural hematomas in 14 patients met the inclusion criteria for this study. Most SDHs were mixed density. Mean SDH volume on presentation was 145.96 +/- 40.22 cm(3) with a mean midline shift of 9.44 +/- 4.84 mm. Mean volumes decreased to 80.00 +/- 31.96 cm(3) and midline shift improved to 4.44 +/- 3.29 mm after SEPS placement (P < 0.0001 and P = 0.0046). All patients were placed on TXA after their procedure. Mean follow-up with computed tomography was 92.1 +/- 27.5 days, and mean SDH volume at last follow-up was 7.41 +/- 15.54 cm(3) with a mean midline shift of 0.19 +/- 0.69 mm (P < 0.0001 and P = 0.0002). Percent volume reduction was significantly higher after TXA than after SEPS (91.31% vs. 40.74%; P < 0.0001). No increase or delayed recurrence of the SDH was noted during TXA treatment. All but 1 clinical presenting symptom improved at follow-up. No venous thromboembolisms were noted among the patients. CONCLUSIONS: In our pilot study, chronic SDH volumes were reduced by 40.74% after SEPS drainage. The residual volume was reduced by an additional 91.31% during oral TXA treatment. No patients developed delayed recurrence or expansion of their SDHs. Further prospective studies are needed to evaluate the role of TXA for adjunctive treatment of chronic SDHs.	[Tanweer, Omar; Frisoli, Fabio A.; Bravate, Crystal; Harrison, Gillian; Pacione, Donato; Kondziolka, Douglas; Huang, Paul P.] NYU, Sch Med, Dept Neurosurg, New York, NY 10016 USA	Frisoli, FA (corresponding author), NYU, Sch Med, Dept Neurosurg, New York, NY 10016 USA.	fabio.frisoli@nyumc.org		Huang, Paul/0000-0003-0563-921X			Asfora W T, 2001, S D J Med, V54, P495; Asghar M, 2002, J ROY SOC MED, V95, P290, DOI 10.1258/jrsm.95.6.290; Balser D, 2013, NEUROL RES, V35, P233, DOI 10.1179/1743132813Y.0000000166; Chari A, 2014, J NEUROSURG, V121, P176, DOI 10.3171/2014.4.JNS131212; Cheriyan T, 2015, SPINE J, V15, P752, DOI 10.1016/j.spinee.2015.01.013; Drapkin A J, 1991, Br J Neurosurg, V5, P467, DOI 10.3109/02688699108998475; Ducruet AF, 2012, NEUROSURG REV, V35, P155, DOI 10.1007/s10143-011-0349-y; Duncan CM, 2015, J ARTHROPLASTY, V30, P272, DOI 10.1016/j.arth.2014.08.022; Dunn CJ, 1999, DRUGS, V57, P1005, DOI 10.2165/00003495-199957060-00017; FUJISAWA H, 1995, J NEUROL NEUROSUR PS, V59, P388, DOI 10.1136/jnnp.59.4.388; Gebel JM, 1998, STROKE, V29, P1799, DOI 10.1161/01.STR.29.9.1799; Kageyama H, 2013, J NEUROSURG, V119, P332, DOI 10.3171/2013.3.JNS122162; Kenning TJ, 2010, J NEUROSURG, V113, pA416, DOI 10.3171/2010.5.JNS1083; Neal MT, 2013, CLIN NEUROL NEUROSUR, V115, P658, DOI 10.1016/j.clineuro.2012.07.017; Park SH, 2011, CLIN NEUROL NEUROSUR, V113, P272, DOI 10.1016/j.clineuro.2010.11.014; Rughani AI, 2010, J NEUROSURG, V113, P609, DOI 10.3171/2009.11.JNS091244; Safain M, 2013, J NEUROSURG, V118, P694, DOI 10.3171/2012.11.JNS12689; Singla A, 2013, CLIN NEUROL NEUROSUR, V115, P425, DOI 10.1016/j.clineuro.2012.06.005; Suzuki M, 1998, ACTA NEUROCHIR, V140, P261, DOI 10.1007/s007010050093	19	18	20	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	JUL	2016	91						29	33		10.1016/j.wneu.2016.03.062			5	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	DS1OH	WOS:000380365000007	27032521				2021-06-18	
J	Yasui, H; Donahue, DL; Walsh, M; Castellino, FJ; Ploplis, VA				Yasui, Hideki; Donahue, Deborah L.; Walsh, Mark; Castellino, Francis J.; Ploplis, Victoria A.			Early coagulation events induce acute lung injury in a rat model of blunt traumatic brain injury	AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY			English	Article						acute lung injury; traumatic brain injury; tissue factor; coagulopathy; coagulation pathway	RESPIRATORY-DISTRESS-SYNDROME; NEUROGENIC PULMONARY-EDEMA; EARLY PLATELET DYSFUNCTION; TISSUE FACTOR; VASCULAR-PERMEABILITY; IN-VIVO; COAGULOPATHY; INFLAMMATION; ACTIVATION; HEMORRHAGE	Early coagulation events induce acute lung injury in a rat model of blunt traumatic brain injury. Am J Physiol Lung Cell Mol Physiol 311:L74-L86, 2016. First published May 17, 2016; doi:10.1152/ajplung.00429.2015.-Acute lung injury (ALI) and systemic coagulopathy are serious complications of traumatic brain injury (TBI) that frequently lead to poor clinical outcomes. Although the release of tissue factor (TF), a potent initiator of the extrinsic pathway of coagulation, from the injured brain is thought to play a key role in coagulopathy after TBI, its function in ALI following TBI remains unclear. In this study, we investigated whether the systemic appearance of TF correlated with the ensuing coagulopathy that follows TBI in ALI using an anesthetized rat blunt trauma TBI model. Blood and lung samples were obtained after TBI. Compared with controls, pulmonary edema and increased pulmonary permeability were observed as early as 5 min after TBI without evidence of norepinephrine involvement. Systemic TF increased at 5 min and then diminished 60 min after TBI. Lung injury and alveolar hemorrhaging were also observed as early as 5 min after TBI. A biphasic elevation of TF was observed in the lungs after TBI, and TF-positive microparticles (MPs) were detected in the alveolar spaces. Fibrin(ogen) deposition was also observed in the lungs within 60 min after TBI. Additionally, preadministration of a direct thrombin inhibitor, Refludan, attenuated lung injuries, thus implicating thrombin as a direct participant in ALI after TBI. The results from this study demonstrated that enhanced systemic TF may be an initiator of coagulation activation that contributes to ALI after TBI.	[Yasui, Hideki; Donahue, Deborah L.; Walsh, Mark; Castellino, Francis J.; Ploplis, Victoria A.] Univ Notre Dame, WM Keck Ctr Transgene Res, 230 Raclin Carmichael Hall, Notre Dame, IN 46556 USA; [Castellino, Francis J.; Ploplis, Victoria A.] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA; [Walsh, Mark] Mem Hosp South Bend, South Bend, IN USA	Ploplis, VA (corresponding author), Univ Notre Dame, WM Keck Ctr Transgene Res, 230 Raclin Carmichael Hall, Notre Dame, IN 46556 USA.	vploplis@nd.edu		Walsh, Mark/0000-0002-5795-1144	Indiana State Department of Health; National Heart, Lung, and Blood InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [HL-019982]	This study was supported by an Indiana Spinal Cord and Brain Injury Grant from the Indiana State Department of Health (to V. A. Ploplis) and, in part, National Heart, Lung, and Blood Institute Grant HL-019982 (to F. J. C).	CARLSON RW, 1979, CHEST, V75, P731, DOI 10.1378/chest.75.6.731; Castellino FJ, 2014, J TRAUMA ACUTE CARE, V76, P1169, DOI 10.1097/TA.0000000000000216; CHAPMAN HA, 1985, J CLIN INVEST, V75, P2030, DOI 10.1172/JCI111922; CHEN HI, 1973, AM J PHYSIOL, V224, P223; Cohan MJ, 2007, J TRAUMA, V63, P1254, DOI 10.1097/TA.0b013e318156ee4c; COLICE GL, 1985, CLIN CHEST MED, V6, P473; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Davis PK, 2013, NEUROCRIT CARE, V18, P201, DOI 10.1007/s12028-012-9745-6; Davison DL, 2012, CRIT CARE, V16, DOI 10.1186/cc11226; DELZOPPO GJ, 1992, THROMB HAEMOSTASIS, V68, P642; DEMLING R, 1990, CRIT CARE MED, V18, P768, DOI 10.1097/00003246-199007000-00019; Donahue DL, 2014, J NEUROTRAUM, V31, P404, DOI 10.1089/neu.2013.3089; DRAKE TA, 1989, AM J PATHOL, V134, P1087; Dudek SM, 2001, J APPL PHYSIOL, V91, P1487; FLECK RA, 1990, THROMB RES, V59, P421, DOI 10.1016/0049-3848(90)90148-6; FuchsBuder T, 1996, AM J RESP CRIT CARE, V153, P163, DOI 10.1164/ajrccm.153.1.8542111; Furie B, 2007, J THROMB HAEMOST, V5, P12, DOI 10.1111/j.1538-7836.2007.02482.x; Harhangi BS, 2008, ACTA NEUROCHIR, V150, P165, DOI 10.1007/s00701-007-1475-8; Heuer JF, 2012, J NEUROL SURG PART A, V73, P289, DOI 10.1055/s-0032-1304813; Hoffman M, 2009, STROKE, V40, P2882, DOI 10.1161/STROKEAHA.109.555433; Holland MC, 2003, J TRAUMA, V55, P106, DOI 10.1097/01.TA.0000071620.27375.BE; Hulka F, 1996, ARCH SURG-CHICAGO, V131, P923; Idell S, 2003, CRIT CARE MED, V31, pS213, DOI 10.1097/01.CCM.0000057846.21303.AB; Jenkins RG, 2006, J CLIN INVEST, V116, P1606, DOI 10.1172/JCI27183; Kalsotra A, 2007, J CEREBR BLOOD F MET, V27, P963, DOI 10.1038/sj.jcbfm.9600396; Kipnis E, 2004, SHOCK, V21, P444, DOI 10.1097/00024382-200405000-00008; Kutcher ME, 2012, J TRAUMA ACUTE CARE, V73, P13, DOI 10.1097/TA.0b013e318256deab; Liu ZY, 2014, INT J MOL SCI, V15, P12861, DOI 10.3390/ijms150712861; LUKACS NW, 1995, J IMMUNOL, V154, P5411; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Maegele M, 2013, TRANSFUSION, V53, p28S, DOI 10.1111/trf.12033; MALIK AB, 1987, AM REV RESPIR DIS, V136, P467, DOI 10.1164/ajrccm/136.2.467; Mascia L, 2007, CRIT CARE MED, V35, P1815, DOI 10.1097/01.CCM.0000275269.77467.DF; Matute-Bello G, 2001, AM J PATHOL, V158, P153, DOI 10.1016/S0002-9440(10)63953-3; MCCLELLAN MD, 1989, J APPL PHYSIOL, V67, P1185; McKeating EG, 1997, BRIT J ANAESTH, V78, P520; Miller DL, 2002, AM J RESP CELL MOL, V26, P650, DOI 10.1165/ajrcmb.26.6.4688; MING WJ, 1987, J IMMUNOL, V138, P1469; Morel N, 2008, J TRAUMA, V64, P698, DOI 10.1097/TA.0b013e31816493ad; Osterud B, 2006, SEMIN THROMB HEMOST, V32, P11, DOI 10.1055/s-2006-933336; Ploplis VA, 2014, J NEUROTRAUM, V31, P1672, DOI 10.1089/neu.2013.3302; Rassler B, 2003, MOL CELL BIOCHEM, V250, P55, DOI 10.1023/A:1024942132705; ROGERS FB, 1995, J TRAUMA, V39, P860, DOI 10.1097/00005373-199511000-00009; Schrieber M, 2007, J TRAUMA, V63, P1261; Sebag SC, 2011, CURR PHARM BIOTECHNO, V12, P1481; Stein SC, 2004, NEUROCRIT CARE, V1, P479, DOI 10.1385/NCC:1:4:479; Sun YR, 2011, BRIT J NEUROSURG, V25, P363, DOI 10.3109/02688697.2011.552650; Tian Y, 2015, BLOOD, V125, P2151, DOI 10.1182/blood-2014-09-598805; Tumer N, 2013, NEUROSCI LETT, V544, P62, DOI 10.1016/j.neulet.2013.03.042; VANDERZEE H, 1980, J APPL PHYSIOL, V48, P273; Veress LA, 2010, AM J RESP CRIT CARE, V182, P1352, DOI 10.1164/rccm.200910-1618OC; Wafaisade A, 2010, NEUROCRIT CARE, V12, P211, DOI 10.1007/s12028-009-9281-1; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Weber DJ, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009443; Wohlauer MV, 2012, J AM COLL SURGEONS, V214, P739, DOI 10.1016/j.jamcollsurg.2012.01.050; WOOLF PD, 1992, ARCH SURG-CHICAGO, V127, P899; Zhang JN, 2012, J NEUROTRAUM, V29, P2597, DOI 10.1089/neu.2012.2348	57	18	18	0	9	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	1040-0605	1522-1504		AM J PHYSIOL-LUNG C	Am. J. Physiol.-Lung Cell. Mol. Physiol.	JUL 1	2016	311	1					L74	L86		10.1152/ajplung.00429.2015			13	Physiology; Respiratory System	Physiology; Respiratory System	DS4RE	WOS:000380767700008	27190065	Green Published, Bronze			2021-06-18	
J	Hammond, FM; Alexander, DN; Cutler, AJ; D'Amico, S; Doody, RS; Sauve, W; Zorowitz, RD; Davis, CS; Shin, P; Ledon, F; Yonan, C; Formella, AE; Siffert, J				Hammond, Flora M.; Alexander, David N.; Cutler, Andrew J.; D'Amico, Stephen; Doody, Rachelle S.; Sauve, William; Zorowitz, Richard D.; Davis, Charles S.; Shin, Paul; Ledon, Fred; Yonan, Charles; Formella, Andrea E.; Siffert, Joao			PRISM II: an open-label study to assess effectiveness of dextromethorphan/quinidine for pseudobulbar affect in patients with dementia, stroke or traumatic brain injury	BMC NEUROLOGY			English	Article						Dextromethorphan; Quinidine; Pseudobulbar affect; Dementia; Brain injuries; Stroke; Neuropsychiatric symptoms; Center for neurologic study-lability scale	EMOTIONAL EXPRESSION DISORDER; MULTIPLE-SCLEROSIS; DEPRESSION; LABILITY; TRIAL	Background: Phase 3 trials supporting dextromethorphan/quinidine (DM/Q) use as a treatment for pseudobulbar affect (PBA) were conducted in patients with amyotrophic lateral sclerosis (ALS) or multiple sclerosis (MS). The PRISM II study provides additional DM/Q experience with PBA secondary to dementia, stroke, or traumatic brain injury (TBI). Methods: Participants in this open-label, multicenter, 90-day trial received DM/Q 20/10 mg twice daily. The primary outcome was the Center for Neurologic Study-Lability Scale (CNS-LS), assessing change in PBA episode frequency and severity. The CNS-LS final visit score was compared to baseline (primary analysis) and to the response in a previously conducted placebo-controlled trial with DM/Q in patients with ALS or MS. Secondary outcomes included change in PBA episode count and Clinical Global Impression of Change with respect to PBA as rated by a clinician (CGI-C) and by the patient or caregiver (PGI-C). Results: The study enrolled 367 participants with PBA secondary to dementia, stroke, or TBI. Mean (standard deviation [SD]) CNS-LS score improved significantly from 20.4 (4.4) at baseline to 12.8 (5.0) at Day 90/Final Visit (change, -7.7 [6.1]; P < .001, 95 % CI: -8.4, -7.0). This magnitude of improvement was consistent with DM/Q improvement in the earlier phase-3, placebo-controlled trial (mean [95 % CI] change from baseline, -8.2 [-9.4, -7.0]) and numerically exceeds the improvement seen with placebo in that study (-5.7 [-6.8, -4.7]). Reduction in PBA episode count was 72.3 % at Day 90/Final Visit compared with baseline (P < .001). Scores on CGI-C and PGI-C showed that 76.6 and 72.4 % of participants, respectively, were "much" or "very much" improved with respect to PBA. The most frequently occurring adverse events (AEs) were diarrhea (5.4 %), headache (4.1 %), urinary tract infection (2.7 %), and dizziness (2.5 %); 9.8 % had AEs that led to discontinuation. Serious AEs were reported in 6.3 %; however, none were considered treatment related. Conclusions: DM/Q was shown to be an effective and well-tolerated treatment for PBA secondary to dementia, stroke, or TBI. The magnitude of PBA improvement was similar to that reported in patients with PBA secondary to ALS or MS, and the adverse event profile was consistent with the known safety profile of DM/Q.	[Hammond, Flora M.] Indiana Univ Sch Med, Rehabil Hosp Indiana, Phys Med & Rehabil, 4141 Shore Dr, Indianapolis, IN 46254 USA; [Alexander, David N.] Univ Calif Los Angeles, Los Angeles, CA USA; [Cutler, Andrew J.] Florida Clin Res Ctr LLC, Bradenton, FL USA; [D'Amico, Stephen] Cornerstone Med Grp, Franklin, TN USA; [Doody, Rachelle S.] Baylor Coll Med, Houston, TX 77030 USA; [Sauve, William] TMS NeuroHlth Ctrs, Richmond, VA USA; [Zorowitz, Richard D.] MedStar Natl Rehabil Network, Washington, DC USA; [Davis, Charles S.] CSD Biostat Inc, Tucson, AZ USA; [Shin, Paul; Ledon, Fred; Yonan, Charles; Formella, Andrea E.; Siffert, Joao] Avanir Pharmaceut Inc, Aliso Viejo, CA USA	Hammond, FM (corresponding author), Indiana Univ Sch Med, Rehabil Hosp Indiana, Phys Med & Rehabil, 4141 Shore Dr, Indianapolis, IN 46254 USA.	Flora.hammond@rhin.com	Group, Prescott Medical Communications/AAE-7494-2019; Formella, Andrea/AAE-4073-2020	Formella, Andrea/0000-0003-2737-7898; Zorowitz, Richard/0000-0001-8938-786X	Avanir Pharmaceuticals, Inc.	This study and medical writing and editing services were funded by Avanir Pharmaceuticals, Inc.	Avanir Pharmaceuticals Inc, 2015, NUED PRESCR INF; Brooks BR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072232; Brooks BR, 2004, NEUROLOGY, V63, P1364; CODD EE, 1995, J PHARMACOL EXP THER, V274, P1263; Colamonico J, 2012, ADV THER, V29, P775, DOI 10.1007/s12325-012-0043-7; Cummings JL, 2006, CNS SPECTRUMS, V11, P1; Doody R. S., 2015, CNS SPECTRUMS, P1; Engelman W, 2014, NEUROPSYCH DIS TREAT, V10, P1903, DOI 10.2147/NDT.S63304; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Hammond F, 2015, 33 ANN S NAT NEUR SO; Hernandez SC, 2000, J PHARMACOL EXP THER, V293, P962; HOUSE A, 1989, BMJ-BRIT MED J, V298, P991, DOI 10.1136/bmj.298.6679.991; Kim JS, 2000, NEUROLOGY, V54, P1805, DOI 10.1212/WNL.54.9.1805; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lowe B, 2004, MED CARE, V42, P1194, DOI 10.1097/00005650-200412000-00006; Moore SR, 1997, J NEUROL NEUROSUR PS, V63, P89, DOI 10.1136/jnnp.63.1.89; MORRIS PLP, 1993, AUST NZ J PSYCHIAT, V27, P601, DOI 10.3109/00048679309075822; Panitch HS, 2006, ANN NEUROL, V59, P780, DOI 10.1002/ana.20828; Parvizi J, 2009, J NEUROPSYCH CLIN N, V21, P75, DOI 10.1176/appi.neuropsych.21.1.75; Pattee GL, 2014, CURR MED RES OPIN, V30, P2255, DOI 10.1185/03007995.2014.940040; Pioro EP, 2011, DRUGS, V71, P1193, DOI 10.2165/11591450-000000000-00000; Pioro EP, 2010, ANN NEUROL, V68, P693, DOI 10.1002/ana.22093; Schiffer R, 2005, J NEUROPSYCH CLIN N, V17, P447, DOI 10.1176/appi.neuropsych.17.4.447; Smith RA, 2004, MULT SCLER J, V10, P679, DOI 10.1191/1352458504ms1106oa; STARKSTEIN SE, 1995, J NEUROL NEUROSUR PS, V59, P55, DOI 10.1136/jnnp.59.1.55; Tateno A, 2004, J NEUROPSYCH CLIN N, V16, P426, DOI 10.1176/appi.neuropsych.16.4.426; Werling LL, 2007, EXP NEUROL, V207, P248, DOI 10.1016/j.expneurol.2007.06.013; Work SS, 2011, ADV THER, V28, P586, DOI 10.1007/s12325-011-0031-3; Wortzel HS, 2008, CNS DRUGS, V22, P531, DOI 10.2165/00023210-200822070-00001; Zeilig G, 1996, BRAIN INJURY, V10, P591, DOI 10.1080/026990596124160; Zorowitz RD, 2015, 92 ANN C AM C REH ME	31	18	18	0	13	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1471-2377			BMC NEUROL	BMC Neurol.	JUN 9	2016	16								89	10.1186/s12883-016-0609-0			12	Clinical Neurology	Neurosciences & Neurology	DO2DW	WOS:000377590900001	27276999	DOAJ Gold, Green Published			2021-06-18	
J	Huang, CJ; Zhao, LX; Gu, J; Nie, DK; Chen, YN; Zuo, H; Huan, W; Shi, JL; Chen, J; Shi, W				Huang, Chuanjun; Zhao, Longxiang; Gu, Jun; Nie, Dekang; Chen, Yinan; Zuo, Hao; Huan, Wei; Shi, Jinlong; Chen, Jian; Shi, Wei			The migration and differentiation of hUC-MSCsCXCR4/GFP encapsulated in BDNF/chitosan scaffolds for brain tissue engineering	BIOMEDICAL MATERIALS			English	Article						traumatic brain injury; hUC-MSCs; CXCR4/SDF-1 alpha axis; migration; neuronal differentiation	MESENCHYMAL STEM-CELLS; BONE-MARROW; INJURY; TRAFFICKING; EXPRESSION; THERAPY; MODEL	We previously developed a biomaterial scaffold that could effectively provide seed cells to a lesion cavity resulting from traumatic brain injury. However, we subsequently found that few transplanted human umbilical cord mesenchymal stem cells (hUC-MSCs) are able to migrate from the scaffold to the lesion boundary. Stromal derived-cell factor-1 alpha and its receptor chemokine (C-X-C motif) receptor (CXCR) 4 are chemotactic factors that control cell migration and stem cell recruitment to target areas. Given the low expression level of CXCR4 on the hUC-MSC membrane, lentiviral vectors were used to generate hUC-MSCs stably expressing CXCR4 fused to green fluorescent protein (GFP) (hUC-MSCsCXCR4/GFP). We constructed a scaffold in which recombinant human brain-derived neurotrophic factor (BDNF) was linked to chitosan scaffolds with the crosslinking agent genipin (CGB scaffold). The scaffold containing hUC-MSCsCXCR4/GFP was transplanted into the lesion cavity of a rat brain, providing exogenous hUC-MSCs to both lesion boundary and cavity. These results demonstrate a novel strategy for inducing tissue regeneration after traumatic brain injury.	[Huang, Chuanjun; Zhao, Longxiang; Gu, Jun; Chen, Yinan; Zuo, Hao; Huan, Wei; Shi, Jinlong; Chen, Jian; Shi, Wei] Nantong Univ, Affiliated Hosp, Dept Neurosurg, Nantong, Peoples R China; [Nie, Dekang] Nantong Univ, Affiliated Hosp 4, Dept Neurosurg, YanCheng City Peoples Hosp 1, Yancheng, Peoples R China	Shi, W (corresponding author), Nantong Univ, Affiliated Hosp, Dept Neurosurg, Nantong, Peoples R China.	ntshiwei123@163.com			National Nature Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81271368]; Natural Science Foundation of Jiangsu ProvinceNatural Science Foundation of Jiangsu Province [BK2012654]	The authors thank the Surgical Comprehensive Laboratory at the Affiliated Hospital of Nantong University for technical assistance and equipment support. This work was supported by the National Nature Science Foundation of China (grant no. 81271368) and the Natural Science Foundation of Jiangsu Province (grant no. BK2012654).	Barbash IM, 2003, CIRCULATION, V108, P863, DOI 10.1161/01.CIR.0000084828.50310.6A; Brooke G, 2008, STEM CELLS DEV, V17, P929, DOI 10.1089/scd.2007.0156; Cao ZQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082949; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; Chamberlain G, 2007, STEM CELLS, V25, P2739, DOI 10.1634/stemcells.2007-0197; Dazzi F, 2007, CURR OPIN ONCOL, V19, P650, DOI 10.1097/CCO.0b013e3282f0e116; Guan J, 2013, BIOMATERIALS, V34, P5937, DOI 10.1016/j.biomaterials.2013.04.047; Imitola J, 2004, P NATL ACAD SCI USA, V101, P18117, DOI 10.1073/pnas.0408258102; Ji JF, 2004, STEM CELLS, V22, P415, DOI 10.1634/stemcells.22-3-415; Jiang QS, 2011, CHINESE MED J-PEKING, V124, P1540, DOI 10.3760/cma.j.issn.0366-6999.2011.10.019; Jiang Q, 2011, NMR BIOMED, V24, P1119, DOI 10.1002/nbm.1667; Keilhoff G, 2006, CELL MOL NEUROBIOL, V26, P1235, DOI 10.1007/s10571-006-9029-9; Kim Ju-Yeon, 2010, World J Stem Cells, V2, P34, DOI 10.4252/wjsc.v2.i2.34; Lee JH, 2011, J NEUROL SCI, V300, P86, DOI 10.1016/j.jns.2010.09.025; Liang J, 2013, NEUROSCI LETT, V532, P59, DOI 10.1016/j.neulet.2012.11.014; Lim JY, 2011, STEM CELL RES THER, V2, DOI 10.1186/scrt79; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Maegele M, 2008, MINIM INVASIV THER, V17, P119, DOI 10.1080/13645700801970087; McConeghy KW, 2012, CNS DRUGS, V26, P613, DOI 10.2165/11634020-000000000-00000; Murphy JM, 2003, ARTHRITIS RHEUM-US, V48, P3464, DOI 10.1002/art.11365; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Qiu YY, 2012, CYTOTHERAPY, V14, P285, DOI 10.3109/14653249.2011.651532; Qu CS, 2011, BRAIN RES, V1371, P129, DOI 10.1016/j.brainres.2010.10.088; Shi MX, 2007, HAEMATOLOGICA, V92, P897, DOI 10.3324/haematol.10669; Shi W, 2012, BIOMATERIALS, V33, P3119, DOI 10.1016/j.biomaterials.2012.01.009; Son BR, 2006, STEM CELLS, V24, P1254, DOI 10.1634/stemcells.2005-0271; Sordi V, 2005, BLOOD, V106, P419, DOI 10.1182/blood-2004-09-3507; Wang KZ, 2014, FLEX SERV MANUF J, V26, P387, DOI 10.1007/s10696-012-9153-4	28	18	19	1	14	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	1748-6041	1748-605X		BIOMED MATER	Biomed. Mater.	JUN	2016	11	3								10.1088/1748-6041/11/3/035004			9	Engineering, Biomedical; Materials Science, Biomaterials	Engineering; Materials Science	DP0GQ	WOS:000378167700005	27147644	Other Gold			2021-06-18	
J	Leng, TD; Si, HF; Li, J; Yang, T; Zhu, MY; Wang, BH; Simon, RP; Xiong, ZG				Leng, Tian-Dong; Si, Hong-Fang; Li, Jun; Yang, Tao; Zhu, Mengyuan; Wang, Binghe; Simon, Roger P.; Xiong, Zhi-Gang			Amiloride Analogs as ASIC1a Inhibitors	CNS NEUROSCIENCE & THERAPEUTICS			English	Article						Acid-sensing ion channel; Amiloride; Benzamil; Neuroprotection; Stroke	SENSING ION CHANNELS; EXCHANGE INHIBITOR; HIPPOCAMPAL-NEURONS; BRAIN-INJURY; ACID; CONTRIBUTES; NA+; NEUROPROTECTION; ISCHEMIA; FEAR	Background: ASIC1a, the predominant acid-sensing ion channels (ASICs), is implicated in neurological disorders including stroke, traumatic spinal cord injury, and ALS. Potent ASIC1a inhibitors should have promising therapeutic potential for ASIC1a-related diseases. Aims: We examined the inhibitory effects of a number of amiloride analogs on ASIC1a currents, aimed at understanding the structure-activity relationship and identifying potent ASIC1a inhibitors for stroke intervention. Methods: Whole-cell patch-clamp techniques and a mouse model of middle cerebral artery occlusion (MCAO)-induced focal ischemia were used. Surflex-Dock was used to dock the analogs into the pocket with default parameters. Results: Amiloride and its analogs inhibit ASIC1a currents expressed in Chinese hamster ovary cells with a potency rank order of benzamil > phenamil > 5-(N, N-dimethyl) amiloride (DMA) > amiloride > 5-(N, N-hexamethylene) amiloride (HMA) >= 5-(N-methyl-N-isopropyl) amiloride (MIA) > 5-(N-ethyl-N-isopropyl) amiloride (EIPA). In addition, amiloride and its analogs inhibit ASIC currents in cortical neurons with the same potency rank order. In mice, benzamil and EIPA decreased MCAO-induced infarct volume. Similar to its effect on the ASIC current, benzamil showed a much higher potency than EIPA. Conclusion: Addition of a benzyl group to the terminal guanidinyl group resulted in enhanced inhibitory activity on ASIC1a. On the other hand, the bulky groups added to the 5-amino residues slightly decreased the activity. Among the tested amiloride analogs, benzamil is the most potent ASIC1a inhibitor.	[Leng, Tian-Dong; Yang, Tao; Simon, Roger P.; Xiong, Zhi-Gang] Morehouse Sch Med, Neurosci Inst, 720 Westview Dr SW, Atlanta, GA 30310 USA; [Si, Hong-Fang; Li, Jun] Anhui Med Univ, Sch Pharm, Hefei, Anhui, Peoples R China; [Zhu, Mengyuan; Wang, Binghe] Georgia State Univ, Dept Chem, Atlanta, GA 30303 USA; [Zhu, Mengyuan; Wang, Binghe] Georgia State Univ, Ctr Diagnost & Therapeut, Atlanta, GA 30303 USA	Xiong, ZG (corresponding author), Morehouse Sch Med, Neurosci Inst, 720 Westview Dr SW, Atlanta, GA 30310 USA.; Wang, BH (corresponding author), Georgia State Univ, Dept Chem, Atlanta, GA 30303 USA.; Wang, BH (corresponding author), Georgia State Univ, Ctr Diagnost & Therapeut, Atlanta, GA 30303 USA.	wang@gsu.edu; zxiong@msm.edu	Wang, Binghe/D-4257-2009	Wang, Binghe/0000-0002-2200-5270	NIMHD [S21MD000101, U54NS08932]; AHAAmerican Heart Association [084013];  [R01NS066027]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U54NS083932, R01NS066027] Funding Source: NIH RePORTER; National Institute on Minority Health and Health DisparitiesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD) [S21MD000101] Funding Source: NIH RePORTER	This work is supported by R01NS066027, NIMHD S21MD000101, U54NS08932, and AHA 084013.	Antcliff A C, 1972, Br J Clin Pract, V26, P413; Baconguis I, 2014, CELL, V156, P717, DOI 10.1016/j.cell.2014.01.011; Bassler EL, 2001, J BIOL CHEM, V276, P33782, DOI 10.1074/jbc.M104030200; Chen XM, 2010, NEUROPHARMACOLOGY, V58, P1045, DOI 10.1016/j.neuropharm.2010.01.011; Coryell MW, 2007, BIOL PSYCHIAT, V62, P1140, DOI 10.1016/j.biopsych.2007.05.008; de la Rosa DA, 2000, ANNU REV PHYSIOL, V62, P573, DOI 10.1146/annurev.physiol.62.1.573; Deval E, 2008, EMBO J, V27, P3047, DOI 10.1038/emboj.2008.213; Duan B, 2007, J NEUROSCI, V27, P11139, DOI 10.1523/JNEUROSCI.3364-07.2007; Friese MA, 2007, NAT MED, V13, P1483, DOI 10.1038/nm1668; Gregoire S, 2009, J NEUROSCI, V29, P6053, DOI 10.1523/JNEUROSCI.0752-09.2009; Hawkins PCD, 2010, J CHEM INF MODEL, V50, P572, DOI 10.1021/ci100031x; Hwang IK, 2008, EXP NEUROL, V212, P314, DOI 10.1016/j.expneurol.2008.04.007; Jain AN, 2007, J COMPUT AID MOL DES, V21, P281, DOI 10.1007/s10822-007-9114-2; Jain AN, 1996, J COMPUT AID MOL DES, V10, P427, DOI 10.1007/BF00124474; Jain AN, 2003, J MED CHEM, V46, P499, DOI 10.1021/jm020406h; JAVITT DC, 1991, AM J PSYCHIAT, V148, P1301; Jeon D, 2008, CELL CALCIUM, V43, P482, DOI 10.1016/j.ceca.2007.08.003; Johanson CE, 2008, FLUIDS BARRIERS CNS, V5, DOI 10.1186/1743-8454-5-10; Kendall GS, 2006, PEDIATR RES, V59, P227, DOI 10.1203/01.pdr.0000196805.68082.22; KLEYMAN TR, 1988, J MEMBRANE BIOL, V105, P1, DOI 10.1007/BF01871102; Krishtal O, 2003, TRENDS NEUROSCI, V26, P477, DOI 10.1016/S0166-2236(03)00210-8; Leng TD, 2015, CNS NEUROSCI THER, V21, P32, DOI 10.1111/cns.12318; Leng TD, 2013, ACTA PHARMACOL SIN, V34, P33, DOI 10.1038/aps.2012.81; Leng TD, 2014, PROG NEUROBIOL, V115, P189, DOI 10.1016/j.pneurobio.2013.12.008; Leng TD, 2013, MOL PAIN, V9, DOI 10.1186/1744-8069-9-27; Lingueglia E, 1997, J BIOL CHEM, V272, P29778, DOI 10.1074/jbc.272.47.29778; Matsuda T, 2001, J PHARMACOL EXP THER, V298, P249; MCKEAN W I, 1970, New Zealand Medical Journal, V72, P110; Miteva MA, 2005, J MED CHEM, V48, P6012, DOI 10.1021/jm050262h; Phillis JW, 1999, BRAIN RES, V839, P199, DOI 10.1016/S0006-8993(99)01705-9; Pignataro G, 2004, STROKE, V35, P2566, DOI 10.1161/01.STR.0000143730.29964.93; Pignataro G, 2007, BRAIN, V130, P151, DOI 10.1093/brain/awl325; Pignataro Giuseppe, 2011, Int J Physiol Pathophysiol Pharmacol, V3, P1; Pignataro G, 2011, J CEREBR BLOOD F MET, V31, P362, DOI 10.1038/jcbfm.2010.100; Price MP, 2000, NATURE, V407, P1007, DOI 10.1038/35039512; Qadri YJ, 2012, AM J PHYSIOL-CELL PH, V302, pC943, DOI 10.1152/ajpcell.00019.2012; Schroder UH, 1999, NEUROPHARMACOLOGY, V38, P319, DOI 10.1016/S0028-3908(98)00198-1; Sobolevsky AI, 1999, NEUROPHARMACOLOGY, V38, P1235, DOI 10.1016/S0028-3908(99)00040-4; Ugawa S, 2002, J CLIN INVEST, V110, P1185, DOI 10.1172/JCI200215709; Voilley N, 2001, J NEUROSCI, V21, P8026; Waldmann R, 1997, J BIOL CHEM, V272, P20975, DOI 10.1074/jbc.272.34.20975; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; Wang X, 2008, AM J PHYSIOL-RENAL, V295, pF272, DOI 10.1152/ajprenal.00200.2007; Wang YP, 2008, EUR J NEUROSCI, V28, P51, DOI 10.1111/j.1460-9568.2008.06304.x; Wang YZ, 2011, MOL NEUROBIOL, V44, P350, DOI 10.1007/s12035-011-8204-2; Wemmie JA, 2002, NEURON, V34, P463, DOI 10.1016/S0896-6273(02)00661-X; Wemmie JA, 2003, J NEUROSCI, V23, P5496; Wong HK, 2008, HUM MOL GENET, V17, P3223, DOI 10.1093/hmg/ddn218; Xiong ZG, 2004, CELL, V118, P687, DOI 10.1016/j.cell.2004.08.026; Yermolaieva O, 2004, P NATL ACAD SCI USA, V101, P6752, DOI 10.1073/pnas.0308636100	50	18	20	0	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1755-5930	1755-5949		CNS NEUROSCI THER	CNS Neurosci. Ther.	JUN	2016	22	6					468	476		10.1111/cns.12524			9	Neurosciences; Pharmacology & Pharmacy	Neurosciences & Neurology; Pharmacology & Pharmacy	DS8DH	WOS:000381012800005	26890278	Green Published, Green Accepted			2021-06-18	
J	Lilley, EJ; Williams, KJ; Schneider, EB; Hammouda, K; Salim, A; Haider, AH; Cooper, Z				Lilley, Elizabeth J.; Williams, Katherine J.; Schneider, Eric B.; Hammouda, Khaled; Salim, Ali; Haider, Adil H.; Cooper, Zara			Intensity of treatment, end-of-life care, and mortality for older patients with severe traumatic brain injury	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Geriatric surgery; traumatic brain injury; palliative care	LONG-TERM SURVIVAL; MEDICARE BENEFICIARIES; GERIATRIC TRAUMA; DECISION-MAKING; ASSOCIATION; OUTCOMES; AGE; PROGNOSIS; ADULTS; COST	BACKGROUND The Eastern Association for the Surgery of Trauma (EAST) recommends that clinicians consider limiting further aggressive treatment in geriatric patients with severe traumatic brain injury (TBI) who do not improve in 72 hours (nonresponders) owing to their poor prognosis. However, little is known about how these guidelines are followed in practice. This study compared mortality and patient care among geriatric patients with severe TBI classified as responders and nonresponders 72 hours after injury. METHODS Retrospective review of patients 65 years or older at a Level I trauma center with severe TBI (GCS < 8) from 2011 to 2014. We compared in-hospital mortality, end-of-life (EOL) decision making, discharge functional status, and 12-month survival in responders (GCS > 8 at 72 hours) and nonresponders (GCS 8 at 72 hours). RESULTS Of 90 patients, 29 (32%) died within 3 days of injury, 29 (32%) were nonresponders, and 32 (34%) were responders. An additional 19 patients (21%) died before hospital discharge, of whom 17 (89%) were nonresponders. Nonresponders had higher odds of in-hospital death (odds ratio, 31.8; 95% confidence interval [CI], 3.71-272.9; p = 0.002). Family meetings to discuss goals of care were more common in the nonresponder group (p < 0.001) and fewer nonresponders were full code at discharge or death (p < 0.001). There were no significant differences in functional status at discharge. Among patients discharged alive, there were no differences in 12-month survival. CONCLUSION The responder/nonresponder dichotomy identifies patients with higher in-hospital mortality outcomes and is associated with differences in EOL decision making. However, functional impairment and poor survival were prevalent, irrespective of neurologic status at 72 hours. LEVEL OF EVIDENCE Prognostic/epidemiologic study, level III; therapeutic study, level IV.	[Lilley, Elizabeth J.; Schneider, Eric B.; Salim, Ali; Haider, Adil H.; Cooper, Zara] Brigham & Womens Hosp, Ctr Surg & Publ Hlth, 75 Francis St, Boston, MA 02115 USA; [Lilley, Elizabeth J.] Rutgers Robert Wood Johnson Med, Dept Surg, New Brunswick, NJ USA; [Williams, Katherine J.] Med Coll Wisconsin, Populat Hlth Management, Dept Clin Affairs, Milwaukee, WI 53226 USA; [Schneider, Eric B.; Hammouda, Khaled; Salim, Ali; Haider, Adil H.; Cooper, Zara] Brigham & Womens Hosp, Dept Surg, 75 Francis St, Boston, MA 02115 USA; [Hammouda, Khaled] Brigham & Womens Hosp, Surg ICU Translat Res STAR Ctr, 75 Francis St, Boston, MA 02115 USA	Cooper, Z (corresponding author), Brigham & Womens Hosp, Dept Surg, 75 Francis St, Boston, MA 02115 USA.	zcooper@partners.org			Patient-Centered Outcomes Research Institute (PCORI)Patient-Centered Outcomes Research Institute - PCORI [AD-1306-03980]; Dept. of Defense through the Henry M Jackson Foundation	Dr. Haider is the primary investigator of a contract (AD-1306-03980) with The Patient-Centered Outcomes Research Institute (PCORI) entitled "Patient-Centered Approaches to Collect Sexual Orientation/Gender Identity Information in the ED" and the PI on a Health Services Grant from the Dept. of Defense through the Henry M Jackson Foundation entitled "Epidemiology and Provider Induced Collaboration". Dr. Haider is also a co-founder and equity holder of a Johns Hopkins University supported start up known as Patient Doctor Technologies which owns and operates the website www.doctella.com. Dr. Schneider is a member of Bergeim, LLC and has patents pending in the area of CNS injury.	Ahluwalia SC, 2011, J ONCOL PRACT, V7, P361, DOI 10.1200/JOP.2011.000364; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Barnato AE, 2004, HEALTH SERV RES, V39, P363, DOI 10.1111/j.1475-6773.2004.00232.x; Calland JF, 2012, J TRAUMA ACUTE CARE, V73, pS345, DOI 10.1097/TA.0b013e318270191f; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Clark DE, 2004, J AM GERIATR SOC, V52, P2023, DOI 10.1111/j.1532-5415.2004.52560.x; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Davidson GH, 2011, JAMA-J AM MED ASSOC, V305, P1001, DOI 10.1001/jama.2011.259; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Donohue JT, 2007, J TRAUMA, V62, P419, DOI 10.1097/01.ta.0000219286.88179.18; Gill TM, 1998, ANN INTERN MED, V128, P96, DOI 10.7326/0003-4819-128-2-199801150-00004; Hernandez RA, 2015, AM J SURG, V210, P52, DOI 10.1016/j.amjsurg.2014.08.025; Hogan, 2014, AGING NATION OLDER P; Institute of Medicine Committee on Approaching Death, 2014, DYIN AM ADDR KEY END; Joseph B, 2014, JAMA SURG, V149, P766, DOI 10.1001/jamasurg.2014.296; Kwok AC, 2011, LANCET, V378, P1408, DOI 10.1016/S0140-6736(11)61268-3; Leblanc J, 2006, BRAIN INJURY, V20, P779, DOI 10.1080/02699050600831835; Livingston DH, 2005, J TRAUMA, V59, P1298, DOI 10.1097/01.ta.0000196002.03681.18; McIntyre A, 2013, NEUROREHABILITATION, V32, P409, DOI 10.3233/NRE-130862; McIntyre A, 2013, BRAIN INJURY, V27, P31, DOI 10.3109/02699052.2012.700086; Morrison RS, 2004, NEW ENGL J MED, V350, P2582, DOI 10.1056/NEJMcp035232; Mosenthal AC, 2004, J TRAUMA, V56, P1042, DOI 10.1097/01.TA.0000127767.83267.33; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; Nalichowski Ruth, 2006, AMIA Annu Symp Proc, P1044; National Quality Forum, 2012, END SUMM PALL CAR EN; Obermeyer Z, 2014, JAMA, V312, P1888; Obermeyer Z, 2015, HEALTH AFFAIR, V34, P993, DOI 10.1377/hlthaff.2014.1055; Powers BW, 2015, J PALLIAT MED, V18, P400, DOI 10.1089/jpm.2015.0014; Ross A M, 1992, J Neurosci Nurs, V24, P88; Schwarze ML, 2014, JAMA SURG, V149, P631, DOI 10.1001/jamasurg.2013.5143; Shinall MC, 2015, J RELIG HEALTH, V54, P977, DOI 10.1007/s10943-014-9869-4; Sirovich B, 2008, HEALTH AFFAIR, V27, P813, DOI 10.1377/hlthaff.27.3.813; Teno JM, 2013, JAMA-J AM MED ASSOC, V309, P470, DOI 10.1001/jama.2012.207624; Turgeon AF, 2013, CRIT CARE MED, V41, P1086, DOI 10.1097/CCM.0b013e318275d046; Turgeon AF, 2011, CAN MED ASSOC J, V183, P1581, DOI 10.1503/cmaj.101786	35	18	18	0	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	JUN	2016	80	6					998	1004		10.1097/TA.0000000000001028			7	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	DO5MX	WOS:000377828300029	26953761				2021-06-18	
J	Rigon, A; Duff, MC; McAuley, E; Kramer, AF; Voss, MW				Rigon, Arianna; Duff, Melissa C.; McAuley, Edward; Kramer, Arthur F.; Voss, Michelle W.			Is Traumatic Brain Injury Associated with Reduced Inter-Hemispheric Functional Connectivity? A Study of Large-Scale Resting State Networks following Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						externally oriented networks; inter-hemispheric functional connectivity; internally oriented networks; resting state fMRI; traumatic brain injury	DEFAULT MODE NETWORK; COMPLEX FIGURE TEST; MILD HEAD-INJURY; EXECUTIVE CONTROL; FMRI; MRI; DEFICITS; DISEASE; CORTEX; MEMORY	Traumatic brain injury (TBI) often has long-term debilitating sequelae in cognitive and behavioral domains. Understanding how TBI impacts functional integrity of brain networks that underlie these domains is key to guiding future approaches to TBI rehabilitation. In the current study, we investigated the differences in inter-hemispheric functional connectivity (FC) of resting state networks (RSNs) between chronic mild-to-severe TBI patients and normal comparisons (NC), focusing on two externally oriented networks (i.e., the fronto-parietal network [FPN] and the executive control network [ECN]), one internally oriented network (i.e., the default mode network [DMN]), and one somato-motor network (SMN). Seed voxel correlation analysis revealed that TBI patients displayed significantly less FC between lateralized seeds and both homologous and non-homologous regions in the opposite hemisphere for externally oriented networks but not for DMN or SMN; conversely, TBI patients showed increased FC within regions of the DMN, especially precuneus and parahippocampal gyrus. Region of interest correlation analyses confirmed the presence of significantly higher inter-hemispheric FC in NC for the FPN (p<0.01), and ECN (p<0.05), but not for the DMN (p>0.05) or SMN (p>0.05). Further analysis revealed that performance on a neuropsychological test measuring organizational skills and visuo-spatial abilities administered to the TBI group, the Rey-Osterrieth Complex Figure Test, positively correlated with FC between the right FPN and homologous regions. Our findings suggest that distinct RSNs display specific patterns of aberrant FC following TBI; this represents a step forward in the search for biomarkers useful for early diagnosis and treatment of TBI-related cognitive impairment.	[Rigon, Arianna; Duff, Melissa C.; Voss, Michelle W.] Univ Iowa, Neurosci Grad Program, WJSHC 250 Hawkins Dr, Iowa City, IA 52242 USA; Univ Iowa, Dept Commun Sci & Disorders, Iowa City, IA 52242 USA; [Duff, Melissa C.] Univ Iowa, Dept Neurol, Iowa City, IA 52242 USA; [Voss, Michelle W.] Univ Iowa, Dept Psychol & Brain Sci, Iowa City, IA 52242 USA; [McAuley, Edward; Kramer, Arthur F.] Univ Illinois, Beckman Inst Adv Sci & Technol, Urbana, IL USA; [McAuley, Edward] Univ Illinois, Dept Kinesiol & Community Hlth, Urbana, IL USA	Rigon, A (corresponding author), Univ Iowa, Neurosci Grad Program, WJSHC 250 Hawkins Dr, Iowa City, IA 52242 USA.	arianna-rigon@uiowa.edu	Kramer, Arthur/AAB-2937-2019	Kramer, Arthur/0000-0001-5870-2724	University of Iowa; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R37 AG025667, RO1 HD069381]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD069381] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R37AG025667] Funding Source: NIH RePORTER	This work was supported in part by start-up funds provided by the University of Iowa to MD and MV, and grant funding from NIH R37 AG025667 and NIH RO1 HD069381 supported image acquisition for the normal control participants. The authors would like to thank Joel Bruss for his advice during visual inspection of the anatomical images, Jocelyn Cole for the hand-tracing of the brain masks and Ruth Henson for logistic support in scheduling TBI participants.	Andersson J.L.R., 2007, TR07JA1 FMRIB; Andrews-Hanna JR, 2010, NEURON, V65, P550, DOI 10.1016/j.neuron.2010.02.005; [Anonymous], 1996, BIOSTATISTICAL ANAL; ARCINIEGAS DB, 2000, CURRENT TREATMENT OP, V2, P169; Arenivas A, 2014, BRAIN IMAGING BEHAV, V8, P407, DOI 10.1007/s11682-012-9191-2; Ashton VL, 2005, J CLIN EXP NEUROPSYC, V27, P55, DOI 10.1080/138033990513636; Beckmann CF, 2003, NEUROIMAGE, V20, P1052, DOI 10.1016/S1053-8119(03)00435-X; Beckmann CF, 2004, IEEE T MED IMAGING, V23, P137, DOI 10.1109/TMI.2003.822821; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Bonnelle V, 2011, J NEUROSCI, V31, P13442, DOI 10.1523/JNEUROSCI.1163-11.2011; Bramlett HM, 2002, ACTA NEUROPATHOL, V103, P607, DOI 10.1007/s00401-001-0510-8; Bullock M Ross, 2002, Neurosurg Focus, V13, pECP1; Centers for Disease Control and Prevention, 2014, INJ PREV CONTR TRAUM; de la Plata CDM, 2011, ARCH NEUROL-CHICAGO, V68, P74, DOI 10.1001/archneurol.2010.342; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Diamond BJ, 1997, BRAIN, V120, P1015, DOI 10.1093/brain/120.6.1015; Dosenbach NUF, 2007, P NATL ACAD SCI USA, V104, P11073, DOI 10.1073/pnas.0704320104; Eickhoff SB, 2007, NEUROIMAGE, V36, P511, DOI 10.1016/j.neuroimage.2007.03.060; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Fox MD, 2010, FRONT SYST NEUROSCI, V4, DOI [10.3389/fnsys.2010.00019, 10.3389/fnsys.2010.0001]; Greve DN, 2009, NEUROIMAGE, V48, P63, DOI 10.1016/j.neuroimage.2009.06.060; Hallquist MN, 2013, NEUROIMAGE, V82, P208, DOI 10.1016/j.neuroimage.2013.05.116; Ham TE, 2012, CURR OPIN NEUROL, V25, P662, DOI 10.1097/WCO.0b013e328359488f; Hsiang JNK, 1997, J NEUROSURG, V87, P234, DOI 10.3171/jns.1997.87.2.0234; Irimia A, 2012, NEUROIMAGE-CLIN, V1, P1, DOI 10.1016/j.nicl.2012.08.002; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Johnson B, 2012, NEUROSCI LETT, V509, P5, DOI 10.1016/j.neulet.2011.11.013; Johnson B, 2012, NEUROIMAGE, V59, P511, DOI 10.1016/j.neuroimage.2011.07.081; Kasahara M, 2010, NEUROLOGY, V75, P168, DOI 10.1212/WNL.0b013e3181e7ca58; Kasahara M, 2011, BRAIN INJURY, V25, P1170, DOI 10.3109/02699052.2011.608210; Kelly RE, 2010, J NEUROSCI METH, V189, P233, DOI 10.1016/j.jneumeth.2010.03.028; Krmpotich TD, 2013, DRUG ALCOHOL DEPEN, V129, P1, DOI 10.1016/j.drugalcdep.2013.01.021; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Leech R, 2014, BRAIN, V137, P12, DOI 10.1093/brain/awt162; Lezack M. D., 2004, NEUROPYCHOLOGICAL AS; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; McDonald BC, 2002, NEUROREHABILITATION, V17, P333; McDonald BC, 2012, BRAIN IMAGING BEHAV, V6, P193, DOI 10.1007/s11682-012-9173-4; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; O'Reilly JX, 2013, P NATL ACAD SCI USA, V110, P13982, DOI 10.1073/pnas.1305062110; Pagulayan KF, 2006, ARCH PHYS MED REHAB, V87, P611, DOI 10.1016/j.apmr.2006.01.018; Pickett TC, 2007, J REHABIL RES DEV, V44, P983, DOI 10.1682/JRRD.2007.01.0001; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Ptak R, 2012, NEUROSCIENTIST, V18, P502, DOI 10.1177/1073858411409051; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Schwarz L, 2009, CLIN NEUROPSYCHOL, V23, P255, DOI 10.1080/13854040802220034; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Shukla D, 2011, CLIN NEUROL NEUROSUR, V113, P435, DOI 10.1016/j.clineuro.2011.02.013; Shumskaya E, 2012, NEUROLOGY, V79, P175, DOI 10.1212/WNL.0b013e31825f04fb; Slobounov SM, 2011, NEUROIMAGE, V55, P1716, DOI 10.1016/j.neuroimage.2011.01.024; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Sours C, 2015, BRAIN IMAGING BEHAV, V9, P190, DOI 10.1007/s11682-014-9295-y; Spreng RN, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00145; Spreng RN, 2010, NEUROIMAGE, V53, P303, DOI 10.1016/j.neuroimage.2010.06.016; Spreng RN, 2010, J COGNITIVE NEUROSCI, V22, P1112, DOI 10.1162/jocn.2009.21282; Stevens MC, 2012, BRAIN IMAGING BEHAV, V6, P293, DOI 10.1007/s11682-012-9157-4; Stonnington CM, 2008, NEUROIMAGE, V39, P1180, DOI 10.1016/j.neuroimage.2007.09.066; TEASDALE G, 1974, LANCET, V2, P81; Tranel D., 1996, IOWA BENTON SCH NEUR; Walker WC, 2007, J REHABIL RES DEV, V44, P975, DOI 10.1682/JRRD.2006.12.0158; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Wortzel HS, 2012, CURR TREAT OPTION NE, V14, P493, DOI 10.1007/s11940-012-0193-6; Zhang DY, 2010, NAT REV NEUROL, V6, P15, DOI 10.1038/nrneurol.2009.198	71	18	18	0	10	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN 1	2016	33	11					977	989		10.1089/neu.2014.3847			13	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	DN3SU	WOS:000376984600001	25719433	Green Published			2021-06-18	
J	Williams, JM; Langdon, JL; McMillan, JL; Buckley, TA				Williams, Joshua M.; Langdon, Jody L.; McMillan, James L.; Buckley, Thomas A.			English professional football players concussion knowledge and attitude	JOURNAL OF SPORT AND HEALTH SCIENCE			English	Article						Concussion; Concussion recovery; Concussion reporting; Football; Mild traumatic brain injury; RoCKAS	CHRONIC TRAUMATIC ENCEPHALOPATHY; RUGBY UNION PLAYERS; HEAD-INJURY; RECURRENT CONCUSSION; NCAA CONCUSSION; PHYSICAL-ACTIVITY; SOCCER PLAYERS; ICE HOCKEY; EDUCATION; SPORT	Background: Concussions are a common pathology in football and multiple misconceptions exist amongst the players and managers. To address these misconceptions, and potentially reduce concussion associated sequela, effective educational interventions need to be developed. However, the current knowledge and attitude status must be ascertained to appropriately develop these interventions. The purpose of this study was to assess the concussion knowledge and attitude of English professional footballers. Methods: Twenty-six participants from one English Football League Championship club completed the study. A mixed methods approach included the Rosenbaum Concussion Knowledge and Attitudes Survey (RoCKAS) and a semi-structured interview. The RoCKAS contains separate knowledge (0-25) and attitude (15-75) scores and was followed by a semi-structured interview consisting of concussion knowledge, attitude, and behavior related questions. Results: The mean score on the RoCKAS knowledge was 16.4 +/- 2.9 (range 11-22) and the attitude score was 59.6 +/- 8.5 (range 41-71). The interview responses identified inconsistencies between the RoCKAS and the intended behaviors, endorsing multiple concussion misconceptions, and revealed barriers to concussion reporting. Conclusion: The results of this study suggest that Championship Level English footballers have moderate concussion knowledge, safe attitudes, and good concussion symptom recognition when assessed with pen and paper questionnaires. However, within the semi-structured interview many respondents reported unsafe concussion behaviors despite accurately identifying the potential risks. Further, multiple barriers to concussion reporting were identified which included perceived severity of the injury, game situations, and the substitution rule. These findings can help form the foundation of educational interventions to potentially improve concussion reporting behaviors amongst professional footballers. (C) 2016 Production and hosting by Elsevier B.V. on behalf of Shanghai University of Sport.	[Williams, Joshua M.] Wagner Coll, Dept Intercoll Athlet, Staten Isl, NY 10301 USA; [Langdon, Jody L.; McMillan, James L.] Georgia So Univ, Sch Hlth & Kinesiol, Statesboro, GA 30460 USA; [Buckley, Thomas A.] Univ Delaware, Dept Kinesiol & Appl Physiol, Newark, DE 19716 USA	Buckley, TA (corresponding author), Univ Delaware, Dept Kinesiol & Appl Physiol, Newark, DE 19716 USA.	TBuckley@UDel.edu	Buckley, Thomas A/B-7525-2016	Buckley, Thomas A/0000-0002-0515-0150	Department of Health and Kinesiology at Georgia Southern University	This project was funded, in part, by the Department of Health and Kinesiology at Georgia Southern University. The data collection and analysis, manuscript write-up and submission, and the decision to submit to the Journal of Sport and Health Science were made by the research team independent of any influence by the funding department.	Baker JF, 2013, IRISH J MED SCI, V182, P121, DOI 10.1007/s11845-012-0846-1; Barnes BC, 1998, AM J SPORT MED, V26, P433, DOI 10.1177/03635465980260031601; Bramley H, 2012, CLIN PEDIATR, V51, P332, DOI 10.1177/0009922811425233; Broglio SP, 2007, NEUROSURGERY, V60, P1050, DOI 10.1227/01.NEU.0000255479.90999.C0; Broglio SP, 2010, J SPORT SCI MED, V9, P418; Cantu RC, 1998, CLIN SPORT MED, V17, P37, DOI 10.1016/S0278-5919(05)70059-4; Cantu RC, 2010, WORLD NEUROSURG, V74, P224, DOI 10.1016/j.wneu.2010.07.023; Chapman RCG, 2010, BRAIN INJURY, V24, P797, DOI 10.3109/02699051003709607; Chrisman SP, 2013, J ADOLESCENT HEALTH, V52, P330, DOI 10.1016/j.jadohealth.2012.10.271; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; Cournoyer J, 2014, J ATHL TRAINING, V49, P654, DOI 10.4085/1062-6050-49.3.34; Covassin T, 2003, APPL NEUROPSYCHOL, V10, P12, DOI 10.1207/S15324826AN1001_3; Echlin PS, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.10.FOCUS10222; Fraas MR, 2015, IRISH J MED SCI, V184, P425, DOI 10.1007/s11845-014-1137-9; Fraas MR, 2014, PHYS THER SPORT, V15, P136, DOI 10.1016/j.ptsp.2013.08.002; Gaughan J, 2013, DAILY MAIL; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; International Federation of Association Football, 2007, THE BIG COUNT; Kaut KP, 2003, CLIN J SPORT MED, V13, P213, DOI 10.1097/00042752-200307000-00004; Kroshus E, 2014, BRIT J SPORT MED, V48, P135, DOI 10.1136/bjsports-2013-092498; Kuczmarski MF, 2001, J AM DIET ASSOC, V101, P28, DOI 10.1016/S0002-8223(01)00008-6; League AF, 2013, LAWS AUSTR FOOTBALL; Levy ML, 2012, WORLD NEUROSURG, V78, P535, DOI 10.1016/j.wneu.2011.10.032; Littleton A, 2013, J SPORT HEALTH SCI, V2, P227, DOI 10.1016/j.jshs.2013.04.003; Llewellyn T, 2014, CLIN J SPORT MED, V24, P76, DOI 10.1097/01.jsm.0000432853.77520.3d; McAllister-Deitrick J, 2014, ATHL TRAIN SPORTS HL, V6, P280, DOI DOI 10.3928/01484834-20141112-03; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2013, BRIT J SPORT MED, V47, P327, DOI 10.1136/bjsports-2013-092248; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McCrory P, 2012, CURR SPORT MED REP, V11, P21, DOI 10.1249/JSR.0b013e3182423bfd; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; McLeod TCV, 2007, CLIN J SPORT MED, V17, P140; Mihalik JP, 2014, J SPORT HEALTH SCI, V3, P307, DOI 10.1016/j.jshs.2014.07.005; Moreau M. S., 2014, INT J EXERCISE SCI, V7, P62; Overturf CD, 2012, NAT PRECEDINGS, P1; POSNER BM, 1992, EPIDEMIOLOGY, V3, P171, DOI 10.1097/00001648-199203000-00016; Price J, 2012, BRIT J SPORT MED, V46, P1000, DOI 10.1136/bjsports-2011-090687; Provvidenza C, 2013, BRIT J SPORT MED, V47, P332, DOI 10.1136/bjsports-2012-092099; Register-Mihalik JK, 2011, J ATHL TRAINING, V46, pS15; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Register-Mihalik JK, 2013, BRAIN INJURY, V27, P878, DOI 10.3109/02699052.2013.775508; Rosenbaum AM, 2010, J CLIN EXP NEUROPSYC, V32, P44, DOI 10.1080/13803390902806535; Rutherford A, 2003, NEUROPSYCHOL REV, V13, P153, DOI 10.1023/A:1025525613477; Rzewnicki R, 2003, PUBLIC HEALTH NUTR, V6, P299, DOI 10.1079/PHN2002427; Saunders EA, 2013, ATHLETIC TRAINING SP, V5, P11, DOI DOI 10.3928/19425864-20121217-02; Shim JS, 2014, EPIDEMIOL HEALTH, V36, DOI 10.4178/epih/e2014009; Vuillemin A, 2000, MED SCI SPORT EXER, V32, P1119, DOI 10.1097/00005768-200006000-00013; Weber M, 2012, ARCH CLIN NEUROPSYCH, V27, P355, DOI 10.1093/arclin/acs029; Wright C., VINCENT KOMPANY PLAY; Zemper ED, 2003, AM J PHYS MED REHAB, V82, P653, DOI 10.1097/01.PHM.0000083666.74494.BA	55	18	18	1	23	SHANGHAI UNIV SPORT	SHANGHAI	EDITORIAL BOARD, 650 QINGYUANHUAN RD, SHANGHAI, 200438, PEOPLES R CHINA	2095-2546	2213-2961		J SPORT HEALTH SCI	J. Sport Health Sci.	JUN	2016	5	2					197	204		10.1016/j.jshs.2015.01.009			8	Hospitality, Leisure, Sport & Tourism; Sport Sciences	Social Sciences - Other Topics; Sport Sciences	DP3MO	WOS:000378398500015	30356509	DOAJ Gold, Green Published			2021-06-18	
J	Shields, C; Ownsworth, T; O'Donovan, A; Fleming, J				Shields, Cassandra; Ownsworth, Tamara; O'Donovan, Analise; Fleming, Jennifer			A transdiagnostic investigation of emotional distress after traumatic brain injury	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Traumatic brain injury; Emotional distress; Transdiagnostic perspective; Emotional dysregulation	COGNITIVE-BEHAVIOR THERAPY; SELF-FOCUSED ATTENTION; QUALITY-OF-LIFE; PSYCHIATRIC-DISORDERS; ANXIETY DISORDERS; POSTTRAUMATIC GROWTH; MULTIPLE IMPUTATION; UNIFIED TREATMENT; VERBAL FLUENCY; DEPRESSION	Emotional distress after traumatic brain injury (TBI) often presents as a range of neurobehavioural and emotional reactions rather than distinct disorders. This study adopted a transdiagnostic approach with the aim of identifying psychological processes common to depression, anxiety and global distress after TBI. Fifty participants with TBI (aged 19-66 years, 12-65 months post-injury) completed measures of threat appraisals and avoidance behaviour (Appraisal of Threat and Avoidance Questionnaire), self-discrepancy (Head Injury Semantic Differential Scale III), emotion dysregulation (Difficulties in Emotion Regulation Scale), worry (Penn State Worry Questionnaire), negative self-focused attention (Self-Focus Sentence Completion) and emotional distress (Depression Anxiety Stress Scales and Brief Symptom Inventory). Significant correlations were found among the proposed transdiagnostic variables (rs=.29-.82, p<.05). A principal components analysis revealed two underlying factors: (1) Threats to Self, and (2) Emotion Dysregulation. Only the Emotion Dysregulation factor accounted for significant unique variance in levels of depression, anxiety and global distress (sr(2)=.12-.17). Such findings indicate the need for interventions to target difficulties in identifying and regulating emotions after TBI to facilitate emotional adjustment.	[Shields, Cassandra; Ownsworth, Tamara; O'Donovan, Analise] Griffith Univ, Sch Appl Psychol, Mt Gravatt, Qld 4122, Australia; [Shields, Cassandra; Ownsworth, Tamara; O'Donovan, Analise] Griffith Univ, Griffith Hlth Inst, Mt Gravatt, Qld 4122, Australia; [Fleming, Jennifer] Univ Queensland, Sch Hlth & Rehabil Sci, Brisbane, Qld, Australia; [Fleming, Jennifer] Princess Alexandra Hosp, Occupat Therapy Dept, Brisbane, Qld 4102, Australia	Shields, C (corresponding author), Logan Clin Psychol, 77 Wembley Rd, Logan Cent, Qld 4114, Australia.	cassandra.shields76@gmail.com		Ownsworth, Tamara/0000-0003-1835-7094			Aldao A, 2010, BEHAV RES THER, V48, P974, DOI 10.1016/j.brat.2010.06.002; Allen L.B., 2008, CLIN HDB PSYCHOL DIS, P216; American Psychiatric Association, 2013, DIAGN STAT MAN MENT, V5, DOI [10.1176/appi.books.9780890425596., DOI 10.1176/APPI.BOOKS.9780890425596, 10.1176/appi.books.9780890425596]; American Psychiatric Association, 2004, DIAGN STAT MAN MENT, VFOURTH; Anson K, 2006, J HEAD TRAUMA REHAB, V21, P248, DOI 10.1097/00001199-200605000-00005; Army Individual Test Battery, 1944, MAN DIR SCOR; Ashman TA, 2009, ARCH PHYS MED REHAB, V90, P733, DOI 10.1016/j.apmr.2008.11.005; Ashworth F, 2011, BRAIN IMPAIR, V12, P128, DOI 10.1375/brim.12.2.128; Australian Bureau of Statistics, 2007, NAT SURV MENT HLTH W; Barlow DH, 2004, BEHAV THER, V35, P205, DOI 10.1016/S0005-7894(04)80036-4; BARTLETT MS, 1954, J ROY STAT SOC B, V16, P296; Beck R, 2003, J PSYCHOPATHOL BEHAV, V25, P251, DOI 10.1023/A:1025899029040; Bedard M, 2003, DISABIL REHABIL, V25, P722, DOI 10.1080/0963828031000090489; Bedard M, 2014, J HEAD TRAUMA REHAB, V29, pE13, DOI 10.1097/HTR.0b013e3182a615a0; Benton A., 1976, MULTILINGUAL APHASIA; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Bradbury CL, 2008, ARCH PHYS MED REHAB, V89, pS61, DOI 10.1016/j.apmr.2008.08.210; Brown TA, 2009, PSYCHOL ASSESSMENT, V21, P256, DOI 10.1037/a0016608; Campbell-Sills L., 2007, HDB EMOTION REGULATI, V2, P542; Cantor JB, 2005, J HEAD TRAUMA REHAB, V20, P527, DOI 10.1097/00001199-200511000-00005; Carlson LE, 2004, BRIT J CANCER, V90, P2297, DOI 10.1038/sj.bjc.6601887; Carroll E, 2011, NEUROPSYCHOL REHABIL, V21, P289, DOI 10.1080/09602011.2011.555972; CARVER CS, 1987, J PERS, V55, P525, DOI 10.1111/j.1467-6494.1987.tb00449.x; Cattran C, 2011, J CLIN EXP NEUROPSYC, V33, P672, DOI 10.1080/13803395.2010.550603; Cicerone KD, 2007, J HEAD TRAUMA REHAB, V22, P257, DOI 10.1097/01.HTR.0000290970.56130.81; CLARK LA, 1991, J ABNORM PSYCHOL, V100, P316, DOI 10.1037/0021-843X.100.3.316; Cooper-Evans S, 2008, NEUROPSYCHOL REHABIL, V18, P607, DOI 10.1080/09602010801948516; Curran CA, 2000, J HEAD TRAUMA REHAB, V15, P1256, DOI 10.1097/00001199-200012000-00006; Dahm J, 2013, J AFFECT DISORDERS, V151, P392, DOI 10.1016/j.jad.2013.06.011; de Jong-Meyer R, 2009, PERS INDIV DIFFER, V46, P547, DOI 10.1016/j.paid.2008.12.010; Derogatis L., 1975, SCL 90 R REVISED VER; Derogatis LR, 2001, BRIEF SYMPTOM INVENT; Dozois DJA, 2009, J COGN PSYCHOTHER, V23, P44, DOI 10.1891/0889-8391.23.1.44; Ehring T, 2008, INT J COGN THER, V1, P192, DOI 10.1680/ijct.2008.1.3.192; Endler N. S., 1989, SELF REALIZATION SUC, P151; EXNER JE, 1973, J PERS ASSESS, V37, P437, DOI 10.1080/00223891.1973.10119902; Falquez R, 2014, FRONT BEHAV NEUROSCI, V8, P1, DOI 10.3389/fnbeh.2014.00165; Fann JR, 2000, J NEUROPSYCH CLIN N, V12, P226, DOI 10.1176/appi.neuropsych.12.2.226; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Fleminger S, 2008, EUR J ANAESTH, V25, P123, DOI 10.1017/S0265021507003250; FOLKMAN S, 1986, J PERS SOC PSYCHOL, V50, P992, DOI 10.1037/0022-3514.50.5.992; Gilbert P., 2010, COMPASSION FOCUSED T; Gillis MM, 1995, PSYCHOL ASSESSMENT, V7, P450, DOI 10.1037/1040-3590.7.4.450; Goldstein K., 1939, CONCEPTION ORGANISM; Goldstein K, 1943, PSYCHOSOM MED, V5, P376, DOI 10.1097/00006842-194310000-00007; Gould KR, 2011, PSYCHOL MED, V41, P2099, DOI 10.1017/S003329171100033X; Gould KR, 2014, J CLIN EXP NEUROPSYC, V36, P1, DOI 10.1080/13803395.2013.863832; Gracey F, 2008, NEUROPSYCHOL REHABIL, V18, P627, DOI 10.1080/09602010802041238; Gracey F, 2009, NEUROPSYCHOL REHABIL, V19, P867, DOI 10.1080/09602010903027763; Gratz KL, 2004, J PSYCHOPATHOL BEHAV, V26, P41, DOI 10.1023/B:JOBA.0000007455.08539.94; Green JD, 2003, BRIT J SOC PSYCHOL, V42, P147, DOI 10.1348/014466603763276171; Gross J. J., 1998, REV GEN PSYCHOL VOL, V2, P271, DOI [DOI 10.1037/1089-2680.2.3.271, 10.1037/1089-2680.2.3.271]; Gross J.J., 2007, HDB EMOTION REGULATI, P3, DOI DOI 10.1080/00140130600971135; Hair J. F., 2006, MULTIVARIATE DATA AN, V6; Hair J.F, 1998, MULTIVARIATE DATA AN; Harvey A.G., 2004, COGNITIVE BEHAV PROC; Harvey AG, 1998, BRAIN INJURY, V12, P147, DOI 10.1080/026990598122773; Hayes S., 2012, ACCEPTANCE COMMITMEN; Hodgson J, 2005, BRAIN IMPAIR, V6, P169, DOI DOI 10.1375/BRIM.2005.6.3.169; Hofmann SG, 2010, J CONSULT CLIN PSYCH, V78, P169, DOI 10.1037/a0018555; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; JORGE RE, 1993, J NEUROPSYCH CLIN N, V5, P369; KAISER HF, 1974, PSYCHOMETRIKA, V39, P31, DOI 10.1007/BF02291575; Kendall E, 2009, SOC SCI MED, V69, P947, DOI 10.1016/j.socscimed.2009.06.021; Kersel DA, 2001, BRAIN INJURY, V15, P683, DOI 10.1080/02699050010013662; KLONOFF PS, 1993, B MENNINGER CLIN, V57, P227; Kohn N, 2014, NEUROIMAGE, V87, P345, DOI 10.1016/j.neuroimage.2013.11.001; Kortte KB, 2003, REHABIL PSYCHOL, V48, P131, DOI 10.1037/0090-5550.48.3.131; Kreutzer JS, 2001, BRAIN INJURY, V15, P563, DOI 10.1080/02699050010009108; Krpan KM, 2011, J INT NEUROPSYCH SOC, V17, P248, DOI 10.1017/S1355617710001499; Lazarus R.S., 1984, STRESS APPRAISAL COP; LAZARUS RS, 1993, PSYCHOSOM MED, V55, P234, DOI 10.1097/00006842-199305000-00002; Levesque J, 2003, BIOL PSYCHIAT, V53, P502, DOI 10.1016/S0006-3223(02)01817-6; Lieberman MD, 2007, ANNU REV PSYCHOL, V58, P259, DOI 10.1146/annurev.psych.58.110405.085654; Linehan M., 1993, SKILLS TRAINING MANU; Lovibond S.H., 1995, MANUAL DEPRESSION AN; MALIA K, 1995, BRAIN INJURY, V9, P607, DOI 10.3109/02699059509008219; Mansell W, 2009, J COGN PSYCHOTHER, V23, P6, DOI 10.1891/0889-8391.23.1.6; Mansell W, 2008, INT J COGN THER, V1, P181, DOI 10.1680/ijct.2008.1.3.181; McDonald S., 2014, UNDERSTANDING TRAUMA, P133; MCDONALD S, 2003, BRAIN IMPAIR, V4, P36, DOI DOI 10.1375/brim.4.1.36.27032; McGrath JC, 2006, BRAIN INJURY, V20, P767, DOI 10.1080/02699050600664566; Meachen SJ, 2008, ARCH PHYS MED REHAB, V89, P958, DOI 10.1016/j.apmr.2007.12.028; Meares S, 2006, J INT NEUROPSYCH SOC, V12, P792, DOI 10.1017/S1355617706060978; MEYER TJ, 1990, BEHAV RES THER, V28, P487, DOI 10.1016/0005-7967(90)90135-6; Moldover JE, 2004, NEUROPSYCHOL REV, V14, P143, DOI 10.1023/B:NERV.0000048181.46159.61; MOORE AD, 1995, BRAIN INJURY, V9, P109, DOI 10.3109/02699059509008185; Mor N, 2002, PSYCHOL BULL, V128, P638, DOI 10.1037//0033-2909.128.4.638; Nalder E, 2012, BRAIN INJURY, V26, P1381, DOI 10.3109/02699052.2012.676225; Nalder E, 2012, J HEAD TRAUMA REHAB, V27, P143, DOI 10.1097/HTR.0b013e3182168fb1; Nolen-Hoeksema S, 2011, PERSPECT PSYCHOL SCI, V6, P589, DOI 10.1177/1745691611419672; Ownsworth T, 2004, DISABIL REHABIL, V26, P765, DOI 10.1080/09638280410001696700; Ownsworth T., 2014, SELF IDENTITY BRAIN; Ownsworth T, 2008, BRAIN INJURY, V22, P858, DOI 10.1080/02699050802446697; Ownsworth T, 2011, J INT NEUROPSYCH SOC, V17, P112, DOI 10.1017/S1355617710001311; Podsakoff PM, 2003, J APPL PSYCHOL, V88, P879, DOI 10.1037/0021-9010.88.5.879; Randolphs C., 1998, REPEATABLE BATTERY A; Raskin SA, 1996, NEUROPSYCHOLOGY, V10, P416, DOI 10.1037/0894-4105.10.3.416; Riley GA, 2004, BRAIN INJURY, V18, P871, DOI 10.1080/02699050410001671829; Robinson J.P., 1991, MEASURES PERSONALITY, P1; Rochat L, 2009, J NEUROPSYCHOL, V3, P213, DOI 10.1348/174866408X397656; Rubin DB, 1996, J AM STAT ASSOC, V91, P473, DOI 10.1080/01621459.1996.10476908; Rutterford NA, 2006, J INT NEUROPSYCH SOC, V12, P359, DOI 10.1017/S1355617706060450; Salas CE, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00242; Salas CE, 2013, NEUROPSYCHOL REHABIL, V23, P467, DOI 10.1080/09602011.2013.784709; SANTORO J, 1994, BRAIN INJURY, V8, P265, DOI 10.3109/02699059409150978; Schulz KF, 2010, ANN INTERN MED, V152, P726, DOI 10.7326/0003-4819-152-11-201006010-00232; Seel RT, 2003, ARCH PHYS MED REHAB, V84, P177, DOI 10.1053/apmr.2003.50106; Shields C., 2013, NEURODISABILITY PSYC, V1, P39; Silva J, 2011, BRAIN IMPAIR, V12, P93, DOI 10.1375/brim.12.2.93; Sinharay S, 2001, PSYCHOL METHODS, V6, P317, DOI 10.1037//1082-989X.6.4.317; Spector PE, 2006, ORGAN RES METHODS, V9, P221, DOI 10.1177/1094428105284955; Spreen O., 1998, COMPENDIUM NEUROPSYC; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Tabachnick BG, 2007, USING MULTIVARIATE S; Tate R. L., 2010, COMPENDIUM TESTS SCA; Tate RL, 1999, CORTEX, V35, P39, DOI 10.1016/S0010-9452(08)70784-6; Tateno A, 2003, J NEUROPSYCH CLIN N, V15, P155, DOI 10.1176/appi.neuropsych.15.2.155; Tombaugh TN, 1999, ARCH CLIN NEUROPSYCH, V14, P167, DOI 10.1016/S0887-6177(97)00095-4; Trosper SE, 2009, CLIN CHILD FAM PSYCH, V12, P234, DOI 10.1007/s10567-009-0043-6; TYERMAN A, 1984, INT J REHABIL RES, V7, P11, DOI 10.1097/00004356-198403000-00002; Tyerman A., 1997, HEAD INJURY SEMANTIC, VIII; Valera EM, 2003, J CONSULT CLIN PSYCH, V71, P797, DOI 10.1037/0022-006X.71.4.797; Vickery CD, 2005, BRAIN INJURY, V19, P657, DOI 10.1080/02699050400005218; Waldron B, 2013, NEUROPSYCHOL REHABIL, V23, P64, DOI 10.1080/09602011.2012.724196; Watson D, 2005, J ABNORM PSYCHOL, V114, P522, DOI 10.1037/0021-843X.114.4.522; Whelan-Goodinson R, 2009, J HEAD TRAUMA REHAB, V24, P324, DOI 10.1097/HTR.0b013e3181a712aa; Wicklund, 1972, THEORY OBJECTIVE SEL; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Williams WH, 2003, NEUROPSYCHOL REHABIL, V13, P133, DOI 10.1080/09602010244000417; Wood RLL, 2006, J INT NEUROPSYCH SOC, V12, P350, DOI 10.1017/S1355617706060498; Wood RL, 2013, J HEAD TRAUMA REHAB, V28, P98, DOI 10.1097/HTR.0b013e3182426029; Woodruff-Borden J, 2001, BEHAV COGN PSYCHOTH, V29, P169, DOI 10.1017/S1352465801002041; WRIGHT JC, 1996, CLIN REHABIL, V10, P334, DOI DOI 10.1177/026921559601000412	134	18	18	1	29	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	MAY 3	2016	26	3					410	445		10.1080/09602011.2015.1037772			36	Neurosciences; Psychology	Neurosciences & Neurology; Psychology	DG2RO	WOS:000371915600005	25918948	Green Accepted			2021-06-18	
J	Agrawal, D; Raghavendran, K; Schaubel, DE; Mishra, MC; Rajajee, V				Agrawal, Deepak; Raghavendran, Krishnan; Schaubel, Douglas E.; Mishra, Mahesh C.; Rajajee, Venkatakrishna			A Propensity Score Analysis of the Impact of Invasive Intracranial Pressure Monitoring on Outcomes after Severe Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						developing countries; Glasgow Outcome Scale; intracranial pressure; traumatic brain injury	ROAD-TRAFFIC INJURIES; DECOMPRESSIVE CRANIECTOMY; MORTALITY; EPIDEMIOLOGY; BURDEN; TRIAL	Although a recent clinical trial (BEST TRIP) demonstrated no improvement in outcomes with invasive intracranial pressure (ICP) monitoring (ICPM) following severe traumatic brain injury (TBI), its generalizability has been called into question. In several global settings ICPM is not the standard of care and is used at the discretion of the attending neurosurgeon. Our objective was to determine the impact of ICPM on mortality and 6-month functional outcomes following severe TBI. The setting was a referral trauma center with 36 intensive care unit (ICU) beds and 300-600 TBI admissions per year. During a 2-year period data were prospectively entered into a severe TBI registry. Patients with severe TBI aged >12 years meeting Brain Trauma Foundation (BTF) criteria for ICPM were included in the study. Outcomes of interest were in-hospital mortality and poor 6-month functional outcome defined as Glasgow Outcome Scale (GOS) score of 3 or lower. A propensity score based analysis incorporating known predictors of outcome in TBI was utilized to examine the impact of ICPM on outcomes. Of 1345 patients meeting study criteria 497 (37%) underwent ICPM. In-hospital mortality was 35% (471/1345). Of 454 patients for whom 6-month outcome was available, 161 (35%) suffered a poor functional outcome. Following propensity score analysis ICPM use was associated with an 8% (p = 0.002) decrease in mortality but no significant effect (p = 0.2) on functional outcome. The use of ICPM following severe TBI was associated with decreased in-hospital mortality. Further clinical trials of ICPM in TBI may be warranted.	[Agrawal, Deepak] All India Inst Med Sci, JPN Apex Trauma Ctr, Ansari Nagar, India; [Agrawal, Deepak] All India Inst Med Sci, Neurosci Ctr, Ansari Nagar, India; [Mishra, Mahesh C.] All India Inst Med Sci, Dept Surg Disciplines, Ansari Nagar, India; [Raghavendran, Krishnan] Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA; [Schaubel, Douglas E.] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; [Rajajee, Venkatakrishna] Univ Michigan, Dept Neurosurg, Ann Arbor, MI 48109 USA; [Rajajee, Venkatakrishna] Univ Michigan, Dept Neurol, Ann Arbor, MI USA	Rajajee, V (corresponding author), Univ Michigan, Dept Neurosurg, Taubman Hlth Care Ctr 3552, 1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.; Rajajee, V (corresponding author), Univ Michigan, Dept Neurol, Taubman Hlth Care Ctr 3552, 1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.	vrajajee@yahoo.com	/AAG-3032-2021	/0000-0002-5499-0746; Rajajee, Venkatakrishna/0000-0002-7183-8324			Ameratunga S, 2006, LANCET, V367, P1533, DOI 10.1016/S0140-6736(06)68654-6; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Chesnut RM, 2013, INTENS CARE MED, V39, P771, DOI 10.1007/s00134-013-2852-9; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Chesnut RM, 2000, J NEUROTRAUM, V17, P555; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Dandona R, 2008, INJURY PREV, V14, P354, DOI 10.1136/ip.2008.019620; Dawes AJ, 2015, J TRAUMA ACUTE CARE, V78, P492, DOI 10.1097/TA.0000000000000559; De Silva MJ, 2009, INT J EPIDEMIOL, V38, P452, DOI 10.1093/ije/dyn189; Farahvar A, 2012, J NEUROSURG, V117, P729, DOI 10.3171/2012.7.JNS111816; Gerber LM, 2013, J NEUROSURG, V119, P1583, DOI 10.3171/2013.8.JNS13276; Gururaj G, 2008, NATL MED J INDIA, V21, P14; Gururaj G, 2002, NEUROL RES, V24, P24, DOI 10.1179/016164102101199503; Heinze G, 2011, EUR HEART J, V32, P1704, DOI 10.1093/eurheartj/ehr031; JENNETT B, 1975, LANCET, V1, P480; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Murray CJL, 1997, LANCET, V349, P1436, DOI 10.1016/S0140-6736(96)07495-8; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Sahuquillo J, 2013, CURR OPIN CRIT CARE, V19, P101, DOI 10.1097/MCC.0b013e32835eba1a	20	18	19	0	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAY 1	2016	33	9					853	858		10.1089/neu.2015.4015			6	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	DK7SA	WOS:000375124800007	26414629				2021-06-18	
J	Greenhill, DA; Navo, P; Zhao, HQ; Torg, J; Comstock, RD; Boden, BP				Greenhill, Dustin A.; Navo, Paul; Zhao, Huaqing; Torg, Joseph; Comstock, R. Dawn; Boden, Barry P.			Inadequate Helmet Fit Increases Concussion Severity in American High School Football Players	SPORTS HEALTH-A MULTIDISCIPLINARY APPROACH			English	Article						concussion; football helmets; athletic trainer	SYMPTOM SEVERITY; RISK-FACTORS; INJURY; PREDICTORS; EQUIPMENT; RATES	Background: There is limited information on the relationship between football helmet fit and concussion severity. Hypothesis: Poor helmet fit may predispose football players to a more severe concussion. Study Design: Descriptive epidemiology study. Level of Evidence: Level 3. Methods: Data from concussion injury reports were obtained from the National High School Sports-Related Injury Surveillance System over a 9-year period. Symptoms, duration, and helmet parameters (fit, interior padding) were analyzed for all first-time concussions. Results: Data from 4580 concussions were analyzed. Patients who suffered concussions with a helmet that did not fit properly (3.22%), as determined by an athletic trainer, had higher rates of drowsiness (RR, 1.46; P = 0.005), hyperexcitability (RR, 2.38; P = 0.047), and sensitivity to noise (RR, 1.88; P < 0.001); had more symptoms (5.34 vs 4.54, P = 0.004); and had longer symptom duration (P = 0.04). Athletes with helmets lined with an air bladder had greater rates of sensitivity to light (RR, 1.13; P = 0.02), sensitivity to noise (RR, 1.25; P = 0.009), and longer symptom duration (P = 0.004) compared with foam or gel liners. Conclusion: An improperly fitted football helmet is a risk factor for a concussion with more symptoms and of longer duration. Concussions of longer duration are also more common in players with an air bladder-lined helmet. Current high school football rules should mandate supervision and maintenance of helmet fit throughout the season, prior to impact.	[Greenhill, Dustin A.; Torg, Joseph] Temple Univ Hosp & Med Sch, Dept Orthopaed Surg & Sports Med, 3401 North Broad St,Zone B 6th Floor, Philadelphia, PA 19140 USA; [Navo, Paul; Zhao, Huaqing] Temple Univ, Sch Med, Philadelphia, PA 19122 USA; [Comstock, R. Dawn] Colorado Sch Publ Hlth, Dept Epidemiol, Aurora, CO USA; [Comstock, R. Dawn] Univ Colorado, Sch Med, Dept Pediat, Aurora, CO USA; [Boden, Barry P.] Orthopaed Ctr, Rockville, MD USA	Greenhill, DA (corresponding author), Temple Univ Hosp & Med Sch, Dept Orthopaed Surg & Sports Med, 3401 North Broad St,Zone B 6th Floor, Philadelphia, PA 19140 USA.	dustin.greenhill2@tuhs.temple.edu					Boden BP, 2007, AM J SPORT MED, V35, P1075, DOI 10.1177/0363546507299239; Cantu RC, 2003, NEUROSURGERY, V52, P846, DOI 10.1227/01.NEU.0000053210.76063.E4; Chrisman SP, 2013, BRAIN INJURY, V27, P1, DOI 10.3109/02699052.2012.722251; Colgate B, 2015, NATL FEDERATION STAT; Collins M, 2006, NEUROSURGERY, V58, P275, DOI 10.1227/01.NEU.0000200441.92742.46; Daneshvar DH, 2011, CLIN SPORT MED, V30, P145, DOI 10.1016/j.csm.2010.09.006; Dischinger PC, 2009, J TRAUMA, V66, P289, DOI 10.1097/TA.0b013e3181961da2; Forbes JA, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.9.FOCUS12288; Gadd C, 1961, NATL RES COUNCIL PUB, P141; GIECK J, 1980, AM J SPORT MED, V8, P192, DOI 10.1177/036354658000800309; Grubenhoff JA, 2014, PEDIATRICS, V134, P54, DOI 10.1542/peds.2013-2988; Kelly JP, 1998, J HEAD TRAUMA REHAB, V13, P53, DOI 10.1097/00001199-199804000-00008; Knowles SB, 2009, EPIDEMIOLOGY, V20, P302, DOI 10.1097/EDE.0b013e318193107c; Leclerc S, 2001, SPORTS MED, V31, P629, DOI 10.2165/00007256-200131080-00007; Lundin A, 2006, BRAIN INJURY, V20, P799, DOI 10.1080/02699050600744327; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McGuine TA, 2014, AM J SPORT MED, V42, P2470, DOI 10.1177/0363546514541926; Merritt VC, 2015, J CLIN EXP NEUROPSYC, V37, P265, DOI 10.1080/13803395.2015.1004303; Rosenthal JA, 2014, AM J SPORT MED, V42, P1710, DOI 10.1177/0363546514530091; Rowson S, 2014, J NEUROSURG, V120, P919, DOI 10.3171/2014.1.JNS13916; Schmidt JD, 2014, AM J SPORT MED, V42, P2056, DOI 10.1177/0363546514536685; Schulz MR, 2004, AM J EPIDEMIOL, V160, P937, DOI 10.1093/aje/kwh304; Viano DC, 2012, ANN BIOMED ENG, V40, P160, DOI 10.1007/s10439-011-0384-4	24	18	18	2	19	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1941-7381	1941-0921		SPORTS HEALTH	Sports Health	MAY-JUN	2016	8	3					238	243		10.1177/1941738116639027			6	Sport Sciences	Sport Sciences	EG8CM	WOS:000391283300005	27005467	Green Published			2021-06-18	
J	Steiner, ME; Berkstresser, BD; Richardson, L; Elia, G; Wang, F				Steiner, Mark E.; Berkstresser, Brant D.; Richardson, Lars; Elia, Greg; Wang, Frank			Full-Contact Practice and Injuries in College Football	SPORTS HEALTH-A MULTIDISCIPLINARY APPROACH			English	Article						football; injuries; injury exposures; concussions	HIGH-SCHOOL FOOTBALL; PROFESSIONAL RUGBY UNION; SURVEILLANCE SYSTEM; DATA-COLLECTION; RISK-FACTORS; TRAINING LOADS; LEAGUE PLAYERS; EPIDEMIOLOGY; IMPACT; DEFINITIONS	Background: Despite recent restrictions being placed on practice in college football, there are little data to correlate such changes with injuries. Hypothesis: Football injuries will correlate with a team's exposure to full-contact practice, total practice, and total games. Study Design: Descriptive epidemiological study. Methods: All injuries and athlete injury exposures (AE x Min = athletes exposed x activity duration in minutes) were recorded for an intercollegiate football team over 4 consecutive fall seasons. Weekly injuries and injury rates (injuries per athletic injury exposure) were correlated with the weekly exposures to full-contact practices, total practices, formal scrimmages, and games. Results: The preseason practice injury rate was over twice the in-season practice injury rate (P < 0.001). For preseason, injury exposures were higher for full-contact practice (P = 0.0166), total practices (P = 0.015), and scrimmages/games (P = 0.034) compared with in-season. Preseason and in-season practice injuries correlated with exposure to full-contact practice combined with scrimmages for preseason (P < 0.008) and full-contact practice combined with games for in-season (P = 0.0325). The game injury rate was over 6 times greater than the practice injury rate (P < 0.0001). Concussions constituted 14.5% of all injuries, and the incidence of concussions correlated with the incidence of all injuries (P = 0.0001). Strength training did not correlate with injuries. Conclusion: Decreased exposure to full-contact practice may decrease the incidence of practice injuries and practice concussions. However, the game injury rate was over 6 times greater than the practice injury rate and had an inverse correlation with full-contact practice.	[Steiner, Mark E.; Berkstresser, Brant D.; Richardson, Lars; Elia, Greg; Wang, Frank] Harvard Univ Hlth Serv, Cambridge, MA USA	Steiner, ME (corresponding author), Harvard Univ Hlth Serv, Dept Orthoped, 75 Mt Auburn St, Cambridge, MA 02138 USA.	msteiner@uhs.harvard.edu			Stryker Orthopedics; New England Baptist Research Department; DonJoy Orthopedics	The following authors declared potential conflicts of interest: Mark E. Steiner, MD, is a paid consultant for, and has patents and royalties from, Stryker Orthopedics; Greg Elia, MD, has received fees for participation in review activities from New England Baptist Research Department. The authors acknowledge and thank DonJoy Orthopedics for research funding, which made this project possible.	Adickes MS, 2004, SPORTS MED, V34, P201, DOI 10.2165/00007256-200434030-00005; Albright JP, 2004, AM J SPORT MED, V32, P1394, DOI 10.1177/0363546504264159; Anderson L, 2003, J STRENGTH COND RES, V17, P734; Bahr R, 2003, BRIT J SPORT MED, V37, P384, DOI 10.1136/bjsm.37.5.384; Bengtsson H, 2013, AM J SPORT MED, V41, P1505, DOI 10.1177/0363546513486769; Booher MA, 2003, CLIN J SPORT MED, V13, P93, DOI 10.1097/00042752-200303000-00005; Brink MS, 2010, BRIT J SPORT MED, V44, P809, DOI 10.1136/bjsm.2009.069476; Broglio SP, 2013, AM J SPORT MED, V41, P2877, DOI 10.1177/0363546513502458; Brooks JHM, 2005, BRIT J SPORT MED, V39, P757, DOI 10.1136/bjsm.2005.018135; Brooks JHM, 2005, BRIT J SPORT MED, V39, P767, DOI 10.1136/bjsm.2005.018408; Brooks JHM, 2005, BRIT J SPORT MED, V39, P288, DOI 10.1136/bjsm.2004.013391; Camp Walter, 1894, FOOTBALL FACTS FIGUR; Chalmers DJ, 2012, BRIT J SPORT MED, V46, P95, DOI 10.1136/bjsports-2011-090272; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; DAGIAU RF, 1980, AM J SPORT MED, V8, P257, DOI 10.1177/036354658000800408; DELEE JC, 1992, AM J SPORT MED, V20, P575, DOI 10.1177/036354659202000515; Dick R, 2007, J ATHL TRAINING, V42, P221; Dick R, 2007, J ATHL TRAINING, V42, P173; Dragoo JL, 2012, AM J SPORT MED, V40, P990, DOI 10.1177/0363546512442336; Dupont G, 2010, AM J SPORT MED, V38, P1752, DOI 10.1177/0363546510361236; Feeley BT, 2008, AM J SPORT MED, V36, P1597, DOI 10.1177/0363546508316021; Fuller CW, 2006, BRIT J SPORT MED, V40, P193, DOI 10.1136/bjsm.2005.025270; Gabbett TJ, 2007, J SPORT SCI, V25, P1507, DOI 10.1080/02640410701215066; Gabbett TJ, 2011, J SCI MED SPORT, V14, P204, DOI 10.1016/j.jsams.2010.12.002; Gabbett TJ, 2004, BRIT J SPORT MED, V38, P743, DOI 10.1136/bjsm.2003.008391; Gabbett TJ, 2004, J SPORT SCI, V22, P409, DOI 10.1080/02640410310001641638; Hagel BE, 2003, AM J EPIDEMIOL, V157, P825, DOI 10.1093/aje/kwg050; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Kerr ZY, 2015, ORTHOP J SPORTS MED, V3; Killen NM, 2010, J STRENGTH COND RES, V24, P2079, DOI 10.1519/JSC.0b013e3181ddafff; Kim J, 2011, REPORT REGARDING IVY; King DA, 2009, J SCI MED SPORT, V12, P12, DOI 10.1016/j.jsams.2007.12.001; Meyers MC, 2010, AM J SPORT MED, V38, P687, DOI 10.1177/0363546509352464; Mihalik JP, 2007, NEUROSURGERY, V61, P1229, DOI 10.1227/01.neu.0000306101.83882.c8; MILLER JOHN J., 2011, THE BIG SCRUM; Nichols EH, 1909, BOSTON MED SURG J, V160, P33, DOI 10.1056/NEJM190901141600201; PRAGER BI, 1989, AM J SPORT MED, V17, P681, DOI 10.1177/036354658901700516; Ramirez M, 2006, AM J SPORT MED, V34, P1147, DOI 10.1177/0363546505284385; Rogalski B, 2013, J SCI MED SPORT, V16, P499, DOI 10.1016/j.jsams.2012.12.004; Rowson S, 2014, J NEUROSURG, V120, P919, DOI 10.3171/2014.1.JNS13916; Shankar PR, 2007, AM J SPORT MED, V35, P1295, DOI 10.1177/0363546507299745; Steiner ME, 2005, AM J SPORT MED, V33, P1545, DOI 10.1177/0363546505275491; THOMPSON N, 1987, AM J SPORT MED, V15, P117, DOI 10.1177/036354658701500204; Thorndike Jr A, 1938, ATHLETIC INJURIES PR, P20	44	18	18	1	2	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1941-7381	1941-0921		SPORTS HEALTH	Sports Health	MAY-JUN	2016	8	3					217	223		10.1177/1941738115626689			7	Sport Sciences	Sport Sciences	EG8CM	WOS:000391283300002	26755741	Green Published			2021-06-18	
J	Jin, YC; Lei, J; Lin, YY; Gao, GY; Jiang, JY				Jin, Yichao; Lei, Jin; Lin, Yingying; Gao, Guo-yi; Jiang, Ji-yao			Autophagy Inhibitor 3-MA Weakens Neuroprotective Effects of Posttraumatic Brain Injury Moderate Hypothermia	WORLD NEUROSURGERY			English	Article						Apoptosis; Autophagy; Behavioral assessment; Moderate hypothermia; Traumatic brain injury	CONTROLLED CORTICAL IMPACT; REDUCES SECONDARY INJURY; ANTI-APOPTOTIC FUNCTION; HIPPOCAMPAL CELL-DEATH; FLUID-PERCUSSION MODEL; THERAPEUTIC HYPOTHERMIA; BEHAVIORAL DEFICITS; NEUROVASCULAR UNIT; BH3-ONLY PROTEIN; MILD HYPOTHERMIA	OBJECTIVE: The role of autophagy in moderate hypothermia in posttraumatic brain injury (post-TBI) remains elusive. In this study, we evaluated the protective role of autophagy in post-TBI moderate hypothermia. METHODS: Adult male Sprague-Dawley rats were randomly divided into 3 groups (n = 36/group): TBI with hypothermia group (sham), TBI with hypothermia and a single intracerebroventricular injection of saline (saline, 5 mu L), and TBI with hypothermia and a single intracerebroventricular injection of 3-methyladenine (600 nmol, diluted in 0.9% saline to a final volume of 5 mu L). All rats, except those in the behavioral tests, were killed at 24 hours after fluid percussion TBI. Immunohistochemistry staining, western blot, and transmission electron microscopy were performed to assess changes in apoptosis and autophagy after injection of 3-methyladenine. Motor function (beam-walk test) and spatial learning/memory (Morris water maze) were assessed on postoperative days 1-5 and 11-15, respectively. RESULTS: Our results showed downregulation of the expression level of microtubule-associated protein 1 light chain 3 and Beclin-1, aggravation of behavioral outcome, and increase of apoptosis. CONCLUSION: Our results suggest that the autophagy pathway is involved in the neuroprotective effect of post-TBI hypothermia and negative modulation of apoptosis may be 1 possible mechanism.	[Jin, Yichao; Lei, Jin; Lin, Yingying; Gao, Guo-yi; Jiang, Ji-yao] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Neurosurg, Shanghai 200030, Peoples R China	Jiang, JY (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Neurosurg, Shanghai 200030, Peoples R China.	jiyaojiangrenji@126.com			National Science and Nature Grant [81271381]; National Key Project Grant [2012CB518100]	This work was supported by National Science and Nature Grant (No. 81271381), and National Key Project Grant (No. 2012CB518100).	Ahmad A, 2012, BRAIN BEHAV IMMUN, V26, P1310, DOI 10.1016/j.bbi.2012.07.021; BRAMLETT HM, 1995, J NEUROTRAUM, V12, P289, DOI 10.1089/neu.1995.12.289; Celik SE, 2006, J NEUROTRAUM, V23, P1355, DOI 10.1089/neu.2006.23.1355; Ciechomska IA, 2009, ONCOGENE, V28, P2128, DOI 10.1038/onc.2009.60; Ciechomska IA, 2009, AUTOPHAGY, V5, P880, DOI 10.4161/auto.9096; Clark RSB, 2008, AUTOPHAGY, V4, P88, DOI 10.4161/auto.5173; Coles JP, 2004, J CEREBR BLOOD F MET, V24, P202, DOI 10.1097/01.WCB.0000103022.98348.24; Crotzer VL, 2005, P NATL ACAD SCI USA, V102, P7779, DOI 10.1073/pnas.0503088102; Dixon CE, 1998, J NEUROTRAUM, V15, P95, DOI 10.1089/neu.1998.15.95; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Eldadah BA, 2000, J NEUROTRAUM, V17, P811, DOI 10.1089/neu.2000.17.811; FEENEY DM, 1982, SCIENCE, V217, P855, DOI 10.1126/science.7100929; Feng W, 2007, J MOL BIOL, V372, P223, DOI 10.1016/j.jmb.2007.06.069; Gordy C, 2012, PROTEIN CELL, V3, P17, DOI 10.1007/s13238-011-1127-x; Graham DI, 2000, J NEUROPATH EXP NEUR, V59, P641, DOI 10.1093/jnen/59.8.641; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; Heckmann BL, 2013, BRIT J PHARMACOL, V168, P163, DOI 10.1111/j.1476-5381.2012.02110.x; Huang XJ, 2014, J NEUROTRAUM, V31, P346, DOI 10.1089/neu.2013.2899; Jia F, 2014, J NEUROTRAUM, V31, P1225, DOI 10.1089/neu.2013.3230; Jia F, 2014, J NEUROTRAUM, V31, P387, DOI 10.1089/neu.2008.0814; Jia F, 2009, J NEUROTRAUM, V26, P243, DOI 10.1089/neu.2008.0670; Jiang JY, 2009, J NEUROTRAUM, V26, P399, DOI 10.1089/neu.2008.0525; Jin YC, 2015, WORLD NEUROSURG, V84, P420, DOI 10.1016/j.wneu.2015.03.039; Jin YC, 2015, J NEUROTRAUM, V32, P1090, DOI 10.1089/neu.2014.3649; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kabeya Y, 2004, J CELL SCI, V117, P2805, DOI 10.1242/jcs.01131; Kermer P, 1999, CELL TISSUE RES, V298, P383, DOI 10.1007/s004410050061; Khan M, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-32; Kihara A, 2001, EMBO REP, V2, P330, DOI 10.1093/embo-reports/kve061; Kline AE, 2002, J NEUROTRAUM, V19, P415, DOI 10.1089/08977150252932370; Kline AE, 2010, J NEUROTRAUM, V27, P2021, DOI 10.1089/neu.2010.1535; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Lipinski MM, 2015, ANTIOXID REDOX SIGN, V23, P565, DOI 10.1089/ars.2015.6306; Liu CL, 2008, J CEREBR BLOOD F MET, V28, P674, DOI 10.1038/sj.jcbfm.9600587; Liu D, 2002, J CEREBR BLOOD F MET, V22, P431, DOI 10.1097/00004647-200204000-00007; Logue SE, 2008, BIOCHEM SOC T, V36, P1, DOI 10.1042/BST0360001; Luo CL, 2011, NEUROSCIENCE, V184, P54, DOI 10.1016/j.neuroscience.2011.03.021; Maiuri MC, 2007, EMBO J, V26, P2527, DOI 10.1038/sj.emboj.7601689; Maiuri MC, 2007, AUTOPHAGY, V3, P374, DOI 10.4161/auto.4237; Maiuri MC, 2010, EMBO J, V29, P515, DOI 10.1038/emboj.2009.377; Mao Q, 2010, NEUROSURGERY, V66, P1134, DOI 10.1227/01.NEU.0000369612.31946.A2; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Moore EM, 2011, INJURY, V42, P843, DOI 10.1016/j.injury.2011.03.027; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Oberstein A, 2007, J BIOL CHEM, V282, P13123, DOI 10.1074/jbc.M700492200; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Polderman KH, 2009, CRIT CARE MED, V37, pS186, DOI 10.1097/CCM.0b013e3181aa5241; Sadasivan S, 2008, BIOCHEM BIOPH RES CO, V373, P478, DOI 10.1016/j.bbrc.2008.05.031; Scheff SW, 1997, J NEUROTRAUM, V14, P615, DOI 10.1089/neu.1997.14.615; Thorburn A, 2008, APOPTOSIS, V13, P1, DOI 10.1007/s10495-007-0154-9; Urbano LA, 2012, CURR NEUROL NEUROSCI, V12, P580, DOI 10.1007/s11910-012-0304-5; Wei YJ, 2008, MOL CELL, V30, P678, DOI 10.1016/j.molcel.2008.06.001; Zhou CC, 2010, CHEMOTHERAPY, V56, P393, DOI 10.1159/000317750	54	18	21	1	12	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	APR	2016	88						433	446		10.1016/j.wneu.2015.10.055			14	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	DK1CI	WOS:000374649700059	26547006				2021-06-18	
J	van der Horn, HJ; Liemburg, EJ; Scheenen, ME; de Koning, ME; Marsman, JBC; Spikman, JM; van der Naalt, J				van der Horn, Harm J.; Liemburg, Edith J.; Scheenen, Myrthe E.; de Koning, Myrthe E.; Marsman, Jan-Bernard C.; Spikman, Jacoba M.; van der Naalt, Joukje			Brain network dysregulation, emotion, and complaints after mild traumatic brain injury	HUMAN BRAIN MAPPING			English	Article						mild traumatic brain injury; emotion regulation; post-traumatic complaints; fMRI; brain networks	DEFAULT-MODE; POSTCONCUSSIVE SYMPTOMS; FUNCTIONAL CONNECTIVITY; HOSPITAL ANXIETY; SEX-DIFFERENCES; CONCUSSION; TASK; PREDICTORS; COMPONENTS; SYSTEM	ObjectivesTo assess the role of brain networks in emotion regulation and post-traumatic complaints in the sub-acute phase after non-complicated mild traumatic brain injury (mTBI). Experimental designFifty-four patients with mTBI (34 with and 20 without complaints) and 20 healthy controls (group-matched for age, sex, education, and handedness) were included. Resting-state fMRI was performed at four weeks post-injury. Static and dynamic functional connectivity were studied within and between the default mode, executive (frontoparietal and bilateral frontal network), and salience network. The hospital anxiety and depression scale (HADS) was used to measure anxiety (HADS-A) and depression (HADS-D). Principal ObservationsRegarding within-network functional connectivity, none of the selected brain networks were different between groups. Regarding between-network interactions, patients with complaints exhibited lower functional connectivity between the bilateral frontal and salience network compared to patients without complaints. In the total patient group, higher HADS-D scores were related to lower functional connectivity between the bilateral frontal network and both the right frontoparietal and salience network, and to higher connectivity between the right frontoparietal and salience network. Furthermore, whereas higher HADS-D scores were associated with lower connectivity within the parietal midline areas of the bilateral frontal network, higher HADS-A scores were related to lower connectivity within medial prefrontal areas of the bilateral frontal network. ConclusionsFunctional interactions of the executive and salience networks were related to emotion regulation and complaints after mTBI, with a key role for the bilateral frontal network. These findings may have implications for future studies on the effect of psychological interventions. Hum Brain Mapp 37:1645-1654, 2016. (c) 2016 Wiley Periodicals, Inc.	[van der Horn, Harm J.; de Koning, Myrthe E.; van der Naalt, Joukje] Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, NL-9700 AB Groningen, Netherlands; [Liemburg, Edith J.; Marsman, Jan-Bernard C.] Univ Groningen, Univ Med Ctr Groningen, BCN NeuroImaging Ctr, NL-9700 AB Groningen, Netherlands; [Liemburg, Edith J.; Marsman, Jan-Bernard C.] Univ Groningen, Univ Med Ctr Groningen, Dept Neurosci, NL-9700 AB Groningen, Netherlands; [Scheenen, Myrthe E.; Spikman, Jacoba M.] Univ Groningen, Univ Med Ctr Groningen, Dept Neuropsychol, Groningen, Netherlands	van der Naalt, J (corresponding author), Hanzepl 1, NL-9700 RB Groningen, Netherlands.	h.j.van.der.horn@umcg.nl		Spikman, Jacoba/0000-0002-6477-0763	de Hersenstichting [Ps2012-06]	Contract grant sponsor: de Hersenstichting; Contract grant number: Ps2012-06	Allen EA, 2014, CEREB CORTEX, V24, P663, DOI 10.1093/cercor/bhs352; Anson K, 2006, J HEAD TRAUMA REHAB, V21, P248, DOI 10.1097/00001199-200605000-00005; Bazarian JJ, 2010, J NEUROTRAUM, V27, P527, DOI 10.1089/neu.2009.1068; Bazarian JJ, 2006, ACAD EMERG MED, V13, P199, DOI 10.1197/j.aem.2005.07.031; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Belleau EL, 2015, SOC COGN AFFECT NEUR, V10, P744, DOI 10.1093/scan/nsu117; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; BOHNEN N, 1992, INT J NEUROSCI, V64, P97, DOI 10.3109/00207459209000536; Bonnelle V, 2011, J NEUROSCI, V31, P13442, DOI 10.1523/JNEUROSCI.1163-11.2011; Calhoun VD, 2001, HUM BRAIN MAPP, V14, P140, DOI 10.1002/hbm.1048; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS132, DOI 10.1016/j.apmr.2013.08.299; Cole MW, 2014, NEUROSCIENTIST, V20, P652, DOI 10.1177/1073858414525995; COPES WS, 1988, J TRAUMA, V28, P69, DOI 10.1097/00005373-198801000-00010; Coutinho JF, 2015, BRAIN IMAGI IN PRESS; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Dischinger PC, 2009, J TRAUMA, V66, P289, DOI 10.1097/TA.0b013e3181961da2; Dosenbach NUF, 2006, NEURON, V50, P799, DOI 10.1016/j.neuron.2006.04.031; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Ettenhofer ML, 2012, J INT NEUROPSYCH SOC, V18, P451, DOI 10.1017/S1355617711001895; Hamilton JP, 2011, BIOL PSYCHIAT, V70, P327, DOI 10.1016/j.biopsych.2011.02.003; Himberg J, 2004, NEUROIMAGE, V22, P1214, DOI 10.1016/j.neuroimage.2004.03.027; Hsu HL, 2015, RADIOLOGY, V276, P828, DOI 10.1148/radiol.2015142549; Iverson GL, 2000, BRAIN INJURY, V14, P1057; Jafri MJ, 2008, NEUROIMAGE, V39, P1666, DOI 10.1016/j.neuroimage.2007.11.001; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Lange RT, 2015, ARCH CLIN NEUROPSYCH, V30, P7, DOI 10.1093/arclin/acu060; Leech R, 2011, J NEUROSCI, V31, P3217, DOI 10.1523/JNEUROSCI.5626-10.2011; Lingsma HF, 2015, J NEUROTRAUM, V32, P83, DOI 10.1089/neu.2014.3384; Lundin A, 2006, BRAIN INJURY, V20, P799, DOI 10.1080/02699050600744327; Manoliu A, 2014, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00930; Mayer AR, 2015, J NEUROTRAUM, V32, P1046, DOI 10.1089/neu.2014.3542; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; Nathan DE, 2015, BRAIN CONNECT, V5, P102, DOI 10.1089/brain.2014.0273; Nielsen MB, 2014, SCAND J PSYCHOL, V55, P142, DOI 10.1111/sjop.12103; Ponsford J, 2011, J NEUROTRAUM, V28, P937, DOI 10.1089/neu.2010.1516; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Rosenbaum SB, 2012, BRAIN IMAGING BEHAV, V6, P255, DOI 10.1007/s11682-012-9162-7; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Silverberg ND, 2011, NEUROREHABILITATION, V29, P317, DOI 10.3233/NRE-2011-0708; Sours C, 2013, BRAIN RES, V1537, P201, DOI 10.1016/j.brainres.2013.08.034; Spreng RN, 2010, NEUROIMAGE, V53, P303, DOI 10.1016/j.neuroimage.2010.06.016; Sridharan D, 2008, P NATL ACAD SCI USA, V105, P12569, DOI 10.1073/pnas.0800005105; Sylvester CM, 2012, TRENDS NEUROSCI, V35, P527, DOI 10.1016/j.tins.2012.04.012; van den Heuvel MP, 2010, EUR NEUROPSYCHOPHARM, V20, P519, DOI 10.1016/j.euroneuro.2010.03.008; van der Horn HJ, 2016, J NEUROTRAUM, V33, P1, DOI 10.1089/neu.2015.3905; van der Horn HJ, 2013, ARCH PHYS MED REHAB, V94, P867, DOI 10.1016/j.apmr.2012.11.039; Veer IM, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00041; Verhage F., 1964, THESIS NETHERLANDS; Vos PE, 2012, EUR J NEUROL, V19, P191, DOI 10.1111/j.1468-1331.2011.03581.x; Waljas M, 2015, J NEUROTRAUM, V32, P534, DOI 10.1089/neu.2014.3339; Whitfield-Gabrieli S, 2012, ANNU REV CLIN PSYCHO, V8, P49, DOI 10.1146/annurev-clinpsy-032511-143049; Willer Barry, 2006, Curr Treat Options Neurol, V8, P415, DOI 10.1007/s11940-006-0031-9; Zhou YX, 2012, RADIOLOGY, V265, P882, DOI 10.1148/radiol.12120748; Zhu DC, 2015, J NEUROTRAUM, V32, P327, DOI 10.1089/neu.2014.3413; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	57	18	18	1	17	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1065-9471	1097-0193		HUM BRAIN MAPP	Hum. Brain Mapp.	APR	2016	37	4					1645	1654		10.1002/hbm.23126			10	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	DG7XH	WOS:000372296500026	26846195	Green Published			2021-06-18	
J	Wilde, EA; Hunter, JV; Li, XQ; Amador, C; Hanten, G; Newsome, MR; Wu, TC; McCauley, SR; Vogt, GS; Chu, ZD; Biekman, B; Levin, HS				Wilde, Elisabeth A.; Hunter, Jill V.; Li, Xiaoqi; Amador, Cristian; Hanten, Gerri; Newsome, Mary R.; Wu, Trevor C.; McCauley, Stephen R.; Vogt, Gregory S.; Chu, Zili David; Biekman, Brian; Levin, Harvey S.			Chronic Effects of Boxing: Diffusion Tensor Imaging and Cognitive Findings	JOURNAL OF NEUROTRAUMA			English	Article						boxing; chronic effects; cognition; imaging	TRAUMATIC BRAIN-INJURY; PROFESSIONAL BOXERS; WHITE-MATTER; MEMORY; STRIATUM; SPECTRUM; DISEASE; AMATEUR; DAMAGE; MRI	We used magnetic resonance imaging (MRI) and diffusion tensor imaging (DTI) to evaluate the effects of boxing on brain structure and cognition in 10 boxers (8 retired, 2 active; mean age = 45.7 years; standard deviation [SD] = 9.71) and 9 participants (mean age = 43.44; SD = 9.11) in noncombative sports. Evans Index (maximum width of the anterior horns of the lateral ventricles/maximal width of the internal diameter of the skull) was significantly larger in the boxers (F = 4.52; p = 0.050; Cohen's f = 0.531). Word list recall was impaired in the boxers (F-(1,F-14) = 10.70; p = 0.006; f = 0.84), whereas implicit memory measured by faster reaction time (RT) to a repeating sequence of numbers than to a random sequence was preserved (t = 2.52; p < 0.04). Fractional anisotropy (FA) and the apparent diffusion coefficient (ADC) measured by tractography did not significantly differ between groups. However, DTI metrics were significantly correlated with declarative memory (e.g., left ventral striatum ADC with delayed recall, r = -0.74; p = 0.02) and with RT to the repeating number sequence (r = 0.70; p = 0.04) in the boxers. Years of boxing had the most consistent, negative correlations with FA, ranging from -0.65 for the right ventral striatum to -0.92 for the right cerebral peduncle. Years of boxing was negatively related to the number of words consistently recalled over trials (r = -0.74; p = 0.02), delayed recall (r = -0.83; p = 0.003), and serial RT (r = 0.66; p = 0.05). We conclude that microstructural integrity of white matter tracts is related to declarative memory and response speed in boxers and to the extent of boxing exposure. Implications for chronic traumatic encephalopathy are discussed.	[Wilde, Elisabeth A.; Newsome, Mary R.; McCauley, Stephen R.; Vogt, Gregory S.; Levin, Harvey S.] Michael E DeBakey VA Med Ctr, Rehabil Res & Dev, Houston, TX USA; [Wilde, Elisabeth A.; Hunter, Jill V.; Li, Xiaoqi; Hanten, Gerri; Newsome, Mary R.; McCauley, Stephen R.; Chu, Zili David; Biekman, Brian; Levin, Harvey S.] Baylor Coll Med, One Baylor Plaza,BCM637, Houston, TX 77030 USA; [Amador, Cristian] Rice Univ, Houston, TX USA; [Wu, Trevor C.] Mercy Hlth St Marys, Hauenstein Neurosci, Grand Rapids, MI USA	Levin, HS (corresponding author), Baylor Coll Med, One Baylor Plaza,BCM637, Houston, TX 77030 USA.	hlevin@bcm.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS056202, R21NS086714] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [I21RX001608] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [5R21-NS086714, 5P01-NS056202] Funding Source: Medline; RRD VA [I21 RX001608] Funding Source: Medline		Benson RR, 2007, J NEUROTRAUM, V24, P446, DOI 10.1089/neu.2006.0153; BUSCHKE H, 1974, NEUROLOGY, V24, P1019, DOI 10.1212/WNL.24.11.1019; Catani M, 2008, CORTEX, V44, P1105, DOI 10.1016/j.cortex.2008.05.004; Chappell MH, 2006, J MAGN RESON IMAGING, V24, P537, DOI 10.1002/jmri.20656; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; Dayan E, 2011, NEURON, V72, P443, DOI 10.1016/j.neuron.2011.10.008; Evans WA, 1942, ARCH NEURO PSYCHIATR, V47, P931, DOI 10.1001/archneurpsyc.1942.02290060069004; Gobel EW, 2013, NEUROPSYCHOLOGY, V27, P314, DOI 10.1037/a0032305; Hahnel S, 2008, AM J NEURORADIOL, V29, P388, DOI 10.3174/ajnr.A0799; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Jordan BD, 2013, NAT REV NEUROL, V9, P222, DOI 10.1038/nrneurol.2013.33; Larrabee GJ, 2000, CLIN NEUROPSYCHOL, V14, P110, DOI 10.1076/1385-4046(200002)14:1;1-8;FT110; Levin HS, 2008, J HEAD TRAUMA REHAB, V23, P197, DOI 10.1097/01.HTR.0000327252.54128.7c; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; LEVIN HS, 1987, J NEUROSURG, V67, P657, DOI 10.3171/jns.1987.67.5.0657; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; Mattfeld AT, 2015, HIPPOCAMPUS, V25, P900, DOI 10.1002/hipo.22411; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; NISSEN MJ, 1987, COGNITIVE PSYCHOL, V19, P1, DOI 10.1016/0010-0285(87)90002-8; Orrison WW, 2009, J NEUROTRAUM, V26, P689, DOI 10.1089/neu.2008.0636; Reber PJ, 2013, NEUROPSYCHOLOGIA, V51, P2026, DOI 10.1016/j.neuropsychologia.2013.06.019; Roberts AH., 1969, BRAIN DAMAGE BOXERS; Shah S, 2012, BRAIN INJURY, V26, P201, DOI 10.3109/02699052.2012.654591; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Shin W, 2014, AM J NEURORADIOL, V35, P285, DOI 10.3174/ajnr.A3676; Unterharnscheidt F, 2003, BOXING MED ASPECTS; Wilde EA, 2009, J CLIN EXP NEUROPSYC, V31, P205, DOI 10.1080/13803390802098118; Zazryn T, 2006, BRIT J SPORT MED, V40, P670, DOI 10.1136/bjsm.2006.025924; Zhang L, 2006, AM J NEURORADIOL, V27, P2000; Zhang LJ, 2003, AM J NEURORADIOL, V24, P52	32	18	18	0	14	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR 1	2016	33	7					672	680		10.1089/neu.2015.4035			9	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	DI6QK	WOS:000373624700006	26414735	Green Published			2021-06-18	
J	Klapal, L; Igelhorst, BA; Dietzel-Meyer, ID				Klapal, Lars; Igelhorst, Birte A.; Dietzel-Meyer, Irmgard D.			Changes in Neuronal Excitability by Activated Microglia: Differential Na+ Current Upregulation in Pyramid-Shaped and Bipolar Neurons by TNF-alpha and IL-18	FRONTIERS IN NEUROLOGY			English	Article						voltage-activated sodium currents; microglia; hippocampal neurons; interleukin-18; tumor necrosis factor-alpha; lipopolysaccharide; transforming growth factor-beta; glial cells	TUMOR-NECROSIS-FACTOR; TRANSFORMING-GROWTH-FACTOR; CENTRAL-NERVOUS-SYSTEM; ROOT GANGLION NEURONS; TRAUMATIC BRAIN-INJURY; GATED SODIUM-CHANNELS; FACTOR-BETA; HIPPOCAMPAL-NEURONS; INNATE IMMUNITY; GLIAL-CELLS	Microglia are activated during pathological events in the brain and are capable of releasing various types of inflammatory cytokines. Here, we demonstrate that the addition of 5% microglia activated by 1 mu g/ml lipopolysaccharides (LPS) to hippocampal cultures upregulates Na current densities (I-NavD) of bipolar as well as pyramid-shaped neurons, thereby increasing their excitability. Deactivation of microglia by the addition of 10 ng/ml transforming growth factor-beta (TGF-beta) decreases I-NavD below control levels suggesting that the residual activated microglial cells influence neuronal excitability in control cultures. Preincubation of hippocampal cultures with 10 ng/ml tumor necrosis factor-alpha (TNF-alpha), a major cytokine released by activated microglia, upregulated I-NavD significantly by similar to 30% in bipolar cells, whereas in pyramid shaped cells, the upregulation only reached an increase of similar to 14%. Incubation of the cultures with antibodies against either TNF-receptor 1 or 2 blocked the upregulation of I-NavD in bipolar cells, whereas in pyramid-shaped cells, increases in I-NavD were exclusively blocked by antibodies against TNF-receptor 2, suggesting that both cell types respond differently to TNIF-alpha exposure. Since additional cytokines, such as interleukin-18 (IL-18), are released from activated microglia, we tested potential effects of IL-18 on I-NavD in both cell types. Exposure to 5-10 ng/ml IL-18 for 4 days increased I-NavD in both pyramid-shaped as well as bipolar neurons, albeit the dose response curves were shifted to lower concentrations in bipolar cells. Our results suggest that by secretion of cytokines, microglial cells upregulate Na+ current densities in bipolar and pyramid shaped neurons to some extent differentially. Depending on the exact cytokine composition and concentration released, this could change the balance between the activity of inhibitory bipolar and excitatory pyramid-shaped cells. Since bipolar cells show a larger upregulation of I-NavD in response to TNF-alpha as well as respond to smaller concentrations of IL-18, our results offer an explanation for the finding, that in certain conditions of brain inflammations periods of dizziness are followed by epileptic seizures.	[Klapal, Lars; Igelhorst, Birte A.; Dietzel-Meyer, Irmgard D.] Ruhr Univ Bochum, Dept Biochem 2, Univ Str 150, Bochum, Germany	Klapal, L; Dietzel-Meyer, ID (corresponding author), Ruhr Univ Bochum, Dept Biochem 2, Univ Str 150, Bochum, Germany.	lars.klapal@rub.de; Irmgard.D.Dietzel-Meyer@rub.de		Dietzel-Meyer, Irmgard/0000-0003-4009-6249			Aloisi F, 2000, IMMUNOL TODAY, V21, P141, DOI 10.1016/S0167-5699(99)01512-1; Amrani Y, 1996, AM J RESP CELL MOL, V15, P55, DOI 10.1165/ajrcmb.15.1.8679222; ASSOIAN RK, 1987, P NATL ACAD SCI USA, V84, P6020, DOI 10.1073/pnas.84.17.6020; BARRALNETTO M, 1992, SCIENCE, V257, P545, DOI 10.1126/science.1636092; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; BREWER GJ, 1989, BRAIN RES, V494, P65, DOI 10.1016/0006-8993(89)90144-3; BRODIE C, 1989, ENDOCRINOLOGY, V125, P842, DOI 10.1210/endo-125-2-842; BROWN AM, 1990, ANNU REV PHYSIOL, V52, P197, DOI 10.1146/annurev.ph.52.030190.001213; Canolle B, 2004, J NEUROCHEM, V88, P1521, DOI 10.1046/j.1471-4159.2003.02301.x; Cantrell AR, 2001, NAT REV NEUROSCI, V2, P397, DOI 10.1038/35077553; Chen X, 2011, EXP NEUROL, V227, P279, DOI 10.1016/j.expneurol.2010.11.017; CHIZHMAKOV IV, 1994, NEUROSCIENCE, V59, P285, DOI 10.1016/0306-4522(94)90596-7; Coma G, 2006, CLIN EXP IMMUNOL, V145, P535, DOI 10.1111/j.1365-2249.2006.03145.x; CONSTAM DB, 1992, J IMMUNOL, V148, P1404; CZARNIECKI CW, 1988, J IMMUNOL, V140, P4217; DACUNHA A, 1993, J NEUROIMMUNOL, V42, P71, DOI 10.1016/0165-5728(93)90214-J; Devinsky O, 2013, TRENDS NEUROSCI, V36, P174, DOI 10.1016/j.tins.2012.11.008; Dib-Hajj SD, 2010, ANNU REV NEUROSCI, V33, P325, DOI 10.1146/annurev-neuro-060909-153234; DING A, 1990, J IMMUNOL, V145, P940; Djouhri L, 1999, J PHYSIOL-LONDON, V520, P565, DOI 10.1111/j.1469-7793.1999.t01-1-00565.x; FANGER GR, 1993, J NEUROCHEM, V61, P1977, DOI 10.1111/j.1471-4159.1993.tb09844.x; FEUERSTEIN GZ, 1994, CEREBROVAS BRAIN MET, V6, P341; Forge A, 2002, BRIT MED BULL, V63, P5, DOI 10.1093/bmb/63.1.5; Franceschetti S, 2000, J PHYSIOL-LONDON, V528, P291, DOI 10.1111/j.1469-7793.2000.00291.x; French AR, 2006, CYTOKINE, V35, P229, DOI 10.1016/j.cyto.2006.08.006; GIULIAN D, 1986, J EXP MED, V164, P594, DOI 10.1084/jem.164.2.594; GIULIAN D, 1987, J NEUROSCI RES, V18, P132, DOI DOI 10.1002/JNR.490180123; Gould HJ, 2000, BRAIN RES, V854, P19, DOI 10.1016/S0006-8993(99)02216-7; Gracie JA, 2003, J LEUKOCYTE BIOL, V73, P213, DOI 10.1189/jlb.0602313; Graeber MB, 2010, SCIENCE, V330, P783, DOI 10.1126/science.1190929; GROTENDORST GR, 1989, J CELL PHYSIOL, V140, P396, DOI 10.1002/jcp.1041400226; Guo LH, 2007, CELL MOL LIFE SCI, V64, P1128, DOI 10.1007/s00018-007-6494-3; Haas E, 1999, J BIOL CHEM, V274, P18107, DOI 10.1074/jbc.274.25.18107; Hanisch UK, 2002, GLIA, V40, P140, DOI 10.1002/glia.10161; He XH, 2010, PAIN, V151, P266, DOI 10.1016/j.pain.2010.06.005; HETIER E, 1990, EUR J NEUROSCI, V2, P762, DOI 10.1111/j.1460-9568.1990.tb00466.x; Hoffmann G, 2004, NEUROSCIENCE, V125, P369, DOI 10.1016/j.neuroscience.2004.01.047; Hudmon A, 2008, J NEUROSCI, V28, P3190, DOI 10.1523/JNEUROSCI.4403-07.2008; HUGHES JR, 1977, DIS NERV SYST, V38, P431; Igelhorst BA, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0194; Imeri L, 2009, NAT REV NEUROSCI, V10, P199, DOI 10.1038/nrn2576; Jack CS, 2005, J IMMUNOL, V175, P4320, DOI 10.4049/jimmunol.175.7.4320; Jin XC, 2006, J NEUROSCI, V26, P246, DOI 10.1523/JNEUROSCI.3858-05.2006; Jones LL, 1998, BRAIN RES, V795, P301, DOI 10.1016/S0006-8993(98)00325-4; Joshi SK, 2006, PAIN, V123, P75, DOI 10.1016/j.pain.2006.02.011; KEHRL JH, 1986, J EXP MED, V163, P1037, DOI 10.1084/jem.163.5.1037; KEHRL JH, 1986, J IMMUNOL, V137, P3855; Kerr BJ, 2001, NEUROREPORT, V12, P3077, DOI 10.1097/00001756-200110080-00019; Kim WK, 2004, J IMMUNOL, V172, P7015, DOI 10.4049/jimmunol.172.11.7015; Kleinsimlinghaus K, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00277; KORNBLUTH RS, 1986, J IMMUNOL, V137, P2585; Krueger JM, 2001, ANN NY ACAD SCI, V933, P211; Lai J, 2004, ANNU REV PHARMACOL, V44, P371, DOI 10.1146/annurev.pharmtox.44.101802.121627; Lam J, 2000, J CLIN INVEST, V106, P1481, DOI 10.1172/JCI11176; Lancman ME, 1996, EPILEPSY RES, V25, P285, DOI 10.1016/S0920-1211(96)00086-1; Lehnardt S, 2010, GLIA, V58, P253, DOI 10.1002/glia.20928; Leo M, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/124942; Liu YP, 2005, BRAIN RES, V1054, P152, DOI 10.1016/j.brainres.2005.06.085; Lodge PA, 1996, J LEUKOCYTE BIOL, V60, P502; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; Magnus T, 2012, BRAIN, V135, P1850, DOI 10.1093/brain/aws090; MARTIN DL, 1992, GLIA, V5, P81, DOI 10.1002/glia.440050202; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; McGowan E, 2009, ANESTH ANALG, V109, P951, DOI 10.1213/ane.0b013e3181b01b02; Najjar S, 2011, NEUROLOGIST, V17, P249, DOI 10.1097/NRL.0b013e31822aad04; Nakajima K, 2001, J BIOCHEM-TOKYO, V130, P169, DOI 10.1093/oxfordjournals.jbchem.a002969; Nakamura Y, 1999, NEUROSCI RES, V35, P95, DOI 10.1016/S0168-0102(99)00071-1; Nguyen MD, 2002, NAT REV NEUROSCI, V3, P216, DOI 10.1038/nrn752; Niederkinkhaus V, 2009, MOL ENDOCRINOL, V23, P1494, DOI 10.1210/me.2009-0132; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Ojaniemi M, 2003, EUR J IMMUNOL, V33, P597, DOI 10.1002/eji.200323376; Olson JK, 2004, J IMMUNOL, V173, P3916, DOI 10.4049/jimmunol.173.6.3916; Opp MR, 2005, SLEEP MED REV, V9, P355, DOI 10.1016/j.smrv.2005.01.002; PFEFFER K, 1993, CELL, V73, P457, DOI 10.1016/0092-8674(93)90134-C; Potthoff O, 1997, P ROY SOC B-BIOL SCI, V264, P367, DOI 10.1098/rspb.1997.0053; Rath PC, 1999, J CLIN IMMUNOL, V19, P350, DOI 10.1023/A:1020546615229; Richter F, 2014, ANN NEUROL, V76, P43, DOI 10.1002/ana.24176; Rolfe M, 1997, CARCINOGENESIS, V18, P2277, DOI 10.1093/carcin/18.11.2277; ROTHE J, 1993, NATURE, V364, P798, DOI 10.1038/364798a0; SAAD B, 1991, J CELL BIOL, V115, P473, DOI 10.1083/jcb.115.2.473; Schilling T, 2000, AM J PHYSIOL-CELL PH, V279, pC1123; Schilling T, 2001, EUR J NEUROSCI, V14, P463, DOI 10.1046/j.0953-816x.2001.01661.x; Singhi P, 2011, DEV MED CHILD NEUROL, V53, P600, DOI 10.1111/j.1469-8749.2011.03928.x; Stence N, 2001, GLIA, V33, P256, DOI 10.1002/1098-1136(200103)33:3<256::AID-GLIA1024>3.0.CO;2-J; STREIT WJ, 1988, GLIA, V1, P301, DOI 10.1002/glia.440010502; SUZUMURA A, 1993, J IMMUNOL, V151, P2150; TAKEMURA R, 1984, AM J PHYSIOL, V246, pC1; Tamura R, 2014, ANESTH ANALG, V118, P318, DOI 10.1213/ANE.0000000000000085; Tang P, 1996, BIOCHEMISTRY-US, V35, P8216, DOI 10.1021/bi952182t; TSUNAWAKI S, 1988, NATURE, V334, P260, DOI 10.1038/334260a0; Vezzani A, 2005, EPILEPSIA, V46, P1724, DOI 10.1111/j.1528-1167.2005.00298.x; WAHL SM, 1987, P NATL ACAD SCI USA, V84, P5788, DOI 10.1073/pnas.84.16.5788; WAHL SM, 1991, J EXP MED, V173, P981, DOI 10.1084/jem.173.4.981; Wheeler RD, 2000, MOL BRAIN RES, V77, P290, DOI 10.1016/S0169-328X(00)00069-3; Wheeler RD, 2003, J NEUROCHEM, V85, P1412, DOI 10.1046/j.1471-4159.2003.01787.x; WICKMAN KD, 1995, CURR OPIN NEUROBIOL, V5, P278, DOI 10.1016/0959-4388(95)80039-5; Yatsiv I, 2002, J CEREBR BLOOD F MET, V22, P971, DOI 10.1097/00004647-200208000-00008; Yuhas Y, 2003, INFECT IMMUN, V71, P2288, DOI 10.1128/IAI.71.4.2288-2291.2003	98	18	18	0	7	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	MAR 30	2016	7								44	10.3389/fneur.2016.00044			13	Clinical Neurology; Neurosciences	Neurosciences & Neurology	DH7GW	WOS:000372961600001	27065940	DOAJ Gold, Green Published			2021-06-18	
J	Li, CY; Limnuson, K; Wu, ZZ; Amin, A; Narayan, A; Golanov, EV; Ahn, CH; Hartings, JA; Narayan, RK				Li, Chunyan; Limnuson, Kanokwan; Wu, Zhizhen; Amin, Aseer; Narayan, Anjali; Golanov, Eugene V.; Ahn, Chong H.; Hartings, Jed A.; Narayan, Raj K.			Single probe for real-time simultaneous monitoring of neurochemistry and direct-current electrocorticography	BIOSENSORS & BIOELECTRONICS			English	Article						Neurochemical; Direct-current electrocorticography; Spreading depolarization; Iridium oxide reference electrode; Real-time monitoring	CORTICAL SPREADING DEPRESSION; OXIDE REFERENCE ELECTRODE; BRAIN GLUCOSE; EXTRACELLULAR GLUTAMATE; ONLINE MICRODIALYSIS; CEREBRAL-CORTEX; MICROELECTRODE; DEPOLARIZATIONS; LACTATE; OXYGEN	We report a novel single neural probe for real-time simultaneous monitoring of multiple neurochemicals and direct-current electrocorticography (DC-ECoG). A major advance of this probe is the inclusion of two iridium oxide reference electrodes to improve sensor accuracy. The ECoG reference electrode is identical to the ECoG recording electrodes to significantly improve DC stability, while the reference for electrochemical sensors has 10-fold lower polarization rate to minimize the small current-induced drift in the reference electrode potential. In vi, the single probe selectively measured oxygen (r(2)=0.985 +/- 0.01, concentration range=0-60 mmHg, limit of detection=0.4 +/- 0.07 mmHg) and glucose (r(2)=0.989 +/- 0.009, concentration range=0-4 mM, limit of detection=31 +/- 8 mu Mu) in a linear fashion. The performance of the single probe was assessed in an in vivo needle prick model to mimic sequelae of traumatic brain injury. It successfully monitored the theoretically expected transient brain oxygen, glucose, and DC potential changes during the passage of spreading depolarization (SD) waves. We envision that the developed probe can be used to decipher the cause-effect relationships between multiple variables of brain pathophysiology with the high temporal and spatial resolutions that it provides. (C) 2015 Elsevier B.V. All rights reserved.	[Li, Chunyan; Limnuson, Kanokwan; Amin, Aseer; Golanov, Eugene V.; Narayan, Raj K.] Feinstein Inst Med Res, Cushing Neuromonitoring Lab, Manhasset, NY 11030 USA; [Li, Chunyan; Narayan, Anjali; Narayan, Raj K.] Hofstra North Shore LIJ Sch Med, Dept Neurosurg, Hempstead, NY 11549 USA; [Wu, Zhizhen; Ahn, Chong H.] Univ Cincinnati, Microsyst & BioMEMS Lab, Cincinnati, OH 45221 USA; [Hartings, Jed A.] Univ Cincinnati, Coll Med, Neurosci Inst, Dept Neurosurg, Cincinnati, OH 45219 USA	Li, CY (corresponding author), Feinstein Inst Med Res, Cushing Neuromonitoring Lab, Manhasset, NY 11030 USA.	cli11@nshs.edu	Golanov, Eugene/B-6462-2011	Golanov, Eugene/0000-0003-0220-822X; Hartings, Jed/0000-0001-8583-3471	U.S. Department of Defense CDMRP PH/TBI Research Program [PT090526P4 (W81XWH-10-1-0978)]	This research was supported by the U.S. Department of Defense CDMRP PH/TBI Research Program under Project no. PT090526P4 (W81XWH-10-1-0978).	Ayata C, 2015, PHYSIOL REV, V95, P953, DOI 10.1152/physrev.00027.2014; Chase Alex, 2014, Nat Rev Neurol, V10, P547, DOI 10.1038/nrneurol.2014.169; Cordeiro CA, 2015, BIOSENS BIOELECTRON, V67, P677, DOI 10.1016/j.bios.2014.09.101; Dash MB, 2009, J NEUROSCI, V29, P580, DOI 10.1523/JNEUROSCI.5486-08.2009; Dreier JP, 2011, NAT MED, V17, P439, DOI 10.1038/nm.2333; Fekete Z, 2015, SENSOR ACTUAT B-CHEM, V215, P300, DOI 10.1016/j.snb.2015.03.055; Ges IA, 2005, BIOSENS BIOELECTRON, V21, P248, DOI 10.1016/j.bios.2004.09.021; Hartings JA, 2011, LANCET NEUROL, V10, P1058, DOI 10.1016/S1474-4422(11)70243-5; Hartings JA, 2009, J NEUROTRAUM, V26, P1857, DOI [10.1089/neu.2009.0961, 10.1089/neu.2009-0961]; Hashemi P, 2009, J CEREBR BLOOD F MET, V29, P166, DOI 10.1038/jcbfm.2008.108; Hinzman JM, 2015, BIOSENS BIOELECTRON, V74, P512, DOI 10.1016/j.bios.2015.06.074; Hinzman JM, 2015, EXP NEUROL, V267, P243, DOI 10.1016/j.expneurol.2015.03.014; Hinzman JM, 2014, BRAIN, V137, P2960, DOI 10.1093/brain/awu241; Johnson MD, 2008, J NEUROSCI METH, V174, P62, DOI 10.1016/j.jneumeth.2008.06.036; Kealy J, 2013, J NEUROSCI METH, V215, P110, DOI 10.1016/j.jneumeth.2013.02.016; Lauritzen M, 2011, J CEREBR BLOOD F MET, V31, P17, DOI 10.1038/jcbfm.2010.191; Leao AAP, 1944, J NEUROPHYSIOL, V7, P359; Lewitus D, 2011, ACTA BIOMATER, V7, P2483, DOI 10.1016/j.actbio.2011.02.027; Li CY, 2007, BIOSENS BIOELECTRON, V22, P1988, DOI 10.1016/j.bios.2006.08.043; Li CY, 2009, BIOSENS BIOELECTRON, V25, P173, DOI 10.1016/j.bios.2009.06.032; Li CY, 2009, LAB CHIP, V9, P1988, DOI 10.1039/b900651f; Marzouk SAM, 1998, ANAL CHEM, V70, P5054, DOI 10.1021/ac980608e; Morales-Villagran A, 2008, J NEUROSCI METH, V168, P48, DOI 10.1016/j.jneumeth.2007.09.005; Muthuswamy J, 2005, J NEUROSCI METH, V142, P45, DOI 10.1016/j.jneumeth.2004.07.017; Naylor E, 2011, J ELECTROANAL CHEM, V656, P106, DOI 10.1016/j.jelechem.2010.12.031; Odijk M, 2015, SENSOR ACTUAT B-CHEM, V207, P945, DOI 10.1016/j.snb.2014.06.138; Parkin MC, 2005, J CEREBR BLOOD F MET, V25, P402, DOI 10.1038/sj.jcbfm.9600051; Peteu SF, 1996, BIOSENS BIOELECTRON, V11, P1059, DOI 10.1016/0956-5663(96)87665-2; Piilgaard H, 2009, J CEREBR BLOOD F MET, V29, P1517, DOI 10.1038/jcbfm.2009.73; Rocchitta G, 2013, ANAL CHEM, V85, P10282, DOI 10.1021/ac402071w; Rogers ML, 2013, ACS CHEM NEUROSCI, V4, P799, DOI 10.1021/cn400047x; Shinwari MW, 2010, SENSORS-BASEL, V10, P1679, DOI 10.3390/s100301679; Song YL, 2012, BIOSENS BIOELECTRON, V38, P416, DOI 10.1016/j.bios.2012.05.011; STENSAAS SS, 1978, ACTA NEUROPATHOL, V41, P145, DOI 10.1007/BF00689766; Takano T, 2007, NAT NEUROSCI, V10, P754, DOI 10.1038/nn1902; Thomas TC, 2009, NEUROPSYCHOPHARMACOL, V34, P436, DOI 10.1038/npp.2008.74; Tolosa VM, 2013, BIOSENS BIOELECTRON, V42, P256, DOI 10.1016/j.bios.2012.10.061; Tseng TTC, 2012, J ELECTROANAL CHEM, V682, P141, DOI 10.1016/j.jelechem.2012.07.014; Wassum KM, 2012, J NEUROSCI, V32, P2734, DOI 10.1523/JNEUROSCI.5780-11.2012; Wei WJ, 2015, MICROSYST NANOENG, V1, DOI 10.1038/micronano.2015.2; Wei WJ, 2014, BIOSENS BIOELECTRON, V55, P66, DOI 10.1016/j.bios.2013.11.048; Weltin A, 2014, BIOSENS BIOELECTRON, V61, P192, DOI 10.1016/j.bios.2014.05.014; Wise KD, 2008, P IEEE, V96, P1184, DOI 10.1109/JPROC.2008.922564; Yang HS, 2004, LAB CHIP, V4, P42, DOI 10.1039/b309899k	44	18	18	1	65	ELSEVIER ADVANCED TECHNOLOGY	OXFORD	OXFORD FULFILLMENT CENTRE THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0956-5663	1873-4235		BIOSENS BIOELECTRON	Biosens. Bioelectron.	MAR 15	2016	77						62	68		10.1016/j.bios.2015.09.021			7	Biophysics; Biotechnology & Applied Microbiology; Chemistry, Analytical; Electrochemistry; Nanoscience & Nanotechnology	Biophysics; Biotechnology & Applied Microbiology; Chemistry; Electrochemistry; Science & Technology - Other Topics	CZ0AG	WOS:000366766900011	26386904	Bronze			2021-06-18	
J	Grech, LB; Kiropoulos, LA; Kirby, KM; Butler, E; Paine, M; Hester, R				Grech, Lisa B.; Kiropoulos, Litza A.; Kirby, Katherine M.; Butler, Ernest; Paine, Mark; Hester, Robert			Coping Mediates and Moderates the Relationship Between Executive Functions and Psychological Adjustment in Multiple Sclerosis	NEUROPSYCHOLOGY			English	Article						coping; multiple sclerosis; psychological adjustment; cognition; mediator moderator	QUALITY-OF-LIFE; TRAUMATIC BRAIN-INJURY; COGNITIVE IMPAIRMENT; DISABILITY STATUS; DEPRESSIVE SYMPTOMS; ECOLOGICAL VALIDITY; WORKING-MEMORY; VERBAL FLUENCY; ANXIETY; DYSFUNCTION	Objective: To identify the moderating and mediating relationship of different coping strategies between executive function and stress, depression and anxiety in people with multiple sclerosis (PwMS). Method: Participants were 107 people with relapsing remitting or secondary progressive multiple sclerosis who were administered tasks of executive function and completed self-report measures of stress, depression, anxiety, and coping. Results: An indirect relationship was found between executive function and psychosocial adjustment through maladaptive coping strategies: behavioral and mental disengagement, and substance abuse; adaptive coping strategies: acceptance, active, positive reinterpretation, and growth, as well as for an index of adaptive coping. In general, a relationship was found between better performance on tasks of executive function and psychosocial adjustment when adaptive coping strategies were low, as opposed to high, or maladaptive coping strategies were high, as opposed to low. Some unexpected findings are also discussed. Conclusion: Executive function and psychosocial adjustment is mediated and moderated by coping strategies used by PwMS. Well-preserved executive function provides relative protection from poorer adjustment in the presence of high maladaptive or low adaptive coping. PwMS who perform poorly on tasks of executive function benefit from using less cognitively demanding adaptive coping strategies to enhance adjustment outcomes and further research in this area would be advantageous to underpin effective intervention strategies.	[Grech, Lisa B.; Kiropoulos, Litza A.; Kirby, Katherine M.; Hester, Robert] Univ Melbourne, Melbourne Sch Psychol Sci, Parkville, Vic 3010, Australia; [Butler, Ernest] Monash Med Ctr, Dept Neurol, Melbourne, Vic, Australia; [Paine, Mark] St Vincents Hosp, Dept Neurol, Melbourne, Vic, Australia	Grech, LB (corresponding author), Univ Melbourne, Melbourne Sch Psychol Sci, Parkville, Vic 3010, Australia.	lbgrech@gmail.com	; Hester, Robert/F-2097-2011	Kiropoulos, Litza/0000-0002-1921-5904; Hester, Robert/0000-0003-0982-8026			Aarstad AKH, 2011, EUR ARCH OTO-RHINO-L, V268, P907, DOI 10.1007/s00405-010-1417-6; Aikens JE, 1999, J BEHAV MED, V22, P127, DOI 10.1023/A:1018731415172; Amato MP, 2006, J NEUROL SCI, V245, P41, DOI 10.1016/j.jns.2005.08.019; Arnett PA, 2002, CLIN NEUROPSYCHOL, V16, P341, DOI 10.1076/clin.16.3.341.13852; Arnett PA, 2008, J INT NEUROPSYCH SOC, V14, P691, DOI 10.1017/S1355617708081174; Australian Bureau of Statistics, 2007, NAT SURV MENT HLTH; Balcer LJ, 2010, NEUROLOGY, V74, pS16, DOI 10.1212/WNL.0b013e3181dbb664; Batty GD, 2008, AM J PUBLIC HEALTH, V98, P2237, DOI 10.2105/AJPH.2007.109488; Beatty WW, 1998, MULT SCLER, V4, P440, DOI 10.1177/135245859800400507; Bechara A., 2007, IOWA GAMBLING TASK P; Beck A. T., 1996, BECK DEPRESSION INVE, VII; Benedict RHB, 2006, J INT NEUROPSYCH SOC, V12, P549, DOI 10.1017/S1355617706060723; Bennett PC, 2005, J INT NEUROPSYCH SOC, V11, P606, DOI 10.1017/S1355617705050721; Brajkovic L, 2009, COLLEGIUM ANTROPOL, V33, P135; BROOKS NA, 1982, SOC SCI MED, V16, P2129, DOI 10.1016/0277-9536(82)90262-3; Brown RF, 2006, MULT SCLER J, V12, P465, DOI 10.1191/1352458506ms1296oa; Brown RF, 2009, PSYCHOL PSYCHOTHER-T, V82, P41, DOI 10.1348/147608308X345614; Bruce JM, 2010, J BEHAV MED, V33, P219, DOI 10.1007/s10865-010-9247-y; Burgess PW, 1998, J INT NEUROPSYCH SOC, V4, P547, DOI 10.1017/S1355617798466037; Burgess PW, 2000, NEUROPSYCHOLOGIA, V38, P848, DOI 10.1016/S0028-3932(99)00134-7; CARVER CS, 1989, J PERS SOC PSYCHOL, V56, P267, DOI 10.1037/0022-3514.56.2.267; Chan RCK, 2008, ARCH CLIN NEUROPSYCH, V23, P201, DOI 10.1016/j.acn.2007.08.010; Chan RCK, 2001, BRIT J PSYCHOL, V92, P551, DOI 10.1348/000712601162338; Chiaravalloti ND, 2008, LANCET NEUROL, V7, P1139, DOI 10.1016/S1474-4422(08)70259-X; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd; Conway ARA, 2005, PSYCHON B REV, V12, P769, DOI 10.3758/BF03196772; Corporation I. B. M., 2012, STAT PACKAGES SOCIAL; Crawford P., 2009, INT J MS CARE, V11, P167, DOI DOI 10.7224/1537-2073-11.4.167; Crigger NJ, 1996, ADV NURS SCI, V18, P37, DOI 10.1097/00012272-199603000-00005; DANEMAN M, 1980, J VERB LEARN VERB BE, V19, P450, DOI 10.1016/S0022-5371(80)90312-6; Diamond A, 2013, ANNU REV PSYCHOL, V64, P135, DOI 10.1146/annurev-psych-113011-143750; Dougher M. J., 1994, ACCEPTANCE CHANGE CO, P125; Drew M, 2008, ARCH CLIN NEUROPSYCH, V23, P1, DOI 10.1016/j.acn.2007.09.005; Feinstein A, 2007, CLINICAL NEUROPSYCHIATRY OF MULTIPLE SCLEROSIS, 2ND EDITION, P1, DOI 10.1017/CBO9780511543760; Feinstein A, 2011, MULT SCLER J, V17, P1276, DOI 10.1177/1352458511417835; Folkman S, 2004, ANNU REV PSYCHOL, V55, P745, DOI 10.1146/annurev.psych.55.090902.141456; FOLKMAN S, 1988, J PERS SOC PSYCHOL, V54, P466, DOI 10.1037/0022-3514.54.3.466; Genova HM, 2013, J CLIN EXP NEUROPSYC, V35, P631, DOI 10.1080/13803395.2013.806649; Goretti B, 2009, NEUROL SCI, V30, P15, DOI 10.1007/s10072-008-0009-3; Harrison T, 2004, WESTERN J NURS RES, V26, P266, DOI 10.1177/0193945903260188; Hayes A. F., 2014, CAN YOUR PROCEDURES; Hayes A.F., 2018, INTRO MEDIATION MODE, V2nd ed.; Hayes AF, 2009, COMMUN MONOGR, V76, P408, DOI 10.1080/03637750903310360; Hayes S. C., 1994, ACCEPTANCE CHANGE CO, P125; Hayes S. C., 2003, EMPIRICALLY SUPPORTE, P4; Henry JD, 2006, NEUROPSYCHOLOGIA, V44, P1166, DOI 10.1016/j.neuropsychologia.2005.10.006; Higginson CI, 2000, ARCH CLIN NEUROPSYCH, V15, P185, DOI 10.1016/S0887-6177(99)00004-9; Hofmann W, 2012, TRENDS COGN SCI, V16, P174, DOI 10.1016/j.tics.2012.01.006; Janssens ACJW, 2003, ACTA NEUROL SCAND, V108, P389, DOI 10.1034/j.1600-0404.2003.00166.x; Janssens ACJW, 2003, MULT SCLER, V9, P397, DOI 10.1191/1352458503ms930oa; Jobin C, 2010, WOMENS HEALTH, V6, P797, DOI [10.2217/whe.10.69, 10.2217/WHE.10.69]; Johnson W, 2009, INTELLIGENCE, V37, P613, DOI 10.1016/j.intell.2008.12.003; Jorm AF, 2004, INTELLIGENCE, V32, P7, DOI 10.1016/j.intell.2003.08.001; KANNER A D, 1981, Journal of Behavioral Medicine, V4, P1, DOI 10.1007/BF00844845; Kehler MD, 2009, J BEHAV MED, V32, P150, DOI 10.1007/s10865-008-9186-z; Korostil M, 2007, MULT SCLER, V13, P67, DOI 10.1177/1352458506071161; Kroencke DC, 1999, MULT SCLER J, V5, P89, DOI 10.1191/135245899678847266; Krpan KM, 2007, J CLIN EXP NEUROPSYC, V29, P36, DOI 10.1080/13803390500376816; Krpan KM, 2011, BRAIN INJURY, V25, P989, DOI 10.3109/02699052.2011.597045; Kubler-Ross E., 2005, GRIEF GRIEVING FINDI; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; LAZARUS R, 1989, MANUAL HASSLES UPLIF; Lazarus R.S., 1984, HDB BEHAV MED, P282; Lester K, 2007, J BEHAV MED, V30, P177, DOI 10.1007/s10865-007-9095-6; Lode K, 2009, MULT SCLER J, V15, P638, DOI 10.1177/1352458509102313; Lynch SG, 2001, MULT SCLER J, V7, P411, DOI 10.1191/135245801701566998; MacKinnon D.P., 2008, INTRO STAT MEDIATION; Makros J, 2003, J RELIG HEALTH, V42, P143, DOI 10.1023/A:1023681830716; McCabe M. P., 2004, PSYCHOL HEALTH MED, V9, P431, DOI DOI 10.1080/1354850042000267021; McCabe MP, 2009, PSYCHOL HEALTH MED, V14, P86, DOI 10.1080/13548500802017682; McCabe MP, 2004, J PSYCHOSOM RES, V56, P355, DOI 10.1016/S0022-3999(03)00132-6; McNulty K, 2004, REHABIL PSYCHOL, V49, P91, DOI 10.1037/0090-5550.49.2.91; Meyer-Moock S, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-58; Minden SL, 2014, NEUROLOGY, V82, P174, DOI 10.1212/WNL.0000000000000013; Mohr DC, 2000, NEUROLOGY, V55, P55, DOI 10.1212/WNL.55.1.55; Moran PJ, 2005, J BEHAV MED, V28, P35, DOI 10.1007/s10865-005-2561-0; Moreau T, 2009, EUR NEUROL, V62, P79, DOI 10.1159/000222777; Muthen L. K., 2012, MPLUS USERS GUIDE, V7th; Nada M., 2011, EGYPT J NEUROL PSYCH, V48, P71; Norris G, 2000, NEUROPSYCHOL REHABIL, V10, P33, DOI 10.1080/096020100389282; O'Keefe DJ, 2003, HUM COMMUN RES, V29, P431, DOI 10.1093/hcr/29.3.431; Pakenham KI, 2006, PSYCHOL HEALTH, V21, P633, DOI 10.1080/14768320500422618; Pakenham KI, 2009, PSYCHOL HEALTH, V24, P373, DOI 10.1080/08870440701832592; Pakenham KI, 2001, PSYCHOL HEALTH MED, V6, P411, DOI DOI 10.1080/13548500126537; Park C. L., 1997, REV GEN PSYCHOL, V1, P115, DOI [10.1037//1089-2680.1.2.115, 10.1037/1089-2680.1.2.115.]; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Pozzilli C, 2012, J NEUROL, V259, P2319, DOI 10.1007/s00415-012-6492-8; Rabinowitz AR, 2009, NEUROPSYCHOLOGY, V23, P581, DOI 10.1037/a0016064; Redick TS, 2012, EUR J PSYCHOL ASSESS, V28, P164, DOI 10.1027/1015-5759/a000123; Robertson I. H., 1994, TEST EVERYDAY ATTENT; ROSS HE, 1989, AM J DRUG ALCOHOL AB, V15, P429, DOI 10.3109/00952998908992802; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; Salthouse TA, 1997, J GERONTOL B-PSYCHOL, V52, pP216, DOI 10.1093/geronb/52B.5.P216; Sanchez-Cubillo I, 2009, J INT NEUROPSYCH SOC, V15, P438, DOI 10.1017/S1355617709090626; Shallice, 1997, HAYLING BRIXTON TEST; Shao Z, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00772; Smith A., 1991, SYMBOL DIGIT MODALIT; Somer E, 2010, MULT SCLER J, V16, P463, DOI 10.1177/1352458509358714; Sparrow EP, 2012, EXECUTIVE FUNCTION AND DYSFUNCTION: IDENTIFICATION, ASSESSMENT AND TREATMENT, P65; Spielberger C, 1983, STAI MANUAL STATE TR; Spitz G, 2013, J HEAD TRAUMA REHAB, V28, P116, DOI 10.1097/HTR.0b013e3182452f4f; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; SULLIVAN MJL, 1995, CAN J NEUROL SCI, V22, P228, DOI 10.1017/S0317167100039895; Summers M, 2008, J NEUROL NEUROSUR PS, V79, P955, DOI 10.1136/jnnp.2007.138685; Taylor AB, 2006, EDUC PSYCHOL MEAS, V66, P228, DOI 10.1177/0013164405278580; Tennen H, 2000, AM PSYCHOL, V55, P626, DOI 10.1037//0003-066X.55.6.626; Tennen H., 1999, COPING PSYCHOL WHAT, P279; Tombaugh TN, 1999, ARCH CLIN NEUROPSYCH, V14, P167, DOI 10.1016/S0887-6177(97)00095-4; Unsworth N, 2005, BEHAV RES METHODS, V37, P498, DOI 10.3758/BF03192720; van der Hiele K, 2012, EUR J NEUROL, V19, P562, DOI 10.1111/j.1468-1331.2011.03538.x; vandenBosch RJ, 1997, COMPR PSYCHIAT, V38, P341, DOI 10.1016/S0010-440X(97)90930-5; Wallin MT, 2006, J REHABIL RES DEV, V43, P63, DOI 10.1682/JRRD.2004.09.0120; White J, 2012, J EPIDEMIOL COMMUN H, V66, P767, DOI 10.1136/jech-2011-200252; Wilder-Willis KE, 2002, SCHIZOPHR RES, V55, P259, DOI 10.1016/S0920-9964(01)00211-0; Wilson BA, 1996, BEHAV ASSESSMENT DYS; Wooldridge J. M., 2009, INTRO ECONOMETRICS M, VFifth	117	18	18	0	36	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0894-4105	1931-1559		NEUROPSYCHOLOGY	Neuropsychology	MAR	2016	30	3					361	376		10.1037/neu0000256			16	Psychology, Clinical; Neurosciences; Psychology	Psychology; Neurosciences & Neurology	DF0ZS	WOS:000371068800011	26618799				2021-06-18	
J	Huang, ZJ; Cheng, CJ; Jiang, L; Yu, ZY; Cao, F; Zhong, JJ; Guo, ZD; Sun, XC				Huang, Zhijian; Cheng, Chongjie; Jiang, Li; Yu, Zhanyang; Cao, Fang; Zhong, Jianjun; Guo, Zongduo; Sun, Xiaochuan			Intraventricular apolipoprotein ApoJ infusion acts protectively in Traumatic Brain Injury	JOURNAL OF NEUROCHEMISTRY			English	Article						ApoJ; complement cascade; oxidative stress; TBI	SPINAL-CORD-INJURY; NEURONAL MAINTENANCE; UP-REGULATION; COMPLEMENT ACTIVATION; CLUSTERIN EXPRESSION; ADULT-RAT; MICE; ISCHEMIA; ASTROCYTES; MOUSE	Traumatic brain injury (TBI) is the leading cause of mortality and morbidity in youth, but to date, effective therapies are still lacking. Previous studies revealed a marked response of apolipoprotein J (ApoJ) expression to the brain injury. The aim of this study was to determine the potential roles of ApoJ in functional recovery following TBI. After controlled cortex impact (CCI), a TBI model, in adult wild-type mice, ApoJ expression was up-regulated since 6h post-injury and sustained for 5days. Animals infused with recombinant human ApoJ intraventricularly at 30min prior to CCI showed significantly reduced oxidative stress (3-nitrotyrosine, 4-hydroxynonenal) and complement activation (C5b-9). In addition, ApoJ treatment was shown to suppress the inflammatory response (glial activation, cytokine expression), blood-brain barrier disruption (Evans blue extravasation), and cerebral edema (water content) induced by CCI. Concomitantly, improved neuronal maintenance and neurological behavioral performance were observed in ApoJ-treated mice compared with the vehicle group. These findings support a neuroprotective role of ApoJ via multifunctional pathways, providing a novel and encouraging treatment strategy for TBI.	[Huang, Zhijian; Cheng, Chongjie; Jiang, Li; Zhong, Jianjun; Guo, Zongduo; Sun, Xiaochuan] Chongqing Med Univ, Affiliated Hosp 1, Dept Neurosurg, Chongqing, Peoples R China; [Yu, Zhanyang] Harvard Univ, Sch Med, Neuroprotect Res Lab, Dept Neurol & Radiol, Cambridge, MA 02138 USA; [Cao, Fang] Zunyi Med Coll, Affiliated Hosp, Dept Cerebrovasc, Zunyi, Guizhou, Peoples R China	Sun, XC (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Dept Neurosurg, Chongqing, Peoples R China.	sunxch1445@qq.com		Huang, Zhijian/0000-0002-8241-0761; sun, xiao chuan/0000-0001-6992-332X	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81371378]; National Construction Project for Clinical Key Specialty [(2011)170]; Guizhou Science and Technology Department [(2013)2332]	The authors thank the following funding agencies for their support: National Natural Science Foundation of China (No. 81371378), National Construction Project for Clinical Key Specialty (No. (2011)170), and Guizhou Science and Technology Department (No. (2013)2332). We acknowledge the service provided by Chongqing Key Laboratory of Ophthalmology. We thank Gilbert Wan for his help in language. All experiments were conducted in compliance with the ARRIVE guidelines. The authors have no conflict of interest to declare.	Abdul-Muneer PM, 2015, MOL NEUROBIOL, V51, P966, DOI 10.1007/s12035-014-8752-3; Ali YO, 2013, TRENDS NEUROSCI, V36, P632, DOI 10.1016/j.tins.2013.07.002; Anderson AJ, 2005, J NEUROTRAUM, V22, P382, DOI 10.1089/neu.2005.22.382; Arent AM, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/723060; Bellander BM, 1996, J NEUROSURG, V85, P468, DOI 10.3171/jns.1996.85.3.0468; Bellander BM, 2001, J NEUROTRAUM, V18, P1295, DOI 10.1089/08977150152725605; Bermpohl D, 2007, J CEREBR BLOOD F MET, V27, P1806, DOI 10.1038/sj.jcbfm.9600487; Bermpohl D, 2006, J CEREBR BLOOD F MET, V26, P625, DOI 10.1038/sj.jcbfm.9600258; Charnay Y, 2008, NEUROSCIENCE, V155, P714, DOI 10.1016/j.neuroscience.2008.06.022; Clausen F, 2009, EUR J NEUROSCI, V30, P385, DOI 10.1111/j.1460-9568.2009.06820.x; Crehan H, 2012, INT J ALZHEIMERS DIS, V2012, P983640, DOI [DOI 10.1155/2012/983640, 10.1155/2012/983640]; Davoust N, 1999, GLIA, V27, P162, DOI 10.1002/(SICI)1098-1136(199908)27:2<162::AID-GLIA6>3.0.CO;2-K; Ducruet AF, 2009, EXP NEUROL, V219, P398, DOI 10.1016/j.expneurol.2009.07.018; Ferguson S, 2010, NEUROSCIENCE, V168, P811, DOI 10.1016/j.neuroscience.2010.01.031; Hayashi H, 2011, BIOL PHARM BULL, V34, P453, DOI 10.1248/bpb.34.453; Holtzman DM, 2001, NAT MED, V7, P977, DOI 10.1038/nm0901-977; Imhof A, 2006, NEUROBIOL DIS, V22, P274, DOI 10.1016/j.nbd.2005.11.009; Iwata A, 2005, J NEUROSCI RES, V82, P103, DOI 10.1002/jnr.20607; JENNE DE, 1989, P NATL ACAD SCI USA, V86, P7123, DOI 10.1073/pnas.86.18.7123; Kim N, 2012, ALCOHOL CLIN EXP RES, V36, P72, DOI 10.1111/j.1530-0277.2011.01588.x; KIM SH, 1987, J IMMUNOL, V138, P1530; Koltai T, 2014, ONCOTARGETS THER, V7, P447, DOI 10.2147/OTT.S58622; Kontos H A, 1986, Cent Nerv Syst Trauma, V3, P257; KONTOS HA, 1986, J NEUROSURG, V64, P803, DOI 10.3171/jns.1986.64.5.0803; Koscielska-Kasprzak K, 2014, ARCH IMMUNOL THER EX, V62, P47, DOI 10.1007/s00005-013-0254-x; Lee YN, 2012, BIOCHEM BIOPH RES CO, V420, P851, DOI 10.1016/j.bbrc.2012.03.087; Liu D, 2009, IMMUNOPHARM IMMUNOT, V31, P524, DOI 10.3109/08923970902845768; Lloyd E, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-28; Masliah E, 1997, BRAIN RES, V751, P307, DOI 10.1016/S0006-8993(96)01420-5; Ohlsson M, 2003, J NEUROTRAUM, V20, P895, DOI 10.1089/089771503322385827; Spasic MR, 2008, J NEUROSCI, V28, P6419, DOI 10.1523/JNEUROSCI.1646-08.2008; Storini C, 2005, NEUROBIOL DIS, V19, P10, DOI 10.1016/j.nbd.2004.11.001; Swanson RA, 2004, CURR MOL MED, V4, P193, DOI 10.2174/1566524043479185; Trendelenburg G, 2005, GLIA, V50, P307, DOI 10.1002/glia.20204; Tsenter J, 2008, J NEUROTRAUM, V25, P324, DOI 10.1089/neu.2007.0452; Veerhuis R, 2011, MOL IMMUNOL, V48, P1592, DOI 10.1016/j.molimm.2011.04.003; Walker DG, 1998, BRAIN RES, V809, P31, DOI 10.1016/S0006-8993(98)00811-7; Wang D, 2013, CELL MOL LIFE SCI, V70, P2919, DOI 10.1007/s00018-012-1201-4; Xiong YQ, 2007, J NEUROCHEM, V100, P639, DOI 10.1111/j.1471-4159.2006.04312.x; Yager PH, 2008, J CEREBR BLOOD F MET, V28, P1030, DOI 10.1038/sj.jcbfm.9600605; Yasuda Y, 2004, BRAIN RES, V1021, P20, DOI 10.1016/j.brainres.2004.06.015; Zhuang JL, 2015, GENE, V555, P150, DOI 10.1016/j.gene.2014.10.056	42	18	21	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3042	1471-4159		J NEUROCHEM	J. Neurochem.	MAR	2016	136	5					1017	1025		10.1111/jnc.13491			9	Biochemistry & Molecular Biology; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	DE5BT	WOS:000370646500012	26670094				2021-06-18	
J	Konda, S; Tiesman, HM; Reichard, AA				Konda, Srinivas; Tiesman, Hope M.; Reichard, Audrey A.			Fatal Traumatic Brain Injuries in the Construction Industry, 2003-2010	AMERICAN JOURNAL OF INDUSTRIAL MEDICINE			English	Article						brain injuries; TBI; falls; roofers; occupational; older workers	WORK; FALLS; US; EPIDEMIOLOGY; SYSTEM; IMPACT	Background Research on fatal work-related traumatic brain injuries (TBIs) is limited. This study describes fatal TBIs in the US construction industry. Methods Fatal TBIs were extracted from the Bureau of Labor Statistics Census of Fatal Occupational Injuries. Results From 2003 to 2010, 2,210 fatal TBIs occurred in construction at a rate of 2.6 per 100,000 full-time equivalent (FTE) workers. Workers aged 65 years and older had the highest fatal TBI rates among all workers (7.9 per 100,000 FTE workers). Falls were the most frequent injury event (n = 1,269, 57%). Structural iron and steel workers and roofers had the highest fatal TBI rate per 100,000 FTE workers (13.7 and 11.2, respectively). Fall-related TBIs were the leading cause of death in these occupations. Conclusions A large percentage of TBIs in the construction industry were due to falls. Emphasis on safety interventions is needed to reduce these fall-related TBIs, especially among vulnerable workers. Published 2016. This article is a U.S. Government work and is in the public domain in the USA.	[Konda, Srinivas; Tiesman, Hope M.; Reichard, Audrey A.] NIOSH, Div Safety Res, Ctr Dis Control & Prevent, 1095 Willowdale Rd,MS 1811, Morgantown, WV 26506 USA	Konda, S (corresponding author), NIOSH, Div Safety Res, 1095 Willowdale Rd,MS 1811, Morgantown, WV 26506 USA.	skonda@cdc.gov	Konda, Srinivas/G-2747-2015	Konda, Srinivas/0000-0002-8934-4111			*AFL CIO, 2005, IMM WORK RISK URG NE; BLS, 2013, CURR POP SURV MICR F; BLS, 2012, BLS SPOTL STAT REC 2; BLS, 2003, FAT OCC INJ EMPL RAT; BLS, 2012, CURR POP SURV BAS MO; BLS, 2014, CENS FAT OCC INJ CHA; BLS, 2011, FAT OCC INJ TOT HOUR; *BLS, 1992, OCC INJ ILLN CLASS M; BLS (US Bureau of Labor Statistics), 2003, CENS FAT OCC INJ CFO; Byler C.G., 2013, MONTHLY LABOR REV; CDC, 2012, NIOSH OSHA CPWR CTR; CDC, 2011, CONSTR SAF HLTH; Center for Disease Control, 2013, PREV FALLS OLD AD; Chang VC, 2015, AM J IND MED, V58, P353, DOI 10.1002/ajim.22418; Colantonio A, 2009, BRAIN INJURY, V23, P873, DOI 10.1080/02699050903036033; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; CPWR, 2013, CONSTR CHART BOOK UK; Dembe AE, 2005, OCCUP ENVIRON MED, V62, P588, DOI 10.1136/oem.2004.016667; Dong XWS, 2011, AM J IND MED, V54, P339, DOI 10.1002/ajim.20928; Dong XWS, 2013, J SAFETY RES, V44, P17, DOI 10.1016/j.jsr.2012.08.024; Dong XWS, 2012, HUM FACTORS, V54, P303, DOI 10.1177/0018720811410057; Dong XWS, 2009, ACCIDENT ANAL PREV, V41, P1047, DOI 10.1016/j.aap.2009.06.012; Fakhry SM, 2004, J TRAUMA, V56, P492, DOI 10.1097/01.TA.0000115650.07193.66; Hartl R, 2006, J TRAUMA, V60, P1250, DOI 10.1097/01.ta.0000203717.57821.8d; Janicak CA, 1998, J OCCUP ENVIRON MED, V40, P347, DOI 10.1097/00043764-199804000-00009; Kica J, 2014, J SAFETY RES, V51, P49, DOI 10.1016/j.jsr.2014.09.003; Konda S, 2014, INJURY PREV, V21, P115; Liu M, 2011, WORK, V39, P283, DOI 10.3233/WOR-2011-1176; Long J, 2015, COMPUT METHOD BIOMEC, V18, P24, DOI 10.1080/10255842.2013.774382; Moyer VA, 2012, ANN INTERN MED, V157, P197, DOI 10.7326/0003-4819-157-3-201208070-00462; NCIPC, 2014, RAT TBI REL EM DEP V; NCOSH, 2000, IMM WORK RISK QUAL S; NIOSH, 2014, MMWR-MORBID MORTAL W, V62, P1037; *OMB, 2000, STAND OCC CLASS MAN; *OMB, 2002, N AM IND CLASS SYST; Orrenius PM, 2009, DEMOGRAPHY, V46, P535, DOI 10.1353/dem.0.0064; OSHA, 2015, SMALL BUSINESS; OSHA, 2005, CONSTR WORK SAF SER; Schwatka NV, 2012, EPIDEMIOL REV, V34, P156, DOI 10.1093/epirev/mxr020; Sears JM, 2013, J OCCUP ENVIRON MED, V55, P507, DOI 10.1097/JOM.0b013e31827ee018; Tiesman H, 2007, J NEUROTRAUM, V24, P1189, DOI 10.1089/neu.2006.0196; Tiesman HM, 2011, AM J PREV MED, V41, P61, DOI 10.1016/j.amepre.2011.03.007; TINETTI ME, 1995, J AM GERIATR SOC, V43, P1214, DOI 10.1111/j.1532-5415.1995.tb07396.x; U.S. Census Bureau, 2002, IND OCC METH; U. S. Census Bureau, 2010, CONSTR SPEND; Us Census Bureau, 2012, COUNT BUS PATT; Wrona RM, 2006, J SAFETY RES, V37, P75, DOI 10.1016/j.jsr.2005.08.008	47	18	20	0	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0271-3586	1097-0274		AM J IND MED	Am. J. Ind. Med.	MAR	2016	59	3					212	220		10.1002/ajim.22557			9	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	DG7UW	WOS:000372290200006	26765167				2021-06-18	
J	Lee, S; Yang, M; Kim, J; Son, Y; Kim, J; Kang, S; Ahn, W; Kim, SH; Kim, JC; Shin, T; Wang, H; Moon, C				Lee, Sueun; Yang, Miyoung; Kim, Juhwan; Son, Yeonghoon; Kim, Jinwook; Kang, Sohi; Ahn, Wooseok; Kim, Sung-Ho; Kim, Jong-Choon; Shin, Taekyun; Wang, Hongbing; Moon, Changjong			Involvement of BDNF/ERK signaling in spontaneous recovery from trimethyltin-induced hippocampal neurotoxicity in mice	BRAIN RESEARCH BULLETIN			English	Article						Trimethyltin; Hippocampus; BDNF; ERK; Spontaneous recovery	REGULATED KINASE ACTIVATION; FOCAL CEREBRAL-ISCHEMIA; TRAUMATIC BRAIN-INJURY; NEURAL STEM-CELLS; NEUROTROPHIC FACTOR; DENTATE GYRUS; MAP KINASE; IN-VITRO; MURINE HIPPOCAMPUS; MOUSE HIPPOCAMPUS	Trimethyltin (TMT) toxicity causes histopathological damage in the hippocampus and induces seizure behaviors in mice. The lesions and symptoms recover spontaneously over time; however, little is known about the precise mechanisms underlying this recovery from TMT toxicity. We investigated changes in the brain-derived neurotrophic factor/extracellular signal-regulated kinases (BDNF/ERK) signaling pathways in the mouse hippocampus following TMT toxicity. Mice (7 weeks old, C57BL/6) administered TMT (2.6 mg/kg intraperitoneally) showed acute and severe neurodegeneration with increased TUNEL-positive cells in the dentate gyrus (DG) of the hippocampus. The mRNA and protein levels of BDNF in the hippocampus were elevated by TMT treatment. Immunohistochemical analysis showed that TMT treatment markedly increased phosphorylated ERK1/2 expression in the mouse hippocampus 1-4 days after TMT treatment, although the intensity of ERK immunoreactivity in mossy fiber decreased at 1-8 days post-treatment. In addition, ERK-immunopositive cells were localized predominantly in doublecortin-positive immature progenitor neurons in the DG. In primary cultured immature hippocampal neurons (4 days in vitro), BDNF treatment alleviated TMT-induced neurotoxicity, via activation of the ERK signaling pathway. Thus, we suggest that BDNF/ERK signaling pathways may be associated with cell differentiation and survival of immature progenitor neurons, and will eventually lead to spontaneous recovery in TMT-induced hippocampal neurodegeneration. (C) 2016 Elsevier Inc. All rights reserved.	[Lee, Sueun; Kim, Juhwan; Son, Yeonghoon; Kim, Jinwook; Kang, Sohi; Ahn, Wooseok; Kim, Sung-Ho; Kim, Jong-Choon; Moon, Changjong] Chonnam Natl Univ, Coll Vet Med, Kwangju 500757, South Korea; [Lee, Sueun; Kim, Juhwan; Son, Yeonghoon; Kim, Jinwook; Kang, Sohi; Ahn, Wooseok; Kim, Sung-Ho; Kim, Jong-Choon; Moon, Changjong] Chonnam Natl Univ, Plus Project Team BK21, Kwangju 500757, South Korea; [Yang, Miyoung] Wonkwang Univ, Sch Med, Dept Anat, Iksan 570740, Jeonbuk, South Korea; [Yang, Miyoung; Wang, Hongbing] Michigan State Univ, Dept Physiol, E Lansing, MI 48824 USA; [Yang, Miyoung; Wang, Hongbing] Michigan State Univ, Neurosci Program, E Lansing, MI 48824 USA; [Shin, Taekyun] Jeju Natl Univ, Coll Vet Med, Jeju 690756, South Korea	Wang, H (corresponding author), Michigan State Univ, Dept Physiol, E Lansing, MI 48824 USA.; Wang, H (corresponding author), Michigan State Univ, Neurosci Program, E Lansing, MI 48824 USA.; Moon, C (corresponding author), Chonnam Natl Univ, Coll Vet Med, Dept Vet Anat, Kwangju 500757, South Korea.	wangho@msu.edu; moonc@chonnam.ac.kr	Moon, Changjong/AAI-2005-2020	Moon, Changjong/0000-0003-2451-0374; SHIN, Taekyun/0000-0002-9851-4354	Animal Medical Institute of Chonnam National University; Basic Science Research Program through the National Research Foundation of Korea - Ministry of Science, ICT and Future Planning, Republic of Korea [NRF-2012R1A1B4001262]; NIH grant, U.S.A. [R01MH093445]; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH093445] Funding Source: NIH RePORTER	The animal experiment in this study was supported by the Animal Medical Institute of Chonnam National University. This work was supported by Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Science, ICT and Future Planning, Republic of Korea (NRF-2012R1A1B4001262 to CM) and NIH grant, U.S.A. (R01MH093445 to HW).	Adderley SR, 1999, J BIOL CHEM, V274, P5038, DOI 10.1074/jbc.274.8.5038; Alessandrini A, 1999, P NATL ACAD SCI USA, V96, P12866, DOI 10.1073/pnas.96.22.12866; Berkeley JL, 2002, J NEUROCHEM, V82, P192, DOI 10.1046/j.1471-4159.2002.00977.x; BESSER R, 1987, NEUROLOGY, V37, P945, DOI 10.1212/WNL.37.6.945; Bhat NR, 1999, J NEUROCHEM, V72, P112, DOI 10.1046/j.1471-4159.1999.0720112.x; Blaiss CA, 2011, J NEUROSCI, V31, P4906, DOI 10.1523/JNEUROSCI.5265-10.2011; Casalbore P, 2010, J CELL PHYSIOL, V224, P710, DOI 10.1002/jcp.22170; CHANG LW, 1987, BIOL TRACE ELEM RES, V13, P77, DOI 10.1007/BF02796623; Choi YS, 2008, GLIA, V56, P791, DOI 10.1002/glia.20653; Corvino V, 2013, NEUROCHEM RES, V38, P240, DOI 10.1007/s11064-012-0932-9; DOCTOR SV, 1982, TOXICOLOGY, V25, P213, DOI 10.1016/0300-483X(82)90031-2; Dougherty KD, 2000, NEUROBIOL DIS, V7, P574, DOI 10.1006/nbdi.2000.0318; Dudek F Edward, 2004, Epilepsy Curr, V4, P184, DOI 10.1111/j.1535-7597.2004.04507.x; Fabrizi C, 2016, NEUROTOXICOLOGY, V52, P12, DOI 10.1016/j.neuro.2015.10.004; Fiedorowicz A, 2001, BRAIN RES, V912, P116, DOI 10.1016/S0006-8993(01)02675-0; Garcia J, 2002, EMBO J, V21, P5151, DOI 10.1093/emboj/cdf488; Geloso MC, 2011, NEUROCHEM INT, V58, P729, DOI 10.1016/j.neuint.2011.03.009; Grewal SS, 1999, CURR OPIN NEUROBIOL, V9, P544, DOI 10.1016/S0959-4388(99)00010-0; Harry GJ, 2004, NEUROTOX RES, V5, P623; Hetman M, 2004, EUR J BIOCHEM, V271, P2050, DOI 10.1111/j.1432-1033.2004.04133.x; Hossain MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083508; Houser CR, 2008, NEUROSCIENCE, V156, P222, DOI 10.1016/j.neuroscience.2008.07.010; Islam O, 2009, CURR NEUROVASC RES, V6, P42, DOI 10.2174/156720209787466028; Jaffe DB, 2007, PROG BRAIN RES, V163, P109, DOI 10.1016/S0079-6123(07)63006-4; JONES KR, 1994, CELL, V76, P989, DOI 10.1016/0092-8674(94)90377-8; Khokhlatchev AV, 1998, CELL, V93, P605, DOI 10.1016/S0092-8674(00)81189-7; Kim DJ, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/729509; Kim J., 2015, INT J DEV NEUROSCI; Kim J, 2014, INT J DEV NEUROSCI, V38, P68, DOI 10.1016/j.ijdevneu.2014.08.001; Kim J, 2014, ACTA HISTOCHEM, V116, P1490, DOI 10.1016/j.acthis.2014.09.003; Kim J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070356; Kulich SM, 2001, J NEUROCHEM, V77, P1058, DOI 10.1046/j.1471-4159.2001.00304.x; Lannuzel A, 1997, ANN NEUROL, V42, P847, DOI 10.1002/ana.410420605; Lee S, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.16; Lee S, 2014, ACTA HISTOCHEM, V116, P1276, DOI 10.1016/j.acthis.2014.07.009; Li Y, 2010, EXP NEUROL, V224, P133, DOI 10.1016/j.expneurol.2010.03.003; Liu Y, 2010, NEUROSCIENCE, V166, P241, DOI 10.1016/j.neuroscience.2009.12.026; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Matsumoto J, 2006, J PHARMACOL EXP THER, V318, P982, DOI 10.1124/jpet.106.104562; Matsumoto T, 2008, NAT NEUROSCI, V11, P131, DOI 10.1038/nn2038; Mebratu Y, 2009, CELL CYCLE, V8, P1168, DOI 10.4161/cc.8.8.8147; Mendoza MC, 2011, TRENDS BIOCHEM SCI, V36, P320, DOI 10.1016/j.tibs.2011.03.006; NAALSUND LU, 1985, NEUROTOXICOLOGY, V6, P145; Nakazawa T, 2002, INVEST OPHTH VIS SCI, V43, P3319; Ogita K, 2005, J NEUROSCI RES, V82, P609, DOI 10.1002/jnr.20678; Park Sin-Young, 2014, Exp Neurobiol, V23, P104, DOI 10.5607/en.2014.23.1.104; Piacentini R, 2008, J NEUROCHEM, V105, P2109, DOI 10.1111/j.1471-4159.2008.05297.x; Pignataro G, 2013, NEUROBIOL DIS, V54, P105, DOI 10.1016/j.nbd.2013.02.008; Pleasure SJ, 2000, J NEUROSCI, V20, P6095, DOI 10.1523/JNEUROSCI.20-16-06095.2000; Qing Y, 2013, ARCH TOXICOL, V87, P1273, DOI 10.1007/s00204-013-1021-9; Rapoport M, 2000, J NEUROCHEM, V74, P125, DOI 10.1046/j.1471-4159.2000.0740125.x; Sanchez A, 2012, NEUROSCI RES, V72, P1, DOI 10.1016/j.neures.2011.09.003; Sathanoori M, 2004, MOL BRAIN RES, V130, P170, DOI 10.1016/j.molbrainres.2004.08.002; Schenk U, 2005, J NEUROSCI, V25, P1654, DOI 10.1523/JNEUROSCI.3074-04.2005; Schinelli S, 2001, J NEUROSCI, V21, P8842, DOI 10.1523/JNEUROSCI.21-22-08842.2001; Schwartz PM, 1997, NEURON, V19, P269, DOI 10.1016/S0896-6273(00)80938-1; Segal RA, 1996, ANNU REV NEUROSCI, V19, P463, DOI 10.1146/annurev.ne.19.030196.002335; Sindreu C, 2011, P NATL ACAD SCI USA, V108, P3366, DOI 10.1073/pnas.1019166108; Slevin M, 2000, NEUROREPORT, V11, P2759, DOI 10.1097/00001756-200008210-00030; Son Y, 2015, NEUROBIOL LEARN MEM, V121, P12, DOI 10.1016/j.nlm.2015.03.002; Svaren J, 1996, MOL CELL BIOL, V16, P3545; Vanhoutte P, 1999, MOL CELL BIOL, V19, P136; Vara H, 2009, P NATL ACAD SCI USA, V106, P9872, DOI 10.1073/pnas.0900077106; Veyrac A, 2013, P NATL ACAD SCI USA, V110, P7062, DOI 10.1073/pnas.1220558110; Wachter B, 2010, CELL TISSUE RES, V342, P147, DOI 10.1007/s00441-010-1061-x; Wuhanqimuge, 2013, FEBS OPEN BIO, V3, P243, DOI 10.1016/j.fob.2013.05.003; Yang M, 2012, NEUROCHEM INT, V61, P955, DOI 10.1016/j.neuint.2012.09.015; Yang M, 2011, BIOCHEM PHARMACOL, V82, P72, DOI 10.1016/j.bcp.2011.03.020; Yoneyama M, 2008, NEUROCHEM INT, V52, P761, DOI 10.1016/j.neuint.2007.09.003; Yun MS, 2005, J CELL SCI, V118, P313, DOI 10.1242/jcs.01601; Zhou XJ, 2009, J NEUROSCI RES, V87, P2632, DOI 10.1002/jnr.22103	72	18	18	0	8	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0361-9230	1873-2747		BRAIN RES BULL	Brain Res. Bull.	MAR	2016	121						48	58		10.1016/j.brainresbull.2016.01.002			11	Neurosciences	Neurosciences & Neurology	DI3SN	WOS:000373418900006	26772626	Green Accepted			2021-06-18	
J	McCredie, VA; Alali, AS; Xiong, W; Rubenfeld, GD; Cuthbertson, BH; Scales, DC; Nathens, AB				McCredie, Victoria A.; Alali, Aziz S.; Xiong, Wei; Rubenfeld, Gordon D.; Cuthbertson, Brian H.; Scales, Damon C.; Nathens, Avery B.			Timing of withdrawal of life-sustaining therapies in severe traumatic brain injury: Impact on overall mortality	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Traumatic brain injury; critical care; mortality; withdrawal of life-sustaining therapies; trauma centers	QUALITY IMPROVEMENT PROGRAM; HEAD-INJURY; INTRACEREBRAL HEMORRHAGE; LOGISTIC-REGRESSION; AMERICAN-COLLEGE; UNITED-STATES; CARE; MANAGEMENT; VARIABLES; OUTCOMES	BACKGROUND The care of patients with severe traumatic brain injury (TBI) is complex and confounded by uncertainty in prognoses. Studies have demonstrated significant unexplained variation in mortality between centers. Possible explanations include differences in the quality and intensity of care across centers, including the appropriateness and timing of withdrawal of life-sustaining therapies. We postulated that centers with a preponderance of early deaths might have a more pessimistic approach to the TBI patient, which would be reflected in an increased hospital TBI-related mortality. METHODS This is a retrospective cohort study. Time to death was used as a proxy for time to withdrawal of life-sustaining therapies. Centers were classified as early or late based on when the majority (75th percentile) of their TBI-related deaths occurred. We evaluated the association between adjusted mortality and center classification using a hierarchical multivariable model. Two hundred trauma centers contributing data to the American College of Surgeons Trauma Quality Improvement Program from 2010 through 2013 were involved. The cohort included 17,505 patients with severe isolated TBI. RESULTS One hundred eight centers were classified as early centers. The 75th percentile for time to death was 4 days among early centers versus 7 days in late centers. Mortality was 34% and 33%, respectively. After adjustment for case mix, care in an early center was not associated with increased odds of death (adjusted odds ratio, 0.95; 95% confidence interval, 0.83-1.09). Higher odds of death were independently associated with age, Glasgow Coma Scale (GCS) score, head Abbreviated Injury Scale (AIS) score, multiple comorbidities, traumatic subarachnoid hemorrhage, intracerebral mass lesions, brainstem lesions, and signs of compressed or absent basal cisterns. CONCLUSION Centers rendering early decisions related to withdrawal of life-sustaining therapies in TBI patients, as measured by time until death, do not have worse outcomes than those making later decisions. How and when these decisions are made requires further exploration to balance an opportunity for clinical improvement with appropriate resource use. LEVEL OF EVIDENCE Prognostic and epidemiologic study, level III.	[McCredie, Victoria A.; Rubenfeld, Gordon D.; Cuthbertson, Brian H.; Scales, Damon C.] Sunnybrook Hlth Sci Ctr, Dept Crit Care Med, 2075 Bayview Ave, Toronto, ON M4N 3M5, Canada; [Alali, Aziz S.; Xiong, Wei; Rubenfeld, Gordon D.; Cuthbertson, Brian H.; Scales, Damon C.; Nathens, Avery B.] Sunnybrook Hlth Sci Ctr, Sunnybrook Res Inst, Toronto, ON M4N 3M5, Canada; [Scales, Damon C.] Sunnybrook Hlth Sci Ctr, Dept Surg, Toronto, ON M4N 3M5, Canada; [Cuthbertson, Brian H.] Univ Toronto, Dept Anesthesia, Toronto, ON, Canada	McCredie, VA (corresponding author), Sunnybrook Hlth Sci Ctr, Dept Crit Care Med, 2075 Bayview Ave, Toronto, ON M4N 3M5, Canada.	Victoria.McCredie@sunnybrook.ca		McCredie, Victoria/0000-0002-1590-2846			Alali AS, 2013, J NEUROTRAUM, V30, P1737, DOI 10.1089/neu.2012.2802; American College of Surgeons, 2016, RES OPT CAR INJ PAT; Andrews PJD, 2002, J NEUROSURG, V97, P326, DOI 10.3171/jns.2002.97.2.0326; Becker KJ, 2001, NEUROLOGY, V56, P766, DOI 10.1212/WNL.56.6.766; Bennett TD, 2012, ARCH PEDIAT ADOL MED, V166, P641, DOI 10.1001/archpediatrics.2012.322; Boucher KM, 1998, J CLIN EPIDEMIOL, V51, P1223, DOI 10.1016/S0895-4356(98)00129-2; Bulger EM, 2002, CRIT CARE MED, V30, P1870, DOI 10.1097/00003246-200208000-00033; Canadian Institutes of Health Research Natural Sciences and Engineering Research Council of Canada and Social Sciences and Humanities Research Council of Can-ada, 2010, TRI COUNC POL STAT E; Clifton GL, 2001, J NEUROSURG, V95, P751, DOI 10.3171/jns.2001.95.5.0751; Cote N, 2013, NEUROCRIT CARE, V18, P154, DOI 10.1007/s12028-012-9787-9; Diringer MN, 2001, CRIT CARE MED, V29, P1792, DOI 10.1097/00003246-200109000-00023; Hemmila MR, 2010, J TRAUMA, V68, P253, DOI 10.1097/TA.0b013e3181cfc8e6; Hemphill JC, 2009, EMERG MED CLIN N AM, V27, P27, DOI 10.1016/j.emc.2008.08.009; Hukkelhoven CWPM, 2006, J CLIN EPIDEMIOL, V59, P132, DOI 10.1016/j.jclinepi.2005.06.009; Khan S, 2002, BRAIN INJURY, V16, P537, DOI 10.1080/02699050110119862; Kirkman MA, 2013, J NEUROTRAUM, V30, P1385, DOI 10.1089/neu.2013.2881; Kozar RA, 2014, J TRAUMA ACUTE CARE, V76, P634, DOI 10.1097/TA.0000000000000130; Lingsma HF, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-201; Lingsma HF, 2011, NEUROSURGERY, V68, P601, DOI 10.1227/NEU.0b013e318209333b; Mamdani M, 2005, BMJ-BRIT MED J, V330, P960, DOI 10.1136/bmj.330.7497.960; Mayor SA, 1999, NEUROLOGY, V52, P1602, DOI 10.1212/WNL.52.8.1602; Meldon SW, 2002, J TRAUMA, V52, P79, DOI 10.1097/00005373-200201000-00014; MICKEY RM, 1989, AM J EPIDEMIOL, V129, P125, DOI 10.1093/oxfordjournals.aje.a115101; Mittlbock M, 1996, STAT MED, V15, P1987, DOI 10.1002/(SICI)1097-0258(19961015)15:19<1987::AID-SIM318>3.0.CO;2-9; Moore Lynne, 2009, J Emerg Trauma Shock, V2, P73, DOI 10.4103/0974-2700.44774; Moore L, 2009, J AM COLL SURGEONS, V209, P572, DOI 10.1016/j.jamcollsurg.2009.07.004; Naidech AM, 2009, NEUROCRIT CARE, V11, P45, DOI 10.1007/s12028-009-9186-z; Newgard CD, 2013, J AM COLL SURGEONS, V216, P147, DOI 10.1016/j.jamcollsurg.2012.08.017; Pillai SV, 2003, NEUROL INDIA, V51, P345; Plaisier BR, 2002, AM SURGEON, V68, P159; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Schaan M, 2002, J TRAUMA, V52, P667, DOI 10.1097/00005373-200204000-00009; Schreiber MA, 2002, ARCH SURG-CHICAGO, V137, P285, DOI 10.1001/archsurg.137.3.285; Shafi S, 2009, J AM COLL SURGEONS, V209; Signorini DF, 1999, J NEUROL NEUROSUR PS, V66, P20, DOI 10.1136/jnnp.66.1.20; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; Turgeon AF, 2011, CAN MED ASSOC J, V183, P1581, DOI 10.1503/cmaj.101786; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac	39	18	18	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	MAR	2016	80	3					484	491		10.1097/TA.0000000000000922			8	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	DF7XT	WOS:000371571900027	26595711				2021-06-18	
J	Mollayeva, T; Mollayeva, S; Shapiro, CM; Cassidy, JD; Colantonio, A				Mollayeva, Tatyana; Mollayeva, Shirin; Shapiro, Colin M.; Cassidy, J. David; Colantonio, Angela			Insomnia in workers with delayed recovery from mild traumatic brain injury	SLEEP MEDICINE			English	Article						Insomnia; Traumatic brain injury; Concussion; Delayed recovery; Rehabilitation; Diagnostic modeling	OLDER-ADULTS; PSYCHIATRIC-DISORDERS; ASSESSING DEPRESSION; SLEEP DISTURBANCES; GENERAL-POPULATION; SEX-DIFFERENCES; RISK-FACTORS; PAIN; PREVALENCE; COMPLAINTS	Objective/Background/Aim: Insomnia has not been explored as it relates to recovery after mild traumatic brain injury (mTBI). We aimed to evaluate the prevalence of insomnia among Ontario workers with delayed recovery from mTBI, and its relationship with sociodemographic, TBI- and claim-related, behavioral, and clinical factors. Patients/Methods: This was a cross-sectional study carried out over a period of 24 months in a large rehabilitation hospital in Ontario. To assess the prevalence of insomnia, we used the Insomnia Severity Index (ISI). Data were collected from standardized questionnaires, insurer records, and clinical assessment at the time of recruitment. Bivariate associations were calculated using the Spearman's correlation coefficient or analysis of variance. We established stepwise multivariate linear regression models of factors associated with insomnia. Additional analyses, including the assessment of the internal consistency of the ISI, were performed. Results: Of the 94 participants diagnosed with mTBI, clinical insomnia was reported by 69.2%. The mean age was 45.20 +/- 9.94 years; 61.2% were men. No sex-related differences were observed in insomnia prevalence or severity. Insomnia was significantly associated with certain sociodemographic, claim-related, behavioral, and clinical variables. In the multivariable regression analysis, several determinants explained 53% of the insomnia variance. The internal consistency of the ISI, as measured by Cronbach's a, was 0.86. Conclusions: Insomnia is common in persons with delayed recovery from mTBI, and is significantly associated with potentially modifiable clinical and nonclinical variables. Care of persons with brain injury requires greater attention with regard to the diagnosis and management of insomnia and associated disorders. (C) 2015 Elsevier B.V. All rights reserved.	[Mollayeva, Tatyana; Colantonio, Angela] Univ Toronto, Fac Med, Grad Dept Rehabil Sci, Toronto, ON, Canada; [Mollayeva, Tatyana] Univ Toronto, Collaborat Program Neurosci, Toronto, ON, Canada; [Mollayeva, Tatyana] Toronto Rehab Univ Hlth Network, Toronto, ON, Canada; [Mollayeva, Shirin; Shapiro, Colin M.] Univ Toronto, Fac Arts & Sci, Toronto, ON, Canada; [Mollayeva, Shirin; Colantonio, Angela] Univ Toronto, Aquired Brain Injury Res Lab, Toronto, ON, Canada; [Mollayeva, Shirin; Shapiro, Colin M.] Youthdale Child & Adolescent Sleep Clin, Toronto, ON, Canada; [Shapiro, Colin M.] Univ Hlth Network, Toronto Western Hosp, Toronto, ON, Canada; [Cassidy, J. David] Univ Southern Denmark, Fac Hlth, Dept Sport Sci & Clin Biomech, Odense M, Denmark; [Cassidy, J. David] Univ Hlth Network, Div Hlth Care & Outcomes Res, Toronto, ON, Canada; [Cassidy, J. David] Univ Toronto, Div Epidemiol, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Colantonio, Angela] Univ Toronto, Dept Occupat Sci & Occupat Therapy, Toronto, ON, Canada	Mollayeva, T (corresponding author), Toronto Rehabil Inst, 550 Univ Ave,Rm 11207, Toronto, ON M5G 2A2, Canada.	tatyana.mollayeva@utoronto.ca	, Mollayeva/A-4522-2018	Mollayeva, Shirin/0000-0001-9612-8655; Mollayeva, Tatyana/0000-0002-2787-1848; Colantonio, Angela/0000-0003-2094-4765	Toronto Rehabilitation Institute Scholarship; Ontario Graduate ScholarshipOntario Graduate Scholarship; Frederick Banting and Charles Best Doctoral Research Award from the Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR); Saunderson Family Chair in Acquired Brain Injury Research; Canadian Institutes of Health Research Grant -Institute for Gender and Health [CGW-126580]	Our study had no external funding source. The first author was supported by 2010/2011 Toronto Rehabilitation Institute Scholarship, the Ontario Graduate Scholarship 2012/2013, and the 2013/2015 Frederick Banting and Charles Best Doctoral Research Award from the Canadian Institutes of Health Research, Angela Colantonio was supported by the Saunderson Family Chair in Acquired Brain Injury Research and by the Canadian Institutes of Health Research Grant -Institute for Gender and Health (#CGW-126580). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrishami A, 2010, CAN J ANAESTH, V57, P423, DOI 10.1007/s12630-010-9280-x; American Academy of Sleep Medicine, 2005, INT CLASS SLEEP DIS, V2nd; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Baglioni C, 2011, J AFFECT DISORDERS, V135, P10, DOI 10.1016/j.jad.2011.01.011; Bastien CH, 2001, SLEEP MED, V2, P297, DOI 10.1016/S1389-9457(00)00065-4; Baumann CR, 2007, BRAIN, V130, P1873, DOI 10.1093/brain/awm109; Beetar JT, 1996, ARCH PHYS MED REHAB, V77, P1298, DOI 10.1016/S0003-9993(96)90196-3; Borsook D, 2012, BRAIN, V135, P320, DOI 10.1093/brain/awr271; Brain Injury Association of America, 2012, AB BRAIN INJ; Casson RJ, 2014, CLIN EXP OPHTHALMOL, V42, P590, DOI 10.1111/ceo.12358; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Dahm J, 2013, J AFFECT DISORDERS, V151, P392, DOI 10.1016/j.jad.2013.06.011; DeMartinis Nicholas A., 2007, CNS & Neurological Disorders-Drug Targets, V6, P17, DOI 10.2174/187152707779940835; Drake CL, 2006, SLEEP MED CLIN, V1, P333, DOI 10.1016/j.jsmc.2006.06.005; Duckworth D, 1881, BRAIN, V4, P145; DUNLEAVY DL, 1972, BRIT J PSYCHIAT, V120, P663, DOI 10.1192/bjp.120.559.663; Edinger JD, 2008, SLEEP, V31, P599, DOI 10.1093/sleep/31.5.599; Fann JR, 2005, J HEAD TRAUMA REHAB, V20, P501, DOI 10.1097/00001199-200511000-00003; FANN JR, 1995, AM J PSYCHIAT, V152, P1493; Fichtenberg NL, 2000, BRAIN INJURY, V14, P659; Fichtenberg NL, 2002, BRAIN INJURY, V16, P197, DOI 10.1080/02699050110103940; Finan PH, 2013, J PAIN, V14, P1539, DOI 10.1016/j.jpain.2013.08.007; Foley D, 2004, J PSYCHOSOM RES, V56, P497, DOI 10.1016/j.jpsychores.2004.02.010; Friedman EM, 2007, PSYCHOSOM MED, V69, P682, DOI 10.1097/PSY.0b013e31814ceada; Harland NJ, 2015, PHYSIOTHERAPY, V101, P50, DOI 10.1016/j.physio.2014.06.004; HARTMANN E, 1973, PSYCHOPHARMACOLOGIA, V33, P185, DOI 10.1007/BF00429087; Harvey AG, 2011, PRINCIPLES PRACTICE, P838; Holsinger T, 2002, ARCH GEN PSYCHIAT, V59, P17, DOI 10.1001/archpsyc.59.1.17; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Jean-Louis G, 2008, J WOMENS HEALTH, V17, P15, DOI 10.1089/jwh.2006.0310; Kikuchi T, 2013, PSYCHIAT RES, V210, P127, DOI 10.1016/j.psychres.2013.05.007; KLINK ME, 1992, ARCH INTERN MED, V152, P1634, DOI 10.1001/archinte.152.8.1634; Koponen S, 2011, BRAIN INJURY, V25, P1029, DOI 10.3109/02699052.2011.607783; Lichstein KL, 2004, EPIDEMIOLOGY OF SLEEP AGE, GENDER, AND ETHNICITY, P1; Lichtstein K. L., 2011, PRINCIPLES PRACTICE, P827, DOI DOI 10.1016/B978-1-4160-6645-3.00076-1; Mar J, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-46; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; Mollayeva T, 2013, ENCY SLEEP, V2, P330; Mollayeva T, 2013, SLEEP MED, V14, P1235, DOI 10.1016/j.sleep.2013.07.009; Mollayeya T, 2013, SLEEP MED REV, V17, P411, DOI 10.1016/j.smrv.2013.02.001; Monk TH, 2003, SLEEP, V26, P208, DOI 10.1093/sleep/26.2.208; Moons KGM, 2015, ANN INTERN MED, V162, pW1, DOI 10.7326/M14-0698; Morgan K, 2003, J SLEEP RES, V12, P231, DOI 10.1046/j.1365-2869.2003.00355.x; Morin CM, 2009, ARCH INTERN MED, V169, P447, DOI 10.1001/archinternmed.2008.610; Mysliwiec V, 2013, SLEEP, V36, P167, DOI 10.5665/sleep.2364; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; National Institutes of Health, 2005, J CLIN SLEEP MED, V1, P412; National Sleep Foundation, 2008, SLEEP AM POLL; NOLENHOEKSEMA S, 1987, PSYCHOL BULL, V101, P259, DOI 10.1037/0033-2909.101.2.259; Nunnally JC, 1978, PSYCHOMETRIC THEORY, P225; Ohayon MM, 2010, SLEEP MED, V11, P1010, DOI 10.1016/j.sleep.2010.02.018; Ohayon MM, 2005, SLEEP, V28, P981; Ohayon MM, 2001, J AM GERIATR SOC, V49, P360, DOI 10.1046/j.1532-5415.2001.49077.x; Ouellet MC, 2006, J HEAD TRAUMA REHAB, V21, P199, DOI 10.1097/00001199-200605000-00001; PATTEN SB, 1992, J AM ACAD CHILD PSY, V31, P100, DOI 10.1097/00004583-199201000-00015; Popat RA, 2010, SLEEP MED, V11, P154, DOI 10.1016/j.sleep.2009.01.012; Rao Vani, 2002, Curr Treat Options Neurol, V4, P77, DOI 10.1007/s11940-002-0006-4; Ryu WHA, 2009, CAN J NEUROL SCI, V36, P429, DOI 10.1017/S0317167100007745; Schutte-Rodin S, 2008, J CLIN SLEEP MED, V4, P487; Sivertsen B, 2014, J SLEEP RES, V23, P124, DOI 10.1111/jsr.12102; Sosin DM, 1996, BRAIN INJURY, V10, P47; SPIELMAN AJ, 1999, SLEEP DISORDERS MED, P385; Stoffers D, 2014, BRAIN, V137, P610, DOI 10.1093/brain/awt329; Streiner DL, 2003, J PERS ASSESS, V80, P217, DOI 10.1207/S15327752JPA8003_01; Sturzenegger C, 2004, J SLEEP RES, V13, P395, DOI 10.1111/j.1365-2869.2004.00422.x; Taylor Daniel J, 2003, Behav Sleep Med, V1, P227, DOI 10.1207/S15402010BSM0104_5; Vitiello MV, 2002, J PSYCHOSOM RES, V53, P555, DOI 10.1016/S0022-3999(02)00435-X; WEITZMAN ED, 1981, ARCH GEN PSYCHIAT, V38, P737; WHO, PROJ MORT BURD DIS 2; Wilson S, 2005, DRUGS, V65, P927, DOI 10.2165/00003495-200565070-00003; Zhang B, 2006, SLEEP, V29, P85, DOI 10.1093/sleep/29.1.85	71	18	18	0	4	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1389-9457	1878-5506		SLEEP MED	Sleep Med.	MAR	2016	19						153	161		10.1016/j.sleep.2015.05.014			9	Clinical Neurology	Neurosciences & Neurology	DM7EH	WOS:000376518600026	26358896				2021-06-18	
J	Yuan, Q; Wu, X; Cheng, HW; Yang, CH; Wang, YH; Wang, ES; Qiu, BH; Fei, ZM; Lan, Q; Wu, SR; Jiang, YZ; Feng, H; Liu, JF; Liu, K; Zhang, FY; Jiang, RC; Zhang, JM; Tu, Y; Wu, XH; Zhou, LF; Hu, J				Yuan, Qiang; Wu, Xing; Cheng, Hongwei; Yang, Chaohua; Wang, Yuhai; Wang, Ersong; Qiu, Binghui; Fei, Zhimin; Lan, Qing; Wu, Sirong; Jiang, Yunzhao; Feng, Hua; Liu, Jingfang; Liu, Ke; Zhang, Fayun; Jiang, Rongcai; Zhang, Jianmin; Tu, Yue; Wu, Xuehai; Zhou, Liangfu; Hu, Jin			Is Intracranial Pressure Monitoring of Patients With Diffuse Traumatic Brain Injury Valuable? An Observational Multicenter Study	NEUROSURGERY			English	Article						Diffuse injury; Intracranial pressure monitoring; Outcome; Propensity score; Traumatic brain injury	SEVERE HEAD-INJURY; TOMOGRAPHIC SCAN CHARACTERISTICS; DECOMPRESSIVE CRANIECTOMY; LINEAR RELATIONSHIP; UNITED-STATES; CLASSIFICATION; MANAGEMENT; MORTALITY; PREDICTORS; DIAGNOSIS	BACKGROUND: Although intracranial pressure (ICP) monitoring of patients with severe traumatic brain injury (TBI) is recommended by the Brain Trauma Foundation, any benefits remain controversial. OBJECTIVE: To evaluate the effects of ICP monitoring on the mortality of and functional outcomes in patients with severe diffuse TBI. METHODS: Data were collected on patients with severe diffuse TBI (Glasgow Coma Scale [GCS] score on admission,9 and Marshall Class II-IV) treated from January 2012 to December 2013 in 24 hospitals (17 level I trauma centers and 7 level II trauma centers) in 9 Chinese provinces. We evaluated the impact of ICP monitoring on 6-month mortality and favorable outcome using propensity score-matched analysis after controlling for independent predictors of these outcomes. RESULTS: ICP monitors were inserted into 287 patients (59.5%). After propensity score matching, ICP monitoring significantly decreased 6-month mortality. ICP monitoring also had a greater impact on the most severely injured patients on the basis of head computed tomography data (Marshall computed tomography classification IV) and on patients with the lowest level of consciousness (GCS scores 3-5). After propensity score matching, monitoring remained nonassociated with a 6-month favorable outcome for the overall sample. However, monitoring had a significant impact on the 6-month favorable outcomes of patients with the lowest level of consciousness (GCS scores 3-5). CONCLUSION: ICP monitor placement was associated with a significant decrease in 6-month mortality after adjustment for the baseline risk profile and the monitoring propensity of patients with diffuse severe TBI, especially those with GCS scores of 3 to 5 or of Marshall computed tomography classification IV.	[Wu, Xing; Wu, Xuehai; Zhou, Liangfu; Hu, Jin] Fudan Univ, Huashan Hosp, Dept Neurosurg, 12 Wulumuqi Zhong Rd, Shanghai 200040, Peoples R China; [Cheng, Hongwei] Anhui Med Univ, Affiliated Hosp 1, Dept Neurosurg, Hefei, Peoples R China; [Yang, Chaohua] Sichuan Univ, West China Hosp, Dept Neurosurg, Chengdu 610064, Peoples R China; [Wang, Yuhai] 101 Hosp Peoples Liberat Army, Dept Neurosurg, Wuxi, Peoples R China; [Wang, Ersong] Fudan Univ, Dept Neurosurg, Jinshan Hosp, Shanghai 200433, Peoples R China; [Qiu, Binghui] Southern Med Univ, Dept Neurosurg, South Hosp, Guangzhou, Guangdong, Peoples R China; [Fei, Zhimin] Shanghai Shu guang Hosp, Dept Neurosurg, Shanghai, Peoples R China; [Lan, Qing] Soochow Univ, Dept Neurosurg, Affiliated Hosp 2, Suzhou, Peoples R China; [Wu, Sirong] Soochow Univ, Affiliated Hosp 1, Dept Emergency Med, Suzhou, Peoples R China; [Jiang, Yunzhao] Wuxi Third People Hosp, Dept Neurosurg, Wuxi, Peoples R China; [Feng, Hua] Southwest Hosp, Dept Neurosurg, Chongqing, Peoples R China; [Liu, Jingfang] Cent S Univ, Dept Neurosurg, Xiangya Hosp, Changsha, Hunan, Peoples R China; [Liu, Ke] Chongqing Emergency Med Ctr, Dept Neurosurg, Chongqing, Peoples R China; [Zhang, Fayun] Luqiao Hosp, Dept Neurosurg, Enze Med Ctr, Taizhou, Peoples R China; [Jiang, Rongcai] Tianjing Med Univ, Dept Neurosurg, Gen Hosp, Tianjin, Peoples R China; [Zhang, Jianmin] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Neurosurg, Hangzhou, Zhejiang, Peoples R China; [Tu, Yue] Logist Univ Peoples Armed Police Force, Affiliated Hosp, Dept Neurosurg, Tianjin, Peoples R China	Hu, J (corresponding author), Fudan Univ, Huashan Hosp, Dept Neurosurg, 12 Wulumuqi Zhong Rd, Shanghai 200040, Peoples R China.	hujin_dana@126.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81471241, 81271375, 81171133]	This work was supported by the National Natural Science Foundation of China (grants 81471241, 81271375, and 81171133). The authors report no conflict of interest concerning the materials or methods used in this study or the findings specified in this paper.	Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Alali AS, 2013, J NEUROTRAUM, V30, P1737, DOI 10.1089/neu.2012.2802; Andriessen TMJC, 2010, J CELL MOL MED, V14, P2381, DOI 10.1111/j.1582-4934.2010.01164.x; Austin PC, 2008, STAT MED, V27, P2037, DOI 10.1002/sim.3150; BECKER DP, 1977, J NEUROSURG, V47, P491, DOI 10.3171/jns.1977.47.4.0491; Biersteker HAR, 2012, CRIT CARE MED, V40, P1914, DOI 10.1097/CCM.0b013e3182474bde; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS37; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS55; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Cremer OL, 2005, CRIT CARE MED, V33, P2207, DOI 10.1097/01.CCM.0000181300.99078.B5; Dawes AJ, 2015, J TRAUMA ACUTE CARE, V78, P492, DOI 10.1097/TA.0000000000000559; Fakhry SM, 2004, J TRAUMA, V56, P492, DOI 10.1097/01.TA.0000115650.07193.66; Farahvar A, 2012, J NEUROSURG, V117, P729, DOI 10.3171/2012.7.JNS111816; Figaji AA., 2012, CAN J NEUROL SCI, V39, P571; Figaji Anthony A, 2013, Can J Neurol Sci, V40, P433; GENNARELLI TA, 1982, J NEUROSURG, V56, P26, DOI 10.3171/jns.1982.56.1.0026; Haviland A, 2007, PSYCHOL METHODS, V12, P247, DOI 10.1037/1082-989X.12.3.247; Hiler M, 2006, J NEUROSURG, V104, P731, DOI 10.3171/jns.2006.104.5.731; Lobato RD, 1997, ACTA NEUROCHIR, V139, P385, DOI 10.1007/BF01808871; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Mauritz W, 2008, INTENS CARE MED, V34, P1208, DOI 10.1007/s00134-008-1079-7; Mendelson AA, 2012, CAN J NEUROL SCI, V39, P571, DOI 10.1017/S0317167100015286; Miller MT, 2004, J TRAUMA, V56, P967, DOI 10.1097/01.TA.0000123699.16465.8B; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; Ropper AH, 2012, NEW ENGL J MED, V367, P2539, DOI 10.1056/NEJMe1212289; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Shafi S, 2008, J TRAUMA, V64, P335, DOI 10.1097/TA.0b013e31815dd017; Shafi S, 2014, J NEUROSURG, V120, P773, DOI 10.3171/2013.12.JNS132151; Stuart EA, 2010, STAT SCI, V25, P1, DOI 10.1214/09-STS313; Talving P, 2013, J NEUROSURG, V119, P1248, DOI 10.3171/2013.7.JNS122255; Timofeev I, 2006, ACTA NEUROCHIR SUPPL, V96, P11; TOUTANT SM, 1984, J NEUROSURG, V61, P691, DOI 10.3171/jns.1984.61.4.0691; Wang D, 2004, J TRAUMA, V56, P972; Zhu GW, 2009, J INT MED RES, V37, P983, DOI 10.1177/147323000903700402	39	18	20	0	10	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	MAR	2016	78	3					361	368		10.1227/NEU.0000000000001050			8	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	DE2DY	WOS:000370438000014	26891376	Bronze			2021-06-18	
J	Lancaster, MA; McCrea, MA; Nelson, LD				Lancaster, Melissa A.; McCrea, Michael A.; Nelson, Lindsay D.			Psychometric properties and normative data for the Brief Symptom Inventory-18 (BSI-18) in high school and collegiate athletes	CLINICAL NEUROPSYCHOLOGIST			English	Article						Brief Symptom Inventory-18; sport-related concussion; concussion; emotional functioning; psychometric properties	TRAUMATIC BRAIN-INJURY; FOOTBALL PLAYERS; LIFE-SCALE; CONCUSSION; OUTCOMES; SATISFACTION; DEPRESSION; RECOVERY; RELIABILITY; DISTRESS	Objective: Assessment of emotional functioning is important in sport-related concussion (SRC) management, although few standardized measures have been validated in this population, and appropriate normative data are lacking. We investigated the psychometric properties of the Brief Symptom Inventory-18 (BSI-18) in high school and collegiate athletes at risk of SRC and compiled normative data.Method: Athletes (n=2,031) completed the BSI-18 and other measures of concussion symptoms, cognition, and psychological functioning. A subset of healthy individuals was re-evaluated at approximately 7, 30, 45, and 165days. Psychometric analyses of test-retest reliability, internal consistency reliability, and concurrent validity were performed. Given significant differences between sexes and education levels (high school or college student) on the BSI-18 Global Severity Index and all subscales, normative conversion tables were produced after stratifying by these variables.Results: The BSI-18 showed good internal consistency, fair to poor test-retest reliability, and good convergent validity with other measures of emotional functioning.Conclusions: These data indicate that the BSI-18 may be a valuable measure of emotional state in concussed athletes and may provide unique information beyond post-concussive symptoms for research on the role of psychological factors in SRC recovery. The limited divergent validity of the BSI-18 depression and anxiety scales implies that they tap into general distress more so than specific mood or anxiety symptoms; therefore, BSI-18 scores should be not relied upon for differential diagnosis of mood and anxiety disorders. Normative data provided can be readily applied to clinical cases with high school and collegiate athletes.	[Lancaster, Melissa A.] Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA; [Lancaster, Melissa A.] Med Coll Wisconsin, Dept Neurol, Milwaukee, WI 53226 USA	Lancaster, MA (corresponding author), Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA.; Lancaster, MA (corresponding author), Med Coll Wisconsin, Dept Neurol, Milwaukee, WI 53226 USA.	mlancaster@mcw.edu			NCATS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1 TR000055] Funding Source: Medline; NCRR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [UL1 RR031973] Funding Source: Medline; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000055] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [UL1RR031973] Funding Source: NIH RePORTER		Arrindell W. A., 1986, HANDLEIDING BIJEEN M; Backhaus SL, 2010, ARCH PHYS MED REHAB, V91, P840, DOI 10.1016/j.apmr.2010.03.015; BLAIS MR, 1989, CAN J BEHAV SCI, V21, P210, DOI 10.1037/h0079854; Buchanan K M, 2001, Axone, V22, P16; BURLINGAME GM, 1995, J MENT HEALTH ADMIN, V22, P226, DOI 10.1007/BF02521118; CLARK LA, 1991, J ABNORM PSYCHOL, V100, P316, DOI 10.1037/0021-843X.100.3.316; Corrigan JD, 1998, ARCH PHYS MED REHAB, V79, P298, DOI 10.1016/S0003-9993(98)90010-7; Dams-O'Connor K, 2013, J NEUROTRAUM, V30, P2014, DOI 10.1089/neu.2013.3049; Derogatis L., 1982, BRIEF SYMPTOM INVENT; Derogatis LR, 2001, BRIEF SYMPTOM INVENT; Derogatis LR, 1977, SCL 90 MANUAL 1 SCOR; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Dikmen SS, 1999, J INT NEUROPSYCH SOC, V5, P346, DOI 10.1017/S1355617799544056; Green P, 2003, GREENS MED SYMPTOM V; Guskiewicz KM, 2001, CLIN J SPORT MED, V11, P182, DOI 10.1097/00042752-200107000-00009; Hart T, 2014, J NEUROTRAUM, V31, P610, DOI 10.1089/neu.2013.3041; Hicks R, 2013, J NEUROTRAUM, V30, P1852, DOI 10.1089/neu.2013.2938; JELLINEK HM, 1982, ARCH PHYS MED REHAB, V63, P160; KELLEY MJ, 1990, J SPORT MED PHYS FIT, V30, P202; McCrea M, 1997, NEUROLOGY, V48, P586, DOI 10.1212/WNL.48.3.586; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Meachen SJ, 2008, ARCH PHYS MED REHAB, V89, P958, DOI 10.1016/j.apmr.2007.12.028; Mooney G, 2005, BRAIN INJURY, V19, P975, DOI 10.1080/02699050500110264; Oler M J, 1994, Arch Fam Med, V3, P781, DOI 10.1001/archfami.3.9.781; Patrick CJ, 2002, PSYCHOL ASSESSMENT, V14, P150, DOI 10.1037//1040-3590.14.2.150; Pavot W., 1993, PSYCHOL ASSESSMENT, V5, P164, DOI DOI 10.1037/1040-3590.5.2.164; Rocke C, 2009, PSYCHOL AGING, V24, P863, DOI 10.1037/a0016276; Satz P, 1998, BRAIN INJURY, V12, P537, DOI 10.1080/026990598122313; Slaughter J, 1999, BRAIN INJURY, V13, P125, DOI 10.1080/026990599121782; Tellegen A., 1985, ANXIETY ANXIETY DISO, P681; Vangel SJ, 2011, J HEAD TRAUMA REHAB, V26, P20, DOI 10.1097/HTR.0b013e318204a70d; Wechsler D., 2001, WECHSLER TEST ADULT; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Williams MW, 2014, REHABIL PSYCHOL, V59, P298, DOI 10.1037/a0037164; Yang JZ, 2014, RES SPORTS MED, V22, P147, DOI 10.1080/15438627.2014.881818	36	18	19	0	57	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.	FEB 17	2016	30	2					321	333		10.1080/13854046.2016.1138504			13	Psychology, Clinical; Clinical Neurology; Psychology	Psychology; Neurosciences & Neurology	DI3LQ	WOS:000373400600011	26924037	Green Accepted			2021-06-18	
J	Nieboer, D; van der Ploeg, T; Steyerberg, EW				Nieboer, Daan; van der Ploeg, Tjeerd; Steyerberg, Ewout W.			Assessing Discriminative Performance at External Validation of Clinical Prediction Models	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; ADMISSION CHARACTERISTICS; IMPACT; REGRESSION; FRAMEWORK	Introduction External validation studies are essential to study the generalizability of prediction models. Recently a permutation test, focusing on discrimination as quantified by the c-statistic, was proposed to judge whether a prediction model is transportable to a new setting. We aimed to evaluate this test and compare it to previously proposed procedures to judge any changes in c-statistic from development to external validation setting. Methods We compared the use of the permutation test to the use of benchmark values of the c-statistic following from a previously proposed framework to judge transportability of a prediction model. In a simulation study we developed a prediction model with logistic regression on a development set and validated them in the validation set. We concentrated on two scenarios: 1) the case-mix was more heterogeneous and predictor effects were weaker in the validation set compared to the development set, and 2) the case-mix was less heterogeneous in the validation set and predictor effects were identical in the validation and development set. Furthermore we illustrated the methods in a case study using 15 datasets of patients suffering from traumatic brain injury. Results The permutation test indicated that the validation and development set were homogenous in scenario 1 (in almost all simulated samples) and heterogeneous in scenario 2 (in 17%-39% of simulated samples). Previously proposed benchmark values of the c-statistic and the standard deviation of the linear predictors correctly pointed at the more heterogeneous case-mix in scenario 1 and the less heterogeneous case-mix in scenario 2. Conclusion The recently proposed permutation test may provide misleading results when externally validating prediction models in the presence of case-mix differences between the development and validation population. To correctly interpret the c-statistic found at external validation it is crucial to disentangle case-mix differences from incorrect regression coefficients.	[Nieboer, Daan; Steyerberg, Ewout W.] Erasmus MC Univ Med Ctr, Dept Publ Hlth, Rotterdam, Netherlands; [van der Ploeg, Tjeerd] Inholland Univ, Med Ctr Alkmaar, Dept Sci, Alkmaar, Netherlands	Nieboer, D (corresponding author), Erasmus MC Univ Med Ctr, Dept Publ Hlth, Rotterdam, Netherlands.	d.nieboer@erasmusmc.nl			Netherlands Organization for Scientific Research (ZonMw)Netherlands Organization for Scientific Research (NWO)Netherlands Organization for Health Research and Development [ZonMw 9120.8004 (TOP)]	This work was funded by The Netherlands Organization for Scientific Research (ZonMw 9120.8004 (TOP)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin PC, 2014, STAT MED, V33, P517, DOI 10.1002/sim.5941; Austin PC, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-82; Bleeker SE, 2003, J CLIN EPIDEMIOL, V56, P826, DOI 10.1016/S0895-4356(03)00207-5; COX DR, 1958, BIOMETRIKA, V45, P562, DOI 10.1093/biomet/45.3-4.562; Debray TPA, 2015, J CLIN EPIDEMIOL, V68, P280, DOI 10.1016/j.jclinepi.2014.06.018; HARRELL FE, 1982, JAMA-J AM MED ASSOC, V247, P2543, DOI 10.1001/jama.247.18.2543; Hukkelhoven CWPM, 2005, J NEUROTRAUM, V22, P1025, DOI 10.1089/neu.2005.22.1025; Justice AC, 1999, ANN INTERN MED, V130, P515, DOI 10.7326/0003-4819-130-6-199903160-00016; Maas AIR, 2013, LANCET NEUROL, V12, P1200, DOI 10.1016/S1474-4422(13)70234-5; Moons KGM, 2012, HEART, V98, P691, DOI 10.1136/heartjnl-2011-301247; R Development Core Team, 2008, R LANGUAGE ENV STAT; Roozenbeek B, 2012, CRIT CARE MED, V40, P1609, DOI 10.1097/CCM.0b013e31824519ce; Siontis GCM, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3318; Steyerberg EW, CLIN PREDICTION MODE, V2nd; Steyerberg EW, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001381; Steyerberg EW, 2010, EPIDEMIOLOGY, V21, P128, DOI 10.1097/EDE.0b013e3181c30fb2; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Vergouwe Y, 2010, AM J EPIDEMIOL, V172, P971, DOI 10.1093/aje/kwq223; Wang LY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116957; Wessler BS, 2015, CIRC-CARDIOVASC QUAL, V8, P368, DOI 10.1161/CIRCOUTCOMES.115.001693	20	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0148820	10.1371/journal.pone.0148820			10	Multidisciplinary Sciences	Science & Technology - Other Topics	DF3BP	WOS:000371219000026	26881753	DOAJ Gold, Green Published			2021-06-18	
J	Ting, WKC; Schweizer, TA; Topolovec-Vranic, J; Cusimano, MD				Ting, Windsor Kwan-Chun; Schweizer, Tom A.; Topolovec-Vranic, Jane; Cusimano, Michael D.			Antisaccadic Eye Movements Are Correlated with Corpus Callosum White Matter Mean Diffusivity, Stroop Performance, and Symptom Burden in Mild Traumatic Brain Injury and Concussion	FRONTIERS IN NEUROLOGY			English	Article						antisaccade; concussion; mild traumatic brain injury; diffusion tensor imaging; executive function; corpus callosum; symptom burden	CLOSED-HEAD INJURY; DEFICITS; REFLEXIVE; SACCADES; MEMORY; INHIBITION; INTEGRITY; CHILDREN; RECOVERY	Antisaccades are thought to involve higher level inputs from neural centers involved in rapid eye movement inhibition and control. Previous work has demonstrated that performance on the antisaccade task can help in the assessment of injury in acute and/or chronic mild traumatic brain injury (mTBI). In this exploratory study, we performed cross-sectional and longitudinal comparisons of rapid eye movement, followed by correlations of antisaccade performance with assessments of symptom burden, diffusion tensor imaging, and a neuropsychological test of response inhibition. Significant deficits in antisaccade median latency, F(2, 31) = 3.65, p = 0.04 and prosaccade error mean duration, F(2, 31) = 3.63, p = 0.04 were found between patient groups and controls: the former was correlated with loss of white matter integrity in the splenium of the corpus callosum in acute mTBI, rho = 0.90, p = 0.0005. Furthermore, increased antisaccade median latency was also correlated with poor performance on an executive functioning task, r(2) = 0.439, p = 0.03, and greater symptom burden, r(2) = 0.480, p = 0.02 in the acute mTBI patients. Our preliminary research suggests that the antisaccade task could be useful as a neurological marker for mTBI and concussion, but more work is required.	[Ting, Windsor Kwan-Chun; Cusimano, Michael D.] St Michaels Hosp, Li Ka Shing Knowledge Inst, Keenan Res Ctr Biomed Sci, Injury Prevent Res Off, Toronto, ON M5B 1W8, Canada; [Ting, Windsor Kwan-Chun; Schweizer, Tom A.; Topolovec-Vranic, Jane; Cusimano, Michael D.] St Michaels Hosp, Neurosci Res Program, Toronto, ON M5B 1W8, Canada; [Schweizer, Tom A.; Cusimano, Michael D.] St Michaels Hosp, Dept Surg, Div Neurosurg, Toronto, ON M5B 1W8, Canada; [Topolovec-Vranic, Jane] Univ Toronto, Dept Occupat Sci & Occupat Therapy, Toronto, ON, Canada	Cusimano, MD (corresponding author), St Michaels Hosp, Li Ka Shing Knowledge Inst, Keenan Res Ctr Biomed Sci, Injury Prevent Res Off, 30 Bond St, Toronto, ON M5B 1W8, Canada.	injuryprevention@smh.ca	Cusimano, Michael/X-4059-2019; Topolovec-Vranic, Jane/A-5293-2013; Ting, Windsor Kwan-Chun/I-4013-2014	Topolovec-Vranic, Jane/0000-0001-7695-4212; Ting, Windsor Kwan-Chun/0000-0003-4293-9617	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [MOP 123371]; Institute of Medical Science Open Fellowship Award at the University of Toronto	We would like to thank the Canadian Institutes of Health Research MOP 123371 for study funding. WT was financially supported by the Institute of Medical Science Open Fellowship Award at the University of Toronto.	Alexander AL, 2007, NEUROTHERAPEUTICS, V4, P316, DOI 10.1016/j.nurt.2007.05.011; Aoki Y, 2012, J NEUROL NEUROSUR PS, V83, P870, DOI 10.1136/jnnp-2012-302742; Arenth PM, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0b013e318289ede5; Broshek DK, 2015, BRAIN INJURY, V29, P228, DOI 10.3109/02699052.2014.974674; Carroll Linda J., 2004, Journal of Rehabilitation Medicine Supplement, P113; Croall ID, 2014, NEUROLOGY, V83, P494, DOI 10.1212/WNL.0000000000000666; DeHaan A, 2007, NEUROPSYCHOLOGIA, V45, P406, DOI 10.1016/j.neuropsychologia.2006.06.008; Everling S, 1998, NEUROPSYCHOLOGIA, V36, P885, DOI 10.1016/S0028-3932(98)00020-7; GUITTON D, 1985, EXP BRAIN RES, V58, P455; Heitger MH, 2007, J NEUROL SCI, V253, P34, DOI 10.1016/j.jns.2006.11.007; Heitger MH, 2006, BRAIN INJURY, V20, P807, DOI 10.1080/02699050600676354; Heitger MH, 2009, BRAIN, V132, P2850, DOI 10.1093/brain/awp181; Heitger MH, 2004, BRAIN, V127, P575, DOI 10.1093/brain/awh066; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Johnson B, 2015, BRAIN IMAGING BEHAV, V9, P564, DOI 10.1007/s11682-014-9316-x; Killian G., 1985, STROOP COLOR WORD TE; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Kraus MF, 2007, COGN BEHAV NEUROL, V20, P170, DOI 10.1097/WNN.0b013e318142badb; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Kumar S, 2013, CLIN NEUROL NEUROSUR, V115, P1326, DOI 10.1016/j.clineuro.2012.12.038; Leigh R. J., 2006, NEUROLOGY EYE MOVEME; Mathias JL, 2007, NEUROPSYCHOLOGY, V21, P212, DOI 10.1037/0894-4105.21.2.212; Mendoza J, 2010, CLIN NEUROANATOMY NE; Muri RM, 2008, BRAIN COGNITION, V68, P284, DOI 10.1016/j.bandc.2008.08.018; Mullen SJ, 2014, CAN J NEUROL SCI, V41, P58, DOI 10.1017/S0317167100016279; Munoz DP, 2004, NAT REV NEUROSCI, V5, P218, DOI 10.1038/nrn1345; NeuroDebian-Team, 2014, FSL JHU DTI WHIT ATL; Niogi SN, 2010, J HEAD TRAUMA REHAB, V25, P241, DOI 10.1097/HTR.0b013e3181e52c2a; Paolozza A, 2014, NEUROIMAGE-CLIN, V5, P53, DOI 10.1016/j.nicl.2014.05.019; Phillipou A, 2014, DEV MED CHILD NEUROL, V56, P337, DOI 10.1111/dmcn.12345; Pierrot-Deseilligny C, 2005, ANN NY ACAD SCI, V1039, P239, DOI 10.1196/annals.1325.023; Ploner CJ, 2005, BIOL PSYCHIAT, V57, P1159, DOI 10.1016/j.biopsych.2005.02.017; Post A, 2015, J BIOMECH ENG-T ASME, V137, DOI 10.1115/1.4028983; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Ting WKC, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00137; Vakil E, 2005, J CLIN EXP NEUROPSYC, V27, P977, DOI 10.1080/13803390490919245; Ventura RE, 2014, LANCET NEUROL, V13, P1006, DOI 10.1016/S1474-4422(14)70111-5; Williams IM, 1997, J CLIN NEUROSCI, V4, P186, DOI 10.1016/S0967-5868(97)90072-2; Wong AMF., 2008, EYE MOVEMENT DISORDE; Wu TC, 2010, DEV NEUROSCI-BASEL, V32, P361, DOI 10.1159/000317058	40	18	18	0	21	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	JAN 18	2016	6								271	10.3389/fneur.2015.00271			10	Clinical Neurology; Neurosciences	Neurosciences & Neurology	DA9JT	WOS:000368125600002	26834693	DOAJ Gold, Green Published			2021-06-18	
J	Orhan, N; Yilmaz, CU; Ekizoglu, O; Ahishali, B; Kucuk, M; Arican, N; Elmas, I; Gurses, C; Kaya, M				Orhan, Nurcan; Yilmaz, Canan Ugur; Ekizoglu, Oguzhan; Ahishali, Bulent; Kucuk, Mutlu; Arican, Nadir; Elmas, Imdat; Gurses, Candan; Kaya, Mehmet			Effects of beta-hydroxybutyrate on brain vascular permeability in rats with traumatic brain injury	BRAIN RESEARCH			English	Article						Traumatic brain injury; Beta-hydroxybutyrate Blood-brain bather; Horseradish peroxidase; Occludin; Glucose transporter-1	FUNCTION IMPROVING AGENT; SPINAL-CORD BARRIER; NF-KAPPA-B; BLOOD-BRAIN; ENDOTHELIAL-CELLS; GLUCOSE-TRANSPORTER; CORTICAL CONTUSION; LIPID-PEROXIDATION; AQUAPORIN-4 EXPRESSION; HEMORRHAGIC-SHOCK	This study investigates the effect of beta-hydroxybutyrate (BHB) on blood-brain barrier (BBB) integrity during traumatic brain injury (TBI) in rats. Evans blue (EB) and horseradish peroxidase (HRP) were used as determinants of BBB permeability. Glutathione (GSH) and malondialdehyde (MDA) levels *ere estimated in the right (injury side) cerebral cortex of animals. The gene expression levels for occludin, glucose transporter (Glut)-1, aquaporin4 (AQP4) and nuclear factor-kappaB (NF-kappa B) were performed, and Glut-1 and NF-kappa B activities were analyzed. BHB treatment decreased GSH and MDA levels in intact animals and in those exposed to TBI (P<0.05). Glut-1 protein levels decreased in sham, BHB and TBI plus BHB groups (P<0.05). NF-kappa B protein levels increased in animals treated with BHB and/or exposed to TBI (P <0.05). The expression levels of occludin and AQP4 did not significantly change among experimental groups. Glut-1 expression levels increased in BHB treated and untreated animals exposed to TBI (P <0.05). While NF-kappa B expression levels increased in animals in TBI (P<0.01), a decrease was noticed in these animals upon BHB treatment (P <0.01). In animals exposed to TBI, EB extravasation was observed in the ipsilateral cortex regardless of BHB treatment. Ultrastructurally, BHB attenuated but did not prevent the presence of HRP in brain capillary endothelial cells of animals with TBI; moreover, the drug also led to the observation of the tracer when used in intact rats (P <0.01). Altogether, these results showed that BHB not only failed to provide overall protective effects on BBB in TBI but also led to BBB disruption in healthy animals. (C) 2015 Elsevier B.V. All rights reserved.	[Orhan, Nurcan] Istanbul Univ, Inst Expt Med, Dept Neurosci, Istanbul, Turkey; [Yilmaz, Canan Ugur; Kucuk, Mutlu] Istanbul Univ, Inst Expt Med, Dept Lab Anim Sci, Istanbul, Turkey; [Ekizoglu, Oguzhan; Arican, Nadir; Elmas, Imdat] Tepecik Training & Res Hosp, Dept Forens Med, Izmir, Turkey; [Ahishali, Bulent] Istanbul Univ, Istanbul Fac Med, Dept Histol & Embryol, Istanbul, Turkey; [Gurses, Candan] Istanbul Univ, Istanbul Fac Med, Dept Neurol, Istanbul, Turkey; [Yilmaz, Canan Ugur] Istanbul Univ, Istanbul Fac Med, Dept Physiol, Istanbul, Turkey; [Kaya, Mehmet] Koc Univ, Sch Med, Dept Physiol, TR-34450 Istanbul, Turkey	Kaya, M (corresponding author), Koc Univ, Sch Med, Rumelifeneri Yolu, TR-34450 Istanbul, Turkey.	mehmetkaya@ku.edu.tr	Orhan, Nurcan/AAC-1954-2020; ARICAN, Nadir/G-2778-2012; Ekizoglu, Oguzhan/AAO-2704-2020; elmas, imdat/AAD-6054-2020	ARICAN, Nadir/0000-0002-9736-0277; Ekizoglu, Oguzhan/0000-0002-0194-595X; Ugur Yilmaz, Canan/0000-0002-0138-5163; Ahishali, Bulent/0000-0003-1275-3723	Istanbul UniversityIstanbul University [12610]	This study was supported by the Research Fund of Istanbul University (12610).	Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Abdul-Muneer PM, 2015, MOL NEUROBIOL, V51, P966, DOI 10.1007/s12035-014-8752-3; Alluri H., 2015, METAB BRAIN DIS; Alves JL, 2014, J NEUROSCI RES, V92, P141, DOI 10.1002/jnr.23300; Arun P, 2013, NEUROSCI LETT, V552, P87, DOI 10.1016/j.neulet.2013.07.047; Badaut J, 2014, BBA-GEN SUBJECTS, V1840, P1554, DOI 10.1016/j.bbagen.2013.10.032; Baeuerle PA, 1996, CELL, V87, P13, DOI 10.1016/S0092-8674(00)81318-5; Balabanov R, 2001, NEUROL RES, V23, P175, DOI 10.1179/016164101101198514; Beaumont A, 2000, ACTA NEUROCHIR SUPPL, V76, P125; Beauparlant Pierre, 1996, Cytokine and Growth Factor Reviews, V7, P175, DOI 10.1016/1359-6101(96)00020-2; Beutler E., 1984, GLUTATHIONE RED CELL; Bramlett HM, 2007, PROG BRAIN RES, V161, P125, DOI 10.1016/S0079-6123(06)61009-1; Brown RC, 2003, J CELL SCI, V116, P693, DOI 10.1242/jcs.00264; Castejon OJ, 2013, FOLIA NEUROPATHOL, V51, P93, DOI 10.5114/fn.2013.35951; CEMAK I, 2000, J NEUROTRAUM, V17, P53; Chen G, 2009, EXP NEUROL, V216, P398, DOI 10.1016/j.expneurol.2008.12.019; Childs EW, 2005, SHOCK, V23, P565, DOI 10.1097/01.shk.0000164188.46364.2a; Chowdhury GMI, 2014, J CEREBR BLOOD F MET, V34, P1233, DOI 10.1038/jcbfm.2014.77; Cornford EM, 1996, J NEUROTRAUM, V13, P523, DOI 10.1089/neu.1996.13.523; Corrigan F, 2014, J NEUROCHEM, V128, P196, DOI 10.1111/jnc.12391; Davis LM, 2008, J NEUROSCI RES, V86, P1812, DOI 10.1002/jnr.21628; Deng-Bryant Y, 2008, J CEREBR BLOOD F MET, V28, P1114, DOI 10.1038/jcbfm.2008.10; Dietrich WD, 1999, J NEUROTRAUM, V16, P567, DOI 10.1089/neu.1999.16.567; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Dore-Duffy P, 1999, MICROVASC RES, V57, P75, DOI 10.1006/mvre.1998.2112; FARRELL CL, 1991, P NATL ACAD SCI USA, V88, P5779, DOI 10.1073/pnas.88.13.5779; Garbuzova-Davis S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001205; HARIK SI, 1994, J APPL PHYSIOL, V77, P896; Ho CF, 2013, VET J, V198, P696, DOI 10.1016/j.tvjl.2013.09.069; Hoffman WH, 2009, BRAIN RES, V1254, P138, DOI 10.1016/j.brainres.2008.11.100; Hu G, 2008, CIRC RES, V102, pE120, DOI 10.1161/CIRCRESAHA.107.167486; Huang XJ, 2015, J NEUROTRAUM, V32, P1179, DOI 10.1089/neu.2015.3873; Huang XN, 2011, ANAT REC, V294, P46, DOI 10.1002/ar.21286; Jain SK, 1998, FREE RADICAL BIO MED, V25, P1083, DOI 10.1016/S0891-5849(98)00140-3; Julio-Amilpas A, 2015, J CEREBR BLOOD F MET, V35, P851, DOI 10.1038/jcbfm.2015.1; Kashiwaya Y, 2000, P NATL ACAD SCI USA, V97, P5440, DOI 10.1073/pnas.97.10.5440; Ke CS, 2001, NEUROSCI LETT, V301, P21, DOI 10.1016/S0304-3940(01)01589-0; Kiening K. L., 1986, CLIN CHIM ACTA, V155, P275; LEDWOZYW A, 1986, CLIN CHIM ACTA, V155, P275, DOI 10.1016/0009-8981(86)90247-0; Leite M, 2004, BRAIN RES BULL, V64, P139, DOI 10.1016/j.brainresbull.2004.06.005; Lin T, 2005, J TRAUMA, V59, P1191, DOI 10.1097/01.ta.0000188646.86995.9d; Manna P, 2014, J BIOL CHEM, V289, P11767, DOI 10.1074/jbc.M113.524645; MAXWELL WL, 1992, ACTA NEUROPATHOL, V84, P289; Minshall RD, 2002, HISTOCHEM CELL BIOL, V117, P105, DOI 10.1007/s00418-001-0367-x; Myer DJ, 2006, BRAIN, V129, P2761, DOI 10.1093/brain/awl165; Nag S, 1996, J NEUROPATH EXP NEUR, V55, P880, DOI 10.1097/00005072-199608000-00003; Neal CJ, 2007, J NEUROTRAUM, V24, P1609, DOI 10.1089/neu.2007.0301; Newport MT, 2015, ALZHEIMERS DEMENT, V11, P99, DOI 10.1016/j.jalz.2014.01.006; Noh HS, 2006, J NEUROSCI RES, V83, P702, DOI 10.1002/jnr.20736; POVLISHOCK JT, 1978, BRAIN RES, V153, P223, DOI 10.1016/0006-8993(78)90404-3; Prins ML, 2014, J LIPID RES, V55, P2450, DOI 10.1194/jlr.R046706; Prins ML, 2005, J NEUROSCI RES, V82, P413, DOI 10.1002/jnr.20633; Prins ML, 2004, J NEUROCHEM, V90, P666, DOI 10.1111/j.1471-4159.2004.02542.x; Pun PBL, 2009, FREE RADICAL RES, V43, P348, DOI 10.1080/10715760902751902; Rains JL, 2012, CAN J PHYSIOL PHARM, V90, P1642, DOI 10.1139/y2012-131; RAMILO O, 1990, J EXP MED, V172, P497, DOI 10.1084/jem.172.2.497; Readnower RD, 2010, J NEUROSCI RES, V88, P3530, DOI 10.1002/jnr.22510; Reger MA, 2004, NEUROBIOL AGING, V25, P311, DOI 10.1016/S0197-4580(03)00087-3; Shellington DK, 2011, CRIT CARE MED, V39, P494, DOI 10.1097/CCM.0b013e318206b1fa; Shubert PJ, 1996, AM J OBSTET GYNECOL, V175, P56, DOI 10.1016/S0002-9378(96)70251-X; Stark B, 2000, EXP BRAIN RES, V131, P74, DOI 10.1007/s002219900300; Suma T, 2008, NEUROL RES, V30, P420, DOI 10.1179/016164107X251745; Sun Y, 2009, CIRC RES, V105, P676, DOI 10.1161/CIRCRESAHA.109.201673; Suzuki M, 2002, JPN J PHARMACOL, V89, P36, DOI 10.1254/jjp.89.36; Suzuki M, 2001, JPN J PHARMACOL, V87, P143, DOI 10.1254/jjp.87.143; Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003; TANNO H, 1992, J NEUROTRAUM, V9, P21, DOI 10.1089/neu.1992.9.21; Tardif A, 2001, AM J PHYSIOL-ENDOC M, V281, pE1205; Taya K, 2010, J NEUROTRAUM, V27, P229, DOI 10.1089/neu.2009.0933; Umschweif G, 2013, J CEREBR BLOOD F MET, V33, P524, DOI 10.1038/jcbfm.2012.193; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Vajtr D, 2009, PHYSIOL RES, V58, P263, DOI 10.33549/physiolres.931253; Wang P, 2013, CELL PHYSIOL BIOCHEM, V32, P859, DOI 10.1159/000354488; YANG KY, 1995, NEUROSCI LETT, V197, P101, DOI 10.1016/0304-3940(95)11919-N; Yosunkaya A, 2004, J TRAUMA, V56, P585, DOI 10.1097/01.TA.0000058119.60074.25; Zhao J, 2007, J NEUROSCI, V27, P10240, DOI 10.1523/JNEUROSCI.1683-07.2007; Zhao XR, 2003, GLIA, V44, P140, DOI 10.1002/glia.10283; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003	78	18	18	0	19	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	JAN 15	2016	1631						113	126		10.1016/j.brainres.2015.11.038			14	Neurosciences	Neurosciences & Neurology	DD7IK	WOS:000370096700011	26656066				2021-06-18	
J	Chapple, LAS; Chapman, MJ; Lange, K; Deane, AM; Heyland, DK				Chapple, Lee-anne S.; Chapman, Marianne J.; Lange, Kylie; Deane, Adam M.; Heyland, Daren K.			Nutrition support practices in critically ill head-injured patients: a global perspective	CRITICAL CARE			English	Article						Nutrition support; Nutritional status; Head injury; Head trauma; Traumatic brain injury; Critical illness	TRAUMATIC BRAIN-INJURY; ENTERAL NUTRITION; CRITICAL ILLNESS; MODERATE; THERAPY; REQUIREMENTS; GUIDELINES; MANAGEMENT; PROVISION; DELIVERY	Background: Critical illness following head injury is associated with a hypermetabolic state but there are insufficient epidemiological data describing acute nutrition delivery to this group of patients. Furthermore, there is little information describing relationships between nutrition and clinical outcomes in this population. Methods: We undertook an analysis of observational data, collected prospectively as part of International Nutrition Surveys 2007-2013, and extracted data obtained from critically ill patients with head trauma. Our objective was to describe global nutrition support practices in the first 12 days of hospital admission after head trauma, and to explore relationships between energy and protein intake and clinical outcomes. Data are presented as mean (SD), median (IQR), or percentages. Results: Data for 1045 patients from 341 ICUs were analyzed. The age of patients was 44.5 (19.7) years, 78 % were male, and median ICU length of stay was 13.1 (IQR 7.9-21.6) days. Most patients (94 %) were enterally fed but received only 58 % of estimated energy and 53 % of estimated protein requirements. Patients from an ICU with a feeding protocol had greater energy and protein intakes (p < 0.001, 0.002 respectively) and were more likely to survive (OR 0.65; 95 % CI 0.42-0.99; p = 0.043) than those without. Energy or protein intakes were not associated with mortality. However, a greater energy and protein deficit was associated with longer times until discharge alive from both ICU and hospital (all p < 0.001). Conclusion: Nutritional deficits are commonplace in critically ill head-injured patients and these deficits are associated with a delay to discharge alive.	[Chapple, Lee-anne S.; Chapman, Marianne J.; Deane, Adam M.] Univ Adelaide, Discipline Acute Care Med, Adelaide, SA 5000, Australia; [Chapman, Marianne J.; Deane, Adam M.] Royal Adelaide Hosp, Intens Care Unit, Adelaide, SA 5000, Australia; [Lange, Kylie] Univ Adelaide, Discipline Med, Adelaide, SA 5000, Australia; [Heyland, Daren K.] Kingston Gen Hosp, Clin Evaluat Res Unit, Kingston, ON K7L 2V7, Canada; [Heyland, Daren K.] Queens Univ, Kingston, ON, Canada	Heyland, DK (corresponding author), Kingston Gen Hosp, Clin Evaluat Res Unit, Kingston, ON K7L 2V7, Canada.	dkh2@queensu.ca	Deane, Adam/AAF-7370-2020; Chapple, Lee-anne/AAN-7751-2021	Deane, Adam/0000-0002-7620-5577; Chapple, Lee-anne S/0000-0002-9818-2484	Nestle; Abbott Nutritional Inc; GlaxoSmithKlineGlaxoSmithKline; Baxter; GSKGlaxoSmithKline; Theravance	DKH has received honorarium and research grant money from Nestle, Abbott Nutritional Inc, GlaxoSmithKline, and Baxter. AMD and MJC have received unrestricted grants from GSK and Theravance for investigator-led studies and have also received research support in kind from Fresenius Kabi. The authors declare that while the results of this analysis may support the use of particular strategies to improve nutrition support practices, they do not promote specific products or drugs.	Adam S, 1997, INTENS CARE MED, V23, P261, DOI 10.1007/s001340050326; Alberda C, 2009, INTENS CARE MED, V35, P1728, DOI 10.1007/s00134-009-1567-4; Alhashemi HH, 2010, NEUROSCIENCES, V15, P231; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS77; BROOKE MM, 1989, J NEUROL REHABIL, V3, P27; Cartwright Martina M, 2004, Crit Care Nurs Clin North Am, V16, P467, DOI 10.1016/j.ccell.2004.07.001; Chapman MJ, 2011, GASTROENTEROL CLIN N, V40, P725, DOI 10.1016/j.gtc.2011.09.003; Chiang YH, 2012, J NEUROTRAUM, V29, P75, DOI 10.1089/neu.2011.1801; Chourdakis M, 2012, JPEN-PARENTER ENTER, V36, P108, DOI 10.1177/0148607110397878; Costello LAS, 2014, INJURY, V45, P1834, DOI 10.1016/j.injury.2014.06.004; Czapran A, 2015, BURNS, V41, P510, DOI 10.1016/j.burns.2014.09.013; De Beaux I, 2001, ANAESTH INTENS CARE, V29, P619, DOI 10.1177/0310057X0102900611; De Jonghe B, 2001, CRIT CARE MED, V29, P8, DOI 10.1097/00003246-200101000-00002; Dickerson RN, 2012, J TRAUMA ACUTE CARE, V73, P549, DOI 10.1097/TA.0b013e318256de1b; Foley N, 2008, J NEUROTRAUM, V25, P1415, DOI 10.1089/neu.2008.0628; Genton L, 2011, INT J VITAM NUTR RES, V81, P143, DOI 10.1024/0300-9831/a000058; Hartl R, 2008, J NEUROSURG, V109, P50, DOI 10.3171/JNS/2008/109/7/0050; Heyland DK, 2011, CRIT CARE MED, V39, P2619, DOI 10.1097/CCM.0b013e318226641d; Heyland DK, 2010, CRIT CARE, V14, DOI 10.1186/cc8991; Heyland DK, 2003, JPEN-PARENTER ENTER, V27, P355, DOI 10.1177/0148607103027005355; Jacobs DG, 2004, J TRAUMA, V57, P660, DOI 10.1097/01.TA.0000135348.48525.A0; Kar P, 2016, JPEN-PARENTER ENTER, V40, P1050, DOI 10.1177/0148607115588333; Kim H, 2010, ASIAN NURS RES, V4, P102, DOI 10.1016/S1976-1317(10)60010-2; Krakau K, 2007, NUTRITION, V23, P308, DOI 10.1016/j.nut.2007.01.010; Krakau K, 2006, BRAIN INJURY, V20, P345, DOI 10.1080/02699050500487571; Lim SL, 2012, CLIN NUTR, V31, P345, DOI 10.1016/j.clnu.2011.11.001; Matters K, 2014, AUSTRALAS J NEUROSCI, V24, P42; Morgan Laurie M, 2004, Nutr Clin Pract, V19, P511, DOI 10.1177/0115426504019005511; Nicolo M, 2016, JPEN-PARENTER ENTER, V40, P45, DOI 10.1177/0148607115583675; Peake SL, 2014, AM J CLIN NUTR, V100, P616, DOI 10.3945/ajcn.114.086322; Reid C, 2006, J HUM NUTR DIET, V19, P13, DOI 10.1111/j.1365-277X.2006.00661.x; ROBERTSON CS, 1984, NEUROSURGERY, V15, P307, DOI 10.1227/00006123-198409000-00003; Sheean PM, 2012, J ACAD NUTR DIET, V112, P1073, DOI 10.1016/j.jand.2012.02.007; Soguel L, 2012, CRIT CARE MED, V40, P412, DOI 10.1097/CCM.0b013e31822f0ad7; SUNDERLAND PM, 1992, NEUROSURGERY, V31, P246, DOI 10.1227/00006123-199208000-00009; Tan M, 2011, BRIT J NEUROSURG, V25, P2, DOI 10.3109/02688697.2010.522745; Tian F, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0902-0; Vitaz TW, 2003, SURG NEUROL, V60, P285, DOI 10.1016/S0090-3019(03)00378-1; Wang X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058838; Wolkewitz M, 2009, INTENS CARE MED, V35, P826, DOI 10.1007/s00134-009-1423-6	40	18	24	0	19	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1466-609X	1364-8535		CRIT CARE	Crit. Care	JAN 7	2016	20								6	10.1186/s13054-015-1177-1			11	Critical Care Medicine	General & Internal Medicine	DA4XW	WOS:000367807100001	26738550	DOAJ Gold, Green Published			2021-06-18	
J	Zhao, E; Tranovich, MJ; DeAngelo, R; Kontos, AP; Wright, VJ				Zhao, Emily; Tranovich, Michael J.; DeAngelo, Ron; Kontos, Anthony P.; Wright, Vonda J.			Chronic exercise preserves brain function in masters athletes when compared to sedentary counterparts	PHYSICIAN AND SPORTSMEDICINE			English	Article						Masters athletes; Neurocognitive decline; Aging; Cognition; Physical activity	PREDICTING BODY DENSITY; COGNITIVE FUNCTION; GENERALIZED EQUATIONS; WORKING-MEMORY; OLDER-ADULTS; FITNESS; HIPPOCAMPAL; PLASTICITY; IMPACT; CORTEX	Objective: Exercise is beneficial for both the body and the mind, and it has been associated with protective neurocognitive effects, such as increased levels of brain-derived neurotrophic factor and neurogenesis. These effects are linked to the attenuation of age-related mental decline and the preservation of mental capacities in older, physically active adults. This study evaluated whether masters athletes, a highly active population, have better cognitive function compared to age-matched non-athletes based on the Immediate Post-concussion Assessment and Cognitive Testing (ImPACT) tool. Methods: Masters athletes and sedentary controls were recruited and screened for eligibility. All subjects were excluded if they had preexisting neurological diseases, psychiatric disorders, substance abuse disorders, learning disorders, and/or a history of traumatic brain injury, and in addition, control subjects were excluded if they performed >1h/week of aerobic exercise. All participants completed a health and activity survey which includes the SF-12 and the ImPACT neurocognitive test which measures verbal and visual memory as well as reaction time. Differences between masters athletes and the control population were determined by ImPACT score composites. Results: 51 pairs of athletes and non-athletes were analyzed. Athletes had significantly higher verbal memory scores (85.9 +/- 7.7 vs 79.9 +/- 13.9, p=0.01) and faster reaction times (0.71 +/- 0.12 vs 0.76 +/- 0.15s, p=0.04) on the ImPACT test. Athletes also scored significantly higher on the physical components summary score of the SF-12 (55.0 +/- 3.3 vs 51.8 +/- 6.7, p=0.004). Conclusion: Masters athletes performed better on verbal memory and reaction time test, as well as on physical function as evaluated by the SF-12, compared to non-athlete controls. Chronic physical activity may preserve neurocognitive processes and increase physical health, which are protective factors for the negative effects of the aging process.	[Zhao, Emily; Tranovich, Michael J.; Kontos, Anthony P.; Wright, Vonda J.] Univ Pittsburgh, Dept Orthopaed Surg, Kaufmann Med Bldg,Suite 1011 3471 Fifth Ave, Pittsburgh, PA 15213 USA; [DeAngelo, Ron] Univ Pittsburgh, Dept Sports Med, UPMC Sports Performance, Pittsburgh, PA USA; [Kontos, Anthony P.] Univ Pittsburgh, UPMC Sports Med Concuss Program, Pittsburgh, PA USA	Zhao, E (corresponding author), Univ Pittsburgh, Dept Orthopaed Surg, Kaufmann Med Bldg,Suite 1011 3471 Fifth Ave, Pittsburgh, PA 15213 USA.	zhaoe@upmc.edu		Kontos, Anthony/0000-0002-3749-4310			Auyeung TW, 2008, NEUROEPIDEMIOLOGY, V31, P167, DOI 10.1159/000154929; Barr WB, 2001, J INT NEUROPSYCH SOC, V7, P693, DOI 10.1017/S1355617701766052; British Columbia Ministry of Health, 1992, PHYS ACT READ QUEST; Bruce RA., 1972, EXERCISE TESTING TRA; Chappell NL, 2010, INT ENCY REHABILITAT; Colcombe S, 2003, PSYCHOL SCI, V14, P125, DOI 10.1111/1467-9280.t01-1-01430; Colcombe SJ, 2004, P NATL ACAD SCI USA, V101, P3316, DOI 10.1073/pnas.0400266101; Colcombe SJ, 2003, J GERONTOL A-BIOL, V58, P176; Colcombe SJ, 2006, J GERONTOL A-BIOL, V61, P1166, DOI 10.1093/gerona/61.11.1166; Davenport MH, 2012, EXERC SPORT SCI REV, V40, P153, DOI 10.1097/JES.0b013e3182553430; Erickson KI, 2012, NEUROSCIENTIST, V18, P82, DOI 10.1177/1073858410397054; Erickson KI, 2011, P NATL ACAD SCI USA, V108, P3017, DOI 10.1073/pnas.1015950108; Fabre C, 2002, INT J SPORTS MED, V23, P415, DOI 10.1055/s-2002-33735; Fedor A, 2013, OBESITY FACTS, V6, P185, DOI 10.1159/000351138; Fjell AM, 2014, PROG NEUROBIOL, V117, P20, DOI 10.1016/j.pneurobio.2014.02.004; Gordon BA, 2008, PSYCHOPHYSIOLOGY, V45, P825, DOI 10.1111/j.1469-8986.2008.00676.x; Gustafson D, 2008, EUR J PHARMACOL, V585, P163, DOI 10.1016/j.ejphar.2008.01.052; Hettich Thomas, 2010, J Spec Oper Med, V10, P48; Heyward V. H., 1998, PHYS FITNESS SPECIAL; Hopkins ME, 2012, NEUROSCIENCE, V215, P59, DOI 10.1016/j.neuroscience.2012.04.056; ImPACT Applications Inc, 2011, IMM POSTC ASS TEST T; JACKSON AS, 1978, BRIT J NUTR, V40, P497, DOI 10.1079/BJN19780152; JACKSON AS, 1980, MED SCI SPORT EXER, V12, P175; Jansen A, 2009, CLIN NEUROL NEUROSUR, V111, P57, DOI 10.1016/j.clineuro.2008.08.005; Langdon KD, 2012, NEUROREHAB NEURAL RE, V26, P523, DOI 10.1177/1545968311425919; Laroche S, 2000, HIPPOCAMPUS, V10, P438; Lees SJ, 2004, CAN J APPL PHYSIOL, V29, P447, DOI 10.1139/h04-029; Leigey D, 2009, SPORTS HEALTH, V1, P508, DOI 10.1177/1941738109347979; Lovell MR, 2000, IMMEDIATE POSTCONCUS; Maki Y, 2012, J AM GERIATR SOC, V60, P505, DOI 10.1111/j.1532-5415.2011.03838.x; Reaburn P, 2008, EUR REV AGING PHYS A, V5, P31, DOI 10.1007/s11556-008-0029-2; ROLAND PE, 1995, CEREB CORTEX, V5, P79, DOI 10.1093/cercor/5.1.79; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Szabo AN, 2011, NEUROPSYCHOLOGY, V25, P545, DOI 10.1037/a0022733; Trivedi J K, 2006, Indian J Psychiatry, V48, P10, DOI 10.4103/0019-5545.31613; Tsushima M, 2013, DIGEST DIS SCI, V58, P2673, DOI 10.1007/s10620-013-2668-z; Vaynman S, 2004, EUR J NEUROSCI, V20, P2580, DOI 10.1111/j.1460-9568.2004.03720.x; Vehrs PR, 2007, MEAS PHYS EDUC EXERC, V11, P61, DOI 10.1080/10913670701294047; Voss MW, 2013, HUM BRAIN MAPP, V34, P2972, DOI 10.1002/hbm.22119; Willeumier KC, 2011, OBESITY, V19, P1095, DOI 10.1038/oby.2011.16; Wroblewski A, 2010, MASTER ATHLETES MODE; Wroblewski AP, 2011, PHYSICIAN SPORTSMED, V39, P172, DOI 10.3810/psm.2011.09.1933; Zhao E, 2014, SPORTS HEALTH, V6, P63, DOI 10.1177/1941738113477832	43	18	19	0	41	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0091-3847	2326-3660		PHYSICIAN SPORTSMED	Physician Sportsmed.	JAN 2	2016	44	1					8	13		10.1080/00913847.2016.1103641			6	Primary Health Care; Orthopedics; Sport Sciences	General & Internal Medicine; Orthopedics; Sport Sciences	DE5GS	WOS:000370660000002	26513012				2021-06-18	
J	Azouvi, P; Ghout, I; Bayen, E; Darnoux, E; Azerad, S; Ruet, A; Vallat-Azouvi, C; Pradat-Diehl, P; Aegerter, P; Charanton, J; Jourdan, C				Azouvi, Philippe; Ghout, Idir; Bayen, Eleonore; Darnoux, Emmanuelle; Azerad, Sylvie; Ruet, Alexis; Vallat-Azouvi, Claire; Pradat-Diehl, Pascale; Aegerter, Philippe; Charanton, James; Jourdan, Claire			Disability and health-related quality-of-life 4 years after a severe traumatic brain injury: A structural equation modelling analysis	BRAIN INJURY			English	Article						Traumatic brain injury; outcome; quality-of-life	PARIS-TBI; OUTCOME MEASURES; HEAD-INJURY; FOLLOW-UP; SCALE; VALIDITY; QOLIBRI; COHORT; REHABILITATION	Objectives: To assess predictors and indicators of disability and quality-of-life 4 years after severe traumatic brain injury (TBI), using structural equation modelling (SEM). Methods: The PariS-TBI study is a longitudinal multi-centre inception cohort study of 504 patients with severe TBI. Among 245 survivors, 147 patients were evaluated upon 4-year follow-up, and 85 completed the full assessment. Two outcome measures were analysed separately using SEM: the Glasgow Outcome Scale-extended (GOS-E), to measure disability, and the QOLIBRI, to assess quality-of-life. Four groups of variables were entered in the model: demographics; injury severity; mood and cognitive impairments; somatic impairments. Results: The GOS-E was directly significantly related to mood and cognition, injury severity, and somatic impairments. Age and education had an indirect effect, mediated by mood/cognition or somatic deficiencies. In contrast, the only direct predictor of QOLIBRI was mood and cognition. Age and somatic impairments had an indirect influence on the QOLIBRI. Conclusion: Although this study should be considered as explorative, it suggests that disability and quality-of-life were directly influenced by different factors. While disability appeared to result from an interaction of a wide range of factors, quality-of-life was solely directly related to psycho-cognitive factors.	[Azouvi, Philippe; Ruet, Alexis; Jourdan, Claire] Hop Raymond Poincare, AP HP, Serv Med Phys & Readaptat, Garches, France; [Azouvi, Philippe; Ruet, Alexis; Vallat-Azouvi, Claire; Jourdan, Claire] Univ Versailles St Quentin, EA HANDIReSP 4047, Versailles, France; [Ghout, Idir; Darnoux, Emmanuelle; Azerad, Sylvie; Aegerter, Philippe] Hop Ambroise Pare, AP HP, URC, Boulogne, France; [Bayen, Eleonore; Pradat-Diehl, Pascale] Grp Hosp Pitie Salpetriere, AP HP, Serv Med Phys & Readaptat, Paris, France; [Bayen, Eleonore; Pradat-Diehl, Pascale] Univ Paris 06, Paris, France; [Darnoux, Emmanuelle; Charanton, James] CRFTC, Paris, France; [Vallat-Azouvi, Claire] Hop Raymond Poincare, Antenne UEROS SAMSAH, UGECAM IDF 92, Garches, France	Azouvi, P (corresponding author), Hop Raymond Poincare, Serv Med Phys & Readaptat, 104 Bd Raymond Poincare, F-92380 Garches, France.	philippe.azouvi@aphp.fr	RUET, Alexis/L-8726-2015	RUET, Alexis/0000-0002-5080-5734; AEGERTER, Philippe/0000-0002-9156-5028	French Ministry of Health (Programme Hospitalier de Recherche Clinique) [AOM04084]; Institut de Recherche en Sante Publique (IRESP); AP-HP (Departement de la Recherche Clinique et du Developpement)	The authors report no conflicts of interest. This study was funded by grants from the French Ministry of Health (Programme Hospitalier de Recherche Clinique 2004), grant number AOM04084, and from the Institut de Recherche en Sante Publique (IRESP). It was supported by AP-HP (Departement de la Recherche Clinique et du Developpement).	Azouvi P, 2014, NEUROPSYCHOL REHABIL, V18, P1; Bayen E, 2016, J HEAD TRAUMA REHAB, V31, pE59, DOI 10.1097/HTR.0000000000000079; Bayen E, 2013, J HEAD TRAUMA REHAB, V28, P408, DOI 10.1097/HTR.0b013e31825413cf; Berger E, 1999, RESTOR NEUROL NEUROS, V14, P93; Burgess PW, 1998, J INT NEUROPSYCH SOC, V4, P547, DOI 10.1017/S1355617798466037; Bush BA, 2003, ARCH PHYS MED REHAB, V84, P1803, DOI 10.1016/S0003-9993(03)00367-8; Cappa KA, 2011, HEALTH PSYCHOL, V30, P542, DOI 10.1037/a0025220; Dijkers M, 1999, AM J PHYS MED REHAB, V78, P286, DOI 10.1097/00002060-199905000-00022; JENNETT B, 1975, LANCET, V1, P480; Jourdan C, 2016, ANN PHYS REHABIL MED, V59, P100, DOI 10.1016/j.rehab.2015.10.009; Jourdan C, 2013, BRAIN INJURY, V27, P1000, DOI 10.3109/02699052.2013.794971; Jourdan C, 2016, J HEAD TRAUMA REHAB, V31, pE42, DOI 10.1097/HTR.0000000000000147; Jourdan C, 2015, BRAIN INJURY, V29, P701, DOI 10.3109/02699052.2015.1004646; Jourdan C, 2013, NEUROREHAB NEURAL RE, V27, P35, DOI 10.1177/1545968312440744; Kline R. B, 2010, PRINCIPLES PRACTICE, V3rd; Levi Y, 2013, J INT NEUROPSYCH SOC, V19, P664, DOI 10.1017/S1355617713000192; Mailhan L, 2005, BRAIN INJURY, V19, P227, DOI 10.1080/02699050410001720149; MARION DW, 1994, J TRAUMA, V36, P89, DOI 10.1097/00005373-199401000-00014; McCauley SR, 2001, J NEUROL NEUROSUR PS, V71, P643, DOI 10.1136/jnnp.71.5.643; Novack TA, 2001, ARCH PHYS MED REHAB, V82, P300, DOI 10.1053/apmr.2001.18222; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; Pretz CR, 2013, ARCH PHYS MED REHAB, V94, P579, DOI 10.1016/j.apmr.2012.08.197; Schonberger M, 2011, J NEUROL NEUROSUR PS, V82, P936, DOI 10.1136/jnnp.2010.210021; Son AHPWV, 2007, CLIN REHABIL, V21, P1024, DOI 10.1177/0269215507077603; Truelle JL, 2010, BRAIN INJURY, V24, P1272, DOI 10.3109/02699052.2010.506865; TRUELLE JL, 1992, SCAND J REHABIL MED, P115; van Buuren S, 2011, J STAT SOFTW, V45, P1; Vanier M, 2000, ARCH PHYS MED REHAB, V81, P796, DOI 10.1053/apmr.2000.4436; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1167, DOI 10.1089/neu.2009.1076; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1157, DOI 10.1089/neu.2009.1077; WEBB CR, 1995, ARCH PHYS MED REHAB, V76, P1113, DOI 10.1016/S0003-9993(95)80118-9; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	35	18	18	0	12	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2016	30	13-14					1665	1671		10.1080/02699052.2016.1201593			7	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	EG8YO	WOS:000391343800021	27740857				2021-06-18	
J	Chen, Q; Tian, S; Zhu, J; Li, KT; Yu, TH; Yu, LH; Bai, DQ				Chen, Qing; Tian, Si; Zhu, Jing; Li, Kai-Ting; Yu, Ting-He; Yu, Le-Hua; Bai, Ding-Qun			Exploring a Novel Target Treatment on Breast Cancer: Aloe-emodin Mediated Photodynamic Therapy Induced Cell Apoptosis and Inhibited Cell Metastasis	ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY			English	Article						Aloe-emodin; cell death; endoplasmic reticulum; mitochondrial; oxidative stress; photodynamic therapy	TRAUMATIC BRAIN-INJURY; MATRIX METALLOPROTEINASES; MOLECULAR-MECHANISMS; HYPERICUM-PERFORATUM; INSIGHTS; PATHWAY; STRESS; PHOTOSENSITIZERS; ELECTROPHILES; ACTIVATION	Photodynamic therapy (PDT) as a clinical cancer therapy, is a mild therapy, which involves application of photosensitizers (PSs) located in target cells and then irradiated by corresponding wavelength. The activation of PSs generates radical oxygen species (ROS) to exert a selective cytotoxic activity for the target cells. Aloe-emodin (AE) has been found to be an anti-tumor agent in many studies, and has also been demonstrated as a photosensitizer, in the recent years. In order to study the mechanisms of aloe-emodin as a photosensitizer, we investigated the mechanisms of photo-cytotoxicity induced by aloe-emodin in breast cancer MCF-7 cells in the present study. Analysis of cell proliferation evidenced that there was a drastic depression after photodynamic treatment with a series of aloe-emodin concentrations and light doses. We observed changes in apoptosis and demonstrated that the mechanisms of apoptosis were involved in mitochondrial and endoplasmic reticulum death pathways. The capacity of adhesion, migration and invasion of breast cells was measured using WST8 and transwell assay and demonstrated that AE-PDT significantly inhibited adhesion, migration and invasion of MCF-7cells. The expression of MMP2, MMP9, VEGF and Nrf2 demonstrated that the metastasis was related to oxidative stress. Analysis of changes in cytoskeleton components (F-actin) evidenced cytoskeleton disorganization after treatment with AE-PDT. Taken together, the present results indicated that PDT with aloe-emodin effectively suppressed cancer development in MCF-7cells, suggesting the potential of AE as a new photosensitizer in PDT which can provide a new modility for treating cancer.	[Chen, Qing; Tian, Si; Li, Kai-Ting; Bai, Ding-Qun] Chongqing Med Univ, Affiliated Hosp 1, Dept Rehabil, Chongqing, Peoples R China; [Zhu, Jing; Yu, Le-Hua] Chongqing Med Univ, Affiliated Hosp 2, Dept Rehabil, Chongqing, Peoples R China; [Yu, Ting-He] Chongqing Med Univ, Affiliated Hosp 2, Dept Gynaecol & Obstet, Chongqing, Peoples R China	Bai, DQ (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Dept Rehabil, Chongqing, Peoples R China.	baidingqun2014@163.com		Yu, T/0000-0002-9014-7967	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81101692, 81171859]; Natural Science Foundation Project of CQ CSTCNatural Science Foundation Project of CQ CSTC [2011BB5136]	We recognize the valuable contribution of Prof. TH Yu (Department of Gynaecology and Obstetrics, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China) and Mr Chen (Flow Cytometry, Centro Nacional de Biotecnologi'a, Madrid). This work was supported by the National Natural Science Foundation of China (81101692); National Natural Science Foundation of China (81171859) and Natural Science Foundation Project of CQ CSTC (2011BB5136).	Acedo P, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.77; Adibhatla RM, 2010, ANTIOXID REDOX SIGN, V12, P125, DOI [10.1089/ars.2009.2668, 10.1089/ARS.2009.2668]; Agostinis P, 2011, CA-CANCER J CLIN, V61, P250, DOI 10.3322/caac.20114; Allison RR, 2013, PHOTODIAGN PHOTODYN, V10, P331, DOI 10.1016/j.pdpdt.2013.03.011; Bais HP, 2003, J BIOL CHEM, V278, P32413, DOI 10.1074/jbc.M301681200; Buytaert E, 2007, BBA-REV CANCER, V1776, P86, DOI 10.1016/j.bbcan.2007.07.001; Chambers AF, 1997, J NATL CANCER I, V89, P1260, DOI 10.1093/jnci/89.17.1260; de Vries HE, 2008, FREE RADICAL BIO MED, V45, P1375, DOI 10.1016/j.freeradbiomed.2008.09.001; Dong DZ, 2008, CANCER RES, V68, P498, DOI 10.1158/0008-5472.CAN-07-2950; Dougherty TJ, 1998, JNCI-J NATL CANCER I, V90, P889, DOI 10.1093/jnci/90.12.889; Du J, 2012, BREAST CANCER RES TR, V131, P65, DOI 10.1007/s10549-011-1396-3; Hartmann S, 2011, CLIN BREAST CANCER, V11, P196, DOI 10.1016/j.clbc.2011.06.001; Hu ZW, 2011, BREAST CANCER RES TR, V126, P589, DOI 10.1007/s10549-010-0957-1; Itoh K, 2004, FREE RADICAL BIO MED, V36, P1208, DOI 10.1016/j.freeradbiomed.2004.02.075; Josefsen LB, 2012, THERANOSTICS, V2, P916, DOI 10.7150/thno.4571; Jozkowicz A, 2002, ANTIOXID REDOX SIGN, V4, P577, DOI 10.1089/15230860260220076; Ke MS, 2008, PHOTOCHEM PHOTOBIOL, V84, P407, DOI 10.1111/j.1751-1097.2007.00278.x; Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004; Kobayashi M, 2006, ADV ENZYME REGUL, V46, P113, DOI 10.1016/j.advenzreg.2006.01.007; KOZUTSUMI Y, 1988, NATURE, V332, P462, DOI 10.1038/332462a0; Lai JC, 2006, CANCER BIOL THER, V5, P413, DOI 10.4161/cbt.5.4.2513; Lee HZ, 2010, EUR J PHARMACOL, V648, P50, DOI 10.1016/j.ejphar.2010.08.033; Lee MS, 2001, CYTOTECHNOLOGY, V36, P61, DOI 10.1023/A:1014032701800; Mohammadpour H, 2015, PHOTODIAGN PHOTODYN, V12, P238, DOI 10.1016/j.pdpdt.2015.02.004; O'Malley CD, 2003, CANCER, V97, P1303, DOI 10.1002/cncr.11160; Rao JS, 2003, NAT REV CANCER, V3, P489, DOI 10.1038/nrc1121; Schonthal AH, 2009, CANCER LETT, V275, P163, DOI 10.1016/j.canlet.2008.07.005; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; Vitale A, 2008, TRAFFIC, V9, P1581, DOI 10.1111/j.1600-0854.2008.00780.x; Vu TH, 2000, GENE DEV, V14, P2123, DOI 10.1101/gad.815400; Wang L, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/47/475103; Wang XZ, 1996, MOL CELL BIOL, V16, P4273; Wilcken N, 2014, ASIA-PAC J CLIN ONCO, V10, P1, DOI 10.1111/ajco.12206; Xue LY, 2003, ONCOGENE, V22, P9197, DOI 10.1038/sj.onc.1207019; Yan N, 2005, ANNU REV CELL DEV BI, V21, P35, DOI 10.1146/annurev.cellbio.21.012704.131040; Yan W, 2008, NEUROSCI LETT, V431, P150, DOI 10.1016/j.neulet.2007.11.060; Yan W, 2009, J TRAUMA, V66, P1431, DOI 10.1097/TA.0b013e318180f5c7; Yilmaz M, 2007, TRENDS MOL MED, V13, P535, DOI 10.1016/j.molmed.2007.10.004; Yoo JO, 2012, INT REV CEL MOL BIO, V295, P139, DOI 10.1016/B978-0-12-394306-4.00010-1; Zhao JF, 2012, ANTI-CANCER AGENT ME, V12, P604; Zhao MY, 2015, AM J PHYSIOL-CELL PH, V308, pC665, DOI 10.1152/ajpcell.00369.2014; Zobayed SMA, 2006, ANN BOT-LONDON, V98, P793, DOI 10.1093/aob/mcl169	42	18	18	0	25	BENTHAM SCIENCE PUBL LTD	SHARJAH	EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES	1871-5206	1875-5992		ANTI-CANCER AGENT ME	Anti-Cancer Agents Med. Chem.		2016	16	6					763	770		10.2174/1871520615666150821093323			8	Oncology; Chemistry, Medicinal	Oncology; Pharmacology & Pharmacy	DK7WR	WOS:000375138000010	26295333				2021-06-18	
J	Cossette, I; Gagne, ME; Ouellet, MC; Fait, P; Gagnon, I; Sirois, K; Blanchet, S; Le Sage, N; McFadyen, BJ				Cossette, Isabelle; Gagne, Marie-Eve; Ouellet, Marie-Christine; Fait, Philippe; Gagnon, Isabelle; Sirois, Katia; Blanchet, Sophie; Le Sage, Natalie; McFadyen, Bradford J.			Executive dysfunction following a mild traumatic brain injury revealed in early adolescence with locomotor-cognitive dual-tasks	BRAIN INJURY			English	Article						Executive functioning; gait; locomotion; concussion; adolescent	STABILITY FOLLOWING CONCUSSION; SPORT-RELATED CONCUSSION; GAIT BALANCE CONTROL; POSTURAL CONTROL; HEAD-INJURY; CHILDREN; CHILDHOOD; PERFORMANCE; MANAGEMENT; ATTENTION	Objective: To compare gait parameters between children in early adolescence (EA) with and without a mild traumatic brain injury (mTBI) during dual-task walking (DTW). Methods: Children in EA with mTBI (n = 14; six girls) were compared to those without (n = 13; five girls) while walking in different combinations of obstacle avoidance and cognitive dual-tasks. Gait speed and fluidity and their related dual-task costs (DTC) were analysed along with foot clearance and proximity to the obstacle. Results: No group effects were found for gait speed, proximity or clearance, but were found for fluidity DTC, specifically during the dual Stroop task and when crossing the deeper obstacle. There were also group differences for fluidity during the planning of obstacle avoidance for the narrow obstacle combined with the verbal fluency task and the deep obstacle with no cognitive task. Finally, gait fluidity showed group differences across unobstructed dual-task situations. Conclusions: Gait fluidity may be a more sensitive variable than gait speed for revealing executive dysfunction following mTBI in EA. Assessing DTW in level walking also seems to show a potential to reveal executive dysfunctions in this age group. These results provide direction for future research on clinical assessment using DTW post-mTBI in adolescents.	[Cossette, Isabelle; Gagne, Marie-Eve; Ouellet, Marie-Christine; Sirois, Katia; McFadyen, Bradford J.] CIUSSS CN, CIRRIS, 525 Hamel, Quebec City, PQ G1M 2S8, Canada; [Cossette, Isabelle; McFadyen, Bradford J.] Univ Laval, Fac Med, Dept Rehabil, Quebec City, PQ, Canada; [Gagne, Marie-Eve; Ouellet, Marie-Christine; Sirois, Katia] Univ Laval, Fac Social Sci, Sch Psychol, Quebec City, PQ, Canada; [Fait, Philippe] Univ Quebec Trois Rivieres, Dept Human Kinet, Trois Rivieres, PQ, Canada; [Fait, Philippe] Univ Montreal, Res Ctr Neuropsychol & Cognit CERNEC, Montreal, PQ, Canada; [Gagnon, Isabelle] McGill Univ, Sch Phys & Occupat Therapy, Fac Med, Montreal, PQ, Canada; [Blanchet, Sophie] Univ Paris 05, Inst Psychol, Paris, France; [Le Sage, Natalie] Univ Quebec, Hop Enfants Jesus, Trauma Res Unit, Ctr Hosp, Quebec City, PQ, Canada	McFadyen, BJ (corresponding author), CIUSSS CN, CIRRIS, 525 Hamel, Quebec City, PQ G1M 2S8, Canada.	brad.mcfadyen@fmed.ulaval.ca	Le Sage, Natalie/G-7063-2016	Le Sage, Natalie/0000-0003-4762-8156; Ouellet, Marie-Christine/0000-0003-3477-1893; McFadyen, Bradford/0000-0003-1992-4927	Canadian Institutes for Health ResearchCanadian Institutes of Health Research (CIHR) [CBI-127052]	The authors report no conflicts of interest. This project was funded by the Canadian Institutes for Health Research (CBI-127052).	Anderson VA, 2001, DEV NEUROPSYCHOL, V20, P385, DOI 10.1207/S15326942DN2001_5; Boonyong S, 2012, GAIT POSTURE, V35, P428, DOI 10.1016/j.gaitpost.2011.11.002; Broglio SP, 2008, SPORTS MED, V38, P53, DOI 10.2165/00007256-200838010-00005; Brooks MA, 2016, AM J SPORT MED, V44, P742, DOI 10.1177/0363546515622387; Catena RD, 2007, EXP BRAIN RES, V176, P23, DOI 10.1007/s00221-006-0596-2; Catena RD, 2011, J NEUROENG REHABIL, V8, DOI 10.1186/1743-0003-8-8; Catena RD, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-25; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Cossette I, 2014, ARCH PHYS MED REHAB, V95, P1594, DOI 10.1016/j.apmr.2014.03.019; Delis D.C., 2001, DELIS KAPLAN EXECUTI; DeMatteo C, 2015, CLIN PEDIATR, V54, P783, DOI 10.1177/0009922814567305; Fait P, 2009, BRAIN INJURY, V23, P362, DOI 10.1080/02699050902788485; Fait P, 2013, J HEAD TRAUMA REHAB, V28, P293, DOI 10.1097/HTR.0b013e3182407ace; Foley C, 2014, CURR SPORT MED REP, V13, P390, DOI 10.1249/JSR.0000000000000104; Gagnon I, 2004, J HEAD TRAUMA REHAB, V19, P391, DOI 10.1097/00001199-200409000-00004; Gagnon I, 1998, BRAIN INJURY, V12, P843, DOI 10.1080/026990598122070; Gagnon I, 2001, J HEAD TRAUMA REHAB, V16, P595, DOI 10.1097/00001199-200112000-00007; George P. S., 1993, EXEMPLARY MIDDLE SCH; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Guskiewicz KM, 2011, PM&R, V3, pS445, DOI 10.1016/j.pmrj.2011.08.009; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Howell DR, 2015, AM J SPORT MED, V43, P625, DOI 10.1177/0363546514560994; Howell DR, 2013, ARCH PHYS MED REHAB, V94, P1513, DOI 10.1016/j.apmr.2013.04.015; Hurd TL., 2005, NURTURING CHILDREN Y; Huxhold O, 2006, BRAIN RES BULL, V69, P294, DOI 10.1016/j.brainresbull.2006.01.002; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Korkman M, 2013, CHILD NEUROPSYCHOL, V19, P516, DOI 10.1080/09297049.2012.705822; Kwok FY, 2008, BRAIN INJURY, V22, P740, DOI 10.1080/02699050802336989; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Lebel C, 2008, NEUROIMAGE, V40, P1044, DOI 10.1016/j.neuroimage.2007.12.053; Lebel C, 2011, J NEUROSCI, V31, P10937, DOI 10.1523/JNEUROSCI.5302-10.2011; Lee H, 2013, J SCI MED SPORT, V16, P2, DOI 10.1016/j.jsams.2012.03.013; Malina R.M., 2004, GROWTH MATURATION PH; Martini DN, 2011, ARCH PHYS MED REHAB, V92, P585, DOI 10.1016/j.apmr.2010.11.029; May KH, 2014, INT J SPORTS PHYS TH, V9, P242; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McFadyen B.J., 2015, NEUROPSYCHOL REHABIL, P1; McFadyen BJ, 2001, GAIT POSTURE, V13, P7, DOI 10.1016/S0966-6362(00)00090-4; Mohagheghi AA, 2004, EXP BRAIN RES, V155, P459, DOI 10.1007/s00221-003-1751-7; Noble JM, 2013, NEUROPSYCHOL REV, V23, P273, DOI 10.1007/s11065-013-9239-0; Olivier I, 2010, GAIT POSTURE, V32, P494, DOI 10.1016/j.gaitpost.2010.07.008; Parker TM, 2006, MED SCI SPORT EXER, V38, P1032, DOI 10.1249/01.mss.0000222828.56982.a4; Patla AE, 1997, NEUROREPORT, V8, P3661, DOI 10.1097/00001756-199712010-00002; Pickett William, 2004, Chronic Dis Can, V25, P32; Register-Mihalik JK, 2013, NEUROPSYCHOL REV, V23, P300, DOI 10.1007/s11065-013-9238-1; Stoller J, 2014, CAN FAM PHYSICIAN, V60, P548; TEASDALE G, 1974, LANCET, V2, P81; Turkstra LS, 2000, APHASIOLOGY, V14, P349, DOI 10.1080/026870300401405; Yogev-Seligmann G, 2012, MOVEMENT DISORD, V27, P765, DOI 10.1002/mds.24963; Young people's health - a challenge for society, 1986, WHO TECH REP SER, V731, P11	51	18	18	0	12	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2016	30	13-14					1648	1655		10.1080/02699052.2016.1200143			8	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	EG8YO	WOS:000391343800019	27740859				2021-06-18	
J	Eakman, AM; Schelly, C; Henry, KL				Eakman, Aaron M.; Schelly, Catherine; Henry, Kimberly L.			Protective and Vulnerability Factors Contributing to Resilience in Post-9/11 Veterans With Service-Related Injuries in Postsecondary Education	AMERICAN JOURNAL OF OCCUPATIONAL THERAPY			English	Article						brain injuries; educational status; health status; protective factors; resilience, psychological; veterans	POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN-INJURY; MENTAL-HEALTH PROBLEMS; OCCUPATIONAL-THERAPY; DEPRESSION; ASSOCIATION; NEEDS; MEMBERS/VETERANS; PRODUCTIVITY; PERFORMANCE	OBJECTIVE. To examine differences in psychosocial protective factors (social support, meaningful occupation, and academic self-efficacy) and health-related vulnerability factors (posttraumatic stress, depression, and somatic symptoms) contributing to resilience in post-9/11 veterans with service-related injuries and nonveterans in postsecondary education. METHOD. A cross-sectional, matched-participants design using propensity score matching was used to test differences in mean levels of protective and vulnerability factors between injured veterans (n = 26) and nonveterans (n = 19); zero-order correlations explored relationships among study variables. RESULTS. The veteran sample demonstrated lower levels of psychosocial protective factors and higher levels of health-related vulnerability factors compared with nonveterans (10.491 to 11.561). Psychosocial protective factors were consistently negatively associated with health-related vulnerability factors (-.27 to -.63). CONCLUSION. Post-9/11 veterans with service-related injuries are at a substantial disadvantage in terms of resilience; lower protective factors and elevated vulnerability factors may increase their risk for poor campus integration and impede academic achievement.	[Eakman, Aaron M.; Schelly, Catherine] Colorado State Univ, Dept Occupat Therapy, New Start Student Vet, Ft Collins, CO 80523 USA; [Eakman, Aaron M.] Colorado State Univ, Dept Occupat Therapy, Res, Ft Collins, CO 80523 USA; [Henry, Kimberly L.] Colorado State Univ, Dept Psychol, Ft Collins, CO 80523 USA; [Henry, Kimberly L.] Colorado State Univ, Colorado Sch Publ Hlth, Ft Collins, CO 80523 USA	Eakman, AM (corresponding author), Colorado State Univ, Dept Occupat Therapy, New Start Student Vet, Ft Collins, CO 80523 USA.	aaron.eakman@colostate.edu		Henry, Kimberly/0000-0002-2303-3759	NSSV program	Funding for the current study was provided through philanthropic support of the NSSV program by a private donor. We thank NSSV student veteran coordinators Joshua Burns and Erica Schelly and graduate research assistants Cara Nippert and Michelle Sutherland for their assistance with data collection and manuscript preparation and David MacPhee for comments on an earlier draft of the manuscript.	Amaker Robinette J, 2009, Am J Occup Ther, V63, P845; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Arbesman M, 2011, AM J OCCUP THER, V65, P238, DOI 10.5014/ajot.2011.001289; Austin PC, 2011, MULTIVAR BEHAV RES, V46, P119, DOI 10.1080/00273171.2011.540480; Bandura A., 1997, SELF EFFICACY EXERCI; Barry AE, 2014, J STUD AFF RES PRACT, V51, P30, DOI 10.1515/jsarp-2014-0003; Barry AE, 2012, J AM COLL HEALTH, V60, P562, DOI 10.1080/07448481.2012.721427; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Bonanno GA, 2004, AM PSYCHOL, V59, P20, DOI 10.1037/0003-066X.59.1.20; Brenner LA, 2009, REHABIL PSYCHOL, V54, P239, DOI 10.1037/a0016908; Brewin CR, 2005, J TRAUMA STRESS, V18, P53, DOI 10.1002/jts.20007; Bryan CJ, 2014, J REHABIL RES DEV, V51, P1035, DOI 10.1682/JRRD.2014.01.0012; Chemers MM, 2001, J EDUC PSYCHOL, V93, P55, DOI 10.1037//0022-0663.93.1.55; Cogan AM, 2014, OTJR-OCCUP PART HEAL, V34, P150, DOI 10.3928/15394492-20140617-01; Durdella N., 2012, J STUDIES ED, V2, P109, DOI [https://doi.org/10.5296/jse.v2i2.1469, DOI 10.5296/JSE.V2I2.1469]; Eakman AM, 2014, OTJR-OCCUP PART HEAL, V34, P93, DOI 10.3928/15394492-20140211-01; Eakman Aaron M, 2012, Am J Occup Ther, V66, pe20, DOI 10.5014/ajot.2012.001867; Eakman AM, 2015, OCCUPATIONAL THERAPY, P313; Elliott M, 2011, J STUD AFF RES PRACT, V48, P279, DOI 10.2202/1949-6605.6293; FINE SB, 1991, AM J OCCUP THER, V45, P493, DOI 10.5014/ajot.45.6.493; Glynn S. M., 2009, EFFECTIVE TREATMENTS, V2, P388, DOI DOI 10.1002/PON.660; Goldberg B, 2002, OCCUP THER MENT HEAL, V18, P17, DOI DOI 10.1300/J004V18N02_; Hammell KW, 2009, CAN J OCCUP THER, V76, P107, DOI 10.1177/000841740907600208; Hasselkus BR, 2011, MEANING OF EVERYDAY OCCUPATION, SECOND EDITION, P1; Hemphill JF, 2003, AM PSYCHOL, V58, P78, DOI 10.1037/0003-066X.58.1.78; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2007, AM J PSYCHIAT, V164, P150, DOI 10.1176/appi.ajp.164.1.150; Hysenbegasi A, 2005, J MENT HEALTH POLICY, V8, P145; King DW, 2006, J APPL SOC PSYCHOL, V36, P2980, DOI 10.1111/j.0021-9029.2006.00138.x; King GA, 2004, AM J ORTHOPSYCHIAT, V74, P72, DOI 10.1037/0002-9432.74.1.72; Kroenke K, 2002, PSYCHOSOM MED, V64, P258, DOI 10.1097/00006842-200203000-00008; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Maher JM, 2013, CBE-LIFE SCI EDUC, V12, P345, DOI 10.1187/cbe.13-04-0082; Manea L, 2012, CAN MED ASSOC J, V184, pE191, DOI 10.1503/cmaj.110829; Markoulakis R, 2013, REV HIGH EDUC, V37, P77, DOI 10.1353/rhe.2013.0073; Masten AS, 2001, AM PSYCHOL, V56, P227, DOI 10.1037/0003-066X.56.3.227; McBain L., 2012, SOLDIER STUDENT; Obama B. H., 2011, STRENGTHENING OUR MI; Pietrzak RH, 2010, J AFFECT DISORDERS, V120, P188, DOI 10.1016/j.jad.2009.04.015; Plach HL, 2013, AM J OCCUP THER, V67, P73, DOI 10.5014/ajot.2013.003871; Radomski MV, 2014, AM J OCCUP THER, V68, P379, DOI 10.5014/ajot.2014.013060; Radomski MV, 2009, AM J OCCUP THER, V63, P646, DOI 10.5014/ajot.63.5.646; Rudd MD, 2011, PROF PSYCHOL-RES PR, V42, P354, DOI 10.1037/a0025164; Rutter M., 1990, PSYCHOSOCIAL RESILIE; Rutter M, 2006, ANN NY ACAD SCI, V1094, P1, DOI 10.1196/annals.1376.002; Rutter M, 2012, DEV PSYCHOPATHOL, V24, P335, DOI 10.1017/S0954579412000028; Smith-Osborne A., 2012, ADV SOC WORK, V13, P34; Smith-Osborne A., 2007, ADV SOCIAL WORK, V8, P152; Smith-Osborne A, 2012, J REHABIL, V78, P4; Steele J. L., 2010, SERVICE MEMBERS SCH; Stuart EA, 2010, STAT SCI, V25, P1, DOI 10.1214/09-STS313; Thoemmes F, 2012, PROPENSITY SCORE MAT; Thomas JL, 2010, ARCH GEN PSYCHIAT, V67, P614, DOI 10.1001/archgenpsychiatry.2010.54; Tomar N, 2014, AM J OCCUP THER, V68, P430, DOI 10.5014/ajot.2014.011163; Vogt D., 2012, MANUAL DEPLOYMENT RI; Vogt DS, 2008, ASSESSMENT, V15, P381, DOI 10.1177/1073191108316030; Whiteman SD, 2013, J COUNS PSYCHOL, V60, P265, DOI 10.1037/a0031650; Wilcock A., 2006, OCCUPATIONAL PERSPEC, V2nd ed.; Wilk JE, 2012, PSYCHOSOM MED, V74, P249, DOI 10.1097/PSY.0b013e318244c604; Yerxa EJ, 1998, AM J OCCUP THER, V52, P412, DOI 10.5014/ajot.52.6.412	60	18	18	0	14	AMER OCCUPATIONAL THERAPY ASSOC, INC	BETHESDA	4720 MONTGOMERY LANE, BETHESDA, MD 20814-3425 USA	0272-9490	1943-7676		AM J OCCUP THER	Am. J. Occup. Ther.	JAN-FEB	2016	70	1							7001260010	10.5014/ajot.2016.016519			10	Rehabilitation	Rehabilitation	DA2QH	WOS:000367640400008	26709427	Bronze			2021-06-18	
J	King, JB; Lopez-Larson, MP; Yurgelun-Todd, DA				King, Jace B.; Lopez-Larson, Melissa P.; Yurgelun-Todd, Deborah A.			Mean cortical curvature reflects cytoarchitecture restructuring in mild traumatic brain injury	NEUROIMAGE-CLINICAL			English	Article						Mean cortical curvature; Mild traumatic brain injury; Cerebral atrophy	HUMAN CEREBRAL-CORTEX; GEOMETRICALLY ACCURATE; VOLUME; THICKNESS; ATROPHY; GYRIFICATION; SEGMENTATION; CONNECTIVITY; DIFFUSION; MILITARY	In the United States alone, the number of persons living with the enduring consequences of traumatic brain injuries is estimated to be between 3.2 and 5 million. This number does not include individuals serving in the United States military or seeking care at Veterans Affairs hospitals. The importance of understanding the neurobiological consequences of mild traumatic brain injury (mTBI) has increased with the return of veterans from conflicts overseas, many of who have suffered this type of brain injury. However, identifying the neuroanatomical regions most affected by mTBI continues to prove challenging. The aim of this study was to assess the use of mean cortical curvature as a potential indicator of progressive tissue loss in a cross-sectional sample of 54 veterans with mTBI compared to 31 controls evaluated with MRI. It was hypothesized that mean cortical curvature would be increased in veterans with mTBI, relative to controls, due in part to cortical restructuring related to tissue volume loss. Mean cortical curvature was assessed in 60 bilateral regions (31 sulcal, 29 gyral). Of the 120 regions investigated, nearly 50% demonstrated significantly increased mean cortical curvature in mTBI relative to controls with 25% remaining significant following multiple comparison correction (all, pFDR < .05). These differences were most prominent in deep gray matter regions of the cortex. Additionally, significant relationships were found between mean cortical curvature and gray and white matter volumes (all, p < .05). These findings suggest potentially unique patterns of atrophy by region and indicate that changes in brain microstructure due to mTBI are sensitive to measures of mean curvature. (C) 2016 The Authors. Published by Elsevier Inc.	[King, Jace B.] Univ Utah, Dept Radiol, 30 North 1900 East 1A071, Salt Lake City, UT 84132 USA; [King, Jace B.; Yurgelun-Todd, Deborah A.] Univ Utah, Interdept Program Neurosci, 20 South 2030 East,390A BPRB, Salt Lake City, UT 84112 USA; [King, Jace B.; Lopez-Larson, Melissa P.; Yurgelun-Todd, Deborah A.] Univ Utah, Diagnost Neuroimaging, 383 Colorow Dr, Salt Lake City, UT 84108 USA; [Lopez-Larson, Melissa P.; Yurgelun-Todd, Deborah A.] Univ Utah, Dept Psychiat, 501 Chipeta Way, Salt Lake City, UT 84108 USA; [Yurgelun-Todd, Deborah A.] VA VISN 19 Mental Illness Res Educ & Clin Ctr MIR, George E Whalen Dept, Vet Affairs Med Ctr, 500 Foothill Dr, Salt Lake City, UT 84148 USA	King, JB (corresponding author), Univ Utah, Dept Radiol, 30 North 1900 East 1A071, Salt Lake City, UT 84132 USA.; King, JB (corresponding author), Univ Utah, Imaging & Neurosci Ctr, 729 Arapeen Dr, Salt Lake City, UT 84108 USA.	jace.king@hsc.utah.edu; melissa.lopez-larson@hsc.utah.edu; deborah.yurgelun-todd@hsc.utah.edu		King, Jace/0000-0002-0206-0475	Department of Veterans Affairs Salt Lake City Mental Illness Research, Education & Clinical Center (MIRECC) [5I01CX000253-02]; Veterans AffairsUS Department of Veterans Affairs [I01CX000253] Funding Source: NIH RePORTER	This work was supported by the Department of Veterans Affairs Salt Lake City Mental Illness Research, Education & Clinical Center (MIRECC), Merit Review 5I01CX000253-02 (PI Yurgelun-Todd). The authors would like to thank Elliott Bueler, Margaret Legaretta, PhD, and Erin McGlade, PhD for their contributions to this work including, but not limited to, subject recruitment and study management. We would also like to thank Jeffrey S. Anderson, MD, PhD for his feedback and assistance with methods, proof reading, and editing and Kagan R. Breitenbach for his assistance in figure creation.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT, P32; Amyot F, 2015, J NEUROTRAUM, V32, P1693, DOI 10.1089/neu.2013.3306; Belanger HG, 2009, J HEAD TRAUMA REHAB, V24, P4, DOI 10.1097/HTR.0b013e3181957032; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bigler ED, 2001, ARCH CLIN NEUROPSYCH, V16, P95; Bigler ED, 2013, NEUROPSYCHOL REV, V23, P169, DOI 10.1007/s11065-013-9237-2; Bigler ED, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00395; Bigler ED, 2010, NEUROIMAGE, V50, P1017, DOI 10.1016/j.neuroimage.2010.01.003; Buck PW, 2011, HEALTH SOC WORK, V36, P299, DOI 10.1093/hsw/36.4.299; Centers for Disease Control and Prevention, 2014, C TRAUM BRAIN INJ US; Cole JH, 2015, ANN NEUROL, V77, P571, DOI 10.1002/ana.24367; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; DALE AM, 1993, J COGNITIVE NEUROSCI, V5, P162, DOI 10.1162/jocn.1993.5.2.162; Deppe M, 2014, NEUROIMAGE-CLIN, V6, P475, DOI 10.1016/j.nicl.2014.02.012; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Destrieux C, 2010, NEUROIMAGE, V53, P1, DOI 10.1016/j.neuroimage.2010.06.010; Ding K, 2008, J NEUROTRAUM, V25, P1433, DOI 10.1089/neu.2008.0683; First M.B., 1996, STRUCTURED CLIN INTE; Fischl B, 2004, NEUROIMAGE, V23, pS69, DOI 10.1016/j.neuroimage.2004.07.016; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 2001, IEEE T MED IMAGING, V20, P70, DOI 10.1109/42.906426; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Guadalupe T, 2015, CORTEX, V62, P41, DOI 10.1016/j.cortex.2014.07.015; Han K, 2014, NEUROIMAGE, V84, P76, DOI 10.1016/j.neuroimage.2013.08.017; Huang MX, 2009, J NEUROTRAUM, V26, P1213, DOI 10.1089/neu.2008.0672; Im K, 2008, NEUROIMAGE, V43, P103, DOI 10.1016/j.neuroimage.2008.07.016; Iraji A, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/4072402; Irimia A, 2014, J NEUROSURG SCI, V58, P129; Irimia Andrei, 2012, Front Neurol, V3, P10, DOI 10.3389/fneur.2012.00010; Lopez-Larson Melissa, 2013, Front Psychiatry, V4, P83, DOI 10.3389/fpsyt.2013.00083; Lopez-Larson MP, 2012, PSYCHIAT RES-NEUROIM, V204, P32, DOI 10.1016/j.pscychresns.2012.09.009; Luders E, 2006, NEUROIMAGE, V29, P1224, DOI 10.1016/j.neuroimage.2005.08.049; Magnotta VA, 1999, CEREB CORTEX, V9, P151, DOI 10.1093/cercor/9.2.151; Maudsley AA, 2015, J NEUROTRAUM, V32, P1056, DOI 10.1089/neu.2014.3505; Mayer AR, 2015, NEUROSCI BIOBEHAV R, V49, P8, DOI 10.1016/j.neubiorev.2014.11.016; Operto G, 2012, 2012 9TH IEEE INTERNATIONAL SYMPOSIUM ON BIOMEDICAL IMAGING (ISBI), P422, DOI 10.1109/ISBI.2012.6235574; Osborn A.G., 2010, DIAGNOSTIC IMAGING; Palacios EM, 2013, J NEUROTRAUM, V30, P1991, DOI 10.1089/neu.2012.2836; Petrie EC, 2014, J NEUROTRAUM, V31, P425, DOI [10.1089/NEU.2013.2952, 10.1089/neu.2013.2952]; Pienaar R, 2008, INT J IMAG SYST TECH, V18, P42, DOI 10.1002/ima.20138; Ronan L, 2012, NEUROIMAGE, V63, P611, DOI 10.1016/j.neuroimage.2012.06.034; Ronan L, 2011, EPILEPSIA, V52, P28, DOI 10.1111/j.1528-1167.2010.02895.x; Schaer M, 2008, IEEE T MED IMAGING, V27, P161, DOI 10.1109/TMI.2007.903576; Segonne F, 2004, NEUROIMAGE, V22, P1060, DOI 10.1016/j.neuroimage.2004.03.032; Segonne F, 2007, IEEE T MED IMAGING, V26, P518, DOI 10.1109/TMI.2006.887364; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Trivedi MA, 2007, J NEUROTRAUM, V24, P766, DOI 10.1089/neu.2006.0205; van Tol MJ, 2010, ARCH GEN PSYCHIAT, V67, P1002, DOI 10.1001/archgenpsychiatry.2010.121; Wang JQ, 2014, MED BIOL ENG COMPUT, V52, P331, DOI 10.1007/s11517-013-1131-9; Warner MA, 2010, ARCH NEUROL-CHICAGO, V67, P1336, DOI 10.1001/archneurol.2010.149; White T, 2003, BIOL PSYCHIAT, V54, P418, DOI 10.1016/S0006-3223(03)00065-9; Yurgelun-Todd DA, 2011, J HEAD TRAUMA REHAB, V26, P276, DOI 10.1097/HTR.0b013e31822251dc; Zhou YX, 2013, RADIOLOGY, V267, P880, DOI 10.1148/radiol.13122542	58	18	19	0	3	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2213-1582			NEUROIMAGE-CLIN	NeuroImage-Clin.		2016	11						81	89		10.1016/j.nicl.2016.01.003			9	Neuroimaging	Neurosciences & Neurology	DQ9BD	WOS:000379504500012	26909332	DOAJ Gold, Green Published			2021-06-18	
J	Liu, S; Cao, YG; Qu, M; Zhang, Z; Feng, L; Ye, ZS; Xiao, MJ; Hou, ST; Zheng, RY; Han, Z				Liu, Shuang; Cao, Yungang; Qu, Man; Zhang, Zheng; Feng, Liang; Ye, Zusen; Xiao, Meijuan; Hou, Sheng T.; Zheng, Rongyuan; Han, Zhao			Curcumin protects against stroke and increases levels of Notch intracellular domain	NEUROLOGICAL RESEARCH			English	Article						Middle cerebral artery occlusion; Curcumin; Neuroprotection; Neurogenesis; Notch; BrdU	TRAUMATIC BRAIN-INJURY; NEURAL STEM-CELLS; HIPPOCAMPAL NEUROGENESIS; CEREBRAL INFARCTION; SUBVENTRICULAR ZONE; RATS; ISCHEMIA; DIFFERENTIATION; ATTENUATION; INVOLVEMENT	Objectives: To investigate whether curcumin regulates Notch signaling to cause neuroprotection and neurogenesis after focal ischemia reperfusion injury. Method: Focal ischemia reperfusion injury was modeled in rats by occluding the middle cerebral artery. These animals were given either curcumin (300 mg/kg) or corn oil (vehicle) by intraperitoneal injection starting 1 h after stroke and continuing for 7 d. In parallel, sham-operated control animals received vehicle. All animals were killed on day 12. The different treatment groups were compared in terms of neurobehavioral deficits, BrdU incorporation, and levels of doublecortin (DCX) and Notch intracellular domain (NICD) using immunohistochemistry, immunofluorescence and Western blotting. Results: Animals treated with curcumin showed significantly smaller neurobehavioral deficits than vehicle-treated animals after 3, 7, and 12 d of reperfusion (all p < 0.05). Tissue sections from curcumin-treated animals contained significantly greater numbers of BrdU-positive cells (p < 0.05) and BrdU/DCX-positive cells (p < 0.01), as well as significantly higher NICD levels (p < 0.01). Conclusion: Curcumin may protect from focal cerebral ischemia reperfusion injury as well as stimulate neurogenesis by activating the Notch signaling pathway.	[Liu, Shuang; Cao, Yungang; Qu, Man; Han, Zhao] Wenzhou Med Univ, Affiliated Hosp 2, Dept Neurol, Wenzhou 325027, Peoples R China; [Zhang, Zheng; Feng, Liang; Ye, Zusen; Xiao, Meijuan; Zheng, Rongyuan] Wenzhou Med Univ, Affiliated Hosp 1, Dept Neurol, Wenzhou, Peoples R China; [Hou, Sheng T.] Natl Res Council Canada, Inst Biol Sci, 100 Sussex Dr, Ottawa, ON K1A 0R6, Canada	Han, Z (corresponding author), Wenzhou Med Univ, Affiliated Hosp 2, Dept Neurol, Wenzhou 325027, Peoples R China.	wzhanzhao@aliyun.com	Hou, Sheng Tao/O-3202-2018; Hou, Sheng Tao/AAM-7756-2020; zhang, zheng/V-9479-2018	Hou, Sheng Tao/0000-0001-9736-342X	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81571114]; Wenzhou Science Technology Bureau [Y20140686]	This study was supported by the National Natural Science Foundation of China [grant number 81571114 to Zhao Han], and Programs of Wenzhou Science Technology Bureau [grant number Y20140686 to Zhao Han].	Ahsan H, 1999, CHEM-BIOL INTERACT, V121, P161, DOI 10.1016/S0009-2797(99)00096-4; Bagley J, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-92; Chen B, 2016, TURK NEUROSURG, V26, P8, DOI 10.5137/1019-5149.JTN.11488-14.3; Chen XM, 2014, EXP NEUROL, V261, P267, DOI 10.1016/j.expneurol.2014.07.007; Chen Y, 2007, BASIC CLIN PHARMACOL, V101, P427, DOI 10.1111/j.1742-7843.2007.00142.x; Darsalia V, 2005, STROKE, V36, P1790, DOI 10.1161/01.STR.0000173151.36031.be; Darsalia V, 2007, EUR J NEUROSCI, V26, P605, DOI 10.1111/j.1460-9568.2007.05702.x; Ehebauer M, 2006, SCIENCE, V314, P1414, DOI 10.1126/science.1134042; Han Z, 2012, BIOCHEM BIOPH RES CO, V424, P544, DOI 10.1016/j.bbrc.2012.06.152; Han Z, 2009, NEUROL RES, V31, P390, DOI 10.1179/174313209X444116; Hoppe JB, 2013, NEUROL RES, V35, P857, DOI 10.1179/1743132813Y.0000000225; Jiang J, 2007, EUR J PHARMACOL, V561, P54, DOI 10.1016/j.ejphar.2006.12.028; Jurenka JS, 2009, ALTERN MED REV, V14, P141; Kim H, 2005, NEUROL RES, V27, P287, DOI 10.1179/016164105X25234; Kulkarni SK, 2009, THESCIENTIFICWORLDJO, V9, P1233, DOI 10.1100/tsw.2009.137; Maheshwari RK, 2006, LIFE SCI, V78, P2081, DOI 10.1016/j.lfs.2005.12.007; Miljan EA, 2009, CURR OPIN MOL THER, V11, P394; Oya S, 2009, NEUROSCIENCE, V158, P683, DOI 10.1016/j.neuroscience.2008.10.043; Rola R, 2006, EXP NEUROL, V202, P189, DOI 10.1016/j.expneurol.2006.05.034; Shen LH, 2006, NEUROSCIENCE, V137, P393, DOI 10.1016/j.neuroscience.2005.08.092; Tsai YM, 2011, INT J PHARMACEUT, V416, P331, DOI 10.1016/j.ijpharm.2011.06.030; Wang K, 2015, NEUROSCI LETT, V591, P53, DOI 10.1016/j.neulet.2015.02.016; Wang SH, 2010, BEHAV PHARMACOL, V21, P47, DOI 10.1097/FBP.0b013e328334b677; Wang XM, 2009, J CEREBR BLOOD F MET, V29, P1644, DOI 10.1038/jcbfm.2009.83; Wang XD, 2016, J MATER PROCESS TECH, V238, P1, DOI 10.1016/j.jmatprotec.2016.06.033; Xiao Mei-Juan, 2009, Int J Physiol Pathophysiol Pharmacol, V1, P192; Xing CH, 2012, NEUROL RES, V34, P325, DOI 10.1179/1743132812Y.0000000019; Xing ZH, 2016, SCI REP-UK, V6, DOI 10.1038/srep20040; Xu Y, 2007, BRAIN RES, V1162, P9, DOI 10.1016/j.brainres.2007.05.071; Yamamoto S, 2014, METHODS MOL BIOL, V1187, P1, DOI 10.1007/978-1-4939-1139-4_1; Yamashita T, 2006, J NEUROSCI, V26, P6627, DOI 10.1523/JNEUROSCI.0149-06.2006; Yao J, 2012, PROTEIN CELL, V3, P251, DOI 10.1007/s13238-012-2033-6; Zhang Bo, 2009, Chinese Medical Sciences Journal, V24, P41; Zhang YM, 2015, NEUROSCI LETT, V603, P12, DOI 10.1016/j.neulet.2015.07.009; Zhao J, 2008, BRAIN RES, V1229, P224, DOI 10.1016/j.brainres.2008.06.117	35	18	20	0	8	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.		2016	38	6			SI		553	559		10.1080/01616412.2016.1187804			7	Clinical Neurology; Neurosciences	Neurosciences & Neurology	DO9ZH	WOS:000378146300012	27320251				2021-06-18	
J	Mansouri, MT; Farbood, Y; Naghizadeh, B; Shabani, S; Mirshekar, MA; Sarkaki, A				Mansouri, Mohammad Taghi; Farbood, Yaghoub; Naghizadeh, Bahareh; Shabani, Sohreh; Mirshekar, Mohammad Ali; Sarkaki, Alireza			Beneficial effects of ellagic acid against animal models of scopolamine- and diazepam-induced cognitive impairments	PHARMACEUTICAL BIOLOGY			English	Article						Elevated plus maze; memory deficit; passive avoidance	OXIDATIVE STRESS; MEMORY IMPAIRMENTS; PASSIVE-AVOIDANCE; RATS; MICE; CELLS; INVOLVEMENT; BRAIN; BENZODIAZEPINES; DISEASE	Context In a previous study, it has been shown that ellagic acid ( EA), a polyphenolic compound found in pomegranate and different berries, prevents cognitive and hippocampal long-term potentiation (LTP) impairments induced by traumatic brain injury in rats through antioxidant and anti-inflammatory mechanisms. Objective The present study was conducted to assess the potential of EA as a memory enhancer. Materials and methods The elevated plus maze (EPM) and passive avoidance (PA) paradigm were used to evaluate learning and memory parameters. Three doses (10, 30 and 100 mg/kg, i.p.) of EA were administered to animals. Memory impairment was induced by scopolamine treatment (0.4 mg/kg, i.p.) and/or diazepam (1 mg/kg, i.p.). Acquisition trials were carried out 30 min after scopolamine treatment and retention trials were performed for 5 min 24 h after the acquisition trials. Results EA at doses 30 and 100 mg/kg significantly reversed the amnesia induced by scopolamine (0.4 mg/kg, i.p.) in the EPM and PA tests in mice. Also, EA at doses 30 and 100 mg/kg significantly antagonized the amnesia induced by diazepam (1 mg/kg, i.p.) in EPM test in rats. Moreover, chronic administration of EA at dose 30 mg/kg ameliorated the memory deficit induced by diazepam (1 mg/kg, i.p.) in rats. Discussion and conclusion This study demonstrates that ellagic acid is effective in preventing scopolamine- and diazepam-induced cognitive impairments without altering the animals' locomotion. This suggests the potential of EA application as a useful memory restorative agent in the treatment of dementia seen in elderly persons.	[Mansouri, Mohammad Taghi; Naghizadeh, Bahareh] Ahvaz Jundishapur Univ Med Sci, Sch Med, Dept Pharmacol, Ahwaz, Iran; [Mansouri, Mohammad Taghi; Farbood, Yaghoub; Shabani, Sohreh; Sarkaki, Alireza] Ahvaz Jundishapur Univ Med Sci, Physiol Res Ctr, Ahwaz, Iran; [Farbood, Yaghoub; Shabani, Sohreh; Sarkaki, Alireza] Ahvaz Jundishapur Univ Med Sci, Sch Med, Dept Physiol, Ahwaz, Iran; [Mirshekar, Mohammad Ali] Zahedan Univ Med Sci, Sch Med, Dept Physiol, Zahedan, Iran	Mansouri, MT (corresponding author), Ahvaz Jundishapur Univ Med Sci, Sch Med, Pharmacol, Ahwaz, Iran.	mansouri_smt@yahoo.com	Farbood, Yaghoob/M-3076-2017; Mirshekar, Mohammad Ali/S-4167-2017; Sarkaki, Alireza/Q-8363-2017; Shabani, Sahreh/AAG-4488-2021; Mansouri, Seyed Mohammad Taghi/F-3847-2014	Farbood, Yaghoob/0000-0002-6390-0079; Mirshekar, Mohammad Ali/0000-0002-0449-6440; Sarkaki, Alireza/0000-0001-9272-6228; Mansouri, Seyed Mohammad Taghi/0000-0002-7549-0708	Physiology Research Center - Vice Chancellor of Research, Ahvaz Jundishapur University of Medical Sciences (Iran) [PRC-121]	This research was financially supported by grants (PRC-121) from the Physiology Research Center, funded by the Vice Chancellor of Research, Ahvaz Jundishapur University of Medical Sciences (Iran).	Blokland A, 1995, BRAIN RES REV, V21, P285, DOI 10.1016/0165-0173(95)00016-X; Buniatian GH, 2003, CELL PROLIFERAT, V36, P307, DOI 10.1046/j.1365-2184.2003.00287.x; Choi YH, 2009, BIOL PHARM BULL, V32, P1118, DOI 10.1248/bpb.32.1118; Dolatshahi M, 2015, IRAN J BASIC MED SCI, V18, P38; Farbood Y, 2015, LIFE SCI, V124, P120, DOI 10.1016/j.lfs.2015.01.013; Feng Y, 2009, BIOCHEM BIOPH RES CO, V390, P1250, DOI 10.1016/j.bbrc.2009.10.130; Festa F, 2001, ANTICANCER RES, V21, P3903; Gacar N, 2011, PHARMACOL BIOCHEM BE, V99, P316, DOI 10.1016/j.pbb.2011.05.017; Girish C, 2013, EUR J PHARMACOL, V710, P49, DOI 10.1016/j.ejphar.2013.04.003; Girish C, 2012, EUR J PHARMACOL, V682, P118, DOI 10.1016/j.ejphar.2012.02.034; Hartman RE, 2006, NEUROBIOL DIS, V24, P506, DOI 10.1016/j.nbd.2006.08.006; Hassoun EA, 2004, J BIOCHEM MOL TOXIC, V18, P196, DOI 10.1002/jbt.20030; Hunter B, 1988, HDB PSYCHOPHARMACOLO, P531; ITOH J, 1991, EUR J PHARMACOL, V194, P71, DOI 10.1016/0014-2999(91)90125-A; Iversen SD, 1997, LIFE SCI, V60, P1145, DOI 10.1016/S0024-3205(97)00059-3; Karlsson S, 2010, BRIT J NUTR, V103, P1102, DOI 10.1017/S0007114509992935; Kim DH, 2007, EUR J PHARMACOL, V574, P140, DOI 10.1016/j.ejphar.2007.07.042; LISTER RG, 1985, NEUROSCI BIOBEHAV R, V9, P87, DOI 10.1016/0149-7634(85)90034-X; Liu QS, 2011, J ETHNOPHARMACOL, V135, P786, DOI 10.1016/j.jep.2011.04.026; MAJID S, 1991, BIOCHEM PHARMACOL, V42, P1441, DOI 10.1016/0006-2952(91)90457-G; Mansouri MT, 2014, PHARMACOL BIOCHEM BE, V120, P43, DOI 10.1016/j.pbb.2014.02.009; Mansouri MT, 2013, EUR J PHARMACOL, V707, P46, DOI 10.1016/j.ejphar.2013.03.031; Mansouri MT, 2013, FOOD CHEM, V138, P1028, DOI 10.1016/j.foodchem.2012.11.022; Park SJ, 2012, EUR J PHARMACOL, V676, P64, DOI 10.1016/j.ejphar.2011.11.050; Pavlica S, 2005, FREE RADICAL RES, V39, P1377, DOI 10.1080/09670260500197660; Rafieirad M, 2014, J HERB DRUGS, V5, P1; Reddy DS, 1998, BRAIN RES, V799, P215, DOI 10.1016/S0006-8993(98)00419-3; Reeta KH, 2009, BRAIN RES, V1301, P52, DOI 10.1016/j.brainres.2009.09.027; Sellappan S, 2002, J AGR FOOD CHEM, V50, P2432, DOI 10.1021/jf011097r; Spencer JPE, 2010, BRIT J NUTR, V104, pS40, DOI 10.1017/S0007114510003934; THIEBOT MH, 1985, NEUROSCI BIOBEHAV R, V9, P95, DOI 10.1016/0149-7634(85)90035-1; Townsend DM, 2003, ONCOGENE, V22, P7369, DOI 10.1038/sj.onc.1206940; Uzar E, 2012, NEUROL SCI, V33, P567, DOI 10.1007/s10072-011-0775-1	33	18	18	0	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1388-0209	1744-5116		PHARM BIOL	Pharm. Biol.		2016	54	10					1947	1953		10.3109/13880209.2015.1137601			7	Plant Sciences; Medical Laboratory Technology; Pharmacology & Pharmacy	Plant Sciences; Medical Laboratory Technology; Pharmacology & Pharmacy	DZ7JP	WOS:000386041500001	26828763				2021-06-18	
J	Portbury, SD; Hare, DJ; Sgambelloni, C; Finkelstein, DI; Adlard, PA				Portbury, Stuart D.; Hare, Dominic J.; Sgambelloni, Charlotte; Finkelstein, David I.; Adlard, Paul A.			A time-course analysis of changes in cerebral metal levels following a controlled cortical impact	METALLOMICS			English	Article							TRAUMATIC BRAIN-INJURY; INDUCED OXIDATIVE STRESS; ALZHEIMERS-DISEASE; TAU PHOSPHORYLATION; SYNAPTIC PROTEINS; DELICATE BALANCE; HEAD-INJURY; RAT MODEL; ZINC; IRON	Traumatic brain injury (TBI) is complicated by a sudden and dramatic change in brain metal levels, including iron (Fe), copper (Cu) and zinc (Zn). Specific 'metallo-pathological' features of TBI include increased non-heme bound Fe and the liberation of free Zn ions, both of which may contribute to the pathogenesis of TBI. To further characterise the metal dyshomeostasis that occurs following brain trauma, we performed a quantitative time-course survey of spatial Fe, Cu and Zn distribution in mice receiving a controlled cortical impact TBI. Images of brain metal levels produced using laser ablation-inductively coupled plasma-mass spectrometry (LA-ICP-MS) in the upper quadrant of the ipsilateral hemisphere were compared to the corresponding contralateral hemisphere, together with regional areas radiating toward the center of the brain from the site of lesion. Significant regional and time point specific elevations in Fe, Zn and Cu were detected immediately and up to 28 days after TBI. The magnitude and timeframe of many of these changes suggest that TBI results in a pronounced and sustained alteration in normal metal levels within the brain. Such alterations are likely to play a role in both the short-and long-term consequences of head trauma and suggest that pharmacological modulation to normalize these metal levels may be efficacious in improving functional outcome.	[Portbury, Stuart D.; Hare, Dominic J.; Sgambelloni, Charlotte; Finkelstein, David I.; Adlard, Paul A.] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Kenneth Myer Bldg,30 Royal Parade, Parkville, Vic 3052, Australia; [Hare, Dominic J.] Univ Technol Sydney, Elemental Bioimaging Facil, Thomas St, Broadway, NSW 2007, Australia	Adlard, PA (corresponding author), Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Kenneth Myer Bldg,30 Royal Parade, Parkville, Vic 3052, Australia.	paul.adlard@florey.edu.au	Finkelstein, David/B-9617-2009; Hare, Dominic/H-2481-2011	Finkelstein, David/0000-0002-8167-4917; Hare, Dominic/0000-0002-5922-7643; Portbury, Stuart/0000-0002-5470-6100	Australian Research CouncilAustralian Research Council [FT120100030, LP140100095]; Victorian Government; Operational Infrastructure Support Grant	P. A. A. is supported by an Australian Research Council Future Fellowship (FT120100030). D. J. H. is supported by an Australian Research Council Linkage Project with Agilent Technologies (LP140100095). In addition, the Florey Institute of Neuroscience and Mental Health acknowledge the strong support from the Victorian Government and in particular the funding from the Operational Infrastructure Support Grant. The Elemental Bio-imaging Facility receives material support from Agilent Technologies.	Adlard PA, 2015, NEUROBIOL DIS, V81, P196, DOI 10.1016/j.nbd.2014.12.012; Ansari MA, 2008, FREE RADICAL BIO MED, V45, P443, DOI 10.1016/j.freeradbiomed.2008.04.038; Ansari MA, 2008, J NEUROTRAUM, V25, P513, DOI 10.1089/neu.2007.0451; Ayton S, 2014, FREE RADICAL BIO MED, V69, P331, DOI 10.1016/j.freeradbiomed.2014.01.041; Barnham KJ, 2014, CHEM SOC REV, V43, P6727, DOI 10.1039/c4cs00138a; Barnham KJ, 2004, NAT REV DRUG DISCOV, V3, P205, DOI 10.1038/nrd1330; Bayir H, 2006, DEV NEUROSCI-BASEL, V28, P420, DOI 10.1159/000094168; Bolognin S, 2009, NEUROMOL MED, V11, P223, DOI 10.1007/s12017-009-8102-1; Bouras C, 1997, EUR NEUROL, V38, P53, DOI 10.1159/000112903; Caliaperumal J, 2012, EXP NEUROL, V237, P363, DOI 10.1016/j.expneurol.2012.07.001; Carbonell T, 2007, CURR MED CHEM, V14, P857, DOI 10.2174/092986707780363014; Chen HL, 2007, AM J EPIDEMIOL, V166, P810, DOI 10.1093/aje/kwm153; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Cope EC, 2012, NEUROREHAB NEURAL RE, V26, P907, DOI 10.1177/1545968311435337; Cope EC, 2012, NUTR REV, V70, P410, DOI 10.1111/j.1753-4887.2012.00486.x; Cope EC, 2011, PHYSIOL BEHAV, V104, P942, DOI 10.1016/j.physbeh.2011.06.007; Cope EC, 2010, CURR OPIN CLIN NUTR, V13, P685, DOI 10.1097/MCO.0b013e32833df61a; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; Creed JA, 2011, J NEUROTRAUM, V28, P547, DOI 10.1089/neu.2010.1729; Egana JT, 2003, BIOMETALS, V16, P215, DOI 10.1023/A:1020727218493; FACTOR SA, 1991, MOVEMENT DISORD, V6, P225, DOI 10.1002/mds.870060306; Faul M, 2010, INJURY PREV, V16, pA268, DOI 10.1136/ip.2010.029215.951; Flygt J, 2013, EUR J NEUROSCI, V38, P2153, DOI 10.1111/ejn.12179; Frederickson CJ, 2004, NEUROSCIENTIST, V10, P18, DOI 10.1177/1073858403255840; FREDERICKSON CJ, 1989, BRAIN RES, V480, P317, DOI 10.1016/0006-8993(89)90199-6; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Hare D, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00034; Hare DJ, 2015, CHEM SOC REV, V44, P5941, DOI 10.1039/c5cs00055f; Hare DJ, 2014, J ANAL ATOM SPECTROM, V29, P1726; Huang XD, 1999, J BIOL CHEM, V274, P37111, DOI 10.1074/jbc.274.52.37111; Huang YP, 2014, CELL REP, V8, P831, DOI 10.1016/j.celrep.2014.06.047; Klevay LM, 2013, MED HYPOTHESES, V81, P995, DOI 10.1016/j.mehy.2013.09.011; Lear J, 2012, ANAL CHEM, V84, P6707, DOI 10.1021/ac301156f; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Levin HS, 2013, J NEUROTRAUM, V30, P610, DOI 10.1089/neu.2012.2394; Liu HD, 2013, NEUROL SCI, V34, P1173, DOI 10.1007/s10072-012-1214-7; Long DA, 1996, BRAIN RES, V717, P109, DOI 10.1016/0006-8993(95)01500-0; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; MCCLAIN CJ, 1986, J NEUROSURG, V64, P224, DOI 10.3171/jns.1986.64.2.0224; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Miller G, 2012, SCIENCE, V336, P790, DOI 10.1126/science.336.6083.790; Montenigro PH, 2015, ANNU REV CLIN PSYCHO, V11, P309, DOI 10.1146/annurev-clinpsy-032814-112814; Morris DR, 2013, CURR OPIN CLIN NUTR, V16, P708, DOI 10.1097/MCO.0b013e328364f39c; Omalu B, 2011, NEUROSURGERY, V69, P173, DOI 10.1227/NEU.0b013e318212bc7b; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; OMeara ES, 1997, AM J EPIDEMIOL, V146, P373, DOI 10.1093/oxfordjournals.aje.a009290; Onyszchuk G, 2009, NEUROSCI LETT, V452, P204, DOI 10.1016/j.neulet.2009.01.049; Opazo C, 2002, J BIOL CHEM, V277, P40302, DOI 10.1074/jbc.M206428200; Pena MMO, 1999, J NUTR, V129, P1251; Portbury SD, 2015, J ALZHEIMERS DIS, V46, P297, DOI 10.3233/JAD-143048; Raven EP, 2013, J ALZHEIMERS DIS, V37, P127, DOI 10.3233/JAD-130209; Raz E, 2011, AM J NEURORADIOL, V32, P1851, DOI 10.3174/ajnr.A2637; Rivera-Mancia S, 2010, CHEM-BIOL INTERACT, V186, P184, DOI 10.1016/j.cbi.2010.04.010; Roberts BR, 2015, METALLOMICS, V7, P124, DOI 10.1039/c4mt00258j; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Skandsen T, 2010, ARCH PHYS MED REHAB, V91, P1904, DOI 10.1016/j.apmr.2010.08.021; Suh SW, 2000, BRAIN RES, V852, P268, DOI 10.1016/S0006-8993(99)02095-8; Sun XY, 2012, J BIOL CHEM, V287, P11174, DOI 10.1074/jbc.M111.309070; Szewczyk B, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00033; TONDER N, 1990, NEUROSCI LETT, V109, P247, DOI 10.1016/0304-3940(90)90002-Q; Van Den Heuvel C, 2007, PROG BRAIN RES, V161, P303, DOI 10.1016/S0079-6123(06)61021-2; Voss K, 2014, TRANSL NEURODEGENER, V3, DOI 10.1186/2047-9158-3-24; Weiner MW, 2013, ALZHEIMERS DEMENT, V9, P445, DOI [10.1016/j.jalz.2013.05.1769, 10.1016/j.jalz.2013.03.005]; Weinreb O, 2013, FREE RADICAL BIO MED, V62, P52, DOI 10.1016/j.freeradbiomed.2013.01.017; Wojnarowicz M. W., 2012, SCI TRANSL MED, V4; Zhang K, 2012, J NEUROTRAUM, V29, P756, DOI 10.1089/neu.2011.2125; Zhang QG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034504; ZIMMERMAN AW, 1976, ARCH NEUROL-CHICAGO, V33, P111, DOI 10.1001/archneur.1976.00500020039007	68	18	18	1	6	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	1756-5901	1756-591X		METALLOMICS	Metallomics		2016	8	2					193	200		10.1039/c5mt00234f			8	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	DE9PV	WOS:000370971200006	26689359	Other Gold, Green Published			2021-06-18	
J	Regasa, LE; Thomas, DM; Gill, RS; Marion, DW; Ivins, BJ				Regasa, Lemma Ebssa; Thomas, D. Michael; Gill, Ranjodh S.; Marion, Donald W.; Ivins, Brian J.			Military Deployment May Increase the Risk for Traumatic Brain Injury Following Deployment	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						deployment; epidemiology; postdeployment; predeployment; TBI; TBI diagnosis; traumatic brain injury; US military	ARMY SOLDIERS; MILD; COMBAT; PROPENSITY; BEHAVIORS; MORTALITY; PERSONNEL; ACCURACY; VETERANS; SEQUELAE	Objective: To compare rates of traumatic brain injury (TBI) diagnosis before and after overseas military deployment. Design: We conducted a retrospective examination of a cohort of 119 353 active duty US military service members (Army, Navy, Air Force, and Marines) whose first lifetime overseas deployment began at any time between January 1, 2011, and December 31, 2011, and lasted at least for 30 days. For this cohort, TBI diagnoses were examined during the 76 weeks prior to deployment, during deployment, and 76 weeks following the end of deployment. Main Measures: 4-week rates of TBI diagnosis. Results: The risk of being diagnosed with TBI within 4 weeks after returning from deployment was 8.4 times higher than the average risk before deployment. The risk gradually decreased thereafter up to 40 weeks postdeployment. However, during the 41 to 76 weeks following deployment, risk stabilized but remained on average 1.7 times higher than before deployment. Conclusion: An increased rate of TBI diagnosis following deployment was identified, which may be partly due to delayed diagnosis of TBIs that occurred while service members were deployed. Also, the increased rate may partly be due to riskier behaviors of service members following deployment that results in an increased occurrence of TBIs.	[Regasa, Lemma Ebssa; Thomas, D. Michael; Gill, Ranjodh S.; Marion, Donald W.; Ivins, Brian J.] Def & Vet Brain Injury Ctr, 1335 East West Hwy,Ste 600, Silver Spring, MD 20910 USA; [Regasa, Lemma Ebssa] Rutgers State Univ, Inst Hlth Hlth Care Policy & Aging Res, 30 Coll Ave, New Brunswick, NJ 08903 USA; [Regasa, Lemma Ebssa; Marion, Donald W.; Ivins, Brian J.] Gen Dynam Informat Technol, Fairfax, VA USA; [Thomas, D. Michael] Univ Illinois, Sch Publ Hlth, Chicago, IL 60680 USA; [Thomas, D. Michael] Creat Comp Solut Inc, Rockville, MD USA; [Gill, Ranjodh S.] US PHS, Washington, DC USA	Regasa, LE (corresponding author), Def & Vet Brain Injury Ctr, 1335 East West Hwy,Ste 600, Silver Spring, MD 20910 USA.	lemma.e.regasa.ctr@mail.mil	Marion, Donald/AAR-5749-2021		Defense and Veterans Brain Injury Center (DVBIC)US Department of Veterans Affairs	This material is supported by the Defense and Veterans Brain Injury Center (DVBIC). No outside sources contributed to the funding of this study. The authors thank CPT Armen Thoumiain for his assistance with study execution. The authors also thank MAJ Patricia Rohrbeck for providing aggregate data. Comments by colleagues at DVBIC in improving the earlier version of this article are acknowledged.	Adler AB, 2011, J TRAUMA STRESS, V24, P381, DOI 10.1002/jts.20665; Armed Forces Health Surveillance Center, CAS DEF DAT AN HLTH; Armed Forces Health Surveillance Center (AFHSC), 2013, MSMR, V20, P9; Bazarian JJ, 2006, ACAD EMERG MED, V13, P31, DOI 10.1197/j.aem.2005.07.038; Bell N S, 2001, Inj Prev, V7, P4, DOI 10.1136/ip.7.1.4; Booth-Kewley S, 2010, AGGRESSIVE BEHAV, V36, P330, DOI 10.1002/ab.20355; Gallaway MS, 2012, AGGRESSIVE BEHAV, V38, P357, DOI 10.1002/ab.21436; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hyatt K, 2014, MIL MED, V179, P849, DOI 10.7205/MILMED-D-13-00526; Iverson GL, 2010, J HEAD TRAUMA REHAB, V25, P313, DOI 10.1097/HTR.0b013e3181d6f9bd; Kang HK, 2001, AM J EPIDEMIOL, V154, P399, DOI 10.1093/aje/154.5.399; Kelley AM, 2012, J PSYCHIATR RES, V46, P582, DOI 10.1016/j.jpsychires.2012.01.017; Killgore WDS, 2008, J PSYCHIATR RES, V42, P1112, DOI 10.1016/j.jpsychires.2008.01.001; Knapik JJ, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-231; Moss NEG, 1996, INJURY, V27, P159, DOI 10.1016/0020-1383(95)00217-0; Powell JM, 2008, ARCH PHYS MED REHAB, V89, P1550, DOI 10.1016/j.apmr.2007.12.035; Rubertone MV, 2002, AM J PUBLIC HEALTH, V92, P1900, DOI 10.2105/AJPH.92.12.1900; Sahai H, 1996, STAT EPIDEMIOLOGY ME; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Schultz BA, 2011, NEUROREHABILITATION, V28, P309, DOI 10.3233/NRE-2011-0659; Sosin DM, 1996, BRAIN INJURY, V10, P47; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Thomsen CJ, 2011, J PSYCHIATR RES, V45, P1321, DOI 10.1016/j.jpsychires.2011.04.003; US Department of Defense, 2014, DD FORM 2796; US Department of Defense, 2006, DEP DEF INSTR 6490 0; US Department of Defense, 2014, DD FORM 200; Vanderploeg RD, 2013, J HEAD TRAUMA REHAB, V28, P211, DOI 10.1097/HTR.0b013e31828b50db	27	18	18	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2016	31	1					E28	E35		10.1097/HTR.0000000000000155			8	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	DK9CN	WOS:000375228000004	26098261				2021-06-18	
J	Rowe, RK; Ziebell, JM; Harrison, JL; Law, LM; Adelson, PD; Lifshitz, J				Rowe, Rachel K.; Ziebell, Jenna M.; Harrison, Jordan L.; Law, L. Matthew; Adelson, P. David; Lifshitz, Jonathan			Aging with Traumatic rain Injury: Effects of Age at Injury on Behavioral Outcome following Diffuse Brain Injury in Rats	DEVELOPMENTAL NEUROSCIENCE			English	Article						Traumatic brain injury; Concussion; Aging; Puberty; Behavior; Juvenile; Age at injury	HEAD-INJURY; LATE-ONSET; CHILDHOOD; RECOVERY; MODEL; ACTIVATION; PLASTICITY; MICROGLIA; CHILDREN; CORTEX	Development and aging are influenced by external factors with the potential to impact health throughout the life span. Traumatic brain injury (TBI) can initiate and sustain a lifetime of physical and mental health symptoms. Over 1.7 million TBIs occur annually in the USA alone, with epidemiology suggesting a higher incidence for young age groups. Additionally, increasing life spans mean more years to age with TBI. While there is ongoing research of experimental pediatric and adult TBI, few studies to date have incorporated animal models of pediatric, adolescent, and adult TBI to understand the role of age at injury across the life span. Here, we explore repeated behavioral performance between rats exposed to diffuse TBI at five different ages. Our aim was to follow neurological morbidities across the rodent life span with respect to age at injury. A single cohort of male Sprague Dawley rats (n = 69) was received at postnatal day (PND) 10. Subgroups of this cohort (n = 11-12/group) were subjected to a single moderate midline fluid percussion injury at age PND 17, PND 35, 2 months, 4 months, or 6 months. A control group of nave rats (n = 12) was assembled from this cohort. The entire cohort was assessed for motor function by beam walk at 1.5, 3, 5, and 7 months of age. Anxiety-like behavior was assessed with the open field test at 8 months of age. Cognitive performance was assessed using the novel object location task at 8, 9, and 10 months of age. Depression-like behavior was assessed using the forced swim test at 10 months of age. Age at injury and time since injury differentially influenced motor, cognitive, and affective behavioral outcomes. Motor and cognitive deficits occurred in rats injured at earlier developmental time points, but not in rats injured in adulthood. In contrast, rats injured during adulthood showed increased anxiety-like behavior compared to uninjured control rats. A single diffuse TBI did not result in chronic depression-like behaviors or changes in body weight among any groups. The interplay of age at injury and aging with an injury are translationally important factors that influence behavioral performance as a quality of life metric. More complete understanding of these factors can direct rehabilitative efforts and personalized medicine for TBI survivors. (C) 2016 S. Karger AG, Basel	[Rowe, Rachel K.; Ziebell, Jenna M.; Harrison, Jordan L.; Law, L. Matthew; Adelson, P. David; Lifshitz, Jonathan] Phoenix Childrens Hosp, Barrow Neurol Inst, Phoenix, AZ USA; [Rowe, Rachel K.; Ziebell, Jenna M.; Harrison, Jordan L.; Law, L. Matthew; Adelson, P. David; Lifshitz, Jonathan] Univ Arizona, Dept Child Hlth, Coll Med Phoenix, Phoenix, AZ USA; [Rowe, Rachel K.; Lifshitz, Jonathan] Phoenix Vet Affairs Healthcare Syst, Phoenix, AZ USA; [Harrison, Jordan L.; Adelson, P. David; Lifshitz, Jonathan] Arizona State Univ, Interdisciplinary Grad Program Neurosci, Tempe, AZ USA; [Ziebell, Jenna M.] Univ Tasmania, Fac Hlth, Wicking Dementia Res & Educ Ctr, Hobart, Tas, Australia	Lifshitz, J (corresponding author), Phoenix Childrens Hosp, Translat Neurotrauma Res Program, Barrow Neurol Inst, 1919 E Thomas Rd, Phoenix, AZ 85016 USA.	jifshitz@email.arizona.edu	Ziebell, Jenna/Y-4496-2019; Adelson, David/W-2083-2019	Rowe, Rachel/0000-0002-9034-3159; Ziebell, Jenna/0000-0003-2497-4347	Arizona Alzheimer's Consortium; University of Arizona; College of Medicine - Phoenix; Barrow Neurological Institute at Phoenix Children's Hospital; National Institute of Neurological Disorders and Stroke of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS-065052]; Bisgrove Scholar award - Science Foundation Arizona; Bruce and Diane Halle Foundation; NIH fellowshipUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [F31-NS090921]	The authors would like to thank Mr. Tony Romero and Mr. Mahir Qureshi for their technical assistance. The research reported in this paper was supported primarily by the Arizona Alzheimer's Consortium with matching funds from the University of Arizona, College of Medicine - Phoenix and Barrow Neurological Institute at Phoenix Children's Hospital. Partial support was provided by the National Institute of Neurological Disorders and Stroke of the National Institutes of Health under award number R01 NS-065052. Dr. Rachel K. Rowe was supported by the Bisgrove Scholar award funded by Science Foundation Arizona. Jordan L. Harrison was supported, in part, by the Bruce and Diane Halle Foundation and NIH fellowship F31-NS090921. L. Matthew Law was supported by the Bruce and Diane Halle Foundation.	Adelson PD, 2000, J NEUROTRAUM, V17, P273, DOI 10.1089/neu.2000.17.273; Anderson V, 2009, PEDIATRICS, V124, pE1064, DOI 10.1542/peds.2009-0365; Anderson V, 2009, BRAIN, V132, P45, DOI 10.1093/brain/awn293; Andruszkow H, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/1477-7525-12-26; Babikian T, 2015, J NEUROTRAUM, V32, P1849, DOI 10.1089/neu.2015.3971; Ballantyne AO, 2008, BRAIN, V131, P2975, DOI 10.1093/brain/awn176; Bittigau D, 1999, ANN NEUROL, V45, P724, DOI 10.1002/1531-8249(199906)45:6<724::AID-ANA6>3.0.CO;2-P; Broshek DK, 2015, BRAIN INJURY, V29, P228, DOI 10.3109/02699052.2014.974674; Cao T, 2012, NEUROSCIENCE, V225, P65, DOI 10.1016/j.neuroscience.2012.08.058; Cole W.R., 2016, TRANSLATIONAL RES TR; Crowe LM, 2012, J PEDIATR PSYCHOL, V37, P745, DOI 10.1093/jpepsy/jss070; Donders J, 2007, J HEAD TRAUMA REHAB, V22, P296, DOI 10.1097/01.HTR.0000290974.01872.82; Fann JR, 2013, MANAGEMENT ADULTS TR; FEENEY DM, 1982, SCIENCE, V217, P855, DOI 10.1126/science.7100929; Gaastra B, 2016, BRIT J NEUROSURG, V30, P221, DOI 10.3109/02688697.2015.1119240; Giza CC, 2006, DEV NEUROSCI-BASEL, V28, P364, DOI 10.1159/000094163; Goldstein FC, 2001, J CLIN EXP NEUROPSYC, V23, P739, DOI 10.1076/jcen.23.6.739.1028; Goodus MT, 2015, DEV NEUROSCI-BASEL, V37, P29, DOI 10.1159/000367784; Harrison JL, 2015, BRAIN BEHAV IMMUN, V47, P131, DOI 10.1016/j.bbi.2015.01.001; Hudak A, 2011, PSYCHIAT RES-NEUROIM, V191, P160, DOI 10.1016/j.pscychresns.2010.10.003; JAFFE KM, 1993, ARCH PHYS MED REHAB, V74, P587, DOI 10.1016/0003-9993(93)90156-5; Jellinger KA, 2004, CURR OPIN NEUROL, V17, P719, DOI 10.1097/00019052-200412000-00012; Jones NC, 2008, J NEUROTRAUM, V25, P1367, DOI 10.1089/neu.2008.0641; Kamper JE, 2013, EXP NEUROL, V250, P8, DOI 10.1016/j.expneurol.2013.09.016; Keenan HT, 2007, PEDIATRICS, V119, pE616, DOI 10.1542/peds.2006-2313; Kennard MA, 1936, AM J PHYSIOL, V115, P138; Lifshitz J, 2008, ANIMAL MODELS ACUTE; Lifshitz Jonathan, 2009, P369, DOI 10.1007/978-1-60327-185-1_32; Malkesman O, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00157; Mallya S, 2015, J NEUROTRAUM, V32, P411, DOI 10.1089/neu.2014.3504; McAllister T. W., 1998, SEMIN CLIN NEUROPSYC, V3, P158; McNamara KCS, 2010, J NEUROTRAUM, V27, P695, DOI 10.1089/neu.2009.1237; Moretti L, 2012, LANCET NEUROL, V11, P1103, DOI 10.1016/S1474-4422(12)70226-0; Nagai T, 2012, J PHARMACOL SCI, V120, P213, DOI 10.1254/jphs.12142FP; Osborn AJ, 2016, NEUROPSYCHOLOGY, V30, P247, DOI 10.1037/neu0000221; Ozen LJ, 2015, AGING NEUROPSYCHOL C, V22, P517, DOI 10.1080/13825585.2014.993584; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; PORSOLT RD, 1979, BIOMEDICINE, V30, P139; PORSOLT RD, 1978, EUR J PHARMACOL, V47, P379, DOI 10.1016/0014-2999(78)90118-8; Prins ML, 1996, DEV BRAIN RES, V95, P272, DOI 10.1016/0165-3806(96)00098-3; Reger ML, 2012, BIOL PSYCHIAT, V71, P335, DOI 10.1016/j.biopsych.2011.11.007; Riggio S, 2009, MT SINAI J MED, V76, P163, DOI 10.1002/msj.20097; Rowe RK, 2014, SLEEP, V37, P743, DOI 10.5665/sleep.3582; Rowe RK, 2014, BRAIN INJURY, V28, P504, DOI 10.3109/02699052.2014.888768; Rowe RK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082507; Russell KL, 2011, J NEUROSCI METH, V199, P214, DOI 10.1016/j.jneumeth.2011.05.008; SCHNEIDER GE, 1979, NEUROPSYCHOLOGIA, V17, P557, DOI 10.1016/0028-3932(79)90033-2; Scholten A.C., 2016, J NEUROTRAUMA; Silver JM, 2009, AM J PSYCHIAT, V166, P653, DOI 10.1176/appi.ajp.2009.08111676; Soltani Z, 2015, PHYSIOL BEHAV, V152, P26, DOI 10.1016/j.physbeh.2015.08.037; Sun D, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00095; Taylor AN, 2006, J NEUROTRAUM, V23, P1802, DOI 10.1089/neu.2006.23.1802; Thomas S, 2000, ACT NEUR S, V76, P397; Thomas TC, 2012, J NEUROTRAUM, V29, P187, DOI 10.1089/neu.2011.2091; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Zhang RS, 2015, BRAIN RES, V1629, P210, DOI 10.1016/j.brainres.2015.10.028; Ziebell JM, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-247	57	18	18	0	10	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	0378-5866	1421-9859		DEV NEUROSCI-BASEL	Dev. Neurosci.		2016	38	3					195	205		10.1159/000446773			11	Developmental Biology; Neurosciences	Developmental Biology; Neurosciences & Neurology	DY7WK	WOS:000385339800004	27449121	Bronze			2021-06-18	
J	Shen, Q; Yin, Y; Xia, QJ; Lin, N; Wang, YC; Liu, J; Wang, HP; Lim, A; Wang, TH				Shen, Qin; Yin, Yong; Xia, Qing-Jie; Lin, Na; Wang, You-Cui; Liu, Jia; Wang, Hang-Ping; Lim, Apiradee; Wang, Ting-Hua			Bone Marrow Stromal Cells Promote Neuronal Restoration in Rats with Traumatic Brain Injury: Involvement of GDNF Regulating BAD and BAX Signaling	CELLULAR PHYSIOLOGY AND BIOCHEMISTRY			English	Article						Bone marrow stromal cells; Traumatic brain injury; Glial cell-line derived neurotrophic factor; BAX; BAD	MESENCHYMAL STEM-CELLS; SPINAL-CORD-INJURY; SCHWANN-CELLS; IN-VIVO; TRANSPLANTATION; BCL-2; APOPTOSIS; SURVIVAL; GENE; EXPRESSION	Background/Aims: To investigate the effects of bone marrow stromal cells (BMSCs) and underlying mechanisms in traumatic brain injury (TBI). Methods: Cultured BMSCs from green fluorescent protein-transgenic mice were isolated and confirmed. Cultured BMSCs were immediately transplanted into the regions surrounding the injured-brain site to test their function in rat models of TBI. Neurological function was evaluated by a modified neurological severity score on the day before, and on days 7 and 14 after transplantation. After 2 weeks of BMSC transplantation, the brain tissue was harvested and analyzed by microarray assay. And the coronal brain sections were determined by immunohistochemistry with mouse anti-growth-associated protein-43 kDa (anti-GAP-43) and anti-synaptophysin to test the effects of transplanted cells on the axonal regeneration in the host brain. Terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL) assay and Western blot were used to detect the apoptosis and expression of BAX and BAD. Results: Microarray analysis showed that BMSCs expressed growth factors such as glial cell-line derived neurotrophic factor (GDNF). The cells migrated around the injury sites in rats with TBI. BMSC grafts resulted in an increased number of GAP-43-immunopositive fibers and synaptophysin-positive varicosity, with suppressed apoptosis. Furthermore, BMSC transplantation significantly downregulated the expression of BAX and BAD signaling. Moreover, cultured BMSC transplantation significantly improved rat neurological function and survival. Conclusion: Transplanted BMSCs could survive and improve neuronal behavior in rats with TBI. Mechanisms of neuroprotection and regeneration were involved, which could be associated with the GDNF regulating the apoptosis signals through BAX and BAD. (C) 2016 The Author(s) Published by S. Karger AG, Basel	[Shen, Qin; Lin, Na; Liu, Jia; Wang, Ting-Hua] Kunming Med Univ, Inst Neurosci, Fac Basic Med, Kunming 650031, Peoples R China; [Yin, Yong] Kunming Med Univ, Affiliated Hosp 4, Dept Rehabil, Kunming 650031, Peoples R China; [Xia, Qing-Jie; Wang, You-Cui; Wang, Ting-Hua] Sichuan Univ, West China Hosp, Translat Neurosci Ctr, Inst Neurobiol Dis, Chengdu 610064, Peoples R China; [Xia, Qing-Jie; Wang, You-Cui; Wang, Ting-Hua] Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Chengdu 610064, Peoples R China; [Wang, Hang-Ping; Wang, Ting-Hua] Yun Nan Normal Univ, Sch Sports, Kunming, Peoples R China; [Lim, Apiradee] Prince Songkla Univ, Fac Sci & Technol, Pattani Campus, Hat Yai 646400, Thailand	Wang, TH (corresponding author), Kunming Med Univ, Inst Neurosci, Fac Basic Med, Kunming 650031, Peoples R China.; Lim, A (corresponding author), Prince Songkla Univ, Fac Sci & Technol, Pattani Campus, Hat Yai 646400, Thailand.	api_45@hotmail.com; tinghuawang263@sina.com			Natural Science Fund of Yunnan ProvinceNatural Science Foundation of Yunnan Province [2010ZC109]; China Nation Science Foundation [81271358, 81070991, 81260191]; Key Natural Science Fund of Yunnan Province [2012ZC107]	This study was supported by the Natural Science Fund of Yunnan Province (No. 2010ZC109) by a grant from the China Nation Science Foundation (No. 81271358, 81070991, and 81260191) and the Key Natural Science Fund of Yunnan Province (No. 2012ZC107).	Amaranath JE, 2014, ANZ J SURG, V84, P424, DOI 10.1111/ans.12445; Bader AM, 2014, CELL PHYSIOL BIOCHEM, V34, P646, DOI 10.1159/000363030; Ban DX, 2011, REGEN MED, V6, P707, DOI [10.2217/rme.11.32, 10.2217/RME.11.32]; BOISE LH, 1993, CELL, V74, P597, DOI 10.1016/0092-8674(93)90508-N; Boxall SA, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/975871; Chadbunchachai Witaya, 2012, J Med Assoc Thai, V95 Suppl 7, pS274; Chang YQ, 2014, CELL PHYSIOL BIOCHEM, V34, P703, DOI 10.1159/000363035; CharriautMarlangue C, 1995, NEUROREPORT, V7, P61, DOI 10.1097/00001756-199512000-00014; Chen CJ, 2007, EXP NEUROL, V204, P443, DOI 10.1016/j.expneurol.2006.12.004; Cheng EHY, 1996, NATURE, V379, P554, DOI 10.1038/379554a0; Ding P, 2014, AM J TRANSL RES, V6, P224; Fairless R, 2005, INT J BIOCHEM CELL B, V37, P693, DOI 10.1016/j.biocel.2004.10.010; FARROW SN, 1995, NATURE, V374, P731, DOI 10.1038/374731a0; Gao Q, 2005, NEUROSCIENCE, V136, P123, DOI 10.1016/j.neuroscience.2005.06.091; Gu WD, 2012, NEUROL RES, V34, P172, DOI 10.1179/1743132811Y.0000000068; Gu WD, 2010, NEUROPATHOLOGY, V30, P205, DOI 10.1111/j.1440-1789.2009.01063.x; Guo X, 2010, ONCOGENE, V29, P3908, DOI 10.1038/onc.2010.143; Harting MT, 2009, J SURG RES, V153, P188, DOI 10.1016/j.jss.2008.03.037; Hirjak D, 2013, NEUROPSYCHOBIOLOGY, V68, P91, DOI 10.1159/000350999; Jiang YF, 2011, NEUROL RES, V33, P331, DOI 10.1179/016164110X12816242542571; Kanelos SK, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199812000-00003; Kernie SG, 2001, J NEUROSCI RES, V66, P317, DOI 10.1002/jnr.10013; KORSMEYER SJ, 1992, BLOOD, V80, P879; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Loncarevic-Vasiljkovic N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037215; Lukashyk SP, 2014, J CLIN TRANSL HEPATO, V2, P217, DOI 10.14218/JCTH.2014.00027; Mahmood A, 2001, J NEUROSURG, V94, P589, DOI 10.3171/jns.2001.94.4.0589; Naghdi Majid, 2009, Iranian Biomedical Journal, V13, P117; Nojiri Yukiko, 2008, J Med Dent Sci, V55, P121; OLTVAI ZN, 1994, CELL, V79, P189, DOI 10.1016/0092-8674(94)90188-0; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; Osanai T, 2012, NEUROSURGERY, V70, P435, DOI 10.1227/NEU.0b013e318230a795; Patel TD, 2003, NEURON, V38, P403, DOI 10.1016/S0896-6273(03)00261-7; REED JC, 1994, J CELL BIOL, V124, P1, DOI 10.1083/jcb.124.1.1; Sandner B, 2016, CELL TRANSPLANT, V25, P125, DOI 10.3727/096368915X687679; SCHADEN H, 1994, J NEUROBIOL, V25, P1570, DOI 10.1002/neu.480251209; Schwab ME, 2002, SCIENCE, V295, P1029, DOI 10.1126/science.1067840; SENTMAN CL, 1991, CELL, V67, P879, DOI 10.1016/0092-8674(91)90361-2; Shen LH, 2010, GLIA, V58, P1074, DOI 10.1002/glia.20988; Shichinohe H, 2015, NEUROREHAB NEURAL RE, V29, P80, DOI 10.1177/1545968314525856; Shintani A, 2007, BRAIN RES, V1186, P48, DOI 10.1016/j.brainres.2007.09.086; Sun Y, 2015, CELL PHYSIOL BIOCHEM, V36, P1331, DOI 10.1159/000430300; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; Wu X, 2008, J TRAUMA, V64, P1313, DOI 10.1097/TA.0b013e318165c803; Yang L, 2015, CELL PHYSIOL BIOCHEM, V37, P2171, DOI 10.1159/000438574	45	18	21	0	15	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1015-8987	1421-9778		CELL PHYSIOL BIOCHEM	Cell. Physiol. Biochem.		2016	38	2					748	762		10.1159/000443031			15	Cell Biology; Physiology	Cell Biology; Physiology	DF1ER	WOS:000371082300025	26871686	DOAJ Gold			2021-06-18	
J	Sullivan, KA; Berndt, SL; Edmed, SL; Smith, SS; Allan, AC				Sullivan, Karen A.; Berndt, Sara L.; Edmed, Shannon L.; Smith, Simon S.; Allan, Alicia C.			Poor sleep predicts subacute postconcussion symptoms following mild traumatic brain injury	APPLIED NEUROPSYCHOLOGY-ADULT			English	Article						Concussion; insomnia; mild traumatic brain injury; postconcussion symptoms; sleep	RANDOMIZED CONTROLLED-TRIALS; POST-CONCUSSION SYNDROME; DISTURBANCE; INSOMNIA; METAANALYSIS; POPULATION; COMPLAINTS; QUALITY; TBI; DISABILITY	The primary objective was to determine if poor sleep predicts postconcussion symptoms in the subacute period after mild traumatic brain injury (TBI). The impact of poor sleep pre- and post-injury was examined. The research design was cross-sectional. After screening to detect response invalidity, 61 individuals with a self-reported history of mild TBI 1-to-6 months prior answered an online fixed order battery of standardized questionnaires assessing their sleep (current and preinjury) and persistent postconcussion symptoms (Neurobehavioral Symptom Inventory, minus sleep, and fatigue items). The sleep measures were the Insomnia Severity Index, Epworth Sleepiness Scale, a single Likert-scale pre-injury sleep quality rating, and two PROMIS measures (sleep-related impairment and sleep disturbance). After controlling for the effects of preinjury sleep quality and demographics, the combination of the sleep measures made a significant contribution to the outcome (F[8,58]=4.013, p=.001, ). Only current sleep-related impairment (ss=.60, p<.05) made a significant and unique contribution to neurobehavioral symptoms. Preinjury sleep was not a predictor (ss=-.19, p>.05), although it contributed 3% of the variance in NSI scores after controlling for demographics. Sleep-related impairment is a modifiable factor. As a significant contributor to neurobehavioral symptoms, treatment for post-injury sleep-related impairment warrants further attention.	[Sullivan, Karen A.; Berndt, Sara L.; Edmed, Shannon L.; Smith, Simon S.; Allan, Alicia C.] Queensland Univ Technol, Sch Psychol & Counseling, Brisbane, Qld, Australia; [Sullivan, Karen A.; Edmed, Shannon L.; Smith, Simon S.; Allan, Alicia C.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld, Australia; [Smith, Simon S.; Allan, Alicia C.] Queensland Univ Technol, Ctr Accid Res & Rd Safety, Brisbane, Qld, Australia; [Smith, Simon S.] Queensland Univ Technol, CCHR, Brisbane, Qld, Australia	Sullivan, KA (corresponding author), Queensland Univ Technol, O Block B Wing,Kelvin Grove Campus,Victoria Pk Rd, Kelvin Grove, Qld 4059, Australia.	karen.sullivan@qut.edu.au	Smith, Simon/P-1859-2017	Smith, Simon/0000-0002-0362-9045; Berndt, Sara/0000-0002-6844-2775			Allan AC, 2017, J HEAD TRAUMA REHAB, V32, pE35, DOI 10.1097/HTR.0000000000000222; Ayalon L, 2007, NEUROLOGY, V68, P1136, DOI 10.1212/01.wnl.0000258672.52836.30; Baumann CR, 2007, BRAIN, V130, P1873, DOI 10.1093/brain/awm109; Belanger HG, 2013, CLIN NEUROPSYCHOL, V27, P159, DOI 10.1080/13854046.2012.758780; Broshek DK, 2015, BRAIN INJURY, V29, P228, DOI 10.3109/02699052.2014.974674; Cancelliere Carol, 2014, Arch Phys Med Rehabil, V95, pS201, DOI 10.1016/j.apmr.2013.10.010; Caplan LJ, 2010, J HEAD TRAUMA REHAB, V25, P447, DOI 10.1097/HTR.0b013e3181d5bdbd; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Coronado VG, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P84; Ettenhofer ML, 2013, J INT NEUROPSYCH SOC, V19, P977, DOI 10.1017/S1355617713000763; Field A., 2013, DISCOVERING STAT USI, V4; Fogelberg DJ, 2012, ARCH PHYS MED REHAB, V93, P1313, DOI 10.1016/j.apmr.2012.04.031; Gilbert KS, 2015, CLIN PSYCHOL REV, V40, P195, DOI 10.1016/j.cpr.2015.05.008; Gosselin N, 2009, SLEEP MED, V10, P35, DOI 10.1016/j.sleep.2007.11.023; JOHNS MW, 1992, SLEEP, V15, P376, DOI 10.1093/sleep/15.4.376; Johns MW, 2000, J SLEEP RES, V9, P5, DOI 10.1046/j.1365-2869.2000.00177.x; Johnson JA, 2016, SLEEP MED REV, V27, P20, DOI 10.1016/j.smrv.2015.07.001; Khoury S, 2013, J NEUROTRAUM, V30, P633, DOI 10.1089/neu.2012.2519; King PR, 2012, J REHABIL RES DEV, V49, P879, DOI 10.1682/JRRD.2011.03.0051; Lange RT, 2013, J NEUROTRAUM, V30, P958, DOI 10.1089/neu.2012.2743; Lu W, 2015, BRAIN INJURY, V29, P1342, DOI 10.3109/02699052.2015.1043947; Makley MJ, 2009, NEUROREHAB NEURAL RE, V23, P320, DOI 10.1177/1545968308325268; Manber R, 2012, J CLIN SLEEP MED, V8, P209, DOI 10.5664/jcsm.1786; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Meterko M, 2012, J HEAD TRAUMA REHAB, V27, P55, DOI 10.1097/HTR.0b013e318230fb17; Mollayeva T, 2016, SLEEP MED, V20, P157, DOI 10.1016/j.sleep.2015.09.008; Morin CM, 2011, SLEEP, V34, P601, DOI 10.1093/sleep/34.5.601; Morin CM., 1993, INSOMNIA PSYCHOL ASS; Naughton F, 2007, PAIN, V127, P243, DOI 10.1016/j.pain.2006.08.019; Oppenheimer DM, 2009, J EXP SOC PSYCHOL, V45, P867, DOI 10.1016/j.jesp.2009.03.009; Orff HJ, 2009, J HEAD TRAUMA REHAB, V24, P155, DOI 10.1097/HTR.0b013e3181a0b281; Ouellet MC, 2006, J HEAD TRAUMA REHAB, V21, P199, DOI 10.1097/00001199-200605000-00001; Parcell DL, 2006, ARCH PHYS MED REHAB, V87, P278, DOI 10.1016/j.apmr.2005.10.024; Ponsford JL, 2014, PSYCHIAT CLIN N AM, V37, P77, DOI 10.1016/j.psc.2013.10.001; Rao V, 2011, J NEUROPSYCH CLIN N, V23, P201, DOI 10.1176/appi.neuropsych.23.2.201; Salmi L Rachid, 2014, Arch Phys Med Rehabil, V95, pS95, DOI 10.1016/j.apmr.2013.10.026; Salo P, 2010, SLEEP, V33, P1323, DOI 10.1093/sleep/33.10.1323; Schmidt AT, 2015, COGN BEHAV NEUROL, V28, P53, DOI 10.1097/WNN.0000000000000056; Schreiber S, 2008, SLEEP MED, V9, P481, DOI 10.1016/j.sleep.2007.04.014; Shekleton JA, 2010, NEUROLOGY, V74, P1732, DOI 10.1212/WNL.0b013e3181e0438b; Silver JM, 2014, PSYCHIAT CLIN N AM, V37, P91, DOI 10.1016/j.psc.2013.11.001; Silverberg ND, 2011, NEUROREHABILITATION, V29, P317, DOI 10.3233/NRE-2011-0708; Soble JR, 2014, CLIN NEUROPSYCHOL, V28, P614, DOI 10.1080/13854046.2014.894576; Sullivan KA, 2015, J NEUROTRAUM, V32, P474, DOI 10.1089/neu.2013.3284; Tang NKY, 2015, SLEEP, V38, P1751, DOI 10.5665/sleep.5158; Te Ao B, 2014, NEUROLOGY, V83, P1645, DOI 10.1212/WNL.0000000000000933; Theadom A, 2015, SLEEP MED, V16, P926, DOI 10.1016/j.sleep.2015.04.013; Towns SJ, 2015, BRAIN INJURY, V29, P1337, DOI 10.3109/02699052.2015.1045030; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Williams BR, 2008, CLIN NEUROPHYSIOL, V119, P429, DOI 10.1016/j.clinph.2007.11.003	53	18	18	0	8	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2327-9095	2327-9109		APPL NEUROPSYCH-ADUL	Appl. Neuropsychol.-Adult		2016	23	6					426	435		10.1080/23279095.2016.1172229			10	Clinical Neurology; Psychology	Neurosciences & Neurology; Psychology	DX6XV	WOS:000384530300006	27183274				2021-06-18	
J	Theadom, A; Starkey, N; Jones, K; Cropley, M; Parmar, P; Barker-Collo, S; Feigin, VL				Theadom, Alice; Starkey, Nicola; Jones, Kelly; Cropley, Mark; Parmar, Priya; Barker-Collo, Suzanne; Feigin, Valery L.			Sleep difficulties and their impact on recovery following mild traumatic brain injury in children	BRAIN INJURY			English	Article						Epidemiology; traumatic brain injury; sleep; longitudinal; children	HEAD-INJURY; DISORDERS; OUTCOMES; DISTURBANCES; INTERVENTION; ADOLESCENTS; PREVALENCE; SYMPTOMS; QUALITY	Objective: To determine the frequency of sleep difficulties in children following mild traumatic brain injury (TBI) over time and explore the role of sleep on recovery and behaviour.Methods: Longitudinal study of 109 children aged between 8-16 years who had experienced a mild TBI, with an embedded case control study. Parents completed assessments of the child's sleep quality, symptoms and behaviour at baseline, 1, 6 and 12 months post-injury. Regression analyses explored the impact of poor sleep on 12-month outcomes. Healthy control children were assessed at one time point for comparison to determine the longer-term impact of brain injury on sleep.Results: The number of children experiencing poor sleep quality peaked 1-month post-injury (39%), reducing to 28% 12-months post-injury. Poor sleep quality at 1-month was associated with increased frequency and severity of symptoms and poorer behavioural outcomes 1 year post-TBI. Cases with TBI were significantly more likely to have sleep difficulties 1-year post-injury than controls (Odds ratio = 3.09).Conclusions: Sleep difficulties are common following mild TBI in children and are predictive of longer-term outcomes. Identifying children with sleep difficulties post-injury and providing support to facilitate sleep may improve their longer-term functioning.	[Theadom, Alice; Jones, Kelly; Parmar, Priya; Feigin, Valery L.] Auckland Univ Technol, Natl Inst Stroke & Appl Neurosci, Auckland, New Zealand; [Starkey, Nicola] Univ Waikato, Sch Psychol, Hamilton, New Zealand; [Cropley, Mark] Univ Surrey, Sch Psychol, Surrey, England; [Barker-Collo, Suzanne] Univ Auckland, Sch Psychol, Auckland, New Zealand	Theadom, A (corresponding author), Auckland Univ Technol, Natl Inst Stroke & Appl Neurosci, Fac Hlth & Environm Studies, AA254C,90 Akoranga Dr,Northcote 0627, Auckland 1142, New Zealand.	alice.theadom@aut.ac.nz	Starkey, Nicola/AAJ-3795-2020; Jones, Kelly/I-5199-2019; Feigin, Valery/AAF-2313-2019; Cropley, Mark/V-2296-2019	Starkey, Nicola/0000-0002-4370-8186; Feigin, Valery L./0000-0002-6372-1740; Parmar, Priya/0000-0001-6001-9326	Health Research Council of New ZealandHealth Research Council of New Zealand [09/063A, 11/192]; ABI Management Rehabilitation	This work was funded by the Health Research Council of New Zealand (09/063A, 11/192). Alice Theadom was co-funded by ABI Management Rehabilitation and Kathryn McPherson held the Laura Fergusson Trust Chair. The authors report no conflicts of interest.	Beebe DW, 2007, J PEDIATR PSYCHOL, V32, P845, DOI 10.1093/jpepsy/jsm003; Bloom DR, 2001, J AM ACAD CHILD PSY, V40, P572, DOI 10.1097/00004583-200105000-00017; Buxton OM, 2015, SLEEP HEALTH, V1, P15, DOI 10.1016/j.sleh.2014.12.002; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Catroppa C, 2009, FUTUR NEUROL, V4, P811, DOI 10.2217/FNL.09.52; Crowe LM, 2012, PEDIATRICS, V129, pE262, DOI 10.1542/peds.2011-0438; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Gagner C, 2015, J NEUROTRAUM, V32, P1539, DOI 10.1089/neu.2014.3753; Gregory AM, 2012, SLEEP MED REV, V16, P129, DOI 10.1016/j.smrv.2011.03.007; Hiscock H, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h68; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; Matricciani L, 2013, SLEEP, V36, P527, DOI 10.5665/sleep.2538; Mindell Jodi A, 2003, J Pediatr Health Care, V17, P324, DOI 10.1016/S0891-5245(03)00215-3; Ouellet MC, 2004, NEUROREHAB NEURAL RE, V18, P187, DOI 10.1177/1545968304271405; Paavonen EJ, 2015, BEHAV SLEEP MED, V17, P1; Pillar G, 2003, PEDIATR NEUROL, V29, P131, DOI 10.1016/S0887-8994(03)00149-8; Ponsford JL, 2013, NEUROREHAB NEURAL RE, V27, P613, DOI 10.1177/1545968313481283; Reynolds C.R., 2004, BEHAV ASSESSMENT SYS; Shay N, 2014, J NEUROTRAUM, V31, P1305, DOI 10.1089/neu.2013.3275; Stores G, 2013, DEV MED CHILD NEUROL, V55, P797, DOI 10.1111/dmcn.12163; Tan E, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-189; Tham SW, 2012, J NEUROTRAUM, V29, P154, DOI 10.1089/neu.2011.2126; Theadom A, 2012, NEUROEPIDEMIOLOGY, V38, P18, DOI 10.1159/000334746; Ucer O, 2014, WORLD J UROL, V32, P239, DOI 10.1007/s00345-013-1193-1; Werner H, 2015, J CLIN SLEEP MED, V11, P241, DOI 10.5664/jcsm.4536; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	28	18	18	0	4	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2016	30	10					1243	1248		10.1080/02699052.2016.1183171			6	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	DX4BR	WOS:000384324300012	27391449				2021-06-18	
J	Truong, JQ; Ciuffreda, KJ				Truong, James Q.; Ciuffreda, Kenneth J.			Comparison of pupillary dynamics to light in the mild traumatic brain injury (mTBI) and normal populations	BRAIN INJURY			English	Article						Mild traumatic brain injury (mTBI); pupillometry; pupil light reflex; visual biomarker; parasympathetic system; sympathetic system		Purpose: To determine if mTBI adversely affects the pupillary light reflex (PLR).Methods: The PLR was evaluated in mTBI and compared to normal individuals under a range of test conditions. Nine pupil parameters (maximum, minimum and final pupil diameter, latency, amplitude and peak and average constriction and dilation velocities) and six stimulus conditions (dim pulse, dim step, bright pulse, bright step, bright red step and bright blue step) were assessed in 32 adults with mTBI (21-60 years of age) and compared to 40 normal (22-56 years of age). The Neuroptics, infrared, DP-2000 binocular pupillometer was used (30 Hz sampling rate; 0.05 mm resolution) with binocular stimulation and recording.Results: Different test conditions allowed for discrimination of different parameters. For any of the given six test conditions, five-to-eight of the nine pupillary parameters were statistically different (p < 0.05) between the two diagnostic groups. The most promising parameters for diagnostic differentiation were constriction latency, all pupillary diameters, average constriction velocity and peak dilation velocity.Conclusions: MTBI adversely affects the PLR. This suggests an impairment of the autonomic nervous system. The findings suggest the potential for quantitative pupillary dynamics to serve as an objective mTBI biomarker.	[Truong, James Q.; Ciuffreda, Kenneth J.] SUNY Coll Optometry, Dept Biol & Vis Sci, 33 West 42nd St, New York, NY 10036 USA	Truong, JQ (corresponding author), SUNY Coll Optometry, Dept Biol & Vis Sci, 33 West 42nd St, New York, NY 10036 USA.	james.q.truong@gmail.com					ALPERN M, 1963, J GEN PHYSIOL, V47, P265, DOI 10.1085/jgp.47.2.265; Bremner FD., 2011, INVEST OPHTHALMOL, V53, P7343; Brown C. E, 1998, APPL MULTIVARIATE ST, P155, DOI [10.1007/978-3-642-80328-4, DOI 10.1007/978-3-642-80328-4_13]; Capo-Aponte JE., 2013, J SPINE S, V4, P1; Capo-Aponte JE, 2012, MIL MED, V177, P804, DOI 10.7205/MILMED-D-12-00061; Ciuffreda K., 1991, AMBLYOPIA BASIC CLIN; Ciuffreda Kenneth J, 2007, Optometry, V78, P155, DOI 10.1016/j.optm.2006.11.011; Ciuffreda KJ, 2014, MIL MED, V179, P1212, DOI 10.7205/MILMED-D-14-00059; Ciuffreda KJ, 1995, EYE MOVEMENT BASICS; Du T, 2005, BRAIN INJURY, V19, P1125, DOI 10.1080/02699050500149817; Duke-Elder S., 1965, SYSTEM OPHTHALMOLOGY; ELLIS CJK, 1981, BRIT J OPHTHALMOL, V65, P754, DOI 10.1136/bjo.65.11.754; Goodman B, 2013, NEUROLOGY, V80, P265; Green D., 1966, SIGNAL DETECTION THE; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; Hellerstein L F, 1995, J Am Optom Assoc, V66, P634; HUNG GK, 1988, OPHTHAL PHYSL OPT, V8, P327, DOI 10.1111/j.1475-1313.1988.tb01062.x; Kapoor Neera, 2002, Curr Treat Options Neurol, V4, P271, DOI 10.1007/s11940-002-0027-z; Kardon R, 2011, ADLERS PHYSL EYE, P502; Kushner D, 1998, ARCH INTERN MED, V158, P1617, DOI 10.1001/archinte.158.15.1617; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Loewenfeld I.E., 1993, PUPIL ANATOMY PHYSL; Marcum JI., 1947, STAT THEORY TARGET D; MARGULIES SS, 1990, J BIOMECH, V23, P823, DOI 10.1016/0021-9290(90)90029-3; METZ CE, 1978, SEMIN NUCL MED, V8, P283, DOI 10.1016/S0001-2998(78)80014-2; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Orr JB, 2015, OPTOMETRY VISION SCI, V92, P834, DOI 10.1097/OPX.0000000000000627; Park JC, 2011, INVEST OPHTH VIS SCI, V52, P6624, DOI 10.1167/iovs.11-7586; SEMMLOW JL, 1986, INVEST OPHTH VIS SCI, V27, P558; Stark Lawrence, 1968, NEUROLOGICAL CONTROL; Suchoff IB, 2001, VISUAL VESTIBULAR CO; TEASDALE G, 1974, LANCET, V2, P81; Thiagarajan P, 2015, BRAIN INJURY, V29, P1420, DOI 10.3109/02699052.2015.1045029; VA/DoD, 2009, CLIN PRACT GUID MAN, P7; Von Noorden GK, 1967, ATLAS OF STRABISMUS; Zasler ND, 2012, BRAIN INJURY MED PRI; Zinn KM, 1972, THE PUPIL	37	18	18	1	7	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2016	30	11					1378	1389		10.1080/02699052.2016.1195922			12	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	DZ8TP	WOS:000386144900011	27541745				2021-06-18	
J	Riganello, F; Cortese, MD; Arcuri, F; Quintieri, M; Dolce, G				Riganello, Francesco; Cortese, Maria D.; Arcuri, Francesco; Quintieri, Maria; Dolce, Giuliano			How Can Music Influence the Autonomic Nervous System Response in Patients with Severe Disorder of Consciousness?	FRONTIERS IN NEUROSCIENCE			English	Article						disorder of consciousness; vegetative state; autonomic nervous system; central autonomic network; heart rate variability; music therapy; entropy	HEART-RATE-VARIABILITY; TRAUMATIC BRAIN-INJURY; TIME-SERIES ANALYSIS; ARTIFICIAL-INTELLIGENCE; AUDITORY-STIMULATION; APPROXIMATE ENTROPY; NONPARAMETRIC-TESTS; RATE COMPLEXITY; CARE-UNIT; THERAPY	Activations to pleasant and unpleasant musical stimuli were observed within an extensive neuronal network and different brain structures, as well as in the processing of the syntactic and semantic aspects of the music. Previous studies evidenced a correlation between autonomic activity and emotion evoked by music listening in patients with Disorders of Consciousness (DoC). In this study, we analyzed retrospectively the autonomic response to musical stimuli by mean of normalized units of Low Frequency (nuLF) and Sample Entropy (SampEn) of Heart Rate Variability (HRV) parameters, and their possible correlation to the different complexity of four musical samples (i.e., Mussorgsky, Tchaikovsky, Grieg, and Boccherini) in Healthy subjects and Vegetative State/Unresponsive Wakefulness Syndrome (VS/UWS) patients. The complexity of musical sample was based on Formal Complexity and General Dynamics parameters defined by Imberty's semiology studies. The results showed a significant difference between the two groups for SampEn during the listening of Mussorgsky's music and for nuLF during the listening of Boccherini and Mussorgsky's music. Moreover, the VS/UWS group showed a reduction of nuLF as well as SampEn comparing music of increasing Formal Complexity and General Dynamics. These results put in evidence how the internal structure of the music can change the autonomic response in patients with DoC. Further investigations are required to better comprehend how musical stimulation can modify the autonomic response in DoC patients, in order to administer the stimuli in a more effective way.	[Riganello, Francesco; Cortese, Maria D.; Arcuri, Francesco; Quintieri, Maria; Dolce, Giuliano] Ist S Anna, Res Adv Neurorehabil, Crotone, Italy	Riganello, F (corresponding author), Ist S Anna, Res Adv Neurorehabil, Crotone, Italy.	f.riganello@istitutosantanna.it	Riganello, Francesco/N-2615-2014; Riganello, Francesco/AAC-3976-2020; Arcuri, Francesco/AAB-8718-2019	Riganello, Francesco/0000-0003-0678-9252; Riganello, Francesco/0000-0003-0678-9252; Arcuri, Francesco/0000-0002-7104-6378			Aboy M, 2007, P ANN INT IEEE EMBS, P5943; [Anonymous], 2001, B WORLD HEALTH ORGAN, V79, P373; Batchinsky AI, 2009, SHOCK, V32, P565, DOI 10.1097/SHK.0b013e3181a993dc; Behne K.-E., 1986, HORERTYPOLOGIEN PSYC; BENARROCH EE, 1993, MAYO CLIN PROC, V68, P988, DOI 10.1016/S0025-6196(12)62272-1; Bernardi L, 2006, HEART, V92, P445, DOI 10.1136/hrt.2005.064600; Biswas AK, 2000, CRIT CARE MED, V28, P3907, DOI 10.1097/00003246-200012000-00030; Burr RL, 2007, SLEEP, V30, P913, DOI 10.1093/sleep/30.7.913; Camm AJ, 1996, EUR HEART J, V17, P354; Cancio LC, 2008, J TRAUMA, V65, P813, DOI 10.1097/TA.0b013e3181848241; Crozier BJ, 1974, STUDIES NEW EXPT AES, P27; da Silva Sheila Ap F, 2014, Int Arch Med, V7, P27, DOI 10.1186/1755-7682-7-27; Dube L, 2003, COGNITION EMOTION, V17, P263, DOI 10.1080/02699930302295; Ellis R. J., 2009, THESIS; Ellis RJ, 2010, MUSIC PERCEPT, V27, P317, DOI 10.1525/MP.2010.27.4.317; Etzel JA, 2006, INT J PSYCHOPHYSIOL, V61, P57, DOI 10.1016/j.ijpsycho.2005.10.025; Fukumoto M, 2010, INT J BIOMETRICS, V2, P124, DOI 10.1504/IJBM.2010.031792; Gabrielsson A, 2001, MUSIC SCI, V5, P123, DOI 10.1177/10298649020050S105; Giacino JT, 2005, NEUROPSYCHOL REHABIL, V15, P166, DOI 10.1080/09602010443000498; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Gibbons J.D., 2011, INT ENCY STAT SCI, P977, DOI DOI 10.1007/978-3-642-04898-2_420; Goldstein B, 1996, CRIT CARE MED, V24, P234, DOI 10.1097/00003246-199602000-00009; Gomez P, 2007, EMOTION, V7, P377, DOI 10.1037/1528-3542.7.2.377; GUZZETTA CE, 1989, HEART LUNG, V18, P609; Hainsworth R, 1995, HEART RATE VARIABILI, P3; Hajizadeh S., 2015, Applied Medical Informatics, V37, P11; Hanser SB, 2014, CARDIOL REV, V22, P37, DOI 10.1097/CRD.0b013e318291c5fc; Harrer G, 1968, Wien Med Wochenschr, V118, P966; Hemphill JF, 2003, AM PSYCHOL, V58, P78, DOI 10.1037/0003-066X.58.1.78; Hodges D. A., 1980, HDB MUSIC PSYCHOL; Holbrook M. B., 1990, PSYCHOL MUSIC, V18, P150, DOI [10.1177/0305735690182004., DOI 10.1177/0305735690182004]; Imberty M, 1997, MUSIC SCI, V1, P33; Imberty M., 1976, SIGNIFICATION MEANIN; Iwanaga M, 2005, BIOL PSYCHOL, V70, P61, DOI 10.1016/j.biopsycho.2004.11.015; Juslin P., 2010, HDB MUSIC EMOTION TH; Juslin P. N., 1996, PSYCHOL MUSIC, V24, P68, DOI [10.1177/0305735696241007, DOI 10.1177/0305735696241007]; Juslin PN, 2000, J EXP PSYCHOL HUMAN, V26, P1797, DOI 10.1037//0096-1523.26.6.1797; Juslin PN, 1997, MUSIC PERCEPT, V14, P383; KAPLAN DT, 1991, BIOPHYS J, V59, P945, DOI 10.1016/S0006-3495(91)82309-8; Kawashima T, 2005, ANAT EMBRYOL, V209, P425, DOI 10.1007/s00429-005-0462-1; Kemper KJ, 2008, PEDIATR RES, V64, P105, DOI 10.1203/PDR.0b013e318174e6fb; Keren O, 2005, BRAIN INJURY, V19, P605, DOI 10.1080/02699050400024946; Khalfa S, 2008, INT J PSYCHOPHYSIOL, V68, P17, DOI 10.1016/j.ijpsycho.2007.12.001; Khandoker AH, 2009, BIOMED ENG ONLINE, V8, DOI 10.1186/1475-925X-8-3; Koelsch S, 2006, HUM BRAIN MAPP, V27, P239, DOI 10.1002/hbm.20180; Koelsch S, 2005, CURR OPIN NEUROBIOL, V15, P207, DOI 10.1016/j.conb.2005.03.005; Lane RD, 2009, NEUROIMAGE, V44, P213, DOI 10.1016/j.neuroimage.2008.07.056; Lee YC, 2011, IEEE ENG MED BIO, P1701, DOI 10.1109/IEMBS.2011.6090488; Magee WL, 2005, NEUROPSYCHOL REHABIL, V15, P522, DOI 10.1080/09602010443000461; Malliani A, 1999, NEWS PHYSIOL SCI, V14, P111; Meyer LB, 2008, EMOTION MEANING MUSI; Montano N, 2009, NEUROSCI BIOBEHAV R, V33, P71, DOI 10.1016/j.neubiorev.2008.07.006; Mukherjee S., 2015, CHAOS COMPLEXITY LEA, P243; Mundry R, 1998, ANIM BEHAV, V56, P256, DOI 10.1006/anbe.1998.0756; Napadow V, 2008, NEUROIMAGE, V42, P169, DOI 10.1016/j.neuroimage.2008.04.238; Niskanen JP, 2004, COMPUT METH PROG BIO, V76, P73, DOI 10.1016/j.cmpb.2004.03.004; Norris PR, 2006, ANN SURG, V243, P804, DOI 10.1097/01.sla.0000219642.92637.fd; O'Kelly J, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00884; O'Kelly J, 2013, NORD J MUSIC THER, V22, P93, DOI 10.1080/08098131.2012.709269; Ockelford A., 2008, REVIEWARTICLE D HURO, P476, DOI DOI 10.1177/0305735608094506; Okada K, 2009, INT HEART J, V50, P95, DOI 10.1536/ihj.50.95; Okumura Y, 2014, BRAIN INJURY, V28, P944, DOI 10.3109/02699052.2014.888477; Orini M, 2010, MED BIOL ENG COMPUT, V48, P423, DOI 10.1007/s11517-010-0592-3; Papaioannou V, 2008, J CRIT CARE, V23, P380, DOI 10.1016/j.jcrc.2007.04.006; Papaioannou VE, 2006, J CRIT CARE, V21, P95, DOI 10.1016/j.jcrc.2005.12.007; Perez-Lloret S, 2014, NOISE HEALTH, V16, P279, DOI 10.4103/1463-1741.140507; Perrin F, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01102; PINCUS SM, 1994, AM J PHYSIOL, V266, pH1643, DOI 10.1152/ajpheart.1994.266.4.H1643; Porta A, 2000, MED BIOL ENG COMPUT, V38, P180, DOI 10.1007/BF02344774; Rapenne T, 2001, J NEUROSURG ANESTH, V13, P260, DOI 10.1097/00008506-200107000-00016; Rauhe H., 1975, BEDINGUNGSZUSAMMENHA, V1975, P137; Richman JS, 2000, AM J PHYSIOL-HEART C, V278, pH2039; Riganello F, 2010, J PSYCHOPHYSIOL, V24, P112, DOI 10.1027/0269-8803/a000021; Riganello F, 2010, CLIN NEUROPHYSIOL, V121, P2024, DOI 10.1016/j.clinph.2010.05.010; Riganello F, 2008, J PSYCHOPHYSIOL, V22, P166, DOI 10.1027/0269-8803.22.4.166; Riganello F., 2014, EXP CLIN CARDIOL, V20, P5584; Riganello F, 2012, J PSYCHOPHYSIOL, V26, P178, DOI 10.1027/0269-8803/a000080; Riganello F, 2012, J REHABIL MED, V44, P495, DOI 10.2340/16501977-0975; Riordan WP, 2009, J SURG RES, V156, P283, DOI 10.1016/j.jss.2009.03.086; Roque AL, 2013, CLINICS, V68, P960, DOI 10.6061/clinics/2013(07)12; Roque AL, 2013, NOISE HEALTH, V15, P281, DOI 10.4103/1463-1741.113527; ROSENTHAL R, 1991, AM PSYCHOL, V46, P1086, DOI 10.1037/0003-066X.46.10.1086; Rosing H, 1985, MUSIK, V1985, P39; Ryan ML, 2011, ANESTHESIOL RES PRAC, V2011, DOI 10.1155/2011/416590; Scherlag BJ, 2006, CURR OPIN CARDIOL, V21, P51, DOI 10.1097/01.hco.0000198980.40390.e4; Siegel S., 1956, NONPARAMETRIC STAT B; SMITH JD, 1990, COGNITION, V34, P279, DOI 10.1016/0010-0277(90)90007-7; Spyer KM, 2009, PHILOS T R SOC B, V364, P2603, DOI 10.1098/rstb.2009.0082; Tanizaki H, 1997, J APPL STAT, V24, P603, DOI 10.1080/02664769723576; Tarvainen MP, 2014, COMPUT METH PROG BIO, V113, P210, DOI 10.1016/j.cmpb.2013.07.024; Tillmann B, 2005, ANN NY ACAD SCI, V1060, P100, DOI 10.1196/annals.1360.007; Trappe Hans-Joachim, 2012, Int J Crit Illn Inj Sci, V2, P27, DOI 10.4103/2229-5151.94893; Umemura M, 1998, J Hum Ergol (Tokyo), V27, P30; VITZ PC, 1966, J EXP PSYCHOL, V71, P74, DOI 10.1037/h0022619; Voss A, 1996, CARDIOVASC RES, V31, P419; Wijnen VJM, 2006, CLIN NEUROPHYSIOL, V117, P1794, DOI 10.1016/j.clinph.2006.03.006; Yen BS, 2010, IEEE INT SYMP CIRC S, P2239, DOI 10.1109/ISCAS.2010.5537211; ZIMMERMAN LM, 1988, HEART LUNG, V17, P560	98	18	20	0	37	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		1662-453X		FRONT NEUROSCI-SWITZ	Front. Neurosci.	DEC 10	2015	9								461	10.3389/fnins.2015.00461			9	Neurosciences	Neurosciences & Neurology	CY9KY	WOS:000366727000001	26696818	DOAJ Gold, Green Published			2021-06-18	
J	Alhilali, LM; Delic, JA; Gumus, S; Fakhran, S				Alhilali, Lea M.; Delic, Joseph A.; Gumus, Serter; Fakhran, Saeed			Evaluation of White Matter Injury Patterns Underlying Neuropsychiatric Symptoms after Mild Traumatic Brain Injury	RADIOLOGY			English	Article							MAJOR DEPRESSION; CLINICAL-OUTCOMES; HEAD-INJURY; CONCUSSION; SEQUELAE; PLAYERS; STIMULATION; ASSOCIATION; DYSFUNCTION; AGGRESSION	Purpose: To determine if a central axonal injury underlies neuropsychiatric symptoms after mild traumatic brain injury (mTBI) by using tract-based spatial statistics analysis of diffusion-tensor images. Materials and Methods: The institutional review board approved this study, with waiver of informed consent. Diffusion-tensor imaging and serial neurocognitive testing with the Immediate Post-Concussion Assessment and Cognitive Testing evaluation were performed in 45 patients with mTBI (38 with irritability, 32 with depression, and 18 with anxiety). Control subjects consisted of 29 patients with mTBI without neuropsychiatric symptoms. Fractional anisotropy and diffusivity maps were analyzed by using tract-based spatial statistics with a multivariate general linear model. Diffusion-tensor imaging findings were correlated with symptom severity, neurocognitive test scores, and time to recovery with the Pearson correlation coefficient. Results: Compared with control subjects, patients with mTBI and depression had decreased fractional anisotropy in the superior longitudinal fasciculus (P = .006), white matter around the nucleus accumbens (P = .03), and anterior limb of the internal capsule (P = .02). Patients with anxiety had diminished fractional anisotropy in the vermis (P = .04). No regions of significantly decreased fractional anisotropy were seen in patients with irritability relative to control subjects. Injury in the region of the nucleus accumbens inversely correlated with recovery time in patients with depression (r = 20.480, P = .005). Conclusion: Unique white matter injury patterns were seen for two major posttraumatic neuropsychiatric symptoms. Injury to the cerebellar vermis in patients with mTBI and anxiety may indicate underlying dysfunction in primitive fear conditioning circuits in the cerebellum. Involvement of the nucleus accumbens in depression after mTBI may suggest an underlying dysfunctional reward circuit that affects the prognosis in these patients. (C) RSNA, 2015	[Alhilali, Lea M.; Delic, Joseph A.; Gumus, Serter; Fakhran, Saeed] Univ Pittsburgh, UPMC Presbyterian Hosp, Med Ctr, Dept Radiol,Div Neuroradiol, 200 Lothrop St,Presby South Tower,3rd Floor,Suite, Pittsburgh, PA 15213 USA	Alhilali, LM (corresponding author), Univ Pittsburgh, UPMC Presbyterian Hosp, Med Ctr, Dept Radiol,Div Neuroradiol, 200 Lothrop St,Presby South Tower,3rd Floor,Suite, Pittsburgh, PA 15213 USA.	alhilalilm@upmc.edu					Alexander AL, 2006, NEUROIMAG CLIN N AM, V16, P299, DOI 10.1016/j.nic.2006.02.006; Alhilali LM, 2014, RADIOLOGY, V272, P224, DOI 10.1148/radiol.14132670; Borek LL, 2001, BRAIN INJURY, V15, P65, DOI 10.1080/02699050150209147; Fakhran S, 2014, RADIOLOGY, V272, P815, DOI 10.1148/radiol.14132512; Fakhran S, 2013, RADIOLOGY, V269, P249, DOI 10.1148/radiol.13122343; Finkelstein EA., 2006, INCIDENCE EC BURDEN; Fletcher JM, 2008, HEALTH ECON, V17, P1215, DOI 10.1002/hec.1319; Giorgio A, 2010, NEUROIMAGE, V49, P94, DOI 10.1016/j.neuroimage.2009.08.003; Grafman J, 1996, NEUROLOGY, V46, P1231, DOI 10.1212/WNL.46.5.1231; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Hall GBC, 2014, EUR ARCH PSY CLIN N, V264, P187, DOI 10.1007/s00406-013-0437-9; Hart J, 2013, JAMA NEUROL, V70, P326, DOI 10.1001/2013.jamaneurol.340; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Levin HS, 2010, J NEUROTRAUM, V27, P683, DOI 10.1089/neu.2009.1073; Lyden H, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.21; Maller JJ, 2014, HUM BRAIN MAPP, V35, P227, DOI 10.1002/hbm.22171; Maschke M, 2002, J NEUROL NEUROSUR PS, V72, P116, DOI 10.1136/jnnp.72.1.116; Matthews SC, 2012, PSYCHIAT RES-NEUROIM, V204, P149, DOI 10.1016/j.pscychresns.2012.04.018; Matthews SC, 2011, NEUROIMAGE, V54, pS69, DOI 10.1016/j.neuroimage.2010.04.269; Millet B, 2014, EUR NEUROPSYCHOPHARM, V24, P1229, DOI 10.1016/j.euroneuro.2014.05.006; Moldover JE, 2004, NEUROPSYCHOL REV, V14, P143, DOI 10.1023/B:NERV.0000048181.46159.61; Moore EL, 2006, BRAIN INJURY, V20, P117, DOI 10.1080/02699050500443558; Morey RA, 2013, HUM BRAIN MAPP, V34, P2986, DOI 10.1002/hbm.22117; Morishita T, 2014, NEUROTHERAPEUTICS, V11, P475, DOI 10.1007/s13311-014-0282-1; Parker RS, 1996, BRAIN INJURY, V10, P287, DOI 10.1080/026990596124467; Peters BD, 2012, SCHIZOPHRENIA BULL, V38, P1308, DOI 10.1093/schbul/sbs054; Petraglia AL, 2014, J NEUROTRAUM, V31, P1211, DOI 10.1089/neu.2013.3255; Rao V, 2012, J NEUROPSYCH CLIN N, V24, P309, DOI 10.1176/appi.neuropsych.11080188; Sacchetti B, 2009, NEUROSCIENCE, V162, P756, DOI 10.1016/j.neuroscience.2009.01.064; Saluja G, 2004, ARCH PEDIAT ADOL MED, V158, P760, DOI 10.1001/archpedi.158.8.760; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Strain J, 2013, NEUROLOGY, V81, P25, DOI 10.1212/WNL.0b013e318299ccf8; Vanderploeg RD, 2007, J CLIN EXP NEUROPSYC, V29, P585, DOI 10.1080/13803390600826587; Yang CC, 2007, J TRAUMA, V62, P657, DOI 10.1097/01.ta.0000203577.68764.b8; Yang CC, 2012, BRAIN INJURY, V26, P1185, DOI 10.3109/02699052.2012.666374	35	18	20	0	7	RADIOLOGICAL SOC NORTH AMERICA	OAK BROOK	820 JORIE BLVD, OAK BROOK, IL 60523 USA	0033-8419			RADIOLOGY	Radiology	DEC	2015	277	3					793	800		10.1148/radiol.2015142974			8	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	DC9EY	WOS:000369525100019	26079380	Bronze			2021-06-18	
J	Resch, JE; Brown, CN; Macciocchi, SN; Cullum, CM; Blueitt, D; Ferrara, MS				Resch, Jacob E.; Brown, Cathleen N.; Macciocchi, Stephen N.; Cullum, C. Munro; Blueitt, Damond; Ferrara, Michael S.			A Preliminary Formula to Predict Timing of Symptom Resolution for Collegiate Athletes Diagnosed With Sport Concussion	JOURNAL OF ATHLETIC TRAINING			English	Article						traumatic brain injuries; prediction; prolonged recovery; symptom severity; symptom duration	TRAUMATIC BRAIN-INJURY; HIGH-SCHOOL; NEUROCOGNITIVE PERFORMANCE; PROLONGED RECOVERY; FOOTBALL PLAYERS; BASE-LINE; DEPRESSION; FEMALE; AGE; PATHOPHYSIOLOGY	Context: Symptom presentation and recovery after sport concussion (SC) are variable. Empirically based models documenting typical symptom duration would assist health care providers in managing return to play after SC. Objective: To develop a prediction model for SC symptom duration. Design: Cross-sectional study. Setting: Two National Collegiate Athletic Association Division I university laboratories. Patients or Other Participants: Seventy-six (51 male and 25 female) concussed athletes with an average age of 19.5 +/- 1.65 years who were evaluated within 24 hours of diagnosis. Intervention(s): Participants completed the Revised Head Injury Scale (HIS-r), Immediate Post-Concussion Assessment and Cognitive Testing (ImPACT), and Sensory Organization Test within 24 hours of SC diagnosis. Main Outcome Measure(s): A stepwise multivariate regression incorporating ImPACT and Sensory Organization Test composites and HIS-r symptom severity-duration was used to predict the number of days athletes reported symptoms after SC. The resulting regression formula was cross-validated using the Stine cross-validation coefficient. Results: The final formula consisted of the HIS-r's self-reported neck pain, drowsiness, tingling, and nervousness duration and ImPACT total symptom severity (R = 0.62, R-2 = 39%, R-adj(2) = 34.2%, P < .001). Approximately 29% (R-cv(2) = 29%) of the variance associated with total days symptomatic after SC was explained by our preliminary formula when cross-validated. The current formula correctly identified 76% of participants who recovered within 10 days of injury. Conclusions: Our results suggest that self-reported duration of 4 symptoms during the initial 24 hours after injury along with total symptom severity as measured by ImPACT accounted for a considerable amount of variance associated with days symptomatic after SC in collegiate athletes. Until the formula is cross-validated in a college-aged sample, caution is warranted in using it clinically.	[Resch, Jacob E.] Univ Virginia, Dept Kinesiol, Exercise & Sport Injury Lab, Charlottesville, VA 22904 USA; [Brown, Cathleen N.] Univ Georgia, Athens, GA 30602 USA; [Macciocchi, Stephen N.] Atlanta Neuropsychol LLC, Atlanta, GA USA; [Cullum, C. Munro] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA; [Blueitt, Damond] Orthoped Specialty Associates, Ft Worth, TX USA; [Ferrara, Michael S.] Univ New Hampshire, Durham, NH 03824 USA	Resch, JE (corresponding author), Univ Virginia, Dept Kinesiol, Exercise & Sport Injury Lab, Mem Gymnasium, Off 223A, Charlottesville, VA 22904 USA.	jer6x@virginia.edu	Cullum, C. Munro/AAC-2496-2019	Cullum, C. Munro/0000-0001-9706-5465; Resch, Jacob/0000-0001-6031-3197			Babcock L, 2013, JAMA PEDIATR, V167, P156, DOI 10.1001/jamapediatrics.2013.434; Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Cantu RC, 2001, J ATHL TRAINING, V36, P244; Cantu RC, 2010, PM&R, V2, P1088, DOI 10.1016/j.pmrj.2010.07.483; Cohen J., 2003, APPL MULTIPLE CORREL; Collins M, 2006, NEUROSURGERY, V58, P275, DOI 10.1227/01.NEU.0000200441.92742.46; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Covassin T, 2012, CLIN J SPORT MED, V22, P98, DOI 10.1097/JSM.0b013e31823403d2; Covassin T, 2010, PHYSICIAN SPORTSMED, V38, P87, DOI 10.3810/psm.2010.12.1830; Covassin T, 2011, CLIN SPORT MED, V30, P125, DOI 10.1016/j.csm.2010.08.001; De La Rue-Evans L, 2013, REHABIL NURS, V38, P2, DOI 10.1002/rnj.66; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; Ettenhofer ML, 2012, J INT NEUROPSYCH SOC, V18, P451, DOI 10.1017/S1355617711001895; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Guskiewicz KM, 2011, PM&R, V3, P353, DOI 10.1016/j.pmrj.2010.12.006; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Huberty C.J., 2006, APPL MANOVA DISCRIMI; Kelly JP, 1997, NEUROLOGY, V48, P581; Klossner D, 2013, 2013 14 NCAA SPORTS; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Kontos AP, 2012, ARCH PHYS MED REHAB, V93, P1751, DOI 10.1016/j.apmr.2012.03.032; Kontos AP, 2011, BRAIN INJURY, V25, P1234, DOI 10.3109/02699052.2011.608209; Lau B, 2009, CLIN J SPORT MED, V19, P216, DOI 10.1097/JSM.0b013e31819d6edb; Lau BC, 2011, AM J SPORT MED, V39, P2311, DOI 10.1177/0363546511410655; Lau BC, 2011, AM J SPORT MED, V39, P1209, DOI 10.1177/0363546510392016; Leddy JJ, 2010, CLIN J SPORT MED, V20, P21, DOI 10.1097/JSM.0b013e3181c6c22c; Master CL, 2012, PEDIATR ANN, V41, pE180, DOI 10.3928/00904481-20120827-09; McCrea M, 2005, J INT NEUROPSYCH SOC, V11, P58, DOI 10.1017/S1355617705050083; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McLeod TCV, 2012, J ATHL TRAINING, V47, P221; Meehan WP, 2013, J PEDIATR-US, V163, P721, DOI 10.1016/j.jpeds.2013.03.012; Mittenberg W, 1996, ARCH CLIN NEUROPSYCH, V11, P139, DOI 10.1016/0887-6177(95)00006-2; Moser RS, 2012, J PEDIATR-US, V161, P922, DOI 10.1016/j.jpeds.2012.04.012; Pedhazur E.J., 1997, MULTIPLE REGRESSION, V3rd ed.; Piland SG, 2006, MED SCI SPORT EXER, V38, P27, DOI 10.1249/01.mss.0000183186.98212.d5; Piland SG, 2003, J ATHL TRAINING, V38, P104; Randolph C, 2009, ARCH CLIN NEUROPSYCH, V24, P219, DOI 10.1093/arclin/acp025; Resch J, 2013, J ATHL TRAINING, V48, P506, DOI 10.4085/1062-6050-48.3.09; Resch JE, 2011, J ATHL TRAINING, V46, P170, DOI 10.4085/1062-6050-46.2.170; Silverberg ND, 2015, J NEUROTRAUM, V32, P517, DOI 10.1089/neu.2014.3600; van der Horn HJ, 2013, ARCH PHYS MED REHAB, V94, P867, DOI 10.1016/j.apmr.2012.11.039; Venes D, 2005, TABERS CYCLOPEDIC ME	45	18	18	0	8	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	DEC	2015	50	12					1292	1298		10.4085/1062-6050-50.12.03			7	Sport Sciences	Sport Sciences	DK2OS	WOS:000374754900011	26565424	Green Published			2021-06-18	
J	Ameloot, K; Genbrugge, C; Meex, I; Janssens, S; Boer, W; Mullens, W; Ferdinande, B; Dupont, M; Dens, J; De Deyne, C				Ameloot, K.; Genbrugge, C.; Meex, I.; Janssens, S.; Boer, W.; Mullens, W.; Ferdinande, B.; Dupont, M.; Dens, J.; De Deyne, C.			Low hemoglobin levels are associated with lower cerebral saturations and poor outcome after cardiac arrest	RESUSCITATION			English	Article						Hemoglobin; Post-cardiac arrest; Cerebral saturation	BLOOD-CELL TRANSFUSION; TRAUMATIC BRAIN-INJURY; THERAPEUTIC HYPOTHERMIA; RESTRICTIVE TRANSFUSION; CRITICALLY-ILL; CLINICAL-TRIAL; ANEMIA; THRESHOLD; MORTALITY; CORONARY	Purpose: Post-cardiac arrest (CA) patients have a large cerebral penumbra at risk for secondary ischemic damage in case of suboptimal brain oxygenation during ICU stay. The aims of this study were to investigate the association between hemoglobin, cerebral oxygenation (SctO(2)) and outcome in post-CA patients. Methods: Prospective observational study in 82 post-CA patients. Hemoglobin, a corresponding SctO2 measured by NIRS and SVO2 in patients with a pulmonary artery catheter (n = 62) were determined hourly during hypothermia in the first 24 h of ICU stay. Results: We found a strong linear relationship between hemoglobin and mean SctO(2) (SctO2 = 0.70 x hemoglobin + 56 (R-2 0.84, p = 10(-6))). Hemoglobin levels below 10 g/dl generally resulted in lower brain oxygenation. There was a significant association between good neurological outcome (43/82 patients in CPC 1-2 at 180 days post-CA) and admission hemoglobin above 13 g/dl (OR 2.76, 95% CI 1.09: 7.00, p = 0.03) or mean hemoglobin above 12.3 g/dl (OR 2.88, 95% CI 1.02: 8.16, p = 0.04). This association was entirely driven by results obtained in patients with a mean SVO2 below 70% (OR 6.25, 95% CI 1.33: 29.43, p = 0.01) and a mean SctO2 below 62.5% (OR 5.87, 95% CI 1.08: 32.00, p = 0.03). Conclusion: Hemoglobin levels below 10 g/dl generally resulted in lower cerebral oxygenation. Average hemoglobin levels below 12.3 g/dl were associated with worse outcome in patients with suboptimal SVO2 or SctO2. The safety of a universal restrictive transfusion threshold of 7 g/dl can be questioned in post-CA patients. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Ameloot, K.; Mullens, W.; Ferdinande, B.; Dupont, M.; Dens, J.] Ziekenhuis Oost Limburg, Dept Cardiol, B-3600 Schiepse Bos, Genk, Belgium; [Genbrugge, C.; Meex, I.; Boer, W.; De Deyne, C.] Ziekenhuis Oost Limburg, Dept Anesthesiol & Crit Care Med, B-3600 Schiepse Bos, Genk, Belgium; [Genbrugge, C.; Meex, I.; Mullens, W.; Dens, J.; De Deyne, C.] Univ Hasselt, Fac Med & Life Sci, Diepenbeek, Belgium; [Janssens, S.] Univ Hosp Leuven, Dept Cardiol, Leuven, Belgium	Ameloot, K (corresponding author), Ziekenhuis Oost Limburg, B-3600 Schiepse Bos, Genk, Belgium.	Koen.ameloot@zol.be	Genbrugge, Cornelia/AAD-8463-2019; Boer, Willem/AAL-9731-2021				Ameloot K, 2015, RESUSCITATION, V91, P56, DOI 10.1016/j.resuscitation.2015.03.016; Ameloot K, 2014, RESUSCITATION, V85, P1263, DOI 10.1016/j.resuscitation.2014.06.025; BORGSTROM L, 1975, ACTA PHYSIOL SCAND, V93, P505, DOI 10.1111/j.1748-1716.1975.tb05842.x; Carlson AP, 2006, J TRAUMA, V61, P567, DOI 10.1097/01.ta.0000231768.44727.a2; Carson JL, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002042.pub3; Carson JL, 2011, NEW ENGL J MED, V365, P2453, DOI 10.1056/NEJMoa1012452; Carson JL, 1996, LANCET, V348, P1055, DOI 10.1016/S0140-6736(96)04330-9; COETZEE A, 1990, SCAND J CLIN LAB INV, V50, P149, DOI 10.3109/00365519009087504; de Groot V, 2003, J CLIN EPIDEMIOL, V56, P221, DOI 10.1016/S0895-4356(02)00585-1; Griesdale DE, 2014, NEUROCRIT CARE; Hare GMT, 2007, J APPL PHYSIOL, V103, P1021, DOI 10.1152/japplphysiol.01315.2006; Hebert PC, 2014, NEW ENGL J MED, V371, P1459, DOI 10.1056/NEJMe1408976; Hebert PC, 1999, NEW ENGL J MED, V340, P409, DOI 10.1056/NEJM199902113400601; Hedstrom M, 1996, ACTA ORTHOP SCAND, V67, P317, DOI 10.3109/17453679609002322; Holst LB, 2014, NEW ENGL J MED, V371, P1381, DOI 10.1056/NEJMoa1406617; KOROSUE K, 1992, STROKE, V23, P1487, DOI 10.1161/01.STR.23.10.1487; Kwok CS, 2015, JACC-CARDIOVASC INTE, V8, P436, DOI 10.1016/j.jcin.2014.09.026; Marik PE, 2008, CRIT CARE MED, V36, P2667, DOI 10.1097/CCM.0b013e3181844677; McIntyre LA, 2006, NEUROCRIT CARE, V5, P4, DOI 10.1385/NCC:5:1:4; Meex I, 2013, RESUSCITATION, V84, P788, DOI 10.1016/j.resuscitation.2013.01.003; Murphy GJ, 2015, NEW ENGL J MED, V372, P997, DOI 10.1056/NEJMoa1403612; Nagao K, 2012, AM J EMERG MED, V30, P770, DOI 10.1016/j.ajem.2011.03.031; Oddo M, 2012, INTENS CARE MED, V38, P1497, DOI 10.1007/s00134-012-2593-1; Rao SV, 2004, JAMA-J AM MED ASSOC, V292, P1555, DOI 10.1001/jama.292.13.1555; Reynolds JD, 2007, P NATL ACAD SCI USA, V104, P17058, DOI 10.1073/pnas.0707958104; Robertson CS, 2014, JAMA-J AM MED ASSOC, V312, P36, DOI 10.1001/jama.2014.6490; Salisbury AC, 2014, J AM COLL CARDIOL, V64, P811, DOI 10.1016/j.jacc.2014.05.040; Sekhon MS, 2012, CRIT CARE, V16, DOI 10.1186/cc11431; Silvain J, 2014, J AM COLL CARDIOL, V63, P1289, DOI 10.1016/j.jacc.2013.11.029; Smith MJ, 2005, CRIT CARE MED, V33, P1104, DOI 10.1097/01.CCM.0000162685.60609.49; Tango HK, 2009, J TRAUMA, V66, P720, DOI 10.1097/TA.0b013e3181719b35; Villanueva C, 2013, NEW ENGL J MED, V368, P11, DOI 10.1056/NEJMoa1211801; Warner MA, 2010, J NEUROSURG, V113, P539, DOI 10.3171/2009.12.JNS091337; WELCH HG, 1992, ANN INTERN MED, V116, P393, DOI 10.7326/0003-4819-116-5-393; Wu WC, 2001, NEW ENGL J MED, V345, P1230, DOI 10.1056/NEJMoa010615; Zygun DA, 2009, CRIT CARE MED, V37, P1074, DOI 10.1097/CCM.0b013e318194ad22	36	18	18	0	3	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0300-9572			RESUSCITATION	Resuscitation	NOV	2015	96						280	286		10.1016/j.resuscitation.2015.08.015			7	Critical Care Medicine; Emergency Medicine	General & Internal Medicine; Emergency Medicine	CY7JM	WOS:000366584500052	26325099				2021-06-18	
J	Peterson, TC; Maass, WR; Anderson, JR; Anderson, GD; Hoane, MR				Peterson, Todd C.; Maass, William R.; Anderson, Jordan R.; Anderson, Gail D.; Hoane, Michael R.			A behavioral and histological comparison of fluid percussion injury and controlled cortical impact injury to the rat sensorimotor cortex	BEHAVIOURAL BRAIN RESEARCH			English	Article						Animal studies; Assessment tools; Fluid percussion injury; Cortical contusion injury; Behavior; Sensorimotor function	TRAUMATIC BRAIN-INJURY; IMPROVES FUNCTIONAL RECOVERY; NICOTINAMIDE TREATMENT; CONTUSION INJURY; PROGESTERONE; PERFORMANCE; MODELS; DEATH	Our primary goal was to evaluate the behavioral and histological outcome of fluid percussion injury (FPI) and cortical contusion injury (CCI) to the sensorimotor cortex (SMC). The SMC has been used to evaluate neuroplasticity following CCI, but has not been extensively examined with FPI. In both the CCI and FPI models, a mechanical force of 4 mm in diameter was applied over the SMC, allowing for a direct comparison to measure the relative rates of histology and recovery of function in these models. Gross behavioral deficits were found on the sensory task (tactile adhesive removal task) and multiple motor assessments (forelimb asymmetry task, forelimb placing task, and rotorod). These sensorimotor deficits occurred in the absence of cognitive deficits in the water maze. The CCI model creates focal damage with a localized injury wheras the FPI model creates a more diffuse injury causing widespread damage. Both behavioral and histological deficits ensued following both models of injury to the SMC. The neuroplastic changes and ease at which damage to this area can be measured behaviorally make this an excellent location to assess traumatic brain injury (TBI) treatments. No injury model can completely mimic the full spectrum of human TBI and any potential treatments should be validated across both focal and diffuse injury models. Both of these injury models to the SMC produce severe and enduring behavioral deficits, which are ideal for evaluating treatment options. (C) 2015 Elsevier B.V. All rights reserved.	[Peterson, Todd C.; Maass, William R.; Anderson, Jordan R.; Hoane, Michael R.] So Illinois Univ, Dept Psychol, Restorat Neurosci Lab, Carbondale, IL 62901 USA; [Anderson, Gail D.] Univ Washington, Dept Pharm, Seattle, WA 98195 USA	Hoane, MR (corresponding author), So Illinois Univ, Dept Psychol, Restorat Neurosci Lab, Life Sci 2, MC 6502, Carbondale, IL 62901 USA.	tcpeters@stanford.edu; bmaass@siu.edu; j.anderson822@siu.edu; gaila@u.washington.edu; mhoane@siu.edu		Hoane, Michael/0000-0001-7779-2657	National Institutes of Health/National Institute of Child, Health and DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)NIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 HD061944-01]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD061944] Funding Source: NIH RePORTER	The authors would like to thank Lynn Moore for her assistance on this project. The research was supported by a grant from the National Institutes of Health/National Institute of Child, Health and Development (R01 HD061944-01).	Albert-Weissenberger Christiane, 2010, Exp Transl Stroke Med, V2, P16, DOI 10.1186/2040-7378-2-16; Allegri RF, 2001, REV NEUROLOGIA, V32, P449, DOI 10.33588/rn.3205.2000167; Allred RP, 2008, FUTUR NEUROL, V3, P189, DOI 10.2217/14796708.3.2.189; Barense MD, 2002, LEARN MEMORY, V9, P191, DOI 10.1101/lm.48602; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Centers for Disease Control, 2010, INJ PREV CONTR TRAUM; Clausen F, 2005, ACTA NEUROCHIR, V147, P775, DOI 10.1007/s00701-005-0550-2; COGGESHALL RE, 1992, TRENDS NEUROSCI, V15, P9, DOI 10.1016/0166-2236(92)90339-A; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Gersh Isidore, 1943, JOUR CELL AND COMP PHYSIOL, V21, P253, DOI 10.1002/jcp.1030210305; Goffus AM, 2010, OXID MED CELL LONGEV, V3, P145, DOI 10.4161/oxim.3.2.11315; GREGERSEN N, 1986, ACTA PAEDIATR SCAND, V75, P676, DOI 10.1111/j.1651-2227.1986.tb10272.x; Haar CV, 2011, BEHAV BRAIN RES, V224, P311, DOI 10.1016/j.bbr.2011.06.009; Hicks RR, 1997, MOL CHEM NEUROPATHOL, V32, P1, DOI 10.1007/BF02815164; Hoane MR, 2008, NEUROSCIENCE, V154, P861, DOI 10.1016/j.neuroscience.2008.04.044; Hoane MR, 2007, J NEUROTRAUM, V24, P1108, DOI 10.1089/neu.2006.0254; Hoane MR, 2006, NEUROSCI LETT, V408, P35, DOI 10.1016/j.neulet.2006.07.011; Hoane MR, 2006, J NEUROTRAUM, V23, P1535, DOI 10.1089/neu.2006.23.1535; Hoane MR, 2008, OXID MED CELL LONGEV, V1, P46, DOI 10.4161/oxim.1.1.6694; Hoane MR, 2009, J NEUROTRAUM, V26, P121, DOI 10.1089/neu.2008.0565; Hoane MR, 2003, J NEUROTRAUM, V20, P1189, DOI 10.1089/089771503770802871; HOFFMAN SW, 1994, J NEUROTRAUM, V11, P417, DOI 10.1089/neu.1994.11.417; Holland MA, 2008, J NEUROTRAUM, V25, P140, DOI 10.1089/neu.2007.0312; Jones TA, 2012, J NEUROTRAUM, V29, P1455, DOI 10.1089/neu.2011.2207; Kozlowski DA, 1996, J NEUROSCI, V16, P4776; Kozlowski DA, 1998, BEHAV BRAIN RES, V97, P89, DOI 10.1016/S0166-4328(98)00030-8; Krantz K P, 1986, Acta Neurochir Suppl (Wien), V36, P47; Kuypers NJ, 2010, J NEUROTRAUM, V27, P1275, DOI 10.1089/neu.2010.1327; Laurer HL, 2000, EUR J TRAUMA, V26, P95, DOI DOI 10.1007/S000680050007; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; LINDGREN STEN, 1965, BIOPHYSIK, V2, P320; Lindner MD, 1998, J NEUROTRAUM, V15, P199, DOI 10.1089/neu.1998.15.199; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; O'Connor WT, 2011, PHARMACOL THERAPEUT, V130, P106, DOI 10.1016/j.pharmthera.2011.01.001; Peterson TC, 2015, J NEUROTRAUM, V32, P765, DOI 10.1089/neu.2014.3530; Peterson TC, 2012, J NEUROTRAUM, V29, P2823, DOI 10.1089/neu.2012.2471; Peterson TC, 2012, BEHAV NEUROSCI, V126, P551, DOI 10.1037/a0028701; POVLISHOCK JT, 1993, ANN EMERG MED, V22, P980, DOI 10.1016/S0196-0644(05)82738-6; Quigley A, 2009, BRAIN RES, V1304, P138, DOI 10.1016/j.brainres.2009.09.062; Ryou Jae-Wook, 2004, Cognitive Affective & Behavioral Neuroscience, V4, P430, DOI 10.3758/CABN.4.4.430; Schneider G, 2002, MAGN RESON MATER PHY, V14, P233, DOI 10.1016/S1352-8661(02)00068-6; Smith DC, 2005, J NEUROTRAUM, V22, P1485, DOI 10.1089/neu.2005.22.1485; Stoica BA, 2010, ACUTE NEURONAL INJURY: THE ROLE OF EXCITOTOXIC PROGRAMMED CELL DEATH MECHANISMS, P169, DOI 10.1007/978-0-387-73226-8_12; Stoica BA, 2010, NEUROTHERAPEUTICS, V7, P3, DOI 10.1016/j.nurt.2009.10.023; Swan AA, 2011, J NEUROTRAUM, V28, P431, DOI 10.1089/neu.2010.1519; Vink R, 2001, J NEUROTRAUM, V18, P839, DOI 10.1089/089771501316919201; Wang HC, 2010, J CLIN NEUROSCI, V17, P157, DOI 10.1016/j.jocn.2009.07.099; Woodlee M.T., 2005, BEHAV LAB RAT HDB TE, P129	49	18	19	0	15	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0166-4328	1872-7549		BEHAV BRAIN RES	Behav. Brain Res.	NOV 1	2015	294						254	263		10.1016/j.bbr.2015.08.007			10	Behavioral Sciences; Neurosciences	Behavioral Sciences; Neurosciences & Neurology	CS2WZ	WOS:000361934000029	26275924	Green Accepted			2021-06-18	
J	Ilie, G; Vingilis, ER; Mann, RE; Hamilton, H; Toplak, M; Adlaf, EM; Kolla, N; Ialomiteanu, A; van der Mass, M; Asbridge, M; Vingilis-Jaremko, L; Rehm, J; Cusimano, MD				Ilie, Gabriela; Vingilis, Evelyn R.; Mann, Robert E.; Hamilton, Hayley; Toplak, Maggie; Adlaf, Edward M.; Kolla, Nathan; Ialomiteanu, Anca; van der Mass, Mark; Asbridge, Mark; Vingilis-Jaremko, Larissa; Rehm, Juergen; Cusimano, Michael D.			The association between traumatic brain injury and ADHD in a Canadian adult sample	JOURNAL OF PSYCHIATRIC RESEARCH			English	Article						Traumatic brain injury; Attention deficit disorders; ADHD; Anxiety; Ontario adults; Population survey	UNITED-STATES; HEAD-INJURY; ATTENTION; DISORDER; SURVEILLANCE; AGGRESSION; PREVALENCE; CHILDREN; RECOVERY; PEOPLE	Objective: This study describes the association between lifetime traumatic brain injury (TBI) and attention deficit and hyperactivity disorder (ADHD) among Canadian adults. Method: A cross-sectional sample of 3993 Ontario adults aged 18 or older were surveyed by Computer Assisted Telephone Interviewing (CATI) throughout 2011 and 2012 as part of the CAMH Monitor, a rolling survey assessing the health, mental health and substance use of Ontario adults. TBI was defined as trauma to the head that ed in loss of consciousness for at least five minutes or overnight hospitalization. ADHD was measured by the 6-item ASRS screener for adult ADHD, and self-reported history of diagnosed ADHD. Results: Among adults with a history of TBI, 6.6% (95% CI: 4.7, 9.4) screened ADHD positive, and 5.9% (95% CI: 3.6, 9.5) reported having been diagnosed with ADHD in their lifetime. Adults with lifetime TBI had significantly greater odds of scoring positive on the ADHD/ASRS screen (OR = 2.49, 95% Cl: 1.54, 4.04), and of reporting a history of diagnosed ADHD (OR = 2.64, 95% Cl: 1.40, 4.98) than without TBI, when holding values of sex, age, and education constant. Conclusion: Significant positive associations between lifetime TBI and both current and past ADHD were observed among adults in this population. More research to understand these associations, and their significance for the etiology and management of TBI and ADHD, is needed. (C) 2015 Elsevier Ltd. All rights reserved.	[Ilie, Gabriela] St Michaels Hosp, Div Neurosurg, Toronto, ON M5B 1W8, Canada; [Vingilis, Evelyn R.] Univ Western Ontario, Dept Family Med, Populat & Community Hlth Unit, London, ON, Canada; [Mann, Robert E.; Hamilton, Hayley; Adlaf, Edward M.; Kolla, Nathan; Ialomiteanu, Anca; Rehm, Juergen] Ctr Addict & Mental Hlth, Toronto, ON, Canada; [Mann, Robert E.; Hamilton, Hayley; Adlaf, Edward M.; Rehm, Juergen; Cusimano, Michael D.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [van der Mass, Mark] Univ Toronto, Dept Sociol, Toronto, ON M5S 1A1, Canada; [Toplak, Maggie] York Univ, Dept Psychol, LaMarsh Ctr Child & Youth Res, Toronto, ON M3J 2R7, Canada; [Kolla, Nathan] Univ Toronto, Dept Psychiat, Toronto, ON, Canada; [Asbridge, Mark] Dalhousie Univ, Dept Community Hlth & Epidemiol, Halifax, NS, Canada; [Ilie, Gabriela; Vingilis-Jaremko, Larissa] Univ Toronto, Dept Psychol, Toronto, ON M5S 1A1, Canada	Ilie, G (corresponding author), St Michaels Hosp, Div Neurosurg, 30 Bond St, Toronto, ON M5B 1W8, Canada.	ilieg@smh.ca	Cusimano, Michael/X-4059-2019; van der Maas, Mark/AAL-5601-2020; Kolla, Nathan/W-4671-2019; Ilie, Gabriela/AAM-9122-2021	van der Maas, Mark/0000-0001-9606-0187; Cusimano, Michael/0000-0002-9989-0650	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [TIR103946]; Ontario Neurotrauma Foundation; Canadian Institutes for Health Research (CIHR)Canadian Institutes of Health Research (CIHR) [MOP 102537]; Natural Sciences and Engineering Research Council (NSERC)Natural Sciences and Engineering Research Council of Canada (NSERC); Canadian Institutes of Health Research (CIHR)Canadian Institutes of Health Research (CIHR); Social Sciences and Humanities Research Council (SSHRC)Social Sciences and Humanities Research Council of Canada (SSHRC); Industry Canada; Ontario Ministry of Health and Long-Term CareMinistry of Health and Long-Term Care, Ontario	This work was financially supported by a Team Grant (TIR103946) from Canadian Institutes of Health Research and by funds from the Ontario Neurotrauma Foundation. Additional funding was obtained from a grant from the Canadian Institutes for Health Research (CIHR) operating grant (no. MOP 102537). AUTO21, a member of the Networks of Centres of Excellence (NCE) program that is administered and funded by the Natural Sciences and Engineering Research Council (NSERC), the Canadian Institutes of Health Research (CIHR), and the Social Sciences and Humanities Research Council (SSHRC), in partnership with Industry Canada. Drs. RM, HH and JR also acknowledge on going funding support from the Ontario Ministry of Health and Long-Term Care.	Able SL, 2007, PSYCHOL MED, V37, P97, DOI 10.1017/S0033291706008713; Adeyemo BO, 2014, J ATTEN DISORD, V18, P576, DOI 10.1177/1087054714543371; Adlaf E. M., 2013, CAMH MONITOR 2012 ME; Anstey KJ, 2004, J CLIN EPIDEMIOL, V57, P1202, DOI 10.1016/j.jclinepi.2003.11.011; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Barkley RA, 2006, ATTENTION DEFICIT HY; Bonfield CM, 2013, J NEUROSURG-PEDIATR, V12, P97, DOI 10.3171/2013.5.PEDS12424; Bowman SM, 2008, PEDIATRICS, V122, P988, DOI 10.1542/peds.2007-3511; Canadian Institute for Health Information, 2006, HEAD INJ CAN DEC CHA; Centre for Disease Control and Prevention, 2010, TRAUM BRAIN INJ US E; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; DeMatteo CA, 2010, PEDIATRICS, V125, P327, DOI 10.1542/peds.2008-2720; Dooley JJ, 2008, BRAIN INJURY, V22, P836, DOI 10.1080/02699050802425444; Eme R, 2012, EXPERT REV NEUROTHER, V12, P475, DOI [10.1586/ern.12.15, 10.1586/ERN.12.15]; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Fayyad J, 2007, BRIT J PSYCHIAT, V190, P402, DOI 10.1192/bjp.bp.106.034389; Finkelstein E, 2000, INCIDENCE EC BURDEN; Frances A, 2000, DSM 4 CLASSIFICATION; Gerring JP, 1998, J AM ACAD CHILD PSY, V37, P647, DOI 10.1097/00004583-199806000-00015; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Gustavsson A, 2011, EUR NEUROPSYCHOPHARM, V21, P718, DOI 10.1016/j.euroneuro.2011.08.008; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Heeringa SG, 2010, APPL SURVEY DATA; Hie G., 2015, J NEUROTRAUM, V32, P10; Hu SS, 2011, AM J EPIDEMIOL, V173, P703, DOI 10.1093/aje/kwq442; Hughes A., 2013, IR, V34, P13, DOI [10.1080/03033910.2012.754323, DOI 10.1080/03033910.2012.754323]; Ialomiteanu A., 2011, CAMH RES DOCUMENT SE, V35; Ilie G, 2015, J HEAD TRAUMA REHAB, V30, P293, DOI 10.1097/HTR.0000000000000101; Ilie G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094936; Ilie G, 2013, JAMA-J AM MED ASSOC, V309, P2550, DOI 10.1001/jama.2013.6750; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Keenan HT, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1984; Kessler RC, 2005, PSYCHOL MED, V35, P245, DOI 10.1017/S0033291704002892; Kessler RC, 2006, AM J PSYCHIAT, V163, P716, DOI 10.1176/appi.ajp.163.4.716; Korn EL, 1999, ANAL HLTH SURVEYS, V1st; Kuipers P, 2000, J HEAD TRAUMA REHAB, V15, P1275, DOI 10.1097/00001199-200012000-00007; Laird RD, 2005, DEV PSYCHOPATHOL, V17, P127, DOI 10.1017/S0954579405050078; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Okie S, 2006, NEW ENGL J MED, V354, P2637, DOI 10.1056/NEJMp068113; Ornstein TJ, 2013, J NEUROPSYCHOL, V7, P1, DOI 10.1111/j.1748-6653.2012.02027.x; Sharp NL, 2006, DISABIL REHABIL, V28, P767, DOI 10.1080/09638280500386668; Silvetti M, 2013, NEURAL NETWORKS, V46, P199, DOI 10.1016/j.neunet.2013.05.008; Simpson G, 2002, PSYCHOL MED, V32, P687, DOI 10.1017/S0033291702005561; Slomine BS, 2005, J INT NEUROPSYCH SOC, V11, P645, DOI 10.1017/S1355617705050769; Tait RJ, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-171; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Vingilis E, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/982072; Wallister TW, 2008, WORLD PSYCHIATRY, V7, P3; Weyandt Lisa L, 2006, J Atten Disord, V10, P9; Wickens CM, 2015, ACCIDENT ANAL PREV, V78, P87, DOI 10.1016/j.aap.2015.02.013; Williams WH, 2010, NEUROPSYCHOL REHABIL, V20, P801, DOI 10.1080/09602011.2010.519613; Zernicke R. F., 2009, Journal of Intercollegiate Sport, V2, P42; Zwi M, 2008, BMJ-BRIT MED J, V6, P2244	55	18	18	0	15	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0022-3956	1879-1379		J PSYCHIATR RES	J. Psychiatr. Res.	OCT	2015	69						174	179		10.1016/j.jpsychires.2015.08.004			6	Psychiatry	Psychiatry	CS2UP	WOS:000361927800025	26343610	Green Accepted			2021-06-18	
J	Lequerica, A; Jasey, N; Tremont, JNP; Chiaravalloti, ND				Lequerica, Anthony; Jasey, Neil; Tremont, Jaclyn N. Portelli; Chiaravalloti, Nancy D.			Pilot Study on the Effect of Ramelteon on Sleep Disturbance After Traumatic Brain Injury: Preliminary Evidence From a Clinical Trial	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injuries; Cognition; Rehabilitation; Sleep	CHRONIC PRIMARY INSOMNIA; OLDER-ADULTS; TRANSIENT INSOMNIA; RECEPTOR AGONIST; DOUBLE-BLIND; EFFICACY; PLACEBO; SAFETY; MELATONIN; MOOD	Objective: To investigate the effect of ramelteon on sleep and daytime functioning among individuals with traumatic brain injury (TBI). Design: A double-blind, placebo-controlled study with a crossover design. Setting: A research facility attached to an acute rehabilitation hospital. Participants: Individuals with TBI (N=13) complaining of sleep difficulties with a Pittsburgh Sleep Quality Index score >5. Interventions: A nightly dosage of ramelteon (8mg) was given over a period of 3 weeks. Main Outcome Measures: An actigraph and a daily sleep log were used to measure sleep/wake patterns. Daytime functioning was measured after 3 weeks of treatment using a computer-administrated neuropsychological test battery in conjunction with subjective questionnaires measuring mood, daytime sleepiness, and fatigue. Results: A significant increase in objectively measured total sleep time and a small increase in sleep latency were observed after 3 weeks of treatment compared with placebo. Treatment also showed a significant increase in standardized neuropsychological test scores, with a particular improvement on an index of executive functioning. Conclusions: Preliminary evidence for the effectiveness of 8mg of ramelteon taken nightly over a 3-week period was found in the treatment of sleep difficulties among individuals with TBI. Improvements in total sleep time and some aspects of cognitive functioning are discussed. (C) 2015 by the American Congress of Rehabilitation Medicine	[Lequerica, Anthony; Chiaravalloti, Nancy D.] Kessler Fdn, W Orange, NJ 07052 USA; [Lequerica, Anthony; Chiaravalloti, Nancy D.] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Phys Med & Rehabil, Rutgers, Newark, NJ 07103 USA; [Jasey, Neil] Kessler Inst Rehabil, W Orange, NJ USA; [Tremont, Jaclyn N. Portelli] Rutgers State Univ, Robert Wood Johnson Med Sch, New Brunswick, NJ 08903 USA	Lequerica, A (corresponding author), Kessler Fdn, Traumat Brain Injury Res, 1199 Pleasant Valley Way, W Orange, NJ 07052 USA.	alequerica@kesslerfoundation.org		Chiaravalloti, Nancy/0000-0003-2943-7567			Ancoli-Israel S, 2003, SLEEP, V26, P342, DOI 10.1093/sleep/26.3.342; Aton SJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006078; Beetar JT, 1996, ARCH PHYS MED REHAB, V77, P1298, DOI 10.1016/S0003-9993(96)90196-3; Bellon Alfredo, 2006, J Psychiatr Pract, V12, P229, DOI 10.1097/00131746-200607000-00005; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Castriotta RJ, 2001, ARCH PHYS MED REHAB, V82, P1403, DOI 10.1053/apmr.2001.26081; Clinchot DM, 1998, AM J PHYS MED REHAB, V77, P291, DOI 10.1097/00002060-199807000-00006; COHEN M, 1992, J NEUROL NEUROSUR PS, V55, P313, DOI 10.1136/jnnp.55.4.313; Erman M, 2006, SLEEP MED, V7, P17, DOI 10.1016/j.sleep.2005.09.004; Fichtenberg NL, 2000, BRAIN INJURY, V14, P659; Fichtenberg NL, 2002, BRAIN INJURY, V16, P197, DOI 10.1080/02699050110103940; Gooneratne NS, 2010, J CLIN SLEEP MED, V6, P572; Greenblatt DJ, 2007, J CLIN PHARMACOL, V47, P485, DOI 10.1177/0091270006298602; Gualtieri CT, 2006, ARCH CLIN NEUROPSYCH, V21, P623, DOI 10.1016/j.acn.2006.05.007; Johnson MW, 2006, ARCH GEN PSYCHIAT, V63, P1149, DOI 10.1001/archpsyc.63.10.1149; Karim A, 2006, J CLIN PHARMACOL, V46, P140, DOI 10.1177/0091270005283461; Kato K, 2005, NEUROPHARMACOLOGY, V48, P301, DOI 10.1016/j.neuropharm.2004.09.007; Kohsaka M, 2011, EXPERT REV NEUROTHER, V11, P1389, DOI [10.1586/ERN.11.128, 10.1586/ern.11.128]; Laustsen G, 2006, NURSE PRACT, V31, P52, DOI 10.1097/00006205-200604000-00011; Mayer G, 2009, SLEEP, V32, P351, DOI 10.1093/sleep/32.3.351; McNair D.M., 1992, MANUAL PROFILE MOOD; Mets MAJ, 2011, SLEEP, V34, P1327, DOI 10.5665/SLEEP.1272; Ouellet MC, 2006, J HEAD TRAUMA REHAB, V21, P199, DOI 10.1097/00001199-200605000-00001; Ouellet MC, 2004, NEUROREHAB NEURAL RE, V18, P187, DOI 10.1177/1545968304271405; Pandi-Perumal SR, 2005, EXP GERONTOL, V40, P911, DOI 10.1016/j.exger.2005.08.009; Parcell DL, 2006, ARCH PHYS MED REHAB, V87, P278, DOI 10.1016/j.apmr.2005.10.024; PASSOUANT P, 1972, REV NEUROL-FRANCE, V127, P173; Richardson GS, 2002, J CLIN PSYCHOPHARM, V22, P511, DOI 10.1097/00004714-200210000-00012; Roth T, 2005, SLEEP, V28, P303; Roth T, 2007, CURR MED RES OPIN, V23, P1005, DOI 10.1185/030079907X178874; Roth T, 2006, SLEEP MED, V7, P312, DOI 10.1016/j.sleep.2006.01.003; SHARPLEY AL, 1995, BIOL PSYCHIAT, V37, P85, DOI 10.1016/0006-3223(94)00135-P; SKOWRON DM, 1992, PHARMACOTHERAPY, V12, P18; Smith C, 2001, SLEEP MED REV, V5, P491, DOI 10.1053/smrv.2001.0164; Terry PC, 1999, J SPORT SCI, V17, P861, DOI 10.1080/026404199365425; Terry PC, 2003, PSYCHOL SPORT EXERC, V4, P125, DOI 10.1016/S1469-0292(01)00035-8; Uchimura N, 2011, EXPERT REV NEUROTHER, V11, P215, DOI [10.1586/ern.10.197, 10.1586/ERN.10.197]; Uchiyama M, 2011, SLEEP MED, V12, P127, DOI 10.1016/j.sleep.2010.10.006; Uchiyama M, 2011, SLEEP MED, V12, P119, DOI 10.1016/j.sleep.2010.08.010; Worthington AD, 2006, BRAIN INJURY, V20, P327, DOI 10.1080/02699050500488249; Zammit G, 2007, J CLIN SLEEP MED, V3, P495; Zammit G, 2009, SLEEP MED, V10, P55, DOI 10.1016/j.sleep.2008.04.010	42	18	18	0	10	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	OCT	2015	96	10					1802	1809		10.1016/j.apmr.2015.05.011			8	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	CT2GX	WOS:000362621100008	26026580				2021-06-18	
J	Ilie, G; Boak, A; Mann, RE; Adlaf, EM; Hamilton, H; Asbridge, M; Rehm, J; Cusimano, MD				Ilie, Gabriela; Boak, Angela; Mann, Robert E.; Adlaf, Edward M.; Hamilton, Hayley; Asbridge, Mark; Rehm, Juergen; Cusimano, Michael D.			Energy Drinks, Alcohol, Sports and Traumatic Brain Injuries among Adolescents	PLOS ONE			English	Article							EXECUTIVE FUNCTION; UNITED-STATES; CONSUMPTION; RISK; CONSEQUENCES; PATTERNS; BEHAVIOR	Importance The high prevalence of traumatic brain injuries (TBI) among adolescents has brought much focus to this area in recent years. Sports injuries have been identified as a main mechanism. Although energy drinks, including those mixed with alcohol, are often used by young athletes and other adolescents they have not been examined in relation to TBI. Objective We report on the prevalence of adolescent TBI and its associations with energy drinks, alcohol and energy drink mixed in with alcohol consumption. Design, Settings and Participants Data were derived from the Centre for Addiction and Mental Health's 2013 Ontario Student Drug Use and Health Survey (OSDUHS). This population-based cross-sectional school survey included 10,272 7th to 12th graders (ages 11-20) who completed anonymous selfadministered questionnaires in classrooms. Main Outcome Measures Mild to severe TBI were defined as those resulting in a loss of consciousness for at least five minutes, or being hospitalized for at least one night. Mechanism of TBI, prevalence estimates of TBI, and odds of energy drink consumption, alcohol use, and consumption of energy drinks mixed with alcohol are assessed. Results Among all students, 22.4%(95% CI: 20.7, 24.1) reported a history of TBI. Sports injuries remain the main mechanism of a recent (past year) TBI (45.5%, 95% CI: 41.0, 50.1). Multinomial logistic regression showed that relative to adolescents who never sustained a TBI, the odds of sustaining a recent TBI were greater for those consuming alcohol, energy drinks, and energy drinks mixed in with alcohol than abstainers. Odds ratios were higher for these behaviors among students who sustained a recent TBI than those who sustained a former TBI (lifetime but not past 12 months). Relative to recent TBI due to other causes of injury, adolescents who sustained a recent TBI while playing sports had higher odds of recent energy drinks consumption than abstainers. Conclusions and Relevance TBI remains a disabling and common condition among adolescents and the consumption of alcohol, energy drinks, and alcohol mixed with energy drinks further increase the odds of TBI among adolescents. These associations warrant further investigation.	[Ilie, Gabriela] St Michaels Hosp, Injury Prevent Res Off, Toronto, ON M5B 1W8, Canada; [Ilie, Gabriela] Univ Toronto, Dept Psychol, Toronto, ON M5S 1A1, Canada; [Boak, Angela; Mann, Robert E.; Adlaf, Edward M.; Hamilton, Hayley; Rehm, Juergen] Ctr Addict & Mental Hlth, Social & Epidemiol Res, Toronto, ON, Canada; [Mann, Robert E.; Adlaf, Edward M.; Hamilton, Hayley; Rehm, Juergen; Cusimano, Michael D.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Asbridge, Mark] Dalhousie Univ, Halifax, NS, Canada; [Cusimano, Michael D.] Univ Toronto, Div Neurosurg, Toronto, ON, Canada	Ilie, G (corresponding author), St Michaels Hosp, Injury Prevent Res Off, 30 Bond St, Toronto, ON M5B 1W8, Canada.	ilieg@smh.ca	Ilie, Gabriela/AAM-9122-2021; Meijer, Anna/K-5118-2016; Cusimano, Michael/X-4059-2019	Cusimano, Michael/0000-0002-9989-0650	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [TIR103946]; Ontario Neurotrauma Foundation [AUTO21]; Natural Sciences and Engineering Research Council (NSERC)Natural Sciences and Engineering Research Council of Canada (NSERC); Canadian Institutes of Health Research (CIHR)Canadian Institutes of Health Research (CIHR); Social Sciences and Humanities Research Council (SSHRC)Social Sciences and Humanities Research Council of Canada (SSHRC); Industry Canada; Ontario Ministry of Health and Long-Term CareMinistry of Health and Long-Term Care, Ontario	This work was financially supported by a Team Grant (TIR103946) from Canadian Institutes of Health Research and by funds from the Ontario Neurotrauma Foundation, AUTO21, a member of the Networks of Centres of Excellence (NCE) program that is administered and funded by the Natural Sciences and Engineering Research Council (NSERC), the Canadian Institutes of Health Research (CIHR), and the Social Sciences and Humanities Research Council (SSHRC), in partnership with Industry Canada. Drs. RM, HH and JR also acknowledge ongoing funding support from the Ontario Ministry of Health and Long-Term Care. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Active Healthy Kids Canada, 2014, IS CAN RUNN 2014 ACT; Anderson V, 2011, NEUROPSYCHOLOGY, V25, P176, DOI 10.1037/a0021217; Arria AM, 2011, ALCOHOL CLIN EXP RES, V35, P365, DOI 10.1111/j.1530-0277.2010.01352.x; Azagba Sunday, 2013, CMAJ Open, V1, pE19, DOI 10.9778/cmajo.20120017; Azagba S, 2014, PREV MED, V62, P54, DOI [10.1016/j.ypmed.2014.01.019, 10.1016/j.ypmed.2014.01.013]; Beauchamp MH, 2013, BRAIN INJURY, V27, P896, DOI 10.3109/02699052.2013.775486; Blakemore SJ, 2006, J CHILD PSYCHOL PSYC, V47, P296, DOI 10.1111/j.1469-7610.2006.01611.x; Brache K, 2011, ADDICT BEHAV, V36, P1133, DOI 10.1016/j.addbeh.2011.07.003; Cherpitel CJ, 2007, DRUG ALCOHOL REV, V26, P201, DOI 10.1080/09595230601146686; Cook LG, 2013, J INT NEUROPSYCH SOC, V19, P508, DOI 10.1017/S1355617712001452; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; Cusimano MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061865; DeMatteo CA, 2010, PEDIATRICS, V125, P327, DOI 10.1542/peds.2008-2720; Dicker BG, 1989, HEAD TRAUMA REHABIL, V4, P73; ESSELMAN PC, 1995, BRAIN INJURY, V9, P417, DOI 10.3109/02699059509005782; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Frances A, DSM 4 CLASSIFICATION; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Hamilton HA, 2013, CAN J PUBLIC HEALTH, V104, pE496, DOI 10.17269/cjph.104.3998; Heeringa SG., 2010, APPL SURVEY DATA ANA; Ilie G, 2015, J HEAD TRAUMA REHAB, V30, P293, DOI 10.1097/HTR.0000000000000101; Ilie G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094936; Ilie G, 2013, JAMA-J AM MED ASSOC, V309, P2550, DOI 10.1001/jama.2013.6750; Kay T., 1993, J HEAD TRAUMA REHABI, V8, P86, DOI [10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kenny DT, 2007, COMTEMPORARY ISSUES, V107, P1; Leon-Carrion J, 2003, BRAIN INJURY, V17, P207, DOI 10.1080/0269905021000010249; MacDonald N, 2010, CAN MED ASSOC J, V182, P1597, DOI 10.1503/cmaj.100953; Meier B, 2012, NY TIMES; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Miller KE, 2008, J AM COLL HEALTH, V56, P481, DOI 10.3200/JACH.56.5.481-490; National Center for Injury Prevention & Control, REP C MILD TRAUM BRA; Paglia-Boak A, 2013, CAMH RES DOCUMENT SE, V36; Peacock A, 2013, ALCOHOL CLIN EXP RES, V37, P1234, DOI 10.1111/acer.12086; Pharo H, 2011, BEHAV NEUROSCI, V125, P970, DOI 10.1037/a0025768; Reissig CJ, 2009, DRUG ALCOHOL DEPEN, V99, P1, DOI 10.1016/j.drugalcdep.2008.08.001; Terry-McElrath YM, 2014, J ADDICT MED, V8, P6, DOI 10.1097/01.ADM.0000435322.07020.53; Timonen M, 2002, PSYCHIAT RES, V113, P217, DOI 10.1016/S0165-1781(02)00269-X; Wolk BJ, 2012, CURR OPIN PEDIATR, V24, P243, DOI 10.1097/MOP.0b013e3283506827; Yeates K. O., 2010, PEDIAT NEUROPSYCHOLO, P112	40	18	19	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0135860	10.1371/journal.pone.0135860			13	Multidisciplinary Sciences	Science & Technology - Other Topics	CR8NH	WOS:000361610200009	26375286	DOAJ Gold, Green Published			2021-06-18	
J	Little, CE; Emery, C; Black, A; Scott, SH; Meeuwisse, W; Nettel-Aguirre, A; Benson, B; Dukelow, S				Little, C. Elaine; Emery, Carolyn; Black, Amanda; Scott, Stephen H.; Meeuwisse, Willem; Nettel-Aguirre, Alberto; Benson, Brian; Dukelow, Sean			Test-retest reliability of KINARM robot sensorimotor and cognitive assessment: in pediatric ice hockey players	JOURNAL OF NEUROENGINEERING AND REHABILITATION			English	Article							HIGH-SCHOOL; CONCUSSION; RECOVERY; TASK; SET; ADOLESCENTS; NUMBER; INJURY; ERROR; SENSE	Background: Better diagnostic and prognostic tools are needed to address issues related to early diagnosis and management of concussion across the continuum of aging but particularly in children and adolescents. The purpose of the current study was to evaluate the reliability of robotic technology (KINARM robot) assessments of reaching, position sense, bimanual motor function, visuospatial skills, attention and decision making in youth ice hockey players (ages 10-14). Methods: Thirty-four male children attended two testing days, one week apart. On day one, each subject completed five tasks on the robot with two examiners (alternating examiner sequence); the 2nd examiner followed the same procedure as the 1st immediately afterwards. One consistent examiner tested subjects one week later. This is a testretest reliability study. The robotic tasks characterize sensorimotor and/or cognitive performance; 63 parameters from 5 tasks are reported. Session 1 was the 1st time the subject performed the 5 tasks, session 2 the 2nd time on day 1, and session 3 one week following. Results: Intra-class correlation coefficients ranged from 0.06 to 0.91 and 0.09 to 0.90 for session 1 to 2 and 2 to 3, respectively. Bland-Altman plots showed agreement in a majority of the parameters and a learning effect in 25 % and 24 % of parameters in session 1 vs 2 and 1 vs 3, respectively but none for session 2 vs 3. Of those that showed a learning effect, only 8 % of parameters in session 1 vs 2 and 10 % in session 1 vs 3 had a clinical relevance measure >= 0.8. Conclusions: The relative homogeneity of the sample and the effect of learning seen in some of the task parameters appears to have negatively impacted the intra-class correlation coefficients from session 1 to 2, with less impact for 2 to 3. The Bland-Altman analysis supports good absolute reliability in healthy male children with no neurological impairment ranging in age from 10 to 14. The clinically relevant learning effect seen, in a small number of parameters could be addressed by creating a learning effect adjustment factor and/or implementing a practice session, which would eliminate the learning effect.	[Little, C. Elaine; Emery, Carolyn; Black, Amanda; Meeuwisse, Willem] Univ Calgary, Dept Kinesiol, Calgary, AB, Canada; [Scott, Stephen H.] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada; [Nettel-Aguirre, Alberto] Univ Calgary, Dept Pediat, Alberta Childrens Hosp, Calgary, AB T2N 1N4, Canada; [Nettel-Aguirre, Alberto] Univ Calgary, Dept Community Hlth Sci, Alberta Childrens Hosp, Calgary, AB, Canada; [Benson, Brian] Univ Calgary, Dept Clin Neurosci, Calgary, AB, Canada; [Dukelow, Sean] Univ Calgary, Dept Clin Neurosci, Hotchkiss Brain Inst, Calgary, AB, Canada	Little, CE (corresponding author), Univ Calgary, Dept Kinesiol, Calgary, AB, Canada.	littlec@ucalgary.ca	Emery, Carolyn/AAI-2761-2020; Black, Amanda/O-7675-2017; Meijer, Anna/K-5118-2016	Black, Amanda/0000-0001-5668-9706; Dukelow, Sean/0000-0002-0609-981X; Nettel-Aguirre, Alberto/0000-0001-6604-0652	Canadian Institutes Health Research Team Grant [201210]; Mild Traumatic Brain Injury in Children and Youth, Hotchkiss Brain Institute; Talisman Energy Fund in support of Healthy Living and Injury Prevention; Alberta Children's Hospital Research Institute for Child and Maternal Health; Alberta Innovates [201201160] Funding Source: researchfish	This work was supported by a Canadian Institutes Health Research Team Grant (201210): Mild Traumatic Brain Injury in Children and Youth, Hotchkiss Brain Institute (Co-PI's - CE, WM) and the Talisman Energy Fund in support of Healthy Living and Injury Prevention and the Alberta Children's Hospital Research Institute for Child and Maternal Health.	Alvarez GA, 2004, PSYCHOL SCI, V15, P106, DOI 10.1111/j.0963-7214.2004.01502006.x; [Anonymous], 2014, KINARM ROB US GUID; [Anonymous], 2012, INJ PREV CONTR TRAUM; Arbuthnott K, 2000, J CLIN EXP NEUROPSYC, V22, P518, DOI 10.1076/1380-3395(200008)22:4;1-0;FT518; Atkinson G, 1998, SPORTS MED, V26, P217, DOI 10.2165/00007256-199826040-00002; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1191/096228099673819272; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Chelune GJ, 1993, NEUROPSYCHOLOGY, V7, P41, DOI DOI 10.1037/0894-4105.7.1.41; Choe MC, 2012, CURR OPIN PEDIATR, V24, P689, DOI 10.1097/MOP.0b013e32835a1a44; Coderre AM, 2010, NEUROREHAB NEURAL RE, V24, P528, DOI 10.1177/1545968309356091; Cohen J., 1977, STAT POWER ANAL BEHA, P1; Dalecki MS, 2015, PROLONGED COGNITIVE; Davis GA, 2014, BRIT J SPORT MED, V48, P98, DOI 10.1136/bjsports-2012-092132; De Beaumont L, 2007, BRAIN INJURY, V21, P631, DOI 10.1080/02699050701426931; Debert CT, 2012, J NEUROL PHYS THER, V36, P58, DOI 10.1097/NPT.0b013e318254bd4f; Dukelow SP, 2012, J NEUROENG REHABIL, V9, DOI 10.1186/1743-0003-9-72; Dukelow SP, 2010, NEUROREHAB NEURAL RE, V24, P178, DOI 10.1177/1545968309345267; Fait P, 2013, J HEAD TRAUMA REHAB, V28, P293, DOI 10.1097/HTR.0b013e3182407ace; Field A. P, 2009, DISCOVERING STAT USI; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Fuelscher I, 2015, J EXP CHILD PSYCHOL, V140, P74, DOI 10.1016/j.jecp.2015.06.013; Halberda J, 2012, P NATL ACAD SCI USA, V109, P11116, DOI 10.1073/pnas.1200196109; Herter TM, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-43; Howell DR, 2014, EXP BRAIN RES, V232, P1773, DOI 10.1007/s00221-014-3869-1; Howell DR, 2013, ARCH PHYS MED REHAB, V94, P1513, DOI 10.1016/j.apmr.2013.04.015; Karlin AM, 2011, PM&R, V3, pS369, DOI 10.1016/j.pmrj.2011.07.015; KAZIS LE, 1989, MED CARE, V27, pS178, DOI 10.1097/00005650-198903001-00015; Langenecker SA, 2007, J CLIN EXP NEUROPSYC, V29, P842, DOI 10.1080/13803390601147611; Little CE, 2014, EXP BRAIN RES, V232, P2049, DOI 10.1007/s00221-014-3894-0; Mayfield R, 2013, ATHLETIC TRAINING SP, V5, P265, DOI DOI 10.3928/19425864-20131017-01; McClincy MP, 2006, BRAIN INJURY, V20, P33, DOI 10.1080/02699050500309817; McLeod TCV, 2006, J ATHL TRAINING, V41, P399; McLeod TCV, 2012, AM J SPORT MED, V40, P927, DOI 10.1177/0363546511431573; McLeod TCV, 2004, CLIN J SPORT MED, V14, P287, DOI 10.1097/00042752-200409000-00007; Moser RS, 2005, NEUROSURGERY, V57, P300, DOI 10.1227/01.NEU.0000166663.98616.E4; Ouatman-Yates C, 2014, PHYSICIAN SPORTSMED, V42, P32; Portney LG, 2009, FDN CLIN RES APPL PR; Register-Mihalik JK, 2012, J ATHL TRAINING, V47, P297, DOI 10.4085/1062-6050-47.3.13; Risdall JE, 2011, PHILOS T R SOC B, V366, P241, DOI 10.1098/rstb.2010.0230; Rishiraj N, 2009, J SPORT MED PHYS FIT, V49, P159; Ruff RM, 2011, NEUROREHABILITATION, V28, P167, DOI 10.3233/NRE-2011-0646; Soukup V M, 1998, Appl Neuropsychol, V5, P65, DOI 10.1207/s15324826an0502_2; Stewart TC, 2014, J TRAUMA ACUTE CARE, V76, P736, DOI 10.1097/TA.0b013e3182aafdf5; Stratford PW, 1997, PHYS THER, V77, P745, DOI 10.1093/ptj/77.7.745; Subbian V, 2014, IEEE ENG MED BIO, P5353, DOI 10.1109/EMBC.2014.6944835; TESTA MA, 1987, J HYPERTENS, V5, pS9; Tyryshkin K, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-47; van der Naalt J, 1999, ANN NEUROL, V46, P70, DOI 10.1002/1531-8249(199907)46:1<70::AID-ANA11>3.0.CO;2-L; Waljas M, 2015, J NEUROTRAUM, V32, P1; Wyrwich KW, 2000, J EVAL CLIN PRACT, V6, P39, DOI 10.1046/j.1365-2753.2000.00238.x	50	18	18	0	25	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1743-0003			J NEUROENG REHABIL	J. NeuroEng. Rehabil.	SEP 5	2015	12								78	10.1186/s12984-015-0070-0			18	Engineering, Biomedical; Neurosciences; Rehabilitation	Engineering; Neurosciences & Neurology; Rehabilitation	CQ4VT	WOS:000360603400001	26341424	DOAJ Gold, Green Published			2021-06-18	
J	Jaramillo, CA; Cooper, DB; Wang, CP; Tate, DF; Eapen, BC; York, GE; Pugh, MJ				Jaramillo, Carlos A.; Cooper, Douglas B.; Wang, Chen-Pin; Tate, David F.; Eapen, Blessen C.; York, Gerald E.; Pugh, Mary Jo			Subgroups of US IRAQ and Afghanistan veterans: associations with traumatic brain injury and mental health conditions	BRAIN IMAGING AND BEHAVIOR			English	Article						Veterans; Iraq; Afghanistan; TBI; PTSD; Latent class analysis	POSTTRAUMATIC-STRESS-DISORDER; PERSISTENT POSTCONCUSSIVE SYMPTOMS; SUBSTANCE USE DISORDERS; ENDURING FREEDOM; PTSD SYMPTOMS; WAR VETERANS; CHRONIC PAIN; LATENT CLASSES; MILITARY; CARE	U. S. veterans of Iraq and Afghanistan are known to have a high prevalence of traumatic brain injury (TBI), posttraumatic stress disorder (PTSD), and depression, which are often comorbid and share many symptoms. Attempts to describe this cohort by single diagnoses have limited our understanding of the complex nature of this population. The objective of this study was to identify subgroups of Iraq and Afghanistan veterans (IAVs) with distinct compositions of symptoms associated with TBI, PTSD, and depression. Our cross-sectional, observational study included 303,716 IAVs who received care in the Veterans Health Administration in 2010-2011. Symptoms and conditions were defined using International Classification of Diseases, Ninth Revision codes and symptom-clusters were identified using latent class analysis. We identified seven classes with distinct symptom compositions. One class had low probability of any condition and low health care utilization (HCU) (48 %). Other classes were characterized by high probabilities of mental health comorbidities (14 %); chronic pain and sleep disturbance (20 %); headaches and memory problems (6 %); and auditory problems (2.5 %). Another class had mental health comorbidities and chronic pain (7 %), and the last had high probabilities of most symptoms examined (3 %). These last two classes had the highest likelihood of TBI, PTSD, and depression and were identified as high healthcare utilizers. There are subgroups of IAVs with distinct clusters of symptom that are meaningfully associated with TBI, PTSD, depression, and HCU. Additional studies examining these veteran subgroups could improve our understanding of this complex comorbid patient population.	[Jaramillo, Carlos A.; Eapen, Blessen C.] South Texas Vet Healthcare Syst ALMD, Polytrauma Rehabil Ctr, San Antonio, TX 78229 USA; [Cooper, Douglas B.; Tate, David F.; York, Gerald E.] San Antonio Mil Med Ctr, Def & Vet Brain Injury Ctr, San Antonio, TX USA; [Wang, Chen-Pin; Pugh, Mary Jo] South Texas Vet Hlth Care Syst, Res & Dev, San Antonio, TX 78229 USA; [Wang, Chen-Pin; Pugh, Mary Jo] Univ Texas Hlth Sci Ctr San Antonio, Dept Epidemiol & Biostat, San Antonio, TX 78229 USA	Jaramillo, CA (corresponding author), South Texas Vet Healthcare Syst ALMD, Polytrauma Rehabil Ctr, 7400 Merton Minter Blvd 11C6, San Antonio, TX 78229 USA.	jaramilloc3@uthscsa.edu; douglas.b.cooper.ctr@mail.mil; wangc3@uthscsa.edu; dftatephd@mac.com; Blessen.Eapen2@va.gov; gerald.e.york4.mil@mail.mil; maryjo.pugh2@va.gov	Pugh, Mary Jo/K-5336-2019; Tate, David F/I-3963-2013	Pugh, Mary Jo/0000-0003-4196-7763; Tate, David F/0000-0003-0213-1920	VA Health Services Research and DevelopmentUS Department of Veterans Affairs [DHI 09-237]; Veterans AffairsUS Department of Veterans Affairs [I01HX000329] Funding Source: NIH RePORTER	The study was funded by VA Health Services Research and Development (DHI 09-237).	Afari N, 2009, HEADACHE, V49, P1267, DOI 10.1111/j.1526-4610.2009.01517.x; Association A. P, 2000, DIAGN STAT MAN MENT; Bandeen-Roche K, 1997, J AM STAT ASSOC, V92, P1375, DOI 10.2307/2965407; Belanger H. G., 2012, VALIDITY VET HLTH AD; Belanger HG, 2009, J HEAD TRAUMA REHAB, V24, P4, DOI 10.1097/HTR.0b013e3181957032; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Borzecki AM, 2004, AM J MED QUAL, V19, P201, DOI 10.1177/106286060401900504; Boscarino JA, 2006, ANN EPIDEMIOL, V16, P248, DOI 10.1016/j.annepidem.2005.03.009; Carlson KF, 2011, J HEAD TRAUMA REHAB, V26, P103, DOI 10.1097/HTR.0b013e3181e50ef1; Carlson KF, 2010, J TRAUMA STRESS, V23, P17, DOI 10.1002/jts.20483; Cifu DX, 2013, J REHABIL RES DEV, V50, P1169, DOI 10.1682/JRRD.2013.01.0006; Cohen BE, 2009, JAMA-J AM MED ASSOC, V302, P489, DOI 10.1001/jama.2009.1084; Elbogen EB, 2013, PSYCHIAT SERV, V64, P134, DOI 10.1176/appi.ps.004792011; Frayne SM, 2011, J GEN INTERN MED, V26, P33, DOI 10.1007/s11606-010-1497-4; Friedemann-Sanchez G, 2008, ARCH PHYS MED REHAB, V89, P171, DOI 10.1016/j.apmr.2007.10.017; Gondusky JS, 2005, MIL MED, V170, P546, DOI 10.7205/MILMED.170.6.546; Hart T, 2004, ARCH PHYS MED REHAB, V85, P1450, DOI 10.1016/j.apmr.2004.01.030; Hebenstreit C, 2014, J AFFECT DISORDERS, V166, P132, DOI 10.1016/j.jad.2014.04.061; Hill JJ, 2009, AM J PHYS MED REHAB, V88, P605, DOI 10.1097/PHM.0b013e3181ae0f83; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2006, JAMA-J AM MED ASSOC, V295, P1023, DOI 10.1001/jama.295.9.1023; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Holowka DW, 2014, J CONSULT CLIN PSYCH, V82, P569, DOI 10.1037/a0036347; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Jacobsen LK, 2001, AM J PSYCHIAT, V158, P1184, DOI 10.1176/appi.ajp.158.8.1184; Kang HK, 2003, AM J EPIDEMIOL, V157, P141, DOI 10.1093/aje/kwf187; Landy PJB, 1998, INJURY, V29, P199, DOI 10.1016/S0020-1383(97)00178-2; Lanza S.T., 2012, HDB PSYCHOL, V2, P691; Lew HL, 2007, J REHABIL RES DEV, V44, P1027, DOI 10.1682/JRRD.2007.05.0073; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Maguen S, 2013, J AFFECT DISORDERS, V145, P344, DOI 10.1016/j.jad.2012.08.021; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; McDevitt-Murphy ME, 2010, J TRAUMA STRESS, V23, P108, DOI 10.1002/jts.20482; Murray CK, 2005, MIL MED, V170, P516, DOI 10.7205/MILMED.170.6.516; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Norman RS, 2013, BRAIN INJURY, V27, P1623, DOI 10.3109/02699052.2013.834380; Norrie J, 2010, BRAIN INJURY, V24, P1528, DOI 10.3109/02699052.2010.531687; Possemato K, 2010, PSYCHOL TRAUMA-US, V2, P218, DOI 10.1037/a0019236; Pugh MJV, 2014, MED CARE, V52, P172, DOI 10.1097/MLR.0000000000000059; Romesser J, 2012, J REHABIL RES DEV, V49, P1127, DOI 10.1682/JRRD.2010.12.0238; Ruff RL, 2008, J REHABIL RES DEV, V45, P941, DOI 10.1682/JRRD.2008.02.0028; Sayer NA, 2009, J REHABIL RES DEV, V46, P703, DOI 10.1682/JRRD.2009.01.0008; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Scholten JD, 2012, BRAIN INJURY, V26, P1177, DOI 10.3109/02699052.2012.661914; Seal KH, 2007, ARCH INTERN MED, V167, P476, DOI 10.1001/archinte.167.5.476; Selim Alfredo J, 2004, J Ambul Care Manage, V27, P281; Sigford BJ, 2008, ARCH PHYS MED REHAB, V89, P160, DOI 10.1016/j.apmr.2007.09.015; Stroupe KT, 2013, J REHABIL RES DEV, V50, P1047, DOI 10.1682/JRRD.2012.06.0107; UOMOTO JM, 1993, ARCH PHYS MED REHAB, V74, P61; Vanderploeg RD, 2007, J CLIN EXP NEUROPSYC, V29, P585, DOI 10.1080/13803390600826587; Vanderploeg RD, 2012, ARCH PHYS MED REHAB, V93, P1887, DOI 10.1016/j.apmr.2012.05.024; Walker W. C., 2012, J HEAD TRAUMA REHAB, V38, P329; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004	53	18	18	0	4	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1931-7557	1931-7565		BRAIN IMAGING BEHAV	Brain Imaging Behav.	SEP	2015	9	3					445	455		10.1007/s11682-015-9402-8			11	Neuroimaging	Neurosciences & Neurology	CR8LQ	WOS:000361604300006	25963862				2021-06-18	
J	Li, J; Yu, C; Sun, Y; Li, YY				Li, Jian; Yu, Chao; Sun, Yang; Li, Yuyuan			Serum ubiquitin C-terminal hydrolase L1 as a biomarker for traumatic brain injury: a systematic review and meta-analysis	AMERICAN JOURNAL OF EMERGENCY MEDICINE			English	Article							ALPHA-II-SPECTRIN; DIAGNOSIS; PROTEIN; PROGNOSIS; MODERATE; UTILITY; PLASMA; IMPACT; MILD	Objective: Serum ubiquitin C-terminal hydrolase L1 (UCH-L1) has been proposed as a biomarker of traumatic brain injury (TBI). However, previous studies on levels of UCH-L1 in serum remain inconsistent. This systematic review andmeta-analysis were conducted on observational studies that reported the association between serum UCH-L1 levels and TBI. Methods: Studies were identified by searching PubMed and ISI Web of Science up to February 2015. For the continuous outcomes, we calculated the weighted mean difference and 95% confidence interval. The statistical analysis was performed by RevMan 5.1 and Stata 12 software. Only case-control studies were included if they had data on serum UCH-L1 levels in TBI patients and healthy controls. Funnel plot and Egger's regression test were applied to assess the potential publication bias. Results: Of the 145 selected studies, 11 observational studies (including 9 case-control and 2 case-crossover studies) met the selection criteria, containing a total of 1138 TBI cases and 1373 controls. Finally, 5 case-control studies (including 673 TBI and 1004 controls) were eligible for the present meta-analysis. The results of our study showed that there was a significant increase in serum UCH-L1 levels in patients with TBI compared to controls (weighted mean difference, 0.96; 95% confidence interval, 0.31-1.61; P = .004). Conclusion: In conclusion, TBI cases had higher serum UCH-L1 concentrations than matched controls. This reinforces the conceptualization of UCH-L1 as a potential biomarker of TBI. (C) 2015 Elsevier Inc. All rights reserved.	[Li, Jian] Dalian Univ, Xinhua Hosp, Dept Orthopaed, Dalian 116021, Peoples R China; [Yu, Chao] Dalian Univ, Coll Life Sci & Technol, Dalian 116622, Peoples R China; [Sun, Yang; Li, Yuyuan] Dalian Med Univ, Inst Brain Disorders, Liaoning Prov Key Lab Cerebral Dis, Dalian 116044, Peoples R China	Li, YY (corresponding author), Dalian Med Univ, Inst Brain Disorders, Liaoning Prov Key Lab Brain Dis, Dalian 116044, Peoples R China.	liyuyuan831221@163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [61302030]; Educational Commission of Liaoning Province of China [L2012320]; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R01CA141479] Funding Source: NIH RePORTER	This work was supported by the National Natural Science Foundation of China (no. 61302030) and the Educational Commission of Liaoning Province of China (no. L2012320).	Aleksovska K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106342; Berger RP, 2012, J NEUROTRAUM, V29, P162, DOI 10.1089/neu.2011.1989; Blyth BJ, 2011, J NEUROTRAUM, V28, P2453, DOI 10.1089/neu.2010.1653; Brophy GM, 2011, J NEUROTRAUM, V28, P861, DOI 10.1089/neu.2010.1564; Chalak LF, 2014, J PEDIATR-US, V164, P468, DOI 10.1016/j.jpeds.2013.10.067; Cheng F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106680; Czeiter E, 2012, J NEUROTRAUM, V29, P1770, DOI 10.1089/neu.2011.2127; Daoud H, 2014, NEUROCRIT CARE, V20, P427, DOI 10.1007/s12028-013-9879-1; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P19, DOI 10.1089/neu.2013.3040; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Ioannidis JPA, 2011, JAMA-J AM MED ASSOC, V305, P2200, DOI 10.1001/jama.2011.713; Kou ZF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080296; Levin HS, 2015, LANCET NEUROL, V14, P506, DOI 10.1016/S1474-4422(15)00002-2; Lewis SB, 2010, J NEUROSCI RES, V88, P1475, DOI 10.1002/jnr.22323; Liu MC, 2010, EUR J NEUROSCI, V31, P722, DOI 10.1111/j.1460-9568.2010.07097.x; Mercier E, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1757; Mondello S, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-85; Mondello S, 2012, J NEUROTRAUM, V29, P1096, DOI 10.1089/neu.2011.2092; Mondello S, 2012, NEUROSURGERY, V70, P666, DOI 10.1227/NEU.0b013e318236a809; Mondello S, 2011, CRIT CARE, V15, DOI 10.1186/cc10286; Pang L, 2014, CLIN BIOCHEM, V47, P72, DOI 10.1016/j.clinbiochem.2013.09.015; Papa L, 2013, J NEUROTRAUM, V30, P324, DOI 10.1089/neu.2012.2545; Papa L, 2012, J TRAUMA ACUTE CARE, V72, P1335, DOI 10.1097/TA.0b013e3182491e3d; Papa L, 2010, CRIT CARE MED, V38, P138, DOI 10.1097/CCM.0b013e3181b788ab; Plog BA, 2015, EXPERT REV NEUROTHER, V30, P1; Puvenna V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096296; Ren CH, 2013, BRAIN RES, V1540, P84, DOI 10.1016/j.brainres.2013.09.051; Roger VL, 1997, CIRCULATION, V95, P405; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Strathmann FG, 2014, CLIN BIOCHEM, V47, P876, DOI 10.1016/j.clinbiochem.2014.01.028; WILKINSON KD, 1989, SCIENCE, V246, P670, DOI 10.1126/science.2530630; Yokobori S, 2013, CNS NEUROSCI THER, V19, P556, DOI 10.1111/cns.12127; Zetterberg H, 2015, MOL CELL NEUROSCI, V66, P99, DOI 10.1016/j.mcn.2015.02.003	33	18	19	0	15	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0735-6757	1532-8171		AM J EMERG MED	Am. J. Emerg. Med.	SEP	2015	33	9					1191	1196		10.1016/j.ajem.2015.05.023			6	Emergency Medicine	Emergency Medicine	CQ9GG	WOS:000360920700015	26087705				2021-06-18	
J	Albrecht, JS; Kiptanui, Z; Tsang, Y; Khokhar, B; Smith, GS; Zuckerman, IH; Simoni-Wastila, L				Albrecht, Jennifer S.; Kiptanui, Zippora; Tsang, Yuen; Khokhar, Bilal; Smith, Gordon S.; Zuckerman, Ilene H.; Simoni-Wastila, Linda			Patterns of Depression Treatment in Medicare Beneficiaries with Depression after Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						antidepressants; depression; older adults; traumatic brain injury	LATE-LIFE DEPRESSION; CLAIMS DATABASE ANALYSIS; MAJOR DEPRESSION; ANTIDEPRESSANT TREATMENT; NATURAL-HISTORY; UNITED-STATES; OLDER; RISK; METAANALYSIS; MORTALITY	There are no clinical guidelines addressing the management of depression after traumatic brain injury (TBI). The objectives of this study were to (1) describe depression treatment patterns among Medicare beneficiaries with a diagnosis of depression post-TBI; (2) compare them with depression treatment patterns among beneficiaries with a diagnosis of depression pre-TBI; and (3) quantify the difference in prevalence of use. We conducted a retrospective analysis of Medicare beneficiaries hospitalized with TBI during 2006-2010. We created two cohorts: beneficiaries with a new diagnosis of depression pre-TBI (n=4841) and beneficiaries with a new diagnosis of depression post-TBI (n=4668). We searched for antidepressant medications in Medicare Part D drug event files and created variables indicating antidepressant use in each 30-day period after diagnosis of depression. We used provider specialty and current procedural terminology to identify psychotherapy in any location. We used generalized estimating equations to quantify the effect of TBI on receipt of depression treatment during the year after diagnosis of depression. Average monthly prevalence of antidepressant use was 42% among beneficiaries with a diagnosis of depression pre-TBI and 36% among those with a diagnosis post-TBI (p<0.001). Beneficiaries with a diagnosis of depression post-TBI were less likely to receive antidepressants compared with a depression diagnosis pre-TBI (adjusted odds ratio [OR] 0.87; 95% confidence interval [CI] 0.82, 0.92). There was no difference in receipt of psychotherapy between the two groups (OR 1.08; 95% CI 0.93, 1.26). Depression after TBI is undertreated among older adults. Knowledge about reasons for this disparity and its long-term effects on post-TBI outcomes is limited and should be examined in future work.	[Albrecht, Jennifer S.] Univ Maryland, Sch Med, Dept Epidemiol & Publ Hlth, Baltimore, MD 21201 USA; [Kiptanui, Zippora; Zuckerman, Ilene H.] IMPAQ Int LLC, Columbia, MD USA; [Tsang, Yuen; Khokhar, Bilal; Zuckerman, Ilene H.; Simoni-Wastila, Linda] Univ Maryland, Sch Pharm, Dept Pharmaceut Hlth Serv Res, Baltimore, MD 21201 USA; [Smith, Gordon S.] Univ Maryland, STAR Organized Res Ctr, Natl Study Ctr Trauma & Emergency Med Serv, Baltimore, MD 21201 USA	Albrecht, JS (corresponding author), Univ Maryland, Sch Med, Dept Epidemiol & Publ Hlth, MSTF 334C,10 S Pine St, Baltimore, MD 21201 USA.	jalbrecht@epi.umaryland.edu		Smith, Gordon/0000-0002-2911-3071; Albrecht, Jennifer/0000-0003-4838-2274	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R21 AG042768-01, T32AG000262-14]; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [T32AG000262, R21AG042768] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISMUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [R01AA018313] Funding Source: NIH RePORTER	This work was supported by National Institutes of Health grant R21 AG042768-01 (Zuckerman, PI). Dr. Albrecht and Mr. Khokhar are supported by National Institutes of Health grant T32AG000262-14 (Magaziner, PI).	Albrecht J.S., 2015, J HEAD TRAUMA REHABI; Barry LC, 2012, J AFFECT DISORDERS, V136, P789, DOI 10.1016/j.jad.2011.09.038; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Centers for Medicare & Medicaid Services, 2011, CHRON COND MED BEN; Chen YH, 2011, STROKE, V42, P2733, DOI 10.1161/STROKEAHA.111.620112; Coupland C, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4551; Dikmen SS, 2004, ARCH PHYS MED REHAB, V85, P1457, DOI 10.1016/j.apmr.2003.12.041; DiMatteo MR, 2000, ARCH INTERN MED, V160, P2101, DOI 10.1001/archinte.160.14.2101; DINAN TG, 1992, ACTA PSYCHIAT SCAND, V85, P292, DOI 10.1111/j.1600-0447.1992.tb01472.x; Fann JR, 2009, J NEUROTRAUM, V26, P2383, DOI 10.1089/neu.2009.1091; Fann JR, 2000, J NEUROPSYCH CLIN N, V12, P226, DOI 10.1176/appi.neuropsych.12.2.226; Faul M.D., 2010, TRAUMATIC BRAIN INJU; FEDOROFF JP, 1992, AM J PSYCHIAT, V149, P918; Grenard JL, 2011, J GEN INTERN MED, V26, P1175, DOI 10.1007/s11606-011-1704-y; Gubler KD, 1997, ARCH SURG-CHICAGO, V132, P1010; Hollon SD, 2005, J CLIN PSYCHIAT, V66, P455, DOI 10.4088/JCP.v66n0408; JORGE RE, 1994, J NEUROSURG, V81, P726, DOI 10.3171/jns.1994.81.5.0726; Livingston DH, 2005, J TRAUMA, V59, P1298, DOI 10.1097/01.ta.0000196002.03681.18; Marr AL., 2004, CENTRAL NERVOUS SYST; Menzel JC, 2008, BRAIN INJURY, V22, P375, DOI 10.1080/02699050802001492; Milea D, 2010, CLIN THER, V32, P2057, DOI 10.1016/j.clinthera.2010.11.011; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; Nelson JC, 2008, AM J GERIAT PSYCHIAT, V16, P558, DOI 10.1097/JGP.0b013e3181693288; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; Perino C, 2001, BRAIN INJURY, V15, P139, DOI 10.1080/026990501458371; Qian JJ, 2013, J AM GERIATR SOC, V61, P754, DOI 10.1111/jgs.12220; Rapoport MJ, 2006, J AFFECT DISORDERS, V92, P273, DOI 10.1016/j.jad.2005.05.022; Rapoport MJ, 2012, CNS DRUGS, V26, P111, DOI 10.2165/11599560-000000000-00000; Rosenthal M, 1998, ARCH PHYS MED REHAB, V79, P90, DOI 10.1016/S0003-9993(98)90215-5; Sanglier T, 2011, J AM GERIATR SOC, V59, P1197, DOI 10.1111/j.1532-5415.2011.03457.x; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Steffens DC, 2000, ARCH GEN PSYCHIAT, V57, P601, DOI 10.1001/archpsyc.57.6.601; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004; Tedeschini E, 2011, J CLIN PSYCHIAT, V72, P1660, DOI 10.4088/JCP.10r06531; Thompson HJ, 2012, J NEUROTRAUM, V29, P1864, DOI 10.1089/neu.2011.2284; Thurman DJ., 1995, GUIDELINES SURVEILLA; Trifiro G, 2010, J CLIN PSYCHOPHARM, V30, P252, DOI 10.1097/JCP.0b013e3181dca10a; Turner-Stokes L, 2002, CLIN REHABIL, V16, P261, DOI 10.1191/0269215502cr489oa; Unutzer J, 2007, NEW ENGL J MED, V357, P2269, DOI 10.1056/NEJMcp073754; Utomo WK, 2009, INJURY, V40, P973, DOI 10.1016/j.injury.2009.05.034; Vaishnavi S, 2009, PSYCHOSOMATICS, V50, P198, DOI 10.1176/appi.psy.50.3.198; Valuck RJ, 2009, J CLIN PSYCHIAT, V70, P1069, DOI 10.4088/JCP.08m04943; Warden DL, 2006, J NEUROTRAUM, V23, P1468, DOI 10.1089/neu.2006.23.1468; Whenlan-Goodinson R., 2009, J HEAD TRAUMA REHAB, V24, P324; Wilson KCM, 1999, BRIT J PSYCHIAT, V175, P439, DOI 10.1192/bjp.175.5.439; Wroblewski BA, 1996, J CLIN PSYCHIAT, V57, P582, DOI 10.4088/JCP.v57n1206; Wu CS, 2011, AM J PSYCHIAT, V168, P511, DOI 10.1176/appi.ajp.2010.10071064	48	18	18	0	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	AUG 15	2015	32	16					1223	1229		10.1089/neu.2014.3651			7	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	CU9RU	WOS:000363883400006	25526613	Green Published			2021-06-18	
J	Kim, H; Cam-Etoz, B; Zhai, GH; Hubbard, WJ; Zinn, KR; Chaudry, IH				Kim, Hyunki; Cam-Etoz, Betul; Zhai, Guihua; Hubbard, William J.; Zinn, Kurt R.; Chaudry, Irshad H.			Salutary Effects of Estrogen Sulfate for Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						DTI; estrogen; PET; TBI	DIFFUSE AXONAL INJURY; SEVERE HEAD-INJURY; INTRACRANIAL-PRESSURE; 17-BETA-ESTRADIOL; HEMORRHAGE; PERFORMANCE; HORMONES; RATS; PET; PROTECTION	Estrogen plays an important role as a neuroprotector in the central nervous system (CNS), directly interacting with neurons and regulating physiological properties of non-neuronal cells. Here we evaluated estrogen sulfate (E-2-SO4) for traumatic brain injury (TBI) using a Sprague-Dawley rat model. TBI was induced via lateral fluid percussion (LFP) at 24h after craniectomy. E-2-SO4 (1mg/kg BW in 1mL/kg BW) or saline (served as control) was intravenously administered at 1h after TBI (n=5/group). Intracranial pressure (ICP), cerebral perfusion pressure (CPP), and partial brain oxygen pressure (pbtO(2)) were measured for 2h (from 23 to 25h after E-2-SO4 injection). Brain edema and diffuse axonal injury (DAI) were assessed by diffusion tensor imaging (DTI), and cerebral glycolysis was measured by F-18-labeled fluorodeoxyglucose (FDG) positron emission tomography (PET) imaging, at 1 and 7 days after E-2-SO4 injection. E-2-SO4 significantly decreased ICP, while increasing CPP and pbtO(2) (p<0.05) as compared with vehicle-treated TBI rats. The edema size in the brains of the E-2-SO4 treated group was also significantly smaller than that of vehicle-treated group at 1 day after E-2-SO4 injection (p=0.04), and cerebral glycolysis of injured region was also increased significantly during the same time period (p=0.04). However, E-2-SO4 treatment did not affect DAI (p>0.05). These findings demonstrated the potential benefits of E-2-SO4 in TBI.	[Kim, Hyunki; Zhai, Guihua; Zinn, Kurt R.] Univ Alabama Birmingham, Dept Radiol, Birmingham, AL 35294 USA; [Cam-Etoz, Betul; Hubbard, William J.; Chaudry, Irshad H.] Univ Alabama Birmingham, Dept Surg, Birmingham, AL 35294 USA	Chaudry, IH (corresponding author), Univ Alabama Birmingham, Dept Surg, Surg Res Ctr, 1670 Univ Blvd,Volker Hall, Birmingham, AL 35294 USA.	IChaudry@uab.edu		Zinn, Kurt/0000-0001-7463-4741	United States Army Medical Research and Material Command, Office of Congressional Directed Medical Research Program in TBI of the Department of Defense [W81XWH-08-20153]	We give special thanks to Dr. Ahmar Ayub for TBI induction in rats, data collection, and analyses. Also, we thank Nicole Day and Tracy Niedzielko for their assistance in animal TBI induction, and Dr. Candace Floyd for letting us use her TBI induction instrument. This study was supported by the United States Army Medical Research and Material Command, Office of Congressional Directed Medical Research Program in TBI W81XWH-08-20153 of the Department of Defense to I.H.C.	Akabori H, 2010, SHOCK, V33, P43, DOI 10.1097/SHK.0b013e3181b0ebcb; Angele MK, 2008, CRIT CARE, V12, DOI 10.1186/cc6919; Beyer C, 1999, ANAT EMBRYOL, V199, P379, DOI 10.1007/s004290050236; Bodanapally UK, 2013, NEURORADIOLOGY, V55, P771, DOI 10.1007/s00234-013-1166-5; Byrnes Kimberly R, 2014, Front Neuroenergetics, V5, P13, DOI 10.3389/fnene.2013.00013; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Choudhry MA, 2005, SHOCK, V24, P101, DOI 10.1097/01.shk.0000191341.31530.5e; Choudhry MA, 2008, J LEUKOCYTE BIOL, V83, P518, DOI 10.1189/jlb.0607369; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Dandekar M, 2007, J NUCL MED, V48, P602, DOI 10.2967/jnumed.106.036608; Day NL, 2013, J NEUROTRAUM, V30, P1531, DOI 10.1089/neu.2013.2854; DeWitt D. S., 1995, NEW HORIZ, V3, P376; Farwell MD, 2014, CANCER-AM CANCER SOC, V120, P3433, DOI 10.1002/cncr.28860; Faul M.D., 2010, TRAUMATIC BRAIN INJU; FEARNSIDE MR, 1993, BRIT J NEUROSURG, V7, P267, DOI 10.3109/02688699309023809; Floyd CL, 2002, J NEUROTRAUM, V19, P303, DOI 10.1089/089771502753594873; Garcia-Panach J, 2011, J NEUROTRAUM, V28, P1707, DOI 10.1089/neu.2011.1851; GARCIASEGURA LM, 1994, PROG NEUROBIOL, V44, P279, DOI 10.1016/0301-0082(94)90042-6; Hiler M, 2006, J NEUROSURG, V104, P731, DOI 10.3171/jns.2006.104.5.731; Kawasaki T, 2012, J ANESTH, V26, P883, DOI 10.1007/s00540-012-1425-3; Khaksari M, 2013, CAN J PHYSIOL PHARM, V91, P700, DOI 10.1139/cjpp-2012-0359; Kim H, 2011, MOL IMAGING BIOL, V13, P94, DOI 10.1007/s11307-010-0320-2; Lafrenaye AD, 2012, J CEREBR BLOOD F MET, V32, P1919, DOI 10.1038/jcbfm.2012.95; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Lee TT, 1998, ACTA NEUROCHIR, V140, P41, DOI 10.1007/s007010050055; Liu R, 2010, J PHARMACOL EXP THER, V332, P1006, DOI 10.1124/jpet.109.160937; Liu YR, 2010, J NUCL MED, V51, P1788, DOI 10.2967/jnumed.110.078626; Ljungqvist J, 2011, BRAIN INJURY, V25, P370, DOI 10.3109/02699052.2011.558038; McEwen B, 2002, RECENT PROG HORM RES, V57, P357, DOI 10.1210/rp.57.1.357; Murakami Y, 2012, J NEUROSCI METH, V203, P115, DOI 10.1016/j.jneumeth.2011.09.025; Neter J., 1996, APPL LINEAR STAT MOD; Ratib O, 2010, J NUCL MED, V51, DOI 10.2967/jnumed.110.076125; Roof RL, 2000, J NEUROTRAUM, V17, P1155, DOI 10.1089/neu.2000.17.1155; Seif M., 2014, J MAGN RESON IMAGING; Selwyn R, 2013, J NEUROTRAUM, V30, P1943, DOI 10.1089/neu.2013.2928; Seo JP, 2012, NEUROREHABILITATION, V30, P323, DOI 10.3233/NRE-2012-0762; Shahrokhi N, 2012, PAK J PHARM SCI, V25, P219; Siriphorn A, 2012, J COMP NEUROL, V520, P2630, DOI 10.1002/cne.23056; Stein Donald G, 2003, Pediatr Rehabil, V6, P13, DOI 10.1080/1363849031000095279; Stocchetti N, 2007, J NEUROTRAUM, V24, P1339, DOI 10.1089/neu.2007.0300; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Watts R, 2014, RADIOLOGY, V272, P217, DOI 10.1148/radiol.14131856; Yu HP, 2009, SHOCK, V31, P227, DOI 10.1097/SHK.0b013e31818347e7; Zuccoli G, 2014, NEURORADIOLOGY, V56, P679, DOI 10.1007/s00234-014-1379-2	44	18	19	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	AUG 15	2015	32	16					1210	1216		10.1089/neu.2014.3771			7	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	CU9RU	WOS:000363883400004	25646701	Green Published			2021-06-18	
J	Chen, S; Yu, SY; Yan, HD; Cai, JY; Ouyang, YM; Ruan, HJ; Fan, CY				Chen, Shuai; Yu, Shi-yang; Yan, Hede; Cai, Jiang-yu; Ouyang, Yuanming; Ruan, Hong-jiang; Fan, Cun-yi			The time point in surgical excision of heterotopic ossification of post-traumatic stiff elbow: recommendation for early excision followed by early exercise	JOURNAL OF SHOULDER AND ELBOW SURGERY			English	Article						Post-traumatic heterotopic ossification; elbow stiffness; time point; early excision; surgical excision	TRAUMATIC BRAIN-INJURY; RADIOULNAR SYNOSTOSIS; ANTERIOR CAPSULOTOMY; FLEXION CONTRACTURE; OPERATIVE TREATMENT; RELEASE; FOREARM; MOTION; BONE; ARTHROLYSIS	Background: Post-traumatic heterotopic ossification (HO) around the elbow may severely impair joint function. Although surgical excision is effective at restoring range of motion (ROM), traditional surgical treatment is postponed for at least 1 year to prevent recurrence, which leads to secondary contracture of the elbow. Because the optimal timing of resection is controversial, our study was performed to compare recurrence and elbow function between early and late excision in our patients to determine whether the delay is necessary. Methods: We retrospectively reviewed 164 patients during a 4-year period. In the control group (112 patients), HO was excised at an average of 23.0 months after initial injury (range, 9-204 months); in the early excision group (52 patients), resection was performed at an average of 6.1 months (range, 3-8 months). HO recurrence was assessed by the Hastings classification system. Final ROM and Mayo Elbow Performance Scores were also evaluated. Results: Recurrent HO was observed in 30 of 112 patients (26.8%) in the control group and 15 of 52 (28.9%) in early excision group. No significant difference in HO recurrence was found between the 2 groups (P = .942). Moreover, there were no notable differences regarding ROM, Mayo Elbow Performance Scores, and complications postoperatively. Conclusions: Early excision associated with early exercise is effective for the treatment of HO aiming at a low recurrence rate and satisfactory function. The conventional surgical delay of more than 1 year may be shortened. (C) 2015 Journal of Shoulder and Elbow Surgery Board of Trustees.	[Chen, Shuai; Yu, Shi-yang; Cai, Jiang-yu; Ouyang, Yuanming; Ruan, Hong-jiang; Fan, Cun-yi] Shanghai Jiao Tong Univ, Dept Orthopaed, Affiliated Peoples Hosp 6, Shanghai 200233, Peoples R China; [Yan, Hede] Wenzhou Med Univ, Affiliated Hosp 2, Dept Orthopaed, Div Plast & Hand Surg, Wenzhou, Peoples R China	Fan, CY (corresponding author), Shanghai Jiao Tong Univ, Dept Orthopaed, Affiliated Peoples Hosp 6, 600 Yishan Rd, Shanghai 200233, Peoples R China.	fancunyi888@hotmail.com	fan, cunyi/ABI-7199-2020	fan, cunyi/0000-0002-7854-5233	Project of Advanced and Appropriate Technology of Shanghai Municipal Commission of Health and Family Planning [2013SY043]; Science and Technology Project of Pudong New Area Health Bureau of Shanghai [PW2013D-7]	This article was supported by the Project of Advanced and Appropriate Technology of Shanghai Municipal Commission of Health and Family Planning (2013SY043) and Science and Technology Project of Pudong New Area Health Bureau of Shanghai (PW2013D-7). The authors declare that the funders had no role in data collection, data analysis, or preparation or editing of the manuscript.	ABRAMS RA, 1993, J HAND SURG-AM, V18A, P703, DOI 10.1016/0363-5023(93)90322-T; Aldridge JM, 2004, J BONE JOINT SURG AM, V86A, P1955, DOI 10.2106/00004623-200409000-00014; Bauer AS, 2012, J HAND SURG-AM, V37A, P1422, DOI 10.1016/j.jhsa.2012.03.013; Beingessner DM, 2000, J HAND SURG-AM, V25A, P483, DOI 10.1053/jhsu.2000.6922; Botte MJ, 1997, ORTHOPEDICS, V20, P335; Breborowicz M, 2014, INT ORTHOP, V38, P561, DOI 10.1007/s00264-013-2172-2; Brinsden Mark D, 2008, J Orthop Surg Res, V3, P39, DOI 10.1186/1749-799X-3-39; Chalidis B, 2007, J NEUROTRAUM, V24, P1675, DOI 10.1089/neu.2007.0342; Charalambous CP, 2012, J BONE JOINT SURG AM, V94A, P1428, DOI 10.2106/JBJS.K.00711; Cipriano CA, 2009, J AM ACAD ORTHOP SUR, V17, P689, DOI 10.5435/00124635-200911000-00003; Darlis NA, 2006, J SHOULDER ELB SURG, V15, P709, DOI 10.1016/j.jse.2006.01.006; Djurickovic S, 1996, J TRAUMA, V41, P825, DOI 10.1097/00005373-199611000-00010; Ellerin BE, 1999, AM J PHYS MED REHAB, V78, P259, DOI 10.1097/00002060-199905000-00016; EVANS EB, 1991, CLIN ORTHOP RELAT R, P94; Evans PJ, 2009, J HAND SURG-AM, V34A, P769, DOI 10.1016/j.jhsa.2009.02.020; Everding NG, 2013, J HAND SURG-AM, V38A, P2496, DOI 10.1016/j.jhsa.2013.06.007; GARLAND DE, 1982, CLIN ORTHOP RELAT R, P38; GARLAND DE, 1985, J BONE JOINT SURG AM, V67A, P1261, DOI 10.2106/00004623-198567080-00019; GARLAND DE, 1980, J BONE JOINT SURG AM, V62, P1143, DOI 10.2106/00004623-198062070-00012; GARLAND DE, 1991, CLIN ORTHOP RELAT R, P13; GATES HS, 1992, J BONE JOINT SURG AM, V74A, P1229, DOI 10.2106/00004623-199274080-00013; HASTINGS H, 1994, HAND CLIN, V10, P417; HOFFER MM, 1978, J TRAUMA, V18, P667, DOI 10.1097/00005373-197809000-00009; Ippolito E, 1999, CLIN ORTHOP RELAT R, P130, DOI 10.1097/00003086-199908000-00018; Jupiter JB, 1998, J BONE JOINT SURG AM, V80A, P248, DOI 10.2106/00004623-199802000-00012; Koh KH, 2013, J SHOULDER ELB SURG, V22, P1128, DOI 10.1016/j.jse.2013.04.019; Lacey BW, 2011, PM&R, V3, P982, DOI 10.1016/j.pmrj.2011.06.004; Liu S, 2011, J TRAUMA, V70, P373, DOI 10.1097/TA.0b013e3181e4f5e3; LUNDBORG G, 1992, J HAND SURG-BRIT EUR, V17B, P245, DOI 10.1016/0266-7681(92)90106-C; Mavrogenis AF, 2011, ORTHOPEDICS, V34, DOI 10.3928/01477447-20110124-08; McAuliffe JA, 1997, J BONE JOINT SURG AM, V79A, P749, DOI 10.2106/00004623-199705000-00015; MENDELSON L, 1975, SCAND J REHABIL MED, V7, P141; Moore T J, 1993, J Orthop Trauma, V7, P11, DOI 10.1097/00005131-199302000-00003; Moritomo H, 2001, J SHOULDER ELB SURG, V10, P164, DOI 10.1067/mse.2001.112055; MORREY BF, 1981, J BONE JOINT SURG AM, V63, P872, DOI 10.2106/00004623-198163060-00002; PETERSON SL, 1989, J TRAUMA, V29, P365, DOI 10.1097/00005373-198903000-00015; Rhee YG, 2009, CLIN ORTHOP SURG, V1, P27, DOI 10.4055/cios.2009.1.1.27; ROBERTS JB, 1979, J BONE JOINT SURG AM, V61, P760, DOI 10.2106/00004623-197961050-00018; Summerfield SL, 1997, J SHOULDER ELB SURG, V6, P321, DOI 10.1016/S1058-2746(97)90025-2; Thompson H C 3rd, 1967, Clin Orthop Relat Res, V50, P129; Tsionos I, 2004, J BONE JOINT SURG BR, V86B, P396, DOI 10.1302/0301-620X.86B3.14480; URBANIAK JR, 1985, J BONE JOINT SURG AM, V67A, P1160, DOI 10.2106/00004623-198567080-00003; VINCE KG, 1987, J BONE JOINT SURG AM, V69A, P640, DOI 10.2106/00004623-198769050-00002; Viola RW, 1999, J HAND SURG-AM, V24A, P370; Williams BG, 2012, J SHOULDER ELB SURG, V21, P1632, DOI 10.1016/j.jse.2012.04.007	45	18	23	1	11	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	1058-2746			J SHOULDER ELB SURG	J. Shoulder Elbow Surg.	AUG	2015	24	8					1165	1171		10.1016/j.jse.2015.05.044			7	Orthopedics; Sport Sciences; Surgery	Orthopedics; Sport Sciences; Surgery	CM9RO	WOS:000358046800006	26189802				2021-06-18	
J	Marcolini, EG; Keegan, J				Marcolini, Evie G.; Keegan, Joshua			Blunt Cardiac Injury	EMERGENCY MEDICINE CLINICS OF NORTH AMERICA			English	Article						Blunt cardiac injury; Cardiac contusion; Cardiac concussion; Commotio cordis; Contusio cordis	COMPLETE HEART-BLOCK; MYOCARDIAL CONTUSION; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; CLINICAL-SIGNIFICANCE; EASTERN ASSOCIATION; TROPONIN-I; TRAUMA; MANAGEMENT; ELECTROCARDIOGRAPHY; ELEVATION	Blunt cardiac injury encompasses multiple different injuries, including contusion, chamber rupture, and acute valvular disorders. Blunt cardiac injury is common and may cause significant morbidity and mortality; a high index of suspicion is needed for accurate diagnosis. Diagnostic work-up should always include electrocardiogram and cardiac enzymes, and may include echocardiography if specific disorders (ie, tamponade or valvular disorders) are suspected. Patients with myocardial contusion should be observed for 24 to 48 hours for arrhythmias. Many other significant forms of blunt cardiac injury require surgical intervention.	[Marcolini, Evie G.] Yale Univ, Sch Med, Dept Emergency Med & Neurol, Div Neurocrit Care & Emergency Neurol, New Haven, CT 06519 USA; [Marcolini, Evie G.] Yale Univ, Sch Med, Div Neurocrit Care & Emergency Neurol, Dept Neurol, New Haven, CT 06520 USA; [Keegan, Joshua] Yale Univ, Sch Med, Dept Emergency Med, New Haven, CT 06519 USA	Marcolini, EG (corresponding author), Yale Univ, Sch Med, Dept Emergency Med & Neurol, Div Neurocrit Care & Emergency Neurol, 464 Congress St,Suite 260, New Haven, CT 06519 USA.	emarcolini@gmail.com					Adams JE, 1996, AM HEART J, V131, P308, DOI 10.1016/S0002-8703(96)90359-2; [Anonymous], AM SURG; Baum VC, 2000, J CARDIOTHOR VASC AN, V14, P71, DOI 10.1016/S1053-0770(00)90062-4; Benitez RM, 1999, PACE, V22, P816, DOI 10.1111/j.1540-8159.1999.tb00549.x; Bertinchant JP, 2000, J TRAUMA, V48, P924, DOI 10.1097/00005373-200005000-00018; Bock JS, 2012, CARDIOL CLIN, V30, P545, DOI 10.1016/j.ccl.2012.07.001; BURCHELL HB, 1954, CIRCULATION, V10, P574, DOI 10.1161/01.CIR.10.4.574; Chirillo F, 1996, HEART, V75, P301, DOI 10.1136/hrt.75.3.301; Clancy K, 2012, J TRAUMA ACUTE CARE, V73, pS301, DOI 10.1097/TA.0b013e318270193a; El-Chami MF, 2008, J EMERG MED, V35, P127, DOI 10.1016/j.jemermed.2007.03.018; El-Menyaru A, 2012, ANN CARD ANAESTH, V15, P287, DOI 10.4103/0971-9784.101875; Fulda GJ, 1997, J TRAUMA, V43, P304, DOI 10.1097/00005373-199708000-00016; Garcia-Fernandez MA, 1998, AM HEART J, V135, P476, DOI 10.1016/S0002-8703(98)70324-2; Gibel W, 1988, Z Arztl Fortbild (Jena), V82, P213; Kaye P, 2002, EMERG MED J, V19, P8, DOI 10.1136/emj.19.1.8; Lazaros GA, 2004, INJURY, V35, P1300, DOI 10.1016/j.injury.2003.10.018; LIEDTKE AJ, 1973, AM HEART J, V86, P687, DOI 10.1016/0002-8703(73)90349-9; Lindstaedt M, 2002, J TRAUMA, V52, P479, DOI 10.1097/00005373-200203000-00011; Link MS, 2003, J AM COLL CARDIOL, V41, P99, DOI 10.1016/S0735-1097(02)02669-4; Maenza RL, 1996, AM J EMERG MED, V14, P237, DOI 10.1016/S0735-6757(96)90165-5; Maron BJ, 2009, CIRCULATION, V119, P1085, DOI 10.1161/CIRCULATIONAHA.108.804617; Marshall DT, 2008, AM J FOREN MED PATH, V29, P1, DOI 10.1097/PAF.0b013e31815b4d37; MATTOX KL, 1992, J TRAUMA, V33, P649; McGillicuddy D, 2007, EMERG MED CLIN N AM, V25, P695, DOI 10.1016/j.emc.2007.06.004; PARMLEY LF, 1958, CIRCULATION, V18, P371, DOI 10.1161/01.CIR.18.3.371; Pasquale M, 1998, J TRAUMA, V44, P941, DOI 10.1097/00005373-199806000-00001; PATTON AS, 1981, AM J SURG, V141, P465, DOI 10.1016/0002-9610(81)90141-0; Plautz CU, 2005, AM J EMERG MED, V23, P510, DOI 10.1016/j.ajem.2004.03.014; Press GM, 2013, J EMERG MED, V44, P9, DOI 10.1016/j.jemermed.2012.03.027; Schultz JM, 2004, CRIT CARE CLIN, V20, P57, DOI 10.1016/S0749-0704(03)00092-7; Simon RJ, 2003, J TRAUMA, V54, P50; Stanford GG, 1997, J TRAUMA, V43, P310; TENZER ML, 1985, J TRAUMA, V25, P620, DOI 10.1097/00005373-198507000-00008; Velmahos GC, 2003, J TRAUMA, V54, P45, DOI 10.1097/00005373-200301000-00006; WOLFSON AB, 2005, HARWOOD NUSS CLIN PR	35	18	21	0	7	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0733-8627	1558-0539		EMERG MED CLIN N AM	Emerg. Med. Clin. N. Am.	AUG	2015	33	3					519	+		10.1016/j.emc.2015.04.003			11	Emergency Medicine	Emergency Medicine	CP9XW	WOS:000360250200005	26226863				2021-06-18	
J	Presley, C; Abidi, A; Suryawanshi, S; Mustafa, S; Meibohm, B; Moore, BM				Presley, Chaela; Abidi, Ammaar; Suryawanshi, Satyendra; Mustafa, Suni; Meibohm, Bernd; Moore, Bob M., II			Preclinical evaluation of SMM-189, a cannabinoid receptor 2-specific inverse agonist	PHARMACOLOGY RESEARCH & PERSPECTIVES			English	Article						ACTOne; cannabinoid receptor 2; inverse agonist; microglia; polarization	TRAUMATIC BRAIN-INJURY; CB2 RECEPTOR; ENDOCANNABINOID SYSTEM; MICROGLIAL ACTIVATION; NEUROMYELITIS-OPTICA; MULTIPLE-SCLEROSIS; GENE-EXPRESSION; LIPOPOLYSACCHARIDE; CELLS; ANTAGONIST	Cannabinoid receptor 2 agonists and inverse agonists are emerging as new therapeutic options for a spectrum of autoimmune-related disease. Of particular interest, is the ability of CB2 ligands to regulate microglia function in neurodegenerative diseases and traumatic brain injury. We have previously reported the receptor affinity of 30,50-dichloro-2,6-dihydroxy-biphenyl-4-yl)-phenyl-methanone ( SMM-189) and the characterization of the beneficial effects of SMM-189 in the mouse model of mild traumatic brain injury. Herein, we report the further characterization of SMM-189 as a potent and selective CB2 inverse agonist, which acts as a noncompetitive inhibitor of CP 55,940. The ability of SMM-189 to regulate microglial activation, in terms of chemokine expression and cell morphology, has been determined. Finally, we have determined that SMM-189 possesses acceptable biopharmaceutical properties indicating that the triaryl class of CB2 inverse agonists are viable compounds for continued preclinical development for the treatment of neurodegenerative disorders and traumatic brain injury.	[Presley, Chaela; Abidi, Ammaar; Suryawanshi, Satyendra; Mustafa, Suni; Meibohm, Bernd; Moore, Bob M., II] Univ Tennessee, Hlth Sci Ctr, Coll Pharm, Dept Pharmaceut Sci, Memphis, TN USA	Moore, BM (corresponding author), 847 Monroe Ave,Ste 327, Memphis, TN 38163 USA.	bmoore@uthsc.edu		Abidi, Ammaar/0000-0003-1826-9377; Meibohm, Bernd/0000-0003-3923-3648	University of Tennessee Health Science Center (UTHSC), College of Pharmacy; UTHSC Neuroscience Institute; Endece LLC; National Institutes of Health (Meibohm)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1S10OD016226]	The University of Tennessee Health Science Center (UTHSC), College of Pharmacy, and the UTHSC Neuroscience Institute provided the stipend for Chaela Presley. Endece LLC provided funding for the ACTOne assay and the biopharmaceutical evaluation of SMM189. This work was also funded in part by National Institutes of Health grant 1S10OD016226 (Meibohm).	Ashton JC, 2007, CURR NEUROPHARMACOL, V5, P73, DOI 10.2174/157015907780866884; Askovic S, 2001, J VIROL, V75, P2665, DOI 10.1128/JVI.75.6.2665-2674.2001; Bhattacharjee H, 2009, BIOORG MED CHEM LETT, V19, P1691, DOI 10.1016/j.bmcl.2009.01.100; Blanchard C, 2006, J CLIN INVEST, V116, P536, DOI 10.1172/JCI26679; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Bouaboula M, 1996, EUR J BIOCHEM, V237, P704, DOI 10.1111/j.1432-1033.1996.0704p.x; Carroll FY, 2001, MOL PHARMACOL, V59, P965; Chen ZH, 2012, J NEUROSCI, V32, P11706, DOI 10.1523/JNEUROSCI.0730-12.2012; Conant K, 1998, P NATL ACAD SCI USA, V95, P3117, DOI 10.1073/pnas.95.6.3117; Crowe MS, 2014, BRAIN BEHAV IMMUN, V42, P1, DOI 10.1016/j.bbi.2014.06.007; Croxford JL, 2003, CNS DRUGS, V17, P179, DOI 10.2165/00023210-200317030-00004; D'Aversa TG, 2004, J NEUROVIROL, V10, P86, DOI 10.1080/13550280490279807; DeJesus Edwin, 2007, J Int Assoc Physicians AIDS Care (Chic), V6, P95, DOI 10.1177/1545109707300157; Depboylu C, 2012, EXP NEUROL, V238, P183, DOI 10.1016/j.expneurol.2012.08.020; Duan RS, 2008, NEUROCHEM RES, V33, P1085, DOI 10.1007/s11064-007-9554-z; Ebner F, 2013, J IMMUNOL, V191, P5594, DOI 10.4049/jimmunol.1203331; Elliott MB, 2011, J NEUROTRAUM, V28, P973, DOI 10.1089/neu.2010.1672; Fitzsimons CP, 2004, J BIOL CHEM, V279, P34431, DOI 10.1074/jbc.M400738200; Fraga D, 2011, J NEUROIMMUNE PHARM, V6, P566, DOI 10.1007/s11481-011-9291-6; Friese MA, 2007, BRAIN, V130, P2755, DOI 10.1093/brain/awm246; Fujinaga M, 2010, BIOORG MED CHEM LETT, V20, P1565, DOI 10.1016/j.bmcl.2010.01.074; Garwood Claire J, 2010, Front Psychiatry, V1, P136, DOI 10.3389/fpsyt.2010.00136; Gibaldi M., 1982, PHARMACOKINETICS; Glomme A, 2005, J PHARM SCI-US, V94, P1, DOI 10.1002/jps.20212; Govaerts SJ, 2004, EUR J PHARM SCI, V23, P233, DOI 10.1016/j.ejps.2004.07.013; Helmy A, 2011, J CEREBR BLOOD F MET, V31, P658, DOI 10.1038/jcbfm.2010.142; HERMAN TS, 1979, NEW ENGL J MED, V300, P1295, DOI 10.1056/NEJM197906073002302; Hilliard A., 2012, ISRN NEUROL, V2012, DOI DOI 10.5402/2012/802649; Ho L, 2012, J ALZHEIMERS DIS, V31, P301, DOI 10.3233/JAD-2012-120598; Kerns EH, 2004, J PHARM SCI-US, V93, P1440, DOI 10.1002/jps.20075; Khilnani G, 2011, INDIAN J PHARMACOL, V43, P492, DOI 10.4103/0253-7613.84947; Kozela E, 2010, J BIOL CHEM, V285, P1616, DOI 10.1074/jbc.M109.069294; Krishnamurthy M, 2008, BIOORGAN MED CHEM, V16, P6489, DOI 10.1016/j.bmc.2008.05.034; Kuhle J, 2009, EUR J NEUROL, V16, P771, DOI 10.1111/j.1468-1331.2009.02560.x; Laforte V, 2014, HUPO 13 ANN WORLD C; Lawrence T, 2011, NAT REV IMMUNOL, V11, P750, DOI 10.1038/nri3088; Liu B, 2003, J PHARMACOL EXP THER, V304, P1, DOI 10.1124/jpet.102.035048; Lively S, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-75; Lou ZY, 2011, MOL IMMUNOL, V49, P453, DOI 10.1016/j.molimm.2011.09.016; Louvet A, 2011, HEPATOLOGY, V54, P1217, DOI 10.1002/hep.24524; Lunn CA, 2008, BRIT J PHARMACOL, V153, P226, DOI 10.1038/sj.bjp.0707480; Martin-Moreno AM, 2011, MOL PHARMACOL, V79, P964, DOI 10.1124/mol.111.071290; Merighi S, 2012, BRIT J PHARMACOL, V165, P1773, DOI 10.1111/j.1476-5381.2011.01673.x; Michael BD, 2013, CYTOKINE, V64, P90, DOI 10.1016/j.cyto.2013.07.019; Mukhopadhyay S, 2006, J NEUROIMMUNOL, V181, P82, DOI 10.1016/j.jneuroim.2006.08.002; Narikawa K, 2004, J NEUROIMMUNOL, V149, P182, DOI 10.1016/j.jneuroim.2003.12.010; Ortega-Gutierrez S, 2005, FASEB J, V19, P1338, DOI 10.1096/fj.04-2464fje; Porter RHP, 2005, J PHARMACOL EXP THER, V315, P711, DOI 10.1124/jpet.105.089839; Pulliam L, 2007, J NEUROIMMUNE PHARM, V2, P87, DOI 10.1007/s11481-006-9053-z; Reiner A, 2015, INT J MOL SCI, V16, P758, DOI 10.3390/ijms16010758; Rhee Man-Hee, 2002, J Vet Sci, V3, P179; Ribeiro R, 2013, PROSTAG OTH LIPID M, V100, P1, DOI 10.1016/j.prostaglandins.2012.11.003; Romero-Sandoval EA, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-25; Selenica MLB, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-86; Shohami E, 2011, BRIT J PHARMACOL, V163, P1402, DOI 10.1111/j.1476-5381.2011.01343.x; Sipe JC, 2005, J LEUKOCYTE BIOL, V78, P231, DOI 10.1189/jlb.0205111; Smit MJ, 1996, P NATL ACAD SCI USA, V93, P6802, DOI 10.1073/pnas.93.13.6802; Stella N, 2010, GLIA, V58, P1017, DOI 10.1002/glia.20983; Tam WY, 2014, SCI REP-UK, V4, DOI 10.1038/srep07279; Tanuma N, 2006, ACTA NEUROPATHOL, V112, P195, DOI 10.1007/s00401-006-0083-7; Thomas A, 2007, BRIT J PHARMACOL, V150, P613, DOI 10.1038/sj.bjp.0707133; Vainchtein ID, 2014, GLIA, V62, P1724, DOI 10.1002/glia.22711; Walter L, 2003, J NEUROSCI, V23, P1398; Westin K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030525; White RE, 2000, ANNU REV PHARMACOL, V40, P133, DOI 10.1146/annurev.pharmtox.40.1.133; WISNIEWSKI HM, 1991, ACTA NEUROPATHOL, V81, P588, DOI 10.1007/BF00310142; Witkamp R, 2014, CURR OPIN CLIN NUTR, V17, P130, DOI 10.1097/MCO.0000000000000027; Wohnsland F, 2001, J MED CHEM, V44, P923, DOI 10.1021/jm001020e; Zarruk JG, 2012, STROKE, V43, P211, DOI 10.1161/STROKEAHA.111.631044; Zhang Y, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-79; Zoppi S, 2014, BRIT J PHARMACOL, V171, P2814, DOI 10.1111/bph.12607	71	18	18	0	0	JOHN WILEY & SONS LTD	CHICHESTER	THE ATRIUM, SOUTHERN GATE, CHICHESTER PO19 8SQ, W SUSSEX, ENGLAND	2052-1707			PHARMACOL RES PERSPE	Pharmacol. Res. Perspect.	AUG	2015	3	4							00159	10.1002/prp2.159			17	Pharmacology & Pharmacy	Pharmacology & Pharmacy	VA7PC	WOS:000410341100010	26196013	DOAJ Gold, Green Published			2021-06-18	
J	Seel, RT; Barrett, RS; Beaulieu, CL; Ryser, DK; Hammond, FM; Cullen, N; Garmoe, W; Sommerfeld, T; Corrigan, JD; Horn, SD				Seel, Ronald T.; Barrett, Ryan S.; Beaulieu, Cynthia L.; Ryser, David K.; Hammond, Flora M.; Cullen, Nora; Garmoe, William; Sommerfeld, Teri; Corrigan, John D.; Horn, Susan D.			Institutional Variation in Traumatic Brain Injury Acute Rehabilitation Practice	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injuries; Craniocerebral trauma; Health services; Health services research; Occupational therapy; Physical therapy specialty; Psychology; Recreation therapy; Rehabilitation; Speech therapy; Therapeutics	FUNCTIONAL INDEPENDENCE MEASURE; SYSTEMS NATIONAL DATABASE; AGITATED BEHAVIOR SCALE; CARE SITE MATTER; REPRESENTATIVENESS; RELIABILITY; RECOVERY; STROKE	Objective: To describe institutional variation in traumatic brain injury (TBI) inpatient rehabilitation program characteristics and evaluate to what extent patient factors and center effects explain how TBI inpatient rehabilitation services are delivered. Design: Secondary analysis of a prospective, multicenter, cohort database. Setting: TBI inpatient rehabilitation programs. Participants: Patients with complicated mild, moderate, or severe TBI (N=2130). Interventions: Not applicable. Main Outcome Measures: Mean minutes; number of treatment activities; use of groups in occupational therapy, physical therapy, speech therapy, therapeutic recreation, and psychology inpatient rehabilitation sessions; and weekly hours of treatment. Results: A wide variation was observed between the 10 TBI programs, including census size, referral flow, payer mix, number of dedicated beds, clinician experience, and patient characteristics. At the centers with the longest weekday therapy sessions, the average session durations were 41.5 to 52.2 minutes. At centers with the shortest weekday sessions, the average session durations were approximately 30 minutes. The centers with the highest mean total weekday hours of occupational, physical, and speech therapies delivered twice as much therapy as the lowest center. Ordinary least-squares regression modeling found that center effects explained substantially more variance than patient factors for duration of therapy sessions, number of activities administered per session, use of group therapy, and amount of psychological services provided. Conclusions: This study provides preliminary evidence that there is significant institutional variation in rehabilitation practice and that center effects play a stronger role than patient factors in determining how TBI inpatient rehabilitation is delivered. (C) 2015 by the American Congress of Rehabilitation Medicine	[Seel, Ronald T.] Shepherd Ctr, Crawford Res Inst, Atlanta, GA 30309 USA; [Barrett, Ryan S.; Horn, Susan D.] Int Sever Informat Syst, Inst Clin Outcomes Res, Salt Lake City, UT USA; [Beaulieu, Cynthia L.] Brooks Rehabil Hosp, Jacksonville, FL USA; [Ryser, David K.] Intermt Med Ctr, Neuro Specialty Rehabil Unit, Salt Lake City, UT USA; [Hammond, Flora M.] Carolinas Rehabil, Charlotte, NC USA; [Hammond, Flora M.] Indiana Univ Sch Med, Indianapolis, IN 46202 USA; [Hammond, Flora M.] Rehabil Hosp Indiana, Indianapolis, IN USA; [Cullen, Nora] Toronto Rehabil Inst, Toronto, ON, Canada; [Garmoe, William] Medstar Natl Rehabil Hosp, Washington, DC USA; [Sommerfeld, Teri] Rush Univ, Med Ctr, Chicago, IL 60612 USA; [Corrigan, John D.] Ohio State Univ, Dept Phys Med & Rehabil, Columbus, OH 43210 USA	Seel, RT (corresponding author), Shepherd Ctr, Crawford Res Inst, 6th Fl,2020 Peachtree Rd, Atlanta, GA 30309 USA.	ron_seel@shepherd.org		Cullen, Nora/0000-0001-6359-9418	National Institutes of Health, National Center for Medical Rehabilitation ResearchUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1R01HD050439-01]; National Institute on Disability and Rehabilitation Research [H133A080023]; American Congress of Rehabilitation Medicine; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD050439] Funding Source: NIH RePORTER	Supported by the National Institutes of Health, National Center for Medical Rehabilitation Research (grant no. 1R01HD050439-01) and the National Institute on Disability and Rehabilitation Research (grant no. H133A080023); Publication of this article was supported by the American Congress of Rehabilitation Medicine.	Agency for Healthcare Research and Quality (US), 2007, AHRQ STRAT PLAN; Bogner JA, 1999, J HEAD TRAUMA REHAB, V14, P91, DOI 10.1097/00001199-199902000-00012; Chan L, 2013, ARCH PHYS MED REHAB, V94, P622, DOI 10.1016/j.apmr.2012.09.033; Commission of the Accreditation of Rehabilitation Facilities (CARF) International, 2014, MED REH STAND MAN; CORDIS, 7 FRAM PROGR FUND EU; CORRIGAN JD, 1994, J CLIN EXP NEUROPSYC, V16, P386, DOI 10.1080/01688639408402649; CORRIGAN JD, 1989, J CLIN EXP NEUROPSYC, V11, P261, DOI 10.1080/01688638908400888; Corrigan JD, 2007, ARCH PHYS MED REHAB, V88, P418, DOI 10.1016/j.apmr.2007.01.010; Corrigan JD, 2012, J HEAD TRAUMA REHAB, V27, P391, DOI 10.1097/HTR.0b013e3182238cdd; Cuthbert JP, 2012, J HEAD TRAUMA REHAB, V27, pE15, DOI 10.1097/HTR.0b013e31826da983; DeJong G, 2009, ARCH PHYS MED REHAB, V90, P1269, DOI 10.1016/j.apmr.2008.11.021; Deutsch A, 2013, ARCH PHYS MED REHAB, V94, P630, DOI 10.1016/j.apmr.2013.02.011; Graham JE, 2010, ARCH PHYS MED REHAB, V91, P43, DOI 10.1016/j.apmr.2009.09.017; Granger CV, 2010, AM J PHYS MED REHAB, V89, P265, DOI 10.1097/PHM.0b013e3181d3eb20; HEINEMANN AW, 1993, ARCH PHYS MED REHAB, V74, P566, DOI 10.1016/0003-9993(93)90153-2; Hoffman JM, 2012, ARCH PHYS MED REHAB, V93, P1305, DOI 10.1016/j.apmr.2012.04.030; Horn SD, 2015, ARCH PHYS MED REHAB, V96, pS178, DOI 10.1016/j.apmr.2014.09.042; Institute of Medicine, 2009, IN NAT PRIOR COMP EF; Institute of Medicine, 2007, FUTURE DISABILITY AM; LINACRE JM, 1994, ARCH PHYS MED REHAB, V75, P127; Ottenbacher KJ, 1996, ARCH PHYS MED REHAB, V77, P1226, DOI 10.1016/S0003-9993(96)90184-7; Rivara FP, 2012, ARCH PHYS MED REHAB, V93, P1371, DOI 10.1016/j.apmr.2012.02.031; Seel RT, 2012, ARCH PHYS MED REHAB, V93, pS138, DOI 10.1016/j.apmr.2012.04.021; Steyerberg EW., 2009, CLIN PREDICTION MODE	24	18	18	0	16	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	AUG	2015	96	8		3			S197	S208		10.1016/j.apmr.2015.02.034			12	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	CO3CV	WOS:000359035100003	26212397				2021-06-18	
J	Maudsley, AA; Govind, V; Levin, B; Saigal, G; Harris, L; Sheriff, S				Maudsley, Andrew A.; Govind, Varan; Levin, Bonnie; Saigal, Gaurav; Harris, Leo; Sheriff, Sulaiman			Distributions of Magnetic Resonance Diffusion and Spectroscopy Measures with Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						diffusion tensor imaging; MR spectroscopy; traumatic brain injury; Z-score image analysis	WHITE-MATTER; ABNORMALITIES; TIME; DTI	Magnetic resonance spectroscopy (MRS) and diffusion tensor imaging (DTI) studies have demonstrated that measures of altered metabolism and axonal injury can be detected following traumatic brain injury. The aim of this study was to characterize and compare the distributions of altered image parameters obtained by these methods in subjects with a range of injury severity and to examine their relative sensitivity for diagnostic imaging in this group of subjects. DTI and volumetric magnetic resonance spectroscopic imaging data were acquired in 40 subjects that had experienced a closed-head traumatic brain injury, with a median of 36d post-injury. Voxel-based analyses were performed to examine differences of group mean values relative to normal controls, and to map significant alterations of image parameters in individual subjects. The between-group analysis revealed widespread alteration of tissue metabolites that was most strongly characterized by increased choline throughout the cerebrum and cerebellum, reaching as much as 40% increase from control values for the group with the worse cognitive assessment score. In contrast, the between-group comparison of DTI measures revealed only minor differences; however, the Z-score image analysis of individual subject DTI parameters revealed regions of altered values relative to controls throughout the major white matter tracts, but with considerable heterogeneity between subjects and with a smaller extent than the findings for altered metabolite measures. The findings of this study illustrate the complimentary nature of these neuroimaging methods.	[Maudsley, Andrew A.; Govind, Varan; Saigal, Gaurav; Harris, Leo; Sheriff, Sulaiman] Univ Miami, Sch Med, Dept Radiol, Miami, FL 33136 USA; [Levin, Bonnie] Univ Miami, Sch Med, Dept Neurol, Miami, FL 33136 USA	Maudsley, AA (corresponding author), Univ Miami, Sch Med, Dept Radiol, 1150 NW 14th St,Suite 713, Miami, FL 33136 USA.	AMaudsley@med.miami.edu		Govind, Varan/0000-0002-1205-5194; Maudsley, Andrew/0000-0001-7653-3063	National Institutes of Health research grantUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01NS055107, R01EB000822]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS055107] Funding Source: NIH RePORTER	This study was supported by National Institutes of Health research grants R01NS055107 and R01EB000822. We thank Dr. Mori for making available resources to perform the DTI analysis and Clara Morales for assistance with the study.	Assaf Y, 2006, AM J NEURORADIOL, V27, P1717; Benjamini Y, 2006, BIOMETRIKA, V93, P491, DOI 10.1093/biomet/93.3.491; Bergsneider M, 2001, J HEAD TRAUMA REHAB, V16, P135, DOI 10.1097/00001199-200104000-00004; Bigler ED, 2012, BRAIN IMAGING BEHAV, V6, P108, DOI 10.1007/s11682-011-9145-0; Gasparovic C, 2009, J NEUROTRAUM, V26, P1635, DOI [10.1089/neu.2009.0896, 10.1089/neu.2009-0896]; Gean AD, 2010, NEUROIMAG CLIN N AM, V20, P527, DOI 10.1016/j.nic.2010.08.001; Govind V, 2010, J NEUROTRAUM, V27, P483, DOI 10.1089/neu.2009.1159; Govindaraju V, 2004, AM J NEURORADIOL, V25, P730; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Kasahara K, 2012, MAGN RESON IMAGING, V30, P496, DOI 10.1016/j.mri.2011.12.018; Kim N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059382; Klimas A, 2013, CLIN IMAG, V37, P637, DOI 10.1016/j.clinimag.2013.01.013; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Lee H, 2008, J NEUROTRAUM, V25, P1049, DOI 10.1089/neu.2008.0566; Lin AP, 2012, BRAIN IMAGING BEHAV, V6, P208, DOI 10.1007/s11682-012-9181-4; Ling JM, 2012, BRAIN, V135, P1281, DOI 10.1093/brain/aws073; Lipton ML, 2012, BRAIN IMAGING BEHAV, V6, P329, DOI 10.1007/s11682-012-9175-2; Lipton ML, 2008, J NEUROTRAUM, V25, P1335, DOI 10.1089/neu.2008.0547; Maudsley AA, 2006, NMR BIOMED, V19, P492, DOI 10.1002/nbm.1025; Maudsley AA, 2009, MAGN RESON MED, V61, P548, DOI 10.1002/mrm.21875; Maudsley A. A., 2008, TISSUE DEPENDENT ANA, P1604; Narayana PA, 2015, NEUROIMAGE-CLIN, V7, P87, DOI 10.1016/j.nicl.2014.07.010; Oishi K, 2009, NEUROIMAGE, V46, P486, DOI 10.1016/j.neuroimage.2009.01.002; Rosenbaum SB, 2012, BRAIN IMAGING BEHAV, V6, P255, DOI 10.1007/s11682-012-9162-7; Rutgers DR, 2008, AM J NEURORADIOL, V29, P514, DOI 10.3174/ajnr.A0856; Schonberg T, 2006, NEUROIMAGE, V30, P1100, DOI 10.1016/j.neuroimage.2005.11.015; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Tollard E, 2009, CRIT CARE MED, V37, P1448, DOI 10.1097/CCM.0b013e31819cf050; Watanabe M, 2013, RADIOLOGY, V266, P575, DOI 10.1148/radiol.12112420; Yeo RA, 2011, J NEUROTRAUM, V28, P1, DOI 10.1089/neu.2010.1578; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	31	18	18	0	10	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL 15	2015	32	14					1056	1063		10.1089/neu.2014.3505			8	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	CV0TB	WOS:000363965000003	25333480	Green Published			2021-06-18	
J	Richard, YF; Swaine, BR; Sylvestre, MP; Lesage, A; Zhang, X; Feldman, DE				Richard, Yvonne F.; Swaine, Bonnie R.; Sylvestre, Marie-Pierre; Lesage, Alain; Zhang, Xun; Feldman, Debbie Ehrmann			The Association Between Traumatic Brain Injury and Suicide: Are Kids at Risk?	AMERICAN JOURNAL OF EPIDEMIOLOGY			English	Article						adults; childhood; mental health; pediatrics; repeated injuries; suicide; traumatic brain injury; youth	PSYCHIATRIC DIAGNOSES; NORTHERN FINLAND; BIRTH COHORT; YOUNG-ADULTS; CHILDREN; POPULATION; CHILDHOOD; BEHAVIOR; OUTCOMES; EPIDEMIOLOGY	Traumatic brain injury (TBI) in late adolescence and adulthood is associated with a higher risk of suicide; however, it is unknown whether this association is also present in people who sustained a TBI during childhood. The purpose of the present study was to determine whether experiencing a TBI during childhood is a risk factor for suicide later in life and to examine whether the risk of suicide differs by sex or injury severity. A cohort of 135,703 children aged 0-17 years was identified from the Quebec population-based physician reimbursement database in 1987, and follow-up was conducted until 2008. Of the children in this cohort, 21,047 had sustained a TBI. Using a survival analysis with time-dependent indicators of TBI, we found a higher risk of suicide for people who sustained a TBI during childhood (hazard ratio (HR) = 1.49, 95% confidence interval (CI): 1.04, 2.14), adolescence (HR = 1.57, 95% CI: 1.09, 2.26), and adulthood (HR = 2.53, 95% CI: 1.79, 3.59). When compared with less severe injuries, such as concussions and cranial fractures, more severe injuries, such as intracranial hemorrhages, were associated with a higher risk of suicide (HR = 2.18 vs. 2.77, respectively). Repeated injuries were associated with higher risks of suicide in all age groups.	[Richard, Yvonne F.; Swaine, Bonnie R.] Univ Montreal, Fac Med, Sch Rehabil, Ctr Interdisciplinary Res Rehabil, Montreal, PQ H3C 3J7, Canada; [Sylvestre, Marie-Pierre] Univ Montreal, Univ Montreal Hosp Res Ctr, Dept Social & Prevent Med, Sch Publ Hlth, Montreal, PQ H3C 3J7, Canada; [Lesage, Alain] Univ Montreal, Dept Psychiat, Inst Univ Sante Mentale, Montreal Res Ctr,Quebec Suicide Res Network, Montreal, PQ H3C 3J7, Canada; [Zhang, Xun] McGill Univ, Dept Epidemiol & Biostat, Montreal, PQ, Canada; [Feldman, Debbie Ehrmann] Univ Montreal, Ctr Interdisciplinary Res Rehabil, Univ Montreal Publ Hlth Res Inst, Fac Med,Sch Rehabil, Montreal, PQ H3C 3J7, Canada	Swaine, BR (corresponding author), Univ Montreal, Ecole Readaptat, CP 6128,Succursale Ctr Ville, Montreal, PQ H3C 3J7, Canada.	bonnie.swaine@umontreal.ca			Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [84479]; Reseau Quebecois de Recherche sur le Suicide; Fonds de Recherche Quebec-Sante	This work was supported by the Canadian Institutes of Health Research (grant 84479). Y.F.R. received a study grant from the Reseau Quebecois de Recherche sur le Suicide. B.R.S. and D.E.F. received a senior research award from the Fonds de Recherche Quebec-Sante.	ACHTE KA, 1971, ACTA PSYCHIAT SCAND, P1; Anderson V, 2012, INT J DEV NEUROSCI, V30, P217, DOI 10.1016/j.ijdevneu.2011.09.008; Anderson V, 2009, J HEAD TRAUMA REHAB, V24, P303, DOI 10.1097/HTR.0b013e3181ada830; April KT, 2013, CHILD CARE HLTH DEV, V39, P442, DOI 10.1111/j.1365-2214.2012.01386.x; Arsenault-Lapierre G, 2004, BMC PSYCHIATRY, V4, DOI 10.1186/1471-244X-4-37; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Barlow KM, 2005, PEDIATRICS, V116, pE174, DOI 10.1542/peds.2004-2739; Beales G, 1983, Nurs Times, V79, P50; Beautrais AL, 2000, AUST NZ J PSYCHIAT, V34, P420, DOI 10.1080/j.1440-1614.2000.00691.x; Bergeron L, 1993, ENQUETE QUEBECOISE S; Bertolote, 2015, SUICIDOLOGY, V7, P6, DOI [10.5617/suicidologi.2330, DOI 10.5617/SUICIDOLOGI.2330]; Bloom DR, 2001, J AM ACAD CHILD PSY, V40, P572, DOI 10.1097/00004583-200105000-00017; Brenner LA, 2011, J HEAD TRAUMA REHAB, V26, P257, DOI 10.1097/HTR.0b013e31821fdb6e; Bridge JA, 2006, J CHILD PSYCHOL PSYC, V47, P372, DOI 10.1111/j.1469-7610.2006.01615.x; Bryan CJ, 2013, JAMA PSYCHIAT, V70, P686, DOI 10.1001/jamapsychiatry.2013.1093; Chen AY, 2011, EMERG THEMES EPIDEMI, V8, DOI 10.1186/1742-7622-8-4; Colantonio A, 2010, CAN J NEUROL SCI, V37, P783, DOI 10.1017/S0317167100051441; Colantonio A, 2009, J TRAUMA, V66, P179, DOI 10.1097/TA.0b013e3181715d66; Ewing-Cobbs L, 2003, DEV NEUROPSYCHOL, V24, P669, DOI 10.1207/S15326942DN242&3_08; Ewing-Cobbs L, 2006, J NEUROSURG, V105, P287, DOI 10.3171/ped.2006.105.4.287; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Fazel S, 2014, JAMA PSYCHIAT, V71, P326, DOI 10.1001/jamapsychiatry.2013.3935; Gagne M, 2012, EVOLUTION HOSPITALIS; Gagne M, 2010, MORTALITE SUICIDE QU; Gagnon I, 2008, BRAIN INJURY, V22, P161, DOI 10.1080/02699050701867381; Galaif Elisha R, 2007, Int J Adolesc Med Health, V19, P27; Gamache P, 2010, INDICE DEFAVORISATIO; Goldston DB, 2009, J CONSULT CLIN PSYCH, V77, P281, DOI 10.1037/a0014732; GomezHernandez R, 1997, ARCH PHYS MED REHAB, V78, P1321, DOI 10.1016/S0003-9993(97)90304-X; Grauwmeijer E, 2012, ARCH PHYS MED REHAB, V93, P993, DOI 10.1016/j.apmr.2012.01.018; Harrison-Felix CL, 2009, ARCH PHYS MED REHAB, V90, P1506, DOI 10.1016/j.apmr.2009.03.015; Hawton K, 2000, BRIT J PSYCHIAT, V177, P484, DOI 10.1192/bjp.177.6.484; Hoge CW, 2006, JAMA-J AM MED ASSOC, V295, P1023, DOI 10.1001/jama.295.9.1023; Kostylova A, 2005, INJURY PREV, V11, P186, DOI 10.1136/ip.2004.006585; Kuhtz-Buschbeck JP, 2003, DEV MED CHILD NEUROL, V45, P821, DOI 10.1017/S001216220300152X; Lesage A., 2006, PREVALENCE MENTAL IL; LESAGE AD, 1994, AM J PSYCHIAT, V151, P1063; Li L, 2013, DEV MED CHILD NEUROL, V55, P37, DOI 10.1111/j.1469-8749.2012.04414.x; Mainio A, 2007, BRAIN INJURY, V21, P851, DOI 10.1080/02699050701504265; Max JE, 2012, INT J DEV NEUROSCI, V30, P239, DOI 10.1016/j.ijdevneu.2011.12.005; McKeown RE, 2006, AM J PUBLIC HEALTH, V96, P1744, DOI 10.2105/AJPH.2005.066951; McKinlay A, 2009, J HEAD TRAUMA REHAB, V24, P221, DOI 10.1097/HTR.0b013e3181a40590; MOSCICKI EK, 1995, SUICIDE LIFE-THREAT, V25, P22; Nowrangi MA, 2014, PSYCHOSOMATICS, V55, P430, DOI 10.1016/j.psym.2013.11.006; Omalu BI, 2010, AM J FOREN MED PATH, V31, P130, DOI 10.1097/PAF.0b013e3181ca7f35; Osmond MH, 2002, J TRAUMA, V52, P8, DOI 10.1097/00005373-200201000-00004; Pampalon R, 2003, SANTE SOC SOLIDARITE, V2, P191, DOI [DOI 10.3406/OSS.2003.932, 10.3406/oss.2003.932]; Pickett W, 2001, CAN MED ASSOC J, V165, P288; Poggi G, 2003, BRAIN INJURY, V17, P835, DOI 10.1080/0269905031000088612; Powell J, 2000, BRIT J PSYCHIAT, V176, P266, DOI 10.1192/bjp.176.3.266; Prins ML, 2012, INT J DEV NEUROSCI, V30, P185, DOI 10.1016/j.ijdevneu.2011.05.009; R Development Core Team, 2013, R LANG ENV STAT COMP; Rehkopf DH, 2006, PSYCHOL MED, V36, P145, DOI 10.1017/S003329170500588X; Rhodes AE, 2012, CAN J PUBLIC HEALTH, V103, P213, DOI 10.1007/BF03403815; SAS INSTITUTE, 2013, SAS SYST WIND REL 9; Schwartz L, 2003, J PEDIATR PSYCHOL, V28, P251, DOI 10.1093/jpepsy/jsg013; Simpson G, 2007, BRAIN INJURY, V21, P1335, DOI 10.1080/02699050701785542; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Swaine BR, 2007, PEDIATRICS, V119, P749, DOI 10.1542/peds.2006-1186; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Tate R, 1997, J HEAD TRAUMA REHAB, V12, P16, DOI 10.1097/00001199-199712000-00003; Taylor H G, 1997, J Int Neuropsychol Soc, V3, P555; Teasdale TW, 2001, J NEUROL NEUROSUR PS, V71, P436, DOI 10.1136/jnnp.71.4.436; Winqvist S, 2007, NEUROEPIDEMIOLOGY, V29, P136, DOI 10.1159/000110741; Yeates KO, 2001, J PEDIATR PSYCHOL, V26, P79, DOI 10.1093/jpepsy/26.2.79	66	18	18	0	7	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0002-9262	1476-6256		AM J EPIDEMIOL	Am. J. Epidemiol.	JUL 15	2015	182	2					177	184		10.1093/aje/kwv014			8	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CM9UJ	WOS:000358054200011	26121988	Green Published			2021-06-18	
J	Klimo, P; Ragel, BT; Jones, GM; McCafferty, R				Klimo, Paul, Jr.; Ragel, Brian T.; Jones, G. Morgan; McCafferty, Randall			Severe Pediatric Head Injury During the Iraq and Afghanistan Conflicts	NEUROSURGERY			English	Article						Head injury; Improvised explosive device; Operation enduring freedom; Operation Iraqi freedom; Pediatric; Penetrating	COMBAT SUPPORT HOSPITALS; TRAUMATIC BRAIN-INJURY; SURGICAL-TEAM; MILITARY; CHILDREN; EXPERIENCE; CARE; MORTALITY; BLAST; EPIDEMIOLOGY	BACKGROUND:Much has been written about injuries sustained by US and coalition soldiers during the Global War on Terrorism campaigns. However, injuries to civilians, including children, have been less well documented.OBJECTIVE:To describe the epidemiologic features and outcomes associated with isolated severe head injury in children during Operations Enduring Freedom and Iraqi Freedom (OEF and OIF).METHODS:A retrospective review of children (<18 years old) in the Joint Theater Trauma Registry with isolated head injury (defined as an Abbreviated Injury Score Severity Code >3) and treated at a US combat support hospital in Iraq or Afghanistan (2004-2012). The primary outcome was in-hospital mortality.RESULTS:We identified 647 children with severe isolated head injuries: 337 from OEF, 268 from OIF, and 42 nontheater specific. Most were boys (76%; median age = 8 years). Penetrating injuries were most common (60.6%). Overall, 330 (51%) children underwent a craniotomy/craniectomy; 156 (24.1%) succumbed to their injuries. Admission Glasgow Coma Score was predictive of survival among the entire cohort and each of the individual conflicts. Male sex also significantly increased the odds of survival for the entire group and OEF, but not for OIF. Closed-head injury improved the predictive ability of our model but did not reach statistical significance as an independent factor.CONCLUSION:This is the largest study of combat-related isolated head injuries in children. Admission Glasgow Coma Score and male sex were found to be predictive of survival. Assets to comprehensively care for the pediatric patient should be established early in future conflicts.ABBREVIATIONS:CI, confidence intervalGCS, Glasgow Coma ScoreICP, intracranial pressureIED, improvised explosive deviceJTTR, Joint Theater Trauma RegistryLN, local nationalMTF, military treatment facilityOEF, Operation Enduring FreedomOIF, Operation Iraqi Freedom	[Klimo, Paul, Jr.] Semmes Murphey Neurol & Spine Inst, Memphis, TN 38120 USA; [Klimo, Paul, Jr.; Jones, G. Morgan] Univ Tennessee, Ctr Hlth Sci, Dept Neurosurg, Memphis, TN 38163 USA; [Ragel, Brian T.] Mercy Hosp & Clin, Dept Neurosurg, Springfield, MO USA; [Jones, G. Morgan] Univ Tennessee, Ctr Hlth Sci, Dept Clin Pharm, Memphis, TN 38163 USA; [McCafferty, Randall] Wilford Hall USAF Med Ctr, Lackland AFB, TX USA	Klimo, P (corresponding author), Semmes Murphey Neurol & Spine Inst, 6325 Humphreys Blvd, Memphis, TN 38120 USA.	pklimo@semmes-murphey.com					Amirjamshidi A, 2003, SURG NEUROL, V60, P105, DOI 10.1016/S0090-3019(03)00358-6; [Anonymous], 1971, JAMA, V215, P277; Arul GS, 2012, ANN ROY COLL SURG, V94, P52, DOI 10.1308/003588412X13171221499027; Beekley AC, 2004, AM J SURG, V187, P652, DOI 10.1016/j.amjsurg.2004.02.001; Beekley AC, 2009, J TRAUMA, V66, pS129, DOI 10.1097/TA.0b013e31819d85e7; Bell RS, 2009, J TRAUMA, V66, pS104, DOI 10.1097/TA.0b013e31819d88c8; Belmont Philip J, 2010, J Surg Orthop Adv, V19, P2; Borgman M, 2012, J TRAUMA ACUTE CARE, V73, pS509, DOI 10.1097/TA.0b013e318275477c; Borgman MA, 2011, PEDIATRICS, V127, pE892, DOI 10.1542/peds.2010-2439; Burnett MW, 2008, PEDIATRICS, V121, P261, DOI 10.1542/peds.2006-3666; Coppola CP, 2006, ARCH PEDIAT ADOL MED, V160, P972, DOI 10.1001/archpedi.160.9.972; Creamer KM, 2009, J TRAUMA, V67, P762, DOI 10.1097/TA.0b013e31818b1e15; Ducrocq SC, 2006, PEDIATR CRIT CARE ME, V7, P461, DOI 10.1097/01.PCC.0000235245.49129.27; Eastridge BJ, 2009, J TRAUMA, V66, pS48, DOI 10.1097/TA.0b013e31819ce315; Edwards MJ, 2014, J AM COLL SURGEONS, V218, P1018, DOI 10.1016/j.jamcollsurg.2013.12.050; Edwards MJ, 2012, J TRAUMA ACUTE CARE, V73, P1278, DOI 10.1097/TA.0b013e318270d3ee; Feickert HJ, 1999, J TRAUMA, V47, P33, DOI 10.1097/00005373-199907000-00008; Fuenfer MM, 2009, MIL MED, V174, P887, DOI 10.7205/MILMED-D-02-2308; Klimo P, 2005, J NEUROSURG, V103, P207, DOI 10.3171/ped.2005.103.3.0207; Klimo P, 2010, J NEUROSURG-PEDIATR, V6, P107, DOI 10.3171/2010.3.PEDS109; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Martin JE, 2010, J NEUROSURG-PEDIATR, V6, P250, DOI 10.3171/2010.6.PEDS1031; Mathew P, 2013, BRIT J NEUROSURG, V27, P489, DOI 10.3109/02688697.2013.767314; Matos RI, 2008, PEDIATRICS, V122, pE959, DOI 10.1542/peds.2008-1244; McGuigan R, 2007, J PEDIATR SURG, V42, P207, DOI 10.1016/j.jpedsurg.2006.09.020; Nessen SC, 2009, J TRAUMA, V66, pS37, DOI 10.1097/TA.0b013e31819ce302; O'Connell KM, 2012, MIL MED, V177, P546, DOI 10.7205/MILMED-D-11-00422; Orman JA, 2012, J TRAUMA ACUTE CARE, V73, pS496, DOI 10.1097/TA.0b013e318275473c; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Patregnani JT, 2012, PEDIATR CRIT CARE ME, V13, P273, DOI 10.1097/PCC.0b013e31822f1727; Peoples GE, 2005, MIL MED, V170, P462, DOI 10.7205/MILMED.170.6.462; Pineda JA, 2013, LANCET NEUROL, V12, P45, DOI 10.1016/S1474-4422(12)70269-7; Spinella PC, 2008, CRIT CARE MED, V36, pS293, DOI 10.1097/CCM.0b013e31817da99f; Melo JRT, 2010, NEUROSURGERY, V67, P1542, DOI 10.1227/NEU.0b013e3181fa7049; White JRM, 2001, CRIT CARE MED, V29, P534, DOI 10.1097/00003246-200103000-00011; Wilson KL, 2013, AM SURGEON, V79, P257	36	18	18	1	2	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	JUL	2015	77	1					1	7		10.1227/NEU.0000000000000743			7	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CL2LS	WOS:000356776100001	25812072				2021-06-18	
J	Ozkan, H; Ekinci, S; Uysal, B; Akyildiz, F; Turkkan, S; Ersen, O; Koca, K; Seven, MM				Ozkan, Huseyin; Ekinci, Safak; Uysal, Bulent; Akyildiz, Faruk; Turkkan, Selim; Ersen, Omer; Koca, Kenan; Seven, Mehmet Murat			Evaluation and comparison of the effect of hypothermia and ozone on ischemia-reperfusion injury of skeletal muscle in rats	JOURNAL OF SURGICAL RESEARCH			English	Article						IR injury; Hypothermia; Ozone; SOD; GSH-Px MDA; NOx; IL-1B; iNOS	POSTISCHEMIC HYPOTHERMIA; HYPERBARIC-OXYGEN; CARDIAC-ARREST; FREE-RADICALS; ISCHEMIA/REPERFUSION; TOURNIQUET; PROTECTS; DAMAGE; BRAIN; ASSAY	Background: Tourniquet-induced ischemia-reperfusion, which affects local and distant organs, is very common in orthopedic surgery. Hypothermia is used in traumatic tissue during ischemic period commonly. Ozone (O-3) has been recommended as a novel therapeutic agent in various medical conditions. The objective of the study was to evaluate and compare the effect of hypothermia (H) and O-3 on ischemia-reperfusion injury of skeletal muscle in rats by measuring oxidative parameters and inducible nitric oxide synthase (iNOS) levels. Materials and methods: Eighteen rats (Wistar albino) were separated into five groups randomly (sham, IR, IR + H, IR + O-3, IR + H + O-3; n = 6). The lower right extremity of all rats was subjected to 2 h of ischemia and 22 h of reperfusion clamping the common iliac artery and using the rubber-band technique at the level of the lesser trochanter under general anesthesia. Two hours of hypothermia were applied during the first 2 h of reperfusion in two groups. O-3 was applied in two groups. All rats were sacrificed after the IR period with high dose of anesthesia. The tibialis anterior muscle and blood were saved. Levels of superoxide dismutase, glutathione peroxidase, MDA, NOx, and interleukin-1 beta were measured in the muscle. Creatinine kinase, lactate dehydrogenase, aspartate aminotransferase, urea, creatinine, and electrolytes were measured in serum. Immunohistochemical iNOS staining was performed on muscle samples. Results: The levels of MDA, NOx, and interleukin-1 beta in muscle were raised in the IR group compared with those in the sham group. The same parameters were lower in the groups of IR + H, IR + O-3, and IR + H + O-3 compared with those in the IR group. Superoxide dismutase and glutathione peroxidase activities in muscle were lower in the IR group compared with those in the sham group; however, same parameters were higher in the groups of IR + H, IR + O-3, and IR + H + O-3 compared with those in the IR group. Score and intensity of iNOS staining in skeletal muscle in the IR group was increased compared with that in the sham group and decreased in the groups of IR + H, IR + O-3, and IR + H + O-3 compared with that in the IR group. Levels of creatinine kinase, aspartate aminotransferase, and K in the three treatment groups decreased compared with those in the IR group. Conclusions: These findings showed that hypothermia, which has more affect, and O-3 decreased the tourniquet-induced IR injury in the rat's muscle-skeletal system by reducing the levels of oxidative and nitrosative stress parameters and enhancing antioxidant enzymes. Hypothermia and O-3 had no synergistic effect. Hypothermic reperfusion and O-3 preconditioning might be beneficial in skeletal muscle IR injury-associated tourniquet. (C) 2015 Elsevier Inc. All rights reserved.	[Ozkan, Huseyin; Turkkan, Selim; Koca, Kenan] Gulhane Mil Med Fac, Dept Orthoped Surg, Ankara, Turkey; [Ekinci, Safak] Agri Mil Hosp, Dept Orthoped Surg, Agri, Turkey; [Uysal, Bulent] Gulhane Mil Med Fac, Dept Physiol, Ankara, Turkey; [Akyildiz, Faruk] Malatya Mil Hosp, Dept Orthoped Surg, Malatya, Turkey; [Ersen, Omer] Erzurum Mil Hosp, Dept Orthoped Surg, Erzurum, Turkey; [Seven, Mehmet Murat] Gulhane Mil, Dept Sport Med, Fac Med, Ankara, Turkey	Ekinci, S (corresponding author), Agri Mil Hosp, Dept Orthoped Surg, Agri, Turkey.	safakekinci@yahoo.com	Ozkan, Huseyin/E-3000-2016; Ozkan, Huseyin/Y-4005-2019	Ozkan, Huseyin/0000-0001-9708-0112; Ersen, Omer/0000-0001-7351-6305; Uysal, Bulent/0000-0003-1254-9749			Al-Dalain SM, 2001, PHARMACOL RES, V44, P391; ARMSTEAD WM, 1988, AM J PHYSIOL, V255, pH401; Canevari L, 1999, BRAIN RES, V817, P241, DOI 10.1016/S0006-8993(98)01278-5; Chen H, 2008, J SURG RES, V149, P287, DOI 10.1016/j.jss.2007.12.756; Koca K, 2010, ACTA ORTHOP TRAUMATO, V44, P476, DOI 10.3944/AOTT.2010.2327; Koca K, 2010, J SURG RES, V164, pE83, DOI 10.1016/j.jss.2010.06.030; KORTHUIS RJ, 1985, CIRC RES, V57, P599, DOI 10.1161/01.RES.57.4.599; LEI BP, 1994, STROKE, V25, P147, DOI 10.1161/01.STR.25.1.147; LOWRY OH, 1951, J BIOL CHEM, V193, P265; NAGANO K, 1990, AM J PHYSIOL, V258, pG910; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; PAGLIA DE, 1967, J LAB CLIN MED, V70, P158; Scarfiotti C, 1997, EUR J CANCER PREV, V6, pS31, DOI 10.1097/00008469-199703001-00007; SUN Y, 1988, CLIN CHEM, V34, P497; Tunc T, 2009, J GASTROEN HEPATOL, V24, P681, DOI 10.1111/j.1440-1746.2008.05673.x; Santos ELW, 2013, ACTA CIR BRAS, V28, P582, DOI 10.1590/S0102-86502013000800005; WEINRAUCH V, 1992, STROKE, V23, P1454, DOI 10.1161/01.STR.23.10.1454; WRIGHT JG, 1989, J SURG RES, V47, P389; WRIGHT JG, 1988, J TRAUMA, V28, P1026, DOI 10.1097/00005373-198807000-00019	19	18	20	1	11	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	JUN 15	2015	196	2					313	319		10.1016/j.jss.2015.01.053			7	Surgery	Surgery	CI9QC	WOS:000355103700016	25840486				2021-06-18	
J	Choi, JL; Tan, JKY; Sellers, DL; Wei, H; Horner, PJ; Pun, SH				Choi, Jennifer L.; Tan, James-Kevin Y.; Sellers, Drew L.; Wei, Hua; Horner, Philip J.; Pun, Suzie H.			Guanidinylated block copolymers for gene transfer: A comparison with amine-based materials for in vitro and in vivo gene transfer efficiency	BIOMATERIALS			English	Article						Gene delivery; Guanidine; Brain; Polymer	TRAUMATIC BRAIN INJURY; CELL-PROLIFERATION; PLASMID DELIVERY; NERVOUS-SYSTEM; NEUROGENESIS; ARGININE; BINDING; HIPPOCAMPUS; PEPTIDES; LYSINE	There is currently no cure for neuron loss in the brain, which can occur due to traumatic injury or neurodegenerative disease. One proposed method to enhance brain neurogenesis is gene transfer to neural progenitor cells. In this work, a guanidine-based copolymer was synthesized and compared to an amine-based copolymer analog previously shown to effectively deliver genes in the murine brain. The guanidine-based copolymer was more efficient at gene transfer to immortalized, cultured cell lines; however, the amine-based copolymer was more effective at gene transfer in the brain. DNA condensation studies revealed that the nucleic acid complexes formed with the guanidine-based copolymer were more susceptible to unpackaging in the presence of anionic proteoglycans compared to complexes formed with the amine-based copolymer. Therefore, polyplexes formed from the amine-based copolymer may be more resistant to destabilization by the heparan sulfate proteoglycans present in the stem cell niches of the brain. (C) 2015 Elsevier Ltd. All rights reserved.	[Choi, Jennifer L.; Tan, James-Kevin Y.; Wei, Hua; Pun, Suzie H.] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA; [Choi, Jennifer L.; Tan, James-Kevin Y.; Wei, Hua; Pun, Suzie H.] Univ Washington, Mol Engn & Sci Inst, Seattle, WA 98195 USA; [Sellers, Drew L.; Horner, Philip J.] Univ Washington, Dept Neurol Surg, Seattle, WA 98104 USA	Pun, SH (corresponding author), Univ Washington, 3720 15th Ave NE,Box 355061, Seattle, WA 98195 USA.	phorner@u.washington.edu; spun@u.washington.edu	Wei, Hua-liang/AAX-4771-2020; Horner, Philip J./AAF-7012-2021	Wei, Hua-liang/0000-0002-4704-7346; Pun, Suzie/0000-0003-1443-4996	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [2R01NS064404]; NSF GRFPNational Science Foundation (NSF)NSF - Office of the Director (OD) [2011128558]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS064404] Funding Source: NIH RePORTER	This work was supported by NIH 2R01NS064404; JKYT was supported by NSF GRFP (2011128558). We are grateful to Prof. Wei Zheng (Purdue University) for the generous donation of the Z310 cell line. We thank Prof. Patrick Stayton (University of Washington) for use of his ZetaPALS analyzer and Prof. Shaoyi Jiang (University of Washington) for use of his Malvern Zetasizer. We would also like to thank Jevin Chan for encouraging and supporting us throughout this work.	Bergen JM, 2008, PHARM RES-DORDR, V25, P983, DOI 10.1007/s11095-007-9439-5; Brancia FL, 2000, RAPID COMMUN MASS SP, V14, P2070, DOI 10.1002/1097-0231(20001115)14:21<2070::AID-RCM133>3.0.CO;2-G; Burke RS, 2008, BIOCONJUGATE CHEM, V19, P693, DOI 10.1021/bc700388u; Carlson PM, 2013, BIOMATER SCI-UK, V1, P736, DOI 10.1039/c3bm60079c; Cheng Q, 2013, BIOMATERIALS, V34, P3120, DOI 10.1016/j.biomaterials.2013.01.043; Chirumamilla S, 2002, J NEUROTRAUM, V19, P693, DOI 10.1089/08977150260139084; Choi JS, 2004, J CONTROL RELEASE, V99, P445, DOI 10.1016/j.jconrel.2004.07.027; Dash PK, 2001, J NEUROSCI RES, V63, P313, DOI 10.1002/1097-4547(20010215)63:4<313::AID-JNR1025>3.0.CO;2-4; Davidson BL, 2003, NAT REV NEUROSCI, V4, P353, DOI 10.1038/nrn1104; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; FROMM JR, 1995, ARCH BIOCHEM BIOPHYS, V323, P279, DOI 10.1006/abbi.1995.9963; Futaki S, 2005, ADV DRUG DELIVER REV, V57, P547, DOI 10.1016/j.addr.2004.10.009; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; GUND P, 1972, J CHEM EDUC, V49, P100, DOI 10.1021/ed049p100; Hallbergson AF, 2003, J CLIN INVEST, V112, P1128, DOI 10.1172/JCI200320098; JUHASZ P, 1994, P NATL ACAD SCI USA, V91, P4333, DOI 10.1073/pnas.91.10.4333; Kerever A, 2007, STEM CELLS, V25, P2146, DOI 10.1634/stemcells.2007-0082; Kim ID, 2010, J CONTROL RELEASE, V142, P422, DOI 10.1016/j.jconrel.2009.11.011; Kim I, 2012, SPACE, P20; Kim TI, 2009, BIOMATERIALS, V30, P658, DOI 10.1016/j.biomaterials.2008.10.009; Kwon EJ, 2010, BIOMATERIALS, V31, P2417, DOI 10.1016/j.biomaterials.2009.11.086; Mascotti DP, 1997, BIOCHEMISTRY-US, V36, P7272, DOI 10.1021/bi970272n; Mercier F, 2012, NEUROSCI LETT, V510, P67, DOI 10.1016/j.neulet.2011.12.046; Pack DW, 2005, NAT REV DRUG DISCOV, V4, P581, DOI 10.1038/nrd1775; Ramaswamy S, 2005, BRAIN RES, V1053, P38, DOI 10.1016/j.brainres.2005.06.042; Schug KA, 2005, CHEM REV, V105, P67, DOI 10.1021/cr040603j; STANDKE KH, 1975, NUCLEIC ACIDS RES, V2, P1839, DOI 10.1093/nar/2.10.1839; Weber CJ, 1928, J BIOL CHEM, V78, P465; WEHLING K, 1975, NUCLEIC ACIDS RES, V2, P799, DOI 10.1093/nar/2.6.799; Wei H, 2013, ANGEW CHEM INT EDIT, V52, P5377, DOI 10.1002/anie.201301896; Wender PA, 2008, ADV DRUG DELIVER REV, V60, P452, DOI 10.1016/j.addr.2007.10.016; Wernersson E, 2010, J PHYS CHEM B, V114, P11934, DOI 10.1021/jp1054342; Yoshimura S, 2001, P NATL ACAD SCI USA, V98, P5874, DOI 10.1073/pnas.101034998; Zhang RJ, 2014, BIOMATERIALS, V35, P3443, DOI 10.1016/j.biomaterials.2013.12.097	34	18	18	1	61	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0142-9612	1878-5905		BIOMATERIALS	Biomaterials	JUN	2015	54						87	96		10.1016/j.biomaterials.2015.03.008			10	Engineering, Biomedical; Materials Science, Biomaterials	Engineering; Materials Science	CI2QD	WOS:000354591200009	25907042	Green Accepted			2021-06-18	
J	Davies, SC; Bird, BM				Davies, Susan C.; Bird, Brenna M.			Motivations for Underreporting Suspected Concussion in College Athletics	JOURNAL OF CLINICAL SPORT PSYCHOLOGY			English	Article						concussion; traumatic brain injury; sports; motivations; underreporting	TRAUMATIC BRAIN-INJURY; SPORT-RELATED CONCUSSION; SCHOOL FOOTBALL PLAYERS; ENCEPHALOPATHY; SEQUELAE; COACHES; IMPACT; COHORT; RETURN; MODEL	Student-athletes often fail to report concussion signs and symptoms, thereby putting themselves at risk for delayed recovery and permanent impairment. The present study examined motivations for underreporting concussion symptoms among college athletes enrolled at an NCAA Division I university. One hundred and ninety-three student-athletes in high-risk sports completed a multiple-choice survey related to self-reporting of suspected concussion symptoms and reporting of teammates' symptoms. Results indicated that 45% of participants did not report their own suspected concussions during the present season and 50% did not report suspected concussions in teammates. Responses revealed that the primary reason for underreporting a suspected concussion was the belief that the blow to the head was not serious enough. Suggestions are provided for athletes, athletic staff, and coaches to improve players' awareness of the signs, symptoms, and consequences of concussions, as well as how to report suspected concussions appropriately.	[Davies, Susan C.; Bird, Brenna M.] Univ Dayton, Dayton, OH 45469 USA	Davies, SC (corresponding author), Univ Dayton, Dayton, OH 45469 USA.	sdavies1@udayton.edu					Benson BW, 2013, BRIT J SPORT MED, V47, P321, DOI 10.1136/bjsports-2013-092216; Centers for Disease Control and Prevention, 2011, NONF TRAUM BRAIN INJ; Centers for Disease Control and Prevention, 2010, CONC; Chrisman SP, 2013, J ADOLESCENT HEALTH, V52, P330, DOI 10.1016/j.jadohealth.2012.10.271; Collins M, 2006, NEUROSURGERY, V58, P275, DOI 10.1227/01.NEU.0000200441.92742.46; Comper P, 2005, BRAIN INJURY, V19, P863, DOI 10.1080/02699050400025042; Comper P, 2012, J CLIN SPORT PSYCHOL, V6, P231, DOI 10.1123/jcsp.6.3.231; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Glang A, 2004, NEUROREHABILITATION, V19, P219; Glang A, 2010, INT J SPORTS SCI COA, V5, P1, DOI 10.1260/1747-9541.5.1.1; Goldberger A., 2014, SPORTS LITIGATION AL, V11, P12; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Institute of Medicine, 2013, SPORTS REL CONC YOUT, P1; Institute of Medicine (IOM) and National Research Council (NRC), 2014, SPORTS REL CONC YOUT; Johnson LSM, 2012, J SCHOOL HEALTH, V82, P180, DOI 10.1111/j.1746-1561.2011.00684.x; Jotwani V, 2010, CURR SPORT MED REP, V9, P21, DOI 10.1249/JSR.0b013e3181ccb55e; Kroshus E, 2014, J ADOLESCENT HEALTH, V54, P269, DOI 10.1016/j.jadohealth.2013.11.011; Laker SR, 2011, PM&R, V3, pS354, DOI 10.1016/j.pmrj.2011.07.017; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Leddy JJ, 2012, SPORTS HEALTH, V4, P147, DOI 10.1177/1941738111433673; Lee LK, 2007, PEDIATR EMERG CARE, V23, P580, DOI 10.1097/PEC.0b013e31813444ea; Lewandowski LJ, 2009, J APPL SCH PSYCHOL, V25, P95, DOI 10.1080/15377900802484547; Mainwaring L, 2012, J CLIN SPORT PSYCHOL, V6, P247, DOI 10.1123/jcsp.6.3.247; McAvoy K, 2013, RETURN LEARNING GOIN; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; McCrory P, 2012, CURR SPORT MED REP, V11, P21, DOI 10.1249/JSR.0b013e3182423bfd; Neumann L, 2010, SPORT J, V14; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Register-Mihalik JK, 2013, BRAIN INJURY, V27, P878, DOI 10.3109/02699052.2013.775508; Roe C, 2009, DISABIL REHABIL, V31, P1235, DOI 10.1080/09638280802532720; Saffary R, 2012, J CLIN SPORT PSYCHOL, V6, P351, DOI 10.1123/jcsp.6.4.351; Sarmiento K, 2010, J SCHOOL HEALTH, V80, P112, DOI 10.1111/j.1746-1561.2010.00491.x; Williamson IJS, 2006, BRIT J SPORT MED, V40, P128, DOI 10.1136/bjsm.2005.021832	35	18	18	2	15	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	1932-9261	1932-927X		J CLIN SPORT PSYCHOL	J. Clin. Sport Psychol.	JUN	2015	9	2					101	115		10.1123/jcsp.2014-0037			15	Psychology, Applied	Psychology	CX7EZ	WOS:000365866200001					2021-06-18	
J	Egawa, EY; Kitamura, N; Nakai, R; Arima, Y; Iwata, H				Egawa, Edgar Y.; Kitamura, Narufumi; Nakai, Ryusuke; Arima, Yusuke; Iwata, Hiroo			A DNA hybridization system for labeling of neural stem cells with SPIO nanoparticles for MRI monitoring post-transplantation	BIOMATERIALS			English	Article						Neural cell; Stem cell; Nanoparticle; MRI (magnetic resonance imaging); In vitro test; Transplantation	IRON-OXIDE NANOPARTICLES; TRAUMATIC BRAIN-INJURY; CENTRAL-NERVOUS-SYSTEM; TRANSPLANTATION; DIFFERENTIATION; MIGRATION; SURVIVAL; AGENTS	Neural stem cells (NSCs) demonstrate encouraging results in cell replacement therapy for neurodegenerative disorders and traumatic injury in the central nervous system. Monitor the survival and migration of transplanted cells would provide us important information concerning the performance and integration of the graft during the therapy time course. Magnetic resonance imaging (MRI) allow us to monitor the transplanted cells in a non-invasive way. The only requirement is to use an appropriate contrast agent to label the transplanted cells. Superparamagnetic iron oxide (SPIO) nanoparticles are one of the most commonly used contrast agent for MRI detection of transplanted cells. SPIO nanoparticles demonstrated to be suitable for labeling several types of cells including NSCs. However, the current methods for SPIO labeling are non-specific, depending mostly on electrostatic interactions, demanding relatively high SPIO concentration, and long incubation time, which can affect the viability of cells. In this study, we propose a specific and relatively fast method to label NSCs with SPIO nanoparticles via DNA hybridization. Two short single stranded DNAs (ssDNAs), oligo[dT](20) and oligo[dA](20) were conjugated with a lipid molecule and SPIO nanoparticle respectively. The labeling process comprises two simple steps; first the cells are modified to present oligo[dT](20) ssDNA on the cell surface, then the oligo[dA](20) ssDNA conjugated with SPIO nanoparticles are presented to the modified cells to allow the oligo[dT](20)-oligo[dA](20) hybridization. The method showed to be non-toxic at concentrations up to 50 mu g/mL oligo[dA](20)-SPIO nanoparticles. Presence of SPIO nanoparticles at cell surface and cell cytoplasm was verified by transmission electron microscopy (TEM). SPIO labeling via DNA hybridization demonstrated to not interfere on NSCs proliferation, aggregates formation, and differentiation. NSCs labeled with SPIO nanoparticles via DNA hybridization system were successfully detected by MRI in vitro as well in vivo. Cells transplanted into the rat brain striatum could be detected by MRI scanning up to 1 month post-transplantation. (C) 2015 Elsevier Ltd. All rights reserved.	[Egawa, Edgar Y.; Kitamura, Narufumi; Nakai, Ryusuke; Arima, Yusuke; Iwata, Hiroo] Kyoto Univ, Inst Frontier Med Sci, Sakyo Ku, Kyoto 6068507, Japan	Iwata, H (corresponding author), Kyoto Univ, Inst Frontier Med Sci, Sakyo Ku, 53 Kawahara Cho, Kyoto 6068507, Japan.	iwata@frontier.kuoyo-u.ac.jp	Egawa, Edgar Y/F-6034-2015	Egawa, Edgar Y/0000-0002-4017-4000; Nakai, Ryusuke/0000-0002-3531-2608	Ministry of Education, Culture, Sports, Science, and Technology of JapanMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT) [2306]	This work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas "Nanomedicine Molecular Science" (No. 2306) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Antonelli A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078542; Arbab Ali Syed, 2004, Mol Imaging, V3, P24, DOI 10.1162/153535004773861697; Arbab AS, 2003, RADIOLOGY, V229, P838, DOI 10.1148/radiol.2293021215; Bochman ML, 2012, NAT REV GENET, V13, P770, DOI 10.1038/nrg3296; Bull E, 2014, INT J NANOMED, V9, P1641, DOI 10.2147/IJN.S48979; Cao QL, 2001, EXP NEUROL, V167, P48, DOI 10.1006/exnr.2000.7536; Castro G, 2013, ISRN OPHTHALMOL, V26; Chen CCV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056125; Crabbe A, 2010, CELL TRANSPLANT, V19, P919, DOI 10.3727/096368910X494623; Darsalia V, 2011, J CEREBR BLOOD F MET, V31, P235, DOI 10.1038/jcbfm.2010.81; Deng X., 2013, SCI WORLD J, V2013, P8, DOI DOI 10.1371/J0URNAL.P0NE.0069881; Deno S, 2014, BIOORGAN MED CHEM, V22, P350, DOI 10.1016/j.bmc.2013.11.023; Dihne M, 2006, STEM CELLS, V24, P1458, DOI 10.1634/stemcells.2005-0413; Dodd CH, 2001, J IMMUNOL METHODS, V256, P89, DOI 10.1016/S0022-1759(01)00433-1; Frank JA, 2003, RADIOLOGY, V228, P480, DOI 10.1148/radiol.2281020638; Futterer S, 2013, J PHARMACEUT BIOMED, V86, P151, DOI 10.1016/j.jpba.2013.08.005; Gupta AK, 2005, BIOMATERIALS, V26, P3995, DOI 10.1016/j.biomaterials.2004.10.012; Guzman R, 2007, P NATL ACAD SCI USA, V104, P10211, DOI 10.1073/pnas.0608519104; Jasmin, 2012, Methods Mol Biol, V906, P239, DOI 10.1007/978-1-61779-953-2_18; Kim SU, 2013, NEUROPATHOLOGY, V33, P491, DOI 10.1111/neup.12020; Kitamura N, 2013, BIOORGAN MED CHEM, V21, P7175, DOI 10.1016/j.bmc.2013.08.063; Li MF, 2013, CELL PHYSIOL BIOCHEM, V32, P1776, DOI 10.1159/000356611; Lin G, 2009, GLIA, V57, P592, DOI 10.1002/glia.20788; Lodhia J, 2010, Biomed Imaging Interv J, V6, pe12, DOI 10.2349/biij.6.2.e12; Lundberg C, 1997, EXP NEUROL, V145, P342, DOI 10.1006/exnr.1997.6503; Magnitsky S, 2008, ACAD RADIOL, V15, P1269, DOI 10.1016/j.acra.2008.05.003; Pardal R, 2012, ADV EXP MED BIOL, V741, P206, DOI 10.1007/978-1-4614-2098-9_14; Pickard MR, 2010, INT J MOL SCI, V11, P967, DOI 10.3390/ijms11030967; Rad AM, 2007, BIOTECHNIQUES, V43, P627, DOI 10.2144/000112599; Rahmer J, 2013, PHYS MED BIOL, V58, P3965, DOI 10.1088/0031-9155/58/12/3965; Sakurai K, 2013, BIOMATERIALS, V34, P361, DOI 10.1016/j.biomaterials.2012.09.080; Tang HL, 2013, CELL REPROGRAM, V15, P435, DOI 10.1089/cell.2012.0081; Teramura Y, 2010, BIOMATERIALS, V31, P2229, DOI 10.1016/j.biomaterials.2009.11.098; Weinstein JS, 2010, J CEREBR BLOOD F MET, V30, P15, DOI 10.1038/jcbfm.2009.192; Wen XH, 2014, BIOMATERIALS, V35, P4627, DOI 10.1016/j.biomaterials.2014.02.042; Wennersten A, 2004, J NEUROSURG, V100, P88, DOI 10.3171/jns.2004.100.1.0088; Yoo J, 2013, J CELL BIOCHEM, V114, P743, DOI 10.1002/jcb.24427; Yu B, 2013, ARCH MED SCI, V9, P132, DOI 10.5114/aoms.2012.31438	38	18	19	0	55	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0142-9612	1878-5905		BIOMATERIALS	Biomaterials	JUN	2015	54						158	167		10.1016/j.biomaterials.2015.03.017			10	Engineering, Biomedical; Materials Science, Biomaterials	Engineering; Materials Science	CI2QD	WOS:000354591200016	25907049				2021-06-18	
J	Katzenberger, RJ; Loewen, CA; Bockstruck, RT; Woods, MA; Ganetzky, B; Wassarman, DA				Katzenberger, Rebeccah J.; Loewen, Carin A.; Bockstruck, R. Tayler; Woods, Mikal A.; Ganetzky, Barry; Wassarman, David A.			A Method to Inflict Closed Head Traumatic Brain Injury in Drosophila	JOVE-JOURNAL OF VISUALIZED EXPERIMENTS			English	Article						Neuroscience; Issue 100; Drosophila melanogaster; High-Impact Trauma device; mortality; traumatic brain injury	MODELS	Traumatic brain injury (TBI) affects millions of people each year, causing impairment of physical, cognitive, and behavioral functions and death. Studies using Drosophila have contributed important breakthroughs in understanding neurological processes. Thus, with the goal of understanding the cellular and molecular basis of TBI pathologies in humans, we developed the High Impact Trauma (HIT) device to inflict closed head TBI in flies. Flies subjected to the HIT device display phenotypes consistent with human TBI such as temporary incapacitation and progressive neurodegeneration. The HIT device uses a spring-based mechanism to propel flies against the wall of a vial, causing mechanical damage to the fly brain. The device is inexpensive and easy to construct, its operation is simple and rapid, and it produces reproducible results. Consequently, the HIT device can be combined with existing experimental tools and techniques for flies to address fundamental questions about TBI that can lead to the development of diagnostics and treatments for TBI. In particular, the HIT device can be used to perform large-scale genetic screens to understand the genetic basis of TBI pathologies.	[Katzenberger, Rebeccah J.; Bockstruck, R. Tayler; Wassarman, David A.] Univ Wisconsin Madison, Dept Cell & Regenerat Biol, Madison, WI 53706 USA; [Loewen, Carin A.; Ganetzky, Barry] Univ Wisconsin Madison, Dept Genet, Madison, WI 53706 USA; [Woods, Mikal A.] Univ Puerto Rico Aguadilla, Dept Nat Sci, Aguadilla, PR 00603 USA	Wassarman, DA (corresponding author), Univ Wisconsin Madison, Dept Cell & Regenerat Biol, Madison, WI 53706 USA.	dawassarman@wisc.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 AG033620]; Robert Draper Technology Innovation Funding; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG033620] Funding Source: NIH RePORTER	This work was supported by National Institutes of Health grant, R01 AG033620 (BG) and by Robert Draper Technology Innovation Funding (DAW).	Andretic R, 2005, METHOD ENZYMOL, V393, P759, DOI 10.1016/S0076-6879(05)93040-1; Babcock DT, 2014, JOVE-J VIS EXP, DOI 10.3791/51223; Balsiger Z, 2014, HIT DEVICE HIGH SPEE; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Coronado VG, 2011, MMWR SURVEILL SUMM, V60, P1; Davceva N, 2012, J FORENSIC LEG MED, V19, P480, DOI 10.1016/j.jflm.2012.04.022; Fang YS, 2012, ANNU REV CELL DEV BI, V28, P575, DOI 10.1146/annurev-cellbio-101011-155836; Harrison-Felix CL, 2009, ARCH PHYS MED REHAB, V90, P1506, DOI 10.1016/j.apmr.2009.03.015; Katzenberger RJ, 2013, P NATL ACAD SCI USA, V110, pE4152, DOI 10.1073/pnas.1316895110; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Menon DK, 2009, CRIT CARE MED, V37, pS129, DOI 10.1097/CCM.0b013e3181921225; Prins M, 2013, DIS MODEL MECH, V6, P1307, DOI 10.1242/dmm.011585; TULLY T, 1994, CELL, V79, P35, DOI 10.1016/0092-8674(94)90398-0; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407	14	18	18	1	14	JOURNAL OF VISUALIZED EXPERIMENTS	CAMBRIDGE	1 ALEWIFE CENTER, STE 200, CAMBRIDGE, MA 02140 USA	1940-087X			JOVE-J VIS EXP	J. Vis. Exp.	JUN	2015		100							e52905	10.3791/52905			5	Multidisciplinary Sciences	Science & Technology - Other Topics	CR7NB	WOS:000361536000066	26168076	Green Published			2021-06-18	
J	Knox, L; Douglas, JM; Bigby, C				Knox, Lucy; Douglas, Jacinta M.; Bigby, Christine			'The biggest thing is trying to live for two people': Spousal experiences of supporting decision-making participation for partners with TBI	BRAIN INJURY			English	Article						Caregivers; couples; marital relationship; qualitative research; relationships after TBI; traumatic brain injury	TRAUMATIC BRAIN-INJURY; FOLLOW-UP; MARITAL RELATIONSHIPS; FAMILY CAREGIVERS; HEAD-INJURY; ADJUSTMENT; COUPLES; HEALTH; SATISFACTION; INDIVIDUALS	Primary objective: To understand how the spouses of individuals with severe TBI experience the process of supporting their partners with decision-making. Design: This study adopted a constructivist grounded theory approach, with data consisting of in-depth interviews conducted with spouses over a 12-month period. Data were analysed through an iterative process of open and focused coding, identification of emergent categories and exploration of relationships between categories. Participants: Participants were four spouses of individuals with severe TBI (with moderate-severe disability). Spouses had shared committed relationships (marriage or domestic partnerships) for at least 4 years at initial interview. Three spouses were in relationships that had commenced following injury. Main outcome and results: Two main themes emerged from the data. The first identified the saliency of the relational space in which decision-making took place. The second revealed the complex nature of decision-making within the spousal relationship. Conclusions: Spouses experience decision-making as a complex multi-stage process underpinned by a number of relational factors. Increased understanding of this process can guide health professionals in their provision of support for couples in exploring decision-making participation after injury.	[Knox, Lucy; Douglas, Jacinta M.] La Trobe Univ, Dept Human Commun Sci, Bundoora, Vic 3086, Australia; [Douglas, Jacinta M.] Summer Fdn, Blackburn, Vic, Australia; [Bigby, Christine] La Trobe Univ, Dept Social Work & Social Policy, Bundoora, Vic 3086, Australia	Knox, L (corresponding author), La Trobe Univ, Fac Hlth Sci, Dept Human Commun Sci, Bundoora, Vic 3086, Australia.	l.knox@latrobe.edu.au	bigby, Christine/I-8526-2015; Knox, Lucy/E-8642-2013	bigby, Christine/0000-0001-7001-8976; Knox, Lucy/0000-0001-8331-6032; Douglas, Jacinta/0000-0003-0940-6624			Blais MC, 2007, BRAIN INJURY, V21, P357, DOI 10.1080/02699050701311075; Blais MC, 2005, BRAIN INJURY, V19, P1223, DOI 10.1080/02699050500309387; Bracy C. A., 2005, BRAIN IMPAIR, V6, P1, DOI [10.1375/brim.6.1.1.65476., DOI 10.1375/BRIM.6.1.1.65476, DOI 10.1375/brim.6.1.1.65476]; Burridge AC, 2007, NEUROPSYCHOL REHABIL, V17, P95, DOI 10.1080/09602010500505070; CHARMAZ K., 2007, HDB CONSTRUCTIONIST, P397; Charmaz Kathy, 2003, STRATEGIES QUALITATI, P249, DOI 10.1111/1467-9566.00338; Colantonio A, 2004, DISABIL REHABIL, V26, P253, DOI 10.1080/09638280310001639722; CREWE NM, 1988, ARCH PHYS MED REHAB, V69, P435; Crotty M., 1998, FDN SOCIAL RES MEANI; DeMaris A, 2010, J SOC PERS RELAT, V27, P449, DOI 10.1177/0265407510363428; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Douglas J, 2015, RETHIKING R IN PRESS; Douglas JM, 2000, BRAIN INJURY, V14, P71, DOI 10.1080/026990500120943; Douglas JM, 1996, BRAIN INJURY, V10, P819, DOI 10.1080/026990596123936; Fellows LK, 2012, J INT NEUROPSYCH SOC, V18, P937, DOI 10.1017/S1355617712001294; Gill CJ, 2011, J HEAD TRAUMA REHAB, V26, P56, DOI 10.1097/HTR.0b013e3182048ee9; Glaser B. G., 1967, DISCOVERY GROUNDED T; Godwin E, 2014, BRAIN INJURY, V28, P398, DOI 10.3109/02699052.2014.880514; Godwin EE, 2011, J HEAD TRAUMA REHAB, V26, P43, DOI 10.1097/HTR.0b013e3182048f54; Gosling J, 1999, BRAIN INJURY, V13, P785; Hammond FM, 2011, J HEAD TRAUMA REHAB, V26, P69, DOI 10.1097/HTR.0b013e318205174d; HILL W, 1982, J MARRIAGE FAM, V44, P927, DOI 10.2307/351455; Hoofien D, 2001, BRAIN INJURY, V15, P189; Jumisko E, 2007, J FAM NURS, V13, P353, DOI 10.1177/1074840707303842; Kelley D. L., 2012, MARITAL COMMUNICATIO; Kennedy TJT, 2006, MED EDUC, V40, P101, DOI 10.1111/j.1365-2929.2005.02378.x; Kerr NL, 2004, ANNU REV PSYCHOL, V55, P623, DOI 10.1146/annurev.psych.55.090902.142009; Kiecolt-Glaser JK, 2001, PSYCHOL BULL, V127, P472, DOI 10.1037//0033-2909.127.4.472; Klonoff PS, 2006, BRAIN INJURY, V20, P601, DOI 10.1080/02699050600744301; Knox L, 2013, DISABIL REHABIL, V35, P1926, DOI 10.3109/09638288.2013.766270; Kreutzer JS, 2007, NEUROREHABILITATION, V22, P53; KRUEGER DL, 1982, J COMMUN, V32, P121, DOI 10.1111/j.1460-2466.1982.tb02505.x; Kurdek LA, 2006, J MARRIAGE FAM, V68, P509, DOI 10.1111/j.1741-3737.2006.00268.x; Lefebvre H, 2005, BRAIN INJURY, V19, P585, DOI 10.1080/02699050400025026; Levine B, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00009; Lincoln YS, 2011, SAGE HDB QUALITATIVE, V4, P97; MARKMAN HJ, 1993, J CONSULT CLIN PSYCH, V61, P70, DOI 10.1037/0022-006X.61.1.70; Mauss-Clum N, 1981, J Neurosurg Nurs, V13, P165; McCabe P, 2007, BRAIN INJURY, V21, P231, DOI 10.1080/02699050701201631; McPherson KM, 2009, CLIN REHABIL, V23, P296, DOI 10.1177/0269215509102980; Mellers BA, 1998, ANNU REV PSYCHOL, V49, P447, DOI 10.1146/annurev.psych.49.1.447; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; Perlesz A, 1999, REHABIL PSYCHOL, V44, P6, DOI 10.1037/0090-5550.44.1.6; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; Poole MS, 1989, DYADIC DECISION MAKI, P216; QSR International Pty Ltd, 2010, NVIVO QUAL DAT AN SO; Rogge RD, 1999, J CONSULT CLIN PSYCH, V67, P340, DOI 10.1037/0022-006X.67.3.340; Rosen-Grandon JR, 2004, J COUNS DEV, V82, P58, DOI 10.1002/j.1556-6678.2004.tb00286.x; Rotondi AJ, 2007, J HEAD TRAUMA REHAB, V22, P14, DOI 10.1097/00001199-200701000-00002; Sady MD, 2010, ARCH PHYS MED REHAB, V91, P1542, DOI 10.1016/j.apmr.2010.07.012; Sander AM, 2013, BRAIN IMPAIR, V14, P113, DOI 10.1017/BrImp.2013.12; Sillars A.L., 1989, DYADIC DECISION MAKI, P179, DOI 10.1007/978-1-4612-3516-3_8; SLOAN S, 2007, BRAIN IMPAIR, V8, P251, DOI DOI 10.1375/BRIM.8.3.251; Strauss A., 1990, BASICS QUALITATIVE R; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; Thomsen IV, 1991, SCANDINAVIAN J REH S, V26, P142; Umberson D, 2006, J HEALTH SOC BEHAV, V47, P1, DOI 10.1177/002214650604700101; Umberson D, 2010, J HEALTH SOC BEHAV, V51, pS54, DOI 10.1177/0022146510383501; Waite LJ, 2009, SOC SCI RES, V38, P201, DOI 10.1016/j.ssresearch.2008.07.001; WINTER WD, 1973, FAM PROCESS, V12, P83, DOI 10.1111/j.1545-5300.1973.00083.x; Wood RL, 2006, J NEUROL NEUROSUR PS, V77, P71, DOI 10.1136/jnnp.2005.065540; Wood RL, 1997, BRAIN INJURY, V11, P491, DOI 10.1080/713802183; Wuest J, 2011, NURS RES, P225; YEATES GN, 2013, NEURODISABILITY PSYC, V1, P108	64	18	18	0	10	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUN	2015	29	6					745	757		10.3109/02699052.2015.1004753			13	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	CL8RL	WOS:000357241700010	25831457				2021-06-18	
J	Skidmore, ER; Whyte, EM; Butters, MA; Terhorst, L; Reynolds, CF				Skidmore, Elizabeth R.; Whyte, Ellen M.; Butters, Meryl A.; Terhorst, Lauren; Reynolds, Charles F., III			Strategy Training During Inpatient Rehabilitation May Prevent Apathy Symptoms After Acute Stroke	PM&R			English	Article							TRAUMATIC BRAIN-INJURY; BEHAVIORAL ACTIVATION; POSTSTROKE DEPRESSION; FUNCTIONAL RECOVERY; RELIABILITY; IMPAIRMENT; SCALE; INDEPENDENCE; DISORDERS; INTERVIEW	Background: Apathy, or lack of motivation for goal-directed activities, contributes to reduced engagement in and benefit from rehabilitation, impeding recovery from stroke. Objective: To examine the effects of strategy training, a behavioral intervention used to augment usual inpatient rehabilitation, on apathy symptoms over the first 6 months after stroke. Design: Secondary analysis of randomized controlled trial. Setting: Acute inpatient rehabilitation. Participants: Participants with acute stroke who exhibited cognitive impairments (Quick Executive Interview Scores >= 3) and were admitted for inpatient rehabilitation were randomized to receive strategy training (n = 15, 1 session per day, 5 days per week, in addition to usual inpatient rehabilitation) or reflective listening (n = 15, same dose). Methods: Strategy training sessions focused on participant-selected goals and participant-derived strategies to address these goals, using a global strategy training method (Goal-Plan-Do-Check). Reflective listening sessions focused on participant reflections on their rehabilitation goals and experiences, facilitated by open-ended questions and active listening skills (attending, following, and responding). Main Outcome Measures: Trained raters blinded to group assignment administered the Apathy Evaluation Scale at study admission, 3 months, and 6 months. Data were analyzed with repeated-measures fixed-effects models. Results: Participants in both groups had similar subsyndromal levels of apathy symptoms at study admission (strategy training, mean = 25.79, standard deviation = 7.62; reflective listening, mean = 25.18, standard deviation = 4.40). A significant group x time interaction (F-2,F-28 = 3.61, P = .040) indicated that changes in apathy symptom levels differed between groups over time. The magnitude of group differences in change scores was large (d = -0.99, t(28) = -2.64, P = .013) at month 3 and moderate to large (d = -0.70, t(28) = -1.86, P = .073) at month 6. Conclusion: Strategy training shows promise as an adjunct to usual rehabilitation for maintaining low levels of poststroke apathy.	[Skidmore, Elizabeth R.; Terhorst, Lauren] Univ Pittsburgh, Sch Hlth & Rehabil Sci, Dept Occupat Therapy, Pittsburgh, PA 15260 USA; [Skidmore, Elizabeth R.; Whyte, Ellen M.] Univ Pittsburgh, Sch Med, Dept Phys Med & Rehabil, Pittsburgh, PA 15260 USA; [Whyte, Ellen M.; Butters, Meryl A.; Reynolds, Charles F., III] Univ Pittsburgh, Sch Med, Dept Psychiat, Pittsburgh, PA 15260 USA; [Whyte, Ellen M.; Butters, Meryl A.; Reynolds, Charles F., III] Western Psychiat Inst & Clin, Adv Ctr Intervent & Serv Res Late Life Mood Disor, Pittsburgh, PA USA	Skidmore, ER (corresponding author), Univ Pittsburgh, Sch Hlth & Rehabil Sci, Dept Occupat Therapy, 5012 Forbes Tower, Pittsburgh, PA 15260 USA.	skidmore@pitt.edu	Butters, Meryl/AAR-2863-2021; Terhorst, Lauren/H-7942-2018		University of Pittsburgh Medical Center Rehabilitation Institute, University of Pittsburgh Office of Research Health Sciences, Pittsburgh, PA [P30 MH090333, K12 HD055931, R01 HD074693]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K12HD055931, R01HD074693, R01HD055525, R21HD071728, R03HD073770] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [UL1RR024153] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [P30MH090333] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS084967] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30AG024827] Funding Source: NIH RePORTER	Support was provided by grants P30 MH090333, K12 HD055931, R01 HD074693, from the University of Pittsburgh Medical Center Rehabilitation Institute, University of Pittsburgh Office of Research Health Sciences, Pittsburgh, PA.	Autret K, 2013, BMJ CASE REP; Brodaty H, 2005, PSYCHOL MED, V35, P1707, DOI 10.1017/S0033291705006173; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; Caeiro L, 2012, EUR J NEUROL, V19, P291, DOI 10.1111/j.1468-1331.2011.03508.x; Caeiro L, 2013, CEREBROVASC DIS, V35, P507, DOI 10.1159/000350202; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cuijpers P, 2007, CLIN PSYCHOL REV, V27, P318, DOI 10.1016/j.cpr.2006.11.001; Delis D.C., 2001, DELIS KAPLAN EXECUTI; Glenn MB, 2002, BRAIN INJURY, V16, P509, DOI 10.1080/02699050110119132; Goodglass H, 2001, ASSESSMENT APHASIA R; Hama S, 2011, PSYCHOGERIATRICS, V11, P68, DOI 10.1111/j.1479-8301.2011.00358.x; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Jorge RE, 2010, CAN J PSYCHIAT, V55, P350, DOI 10.1177/070674371005500603; Kanter JW, 2010, CLIN PSYCHOL REV, V30, P608, DOI 10.1016/j.cpr.2010.04.001; Khan A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041778; KRAUS MF, 1995, INT J PSYCHIAT MED, V25, P39, DOI 10.2190/BXRM-3M58-WBC5-A7EL; Lane-Brown AT, 2009, NEUROPSYCHOL REHABIL, V19, P481, DOI 10.1080/09602010902949207; Lane-Brown A, 2010, J HEAD TRAUMA REHAB, V25, P459, DOI 10.1097/HTR.0b013e3181d98e1d; Larson EB, 2010, ARCH PHYS MED REHAB, V91, P389, DOI 10.1016/j.apmr.2009.11.015; Law M, 1998, CANADIAN OCCUPATIONA; Lenze EJ, 2004, ARCH PHYS MED REHAB, V85, P380, DOI 10.1016/j.apmr.2003.06.001; MARIN RS, 1991, PSYCHIAT RES, V38, P143, DOI 10.1016/0165-1781(91)90040-V; MARIN RS, 1991, J NEUROPSYCH CLIN N, V3, P243; MARIN RS, 1990, AM J PSYCHIAT, V147, P22; MARIN RS, 1993, J AFFECT DISORDERS, V28, P7, DOI 10.1016/0165-0327(93)90072-R; Marit RS, 2005, J HEAD TRAUMA REHAB, V20, P377, DOI 10.1097/00001199-200507000-00009; Mayo NE, 2009, STROKE, V40, P3299, DOI 10.1161/STROKEAHA.109.554410; Meichenbaum D., 1977, COGNITIVE BEHAV MODI; Mikami K, 2013, AM J GERIAT PSYCHIAT, V21, P855, DOI 10.1016/j.jagp.2012.07.003; MILLER MD, 1992, PSYCHIAT RES, V41, P237, DOI 10.1016/0165-1781(92)90005-N; Newburn G, 2005, BRAIN INJURY, V19, P149, DOI 10.1080/02699050410001719989; Njomboro P, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00073; Peugh JL, 2010, J SCHOOL PSYCHOL, V48, P85, DOI 10.1016/j.jsp.2009.09.002; Robert P, 2009, EUR PSYCHIAT, V24, P98, DOI 10.1016/j.eurpsy.2008.09.001; Robinson RG, 2009, J NEUROPSYCH CLIN N, V21, P144, DOI 10.1176/appi.neuropsych.21.2.144; Rochat L, 2013, NEUROLOGY, V81, P1674, DOI 10.1212/01.wnl.0000435290.49598.1d; ROYALL DR, 1992, J AM GERIATR SOC, V40, P1221, DOI 10.1111/j.1532-5415.1992.tb03646.x; Salamone JD, 2012, NEURON, V76, P470, DOI 10.1016/j.neuron.2012.10.021; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; Skidmore ER, 2014, CLIN REHABIL, V28, P378, DOI 10.1177/0269215513502799; Skidmore ER, 2011, NEUROPSYCHOL REHABIL, V21, P208, DOI 10.1080/09602011.2011.552559; Skidmore ER, 2014, NEUROREHABIL NEURAL; SPITZER RL, 1994, JAMA-J AM MED ASSOC, V272, P1749, DOI 10.1001/jama.272.22.1749; STARKSTEIN SE, 1993, STROKE, V24, P1625, DOI 10.1161/01.STR.24.11.1625; Stineman MG, 1996, ARCH PHYS MED REHAB, V77, P1101, DOI 10.1016/S0003-9993(96)90130-6; Stuss DT., 2000, DIFFERENTIATION STAT, P340; Tang WK, 2013, CEREBROVASC DIS, V35, P566, DOI 10.1159/000351152; van Buuren S, 2007, STAT METHODS MED RES, V16, P219, DOI 10.1177/0962280206074463; van Dalen JW, 2013, STROKE, V44, P851, DOI 10.1161/STROKEAHA.112.674614; van Reekum R, 2005, J NEUROPSYCH CLIN N, V17, P7, DOI 10.1176/appi.neuropsych.17.1.7; VANREEKUM R, 1995, BRAIN INJURY, V9, P49, DOI 10.3109/02699059509004571; Watanabe A, 2003, J NEUROPSYCH CLIN N, V15, P442, DOI 10.1176/appi.neuropsych.15.4.442; Whyte EM, 2008, CEREBROVASC DIS, V26, P317, DOI 10.1159/000149580; Withall A, 2011, INT PSYCHOGERIATR, V23, P264, DOI 10.1017/S1041610209991116	54	18	18	0	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1934-1482	1934-1563		PM&R	PM&R	JUN	2015	7	6					562	570		10.1016/j.pmrj.2014.12.010			9	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	CK2PO	WOS:000356053400002	25595665	Green Accepted			2021-06-18	
J	Cromer, JA; Harel, BT; Yu, K; Valadka, JS; Brunwin, JW; Crawford, CD; Mayes, LC; Maruff, P				Cromer, Jason A.; Harel, Brian T.; Yu, Karen; Valadka, Jaclyn S.; Brunwin, Jack W.; Crawford, Cameron D.; Mayes, Linda C.; Maruff, Paul			Comparison of Cognitive Performance on the Cogstate Brief Battery When Taken In-Clinic, In-Group, and Unsupervised	CLINICAL NEUROPSYCHOLOGIST			English	Article						Computerized testing; Group testing; Baseline testing; Cognition.; Concussion; Remote testing; Unsupervised testing	BASE-LINE; IMPAIRMENT; CONCUSSION; SENSITIVITY; SPORT; IMPACT	Objective: Repeat cognitive assessment comparing post-injury performance to a pre-injury baseline is common in concussion management. Although post-injury tests are typically administered in clinical settings, baseline tests may be conducted individually with one-on-one supervision, in a group with supervision, or without supervision. The extent to which these different test settings affect cognitive performance is not well understood. To assess if performance on the Cogstate Brief Battery (CBB) differs across these settings, tests completed individually with one-on-one supervision were compared to those taken either in a group with supervision or individually but without supervision. Method: A crossover study design was utilized to account for any effect of individual variability or test order to provide an unbiased examination of the effect of test setting on cognitive performance. Young adult participants completed an individually supervised test either before or after also completing a group or unsupervised test. Results: CBB scores from the same individuals were not significantly different across test settings. Effect sizes ranged in magnitude from .09 to .12 for supervised versus unsupervised tests and from .01 to .37 for individual versus group tests across CBB tasks. Conclusion: These results suggest that cognitive testing with the CBB in alternate settings can provide valid cognitive data comparable to data obtained during individually supervised testing.	[Cromer, Jason A.; Harel, Brian T.; Valadka, Jaclyn S.; Brunwin, Jack W.; Mayes, Linda C.] Yale Univ, Ctr Child Study, New Haven, CT 06520 USA; [Cromer, Jason A.; Harel, Brian T.; Valadka, Jaclyn S.; Brunwin, Jack W.; Maruff, Paul] Cogstate Ltd, New Haven, CT USA; [Yu, Karen; Valadka, Jaclyn S.; Crawford, Cameron D.] Sewanee Univ South, Dept Psychol, Sewanee, TN USA; [Maruff, Paul] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Melbourne, Vic, Australia	Cromer, JA (corresponding author), 195 Church St,8th Floor, New Haven, CT 06510 USA.	jason.cromer@yale.edu	Maruff, Paul/AAD-2454-2021; Maruff, Paul/ABA-1673-2020; Meijer, Anna/K-5118-2016	Maruff, Paul/0000-0002-6947-9537; 			Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Bailey CM, 2006, J INT NEUROPSYCH SOC, V12, P475, DOI 10.1017/S1355617706060619; Collie A, 2004, BRIT J SPORT MED, V38, P273, DOI 10.1136/bjsm.2003.000293; Collie A, 2003, BRIT J SPORT MED, V37, P2, DOI 10.1136/bjsm.37.1.2; Collie A, 2001, BRIT J SPORT MED, V35, P297, DOI 10.1136/bjsm.35.5.297; Crawford JR, 1998, J CLIN EXP NEUROPSYC, V20, P755, DOI 10.1076/jcen.20.5.755.1132; Cromer JA, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00704; Dickinson D., 2009, SCHIZOPHR RES, V167, P170, DOI [10.1016/j.schres.2010.10.023, DOI 10.1016/J.SCHRES.2010.10.023]; Dunlap WP, 1996, PSYCHOL METHODS, V1, P170, DOI 10.1037/1082-989X.1.2.170; Echemendia R. J., 2012, NEUROPSYCHOLOGICAL T; Echemendia RJ, 2013, BRIT J SPORT MED, V47, P294, DOI 10.1136/bjsports-2013-092186; Erlanger D, 2001, J ATHL TRAINING, V36, P280; Falleti MG, 2006, J CLIN EXP NEUROPSYC, V28, P1095, DOI 10.1080/13803390500205718; Falleti MG, 2003, J SLEEP RES, V12, P265, DOI 10.1111/j.1365-2869.2003.00363.x; Hinton-Bayre AD, 2012, CLIN J SPORT MED, V22, P105, DOI 10.1097/JSM.0b013e318248a526; Hinton-Bayre AD, 2010, ARCH CLIN NEUROPSYCH, V25, P244, DOI 10.1093/arclin/acq008; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; Kivi M, 2014, COGN BEHAV THERAPY, V43, P289, DOI 10.1080/16506073.2014.921834; Klatte M, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00578; Lewis MS, 2011, NEUROUROL URODYNAM, V30, P183, DOI 10.1002/nau.20963; Lichtenstein JD, 2014, AM J SPORT MED, V42, P479, DOI 10.1177/0363546513509225; Liebl A, 2012, APPL ERGON, V43, P424, DOI 10.1016/j.apergo.2011.06.017; Louey AG, 2014, ARCH CLIN NEUROPSYCH, V29, P432, DOI 10.1093/arclin/acu020; Makdissi M, 2001, BRIT J SPORT MED, V35, P354, DOI 10.1136/bjsm.35.5.354; Maruff P, 2009, ARCH CLIN NEUROPSYCH, V24, P165, DOI 10.1093/arclin/acp010; Mayas J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092269; McCrory P, 2004, BRIT J SPORT MED, V38, P516, DOI 10.1136/bjsm.2004.014811; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Moser RS, 2007, ARCH CLIN NEUROPSYCH, V22, P909, DOI 10.1016/j.acn.2007.09.004; Moser RS, 2011, AM J SPORT MED, V39, P2325, DOI 10.1177/0363546511417114; Olver JS, 2015, STRESS HEALTH, V31, P115, DOI 10.1002/smi.2533; Reeves DL, 2007, ARCH CLIN NEUROPSYCH, V22, pS15, DOI 10.1016/j.acn.2006.10.013; Roebuck-Spencer TM, 2013, J ATHL TRAINING, V48, P499, DOI 10.4085/1062-6050-48.3.11; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Spielberg F, 2011, AIDS EDUC PREV, V23, P110, DOI 10.1521/aeap.2011.23.3_supp.110; Tian Ho-Heng, 2011, Asian J Sports Med, V2, P145; Vaughan CG, 2014, AM J SPORT MED, V42, P1716, DOI 10.1177/0363546514531732	37	18	18	0	5	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.	MAY 19	2015	29	4					542	558		10.1080/13854046.2015.1054437			17	Psychology, Clinical; Clinical Neurology; Psychology	Psychology; Neurosciences & Neurology	CM8FZ	WOS:000357935100010	26165425				2021-06-18	
J	Allen, RS; Olsen, TW; Sayeed, I; Cale, HA; Morrison, KC; Oumarbaeva, Y; Lucaciu, I; Boatright, JH; Pardue, MT; Stein, DG				Allen, Rachael S.; Olsen, Timothy W.; Sayeed, Iqbal; Cale, Heather A.; Morrison, Katherine C.; Oumarbaeva, Yuliya; Lucaciu, Irina; Boatright, Jeffrey H.; Pardue, Machelle T.; Stein, Donald G.			Progesterone Treatment in Two Rat Models of Ocular Ischemia	INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE			English	Article						progesterone; retinal ischemia; electroretinogram; middle cerebral artery occlusion; anterior ischemia optic neuropathy	CEREBRAL-ARTERY OCCLUSION; TRAUMATIC BRAIN-INJURY; RETINAL GLIAL-CELLS; NF-KAPPA-B; OPTIC NEUROPATHY; GLUCOCORTICOID RECEPTOR; EXPERIMENTAL STROKE; SIGNALING PATHWAY; OXIDATIVE STRESS; GENE-EXPRESSION	PURPOSE. To determine whether the neurosteroid progesterone, shown to have protective effects in animal models of traumatic brain injury, stroke, and spinal cord injury, is also protective in ocular ischemia animal models. METHODS. Progesterone treatment was tested in two ocular ischemia models in rats: a rodent anterior ischemic optic neuropathy (rAION) model, which induces permanent monocular optic nerve stroke, and the middle cerebral artery occlusion (MCAO) model, which causes transient ischemia in both the retina and brain due to an intraluminal filament that blocks the ophthalmic and middle cerebral arteries. Visual function and retinal histology were assessed to determine whether progesterone attenuated retinal injury in these models. Additionally, behavioral testing and 2% 2,3,5 - triphenyltetrazolium chloride (TTC) staining in brains were used to compare progesterone's neuroprotective effects in both retina and brain using the MCAO model. RESULTS. Progesterone treatment showed no effect on visual evoked potential (VEP) reduction and retinal ganglion cell loss in the permanent rAION model. In the transient MCAO model, progesterone treatment reduced (1) electroretinogram (ERG) deficits, (2) MCAO - induced upregulation of glutamine synthetase (GS) and glial fibrillary acidic protein (GFAP), and (3) retinal ganglion cell loss. As expected, progesterone treatment also had significant protective effects in behavioral tests and a reduction in infarct size in the brain. CONCLUSIONS. Progesterone treatment showed protective effects in the retina following MCAO but not rAION injury, which may result from mechanistic differences with injury type and the therapeutic action of progesterone.	[Allen, Rachael S.; Sayeed, Iqbal; Cale, Heather A.; Morrison, Katherine C.; Oumarbaeva, Yuliya; Lucaciu, Irina; Stein, Donald G.] Emory Univ, Emergency Med, Atlanta, GA 30322 USA; [Allen, Rachael S.; Olsen, Timothy W.; Boatright, Jeffrey H.; Pardue, Machelle T.] Emory Univ, Dept Ophthalmol, Atlanta, GA 30322 USA; [Allen, Rachael S.; Boatright, Jeffrey H.; Pardue, Machelle T.] Atlanta VA Ctr Visual & Neurocognit Rehabil, Decatur, GA USA	Allen, RS (corresponding author), Atlanta VA Ctr Visual & Neurocognit Rehabil, Res Serv Oph 151, 1670 Clairmont Rd, Decatur, GA 30033 USA.	restewa@emory.edu	Lucaciu, Irina/AAZ-8624-2020; Stein, Donald/AAJ-5139-2020		H. Allen and Company; Atlanta VA Rehab R&D Center of Excellence; Abraham J. and Phyllis Katz Foundation; Foundation Fighting BlindnessEuropean Commission; Research to Prevent BlindnessResearch to Prevent Blindness (RPB); National Eye InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [R01EY014026, R01EY016470, R24EY017045, P30EY006360, T32EY007092-24]; NATIONAL EYE INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [R01EY016470, P30EY006360, T32EY007092, R01EY014026, R24EY017045] Funding Source: NIH RePORTER	Supported by H. Allen and Company; Atlanta VA Rehab R&D Center of Excellence; The Abraham J. and Phyllis Katz Foundation; Foundation Fighting Blindness; an unrestricted departmental grant from Research to Prevent Blindness; and National Eye Institute Grants R01EY014026, R01EY016470, R24EY017045, P30EY006360, and T32EY007092-24.	Allen RS, 2014, EXP NEUROL, V254, P206, DOI 10.1016/j.expneurol.2014.02.005; Ardeshiri A, 2006, EUR J NEUROSCI, V24, P2567, DOI 10.1111/j.1460-9568.2006.05142.x; Avitabile T, 2007, CURR EYE RES, V32, P999, DOI 10.1080/02713680701679006; Barnett NL, 2000, INVEST OPHTH VIS SCI, V41, P585; Benavente O, 2001, NEW ENGL J MED, V345, P1084, DOI 10.1056/NEJMoa002994; Bernstein SL, 2003, INVEST OPHTH VIS SCI, V44, P4153, DOI 10.1167/iovs.03-0274; Block F, 1997, NEUROSCI LETT, V232, P45, DOI 10.1016/S0304-3940(97)00575-2; Cai WY, 2008, NEUROPHARMACOLOGY, V55, P127, DOI 10.1016/j.neuropharm.2008.04.023; Cascio C, 2007, EXP EYE RES, V85, P166, DOI 10.1016/j.exer.2007.02.008; Chang CH, 2014, EXP EYE RES, V118, P109, DOI 10.1016/j.exer.2013.11.012; Coca-Prados M, 2003, J STEROID BIOCHEM, V86, P207, DOI 10.1016/j.jsbmb.2003.08.001; Cutler SM, 2007, J NEUROTRAUM, V24, P1475, DOI 10.1089/neu.2007.0294; Cutler SM, 2006, EXP NEUROL, V200, P378, DOI 10.1016/j.expneurol.2006.02.137; Cutler SM, 2005, EXP NEUROL, V195, P423, DOI 10.1016/j.expneurol.2005.06.003; Doonan F, 2011, J NEUROCHEM, V118, P915, DOI 10.1111/j.1471-4159.2011.07354.x; Dvoriantchikova G, 2009, EUR J NEUROSCI, V30, P175, DOI 10.1111/j.1460-9568.2009.06814.x; Espinosa-Garcia C, 2013, NEUROSCI LETT, V550, P98, DOI 10.1016/j.neulet.2013.06.023; Fazzone HE, 2003, BRIT J OPHTHALMOL, V87, P1193, DOI 10.1136/bjo.87.9.1193; Ghoumari AM, 2005, NEUROSCIENCE, V135, P47, DOI 10.1016/j.neuroscience.2005.05.023; Gronberg NV, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-115; GUARNERI P, 1994, J NEUROCHEM, V63, P86; Hangai M, 1996, OPHTHALMIC RES, V28, P248, DOI 10.1159/000267910; HAYREH SS, 1974, BRIT J OPHTHALMOL, V58, P955, DOI 10.1136/bjo.58.12.955; Helenius J, 2012, ANN NEUROL, V72, P286, DOI 10.1002/ana.23597; Hill JK, 1999, BRAIN RES, V820, P45, DOI 10.1016/S0006-8993(98)01140-8; HILLERED L, 1989, J CEREBR BLOOD F MET, V9, P607, DOI 10.1038/jcbfm.1989.87; Iandiev I, 2006, NEUROSCI LETT, V408, P108, DOI 10.1016/j.neulet.2006.08.084; Ishrat T, 2012, NEUROSCIENCE, V210, P442, DOI 10.1016/j.neuroscience.2012.03.008; Ishrat T, 2010, EXP NEUROL, V226, P183, DOI 10.1016/j.expneurol.2010.08.023; Ishrat T, 2009, BRAIN RES, V1257, P94, DOI 10.1016/j.brainres.2008.12.048; Kalloniatis M, 1995, J Am Optom Assoc, V66, P750; Kalogeris T, 2012, INT REV CEL MOL BIO, V298, P229, DOI 10.1016/B978-0-12-394309-5.00006-7; Kliewer SA, 1998, CELL, V92, P73, DOI 10.1016/S0092-8674(00)80900-9; Knight SR, 2012, J NEUROENDOCRINOL, V24, P1135, DOI 10.1111/j.1365-2826.2012.02319.x; Koulen P, 2008, CELL PHYSIOL BIOCHEM, V21, P161, DOI 10.1159/000113758; Labombarda F, 2013, NEUROPHARMACOLOGY, V71, P46, DOI 10.1016/j.neuropharm.2013.03.010; Langmade SJ, 2006, P NATL ACAD SCI USA, V103, P13807, DOI 10.1073/pnas.0606218103; LANTHIER A, 1988, BRAIN RES, V463, P403, DOI 10.1016/0006-8993(88)90419-2; LANTHIER A, 1986, J STEROID BIOCHEM, V25, P445, DOI 10.1016/0022-4731(86)90259-1; LANTHIER A, 1987, J STEROID BIOCHEM, V28, P697, DOI 10.1016/0022-4731(87)90400-6; Li Xin-Juan, 2012, Zhongguo Ying Yong Sheng Li Xue Za Zhi, V28, P472; Li YC, 1997, J MOL NEUROSCI, V8, P145, DOI 10.1007/BF02736779; Liu AL, 2012, ENDOCRINOLOGY, V153, P3747, DOI 10.1210/en.2012-1138; Liu Y, 2012, FREE RADICAL BIO MED, V52, P909, DOI 10.1016/j.freeradbiomed.2011.12.013; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Lu Na, 2008, Nan Fang Yi Ke Da Xue Xue Bao, V28, P2026; Maurice T, 1998, NEUROSCIENCE, V83, P413, DOI 10.1016/S0306-4522(97)00405-3; Mead GE, 2002, STROKE, V33, P2383, DOI 10.1161/01.STR.0000029827.93497.97; MILLER NR, 1982, WALSH HOYTS CLIN NEU, P212; Moller A, 2003, VISUAL NEUROSCI, V20, P535, DOI 10.1017/S0952523803205071; MONNET FP, 1995, P NATL ACAD SCI USA, V92, P3774, DOI 10.1073/pnas.92.9.3774; Neumann F, 2010, NEUROCHEM RES, V35, P522, DOI 10.1007/s11064-009-0092-8; Nilsen J, 2002, ENDOCRINOLOGY, V143, P205, DOI 10.1210/en.143.1.205; OGATA T, 1993, NEUROSCIENCE, V55, P445, DOI 10.1016/0306-4522(93)90513-F; Ozacmak VH, 2009, PHYSIOL RES, V58, P909, DOI 10.33549/physiolres.931647; Panchami, 2013, J CLIN DIAGN RES, V7, P1322, DOI 10.7860/JCDR/2013/5325.3145; Perlman JI, 1996, CURR EYE RES, V15, P589, DOI 10.3109/02713689609008898; PRICE MJ, 1988, GRAEF ARCH CLIN EXP, V226, P542, DOI 10.1007/BF02169202; Puia Giulia, 2001, Trends in Pharmacological Sciences, V22, P266, DOI 10.1016/S0165-6147(00)01706-5; Puig N, 2000, CEREBROVASC DIS, V10, P449, DOI 10.1159/000016106; Reddy DS, 2005, NEUROPHARMACOLOGY, V48, P14, DOI 10.1016/j.neuropharm.2004.09.002; Sakamoto H, 2001, J COMP NEUROL, V439, P291, DOI 10.1002/cne.1351; Sayeed I, 2009, PROG BRAIN RES, V175, P219, DOI 10.1016/S0079-6123(09)17515-5; Sayeed L, 2007, RESTOR NEUROL NEUROS, V25, P151; Schmidt-Kastner R, 2000, MOL BRAIN RES, V79, P88, DOI 10.1016/S0169-328X(00)00104-2; Schneider A, 1999, NAT MED, V5, P554; Schumacher M, 2014, PROG NEUROBIOL, V113, P6, DOI 10.1016/j.pneurobio.2013.09.004; Schumacher M, 2007, PHARMACOL THERAPEUT, V116, P77, DOI 10.1016/j.pharmthera.2007.06.001; Sharma RK, 2002, ADLERS PHYSL EYE, P319; SLEPYAN DH, 1975, STROKE, V6, P493, DOI 10.1161/01.STR.6.5.493; Steele EC, 2008, STROKE, V39, P2099, DOI 10.1161/STROKEAHA.107.504357; Stein DG, 2010, EXPERT OPIN INV DRUG, V19, P847, DOI 10.1517/13543784.2010.489549; Su TP, 2003, CURR MED CHEM, V10, P2073, DOI 10.2174/0929867033456783; SVEC F, 1989, ENDOCRINOLOGY, V125, P3103, DOI 10.1210/endo-125-6-3103; SVEC F, 1980, ENDOCRINOLOGY, V107, P566, DOI 10.1210/endo-107-2-566; Swiatek-De Lange M, 2007, GLIA, V55, P1061, DOI 10.1002/glia.20523; Wali B, 2014, BRAIN, V137, P486, DOI 10.1093/brain/awt319; Wang JP, 2010, BEHAV BRAIN RES, V209, P119, DOI 10.1016/j.bbr.2010.01.026; Wang XY, 2013, EXP THER MED, V6, P263, DOI 10.3892/etm.2013.1116; Wickham LA, 2000, ACTA OPHTHALMOL SCAN, V78, P146, DOI 10.1034/j.1600-0420.2000.078002146.x; Won S, 2014, J CEREBR BLOOD F MET, V34, P72, DOI 10.1038/jcbfm.2013.163; Yang CS, 1996, FREE RADICAL BIO MED, V20, P245, DOI 10.1016/0891-5849(95)02042-X; Yousuf S, 2013, NEUROSCIENCE, V239, P92, DOI 10.1016/j.neuroscience.2012.10.017; Yousuf S, 2014, J CEREBR BLOOD F MET, V34, P297, DOI 10.1038/jcbfm.2013.198; Yucel I, 2005, CAN J OPHTHALMOL, V40, P51, DOI 10.1016/S0008-4182(05)80117-6; Zador Zsolt, 2009, Handb Exp Pharmacol, P159, DOI 10.1007/978-3-540-79885-9_7; Zhang C, 2005, EXP EYE RES, V81, P700, DOI 10.1016/j.exer.2005.04.008; Zhang Y, 2005, INVEST OPHTH VIS SCI, V46, P2133, DOI 10.1167/iovs.04-1235; ZIAI N, 1994, ARCH OPHTHALMOL-CHIC, V112, P801, DOI 10.1001/archopht.1994.01090180099043	89	18	18	0	8	ASSOC RESEARCH VISION OPHTHALMOLOGY INC	ROCKVILLE	12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA	0146-0404	1552-5783		INVEST OPHTH VIS SCI	Invest. Ophthalmol. Vis. Sci.	MAY	2015	56	5					2880	2891		10.1167/iovs.14-16070			12	Ophthalmology	Ophthalmology	CK7UJ	WOS:000356439200013	26024074	Green Published			2021-06-18	
J	Chan, S; Kurowski, B; Byczkowski, T; Timm, N				Chan, Steven; Kurowski, Brad; Byczkowski, Terri; Timm, Nathan			Intravenous migraine therapy in children with posttraumatic headache in the ED	AMERICAN JOURNAL OF EMERGENCY MEDICINE			English	Article							TRAUMATIC BRAIN-INJURY; SPORT-RELATED CONCUSSION; SEX-DIFFERENCES; PROCHLORPERAZINE; SUMATRIPTAN; SYMPTOMS; COHORT; TRIAL; PAIN	Background: More than 3.8 million children sustain traumatic brain injuries annually. Treatment of posttraumatic headache (PTH) in the emergency department (ED) is variable, and benefits are unclear. Objective: The objective of the study is to determine if intravenous migraine therapy reduces pain scores in children with PTH and factors associated with improved response. Methods: This was a retrospective study of children, 8 to 21 years old, presenting to a tertiary pediatric ED with mild traumatic brain injury (mTBI) and PTH from November 2009 to June 2013. Inclusion criteria were mTBI (defined by diagnosis codes) within 14 days of ED visit, headache, and administration of one or more intravenous medications: ketorolac, prochlorperazine, metoclopramide, chlorpromazine, and ondansetron. Primary outcome was treatment success defined by greater than or equal to 50% pain score reduction during ED visit. Bivariate analysis and logistic regression were used to determine predictors of treatment success: age, sex, migraine or mTBI history, time since injury, ED head computed tomographic (CT) imaging, and pretreatment with oral analgesics. Results: A total of 254 patients were included. Mean age was 13.8 years, 51% were female, 80% were white, mean time since injury was 2 days, and 114 patients had negative head CTs. Eighty-six percent of patients had treatment success with 52% experiencing complete resolution of headache. Bivariate analysis showed that patients who had a head CT were less likely to respond (80% vs 91%; P = .008). Conclusions: Intravenous migraine therapy reduces PTH pain scores for children presenting within 14 days after mTBI. Further prospective work is needed to determine long-term benefits of acute PTH treatment in the ED. (C) 2015 Elsevier Inc. All rights reserved.	[Chan, Steven; Byczkowski, Terri; Timm, Nathan] Cincinnati Childrens Hosp Med Ctr, Div Emergency Med, Cincinnati, OH 45229 USA; [Kurowski, Brad] Cincinnati Childrens Hosp Med Ctr, Div Phys Med & Rehabil, Cincinnati, OH 45229 USA	Chan, S (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Emergency Med, 3333 Burnet Ave,ML2008, Cincinnati, OH 45229 USA.	steven.chan@cchmc.org			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [K23HD074683-01]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23HD074683] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001425, UL1TR000077] Funding Source: NIH RePORTER	Funding from National Institutes of Health grant K23HD074683-01 supported, in part, Brad G. Kurowski's time for participation in the study development and manuscript preparation.	Bazarian JJ, 2010, J NEUROTRAUM, V27, P527, DOI 10.1089/neu.2009.1068; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Blinman TA, 2009, J PEDIATR SURG, V44, P1223, DOI 10.1016/j.jpedsurg.2009.02.027; Blume HK, 2012, PEDIATRICS, V129, pE31, DOI 10.1542/peds.2011-1742; Brousseau DC, 2004, ANN EMERG MED, V43, P256, DOI 10.1016/S0196-0644(03)00716-9; Covassin T, 2003, J ATHL TRAINING, V38, P238; Eisenberg MA, 2013, PEDIATRICS, V132, P8, DOI 10.1542/peds.2013-0432; Erickson JC, 2011, HEADACHE, V51, P932, DOI 10.1111/j.1526-4610.2011.01909.x; Ferreira-Valente MA, 2011, PAIN, V152, P2399, DOI 10.1016/j.pain.2011.07.005; Friedman BW, 2008, ANN EMERG MED, V52, P399, DOI 10.1016/j.annemergmed.2007.09.027; GAWEL MJ, 1993, HEADACHE, V33, P96, DOI 10.1111/j.1526-4610.1993.hed3302096.x; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Hamalainen ML, 1997, NEUROLOGY, V48, P1100, DOI 10.1212/WNL.48.4.1100; Kabbouche MA, 2001, PEDIATRICS, V107, part. no., DOI 10.1542/peds.107.4.e62; Kontos AP, 2013, AM J SPORT MED, V41, P1497, DOI 10.1177/0363546513488751; Kuczynski A, 2013, DEV MED CHILD NEUROL, V55, P636, DOI 10.1111/dmcn.12152; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Lay CL, 1999, HEADACHE, V39, P275, DOI 10.1046/j.1526-4610.1999.3904275.x; Leung S, 2013, HEADACHE, V53, P491, DOI 10.1111/head.12042; Lew HL, 2006, AM J PHYS MED REHAB, V85, P619, DOI 10.1097/01.phm.0000223235.09931.c0; Lucas S, 2012, CEPHALALGIA, V32, P600, DOI 10.1177/0333102412445224; Lucas S, 2011, PM&R, V3, pS406, DOI 10.1016/j.pmrj.2011.07.016; Lumba-Brown A, 2014, PEDIATR EMERG CARE, V30, P139, DOI 10.1097/PEC.0000000000000084; MCBEATH JG, 1994, HEADACHE, V34, P148, DOI 10.1111/j.1526-4610.1994.hed3403148.x; Mihalik JP, 2005, J NEUROSURG, V102, P850, DOI 10.3171/jns.2005.102.5.0850; Moreno MA, 2012, ARCH PEDIAT ADOL MED, V166, P296, DOI [10.1001/archpediatrics.2012.8, 10.1001/archpediatrics.2012.79]; Packard RC, 2000, HEADACHE, V40, P736, DOI 10.1046/j.1526-4610.2000.00128.x; Powers SW, 2003, PEDIATRICS, V112, pE1, DOI 10.1542/peds.112.1.e1; Preiss-Farzanegan SJ, 2009, PM&R, V1, P245, DOI 10.1016/j.pmrj.2009.01.011; Trottier ED, 2012, AM J EMERG MED, V30, P456, DOI 10.1016/j.ajem.2010.12.020; Trottier ED, 2010, J EMERG MED, V39, P166, DOI 10.1016/j.jemermed.2008.08.012; von Baeyer CL, 2009, PAIN, V143, P223, DOI 10.1016/j.pain.2009.03.002; Watanabe TK, 2012, PM&R, V4, P129, DOI 10.1016/j.pmrj.2011.06.003; WEISS HD, 1991, HEADACHE, V31, P451, DOI 10.1111/j.1526-4610.1991.hed3107451.x; Williams K, 2012, PEDIATRICS, V129, pS153, DOI 10.1542/peds.2012-0055I	35	18	18	1	4	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0735-6757	1532-8171		AM J EMERG MED	Am. J. Emerg. Med.	MAY	2015	33	5					635	639		10.1016/j.ajem.2015.01.053			5	Emergency Medicine	Emergency Medicine	CH8MX	WOS:000354291600006	25676851	Green Accepted			2021-06-18	
J	Fortress, AM; Heisler, JD; Frick, KM				Fortress, Ashley M.; Heisler, John D.; Frick, Karyn M.			The mTOR and Canonical Wnt Signaling Pathways Mediate the Mnemonic Effects of Progesterone in the Dorsal Hippocampus	HIPPOCAMPUS			English	Article						progesterone receptors; memory; ERK; mTOR; Wnt	RECOGNITION MEMORY CONSOLIDATION; TRAUMATIC BRAIN-INJURY; ESTRADIOL-INDUCED ENHANCEMENT; REGULATED KINASE ACTIVATION; LONG-TERM POTENTIATION; BREAST-CANCER CELLS; OBJECT RECOGNITION; RECEPTOR ISOFORMS; NERVOUS-SYSTEM; FEMALE MICE	Although much is known about the neural mechanisms responsible for the mnemonic effects of 17-estradiol (E-2), very little is understood about the mechanisms through which progesterone (P-4) regulates memory. We previously showed that intrahippocampal infusion of P-4 in ovariectomized female mice enhances object recognition (OR) memory consolidation in a manner dependent on activation of dorsal hippocampal ERK and mTOR signaling. However, the role of specific progesterone receptors (PRs) in mediating the effects of progesterone on memory consolidation and hippocampal cell signaling are unknown. Therefore, the goals of this study were to investigate the roles of membrane-associated and intracellular PRs in mediating hippocampal memory consolidation, and identify downstream cell signaling pathways activated by PRs. Membrane-associated PRs were targeted using bovine serum albumin-conjugated progesterone (BSA-P), and intracellular PRs (PR-A, PR-B) were targeted using the intracellular PR agonist R5020. Immediately after OR training, ovariectomized mice received bilateral dorsal hippocampal infusion of vehicle, P-4, BSA-P, or R5020. OR memory consolidation was enhanced by P-4, BSA-P, and R5020. However, only P-4 and BSA-P activated ERK and mTOR signaling. Furthermore, dorsal hippocampal infusion of the ERK inhibitor U0126 blocked the memory-enhancing effects of BSA-P, but not R5020. The intracellular PR antagonist RU486 blocked the memory-enhancing effects of R5020, but not BSA-P. Interestingly, P-4 robustly activated canonical Wnt signaling in the dorsal hippocampus, which is consistent with our recent findings that canonical Wnt signaling is necessary for OR memory consolidation. R5020, but not BSA-P, also elicited a modest increase in canonical Wnt signaling. Collectively, these data suggest that activation of ERK signaling is necessary for membrane-associated PRs to enhance OR, and indicate a role for canonical Wnt signaling in the memory-enhancing effects of intracellular PRs. This study provides the first evidence that membrane and intracellular PRs may employ different molecular mechanisms to enhance hippocampal memory. (c) 2014 Wiley Periodicals, Inc.	[Fortress, Ashley M.; Heisler, John D.; Frick, Karyn M.] Univ Wisconsin, Dept Psychol, Milwaukee, WI 53211 USA	Frick, KM (corresponding author), Univ Wisconsin, Dept Psychol, 2441 E Hartford Ave, Milwaukee, WI 53211 USA.	frickk@uwm.edu		Frick, Karyn/0000-0002-4237-0208	University of Wisconsin-Milwaukee; Ellison Medical Foundation/AFAR Postdoctoral Fellowship in Aging	Grant sponsors: University of Wisconsin-Milwaukee and an Ellison Medical Foundation/AFAR Postdoctoral Fellowship in Aging (to A.M.F.).	Baker KB, 2002, LEARN MEMORY, V9, P58, DOI 10.1101/lm.46102; Barron Anna M, 2012, Front Biosci (Elite Ed), V4, P976; Ben-Yehoshua LJ, 2007, MOL ENDOCRINOL, V21, P664, DOI 10.1210/me.2006-0256; Bhattacharya A, 2012, NEURON, V76, P325, DOI 10.1016/j.neuron.2012.07.022; Bimonte-Nelson HA, 2004, BEHAV NEUROSCI, V118, P707, DOI 10.1037/0735-7044.118.4.707; BITRAN D, 1991, BEHAV NEUROSCI, V105, P653, DOI 10.1037/0735-7044.105.5.653; BITRAN D, 1991, BRAIN RES, V561, P157, DOI 10.1016/0006-8993(91)90761-J; Boras-Granic K, 2013, J MAMMARY GLAND BIOL, V18, P155, DOI 10.1007/s10911-013-9280-x; Boulware MI, 2013, J NEUROSCI, V33, P15184, DOI 10.1523/JNEUROSCI.1716-13.2013; Bove R, 2014, NEUROLOGY, V82, P222, DOI 10.1212/WNL.0000000000000033; Brinton RD, 2008, FRONT NEUROENDOCRIN, V29, P313, DOI 10.1016/j.yfrne.2008.02.001; BROGDEN RN, 1993, DRUGS, V45, P384, DOI 10.2165/00003495-199345030-00007; Bychowski ME, 2012, HORM BEHAV, V61, P598, DOI 10.1016/j.yhbeh.2012.02.009; Camacho-Arroyo I, 1998, NEUROREPORT, V9, P3993, DOI 10.1097/00001756-199812210-00001; Chen DY, 2012, NAT NEUROSCI, V15, P1707, DOI 10.1038/nn.3266; Chen JY, 2006, J BIOL CHEM, V281, P11910, DOI 10.1074/jbc.M511920200; Cherrier MM, 2009, FRONT HORM RES, V37, P150, DOI 10.1159/000176051; Chesler EJ, 2000, HORM BEHAV, V38, P234, DOI 10.1006/hbeh.2000.1626; Ciani L, 2005, NAT REV NEUROSCI, V6, P351, DOI 10.1038/nrn1665; Cohen SJ, 2013, CURR BIOL, V23, P1685, DOI 10.1016/j.cub.2013.07.002; Compagnone NA, 2000, FRONT NEUROENDOCRIN, V21, P1, DOI 10.1006/frne.1999.0188; Cooke PS, 2013, MOL HUM REPROD, V19, P547, DOI 10.1093/molehr/gat031; de Quervain DJF, 2009, FRONT NEUROENDOCRIN, V30, P358, DOI 10.1016/j.yfrne.2009.03.002; Dong ZF, 2006, HIPPOCAMPUS, V16, P809, DOI 10.1002/hipo.20216; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; Faivre EJ, 2007, MOL CELL BIOL, V27, P466, DOI 10.1128/MCB.01539-06; FARR SA, 1995, PHYSIOL BEHAV, V58, P715, DOI 10.1016/0031-9384(95)00124-2; Feeser VR, 2011, J NEUROIMMUNOL, V237, P4, DOI 10.1016/j.jneuroim.2011.06.007; Fernandez SM, 2008, J NEUROSCI, V28, P8660, DOI 10.1523/JNEUROSCI.1968-08.2008; Fortress AM, 2014, FRONT NEUROENDOCRIN, V35, P530, DOI 10.1016/j.yfrne.2014.05.001; Fortress AM, 2013, J NEUROSCI, V33, P12619, DOI 10.1523/JNEUROSCI.0659-13.2013; Fortress AM, 2013, LEARN MEMORY, V20, P147, DOI 10.1101/lm.026732.112; Foy MR, 2011, NEUROBIOL LEARN MEM, V95, P134, DOI 10.1016/j.nlm.2010.11.003; Frick KM, 2003, BEHAV NEUROSCI, V117, P1283, DOI 10.1037/0735-7044.117.6.1283; Frye CA, 2008, NEUROBIOL LEARN MEM, V90, P171, DOI 10.1016/j.nlm.2008.03.005; Frye CA, 2007, NEUROBIOL LEARN MEM, V88, P208, DOI 10.1016/j.nlm.2007.04.003; Frye CA, 2013, NEUROSCI LETT, V551, P53, DOI 10.1016/j.neulet.2013.07.002; Frye CA, 2010, NEUROSCI LETT, V472, P38, DOI 10.1016/j.neulet.2010.01.051; Gogolla N, 2009, NEURON, V62, P510, DOI 10.1016/j.neuron.2009.04.022; Graber TE, 2013, LEARN MEMORY, V20, P518, DOI 10.1101/lm.027664.112; Gregory CW, 2001, J ANDROL, V22, P537; Gresack JE, 2007, NEUROBIOL LEARN MEM, V88, P393, DOI 10.1016/j.nlm.2007.07.015; Guennoun R, J STEROID B IN PRESS; Guerra-Araiza C, 2003, J NEUROENDOCRINOL, V15, P984, DOI 10.1046/j.1365-2826.2003.01088.x; Guerra-Araiza C, 2002, BRAIN RES BULL, V59, P105, DOI 10.1016/S0361-9230(02)00845-6; Hagan CR, 2012, MOL CELL ENDOCRINOL, V357, P43, DOI 10.1016/j.mce.2011.09.017; Harburger LL, 2009, NEUROSCIENCE, V160, P6, DOI 10.1016/j.neuroscience.2009.02.024; Harburger LL, 2008, BEHAV BRAIN RES, V194, P174, DOI 10.1016/j.bbr.2008.07.014; He L, 2011, ARCH MED SCI, V7, P397, DOI 10.5114/aoms.2011.23402; Hoeffer CA, 2010, TRENDS NEUROSCI, V33, P67, DOI 10.1016/j.tins.2009.11.003; HURD C, 1988, BIOCHEMISTRY-US, V27, P3618, DOI 10.1021/bi00410a014; Inestrosa NC, 2010, NAT REV NEUROSCI, V11, P77, DOI 10.1038/nrn2755; Inoki K, 2006, CELL, V126, P955, DOI 10.1016/j.cell.2006.06.055; Karteris E, 2006, MOL ENDOCRINOL, V20, P1519, DOI 10.1210/me.2005-0243; Kato A, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00149; KATO J, 1994, HORM BEHAV, V28, P454, DOI 10.1006/hbeh.1994.1043; Lamb R, 2007, E SCHERING FDN S P, V1, P1; Liu LF, 2009, ENDOCRINOLOGY, V150, P3186, DOI 10.1210/en.2008-1447; Luine VN, 2003, ENDOCRINOLOGY, V144, P2836, DOI 10.1210/en.2003-0004; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Meffre D, 2014, CELL MOL LIFE SCI, V71, P1123, DOI 10.1007/s00018-013-1378-1; Melcangi RC, 2014, PROG NEUROBIOL, V113, P56, DOI 10.1016/j.pneurobio.2013.07.006; Mitterling KL, 2010, J COMP NEUROL, V518, P2729, DOI 10.1002/cne.22361; Molenda-Figueira HA, 2008, ENDOCRINOLOGY, V149, P5272, DOI 10.1210/en.2008-0048; Moore MR, 1997, J STEROID BIOCHEM, V62, P243, DOI 10.1016/S0960-0760(97)00036-8; Oliva CA, 2013, AGEING RES REV, V12, P786, DOI 10.1016/j.arr.2013.03.006; Orr PI, 2009, PHARMACOL BIOCHEM BE, V93, P177, DOI 10.1016/j.pbb.2009.05.012; Orr PT, 2012, HORM BEHAV, V61, P487, DOI 10.1016/j.yhbeh.2012.01.004; Ortiz-Matamoros A, 2013, CURR NEUROPHARMACOL, V11, P465, DOI 10.2174/1570159X11311050001; Phan A, 2012, NEUROPSYCHOPHARMACOL, V37, P2299, DOI 10.1038/npp.2012.82; PITHA J, 1986, J PHARM SCI, V75, P165, DOI 10.1002/jps.2600750213; Proietti C, 2005, MOL CELL BIOL, V25, P4826, DOI 10.1128/MCB.25.12.4826-4840.2005; Purro SA, 2014, J MOL CELL BIOL, V6, P75, DOI 10.1093/jmcb/mjt049; Qu QH, 2013, MOL CELL BIOL, V33, P2551, DOI 10.1128/MCB.00325-13; Richter JD, 2009, GENE DEV, V23, P1, DOI 10.1101/gad.1735809; Robinson GW, 2000, GENE DEV, V14, P889; Sahores M, 2010, DEVELOPMENT, V137, P2215, DOI 10.1242/dev.046722; Sani G, 2012, CURR NEUROPHARMACOL, V10, P239, DOI 10.2174/157015912803217279; Satterfield MC, 2008, REPROD FERT DEVELOP, V20, P935, DOI 10.1071/RD08069; Sayeed I, 2009, PROG BRAIN RES, V175, P219, DOI 10.1016/S0079-6123(09)17515-5; Scott EL, 2013, BRAIN RES, V1514, P63, DOI 10.1016/j.brainres.2012.12.015; Singh M, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00159; Skildum A, 2005, MOL ENDOCRINOL, V19, P327, DOI 10.1210/me.2004-0306; Sweatt JD, 2004, CURR OPIN NEUROBIOL, V14, P311, DOI 10.1016/j.conb.2004.04.001; Tabatadze N, 2012, HIPPOCAMPUS, V22, P1228, DOI 10.1002/hipo.20991; Tsokas P, 2007, J NEUROSCI, V27, P5885, DOI 10.1523/JNEUROSCI.4548-06.2007; Tuscher JJ, BEHAV BRAIN IN PRESS; Varea O, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005153; Varela-Nallar L, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00100; Vargas JY, 2014, J NEUROSCI, V34, P2191, DOI 10.1523/JNEUROSCI.0862-13.2014; Walf AA, 2006, NEUROBIOL LEARN MEM, V86, P35, DOI 10.1016/j.nlm.2006.01.004; WOOLLEY CS, 1993, J COMP NEUROL, V336, P293, DOI 10.1002/cne.903360210; Wright DW, 2007, ANN EMERG MED, V49, P391, DOI 10.1016/j.annemergmed.2006.07.932; Xiao GM, 2008, CRIT CARE, V12, DOI 10.1186/cc6887; Yoshiya M, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00191; Yousuf S, 2014, PSYCHOPHARMACOLOGY, V231, P3313, DOI 10.1007/s00213-014-3556-8; Zhang QG, 2008, J NEUROSCI, V28, P8430, DOI 10.1523/JNEUROSCI.2752-08.2008; Zhang Z, 2010, HIPPOCAMPUS, V20, P402, DOI 10.1002/hipo.20642; Zhao ZR, 2012, J NEUROSCI, V32, P2344, DOI 10.1523/JNEUROSCI.5819-11.2012	99	18	18	0	6	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1050-9631	1098-1063		HIPPOCAMPUS	Hippocampus	MAY	2015	25	5					616	629		10.1002/hipo.22398			14	Neurosciences	Neurosciences & Neurology	CH4BF	WOS:000353975200007	25483228				2021-06-18	
J	Malik, M; Rangel-Barajas, C; Sumien, N; Su, C; Singh, M; Chen, ZL; Huang, RQ; Meunier, J; Maurice, T; Mach, RH; Luedtke, RR				Malik, Maninder; Rangel-Barajas, Claudia; Sumien, Nathalie; Su, Chang; Singh, Meharvan; Chen, Zhenglan; Huang, Ren-Qi; Meunier, Johann; Maurice, Tangui; Mach, Robert H.; Luedtke, Robert R.			The effects of sigma (sigma 1) receptor-selective ligands on muscarinic receptor antagonist-induced cognitive deficits in mice	BRITISH JOURNAL OF PHARMACOLOGY			English	Article							EXTRACELLULAR ACETYLCHOLINE LEVEL; D-ASPARTATE RECEPTOR; NMDA RECEPTORS; NEUROTROPHIC FACTOR; ALZHEIMERS-DISEASE; CONCISE GUIDE; IN-VIVO; CHOLINERGIC HYPOTHESIS; NEURONAL PLASTICITY; LEARNING IMPAIRMENT	Background and PurposeCognitive deficits in patients with Alzheimer's disease, Parkinson's disease, traumatic brain injury and stroke often involve alterations in cholinergic signalling. Currently available therapeutic drugs provide only symptomatic relief. Therefore, novel therapeutic strategies are needed to retard and/or arrest the progressive loss of memory. Experimental ApproachScopolamine-induced memory impairment provides a rapid and reversible phenotypic screening paradigm for cognition enhancement drug discovery. Male C57BL/6J mice given scopolamine (1mgkg(-1)) were used to evaluate the ability of LS-1-137, a novel sigma (sigma 1) receptor-selective agonist, to improve the cognitive deficits associated with muscarinic antagonist administration. Key ResultsLS-1-137 is a high-affinity (K-i = 3.2nM) sigma 1 receptor agonist that is 80-fold selective for sigma 1, compared with sigma 2 receptors. LS-1-137 binds with low affinity at D2-like (D2, D3 and D4) dopamine and muscarinic receptors. LS-1-137 was found to partially reverse the learning deficits associated with scopolamine administration using a water maze test and an active avoidance task. LS-1-137 treatment was also found to trigger the release of brain-derived neurotrophic factor from rat astrocytes. Conclusions and ImplicationsThe sigma 1 receptor-selective compound LS-1-137 may represent a novel candidate cognitive enhancer for the treatment of muscarinic receptor-dependent cognitive deficits.	[Malik, Maninder; Rangel-Barajas, Claudia; Sumien, Nathalie; Su, Chang; Singh, Meharvan; Chen, Zhenglan; Huang, Ren-Qi; Luedtke, Robert R.] Univ North Texas Hlth Sci Ctr, Dept Pharmacol & Neurosci, Ft Worth, TX 76107 USA; [Meunier, Johann; Maurice, Tangui] AMYLGEN, Montferrier Surlez, France; [Meunier, Johann; Maurice, Tangui] INSERM, U710, F-75654 Paris 13, France; [Maurice, Tangui] Univ Montpellier, F-34059 Montpellier, France; [Mach, Robert H.] Univ Penn, Dept Radiol, Philadelphia, PA 19104 USA	Luedtke, RR (corresponding author), Univ North Texas Hlth Sci Ctr, Dept Pharmacol & Neurosci, 3500 Camp Bowie, Ft Worth, TX 76107 USA.	robert.luedtke@unthsc.edu	Maurice, Tangui/AAP-2499-2020	Maurice, Tangui/0000-0002-4074-6793; Singh, Meharvan/0000-0002-8072-1769	NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P01 AG027956] Funding Source: Medline; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P01AG027956] Funding Source: NIH RePORTER		Alexander SPH, 2013, BRIT J PHARMACOL, V170, P1607, DOI 10.1111/bph.12447; Alexander SPH, 2013, BRIT J PHARMACOL, V170, P1582, DOI 10.1111/bph.12446; Alexander SPH, 2013, BRIT J PHARMACOL, V170, P1459, DOI 10.1111/bph.12445; Alexander SPH, 2013, BRIT J PHARMACOL, V170, P1449, DOI 10.1111/bph.12444; Antonini V, 2011, J ALZHEIMERS DIS, V24, P569, DOI 10.3233/JAD-2011-101794; Antonini V, 2009, J NEUROCHEM, V109, P744, DOI 10.1111/j.1471-4159.2009.06000.x; BARTUS RT, 1982, SCIENCE, V217, P408, DOI 10.1126/science.7046051; Bejar C, 1999, EUR J PHARMACOL, V383, P231, DOI 10.1016/S0014-2999(99)00643-3; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; COYLE JT, 1983, SCIENCE, V219, P1184, DOI 10.1126/science.6338589; Craig LA, 2011, NEUROSCI BIOBEHAV R, V35, P1397, DOI 10.1016/j.neubiorev.2011.03.001; D'Hooge R, 2001, BRAIN RES REV, V36, P60, DOI 10.1016/S0165-0173(01)00067-4; Dumas JA, 2011, PHARMACOL BIOCHEM BE, V99, P254, DOI 10.1016/j.pbb.2011.02.022; Ebert U, 1998, EUR J CLIN INVEST, V28, P944; ENNACEUR A, 1992, PSYCHOPHARMACOLOGY, V109, P321, DOI 10.1007/BF02245880; Espallergues J, 2007, BRIT J PHARMACOL, V152, P267, DOI 10.1038/sj.bjp.0707386; FLOOD JF, 1986, BEHAV NEURAL BIOL, V45, P169, DOI 10.1016/S0163-1047(86)90750-8; Fontanilla D, 2009, SCIENCE, V323, P934, DOI 10.1126/science.1166127; Francardo V, 2014, BRAIN, V137, P1998, DOI 10.1093/brain/awu107; Francis PT, 1999, J NEUROL NEUROSUR PS, V66, P137, DOI 10.1136/jnnp.66.2.137; Fujimoto M, 2012, SYNAPSE, V66, P630, DOI 10.1002/syn.21549; Hashimoto K, 2013, PROG NEUROBIOL, V100, P15, DOI 10.1016/j.pneurobio.2012.09.001; Hayashi T., 2005, Current Neuropharmacology, V3, P267, DOI 10.2174/157015905774322516; Hayashi T, 2007, CELL, V131, P596, DOI 10.1016/j.cell.2007.08.036; Hayashi T, 2011, EXPERT OPIN THER TAR, V15, P557, DOI 10.1517/14728222.2011.560837; Huang RQ, 2010, NEUROPHARMACOLOGY, V58, P1246, DOI 10.1016/j.neuropharm.2010.03.006; Huang RQ, 1999, J NEUROPHYSIOL, V82, P1233; Huang YS, 2001, J MED CHEM, V44, P4404, DOI 10.1021/jm010384j; Huang YS, 1998, J MED CHEM, V41, P2361, DOI 10.1021/jm980032l; HULME EC, 1978, MOL PHARMACOL, V14, P737; Hunt DL, 2012, CURR OPIN NEUROBIOL, V22, P496, DOI 10.1016/j.conb.2012.01.007; Institute of Laboratory Animal Research, 1996, GUIDE CARE USE LAB A, V7th; Ishikawa M, 2010, J RECEPT LIGAND CH R, V3, P25; Ito K, 2013, J CARDIOVASC PHARM, V62, P222, DOI 10.1097/FJC.0b013e3182970b15; JUNIEN JL, 1991, EUR J PHARMACOL, V200, P343, DOI 10.1016/0014-2999(91)90593-F; Kilkenny C, 2010, BRIT J PHARMACOL, V160, P1577, DOI 10.1111/j.1476-5381.2010.00872.x; KIRK CJ, 1994, J PHARMACOL EXP THER, V271, P1080; Kitaichi K, 2000, J CHEM NEUROANAT, V20, P375, DOI 10.1016/S0891-0618(00)00106-X; Klinkenberg I, 2010, NEUROSCI BIOBEHAV R, V34, P1307, DOI 10.1016/j.neubiorev.2010.04.001; Kourrich S, 2012, TRENDS NEUROSCI, V35, P762, DOI 10.1016/j.tins.2012.09.007; Kume T, 2002, EUR J PHARMACOL, V455, P91, DOI 10.1016/S0014-2999(02)02582-7; LINDEFORS N, 1992, EXP BRAIN RES, V88, P78, DOI 10.1007/BF02259130; Liu YT, 2007, J NEUROSCI, V27, P2846, DOI 10.1523/JNEUROSCI.0116-07.2007; Luedtke RR, 2012, BRAIN RES, V1441, P17, DOI 10.1016/j.brainres.2011.12.047; LUTHIN GR, 1984, J PHARMACOL EXP THER, V228, P648; Martina M, 2007, J PHYSIOL-LONDON, V578, P143, DOI 10.1113/jphysiol.2006.116178; Massey PV, 2004, J NEUROSCI, V24, P7821, DOI 10.1523/JNEUROSCI.1697-04.2004; MATSUNO K, 1993, J PHARMACOL EXP THER, V265, P851; MATSUNO K, 1995, BRAIN RES, V690, P200, DOI 10.1016/0006-8993(95)00618-Z; MATSUNO K, 1992, BRAIN RES, V575, P315, DOI 10.1016/0006-8993(92)90096-R; MATSUNO K, 1994, EUR J PHARMACOL, V261, P43, DOI 10.1016/0014-2999(94)90298-4; Mattson Mark P, 2004, NeuroRx, V1, P111, DOI 10.1602/neurorx.1.1.111; Mattson MP, 2004, TRENDS NEUROSCI, V27, P589, DOI 10.1016/j.tins.2004.08.001; Maurice T, 2006, J PHARMACOL EXP THER, V317, P606, DOI 10.1124/jpet.105.097394; MAURICE T, 1994, PHARMACOL BIOCHEM BE, V49, P859, DOI 10.1016/0091-3057(94)90235-6; Maurice T, 1998, NEUROSCIENCE, V83, P413, DOI 10.1016/S0306-4522(97)00405-3; Maurice T, 2002, DRUG NEWS PERSPECT, V15, P617, DOI 10.1358/dnp.2002.15.10.740241; Maurice T, 2001, BRAIN RES, V898, P113, DOI 10.1016/S0006-8993(01)02152-7; Maurice T, 1996, BRAIN RES, V733, P219, DOI 10.1016/0006-8993(96)00565-3; Maurice T, 2009, PHARMACOL THERAPEUT, V124, P195, DOI 10.1016/j.pharmthera.2009.07.001; McGrath JC, 2010, BRIT J PHARMACOL, V160, P1573, DOI 10.1111/j.1476-5381.2010.00873.x; Meunier J, 2006, BRIT J PHARMACOL, V149, P998, DOI 10.1038/sj.bjp.0706927; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Niitsu T, 2012, CURR PHARM DESIGN, V18, P875, DOI 10.2174/138161212799436476; Nishikawa H, 2000, EUR J PHARMACOL, V404, P41, DOI 10.1016/S0014-2999(00)00595-1; OLTON DS, 1968, PHYSIOL BEHAV, V3, P719, DOI 10.1016/0031-9384(68)90142-X; Ortega-Roldan JL, 2013, J BIOL CHEM, V288, P21448, DOI 10.1074/jbc.M113.450379; Pawson AJ, 2014, NUCLEIC ACIDS RES, V42, pD1098, DOI 10.1093/nar/gkt1143; Peviani M, 2014, NEUROBIOL DIS, V62, P218, DOI 10.1016/j.nbd.2013.10.010; Ring RM, 2013, J PSYCHOPHARMACOL, V27, P930, DOI 10.1177/0269881113497614; Ruscher K, 2011, BRAIN, V134, P732, DOI 10.1093/brain/awq367; Scarpini E, 2003, LANCET NEUROL, V2, P539, DOI 10.1016/S1474-4422(03)00502-7; Senda T, 1997, PHYSIOL BEHAV, V61, P257, DOI 10.1016/S0031-9384(96)00447-7; Seth P, 1998, J NEUROCHEM, V70, P922; Shetty RA, 2013, AGE, V35, P1821, DOI 10.1007/s11357-012-9484-9; Su C, 2012, ENDOCRINOLOGY, V153, P4389, DOI 10.1210/en.2011-2177; Su TP, 2003, CURR MED CHEM, V10, P2073, DOI 10.2174/0929867033456783; Tarawneh R, 2010, CLIN GERIATR MED, V26, P125, DOI 10.1016/j.cger.2009.12.003; Tchedre KT, 2008, INVEST OPHTH VIS SCI, V49, P4993, DOI 10.1167/iovs.08-1867; Tovar KR, 2002, NEURON, V34, P253; Tsai Shang-Yi, 2009, Central Nervous System Agents in Medicinal Chemistry, V9, P184; Urani A, 1998, BRAIN RES, V799, P64, DOI 10.1016/S0006-8993(98)00469-7; van Waarde A, 2011, BEHAV BRAIN RES, V221, P543, DOI 10.1016/j.bbr.2009.12.043; Villard V, 2011, J PSYCHOPHARMACOL, V25, P1101, DOI 10.1177/0269881110379286; VILNER BJ, 1995, CANCER RES, V55, P408; Yagasaki Y, 2006, J BIOL CHEM, V281, P12941, DOI 10.1074/jbc.M508157200; Yamada K, 2002, LIFE SCI, V70, P735, DOI 10.1016/S0024-3205(01)01461-8; Yamada K, 2004, DRUG NEWS PERSPECT, V17, P435, DOI 10.1358/dnp.2004.17.7.863702	88	18	18	0	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0007-1188	1476-5381		BRIT J PHARMACOL	Br. J. Pharmacol.	MAY	2015	172	10					2519	2531		10.1111/bph.13076			13	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CG6EQ	WOS:000353389600009	25573298	Green Published, Bronze			2021-06-18	
J	Seiger, A; Goldwater, E; Deibert, E				Seiger, Ashley; Goldwater, Eva; Deibert, Ellen			Does Mechanism of Injury Play a Role in Recovery from Concussion?	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						concussion; football; high school; motor vehicle	TRAUMATIC BRAIN-INJURY; SPORTS-RELATED CONCUSSION; HIGH-SCHOOL; ATHLETE; RETURN	Background: High school football and soccer are 2 of the leading causes of concussion injuries. However, concussions also occur from mechanisms of injury such as motor vehicle accidents (MVAs), assault, and work-related accidents. Purpose: Determine if recovery from concussion could be related to the mechanism of injury. Setting: Berkshire Medical Center Concussion Clinic. Participants: Patients aged 13 to 21 years suffering concussion from football (n = 31), soccer (n = 9), or MVAs (n = 20). Outcome Measurements: ImPACT (Immediate Post Concussion Assessment Tool) test scores including symptom inventory; number of days sick; length of time to recovery. Results: Most commonly reported symptom at the time of injury was headache. Patients were seen in clinic an average of 16 (football), 14 (soccer), and 21 (MVA) days postinjury. Groups differed significantly on ImPACT Visual Memory and Visual Motor Speed scores (P < .05). MVA patients had a longer median number of days sick (97 days) than football players (32 days; P < .05). Conclusion: This study suggests that concussion from an MVA may be a more serious injury than a typical concussion sustained during sports. Data suggest that MVA patients take longer to present to clinic, have lower Visual Memory and Visual Motor Speed scores on ImPACT, and take longer to recover. Further studies are needed to better understand how the mechanism of injury of concussion may relate to prognosis.	[Seiger, Ashley] Brigham & Womens Hosp, Boston, MA 02115 USA; [Goldwater, Eva] Univ Massachusetts, Sch Publ Hlth & Hlth Sci, Amherst, MA 01003 USA; [Deibert, Ellen] Wellspan Adult Neurol, York, PA USA	Seiger, A (corresponding author), Brigham & Womens Hosp, 221 Longwood Ave,BL230, Boston, MA 02115 USA.	aseiger@partners.org					Bailes JE, 2001, NEUROSURGERY, V48, P26, DOI 10.1097/00006123-200101000-00005; Barnes BC, 1998, AM J SPORT MED, V26, P433, DOI 10.1177/03635465980260031601; Buzzini SRR, 2006, CURR OPIN PEDIATR, V18, P376, DOI 10.1097/01.mop.0000236385.26284.ec; Cantu RC, 2001, J ATHL TRAINING, V36, P244; Centers for Disease Control and Prevention, TRAUMATIC BRAIN INJU; Frommer LJ, 2011, J ATHL TRAINING, V46, P76, DOI 10.4085/1062-6050-46.1.76; Grady MF, 2010, CURR PROB PEDIATR AD, V40, P154, DOI 10.1016/j.cppeds.2010.06.002; Guskiewicz KM, 2011, EXERC SPORT SCI REV, V39, P4, DOI 10.1097/JES.0b013e318201f53e; Iverson GL, 2006, BRAIN INJURY, V20, P245, DOI 10.1080/02699050500487910; Keller M, 2000, J NEUROL NEUROSUR PS, V68, P761, DOI 10.1136/jnnp.68.6.761; Lau BC, 2001, AM J SPORTS MED, V39, P2311; Lovell M, 2004, CLIN SPORT MED, V23, P421, DOI 10.1016/j.csm.2004.04.001; Lovell MR, 2006, IMPACT BEST APPROACH; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McClincy MP, 2006, BRAIN INJURY, V20, P33, DOI 10.1080/02699050500309817; Moser RS, 2007, ARCH CLIN NEUROPSYCH, V22, P909, DOI 10.1016/j.acn.2007.09.004; Preece MHW, 2010, NEUROPSYCHOLOGY, V24, P493, DOI 10.1037/a0018903; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Tellier A, 2009, BRAIN INJURY, V23, P879, DOI 10.1080/02699050903200555; Van Kampen DA, 2006, AM J SPORT MED, V34, P1630, DOI 10.1177/0363546506288677; Wilson KR, 2011, REHABIL PSYCHOL, V56, P100, DOI 10.1037/a0023446	21	18	18	0	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2015	30	3					E52	E56		10.1097/HTR.0000000000000051			5	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	CH8PJ	WOS:000354298100006	24901324				2021-06-18	
J	Poon, W; Vos, P; Muresanu, D; Vester, J; von Wild, K; Homberg, V; Wang, E; Lee, TMC; Matula, C				Poon, Wai; Vos, Pieter; Muresanu, Dafin; Vester, Johannes; von Wild, Klaus; Hoemberg, Volker; Wang, Ernest; Lee, Tatia M. C.; Matula, Christian			Cerebrolysin Asian Pacific Trial in Acute Brain Injury and Neurorecovery: Design and Methods	JOURNAL OF NEUROTRAUMA			English	Article						traumatic brain injury; Cerebrolysin; recovery; multidimensional; neuroprotection	GLASGOW OUTCOME SCALE; SEVERE HEAD-INJURY; CLINICAL-TRIALS; PEPTIDE PREPARATION; COMA SCALE; NEUROPROTECTION; RECOMMENDATIONS; REHABILITATION; MANAGEMENT; VETERANS	Traumatic brain injury (TBI) is one of the leading causes of injury-related death. In the United States alone, an estimated 1.7 million people sustain a TBI each year, and approximately 5.3 million people live with a TBI-related disability. The direct medical costs and indirect costs such as lost productivity of TBIs totaled an estimated $76.5 billion in the U.S. in the year 2000. Improving the limited treatment options for this condition remains challenging. However, recent reports from interdisciplinary working groups (consisting primarily of neurologists, neurosurgeons, neuropsychologists, and biostatisticians) have stated that to improve TBI treatment, important methodological lessons from the past must be taken into account in future clinical research. An evaluation of the neuroprotection intervention studies conducted over the last 30 years has indicated that a limited understanding of the underlying biological concepts and methodological design flaws are the major reasons for the failure of pharmacological agents to demonstrate efficacy. Cerebrolysin is a parenterally-administered neuro-peptide preparation that acts in a manner similar to endogenous neurotrophic factors. Cerebrolysin has a favorable adverse effect profile, and several meta-analyses have suggested that Cerebrolysin is beneficial as a dementia treatment. CAPTAIN is a randomized, double-blind, placebo-controlled, multi-center, multinational trial of the effects of Cerebrolysin on neuroprotection and neurorecovery after TBI using a multidimensional ensemble of outcome scales. The CAPTAIN trial will be the first TBI trial with a 'true' multidimensional approach based on full outcome scales, while avoiding prior weaknesses, such as loss of information through "dichotomization," or unrealistic assumptions such as "normal distribution."	[Poon, Wai] Chinese Univ Hong Kong, Prince Wales Hosp, Div Neurosurg, Hong Kong, Hong Kong, Peoples R China; [Vos, Pieter] Slingeland Ziekenhuis, Dept Neurol, Doetinchem, Netherlands; [Muresanu, Dafin] Iuliu Hatieganu Univ Med & Pharm, Dept Clin Neurosci, Cluj Napoca, Romania; [Vester, Johannes] Idv Data Anal & Study Planning, Dept Biometry & Clin Res, Krailling, Germany; [von Wild, Klaus] Univ Munster, Fac Med, D-48149 Munster, Germany; [Hoemberg, Volker] SHR Gesundheitszentrum Bad Wimpfen, Wad Wimpfen, Germany; [Wang, Ernest] Natl Neurosci Inst, Dept Neurosurg, Singapore, Singapore; [Lee, Tatia M. C.] Univ Hong Kong, Neuropsychol Lab, Hong Kong, Hong Kong, Peoples R China; [Matula, Christian] Med Univ Vienna, Dept Neurosurg, Vienna, Austria	Muresanu, D (corresponding author), Univ Med & Pharm Iuliu Hatieganu, Dept Clin Neurosci, Victor Babes St 8, Cluj Napoca 400012, Romania.	dafinm@ssnn.ro	Muresanu, Fior-Dafin/AAI-8120-2021				AKAI F, 1992, HISTOL HISTOPATHOL, V7, P213; [Anonymous], 2010, LANCET NEUROL, V9, P331, DOI 10.1016/S1474-4422(10)70069-7; Bagiella E, 2010, J HEAD TRAUMA REHAB, V25, P375, DOI 10.1097/HTR.0b013e3181d27fe3; Banik N, 1996, BIOMETRICAL J, V38, P25, DOI 10.1002/bimj.4710380103; Bauer P, 1999, STAT MED, V18, P1833, DOI 10.1002/(SICI)1097-0258(19990730)18:14<1833::AID-SIM221>3.0.CO;2-3; BAUER P, 1994, BIOMETRICS, V50, P1029, DOI 10.2307/2533441; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Bretz F, 2009, STAT MED, V28, P1181, DOI 10.1002/sim.3538; Bulger EM, 2002, CRIT CARE MED, V30, P1870, DOI 10.1097/00003246-200208000-00033; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd; Colditz G A, 1988, Int J Technol Assess Health Care, V4, P637; Coronado V.G., EPIDEMIOLOG IN PRESS; D'Agostino RB, 2006, STAT MED, V25, P541, DOI 10.1002/sim.2508; D'Elia LF, 1996, COLOR TRIALS TEST PR; Degracia Donald J, 2010, J Exp Stroke Transl Med, V3, P59; Dimitrenko A., 2009, MULTIPLE TESTING PRO; Donders J, 1997, CHILD NEUROPSYCHOL, V3, P71, DOI 10.1080/09297049708401369; Fakhry SM, 2004, J TRAUMA, V56, P492, DOI 10.1097/01.TA.0000115650.07193.66; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Finkelstein EA., 2006, INCIDENCE EC BURDEN; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Frick H, 1997, BIOMETRICAL J, V39, P125, DOI 10.1002/bimj.4710390112; Gill MR, 2004, ANN EMERG MED, V43, P215, DOI 10.1016/S0196-0644(03)00814-X; Ginsberg MD, 1997, CEREBROVASC DIS, V7, P7, DOI 10.1159/000108237; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; Hardingham GE, 2006, BIOCHEM SOC T, V34, P936, DOI 10.1042/BST0340936; Hardingham GE, 2001, NAT NEUROSCI, V4, P565, DOI 10.1038/88380; Hawkins KA, 1998, CLIN NEUROPSYCHOL, V12, P535, DOI 10.1076/clin.12.4.535.7236; Hedges L.V., 1985, STAT METHODS META AN; Hetman M, 2006, CURR TOP MED CHEM, V6, P787, DOI 10.2174/156802606777057553; Hoge CW, 2009, NEW ENGL J MED, V360, P1588, DOI 10.1056/NEJMp0810606; Huang P, 2008, STAT MED, V27, P3084, DOI 10.1002/sim.3182; Hukkelhoven CWPM, 2005, J NEUROTRAUM, V22, P1025, DOI 10.1089/neu.2005.22.1025; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Johnson S. C., 2000, BNI Q, V16, P37; Lachin J. M., 2000, WILEY SER PROB STAT; LACHIN JM, 1981, CONTROL CLIN TRIALS, V2, P93, DOI 10.1016/0197-2456(81)90001-5; LACHIN JM, 1992, STAT MED, V11, P1151, DOI 10.1002/sim.4780110903; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; LaVange LM, 2005, STAT METHODS MED RES, V14, P281, DOI 10.1191/0962280205sm397oa; Lee TMC, 2000, J CLIN EXP NEUROPSYC, V22, P465, DOI 10.1076/1380-3395(200008)22:4;1-0;FT465; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Lombardi VRM, 1999, METHOD FIND EXP CLIN, V21, P331, DOI 10.1358/mf.1999.21.5.541910; Lu M, 2001, STAT MED, V20, P1891, DOI 10.1002/sim.841; Maas AIR, 2006, LANCET NEUROL, V5, P38, DOI 10.1016/S1474-4422(05)70253-2; Maas AI, 2010, ARCH PHYS MED REHAB, V91, P1641, DOI 10.1016/j.apmr.2010.07.232; Maas AIR, 2010, NEUROTHERAPEUTICS, V7, P127, DOI 10.1016/j.nurt.2009.10.020; Maas AIR, 2010, NEUROTHERAPEUTICS, V7, P115, DOI 10.1016/j.nurt.2009.10.022; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; MAHONEY F I, 1965, Md State Med J, V14, P61; Margulies S, 2009, J NEUROTRAUM, V26, P925, DOI [10.1089/neu.2008.0794, 10.1089/neu.2008-0794]; Martin TA, 2000, REHABIL PSYCHOL, V45, P402, DOI 10.1037/0090-5550.45.4.402; Masliah E, 1999, PHARMACOL BIOCHEM BE, V62, P239, DOI 10.1016/S0091-3057(98)00144-0; Maurer W., 1995, BIOMETRIE CHEM PHARM, P3; Mitrushina M., 1999, HDB NORMATIVE DATA N; Muresanu DF, 2012, J CELL MOL MED, V16, P2861, DOI 10.1111/j.1582-4934.2012.01605.x; Muresanu DF, 2010, ACTA NEUROCHIR SUPPL, V106, P291, DOI 10.1007/978-3-211-98811-4_54; Murray GD, 2005, J NEUROTRAUM, V22, P511, DOI 10.1089/neu.2005.22.511; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; Nijboer JMM, 2007, J TRAUMA, V63, P670, DOI 10.1097/01.ta.0000228890.65522.53; OBRIEN PC, 1984, BIOMETRICS, V40, P1079, DOI 10.2307/2531158; Palmer S, 2001, J TRAUMA, V50, P657, DOI 10.1097/00005373-200104000-00010; Prins ML, 2012, INT J DEV NEUROSCI, V30, P185, DOI 10.1016/j.ijdevneu.2011.05.009; Riley C, 2006, J NEURAL TRANSM, V113, P103, DOI 10.1007/s00702-005-0302-8; Rockenstein E, 2006, J NEUROSCI RES, V83, P1252, DOI 10.1002/jnr.20818; Roozenbeek B, 2011, CRIT CARE, V15, DOI 10.1186/cc10240; Salazar AM, 2000, JAMA-J AM MED ASSOC, V283, P3075, DOI 10.1001/jama.283.23.3075; Satou T, 2000, J NEURAL TRANSM, V107, P1253, DOI 10.1007/s007020070015; Schonle P W, 1995, Rehabilitation (Stuttg), V34, P69; Stein SC, 2010, J NEUROTRAUM, V27, P1343, DOI 10.1089/neu.2009.1206; Sugita Y, 1993, No To Shinkei, V45, P325; TANG DI, 1989, J AM STAT ASSOC, V84, P776, DOI 10.2307/2289665; Tatebayashi Y, 2003, ACTA NEUROPATHOL, V105, P225, DOI 10.1007/s00401-002-0636-3; Temkin NR, 2007, LANCET NEUROL, V6, P29, DOI 10.1016/S1474-4422(06)70630-5; Vanderploeg RD, 2008, ARCH PHYS MED REHAB, V89, P2227, DOI 10.1016/j.apmr.2008.06.015; Wechsler D, 1997, ADULT INTELLIGENCE S; WEI LJ, 1984, J AM STAT ASSOC, V79, P653, DOI 10.2307/2288413; Weir J, 2012, J NEUROTRAUM, V29, P53, DOI 10.1089/neu.2011.2137; Wilson BA, 2008, ANNU REV CLIN PSYCHO, V4, P141, DOI 10.1146/annurev.clinpsy.4.022007.141212; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wolfson D., 1993, HALSTEAD REITAN NEUR; Wronski R, 2000, J NEURAL TRANSM, V107, P145, DOI 10.1007/s007020050013; Xiong Y, 2009, EXPERT OPIN EMERG DR, V14, P67, DOI [10.1517/14728210902769601, 10.1517/14728210902769601 ]; Zafonte R, 2009, J NEUROTRAUM, V26, P2207, DOI 10.1089/neu.2009.1015; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; Zollikofer CPE, 2002, P NATL ACAD SCI USA, V99, P6444, DOI 10.1073/pnas.082111899; Zuercher M, 2009, BRAIN INJURY, V23, P371, DOI 10.1080/02699050902926267	87	18	18	0	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR 15	2015	32	8					571	580		10.1089/neu.2014.3558			10	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	CF2BS	WOS:000352352900007	25222349				2021-06-18	
J	Garcia, SF; Hahn, EA; Magasi, S; Lai, JS; Semik, P; Hammel, J; Heinemann, AW				Garcia, Sofia F.; Hahn, Elizabeth A.; Magasi, Susan; Lai, Jin-Shei; Semik, Patrick; Hammel, Joy; Heinemann, Allen W.			Development of Self-Report Measures of Social Attitudes That Act As Environmental Barriers and Facilitators for People With Disabilities	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Environment; International classification of functioning, disability and health; Qualitative research; Questionnaires; Rehabilitation; Social environment; Social participation	ITEM; PARTICIPATION; ISSUES	Objective: To describe the development of new self-report measures of social attitudes that act as environmental facilitators or barriers to the participation of people with disabilities in society. Design: A mixed-methods approach included a literature review; item classification, selection, and writing; cognitive interviews and field testing of participants with spinal cord injury (SCI), traumatic brain injury (TBI), or stroke; and rating scale analysis to evaluate initial psychometric properties. Setting: General community. Participants: Individuals with SCI, TBI, or stroke participated in cognitive interviews (n=9); community residents with those same conditions participated in field testing (n=305). Interventions: None. Main Outcome Measure: Self-report item pool of social attitudes that act as facilitators or barriers to people with disabilities participating in society. Results: An interdisciplinary team of experts classified 710 existing social environment items into content areas and wrote 32 new items. Additional qualitative item review included item refinement and winnowing of the pool prior to cognitive interviews and field testing of 82 items. Field test data indicated that the pool satisfies a 1-parameter item response theory measurement model and would be appropriate for development into a calibrated item bank. Conclusions: Our qualitative item review process supported a social environment conceptual framework that includes both social support and social attitudes. We developed a new social attitudes self-report item pool. Calibration testing of that pool is underway with a larger sample to develop a social attitudes item bank for persons with disabilities. (C) 2015 by the American Congress of Rehabilitation Medicine	[Garcia, Sofia F.; Hahn, Elizabeth A.; Lai, Jin-Shei; Heinemann, Allen W.] Northwestern Univ, Feinberg Sch Med, Dept Med Social Sci, Chicago, IL 60611 USA; [Garcia, Sofia F.] Northwestern Univ, Feinberg Sch Med, Dept Psychiat & Behav Sci, Chicago, IL 60611 USA; [Garcia, Sofia F.; Hahn, Elizabeth A.; Lai, Jin-Shei; Heinemann, Allen W.] Northwestern Univ, Feinberg Sch Med, Inst Publ Hlth & Med, Chicago, IL 60611 USA; [Magasi, Susan; Hammel, Joy] Univ Illinois, Dept Occupat Therapy, Chicago, IL USA; [Semik, Patrick; Heinemann, Allen W.] Rehabil Inst Chicago, Chicago, IL 60611 USA; [Heinemann, Allen W.] Northwestern Univ, Feinberg Sch Med, Dept Phys Med & Rehabil, Chicago, IL 60611 USA	Garcia, SF (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Med Social Sci, 625 N Michigan Ave,Ste 2700, Chicago, IL 60611 USA.	sofia-garcia@northwestern.edu	Heinemann, Allen W./AAI-2790-2021	Heinemann, Allen W./0000-0003-2782-7326	National Institute on Disability and Rehabilitation Research [H133B090024]; National Center for Complementary and Alternative MedicineUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine; National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS) [U54AR057951-S1]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS) [U54AR057951] Funding Source: NIH RePORTER	Supported by the National Institute on Disability and Rehabilitation Research (grant no. H133B090024). A portion of Dr. Garcia's time toward this publication was supported by the National Center for Complementary and Alternative Medicine and the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health (award no. U54AR057951-S1).	ANDRICH D, 1978, EDUC PSYCHOL MEAS, V38, P665, DOI 10.1177/001316447803800308; Bode RK, 2003, ARCH PHYS MED REHAB, V84, pS52, DOI 10.1053/apmr.2003.50247; Cella D, 2000, MED CARE, V38, P66; CSDH, 2008, CLOS GAP GEN HLTH EQ; Daruwalla P, 2005, ANN TOURISM RES, V32, P549, DOI 10.1016/j.annals.2004.10.008; Daruwalla PS, 1999, ATTITUDES DISABILITY; DeWalt DA, 2007, MED CARE, V45, pS12, DOI 10.1097/01.mlr.0000254567.79743.e2; Dunn DS, 2013, REHABIL PSYCHOL, V58, P148, DOI 10.1037/a0031691; Field Marilyn J., 2007, FUTURE DISABILITY AM; Fougeyrollas P., 1988, QUEBEC CLASSIFICATIO; Fougeyrollas P, 1999, MEASURE QUALITY ENV; Gill C.J, 1997, J VOCAT REHABIL, V9, P39, DOI [DOI 10.1016/S1052-2263(97)00020-2, 10.3233/jvr-1997-9106, DOI 10.3233/JVR-1997-9106]; Hahn EA, 2006, MED CARE, V44, pS189, DOI 10.1097/01.mlr.0000245145.21869.5b; Hahn EA, 2014, HEALTH PSYCHOL, V33, P490, DOI 10.1037/hea0000055; Hammel J, 2015, ARCH PHYS MED REHAB, V96, P578, DOI 10.1016/j.apmr.2014.12.008; Hays RD, 2000, MED CARE, V38, P28; Heinemann AW, 2015, ARCH PHYS MED REHAB, V96, P589, DOI 10.1016/j.apmr.2013.11.024; Keller C, 2010, J APPL SOC PSYCHOL, V40, P389, DOI 10.1111/j.1559-1816.2009.00579.x; Kimberlin SE, 2009, J HUM BEHAV SOC ENVI, V19, P26, DOI 10.1080/10911350802619870; Kincaid J. P., 1975, 875 US NAV AIR STAT; Lennon C., LEXILE FRAMEWORK APP; Linacre J.M., 1994, RASCH MEASUREMENT T, V7, P328; Oliver M., 1990, POLITICS DISABLEMENT; Olkin R, 2003, AM PSYCHOL, V58, P296, DOI 10.1037/0003-066X.58.4.296; Rao D, 2009, QUAL LIFE RES, V18, P585, DOI 10.1007/s11136-009-9475-1; Rasch G., 1980, PROBABILISTIC MODELS; Solar O., 2010, CONCEPTUAL FRAMEWORK; Teasdale G, 1979, Acta Neurochir Suppl (Wien), V28, P13; United Nations, 2006, CONVENTION RIGHTS PE; Whiteneck G, 2009, ARCH PHYS MED REHAB, V90, pS22, DOI 10.1016/j.apmr.2009.06.009; Whiteneck GG, 2004, ARCH PHYS MED REHAB, V85, P1324, DOI 10.1016/j.apmr.2003.09.027; World Health Organization, 2001, INT CLASS FUNCT DIS; World Health Organization ( WHO ), 2002, COMM LANG FUNCT DIS; Wright BD, 1985, RATING SCALE ANAL RA	34	18	19	0	19	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	APR	2015	96	4					596	603		10.1016/j.apmr.2014.06.019			8	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	CE9RC	WOS:000352180100004	25045803	Green Accepted			2021-06-18	
J	Jackson, TC; Du, LN; Janesko-Feldman, K; Vagni, VA; Dezfulian, C; Poloyac, SM; Jackson, EK; Clark, RSB; Kochanek, PM				Jackson, Travis C.; Du, Lina; Janesko-Feldman, Keri; Vagni, Vincent A.; Dezfulian, Cameron; Poloyac, Samuel M.; Jackson, Edwin K.; Clark, Robert S. B.; Kochanek, Patrick M.			The nuclear splicing factor RNA binding motif 5 promotes caspase activation in human neuronal cells, and increases after traumatic brain injury in mice	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						brain; neuron; RBM5; RBM10; splicing factors; traumatic brain injury	CANDIDATE TUMOR-SUPPRESSOR; MESSENGER-RNA; MEDIATED APOPTOSIS; SIGNALING COMPLEX; CEREBRAL-CORTEX; IN-VIVO; DEATH; PROTEIN; FLIP; APLP2	Splicing factors (SFs) coordinate nuclear intron/exon splicing of RNA. Splicing factor disturbances can cause cell death. RNA binding motif 5 (RBM5) and 10 (RBM10) promote apoptosis in cancer cells by activating detrimental alternative splicing of key death/survival genes. The role(s) of RBM5/10 in neurons has not been established. Here, we report that RBM5 knockdown in human neuronal cells decreases caspase activation by staurosporine. In contrast, RBM10 knockdown augments caspase activation. To determine whether brain injury alters RBM signaling, we measured RBM5/10 protein in mouse cortical/hippocampus homogenates after controlled cortical impact (CCI) traumatic brain injury (TBI) plus hemorrhagic shock (CCI+HS). The RBM5/10 staining was higher 48 to 72 hours after injury and appeared to be increased in neuronal nuclei of the hippocampus. We also measured levels of other nuclear SFs known to be essential for cellular viability and report that splicing factor 1 (SF1) but not splicing factor 3A (SF3A) decreased 4 to 72 hours after injury. Finally, we confirm that RBM5/10 regulate protein expression of several target genes including caspase-2, cellular FLICE-like inhibitory protein (c-FLIP), LETM1 Domain-Containing Protein 1 (LETMD1), and amyloid precursor-like protein 2 (APLP2) in neuronal cells. Knockdown of RBM5 appeared to increase expression of c-FLIP(s), LETMD1, and APLP2 but decrease caspase-2.	[Jackson, Travis C.; Du, Lina; Janesko-Feldman, Keri; Vagni, Vincent A.; Dezfulian, Cameron; Clark, Robert S. B.; Kochanek, Patrick M.] Univ Pittsburgh, Dept Crit Care Med, Safar Ctr Resuscitat Res, Sch Med, Pittsburgh, PA 15260 USA; [Poloyac, Samuel M.] Univ Pittsburgh, Sch Pharm, Dept Pharmaceut Sci, Pittsburgh, PA 15261 USA; [Jackson, Edwin K.] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15260 USA	Jackson, TC (corresponding author), Univ Pittsburgh, Dept Crit Care Med, Safar Ctr Resuscitat Res, Sch Med, 3434 Fifth Ave, Pittsburgh, PA 15260 USA.	jacksontc@upmc.edu	Kochanek, Patrick M/D-2371-2015	Kochanek, Patrick M/0000-0002-2627-913X; Jackson, Edwin/0000-0002-8101-6009; Dezfulian, Cameron/0000-0002-4486-0446	NIH/NINDS grant [1R21NS088145, R01NS087978]; US Army grant [W81XWH-10-1-0623]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS087978, R21NS088145] Funding Source: NIH RePORTER	This work was supported by NIH/NINDS grant 1R21NS088145 to TCJ, US Army grant W81XWH-10-1-0623 to PMK, and NIH/NINDS grant R01NS087978 to PMK and EKJ.	Aldridge GM, 2008, J NEUROSCI METH, V172, P250, DOI 10.1016/j.jneumeth.2008.05.003; Bin LH, 2002, FEBS LETT, V510, P37, DOI 10.1016/S0014-5793(01)03222-7; Bonnal S, 2008, MOL CELL, V32, P81, DOI 10.1016/j.molcel.2008.08.008; Carlsson Y, 2011, ANN NEUROL, V70, P781, DOI 10.1002/ana.22431; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Cho GW, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-50; Covini N, 1999, EUR J NEUROSCI, V11, P781, DOI 10.1046/j.1460-9568.1999.00485.x; Fushimi K, 2008, P NATL ACAD SCI USA, V105, P15708, DOI 10.1073/pnas.0805569105; Hainsworth AH, 2005, J CEREBR BLOOD F MET, V25, P1030, DOI 10.1038/sj.jcbfm.9600104; Han CH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067033; Hemerka JN, 2012, J NEUROTRAUM, V29, P2192, DOI 10.1089/neu.2011.2303; Inoue A, 2014, FEBS LETT, V588, P942, DOI 10.1016/j.febslet.2014.01.052; Jackson TC, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2012.187; Krueger A, 2001, J BIOL CHEM, V276, P20633, DOI 10.1074/jbc.M101780200; Li RN, 2013, LIFE SCI, V92, P747, DOI 10.1016/j.lfs.2013.02.014; Micheau O, 2002, J BIOL CHEM, V277, P45162, DOI 10.1074/jbc.M206882200; Mourtada-Maarabouni M, 2002, APOPTOSIS, V7, P421, DOI 10.1023/A:1020083008017; O'Bryan MK, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003628; Poukkula M, 2005, J BIOL CHEM, V280, P27345, DOI 10.1074/jbc.M504019200; Rappsilber J, 2002, GENOME RES, V12, P1231, DOI 10.1101/gr.473902; Rintala-Maki ND, 2004, APOPTOSIS, V9, P475, DOI 10.1023/B:APPT.0000031455.79352.57; Salon C, 2006, CELL DEATH DIFFER, V13, P260, DOI 10.1038/sj.cdd.4401739; Schaible EV, 2014, J NEUROCHEM, V129, P940, DOI 10.1111/jnc.12708; Schober ME, 2012, J NEUROTRAUM, V29, P2075, DOI 10.1089/neu.2011.2276; Schwerk C, 2005, MOL CELL, V19, P1, DOI 10.1016/j.molcel.2005.05.026; Shariati SAM, 2013, J CELL SCI, V126, P1268, DOI 10.1242/jcs.122440; Solier S, 2005, CELL DEATH DIFFER, V12, P687, DOI 10.1038/sj.cdd.4401594; Spector DL, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a000646; Sutherland LC, 2005, J CELL BIOCHEM, V94, P5, DOI 10.1002/jcb.20204; Tanackovic G, 2005, MOL BIOL CELL, V16, P1366, DOI 10.1091/mbc.E04-11-1034; Taoufik E, 2007, J NEUROSCI, V27, P6633, DOI 10.1523/JNEUROSCI.1091-07.2007; Ueffing N, 2008, CELL DEATH DIFFER, V15, P773, DOI 10.1038/sj.cdd.4402314; Von Koch CS, 1997, NEUROBIOL AGING, V18, P661, DOI 10.1016/S0197-4580(97)00151-6; Wang K, 2011, RESPIROLOGY, V16, P187; Wang Ke, 2012, J Cell Death, V5, P1, DOI 10.4137/JCD.S9073; WANG L, 1994, CELL, V78, P739, DOI 10.1016/S0092-8674(94)90422-7; Wang YB, 2013, EMBO MOL MED, V5, P1431, DOI 10.1002/emmm.201302663; Weyer SW, 2011, EMBO J, V30, P2266, DOI 10.1038/emboj.2011.119; Yi JH, 2005, GLIA, V49, P121, DOI 10.1002/glia.20099; Zhang XM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061198	40	18	19	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	APR	2015	35	4					655	666		10.1038/jcbfm.2014.242			12	Endocrinology & Metabolism; Hematology; Neurosciences	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	CE7NF	WOS:000352027900016	25586139	Green Published, Bronze			2021-06-18	
J	Siebenrock, KA; Kienle, KP; Steppacher, SD; Tannast, M; Mamisch, TC; von Rechenberg, B				Siebenrock, Klaus A.; Kienle, Karl-Philipp; Steppacher, Simon D.; Tannast, Moritz; Mamisch, Tallal C.; von Rechenberg, Brigitte			Biochemical MRI Predicts Hip Osteoarthritis in an Experimental Ovine Femoroacetabular Impingement Model	CLINICAL ORTHOPAEDICS AND RELATED RESEARCH			English	Article; Proceedings Paper	Bernese Hip Symposium	FEB 06-08, 2014	Berne, SWITZERLAND	Univ Berne, Inselspital			ARTICULAR-CARTILAGE; JOINT CARTILAGE; MORPHOLOGY; SEQUENCE; INJURY	Cam-type femoroacetabular impingement (FAI) resulting from an abnormal nonspherical femoral head shape leads to chondrolabral damage and is considered a cause of early osteoarthritis. A previously developed experimental ovine FAI model induces a cam-type impingement that results in localized chondrolabral damage, replicating the patterns found in the human hip. Biochemical MRI modalities such as T2 and T2* may allow for evaluation of the cartilage biochemistry long before cartilage loss occurs and, for that reason, may be a worthwhile avenue of inquiry. We asked: (1) Does the histological grading of degenerated cartilage correlate with T2 or T2* values in this ovine FAI model? (2) How accurately can zones of degenerated cartilage be predicted with T2 or T2* MRI in this model? A cam-type FAI was induced in eight Swiss alpine sheep by performing a closing wedge intertrochanteric varus osteotomy. After ambulation of 10 to 14 weeks, the sheep were euthanized and a 3-T MRI of the hip was performed. T2 and T2* values were measured at six locations on the acetabulum and compared with the histological damage pattern using the Mankin score. This is an established histological scoring system to quantify cartilage degeneration. Both T2 and T2* values are determined by cartilage water content and its collagen fiber network. Of those, the T2* mapping is a more modern sequence with technical advantages (eg, shorter acquisition time). Correlation of the Mankin score and the T2 and T2* values, respectively, was evaluated using the Spearman's rank correlation coefficient. We used a hierarchical cluster analysis to calculate the positive and negative predictive values of T2 and T2* to predict advanced cartilage degeneration (Mankin a parts per thousand yen 3). We found a negative correlation between the Mankin score and both the T2 (p < 0.001, r = -0.79) and T2* values (p < 0.001, r = -0.90). For the T2 MRI technique, we found a positive predictive value of 100% (95% confidence interval [CI], 79%-100%) and a negative predictive value of 84% (95% CI, 67%-95%). For the T2* technique, we found a positive predictive value of 100% (95% CI, 79%-100%) and a negative predictive value of 94% (95% CI, 79%-99%). T2 and T2* MRI modalities can reliably detect early cartilage degeneration in the experimental ovine FAI model. T2 and T2* MRI modalities have the potential to allow for monitoring the natural course of osteoarthrosis noninvasively and to evaluate the results of surgical treatments targeted to joint preservation.	[Siebenrock, Klaus A.; Kienle, Karl-Philipp; Steppacher, Simon D.; Tannast, Moritz; Mamisch, Tallal C.] Univ Bern, Inselspital, Dept Orthopaed Surg, CH-3010 Bern, Switzerland; [Tannast, Moritz; von Rechenberg, Brigitte] Univ Bern, Musculoskeletal Res Unit, CH-3010 Bern, Switzerland	Siebenrock, KA (corresponding author), Univ Bern, Inselspital, Dept Orthopaed Surg, Freiburgstr, CH-3010 Bern, Switzerland.	klaus.siebenrock@insel.ch	Tannast, Moritz/ABB-9548-2020	Tannast, Moritz/0000-0002-2761-565X; Siebenrock, Klaus Arno/0000-0003-3627-4313			Beck M, 2005, J BONE JOINT SURG BR, V87B, P1012, DOI 10.1302/0301-620X.87B7.15203; Bittersohl B, 2012, OSTEOARTHR CARTILAGE, V20, P653, DOI 10.1016/j.joca.2012.03.011; Bittersohl B, 2009, MAGN RESON MED, V62, P896, DOI 10.1002/mrm.22096; Ganz R, 2003, CLIN ORTHOP RELAT R, P112, DOI 10.1097/01.blo.0000096804.78689.c2; Gold SL, 2012, CLIN ORTHOP RELAT R, V470, P3321, DOI 10.1007/s11999-012-2403-7; Hesper T, 2014, SKELETAL RADIOL; Jazrawi LM, 2011, J AM ACAD ORTHOP SUR, V19, P420, DOI 10.5435/00124635-201107000-00005; Kijowski R, 2013, RADIOLOGY, V267, P503, DOI 10.1148/radiol.12121413; Kim YJ, 2013, MAGN RESON IMAGING C, V21, P35, DOI 10.1016/j.mric.2012.09.003; Koff MF, 2009, RADIOL CLIN N AM, V47, P495, DOI 10.1016/j.rcl.2009.01.004; MANKIN HJ, 1974, NEW ENGL J MED, V291, P1285, DOI 10.1056/NEJM197412122912406; MANKIN HJ, 1974, NEW ENGL J MED, V291, P1335, DOI 10.1056/NEJM197412192912507; Miese FR, 2011, ACTA RADIOL, V52, P106, DOI 10.3109/02841851.2010.516015; Nishii T, 2010, RADIOLOGY, V256, P955, DOI 10.1148/radiol.10091928; Phillips T W, 1987, J Arthroplasty, V2, P111, DOI 10.1016/S0883-5403(87)80017-7; Siebenrock KA, 2013, J ORTHOP RES, V31, P580, DOI 10.1002/jor.22273; Steppacher SD, 2013, CLIN ORTHOP RELAT R, V472, P337; VANDERSLUIJS JA, 1992, J ORTHOPAED RES, V10, P58, DOI 10.1002/jor.1100100107; Wagner S, 2003, OSTEOARTHR CARTILAGE, V11, P508, DOI 10.1016/S1063-4584(03)00075-X; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967	20	18	19	1	8	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0009-921X	1528-1132		CLIN ORTHOP RELAT R	Clin. Orthop. Rel. Res.	APR	2015	473	4					1318	1324		10.1007/s11999-014-3849-6			7	Orthopedics; Surgery	Orthopedics; Surgery	CD2DY	WOS:000350885600022	25183216	Green Published			2021-06-18	
J	Sun, J; Chen, W				Sun, J.; Chen, W.			Music therapy for coma patients: preliminary results	EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES			English	Article						Coma; Traumatic brain injury (TBI); Music therapy; Electroencephalography (QEEG)	TRAUMATIC BRAIN-INJURY; STIMULATION	OBJECTIVE: The application of quantitative EEG (delta+theta/alpha+beta value) and GCS value to evaluate the role of music therapy for traumatic brain injury coma patients. PATIENTS AND METHODS: Forty patients of traumatic brain injury coma were selected to meet the inclusion criteria. Twenty cases were selected for the rehabilitation, neurology and neurosurgery ward, whose families could actively cooperate with, and the patients could receive a long-term fixed nursing staff with formal music therapy (music group). Twenty cases were in the intensive care unit of the rehabilitation, neurology and neurosurgery ward. Their families members cooperated poorly, had often changing nursing staff, and without a formal music therapy (control group). After a one monthe follow up, the GCS value and quantitative EEG (delta+theta/alpha+beta value) were compared between the two groups. Between the two groups, except for the presence or absence of formal music therapy, the rest of treatment had no significant difference and was matched by age, gender, and injury types. RESULTS: In 40 cases of traumatic brain injury patients, the GCS value increased in the music group after treatment when compared to the control group. The difference between the two groups was significant (p < 0.05). The quantitative EEG value (delta+theta/alpha+beta value) of music group values were decreased after treatment, and the difference was significant compared with the control group (p < 0.05). CONCLUSIONS: Through the quantitative EEG (delta+theta/alpha+beta value) and the GCS observation score, music therapy in patients with craniocerebral trauma coma has obviously an effect on promoting to regain consciousness. The quantitative EEG (delta+theta/alpha+beta value) can be used as an objective index to evaluate the state of brain function.	[Sun, J.; Chen, W.] Xuzhou Cent Hosp, Dept Rehabil Med, Xuzhou, Jiangsu, Peoples R China	Chen, W (corresponding author), Xuzhou Cent Hosp, Dept Rehabil Med, Xuzhou, Jiangsu, Peoples R China.	chenwei2339@163.com					Abend NS, 2008, PEDIATR CRIT CARE ME, V9, P32, DOI 10.1097/01.PCC.0000288714.61037.56; Ashby FG, 1999, PSYCHOL REV, V106, P529, DOI 10.1037/0033-295X.106.3.529; Bos S, 1997, ONLINE J KNOWL SYN N, V4, pU3, DOI 10.1111/j.1524-475X.1997.00001.x; Bu C, 2002, JILIN MED J, V23, P161; Celesia GG, 1999, CLIN NEUROPHYSIOL, V110, P203; Chen C, 2011, TODAY NURSE SPECIAL, V2, P54; Chen R, 1996, CRIT CARE MED, V24, P672, DOI 10.1097/00003246-199604000-00020; Chen Z, 2011, J MODERN ELECTROPHYS, V18, P60; Dong H, 2013, CHIN J NEUROMED, V12, P296; Fei L, 2007, MED J NATL DEFENDING, V17, P573; Fei W, 2013, HEBEI J TRAD CHIN ME, V35, P31; Gerber CS, 2005, CRIT CARE NURS Q, V28, P94, DOI 10.1097/00002727-200504000-00002; Horn J, 2008, Ned Tijdschr Geneeskd, V152, P308; Huang W, 2007, MODERN CLIN NURSING, V6, P4; Huang W, 2009, CHIN J CRIT CARE MED, V2, P6; Jiaxi L., 2013, GUIDING J TRAD CHIN, V19, P79; Juan L, 2011, SIGNIFICANCE AMBULAT; Kaplan PW, 2000, CLIN NEUROPHYSIOL, V111, P584, DOI 10.1016/S1388-2457(99)00303-X; Karma D, 2006, INDIAN PEDIATR, V43, P856; Kui Z, 2010, SICHUAN MED J, V31, P1425; Le Meifen WS, 2001, SHANGHAI NURSING J, V1, P1; Leon-Carrion J, 2008, CLIN NEUROPHYSIOL, V119, P1506, DOI 10.1016/j.clinph.2008.03.030; Lew HL, 2004, AM J PHYS MED REHAB, V83, P428, DOI 10.1097/00002060-200406000-00004; Li S, 2012, MED J CHIN PEOPLES A, V23, P14; Liang F, 2008, CHIN MED GUIDES, V5, P146; Liang Q, 2010, MODERN J INTEGR TRAD, V19, P2967; Liu X, 2004, CLIN ELECTROPHYSIOLO, P288; Lu Z, 2011, RES PROGNOSIS FORECA; Magis D, 2013, CEPHALALGIA, V33, P526, DOI 10.1177/0333102413477739; Man Li GM, 2003, CHIN J NURSING ED, V38, P205; Masdeu JC, 2005, J NEUROL SCI, V236, P55, DOI 10.1016/j.jns.2005.05.001; Ming Y, 2012, PREV TREAT CARDIOCER, V12, P376; Peretz I, 2005, ANNU REV PSYCHOL, V56, P89, DOI 10.1146/annurev.psych.56.091103.070225; Qing X, 2013, CHIN GEN PRACT, V16, P2584; Qiuli B, 2011, J NURS SCI, V26, P26; Shen Y, 2008, CHIN J PRACT NERVOUS, V11, P17; Shuangyi F, 2009, J EPILEPSY ELECTRONE, V18, P13; Tan X, 1996, CHIN J MODERN MED, V6, P17; Tao Z, 2013, CHIN J NAUTICAL MED, V20, P76; Wallace BE, 2001, J HEAD TRAUMA REHAB, V16, P165, DOI 10.1097/00001199-200104000-00006; Wenjian P, 2011, CHIN J CLIN REHABIL, V26, P192; Xiaoying T, 2008, CHIN J REHABIL, V23, P241; Xiuling P, 2013, SHAANXI MED J, V42, P305; Xue X, 2001, J NURS SCI, V16, P484; Yanwei C, 2011, CHIN J NEUROSURG, V27, P56; 陈玉宝, 2012, [中国全科医学, Chinese General Practice], V15, P209; 张丽华, 2008, [中国康复医学杂志, Chinese Journal of Rehabilitation Medicine], V23, P76	47	18	22	0	21	VERDUCI PUBLISHER	ROME	VIA GREGORIO VII, ROME, 186-00165, ITALY	1128-3602			EUR REV MED PHARMACO	Eur. Rev. Med. Pharmacol. Sci.	APR	2015	19	7					1209	1218					10	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CG8TX	WOS:000353587000015	25912580				2021-06-18	
J	Xie, HY; Cui, Y; Deng, F; Feng, JC				Xie, Hong-yan; Cui, Yu; Deng, Fang; Feng, Jia-chun			Connexin: a potential novel target for protecting the central nervous system?	NEURAL REGENERATION RESEARCH			English	Article						connexin; gap junction; biosynthetic pathways; biodegradation; brain; central nervous system diseases	SPINAL-CORD-INJURY; GAP-JUNCTION CHANNELS; HEREDITARY SPASTIC PARAPLEGIA; MERZBACHER-LIKE-DISEASE; ALZHEIMERS-DISEASE; PLASMA-MEMBRANE; AMYLOID PLAQUES; GLIOMA-CELLS; ASTROCYTE DYSFUNCTION; TRIGEMINAL GANGLION	Connexin subunits are proteins that form gap junction channels, and play an important role in communication between adjacent cells. This review article discusses the function of connexins/hemichannels/gap junctions under physiological conditions, and summarizes the findings regarding the role of connexins/hemichannels/gap junctions in the physiological and pathological mechanisms underlying central nervous system diseases such as brain ischemia, traumatic brain and spinal cord injury, epilepsy, brain and spinal cord tumor, migraine, neuroautoimmune disease, Alzheimer's disease, Parkinson's disease, X-linked Charcot-Marie-Tooth disease, Pelizaeus-Merzbacher-like disease, spastic paraplegia and maxillofacial dysplasia. Connexins are considered to be a potential novel target for protecting the central nervous system.	[Xie, Hong-yan; Deng, Fang; Feng, Jia-chun] Jilin Univ, Hosp 1, Dept Neurol, Changchun 130023, Jilin Province, Peoples R China; [Cui, Yu] First Peoples Hosp Xianyang, Dept Neurosurg, Xianyang, Shaanxi, Peoples R China	Feng, JC (corresponding author), Jilin Univ, Hosp 1, Dept Neurol, Changchun 130023, Jilin Province, Peoples R China.	defrances2000@163.com; clinicalted@gmail.com			National Natural Science Foundation of China (General Program)National Natural Science Foundation of China (NSFC) [81271293]; National Science Foundation for Young Scientists of China [81000490]	This study was supported by the National Natural Science Foundation of China (General Program), No. 81271293 and the National Science Foundation for Young Scientists of China, No. 81000490.	Abrams CK, 2012, BBA-BIOMEMBRANES, V1818, P2030, DOI 10.1016/j.bbamem.2011.08.015; Alexander DB, 2003, CURR MED CHEM, V10, P2045, DOI 10.2174/0929867033456927; Anders S, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0600; Behin A, 2003, LANCET, V361, P323, DOI 10.1016/S0140-6736(03)12328-8; Berthoud VA, 2004, CARDIOVASC RES, V62, P256, DOI 10.1016/j.cardiores.2003.12.021; BEYER EC, 1987, J CELL BIOL, V105, P2621, DOI 10.1083/jcb.105.6.2621; Bicego M, 2006, NEUROBIOL DIS, V21, P607, DOI 10.1016/j.nbd.2005.09.005; Bruzzone R., 1997, EJB REV, P135; Burra S, 2010, P NATL ACAD SCI USA, V107, P13648, DOI 10.1073/pnas.1009382107; Caltabiano R, 2010, ACTA HISTOCHEM, V112, P529, DOI 10.1016/j.acthis.2009.05.008; Cina C, 2009, J NEUROSCI, V29, P2009, DOI 10.1523/JNEUROSCI.5025-08.2009; Compston A, 2002, LANCET, V359, P1221, DOI 10.1016/S0140-6736(02)08220-X; Cronin M, 2008, MOL CELL NEUROSCI, V39, P152, DOI 10.1016/j.mcn.2008.06.005; De Bock M, 2014, BBA-MOL CELL RES, V1843, P2211, DOI 10.1016/j.bbamcr.2014.04.016; De Bock M, 2014, FEBS LETT, V588, P1259, DOI 10.1016/j.febslet.2014.02.060; Decrock E, 2011, CELL CALCIUM, V50, P310, DOI 10.1016/j.ceca.2011.05.007; Durham PL, 2008, HEADACHE, V48, pS5, DOI 10.1111/j.1526-4610.2008.01262.x; Edvinsson L, 2005, BRAIN RES REV, V48, P438, DOI 10.1016/j.brainresrev.2004.09.007; Eugenin EA, 2012, J NEUROIMMUNE PHARM, V7, P499, DOI 10.1007/s11481-012-9352-5; Falk MM, 2009, MOL BIOL CELL, V20, P3342, DOI 10.1091/mbc.E09-04-0288; Falk MM, 2000, J CELL SCI, V113, P4109; Fink JK, 2013, ACTA NEUROPATHOL, V126, P307, DOI 10.1007/s00401-013-1115-8; Fiori MC, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00071; Froger N, 2010, MOL CELL NEUROSCI, V45, P37, DOI 10.1016/j.mcn.2010.05.007; Fu CT, 2004, J BIOL CHEM, V279, P36943, DOI 10.1074/jbc.M403952200; Gaietta G, 2002, SCIENCE, V296, P503, DOI 10.1126/science.1068793; Goadsby PJ, 2009, NEUROSCIENCE, V161, P327, DOI 10.1016/j.neuroscience.2009.03.019; Goodenough DA, 2003, NAT REV MOL CELL BIO, V4, P285, DOI 10.1038/nrm1072; Guo YH, 2003, AM J PHYSIOL-LUNG C, V285, pL1213, DOI 10.1152/ajplung.00066.2003; Hausmann O, 2003, SPINAL CORD, V41, P369, DOI 10.1038/sj.sc.3101483; Hesketh GG, 2010, CIRC RES, V106, P1153, DOI 10.1161/CIRCRESAHA.108.182147; Huang RP, 1999, J SURG ONCOL, V70, P21, DOI 10.1002/(SICI)1096-9098(199901)70:1<21::AID-JSO4>3.0.CO;2-0; Jamsheer A, 2014, GENE, V539, P157, DOI 10.1016/j.gene.2014.01.066; Johnson RG, 2002, EXP CELL RES, V275, P67, DOI 10.1006/excr.2002.5480; Jordan K, 2001, J CELL SCI, V114, P763; Kameritsch P, 2012, BBA-BIOMEMBRANES, V1818, P1993, DOI 10.1016/j.bbamem.2011.11.016; Kardami E, 2007, PROG BIOPHYS MOL BIO, V94, P245, DOI 10.1016/j.pbiomolbio.2007.03.009; Kawasaki A, 2009, NEUROSCIENCE, V160, P61, DOI 10.1016/j.neuroscience.2009.01.080; Kelly SM, 2007, MOL BIOL CELL, V18, P4279, DOI 10.1091/mbc.E07-05-0487; Kielian T, 2008, J NEUROCHEM, V106, P1000, DOI 10.1111/j.1471-4159.2008.05405.x; Kim MS, 2013, BIOCHEM J, V452, P249, DOI 10.1042/BJ20121821; Kumar NM, 1996, CELL, V84, P381, DOI 10.1016/S0092-8674(00)81282-9; Laird DW, 2010, TRENDS CELL BIOL, V20, P92, DOI 10.1016/j.tcb.2009.11.001; Laird DW, 2006, BIOCHEM J, V394, P527, DOI 10.1042/BJ20051922; Lauf U, 2002, P NATL ACAD SCI USA, V99, P10446, DOI 10.1073/pnas.162055899; Leithe E, 2012, BBA-BIOMEMBRANES, V1818, P1870, DOI 10.1016/j.bbamem.2011.09.029; Loewenstein Y, 2002, MOL PSYCHIATR, V7, P129, DOI 10.1038/sj.mp.4000994; Long MA, 2002, J NEUROSCI, V22, P10898; Vega JL, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/589130; Masaki K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072919; Matsuuchi L, 2013, BBA-BIOMEMBRANES, V1828, P94, DOI 10.1016/j.bbamem.2012.05.014; Mei X, 2010, NEUROSCIENCE, V171, P92, DOI 10.1016/j.neuroscience.2010.08.001; Menichella DM, 2003, J NEUROSCI, V23, P5963, DOI 10.1523/jneurosci.23-13-05963.2003; Moinfar Z, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00186; Moon Y, 2010, NEUROREPORT, V21, P1135, DOI 10.1097/WNR.0b013e32834051c7; Mylvaganam S, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00172; Nagele RG, 2004, NEUROBIOL AGING, V25, P663, DOI 10.1016/j.neurobiolaging.2004.01.007; Nagy JI, 1996, BRAIN RES, V717, P173, DOI 10.1016/0006-8993(95)01526-4; Naus CC, 2010, NAT REV CANCER, V10, P435, DOI 10.1038/nrc2841; Norenberg MD, 2004, J NEUROTRAUM, V21, P429, DOI 10.1089/089771504323004575; O'Carroll SJ, 2013, NEUROSCI RES, V75, P256, DOI 10.1016/j.neures.2013.01.004; Olabarria M, 2010, GLIA, V58, P831, DOI 10.1002/glia.20967; Olbina G, 2003, MOL CANCER RES, V1, P690; Orellana JA, 2011, J NEUROSCI, V31, P4962, DOI 10.1523/JNEUROSCI.6417-10.2011; Orthmann-Murphy JL, 2007, MOL CELL NEUROSCI, V34, P629, DOI 10.1016/j.mcn.2007.01.010; Orthmann-Murphy JL, 2009, BRAIN, V132, P426, DOI 10.1093/brain/awn328; Parkin DM, 2001, EUR J CANCER, V37, pS4, DOI 10.1016/S0959-8049(01)00267-2; PAUL DL, 1986, J CELL BIOL, V103, P123, DOI 10.1083/jcb.103.1.123; Paznekas WA, 2003, AM J HUM GENET, V72, P408, DOI 10.1086/346090; Piehl M, 2007, MOL BIOL CELL, V18, P337, DOI 10.1091/mbc.E06-06-0487; Pizzuti Antonio, 2004, Hum Mutat, V23, P286, DOI 10.1002/humu.9220; Pu PY, 2004, CLIN NEUROL NEUROSUR, V107, P49, DOI 10.1016/j.clineuro.2004.03.006; Retamal MA, 2007, J MEMBRANE BIOL, V218, P49, DOI 10.1007/s00232-007-9043-y; REVEL JP, 1967, J CELL BIOL, V33, pC7, DOI 10.1083/jcb.33.3.C7; Roscoe WA, 2007, CELL COMMUN ADHES, V14, P57, DOI 10.1080/15419060701459569; Rufer M, 1996, J NEUROSCI RES, V46, P606, DOI 10.1002/(SICI)1097-4547(19961201)46:5<606::AID-JNR9>3.3.CO;2-2; Schalper KA, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00237; Scherer Steven S, 2012, J Peripher Nerv Syst, V17 Suppl 3, P9, DOI 10.1111/j.1529-8027.2012.00424.x; Scita G, 2010, NATURE, V463, P464, DOI 10.1038/nature08910; Seifert G, 2006, NAT REV NEUROSCI, V7, P194, DOI 10.1038/nrn1870; Seifert G, 2010, BRAIN RES REV, V63, P212, DOI 10.1016/j.brainresrev.2009.10.004; Selkoe DJ, 2001, PHYSIOL REV, V81, P741; SEVERS NJ, 1989, CIRC RES, V65, P22, DOI 10.1161/01.RES.65.1.22; Shy ME, 2007, NEUROLOGY, V68, P849, DOI 10.1212/01.wnl.0000256709.08271.4d; Silberstein SD, 2009, CEPHALALGIA, V29, P28, DOI 10.1111/j.1468-2982.2009.01973.x; Sin WC, 2012, BBA-BIOMEMBRANES, V1818, P2058, DOI 10.1016/j.bbamem.2011.10.022; Solan JL, 2009, BIOCHEM J, V419, P261, DOI 10.1042/BJ20082319; Soroceanu L, 2001, GLIA, V33, P107, DOI 10.1002/1098-1136(200102)33:2<107::AID-GLIA1010>3.0.CO;2-4; Sosinsky GE, 2005, BBA-BIOMEMBRANES, V1711, P99, DOI 10.1016/j.bbamem.2005.04.001; Spray David C, 2013, Wiley Interdiscip Rev Membr Transp Signal, V2, P1; Stancanelli C, 2012, J PERIPHER NERV SYST, V17, P407, DOI 10.1111/j.1529-8027.2012.00439.x; Steinhauser C, 2012, GLIA, V60, P1192, DOI 10.1002/glia.22313; Stout C, 2004, CURR OPIN CELL BIOL, V16, P507, DOI 10.1016/j.ceb.2004.07.014; Thalakoti S, 2007, HEADACHE, V47, P1008, DOI 10.1111/j.1526-4610.2007.00854.x; Theis M, 2003, J NEUROSCI, V23, P766; Thomas Jayakar, 2013, Indian J Dermatol, V58, P383, DOI 10.4103/0019-5154.117311; Tress O, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002146; Turner RC, 2013, J NEUROSURG, V118, P1072, DOI 10.3171/2012.11.JNS12408; Uhlenberg B, 2004, AM J HUM GENET, V75, P251, DOI 10.1086/422763; VanSlyke JK, 2002, J CELL BIOL, V157, P381, DOI 10.1083/jcb.200111045; Wang N, 2013, BBA-BIOMEMBRANES, V1828, P35, DOI 10.1016/j.bbamem.2012.07.002; Wang XY, 2013, CELL MOL NEUROBIOL, V33, P401, DOI 10.1007/s10571-013-9906-y; Wang YF, 2012, J NEUROSCI, V32, P713, DOI 10.1523/JNEUROSCI.3872-11.2012; Willecke K, 2002, BIOL CHEM, V383, P725, DOI 10.1515/BC.2002.076; Zhang W, 1999, CANCER RES, V59, P1994	105	18	19	0	10	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	1673-5374	1876-7958		NEURAL REGEN RES	Neural Regen. Res.	APR	2015	10	4					659	666		10.4103/1673-5374.155444			8	Cell Biology; Neurosciences	Cell Biology; Neurosciences & Neurology	CH6OP	WOS:000354156200032	26170830	DOAJ Gold, Green Published			2021-06-18	
J	Max, JE; Friedman, K; Wilde, EA; Bigler, ED; Hanten, G; Schachar, RJ; Saunders, AE; Dennis, M; Ewing-Cobbs, L; Chapman, SB; Yang, TT; Levin, HS				Max, Jeffrey E.; Friedman, Keren; Wilde, Elisabeth A.; Bigler, Erin D.; Hanten, Gerri; Schachar, Russell J.; Saunders, Ann E.; Dennis, Maureen; Ewing-Cobbs, Linda; Chapman, Sandra B.; Yang, Tony T.; Levin, Harvey S.			Psychiatric Disorders in Children and Adolescents 24 Months After Mild Traumatic Brain Injury	JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Article							HEAD-INJURY; POSTCONCUSSIVE SYMPTOMS; PERSONALITY-CHANGE; COGNITIVE RESERVE; RELIABILITY; VALIDITY; CHILDHOOD; SCHEDULE	This study aimed to better understand the occurrence of novel psychiatric disorders (NPDs) in children with mild traumatic brain injury (mTBI) in relation to preinjury variables, injury-related variables, and concurrent neurocognitive outcome. Eighty-seven children aged 5-14 years who had experienced mTBI were studied from consecutive hospital admissions with semistructured psychiatric interviews soon after injury (baseline). Fifty-four children were reassessed 24 months postinjury. Standardized instruments were used to evaluate injury severity, lesion characteristics, preinjury variables (lifetime psychiatric disorder, family psychiatric history, family function, socioeconomic status, psychosocial adversity, adaptive function, and academic function), and finally, postinjury neurocognitive and adaptive function. At 24 months postinjury, NPDs had occurred in 17 of 54 (31%) participants. NPD at 24 months was related to frontal white matter lesions and was associated with estimated preinjury reading, preinjury adaptive function, and concurrent deficits in reading, processing speed, and adaptive function. These findings extend earlier reports that the psychiatric morbidity after mTBI in children is more common than previously thought, and moreover, it is linked to preinjury individual variables and injury characteristics and is associated with postinjury adaptive and neurocognitive functioning.	[Max, Jeffrey E.] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA; [Max, Jeffrey E.] Rady Childrens Hosp, San Diego, CA USA; [Friedman, Keren] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel; [Wilde, Elisabeth A.; Levin, Harvey S.] Baylor Coll Med, Houston, TX 77030 USA; [Bigler, Erin D.] Brigham Young Univ, Provo, UT 84602 USA; [Schachar, Russell J.; Dennis, Maureen] Univ Toronto, Toronto, ON, Canada; [Saunders, Ann E.; Ewing-Cobbs, Linda] Univ Texas Hlth Sci Ctr Houston, Houston, TX 77030 USA; [Chapman, Sandra B.] Univ Texas Dallas, Dallas, TX 75230 USA; [Yang, Tony T.] Univ Calif San Francisco, San Francisco, CA 94143 USA	Max, JE (corresponding author), Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA.	jmax@ucsd.edu		Schachar, Russell/0000-0002-2015-4395	National Institute of Mental HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [K-08 MH01800]; National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS-21889]; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH085734, K08MH001800] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS021889] Funding Source: NIH RePORTER	This study was supported by grants from the National Institute of Mental Health (K-08 MH01800 to Dr. Max) and the National Institute of Neurological Disorders and Stroke (NS-21889 to Dr. Levin).	American Psychiatric Association, 1994, DIAGN STAT MAN MENT; ANDREASEN NC, 1977, ARCH GEN PSYCHIAT, V34, P1229; Association for the Advancement of Automotive Medicine, 1990, ABBR INJ SCAL 1990 R; Babikian T, 2005, PEDIATR NEUROL, V33, P184, DOI 10.1016/j.pediatrneurol.2005.03.015; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Boyle MH, 1996, J AM ACAD CHILD PSY, V35, P1440, DOI 10.1097/00004583-199611000-00012; BROWN G, 1981, PSYCHOL MED, V11, P63, DOI 10.1017/S0033291700053289; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd; Costello EJ, 1996, ARCH GEN PSYCHIAT, V53, P1137; Delis D.C., 1994, CVLT C CALIFORNIA VE; Dennis M, 2013, DEV COGN NEUROS-NETH, V5, P25, DOI 10.1016/j.dcn.2012.11.006; Fay TB, 2010, J INT NEUROPSYCH SOC, V16, P94, DOI 10.1017/S1355617709991007; Hawley CA, 2003, BRAIN INJURY, V17, P105, DOI 10.1080/0269905021000010131; Hollingshead A. B., 1975, 4 FACTOR INDEX SOCIA; Kaufman J, 1997, J AM ACAD CHILD PSY, V36, P980, DOI 10.1097/00004583-199707000-00021; Kesler SR, 2003, APPL NEUROPSYCHOL, V10, P153, DOI 10.1207/S15324826AN1003_04; Koepsell TD, 2011, PEDIATRICS, V128, P946, DOI 10.1542/peds.2010-2259; LECKMAN JF, 1982, ARCH GEN PSYCHIAT, V39, P879; Levin HS, 2008, J NEUROSURG-PEDIATR, V1, P461, DOI 10.3171/PED/2008/1/6/461; Max JE, 1999, J INT NEUROPSYCH SOC, V5, P58, DOI 10.1017/S1355617799511089; Max JE, 2006, J NEUROPSYCH CLIN N, V18, P21, DOI 10.1176/appi.neuropsych.18.1.21; Max JE, 1998, J AM ACAD CHILD PSY, V37, P832, DOI 10.1097/00004583-199808000-00013; Max JE, 1998, J AM ACAD CHILD PSY, V37, P297, DOI 10.1097/00004583-199803000-00015; Max JE, 1997, J AM ACAD CHILD PSY, V36, P1278, DOI 10.1097/00004583-199709000-00021; Max JE, 2000, J INT NEUROPSYCH SOC, V6, P279, DOI 10.1017/S1355617700633039; Max JE, 2010, COGNITIVE BEHAV ABNO; Max JE, 2013, J NEUROPSYCH CLIN N, V25, P272, DOI 10.1176/appi.neuropsych.12040078; Max JE, 2013, J NEUROPSYCH CLIN N, V25, P187, DOI 10.1176/appi.neuropsych.12010011; Max JE, 2012, J NEUROPSYCH CLIN N, V24, P427, DOI 10.1176/appi.neuropsych.12060149; Mayer AR, 2012, J NEUROSCI, V32, P17961, DOI 10.1523/JNEUROSCI.3379-12.2012; McKinlay A, 2002, J NEUROL NEUROSUR PS, V73, P281, DOI 10.1136/jnnp.73.3.281; MILLER IW, 1985, J MARITAL FAM THER, V11, P345, DOI 10.1111/j.1752-0606.1985.tb00028.x; POLISSAR NL, 1994, BRAIN INJURY, V8, P249, DOI 10.3109/02699059409150977; Ponsford J, 1999, J HEAD TRAUMA REHAB, V14, P360, DOI 10.1097/00001199-199908000-00005; Satz P, 1997, PSYCHOL BULL, V122, P107, DOI 10.1037/0033-2909.122.2.107; Semel E. M., 1995, CLIN EVALUATION LANG; Sparrow S., 1984, VINELAND ADAPTIVE BE; Taylor HG, 2010, NEUROPSYCHOLOGY, V24, P148, DOI 10.1037/a0018112; TEASDALE G, 1974, LANCET, V2, P81; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; Wechsler D., 2011, WECHLSER ABBREVIATED; Wechsler D., 1991, WECHSLER INTELLIGENC; Woodcock R.W., 1989, WOODCOCK JOHNSON TES; Yeates KO, 1997, J CLIN EXP NEUROPSYC, V19, P825, DOI 10.1080/01688639708403763; Yeates KO, 1999, J HEAD TRAUMA REHAB, V14, P337, DOI 10.1097/00001199-199908000-00003; Yeates KO, CLIN PSYCHOL SCI	47	18	18	0	10	AMER PSYCHIATRIC PUBLISHING, INC	WASHINGTON	800 MAINE AVE SW, SUITE 900, WASHINGTON, DC 20024 USA	0895-0172	1545-7222		J NEUROPSYCH CLIN N	J. Neuropsychiatr. Clin. Neurosci.	SPR	2015	27	2					112	120		10.1176/appi.neuropsych.13080190			9	Clinical Neurology; Neurosciences; Psychiatry	Neurosciences & Neurology; Psychiatry	CJ1NM	WOS:000355250300106	25923850	Green Accepted			2021-06-18	
J	Teel, EF; Slobounov, SM				Teel, Elizabeth F.; Slobounov, Semyon M.			Validation of a Virtual Reality Balance Module for Use in Clinical Concussion Assessment and Management	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						concussion; VR balance; force plate; BESS; SOT; validation	POSTURAL STABILITY; TASK CONSTRAINTS; DEFICITS; PLAYERS; SKILL	Objective: To determine the criterion and content validity of a virtual reality (VR) balance module for use in clinical practice. Design: Retrospective, VR balance module completed by participants during concussion baseline or assessment testing session. Setting: A Pennsylvania State University research laboratory. Participants: A total of 60 control and 28 concussed students and athletes from the Pennsylvania State University. Interventions: None. Main Outcome Measures: This study examined: (1) the relationship between VR composite balance scores (final, stationary, yaw, pitch, and roll) and area of the center-of-pressure (eyes open and closed) scores and (2) group differences (normal volunteers and concussed student-athletes) on VR composite balance scores. Results: With the exception of the stationary composite score, all other VR balance composite scores were significantly correlated with the center of pressure data obtained from a force platform. Significant correlations ranged from r = -0.273 to -0.704 for the eyes open conditions and from r = -0.353 to -0.876 for the eyes closed condition. When examining group differences on the VR balance composite modules, the concussed group did significantly (P < 0.01) worse on all measures compared with the control group. Conclusions: The VR balance module met or exceeded the criterion and content validity standard set by the current balance tools and may be appropriate for use in a clinical concussion setting.	[Teel, Elizabeth F.; Slobounov, Semyon M.] Penn State Univ, Dept Kinesiol, University Pk, PA 16802 USA; [Teel, Elizabeth F.; Slobounov, Semyon M.] Penn State Ctr Sport Concuss Res & Serv, University Pk, PA USA	Slobounov, SM (corresponding author), Penn State Univ, 276 Recreat Bldg, University Pk, PA 16802 USA.	sms18@psu.edu		Teel, Elizabeth/0000-0002-2846-5884	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [2R01 NS056227-06]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS056227] Funding Source: NIH RePORTER	Supported by the National Institutes of Health Grant 2R01 NS056227-06 to "The Effects of Mild Traumatic Brain Injury on Neuropsychological Test Scores, Postural Stability and General Brain Function."	Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; Broglio SP, 2007, NEUROSURGERY, V60, P1050, DOI 10.1227/01.NEU.0000255479.90999.C0; Cavanaugh JT, 2005, BRIT J SPORT MED, V39, P805, DOI 10.1136/bjsm.2004.015909; Cochrane JL, 2010, MED SCI SPORT EXER, V42, P1535, DOI 10.1249/MSS.0b013e3181d03ba0; Guskiewicz KM, 2011, PM&R, V3, pS445, DOI 10.1016/j.pmrj.2011.08.009; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; IBM Corp, 2010, REL 2010 IBM SPSS ST; Mansell JL, 2012, BRAIN INJURY, V24, P1070; Mayers LB, 2012, J CLIN EXP NEUROPSYC, V34, P235, DOI 10.1080/13803395.2011.630655; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; Register-Mihalik JK, 2008, NEUROSURGERY, V63, P76, DOI 10.1227/01.NEU.0000335073.39728.CE; Riemann BL, 1999, J SPORT REHABIL, V8, P71, DOI 10.1123/jsr.8.2.71; Slobounov S., 1994, GAIT POSTURE, V2, P85, DOI [10.1016/0966-6362(94)90097-3, DOI 10.1016/0966-6362(94)90097-3]; Slobounov S, 2008, CLIN NEUROPHYSIOL, V119, P281, DOI 10.1016/j.clinph.2007.10.006; Slobounov S, 2007, NEUROSURGERY, V61, P338, DOI 10.1227/01.NEU.0000280001.03578.FF; Slobounov S, 2006, CYBERPSYCHOL BEHAV, V9, P188, DOI 10.1089/cpb.2006.9.188; Slobounov S, 2006, NEUROSURGERY, V59, P134, DOI 10.1227/01.NEU.0000219197.33182.3F; Vaeyens R, 2007, J SPORT EXERCISE PSY, V29, P147, DOI 10.1123/jsep.29.2.147; Valovich TC, 2003, J ATHL TRAINING, V38, P51	19	18	18	1	13	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	MAR	2015	25	2					144	148		10.1097/JSM.0000000000000109			5	Orthopedics; Physiology; Sport Sciences	Orthopedics; Physiology; Sport Sciences	CD3RP	WOS:000350998200011	24905539	Green Accepted			2021-06-18	
J	Xu, L; Yu, WK; Lin, ZL; Tan, SJ; Bai, XW; Ding, K; Li, N				Xu, Lin; Yu, Wen-Kui; Lin, Zhi-Liang; Tan, Shan-Jun; Bai, Xiao-Wu; Ding, Kai; Li, Ning			Chemical sympathectomy attenuates inflammation, glycocalyx shedding and coagulation disorders in rats with acute traumatic coagulopathy	BLOOD COAGULATION & FIBRINOLYSIS			English	Article						catecholamine; chemical sympathectomy; coagulopathy; heart rate variability; hemorrhage; trauma	HEART-RATE-VARIABILITY; DIMINISHED PHYSIOLOGICAL RESERVE; TISSUE-PLASMINOGEN ACTIVATOR; ENDOTHELIAL GLYCOCALYX; NERVOUS-SYSTEM; BRAIN-INJURY; TNF-ALPHA; FIBRINOLYSIS; HYPERACTIVITY; DEGRADATION	Acute traumatic coagulopathy (ATC) may trigger sympathoadrenal activation associated with endothelial damage and coagulation disturbances. Overexcitation of sympathetic nerve in this state would disrupt sympathetic-vagal balance, leading to autonomic nervous system dysfunction. The aim of this study was to evaluate the autonomic function in ATC and its influence on inflammation, endothelial and coagulation activation. Male Sprague-Dawley rats were randomly assigned to sham, ATC control (ATCC) and ATC with sympathectomy by 6-hydroxydopamine (ATCS) group. Sham animals underwent the same procedure without trauma and bleeding. Following trauma and hemorrhage, rats underwent heart rate variability (HRV) test, which predicts autonomic dysfunction through the analysis of variation in individual R-R intervals. Then, rats were euthanized at baseline, and at 0, 1 and 2 h after shock and blood gas, conventional coagulation test and markers of inflammation, coagulation, fibrinolysis, endothelial damage and catecholamine were measured. HRV showed an attenuation of total power and high frequency, along with a rise of low frequency and low frequency : high frequency ratio in the ATC rats, which both were reversed by sympathectomy in the ATCS group. Additionally, sympathetic denervation significantly suppressed the increase of proinflammatory cytokines, tumor necrosis factor-a and the fibrinolysis markers including tissue-type plasminogen activator and plasmin-antiplasmin complex. Serum catecholamine, soluble thrombomodulin and syndecan-1 were also effectively inhibited by sympathectomy. These data indicated that autonomic dysfunction in ATC involves both sympathetic activation and parasympathetic inhibition. Moreover, sympathectomy yielded anti-inflammatory, antifibrinolysis and endothelial protective effects in rats with ATC. The role of autonomic neuropathy in ATC should be explored further. Copyright (C) 2015 Wolters Kluwer Health, Inc. All rights reserved.	[Xu, Lin; Yu, Wen-Kui; Lin, Zhi-Liang; Tan, Shan-Jun; Bai, Xiao-Wu; Ding, Kai; Li, Ning] Second Mil Med Univ, Clin Sch Nanjing, Res Inst Gen Surg, Jinling Hosp, Nanjing, Jiangsu, Peoples R China	Li, N (corresponding author), Jinling Hosp, Res Inst Gen Surg, 305 Zhong Shan East Rd, Nanjing 210002, Jiangsu, Peoples R China.	ning_liprof@126.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81270884]; 12th 5-year plan major project of PLA [WS12J001]; Jiangsu Province's Key Medical Talent Program of China [RC2011128]	Source of support: National Natural Science Foundation of China (nos. 81270884), the 12th 5-year plan major project of PLA (nos. WS12J001) and the Jiangsu Province's Key Medical Talent Program of China (nos. RC2011128).	Brohi K, 2007, ANN SURG, V245, P812, DOI 10.1097/01.sla.0000256862.79374.31; Chapman MP, 2013, J TRAUMA ACUTE CARE, V75, P961, DOI 10.1097/TA.0b013e3182aa9c9f; Chappell D, 2009, BASIC RES CARDIOL, V104, P78, DOI 10.1007/s00395-008-0749-5; Chaswal M, 2011, CAN J PHYSIOL PHARM, V89, P865, DOI [10.1139/Y11-084, 10.1139/y11-084]; Chesebro BB, 2009, SHOCK, V32, P659, DOI 10.1097/SHK.0b013e3181a5a632; Cohen MJ, 2013, J TRAUMA ACUTE CARE, V75, pS40, DOI 10.1097/TA.0b013e31828fa43d; Cooke WH, 2006, J TRAUMA, V60, P363, DOI 10.1097/01.ta.0000196623.48952.0e; da Silva VJD, 2012, EXP PHYSIOL, V97, P1143, DOI 10.1113/expphysiol.2011.061473; Darlington DN, 2013, SHOCK, V39, P440, DOI 10.1097/SHK.0b013e31829040e3; Esmon CT, 2005, BRIT J HAEMATOL, V131, P417, DOI 10.1111/j.1365-2141.2005.05753.x; Floccard B, 2012, INJURY, V43, P26, DOI 10.1016/j.injury.2010.11.003; Frith D, 2010, J THROMB HAEMOST, V8, P1919, DOI 10.1111/j.1538-7836.2010.03945.x; Heffernan DS, 2010, J TRAUMA, V69, P1602, DOI 10.1097/TA.0b013e3181f2d3e8; Hermann GE, 2008, NEUROSCIENTIST, V14, P53, DOI 10.1177/1073858407305725; Holcomb JB, 2008, ANN SURG, V248, P447, DOI 10.1097/SLA.0b013e318185a9ad; Jiang X, 2002, MICROVASC RES, V64, P438, DOI 10.1006/mvre.2002.2441; Johansson PI, 2011, ANN SURG, V254, P194, DOI 10.1097/SLA.0b013e318226113d; Johansson PI, 2012, J TRAUMA ACUTE CARE, V72, P428, DOI 10.1097/TA.0b013e31821e0f93; Kashuk JL, 2010, ANN SURG, V252, P434, DOI 10.1097/SLA.0b013e3181f09191; Kawada T, 2013, ACTA PHYSIOL, V209, P55, DOI 10.1111/apha.12123; Molina PE, 2005, SHOCK, V24, P3, DOI 10.1097/01.shk.0000167112.18871.5c; Morris JA, 2006, J TRAUMA, V60, P1165, DOI 10.1097/01.ta.0000220384.04978.3b; Norris PR, 2005, J SURG RES, V129, P122, DOI 10.1016/j.jss.2005.04.024; Ostrowski SR, 2012, J TRAUMA ACUTE CARE, V73, P60, DOI 10.1097/TA.0b013e31825b5c10; Patel MB, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-177; Picklo MJ, 1997, J AUTONOM NERV SYST, V62, P111, DOI 10.1016/S0165-1838(96)00121-X; Pierce A, 2014, CURR OPIN ANESTHESIO, V27, P246, DOI 10.1097/ACO.0000000000000047; Preckel Daniel, 2004, HeartDrug, V4, P123; Raza I, 2013, J THROMB HAEMOST, V11, P307, DOI 10.1111/jth.12078; Saeed RW, 2005, J EXP MED, V201, P1113, DOI 10.1084/jem.20040463; SAUAIA A, 1995, J TRAUMA, V38, P185, DOI 10.1097/00005373-199502000-00006; Wang Y, 2002, BLOOD COAGUL FIBRIN, V13, P471, DOI 10.1097/00001721-200209000-00001; Winchell RJ, 2006, J TRAUMA, V60, P1173; Yamakawa K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056728	34	18	19	0	13	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0957-5235	1473-5733		BLOOD COAGUL FIBRIN	Blood Coagul. Fibrinolysis	MAR	2015	26	2					152	160		10.1097/MBC.0000000000000211			9	Hematology	Hematology	CA6GC	WOS:000349007300006	25325345				2021-06-18	
J	Yousefzadeh-Chabok, S; Moghaddam, AD; Kazemnejad-Leili, E; Saneei, Z; Hosseinpour, M; Kouchakinejad-Eramsadati, L; Razzaghi, A; Mohtasham-Amiri, Z				Yousefzadeh-Chabok, Sharhokh; Moghaddam, Anoush Dehnadi; Kazemnejad-Leili, Ehsan; Saneei, Zahra; Hosseinpour, Marieh; Kouchakinejad-Eramsadati, Leila; Razzaghi, Alireza; Mohtasham-Amiri, Zahra			The Relationship Between Serum Levels of Interleukins 6, 8, 10 and Clinical Outcome in Patients With Severe Traumatic Brain Injury	ARCHIVES OF TRAUMA RESEARCH			English	Article						Head Injury; Interleukin; Brain	EXCITATORY AMINO-ACIDS; CEREBROSPINAL-FLUID; HEAD-INJURY; CHILDREN; CYTOKINES; PLASMA; IL-6	Background: Clinical outcome in patients with severe traumatic brain injury (TBI) depends on both primary and secondary brain injuries. Neuroinflammation is an important secondary mechanism, which occurs by releasing interleukins (ILs). Increased levels of ILs may affect clinical outcome following TBI. Objectives: This study aimed to determine the relationship between the serum levels of interleukins 6, 8 and 10 and clinical outcome in patients with severe TBI 6 months after injury. Patients and Methods: In a descriptive-analytical study, 44 patients with GCS <= 8 (Glasgow coma scale) and age >= 14 years were included. Their blood samples were collected at first 6 hours after injury. Clinical outcome was determined based on GOS (Glasgow Outcome Scale) at 6 months after head injury. Serum levels of interleukins 6, 8 and 10 were measured using the ELISA method. Spearman's rho, independent T-Test, and Mann-Whitney Test were used for data analysis. Results: Comparing the serum levels of interleukins in two groups with favorable and unfavorable clinical outcomes showed that the mean serum levels of interleukins 6 and 8 in group with favorable outcome was 85.2 +/- 51.6 and 52.2 +/- 31.9, respectively lower than those of group with unfavorable outcome with 162.3 +/- 141.1 and 173.6 +/- 257.3 (P < 0.03) and (P < 0.01). Conclusions: Increased serum levels of interleukins 6 and 8 as a predictive marker might be associated with unfavorable clinical outcome in patients with severe TBI.	[Yousefzadeh-Chabok, Sharhokh] Guilan Univ Med Sci, Guilan Rd Trauma Res Ctr, Neurosurg Dept, Rasht, Iran; [Moghaddam, Anoush Dehnadi] Guilan Univ Med Sci, Guilan Rd Trauma Res Ctr, Anesthesiol Dept, Rasht, Iran; [Kazemnejad-Leili, Ehsan] Guilan Univ Med Sci, Guilan Rd Trauma Res Ctr, Biostat Dept, Rasht, Iran; [Saneei, Zahra; Hosseinpour, Marieh; Razzaghi, Alireza; Mohtasham-Amiri, Zahra] Guilan Univ Med Sci, Guilan Rd Trauma Res Ctr, Rasht, Iran; [Kouchakinejad-Eramsadati, Leila] Guilan Univ Med Sci, Guilan Rd Trauma Res Ctr, Human Resource Management, Rasht, Iran	Mohtasham-Amiri, Z (corresponding author), Guilan Univ Med Sci, Guilan Rd Trauma Res Ctr, Rasht, Iran.	mohtasham@gums.ac.ir	Mohtasham-Amiri, Zahra/C-4469-2012; Razzaghi, Alireza/E-6855-2018; Kazemnezhad Leyli, Ehsan/S-2292-2017	Mohtasham-Amiri, Zahra/0000-0002-4896-6248; Razzaghi, Alireza/0000-0003-1874-6364; Kazemnezhad Leyli, Ehsan/0000-0002-9195-9094; Dehnadi Moghadam, Anoush/0000-0002-8408-2909			Antunes Alessandra Armstrong, 2010, Asian J Neurosurg, V5, P68; Chiaretti A, 2005, CHILD NERV SYST, V21, P185, DOI 10.1007/s00381-004-1032-1; Chiaretti A, 2008, J NEUROTRAUM, V25, P225, DOI 10.1089/neu.2007.0405; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; GENTILE NT, 1993, ANN EMERG MED, V22, P1028, DOI 10.1016/S0196-0644(05)82746-5; Goodman JC, 2008, ACTA NEUROCHIR SUPPL, V102, P437, DOI 10.1007/978-3-211-85578-2_85; Hall ED, 2004, J NEUROTRAUM, V21, P9, DOI 10.1089/089771504772695904; Hayakata T, 2004, SHOCK, V22, P102, DOI 10.1097/01.shk.0000131193.80038.f1; Hopkins SJ, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-255; Kalabalikis P, 1999, INTENS CARE MED, V25, P288, DOI 10.1007/s001340050837; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Maier B, 2001, SHOCK, V15, P421, DOI 10.1097/00024382-200115060-00002; McIntosh TK, 1996, LAB INVEST, V74, P315; Morganti-Kossmann MC, 2007, INJURY, V38, P1392, DOI 10.1016/j.injury.2007.10.005; Morganti-Kossmann MC, 2001, SHOCK, V16, P165, DOI 10.1097/00024382-200116030-00001; Mukherjee S, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00021; Myburgh JA, 2008, J TRAUMA, V64, P854, DOI 10.1097/TA.0b013e3180340e77; Oda S, 2005, CYTOKINE, V29, P169, DOI 10.1016/j.cyto.2004.10.010; ROUMEN RMH, 1993, ANN SURG, V218, P769, DOI 10.1097/00000658-199312000-00011; Shiozaki T, 2005, SHOCK, V23, P406, DOI 10.1097/01.shk.0000161385.62758.24; Singhal A, 2002, J NEUROTRAUM, V19, P929, DOI 10.1089/089771502320317087; Whalen MJ, 2000, CRIT CARE MED, V28, P929, DOI 10.1097/00003246-200004000-00003; Winter CD, 2004, BRAIN, V127, P315, DOI 10.1093/brain/awh039; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	25	18	18	0	4	KASHAN UNIV MEDICAL SCIENCES	KASHAN	PO BOX 87159-88141, KASHAN, REPUBLIC ISLAMIC 00000, IRAN	2251-953X	2251-9599		ARCH TRAUMA RES	Arch. Trauma Res.	MAR	2015	4	1							e18357	10.5812/atr.18357			4	Orthopedics	Orthopedics	CP9GI	WOS:000360201400002	26064865	Bronze, Green Published			2021-06-18	
J	Nichol, A; French, C; Little, L; Presneill, J; Cooper, DJ; Haddad, S; Duranteau, J; Huet, O; Skrifvars, M; Arabi, Y; Bellomo, R				Nichol, Alistair; French, Craig; Little, Lorraine; Presneill, Jeffrey; Cooper, D. James; Haddad, Samir; Duranteau, Jacques; Huet, Olivier; Skrifvars, Markus; Arabi, Yaseen; Bellomo, Rinaldo		EPO-TBI Investigators; New Zealand Intensive Care Soc	Erythropoietin in traumatic brain injury: study protocol for a randomised controlled trial	TRIALS			English	Article						Traumatic brain injury; Erythropoietin; Outcome; Critical care; Randomised controlled trials	RECOMBINANT-HUMAN-ERYTHROPOIETIN; GLASGOW OUTCOME SCALE; QUALITY-OF-LIFE; CRITICALLY-ILL; BLOOD-TRANSFUSION; EPOETIN-ALPHA; ANEMIA; EFFICACY	Background: Traumatic brain injury is a leading cause of death and disability worldwide. Laboratory and clinical studies demonstrate a possible beneficial effect of erythropoietin in improving outcomes in the traumatic brain injury cohort. However, there are concerns regarding the association of erythropoietin and thrombosis in the critically ill. A large-scale, multi-centre, blinded, parallel-group, placebo-controlled, randomised trial is currently underway to address this hypothesis. Methods/design: The erythropoietin in traumatic brain injury trial is a stratified prospective, multi-centre, randomised, blinded, parallel-group, placebo-controlled phase III trial. It aims to determine whether the administration of erythropoietin compared to placebo improves neurological outcome in patients with moderate or severe traumatic brain injury at six months after injury. The trial is designed to recruit 606 patients between 15 and 65 years of age with severe (Glasgow Coma Score: 3 to 8) or moderate (Glasgow Coma Score: 9 to 12) traumatic brain injury in Australia, New Zealand, Kingdom of Saudi Arabia, France, Finland, Germany and Ireland. Trial patients will receive either subcutaneous erythropoietin or placebo within 24 hours of injury, and weekly thereafter for up to three doses during the intensive care unit admission. The primary outcome will be the combined proportion of unfavourable neurological outcomes at six months: severe disability or death. Secondary outcomes will include the rate of proximal deep venous thrombosis detected by compression Doppler ultrasound, six-month mortality, the proportion of patients with composite vascular events (deep venous thrombosis, pulmonary embolism, myocardial infarction, cardiac arrest and cerebrovascular events) at six months and quality of life with health economic evaluations. Discussion: When completed, the trial aims to provide evidence on the efficacy and safety of erythropoietin in traumatic brain injury patients, and to provide clear guidance for clinicians in their management of this devastating condition.	[Nichol, Alistair; Little, Lorraine; Presneill, Jeffrey; Cooper, D. James; Haddad, Samir; Duranteau, Jacques; Arabi, Yaseen; Bellomo, Rinaldo] Monash Univ, Sch Publ Hlth & Prevent Med, Australian & New Zealand Intens Care Res Ctr, Melbourne, Vic 3004, Australia; [Nichol, Alistair; Cooper, D. James] The Alfred, Dept Intens Care Med, Melbourne, Vic 3004, Australia; [Nichol, Alistair] St Vincents Univ Hosp, Dept Anaesthesia & Intens Care Med, Dublin 4, Ireland; [Nichol, Alistair] Univ Coll Dublin, Sch Med & Med Sci, Dublin 4, Ireland; [French, Craig] Western Hlth, Dept Intens Care, Footscray, Vic 3011, Australia; [French, Craig] Univ Melbourne, North West Acad Ctr, Dept Med, Parkville, Vic 3052, Australia; [Presneill, Jeffrey] Mater Hlth Serv, Dept Intens Care, South Brisbane, Qld 4101, Australia; [Haddad, Samir] King Abdul Aziz Med City, Dept Intens Care, Riyadh 11426, Saudi Arabia; [Duranteau, Jacques] Hop Univ Paris Sud, Hop Bicetre, Assistance Publ Hop Paris, Serv Anesthesie Reanimat, F-94275 Le Kremlin Bicetre, France; [Huet, Olivier] Univ Bretagne Ouest, Ctr Hosp Univ Cavale Blanche, Dept Anesthesiol & Intens Care Med, F-29609 Brest, France; [Skrifvars, Markus] Helsinki Univ Hosp, Dept Anaesthesiol & Intens Care Med, FIN-00029 Helsinki, Finland; [Arabi, Yaseen] King Saud Bin Abdulaziz Univ Hlth Sci, Coll Med, Intens Care Dept, Riyadh 11426, Saudi Arabia; [Arabi, Yaseen] King Abdullah Int Med Res Ctr, Riyadh 11426, Saudi Arabia; [Bellomo, Rinaldo] Austin Hlth, Dept Intens Care, Heidelberg, Vic 3084, Australia	Bellomo, R (corresponding author), Monash Univ, Sch Publ Hlth & Prevent Med, Australian & New Zealand Intens Care Res Ctr, 99 Commercial Rd, Melbourne, Vic 3004, Australia.	rinaldo.bellomo@austin.org.au	Arabi, Yaseen/ABF-3316-2020; Presneill, Jeffrey J/B-4894-2012; French, Craig/ABF-5087-2020; Cooper, D. James/G-7961-2013	Arabi, Yaseen/0000-0001-5735-6241; Presneill, Jeffrey J/0000-0001-7177-7667; French, Craig/0000-0003-1363-9711; Cooper, D. James/0000-0002-5872-9051; Nichol, Alistair Dualta/0000-0002-4771-5615; Nichol, Alistair/0000-0002-4689-1238; Bellomo, Rinaldo/0000-0002-1650-8939; Huet, Olivier/0000-0001-7345-0334	Australian National Health and Medical Research Council ProjectNational Health and Medical Research Council of Australia [545901]; Victorian Transport Accident Commission [D162]	EPO-TBI is funded by the Australian National Health and Medical Research Council Project (project grant ID 545901), and the Victorian Transport Accident Commission (project grant ID D162 - formerly, the Victorian Neurotrauma Initiative). The cost of Epoetin alfa was reimbursed to hospital pharmacy departments by using project grant funds. Neither funding agencies nor the manufacturer of Epoetin alfa had any role in the trial design, data collection or analysis. EPO-TBI trial is coordinated by the Australian and New Zealand Intensive Care Research Centre (ANZIC-RC), Monash University, Melbourne, Australia and endorsed by the Australian and New Zealand Intensive Care Society Clinical Trials Group (ANZICS CTG) and the Irish Critical Care Trials Group. The members of Management Committee are listed in Appendix 3	Abrishamkar S, 2012, J RES MED SCI, V17, P51; [Anonymous], 2009, EC COST SPINAL CORD, P1; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Bullinger M, 2002, RESTOR NEUROL NEUROS, V20, P111; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Coleman T, 2004, CRIT CARE, V8, P337, DOI 10.1186/cc2897; Cook D, 2008, CAN MED ASSOC J, V178, P1181, DOI 10.1503/cmaj.071366; Cook DJ, 2005, J CRIT CARE, V20, P364, DOI 10.1016/j.jcrc.2005.09.010; Corwin HL, 2002, JAMA-J AM MED ASSOC, V288, P2827, DOI 10.1001/jama.288.22.2827; Corwin HL, 2004, CRIT CARE MED, V32, P39, DOI 10.1097/01.CCM.0000104112.34142.79; Corwin HL, 2007, NEW ENGL J MED, V357, P965, DOI 10.1056/NEJMoa071533; Cummings P, 2014, BMJ-BRIT MED J, V348; Dijkers MP, 2004, ARCH PHYS MED REHAB, V85, pS21, DOI 10.1016/j.apmr.2003.08.119; EuroQol Group, 2014, EQ 5D INSTR DESCR VA; Fergusson D, 2002, BMJ-BRIT MED J, V325, P652, DOI 10.1136/bmj.325.7365.652; Grant RL, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.f7450; Hosmer DW., 2013, APPL LOGISTIC REGRES, V3rd ed.; Jennison C, 2000, GROUP SEQUENTIAL MET; Lu DY, 2005, J NEUROTRAUM, V22, P1011, DOI 10.1089/neu.2005.22.1011; Lykissas MG, 2007, CLIN NEUROL NEUROSUR, V109, P639, DOI 10.1016/j.clineuro.2007.05.013; Marshall LF, J NEUROTRAUMA; Myburgh J, 2007, NEW ENGL J MED, V357, P874; Myburgh JA, 2008, J TRAUMA, V64, P854, DOI 10.1097/TA.0b013e3180340e77; Norton EC, 2013, STATA J, V13, P492, DOI 10.1177/1536867X1301300304; Perner A, 2012, NEW ENGL J MED, V367, P124, DOI 10.1056/NEJMoa1204242; Roozenbeek B, 2011, CRIT CARE, V15, DOI 10.1186/cc10240; Singh AK, 2006, NEW ENGL J MED, V355, P2085, DOI 10.1056/NEJMoa065485; Talving P, 2012, ARCH SURG-CHICAGO, V147, P251, DOI 10.1001/archsurg.2011.1838; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Tonia T, 2012, COCHRANE DB SYST REV, V12, DOI DOI 10.1002/14651858.CD003407.PUB5; Vincent JL, 2002, JAMA-J AM MED ASSOC, V288, P1499, DOI 10.1001/jama.288.12.1499; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Yatsiv I, 2005, FASEB J, V19, P1701, DOI 10.1096/fj.05-3907fje	34	18	19	0	4	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1745-6215		TRIALS	Trials	FEB 8	2015	16								39	10.1186/s13063-014-0528-6			10	Medicine, Research & Experimental	Research & Experimental Medicine	CB9BT	WOS:000349927000001	25884605	DOAJ Gold, Green Published			2021-06-18	
J	Chohan, MO; Bragina, O; Kazim, SF; Statom, G; Baazaoui, N; Bragin, D; Iqbal, K; Nemoto, E; Yonas, H				Chohan, Muhammad Omar; Bragina, Olga; Kazim, Syed Faraz; Statom, Gloria; Baazaoui, Narjes; Bragin, Denis; Iqbal, Khalid; Nemoto, Edwin; Yonas, Howard			Enhancement of Neurogenesis and Memory by a Neurotrophic Peptide in Mild to Moderate Traumatic Brain Injury	NEUROSURGERY			English	Article						Ciliary neurotrophic factor; Dentate gyrus; Memory; Neurogenesis; Neural stem cells; Therapeutics; Traumatic brain injury	ADULT HIPPOCAMPAL NEUROGENESIS; DENTATE GYRUS NEUROGENESIS; LATERAL FLUID PERCUSSION; FIBROBLAST-GROWTH-FACTOR; FOOTBALL-LEAGUE PLAYER; ALZHEIMERS-DISEASE; COGNITIVE RECOVERY; MOUSE MODEL; RISK-FACTOR; REGIONAL DIFFERENCES	BACKGROUND: Traumatic brain injury (TBI) is a risk factor for Alzheimer disease (AD), a neurocognitive disorder with similar cellular abnormalities. We recently discovered a small molecule (Peptide 6) corresponding to an active region of human ciliary neurotrophic factor, with neurogenic and neurotrophic properties in mouse models of AD and Down syndrome. OBJECTIVE: To describe hippocampal abnormalities in a mouse model of mild to moderate TBI and their reversal by Peptide 6. METHODS: TBI was induced in adult C57Bl6 mice using controlled cortical impact with 1.5 mm of cortical penetration. The animals were treated with 50 nmol/d of Peptide 6 or saline solution for 30 days. Dentate gyrus neurogenesis, dendritic and synaptic density, and AD biomarkers were quantitatively analyzed, and behavioral tests were performed. RESULTS: Ipsilateral neuronal loss in CA1 and the parietal cortex and increase in Alzheimer-type hyperphosphorylated tau and A-beta were seen in TBI mice. Compared with saline solution, Peptide 6 treatment increased the number of newborn neurons, but not uncommitted progenitor cells, in dentate gyrus by 80%. Peptide 6 treatment also reversed TBI-induced dendritic and synaptic density loss while increasing activity in trisynaptic hippocampal circuitry, ultimately leading to improvement in memory recall on behavioral testing. CONCLUSION: Long-term treatment with Peptide 6 enhances the pool of newborn neurons in the dentate gyrus, prevents neuronal loss in CA1 and parietal cortex, preserves the dendritic and synaptic architecture in the hippocampus, and improves performance on a hippocampus-dependent memory task in TBI mice. These findings necessitate further inquiry into the therapeutic potential of small molecules based on neurotrophic factors.	[Chohan, Muhammad Omar; Bragina, Olga; Statom, Gloria; Bragin, Denis; Nemoto, Edwin; Yonas, Howard] Univ New Mexico Hosp, Dept Neurosurg, Albuquerque, NM USA; [Kazim, Syed Faraz; Baazaoui, Narjes; Iqbal, Khalid] New York State Inst Basic Res Dev Disabil, Dept Neurochem, Staten Isl, NY 10314 USA; [Kazim, Syed Faraz] Suny Downstate Med Ctr, Neural & Behav Sci Grad Program, Brooklyn, NY 11203 USA	Chohan, MO (corresponding author), 1 Univ New Mexico, Dept Neurosurg, MSC 10-5615, Albuquerque, NM 87131 USA.	mchohan@salud.unm.edu	Bragin, Denis/E-5494-2016; Bragina, Olga A/H-6696-2016	Bragin, Denis/0000-0003-4894-0061; Chohan, Muhammad/0000-0003-4542-4651; Bragina, Olga A/0000-0003-2810-9764	Dedicated Health Research Funds from the University of New Mexico; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P20GM109089, P30GM103400] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS091600] Funding Source: NIH RePORTER	The authors have no personal, financial, or institutional interest in any of the drugs, materials, or devices described in this article. This study was supported in part by Dedicated Health Research Funds from the University of New Mexico.	Acosta SA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090953; Acosta SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053376; AITKEN PG, 1986, NEUROSCI LETT, V67, P92, DOI 10.1016/0304-3940(86)90215-6; Bauer S, 2006, J NEUROSCI, V26, P12089, DOI 10.1523/JNEUROSCI.3047-06.2006; Blanchard J, 2011, J NEUROPATH EXP NEUR, V70, P1070, DOI 10.1097/NEN.0b013e318236e9ad; Blanchard J, 2010, ACTA NEUROPATHOL, V120, P605, DOI 10.1007/s00401-010-0734-6; Bonaguidi MA, 2005, DEVELOPMENT, V132, P5503, DOI 10.1242/dev.02166; Chauhan NB, 2014, RESTOR NEUROL NEUROS, V32, P337, DOI 10.3233/RNN-130354; Chen HH, 2007, NEUROBIOL AGING, V28, P1148, DOI 10.1016/j.neurobiolaging.2006.05.036; Chen LJ, 2010, J NEUROTRAUM, V27, P1657, DOI 10.1089/neu.2010.1308; Chen ZY, 2001, CURR PROTEIN PEPT SC, V2, P261, DOI 10.2174/1389203013381125; Chiaretti A, 2003, INTENS CARE MED, V29, P1329, DOI 10.1007/s00134-003-1852-6; Chirumamilla S, 2002, J NEUROTRAUM, V19, P693, DOI 10.1089/08977150260139084; Chohan MO, 2005, J NEURAL TRANSM, V112, P1035, DOI 10.1007/s00702-004-0241-9; Chohan MO, 2011, NEUROBIOL AGING, V32, P1420, DOI 10.1016/j.neurobiolaging.2009.08.008; CREPEL V, 1992, NEUROSCIENCE, V47, P579, DOI 10.1016/0306-4522(92)90167-Z; Dash PK, 2001, J NEUROSCI RES, V63, P313, DOI 10.1002/1097-4547(20010215)63:4<313::AID-JNR1025>3.0.CO;2-4; Deng W, 2010, NAT REV NEUROSCI, V11, P339, DOI 10.1038/nrn2822; Dodart JC, 2002, GENES BRAIN BEHAV, V1, P142, DOI 10.1034/j.1601-183X.2002.10302.x; Donovan MH, 2006, J COMP NEUROL, V495, P70, DOI 10.1002/cne.20840; Duan X, 2007, CELL, V130, P1146, DOI 10.1016/j.cell.2007.07.010; Emerich DF, 2006, CURR GENE THER, V6, P147, DOI 10.2174/156652306775515547; Emsley JG, 2003, EXP NEUROL, V183, P298, DOI 10.1016/S0014-4886(03)00129-8; Exo JL, 2009, J NEUROTRAUM, V26, P2403, DOI 10.1089/neu.2009.0980; Fahnestock M, 2001, MOL CELL NEUROSCI, V18, P210, DOI 10.1006/mcne.2001.1016; Fakhran S, 2013, RADIOLOGY, V269, P249, DOI 10.1148/radiol.13122343; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Finkelstein EA., 2006, INCIDENCE EC BURDEN; Florian C, 2004, BEHAV BRAIN RES, V154, P365, DOI 10.1016/j.bbr.2004.03.003; GAO X, 2011, PLOS ONE, P6; Gao X, 2013, EXP NEUROL, V239, P38, DOI 10.1016/j.expneurol.2012.09.012; Gao X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024566; Gao X, 2009, EXP NEUROL, V219, P516, DOI 10.1016/j.expneurol.2009.07.007; Guzowski JF, 2005, CURR OPIN NEUROBIOL, V15, P599, DOI 10.1016/j.conb.2005.08.018; Hicks RR, 1997, MOL CHEM NEUROPATHOL, V32, P1, DOI 10.1007/BF02815164; Hicks RR, 1997, MOL BRAIN RES, V48, P401, DOI 10.1016/S0169-328X(97)00158-7; Hill-Felberg SJ, 1999, J NEUROSCI RES, V57, P271, DOI 10.1002/(SICI)1097-4547(19990715)57:2<271::AID-JNR13>3.0.CO;2-Z; Hock C, 2000, ARCH NEUROL-CHICAGO, V57, P846, DOI 10.1001/archneur.57.6.846; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; INOUE M, 1995, P NATL ACAD SCI USA, V92, P8579, DOI 10.1073/pnas.92.19.8579; Jain KK, 2008, DRUG DISCOV TODAY, V13, P1082, DOI 10.1016/j.drudis.2008.09.006; Jellinger KA, 2004, J NEUROL NEUROSUR PS, V75, P511; Jessberger S, 2003, EUR J NEUROSCI, V18, P2707, DOI 10.1111/j.1460-9568.2003.02986.x; Jiang T, 2013, CURR ALZHEIMER RES, V10, P852; KASS IS, 1986, J PHYSIOL-LONDON, V378, P313, DOI 10.1113/jphysiol.1986.sp016221; Kazim SF, 2014, NEUROBIOL DIS, V71, P110, DOI 10.1016/j.nbd.2014.07.001; Kempermann G, 2003, DEVELOPMENT, V130, P391, DOI 10.1242/dev.00203; Kleindienst A, 2005, J NEUROTRAUM, V22, P645, DOI 10.1089/neu.2005.22.645; Kleindienst A, 2004, J NEUROTRAUM, V21, P541, DOI 10.1089/089771504774129874; KOTAPKA MJ, 1994, J NEUROTRAUM, V11, P317, DOI 10.1089/neu.1994.11.317; Kreisman NR, 2000, J NEUROPHYSIOL, V83, P1031; Laeremans A, 2014, BRAIN STRUCT FUNCT; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lewis J, 2000, NAT GENET, V25, P402; Lu DY, 2005, J NEUROTRAUM, V22, P1011, DOI 10.1089/neu.2005.22.1011; Lu XCM, 2009, J NEUROTRAUM, V26, P141, DOI 10.1089/neu.2008.0629; Lye TC, 2000, NEUROPSYCHOL REV, V10, P115, DOI 10.1023/A:1009068804787; Magen I, 2014, CURR MED CHEM, V21, P2591, DOI 10.2174/0929867321666140217124945; Margulies S, 2009, J NEUROTRAUM, V26, P925, DOI [10.1089/neu.2008.0794, 10.1089/neu.2008-0794]; Masliah E, 1996, J NEUROSCI, V16, P5795; Miller RG, 2004, AMYOTROPH LATERAL SC, V5, P121, DOI 10.1080/17434470410019988; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Oyesiku NM, 1999, BRAIN RES, V833, P161, DOI 10.1016/S0006-8993(99)01501-2; Posmantur RM, 1996, J NEUROTRAUM, V13, P125, DOI 10.1089/neu.1996.13.125; Price RD, 2007, PHARMACOL THERAPEUT, V115, P292, DOI 10.1016/j.pharmthera.2007.03.005; Riedel G, 1999, NAT NEUROSCI, V2, P898; Rola R, 2006, EXP NEUROL, V202, P189, DOI 10.1016/j.expneurol.2006.05.034; Saatman KE, 2006, J NEUROTRAUM, V23, P1241, DOI 10.1089/neu.2006.23.1241; SCHMIDTKASTNER R, 1991, NEUROSCIENCE, V40, P599, DOI 10.1016/0306-4522(91)90001-5; Shimazaki T, 2001, J NEUROSCI, V21, P7642; Sivanandam TM, 2012, NEUROSCI BIOBEHAV R, V36, P1376, DOI 10.1016/j.neubiorev.2012.02.013; Small GW, 2013, AM J GERIAT PSYCHIAT, V21, P138, DOI 10.1016/j.jagp.2012.11.019; Snyder JS, 2009, J NEUROSCI, V29, P14484, DOI 10.1523/JNEUROSCI.1768-09.2009; STOPA EG, 1990, BIOCHEM BIOPH RES CO, V171, P690, DOI 10.1016/0006-291X(90)91201-3; Sun D, 2009, EXP NEUROL, V216, P56, DOI 10.1016/j.expneurol.2008.11.011; Tatebayashi Y, 2003, ACTA NEUROPATHOL, V105, P225, DOI 10.1007/s00401-002-0636-3; Tatebayashi Y, 2002, P NATL ACAD SCI USA, V99, P13896, DOI 10.1073/pnas.202205599; Truettner J, 1999, J NEUROTRAUM, V16, P471, DOI 10.1089/neu.1999.16.471; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; Williams S, 2001, ACTA NEUROPATHOL, V102, P581, DOI 10.1007/s004010100410; Yang K, 1996, J NEUROSCI RES, V44, P157, DOI 10.1002/(SICI)1097-4547(19960415)44:2<157::AID-JNR8>3.0.CO;2-C; Yang P, 2008, J NEUROSCI, V28, P2231, DOI 10.1523/JNEUROSCI.3574-07.2008; Yoshimura S, 2003, J CLIN INVEST, V112, P1202, DOI 10.1172/JCI200316618; Yoshimura S, 2001, P NATL ACAD SCI USA, V98, P5874, DOI 10.1073/pnas.101034998; Zhou HZ, 2012, J NEUROPATH EXP NEUR, V71, P348, DOI 10.1097/NEN.0b013e31824ea078	88	18	19	0	17	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	FEB	2015	76	2					201	214		10.1227/NEU.0000000000000577			14	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	AZ3SR	WOS:000348147500039	25255260	Green Accepted			2021-06-18	
J	Gan, M; Moussaud, S; Jiang, PZ; McLean, PJ				Gan, Ming; Moussaud, Simon; Jiang, Peizhou; McLean, Pamela J.			Extracellular ATP induces intracellular alpha-synuclein accumulation via P2X1 receptor-mediated lysosomal dysfunction	NEUROBIOLOGY OF AGING			English	Article						Alpha-synuclein; ATP; Luhmes cells; P2X1 receptor; Parkinson's disease; Purinergic signaling	TRAUMATIC BRAIN-INJURY; PARKINSONS-DISEASE; NEURODEGENERATIVE DISEASES; CEREBRAL-ISCHEMIA; IN-VIVO; CELLS; OLIGOMERS; INFLAMMATION; ACTIVATION; ADENOSINE	The pathologic hallmark of Parkinson's disease (PD) is the accumulation of alpha-synuclein (alpha syn) in susceptible neurons in the form of Lewy bodies and Lewy neurites. The etiology of PD remains unclear. Because brain injury has been suggested to facilitate alpha syn aggregation, we investigated whether cellular breakdown products from damaged cells can act on neighboring healthy cells and cause intracellular alpha syn accumulation and/or aggregation. Using 2 neuronal cell models, we found that extracellular adenosine triphosphate (ATP) induced a significant increase in intracellular alpha syn levels between 24 and 48 hours after treatment. Further investigation revealed that the observed alpha syn accumulation is a result of lysosome dysfunction caused by extracellular ATP-induced elevation of lysosomal pH. Interestingly, P2X1 receptor appears to mediate the cells' response to extracellular ATP. Although Ca2+ influx via P2X1 receptor is necessary for alpha syn accumulation, Ca2+ influx per se is not sufficient for increased alpha syn accumulation. These findings provide new insight into our knowledge of the role of P2X receptors in PD pathogenesis and may be helpful in identifying new therapeutic targets for PD. (C) 2015 Elsevier Inc. All rights reserved.	[Gan, Ming; Moussaud, Simon; Jiang, Peizhou; McLean, Pamela J.] Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA; [McLean, Pamela J.] Mayo Clin, Mayo Grad Sch, Jacksonville, FL USA	McLean, PJ (corresponding author), Mayo Clin, Dept Neurosci, 4500 San Pablo Rd, Jacksonville, FL 32224 USA.	mclean.pamela@mayo.edu		McLean, Pamela/0000-0003-4870-5715; Moussaud, Simon/0000-0002-6340-9511	NIH NS [073740]; Mayo Clinic; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS073740] Funding Source: NIH RePORTER	This work was supported by NIH NS 073740 (Pamela J. McLean) and the Mayo Clinic. The authors thank Ann-Marie Baine for excellent technical assistance.	Apolloni S, 2009, FEBS J, V276, P354, DOI 10.1111/j.1742-4658.2008.06796.x; Bours Martijn Jan Leo, 2011, Front Biosci (Schol Ed), V3, P1443; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Bramlett HM, 2003, EXP NEUROL, V184, P27, DOI 10.1016/S0014-4886(03)00401-1; Clark RSB, 1997, J NEUROSCI, V17, P9172; Danzer KM, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-42; Danzer KM, 2011, FASEB J, V25, P326, DOI 10.1096/fj.10-164624; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Di Virgilio F, 2003, DRUG DEVELOP RES, V59, P171, DOI 10.1002/ddr.10191; Di Virgilio F, 2000, J AUTONOM NERV SYST, V81, P59, DOI 10.1016/S0165-1838(00)00114-4; Diaz-Hernandez M, 2009, FASEB J, V23, P1893, DOI 10.1096/fj.08-122275; Ebrahimi-Fakhari D, 2011, J NEUROSCI, V31, P14508, DOI 10.1523/JNEUROSCI.1560-11.2011; Falzoni S, 2013, INTERFACE FOCUS, V3, DOI 10.1098/rsfs.2012.0101; Gourine AV, 2007, J PHYSIOL-LONDON, V585, P305, DOI 10.1113/jphysiol.2007.143933; Greco NJ, 2001, BLOOD, V98, P100, DOI 10.1182/blood.V98.1.100; Guha S, 2013, FASEB J, V27, P4500, DOI 10.1096/fj.13-236166; Hirsch Etienne C, 2012, Parkinsonism Relat Disord, V18 Suppl 1, pS210, DOI 10.1016/S1353-8020(11)70065-7; Hodges RR, 2011, INVEST OPHTH VIS SCI, V52, P3254, DOI 10.1167/iovs.10-7042; Hracsko Z, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-28; Inscho EW, 1999, HYPERTENSION, V33, P195, DOI 10.1161/01.HYP.33.1.195; Iyer SS, 2009, P NATL ACAD SCI USA, V106, P20388, DOI 10.1073/pnas.0908698106; Jafari S, 2013, MOVEMENT DISORD, V28, P1222, DOI 10.1002/mds.25458; Jellinger KA, 2012, J CELL MOL MED, V16, P1166, DOI 10.1111/j.1582-4934.2011.01507.x; Jiang PZ, 2013, NEUROBIOL AGING, V34, P1504, DOI 10.1016/j.neurobiolaging.2012.11.001; Jin QH, 2004, CELL MOL LIFE SCI, V61, P1816, DOI 10.1007/s00018-004-4143-7; Kawamura H, 2012, IMMUNOLOGY, V136, P448, DOI 10.1111/j.1365-2567.2012.03601.x; Kew JNC, 2010, ION CHANNELS STRUCTU; Korngreen A, 1996, J PHYSIOL-LONDON, V497, P53, DOI 10.1113/jphysiol.1996.sp021749; Kurashima Y, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2023; Lee PC, 2012, NEUROLOGY, V79, P2061, DOI 10.1212/WNL.0b013e3182749f28; Liu J, 2014, MOL BRAIN, V7, DOI 10.1186/1756-6606-7-6; Lotharius J, 2005, J NEUROSCI, V25, P6329, DOI 10.1523/JNEUROSCI.1746-05.2005; North RA, 2013, MOL PHARMACOL, V83, P759, DOI 10.1124/mol.112.083758; Planchard MS, 2014, PROTEIN SCI, V23, P1369, DOI 10.1002/pro.2521; Prasai P, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-90; Prots I, 2013, J BIOL CHEM, V288, P21742, DOI 10.1074/jbc.M113.451815; Putcha P, 2010, J PHARMACOL EXP THER, V332, P849, DOI 10.1124/jpet.109.158436; Rettinger J, 2003, J GEN PHYSIOL, V121, P451, DOI 10.1085/jgp.200208730; Rodriguez-Grande B, 2013, BRAIN BEHAV IMMUN, V29, P51, DOI 10.1016/j.bbi.2012.11.017; Ryu JK, 2008, NEUROREPORT, V19, P1715, DOI 10.1097/WNR.0b013e3283179333; Schildknecht S, 2009, J NEUROCHEM, V110, P13; Schildknecht S, 2013, ALTEX-ALTERN ANIM EX, V30, P427, DOI 10.14573/altex.2013.4.427; Seminario-Vidal L, 2009, METHODS MOL BIOL, V574, P25, DOI 10.1007/978-1-60327-321-3_3; Sperlagh B, 2011, CURR TOP MED CHEM, V11, P1034, DOI 10.2174/156802611795347564; STERN MB, 1991, MOVEMENT DISORD, V6, P95, DOI 10.1002/mds.870060202; Stern ST, 2012, PART FIBRE TOXICOL, V9, DOI 10.1186/1743-8977-9-20; Tanaka K, 2010, PLANT PHYSIOL, V154, P705, DOI 10.1104/pp.110.162503; Trabanelli S, 2012, J IMMUNOL, V189, P1303, DOI 10.4049/jimmunol.1103800; Unal-Cevik I, 2011, J CEREBR BLOOD F MET, V31, P913, DOI 10.1038/jcbfm.2010.170; Uryu K, 2003, EXP NEUROL, V184, P214, DOI 10.1016/S0014-4886(03)00245-0; Uryu K, 2007, EXP NEUROL, V208, P185, DOI 10.1016/j.expneurol.2007.06.018; Vogiatzi T, 2008, J BIOL CHEM, V283, P23542, DOI 10.1074/jbc.M801992200; Volonte C, 2003, CNS NEUROL DISORD-DR, V2, P403, DOI 10.2174/1568007033482643	53	18	19	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0197-4580	1558-1497		NEUROBIOL AGING	Neurobiol. Aging	FEB	2015	36	2					1209	1220		10.1016/j.neurobiolaging.2014.10.037			12	Geriatrics & Gerontology; Neurosciences	Geriatrics & Gerontology; Neurosciences & Neurology	CF3MZ	WOS:000352454400066	25480524	Green Accepted			2021-06-18	
J	Lu, HY; Li, TC; Tu, YK; Tsai, JC; Lai, HS; Kuo, LT				Lu, Hsueh-Yi; Li, Tzu-Chi; Tu, Yong-Kwang; Tsai, Jui-Chang; Lai, Hong-Shiee; Kuo, Lu-Ting			Predicting Long-Term Outcome After Traumatic Brain Injury Using Repeated Measurements of Glasgow Coma Scale and Data Mining Methods	JOURNAL OF MEDICAL SYSTEMS			English	Article						Glasgow coma scale; Traumatic brain injury; Mortality; Data mining; Projections and predictions	SEVERE HEAD-INJURY; LIKELIHOOD RATIOS; PROGNOSIS; CLASSIFICATION; VALIDATION; MODELS; IMPACT; COMPONENTS; REGRESSION; MORTALITY	Previous studies have identified some clinical parameters for predicting long-term functional recovery and mortality after traumatic brain injury (TBI). Here, data mining methods were combined with serial Glasgow Coma Scale (GCS) scores and clinical and laboratory parameters to predict 6-month functional outcome and mortality in patients with TBI. Data of consecutive adult patients presenting at a trauma center with moderate-to-severe head injury were retrospectively analyzed. Clinical parameters including serial GCS measurements at emergency department, 7th day, and 14th day and laboratory data were included for analysis (n=115). We employed artificial neural network (ANN), naive Bayes (NB), decision tree, and logistic regression to predict mortality and functional outcomes at 6 months after TBI. Favorable functional outcome was achieved by 34.8 % of the patients, and overall 6-month mortality was 25.2 %. For 6-month functional outcome prediction, ANN was the best model, with an area under the receiver operating characteristic curve (AUC) of 96.13 %, sensitivity of 83.50 %, and specificity of 89.73 %. The best predictive model for mortality was NB with AUC of 91.14 %, sensitivity of 81.17 %, and specificity of 90.65 %. Sensitivity analysis demonstrated GCS measurements on the 7th and 14th day and difference between emergency room and 14th day GCS score as the most influential attributes both in mortality and functional outcome prediction models. Analysis of serial GCS measurements using data mining methods provided additional predictive information in relation to 6-month mortality and functional outcome in patients with moderate-to-severe TBI.	[Lu, Hsueh-Yi] Natl Yunlin Univ Sci & Technol, Dept Ind Engn & Management, Douliou City 640, Yun Lin County, Taiwan; [Li, Tzu-Chi] Natl Taiwan Univ Hosp, Dept Nursing, Yun Lin Branch, Taipei 640, Yun Lin County, Taiwan; [Tu, Yong-Kwang; Tsai, Jui-Chang; Kuo, Lu-Ting] Natl Taiwan Univ Hosp, Dept Surg, Div Neurosurg, Taipei 100, Taiwan; [Tu, Yong-Kwang; Tsai, Jui-Chang; Kuo, Lu-Ting] Coll Med, Taipei 100, Taiwan; [Lai, Hong-Shiee] Natl Taiwan Univ Hosp, Dept Surg, Taipei 100, Taiwan	Kuo, LT (corresponding author), Natl Taiwan Univ Hosp, Dept Surg, Div Neurosurg, 7 Chungshan S Rd, Taipei 100, Taiwan.	hylu@yuntech.edu.tw; ci6964@yahoo.com.tw; yktu@ntu.edu.tw; jctsai@ntu.edu.tw; hslai@ntu.edu.tw; kuoluting@gmail.com		TSAI, JUI-CHANG/0000-0003-2723-6841; Tu, Yong-kwang/0000-0003-2113-1176; Kuo, Lu-Ting/0000-0002-1405-8700			Akobeng AK, 2007, ACTA PAEDIATR, V96, P487, DOI 10.1111/j.1651-2227.2006.00179.x; Akobeng AK, 2007, ACTA PAEDIATR, V96, P338, DOI 10.1111/j.1651-2227.2006.00180.x; ALTMAN DG, 1994, BRIT MED J, V309, P188, DOI 10.1136/bmj.309.6948.188; [Anonymous], 2010, NAT METHODS, V7, P331, DOI 10.1038/nmeth0510-331; BECKER DP, 1977, J NEUROSURG, V47, P491, DOI 10.3171/jns.1977.47.4.0491; Bellazzi R, 2008, INT J MED INFORM, V77, P81, DOI 10.1016/j.ijmedinf.2006.11.006; Bengio Y, 2004, J MACH LEARN RES, V5, P1089; BOWERS SA, 1980, NEUROSURGERY, V6, P237; Breiman L, 1984, WADSWORTH STAT PROBA; Brown AW, 2005, J NEUROTRAUM, V22, P1040, DOI 10.1089/neu.2005.22.1040; CARLSSON CA, 1968, J NEUROSURG, V29, P242, DOI 10.3171/jns.1968.29.3.0242; CODE C, 1994, CORTEX, V30, P527, DOI 10.1016/S0010-9452(13)80348-6; Deeks JJ, 2004, BRIT MED J, V329, P168, DOI 10.1136/bmj.329.7458.168; Dreiseitl S, 2002, J BIOMED INFORM, V35, P352, DOI 10.1016/S1532-0464(03)00034-0; DUJARDIN B, 1994, EUR J EPIDEMIOL, V10, P29, DOI 10.1007/BF01717448; Duncan R, 2009, J EMERG MED, V37, P451, DOI 10.1016/j.jemermed.2008.11.026; Efron B, 1997, J AM STAT ASSOC, V92, P548, DOI 10.2307/2965703; Eftekhar Behzad, 2005, BMC Med Inform Decis Mak, V5, P3; Frawley W. J., 1996, DATA MIN KNOWL DISC, P661; Galanaud D, 2012, ANESTHESIOLOGY, V117, P1300, DOI 10.1097/ALN.0b013e3182755558; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Gill CJ, 2005, BRIT MED J, V330, P1080, DOI 10.1136/bmj.330.7499.1080; Han J., 2006, DATA MINING CONCEPTS; Hoffmann M, 2012, BRIT J SURG, V99, P122, DOI 10.1002/bjs.7707; Jain S, 2008, INJURY, V39, P598, DOI 10.1016/j.injury.2007.06.003; JENNETT B, 1977, J NEUROL NEUROSUR PS, V40, P291, DOI 10.1136/jnnp.40.3.291; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Keltch B, 2014, J MED SYST, V38, DOI 10.1007/s10916-014-0060-y; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Lee SY, 2012, J CLIN NEUROL, V8, P224, DOI 10.3988/jcn.2012.8.3.224; Leitgeb J, 2013, EUR J TRAUMA EMERG S, V39, P285, DOI 10.1007/s00068-013-0269-3; Lesko MM, 2013, J NEUROTRAUM, V30, P17, DOI 10.1089/neu.2012.2438; LEVATI A, 1982, J NEUROSURG, V57, P779, DOI 10.3171/jns.1982.57.6.0779; Lin CC, 2010, INJURY, V41, P869, DOI 10.1016/j.injury.2010.04.023; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Marmarou A, 2007, J NEUROTRAUM, V24, P270, DOI 10.1089/neu.2006.0029; Mazumdar M, 2000, STAT MED, V19, P113, DOI 10.1002/(SICI)1097-0258(20000115)19:1<113::AID-SIM245>3.3.CO;2-F; Meisel S, 2010, EUR J OPER RES, V206, P1, DOI 10.1016/j.ejor.2009.10.017; NARAYAN RK, 1981, J NEUROSURG, V54, P751, DOI 10.3171/jns.1981.54.6.0751; Nelson DW, 2012, J NEUROTRAUM, V29, P2613, DOI 10.1089/neu.2012.2468; Olshen RA, 1984, CLASSIFICATION REGRE; OVERGAARD J, 1973, LANCET, V2, P631; Patterson D., 1996, ARTIFICIAL NEURAL NE; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Perez R, 2010, SENSORS-BASEL, V10, P10733, DOI 10.3390/s101210733; Podgorelec Vili, 2002, J Med Syst, V26, P445, DOI 10.1023/A:1016409317640; Polat K, 2006, EXPERT SYST APPL, V31, P264, DOI 10.1016/j.eswa.2005.09.019; Quigley MR, 1997, J TRAUMA, V42, P7, DOI 10.1097/00005373-199701000-00003; Quinlan J. R., 1986, Machine Learning, V1, P81, DOI 10.1007/BF00116251; Quinlan J. R., 1993, C4 5 PROGRAMS MACHIN; Ramesh AN, 2004, ANN ROY COLL SURG, V86, P334, DOI 10.1308/147870804290; RIMEL RW, 1979, JACEP-J AM COLL EMER, V8, P64, DOI 10.1016/S0361-1124(79)80039-8; Roozenbeek B, 2012, CRIT CARE MED, V40, P1609, DOI 10.1097/CCM.0b013e31824519ce; Roozenbeek B, 2012, J NEUROTRAUM, V29, P1306, DOI 10.1089/neu.2011.1988; Rovlias A, 2004, J NEUROTRAUM, V21, P886, DOI 10.1089/0897715041526249; Schreiber MA, 2002, ARCH SURG-CHICAGO, V137, P285, DOI 10.1001/archsurg.137.3.285; Segal ME, 2006, J HEAD TRAUMA REHAB, V21, P298, DOI 10.1097/00001199-200607000-00003; Sen B, 2014, J MED SYST, V38, DOI 10.1007/s10916-014-0018-0; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Signorini DF, 1999, J NEUROL NEUROSUR PS, V66, P20, DOI 10.1136/jnnp.66.1.20; Silver JM., 2011, TXB TRAUMATIC BRAIN, V2nd ed.; Stevens RD, 2013, CRIT CARE MED, V41, P1104, DOI 10.1097/CCM.0b013e318287ee79; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; STONE M, 1974, J R STAT SOC B, V36, P111, DOI 10.1111/j.2517-6161.1974.tb00994.x; TEASDALE G, 1974, LANCET, V2, P81; Ting H, 2014, J MED SYST, V38, DOI 10.1007/s10916-014-0094-1; WYATT JC, 1995, BMJ-BRIT MED J, V311, P1539, DOI 10.1136/bmj.311.7019.1539	69	18	18	0	8	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0148-5598	1573-689X		J MED SYST	J. Med. Syst.	FEB	2015	39	2							14	10.1007/s10916-014-0187-x			10	Health Care Sciences & Services; Medical Informatics	Health Care Sciences & Services; Medical Informatics	CA6EG	WOS:000349001200014	25637541				2021-06-18	
J	Nichols, J; Perez, R; Wu, C; Adelson, PD; Anderson, T				Nichols, Joshua; Perez, Roxy; Wu, Chen; Adelson, P. David; Anderson, Trent			Traumatic Brain Injury Induces Rapid Enhancement of Cortical Excitability in Juvenile Rats	CNS NEUROSCIENCE & THERAPEUTICS			English	Article						Cerebral cortex; Epilepsy; Neurophysiology; Synaptic plasticity; Traumatic brain injury	IMMEDIATE POSTTRAUMATIC SEIZURES; PEDIATRIC HEAD-INJURY; METHYL-D-ASPARTATE; IMPACT INJURY; SYNAPTIC INHIBITION; NEURAL INFORMATION; IMMATURE RAT; ADULT MICE; IN-VITRO; EPILEPSY	AimsFollowing a traumatic brain injury (TBI), 5-50% of patients will develop posttraumatic epilepsy (PTE) with children being particularly susceptible. Currently, PTE cannot be prevented and there is limited understanding of the underlying epileptogenic mechanisms. We hypothesize that early after TBI the brain undergoes distinct cellular and synaptic reorganization that facilitates cortical excitability and promotes the development of epilepsy. MethodsTo examine the effect of pediatric TBI on cortical excitability, we performed controlled cortical impact (CCI) on juvenile rats (postnatal day 17). Following CCI, animals were monitored for the presence of epileptiform activity by continuous in vivo electroencephalography (EEG) and/or sacrificed for in vitro whole-cell patch-clamp recordings. ResultsFollowing a short latent period, all animals subjected to CCI developed spontaneous recurrent epileptiform activity within 14days. Whole-cell patch-clamp recordings of layer V pyramidal neurons showed no changes in intrinsic excitability or spontaneous excitatory postsynaptic currents (sEPSCs) properties. However, the decay of spontaneous inhibitory postsynaptic currents (sIPSCs) was significantly increased. In addition, CCI induced over a 300% increase in excitatory and inhibitory synaptic bursting. Synaptic bursting was prevented by blockade of Na+-dependent action potentials or select antagonism of glutamate or GABA-A receptors, respectively. ConclusionOur results demonstrate that CCI in juvenile rats rapidly induces epileptiform activity and enhanced cortical synaptic bursting. Detection of epileptiform activity early after injury suggests it may be an important pathophysiological component and potential indicator of developing PTE.	[Nichols, Joshua; Perez, Roxy; Wu, Chen; Anderson, Trent] Univ Arizona, Coll Med Phoenix, Phoenix, AZ 85004 USA; [Nichols, Joshua] Arizona State Univ, Sch Life Sci, Phoenix, AZ USA; [Adelson, P. David] Phoenix Childrens Hosp, Barrow Neurol Inst, Phoenix, AZ USA	Anderson, T (corresponding author), Univ Arizona, Coll Med Phoenix, 425 N 5th St, Phoenix, AZ 85004 USA.	andersot@email.arizona.edu	Adelson, David/W-2083-2019		NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS087031] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS087031] Funding Source: NIH RePORTER		Adelson P David, 2003, Pediatr Crit Care Med, V4, pS72; Adelson PD, 2013, CHILD NERV SYST, V29, P43, DOI 10.1007/s00381-012-1932-4; Adelson PD, 1999, EXP TOXICOL PATHOL, V51, P130; Agrawal A, 2006, CLIN NEUROL NEUROSUR, V108, P433, DOI 10.1016/j.clineuro.2005.09.001; Anderson KJ, 2005, EXP NEUROL, V193, P125, DOI 10.1016/j.expneurol.2004.11.025; Anderson TR, 2005, J NEUROPHYSIOL, V93, P963, DOI 10.1152/jn.00654.2004; Anderson TR, 2010, J PHYSIOL-LONDON, V588, P4401, DOI 10.1113/jphysiol.2010.191858; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson V, 1995, CHILD NEUROPSYCHOL, V1, P187, DOI 10.1080/09297049508400224; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Appleton RE, 2002, J NEUROL NEUROSUR PS, V72, P669, DOI 10.1136/jnnp.72.5.669; Arango JI, 2012, CHILD NERV SYST, V28, P1925, DOI 10.1007/s00381-012-1863-0; Arndt DH, 2013, EPILEPSIA, V54, P1780, DOI 10.1111/epi.12369; Bacci A, 2006, NEURON, V49, P119, DOI 10.1016/j.neuron.2005.12.014; Barlow KM, 2000, DEV MED CHILD NEUROL, V42, P591, DOI 10.1017/S0012162200001110; Bauer J, 2001, SEIZURE-EUR J EPILEP, V10, P239, DOI 10.1053/seiz.2000.0499; Bolkvadze T, 2012, J NEUROTRAUM, V29, P789, DOI 10.1089/neu.2011.1954; Calcagnotto ME, 2005, J NEUROSCI, V25, P9649, DOI 10.1523/JNEUROSCI.2687-05.2005; Cantu D, 2015, CEREB CORTEX, V25, P2306, DOI 10.1093/cercor/bhu041; Card JP, 2005, J NEUROTRAUM, V22, P989, DOI 10.1089/neu.2005.22.989; Casella EM, 2014, CHILD NERV SYST, V30, P1333, DOI 10.1007/s00381-014-2446-z; CAVENESS WF, 1979, J NEUROSURG, V50, P545, DOI 10.3171/jns.1979.50.5.0545; Chiaretti A, 2000, CHILD NERV SYST, V16, P862, DOI 10.1007/s003810000368; CHUGANI HT, 1987, ANN NEUROL, V22, P487, DOI 10.1002/ana.410220408; Cole JT, 2011, J NEUROTRAUM, V28, P359, DOI 10.1089/neu.2010.1427; Cuccurullo S, 2004, PHYS MED REHABILITAT; Dias MS, 1999, PEDIATR NEUROSURG, V30, P232, DOI 10.1159/000028803; Englander J, 2003, ARCH PHYS MED REHAB, V84, P365, DOI 10.1053/apmr.2003.50022; Evans R., 2006, NEUROLOGY AND TRAUMA; EWINGCOBBS L, 1989, J PEDIATR PSYCHOL, V14, P531, DOI 10.1093/jpepsy/14.4.531; Fox GB, 1998, J NEUROTRAUM, V15, P599, DOI 10.1089/neu.1998.15.599; FRIEDMAN WJ, 1991, EUR J NEUROSCI, V3, P688, DOI 10.1111/j.1460-9568.1991.tb00854.x; Gajda Z, 2006, EPILEPSIA, V47, P1009, DOI 10.1111/j.1528-1167.2006.00573.x; Garga Nina, 2006, Epilepsy Curr, V6, P1, DOI 10.1111/j.1535-7511.2005.00083.x; Gill R, 2013, EUR J NEUROSCI, V38, P3554, DOI 10.1111/ejn.12367; Giza CC, 2006, J NEUROTRAUM, V23, P950, DOI 10.1089/neu.2006.23.950; GOODMAN JC, 1994, J NEUROTRAUM, V11, P587, DOI 10.1089/neu.1994.11.587; Graber KD, 2004, ANN NEUROL, V55, P860, DOI 10.1002/ana.20124; GUATTEO E, 1994, NEUROSCI LETT, V175, P117, DOI 10.1016/0304-3940(94)91093-6; Hall ED, 2005, J NEUROTRAUM, V22, P252, DOI 10.1089/neu.2005.22.252; HOFFMAN SN, 1994, J NEUROPHYSIOL, V71, P1762; Holmes JF, 2004, ANN EMERG MED, V43, P706, DOI 10.1016/j.annemergmed.2003.11.008; HORITA H, 1991, BRAIN DEV-JPN, V13, P200, DOI 10.1016/S0387-7604(12)80032-5; Houston CM, 2009, J NEUROSCI, V29, P10416, DOI 10.1523/JNEUROSCI.1670-09.2009; Hunt RF, 2009, EXP NEUROL, V215, P243, DOI 10.1016/j.expneurol.2008.10.005; INSEL TR, 1990, NEUROSCIENCE, V35, P31, DOI 10.1016/0306-4522(90)90117-M; Iudice A, 2000, DRUGS, V59, P1091, DOI 10.2165/00003495-200059050-00005; Izhikevich EM, 2003, TRENDS NEUROSCI, V26, P161, DOI 10.1016/S0166-2236(03)00034-1; Jenkins LW, 2002, J NEUROTRAUM, V19, P715, DOI 10.1089/08977150260139101; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; LIGHTHALL J W, 1989, Journal of Neurotrauma, V6, P83, DOI 10.1089/neu.1989.6.83; Lisman JE, 1997, TRENDS NEUROSCI, V20, P38, DOI 10.1016/S0166-2236(96)10070-9; Liu NK, 2013, BRAIN RES, V1499, P121, DOI 10.1016/j.brainres.2012.12.031; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; Mannix RC, 2011, J NEUROTRAUM, V28, P1855, DOI 10.1089/neu.2011.1759; McKinlay A, 2002, J NEUROL NEUROSUR PS, V73, P281, DOI 10.1136/jnnp.73.3.281; NILSSON P, 1994, BRAIN RES, V637, P227, DOI 10.1016/0006-8993(94)91237-8; OLESEN SP, 1987, ACTA PHYSIOL SCAND, V130, P63, DOI 10.1111/j.1748-1716.1987.tb08112.x; PETERS A, 1984, CEREBRAL CORTEX, V1; Prince D A, 1986, Adv Neurol, V44, P275; PRINCE DA, 1993, J NEUROPHYSIOL, V69, P1276; Prins ML, 2010, DEV NEUROSCI-BASEL, V32, P510, DOI 10.1159/000316800; Ramantani G, 2013, EPILEPTIC DISORD, V15, P365, DOI 10.1684/epd.2013.0619; Rola R, 2006, EXP NEUROL, V202, P189, DOI 10.1016/j.expneurol.2006.05.034; Sarkar K, 2014, J NEUROSURG-PEDIATR, V13, P307, DOI 10.3171/2013.12.PEDS13223; SATO H, 1979, FOLIA PSYCHIAT NEU J, V33, P323; Scheff SW, 2005, J NEUROTRAUM, V22, P719, DOI 10.1089/neu.2005.22.719; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Statler KD, 2009, EPILEPSY RES, V86, P221, DOI 10.1016/j.eplepsyres.2009.05.006; Sun QQ, 2006, J NEUROSCI, V26, P1219, DOI 10.1523/JNEUROSCI.4727-04.2006; Taylor HG, 2008, J INT NEUROPSYCH SOC, V14, P734, DOI 10.1017/S1355617708081150; Telfeian AE, 1998, EPILEPSIA, V39, P700, DOI 10.1111/j.1528-1157.1998.tb01154.x; vandenPol AN, 1996, J NEUROSCI, V16, P4283; Vespa PM, 2007, CRIT CARE MED, V35, P2830, DOI 10.1097/01.CCM.0000295667.66853.BC; WILLMORE LJ, 1990, EPILEPSIA, V31, pS67, DOI 10.1111/j.1528-1157.1990.tb05861.x; WISE SP, 1975, BRAIN RES, V90, P139, DOI 10.1016/0006-8993(75)90688-5; YABLON SA, 1993, ARCH PHYS MED REHAB, V74, P983; Yang L, 2007, J NEUROPHYSIOL, V97, P178, DOI 10.1152/jn.01374.2005; Yang L, 2010, J NEUROTRAUM, V27, P1541, DOI 10.1089/neu.2009.1244; Zayachkivsky A, 2013, J NEUROPHYSIOL, V109, P900, DOI 10.1152/jn.00593.2012; Ziyatdinova S, 2011, EPILEPSY RES, V94, P75, DOI 10.1016/j.eplepsyres.2011.01.003	81	18	19	0	18	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1755-5930	1755-5949		CNS NEUROSCI THER	CNS Neurosci. Ther.	FEB	2015	21	2			SI		193	203		10.1111/cns.12351			11	Neurosciences; Pharmacology & Pharmacy	Neurosciences & Neurology; Pharmacology & Pharmacy	CA3YL	WOS:000348841000013	25475223	Green Published, Green Accepted			2021-06-18	
J	Burkhart, KJ; Franke, S; Wegmann, K; Ries, C; Dehlinger, F; Muller, LP; Hollinger, B				Burkhart, K. J.; Franke, S.; Wegmann, K.; Ries, C.; Dehlinger, F.; Mueller, L. P.; Hollinger, B.			Mason I fracture - a simple injury?	UNFALLCHIRURG			German	Article						Radial head fracture; Complications; Elbow instability; Elbow osteoarthritis; Elbow stiffness	RADIAL HEAD FRACTURES; NECK FRACTURES; FIXATION	Mason I fractures of the radial head are judged to be simple injuries that can generally be treated nonoperatively. According to the current literature mainly good and excellent results can be expected. We present a case series of patients presenting to us due to complications of Mason I fractures. We reviewed all cases of patients that were treated because of complaints following Mason I radial head fractures. In all, 16 patients (10 men and 6 women) were identified. Mean age was 37 years (range 16-59 years). Mean time between trauma and surgery was 25 months (range 1-108 months). Ten patients developed painful osteoarthritis with elbow stiffness and loose bodies, 4 patients suffered a posterolateral rotatory instability that had to be treated with ligament reconstruction, 1 patient presented with a combined medial and lateral instability, and 1 patient with a symptomatic hypertophic plica posterolateralis. Diagnotics and therapeutic concepts of these complications will be presented. In light of the complications, Mason I fractures must be reevaluated. They remain the domain of conservative treatment but close follow-up is recommended to recognize possible complications early in order to prevent stiffness, chronic instabilities, and osteoarthritis.	[Burkhart, K. J.; Wegmann, K.; Ries, C.; Mueller, L. P.] Univ Klinikum Koln, Klin & Poliklin Orthopadie & Unfallchirurg, D-50937 Cologne, Germany; [Franke, S.; Ries, C.; Dehlinger, F.; Hollinger, B.] Arcus Sportklin Pforzheim, Pforzheim, Germany	Burkhart, KJ (corresponding author), Univ Klinikum Koln, Klin & Poliklin Orthopadie & Unfallchirurg, Kerpener Str 62, D-50937 Cologne, Germany.	klaus.burkhart@uk-koeln.de	Mueller, Lars P/N-1700-2017	Mueller, Lars P/0000-0001-9769-6865			Akesson T, 2006, J BONE JOINT SURG AM, V88A, P1909, DOI 10.2106/JBJS.E.01052; Burkhart KJ, 2010, INJURY, V41, P1015, DOI 10.1016/j.injury.2010.03.001; Burkhart KJ, 2007, J HAND SURG-AM, V32A, P1569, DOI 10.1016/j.jhsa.2007.08.023; Duckworth AD, 2011, J TRAUMA, V71, P643, DOI 10.1097/TA.0b013e3181f8fa5f; Hausmann JT, 2009, J TRAUMA, V66, P457, DOI 10.1097/TA.0b013e31817fdedd; Herbertsson P, 2005, J SHOULDER ELB SURG, V14, P73, DOI 10.1016/j.jse.2004.07.001; Itamura J, 2005, J SHOULDER ELB SURG, V14, P421, DOI 10.1016/j.jse.2004.11.003; JOHNSTON G W, 1962, Ulster Med J, V31, P51; Kaas L, 2011, J SHOULDER ELB SURG, V20, P1282, DOI 10.1016/j.jse.2011.06.011; Kaas L, 2010, ACTA ORTHOP, V81, P373, DOI 10.3109/17453674.2010.483988; Kaas L, 2010, J SHOULDER ELB SURG, V19, P520, DOI 10.1016/j.jse.2009.10.015; Koslowsky TC, 2007, J BONE JOINT SURG BR, V89B, P1545, DOI 10.1302/0301-620X.89B11.19433; Lindenhovius ALC, 2009, J TRAUMA, V67, P143, DOI 10.1097/TA.0b013e31818234d6; Liow RYL, 2002, INJURY, V33, P801, DOI 10.1016/S0020-1383(02)00164-X; MASON ML, 1954, BRIT J SURG, V42, P123, DOI 10.1002/bjs.18004217203; ODRISCOLL SW, 1991, J BONE JOINT SURG AM, V73A, P440, DOI 10.2106/00004623-199173030-00015; Pike JM, 2009, J HAND SURG-AM, V34A, P557, DOI 10.1016/j.jhsa.2008.12.024; Struijs PAA, 2007, ARCH ORTHOP TRAUM SU, V127, P125, DOI 10.1007/s00402-006-0240-4; WESELEY MS, 1983, J TRAUMA, V23, P36, DOI 10.1097/00005373-198301000-00007	19	18	18	0	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0177-5537	1433-044X		UNFALLCHIRURG	Unfallchirurg	JAN	2015	118	1					9	17		10.1007/s00113-013-2532-9			9	Emergency Medicine; Surgery	Emergency Medicine; Surgery	CA5AZ	WOS:000348920800006	24452244				2021-06-18	
J	Chan, ST; Evans, KC; Rosen, BR; Song, TY; Kwong, KK				Chan, Suk-tak; Evans, Karleyton C.; Rosen, Bruce R.; Song, Tian-yue; Kwong, Kenneth K.			A case study of magnetic resonance imaging of cerebrovascular reactivity: A powerful imaging marker for mild traumatic brain injury	BRAIN INJURY			English	Article						Cerebrovascular reactivity; functional magnetic resonance imaging; mild brain injury	LEVEL-DEPENDENT MRI; RECURRENT CONCUSSION; FOOTBALL PLAYERS; WHITE-MATTER; IMPAIRMENT; PERFUSION; CO2; SOFTWARE; FMRI	Primary objective: To use breath-hold functional magnetic resonance imaging (fMRI) to localize the brain regions with impaired cerebrovascular reactivity (CVR) in a female patient diagnosed with mild traumatic brain injury (mTBI). The extent of impaired CVR was evaluated 2 months after concussion. Follow-up scan was performed 1 year post-mTBI using the same breath-hold fMRI technique. Research design: Case report. Methods and procedures: fMRI blood oxygenation dependent level (BOLD) signals were measured under breath-hold challenge in a female mTBI patient 2 months after concussion followed by a second fMRI with breath-hold challenge 1 year later. CVR was expressed as the percentage change of BOLD signals per unit time of breath-hold. Main outcomes: In comparison with CVR measurement of normal control subjects, statistical maps of CVR revealed substantial neurovascular deficits and hemispheric asymmetry within grey and white matter in the initial breath-hold fMRI scan. Follow-up breath-hold fMRI performed 1 year post-mTBI demonstrated normalization of CVR accompanied with symptomatic recovery. Conclusions: CVR may serve as an imaging biomarker to detect subtle deficits in both grey and white matter for individual diagnosis of mTBI. The findings encourage further investigation of hypercapnic fMRI as a diagnostic tool for mTBI.	[Chan, Suk-tak; Rosen, Bruce R.; Song, Tian-yue; Kwong, Kenneth K.] Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Dept Radiol, Boston, MA 02114 USA; [Evans, Karleyton C.; Song, Tian-yue] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA	Chan, ST (corresponding author), Athinoula A Martinos Ctr Biomed Imaging, Bldg 149,Thirteenth St,Mail Code 149-2301, Charlestown, MA 02129 USA.	phoebe@nmr.mgh.harvard.edu	Chan, Suk-tak/G-5846-2015	Kwong, Kenneth K./0000-0001-5056-2173; CHAN, SUK-TAK/0000-0001-6627-3173	National Institute of Biomedical Imaging and Bioengineering (NIBIB), National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [P41EB015896];  [NIH-K23MH086619]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [P41EB015896] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [K23MH086619] Funding Source: NIH RePORTER	This research was carried out in whole at the Athinoula A. Martinos Center for Biomedical Imaging at the Massachusetts General Hospital, using resources provided by the Center for Functional Neuroimaging Technologies, P41EB015896, a P41 Biotechnology Resource Grant supported by the National Institute of Biomedical Imaging and Bioengineering (NIBIB), National Institutes of Health. This work was also supported, in part, by NIH-K23MH086619. The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.	Bigler ED, 2013, NEUROPSYCHOL REV, V23, P169, DOI 10.1007/s11065-013-9237-2; Chang C, 2009, NEUROIMAGE, V47, P1381, DOI 10.1016/j.neuroimage.2009.04.048; Chang TY, 2009, AM J NEURORADIOL, V30, P1330, DOI 10.3174/ajnr.A1589; Conklin J, 2010, STROKE, V41, P1610, DOI 10.1161/STROKEAHA.110.579540; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Gold S, 1998, HUM BRAIN MAPP, V6, P73; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Han JS, 2011, STROKE, V42, P1261, DOI 10.1161/STROKEAHA.110.603225; Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352; Katzenberger RJ, 2013, P NATL ACAD SCI USA, V110, pE4152, DOI 10.1073/pnas.1316895110; Keightley ML, 2014, J NEUROTRAUM, V31, P437, DOI [10.1089/NEU.2013.3052, 10.1089/neu.2013.3052]; Korngold C, 2013, J AM ACAD PSYCHIATRY, V41, P430; Krainik A, 2005, STROKE, V36, P1146, DOI 10.1161/01.STR.0000166178.40973.a7; Len TK, 2011, MED SCI SPORT EXER, V43, P2241, DOI 10.1249/MSS.0b013e3182249539; Longhi L, 2005, NEUROSURGERY, V56, P364, DOI 10.1227/01.NEU.0000149008.73513.44; Mannix R, 2013, NEUROSURGERY, V73, P129, DOI 10.1227/01.neu.0000429846.14579.41; Pillai JJ, 2012, TECHNOL CANCER RES T, V11, P361, DOI 10.7785/tcrt.2012.500284; Roth TL, 2014, NATURE, V505, P223, DOI 10.1038/nature12808; Talairach J., 1988, COPLANAR STEREOTAXIC; Tancredi FB, 2013, J CEREBR BLOOD F MET, V33, P1066, DOI 10.1038/jcbfm.2013.48; Tancredi FB, 2012, J MAGN RESON IMAGING, V36, P312, DOI 10.1002/jmri.23658; Vakhtin AA, 2013, BRAIN INJURY, V27, P1304, DOI 10.3109/02699052.2013.823561; van Gelderen P, 2008, MAGN RESON MED, V59, P788, DOI 10.1002/mrm.21515; Zaca D, 2014, J MAGN RESON IMAGING, V40, P383, DOI 10.1002/jmri.24406; Ziyeh S, 2005, STROKE, V36, P751, DOI 10.1161/01.STR.0000157593.03470.3d	26	18	19	0	7	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2015	29	3					403	407		10.3109/02699052.2014.974209			5	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	CB0HQ	WOS:000349307000015	25384127	Green Accepted			2021-06-18	
J	Mansfield, E; Stergiou-Kita, M; Cassidy, JD; Bayley, M; Mantis, S; Kristman, V; Kirsh, B; Gomez, M; Jeschke, MG; Vartanian, O; Moody, J; Colantonio, A				Mansfield, Elizabeth; Stergiou-Kita, Mary; Cassidy, John David; Bayley, Mark; Mantis, Steve; Kristman, Vicki; Kirsh, Bonnie; Gomez, Manuel; Jeschke, Mark G.; Vartanian, Oshin; Moody, Joel; Colantonio, Angela			Return-to-work challenges following a work-related mild TBI: The injured worker perspective	BRAIN INJURY			English	Article						Injured workers; insurance; mild traumatic brain injury; occupational injuries; return-to-work; workers' compensation	TRAUMATIC BRAIN-INJURY; LONG-TERM SYMPTOMS; EXPERIENCE; RECOMMENDATIONS; REHABILITATION; RECOVERY; PATIENT; PEOPLE; HEALTH	Primary objective: To explore how individuals with work-related mild traumatic brain injury (wrMTBI) experience return-to-work (RTW) processes when returning to the workplace where the injury occurred. Design: RTW experiences were explored using in-depth interviews and an inductive analytic approach. Qualitative analysis guided by the research question moved through phases of line-by-line and thematic coding through which categories and the interaction between categories emerged. Participants: Twelve workers diagnosed with a wrMTBI reported on their RTW experiences following wrMTBIs that occurred 3-5 years prior to the time of the interview. Main outcomes and results: Participants perceived employer and workers' compensation factors as profoundly influencing their RTW experiences. Participants consistently reported that employers and workers' compensation representatives had an inadequate understanding of wrMTBI sequelae. Six of 12 participants were re-injured following their wrMTBI, with three of these injuries occurring at work. Conclusion: Employers, co-workers and workers' compensation representatives should be aware of wrMTBI sequelae so injured workers can receive appropriate supports and both stigmatization and re-injury can be mitigated. Greater attention to the structural and social elements of workplace and compensation environments could inform strategies to break down barriers to successful return-to-work following a wrMTBI.	[Mansfield, Elizabeth; Stergiou-Kita, Mary; Bayley, Mark; Kristman, Vicki; Kirsh, Bonnie; Gomez, Manuel; Jeschke, Mark G.; Vartanian, Oshin; Colantonio, Angela] Univ Toronto, Toronto, ON, Canada; [Stergiou-Kita, Mary; Bayley, Mark; Colantonio, Angela] Univ Hlth Network, Toronto Rehabil Inst, Toronto, ON, Canada; [Stergiou-Kita, Mary; Kristman, Vicki] Inst Work & Hlth, Toronto, ON, Canada; [Cassidy, John David] Univ Southern Denmark, Odense, Denmark; [Mantis, Steve] Ontario Network Injured Workers Grp, Kaministiquia, ON, Canada; [Kristman, Vicki] Lakehead Univ, Thunder Bay, ON P7B 5E1, Canada; [Jeschke, Mark G.] Sunnybrook Hlth Sci Ctr, Ross Tilley Burn Ctr, Toronto, ON M4N 3M5, Canada; [Jeschke, Mark G.] Sunnybrook Res Inst, Toronto, ON, Canada; [Moody, Joel] Elect Safety Author, Mississauga, ON, Canada			Mansfield, Elizabeth/S-3426-2016	Mansfield, Elizabeth/0000-0003-1776-8641; Colantonio, Angela/0000-0003-2094-4765; Moody, Joel/0000-0002-6002-0316; Bayley, Mark/0000-0001-7860-9463	Canadian Institutes of Health Research-Institute for Gender and Health GrantCanadian Institutes of Health Research (CIHR) [OGW-123786]; Toronto Rehabilitation Institute Foundation - UHN; Ontario Ministry of Health and Long Term CareMinistry of Health and Long-Term Care, Ontario; CIHR Research Chair in Gender, Work and HealthCanadian Institutes of Health Research (CIHR) [CGW-126580]; Saunderson Family Chair in Acquired Brain Injury Research at the Toronto Rehabilitation Institute	This study was supported by a Canadian Institutes of Health Research-Institute for Gender and Health Grant (#OGW-123786). We also acknowledge the Toronto Rehabilitation Institute Foundation - UHN and the Ontario Ministry of Health and Long Term Care, which provided funding under the Provincial Rehabilitation Research Program to the Toronto Rehabilitation Institute, University Health Network. Support for Dr. Colantonio was provided by the CIHR Research Chair in Gender, Work and Health (#CGW-126580) and the Saunderson Family Chair in Acquired Brain Injury Research at the Toronto Rehabilitation Institute.	Ahman S, 2013, J REHABIL MED, V45, P758, DOI 10.2340/16501977-1182; Arciniegas David B, 2005, Neuropsychiatr Dis Treat, V1, P311; Bernhard D, 2010, INT J SOCIAL SECURIT, V2, P1; Braun V., 2006, QUALITATIVE RES PSYC, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706qp063oa]; Brown GD, 2007, NEW SOLUT, V17, P311, DOI 10.2190/NS.17.4.g; Cancelliere C, 2013, HDB WORK DISABILITY, P303; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS132, DOI 10.1016/j.apmr.2013.08.299; Chapman RCG, 2010, BRAIN INJURY, V24, P797, DOI 10.3109/02699051003709607; Clayton A, 2002, 5 AUSTR NAT U; Colantonio A, 2012, WORK, V43, P195, DOI 10.3233/WOR-2012-1377; Colantonio A, 2010, CAN J PUBLIC HEALTH, V101, pS58, DOI 10.1007/BF03403848; Dembe AE, 2001, AM J IND MED, V40, P403, DOI 10.1002/ajim.1113; Eakin JM, 2005, OCCUPATIONAL HLTH SA, P159; Franche RL, 2005, J OCCUP REHABIL, V15, P525, DOI 10.1007/s10926-005-8032-1; Galizzi M, 2010, IND RELAT, V49, P22, DOI 10.1111/j.1468-232X.2009.00585.x; Gillespie BM, 2010, INT J NURS STUD, V47, P732, DOI 10.1016/j.ijnurstu.2009.11.001; Gilworth G, 2008, J REHABIL MED, V40, P334, DOI 10.2340/16501977-0169; Harkins C, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-391; Hooson JM, 2013, NEUROPSYCHOL REHABIL, V23, P19, DOI 10.1080/09602011.2012.713314; Hopkins A, 1994, J OCCUP HEALTH, V10, P129; Ison T. G., 1986, OSGOODE HALL LAW J, V24, P723; Kristman Vicki L, 2014, Arch Phys Med Rehabil, V95, pS265, DOI 10.1016/j.apmr.2013.04.026; Laker SR, 2011, PM&R, V3, pS354, DOI 10.1016/j.pmrj.2011.07.017; Levack W, 2004, DISABIL REHABIL, V26, P290, DOI 10.1080/09638280310001647615; Levack WMM, 2010, DISABIL REHABIL, V32, P986, DOI 10.3109/09638281003775394; Lippel K, 2007, INT J LAW PSYCHIAT, V30, P427, DOI 10.1016/j.ijlp.2007.06.013; Lippel Katherine, 2003, POLICY PRACTICE HLTH, V1, P97; Lund T, 2006, INT J REHABIL RES, V29, P229, DOI 10.1097/01.mrr.0000210056.24915.c2; MacEachen E, 2010, J OCCUP REHABIL, V20, P349, DOI 10.1007/s10926-010-9229-5; MacEachen E, 2007, POLICY PRACT HEALTH, V5, P41, DOI 10.1080/14774003.2007.11667693; Mansfield E, 2014, QUAL HEALTH RES, V24, P1183, DOI 10.1177/1049732314545887; Mansfield L, 2012, POLICY PRACT HEALTH, V10, P3, DOI 10.1080/14774003.2012.11667766; Marshall S, 2012, CAN FAM PHYSICIAN, V58, P257; Marshall S, 2012, CAN FAM PHYSICIAN, V58, pE128; Mooney G, 2005, BRAIN INJURY, V19, P975, DOI 10.1080/02699050500110264; Nolin P, 2006, BRAIN INJURY, V20, P1147, DOI 10.1080/02699050601049247; O'Connor C, 2005, PSYCHOL REP, V97, P169, DOI 10.2466/PR0.97.5.169-179; Purse K, 1998, ECON LABOUR RELAT RE, V9, P246; Roberts-Yates C, 2003, DISABIL REHABIL, V25, P898, DOI 10.1080/0963828031000122203; Rubenson Camilla, 2007, Scand J Occup Ther, V14, P205, DOI 10.1080/11038120601110934; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Soeker MS, 2011, J OCCUP SCI, V18, P81, DOI 10.1080/14427591.2011.554155; Steenstra IA, 2005, OCCUP ENVIRON MED, V62, P851, DOI 10.1136/oem.2004.015842; Stergiou-Kita M, 2014, J OCCUP REHABIL, V24, P173, DOI 10.1007/s10926-013-9463-8; Stewart BJ, 2012, INT J NURS STUD, V49, P560, DOI 10.1016/j.ijnurstu.2011.11.004; Strunin L, 2004, AM J IND MED, V45, P338, DOI 10.1002/ajim.10356; Sveen U, 2013, DISABIL REHABIL, V35, P749, DOI 10.3109/09638288.2012.707741; TARASUK V, 1995, QUAL HEALTH RES, V5, P204, DOI 10.1177/104973239500500205; Tjulin A, 2011, DISABIL REHABIL, V33, P1979, DOI 10.3109/09638288.2011.553708; van Velzen JM, 2009, BRAIN INJURY, V23, P473, DOI 10.1080/02699050902970737; Weightman MM, 2010, J HEAD TRAUMA REHAB, V25, P206, DOI 10.1097/HTR.0b013e3181dc82d3; Workplace Safety and Insurance Board (WSIB), 2013, NUMB 2012 WSIB STAT; World Health Organization, 2006, NEUR DIS PUBL HLTH C; Young AE, 2010, SCAND J WORK ENV HEA, V36, P473, DOI 10.5271/sjweh.2986	54	18	19	0	15	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2015	29	11					1362	1369		10.3109/02699052.2015.1053524			8	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	CR4MF	WOS:000361306100011	26287754				2021-06-18	
J	McKenzie, ED; Spiegel, P; Khalifa, A; Mateen, FJ				McKenzie, Erica D.; Spiegel, Paul; Khalifa, Adam; Mateen, Farrah J.			Neuropsychiatric disorders among Syrian and Iraqi refugees in Jordan: a retrospective cohort study 2012-2013	CONFLICT AND HEALTH			English	Article						Refugees; Health services; Syria; Iraq; Humanitarian emergencies; Psychiatry		Background: The burden of neuropsychiatric disorders in refugees is likely high, but little has been reported on the neuropsychiatric disorders that affect Syrian and Iraqi refugees in a country of first asylum. This analysis aimed to study the cost and burden of neuropsychiatric disorders among refugees from Syria and Iraq requiring exceptional, United Nations-funded care in a country of first asylum. Methods: The United Nations High Commissioner for Refugees works with multi-disciplinary, in-country exceptional care committees to review refugees' applications for emergency or exceptional medical care. Neuropsychiatric diagnoses among refugee applicants were identified through a retrospective review of applications to the Jordanian Exceptional Care Committee (2012-2013). Diagnoses were made using International Classification of Disease-10th edition codes rendered by treating physicians. Results: Neuropsychiatric applications accounted for 11% (264/2526) of all Exceptional Care Committee applications, representing 223 refugees (40% female; median age 35 years; 57% Syrian, 36% Iraqi, 7% other countries of origin). Two-thirds of neuropsychiatric cases were for emergency care. The total amount requested for neuropsychiatric disorders was 925,674 USD. Syrian refugees were significantly more likely to request neurotrauma care than Iraqis (18/128 vs. 3/80, p = 0.03). The most expensive care per person was for brain tumor (7,905 USD), multiple sclerosis (7,502 USD), and nervous system trauma (6,466 USD), although stroke was the most frequent diagnosis. Schizophrenia was the most costly and frequent diagnosis among the psychiatric disorders (2,269 USD per person, 27,226 USD total). Conclusions: Neuropsychiatric disorders, including those traditionally considered outside the purview of refugee health, are an important burden to health among Iraqi and Syrian refugees. Possible interventions could include stroke risk factor reduction and targeted medication donations for multiple sclerosis, epilepsy, and schizophrenia.	[McKenzie, Erica D.; Mateen, Farrah J.] Massachusetts Gen Hosp, Dept Neurol, 165 Cambridge St,627, Boston, MA 02114 USA; [McKenzie, Erica D.] Queens Univ, Sch Med, Kingston, ON, Canada; [Spiegel, Paul] United Nations High Commissioner Refugees, Geneva, Switzerland; [Khalifa, Adam] United Nations High Commissioner Refugees, Damascus, Syria; [Mateen, Farrah J.] Harvard Med Sch, Boston, MA USA	Mateen, FJ (corresponding author), Massachusetts Gen Hosp, Dept Neurol, 165 Cambridge St,627, Boston, MA 02114 USA.	fmateen@partners.org	Spiegel, Paul/AAL-3238-2021	Mateen, Farrah/0000-0002-4293-8115			Aylward RB, 2014, LANCET, V383, P489, DOI 10.1016/S0140-6736(14)60132-X; Doocy S, 2013, INT J HEALTH PLAN M, V28, pe1, DOI 10.1002/hpm.2119; Editorial L, 2013, LANCET, V381; Mateen FJ, 2012, NEUROLOGY, V79, P937, DOI 10.1212/WNL.0b013e318266fcf1; Mateen FJ, 2012, J NEUROL, V259, P694, DOI 10.1007/s00415-011-6248-x; Murshidi MM, 2013, LANCET, V382, P206, DOI 10.1016/S0140-6736(13)61506-8; Sherlock R., 2014, JORDAN REPEALS FREE; Spiegel P, 2014, LANCET ONCOL, V15, pE290, DOI 10.1016/S1470-2045(14)70067-1; UNHCR Jordan Public Health Unit, 2011, GUID UNHCR SUPP HLTH; UNHCR-Public Health and HIV Section, 2008, UNHCR PRINC GUID REF; Yanni EA, 2013, J IMMIGR MINOR HEALT, V15, P1, DOI 10.1007/s10903-012-9578-6	11	18	18	0	4	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1752-1505			CONFL HEALTH	Confl. Health		2015	9								10	10.1186/s13031-015-0038-5			5	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	V1N0K	WOS:000217052500009	25904979	DOAJ Gold, Green Published			2021-06-18	
J	Norup, A; Mortensen, EL				Norup, Anne; Mortensen, Erik Lykke			Prevalence and Predictors of Personality Change After Severe Brain Injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injuries; Brain injuries; traumatic; Family members; Personality; Prevalence; Rehabilitation	BLUNT HEAD-INJURY; RELATIVES VIEW; DISTRESS; TRAITS	Objectives: To investigate the prevalence of personality change after severe brain injury; to identify predictors of personality change; and to investigate whether personality change is associated with distress in family members. Design: A longitudinal study of personality change. Setting: Rehabilitation unit. Participants: The study sample was composed of 22 pairs of patients with traumatic brain injury or nontraumatic brain injury (N=22) and their significant others (SOs). Interventions: Not applicable. Main Outcome Measures: An SO completed the observer version of the NEO Five Factor Inventory rating the patient at discharge from hospital and 1 year after injury. The SOs were also asked to complete the anxiety and depression scales of the Symptom Checklist-90-Revised, rating their own emotional condition and health-related quality of life (HRQOL) as assessed by the 4 mental scales of the Medical Outcomes Study 36-Item Short-Form Health Survey. Results: Of the sample, 59.1% experienced personality change after acquired brain injury, and the most dominant changes were observed in the personality traits of neuroticism, extraversion, and conscientiousness. Changes in neuroticism were most often observed in patients with frontal or temporal lesions. Generally, personality changes in patients were not associated with more distress and lower HRQOL in family members; however, change in patient agreeableness was associated with lower HRQOL on the role limitations-emotional scale. Conclusions: Personality change was observed in most patients with severe brain injury. Change in neuroticism was associated with frontal and temporal lesions. Generally, personality change was not associated with more distress and lower HRQOL in SOs. (C) 2015 by the American Congress of Rehabilitation Medicine	[Norup, Anne] Copenhagen Univ Hosp, Dept Neurorehabil, Traumat Brain Injury Unit, RUBRIC,Res Unit BRain Injury Rehabil Copenhagen, Glostrup, Denmark; [Mortensen, Erik Lykke] Univ Copenhagen, Inst Publ Hlth, Copenhagen, Denmark; [Mortensen, Erik Lykke] Univ Copenhagen, Ctr Hlth Aging, Copenhagen, Denmark	Norup, A (corresponding author), Copenhagen Univ Hosp, Dept Neurorehabil, Traumat Brain Injury Unit, Kettegard Alle 30, DK-2650 Hvidovre, Denmark.	anne.norup@regionh.dk		Norup, Anne/0000-0002-5598-6116			Bayen E, 2013, J HEAD TRAUMA REHAB, V28, P408, DOI 10.1097/HTR.0b013e31825413cf; Bjorner JB, 1997, DANISH MANUAL SF36 H; BROOKS DN, 1983, J NEUROL NEUROSUR PS, V46, P336, DOI 10.1136/jnnp.46.4.336; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; Costa PT, 1989, NEO  PIRNEOFFI MANUA; Derogatis LR, 2006, SCL90R MANUAL; Ergh TC, 2002, J HEAD TRAUMA REHAB, V17, P155, DOI 10.1097/00001199-200204000-00006; Gracia-Garcia P, 2011, J NEUROPSYCH CLIN N, V23, pE14, DOI 10.1176/appi.neuropsych.23.2.E14; Groom KN, 1998, ARCH CLIN NEUROPSYCH, V13, P695, DOI 10.1016/S0887-6177(98)00005-5; Jackson D, 2009, BRAIN INJURY, V23, P433, DOI 10.1080/02699050902788451; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; Kurtz JE, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199806000-00002; Labbate L A, 1997, Ann Clin Psychiatry, V9, P27, DOI 10.1023/A:1026278224598; LEZAK MD, 1978, J CLIN PSYCHIAT, V39, P592; Lishman W. A., 1997, ORGANIC PSYCHIAT; LISHMAN WA, 1973, PSYCHOL MED, V3, P304, DOI 10.1017/S003329170004959X; MALLOY P, 1993, ARCH CLIN NEUROPSYCH, V8, P185, DOI 10.1016/0887-6177(93)90035-Y; McCrae R.R., 2003, PERSONALITY ADULTHOO; McCrae RR, 2005, J PERS SOC PSYCHOL, V88, P547, DOI 10.1037/0022-3514.88.3.547; Norup A, 2013, THESIS U COPENHAGEN, Vdissertation; Norup A, 2013, AUST J REHABIL COUNS, V19, P71, DOI 10.1017/jrc.2013.12; Olsen LR, 2006, ACTA PSYCHIAT SCAND, V113, P477, DOI 10.1111/j.1600-0447.2005.00743.x; Ponsford J, 2003, BRAIN INJURY, V17, P453, DOI 10.1080/0269905031000070143; PRIGATANO GP, 1992, J CONSULT CLIN PSYCH, V60, P360, DOI 10.1037/0022-006X.60.3.360; Skovdahl Hansen H, 2004, NEO PI R MANUAL KLIN, P53; Tate RL, 2003, NEUROPSYCHOL REHABIL, V13, P43, DOI 10.1080/09602010244000372; Wells R, 2005, BRAIN INJURY, V19, P1105, DOI 10.1080/02699050500150062	27	18	19	0	13	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	JAN	2015	96	1					56	62		10.1016/j.apmr.2014.08.009			7	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	AY6EW	WOS:000347661100008	25193491				2021-06-18	
J	Odgaard, L; Poulsen, I; Kammersgaard, LP; Johnsen, SP; Nielsen, JF				Odgaard, Lene; Poulsen, Ingrid; Kammersgaard, Lars Peter; Johnsen, Soren Paaske; Nielsen, Jorgen Feldbeak			Surviving severe traumatic brain injury in Denmark: incidence and predictors of highly specialized rehabilitation	CLINICAL EPIDEMIOLOGY			English	Article						database; health care disparities; registries; validity		Purpose: To identify all hospitalized patients surviving severe traumatic brain injury (TBI) in Denmark and to compare these patients to TBI patients admitted to highly specialized rehabilitation (HS-rehabilitation). Patients and methods: Patients surviving severe TBI were identified from The Danish National Patient Registry and The Danish Head Trauma Database. Overall incidence rates of surviving severe TBI and incidence rates of admission to HS-rehabilitation after severe TBI were estimated and compared. Patient-related predictors of no admission to HS-rehabilitation among patients surviving severe TBI were identified using multivariable logistic regression. Results: The average incidence rate of surviving severe TBI was 2.3 per 100,000 person years. Incidence rates of HS-rehabilitation were generally stable around 2.0 per 100,000 person years. Overall, 84% of all patients surviving severe TBI were admitted to HS-rehabilitation. Female sex, older age, and non-working status pre-injury were independent predictors of no HS-rehabilitation among patients surviving severe TBI. Conclusion: The incidence rate of hospitalized patients surviving severe TBI was stable in Denmark and the majority of the patients were admitted to HS-rehabilitation. However, potential inequity in access to HS-rehabilitation may still be present despite a health care system based on equal access for all citizens.	[Odgaard, Lene; Nielsen, Jorgen Feldbeak] Aarhus Univ, Hammel Neurorehabil Ctr, Aarhus, Denmark; [Odgaard, Lene; Nielsen, Jorgen Feldbeak] Aarhus Univ, Univ Res Clin, Aarhus, Denmark; [Poulsen, Ingrid; Kammersgaard, Lars Peter] Copenhagen Univ Hosp, Dept Neurorehabil, TBI, Copenhagen, Denmark; [Poulsen, Ingrid; Kammersgaard, Lars Peter] Copenhagen Univ Hosp, Glostrup, Res Unit Brain Injury Rehabil RUBRIC, Copenhagen, Denmark; [Johnsen, Soren Paaske] Aarhus Univ Hosp, Dept Clin Epidemiol, Aarhus, Denmark	Odgaard, L (corresponding author), Hammel Neurorehabil Ctr, Voldbyvej 14, DK-8450 Hammel, Denmark.; Odgaard, L (corresponding author), Univ Res Clin, Voldbyvej 14, DK-8450 Hammel, Denmark.	lenhel@rm.dk	Nielsen, Jorgen Feldbak/AAR-6384-2021; Poulsen, ingrid/AAH-2052-2019; Odgaard, Lene/AAF-1909-2020	Nielsen, Jorgen Feldbak/0000-0001-5339-171X; Odgaard, Lene/0000-0002-9830-3282			Ahlgren A, 2004, INT J REHABIL RES, V27, P171, DOI 10.1097/00004356-200409000-00001; Andelic N, 2012, NEUROEPIDEMIOLOGY, V38, P259, DOI 10.1159/000338032; Annoni J M, 1992, Disabil Rehabil, V14, P23; Ashley Mark J, 2012, Cerebrum, V2012, P8; Berry C, 2009, J TRAUMA, V67, P950, DOI 10.1097/TA.0b013e3181ba3354; Bushnik T, 2003, ARCH PHYS MED REHAB, V84, P151, DOI 10.1053/apmr.2003.50123; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; de Kloet AJ, 2013, BRAIN INJURY, V27, P843, DOI 10.3109/02699052.2013.775496; Engberg A, 1995, Acta Neurol Scand Suppl, V164, P1; Engberg AW, 2007, J HEAD TRAUMA REHAB, V22, P221, DOI 10.1097/01.HTR.0000281837.62226.54; Grote S, 2011, J NEUROTRAUM, V28, P527, DOI 10.1089/neu.2010.1433; Holm LV, 2013, ACTA ONCOL, V52, P410, DOI 10.3109/0284186X.2012.745014; Holm LV, 2012, SUPPORT CARE CANCER, V20, P2913, DOI 10.1007/s00520-012-1420-0; Kadyan V, 2004, AM J PHYS MED REHAB, V83, P747, DOI 10.1097/01.PHM.0000140790.30468.F4; Lidwall U., 2006, SWEDISH SOCIAL INSUR; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Maas AIR, 2013, LANCET NEUROL, V12, P1200, DOI 10.1016/S1474-4422(13)70234-5; Maas AIR, 2012, J NEUROTRAUM, V29, P32, DOI 10.1089/neu.2010.1599; Maas AIR, 2011, J NEUROTRAUM, V28, P177, DOI 10.1089/neu.2010.1617; Masson F, 2003, BRAIN INJURY, V17, P279, DOI 10.1080/0269905021000030805; Masson F, 2001, J TRAUMA, V51, P481, DOI 10.1097/00005373-200109000-00010; Nakase-Richardson R, 2009, ARCH PHYS MED REHAB, V90, P17, DOI 10.1016/j.apmr.2008.06.030; OECD, 2013, OECD REV HLTH CAR QU; Oliver A, 2004, J EPIDEMIOL COMMUN H, V58, P655, DOI 10.1136/jech.2003.017731; Pedersen CB, 2011, SCAND J PUBLIC HEALT, V39, P22, DOI 10.1177/1403494810387965; Perez K, 2012, ACCIDENT ANAL PREV, V46, P37, DOI 10.1016/j.aap.2011.12.004; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Sundhedsstyrelsen [National Board of Health], 1997, BEH TRAUM HJERN TILG	30	18	18	0	2	DOVE MEDICAL PRESS LTD	ALBANY	PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND	1179-1349			CLIN EPIDEMIOL	Clin. Epidemiol.		2015	7						225	234		10.2147/CLEP.S78141			10	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	V46UY	WOS:000209910300024	25848317	DOAJ Gold, Green Published			2021-06-18	
J	Seo, JP; Jang, SH				Seo, Jeong Pyo; Jang, Sung Ho			Traumatic axonal injury of the corticospinal tract in the subcortical white matter in patients with mild traumatic brain injury	BRAIN INJURY			English	Article						Axonal injury; corticospinal tract; diffusion tensor imaging; mild traumatic brain injury	TRACTOGRAPHY; STIMULATION; MULTICENTER; IMPAIRMENT; RECOVERY; HUMANS	Background: Little is known about injury of the corticospinal tract (CST) in patients with mild traumatic brain injury (TBI). This study reports on patients with mild TBI who showed traumatic axonal injury of the CST in the sub-cortical white matter, as demonstrated by diffusion tensor tractography (DTT). Methods: Four patients with mild TBI who complained of motor weakness and had DTT parameters within the normal range, including fractional anisotropy, apparent diffusion coefficient and fibre number of the CST, and 10 normal control subjects were recruited for this study. Results: All four patients showed partial tearing of the CSTs in a portion of the sub-cortical white matter in both hemispheres on DTT. However, three patients showed low amplitude on motor evoked potential obtained from both hand muscles by transcranial magnetic stimulation and two patients revealed abnormality of hand motor function in terms of grip strength or Purdue Pegboard score. Conclusions: This study demonstrated traumatic axonal injury of the CST using configurational evaluation of DTT in patients with mild TBI. It is believed that configurational evaluation using DTT would be a useful technique for detection of localized traumatic axonal injury in patients with mild TBI.	[Seo, Jeong Pyo; Jang, Sung Ho] Yeungnam Univ, Coll Med, Dept Phys Med & Rehabil, Taegu 705717, South Korea	Jang, SH (corresponding author), Yeungnam Univ, Coll Med, Dept Phys Med & Rehabil, 317-1 Daemyungdong, Taegu 705717, South Korea.	strokerehab@hanmail.net			Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2012R1A1A4A01001873]	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2012R1A1A4A01001873).	ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Brown AW, 2007, BRAIN INJURY, V21, P673, DOI 10.1080/02699050701468925; Cho HK, 2011, BRAIN INJURY, V25, P1005, DOI 10.3109/02699052.2011.605095; Choi GS, 2012, ARCH NEUROL-CHICAGO, V69, P363, DOI 10.1001/archneurol.2011.1930; DAVIDOFF RA, 1990, NEUROLOGY, V40, P332; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; Jang SH, 2005, RESTOR NEUROL NEUROS, V23, P51; Jang SH, 2011, NEUROREHABILITATION, V29, P339, DOI 10.3233/NRE-2011-0710; Jang SH, 2011, YONSEI MED J, V52, P553, DOI 10.3349/ymj.2011.52.4.553; Jang SH, 2009, NEUROREHABILITATION, V25, P229, DOI 10.3233/NRE-2009-0519; Kasahara K, 2012, MAGN RESON IMAGING, V30, P496, DOI 10.1016/j.mri.2011.12.018; Kim YT, 1994, J KOREAN ACAD REHAB, V18, P780; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Lee JW, 2006, J HEAD TRAUMA REHAB, V21, P272, DOI 10.1097/00001199-200605000-00007; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Singh M, 2010, MAGN RESON IMAGING, V28, P22, DOI 10.1016/j.mri.2009.05.049; Skoglund TS, 2008, ACTA RADIOL, V49, P98, DOI 10.1080/02841850701561372; Walker WC, 2007, J REHABIL RES DEV, V44, P975, DOI 10.1682/JRRD.2006.12.0158; Wedeen VJ, 2008, NEUROIMAGE, V41, P1267, DOI 10.1016/j.neuroimage.2008.03.036; Yamada K, 2009, MAGN RESON MED SCI, V8, P165, DOI 10.2463/mrms.8.165; Yasokawa YT, 2007, J NEUROTRAUM, V24, P163, DOI 10.1089/neu.2006.0073; YORK DH, 1987, NEUROSURGERY, V20, P70	26	18	18	0	12	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2015	29	1					110	114		10.3109/02699052.2014.973447			5	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	AW1WC	WOS:000346078000015	25356741				2021-06-18	
J	Walthers, CM; Seidlits, SK				Walthers, Christopher M.; Seidlits, Stephanie K.			Gene Delivery Strategies to Promote Spinal Cord Repair	BIOMARKER INSIGHTS			English	Article						gene therapy; spinal cord; neurodegeneration	ADENOASSOCIATED VIRAL VECTOR; NEURAL STEM-CELLS; IMPROVES FUNCTIONAL RECOVERY; SUPPORTED LIPID-BILAYERS; IN-VIVO ELECTROPORATION; BLOOD-BRAIN-BARRIER; TRANSGENE EXPRESSION; NEUROTROPHIC FACTOR; LENTIVIRAL VECTORS; GROWTH-FACTOR	Gene therapies hold great promise for the treatment of many neurodegenerative disorders and traumatic injuries in the central nervous system. However, development of effective methods to deliver such therapies in a controlled manner to the spinal cord is a necessity for their translation to the clinic. Although essential progress has been made to improve efficiency of transgene delivery and reduce the immunogenicity of genetic vectors, there is still much work to be done to achieve clinical strategies capable of reversing neurodegeneration and mediating tissue regeneration. In particular, strategies to achieve localized, robust expression of therapeutic transgenes by target cell types, at controlled levels over defined time periods, will be necessary to fully regenerate functional spinal cord tissues. This review summarizes the progress over the last decade toward the development of effective gene therapies in the spinal cord, including identification of appropriate target genes, improvements to design of genetic vectors, advances in delivery methods, and strategies for delivery of multiple transgenes with synergistic actions. The potential of biomaterials to mediate gene delivery while simultaneously providing inductive scaffolding to facilitate tissue regeneration is also discussed.	[Walthers, Christopher M.; Seidlits, Stephanie K.] Univ Calif Los Angeles, Dept Bioengn, Los Angeles, CA USA	Seidlits, SK (corresponding author), Univ Calif Los Angeles, Dept Bioengn, Los Angeles, CA USA.	seidlits@ucla.edu	Seidlits, Stephanie/D-4921-2014				Abdellatif AA, 2006, J NEUROSCI RES, V84, P553, DOI 10.1002/jnr.20968; Adams CF, 2013, NANOMED-NANOTECHNOL, V9, P737, DOI 10.1016/j.nano.2013.05.014; Aguado BA, 2012, TISSUE ENG PT A, V18, P806, DOI [10.1089/ten.tea.2011.0391, 10.1089/ten.TEA.2011.0391]; Ahn M, 2012, BRAIN RES, V1445, P11, DOI 10.1016/j.brainres.2012.01.045; Alimperti S, 2012, GENE THER, V19, P1123, DOI 10.1038/gt.2011.208; An S, 2013, BIOMATERIALS, V34, P8949, DOI 10.1016/j.biomaterials.2013.07.060; Ando T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051744; Angeli CA, 2014, BRAIN, V137, P1394, DOI 10.1093/brain/awu038; Aschauer DF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076310; Aviles MO, 2011, DRUG DELIV TRANSL RE, V1, P91, DOI 10.1007/s13346-010-0011-1; Aviles MO, 2010, BIOMATERIALS, V31, P1140, DOI 10.1016/j.biomaterials.2009.10.035; Barateiro A, 2014, BBA-MOL CELL RES, V1843, P1917, DOI 10.1016/j.bbamcr.2014.04.018; Bartus K, 2014, J NEUROSCI, V34, P4822, DOI 10.1523/JNEUROSCI.4369-13.2014; Baumgartner BJ, 1997, J NEUROSCI, V17, P6504; Beck KD, 2010, BRAIN, V133, P433, DOI 10.1093/brain/awp322; Benkhelifa-Ziyyat S, 2013, MOL THER, V21, P282, DOI 10.1038/mt.2012.261; Berry M, 2001, MOL CELL NEUROSCI, V17, P706, DOI 10.1006/mcne.2001.0975; Bevan AK, 2011, MOL THER, V19, P1971, DOI 10.1038/mt.2011.157; Bevan AK, 2014, DRUG DELIVERY BRAIN, P485; Blesch A, 2002, BRAIN RES BULL, V57, P833, DOI 10.1016/S0361-9230(01)00774-2; Blesch A, 2007, J NEUROSCI, V27, P10535, DOI 10.1523/JNEUROSCI.1903-07.2007; Blits B, 2006, J NEUROTRAUM, V23, P508, DOI 10.1089/neu.2006.23.508; Blits B, 2005, RESTOR NEUROL NEUROS, V23, P313; Blitts B, 2003, NEUROSCIENCE, V118, P271, DOI 10.1016/S0306-4522(02)00970-3; Boehler RM, 2013, BIOMATERIALS, V34, P5431, DOI 10.1016/j.biomaterials.2013.04.009; Bonner JF, 2010, J NEUROSCI RES, V88, P1182, DOI 10.1002/jnr.22288; Bradbury EJ, 2011, BRAIN RES BULL, V84, P306, DOI 10.1016/j.brainresbull.2010.06.015; Brooks AR, 2004, J GENE MED, V6, P395, DOI 10.1002/jgm.516; Cafferty WBJ, 2007, J NEUROSCI, V27, P2176, DOI 10.1523/JNEUROSCI.5176-06.2007; Cai D, 2001, J NEUROSCI, V21, P4731, DOI 10.1523/JNEUROSCI.21-13-04731.2001; Cameron AA, 2006, J NEUROSCI, V26, P2923, DOI 10.1523/JNEUROSCI.4390-05.2006; Cao QL, 2010, J NEUROSCI, V30, P2989, DOI 10.1523/JNEUROSCI.3174-09.2010; Cao QL, 2005, J NEUROSCI, V25, P6947, DOI 10.1523/JNEUROSCI.1065-05.2005; Castle MJ, 2014, HUM GENE THER, V25, P705, DOI 10.1089/hum.2013.189; Cen JS, 2013, SPINE, V38, P1632, DOI 10.1097/BRS.0b013e31829dd58f; Chamberlin NL, 1998, BRAIN RES, V793, P169, DOI 10.1016/S0006-8993(98)00169-3; Chen MH, 2013, INT J CLIN EXP PATHO, V6, P2312; Chitty DW, 2012, J NEUROSCI METH, V205, P17, DOI 10.1016/j.jneumeth.2011.12.007; Chtarto A, 2003, GENE THER, V10, P84, DOI 10.1038/sj.gt.3301838; Clark ZJ, 2010, ANN NEUROSCI, V17, P142, DOI 10.5214/ans.0972-7531.1017310; Cregg JM, 2014, EXP NEUROL, V253, P197, DOI 10.1016/j.expneurol.2013.12.024; Croyle MA, 2004, J VIROL, V78, P912, DOI 10.1128/JVI.78.2.912-921.2004; Curinga GM, 2007, J NEUROCHEM, V102, P275, DOI 10.1111/j.1471-4159.2007.04530.x; De Laporte L, 2011, J BIOMED MATER RES A, V98A, P372, DOI 10.1002/jbm.a.33112; De Laporte L, 2010, ACTA BIOMATER, V6, P2889, DOI 10.1016/j.actbio.2010.02.018; De Laporte L, 2009, MOL THER, V17, P318, DOI 10.1038/mt.2008.252; De Laporte L, 2009, BIOMATERIALS, V30, P2361, DOI 10.1016/j.biomaterials.2008.12.051; Delenda C, 2004, J GENE MED, V6, pS125, DOI 10.1002/jgm.501; Dengler EC, 2013, J CONTROL RELEASE, V168, P209, DOI 10.1016/j.jconrel.2013.03.009; Desclaux M, 2015, J NEUROSCI RES, V93, P43, DOI 10.1002/jnr.23468; Doring A, 2011, EUR J IMMUNOL, V41, P813, DOI 10.1002/eji.201040912; Donnelly EM, 2012, CYTOTHERAPY, V14, P1235, DOI 10.3109/14653249.2012.714865; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Eleftheriadou I, 2014, MOL THER, V22, P1285, DOI 10.1038/mt.2014.49; Ellinwood NM, 2011, MOL THER, V19, P251, DOI 10.1038/mt.2010.265; Fagoe ND, 2014, GENE THER, V21, P242, DOI 10.1038/gt.2013.71; Foley CP, 2014, J CONTROL RELEASE, V196, P71, DOI 10.1016/j.jconrel.2014.09.018; Foust KD, 2008, HUM GENE THER, V19, P71, DOI 10.1089/hum.2007.104; Foust KD, 2010, NAT BIOTECHNOL, V28, P271, DOI 10.1038/nbt.1610; Franz S, 2012, EXP NEUROL, V235, P62, DOI 10.1016/j.expneurol.2011.01.015; Fujita Y, 2014, FRONT NEUROSCI, V8, P1; Garbossa D, 2012, NEUROSURG REV, V35, P293, DOI 10.1007/s10143-012-0385-2; Gensel JC, 2012, CELL TISSUE RES, V349, P201, DOI 10.1007/s00441-012-1425-5; Gerin CG, 2011, SYNAPSE, V65, P1255, DOI 10.1002/syn.20903; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; Glorioso JC, 2004, ANNU REV MICROBIOL, V58, P253, DOI 10.1146/annurev.micro.58.030603.123709; Gonzalez AM, 2006, J GENE MED, V8, P901, DOI 10.1002/jgm.919; Gonzalez AM, 2009, J GENE MED, V11, P679, DOI 10.1002/jgm.1354; Gower RM, 2014, BIOMATERIALS, V35, P2024, DOI 10.1016/j.biomaterials.2013.11.036; Grill RJ, 1997, EXP NEUROL, V148, P444, DOI 10.1006/exnr.1997.6704; Gros T, 2010, BIOMATERIALS, V31, P6719, DOI 10.1016/j.biomaterials.2010.04.035; Gross RE, 2007, CELL TRANSPLANT, V16, P245, DOI 10.3727/000000007783464740; Grulova I, 2013, SPINE J, V13, P1881, DOI 10.1016/j.spinee.2013.06.073; Haberman RP, 1998, GENE THER, V5, P1604, DOI 10.1038/sj.gt.3300782; Hacein-Bey-Abina S, 2003, NEW ENGL J MED, V348, P255, DOI 10.1056/NEJM200301163480314; Hannila SS, 2008, EXP NEUROL, V209, P321, DOI 10.1016/j.expneurol.2007.06.020; Hausmann O, 2003, SPINAL CORD, V41, P369, DOI 10.1038/sj.sc.3101483; Hayakawa K, 2015, J CONTROL RELEASE, V197, P1, DOI 10.1016/j.jconrel.2014.10.027; Hendriks WTJ, 2007, J NEUROSCI RES, V85, P3041, DOI 10.1002/jnr.21432; Hendriks WTJ, 2007, RESTOR NEUROL NEUROS, V25, P585; Hendriks WTJ, 2004, PROG BRAIN RES, V146, P451; Hermens WTJMC, 1998, BRAIN RES BULL, V47, P133, DOI 10.1016/S0361-9230(98)00042-2; Hirano M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075896; Hollis ER, 2009, P NATL ACAD SCI USA, V106, P7215, DOI 10.1073/pnas.0810624106; Hooshmand MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005871; Horn KP, 2008, J NEUROSCI, V28, P9330, DOI 10.1523/JNEUROSCI.2488-08.2008; Hou SP, 2012, J NEUROSCI, V32, P13206, DOI 10.1523/JNEUROSCI.5041-11.2012; Houchin-Ray T, 2007, MOL THER, V15, P705, DOI 10.1038/sj.mt.6300106; Houchin-Ray T, 2009, BIOTECHNOL BIOENG, V103, P1023, DOI 10.1002/bit.22311; Houchin-Ray T, 2009, J NEUROSCI RES, V87, P844, DOI 10.1002/jnr.21908; Hurtado A, 2006, BIOMATERIALS, V27, P430, DOI 10.1016/j.biomaterials.2005.07.014; Hutson TH, 2012, GENE THER, V19, P49, DOI 10.1038/gt.2011.71; Hutson TH, 2014, METHODS MOL BIOL, V1162, P189, DOI 10.1007/978-1-4939-0777-9_16; Hyun J, 2013, STEM CELL TRANSL MED, V2, P690, DOI 10.5966/sctm.2013-0035; Jandial R, 2008, MOL THER, V16, P450, DOI 10.1038/sj.mt.6300402; Jeffery ND, 2009, J TISSUE ENG REGEN M, V3, P153, DOI 10.1002/term.139; Jin HL, 2011, SPINE, V36, P857, DOI 10.1097/BRS.0b013e3181e7f34b; Johnson PJ, 2010, CELL TRANSPLANT, V19, P89, DOI 10.3727/096368909X477273; Jones LL, 2001, J PHYSIOL-LONDON, V533, P83, DOI 10.1111/j.1469-7793.2001.0083b.x; Kadoya K, 2009, NEURON, V64, P165, DOI 10.1016/j.neuron.2009.09.016; Kaspar BK, 2002, P NATL ACAD SCI USA, V99, P2320, DOI 10.1073/pnas.042678699; Kidd ME, 2012, J CONTROL RELEASE, V157, P80, DOI 10.1016/j.jconrel.2011.08.036; Kim E, 2014, ACS APPL MATER INTER, V6, P8288, DOI 10.1021/am5011095; Kim JS, 2012, GENE THER, V19, P329, DOI 10.1038/gt.2011.84; Kopp MA, 2012, CELL TISSUE RES, V349, P119, DOI 10.1007/s00441-012-1334-7; Kusano K, 2010, BIOCHEM BIOPH RES CO, V393, P812, DOI 10.1016/j.bbrc.2010.02.088; Kwon EJ, 2008, J CONTROL RELEASE, V132, P230, DOI 10.1016/j.jconrel.2008.06.012; Kwon EJ, 2010, BIOMATERIALS, V31, P2417, DOI 10.1016/j.biomaterials.2009.11.086; Kwon I, 2008, PHARM RES, V25, P489, DOI 10.1007/s11095-007-9431-0; Lang BT, 2015, NATURE, V518, P404, DOI 10.1038/nature13974; Lau BYB, 2013, EXP NEUROL, V250, P31, DOI 10.1016/j.expneurol.2013.09.004; Lavdas AA, 2010, EXP NEUROL, V221, P206, DOI 10.1016/j.expneurol.2009.10.024; Lei YG, 2010, BIOMATERIALS, V31, P9106, DOI 10.1016/j.biomaterials.2010.08.016; Lentz TB, 2012, NEUROBIOL DIS, V48, P179, DOI 10.1016/j.nbd.2011.09.014; Li MJ, 2010, J NEUROSCI METH, V189, P56, DOI 10.1016/j.jneumeth.2010.03.019; Li Yan, 2014, World J Stem Cells, V6, P11, DOI 10.4252/wjsc.v6.i1.11; Liu JW, 2009, CHEM COMMUN, P5100, DOI 10.1039/b911472f; Lutton C, 2012, J NEUROTRAUM, V29, P957, DOI 10.1089/neu.2010.1423; Maheshri N, 2006, NAT BIOTECHNOL, V24, P198, DOI 10.1038/nbt1182; Mantilla CB, 2013, EXP NEUROL, V247, P101, DOI 10.1016/j.expneurol.2013.04.002; Marumoto T, 2009, NAT MED, V15, P110, DOI 10.1038/nm.1863; McIver SR, 2005, J NEUROSCI RES, V82, P397, DOI 10.1002/jnr.20626; Meunier A, 2008, J NEUROSCI METH, V167, P148, DOI 10.1016/j.jneumeth.2007.07.022; Mohan R, 2014, NEUROSCIENCE, V274, P318, DOI 10.1016/j.neuroscience.2014.05.045; Mullick A, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-43; Naidoo J, 2012, NEUROL RES INT, V2012, DOI 10.1155/2012/595410; Nakajima H., 2014, NEUROPROTECTION REGE, V1, P193; Nakajima H, 2010, SPINE, V35, P497, DOI 10.1097/BRS.0b013e3181b8e89b; Negro-Demontel ML, 2014, MOL THER-METH CLIN D, V1, DOI 10.1038/mtm.2014.47; Nistor GI, 2005, GLIA, V49, P385, DOI 10.1002/glia.20127; Padmashali RM, 2011, BIOMATERIALS, V32, P3330, DOI 10.1016/j.biomaterials.2011.01.035; Pakulska MM, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/2/024101; Papastefanaki F, 2007, BRAIN, V130, P2159, DOI 10.1093/brain/awm155; Park IK, 2007, J GENE MED, V9, P691, DOI 10.1002/jgm.1062; Park TE, 2015, BIOMATERIALS, V38, P61, DOI 10.1016/j.biomaterials.2014.10.068; Pearse DD, 2006, J NEUROTRAUM, V23, P438, DOI 10.1089/neu.2006.23.437; Peel AL, 1997, GENE THER, V4, P16, DOI 10.1038/sj.gt.3300358; Pennant WA, 2014, SPINAL CORD, V52, P3, DOI 10.1038/sc.2013.106; Perez-Martinez FC, 2012, J ALZHEIMERS DIS, V31, P697, DOI 10.3233/JAD-2012-120661; Pickard MR, 2011, BIOMATERIALS, V32, P2274, DOI 10.1016/j.biomaterials.2010.12.007; Popovich PG, 1997, J COMP NEUROL, V377, P443, DOI 10.1002/(SICI)1096-9861(19970120)377:3<443::AID-CNE10>3.0.CO;2-S; Qi YH, 2014, GENET MOL RES, V13, P1366, DOI 10.4238/2014.February.28.9; Qin LH, 1997, HUM GENE THER, V8, P2019, DOI 10.1089/hum.1997.8.17-2019; Rabchevsky AG, 2000, EXP NEUROL, V164, P280, DOI 10.1006/exnr.2000.7399; Rahim AA, 2009, GENE THER, V16, P509, DOI 10.1038/gt.2008.186; Rappa G, 2004, NEUROSCIENCE, V124, P823, DOI 10.1016/j.neuroscience.2003.11.030; Rodriguez JP, 2014, J NEUROSCI, V34, P10285, DOI 10.1523/JNEUROSCI.4915-13.2014; Ronaghi M, 2010, STEM CELLS, V28, P93, DOI 10.1002/stem.253; Rosenberg JB, 2014, HUM GENE THER CL DEV, V25, P164, DOI 10.1089/humc.2013.239; Ruitenberg MJ, 2004, NEUROBIOL DIS, V15, P394, DOI 10.1016/j.nbd.2003.11.018; Saito T, 2006, NAT PROTOC, V1, P1552, DOI 10.1038/nprot.2006.276; Salegio EA, 2013, GENE THER, V20, P348, DOI 10.1038/gt.2012.27; Salvay DM, 2006, MOL BIOSYST, V2, P36, DOI 10.1039/b514174p; Sareen D, 2014, J COMP NEUROL, V522, P2707, DOI 10.1002/cne.23578; Sasaki M, 2009, J NEUROSCI, V29, P14932, DOI 10.1523/JNEUROSCI.2769-09.2009; Sato T, 2013, J NEUROSCI METH, V214, P170, DOI 10.1016/j.jneumeth.2013.01.014; Schwab ME, 2002, SCIENCE, V295, P1029, DOI 10.1126/science.1067840; Segura T, 2005, BIOMATERIALS, V26, P1575, DOI 10.1016/j.biomaterials.2004.05.007; Seidlits SK, 2014, BIOMATERIALS AND REGENERATIVE MEDICINE, P431; Seidlits SK, 2013, EXPERT OPIN DRUG DEL, V10, P499, DOI 10.1517/17425247.2013.764864; Seijffers R, 2006, MOL CELL NEUROSCI, V32, P143, DOI 10.1016/j.mcn.2006.03.005; Seijffers R, 2014, P NATL ACAD SCI USA, V111, P1622, DOI 10.1073/pnas.1314826111; Sharp KG, 2013, EXP NEUROL, V248, P321, DOI 10.1016/j.expneurol.2013.06.023; Sharp KG, 2012, EXP NEUROL, V235, P345, DOI 10.1016/j.expneurol.2012.02.016; Shaw A, 2014, BIOMEDICINES, V2, P14, DOI 10.3390/biomedicines2010014; Shea LD, 1999, NAT BIOTECHNOL, V17, P551; Shepard JA, 2012, BIOMATERIALS, V33, P7412, DOI 10.1016/j.biomaterials.2012.06.081; Shepard JA, 2010, J CONTROL RELEASE, V146, P128, DOI 10.1016/j.jconrel.2010.04.032; Shimamura M, 2005, J GENE MED, V7, P1468, DOI 10.1002/jgm.793; Shin DA, 2014, ACTA NEUROCHIR, V156, P297, DOI 10.1007/s00701-013-1963-y; Shin SJ, 2010, BIOMATERIALS, V31, P4353, DOI 10.1016/j.biomaterials.2010.02.013; Silva NA, 2014, PROG NEUROBIOL, V114, P25, DOI 10.1016/j.pneurobio.2013.11.002; Snyder BR, 2011, HUM GENE THER, V22, P1129, DOI 10.1089/hum.2011.008; Somia N, 2000, NAT REV GENET, V1, P91, DOI 10.1038/35038533; Song HP, 2010, BIOMATERIALS, V31, P769, DOI 10.1016/j.biomaterials.2009.09.085; Sontag CJ, 2014, STEM CELL REP, V2, P620, DOI 10.1016/j.stemcr.2014.03.005; Stenudd M, 2015, JAMA NEUROL, V72, P235, DOI 10.1001/jamaneurol.2014.2927; Strappe PM, 2005, EUR J PHARM BIOPHARM, V61, P126, DOI 10.1016/j.ejpb.2005.06.006; Tang BL, 2007, CELL MOL NEUROBIOL, V27, P75, DOI 10.1007/s10571-006-9119-8; Tator CH, 1998, NEUROSURGERY, V42, P696, DOI 10.1097/00006123-199804000-00007; Taylor L, 2006, J NEUROSCI, V26, P9713, DOI 10.1523/JNEUROSCI.0734-06.2006; Thomas AM, 2014, INTEGR BIOL-UK, V6, P694, DOI 10.1039/c4ib00009a; Thomas AM, 2013, J CONTROL RELEASE, V170, P421, DOI 10.1016/j.jconrel.2013.06.013; Thomas AM, 2013, BIOMATERIALS, V34, P2213, DOI 10.1016/j.biomaterials.2012.12.002; Tobias CA, 2003, EXP NEUROL, V184, P97, DOI 10.1016/S0014-4886(03)00394-7; Tokatlian T, 2014, BIOMATERIALS, V35, P825, DOI 10.1016/j.biomaterials.2013.10.014; Toyooka T, 2011, J NEUROTRAUM, V28, P607, DOI 10.1089/neu.2010.1520; Tuinstra HM, 2012, BIOMATERIALS, V33, P1618, DOI 10.1016/j.biomaterials.2011.11.002; Uchida K, 2012, SPINE, V37, P2125, DOI 10.1097/BRS.0b013e3182600ef7; van Gestel MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097639; Volpato FZ, 2013, BIOMATERIALS, V34, P4945, DOI 10.1016/j.biomaterials.2013.03.057; Wallach Corey J, 2006, Spine J, V6, P107, DOI 10.1016/j.spinee.2005.05.002; Wang JM, 2011, BIOMATERIALS, V32, P7454, DOI 10.1016/j.biomaterials.2011.06.036; Wang YX, 2012, BRAIN RES, V1448, P137, DOI 10.1016/j.brainres.2012.02.007; Wells DJ, 2004, GENE THER, V11, P1363, DOI 10.1038/sj.gt.3302337; Wolfe D, 2009, PAIN MED, V10, P1325, DOI 10.1111/j.1526-4637.2009.00720.x; Wu HF, 2013, BIOMATERIALS, V34, P1686, DOI 10.1016/j.biomaterials.2012.11.013; Yamaguchi M, 2013, ACS SYNTH BIOL, V3, P239; Yao L, 2013, GENE THER, V20, P1149, DOI 10.1038/gt.2013.42; Yao L, 2012, DRUG DISCOV TODAY, V17, P998, DOI 10.1016/j.drudis.2012.05.009; Yin H, 2014, NAT REV GENET, V15, P541, DOI 10.1038/nrg3763; Yip PK, 2006, HUM MOL GENET, V15, P3107, DOI 10.1093/hmg/ddl251; Yip PK, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000399; Yoo M, 2014, J NEUROTRAUM, V31, P553, DOI 10.1089/neu.2013.2886; Yukawa Y, 2002, J NEUROTRAUM, V19, P1091, DOI 10.1089/089771502760341992; Zhang HY, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-130; Zhao RR, 2011, J NEUROSCI METH, V201, P228, DOI 10.1016/j.jneumeth.2011.08.003; Zhou HX, 2014, BRAIN RES, V1586, P46, DOI 10.1016/j.brainres.2014.08.048; Zhou LJ, 2003, J NEUROSCI, V23, P1424	209	18	19	0	12	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1177-2719			BIOMARK INSIGHTS	Biomark. Insights		2015	10			1			11	29		10.4137/BMIMI.S20063			19	Medicine, Research & Experimental	Research & Experimental Medicine	DB5UQ	WOS:000368579500002	25922572	DOAJ Gold			2021-06-18	
J	Andrews, G; Halford, GS; Chappell, M; Maujean, A; Shum, DHK				Andrews, Glenda; Halford, Graeme S.; Chappell, Mark; Maujean, Annick; Shum, David H. K.			Planning following stroke: a relational complexity approach using the Tower of London	FRONTIERS IN HUMAN NEUROSCIENCE			English	Article						Tower of London; planning; moves to solution; search depth; goal ambiguity; relational complexity; stroke; frontal lobes	TRAUMATIC BRAIN-INJURY; PREMISE INTEGRATION; YOUNG-CHILDREN; TRANSITIVE INFERENCE; PREFRONTAL CORTEX; 4-DISK VERSION; OF-LONDON; TASK; CAPACITY; PERFORMANCE	Planning on the 4-disk version of the Tower of London (TOL4) was examined in stroke patients and unimpaired controls. Overall TOL4 solution scores indicated impaired planning in the frontal stroke but not non-frontal stroke patients. Consistent with the claim that processing the relations between current states, intermediate states, and goal states is a key process in planning, the domain-general relational complexity metric was a good indicator of the experienced difficulty of TOL4 problems. The relational complexity metric shared variance with task-specific metrics of moves to solution and search depth. Frontal stroke patients showed impaired planning compared to controls on problems at all three complexity levels, but at only two of the three levels of moves to solution, search depth and goal ambiguity. Non-frontal stroke patients showed impaired planning only on the most difficult quaternary-relational and high search depth problems. An independent measure of relational processing (viz., Latin square task) predicted TOL4 solution scores after controlling for stroke status and location, and executive processing (Trail Making Test). The findings suggest that planning involves a domain-general capacity for relational processing that depends on the frontal brain regions.	[Andrews, Glenda] Griffith Univ, Sch Appl Psychol, Griffith Hlth Inst, Behav Basis Hlth Program, Gold Coast, Qld 4222, Australia; [Halford, Graeme S.; Chappell, Mark; Shum, David H. K.] Griffith Univ, Sch Appl Psychol, Griffith Hlth Inst, Behav Basis Hlth Program, Brisbane, Qld, Australia; [Maujean, Annick] Griffith Univ, Griffith Hlth Inst, Ctr Natl Res Disabil & Rehabil Med CONROD, Meadowbrook, Qld 4131, Australia	Andrews, G (corresponding author), Griffith Univ, Sch Appl Psychol, Parklands Dr, Gold Coast, Qld 4222, Australia.	g.andrews@griffith.edu.au	Shum, David/A-3914-2008; Andrews, Glenda/H-5665-2012	Shum, David/0000-0002-4810-9262; Maujean, Annick/0000-0002-9623-1369; Andrews, Glenda/0000-0001-8047-9151	Australian Research Council DiscoveryAustralian Research Council [DPO452547]	We are grateful to the organizations that assisted with recruitment of the stroke and control groups and to participants themselves. This research was funded by an Australian Research Council Discovery Grant (DPO452547) awarded to Halford, Andrews, Birney, Chappell, and Shum.	Andrews G, 2002, COGNITIVE PSYCHOL, V45, P153, DOI 10.1016/S0010-0285(02)00002-6; Andrews G, 2003, CHILD DEV, V74, P1476, DOI 10.1111/1467-8624.00618; Andrews G, 1998, COGNITIVE DEV, V13, P479, DOI 10.1016/S0885-2014(98)90004-1; Andrews G, 2012, PSYCHOL POWER, P1; Andrews G., 2008, PSYCHOL GAMBLING, P111; Andrews G, 2008, NEW RES SHORT TERM M, P93; Andrews G, 2006, MEM COGNITION, V34, P1325, DOI 10.3758/BF03193275; Andrews G, 2014, J COGN PSYCHOL, V26, P588, DOI 10.1080/20445911.2014.909434; Andrews G, 2013, BRAIN COGNITION, V81, P44, DOI 10.1016/j.bandc.2012.09.003; Andrews G, 2012, J EXP CHILD PSYCHOL, V112, P84, DOI 10.1016/j.jecp.2011.12.004; Andrews G, 2011, COGNITIVE DEVELOPMENT AND WORKING MEMORY: A DIALOGUE BETWEEN NEO-PIAGETIAN THEORIES AND COGNITIVE APPROACHES, P47; Andrews G, 2010, MEM COGNITION, V38, P928, DOI 10.3758/MC.38.7.928; Andrews G, 2009, COGNITIVE DEV, V24, P49, DOI 10.1016/j.cogdev.2008.07.005; Birney D. P., 2002, Thinking & Reasoning, V8, P109, DOI 10.1080/13546780143000161; Birney DP, 2012, EUR J PSYCHOL ASSESS, V28, P216, DOI 10.1027/1015-5759/a000146; Birney DP, 2006, EDUC PSYCHOL MEAS, V66, P146, DOI 10.1177/0013164405278570; Bunch KM, 2007, COGNITIVE DEV, V22, P376, DOI 10.1016/j.cogdev.2007.01.004; Bunch KM, 2012, DEV NEUROPSYCHOL, V37, P134, DOI 10.1080/87565641.2011.632457; Cocchi L, 2014, CEREB CORTEX, V24, P2283, DOI 10.1093/cercor/bht075; Cockburn J, 1995, J Int Neuropsychol Soc, V1, P537; Crone EA, 2009, DEVELOPMENTAL SCI, V12, P55, DOI 10.1111/j.1467-7687.2008.00743.x; Dehaene S, 1997, P NATL ACAD SCI USA, V94, P13293, DOI 10.1073/pnas.94.24.13293; English L.D., 1995, MATH ED MODELS PROCE; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gentner D, 2011, CHILD DEV, V82, P1173, DOI 10.1111/j.1467-8624.2011.01599.x; Halford GS, 2007, TRENDS COGN SCI, V11, P236, DOI 10.1016/j.tics.2007.04.001; Halford GS, 2007, COGNITIVE DEV, V22, P384, DOI 10.1016/j.cogdev.2006.12.001; Halford GS, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00682; Halford GS, 2002, J COGN DEV, V3, P143, DOI 10.1207/S15327647JCD0302_2; Halford GS, 2010, TRENDS COGN SCI, V14, P497, DOI 10.1016/j.tics.2010.08.005; Halford GS, 2002, J EXP CHILD PSYCHOL, V81, P417, DOI 10.1006/jecp.2002.2665; Halford GS, 1998, BEHAV BRAIN SCI, V21, P803, DOI 10.1017/S0140525X98001769; Halford GS, 2005, PSYCHOL SCI, V16, P70, DOI 10.1111/j.0956-7976.2005.00782.x; HALFORD GS, 1989, PROCEEDINGS OF THE XXIV INTERNATIONAL CONGRESS OF PSYCHOLOGY, VOL 7, P151; HALFORD GS, 1984, COGNITIVE PSYCHOL, V16, P65, DOI 10.1016/0010-0285(84)90004-5; Hribar A, 2012, J EXP CHILD PSYCHOL, V111, P490, DOI 10.1016/j.jecp.2011.11.004; Jefferson AL, 2006, ARCH CLIN NEUROPSYCH, V21, P311, DOI 10.1016/j.acn.2006.03.007; Kaller CP, 2012, PSYCHOL ASSESSMENT, V24, P46, DOI 10.1037/a0025174; Kaller CP, 2011, BEHAV BRAIN RES, V216, P1, DOI 10.1016/j.bbr.2010.07.029; Knox K., 2010, ASCS09 P 9 C AUSTR S; Kostering L, 2014, DEV PSYCHOL, V50, P293, DOI 10.1037/a0032467; Kroger JK, 2002, CEREB CORTEX, V12, P477, DOI 10.1093/cercor/12.5.477; Muller LD, 2014, NEUROPSYCHOLOGIA, V56, P271, DOI 10.1016/j.neuropsychologia.2014.01.019; Newman SD, 2003, NEUROPSYCHOLOGIA, V41, P1668, DOI 10.1016/S0028-3932(03)00091-5; Perret P, 2011, COGNITIVE DEV, V26, P127, DOI 10.1016/j.cogdev.2010.12.003; Rasmussen IA, 2006, ACTA NEUROPSYCHIATR, V18, P216, DOI 10.1111/j.1601-5215.2006.00145.x; REITAN RM, 1995, CLIN NEUROPSYCHOL, V9, P50, DOI 10.1080/13854049508402057; SHALLICE T, 1982, PHILOS T ROY SOC B, V298, P199, DOI 10.1098/rstb.1982.0082; Shum D, 2000, BRAIN COGNITION, V44, P59; Shum D, 2009, BRAIN IMPAIR, V10, P320, DOI 10.1375/brim.10.3.320; Son JY, 2011, J EXP CHILD PSYCHOL, V108, P260, DOI 10.1016/j.jecp.2010.08.011; Tunstall J., 1999, THESIS GRIFFITH U BR; Unterrainer JM, 2006, J PHYSIOL-PARIS, V99, P308, DOI 10.1016/j.jphysparis.2006.03.014; Viskontas IV, 2005, THINK REASONING, V11, P390, DOI 10.1080/13546780542000014; Waltz JA, 1999, PSYCHOL SCI, V10, P119, DOI 10.1111/1467-9280.00118; Waltz JA, 2004, NEUROPSYCHOLOGY, V18, P296, DOI 10.1037/0894-4105.18.2.296; Ward G, 1997, Q J EXP PSYCHOL-A, V50, P49, DOI 10.1080/027249897392224; Zielinski TA, 2010, EUR J COGN PSYCHOL, V22, P391, DOI 10.1080/09541440902830509	58	18	19	0	0	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-5161			FRONT HUM NEUROSCI	Front. Hum. Neurosci.	DEC 23	2014	8								1032	10.3389/fnhum.2014.01032			14	Neurosciences; Psychology	Neurosciences & Neurology; Psychology	AX1IF	WOS:000346700300003	25566042	DOAJ Gold, Green Published			2021-06-18	
J	Mitchell, SJ; Bennett, MH				Mitchell, Simon J.; Bennett, Michael H.			Unestablished indications for hyperbaric oxygen therapy	DIVING AND HYPERBARIC MEDICINE			English	Article						Hyperbaric oxygen therapy; hyperbaric research; trauma and stress; central nervous system; children; evidence; ethics; review article	POST-CONCUSSION SYNDROME; CEREBRAL-PALSY; DOUBLE-BLIND; CHILDREN; DESIGN	Unestablished indications are conditions in which systematic clinical use of hyperbaric oxygen treatment (HBOT) is not supported by adequate proof of benefit. HBOT is vulnerable to use in many such conditions for various reasons, perhaps the most important being that a placebo or participation effect may create an impression of efficacy. The systematic use of HBOT in unestablished indications raises ethical concerns about provision of misleading information, giving false hope, and taking payment for therapy of doubtful benefit. Any practice perceived as unethical or unscientific has the potential to draw the wider field into disrepute. Of substantial contemporary relevance is the use of HBOT in treatment of various forms of chronic brain injury; in particular, cerebral palsy in children and the sequelae of mild traumatic brain injury in adults. There are now multiple, randomised, blinded, sham-controlled trials of HBOT in both indications. None of these studies showed benefit of HBOT when compared to sham control, though the sham and HBOT groups often both improved, indicating that a placebo or participation effect influenced outcomes. These results almost certainly explain those of open-label trials (lacking sham controls) in which HBOT frequently seems beneficial. Advocates for HBOT in chronic brain injury claim that the sham treatments (usually 1.3 ATA* pressure exposure whilst air breathing) in the blinded trials are actually active treatments; however, the same dose of oxygen can be achieved at 1 ATA breathing 27% oxygen. To counter this argument, advocates also claim that the extra 0.3 ATA of pressure is somehow independently beneficial, but this notion has limited biological plausibility and there is little supporting evidence. Chronic brain injuries remain unestablished indications at this time and, in our opinion, should not be systematically treated with HBOT.	[Mitchell, Simon J.] Auckland City Hosp, Auckland, New Zealand; [Mitchell, Simon J.] Univ Auckland, Dept Anaesthesiol, Auckland, New Zealand; [Bennett, Michael H.] Prince Wales Hosp, Sydney, NSW, Australia	Mitchell, SJ (corresponding author), Univ Auckland, Sch Med, Dept Anaesthesiol, Private Bag 92019, Auckland, New Zealand.	sj.mitchell@auckland.ac.nz		Mitchell, Simon/0000-0002-5149-6371			[Anonymous], 1942, JAMA-J AM MED ASSOC, V118, P1300; Bennett MH, 2011, HARRISONS PRINCIPLES; Boussi-Gross R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079995; Churchill S, 2013, UNDERSEA HYPERBAR M, V40, P165; Cifu DX, 2014, ANN NEUROL, V75, P277, DOI 10.1002/ana.24067; Cifu DX, 2014, J HEAD TRAUMA REHAB, V29, P11, DOI 10.1097/HTR.0b013e3182a6aaf0; Clarke D, 2008, PHYSL MED HYPERBARIC, P3; Collet JP, 2001, LANCET, V357, P582, DOI 10.1016/S0140-6736(00)04054-X; Dean JB, 2003, J APPL PHYSIOL, V95, P883, DOI 10.1152/japplphysiol.00920.2002; Efrati S, 2014, UNDERSEA HYPERBAR M, V41, P71; Efrati S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053716; Federal Drug Administration, HYP OX THER DONT BE; GABB G, 1987, CHEST, V92, P1074, DOI 10.1378/chest.92.6.1074; Harch PG, 2013, UNDERSEA HYPERBAR M, V40, P469; Harch PG, 2012, J NEUROTRAUM, V29, P168, DOI 10.1089/neu.2011.1895; Joo EP, 2008, J SLEEP RES, V17, P82, DOI 10.1111/j.1365-2869.2008.00624.x; Laatsch L, 1999, BRAIN INJURY, V13, P555, DOI 10.1080/026990599121304; Lacey DJ, 2012, ANN NEUROL, V72, P695, DOI 10.1002/ana.23681; Macdonald AG, 1999, COMP BIOCHEM PHYS A, V122, P13, DOI 10.1016/S1095-6433(98)10173-3; Miller RS, 2014, JAMA INT MED    1117, DOI P10.1001/JAMAinternmed.2014.5479; Mukherjee A, 2014, UNDERSEA HYPERBAR M, V41, P77; Newberg AB, 2011, CLIN THER, V33, P1894, DOI 10.1016/j.clinthera.2011.10.013; *SCI ADV COMM, 2000, REP HYP OX THER CHIL; The College of Physicians and Surgeons of Saskatchewan, STAND UNPR UNC TREAT; Undersea and Hyperbaric Medical Society Committee Report, 2014, HYPERBARIC OXYGEN TH; Wager TD, 2004, SCIENCE, V303, P1162, DOI 10.1126/science.1093065; Walker WC, 2014, NEUROREHAB NEURAL RE, V28, P420, DOI 10.1177/1545968313516869; Weaver LK, 2012, UNDERSEA HYPERBAR M, V39, P807; Wolf G, 2012, J NEUROTRAUM, V29, P2606, DOI 10.1089/neu.2012.2549	29	18	19	0	10	SOUTH PACIFIC UNDERWATER MED SOC	MELBOURNE	C/O AUSTRALIAN & NEW ZEALAND COLL ANAESTHETISTS, 630 ST KILDA RD, MELBOURNE, VIC 3004, AUSTRALIA	1833-3516			DIVING HYPERB MED	Diving Hyperb. Med.	DEC	2014	44	4					228	234					7	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	AW5EX	WOS:000346299800010	25596836				2021-06-18	
J	Rognas, L; Hansen, TM; Kirkegaard, H; Tonnesen, E				Rognas, Leif; Hansen, Troels M.; Kirkegaard, Hans; Tonnesen, Else			Anaesthesiologist-provided prehospital airway management in patients with traumatic brain injury: an observational study	EUROPEAN JOURNAL OF EMERGENCY MEDICINE			English	Article						airway management; critical care; emergency medical services; prehospital emergency care; traumatic brain injury	RAPID-SEQUENCE INTUBATION; HEMODYNAMIC-RESPONSE; HEAD-INJURY; DESATURATION; SERVICE	Background Guidelines recommend that patients with brain trauma with a Glasgow Coma Scale (GCS) score of less than 9 should have an airway established. Hypoxia, hypotension and hypertension as well as hypoventilation and hyperventilation may worsen outcome in these patients. Objectives The objectives were to investigate guideline adherence, reasons for nonadherence and the incidences of complications related to prehospital advanced airway management in patients with traumatic brain injury. Materials and methods We prospectively collected data from eight anaesthesiologist-staffed prehospital critical care teams in the Central Denmark Region according to the Utstein-style template. Results Among 1081 consecutive prehospital advanced airway management patients, we identified 54 with a traumatic brain injury and an initial GCS score of less than 9. Guideline adherence in terms of airway management was 92.6%. The reasons for nonadherence were the patient's condition, anticipated difficult airway management and short distance to the emergency department. Following rapid sequence intubation (RSI), 11.4% developed oxygen saturation below 90%, 9.1% had a first post-RSI systolic blood pressure below 90mmHg and 48.9% had a first post-RSI systolic blood pressure below 120 mmHg. The incidence of hypertension following prehospital RSI was 4.5%. The incidence of postendotracheal intubation hyperventilation was as high as 71.1%. Conclusion The guideline adherence was high. The incidences of post-RSI hypoxia and systolic blood pressure below 90 compare with the results reported from other physician-staffed prehospital services. The incidence of systolic blood pressure below 120 as well as that of hyperventilation following prehospital endotracheal intubation in patients with traumatic brain injury call for a change in our current practice. (c) 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins.	[Rognas, Leif] Norwegian Air Ambulance Fdn, Dept Res & Dev, Drobak, Denmark; [Rognas, Leif] Viborg Reg Hosp, Prehosp Crit Care Team, Dept Anaesthesiol, Viborg, Denmark; [Rognas, Leif; Hansen, Troels M.] Aarhus Univ Hosp, Cent Denmark Reg, Dept Prehosp Med Serv, DK-8000 Aarhus N, Denmark; [Rognas, Leif; Hansen, Troels M.] Aarhus Univ Hosp, Prehosp Crit Care Team, DK-8000 Aarhus N, Denmark; [Kirkegaard, Hans] Aarhus Univ Hosp, Ctr Emergency Med Res, DK-8000 Aarhus N, Denmark; [Tonnesen, Else] Aarhus Univ Hosp, Dept Anaesthesiol, DK-8000 Aarhus N, Denmark	Rognas, L (corresponding author), Trindsovej 4-10, DK-8100 Aarhus C, Denmark.	leifrogn@rm.dk	Rognas, Leif/AAF-6182-2020; Rognas, Leif/AAI-9373-2020	Rognas, Leif/0000-0002-2542-565X	Norwegian Air Ambulance Foundation; Laerdal Foundation for Acute Medicine	L.R. received funding from The Norwegian Air Ambulance Foundation and the Laerdal Foundation for Acute Medicine. For the remaining authors there are no conflicts of interest.	Badjatia N, 2008, PREHOSP EMERG CARE, V12, pS1, DOI 10.1080/10903120701732052; Boer C, 2012, CURR OPIN ANESTHESIO, V25, P556, DOI 10.1097/ACO.0b013e328357225c; Brenner M, 2012, J TRAUMA ACUTE CARE, V72, P1135, DOI 10.1097/TA.0b013e31824af90b; Chesters A, 2013, EMERG MED J; Davis DP, 2004, J TRAUMA, V56, P808, DOI 10.1097/01.TA.0000100217.05066.87; Eich C, 2009, ACTA ANAESTH SCAND, V53, P1167, DOI 10.1111/j.1399-6576.2009.02060.x; Franschman G, 2009, RESUSCITATION, V80, P1147, DOI 10.1016/j.resuscitation.2009.06.029; Helm M, 2013, ACTA ANAESTH SCAND, V57, P199, DOI 10.1111/aas.12032; Holmes J, 2012, PREHOSP EMERG CARE, V16, P210, DOI 10.3109/10903127.2011.640416; Juul Niels, 2008, Ugeskr Laeger, V170, P2337; Lockey DJ, 2013, BMC ANESTHESIOL, V13, DOI 10.1186/1471-2253-13-21; Nakstad AR, 2011, AM J EMERG MED, V29, P639, DOI 10.1016/j.ajem.2010.01.013; Newton A, 2008, J TRAUMA, V64, P487, DOI 10.1097/TA.0b013e31802e7476; Perkins ZB, 2013, INJURY, V44, P618, DOI 10.1016/j.injury.2012.03.019; Perkins ZB, 2013, J TRAUMA ACUTE CARE, V74, P1074, DOI 10.1097/TA.0b013e3182827305; Rognas L, 2013, SCAND J TRAUMA RESUS, V21, DOI 10.1186/1757-7241-21-58; Rognas LK, 2011, SCAND J TRAUMA RESUS, V19, DOI 10.1186/1757-7241-19-10; Sollid SJM, 2009, SCAND J TRAUMA RESUS, V17, DOI 10.1186/1757-7241-17-58; von Vopelius-Feldt J, 2013, EUR J EMERG MED, V20, P382, DOI 10.1097/MEJ.0b013e32835b08b7; Warner KJ, 2009, J TRAUMA, V66, P26, DOI 10.1097/TA.0b013e3181957a25; Weingart SD, 2012, ANN EMERG MED, V59, P165, DOI 10.1016/j.annemergmed.2011.10.002	21	18	21	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0969-9546	1473-5695		EUR J EMERG MED	Eur. J. Emerg. Med.	DEC	2014	21	6					418	423		10.1097/MEJ.0000000000000103			6	Emergency Medicine	Emergency Medicine	AT2SZ	WOS:000344787600005	24368407	Green Published			2021-06-18	
J	Wright, DW; Espinoza, TR; Merck, LH; Ratcliff, JJ; Backster, A; Stein, DG				Wright, David W.; Espinoza, Tamara R.; Merck, Lisa H.; Ratcliff, Jonathan J.; Backster, Anika; Stein, Donald G.			Gender Differences in Neurological Emergencies Part II: A Consensus Summary and Research Agenda on Traumatic Brain Injury	ACADEMIC EMERGENCY MEDICINE			English	Article							MINOR HEAD-INJURY; SEX-DIFFERENCES; CONTUSION INJURY; UNITED-STATES; RISK-FACTORS; SYMPTOMS; RECOVERY; EDEMA; EPIDEMIOLOGY; POPULATION	Traumatic brain injury (TBI) is a major cause of death and disability worldwide. There is strong evidence that gender and sex play an important role across the spectrum of TBI, from pathophysiology to clinical care. In May 2014, Academic Emergency Medicine held a consensus conference Gender-Specific Research in Emergency Care: Investigate, Understand, and Translate How Gender Affects Patient Outcomes. A TBI working group was formed to explore what was known about the influence of sex and gender on TBI and to identify gaps for future research. The findings resulted in four major recommendations to guide the TBI research agenda.	[Wright, David W.; Espinoza, Tamara R.; Backster, Anika] Emory Univ, Dept Emergency Med, Atlanta, GA 30322 USA; [Stein, Donald G.] Emory Univ, Dept Emergency Med, Brain Res Lab, Atlanta, GA 30322 USA; [Merck, Lisa H.] Brown Univ, Dept Emergency Med, Neurol Emergencies Res Program, Providence, RI 02912 USA; [Ratcliff, Jonathan J.] Univ Cincinnati, Dept Emergency Med, Cincinnati, OH USA	Wright, DW (corresponding author), Emory Univ, Dept Emergency Med, Atlanta, GA 30322 USA.	david.wright@emory.edu	Stein, Donald/AAJ-5139-2020		National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [1R13NS087861-01]; Office of Research on Women's Health at the National Institutes of Health; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [T32NS047996, R13NS087861] Funding Source: NIH RePORTER	The consensus conference was supported by grant 1R13NS087861-01 from the National Institute of Neurological Disorders and Stroke and the Office of Research on Women's Health at the National Institutes of Health. Additional funding was provided by several organizational, institutional, and individual donors. Non-CME events were supported by Janssen Pharmaceuticals and Besins Critical Care/BH Pharma. See the executive summary elsewhere in this issue for full funding information.	Amara J, 2014, WOMEN HEALTH ISS, V24, pE171, DOI 10.1016/j.whi.2013.12.004; ATTELLA MJ, 1987, BEHAV NEURAL BIOL, V48, P352, DOI 10.1016/S0163-1047(87)90918-6; Bazarian JJ, 2010, J NEUROTRAUM, V27, P527, DOI 10.1089/neu.2009.1068; Bazarian JJ, 1999, BRAIN INJURY, V13, P173, DOI 10.1080/026990599121692; Coimbra R, 2003, J TRAUMA, V54, P689, DOI 10.1097/01.TA.0000058314.31655.5F; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Covassin T, 2006, BRIT J SPORT MED, V40, P923, DOI 10.1136/bjsm.2006.029496; Demakis GJ, 2010, ARCH CLIN NEUROPSYCH, V25, P191, DOI 10.1093/arclin/acq004; Deutsch ER, 2013, BRAIN RES, V1530, P82, DOI 10.1016/j.brainres.2013.07.014; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; Dischinger PC, 2009, J TRAUMA, V66, P289, DOI 10.1097/TA.0b013e3181961da2; Farace E, 2000, Neurosurg Focus, V8, pe6; Gur RC, 2012, NEUROPSYCHOLOGY, V26, P251, DOI 10.1037/a0026712; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; Mena JH, 2011, J TRAUMA, V71, P1185, DOI 10.1097/TA.0b013e31823321f8; Institute of Medicine, 2001, EXPLORING BIOL CONTR; Jehle D, 2007, ACAD EMERG MED, V14, P899, DOI 10.1197/j.aem.2007.06.029; JENSEN OK, 1990, CEPHALALGIA, V10, P285, DOI 10.1046/j.1468-2982.1990.1006285.x; Kraus J, 2009, J HEAD TRAUMA REHAB, V24, P344, DOI 10.1097/HTR.0b013e3181ae35fd; Laker SR, 2011, PM R S2, V3, P8; Langlois J, 2005, TRAUMATIC BRAIN INJU; Lannsjo M, 2013, EUR J NEUROL, V20, P124, DOI 10.1111/j.1468-1331.2012.03813.x; Lee YB, 2009, J KOREAN NEUROSURG S, V46, P451, DOI 10.3340/jkns.2009.46.5.451; Maghool F, 2013, BRAIN RES, V1497, P61, DOI 10.1016/j.brainres.2012.12.014; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McCarthy MM, 2012, J NEUROSCI, V32, P2241, DOI 10.1523/JNEUROSCI.5372-11.2012; McCauley SR, 2001, J CLIN EXP NEUROPSYC, V23, P792, DOI 10.1076/jcen.23.6.792.1016; Meares S, 2008, J NEUROL NEUROSUR PS, V79, P300, DOI 10.1136/jnnp.2007.126565; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; National Institute of Mental Health, SEX DIFF BRAIN BEH M; Pearson WS, 2012, PREHOSP EMERG CARE, V16, P323, DOI 10.3109/10903127.2012.682701; Ratcliff JJ, 2007, BRAIN INJURY, V21, P1023, DOI 10.1080/02699050701633072; Raukar NP, 2014, ACAD EMERG MED, V21, P1370, DOI 10.1111/acem.12535; Renner C, 2012, BRAIN INJURY, V26, P1360, DOI 10.3109/02699052.2012.667592; ROOF RL, 1992, RESTOR NEUROL NEUROS, V4, P425, DOI 10.3233/RNN-1992-4608; ROOF RL, 1993, BEHAV BRAIN RES, V57, P47, DOI 10.1016/0166-4328(93)90060-4; Roof RL, 1996, EXP NEUROL, V138, P246, DOI 10.1006/exnr.1996.0063; ROOF RL, 1993, BRAIN RES, V607, P333, DOI 10.1016/0006-8993(93)91526-X; ROOF RL, 1994, EXP NEUROL, V129, P64, DOI 10.1006/exnr.1994.1147; Safdar B, 2014, ACAD EMERG MED, V21, P1307, DOI 10.1111/acem.12530; Selassie AW, 2004, AM J EMERG MED, V22, P465, DOI 10.1016/j.ajem.2004.07.024; Stein DG, 2007, PROG BRAIN RES, V161, P339, DOI 10.1016/S0079-6123(06)61024-8; Stein SC, 2001, J TRAUMA, V50, P759, DOI 10.1097/00005373-200104000-00032; Styrke J, 2013, J REHABIL MED, V45, P749, DOI 10.2340/16501977-1215; Tierney RT, 2005, MED SCI SPORT EXER, V37, P272, DOI 10.1249/01.MSS.0000152734.47516.AA; Tierney RT, 2008, J ATHL TRAINING, V43, P578, DOI 10.4085/1062-6050-43.6.578; Tsaousides T, 2011, J HEAD TRAUMA REHAB, V26, P265, DOI 10.1097/HTR.0b013e3182225271; U.S. Department of Health and Human Services, WOM HLTH US 2012 ILL; Wagner AK, 2011, J NEUROTRAUM, V28, P871, DOI 10.1089/neu.2010.1586; Waljas M, 2013, J HEAD TRAUMA REHAB, V20, P20; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Wunderle K, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0000000000000006; Zuckerman SL, 2012, J NEUROSURG-PEDIATR, V10, P504, DOI 10.3171/2012.8.PEDS12139	55	18	19	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1069-6563	1553-2712		ACAD EMERG MED	Acad. Emerg. Med.	DEC	2014	21	12					1414	1420		10.1111/acem.12532			7	Emergency Medicine	Emergency Medicine	AW9KS	WOS:000346576700016	25420582	Green Accepted, Bronze			2021-06-18	
J	Casey-Trott, TM; Millman, ST; Turner, PV; Nykamp, SG; Lawlis, PC; Widowski, TM				Casey-Trott, T. M.; Millman, S. T.; Turner, P. V.; Nykamp, S. G.; Lawlis, P. C.; Widowski, T. M.			Effectiveness of a nonpenetrating captive bolt for euthanasia of 3 kg to 9 kg pigs	JOURNAL OF ANIMAL SCIENCE			English	Article						animal welfare; captive bolt; euthanasia; insensibility; nursery; pig	MATURATION-DEPENDENT RESPONSE; DETERMINING BRAIN-DEATH; CERVICAL DISLOCATION; WELFARE IMPLICATIONS; BLUNT TRAUMA; NEUROPHYSIOLOGY; DEPOPULATION; MOVEMENTS; CESSATION; PIGLETS	The objective of this study was to determine the effectiveness of a nonpenetrating captive bolt, Zephyr-E, for euthanasia of suckling and weaned pigs from 3 to 9 kg (5-49 d of age) using signs of insensibility and death as well as postmortem assessment of traumatic brain injury (TBI). The Zephyr-E was used by 15 stock people to euthanize 150 compromised pigs from 4 farrowing and nursery units from commercial farms and 2 research stations. Brainstem reflexes, convulsions, and heartbeat were used to assess insensibility, time of brain death, and cardiac arrest following Zephyr-E application. Skull fracture displacement (FD) was quantified from computed tomography (CT) scans (n = 24), macroscopic scoring was used to assess brain hemorrhage and skull fracture severity (n = 150), and microscopic scoring was used to assess subdural hemorrhage (SDH) and parenchymal hemorrhage within specific brain regions that are responsible for consciousness and vital function (n = 32). The Zephyr-E caused immediate, sustained insensibility until death in 98.6% of pigs. On average, clonic convulsions (CC) ceased in 82.2 s (+/- 3.4 SE), brain death was achieved in 144.9 s (+/- 5.4 SE), and cardiac arrest occurred in 226.5 s (+/- 8.7 SE). Time of brain death and cardiac arrest differed significantly among stock people (P = 0.0225 and P = 0.0369). Age was positively related to the duration of CC (P = 0.0092), time of brain death (P = 0.0025), and cardiac arrest (P = 0.0068) with shorter durations seen in younger pigs. Average FD was 8.3 mm (+/- 1.0 SE). Macroscopic scores were significantly different among weight classes for subcutaneous (P = 0.0402) and subdural-ventral (P = 0.0037) hemorrhage with the lowest severity hemorrhage found in the 9-kg weight category. Microscopic scores differed among brain sections (P = 0.0070) for SDH with lower scores found in the brainstem compared to the cerebral cortex and midbrain. Parenchymal hemorrhage differed among brain sections (P = 0.0052) and weight categories (P = 0.0128) with the lowest scores in the midbrain and brainstem and the 7-and 9-kg weight categories. The Zephyr-E was highly effective for the euthanasia of pigs up to 9 kg (49 d) based on immediate insensibility sustained until death. Postmortem results confirmed that severe skull fracture and widespread brain hemorrhage were caused by the Zephyr-E nonpenetrating captive bolt.	[Casey-Trott, T. M.; Widowski, T. M.] Univ Guelph, Dept Anim & Poultry Sci, Guelph, ON N1G 2W1, Canada; [Millman, S. T.] Iowa State Univ, Ames, IA 50011 USA; [Turner, P. V.] Univ Guelph, Dept Pathobiol, Guelph, ON N1G 2W1, Canada; [Nykamp, S. G.] Ontario Vet Coll, Primary Healthcare Ctr, Hlth Sci Ctr, Guelph, ON N1G 2W1, Canada; [Lawlis, P. C.] Ontario Minist Agr & Food, Guelph, ON N1G 4Y2, Canada	Widowski, TM (corresponding author), Univ Guelph, Dept Anim & Poultry Sci, Guelph, ON N1G 2W1, Canada.	twidowsk@uoguelph.ca		Millman, Suzanne/0000-0001-5752-4647	National Pork Board	Funding was provided by the National Pork Board. The authors wish to thank the dedicated stock people from the farms in Ontario and Saskatchewan who were willing to take on this task. We are also grateful to the students and staff from the University of Guelph and University of Saskatchewan; in particular, J. Brown and C. Large, for their contributions to data collection, and to M. Edwards for her statistical advice. The prototype Zephyr-E used in the study reported here was manufactured by the University of Guelph. Since completion of this study, the Zephyr-E has been made commercially available by Bock Industries Inc. (128 North Front St., Phillipsburg, PA 16866)	AKRITAS MG, 1990, J AM STAT ASSOC, V85, P73, DOI 10.2307/2289527; American Association of Swine Veterinarians (AASV) and National Pork Board (NPB), 2009, AASV PUBL; ANIL MH, 1991, MEAT SCI, V30, P13, DOI 10.1016/0309-1740(91)90030-T; Aroni F, 2012, J MATERN-FETAL NEO M, V25, P1750, DOI 10.3109/14767058.2012.663823; AVMA, 2013, AVMA GUID EUTH AN; Baxter EM, 2008, THERIOGENOLOGY, V69, P773, DOI 10.1016/j.theriogenology.2007.12.007; Casey-Trott TM, 2013, J ANIM SCI, V91, P5477, DOI 10.2527/jas.2013-6320; Chevillon P., 2004, P INT SOC ANIM HYG, P45; Conci F, 2001, J NEUROL NEUROSUR PS, V71, P621, DOI 10.1136/jnnp.71.5.621; Dawson MD, 2007, J APPL POULTRY RES, V16, P583, DOI 10.3382/japr.2007-00023; Dawson MD, 2009, J APPL POULTRY RES, V18, P135, DOI 10.3382/japr.2008-00072; Duhaime AC, 2000, J NEUROSURG, V93, P455, DOI 10.3171/jns.2000.93.3.0455; Durham SR, 2007, J NEUROTRAUM, V24, P5, DOI 10.1089/neu.2006.0054; Erasmus MA, 2010, VET REC, V167, P850, DOI 10.1136/vr.c5051; Erasmus MA, 2010, POULTRY SCI, V89, P1345, DOI 10.3382/ps.2009-00445; Finnie JW, 2003, AUST VET J, V81, P153, DOI 10.1111/j.1751-0813.2003.tb11078.x; Gaetz M, 2004, CLIN NEUROPHYSIOL, V115, P4, DOI 10.1016/S1388-2457(03)00258-X; Hameister T, 2010, BERL MUNCH TIERARZTL, V123, P11, DOI 10.2376/0005-9366-123-11; HANNA JP, 1995, NEUROLOGY, V45, P985, DOI 10.1212/WNL.45.5.985; Hills Teresa E, 2010, Nursing, V40, P34, DOI 10.1097/01.NURSE.0000390667.52579.8e; Hurn PD, 2005, STROKE, V36, P193, DOI 10.1161/01.STR.0000153064.41332.f6; Ibrahim N. G., 2010, BIOCH ENG J, V132, P1; Lee PH, 2005, PARKINSONISM RELAT D, V11, P105, DOI 10.1016/j.parkreldis.2004.09.005; MADSEN FF, 1990, ACTA NEUROCHIR, V105, P150, DOI 10.1007/BF01670000; Matthis J. S., 2004, THESIS N CAROLINA ST; McKinstry JL, 2004, MEAT SCI, V67, P121, DOI 10.1016/j.meatsci.2003.10.002; Missios S, 2009, J NEUROTRAUM, V26, P1943, DOI [10.1089/neu.2009.0956, 10.1089/neu.2009-0956]; Morrow WEM, 2006, J SWINE HEALTH PROD, V14, P25; NEDD K, 1993, BRAIN INJURY, V7, P469, DOI 10.3109/02699059309008174; Raj ABM, 1996, ANIM WELFARE, V5, P71; ROPPER AH, 1984, NEUROLOGY, V34, P1089, DOI 10.1212/WNL.34.8.1089; Sadler LJ, 2014, J ANIM SCI, V92, P793, DOI 10.2527/jas.2013-6598; Schinckel A. P., 2004, Professional Animal Scientist, V20, P79; Shaw NA, 2002, PROG NEUROBIOL, V67, P281, DOI 10.1016/S0301-0082(02)00018-7; Shear DA, 2002, EXP NEUROL, V178, P59, DOI 10.1006/exnr.2002.8020; Sutherland M., 2010, 08145 NAT PORK BOARD; Turner PV, 2012, POULTRY SCI, V91, P1558, DOI 10.3382/ps.2012-02139; Whiting TL, 2011, CAN VET J, V52, P753; Widowski T., 2008, P AD LEM SWIN C ST P, P107; Wijdicks EFM, 2001, NEW ENGL J MED, V344, P1215, DOI 10.1056/NEJM200104193441606; WIJDICKS EFM, 1995, NEUROLOGY, V45, P1003, DOI 10.1212/WNL.45.5.1003; Woods J., 2012, THESIS IOWA STATE U; Young RJ, 2002, NEUROIMAG CLIN N AM, V12, P189, DOI 10.1016/S1052-5149(02)00003-5	43	18	18	1	17	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0021-8812	1525-3163		J ANIM SCI	J. Anim. Sci.	NOV	2014	92	11					5166	5174		10.2527/jas.2014-7980			9	Agriculture, Dairy & Animal Science	Agriculture	AT0JM	WOS:000344622600036	25349360				2021-06-18	
J	Gandhi, RR; Overton, TL; Haut, ER; Lau, B; Vallier, HA; Rohs, T; Hasenboehler, E; Lee, JK; Alley, D; Watters, J; Rogers, FB; Shafi, S				Gandhi, Rajesh R.; Overton, Tiffany L.; Haut, Elliott R.; Lau, Brandyn; Vallier, Heather A.; Rohs, Thomas; Hasenboehler, Erik; Lee, Jane Kayle; Alley, Darrell; Watters, Jennifer; Rogers, Frederick B.; Shafi, Shahid			Optimal timing of femur fracture stabilization in polytrauma patients: A practice management guideline from the Eastern Association for the Surgery of Trauma	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Long bone stabilization; fracture fixation; timing fixation; early fixation; delayed fixation	FEMORAL-SHAFT FRACTURE; RESPIRATORY-DISTRESS-SYNDROME; DELAYED INTERNAL-FIXATION; MULTIPLE TRAUMA; THORACIC TRAUMA; HEAD-INJURY; GRADE; MORTALITY; QUALITY; RECOMMENDATIONS	BACKGROUND: Femur fractures are common among trauma patients and are typically seen in patients with multiple injuries resulting from high-energy mechanisms. Internal fixation with intramedullary nailing is the ideal method of treatment; however, there is no consensus regarding the optimal timing for internal fixation. We critically evaluated the literature regarding the benefit of early (<24 hours) versus late (>24 hours) open reduction and internal fixation of open or closed femur fractures on mortality, infection, and venous thromboembolism (VTE) in trauma patients. METHODS: A subcommittee of the Practice Management Guideline Committee of the Eastern Association for the Surgery of Trauma conducted a systematic review and meta-analysis for the earlier question. RevMan software was used to generate forest plots. Grading of Recommendations, Assessment, Development, and Evaluations methodology was used to rate the quality of the evidence, using GRADEpro software to create evidence tables. RESULTS: No significant reduction in mortality was associated with early stabilization, with a risk ratio (RR) of 0.74 (95% confidence interval [CI], 0.50-1.08). The quality of evidence was rated as "low.'' No significant reduction in infection (RR, 0.4; 95% CI, 0.10Y1.6) or VTE (RR, 0.63; 95% CI, 0.37-1.07) was associated with early stabilization. The quality of evidence was rated "low.'' CONCLUSION: In trauma patients with open or closed femur fractures, we suggest early (<24 hours) open reduction and internal fracture fixation. This recommendation is conditional because the strength of the evidence is low. Early stabilization of femur fractures shows a trend (statistically insignificant) toward lower risk of infection, mortality, and VTE. Therefore, the panel concludes the desirable effects of early femur fracture stabilization probably outweigh the undesirable effects in most patients. Copyright (C) 2014 by Lippincott Williams & Wilkins	[Gandhi, Rajesh R.; Overton, Tiffany L.; Shafi, Shahid] JPS Hlth Network, Dept Surg, Ft Worth, TX USA; [Alley, Darrell] East Texas Med Ctr, Dept Surg, Tyler, TX USA; [Haut, Elliott R.; Lau, Brandyn] Johns Hopkins Univ, Sch Med, Dept Surg, Baltimore, MD 21205 USA; [Hasenboehler, Erik] Johns Hopkins Univ, Sch Med, Dept Orthopaed Surg, Baltimore, MD USA; [Vallier, Heather A.] MetroHealth, Dept Orthopaed, Cleveland, OH USA; [Rohs, Thomas] Borgess Hlth, Dept Surg, Kalamazoo, MI USA; [Lee, Jane Kayle] Advocate Med Grp, Dept Surg, Chicago, IL USA; [Watters, Jennifer] Oregon Hlth & Sci Univ, Dept Surg, Portland, OR 97201 USA; [Rogers, Frederick B.] Lancaster Gen Hlth, Dept Trauma & Acute Care Surg, Lancaster, PA USA	Overton, TL (corresponding author), JPS Hlth Network, Trauma Serv, 1500 S Main St, Ft Worth, TX 76104 USA.	toverton@jpshealth.org	Haut, Elliott R./J-3948-2019; Lau, Brandyn/H-4825-2018	Lau, Brandyn/0000-0003-3575-2440; Vallier, Heather/0000-0003-3881-6518	Patient-Centered Outcomes Research Institute (PCORI)Patient-Centered Outcomes Research Institute - PCORI [CE-12-11-4489]; Synthes; Smith and Nephew; Department of DefenseUnited States Department of Defense; National Institute of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; Orthopaedic Trauma Association; Medical Research FoundationUK Research & Innovation (UKRI)Medical Research Council UK (MRC)	E.R.H. is the primary investigator and supported by a contract (CE-12-11-4489) from the Patient-Centered Outcomes Research Institute (PCORI) entitled "Preventing Venous Thromboembolism: Empowering Patients and Enabling Patient-Centered Care Via Health Information Technology." E.R.H. receives royalties from Lippincott, Williams, & Wilkins for a book, "Avoiding Common ICU Errors" and has given expert witness testimony in various medical malpractice cases. E.R.H. is a member of the EAST Board of Directors and Chairs the EAST Guidelines Committee. R.R.J. is a speaker for Lifecell. E.H. is supported by grants from Synthes and Smith and Nephew and is a consultant for Synthes. E.H. is also a speaker for AO North America Faculty. B.L. is the co-principal investigator of a contract (CE-12-11-4489) with the Patient-Centered Outcomes Research Institute (PCORI) entitled "Preventing Venous Thromboembolism: Empowering Patients and Enabling Patient-Centered Care Via Health Information Technology." H.A.V. is a member of the board for the Orthopaedic Trauma Association and Center for Orthopaedic Trauma Advancement. H.A.V. receives support for the METRC research consortium funded by the Department of Defense, the FAITH research study funded by the National Institute of Health, and the sacrum research study funded by the Orthopaedic Trauma Association. J.W. is supported by a grant to study acupuncture in the ICU by the Medical Research Foundation and receives travel expenses for PROPPR trial meetings. S.S., F.B.R., T.R., D.A., J.K.L., and T.L.O. have nothing to disclose.	Baixauli F, 1998, CLIN ORTHOP RELAT R, P67; Balshem H, 2011, J CLIN EPIDEMIOL, V64, P401, DOI 10.1016/j.jclinepi.2010.07.015; BEHRMAN SW, 1990, J TRAUMA, V30, P792, DOI 10.1097/00005373-199007000-00005; BONE LB, 1989, J BONE JOINT SURG AM, V71A, P336, DOI 10.2106/00004623-198971030-00004; Bosse MJ, 1997, J BONE JOINT SURG AM, V79A, P799, DOI 10.2106/00004623-199706000-00001; Brundage SI, 2002, J TRAUMA, V52, P299, DOI 10.1097/00005373-200202000-00016; Brunetti M, 2012, J CLIN EPIDEMIOL; Cantu RV, 2014, J TRAUMA ACUTE CARE, V76, P1433, DOI 10.1097/TA.0000000000000230; CHARASH WE, 1994, J TRAUMA, V37, P667, DOI 10.1097/00005373-199410000-00023; DAVIS TRC, 1988, INJURY, V19, P244, DOI 10.1016/0020-1383(88)90036-8; Debrauwer S, 2000, Acta Orthop Belg, V66, P484; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dunham CM, 2001, J TRAUMA, V50, P958, DOI 10.1097/00005373-200105000-00037; FAKHRY SM, 1994, J TRAUMA, V37, P255, DOI 10.1097/00005373-199408000-00018; Giannoudis PV, 2002, AM J SURG, V183, P261, DOI 10.1016/S0002-9610(02)00783-3; Giannoudis PV, 2006, J BONE JOINT SURG BR, V88B, P281, DOI 10.1302/0301-620X.88B3.16465; GREGORY P, 1995, CLIN ORTHOP RELAT R, P95; Guyatt GH, 2012, J CLIN EPIDEMIOL; Guyatt G, 2011, J CLIN EPIDEMIOL, V64, P383, DOI 10.1016/j.jclinepi.2010.04.026; Guyatt GH, 2008, BMJ-BRIT MED J, V336, P1049, DOI 10.1136/bmj.39493.646875.AE; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1311, DOI 10.1016/j.jclinepi.2011.06.004; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1294, DOI 10.1016/j.jclinepi.2011.03.017; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1303, DOI 10.1016/j.jclinepi.2011.04.014; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1277, DOI 10.1016/j.jclinepi.2011.01.011; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P407, DOI 10.1016/j.jclinepi.2010.07.017; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P395, DOI 10.1016/j.jclinepi.2010.09.012; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P380, DOI 10.1016/j.jclinepi.2010.09.011; Jaicks RR, 1997, J TRAUMA, V42, P1, DOI 10.1097/00005373-199701000-00001; JOHNSON KD, 1985, J TRAUMA, V25, P375, DOI 10.1097/00005373-198505000-00001; KALTENECKER G, 1990, J TRAUMA, V30, P474, DOI 10.1097/00005373-199030040-00019; Kerwin AJ, 2012, J TRAUMA ACUTE CARE, V73, pS283, DOI 10.1097/TA.0b013e31827013e9; Labeeu F, 1996, J TRAUMA, V40, P223; Morshed S, 2009, J BONE JOINT SURG AM, V91A, P3, DOI 10.2106/JBJS.H.00338; Nahm NJ, 2011, J TRAUMA, V71, P175, DOI 10.1097/TA.0b013e3181fc93a2; PAPE HC, 1993, J TRAUMA, V34, P540, DOI 10.1097/00005373-199304000-00010; PAPE HC, 1993, INJURY, V24, pS82, DOI 10.1016/0020-1383(93)90012-U; POOLE GV, 1992, J TRAUMA, V32, P654, DOI 10.1097/00005373-199205000-00019; REYNOLDS MA, 1995, ANN SURG, V222, P470; ROGERS FB, 1994, J TRAUMA, V36, P774, DOI 10.1097/00005373-199406000-00004; Scalea TM, 1999, J TRAUMA, V46, P839, DOI 10.1097/00005373-199905000-00012; Schunemann HJ, 2008, ANN INTERN MED, V149, DOI 10.7326/0003-4819-149-12-200812160-02002; SEIBEL R, 1985, ANN SURG, V202, P283, DOI 10.1097/00000658-198509000-00003; Starr AJ, 1998, J ORTHOP TRAUMA, V12, P38, DOI 10.1097/00005131-199801000-00007; StataCorp, 2011, STAT STAT SOFTW REL; Townsend RN, 1998, J TRAUMA, V44, P977, DOI 10.1097/00005373-199806000-00008; VANNIEKERK JLM, 1987, INJURY, V18, P120, DOI 10.1016/0020-1383(87)90187-2; Weninger P, 2007, J TRAUMA, V62, P692, DOI 10.1097/01.ta.0000243203.38466.e0; WILLIAMS MM, 1995, CLIN ORTHOP RELAT R, P182; Ziran BH, 1997, J TRAUMA, V43, P916, DOI 10.1097/00005373-199712000-00008	49	18	19	1	9	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	NOV	2014	77	5					787	795		10.1097/TA.0000000000000434			9	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	AT1OB	WOS:000344702300025		Bronze			2021-06-18	
J	Lindquist, BE; Shuttleworth, CW				Lindquist, Britta E.; Shuttleworth, C. William			Spreading depolarization-induced adenosine accumulation reflects metabolic status in vitro and in vivo	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						acute stroke; adenosine; brain slice; electrophysiology; energy metabolism; spreading depression	RAT HIPPOCAMPAL SLICES; CEREBRAL-ARTERY OCCLUSION; BLOOD-FLOW; BRAIN ISCHEMIA; SYNAPTIC-TRANSMISSION; NEURONAL ACTIVATION; GLUTAMATE RELEASE; FOCAL ISCHEMIA; DC SHIFTS; DEPRESSION	Spreading depolarization (SD), a pathologic feature of migraine, stroke and traumatic brain injury, is a propagating depolarization of neurons and glia Causing profound metabolic demand. Adenosine, the low-energy metabolite of ATP, has been shown to be elevated after SD in brain slices and under conditions likely to trigger SD in vivo. The relationship between metabolic status and adenosine accumulation after SD was tested here, in brain slices and in vivo: In brain slides, metabolic impairment(assessed by nicotinamide adenine dinucleotide (phosphate) autofluorescence and O-2 availability) was associated with prolonged extracellular direct current (DC) shifts indicating delayed repolarization, and increased adenosine accumulation. In Vivo, adenosine accumulation was observed after SD even in otherwise healthy mice. As in brain slices, in vivo adenosine accumulation correlated with DC shift duration and increased when DC shifts were prolonged by metabolic impairment (i.e., hypoglycemia or middle cerebral artery occlusion). A striking pattern of adenosine dynamics was observed during focal ischemic stroke, with nearly all the observed adenosine signals in the periinfarct region occurring in association with SDs. These findings suggest that adenosine accumulation could serve as a biomarker of SD incidence and severity; in a range of clinical conditions.	[Lindquist, Britta E.; Shuttleworth, C. William] Univ New Mexico, Sch Med, Dept Neurosci, Albuquerque, NM 87131 USA	Shuttleworth, CW (corresponding author), Univ New Mexico, Sch Med, Dept Neurosci, 1 Univ New Mexico, Albuquerque, NM 87131 USA.	Bshuttleworth@salud.unm.edu			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS078805, NS051288]; UNM Clinical and Translational Science Center [NCATS UL1TR000041]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P30GM103400] Funding Source: NIH RePORTER	This work was supported by NIH grants NS078805 (BEL) and NS051288 (CWS). Statistical support was provided by UNM Clinical and Translational Science Center (NCATS UL1TR000041).	ASTRUP J, 1976, BRAIN RES, V103, P418, DOI 10.1016/0006-8993(76)90817-9; Back T, 1996, J CEREBR BLOOD F MET, V16, P202, DOI 10.1097/00004647-199603000-00004; Canals S, 2008, J CEREBR BLOOD F MET, V28, P1835, DOI 10.1038/jcbfm.2008.71; Carter RE, 2013, J NEUROCHEM, V125, P673, DOI 10.1111/jnc.12237; Dreier JP, 2011, NAT MED, V17, P439, DOI 10.1038/nm.2333; Dreier JP, 2004, NEUROCRIT CARE, V1, P85, DOI 10.1385/NCC:1:1:85; Etherington LAV, 2004, EUR J NEUROSCI, V19, P2539, DOI 10.1111/j.0953-816X.2004.03355.x; Feuerstein D, 2010, J CEREBR BLOOD F MET, V30, P1343, DOI 10.1038/jcbfm.2010.17; Foster KA, 2005, NEUROSCIENCE, V132, P645, DOI 10.1016/j.neuroscience.2005.01.040; FOWLER JC, 1993, NEUROSCI LETT, V157, P83, DOI 10.1016/0304-3940(93)90648-5; Frenguelli BG, 2007, J NEUROCHEM, V101, P1400, DOI 10.1111/j.1471-4159.2006.04425.x; Galeffi F, 2011, J CEREBR BLOOD F MET, V31, P626, DOI 10.1038/jcbfm.2010.136; GIDO G, 1993, J CEREBR BLOOD F MET, V13, P179, DOI 10.1038/jcbfm.1993.21; Hall CN, 2012, J NEUROSCI, V32, P8940, DOI 10.1523/JNEUROSCI.0026-12.2012; Hartings JA, 2011, BRAIN, V134, P1529, DOI 10.1093/brain/awr048; Hashemi P, 2009, J CEREBR BLOOD F MET, V29, P166, DOI 10.1038/jcbfm.2008.108; HEADRICK JP, 1994, J CEREBR BLOOD F MET, V14, P853, DOI 10.1038/jcbfm.1994.107; Heinrich A, 2012, BRIT J PHARMACOL, V167, P1003, DOI 10.1111/j.1476-5381.2012.01932.x; HILLERED L, 1989, J CEREBR BLOOD F MET, V9, P607, DOI 10.1038/jcbfm.1989.87; Hoffmann U, 2013, J CEREBR BLOOD F MET, V33, P191, DOI 10.1038/jcbfm.2012.132; Ivanov Anton, 2011, Front Neuroenergetics, V3, P9, DOI 10.3389/fnene.2011.00009; KAKU T, 1994, BRAIN RES, V658, P39, DOI 10.1016/S0006-8993(09)90008-7; KRAIG RP, 1985, PROG BRAIN RES, V63, P155; Kuraoka M, 2009, EXP ANIM TOKYO, V58, P19, DOI 10.1538/expanim.58.19; Latini S, 1999, BRIT J PHARMACOL, V127, P729, DOI 10.1038/sj.bjp.0702591; Lauritzen M, 2011, J CEREBR BLOOD F MET, V31, P17, DOI 10.1038/jcbfm.2010.191; Leao AAP, 1944, J NEUROPHYSIOL, V7, P359; Lindquist B, 2013, A1R MEDIATED SPREADI; Lindquist BE, 2012, NEUROSCIENCE, V223, P365, DOI 10.1016/j.neuroscience.2012.07.053; Masino S, 2013, ADENOSINE KEY LINK M; Melani A, 1999, STROKE, V30, P2448, DOI 10.1161/01.STR.30.11.2448; Mies G, 1997, NEUROSCI LETT, V221, P165, DOI 10.1016/S0304-3940(96)13317-6; MIES G, 1984, EXP NEUROL, V84, P249, DOI 10.1016/0014-4886(84)90222-X; MIES G, 1993, NEUROREPORT, V4, P709, DOI 10.1097/00001756-199306000-00027; NEDERGAARD M, 1988, BRAIN RES, V449, P395, DOI 10.1016/0006-8993(88)91062-1; NEWMAN GC, 1991, J CEREBR BLOOD F MET, V11, P398, DOI 10.1038/jcbfm.1991.80; Office of Laboratory Animal Welfare (OLAW), 2002, PUBL HLTH SERV POL H; Oliveira-Ferreira AI, 2010, J CEREBR BLOOD F MET, V30, P1504, DOI 10.1038/jcbfm.2010.40; Pasini FL, 2000, BRAIN RES BULL, V51, P327, DOI 10.1016/S0361-9230(99)00240-3; Piilgaard H, 2009, J CEREBR BLOOD F MET, V29, P1517, DOI 10.1038/jcbfm.2009.73; Sakowitz OW, 2013, STROKE, V44, P220, DOI 10.1161/STROKEAHA.112.672352; Shin HK, 2007, BRAIN, V130, P1631, DOI 10.1093/brain/awm071; Shuttleworth CW, 2003, J NEUROSCI, V23, P3196; Somjen GG, 2001, PHYSIOL REV, V81, P1065; Takagaki M, 2014, EXP NEUROL, V252, P12, DOI 10.1016/j.expneurol.2013.11.003; Takano T, 2007, NAT NEUROSCI, V10, P754, DOI 10.1038/nn1902; VANWYLEN DGL, 1986, J CEREBR BLOOD F MET, V6, P522, DOI 10.1038/jcbfm.1986.97; Warren RE, 2005, DIABETES OBES METAB, V7, P493, DOI 10.1111/j.1463-1326.2004.00421.x; Yang O, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3528610	49	18	18	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	NOV	2014	34	11					1779	1790		10.1038/jcbfm.2014.146			12	Endocrinology & Metabolism; Hematology; Neurosciences	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	AS7HZ	WOS:000344428800006	25160669	Green Published, Bronze			2021-06-18	
J	Ornstein, TJ; Sagar, S; Schachar, RJ; Ewing-Cobbs, L; Chapman, SB; Dennis, M; Saunders, AE; Yang, TT; Levin, HS; Max, JE				Ornstein, Tisha J.; Sagar, Sanya; Schachar, Russell J.; Ewing-Cobbs, Linda; Chapman, Sandra B.; Dennis, Maureen; Saunders, Ann E.; Yang, Tony T.; Levin, Harvey S.; Max, Jeffrey E.			Neuropsychological Performance of Youth with Secondary Attention-Deficit/Hyperactivity Disorder 6-and 12-Months after Traumatic Brain Injury	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Traumatic brain injury; Children; Adolescents; S-ADHD; P-ADHD; Neurocognitive function	DEFICIT HYPERACTIVITY DISORDER; EXECUTIVE FUNCTION EF; CLOSED-HEAD INJURY; PSYCHIATRIC-DISORDERS; SUSTAINED ATTENTION; RESPONSE-INHIBITION; DIVIDED ATTENTION; WORKING-MEMORY; K-SADS; CHILDREN	The present study compared executive dysfunction among children with attention-deficit/hyperactivity disorder (ADHD) after traumatic brain injury (TBI), also called secondary ADHD (S-ADHD), pre-injury ADHD and children with TBI only (i.e., no ADHD). Youth aged 6-16 years admitted for TBI to five trauma centers were enrolled (n = 177) and evaluated with a semi-structured psychiatric interview scheduled on three occasions (within 2 weeks of TBI, i.e., baseline assessment for pre-injury status; 6-months and 12-months post-TBI). This permitted the determination of 6- and 12-month post-injury classifications of membership in three mutually exclusive groups (S-ADHD; pre-injury ADHD; TBI-only). Several executive control measures were administered. Unremitted S-ADHD was present in 17/141 (12%) children at the 6-month assessment, and in 14/125 (11%) children at 12-months post-injury. The study found that children with S-ADHD exhibited deficient working memory, attention, and psychomotor speed as compared to children with pre-injury ADHD. Furthermore, the children with S-ADHD and the children with TBI-only were impaired compared to the children with pre-injury ADHD with regard to planning. No group differences related to response inhibition emerged. Age, but not injury severity, gender, or adaptive functioning was related to executive function outcome. Neuropsychological sequelae distinguish among children who develop S-ADHD following TBI and those with TBI only. Moreover, there appears to be a different pattern of executive control performance in those who develop S-ADHD than in children with pre-injury ADHD suggesting that differences exist in the underlying neural mechanisms that define each disorder, underscoring the need to identify targeted treatment interventions.	[Ornstein, Tisha J.; Sagar, Sanya] Ryerson Univ, Dept Psychol, Toronto, ON, Canada; [Schachar, Russell J.] Hosp Sick Children, Res Inst, Dept Psychiat Neurosci & Mental Hlth, Toronto, ON M5G 1X8, Canada; [Schachar, Russell J.] Hosp Sick Children, Res Inst, Brain & Behav Program, Toronto, ON M5G 1X8, Canada; [Ewing-Cobbs, Linda] Univ Texas Hlth Sci Ctr Houston, Dept Pediat, Houston, TX 77030 USA; [Chapman, Sandra B.] Univ Texas Dallas, Ctr Brain Hlth, Dallas, TX 75230 USA; [Dennis, Maureen] Hosp Sick Children, Res Inst, Brain & Behav Program, Dept Psychol, Toronto, ON M5G 1X8, Canada; [Saunders, Ann E.] Univ Texas Hlth Sci Ctr Houston, Dept Psychiat, Houston, TX 77030 USA; [Yang, Tony T.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA USA; [Levin, Harvey S.] Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Levin, Harvey S.] Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA; [Levin, Harvey S.] Baylor Coll Med, Dept Psychiat & Behav Sci, Houston, TX 77030 USA; [Max, Jeffrey E.] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA; [Max, Jeffrey E.] Rady Childrens Hosp, San Diego, CA USA; [Dennis, Maureen] Hosp Sick Children, Dept Psychol, Toronto, ON, Canada	Max, JE (corresponding author), Rady Childrens Hosp, 3020 Childrens Way,MC 5018, San Diego, CA 92123 USA.	jmax@ucsd.edu		Schachar, Russell/0000-0002-2015-4395; Sagar, Sanya/0000-0001-7381-0803	National Institute of Mental HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [K-08 MH01800]; National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS-21889]; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH085734, K08MH001800] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS021889] Funding Source: NIH RePORTER	This research was supported by the National Institute of Mental Health (J. M., K-08 MH01800); and the National Institute of Neurological Disorders and Stroke (H. L., NS-21889). The authors thank Xioaqi Li, M. S. for database management. Russell Schachar is the Toronto Dominion Bank Financial Group Chair in Child and Adolescent Psychiatry. He has participated in an advisory or consultative capacity with Lilly Corporation, Purdue Pharma, and Highland Therapeutics. His institution has intellectual property rights on the stop signal task and several genes involved in ADHD. Dr. Max provides expert testimony in cases of traumatic brain injury on an ad hoc basis for plaintiffs and defendants on a more or less equal ratio. This activity constitutes approximately 5% of his professional activities. The other authors have no disclosures.	American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Anderson P, 2002, CHILD NEUROPSYCHOL, V8, P71, DOI 10.1076/chin.8.2.71.8724; Anderson P, 1996, CLIN NEUROPSYCHOL, V10, P54, DOI 10.1080/13854049608406663; Anderson VA, 2001, DEV NEUROPSYCHOL, V20, P385, DOI 10.1207/S15326942DN2001_5; Azouvi P, 2004, NEUROPSYCHOLOGIA, V42, P1260, DOI 10.1016/j.neuropsychologia.2004.01.001; Barkley RA, 1997, PSYCHOL BULL, V121, P65, DOI 10.1037/0033-2909.121.1.65; Barkley RA, 2011, DEV NEUROPSYCHOL, V36, P137, DOI 10.1080/87565641.2010.549877; Best JR, 2009, DEV REV, V29, P180, DOI 10.1016/j.dr.2009.05.002; Bloom DR, 2001, J AM ACAD CHILD PSY, V40, P572, DOI 10.1097/00004583-200105000-00017; Boyle MH, 1996, J AM ACAD CHILD PSY, V35, P1440, DOI 10.1097/00004583-199611000-00012; BROWN G, 1981, PSYCHOL MED, V11, P63, DOI 10.1017/S0033291700053289; Chapman SB, 2000, J COMMUN DISORD, V33, P333, DOI 10.1016/S0021-9924(00)00029-0; Dickstein SG, 2006, J CHILD PSYCHOL PSYC, V47, P1051, DOI 10.1111/j.1469-7610.2006.01671.x; Fenwick T, 1999, CHILD NEUROPSYCHOL, V5, P213, DOI 10.1076/0929-7049(199912)05:04;1-R;FT213; Gerring J, 2000, BRAIN INJURY, V14, P205; Gerring JP, 1998, J AM ACAD CHILD PSY, V37, P647, DOI 10.1097/00004583-199806000-00015; Ginstfeldt T, 2010, BRAIN INJURY, V24, P1123, DOI 10.3109/02699052.2010.506853; Gopin C. B., 2011, J INFANT CHILD ADOLE, V10, P13, DOI DOI 10.1080/15289168.2011.575700; Helton WS, 2011, EXP BRAIN RES, V212, P429, DOI 10.1007/s00221-011-2749-1; Hinshaw SP, 2007, NEUROPSYCHOLOGY, V21, P263, DOI 10.1037/0894-4105.21.2.263; Hiscock Kinsbourne, 1987, J EXP PSYCHOL, V18, P643; Hollingshead A. B., 1975, 4 FACTOR INDEX SOCIA; Horton AM, 2010, APPL NEUROPSYCHOL, V17, P99, DOI 10.1080/09084281003708944; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; JAFFE KM, 1995, ARCH PHYS MED REHAB, V76, P17, DOI 10.1016/S0003-9993(95)80037-9; Kaufman J, 1997, J AM ACAD CHILD PSY, V36, P980, DOI 10.1097/00004583-199707000-00021; Klorman R, 1999, J AM ACAD CHILD PSY, V38, P1148, DOI 10.1097/00004583-199909000-00020; Konrad KN, 2000, BRAIN INJURY, V14, P859; Lajiness-O'Neill R, 2010, APPL NEUROPSYCHOL, V17, P83, DOI 10.1080/09084281003708837; Leblanc N, 2005, DEV NEUROPSYCHOL, V28, P829, DOI 10.1207/s15326942dn2803_5; LECKMAN JF, 1982, ARCH GEN PSYCHIAT, V39, P879; Levin H S, 1997, J Int Neuropsychol Soc, V3, P598; Levin H, 2007, J DEV BEHAV PEDIATR, V28, P108, DOI 10.1097/01.DBP.0000267559.26576.cd; Levin HS, 2008, J HEAD TRAUMA REHAB, V23, P197, DOI 10.1097/01.HTR.0000327252.54128.7c; Levin HS, 2004, J CLIN EXP NEUROPSYC, V26, P589, DOI 10.1080/13803390490504434; Levin HS, 2002, ANN NEUROL, V52, P82, DOI 10.1002/ana.10252; Logan Gordon D., 1994, P189; Max JE, 1998, J AM ACAD CHILD PSY, V37, P841, DOI 10.1097/00004583-199808000-00014; Max JE, 2005, J AM ACAD CHILD PSY, V44, P1032, DOI 10.1097/01.chi.0000173293.05817.b1; Max JE, 2004, DEV NEUROPSYCHOL, V25, P159, DOI 10.1207/s15326942dn2501&2_9; Max JE, 1997, J AM ACAD CHILD PSY, V36, P1278, DOI 10.1097/00004583-199709000-00021; Ornstein TJ, 2013, J NEUROPSYCHOL, V7, P1, DOI 10.1111/j.1748-6653.2012.02027.x; Park NW, 1999, NEUROPSYCHOLOGIA, V37, P1119, DOI 10.1016/S0028-3932(99)00034-2; Pennington BF, 1996, J CHILD PSYCHOL PSYC, V37, P51, DOI 10.1111/j.1469-7610.1996.tb01380.x; Robin DA, 1999, APHASIOLOGY, V13, P701, DOI 10.1080/026870399401812; Schachar R, 2000, J ABNORM CHILD PSYCH, V28, P227, DOI 10.1023/A:1005140103162; Schachar R, 2004, DEV NEUROPSYCHOL, V25, P179, DOI 10.1207/s15326942dn2501&2_10; Schwartz L, 2003, J PEDIATR PSYCHOL, V28, P251, DOI 10.1093/jpepsy/jsg013; SHALLICE T, 1982, PHILOS T ROY SOC B, V298, P199, DOI 10.1098/rstb.1982.0082; Shum D, 2009, BRAIN IMPAIR, V10, P320, DOI 10.1375/brim.10.3.320; Sinopoli KJ, 2011, J CLIN EXP NEUROPSYC, V33, P805, DOI 10.1080/13803395.2011.562864; Slomine BS, 2005, J INT NEUROPSYCH SOC, V11, P645, DOI 10.1017/S1355617705050769; Sparrow S., 1984, VINELAND ADAPTIVE BE; Taylor H G, 1997, J Int Neuropsychol Soc, V3, P555; Taylor HG, 2004, DEV NEUROPSYCHOL, V25, P199, DOI 10.1207/s15326942dn2501&2_11; TEASDALE G, 1974, LANCET, V2, P81; Thorell LB, 2007, J CHILD PSYCHOL PSYC, V48, P1061, DOI 10.1111/j.1469-7610.2007.01777.x; Travis F, 1998, BIOL PSYCHOL, V48, P37, DOI 10.1016/S0301-0511(98)00005-2; Wassenberg R, 2004, BRAIN INJURY, V18, P751, DOI 10.1080/02699050410001671775; Wassenberg R, 2004, BRAIN INJURY, V18, P377, DOI 10.1080/02699050310001617325; Wechsler D., 1997, WAIS 3 ADM SCORING M; WELSH MC, 1991, COGNITIVE DEV, V6, P59, DOI 10.1016/0885-2014(91)90006-Y; Yeates KO, 2002, NEUROPSYCHOLOGY, V16, P514, DOI 10.1037//0894-4105.16.4.514	63	18	18	0	22	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	NOV	2014	20	10					971	981		10.1017/S1355617714000903			11	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Neurosciences & Neurology; Psychiatry; Psychology	AW3FN	WOS:000346171700003	25489810	Green Accepted			2021-06-18	
J	Raj, R; Siironen, J; Kivisaari, R; Hernesniemi, J; Skrifvars, MB				Raj, Rahul; Siironen, Jari; Kivisaari, Riku; Hernesniemi, Juha; Skrifvars, Markus B.			Predicting Outcome after Traumatic Brain Injury: Development of Prognostic Scores Based on the IMPACT and the APACHE II	JOURNAL OF NEUROTRAUMA			English	Article						APACHE II; external validation; IMPACT; outcome; prognostic models; traumatic brain injury	CLINICAL-RESEARCH; CARE; MORTALITY; SEVERITY; VALIDATION; CLASSIFICATION; EPIDEMIOLOGY; PERFORMANCE; IMPROVEMENT; QUALITY	Prediction models are important tools for heterogeneity adjustment in clinical trials and for the evaluation of quality of delivered care to patients with traumatic brain injury (TBI). We sought to improve the predictive performance of the IMPACT (International Mission for Prognosis and Analysis of Clinical Trials) prognostic model by combining it with the APACHE II (Acute Physiology and Chronic Health Evaluation II) for 6-month outcome prediction in patients with TBI treated in the intensive care unit. A total of 890 patients with TBI admitted to a large urban level 1 trauma center in 2009-2012 comprised the study population. The IMPACT and the APACHE II scores were combined using binary logistic regression. A randomized, split-sample technique with secondary bootstrapping was used for model development and internal validation. Model performance was assessed by discrimination (by area under the curve [ AUC]), calibration, precision, and net reclassification improvement (NRI). Overall 6-month mortality was 22% and unfavorable neurological outcome 47%. The predictive power of the new combined IMPACT-APACHE II models was significantly superior, compared to the original IMPACT models (AUC, 0.81-0.82 vs. 0.84-0.85; p < 0.05) for 6-month mortality prediction, but not for unfavorable outcome prediction (AUC, 0.81-0.82 vs. 0.83; p > 0.05). However, NRI showed a significant improvement in risk stratification of patients with unfavorable outcome by the IMPACT-APACHE II models, compared to the original models (NRI, 5.4-23.2%; p < 0.05). Internal validation using split-sample and resample bootstrap techniques yielded equivalent results, indicating low grade of overestimation. Our findings show that by combining the APACHE II with the IMPACT, improved 6-month outcome predictive performance is achieved. This may be applicable for heterogeneity adjustment in forthcoming TBI studies.	[Raj, Rahul; Siironen, Jari; Kivisaari, Riku; Hernesniemi, Juha] Helsinki Univ Hosp, Dept Neurosurg, Helsinki 00029, Finland; [Skrifvars, Markus B.] Helsinki Univ Hosp, Dept Intens Care, Helsinki 00029, Finland	Raj, R (corresponding author), Helsinki Univ Hosp, Dept Neurosurg, Topeliuksenkatu 5,PB-266, Helsinki 00029, Finland.	rahul.br.raj@icloud.com	Raj, Rahul/K-7693-2012	Raj, Rahul/0000-0003-4243-9591	Helsinki University Hospital EVO grant [TYH2012142]; Medicinska Understodsforeningen Liv och Halsa; Maire Taponen foundation	The study was funded by a Helsinki University Hospital EVO grant (TYH2012142), Medicinska Understodsforeningen Liv och Halsa and by the Maire Taponen foundation. The authors express their gratitude to Jaakko Lappalainen (MD, PhD) and Professor Per Rosenberg (MD, PhD) for their valuable comments on the manuscript and to Giovanni Nattino (IRCCS-Istituto di Ricerche Farmacologiche "Mario Negri" Laboratory of Clinical Epidemiology) and Tuomas Selander (Science Service Center, Kuopio University Hospital) for their statistical assistance.	Beynon C, 2012, J NEUROTRAUM, V29, P2109, DOI 10.1089/neu.2012.2365; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Finazzi S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016110; Hemmila MR, 2010, J TRAUMA, V68, P253, DOI 10.1097/TA.0b013e3181cfc8e6; HILDEN J, 1978, METHOD INFORM MED, V17, P238; Hosmer DW., 2013, APPL LOGISTIC REGRES, V3rd ed.; JENNETT B, 1975, LANCET, V1, P480; Kaukonen KM, 2014, JAMA-J AM MED ASSOC, V311, P1308, DOI 10.1001/jama.2014.2637; Khuri SF, 2002, ARCH SURG-CHICAGO, V137, P20, DOI 10.1001/archsurg.137.1.20; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Kramer AA, 2007, CRIT CARE MED, V35, P2052, DOI 10.1097/01.CCM.0000275267.64078.B0; Kundu S, 2011, EUR J EPIDEMIOL, V26, P261, DOI 10.1007/s10654-011-9567-4; Le Gall JR, 2005, INTENS CARE MED, V31, P1618, DOI 10.1007/s00134-005-2825-8; LEMESHOW S, 1982, AM J EPIDEMIOL, V115, P92, DOI 10.1093/oxfordjournals.aje.a113284; Lingsma HF, 2011, NEUROSURGERY, V68, P601, DOI 10.1227/NEU.0b013e318209333b; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; Maas AIR, 2006, LANCET NEUROL, V5, P38, DOI 10.1016/S1474-4422(05)70253-2; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maas AIR, 2013, LANCET NEUROL, V12, P1200, DOI 10.1016/S1474-4422(13)70234-5; Maas AIR, 2012, J NEUROTRAUM, V29, P32, DOI 10.1089/neu.2010.1599; Maas AIR, 2010, NEUROTHERAPEUTICS, V7, P127, DOI 10.1016/j.nurt.2009.10.020; Marmarou A, 2007, J NEUROTRAUM, V24, P239, DOI 10.1089/neu.2006.0036; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Myburgh JA, 2008, J TRAUMA, V64, P854, DOI 10.1097/TA.0b013e3180340e77; Papa L, 2013, J NEUROTRAUM, V30, P324, DOI 10.1089/neu.2012.2545; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; PICARD RR, 1990, AM STAT, V44, P140, DOI 10.2307/2684155; Pouw ME, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5913; Raj R, 2014, CRIT CARE, V18, DOI 10.1186/cc13814; Raj R, 2013, NEUROSURGERY, V73, P305, DOI 10.1227/01.neu.0000430326.40763.ec; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Sanchez Jose J, 2013, Acta Neurochir Suppl, V118, P223, DOI 10.1007/978-3-7091-1434-6_42; Seshan VE, 2013, STAT MED, V32, P1483, DOI 10.1002/sim.5648; Shann F, 2000, BRIT MED J, V320, P714, DOI 10.1136/bmj.320.7236.714; Stein SC, 2010, J NEUROTRAUM, V27, P1343, DOI 10.1089/neu.2009.1206; Stevens RD, 2013, CRIT CARE MED, V41, P1104, DOI 10.1097/CCM.0b013e318287ee79; Steyerberg EW, 2001, J CLIN EPIDEMIOL, V54, P774, DOI 10.1016/S0895-4356(01)00341-9; Steyerberg EW, 2010, EPIDEMIOLOGY, V21, P128, DOI 10.1097/EDE.0b013e3181c30fb2; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Vassar MJ, 1999, J TRAUMA, V47, P324, DOI 10.1097/00005373-199908000-00017; Vincent JL, 2010, CRIT CARE, V14, DOI 10.1186/cc8204; Weir J, 2012, J NEUROTRAUM, V29, P53, DOI 10.1089/neu.2011.2137	44	18	19	0	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT 15	2014	31	20					1721	1732		10.1089/neu.2014.3361			12	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	AP8BF	WOS:000342302200005	24836936	Green Published			2021-06-18	
J	Johnson, U; Lewen, A; Ronne-Engstrom, E; Howells, T; Enblad, P				Johnson, Ulf; Lewen, Anders; Ronne-Engstrom, Elisabeth; Howells, Tim; Enblad, Per			Should the Neurointensive Care Management of Traumatic Brain Injury Patients be Individualized According to Autoregulation Status and Injury Subtype?	NEUROCRITICAL CARE			English	Article						Cerebral perfusion pressure; Cerebrovascular pressure autoregulation; Head injury; Outcome	CEREBRAL-BLOOD-FLOW; CEREBROVASCULAR PRESSURE REACTIVITY; HEAD-INJURY; CRITICAL THRESHOLDS; PERFUSION-PRESSURE; HYPEREMIA; EDEMA; THERAPY	The status of autoregulation is an important prognostic factor in traumatic brain injury (TBI), and is important to consider in the management of TBI patients. Pressure reactivity index (PRx) is a measure of autoregulation that has been thoroughly studied, but little is known about its variation in different subtypes of TBI. In this study, we examined the impact of PRx and cerebral perfusion pressure (CPP) on outcome in different TBI subtypes. 107 patients were retrospectively studied. Data on PRx, CPP, and outcome were collected from our database. The first CT scan was classified according to the Marshall classification system. Patients were assigned to "diffuse" (Marshall class: diffuse-1, diffuse-2, and diffuse-3) or "focal" (Marshall class: diffuse-4, evacuated mass lesion, and non-evacuated mass lesion) groups. 2 x 2 tables were constructed calculating the proportions of favorable/unfavorable outcome at different combinations of PRx and CPP. Low PRx was significantly associated with favorable outcome in the combined group (p = 0.002) and the diffuse group (p = 0.04), but not in the focal group (p = 0.06). In the focal group higher CPP values were associated with worse outcome (p = 0.02). In diffuse injury patients with disturbed autoregulation (PRx > 0.1), CPP > 70 mmHg was associated with better outcome (p = 0.03). TBI patients with diffuse injury may differ from those with mass lesions. In the latter higher levels of CPP may be harmful, possibly due to BBB disruption. In TBI patients with diffuse injury and disturbed autoregulation higher levels of CPP may be beneficial.	[Johnson, Ulf; Lewen, Anders; Ronne-Engstrom, Elisabeth; Howells, Tim; Enblad, Per] Univ Uppsala Hosp, Dept Neurosci, Neurosurg Sect, S-75185 Uppsala, Sweden	Johnson, U (corresponding author), Univ Uppsala Hosp, Dept Neurosci, Neurosurg Sect, S-75185 Uppsala, Sweden.	ulf.johnson@neuro.uu.se	Lewen, Anders/A-5156-2013	Lewen, Anders/0000-0003-4925-1348; Johnson, Ulf/0000-0002-3879-6476			AASLID R, 1989, STROKE, V20, P45, DOI 10.1161/01.STR.20.1.45; ASGEIRSSON B, 1994, INTENS CARE MED, V20, P260, DOI 10.1007/BF01708961; Barzo P, 1997, J NEUROSURG, V87, P900, DOI 10.3171/jns.1997.87.6.0900; Brady KM, 2009, PEDIATRICS, V124, pE1205, DOI 10.1542/peds.2009-0550; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS59, DOI 10.1089/neu.2007.9990; Budohoski KP, 2012, NEUROSURGERY, V71, P652, DOI 10.1227/NEU.0b013e318260feb1; Caricato A, 2012, CRIT CARE MED, V40, P2526, DOI 10.1097/CCM.0b013e318256b9af; Chieregato A, 2005, ACTA NEUROCHIR SUPPL, V95, P159; Chieregato A, 2009, NEUROSURGERY, V64, P705, DOI 10.1227/01.NEU.0000341872.17024.44; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Czosnyka M, 2009, NEUROCRIT CARE, V10, P373, DOI 10.1007/s12028-008-9175-7; Dengler J, 2013, NEUROCRIT CARE, V19, P74, DOI 10.1007/s12028-012-9686-0; DESALLES AAF, 1987, NEUROSURGERY, V21, P45, DOI 10.1227/00006123-198707000-00009; Dias C, 2014, NEUROCRIT CARE, V21, P124, DOI 10.1007/s12028-013-9918-y; Elf K, 2005, NEUROSURGERY, V56, P962, DOI 10.1227/01.NEU.0000158317.00603.40; Hiler M, 2006, J NEUROSURG, V104, P731, DOI 10.3171/jns.2006.104.5.731; Howells T, 2005, J NEUROSURG, V102, P311, DOI 10.3171/jns.2005.102.2.0311; JENNETT B, 1975, LANCET, V1, P480; Johnson U, 2010, NEUROSURGERY, V68, P21; Johnson U, 2011, NEUROSURGERY, V68, P714, DOI 10.1227/NEU.0b013e3182077313; Kelly DF, 1997, J NEUROSURG, V86, P633, DOI 10.3171/jns.1997.86.4.0633; Kelly DF, 1996, J NEUROSURG, V85, P762, DOI 10.3171/jns.1996.85.5.0762; Lang EW, 2000, BRIT J NEUROSURG, V14, P117; MACFARLANE R, 1991, J NEUROSURG, V75, P845, DOI 10.3171/jns.1991.75.6.0845; Marmarou A, 2006, ACTA NEUROCHIR SUPPL, V96, P24; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Martin NA, 1997, J NEUROSURG, V87, P9, DOI 10.3171/jns.1997.87.1.0009; Ojha BK, 2005, SURG NEUROL, V64, P174, DOI 10.1016/j.surneu.2004.11.030; Panerai RB, 2004, BRIT J NEUROSURG, V18, P471, DOI 10.1080/02688690400012343; SAKAS DE, 1995, J NEUROSURG, V83, P277, DOI 10.3171/jns.1995.83.2.0277; Sanchez-Porras R, 2012, ACTA NEUROCHIR, V154, P1575, DOI 10.1007/s00701-012-1423-0; SMIELEWSKI P, 1995, ULTRASOUND MED BIOL, V21, P599, DOI 10.1016/0301-5629(94)00154-6; Sorrentino E, 2012, NEUROCRIT CARE, V16, P258, DOI 10.1007/s12028-011-9630-8; Steiner LA, 2003, STROKE, V34, P2404, DOI 10.1161/01.STR.0000089014.59668.04; Wei XE, 2012, J NEUROTRAUM, V29, P2413, DOI 10.1089/neu.2010.1510; Wei XE, 2011, J TRAUMA, V71, P1645, DOI 10.1097/TA.0b013e31823498eb; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Zweifel C, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E2	38	18	18	0	2	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	OCT	2014	21	2					259	265		10.1007/s12028-014-9954-2			7	Critical Care Medicine; Clinical Neurology	General & Internal Medicine; Neurosciences & Neurology	AQ9AR	WOS:000343132900013	24515639				2021-06-18	
J	Kaye, JL; Dunlop, BW; Iosifescu, DV; Mathew, SJ; Kelley, ME; Harvey, PD				Kaye, Joanna L.; Dunlop, Boadie W.; Iosifescu, Dan V.; Mathew, Sanjay J.; Kelley, Mary E.; Harvey, Philip D.			Cognition, functional capacity, and self-reported disability in women with posttraumatic stress disorder: Examining the convergence of performance-based measures and self-reports	JOURNAL OF PSYCHIATRIC RESEARCH			English	Article						PTSD; Depression; Neuropsychology; Psychiatric status rating scales; Functional outcome; Employment	TRAUMATIC BRAIN-INJURY; BIPOLAR DISORDER; OLDER PATIENTS; SCHIZOPHRENIA; VETERANS; PTSD; OUTCOMES; MEMORY; SCALE; DETERMINANTS	Individuals with posttraumatic stress disorder (PTSD) experience cognitive impairments and disability in everyday activities. In other neuropsychiatric disorders, impairments in cognition and functional capacity (i.e., the ability to perform everyday tasks) are associated with impairments in real-world functioning, independent of symptom severity. To date, no studies of functional capacity have been conducted in PTSD. Seventy-three women with moderate to severe PTSD underwent assessment with measures of cognition (MATRICS Consensus Cognitive Battery: MCCB), functional capacity (UCSD Performance-Based Skills Assessment-Brief: UPSA-B), PTSD (Clinician-Administered PTSD Scale and PTSD Symptom Scale Self-report (PSS-SR)), and depression (Montgomery Asberg Depression Rating Scale). Patients also reported their subjective level of disability (Sheehan Disability Scale). Over-reporting of symptom severity was assessed using six validity items embedded within the PSS-SR. Results indicated that on average PTSD patients manifested mild impairments on the functional capacity measure, performing about 1/3 standard deviation below healthy norms, and similar performance on the MCCB. Both clinician-rated and self-rated PTSD symptom severity correlated with self-reported disability but not with functional capacity. Self-reported disability did not correlate with functional capacity or cognition. Greater self-reported disability, depression, and PTSD symptoms all correlated with higher scores on the PSS-SR validity scale. The divergence between objective and subjective measures of disability suggests that individuals' distress, as indexed by symptom validity measures, may be impacting self-reports of disability. Future studies of disability should incorporate objective measures in order to obtain a broad perspective on functioning. (C) 2014 Elsevier Ltd. All rights reserved.	[Kaye, Joanna L.; Dunlop, Boadie W.; Kelley, Mary E.] Emory Univ, Sch Med, Dept Psychiat & Behav Sci, Atlanta, GA USA; [Iosifescu, Dan V.] Mt Sinai Sch Med, Dept Psychiat, New York, NY USA; [Mathew, Sanjay J.] Michael E Debakey VA Med Ctr, Houston, TX USA; [Mathew, Sanjay J.] Baylor Coll Med, Menninger Dept Psychiat & Behav Sci, Houston, TX 77030 USA; [Harvey, Philip D.] Univ Miami, Miller Sch Med, Miami, FL 33136 USA; [Harvey, Philip D.] Bruce W Carter VA Med Ctr, Miami, FL USA	Harvey, PD (corresponding author), Univ Miami, Miller Sch Med, 1120 NW 14th St,Suite 1450, Miami, FL 33136 USA.	Philipdharvey1@cs.com	Iosifescu, Dan/L-3305-2019; Dunlop, Boadie/N-3362-2017; Mathew, Sanjay J/J-2830-2014	Iosifescu, Dan/0000-0002-2512-2835; Dunlop, Boadie/0000-0002-4653-0483; Mathew, Sanjay J/0000-0002-2715-6641; Harvey, Philip/0000-0002-9501-9366	National Institute of Mental HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [U19 MH069056]; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [U19MH069056, K23MH086690] Funding Source: NIH RePORTER	This project was supported by a grant from National Institute of Mental Health (U19 MH069056). The NIMH had no role in the preparation of this paper.	Barrett DH, 1996, AM J PSYCHIAT, V153, P1492; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1002/jts.2490080106; Bowie CR, 2008, BIOL PSYCHIAT, V63, P505, DOI 10.1016/j.biopsych.2007.05.022; Bowie CR, 2007, J PSYCHIATR RES, V41, P1012, DOI 10.1016/j.jpsychires.2006.08.003; Bowie CR, 2010, AM J PSYCHIAT, V167, P1116, DOI 10.1176/appi.ajp.2010.09101406; Bowie CR, 2006, AM J PSYCHIAT, V163, P418, DOI 10.1176/appi.ajp.163.3.418; Burdick KE, 2005, PSYCHIAT RES, V136, P43, DOI 10.1016/j.psychres.2004.12.009; Carone DA, 2005, J INT NEUROPSYCH SOC, V11, P574, DOI 10.1017/S135561770505068X; Depp CA, 2008, J CLIN PSYCHOPHARM, V28, P225, DOI 10.1097/JCP.0b013e318166dfed; Depp CA, 2009, J NERV MENT DIS, V197, P471, DOI 10.1097/NMD.0b013e3181ab5c9b; Fett AKJ, 2011, NEUROSCI BIOBEHAV R, V35, P573, DOI 10.1016/j.neubiorev.2010.07.001; FIRST MB, 1995, USERS GUIDE STRUCTUR; Foa EB, 1997, PSYCHOL ASSESSMENT, V9, P445, DOI 10.1037/1040-3590.9.4.445; FOA EB, 1993, J TRAUMA STRESS, V6, P459, DOI 10.1002/jts.2490060405; Franklin CL, 2002, J PERS ASSESS, V79, P274, DOI 10.1207/S15327752JPA7902_10; Geuze E, 2009, DEPRESS ANXIETY, V26, P7, DOI 10.1002/da.20476; Gildengers AG, 2007, AM J GERIAT PSYCHIAT, V15, P174, DOI 10.1097/JGP.0b013e31802dd367; Harvey PD, 2010, CURR DIR PSYCHOL SCI, V19, P249, DOI 10.1177/0963721410378033; Harvey PD, 2010, BIPOLAR DISORD, V12, P364, DOI 10.1111/j.1399-5618.2010.00831.x; HEATON RK, 1981, J CONSULT CLIN PSYCH, V49, P807, DOI 10.1037/0022-006X.49.6.807; Hollingshead A. B., 1975, 4 FACTOR INDEX SOCIA; Leifker FR, 2009, SCHIZOPHR RES, V115, P82, DOI 10.1016/j.schres.2009.09.004; Macklin ML, 1998, J CONSULT CLIN PSYCH, V66, P323, DOI 10.1037/0022-006X.66.2.323; Margolies SO, 2013, J CLIN PSYCHOL, V69, P1026, DOI 10.1002/jclp.21970; Martinez-Aran A, 2004, AM J PSYCHIAT, V161, P262, DOI 10.1176/appi.ajp.161.2.262; Mausbach BT, 2007, SCHIZOPHRENIA BULL, V33, P1364, DOI 10.1093/schbul/sbm014; Mausbach BT, 2010, BIPOLAR DISORD, V12, P45, DOI 10.1111/j.1399-5618.2009.00787.x; McDevitt-Murphy ME, 2010, J TRAUMA STRESS, V23, P108, DOI 10.1002/jts.20482; McKibbin C, 2004, J NERV MENT DIS, V192, P405, DOI 10.1097/01.nmd.0000130133.32276.83; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; Nuechterlein KH, 2008, AM J PSYCHIAT, V165, P203, DOI 10.1176/appi.ajp.2007.07010042; Sabbag S, 2012, SCHIZOPHR RES, V137, P190, DOI 10.1016/j.schres.2012.02.002; Sabbag S, 2011, SCHIZOPHR RES, V131, P250, DOI 10.1016/j.schres.2011.05.003; Schnurr PP, 2007, JAMA-J AM MED ASSOC, V297, P820, DOI 10.1001/jama.297.8.820; Schnurr PP, 2012, PSYCHIAT SERV, V63, P1072, DOI 10.1176/appi.ps.201100415; Sheehan DV, 1996, INT CLIN PSYCHOPHARM, V11, P89, DOI 10.1097/00004850-199606003-00015; Simonsen C, 2008, BIPOLAR DISORD, V10, P245, DOI 10.1111/j.1399-5618.2007.00492.x; Spikman JM, 2010, J NEUROTRAUM, V27, P1195, DOI 10.1089/neu.2010.1277; Twamley EW, 2009, J INT NEUROPSYCH SOC, V15, P879, DOI 10.1017/S135561770999049X; Twamley EW, 2002, AM J PSYCHIAT, V159, P2013, DOI 10.1176/appi.ajp.159.12.2013; Vasterling JJ, 2012, BRIT J PSYCHIAT, V201, P186, DOI 10.1192/bjp.bp.111.096461; Vasterling JJ, 2002, NEUROPSYCHOLOGY, V16, P5, DOI 10.1037//0894-4105.16.1.5; Vermetten E, 2003, BIOL PSYCHIAT, V54, P693, DOI 10.1016/S0006-3223(03)00634-6; Weathers FW, 2001, DEPRESS ANXIETY, V13, P132, DOI 10.1002/da.1029; YEHUDA R, 1995, AM J PSYCHIAT, V152, P137; Zatzick DF, 1997, AM J PSYCHIAT, V154, P1690, DOI 10.1176/ajp.154.12.1690	46	18	19	0	12	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0022-3956	1879-1379		J PSYCHIATR RES	J. Psychiatr. Res.	OCT	2014	57						51	57		10.1016/j.jpsychires.2014.06.002			7	Psychiatry	Psychiatry	AO7RK	WOS:000341550100006	24974001	Green Accepted			2021-06-18	
J	Zhang, H; Han, MQ; Zhang, XN; Sun, XT; Ling, F				Zhang, Hao; Han, Mengqi; Zhang, Xiaonian; Sun, Xinting; Ling, Feng			The Effect and Mechanism of Growth Hormone Replacement on Cognitive Function in Rats with Traumatic Brain Injury	PLOS ONE			English	Article							NEUROTROPHIC FACTOR; SYNAPTIC PLASTICITY; GH DEFICIENCY; PERFORMANCE; THERAPY; NEURONS; MEMORY; MODEL; HYPOPITUITARISM; EXPRESSION	Objective: The effects of growth hormone on cognitive dysfunction were observed in a controlled cortical impact (CCI) rat model and the underlying mechanism was explored. Method: Three-month-old male SD rats were randomly divided into sham (n = 10), control (n = 10), and CCI groups (n = 40) The parameters were set as follows: striking speed, 3.5 m/s; impact depth, 1.5 mm; and dwell time, 400 msec. Eight and ten weeks post-injury, the GH levels were measured the water maze test and novel object recognition test were performed. CCI rats were divided into normal and decreased GH groups, and further randomly divided into two sub-groups (rhGH treatment and saline vehicle groups). All rats were tested for SYN, BDNF, and TrkB mRNA in the prefrontal cortex and hippocampus by RT-PCR. Results: CCI rats 8 weeks post-injury had cognitive dysfunction regardless of the GH level (P, 0.05). rhGH treatment improved cognitive function in CCI rats. There was a positive correlation between the expression of prefrontal BDNF and SYN mRNA in CCI rats after rhGH therapy and the water maze test score (r = 0.773 and 0.534, respectively; P<0.05). Furthermore, the expression of BDNF, TrkB, and SYN mRNA in the hippocampus was negatively correlated with the water maze test score (r = 0.602, 0.773, 0.672, and 0.783, respectively; P<0.05). There was a difference in the expression of hippocampal and prefrontal BDNF, TrkB, and SYN mRNA (P<0.05) Conclusion: rhGH treatment had a positive effect on cognitive function, which was more evident in GH-deficient rats. The increased expression of hippocampal and prefrontal BDNF and TrkB mRNA is implicated in rhGH therapy to improve cognitive function. Changes in the expression of hippocampal SYN mRNA following rhGH therapy may also play a role in improving cognitive function.	[Zhang, Hao; Zhang, Xiaonian; Sun, Xinting] Capital Med Univ, China Rehabil Res Ctr, Beijing, Peoples R China; [Han, Mengqi] Beijing Jishuitan Hosp, Beijing, Peoples R China; [Ling, Feng] Capital Med Univ, Beijing Xuanwu Hosp, Beijing, Peoples R China	Ling, F (corresponding author), Capital Med Univ, China Rehabil Res Ctr, Beijing, Peoples R China.	crrck3@sina.com			Chinese central public research institutes [2011CZ-6, 2012CZ-5]	The special basic research fund for Chinese central public research institutes (2011CZ-6,2012CZ-5) http://www.most.gov.cn/ztzl/gjzctx/ptzckjtr/200802/t20080222_59209.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beca SG, 2012, PITUITARY, V15, P10, DOI 10.1007/s11102-008-0133-3; Bhagia V, 2010, BRAIN INJURY, V24, P560, DOI 10.3109/02699051003601705; Brandoli C, 1998, J NEUROSCI, V18, P7953; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Christophidis LJ, 2009, GROWTH HORM IGF RES, V19, P497, DOI 10.1016/j.ghir.2009.05.001; Cole JT, 2011, J NEUROTRAUM, V28, P359, DOI 10.1089/neu.2010.1427; Creyghton Wouter M, 2004, Semin Vasc Med, V4, P167, DOI 10.1055/s-2004-835375; Crispino M, 1999, EXP NEUROL, V159, P574, DOI 10.1006/exnr.1999.7186; D'Hooge R, 2001, BRAIN RES REV, V36, P60, DOI 10.1016/S0165-0173(01)00067-4; Deijen JB, 1998, PSYCHONEUROENDOCRINO, V23, P45, DOI 10.1016/S0306-4530(97)00092-9; DIXON CE, 1991, J NEUROSCI METH, V39, P253; DOU Yi, 2009, Zhonghua Shao Shang Za Zhi, V25, P275; Doulah AH, 2009, NEUROSCI LETT, V466, P47, DOI 10.1016/j.neulet.2009.09.016; Eastwood SL, 2000, BRIT J PSYCHIAT, V176, P236, DOI 10.1192/bjp.176.3.236; Falleti MG, 2006, PSYCHONEUROENDOCRINO, V31, P681, DOI 10.1016/j.psyneuen.2006.01.005; Ferrer I, 1999, DEMENT GERIATR COGN, V10, P55, DOI 10.1159/000051214; GRANON S, 1995, BEHAV NEUROSCI, V109, P474, DOI 10.1037/0735-7044.109.3.474; Griesbach GS, 2009, J NEUROSCI RES, V87, P795, DOI 10.1002/jnr.21893; Guseva MV, 2008, J NEUROTRAUM, V25, P975, DOI 10.1089/neu.2008.0516; Hao LY, 2010, NEUROSCIENCE, V166, P763, DOI 10.1016/j.neuroscience.2010.01.006; High WM, 2010, J NEUROTRAUM, V27, P1565, DOI 10.1089/neu.2009.1253; Isgaard J, 2007, Minerva Endocrinol, V32, P103; Kasturi BS, 2009, J NEUROTRAUM, V26, P1315, DOI [10.1089/neu.2008.0751, 10.1089/neu.2008-0751]; Kelly DF, 2006, J NEUROTRAUM, V23, P928, DOI 10.1089/neu.2006.23.928; Kinney BA, 2001, PHYSIOL BEHAV, V72, P653, DOI 10.1016/S0031-9384(01)00423-1; Kurihara M, 2011, GEN COMP ENDOCR, V170, P156, DOI 10.1016/j.ygcen.2010.09.020; Kwak MJ, 2009, J KOREAN MED SCI, V24, P729, DOI 10.3346/jkms.2009.24.4.729; LAI ZN, 1993, BRAIN RES, V621, P260, DOI 10.1016/0006-8993(93)90114-3; Leeds P, 2005, NEUROCHEM INT, V46, P61, DOI 10.1016/j.neuint.2004.07.001; Leon-Carrion J, 2007, BRAIN INJURY, V21, P871, DOI 10.1080/02699050701484849; Lippert-Gruner M, 2007, PHYSIOL RES, V56, P359; Maiya B, 2008, INTENS CARE MED, V34, P468, DOI 10.1007/s00134-007-0902-x; Maric NP, 2010, J ENDOCRINOL INVEST, V33, P770, DOI [10.1007/BF03350340, 10.3275/7045]; Miladi-Gorji H, 2011, NEUROBIOL LEARN MEM, V96, P479, DOI 10.1016/j.nlm.2011.08.001; Moreau OK, 2013, J NEUROTRAUM, V30, P998, DOI 10.1089/neu.2012.2705; Morris GM, 2008, SCHOLARPEDIA US, V3, P6315; Morselli L L, 2008, J Endocrinol Invest, V31, P39; Nieuwpoort IC, 2008, EUR J ENDOCRINOL ENG, V159, pS53; Oertel H, 2004, PSYCHONEUROENDOCRINO, V29, P839, DOI 10.1016/S0306-4530(03)00151-3; OMMAYA AK, 1995, J NEUROTRAUM, V12, P527, DOI 10.1089/neu.1995.12.527; Pathipati P, 2009, BEHAV BRAIN RES, V204, P93, DOI 10.1016/j.bbr.2009.05.023; Popovic Vera, 2005, Pituitary, V8, P239, DOI 10.1007/s11102-006-6047-z; Quik EH, 2012, GROWTH HORM IGF RES, V22, P42, DOI 10.1016/j.ghir.2011.12.007; Rocha M, 1999, BRAIN RES, V827, P79, DOI 10.1016/S0006-8993(99)01307-4; Schober ME, 2012, METAB BRAIN DIS, V27, P167, DOI 10.1007/s11011-012-9309-7; Shojo H, 2006, BRAIN RES, V1078, P198, DOI 10.1016/j.brainres.2006.01.063; Tarsa L, 2002, P NATL ACAD SCI USA, V99, P1012, DOI 10.1073/pnas.022575999; Thornton PL, 2000, J GERONTOL A-BIOL, V55, pB106; Tong LQ, 2012, J NEUROSCI, V32, P17714, DOI 10.1523/JNEUROSCI.1253-12.2012; Urban RJ, 2006, GROWTH HORM IGF RES, V16, pS25, DOI 10.1016/j.ghir.2006.03.017; VanGuilder HD, 2011, NEUROBIOL DIS, V43, P201, DOI 10.1016/j.nbd.2011.03.012; Wass JAH, 2010, J ENDOCRINOL, V207, P125, DOI 10.1677/JOE-10-0126; Ying XG, 2004, J CLIN CARDIOVASCU D, V10, P613; Zhou JP, 2007, INFLUENCE GNRH ANALO	54	18	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108518	10.1371/journal.pone.0108518			9	Multidisciplinary Sciences	Science & Technology - Other Topics	AR6CW	WOS:000343671700105	25268832	DOAJ Gold, Green Published			2021-06-18	
J	Dekker, SE; Sillesen, M; Bambakidis, T; Jin, G; Liu, BL; Boer, C; Johansson, PI; Halaweish, I; Maxwell, J; Alam, HB				Dekker, Simone E.; Sillesen, Martin; Bambakidis, Ted; Jin, Guang; Liu, Baoling; Boer, Christa; Johansson, Par I.; Halaweish, Ihab; Maxwell, Jake; Alam, Hasan B.			Normal saline influences coagulation and endothelial function after traumatic brain injury and hemorrhagic shock in pigs	SURGERY			English	Article							FRESH-FROZEN PLASMA; LARGE-ANIMAL-MODEL; PREHOSPITAL MANAGEMENT; INTRACRANIAL-PRESSURE; MASSIVE TRANSFUSION; E-SELECTIN; RESUSCITATION; BLOOD; COAGULOPATHY; NEUTROPHILS	Background. Traumatic brain injury (TBI) and hemorrhagic shock (HS) are the leading causes of trauma-related deaths. These insults disrupt coagulation and endothelial systems. This study investigated whether previously reported differences in lesion size and brain swelling during normal saline (NS), colloids (Hextend [HEX]), and fresh frozen plasma (HP) resuscitation are associated with differential effects on coagulation and endothelial systems. Methods. We subjected 15 Yorkshire swine to TBI and HS (40% blood volume), and kept in HS for 2 hours before resuscitation with NS, HEX, or REP Markers of endothelial activation (E-selectin, Intercellular adhesion molecule [ICAM]-1), coagulation activation (prothrombin fragment 1 + 2), and natural anticoagulation (activated protein C (aPC]) were determined in serum and brain whole cell lysates. Results. Serum levels of aPC were greater in the NS group (203 +/- 30 pg/mL) compared with HEX (77 +/- 28 pg/mL; P = .02) and HP (110 +/- 28 pg/mL; P = .09), as was PF 1 + 2 in the brain when compared with FFP (PF 1 + 2, 89 +/- 46 vs 37 +/- 14 ng/mL; P = .035). Brain E-selectin was greater in the NS group compared with FFP (3.36 +/- 0.02 vs 3.31 +/- 0.01 ng/mL; P = .029). Circulating ICAM-1 levels were increased in the NS group (151 +/- 9 ng/mL) compared with the HEX (100 +/- 9 ng/mL; P < .01) and REP (108 +/- 9 ng/mL; P = .01). Conclusion. In this clinically realistic large animal model of TBI + HS, NS resuscitation was associated with an early activation of coagulation, natural anticoagulation, and endothelial systems, compared with HEX and FFP.	[Dekker, Simone E.; Bambakidis, Ted; Jin, Guang; Liu, Baoling; Halaweish, Ihab; Maxwell, Jake; Alam, Hasan B.] Univ Michigan Hosp, Dept Surg, Ann Arbor, MI 48109 USA; [Dekker, Simone E.; Boer, Christa] Vrije Univ Amsterdam, Med Ctr, Inst Cardiovasc Res, Dept Anesthesiol, Amsterdam, Netherlands; [Sillesen, Martin] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Trauma Emergency Surg & Surg Crit Care,Dept S, Boston, MA USA; [Sillesen, Martin] Copenhagen Univ Hosp, Dept Surg, Hillerod, Denmark; [Johansson, Par I.] Univ Copenhagen, Rigshosp, Capital Reg Blood Bank, DK-2100 Copenhagen, Denmark; [Johansson, Par I.] Univ Texas Houston, Sch Med, Dept Surg, Ctr Translat Injury Res CeTIR, Houston, TX USA	Alam, HB (corresponding author), Univ Michigan Hosp, Taubman Ctr 2920, 1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.	alamh@med.umich.edu	Johansson, Par I/P-9283-2015	Johansson, Par I/0000-0001-9778-5964; Sillesen, Martin/0000-0001-9494-5475; Boer, Christa/0000-0002-7781-6951	US Army Medical Research Material CommandU.S. Army Medical Research & Materiel Command (USAMRMC) [00521959]; Lundbeck FoundationLundbeckfonden [R134-A12630]	Funded by a grant from the US Army Medical Research Material Command GRANTT00521959 (to H.B.A.) and a grant from the Lundbeck Foundation R134-A12630 (to M.S and P.I.J).	Alam HB, 2009, J TRAUMA, V67, P856, DOI 10.1097/TA.0b013e3181b5ae75; Badjatia N, 2008, PREHOSP EMERG CARE, V12, pS1, DOI 10.1080/10903120701732052; Baker AJ, 2008, J TRAUMA, V64, P348, DOI 10.1097/01.ta.0000245973.71929.db; Bernardes-Silva M, 2001, J CEREBR BLOOD F MET, V21, P1115, DOI 10.1097/00004647-200109000-00009; Bolliger D, 2010, BRIT J ANAESTH, V104, P318, DOI 10.1093/bja/aeq001; Brohi K, 2007, ANN SURG, V245, P812, DOI 10.1097/01.sla.0000256862.79374.31; Carlos TM, 1997, J LEUKOCYTE BIOL, V61, P279; Cohan MJ, 2007, J TRAUMA, V63, P1254, DOI 10.1097/TA.0b013e318156ee4c; EDWARDS RL, 1992, SEMIN HEMATOL, V29, P202; Gan TJ, 1999, ANESTH ANALG, V88, P992, DOI 10.1097/00000539-199905000-00005; Ganter MT, 2010, BEST PRACT RES-CLIN, V24, P15, DOI 10.1016/j.bpa.2009.09.010; GENNARELLI TA, 1994, J TRAUMA, V37, P962, DOI 10.1097/00005373-199412000-00016; Gonzalez EA, 2007, J TRAUMA, V62, P112, DOI 10.1097/01.ta.0000250497.08101.8b; Grande PO, 1997, J TRAUMA, V42, pS23, DOI 10.1097/00005373-199705001-00005; Greuters S, 2011, CRIT CARE, V15, DOI 10.1186/cc9399; Hammell CL, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1683; Harhangi BS, 2008, ACTA NEUROCHIR, V150, P165, DOI 10.1007/s00701-007-1475-8; HESS DC, 1994, NEUROSCI LETT, V168, P201, DOI 10.1016/0304-3940(94)90450-2; Hwabejire JO, 2013, J TRAUMA ACUTE CARE, V75, P968, DOI 10.1097/TA.0b013e31829a021a; Imam AM, 2013, SURGERY, V154, P388, DOI 10.1016/j.surg.2013.05.008; Jin G, 2012, SHOCK, V38, P49, DOI 10.1097/SHK.0b013e3182574778; King DR, 2004, SURGERY, V136, P355, DOI 10.1016/j.surg.2004.05.011; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Laroche M, 2012, NEUROSURGERY, V70, P1334, DOI 10.1227/NEU.0b013e31824d179b; Lustenberger T, 2010, J TRAUMA, V69, P1410, DOI 10.1097/TA.0b013e3181cdae81; McKeating EG, 1998, ACT NEUR S, V71, P200; McMahon CG, 1999, J TRAUMA, V47, P891, DOI 10.1097/00005373-199911000-00013; Myburgh J, 2007, NEW ENGL J MED, V357, P874; OLSON JD, 1989, NEUROSURGERY, V24, P825, DOI 10.1227/00006123-198906000-00007; Pati S, 2010, J TRAUMA, V69, pS55, DOI 10.1097/TA.0b013e3181e453d4; Peiniger S, 2011, CRIT CARE, V15, DOI 10.1186/cc10048; Ragaller Max, 2010, J Emerg Trauma Shock, V3, P1, DOI 10.4103/0974-2700.58649; Saggar V, 2009, J NEUROTRAUM, V26, P1665, DOI 10.1089/neu.2008.0799; Scholz M, 2007, MED RES REV, V27, P401, DOI 10.1002/med.20064; SHACKFORD SR, 1992, J NEUROSURG, V76, P91, DOI 10.3171/jns.1992.76.1.0091; Sillesen M, 2013, SURGERY, V154, P197, DOI 10.1016/j.surg.2013.04.002; Sillesen M, 2013, J TRAUMA ACUTE CARE, V74, P1252, DOI 10.1097/TA.0b013e31828c7a6b; Stanimirovic DB, 1997, ACT NEUR S, V70, P12; Talving P, 2009, J TRAUMA, V66, P55, DOI 10.1097/TA.0b013e318190c3c0; Velik-Salchner C, 2006, THROMB RES, V117, P597, DOI 10.1016/j.thromres.2005.05.015; Wafaisade A, 2010, NEUROCRIT CARE, V12, P211, DOI 10.1007/s12028-009-9281-1	41	18	18	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0039-6060			SURGERY	Surgery	SEP	2014	156	3					556	563		10.1016/j.surg.2014.04.016			8	Surgery	Surgery	AO3KN	WOS:000341228200009	24953275				2021-06-18	
J	Hamden, K; Agresti, D; Jeanmonod, R; Woods, D; Reiter, M; Jeanmonod, D				Hamden, Khalief; Agresti, Darin; Jeanmonod, Rebecca; Woods, Dexter; Reiter, Mark; Jeanmonod, Donald			Characteristics of elderly fall patients with baseline mental status: high-risk features for intracranial injury	AMERICAN JOURNAL OF EMERGENCY MEDICINE			English	Article; Proceedings Paper	Annual Meeting of the Society-for-Academic-Emergency-Medicine (SAEM)	MAY 16, 2013	Atlanta, GA	Soc Acad Emergency Med			TRAUMATIC BRAIN-INJURY; MINOR HEAD-INJURY; COMPUTED-TOMOGRAPHY; OLDER PATIENTS; WARFARIN USE; EMERGENCY; ANTICOAGULATION; HEMORRHAGE; INTERVENTION; MORTALITY	Background: Falls are a major cause of morbidity in the elderly. Objectives: We describe the low-acuity elderly fall population and study which historical and clinical features predict traumatic intracranial injuries (ICIs). Methods: This is a prospective observational study of patients at least 65 years old presenting with fall to a tertiary care facility. Patients were eligible if they were at baseline mental status and were not triaged to the trauma bay. At presentation, a data form was completed by treating physicians regarding mechanism and position of fall, history of head strike, headache, loss of consciousness (LOC), and signs of head trauma. Radiographic imaging was obtained at the discretion of treating physicians. Medical records were subsequently reviewed to determine imaging results. All patients were called in follow-up at 30 days to determine outcome in those not imaged. The study was institutional review board approved. Results: A total of 799 patients were enrolled; 79.5% of patients underwent imaging. Twenty-seven had ICIs (3.4%). Fourteen had subdural hematoma, 7 had subarachnoid hemorrhage, 3 had cerebral contusion, and 3 had a combination of injuries. Logistic regression demonstrated 2 study variables that were associated with ICIs: LOC (odds ratio, 2.8; confidence interval, 1.2-6.3) and signs of head trauma (odds ratio, 13.2; confidence interval, 2.7-64.1). History of head strike, mechanism and position, headache, and anticoagulant and antiplatelet use were not associated with ICIs. Conclusion: Elderly fall patients who are at their baseline mental status have a low incidence of ICIs. The best predictors of ICIs are physical findings of trauma to the head and history of LOC. (C) 2014 Elsevier Inc. All rights reserved.	[Hamden, Khalief] Caril Clin, Dept Emergency Med, Blacksburg, VA USA; [Agresti, Darin; Jeanmonod, Rebecca; Jeanmonod, Donald] St Lukes Univ Hosp & Hlth Network, Dept Emergency, Bethlehem, PA USA; [Woods, Dexter; Reiter, Mark] Univ Tennessee, Sch Med, Dept Emergency Med, Nashville, TN USA	Jeanmonod, R (corresponding author), St Lukes Hosp & Hlth Network, Dept Emergency Med, 801 Ostrum St, Bethlehem, PA 18015 USA.	rebeccajeanmonod@yahoo.com					Birnbaumer DM, 2010, ROSENS EMERGENCY MED, P286; Borczuk P, 2013, J TRAUMA ACUTE CARE, V74, P1504, DOI 10.1097/TA.0b013e31829215cf; Centers for Disease Control and Prevention (CDC), 2013, MMWR-MORBID MORTAL W, V62, P347; Claudia C, 2011, J TRAUMA, V70, P906, DOI 10.1097/TA.0b013e3182031ab7; Foo CL, 2012, AUSTRALAS J AGEING, V31, P40, DOI 10.1111/j.1741-6612.2010.00499.x; Franko J, 2006, J TRAUMA, V61, P107, DOI 10.1097/01.ta.0000224220.89528.fc; Fuller GF, 2000, AM FAM PHYSICIAN, V61, P2159; Gage BF, 2005, AM J MED, V118, P612, DOI 10.1016/j.amjmed.2005.02.022; Garra G, 1999, ACAD EMERG MED, V6, P121, DOI 10.1111/j.1553-2712.1999.tb01048.x; Gerber Linda M, 2009, J Trauma Manag Outcomes, V3, P9, DOI 10.1186/1752-2897-3-9; Government Accountability Office (GAO), 2008, MED B; Gray LC, 2013, ANN EMERG MED, V62, P467, DOI 10.1016/j.annemergmed.2013.05.008; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; Karni A, 2001, AM SURGEON, V67, P1098; Kennedy DM, 2000, J TRAUMA, V48, P451, DOI 10.1097/00005373-200003000-00012; Mack LR, 2003, J EMERG MED, V24, P157, DOI 10.1016/S0736-4679(02)00714-X; Melnick ER, 2012, JT COMM J QUAL PATIE, V38, P483, DOI 10.1016/S1553-7250(12)38064-1; Mower WR, 2005, J TRAUMA, V59, P954, DOI 10.1097/01.ta.0000187813.79047.42; Nagurney J T, 1998, J Emerg Med, V16, P709, DOI 10.1016/S0736-4679(98)00083-3; Paniagua MA, 2006, AM J EMERG MED, V24, P413, DOI 10.1016/j.ajem.2005.12.005; Papa L, 2012, ACAD EMERG MED, V19, P2, DOI 10.1111/j.1553-2712.2011.01247.x; Pieracci FM, 2007, J TRAUMA, V63, P519, DOI 10.1097/TA.0b013e31812e519b; Pieracci FM, 2007, J TRAUMA, V63, P525, DOI 10.1097/TA.0b013e31812e5216; Rathlev NK, 2006, ACAD EMERG MED, V13, P302, DOI 10.1197/j.aem.2005.10.015; Riccardi A, 2013, AM J EMERG MED, V31, P37, DOI 10.1016/j.ajem.2012.05.023; Schiller J. S., 2007, FALL INJURY EPISODES; SCOTT JC, 1990, RHEUM DIS CLIN N AM, V16, P717; Shaw FE, 2003, BRIT MED J, V326, P73, DOI 10.1136/bmj.326.7380.73; Sterling DA, 2001, J TRAUMA, V50, P116, DOI 10.1097/00005373-200101000-00021; Stevens JA, 2006, INJURY PREV, V12, P290, DOI 10.1136/ip.2005.011015; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Tiedemann A, 2013, EMERG MED J, V30, P918, DOI 10.1136/emermed-2012-201783; Tinetti ME, 1997, NEW ENGL J MED, V337, P1279, DOI 10.1056/NEJM199710303371806	34	18	18	1	5	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0735-6757	1532-8171		AM J EMERG MED	Am. J. Emerg. Med.	AUG	2014	32	8					890	894		10.1016/j.ajem.2014.04.051			5	Emergency Medicine	Emergency Medicine	AR1AK	WOS:000343311000011	24929771				2021-06-18	
J	Larson, MJ; Mohr, BA; Adams, RS; Wooten, NR; Williams, TV				Larson, Mary Jo; Mohr, Beth A.; Adams, Rachel Sayko; Wooten, Nikki R.; Williams, Thomas V.			Missed Opportunity for Alcohol Problem Prevention Among Army Active Duty Service Members Postdeployment	AMERICAN JOURNAL OF PUBLIC HEALTH			English	Article							MENTAL-HEALTH PROBLEMS; TRAUMATIC BRAIN-INJURY; MILITARY PERSONNEL; BINGE DRINKING; SUBSTANCE USE; PRIMARY-CARE; AUDIT-C; DIAGNOSTIC EFFICIENCY; SEPTEMBER 11; COMBAT	Objectives. We identified to what extent the Department of Defense post-deployment health surveillance program identifies at-risk drinking, alone or in conjunction with psychological comorbidities, and refers service members who screen positive for additional assessment or care. Methods. We completed a cross-sectional analysis of 333 803 US Army active duty members returning from Iraq or Afghanistan deployments in fiscal years 2008 to 2011 with a postdeployment health assessment. Alcohol measures included 2 based on self-report quantity-frequency items-at-risk drinking (positive Alcohol Use Disorders Identification Test alcohol consumption questions [AUDIT-C] screen) and severe alcohol problems (AUDIT-C score of 8 or higher)- and another based on the interviewing provider's assessment. Results. Nearly 29% of US Army active duty members screened positive for at-risk drinking, and 5.6% had an AUDIT-C score of 8 or higher. Interviewing providers identified potential alcohol problems among only 61.8% of those screening positive for at-risk drinking and only 74.9% of those with AUDIT-C scores of 8 or higher. They referred for a follow-up visit to primary care or another setting only 29.2% of at-risk drinkers and only 35.9% of those with AUDIT-C scores of 8 or higher. Conclusions. This study identified missed opportunities for early intervention for at-risk drinking. Future research should evaluate the effect of early intervention on long-term outcomes.	[Larson, Mary Jo; Adams, Rachel Sayko] Brandeis Univ, Heller Sch Social Policy & Management, Inst Behav Hlth, Waltham, MA 02454 USA; [Mohr, Beth A.] Brandeis Univ, Heller Sch Social Policy & Management, Schneider Inst Hlth Policy, Waltham, MA 02454 USA; [Wooten, Nikki R.] Univ S Carolina, Coll Social Work, Mil Social Work Res & Practice, Columbia, SC 29208 USA; [Williams, Thomas V.] Def Hlth Agcy, Dept Def, Def Hlth Cost Assessment, Falls Church, VA USA; [Williams, Thomas V.] Def Hlth Agcy, Dept Def, Program Evaluat, Falls Church, VA USA	Larson, MJ (corresponding author), Brandeis Univ, Heller Sch Social Policy & Management, Inst Behav Hlth, 415 South St,MS 035, Waltham, MA 02454 USA.	larson@brandeis.edu	Wooten, Nikki/R-7071-2019; Adams, Rachel/AAH-4653-2020	Wooten, Nikki/0000-0002-6319-8224	National Institute on Drug Abuse (NIDA)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA) [R01DA030150]; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [R01DA030150, K01DA037412] Funding Source: NIH RePORTER	This study was funded by the National Institute on Drug Abuse (NIDA; grant R01DA030150).	Adams RS, 2013, SUBST USE MISUSE, V48, P821, DOI 10.3109/10826084.2013.797995; Adams RS, 2012, J HEAD TRAUMA REHAB, V27, P349, DOI 10.1097/HTR.0b013e318268db94; Ames G, 2004, ALCOHOL RES HEALTH, V28, P252; Armed Forces Health Surveillance Center, 2012, MSMR, V19, P1; Army Suicide Prevention Task Force, 2010, ARMY HEALTH PROMOTIO; Barlas FM, 2011, 2011 DEPARTMENT OF D; Ben-Zeev D, 2012, J MENT HEALTH, V21, P264, DOI 10.3109/09638237.2011.621468; Bliese PD, 2008, J CONSULT CLIN PSYCH, V76, P272, DOI 10.1037/0022-006X.76.2.272; Bliese PD, 2011, DEPLOYMENT PSYCHOL E, P175; Bradley KA, 2003, ARCH INTERN MED, V163, P821, DOI 10.1001/archinte.163.7.821; Bradley KA, 2007, ALCOHOL CLIN EXP RES, V31, P1208, DOI 10.1111/j.1530-0277.2007.00403.x; Bradley Katharine A, 2007, Subst Abus, V28, P133, DOI 10.1300/J465v28n04_05; Bray RM, 2010, MIL MED, V175, P390, DOI 10.7205/MILMED-D-09-00132; Britt TW, 2007, MIL MED, V172, P157, DOI 10.7205/MILMED.172.2.157; Brown MC, 2011, J NERV MENT DIS, V199, P797, DOI 10.1097/NMD.0b013e31822fc9bf; Brown R L, 2001, J Am Board Fam Pract, V14, P95; Bush K, 1998, ARCH INTERN MED, V158, P1789, DOI 10.1001/archinte.158.16.1789; Calhoun PS, 2010, PSYCHIAT RES, V178, P330, DOI 10.1016/j.psychres.2009.11.009; Center for Substance Abuse Research, MILITARY PERSONNEL M, V182009; Clarke-Walper K, 2014, ADDICT BEHAV, V39, P414, DOI 10.1016/j.addbeh.2013.05.001; Crawford EF, 2013, DRUG ALCOHOL DEPEN, V132, P101, DOI 10.1016/j.drugalcdep.2013.01.012; Department of Defense, 2013, INSTRUCTION 6490 12; Department of Defense, 2010, OFFICE OF FORCE HEAL; Department of Defense, 2011, INSTRUCTION 6490 08; Department of Defense, 1997, IMPLEMENTATION AND A; Department of the Navy DoD. Letter of instruction for the Marine Corps Alcohol Screening Program, 2013, 5300 MFC4; Department of the Navy DoD. Use of Hand- Held Alcohol Detection Devices, 2013, OPNAVINST 5350 8; Department of Veterans Affairs and Department of Defense, 2009, VA DOD CLINICAL PRAC; Deployment Health Clinical Center, ENHANCED POST DEPLOY; Eisen SV, 2012, AM J PUBLIC HEALTH, V102, pS66, DOI 10.2105/AJPH.2011.300609; Funderburk JS, 2013, MIL MED, V178, P1071, DOI 10.7205/MILMED-D-13-00165; Gibbs DA, 2011, MIL PSYCHOL, V23, P36, DOI 10.1080/08995605.2011.534409; Gibbs DA, 2011, MIL PSYCHOL, V23, P97, DOI 10.1080/08995605.2011.534418; Harmon SC, 2012, MIL MED, V177, P366, DOI 10.7205/MILMED-D-11-00343; Harwood HJ, 2009, MIL MED, V174, P728, DOI 10.7205/MILMED-D-03-9008; Hoge CW, 2006, JAMA-J AM MED ASSOC, V295, P1023, DOI 10.1001/jama.295.9.1023; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Hoge CW, 2011, DEPLOYMENT PSYCHOL E, P17, DOI DOI 10.1037/12300-001; Hourani L, 2012, MIL MED, V177, P643, DOI 10.7205/MILMED-D-11-00421; Institute of Medicine, 2013, SUBSTANCE USE DISORD; Jacobson IG, 2008, JAMA-J AM MED ASSOC, V300, P663, DOI 10.1001/jama.300.6.663; Kaner EFS, 2009, DRUG ALCOHOL REV, V28, P301, DOI 10.1111/j.1465-3362.2009.00071.x; Kim PY, 2011, MIL PSYCHOL, V23, P65, DOI 10.1080/08995605.2011.534415; Kinder LS, 2009, J STUD ALCOHOL DRUGS, V70, P253, DOI 10.15288/jsad.2009.70.253; Kroenke K, 2003, MED CARE, V41, P1284, DOI 10.1097/01.MLR.0000093487.78664.3C; Lande RG, 2008, J ADDICT DIS, V27, P115, DOI 10.1080/10550880802122711; Larson MJ, 2012, J SOC WORK PRACT ADD, V12, P6, DOI 10.1080/1533256X.2012.647586; Larson MJ, 2013, SUBST USE MISUSE, V48, P863, DOI 10.3109/10826084.2013.794840; Luxton DD, 2012, DODSER DEPARTMENT OF; Mattiko MJ, 2011, ADDICT BEHAV, V36, P608, DOI 10.1016/j.addbeh.2011.01.023; Milliken CS, 2007, JAMA-J AM MED ASSOC, V298, P2141, DOI 10.1001/jama.298.18.2141; Milliken CS, 2011, ACCESS TO SUD CARE C; National Institute on Alcohol Abuse and Alcoholism, 2005, NIH PUBLICATION, V07-3769; Ong AL, 2008, MIL MED, V173, P871, DOI 10.7205/MILMED.173.9.871; Polen MR, 2008, AHRQ PUBLICATION; Prins A, 2003, PRIMARY CARE PSYCHIA, V9, P9; Ramchand R, 2011, MIL PSYCHOL, V23, P6, DOI 10.1080/08995605.2011.534407; Rona RJ, 2005, JAMA-J AM MED ASSOC, V293, P1257, DOI 10.1001/jama.293.10.1257; Rubinsky AD, 2010, DRUG ALCOHOL DEPEN, V108, P29, DOI 10.1016/j.drugalcdep.2009.11.009; Saitz R, 2005, NEW ENGL J MED, V352, P596, DOI 10.1056/NEJMcp042262; Santiago PN, 2010, PSYCHIAT SERV, V61, P575, DOI 10.1176/ps.2010.61.6.575; Simon S, 2013, THE RELIABILITY OF A; Skopp NA, 2012, J CLIN PSYCHOL, V68, P1253, DOI 10.1002/jclp.21887; Spera C, 2011, J STUD ALCOHOL DRUGS, V72, P5, DOI 10.15288/jsad.2011.72.5; Stahre MA, 2009, AM J PREV MED, V36, P208, DOI 10.1016/j.amepre.2008.10.017; The Management of Substance Use Disorders Working Group, 2009, DOD CLINICAL PRACTIC; United States Government Accountability Office, 2008, GAO 08 276; Veterans Health Administration, 2007, SCREENING AND EVALUA; Warner CH, 2011, ARCH GEN PSYCHIAT, V68, P1065, DOI 10.1001/archgenpsychiatry.2011.112; Wilk JE, 2010, DRUG ALCOHOL DEPEN, V108, P115, DOI 10.1016/j.drugalcdep.2009.12.003; Williams J, 2010, ADDICT BEHAV, V35, P444, DOI 10.1016/j.addbeh.2009.12.012	71	18	18	0	13	AMER PUBLIC HEALTH ASSOC INC	WASHINGTON	800 I STREET, NW, WASHINGTON, DC 20001-3710 USA	0090-0036	1541-0048		AM J PUBLIC HEALTH	Am. J. Public Health	AUG	2014	104	8					1402	1412		10.2105/AJPH.2014.301901			11	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	AP1EY	WOS:000341811000037	24922163	Green Published			2021-06-18	
J	Thomas, EJ; Levack, WMM; Taylor, WJ				Thomas, Emily J.; Levack, William M. M.; Taylor, William J.			Self-Reflective Meaning Making in Troubled Times: Change in Self-Identity After Traumatic Brain Injury	QUALITATIVE HEALTH RESEARCH			English	Article						brain injury; concept analysis; recovery; rehabilitation; self; social identity	QUALITY-OF-LIFE; HEAD-INJURY; REHABILITATION; EXPERIENCE; NARRATIVES; RECOVERY; MEMORY; INTERVENTIONS; CONSTRUCTION; IMPAIRMENT	Our aim with this article is to clarify the concept of change in self-identity following traumatic brain injury (TBI). We used concept analysis methodology-predominantly concept clarification. We identified 110 articles using a systematic literature search, and used critical appraisal, content analysis, and analytical questioning to explore attributes and boundaries. A reported change in self-identity is the ultimate expression of a variety of cognitive, psychological, and social sequelae of TBI. We present an integrative model of this process, identifying three potential levels of change: (a) component parts (egocentric self, sociocentric self, and "identity as shared with others"); (b) integral processes (self-awareness and expression via meaningful occupation and narratives); and (c) whole-system disruption. Change in self-identity after TBI is a highly individualistic process. The driver of this process is "self-reflective meaning making," giving a purpose and direction in life, providing motivation and goals for future behavior.	[Thomas, Emily J.; Levack, William M. M.; Taylor, William J.] Univ Otago, Wellington, New Zealand	Thomas, EJ (corresponding author), Univ Otago Wellington, RTRU, POB 7343, Wellington, New Zealand.	em@doctors.org.uk	Levack, William Mark Magnus/F-9607-2018	Levack, William Mark Magnus/0000-0001-6631-908X; Taylor, William/0000-0001-6075-8479			Abrams LS, 2011, QUAL HEALTH RES, V21, P373, DOI 10.1177/1049732310385123; [Anonymous], 2013, OXFORD ENGLISH DICT; Bach LJ, 2006, NEUROPSYCHOL REHABIL, V16, P397, DOI 10.1080/09602010500412830; Barnes-Holmes Y, 2001, ADV CHILD DEV BEHAV, V28, P101; Ben-Yishay Y., 2000, INT HDB NEUROPSYCHOL, P127, DOI [10.1007/978-1-4757-5569-5_8, DOI 10.1007/978-1-4757-5569-5_8]; Biderman D, 2006, INT J PSYCHOL, V41, P355, DOI 10.1080/00207590500345963; Brenner LA, 2009, REHABIL PSYCHOL, V54, P390, DOI 10.1037/a0017802; Brown D, 2006, BRAIN INJURY, V20, P937, DOI 10.1080/02699050600909821; Cantor JB, 2005, J HEAD TRAUMA REHAB, V20, P527, DOI 10.1097/00001199-200511000-00005; Carroll E, 2011, NEUROPSYCHOL REHABIL, V21, P289, DOI 10.1080/09602011.2011.555972; Chamberlain DJ, 2006, J ADV NURS, V54, P407, DOI 10.1111/j.1365-2648.2006.03840.x; Charmaz K, 1995, SOCIOL QUART, V36, P657, DOI 10.1111/j.1533-8525.1995.tb00459.x; Christiansen CH, 1999, AM J OCCUP THER, V53, P547, DOI 10.5014/ajot.53.6.547; Christman J, 2004, METAPHILOSOPHY, V35, P695, DOI 10.1111/j.1467-9973.2004.00345.x; Cloute K, 2008, NEUROPSYCHOL REHABIL, V18, P651, DOI 10.1080/09602010701306989; Coetzer BR, 2001, J COGN REHABIL, V19, P8; Coetzer R, 2008, NEUROPSYCHOL REHABIL, V18, P766, DOI 10.1080/09602010701860266; Conneeley A. L., 2002, BRIT J OCCUPATIONAL, V65, P356; Conway MA, 2005, J MEM LANG, V53, P594, DOI 10.1016/j.jml.2005.08.005; Cooley C. H., 1902, HUMAN NATURE SOCIAL; Crisp R, 1992, Aust Occup Ther J, V39, P15, DOI 10.1111/j.1440-1630.1992.tb01730.x; Damasio A, 2003, ANN NY ACAD SCI, V1001, P253, DOI 10.1196/annals.1279.014; DAMON W, 1982, CHILD DEV, V53, P841, DOI 10.2307/1129122; Douglas Jacinta M., 2010, Seminars in Speech and Language, V31, P197, DOI 10.1055/s-0030-1257536; Erikson E. H., 1963, CHILDHOOD SOC; Fitts W.H., 1996, TENNESSEE SELF CONCE, V2nd ed; Gazzaniga Michael, 2005, ETHICAL BRAIN; Gelech JM, 2011, QUAL HEALTH RES, V21, P62, DOI 10.1177/1049732310377454; Gracey F., 2012, SOCIAL CURE IDENTITY, P273, DOI DOI 10.4324/9780203813195; Gracey F, 2008, NEUROPSYCHOL REHABIL, V18, P627, DOI 10.1080/09602010802041238; Gracey F, 2008, NEUROPSYCHOL REHABIL, V18, P522, DOI 10.1080/09602010802141509; Gracey F, 2009, NEUROPSYCHOL REHABIL, V19, P867, DOI 10.1080/09602010903027763; Gutman SA, 1996, AM J OCCUP THER, V50, P535, DOI 10.5014/ajot.50.7.535; Hammell KW, 2007, SPINAL CORD, V45, P124, DOI 10.1038/sj.sc.3101992; Heller W, 2006, J REHABIL, V72, P44; Hogan BA, 1999, NEUROREHABILITATION, V13, P21; James W., 1890, PRINCIPLES PSYCHOL B; Jetten J., 2012, SOCIAL CURE IDENTITY, P3, DOI DOI 10.4324/9780203813195; Johansson U, 2006, AM J OCCUP THER, V60, P60, DOI 10.5014/ajot.60.1.60; John, 1999, HDB PERSONALITY THEO, P478; Jones J, 2010, QUAL HEALTH RES, V20, P942, DOI 10.1177/1049732310365501; Jumisko Eija, 2005, J Neurosci Nurs, V37, P42; Klinger L, 2005, J OCCUP SCI, V12, P9, DOI 10.1080/14427591.2005.9686543; Knafl, 2000, CONCEPT DEV NURSING, P333; KREFTING L, 1989, OCCUP THER J RES, V9, P67, DOI 10.1177/153944928900900201; Lawson S, 2008, THER RECREAT J, V42, P236; Leary M, 2012, HDB SELF IDENTITY, V2; Leplege A, 2007, DISABIL REHABIL, V29, P1555, DOI 10.1080/09638280701618661; Levack WMM, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004630; Levack WMM, 2010, DISABIL REHABIL, V32, P986, DOI 10.3109/09638281003775394; LEVINE MJ, 1993, BRAIN INJURY, V7, P153, DOI 10.3109/02699059309008169; LINVILLE PW, 1987, J PERS SOC PSYCHOL, V52, P663, DOI 10.1037/0022-3514.52.4.663; Locke J, 1690, ESSAY HUMAN UNDERSTA; Man DWK, 2003, BRAIN INJURY, V17, P775, DOI 10.1080/0269905031000088577; MARKUS H, 1986, AM PSYCHOL, V41, P954, DOI 10.1037/0003-066X.41.9.954; Mattingly Cheryl., 1998, HEALING DRAMAS CLIN; McGrath J, 2004, CLIN REHABIL, V18, P767, DOI 10.1191/0269215504cr802oa; MCGRATH JC, 2008, TRAUMA RECOVERY GROW, P259; Mead G. H., 1934, MIND SELF SOC STANDP; Medved MI, 2008, QUAL HEALTH RES, V18, P469, DOI 10.1177/1049732308315731; MORRIS SD, 2004, J COGN REHABIL, V22, P15; Morse J M, 1996, Sch Inq Nurs Pract, V10, P253; MORSE JM, 1995, ADV NURS SCI, V17, P31, DOI 10.1097/00012272-199503000-00005; Morse JM, 1996, J ADV NURS, V24, P385, DOI 10.1046/j.1365-2648.1996.18022.x; Muenchberger H, 2008, BRAIN INJURY, V22, P979, DOI 10.1080/02699050802530532; Myles SM, 2004, INT J PSYCHOL PSYCHO, V4, P487; Nochi M, 1997, DISABIL SOC, V12, P533, DOI 10.1080/09687599727119; Nochi M, 1998, QUAL HEALTH RES, V8, P665, DOI 10.1177/104973239800800507; Nochi M, 2000, SOC SCI MED, V51, P1795, DOI 10.1016/S0277-9536(00)00111-8; Nochi M, 1998, SOC SCI MED, V46, P869, DOI 10.1016/S0277-9536(97)00211-6; Noggle R, 1999, PHILOS STUD, V96, P303; Oke M, 2008, AUST N Z J FAM THER, V29, P148, DOI 10.1375/anft.29.3.148; Ownsworth T, 2011, BRAIN IMPAIR, V12, P79; Padilla R, 2003, AM J OCCUP THER, V57, P413, DOI 10.5014/ajot.57.4.413; Paterson J., 2002, REHABILITATION NURSI, V27, P13, DOI [10.1002/j.2048-7940.2002.tb01973.x, DOI 10.1002/J.2048-7940.2002.TB01973.X]; Patterson FL, 2009, J MENT HLTH COUNS, V31, P149; Perna R. B., 2004, J COGNITIVE REHABILI, V22, P10; PERSINGER MA, 1993, PSYCHOL REP, V72, P1059, DOI 10.2466/pr0.1993.72.3c.1059; Piolino P, 2007, CORTEX, V43, P176, DOI 10.1016/S0010-9452(08)70474-X; PriceLackey P, 1996, AM J OCCUP THER, V50, P306, DOI 10.5014/ajot.50.4.306; Prigatano G. P., 1991, AWARENESS DEFICIT BR; Prigatano G. P., 1986, NEUROPSYCHOLOGICAL R; Rathbone CJ, 2009, NEUROCASE, V15, P405, DOI 10.1080/13554790902849164; Ricoeur P., 1984, TIME NARRATIVE, V1; Roscigno CI, 2008, J NEUROSCI NURS, V40, P212, DOI 10.1097/01376517-200808000-00005; Rubin D., 1988, AUTOBIOGRAPHICAL MEM, P202; Sani F., 2008, SELF CONTINUITY INDI, P71, DOI DOI 10.4324/9780203888513; Schechtman M., 1996, CONSTITUTION SELVES; Schmidt J, 2011, J REHABIL MED, V43, P673, DOI 10.2340/16501977-0846; Smith C., 2008, FORUM QUALITATIVE SO, V9; Soeker MS, 2011, J OCCUP SCI, V18, P81, DOI 10.1080/14427591.2011.554155; Strawson G, 2004, RATIO, V17, P428, DOI 10.1111/j.1467-9329.2004.00264.x; Taylor C., 1989, SOURCES SELF MAKING; TYERMAN A, 1984, INT J REHABIL RES, V7, P11, DOI 10.1097/00004356-198403000-00002; Vickery CD, 2005, BRAIN INJURY, V19, P657, DOI 10.1080/02699050400005218; Witt K, 2013, NEUROETHICS-NETH, V6, P499, DOI 10.1007/s12152-011-9100-1; Yeates GN, 2008, NEUROPSYCHOL REHABIL, V18, P566, DOI 10.1080/09602010802151532; Ylvisaker M, 2000, BRAIN IMPAIR, V1, P12, DOI DOI 10.1375/BRIM.1.1.12; Ylvisaker M, 2008, NEUROPSYCHOL REHABIL, V18, P713, DOI 10.1080/09602010802201832	99	18	18	0	24	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1049-7323	1552-7557		QUAL HEALTH RES	Qual. Health Res.	AUG	2014	24	8			SI		1033	1047		10.1177/1049732314542809			15	Information Science & Library Science; Social Sciences, Interdisciplinary; Social Sciences, Biomedical	Information Science & Library Science; Social Sciences - Other Topics; Biomedical Social Sciences	AQ2OB	WOS:000342625100002	25015780				2021-06-18	
J	Diaz, AP; Schwarzbold, ML; Thais, ME; Cavallazzi, GG; Schmoeller, R; Nunes, JC; Hohl, A; Guarnieri, R; Linhares, MN; Walz, R				Diaz, Alexandre P.; Schwarzbold, Marcelo L.; Thais, Maria E.; Cavallazzi, Gisele G.; Schmoeller, Roseli; Nunes, Jean C.; Hohl, Alexandre; Guarnieri, Ricardo; Linhares, Marcelo N.; Walz, Roger			Personality changes and return to work after severe traumatic brain injury: a prospective study	REVISTA BRASILEIRA DE PSIQUIATRIA			English	Article						Traumatic brain injury; return to work; mental disorders	HEAD-INJURY; PSYCHIATRIC-DISORDERS; ACUTE PREDICTORS; MORTALITY; RECOVERY; IMPACT; AGE; EPIDEMIOLOGY; MULTICENTER; APATHY	Objective: To evaluate predictors of non-return to work (nRTW) among social, demographic, clinical, and psychiatric variables after severe traumatic brain injury (TBI) in a cohort of Brazilian patients. Methods: Prospective study. Forty-three community-dwelling individuals treated at a Level I trauma center at the time of TBI were evaluated 18 months after trauma. Measures included DSM-IV-TR criteria for personality changes after TBI and Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I) to assess psychiatric diagnosis. Hospitalization variables included Glasgow Coma Scale scores, pupil examination findings, associated limb trauma, Marshall computed tomography classification, and blood glucose levels. Results: After multiple logistic regression analysis, only the diagnosis of personality changes was found to be independently associated with nRTW, with an adjusted odds ratio of 10.92 (p = 0.02, 95% confidence interval 1.41-84.28). Conclusions: In this study, personality changes were an independent predictor of nRTW after severe TBI. Ways to predict risk factors associated with personality changes after severe brain injury could aid in identification of early and effective interventions that might ease the burden associated with this condition.	[Diaz, Alexandre P.; Schwarzbold, Marcelo L.; Thais, Maria E.; Cavallazzi, Gisele G.; Schmoeller, Roseli; Nunes, Jean C.; Hohl, Alexandre; Guarnieri, Ricardo; Linhares, Marcelo N.; Walz, Roger] Univ Fed Santa Catarina, HU, Ctr Appl Neurosci CeNAp, Florianopolis, SC, Brazil; [Diaz, Alexandre P.; Guarnieri, Ricardo; Linhares, Marcelo N.] Hosp Governador Celso Ramos, Neurosurg Serv, Florianopolis, SC, Brazil; [Walz, Roger] Univ Fed Santa Catarina, HU, Dept Clin Med, Florianopolis, SC, Brazil	Diaz, AP (corresponding author), Univ Fed Santa Catarina, Ctr Neurociencias Aplicadas CENAP, BR-88040970 Florianopolis, SC, Brazil.	alexandrepaimdiaz@gmail.com	Diaz, Alexandre Paim/J-9042-2014; Schwarzbold, Marcelo Liborio/J-8960-2014; Hohl, Alexandre/R-9269-2019; Walz, Roger/K-9096-2013; Diaz, Alexandre Paim/AAD-8323-2019	Hohl, Alexandre/0000-0002-8073-5837; Walz, Roger/0000-0002-9875-6687; Diaz, Alexandre Paim/0000-0002-6591-6648	PRONEX Program (NENASC Project); PPSUS Program of Fundacao de Amparo a Pesquisa e Inovacao do Estado de Santa Catarina (FAPESC); National Science and Technology Institute for Translational Medicine (INCT-TM)	This work was supported by PRONEX Program (NENASC Project) and PPSUS Program of Fundacao de Amparo a Pesquisa e Inovacao do Estado de Santa Catarina (FAPESC) and the National Science and Technology Institute for Translational Medicine (INCT-TM).	Alonso J, 2012, REV BRAS PSIQUIATR, V34, P7, DOI 10.1590/S1516-44462012000100003; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Benedictus MR, 2010, ARCH PHYS MED REHAB, V91, P1436, DOI 10.1016/j.apmr.2010.06.019; Botega NJ, 1998, J BRAS PSIQUIAT, V47, P285; Brooks N, 1988, Acta Neurochir Suppl (Wien), V44, P59; Cifu DX, 1997, ARCH PHYS MED REHAB, V78, P125, DOI 10.1016/S0003-9993(97)90252-5; de la Plata CAM, 2008, ARCH PHYS MED REHAB, V89, P896, DOI 10.1016/j.apmr.2007.12.030; Diaz AP, 2012, J NEUROTRAUM, V29, P1029, DOI 10.1089/neu.2011.2089; Druss BG, 2009, MOL PSYCHIATR, V14, P728, DOI 10.1038/mp.2008.13; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; First M.B., 1996, STRUCTURED CLIN INTE; Groswasser Z, 1999, NEUROPSYCHOL REHABIL, V9, P493, DOI 10.1080/096020199389545; Gullo JD, 2011, NEUROCRIT CARE, V14, P194, DOI 10.1007/s12028-010-9462-y; Gustavsson A, 2011, EUR NEUROPSYCHOPHARM, V21, P718, DOI 10.1016/j.euroneuro.2011.08.008; Keyser-Marcus LA, 2002, ARCH PHYS MED REHAB, V83, P635, DOI 10.1053/apmr.2002.31605; Koizumi MS, 2000, ARQ NEURO-PSIQUIAT, V58, P81, DOI 10.1590/S0004-282X2000000100013; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Levy R, 2006, CEREB CORTEX, V16, P916, DOI 10.1093/cercor/bhj043; Lippert-Gruener M, 2007, BRAIN INJURY, V21, P1001, DOI 10.1080/02699050701468933; Martins ET, 2009, J TRAUMA, V67, P85, DOI 10.1097/TA.0b013e318187acee; Masini M, 1994, J BRAS NEUROCIRURG, V5, P61; McCrimmon S, 2006, BRAIN INJURY, V20, P1037, DOI 10.1080/02699050600909656; McMillan TM, 1996, J NEUROL NEUROSUR PS, V60, P422, DOI 10.1136/jnnp.60.4.422; Olesen J, 2012, EUR J NEUROL, V19, P155, DOI 10.1111/j.1468-1331.2011.03590.x; Rochat L, 2009, J NEUROPSYCHOL, V3, P213, DOI 10.1348/174866408X397656; Roe C, 2013, J REHABIL MED, V45, P734, DOI 10.2340/16501977-1198; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Ruiz Pedro, 2009, COMPREHENSIVE TXB PS; Schwarzbold Marcelo, 2008, Neuropsychiatr Dis Treat, V4, P797; Sigurdardottir S, 2009, J INT NEUROPSYCH SOC, V15, P740, DOI 10.1017/S1355617709990452; Stulemeijer M, 2008, J NEUROL NEUROSUR PS, V79, P936, DOI 10.1136/jnnp.2007.131250; Tavares M., 1996, CLIN ESTRUCTURADA DS; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207; van Reekum R, 2005, J NEUROPSYCH CLIN N, V17, P7, DOI 10.1176/appi.neuropsych.17.1.7; van Velzen JM, 2009, BRAIN INJURY, V23, P385, DOI 10.1080/02699050902838165; Viana MC, 2012, REV BRAS PSIQUIATR, V34, P249, DOI 10.1016/j.rbp.2012.03.001; Walker WC, 2006, ARCH PHYS MED REHAB, V87, P1576, DOI 10.1016/j.apmr.2006.08.335; Wang HQ, 2013, EPILEPSY RES, V107, P272, DOI 10.1016/j.eplepsyres.2013.10.006; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	40	18	18	0	7	ASSOC BRASILEIRA PSIQUIATRIA	SAO PAULO	SUBSCRIPTION DEPARTMENT, RUA PEDRO DE TOLEDO, 967 - CASA 01, SAO PAULO, SP 04039-032  A, BRAZIL	1516-4446	1809-452X		REV BRAS PSIQUIATR	Rev. Bras. Psiquiatr.	JUL-SEP	2014	36	3					213	219		10.1590/1516-4446-2013-1303			7	Psychiatry	Psychiatry	AN2PD	WOS:000340426900006	24770655	DOAJ Gold			2021-06-18	
J	Vasudevan, EVL; Glass, RN; Packel, AT				Vasudevan, Erin V. L.; Glass, Rebecca N.; Packel, Andrew T.			Effects of Traumatic Brain Injury on Locomotor Adaptation	JOURNAL OF NEUROLOGIC PHYSICAL THERAPY			English	Article						feedback control; feed-forward control; motor learning; locomotor adaptation; traumatic brain injury; walking	MOBILITY ASSESSMENT-TOOL; SPLIT-BELT TREADMILL; DIFFUSE AXONAL INJURY; NEUROPSYCHIATRIC SEQUELAE; CEREBELLAR ATROPHY; DOUBLE-BLIND; SWING PHASE; HEAD-INJURY; GAIT; MOTOR	Background and Purpose: Locomotor adaptation is a form of short-term learning that enables gait modifications and reduces movement errors when the environment changes. This adaptation is critical for community ambulation for example, when walking on different surfaces. While many individuals with traumatic brain injury (TBI) recover basic ambulation, less is known about recovery of more complex locomotor skills, like adaptation. The purpose of this study was to investigate how TBI affects locomotor adaptation. Methods: Fourteen adults with TBI and 11 nondisabled comparison participants walked for 15 minutes on a split-belt treadmill with 1 belt moving at 0.7 m/s, and the other at 1.4 m/s. Subsequently, aftereffects were assessed and de-adapted during 15 minutes of tied-belt walking (both belts at 0.7 m/s). Results: Participants with TBI showed greater asymmetry in inter-limb coordination on split-belts than the comparison group. Those with TBI did not adapt back to baseline symmetry, and some individuals did not store significant aftereffects. Greater asymmetry on split-belts and smaller aftereffects were associated with greater ataxia. Discussion: Participants with TBI were more perturbed by walking on split-belts and showed some impairment in adaptation. This suggests a reduced ability to learn a new form of coordination to compensate for environmental changes. Multiple interacting factors, including cerebellar damage and impairments in higher-level cognitive processes, may influence adaptation post-TBI. Conclusions: Gait adaptation to novel environment demands is impaired in persons with chronic TBI and may be an important skill to target in rehabilitation. Video Abstract Available (See Video, Supplemental Digital Content 1, http://links.lww.com/JNPT/A74) for more insights from the authors.	[Vasudevan, Erin V. L.; Glass, Rebecca N.; Packel, Andrew T.] Moss Rehabil Res Inst, Albert Einstein Healthcare Network, Motor Learning Lab, Elkins Pk, PA 19027 USA	Vasudevan, EVL (corresponding author), Moss Rehabil Res Inst, 50 Township Line Rd, Elkins Pk, PA 19027 USA.	vasudeve@einstein.edu	Packel, Andrew/AAJ-4840-2021; Vasudevan, Erin/F-7081-2017	Packel, Andrew/0000-0002-5048-1661; Vasudevan, Erin/0000-0003-1129-3489	Moss Rehabilitation Research Institute Peer Review Committee	This work has been supported by seed funding from the Moss Rehabilitation Research Institute Peer Review Committee.	ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Basford JR, 2003, ARCH PHYS MED REHAB, V84, P343, DOI 10.1053/apmr.2003.50034; Bier JC, 2003, J NEUROL, V250, P693, DOI 10.1007/s00415-003-1061-9; Cantin JF, 2007, BRAIN INJURY, V21, P327, DOI 10.1080/02699050701209972; Catena RD, 2007, EXP BRAIN RES, V176, P23, DOI 10.1007/s00221-006-0596-2; Chen HY, 2006, CEREB CORTEX, V16, P1462, DOI 10.1093/bhj087; Choi JT, 2009, BRAIN, V132, P722, DOI 10.1093/brain/awn333; Chou LS, 2004, GAIT POSTURE, V20, P245, DOI 10.1016/j.gaitpost.2003.09.007; DUYSENS J, 1980, BRAIN RES, V187, P321, DOI 10.1016/0006-8993(80)90206-1; FUGLMEYER AR, 1975, SCAND J REHABIL MED, V7, P13; Galea JM, 2011, CEREB CORTEX, V21, P1761, DOI 10.1093/cercor/bhq246; Gordon KE, 2010, J NEUROPHYSIOL, V104, P1325, DOI 10.1152/jn.00604.2009; GRILLNER S, 1978, BRAIN RES, V146, P269, DOI 10.1016/0006-8993(78)90973-3; GRILLNER S, 1985, ANNU REV NEUROSCI, V8, P233, DOI 10.1146/annurev.ne.08.030185.001313; HOLM S, 1979, SCAND J STAT, V6, P65; Howell DR, 2013, ARCH PHYS MED REHAB, V94, P1513, DOI 10.1016/j.apmr.2013.04.015; Ilg W, 2008, BRAIN, V131, P2913, DOI 10.1093/brain/awn246; IWADATE Y, 1989, Neurosurgical Review, V12, P500, DOI 10.1007/BF01790695; Jayaram G, 2011, CEREB CORTEX, V21, P1901, DOI 10.1093/cercor/bhq263; JORDAN BD, 1988, ARCH NEUROL-CHICAGO, V45, P1207, DOI 10.1001/archneur.1988.00520350045014; Kahn JH, 2009, PHYS THER, V89, P474, DOI 10.2522/ptj.20080237; Katz DI, 2004, ARCH PHYS MED REHAB, V85, P865, DOI 10.1016/j.apmr.2003.11.020; Kaufman KR, 2006, MED ENG PHYS, V28, P234, DOI 10.1016/j.medengphy.2005.05.005; Kraus MF, 1999, TRAUMATIC BRAIN INJU, V14, P173; Lam T, 2006, J NEUROPHYSIOL, V95, P766, DOI 10.1152/jn.00473.2005; Lam T, 2008, NEUROREHAB NEURAL RE, V22, P438, DOI 10.1177/1545968308315595; Lam T, 2009, J NEUROL PHYS THER, V33, P129, DOI 10.1097/NPT.0b013e3181b57de5; Louis ED, 1996, ARCH NEUROL-CHICAGO, V53, P450, DOI 10.1001/archneur.1996.00550050080027; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Malone LA, 2012, J NEUROPHYSIOL, V108, P672, DOI 10.1152/jn.00391.2011; Malone LA, 2011, J NEUROSCI, V31, P15136, DOI 10.1523/JNEUROSCI.1367-11.2011; Malone LA, 2010, J NEUROPHYSIOL, V103, P1954, DOI 10.1152/jn.00832.2009; Martin TA, 1996, BRAIN, V119, P1183, DOI 10.1093/brain/119.4.1183; Mazaux JM, 1998, DISABIL REHABIL, V20, P435, DOI 10.3109/09638289809166108; MCALLISTER TW, 1992, PSYCHIAT CLIN N AM, V15, P395; McCulloch KL, 2010, J HEAD TRAUMA REHAB, V25, P155, DOI 10.1097/HTR.0b013e3181dc82e7; McFadyen BJ, 2003, J HEAD TRAUMA REHAB, V18, P512, DOI 10.1097/00001199-200311000-00005; McFadyen BJ, 2009, ARCH PHYS MED REHAB, V90, P1596, DOI 10.1016/j.apmr.2009.03.010; Saute JAM, 2012, CEREBELLUM, V11, P488, DOI 10.1007/s12311-011-0316-8; Morton SM, 2004, J NEUROPHYSIOL, V92, P2497, DOI 10.1152/jn.00129.2004; Morton SM, 2003, J NEUROPHYSIOL, V89, P1844, DOI 10.1152/jn.00787.2002; Morton SM, 2006, J NEUROSCI, V26, P9107, DOI 10.1523/JNEUROSCI.2622-06.2006; Niimura K, 1999, NEUROLOGY, V52, P792, DOI 10.1212/WNL.52.4.792; Ochi F, 1999, J HEAD TRAUMA REHAB, V14, P105, DOI 10.1097/00001199-199904000-00002; Parker TM, 2005, CLIN BIOMECH, V20, P389, DOI 10.1016/j.clinbiomech.2004.12.004; Parker TM, 2006, MED SCI SPORT EXER, V38, P1032, DOI 10.1249/01.mss.0000222828.56982.a4; Pearson KG, 2000, ANNU REV PHYSIOL, V62, P723, DOI 10.1146/annurev.physiol.62.1.723; Platz T, 2005, CLIN REHABIL, V19, P404, DOI 10.1191/0269215505cr832oa; Potts MB, 2009, CEREBELLUM, V8, P211, DOI 10.1007/s12311-009-0114-8; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Rao V, 2000, PSYCHOSOMATICS, V41, P95, DOI 10.1176/appi.psy.41.2.95; Regnaux JP, 2008, CLIN BIOMECH, V23, P762, DOI 10.1016/j.clinbiomech.2008.01.011; Reisman DS, 2007, BRAIN, V130, P1861, DOI 10.1093/brain/awm035; Reisman DS, 2010, PHYS THER, V90, P187, DOI 10.2522/ptj.20090073; Reisman DS, 2005, J NEUROPHYSIOL, V94, P2403, DOI 10.1152/jn.00089.2005; Ristori G, 2010, NEUROLOGY, V74, P839, DOI 10.1212/WNL.0b013e3181d31e23; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; SAHUQUILLO J, 1989, ACTA NEUROCHIR, V101, P149, DOI 10.1007/BF01410531; Saibene F, 2003, EUR J APPL PHYSIOL, V88, P297, DOI 10.1007/s00421-002-0654-9; Sato M, 2001, BRAIN RES, V917, P45, DOI 10.1016/S0006-8993(01)02905-5; Savin DN, 2013, NEUROREHAB NEURAL RE, V27, P24, DOI 10.1177/1545968311434552; Schmahmann JD, 2009, NEUROSCIENCE, V162, P852, DOI 10.1016/j.neuroscience.2009.06.023; SHADMEHR R, 1994, J NEUROSCI, V14, P3208; Smith MA, 2005, J NEUROPHYSIOL, V93, P2809, DOI 10.1152/jn.00943.2004; Smith MA, 2006, PLOS BIOL, V4, P1035, DOI 10.1371/journal.pbio.0040179; Soto-Ares G, 2001, CHILD NERV SYST, V17, P263, DOI 10.1007/s003810000411; Spanos GK, 2007, AM J NEURORADIOL, V28, P537; Swaine BR, 1996, BRAIN INJURY, V10, P347, DOI 10.1080/026990596124368; Taylor JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002485; TEASDALE G, 1974, LANCET, V2, P81; THACH WT, 1992, ANNU REV NEUROSCI, V15, P403, DOI 10.1146/annurev.ne.15.030192.002155; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Tison F, 2002, MOVEMENT DISORD, V17, P1248, DOI 10.1002/mds.10290; Torres-Oviedo G, 2010, J NEUROSCI, V30, P17015, DOI 10.1523/JNEUROSCI.4205-10.2010; Trouillas P, 1997, J NEUROL SCI, V145, P205, DOI 10.1016/S0022-510X(96)00231-6; Vallee M, 2006, ARCH PHYS MED REHAB, V87, P806, DOI 10.1016/j.apmr.2006.02.031; Vasudevan EVL, 2011, J NEUROSCI, V31, P3055, DOI 10.1523/JNEUROSCI.5781-10.2011; Vasudevan EVL, 2010, J NEUROPHYSIOL, V103, P183, DOI 10.1152/jn.00501.2009; Whyte J, 2010, DELISAS PHYS MED REH, P575; Williams G, 2006, ARCH PHYS MED REHAB, V87, P437, DOI 10.1016/j.apmr.2005.10.028; Williams G, 2005, BRAIN INJURY, V19, P925, DOI 10.1080/02699050500058687; Williams GP, 2009, INT J THER REHABIL, V16, P370, DOI 10.12968/ijtr.2009.16.7.43046; Williams G, 2013, BRAIN INJURY, V27, P434, DOI 10.3109/02699052.2012.750754; Williams G, 2010, J HEAD TRAUMA REHAB, V25, P366, DOI 10.1097/HTR.0b013e3181cd3600; Williams G, 2009, ARCH PHYS MED REHAB, V90, P587, DOI 10.1016/j.apmr.2008.10.013; Williams GP, 2006, PHYS THER, V86, P395, DOI 10.1093/ptj/86.3.395; Williams GP, 2005, BRAIN INJURY, V19, P833, DOI 10.1080/02699050500058711	87	18	18	0	22	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1557-0576	1557-0584		J NEUROL PHYS THER	J. Neurol. Phys. Ther.	JUL	2014	38	3					172	182		10.1097/NPT.0000000000000049			11	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	AL3UA	WOS:000339053700006	24892766				2021-06-18	
J	Sakurai, A; Tamvacakis, AN; Katz, PS				Sakurai, Akira; Tamvacakis, Arianna N.; Katz, Paul S.			Hidden synaptic differences in a neural circuit underlie differential behavioral susceptibility to a neural injury	ELIFE			English	Article						Individual variability; synapse; central pattern generator; dynamic clamp; neural injury	TRAUMATIC BRAIN-INJURY; AXONAL SPIKE INITIATION; CENTRAL NERVOUS SYSTEMS; WHITE-MATTER STROKE; MOTOR PATTERNS; DYNAMIC CLAMP; FUNCTIONAL-ORGANIZATION; IMMUNOREACTIVE NEURONS; ACTION-POTENTIALS; VARIABILITY	Individuals vary in their responses to stroke and trauma, hampering predictions of outcomes. One reason might be that neural circuits contain hidden variability that becomes relevant only when those individuals are challenged by injury. We found that in the mollusc, Tritonia diomedea, subtle differences between animals within the neural circuit underlying swimming behavior had no behavioral relevance under normal conditions but caused differential vulnerability of the behavior to a particular brain lesion. The extent of motor impairment correlated with the site of spike initiation in a specific neuron in the neural circuit, which was determined by the strength of an inhibitory synapse onto this neuron. Artificially increasing or decreasing this inhibitory synaptic conductance with dynamic clamp correspondingly altered the extent of motor impairment by lesion without affecting normal operation. The results suggest that neural circuit differences could serve as hidden phenotypes for predicting the behavioral outcome of neural damage.	[Sakurai, Akira; Tamvacakis, Arianna N.; Katz, Paul S.] Georgia State Univ, Inst Neurosci, Atlanta, GA 30303 USA	Sakurai, A (corresponding author), Georgia State Univ, Inst Neurosci, Atlanta, GA 30303 USA.		Sakurai, Akira/A-6755-2008	Sakurai, Akira/0000-0003-2858-1620; Tamvacakis, Arianna/0000-0002-8245-3067	Brains and Behavior Seed Grant Program Georgia State University; March of Dimes FoundationMarch of Dimes;  [NSF-IOS-1120950]	Supported by NSF-IOS-1120950, Brains and Behavior Seed Grant Program Georgia State University, and March of Dimes Foundation	Adams JH, 2000, BRAIN, V123, P1327, DOI 10.1093/brain/123.7.1327; Andreasen M, 1998, J PHYSIOL-LONDON, V507, P441, DOI 10.1111/j.1469-7793.1998.441bt.x; Antic S, 2000, J PHYSIOL-LONDON, V527, P55, DOI 10.1111/j.1469-7793.2000.00055.x; Bair W, 2001, J NEUROSCI, V21, P1676; BAMFORD J, 1991, LANCET, V337, P1521, DOI 10.1016/0140-6736(91)93206-O; Berg RW, 2007, SCIENCE, V315, P390, DOI 10.1126/science.1134960; Bigler ED, 2013, NEUROPSYCHOLOGY, V27, P438, DOI 10.1037/a0032837; Blasi F, 2014, STROKE, V45, P1468, DOI 10.1161/STROKEAHA.114.005324; Brown GG, 2010, CURR TOP BEHAV NEURO, V4, P181, DOI 10.1007/7854_2010_54; Bucher D, 2011, PROG NEUROBIOL, V94, P307, DOI 10.1016/j.pneurobio.2011.06.001; Bukalo O, 2013, P NATL ACAD SCI USA, V110, P5175, DOI 10.1073/pnas.1210735110; BULLOCK TH, 1957, J PHYSIOL-LONDON, V138, P341, DOI 10.1113/jphysiol.1957.sp005855; Cai LL, 2006, PHILOS T R SOC B, V361, P1635, DOI 10.1098/rstb.2006.1884; CALABRESE RL, 1980, J NEUROPHYSIOL, V44, P878; CALABRESE RL, 1974, BRAIN RES, V82, P316, DOI 10.1016/0006-8993(74)90612-X; Calabrese RL, 2011, INTEGR COMP BIOL, V51, P845, DOI 10.1093/icb/icr074; Calin-Jageman RJ, 2007, J NEUROPHYSIOL, V98, P2382, DOI 10.1152/jn.00572.2007; COMBES D, 1993, J PHYSIOL-LONDON, V460, P581, DOI 10.1113/jphysiol.1993.sp019488; Cramer SC, 2003, NEUROL RES, V25, P811, DOI 10.1179/016164103771953899; Cramer SC, 2008, ANN NEUROL, V63, P549, DOI 10.1002/ana.21412; Cramer SC, 2008, ANN NEUROL, V63, P272, DOI 10.1002/ana.21393; Darwin Charles, 1876, ORIGIN SPECIES NATUR; Daur N, 2009, EUR J NEUROSCI, V30, P808, DOI 10.1111/j.1460-9568.2009.06866.x; DESTEXHE A, 1994, NEURAL COMPUT, V6, P14, DOI 10.1162/neco.1994.6.1.14; Dougherty KJ, 2010, ANN NY ACAD SCI, V1198, P85, DOI 10.1111/j.1749-6632.2010.05502.x; Essen Van, 2012, PNAS, P788; Fickbohm DJ, 2000, J NEUROSCI, V20, P1622; Forsyth R, 2012, CAN MED ASSOC J, V184, P1257, DOI 10.1503/cmaj.111045; Frost WN, 1996, NEUROBIOL LEARN MEM, V65, P125, DOI 10.1006/nlme.1996.0015; Getting P., 1989, METHODS NEURONAL MOD, P171; GETTING PA, 1989, ANNU REV NEUROSCI, V12, P185, DOI 10.1146/annurev.neuro.12.1.185; GETTING PA, 1983, J NEUROPHYSIOL, V49, P1036; GETTING PA, 1980, J NEUROPHYSIOL, V44, P151; GETTING PA, 1981, J NEUROPHYSIOL, V46, P65; GETTING PA, 1983, J NEUROPHYSIOL, V49, P1017; Getting PA, 1989, NEURONAL CELLULAR OS, P215; Goaillard JM, 2009, NAT NEUROSCI, V12, P1424, DOI 10.1038/nn.2404; Golowasch J, 2002, J NEUROPHYSIOL, V87, P1129, DOI 10.1152/jn.00412.2001; Gunaratne CA, 2014, J COMP NEUROL, V522, P794, DOI 10.1002/cne.23446; Hansen BJ, 2012, NEURON, V76, P590, DOI 10.1016/j.neuron.2012.08.029; HEITLER WJ, 1978, J EXP BIOL, V76, P63; Hill ES, 2007, J NEUROPHYSIOL, V97, P2204, DOI 10.1152/jn.01244.2006; HUGHES GM, 1960, J EXP BIOL, V37, P291; Hukkelhoven CWPM, 2005, J NEUROTRAUM, V22, P1025, DOI 10.1089/neu.2005.22.1025; Katz P. S., 2007, SCHOLARPEDIA, V2, P3504; Katz P. S., 2009, SCHOLARPEDIA, V4, P3638, DOI DOI 10.4249/SCHOLARPEDIA.3638; Katz PS, 2007, CURR OPIN NEUROBIOL, V17, P59, DOI 10.1016/j.conb.2006.12.003; Katz PS, 2004, J NEUROPHYSIOL, V92, P1904, DOI 10.1152/jn.00864.2003; Kemenes I, 2011, NAT PROTOC, V6, DOI 10.1038/nprot.2010.200; Kiehn O, 2011, CURR OPIN NEUROBIOL, V21, P100, DOI 10.1016/j.conb.2010.09.004; Killian KA, 2000, J EXP ZOOL, V286, P350, DOI 10.1002/(SICI)1097-010X(20000301)286:4&lt;350::AID-JEZ3&gt;3.0.CO;2-3; Kim JH, 2014, NEUROSCI LETT, V564, P6, DOI 10.1016/j.neulet.2014.01.054; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Larkum ME, 2002, J NEUROSCI, V22, P6991; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; LLINAS R, 1968, SCIENCE, V160, P1132, DOI 10.1126/science.160.3832.1132; Lopez-Alonso V, 2014, BRAIN STIMUL, V7, P372, DOI 10.1016/j.brs.2014.02.004; Luebke AE, 2002, J NEUROSCI, V22, P4241, DOI 10.1523/JNEUROSCI.22-10-04241.2002; Magoski NS, 1999, J NEUROPHYSIOL, V81, P1330; Magoski NS, 2000, J NEUROBIOL, V42, P410; McLean DL, 2007, NATURE, V446, P71, DOI 10.1038/nature05588; McLean DL, 2008, NAT NEUROSCI, V11, P1419, DOI 10.1038/nn.2225; MEYRAND P, 1992, J NEUROSCI, V12, P2803; MOULINS M, 1979, NEUROSCI LETT, V13, P231, DOI 10.1016/0304-3940(79)91499-X; Nenadic I, 2012, NEUROPSYCHOBIOLOGY, V66, P44, DOI 10.1159/000338547; Newcomb JM, 2006, J COMP NEUROL, V499, P485, DOI 10.1002/cne.21111; Norris BJ, 2011, J NEUROSCI, V31, P4663, DOI 10.1523/JNEUROSCI.5072-10.2011; OSHEA M, 1975, BRAIN RES, V96, P93, DOI 10.1016/0006-8993(75)90577-6; Penzes P, 2011, NAT NEUROSCI, V14, P285, DOI 10.1038/nn.2741; Petersen PC, 2014, J NEUROSCI, V34, P2774, DOI 10.1523/JNEUROSCI.3349-13.2014; Prasad KM, 2008, SCHIZOPHRENIA BULL, V34, P774, DOI 10.1093/schbul/sbn017; Prinz AA, 2004, NAT NEUROSCI, V7, P1345, DOI 10.1038/nn1352; RADEMACHER J, 1993, CEREB CORTEX, V3, P313, DOI 10.1093/cercor/3.4.313; Riddle A, 2012, STROKE, V43, P178, DOI 10.1161/STROKEAHA.111.632265; Rinberg A, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002857; Roffman RC, 2012, J NEUROPHYSIOL, V107, P1681, DOI 10.1152/jn.00903.2011; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Sakurai A, 2003, J NEUROSCI, V23, P10745; Sakurai A, 2009, J NEUROSCI, V29, P13115, DOI 10.1523/JNEUROSCI.3485-09.2009; Sakurai A, 2009, J NEUROSCI, V29, P268, DOI 10.1523/JNEUROSCI.4456-08.2009; Sasaki K, 2009, J NEUROSCI, V29, P11732, DOI 10.1523/JNEUROSCI.3051-09.2009; Schiff ND, 2007, NATURE, V448, P600, DOI 10.1038/nature06041; Schiller J, 1997, J PHYSIOL-LONDON, V505, P605, DOI 10.1111/j.1469-7793.1997.605ba.x; Shadlen MN, 1998, J NEUROSCI, V18, P3870; SHARP AA, 1993, J NEUROPHYSIOL, V69, P992; SHARP AA, 1992, J NEUROPHYSIOL, V67, P1691; Sharp AA, 1996, J NEUROPHYSIOL, V76, P867; SHARP AA, 1993, TRENDS NEUROSCI, V16, P389, DOI 10.1016/0166-2236(93)90004-6; Smarandache CR, 2007, J EXP BIOL, V210, P2912, DOI 10.1242/jeb.006874; Smith DV, 2014, NEUROIMAGE, V95, P1, DOI 10.1016/j.neuroimage.2014.03.042; Sozmen EG, 2009, J NEUROSCI METH, V180, P261, DOI 10.1016/j.jneumeth.2009.03.017; Squarcina L, 2012, NEUROIMAGE, V63, P779, DOI 10.1016/j.neuroimage.2012.07.016; Stuart G, 1997, J PHYSIOL-LONDON, V505, P617, DOI 10.1111/j.1469-7793.1997.617ba.x; Tang LS, 2012, J NEUROSCI, V32, P10075, DOI 10.1523/JNEUROSCI.1443-12.2012; TAUC L., 1963, JOUR GEN PHYSIOL, V46, P533; Thuma JB, 2009, BRAIN BEHAV EVOLUT, V73, P26, DOI 10.1159/000202988; van Spronsen M, 2010, CURR NEUROL NEUROSCI, V10, P207, DOI 10.1007/s11910-010-0104-8; Walhovd KB, 2014, CURR OPIN NEUROL, V27, P176, DOI 10.1097/WCO.0000000000000074; WHITAKER HA, 1976, ANN NY ACAD SCI, V280, P844, DOI 10.1111/j.1749-6632.1976.tb25547.x; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Zecevic D, 1996, NATURE, V381, P322, DOI 10.1038/381322a0	102	18	18	0	9	ELIFE SCIENCES PUBLICATIONS LTD	CAMBRIDGE	SHERATON HOUSE, CASTLE PARK, CAMBRIDGE, CB3 0AX, ENGLAND	2050-084X			ELIFE	eLife	JUN 11	2014	3								e02598	10.7554/eLife.02598			45	Biology	Life Sciences & Biomedicine - Other Topics	AK8ZM	WOS:000338717300002	24920390	DOAJ Gold, Green Published			2021-06-18	
J	Mahmood, G; Mei, Z; Hojjat, H; Pace, E; Kallakuri, S; Zhang, JS				Mahmood, G.; Mei, Z.; Hojjat, H.; Pace, E.; Kallakuri, S.; Zhang, J. S.			THERAPEUTIC EFFECT OF SILDENAFIL ON BLAST-INDUCED TINNITUS AND AUDITORY IMPAIRMENT	NEUROSCIENCE			English	Article						tinnitus; blast; traumatic brain injury; sildenafil (Viagra, Revatio); hyperacusis; rat	TRAUMATIC BRAIN-INJURY; DORSAL COCHLEAR NUCLEUS; INDUCED HEARING-LOSS; INTENSE SOUND EXPOSURE; SALICYLATE-INDUCED TINNITUS; QUININE-INDUCED TINNITUS; FUNCTIONAL RECOVERY; ACOUSTIC TRAUMA; NEURAL ACTIVITY; GAP DETECTION	Blast-induced tinnitus, along with associated auditory impairment and traumatic brain injury, is a primary concern facing military service members. To search for treatment, we investigated the therapeutic effects of sildenafil, a phosphodiesterase-5 inhibitor, given its vasodilatory effects and evidence suggesting its beneficial effects on noise-induced hearing loss. Rats were subjected to three consecutive blast exposures at 22 psi and were monitored for tinnitus using a gap-detection acoustic startle reflex paradigm. Hearing thresholds and detection were tested using auditory brainstem responses and prepulse inhibition, respectively. Blasted rats were either treated with sildenafil or tap water following blast exposure, while age-matched sham control rats were treated with sildenafil and no blast exposure. Our results showed that sildenafil did not effectively prevent acute tinnitus onset and hearing impairment. Instead, sildenafil significantly suppressed high-frequency tinnitus from 3 to 6 weeks after blast exposure and reduced hearing impairment during the first week after blast exposure. Complex results were observed in the startle force data, where sildenafil-treated rats displayed significantly reduced startle force compared to the untreated blasted group, suggesting possible mitigation of traumatic brain injury and suppression of hyperacusis-like percepts. Taken together, sildenafil showed a therapeutic effect on blastinduced tinnitus and audiological impairment in a time-dependent manner. Other regimens such as higher dosage prior to blast exposure and combination with other treatments deserve further investigation to optimize the therapeutic effects. (C) 2014 IBRO. Published by Elsevier Ltd. All rights reserved.	[Mahmood, G.; Mei, Z.; Hojjat, H.; Pace, E.; Zhang, J. S.] Wayne State Univ, Dept Otolaryngol Head & Neck Surg, Sch Med, Detroit, MI 48201 USA; [Kallakuri, S.] Wayne State Univ, Coll Engn, Dept Biomed Engn, Detroit, MI 48201 USA; [Zhang, J. S.] Wayne State Univ, Coll Liberal Arts & Sci, Dept Commun Sci & Disorders, Detroit, MI 48201 USA	Zhang, JS (corresponding author), Wayne State Univ, Sch Med, 5E-UHC,4201 St Antoine, Detroit, MI 48201 USA.	jinzhang@med.wayne.edu			US Department of DefenseUnited States Department of Defense [W81XWH-11-2-0031]	This work was supported by the US Department of Defense (Grant award # W81XWH-11-2-0031).	Abdul-Muneer PM, 2013, FREE RADICAL BIO MED, V60, P282, DOI 10.1016/j.freeradbiomed.2013.02.029; Administration VB, 2011, ANN BEN REP; Angrilli A, 2008, NEUROPSYCHOLOGIA, V46, P1179, DOI 10.1016/j.neuropsychologia.2007.10.018; Arun P, 2013, J NEUROTRAUM, V30, P1645, DOI 10.1089/neu.2012.2834; Attias J., 2005, Journal of Basic and Clinical Physiology and Pharmacology, V16, P117; Baguley DM, 2005, OTOL NEUROTOL, V26, P169, DOI 10.1097/00129492-200503000-00007; Baldo P, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003853.pub2; Bauer C.A., 2008, J NEUROSCI RES; Bauer CA, 2006, LARYNGOSCOPE, V116, P675, DOI 10.1097/01.MLG.0000216812.65206.CD; Bauer CA, 2001, JARO-J ASSOC RES OTO, V2, P54, DOI 10.1007/s101620010030; Boolell M, 1996, Int J Impot Res, V8, P47; CAHANI M, 1983, AUDIOLOGY, V22, P357; Cazals Y, 2000, PROG NEUROBIOL, V62, P583, DOI 10.1016/S0301-0082(00)00027-7; Chen G, 2013, JARO-J ASSOC RES OTO, V14, P413, DOI 10.1007/s10162-013-0375-2; CHEN GD, 1995, HEARING RES, V82, P158, DOI 10.1016/0378-5955(94)00174-O; Chen W, 2013, INT J CLIN EXP PATHO, V6, P375; Cherian L, 1999, CRIT CARE MED, V27, P2512, DOI 10.1097/00003246-199911000-00031; Chiueh CC, 1999, ANN NY ACAD SCI, V890, P301, DOI 10.1111/j.1749-6632.1999.tb08007.x; Crocetti A, 2009, OTOLARYNG HEAD NECK, V140, P403, DOI 10.1016/j.otohns.2008.11.036; Das A, 2005, J BIOL CHEM, V280, P12944, DOI 10.1074/jbc.M404706200; DeWitt DS, 1997, J NEUROTRAUM, V14, P223, DOI 10.1089/neu.1997.14.223; Eggermont JJ, 2004, TRENDS NEUROSCI, V27, P676, DOI 10.1016/j.tins.2004.08.010; Eggermont JJ, 2007, HEARING RES, V229, P69, DOI 10.1016/j.heares.2007.01.008; Ewert DL, 2012, HEARING RES, V285, P29, DOI 10.1016/j.heares.2012.01.013; Finlayson PG, 2009, HEARING RES, V256, P104, DOI 10.1016/j.heares.2009.07.006; Franke LM, 2012, J REHABIL RES DEV, V49, P985, DOI 10.1682/JRRD.2011.12.0250; Franz P, 1996, ACTA OTO-LARYNGOL, V116, P726, DOI 10.3109/00016489609137914; Giuliano F, 2010, INT J CLIN PRACT, V64, P240, DOI 10.1111/j.1742-1241.2009.02254.x; Gondusky JS, 2005, MIL MED, V170, P546, DOI 10.7205/MILMED.170.6.546; GOODWIN PE, 1980, ACTA OTO-LARYNGOL, V90, P353, DOI 10.3109/00016488009131736; Gosepath K, 1997, BRAIN RES, V747, P26, DOI 10.1016/S0006-8993(96)01149-3; HALLAM RS, 1985, ACTA OTO-LARYNGOL, V99, P501, DOI 10.3109/00016488509182253; Hasson D, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-130; Hebert S, 2011, J SLEEP RES, V20, P38, DOI 10.1111/j.1365-2869.2010.00860.x; Hess A, 2006, EUR ARCH OTO-RHINO-L, V263, P75, DOI 10.1007/s00405-005-0953-y; Hesser H, 2009, INT J AUDIOL, V48, P295, DOI 10.1080/14992020802635325; Hiller W, 1999, INT J BEHAV MED, V6, P312, DOI 10.1207/s15327558ijbm0604_2; Hong BN, 2008, BIOL PHARM BULL, V31, P1981, DOI 10.1248/bpb.31.1981; Hue CD, 2013, J NEUROTRAUM, V30, P1652, DOI 10.1089/neu.2012.2773; Ison JR, 2007, JARO-J ASSOC RES OTO, V8, P539, DOI 10.1007/s10162-007-0098-3; Ison JR, 2003, JARO-J ASSOC RES OTO, V4, P495, DOI 10.1007/s10162-002-3046-2; JASTREBOFF PJ, 1991, ARCH OTOLARYNGOL, V117, P1162; JASTREBOFF PJ, 1988, BEHAV NEUROSCI, V102, P811, DOI 10.1037/0735-7044.102.6.811; Jaumann M, 2012, NAT MED, V18, P252, DOI 10.1038/nm.2634; Jury MA, 2001, NEW ZEAL MED J, V114, P286; Kaltenbach JA, 2000, HEARING RES, V147, P282, DOI 10.1016/S0378-5955(00)00138-6; Kaltenbach JA, 2002, J NEUROPHYSIOL, V88, P699, DOI 10.1152/jn.2002.88.2.699; Khan AS, 2011, LARYNGOSCOPE, V121, P1049, DOI 10.1002/lary.21450; Kimura M, 1999, HEARING RES, V135, P146, DOI 10.1016/S0378-5955(99)00104-5; Kraus KS, 2011, NEUROSCIENCE, V194, P309, DOI 10.1016/j.neuroscience.2011.07.056; Kraus KS, 2010, NEUROSCIENCE, V167, P1216, DOI 10.1016/j.neuroscience.2010.02.071; Kujawa SG, 2009, J NEUROSCI, V29, P14077, DOI 10.1523/JNEUROSCI.2845-09.2009; Lamm K, 1999, ANN NY ACAD SCI, V884, P233, DOI 10.1111/j.1749-6632.1999.tb08645.x; Langguth B, 2012, EXPERT OPIN PHARMACO, V13, P2495, DOI 10.1517/14656566.2012.739608; LENARZ T, 1986, SCAND AUDIOL, P49; Lew HL, 2007, J REHABIL RES DEV, V44, P921, DOI 10.1682/JRRD.2007.09.0140; Li L, 2007, BRAIN RES, V1132, P185, DOI 10.1016/j.brainres.2006.10.098; Li Yan, 2011, Stapp Car Crash J, V55, P25; Li Y, 2011, J NEUROTRAUM, V28, P1767, DOI 10.1089/neu.2010.1687; Lobarinas E, 2006, ACTA OTO-LARYNGOL, V126, P13, DOI 10.1080/03655230600895408; Lobarinas E, 2013, HEARING RES, V295, P150, DOI 10.1016/j.heares.2012.06.001; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; Longenecker RJ, 2011, JARO-J ASSOC RES OTO, V12, P647, DOI 10.1007/s10162-011-0276-1; Lu J, 2011, NEUROSCIENCE, V189, P187, DOI 10.1016/j.neuroscience.2011.04.073; Lu J, 2003, NEUROPHARMACOLOGY, V44, P253, DOI 10.1016/S0028-3908(02)00380-5; Lundblad C, 2009, J NEUROTRAUM, V26, P1953, DOI 10.1089/neu.2009.0955; Luo H, 2012, NEUROSCI LETT, V522, P16, DOI 10.1016/j.neulet.2012.05.072; Ma WLD, 2006, HEARING RES, V212, P9, DOI 10.1016/j.heares.2005.10.003; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Maddox PT, 2009, LARYNGOSCOPE, V119, P1586, DOI 10.1002/lary.20511; Mahlke C, 2004, HEARING RES, V195, P17, DOI 10.1016/j.heares.2004.03.005; Mammi C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014542; MAN A, 1981, AUDIOLOGY, V20, P72; Mao JC, 2012, J NEUROTRAUM, V29, P430, DOI 10.1089/neu.2011.1934; Mazurek B, 2009, J NEGAT RESULTS BIOM, V8, DOI 10.1186/1477-5751-8-3; McGwin G, 2010, ARCH OTOLARYNGOL, V136, P488, DOI 10.1001/archoto.2010.51; Moller AR, 2007, PROG BRAIN RES, V166, P3, DOI 10.1016/S0079-6123(07)66001-4; Mukherjee B, 2007, J LARYNGOL OTOL, V121, P395, DOI 10.1017/S0022215106005512; Myers SA, 2012, J NEUROTRAUM, V29, P528, DOI 10.1089/neu.2011.2036; Nelson Jeffrey J, 2004, Ear Nose Throat J, V83, P472; Norman M, 2012, HEARING RES, V290, P64, DOI 10.1016/j.heares.2012.03.015; Noshita N, 2002, NEUROBIOL DIS, V9, P294, DOI 10.1006/nbdi.2002.0482; Nowotny M, 2011, J ACOUST SOC AM, V130, P2827, DOI 10.1121/1.3646902; Oishi N, 2010, AUDIOL NEURO-OTOL, V15, P187, DOI 10.1159/000251916; Okuyucu S, 2009, J LARYNGOL OTOL, V123, P718, DOI 10.1017/S002221510900423X; Otake H, 2009, ACTA OTO-LARYNGOL, V129, P127, DOI 10.1080/00016480802078119; Pace E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075011; Peiffer AM, 2004, DEV BRAIN RES, V152, P93, DOI 10.1016/j.devbrainres.2004.06.003; Pifarre P, 2010, J NEUROCHEM, V112, P807, DOI 10.1111/j.1471-4159.2009.06518.x; Prabhu Latha V, 2013, Int J Appl Basic Med Res, V3, P84, DOI 10.4103/2229-516X.117056; Ren TY, 1995, HEARING RES, V92, P30, DOI 10.1016/0378-5955(95)00192-1; Reyes SA, 2002, HEARING RES, V171, P43, DOI 10.1016/S0378-5955(02)00346-5; Rossiter S, 2006, J SPEECH LANG HEAR R, V49, P150, DOI 10.1044/1092-4388(2006/012); Rybalko N, 2011, PHYSIOL BEHAV, V102, P453, DOI 10.1016/j.physbeh.2010.12.010; Sajja VSSS, 2012, NMR BIOMED, V25, P1331, DOI 10.1002/nbm.2805; SCHEIBE F, 1993, EUR ARCH OTO-RHINO-L, V250, P281; SCHEIBE F, 1992, HEARING RES, V63, P19, DOI 10.1016/0378-5955(92)90069-Y; Seki S, 2003, HEARING RES, V180, P28, DOI 10.1016/S0378-5955(03)00074-1; Shao ZH, 2009, J CELL BIOCHEM, V107, P697, DOI 10.1002/jcb.22170; Shargorodsky J, 2010, AM J MED, V123, P711, DOI 10.1016/j.amjmed.2010.02.015; Shin HS, 2006, INT J PHARM, V320, P64, DOI 10.1016/j.ijpharm.2006.04.005; Shulman A., 1995, INT TINNITUS J, V1, P13; Snodgrass Amanda J, 2010, Pharmacotherapy, V30, P112, DOI 10.1592/phco.30.1.112; Solt K, 2011, ANESTHESIOLOGY, V115, P791, DOI 10.1097/ALN.0b013e31822e92e5; Stevens C, 2007, INT J AUDIOL, V46, P208, DOI 10.1080/14992020601102329; Sun W, 2009, NEUROSCIENCE, V159, P325, DOI 10.1016/j.neuroscience.2008.12.024; Sun W, 2012, BRAIN RES, V1485, P108, DOI 10.1016/j.brainres.2012.02.008; Svetlov SI, 2010, J TRAUMA, V69, P795, DOI 10.1097/TA.0b013e3181bbd885; Swetter BJ, 2010, BEHAV NEUROSCI, V124, P370, DOI 10.1037/a0019519; Temmel AFP, 1999, WIEN KLIN WOCHENSCHR, V111, P891; Test T, 2011, SLEEP, V34, P25, DOI 10.1093/sleep/34.1.25; Thakur JS, 2013, LARYNGOSCOPE, V123, P1527, DOI 10.1002/lary.23865; Turner J, 2012, J NEUROSCI RES, V90, P1480, DOI 10.1002/jnr.22827; Turner JG, 2008, AM J AUDIOL, V17, pS185, DOI 10.1044/1059-0889(2008/08-0006); Turner JG, 2006, BEHAV NEUROSCI, V120, P188, DOI 10.1037/0735-7044.120.1.188; Valiyaveettil M, 2013, CHEM-BIOL INTERACT, V203, P371, DOI 10.1016/j.cbi.2012.10.022; Valiyaveettil M, 2012, J REHABIL RES DEV, V49, P1153, DOI 10.1682/JRRD.2011.09.0182; Vogler DP, 2011, J NEUROSCI, V31, P6639, DOI 10.1523/JNEUROSCI.6538-10.2011; Wallhausser-Franke E, 2003, EXP BRAIN RES, V153, P649, DOI 10.1007/s00221-003-1614-2; Wang H, 2000, Zhonghua Er Bi Yan Hou Ke Za Zhi, V35, P420; Wang H, 2009, NEUROSCIENCE, V164, P747, DOI 10.1016/j.neuroscience.2009.08.026; Wang HN, 2011, HEARING RES, V279, P111, DOI 10.1016/j.heares.2011.04.004; Wang L, 2005, J CEREBR BLOOD F MET, V25, P1150, DOI 10.1038/sj.jcbfm.9600112; Wiley JL, 1996, BRAIN RES, V716, P47, DOI 10.1016/0006-8993(96)00045-5; Wu Y, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/384627; Yang G, 2007, HEARING RES, V226, P244, DOI 10.1016/j.heares.2006.06.013; Yuan ZX, 2008, INVEST OPHTH VIS SCI, V49, P720, DOI 10.1167/iovs.07-1208; Zhang JS, 2011, JARO-J ASSOC RES OTO, V12, P185, DOI 10.1007/s10162-010-0246-z; Zhang JS, 2003, EXP BRAIN RES, V153, P655, DOI 10.1007/s00221-003-1612-4; Zhang JS, 1998, NEUROSCI LETT, V250, P197, DOI 10.1016/S0304-3940(98)00482-0; Zhang L, 2005, STROKE, V36, P847, DOI 10.1161/01.STR.0000158923.19956.73; Zhang L, 2006, BRAIN RES, V1118, P192, DOI 10.1016/j.brainres.2006.08.028; Zhang RL, 2002, STROKE, V33, P2675, DOI 10.1161/01.STR.0000034399.95249.59; Zhang Shu-jun, 2011, Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, V46, P844; Zheng YW, 2012, NEUROPHARMACOLOGY, V62, P940, DOI 10.1016/j.neuropharm.2011.09.027	135	18	19	0	15	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	JUN 6	2014	269						367	382		10.1016/j.neuroscience.2014.03.020			16	Neurosciences	Neurosciences & Neurology	AH1TL	WOS:000335903900034	24662845				2021-06-18	
J	Brenner, JS; Brooks, A; Demorest, RA; Halstead, ME; Kelly, AKW; Koutures, CG; LaBella, CR; LaBotz, M; Loud, KJ; Martin, SS; Moffatt, K				Brenner, Joel S.; Brooks, Alison; Demorest, Rebecca A.; Halstead, Mark E.; Kelly, Amanda K. Weiss; Koutures, Chris G.; LaBella, Cynthia R.; LaBotz, Michele; Loud, Keith J.; Martin, Stephanie S.; Moffatt, Kody		Council Sports Med Fittness	Reducing Injury Risk From Body Checking in Boys' Youth Ice Hockey	PEDIATRICS			English	Article						athletic injury; injury prevention; concussion; body checking	EMERGENCY-DEPARTMENTS; FACIAL INJURIES; HEAD IMPACTS; PLAYERS; RATES; CONCUSSION; RULES; FACE; AGGRESSION; SEVERITY	Ice hockey is an increasingly popular sport that allows intentional collision in the form of body checking for males but not for females. There is a two-to threefold increased risk of all injury, severe injury, and concussion related to body checking at all levels of boys' youth ice hockey. The American Academy of Pediatrics reinforces the importance of stringent enforcement of rules to protect player safety as well as educational interventions to decrease unsafe tactics. To promote ice hockey as a lifelong recreational pursuit for boys, the American Academy of Pediatrics recommends the expansion of nonchecking programs and the restriction of body checking to elite levels of boys' youth ice hockey, starting no earlier than 15 years of age.					Moffatt, Kody/0000-0001-5539-9969			Anderson AJ, 2000, PEDIATRICS, V105, P657; Asplund C, 2009, BRIT J SPORT MED, V43, P993, DOI 10.1136/bjsm.2009.060152; Benson BW, 2009, BRIT J SPORT MED, V43, pI56, DOI 10.1136/bjsm.2009.058271; Benson BW, 1999, JAMA-J AM MED ASSOC, V282, P2328, DOI 10.1001/jama.282.24.2328; Benson BW, 2002, BRIT J SPORT MED, V36, P27, DOI 10.1136/bjsm.36.1.27; Bernard D, 1993, SAFETY ICE HOCKEY, V2; Blake Tracy, 2012, Clin J Sport Med, V22, P377, DOI 10.1097/JSM.0b013e31826038e0; Brainard LL, 2012, MED SCI SPORT EXER, V44, P297, DOI 10.1249/MSS.0b013e31822b0ab4; Brunelle JP, 2005, J SCI MED SPORT, V8, P294, DOI 10.1016/S1440-2440(05)80040-4; Bunn JW, 2008, PHYSICIAN SPORTSMED, V36, P76, DOI 10.3810/psm.2008.12.15; Comstock R.D., 2009, HIGH SCH RIO CONVENI; Cusimano MD, 2013, CAN MED ASSOC J, V185, pE57, DOI 10.1503/cmaj.112017; Cusimano Michael D, 2011, Open Med, V5, pe57; Darling SR, 2011, BRIT J SPORT MED, V45, P492, DOI 10.1136/bjsm.2009.063693; Deits J, 2010, J ATHL TRAINING, V45, P467, DOI 10.4085/1062-6050-45.5.467; Emery C, 2011, CAN MED ASSOC J, V183, P1249, DOI 10.1503/cmaj.101540; Emery CA, 2006, AM J SPORT MED, V34, P1960, DOI 10.1177/0363546506290061; Emery CA, 2010, JAMA-J AM MED ASSOC, V303, P2265, DOI 10.1001/jama.2010.755; Emery CA, 2010, INJURY PREV, V16, P113, DOI 10.1136/ip.2009.022764; Emery CA, 2009, CLIN J SPORT MED, V19, P207, DOI 10.1097/JSM.0b013e31819d658e; Hagel BE, 2006, CAN MED ASSOC J, V175, P155, DOI 10.1503/cmaj.051531; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Harris AW, 2012, CLIN J SPORT MED, V22, P455, DOI 10.1097/JSM.0b013e318259ed09; Hockey USA, 2011 2012 SEAS FIN R; Kukaswadia A, 2010, PEDIATRICS, V125, P735, DOI 10.1542/peds.2009-2083; Le Gall F, 2007, SCAND J MED SCI SPOR, V17, P564, DOI 10.1111/j.1600-0838.2006.00594.x; Macpherson A, 2006, PEDIATRICS, V117, pE143, DOI 10.1542/peds.2005-1163; Malenfant S, 2012, J SCI MED SPORT, V15, P463, DOI 10.1016/j.jsams.2012.03.003; Malina RM, 2005, MED SCI SPORT EXER, V37, P1044, DOI 10.1249/01.mss.0000171622.45134.cb; Malina RM, 2006, CLIN J SPORT MED, V16, P214, DOI 10.1097/00042752-200605000-00005; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McAllister TW, 2012, NEUROLOGY, V78, P1777, DOI 10.1212/WNL.0b013e3182582fe7; McPherson MN, 2009, J ASTM INT, V6; Mihalik JP, 2010, MED SCI SPORT EXER, V42, P1431, DOI 10.1249/MSS.0b013e3181d2521a; Roberts WO, 1999, MED SCI SPORT EXER, V31, P46, DOI 10.1097/00005768-199901000-00009; Smith A., 2009, J ASTM INT, V6; Smith AM, 2011, CLIN J SPORT MED, V21, P281, DOI 10.1097/JSM.0b013e318225bc15; Stevens ST, 2006, J SCI MED SPORT, V9, P238, DOI 10.1016/j.jsams.2006.03.025; Stuart MJ, 2002, AM J SPORT MED, V30, P39, DOI 10.1177/03635465020300012001; ThinkFirst Canada, 2011, POS STAT SAF HOCK; Warsh JM, 2009, CLIN J SPORT MED, V19, P134, DOI 10.1097/JSM.0b013e3181987783; Wattie N, 2007, PEDIATRICS, V120, P142, DOI 10.1542/peds.2006-2672; Wattie N, 2010, CLIN J SPORT MED, V20, P113, DOI 10.1097/JSM.0b013e3181d2de78; Yard EE, 2006, J ATHL TRAINING, V41, P441	44	18	18	0	17	AMER ACAD PEDIATRICS	ELK GROVE VILLAGE	141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA	0031-4005	1098-4275		PEDIATRICS	Pediatrics	JUN	2014	133	6					1151	1157		10.1542/peds.2014-0692			7	Pediatrics	Pediatrics	AI8MY	WOS:000337172600066	24864185	Bronze			2021-06-18	
J	Hald, ES; Alford, PW				Hald, Eric S.; Alford, Patrick W.			Smooth Muscle Phenotype Switching in Blast Traumatic Brain Injury-Induced Cerebral Vasospasm	TRANSLATIONAL STROKE RESEARCH			English	Article						Blast traumatic brain injury; Cerebral vasospasm; Vascular smooth muscle cells; Phenotype transformation; Subarachnoid hemorrhage; Biomechanics	EXPERIMENTAL SUBARACHNOID HEMORRHAGE; ENDOTHELIN RECEPTOR ANTAGONIST; GROWTH-FACTOR; CELL DIFFERENTIATION; ARTERIES; MODEL; SUPPRESSION; DYSFUNCTION; CLAZOSENTAN; INHIBITOR	Due to increased survival rates among soldiers exposed to explosive blasts, blast-induced traumatic brain injury (bTBI) has become much more prevalent in recent years. Cerebral vasospasm (CVS) is a common manifestation of brain injury whose incidence is significantly increased in bTBI. CVS is characterized by initial vascular smooth muscle cell (VSMC) hypercontractility, followed by prolonged vessel remodeling and lumen occlusion, and is traditionally associated with subarachnoid hemorrhage (SAH), but recent results suggest that mechanical injury during bTBI can cause mechanotransduced VSMC hypercontractility and phenotype switching necessary for CVS development, even in the absence of SAH. Here, we review the mechanisms by which mechanical stimulation and SAH can synergistically drive CVS progression, complicating treatment options in bTBI patients.	[Hald, Eric S.; Alford, Patrick W.] Univ Minnesota, Dept Biomed Engn, Minneapolis, MN 55455 USA	Alford, PW (corresponding author), Univ Minnesota, Dept Biomed Engn, 312 Church St SE,7-105 Hasselmo Hall, Minneapolis, MN 55455 USA.	pwalford@umn.edu					Adeoye OO, 2013, AM J PHYSIOL-CELL PH, V304, pC656, DOI 10.1152/ajpcell.00110.2012; Alexander MR, 2012, ANNU REV PHYSIOL, V74, P13, DOI 10.1146/annurev-physiol-012110-142315; Alford PW, 2008, COMPUT METHOD BIOMEC, V11, P525, DOI 10.1080/10255840801930710; Alford PW, 2008, BIOMECH MODEL MECHAN, V7, P245, DOI 10.1007/s10237-007-0101-2; Alford PW, 2011, INTEGR BIOL-UK, V3, P1063, DOI 10.1039/c1ib00061f; Alford PW, 2011, P NATL ACAD SCI USA, V108, P12705, DOI 10.1073/pnas.1105860108; Amenta F, 2009, J NEUROL SCI, V283, P219, DOI 10.1016/j.jns.2009.02.335; ARMENTANO R, 1991, HYPERTENSION, V18, P657, DOI 10.1161/01.HYP.18.5.657; Armonda RA, 2006, NEUROSURGERY, V59, P1215, DOI 10.1227/01.NEU.0000249190.46033.94; Balabanov R, 2001, NEUROL RES, V23, P175, DOI 10.1179/016164101101198514; Bauman RA, 2009, J NEUROTRAUM, V26, P841, DOI 10.1089/neu.2009-0898; Berra-Romani R, 2008, AM J PHYSIOL-CELL PH, V295, pC779, DOI 10.1152/ajpcell.00173.2008; Bhattacharjee Y, 2008, SCIENCE, V319, P406, DOI 10.1126/science.319.5862.406; Bohm F, 2007, CARDIOVASC RES, V76, P8, DOI 10.1016/j.cardiores.2007.06.004; Borel CO, 2003, STROKE, V34, P427, DOI 10.1161/01.STR.0000053848.06436.AB; Boron W.F., 2003, MED PHYSL CELLULAR M; Cemak I., 1997, INT REV ARMED FORCES, V70, P114; Cernak I, 1991, Vojnosanit Pregl, V48, P515; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; Cernak I, 1996, CHINESE J TRAUMATOL, V12, P28; Chambers RC, 2003, AM J PATHOL, V162, P533, DOI 10.1016/S0002-9440(10)63847-3; Chapman GB, 2000, AM J PHYSIOL-HEART C, V278, pH748; Chen Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039353; Chesler NC, 1999, AM J PHYSIOL-HEART C, V277, pH2002; Chow N, 2007, P NATL ACAD SCI USA, V104, P823, DOI 10.1073/pnas.0608251104; CLOWER BR, 1994, ANAT REC, V240, P104, DOI 10.1002/ar.1092400110; Courtney AC, 2009, MED HYPOTHESES, V72, P76, DOI 10.1016/j.mehy.2008.08.015; DeWitt DS, 2009, J NEUROTRAUM, V26, P877, DOI 10.1089/neu.2007.0439; Dietrich HH, 2000, NEUROSURGERY, V46, P517, DOI 10.1097/00006123-200003000-00001; Dreier JP, 2009, BRAIN, V132, P1866, DOI 10.1093/brain/awp102; Dumont AS, 2003, NEUROSURGERY, V53, P123, DOI 10.1227/01.NEU.0000068863.37133.9E; Faul MD, 2010, TRAUMATIC BRAIN INJU; FUNG YC, 1989, CIRC RES, V65, P1340, DOI 10.1161/01.RES.65.5.1340; FUNG YC, 1991, J APPL PHYSIOL, V70, P2455; Garman RH, 2011, J NEUROTRAUM, V28, P947, DOI 10.1089/neu.2010.1540; Geddes DM, 2003, J NEUROTRAUM, V20, P1039, DOI 10.1089/089771503770195885; Gladwin MT, 2003, NAT MED, V9, P496, DOI 10.1038/nm0503-496; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Gow AJ, 1998, NATURE, V391, P169; Grasso G, 2004, BRAIN RES REV, V44, P49, DOI 10.1016/j.brainresrev.2003.10.003; HARRISON P, 1993, BLOOD REV, V7, P52, DOI 10.1016/0268-960X(93)90024-X; Hemphill MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022899; HOLYCROSS BJ, 1992, CIRC RES, V71, P1525, DOI 10.1161/01.RES.71.6.1525; House SJ, 2008, PFLUG ARCH EUR J PHY, V456, P769, DOI 10.1007/s00424-008-0491-8; Huang B, 2010, TRANSL STROKE RES, V1, P108, DOI 10.1007/s12975-010-0022-8; Hubbell MC, 2012, AM J PHYSIOL-CELL PH, V303, pC1090, DOI 10.1152/ajpcell.00408.2011; Hue CD, 2013, J NEUROTRAUM, V30, P1652, DOI 10.1089/neu.2012.2773; Humphrey JD, 2007, ANN BIOMED ENG, V35, P1485, DOI 10.1007/s10439-007-9321-y; Intengan HD, 2001, HYPERTENSION, V38, P581, DOI 10.1161/hy09t1.096249; Inzitari Domenico, 2005, Aging Clin Exp Res, V17, P16; Iyemere VP, 2006, J INTERN MED, V260, P192, DOI 10.1111/j.1365-2796.2006.01692.x; Jackson ZS, 2002, CIRC RES, V90, P918, DOI 10.1161/01.RES.0000016481.87703.CC; Jain MK, 1996, J BIOL CHEM, V271, P10194, DOI 10.1074/jbc.271.17.10194; Kawai-Kowase K, 2007, AM J PHYSIOL-CELL PH, V292, pC59, DOI 10.1152/ajpcell.00394.2006; Keilin D., 1937, NATURE, V139, P548; Kilinc D, 2008, EXP NEUROL, V212, P422, DOI 10.1016/j.expneurol.2008.04.025; Kim BS, 1999, NAT BIOTECHNOL, V17, P979, DOI 10.1038/13671; Kuehn R, 2011, J NEUROTRAUM, V28, P2155, DOI 10.1089/neu.2010.1532; Lehti K, 2009, J CELL SCI, V122, P126, DOI 10.1242/jcs.035279; Li Song, 2003, FASEB Journal, V17, P97; Li XM, 1997, BIOCHEM J, V327, P709, DOI 10.1042/bj3270709; Lin DW, 2008, J BIOL CHEM, V283, P15003, DOI 10.1074/jbc.M801621200; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Liu GX, 2002, CHINESE MED J-PEKING, V115, P750; LIU SQ, 1988, J BIOMECH ENG-T ASME, V110, P82, DOI 10.1115/1.3108410; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; Macdonald RL, 2008, EXPERT OPIN INV DRUG, V17, P1761, DOI [10.1517/13543784.17.11.1761, 10.1517/13543784.17.11.1761 ]; Macdonald RL, 2012, STROKE, V43, P1463, DOI 10.1161/STROKEAHA.111.648980; Macdonald RL, 2011, LANCET NEUROL, V10, P618, DOI 10.1016/S1474-4422(11)70108-9; Macdonald RL, 2001, ACTA NEUROCHIR SUPPL, V77, P7; Macdonald RL, 2001, CEREBRAL VASOSPASM; MacDonald RL, 2006, NEUROSURGERY, V59, P453, DOI 10.1227/00006123-200608000-00039; Masel BE, 2012, J NEUROTRAUM, V29, P2143, DOI 10.1089/neu.2011.2258; MAYBERG MR, 1990, J NEUROSURG, V72, P626, DOI 10.3171/jns.1990.72.4.0626; McDaniel DP, 2007, BIOPHYS J, V92, P1759, DOI 10.1529/biophysj.106.089003; McGirt MJ, 2002, NEUROSURGERY, V51, P1128, DOI 10.1097/00006123-200211000-00005; Mesis Rachel G, 2006, Neurosurg Focus, V21, pE4; Monson KL, 2011, J MECH BEHAV BIOMED, V4, P9, DOI 10.1016/j.jmbbm.2010.08.003; Murakami K, 2011, TRANSL STROKE RES, V2, P72, DOI 10.1007/s12975-010-0052-2; Naraoka M, 2013, TRANSL STROKE RES, V4, P368, DOI 10.1007/s12975-012-0247-9; North SH, 2012, ANNU REV ANAL CHEM, V5, P35, DOI 10.1146/annurev-anchem-062011-143105; Ogawa T, 2011, J CEREBR BLOOD F MET, V31, P2231, DOI 10.1038/jcbfm.2011.87; Ostrowski RP, 2011, TRANSL STROKE RES, V2, P316, DOI 10.1007/s12975-011-0069-1; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; OWENS GK, 1995, PHYSIOL REV, V75, P487; PETTUS EH, 1994, J NEUROTRAUM, V11, P507, DOI 10.1089/neu.1994.11.507; Peyton SR, 2005, J CELL PHYSIOL, V204, P198, DOI 10.1002/jcp.20274; Pluta RM, 2005, PHARMACOL THERAPEUT, V105, P23, DOI 10.1016/j.pharmthera.2004.10.002; RAM Z, 1991, STROKE, V22, P922, DOI 10.1161/01.STR.22.7.922; Readnower RD, 2010, J NEUROSCI RES, V88, P3530, DOI 10.1002/jnr.22510; Satoh S, 2012, J PHARMACOL SCI, V118, P92, DOI 10.1254/jphs.11075FP; Sazonova OV, 2011, BIOPHYS J, V101, P622, DOI 10.1016/j.bpj.2011.06.051; Schulze PC, 2003, CIRC RES, V93, P1210, DOI 10.1161/01.RES.0000103635.38096.2F; Shimokawa H, 1996, J CLIN INVEST, V97, P769, DOI 10.1172/JCI118476; Soejima Y, 2013, EXP NEUROL, V247, P737, DOI 10.1016/j.expneurol.2013.03.019; Song JN, 2013, BRAIN RES, V1517, P93, DOI 10.1016/j.brainres.2013.01.004; Stegemann JP, 2005, J APPL PHYSIOL, V98, P2321, DOI 10.1152/japplphysiol.01114.2004; SUGAWARA T, 2011, ACTA NEUROCHIR SUPPL, V2, P9, DOI DOI 10.1007/978-3-7091-0356-2_2; Vatter H, 2011, ACTA NEUROCHIR SUPPL, V110, P177, DOI 10.1007/978-3-7091-0353-1_31; Vergouwen MDI, 2011, J CEREBR BLOOD F MET, V31, P1545, DOI 10.1038/jcbfm.2011.56; Vergouwen MDI, 2011, STROKE, V42, P924, DOI 10.1161/STROKEAHA.110.597914; Williams B, 1998, J HYPERTENS, V16, P1921, DOI 10.1097/00004872-199816121-00011; Wu Ying-chen, 2007, Zhonghua Zheng Xing Wai Ke Za Zhi, V23, P335; Yamaguchi-Okada M, 2009, CEREBROVASC DIS, V28, P135, DOI 10.1159/000223439; Yeoh S, 2013, ANN BIOMED ENG, V41, P2206, DOI 10.1007/s10439-013-0805-7; Zabramski JM, 1997, SUBARACHNOID HEMORRH, P127; Zhang BP, 2003, INT J BIOCHEM CELL B, V35, P1341, DOI 10.1016/S1357-2725(03)00043-8; Zhang ZD, 2006, NEUROL RES, V28, P713, DOI 10.1179/016164106X151990; Zhang ZQ, 2011, TRANSL STROKE RES, V2, P455, DOI 10.1007/s12975-011-0137-6; Zimmermann M, 1998, NEUROSURGERY, V43, P863, DOI 10.1097/00006123-199810000-00083; Zlokovic BV, 2011, NAT REV NEUROSCI, V12, P723, DOI 10.1038/nrn3114	111	18	18	0	12	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1868-4483	1868-601X		TRANSL STROKE RES	Transl. Stroke Res.	JUN	2014	5	3					385	393		10.1007/s12975-013-0300-3			9	Clinical Neurology; Neurosciences	Neurosciences & Neurology	AH7TD	WOS:000336336200009	24323722				2021-06-18	
J	Lawson, J; Reynolds, F; Bryant, W; Wilson, L				Lawson, Jackie; Reynolds, Frances; Bryant, Wendy; Wilson, Lesley			'It's like having a day of freedom, a day off from being ill': Exploring the experiences of people living with mental health problems who attend a community-based arts project, using interpretative phenomenological analysis	JOURNAL OF HEALTH PSYCHOLOGY			English	Article						activity; art; creativity; depression; interpretative phenomenological analysis; mental illness; well-being	TRAUMATIC BRAIN-INJURY; RECOVERY; PSYCHOLOGY; SERVICES	To explore the psychosocial benefits of participating in a 2-year community arts project, eight people living with long-term mental health problems were interviewed. The project involved participants in selecting items of professional artwork, creating personal responses and curating a public exhibition. Interviews were analysed using interpretative phenomenological analysis. Participants experienced the arts project as improving self-worth, emancipating self from illness labels, offering a sense of belonging, enabling acquisition of valued skills and offering meaningful occupation and routines. Some regarded their developing creative skills as improving their self-management of mental health. However, some anticipated the project's ending with anxiety.	[Lawson, Jackie] Dorset HealthCare Univ NHS Fdn Trust, Dorset, England; [Reynolds, Frances; Bryant, Wendy; Wilson, Lesley] Brunel Univ, Uxbridge UB8 3PH, Middx, England	Reynolds, F (corresponding author), Brunel Univ, Sch Hlth Sci & Social Care, Seacole Bldg,Uxbridge Campus, Uxbridge UB8 3PH, Middx, England.	frances.reynolds@brunel.ac.uk		Reynolds, Frances/0000-0001-7228-6931			Camic PM, 2008, J HEALTH PSYCHOL, V13, P287, DOI 10.1177/1359105307086698; Cattanach A, 1999, PROCESS ARTS THERAPI; Csikszentmihalyi M., 1996, CREATIVITY FLOW PSYC; Finlay L, 2008, J PHENOMENOLOGICAL P, V39, P1, DOI DOI 10.1163/156916208X311601; Gale E, 2005, WATER TOWERS, P103; Gleadell C., 2012, TELEGRAPH; Griffiths S, 2008, J MENT HEALTH, V17, P49, DOI 10.1080/09638230701506242; Hacking S, 2008, HEALTH SOC CARE COMM, V16, P638, DOI 10.1111/j.1365-2524.2008.00789.x; Heenan D, 2006, DISABIL SOC, V21, P179, DOI 10.1080/09687590500498143; Jacobson N, 2001, PSYCHIATR SERV, V52, P482, DOI 10.1176/appi.ps.52.4.482; Johnson V, 2007, INT J MENT HEALTH PR, V9, P28, DOI DOI 10.1080/14623730.2007.9721836; Jones DFW, 2004, ELECTRON WORLD, V110, P55; Lloyd C, 2007, BRIT J OCCUPATIONAL, V70, P207, DOI DOI 10.1177/030802260707000505; Mooney G, 2005, BRAIN INJURY, V19, P975, DOI 10.1080/02699050500110264; Mooney G, 2001, BRAIN INJURY, V15, P865, DOI 10.1080/02699050110065286; Murray M, 2008, J HEALTH PSYCHOL, V13, P147, DOI 10.1177/1359105307086704; *OFF DEP PRIM MIN, 2004, MENT HLTH SOC EXCL; Parr H, 2006, T I BRIT GEOGR, V31, P150, DOI 10.1111/j.1475-5661.2006.00207.x; Repper J., 2003, SOCIAL INCLUSION REC; Reynolds F, 2011, J AGING STUD, V25, P328, DOI 10.1016/j.jaging.2010.12.001; Secker J., 2007, MENTAL HLTH SOCIAL I; Secker J, 2007, J PUBLIC MENT HEALTH, V6, P14, DOI 10.1108/17465729200700024; Slade M, 2009, J MENT HEALTH, V18, P367, DOI 10.3109/09638230903191256; Smith J.A., 2009, INTERPRETATIVE PHENO; Spandler H, 2007, J PSYCHIATR MENT HLT, V14, P791, DOI 10.1111/j.1365-2850.2007.01174.x; Stacey G, 2010, PERSPECT PUBLIC HEAL, V130, P70, DOI 10.1177/1466424008094811; Stickley T, 2010, ARTS HEALTH, V2, P23, DOI DOI 10.1080/17533010903031614; Teall W, 2010, STAYING AHEAD HELD P; Van Lith T, 2011, DISABIL REHABIL, V33, P652, DOI 10.3109/09638288.2010.505998; VanLith T, 2009, AUSTR E J ADVANCEMEN, V8, P1; Williams WH, 2003, NEUROPSYCHOL REHABIL, V13, P1, DOI [10.1080/09602010244000444, 10.1016/S0960-9822(02)01374-X]	31	18	18	3	25	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1359-1053	1461-7277		J HEALTH PSYCHOL	J. Health Psychol.	JUN	2014	19	6					765	777		10.1177/1359105313479627			13	Psychology, Clinical	Psychology	AJ3WJ	WOS:000337598300007	23520347	Green Accepted			2021-06-18	
J	Little, DM; Geary, EK; Moynihan, M; Alexander, A; Pennington, M; Glang, P; Schulze, ET; Dretsch, M; Pacifico, A; Davis, ML; Stevens, AB; Huang, JH				Little, Deborah M.; Geary, Elizabeth K.; Moynihan, Michael; Alexander, Aristides; Pennington, Michelle; Glang, Patrick; Schulze, Evan T.; Dretsch, Michael; Pacifico, Anthony; Davis, Matthew L.; Stevens, Alan B.; Huang, Jason H.			Imaging chronic traumatic brain injury as a risk factor for neurodegeneration	ALZHEIMERS & DEMENTIA			English	Article						Traumatic brain injury; Repetitive TBI; Dementia; Neuroimaging	MINI-MENTAL-STATE; INTEGRITY	Population-based studies have supported the hypothesis that a positive history of traumatic brain injury (TBI) is associated with an increased incidence of neurological disease and psychiatric comorbidities, including chronic traumatic encephalopathy, Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis. These epidemiologic studies, however, do not offer a clear definition of that risk, and leave unanswered the bounding criteria for greater lifetime risk of neurodegeneration. Key factors that likely mediate the degree of risk of neurodegeneration include genetic factors, significant premorbid and comorbid medical history (e.g. depression, multiple head injuries and repetitive subconcussive impact to the brain, occupational risk, age at injury, and severity of brain injury). However, given the often-described concerns in self-report accuracy as it relates to history of multiple TBIs, low frequency of patient presentation to a physician in the case of mild brain injuries, and challenges with creating clear distinctions between injury severities, disentangling the true risk for neurodegeneration based solely on population-based studies will likely remain elusive. Given this reality, multiple modalities and approaches must be combined to characterize who are at risk so that appropriate interventions to alter progression of neurodegeneration can be evaluated. This article presents data from a study that highlights uses of neuro-imaging and areas of needed research in the link between TBI and neurodegenerative disease. (C) 2014 Published by Elsevier Inc. on behalf of The Alzheimer's Association.	[Little, Deborah M.; Pennington, Michelle; Davis, Matthew L.; Stevens, Alan B.; Huang, Jason H.] BaylorScott & White Hlth, Temple, TX 75201 USA; [Little, Deborah M.; Davis, Matthew L.; Stevens, Alan B.; Huang, Jason H.] Texas A&M Univ Hlth Sci, Temple, TX USA; [Geary, Elizabeth K.] Northshore Hlth Syst, Evanston, IL USA; [Moynihan, Michael] West Virginia Sch Osteopath Med, Lewisburg, WV USA; [Alexander, Aristides] Advocate Christ Med Ctr, Chicago, IL USA; [Glang, Patrick] Univ Oregon, Eugene, OR 97403 USA; [Schulze, Evan T.] St Louis Univ, St Louis, MO 63103 USA; [Dretsch, Michael] Walter Reed Natl Mil Med Ctr, Natl Intrepid Ctr Excellence, Bethesda, MD USA; [Pacifico, Anthony] US Army Med Res & Mat Command, Telemed & Adv Technol Res Ctr, Ft Detrick, MD USA	Little, DM (corresponding author), BaylorScott & White Hlth, Temple, TX 75201 USA.	deborahmlittle@gmail.com	Huang, Jason H/J-4739-2019	Huang, Jason H/0000-0002-4426-0168	Department of Defense/Congressionally Directed Medical Research ProgramUnited States Department of Defense [PT 075675]; Marshall Goldberg Traumatic Brain Injury Fund; Chicago Institute for Neurosurgery and Neuroresearch Foundation	This work is supported in part by a Department of Defense/Congressionally Directed Medical Research Program grant (PT 075675 to DML), the Marshall Goldberg Traumatic Brain Injury Fund (to DML), and a grant from the Chicago Institute for Neurosurgery and Neuroresearch Foundation (to DML). The contents of this article are the sole responsibility of the authors and do not necessarily represent the official views of the University of Illinois at Chicago, Baylor Scott & White Health, Texas A&M University Health Sciences, the U.S. Department of the Army, the Department of Defense, or the National Institutes of Health.	American Congress of Rehabilitation Medicine, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Assistant Secretary of Defense for Health Affairs, 2007, HLTH AFF MEM TRAUM B; Benedict R., 1997, BRIEF VISUOSPATIAL M; Benton A, 1989, MULTILINGUAL APHASIA; Benton A., 1976, MULTILINGUAL APHASIA; COCKRELL JR, 1988, PSYCHOPHARMACOL BULL, V24, P689; Conners D. K., 2000, CONTINUOUS PERFORMAN; Delis DC, 2000, CALIFORNIA VERBAL LE; Fiszbein A., 1986, POSITIVE NEGATIVE SY; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Golden CJ, 2002, STROOP COLOR WORD TE; Jensen A R, 1965, Acta Psychol (Amst), V24, P398; Kelly JP, 1997, NEUROLOGY, V48, P581; Kraus MF, 2007, COGN BEHAV NEUROL, V20, P170, DOI 10.1097/WNN.0b013e318142badb; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Little DM, 2010, NEUROLOGY, V74, P558, DOI 10.1212/WNL.0b013e3181cff5d5; MacKenzie JD, 2002, AM J NEURORADIOL, V23, P1509; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; Ruff R. M., 1988, RUFF FIGURAL FLUENCY; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Tombaugh T, 1997, TEST MEMORY MALINGER; Tombaugh TN, 1996, TEST MEMORY MALINGER; Wechsler D, 1997, WMS 3 ADM SCORING MA; Wechsler D., 2001, WECHSLER TEST ADULT	25	18	19	0	10	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1552-5260	1552-5279		ALZHEIMERS DEMENT	Alzheimers. Dement.	JUN	2014	10	3		1			S188	S195		10.1016/j.jalz.2014.04.002			8	Clinical Neurology	Neurosciences & Neurology	CP8GM	WOS:000360130700013	24924670	Other Gold			2021-06-18	
J	Morton, RP; Hanak, BW; Levitt, MR; Fink, KR; Peterson, EC; Vilela, MD; Kim, LJ; Chesnut, RM				Morton, Ryan P.; Hanak, Brian W.; Levitt, Michael R.; Fink, Kathleen R.; Peterson, Eric C.; Vilela, Marcelo D.; Kim, Louis J.; Chesnut, Randall M.			Blunt traumatic occlusion of the internal carotid and vertebral arteries Clinical article	JOURNAL OF NEUROSURGERY			English	Article						blunt cerebrovascular injury; Biffl grade; stroke; trauma; TCD; emboli; internal carotid artery; vertebral artery; vascular disorders; traumatic brain injury	CEREBROVASCULAR INJURIES; EARLY-DIAGNOSIS; FOLLOW-UP; THERAPY	Object. The stroke rate, management, and outcome after blunt cerebrovascular occlusion (Biffl Grade IV injury) is not well defined, given the rarity of the disease. Both hemodynamic failure and embolic mechanisms have been implicated in the pathophysiology of subsequent stroke after blunt cerebrovascular occlusion. In this study, the authors evaluated their center's experience with Biffl Grade IV injuries, focusing on elucidating the mechanisms of stroke and their optimal management. Methods. A retrospective review identified all internal carotid artery (ICA) or vertebral artery (VA) Biffl Grade IV injuries over a 7-year period at a single institution. Results. Fifty-nine Biffl Grade IV injuries were diagnosed affecting 11 ICAs, 44 unilateral VAs, and 2 bilateral VAs. The stroke rates were 64%, 9%, and 50%, respectively. Of the 11 Biffl Grade IV ICA injuries, 5 presented with stroke while 2 developed delayed stroke. An ipsilateral posterior communicating artery greater than 1 mm on CT angiography was protective against stroke due to hemodynamic failure (p = 0.015). All patients with Biffl Grade IV injuries affecting the ICA who had at least 8 emboli per hour on transcranial Doppler (TCD) ultrasonography developed an embolic pattern of stroke (p = 0.006). Treatment with aspirin versus dual antiplatelet therapy had a similar effect on stroke rate in the ICA group (p = 0.5) and all patients who suffered stroke either died (n = 3) or required a decompressive hemicraniectomy with subsequent poor outcome (n = 4). All 10 strokes associated with Biffl Grade IV VA injuries were embolic and clinically asymptomatic. In VA Biffl Grade IV injury, neither the presence of emboli nor treatment with antiplatelet agents affected stroke rates. Conclusions. At the authors' institution, traumatic ICA occlusion is rare but associated with a high stroke rate. Robust collateral circulation may mitigate its severity. Embolic monitoring with TCD ultrasonography and prophylactic antiplatelet therapy should be used in all ICA Biffl Grade IV injuries. Unilateral VA Biffl Grade IV injury is the most common type of traumatic occlusion and is associated with significantly less morbidity. Embolic monitoring using TCD and prophylactic antiplatelet therapy do not appear to be beneficial in patients with traumatic VA occlusion.	[Morton, Ryan P.; Hanak, Brian W.; Levitt, Michael R.; Kim, Louis J.; Chesnut, Randall M.] Univ Washington, Harborview Med Ctr, Dept Neurol Surg, Seattle, WA 98104 USA; [Fink, Kathleen R.] Univ Washington, Harborview Med Ctr, Dept Radiol, Seattle, WA 98104 USA; [Peterson, Eric C.] Univ Miami, Miller Sch Med, Dept Neurol Surg, Miami, FL 33136 USA; [Vilela, Marcelo D.] Hosp Mater Dei, Dept Neurol Surg, Belo Horizonte, MG, Brazil	Morton, RP (corresponding author), Univ Washington, Sch Med, Dept Neurol Surg, Box 359766,325 9th Ave, Seattle, WA 98104 USA.	rymorton@uw.edu		Hanak, Brian/0000-0002-3155-7413	Volcano, Inc.	Dr. Kim has ownership in, and is a patent holder for, SPI Surgical, Inc.; serves as a consultant to Aesculap and MicroVention; and has received clinical or research support for this study from Volcano, Inc.	Biffl WL, 2002, ANN SURG, V235, P699, DOI 10.1097/00000658-200205000-00012; Biffl WL, 2000, ANN SURG, V231, P672, DOI 10.1097/00000658-200005000-00007; Biffl WL, 1999, J TRAUMA, V47, P845, DOI 10.1097/00005373-199911000-00004; Cothren CC, 2004, ARCH SURG-CHICAGO, V139, P540, DOI 10.1001/archsurg.139.5.540; Eachempati SR, 1998, J TRAUMA, V45, P997, DOI 10.1097/00005373-199812000-00004; Edwards NM, 2007, J AM COLL SURGEONS, V204, P1007, DOI 10.1016/j.jamcollsurg.2006.12.041; Fabian TC, 1996, ANN SURG, V223, P513, DOI 10.1097/00000658-199605000-00007; Fusco MR, 2011, NEUROSURGERY, V68, P517, DOI 10.1227/NEU.0b013e3181fe2fda; Miller PR, 2001, J TRAUMA, V51, P279, DOI 10.1097/00005373-200108000-00009; SCHOMER DF, 1994, NEW ENGL J MED, V330, P1565, DOI 10.1056/NEJM199406023302204; SPENCER MP, 1990, STROKE, V21, P415, DOI 10.1161/01.STR.21.3.415; Stein DM, 2009, J TRAUMA, V66, P132, DOI 10.1097/TA.0b013e318142d146; STEINBERG GK, 1993, J NEUROSURG, V79, P161, DOI 10.3171/jns.1993.79.2.0161; STURZENEGGER M, 1995, J NEUROL, V242, P231, DOI 10.1007/BF00919596; Wahl WL, 2002, J TRAUMA, V52, P896, DOI 10.1097/00005373-200205000-00012	15	18	20	0	5	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	JUN	2014	120	6					1446	1450		10.3171/2014.2.JNS131658			5	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	AH7ZA	WOS:000336352700021	24678781				2021-06-18	
J	Probst, MA; Kanzaria, HK; Schriger, DL				Probst, Marc A.; Kanzaria, Hemal K.; Schriger, David L.			A conceptual model of emergency physician decision making for head computed tomography in mild head injury	AMERICAN JOURNAL OF EMERGENCY MEDICINE			English	Article							TRAUMATIC BRAIN-INJURY; QUALITY-OF-CARE; RADIATION-EXPOSURE; CLINICAL PREDICTORS; DEFENSIVE MEDICINE; RISK TOLERANCE; UNITED-STATES; CT SCANS; DEPARTMENTS; RULE	The use of computed tomographic scanning in blunt head trauma has increased dramatically in recent years without an accompanying rise in the prevalence of injury or hospital admission for serious conditions. Because computed tomography is neither harmless nor inexpensive, researchers have attempted to optimize utilization, largely through research that describes which clinical variables predict intracranial injury, and use this information to develop clinical decision instruments. Although such techniques may be useful when the benefits and harms of each strategy (neuroimaging vs observation) are quantifiable and amenable to comparison, the exact magnitude of these benefits and harms remains unknown in this clinical scenario. We believe that most clinical decision instrument development efforts are misguided insofar as they ignore critical, nonclinical factors influencing the decision to image. In this article, we propose a conceptual model to illustrate how clinical and nonclinical factors influence emergency physicians making this decision. We posit that elements unrelated to standard clinical factors, such as personality of the physician, fear of litigation and of missed diagnoses, patient expectations, and compensation method, may have equal or greater impact on actual decision making than traditional clinical factors. We believe that 3 particular factors deserve special consideration for further research: fear of error/malpractice, financial incentives, and patient engagement. Acknowledgement and study of these factors will be essential if we are to understand how emergency physicians truly make these decisions and how test-ordering behavior can be modified. (C) 2014 Elsevier Inc. All rights reserved.	[Probst, Marc A.; Schriger, David L.] Univ Calif Los Angeles, Sch Med, Ctr Emergency Med, Los Angeles, CA 90024 USA; [Kanzaria, Hemal K.] Univ Calif Los Angeles, Sch Med, Ctr Emergency Med, Robert Wood Johnson Fdn Clin Scholars Program, Los Angeles, CA 90024 USA	Probst, MA (corresponding author), Univ Calif Los Angeles, Sch Med, Ctr Emergency Med, Los Angeles, CA 90024 USA.	mprobst@gmail.com			Robert Wood Johnson Foundation Clinical Scholars ProgramRobert Wood Johnson Foundation (RWJF); National Heart, Lung, and Blood Institute of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [F32HL120466]	This work was supported by the Robert Wood Johnson Foundation Clinical Scholars Program (Dr Kanzaria) and by the National Heart, Lung, and Blood Institute of the National Institutes of Health under Award Number F32HL120466 (Dr Probst). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the Robert Wood Johnson Foundation. There are no other conflicts of interest.	ANDERSEN RM, 1995, J HEALTH SOC BEHAV, V36, P1, DOI 10.2307/2137284; Andruchow JE, 2012, ARCH INTERN MED, V172, P660, DOI 10.1001/archinternmed.2011.2243; Asplin BR, 2003, ANN EMERG MED, V42, P173, DOI 10.1067/mem.2003.302; Baicker K, 2007, HEALTH AFFAIR, V26, P841, DOI 10.1377/hlthaff.26.3.841; Baskerville JR, 2012, AM J EMERG MED, V30, P367, DOI 10.1016/j.ajem.2010.12.008; Berdahl CT, 2013, ANN EMERG MED, V62, P486, DOI 10.1016/j.annemergmed.2013.02.018; BORCZUK P, 1995, ANN EMERG MED, V25, P731, DOI 10.1016/S0196-0644(95)70199-0; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Brenner DJ, 2001, AM J ROENTGENOL, V176, P289, DOI 10.2214/ajr.176.2.1760289; Brook RH, 2010, JAMA-J AM MED ASSOC, V304, P795, DOI 10.1001/jama.2010.1174; Eagles D, 2008, ACAD EMERG MED, V15, P1256, DOI 10.1111/j.1553-2712.2008.00265.x; Flynn D, 2012, ACAD EMERG MED, V19, P959, DOI 10.1111/j.1553-2712.2012.01414.x; Ginde AA, 2008, ACAD EMERG MED, V15, P780, DOI 10.1111/j.1553-2712.2008.00192.x; Gordon JA, 2001, ACAD EMERG MED, V8, P54, DOI 10.1111/j.1553-2712.2001.tb00552.x; Gupta M, 2011, ANN EMERG MED, V58, P407, DOI 10.1016/j.annemergmed.2011.06.003; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; HENNES H, 1988, AM J DIS CHILD, V142, P1045, DOI 10.1001/archpedi.1988.02150100039021; Heyer CM, 2007, ROFO-FORTSCHR RONTG, V179, P261, DOI 10.1055/s-2006-927366; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; JERET JS, 1993, NEUROSURGERY, V32, P9, DOI 10.1227/00006123-199301000-00002; Jones JGA, 2012, WEST J EMERG MED, V13, P202, DOI 10.5811/westjem.2011.11.6804; Kessler D, 1996, Q J ECON, V111, P353, DOI 10.2307/2946682; Kocher KE, 2011, ANN EMERG MED, V58, P452, DOI 10.1016/j.annemergmed.2011.05.020; Korley FK, 2010, JAMA-J AM MED ASSOC, V304, P1465, DOI 10.1001/jama.2010.1408; Kovacs G, 1999, ACAD EMERG MED, V6, P947, DOI 10.1111/j.1553-2712.1999.tb01246.x; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Larson DB, 2007, AM J ROENTGENOL, V189, P271, DOI 10.2214/AJR.07.2248; Lee CI, 2004, RADIOLOGY, V231, P393, DOI 10.1148/radiol.2312030767; Liu SW, 2011, ACAD EMERG MED, V18, P430, DOI 10.1111/j.1553-2712.2011.01033.x; Mannix R, 2012, J PEDIATR-US, V160, P136, DOI 10.1016/j.jpeds.2011.06.024; Menditto VG, 2012, ANN EMERG MED, V59, P451, DOI 10.1016/j.annemergmed.2011.12.003; Mitchell JM, 2008, MED CARE, V46, P460, DOI 10.1097/MLR.0b013e31815dc5ae; Mitchell JM, 2012, HEALTH AFFAIR, V31, P741, DOI 10.1377/hlthaff.2011.1372; Mitchell JM, 2010, ARCH SURG-CHICAGO, V145, P732, DOI 10.1001/archsurg.2010.149; Mitchell JM, 2000, INQUIRY-J HEALTH CAR, V37, P134; Morton MJ, 2012, ANN EMERG MED, V60, P361, DOI 10.1016/j.annemergmed.2011.12.026; Mower WR, 2005, J TRAUMA, V59, P954, DOI 10.1097/01.ta.0000187813.79047.42; Mower WR, 2002, ANN EMERG MED, V40, P505, DOI 10.1067/mem.2002.129245; Nahed BV, 2012, PLOS ONE US; PEARSON SD, 1995, J GEN INTERN MED, V10, P557, DOI 10.1007/BF02640365; Pines JM, 2010, AM J EMERG MED, V28, P771, DOI 10.1016/j.ajem.2009.03.019; Pines JM, 2009, AM J EMERG MED, V27, P552, DOI 10.1016/j.ajem.2008.04.031; Pitts SR, 2012, NEW ENGL J MED, V367, P2465, DOI 10.1056/NEJMp1211315; Prevedello LM, 2012, AM J MED, V125, P356, DOI 10.1016/j.amjmed.2011.06.023; Raja AS, 2011, ARCH INTERN MED, V171, P260, DOI 10.1001/archinternmed.2010.520; Ratnapalan S, 2004, AM J ROENTGENOL, V182, P1107, DOI 10.2214/ajr.182.5.1821107; REDELMEIER DA, 1993, JAMA-J AM MED ASSOC, V270, P72, DOI 10.1001/jama.270.1.72; Rohacek M, 2012, INTENS CARE MED, V38, P1345, DOI 10.1007/s00134-012-2595-z; Ryu WHA, 2009, CAN J NEUROL SCI, V36, P42, DOI 10.1017/S0317167100006296; Sandhu H, 2006, ANN EMERG MED, V48, P713, DOI 10.1016/j.annemergmed.2006.03.011; Smith-Bindman R, 2012, JAMA-J AM MED ASSOC, V307, P2400, DOI 10.1001/jama.2012.5960; Smith-Bindman R, 2009, ARCH INTERN MED, V169, P2078, DOI 10.1001/archinternmed.2009.427; Song YJ, 2010, NEW ENGL J MED, V363, P45, DOI 10.1056/NEJMsa0910881; Soumerai SB, 1998, JAMA-J AM MED ASSOC, V279, P1358, DOI 10.1001/jama.279.17.1358; SOUMERAI SB, 1990, JAMA-J AM MED ASSOC, V263, P549, DOI 10.1001/jama.263.4.549; Stiell IG, 2010, CAN MED ASSOC J, V182, P1527, DOI 10.1503/cmaj.091974; Stiell IG, 2005, JAMA-J AM MED ASSOC, V294, P1511, DOI 10.1001/jama.294.12.1511; Stiell IG, 1997, ANN EMERG MED, V30, P14, DOI 10.1016/S0196-0644(97)70104-5; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Studdert DM, 2005, JAMA-J AM MED ASSOC, V293, P2609, DOI 10.1001/jama.293.21.2609; Takakuwa KM, 2010, AM J ROENTGENOL, V195, P1151, DOI 10.2214/AJR.09.3847; TVERSKY A, 1974, SCIENCE, V185, P1124, DOI 10.1126/science.185.4157.1124; Wears RL, 2011, ANN EMERG MED, V58, P9, DOI 10.1016/j.annemergmed.2011.02.026; Wennberg JE., 1999, QUALITY MED CARE US; Wong AC, 2011, PEDIATR EMERG CARE, V27, P182, DOI 10.1097/PEC.0b013e31820d64f7	65	18	18	0	6	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0735-6757	1532-8171		AM J EMERG MED	Am. J. Emerg. Med.	JUN	2014	32	6					645	650		10.1016/j.ajem.2014.01.003			6	Emergency Medicine	Emergency Medicine	AI1AK	WOS:000336581800031	24560384	Green Accepted			2021-06-18	
J	Senol, N; Naziroglu, M				Senol, Nilgun; Naziroglu, Mustafa			Melatonin reduces traumatic brain injury-induced oxidative stress in the cerebral cortex and blood of rats	NEURAL REGENERATION RESEARCH			English	Article						nerve regeneration; melatonin; traumatic brain injury; antioxidant; oxidative stress; vitamin E; vitamin C; glutathione; brain; neural regeneration	DORSAL-ROOT GANGLION; VITAMIN-E; MOLECULAR PATHWAYS; NERVOUS-SYSTEM; TRPM2 CHANNELS; ANTIOXIDANT; ACTIVATION; APOPTOSIS; REAGENT; DAMAGE	Free radicals induced by traumatic brain injury have deleterious effects on the function and antioxidant vitamin levels of several organ systems including the brain. Melatonin possesses antioxidant effect on the brain by maintaining antioxidant enzyme and vitamin levels. We investigated the effects of melatonin on antioxidant ability in the cerebral cortex and blood of traumatic brain injury rats. Results showed that the cerebral cortex beta-carotene, vitamin C, vitamin E, reduced glutathione, and erythrocyte reduced glutathione levels, and plasma vitamin C level were decreased by traumatic brain injury whereas they were increased following melatonin treatment. In conclusion, melatonin seems to have protective effects on traumatic brain injury-induced cerebral cortex and blood toxicity by inhibiting free radical formation and supporting antioxidant vitamin redox system.	[Senol, Nilgun] Suleyman Demirel Univ, Dept Neurosurg, Fac Med, TR-32200 Isparta, Turkey; [Naziroglu, Mustafa] Suleyman Demirel Univ, Neurosci Res Ctr, TR-32200 Isparta, Turkey	Naziroglu, M (corresponding author), Suleyman Demirel Univ, Neurosci Res Ctr, TR-32200 Isparta, Turkey.	mustafanaziroglu@sdu.edu.tr					Bowman GL, 2012, BIOFACTORS, V38, P114, DOI 10.1002/biof.1002; Campolo M, 2013, J ENDOCRINOL, V217, P291, DOI 10.1530/JOE-13-0022; Celik O, 2012, PHYSIOL BEHAV, V107, P458, DOI 10.1016/j.physbeh.2012.09.013; Cherubini A, 2008, CURR MED CHEM, V15, P1236, DOI 10.2174/092986708784310431; Cornelius C, 2013, ANTIOXID REDOX SIGN, V19, P836, DOI 10.1089/ars.2012.4981; DESAI ID, 1984, METHOD ENZYMOL, V105, P138, DOI 10.1016/S0076-6879(84)05019-9; Dilek M, 2010, J MEMBRANE BIOL, V233, P135, DOI 10.1007/s00232-010-9233-x; Ekmekcioglu C, 2006, BIOMED PHARMACOTHER, V60, P97, DOI 10.1016/j.biopha.2006.01.002; Espino J, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/670294; Esposito E, 2010, CURR NEUROPHARMACOL, V8, P228, DOI 10.2174/157015910792246155; Fernandez-Gajardo R, 2014, CNS DRUGS, V28, P229, DOI 10.1007/s40263-013-0138-y; Ishaq GM, 2013, J NEUROSCI RURAL PRA, V4, P292, DOI 10.4103/0976-3147.118784; JAGOTA SK, 1982, ANAL BIOCHEM, V127, P178, DOI 10.1016/0003-2697(82)90162-2; Kayan M, 2012, J MEMBRANE BIOL, V245, P833, DOI 10.1007/s00232-012-9491-x; Kerman M, 2005, EXP BRAIN RES, V163, P406, DOI 10.1007/s00221-005-2338-2; LAWRENCE RA, 1976, BIOCHEM BIOPH RES CO, V71, P952, DOI 10.1016/0006-291X(76)90747-6; Lee S, 2009, J PINEAL RES, V46, P43, DOI 10.1111/j.1600-079X.2008.00607.x; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Martin M, 2000, FASEB J, V14, P1677; Naziroglu M, 2012, PHYSIOL BEHAV, V105, P683, DOI 10.1016/j.physbeh.2011.10.005; Naziroglu M, 2007, NEUROCHEM RES, V32, P1990, DOI 10.1007/s11064-007-9386-x; Naziroglu M, 2013, J BIOENERG BIOMEMBR, V45, P541, DOI 10.1007/s10863-013-9524-x; Naziroglu M, 2013, CELL MOL NEUROBIOL, V33, P589, DOI 10.1007/s10571-013-9936-5; Naziroglu M, 2013, J NAT MED-TOKYO, V67, P152, DOI 10.1007/s11418-012-0666-7; Naziroglu M, 2012, J RECEPT SIG TRANSD, V32, P290, DOI 10.3109/10799893.2012.737002; Naziroglu M, 2012, J RECEPT SIG TRANSD, V32, P134, DOI 10.3109/10799893.2012.672994; Naziroglu M, 2011, NEUROCHEM RES, V36, P355, DOI 10.1007/s11064-010-0347-4; Niesman IR, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-39; Ozdemir D, 2005, PHYSIOL RES, V54, P631; PLACER ZA, 1966, ANAL BIOCHEM, V16, P359, DOI 10.1016/0003-2697(66)90167-9; Reiter RJ, 1997, ANN NY ACAD SCI, V825, P70, DOI 10.1111/j.1749-6632.1997.tb48415.x; SEDLAK J, 1968, ANAL BIOCHEM, V25, P192, DOI 10.1016/0003-2697(68)90092-4; Senol N, 2014, NEUROCHEM RES, V39, P685, DOI 10.1007/s11064-014-1255-9; SUZUKI J, 1990, JPN J VET SCI, V52, P1282; Tuzcu M, 2006, EUR J PHARMACOL, V537, P106, DOI 10.1016/j.ejphar.2006.03.024; Yatin Servet M., 2000, Journal of Alzheimer's Disease, V2, P123	37	18	19	0	9	SHENYANG EDITORIAL DEPT NEURAL REGENERATION RES	SHENYANG	PO BOX 1234, SHENYANG, LIAONING 110004, PEOPLES R CHINA	1673-5374			NEURAL REGEN RES	Neural Regen. Res.	JUN	2014	9	11					1112	1116		10.4103/1673-5374.135312			5	Cell Biology; Neurosciences	Cell Biology; Neurosciences & Neurology	AL0FX	WOS:000338803900007	25206769	DOAJ Gold, Green Published			2021-06-18	
J	Kraitsy, K; Uecal, M; Grossauer, S; Bruckmann, L; Pfleger, F; Ropele, S; Fazekas, F; Gruenbacher, G; Patz, S; Absenger, M; Porubsky, C; Smolle-Juettner, F; Tezer, I; Molcanyi, M; Fasching, U; Schaefer, U				Kraitsy, Klaus; Uecal, Muammer; Grossauer, Stefan; Bruckmann, Lukas; Pfleger, Florentina; Ropele, Stefan; Fazekas, Franz; Gruenbacher, Gerda; Patz, Silke; Absenger, Markus; Porubsky, Christian; Smolle-Juettner, Freyja; Tezer, Irem; Molcanyi, Marek; Fasching, Ulrike; Schaefer, Ute			Repetitive Long-Term Hyperbaric Oxygen Treatment (HBOT) Administered after Experimental Traumatic Brain Injury in Rats Induces Significant Remyelination and a Recovery of Sensorimotor Function	PLOS ONE			English	Article							MYELIN BASIC-PROTEIN; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; SOMATOSENSORY-EVOKED POTENTIALS; ISCHEMIA-REPERFUSION INJURY; FLUID-PERCUSSION INJURY; MITOCHONDRIAL-FUNCTION; CEREBRAL-ISCHEMIA; HEAD-INJURY; THERAPY; MODEL	Cells in the central nervous system rely almost exclusively on aerobic metabolism. Oxygen deprivation, such as injury-associated ischemia, results in detrimental apoptotic and necrotic cell loss. There is evidence that repetitive hyperbaric oxygen therapy (HBOT) improves outcomes in traumatic brain-injured patients. However, there are no experimental studies investigating the mechanism of repetitive long-term HBOT treatment-associated protective effects. We have therefore analysed the effect of long-term repetitive HBOT treatment on brain trauma-associated cerebral modulations using the lateral fluid percussion model for rats. Trauma-associated neurological impairment regressed significantly in the group of HBO-treated animals within three weeks post trauma. Evaluation of somatosensory-evoked potentials indicated a possible remyelination of neurons in the injured hemisphere following HBOT. This presumption was confirmed by a pronounced increase in myelin basic protein isoforms, PLP expression as well as an increase in myelin following three weeks of repetitive HBO treatment. Our results indicate that protective long-term HBOT effects following brain injury is mediated by a pronounced remyelination in the ipsilateral injured cortex as substantiated by the associated recovery of sensorimotor function.	[Kraitsy, Klaus; Uecal, Muammer; Pfleger, Florentina; Gruenbacher, Gerda; Patz, Silke; Fasching, Ulrike; Schaefer, Ute] Med Univ Graz, Res Unit Expt Neurotraumatol, Graz, Austria; [Grossauer, Stefan; Bruckmann, Lukas] Med Univ Graz, Dept Neurosurg, Graz, Austria; [Ropele, Stefan; Fazekas, Franz] Med Univ Graz, Clin Div Gen Neurol, Graz, Austria; [Absenger, Markus] Med Univ Graz, Med Res Ctr, Core Facil Microscopy, Graz, Austria; [Porubsky, Christian; Smolle-Juettner, Freyja; Tezer, Irem] Med Univ Graz, Dept Surg, Div Thorac & Hyperbar Surg, Graz, Austria; [Molcanyi, Marek] Univ Cologne, Dept Neurosurg, D-50931 Cologne, Germany; [Molcanyi, Marek] Univ Cologne, Inst Neurophysiol, D-50931 Cologne, Germany	Schaefer, U (corresponding author), Med Univ Graz, Res Unit Expt Neurotraumatol, Graz, Austria.	ute.schaefer@medunigraz.at					Adamides AA, 2009, ACTA NEUROCHIR, V151, P1399, DOI 10.1007/s00701-009-0398-y; Amantini A, 2008, EUR J ANAESTH, V25, P196, DOI 10.1017/S0265021507003183; Ames A, 2000, BRAIN RES REV, V34, P42, DOI 10.1016/S0165-0173(00)00038-2; Asou Hiroaki, 1995, Keio Journal of Medicine, V44, P47; Barrett KF, 2004, UNDERSEA HYPERBAR M, V31, P395; Bentz K, 2010, CELL PHYSIOL BIOCHEM, V26, P821, DOI 10.1159/000323991; Beynon C, 2012, J NEUROTRAUM, V29, P2109, DOI 10.1089/neu.2012.2365; Brkic P, 2012, BRAIN INJ; Butt AM, 1997, J NEUROSCI RES, V48, P588; Calvert JW, 2002, BRAIN RES, V951, P1, DOI 10.1016/S0006-8993(02)03094-9; Campbell JN, 2011, J NEUROTRAUMA; Capello E, 1997, ANN NEUROL, V41, P797, DOI 10.1002/ana.410410616; Chang CF, 2000, EXP NEUROL, V166, P298, DOI 10.1006/exnr.2000.7506; Chang JJJ, 2009, CRIT CARE MED, V37, P283, DOI 10.1097/CCM.0b013e318192fbd7; CONTRERAS FL, 1988, J NEUROSURG, V68, P137, DOI 10.3171/jns.1988.68.1.0137; Crawford AH, 2013, J COMP PATHOL, V149, P242, DOI 10.1016/j.jcpa.2013.05.004; Cummins FJ, 2010, J CARDIOVASC TRANSL, V3, P683, DOI 10.1007/s12265-010-9221-7; Daugherty WP, 2004, J NEUROSURG, V101, P499, DOI 10.3171/jns.2004.101.3.0499; DeBruin LS, 2006, BIOCHEM CELL BIOL, V84, P993, DOI 10.1139/O06-180; Dell'Acqua ML, 2012, NEUROPATH APPL NEURO, V38, P454, DOI 10.1111/j.1365-2990.2011.01228.x; DEROSBO NK, 1991, DEV NEUROSCI-BASEL, V13, P34; Eovaldi B, 2010, NEUROPSYCH DIS TREAT, V6, P785, DOI 10.2147/NDT.S16071; Franklin RJM, 2008, NAT REV NEUROSCI, V9, P839, DOI 10.1038/nrn2480; Freund P, 2012, J NEUROL NEUROSUR PS, V83, P629, DOI 10.1136/jnnp-2011-301875; Furlonger A J, 2000, Crit Care Resusc, V2, P246; Gambi D, 1996, ITAL J NEUROL SCI, V17, P23, DOI 10.1007/BF01995706; Golden Z, 2006, DISABIL REHABIL, V28, P1379, DOI 10.1080/09638280600638364; Golden ZL, 2002, INT J NEUROSCI, V112, P119, DOI 10.1080/00207450212027; Grin'kina NM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053775; Harauz G, 2013, J NEUROCHEM, V125, P334, DOI 10.1111/jnc.12195; Harch PG, 2007, BRAIN RES, V1174, P120, DOI 10.1016/j.brainres.2007.06.105; Hardy P, 2007, J NEUROL SCI, V253, P94, DOI 10.1016/j.jns.2006.12.005; HOMAN RW, 1987, ELECTROEN CLIN NEURO, V66, P376, DOI 10.1016/0013-4694(87)90206-9; Huchzermeyer C, 2013, J CEREBR BLOOD F MET, V33, P263, DOI 10.1038/jcbfm.2012.165; Hyder F, 2006, J CEREBR BLOOD F MET, V26, P865, DOI 10.1038/sj.jcbfm.9600263; IULIANO BA, 1994, J NEUROL SCI, V123, P186, DOI 10.1016/0022-510X(94)90222-4; Kann O, 2007, AM J PHYSIOL-CELL PH, V292, pC641, DOI 10.1152/ajpcell.00222.2006; Kao HK, 2009, PULM PHARMACOL THER, V22, P473, DOI 10.1016/j.pupt.2009.04.006; KEREN O, 1991, Brain Injury, V5, P233, DOI 10.3109/02699059109008094; Koch JD, 2008, J CEREBR BLOOD F MET, V28, P1294, DOI 10.1038/jcbfm.2008.15; Lee LC, 2012, AM J PHYS MED REHAB, V91, P528, DOI 10.1097/PHM.0b013e31824ad556; Li JS, 2009, NEUROSCIENCE, V159, P1309, DOI 10.1016/j.neuroscience.2009.01.011; Li JS, 2008, BRAIN RES, V1210, P223, DOI 10.1016/j.brainres.2008.03.007; Liu ZJ, 2008, ANTIOXID REDOX SIGN, V10, P1869, DOI 10.1089/ars.2008.2121; Maegele M, 2008, MINIM INVASIV THER, V17, P119, DOI 10.1080/13645700801970087; Martini RP, 2009, J NEUROSURG, V111, P644, DOI 10.3171/2009.2.JNS08998; Mattiasson GJ, 2000, J NEUROSCI METH, V95, P75, DOI 10.1016/S0165-0270(99)00162-4; McIntosh TK, 1989, J NEUROTRAUM, V6, P247, DOI 10.1089/neu.1989.6.247; Michalski D, 2009, BRAIN RES, V1303, P161, DOI 10.1016/j.brainres.2009.09.038; Miljkovic-Lolic M, 2003, BRAIN RES, V971, P90, DOI 10.1016/S0006-8993(03)02364-3; MINK RB, 1995, STROKE, V26, P2307, DOI 10.1161/01.STR.26.12.2307; Molcanyi M, 2007, J NEUROTRAUM, V24, P625, DOI 10.1089/neu.2006.0180; MONDELLI M, 1989, ITAL J NEUROL SCI, V10, P433, DOI 10.1007/BF02334949; Morelli A, 2011, CELL BIOCHEM BIOPHYS, V61, P179, DOI 10.1007/s12013-011-9174-8; Murtie JC, 2005, NEUROBIOL DIS, V19, P171, DOI 10.1016/j.nbd.2004.12.006; NEUBAUER RA, 1992, CLIN NUCL MED, V17, P477, DOI 10.1097/00003072-199206000-00010; NEUBAUER RA, 1993, J NEUROSURG, V78, P687; NEUBAUER RA, 1994, SOUTHERN MED J, V87, P933, DOI 10.1097/00007611-199409000-00015; Niklas A, 2004, J NEUROL SCI, V219, P77, DOI 10.1016/j.jns.2003.12.013; Ohguri T, 2007, INT J RADIAT ONCOL, V67, P248, DOI 10.1016/j.ijrobp.2006.08.009; Ostrowski RP, 2006, STROKE, V37, P1314, DOI 10.1161/01.STR.0000217310.88450.c3; Ostrowski RP, 2005, J CEREBR BLOOD F MET, V25, P554, DOI 10.1038/sj.jcbfm.9600048; Palzur E, 2004, J NEUROTRAUM, V21, P41, DOI 10.1089/089771504772695931; Palzur E, 2008, BRAIN RES, V1221, P126, DOI 10.1016/j.brainres.2008.04.078; Prakash A, 2012, J PEDIATR NEUROSCI, V7, P4, DOI 10.4103/1817-1745.97610; Puri V, 2005, MUSCLE NERVE, V32, P230, DOI 10.1002/mus.20316; Raible DJ, 2012, J NEUROTRAUM, V29, P2548, DOI 10.1089/neu.2012.2483; Ren HJ, 2001, CHINESE MED J-PEKING, V114, P387; Riess P, 2007, J NEUROTRAUM, V24, P216, DOI 10.1089/neu.2006.0141; ROBERTSON A, 1993, ACTA NEUROPATHOL, V86, P163, DOI 10.1007/BF00334883; ROCKSWOLD GL, 1992, J NEUROSURG, V76, P929, DOI 10.3171/jns.1992.76.6.0929; Rockswold SB, 2007, NEUROL RES, V29, P162, DOI 10.1179/016164107X181798; Rockswold SB, 2010, J NEUROSURG, V112, P1080, DOI 10.3171/2009.7.JNS09363; Rogatsky GG, 2005, BRAIN RES, V1047, P131, DOI 10.1016/j.brainres.2005.02.049; SHIBASAKI H, 1982, ANN NEUROL, V12, P355, DOI 10.1002/ana.410120407; Sleigh JW, 1999, J NEUROSURG, V91, P577, DOI 10.3171/jns.1999.91.4.0577; Smith G, 2012, BALLET REV, V40, P18; Soustiel JF, 2008, NEUROPATH APPL NEURO, V34, P412, DOI 10.1111/j.1365-2990.2007.00906.x; STANLEY GP, 1991, BRAIN, V114, P1827, DOI 10.1093/brain/114.4.1827; Stiefel MF, 2005, J NEUROSURG, V103, P805, DOI 10.3171/jns.2005.103.5.0805; Sullivan GM, 2013, J NEUROPATH EXP NEUR, V72, P1106, DOI 10.1097/NEN.0000000000000009; Thompson JK, 2003, SCIENCE, V299, P1070, DOI 10.1126/science.1079220; Vlodavsky E, 2006, NEUROPATH APPL NEURO, V32, P40, DOI 10.1111/j.1365-2990.2005.00698.x; Vlodavsky E, 2005, ACTA NEUROPATHOL, V110, P120, DOI 10.1007/s00401-004-0946-8; Wang GH, 2010, J NEUROTRAUM, V27, P1733, DOI 10.1089/neu.2009.1175; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Yi JH, 2007, BRAIN RES, V1154, P200, DOI 10.1016/j.brainres.2007.04.011; Zhang K, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00005; Zhou ZW, 2007, J NEUROSURG, V106, P687, DOI 10.3171/jns.2007.106.4.687	89	18	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e97750	10.1371/journal.pone.0097750			12	Multidisciplinary Sciences	Science & Technology - Other Topics	AI3AL	WOS:000336730600054	24848795	DOAJ Gold, Green Published			2021-06-18	
J	Flynn, JR; te Nijenhuis, J; Metzen, D				Flynn, James R.; te Nijenhuis, Jan; Metzen, Daniel			The g beyond Spearman's g: Flynn's paradoxes resolved using four exploratory meta-analyses	INTELLIGENCE			English	Article						Flynn effect; Jensen effect; Method of correlated vectors; Significance of IQ gains over time; Significance of black IQ gains on whites	TRAUMATIC BRAIN-INJURY; PRENATAL COCAINE EXPOSURE; PRESCHOOL-CHILDREN; IQ; OUTCOMES; PERFORMANCE; ABILITIES; LITIGANTS; GAINS	When IQ tests are ranked by the magnitude of their score gains over time, this hierarchy lacks a positive correlation with the same tests ranked by their g loadings. Therefore, Jensen declared IQ gains "hollow" and, by implication, extended this judgment to score gains that indicated that blacks had made IQ gains on whites. We offer four exploratory meta-analyses that apply Jensen's method to the subtest score differences between normal subjects and those suffering from certain afflictions; iodine deficiency (K = 6, N = 196), prenatal cocaine exposure (K = 2, N = 215), fetal alcohol syndrome and degree of fetal alcohol syndrome (respectively, K = 1, N = 110; and K = 3, N = 125), and traumatic brain injury (K = 14, N = 629). All of these create a substantial cognitive deficit in those afflicted. However, the correlations between subtest score differences and g loadings run from -0.23 to +0.12, with an unweighted average of 0.00. (C) 2014 Elsevier Inc. All rights reserved.	[Flynn, James R.] Univ Otago, Dept Polit Studies, Dunedin, New Zealand; [Flynn, James R.] Univ Otago, Dept Psychol, Dunedin, New Zealand; [te Nijenhuis, Jan; Metzen, Daniel] Univ Amsterdam, Amsterdam, Netherlands	Flynn, JR (corresponding author), Univ Otago, Dept Polit Studies, POB 56, Dunedin, New Zealand.		Nijenhuis, Jan te/D-1015-2013	Nijenhuis, Jan te/0000-0002-1268-6121			Allen DN, 2010, PSYCHOL ASSESSMENT, V22, P57, DOI 10.1037/a0016056; Arendt RE, 2004, J DEV BEHAV PEDIATR, V25, P83, DOI 10.1097/00004703-200404000-00002; Armstrong EL, 2014, LEARN INDIVID DIFFER, V29, P41, DOI 10.1016/j.lindif.2013.10.009; Asanbe CB, 2006, J HEALTH CARE POOR U, V17, P400, DOI 10.1353/hpu.2006.0054; Bandstra ES, 2001, NEUROTOXICOL TERATOL, V23, P545, DOI 10.1016/S0892-0362(01)00181-7; Batty GD, 2007, ANN EPIDEMIOL, V17, P278, DOI 10.1016/j.annepidem.2006.07.010; Bittner RM, 2007, BRAIN INJURY, V21, P709, DOI 10.1080/02699050701468917; Blake TM, 2009, CLIN NEUROPSYCHOL, V23, P373, DOI 10.1080/13854040802279691; BLEICHRODT N, 1994, DAMAGED BRAIN OF IODINE DEFICIENCY, P195; BLEICHRODT N, 1980, AM J PHYS ANTHROPOL, V53, P55, DOI 10.1002/ajpa.1330530110; BLEICHRODT N, 1987, PREVENTION CONTROL I, P65; Borenstein M., 2009, INTRO METAANALYSIS; Cattelani R, 1998, BRAIN INJURY, V12, P283, DOI 10.1080/026990598122584; Coyle TR, 2008, INTELLIGENCE, V36, P719, DOI 10.1016/j.intell.2008.05.001; Dehaene P, 1995, GROSSESSE ALCOOL PRE; Demakis GJ, 2001, PSYCHOL ASSESSMENT, V13, P240, DOI 10.1037//1040-3590.13.2.240; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; Flynn J. R, 2009, WHAT IS INT BEYOND; Flynn J. R., 2014, HDB INTELLIGENCE EVO; Flynn JR, 2013, INTELLIGENCE, V41, P851, DOI 10.1016/j.intell.2013.06.014; Flynn James R., 2008, HAVE ALL LIBERALS GO; Flynn JR, 2013, INTELLIGENCE AND HUMAN PROGRESS: THE STORY OF WHAT WAS HIDDEN IN OUR GENES, P1; Genovese JEC, 2002, J EDUC RES, V96, P101, DOI 10.1080/00220670209598797; Gottfredson LS, 2004, CURR DIR PSYCHOL SCI, V13, P1, DOI 10.1111/j.0963-7214.2004.01301001.x; Hunter J.E., 2004, METHODS METAANALYSIS; Hunter JE, 1990, METHODS METAANALYSIS; Jensen A. R., 1998, G FACTOR SCI MENTAL; Juretko K., 2006, MUSTER KOGNITUVER FU; Langeluddecke PM, 2003, CLIN NEUROPSYCHOL, V17, P273, DOI 10.1076/clin.17.2.273.16499; Langeluddecke PM, 2005, J CLIN EXP NEUROPSYC, V27, P576, DOI 10.1080/13803390490918372; Lewis BA, 2004, NEUROTOXICOL TERATOL, V26, P617, DOI 10.1016/j.ntt.2004.06.007; Loser H, 1995, ALKOHOLEMBRYPATHIE A; Morrow CE, 2004, J PEDIATR PSYCHOL, V29, P543, DOI 10.1093/jpepsy/jsh056; Rindermann H, 2013, INTELLIGENCE, V41, P821, DOI 10.1016/j.intell.2013.06.016; Ritchie S. J., 2014, PSYCHOL AGI IN PRESS; Rothstein HR, 2005, PUBLICATION BIAS IN META-ANALYSIS: PREVENTION, ASSESSMENT AND ADJUSTMENTS, P1, DOI 10.1002/0470870168; Rushton JP, 2007, INTELLIGENCE, V35, P1, DOI 10.1016/j.intell.2006.09.002; Rushton JP, 2006, PSYCHOL SCI, V17, P921, DOI 10.1111/j.1467-9280.2006.01803.x; Schmidt F., 2004, SOFTWARE HUNTER SCHM; Singer LT, 2004, JAMA-J AM MED ASSOC, V291, P2448, DOI 10.1001/jama.291.20.2448; te Nijenhuis J., 2013, INTELLIGENCE; te Nijenhuis J, 2007, INTELLIGENCE, V35, P283, DOI 10.1016/j.intell.2006.07.006; Tremont G, 1999, CHILD NEUROPSYCHOL, V5, P104, DOI 10.1076/chin.5.2.104.3166; van den Briel T, 2000, AM J CLIN NUTR, V72, P1179; Wechsler D., 1958, MEASUREMENT APPRAISA; Woodley MA, 2013, INTELLIGENCE, V41, P832, DOI 10.1016/j.intell.2013.02.002; Woodley MA, 2012, INTELLIGENCE, V40, P189, DOI 10.1016/j.intell.2011.12.002; Woodley MA, 2012, PERS INDIV DIFFER, V53, P152, DOI 10.1016/j.paid.2011.03.028	48	18	18	0	15	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0160-2896	1873-7935		INTELLIGENCE	Intelligence	MAY-JUN	2014	44						1	10		10.1016/j.intell.2014.01.009			10	Psychology, Multidisciplinary	Psychology	AJ6DN	WOS:000337780000001					2021-06-18	
J	Manohar, S; Jamesdaniel, S; Salvi, R				Manohar, Senthilvelan; Jamesdaniel, Samson; Salvi, Richard			Cisplatin Inhibits Hippocampal Cell Proliferation and Alters the Expression of Apoptotic Genes	NEUROTOXICITY RESEARCH			English	Article						Cisplatin; Apoptosis; Hippocampus; Bid; Bcl2a1	KAPPA-B ACTIVATION; TRAUMATIC BRAIN-INJURY; LONG-TERM POTENTIATION; BCL-2 FAMILY-MEMBERS; HUMAN BREAST-CANCER; SUBVENTRICULAR ZONE; ADULT NEUROGENESIS; DOWN-REGULATION; DENTATE GYRUS; UP-REGULATION	The hippocampus, which is critical for memory and spatial navigation, contains a proliferating stem cell niche that is especially vulnerable to antineoplastic drugs such as cisplatin. Although the damaging effects of cisplatin have recently been recognized, the molecular mechanisms underlying its toxic effects on this vital region are largely unknown. Using a focused apoptosis gene array, we analyzed the early cisplatin-induced changes in gene expression in the hippocampus of adult Sprague-Dawley rats and compared the results to those from the inferior colliculus, a non-mitotic auditory region resistant to cisplatin-induced cell death. Two days after a 12 mg/kg dose of cisplatin, significant increases were observed in five proapoptotic genes: Bik, Bid, Bok, Trp53p2, and Card6 and a significant decrease in one antiapoptotic gene Bcl2a1. In contrast, Nol3, an antiapoptotic gene, showed a significant increase in expression. The cisplatin-induced increase in Bid mRNA and decrease in Bcl2a1 mRNA were accompanied by a corresponding increase and decrease of their respective proteins in the hippocampus. In contrast, the cisplatin-induced changes in Bcl2a1, Bid, Bik, and Bok gene expression in the inferior colliculus were strikingly different from those in the hippocampus consistent with the greater susceptibility of the hippocampus to cisplatin toxicity. Cisplatin also significantly reduced immunolabeling of the cell proliferation marker Ki67 in the subgranular zone of the hippocampus 2 days post-treatment. These results indicate that cisplatin-induced hippocampal cell death is mediated by increased expression of proapoptotic and decreased antiapoptotic genes and proteins that likely inhibit hippocampal cell proliferation.	[Manohar, Senthilvelan; Jamesdaniel, Samson; Salvi, Richard] SUNY Buffalo, Ctr Hearing & Deafness, Buffalo, NY 14214 USA	Salvi, R (corresponding author), SUNY Buffalo, Ctr Hearing & Deafness, 137 Cary Hall, Buffalo, NY 14214 USA.	smanohar@buffalo.edu; salvi@buffalo.edu		Jamesdaniel, Samson/0000-0002-5269-9007	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01DC011808]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [R01DC011808] Funding Source: NIH RePORTER	Research supported in part by NIH grant (R01DC011808).	Abe K, 2009, WORLD J GASTROENTERO, V15, P5228, DOI 10.3748/wjg.15.5228; Aimone JB, 2009, NEURON, V61, P187, DOI 10.1016/j.neuron.2008.11.026; Amptoulach Sousana, 2011, Chemother Res Pract, V2011, P843019, DOI 10.1155/2011/843019; Appleby PA, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001063; Bachstetter AD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010496; Barha CK, 2011, EXP NEUROL, V231, P72, DOI 10.1016/j.expneurol.2011.05.016; Bekinschtein P, 2007, NEURON, V53, P261, DOI 10.1016/j.neuron.2006.11.025; Blank T, 2002, J NEUROSCI, V22, P3788; Bolouri MR, 2004, J NEUROIMAGING, V14, P290, DOI 10.1177/1051228404265751; Bullwinkel J, 2006, J CELL PHYSIOL, V206, P624, DOI 10.1002/jcp.20494; Cameron HA, 2001, J COMP NEUROL, V435, P406, DOI 10.1002/cne.1040; Chang L W, 1990, J Toxicol Sci, V15 Suppl 4, P125; Chen D, 2005, CELL DEATH DIFFER, V12, P358, DOI 10.1038/sj.cdd.4401536; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Cheng QW, 2000, ONCOGENE, V19, P4936, DOI 10.1038/sj.onc.1203861; Couillard-Despres S, 2009, MOL PSYCHIATR, V14, P856, DOI 10.1038/mp.2008.147; Dawe RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026286; Deng W, 2010, NAT REV NEUROSCI, V11, P339, DOI 10.1038/nrn2822; Devarajan P, 2002, HEARING RES, V174, P45, DOI 10.1016/S0378-5955(02)00634-2; Dietrich Joerg, 2006, J Biol, V5, P22, DOI 10.1186/jbiol50; Dufner A, 2006, P NATL ACAD SCI USA, V103, P988, DOI 10.1073/pnas.0510380103; Dufner A, 2008, MOL CELL BIOL, V28, P1541, DOI 10.1128/MCB.01359-07; Ekdahl CT, 2003, P NATL ACAD SCI USA, V100, P13632, DOI 10.1073/pnas.2234031100; Femenia T, 2012, BRAIN RES, V1476, P58, DOI 10.1016/j.brainres.2012.03.053; FuseNagase Y, 1997, CLIN ELECTROENCEPHAL, V28, P55, DOI 10.1177/155005949702800110; Geddes DM, 2003, EXP NEUROL, V184, P420, DOI 10.1016/S0014-4886(03)00254-1; Graciarena M, 2010, BRAIN BEHAV IMMUN, V24, P1301, DOI 10.1016/j.bbi.2010.06.005; GREGG RW, 1992, J CLIN ONCOL, V10, P795, DOI 10.1200/JCO.1992.10.5.795; Harter P, 2011, INT J GYNECOL CANCER, V21, P289, DOI 10.1097/IGC.0b013e31820aaafd; Hattiangady B, 2004, NEUROBIOL DIS, V17, P473, DOI 10.1016/j.nbd.2004.08.008; Henshall DC, 2001, CELL DEATH DIFFER, V8, P1169, DOI 10.1038/sj.cdd.4400921; HIGHLEY M, 1992, MED PEDIATR ONCOL, V20, P143, DOI 10.1002/mpo.2950200210; Holmgreen SP, 1999, CELL DEATH DIFFER, V6, P525, DOI 10.1038/sj.cdd.4400519; Hsu SY, 1997, P NATL ACAD SCI USA, V94, P12401, DOI 10.1073/pnas.94.23.12401; Hur J, 2006, CANCER RES, V66, P10153, DOI 10.1158/0008-5472.CAN-05-3696; Hurria A, 2006, BREAST CANCER RES TR, V98, P343, DOI 10.1007/s10549-006-9171-6; Iosif RE, 2006, J NEUROSCI, V26, P9703, DOI 10.1523/JNEUROSCI.2723-06.2006; Ishida N, 1997, NEUROSCIENCE, V81, P1183, DOI 10.1016/S0306-4522(97)00220-0; Ishikawa K, 1997, BEHAV BRAIN RES, V83, P39, DOI 10.1016/S0166-4328(97)86043-3; Jacobs S, 2010, CANCER CHEMOTH PHARM, V65, P817, DOI 10.1007/s00280-009-1085-7; James SE, 2008, NEUROTOXICOLOGY, V29, P605, DOI 10.1016/j.neuro.2008.04.008; Jamesdaniel S, 2008, J PROTEOME RES, V7, P3516, DOI 10.1021/pr8002479; Jessberger S, 2009, LEARN MEMORY, V16, P147, DOI 10.1101/lm.1172609; Jin KL, 2003, AGING CELL, V2, P175, DOI 10.1046/j.1474-9728.2003.00046.x; Ju CX, 2008, EUR J PHARMACOL, V589, P281, DOI 10.1016/j.ejphar.2008.04.050; Jung M, 2009, TOXICOL APPL PHARM, V234, P236, DOI 10.1016/j.taap.2008.10.014; Kaasa S, 1988, Antibiot Chemother (1971), V41, P226; Kang KP, 2009, NEPHROL DIAL TRANSPL, V24, P3012, DOI 10.1093/ndt/gfp242; Kannarkat G, 2007, CURR OPIN NEUROL, V20, P719; KESNER RP, 1995, NEUROBIOL LEARN MEM, V64, P237, DOI 10.1006/nlme.1995.0006; Kim JB, 2004, BRAIN RES, V1027, P1, DOI 10.1016/j.brainres.2004.070.93; Kim JK, 2004, CANCER LETT, V212, P61, DOI 10.1016/j.canlet.2004.02.021; Kraus KS, 2010, NEUROSCIENCE, V167, P1216, DOI 10.1016/j.neuroscience.2010.02.071; Kyd RJ, 2005, CEREB CORTEX, V15, P720, DOI 10.1093/cercor/bhh173; Lane David P., 1992, Current Biology, V2, P581, DOI 10.1016/0960-9822(92)90154-3; Lee S, 2006, NEPHROL DIAL TRANSPL, V21, P2085, DOI 10.1093/ndt/gfl209; Li CY, 2008, MOL CANCER THER, V7, P1647, DOI 10.1158/1535-7163.MCT-07-2444; Li SY, 2005, AM J PHYSIOL-RENAL, V289, pF469, DOI 10.1152/ajprenal.00038.2005; Lim CS, 2005, J NEUROSCI RES, V82, P831, DOI 10.1002/jnr.20692; Liu Yanxia, 2003, Research Communications in Molecular Pathology and Pharmacology, V113, P97; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; Luft T, 2008, CURR NEUROVASC RES, V5, P21; Mandic A, 2002, MOL CELL BIOL, V22, P3003, DOI 10.1128/MCB.22.9.3003-3013.2002; Manohar S, 2012, NEUROSCIENCE, V202, P169, DOI 10.1016/j.neuroscience.2011.12.013; Martinou JC, 2011, DEV CELL, V21, P92, DOI 10.1016/j.devcel.2011.06.017; Matsuda Tomohiro, 2005, Breast Cancer, V12, P279, DOI 10.2325/jbcs.12.279; Medina-Ramirez CM, 2011, CANCER RES, V71, P7705, DOI 10.1158/0008-5472.CAN-11-2192; Mercier I, 2005, CELL DEATH DIFFER, V12, P682, DOI 10.1038/sj.cdd.4401631; Mezosi E, 2004, J CLIN ENDOCR METAB, V89, P250, DOI 10.1210/jc.2003-030697; Minami T, 1998, TOXICOLOGY, V130, P107, DOI 10.1016/S0300-483X(98)00103-6; Moita MAP, 2003, NEURON, V37, P485, DOI 10.1016/S0896-6273(03)00033-3; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; Morgan RJ, 2012, INVEST NEW DRUG, V30, P723, DOI 10.1007/s10637-010-9557-5; Mustafa S, 2008, EUR J NEUROSCI, V28, P323, DOI 10.1111/j.1460-9568.2008.06325.x; Naumovski L, 1996, MOL CELL BIOL, V16, P3884; Navarro-Quiroga I, 2006, J COMP NEUROL, V497, P833, DOI 10.1002/cne.21037; Niedermeyer Ernst, 2011, Am J Electroneurodiagnostic Technol, V51, P82; Ortin I, 2009, BIOORGAN MED CHEM, V17, P8040, DOI 10.1016/j.bmc.2009.10.007; Piccolini VM, 2012, EXP NEUROL, V234, P239, DOI 10.1016/j.expneurol.2011.12.044; Pietropaolo S, 2007, BEHAV PHARMACOL, V18, P533, DOI 10.1097/FBP.0b013e3282da0bf6; Prestia A, 2011, PSYCHIAT RES-NEUROIM, V192, P77, DOI 10.1016/j.pscychresns.2010.12.015; Ramesh G, 2004, KIDNEY INT, V66, pS56, DOI 10.1111/j.1523-1755.2004.09109.x; Rzeski W, 2004, ANN NEUROL, V56, P351, DOI 10.1002/ana.20185; Scoville WB, 2000, J NEUROPSYCH CLIN N, V12, P103; Sehouli J, 2012, ANN ONCOL, V23, P2259, DOI 10.1093/annonc/mdr628; Shabani M, 2012, INT J NEUROSCI, V122, P439, DOI 10.3109/00207454.2012.673515; Shih AY, 2006, J NEUROSCI, V26, P10514, DOI 10.1523/JNEUROSCI.3178-06.2006; SHU SY, 1988, NEUROSCI LETT, V85, P169, DOI 10.1016/0304-3940(88)90346-1; So H, 2008, JARO-J ASSOC RES OTO, V9, P290, DOI 10.1007/s10162-008-0126-y; Soussain C, 2009, LANCET, V374, P1639, DOI 10.1016/S0140-6736(09)61299-X; Tanaka A, 2007, MECH AGEING DEV, V128, P303, DOI 10.1016/j.mad.2007.01.002; Troy L, 2000, PSYCHO-ONCOL, V9, P29, DOI 10.1002/(SICI)1099-1611(200001/02)9:1<29::AID-PON428>3.3.CO;2-Q; Tsuji T, 2009, TOXICOL APPL PHARM, V234, P202, DOI 10.1016/j.taap.2008.09.031; Valente T, 2009, J ALZHEIMERS DIS, V18, P849, DOI 10.3233/JAD-2009-1188; Van der Gucht E, 2006, ANAT REC PART A, V288A, P753, DOI 10.1002/ar.a.20350; van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Vanderwolf CH, 2001, BEHAV BRAIN RES, V127, P25, DOI 10.1016/S0166-4328(01)00354-0; Veena J, 2009, J NEUROSCI RES, V87, P831, DOI 10.1002/jnr.21907; Verstappen CCP, 2003, DRUGS, V63, P1549, DOI 10.2165/00003495-200363150-00003; Vogler M, 2012, CELL DEATH DIFFER, V19, P67, DOI 10.1038/cdd.2011.158; Wakahara K, 2005, J INFECT DIS, V191, P930, DOI 10.1086/428134; Wang GQ, 2001, J BIOL CHEM, V276, P34307, DOI 10.1074/jbc.M103526200; Wang Q, 2012, INT J CLIN EXP PATHO, V5, P555; Wei L, 2010, NEUROSCIENCE, V168, P288, DOI 10.1016/j.neuroscience.2010.03.015; Weiss B, 2008, NEUROTOXICOLOGY, V29, P891, DOI 10.1016/j.neuro.2008.03.009; Werner AB, 2002, J BIOL CHEM, V277, P22781, DOI 10.1074/jbc.M201469200; Whitney Kriscinda A, 2008, J Support Oncol, V6, P313; Xu Y, 2012, CANCER LETT, V314, P232, DOI 10.1016/j.canlet.2011.09.034; Yakovlev AG, 2004, J BIOL CHEM, V279, P28367, DOI 10.1074/jbc.M313526200; Yang FY, 2012, INT J NANOMED, V7, P2573, DOI 10.2147/IJN.S31675; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zhang N, 2005, CELL RES, V15, P749, DOI 10.1038/sj.cr.7290345	113	18	18	0	7	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1029-8428	1476-3524		NEUROTOX RES	Neurotox. Res.	MAY	2014	25	4					369	380		10.1007/s12640-013-9443-y			12	Neurosciences	Neurosciences & Neurology	AE7JH	WOS:000334173200005	24277158	Green Accepted			2021-06-18	
J	Yang, CC; Yuen, KM; Huang, SJ; Hsiao, SH; Tsai, YH; Lin, WC				Yang, Chi-Cheng; Yuen, Kit-Man; Huang, Sheng-Jean; Hsiao, Sheng-Huang; Tsai, Yi-Hsin; Lin, Wei-Chi			"Good-old-days" bias: A prospective follow-up study to examine the preinjury supernormal status in patients with mild traumatic brain injury	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Good-old-days bias; Mild traumatic brain injury; Postconcussion symptoms	MINOR HEAD-INJURY; POST-CONCUSSION SYNDROME; POSTCONCUSSION SYMPTOMS; NONCLINICAL SAMPLE; SEQUELAE; SPECTROSCOPY; EXPECTATION; PERSONALITY; ETIOLOGY; STRESS	Primary objective: Postconcussion symptoms (PCS) are common following mild traumatic brain injury (mTBI). A psychological misperception, the "good-old-days" bias, has been indicated as one of the influencing factors on symptom reporting after injury. To date, this response bias has only been examined in a small number of cross-sectional studies. This study thus prospectively evaluated the "good-old-days" bias in patients with mTBI. Research design: A prospective follow-up study. Method and procedures: Fifty-three patients with mTBI were recruited in this study. The PCS was evaluated by the modified Checklist of Postconcussion Symptoms (mCPCS) at 1 month post injury. Twenty-five patients were evaluated again at 3 months after injuries. In addition, 53 healthy participants were also evaluated for the PCS, and 23 of them underwent a second evaluation at 2 months after the first one. Main outcomes and results: Patients with mTBI showed significantly higher PCS reporting at 1 month post injury than healthy participants did, but not at 3 months post injury. Consistent with the "good-old-days" bias, patients remarkably underestimated their preinjury PCS at 1 month post injury. Interestingly, our results further revealed that this response bias diminished more at 3 months than at 1 month after mTBI. Conclusions: This study thus might be the first one to prospectively reveal the progression of the "good-old-days" bias in patients with mTBI.	[Yang, Chi-Cheng; Yuen, Kit-Man; Lin, Wei-Chi] Chang Gung Univ, Div Clin Psychol, Coll Med, Taoyuan, Taiwan; [Huang, Sheng-Jean] Natl Taiwan Univ Hosp, Jin Shan Branch, New Taipei City, Taiwan; [Hsiao, Sheng-Huang] Taipei City Hosp, Dept Neurosurg, Taipei, Taiwan; [Hsiao, Sheng-Huang] Natl Yang Ming Univ, Dept Surg, Taipei 112, Taiwan; [Tsai, Yi-Hsin] Far Eastern Mem Hosp, Dept Neurosurg, New Taipei City, Taiwan	Yang, CC (corresponding author), Chang Gung Univ, Div Clin Psychol, Coll Med, Taoyuan, Taiwan.	ccyang@mail.cgu.edu.tw			National Science Council of TaiwanMinistry of Science and Technology, Taiwan [NSC 101-2410-H-182-009-MY2]	This work was supported by the National Science Council of Taiwan [grant number NSC 101-2410-H-182-009-MY2].	Ashwal S, 2006, ARCH PHYS MED REHAB, V87, pS50, DOI 10.1016/j.apmr.2006.07.275; Bazarian JJ, 1999, BRAIN INJURY, V13, P173, DOI 10.1080/026990599121692; Bigler ED, 2004, J INT NEUROPSYCH SOC, V10, P794, DOI 10.1017/S1355617704105146; BINDER LM, 1986, J CLIN EXP NEUROPSYC, V8, P323, DOI 10.1080/01688638608401325; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P432, DOI 10.1080/01688639708403871; BOHNEN N, 1992, J NERV MENT DIS, V180, P683, DOI 10.1097/00005053-199211000-00002; Cohen BA, 2007, AM J NEURORADIOL, V28, P907; Dijkers MP, 2004, ARCH PHYS MED REHAB, V85, pS21, DOI 10.1016/j.apmr.2003.08.119; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; FANN JR, 1995, AM J PSYCHIAT, V152, P1493; Furnham A, 2004, BRIT J PSYCHOL, V95, P149, DOI 10.1348/000712604773952395; Garden N, 2010, NEUROPSYCHOLOGY, V24, P168, DOI 10.1037/a0017431; Gasquoine PG, 1997, NEUROPSYCHOL REV, V7, P77, DOI 10.1023/B:NERV.0000005945.58251.c0; GENTILINI M, 1985, J NEUROL NEUROSUR PS, V48, P137, DOI 10.1136/jnnp.48.2.137; GOUVIER WD, 1992, ARCH CLIN NEUROPSYCH, V7, P193, DOI 10.1016/0887-6177(92)90162-G; Gunstad J, 2004, ARCH CLIN NEUROPSYCH, V19, P391, DOI 10.1016/S0887-6177(03)00073-8; Gunstad J, 2001, J INT NEUROPSYCH SOC, V7, P323, DOI 10.1017/S1355617701733061; Hua M. S, 1986, WORD SEQUENCE LEARNI; Iverson G.L., 2007, BRAIN INJURY MED PRI, P373; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Iverson GL, 2006, ARCH CLIN NEUROPSYCH, V21, P303, DOI 10.1016/j.acn.2005.12.008; Iverson GL, 2010, CLIN NEUROPSYCHOL, V24, P17, DOI 10.1080/13854040903190797; JENNETT B, 1975, LANCET, V1, P480; Kay T., 1993, J HEAD TRAUMA REHABI, V8, P86, DOI [10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kendall E, 1996, NEUROPSYCHOL REHABIL, V6, P101, DOI 10.1080/713755502; Lange RT, 2010, ARCH CLIN NEUROPSYCH, V25, P442, DOI 10.1093/arclin/acq031; Lees-Haley PR, 2001, ARCH CLIN NEUROPSYCH, V16, P689, DOI 10.1016/S0887-6177(00)00092-5; Levin H. S., 1983, PACED AUDITORY UNPUB; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; LISHMAN WA, 1988, BRIT J PSYCHIAT, V153, P460, DOI 10.1192/bjp.153.4.460; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; NEWCOMBE F, 1994, J NEUROL NEUROSUR PS, V57, P709, DOI 10.1136/jnnp.57.6.709; Ruff R, 2005, J HEAD TRAUMA REHAB, V20, P5, DOI 10.1097/00001199-200501000-00003; Ruff R. M., 1996, NEUROPSYCHOLOGY, V6, P371; Rutherford W. H., 1989, MILD HEAD INJURY, P217; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Scheid R, 2006, ARCH NEUROL-CHICAGO, V63, P418, DOI 10.1001/archneur.63.3.418; Smith-Seemiller L, 2003, BRAIN INJURY, V17, P199, DOI 10.1080/0269905021000030823; Sullivan KA, 2012, BRAIN INJURY, V26, P1098, DOI 10.3109/02699052.2012.666367; Vanderploeg RD, 2005, J INT NEUROPSYCH SOC, V11, P228, DOI 10.1017/S1355617705050289; Warriner EM, 2003, J CLIN EXP NEUROPSYC, V25, P904, DOI 10.1076/jcen.25.7.904.16494; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Wood RL, 2004, BRAIN INJURY, V18, P1135, DOI 10.1080/02699050410001675906; World Health Organization, 1992, ICD 10 CLASS MENT BE; Yang CC, 2007, J TRAUMA, V62, P657, DOI 10.1097/01.ta.0000203577.68764.b8; Yuen K. M., 2012, MODIFIED CHECK UNPUB	46	18	18	0	6	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	APR 21	2014	36	4					399	409		10.1080/13803395.2014.903899			11	Psychology, Clinical; Clinical Neurology; Psychology	Psychology; Neurosciences & Neurology	AH0YS	WOS:000335847300006	24702428				2021-06-18	
J	Hoogmartens, O; Heselmans, A; Van de Velde, S; Castren, M; Sjolin, H; Sabbe, M; Aertgeerts, B; Ramaekers, D				Hoogmartens, Olivier; Heselmans, Annemie; Van de Velde, Stijn; Castren, Maaret; Sjolin, Helena; Sabbe, Marc; Aertgeerts, Bert; Ramaekers, Dirk			EVIDENCE-BASED PREHOSPITAL MANAGEMENT OF SEVERE TRAUMATIC BRAIN INJURY: A COMPARATIVE ANALYSIS OF CURRENT CLINICAL PRACTICE GUIDELINES	PREHOSPITAL EMERGENCY CARE			English	Article						practice guidelines; brain injuries; emergency medical services; evidence-based practice; emergency responders	INTENSIVE INSULIN THERAPY; ADVANCED LIFE-SUPPORT; TIDAL CARBON-DIOXIDE; EMERGENCY; CARE; RECOMMENDATIONS; INTUBATION; MORTALITY; QUALITY	Objective. This study appraised the completeness and level of evidence behind prehospital recommendations in clinical practice guidelines (CPGs) for management of severe traumatic brain injury (TBI). Differences and similarities in key recommendations for prehospital emergency care were assessed between current CPGs. Methods. A systematic search identified current evidence-based CPGs for the management of severe TBI. The identified CPGs were screened for prehospital recommendations. Finally, an evaluation of the completeness and level of evidence for each of the identified recommendations was carried out. A review of the literature identified additional evidence. Designs of the retrieved publications were considered and classified according to the GRADE levels of evidence. Results. This study identified 12 current CPGs for the management of patients after traumatic brain injury. Of these, twenty-one prehospital recommendations were selected. Only a few CPGs made recommendations on temperature management and ventilation patterns. Statements on prehospital transport and advanced airway management were common to all of the guidelines. Statements on initial treatment demonstrated the greatest variability. The literature review identified several relevant publications not included in the CPGs even after we controlled for the indicated time-intervals of their literature search. In addition, evidence from more recent trials published outside the search-interval of the clinical practice guidelines was found. Conclusions. The use of current guidelines on traumatic brain injury will not always facilitate decisions about best or most appropriate practice for prehospital practitioners. The amount of recommended prehospital interventions varied considerably, and there was large content variation in prehospital recommendations in these guidelines. Not all evidence was taken into account and not all CPGs were up-to-date.	[Hoogmartens, Olivier; Heselmans, Annemie; Van de Velde, Stijn; Ramaekers, Dirk] Katholieke Univ Leuven, Dept Publ Hlth & Primary Care, Louvain, Belgium; [Castren, Maaret; Sjolin, Helena] Karolinska Inst, Dept Clin Sci & Educ, Stockholm, Sweden; [Castren, Maaret; Sjolin, Helena] Soder Sjukhuset, Sect Emergency Med, S-10064 Stockholm, Sweden; [Sabbe, Marc] Katholieke Univ Leuven Hosp, Dept Emergency Med, Louvain, Belgium; [Aertgeerts, Bert] Katholieke Univ Leuven, Acad Ctr Gen Practice, Louvain, Belgium	Hoogmartens, O (corresponding author), Dept Publ Hlth & Primary Care, Kapucijnenvoer 33,Blok J Box 7001, Louvain, Belgium.	Olivier.hoogmartens@student.kuleuven.be	Heselmans, Annemie/F-1820-2015; Van de Velde, Stijn/F-6449-2013	Heselmans, Annemie/0000-0002-1686-8168; Van de Velde, Stijn/0000-0001-8908-3823	Falck Foundation	Olivier Hoogmartens received a research grant from the Falck Foundation.	Andriessen TMJC, 2011, J NEUROTRAUM, V28, P2019, DOI 10.1089/neu.2011.2034; Atkins D, 2004, BMC HEALTH SERV RES, V4, DOI 10.1186/1472-6963-4-38; Badjatia N, 2008, PREHOSP EMERG CARE, V12, pS1, DOI 10.1080/10903120701732052; Bahtsevani C, 2004, INT J TECHNOL ASSESS, V20, P427, DOI 10.1017/S026646230400131X; Berge LR, 2011, JAMA-J AM MED ASSOC, V305, P203; Bilotta F, 2008, NEUROCRIT CARE, V9, P159, DOI 10.1007/s12028-008-9084-9; Brazier H, 1999, J ACCID EMERG MED, V16, P18; Brouwers MC, 2010, CAN MED ASSOC J, V182, pE839, DOI 10.1503/cmaj.090449; Bulger EM, 2011, ANN SURG, V253, P431, DOI 10.1097/SLA.0b013e3181fcdb22; Bulger EM, 2010, JAMA-J AM MED ASSOC, V304, P1455, DOI 10.1001/jama.2010.1405; Burgers JS, 2002, DIABETES CARE, V25, P1933, DOI 10.2337/diacare.25.11.1933; Care NCCfA, 2007, HEAD INJ TRIAG ASS I, P230; Castren M, 2008, RESUSCITATION, V79, P193, DOI 10.1016/j.resuscitation.2008.07.007; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Coester A, 2010, J TRAUMA, V68, P904, DOI 10.1097/TA.0b013e3181c9afc2; Dewall J, 2010, JEMS, V35, P3; Dewall Jeremy, 2010, JEMS, V35, P54, DOI 10.1016/S0197-2510(10)70095-4; Figgis K, 2010, EMERG MED J, V27, P151, DOI 10.1136/emj.2008.064816; Franschman G, 2009, RESUSCITATION, V80, P1147, DOI 10.1016/j.resuscitation.2009.06.029; Graham R, 2011, CLIN PRACTICE GUIDEL, P266; Grimshaw JM, 2004, HEALTH TECHNOL ASSES, V8, P1, DOI 10.3310/hta8060; Group GW, 2000, GRAD QUAL EV STRENGH; Hemphill C, 2012, UPTODATE; Hoffmann M, 2012, BRIT J SURG, V99, P122, DOI 10.1002/bjs.7707; Hussmann B, 2011, CRIT CARE, V15, DOI 10.1186/cc10442; Iedema R, 2012, BMJ QUAL SAF, V21, P627, DOI 10.1136/bmjqs-2011-000766; Jayaraman S, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003109.pub2; Junpeng M, 2011, COCHRANE DATABASE SY; Kansagara D, 2011, ANN INTERN MED, V154, P268, DOI 10.7326/0003-4819-154-4-201102150-00008; Kett DH, 2011, LANCET INFECT DIS, V11, P181, DOI 10.1016/S1473-3099(10)70314-5; Krinsley JS, 2008, CRIT CARE MED, V36, P3008, DOI 10.1097/CCM.0b013e31818b38d2; Krinsley JS, 2007, CRIT CARE MED, V35, P2262, DOI 10.1097/01.CCM.0000282073.98414.4B; Lee SW, 2009, J TRAUMA, V67, P526, DOI 10.1097/TA.0b013e3181866432; Lenartova L, 2007, WIEN KLIN WOCHENSCHR, V119, P35, DOI 10.1007/s00508-006-0762-3; Lugtenberg M, 2009, QUAL SAF HEALTH CARE, V18, P385, DOI 10.1136/qshc.2008.028043; National Guideline C, 2008, NURS MAN AD SEV TRAU; [NSW dept. NSWGH], 2011, CLIN PRACT GUID; NZGG, 2006, TRAUM BRAIN INJ DIAG; Oxman AD, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a2530; Perel P, 2012, HEALTH TECHNOL ASSES, V16, P1, DOI 10.3310/hta16130; Perel P, 2012, COCHRANE DB SYST REV, V6; Perel P, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007877.pub2; Roberts I, 2011, COCHRANE DATABASE SY; Rusticali B, 2008, MINERVA ANESTESIOL, V74, P583; Ryynanen OP, 2010, SCAND J TRAUMA RESUS, V18, DOI 10.1186/1757-7241-18-62; Sacco Frank, 2004, Alaska Med, V46, P58; Schneider SM, 2010, J EMERG NURS, V36, P330, DOI 10.1016/j.jen.2010.06.013; Shima Katsuji, 2010, Asian J Neurosurg, V5, P15; [SIGN (SIGN) SIGN], 2009, NAT CLIN GUID, P78; Silvestri S, 2005, ANN EMERG MED, V45, P497, DOI 10.1016/j.annemergmed.2004.09.014; Simera I, 2010, EUR J CLIN INVEST, V40, P35, DOI 10.1111/j.1365-2362.2009.02234.x; Stiell IG, 2008, CAN MED ASSOC J, V178, P1141, DOI 10.1503/cmaj.071154; Timmons SD, 2011, J TRAUMA, V71, P1172, DOI 10.1097/TA.0b013e31822b0f4b; Van de Velde S, 2011, BMJ QUAL SAF, V20, P747, DOI 10.1136/bmjqs.2010.045435; Wang HE, 2013, EMERG MED J; Williamson B, SYNAPSE GLOBAL PHASE; Wright D, PROTECT PROGESTERONE	57	18	20	0	8	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1090-3127	1545-0066		PREHOSP EMERG CARE	Prehosp. Emerg. Care	APR-JUN	2014	18	2					265	273		10.3109/10903127.2013.856506			9	Emergency Medicine; Public, Environmental & Occupational Health	Emergency Medicine; Public, Environmental & Occupational Health	AD2WU	WOS:000333098000014	24401184				2021-06-18	
J	Kou, ZF; Iraji, A				Kou, Zhifeng; Iraji, Armin			Imaging brain plasticity after trauma	NEURAL REGENERATION RESEARCH			English	Article						traumatic brain injury; brain plasticity; neuroplasticity; neuroimaging; magnetic resonance imaging; fMRI; diffusion tensor imaging	CONTROLLED CORTICAL IMPACT; NETWORK PLASTICITY; NEURAL PLASTICITY; DEFAULT NETWORK; STROKE RECOVERY; FUNCTIONAL MRI; WORKING-MEMORY; INJURY; ACTIVATION; REORGANIZATION	The brain is highly plastic after stroke or epilepsy; however, there is a paucity of brain plasticity investigation after traumatic brain injury (TBI). This mini review summarizes the most recent evidence of brain plasticity in human TBI patients from the perspective of advanced magnetic resonance imaging. Similar to other forms of acquired brain injury, TBI patients also demonstrated both structural reorganization as well as functional compensation by the recruitment of other brain regions. However, the large scale brain network alterations after TBI are still unknown, and the field is still short of proper means on how to guide the choice of TBI rehabilitation or treatment plan to promote brain plasticity. The authors also point out the new direction of brain plasticity investigation.	[Kou, Zhifeng; Iraji, Armin] Wayne State Univ, Dept Biomed Engn, Detroit, MI 48201 USA; [Kou, Zhifeng] Wayne State Univ, Dept Radiol, Detroit, MI 48201 USA	Kou, ZF (corresponding author), Wayne State Univ, Dept Biomed Engn, Detroit, MI 48201 USA.	zhifeng_kou@wayne.edu			Department of DefenseUnited States Department of Defense [W81X-WH-11-1-0493]	The work was supported by the Department of Defense, grant number W81X-WH-11-1-0493.	Baranauskas G, 2001, THEORY NEUROPLASTICI; Black JE, 2004, AM J PSYCHIAT, V161, P742, DOI 10.1176/appi.ajp.161.4.742; Broyd SJ, 2009, NEUROSCI BIOBEHAV R, V33, P279, DOI 10.1016/j.neubiorev.2008.09.002; Budde MD, 2011, BRAIN, V134, P2248, DOI 10.1093/brain/awr161; Calabresi P, 2000, J NEUROSCI, V20, P8443, DOI 10.1523/JNEUROSCI.20-22-08443.2000; Campbell JN, 2012, J NEUROTRAUM, V29, P201, DOI 10.1089/neu.2011.1761; Carey LM, 2007, INT J STROKE, V2, P245, DOI 10.1111/j.1747-4949.2007.00164.x; Chen CJ, 2012, RADIOLOGY, V264, P844, DOI 10.1148/radiol.12112154; Chen HW, 2010, PM&R, V2, pS306, DOI 10.1016/j.pmrj.2010.10.006; Dams-O'Connor K, 2013, J NEUROTRAUM, V30, P2014, DOI 10.1089/neu.2013.3049; Dijkhuizen RM, 2012, TRANSL STROKE RES, V3, P36, DOI 10.1007/s12975-011-0143-8; Eyo UB, 2013, J NEUROIMMUNE PHARM, V8, P494, DOI 10.1007/s11481-013-9434-z; Folkersma H, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-67; Gilbert SJ, 2007, SCIENCE, V317, P43, DOI 10.1126/science.1140801; Hall KD, 2010, BRAIN RES, V1323, P161, DOI 10.1016/j.brainres.2010.01.067; Hampshire A, 2013, SCI REP-UK, V3, DOI 10.1038/srep02972; Hunt RF, 2009, EXP NEUROL, V215, P243, DOI 10.1016/j.expneurol.2008.10.005; Johnson B, 2012, NEUROIMAGE, V59, P511, DOI 10.1016/j.neuroimage.2011.07.081; Jones TA, 2012, J NEUROTRAUM, V29, P1455, DOI 10.1089/neu.2011.2207; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P74, DOI DOI 10.1097/00001199-199309000-00009; Kolb B, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00204; Kou Z, 2014, GLIA IN PRESS; Kou ZF, 2010, J HEAD TRAUMA REHAB, V25, P267, DOI 10.1097/HTR.0b013e3181e54793; Laitinen T, 2010, NEUROIMAGE, V51, P521, DOI 10.1016/j.neuroimage.2010.02.077; Li KM, 2013, HUM BRAIN MAPP, V34, P2494, DOI 10.1002/hbm.22082; Li N, 2014, J NEUROTRAUM, V31, P395, DOI 10.1089/neu.2013.3059; Luft AR, 2004, JAMA-J AM MED ASSOC, V292, P1853, DOI 10.1001/jama.292.15.1853; Maguire EA, 2000, P NATL ACAD SCI USA, V97, P4398, DOI 10.1073/pnas.070039597; Margulies S, 2009, J NEUROTRAUM, V26, P925, DOI [10.1089/neu.2008.0794, 10.1089/neu.2008-0794]; Mattson MP, 2001, THEORY NEUROPLASTICI; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; Meinzer M, 2007, NEUROREHABILITATION, V22, P311; Morgan AT, 2013, BRAIN, V136, P646, DOI 10.1093/brain/aws355; Morris GP, 2013, NEUROBIOL LEARN MEM, V105, P40, DOI 10.1016/j.nlm.2013.07.002; Munoz-Cespedes JM, 2005, NEUROPSYCHOL REV, V15, P169, DOI 10.1007/s11065-005-9178-5; Murphy TH, 2009, NAT REV NEUROSCI, V10, P861, DOI 10.1038/nrn2735; Nakamura T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008220; Ndode-Ekane XE, 2010, NEUROSCIENCE, V166, P312, DOI 10.1016/j.neuroscience.2009.12.002; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Niogi SN, 2010, J HEAD TRAUMA REHAB, V25, P241, DOI 10.1097/HTR.0b013e3181e52c2a; Niogi SN, 2008, BRAIN, V131, P3209, DOI 10.1093/brain/awn247; Nishibe M, 2010, J NEUROTRAUM, V27, P2221, DOI 10.1089/neu.2010.1456; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; Raison CL, 2006, TRENDS IMMUNOL, V27, P24, DOI 10.1016/j.it.2005.11.006; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Richter M, 2008, BRAIN, V131, P1391, DOI 10.1093/brain/awn043; Sacco K, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00146; Staudt M, 2010, SEMIN PERINATOL, V34, P87, DOI 10.1053/j.semperi.2009.10.009; Stevens MC, 2012, BRAIN IMAGING BEHAV, V6, P293, DOI 10.1007/s11682-012-9157-4; Takahashi CD, 2008, BRAIN, V131, P425, DOI 10.1093/brain/awm311; Teskey GC, 2001, THEORY NEUROPLASTICI; Tivarus ME, 2012, BRAIN LANG, V123, P1, DOI 10.1016/j.bandl.2012.06.006; Ungerleider LG, 2002, NEUROBIOL LEARN MEM, V78, P553, DOI 10.1006/nlme.2002.4091; van Bregt DR, 2012, EXP NEUROL, V234, P8, DOI 10.1016/j.expneurol.2011.12.003; Voss HU, 2009, PROG BRAIN RES, V175, P483, DOI 10.1016/S0079-6123(09)17532-5; Yan HQ, 2007, BRAIN RES, V1134, P171, DOI 10.1016/j.brainres.2006.11.087; Yeatman JD, 2013, CORTEX, V49, P301, DOI 10.1016/j.cortex.2011.08.006; Yogarajah M, 2010, BRAIN, V133, P2348, DOI 10.1093/brain/awq175; Yu X, 2012, NEURON, V74, P731, DOI 10.1016/j.neuron.2012.04.024; Zhou IY, 2014, NEUROIMAGE, V84, P1, DOI 10.1016/j.neuroimage.2013.08.037; Zhu DJ, 2014, HUM BRAIN MAPP, V35, P2911, DOI 10.1002/hbm.22373; Zhu DJ, 2013, CEREB CORTEX, V23, P786, DOI 10.1093/cercor/bhs072; Zhuo JC, 2012, NEUROIMAGE, V59, P467, DOI 10.1016/j.neuroimage.2011.07.050	64	18	19	1	22	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	1673-5374	1876-7958		NEURAL REGEN RES	Neural Regen. Res.	APR	2014	9	7					693	700		10.4103/1673-5374.131568			8	Cell Biology; Neurosciences	Cell Biology; Neurosciences & Neurology	AH0KF	WOS:000335807100004	25206874	DOAJ Gold, Green Published			2021-06-18	
J	Seo, JP; Jang, SH				Seo, Jeong Pyo; Jang, Sung Ho			INJURY OF THE SPINOTHALAMIC TRACT IN A PATIENT WITH MILD TRAUMATIC BRAIN INJURY: DIFFUSION TENSOR TRACTOGRAPHY STUDY	JOURNAL OF REHABILITATION MEDICINE			English	Article						spinothalamic tract; diffusion tensor imaging; head trauma, traumatic axonal injury	CENTRAL POSTSTROKE PAIN; PREVALENCE	Objective: To report on a patient found to have injury of the spinothalamic tract on diffusion tensor tractography following traumatic brain injury. Case description: A 29-year-old male patient with head trauma resulting from a pedestrian car accident presented with pain in multiple areas (both subscapular areas, posterior head and neck, both upper trapezius areas, and the right arm and leg). His pain had not improved with various types of conservative management. Results: Evaluations (conventional brain magnetic resonance imaging, electromyography, and whole spine magnetic resonance imaging), performed 2 years after the head trauma, did not reveal any specific abnormality. Fibromyalgia and myofascial pain syndrome were ruled out by physical examination. Injuries of the spinothalamic tracts in both hemispheres were observed on diffusion tensor imaging in terms of the configuration (thinning) and diffusion tensor tractography parameters (decreased fractional anisotropy or tract volume). Conclusion: Some of the pain in the trunk and extremities in this patient could be ascribed to central pain caused by injury of both spinothalamic tracts. We conclude that diffusion tensor tractography provides a useful means of detecting injury of the spinothalamic tract in patients with traumatic brain injury.	[Seo, Jeong Pyo; Jang, Sung Ho] Yeungnam Univ, Coll Med, Dept Phys Med & Rehabil, Taegu 705717, South Korea	Jang, SH (corresponding author), Yeungnam Univ, Coll Med, Dept Phys Med & Rehabil, 317-1 Daemyungdong, Taegu 705717, South Korea.	strokerehab@hanmail.net			DGIST R&D Program of the Ministry of Education, Science and Technology of Korea [14-BD-0401]	This work was supported by the DGIST R&D Program of the Ministry of Education, Science and Technology of Korea (14-BD-0401).	Assaf Y, 2008, J MOL NEUROSCI, V34, P51, DOI 10.1007/s12031-007-0029-0; DeCuypere M, 2012, SURG CLIN N AM, V92, P939, DOI 10.1016/j.suc.2012.04.005; Goto T, 2008, PAIN, V140, P509, DOI 10.1016/j.pain.2008.10.009; Hong JH, 2011, AM J NEURORADIOL, V32, P1358, DOI 10.3174/ajnr.A2497; Hong JH, 2012, EUR NEUROL, V67, P12, DOI 10.1159/000333012; Hong JH, 2010, J REHABIL MED, V42, P979, DOI 10.2340/16501977-0603; Hong JH, 2010, NEUROSCI LETT, V468, P102, DOI 10.1016/j.neulet.2009.10.075; Lincoln N. B., 1998, PHYSIOTHERAPY, V84, P358, DOI DOI 10.1016/S0031-9406(05)61454-X; Meek MF, 2003, MICROSURG, V23, P2, DOI 10.1002/micr.10087; Miller M D, 1993, Fam Pract Res J, V13, P15; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Ofek H, 2007, PAIN, V131, P330, DOI 10.1016/j.pain.2007.06.015; Parker GJM, 2005, PHILOS T R SOC B, V360, P893, DOI 10.1098/rstb.2005.1639; Seghier ML, 2005, J PAIN, V6, P208, DOI 10.1016/j.jpain.2004.11.004; Seo JP, 2013, BRAIN INJURY, V27, P749, DOI 10.3109/02699052.2013.771794; Sherman Kristen Brewer, 2006, Phys Med Rehabil Clin N Am, V17, P473, DOI 10.1016/j.pmr.2005.11.007; Tenovuo O, 2007, PAIN, V131, P241, DOI 10.1016/j.pain.2007.07.003; Walker WC, 2004, J HEAD TRAUMA REHAB, V19, P72, DOI 10.1097/00001199-200401000-00007; Yamada K, 2009, MAGN RESON MED SCI, V8, P165, DOI 10.2463/mrms.8.165	19	18	18	0	1	FOUNDATION REHABILITATION INFORMATION	UPPSALA	TRADGARDSGATAN 14, UPPSALA, SE-753 09, SWEDEN	1650-1977	1651-2081		J REHABIL MED	J. Rehabil. Med.	APR	2014	46	4					374	377		10.2340/16501977-1783			4	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	AE7CR	WOS:000334154800013	24577424	DOAJ Gold			2021-06-18	
J	Koskinen, EA; Hakulinen, U; Brander, AE; Luoto, TM; Ylinen, A; Ohman, JE				Koskinen, E. A.; Hakulinen, U.; Brander, A. E.; Luoto, T. M.; Ylinen, A.; Ohman, J. E.			Clinical correlates of cerebral diffusion tensor imaging findings in chronic traumatic spinal cord injury	SPINAL CORD			English	Article						traumatic spinal cord injury; magnetic resonance imaging; diffusion tensor imaging; degeneration; cerebral white matter	WALLERIAN DEGENERATION; WHITE-MATTER; INTERNATIONAL STANDARDS; CORTICOSPINAL TRACT; CENTRUM SEMIOVALE; PYRAMIDAL TRACT; WATER DIFFUSION; BRAIN-INJURY; DATA SET; CLASSIFICATION	Study design: Prospective clinical case-control study. Objectives: The aim of this study was to use diffusion tensor imaging (DTI) to assess the state of cerebral white matter tracts after spinal cord injury (SCI). The DTI metrics were evaluated in relation to neurological deficits and to the size and level of the spinal cord lesions. Setting: Tampere University Hospital, Tampere, Finland. Methods: Thirty-four patients (n = 34) with clinically complete and incomplete SCI were evaluated using the International Standards for Neurological Classification of Spinal Cord Injury (ISNCSCI). DTI metrics (fractional anisotropy (FA) and apparent diffusion coefficient (ADC)) were calculated for multiple levels along the course of the corticospinal tract. The state of the spinal cord after injury was assessed using conventional magnetic resonance imaging (MRI). DTI parameters were compared with 40 orthopedically injured control subjects. Results: Statistically significant differences in the DTI values between patients and controls were detected in the posterior area of the centrum semiovale. In this area, the FA values were lower in the patients compared with controls (P = 0.008). For patients with clinically complete injury, the difference was even more significant (P= 0.0005). Motor and sensory scores of the ISNCSCI correlated positively with FA and negatively with ADC values of the centrum semiovale. A moderate association was observed between the macroscopic changes in the spinal cord and the DTI abnormalities in the centrum semiovale. Conclusion: In patients with chronic SCI, DTI changes can be observed in the cerebral white matter. These alterations are associated with the clinical state of the patients.	[Koskinen, E. A.; Luoto, T. M.; Ohman, J. E.] Tampere Univ Hosp, Dept Neurosci & Rehabil, Tampere 33521, Finland; [Hakulinen, U.; Brander, A. E.] Pirkanmaa Hosp Dist, Med Imaging Ctr, Dept Radiol, Tampere, Finland; [Hakulinen, U.] Tampere Univ Technol, Dept Elect & Commun Engn, FIN-33101 Tampere, Finland; [Ylinen, A.] Univ Helsinki, Dept Neurol Sci, Helsinki, Finland; [Ylinen, A.] Univ Helsinki, Cent Hosp, Dept Neurol, Helsinki, Finland; [Ohman, J. E.] Univ Tampere, Sch Med, FIN-33101 Tampere, Finland	Koskinen, EA (corresponding author), Tampere Univ Hosp, Dept Neurosci & Rehabil, PL 2000, Tampere 33521, Finland.	eerika.koskinen@uta.fi	Luoto, Teemu/W-6468-2018	Luoto, Teemu/0000-0002-7329-3284; Ohman, Juha/0000-0002-6592-1367	Pirkanmaa Regional Fund of the Finnish Cultural Foundation	We thank our research assistant Anne Simi and our rehabilitation counselors, Raija Pettersson and Eija Vaarala, for their contribution in patient recruitment and our biostatistician Mika Helminen for his assistance in statistical analysis. We are grateful to the Tampere University Hospital staff of the Department of Neuroscience and Rehabilitation and Department of Radiology for their support. This work was supported by funds from the Pirkanmaa Regional Fund of the Finnish Cultural Foundation.	Aoki Y, 2012, J NEUROL NEUROSUR PS, V83, P870, DOI 10.1136/jnnp-2012-302742; Ashley J., 1990, HLTH TRENDS, V1991, P135; Basser PJ, 1995, NMR BIOMED, V8, P333, DOI 10.1002/nbm.1940080707; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI 10.1016/j.jmr.2011.09.022; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Beirowski B, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-6; Buss A, 2004, BRAIN, V127, P34, DOI 10.1093/brain/awh001; Chang Y, 2010, J NEUROTRAUM, V27, P2033, DOI 10.1089/neu.2009.1265; Cohen-Adad J, 2011, NEUROIMAGE, V55, P1024, DOI 10.1016/j.neuroimage.2010.11.089; DeVivo M, 2006, SPINAL CORD, V44, P535, DOI 10.1038/sj.sc.3101958; Freund P, 2011, BRAIN, V134, P1610, DOI 10.1093/brain/awr093; Guleria S, 2008, J NEUROSCI RES, V86, P2271, DOI 10.1002/jnr.21664; Hall KM, 1999, ARCH PHYS MED REHAB, V80, P1471, DOI 10.1016/S0003-9993(99)90260-5; Han BS, 2010, BRAIN RES, V1326, P75, DOI 10.1016/j.brainres.2010.02.050; Henderson LA, 2011, J NEUROSCI, V31, P2630, DOI 10.1523/JNEUROSCI.2717-10.2011; Hsu JL, 2008, NEUROIMAGE, V39, P566, DOI 10.1016/j.neuroimage.2007.09.017; Kakulas B A, 1999, J Spinal Cord Med, V22, P119; Maynard FM, 1997, SPINAL CORD, V35, P266, DOI 10.1038/sj.sc.3100432; Mukherjee P, 2008, AM J NEURORADIOL, V29, P843, DOI 10.3174/ajnr.A1052; Mulcahey MJ, 2012, SPINE, V37, pE797, DOI 10.1097/BRS.0b013e3182470a08; Petersen JA, 2012, J NEUROTRAUM, V29, P1556, DOI 10.1089/neu.2011.2027; Pierpaoli C, 2001, NEUROIMAGE, V13, P1174, DOI 10.1006/nimg.2001.0765; Sen PN, 2005, BIOPHYS J, V89, P2927, DOI 10.1529/biophysj.105.063016; Seo JP, 2012, NEUROSCI LETT, V523, P111, DOI 10.1016/j.neulet.2012.06.053; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Tolonen A, 2007, J REHABIL MED, V39, P622, DOI 10.2340/16501977-0101; Waring WP, 2010, J SPINAL CORD MED, V33, P346, DOI 10.1080/10790268.2010.11689712; Widerstrom-Noga E, 2008, SPINAL CORD, V46, P818, DOI 10.1038/sc.2008.64; Wrigley PJ, 2009, CEREB CORTEX, V19, P224, DOI 10.1093/cercor/bhn072; Yamada K, 2007, J MAGN RESON IMAGING, V26, P519, DOI 10.1002/jmri.21006; YAMAMOTO T, 1989, J NEUROL NEUROSUR PS, V52, P382, DOI 10.1136/jnnp.52.3.382; Zarei M, 2007, J MAGN RESON IMAGING, V25, P48, DOI 10.1002/jmri.20810	32	18	22	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1362-4393	1476-5624		SPINAL CORD	Spinal Cord	MAR	2014	52	3					202	208		10.1038/sc.2013.163			7	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	AC3VX	WOS:000332450500008	24418961	Bronze			2021-06-18	
J	Maier, D; Njoku, I; Schmutzhard, E; Dharsee, J; Doppler, M; Hartl, R; Winkler, AS				Maier, Daniel; Njoku, Innocent, Jr.; Schmutzhard, Erich; Dharsee, Jaffer; Doppler, Magdalena; Haertl, Roger; Winkler, Andrea Sylvia			Traumatic Brain Injury in a Rural and an Urban Tanzanian Hospital-A Comparative, Retrospective Analysis Based on Computed Tomography	WORLD NEUROSURGERY			English	Article						Africa; Brain; Computed tomography; Epidemiology; Radiography; Rural population; Tanzania; Traumatic brain injury	CONSECUTIVE SERIES; NEUROLOGIC DISEASE; PATTERN; DISORDERS; AFRICA	BACKGROUND: In a resource-poor environment such as rural East Africa, expensive medical devices such as computed tomographic (CT) scanners are rare. The CT scanner at the rural Haydom Lutheran Hospital (HLH) in Tanzania therefore offers a unique chance to observe possible differences with urban medical centers in the disease pattern of trauma-related cranial pathologies. The purpose of this study was to compare traumatic brain injuries (TBIs) between a rural and an urban area of Tanzania. METHODS: HLH has 350 beds and one CT scanner. The urban Aga Khan Hospital is a private hospital with 80 beds and one CT scanner. This was a retrospective study. Data of 248 patients at HLH and of 432 patients at Aga Khan Hospital with TBI could be collected. RESULTS: The prevalence of TBI was significantly higher in the rural area compared to the urban area (34.2% vs. 21.9%, P < 0.0001). TBI due to violence was noted to occur more frequently at HLH, whereas road traffic accidents were more frequent at the Aga Khan Hospital. The number of patients showing a normal CT result was significantly higher in the urban area (53.0% vs. 35.9%, P < 0.0001). Bone fractures (35.9% vs. 15.7%, P < 0.0001) and pneumocephalus (6.9% vs. 0.9%, P < 0.0001) were diagnosed significantly more frequently in the rural survey. Soft tissue swelling (11.6% vs. 1.2%, P < 0.0001) and frontal sinus injuries (7.4% vs. 0.4%, P < 0.0001) were observed significantly more often in the urban setting. CONCLUSIONS: This study documents the burden of TBI and the differences in TBI-related CT diagnoses and their incidence between urban and rural areas in Eastern Africa. These results are important as they demonstrate that patients with severe TBI are not a primarily urban concern. Management of TBI should be included in the training curricula for health personnel alike irrespective of whether their workplace is primarily urban or rural.	[Maier, Daniel; Schmutzhard, Erich; Doppler, Magdalena] Med Univ Innsbruck, Dept Neurol, A-6020 Innsbruck, Austria; [Njoku, Innocent, Jr.; Haertl, Roger] New York Presbyterian Hosp, Weill Cornell Med Coll, Dept Neurol Surg, Weill Cornell Brain & Spine Ctr, New York, NY 10032 USA; [Dharsee, Jaffer] Aga Khan Hosp, Dept Radiol, Dar Es Salaam, Tanzania; [Winkler, Andrea Sylvia] Tech Univ Munich, Klinikum Rechts Isar, Dept Neurol, D-80290 Munich, Germany	Hartl, R (corresponding author), New York Presbyterian Hosp, Weill Cornell Med Coll, Dept Neurol Surg, Weill Cornell Brain & Spine Ctr, New York, NY 10032 USA.	roh9005@med.cornell.edu					Adeleye AO, 2009, NEUROEPIDEMIOLOGY, V32, P136, DOI 10.1159/000182821; Attebery JE, 2010, WORLD NEUROSURG, V73, P290, DOI 10.1016/j.wneu.2010.02.008; Bailey BM, 2012, J TRAUMA ACUTE CARE, V72, P263, DOI 10.1097/TA.0b013e31822a9512; Birbeck GL, 2001, TROP DOCT, V31, P82, DOI 10.1177/004947550103100209; Bouida W, 2013, ANN EMERG MED, V61, P521, DOI 10.1016/j.annemergmed.2012.07.016; Bower JH, 2007, NEUROLOGY, V68, P338, DOI 10.1212/01.wnl.0000252801.61190.e8; Haydom Lutheran Hospital, ANN REP 2007; Hulme P, 2010, PAN AFR MED J, V7; JERET JS, 1993, NEUROSURGERY, V32, P9, DOI 10.1227/00006123-199301000-00002; Maas AIR, 2007, WIEN KLIN WOCHENSCHR, V119, P20, DOI 10.1007/s00508-006-0759-y; Maier D, 2010, WIEN KLIN WOCHENSCHR, V122, P40, DOI 10.1007/s00508-010-1436-8; Moshiro C, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-11; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; Muyembe VM, 1998, E AFR MED J, V75, P364; Ogunseyinde A O, 1999, West Afr J Med, V18, P33; Ohaegbulam Samuel C, 2011, Surg Neurol Int, V2, P182, DOI 10.4103/2152-7806.91137; Otieno T, 2004, INJURY, V35, P1228, DOI 10.1016/j.injury.2004.03.013; Owolabi MO, 2007, ARCH NEUROL-CHICAGO, V64, P1696, DOI 10.1001/archneur.64.12.1696; Winkler AS, 2010, WORLD NEUROSURG, V73, P264, DOI 10.1016/j.wneu.2010.03.037; Winkler AS, 2009, EPILEPSIA, V50, P987, DOI 10.1111/j.1528-1167.2008.01867.x; Winkler AS, 2009, TROP DOCT, V39, P102, DOI 10.1258/td.2008.080144; World Health Organization, 2004, ATL COUNTR RES NEUR, P26; Zellner H, 2010, WIEN KLIN WOCHENSCHR, V122, P47, DOI 10.1007/s00508-010-1437-7	23	18	18	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	MAR-APR	2014	81	3-4					478	482		10.1016/j.wneu.2013.08.014			5	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	AG7EP	WOS:000335581200020	23954733				2021-06-18	
J	Purcell, LK				Purcell, Laura K.			Sport-related concussion: Evaluation and management	PAEDIATRICS & CHILD HEALTH			English	Article						Adolescents; Children; Concussion; Return to learn; Return to play; Sport; Youth	TRAUMATIC BRAIN-INJURY; HIGH-SCHOOL; PROTECTIVE EQUIPMENT; UNITED-STATES; CHILDREN; RECOVERY; PLAY; REHABILITATION; SYMPTOMS; RETURN	Concussion is a common injury among children and adolescents participating in organized sports and recreational activities. Any child or youth who sustains a concussion should be removed from play immediately and medically evaluated as soon as possible. Cognitive and physical rest are recommended to allow symptoms to resolve. Cognitive rest may require temporary school absence and/or a modified class work or homework load. After symptoms have completely resolved at rest and a full return to school is achieved, the student can progress through a medically supervised, stepwise exertion protocol to return to play. Everyone involved in child and youth sports must recognize the signs and symptoms of concussion, and ensure that any child or adolescent suspected of sustaining a concussion is properly evaluated and managed by qualified medical personnel. The present statement replaces a previous Canadian Paediatric Society position statement published in 2006 and revised in 2012.	[Purcell, Laura K.] Canadian Paediat Soc, Hlth Act Living & Sports Med Comm, Ottawa, ON K1G 4J8, Canada	Purcell, LK (corresponding author), Canadian Paediat Soc, 2305 St Laurent Blvd, Ottawa, ON K1G 4J8, Canada.	info@cps.ca	Meijer, Anna/K-5118-2016				Alsalaheen BA, 2010, J NEUROL PHYS THER, V34, P87, DOI 10.1097/NPT.0b013e3181dde568; [Anonymous], 2013, GUIDELINES CONCUSSIO; Benson BW, 2009, BRIT J SPORT MED, V43, pI56, DOI 10.1136/bjsm.2009.058271; Blume HK, 2012, PEDIATR REV, V33, P562, DOI 10.1542/pir.33-12-562; Canadian Pediatric Society, 2006, PAEDIAT CHILD HLTH, V11, P420; Centers for Disease Control and Prevention, 2010, HEADS SCH KNOW YOUR; Collie A, 2003, CLIN J SPORT MED, V13, P28, DOI 10.1097/00042752-200301000-00006; Davis GA, 2014, BRIT J SPORT MED, V48, P98, DOI 10.1136/bjsports-2012-092132; Emery CA, 2006, CLIN J SPORT MED, V16, P20, DOI 10.1097/01.jsm.0000184638.72075.b7; Emery CA, 2010, JAMA-J AM MED ASSOC, V303, P2265, DOI 10.1001/jama.2010.755; Fazio VC, 2007, NEUROREHABILITATION, V22, P207; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Gagnon I, 2009, BRAIN INJURY, V23, P956, DOI 10.3109/02699050903373477; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Hagel B, 2004, CLIN J SPORT MED, V14, P193, DOI 10.1097/00042752-200407000-00001; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Kelly KD, 2001, CLIN J SPORT MED, V11, P77, DOI 10.1097/00042752-200104000-00003; Kirkwood MW, 2008, CLIN NEUROPSYCHOL, V22, P769, DOI 10.1080/13854040701543700; Kirkwood MW, 2009, ACTA PAEDIATR, V98, P1409, DOI 10.1111/j.1651-2227.2009.01448.x; Kirkwood MW, 2006, PEDIATRICS, V117, P1359, DOI 10.1542/peds.2005-0994; Leblanc John C, 2004, Paediatr Child Health, V9, P315; Lovell MR, 2008, CURR SPORT MED REP, V7, P12, DOI 10.1097/01.CSMR.0000308671.45558.e2; Makdissi M, 2013, BRIT J SPORT MED, V47, P308, DOI 10.1136/bjsports-2013-092255; Makdissi M, 2013, BRIT J SPORT MED, V47, P314, DOI 10.1136/bjsports-2013-092256; McCrory P, 2004, BRIT J SPORT MED, V38, P516, DOI 10.1136/bjsm.2004.014811; McCrory P, 2013, CLIN J SPORT MED, V23, P89, DOI 10.1097/JSM.0b013e31828b67cf; McCrory P, 2012, CURR SPORT MED REP, V11, P21, DOI 10.1249/JSR.0b013e3182423bfd; McGrath N, 2010, J ATHL TRAINING, V45, P492, DOI 10.4085/1062-6050-45.5.492; Moser RS, 2012, J PEDIATR-US, V161, P922, DOI 10.1016/j.jpeds.2012.04.012; Moser RS, 2005, NEUROSURGERY, V57, P300, DOI 10.1227/01.NEU.0000166663.98616.E4; Osmond MH, 2010, CAN MED ASSOC J, V182, P341, DOI 10.1503/cmaj.091421; Purcell L, 2009, BRIT J SPORT MED, V43, pI51, DOI 10.1136/bjsm.2009.058214; Purcell LK, 2012, PAED CHILD HEALT-CAN, V17, P36; Russell K, 2010, CAN MED ASSOC J, V182, P333, DOI 10.1503/cmaj.091080; Sady MD, 2011, PHYS MED REH CLIN N, V22, P701, DOI 10.1016/j.pmr.2011.08.008; Sady MD, 2011, PHYS MED REH CLIN N, V22, pix; Sim A, 2008, J NEUROSURG, V108, P511, DOI 10.3171/JNS/2008/108/3/0511; Thompson RS, 1996, NEW ENGL J MED, V335, P1680, DOI 10.1056/NEJM199611283352211	39	18	18	1	14	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	1205-7088	1918-1485		PAED CHILD HEALT-CAN	Paediatr. Child Health	MAR	2014	19	3					153	158		10.1093/pch/19.3.153			6	Pediatrics	Pediatrics	AC6KK	WOS:000332631400012	24665227	Green Published			2021-06-18	
J	Silver, JM				Silver, Jonathan M.			Neuropsychiatry of Persistent Symptoms After Concussion	PSYCHIATRIC CLINICS OF NORTH AMERICA			English	Article						Concussion; Brain injury; Neuropsychiatry; Chronic symptoms	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; RANDOMIZED CONTROLLED-TRIAL; HEART-RATE-VARIABILITY; POSTCONCUSSION SYNDROME; FOLLOW-UP; MAJOR DEPRESSION; RECOVERY; RESONANCE; EXERCISE	A minority of individuals will continue to experience debilitating symptoms for more than several months after sustaining a concussion. These problems may have multiple causes, including persistence of the original concussion symptoms, but they also may be due to factors such as depression and anxiety, physical problems, and psychological issues (including coping with an adverse insurance and legal system). This article reviews the differential diagnosis and treatment strategies for patients with chronic symptoms that persist after a concussion.	NYU, Sch Med, New York, NY 10028 USA	Silver, JM (corresponding author), NYU, Sch Med, 40 East 83rd St,Suite 1E, New York, NY 10028 USA.	jonsilver@gmail.com					Ariely D., 2010, UPSIDE IRRATIONALITY; Ariely D., 2009, PREDICTABLY IRRATION; Azulay J, 2013, J HEAD TRAUMA REHAB, V28, P323, DOI 10.1097/HTR.0b013e318250ebda; Bigler ED, 2011, TXB TRAUMATIC BRAIN, P73, DOI DOI 10.1177/1753193410381840; Binder LM, 1996, AM J PSYCHIAT, V153, P7; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Chamelian L, 2006, J NEUROPSYCH CLIN N, V18, P33, DOI 10.1176/appi.neuropsych.18.1.33; Ciuffreda Kenneth J, 2007, Optometry, V78, P155, DOI 10.1016/j.optm.2006.11.011; Ciuffreda Kenneth J, 2008, Optometry, V79, P18, DOI 10.1016/j.optm.2007.10.004; de Quervain DJF, 2004, SCIENCE, V305, P1254, DOI 10.1126/science.1100735; Deb S, 1999, AM J PSYCHIAT, V156, P374; el Barzouhi A, 2013, NEW ENGL J MED, V368, P999, DOI 10.1056/NEJMoa1209250; FANN JR, 1995, AM J PSYCHIAT, V152, P1493; Gall B, 2004, MED SCI SPORT EXER, V36, P1269, DOI 10.1249/01.MSS.0000135787.73757.4D; Giza CC, 2001, J ATHL TRAINING, V36, P228; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Green Paul, 2007, Phys Med Rehabil Clin N Am, V18, P43, DOI 10.1016/j.pmr.2006.11.002; Green W, 2010, J REHABIL RES DEV, V47, P183, DOI 10.1682/JRRD.2009.04.0041; Gurr B, 2001, BRAIN INJURY, V15, P387, DOI 10.1080/02699050010005904; Hanna-Pladdy B, 2001, CLIN NEUROPSYCHOL, V15, P289, DOI 10.1076/clin.15.3.289.10272; Herrmann N, 2009, J NEUROPSYCH CLIN N, V21, P181, DOI 10.1176/appi.neuropsych.21.2.181; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hou R., 2011, J NEUROL NEUROSUR PS, V83, P217; Jarvik JG, 2003, JAMA-J AM MED ASSOC, V289, P2810, DOI 10.1001/jama.289.21.2810; Jorge RE, 2012, AM J PSYCHIAT, V169, P1284, DOI 10.1176/appi.ajp.2012.12050600; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Kapoor N, 2011, TXB TRAUMATIC BRAIN, P363; Kim N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059382; Koren D, 1999, AM J PSYCHIAT, V156, P367; Lalwani AK, 2011, TXB TRAUMATIC BRAIN, P351; Larson EB, 2013, J INT NEUROPSYCH SOC, V19, P88, DOI 10.1017/S1355617712000999; Leddy JJ, 2013, J HEAD TRAUMA REHAB, V28, P241, DOI 10.1097/HTR.0b013e31826da964; Leddy JJ, 2011, CLIN J SPORT MED, V21, P89, DOI 10.1097/JSM.0b013e3181fdc721; Leddy JJ, 2010, CLIN J SPORT MED, V20, P21, DOI 10.1097/JSM.0b013e3181c6c22c; Lipton ML, 2012, BRAIN IMAGING BEHAV, V6, P329, DOI 10.1007/s11682-012-9175-2; McAllister TW, 2011, TXB TRAUMATIC BRAIN, P239; McCauley SR, 2013, J NEUROTRAUM, V30, P642, DOI 10.1089/neu.2012.2393; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; McCrory P, 2013, CLIN J SPORT MED, V23, P89, DOI 10.1097/JSM.0b013e31828b67cf; Meares S, 2008, J NEUROL NEUROSUR PS, V79, P300, DOI 10.1136/jnnp.2007.126565; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; Paniak C, 2002, J CLIN EXP NEUROPSYC, V24, P187, DOI 10.1076/jcen.24.2.187.999; Pavawalla SP, 2013, J INT NEUROPSYCH SOC, V19, P305, DOI 10.1017/S135561771200135X; Pietrzak RH, 2009, J NERV MENT DIS, V197, P748, DOI 10.1097/NMD.0b013e3181b97a75; Powell JM, 2008, ARCH PHYS MED REHAB, V89, P1550, DOI 10.1016/j.apmr.2007.12.035; Rapoport MJ, 2003, PSYCHOSOMATICS, V44, P31, DOI 10.1176/appi.psy.44.1.31; Satz P, 1998, BRAIN INJURY, V12, P537, DOI 10.1080/026990598122313; Silver JM, 2012, J NEUROL NEUROSUR PS, V83, P836, DOI 10.1136/jnnp-2011-302078; Silver JM, 2009, AM J PSYCHIAT, V166, P653, DOI 10.1176/appi.ajp.2009.08111676; Silverberg ND, 2013, J HEAD TRAUMA REHAB, V28, P250, DOI 10.1097/HTR.0b013e31825ad658; Steele ClaudeM., 2010, WHISTLING VIVALDI OT; Stein MB, 2009, AM J PSYCHIAT, V166, P768, DOI 10.1176/appi.ajp.2009.08101604; Sullivan KA, 2012, J HEAD TRAUMA REHAB, V27, P293, DOI 10.1097/HTR.0b013e31822123ce; Tharion Elizabeth, 2012, Indian J Physiol Pharmacol, V56, P80; Tsanadis J, 2008, CLIN NEUROPSYCHOL, V22, P1080, DOI 10.1080/13854040701796928; Vanderploeg RD, 2013, J HEAD TRAUMA REHAB, V28, P211, DOI 10.1097/HTR.0b013e31828b50db; Vaschillo E, 2002, APPL PSYCHOPHYS BIOF, V27, P1, DOI 10.1023/A:1014587304314; Wade DT, 1998, J NEUROL NEUROSUR PS, V65, P177, DOI 10.1136/jnnp.65.2.177; Whittaker R, 2007, J NEUROL NEUROSUR PS, V78, P644, DOI 10.1136/jnnp.2006.101105; Zasler ND, 2011, TXB TRAUMATIC BRAIN, P375; Zhou YX, 2013, RADIOLOGY, V267, P880, DOI 10.1148/radiol.13122542	63	18	18	0	14	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0193-953X	1558-3147		PSYCHIAT CLIN N AM	Psychiatr. Clin. North Amer.	MAR	2014	37	1					91	+		10.1016/j.psc.2013.11.001			13	Psychiatry	Psychiatry	AD8UM	WOS:000333541200007	24529425				2021-06-18	
J	Wang, KW; Chen, HJ; Lu, K; Liliang, PC; Liang, CL; Tsai, YD; Cho, CL				Wang, Kuo-Wei; Chen, Han-Jung; Lu, Kang; Liliang, Po-Chou; Liang, Cheng-Loong; Tsai, Yu-Duan; Cho, Chung-Lung			Simvastatin Attenuates the Cerebral Vascular Endothelial Inflammatory Response in a Rat Traumatic Brain Injury	ANNALS OF CLINICAL AND LABORATORY SCIENCE			English	Article						Simvastatin; cerebral vascular endothelial inflammatory response; ICAM-1; traumatic brain injury	CIRCULATING MONOCYTES; ADHESION MOLECULES; ARTERY OCCLUSION; STATINS; ATORVASTATIN; PATHOGENESIS; EXPRESSION; ISCHEMIA; MICE	Traumatic brain injury (TBI) leads to important and deleterious inflammation, as evidenced by edema, cytokine production, induction of nitric oxide synthase, and leukocyte infiltration. After TBI, the activation of cerebral vascular endothelial cells plays a crucial role in the pathogenesis of inflammation. In this study, we hypothesized that the activation of cerebral vascular endothelial cells plays a crucial role in the pathogenesis of inflammation and outcome after TBI. It may represent a key cellular target for statin therapy. Methods. In our study, cortical contusions were induced, and the effect of continuous treatment of simvastatin on behavior and inflammation in adult rats following experimental TBI was evaluated. The treatment group received 15 mg/kg of simvastatin daily for 3 days. Neurological function was assessed with the grip test. Results. The results showed that the non-treatment control group had a significantly greater increase in ICAM-1 expression from pre-injury to the post-injury 72 h time point as compared to the expression in treatment group. The treatment group had better neurological function as evidenced in a grip test performed from baseline to 72 h. The analysis of a western blot test and pathology also demonstrated reduced ICAM-1 expression and a smaller area of damage and tissue loss. Conclusion. Our findings suggest that simvastatin could attenuate the activation of cerebral vascular endothelial inflammatory response and decrease the loss of neurological function and brain tissue.	[Wang, Kuo-Wei; Chen, Han-Jung; Lu, Kang; Liliang, Po-Chou; Liang, Cheng-Loong; Tsai, Yu-Duan] I Shou Univ, E Da Hosp, Dept Neurosurg, Kaohsiung, Taiwan; [Cho, Chung-Lung] Natl Sun Yat Sen Univ, Dept Biol Sci, Kaohsiung 804, Taiwan	Cho, CL (corresponding author), Natl Sun Yat Sen Univ, Dept Biol Sci, 70 LienHai Rd, Kaohsiung 804, Taiwan.	q1207@ms8.hinet.net			E-DA hospital [EDAHP 99027]	The study was supported by research program of E-DA hospital. (EDAHP 99027)	Adelson PD, 1997, J NEUROTRAUM, V14, P99, DOI 10.1089/neu.1997.14.99; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; CARLOS TM, 1994, BLOOD, V84, P2068; Chen SF, 2007, LIFE SCI, V81, P288, DOI 10.1016/j.lfs.2007.05.023; Chen XR, 2007, J NEUROTRAUM, V24, P1119, DOI 10.1089/neu.2006.0216; Connolly ES, 1996, J CLIN INVEST, V97, P209, DOI 10.1172/JCI118392; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Greenwood J, 2007, TRENDS IMMUNOL, V28, P88, DOI 10.1016/j.it.2006.12.003; HALL RD, 1974, BRAIN RES, V66, P23, DOI 10.1016/0006-8993(74)90076-6; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; Liao JK, 2005, ANNU REV PHARMACOL, V45, P89, DOI 10.1146/annurev.pharmtox.45.120403.095748; Lu DY, 2007, J NEUROTRAUM, V24, P1132, DOI 10.1089/neu.2007.0288; MATSUO Y, 1994, BRAIN RES, V656, P344, DOI 10.1016/0006-8993(94)91478-8; Pirat A, 2006, ANESTH ANALG, V102, P225, DOI 10.1213/01.ane.0000189554.41095.98; Pleiner J, 2004, CIRCULATION, V110, P3349, DOI 10.1161/01.CIR.0000147774.90396.ED; Qu CS, 2005, J NEUROSURG, V103, P695, DOI 10.3171/jns.2005.103.4.0695; Ray SK, 2002, HISTOL HISTOPATHOL, V17, P1137, DOI 10.14670/HH-17.1137; Rezaie-Majd A, 2003, ARTERIOSCL THROM VAS, V23, P397, DOI 10.1161/01.ATV.0000059384.34874.F0; Rezaie-Majd A, 2002, ARTERIOSCL THROM VAS, V22, P1194, DOI 10.1161/01.ATV.0000022694.16328.CC; Rikitake Y, 2005, CIRC RES, V97, P1232, DOI 10.1161/01.RES.0000196564.18314.23; Scalia R, 2001, CIRCULATION, V103, P2598; Shao HT, 2007, ANN THORAC SURG, V84, P2011, DOI 10.1016/j.athoracsur.2007.07.022; Sheu JR, 2008, YB CHINESE MED PHARM, V26, P161; Tang T, 1996, J CLIN INVEST, V97, P2485, DOI 10.1172/JCI118695; Wang HC, 2007, EXP NEUROL, V206, P59, DOI 10.1016/j.expneurol.2007.03.031; Weber JR, 1995, J NEUROIMMUNOL, V63, P63; Weitz-Schmidt G, 2001, NAT MED, V7, P687, DOI 10.1038/89058	27	18	19	0	3	ASSOC CLINICAL SCIENTISTS	MIDDLEBURY	PO BOX 1287, MIDDLEBURY, VT 05753 USA	0091-7370	1550-8080		ANN CLIN LAB SCI	Ann. Clin. Lab. Sci.	SPR	2014	44	2					145	150					6	Medical Laboratory Technology	Medical Laboratory Technology	AT2HS	WOS:000344755200005	24795052				2021-06-18	
J	Almenar-Queralt, A; Falzone, TL; Shen, ZX; Lillo, C; Killian, RL; Arreola, AS; Niederst, ED; Ng, KS; Kim, SN; Briggs, SP; Williams, DS; Goldstein, LSB				Almenar-Queralt, Angels; Falzone, Tomas L.; Shen, Zhouxin; Lillo, Concepcion; Killian, Rhiannon L.; Arreola, Angela S.; Niederst, Emily D.; Ng, Kheng S.; Kim, Sonia N.; Briggs, Steven P.; Williams, David S.; Goldstein, Lawrence S. B.			UV Irradiation Accelerates Amyloid Precursor Protein (APP) Processing and Disrupts APP Axonal Transport	JOURNAL OF NEUROSCIENCE			English	Article						amyloid precursor protein; APP axonal vesicles; axonal transport; gamma-secretase; kinesin; UV-irradiation	TRAUMATIC BRAIN-INJURY; C-TERMINAL FRAGMENTS; KINESIN LIGHT-CHAIN; BETA-PROTEIN; ALZHEIMERS-DISEASE; GAMMA-SECRETASE; IN-VIVO; GROWTH-FACTOR; DNA-DAMAGE; TRAFFICKING ORGANELLE	Overexpression and/or abnormal cleavage of amyloid precursor protein (APP) are linked to Alzheimer's disease (AD) development and progression. However, the molecular mechanisms regulating cellular levels of APP or its processing, and the physiological and pathological consequences of altered processing are not well understood. Here, using mouse and human cells, we found that neuronal damage induced by UV irradiation leads to specific APP, APLP1, and APLP2 decline by accelerating their secretase-dependent processing. Pharmacological inhibition of endosomal/lysosomal activity partially protects UV-induced APP processing implying contribution of the endosomal and/or lysosomal compartments in this process. We found that a biological consequence of UV-induced gamma-secretase processing of APP is impairment of APP axonal transport. To probe the functional consequences of impaired APP axonal transport, we isolated and analyzed presumptive APP-containing axonal transport vesicles from mouse cortical synaptosomes using electron microscopy, biochemical, and mass spectrometry analyses. We identified a population of morphologically heterogeneous organelles that contains APP, the secretase machinery, molecular motors, and previously proposed and new residents of APP vesicles. These possible cargoes are enriched in proteins whose dysfunction could contribute to neuronal malfunction and diseases of the nervous system including AD. Together, these results suggest that damage-induced APP processing might impair APP axonal transport, which could result in failure of synaptic maintenance and neuronal dysfunction.	[Almenar-Queralt, Angels; Falzone, Tomas L.; Killian, Rhiannon L.; Arreola, Angela S.; Niederst, Emily D.; Ng, Kheng S.; Kim, Sonia N.; Goldstein, Lawrence S. B.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Goldstein, Lawrence S. B.] Univ Calif San Diego, Sch Med, Dept Neurosci, La Jolla, CA 92093 USA; [Lillo, Concepcion; Williams, David S.] Univ Calif San Diego, Dept Pharmacol & Neurosci, La Jolla, CA 92093 USA; [Shen, Zhouxin; Briggs, Steven P.] Univ Calif San Diego, Div Biol Sci, Sect Cell & Dev Biol, La Jolla, CA 92093 USA; [Almenar-Queralt, Angels; Arreola, Angela S.; Kim, Sonia N.; Goldstein, Lawrence S. B.] Sanford Consortium Regenerat Med, La Jolla, CA 92037 USA	Goldstein, LSB (corresponding author), Sanford Consortium Regenerat Med, 2880 Torrey Pines Scen Dr, La Jolla, CA 92037 USA.	lgoldstein@ucsd.edu	Falzone, Tomas/W-2528-2019; Lillo, Concepcion/A-6321-2009; Ng, Ted Kheng Siang/ABI-1863-2020	Lillo, Concepcion/0000-0001-5814-9826; Ng, Ted Kheng Siang/0000-0001-7348-0410; Kim, Sonia Nan/0000-0002-2998-2621; Falzone, Tomas/0000-0002-7984-1149	National Institute on AgingUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01 AG032180]; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG032180, P50AG005131] Funding Source: NIH RePORTER	This study was supported by the National Institute on Aging grant R01 AG032180. We thank Christine Vande Velde and Robert Vassar for providing the VDAC1 and BACE1 antibodies, respectively, and Laurent Taupenot for providing us with SH-SY5Y cells. We also thank Valeria Cavalli for technical expertise with synaptosome fractionations. We are grateful to Eddie Koo and David Kang for providing PSEN1/2 dKO MEFs and PSEN1/2 dKO rescued with PSEN1/2. We also thank Ivan Garcia-Bassets for providing LN-CaP cells and advice with GREAT analysis. We also thank Sol Reyna for her advice on statistical analysis. Finally, we thank Anthony H. Nguyen and Nisha Parmeswar for technical assistance.	Abe N, 2009, J BIOL CHEM, V284, P34628, DOI 10.1074/jbc.M109.035022; AMARATUNGA A, 1995, J NEUROCHEM, V64, P2374; AMARATUNGA A, 1995, J BIOL CHEM, V270, P17268, DOI 10.1074/jbc.270.29.17268; Araki Y, 2003, J BIOL CHEM, V278, P49448, DOI 10.1074/jbc.M306024200; Araki Y, 2007, EMBO J, V26, P1475, DOI 10.1038/sj.emboj.7601609; Beher D, 1999, J NEUROCHEM, V72, P1564, DOI 10.1046/j.1471-4159.1999.721564.x; Brunholz S, 2012, EXP BRAIN RES, V217, P353, DOI 10.1007/s00221-011-2870-1; CAPORASO GL, 1994, J NEUROSCI, V14, P3122; Carey RM, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-30; Cavalli V, 2001, MOL CELL, V7, P421, DOI 10.1016/S1097-2765(01)00189-7; Chen XH, 2004, AM J PATHOL, V165, P357, DOI 10.1016/S0002-9440(10)63303-2; Cirrito JR, 2008, NEURON, V58, P42, DOI 10.1016/j.neuron.2008.02.003; COLE GM, 1989, NEUROCHEM RES, V14, P933, DOI 10.1007/BF00965926; Corrigan F, 2012, BRAIN RES, V1451, P87, DOI 10.1016/j.brainres.2012.02.045; Cuesta A, 2009, FEBS LETT, V583, P2401, DOI 10.1016/j.febslet.2009.06.040; Cuesta A, 2009, BIOCHEM J, V418, P643, DOI 10.1042/BJ20081793; Falzone Tomas L, 2012, Methods Mol Biol, V846, P295, DOI 10.1007/978-1-61779-536-7_25; Falzone TL, 2009, J NEUROSCI, V29, P5758, DOI 10.1523/JNEUROSCI.0780-09.2009; Frykman S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008948; Fu MM, 2013, J CELL BIOL, V202, P495, DOI 10.1083/jcb.201302078; GOLDE TE, 1992, SCIENCE, V255, P728, DOI 10.1126/science.1738847; Goldsbury C, 2006, TRAFFIC, V7, P873, DOI 10.1111/j.1600-0854.2006.00434.x; Goldstein LSB, 2012, PROG NEUROBIOL, V99, P186, DOI 10.1016/j.pneurobio.2012.03.006; Groemer TW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018754; Gunawardena S, 2001, NEURON, V32, P389, DOI 10.1016/S0896-6273(01)00496-2; Haapasalo A, 2011, J ALZHEIMERS DIS, V25, P3, DOI 10.3233/JAD-2011-101065; Hata S, 2009, J BIOL CHEM, V284, P36024, DOI 10.1074/jbc.M109.057497; HUTTNER WB, 1983, J CELL BIOL, V96, P1374, DOI 10.1083/jcb.96.5.1374; Ikin AF, 1996, J BIOL CHEM, V271, P31783, DOI 10.1074/jbc.271.50.31783; Inomata H, 2003, J BIOL CHEM, V278, P22946, DOI 10.1074/jbc.M212160200; Ip YT, 1998, CURR OPIN CELL BIOL, V10, P205, DOI 10.1016/S0955-0674(98)80143-9; Israel MA, 2012, NATURE, V482, P216, DOI 10.1038/nature10821; Jin SM, 2008, CELL DEATH DIFFER, V15, P1375, DOI 10.1038/cdd.2008.49; Jin SM, 2007, CELL DEATH DIFFER, V14, P189, DOI 10.1038/sj.cdd.4402003; Kaether C, 2000, MOL BIOL CELL, V11, P1213, DOI 10.1091/mbc.11.4.1213; Kamal A, 2000, NEURON, V28, P449, DOI 10.1016/S0896-6273(00)00124-0; Kamal A, 2001, NATURE, V414, P643, DOI 10.1038/414643a; Kang DE, 2005, J BIOL CHEM, V280, P31537, DOI 10.1074/jbc.M500833200; Kasa P, 2001, BRAIN RES, V909, P159, DOI 10.1016/S0006-8993(01)02679-8; Kohli BM, 2012, J PROTEOME RES, V11, P4075, DOI 10.1021/pr300123g; Konecna A, 2006, MOL BIOL CELL, V17, P3651, DOI 10.1091/mbc.E06-02-0112; KOO EH, 1994, J BIOL CHEM, V269, P17386; Lazarov O, 2005, J NEUROSCI, V25, P2386, DOI 10.1523/JNEUROSCI.3089-04.2005; Lee PH, 2006, NEUROCHEM RES, V31, P821, DOI 10.1007/s11064-006-9086-y; Leyssen M, 2005, EMBO J, V24, P2944, DOI 10.1038/sj.emboj.7600757; Li L, 2009, NEUROBIOL AGING, V30, P1091, DOI 10.1016/j.neurobiolaging.2007.10.011; Ludwig A, 2009, TRAFFIC, V10, P572, DOI 10.1111/j.1600-0854.2009.00886.x; Lyckman AW, 1998, J BIOL CHEM, V273, P11100, DOI 10.1074/jbc.273.18.11100; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; MarquezSterling NR, 1997, J NEUROSCI, V17, P140; Matsuda S, 2003, J BIOL CHEM, V278, P38601, DOI 10.1074/jbc.M304379200; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Minopoli G, 2007, J BIOL CHEM, V282, P831, DOI 10.1074/jbc.C600276200; Muresan V, 2009, J NEUROSCI, V29, P3565, DOI 10.1523/JNEUROSCI.2558-08.2009; Nikolaev A, 2009, NATURE, V457, P981, DOI 10.1038/nature07767; Nunan J, 2001, EUR J BIOCHEM, V268, P5329, DOI 10.1046/j.0014-2956.2001.02465.x; Oksvold MP, 2002, J CELL SCI, V115, P793; Papp H, 2002, NEUROCHEM INT, V41, P429, DOI 10.1016/S0197-0186(02)00014-1; Reis GF, 2012, MOL BIOL CELL, V23, P1700, DOI 10.1091/mbc.E11-11-0938; Repetto E, 2007, J BIOL CHEM, V282, P31504, DOI 10.1074/jbc.M704273200; ROBERTS GW, 1991, LANCET, V338, P1422, DOI 10.1016/0140-6736(91)92724-G; Rodrigues EM, 2012, HUM MOL GENET, V21, P4587, DOI 10.1093/hmg/dds297; Rosette C, 1996, SCIENCE, V274, P1194, DOI 10.1126/science.274.5290.1194; Rusu P, 2007, EUR J NEUROSCI, V25, P1079, DOI 10.1111/j.1460-9568.2007.05341.x; Satpute-Krishnan P, 2006, P NATL ACAD SCI USA, V103, P16532, DOI 10.1073/pnas.0607527103; SCOTT JN, 1991, MOL BRAIN RES, V10, P315, DOI 10.1016/0169-328X(91)90090-K; Sheng JG, 2003, EXP NEUROL, V184, P1053, DOI 10.1016/j.expneurol.2003.08.018; Shi J, 2000, BRAIN RES, V853, P1, DOI 10.1016/S0006-8993(99)02113-7; Skovronsky DM, 2000, BIOCHEMISTRY-US, V39, P810, DOI 10.1021/bi991728z; Smith DH, 2003, J NEUROSURG, V98, P1072, DOI 10.3171/jns.2003.98.5.1072; Somosy Z, 2000, MICRON, V31, P165, DOI 10.1016/S0968-4328(99)00083-9; Steuble M, 2012, BIOL OPEN, V1, P761, DOI 10.1242/bio.20121578; Steuble M, 2010, PROTEOMICS, V10, P3775, DOI 10.1002/pmic.201000384; Stokin GB, 2005, SCIENCE, V307, P1282, DOI 10.1126/science.1105681; Stokin GB, 2006, ANNU REV BIOCHEM, V75, P607, DOI 10.1146/annurev.biochem.75.103004.142637; Szodorai A, 2009, J NEUROSCI, V29, P14534, DOI 10.1523/JNEUROSCI.1546-09.2009; Szpankowski L, 2012, P NATL ACAD SCI USA, V109, P8582, DOI 10.1073/pnas.1120510109; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Thinakaran G, 2008, J BIOL CHEM, V283, P29615, DOI 10.1074/jbc.R800019200; Tienari PJ, 1996, EMBO J, V15, P5218, DOI 10.1002/j.1460-2075.1996.tb00907.x; Tokuda T, 1996, BIOCHEM BIOPH RES CO, V223, P165, DOI 10.1006/bbrc.1996.0863; Vagnoni A, 2012, HUM MOL GENET, V21, P2845, DOI 10.1093/hmg/dds109; Van den Heuvel C, 1999, EXP NEUROL, V159, P441, DOI 10.1006/exnr.1999.7150; Vogt L, 2001, MOL CELL NEUROSCI, V17, P151, DOI 10.1006/mcne.2000.0937; Volknandt W, 2012, EXP BRAIN RES, V217, P449, DOI 10.1007/s00221-012-3031-x; WEIDEMANN A, 1989, CELL, V57, P115, DOI 10.1016/0092-8674(89)90177-3; Yamazaki T, 1996, J CELL SCI, V109, P999; Zhang H, 2012, J NEUROCHEM, V120, P9, DOI 10.1111/j.1471-4159.2011.07519.x	88	18	18	0	7	SOC NEUROSCIENCE	WASHINGTON	11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA	0270-6474			J NEUROSCI	J. Neurosci.	FEB 26	2014	34	9					3320	3339		10.1523/JNEUROSCI.1503-13.2014			20	Neurosciences	Neurosciences & Neurology	AB8IX	WOS:000332034700020	24573290	Green Published, Bronze			2021-06-18	
J	Shetty, PK; Galeffi, F; Turner, DA				Shetty, Pavan K.; Galeffi, Francesca; Turner, Dennis A.			Nicotinamide pre-treatment ameliorates NAD(H) hyperoxidation and improves neuronal function after severe hypoxia	NEUROBIOLOGY OF DISEASE			English	Article						Nicotinamide; Hypoxia; Brain; Spreading depression; Hippocampus; PARP-1	MITOCHONDRIAL PERMEABILITY TRANSITION; FOCAL CEREBRAL-ISCHEMIA; TRAUMATIC BRAIN-INJURY; NADH HYPEROXIDATION; HIPPOCAMPAL SLICES; OXIDATIVE STRESS; CELL-DEATH; PHARMACOLOGICAL TOOLS; ENERGY-METABOLISM; PROTECTS NEURONS	Prolonged hypoxia leads to irreversible loss of neuronal function and metabolic impairment of nicotinamide adenine dinucleotide recycling (between NAD(+) and NADH) immediately after reoxygenation, resulting in NADH hyperoxidation. We test whether the addition of nicotinamide (to enhance NAD(+) levels) or PARP-1 inhibition (to prevent consumption of NAD(+)) can be effective in improving either loss of neuronal function or hyperoxidation following severe hypoxic injury in hippocampal slices. After severe, prolonged hypoxia (maintained for 3 min after spreading depression) there was hyperoxidation of NADH following reoxygenation, an increased soluble NAD(+)/NADH ratio, loss of neuronal field excitatory post-synaptic potential (fEPSP) and decreased ATP content. Nicotinamide incubation (5 mM) 2 h prior to hypoxia significantly increased total NAD(H) content, improved neuronal recovery, enhanced ATP content, and prevented NADH hyperoxidation. The nicotinamide-induced increase in total soluble NAD(H) was more significant in the cytosolic compartment than within mitochondria. Prolonged incubation with PJ-34 (>1 h) led to enhanced baseline NADH fluorescence prior to hypoxia, as well as improved neuronal recovery, NADH hyperoxidation and ATP content on recovery from severe hypoxia and reoxygenation. In this acute model of severe neuronal dysfunction prolonged incubation with either nicotinamide or PJ-34 prior to hypoxia improved recovery of neuronal function, enhanced NADH reduction and ATP content, but neither treatment restored function when administered during or after prolonged hypoxia and reoxygenation. (C) 2013 Elsevier Inc All rights reserved.	[Shetty, Pavan K.; Galeffi, Francesca; Turner, Dennis A.] Duke Univ, Med Ctr, Res & Surg Serv, VAMC, Durham, NC 27710 USA	Shetty, PK (corresponding author), DUMC, Box 3807, Durham, NC 27710 USA.	shetty.p@duke.edu		Shetty, Pavan/0000-0002-6484-7417	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [RO1AG037599]; VAMC Merit Review Award; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG037599] Funding Source: NIH RePORTER	This research was supported by NIH Grant NIA RO1AG037599 and a VAMC Merit Review Award. We would also like to thank Dr. Shawn Acheson for helpful suggestions regarding this manuscript.	Abdelkarim GE, 2001, INT J MOL MED, V7, P255; Alano CC, 2004, J BIOL CHEM, V279, P18895, DOI 10.1074/jbc.M313329200; Alano CC, 2007, J NEUROSCI RES, V85, P3378, DOI 10.1002/jnr.21479; Alano CC, 2010, J NEUROSCI, V30, P2967, DOI 10.1523/JNEUROSCI.5552-09.2010; Assaly R, 2012, EUR J PHARMACOL, V675, P6, DOI 10.1016/j.ejphar.2011.11.036; Ayoub IA, 1999, NEUROSCI LETT, V259, P21, DOI 10.1016/S0304-3940(98)00881-7; Bai P, 2012, CELL METAB, V16, P290, DOI 10.1016/j.cmet.2012.06.016; Bai P, 2011, CELL METAB, V13, P461, DOI 10.1016/j.cmet.2011.03.004; Canto C, 2012, CELL METAB, V15, P838, DOI 10.1016/j.cmet.2012.04.022; CHANCE B, 1962, SCIENCE, V137, P499, DOI 10.1126/science.137.3529.499; Clark RSB, 2007, J NEUROTRAUM, V24, P1399, DOI 10.1089/neu.2007.0305; DORA E, 1986, ANN NEUROL, V19, P536, DOI 10.1002/ana.410190604; Fiskum G, 2008, ANN NY ACAD SCI, V1147, P129, DOI 10.1196/annals.1427.026; Foster KA, 2005, NEUROSCIENCE, V132, P645, DOI 10.1016/j.neuroscience.2005.01.040; Foster KA, 2008, NEUROBIOL AGING, V29, P598, DOI 10.1016/j.neurobiolaging.2006.11.006; Foster KA, 2006, PROG NEUROBIOL, V79, P136, DOI 10.1016/j.pneurobio.2006.07.001; Ghosh D, 2012, J NEUROSCI, V32, P5821, DOI 10.1523/JNEUROSCI.6192-11.2012; Haar CV, 2011, BEHAV BRAIN RES, V224, P311, DOI 10.1016/j.bbr.2011.06.009; Hoane MR, 2008, OXID MED CELL LONGEV, V1, P46, DOI 10.4161/oxim.1.1.6694; Houtkooper RH, 2012, J CELL BIOL, V199, P205, DOI 10.1083/jcb.201207019; Houtkooper RH, 2012, NAT REV MOL CELL BIO, V13, P225, DOI 10.1038/nrm3293; Kauppinen TM, 2007, NEUROSCIENCE, V145, P1267, DOI 10.1016/j.neuroscience.2006.09.034; Kim SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014731; Kirsch M, 2001, FASEB J, V15, P1569, DOI 10.1096/fj.00-0823hyp; Klaidman L, 2003, PHARMACOLOGY, V69, P150, DOI 10.1159/000072668; KOGURE K, 1980, ANN NEUROL, V8, P278, DOI 10.1002/ana.410080310; Liu D, 2009, NEUROMOL MED, V11, P28, DOI 10.1007/s12017-009-8058-1; Liu D, 2008, ANN NY ACAD SCI, V1147, P275, DOI 10.1196/annals.1427.028; McKenna MC, 2006, BIOCHEM PHARMACOL, V71, P399, DOI 10.1016/j.bcp.2005.10.011; Moroni F, 2001, CELL DEATH DIFFER, V8, P921, DOI 10.1038/sj.cdd.4400884; Paschen W, 2000, J NEUROCHEM, V75, P1675, DOI 10.1046/j.1471-4159.2000.0751675.x; Perez-Pinzon MA, 1998, BRAIN RES, V786, P165, DOI 10.1016/S0006-8993(97)01438-8; Perez-Pinzon MA, 1998, J CEREBR BLOOD F MET, V18, P215, DOI 10.1097/00004647-199802000-00013; Peterson TC, 2012, J NEUROTRAUM, V29, P2823, DOI 10.1089/neu.2012.2471; Pittelli M, 2011, MOL PHARMACOL, V80, P1136, DOI 10.1124/mol.111.073916; ROSENTHAL M, 1995, J CEREBR BLOOD F MET, V15, P655, DOI 10.1038/jcbfm.1995.81; Shetty PK, 2012, NEUROBIOL DIS, V45, P177, DOI 10.1016/j.nbd.2011.08.002; Stein LR, 2012, TRENDS ENDOCRIN MET, V23, P420, DOI 10.1016/j.tem.2012.06.005; Suh SW, 2005, DIABETES, V54, P1452, DOI 10.2337/diabetes.54.5.1452; Yang J, 2002, MINI-REV MED CHEM, V2, P125, DOI 10.2174/1389557024605483; Yang J, 2004, PHARMACOL BIOCHEM BE, V78, P179, DOI 10.1016/j.pbb.2004.03.007; Yang J, 2002, PHARMACOL BIOCHEM BE, V73, P901, DOI 10.1016/S0091-3057(02)00939-5; Yang J, 2002, NEUROSCI LETT, V333, P91, DOI 10.1016/S0304-3940(02)01005-4; Ying WH, 2008, ANTIOXID REDOX SIGN, V10, P179, DOI 10.1089/ars.2007.1672; Ying WH, 2002, J CEREBR BLOOD F MET, V22, P774, DOI 10.1097/00004647-200207000-00002	45	18	20	0	5	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0969-9961	1095-953X		NEUROBIOL DIS	Neurobiol. Dis.	FEB	2014	62						469	478		10.1016/j.nbd.2013.10.025			10	Neurosciences	Neurosciences & Neurology	301SY	WOS:000330553600043	24184921	Green Accepted			2021-06-18	
J	Whealin, JM; Stotzer, RL; Pietrzak, RH; Vogt, D; Shore, J; Morland, L; Southwick, SM				Whealin, Julia M.; Stotzer, Rebecca L.; Pietrzak, Robert H.; Vogt, Dawne; Shore, Jay; Morland, Leslie; Southwick, Steven M.			Deployment-Related Sequelae and Treatment Utilization in Rural and Urban War Veterans in Hawaii	PSYCHOLOGICAL SERVICES			English	Article						military; Pacific Islands; mental health services; mental health access; mental health utilization	POSTTRAUMATIC-STRESS-DISORDER; MENTAL-HEALTH-CARE; TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; SERVICE USE; AFGHANISTAN VETERANS; NATIONAL SAMPLE; SOCIAL SUPPORT; ALCOHOL MISUSE; RISK-FACTORS	This study compared common deployment-related health issues and correlates of mental health service utilization among rural and urban veterans of Operation Enduring Freedom (OEF), Operation Iraqi Freedom (OIF), and Operation New Dawn (OND) living in Hawaii. Frequency of utilization of a broad range of mental health resources, including clergy/spiritual leaders, videoconference/online programs, and traditional/alternative healers, was also characterized. A random sample of 116 rural and 117 urban ethnoracially diverse veterans completed a mail survey. Rural veterans were more likely than urban veterans to meet screening criteria for posttraumatic stress disorder (PTSD), deployment-related concussion with persistent postconcussive symptoms, and alcohol use problems. Over one third of veterans who desired help for a mental health problem reported no current use of any services. Rural veterans were more likely than urban veterans to have accessed Veteran Readjustment Centers, but they did not differ with respect to utilization of other services. Correlates of mental health service utilization included higher education, PTSD, and lower mental-health-related quality of life. Results of this study underscore the need for dissemination efforts to enable OEF/OIF/OND veterans to access mental health resources.	[Whealin, Julia M.] VA Pacific Isl HealthCare Syst, Natl Ctr PTSD, Pacific Isl Div, Honolulu, HI 96819 USA; [Whealin, Julia M.] Univ Hawaii, John A Burns Sch Med, Dept Psychiat, Honolulu, HI 96822 USA; [Stotzer, Rebecca L.] Univ Hawaii, Myron B Thompson Sch Social Work, Honolulu, HI 96822 USA; [Pietrzak, Robert H.] VA Connecticut Healthcare Syst, Natl Ctr Posttraumat Stress Disorder, Clin Neurosci Div, West Haven, CT USA; [Pietrzak, Robert H.] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06520 USA; [Vogt, Dawne] VA Boston Healthcare Syst, Natl Ctr Posttraumat Stress Disorder, Womens Hlth Sci Div, Boston, MA USA; [Vogt, Dawne] Boston Univ, Dept Psychiat, Boston, MA 02215 USA; [Shore, Jay] US Dept Vet Affairs Off Rural Vet, Rural Hlth Resource Ctr Western Reg, Salt Lake City, UT USA; [Shore, Jay] Ctr Amer Indian & Alaska Native Hlth, Dept Psychiat, Denver, CO USA; [Morland, Leslie] VA Pacific Isl HealthCare Syst, Natl Ctr Posttraumat Stress Disorder, Pacific Isl Div, Honolulu, HI 96819 USA; [Morland, Leslie] Univ Hawaii, Sch Med, Dept Psychiat, Honolulu, HI 96822 USA; [Southwick, Steven M.] VA Connecticut Healthcare Syst, Natl Ctr Posttraumat Stress Disorder, Clin Neurosci Div, West Haven, CT USA; [Southwick, Steven M.] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06520 USA	Whealin, JM (corresponding author), VA Pacific Isl HealthCare Syst, Natl Ctr PTSD, 3375 Koapaka St,Suite I-150, Honolulu, HI 96819 USA.	julia.whealin@va.gov	Whealin, Julia/J-8819-2015	Whealin, Julia/0000-0002-2876-6783			ANDERSEN RM, 1995, J HEALTH SOC BEHAV, V36, P1, DOI 10.2307/2137284; Andrews B, 2003, J TRAUMA STRESS, V16, P421, DOI 10.1023/A:1024478305142; Backhaus A, 2012, PSYCHOL SERV, V9, P111, DOI 10.1037/a0027924; Brewin CR, 2000, J CONSULT CLIN PSYCH, V68, P748, DOI 10.1037/0022-006X.68.5.748; Brooks E, 2012, PSYCHIAT SERV, V63, P862, DOI 10.1176/appi.ps.201100444; BUCHSBAUM DG, 1991, ANN INTERN MED, V115, P774, DOI 10.7326/0003-4819-115-10-774; Carlson KF, 2011, J HEAD TRAUMA REHAB, V26, P103, DOI 10.1097/HTR.0b013e3181e50ef1; Cheak-Zamora NC, 2009, QUAL LIFE RES, V18, P727, DOI 10.1007/s11136-009-9483-1; Chermack ST, 2008, MED CARE, V46, P813, DOI 10.1097/MLR.0b013e318178eb08; Cohen BE, 2010, J GEN INTERN MED, V25, P18, DOI 10.1007/s11606-009-1117-3; Corrigan PW, 2007, AUST PSYCHOL, V42, P90, DOI 10.1080/00050060701280573; Courtenay WH, 2011, DYING BE MEN PSYCHOS; Cully JA, 2010, J RURAL HEALTH, V26, P225, DOI 10.1111/j.1748-0361.2010.00294.x; Cully Jeffrey A, 2008, Psychol Serv, V5, P320, DOI 10.1037/a0013719; Dew B, 2007, J RURAL HEALTH, V23, P16, DOI 10.1111/j.1748-0361.2007.00119.x; Dhalla S, 2007, CLIN INVEST MED, V30, P33, DOI 10.25011/cim.v30i1.447; Elhai JD, 2004, PSYCHOL SERV, V1, P111, DOI DOI 10.1037/1541-1559.1.2.111; Elhai JD, 2008, J PSYCHIATR RES, V42, P858, DOI 10.1016/j.jpsychires.2007.09.006; Elhai JD, 2007, J ANXIETY DISORD, V21, P580, DOI 10.1016/j.janxdis.2006.07.001; Ettenhofer ML, 2012, MIL MED, V177, P1272, DOI 10.7205/MILMED-D-12-00095; EWING JA, 1984, JAMA-J AM MED ASSOC, V252, P1905, DOI 10.1001/jama.252.14.1905; Fontana A, 2006, VETERANS AFFAIRS MIL; Fox JC, 2001, COMMUNITY MENT HLT J, V37, P421, DOI 10.1023/A:1017580013197; Girton R., 2011, VA PAC ISL HLTH CAR; Grubaugh AL, 2008, WOMEN HEALTH ISS, V18, P433, DOI 10.1016/j.whi.2008.08.001; Harpaz-Rotem I., 2012, DETERMINANTS P UNPUB; Hawkins EJ, 2010, DRUG ALCOHOL DEPEN, V109, P147, DOI 10.1016/j.drugalcdep.2009.12.025; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Iverson GL, 2009, CLIN NEUROPSYCHOL, V23, P1299, DOI 10.1080/13854040903153902; Jones-Hazledine C., 2006, J RURAL COMMUNITY E, VE9, P1; KANIASTY K, 1995, CURR DIR PSYCHOL SCI, V4, P94, DOI 10.1111/1467-8721.ep10772341; King AC, 2004, J SUBST ABUSE TREAT, V26, P189, DOI 10.1016/S0740-5472(03)00210-1; Lebowitz MS, 2012, PSYCHIAT SERV, V63, P496, DOI 10.1176/appi.ps.201100265; MANGIONE TW, 1998, HDB APPL SOCIAL RES, P399; Milliken CS, 2007, JAMA-J AM MED ASSOC, V298, P2141, DOI 10.1001/jama.298.18.2141; Mohamed S, 2009, PSYCHIAT SERV, V60, P914, DOI 10.1176/appi.ps.60.7.914; Naragon-Gainey K, 2012, PSYCHIAT SERV, V63, P942, DOI 10.1176/appi.ps.201100349; Nelson D. D., EXAMINING SELF UNPUB; OHARE W, 2006, US RURAL SOLDIERS AC; Pole N, 2008, CLIN PSYCHOL-SCI PR, V15, P35, DOI 10.1111/j.1468-2850.2008.00109.x; Proctor S. P., 2011, Journal of Rural Social Sciences (JRSS), V26, P32; Quine S, 2003, Rural Remote Health, V3, P245; Riviere LA, 2011, J NERV MENT DIS, V199, P199, DOI 10.1097/NMD.0b013e31820caee4; Roberts RO, 1996, J CLIN EPIDEMIOL, V49, P989, DOI 10.1016/0895-4356(96)00143-6; Rost K, 1993, J Rural Health, V9, P57, DOI 10.1111/j.1748-0361.1993.tb00495.x; Santa Ana EJ, 2013, PSYCHOL SERV, V10, P304, DOI 10.1037/a0026511; Sareen J, 2007, ARCH GEN PSYCHIAT, V64, P843, DOI 10.1001/archpsyc.64.7.843; Sayer NA, 2007, J TRAUMA STRESS, V20, P15, DOI 10.1002/jts.20182; Seal KH, 2007, ARCH INTERN MED, V167, P476, DOI 10.1001/archinte.167.5.476; Seal KH, 2011, DRUG ALCOHOL DEPEN, V116, P93, DOI 10.1016/j.drugalcdep.2010.11.027; Seal KH, 2009, AM J PUBLIC HEALTH, V99, P1651, DOI 10.2105/AJPH.2008.150284; Spoont MR, 2009, J TRAUMA STRESS, V22, P648, DOI 10.1002/jts.20470; Stecker T, 2007, PSYCHIAT SERV, V58, P1358, DOI 10.1176/appi.ps.58.10.1358; Steele Leah S, 2007, Healthc Policy, V3, P96; Stotzer R, 2012, ADV SOCIAL WORK, V13, P1; Struening FL, 2001, PSYCHIATR SERV, V52, P1633; Tanielian T. L., 2008, INVISIBLE WOUNDS WAR, V1, DOI [10.1037/e527612010-001, DOI 10.1037/E527612010-001]; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; U.S. Department of Health and Human Services, 2011, FIN DAT COLL STAND R; U.S. Department of Veterans Affairs, 2012, COMM PROV TOOLK; *USDA, 2000, RUR URB COMM AR COD; Vogt D, 2011, PSYCHIAT SERV, V62, P135, DOI 10.1176/ps.62.2.pss6202_0135; Wallace AE, 2006, PSYCHIAT SERV, V57, P851, DOI 10.1176/appi.ps.57.6.851; Weathers FW, 1999, PSYCHOL ASSESSMENT, V11, P124, DOI 10.1037/1040-3590.11.2.124; Weeks WB, 2005, J HEALTHC MANAG, V50, P95; Weeks WB, 2004, AM J PUBLIC HEALTH, V94, P1762, DOI 10.2105/AJPH.94.10.1762; Weg MWV, 2012, AM J ADDICTION, V21, P31, DOI 10.1111/j.1521-0391.2011.00191.x; West AN, 2010, J RURAL HEALTH, V26, P301, DOI 10.1111/j.1748-0361.2010.00298.x; Williams EC, 2012, J RURAL HEALTH, V28, P202, DOI 10.1111/j.1748-0361.2011.00389.x	69	18	18	0	10	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	1541-1559	1939-148X		PSYCHOL SERV	Psychol. Serv.	FEB	2014	11	1					114	123		10.1037/a0032782			10	Psychology, Clinical	Psychology	AB6AL	WOS:000331869700013	24099457				2021-06-18	
J	Del Turco, D; Schlaudraff, J; Bonin, M; Deller, T				Del Turco, Domenico; Schlaudraff, Jessica; Bonin, Michael; Deller, Thomas			Upregulation of APP, ADAM10 and ADAM17 in the Denervated Mouse Dentate Gyrus	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; TRAUMATIC BRAIN-INJURY; ENTORHINAL CORTEX LESION; BETA-SECRETASE ACTIVITY; RAT FASCIA-DENTATA; ALZHEIMERS-DISEASE; ALPHA-SECRETASE; REACTIVE ASTROCYTES; TRANSGENIC MICE; FAMILY-MEMBERS	The disintegrin and metalloproteinases ADAM10 and ADAM17 are regarded as the most important alpha-secretases involved in the physiological processing of amyloid precursor protein (APP) in brain. Since it has been suggested that processing of APP by alpha-secretases could be involved in the reorganization of the brain following injury, we studied mRNA expression of the two alpha-secretases Adam10 and Adam17, the beta-secretase Bace1, and the App-gene family (App, Aplp1, Aplp2) in the dentate gyrus of the mouse following entorhinal denervation. Using laser microdissection, tissue was harvested from the outer molecular layer and the granule cell layer of the denervated dentate gyrus. Expression levels of candidate genes were assessed using Affymetrix GeneChip Mouse Gene 1.0 ST arrays and reverse transcription-quantitative PCR, revealing an upregulation of Adam10 mRNA and Adam17 mRNA in the denervated outer molecular layer and an upregulation of Adam10 mRNA and App mRNA in the dentate granule cell layer. Immunolabeling for ADAM10 or ADAM17 in combination with markers for astro- and microglia revealed an increased labeling of ADAM10 and ADAM17 in the denervated outer molecular layer that was associated with reactive astrocytes but not with microglia. Collectively, these data show that denervation affects the expression level of APP and its two most important alpha-secretases. This suggests that APP-processing could be shifted towards the non-amyloidogenic pathway in denervated areas of the brain and, thus, towards the formation of neuroprotective APP cleavage products, such as APPs alpha.	[Del Turco, Domenico; Schlaudraff, Jessica; Deller, Thomas] Goethe Univ Frankfurt, Inst Clin Neuroanat, Ctr Neurosci, D-60054 Frankfurt, Germany; [Bonin, Michael] Univ Tubingen, Dept Med Genet, Inst Human Genet, Tubingen, Germany	Del Turco, D (corresponding author), Goethe Univ Frankfurt, Inst Clin Neuroanat, Ctr Neurosci, D-60054 Frankfurt, Germany.	DelTurco@em.uni-frankfurt.de			Deutsche ForschungsgemeinschaftGerman Research Foundation (DFG) [DE 551/11-1, DE 551/11-2]	The grant sponsor was Deutsche Forschungsgemeinschaft (http://www.dfg.de), Grant number: DE 551/11-1; DE 551/11-2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aydin D, 2012, EXP BRAIN RES, V217, P423, DOI 10.1007/s00221-011-2861-2; Bell KFS, 2008, NEUROBIOL AGING, V29, P554, DOI 10.1016/j.neurobiolaging.2006.11.004; Burbach GJ, 2003, J NEUROSCI METH, V131, P83, DOI 10.1016/S0165-0270(03)00232-2; Copanaki E, 2010, MOL CELL NEUROSCI, V44, P386, DOI 10.1016/j.mcn.2010.04.007; Corrigan F, 2012, J NEUROCHEM, V122, P208, DOI 10.1111/j.1471-4159.2012.07761.x; Corrigan F, 2012, BRAIN RES, V1451, P87, DOI 10.1016/j.brainres.2012.02.045; Corrigan F, 2012, NEUROSCI LETT, V515, P50, DOI 10.1016/j.neulet.2012.03.017; Del Turco D, 2003, HIPPOCAMPUS, V13, P685, DOI 10.1002/hipo.10118; Deller T, 1997, PROG NEUROBIOL, V53, P687, DOI 10.1016/S0301-0082(97)00044-0; Deller T, 2000, ANN NY ACAD SCI, V911, P207; Deller T, 2007, PROG BRAIN RES, V163, P501, DOI 10.1016/S0079-6123(07)63027-1; Endres K, 2012, EXP BRAIN RES, V217, P343, DOI 10.1007/s00221-011-2885-7; Fahrenholz F, 2007, CURR ALZHEIMER RES, V4, P412, DOI 10.2174/156720507781788837; Fahrenholz F, 2006, NEURODEGENER DIS, V3, P255, DOI 10.1159/000095264; Fahrenholz F, 2010, NEURODEGENER DIS, V7, P190, DOI 10.1159/000295662; Faissner A, 2010, BRAIN RES REV, V63, P26, DOI 10.1016/j.brainresrev.2010.01.001; Finsen B, 1999, ADV EXP MED BIOL, V468, P157; Fluhrer R, 2003, J BIOL CHEM, V278, P5531, DOI 10.1074/jbc.M211485200; Frank S, 2008, GLIA, V56, P1438, DOI 10.1002/glia.20710; Freese C, 2009, FEBS J, V276, P1568, DOI 10.1111/j.1742-4658.2009.06889.x; GAGE FH, 1988, EXP NEUROL, V102, P2, DOI 10.1016/0014-4886(88)90073-8; GALL C, 1979, J COMP NEUROL, V183, P539, DOI 10.1002/cne.901830306; GOODMAN Y, 1994, EXP NEUROL, V128, P1, DOI 10.1006/exnr.1994.1107; Haas CA, 1999, J NEUROSCI, V19, P9953; Heber S, 2000, J NEUROSCI, V20, P7951; Hiltunen M, 2009, J ALZHEIMERS DIS, V18, P401, DOI 10.3233/JAD-2009-1154; Itoh T, 2009, NEUROL RES, V31, P103, DOI 10.1179/016164108X323771; Jensen MB, 1999, NEUROSCIENCE, V93, P507, DOI 10.1016/S0306-4522(99)00139-6; KAWAJA MD, 1991, NEURON, V7, P1019, DOI 10.1016/0896-6273(91)90346-2; Kogel D, 2012, EXP BRAIN RES, V217, P471, DOI 10.1007/s00221-011-2932-4; MATTSON MP, 1993, NEURON, V10, P243, DOI 10.1016/0896-6273(93)90315-I; MATTSON MP, 1994, J NEUROTRAUM, V11, P3, DOI 10.1089/neu.1994.11.3; Mattson MP, 1999, J NEUROCHEM, V73, P532, DOI 10.1046/j.1471-4159.1999.0730532.x; MORTIMER JA, 1991, INT J EPIDEMIOL, V20, pS28, DOI 10.1093/ije/20.Supplement_2.S28; Muller UC, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006288; Murakami N, 1998, J NEUROTRAUM, V15, P993, DOI 10.1089/neu.1998.15.993; Nielsen HH, 2006, GLIA, V54, P105, DOI 10.1002/glia.20357; O'Brien RJ, 2011, ANNU REV NEUROSCI, V34, P185, DOI 10.1146/annurev-neuro-061010-113613; Obregon D, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1781; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Perea G, 2009, TRENDS NEUROSCI, V32, P421, DOI 10.1016/j.tins.2009.05.001; Postina R, 2004, J CLIN INVEST, V113, P1456, DOI 10.1172/JCI200420864; Postina R, 2012, J NEUROCHEM, V120, P46, DOI 10.1111/j.1471-4159.2011.07459.x; Prinzen C, 2008, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-66; Ramirez MJ, 2001, BRAIN RES, V907, P222, DOI 10.1016/S0006-8993(01)02580-X; Reeves TM, 2003, J NEUROSCI, V23, P10182; Ring S, 2007, J NEUROSCI, V27, P7817, DOI 10.1523/JNEUROSCI.1026-07.2007; Saftig P, 2011, EUR J CELL BIOL, V90, P527, DOI 10.1016/j.ejcb.2010.11.005; Schmued LC, 2005, BRAIN RES, V1035, P24, DOI 10.1016/j.brainres.2004.11.054; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Skovronsky DM, 2001, J NEUROBIOL, V49, P40, DOI 10.1002/neu.1064; Soba P, 2005, EMBO J, V24, P3624, DOI 10.1038/sj.emboj.7600824; Steinbach JP, 1998, CELL DEATH DIFFER, V5, P858, DOI 10.1038/sj.cdd.4400391; STEWARD O, 1994, EXP NEUROL, V129, P103, DOI 10.1006/exnr.1994.1151; STEWARD O, 1993, EXP NEUROL, V124, P167, DOI 10.1006/exnr.1993.1187; STEWARD O, 1991, CEREB CORTEX, V9, P81; Thon N, 2000, EUR J NEUROSCI, V12, P2547, DOI 10.1046/j.1460-9568.2000.00109.x; Thornton E, 2006, BRAIN RES, V1094, P38, DOI 10.1016/j.brainres.2006.03.107; Tian YA, 2010, J BIOL CHEM, V285, P32549, DOI 10.1074/jbc.M110.128439; Turner PR, 2003, PROG NEUROBIOL, V70, P1, DOI 10.1016/S0301-0082(03)00089-3; Uryu K, 2007, EXP NEUROL, V208, P185, DOI 10.1016/j.expneurol.2007.06.018; Van den Heuvel C, 1999, EXP NEUROL, V159, P441, DOI 10.1006/exnr.1999.7150; Van Den Heuvel C, 2007, PROG BRAIN RES, V161, P303, DOI 10.1016/S0079-6123(06)61021-2; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Vassar R, 2011, ALZHEIMERS RES THER, V3, DOI 10.1186/alzrt82; Vassar R, 2009, J NEUROSCI, V29, P12787, DOI 10.1523/JNEUROSCI.3657-09.2009; Vuksic M, 2011, EXP NEUROL, V230, P176, DOI 10.1016/j.expneurol.2011.04.011; Walsh DM, 2007, BIOCHEM SOC T, V35, P416, DOI 10.1042/BST0350416; Wang ZL, 2009, J NEUROSCI, V29, P10788, DOI 10.1523/JNEUROSCI.2132-09.2009; Warren KM, 2012, J NEUROTRAUM, V29, P1922, DOI 10.1089/neu.2012.2383; Yang P, 2006, PROG NEUROBIOL, V79, P73, DOI 10.1016/j.pneurobio.2006.05.001; Zhang H, 2012, J NEUROCHEM, V120, P9, DOI 10.1111/j.1471-4159.2011.07519.x; Zhao J, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-150	73	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e84962	10.1371/journal.pone.0084962			11	Multidisciplinary Sciences	Science & Technology - Other Topics	286IH	WOS:000329460800076	24404197	DOAJ Gold, Green Published			2021-06-18	
J	Bobkova, NV; Medvinskaya, NI; Kamynina, AV; Aleksandrova, IY; Nesterova, IV; Samokhin, AN; Koroev, DO; Filatova, MP; Nekrasov, PV; Abramov, AY; Leonov, SV; Volpina, OM				Bobkova, N. V.; Medvinskaya, N. I.; Kamynina, A. V.; Aleksandrova, I. Y.; Nesterova, I. V.; Samokhin, A. N.; Koroev, D. O.; Filatova, M. P.; Nekrasov, P. V.; Abramov, A. Y.; Leonov, S. V.; Volpina, O. M.			Immunization with either prion protein fragment 95-123 or the fragment-specific antibodies rescue memory loss and neurodegenerative phenotype of neurons in olfactory bulbectomized mice	NEUROBIOLOGY OF LEARNING AND MEMORY			English	Article						Prion; Peptide; Amyloid; Antibody; Bulbectomy; Memory	TRAUMATIC BRAIN-INJURY; ALZHEIMERS-DISEASE; HEAD-INJURY; CEREBROSPINAL-FLUID; ENDOTHELIAL-CELLS; MOUSE MODEL; RISK-FACTOR; IMPAIRMENT; PRPC; LOCALIZATION	Epidemiological studies demonstrated association between head injury (I-II) and the subsequent development of Alzheimer's disease (AD). Certain hallmarks of AD, e.g. amyloid-beta (A beta) containing deposits, may be found in patients following traumatic BI (TBI). Recent studies uncover the cellular prion protein, PrPC, as a receptor for soluble polymeric forms of A beta (sA beta) which are an intermediate of such deposits. We aimed to test the hypothesis that targeting of PrPC can prevent A beta related spatial memory deficits in olfactory bulbectomized (OBX) mice utilized here to resemble some clinical features of AD, such as increased level of A beta, memory loss and deficit of the CNS cholin- and serotonin-ergic systems. We demonstrated that immunization with the a.a. 95-123 fragment of cellular prion (PrP-I) recovered cortical and hippocampus neurons from OBX induced degeneration, rescued spatial memory loss in Morris water maze test and significantly decrease the A beta level in brain tissue of these animals. Affinity purified anti-PrP-I antibodies rescued pre-synaptic biomarker synaptophysin eliciting similar effect on memory of OBX mice, and protected hippocampal neurones from A beta(25-35)-induced toxicity in vitro. Immunization OBX mice with a.a. 200-213 fragment of cellular prion (PrP-II) did not reach a significance in memory protection albeit having similar to PrP-I immunization impact on A beta level in brain tissue. The observed positive effect of targeting the PrP-I by either active or passive immunization on memory of OBX mice revealed the involvement of the PrPC in AD-like pathology induced by olfactory bulbectomy. This OBX model may be a useful tool for mechanistic and preclinical therapeutic investigations into the association between PrPC and AD. (C) 2013 Elsevier Inc. All rights reserved.	[Bobkova, N. V.; Medvinskaya, N. I.; Aleksandrova, I. Y.; Nesterova, I. V.; Samokhin, A. N.; Nekrasov, P. V.; Leonov, S. V.] Russian Acad Sci, Inst Cell Biophys, Pushchino 142292, Russia; [Leonov, S. V.] CDRI, Dept Biol, Chimki 141400, Moscow Region, Russia; [Leonov, S. V.] Moscow Inst Phys & Technol, Inst Pereulok, BioBusiness Incubator, Dolgoprudnyi 141700, Moscow Region, Russia; [Kamynina, A. V.; Koroev, D. O.; Filatova, M. P.; Volpina, O. M.] Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow 117997, Russia; [Abramov, A. Y.] UCL Inst Neurol, Dept Mol Neurosci, London WC1N 3BG, England	Leonov, SV (corresponding author), Russian Acad Sci, Inst Cell Biophys, Ul Inst Skaya 3, Pushchino 142292, Russia.	nbobkova@mail.ru; nmedvinskaya@rambler.ru; aneskaminina@mail.ru; iualex@rambler.ru; nprivat@rambler.ru; sam.alexandre@gmail.com; koroev@mx.ibch.ru; filatova07@mail.ru; pgta01@mail.ru; a.abramov@ucl.ac.uk; sergey.leonov@yahoo.com; volpina@ibch.ru	Abramov, Andrey/AAC-6712-2019; Bobkova, Natalia/D-6379-2015; Leonov, Sergey V/M-5514-2013; Volpina, Olga/P-7454-2017; Samokhin, Alexander/C-4865-2015; Filatova, Margarita/J-1106-2018; Nesterova, Inna/D-2227-2015; Abramov, Andrey Y/H-9053-2012; Kamynina, Anna/R-6461-2016; Nekrasov, Pavel/P-2016-2017	Abramov, Andrey/0000-0002-7646-7235; Leonov, Sergey V/0000-0002-3425-723X; Samokhin, Alexander/0000-0002-3299-4906; Nesterova, Inna/0000-0002-0492-0600; Abramov, Andrey Y/0000-0002-7646-7235; Nekrasov, Pavel/0000-0002-5168-5404; Volpina, Olga/0000-0003-0740-6110; Kamynina, Anna/0000-0002-9107-3891	RASRussian Academy of SciencesRegione Sardegna; Federal Targeted Program "Scientific & Scientific-Pedagogical Human Resources for Innovative Russia" [8128]; RFBRRussian Foundation for Basic Research (RFBR) [13-04-40106-H]	The study was supported with the program RAS "Fundamental sciences to medicine 2009-2013", Federal Targeted Program "Scientific & Scientific-Pedagogical Human Resources for Innovative Russia in 2009-2013" (8128), and RFBR Grant No. 13-04-40106-H.	Abramov AY, 2003, J NEUROSCI, V23, P5088; Aguzzi A, 2010, NAT REV DRUG DISCOV, V9, P237, DOI 10.1038/nrd3050; Aleksandrova IY, 2004, BIOCHEMISTRY-MOSCOW+, V69, P176, DOI 10.1023/B:BIRY.0000018948.04559.ab; Balducci C, 2010, P NATL ACAD SCI USA, V107, P2295, DOI 10.1073/pnas.0911829107; Banks WA, 2009, EXP NEUROL, V218, P162, DOI 10.1016/j.expneurol.2009.04.025; Barry AE, 2011, J NEUROSCI, V31, P7259, DOI 10.1523/JNEUROSCI.6500-10.2011; Bayer TA, 2003, P NATL ACAD SCI USA, V100, P14187, DOI 10.1073/pnas.2332818100; Bobkova N V, 2004, Neurosci Behav Physiol, V34, P671, DOI 10.1023/B:NEAB.0000036005.70153.3b; Bobkova N, 2008, BRAIN RES, V1232, P185, DOI 10.1016/j.brainres.2008.07.036; Bobkova NV, 2001, B EXP BIOL MED+, V131, P427, DOI 10.1023/A:1017907511482; Caetano FA, 2011, J NEUROCHEM, V117, P538, DOI 10.1111/j.1471-4159.2011.07225.x; Calella AM, 2010, EMBO MOL MED, V2, P306, DOI 10.1002/emmm.201000082; Chen SG, 2010, J BIOL CHEM, V285, P26377, DOI 10.1074/jbc.M110.145516; Chung E, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-130; Deane R, 2007, CURR ALZHEIMER RES, V4, P191, DOI 10.2174/156720507780362245; Deli MA, 2000, NEUROREPORT, V11, P3931, DOI 10.1097/00001756-200011270-00064; Desai V, 2008, AM J CLIN NUTR, V88, p855S; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; FORLONI G, 1993, NATURE, V362, P543, DOI 10.1038/362543a0; Franz G, 2003, NEUROLOGY, V60, P1457, DOI 10.1212/01.WNL.0000063313.57292.00; Gimbel DA, 2010, J NEUROSCI, V30, P6367, DOI 10.1523/JNEUROSCI.0395-10.2010; Girl R., 2000, AM J PHYSIOL, V279, pC1772; Gunther EC, 2010, J MOL MED, V88, P331, DOI 10.1007/s00109-009-0568-7; Guo Z, 2000, NEUROLOGY, V54, P1316, DOI 10.1212/WNL.54.6.1316; Han F, 2008, J PHARMACOL EXP THER, V326, P127, DOI 10.1124/jpet.108.137471; Hardy J, 1998, NAT NEUROSCI, V1, P355, DOI 10.1038/1565; Hartman RE, 2002, J NEUROSCI, V22, P10083; Hawkes C, 2003, MOVEMENT DISORD, V18, P364, DOI 10.1002/mds.10379; Hozumi S, 2003, BEHAV BRAIN RES, V138, P9, DOI 10.1016/S0166-4328(02)00183-3; Ikonomovic MD, 2004, EXP NEUROL, V190, P192, DOI 10.1016/j.expneurol.2004.06.011; Jeffrey M, 2004, ANN NEUROL, V55, P781, DOI 10.1002/ana.20093; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Kamynina AV, 2010, J ALZHEIMERS DIS, V21, P249, DOI 10.3233/JAD-2010-091474; Kovacs T, 2004, AGEING RES REV, V3, P215, DOI 10.1016/j.arr.2003.10.003; Kovacs T, 2001, NEUROREPORT, V12, P285, DOI 10.1097/00001756-200102120-00021; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Le Pichon CE, 2008, J COMP NEUROL, V508, P487, DOI 10.1002/cne.21698; Lee HCB, 2003, BIOL PSYCHIAT, V54, P353, DOI 10.1016/S0006-3223(03)00543-2; Loane DJ, 2009, NAT MED, V15, P377, DOI 10.1038/nm.1940; Luukinen H, 1999, NEUROLOGY, V52, P557, DOI 10.1212/WNL.52.3.557; Mallucci GR, 2002, EMBO J, V21, P202, DOI 10.1093/emboj/21.3.202; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; MORTIMER JA, 1985, NEUROLOGY, V35, P264, DOI 10.1212/WNL.35.2.264; MOSER M, 1995, NEURON, V14, P509, DOI 10.1016/0896-6273(95)90307-0; Nakajima A, 2007, J PHARMACOL SCI, V105, P122, DOI 10.1254/jphs.SC0070155; Nemetz PN, 1999, AM J EPIDEMIOL, V149, P32; Nesterova I V, 2008, Neurosci Behav Physiol, V38, P349, DOI 10.1007/s11055-008-0048-5; Nesterova IV, 1997, PROG NEURO-PSYCHOPH, V21, P127, DOI 10.1016/S0278-5846(96)00163-7; Oboznaya MB, 2007, CELL MOL NEUROBIOL, V27, P271, DOI 10.1007/s10571-006-9108-y; Ostrovskaya RU, 2007, J PSYCHOPHARMACOL, V21, P611, DOI 10.1177/0269881106071335; Pankiewicz J, 2006, EUR J NEUROSCI, V23, P2635, DOI 10.1111/j.1460-9568.2006.04805.x; Parkin ET, 2007, P NATL ACAD SCI USA, V104, P11062, DOI 10.1073/pnas.0609621104; Pentzek M, 2007, AGING CLIN EXP RES, V19, P255; Peretz D, 2001, NATURE, V412, P739, DOI 10.1038/35089090; Picard-Hagen N, 2006, J GEN VIROL, V87, P3723, DOI 10.1099/vir.0.81859-0; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Prinz M, 2004, J NEUROSCI, V24, P5974, DOI 10.1523/JNEUROSCI.0122-04.2004; Reuber M, 2001, J NEUROL NEUROSUR PS, V71, P412, DOI 10.1136/jnnp.71.3.412; Rial D, 2009, NEUROSCIENCE, V164, P896, DOI 10.1016/j.neuroscience.2009.09.005; ROBERTS GW, 1994, J NEUROL NEUROSUR PS, V57, P419, DOI 10.1136/jnnp.57.4.419; Roucou X, 2005, J MOL MED, V83, P3, DOI 10.1007/s00109-004-0605-5; Sadowski MJ, 2009, NEUROBIOL DIS, V34, P267, DOI 10.1016/j.nbd.2009.01.013; Sales N, 1998, EUR J NEUROSCI, V10, P2464, DOI 10.1046/j.1460-9568.1998.00258.x; Schwarz A, 2003, NEUROSCI LETT, V350, P187, DOI 10.1016/S0304-3940(03)00907-8; Shyu WC, 2005, J NEUROSCI, V25, P8967, DOI 10.1523/JNEUROSCI.1115-05.2005; Smith C, 2003, NEUROPATH APPL NEURO, V29, P496, DOI 10.1046/j.1365-2990.2003.00488.x; Struble RG, 1998, BRAIN RES, V780, P129, DOI 10.1016/S0006-8993(97)01187-6; Tran HT, 2011, J NEUROSCI, V31, P9513, DOI 10.1523/JNEUROSCI.0858-11.2011; Udenfriend S., 1987, PEPTIDES ANAL SYNTHE, P9; Uryu K, 2002, J NEUROSCI, V22, P446, DOI 10.1523/JNEUROSCI.22-02-00446.2002; Uryu K, 2007, EXP NEUROL, V208, P185, DOI 10.1016/j.expneurol.2007.06.018; Viegas P, 2006, J CELL SCI, V119, P4634, DOI 10.1242/jcs.03222; Volkel D, 2001, TRANSFUSION, V41, P441, DOI 10.1046/j.1537-2995.2001.41040441.x; WARNER MD, 1986, BIOL PSYCHIAT, V21, P116, DOI 10.1016/0006-3223(86)90013-2; White AR, 2003, NATURE, V422, P80, DOI 10.1038/nature01457; Wisniewski T, 2010, BBA-MOL BASIS DIS, V1802, P847, DOI 10.1016/j.bbadis.2010.05.004; Yamamoto T, 1997, BEHAV BRAIN RES, V83, P57, DOI 10.1016/S0166-4328(97)86046-9	77	18	20	0	12	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1074-7427	1095-9564		NEUROBIOL LEARN MEM	Neurobiol. Learn. Mem.	JAN	2014	107						50	64		10.1016/j.nlm.2013.10.019			15	Behavioral Sciences; Neurosciences; Psychology; Psychology, Multidisciplinary	Behavioral Sciences; Neurosciences & Neurology; Psychology	287SK	WOS:000329562300007	24239620				2021-06-18	
J	Coelho, F; Oliveira, AM; Paiva, WS; Freire, FR; Calado, VT; Amorim, RL; Neville, IS; de Andrade, AF; Bor-Seng-Shu, E; Anghinah, R; Teixeira, MJ				Coelho, Fernanda; Oliveira, Arthur Maynart; Paiva, Wellingson Silva; Freire, Fabio Rios; Calado, Vanessa Tome; Amorim, Robson Luis; Neville, Iuri Santana; de Andrade, Almir Ferreira; Bor-Seng-Shu, Edson; Anghinah, Renato; Teixeira, Manoel Jacobsen			Comprehensive cognitive and cerebral hemodynamic evaluation after cranioplasty	NEUROPSYCHIATRIC DISEASE AND TREATMENT			English	Article						cranioplasty; decompressive craniotomy; perfusion CT; traumatic brain injury; cognition; neuropsychological test	SINKING SKIN-FLAP; TRAUMATIC BRAIN-INJURY; BLOOD-FLOW REGULATION; DECOMPRESSIVE CRANIECTOMY; NEUROLOGICAL IMPROVEMENT; INTRACRANIAL-PRESSURE; CT; HEMICRANIECTOMY; RECOVERY; MULTICENTER	Decompressive craniectomy is an established procedure to lower intracranial pressure and can save patients' lives. However, this procedure is associated with delayed cognitive decline and cerebral hemodynamics complications. Studies show the benefits of cranioplasty beyond cosmetic aspects, including brain protection, and functional and cerebrovascular aspects, but a detailed description of the concrete changes following this procedure are lacking. In this paper, the authors report a patient with trephine syndrome who underwent cranioplasty; comprehensive cognitive and cerebral hemodynamic evaluations were performed prior to and following the cranioplasty. The discussion was based on a critical literature review.	[Coelho, Fernanda; Freire, Fabio Rios; Calado, Vanessa Tome; Anghinah, Renato] Univ Sao Paulo, Sch Med, Neurorehabil Grp, Div Neurol, BR-05403010 Sao Paulo, Brazil; [Oliveira, Arthur Maynart; Paiva, Wellingson Silva; Amorim, Robson Luis; Neville, Iuri Santana; de Andrade, Almir Ferreira; Teixeira, Manoel Jacobsen] Univ Sao Paulo, Sch Med, Div Neurosurg, BR-05403010 Sao Paulo, Brazil; [Bor-Seng-Shu, Edson] Univ Sao Paulo, Sch Med, Neurosonol & Cerebral Hemodynam Grp, BR-05403010 Sao Paulo, Brazil	Neville, IS (corresponding author), Univ Sao Paulo, Sch Med, 255 Eneas Aguiar St,Off 4080, BR-05403010 Sao Paulo, Brazil.	iurineville@yahoo.com.br	BOR-SENG-SHU, EDSON/AAC-9762-2019; Amorim, Robson/AAK-1368-2021; Neville, Iuri S/P-5360-2014; Neville, Iuri/AAI-2852-2021; Paiva, Wellingson S/G-5517-2013	BOR-SENG-SHU, EDSON/0000-0002-6713-8974; Amorim, Robson/0000-0003-2391-7519; Neville, Iuri S/0000-0002-8561-9069; Neville, Iuri/0000-0002-8561-9069; Paiva, Wellingson S/0000-0002-5165-7040			Agner C, 2002, ACTA NEUROCHIR, V144, P1033, DOI 10.1007/s00701-002-0996-4; Amorim RL, 2012, J NEURORADIOLOGY, V39, P346, DOI 10.1016/j.neurad.2012.02.006; Bijlenga P, 2007, J NEUROL NEUROSUR PS, V78, P430, DOI 10.1136/jnnp.2006.099242; Bohman LE, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0392-x; Carota A, 2011, EUR NEUROL, V66, P227, DOI 10.1159/000331939; Chibbaro S, 2013, REV NEUROL-FRANCE, V169, P240, DOI 10.1016/j.neurol.2012.06.016; Chibbaro S, 2007, SURG NEUROL, V68, P632, DOI 10.1016/j.surneu.2006.12.046; Chieregato A, 2006, INTENS CARE MED, V32, P1668, DOI 10.1007/s00134-006-0302-7; Cushing H, 1905, SURG GYNECOL OBSTET, V1, P297; de Quintana-Schmidt C, 2011, REV NEUROLOGIA, V52, P661, DOI 10.33588/rn.5211.2010732; Di Stefano C, 2012, BRIT J NEUROSURG, V26, P827, DOI 10.3109/02688697.2012.692838; Erdogan E, 2003, NEUROL INDIA, V51, P479; FARRINGTON P R, 1945, Rocky Mt Med J, V42, P842; Flint AC, 2008, J NEUROTRAUM, V25, P503, DOI 10.1089/neu.2007.0442; FODSTAD H, 1984, ACTA NEUROCHIR, V70, P21, DOI 10.1007/BF01406039; Gottlob Irene, 2002, Strabismus, V10, P271, DOI 10.1076/stra.10.4.271.13830; Grant FC, 1939, ANN SURG, V110, P488, DOI 10.1097/00000658-193910000-00002; GRANTHAM EG, 1948, J NEUROSURG, V5, P19, DOI 10.3171/jns.1948.5.1.0019; Han PY, 2008, J KOREAN NEUROSURG S, V43, P51, DOI 10.3340/jkns.2008.43.1.51; Honeybul S, 2010, J CLIN NEUROSCI, V17, P430, DOI 10.1016/j.jocn.2009.09.007; Honeybul S, 2013, BRIT J NEUROSURG, V27, P636, DOI 10.3109/02688697.2013.817532; Isago T, 2004, ANN PLAS SURG, V53, P288, DOI 10.1097/01.sap.0000106433.89983.72; Jiang JY, 2005, J NEUROTRAUM, V22, P623, DOI 10.1089/neu.2005.22.623; Joseph V, 2009, J NEUROSURG, V111, P650, DOI 10.3171/2009.3.JNS0984; Kemmling A, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-80; KJELLBERG RN, 1971, J NEUROSURG, V34, P488, DOI 10.3171/jns.1971.34.4.0488; KONDZIOLKA D, 1988, NEUROSURGERY, V23, P143, DOI 10.1227/00006123-198808000-00002; Kumar GSS, 2004, NEUROL INDIA, V52, P504; Kuo JR, 2004, J CLIN NEUROSCI, V11, P486, DOI 10.1016/j.jocn.2003.06.005; Langfitt T.W, 1968, CLIN NEUROSURG, V16, P436; Maeshima S, 2005, EUR NEUROL, V53, P164, DOI 10.1159/000086129; Mokri B, 2010, HEADACHE, V50, P1206, DOI 10.1111/j.1526-4610.2010.01715.x; NAKAMURA T, 1980, Neurologia Medico-Chirurgica, V20, P89, DOI 10.2176/nmc.20.89; Ng D, 1997, J CLIN NEUROSCI, V4, P346, DOI 10.1016/S0967-5868(97)90103-X; RICHAUD J, 1985, NEUROCHIRURGIE, V31, P183; ROYALL DR, 1992, J AM GERIATR SOC, V40, P1221, DOI 10.1111/j.1532-5415.1992.tb03646.x; Sakamoto S, 2006, CLIN NEUROL NEUROSUR, V108, P583, DOI 10.1016/j.clineuro.2005.03.012; Sarov M, 2010, STROKE, V41, P560, DOI 10.1161/STROKEAHA.109.568543; Schiffer J, 1997, SURG NEUROL, V47, P231, DOI 10.1016/S0090-3019(96)00376-X; SEGAL DH, 1994, NEUROSURGERY, V34, P729, DOI 10.1227/00006123-199404000-00024; Stiver SI, 2008, J NEUROSURG, V109, P245, DOI 10.3171/JNS/2008/109/8/0245; Stiver SI, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.4.FOCUS0965; Stiver SI, 2008, ACTA NEUROCHIR SUPPL, V102, P273, DOI 10.1007/978-3-211-85578-2_51; STULA D, 1985, NEUROCHIRURGIA, V28, P164; Sugiyama K, 2004, JPN J REHABIL MED, V41, P104; SUZUKI N, 1993, ACTA NEUROCHIR, V122, P49, DOI 10.1007/BF01446986; TABADDOR K, 1976, J NEUROSURG, V44, P506, DOI 10.3171/jns.1976.44.4.0506; Winkler PA, 2000, J NEUROSURG, V93, P53, DOI 10.3171/jns.2000.93.1.0053; YAMAURA A, 1977, Neurologia Medico-Chirurgica, V17, P43, DOI 10.2176/nmc.17pt1.43; Yang Xue-Jun, 2003, Chin J Traumatol, V6, P99; Yoshida K, 1996, J NEUROL NEUROSUR PS, V61, P166, DOI 10.1136/jnnp.61.2.166	51	18	24	0	4	DOVE MEDICAL PRESS LTD	ALBANY	PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND	1178-2021			NEUROPSYCH DIS TREAT	Neuropsychiatr. Dis. Treat.		2014	10						695	701		10.2147/NDT.S52875			7	Clinical Neurology; Psychiatry	Neurosciences & Neurology; Psychiatry	AG3KE	WOS:000335314100001	24833902	DOAJ Gold, Green Published			2021-06-18	
J	Cooper, DB; Vanderploeg, RD; Armistead-Jehle, P; Lewis, JD; Bowles, AO				Cooper, Douglas B.; Vanderploeg, Rodney D.; Armistead-Jehle, Patrick; Lewis, Jeffrey D.; Bowles, Amy O.			Factors associated with neurocognitive performance in OIF/OEF servicemembers with postconcussive complaints in postdeployment clinical settings	JOURNAL OF REHABILITATION RESEARCH AND DEVELOPMENT			English	Article						blast injuries; cognitive complaints; combat veterans; mild traumatic brain injury; neuropsychological assessment; OIF/OEF; performance validity; postconcussive symptoms; postdeployment; posttraumatic stress disorder	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; NEUROPSYCHOLOGICAL STATUS RBANS; SYMPTOM VALIDITY TESTS; REPEATABLE BATTERY; PSYCHOMETRIC PROPERTIES; EVALUATION CONTEXT; OEF/OIF VETERANS; MILITARY SAMPLE; COMBAT VETERANS	Cognitive difficulties are frequently reported by Operation Iraqi Freedom/Operation Enduring Freedom military personnel who sustained mild traumatic brain injuries (TBIs). The current study examined several potential factors that may contribute to self-reported cognitive difficulties in postdeployment clinical settings. Eighty-four subjects who sustained a mild or moderate TBI and reported cognitive difficulties underwent neurocognitive testing. Multiple regression analyses were used to determine the amount of variance in neurocognitive performance accounted for by the predictor variables (demographic, mechanism of injury, time since injury, headache severity, combat stress, postconcussive complaints, and effort/performance validity). The predictor variables collectively accounted for 51.7% of the variance in cognitive performance (F (8,72) = 11/99, p < 0.001). The most potent predictor of cognitive functioning was performance validity/effort, which uniquely accounted for 16.3% of the variance(p < 0.01). Self-reported symptom severity, including postconcussive complaints, combat stress, and headache intensity, accounted for 7.2% of the variance (p < 0.05). Demographic factors and injury characteristics, such as time since injury and mechanism of injury, were not significant predictive factors of cognitive performance. The findings of the current study underscore the need to include measurement of effort as part of neurocognitive evaluation in postdeployment settings when evaluating cognitive complaints associated with mild TBI.	[Cooper, Douglas B.; Vanderploeg, Rodney D.] Def & Vet Brain Injury Ctr, Silver Spring, MD USA; [Cooper, Douglas B.] San Antonio Mil Med Ctr, Dept Neurol, Ft Sam Houston, TX USA; [Vanderploeg, Rodney D.] James A Haley Vet Hosp, Tampa, FL 33612 USA; [Vanderploeg, Rodney D.] Univ S Florida, Dept Psychiat & Neurosci, Tampa, FL USA; [Vanderploeg, Rodney D.] Univ S Florida, Dept Psychol, Tampa, FL 33620 USA; [Armistead-Jehle, Patrick] Munson Army Hlth Ctr, Concuss Clin, Ft Leavenworth, KS USA; [Lewis, Jeffrey D.] NINDS, Behav Neurol Unit, Bethesda, MD 20892 USA; [Bowles, Amy O.] San Antonio Mil Med Ctr, Traumat Brain Injury Serv, Dept Orthoped & Rehabil, Ft Sam Houston, TX USA	Cooper, DB (corresponding author), MCHE MDU DVBIC, San Antonio Mil Med Ctr, Def & Vet Brain Injury Ctr, 3551 Roger Brooke Dr, Jbsa Ft Sam Houston, TX 78234 USA.	douglas.b.cooper.ctr@mail.mil	Armistead-Jehle, Patrick/AAU-5741-2020	Armistead-Jehle, Patrick/0000-0002-6784-1432	DVBIC through Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.	This material was based on work supported in part by the DVBIC through contract support provided by the Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.	Armistead-Jehle P, 2012, ARCH CLIN NEUROPSYCH, V27, P828, DOI 10.1093/arclin/acs086; Armistead-Jehle P, 2011, ARCH CLIN NEUROPSYCH, V26, P592, DOI 10.1093/arclin/acr049; Armistead-Jehle P, 2010, APPL NEUROPSYCHOL, V17, P52, DOI 10.1080/09084280903526182; Beckham JC, 1998, J TRAUMA STRESS, V11, P811, DOI 10.1023/A:1024409903617; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Benge JF, 2009, REHABIL PSYCHOL, V54, P270, DOI 10.1037/a0016736; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; BONNET MH, 1985, PERCEPT MOTOR SKILL, V60, P323, DOI 10.2466/pms.1985.60.1.323; Brenner LA, 2010, J HEAD TRAUMA REHAB, V25, P307, DOI 10.1097/HTR.0b013e3181cada03; Caplan LJ, 2010, J HEAD TRAUMA REHAB, V25, P447, DOI 10.1097/HTR.0b013e3181d5bdbd; Casscells S., 2007, HLTH AFFAIRS MEMORAN; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Cooper DB, 2010, NEUROREHABILITATION, V26, P233, DOI 10.3233/NRE-2010-0559; Defense and Veterans Brain Injury Center, DEP DEF NUMB TRAUM B; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Drag LL, 2012, J INT NEUROPSYCH SOC, V18, P576, DOI 10.1017/S1355617712000203; Edinger JD, 2003, J SLEEP RES, V12, P43, DOI 10.1046/j.1365-2869.2003.00335.x; Gilbertson MW, 2001, J TRAUMA STRESS, V14, P413, DOI 10.1023/A:1011181305501; Green P, 2001, BRAIN INJURY, V15, P1045, DOI 10.1080/02699050110088254; Hart Robert P, 2003, Curr Pain Headache Rep, V7, P116, DOI 10.1007/s11916-003-0021-5; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2006, JAMA-J AM MED ASSOC, V295, P1023, DOI 10.1001/jama.295.9.1023; Horner MD, 2002, NEUROPSYCHOL REV, V12, P15, DOI 10.1023/A:1015439106231; Kalska H, 1999, Appl Neuropsychol, V6, P96, DOI 10.1207/s15324826an0602_5; Kanagaratnam P, 2007, J ANXIETY DISORD, V21, P510, DOI 10.1016/j.janxdis.2006.06.008; Keen SM, 2008, J REHABIL RES DEV, V45, P465, DOI 10.1682/JRRD.2007.09.0138; King D., 1996, NEUROPSYCHOLOGICAL A, P200; Koso M, 2006, EUR PSYCHIAT, V21, P167, DOI 10.1016/j.eurpsy.2005.06.004; Lange RT, 2012, J CLIN EXP NEUROPSYC, V34, P453, DOI 10.1080/13803395.2011.648175; Lapierre CB, 2007, J TRAUMA STRESS, V20, P933, DOI 10.1002/jts.20278; Larson EB, 2013, J INT NEUROPSYCH SOC, V19, P88, DOI 10.1017/S1355617712000999; McCracken LM, 2001, J PAIN SYMPTOM MANAG, V21, P392, DOI 10.1016/S0885-3924(01)00267-6; McCrea M, 2008, MILD TRAUMATIC BRAIN; Mckay C, 2008, CLIN NEUROPSYCHOL, V22, P228, DOI 10.1080/13854040701260370; Meyers JE, 2011, ARCH CLIN NEUROPSYCH, V26, P8, DOI 10.1093/arclin/acq083; MILLER LS, 1991, PSYCHIAT RES, V37, P219, DOI 10.1016/0165-1781(91)90058-W; Moriarty O, 2011, PROG NEUROBIOL, V93, P385, DOI 10.1016/j.pneurobio.2011.01.002; Moss A, 2003, BRAIN INJURY, V17, P377, DOI 10.1080/0269905031000070125; Munoz M, 2005, CLIN J PAIN, V21, P287; Nelson NW, 2010, ARCH CLIN NEUROPSYCH, V25, P713, DOI 10.1093/arclin/acq075; Orff HJ, 2007, SLEEP, V30, P1205, DOI 10.1093/sleep/30.9.1205; Randolph C, 1998, J CLIN EXP NEUROPSYC, V20, P310, DOI 10.1076/jcen.20.3.310.823; Randolph C, 1998, REPEATABLE BATTERY A; Rohling ML, 2011, CLIN NEUROPSYCHOL, V25, P608, DOI 10.1080/13854046.2011.565076; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Silverberg ND, 2007, CLIN NEUROPSYCHOL, V21, P841, DOI 10.1080/13854040600850958; Spencer RJ, 2010, J REHABIL RES DEV, V47, P521, DOI 10.1682/JRRD.2009.11.0181; Vasterling JJ, 2002, NEUROPSYCHOLOGY, V16, P5, DOI 10.1037//0894-4105.16.1.5; Vasterling JJ, 1998, NEUROPSYCHOLOGY, V12, P125, DOI 10.1037/0894-4105.12.1.125; Vasterling JJ, 2002, NEUROPSYCHOLOGY PTSD, P178; Vignola A, 2000, J GERONTOL B-PSYCHOL, V55, pP54; Ware JE, 2000, NEUROLOGY, V54, pA336; West LK, 2011, J NEUROPSYCHOL, V5, P114, DOI 10.1348/174866410X521434; Wilk JE, 2010, J HEAD TRAUMA REHAB, V25, P9, DOI 10.1097/HTR.0b013e3181bd090f	54	18	18	0	7	JOURNAL REHAB RES & DEV	BALTIMORE	DEPT OF VETERANS AFFAIRS REHABIL RES & DEVELOP CTR 103 SOUTH GAY STREET, BALTIMORE, MD 21202-4051 USA	0748-7711	1938-1352		J REHABIL RES DEV	J. Rehabil. Res. Dev.		2014	51	7					1023	1033		10.1682/JRRD.2013.05.0104			11	Rehabilitation	Rehabilitation	AU8JB	WOS:000345841300002	25479335	Bronze			2021-06-18	
J	Cullen, N; Krakowski, A; Taggart, C				Cullen, Nora; Krakowski, Aneta; Taggart, Christina			Early neuropsychological tests as correlates of return to driving after traumatic brain injury	BRAIN INJURY			English	Article						Cognition; driving abilities; neuropsychological; prediction; traumatic brain injury	COMMUNITY INTEGRATION; HEAD-INJURY; REHABILITATION; PERFORMANCE; PREDICTION; ATTENTION; RECOVERY; TRAIL	Objective: To assess the ability of neuropsychometric tests administered during inpatient rehabilitation to predict return to driving after traumatic brain injury (TBI). Design: Retrospective, matched case-controlled study. Methods: Sixty-seven participants with TBI, drawn from an existing database, completed a questionnaire that assessed return to driving post-TBI, as measured by reinstatement of the driver's license. Drivers were individually case-matched to non-drivers on age, Glasgow Coma Scale (GCS), Disability Rating Scale (DRS) and the rehabilitation admission interval (RAI). Scores on four neuropsychological tests (Trail-Making A, Trail Making B, Digit Span-forward and Digit Span-backward), administered during the rehabilitation stay, were compared between case-matched drivers and non-drivers. Outcome measure: Return to driving, as defined by reinstatement of the driver's license. Results: Participants who had returned to driving were comparable to those who had not returned to driving with respect to demographic variables, initial injury severity and baseline functioning. Scores on two neuropsychological assessments were significantly better in participants who had returned to driving than in those who had not: Trail-making A (p<0.01) and Trail-making B (p<0.01). Conclusions: The results suggest that neuropsychological measures of processing speed and cognitive flexibility may predict return to driving after TBI.	[Cullen, Nora; Taggart, Christina] Univ Hlth Network, Toronto Rehabil Inst, Toronto, ON M5G 2A2, Canada; [Cullen, Nora] Univ Toronto, Div Physiatry, Toronto, ON, Canada; [Krakowski, Aneta] Univ Toronto, Dept Med, Toronto, ON, Canada	Cullen, N (corresponding author), Univ Hlth Network, Toronto Rehabil Inst, 550 Univ Ave, Toronto, ON M5G 2A2, Canada.	nora.cullen@uhn.ca		Cullen, Nora/0000-0001-6359-9418	Canada Foundation for InnovationCanada Foundation for InnovationCGIAR; Province of Ontario	The authors thank the staff members of the Toronto Rehabilitation Institute-University Health Network, ABI Service, for their assistance in data collection. The research assistance of Patricia Aznar and Carolyn Go is also gratefully acknowledged. Equipment and space have been funded with grants from the Canada Foundation for Innovation and the Province of Ontario. The views expressed here do not necessarily reflect those of the Ontario Ministry of Health and Long-Term Care.	Bate AJ, 2001, CLIN NEUROPSYCHOL, V15, P405, DOI 10.1076/clin.15.3.405.10279; Boake C, 2001, ARCH PHYS MED REHAB, V82, P761, DOI 10.1053/apmr.2001.23753; Bowie CR, 2006, NAT PROTOC, V1, P2277, DOI 10.1038/nprot.2006.390; Christensen BK, 2008, ARCH PHYS MED REHAB, V89, pS3, DOI 10.1016/j.apmr.2008.10.002; Cicerone K, 2006, J COGNITIVE NEUROSCI, V18, P1212, DOI 10.1162/jocn.2006.18.7.1212; Cifu DX, 1997, ARCH PHYS MED REHAB, V78, P125, DOI 10.1016/S0003-9993(97)90252-5; Coleman RD, 2002, ARCH PHYS MED REHAB, V83, P1415, DOI 10.1053/apmr.2002.35111; DIKMEN SS, 1994, ARCH NEUROL-CHICAGO, V51, P177, DOI 10.1001/archneur.1994.00540140087018; FABIANO RJ, 1995, REHABIL PSYCHOL, V40, P223, DOI 10.1037/0090-5550.40.3.223; Fisk GD, 2002, J HEAD TRAUMA REHAB, V17, P16, DOI 10.1097/00001199-200202000-00004; Fleming J, 1999, BRAIN INJURY, V13, P417; Fox G K, 1992, Disabil Rehabil, V14, P140; Helmy A, 2007, BRIT J ANAESTH, V99, P32, DOI 10.1093/bja/aem139; Hopewell CA, 2002, J HEAD TRAUMA REHAB, V17, P48, DOI 10.1097/00001199-200202000-00007; Johnstone B, 1995, Appl Neuropsychol, V2, P24, DOI 10.1207/s15324826an0201_4; Kashluba S, 2008, ARCH PHYS MED REHAB, V89, P904, DOI 10.1016/j.apmr.2007.12.029; Kim J, 2012, NEUROREHAB NEURAL RE, V26, P870, DOI 10.1177/1545968311434553; Korteling JE, 1996, ARCH PHYS MED REHAB, V77, P138, DOI 10.1016/S0003-9993(96)90158-6; McCabe P, 2007, BRAIN INJURY, V21, P231, DOI 10.1080/02699050701201631; Novack TA, 2006, BRAIN INJURY, V20, P455, DOI 10.1080/02699050600664541; Ontario Ministry of Transportation, 2010, MED REV SECT FREQ AS; Ontario Neurotrauma Foundation, 2008, ONT NEUR FDN ANN REP; Pietrapiana P, 2005, BRAIN INJURY, V19, P197, DOI 10.1080/02699050400017197; Psychological Corporation, 1999, WECHSLER ABBREVIATED; Rapport L, 2006, J HEAD TRAUMA REHAB, V21, P34, DOI 10.1097/00001199-200601000-00004; Reitan RM, 1955, J CONSULT PSYCHOL, V19, P393, DOI 10.1037/h0044509; Reynolds CR, 1997, ARCH CLIN NEUROPSYCH, V12, P29, DOI 10.1016/S0887-6177(96)00015-7; Rossini Paolo M, 2004, Phys Med Rehabil Clin N Am, V15, P263, DOI 10.1016/S1047-9651(03)00124-4; Ryu WHA, 2010, INT J REHABIL RES, V33, P84, DOI 10.1097/MRR.0b013e32832e6b4b; Schneider JJ, 2005, APPL NEUROPSYCHOL, V12, P138, DOI 10.1207/S15324826AN1203_3; Sherer M, 2000, J HEAD TRAUMA REHAB, V15, P767, DOI 10.1097/00001199-200004000-00002; Sherer M, 2002, ARCH PHYS MED REHAB, V83, P183, DOI 10.1053/apmr.2002.28802; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; VILKKI J, 1994, J CLIN EXP NEUROPSYC, V16, P325, DOI 10.1080/01688639408402643; Villamar MF, 2012, NEUROMODULATION, V15, P326, DOI 10.1111/j.1525-1403.2012.00474.x; Walker WC, 2007, J REHABIL RES DEV, V44, P975, DOI 10.1682/JRRD.2006.12.0158; Wang C, 2003, PHYS GUIDE ASSESSING; Yale SH, 2006, J CLIN MED RES, V21, P177	38	18	18	0	8	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JAN	2014	28	1					38	43		10.3109/02699052.2013.849005			6	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	274CC	WOS:000328581700005	24328798				2021-06-18	
J	Curtis, K; Lam, M; Mitchell, R; Dickson, C; McDonnell, K				Curtis, Kate; Lam, Mary; Mitchell, Rebecca; Dickson, Cara; McDonnell, Karon			Major trauma: the unseen financial burden to trauma centres, a descriptive multicentre analysis	AUSTRALIAN HEALTH REVIEW			English	Article						cost; injury; health economics; health services	INJURY; REIMBURSEMENT; POLYTRAUMA; MORTALITY; VICTORIA; QUALITY; SYSTEM; COSTS; RISK; LIFE	Objective. This research examines the existing funding model for in-hospital trauma patient episodes in New South Wales (NSW), Australia and identifies factors that cause above-average treatment costs. Accurate information on the treatment costs of injury is needed to guide health-funding strategy and prevent inadvertent underfunding of specialist trauma centres, which treat a high trauma casemix. Methods. Admitted trauma patient data provided by 12 trauma centres were linked with financial data for 2008-09. Actual costs incurred by each hospital were compared with state-wide Australian Refined Diagnostic Related Groups (AR-DRG) average costs. Patient episodes where actual cost was higher than AR-DRG cost allocation were examined. Results. There were 16 693 patients at a total cost of AU$178.7 million. The total costs incurred by trauma centres were $14.7 million above the NSW peer-group average cost estimates. There were 10 AR-DRG where the total cost variance was greater than $500 000. The AR-DRG with the largest proportion of patients were the upper limb injury categories, many of whom had multiple body regions injured and/or a traumatic brain injury (P < 0.001). Conclusions. AR-DRG classifications do not adequately describe the trauma patient episode and are not commensurate with the expense of trauma treatment. A revision of AR-DRG used for trauma is needed.	[Curtis, Kate] Univ Sydney, Sydney Nursing Sch, Camperdown, NSW 2050, Australia; [Curtis, Kate; Dickson, Cara] St George Hosp, Kogarah, NSW 2217, Australia; [Curtis, Kate] George Inst Global Hlth, Sydney, NSW 2000, Australia; [Lam, Mary] Univ Sydney, Fac Hlth Sci, Sydney, NSW 2141, Australia; [Mitchell, Rebecca] Univ New S Wales, Kensington, NSW 2033, Australia; [McDonnell, Karon] St Vincents Hosp, Sydney, NSW 2010, Australia	Curtis, K (corresponding author), Univ Sydney, Sydney Nursing Sch, 88 Mallet St, Camperdown, NSW 2050, Australia.	kate.curtis@sydney.edu.au; mary.lam@sydney.edu.au; r.mitchell@unsw.edu.au; cara.dickson@sesiahs.health.nsw.gov.au; kmcdonell@stvincents.com.au	Mitchell, Rebecca/Z-5476-2019	Mitchell, Rebecca/0000-0003-1939-1761	St George Honda Trauma and Critical Care Research program; Sydney Nursing School, University of Sydney	The authors thank the trauma coordinators and data managers of participating centres for assistance with ethics and provision of data. Funding support for statistical analysis was provided by the St George Honda Trauma and Critical Care Research program. Associate Professor Curtis was supported by a Sydney Nursing School, University of Sydney post-doctoral fellowship.	AIHW, 2010, AUSTR HLTH 2010; Association for the Advancement of Automotive Medicine, 2008, ABBR VIAT INJ SCAL 2; *AUSTR I HLTH WELF, 2010, HLTH SERV SER, V17; Australian Institute of Health and Welfare, 2010, HLTH WELF EXP SER, V42; Banfield JM, 2011, J TRAUMA, V70, P732, DOI 10.1097/TA.0b013e31820783a3; Butcher N, 2009, INJURY, V40, pS12, DOI 10.1016/j.injury.2009.10.032; Callaway DW, 2007, EMERG MED CLIN N AM, V25, P837, DOI 10.1016/j.emc.2007.06.005; Cameron PA, 2008, MED J AUSTRALIA, V189, P546, DOI 10.5694/j.1326-5377.2008.tb02176.x; CAMPBELL AR, 1995, J TRAUMA, V39, P246, DOI 10.1097/00005373-199508000-00010; Celso B, 2006, J TRAUMA, V60, P371, DOI 10.1097/01.ta.0000197916.99629.eb; Curtis K, 2014, INJURY, V45, P279, DOI 10.1016/j.injury.2012.10.002; Curtis Kate, 2002, Aust Health Rev, V25, P73; Curtis K, 2011, HEALTH INF MANAG J, V40, P7, DOI 10.1177/183335831104000102; Curtis KA, 2012, MED J AUSTRALIA, V197, P233, DOI 10.5694/mja11.11351; Eager K, 2001, HLTH COVER, V10, P52; Forum on Global Violence Prevention Institute of Medicine, 2012, SOC EC COSTS VIOL WO; Gabbe BJ, 2011, ANN SURG, V253, P138, DOI 10.1097/SLA.0b013e3181f6685b; Grotz M, 2004, UNFALLCHIRURG, V107, P68, DOI 10.1007/s00113-003-0715-5; Hayen Andrew, 2006, N S W Public Health Bull, V17, P8; Health Education and Training Institute, 2012, CLIN COD WORKF ENH P; Holbrook TL, 2001, J TRAUMA, V50, P91, DOI 10.1097/00005373-200101000-00016; Horton R, 2012, LANCET, V380, P2053, DOI 10.1016/S0140-6736(12)62133-3; Ivers R, 2006, INJURY PREV, V12, P351, DOI 10.1136/ip.2006.013813; JACOBS BB, 1992, J TRAUMA, V33, P495, DOI 10.1097/00005373-199210000-00002; Lyons RA, 2010, INT J INJ CONTROL SA, V17, P145, DOI 10.1080/17457300903453104; Moczygemba J, 2012, PERSPEC HLTH INF WIN, P9; NSW Health, 2009, SEL SPEC STAT SERV P; NSW Health Department, 2006, 2006 2007 NSW PROGR; NSW Health Department, 2008, EP FUND POL 2008 200, P1; NSW Health Department, 2010, NSW HLTH EP FUND POL; NSW Institute of Trauma and Injury Management, 2012, NSW TRAUM REG PROF S; Palmer Cameron, 2007, Annu Proc Assoc Adv Automot Med, V51, P13; Pape HC, 2009, EUR J TRAUMA EMERG S, V35, P61, DOI 10.1007/s00068-008-8013-0; Peden M., 2002, INJURY LEADING CAUSE; PowerHealth Solutions, POW MAN AD 2006; Rotondo MF, 2009, J TRAUMA, V67, P915, DOI 10.1097/TA.0b013e3181b848e7; Rowell D, 2011, J TRAUMA, V70, P1086, DOI 10.1097/TA.0b013e3181ed4d29; Santos S, 2008, HEALTH INF MANAG J, V37, P25, DOI 10.1177/183335830803700103; SPSS, 2012, SPSS STAT PROGR SOC; Taheri PA, 1999, J AM COLL SURGEONS, V188, P349, DOI 10.1016/S1072-7515(99)00021-6; Watson W., 1997, COST INJURY VICTORIA; Willenberg L, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-267; World Health Organization, 2009, GLOB STAT REP ROAD S	43	18	18	0	3	CSIRO PUBLISHING	COLLINGWOOD	150 OXFORD ST, PO BOX 1139, COLLINGWOOD, VICTORIA 3066, AUSTRALIA	0156-5788	1449-8944		AUST HEALTH REV	Aust. Health Rev.		2014	38	1					30	37		10.1071/AH13061			8	Health Care Sciences & Services; Health Policy & Services	Health Care Sciences & Services	AI0PH	WOS:000336549200006	24240704	Bronze			2021-06-18	
J	De Maio, VJ; Joseph, DO; Tibbo-Valeriote, H; Cabanas, JG; Lanier, B; Mann, CH; Register-Mihalik, J				De Maio, Valerie J.; Joseph, Damilola O.; Tibbo-Valeriote, Holly; Cabanas, Jose G.; Lanier, Brian; Mann, Courtney H.; Register-Mihalik, Johna			Variability in Discharge Instructions and Activity Restrictions for Patients in a Children's ED Postconcussion	PEDIATRIC EMERGENCY CARE			English	Article						concussion; trauma; discharge instructions	TRAUMATIC BRAIN-INJURY; SPORT-RELATED CONCUSSION; COLLEGIATE FOOTBALL PLAYERS; HIGH-SCHOOL; RECURRENT CONCUSSION; SYMPTOMS; RECOVERY; RISK; ASSOCIATION; DEPRESSION	Objective The objective of this study was to describe discharge instructions given to school-aged patients evaluated in a children's emergency department (ED) following concussion. Methods This was a retrospective cohort study of children 6 to 18 years evaluated in a dedicated children's ED at a level I trauma center in 2008 following acute head trauma regardless of mechanism, identified by any of 27 International Classification of Disease, Ninth Revision diagnoses for head injury, concussion, or skull fracture. Included were those presentations consistent with the Zurich definition for concussion. Excluded were hospital admission, death before admission, evidence of intoxication, or structural abnormality on imaging. Univariate and multivariate analyses determined adjusted odds ratios (ORs) for receipt of concussion-specific discharge instructions and activity restrictions. Results Of 350 eligible patients, the 218 included patients were mostly male (68%) with mean age 12.8 (SD, 3.4) years. Injury characteristics included sports-related, 42%; fall, 23%; loss of consciousness, 33%; headache, 75%; dizziness, 29%; amnesia, 25%; and vomiting, 19%. Most patients underwent imaging (81%). Discharge characteristics included concussion stated in final diagnosis, 31%; concussion-specific instructions, 62%; and activity restrictions, 34%. Concussion-specific discharge instructions were more likely for loss of consciousness (OR, 1.7; 95% confidence interval [CI], 1.22-2.36), and activity restrictions were more likely for sport-related injury (OR, 1.31; 95% CI, 1.02-1.76) and amnesia (OR, 1.42; 95% CI, 1.01-1.98). Conclusions Most children meeting diagnostic criteria for concussion were discharged without concussion-specific diagnoses or activity restrictions. Given the risks associated with untimely return to both physical and cognitive activity after concussion, improved awareness and standardization of disposition are imperative for the management of these young patients in the ED.	[De Maio, Valerie J.; Tibbo-Valeriote, Holly; Lanier, Brian; Register-Mihalik, Johna] WakeMed Hlth & Hosp, Emergency Serv Inst, Raleigh, NC 27610 USA; [Cabanas, Jose G.] Austin Travis Cty Emergency Med Serv, Austin, TX USA	De Maio, VJ (corresponding author), WakeMed Hlth & Hosp, 3024 New Bern Ave,Suite G01, Raleigh, NC 27610 USA.	demaio@weppa.org	Meijer, Anna/K-5118-2016	Register-Mihalik, Johna/0000-0002-4229-4743			[Anonymous], 2011, MED SCI SPORT EXER, V43, P2412, DOI 10.1249/MSS.0b013e3182342e64; Asplund CA, 2004, CLIN J SPORT MED, V14, P339, DOI 10.1097/00042752-200411000-00003; Bay E, 2011, ADV EMERG NURS J, V33, P71, DOI 10.1097/TME.0b013e318207e851; Boden BP, 2007, AM J SPORT MED, V35, P1075, DOI 10.1177/0363546507299239; Cantu RC, 1998, CLIN SPORT MED, V17, P37, DOI 10.1016/S0278-5919(05)70059-4; Cantu RC, 2010, PM&R, V2, P1088, DOI 10.1016/j.pmrj.2010.07.483; Centers for Disease Control and Prevention, 2003, REP C MILD TRAUM BRA; Chen JK, 2008, ARCH GEN PSYCHIAT, V65, P81, DOI 10.1001/archgenpsychiatry.2007.8; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Fung M, 2006, BRAIN INJURY, V20, P889, DOI 10.1080/02699050600831934; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Kissick J, 2005, CLIN J SPORT MED, V15, P426, DOI 10.1097/01.jsm.0000186683.59158.8b; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Lau BC, 2011, AM J SPORT MED, V39, P2311, DOI 10.1177/0363546511410655; Lyttle MD, 2012, EMERG MED J, V29, P785, DOI 10.1136/emermed-2011-200225; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2009, NEUROSURGERY, V65, P876, DOI 10.1227/01.NEU.0000350155.89800.00; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; Meehan WP, 2010, AM J SPORT MED, V38, P2405, DOI 10.1177/0363546510376737; Meehan WP, 2010, J PEDIATR-US, V157, P889, DOI 10.1016/j.jpeds.2010.06.040; Moser RS, 2012, J PEDIATR-US, V161, P922, DOI 10.1016/j.jpeds.2012.04.012; Moser RS, 2005, NEUROSURGERY, V57, P300, DOI 10.1227/01.NEU.0000166663.98616.E4; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Schnadower D, 2007, CURR OPIN PEDIATR, V19, P258, DOI 10.1097/MOP.0b013e3281084e85; Silverberg ND, 2012, J HEAD TRAUMA REHABI; Sim A, 2008, J NEUROSURG, V108, P511, DOI 10.3171/JNS/2008/108/3/0511; Stevens Penelope K, 2010, J Trauma Nurs, V17, P178, DOI 10.1097/JTN.0b013e3181ff2789; Stevens PK, 2010, J TRAUMA NURS, V17, P174; Valentine V, 2012, AM FAM PHYSICIAN, V85, P100; Wetjen NM, 2010, J AM COLL SURGEONS, V211, P553, DOI 10.1016/j.jamcollsurg.2010.05.020; Yeates KO, 2009, PEDIATRICS, V123, P735, DOI 10.1542/peds.2008-1056; Yeates KO, 2002, NEUROPSYCHOLOGY, V16, P514, DOI 10.1037//0894-4105.16.4.514; Zemper ED, 2003, AM J PHYS MED REHAB, V82, P653, DOI 10.1097/01.PHM.0000083666.74494.BA	37	18	18	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0749-5161	1535-1815		PEDIATR EMERG CARE	Pediatr. Emerg. Care	JAN	2014	30	1					20	25		10.1097/PEC.0000000000000058			6	Emergency Medicine; Pediatrics	Emergency Medicine; Pediatrics	AH6ST	WOS:000336261700005	24365726				2021-06-18	
J	Frey, L; Lepkin, A; Schickedanz, A; Huber, K; Brown, MS; Serkova, N				Frey, Lauren; Lepkin, Aaron; Schickedanz, Alyssa; Huber, Kendra; Brown, Mark S.; Serkova, Natalie			ADC mapping and T-1-weighted signal changes on post-injury MRI predict seizure susceptibility after experimental traumatic brain injury	NEUROLOGICAL RESEARCH			English	Article						Epileptogenesis; Fluid percussion injury; Kainate; MRI; Post-traumatic epilepsy	FLUID PERCUSSION INJURY; HEAD-INJURY; POSTTRAUMATIC EPILEPSY; CEREBRAL EDEMA; RATS; HYPEREXCITABILITY; EPILEPTOGENESIS; MODEL	Objective: Post-traumatic epilepsy (PTE) is a serious complication of traumatic brain injury (TBI). This study is designed to determine the feasibility of using multiparametric MRI endpoints to predict differences in seizure susceptibility after experimental TBI. Methods: MRI imaging and behavioral measurements were performed at multiple time points after lateral fluid percussion injury (FPI) in rats. Seizure susceptibility was determined by video-electroencephalogram (EEG) monitoring and off-line signal analysis after chemoconvulsant challenge. Results: Multiple MRI endpoints, including measures of injury-related brain swelling (normalized interhemispheric volume difference, NIVD) and T1-weighted signal change with contrast enhancement (a measure of blood-brain barrier disruption, BBBD), reliably distinguished between injured and sham-injured animals at 72 hours after injury. ADC (apparent diffusion coefficient) values (a measure of water diffusivity) in injured cortex at 72 hours and 1 week after injury, BBBD in injured cortex at 72 hours after injury and NIVD at 72 hours after injury were significantly correlated with EEG-based measures of seizure susceptibility to chemoconvulsant challenge at 3 months after injury. Conclusions: The correlations between our MRI quantitative endpoints and EEG-based measures of seizure susceptibility to chemoconvulsant challenge in injured animals versus sham-injured animals support the feasibility of these MRI endpoints as potential biomarkers for post-traumatic epileptogenesis.	[Frey, Lauren; Lepkin, Aaron; Schickedanz, Alyssa] Univ Colorado, Dept Neurol, Aurora, CO USA; [Frey, Lauren] Colorado State Univ, Colorado Injury Control & Res Ctr, Ft Collins, CO 80523 USA; [Huber, Kendra; Serkova, Natalie] Univ Colorado, Dept Anesthesiol, Aurora, CO USA; [Huber, Kendra; Brown, Mark S.; Serkova, Natalie] Univ Colorado, Dept Radiol, Aurora, CO USA	Frey, L (corresponding author), Univ Colorado, Aurora, CO 80045 USA.	Lauren.Frey@ucdenver.edu			Colorado Injury Control and Research Center; CDCCentre National de la Recherche Scientifique (CNRS)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA; NCI P30 Cancer Center Grant [CA046934]; CTSAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL 1RR025780]; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [P30CA046934] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001082] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [UL1RR025780] Funding Source: NIH RePORTER	The authors wish to thank the Colorado Injury Control and Research Center for funding support for this project. The authors also wish to thank Archana Shrestha, MD, and Amy Brooks-Kayal, MD, for their invaluable editing assistance. Funding for this project was provided by the CDC and the Colorado Injury Control and Research Center. The Animal Imaging Core is supported through the Animal Imaging Shared Resources Core by the NCI P30 Cancer Center Grant (CA046934) and CTSA award (UL 1RR025780).	Altman D, 1991, PRACTICAL STAT MED R; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Bareyre F, 1997, J NEUROTRAUM, V14, P839, DOI 10.1089/neu.1997.14.839; Chen K, 2007, J NEUROSCI, V27, P46, DOI 10.1523/JNEUROSCI.3966-06.2007; D'Ambrosio R, 2005, BRAIN, V128, P174, DOI 10.1093/brain/awh337; Diaz-Arrastia R, 2000, ARCH NEUROL-CHICAGO, V57, P1611, DOI 10.1001/archneur.57.11.1611; Echegoyen J, 2009, EPILEPSY RES, V85, P123, DOI 10.1016/j.eplepsyres.2009.02.019; Farias S, 2009, J NEUROTRAUM, V26, P1977, DOI 10.1089/neu.2009.0877; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Feldmann H, 1979, Acta Neurochir Suppl (Wien), V28, P74; Floyd CL, 2002, J NEUROTRAUM, V19, P303, DOI 10.1089/089771502753594873; Frey LC, 2009, J NEUROSCI METH, V177, P267, DOI 10.1016/j.jneumeth.2008.10.022; Frey LC, 2003, EPILEPSIA, V44, P11, DOI 10.1046/j.1528-1157.44.s10.4.x; Fujimoto ST, 2004, NEUROSCI BIOBEHAV R, V28, P365, DOI 10.1016/j.neubiorev.2004.06.002; Hamm RJ, 2001, J NEUROTRAUM, V18, P1207, DOI 10.1089/089771501317095241; Immonen RJ, 2009, NEUROIMAGE, V45, P1, DOI 10.1016/j.neuroimage.2008.11.022; Janigro D, 2010, EPILEPSY CURR, V10, P67, DOI 10.1111/j.1535-7511.2010.01359.x; Kharatishvili I, 2006, NEUROSCIENCE, V140, P685, DOI 10.1016/j.neuroscience.2006.03.012; Kharatishvili I, 2007, BRAIN, V130, P3155, DOI 10.1093/brain/awm268; Kharatishvili I, 2009, EXP NEUROL, V217, P154, DOI 10.1016/j.expneurol.2009.01.026; Lenzlinger PM, 2004, RESTOR NEUROL NEUROS, V22, P73; LEVIN HS, 1991, NEUROSURGERY, V28, P196, DOI 10.1227/00006123-199102000-00004; Liang LP, 2000, NEUROSCIENCE, V101, P563, DOI 10.1016/S0306-4522(00)00397-3; MARKS DA, 1995, NEUROLOGY, V45, P2051, DOI 10.1212/WNL.45.11.2051; Marmarou A, 2006, J NEUROSURG, V104, P720, DOI 10.3171/jns.2006.104.5.720; Marmarou Anthony, 2007, Neurosurg Focus, V22, pE1; NAKASU Y, 1995, AM J NEURORADIOL, V16, P1185; Obenaus A, 2007, J NEUROTRAUM, V24, P1147, DOI 10.1089/neu.2006.0211; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Tokumitsu T, 1997, BRAIN RES, V744, P57, DOI 10.1016/S0006-8993(96)01071-2; Van Putten HP, 2005, J NEUROTRAUM, V22, P857; WEISS GH, 1986, ARCH NEUROL-CHICAGO, V43, P771, DOI 10.1001/archneur.1986.00520080019013; WEISS GH, 1983, ARCH NEUROL-CHICAGO, V40, P7, DOI 10.1001/archneur.1983.04050010027006	33	18	19	0	5	MANEY PUBLISHING	LEEDS	STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.	JAN	2014	36	1					26	37		10.1179/1743132813Y.0000000269			12	Clinical Neurology; Neurosciences	Neurosciences & Neurology	AI7VH	WOS:000337108300003	24107461	Green Accepted			2021-06-18	
J	Hoyle, JD; Callahan, JM; Badawy, M; Powell, E; Jacobs, E; Gerardi, M; Melville, K; Miskin, M; Atabaki, SM; Dayan, P; Holmes, JF; Kuppermann, N				Hoyle, John D., Jr.; Callahan, James M.; Badawy, Mohamed; Powell, Elizabeth; Jacobs, Elizabeth; Gerardi, Michael; Melville, Kraig; Miskin, Michelle; Atabaki, Shireen M.; Dayan, Peter; Holmes, James F.; Kuppermann, Nathan		Traumatic Brain Injury Study Grp P	Pharmacological Sedation for Cranial Computed Tomography in Children After Minor Blunt Head Trauma	PEDIATRIC EMERGENCY CARE			English	Article						traumatic brain injury; pharmacological sedation; computed tomography	PEDIATRIC EMERGENCY-DEPARTMENT; PROCEDURAL SEDATION; ADVERSE EVENTS; CHLORAL HYDRATE; YOUNG-CHILDREN; HELICAL CT; ANALGESIA; SAFE; DEXMEDETOMIDINE; PHYSICIANS	Objective Children evaluated in emergency departments for blunt head trauma (BHT) frequently undergo computed tomography (CT), with some requiring pharmacological sedation. Cranial CT sedation complications are understudied. The objective of this study was to document the frequency, type, and complications of pharmacological sedation for cranial CT in children. Methods We prospectively enrolled children (younger than 18 years) with minor BHT presenting to 25 emergency departments from 2004 to 2006. Data collected included sedation agent and complications. We excluded patients with Glasgow Coma Scale scores of less than 14. Results Of 57,030 eligible patients, 43,904 (77%) were enrolled in the parent study; 15,176 (35%) had CT scans performed or planned, and 527 (3%) received pharmacological sedation for CT. Sedated patients' characteristics were as follows: median age, 1.7 years (interquartile range, 1.1-2.5 years); male 61%; Glasgow Coma Scale score of 15, 86%; traumatic brain injury on CT, 8%. There were 488 patients (93%) who received 1 sedative. Sedation use (0%-21%) and regimen varied by site. Pentobarbital (n = 164) and chloral hydrate (n = 149) were the most frequently used agents. Sedation complications occurred in 49 patients (9%; 95% confidence interval [CI], 7%-12%): laryngospasm 1 (0.2%; 95% CI, 0%-1.1%), failed sedation 31 (6%; 95% CI, 4%-8%), vomiting 6 (1%; 95% CI, 0.4%-2%), hypotension 13 (4%; 95% CI, 2%-7%), and hypoxia 1 (0.2%; 95% CI, 0%-2%). No cases of apnea, aspiration, or reversal agent use occurred. One patient required intubation. Vomiting and failed sedation were most common with chloral hydrate. Conclusions Pharmacological sedation is infrequently used for children with minor BHT undergoing CT, and complications are uncommon. The variability in sedation medications and frequency suggests a need for evidence-based guidelines.	[Hoyle, John D., Jr.] Western Michigan Univ, Sch Med, Dept Emergency Med, Kalamazoo, MI 49008 USA; [Hoyle, John D., Jr.] Western Michigan Univ, Sch Med, Dept Pediat, Kalamazoo, MI 49008 USA; [Hoyle, John D., Jr.] Michigan State Univ, Dept Emergency Med, E Lansing, MI 48824 USA; [Callahan, James M.] SUNY Upstate Med Univ, Dept Emergency Med, Syracuse, NY 13210 USA; [Callahan, James M.] SUNY Upstate Med Univ, Dept Pediat, Syracuse, NY 13210 USA; [Badawy, Mohamed] Univ Rochester, Sch Med & Dent, Dept Emergency Med, Rochester, NY USA; [Badawy, Mohamed] Univ Rochester, Sch Med & Dent, Dept Pediat, Rochester, NY USA; [Powell, Elizabeth] Northwestern Univ, Dept Pediat, Feinberg Sch Med, Chicago, IL 60611 USA; [Jacobs, Elizabeth] Holy Cross Hosp, Dept Pediat, Silver Spring, MD USA; [Gerardi, Michael] Morristown Mem Hosp, Atlantic Hlth Syst, Dept Emergency Med, Morristown, NJ USA; [Melville, Kraig] Calvert Mem Hosp, Dept Emergency Med, Prince Frederick, MD USA; [Miskin, Michelle] Univ Utah, Dept Pediat, Salt Lake City, UT USA; [Atabaki, Shireen M.] George Washington Univ, Dept Pediat, Childrens Natl Med Ctr, Sch Med, Washington, DC 20052 USA; [Atabaki, Shireen M.] George Washington Univ, Dept Emergency Med, Sch Med, Washington, DC 20052 USA; [Dayan, Peter] Columbia Univ Coll Phys & Surg, Dept Pediat, New York, NY 10032 USA; [Holmes, James F.; Kuppermann, Nathan] Univ Calif Davis, Dept Emergency Med, Davis, CA 95616 USA; [Kuppermann, Nathan] Univ Calif Davis, Dept Pediat, Davis, CA 95616 USA	Hoyle, JD (corresponding author), Helen DeVos Childrens Hosp, Emergency Dept, MC 49,100 Michigan St NE, Grand Rapids, MI 49503 USA.	jdhoyle@hotmail.com		Powell, Elizabeth/0000-0003-3147-9889; Holubkov, Richard/0000-0003-0431-3381	Health Resources and Services Administration/Maternal and Child Health Bureau, Division of Research, Training, and EducationUnited States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA); Emergency Medical Services of Children Program [R40MC02461]; Emergency Medical Services of Children Program of the Health Resources and Services Administration/Maternal and Child Health Bureau [U03MC00001, U03MC00003, U03MC00006, U03MC00007, U03MC00008]	This work was supported by a grant from the Health Resources and Services Administration/Maternal and Child Health Bureau, Division of Research, Training, and Education, and the Emergency Medical Services of Children Program (R40MC02461). The Pediatric Emergency Care Applied Research Network (PECARN) is supported by cooperative agreements U03MC00001, U03MC00003, U03MC00006, U03MC00007, and U03MC00008 from the Emergency Medical Services of Children Program of the Health Resources and Services Administration/Maternal and Child Health Bureau.	Agrawal D, 2003, ANN EMERG MED, V42, P636, DOI 10.1016/S0196-0644(03)00516-X; [Anonymous], 2004, ANN EMERG MED, V44, P342, DOI 10.1016/j.annemergmed.2004.04.012; BARST SM, 1994, PAEDIATR ANAESTH, V4, P243; Baxter AL, 2007, PEDIATR EMERG CARE, V23, P690, DOI 10.1097/PEC.0b013e3181558d5c; Bell A, 2011, EMERG MED AUSTRALAS, V23, P458, DOI 10.1111/j.1742-6723.2011.01418.x; Bender BJ, 2007, PEDIATR EMERG CARE, V23, P624, DOI 10.1097/PEC.0b013e318149f66f; Bhatt M, 2009, ANN EMERG MED, V53, P426, DOI 10.1016/j.annemergmed.2008.09.030; Boswinkel JP, 2005, PEDIATR ANN, V34, P650, DOI 10.3928/0090-4481-20050801-13; Casamassimo P, 2006, PEDIATRICS, V118, P2587, DOI 10.1542/peds.2006-2780; Cengiz M, 2006, PEDIATR ANESTH, V16, P621, DOI 10.1111/j.1460-9592.2005.01820.x; Chung T, 2000, PEDIATR RADIOL, V30, P332, DOI 10.1007/s002470050752; Conners GP, 1999, PEDIATR EMERG CARE, V15, P241; Cote CJ, 2000, PEDIATRICS, V105, P805, DOI 10.1542/peds.105.4.805; Cote CJ, 2000, PEDIATRICS, V106, P633, DOI 10.1542/peds.106.4.633; Cravero JP, 2006, CURR OPIN ANESTHESIO, V19, P443, DOI 10.1097/01.aco.0000236147.83364.99; Cravero JP, 2006, PEDIATRICS, V118, P1087, DOI 10.1542/peds.2006-0313; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Ferguson CC, 2010, CLIN PEDIATR, V49, P350, DOI 10.1177/0009922809339346; Freedman SB, 2011, ACAD EMERG MED, V18, P38, DOI 10.1111/j.1553-2712.2010.00960.x; Godwin SA, 2005, ANN EMERG MED, V45, P177, DOI 10.1016/j.annemergmed.2004.11.002; Hoyle JD, 2011, ACAD EMERG MED, V18, P140, DOI 10.1111/j.1553-2712.2010.00970.x; Isaacman DJ, 2001, PEDIATRICS, V108, P354, DOI 10.1542/peds.108.2.354; Kaste SC, 1997, AM J ROENTGENOL, V168, P1001, DOI 10.2214/ajr.168.4.9124104; Klassen TP, 2000, ACAD EMERG MED, V7, P739, DOI 10.1111/j.1553-2712.2000.tb02260.x; Krauss B, 2006, LANCET, V367, P766, DOI 10.1016/S0140-6736(06)68230-5; Kroft Lucia J M, 2010, Pediatr Radiol, V40, P294, DOI 10.1007/s00247-009-1436-x; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Langlois J., 2001, TRAUMATIC BRAIN INJU, P1; Lemos AA, 2006, RADIOL MED, V111, P911, DOI 10.1007/s11547-006-0090-8; Malis DJ, 1997, OTOLARYNG HEAD NECK, V116, P53, DOI 10.1016/S0194-5998(97)70352-8; Malviya S, 1997, ANESTH ANALG, V85, P1207, DOI 10.1097/00000539-199712000-00005; Malviya S, 2000, PEDIATRICS, V105, DOI 10.1542/peds.105.3.e42; Mason KP, 2012, BRIT J ANAESTH, V108, P13, DOI 10.1093/bja/aer407; Mason KP, 2008, PEDIATR ANESTH, V18, P393, DOI 10.1111/j.1460-9592.2008.02451.x; Mason KP, 2011, AM J ROENTGENOL, V196, pW194, DOI 10.2214/AJR.10.5045; Mason KP, 2004, RADIOLOGY, V233, P723, DOI 10.1148/radiol.2333031872; Mason KP, 2004, RADIOLOGY, V230, P537, DOI 10.1148/radiol.2302030107; Mensour Mark, 2006, CJEM, V8, P94; Moro-Sutherland DM, 2000, ACAD EMERG MED, V7, P1370, DOI 10.1111/j.1553-2712.2000.tb00494.x; Newman DH, 2003, ANN EMERG MED, V42, P627, DOI 10.1016/S0196-0644(03)00446-3; Pappas JN, 2000, RADIOLOGY, V215, P897, DOI 10.1148/radiology.215.3.r00jn34897; Pena BMG, 1999, ANN EMERG MED, V34, P483, DOI 10.1016/S0196-0644(99)80050-X; Pitetti RD, 2003, ARCH PEDIAT ADOL MED, V157, P1090, DOI 10.1001/archpedi.157.11.1090; Pomeranz ES, 2000, PEDIATRICS, V105, P1110, DOI 10.1542/peds.105.5.1110; Roback MG, 2005, ACAD EMERG MED, V12, P508, DOI 10.1197/j.aem.2004.12.009; Roback MG, 2004, ANN EMERG MED, V44, P454, DOI 10.1016/j.annemergmed.2004.03.015; Sacchetti A, 2005, PEDIATR EMERG CARE, V21, P295, DOI 10.1097/01.pec.0000159072.40067.c8; Sacchetti A, 2007, PEDIATR EMERG CARE, V23, P218, DOI 10.1097/PEC.0b013e31803e176c; Sanborn PA, 2005, RADIOLOGY, V237, P288, DOI 10.1148/radiol.2371041415; Shavit I, 2010, PEDIATR EMERG CARE, V26, P742, DOI 10.1097/PEC.0b013e3181f70e4e; Starkey E, 2011, ARCH DIS CHILDHOOD-E, V96, P101, DOI 10.1136/adc.2008.153072; Treluyer JM, 2004, FUND CLIN PHARMACOL, V18, P347, DOI 10.1111/j.1472-8206.2004.00232.x; WHITE KS, 1995, PEDIATR RADIOL, V25, P344, DOI 10.1007/BF02021698	53	18	18	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0749-5161	1535-1815		PEDIATR EMERG CARE	Pediatr. Emerg. Care	JAN	2014	30	1					1	7		10.1097/PEC.0000000000000059			7	Emergency Medicine; Pediatrics	Emergency Medicine; Pediatrics	AH6ST	WOS:000336261700001	24365725				2021-06-18	
J	Linton, KF; Kim, BJ				Linton, Kristen F.; Kim, Bum Jung			Traumatic brain injury as a result of violence in native American and black communities spanning from childhood to older adulthood	BRAIN INJURY			English	Article						Adult; black; children; Native American; traumatic brain injury; violent	FUNCTIONAL OUTCOMES; CHILDREN	Primary objective: The purpose of this study was to compare the aetiology of TBI between different race, gender and age groups to understand demographic characteristics of people who experience TBI. Research design: A secondary data analysis of the Arizona Trauma Database consisting of 18 868 cases of TBI between 2008-2010 was conducted. Methods and procedures: The sample consisted of patients who ranged in age from 0-79 and were White, Black, Native American, Asian or other race. Cross-tabulations, chi-squares and a logistic regression were conducted. Main outcomes and results: Standardized residuals indicated that Native Americans and Blacks were more likely to experience violent TBI, regardless of gender or age group (p < 0.01). The logistic regression indicated that Native Americans (OR = 3.13), Blacks (OR = 1.95) and other race (OR = 1.56) patients had statistically significantly (p < 0.001) higher odds of experiencing violent TBI compared to Whites. In addition, females (OR = 0.40), children (OR = 0.75) and older adults (OR = 0.17) had statistically significantly (p < 0.001) lower odds of violent TBI. Conclusions: Providers of Native American and Black patients who have experienced violence should encourage them to receive assessments and treatment for TBI.	[Linton, Kristen F.; Kim, Bum Jung] Univ Hawaii Manoa, Myron B Thompson Sch Social Work, Honolulu, HI 96822 USA	Linton, KF (corresponding author), Univ Hawaii Manoa, Myron B Thompson Sch Social Work, 1800 East West Rd, Honolulu, HI 96822 USA.	kfbean@hawaii.edu					Advertising Education Foundation [internet], 2003, SEAT BELT ED 1985 PR; Allen CT, 2010, THESIS U S CAROLINA; Arango-Lasprilla JC, 2007, ARCH PHYS MED REHAB, V88, P11, DOI 10.1016/j.apmr.2006.10.029; BERGER LR, 1989, PEDIATRICS, V84, P152; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Burnett DM, 2003, ARCH PHYS MED REHAB, V84, P263, DOI 10.1053/apmr.2003.50091; Centers for Disease Control and Prevention, 2010, TRAUM BRAIN INJ US R; Centers for Disease Control and Prevention, 2010, TRAUMATIC BRAIN INJU; Davis JS, 2013, J SURG RES, pe1; Friedman LS, 2011, J AM GERIATR SOC, V59, P417, DOI 10.1111/j.1532-5415.2010.03313.x; Haider AH, 2007, J TRAUMA, V62, P1259, DOI 10.1097/TA.0b013e31803c760e; Hanks RA, 2003, ARCH PHYS MED REHAB, V84, P249, DOI 10.1053/apmr.2003.50096; Harrison-Felix C, 1998, ARCH PHYS MED REHAB, V79, P730, DOI 10.1016/S0003-9993(98)90348-3; Kim H, 2013, CAN J OCCUP THER, V80, P49, DOI 10.1177/0008417412473262; Malcoe LH, 2004, BMC MED, V2, DOI 10.1186/1741-7015-2-20; Nelson LA, 2007, J HEAD TRAUMA REHAB, V22, P105, DOI 10.1097/01.HTR.0000265098.52306.a9; Perciaccante VJ, 1999, J ORAL MAXIL SURG, V57, P760, DOI 10.1016/S0278-2391(99)90808-X; Schootman M, 2000, J TRAUMA, V48, P70, DOI 10.1097/00005373-200001000-00012; Spivak H., 2013, 141 APHA ANN M NOV 2; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; U. S. Census Bureau, 2013, STAT COUNT QUICK FAC	21	18	18	0	6	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2014	28	8					1076	1081		10.3109/02699052.2014.901558			6	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	AI6KP	WOS:000336983200008	24702677				2021-06-18	
J	Maller, JJ; Thomson, RHS; Pannek, K; Rose, SE; Bailey, N; Lewis, PM; Fitzgerald, PB				Maller, Jerome J.; Thomson, Richard H. S.; Pannek, Kerstin; Rose, Stephen E.; Bailey, Neil; Lewis, Philip M.; Fitzgerald, Paul B.			The (Eigen)Value of Diffusion Tensor Imaging to Investigate Depression After Traumatic Brain Injury	HUMAN BRAIN MAPPING			English	Article						depression; magnetic resonance imaging; diffusion; dorsolateral prefrontal cortex; longitudinal fasciculus; white matter	WHITE-MATTER ABNORMALITIES; HIPPOCAMPAL VOLUMETRICS; ANATOMICAL MRI; MILD; DISORDER; ADULTS; EEG; PHARMACOTHERAPY; STIMULATION; 1ST-EPISODE	Background: Many people with a traumatic brain injury (TBI), even mild to moderate, will develop major depression (MD). Recent studies of patients with MD suggest reduced fractional anisotropy (FA) in dorsolateral prefrontal cortex (DLPFC), temporal lobe tracts, midline, and capsule regions. Some of these pathways have also been found to have reduced FA in patients with TBI. It is unknown whether the pathways implicated in MD after TBI are similar to those with MD without TBI. This study sought to investigate whether there were specific pathways unique to TBI patients who develop MD. Methods: A sample of TBI-MD subjects (N = 14), TBI-no-MD subjects (N = 12), MD-no-TBI (N = 26), and control subjects (no TBI or MD, N = 23), using a strict measurement protocol underwent psychiatric assessments and diffusion tensor brain Magnetic Resonance Imaging (MRI). Results: The findings of this study indicate that (1) TBI patients who develop MD have reduced axial diffusivity in DLPFC, corpus callosum (CC), and nucleus accumbens white matter tracts compared to TBI patients who do not develop MD and (2) MD patients without a history of TBI have reduced FA along the CC. We also found that more severe MD relates to altered radial diffusivity. Conclusions: These findings suggest that compromise to specific white matter pathways, including both axonal and myelination aspects, after a mild TBI underlie the susceptibility of these patients developing MD. Hum Brain Mapp 35:227-237, 2014. (c) 2012 Wiley Periodicals, Inc.	[Maller, Jerome J.; Thomson, Richard H. S.; Bailey, Neil; Fitzgerald, Paul B.] Alfred & Monash Univ, Sch Psychol & Psychiat, Monash Alfred Psychiat Res Ctr, Melbourne, Vic 3181, Australia; [Pannek, Kerstin] Univ Queensland, Clin Res Ctr, Ctr Adv Imaging, Sch Med, Brisbane, Qld, Australia; [Rose, Stephen E.] Univ Queensland, Ctr Med Diagnost Technol Queensland, Clin Res Ctr, Ctr Magnet Resonance, Brisbane, Qld, Australia; [Lewis, Philip M.] Alfred Hosp, Dept Neurosurg, Melbourne, Vic, Australia	Maller, JJ (corresponding author), Alfred & Monash Univ, Sch Psychol & Psychiat, Monash Alfred Psychiat Res Ctr, Melbourne, Vic 3181, Australia.	j.maller@alfred.org.au	Maller, Jerome J/H-4963-2014; Pannek, Kerstin/C-8059-2011; Bailey, Neil/AAB-2741-2021; Fitzgerald, Paul B/A-1225-2008; Rose, Stephen/C-8044-2009	Maller, Jerome J/0000-0003-4685-1508; Pannek, Kerstin/0000-0002-6512-7630; Fitzgerald, Paul B/0000-0003-4217-8096; Bailey, Neil/0000-0002-8483-1068			Ahdidan J, 2011, ACTA PSYCHIAT SCAND, V123, P211, DOI 10.1111/j.1600-0447.2010.01644.x; Airan RD, 2007, SCIENCE, V317, P819, DOI 10.1126/science.1144400; Alderfer BS, 2005, J HEAD TRAUMA REHAB, V20, P544, DOI 10.1097/00001199-200511000-00006; Alexopoulos GS, 2008, AM J PSYCHIAT, V165, P238, DOI 10.1176/appi.ajp.2007.07050744; Alexopoulos GS, 1997, ARCH GEN PSYCHIAT, V54, P915; Arciniegas DB, 2006, BEHAV NEUROL, V17, P25, DOI 10.1155/2006/460592; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Beauchamp MH, 2009, J NEUROTRAUM, V26, P1645, DOI [10.1089/neu.2009.0916, 10.1089/neu.2009-0916]; Bell-McGinty S, 2002, AM J PSYCHIAT, V159, P1424, DOI 10.1176/appi.ajp.159.8.1424; Bennett MR, 2010, AUST NZ J PSYCHIAT, V44, P301, DOI 10.3109/00048670903555146; Bigler ED, 2011, NEUROREHABILITATION, V28, P63, DOI 10.3233/NRE-2011-0633; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Bruder GE, 2012, HUM BRAIN MAPP, V33, P1325, DOI 10.1002/hbm.21284; Bryant RA, 2008, NEW ENGL J MED, V358, P525, DOI 10.1056/NEJMe078235; Chen JK, 2008, ARCH GEN PSYCHIAT, V65, P81, DOI 10.1001/archgenpsychiatry.2007.8; Drevets WC, 2000, NUCL MED BIOL, V27, P499, DOI 10.1016/S0969-8051(00)00119-0; First MB, 2001, STRUCTURED CLIN INTE; Foster JK, 1999, MEMORY, V7, P715, DOI 10.1080/096582199387823; Garrett A, 2011, AM J PSYCHIAT, V168, P173, DOI 10.1176/appi.ajp.2010.09121718; Geuze E, 2005, MOL PSYCHIATR, V10, P147, DOI 10.1038/sj.mp.4001580; Gordon E, 2010, CLIN EEG NEUROSCI, V41, P178, DOI 10.1177/155005941004100404; Gordon WA, 2006, AM J PHYS MED REHAB, V85, P343, DOI 10.1097/01.phm.0000202106.01654.61; Gutman DA, 2009, BIOL PSYCHIAT, V65, P276, DOI 10.1016/j.biopsych.2008.09.021; Hart T, 2011, ARCH PHYS MED REHAB, V92, P1211, DOI 10.1016/j.apmr.2011.03.005; Heller W, 1993, NEUROPSYCHOLOGY, V7, P746; Herrington JD, 2010, PSYCHOPHYSIOLOGY, V47, P442, DOI 10.1111/j.1469-8986.2009.00958.x; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hudak A, 2011, PSYCHIAT RES-NEUROIM, V191, P160, DOI 10.1016/j.pscychresns.2010.10.003; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Jorge RE, 2005, CURR OPIN PSYCHIATR, V18, P289, DOI 10.1097/01.yco.0000165600.90928.92; Kato N, 2000, NEUROPHARMACOLOGY, V39, P1107, DOI 10.1016/S0028-3908(99)00234-8; Kennedy MRT, 2009, J INT NEUROPSYCH SOC, V15, P130, DOI 10.1017/S1355617708090024; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Koolschijn PCMP, 2009, HUM BRAIN MAPP, V30, P3719, DOI 10.1002/hbm.20801; Koponen S, 2011, BRAIN INJURY, V25, P1029, DOI 10.3109/02699052.2011.607783; Lacerda ALT, 2005, J PSYCHIATR RES, V39, P347, DOI 10.1016/j.jpsychires.2004.10.004; Li J, 2011, EUR J NEUROSCI, V33, P933, DOI 10.1111/j.1460-9568.2010.07573.x; Ma N, 2007, AM J PSYCHIAT, V164, P823, DOI 10.1176/appi.ajp.164.5.823; Maller JJ, 2007, HIPPOCAMPUS, V17, P1023, DOI 10.1002/hipo.20339; Maller JJ, 2010, BRAIN RES REV, V64, P213, DOI 10.1016/j.brainresrev.2010.04.003; McAllister TW, 2006, J NEUROTRAUM, V23, P1450, DOI 10.1089/neu.2006.23.1450; Milman A, 2005, J NEUROTRAUM, V22, P1003, DOI 10.1089/neu.2005.22.1003; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; Mori S., 2005, MRI ATLAS HUMAN WHIT; Muller N, 2011, NEUROTOX RES, V19, P308, DOI 10.1007/s12640-010-9210-2; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Pandey DK, 2009, BEHAV BRAIN RES, V205, P436, DOI 10.1016/j.bbr.2009.07.027; Provenzale JM, 2010, AM J ROENTGENOL, V194, P16, DOI 10.2214/AJR.09.3687; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Saletu B, 2010, CLIN EEG NEUROSCI, V41, P203, DOI 10.1177/155005941004100407; Salmond CH, 2006, NEUROIMAGE, V29, P117, DOI 10.1016/j.neuroimage.2005.07.012; Schlaepfer TE, 2008, NEUROPSYCHOPHARMACOL, V33, P368, DOI 10.1038/sj.npp.1301408; Schonberger M, 2011, BRAIN INJURY, V25, P543, DOI 10.3109/02699052.2011.565013; Shankman SA, 2011, INT J PSYCHOPHYSIOL, V79, P287, DOI 10.1016/j.ijpsycho.2010.11.004; Shapira M, 2007, MOL CELL NEUROSCI, V34, P571, DOI 10.1016/j.mcn.2006.12.006; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; Sheline YI, 2010, ARCH GEN PSYCHIAT, V67, P277, DOI 10.1001/archgenpsychiatry.2009.204; Silver JM, 2009, AM J PSYCHIAT, V166, P653, DOI 10.1176/appi.ajp.2009.08111676; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Tanis Keith Q., 2007, CNS & Neurological Disorders-Drug Targets, V6, P151, DOI 10.2174/187152707780363276; Tasker RC, 2005, PEDIATR RES, V58, P302, DOI 10.1203/01.PDR.0000169965.08854.25; Thomalla G, 2004, NEUROIMAGE, V22, P1767, DOI 10.1016/j.neuroimage.2004.03.041; Thomas AJ, 2002, ANN NY ACAD SCI, V977, P333, DOI 10.1111/j.1749-6632.2002.tb04835.x; von Gunten A, 2000, J NEUROPSYCH CLIN N, V12, P493, DOI 10.1176/appi.neuropsych.12.4.493; Wager-Smith K, 2011, NEUROSCI BIOBEHAV R, V35, P742, DOI 10.1016/j.neubiorev.2010.09.010; Wagner G, 2010, J PSYCHIATR NEUROSCI, V35, P247, DOI 10.1503/jpn.090081; Yuan YG, 2007, NEUROREPORT, V18, P1845, DOI 10.1097/WNR.0b013e3282f1939f; Zou K, 2008, J PSYCHIATR NEUROSCI, V33, P525	71	18	18	0	14	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1065-9471	1097-0193		HUM BRAIN MAPP	Hum. Brain Mapp.	JAN	2014	35	1					227	237		10.1002/hbm.22171			11	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	264EN	WOS:000327859900018	23008175	Green Published			2021-06-18	
J	Moen, KG; Haberg, AK; Skandsen, T; Finnanger, TG; Vik, A				Moen, Kent Goran; Haberg, Asta Kristine; Skandsen, Toril; Finnanger, Torun Gangaune; Vik, Anne			A Longitudinal Magnetic Resonance Imaging Study of the Apparent Diffusion Coefficient Values in Corpus Callosum during the First Year after Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						craniocerebral trauma; GOS; MRI; prospective studies; neuropsychological tests	WHITE-MATTER INTEGRITY; AXONAL INJURY; HEAD-INJURY; TENSOR; MODERATE; MRI	The objective of this study was to explore the evolution of apparent diffusion coefficient (ADC) values in magnetic resonance imaging (MRI) in normal-appearing tissue of the corpus callosum during the 1st year after traumatic brain injury (TBI), and relate findings to outcome. Fifty-seven patients (mean age 34 [range 11-63] years) with moderate to severe TBI were examined with diffusion weighted MRI at three time points (median 7 days, 3 and 12 months), and a sex- and age-matched control group of 47 healthy individuals, were examined once. The corpus callosum was subdivided and the mean ADC values computed blinded in 10 regions of interests without any visible lesions in the ADC map. Outcome measures were Glasgow Outcome Scale Extended (GOSE) and neuropsychological domain scores at 12 months. We found a gradual increase of the mean ADC values during the 12 month follow-up, most evident in the posterior truncus (r=0.19, p<0.001). Compared with the healthy control group, we found higher mean ADC values in posterior truncus both at 3 months (p=0.021) and 12 months (p=0.003) post-injury. Patients with fluid-attenuated inversion recovery (FLAIR) lesions in the corpus callosum in the early MRI, and patients with disability (GOSE score 6) showed evidence of increased mean ADC values in the genu and posterior truncus at 12 months. Mean ADC values in posterior parts of the corpus callosum at 3 months predicted the sensory-motor function domain score (p=0.010-0.028). During the 1st year after moderate and severe TBI, we demonstrated a slowly evolving disruption of the microstructure in normal appearing corpus callosum in the ADC map, most evident in the posterior truncus. The mean ADC values were associated with both outcome and ability to perform speeded, complex sensory-motor action.	[Moen, Kent Goran; Haberg, Asta Kristine; Skandsen, Toril; Vik, Anne] Norwegian Univ Sci & Technol, Dept Neurosci, N-7491 Trondheim, Norway; [Finnanger, Torun Gangaune] Norwegian Univ Sci & Technol, Reg Ctr Child & Adolescence Mental Hlth, Fac Med, N-7491 Trondheim, Norway; [Moen, Kent Goran; Vik, Anne] St Olavs Univ Hosp, Dept Neurosurg, Trondheim, Norway; [Haberg, Asta Kristine] St Olavs Univ Hosp, Dept Med Imaging, Trondheim, Norway; [Skandsen, Toril] St Olavs Univ Hosp, Dept Phys Med & Rehabil, Trondheim, Norway; [Finnanger, Torun Gangaune] St Olavs Univ Hosp, Dept Child & Adolescent Psychiat, Dept Div Mental Hlth, Trondheim, Norway	Moen, KG (corresponding author), Norwegian Univ Sci & Technol, Dept Neurosci, N-7491 Trondheim, Norway.	kent.g.moen@ntnu.no	Skandsen, Toril/P-6767-2014	Skandsen, Toril/0000-0001-5495-9338	Liaison Committee; Norwegian ExtraFoundation for Health and Rehabilitation [2010/2/0105]	We thank Stine Borgen Lund and Beate Holmqvist Karlsen for participating in the management of the database and the GOSE interviews. Drs. Moen, Skandsen, and Finnanger received a research grant from the Liaison Committee between the Central Norway Regional Health Authority (RHA) and the Norwegian University of Science and Technology (NTNU) during the study period. This work was also supported by the Norwegian ExtraFoundation for Health and Rehabilitation (Dr. Finnanger, grant number 2010/2/0105).	ABOITIZ F, 1992, BRAIN RES, V598, P143, DOI 10.1016/0006-8993(92)90178-C; Aboitiz F, 1992, Biol Res, V25, P51; Basser PJ, 2002, NMR BIOMED, V15, P456, DOI 10.1002/nbm.783; Bendlin BB, 2008, NEUROIMAGE, V42, P503, DOI 10.1016/j.neuroimage.2008.04.254; Brandstack N, 2011, CLIN NEURORADIOL, V21, P75, DOI 10.1007/s00062-011-0058-5; Caeyenberghs K, 2011, NEUROREHAB NEURAL RE, V25, P492, DOI 10.1177/1545968310394870; Chan JHM, 2003, NEURORADIOLOGY, V45, P34, DOI 10.1007/s00234-002-0891-y; Chang MC, 2010, NEUROREHABILITATION, V26, P339, DOI 10.3233/NRE-2010-0571; Delis D.C., 2001, DELIS KAPLAN EXECUTI; Gasparetto EL, 2011, NEUROIMAG CLIN N AM, V21, P115, DOI 10.1016/j.nic.2011.02.003; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; Goetz P, 2004, J NEUROTRAUM, V21, P645, DOI 10.1089/0897715041269731; Heaton R., 1993, WISCONSIN CARD SORTI; Hofer S, 2006, NEUROIMAGE, V32, P989, DOI 10.1016/j.neuroimage.2006.05.044; Hou DJ, 2007, J NEUROTRAUM, V24, P1558, DOI 10.1089/neu.2007.0339; Huisman TAGM, 2003, J COMPUT ASSIST TOMO, V27, P5, DOI 10.1097/00004728-200301000-00002; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Kumar R, 2010, J HEAD TRAUMA REHAB, V25, P31, DOI 10.1097/HTR.0b013e3181bff331; Kurth F, 2013, HUM BRAIN MAPP, V34, P2259, DOI 10.1002/hbm.22060; LEBIHAN D, 1986, RADIOLOGY, V161, P401, DOI 10.1148/radiology.161.2.3763909; Leclercq PD, 2001, J NEUROTRAUM, V18, P1, DOI 10.1089/089771501750055721; Lezak M.D., 2004, NEUROPSYCHOLOGICAL A, Vfourth; Liu AY, 1999, AM J NEURORADIOL, V20, P1636; Ljungqvist J, 2011, BRAIN INJURY, V25, P370, DOI 10.3109/02699052.2011.558038; Matthews C, 1964, INSTRUCTION MANUAL A; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Moen KG, 2012, J NEUROL NEUROSUR PS, V83, P1193, DOI 10.1136/jnnp-2012-302644; Newcombe V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019214; Perlbarg V, 2009, HUM BRAIN MAPP, V30, P3924, DOI 10.1002/hbm.20817; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Skandsen T, 2010, ARCH PHYS MED REHAB, V91, P1904, DOI 10.1016/j.apmr.2010.08.021; Skandsen T, 2010, J NEUROSURG, V113, P556, DOI 10.3171/2009.9.JNS09626; Smith A., 2002, SYMBOL DIGIT MODALIT; TOMASCH J, 1954, ANAT REC, V119, P119, DOI 10.1002/ar.1091190109; Vargas ME, 2007, ANNU REV NEUROSCI, V30, P153, DOI 10.1146/annurev.neuro.30.051606.094354	37	18	18	0	7	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 1	2014	31	1					56	63		10.1089/neu.2013.3000			8	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	302WJ	WOS:000330635500006	23837731	Green Published			2021-06-18	
J	Mondello, S; Cantrell, A; Italiano, D; Fodale, V; Mondello, P; Ang, D				Mondello, Stefania; Cantrell, Amy; Italiano, Domenico; Fodale, Vincenzo; Mondello, Patrizia; Ang, Darwin			Complications of Trauma Patients Admitted to the ICU in Level I Academic Trauma Centers in the United States	BIOMED RESEARCH INTERNATIONAL			English	Article							BLUNT CHEST TRAUMA; BRAIN-INJURY; GENDER; MORTALITY; OUTCOMES; MALES; IMPACT; ADULT; COSTS	Background. The aims of this study were to evaluate the complications that occur after trauma and the characteristics of individuals who develop complications, to identify potential risk factors that increase their incidence, and finally to investigate the relationship between complications and mortality. Methods. We did a population-based retrospective study of trauma patients admitted to ICUs of a level I trauma center. Logistic regression analyses were performed to determine independent predictors for complications. Results. Of the 11,064 patients studied, 3,451 trauma patients developed complications (31.2%). Complications occurred significantly more in younger male patients. Length of stay was correlated with the number of complications (R = 0.435, P < 0.0001). The overall death rate did not differ between patients with or without complications. The adjusted odds ratio (OR) of developing complication for patients over age 75 versus young adults was 0.7 (P < 0.0001). Among males, traumatic central nervous system (CNS) injury was an important predictor for complications (adjusted OR 1.24). Conclusions. Complications after trauma were found to be associated with age, gender, and traumatic CNS injury. Although these are not modifiable factors, they may identify subjects at high risk for the development of complications, allowing for preemptive strategies for prevention.	[Mondello, Stefania; Fodale, Vincenzo] Univ Messina, Dept Neurosci, I-98125 Messina, Italy; [Cantrell, Amy] Univ Florida, Coll Publ Hlth & Hlth Profess, Coll Med, Dept Biostat, Gainesville, FL 32611 USA; [Italiano, Domenico] Univ Messina, Dept Clin & Expt Med & Pharmacol, I-98125 Messina, Italy; [Mondello, Patrizia] Univ Messina, Dept Human Pathol, I-98125 Messina, Italy; [Ang, Darwin] Univ S Florida, Ocala, FL USA; [Ang, Darwin] Ocala Reg Med Ctr, Trauma Serv, Ocala, FL USA	Mondello, S (corresponding author), Univ Messina, Dept Neurosci, Via Consolare Valeria, I-98125 Messina, Italy.	stm_mondello@hotmail.com	Fodale, Vincenzo/G-5554-2010; Mondello, Patrizia/AAD-2126-2021; Mondello, Patrizia/AAD-6271-2020; Mondello, Stefania/A-1813-2012	Fodale, Vincenzo/0000-0001-9540-5665; Mondello, Patrizia/0000-0002-0355-3757; Mondello, Stefania/0000-0002-8587-3614			Ang DN, 2009, J AM COLL SURGEONS, V209, P595, DOI 10.1016/j.jamcollsurg.2009.08.003; Angele MK, 1998, J TRAUMA, V44, P78, DOI 10.1097/00005373-199801000-00007; Bardenheuer M, 2000, UNFALLCHIRURG, V103, P355, DOI 10.1007/s001130050550; Bramlett HM, 2001, J NEUROTRAUM, V18, P891, DOI 10.1089/089771501750451811; CDC, 2004, NAT EST TENLEADING C; de Jongh MAC, 2011, J TRAUMA, V71, pE102, DOI 10.1097/TA.0b013e31820e351f; DePorter J, 1997, Best Pract Benchmarking Healthc, V2, P147; Djebaili M, 2004, NEUROSCIENCE, V123, P349, DOI 10.1016/j.neuroscience.2003.09.023; Feliciano DV, 2008, TRAUMA; Glance LG, 2012, ARCH SURG-CHICAGO, V147, P732, DOI 10.1001/archsurg.2012.1138; Haider AH, 2009, SURGERY, V146, P308, DOI 10.1016/j.surg.2009.05.006; Harrington DT, 2010, ARCH SURG-CHICAGO, V145, P432, DOI 10.1001/archsurg.2010.71; Holbrook TL, 2001, J TRAUMA, V50, P91, DOI 10.1097/00005373-200101000-00016; Ingraham AM, 2010, ANN SURG, V252, P358, DOI 10.1097/SLA.0b013e3181e623bf; Irwin ZN, 2004, SPINE, V29, P796, DOI 10.1097/01.BRS.0000119400.92204.B5; Kuhne CA, 2005, WORLD J SURG, V29, P1476, DOI 10.1007/s00268-005-7796-y; MacKenzie EJ, 2007, J TRAUMA, V63, pS54, DOI 10.1097/TA.0b013e31815acb09; Magnotti LJ, 2008, J AM COLL SURGEONS, V206, P984, DOI 10.1016/j.jamcollsurg.2007.12.038; McDonald K, 2002, TECHNICAL REV; Napolitano LM, 2001, J TRAUMA, V50, P274, DOI 10.1097/00005373-200102000-00013; Pape HC, 2000, J TRAUMA, V49, P496, DOI 10.1097/00005373-200009000-00018; Pfeifer R, 2009, INJURY, V40, P907, DOI 10.1016/j.injury.2009.05.006; Roof RL, 1997, MOL CHEM NEUROPATHOL, V31, P1, DOI 10.1007/BF02815156; ROOF RL, 1993, BRAIN RES, V607, P333, DOI 10.1016/0006-8993(93)91526-X; Ruchholtz S, 2000, UNFALLCHIRURG, V103, P30, DOI 10.1007/s001130050005; Shafi S, 2010, J TRAUMA, V69, P1367, DOI 10.1097/TA.0b013e3181fb785d; Slee V. N., 2005, N CAROLINA MED J, V66, P331; SLEE VN, 1978, ANN INTERN MED, V88, P424, DOI 10.7326/0003-4819-88-3-424; Sperry JL, 2008, J LEUKOCYTE BIOL, V83, P499, DOI 10.1189/jlb.0607360; Taylor MD, 2002, J TRAUMA, V53, P407, DOI 10.1097/00005373-200209000-00001; Wagner AK, 2004, BRAIN RES, V998, P113, DOI 10.1016/j.brainres.2003.11.027; World Health Organization, GLOBAL BURDEN DIS	32	18	19	0	0	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	2314-6133	2314-6141		BIOMED RES INT	Biomed Res. Int.		2014	2014								473419	10.1155/2014/473419			7	Biotechnology & Applied Microbiology; Medicine, Research & Experimental	Biotechnology & Applied Microbiology; Research & Experimental Medicine	AJ1PQ	WOS:000337428500001	24995300	DOAJ Gold, Green Published			2021-06-18	
J	Mullen, SJ; Yucel, YH; Cusimano, M; Schweizer, TA; Oentoro, A; Gupta, N				Mullen, Sarah J.; Yuecel, Yeni H.; Cusimano, Michael; Schweizer, Tom A.; Oentoro, Anton; Gupta, Neeru			Saccadic Eye Movements in Mild Traumatic Brain Injury: A Pilot Study	CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES			English	Article							HEAD-INJURY; CONCUSSION; RECOVERY; LATENCY; DEPRESSION; EPIDEMIOLOGY; SACCADOMETRY; PERFORMANCE; DYSFUNCTION; GUIDELINES	Objective: To investigate whether repeat saccadic reaction time (SRT) measurements using a portable saccadometer is useful to monitor patients with mild traumatic brain injury (mTBI). Methods: Seven patients with newly-diagnosed mTBI and five age-matched controls were prospectively recruited from an Emergency Department. Saccadic eye movements, symptom self-reporting and neuropsychological tests were performed within one week of injury and again at follow-up three weeks post-injury. Control patients underwent saccade recordings at similar intervals. Results: Median saccade reaction times were significantly prolonged within one week post-injury in mTBI compared to controls. At follow-up assessment there was no significant between-groups difference. Changes in median SRT between the two assessments were not statistically significant. Four of the seven mTBI patients showed significantly increased SRT at follow-up; three of the mTBI patients and all controls showed no significant change. Among the three mTBI patients with persistent decreased SRT, two experienced loss of consciousness and reported the greatest symptoms, while the third was the only subject with significant decrease in neuropsychological testing scores at both assessments. Conclusion: In three of seven mTBI patients, saccadic eye movements remained delayed within three weeks post-injury. These three patients also showed persistent symptoms or no improvement on neuropsychological testing. This pilot study using a portable saccadometer suggests that comparing SRT from three weeks post-injury to that within one week of injury may be useful for early detection of a subpopulation at risk of persistent disability from mTBI. This finding suggests that further investigation in a large study population is warranted.	[Mullen, Sarah J.; Yuecel, Yeni H.; Cusimano, Michael; Schweizer, Tom A.; Oentoro, Anton; Gupta, Neeru] St Michaels Hosp, Toronto, ON M5B 1W8, Canada; [Mullen, Sarah J.; Yuecel, Yeni H.; Cusimano, Michael; Schweizer, Tom A.; Gupta, Neeru] St Michaels Hosp, Li Ka Shing Knowledge Inst, Div Neurosurg, Keenan Res Ctr, Toronto, ON M5B 1W8, Canada; [Gupta, Neeru] St Michaels Hosp, Glaucoma & Nerve Protect Unit, Toronto, ON M5B 1W8, Canada	Yucel, YH (corresponding author), St Michaels Hosp, Li Ka Shing Knowledge Inst, 30 Bond St,209 LKSKI,Room 409, Toronto, ON M5B 1W8, Canada.	yucely@smh.ca	yucel, yeni/AAX-9628-2020; Cusimano, Michael/X-4059-2019	Gupta, Neeru/0000-0001-8141-7710; Cusimano, Michael/0000-0002-9989-0650	Ontario Neurotrauma Foundation; Glaucoma Research Society of Canada; Dorothy Pitts Research Fund; Canadian Institutes of Health Research Strategic Team Grant in Applied Injury ResearchCanadian Institutes of Health Research (CIHR) [TIR-103946]	This study was supported by the Ontario Neurotrauma Foundation, Glaucoma Research Society of Canada (NG, YY), Dorothy Pitts Research Fund (NG) and Canadian Institutes of Health Research Strategic Team Grant in Applied Injury Research # TIR-103946. The authors thank Barbara Thomson MSc for her help with statistical analysis. The authors report no conflicts of interest in this work.	Alessandrini M, 2001, An Otorrinolaringol Ibero Am, V28, P269; Antoniades CA, 2007, NEUROREPORT, V18, P1133, DOI 10.1097/WNR.0b013e32821c560d; Bay E, 2007, ARCH PSYCHIAT NURS, V21, P2, DOI 10.1016/j.apnu.2006.07.005; Bazarian JJ, 1999, BRAIN INJURY, V13, P173, DOI 10.1080/026990599121692; Bazarian JJ, 2001, ACAD EMERG MED, V8, P788, DOI 10.1111/j.1553-2712.2001.tb00208.x; Becker W., 1989, NEUROBIOLOGY SACCADI, P13; BRIGELL MG, 1988, INVEST OPHTH VIS SCI, V29, P1331; Burrell JR, 2012, NEUROLOGY, V78, P1816, DOI 10.1212/WNL.0b013e318258f75c; Carpenter RH, 2004, ADV CLIN NEUROSCI RE, V4, P6, DOI DOI 10.1016/J.CUB.2004.08.058; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Echemendia RJ, 2009, BRIT J SPORT MED, V43, pI32, DOI 10.1136/bjsm.2009.058164; Echemendia RJ, 2001, CLIN J SPORT MED, V11, P23, DOI 10.1097/00042752-200101000-00005; Falconer EK, 2006, BRAIN INJURY, V20, P1251, DOI 10.1080/02699050601049601; FISCHER B, 1993, EXP BRAIN RES, V92, P528; Fischer B, 1997, BRAIN RES, V754, P285, DOI 10.1016/S0006-8993(97)00094-2; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Heitger MH, 2006, BRAIN INJURY, V20, P807, DOI 10.1080/02699050600676354; Heitger MH, 2009, BRAIN, V132, P2850, DOI 10.1093/brain/awp181; Heitger MH, 2005, BRAIN INJURY, V19, P109, DOI 10.1080/02699050410001720095; Heitger MH, 2002, PROG BRAIN RES, V140, P433; Irving EL, 2006, INVEST OPHTH VIS SCI, V47, P2478, DOI 10.1167/iovs.05-1311; Kanjee R, 2012, EYE BRAIN, V4, P63, DOI 10.2147/EB.S38467; Kelly JP, 1997, NEUROLOGY, V48, P575, DOI 10.1212/WNL.48.3.575; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kushner D, 1998, ARCH INTERN MED, V158, P1617, DOI 10.1001/archinte.158.15.1617; Laker SR, 2011, PM&R, V3, pS354, DOI 10.1016/j.pmrj.2011.07.017; Lange RT, 2009, BRAIN INJURY, V23, P83, DOI 10.1080/02699050802635281; Lannsjo M, 2011, J REHABIL MED, V43, P997, DOI 10.2340/16501977-0875; Leigh JR, 1999, NEUROLOGY EYE MOVEME, P101; Leigh RJ, 2004, BRAIN, V127, P460, DOI 10.1093/brain/awh035; Lovell MR, 2011, APPL NEUROPSYCHOL, V18, P197, DOI 10.1080/09084282.2011.595446; Macciocchi SN, 1996, NEUROSURGERY, V39, P510, DOI 10.1097/00006123-199609000-00014; Maruta J, 2010, ANN NY ACAD SCI, V1208, P58, DOI 10.1111/j.1749-6632.2010.05695.x; McCauley SR, 2006, BRAIN INJURY, V20, P519, DOI 10.1080/02699050600676651; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2002, NEUROSURGERY, V50, P1032, DOI 10.1097/00006123-200205000-00017; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; Michell AW, 2006, EXP BRAIN RES, V174, P7, DOI 10.1007/s00221-006-0412-z; Munoz DP, 1998, EXP BRAIN RES, V121, P391, DOI 10.1007/s002210050473; Ober JK, 2003, MODELLING MEASUREMEN, P187; Pearson BC, 2007, BRIT J SPORT MED, V41, DOI 10.1136/bjsm.2007.036731; Pellman EJ, 2006, NEUROSURGERY, V58, P263, DOI 10.1227/01.NEU.0000200272.56192.62; Peloso PM, 2004, J REHABIL MED, V36, P106, DOI 10.1080/16501960410023868; PIERROTDESEILLIGNY C, 1991, BRAIN, V114, P1473, DOI 10.1093/brain/114.3.1473; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Preece MHW, 2007, BRAIN INJURY, V21, P951, DOI 10.1080/02699050701481647; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Reddi BAJ, 2000, NAT NEUROSCI, V3, P827; Reilly JL, 2008, BRAIN COGNITION, V68, P415, DOI 10.1016/j.bandc.2008.08.026; REULEN JPH, 1984, BIOL CYBERN, V50, P263, DOI 10.1007/BF00337076; RIVAUD S, 1994, EXP BRAIN RES, V102, P110; Schmidt JD, 2012, MED SCI SPORT EXER, V44, P1621, DOI 10.1249/MSS.0b013e318258a9fb; Shafiq-Antonacci R, 1999, J GERONTOL B-PSYCHOL, V54, pP361, DOI 10.1093/geronb/54B.6.P361; Sherman EMS, 2006, COMPENDIUM NEUROPSYC, P767; Sparks D, 2000, VISION RES, V40, P2763, DOI 10.1016/S0042-6989(00)00133-4; SWEENEY JA, 1991, J PSYCHIATR NEUROSCI, V16, P247; Tavender EJ, 2011, ACAD EMERG MED, V18, P880, DOI 10.1111/j.1553-2712.2011.01134.x; Vos PE, 2002, EUR J NEUROL, V9, P207, DOI 10.1046/j.1468-1331.2002.00407.x; Williams IM, 1997, J CLIN NEUROSCI, V4, P186, DOI 10.1016/S0967-5868(97)90072-2; Winograd-Gurvich C, 2006, NEUROSCI RES, V56, P253, DOI 10.1016/j.neures.2006.07.003	60	18	18	0	16	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0317-1671	2057-0155		CAN J NEUROL SCI	Can. J. Neurol. Sci.	JAN	2014	41	1					58	65		10.1017/S0317167100016279			8	Clinical Neurology	Neurosciences & Neurology	AY4WK	WOS:000347575700012	24384339	Bronze			2021-06-18	
J	Piras, F; Piras, F; Ciullo, V; Danese, E; Caltagirone, C; Spalletta, G				Piras, Federica; Piras, Fabrizio; Ciullo, Valentina; Danese, Emanuela; Caltagirone, Carlo; Spalletta, Gianfranco			Time dysperception perspective for acquired brain injury	FRONTIERS IN NEUROLOGY			English	Article						interval timing; cognitive dysfunction; time distortions; brain damage; information processing	MEDIAL-TEMPORAL-LOBE; WORKING-MEMORY; INTERNAL CLOCK; PARKINSONS-DISEASE; TIMING DEFICITS; SUBJECTIVE TIME; SMOOTH-PURSUIT; PERCEPTION; ATTENTION; DURATION	Distortions of time perception are presented by a number of neuropsychiatric illnesses. Here we survey timing abilities in clinical populations with focal lesions in key brain structures recently implicated in human studies of timing. We also review timing performance in amnesic and traumatic brain injured patients in order to identify the nature of specific timing disorders in different brain damaged populations. We purposely analyzed the complex relationship between both cognitive and contextual factors involved in time estimation, as to characterize the correlation between timed and other cognitive behaviors in each group. We assume that interval timing is a solid construct to study cognitive dysfunctions following brain injury, as timing performance is a sensitive metric of information processing, while temporal cognition has the potential of influencing a wide range of cognitive processes. Moreover, temporal performance is a sensitive assay of damage to the underlying neural substrate after a brain insult. Further research in neurological and psychiatric patients will clarify whether time distortions are a manifestation of, or a mechanism for, cognitive and behavioral symptoms of neuropsychiatric disorders.	[Piras, Federica; Piras, Fabrizio; Ciullo, Valentina; Caltagirone, Carlo; Spalletta, Gianfranco] IRCCS Santa Lucia Fdn, Dept Clin & Behav Neurol, Neuropsychiat Lab, Via Ardeatina 306, I-00179 Rome, Italy; [Danese, Emanuela] Univ Roma La Sapienza, Fac Med 2, St Andrea Hosp, NESMOS Dept, Rome, Italy	Spalletta, G (corresponding author), IRCCS Santa Lucia Fdn, Dept Clin & Behav Neurol, Neuropsychiat Lab, Via Ardeatina 306, I-00179 Rome, Italy.	g.spalletta@hsantalucia.it	Spalletta, Gianfranco/K-3828-2018; Piras, Fabrizio/M-7902-2016	Spalletta, Gianfranco/0000-0002-7432-4249; Piras, Fabrizio/0000-0003-3566-5494; Ciullo, Valentina/0000-0002-6870-6259			Adcock RA, 2006, NEURON, V50, P507, DOI 10.1016/j.neuron.2006.03.036; Allman MJ, 2012, BRAIN, V135, P656, DOI 10.1093/brain/awr210; Anderson JW, 2011, NEUROPSYCHOLOGY, V25, P36, DOI 10.1037/a0020333; Aparicio P, 2005, BRAIN COGNITION, V58, P62, DOI 10.1016/j.bandc.2004.09.009; BADLER J, 2008, J VIS, V8, P672, DOI DOI 10.1167/8.6.672; Balci Fuat, 2009, P161, DOI 10.1007/978-1-59745-422-3_8; Bares M, 2010, CEREBELLUM, V9, P124, DOI 10.1007/s12311-009-0133-5; Basso G, 1996, NEUROREPORT, V7, P2111, DOI 10.1097/00001756-199609020-00009; Battelli L, 2007, TRENDS COGN SCI, V11, P204, DOI 10.1016/j.tics.2007.03.001; Baudouin A, 2006, ACTA PSYCHOL, V121, P285, DOI 10.1016/j.actpsy.2005.07.004; Beste C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001263; Beudel M, 2009, NEUROIMAGE, V44, P1032, DOI 10.1016/j.neuroimage.2008.09.028; Bidwell LC, 2010, CURR PSYCHIAT REP, V12, P366, DOI 10.1007/s11920-010-0136-4; Blanchard MM, 2011, PSYCHOL MED, V41, P611, DOI 10.1017/S003329171000098X; Block RA, 2010, ACTA PSYCHOL, V134, P330, DOI 10.1016/j.actpsy.2010.03.006; Bueti D, 2009, PHILOS T R SOC B, V364, P1831, DOI 10.1098/rstb.2009.0028; Buhusi CV, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006268; Buhusi CV, 2009, PHILOS T R SOC B, V364, P1875, DOI 10.1098/rstb.2009.0022; Buhusi CV, 2002, BEHAV NEUROSCI, V116, P291, DOI 10.1037//0735-7044.116.2.291; Carroll CA, 2009, BRAIN COGNITION, V70, P181, DOI 10.1016/j.bandc.2009.02.001; Casini L, 1999, NEUROPSYCHOLOGY, V13, P10, DOI 10.1037/0894-4105.13.1.10; CHURCH RM, 1984, ANN NY ACAD SCI, V423, P566, DOI 10.1111/j.1749-6632.1984.tb23459.x; Claassen DO, 2013, NEUROPSYCHOLOGIA, V51, P267, DOI 10.1016/j.neuropsychologia.2012.09.018; Coslett HB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010324; Coull JT, 2008, CURR OPIN NEUROBIOL, V18, P137, DOI 10.1016/j.conb.2008.07.011; Coull JT, 2008, J COGNITIVE NEUROSCI, V20, P2185, DOI 10.1162/jocn.2008.20153; Coull JT, 2012, J NEUROSCI, V32, P16704, DOI 10.1523/JNEUROSCI.1258-12.2012; Coull JT, 2011, NEUROPSYCHOPHARMACOL, V36, P3, DOI 10.1038/npp.2010.113; Coull JT, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000166; Coull JT, 2001, CEREB CORTEX, V11, P73, DOI 10.1093/cercor/11.1.73; Coull JT, 1998, J NEUROSCI, V18, P7426; Coull JT, 2004, SCIENCE, V303, P1506, DOI 10.1126/science.1091573; CREELMAN CD, 1962, J ACOUST SOC AM, V34, P582, DOI 10.1121/1.1918172; Danckert J, 2007, J COGNITIVE NEUROSCI, V19, P1706, DOI 10.1162/jocn.2007.19.10.1706; Foster SM, 2013, NEUROPSYCHOLOGIA, V51, P211, DOI 10.1016/j.neuropsychologia.2012.09.017; Fukushima K, 2013, FRONT SYST NEUROSCI, V7, DOI 10.3389/fnsys.2013.00004; Gallistel C.R., 1990, ORG LEARNING LEARNIN; Gibbon J, 1984, AN COGN P HF GUGGENH; Gilden DL, 2009, NEUROPSYCHOLOGY, V23, P265, DOI 10.1037/a0014553; Harrington DL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017461; Harrington DL, 1998, NEUROPSYCHOLOGY, V12, P3, DOI 10.1037/0894-4105.12.1.3; Harrington DL, 2004, BRAIN, V127, P561, DOI 10.1093/brain/awh065; Hartikainen KM, 2010, J CLIN EXP NEUROPSYC, V32, P767, DOI 10.1080/13803390903521000; Head D, 2008, NEUROPSYCHOLOGY, V22, P491, DOI 10.1037/0894-4105.22.4.491; Henry MJ, 2015, CEREB CORTEX, V25, P450, DOI 10.1093/cercor/bht240; Huang J, 2012, RES DEV DISABIL, V33, P538, DOI 10.1016/j.ridd.2011.10.021; Ivry RB, 1996, CURR OPIN NEUROBIOL, V6, P851, DOI 10.1016/S0959-4388(96)80037-7; Jahanshahi M, 2010, BRAIN, V133, P727, DOI 10.1093/brain/awq012; Jones CRG, 2011, FRONT INTEGR NEUROSC, V5, DOI 10.3389/fnint.2011.00081; Jones LA, 2004, Q J EXP PSYCHOL-B, V57, P55, DOI 10.1080/02724990344000088; Kagerer FA, 2002, NEUROPSYCHOLOGIA, V40, P357, DOI 10.1016/S0028-3932(01)00111-7; Kinsbourne M, 2002, NEUROBEHAVIOR LANGUA, P315; Kinsbourne M, 1990, NEUROPSYCHOLOGICAL I, P319, DOI DOI 10.1017/CBO9780511665547.017; Koch G, 2003, NEUROLOGY, V60, P1844, DOI 10.1212/WNL.60.11.1844; Koch G, 2002, NEUROLOGY, V59, P1658, DOI 10.1212/01.WNL.0000032504.45792.8F; Koch G, 2009, PHILOS T R SOC B, V364, P1907, DOI 10.1098/rstb.2009.0018; Leea AS, 2008, P NATL ACAD SCI USA, V105, P17163, DOI 10.1073/pnas.0807749105; Lewis PA, 2006, BEHAV PROCESS, V71, P226, DOI 10.1016/j.beproc.2005.12.009; Lewis PA, 2003, NEUROPSYCHOLOGIA, V41, P1583, DOI 10.1016/S0028-3932(03)00118-0; Lewis PA, 2012, PSYCHOLOGIST, V25, P594; Lustig C, 2005, BRAIN COGNITION, V58, P9, DOI 10.1016/j.bandc.2004.09.005; MACAR F, 2003, METH NE FRO NEUROSCI, P533; Mangels JA, 1998, COGNITIVE BRAIN RES, V7, P15, DOI 10.1016/S0926-6410(98)00005-6; Marx I, 2010, J NEURAL TRANSM, V117, P403, DOI 10.1007/s00702-009-0345-3; Matell MS, 2004, COGNITIVE BRAIN RES, V21, P139, DOI 10.1016/j.cogbrainres.2004.06.012; MECK WH, 1984, ANN NY ACAD SCI, V423, P528, DOI 10.1111/j.1749-6632.1984.tb23457.x; Meck WH, 2005, BRAIN COGNITION, V58, P1, DOI 10.1016/j.bandc.2004.09.004; Meck WH, 1996, COGNITIVE BRAIN RES, V3, P227, DOI 10.1016/0926-6410(96)00009-2; Meck WH, 2002, LEARN MOTIV, V33, P88, DOI 10.1006/lmot.2001.1101; Melgire M, 2005, BRAIN COGNITION, V58, P119, DOI 10.1016/j.bandc.2004.09.013; MEYERS CA, 1992, NEUROPSY NEUROPSY BE, V5, P28; MILNER B, 1991, NEUROPSYCHOLOGIA, V29, P601, DOI 10.1016/0028-3932(91)90013-X; Mimura M, 2000, J INT NEUROPSYCH SOC, V6, P517, DOI 10.1017/S1355617700655017; Mioni G, 2013, BRAIN COGNITION, V81, P305, DOI 10.1016/j.bandc.2012.12.005; Mioni G, 2013, J CLIN EXP NEUROPSYC, V35, P90, DOI 10.1080/13803395.2012.755151; Mioni G, 2012, J INT NEUROPSYCH SOC, V18, P697, DOI 10.1017/S1355617712000306; N'Diaye K, 2004, COGNITIVE BRAIN RES, V21, P250, DOI 10.1016/j.cogbrainres.2004.04.006; Nichelli P, 1995, ANN NY ACAD SCI, V769, P183, DOI 10.1111/j.1749-6632.1995.tb38139.x; Noulhiane M, 2007, NEUROREPORT, V18, P1035, DOI 10.1097/WNR.0b013e3281668be1; O'Reilly JX, 2008, J NEUROSCI, V28, P2252, DOI 10.1523/JNEUROSCI.2742-07.2008; Papageorgiou C, 2013, PROG NEURO-PSYCHOPH, V40, P173, DOI 10.1016/j.pnpbp.2012.07.017; Paulsen JS, 2004, AM J NEURORADIOL, V25, P1715; Penhune VB, 1999, NEUROPSYCHOLOGIA, V37, P315, DOI 10.1016/S0028-3932(98)00075-X; Penney TB, 2005, BRAIN COGNITION, V58, P109, DOI 10.1016/j.bandc.2004.09.012; PentonVoak IS, 1996, J EXP PSYCHOL ANIM B, V22, P307, DOI 10.1037/0097-7403.22.3.307; Perbal S, 2003, NEUROPSYCHOLOGIA, V41, P1599, DOI 10.1016/S0028-3932(03)00110-6; Perbal S, 2001, NEUROREPORT, V12, P939, DOI 10.1097/00001756-200104170-00015; Perbal S, 2000, NEUROCASE, V6, P347, DOI 10.1080/13554790008402782; Perbal-Hatif Severine, 2012, Dialogues Clin Neurosci, V14, P425; Pierce RC, 2006, NEUROSCI BIOBEHAV R, V30, P215, DOI 10.1016/j.neubiorev.2005.04.016; Piras F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018203; Pouthas V, 2004, ACTA NEUROBIOL EXP, V64, P367; RAMMSAYER TH, 1991, PERCEPT PSYCHOPHYS, V50, P565, DOI 10.3758/BF03207541; Rammsayer TH, 1997, NEUROPSYCHOBIOLOGY, V35, P36, DOI 10.1159/000119328; Rammsayer TH, 1999, Q J EXP PSYCHOL-B, V52, P273; Rammsayer TH, 2001, Q J EXP PSYCHOL-B, V54, P247, DOI 10.1080/02724990143000036; Rammsayer TH, 2001, EUR J COGN PSYCHOL, V13, P549, DOI 10.1080/09541440042000322; Roy M, 2012, PSYCHIAT RES, V200, P159, DOI 10.1016/j.psychres.2012.06.008; Rubia K, 1997, NEUROREPORT, V8, P1273, DOI 10.1097/00001756-199703240-00043; Schmitter-Edgecombe M, 2008, J CLIN EXP NEUROPSYC, V30, P212, DOI 10.1080/13803390701363803; SHAW C, 1994, NEUROPSYCHOLOGIA, V32, P857, DOI 10.1016/0028-3932(94)90023-X; Skandsen T, 2010, J NEUROSURG, V113, P556, DOI 10.3171/2009.9.JNS09626; Smith A, 2002, J CHILD PSYCHOL PSYC, V43, P529, DOI 10.1111/1469-7610.00043; Smith JG, 2007, BRAIN COGNITION, V64, P130, DOI 10.1016/j.bandc.2007.01.005; Stuss DT, 2005, NEUROPSYCHOLOGIA, V43, P396, DOI 10.1016/j.neuropsychologia.2004.06.010; Suh M, 2006, NEUROSCI LETT, V401, P108, DOI 10.1016/j.neulet.2006.02.074; Teixeira S, 2013, CNS NEUROL DISORD-DR, V12, P567; Toplak ME, 2005, PERCEPT MOTOR SKILL, V100, P659, DOI 10.2466/PMS.100.3.659-675; TREISMAN M, 1963, PSYCHOL MONOGR, V77, P1, DOI 10.1037/h0093864; Trivino M, 2010, BRAIN, V133, P1173, DOI 10.1093/brain/awp346; TYSK L, 1983, PERCEPT MOTOR SKILL, V56, P983, DOI 10.2466/pms.1983.56.3.983; Vallesi A, 2007, NEUROPSYCHOLOGIA, V45, P2755, DOI 10.1016/j.neuropsychologia.2007.04.017; Vidalaki VN, 1999, NEUROPSYCHOLOGIA, V37, P1061, DOI 10.1016/S0028-3932(98)00155-9; VONSTEINBUCHEL N, 1993, BEHAV BRAIN RES, V56, P1, DOI 10.1016/0166-4328(93)90017-K; WAHL OF, 1980, PERCEPT MOTOR SKILL, V50, P535, DOI 10.2466/pms.1980.50.2.535; Wearden JH, 2008, BRAIN COGNITION, V67, P264, DOI 10.1016/j.bandc.2008.01.010; Wearden JH, 1997, J EXP PSYCHOL HUMAN, V23, P962; WEARDEN JH, 1995, Q J EXP PSYCHOL-B, V48, P129; Wearden JH, 1999, BEHAV PROCESS, V46, P25, DOI 10.1016/S0376-6357(98)00059-X; Wearden JH, 2001, Q J EXP PSYCHOL-B, V54, P289, DOI 10.1080/02724990042000173; Wiener M, 2008, NEUROPSYCHOLOGIA, V46, P1927, DOI 10.1016/j.neuropsychologia.2008.01.021; Wiener M, 2011, J COGNITIVE NEUROSCI, V23, P2811, DOI 10.1162/jocn.2011.21626; WILLIAMS JM, 1989, J CLIN EXP NEUROPSYC, V11, P713, DOI 10.1080/01688638908400927; Yin B, 2011, FRONT INTEGR NEUROSC, V5, DOI 10.3389/fnint.2011.00036; Zakay D, 1997, CURR DIR PSYCHOL SCI, V6, P12, DOI 10.1111/1467-8721.ep11512604; Zelaznik HN, 2012, HUM MOVEMENT SCI, V31, P255, DOI 10.1016/j.humov.2011.05.003	126	18	18	0	11	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.		2014	4								217	10.3389/fneur.2013.00217			10	Clinical Neurology; Neurosciences	Neurosciences & Neurology	V42QV	WOS:000209629200006	24454304	DOAJ Gold, Green Published			2021-06-18	
J	Purins, K; Lewen, A; Hillered, L; Howells, T; Enblad, P				Purins, Karlis; Lewen, Anders; Hillered, Lars; Howells, Tim; Enblad, Per			Brain tissue oxygenation and cerebral metabolic patterns in focal and diffuse traumatic brain injury	FRONTIERS IN NEUROLOGY			English	Article						brain tissue oxygenation; cerebral metabolism; traumatic brain injury; cerebral ischemia; Neurovent-PTO	MEMBRANE PHOSPHOLIPID DEGRADATION; INTRACEREBRAL MICRODIALYSIS; PERFUSION-PRESSURE; SUBARACHNOID HEMORRHAGE; HEAD-INJURY; INTERSTITIAL GLYCEROL; ARTERY OCCLUSION; ISCHEMIA; MANAGEMENT; RELEASE	Introduction: Neurointensive care of traumatic brain injury (TBI) patients is currently based on intracranial pressure (ICP) and cerebral perfusion pressure (CPP) targeted protocols. There are reasons to believe that knowledge of brain tissue oxygenation (BtipO(2)) would add information with the potential of improving patient outcome. The aim of this study was to examine B(ti)pO(2) and cerebral metabolism using the Neurovent-PTO probe and cerebral microdialysis (MD) in TBI patients. Methods: Twenty-three severe TBI patients with monitoring of physiological parameters, ICP CPP B(ti)pO(2), and MD for biomarkers of energy metabolism (glucose, lactate, and pyruvate) and cellular distress (glutamate, glycerol) were included. Patients were grouped according to injury type (focal/diffuse) and placement of the Neurovent-PTO probe and MD catheter (injured/non-injured hemisphere). Results: We observed different patterns in B(ti)pO(2) and MD biomarkers in diffuse and focal injury where placement of the probe also influenced the results (ipsilateral/contralateral). In all groups, despite fairly normal levels of ICP and CPP, increased MD levels of glutamate, glycerol, or the L/P ratio were observed at B(ti)pO(2) <5 mmHg, indicating increased vulnerability of the brain at this level. Conclusion: Monitoring of B(ti)pO(2) adds important information in addition to traditional ICP and CPP surveillance. Because of the different metabolic responses to very low B(ti)pO(2) in the individual patient groups we submit that brain tissue oximetry is a complementary tool rather than an alternative to MD monitoring.	[Purins, Karlis; Lewen, Anders; Hillered, Lars; Howells, Tim; Enblad, Per] Uppsala Univ, Dept Neurosci, Neurosurg Sect, Uppsala, Sweden	Purins, K (corresponding author), Uppsala Univ, Dept Neurosci, Neurosurg Sect, Uppsala, Sweden.; Purins, K (corresponding author), Uppsala Univ, Neurosurg Sect, Univ Uppsala Hosp, Dept Neurosci, SE-75185 Uppsala, Sweden.	karlis.purins@neuro.uu.se	Lewen, Anders/A-5156-2013	Lewen, Anders/0000-0003-4925-1348; Hillered, Lars/0000-0002-2808-9292	Swedish Research CouncilSwedish Research CouncilEuropean Commission; Swedish Brain Foundation; Selander Foundation; Ahlen Foundation; Uppsala University Hospital	Inger Stahl Myllyaho is acknowledged for excellent laboratory assistance. Financial support: the study was supported by The Swedish Research Council, Swedish Brain Foundation, Selander Foundation, Ahlen Foundation, and funds from the Uppsala University Hospital.	Bardt TF, 1998, ACT NEUR S, V71, P153; Beynon C, 2012, J NEUROTRAUM, V29, P2109, DOI 10.1089/neu.2012.2365; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS37; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; BULLOCK R, 1992, J NEUROTRAUM, V9, pS443; Bullock R, 1998, J NEUROSURG, V89, P507, DOI 10.3171/jns.1998.89.4.0507; Chamoun R, 2010, J NEUROSURG, V113, P564, DOI 10.3171/2009.12.JNS09689; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Clausen F, 2012, J NEUROTRAUM, V29, P766, DOI 10.1089/neu.2011.1754; Clausen T, 2005, J NEUROSURG, V103, P233, DOI 10.3171/jns.2005.103.2.0233; Dings J, 1998, NEUROL RES, V20, pS71; Enblad P, 1996, J CEREBR BLOOD F MET, V16, P637, DOI 10.1097/00004647-199607000-00014; Enblad P, 2001, STROKE, V32, P1574, DOI 10.1161/01.STR.32.7.1574; Engstrom M, 2005, J NEUROSURG, V102, P460, DOI 10.3171/jns.2005.102.3.0460; Frykholm P, 2001, J NEUROL NEUROSUR PS, V71, P455, DOI 10.1136/jnnp.71.4.455; GRAHAM DI, 1989, J NEUROL NEUROSUR PS, V52, P346, DOI 10.1136/jnnp.52.3.346; GRAHAM DI, 1978, J NEUROL SCI, V39, P213, DOI 10.1016/0022-510X(78)90124-7; Hillered L, 2005, J NEUROTRAUM, V22, P3, DOI 10.1089/neu.2005.22.3; Hillered L, 1998, J NEUROL NEUROSUR PS, V64, P486, DOI 10.1136/jnnp.64.4.486; Howells T, 2005, J NEUROSURG, V102, P311, DOI 10.3171/jns.2005.102.2.0311; Hutchinson PJ, 2002, J CEREBR BLOOD F MET, V22, P735, DOI 10.1097/00004647-200206000-00012; KATAYAMA Y, 1991, BRAIN RES, V558, P136, DOI 10.1016/0006-8993(91)90730-J; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Maas AIR, 1997, ACTA NEUROCHIR, V139, P286, DOI 10.1007/BF01808823; Marklund N, 1997, NEUROREPORT, V8, P1457, DOI 10.1097/00001756-199704140-00026; Nilsson OG, 1999, NEUROSURGERY, V45, P1176, DOI 10.1097/00006123-199911000-00032; NILSSON P, 1990, J CEREBR BLOOD F MET, V10, P631, DOI 10.1038/jcbfm.1990.115; Nordstrom CH, 2003, ANESTHESIOLOGY, V98, P809, DOI 10.1097/00000542-200304000-00004; Orakcioglu B, 2010, NEUROSURGERY, V67, P1716, DOI 10.1227/NEU.0b013e3181f9bb5b; PERSSON L, 1992, J NEUROSURG, V76, P72, DOI 10.3171/jns.1992.76.1.0072; Persson L, 1996, J NEUROSURG, V84, P606, DOI 10.3171/jns.1996.84.4.0606; Purins K, 2012, NEUROCRIT CARE, V16, P462, DOI 10.1007/s12028-012-9675-3; Purins K, 2011, CRIT CARE MED, V39, P512, DOI 10.1097/CCM.0b013e318206b824; Purins K, 2010, ACTA NEUROCHIR, V152, P681, DOI 10.1007/s00701-009-0532-x; Reinstrup P, 2000, NEUROSURGERY, V47, P701, DOI 10.1097/00006123-200009000-00035; ROSNER MJ, 1990, J TRAUMA, V30, P933, DOI 10.1097/00005373-199008000-00001; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; Samuelsson C, 2007, J CEREBR BLOOD F MET, V27, P1309, DOI 10.1038/sj.jcbfm.9600433; Sarrafzadeh A S, 2000, Neurosurg Focus, V9, pe2; Sarrafzadeh AS, 2004, STROKE, V35, P638, DOI 10.1161/01.STR.0000116101.66624.F1; Schulz MK, 2000, J NEUROSURG, V93, P808, DOI 10.3171/jns.2000.93.5.0808; Stocchetti N, 1996, J TRAUMA, V40, P764, DOI 10.1097/00005373-199605000-00014; Sundstrom T, 2007, J NEUROTRAUM, V24, P147, DOI 10.1089/neu.2006.0099; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Timofeev I, 2011, BRAIN, V134, P484, DOI 10.1093/brain/awq353; Vespa P, 1998, J NEUROSURG, V89, P971, DOI 10.3171/jns.1998.89.6.0971; Vespa PM, 2007, CRIT CARE MED, V35, P1153, DOI 10.1097/01.CCM.0000259466.66310.4F	48	18	18	0	3	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.		2014	5								64	10.3389/fneur.2014.00064			10	Clinical Neurology; Neurosciences	Neurosciences & Neurology	V42QW	WOS:000209629300064	24817863	DOAJ Gold, Green Published			2021-06-18	
J	Smyth, K; Sandhu, SS; Crawford, S; Dewey, D; Parboosingh, J; Barlow, KM				Smyth, Kim; Sandhu, Sandeep S.; Crawford, Susan; Dewey, Deborah; Parboosingh, Jillian; Barlow, Karen M.			The role of serotonin receptor alleles and environmental stressors in the development of post-concussive symptoms after pediatric mild traumatic brain injury	DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY			English	Article							MAJOR DEPRESSION; PSYCHIATRIC-DISORDERS; CHILDREN; ADOLESCENTS	AimTo determine whether post-injury depressive symptoms, and pre-injury major life stressors and genetic factors (HTR1A C(-1019)G alleles; rs6295) are more common in children with mild traumatic brain injury (mTBI) who develop postconcussion syndrome (PCS) symptoms compared with children with asymptomatic mTBI. MethodThis was a cross-sectional study of 47 symptomatic children (32 males, 15 females; mean age 14y [SD 3y 3mo]) who experienced post-concussive symptoms for 7 or more days and 42 asymptomatic children (26 males 16 females; mean age 13y 6mo [SD 3y 1mo]) after mTBI. Outcome measures were the Postconcussion Symptoms Inventory (PCSI), the Children's Depression Inventory (CDI), standard questionnaire of previous life events, and buccal DNA analysis to determine genotype and allele frequencies for the HTR1A C(-1019)G polymorphism. ResultsDepressive symptoms were uncommon. CDI scores did not differ between groups. Allelic and genotypic frequencies for HTR1A C(-1019)G were similar in both groups. Symptomatic children continued to have elevated PCS scores compared with asymptomatic children 1.72 (SD 0.69) years later and had experienced significantly more life stressors (Wald (1)=8.51, p=0.004). InterpretationHTR1A polymorphisms do not differ in children with PCS. Children who have experienced more significant life stresses are more likely to develop PCS symptoms after mTBI.	[Smyth, Kim; Barlow, Karen M.] Alberta Childrens Prov Gen Hosp, Dept Pediat, Sect Pediat Neurol, Calgary, AB T3B 6A8, Canada; [Sandhu, Sandeep S.; Crawford, Susan; Dewey, Deborah; Barlow, Karen M.] Alberta Childrens Prov Gen Hosp, Res Inst, Calgary, AB T3B 6A8, Canada; [Parboosingh, Jillian] Univ Calgary, Dept Med Genet, Calgary, AB, Canada	Barlow, KM (corresponding author), Alberta Childrens Prov Gen Hosp, Div Pediat Neurol, 2888 Shaganappi Trail NW, Calgary, AB T3B 6A8, Canada.	karen.barlow@albertahealthservices.ca	Barlow, Karen/I-6492-2019; Barlow, Karen/C-1323-2014	Dewey, Deborah/0000-0002-1323-5832; Barlow, Karen/0000-0003-2612-8507	Alberta Children's Hospital Foundation	This study was funded by a research grant provided by the Alberta Children's Hospital Foundation.	Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Bay E, 2008, BRAIN INJURY, V22, P233, DOI 10.1080/02699050801953073; Bloom DR, 2001, J AM ACAD CHILD PSY, V40, P572, DOI 10.1097/00004583-200105000-00017; Busch CR, 1998, NEUROPSYCHOL REV, V8, P95, DOI 10.1023/A:1025661200911; Chan F, 2008, BRAIN INJURY, V22, P471, DOI 10.1080/02699050802084886; CODDINGTON RD, 1972, J PSYCHOSOM RES, V16, P205, DOI 10.1016/0022-3999(72)90045-1; Giza CC, 2001, J ATHL TRAINING, V36, P228; GLASS KL, 2005, ANN M INT NEUR SOC F; Grant KE, 2004, J CLIN CHILD ADOLESC, V33, P412, DOI 10.1207/s15374424jccp3302_23; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; JORGE RE, 1993, J AFFECT DISORDERS, V27, P233, DOI 10.1016/0165-0327(93)90047-N; Kirkwood MW, 2008, CLIN NEUROPSYCHOL, V22, P769, DOI 10.1080/13854040701543700; KNIGHT D, 1988, J CHILD PSYCHOL PSYC, V29, P853, DOI 10.1111/j.1469-7610.1988.tb00758.x; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Lemonde S, 2003, J NEUROSCI, V23, P8788; Luis CA, 2002, J CLIN EXP NEUROPSYC, V24, P270, DOI 10.1076/jcen.24.3.270.982; Massagli TL, 2004, ARCH PHYS MED REHAB, V85, P1428, DOI 10.1016/j.apmr.2003.12.036; Max JE, 1997, J AM ACAD CHILD PSY, V36, P1278, DOI 10.1097/00004583-199709000-00021; Max JE, 2012, INT J DEV NEUROSCI, V30, P239, DOI 10.1016/j.ijdevneu.2011.12.005; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; Patten SB, 2013, SOC PSYCH PSYCH EPID, V48, P927, DOI 10.1007/s00127-012-0603-9; Ponsford J, 1999, J HEAD TRAUMA REHAB, V14, P360, DOI 10.1097/00001199-199908000-00005; Shrey DW, 2011, PHYS MED REH CLIN N, V22, P577, DOI 10.1016/j.pmr.2011.08.002; SMUCKER MR, 1986, J ABNORM CHILD PSYCH, V14, P25, DOI 10.1007/BF00917219; Taylor HG, 2010, NEUROPSYCHOLOGY, V24, P148, DOI 10.1037/a0018112; Vanderploeg RD, 2007, J CLIN EXP NEUROPSYC, V29, P585, DOI 10.1080/13803390600826587; Yeates KO, 2009, PEDIATRICS, V123, P735, DOI 10.1542/peds.2008-1056	27	18	18	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0012-1622	1469-8749		DEV MED CHILD NEUROL	Dev. Med. Child Neurol.	JAN	2014	56	1					73	77		10.1111/dmcn.12263			5	Clinical Neurology; Pediatrics	Neurosciences & Neurology; Pediatrics	267WG	WOS:000328128400015	23992222	Bronze			2021-06-18	
J	Kauser, H; Sahu, S; Kumar, S; Panjwani, U				Kauser, H.; Sahu, S.; Kumar, S.; Panjwani, U.			GUANFACINE IS AN EFFECTIVE COUNTERMEASURE FOR HYPOBARIC HYPDXIA-INDUCED COGNITIVE DECLINE	NEUROSCIENCE			English	Article						hypobaric hypoxia; guanfacine; prefrontal cortex; dendritic morphology	MEDIAL PREFRONTAL CORTEX; TRAUMATIC BRAIN-INJURY; WORKING-MEMORY; DENDRITIC SPINES; TYROSINE-HYDROXYLASE; PYRAMIDAL NEURONS; EXTENDED-RELEASE; BIOGENIC-AMINES; SPATIAL MEMORY; HYPOXIA	Hypobaric hypoxia (HH), an environmental stress resulting from ascent to high altitude, affects perception, memory, judgment, and attention, resulting in degradation of many aspects of normal functioning. Alpha 2A adrenergic agonist, guanfacine proved to be beneficial in the amelioration of neurological outcomes of many neuropsychiatric disorders involving adrenergic imbalance and neurodegeneration. Adrenergic dysregulation and neuronal damage have been implicated in hypoxia-induced cognitive deficits, however, efficacy of guanfacine as a countermeasure for HH-induced cognitive decline remains to be evaluated. We, therefore, have studied the effect of this drug on the HH-induced cognitive deficits, adrenergic dysfunction and neuronal damage. Rats were exposed to HH at a simulated altitude of 25,000 feet for 7 days and received an IM injection of either saline or guanfacine at a dose of 1 mg/kg. Adrenergic transmission was evaluated by biomarkers i.e. norepinephrine (NE), dopamine (DA) and tyrosine hydroxylase (TH) in medial prefrontal cortex (PFC) by biochemical and immunohistochemical assays. Spine and dendritic morphology of pyramidal neurons in layer ll of medial PFC was studied using Golgi Cox staining and Neurolucida neuronal tracing. The cognitive performance was assessed by Delayed Alternation Task using a T-Maze. There was a significant reduction in HH-induced increases in NE, DA and TH levels with guanfacine treatment. Guanfacine rescued HH-induced dendritic atrophy and mushroom type spine loss. The spatial working memory deficits induced by HH were significantly ameliorated with guanfacine treatment. Furthermore, the cognitive performance showed a positive correlation with dendritic arbors and spine numbers. These results showed that the HH-induced cognitive decline is associated with adrenergic dysregulation and neuronal damage in layer II of medial PFC, and that guanfacine treatment during HH ameliorated these functional and morphological deficits. The study suggests a potential role of the alpha-2A adrenergic agonist, guanfacine, in amelioration of PFC dysfunction caused by high altitude exposure. (C) 2013 IBRO. Published by Elsevier Ltd. All rights reserved.	[Kauser, H.; Sahu, S.; Kumar, S.; Panjwani, U.] DRDO, DIPAS, Delhi 110054, India	Panjwani, U (corresponding author), DRDO, DIPAS, Neurophysiol Div, Lucknow Rd, Delhi 110054, India.	usha_dipas@rediffmail.com		Sahu, Surajit/0000-0002-9529-3939	Defence Research and Development Organization, Ministry of Defence, Government of IndiaDefence Research & Development Organisation (DRDO); Department of Science and Technology, Government of IndiaDepartment of Science & Technology (India)	We would like to thank Prof. Shashi Wadhwa, Department of Anatomy, All India Institute of Medical Sciences for extending the morphological and morphometric analysis facility. The first author, H. Kauser, is the WOS-B fellow of the Department of Science and Technology, Government of India. This study was funded by the Defence Research and Development Organization, Ministry of Defence, Government of India and the Department of Science and Technology, Government of India.	ADAMS JH, 1975, BRIT J ANAESTH, V47, P121, DOI 10.1093/bja/47.2.121; Arnsten AFT, 2000, NEURAL PLAST, V7, P133, DOI 10.1155/NP.2000.133; ARNSTEN AFT, 1988, J NEUROSCI, V8, P4287; Arnsten AFT, 2007, CEREB CORTEX, V17, pI6, DOI 10.1093/cercor/bhm033; Arnsten AFT, 2012, NEURON, V76, P223, DOI 10.1016/j.neuron.2012.08.038; Arnsten Amy F. T., 2012, Yale Journal of Biology and Medicine, V85, P45; Baitharu I, 2013, BEHAV BRAIN RES, V240, P76, DOI 10.1016/j.bbr.2012.11.005; Birnbaum SG, 2004, SCIENCE, V306, P882, DOI 10.1126/science.1100021; Birnbaum SG, 2000, PHARMACOL BIOCHEM BE, V67, P397, DOI 10.1016/S0091-3057(00)00306-3; BYLUND DB, 1988, TRENDS PHARMACOL SCI, V9, P356, DOI 10.1016/0165-6147(88)90254-4; Calabrese B, 2005, NEURON, V48, P77, DOI 10.1016/j.neuron.2005.08.027; CAVALETTI G, 1990, INT J SPORTS MED, V11, P176, DOI 10.1055/s-2007-1024787; Connor DF, 2013, J CHILD ADOL PSYCHOP, V23, P244, DOI 10.1089/cap.2012.0119; Deacon RMJ, 2006, NAT PROTOC, V1, P7, DOI 10.1038/nprot.2006.2; Delatour B, 2000, BEHAV BRAIN RES, V109, P113, DOI 10.1016/S0166-4328(99)00168-0; Engelhard K, 2003, ANESTH ANALG, V97, P1155, DOI 10.1213/01.ANE.0000078576.93190.6F; Franowicz JS, 2002, J NEUROSCI, V22, P8771; Friedman JI, 2001, NEUROPSYCHOPHARMACOL, V25, P402, DOI 10.1016/S0893-133X(01)00249-4; GARRIDO E, 1993, INT J SPORTS MED, V14, P232, DOI 10.1055/s-2007-1021169; GOLDMANRAKIC PS, 1995, NEURON, V14, P477, DOI 10.1016/0896-6273(95)90304-6; Hains AB, 2009, P NATL ACAD SCI USA, V106, P17957, DOI 10.1073/pnas.0908563106; HARDEBO JE, 1980, ANN NEUROL, V8, P1, DOI 10.1002/ana.410080102; Heidbreder CA, 2003, NEUROSCI BIOBEHAV R, V27, P555, DOI 10.1016/j.neubiorev.2003.09.003; Hering H, 2001, NAT REV NEUROSCI, V2, P880, DOI 10.1038/35104061; Hu J, 2008, BRAIN RES, V1199, P37, DOI 10.1016/j.brainres.2007.12.073; Jain V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062235; Jentsch JD, 2008, BRAIN RES, V1246, P41, DOI 10.1016/j.brainres.2008.10.006; Ji XH, 2008, NEUROPSYCHOPHARMACOL, V33, P2263, DOI 10.1038/sj.npp.1301603; Jin Xin-Chun, 2007, Shengli Xuebao, V59, P739; KIECHEL JR, 1980, BRIT J CLIN PHARMACO, V10, pS25, DOI 10.1111/j.1365-2125.1980.tb04901.x; Kobori N, 2011, NEUROSCIENCE, V172, P293, DOI 10.1016/j.neuroscience.2010.10.048; Kobori N, 2006, J NEUROTRAUM, V23, P1094, DOI 10.1089/neu.2006.23.1094; KRAMER AF, 1993, HUM FACTORS, V35, P329, DOI 10.1177/001872089303500208; LARSEN JK, 1978, PHYSIOL PSYCHOL, V6, P15; Leuner B, 2010, J NEUROSCI, V30, P13499, DOI 10.1523/JNEUROSCI.3388-10.2010; LIEBERMAN P, 1994, NATURE, V372, P325, DOI 10.1038/372325a0; Liston C, 2006, J NEUROSCI, V26, P7870, DOI 10.1523/JNEUROSCI.1184-06.2006; MA D, 2005, BR MED B, V71, P77, DOI DOI 10.1086/433195; Ma DQ, 2004, EUR J PHARMACOL, V502, P87, DOI 10.1016/j.ejphar.2004.08.044; Maiti P, 2008, BEHAV BRAIN RES, V189, P233, DOI 10.1016/j.bbr.2008.01.007; Malhotra PA, 2006, ANN NEUROL, V59, P186, DOI 10.1002/ana.20701; McAllister TW, 2011, INT J PSYCHOPHYSIOL, V82, P107, DOI 10.1016/j.ijpsycho.2011.06.022; Miner LH, 2006, J NEUROSCI, V26, P1571, DOI 10.1523/JNEUROSCI.4450-05.2006; Nellgard BMG, 1999, BRAIN RES, V847, P262, DOI 10.1016/S0006-8993(99)02059-4; Pudovkina OL, 2001, BRAIN RES, V906, P38, DOI 10.1016/S0006-8993(01)02553-7; RAO BSS, 1993, BRAIN RES, V627, P216; Ray K, 2011, NEUROCHEM INT, V58, P112, DOI 10.1016/j.neuint.2010.11.003; REGARD M, 1989, NEUROLOGY, V39, P210, DOI 10.1212/WNL.39.2.210; Ren WW, 2012, MOL CELL NEUROSCI, V49, P205, DOI 10.1016/j.mcn.2011.10.001; Rodway GW, 2003, HEART LUNG, V32, P353, DOI 10.1016/j.hrtlng.2003.08.002; Sahu S, 2012, PHYTOMEDICINE, V19, P924, DOI 10.1016/j.phymed.2012.05.005; Sallee FR, 2009, J AM ACAD CHILD PSY, V48, P155, DOI 10.1097/CHI.0b013e318191769e; Salvatore MF, 2001, J NEUROCHEM, V79, P349, DOI 10.1046/j.1471-4159.2001.00593.x; Savourey G, 2003, EUR J APPL PHYSIOL, V89, P122, DOI 10.1007/s00421-002-0789-8; SHUKITTHALE B, 1994, BEHAV NEURAL BIOL, V62, P244, DOI 10.1016/S0163-1047(05)80023-8; Singh-Curry V, 2011, J NEUROL NEUROSUR PS, V82, P688, DOI 10.1136/jnnp.2009.195792; Tanila H, 1999, EUR J NEUROSCI, V11, P599, DOI 10.1046/j.1460-9568.1999.00464.x; TAYLOR RB, 1983, J CHROMATOGR, V277, P101, DOI 10.1016/S0378-4347(00)84827-6; Titus ADJ, 2007, NEUROSCIENCE, V145, P265, DOI 10.1016/j.neuroscience.2006.11.037; TROUVIN JH, 1986, GEN PHARMACOL, V17, P69, DOI 10.1016/0306-3623(86)90013-3; Wang M, 2007, CELL, V129, P397, DOI 10.1016/j.cell.2007.03.015; Wilson MH, 2009, LANCET NEUROL, V8, P175, DOI 10.1016/S1474-4422(09)70014-6; Zhang Yonghua, 2005, Current Neuropharmacology, V3, P317, DOI 10.2174/157015905774322534	63	18	18	0	12	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	DEC 19	2013	254						110	119		10.1016/j.neuroscience.2013.09.023			10	Neurosciences	Neurosciences & Neurology	255ZN	WOS:000327279400010	24056194				2021-06-18	
J	Hawley, C; Wilson, J; Hickson, C; Mills, S; Ekeocha, S; Sakr, M				Hawley, Carol; Wilson, James; Hickson, Craig; Mills, Sara; Ekeocha, Samila; Sakr, Magdy			Epidemiology of paediatric minor head injury: Comparison of injury characteristics with Indices of Multiple Deprivation	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Head injury; Trauma; Paediatric; Information; Emergency department; Epidemiology; Deprivation; Population	TRAUMATIC BRAIN-INJURY; EMERGENCY-DEPARTMENTS; UNINTENTIONAL INJURY; CHILDREN; CHILDHOOD; RISK; HOME; AGE; ETHNICITY; ACCIDENT	Background: Head injury (HI) is a common presentation to Child Emergency Departments (CEDs), but the actual number of children attending with minor HI is unclear. Most research has focussed on admitted patients, often relying on hospital-coded admission data. We studied the incidence of minor HI presenting to the CED of a major teaching hospital in Coventry and Warwickshire. HI attendances were compared with population data to identify injury patterns relating to deprivation. Methods: All CED admissions were screened by the research team, and data on minor head injuries (GCS 13-15) collected prospectively from 1st January until 31st August 2011. Information was collected on demographics, ethnicity, cause and severity of injury, injury location (in or outside the home), other injuries and mode of arrival. Deprivation data were obtained by cross-referencing postcodes with English Indices of Multiple Deprivation (IMD 2010). For comparison, the hospital audit department provided figures for coded head injuries during the same period. Results: During the 8 month period, hand-searching identified 1747 children with minor HI, aged between 0 and 16 years. Of these 99% had minimal HI (GCS 15 or 'alert'). In the same period, hospitalcoded minor HIs numbered only 1081. HIs formed 9% of all CED attendances. Thirteen children returned to the CED with worrying symptoms after discharge home. Approximately 3.4% of the local paediatric population attend the CED with HI per year (3419/ 100,000 population). Falls accounted for 62% of HIs overall, rising to 77% in children aged 0-5. Most in-home head injuries (81%) were the result of falls (p < 0.0001). Significantly more injuries took place inside the home for 0-5 year olds (58%) than for older children (20%) (p < 0.0001). Children living in the most deprived areas were more likely to attend the CED with HI (RR: 1.19; CI: 1.06-1.35, p = 0.004), and arrive using emergency services (OR: 1.77; CI: 1.302.40, p < 0.001). There were no significant differences between the deprived and non-deprived groups for location or cause of injury. Conclusions: Young children are particularly at risk of HI and parents should be offered information on injury prevention. More children from deprived areas attended with HI and these families may benefit most from targeted interventions. (C) 2013 Elsevier Ltd. All rights reserved.	[Hawley, Carol; Wilson, James; Mills, Sara; Ekeocha, Samila] Univ Warwick, Sch Med, Coventry CV4 7AL, W Midlands, England; [Hickson, Craig; Sakr, Magdy] Univ Hosp Coventry & Warwickshire, Coventry, W Midlands, England	Hawley, C (corresponding author), Univ Warwick, Warwick Med Sch, Div Mental Hlth & Wellbeing, Coventry CV4 7AL, W Midlands, England.	c.a.hawley@warwick.ac.uk	Hawley, Carol/AAG-3830-2019		University Research Scholarship Scheme	Drs Hickson, JW, SM and SE shared a small bursary provided by the University Research Scholarship Scheme.	Adamson J, 2003, SOC SCI MED, V57, P895, DOI 10.1016/S0277-9536(02)00458-6; Adelson PD, 1998, J CHILD NEUROL, V13, P2, DOI 10.1177/088307389801300102; Agran PF, 2003, PEDIATRICS, V111, pE683, DOI 10.1542/peds.111.6.e683; Agran PF, 2001, PEDIATRICS, V108, part. no., DOI 10.1542/peds.108.3.e45; Beattie TF, 2001, EMERG MED J, V18, P110, DOI 10.1136/emj.18.2.110; Beattie TF, 1997, ARCH DIS CHILD, V77, P82, DOI 10.1136/adc.77.1.82; BROOKES M, 1990, J EPIDEMIOL COMMUN H, V44, P147, DOI 10.1136/jech.44.2.147; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Census, 2011, CENS; Deb S, 1999, BRAIN INJURY, V13, P369, DOI 10.1080/026990599121557; Department for Communities and Local Government, 2011, ENGL IND DEPR 2010 S; Department of Health, 2010, HOSP EP STAT ACC EM; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; GARLING A, 1993, J PEDIATR PSYCHOL, V18, P105, DOI 10.1093/jpepsy/18.1.105; GLIK DC, 1993, J PEDIATR PSYCHOL, V18, P115, DOI 10.1093/jpepsy/18.1.115; Green SA, 2013, J PUBLIC HEALTH-UK, V35, P286, DOI 10.1093/pubmed/fds071; Hawley CA, 2003, INJURY, V34, P256, DOI 10.1016/S0020-1383(02)00193-6; Jager TE, 2000, ACAD EMERG MED, V7, P134, DOI 10.1111/j.1553-2712.2000.tb00515.x; Jennett B, 1998, ARCH DIS CHILD, V78, P403, DOI 10.1136/adc.78.5.403; Keenan HT, 2003, JAMA-J AM MED ASSOC, V290, P621, DOI 10.1001/jama.290.5.621; Kendrick D, 2009, INJURY PREV, V15, P197, DOI 10.1136/ip.2008.020677; Kendrick D., 2007, COCHRANE DB SYST REV, V24; Khambalia A, 2006, INJURY PREV, V12, P378, DOI 10.1136/ip.2006.012161; Kirkwood MW, 2008, CLIN NEUROPSYCHOL, V22, P769, DOI 10.1080/13854040701543700; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Laflamme L, 2010, INT J PEDIAT, V2010, DOI 10.1155/2010/819687; Laing GJ, 1999, PUBLIC HEALTH, V113, P291, DOI 10.1016/S0033-3506(99)00182-1; Laker SR, 2011, PM&R, V3, pS354, DOI 10.1016/j.pmrj.2011.07.017; Laursen B, 2008, EUR J PUBLIC HEALTH, V18, P366, DOI 10.1093/eurpub/ckn034; Love PF, 2009, J TRAUMA, V67, pS12, DOI 10.1097/TA.0b013e3181ac7f22; National Institute for Health and Clinical Excellence (NICE), 2007, HEAD INJ TRIAG ASS I; NERSESIAN WS, 1985, PEDIATRICS, V75, P41; Office for National Statistics, 2012, POP HOUS EST ENGL WA; Pearson M, 2011, HEALTH PROMOT INT, V26, P376, DOI 10.1093/heapro/daq074; RIVARA FP, 1987, J SOC ISSUES, V43, P13, DOI 10.1111/j.1540-4560.1987.tb01292.x; Roberts I, 1996, BRIT MED J, V312, P29, DOI 10.1136/bmj.312.7022.29; Sorani MD, 2009, J TRAUMA, V67, P75, DOI 10.1097/TA.0b013e31818234e8; Strong Mark, 2006, Int J Health Geogr, V5, P29, DOI 10.1186/1476-072X-5-29; TEASDALE G, 1974, LANCET, V2, P81; VOSS M, 1995, BRIT MED J, V311, P1395, DOI 10.1136/bmj.311.7017.1395; Yates PJ, 2006, J NEUROL NEUROSUR PS, V77, P699, DOI 10.1136/jnnp.2005.081901	41	18	18	1	17	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	DEC	2013	44	12					1855	1861		10.1016/j.injury.2013.07.021			7	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	244GV	WOS:000326376500030	23958554				2021-06-18	
J	Le, Q; Gelinas, C; Arbour, C; Rodrigue, N				Le, Quynh; Gelinas, Celine; Arbour, Caroline; Rodrigue, Nathalie			Description of Behaviors in Nonverbal Critically Ill Patients With a Traumatic Brain Injury When Exposed to Common Procedures in the Intensive Care Unit: A Pilot Study	PAIN MANAGEMENT NURSING			English	Article							PAIN OBSERVATION TOOL; ADULT; RELIABILITY; VALIDATION	Behavioral indicators are strongly recommended for pain assessment in nonverbal patients. Although pain-related behaviors have been studied in critically ill patients, those with a traumatic brain injury (TBI) have been either excluded or underrepresented. Because these patients also likely experience pain, research is urgently needed to generate knowledge in this field. This pilot study aimed to explore pain-related behaviors of critically ill TBI patients when exposed to common procedures in the intensive care unit (ICU), using video recording at the bedside and a newly developed coding system. Ten TBI patients hospitalized in the ICU participated. A 44-item behavioral checklist created from existing tools was used as a coding system to identify behaviors before, during, and 20 minutes after a nociceptive procedure (turning) and a nonnociceptive procedure (noninvasive blood pressure [NIBP]). Patients were video recorded to check for interrater agreement between two trained observers. TBI patients exhibited more behaviors during turning than at rest or during NIBP (p < .001). The following behaviors were observed during turning: levator contraction (n = 7), frowning (n = 5), opening eyes (n = 5), weeping eyes (n = 5), raising eyebrows (n = 5), activating the ventilator alarms (n = 7), and muscle tension (n = 5). No change in behaviors was noted during NIBP. After educational training and using videos, the average percentage of agreement for observed behaviors between two trained research assistants was 96%. Pain in critically ill TBI patients can be detrimental to health and recovery. ICU clinicians should be aware of pain-related behaviors to enable better detection and treatment in this highly vulnerable group. (C) 2013 by the American Society for Pain Management Nursing	[Le, Quynh; Gelinas, Celine; Arbour, Caroline] McGill Univ, Sch Nursing, Montreal, PQ H3A 2A7, Canada; [Gelinas, Celine; Arbour, Caroline] McGill Univ, Jewish Gen Hosp, Ctr Nursing Res, Montreal, PQ H3T 1E2, Canada; [Gelinas, Celine; Arbour, Caroline] McGill Univ, Jewish Gen Hosp, Lady Davis Inst, Montreal, PQ H3T 1E2, Canada; [Gelinas, Celine; Arbour, Caroline] Quebec Interuniv Nursing Intervent Res Grp, Montreal, PQ, Canada; [Rodrigue, Nathalie] McGill Univ, Montreal Gen Hosp, Ctr Hlth, Montreal, PQ H3A 2A7, Canada	Gelinas, C (corresponding author), McGill Univ, Sch Nursing, 3506 Univ St, Montreal, PQ H3A 2A7, Canada.	celine.gelinas@mcgill.ca					[Anonymous], 1979, Pain, V6, P249; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Dunwoody Colleen J, 2008, J Perianesth Nurs, V23, pS15, DOI 10.1016/j.jopan.2007.11.007; Feeley N, 2009, CAN J NURS RES, V41, P84; Gelinas C, 2007, CLIN J PAIN, V23, P497, DOI 10.1097/ajp.0b013e31806a23fb; Gelinas C, 2006, AM J CRIT CARE, V15, P420; Gelinas C, 2011, INT J NURS STUD, V48, P1495, DOI 10.1016/j.ijnurstu.2011.03.012; Gelinas C, 2009, J CRIT CARE, V24, DOI 10.1016/j.jcrc.2009.01.013; GOODWIN LD, 1981, RES NURS HEALTH, V4, P323, DOI 10.1002/nur.4770040308; Haidet KK, 2009, RES NURS HEALTH, V32, P465, DOI 10.1002/nur.20334; Herr K, 2011, PAIN MANAG NURS, V12, P230, DOI 10.1016/j.pmn.2011.10.002; International Association for the Study of Pain, 2011, PAIN TERM; Keay KA, 2002, EXP PHYSIOL, V87, P275, DOI 10.1113/eph8702355; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Li D, 2008, J PAIN, V9, P2, DOI 10.1016/j.jpain.2007.08.009; Marmo L, 2010, PAIN MANAG NURS, V11, P134, DOI 10.1016/j.pmn.2009.05.007; Marr AL., 2004, CENTRAL NERVOUS SYST; Martelli M. F., 2006, BRAIN INJURY MED PRI, P723; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; O'Donnell ML, 2010, J TRAUMA, V69, P627, DOI 10.1097/TA.0b013e3181bc0923; Payen JF, 2001, CRIT CARE MED, V29, P2258, DOI 10.1097/00003246-200112000-00004; Pudas-Tahka SM, 2009, J ADV NURS, V65, P946, DOI 10.1111/j.1365-2648.2008.04947.x; Puntillo K A, 2001, Am J Crit Care, V10, P238; Puntillo KA, 2004, CRIT CARE MED, V32, P421, DOI 10.1097/01.CCM.0000108875.35298.D2; Rotondi AJ, 2002, CRIT CARE MED, V30, P746, DOI 10.1097/00003246-200204000-00004; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Sessler CN, 2002, AM J RESP CRIT CARE, V166, P1338, DOI 10.1164/rccm.2107138; Shannon Kathleen, 2003, Intensive Crit Care Nurs, V19, P154, DOI 10.1016/S0964-3397(03)00027-2; Stanik-Hutt J A, 2001, Am J Crit Care, V10, P252; TEASDALE G, 1974, LANCET, V2, P81; Themessl-Huber M, 2008, PATIENT EDUC COUNS, V71, P157, DOI 10.1016/j.pec.2008.01.015; Young James A, 2007, Phys Med Rehabil Clin N Am, V18, P145, DOI 10.1016/j.pmr.2006.11.008	32	18	19	0	11	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1524-9042	1532-8635		PAIN MANAG NURS	Pain Manag. Nurs.	DEC	2013	14	4					E251	E261		10.1016/j.pmn.2012.02.005			11	Nursing	Nursing	269QD	WOS:000328256100019	24315278				2021-06-18	
J	Peleg, RK; Fishlev, G; Bechor, Y; Bergan, J; Friedman, M; Koren, S; Tirosh, A; Efrati, S				Peleg, Ronit Koren; Fishlev, Gregori; Bechor, Yair; Bergan, Jacob; Friedman, Mony; Koren, Shlomit; Tirosh, Amit; Efrati, Shai			Effects of hyperbaric oxygen on blood glucose levels in patients with diabetes mellitus, stroke or traumatic brain injury and healthy volunteers: a prospective, crossover, controlled trial	DIVING AND HYPERBARIC MEDICINE			English	Article						Hyperbaric oxygen; blood glucose; prospective controlled trial; blood pressure; heart rate	THERAPY	Introduction: A decrease in blood glucose levels (BGL) during hyperbaric oxygen treatment (HBOT) is a well-recognised phenomenon, but studies of this are limited and inconclusive. This study evaluated the effect of HBOT on BGL in patients with diabetes mellitus (DM), traumatic brain injury (TBI) or stroke and healthy volunteers in a prospective, open, controlled trial. Methods: Thirty-nine participants were enrolled and evaluated twice: once during HBOT (90 minutes at 203 kPa), and once during a control session on normobaric air. Sessions were held up to two weeks apart and participants were instructed to eat the same diet. BGI was measured before, during and at the completion of each session. Results: For the whole study group, there was a small but statistically significant decrease in BGL in both the HBOT (7.27 +/- 3.66 mmol L-1 before to 6.71 +/- 3.88 mmol L-1 after, P = 0.037) and control (air) sessions (7.43 +/- 3.49 mmol L-1 before to 6.71 +/- 3.77 mmol L-1 after, P = 0.004). This fall did not differ between the two conditions (P = 0.59). Examining the three groups separately, BGL fell in all three subgroups, but this fall was only statistically significant for the air session in the diabetic group. There were no statistically significant differences in the BGL reduction when HBOT was compared to normobaric air in any of the three subgroups. Conclusions: BGL may decrease during HBOT and accordingly it should be monitored before entering the chamber. However, this decrease in BGL should probably not be attributed to the hyperbaric environment per se.	[Peleg, Ronit Koren; Koren, Shlomit; Tirosh, Amit; Efrati, Shai] Assaf Harofeh Med Ctr, Dept Internal Med A, IL-70300 Zerifin, Israel; [Peleg, Ronit Koren; Koren, Shlomit; Tirosh, Amit; Efrati, Shai] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel; [Fishlev, Gregori; Bechor, Yair; Bergan, Jacob; Friedman, Mony] Assaf Harofeh Med Ctr, Inst Hyperbar Med, IL-70300 Zerifin, Israel; [Koren, Shlomit; Tirosh, Amit; Efrati, Shai] Assaf Harofeh Med Ctr, Res & Dev Unit, IL-70300 Zerifin, Israel; [Efrati, Shai] Tel Aviv Univ, Sagol Sch Neurosci, IL-69978 Tel Aviv, Israel	Peleg, RK (corresponding author), Assaf Harofeh Med Ctr, Dept Internal Med A, IL-70300 Zerifin, Israel.	ronitkoren@gmail.com		Tirosh, Amit/0000-0003-3794-9634			Al-Waili NS, 2006, ARCH MED RES, V37, P991, DOI 10.1016/j.arcmed.2006.05.009; CONTRERAS FL, 1988, J NEUROSURG, V68, P137, DOI 10.3171/jns.1988.68.1.0137; DEDOV I I, 1987, Problemy Endokria, V33, P10; Efrati S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053716; Ekanayake L., 2001, SPUMS J, V31, P16; Gill AL, 2004, QJM-INT J MED, V97, P385, DOI 10.1093/qjmed/hch074; Jungehulsing GJ, 2013, ACTA NEUROL SCAND, V127, P427, DOI 10.1111/ane.12070; Leach RM, 1998, BRIT MED J, V317, P1140; Neuman TS, 2008, PHYSL MED HYPERBARIC; Tibbles PM, 1996, NEW ENGL J MED, V334, P1642, DOI 10.1056/NEJM199606203342506; TORBATI D, 1985, NEUROSCI LETT, V55, P109, DOI 10.1016/0304-3940(85)90003-5; Trytko B.E., 2003, SPUMS J, V33, P62; Wilkinson D, 2012, DIABETIC MED, V29, P986, DOI 10.1111/j.1464-5491.2012.03587.x	13	18	22	0	3	SOUTH PACIFIC UNDERWATER MED SOC	MELBOURNE	C/O AUSTRALIAN & NEW ZEALAND COLL ANAESTHETISTS, 630 ST KILDA RD, MELBOURNE, VIC 3004, AUSTRALIA	1833-3516			DIVING HYPERB MED	Diving Hyperb. Med.	DEC	2013	43	4					218	221					4	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	281CG	WOS:000329076500003	24510327				2021-06-18	
J	Russell, LM; Devore, MD; Barnes, SM; Forster, JE; Hostetter, TA; Montgomery, AE; Casey, R; Kane, V; Brenner, LA				Russell, Leah M.; Devore, Maria D.; Barnes, Sean M.; Forster, Jeri E.; Hostetter, Trisha A.; Montgomery, Ann Elizabeth; Casey, Roger; Kane, Vincent; Brenner, Lisa A.			Challenges Associated With Screening for Traumatic Brain Injury Among US Veterans Seeking Homeless Services	AMERICAN JOURNAL OF PUBLIC HEALTH			English	Article							PREVALENCE; METAANALYSIS; HEALTH	We identified the prevalence of traumatic brain injury (TBI) among homeless veterans and assessed the TBI-4, a screening tool created to identify TBI history. Between May 2010 and October 2011, 800 US veterans from 2 hospitals, one eastern (n = 122) and one western (n = 678) completed some or all measures. Findings suggested that 47% of veterans seeking homeless services had a probable history of TBI (data for prevalence obtained only at the western hospital). However, psychometric results from the screening measure suggested that this may be an underestimate and supported comprehensive assessment of TBI in this population.	[Russell, Leah M.; Devore, Maria D.; Barnes, Sean M.; Forster, Jeri E.; Hostetter, Trisha A.; Brenner, Lisa A.] 19 Mental Illness Res Educ & Clin Ctr MIRECC, VISN, Denver, CO USA; [Montgomery, Ann Elizabeth; Kane, Vincent] Vet Affairs Natl Ctr Homelessness Vet, Philadelphia, PA USA; [Casey, Roger] Vet Affairs Natl Ctr Homelessness Vet, Tampa, FL USA	Brenner, LA (corresponding author), MIRECC, Denver VA Med Ctr, 1055 Clermont St, Denver, CO 80203 USA.	lisa.brenner@va.gov	Brenner, Lisa A./AAG-2442-2019		National Center on Homelessness Among Veterans; VISN 19 MIRECC	This project was funded by the National Center on Homelessness Among Veterans. Additional support was provided by the VISN 19 MIRECC.	Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Brenner LA, 2013, J HEAD TRAUMA REHAB, V28, P21, DOI 10.1097/HTR.0b013e31827df0b5; Centers for Disease Control and Prevention, 1999, TRAUM BRAIN INJ US R; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Frost RB, 2013, NEUROEPIDEMIOLOGY, V40, P154, DOI 10.1159/000343275; Hwang SW, 2008, CAN MED ASSOC J, V179, P779, DOI 10.1503/cmaj.080341; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Oddy M, 2012, BRAIN INJURY, V26, P1058, DOI 10.3109/02699052.2012.667595; US Department of Veterans Affairs, STRAT PLAN FY210 201; US Department of Veterans Affairs, HOM VET GRANT DIEM P; US Department of Veterans Affairs, HOM VET DEP HOUS URB; US Department of Veterans Affairs/Department of Defense, CLIN PRACT GUID MAN	12	18	18	1	4	AMER PUBLIC HEALTH ASSOC INC	WASHINGTON	800 I STREET, NW, WASHINGTON, DC 20001-3710 USA	0090-0036	1541-0048		AM J PUBLIC HEALTH	Am. J. Public Health	DEC	2013	103			2			S211	S213		10.2105/AJPH.2013.301485			4	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	AA4NP	WOS:000331073100014	24148060	Green Published			2021-06-18	
J	Deepika, A; Munivenkatappa, A; Devi, BI; Shukla, D				Deepika, Akhil; Munivenkatappa, Ashok; Devi, Bhagavatula Indira; Shukla, Dhaval			Does Isolated Traumatic Subarachnoid Hemorrhage Affect Outcome in Patients With Mild Traumatic Brain Injury?	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						concussion; mild traumatic brain injury; traumatic subarachnoid hemorrhage	HEAD-INJURY; SCALE; QUESTIONNAIRE; RELIABILITY; CONCUSSION; MANAGEMENT; SYMPTOMS	Background: The importance of isolated traumatic subarachnoid hemorrhage (SAH) in relation to functional outcome in patients with mild traumatic brain injury (TBI) has not been frequently studied. The aim of this study was to compare the impact of isolated SAH with normal computed tomographic (CT) scan on outcome of patients with mild TBI. Methods: This is a retrospective study of clinical records and CT scans of all patients with mild TBI (Glasgow Coma Scale score >= 13) evaluated from January 1, 2010, to March 15, 2010, at our institution. The patients were divided into 2 groups: isolated SAH and normal CT scan. The telephonic Glasgow Outcome Scale-Extended, Rivermead Post-Concussion Symptoms Questionnaire (RPCSQ), and Rivermead Head Injury Follow-up Questionnaire (RHFUQ) scores were used to assess outcome after 1 year of injury. Independent sample t test in SPSS was used to assess difference in outcome. Results: A total of 1149 patients with mild TBI were evaluated during study period. Among them, 34 (2.9%) patients had isolated SAH. Twenty-eight patients were male and 6 were female, with a mean age of 36.5 years. Subarachnoid hemorrhage was cortical in 19 (55.9%) patients, interhemispheric in 3 (8.8%) patients, Sylvian fissure in 2 (5.9%) patients, and basal cisternal in 1 (2.9%) patient. Nine (26.5%) patients had SAH at multiple locations. The mean RPCSQ and RHFUQ scores for patients with isolated SAH were 1.38 +/- 2.40 and 1.11 +/- 3.305, respectively. The mean RPCSQ and RHFUQ scores for patients with normal CT scans were 0.40 +/- 1.549 and 0.533 +/- 1.59, respectively. There was no significant difference in the outcome scores between the SAH and the normal CT scan groups (RHFUQ, P = .45; RPCSQ, P = .248). Conclusion: In our study sample of patients with mild TBI, there is no difference in outcome of patients with isolated SAH compared with those with normal CT scans 1 year after injury.	[Deepika, Akhil; Munivenkatappa, Ashok; Devi, Bhagavatula Indira; Shukla, Dhaval] Natl Inst Mental Hlth & Neurosci NIMHANS, Dept Neurosurg, Bangalore 560029, Karnataka, India	Shukla, D (corresponding author), Natl Inst Mental Hlth & Neurosci, Dept Neurosurg, Bangalore 560029, Karnataka, India.	neurodhaval@rediffmail.com					Armin SS, 2006, NEUROL RES, V28, P445, DOI 10.1179/016164106X115053; Chieregato A, 2005, NEUROSURGERY, V56, P671, DOI 10.1227/01.NEU.0000156200.76331.7A; Crawford S, 1996, J NEUROL NEUROSUR PS, V60, P510, DOI 10.1136/jnnp.60.5.510; DEMIRCIVI F, 1993, ACTA NEUROCHIR, V122, P45, DOI 10.1007/BF01446985; Gomez PA, 1996, BRIT J NEUROSURG, V10, P453, DOI 10.1080/02688699647078; GREENE KA, 1995, J NEUROSURG, V83, P445, DOI 10.3171/jns.1995.83.3.0445; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Lee JH, 1997, J NEUROSURG, V87, P221, DOI 10.3171/jns.1997.87.2.0221; Levy AS, 2011, J TRAUMA, V71, P1199, DOI 10.1097/TA.0b013e31822067fc; Petchprapai Nutthita, 2007, J Neurosci Nurs, V39, P260; Pettigrew LEL, 2003, J HEAD TRAUMA REHAB, V18, P252, DOI 10.1097/00001199-200305000-00003; Ponsford J, 2005, CURR OPIN NEUROL, V18, P692, DOI 10.1097/01.wco.0000186840.61431.44; Servadei F, 2002, NEUROSURGERY, V50, P261, DOI 10.1097/00006123-200202000-00006; SHACKFORD SR, 1992, J TRAUMA, V33, P385, DOI 10.1097/00005373-199209000-00009; Shukla D, 2010, J NEUROSCI RURAL PRA, V1, P82, DOI 10.4103/0976-3147.71723; Shukla D, 2011, CLIN NEUROL NEUROSUR, V113, P435, DOI 10.1016/j.clineuro.2011.02.013; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Takinami K, 2003, NEUROL SURG TOKYO, V31, P175; Ullman JS, 1996, SUBARACHNOID HEMORRH, P225; Villemure R, 2011, BRAIN INJURY, V25, P53, DOI 10.3109/02699052.2010.531881	20	18	18	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2013	28	6					442	445		10.1097/HTR.0b013e31825e19e5			4	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	299AA	WOS:000330365200008	22832372				2021-06-18	
J	Gump, WC; Mutchnick, IS; Moriarty, TM				Gump, William C.; Mutchnick, Ian S.; Moriarty, Thomas M.			Selective dorsal rhizotomy for spasticity not associated with cerebral palsy: reconsideration of surgical inclusion criteria	NEUROSURGICAL FOCUS			English	Article						selective dorsal rhizotomy; spasticity; cerebral palsy; hypertonia	GROSS MOTOR FUNCTION; POSTERIOR RHIZOTOMY; CHILDREN; EXPERIENCE; PAINFUL	Children with spastic diplegia from cerebral palsy (CP) experience measurable improvement in their spasticity and motor function following selective dorsal rhizotomy (SDR). The role of this operation in the treatment of other spasticity causes is less well defined. A literature review was undertaken to survey outcomes from SDRs performed outside the CP population. Multiple sclerosis was the most common diagnosis found, accounting for 74 of 145 patients described. Selective dorsal rhizotomies have also been reported in patients with traumatic brain and spinal cord injuries, ischemic and hemorrhagic stroke, neurodegenerative disease, hypoxic encephalopathy, and other causes of spasticity. Outcomes from surgery are generally described as favorable, although postoperative assessments and follow-up times are not standardized across reports. Long-term outcomes are sparsely reported. Larger numbers of patients and more detailed outcomes data have the potential to form a basis for expanding the inclusion criteria for SDR.	[Gump, William C.; Mutchnick, Ian S.; Moriarty, Thomas M.] Norton Neurosci Inst, Div Pediat Neurosurg, Louisville, KY 40202 USA; [Gump, William C.; Mutchnick, Ian S.; Moriarty, Thomas M.] Kosair Childrens Hosp, Louisville, KY USA; [Moriarty, Thomas M.] Univ Kentucky, Coll Med, Dept Neurol Surg, Lexington, KY USA	Gump, WC (corresponding author), Norton Neurosci Inst, Div Pediat Neurosurg, 210 E Gray St,Ste 1102, Louisville, KY 40202 USA.	william.gump@nortonhealthcare.org					Albright AL, 2008, PRINCIPLES PRACTICE, P1121; Ashwal S, 2004, NEUROLOGY, V62, P851, DOI 10.1212/01.WNL.0000117981.35364.1B; BAROLAT G, 1991, J NEUROSURG, V75, P804, DOI 10.3171/jns.1991.75.5.0804; Bolster EAM, 2013, DEV MED CHILD NEUROL, V55, P610, DOI 10.1111/dmcn.12148; Cole GF, 2007, ARCH DIS CHILD, V92, P781, DOI 10.1136/adc.2006.111559; Crilly MA, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e6670; Dudley RWR, 2013, J NEUROSURG-PEDIATR, V12, P142, DOI 10.3171/2013.4.PEDS12539; Farmer JP, 2007, CHILD NERV SYST, V23, P991, DOI 10.1007/s00381-007-0398-2; FASANO VA, 1978, CHILD BRAIN, V4, P289; Finsterer J, 2012, J NEUROL SCI, V318, P1, DOI 10.1016/j.jns.2012.03.025; Folkerth RD, 2005, J CHILD NEUROL, V20, P940, DOI 10.1177/08830738050200120301; Folkerth RD, 2006, PEDIATR DEVEL PATHOL, V9, P3, DOI 10.2350/06-01-0024.1; Forster O, 1913, SURG GYNECOL OBSTET, V16, P463; Fukuhara T, 2004, NEUROSURGERY, V54, P1268, DOI 10.1227/01.NEU.0000119605.32216.2E; Garcia-Campmany L, 2010, CURR OPIN NEUROBIOL, V20, P116, DOI 10.1016/j.conb.2010.01.002; Grunt S, 2008, J CHILD NEUROL, V23, P818, DOI 10.1177/0883073808316372; LAITINEN LV, 1983, J NEUROSURG, V58, P895, DOI 10.3171/jns.1983.58.6.0895; Langerak NG, 2012, GAIT POSTURE, V35, P244, DOI 10.1016/j.gaitpost.2011.09.014; Macwilliams BA, 2011, DEV MED CHILD NEUROL, V53, P717, DOI 10.1111/j.1469-8749.2011.04010.x; McLaughlin J, 2002, DEV MED CHILD NEUROL, V44, P17, DOI 10.1017/S0012162201001608; McLaughlin JF, 1998, DEV MED CHILD NEUROL, V40, P220; MUNRO D, 1952, NEW ENGL J MED, V246, P161, DOI 10.1056/NEJM195201312460501; Oki A, 2010, J NEUROSURG-PEDIATR, V6, P353, DOI 10.3171/2010.7.PEDS09318; Park T S, 2000, Clin Neurosurg, V47, P422; PEACOCK WJ, 1987, PEDIATR NEUROSCI, V13, P61, DOI 10.1159/000120302; PRIVAT JM, 1976, ACTA NEUROCHIR, V35, P181, DOI 10.1007/BF01405946; Sacco DJ, 2000, PEDIATR NEUROSURG, V32, P114, DOI 10.1159/000028914; Salame K, 2003, ISRAEL MED ASSOC J, V5, P543; SCHIJMAN E, 1993, CHILD NERV SYST, V9, P474, DOI 10.1007/BF00393554; Sherrington C S, 1898, J Physiol, V22, P319; SIDDIQUE N, 2003, TXB CLIN NEUROLOGY, P759; SINDOU M, 1982, APPL NEUROPHYSIOL, V45, P335; Steinbok P, 1997, DEV MED CHILD NEUROL, V39, P178; Steinbok P, 2007, CHILD NERV SYST, V23, P981, DOI 10.1007/s00381-007-0379-5; Tubbs RS, 2007, J NEUROSURG, V106, P407, DOI 10.3171/ped.2007.106.5.407; van Schie PEM, 2011, J NEUROSURG-PEDIATR, V7, P557, DOI 10.3171/2011.2.PEDS10452; Wright FV, 1998, DEV MED CHILD NEUROL, V40, P239; Yang TF, 2002, AM J PHYS MED REHAB, V81, P467, DOI 10.1097/00002060-200206000-00013	38	18	19	0	7	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1092-0684			NEUROSURG FOCUS	Neurosurg. Focus	NOV	2013	35	5							E6	10.3171/2013.8.FOCUS13294			6	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	247EB	WOS:000326596900006	24175866	Bronze			2021-06-18	
J	Hamasaki, T; Yamada, K; Kuratsu, J				Hamasaki, Tadashi; Yamada, Kazumichi; Kuratsu, Jun-ichi			Seizures as a presenting symptom in neurosurgical patients: A retrospective single-institution analysis	CLINICAL NEUROLOGY AND NEUROSURGERY			English	Article						Epilepsy; Incidence; Organic lesion; Seizure	TRAUMATIC BRAIN-INJURY; EPILEPSY; MENINGIOMAS; POPULATION; TUMORS; GANGLIOGLIOMA; PROPHYLAXIS; PHENYTOIN; RESECTION; OUTCOMES	Background: In patients with brain lesions, the appropriate management of epileptic seizures is important because recurrent seizures have a negative effect on the clinical course and quality of life. Acute symptomatic seizures are known to be one of the risk factors to develop epilepsy that cause recurrent unprovoked seizures in the later stage. To obtain background information, we performed a retrospective study in which we investigated the incidence of seizures as one of the presenting symptoms in neurosurgical patients admitted to our department during the past 43 years. Methods: We extracted 4537 consecutive patients from 11,675 records in our inpatient database to calculate the seizure incidence in patients with 19 most common diagnoses. We also studied whether the location of cortical lesions have relation to the seizure incidence. Results: Among 2342 patients with brain tumors, 9 of 18 (50%) ganglioglioma-, 40 of 87 (46%) oligodendroglioma-, 69 of 207(33%) low-grade astrocytoma-, 172 of 804(21%) high-grade astrocytoma- or anaplastic oligodendroglioma-, 84 of 598(14%) meningioma-, 38 of 313 (12%) metastatic brain tumor-, 7 of 67 (10%) malignant meningioma-, 7 of 79 (9%) ependymoma-, and 11 of 169(7%) malignant lymphoma patients suffered seizures. There were 1626 patients with vascular lesions, 20 of 80 (25%) with cavernous malformation, 61 of 281 (22%) with arteriovenous malformation, 50 of 666(8%) with subarachnoid hemorrhage, 26 of 457 (6%) with brain infarcts, and 5 of 142 (4%) with hypertensive brain hemorrhage had seizures. Of the 569 patients with traumatic brain injury, 33 of 168 (20%) with traumatic intracranial hemorrhage, 6 of 31 (19%) with brain concussion, 18 of 96 (19%) with brain contusion, 15 of 244 (6%) with chronic subdural hematoma, and 1 of 30 (3%) with minor head injury suffered seizures. We found that these seizure incidences were significantly higher when the cortical lesion was located in the frontal lobe (p < 0.01, chi square test) but not in parietal, occipital, nor temporal lobes. Conclusion: We investigated the prevalence rate of seizures at the time of admission in a large number of patients who had been treated in our institution. Our results suggest that seizures are a common feature in patients with slow-growing and frontal intra-parenchymal lesions. (C) 2013 Elsevier B.V. All rights reserved.	[Hamasaki, Tadashi; Yamada, Kazumichi; Kuratsu, Jun-ichi] Kumamoto Univ Hosp, Dept Neurosurg, Chuo Ku, Kumamoto 8608556, Japan	Hamasaki, T (corresponding author), Kumamoto Univ, Sch Med, Dept Neurosurg, Chuo Ku, 1-1-1 Honjo, Kumamoto 8608556, Japan.	thamasaki-nsu@umin.ac.jp			Department of Neurosurgery, Kumamoto University Medical School	This research was supported by Department of Neurosurgery, Kumamoto University Medical School.	Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Arboix A, 1997, STROKE, V28, P1590, DOI 10.1161/01.STR.28.8.1590; Bladin CF, 2000, ARCH NEUROL-CHICAGO, V57, P1617, DOI 10.1001/archneur.57.11.1617; Camilo O, 2004, STROKE, V35, P1769, DOI 10.1161/01.STR.0000130989.17100.96; Chang EF, 2008, J NEUROSURG, V108, P227, DOI 10.3171/JNS/2008/108/2/0227; Christensen J, 2012, EPILEPSIA, V53, P43, DOI 10.1111/j.1528-1167.2012.03612.x; Compton JJ, 2012, J NEUROSURG, V117, P825, DOI 10.3171/2012.7.JNS111260; Forsyth PA, 2003, CAN J NEUROL SCI, V30, P106, DOI 10.1017/S0317167100053361; FRANCESCHETTI S, 1990, ACTA NEUROCHIR, V103, P47, DOI 10.1007/BF01420191; Glantz MJ, 1996, NEUROLOGY, V46, P985, DOI 10.1212/WNL.46.4.985; Glantz MJ, 2000, NEUROLOGY, V54, P1886, DOI 10.1212/WNL.54.10.1886; Grobelny BT, 2009, J NEUROSURG, V111, P1257, DOI 10.3171/2009.6.JNS0928; Gross BA, 2011, NEUROSURG FOCUS, V30, DOI 10.3171/2011.3.FOCUS1165; Hamasaki T, 2012, ACTA NEUROCHIR, V154, P2241, DOI 10.1007/s00701-012-1511-1; HAUSER WA, 1993, EPILEPSIA, V34, P453, DOI 10.1111/j.1528-1157.1993.tb02586.x; Herman ST, 2002, NEUROLOGY, V59, pS21, DOI 10.1212/WNL.59.9_suppl_5.S21; Hu WH, 2012, ACTA NEUROCHIR, V154, P855, DOI 10.1007/s00701-011-1259-z; Kawaguchi T, 1996, NEUROL MED CHIR TOKY, V36, P573; Kawaguchi Tadashi, 1996, Neurologia Medico-Chirurgica, V36, P568, DOI 10.2176/nmc.36.568; Kuratsu Jun-ichi, 2001, International Journal of Clinical Oncology, V6, P183; Lanzino G, 2011, NEUROCRIT CARE, V15, P247, DOI 10.1007/s12028-011-9584-x; Lieu AS, 2000, EPILEPSY RES, V38, P45; Lowenstein DH, 2009, EPILEPSIA, V50, P4, DOI 10.1111/j.1528-1167.2008.02004.x; Makino K, 2010, CHILD NERV SYST, V26, P1029, DOI 10.1007/s00381-010-1126-x; Menon B, 2009, EPILEPSY RES, V87, P1, DOI 10.1016/j.eplepsyres.2009.08.007; Myint PK, 2006, POSTGRAD MED J, V82, P568, DOI 10.1136/pgmj.2005.041426; Nakamura H, 2011, INT J CLIN ONCOL, V16, P314, DOI 10.1007/s10147-010-0178-y; NORTH JB, 1983, J NEUROSURG, V58, P672, DOI 10.3171/jns.1983.58.5.0672; OHNO K, 1993, J NEUROL NEUROSUR PS, V56, P1231, DOI 10.1136/jnnp.56.11.1231; Olsen T S, 2001, Curr Atheroscler Rep, V3, P340, DOI 10.1007/s11883-001-0029-4; Pohlmann-Eden B, 2002, ARCH NEUROL-CHICAGO, V59, P1831, DOI 10.1001/archneur.59.11.1831; Rothoerl RD, 2003, NEUROSURG REV, V26, P108, DOI 10.1007/s10143-002-0240-y; RUBIN G, 1993, ACTA NEUROCHIR, V123, P39, DOI 10.1007/BF01476283; SABO RA, 1995, SURG NEUROL, V43, P579, DOI 10.1016/0090-3019(95)00155-7; SHERWIN A, 1988, NEUROLOGY, V38, P920, DOI 10.1212/WNL.38.6.920; Southwell DG, 2012, NEUROSURGERY, V70, P1406, DOI 10.1227/NEU.0b013e3182500a4c; Temkin NR, 2007, LANCET NEUROL, V6, P29, DOI 10.1016/S1474-4422(06)70630-5; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; Temkin NR, 2003, EPILEPSIA, V44, P18, DOI 10.1046/j.1528-1157.44.s10.6.x; van Breemen MSM, 2007, LANCET NEUROL, V6, P421, DOI 10.1016/S1474-4422(07)70103-5; Villemure JG, 1996, CURR OPIN NEUROL, V9, P424, DOI 10.1097/00019052-199612000-00005; von der Brelie C, 2011, ACTA NEUROCHIR, V153, P249, DOI 10.1007/s00701-010-0915-z; Wallace H, 1998, LANCET, V352, P1970, DOI 10.1016/S0140-6736(98)04512-7; Yano S, 2006, J NEUROSURG, V105, P538, DOI 10.3171/jns.2006.105.4.538	44	18	19	0	8	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0303-8467	1872-6968		CLIN NEUROL NEUROSUR	Clin. Neurol. Neurosurg.	NOV	2013	115	11					2336	2340		10.1016/j.clineuro.2013.08.016			5	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	264TX	WOS:000327905000005	24011499				2021-06-18	
J	Hildenbrand, KJ; Vasavada, AN				Hildenbrand, Kasee J.; Vasavada, Anita N.			COLLEGIATE AND HIGH SCHOOL ATHLETE NECK STRENGTH IN NEUTRAL AND ROTATED POSTURES	JOURNAL OF STRENGTH AND CONDITIONING RESEARCH			English	Article						isometric; cervical musculature; MCU; concussion	CERVICAL EXTENSION STRENGTH; ISOMETRIC STRENGTH; MUSCLE STRENGTH; HEALTHY-VOLUNTEERS; HEAD; BIOMECHANICS; MUSCULATURE; RELIABILITY; FOOTBALL; DATABASE	A knowledge of neck strength is important for developing conditioning protocols and for evaluating the relationship between neck strength and head and neck injury, but very few studies have examined neck strength in relationship to athletic participation. The purpose of this study was to quantify isometric neck strength in collegiate and high school athletes. We hypothesized that (a) male athletes would have significantly greater neck strength than females; (b) collegiate athletes would be significantly stronger than high school athletes; and (c) neck strength would vary significantly with head posture. A total of 149 subjects participated (77 men and 72 women; 90 college and 59 high school level). Flexion, extension, and lateral flexion neck strength were measured in neutral and rotated head and neck postures. Neck strength varied significantly according to participants' sex, age, and posture (p < 0.05). Male college students were stronger than those in all other groups (female college students, male high school students, and female high school students). The average female neck strength was 61, 54, and 56% of the average male neck strength for extension, flexion, and lateral flexion, respectively. High school athletes' neck strength was 75, 68, and 65% of collegiate athletes' neck strength for extension, flexion, and lateral flexion, respectively. On average, neck strength was the greatest for extension compared with other force directions. The subjects showed large variation in neck strength with posture, but in general, there were no consistent trends among the subjects. This finding suggests that those whose neck strength was considerably lower in nonneutral postures may consider training to increase strength in rotated postures. These data provide important baseline information for future studies evaluating injury risk or training protocols.	[Hildenbrand, Kasee J.] Washington State Univ, Coll Educ, Athlet Training Educ Program, Pullman, WA 99164 USA; [Vasavada, Anita N.] Washington State Univ, Voiland Sch Chem Engn & Bioengn, Pullman, WA 99164 USA; [Vasavada, Anita N.] Washington State Univ, Dept Vet & Comparat Anat Pharmacol & Physiol, Pullman, WA 99164 USA	Hildenbrand, KJ (corresponding author), Washington State Univ, Coll Educ, Athlet Training Educ Program, Pullman, WA 99164 USA.	khildenbrand@wsu.edu					Bauer JA, 2001, J SPORT SCI, V19, P171, DOI 10.1080/026404101750095312; BERG HE, 1994, ARCH PHYS MED REHAB, V75, P661, DOI 10.1016/0003-9993(94)90189-9; Broglio SP, 2010, MED SCI SPORT EXER, V42, P2064, DOI 10.1249/MSS.0b013e3181dd9156; Broglio SP, 2009, J ATHL TRAINING, V44, P342, DOI 10.4085/1062-6050-44.4.342; Burnett AF, 2004, AVIAT SPACE ENVIR MD, V75, P611; Burnett Angus F, 2005, Work, V25, P205; Chiu TTW, 2002, CLIN REHABIL, V16, P851, DOI 10.1191/0269215502cr550oa; Chiu TTW, 2002, CLIN REHABIL, V16, P772, DOI 10.1191/0269215502cr552oa; Choi H, 1999, J APPL BIOMECH, V15, P120, DOI 10.1123/jab.15.2.120; ELIASZIW M, 1987, STAT MED, V6, P647, DOI 10.1002/sim.4780060602; Garces GL, 2002, MED SCI SPORT EXER, V34, P464, DOI 10.1097/00005768-200203000-00013; Guskiewicz KM, 2011, EXERC SPORT SCI REV, V39, P4, DOI 10.1097/JES.0b013e318201f53e; JACOBS K, 1995, CAN J APPL PHYSIOL, V20, P230, DOI 10.1139/h95-017; Jordan A, 1999, SPINE, V24, P1343, DOI 10.1097/00007632-199907010-00012; Keating LJ, 2005, J WHIPLASH RELAT DIS, V4, P43; KREIGHBAUM E., 1996, BIOMECHANICS QUALITA; Kumar S, 2001, CLIN BIOMECH, V16, P380, DOI 10.1016/S0268-0033(01)00023-7; Lavallee AV, 2013, J BIOMECH, V46, P527, DOI 10.1016/j.jbiomech.2012.09.029; Lee SG, 1989, ISSUES CONTROL MODEL, P5; MAYER T, 1994, SPINE, V19, P762, DOI 10.1097/00007632-199404000-00006; Mihalik JP, 2011, CLIN J SPORT MED, V21, P416, DOI 10.1097/JSM.0B013E31822C8A5C; MORONEY SP, 1988, J ORTHOPAED RES, V6, P713, DOI 10.1002/jor.1100060514; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; POLLOCK ML, 1993, ARCH PHYS MED REHAB, V74, P1080, DOI 10.1016/0003-9993(93)90065-I; Salo PK, 2006, J ORTHOP SPORT PHYS, V36, P495, DOI 10.2519/jospt.2006.2122; STURZENEGGER M, 1994, NEUROLOGY, V44, P688, DOI 10.1212/WNL.44.4.688; Suderman BL, 2012, THESIS WASHINGTON ST; Taylor MK, 2006, AVIAT SPACE ENVIR MD, V77, P1131; Vasavada AN, 2001, SPINE, V26, P1904, DOI 10.1097/00007632-200109010-00018; Vasavada AN, 2008, J BIOMECH, V41, P114, DOI 10.1016/j.jbiomech.2007.07.007; Vincent A., 2006, THESIS U WASHINGTON; Ylinen JJ, 2003, J STRENGTH COND RES, V17, P755	32	18	18	0	14	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1064-8011	1533-4287		J STRENGTH COND RES	J. Strength Cond. Res.	NOV	2013	27	11					3173	3182		10.1519/JSC.0b013e31828a1fe2			10	Sport Sciences	Sport Sciences	245WS	WOS:000326495200031	23439331				2021-06-18	
J	Irimia, A; Goh, SYM; Torgerson, CM; Chambers, MC; Kikinis, R; Van Horn, JD				Irimia, Andrei; Goh, S. Y. Matthew; Torgerson, Carinna M.; Chambers, Micah C.; Kikinis, Ron; Van Horn, John D.			Forward and inverse electroencephalographic modeling in health and in acute traumatic brain injury	CLINICAL NEUROPHYSIOLOGY			English	Article						Electroencephalography; Traumatic brain injury; finite element method; Magnetic resonance imaging	ELECTRICAL-CONDUCTIVITY; SOURCE LOCALIZATION; POSTTRAUMATIC EPILEPSY; DIELECTRIC-PROPERTIES; EEG; HEAD; ANISOTROPY; MEG; PERTURBATIONS; SEGMENTATION	Objective: EEG source localization is demonstrated in three cases of acute traumatic brain injury (TBI) with progressive lesion loads using anatomically faithful models of the head which account for pathology. Methods: Multimodal magnetic resonance imaging (MRI) volumes were used to generate head models via the finite element method (FEM). A total of 25 tissue types-including 6 types accounting for pathology-were included. To determine the effects of TBI upon source localization accuracy, a minimum-norm operator was used to perform inverse localization and to determine the accuracy of the latter. Results: The importance of using a more comprehensive number of tissue types is confirmed in both health and in TBI. Pathology omission is found to cause substantial inaccuracies in EEG forward matrix calculations, with lead field sensitivity being underestimated by as much as similar to 200% in (peri-) contusional regions when TBI-related changes are ignored. Failing to account for such conductivity changes is found to misestimate substantial localization error by up to 35 mm. Conclusions: Changes in head conductivity profiles should be accounted for when performing EEG modeling in acute TBI. Significance: Given the challenges of inverse localization in TBI, this framework can benefit neurotrauma patients by providing useful insights on pathophysiology. (c) 2013 International Federation of Clinical Neurophysiology. Published by Elsevier Ireland Ltd. All rights reserved.	[Irimia, Andrei; Goh, S. Y. Matthew; Torgerson, Carinna M.; Chambers, Micah C.; Van Horn, John D.] Univ Calif Los Angeles, Dept Neurol, Lab Neuro Imaging, Los Angeles, CA 90095 USA; [Kikinis, Ron] Harvard Univ, Sch Med, Dept Radiol, Surg Planning Lab, Boston, MA 02115 USA	Van Horn, JD (corresponding author), Univ Calif Los Angeles, Dept Neurol, Lab Neuro Imaging, Los Angeles, CA 90095 USA.	jack.vanhorn@loni.ucla.edu	Irimia, Andrei/B-8275-2008	Irimia, Andrei/0000-0002-9254-9388; Van Horn, John/0000-0003-1537-0816	National Alliance for Medical Image Computing (NA-MIC), under NIH Roadmap Initiative Grant [2U54EB005149]; NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R41NS081792, P01NS058489]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [U54EB005149, P41EB015922] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS058489, R41NS081792] Funding Source: NIH RePORTER	We acknowledge Zeynep Akalin Akar, Eric Halgren, Eran Mukamel, Paul M. Vespa, and the staff in the Laboratory of Neuro Imaging at UCLA for assistance and useful discussions. 3D Slicer is a multi-platform, free and open source software package for visualization and medical image computing available from www.slicer.org. This work was supported by the National Alliance for Medical Image Computing (NA-MIC; www.na-mic.org), under NIH Roadmap Initiative Grant 2U54EB005149 (to R. K., sub-award to J. D. V. H.), and by the NINDS, Grants R41NS081792 (to Stephen R. Aylward and J. D. V. H.) and P01NS058489 (to Paul M. Vespa). The authors report no conflict of interest.	Acar Z., 2004, PHYS MED BIOL, V49, P5011; Acar ZA, 2010, J NEUROSCI METH, V190, P258, DOI 10.1016/j.jneumeth.2010.04.031; Akhtari M, 2002, BRAIN TOPOGR, V14, P151, DOI 10.1023/A:1014590923185; Angeleri F, 1999, EPILEPSIA, V40, P1222, DOI 10.1111/j.1528-1157.1999.tb00850.x; Awada KA, 1998, IEEE T BIO-MED ENG, V45, P1135, DOI 10.1109/10.709557; Baumann SB, 1997, IEEE T BIO-MED ENG, V44, P220, DOI 10.1109/10.554770; Binette JS, 2004, J BIOMECH ENG-T ASME, V126, P475, DOI 10.1115/1.1785805; Brophy GM, 2012, NEUROCRIT CARE, V17, P3, DOI 10.1007/s12028-012-9695-z; Chauveau N, 2004, HUM BRAIN MAPP, V21, P86, DOI 10.1002/hbm.10152; Chen FM, 2010, MED PHYS, V37, P4475, DOI 10.1118/1.3466831; Cook MJD, 2008, IEEE ENG MED BIO, P4563, DOI 10.1109/IEMBS.2008.4650228; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; DALE AM, 1993, J COGNITIVE NEUROSCI, V5, P162, DOI 10.1162/jocn.1993.5.2.162; EBERSOLE J S, 1990, Brain Topography, V3, P21, DOI 10.1007/BF01128858; Ebersole JS, 1999, EEG CL N SU, V50, P167; EBERSOLE JS, 1991, NEUROLOGY, V41, P1425, DOI 10.1212/WNL.41.9.1425; Ferree TC, 2000, IEEE T BIO-MED ENG, V47, P1584, DOI 10.1109/10.887939; Ferris D.P., 2012, J BEHAV BRAIN SCI, V02, P387, DOI [DOI 10.4236/JBBS.2012.23044, 10.4236/jbbs.2012.23044]; FOSTER KR, 1989, CRIT REV BIOMED ENG, V17, P25; Friedman D, 2009, ANESTH ANALG, V109, P506, DOI 10.1213/ane.0b013e3181a9d8b5; Gabriel C, 1996, PHYS MED BIOL, V41, P2231, DOI 10.1088/0031-9155/41/11/001; Gabriel S, 1996, PHYS MED BIOL, V41, P2251, DOI 10.1088/0031-9155/41/11/002; Garga Nina, 2006, Epilepsy Curr, V6, P1, DOI 10.1111/j.1535-7511.2005.00083.x; Gencer NG, 2004, PHYS MED BIOL, V49, P701, DOI 10.1088/0031-9155/49/5/004; Hallez H, 2007, J NEUROENG REHABIL, V4, DOI 10.1186/1743-0003-4-46; Haufe S, 2010, IEEE T BIO-MED ENG, V57, P1954, DOI 10.1109/TBME.2010.2046325; Haynes W., 2011, CRC HDB CHEM PHYS; HE B, 1987, IEEE T BIO-MED ENG, V34, P406, DOI 10.1109/TBME.1987.326056; Holmes MJ, 2013, BRAIN CONNECT, V3, P22, DOI 10.1089/brain.2012.0103; Irimia Andrei, 2012, Front Neurol, V3, P10, DOI 10.3389/fneur.2012.00010; Irimia A, 2012, NEUROIMAGE, V59, P2464, DOI 10.1016/j.neuroimage.2011.08.104; Irimia A, 2011, J NEUROTRAUM, V28, P2287, DOI 10.1089/neu.2011.1920; Irimia A, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.051908; Jacquir S, 2007, P ANN INT IEEE EMBS, P1711, DOI 10.1109/IEMBS.2007.4352639; Lantz G, 2003, CLIN NEUROPHYSIOL, V114, P63, DOI 10.1016/S1388-2457(02)00337-1; Lee HO, 2008, J KOREAN NEUROSURG S, V44, P196, DOI 10.3340/jkns.2008.44.4.196; Lee WH, 2009, CLIN NEUROPHYSIOL, V120, P2071, DOI 10.1016/j.clinph.2009.09.007; Lima EA, 2006, SQUID HDB APPL SQUID; Lindenblatt G, 2001, PHYS MED BIOL, V46, P3051, DOI 10.1088/0031-9155/46/11/319; Liu AK, 2002, HUM BRAIN MAPP, V16, P47, DOI 10.1002/hbm.10024; Mani J, 2006, POSTTRAUMATIC EPILEP; Marin G, 1998, HUM BRAIN MAPP, V6, P250, DOI 10.1002/(SICI)1097-0193(1998)6:4<250::AID-HBM5>3.0.CO;2-2; Odabaee M, 2013, NEUROIMAGE, V68, P229, DOI 10.1016/j.neuroimage.2012.11.062; Pohlmeier R, 1997, BRAIN TOPOGR, V9, P157, DOI 10.1007/BF01190384; Ramon C, 2005, BIOMED ENG ONLINE, V4, DOI 10.1186/1475-925X-4-55; Reyes-Gasga J, 1999, J MATER SCI, V34, P2183, DOI 10.1023/A:1004540617013; RIJKHOFF NJM, 1994, IEEE T BIO-MED ENG, V41, P413, DOI 10.1109/10.293215; SALAZAR AM, 1985, NEUROLOGY, V35, P1406, DOI 10.1212/WNL.35.10.1406; Sazonov AV, 2009, BIOL CYBERN, V100, P129, DOI 10.1007/s00422-008-0283-4; Trakic A, 2010, PHYSIOL MEAS, V31, P13, DOI 10.1088/0967-3334/31/1/002; Vespa PM, 2010, NEUROLOGY, V75, P792, DOI 10.1212/WNL.0b013e3181f07334; von Ellenrieder N, 2006, IEEE T BIO-MED ENG, V53, P421, DOI 10.1109/TBME.2005.869769; YAN Y, 1991, MED BIOL ENG COMPUT, V29, P475, DOI 10.1007/BF02442317; Yang L, 2010, CLIN NEUROPHYSIOL, V121, P1240, DOI 10.1016/j.clinph.2010.02.153; Yitembe BR, 2013, INT J NUMER METH BIO, V29, P363, DOI 10.1002/cnm.2510; Yitembe BR, 2011, IEEE T BIO-MED ENG, V58, P1430, DOI 10.1109/TBME.2011.2107740; Zhang YC, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2398883	57	18	18	0	11	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	1388-2457	1872-8952		CLIN NEUROPHYSIOL	Clin. Neurophysiol.	NOV	2013	124	11					2129	2145		10.1016/j.clinph.2013.04.336			17	Clinical Neurology; Neurosciences	Neurosciences & Neurology	236FE	WOS:000325779800011	23746499	Green Accepted			2021-06-18	
J	Kiss, P; Vadasz, G; Kiss-Illes, B; Horvath, G; Tamas, A; Reglodi, D; Koppan, M				Kiss, Peter; Vadasz, Gyongyver; Kiss-Illes, Blanka; Horvath, Gabor; Tamas, Andrea; Reglodi, Dora; Koppan, Miklos			Environmental Enrichment Decreases Asphyxia-Induced Neurobehavioral Developmental Delay in Neonatal Rats	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Article						asphyxia; enriched environment; reflex development; motor coordination	HYPOXIC-ISCHEMIC ENCEPHALOPATHY; ACUTE PERINATAL ASPHYXIA; EXCITATORY AMINO-ACIDS; TRAUMATIC BRAIN-INJURY; ANXIETY-LIKE BEHAVIOR; GROWTH-FACTOR 1; MONOSODIUM GLUTAMATE; NEUROLOGICAL REFLEXES; CEREBROSPINAL-FLUID; NEUROTROPHIC FACTOR	Perinatal asphyxia during delivery produces long-term disability and represents a major problem in neonatal and pediatric care. Numerous neuroprotective approaches have been described to decrease the effects of perinatal asphyxia. Enriched environment is a popular strategy to counteract nervous system injuries. The aim of the present study was to investigate whether enriched environment is able to decrease the asphyxia-induced neurobehavioral developmental delay in neonatal rats. Asphyxia was induced in ready-to-deliver mothers by removing the pups by caesarian section after 15 min of asphyxia. Somatic and neurobehavioral development was tested daily and motor coordination weekly. Our results show that rats undergoing perinatal asphyxia had a marked developmental delay and worse performance in motor coordination tests. However, pups kept in enriched environment showed a decrease in the developmental delay observed in control asphyctic pups. Rats growing up in enriched environment did not show decrease in weight gain after the first week and the delay in reflex appearance was not as marked as in control rats. In addition, the development of motor coordination was not as strikingly delayed as in the control group. Short-term neurofunctional outcome are known to correlate with long-term deficits. Our results thus show that enriched environment could be a powerful strategy to decrease the deleterious developmental effects of perinatal asphyxia.	[Kiss, Peter; Vadasz, Gyongyver; Kiss-Illes, Blanka; Horvath, Gabor; Tamas, Andrea; Reglodi, Dora] Univ Pecs, Dept Anat, PTE MTA Lendulet PACAP Res Team, H-7624 Pecs, Hungary; [Koppan, Miklos] Univ Pecs, Dept Obstet & Gynecol, H-7624 Pecs, Hungary	Reglodi, D (corresponding author), Univ Pecs, Dept Anat, PTE MTA Lendulet PACAP Res Team, H-7624 Pecs, Hungary.	peter.kiss@aok.pte.hu; vadaszgyongyi@gmail.com; blanka.illes@gmail.com; gabor.horvathmd@gmail.com; andreatamassz@gmail.com; dora.reglodi@aok.pte.hu; mkoppan@gmail.com			OTKAOrszagos Tudomanyos Kutatasi Alapprogramok (OTKA) [K104984, PD109644]; TAMOP [4.2.2.B-10/1-2010-0029, 4.2.2.A-11/1/KONV-2012-0024, 4.2.4.A/2-11-1-2012-0001]; Arimura Foundation; NAP Program; PTE-MTA "Lendulet" Program; Bolyai ScholarshipHungarian Academy of Sciences; University of Pecs Research Grant [AOK-KA 2013]	This study was supported by OTKA K104984, PD109644, TAMOP (4.2.2.B-10/1-2010-0029, 4.2.2.A-11/1/KONV-2012-0024), Arimura Foundation, NAP Program, PTE-MTA "Lendulet" Program, Bolyai Scholarship, University of Pecs Research Grant AOK-KA 2013, TAMOP 4.2.4.A/2-11-1-2012-0001 "National Excellence Program".	Adriani W, 2006, PSYCHOPHARMACOLOGY, V184, P155, DOI 10.1007/s00213-005-0223-0; Allende-Castro C, 2012, NEUROTOX RES, V22, P79, DOI 10.1007/s12640-012-9310-2; Alonso-Alconada D, 2012, HISTOL HISTOPATHOL, V27, P771, DOI 10.14670/HH-27.771; ALTMAN J, 1975, ANIM BEHAV, V23, P896, DOI 10.1016/0003-3472(75)90114-1; Baldini S, 2013, J NEUROSCI, V33, P11715, DOI 10.1523/JNEUROSCI.3541-12.2013; Baroncelli L, 2013, NEUROSCIENCE, V236, P313, DOI 10.1016/j.neuroscience.2013.01.036; BONESTROO HJ, 2013, NEUROSCIENCE, V35, P197; Bustamante D, 2007, EXP BRAIN RES, V177, P358, DOI 10.1007/s00221-006-0679-0; Capani F, 2009, EXP NEUROL, V219, P404, DOI 10.1016/j.expneurol.2009.06.007; Cebral E, 2011, BRAIN RES BULL, V84, P31, DOI 10.1016/j.brainresbull.2010.10.003; Chen Y, 1997, NEUROSCI LETT, V221, P77, DOI 10.1016/S0304-3940(96)13293-6; Clayton Kellie, 2003, Physical & Occupational Therapy in Pediatrics, V23, P43, DOI 10.1300/J006v23n01_04; Comeau W, 2008, DEV PSYCHOBIOL, V50, P134, DOI 10.1002/dev.20253; Dam K, 2000, DEV BRAIN RES, V121, P179, DOI 10.1016/S0165-3806(00)00044-4; de Haan M, 2006, DEVELOPMENTAL SCI, V9, P350, DOI 10.1111/j.1467-7687.2006.00499.x; DellAnna E, 1997, EXP BRAIN RES, V115, P105, DOI 10.1007/PL00005670; Eisenberg-Lerner A, 2009, CELL DEATH DIFFER, V16, P966, DOI 10.1038/cdd.2009.33; Farkas J, 2009, BRAIN RES BULL, V79, P208, DOI 10.1016/j.brainresbull.2008.12.011; Fernandez-Teruel A, 1997, BEHAV GENET, V27, P513, DOI 10.1023/A:1021400830503; Frizzo JK, 2010, CELL MOL NEUROBIOL, V30, P683, DOI 10.1007/s10571-009-9492-1; Ginet V, 2009, AM J PATHOL, V175, P1962, DOI 10.2353/ajpath.2009.090463; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; HAGBERG H, 1993, ACTA PAEDIATR, V82, P925, DOI 10.1111/j.1651-2227.1993.tb12601.x; Hagberg H, 2009, J CHILD NEUROL, V24, P1141, DOI 10.1177/0883073809338212; Hannigan JH, 2007, NEUROSCI BIOBEHAV R, V31, P202, DOI 10.1016/j.neubiorev.2006.06.019; HEBB DO, 1947, AM PSYCHOL, V2, P302; Herrera-Marschitz M, 2011, NEUROTOX RES, V19, P603, DOI 10.1007/s12640-010-9208-9; HILL JM, 1991, PEPTIDES, V12, P187, DOI 10.1016/0196-9781(91)90186-S; Holopainen IE, 2012, PHARMACOL BIOCHEM BE, V100, P825, DOI 10.1016/j.pbb.2011.03.016; Horvath G, 2013, INT J MOL SCI, V14, P19054, DOI 10.3390/ijms140919054; Imanaka A, 2008, BEHAV BRAIN RES, V186, P91, DOI 10.1016/j.bbr.2007.07.039; Imanaka A, 2006, BEHAV BRAIN RES, V173, P129, DOI 10.1016/j.bbr.2006.06.012; Johnson EM, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00044; Kajta M, 2009, NEUROCHEM INT, V55, P265, DOI 10.1016/j.neuint.2009.03.010; Keilhoff G, 2010, NEUROSCIENCE, V171, P869, DOI 10.1016/j.neuroscience.2010.09.024; Kiss P, 2007, NEUROTOX RES, V12, P85, DOI 10.1007/BF03033917; Kiss P, 2005, NEUROTOX RES, V8, P235, DOI 10.1007/BF03033977; KISS P, 2013, INT J MOL SCI, V14, P1; Kiss P, 2011, NEUROSCI LETT, V487, P400, DOI 10.1016/j.neulet.2010.10.065; Kiss P, 2009, BRAIN RES, V1255, P42, DOI 10.1016/j.brainres.2008.12.018; Klawitter V, 2007, EXP BRAIN RES, V180, P139, DOI 10.1007/s00221-006-0842-7; Kondo M, 2012, NEURON, V73, P743, DOI 10.1016/j.neuron.2011.12.020; Kumral A, 2006, BIOL NEONATE, V89, P205, DOI 10.1159/000089951; Kusaka K, 2004, SYNAPSE, V54, P223, DOI 10.1002/syn.20086; Landi S, 2009, J NEUROSCI, V29, P10809, DOI 10.1523/JNEUROSCI.1857-09.2009; Lehnardt S, 2007, J NEUROIMMUNOL, V190, P28, DOI 10.1016/j.jneuroim.2007.07.023; Leuthner SR, 2004, PEDIATR CLIN N AM, V51, P737, DOI 10.1016/j.pcl.2004.01.016; Lubics A, 2005, BEHAV BRAIN RES, V157, P157, DOI 10.1016/j.bbr.2004.06.019; MALISKA D, 2002, FOLIA NEUROPATHOL, V40, P177; Monaco CM, 2013, EXP NEUROL, V247, P410, DOI 10.1016/j.expneurol.2013.01.007; Morales P, 2008, J NEUROSCI RES, V86, P2650, DOI 10.1002/jnr.21715; Morales P, 2007, NEUROTOX RES, V12, P81, DOI 10.1007/BF03033903; Morales P, 2010, EXP BRAIN RES, V202, P1, DOI 10.1007/s00221-009-2103-z; Nithianantharajah J, 2006, NAT REV NEUROSCI, V7, P697, DOI 10.1038/nrn1970; NOBREGA JN, 1992, DEV PSYCHOBIOL, V25, P183, DOI 10.1002/dev.420250304; Northington FJ, 2007, NEUROSCIENCE, V149, P822, DOI 10.1016/j.neuroscience.2007.06.060; OLSSON T, 1994, MOL BRAIN RES, V23, P349, DOI 10.1016/0169-328X(94)90246-1; Pereira LO, 2007, NEUROBIOL LEARN MEM, V87, P101, DOI 10.1016/j.nlm.2006.07.003; Ortuzar N, 2011, J NEURAL TRANSM, V118, P135, DOI 10.1007/s00702-010-0496-2; Pattison KF, 2013, ANIM COGN, V16, P429, DOI 10.1007/s10071-012-0583-x; Ravenelle R, 2013, BEHAV BRAIN RES, V252, P49, DOI 10.1016/j.bbr.2013.05.041; Reglodi D, 2003, BEHAV BRAIN RES, V140, P131, DOI 10.1016/S0166-4328(02)00289-9; REYNOLDS S, 2013, AUTISM RES; Richter SH, 2013, BEHAV BRAIN RES, V252, P287, DOI 10.1016/j.bbr.2013.06.021; RIIKONEN RS, 1992, PEDIATR NEUROL, V8, P37, DOI 10.1016/0887-8994(92)90050-9; Robertson CL, 2009, EXP NEUROL, V218, P371, DOI 10.1016/j.expneurol.2009.04.030; Rojas JJ, 2013, EXP NEUROL, V241, P25, DOI 10.1016/j.expneurol.2012.11.026; SARNAT HB, 1976, NEUROLOGY, V33, P696; Schneider JS, 2001, BRAIN RES, V896, P48, DOI 10.1016/S0006-8993(00)03249-2; Simola N, 2008, EXP BRAIN RES, V185, P595, DOI 10.1007/s00221-007-1186-7; SMART JL, 1971, BRAIN RES, V28, P85, DOI 10.1016/0006-8993(71)90526-9; SMART JL, 1971, BRAIN RES, V33, P303, DOI 10.1016/0006-8993(71)90105-3; Souza SK, 2013, METAB BRAIN DIS, V28, P25, DOI 10.1007/s11011-012-9367-x; Strata F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015326; Sun XM, 2008, INT J DEV NEUROSCI, V26, P363, DOI 10.1016/j.ijdevneu.2007.11.005; Szabadfi K, 2009, BRAIN RES, V1259, P107, DOI 10.1016/j.brainres.2009.01.004; Ten VS, 2003, BEHAV BRAIN RES, V145, P209, DOI 10.1016/S0166-4328(03)00146-3; Tracey KJ, 2007, J CLIN INVEST, V117, P289, DOI 10.1172/JCI30555; UJHAZY E, FOOD CHEM T IN PRESS; Van de Berg WDJ, 2002, EXP NEUROL, V174, P29, DOI 10.1006/exnr.2001.7855; Vannucci RC, 2000, AM J PERINAT, V17, P113, DOI 10.1055/s-2000-9293; VANNUCCI RC, 1993, PEDIATR NEUROL, V9, P29, DOI 10.1016/0887-8994(93)90006-X; Vazquez-Sanroman D, 2013, BEHAV BRAIN RES, V243, P118, DOI 10.1016/j.bbr.2012.12.047; Vlassaks E, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-14; Yang T, 2011, BRAIN RES, V1383, P317, DOI 10.1016/j.brainres.2011.01.081; YU K, 2013, BRAIN RES; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	87	18	18	0	17	MDPI AG	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND	1422-0067			INT J MOL SCI	Int. J. Mol. Sci.	NOV	2013	14	11					22258	22273		10.3390/ijms141122258			16	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Biochemistry & Molecular Biology; Chemistry	274RR	WOS:000328624400066	24232451	DOAJ Gold, Green Published			2021-06-18	
J	Kourtidou, P; McCauley, SR; Bigler, ED; Traipe, E; Wu, TC; Chu, ZLD; Hunter, JV; Li, XQ; Levin, HS; Wilde, EA				Kourtidou, Paraskevi; McCauley, Stephen R.; Bigler, Erin D.; Traipe, Elfrides; Wu, Trevor C.; Chu, Zili D.; Hunter, Jill V.; Li, Xiaoqi; Levin, Harvey S.; Wilde, Elisabeth A.			Centrum Semiovale and Corpus Callosum Integrity in Relation to Information Processing Speed in Patients With Severe Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						centrum semiovale; corpus callosum; diffusion tensor imaging; magnetization transfer imaging; processing speed; traumatic axonal injury; traumatic brain injury	DIFFUSE AXONAL INJURY; WHITE-MATTER; COEFFICIENT; RECOVERY; MODERATE; MEMORY; TBI	Objectives: This study investigated white matter alterations in the corpus callosum (CC) and centrum semiovale (CSO), using diffusion tensor imaging and magnetization transfer imaging, in participants with severe traumatic brain injury (TBI) and related these changes to processing speed measures. Participants and Methods: Fourteen adult participants with severe TBI underwent neuroimaging and assessment, using the Symbol Digit Modalities Test and Trail-Making Test, Part B, at approximately 6 months postinjury. Thirteen demographically similar, neurologically intact adults were imaged for comparison. Results: The TBI group demonstrated lower fractional anisotropy (FA) for the right CSO and higher apparent diffusion coefficient (ADC) for the CSO bilaterally than the control group. Lower FA and higher ADC were noted in all CC regions. Magnetization transfer imaging revealed smaller magnetization transfer ratios (MTRs) in the right and left CSO and CC genu and splenium. Written Symbol Digit Modalities Test performance was related to right CSO FA, bilateral CSO ADC, CC FA, and right CSO MTR, whereas oral Symbol Digit Modalities Test was related to right CSO FA, ADC, and MTR. Trail-Making Test, Part B, was related to right CSO FA and MTR. Conclusions: Advanced neuroimaging modalities such as diffusion tensor imaging and magnetization transfer imaging demonstrate significant alterations in white matter, which are related to processing speed. These techniques may be useful in quantifying the extent of injury even in normal appearing white matter after TBI.	[Kourtidou, Paraskevi] Univ Athens, Postgrad Program Clin Neuropsychol, Sch Med, Athens, Greece; [Kourtidou, Paraskevi] Univ Texas Hlth Sci Ctr, Houston, TX 77225 USA; [McCauley, Stephen R.; Traipe, Elfrides; Wu, Trevor C.; Li, Xiaoqi; Levin, Harvey S.; Wilde, Elisabeth A.] Baylor Coll Med, Phys Med & Rehabil Alliance, Houston, TX 77030 USA; [McCauley, Stephen R.; Traipe, Elfrides; Wu, Trevor C.; Li, Xiaoqi; Levin, Harvey S.; Wilde, Elisabeth A.] Univ Texas Houston, Sch Med, Houston, TX 77030 USA; [Traipe, Elfrides; Chu, Zili D.; Hunter, Jill V.; Wilde, Elisabeth A.] Baylor Coll Med, Dept Radiol, Houston, TX 77030 USA; [McCauley, Stephen R.; Levin, Harvey S.; Wilde, Elisabeth A.] Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; [McCauley, Stephen R.; Levin, Harvey S.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [McCauley, Stephen R.; Levin, Harvey S.; Wilde, Elisabeth A.] Michael E DeBakey VA Med Ctr, Houston, TX USA; [Traipe, Elfrides; Chu, Zili D.; Hunter, Jill V.] Texas Childrens Hosp, Dept Pediat Radiol, Houston, TX 77030 USA; [Bigler, Erin D.; Wu, Trevor C.] Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA; [Bigler, Erin D.] Brigham Young Univ, Dept Neurosci, Provo, UT 84602 USA; [Bigler, Erin D.] Univ Utah, Dept Psychiat, Salt Lake City, UT USA; [Bigler, Erin D.] Univ Utah, Utah Brain Inst, Salt Lake City, UT USA	Wilde, EA (corresponding author), Baylor Coll Med, 1709 Dryden Rd,Ste 1200, Houston, TX 77030 USA.	ewilde@bcm.edu		Kourtidou, Evie/0000-0001-6058-5424	Dana Foundation; organization committee of the clinical neuropsychology program of the Medical School, National and Kapodistrian University of Athens, Greece; University of Texas Health Science Center at Houston, Texas	Funding for this project was provided by a grant from the Dana Foundation (PI: Dr Wilde). The authors thank the organization committee of the clinical neuropsychology program of the Medical School, National and Kapodistrian University of Athens, Greece, and The University of Texas Health Science Center at Houston, Texas (A. C. Papanicolaou, D. Vassilopoulos, I. Evdokimidis, I. Zalonis, S. G. Papageorgiou, C. Potagas, and N. Smyrnis), for their financial assistance to author P. K. They also thank Jonathan Chia, Vipulkumar Patel, and Dr Ponnada Narayana for their assistance in the development and implementation of the magnetic resonance sequences and Joshua Cooper for his assistance in manuscript preparation.	ABOITIZ F, 1992, BRAIN RES, V598, P143, DOI 10.1016/0006-8993(92)90178-C; ADAMS JH, 1991, J NEUROL NEUROSUR PS, V54, P481, DOI 10.1136/jnnp.54.6.481; Alexander AL, 2007, NEUROTHERAPEUTICS, V4, P316, DOI 10.1016/j.nurt.2007.05.011; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Bagley LJ, 2000, J MAGN RESON IMAGING, V11, P1, DOI 10.1002/(SICI)1522-2586(200001)11:1<1::AID-JMRI1>3.0.CO;2-H; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; DOUSSET V, 1992, RADIOLOGY, V182, P483, DOI 10.1148/radiology.182.2.1732968; Duckworth JL, 2010, CURR OPIN CRIT CARE, V16, P92, DOI 10.1097/MCC.0b013e3283374900; Ewing-Cobbs L, 2008, NEUROIMAGE, V42, P1305, DOI 10.1016/j.neuroimage.2008.06.031; Felmingham KL, 2004, NEUROPSYCHOLOGY, V18, P564, DOI 10.1037/0894-4105.18.3.564; Goetz P, 2004, J NEUROTRAUM, V21, P645, DOI 10.1089/0897715041269731; Graham DI, 2000, J NEUROPATH EXP NEUR, V59, P641, DOI 10.1093/jnen/59.8.641; Hammeke T. A., 2003, NEUROPSYCHIATRY, P1149; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Jennett B, 1996, J NEUROL NEUROSUR PS, V60, P362, DOI 10.1136/jnnp.60.4.362; Jones DK, 1999, MAGNET RESON MED, V42, P515, DOI 10.1002/(SICI)1522-2594(199909)42:3<515::AID-MRM14>3.3.CO;2-H; KAIL R, 1994, ACTA PSYCHOL, V86, P199, DOI 10.1016/0001-6918(94)90003-5; Kennedy JE, 2003, CLIN NEUROPSYCHOL, V17, P303, DOI 10.1076/clin.17.3.303.18091; Kennedy MRT, 2009, J INT NEUROPSYCH SOC, V15, P130, DOI 10.1017/S1355617708090024; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Le Bihan D, 2002, NMR BIOMED, V15, P431, DOI 10.1002/nbm.798; LEVIN HS, 1990, J NEUROSURG, V73, P699, DOI 10.3171/jns.1990.73.5.0699; Ljungqvist J, 2011, BRAIN INJURY, V25, P370, DOI 10.3109/02699052.2011.558038; Lockwood-Estrin G, 2012, J NEUROSCI METH, V205, P182, DOI 10.1016/j.jneumeth.2011.12.014; Mamere AE, 2009, AM J NEURORADIOL, V30, P947, DOI 10.3174/ajnr.A1477; McAllister TW, 2012, ANN BIOMED ENG, V40, P127, DOI 10.1007/s10439-011-0402-6; McGowan JC, 2000, AM J NEURORADIOL, V21, P875; McGowan JC, 1999, MAGN RESON MED, V41, P727, DOI 10.1002/(SICI)1522-2594(199904)41:4<727::AID-MRM11>3.3.CO;2-Y; Netsch T, 2004, IEEE T MED IMAGING, V23, P789, DOI 10.1109/TMI.2004.827479; O'Jile JR, 2006, ARCH CLIN NEUROPSYCH, V21, P293, DOI 10.1016/j.acn.2006.03.003; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; Porto L, 2011, EUR J PAEDIATR NEURO, V15, P493, DOI 10.1016/j.ejpn.2011.06.004; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Rassovsky Y, 2006, J CLIN EXP NEUROPSYC, V28, P581, DOI 10.1080/13803390500434474; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Royan J, 2004, ARCH CLIN NEUROPSYCH, V19, P131, DOI 10.1016/S0887-6177(02)00216-0; Rutgers DR, 2008, AM J NEURORADIOL, V29, P514, DOI 10.3174/ajnr.A0856; Shum D. H. K., 1990, CLIN NEUROPSYCHOL, V4, P151, DOI DOI 10.1080/13854049008401508; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Sinson G, 2001, AM J NEURORADIOL, V22, P143; Smith A., 1982, SYMBOL DIGIT MODALIT; Stanford TR, 2010, NAT NEUROSCI, V13, P379, DOI 10.1038/nn.2485; STRICH SJ, 1956, J NEUROL NEUROSUR PS, V19, P163, DOI 10.1136/jnnp.19.3.163; VILKKI J, 1994, NEUROPSYCHOLOGIA, V32, P1257, DOI 10.1016/0028-3932(94)90107-4; Wilde EA, 2006, J NEUROTRAUM, V23, P1412, DOI 10.1089/neu.2006.23.1412; WOLFF SD, 1989, MAGNET RESON MED, V10, P135, DOI 10.1002/mrm.1910100113; Wu TC, 2010, DEV NEUROSCI-BASEL, V32, P361, DOI 10.1159/000317058	48	18	19	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2013	28	6					433	441		10.1097/HTR.0b013e3182585d06			9	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	299AA	WOS:000330365200007	22832369				2021-06-18	
J	Kulstad, E; Metzger, AK; Courtney, DM; Rees, J; Shanley, P; Matsuura, T; McKnite, S; Lurie, K				Kulstad, Erik; Metzger, Anja K.; Courtney, D. Mark; Rees, Jennifer; Shanley, Patrick; Matsuura, Timothy; McKnite, Scott; Lurie, Keith			Induction, maintenance, and reversal of therapeutic hypothermia with an esophageal heat transfer device	RESUSCITATION			English	Article						Therapeutic hypothermia; esophageal; cooling; temperature maintenance; medical device; swine mode	HOSPITAL CARDIAC-ARREST; TRAUMATIC BRAIN-INJURY; INTENSIVE-CARE-UNIT; TARGET TEMPERATURE; COMATOSE SURVIVORS; SURFACE; SAFETY	Aim of the study: To evaluate a novel esophageal heat transfer device for use in inducing, maintaining, and reversing hypothermia. We hypothesized that this device could successfully induce, maintain (within a 1 degrees C range of goal temperature), and reverse, mild therapeutic hypothermia in a large animal model over a 30-h treatment protocol. Methods: Five female Yorkshire swine, weighing a mean of 65 kg (range 61-70) kg each, were anesthetized with inhalational isoflurane via endotracheal intubation and instrumented. The esophageal device was connected to an external chiller and then placed into the esophagus and connected to wall suction. Reduction to goal temperature was achieved by setting the chiller to cooling mode, and a 24 h cooling protocol was completed before rewarming and recovering the animals. Histopathologic analysis was scheduled for 3-14 days after protocol completion. Results: Average baseline temperature for the 5 animals was 38.6 degrees C (range 38.1-39.2 degrees C). All swine were cooled successfully, with average rate of temperature decrease of 1.3 degrees C/h (range 1.1-1.9)degrees C/h. Standard deviation from goal temperature averaged 0.2 degrees C throughout the steady-state maintenance phase, and no treatment for shivering was necessary during the protocol. Histopathology of esophageal tissue showed no adverse effects from the device. Conclusion: A new esophageal heat transfer device successfully and safely induced, maintained, and reversed therapeutic hypothermia in large swine. Goal temperature was maintained within a narrow range, and thermogenic shivering did not occur. These findings suggest a useful new modality to induce therapeutic hypothermia. (C) 2013 The Authors. Published by Elsevier Ireland Ltd. All rights reserved.	[Kulstad, Erik] Advocate Christ Med Ctr, Dept Emergency Med, Oak Lawn, IL 60453 USA; [Metzger, Anja K.] Univ Minnesota, Med Ctr, Dept Emergency Med, Minneapolis, MN 55455 USA; [Courtney, D. Mark] Northwestern Univ, Feinberg Sch Med, Dept Emergency Med, Chicago, IL 60611 USA; [Rees, Jennifer] Adv Circulatory Syst Inc, Roseville, MN 55113 USA; [Shanley, Patrick] Northwestern Univ, Evanston, IL 60208 USA; [Matsuura, Timothy] Univ Minnesota, Minneapolis, MN 55455 USA; [McKnite, Scott; Lurie, Keith] Minneapolis Med Res Fdn Inc, Minneapolis, MN 55455 USA	Kulstad, E (corresponding author), Advocate Christ Med Ctr, Dept Emergency Med, Oak Lawn, IL 60453 USA.	kulstad@uic.edu		Kulstad, Erik/0000-0002-9331-8266	National Science FoundationNational Science Foundation (NSF) [1142664]	Funded by a grant from the National Science Foundation (Award Number 1142664). The authors were solely responsible for study design, collection, analysis, and interpretation of data, the writing of the manuscript, and the decision to submit the manuscript for publication.	Abella BS, 2005, RESUSCITATION, V64, P181, DOI 10.1016/j.resuscitation.2004.09.014; Al-Senani FM, 2004, RESUSCITATION, V62, P143, DOI 10.1016/j.resuscitation.2004.02.016; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Brooks SC, 2008, RESUSCITATION, V77, P286, DOI 10.1016/j.resuscitation.2008.01.017; Choi HA, 2011, NEUROCRIT CARE, V14, P389, DOI 10.1007/s12028-010-9474-7; Dietrich WD, 2010, NEUROTHERAPEUTICS, V7, P43, DOI 10.1016/j.nurt.2009.10.015; Flint AC, 2007, NEUROCRIT CARE, V7, P109, DOI 10.1007/s12028-007-0068-y; Froehler MT, 2010, EXPERT REV CARDIOVAS, V8, P593, DOI 10.1586/ERC.09.129; Gillies MA, 2010, RESUSCITATION, V81, P1117, DOI 10.1016/j.resuscitation.2010.05.001; Hoedemaekers CW, 2007, CRIT CARE, V11, DOI 10.1186/cc6104; Holzer M, 2002, NEW ENGL J MED, V346, P549; Jaber S, 2007, INTENS CARE MED, V33, P917, DOI 10.1007/s00134-007-0594-2; KASTANOS N, 1983, CRIT CARE MED, V11, P362, DOI 10.1097/00003246-198305000-00009; Kelly FE, 2010, ANAESTHESIA, V65, P505, DOI 10.1111/j.1365-2044.2009.06237.x; Knapik P, 2012, RESUSCITATION, V83, P208, DOI 10.1016/j.resuscitation.2011.09.001; Knapik P, 2011, KARDIOL POL, V69, P1157; Kory P, 2011, RESUSCITATION, V82, P15, DOI 10.1016/j.resuscitation.2010.08.020; Kulstad EB, 2012, WORLD J EMERG MED, V3, P118, DOI [10.5847/wjem.j.issn.1920-8642.2012.02.007, 10.5847/wjem.j.1920-8642.2012.02.007]; Levi AD, 2010, NEUROSURGERY, V66, P670, DOI 10.1227/01.NEU.0000367557.77973.5F; Lopez-de-Sa E, 2012, CIRCULATION, V126, P2826, DOI 10.1161/CIRCULATIONAHA.112.136408; Merchant RM, 2009, CIRC-CARDIOVASC QUAL, V2, P421, DOI 10.1161/CIRCOUTCOMES.108.839605; Nielsen N, 2012, AM HEART J, V163, P541, DOI 10.1016/j.ahj.2012.01.013; Patel PV, 2011, THER HYPOTHERMIA TEM, V1, DOI 10.1089/ther.2011.0015; Shankaran S, 2010, NEW ENGL J MED, V362, P1051, DOI 10.1056/NEJMc0912848; Sinclair HL, 2010, CRIT CARE, V14, DOI 10.1186/cc8220; Vaicys V, 2012, AM J EMERG MED, V30, P932, DOI 10.1016/j.ajem.2011.04.026; Wissler EH, 1998, J APPL PHYSIOL, V85, P35	27	18	20	0	4	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0300-9572			RESUSCITATION	Resuscitation	NOV	2013	84	11					1619	1624		10.1016/j.resuscitation.2013.06.019			6	Critical Care Medicine; Emergency Medicine	General & Internal Medicine; Emergency Medicine	275DA	WOS:000328654800033	23827887	Other Gold			2021-06-18	
J	Liu, X; Sha, O; Cho, EYP				Liu, Xia; Sha, Ou; Cho, Eric Y. P.			Remote Ischemic Postconditioning Promotes the Survival of Retinal Ganglion Cells after Optic Nerve Injury	JOURNAL OF MOLECULAR NEUROSCIENCE			English	Article						Retinal ganglion cell; Optic nerve; Remote ischemic postconditioning; Neuroprotection	IN-VITRO; RAT; TOLERANCE; PROTECTS; HSP27; NEUROPROTECTION; REGENERATION; NEURONS; SYSTEM	Ischemic conditioning, the application of a mild ischemic stimulus to an ischemia-sensitive structure like the heart or brain either before (preconditioning) or after (postconditioning) its exposure to a lethal ischemic insult, is known to switch on endogenous protective mechanisms. However, most studies of its neuroprotective effect in the central nervous system (CNS) have focused on ischemic damage or related conditions like hypoxia, while its potential in treating other neural diseases remains uncertain. In particular, the recent discovery of remote ischemic postconditioning whereby mild ischemia applied to a region remote from the target after the main ischemic insult also confers protection offers an attractive paradigm to study its potential in other types of neural injury. Retinal ganglion cells damaged by optic nerve transection undergo extensive cell death. However, application of a series of mild ischemic/reperfusion cycles to the hind limb (limb remote ischemic postconditioning) at 10 min or 6 h after optic nerve cut was found to promote ganglion cell survival at 7 days post-injury, with the 10 min postconditioning still exerting protection at 14 days post-injury. Concomitant with the increased ganglion cell survival, 51 % more ganglion cells expressed the small heat shock protein HSP27, when remote ischemic postconditioning was performed at 10 min post-injury, as compared to the sham conditioning group. Our results highlight the potential of using remote ischemic postconditioning as a noninvasive neuroprotective strategy in different CNS disorders like spinal cord and traumatic brain injury.	[Liu, Xia; Cho, Eric Y. P.] Chinese Univ Hong Kong, Sch Biomed Sci, Shatin, Hong Kong, Peoples R China; [Sha, Ou] Shenzhen Univ, Sch Med, Dept Preclin Med, Guangzhou, Guangdong, Peoples R China	Cho, EYP (corresponding author), Chinese Univ Hong Kong, Sch Biomed Sci, Shatin, Hong Kong, Peoples R China.	eric-cho@cuhk.edu.hk	Cho, Eric/AAF-9597-2020	Cho, Eric/0000-0001-7469-8622	General Research Fund of the Research Grants Council of Hong Kong [CUHK463309]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81171154]; Chinese University of Hong KongChinese University of Hong Kong	This study was supported by the General Research Fund CUHK463309 of the Research Grants Council of Hong Kong (E.Y.P. Cho), the National Natural Science Foundation of China (81171154, O. Sha), and a postgraduate studentship of the Chinese University of Hong Kong (X. Liu). The authors are grateful to Ms. Anny Cheung for the technical help provided.	Belforte N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023763; Brown IR, 2007, ANN NY ACAD SCI, V1113, P147, DOI 10.1196/annals.1391.032; Cho EYP, 2005, ARVO 2005 ANN M; Cui Q, 2003, MOL CELL NEUROSCI, V22, P49, DOI 10.1016/S1044-7431(02)00037-4; Dreixler JC, 2010, EXP EYE RES, V91, P844, DOI 10.1016/j.exer.2010.06.015; Fernandez DC, 2011, AM J PATHOL, V178, P2264, DOI 10.1016/j.ajpath.2011.01.040; Fernandez DC, 2009, INVEST OPHTH VIS SCI, V50, P3922, DOI 10.1167/iovs.08-3344; Fitch MT, 2008, EXP NEUROL, V209, P294, DOI 10.1016/j.expneurol.2007.05.014; Gidday JM, 2006, NAT REV NEUROSCI, V7, P437, DOI 10.1038/nrn1927; Krueger-Naug AMR, 2002, NEUROSCIENCE, V110, P653, DOI 10.1016/S0306-4522(01)00453-5; Latchman DS, 2005, INT J HYPERTHER, V21, P393, DOI 10.1080/02656730400023664; Lim SY, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00027; MURRY CE, 1986, CIRCULATION, V74, P1124, DOI 10.1161/01.CIR.74.5.1124; Pignataro G, 2008, J CEREBR BLOOD F MET, V28, P232, DOI 10.1038/sj.jcbfm.9600559; Ren CC, 2009, BRAIN RES, V1288, P88, DOI 10.1016/j.brainres.2009.07.029; Ren CC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003851; Roth S, 2004, BRAIN RES BULL, V62, P461, DOI 10.1016/j.brainresbull.2003.07.006; Sun F, 2010, CURR OPIN NEUROBIOL, V20, P510, DOI 10.1016/j.conb.2010.03.013; Sun J, 2012, J CEREBR BLOOD F MET, V32, P851, DOI 10.1038/jcbfm.2011.199; Sun XC, 2010, EXP NEUROL, V224, P347, DOI 10.1016/j.expneurol.2010.04.009; Wang JY, 2008, STROKE, V39, P983, DOI 10.1161/STROKEAHA.107.499079; Williams KL, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-24; Xing BZ, 2008, STROKE, V39, P2362, DOI 10.1161/STROKEAHA.107.507939; Zhao H, 2012, CURR DRUG TARGETS, V13, P173, DOI 10.2174/138945012799201621; Zhou YL, 2011, STROKE, V42, P439, DOI 10.1161/STROKEAHA.110.592162	25	18	18	0	21	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	0895-8696	1559-1166		J MOL NEUROSCI	J. Mol. Neurosci.	NOV	2013	51	3					639	646		10.1007/s12031-013-0036-2			8	Biochemistry & Molecular Biology; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	235IH	WOS:000325710500001	23733254				2021-06-18	
J	Bosco, MA; Murphy, JL; Clark, ME				Bosco, Michelle A.; Murphy, Jennifer L.; Clark, Michael E.			Chronic Pain and Traumatic Brain Injury in OEF/OIF Service Members and Veterans	HEADACHE			English	Article						pain; traumatic brain injury; post deployment multisymptom disorder	OPERATIONS ENDURING FREEDOM; IRAQI-FREEDOM; HEAD-INJURY; POLYTRAUMA; BLAST; PREVALENCE; SOLDIERS; CARE; REHABILITATION; ENCEPHALOPATHY	The co-occurrence of chronic pain and traumatic brain injury (TBI) are 2 of the most common concerns among the Operations Enduring Freedom and Iraqi Freedom population and present unique challenges for evaluation and treatment. Previous research suggests that almost half the cohort report clinically significant pain, while up to 1 in 4 experiences some form of TBI. There is limited information regarding how TBI affects the presence and course of pain, and how pain impacts TBI and its symptoms. The present paper provides an overview of the range and degree of TBIs as well as a brief summary of current knowledge regarding the interaction between chronic pain and TBI, particularly in light of the numerous variables impacting it. Information on ways to best assess for and treat pain in the TBI population, including in those with multiple system injuries or associated affective symptoms, is provided. In addition, several innovative approaches for addressing the needs of this complex cohort of patients are described, which may stimulate further research and clinical innovation for this important subgroup.	[Bosco, Michelle A.; Murphy, Jennifer L.; Clark, Michael E.] James A Haley VA Hosp, Tampa, FL 33612 USA	Bosco, MA (corresponding author), James A Haley VA Hosp, Ctr Postdeployment Hlth & Educ, 13000 Bruce B Downs Blvd, Tampa, FL 33612 USA.	michelle.bosco@va.gov					[Anonymous], 2007, REP MIL TBI TASK FOR; Belanger HG, 2005, J REHABIL RES DEV, V42, P403, DOI 10.1682/JRRD.2004.08.0095; Bhattacharjee Y, 2008, SCIENCE, V319, P406, DOI 10.1126/science.319.5862.406; Buffum MD, 2007, J REHABIL RES DEV, V44, P315, DOI 10.1682/JRRD.2006.06.0064; Clark ME, 2007, J REHABIL RES DEV, V44, P179, DOI 10.1682/JRRD.2006.05.0057; Clark ME, 2009, PAIN MED, V10, P456, DOI 10.1111/j.1526-4637.2009.00589.x; Clark ME, 2009, PAIN MED, V10, P447, DOI 10.1111/j.1526-4637.2009.00590.x; Dobscha SK, 2009, PAIN MED, V10, P1200, DOI 10.1111/j.1526-4637.2009.00721.x; Gawande A, 2004, NEW ENGL J MED, V351, P2471, DOI 10.1056/NEJMp048317; Gironda RJ, 2006, PAIN MED, V7, P339, DOI 10.1111/j.1526-4637.2006.00146.x; Gironda RJ, 2009, REHABIL PSYCHOL, V54, P247, DOI 10.1037/a0016906; Godunsky JS, 2005, MIL MED, V170, P546; Hart RP, 2000, NEUROPSYCHOL REV, V10, P131, DOI 10.1023/A:1009020914358; Hockenberry MJ, 2009, WONGS ESSENTIALS PED; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Leuthcke CA, 2011, J INT NEUROPSYCH SOC, V17, P1; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Mersky H, 1994, INT ASS STUDY PAIN T, P226; Murray CK, 2005, MIL MED, V170, P516, DOI 10.7205/MILMED.170.6.516; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Ruff RL, 2008, J REHABIL RES DEV, V45, P941, DOI 10.1682/JRRD.2008.02.0028; Sayer NA, 2008, ARCH PHYS MED REHAB, V89, P163, DOI 10.1016/j.apmr.2007.05.025; Sherman Kristen Brewer, 2006, Phys Med Rehabil Clin N Am, V17, P473, DOI 10.1016/j.pmr.2005.11.007; Sigford BJ, 2008, ARCH PHYS MED REHAB, V89, P160, DOI 10.1016/j.apmr.2007.09.015; UOMOTO JM, 1993, ARCH PHYS MED REHAB, V74, P61; Vanderploeg RD, 2007, J REHABIL RES DEV, V44, P937, DOI 10.1682/JRRD.2006.12.0163; Veterans Affairs/Department of Defense, 2009, CLIN PRACT GUID MAN, P16; Veterans Health Administration, 2005, VHA HDB 2A, P1; Veterans Health Administration Epidemiology Program Post-Deployment Health Group's Office of Public Health Veterans Health Administration Department of Veterans Affairs, 2012, UT OP END FREED OEF; Walker RL, 2008, NAT M VA HLTH SERV R; Walker RL, 2010, PSYCHOL SERV, V7, P136, DOI 10.1037/a0019684; Walker WC, 2005, ARCH PHYS MED REHAB, V86, P1793, DOI 10.1016/j.apmr.2004.12.042; Weiner DK, 2002, PERSISTENT PAIN IN OLDER ADULTS: INTERDISCIPLINARY GUIDE FOR TREATMENT, P18; Zoroya G, CTR WAR RELATED BRAI	36	18	18	0	7	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0017-8748			HEADACHE	Headache	OCT	2013	53	9					1518	1522		10.1111/head.12172			5	Clinical Neurology	Neurosciences & Neurology	228AH	WOS:000325156600019	23848062				2021-06-18	
J	Kunz, M; Nussberger, J; Holtmannspotter, M; Bitterling, H; Plesnila, N; Zausinger, S				Kunz, Mathias; Nussberger, Juerg; Holtmannspoetter, Markus; Bitterling, Harro; Plesnila, Nikolaus; Zausinger, Stefan			Bradykinin in Blood and Cerebrospinal Fluid after Acute Cerebral Lesions: Correlations with Cerebral Edema and Intracranial Pressure	JOURNAL OF NEUROTRAUMA			English	Article						acute cerebral lesions; bradykinin; cerebral edema; CSF; intracranial pressure	TRAUMATIC BRAIN-INJURY; KALLIKREIN-KININ SYSTEM; B-2 RECEPTOR ANTAGONIST; PLACEBO-CONTROLLED TRIAL; SUBARACHNOID HEMORRHAGE; TISSUE KALLIKREIN; PLASMA; RATS; INHIBITION; ISCHEMIA	Bradykinin (BK) was shown to stimulate the production of physiologically active metabolites, blood-brain barrier disruption, and brain edema. The aim of this prospective study was to measure BK concentrations in blood and cerebrospinal fluid (CSF) of patients with traumatic brain injury (TBI), subarachnoid hemorrhage (SAH), intracerebral hemorrhage (ICH), and ischemic stroke and to correlate BK levels with the extent of cerebral edema and intracranial pressure (ICP). Blood and CSF samples of 29 patients suffering from acute cerebral lesions (TBI, 7; SAH,: 10; ICH, 8; ischemic stroke, 4) were collected for up to 8 days after insult. Seven patients with lumbar drainage were used as controls. Edema (5-point scale), ICP, and the GCS (Glasgow Coma Score) at the time of sample withdrawal were correlated with BK concentrations. Though all plasma-BK samples were not significantly elevated, CSF-BK levels of all patients were significantly elevated in overall (n=73) and early (72h) measurements (n=55; 4.3 +/- 6.9 and 5.6 +/- 8.9 fmol/mL), compared to 1.2 +/- 0.7 fmol/mL of controls (p=0.05 and 0.006). Within 72h after ictus, patients suffering from TBI (p=0.01), ICH (p=0.001), and ischemic stroke (p=0.02) showed significant increases. CSF-BK concentrations correlated with extent of edema formation (r=0.53; p<0.001) and with ICP (r=0.49; p<0.001). Our results demonstrate that acute cerebral lesions are associated with increased CSF-BK levels. Especially after TBI, subarachnoid and intracerebral hemorrhage CSF-BK levels correlate with extent of edema evolution and ICP. BK-blocking agents may turn out to be effective remedies in brain injuries.	[Kunz, Mathias; Zausinger, Stefan] Univ Munich, Dept Neurosurg, D-81377 Munich, Germany; [Holtmannspoetter, Markus; Bitterling, Harro] Univ Munich, Dept Neuroradiol, D-81377 Munich, Germany; [Plesnila, Nikolaus] Univ Munich, Inst Stroke & Dementia Res, D-81377 Munich, Germany; [Plesnila, Nikolaus] Univ Munich, Inst Surg Res, Klinikum Grosshadern, D-81377 Munich, Germany; [Nussberger, Juerg] CHU Vaudois, Serv Angiol, CH-1011 Lausanne, Switzerland	Kunz, M (corresponding author), Univ Munich, Dept Neurosurg, Marchioninistr 15, D-81377 Munich, Germany.	Mathias.Kunz@med.uni-muenchen.de	Plesnila, Nikolaus/T-7522-2019	Kunz MD, Mathias/0000-0003-1641-450X	Laboratoires Fournier S.A. (Dijon, France)	This study was partly supported by a donation from Laboratoires Fournier S.A. (Dijon, France). The authors thank Mrs. Catherine Amstutz (Lausanne) for her excellent technical support in BK measurements.	BHOOLA KD, 1992, PHARMACOL REV, V44, P1; Bryant J. W., 2009, Cardiovascular & Hematological Agents in Medicinal Chemistry, V7, P234; Cugno M, 2001, CHEST, V120, P1776, DOI 10.1378/chest.120.6.1776; ELLIS EF, 1989, J NEUROSURG, V71, P437, DOI 10.3171/jns.1989.71.3.0437; FRANCEL PC, 1992, J NEUROTRAUMA S1, V9, P27; Gorlach C, 2001, J NEUROTRAUM, V18, P833, DOI 10.1089/089771501316919193; Gorlach C, 1996, PEPTIDES, V17, P1373, DOI 10.1016/S0196-9781(96)00223-9; Groger M, 2005, J CEREBR BLOOD F MET, V25, P978, DOI 10.1038/sj.jcbfm.9600096; HALL JM, 1992, PHARMACOL THERAPEUT, V56, P131, DOI 10.1016/0163-7258(92)90016-S; Hellal F, 2003, J NEUROTRAUM, V20, P841, DOI 10.1089/089771503322385773; KAMIYA T, 1993, STROKE, V24, P571, DOI 10.1161/01.STR.24.4.571; Kaplan AP, 2010, CHEM IMMUNOL ALLERGY, V95, P67, DOI 10.1159/000315938; KASUYA H, 1988, ACTA NEUROCHIR, V91, P120, DOI 10.1007/BF01424566; Lehmberg J, 2003, J CEREBR BLOOD F MET, V23, P441, DOI 10.1097/01.WCB.0000052280.23292.35; Marmarou A, 2005, J NEUROTRAUM, V22, P1444, DOI 10.1089/neu.2005.22.1444; Marmarou A, 1999, J NEUROTRAUM, V16, P431, DOI 10.1089/neu.1999.16.431; Marmarou Anthony, 2007, Neurosurg Focus, V22, pE1; Nussberger J, 1998, LANCET, V351, P1693, DOI 10.1016/S0140-6736(97)09137-X; PELLACANI A, 1994, CLIN SCI, V87, P567, DOI 10.1042/cs0870567; Plesnila N, 2001, J NEUROTRAUM, V18, P1049, DOI 10.1089/08977150152693746; Raidoo DM, 1996, IMMUNOPHARMACOLOGY, V33, P104, DOI 10.1016/0162-3109(96)00021-5; Raidoo DM, 1996, IMMUNOPHARMACOLOGY, V32, P39, DOI 10.1016/0162-3109(96)00007-0; Regoli D, 1996, IMMUNOPHARMACOLOGY, V33, P24, DOI 10.1016/0162-3109(96)00077-X; Shakur H, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-109; Sobey CG, 1997, STROKE, V28, P2290, DOI 10.1161/01.STR.28.11.2290; Stover JF, 2000, J NEUROSURG, V92, P853, DOI 10.3171/jns.2000.92.5.0853; Thal SC, 2009, CRIT CARE MED, V37, P2228, DOI 10.1097/CCM.0b013e3181a068fc; Trabold R, 2010, J CEREBR BLOOD F MET, V30, P130, DOI 10.1038/jcbfm.2009.196; UNTERBERG A, 1986, J NEUROSURG, V64, P269, DOI 10.3171/jns.1986.64.2.0269; Wagner S, 2002, J NEUROL SCI, V202, P75, DOI 10.1016/S0022-510X(02)00208-3; Wahl M, 1996, IMMUNOPHARMACOLOGY, V33, P257, DOI 10.1016/0162-3109(96)00068-9; Wahl M, 1993, Acta Neurochir Suppl (Wien), V57, P64; Zausinger S, 2002, BRAIN RES, V950, P268, DOI 10.1016/S0006-8993(02)03053-6	33	18	18	0	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	OCT 1	2013	30	19					1638	1644		10.1089/neu.2012.2774			7	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	227WQ	WOS:000325146800004	23638655				2021-06-18	
J	Kuo, CP; Wen, LL; Chen, CM; Huh, B; Cherng, CH; Wong, CS; Liaw, WJ; Yeh, CC; Lin, BF; Wu, CT				Kuo, Chang-Po; Wen, Li-Li; Chen, Chun-Mei; Huh, Billy; Cherng, Chen-Hwan; Wong, Chih-Shung; Liaw, Wen-Jinn; Yeh, Chun-Chang; Lin, Bo-Feng; Wu, Ching-Tang			Attenuation of neurological injury with early baicalein treatment following sub arachnoid hemorrhage in rats Laboratory investigation	JOURNAL OF NEUROSURGERY			English	Article						subarachnoid hemorrhage; neurological injury; baicalein lutamate; oxidative stress; vascular disorders	EXPERIMENTAL SUBARACHNOID HEMORRHAGE; TRAUMATIC BRAIN-INJURY; ACUTE ISCHEMIC-STROKE; CEREBRAL VASOSPASM; GLUTAMATE TRANSPORTERS; EXPRESSION; EDEMA; ASTROCYTES; DEFICITS; DEATH	Object. Baicalein has been shown to offer neuroprotection in the ischemic brain, but its effect in subarachnoid hemorrhage (SAH) is unknown. The authors used a double-hemorrhage model to study the role of early baicalein treatment in SAH. Methods. Subarachnoid hemorrhage was induced in male Wistar rats through a repeat injection of autologous blood at a 48-hour interval. Rats subjected or not subjected to SAH received a 30-mg/kg baicalein injection 3 hours after SAH and daily for 6 consecutive days, and results were compared with those obtained in vehicle-treated control rats. Mortality of the rats was recorded. Neurological outcome was assessed daily. Cerebrospinal fluid dialysates were collected and examined for glutamate concentrations. Cerebral vasospasm (CVS), brain water content, neuron variability, expression of glutamate transporter-1 (GLT-1), immunoreactivity of astrocyte, and level of malondialdehyde, activities of superoxide dismutase (SOD), and catalase in brain tissues content were determined on post-SAH Day 7. Results. Mortality rate, neuronal degeneration, brain water content, and CVS were decreased and neurological function improved in the baicalein-treated rats. Baicalein increased astrocyte activity and preserved GLT-1, which attenuated the glutamate surge after SAH. Baicalein also provided antioxidative stress by preserving activities of SOD and catalase and decreased malondialdehydelevel after SAH. The glutamate, body weight, neurological scores, and glial fibrillary acidic protein activity were significantly correlated. The CVS was correlated with neuronal degeneration, and GLT-1 was correlated with oxidative stress. Conclusions. Early baicalein treatment attenuated CVS and limited neurological injury following SAH. These data may indicate clinical utility for baicalein as an adjunct therapy to reduce brain injury and improve patient outcomes.	[Kuo, Chang-Po; Chen, Chun-Mei; Cherng, Chen-Hwan; Liaw, Wen-Jinn; Yeh, Chun-Chang; Lin, Bo-Feng; Wu, Ching-Tang] Natl Def Med Ctr, Dept Anesthesiol, Taipei, Taiwan; [Lin, Bo-Feng] Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan; Triserv Gen Hosp, Taipei, Taiwan; [Wen, Li-Li] En Chu Kong Hosp, Dept Clin Lab, New Taipei City, Taiwan; [Huh, Billy] Duke Univ, Med Ctr, Dept Anesthesiol, Durham, NC 27710 USA; [Wong, Chih-Shung] Cathay Gen Hosp, Dept Anesthesiol, Taipei, Taiwan	Wu, CT (corresponding author), Natl Def Med Ctr, Dept Anesthesiol, Sect 2,Chenggung Rd,Neihu 114, Taipei, Taiwan.	aneswu@gmail.com	Wu, Zhi-Fu/ABE-6379-2020		National Science Council, Taiwan, Republic of ChinaMinistry of Science and Technology, Taiwan [NSC 96-2314-B-016-013]	This work was supported by a grant from the National Science Council (NSC 96-2314-B-016-013), Taiwan, Republic of China. The authors have no personal financial or institutional interest in any of the drugs, materials, or devices described in this article.	Anderson CM, 2000, GLIA, V32, P1; Cahill J, 2006, J CEREBR BLOOD F MET, V26, P1463, DOI 10.1038/sj.jcbfm.9600307; Chen SF, 2008, BRIT J PHARMACOL, V155, P1279, DOI 10.1038/bjp.2008.345; Claassen J, 2002, STROKE, V33, P1225, DOI 10.1161/01.STR.0000015624.29071.1F; Davalos A, 1997, STROKE, V28, P708, DOI 10.1161/01.STR.28.4.708; Dumont AS, 2003, NEUROSURGERY, V53, P123, DOI 10.1227/01.NEU.0000068863.37133.9E; Fagan SC, 2004, STROKE, V35, P2220, DOI 10.1161/01.STR.0000138023.60272.9e; GARCIA JH, 1995, STROKE, V26, P627, DOI 10.1161/01.STR.26.4.627; Germano A, 2007, J NEUROTRAUM, V24, P732, DOI 10.1089/neu.2006.0181; Gules I, 2002, AM J PHYSIOL-HEART C, V283, pH2551, DOI 10.1152/ajpheart.00616.2002; Huang WH, 2006, BIOSCI BIOTECH BIOCH, V70, P2371, DOI 10.1271/bbb.50698; Jeon H, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-103; Jin G, 2008, STROKE, V39, P2538, DOI 10.1161/STROKEAHA.108.514927; Kerman M, 2012, J MOL HISTOL, V43, P49, DOI 10.1007/s10735-011-9376-9; KUBO M, 1984, CHEM PHARM BULL, V32, P2724; Kuo CP, 2011, ANESTHESIOLOGY, V115, P1229, DOI 10.1097/ALN.0b013e31823306f0; Lee HH, 2003, BRAIN RES, V986, P103, DOI 10.1016/S0006-8993(03)03197-4; Lo EH, 2005, STROKE, V36, P189, DOI 10.1161/01.STR.0000153069.96296.fd; Lopez-Redondo F, 2000, MOL BRAIN RES, V76, P429, DOI 10.1016/S0169-328X(00)00022-X; O'Callaghan James P, 2005, Expert Opin Drug Saf, V4, P433, DOI 10.1517/14740338.4.3.433; Ostrowski RP, 2006, NEUROL RES, V28, P399, DOI 10.1179/016164106X115008; Prunell GF, 2005, J NEUROSURG, V102, P1046, DOI 10.3171/jns.2005.102.6.1046; Rossi DJ, 2007, NAT NEUROSCI, V10, P1377, DOI 10.1038/nn2004; Rothoerl RD, 2006, CEREBROVASC DIS, V22, P143, DOI 10.1159/000093243; Sabri M, 2008, BRAIN RES, V1238, P163, DOI 10.1016/j.brainres.2008.08.031; Seckin H, 2008, SURG NEUROL, V70, P344, DOI 10.1016/j.surneu.2007.07.052; Sehba FA, 2011, MOL NEUROBIOL, V43, P27, DOI 10.1007/s12035-010-8155-z; Stegmayr B, 2004, STROKE, V35, P2059, DOI 10.1161/01.STR.0000138451.07853.b6; Suarez JI, 2006, NEW ENGL J MED, V354, P387, DOI 10.1056/NEJMra052732; Sullivan SM, 2010, BRAIN RES, V1319, P164, DOI 10.1016/j.brainres.2010.01.010; Sung CS, 2004, BRAIN RES, V1015, P145, DOI 10.1016/j.brainres.2004.04.068; Van Landeghem FKH, 2006, J NEUROTRAUM, V23, P1518, DOI 10.1089/neu.2006.23.1518; Vicente E, 2009, BRAIN RES, V1251, P204, DOI 10.1016/j.brainres.2008.11.032; Wu CT, 2011, ANESTH ANALG, V112, P666, DOI 10.1213/ANE.0b013e318207c51f; Xi G, 2002, ACT NEUR S, V81, P253	35	18	19	0	9	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085			J NEUROSURG	J. Neurosurg.	OCT	2013	119	4					1028	1037		10.3171/2013.4.JNS121919			10	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	225LM	WOS:000324964400033	23724981				2021-06-18	
J	Liu, JH; Li, LD				Liu, Jianghong; Li, Linda			Parent-reported mild head injury history and behavioural performance in children at 6 years	BRAIN INJURY			English	Article						Behaviour; childhood; head injury; mild traumatic brain injury (MTBI)	TRAUMATIC BRAIN-INJURY; DEFICIT HYPERACTIVITY DISORDER; PROBLEM-SOLVING SKILLS; PSYCHIATRIC-DISORDERS; CHINESE CHILDREN; SELF-REGULATION; EARLY-CHILDHOOD; ADOLESCENTS; OUTCOMES; SYMPTOMS	Objective: Mild head and brain injuries have gained increasing attention from health professionals and researchers. Little is known about mild injuries, which may not always be diagnosed or brought to medical attention. This study examines the associations between parent-reported history of mild head injury and behavioural problems in a large community-based sample of Chinese children. Method: Subjects included 725 children from China. Parents reported on children's head injury history and behaviour at age 6 years using the Chinese version of the Child Behavior Checklist. Mild head injury was defined as injury without loss of consciousness or hospitalization. Standardized T-scores were compared for each of the seven clinical sub-scales and three summary behavioural measures, adjusting for confounders. Logistic models were used to calculate odds ratios (ORs) between head injury and behavioural problems. Results: Parents reported that 97 children (14%) had a single injury and 70 (10%) had multiple injuries. Compared to the controls, head-injured children had worse behavioural outcomes and a higher prevalence of behavioural problems. Multiple injuries were associated with higher risk of certain internalizing and externalizing problems. Conclusion: Mild head injuries, especially incurred repeatedly, may still be a significant risk for adverse behaviours in children.	[Liu, Jianghong] Univ Penn, Sch Nursing, Philadelphia, PA 19104 USA; [Liu, Jianghong] Univ Penn, Sch Med, Philadelphia, PA 19104 USA	Liu, JH (corresponding author), Univ Penn, Sch Nursing, 418 Curie Blvd,Room 426,Claire M Fagin Hall, Philadelphia, PA 19104 USA.	jhliu@nursing.upenn.edu		Li, Linda/0000-0001-5731-9643	National Institute of Environment Health Sciences (NIEHS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS) [R01-ES018858, K01-ES015 877, K02-ES019878-01]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS) [K02ES019878, R01ES018858, K01ES015877] Funding Source: NIH RePORTER	Funding was provided by the National Institute of Environment Health Sciences (NIEHS, R01-ES018858; K01-ES015 877; K02-ES019878-01). The funders had no role in study design, data collection, data analysis, manuscript preparation and/or publication decision. The authors report no conflicts of interest.	Achenbach T. M., 2000, MANUAL ASEBA PRESCHO; Anderson V, 2005, BRAIN INJURY, V19, P699, DOI 10.1080/02699050400025281; Andrews TK, 1998, BRAIN INJURY, V12, P133, DOI 10.1080/026990598122755; BIJUR PE, 1990, PEDIATRICS, V86, P337; Bloom DR, 2001, J AM ACAD CHILD PSY, V40, P572, DOI 10.1097/00004583-200105000-00017; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Centers for Disease Control and Prevention, HEADS FACTS PHYS MIL; Chapman LA, 2010, REHABIL PSYCHOL, V55, P48, DOI 10.1037/a0018418; Cole WR, 2008, BRAIN INJURY, V22, P932, DOI 10.1080/02699050802454808; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; Copeland SA, 2008, ANN NEUROL, V64, pS128; DAVIDSON LL, 1988, PEDIATRICS, V82, P644; Demellweek Colin, 2002, Pediatr Rehabil, V5, P81, DOI 10.1080/136384902320807194; Ganesalingam K, 2007, J INT NEUROPSYCH SOC, V13, P298, DOI 10.1017/S1355617707070324; Ganesalingam K, 2007, J NEUROPSYCHOL, V1, P149, DOI 10.1348/174866407X185300; Hamilton NA, 2012, SEMINARS PEDIAT SURG, V19, P271; Hayman-Abello SE, 2003, J INT NEUROPSYCH SOC, V9, P887, DOI 10.1017/S1355617703960097; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Janusz JA, 2002, CHILD NEUROPSYCHOL, V8, P179, DOI 10.1076/chin.8.3.179.13499; Kaldoja ML, 2012, BRAIN INJURY, V26, P1005, DOI 10.3109/02699052.2012.660516; Kirkwood M, 2000, CHILD NEUROPSYCHOL, V6, P195, DOI 10.1076/chin.6.3.195.3157; Konrad KN, 2000, BRAIN INJURY, V14, P859; Len TK, 2011, CLIN PHYSIOL FUNCT I, V31, P85, DOI 10.1111/j.1475-097X.2010.00990.x; Leung PWL, 2006, J CHILD PSYCHOL PSYC, V47, P970, DOI 10.1111/j.1469-7610.2005.01570.x; Li L, 2013, DEV MED CHILD NEUROL, V55, P37, DOI 10.1111/j.1469-8749.2012.04414.x; Li M, 2006, MED SCI SPORT EXER, V38, P2075, DOI 10.1249/01.mss.0000233802.54529.87; Liu JH, 2011, WORLD J PEDIATR, V7, P217, DOI 10.1007/s12519-011-0317-1; Liu JH, 2011, J ABNORM CHILD PSYCH, V39, P251, DOI 10.1007/s10802-010-9452-8; Liu JH, 2010, INT J EPIDEMIOL, V39, P668, DOI 10.1093/ije/dyp205; Max JE, 2004, DEV NEUROPSYCHOL, V25, P159, DOI 10.1207/s15326942dn2501&2_9; Max JE, 1998, J AM ACAD CHILD PSY, V37, P832, DOI 10.1097/00004583-199808000-00013; Max JE, 1998, J NERV MENT DIS, V186, P325, DOI 10.1097/00005053-199806000-00001; Max JE, 2012, INT J DEV NEUROSCI, V30, P239, DOI 10.1016/j.ijdevneu.2011.12.005; McKinlay A, 2010, INJURY PREV, V16, P31, DOI 10.1136/ip.2009.022483; McKinlay A, 2010, CHILD CARE HLTH DEV, V36, P3, DOI 10.1111/j.1365-2214.2009.01006.x; McKinlay A, 2010, CHILD CARE HLTH DEV, V36, P22, DOI 10.1111/j.1365-2214.2009.00947.x; Miller KJ, 2013, J HEAD TRAUMA REHAB, V28, P31, DOI 10.1097/HTR.0b013e318255ceae; Moore E, 2006, PARIS REV, P117; Norrie J, 2010, BRAIN INJURY, V24, P1528, DOI 10.3109/02699052.2010.531687; Poggi G, 2003, BRAIN INJURY, V17, P835, DOI 10.1080/0269905031000088612; Powell JM, 2008, ARCH PHYS MED REHAB, V89, P1550, DOI 10.1016/j.apmr.2007.12.035; Prins ML, 2010, DEV NEUROSCI-BASEL, V32, P510, DOI 10.1159/000316800; Roebuck-Spencer TM, 2012, CLIN NEUROPSYCHOL, V26, P473, DOI 10.1080/13854046.2011.650214; Schachar R, 2004, DEV NEUROPSYCHOL, V25, P179, DOI 10.1207/s15326942dn2501&2_10; Slemmer JE, 2002, BRAIN, V125, P2699, DOI 10.1093/brain/awf271; Smith DH, 2000, NEUROSCIENTIST, V6, P483, DOI 10.1177/107385840000600611; Tonks J, 2011, BRAIN INJURY, V25, P870, DOI 10.3109/02699052.2011.581641; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Williams WH, 2010, NEUROPSYCHOL REHABIL, V20, P801, DOI 10.1080/09602011.2010.519613; Wu X, 2008, J TRAUMA, V64, P1313, DOI 10.1097/TA.0b013e318165c803	50	18	18	1	29	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	OCT	2013	27	11					1263	1270		10.3109/02699052.2013.804205			8	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	217YQ	WOS:000324399800005	23875827	Green Accepted			2021-06-18	
J	Cai, JY; Lu, C; Chen, MH; Ba, HJ; Chen, XD; Lin, JH; Sun, J				Cai, Jian-Yong; Lu, Chuan; Chen, Mao-Hua; Ba, Hua-Jun; Chen, Xian-Dong; Lin, Jian-Hu; Sun, Jun			Predictive value of phosphorylated axonal neurofilament subunit H for clinical outcome in patients with acute intracerebral hemorrhage	CLINICA CHIMICA ACTA			English	Article						Early neurological deterioration; Intracerebral hemorrhage; Outcome; Neurofilament; Stroke	ANEURYSMAL SUBARACHNOID HEMORRHAGE; TRAUMATIC BRAIN-INJURY; NF-H; CEREBROSPINAL-FLUID; SERUM BIOMARKER; SPINAL-CORD; PNF-H; PROTEOLYSIS; PROTEINS; CALPAIN	Background: Phosphorylated axonal neurofilament subunit H (pNF-H) is a biomarker of axonal injury. We investigated whether plasma pNF-H concentrations were associated with 6-month clinical outcomes and early neurological deterioration (END) of patients with acute intracerebral hemorrhage. Methods: Plasma pNF-H concentrations of 112 patients and 112 healthy individuals were quantified by ELISA. Unfavorable outcome was defined as modified Rankin Scale score >2. Associations of plasma pNF-H concentrations with END, 6-month mortality and unfavorable outcome were evaluated. Results: Plasma pNF-H concentrations were increased in patients than in healthy individuals [700.2 (430.8) pg/ml vs. 25.5 (32.4) pg/ml, P < 0.001]. A logistic regression analysis selected plasma pNF-H concentration as an independent predictor for 6-month mortality [OR: 1.287, 95% CI: 1.140-1.524, P < 0.001], 6-month unfavorable outcome (OR 1.265, 95% CI 1.121-1.517, P < 0.001) and END (OR 1.246, 95% CI 1.109-1.498, P < 0.001). A receiver operating characteristic curve analysis showed that plasma pNF-H concentration predicted 6-month clinical outcomes and END with high area under curves (all P < 0.001). The predictive value of pNF-H was similar to that of the National Institutes of Health Stroke Scale score (all P > 0.05). In a combined logistic-regression model, pNF-H did not improve the predictive value of National Institutes of Health Stroke Scale score (all P > 0.05). Conclusions: Increased plasma pNF-H concentration was highly associated with 6-month clinical outcomes and END of patients with intracerebral hemorrhage. (c) 2013 Elsevier B.V. All rights reserved.	[Cai, Jian-Yong; Lu, Chuan; Chen, Mao-Hua; Ba, Hua-Jun; Chen, Xian-Dong; Lin, Jian-Hu; Sun, Jun] Cent Hosp Wenzhou City, Dept Neurosurg, Wenzhou 325000, Peoples R China	Sun, J (corresponding author), Cent Hosp Wenzhou City, Dept Neurosurg, 32 Dajian Lane, Wenzhou 325000, Peoples R China.	junsunmd@163.com			Zhejiang Medical and Health Science and Technology Plan Project [2010SSA004]; Zhejiang Province Public Technology Applied Research Projects [2010C33015]	The authors thank all staffs in the Department of Neurosurgery, The Central Hospital of Wenzhou City (Wenzhou, China) for their technical support. This work was financially supported by Zhejiang Medical and Health Science and Technology Plan Project (2010SSA004) and Zhejiang Province Public Technology Applied Research Projects (2010C33015).	Anderson KJ, 2008, J NEUROTRAUM, V25, P1079, DOI 10.1089/neu.2007.0488; Aronowski J, 1999, J CEREBR BLOOD F MET, V19, P652, DOI 10.1097/00004647-199906000-00008; Boylan K, 2009, J NEUROCHEM, V111, P1182, DOI 10.1111/j.1471-4159.2009.06386.x; Brott T, 1997, STROKE, V28, P1, DOI 10.1161/01.STR.28.1.1; GOLDSTEIN ME, 1987, J NEUROIMMUNOL, V14, P149, DOI 10.1016/0165-5728(87)90049-X; GREENWOOD JA, 1993, J NEUROCHEM, V61, P191, DOI 10.1111/j.1471-4159.1993.tb03555.x; Gyorgy A, 2011, J NEUROTRAUM, V28, P1121, DOI 10.1089/neu.2010.1561; Hayakawa K, 2012, SPINAL CORD, V50, P493, DOI 10.1038/sc.2011.184; Hu YY, 2002, NEUROSCI LETT, V320, P156, DOI 10.1016/S0304-3940(02)00047-2; Huh JW, 2002, EXP NEUROL, V175, P198, DOI 10.1006/exnr.2002.7880; JOHNSON GVW, 1991, NEUROCHEM RES, V16, P869, DOI 10.1007/BF00965535; Kothari U, 1996, STROKE, V27, P1304, DOI 10.1161/01.STR.27.8.1304; Lewis SB, 2008, J CEREBR BLOOD F MET, V28, P1261, DOI 10.1038/jcbfm.2008.12; Matsushige T, 2012, J NEUROL SCI, V321, P39, DOI 10.1016/j.jns.2012.07.043; Matsushige T, 2009, J NEUROL SCI, V280, P59, DOI 10.1016/j.jns.2009.01.021; Norgren N, 2003, BRAIN RES, V987, P25, DOI 10.1016/S0006-8993(03)03219-0; Nylen K, 2006, NEUROSCI LETT, V404, P132, DOI 10.1016/j.neulet.2006.05.029; PANT HC, 1988, BIOCHEM J, V256, P665, DOI 10.1042/bj2560665; Petzold A, 2005, J NEUROL SCI, V233, P183, DOI 10.1016/j.jns.2005.03.015; Rodriguez-Luna D, 2011, NEUROLOGY, V77, P1599, DOI 10.1212/WNL.0b013e3182343387; Rosen H, 2004, J NEUROL SCI, V221, P19, DOI 10.1016/j.jns.2004.03.003; SCHLAEPFER WW, 1985, J NEUROCHEM, V44, P502, DOI 10.1111/j.1471-4159.1985.tb05442.x; Shaw G, 2005, BIOCHEM BIOPH RES CO, V336, P1268, DOI 10.1016/j.bbrc.2005.08.252; Shaw G, 2004, BIOCHEM BIOPH RES CO, V325, P619, DOI 10.1016/j.bbrc.2004.09.223; Singh P, 2011, J NEUROL SCI, V304, P117, DOI 10.1016/j.jns.2011.01.025; Strong MJ, 2001, J NEUROCHEM, V76, P1315, DOI 10.1046/j.1471-4159.2001.00094.x; Vajtr D, 2012, Soud Lek, V57, P7; Zanier ER, 2011, J NEUROL NEUROSUR PS, V82, P157, DOI 10.1136/jnnp.2009.177667; Zurek J, 2012, ACTA NEUROCHIR, V154, P93, DOI 10.1007/s00701-011-1175-2; Zurek J, 2011, BRAIN INJURY, V25, P221, DOI 10.3109/02699052.2010.541895	30	18	19	0	6	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0009-8981	1873-3492		CLIN CHIM ACTA	Clin. Chim. Acta	SEP 23	2013	424						182	186		10.1016/j.cca.2013.06.019			5	Medical Laboratory Technology	Medical Laboratory Technology	226NH	WOS:000325042600035	23810564				2021-06-18	
J	Okon, EB; Streijger, F; Lee, JHT; Anderson, LM; Russell, AK; Kwon, BK				Okon, Elena B.; Streijger, Femke; Lee, Jae H. T.; Anderson, Lisa M.; Russell, Amy K.; Kwon, Brian K.			Intraparenchymal Microdialysis after Acute Spinal Cord Injury Reveals Differential Metabolic Responses to Contusive versus Compressive Mechanisms of Injury	JOURNAL OF NEUROTRAUMA			English	Article						compression; glucose; lactate; pyruvate; SCI	TRAUMATIC BRAIN-INJURY; POSITRON-EMISSION-TOMOGRAPHY; CEREBRAL-ARTERY OCCLUSION; BLOOD-FLOW; AMINO-ACIDS; TIME-COURSE; SUBARACHNOID HEMORRHAGE; EXTRACELLULAR GLUCOSE; VASCULAR CHANGES; MODEL	In animal models, spinal cord injury (SCI) is typically imparted by contusion alone (e.g., weight drop) or by compression alone (e.g., clip compression). In humans, however, the cord is typically injured by a combination of violent contusion followed by varying degrees of ongoing mechanical compression. Understanding how the combination of contusion and compression influences the early pathophysiology of SCI is important for the pre-clinical development of neuroprotective therapies that are applicable to the human condition. Disturbances in the metabolism of energy-related substrates such as lactate, pyruvate, and glucose are important aspects of secondary damage. In this study, we used a porcine model of traumatic SCI to determine the extent to which these metabolites were influenced by contusion followed by sustained compression, using the microdialysis technique. Following contusion injury, lactate and pyruvate levels near the epicenter both increased, while glucose remained quite stable. When the contusion injury was followed by sustained compression, we observed a transient rise in lactate, while pyruvate and glucose levels dropped rapidly, which may reflect decreased regional spinal cord blood flow. Furthermore, contusion with sustained compression produced a prolonged and dramatic increase in the lactate-pyruvate (L/P) ratio as a marker of tissue hypoxia, whereas after contusion injury alone, a transient and less significant elevation of the L/P ratio was observed. In this study, we demonstrate that disturbances in energy metabolism within the injured spinal cord vary greatly depending upon the biomechanical nature of the injury. Such differences are likely to be relevant to the applicability of novel therapies targeting specific aspects of the early secondary injury cascade after acute human SCI.	[Okon, Elena B.; Streijger, Femke; Lee, Jae H. T.; Anderson, Lisa M.; Russell, Amy K.; Kwon, Brian K.] Univ British Columbia, Dept Orthopaed, Int Collaborat Repair Discoveries ICORD, Vancouver, BC V5Z 1M9, Canada; [Kwon, Brian K.] Univ British Columbia, Dept Orthopaed, CNOSP, Vancouver, BC V5Z 1M9, Canada	Kwon, BK (corresponding author), Univ British Columbia, Dept Orthopaed, Blusson Spinal Cord Ctr, VGH, 6th Floor,818 West 10th Ave, Vancouver, BC V5Z 1M9, Canada.	brian.kwon@vch.ca		Okon, Elena/0000-0001-8568-5771	Best in Health Fund from the VGH and UBC Hospital Foundation	We thank Dr. Eric C. Sayre for his help with statistical data analysis. We also thank the veterinary medical team at the Centre for Comparative Medicine, and Stephanie Smith and Kate Orchard at the Jack Bell Research Center, for their help and advice. Dr. Kwan holds the Canada Research Chair in Spinal Cord Injury, and is supported by the Best in Health Fund from the VGH and UBC Hospital Foundation.	Allen A.R., 1911, JAMA-J AM MED ASSOC, V57, P878, DOI DOI 10.1001/JAMA.1911.04260090100008; Allen AR, 1914, J NERV MENT DIS, V41, P141, DOI 10.1097/00005053-191403000-00002; Backstrom T, 2001, EUR J VASC ENDOVASC, V22, P410, DOI 10.1053/ejvs.2001.1488; Basso DM, 1996, J NEUROTRAUM, V13, P343, DOI 10.1089/neu.1996.13.343; Basso DM, 1996, EXP NEUROL, V139, P244, DOI 10.1006/exnr.1996.0098; Choo AM, 2008, EXP NEUROL, V212, P490, DOI 10.1016/j.expneurol.2008.04.038; Choo AM, 2007, J NEUROSURG-SPINE, V6, P255, DOI 10.3171/spi.2007.6.3.255; Cirrito JR, 2003, J NEUROSCI, V23, P8844; Darveau CA, 2002, NATURE, V417, P166, DOI 10.1038/417166a; DYKSTRA KH, 1992, J NEUROCHEM, V58, P931, DOI 10.1111/j.1471-4159.1992.tb09346.x; Enblad P, 2001, STROKE, V32, P1574, DOI 10.1161/01.STR.32.7.1574; Farooque M, 1996, J NEUROTRAUM, V13, P537, DOI 10.1089/neu.1996.13.537; FEHLINGS MG, 1995, EXP NEUROL, V132, P220, DOI 10.1016/0014-4886(95)90027-6; Frykholm P, 2005, J NEUROSURG, V102, P1076, DOI 10.3171/jns.2005.102.6.1076; Geddes-Klein DM, 2006, J NEUROTRAUM, V23, P193, DOI 10.1089/neu.2006.23.193; Granger N, 2012, BRAIN, V135, P3227, DOI 10.1093/brain/aws268; Greaves CY, 2008, ANN BIOMED ENG, V36, P396, DOI 10.1007/s10439-008-9440-0; GRIFFITHS IR, 1978, ACTA NEUROPATHOL, V41, P33, DOI 10.1007/BF00689554; GRIFFITHS IR, 1979, J NEUROSURG, V50, P353, DOI 10.3171/jns.1979.50.3.0353; GRUNER JA, 1992, J NEUROTRAUM, V9, P123, DOI 10.1089/neu.1992.9.123; HANSEN AJ, 1981, ACTA PHYSIOL SCAND, V113, P437, DOI 10.1111/j.1748-1716.1981.tb06920.x; Hillered L, 2005, J NEUROTRAUM, V22, P3, DOI 10.1089/neu.2005.22.3; HITCHON PW, 1990, J SPINAL DISORD, V3, P210; Kaptanoglu E, 2003, NEUROSURG REV, V26, P283, DOI 10.1007/s10143-003-0272-y; KAWAMATA T, 1995, BRAIN RES, V674, P196, DOI 10.1016/0006-8993(94)01444-M; KEARNEY P A, 1988, Journal of Neurotrauma, V5, P187, DOI 10.1089/neu.1988.5.187; Krueger H., 2010, EC BURDEN SPINAL COR; Kubota K, 2012, SPINE, V37, P1448, DOI 10.1097/BRS.0b013e31824ffda5; Kwon BK, 2002, SPINE, V27, P1504, DOI 10.1097/00007632-200207150-00005; Kwon BK, 2011, J NEUROTRAUM, V28, P1545, DOI 10.1089/neu.2009.1149; Kwon BK, 2010, SPINE, V35, pS263, DOI 10.1097/BRS.0b013e3181f3286d; Larach DB, 2011, NEUROCRIT CARE, V15, P609, DOI 10.1007/s12028-011-9517-8; Lee JHT, 2013, J NEUROTRAUM, V30, P142, DOI 10.1089/neu.2012.2386; Metz GAS, 2000, J NEUROTRAUM, V17, P1, DOI 10.1089/neu.2000.17.1; Navarro R, 2012, J NEUROTRAUM, V29, P499, DOI 10.1089/neu.2011.2076; NILSSON P, 1990, J CEREBR BLOOD F MET, V10, P631, DOI 10.1038/jcbfm.1990.115; NOBLE LJ, 1989, BRAIN RES, V482, P57, DOI 10.1016/0006-8993(89)90542-8; NOYES DH, 1987, MED BIOL ENG COMPUT, V25, P335, DOI 10.1007/BF02447434; Oddo M, 2008, CRIT CARE MED, V36, P3233, DOI 10.1097/CCM.0b013e31818f4026; PALJARVI L, 1983, ACTA NEUROPATHOL, V60, P232, DOI 10.1007/BF00691871; Pellerin L., 1994, P NATL ACAD SCI USA, V91, P10; Poon PC, 2007, SPINE, V32, P2853, DOI 10.1097/BRS.0b013e31815b7e6b; Rabchevsky AG, 2003, J NEUROTRAUM, V20, P659, DOI 10.1089/089771503322144572; Rabchevsky AG, 2001, J NEUROTRAUM, V18, P513, DOI 10.1089/089771501300227314; Rivlin A. S., 1978, NEUROLOGY, V10, P38; Rosenzweig ES, 2010, NAT NEUROSCI, V13, P1505, DOI 10.1038/nn.2691; Samuelsson C, 2007, J CEREBR BLOOD F MET, V27, P1309, DOI 10.1038/sj.jcbfm.9600433; SANDLER AN, 1976, J NEUROSURG, V45, P660, DOI 10.3171/jns.1976.45.6.0660; Scheff SW, 2003, J NEUROTRAUM, V20, P179, DOI 10.1089/08977150360547099; Schmidt JM, 2011, STROKE, V42, P1351, DOI 10.1161/STROKEAHA.110.596874; Sekhon LHS, 2001, SPINE, V26, pS2, DOI 10.1097/00007632-200112151-00002; Sharma HS, 2011, J NEURAL TRANSM, V118, P155, DOI 10.1007/s00702-010-0514-4; Sharma HS, 2005, CURR PHARM DESIGN, V11, P1353, DOI 10.2174/1381612053507837; SHUAIB A, 1990, NEUROSCI LETT, V112, P149, DOI 10.1016/0304-3940(90)90194-E; Singh IN, 2006, J CEREBR BLOOD F MET, V26, P1407, DOI 10.1038/sj.jcbfm.9600297; Stenken JA, 2010, AAPS J, V12, P73, DOI 10.1208/s12248-009-9163-7; Sullivan PG, 2007, J NEUROTRAUM, V24, P991, DOI 10.1089/neu.2006.0242; Sullivan PG, 1998, J NEUROTRAUM, V15, P789, DOI 10.1089/neu.1998.15.789; Tator CH, 2006, NEUROSURGERY, V59, P957, DOI 10.1227/01.NEU.0000245591.16087.89; Tator CH, 2012, J NEUROSURG-SPINE, V17, P157, DOI 10.3171/2012.5.AOSPINE12116; Tetzlaff W, 2011, J NEUROTRAUM, V28, P1611, DOI 10.1089/neu.2009.1177; Tholance Y, 2011, CLIN CHIM ACTA, V412, P647, DOI 10.1016/j.cca.2010.12.025; Tisdall MM, 2006, BRIT J ANAESTH, V97, P18, DOI 10.1093/bja/ael109; Vespa PM, 2005, CURR OPIN CRIT CARE, V11, P133, DOI 10.1097/01.ccx.0000155353.01489.58; Vespa PM, 2003, J CEREBR BLOOD F MET, V23, P865, DOI 10.1097/01.WCB.0000076701.45782.EF; Whetstone WD, 2003, J NEUROSCI RES, V74, P227, DOI 10.1002/jnr.10759; Wisniewski N, 2002, AM J PHYSIOL-ENDOC M, V282, pE1316, DOI 10.1152/ajpendo.00259.2001; Wisniewski N, 2001, J BIOMED MATER RES, V57, P513, DOI 10.1002/1097-4636(20011215)57:4<513::AID-JBM1197>3.0.CO;2-E; Xiong Y, 1997, J NEUROTRAUM, V14, P23, DOI 10.1089/neu.1997.14.23; ZHANG Y, 1993, SURG NEUROL, V39, P297, DOI 10.1016/0090-3019(93)90009-P	70	18	19	0	10	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	SEP 15	2013	30	18					1564	1576		10.1089/neu.2013.2956			13	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	211EB	WOS:000323886600002	23768189				2021-06-18	
J	Ansari, MA; Roberts, KN; Scheff, SW				Ansari, Mubeen A.; Roberts, Kelly N.; Scheff, Stephen W.			Dose- and Time-Dependent Neuroprotective Effects of Pycnogenol (R) following Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						bioflavonoids; natural compounds; neurotrauma; oxidative stress; pycnogenol; synaptic proteins; traumatic brain injury	OXIDATIVE STRESS; SUPEROXIDE-DISMUTASE; AKT PHOSPHORYLATION; CORTICAL CONTUSION; SIGNALING PATHWAYS; SYNAPTIC PROTEINS; GENE-EXPRESSION; MOUSE MODEL; FLAVONOIDS; NEURONS	After traumatic brain injury (TBI), both primary and secondary injury cascades are initiated, leading to neuronal death and cognitive dysfunction. We have previously shown that the combinational bioflavonoid, Pycnogenol (R) (PYC), alters some secondary injury cascades and protects synaptic proteins when administered immediately following trauma. The purpose of the present study was to explore further the beneficial effects of PYC and to test whether it can be used in a more clinically relevant fashion. Young adult male Sprague-Dawley rats were subjected to a unilateral moderate/severe cortical contusion. Subjects received a single intravenous (i.v.) injection of PYC (1, 5, or 10 mg/kg) or vehicle, with treatment initiated at 15 min, 2 h, or 4 h post injury. All rats were killed at 96 h post TBI. Both the cortex and hippocampus ipsilateral and contralateral to the injury were evaluated for possible changes in oxidative stress (thiobarbituric acid reactive species; TBARS) and both pre- and post-synaptic proteins (synapsin-I, synaptophysin, drebrin, post synaptic density protein-95, and synapse associated protein-97). Following TBI, TBARS were significantly increased in both the injured cortex and ipsilateral hippocampus. Regardless of the dose and delay in treatment, PYC treatment significantly lowered TBARS. PYC treatment significantly protected both the cortex and hippocampus from injury-related declines in pre- and post-synaptic proteins. These results demonstrate that a single i.v. treatment of PYC is neuroprotective after TBI with a therapeutic window of at least 4 h post trauma. The natural bioflavonoid PYC may provide a possible therapeutic intervention in neurotrauma.	[Ansari, Mubeen A.; Roberts, Kelly N.; Scheff, Stephen W.] Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40536 USA	Scheff, SW (corresponding author), Univ Kentucky, Sanders Brown Ctr Aging 101, Lexington, KY 40536 USA.	sscheff@email.uky.edu			National Institute of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R21NS66117]; Kentucky Spinal Cord Brain Injury Trust [12-16A]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS066117] Funding Source: NIH RePORTER	This work was supported by National Institute of Health Grant R21NS66117 and Kentucky Spinal Cord Brain Injury Trust 12-16A. Pycnogenol (R) was a very generous gift from Horphag Research Inc., Hoboken, NJ.	Ansari MA, 2008, FREE RADICAL BIO MED, V45, P443, DOI 10.1016/j.freeradbiomed.2008.04.038; Ansari MA, 2008, J NEUROTRAUM, V25, P513, DOI 10.1089/neu.2007.0451; Ansari MA, 2008, FREE RADICAL BIO MED, V45, P1510, DOI 10.1016/j.freeradbiomed.2008.08.025; Ates O, 2007, MOL CELL BIOCHEM, V294, P137, DOI 10.1007/s11010-006-9253-0; Azevedo MF, 2010, PHYTOTHER RES, V24, pS220, DOI 10.1002/ptr.3118; Baldwin SA, 1997, J NEUROTRAUM, V14, P385, DOI 10.1089/neu.1997.14.385; Baldwin SA, 1996, J NEUROSURG, V85, P476, DOI 10.3171/jns.1996.85.3.0476; Bayir H, 2007, J NEUROCHEM, V101, P168, DOI 10.1111/j.1471-4159.2006.04353.x; Biegon A, 2004, P NATL ACAD SCI USA, V101, P5117, DOI 10.1073/pnas.0305741101; Bistrian BR, 2011, JPEN-PARENTER ENTER, V35, P556, DOI 10.1177/0148607111416122; Carloni S, 2010, AUTOPHAGY, V6, P366, DOI 10.4161/auto.6.3.11261; Cayabyab FS, 2000, EUR J NEUROSCI, V12, P1949, DOI 10.1046/j.1460-9568.2000.00083.x; Chen CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030294; Chen SF, 2008, BRIT J PHARMACOL, V155, P1279, DOI 10.1038/bjp.2008.345; Cho KJ, 2001, ANN NY ACAD SCI, V928, P141; de la Monte SM, 2000, CELL MOL LIFE SCI, V57, P1471, DOI 10.1007/PL00000630; Di Giovanni S, 2005, P NATL ACAD SCI USA, V102, P8333, DOI 10.1073/pnas.0500989102; Endo H, 2006, J CEREBR BLOOD F MET, V26, P1479, DOI 10.1038/sj.jcbfm.9600303; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Gamet-Payrastre L, 1999, GEN PHARMACOL-VASC S, V32, P279, DOI 10.1016/S0306-3623(98)00220-1; Gilmer LK, 2010, J NEUROTRAUM, V27, P939, DOI 10.1089/neu.2009.1181; Hall ED, 2004, J NEUROTRAUM, V21, P9, DOI 10.1089/089771504772695904; Hall ED, 2010, NEUROTHERAPEUTICS, V7, P51, DOI 10.1016/j.nurt.2009.10.021; HOVDA DA, 1991, BRAIN RES, V567, P1, DOI 10.1016/0006-8993(91)91429-5; Hu LY, 2010, NEUROSCIENCE, V169, P1046, DOI 10.1016/j.neuroscience.2010.05.046; Ince I, 2009, PHYTOMEDICINE, V16, P1101, DOI 10.1016/j.phymed.2009.05.004; Itoh T, 2011, NEUROMOL MED, V13, P300, DOI 10.1007/s12017-011-8162-x; Johnson JL, 2011, J MED FOOD, V14, P325, DOI 10.1089/jmf.2010.0310; KAWAMATA T, 1995, BRAIN RES, V674, P196, DOI 10.1016/0006-8993(94)01444-M; Kotulska K, 2006, J NEUROSCI RES, V84, P1091, DOI 10.1002/jnr.21000; Laird MD, 2010, J NEUROCHEM, V113, P637, DOI 10.1111/j.1471-4159.2010.06630.x; Lee HF, 2012, RESP PHYSIOL NEUROBI, V182, P1, DOI 10.1016/j.resp.2012.01.016; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; Margulies S, 2009, J NEUROTRAUM, V26, P925, DOI [10.1089/neu.2008.0794, 10.1089/neu.2008-0794]; Matzilevich DA, 2002, J NEUROSCI RES, V67, P646, DOI 10.1002/jnr.10157; McIntosh TK, 1996, LAB INVEST, V74, P315; Mercer LD, 2005, BIOCHEM PHARMACOL, V69, P339, DOI 10.1016/j.bcp.2004.09.018; Morales DM, 2005, NEUROSCIENCE, V136, P971, DOI 10.1016/j.neuroscience.2005.08.030; Noshita N, 2002, NEUROBIOL DIS, V9, P294, DOI 10.1006/nbdi.2002.0482; Parajuli P, 2011, J NEURO-ONCOL, V101, P15, DOI 10.1007/s11060-010-0221-x; Rohdewald P, 2002, INT J CLIN PHARM TH, V40, P158; Ryan J, 2008, J PSYCHOPHARMACOL, V22, P553, DOI 10.1177/0269881108091584; Scheff SW, 2013, EXP NEUROL, V239, P183, DOI 10.1016/j.expneurol.2012.09.019; Scheff SW, 2005, J NEUROTRAUM, V22, P719, DOI 10.1089/neu.2005.22.719; Schroeter H, 2001, BIOCHEM J, V358, P547, DOI 10.1042/0264-6021:3580547; Schultke E, 2005, J NEUROTRAUM, V22, P1475, DOI 10.1089/neu.2005.22.1475; SEGER R, 1995, FASEB J, V9, P726; Shao CX, 2006, FREE RADICAL BIO MED, V41, P77, DOI 10.1016/j.freeradbiomed.2006.03.007; Shapira M, 2007, MOL CELL NEUROSCI, V34, P571, DOI 10.1016/j.mcn.2006.12.006; Sharma S, 2009, NEUROSCIENCE, V161, P1037, DOI 10.1016/j.neuroscience.2009.04.042; Shein NA, 2007, J NEUROCHEM, V103, P1523, DOI 10.1111/j.1471-4159.2007.04862.x; Singh IN, 2007, J NEUROSCI RES, V85, P2216, DOI 10.1002/jnr.21360; Singh IN, 2006, J CEREBR BLOOD F MET, V26, P1407, DOI 10.1038/sj.jcbfm.9600297; Singleton RH, 2010, J NEUROTRAUM, V27, P1091, DOI 10.1089/neu.2010.1291; Spencer JPE, 2007, GENES NUTR, V2, P257, DOI 10.1007/s12263-007-0056-z; Tunon MJ, 2009, CURR DRUG METAB, V10, P256, DOI 10.2174/138920009787846369; Vauzour D, 2007, J NEUROCHEM, V103, P1355, DOI 10.1111/j.1471-4159.2007.04841.x; de la Torre AV, 2012, PHARMACOL RES, V65, P66, DOI 10.1016/j.phrs.2011.08.006; Williams RJ, 2004, FREE RADICAL BIO MED, V36, P838, DOI 10.1016/j.freeradbiomed.2004.01.001; Wu AG, 2006, EXP NEUROL, V197, P309, DOI 10.1016/j.expneurol.2005.09.004; Xiong Y, 1997, J NEUROTRAUM, V14, P23, DOI 10.1089/neu.1997.14.23; Yen TL, 2012, J AGR FOOD CHEM, V60, P1937, DOI 10.1021/jf204909p	62	18	18	0	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	SEP	2013	30	17					1542	1549		10.1089/neu.2013.2910			8	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	202HX	WOS:000323205800010	23557184	Green Published			2021-06-18	
J	Halpern, R; Gillard, P; Graham, GD; Varon, SF; Zorowitz, RD				Halpern, Rachel; Gillard, Patrick; Graham, Glenn D.; Varon, Sepideh F.; Zorowitz, Richard D.			Adherence Associated With Oral Medications in the Treatment of Spasticity	PM&R			English	Article							SPINAL-CORD-INJURY; MULTIPLE-SCLEROSIS; MANAGEMENT; STROKE; PERSISTENCE	Objective: To examine adherence to badofen, tizanidine, and dantrolene (U.S. Food and Drug Administration-approved oral spasticity medications), and identified determinants of adherence. Design: A retrospective administrative claims data analysis that used medical and pharmacy claims data and enrollment information from a large, national U.S. health plan. Subjects and Methods: The subjects were commercial health plan members who initiated treatment on badofen, tizanidine, or dantrolene from January 1, 2004, through September 30, 2009, and who had stroke, spinal cord injury, traumatic brain injury, cerebral palsy, or multiple sclerosis. Descriptive and logistic regression statistical analyses were performed. Main Outcome Measurements: Outcomes were adherence, measured as continuous medication possession ratio (MPR) and as a binary indicator (MPR >= 0.80, adherent; MPR <0.80, nonadherent), change in oral spasticity medication, and use of nonoral spasticity therapy. Results: The study population included 2840 subjects. Adherence overall was poor: the range of mean unadjusted MPR values was 0.10-0.50, which indicated that, at best, the subjects were adherent to their index spasticity medications for 50% of their treatment periods. Unadjusted overall MPRs for badofen and tizanidine were 20.4% and 9.1%, respectively. Fewer than 5% of subjects changed oral spasticity medications. The results of logistic regression to identify determinants of adherence showed that subjects treated with tizanidine versus badofen had 37.4% lower odds of adherence and that subjects with traumatic brain injury versus stroke had 77.5% lower odds of adherence. The odds of adherence increased with age and with preindex contracture or decubitus ulcer. Conclusions: Adherence to oral spasticity medication was poor irrespective of index spasticity medication or condition. Results from this study indicated that physicians cannot assume that patients are adherent to prescribed oral spasticity medications. A more complete understanding of the reasons behind nonadherence is required.	[Halpern, Rachel] OptumInsight, Hlth Econ & Outcomes Res, Eden Prairie, MN 55344 USA; [Gillard, Patrick; Varon, Sepideh F.] Allergan Pharmaceut Inc, Global Hlth Outcomes Strategy & Res, Irvine, CA 92715 USA; [Graham, Glenn D.] Dept Vet Affairs, Washington, DC USA; [Zorowitz, Richard D.] Johns Hopkins Univ, Sch Med, Dept Phys Med & Rehabil, Johns Hopkins Bayview Med Ctr, Baltimore, MD USA	Halpern, R (corresponding author), OptumInsight, Hlth Econ & Outcomes Res, 12125 Technol Dr, Eden Prairie, MN 55344 USA.	rachel.halpern@optum.com		Zorowitz, Richard/0000-0001-8938-786X	Allergan Inc, Irvine, CAAbbVieAllergan	Research support: Support was provided by Allergan Inc, Irvine, CA.	Adams MM, 2005, SPINAL CORD, V43, P577, DOI 10.1038/sj.sc.3101757; Andrade SE, 2006, PHARMACOEPIDEM DR S, V15, P565, DOI 10.1002/pds.1230; Becker R, 1997, J NEUROL, V244, P160, DOI 10.1007/s004150050067; Brashear A, 2002, NEW ENGL J MED, V347, P395, DOI 10.1056/NEJMoa011892; Burke DA, 2001, SPINAL CORD, V39, P274, DOI 10.1038/sj.sc.3101158; Centers for Disease Control and Prevention, 2011, STROK FACTS; Delgado MR, 2010, NEUROLOGY, V74, P336, DOI 10.1212/WNL.0b013e3181cbcd2f; Devonshire V, 2011, EUR J NEUROL, V18, P69, DOI 10.1111/j.1468-1331.2010.03110.x; Duncan PW, 2005, STROKE, V36, pE100, DOI 10.1161/01.STR.0000180861.54180.FF; Esquenazi A, 2011, J CLIN OUTCOMES MANA, V18, P607; Fang Jing, 2012, Morbidity and Mortality Weekly Report, V61, P379; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Gelber DA, 2001, STROKE, V32, P1841, DOI 10.1161/01.STR.32.8.1841; Haselkorn JK, 2005, J SPINAL CORD MED, V28, P167; Jackson AB, 2004, ARCH PHYS MED REHAB, V85, P1740, DOI 10.1016/j.apmr.2004.04.035; Lance J., 1980, SPASTICITY DISORDERE; Moberg-Wolff EA, 2011, MEDSCAPE REFERENCE; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; PARZIALE JR, 1993, ORTHOPEDICS, V16, P801; Rabchevsky AG, 2011, NEUROTHERAPEUTICS, V8, P274, DOI 10.1007/s13311-011-0025-5; RxList, 2007, INT DRUG IND; Sajatovic M, 2009, COMPR PSYCHIAT, V50, P100, DOI 10.1016/j.comppsych.2008.06.008; Sikka R, 2005, AM J MANAG CARE, V11, P453; Simon O, 2010, EUR J PHYS REHAB MED, V46, P401; Simpson DM, 1997, MUSCLE NERVE, pS169; StataCorp LP, 2007, STAT 10 BAS REF MAN, V3; Vanek ZF, 2012, SPASTICITY INTRO PAT; Weidle PJ, 1999, J ACQ IMMUN DEF SYND, V22, P498; World Health Organization, 2003, ADHERENCE LONG TERM; Yeaw J, 2009, J MANAGE CARE PHARM, V15, P728, DOI 10.18553/jmcp.2009.15.9.728; Yelnik A. P., 2009, Annals of Physical and Rehabilitation Medicine, V52, P746, DOI 10.1016/j.rehab.2009.09.005	31	18	18	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1934-1482	1934-1563		PM&R	PM&R	SEP	2013	5	9					747	756		10.1016/j.pmrj.2013.04.022			10	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	226MX	WOS:000325041600002	23648652				2021-06-18	
J	Leon-Carrion, J; Machuca-Murga, F; Solis-Marcos, I; Leon-Dominguez, U; Dominguez-Morales, MD				Leon-Carrion, Jose; Machuca-Murga, Fernando; Solis-Marcos, Ignacio; Leon-Dominguez, Umberto; del Rosario Dominguez-Morales, Maria			The sooner patients begin neurorehabilitation, the better their functional outcome	BRAIN INJURY			English	Article						Early treatment; FAM; functional outcome; FIM; neurorehabilitation programmes; traumatic brain injury	TRAUMATIC BRAIN-INJURY; REHABILITATION	Primary objective: To determine whether early neurorehabilitation improves a patient's functional recovery. Research design: A retrospective study was carried out on patients with severe traumatic brain injury (TBI) who underwent a minimum of 4 months of integral and multidisciplinary neurorehabilitation. Methods and procedures: Fifty-eight patients with severe TBI were assessed at admission and at discharge using the FIM+FAM scale. Two groups were formed based on time elapsed from brain injury to onset of rehabilitation. The early treatment group (ET) included patients who began rehabilitation within the first 9 months post-trauma; the late treatment group (LT) began after the 9-month cut-off date. Intra-and between-group analysis of FIM+FAM scores were carried out at admission and discharge. Multiple linear regression was used to determine the best predictors for functional rehabilitation. Main outcomes and results: After neurorehabilitation, all subjects showed significant improvement in cognitive, motor, communication and psychosocial functioning. Moreover, the ET group showed better global functional outcome at discharge than patients who began later treatment. The best predictors for functional neurorehabilitation were months since injury, age, GCS score and months of treatment. Conclusions: It is concluded that the sooner patients begin neurorehabilitation, the better their functional outcome.	[Leon-Carrion, Jose; Machuca-Murga, Fernando; Solis-Marcos, Ignacio] Univ Seville, Dept Expt Psychol, Sch Psychol, Human Neuropsychol Lab, Seville 41005, Spain; [Leon-Dominguez, Umberto; del Rosario Dominguez-Morales, Maria] Ctr Brain Injury Rehabil CRECER, Seville, Spain	Leon-Carrion, J (corresponding author), Univ Seville, C Camilo Jose Cela S-N, Seville 41005, Spain.	leoncarrion@us.es	Marcos, Ignacio Solis/AAE-9161-2019	Marcos, Ignacio Solis/0000-0001-9309-5552; Leon-Dominguez, Umberto/0000-0001-5170-2553			Calzavacca P, 2008, INTENS CARE MED, V34, P2112, DOI 10.1007/s00134-008-1229-y; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; CONOVER WJ, 1981, AM STAT, V35, P124, DOI 10.2307/2683975; Cope DN, 2004, TXB TRAUMATIC BRAIN, P559; DODDS TA, 1993, ARCH PHYS MED REHAB, V74, P531, DOI 10.1016/0003-9993(93)90119-U; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; GRANGER CV, 1990, ARCH PHYS MED REHAB, V71, P870; Haddad SH, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-12; HAMILTON B B, 1991, Archives of Physical Medicine and Rehabilitation, V72, P790; Leon Carrion J., 2001, REV ESPANOLA NEUROPS, V3, P58; Leon Carrion J, 1997, NEUROPSYCHOLOGICAL R; Leon-Carrion J, 2006, BRAIN INJURY TREATME; Leon-Carrion J, 2012, J REHABIL MED, V44, P505, DOI 10.2340/16501977-0982; Leon-Carrion J, 2010, BRAIN INJURY, V24, P1193, DOI 10.3109/02699052.2010.506636; LINACRE JM, 1994, ARCH PHYS MED REHAB, V75, P127; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Pistarini C, 1997, ADV NEUROTRAUMA RES, P114; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; Tang ME, 2009, MT SINAI J MED, V76, P119, DOI 10.1002/msj.20106; van Baalen B, 2006, CLIN REHABIL, V20, P686, DOI 10.1191/0269215506cre982oa	20	18	19	0	12	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	SEP	2013	27	10					1119	1123		10.3109/02699052.2013.804204			5	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	204KW	WOS:000323365200003	23895589				2021-06-18	
J	Li, M; Hu, YH; Chen, G				Li, M.; Hu, Y. H.; Chen, G.			Hypernatremia severity and the risk of death after traumatic brain injury	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Traumatic brain injury; Hypernatremia; Intensive care unit; Mortality rate	INTENSIVE-CARE-UNIT; CRITICALLY-ILL; ACQUIRED HYPERNATREMIA; MORTALITY; SODIUM; SERUM; TOO	Purpose: To investigate the relationship between severity of hypernatremia and the risk of death for patients with traumatic brain injury (TBI) who have been admitted to the neurosurgical intensive care unit (NICU). Methods: A total of 1044 patients with TBI were admitted to our NICU from January 2005 to January 2010. Of these patients, 881 were included in this study. Based on blood serum sodium level in the NICU the 881 patients were divided into four groups: 614 had normal serum sodium (Na < 150 mmol/L), 34 had mild hypernatremia (Na 150-<155 mmol/L), 66 had moderate hypernatremia (Na 155-160 mmol/L) and 167 had severe hypernatremia (Na >= 160 mmol/L). Results: The mortality rates for the mild, moderate, and severe hypernatremia groups were 20.6%, 42.4%, and 86.8%, respectively; the mortality rate for the normal group was 2.0%. In multivariable analysis, mild, moderate, and severe hypernatremia were independent risk factors for mortality; compared with the normal group the odds ratios of mild, moderate, and severe hypernatremia were 9.50, 4.34, and 29.35, respectively. Conclusions: Severe hypernatremia is an independent risk factor with extremely high odds ratio for death in patients with TBI who are admitted to the NICU. (C) 2012 Elsevier Ltd. All rights reserved.	[Li, M.; Hu, Y. H.] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Neurosurg Intens Care Unit, Hangzhou 310009, Zhejiang, Peoples R China; [Chen, G.] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Neurosurg, Hangzhou 310009, Zhejiang, Peoples R China	Chen, G (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Neurosurg, 88 Jie Fang Rd, Hangzhou 310009, Zhejiang, Peoples R China.	Limin258481@163.com					Adrogue HJ, 2000, NEW ENGL J MED, V342, P1493, DOI 10.1056/NEJM200005183422006; Agha A, 2004, CLIN ENDOCRINOL, V60, P584, DOI 10.1111/j.1365-2265.2004.02023.x; Aiyagari V, 2006, J CRIT CARE, V21, P163, DOI 10.1016/j.jcrc.2005.10.002; Bullock MR, 1996, J NEUROTRAUM, V13, P705; Funk GC, 2010, INTENS CARE MED, V36, P304, DOI 10.1007/s00134-009-1692-0; GENNARI FJ, 1974, NEW ENGL J MED, V291, P714, DOI 10.1056/NEJM197410032911408; Hadjizacharia P, 2008, J AM COLL SURGEONS, V207, P477, DOI 10.1016/j.jamcollsurg.2008.04.017; Hoorn EJ, 2008, NEPHROL DIAL TRANSPL, V23, P1562, DOI 10.1093/ndt/gfm831; Howanitz JH, 2007, AM J CLIN PATHOL, V127, P56, DOI 10.1309/Q3Y27QQLEL19340A; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Kumar S, 1998, LANCET, V352, P220, DOI 10.1016/S0140-6736(97)12169-9; Lindner G, 2007, AM J KIDNEY DIS, V50, P952, DOI 10.1053/j.ajkd.2007.08.016; Lindner G, 2010, INTENS CARE MED, V36, P1718, DOI 10.1007/s00134-010-1968-4; Lindner G, 2009, AM J KIDNEY DIS, V54, P674, DOI 10.1053/j.ajkd.2009.04.015; LOEB JN, 1974, NEW ENGL J MED, V290, P1184, DOI 10.1056/NEJM197405232902107; Maggiore U, 2009, CRIT CARE, V13, DOI 10.1186/cc7953; Mandal AK, 1997, AM J EMERG MED, V15, P130, DOI 10.1016/S0735-6757(97)90082-6; O'Donoghue SD, 2009, ANAESTHESIA, V64, P514, DOI 10.1111/j.1365-2044.2008.05857.x; Palevsky PM, 1996, ANN INTERN MED, V124, P197, DOI 10.7326/0003-4819-124-2-199601150-00002; Polderman KH, 1999, CRIT CARE MED, V27, P1105, DOI 10.1097/00003246-199906000-00029; Shea AM, 2008, J AM SOC NEPHROL, V19, P764, DOI 10.1681/ASN.2007070752; SNYDER NA, 1987, ANN INTERN MED, V107, P309, DOI 10.7326/0003-4819-107-2-309; Stelfox HT, 2008, CRIT CARE, V12, DOI 10.1186/cc7162; Tisdall M, 2006, J NEUROSURG ANESTH, V18, P57, DOI 10.1097/01.ana.0000191280.05170.0f; Wong M. F. M., 1998, Annals Academy of Medicine Singapore, V27, P340	25	18	20	0	6	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	SEP	2013	44	9					1213	1218		10.1016/j.injury.2012.05.021			6	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	211VX	WOS:000323940600014	22709549				2021-06-18	
J	Merkley, TL; Larson, MJ; Bigler, ED; Good, DA; Perlstein, WM				Merkley, Tricia L.; Larson, Michael J.; Bigler, Erin D.; Good, Daniel A.; Perlstein, William M.			Structural and Functional Changes of the Cingulate Gyrus following Traumatic Brain Injury: Relation to Attention and Executive Skills	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						MRI; TBI; Cortical volume; Cognitive flexibility; Working memory; Anterior cingulate; ACC	CLOSED-HEAD INJURY; OBSESSIVE-COMPULSIVE DISORDER; COGNITIVE CONTROL; DIFFUSION-TENSOR; WORKING-MEMORY; STROOP TASK; POSTTRAUMATIC AMNESIA; CORTICAL SURFACE; COUNTING STROOP; ERROR-DETECTION	Impairments of attention and executive functions are common sequelae of traumatic brain injury (TBI). The anterior cingulate is implicated in conflict-related task performance, such as the Stroop, and is susceptible to TBI-related injury due to its frontal location and proximity to the rough surface of the falx cerebri. We investigated the relationship between cingulate cortex volume and performance on tasks of selective attention and cognitive flexibility (single-trial Stroop and Auditory Consonant Trigrams [ACT]). Participants consisted of 12 adults with severe TBI and 18 controls. T1-weighted volumetric MRI data were analyzed using automated cortical reconstruction, segmentation, parcellation, and volume measurement. Cortical volume reductions were prominent bilaterally in frontal, temporal, and inferior parietal regions. Specific regional reduction of the cingulate cortex was observed only for cortical volume of right caudal anterior cingulate (cACC). The TBI group performed significantly worse than control participants on the Stroop and ACT tasks. Findings suggest that atrophy of the right cACC may contribute to reduced performance on executive function tasks, such as the Stroop and ACT, although this is likely but one node of an extensive brain network involved in these cognitive processes.	[Merkley, Tricia L.; Larson, Michael J.; Bigler, Erin D.; Good, Daniel A.] Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA; [Merkley, Tricia L.] Baylor Coll Med, Phys Med & Rehabil Alliance, Houston, TX 77030 USA; [Merkley, Tricia L.] Univ Texas Houston, Sch Med, Houston, TX USA; [Merkley, Tricia L.] Inst Rehabil & Res TIRR Mem Hermann, Houston, TX USA; [Larson, Michael J.; Bigler, Erin D.] Brigham Young Univ, Ctr Neurosci, Provo, UT 84602 USA; [Bigler, Erin D.] Univ Utah, Dept Psychiat, Salt Lake City, UT USA; [Perlstein, William M.] Univ Florida, Dept Clin & Hlth Psychol, Gainesville, FL USA; [Perlstein, William M.] Malcom Randall VA, VA RR&D Brain Rehabil & Res Ctr Excellence, Gainesville, FL USA	Larson, MJ (corresponding author), Brigham Young Univ, Dept Psychol, 244 TLRB, Provo, UT 84602 USA.	michael_larson@byu.edu	Merkley, Tricia/AAN-2989-2020; Larson, Michael J/C-8543-2012	Larson, Michael J/0000-0002-8199-8065; Merkley, Tricia/0000-0002-0897-8391	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [F31 NS053335, R21 MH073076]; Ira Fulton Foundation at Brigham Young University; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R21MH073076] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [F31NS053335] Funding Source: NIH RePORTER	This research was supported by grants NIH F31 NS053335 toMJL and NIH R21 MH073076 to WMP, and by the Ira Fulton Foundation at Brigham Young University. Dr. Erin Bigler notes that he sees forensic neuropsychology cases. No other conflicts of interest are reported.	Bendlin BB, 2008, NEUROIMAGE, V42, P503, DOI 10.1016/j.neuroimage.2008.04.254; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bigler E.D., 2006, BRAIN INJURY MED PRI, P201; Bigler ED, 2007, NEUROPSYCHOLOGY, V21, P515, DOI 10.1037/0894-4105.21.5.515; Bigler ED, 2011, NEUROREHABILITATION, V28, P63, DOI 10.3233/NRE-2011-0633; Bigler ED, 2010, NEUROIMAGE, V50, P1017, DOI 10.1016/j.neuroimage.2010.01.003; Blair JR., 1989, CLIN NEUROPSYCHOL, V3, P129; Boone KB, 1998, ARCH CLIN NEUROPSYCH, V13, P585, DOI 10.1016/S0887-6177(97)00074-7; BROWN J, 1958, Q J EXP PSYCHOL, V10, P12, DOI 10.1080/17470215808416249; Buckner RL, 2004, NEUROIMAGE, V23, P724, DOI 10.1016/j.neuroimage.2004.06.018; Burgess P. W., 1996, BEHAV ASSESSMENT DYS; Bush G, 1998, HUM BRAIN MAPP, V6, P270, DOI 10.1002/(SICI)1097-0193(1998)6:4<270::AID-HBM6>3.3.CO;2-H; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Bush G, 1999, BIOL PSYCHIAT, V45, P1542, DOI 10.1016/S0006-3223(99)00083-9; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; Carter CS, 2000, P NATL ACAD SCI USA, V97, P1944, DOI 10.1073/pnas.97.4.1944; Clayson PE, 2011, NEUROPSYCHOLOGIA, V49, P1953, DOI 10.1016/j.neuropsychologia.2011.03.023; Cohen, 1988, STAT POWER ANAL BEHA; Cohen JD, 1999, J ABNORM PSYCHOL, V108, P120, DOI 10.1037/0021-843X.108.1.120; Collin G, 2014, CEREB CORTEX, V24, P2258, DOI 10.1093/cercor/bht064; Damasio A. R., 2011, CLIN NEUROPSYCHOLOGY, P417; Dennis M, 2013, DEV COGN NEUROS-NETH, V5, P25, DOI 10.1016/j.dcn.2012.11.006; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Etkin A, 2006, NEURON, V51, P871, DOI 10.1016/j.neuron.2006.07.029; Etkin A, 2011, AM J PSYCHIAT, V168, P968, DOI 10.1176/appi.ajp.2011.10091290; Fassbender C, 2006, CLIN PSYCHOL REV, V26, P445, DOI 10.1016/j.cpr.2006.01.003; Fischl B, 1999, HUM BRAIN MAPP, V8, P272, DOI 10.1002/(SICI)1097-0193(1999)8:4<272::AID-HBM10>3.0.CO;2-4; GEHRING WJ, 1993, PSYCHOL SCI, V4, P385, DOI 10.1111/j.1467-9280.1993.tb00586.x; Gu BM, 2008, BRAIN, V131, P155, DOI 10.1093/brain/awm277; Hagler DJ, 2006, NEUROIMAGE, V33, P1093, DOI 10.1016/j.neuroimage.2006.07.036; Hajcak G, 2010, DEV NEUROPSYCHOL, V35, P129, DOI 10.1080/87565640903526504; Heflin LH, 2011, NEUROPSYCHOLOGY, V25, P655, DOI 10.1037/a0023863; Hillary FG, 2014, BRAIN IMAGING BEHAV, V8, P435, DOI 10.1007/s11682-012-9205-0; Hinnant D.W., 1999, TRAUMATIC BRAIN INJU, P187; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI [10.1037//0033-295X.109.4.679, 10.1037/0033-295X.109.4.679]; Hudak A, 2011, PSYCHIAT RES-NEUROIM, V191, P160, DOI 10.1016/j.pscychresns.2010.10.003; Kennedy DP, 2012, TRENDS COGN SCI, V16, P559, DOI 10.1016/j.tics.2012.09.006; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; Kim C, 2010, NEUROSCI LETT, V476, P156, DOI 10.1016/j.neulet.2010.04.019; King NS, 1997, J NEUROL NEUROSUR PS, V62, P38, DOI 10.1136/jnnp.62.1.38; Kondo H, 2004, NEUROIMAGE, V21, P2, DOI 10.1016/j.neuroimage.2003.09.046; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Krebs RM, 2012, CEREB CORTEX, V22, P607, DOI 10.1093/cercor/bhr134; LEVIN HS, 1995, J NEUROTRAUM, V12, P601, DOI 10.1089/neu.1995.12.601; Levine B, 2008, NEUROLOGY, V70, P771, DOI 10.1212/01.wnl.0000304108.32283.aa; Margulies DS, 2007, NEUROIMAGE, V37, P579, DOI 10.1016/j.neuroimage.2007.05.019; Mathias JL, 2007, BRIT J CLIN PSYCHOL, V46, P457, DOI 10.1348/014466507X190197; McMillan TM, 1996, J NEUROL NEUROSUR PS, V60, P422, DOI 10.1136/jnnp.60.4.422; Meador KJ, 2011, EPILEPSY BEHAV, V21, P147, DOI 10.1016/j.yebeh.2011.03.020; Merkley TL, 2008, J NEUROTRAUM, V25, P1343, DOI 10.1089/neu.2008.0615; Mertens VB, 2006, ARCH CLIN NEUROPSYCH, V21, P733, DOI 10.1016/j.acn.2006.08.005; Nebel K, 2005, COGNITIVE BRAIN RES, V25, P760, DOI 10.1016/j.cogbrainres.2005.09.011; Nieuwenhuis S, 2011, NAT NEUROSCI, V14, P1105, DOI 10.1038/nn.2886; Overbeek TJM, 2005, J PSYCHOPHYSIOL, V19, P319, DOI 10.1027/0269-8803.19.4.319; Pandit AS, 2013, NEUROLOGY, V80, P1826, DOI 10.1212/WNL.0b013e3182929f38; Perlstein WM, 1998, NEUROPSYCHOLOGY, V12, P414, DOI 10.1037/0894-4105.12.3.414; Perlstein WM, 2006, NEUROPSYCHOLOGIA, V44, P260, DOI 10.1016/j.neuropsychologia.2005.05.009; PETERSON LR, 1959, J EXP PSYCHOL, V58, P193, DOI 10.1037/h0049234; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Posner MI, 1998, PHILOS T R SOC B, V353, P1915, DOI 10.1098/rstb.1998.0344; Rutgers DR, 2008, AM J NEURORADIOL, V29, P514, DOI 10.3174/ajnr.A0856; Sattler J. M., 2008, ASSESSMENT CHILDREN; Seignourel PJ, 2005, NEUROPSYCHOLOGY, V19, P578, DOI 10.1037/0894-4105.19.5.578; Shackman AJ, 2011, NAT REV NEUROSCI, V12, P154, DOI 10.1038/nrn2994; Shafritz KM, 2005, NEUROIMAGE, V25, P600, DOI 10.1016/j.neuroimage.2004.12.054; Soeda A, 2005, NEURORADIOLOGY, V47, P501, DOI 10.1007/s00234-005-1372-x; Sohn MH, 2007, P NATL ACAD SCI USA, V104, P10330, DOI 10.1073/pnas.0703225104; Sozda CN, 2011, INT J PSYCHOPHYSIOL, V82, P97, DOI 10.1016/j.ijpsycho.2011.06.019; Spielberger CD., 1989, MANUAL STATE TRAIT A, V2; Stamatakis EA, 2002, J NUCL MED, V43, P476; Tate DF, 2011, J INT NEUROPSYCH SOC, V17, P308, DOI 10.1017/S1355617710001670; TEASDALE G, 1974, LANCET, V2, P81; van den Heuvel MP, 2011, J NEUROSCI, V31, P15775, DOI 10.1523/JNEUROSCI.3539-11.2011; van der Wee NJA, 2003, NEUROIMAGE, V20, P2271, DOI 10.1016/j.neuroimage.2003.05.001; Vanier M, 2000, ARCH PHYS MED REHAB, V81, P796, DOI 10.1053/apmr.2000.4436; VOGT BA, 1995, J COMP NEUROL, V359, P490, DOI 10.1002/cne.903590310; VOGT BA, 1992, CEREB CORTEX, V2, P435, DOI 10.1093/cercor/2.6.435-a; Weible AP, 2013, BEHAV BRAIN RES, V245, P63, DOI 10.1016/j.bbr.2013.02.010; Wilde EA, 2011, INT J PSYCHOPHYSIOL, V82, P86, DOI 10.1016/j.ijpsycho.2011.04.006; Wu TC, 2010, J NEUROTRAUM, V27, P303, DOI 10.1089/neu.2009.1110; Yount R, 2002, J NEUROPSYCH CLIN N, V14, P416, DOI 10.1176/appi.neuropsych.14.4.416; Zhou YX, 2013, RADIOLOGY, V267, P880, DOI 10.1148/radiol.13122542	82	18	19	0	24	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	SEP	2013	19	8					899	910		10.1017/S135561771300074X			12	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Neurosciences & Neurology; Psychiatry; Psychology	209AQ	WOS:000323725800007	23845701				2021-06-18	
J	Mrazik, M; Naidu, D; Lebrun, C; Game, A; Matthews-White, J				Mrazik, Martin; Naidu, Dhiren; Lebrun, Constance; Game, Alex; Matthews-White, Joan			Does an Individual's Fitness Level Affect Baseline Concussion Symptoms?	JOURNAL OF ATHLETIC TRAINING			English	Article						sports; traumatic brain injuries; assessment; self-report symptoms	SHUTTLE RUN TEST; VALIDITY; SCALE	Context: Variables that may influence baseline concussion symptoms should be investigated. Objective: To evaluate the effect of physical fitness on self-report of baseline concussion symptoms in collegiate athletes and students. Design: Controlled laboratory study. Patients or Other Participants: A total of 125 undergraduates, including 95 collegiate athletes and 30 recreational athletes (83 males, 42 females). Intervention(s): Participants completed the Standardized Concussion Assessment Tool 2 (SCAT2; symptom report) at baseline, within 10 minutes of completing the Leger test, and within 24 hours of the initial baseline test. The Leger (beep) test is a shuttle-run field test used to predict maximal aerobic power. Main Outcome Measure(s): The total symptom score on the SCAT2 was calculated and analyzed with a repeated-measures analysis of variance. A linear regression analysis was used to determine if 3 variables (sport type, sex, or fitness level) accounted for a significant amount of the variance in the baseline symptom report. Results: Participants reported more symptoms postactivity but fewer symptoms at 24 hours compared with baseline, representing a time effect in our model (F-2,F-234 = 47.738, P < .001). No interactions were seen among the independent variables. We also found an effect for fitness level, with fitter individuals reporting fewer symptoms at all 3 time intervals. The regression analysis revealed that fitness level accounted for a significant amount of the variance in SCAT2 symptoms at baseline (R-2 = 0.22, F-3,F-121 = 11.44, P < .01). Conclusions: Fitness level affected the baseline concussion symptom report. Exercise seems to induce concussion symptom reporting, and symptom severity may be a function of an athlete's level of conditioning. Sports medicine professionals should consider an athlete's level of fitness when conducting baseline concussion symptom assessments.	[Mrazik, Martin; Naidu, Dhiren; Lebrun, Constance; Game, Alex; Matthews-White, Joan] Univ Alberta, Edmonton, AB T6G 2G5, Canada	Mrazik, M (corresponding author), Univ Alberta, 6-135 Educ North, Edmonton, AB T6G 2G5, Canada.	mrazik@ualberta.ca					Alla S, 2010, J SCI MED SPORT, V13, P24, DOI 10.1016/j.jsams.2008.12.629; American College of Sports Medicine, 2010, ACSMS GUID EX TEST P; Chen MJ, 2002, J SPORT SCI, V20, P873, DOI 10.1080/026404102320761787; Covassin T, 2006, BRIT J SPORT MED, V40, P923, DOI 10.1136/bjsm.2006.029496; Ferrara MS, 2001, J ATHL TRAINING, V36, P145; Hunt TN, 2007, ARCH CLIN NEUROPSYCH, V22, P615, DOI 10.1016/j.acn.2007.04.005; Iverson GL, 2010, J HEAD TRAUMA REHAB, V25, P23, DOI 10.1097/HTR.0b013e3181b4b6ab; Johnston KM, 2001, CLIN J SPORT MED, V11, P166, DOI 10.1097/00042752-200107000-00007; LEGER L, 1989, CAN J SPORT SCI, V14, P21; LEGER LA, 1982, EUR J APPL PHYSIOL O, V49, P1, DOI 10.1007/BF00428958; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; McCrory P, 2009, PHYSICIAN SPORTSMED, V37, P141, DOI 10.3810/psm.2009.06.1721; McCrory Paul, 2009, Scand J Med Sci Sports, V19, P452, DOI 10.1111/j.1600-0838.2009.00978.x; Mihalik JP, 2009, J SCI MED SPORT, V12, P383, DOI 10.1016/j.jsams.2008.05.003; Patel AV, 2007, J ATHL TRAINING, V42, P66; Piland SG, 2006, MED SCI SPORT EXER, V38, P27, DOI 10.1249/01.mss.0000183186.98212.d5; Stickland MK, 2003, CAN J APPL PHYSIOL, V28, P272, DOI 10.1139/h03-021	17	18	18	0	5	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	SEP-OCT	2013	48	5					654	658		10.4085/1062-6050-48.3.19			5	Sport Sciences	Sport Sciences	268AR	WOS:000328140600009	23725489	Green Published, Bronze			2021-06-18	
J	Tollefsen, WW; Brown, CA; Cox, KL; Walls, RM				Tollefsen, William Wallace; Brown, Calvin A., III; Cox, Kelly L.; Walls, Ron M.			Two Hundred Sixty Pediatric Emergency Airway Encounters by Air Transport Personnel A Report of the Air Transport Emergency Airway Management (NEAR VI: "A-TEAM") Project	PEDIATRIC EMERGENCY CARE			English	Article						prehospital; helicopter; intubation	TRAUMATIC BRAIN-INJURY; HOSPITAL ENDOTRACHEAL INTUBATION; RAPID-SEQUENCE INTUBATION; CENTRAL LINE SIMULATION; SEVERE HEAD-INJURY; TRAINING ALGORITHM; SUCCESS RATES; URBAN; FIELD; EXPERIENCE	Background: Effective airway management is the cornerstone of resuscitative efforts for any critically ill or injured patient. The role and safety of pediatric prehospital intubation is controversial, particularly after prior research has shown varying degrees of intubation success. We report a series of consecutive prehospital pediatric intubations performed by air-transport providers. Methods: We retrospectively reviewed intubation flight records from an 89-rotorcraft, multistate emergency flight service during the time period from January 1, 2007, to December 31, 2009. All patients younger than 15 years were included in our analysis. We characterized patient, flight, and operator demographics; intubation methods; success rates; rescue techniques; and adverse events with descriptive statistics. We report proportions with 95% confidence intervals and differences between groups with Fisher exact and chi(2) tests; P < 0.05 was considered significant. Results: Two hundred sixty pediatric intubations were performed consisting of 88 medical (33.8%) and 172 trauma (66.2%) cases; 98.8% (n = 257) underwent an orotracheal intubation attempt as the first method. First-pass intubation success was 78.6% (n = 202), and intubation was ultimately successful in 95.7% (n = 246) of cases. Medical and trauma intubations had similar success rates (98% vs 95%, Fisher exact test P = 0.3412). There was no difference in intubation success between age groups (chi(2) = 0.26, P = 0.88). Three patients were managed primarily with an extraglottic device. Rescue techniques were used in 11 encounters (4.2%), all of which were successful. Cricothyrotomy was performed twice, both successful. Conclusions: Prehospital pediatric intubation performed by air-transport providers, using rapid sequence intubation protocols, is highly successful. This effect on patient outcome requires further study.	[Tollefsen, William Wallace; Brown, Calvin A., III; Walls, Ron M.] Brigham & Womens Hosp, Dept Emergency Med, Boston, MA 02115 USA; [Tollefsen, William Wallace] Harvard Affiliated Emergency Med Residency, Boston, MA USA; [Tollefsen, William Wallace] Univ Massachusetts, Dept Emergency Med, Worcester, MA 01605 USA; [Brown, Calvin A., III; Walls, Ron M.] Harvard Univ, Sch Med, Div Emergency Med, Boston, MA USA; [Cox, Kelly L.] Univ Illinois, Dept Emergency Med, Peoria, IL USA	Tollefsen, WW (corresponding author), 75 Francis St,NH-236A, Boston, MA 02115 USA.	wtollefsen@partners.org			Air-Evac EMS, Inc.	This study was supported by a research grant from Air-Evac EMS, Inc.	Barsuk JH, 2009, J HOSP MED, V4, P397, DOI 10.1002/jhm.468; Berlot G, 2009, EUR J EMERG MED, V16, P312, DOI 10.1097/MEJ.0b013e32832d3aa1; Britt RC, 2007, AM SURGEON, V73, P680; Britt RC, 2009, AM J SURG, V197, P533, DOI 10.1016/j.amjsurg.2008.11.016; Burton John H, 2003, Prehosp Emerg Care, V7, P352, DOI 10.1080/10903120390936554; Colwell CB, 2005, ACAD EMERG MED, V12, P417, DOI 10.1197/j.aem.2004.11.024; Cook BS, 2006, J TRAUMA NURS, V13, P146; Cooper A, 2001, Semin Pediatr Surg, V10, P3, DOI 10.1053/spsu.2001.19379; Davis DP, 2005, J TRAUMA, V59, P484, DOI 10.1097/00005373-200508000-00037; Davis DP, 2005, J TRAUMA, V58, P933, DOI 10.1097/01.TA.0000162731.53812.58; Davis DP, 2003, J TRAUMA, V54, P444, DOI 10.1097/01.TA.0000053396.02126.CD; Gausche M, 2000, JAMA-J AM MED ASSOC, V283, P783, DOI 10.1001/jama.283.6.783; Germann C, 2009, PREHOSP EMERG CARE, V13, P44, DOI 10.1080/10903120802474505; Jemmett ME, 2003, ACAD EMERG MED, V10, P961, DOI 10.1197/S1069-6563(03)00315-4; Jones JH, 2004, ACAD EMERG MED, V11, P707, DOI 10.1197/j.aem.2003.12.026; Katz SH, 2001, ANN EMERG MED, V37, P32, DOI 10.1067/mem.2001.112098; Kovacs G, 2000, ANN EMERG MED, V36, P301, DOI 10.1067/mem.2000.109339; Lowe L, 1998, Air Med J, V17, P101, DOI 10.1016/S1067-991X(98)90103-1; Ma OJ, 1998, AM J EMERG MED, V16, P125, DOI 10.1016/S0735-6757(98)90027-4; MURPHYMACABOBBY M, 1992, ANN EMERG MED, V21, P664, DOI 10.1016/S0196-0644(05)82776-3; Murray JA, 2000, J TRAUMA, V49, P1065, DOI 10.1097/00005373-200012000-00015; Poste Jennifer C, 2004, Air Med J, V23, P36, DOI 10.1016/j.amj.2004.04.006; Reed MJ, 2005, EMERG MED J, V22, P99, DOI 10.1136/emj.2003.008771; Rose W D, 1994, Air Med J, V13, P475, DOI 10.1016/S1067-991X(05)80289-5; Sing RF, 1998, AM J EMERG MED, V16, P598, DOI 10.1016/S0735-6757(98)90227-3; Sloane C, 2000, J EMERG MED, V19, P259, DOI 10.1016/S0736-4679(00)00235-3; STEWART RD, 1984, ANN EMERG MED, V13, P1032, DOI 10.1016/S0196-0644(84)80064-5; STRATTON SJ, 1991, ANN EMERG MED, V20, P1314, DOI 10.1016/S0196-0644(05)81073-X; Walls RM, 2008, MANUAL EMERGENCY AIR, P81; Wang HE, 2005, CRIT CARE MED, V33, P1718, DOI 10.1097/01.CCM.0000171208.07895.2A; Wang HE, 2004, ANN EMERG MED, V44, P439, DOI 10.1016/j.annemergmed.2004.04.008; Wang HE, 2003, RESUSCITATION, V58, P49, DOI 10.1016/S0300-9572(03)00058-3; Warner KJ, 2010, PREHOSP EMERG CARE, V14, P103, DOI 10.3109/10903120903144858; Winchell RJ, 1997, ARCH SURG-CHICAGO, V132, P592	34	18	18	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0749-5161	1535-1815		PEDIATR EMERG CARE	Pediatr. Emerg. Care	SEP	2013	29	9					963	968					6	Emergency Medicine; Pediatrics	Emergency Medicine; Pediatrics	300NP	WOS:000330470900002	23974713				2021-06-18	
J	Collins, NC; Molcho, M; Carney, P; McEvoy, L; Geoghegan, L; Phillips, JP; Nicholson, AJ				Collins, Niamh C.; Molcho, Michal; Carney, Peter; McEvoy, Linda; Geoghegan, Lourda; Phillips, Jack P.; Nicholson, Alf J.			Are boys and girls that different? An analysis of traumatic brain injury in children	EMERGENCY MEDICINE JOURNAL			English	Article							MORTALITY; PATTERN; APPRAISALS; RISK; AGE	Introduction The Phillips Report on traumatic brain injury (TBI) in Ireland found that injury was more frequent in men and that gender differences were present in childhood. This study determined when gender differences emerge and examined the effect of gender on the mechanism of injury, injury type and severity and outcome. Methods A national prospective, observational study was conducted over a 2-year period. All patients under 17 years of age referred to a neurosurgical service following TBI were included. Data on patient demographics, events surrounding injury, injury type and severity, patient management and outcome were collected from 'on-call' logbooks and neurosurgical admissions records. Results 342 patients were included. Falls were the leading cause of injury for both sexes. Boys' injuries tended to involve greater energy transfer and involved more risk-prone behaviour resulting in a higher rate of other (non-brain) injury and a higher mortality rate. Intentional injury occurred only in boys. While injury severity was similar for boys and girls, significant gender differences in injury type were present; extradural haematomas were significantly higher in boys (p=0.014) and subdural haematomas were significantly higher in girls (p=0.011). Mortality was 1.8% for girls and 4.3% for boys. Conclusions Falls were responsible for most TBI, the home is the most common place of injury and non-operable TBI was common. These findings relate to all children. Significant gender differences exist from infancy. Boys sustained injuries associated with a greater energy transfer, were less likely to use protective devices and more likely to be injured deliberately. This results in a different pattern of injury, higher levels of associated injury and a higher mortality rate.	[Collins, Niamh C.] James Connolly Mem Hosp, Dept Emergency Med, Dublin 15, Ireland; [Molcho, Michal] Natl Univ Ireland, Hlth Promot Res Ctr, Galway, Ireland; [Carney, Peter] Univ Coll Dublin, Geary Inst, Dublin 2, Ireland; [McEvoy, Linda; Phillips, Jack P.] Beaumont Hosp, Traumat Brain Injury Res Grp, Dublin 9, Ireland; [Geoghegan, Lourda] Publ Hlth Agcy Northern Ireland, Belfast, Antrim, North Ireland; [Nicholson, Alf J.] Childrens Univ Hosp, Dept Paediat Med, Dublin, Ireland	Collins, NC (corresponding author), James Connolly Mem Hosp, Dept Emergency Med, Dublin 15, Ireland.	nievoc@yahoo.co.uk					Bayreuther J, 2009, ARCH DIS CHILDHOOD-E, V94, P37, DOI 10.1136/adc.2007.132787; Consumer Safety Institute, 2000, DEATHS INJ DUE ACC V; Granie MA, 2010, ACCIDENT ANAL PREV, V42, P726, DOI 10.1016/j.aap.2009.10.022; Granie MA, 2009, SAFETY SCI, V47, P1277, DOI 10.1016/j.ssci.2009.03.010; Hillier LM, 1998, J PEDIATR PSYCHOL, V23, P229, DOI 10.1093/jpepsy/23.4.229; Kendrick D., 2007, COCHRANE DB SYST REV, V24; Klein KS, 2005, INJURY PREV, V11, P288, DOI 10.1136/ip.2004.007013; Molcho M, SLAN 2007 SURVEY LIF; Morrongiello BA, 2000, J EXP CHILD PSYCHOL, V76, P89, DOI 10.1006/jecp.2000.2572; Morrongiello BA, 2000, J EXP CHILD PSYCHOL, V77, P317, DOI 10.1006/jecp.2000.2595; Pearson J, 2009, ARCH DIS CHILD, V94, P524, DOI 10.1136/adc.2008.148403; Pearson J, 2009, BMC PEDIATR, V9, DOI 10.1186/1471-2431-9-26; RIVARA FP, 1982, AM J DIS CHILD, V136, P502, DOI 10.1001/archpedi.1982.03970420026004; StataCorp, 2005, STAT STAT SOFTW REL, V9; Unicef, 2001, LEAG TABL CHILD DEAT	15	18	18	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1472-0205	1472-0213		EMERG MED J	Emerg. Med. J.	AUG	2013	30	8					675	678		10.1136/emermed-2011-200496			4	Emergency Medicine	Emergency Medicine	301GH	WOS:000330520300016	22962053	Green Published, Other Gold			2021-06-18	
J	Lo Pizzo, M; Schiera, G; Di Liegro, I; Di Liegro, CM; Pal, J; Czeiter, E; Sulyok, E; Doczi, T				Lo Pizzo, Marianna; Schiera, Gabriella; Di Liegro, Italia; Di Liegro, Carlo Maria; Pal, Jozsef; Czeiter, Endre; Sulyok, Endre; Doczi, Tamas			Aquaporin-4 distribution in control and stressed astrocytes in culture and in the cerebrospinal fluid of patients with traumatic brain injuries	NEUROLOGICAL SCIENCES			English	Article						Cultured astrocytes; Cerebrospinal fluid; Aquaporin-4; Traumatic brain injury	URINARY-EXCRETION; ARGININE-VASOPRESSIN; RAT-BRAIN; EXPRESSION; PROTEIN; EDEMA; MODEL	Distribution of aquaporin-4 (AQP4) was studied by western analysis and immunofluorescence in rat astrocytes exposed to either hypothermic (30 A degrees C) or hyperosmolar (0.45 M sucrose) stress, and in the cerebrospinal fluid (CSF) of patients who suffered traumatic brain injury (TBI). CSF was obtained from 5 healthy subjects and from 20 patients suffering from severe TBI. CSF samples were taken at admission and on days 3 and 5-7. Here we report that, in response to both hypothermia and hyperosmolar stress, AQP4 was markedly reduced in cultured astrocytes. We also found that AQP4 significantly increased in patients with severe brain injury in respect to healthy subjects (P < 0.002). AQP4 in CSF remained unchanged in patients with elevated intracranial pressure (ICP), whereas there was a clear tendency to further increase in those patients whose ICP could be controlled within the normal range. We conclude that AQP4 levels in CSF are elevated after TBI and it might serve as a useful biochemical marker to assess brain water metabolism in clinical settings.	[Lo Pizzo, Marianna; Di Liegro, Italia] Univ Palermo, Dept Expt Biomed & Clin Neurosci BIONEC, I-90127 Palermo, Italy; [Schiera, Gabriella; Di Liegro, Carlo Maria] Univ Palermo, Dept Mol & Biomol Technol Sci STEMBIO, I-90128 Palermo, Italy; [Pal, Jozsef; Doczi, Tamas] Univ Pecs, Fac Med, Dept Neurosurg, H-7624 Pecs, Hungary; [Pal, Jozsef; Doczi, Tamas] MTA PTE Clin Neurosci MR Res Grp, H-7624 Pecs, Hungary; [Czeiter, Endre] Univ Pecs, Dept Anat, Fac Med, H-7624 Pecs, Hungary; [Sulyok, Endre] Univ Pecs, Fac Hlth Sci, Inst Hlth Promot & Family Care, H-7621 Pecs, Hungary	Di Liegro, I (corresponding author), Univ Palermo, Dept Expt Biomed & Clin Neurosci BIONEC, I-90127 Palermo, Italy.	italia.diliegro@unipa.it	Czeiter, Endre/B-1404-2009; Doczi, Tamas/C-5750-2009	Schiera, Gabriella/0000-0002-8638-6455; Di Liegro, Carlo Maria/0000-0001-7362-7814; Di Liegro, Italia/0000-0002-0546-1274; Pal, Jozsef/0000-0001-6468-6409	University of Palermo (Italy)	The experimental work was supported by the University of Palermo (Italy). The studies were carried out with the written permission and under the control of the Institutional Review Board of the University of Pecs (IRB 00003108).	Arima H, 2003, J BIOL CHEM, V278, P44525, DOI 10.1074/jbc.M304368200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Cole R., 1989, DISSECTION TISSUE CU, P121; Deen PMT, 1996, J AM SOC NEPHROL, V7, P836; Fryclenlund DS, 2006, P NATL ACAD SCI USA, V103, P13532, DOI 10.1073/pnas.0605796103; Fujita Y, 2003, NEUROSCI RES, V47, P437, DOI 10.1016/j.neures.2003.08.006; Hasler U, 2002, J BIOL CHEM, V277, P10379, DOI 10.1074/jbc.M111880200; Hozawa S, 1996, AM J PHYSIOL-CELL PH, V270, pC1695; Ishikawa SE, 2001, J CLIN ENDOCR METAB, V86, P1665, DOI 10.1210/jc.86.4.1665; KANNO K, 1995, NEW ENGL J MED, V332, P1540, DOI 10.1056/NEJM199506083322303; Ke CS, 2001, NEUROSCI LETT, V301, P21, DOI 10.1016/S0304-3940(01)01589-0; Kroksveen AC, 2011, J PROTEOMICS, V74, P371, DOI 10.1016/j.jprot.2010.11.010; Manley GT, 2000, NAT MED, V6, P159, DOI 10.1038/72256; Nielsen S, 1997, J NEUROSCI, V17, P171; Niermann H, 2001, J NEUROSCI, V21, P3045, DOI 10.1523/JNEUROSCI.21-09-03045.2001; Papadopoulos MC, 2007, PEDIATR NEPHROL, V22, P778, DOI 10.1007/s00467-006-0411-0; Papadopoulos MC, 2001, BRIT J NEUROSURG, V15, P101; Rai T, 1997, J AM SOC NEPHROL, V8, P1357; Rash JE, 1998, P NATL ACAD SCI USA, V95, P11981, DOI 10.1073/pnas.95.20.11981; Sarfaraz D, 1999, AM J PHYSIOL-ENDOC M, V276, pE596; Schiera G, 2005, J CELL MOL MED, V9, P373, DOI 10.1111/j.1582-4934.2005.tb00362.x; Starklint J, 2006, SCAND J CLIN LAB INV, V66, P55, DOI 10.1080/00365510500452955; Sulyok E, 2004, ACTA NEUROCHIR, V146, P955, DOI 10.1007/s00701-004-0319-z; Taniguchi M, 2000, MOL BRAIN RES, V78, P131, DOI 10.1016/S0169-328X(00)00084-X; Vajda Z, 2000, BIOCHEM BIOPH RES CO, V270, P495, DOI 10.1006/bbrc.2000.2472; Vizuete ML, 1999, NEUROBIOL DIS, V6, P245, DOI 10.1006/nbdi.1999.0246	27	18	18	0	6	SPRINGER-VERLAG ITALIA SRL	MILAN	VIA DECEMBRIO, 28, MILAN, 20137, ITALY	1590-1874	1590-3478		NEUROL SCI	Neurol. Sci.	AUG	2013	34	8					1309	1314		10.1007/s10072-012-1233-4			6	Clinical Neurology; Neurosciences	Neurosciences & Neurology	204RU	WOS:000323387100006	23143012				2021-06-18	
J	Nyholm, L; Howells, T; Enblad, P; Lewen, A				Nyholm, Lena; Howells, Tim; Enblad, Per; Lewen, Anders			Introduction of the Uppsala Traumatic Brain Injury register for regular surveillance of patient characteristics and neurointensive care management including secondary insult quantification and clinical outcome	UPSALA JOURNAL OF MEDICAL SCIENCES			English	Article						Database; neurointensive care; outcome; quality register; secondary insults; traumatic brain injury	SEVERE HEAD-INJURY; PROSTACYCLIN TREATMENT; INTRACRANIAL-PRESSURE; GUIDELINE COMPLIANCE; THERAPY; TALK; IMPACT; SCALE; COMA; UNIT	Background. To improve neurointensive care (NIC) and outcome for traumatic brain injury (TBI) patients it is crucial to define and monitor indexes of the quality of patient care. With this purpose we established the web-based Uppsala TBI register in 2008. In this study we will describe and analyze the data collected during the first three years of this project. Methods. Data from the medical charts were organized in three columns containing: 1) Admission data; 2) Data from the NIC period including neurosurgery, type of monitoring, treatment, complications, neurological condition at discharge, and the amount of secondary insults; 3) Outcome six months after injury. Indexes of the quality of care implemented include: 1) Index of improvement; 2) Index of change; 3) The percentages of 'Talk and die' and `Talk and deteriorate' patients. Results. Altogether 314 patients were included 2008-2010: 66 women and 248 men aged 0-86 years. Automatic reports showed that the proportion of patients improving during NIC varied between 80% and 60%. The percentage of deteriorated patients was less than 10%. The percentage of Talk and die/Talk and deteriorate cases was <1%. The mean Glasgow Coma Score (Motor) improved from 5.04 to 5.68 during the NIC unit stay. The occurrences of secondary insults were less than 5% of good monitoring time for intracranial pressure (ICP) >25 mmHg, cerebral perfusion pressure (CPP) <50 mmHg, and systolic blood pressure <100 mmHg. Favorable outcome was achieved by 64% of adults. Conclusion. The Uppsala TBI register enables the routine monitoring of NIC quality indexes.	[Nyholm, Lena; Howells, Tim; Enblad, Per; Lewen, Anders] Uppsala Univ, Dept Neurosci, SE-75185 Uppsala, Sweden	Lewen, A (corresponding author), Uppsala Univ, Univ Uppsala Hosp, Dept Neurosci, SE-75185 Uppsala, Sweden.	anders.lewen@neuro.uu.se	Lewen, Anders/A-5156-2013	Lewen, Anders/0000-0003-4925-1348	Swedish research councilSwedish Research CouncilEuropean Commission	The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper. The study was supported by grants from the Swedish research council.	Afessa B, 2007, BMC EMERG MED, V7, DOI 10.1186/1471-227X-7-10; Bhatia A, 2007, INTENS CARE MED, V33, P1263, DOI 10.1007/s00134-007-0678-z; Biersteker HAR, 2012, CRIT CARE MED, V40, P1914, DOI 10.1097/CCM.0b013e3182474bde; Bullock MR, 2007, J NEUROTRAUMA SUPPL, V24, P1; Chambers IR, 2000, BRIT J NEUROSURG, V14, P424; Citerio G, 2000, ACTA NEUROCHIR, V142, P769, DOI 10.1007/s007010070091; Davis DP, 2007, J TRAUMA, V62, P277, DOI 10.1097/TA.0b013e31802ef4a3; Eker C, 1998, CRIT CARE MED, V26, P1881, DOI 10.1097/00003246-199811000-00033; Elf K, 2005, NEUROSURGERY, V56, P962, DOI 10.1227/01.NEU.0000158317.00603.40; Elf K, 2002, CRIT CARE MED, V30, P2129, DOI 10.1097/00003246-200209000-00029; Emanuelson I, 1997, ACTA PAEDIATR, V86, P730, DOI 10.1111/j.1651-2227.1997.tb08576.x; Heskestad B, 2008, J TRAUMA, V65, P1309, DOI 10.1097/TA.0b013e31815e40cd; Howells T, 1995, J NEUROTRAUMA; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Jiang JY, 2002, J NEUROTRAUM, V19, P869, DOI 10.1089/08977150260190456; Kim YJ, 2011, J CLIN NURS, V20, P1518, DOI 10.1111/j.1365-2702.2010.03618.x; Koskinen S, 2008, BRAIN INJURY, V22, P205, DOI 10.1080/02699050801938975; Maas AIR, 1997, ACTA NEUROCHIR, V139, P286, DOI 10.1007/BF01808823; Majdan M, 2012, EUR J PUBLIC HEALTH, V10, P1; MARSHALL LF, 1983, J NEUROSURG, V59, P285, DOI 10.3171/jns.1983.59.2.0285; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; Naredi S, 2001, ACTA ANAESTH SCAND, V45, P402, DOI 10.1034/j.1399-6576.2001.045004402.x; Olivecrona M, 2012, BRAIN INJURY, V26, P67, DOI 10.3109/02699052.2011.635351; Olivecrona M, 2009, J NEUROTRAUM, V26, P1251, DOI [10.1089/neu.2008.0605, 10.1089/neu.2008-0605]; Piper I, 2010, ACTA NEUROCHIR, V152, P1859, DOI 10.1007/s00701-010-0719-1; REILLY PL, 1975, LANCET, V2, P375; Rusnak M, 2007, WIEN KLIN WOCHENSCHR, V119, P23, DOI 10.1007/s00508-006-0760-5; Ryttlefors M, 2007, NEUROSURGERY, V61, P704, DOI 10.1227/01.NEU.0000298898.38979.E3; STARMARK JE, 1988, ACTA NEUROCHIR, V91, P12, DOI 10.1007/BF01400521; TEASDALE G, 1974, LANCET, V2, P81; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	32	18	18	0	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0300-9734	2000-1967		UPSALA J MED SCI	Ups. J. Med. Sci.	AUG	2013	118	3					169	180		10.3109/03009734.2013.806616			12	Medicine, General & Internal	General & Internal Medicine	180IJ	WOS:000321587100004	23837596	DOAJ Gold, Green Published			2021-06-18	
J	Pistoia, F; Sacco, S; Carolei, A; Sara, M				Pistoia, Francesca; Sacco, Simona; Carolei, Antonio; Sara, Marco			Corticomotor Facilitation in Vegetative State: Results of a Pilot Study	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injuries; Minimally conscious state; Rehabilitation; Transcranial magnetic stimulation; Vegetative state	TRAUMATIC BRAIN-INJURY; REVISED CRS-R; ITALIAN VERSION; HAND ACTIONS; CONSCIOUSNESS; DISORDERS; RECOVERY; MODULATION; IMITATION; AWARENESS	Objective: To investigate whether corticomotor facilitation induced by transcranial magnetic stimulation (TMS-CF) could evoke a simple purposeful motor behavior in patients with a diagnosis of vegetative state. Design: Cross-sectional survey. Setting: Post-coma and rehabilitation care unit. Participants: Patients (N=6) with a diagnosis of vegetative state. Interventions: A cascade of consecutive motor-evoked potentials (MEPs) was elicited under 3 different conditions: in the first condition, patients were at rest (Rest); in the second, they were asked to open and close the right hand (Execution); in the third, the examiner modeled a movement of abduction of the thumb in front of the patient who was encouraged in advance to imitate the action (Observation to Imitate). Main Outcome Measures: Changes in MEP values from the abductor pollicis brevis muscle and improvement in scores on the Coma Recovery Scale-Revised. Results: TMS-CF alone or combined with verbal instructions did not yield any change; only the combination with imitation caused changes in MEPs (shorter latency and increased amplitude) associated with behavioral improvement in 4 patients. Conclusions: Encouraging observation to imitate may favor the transformation of some perceived actions into motor images and performances, probably depending on the activation of mirror motor neurons. In our opinion, combining visual input with TMS-CF might have reinforced the coupling between movement planning and execution, promoting the recovery of elementary motor activities in some patients. The proposed protocol may contribute to unmasking signs of preserved consciousness in patients with latent capacities for recovery. (c) 2013 by the American Congress of Rehabilitation Medicine	[Pistoia, Francesca; Sacco, Simona; Carolei, Antonio] Univ Aquila, Dept Neurol, I-67100 Laquila, Italy; [Pistoia, Francesca; Sara, Marco] Hosp San Raffaele, Post Coma & Rehabil Care Unit, I-03043 Cassino, FR, Italy	Sara, M (corresponding author), Hosp San Raffaele, Via Gaetano Biasio 1, I-03043 Cassino, FR, Italy.	marco.sara@sanraffaele.it	Sara, Marco/AAB-3651-2019; Pistoia, Francesca/AAC-1027-2019; Sacco, Simona/I-5253-2012	Sacco, Simona/0000-0003-0651-1939; PISTOIA, Francesca/0000-0003-0790-4240	Italian Ministry of HealthMinistry of Health, Italy [RF2008 n.31]	Supported in part by the Italian Ministry of Health (grant no. RF2008 n.31).	ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; Bagnato S, 2012, CLIN NEUROPHYSIOL, V123, P1937, DOI 10.1016/j.clinph.2012.03.014; BAUER G, 1979, J NEUROL, V221, P77, DOI 10.1007/BF00313105; Bruno MA, 2011, J NEUROL, V258, P1373, DOI 10.1007/s00415-011-6114-x; Clark S, 2004, NEUROPSYCHOLOGIA, V42, P105, DOI 10.1016/S0028-3932(03)00144-1; Clauss R, 2006, NEUROREHABILITATION, V21, P23; Conson M, 2009, EXP BRAIN RES, V199, P71, DOI 10.1007/s00221-009-1974-3; Craighero L, 2002, NEUROPSYCHOLOGIA, V40, P492, DOI 10.1016/S0028-3932(01)00134-8; FADIGA L, 1995, J NEUROPHYSIOL, V73, P2608; Formisano R, 2011, BRAIN INJURY, V25, P638, DOI 10.3109/02699052.2011.572948; Garrison KA, 2010, NEUROREHAB NEURAL RE, V24, P404, DOI 10.1177/1545968309354536; Giacino JT, 2012, NEW ENGL J MED, V366, P819, DOI 10.1056/NEJMoa1102609; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Leonard G, 2007, EXP BRAIN RES, V177, P167, DOI 10.1007/s00221-006-0657-6; Lombardi F, 2007, FUNCT NEUROL, V22, P47; Owen AM, 2007, ARCH NEUROL-CHICAGO, V64, P1098, DOI 10.1001/archneur.64.8.1098; Pistoia F, 2012, J NEUROTRAUM, V29, P2328, DOI 10.1089/neu.2009.1257; Pistoia F, 2010, CNS DRUGS, V24, P625, DOI 10.2165/11535940-000000000-00000; Sacco S, 2011, BRAIN INJURY, V25, P488, DOI 10.3109/02699052.2011.558043; Sara M, 2008, BRAIN INJURY, V22, P33, DOI 10.1080/02699050701810670; Sara M, 2007, BRAIN INJURY, V21, P101, DOI 10.1080/02699050601151761; Sara M, 2011, NEUROREHAB NEURAL RE, V25, P35, DOI 10.1177/1545968310378508; Sara M, 2010, NONLIN DYNAM PSYCHOL, V14, P1; Sara M, 2010, J NEUROTRAUM, V27, P771, DOI [10.1089/neu.2008.0804, 10.1089/neu.2008-0804]; Sara M, 2009, ARCH PHYS MED REHAB, V90, P1245, DOI 10.1016/j.apmr.2009.01.012; Tallus J, 2012, ACTA NEUROL SCAND, V126, P178, DOI 10.1111/j.1600-0404.2011.01623.x; Trojano L, 2012, J NEUROL, V259, P1888, DOI 10.1007/s00415-012-6435-4	27	18	23	1	11	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	AUG	2013	94	8					1599	1606		10.1016/j.apmr.2013.01.019			8	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	196TZ	WOS:000322801600024	23385107				2021-06-18	
J	Rauen, K; Trabold, R; Brem, C; Terpolilli, NA; Plesnila, N				Rauen, Katrin; Trabold, Raimund; Brem, Christian; Terpolilli, Nicole A.; Plesnila, Nikolaus			Arginine Vasopressin V-1a Receptor- Deficient Mice Have Reduced Brain Edema and Secondary Brain Damage following Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						Antidiuretic hormone; arginine vasopressin; brain edema; traumatic brain injury; V-1a receptor	CONTROLLED CORTICAL IMPACT; ANTAGONIST SR49059; VOLUME REGULATION; CHOROID-PLEXUS; V-2 RECEPTORS; BLOOD-VOLUME; RAT; AQUAPORIN-4; EXPRESSION; SYSTEM	The formation of brain edema and subsequent intracranial hypertension are major predictors of unfavorable outcome following traumatic brain injury (TBI). Previously, we reported that arginine vasopressin (AVP) receptor antagonists reduce post-traumatic and post-ischemic brain edema in mice. The aim of the current study was to investigate further the contribution of arginine vasopressin V-1a receptors to TBI-induced secondary brain damage in V-1a receptor knock-out mice. V-1a receptor knock-out (V-1a -/-) and wild-type mice were subjected to controlled cortical impact (CCI), and edema (brain water content measured before and 24 h after CCI), primary and secondary contusion volume (15 min and 24 h after CCI), neurological function (one day before and seven days after CCI), body weight (before and seven days after CCI) and mortality were measured. Twenty-four h after CCI, V1a receptor knock-out mice had significantly less brain water content than wild-type mice (mean +/- standard error of the mean: 79.8% +/- 0.3 vs. 80.6% +/- 0.2, respectively), and secondary contusion volume was significantly smaller (38.2 +/- 1.7 mm(3) vs. 45.1 +/- 1.5 mm(3) in wild-type mice). Furthermore, the V1a receptor knock-out mice had less neurological dysfunction (3.2 +/- 0.8 vs. 7.0 +/- 1.4 in wild-type mice) and weight loss (1.0 +/- 1.0% vs. 4.9 +/- 1.8% in wild-type mice) seven days after CCI. Our data show that mice lacking V1a receptors have less secondary brain damage following experimental traumatic brain injury. We therefore conclude that V-1a receptors may represent a novel drug target for preventing post-traumatic brain edema.	[Rauen, Katrin; Trabold, Raimund; Brem, Christian; Terpolilli, Nicole A.; Plesnila, Nikolaus] Univ Munich, Med Ctr, Dept Neurosurg, Munich, Germany; [Rauen, Katrin; Trabold, Raimund; Brem, Christian; Terpolilli, Nicole A.; Plesnila, Nikolaus] Univ Munich, Inst Surg Res, Med Ctr, D-80539 Munich, Germany; [Plesnila, Nikolaus] Univ Munich, Inst Stroke & Dementia Res, Med Ctr, Munich, Germany	Plesnila, N (corresponding author), Inst Stroke & Dementia Res, Max Lebsche Pl 30, D-81377 Munich, Germany.	nikolaus.plesnila@med.uni-muenchen.de	Plesnila, Nikolaus/T-7522-2019; Terpolilli, Nicole/AAG-3598-2021	Rauen, Katrin/0000-0003-4555-6697			Amiry-Moghaddam M, 2003, P NATL ACAD SCI USA, V100, P2106, DOI 10.1073/pnas.0437946100; BARGMANN WOLFGANG, 1951, AMER SCI, V39, P255; Barreca T, 2001, CEREBROVASC DIS, V11, P113, DOI 10.1159/000047622; Barzo P, 1996, J NEUROSURG, V85, P1113, DOI 10.3171/jns.1996.85.6.1113; Birnbaumer M, 2000, TRENDS ENDOCRIN MET, V11, P406, DOI 10.1016/S1043-2760(00)00304-0; BUIJS RM, 1978, CELL TISSUE RES, V192, P423, DOI 10.1007/bf00224932; Chodobski A, 1997, MOL BRAIN RES, V48, P67, DOI 10.1016/S0169-328X(97)00079-X; Cintra ED, 2004, ARQ NEURO-PSIQUIAT, V62, P226, DOI 10.1590/S0004-282X2004000200007; CSERR HF, 1992, PROG BRAIN RES, V91, P3; DELBIGIO MR, 1990, ACT NEUR S, V51, P14; DEPASQUALE M, 1989, AM J PHYSIOL, V256, pF1059; DOCZI T, 1984, NEUROSURGERY, V14, P436, DOI 10.1227/00006123-198404000-00008; DOCZI T, 1993, ACTA NEUROCHIR, V121, P1, DOI 10.1007/BF01405174; FARACI FM, 1988, CIRC RES, V63, P373, DOI 10.1161/01.RES.63.2.373; Hockel K, 2012, STROKE, V43, P227, DOI 10.1161/STROKEAHA.111.626168; Holmes CL, 2003, CRIT CARE, V7, P427, DOI 10.1186/cc2337; Huang Wei-dong, 2003, Chin J Traumatol, V6, P139; KIMELBERG HK, 1995, J NEUROSURG, V83, P1051, DOI 10.3171/jns.1995.83.6.1051; KLATZO I, 1967, J NEUROPATH EXP NEUR, V26, P1, DOI 10.1097/00005072-196701000-00001; Kleindienst A, 2006, ACTA NEUROCHIR SUPPL, V96, P303; Koshimizu T, 2006, P NATL ACAD SCI USA, V103, P7807, DOI 10.1073/pnas.0600875103; Lam TI, 2009, AM J PHYSIOL-CELL PH, V297, pC278, DOI 10.1152/ajpcell.00093.2009; LATZKOVITS L, 1993, AM J PHYSIOL, V264, pC603; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; Liu XQ, 2010, NEUROCRIT CARE, V12, P124, DOI 10.1007/s12028-009-9277-x; Manaenko A, 2011, NEUROCHEM INT, V58, P542, DOI 10.1016/j.neuint.2011.01.018; Marmarou A, 2005, ACT NEUR S, V95, P277; Marmarou A, 2000, J NEUROSURG, V93, P183, DOI 10.3171/jns.2000.93.2.0183; Marmarou A, 2003, ACT NEUR S, V86, P7; Maybauer MO, 2008, BEST PRACT RES-CLIN, V22, P253, DOI 10.1016/j.bpa.2008.03.003; Moeller HB, 2009, NEUROSCIENCE, V164, P1674, DOI 10.1016/j.neuroscience.2009.09.072; Neves SR, 2002, SCIENCE, V296, P1636, DOI 10.1126/science.1071550; Nielsen S, 1997, J NEUROSCI, V17, P171; O'Donnell ME, 2005, AM J PHYSIOL-CELL PH, V289, pC283, DOI 10.1152/ajpcell.00001.2005; Okuno K, 2008, ACTA NEUROCHIR SUPPL, V102, P431, DOI 10.1007/978-3-211-85578-2_84; Oliver G, 1895, J Physiol, V18, P277; Pascale CL, 2006, J PHYSIOL PHARMACOL, V57, P161; Plesnila N, 2007, PROG BRAIN RES, V161, P393, DOI 10.1016/S0079-6123(06)61028-5; Raggenbass M, 2008, EUR J PHARMACOL, V583, P243, DOI 10.1016/j.ejphar.2007.11.074; RAICHLE ME, 1978, BRAIN RES, V143, P191, DOI 10.1016/0006-8993(78)90766-7; Rap Z M, 1978, Adv Neurol, V20, P381; Rosenberg G A, 1990, Adv Neurol, V52, P149; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; SORENSEN PS, 1985, J NEUROL NEUROSUR PS, V48, P50, DOI 10.1136/jnnp.48.1.50; Stroop R, 1998, ACT NEUR S, V71, P303; Szmydynger-Chodobska J, 2004, J NEUROTRAUM, V21, P1090, DOI 10.1089/0897715041651033; Szmydynger-Chodobska J, 2011, J CEREBR BLOOD F MET, V31, P47, DOI 10.1038/jcbfm.2010.188; Szmydynger-Chodobska J, 2010, J NEUROTRAUM, V27, P1449, DOI 10.1089/neu.2010.1331; Taya K, 2008, ACTA NEUROCHIR SUPPL, V102, P425, DOI 10.1007/978-3-211-85578-2_83; Terpolilli NA, 2009, J NEUROTRAUM, V26, P1963, DOI 10.1089/neu.2008.0853; Thibonnier M, 1998, PROG BRAIN RES, V119, P147; Trabold R, 2008, J NEUROTRAUM, V25, P1459, DOI 10.1089/neu.2008.0597; Tribollet E, 1998, PROG BRAIN RES, V119, P45; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Vakili A, 2005, J CEREBR BLOOD F MET, V25, P1012, DOI 10.1038/sj.jcbfm.9600097; Verkman AS, 2006, BBA-BIOMEMBRANES, V1758, P1085, DOI 10.1016/j.bbamem.2006.02.018; Xu Miao, 2007, Chin J Traumatol, V10, P90; Yoshida M, 2006, ENDOCRINOLOGY, V147, P2850, DOI 10.1210/en.2005-1222; Yukutake Y, 2010, NEUROSCIENCE, V168, P885, DOI 10.1016/j.neuroscience.2009.10.029; Zweckberger K, 2003, J NEUROTRAUM, V20, P1307, DOI 10.1089/089771503322686102; Zweckberger K, 2006, J NEUROTRAUM, V23, P1083, DOI 10.1089/neu.2006.23.1083	61	18	19	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	AUG	2013	30	16					1442	1448		10.1089/neu.2012.2807			7	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	199JB	WOS:000322989500008	23441636				2021-06-18	
J	Allen, AR; Eilertson, K; Sharma, S; Schneider, D; Baure, J; Allen, B; Rosi, S; Raber, J; Fike, JR				Allen, Antino R.; Eilertson, Kirsten; Sharma, Sourabh; Schneider, Danielle; Baure, Jennifer; Allen, Barrett; Rosi, Susanna; Raber, Jacob; Fike, John R.			Effects of Radiation Combined Injury on Hippocampal Function are Modulated in Mice Deficient in Chemokine Receptor 2 (CCR2)	RADIATION RESEARCH			English	Article							TRAUMATIC BRAIN-INJURY; MONOCYTE CHEMOATTRACTANT PROTEIN-1; COGNITIVE IMPAIRMENTS; CRANIAL IRRADIATION; ADULT NEUROGENESIS; IONIZING-RADIATION; EXPRESSION; CELLS; PATHOPHYSIOLOGY; MACROPHAGES	Chemokines and their receptors play a crucial role in normal brain function as well as in pathological conditions such as injury and disease-associated neuroinflammation. Chemokine receptor-2 (CCR2), which mediates the recruitment of infiltrating and resident microglia to sites of central nervous system (CNS) inflammation, is upregulated by ionizing irradiation and traumatic brain injury. Our objective was to determine if a deficiency in CCR2 and subsequent effects on brain microglia affect neurogenesis and cognitive function after radiation combined injury (RCI). CCR2 knock-out (-/-) and wild-type (WT) mice received 4 Gy of whole body Cs-137 irradiation. Immediately after irradiation, unilateral traumatic brain injury was induced using a controlled cortical impact system. Forty-four days postirradiation, animals were tested for hippocampus-dependent cognitive performance in the Morris water-maze. After cognitive testing, animals were euthanized and their brains snap frozen for immunohistochemical assessment of neuroinflammation (activated microglia) and neurogenesis in the hippocampal dentate gyrus. All animals were able to locate the visible and hidden platform locations in the water maze; however, treatment effects were seen when spatial memory retention was assessed in the probe trials (no platform). In WT animals that received combined injury, a significant impairment in spatial memory retention was observed in the probe trial after the first day of hidden platform training (first probe trial). This impairment was associated with increased neurogenesis in the ipsilateral hemisphere of the dentate gyrus. In contrast, CCR2(-/-) mice, independent of insult showed significant memory retention in the first probe trial and there were no differences in the numbers of newly born neurons in the animals receiving irradiation, trauma or combined injury. Although the mechanisms involved are not clear, our data suggests that CCR2 deficiency can exert a protective effect preventing the impairment of cognitive function after combined injury. (C) 2013 by Radiation Research Society	[Allen, Antino R.; Sharma, Sourabh; Schneider, Danielle; Baure, Jennifer; Allen, Barrett; Rosi, Susanna; Fike, John R.] Univ Calif San Francisco, Dept Neurol Surg, Brain & Spinal Injury Ctr, San Francisco, CA 94110 USA; [Rosi, Susanna] Univ Calif San Francisco, San Francisco, CA 94110 USA; [Fike, John R.] Univ Calif San Francisco, Dept Radiat Oncol, San Francisco, CA 94110 USA; [Eilertson, Kirsten] Gladstone Inst San Francisco, Bioinformat Core, San Francisco, CA 94158 USA; [Raber, Jacob] Oregon Hlth & Sci Univ, ONPRC, Dept Behav Neurosci, Portland, OR 97239 USA; [Raber, Jacob] Oregon Hlth & Sci Univ, ONPRC, Dept Neurol, Div Neurosci, Portland, OR 97239 USA	Fike, JR (corresponding author), San Francisco Gen Hosp, Brain & Spinal Injury Ctr, Bldg 1 Rm 101,1001 Potrero Ave, San Francisco, CA 94140 USA.	john.fike@ucsf.edu		Eilertson, Kirsten/0000-0003-4850-1210	National Institute of General Medical Sciences/National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [K12GM081266]; National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R33 AI080531]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID) [R33AI080531] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [K12GM081266] Funding Source: NIH RePORTER	The research described was supported by award number K12GM081266 from the National Institute of General Medical Sciences/National Institutes of Health and National Institutes of Health (NIH) grant R33 AI080531.	Abayomi OK, 1996, ACTA ONCOL, V35, P659, DOI 10.3109/02841869609083995; Banisadr G, 2002, J NEUROCHEM, V81, P257, DOI 10.1046/j.1471-4159.2002.00809.x; Belarbi K, 2013, CANCER RES, V73, P1201, DOI 10.1158/0008-5472.CAN-12-2989; Bennett LD, 2011, IMMUNOLOGY, V134, P246, DOI 10.1111/j.1365-2567.2011.03485.x; Brody DL, 2007, J NEUROTRAUM, V24, P657, DOI 10.1089/neu.2006.0011; Chao NJ, 2007, EXP HEMATOL, V35, P24, DOI 10.1016/j.exphem.2007.01.008; Chin F. K. C., 2007, SMJ Singapore Medical Journal, V48, P950; CROSSEN JR, 1994, J CLIN ONCOL, V12, P627, DOI 10.1200/JCO.1994.12.3.627; d'Avila JC, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-31; Deshmane SL, 2009, J INTERF CYTOK RES, V29, P313, DOI 10.1089/jir.2008.0027; DiCarlo AL, 2008, RADIAT RES, V169, P712, DOI 10.1667/RR1295.1; Dragic T, 1996, NATURE, V381, P667, DOI 10.1038/381667a0; Dzenko KA, 2005, MICROVASC RES, V70, P53, DOI 10.1016/j.mvr.2005.04.005; Ekdahl CT, 2009, NEUROSCIENCE, V158, P1021, DOI 10.1016/j.neuroscience.2008.06.052; El Khoury J, 2007, NAT MED, V13, P432, DOI 10.1038/nm1555; Fan Y, 2007, EUR J NEUROSCI, V25, P38, DOI 10.1111/j.1460-9568.2006.05269.x; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Goser S, 2005, CIRCULATION, V112, P3400, DOI 10.1161/CIRCULATIONAHA.105.572396; Hesselgesser J, 1999, J NEUROVIROL, V5, P13, DOI 10.3109/13550289909029741; Jacob A, 2010, MOL MED, V16, P137, DOI 10.2119/molmed.2009.00154; Jaerve A, 2012, CELL TISSUE RES, V349, P229, DOI 10.1007/s00441-012-1427-3; Joo KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0025936; Kadhim Hazim J, 2008, J Intensive Care Med, V23, P236, DOI 10.1177/0885066608318458; Kernie SG, 2010, NEUROBIOL DIS, V37, P267, DOI 10.1016/j.nbd.2009.11.002; Kleindienst A, 2005, J NEUROTRAUM, V22, P645, DOI 10.1089/neu.2005.22.645; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Lu DY, 2007, J NEUROTRAUM, V24, P1132, DOI 10.1089/neu.2007.0288; Ma MH, 2002, J NEUROSCI RES, V68, P691, DOI 10.1002/jnr.10269; Madsen TM, 2003, NEUROSCIENCE, V119, P635, DOI 10.1016/S0306-4522(03)00199-4; Mannix Rebekah C, 2012, Int J Alzheimers Dis, V2012, P608732, DOI 10.1155/2012/608732; Manthous CA, 2007, CRIT CARE MED, V35, P716, DOI 10.1097/01.CCM.0000257328.31668.22; Marazziti D, 2012, CURR MED CHEM, V19, P1864, DOI 10.2174/092986712800099776; Mizumatsu S, 2003, CANCER RES, V63, P4021; Monje ML, 2003, CURR OPIN NEUROL, V16, P129, DOI 10.1097/00019052-200304000-00002; Monje ML, 2002, NAT MED, V8, P955, DOI 10.1038/nm749; Moser B, 2004, TRENDS IMMUNOL, V25, P75, DOI 10.1016/j.it.2003.12.005; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Naert G, 2011, J NEUROSCI, V31, P6208, DOI 10.1523/JNEUROSCI.0299-11.2011; Raber J, 2004, ANN NEUROL, V55, P381, DOI 10.1002/ana.10853; Raber J, 2004, RADIAT RES, V162, P39, DOI 10.1667/RR3206; Raber J, 2011, HIPPOCAMPUS, V21, P72, DOI 10.1002/hipo.20724; Raber J, 2010, TOXICOL PATHOL, V38, P198, DOI 10.1177/0192623309352003; Ransohoff RM, 2007, INT REV NEUROBIOL, V82, P187, DOI 10.1016/S0074-7742(07)82010-1; Rola R, 2004, RADIAT RES, V162, P442, DOI 10.1667/RR3234; Rola R, 2004, EXP NEUROL, V188, P316, DOI 10.1016/j.expneurol.2004.05.005; Rola R, 2007, FREE RADICAL BIO MED, V42, P1133, DOI 10.1016/j.freeradbiomed.2007.01.020; Rola R, 2006, EXP NEUROL, V202, P189, DOI 10.1016/j.expneurol.2006.05.034; Rosi S, 2005, J NEUROSCI, V25, P723, DOI 10.1523/JNEUROSCI.4469-04.2005; Rosi S, 2012, HIPPOCAMPUS, V22, P544, DOI 10.1002/hipo.20920; Saatman KE, 2006, J NEUROTRAUM, V23, P1241, DOI 10.1089/neu.2006.23.1241; Semple BD, 2010, J CEREBR BLOOD F MET, V30, P769, DOI 10.1038/jcbfm.2009.262; Semple BD, 2010, J CEREBR BLOOD F MET, V30, P459, DOI 10.1038/jcbfm.2009.240; Shi L, 2006, RADIAT RES, V166, P892, DOI 10.1667/RR0588.1; Smits HA, 2002, J NEUROIMMUNOL, V127, P160, DOI 10.1016/S0165-5728(02)00112-1; Stoll G, 1999, PROG NEUROBIOL, V58, P233, DOI 10.1016/S0301-0082(98)00083-5; Sun D, 2007, EXP NEUROL, V204, P264, DOI 10.1016/j.expneurol.2006.11.005; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; Tofilon PJ, 2000, RADIAT RES, V153, P357, DOI 10.1667/0033-7587(2000)153[0357:TROTCN]2.0.CO;2; Tran PB, 2007, J COMP NEUROL, V500, P1007, DOI 10.1002/cne.21229; van der Meer P, 2000, EXP MOL PATHOL, V69, P192, DOI 10.1006/exmp.2000.2336; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; Villasana L, 2006, RADIAT RES, V166, P883, DOI 10.1667/RR0642.1; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Yu SJ, 2009, BRAIN RES, V1287, P157, DOI 10.1016/j.brainres.2009.06.067	64	18	21	0	6	RADIATION RESEARCH SOC	LAWRENCE	810 E TENTH STREET, LAWRENCE, KS 66044 USA	0033-7587	1938-5404		RADIAT RES	Radiat. Res.	JUL	2013	180	1					78	88		10.1667/RR3344.1			11	Biology; Biophysics; Radiology, Nuclear Medicine & Medical Imaging	Life Sciences & Biomedicine - Other Topics; Biophysics; Radiology, Nuclear Medicine & Medical Imaging	AA3JD	WOS:000330987800009	23772926	Green Accepted			2021-06-18	
J	Brewer, BL; Diehl, AH; Johnson, LS; Salomone, JP; Wilson, KL; Atallah, HY; Feliciano, DV; Rozycki, GS				Brewer, Brian L.; Diehl, Albert H., III; Johnson, Laura S.; Salomone, Jeffrey P.; Wilson, Kenneth L.; Atallah, Hany Y.; Feliciano, David V.; Rozycki, Grace S.			Choice of motorcycle helmet makes a difference: A prospective observational study	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article; Proceedings Paper	26th Annual Scientific Assembly of the Eastern-Association-for-the-Surgery-of-Trauma	JAN 15-19, 2013	Scottsdale, AZ	Eastern Assoc Surg Trauma		Motorcycle; helmet; motorcycle collision; full-face helmet	FATAL INJURIES; RIDERS; IMPACT	BACKGROUND: Although many states mandate that motorcyclists wear helmets, their laws do not indicate which type of helmet should be used. In addition, there are no prospective studies in the literature evaluating patterns of injuries as they relate to helmet type. The hypothesis in this study was that full-face helmets (FFHs) reduce craniofacial injuries associated with motorcycle collisions when compared with other helmet types. METHODS: A prospective observational study was conducted at a Level I trauma center to evaluate the efficacy of helmet types relative to craniofacial injuries. Data included patient demographics, helmet types, injuries, and outcomes. The incidences of facial fractures, skull fractures, and traumatic brain injuries (TBIs) were compared in patients wearing FFHs versus other helmet types (OH) during motorcycle crashes. RESULTS: From 2011 to 2012, 151 patients of motorcycle crashes (135 males, 16 female; mean age, 38.4 years; range, 19-74 years) whose helmet types were identified by health care providers were entered into the study. The distribution of helmets was 84 FFH and 67 OH (39 half and 28 modular). Facial fractures were present in 7% of the patients wearing FFH (95% confidence interval, 0.015-0.125) versus 27% (95% confidence interval, 0.164-0.376) of those wearing OH (p = 0.004). In addition skull fractures were present in 1% of the patients wearing FFH versus 8% in those wearing OH(p < 0.05). While there was a trend for patients wearing FFH to have a lower incidence of TBI (13% vs. 25% in those wearing OH), this was not statistically significant (p = 0.053). There were no differences in Injury Severity Score (ISS), length of stay, or mortality between the two groups. CONCLUSION: Victims of motorcycle crashes who are wearing FFH have a significant reduction in facial and skull fractures when compared with those wearing OH. Further studies will be needed to assess whether FFH will significantly decrease the incidence of TBI. Copyright (C) 2013 by Lippincott Williams & Wilkins	[Brewer, Brian L.] Sinai Hosp, Dept Surg, Baltimore, MD 21215 USA; [Diehl, Albert H., III; Atallah, Hany Y.; Rozycki, Grace S.] Emory Univ, Sch Med, Dept Surg, Atlanta, GA 30322 USA; [Wilson, Kenneth L.] Morehouse Sch Med, Atlanta, GA 30310 USA; [Feliciano, David V.] Mercer Univ, Sch Med, Atlanta Med Ctr, Dept Surg, Atlanta, GA USA; [Johnson, Laura S.] Washington Hosp Ctr, Dept Surg, Washington, DC 20010 USA; [Salomone, Jeffrey P.] Univ Arizona Pheonix, Maricopa Med Ctr, Dept Surg, Phoenix, AZ USA	Brewer, BL (corresponding author), 2435 West Belvedere Ave, Baltimore, MD 21215 USA.	bbrewer@lifebridgehealth.org	Johnson, Laura S/ABE-5478-2020	Johnson, Laura S/0000-0001-6969-2648; Salomone, Jeffrey/0000-0002-1322-202X			Bledsoe GH, 2002, J TRAUMA, V53, P1078, DOI 10.1097/00005373-200212000-00009; Christian W Jay, 2003, J Ky Med Assoc, V101, P21; Croce MA, 2009, ANN SURG, V250, P390, DOI 10.1097/SLA.0b013e3181b365a2; Hitosugi M, 2004, AM J FOREN MED PATH, V25, P125, DOI 10.1097/01.paf.0000127397.67081.f5; Homer J, 2009, AM J PUBLIC HEALTH, V99, P415, DOI 10.2105/AJPH.2008.134106; Insurance Institute for Highway Safety, HIGHW SAF RES COMM; JOHNSON RM, 1995, J TRAUMA, V38, P876, DOI 10.1097/00005373-199506000-00008; Liu B. C., 2004, COCHRANE DB SYST REV; Mayrose J, 2008, J SAFETY RES, V39, P429, DOI 10.1016/j.jsr.2008.07.001; NHTSA, 2010, HSW811363 NHTSA DOT; NHTSA, 2008, MOT HELM US LAWS; O'Connor Peter J, 2005, Traffic Inj Prev, V6, P60, DOI 10.1080/15389580590903195; SARKAR S, 1995, J TRAUMA, V38, P242, DOI 10.1097/00005373-199502000-00017; SOSIN DM, 1990, JAMA-J AM MED ASSOC, V264, P2395, DOI 10.1001/jama.264.18.2395; TSAI YJ, 1995, AM J EPIDEMIOL, V142, P974, DOI 10.1093/oxfordjournals.aje.a117746	15	18	19	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	JUL	2013	75	1					88	91		10.1097/TA.0b013e3182988b59			4	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	300EV	WOS:000330448100023	23778444				2021-06-18	
J	Kim, JY; Kim, N; Yenari, MA; Chang, WH				Kim, Jong Youl; Kim, Nuri; Yenari, Midori A.; Chang, Wenhan			Hypothermia and Pharmacological Regimens that Prevent Overexpression and Overactivity of the Extracellular Calcium-Sensing Receptor Protect Neurons against Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						calcilytics; calcium-sensing receptor; CaSR; controlled cortical impact; extracellular calcium-sensing receptor; hypothermia, neuroprotection; traumatic brain injury; type B GABA receptor	CLOMETHIAZOLE ACUTE STROKE; OUTWARD K+ CHANNEL; EXPRESSION; SECRETION; IMPACT; CELLS	Traumatic brain injury (TBI) leads to acute functional deficit in the brain. Molecular events underlying TBI remain unclear. In mouse brains, we found controlled cortical impact (CCI) injury induced overexpression of the extracellular calcium-sensing receptor (CaSR), which is known to stimulate neuronal activity and accumulation of intracellular Ca2+ and concurrent down-regulation of type B or metabotropic GABA receptor 1 (GABA-B-R1), a prominent inhibitory pathway in the brain. These changes in protein expression preceded and were closely associated with the loss of brain tissue, as indicated by the increased size of cortical cavity at impact sites, and the development of motor deficit, as indicated by the increased frequency of right-biased swing and turn in the CCI mice. Mild hypothermia, an established practice of neuroprotection for brain ischemia, partially but significantly blunted all of the above effects of CCI. Administration of CaSR antagonist NPS89636 mimicked hypothermia to reduce loss of brain tissue and motor functions in the CCI mice. These data together support the concept that CaSR overexpression and overactivity play a causal role in potentiating TBI potentially by stimulating excitatory neuronal responses and by interfering with inhibitory GABA-B-R signaling and that the CaSR could be a novel target for neuroprotection against TBI.	[Kim, Jong Youl; Chang, Wenhan] Univ Calif San Francisco, Endocrine Unit, San Francisco, CA 94143 USA; [Kim, Jong Youl; Kim, Nuri; Yenari, Midori A.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA; Vet Affairs Med Ctr, San Francisco, CA 94121 USA	Chang, WH (corresponding author), Vet Affairs Med Ctr, Endocrine Unit 111N, 4150 Clement St, San Francisco, CA 94121 USA.	Yenari@alum.mit.edu; Wenhan.chang@alum.mit.edu			NIH NIAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [AG21353]; NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS40516, P50 NS014543]; Department of DefenseUnited States Department of Defense; Department of Veterans AffairsUS Department of Veterans Affairs; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS014543, R01NS040516] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG021353] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [I01BX001960] Funding Source: NIH RePORTER	We thank Dr. Edward Nemeth for providing the invaluable NPS89636 compound for this study. This work was supported by grants from: NIH NIA (AG21353 to WC), NINDS (NS40516, P50 NS014543 to MAY), the Department of Defense (WC, MAY), and Department of Veterans Affairs (WC, MAY).	Bandyopadhyay S, 2007, J NEUROSCI RES, V85, P882, DOI 10.1002/jnr.21177; BORLONGAN CV, 1995, J NEUROSCI, V15, P5372; Chang EF, 2003, J NEUROSCI, V23, P3689; Chang WH, 2007, J BIOL CHEM, V282, P25030, DOI 10.1074/jbc.M700924200; Chang WH, 2004, CELL CALCIUM, V35, P183, DOI 10.1016/j.ceca.2003.10.012; Chattopadhyay N, 1999, GLIA, V26, P64, DOI 10.1002/(SICI)1098-1136(199903)26:1<64::AID-GLIA7>3.0.CO;2-X; Chattopadhyay N, 1999, J NEUROCHEM, V72, P1915, DOI 10.1046/j.1471-4159.1999.0721915.x; Chattopadhyay N, 2007, AM J PHYSIOL-ENDOC M, V292, pE523, DOI 10.1152/ajpendo.00372.2005; Davies SL, 2007, J BIOL CHEM, V282, P15048, DOI 10.1074/jbc.M607469200; Davies SL, 2006, AM J PHYSIOL-CELL PH, V290, pC1543, DOI 10.1152/ajpcell.00482.2005; DeLorenzo RJ, 2005, PHARMACOL THERAPEUT, V105, P229, DOI 10.1016/j.pharmthera.2004.10.004; Dietrich WD, 2010, NEUROTHERAPEUTICS, V7, P43, DOI 10.1016/j.nurt.2009.10.015; Dixon CE, 1998, J NEUROTRAUM, V15, P95, DOI 10.1089/neu.1998.15.95; Dvorak MM, 2004, P NATL ACAD SCI USA, V101, P5140, DOI 10.1073/pnas.0306141101; FAROOQUI AA, 1994, J NEUROSCI RES, V38, P6, DOI 10.1002/jnr.490380103; Gilby KL, 2005, BRAIN RES, V1035, P196, DOI 10.1016/j.brainres.2004.12.015; Kim J.Y., 2011, 41 SOC NEUR ANN M WA; Kim JY, 2011, TRANSL STROKE RES, V2, P195, DOI 10.1007/s12975-011-0082-4; Kumar S, 2010, BONE, V46, P534, DOI 10.1016/j.bone.2009.09.028; Lyden P, 2002, STROKE, V33, P122, DOI 10.1161/hs0102.101478; Lyden P, 2001, NEUROLOGY, V57, P1199, DOI 10.1212/WNL.57.7.1199; Munoz A, 2002, J COMP NEUROL, V449, P166, DOI 10.1002/cne.10287; Potts MB, 2009, CEREBELLUM, V8, P211, DOI 10.1007/s12311-009-0114-8; Povlishock JT, 2009, J NEUROTRAUM, V26, P333, DOI 10.1089/neu.2008.0604; Shah MP, 2011, STROKE RES TREAT, V2011, DOI 10.4061/2011/791639; Sun JH, 2010, AM J PHYSIOL-HEART C, V299, pH1309, DOI 10.1152/ajpheart.00373.2010; Tang MN, 2007, J NUCL MED, V48, P1822, DOI 10.2967/jnumed.107.041335; Vizard TN, 2008, NAT NEUROSCI, V11, P285, DOI 10.1038/nn2044; Wahlgren N G, 2000, J Stroke Cerebrovasc Dis, V9, P32, DOI 10.1053/jscd.2000.19320; Wahlgren NG, 1999, STROKE, V30, P21, DOI 10.1161/01.STR.30.1.21; Washburn DLS, 1999, EUR J NEUROSCI, V11, P1947, DOI 10.1046/j.1460-9568.1999.00619.x; Yano S, 2004, CELL CALCIUM, V35, P257, DOI 10.1016/j.ceca.2003.10.008; Ye CP, 2000, BONE, V27, P21, DOI 10.1016/S8756-3282(00)00288-X; Yenari MA, 2000, BRAIN RES, V885, P208, DOI 10.1016/S0006-8993(00)02942-5; YOUNG W, 1992, J NEUROTRAUM, V9, pS9	35	18	20	1	7	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL	2013	30	13					1170	1176		10.1089/neu.2012.2691			7	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	174WB	WOS:000321186400008	23360235	Green Published			2021-06-18	
J	Leung, LY; Wei, G; Shear, DA; Tortella, FC				Leung, Lai Yee; Wei, Guo; Shear, Deborah A.; Tortella, Frank C.			The Acute Effects of Hemorrhagic Shock on Cerebral Blood Flow, Brain Tissue Oxygen Tension, and Spreading Depolarization following Penetrating Ballistic-Like Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						brain tissue oxygen tension; cerebral blood flow; cortical spreading depolarization; hemorrhagic shock; traumatic brain injury	SEVERE HEAD-INJURY; SUBARACHNOID HEMORRHAGE; INTRACRANIAL-PRESSURE; PERFUSION-PRESSURE; SECONDARY INSULTS; NITRIC-OXIDE; DEPRESSION; MODEL; HYPOTENSION; DAMAGE	Traumatic brain injury (TBI) often occurs in conjunction with additional trauma, resulting in secondary complications, such as hypotension as a result of blood loss. This study investigated the combined effects of penetrating ballistic-like brain injury (PBBI) and hemorrhagic shock (HS) on physiological parameters, including acute changes in regional cerebral blood flow (rCBF), brain tissue oxygen tension (PbtO2), and cortical spreading depolarizations (CSDs). All recordings were initiated before injury (PBBI/HS/both) and maintained for 2.5 h. Results showed that PBBI alone and combined PBBI and HS produced a sustained impairment of ipsilateral rCBF that decreased by 70% from baseline (p < 0.05). Significant and sustained reductions in PbtO2 (50% baseline; p < 0.05) were also observed in the injured hemisphere of the animals subjected to both PBBI and HS (PBBI + HS). In contrast, PBBI alone produced smaller, more transient reductions in PbtO2 levels. The lower limit of cerebral autoregulation was significantly higher in the PBBI + HS group (p < 0.05, compared to HS alone). Critically, combined injury resulted in twice the number of spontaneous CSDs as in PBBI alone (p < 0.05). It also lowered the propagation speed of CSD and the threshold of CSD occurrence [induced CSD at higher mean arterial pressure (MAP)]. However, rCBF and PbtO2 were not responsive to the depolarizations. Our data suggest that PBBI together with HS causes persistent impairment of CBF and brain tissue oxygen tension, increasing the probability of CSDs that likely contribute to secondary neuropathology and compromise neurological recovery.	[Leung, Lai Yee; Wei, Guo; Shear, Deborah A.; Tortella, Frank C.] Walter Reed Army Inst Res, Brain Trauma Neuroprotect & Neurorestorat Branch, Ctr Mil Psychiat & Neurosci, Silver Spring, MD 20910 USA	Leung, LY (corresponding author), Walter Reed Army Inst Res, Brain Trauma Neuroprotect & Neurorestorat Branch, Ctr Mil Psychiat & Neurosci, 503 Robert Grant Ave,2W12, Silver Spring, MD 20910 USA.	laiyee.leung@us.army.mil	Leung, Lai Yee/H-8204-2013		Combat Casualty Care Research ProgramUnited States Department of Defense; U.S. Army Medical Research and Materiel CommandU.S. Army Medical Research & Materiel Command (USAMRMC); National Research Council Research Associateship Program (National Academy of Sciences, Washington, DC)	The views of the authors do not purport or reflect the position of the Department of the Army or the Department of Defense (para 4-3, AR 360-5). This research is funded by the Combat Casualty Care Research Program, U.S. Army Medical Research and Materiel Command. The primary author is sponsored by the National Research Council Research Associateship Program (National Academy of Sciences, Washington, DC). The authors thank Dr. Jed A. Hartings (University of Cincinnati, Cincinnati, OH) for his valuable advice on cortical spreading depolarization and SPC Shawn McLoughlin and Ms. Xiaofang Yang for their technical support.	Ayata C, 2000, NEUROSCIENCE, V95, P639; BARRIOT P, 1987, INTENS CARE MED, V13, P203; Cherian L, 2004, BRAIN PATHOL, V14, P195, DOI 10.1111/j.1750-3639.2004.tb00053.x; CLIFTON GL, 1983, J NEUROSURG, V59, P447, DOI 10.3171/jns.1983.59.3.0447; De Fusco M, 2003, NAT GENET, V33, P192, DOI 10.1038/ng1081; Dreier JP, 2011, NAT MED, V17, P439, DOI 10.1038/nm.2333; Dreier JP, 2009, BRAIN, V132, P1866, DOI 10.1093/brain/awp102; Dreier JP, 2000, J NEUROSURG, V93, P658, DOI 10.3171/jns.2000.93.4.0658; Engelborghs K, 2000, J NEUROTRAUM, V17, P667, DOI 10.1089/089771500415418; Hartings JA, 2006, J CEREBR BLOOD F MET, V26, P696, DOI 10.1038/sj.jcbfm.9600223; Hartings JA, 2011, LANCET NEUROL, V10, P1058, DOI 10.1016/S1474-4422(11)70243-5; Hartings JA, 2011, BRAIN, V134, P1529, DOI 10.1093/brain/awr048; Hartings JA, 2009, J NEUROTRAUM, V26, P1857, DOI [10.1089/neu.2009.0961, 10.1089/neu.2009-0961]; Hellmich HL, 2005, ANESTHESIOLOGY, V102, P806, DOI 10.1097/00000542-200504000-00017; Jordan BD, 2007, NEUROCHEM RES, V32, P905, DOI 10.1007/s11064-006-9251-3; Kawase M, 2000, CAN J ANAESTH, V47, P807, DOI 10.1007/BF03019486; Lammie GA, 1999, J NEUROTRAUM, V16, P603, DOI 10.1089/neu.1999.16.603; Lauritzen M, 2011, J CEREBR BLOOD F MET, V31, P17, DOI 10.1038/jcbfm.2010.191; Liebetanz D, 2006, NEUROSCI LETT, V398, P85, DOI 10.1016/j.neulet.2005.12.058; MARSHALL WH, 1959, PHYSIOL REV, V39, P239; Matsushita Y, 2001, J CEREBR BLOOD F MET, V21, P847, DOI 10.1097/00004647-200107000-00010; McMahon CG, 2008, CRIT CARE MED, V36, P216, DOI 10.1097/01.CCM.0000295425.41831.85; Merkler D, 2009, ANN NEUROL, V66, P355, DOI 10.1002/ana.21746; MURR R, 1993, ANESTH ANALG, V77, P898; Mytar J, 2012, NEUROSURGERY, V71, P138, DOI 10.1227/NEU.0b013e318251795a; Peitzman A B, 1995, Curr Probl Surg, V32, P925, DOI 10.1016/S0011-3840(05)80008-5; Petzold GC, 2008, STROKE, V39, P1292, DOI 10.1161/STROKEAHA.107.500710; Rogatsky GG, 2003, J NEUROTRAUM, V20, P1315, DOI 10.1089/089771503322686111; Sarrafzadeh AS, 2001, CRIT CARE MED, V29, P1116, DOI 10.1097/00003246-200106000-00004; Schmidt EA, 2003, J NEUROSURG, V99, P991, DOI 10.3171/jns.2003.99.6.0991; Schutz C, 2006, CRIT CARE MED, V34, P492, DOI 10.1097/01.CCM.0000198326.32049.7F; Statler KD, 2001, J NEUROTRAUM, V18, P1195, DOI 10.1089/089771501317095232; Strong AJ, 2002, STROKE, V33, P2738, DOI 10.1161/01.STR.0000043073.69602.09; Sukhotinsky I, 2010, J CEREBR BLOOD F MET, V30, P1168, DOI 10.1038/jcbfm.2009.285; THIBAULT LE, 1992, J NEUROTRAUM, V9, P311, DOI 10.1089/neu.1992.9.311; Trabold R, 2006, BRAIN RES, V1071, P237, DOI 10.1016/j.brainres.2005.11.095; von Baumgarten L, 2008, J CEREBR BLOOD F MET, V28, P1353, DOI 10.1038/jcbfm.2008.30; Wei G, 2010, J NEUROTRAUM, V27, P1635, DOI 10.1089/neu.2010.1378; White H, 2008, ANESTH ANALG, V107, P979, DOI 10.1213/ane.0b013e31817e7b1a; Williams AJ, 2005, J NEUROTRAUM, V22, P313, DOI 10.1089/neu.2005.22.313; Williams AJ, 2006, J NEUROTRAUM, V23, P1828, DOI 10.1089/neu.2006.23.1828; YUAN XQ, 1992, SURG GYNECOL OBSTET, V174, P305; Zaharchuk G, 1999, STROKE, V30, P2197, DOI 10.1161/01.STR.30.10.2197; Zauner A., 1997, HEAD INJURY	44	18	18	0	9	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	JUL	2013	30	14					1288	1298		10.1089/neu.2012.2715			11	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	183MV	WOS:000321821100009	23461630				2021-06-18	
J	Schoch, KM; von Reyn, CR; Bian, JF; Telling, GC; Meaney, DF; Saatman, KE				Schoch, Kathleen M.; von Reyn, Catherine R.; Bian, Jifeng; Telling, Glenn C.; Meaney, David F.; Saatman, Kathryn E.			Brain injury-induced proteolysis is reduced in a novel calpastatin-overexpressing transgenic mouse	JOURNAL OF NEUROCHEMISTRY			English	Article						calcium; calpain; CRMP-2; protease; sodium channel; spectrin	ALPHA-II-SPECTRIN; CALPAIN-MEDIATED PROTEOLYSIS; BREAKDOWN PRODUCTS; NEURITE OUTGROWTH; PROTEIN-2 CRMP2; PRION PROTEIN; INHIBITOR; MICE; NEURODEGENERATION; CLEAVAGE	The calpain family of calcium-dependent proteases has been implicated in a variety of diseases and neurodegenerative pathologies. Prolonged activation of calpains results in proteolysis of numerous cellular substrates including cytoskeletal components and membrane receptors, contributing to cell demise despite coincident expression of calpastatin, the specific inhibitor of calpains. Pharmacological and gene-knockout strategies have targeted calpains to determine their contribution to neurodegenerative pathology; however, limitations associated with treatment paradigms, drug specificity, and genetic disruptions have produced inconsistent results and complicated interpretation. Specific, targeted calpain inhibition achieved by enhancing endogenous calpastatin levels offers unique advantages in studying pathological calpain activation. We have characterized a novel calpastatin-overexpressing transgenic mouse model, demonstrating a substantial increase in calpastatin expression within nervous system and peripheral tissues and associated reduction in protease activity. Experimental activation of calpains via traumatic brain injury resulted in cleavage of -spectrin, collapsin response mediator protein-2, and voltage-gated sodium channel, critical proteins for the maintenance of neuronal structure and function. Calpastatin overexpression significantly attenuated calpain-mediated proteolysis of these selected substrates acutely following severe controlled cortical impact injury, but with no effect on acute hippocampal neurodegeneration. Augmenting calpastatin levels may be an effective method for calpain inhibition in traumatic brain injury and neurodegenerative disorders.	[Schoch, Kathleen M.; Saatman, Kathryn E.] Univ Kentucky, Coll Med, Spinal Cord & Brain Injury Res Ctr, Lexington, KY 40536 USA; [Schoch, Kathleen M.; Saatman, Kathryn E.] Univ Kentucky, Coll Med, Dept Physiol, Lexington, KY 40536 USA; [von Reyn, Catherine R.; Meaney, David F.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA; [von Reyn, Catherine R.] Janelia Farm Res Campus HHMI, Ashburn, VA USA; [Bian, Jifeng; Telling, Glenn C.] Colorado State Univ, PRC, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA	Saatman, KE (corresponding author), Univ Kentucky, Spinal Cord & Brain Injury Res Ctr SCoBIRC, B473 Biomed & Biol Sci Res Bldg BBSRB,741 South L, Lexington, KY 40536 USA.	k.saatman@uky.edu	Telling, Glenn C/G-1217-2019; Bian, Jifeng/AAE-6262-2019	Telling, Glenn C/0000-0002-6294-1805; Bian, Jifeng/0000-0001-6838-9938; von Reyn, Catherine/0000-0002-5753-2134; Meaney, David/0000-0002-0954-4122	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [F31 NS071804, T32 DA0222738, P30 NS051220, P01 NS058484, P01 NS056202]; Kentucky Spinal Cord and Head Injury Research Trust (KSCHIRT) [6-12]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS056202, F31NS071804, P01NS058484, P30NS051220] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [T32DA022738] Funding Source: NIH RePORTER	This work was funded by NIH grants F31 NS071804 (KMS), T32 DA0222738 (KMS), P30 NS051220, P01 NS058484 (KES), and P01 NS056202 (DFM), and Kentucky Spinal Cord and Head Injury Research Trust (KSCHIRT) 6-12 (KES). The authors have no conflicts of interest.	Anagli J, 2009, BIOCHEM BIOPH RES CO, V385, P94, DOI 10.1016/j.bbrc.2009.04.141; Angers RC, 2009, EMERG INFECT DIS, V15, P696, DOI 10.3201/eid1505.081458; Barmada S, 2004, NEUROBIOL DIS, V16, P527, DOI 10.1016/j.nbd.2004.05.005; Borchelt DR, 1996, GENET ANAL-BIOMOL E, V13, P159, DOI 10.1016/S1050-3862(96)00167-2; Bretin S, 2006, J NEUROCHEM, V98, P1252, DOI 10.1111/j.1471-4159.2006.03969.x; Brittain JM, 2011, J BIOL CHEM, V286, P37778, DOI 10.1074/jbc.M111.255455; Brittain JM, 2009, J BIOL CHEM, V284, P31375, DOI 10.1074/jbc.M109.009951; Camins A, 2006, CNS DRUG REV, V12, P135, DOI 10.1111/j.1527-3458.2006.00135.x; Carragher NO, 2006, CURR PHARM DESIGN, V12, P615, DOI 10.2174/138161206775474314; Deng Y, 2007, EXP NEUROL, V205, P154, DOI 10.1016/j.expneurol.2007.01.023; Fukata Y, 2002, NAT CELL BIOL, V4, P583, DOI 10.1038/ncb825; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Higuchi M, 2005, J BIOL CHEM, V280, P15229, DOI 10.1074/jbc.M500939200; Institute of Laboratory Animal Resources (US), 2011, COMM CAR US LAB AN G; Iwata A, 2004, J NEUROSCI, V24, P4605, DOI 10.1523/JNEUROSCI.0515-03.2004; Kampfl A, 1996, J NEUROCHEM, V67, P1575; Kupina NC, 2001, J NEUROTRAUM, V18, P1229, DOI 10.1089/089771501317095269; Li AM, 2007, EMBO J, V26, P548, DOI 10.1038/sj.emboj.7601507; MAKI M, 1987, FEBS LETT, V223, P174, DOI 10.1016/0014-5793(87)80531-8; McCollum AT, 2006, EXP NEUROL, V202, P506, DOI 10.1016/j.expneurol.2006.07.016; Moldoveanu T, 2008, NATURE, V456, P404, DOI 10.1038/nature07353; Mondello S, 2010, J NEUROTRAUM, V27, P1203, DOI 10.1089/neu.2010.1278; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Pike BR, 2001, J NEUROCHEM, V78, P1297, DOI 10.1046/j.1471-4159.2001.00510.x; Pike BR, 1998, NEUROREPORT, V9, P2437, DOI 10.1097/00001756-199808030-00002; Pleasant JM, 2011, J NEUROTRAUM, V28, P2245, DOI 10.1089/neu.2010.1499; Posmantur R, 1997, NEUROSCIENCE, V77, P875, DOI 10.1016/S0306-4522(96)00483-6; Quinn CC, 1999, J NEUROBIOL, V41, P158, DOI 10.1002/(SICI)1097-4695(199910)41:1<158::AID-NEU19>3.3.CO;2-S; Quinn CC, 2003, J NEUROSCI, V23, P2815; Rahajeng J, 2010, J BIOL CHEM, V285, P31918, DOI 10.1074/jbc.C110.166066; Rao MV, 2008, J NEUROSCI, V28, P12241, DOI 10.1523/JNEUROSCI.4119-08.2008; Ringger NC, 2004, J NEUROTRAUM, V21, P1443, DOI 10.1089/neu.2004.21.1443; Saatman KE, 2010, NEUROTHERAPEUTICS, V7, P31, DOI 10.1016/j.nurt.2009.11.002; Saatman KE, 1996, J NEUROPATH EXP NEUR, V55, P850, DOI 10.1097/00005072-199607000-00010; Saatman KE, 2000, J CEREBR BLOOD F MET, V20, P66, DOI 10.1097/00004647-200001000-00010; Sato K, 2011, J NEUROCHEM, V117, P504, DOI 10.1111/j.1471-4159.2011.07222.x; Schoch KM, 2012, EXP NEUROL, V236, P371, DOI 10.1016/j.expneurol.2012.04.022; Sorimachi H, 2011, P JPN ACAD B-PHYS, V87, P287, DOI 10.2183/pjab.87.287; Taghian K, 2012, J NEUROTRAUM, V29, P1728, DOI 10.1089/neu.2011.2063; Thompson SN, 2010, J NEUROTRAUM, V27, P2233, DOI 10.1089/neu.2010.1474; Touma E, 2007, EUR J NEUROSCI, V26, P3368, DOI 10.1111/j.1460-9568.2007.05943.x; von Reyn CR, 2012, J NEUROCHEM, V121, P793, DOI 10.1111/j.1471-4159.2012.07735.x; von Reyn CR, 2009, J NEUROSCI, V29, P10350, DOI 10.1523/JNEUROSCI.2339-09.2009; WESTENBROEK RE, 1989, NEURON, V3, P695, DOI 10.1016/0896-6273(89)90238-9; Wilson SM, 2012, NEUROSCIENCE, V210, P451, DOI 10.1016/j.neuroscience.2012.02.038; Yuen TJ, 2009, J NEUROSCI RES, V87, P3620, DOI 10.1002/jnr.22161; Zhang ZQ, 2007, J NEUROTRAUM, V24, P460, DOI 10.1089/neu.2006.0078; Zhang ZQ, 2009, APOPTOSIS, V14, P1289, DOI 10.1007/s10495-009-0405-z	48	18	18	0	6	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3042			J NEUROCHEM	J. Neurochem.	JUN	2013	125	6					909	920		10.1111/jnc.12144			12	Biochemistry & Molecular Biology; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	159JM	WOS:000320041700011	23305291	Green Accepted			2021-06-18	
J	Megha, M; Harpreet, S; Nayeem, Z				Megha, M.; Harpreet, S.; Nayeem, Z.			Effect of frequency of multimodal coma stimulation on the consciousness levels of traumatic brain injury comatose patients	BRAIN INJURY			English	Article						Brain Injury; Western Neuro Sensory Stimulation Profile; Glasgow Coma Scale	SEVERE HEAD-INJURY; VEGETATIVE STATE; SENSORY STIMULATION; REHABILITATION; INDIVIDUALS; DYSFUNCTION; PARAMETERS; RECOVERY; ONSET	Objectives: To evaluate the effectiveness of multimodal coma stimulation on the conscious levels of head injury comatose patients and to find out which of the two protocols of coma stimulation, i.e. administrating twice a day or 5-times a day is more beneficial. Methods: Thirty comatose patients with traumatic head injury (GCS<8) were selected and were divided into three groups randomly. Group A (n=10) received multimodal coma stimulation 5-times a day (20 minutes each session), Group B (n=10) received stimulation twice a day (50 minutes each session) and Group C (n=10) received conventional physiotherapy twice daily. Subjects in all the three groups received treatment for 2 weeks. Results and conclusion: The results showed a significant difference (p<0.01) for Glasgow Coma Scale as well as Western Neuro Sensory Stimulation Profile scores between Groups A & C and B & C, i.e. multimodal coma stimulation is effective as compared to the control group. The results also revealed a significant difference (p<0.01) between Groups A, B and C on the Western Neuro Sensory Stimulation Profile but a non-significant difference (p>0.01) on the Glasgow coma scale. This indicates that short sessions of high frequency can be more beneficial.	[Megha, M.; Nayeem, Z.] Hamdard Univ, MPT Neurol, New Delhi, India; [Harpreet, S.] AIIMS, MPT Neurol, New Delhi, India	Nayeem, Z (corresponding author), Hamdard Univ, Dept Rehabil Sci, New Delhi, India.	naya_bpt@yahoo.co.in					Andrews K, 1996, BRAIN INJURY, V10, P797, DOI 10.1080/026990596123918; ANSELL BJ, 1989, ARCH PHYS MED REHAB, V70, P104; ANSELL BJ, 1991, J SPEECH HEAR RES, V34, P1017, DOI 10.1044/jshr.3405.1017; Arciniegas D, 1999, BRAIN INJURY, V13, P1, DOI 10.1080/026990599121827; Belayev A, 2003, BRAIN RES, V964, P121, DOI 10.1016/S0006-8993(02)04089-1; Brimioulle S, 1997, PHYS THER, V77, P1682, DOI 10.1093/ptj/77.12.1682; COPE DN, 1982, ARCH PHYS MED REHAB, V63, P433; Dettmers C, 2005, ARCH PHYS MED REHAB, V86, P204, DOI 10.1016/j.apmr.2004.05.007; Duff D L, 1997, J Neurosci Nurs, V29, P305; Gerber CS, 2005, CRIT CARE NURS Q, V28, P94, DOI 10.1097/00002727-200504000-00002; Gruner ML, 2000, BRAIN INJURY, V14, P585; Gururaj G, 2002, NEUROL RES, V24, P24, DOI 10.1179/016164102101199503; JOHNSON DA, 1993, BRAIN INJURY, V7, P491, DOI 10.3109/02699059309008176; JONES R, 1994, ARCH PHYS MED REHAB, V75, P164; Karma D, 2006, INDIAN PEDIATR, V43, P856; Kater K M, 1989, West J Nurs Res, V11, P20, DOI 10.1177/019394598901100103; Keller I, 2007, FUNCT NEUROL, V22, P159; Kleim JA, 2008, J SPEECH LANG HEAR R, V51, pS225, DOI 10.1044/1092-4388(2008/018); LEWINN EB, 1978, LANCET, V2, P156; LEWINN EB, 1980, ROY SOC HEALTH J, V100, P19, DOI 10.1177/146642408010000107; Lombardi F, 2002, CLIN REHABIL, V16, P464, DOI 10.1191/0269215502cr519oa; MACKAY LE, 1992, ARCH PHYS MED REHAB, V73, P635; Maegele M, 2005, J NEUROTRAUM, V22, P772, DOI 10.1089/neu.2005.22.772; MALKMUS D, 1983, PHYS THER, V63, P1952, DOI 10.1093/ptj/63.12.1952; MITCHELL S, 1990, Brain Injury, V4, P273, DOI 10.3109/02699059009026177; Moulton CAE, 2006, ANN SURG, V244, P400, DOI 10.1097/01.sla.0000234808.85789.6a; Oh H, 2003, J CLIN NURS, V12, P394, DOI 10.1046/j.1365-2702.2003.00750.x; Perrin F, 2006, ARCH NEUROL-CHICAGO, V63, P562, DOI 10.1001/archneur.63.4.562; PIERCE J P, 1990, Brain Injury, V4, P191, DOI 10.3109/02699059009026165; Rader M A, 1989, Brain Inj, V3, P141, DOI 10.3109/02699058909004545; Seabrook R, 2005, APPL COGNITIVE PSYCH, V19, P107, DOI 10.1002/acp.1066; Sullivan TE, 1998, J CLIN EXP NEUROPSYC, V20, P227, DOI 10.1076/jcen.20.2.227.1175; WILSON S L, 1991, Brain Injury, V5, P393, DOI 10.3109/02699059109008112; Wilson SL, 1996, BRAIN INJURY, V10, P509, DOI 10.1080/026990596124223; Wood R L, 1992, Brain Inj, V6, P411, DOI 10.3109/02699059209008137; WOOD R L, 1991, Brain Injury, V5, P401, DOI 10.3109/02699059109008113	36	18	19	0	31	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	MAY	2013	27	5					570	577		10.3109/02699052.2013.767937			8	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	124UK	WOS:000317493000007	23473238				2021-06-18	
J	Robertson, CS; Garcia, R; Gaddam, SSK; Grill, RJ; Hand, CC; Tian, TS; Hannay, HJ				Robertson, Claudia S.; Garcia, Robert; Gaddam, Samson Sujit Kumar; Grill, Raymond J.; Hand, Carla Cerami; Tian, Tian Siva; Hannay, H. Julia			Treatment of Mild Traumatic Brain Injury with an Erythropoietin-Mimetic Peptide	JOURNAL OF NEUROTRAUMA			English	Article						adult brain injury; traumatic brain injury; treatment strategies for traumatic brain injury	RECOMBINANT-HUMAN-ERYTHROPOIETIN; LATERAL FLUID PERCUSSION; ENHANCES NEUROGENESIS; BEHAVIORAL DEFICITS; NEURONAL APOPTOSIS; CEREBRAL-ISCHEMIA; 3D STRUCTURE; RATS; MODEL; NEUROPROTECTION	Mild traumatic brain injury (mTBI) results in an estimated 75-90% of the 1.7 million TBI-related emergency room visits each year. Post-concussion symptoms, which can include impaired memory problems, may persist for prolonged periods of time in a fraction of these cases. The purpose of this study was to determine if an erythropoietin-mimetic peptide, pyroglutamate helix B surface peptide (pHBSP), would improve neurological outcomes following mTBI. Sixty-four rats were randomly assigned to pHBSP or control (inactive peptide) 30 mu g/kg IP every 12 h for 3 days, starting at either 1 hour (early treatment) or 24 h (delayed treatment), after mTBI (cortical impact injury 3 m/sec, 2.5mm deformation). Treatment with pHBSP resulted in significantly improved performance on the Morris water maze task. Rats that received pHBSP required 22.3 +/- 1.3 sec to find the platform, compared to 26.3 +/- 1.3 sec in control rats (p = 0.022). The rats that received pHBSP also traveled a significantly shorter distance to get to the platform, 5.0 +/- 0.3 meters, compared to 6.1 +/- 0.3 meters in control rats (p = 0.019). Motor tasks were only transiently impaired in this mTBI model, and no treatment effect on motor performance was observed with pHBSP. Despite the minimal tissue injury with this mTBI model, there was significant activation of inflammatory cells identified by labeling with CD68, which was reduced in the pHBSP-treated animals. The results suggest that pHBSP may improve cognitive function following mTBI.	[Robertson, Claudia S.; Garcia, Robert; Gaddam, Samson Sujit Kumar] Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA; [Grill, Raymond J.] Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol & Pharmacol, Houston, TX USA; [Hand, Carla Cerami] Univ N Carolina, Dept Epidemiol, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA; [Tian, Tian Siva; Hannay, H. Julia] Univ Houston, Dept Psychol, Houston, TX USA	Robertson, CS (corresponding author), Baylor Coll Med, Dept Neurosurg, 1 Baylor Plaza, Houston, TX 77030 USA.	claudiar@bcm.edu		Hannay, H. Julia/0000-0001-7023-912X; Cerami, Carla/0000-0002-7634-0955	U.S. Army Award [W81XWH-08-2-0132, W81XWH-08-2-0150]	This work was funded by U.S. Army Award numbers W81XWH-08-2-0132 (C.S.R.) and W81XWH-08-2-0150 (R.J.G.).	Ahmet I, 2011, MOL MED, V17, P194, DOI 10.2119/molmed.2010.00235; Atalay B, 2007, BRIT J NEUROSURG, V21, P281, DOI 10.1080/02688690701364781; Atalay B, 2008, TURK NEUROSURG, V18, P356; Baki SGA, 2009, BRAIN RES, V1280, P98, DOI 10.1016/j.brainres.2009.05.034; Baratz R, 2011, J NEUROCHEM, V118, P1032, DOI 10.1111/j.1471-4159.2011.07377.x; Bian XX, 2010, NEUROL MED-CHIR, V50, P361, DOI 10.2176/nmc.50.361; Brines M, 2004, P NATL ACAD SCI USA, V101, P14907, DOI 10.1073/pnas.0406491101; Brines M, 2008, P NATL ACAD SCI USA, V105, P10925, DOI 10.1073/pnas.0805594105; Brines ML, 2000, P NATL ACAD SCI USA, V97, P10526, DOI 10.1073/pnas.97.19.10526; Chen G, 2007, NEUROSCI LETT, V425, P177, DOI 10.1016/j.neulet.2007.08.022; Cherian L, 2007, J PHARMACOL EXP THER, V322, P789, DOI 10.1124/jpet.107.119628; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd; Costa T, 2010, J NEUROSCI RES, V88, P1329, DOI 10.1002/jnr.22300; Drude S, 2011, LAB ANIMAL, V40, P119, DOI 10.1038/laban0411-119; Ferguson CJ, 2009, PROF PSYCHOL-RES PR, V40, P532, DOI 10.1037/a0015808; Fujiki M, 2008, J CLIN NEUROSCI, V15, P791, DOI 10.1016/j.jocn.2007.07.002; Hallam TM, 2004, J NEUROTRAUM, V21, P521, DOI 10.1089/089771504774129865; Hamm RJ, 2001, J NEUROTRAUM, V18, P1207, DOI 10.1089/089771501317095241; Haselkorn ML, 2010, J NEUROTRAUM, V27, P901, DOI 10.1089/neu.2009.1075; Kline AE, 2002, J NEUROTRAUM, V19, P415, DOI 10.1089/08977150252932370; Leist M, 2004, SCIENCE, V305, P239, DOI 10.1126/science.1098313; Lieutaud T, 2008, J NEUROTRAUM, V25, P1179, DOI 10.1089/neu.2008.0591; Livingstone SA, 2007, BEHAV BRAIN RES, V185, P21, DOI 10.1016/j.bbr.2007.07.015; Lu DY, 2005, J NEUROTRAUM, V22, P1011, DOI 10.1089/neu.2005.22.1011; Marti HH, 2000, NEWS PHYSIOL SCI, V15, P225; McVicar CM, 2011, DIABETES, V60, P2995, DOI 10.2337/db11-0026; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Milman A, 2008, EUR NEUROPSYCHOPHARM, V18, P181, DOI 10.1016/j.euroneuro.2007.05.007; Miskowiak K, 2008, EXP BRAIN RES, V184, P313, DOI 10.1007/s00221-007-1102-1; Miskowiak K, 2007, J NEUROSCI, V27, P2788, DOI 10.1523/JNEUROSCI.5013-06.2007; Patel AD, 2010, J NEUROPATH EXP NEUR, V69, P1177, DOI 10.1097/NEN.0b013e3181fbf6d6; Patel NSA, 2011, MOL MED, V17, P883, DOI 10.2119/molmed.2011.00053; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Pickett JL, 1999, AM J KIDNEY DIS, V33, P1122, DOI 10.1016/S0272-6386(99)70150-2; Ray B, 2011, NEUROSCIENCE, V184, P139, DOI 10.1016/j.neuroscience.2011.03.067; Robertson CS, 2012, J NEUROTRAUM, V29, P1156, DOI 10.1089/neu.2011.1827; Rubovitch V, 2010, NEUROBIOL DIS, V38, P299, DOI 10.1016/j.nbd.2010.01.021; Schmidt RH, 2000, J NEUROTRAUM, V17, P1129, DOI 10.1089/neu.2000.17.1129; Seeger N, 2011, EPILEPSIA, V52, P2333, DOI 10.1111/j.1528-1167.2011.03302.x; Siren AL, 2001, P NATL ACAD SCI USA, V98, P4044, DOI 10.1073/pnas.051606598; Szabo Z, 2010, BRAIN RES, V1341, P25, DOI 10.1016/j.brainres.2009.01.035; Ueba H, 2010, P NATL ACAD SCI USA, V107, P14357, DOI 10.1073/pnas.1003019107; Villa P, 2003, J EXP MED, V198, P971, DOI 10.1084/jem.20021067; Wang L, 2004, STROKE, V35, P1732, DOI 10.1161/01.STR.0000132196.49028.a4; Wu AG, 2010, NEUROREHAB NEURAL RE, V24, P290, DOI 10.1177/1545968309348318; Xiong Y, 2011, J NEUROSURG, V114, P549, DOI 10.3171/2010.10.JNS10925; Xiong Y, 2010, J NEUROSURG, V113, P598, DOI 10.3171/2009.9.JNS09844; Yatsiv I, 2005, FASEB J, V19, P1701, DOI 10.1096/fj.05-3907fje; Zellinger C, 2011, EPILEPSY RES, V96, P241, DOI 10.1016/j.eplepsyres.2011.06.009; Zohar O, 2011, ACTA NEUROBIOL EXP, V71, P36	50	18	19	0	9	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAY	2013	30	9			SI		765	774		10.1089/neu.2012.2431			10	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	145BJ	WOS:000318987600008	22827443	Green Published			2021-06-18	
J	Stolwyk, RJ; Downing, MG; Taffe, J; Kreutzer, JS; Zasler, ND; Ponsford, JL				Stolwyk, Renerus J.; Downing, Marina G.; Taffe, John; Kreutzer, Jeffrey S.; Zasler, Nathan D.; Ponsford, Jennie L.			Assessment of Sexuality Following Traumatic Brain Injury: Validation of the Brain Injury Questionnaire of Sexuality	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						assessment; reliability; sexual function; sexual well-being; sexuality; traumatic brain injury; validity		Background: The importance of effectively identifying and managing sexuality issues following acquired brain injury is being increasingly recognized within clinical and research domains. However, a tool specifically developed to measure sexuality following brain injury is yet to be validated. Objectives: In this study, the reliability and validity of the Brain Injury Questionnaire of Sexuality (BIQS) was evaluated. Method: Eight hundred and sixty-five people who had sustained traumatic brain injury participated in this study. All participants completed the BIQS, and a subsample also completed the Derogatis Interview for Sexual Functioning-Self-Report version (DISF-SR). Results: Exploratory factor analysis supported a 3-subscale structure of the BIQS, which aligns with contemporary conceptual models of sexuality in chronic disease. All subscales of the BIQS demonstrated very good internal consistency. Convergent and divergent validity of all BIQS subscales was also demonstrated. Conclusions: Results from the study support the reliability and validity of the BIQS, which shows promise as a measurement tool for future traumatic brain injury sexuality research. Further validation work including evaluation for potential clinical applications is encouraged.	[Stolwyk, Renerus J.; Downing, Marina G.; Taffe, John; Ponsford, Jennie L.] Monash Univ, Sch Psychol & Psychiat, Melbourne, Vic 3800, Australia; [Downing, Marina G.; Ponsford, Jennie L.] Monash Epworth Rehabil Res Ctr, Melbourne, Vic, Australia; [Ponsford, Jennie L.] Natl Trauma Res Inst, Melbourne, Vic, Australia; [Kreutzer, Jeffrey S.] Virginia Commonwealth Univ, Med Ctr, Richmond, VA USA; [Zasler, Nathan D.] Concuss Care Ctr Virginia Ltd, Richmond, VA USA; [Zasler, Nathan D.] Tree Life Serv Inc, Richmond, VA USA; [Zasler, Nathan D.] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Richmond, VA USA	Stolwyk, RJ (corresponding author), Monash Univ, Sch Psychol & Psychiat, Bldg 17,Clayton Campus, Melbourne, Vic 3800, Australia.	rene.stolwyk@monash.edu	Downing, Marina/AAX-2380-2020	Downing, Marina/0000-0002-3126-6632	Transport Accident Commission through the Institute for Safety, Compensation and Recovery Research	This project was funded by the Transport Accident Commission through the Institute for Safety, Compensation and Recovery Research.	Althof SE, 2005, J SEX MARITAL THER, V31, P153, DOI 10.1080/00926230590909989; Basson R, 2007, LANCET, V369, P409, DOI 10.1016/S0140-6736(07)60197-4; Clayton A, 2008, ADV PSYCHOSOM MED, V29, P70, DOI 10.1159/000126625; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Derogatis LR, 1997, J SEX MARITAL THER, V23, P291; Derogatis LR., 1996, DEROGATIS INTERVIEW; DeVellis R.F., 2012, SCALE DEV THEORY APP, V3rd ed.; Elliott ML, 1996, BRAIN INJURY, V10, P703, DOI 10.1080/026990596123972; Garden F. H., 1990, J HEAD TRAUMA REHAB, V5, P52, DOI DOI 10.1097/00001199-199005020-00009; Gosling J, 1999, BRAIN INJURY, V13, P785; Hibbard MR, 2000, NEUROREHABILITATION, V15, P109; Jennett B, 1981, MANAGEMENT HEAD INJU; Kreuter M, 1998, BRAIN INJURY, V12, P349, DOI 10.1080/026990598122494; Kreutzer J S, 1989, Brain Inj, V3, P177, DOI 10.3109/02699058909004550; O'CARROLL R E, 1991, Brain Injury, V5, P303, DOI 10.3109/02699059109008100; PETERS L C, 1990, Brain Injury, V4, P39, DOI 10.3109/02699059009026147; Ponsford J, 2003, NEUROPSYCHOL REHABIL, V13, P275, DOI 10.1080/09602010244000363; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; RUST J, 1986, GOLOMBOK RUST INVENT; Sandel ME, 1996, BRAIN INJURY, V10, P719, DOI 10.1080/026990596123981; SANDEL ME, 2007, BRAIN INJURY MED PRI, P673; Sander AM, 2012, ARCH PHYS MED REHAB, V93, P1331, DOI 10.1016/j.apmr.2012.03.037; SCHAEFER MT, 1981, J MARITAL FAM THER, V7, P47, DOI 10.1111/j.1752-0606.1981.tb01351.x; Verschuren JEA, 2010, J SEX RES, V47, P153, DOI 10.1080/00224491003658227	24	18	18	1	12	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2013	28	3					164	170		10.1097/HTR.0b013e31828197d1			7	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	149PS	WOS:000319334000002	23474881				2021-06-18	
J	Fedor, A; Gunstad, J				Fedor, Andrew; Gunstad, John			Higher BMI Is Associated with Reduced Cognitive Performance in Division I Athletes	OBESITY FACTS			English	Article						Body mass index; Physical activity; Risk factors; Weight status	CARDIOVASCULAR FITNESS; PHYSICAL-ACTIVITY; OBESITY; OVERWEIGHT; RISK; VARIABILITY; SENSITIVITY; IMPAIRMENT; EXERCISE; DECLINE	Objective: Poor cardiovascular fitness has been implicated as a possible mechanism for obesity-related cognitive decline, though no study has examined whether BMI is associated with poorer cognitive function in persons with excellent fitness levels. The current study examined the relationship between BMI and cognitive function by the Immediate Post Concussion and Cognitive Test (ImPACT) in Division I collegiate athletes. Methods: Participants had an average age of 20.14 +/- 1.78 years, were 31.3% female, and 53.9% football players. BMI ranged from 19.04 to 41.14 and averaged 26.72 +/- 4.62. Results: Regression analyses revealed that BMI incrementally predicted performance on visual memory (R-2 change = 0.015, p = 0.026) beyond control variables. Follow-up partial correlation analyses revealed small but significant negative correlations between BMI and verbal memory (r = -0.17), visual memory (r = -0.16), and visual motor speed (r = -0.12). Conclusions: These results suggest that higher BMI is associated with reduced cognitive function, even in a sample expected to have excellent levels of cardiovascular fitness. Further work is needed to better understand mechanisms for these associations. Copyright (C) 2013 S. Karger GmbH, Freiburg	[Fedor, Andrew; Gunstad, John] Kent State Univ, Dept Psychol, Kent, OH 44242 USA	Gunstad, J (corresponding author), Kent State Univ, Dept Psychol, 221 Kent Hall, Kent, OH 44242 USA.	jgunstad@kent.edu					Aberg MAI, 2009, P NATL ACAD SCI USA, V106, P20906, DOI 10.1073/pnas.0905307106; [Anonymous], 2008, SPSS VERS 16; Bray GA, 2004, J CLIN ENDOCR METAB, V89, P2583, DOI 10.1210/jc.2004-0535; Colcombe S, 2003, PSYCHOL SCI, V14, P125, DOI 10.1111/1467-9280.t01-1-01430; Colcombe SJ, 2004, P NATL ACAD SCI USA, V101, P3316, DOI 10.1073/pnas.0400266101; Covassin T, 2003, J ATHL TRAINING, V38, P238; Cukierman-Yaffe T, 2009, DIABETES CARE, V32, P221, DOI 10.2337/dc08-1153; de la Monte SM, 2010, J ALZHEIMERS DIS, V21, P967, DOI 10.3233/JAD-2010-091726; Fergenbaum JH, 2009, OBESITY, V17, P1957, DOI 10.1038/oby.2009.161; Fitzpatrick AL, 2009, ARCH NEUROL-CHICAGO, V66, P336, DOI 10.1001/archneurol.2008.582; Gonzales MM, 2010, OBESITY, V18, P2131, DOI 10.1038/oby.2010.183; Gunstad J, 2006, Eat Weight Disord, V11, pe15; Gunstad J, 2007, COMPR PSYCHIAT, V48, P57, DOI 10.1016/j.comppsych.2006.05.001; Gunstad J, 2010, NEUROEPIDEMIOLOGY, V34, P222, DOI 10.1159/000297742; Gustafson D, 2003, ARCH INTERN MED, V163, P1524, DOI 10.1001/archinte.163.13.1524; Haennel RG, 2002, CAN FAM PHYSICIAN, V48, P65; Hansen AL, 2004, EUR J APPL PHYSIOL, V93, P263, DOI 10.1007/s00421-004-1208-0; Hassenstab JJ, 2010, DEMENT GERIATR COGN, V29, P356, DOI 10.1159/000296071; Huizinga MM, 2008, OBESITY, V16, P1966, DOI 10.1038/oby.2008.294; Iverson GL, 2004, ARCH CLIN NEUROPSYCH, V19, P961; Kakos Lynn S, 2010, Prev Cardiol, V13, P100, DOI 10.1111/j.1751-7141.2009.00065.x; Kohrt WM, 1998, CORONARY ARTERY DIS, V9, P489, DOI 10.1097/00019501-199809080-00004; Lovell MR, 2007, IMPACT VERSION 6 0 C; Mokdad AH, 2005, JAMA-J AM MED ASSOC, V293, P293, DOI 10.1001/jama.293.3.293; Mokdad AH, 2004, JAMA-J AM MED ASSOC, V291, P1238, DOI 10.1001/jama.291.10.1238; Nilsson LG, 2009, SCAND J PSYCHOL, V50, P660, DOI 10.1111/j.1467-9450.2009.00777.x; Okonkwo OC, 2011, J CARDIOPULM REHABIL, V31, P290, DOI 10.1097/HCR.0b013e318220a817; Rothman KJ, 2008, INT J OBESITY, V32, pS56, DOI 10.1038/ijo.2008.87; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Sellbom KS, 2012, J ALZHEIMERS DIS, V30, pS89, DOI 10.3233/JAD-2011-111073; Sherry B., 2010, Morbidity and Mortality Weekly Report, V59, P951; Smith E, 2011, OBES REV, V12, P740, DOI 10.1111/j.1467-789X.2011.00920.x; Smith PJ, 2010, HYPERTENSION, V55, P1331, DOI 10.1161/HYPERTENSIONAHA.109.146795; Stanek KM, 2010, OBESITY, V19, P500; Stephan BC, 2010, HYPERTENSION, V55, P1331; STEVENSON JS, 1990, RES NURS HEALTH, V13, P209, DOI 10.1002/nur.4770130403; STUNKARD A, 1958, PSYCHOSOM MED, V20, P366, DOI 10.1097/00006842-195809000-00004; Taylor VH, 2007, OBES REV, V8, P409, DOI 10.1111/j.1467-789X.2007.00401.x; Wilkerson GB, 2010, J ATHL TRAINING, V45, P67, DOI 10.4085/1062-6050-45.1.67; Willeumier KC, 2011, OBESITY SILVER SPRIN, V16, P1; Willeumier KC, 2011, OBESITY, V19, P1095, DOI 10.1038/oby.2011.16; World Health Organization, 2011, OB OV	42	18	19	0	12	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1662-4025	1662-4033		OBESITY FACTS	Obes. Facts	APR	2013	6	2					185	192		10.1159/000351138			8	Endocrinology & Metabolism; Nutrition & Dietetics	Endocrinology & Metabolism; Nutrition & Dietetics	137ZT	WOS:000318478500009	23594505	DOAJ Gold, Green Published			2021-06-18	
J	Lien, E; Andersen, GL; Bao, YD; Gordish-Dressman, H; Skranes, JS; Vik, T; Blackman, JA				Lien, Espen; Andersen, Guro L.; Bao, Yongde; Gordish-Dressman, Heather; Skranes, Jon S.; Vik, Torstein; Blackman, James A.			Apolipoprotein E polymorphisms and severity of cerebral palsy: a cross-sectional study in 255 children in Norway	DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY			English	Article							TRAUMATIC BRAIN-INJURY; E GENOTYPE; ALZHEIMERS-DISEASE; APOE EPSILON-4; ASSOCIATION; ALLELE; POPULATION; RISK	Aim The aim of this study was to examine whether the presence of the apolipoprotein E (ApoE) allele APOE epsilon 4 is associated with less severe manifestations of cerebral palsy (CP), consistent with the suggested beneficial effect of this allele on neurodevelopment in children. Method ApoE genotyping was performed on buccal epithelial cells from 255 children (141 males 114 females; mean age 12y, SD 2y 3mo, range 917y) recorded in the Cerebral Palsy Register of Norway. The main outcome measure of CP severity was the Gross Motor Function Classification System (GMFCS). Secondary outcome measures were fine motor function, epilepsy, and the need for gastrostomy tube feeding (GTF). Results There was no association between the APOE epsilon 4 genotype and GMFCS levels (odds ratio [OR] 1.15; 95% confidence interval [CI] 0.661.99). However, the APOE epsilon 4 genotype was more often present among children with epilepsy (OR 2.2; 95% CI 1.14.2) and/or receiving GTF (OR 2.7; 95% CI 1.16.6). Among children with unilateral CP, the presence of APOE epsilon 4 was associated with more severe fine motor impairment (OR 2.6; 95% CI 1.36.9). Interpretation Our main hypothesis that APOE epsilon 4 would have a protective effect on neurodevelopment was not supported. Instead, subgroup analyses suggested an adverse effect of the APOE epsilon 4 genotype on the developing brain after injury.	[Lien, Espen; Skranes, Jon S.; Vik, Torstein] Norwegian Univ Sci & Technol, Dept Lab Med, Childrens & Womens Hlth, Fac Med, N-7491 Trondheim, Norway; [Lien, Espen; Vik, Torstein] Univ Hosp Trondheim, Dept Paediat, St Olavs Hosp, Trondheim, Norway; [Andersen, Guro L.] Vestfold Hosp Trust, Cerebral Palsy Register Norway, Tonsberg, Norway; [Bao, Yongde] Univ Virginia, Sch Med, DNA Sci Core, Charlottesville, VA 22908 USA; [Gordish-Dressman, Heather] Childrens Natl Med Ctr, Med Genet Res Ctr, Washington, DC 20010 USA; [Blackman, James A.] Univ Virginia, Dept Pediat, Charlottesville, VA USA; [Blackman, James A.] Cerebral Palsy Int Res Fdn, Princeton Jct, NJ USA	Lien, E (corresponding author), Norwegian Univ Sci & Technol, Dept Lab Med, Childrens & Womens Hlth, Fac Med, PB 8905, N-7491 Trondheim, Norway.	espen.lien@ntnu.no			National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R03HD65826]; University of Virginia Children's Hospital; University of Virginia Pratt Research Fund; Health Authority of Central Norway; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD065826] Funding Source: NIH RePORTER	This study was supported by the National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development (R03HD65826), University of Virginia Children's Hospital Grant-in-Aid, the University of Virginia Pratt Research Fund, and the Health Authority of Central Norway. We would also like to thank Ms Jodi Darring at the University of Virginia, and Ms Sandra Julsen Hollung at the CPRN for their assistance, and all the children and their families who contributed to the study.	Aboud O, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-35; Andersen GL, 2008, EUR J PAEDIATR NEURO, V12, P4, DOI 10.1016/j.ejpn.2007.05.001; Kauffman MA, 2010, EPILEPSY RES, V90, P234, DOI 10.1016/j.eplepsyres.2010.05.007; [Anonymous], 2000, DEV MED CHILD NEUROL, V42, P816; Bax M, 2005, DEV MED CHILD NEUROL, V47, P571, DOI 10.1017/S001216220500112X; Beckung E, 2002, DEV MED CHILD NEUROL, V44, P309; Blackman JA, 2009, J PEDIATR REHAB MED, V2, P67, DOI 10.3233/PRM-2009-0063; Braga LW, 2010, DEV MED CHILD NEUROL, V52, P666, DOI 10.1111/j.1469-8749.2009.03465.x; Brichtova E, 2008, CHILD NERV SYST, V24, P349, DOI 10.1007/s00381-007-0459-6; Briellmann RS, 2000, NEUROLOGY, V55, P435, DOI 10.1212/WNL.55.3.435; Corbo RM, 1999, ANN HUM GENET, V63, P301, DOI 10.1046/j.1469-1809.1999.6340301.x; Diaz-Arrastia R, 2003, ARCH NEUROL-CHICAGO, V60, P818, DOI 10.1001/archneur.60.6.818; Dumanis SB, 2009, J NEUROSCI, V29, P15317, DOI 10.1523/JNEUROSCI.4026-09.2009; Guo L, 2004, J MOL NEUROSCI, V23, P205, DOI 10.1385/JMN:23:3:205; Hauser PS, 2011, PROG LIPID RES, V50, P62, DOI 10.1016/j.plipres.2010.09.001; Jordan BD, 2007, NEUROCHEM RES, V32, P905, DOI 10.1007/s11064-006-9251-3; Kim J, 2009, NEURON, V63, P287, DOI 10.1016/j.neuron.2009.06.026; Kumar T, 2002, HUM BIOL, V74, P137, DOI 10.1353/hub.2002.0006; Kuroda MM, 2007, PEDIATRICS, V119, P306, DOI 10.1542/peds.2006-1083; McMichael GL, 2008, HUM GENET, V124, P411, DOI 10.1007/s00439-008-0564-y; Meirelles Kalil Pessoa de B., 2000, J PEDIATR ORTHOPED, V20, P786; O'Callaghan ME, 2009, HUM GENET, V126, P149, DOI 10.1007/s00439-009-0638-5; Oria RB, 2007, MED HYPOTHESES, V68, P1099, DOI 10.1016/j.mehy.2006.09.036; Palisano R, 1997, DEV MED CHILD NEUROL, V39, P214, DOI 10.1111/j.1469-8749.1997.tb07414.x; Stoknes M, 2012, EUR J PAEDIATR NEURO, V16, P56, DOI 10.1016/j.ejpn.2011.10.004; Teasdale GM, 2005, BRAIN, V128, P2556, DOI 10.1093/brain/awh595; Verghese PB, 2011, LANCET NEUROL, V10, P241, DOI 10.1016/S1474-4422(10)70325-2; Zhou WD, 2008, J NEUROTRAUM, V25, P279, DOI 10.1089/neu.2007.0489	28	18	18	0	4	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0012-1622			DEV MED CHILD NEUROL	Dev. Med. Child Neurol.	APR	2013	55	4					372	377		10.1111/dmcn.12086			6	Clinical Neurology; Pediatrics	Neurosciences & Neurology; Pediatrics	108AF	WOS:000316262100016	23384326	Green Accepted			2021-06-18	
J	Turtzo, LC; Budde, MD; Gold, EM; Lewis, BK; Janes, L; Yarnell, A; Grunberg, NE; Watson, W; Frank, JA				Turtzo, L. Christine; Budde, Matthew D.; Gold, Eric M.; Lewis, Bobbi K.; Janes, Lindsay; Yarnell, Angela; Grunberg, Neil E.; Watson, William; Frank, Joseph A.			The evolution of traumatic brain injury in a rat focal contusion model	NMR IN BIOMEDICINE			English	Article						traumatic brain injury; controlled cortical impact; MRI; hemorrhage; autofluorescence	CONTROLLED CORTICAL IMPACT; GADOLINIUM OXIDE NANOPARTICLES; CENTRAL-NERVOUS-SYSTEM; MARROW STROMAL CELLS; NEURAL STEM-CELLS; SUPERFICIAL SIDEROSIS; HEAD-INJURY; VASCULAR DISRUPTION; FEMALE RATS; IN-VIVO	Serial MRI facilitates the in vivo analysis of the intra- and intersubject evolution of traumatic brain injury lesions. Despite the availability of MRI, the natural history of experimental focal contusion lesions in the controlled cortical impact (CCI) rat model has not been well described. We performed CCI on rats and MRI during the acute to chronic stages of cerebral injury to investigate the time course of changes in the brain. Female Wistar rats underwent CCI of their left motor cortex with a flat impact tip driven by an electromagnetic piston. In vivo MRI was performed at 7T serially over 6weeks post-CCI. The appearances of CCI-induced lesions and lesion-associated cortical volumes were variable on MRI, with the percentage change in cortical volume of the CCI ipsilateral side relative to the contralateral side ranging from 18% within 2h of injury on day 0 to a peak of 35% on day 1, and a trough of 28% by week 5/6, with an average standard deviation of +/- 14% at any given time point. In contrast, the percentage change in cortical volume of the ipsilateral side relative to the contralateral side in control rats was not significant (1 +/- 2%). Hemorrhagic conversion within and surrounding the CCI lesion occurred between days 2 and 9 in 45% of rats, with no hemorrhage noted on the initial scan. Furthermore, hemorrhage and hemosiderin within the lesion were positive for Prussian blue and highly autofluorescent on histological examination. Although some variation in injuries may be technique related, the divergence of similar lesions between initial and final scans demonstrates the inherent biological variability of the CCI rat model. Published 2012. This article is a US Government work and is in the public domain in the USA.	[Turtzo, L. Christine; Gold, Eric M.; Janes, Lindsay] Uniformed Serv Univ Hlth Sci, Ctr Neurosci & Regenerat Med, Bethesda, MD 20814 USA; [Turtzo, L. Christine; Budde, Matthew D.; Gold, Eric M.; Lewis, Bobbi K.; Janes, Lindsay; Frank, Joseph A.] NIH, Frank Lab, Bethesda, MD 20892 USA; [Yarnell, Angela; Grunberg, Neil E.] Uniformed Serv Univ Hlth Sci, Dept Med & Clin Psychol, Bethesda, MD 20814 USA; [Watson, William] Uniformed Serv Univ Hlth Sci, Dept Neurol, Bethesda, MD 20814 USA; [Frank, Joseph A.] Natl Inst Biomed Imaging & Bioengn, NIH, Bethesda, MD USA	Turtzo, LC (corresponding author), NIH, Frank Lab, Bldg 10,Room B1N256 MSC 1074,10 Ctr Dr, Bethesda, MD 20892 USA.	l.turtzo@nih.gov; jafrank@helix.nih.gov	Frank, Joseph/W-2021-2019		Department of Defense through the Center for Neuroscience and Regenerative MedicineUnited States Department of Defense [300604-8.01-60855]; Intramural Research Program of the Clinical Center at the National Institutes of Health; CLINICAL CENTER [ZIACL090020] Funding Source: NIH RePORTER	This work was supported by funding from the Department of Defense through the Center for Neuroscience and Regenerative Medicine (Henry M. Jackson Foundation Award #300604-8.01-60855) and from the Intramural Research Program of the Clinical Center at the National Institutes of Health.	Agudelo CA, 2011, TISSUE ENG PT A, V17, P2079, DOI [10.1089/ten.tea.2010.0482, 10.1089/ten.TEA.2010.0482]; Agudelo CA, 2012, BIOMATERIALS, V33, P2439, DOI 10.1016/j.biomaterials.2011.11.075; Alahmadi H, 2010, J NEUROSURG, V112, P1139, DOI 10.3171/2009.5.JNS081369; Albensi BC, 2000, EXP NEUROL, V162, P61, DOI 10.1006/exnr.2000.7256; Anderson SA, 2006, INVEST RADIOL, V41, P332, DOI 10.1097/01.rli.0000192420.94038.9e; Andriessen TMJC, 2010, J CELL MOL MED, V14, P2381, DOI 10.1111/j.1582-4934.2010.01164.x; Belayev L, 2007, BRAIN RES, V1157, P146, DOI 10.1016/j.brainres.2007.04.077; Bell RS, 2009, J TRAUMA, V66, pS104, DOI 10.1097/TA.0b013e31819d88c8; Berman SC, 2011, MAGN RESON MED, V65, P564, DOI 10.1002/mrm.22613; Bouilleret V, 2009, J NEUROTRAUM, V26, P1999, DOI 10.1089/neu.2009.0943; Bramlett HM, 2001, J NEUROTRAUM, V18, P891, DOI 10.1089/089771501750451811; Brody DL, 2007, J NEUROTRAUM, V24, P657, DOI 10.1089/neu.2006.0011; Cheng JL, 2010, CHIN J TRAUMATOL, V13, P173, DOI 10.3760/cma.j.issn.1008-1275.2010.03.008; Clark RSB, 1997, J NEUROTRAUM, V14, P179, DOI 10.1089/neu.1997.14.179; Cole JT, 2011, J NEUROTRAUM, V28, P359, DOI 10.1089/neu.2010.1427; Colgan NC, 2010, J NEUROTRAUM, V27, P1265, DOI 10.1089/neu.2009.1267; CORTEZ SC, 1989, BRAIN RES, V482, P271, DOI 10.1016/0006-8993(89)91190-6; Dierksen GA, 2010, ANN NEUROL, V68, P545, DOI 10.1002/ana.22099; DIETRICH WD, 1994, J NEUROTRAUM, V11, P289, DOI 10.1089/neu.1994.11.289; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Faucher L, 2012, ACS APPL MATER INTER, V4, P4506, DOI 10.1021/am3006466; Faucher L, 2011, CONTRAST MEDIA MOL I, V6, P209, DOI 10.1002/cmmi.420; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Flint AC, 2008, J NEUROTRAUM, V25, P503, DOI 10.1089/neu.2007.0442; Foley LM, 2009, J NEUROTRAUM, V26, P1509, DOI 10.1089/neu.2008.0747; Giesel FL, 2006, INVEST RADIOL, V41, P868, DOI 10.1097/01.rli.0000246147.44835.4c; Hamm RJ, 2001, J NEUROTRAUM, V18, P1207, DOI 10.1089/089771501317095241; Harting MT, 2009, J SURG RES, V153, P188, DOI 10.1016/j.jss.2008.03.037; Hayward NMEA, 2011, J CEREBR BLOOD F MET, V31, P166, DOI 10.1038/jcbfm.2010.67; Herson PS, 2009, SEMIN REPROD MED, V27, P229, DOI 10.1055/s-0029-1216276; Imaizumi T, 2004, J NEUROSURG, V101, P915, DOI 10.3171/jns.2004.101.6.0915; Immonen R, 2010, J CEREBR BLOOD F MET, V30, P1318, DOI 10.1038/jcbfm.2010.15; Immonen RJ, 2009, NEUROIMAGE, V45, P1, DOI 10.1016/j.neuroimage.2008.11.022; Immonen RJ, 2009, EXP NEUROL, V215, P29, DOI 10.1016/j.expneurol.2008.09.009; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Iwamoto Y, 1997, NEUROSURGERY, V40, P163, DOI 10.1097/00006123-199701000-00036; Jiang Q, 2011, NMR BIOMED, V24, P1119, DOI 10.1002/nbm.1667; Kakeda S, 2010, ACAD RADIOL, V17, P871, DOI 10.1016/j.acra.2010.02.014; Kellermier H, 2009, NEUROPATHOLOGY, V29, P187, DOI 10.1111/j.1440-1789.2008.00943.x; Kharatishvili I, 2009, EXP NEUROL, V217, P154, DOI 10.1016/j.expneurol.2009.01.026; Kochanek OM, 1995, J NEUROTRAUM, V12, P1015, DOI 10.1089/neu.1995.12.1015; Kochanek PM, 2002, J NEUROTRAUM, V19, P1029, DOI 10.1089/089771502760341947; Kumar N, 2007, ARCH NEUROL-CHICAGO, V64, P491, DOI 10.1001/archneur.64.4.491; Kurland D, 2012, J NEUROTRAUM, V29, P19, DOI 10.1089/neu.2011.2122; Li LA, 2011, J NEUROTRAUM, V28, P535, DOI 10.1089/neu.2010.1619; Mahmood A, 2003, NEUROSURGERY, V53, P697, DOI 10.1227/01.NEU.0000079333.61863.AA; Mahmood A, 2001, NEUROSURGERY, V49, P1196, DOI 10.1097/00006123-200111000-00031; MANDL AM, 1951, J EXP BIOL, V28, P576; Marklund N, 2011, BRIT J PHARMACOL, V164, P1207, DOI 10.1111/j.1476-5381.2010.01163.x; Marti M, 2005, J NEUROSCI, V25, P9591, DOI 10.1523/JNEUROSCI.2546-05.2005; MCCLINTOCK MK, 1978, HORM BEHAV, V10, P264, DOI 10.1016/0018-506X(78)90071-5; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Meng YL, 2011, J NEUROSURG, V115, P550, DOI 10.3171/2011.3.JNS101721; Nanda S, 2010, ANN CLIN BIOCHEM, V47, P275, DOI 10.1258/acb.2010.009226; O'Connor CA, 2007, EXP NEUROL, V205, P145, DOI 10.1016/j.expneurol.2007.01.034; Obenaus A, 2007, J NEUROTRAUM, V24, P1147, DOI 10.1089/neu.2006.0211; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; Onyszchuk G, 2008, J NEUROTRAUM, V25, P153, DOI 10.1089/neu.2007.0430; Onyszchuk G, 2007, J NEUROSCI METH, V160, P187, DOI 10.1016/j.jneumeth.2006.09.007; Onyszchuk G, 2009, NEUROSCI LETT, V452, P204, DOI 10.1016/j.neulet.2009.01.049; Risdall JE, 2011, PHILOS T R SOC B, V366, P241, DOI 10.1098/rstb.2010.0230; Roberts I, 1998, J NEUROL NEUROSUR PS, V65, P729, DOI 10.1136/jnnp.65.5.729; Roof RL, 1996, EXP NEUROL, V138, P246, DOI 10.1006/exnr.1996.0063; ROOF RL, 1993, BRAIN RES, V607, P333, DOI 10.1016/0006-8993(93)91526-X; ROOF RL, 1994, EXP NEUROL, V129, P64, DOI 10.1006/exnr.1994.1147; Rosell A, 2008, ACTA NEUROCHIR SUPPL, V105, P173; Sena ES, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000344; SHOHAMI E, 1995, BRAIN RES, V674, P55, DOI 10.1016/0006-8993(94)01433-I; Sifri ZC, 2006, J TRAUMA, V61, P862, DOI 10.1097/01.ta.0000224225.54982.90; Simard JM, 2009, J NEUROTRAUM, V26, P2257, DOI 10.1089/neu.2009.1021; SUTTON RL, 1993, J NEUROTRAUM, V10, P135, DOI 10.1089/neu.1993.10.135; Thomale UW, 2007, NEUROL RES, V29, P594, DOI 10.1179/016164107X166272; Turtzo LC, 2010, FUTUR NEUROL, V5, P47, DOI 10.2217/FNL.09.66; van der Worp HB, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000245; Walker PA, 2010, EXP NEUROL, V225, P341, DOI 10.1016/j.expneurol.2010.07.005; Walker PA, 2010, STEM CELLS DEV, V19, P867, DOI 10.1089/scd.2009.0188; Westwood FR, 2008, TOXICOL PATHOL, V36, P375, DOI 10.1177/0192623308315665; Zhu JH, 2006, NEW ENGL J MED, V355, P2376, DOI 10.1056/NEJMc055304	78	18	18	0	15	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0952-3480	1099-1492		NMR BIOMED	NMR Biomed.	APR	2013	26	4					468	479		10.1002/nbm.2886			12	Biophysics; Radiology, Nuclear Medicine & Medical Imaging; Spectroscopy	Biophysics; Radiology, Nuclear Medicine & Medical Imaging; Spectroscopy	107IK	WOS:000316209200014	23225324	Green Accepted			2021-06-18	
J	Tayra, JT; Kameda, M; Yasuhara, T; Agari, T; Kadota, T; Wang, FF; Kikuchi, Y; Liang, HB; Shinko, A; Wakamori, T; Vcelar, B; Weik, R; Date, I				Tayra, Judith Thomas; Kameda, Masahiro; Yasuhara, Takao; Agari, Takashi; Kadota, Tomohito; Wang, Feifei; Kikuchi, Yoichiro; Liang, Hanbai; Shinko, Aiko; Wakamori, Takaaki; Vcelar, Brigitta; Weik, Robert; Date, Isao			The neuroprotective and neurorescue effects of carbamylated erythropoietin Fc fusion protein (CEPO-Fc) in a rat model of Parkinson's disease	BRAIN RESEARCH			English	Article						Carbamylated erythropoietin; Dopamine; Neuroprotection; Neurorescue; Parkinson's disease	TRAUMATIC BRAIN-INJURY; MEAN PLATELET VOLUME; NEURAL STEM-CELLS; NEUROTROPHIC FACTOR; ACUTE STROKE; ACTIVATION; DIFFERENTIATION; NEURONS; EDEMA; DEATH	Parkinson's disease is characterized by progressive degeneration of dopaminergic neurons. Thus the development of therapeutic neuroprotection and neurorescue strategies to mitigate disease progression is important. In this study we evaluated the neuroprotective/rescue effects of erythropoietin Fc fusion protein (EPO-Fc) and carbamylated erythropoietin Fe fusion protein (CEPO-Fc) in a rat model of Parkinson's disease. Adult female Sprague-Dawley rats received intraperitoneal injection of EPO-Fc, CEPO-Fc or PBS. Behavioral evaluations consisted of rota-rod, cylinder and amphetamine-induced rotation tests. In the neuroprotection experiment, the CEPO-Fc group demonstrated significant improvement compared with the EPO-Fc group on the amphetamine-induced rotation test throughout the four-week follow-up period. Histologically, significantly more tyrosine hydroxylase (TH)-positive neurons were recognized in the substantia nigra (SN) pars compacta in the CEPO-Fc group than in the PBS and EPO-Fc groups. In the neurorescue experiment, rats receiving CEPO-Fc showed significantly better behavioural scores than those receiving PBS. The histological data concerning striatum also showed that the CEPO-Fc group had significantly better preservation of TH-positive fibers compared to the PBS and EPO-Fc groups. Importantly, there were no increases in hematocrit or hemoglobin levels in the CEPO-Fc group in either the neuroprotection or the neurorescue experiments. In conclusion, the newly developed CEPO-Fc might confer neuroprotective and neurorescue benefits in a rat model of Parkinson's disease without the side effects associated with polycythemia. CEPO-Fc might be a therapeutic tool for patients with Parkinson's disease. (C) 2013 Elsevier B.V. All rights reserved.	[Tayra, Judith Thomas; Kameda, Masahiro; Yasuhara, Takao; Agari, Takashi; Kadota, Tomohito; Wang, Feifei; Kikuchi, Yoichiro; Liang, Hanbai; Shinko, Aiko; Wakamori, Takaaki; Date, Isao] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Neurol Surg, Okayama 7008558, Japan; [Vcelar, Brigitta; Weik, Robert] Polymun Sci GmbH, Vienna, Austria	Kameda, M (corresponding author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Neurol Surg, 2-5-1 Shikata Cho, Okayama 7008558, Japan.	mrkameda@gmail.com			Ministry of Education, Culture, Sports, Science and Technology, JapanMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT); Health Science Research Grants for Research on Brain Science from the Ministry of Education, Culture, Sports, Science and Technology, Japan; Grants-in-Aid for Scientific ResearchMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI) [23791602, 25861277] Funding Source: KAKEN	The authors thank Ms. Masako Arao and Ms. Natsuki Uemori for their assistance. This work was supported in part by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan, and by Health Science Research Grants for Research on Brain Science from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Adembri C, 2008, CRIT CARE MED, V36, P975, DOI 10.1097/CCM.0B013E3181644343; Ahn S, 2005, NATURE, V437, P894, DOI 10.1038/nature03994; Aluf Y, 2010, FREE RADICAL RES, V44, P635, DOI 10.3109/10715761003692529; Amankulor NM, 2009, J NEUROSCI, V29, P10299, DOI 10.1523/JNEUROSCI.2500-09.2009; Andre P, 2000, P NATL ACAD SCI USA, V97, P13835, DOI 10.1073/pnas.250475997; Bar-Or D, 2011, CRIT CARE MED, V39, P2191, DOI 10.1097/CCM.0b013e3182204a9c; Bath P, 2004, STROKE, V35, P622, DOI 10.1161/01.STR.0000116105.26237.EC; BECK G, 1986, J IMMUNOL, V136, P3025; Blann AD, 1997, BLOOD COAGUL FIBRIN, V8, P383, DOI 10.1097/00001721-199710000-00002; Bouzat P, 2011, CRIT CARE MED, V39, P2099, DOI 10.1097/CCM.0b013e31821cb7b2; Brines M, 2005, NAT REV NEUROSCI, V6, P484, DOI 10.1038/nrn1687; Brines M, 2004, P NATL ACAD SCI USA, V101, P14907, DOI 10.1073/pnas.0406491101; Brines ML, 2000, P NATL ACAD SCI USA, V97, P10526, DOI 10.1073/pnas.97.19.10526; CAPON DJ, 1989, NATURE, V337, P525, DOI 10.1038/337525a0; Cerami A, 2011, J INTERN MED, V269, P8, DOI 10.1111/j.1365-2796.2010.02319.x; Cerami A, 2001, SEMIN ONCOL, V28, P66, DOI 10.1053/sonc.2001.25401; Coleman TR, 2006, P NATL ACAD SCI USA, V103, P5965, DOI 10.1073/pnas.0601377103; Diaz Z, 2005, J NEUROCHEM, V93, P392, DOI 10.1111/j.1471-4159.2005.03038.x; Ehrenreich H, 2005, P NATL ACAD SCI USA, V102, P862, DOI 10.1073/pnas.0406008102; Ehrenreich H, 2004, SCIENCE, V305, P184, DOI 10.1126/science.1100891; Ehrenreich H, 2002, MOL MED, V8, P495, DOI 10.1007/BF03402029; Ehrenreich H, 2004, MOL PSYCHIATR, V9, P42, DOI 10.1038/sj.mp.4001442; Ehrenreich H, 2009, STROKE, V40, pE647, DOI 10.1161/STROKEAHA.109.564872; Erbayraktar S, 2006, MOL MED, V12, P74, DOI 10.2119/2006-00042.Erbayraktar; Erbayraktar Z, 2009, MOL MED, V15, P235, DOI 10.2119/molmed.2009.00051; FEARNLEY JM, 1991, BRAIN, V114, P2283, DOI 10.1093/brain/114.5.2283; Ferruci L., 2007, BRIT J HAEMATOL, V136, P549; Fu ZQ, 2010, J NEUROIMMUNOL, V221, P15, DOI 10.1016/j.jneuroim.2010.01.016; Greisenegger S, 2004, STROKE, V35, P1688, DOI 10.1161/01.STR.0000130512.81212.a2; Hashimoto M, 2008, J NEUROCHEM, V107, P918, DOI 10.1111/j.1471-4159.2008.05666.x; Hasselblatt M, 2006, J NEUROSURG ANESTH, V18, P132, DOI 10.1097/00008506-200604000-00007; HIRANO T, 1992, CLIN IMMUNOL IMMUNOP, V62, pS60, DOI 10.1016/0090-1229(92)90042-M; HORNYKIEWICZ O, 1988, MT SINAI J MED, V55, P11; Huh GS, 2000, SCIENCE, V290, P2155, DOI 10.1126/science.290.5499.2155; Jubinsky PT, 1997, BLOOD, V90, P1867, DOI 10.1182/blood.V90.5.1867; Kadota T, 2009, BRAIN RES, V1254, P120, DOI 10.1016/j.brainres.2008.11.094; Kennedy J, 2005, CEREBROVASC DIS, V19, P272, DOI 10.1159/000084140; Kikuchi Y, 2011, J CELL PHYSIOL, V226, P1390, DOI 10.1002/jcp.22467; Kirkeby A, 2008, THROMB HAEMOSTASIS, V99, P720, DOI 10.1160/TH07-03-0208; Leconte C, 2011, NEUROPHARMACOLOGY, V60, P354, DOI 10.1016/j.neuropharm.2010.09.025; Lee SM, 2004, BIOCHEM BIOPH RES CO, V320, P1087, DOI 10.1016/j.bbrc.2004.06.060; Leist M, 2004, SCIENCE, V305, P239, DOI 10.1126/science.1098313; Lip GYH, 2002, BLOOD COAGUL FIBRIN, V13, P339, DOI 10.1097/00001721-200206000-00010; Liu J, 2005, STROKE, V36, P1264, DOI 10.1161/01.STR.0000166180.91042.02; Liu W, 2011, EXP NEUROL, V230, P227, DOI 10.1016/j.expneurol.2011.04.021; Mahmood A, 2007, J NEUROSURG, V107, P392, DOI 10.3171/JNS-07/08/0392; MARTIN JF, 1991, LANCET, V338, P1409, DOI 10.1016/0140-6736(91)92719-I; Motero M., 2007, EXP NEUROL, V204, P106; Nijboer WN, 2010, CRIT CARE MED, V38, P1155, DOI 10.1097/CCM.0b013e3181cf6e78; Ogunshola OO, 2006, AM J PHYSIOL-REG I, V290, pR678, DOI 10.1152/ajpregu.00246.2005; Oliveira ALR, 2004, P NATL ACAD SCI USA, V101, P17843, DOI 10.1073/pnas.0408154101; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Piloto N, 2009, CARDIOVASC TOXICOL, V9, P201, DOI 10.1007/s12012-009-9054-2; Sakanaka M, 1998, P NATL ACAD SCI USA, V95, P4635, DOI 10.1073/pnas.95.8.4635; Sasaki R, 2003, INTERNAL MED, V42, P142, DOI 10.2169/internalmedicine.42.142; Schallert T, 2000, NEUROPHARMACOLOGY, V39, P777, DOI 10.1016/S0028-3908(00)00005-8; Schmidt RE, 2008, EXP NEUROL, V209, P161, DOI 10.1016/j.expneurol.2007.09.018; Schriebl K, 2006, PROTEIN EXPRES PURIF, V49, P265, DOI 10.1016/j.pep.2006.05.018; Sethi KD, 2002, CURR OPIN NEUROL, V15, P457, DOI 10.1097/00019052-200208000-00009; Shingo T, 2001, J NEUROSCI, V21, P9733, DOI 10.1523/JNEUROSCI.21-24-09733.2001; Sifringer M, 2010, BRAIN BEHAV IMMUN, V24, P792, DOI 10.1016/j.bbi.2009.08.010; Siren AL, 2009, NEUROTHERAPEUTICS, V6, P108, DOI 10.1016/j.nurt.2008.10.041; Sturm B, 2010, EUR J CLIN INVEST, V40, P561, DOI 10.1111/j.1365-2362.2010.02292.x; Sugawa M, 2002, NEUROSCI RES, V44, P391, DOI 10.1016/S0168-0102(02)00161-X; Takahashi K, 2008, BRAIN RES, V1234, P172, DOI 10.1016/j.brainres.2008.07.086; Verdonck O, 2007, J CEREBR BLOOD F MET, V27, P1369, DOI 10.1038/sj.jcbfm.9600443; Wang L, 2004, STROKE, V35, P1732, DOI 10.1161/01.STR.0000132196.49028.a4; Wang L, 2004, NEUROREPORT, V15, P1225, DOI 10.1097/01.wnr.0000127636.15181.c1; Wang L, 2007, J BIOL CHEM, V282, P32462, DOI 10.1074/jbc.M706880200; Wei L, 2006, J PHARMACOL EXP THER, V317, P109, DOI 10.1124/jpet.105.094391; Wu CL, 2010, NEUROBIOL DIS, V40, P146, DOI 10.1016/j.nbd.2010.05.019; Xiong Y, 2011, J NEUROSURG, V114, P549, DOI 10.3171/2010.10.JNS10925; Yasuhara T, 2006, FRONT BIOSCI-LANDMRK, V11, P760, DOI 10.2741/1834; Yu SW, 2002, SCIENCE, V297, P259, DOI 10.1126/science.1072221; Yuan WJ, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-75; Zhang F, 2006, J NEUROSCI RES, V83, P1241, DOI 10.1002/jnr.20816; Zhou QH, 2011, BRAIN RES, V1382, P315, DOI 10.1016/j.brainres.2011.01.061	77	18	18	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	MAR 28	2013	1502						55	70		10.1016/j.brainres.2013.01.042			16	Neurosciences	Neurosciences & Neurology	126SG	WOS:000317640900006	23380533				2021-06-18	
J	Blasiole, B; Bayir, H; Vagni, VA; Janesko-Feldman, K; Cheikhi, A; Wisniewski, SR; Long, JB; Atkins, J; Kagan, V; Kochanek, PM				Blasiole, Brian; Bayir, Huelya; Vagni, Vincent A.; Janesko-Feldman, Keri; Cheikhi, Amin; Wisniewski, Stephen R.; Long, Joseph B.; Atkins, James; Kagan, Valerian; Kochanek, Patrick M.			Effect of Hyperoxia on Resuscitation of Experimental Combined Traumatic Brain Injury and Hemorrhagic Shock in Mice	ANESTHESIOLOGY			English	Article							SEVERE HEAD-INJURY; FOCAL CEREBRAL-ISCHEMIA; FLUID PERCUSSION INJURY; NORMOBARIC HYPEROXIA; BLOOD-FLOW; OXIDATIVE STRESS; CEREBROSPINAL-FLUID; NEURONAL DEATH; OXYGEN-THERAPY; CARDIAC-ARREST	Background: Hypotension and hypoxemia worsen traumatic brain injury outcomes. Hyperoxic resuscitation is controversial. The authors proposed that hyperoxia would improve hemodynamics and neuronal survival by augmenting oxygen delivery despite increased oxidative stress and neuroinflammation in experimental combined controlled cortical impact plus hemorrhagic shock in mice. Methods: Adult C57BL6 mice received controlled cortical impact followed by 35 min of hemorrhagic shock (mean arterial pressure, 25-27 mmHg). The resuscitation phase consisted of lactated Ringer's boluses titrated to mean arterial pressure greater than 70 mmHg. Definitive care included returning shed blood. Either oxygen or room air was administered during the resuscitation phases. Brain tissue levels of oxidative stress and inflammatory markers were measured at 24 h and hippocampal neuronal survival was quantified at 7 days. Results: Hyperoxia markedly increased brain tissue oxygen tension approximately four-to fivefold (n = 8) and reduced resuscitation fluid requirements approximately 15% (n = 53; both P < 0.05). Systemic and cerebral physiologic variables were not significantly affected by hyperoxia. Hippocampal neuron survival was approximately 40% greater with oxygen versus room air (n = 18, P = 0.03). However, ascorbate depletion doubled with oxygen versus room air (n = 11, P < 0.05). Brain tissue cytokines and chemokines were increased approximately 2-to 20-fold (n = 10) after combined controlled cortical impact injury plus hemorrhagic shock, whereas hyperoxia shifted cytokines toward a proinflammatory profile. Conclusions: Hyperoxic resuscitation of cortical impact plus hemorrhagic shock reduced fluid requirements and increased brain tissue oxygen tension and hippocampal neuronal survival but exacerbated ascorbate depletion and neuroinflammation. The benefits of enhanced oxygen delivery during resuscitation of traumatic brain injury may outweigh detrimental increases in oxidative stress and neuroinflammation.	[Blasiole, Brian; Bayir, Huelya; Vagni, Vincent A.; Janesko-Feldman, Keri; Cheikhi, Amin; Wisniewski, Stephen R.; Long, Joseph B.; Atkins, James; Kagan, Valerian; Kochanek, Patrick M.] Univ Pittsburgh, Sch Med, Dept Crit Care Med, Pittsburgh, PA 15260 USA	Kochanek, PM (corresponding author), Univ Pittsburgh, Sch Med, Dept Crit Care Med, 3434 5th Ave, Pittsburgh, PA 15260 USA.	kochanekpm@ccm.upmc.edu	Kochanek, Patrick M/D-2371-2015	Kochanek, Patrick M/0000-0002-2627-913X; Wisniewski, Stephen/0000-0002-3877-9860; Kagan, Valerian E./0000-0002-7245-1885	United States Army, Tacoma, Washington [W81XWH-09-2-0187]	Received from the Department of Critical Care Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania. Submitted for publication May 17, 2012. Accepted for publication November 8, 2012. Supported by W81XWH-09-2-0187 from the United States Army, Tacoma, Washington.	Adelson PD, 2011, CHILD NERV SYST, V27, P1465, DOI 10.1007/s00381-011-1476-z; Amick Jonathan E., 2001, Pediatr Crit Care Med, V2, P260, DOI 10.1097/00130478-200107000-00013; Atkins JL, 2007, AM J PHYSIOL-HEART C, V292, pH776, DOI 10.1152/ajpheart.00381.2006; Badjatia N, 2008, PREHOSP EMERG CARE, V12, pS1, DOI 10.1080/10903120701732052; Bayir H, 2004, J NEUROTRAUM, V21, P1, DOI 10.1089/089771504772695896; Bayir H, 2002, PEDIATR RES, V51, P571, DOI 10.1203/00006450-200205000-00005; Bayir H, 2005, J CEREBR BLOOD F MET, V25, P673, DOI 10.1038/sj.jcbfm.9600068; Bayir H, 2007, J NEUROCHEM, V101, P168, DOI 10.1111/j.1471-4159.2006.04353.x; Belikova NA, 2011, J NEUROSCI METH, V201, P185, DOI 10.1016/j.jneumeth.2011.08.001; Bell MJ, 1997, J NEUROTRAUM, V14, P451, DOI 10.1089/neu.1997.14.451; Benedict FG, 1911, AM J PHYSIOL, V28, P1; Bitterman H, 1996, AM J PHYSIOL-HEART C, V271, pH203; BOUMA GJ, 1992, J NEUROSURG, V77, P360, DOI 10.3171/jns.1992.77.3.0360; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; Buttram SDW, 2007, J NEUROTRAUM, V24, P1707, DOI 10.1089/neu.2007.0349; CAMPBELL IL, 1993, P NATL ACAD SCI USA, V90, P10061, DOI 10.1073/pnas.90.21.10061; Carlos TM, 1997, J LEUKOCYTE BIOL, V61, P279; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; CHESNUT RM, 1993, ACTA NEUROCHIR, P121; CLARK RSB, 1994, J NEUROTRAUM, V11, P499, DOI 10.1089/neu.1994.11.499; Dalgard CL, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00006; DALY WJ, 1967, J CLIN INVEST, V46, P1617, DOI 10.1172/JCI105654; DEJOURS P, 1962, PHYSIOL REV, V42, P335; DeKosky ST, 1996, ANN NEUROL, V39, P123, DOI 10.1002/ana.410390118; Dennis AM, 2009, J NEUROTRAUM, V26, P889, DOI 10.1089/neu.2008.0512; DeWitt DS, 2009, J NEUROTRAUM, V26, P877, DOI 10.1089/neu.2007.0439; Diringer MN, 2007, J NEUROSURG, V106, P526, DOI 10.3171/jns.2007.106.4.526; EGGERS GWN, 1962, J APPL PHYSIOL, V17, P75; Exo JL, 2009, J NEUROTRAUM, V26, P2403, DOI 10.1089/neu.2009.0980; Figaji AA, 2010, NEUROCRIT CARE, V12, P430, DOI 10.1007/s12028-010-9344-3; Floyd TF, 2003, J APPL PHYSIOL, V95, P2453, DOI 10.1152/japplphysiol.00303.2003; Flynn EP, 2002, ANN NEUROL, V52, P566, DOI 10.1002/ana.10322; Foley LM, 2009, J NEUROTRAUM, V26, P1509, DOI 10.1089/neu.2008.0747; Hazelton JL, 2010, J NEUROTRAUM, V27, P753, DOI 10.1089/neu.2009.1186; Hemerka JN, 2012, J NEUROTRAUM, V29, P2192, DOI 10.1089/neu.2011.2303; Jadidi-Niaragh F, 2011, SCAND J IMMUNOL, V74, P1, DOI 10.1111/j.1365-3083.2011.02536.x; Kilgannon JH, 2010, JAMA-J AM MED ASSOC, V303, P2165, DOI 10.1001/jama.2010.707; Kim HY, 2005, ANN NEUROL, V57, P571, DOI 10.1002/ana.20430; Kochanek PM, 2010, JAMA-J AM MED ASSOC, V303, P2190, DOI 10.1001/jama.2010.715; Koedel U, 2007, AM J PATHOL, V171, P200, DOI 10.2353/ajpath.2007.060821; KOSSMANN T, 1995, SHOCK, V4, P311, DOI 10.1097/00024382-199511000-00001; Li ZJ, 2011, AM J PATHOL, V178, P1106, DOI 10.1016/j.ajpath.2010.12.001; Liu SM, 2006, J CEREBR BLOOD F MET, V26, P1274, DOI 10.1038/sj.jcbfm.9600277; Liu YB, 1998, STROKE, V29, P1679, DOI 10.1161/01.STR.29.8.1679; Magnoni S, 2003, J NEUROSURG, V98, P952, DOI 10.3171/jns.2003.98.5.0952; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; MARION DW, 1991, J NEUROSURG, V74, P407, DOI 10.3171/jns.1991.74.3.0407; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; Mills PH, 2012, MAGN RESON MED, V67, P278, DOI 10.1002/mrm.22998; Milone SD, 1999, CAN J PHYSIOL PHARM, V77, P124, DOI 10.1139/cjpp-77-2-124; Morganti-Kossmann MC, 2007, INJURY, V38, P1392, DOI 10.1016/j.injury.2007.10.005; Narotam PK, 2009, J NEUROSURG, V111, P672, DOI 10.3171/2009.4.JNS081150; Nelson TJ, 2006, J AM COLL SURGEONS, V202, P418, DOI 10.1016/j.jamcollsurg.2005.11.011; Nygardas M, 2011, GENE THER, V18, P646, DOI 10.1038/gt.2011.4; Otto VI, 2001, NEUROREPORT, V12, P2059, DOI 10.1097/00001756-200107030-00053; Pasgaard T, 2007, ACTA PHYSIOL, V191, P285, DOI 10.1111/j.1748-1716.2007.01745.x; Rangel-Castilla L, 2010, J NEUROTRAUM, V27, P1853, DOI 10.1089/neu.2010.1339; Rink C, 2010, J CEREBR BLOOD F MET, V30, P1275, DOI 10.1038/jcbfm.2010.7; Rockswold SB, 2010, J NEUROSURG, V112, P1080, DOI 10.3171/2009.7.JNS09363; Rousseau A, 2005, ACTA PHYSIOL SCAND, V183, P231, DOI 10.1111/j.1365-201X.2005.01405.x; Shein SL, 2011, CRIT CARE MED S, V38, pA144; Shellington DK, 2011, CRIT CARE MED, V39, P494, DOI 10.1097/CCM.0b013e318206b1fa; Shin HK, 2007, BRAIN, V130, P1631, DOI 10.1093/brain/awm071; Singhal AB, 2005, STROKE, V36, P797, DOI 10.1161/01.STR.0000158914.66827.2e; Singhal AB, 2002, NEUROLOGY, V58, P945, DOI 10.1212/WNL.58.6.945; Singhal AB, 2002, J CEREBR BLOOD F MET, V22, P861, DOI 10.1097/00004647-200207000-00011; Singhal AB, 2007, STROKE, V38, P2851, DOI 10.1161/STROKEAHA.107.487280; Spiotta AM, 2010, J NEUROSURG, V113, P571, DOI 10.3171/2010.1.JNS09506; Stamler JS, 1997, SCIENCE, V276, P2034, DOI 10.1126/science.276.5321.2034; Sukhotnik I, 2002, SHOCK, V18, P277, DOI 10.1097/00024382-200209000-00013; Sullivan PG, 1999, J NEUROSCI, V19, P6248; Tang MK, 2010, J CEREBR BLOOD F MET, V30, P119, DOI 10.1038/jcbfm.2009.194; Tisdall MM, 2008, J NEUROSURG, V109, P424, DOI 10.3171/JNS/2008/109/9/0424; Tolias CM, 2004, J NEUROSURG, V101, P435, DOI 10.3171/jns.2004.101.3.0435; TOULMOND S, 1995, BRAIN RES, V671, P261, DOI 10.1016/0006-8993(94)01343-G; Tyurin VA, 2000, J NEUROCHEM, V75, P2178, DOI 10.1046/j.1471-4159.2000.0752178.x; Valadka AB, 1998, CRIT CARE MED, V26, P1576, DOI 10.1097/00003246-199809000-00029; Vereczki V, 2006, J CEREBR BLOOD F MET, V26, P821, DOI 10.1038/sj.jcbfm.9600234; Vilalta A, 2011, J NEUROTRAUM, V28, P1139, DOI 10.1089/neu.2010.1720; Waisman D, 2003, AM J PHYSIOL-HEART C, V285, pH643, DOI 10.1152/ajpheart.00900.2002; Walson KH, 2011, CRIT CARE MED, V39, P335, DOI 10.1097/CCM.0b013e3181ffda0e; WHITEHORN WV, 1946, AM J PHYSIOL, V146, P61; Zanier ER, 2003, J NEUROTRAUM, V20, P409, DOI 10.1089/089771503765355496; Zhao D, 2011, J CLIN IMMUNOL, V31, P719, DOI 10.1007/s10875-011-9534-6; Zhao WH, 2006, J NEUROCHEM, V99, P1176, DOI 10.1111/j.1471-4159.2006.04172.x	85	18	19	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0003-3022	1528-1175		ANESTHESIOLOGY	Anesthesiology	MAR	2013	118	3					649	663		10.1097/ALN.0b013e318280a42d			15	Anesthesiology	Anesthesiology	093LH	WOS:000315192900022	23299361	Bronze			2021-06-18	
J	Brush, LN; Monagle, PT; Mackay, MT; Gordon, AL				Brush, Lauren N.; Monagle, Paul T.; Mackay, Mark T.; Gordon, Anne L.			Hypertension at time of diagnosis and long-term outcome after childhood ischemic stroke	NEUROLOGY			English	Article							TRAUMATIC BRAIN-INJURY; HIGH BLOOD-PRESSURE; RISK-FACTORS; CEREBRAL-PALSY; HEAD-INJURY; CHILDREN; SCALE; CLASSIFICATION; ASSOCIATION; RELIABILITY	Objective: To determine the prevalence of hypertension (HPT) in the acute phase after ischemic stroke (IS) and explore its relationship to outcome. Methods: We performed a retrospective review of children aged 1 month to 18 years with first IS admitted to a tertiary hospital between 2003 and 2008. Blood pressure readings recorded over the first 72 hours after diagnosis and morbidity or mortality at 12 months were documented. HPT was defined as 2 consecutive readings of systolic blood pressure >= 95th percentile for age. Results: Ninety children were identified (median age 3.8 years). Fifty-three of 84 patients (63%) who had blood pressure readings available had at least 1 episode of HPT and 19 (22%) had HPT on 3 consecutive days. HPT was more prevalent at both ends of the age spectrum. The relative risk of 12-month mortality was 4.5 times higher (95% confidence interval = 0.6-34.5, p = 0.096) and relative risk of death in the hospital was 1.7 times higher (95% confidence interval = 1.4-2.0, p = 0.05) if the patient experienced HPT. There was no association between HPT and vascular territory, etiology, or neurologic disability. Conclusions: HPT is prevalent in children with IS in the first 3 days after diagnosis and is associated with increased risk of death. Larger prospective studies involving systematic recording of blood pressure are required to delineate the impact of HPT on risk of death or disability. Neurology (R) 2013;80:1225-1230	[Brush, Lauren N.] Univ Melbourne, Sch Med, Melbourne, Vic, Australia; [Monagle, Paul T.; Mackay, Mark T.] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia; [Monagle, Paul T.] Royal Childrens Hosp, Dept Haematol, Melbourne, Vic, Australia; [Mackay, Mark T.] Royal Childrens Hosp, Dept Neurol, Melbourne, Vic, Australia; [Monagle, Paul T.; Mackay, Mark T.; Gordon, Anne L.] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; Guys & St Thomas Hosp NHS Fdn Trust, Evelina Childrens Hosp, London, England	Gordon, AL (corresponding author), Murdoch Childrens Res Inst, Melbourne, Vic, Australia.	anne.gordon@gstt.nhs.uk		Monagle, Paul/0000-0002-3970-8984; Mackay, Mark/0000-0002-3787-1112	Murdoch Children's Research Institute; Brain Foundation; National Stroke Foundation; National Health and Medical Research Council of AustraliaNational Health and Medical Research Council of AustraliaUK Research & Innovation (UKRI)Medical Research Council UK (MRC); Brockoff Foundation; Royal Children's Hospital Foundation Melbourne; University of MelbourneUniversity of Melbourne; BayerBayer AG; Stago	L. Brush reports no disclosures. M. Mackay received research funding from the Murdoch Children's Research Institute, the Brain Foundation, and the National Stroke Foundation. P. Monagle received research funding from the National Health and Medical Research Council of Australia, the Brockoff Foundation, Royal Children's Hospital Foundation Melbourne, University of Melbourne, Murdoch Children's Research Institute, and Bayer. He is a member of the steering committee of the Bayer-sponsored trial of rivaroxaban in children, and has given talks at a Stago-sponsored symposium. He gave evidence as an expert witness in the trial Waller v James. A. Gordon received research funding from the Murdoch Children's Research Institute. Go to Neurology.org for full disclosures.	Agrawal N, 2009, STROKE, V40, P3415, DOI 10.1161/STROKEAHA.109.564633; Amlie-Lefond C, 2008, LANCET NEUROL, V7, P425, DOI 10.1016/S1474-4422(08)70086-3; Bath P, 2004, CEREBROVASC DIS, V17, P51, DOI 10.1159/000074795; BRINK JD, 1980, J PEDIATR-US, V97, P721, DOI 10.1016/S0022-3476(80)80253-8; Crouchman M, 2001, ARCH DIS CHILD, V84, P120, DOI 10.1136/adc.84.2.120; DESWIET M, 1980, PEDIATRICS, V65, P1028; deVeber G, 2003, ANN NEUROL, V53, P149, DOI 10.1002/ana.10461; deVeber G, 2000, Semin Pediatr Neurol, V7, P309, DOI 10.1053/spen.2000.20074; deVeber GA, 2000, J CHILD NEUROL, V15, P316, DOI 10.1177/088307380001500508; Dickinson CJ, 2003, CURR OPIN NEPHROL HY, V12, P91, DOI 10.1097/00041552-200301000-00015; Dickinson CJ, 2001, J HYPERTENS, V19, P1515, DOI 10.1097/00004872-200109000-00001; Eliasson AC, 2006, DEV MED CHILD NEUROL, V48, P549, DOI 10.1017/S0012162206001162; Fullerton HJ, 2007, PEDIATRICS, V119, P495, DOI 10.1542/peds.2006-2791; Ganesan V, 2003, ANN NEUROL, V53, P167, DOI 10.1002/ana.10423; Ganesan V, 2006, CIRCULATION, V114, P2170, DOI 10.1161/CIRCULATIONAHA.105.583690; Gordon AL, 2002, J CHILD NEUROL, V17, P429, DOI 10.1177/088307380201700606; Horan M, 1987, PEDIATRICS, V79, P1; Hutchison James S, 2004, Semin Pediatr Neurol, V11, P139, DOI 10.1016/j.spen.2004.04.004; Jordan LC, 2006, NEUROLOGIST, V12, P94, DOI 10.1097/01.nrl.0000195826.72179.0b; KANTER RK, 1985, CLIN PEDIATR, V24, P320, DOI 10.1177/000992288502400603; Keezer MR, 2008, CEREBROVASC DIS, V25, P202, DOI 10.1159/000113857; Kirkham FJ, 2003, CURR OPIN PEDIATR, V15, P547, DOI 10.1097/00008480-200312000-00002; Leonardi-Bee J, 2002, STROKE, V33, P1315, DOI 10.1161/01.STR.0000014509.11540.66; Mackay MT, 2007, AUST FAM PHYSICIAN, V36, P896; MACMAHON S, 1990, LANCET, V335, P765, DOI 10.1016/0140-6736(90)90878-9; Molofsky WJ, 2006, PEDIATR ANN, V35, P379, DOI 10.3928/0090-4481-20060501-10; Murphy S L, 2000, Natl Vital Stat Rep, V48, P1; Natl High Blood Pressure Educ Prog, 2004, PEDIATRICS, V114, P555; OCONNELL JE, 1994, BMJ-BRIT MED J, V308, P1523, DOI 10.1136/bmj.308.6943.1523; Paget SP, 2012, DEV NEUROREHABIL, V15, P171, DOI 10.3109/17518423.2012.671381; Palisano R, 1997, DEV MED CHILD NEUROL, V39, P214, DOI 10.1111/j.1469-8749.1997.tb07414.x; Pavlakis SG, 2009, STROKE, V40, pS79, DOI 10.1161/STROKEAHA.108.531749; Roach ES, 2008, STROKE, V39, P2644, DOI 10.1161/STROKEAHA.108.189696; Salorio CF, 2008, PEDIATR CRIT CARE ME, V9, P47, DOI 10.1097/01.PCC.0000298638.66240.0E; Strater R, 2002, LANCET, V360, P1540, DOI 10.1016/S0140-6736(02)11520-0; Tikhonoff V, 2009, LANCET NEUROL, V8, P938, DOI 10.1016/S1474-4422(09)70184-X; Vavilala MS, 2003, J TRAUMA, V55, P1039, DOI 10.1097/01.TA.0000101759.23607.57; WALLACE JD, 1981, JAMA-J AM MED ASSOC, V246, P2177, DOI 10.1001/jama.246.19.2177; Willmot M, 2004, HYPERTENSION, V43, P18, DOI 10.1161/01.HYP.0000105052.65787.35; World Health Organization, INT STAT CLASS DIS R; Wraige E, 2005, DEV MED CHILD NEUROL, V47, P252, DOI 10.1017/S0012162205000484	41	18	18	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0028-3878	1526-632X		NEUROLOGY	Neurology	MAR	2013	80	13					1225	1230		10.1212/WNL.0b013e3182896ffb			6	Clinical Neurology	Neurosciences & Neurology	113OF	WOS:000316676700019	23468545				2021-06-18	
J	Crowe, LM; Catroppa, C; Babl, FE; Anderson, V				Crowe, Louise M.; Catroppa, Cathy; Babl, Franz E.; Anderson, Vicki			Executive function outcomes of children with traumatic brain injury sustained before three years	CHILD NEUROPSYCHOLOGY			English	Article						Traumatic brain injury; Executive function; Attention; Early brain injury; Cognitive development	PEDIATRIC HEAD-INJURY; GLASGOW COMA SCALE; YOUNG-CHILDREN; ATTENTION DEFICITS; FOLLOW-UP; INFANTS; CHILDHOOD; RECOVERY; AGE; MATURATION	Traumatic brain injury (TBI) is a common cause of disability in childhood. While the outcomes of TBI sustained in school years has been heavily researched, very little is known about the impact of TBI in infants and young children. The aim of this study was to investigate the impact of TBI on executive function (EF) in children who sustained a TBI before 3 years of age. A group of 55 children, 19 with a mild TBI, 16 children with a moderate-severe TBI, and 20 uninjured comparison children participated. The EF of children aged 3 to 6 years were compared using child-based measures of attentional control and information processing. Parents completed questionnaires rating their child's EF. Severity groups differed on the child-based EF measure of attentional control with children with TBI performing below the control group. There were no significant group differences for information processing or parent-rated EF. It appears that children who sustain a TBI before the age of 3 years display impairments in some areas of attentional control 34 years postinjury. The findings fit with the existing EF literature for older children.	[Crowe, Louise M.; Catroppa, Cathy; Anderson, Vicki] Univ Melbourne, Dept Psychol Sci, Melbourne, Vic, Australia; [Crowe, Louise M.; Catroppa, Cathy; Babl, Franz E.; Anderson, Vicki] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Babl, Franz E.; Anderson, Vicki] Royal Childrens Hosp, Emergency Dept, Melbourne, Vic, Australia; [Anderson, Vicki] Royal Childrens Hosp, Dept Psychol, Melbourne, Vic, Australia	Crowe, LM (corresponding author), Royal Childrens Hosp, Murdoch Childrens Res Inst, Australian Ctr Child Neuropsychol Studies, Flemington Rd, Parkville, Vic 3052, Australia.	louise.crowe@mcri.edu.au		Crowe, Louise/0000-0003-4619-9708	Foundation for Children; Victorian Government's Operational Infrastructure Support Program	This study was supported by a grant from the Foundation for Children and the Victorian Government's Operational Infrastructure Support Program.	Agran PF, 2003, PEDIATRICS, V111, pE683, DOI 10.1542/peds.111.6.e683; Anderson P, 2002, CHILD NEUROPSYCHOL, V8, P71, DOI 10.1076/chin.8.2.71.8724; Anderson V, 1998, NEUROPSYCHOL REHABIL, V8, P283; Anderson V, 2005, BRAIN INJURY, V19, P459, DOI 10.1080/02699050400004823; Anderson V, 1995, CHILD NEUROPSYCHOL, V1, P187, DOI 10.1080/09297049508400224; Anderson VA, 2005, J NEUROL NEUROSUR PS, V76, P401, DOI 10.1136/jnnp.2003.019174; Anderson VA, 2001, DEV NEUROPSYCHOL, V20, P385, DOI 10.1207/S15326942DN2001_5; Anderson V, 2009, DEV NEUROREHABIL, V12, P253, DOI 10.3109/17518420903086899; Anderson V, 2009, PEDIATRICS, V124, pE1064, DOI 10.1542/peds.2009-0365; BERNEY J, 1994, CHILD NERV SYST, V10, P517, DOI 10.1007/BF00335074; Case ME, 2008, BRAIN PATHOL, V18, P583, DOI 10.1111/j.1750-3639.2008.00203.x; Catroppa C, 2005, J INT NEUROPSYCH SOC, V11, P84, DOI 10.1017/S1355617705050101; Catroppa C, 2007, J PEDIATR PSYCHOL, V32, P354, DOI 10.1093/jpepsy/jsl019; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd; Crowe L, 2009, J PAEDIATR CHILD H, V45, P346, DOI 10.1111/j.1440-1754.2009.01499.x; Dennis M, 1995, TRAUMATIC HEAD INJUR; Dennis M., 1989, CLIN NEUROPSYCHOLOGY, P89; Ennis Elaine, 2004, Pediatr Rehabil, V7, P205, DOI 10.1080/13638490410001703316; Espy KA, 2001, CLIN NEUROPSYCHOL, V15, P46, DOI 10.1076/clin.15.1.46.1908; Ewing-Cobbs L, 2004, DEV NEUROPSYCHOL, V26, P487, DOI 10.1207/s15326942dn2601_7; Ewing-Cobbs L, 1997, J Int Neuropsychol Soc, V3, P581; Ewing-Cobbs L, 1998, PEDIATRICS, V102, P300, DOI 10.1542/peds.102.2.300; Ewing-Cobbs L, 1998, CHILD NEUROPSYCHOL, V4, P35, DOI 10.1076/chin.4.1.35.3194; Ghahreman A, 2005, J NEUROSURG, V103, P213, DOI 10.3171/ped.2005.103.3.0213; Ginstfeldt T, 2010, BRAIN INJURY, V24, P1123, DOI 10.3109/02699052.2010.506853; Gioia G.A., 2002, BEHAV RATING INVENTO; Greenes DS, 1999, PEDIATRICS, V104, P861, DOI 10.1542/peds.104.4.861; Gronwall D, 1997, J Int Neuropsychol Soc, V3, P592; HUDSPETH WJ, 1990, J EDUC PSYCHOL, V82, P881, DOI 10.1037/0022-0663.82.4.881; Jacobs R., 2010, CORTEX; KAUFMANN PM, 1993, J CHILD NEUROL, V8, P348, DOI 10.1177/088307389300800410; Keenan HT, 2007, PEDIATRICS, V119, pE616, DOI 10.1542/peds.2006-2313; Kelly T P, 1999, Pediatr Rehabil, V3, P187; Korkman M., 2007, NEPSY 2; LEVIN HS, 1993, ARCH NEUROL-CHICAGO, V50, P897, DOI 10.1001/archneur.1993.00540090008004; LEZAK MD, 1982, INT J PSYCHOL, V17, P281, DOI 10.1080/00207598208247445; LIEHLAI MW, 1992, J PEDIATR-US, V120, P195, DOI 10.1016/S0022-3476(05)80426-3; Mack KA, 2008, PEDIATRICS, V121, P930, DOI 10.1542/peds.2007-1731; Maillard-Wermelinger A, 2009, DEV NEUROREHABIL, V12, P330, DOI 10.3109/17518420903087251; Mangeot S, 2002, CHILD NEUROPSYCHOL, V8, P271, DOI 10.1076/chin.8.4.271.13503; Margulies SS, 2000, J BIOMECH ENG-T ASME, V122, P364, DOI 10.1115/1.1287160; MCKAY KE, 1994, DEV NEUROPSYCHOL, V10, P121, DOI 10.1080/87565649409540572; MIRSKY A F, 1991, Neuropsychology Review, V2, P109, DOI 10.1007/BF01109051; Muscara F, 2008, DEV NEUROPSYCHOL, V33, P623, DOI 10.1080/87565640802171162; Nadebaum C, 2007, DEV NEUROPSYCHOL, V32, P703, DOI 10.1080/87565640701376086; Ommaya AK, 2002, BRIT J NEUROSURG, V16, P220, DOI 10.1080/02688690220148824; Ornstein TJ, 2009, J CHILD PSYCHOL PSYC, V50, P506, DOI 10.1111/j.1469-7610.2008.01997.x; Pickett W, 2003, PEDIATRICS, V111, DOI 10.1542/peds.111.4.e365; REILLY PL, 1988, CHILD NERV SYST, V4, P30; Semsa H., 2008, PEDIATRICS, V121, pe1686; Smidts DP, 2004, DEV NEUROPSYCHOL, V26, P385, DOI 10.1207/s15326942dn2601_2; Spencer-Smith M, 2009, DEV NEUROREHABIL, V12, P279, DOI 10.3109/17518420903090701; Tamm L, 2002, J AM ACAD CHILD PSY, V41, P1231, DOI 10.1097/00004583-200210000-00013; Taylor HG, 1999, NEUROPSYCHOLOGY, V13, P76, DOI 10.1037/0894-4105.13.1.76; TEASDALE G, 1974, LANCET, V2, P81; Trewin D., 2006, AUSTR NZ STANDARD CL; Wade SL, 2011, DEV PSYCHOL, V47, P119, DOI 10.1037/a0021028; Warrington SA, 2001, ARCH DIS CHILD, V85, P104, DOI 10.1136/adc.85.2.104; Wechsler, 2002, WECHSLER PRESCHOOL P; Wechsler D., 1974, MANUAL WECHSLER INTE; WELSH MC, 1991, DEV NEUROPSYCHOL, V7, P131, DOI 10.1080/87565649109540483; Wetherington CE, 2010, J PEDIATR PSYCHOL, V35, P662, DOI 10.1093/jpepsy/jsp081; Yeates KO, 2010, NEUROPSYCHOLOGY, V24, P345, DOI 10.1037/a0018387	63	18	18	2	21	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0929-7049	1744-4136		CHILD NEUROPSYCHOL	Child Neuropsychol.	MAR 1	2013	19	2					113	126		10.1080/09297049.2011.651079			14	Clinical Neurology	Neurosciences & Neurology	100DI	WOS:000315675600001	22384854				2021-06-18	
J	Eriksson, G; Tham, K; Kottorp, A				Eriksson, Gunilla; Tham, Kerstin; Kottorp, Anders			A cross-diagnostic validation of an instrument measuring participation in everyday occupations: The Occupational Gaps Questionnaire (OGQ)	SCANDINAVIAN JOURNAL OF OCCUPATIONAL THERAPY			English	Article						assessment; construct validity; occupational therapy; Rasch analysis; rehabilitation	LIFE; MODEL	The aim of this study was to validate the Occupational Gaps Questionnaire (OGQ) when used in samples of people with acquired brain injuries (ABI), stroke, stress-related disorders, concussion, and persons receiving rehabilitation after ABI to investigate whether the OGQ could be used as a generic scale. A total of 601 individuals answered the OGQ at various time points after illness/injury. A Rasch analysis was performed on the data to evaluate evidence of internal scale validity and person response validity, and the capability of the OGQ to separate people into different levels of participation in everyday occupations. The results provided evidence that the OGQ is a valid measure across different diagnostic groups. A generic version of the OGQ can separate at least two levels of perceived occupational gaps and is therefore recommended as a screening tool to be used by occupational therapists working with different diagnostic groups.	[Eriksson, Gunilla; Tham, Kerstin; Kottorp, Anders] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Div Occupat Therapy, S-14183 Stockholm, Sweden; [Eriksson, Gunilla] Akad Sjukhuset, Univ Hosp, Dept Speech Pathol Physiotherapy & Occupat Therap, Uppsala, Sweden; [Eriksson, Gunilla] Uppsala Univ, Dept Publ Hlth & Care Sci, Uppsala, Sweden; [Kottorp, Anders] Zurich Univ Appl Sci, Winterthur, Switzerland	Eriksson, G (corresponding author), Karolinska Inst, Dept Neurobiol Care Sci & Soc, Div Occupat Therapy, Alfred Nobels Alle 23, S-14183 Stockholm, Sweden.	gunilla.eriksson@ki.se	Tham, Kerstin/T-3964-2018	Tham, Kerstin/0000-0001-7025-5226; Kottorp, Anders/0000-0002-8976-2612	Health Care Sciences Postgraduate School at Karolinska Institutet, Stockholm, Sweden; Swedish Brain Foundation; Swedish Stroke Association; Swedish Research CouncilSwedish Research CouncilEuropean Commission; Swedish Council for Working Life and Social WelfareSwedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte); Stockholm County CouncilStockholm County Council; Karolinska Institutet, Stockholm, Sweden; Uppsala County Council; Uppsala University, Uppsala, Sweden; Swedish Association of Occupational Therapists	The authors would like to thank the researchers who collected the data in the subsamples. Financial support was provided by the Health Care Sciences Postgraduate School at Karolinska Institutet, Stockholm, Sweden, the Swedish Brain Foundation, the Swedish Stroke Association, the Swedish Research Council, the Swedish Council for Working Life and Social Welfare, the regional agreement on medical training and clinical research (ALF) between Stockholm County Council and Karolinska Institutet, Stockholm, Sweden and between Uppsala County Council and Uppsala University, Uppsala, Sweden, and the Swedish Association of Occupational Therapists.	Baum C.M, 2001, ACTIVITY CARD SORT T; Bond T.G., 2007, APPL RASCH MODEL FUN; Eriksson G, 2006, J REHABIL MED, V38, P159, DOI 10.1080/16501970500415322; Eriksson G, 2010, OTJR-OCCUP PART HEAL, V30, P184, DOI 10.3928/15394492-20091123-01; Eriksson G, 2009, J REHABIL MED, V41, P187, DOI 10.2340/16501977-0307; Fallahpour M, 2011, OTJR-OCCUP PART HEAL, V31, P200, DOI 10.3928/15394492-20110513-01; Fisher AG, 2006, ASSESSMENT MOTOR PRO, V1; Fisher WP., 1992, RASCH MEASUREMENT T, V6, P238; FSA, 2012, GAP VARD AKT INSR SO; Heinemann AW, 2010, ARCH PHYS MED REHAB, V91, pS72, DOI 10.1016/j.apmr.2009.11.031; Kielhofner G, 2008, MODEL HUMAN OCCUPATI; Law M, 2002, AM J OCCUP THER, V56, P640, DOI 10.5014/ajot.56.6.640; Linacre J. M., 2007, WINSTEPS RASCH MEASU; Linacre J.M., 2002, RASCH MEASUREMENT T, V16, P878; Linacre JM., 2011, USERS GUIDE WINSTEPS; MANTEL N, 1959, J NATL CANCER I, V22, P719; MANTEL N, 1963, J AM STAT ASSOC, V58, P690; Mayo NE, 1999, DISABIL REHABIL, V21, P258; Patomella AH, 2006, J REHABIL MED, V38, P273, DOI 10.1080/16501970600632594; Polatajko, 2007, ENABLING OCCUPATION; Tennant A, 2004, MED CARE, V42, P37, DOI 10.1097/01.mlr.0000103529.63132.77; Tennant A, 2007, ARTHRIT RHEUM-ARTHR, V57, P1358, DOI 10.1002/art.23108; Wright BD., 1994, RASCH MEASUREMENT T, V8, P370, DOI DOI 10.1177/01461672012710004	23	18	19	0	13	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1103-8128	1651-2014		SCAND J OCCUP THER	Scand. J. Occup. Ther.	MAR	2013	20	2					152	160		10.3109/11038128.2012.749944			9	Rehabilitation	Rehabilitation	095TN	WOS:000315357700010	23216376				2021-06-18	
J	Rust, DA; Gilmore, CJ; Treme, G				Rust, David A.; Gilmore, C. Jan; Treme, Gehron			Injury Patterns at a Large Western United States Ski Resort With and Without Snowboarders The Taos Experience	AMERICAN JOURNAL OF SPORTS MEDICINE			English	Article						ski; snowboard; ACL; knee sprain; wrist sprain; distal radius fracture; closed head injuries; AC separation; wrist guard; helmet	RISK; 10-YEAR	Background: Differences in injury patterns among alpine skiers and snowboarders have previously been recognized, and controversy remains about the safety implications that snowboarding may pose to a ski resort. A change of policy at Taos Ski Valley provides a unique and modern perspective on the effect that snowboarders have on ski resort injuries. Hypothesis: The addition of snowboarders to a large ski resort may result in a significant change in both the rate and pattern of injuries treated. Study Design: Descriptive epidemiology study. Methods: Patient records from the Mogul Medical Clinic at Taos Ski Valley were reviewed from the 2006-2007 ski season through the 2009-2010 season (approximately 2 years before and after snowboarding was allowed) and recorded for age, sex, diagnosis, body region, anatomic location, injury type, and sport (skiing, snowboarding). The total numbers of mountain visits for the time periods with and without snowboarding were used to determine injury rates. Results: The overall rate of persons injured increased from 206.7 per 100,000 mountain visits without snowboarders to 233.8 with snowboarders. The relative risk ratio was 1.131, also represented as a 13.1% increased risk of injury (IRI) (statistically significant; 95% CI, 3.5%-23.6%). Increases were seen in the rate of upper extremity injuries (IRI, 39.1%; 95% CI, 14.3-69.4) and head/neck injuries (IRI 30.8%; not significant), while lower extremity and trunk/pelvis injuries remained relatively constant. Distal radius fractures, closed head injuries, and acromioclavicular separations showed statistically significant increases with the addition of snowboarding. The most frequent injuries among snowboarders were distal radius fractures, wrist sprains, closed head injuries, and acromioclavicular separations. The most frequent injuries among skiers were anterior cruciate ligament tears, knee sprains, closed head injuries, and gastrocnemius tears. The median age of injured persons decreased from 39 years (range, 4-100 years) without snowboarders to 31 years (range, 4-99 years) with snowboarders, and this was significant. Approximately 45% of injured persons were female, and this did not change with the addition of snowboarders. Conclusion: In this study, there was a small but statistically significant increase in the likelihood of injury with the addition of snowboarding to a large ski resort. It is likely that factors such as younger demographic, elevated risk-taking behavior, or increased mountain crowding are involved. The difference in injuries is largely because of a significant increase in distal radius fractures, closed head injuries, and acromioclavicular separations. On mountain safety precautions such as widening of runs and streamlining of high traffic areas, training medical providers to recognize and treat sport-specific injuries, and promoting the use of wrist guards and helmets may be useful in reducing the effect that snowboarders have on ski resort injuries.	[Rust, David A.; Gilmore, C. Jan; Treme, Gehron] Univ New Mexico, Hlth Sci Ctr, Albuquerque, NM 87131 USA	Rust, DA (corresponding author), 1 Univ New Mexico, Dept Orthopaed & Rehabil, MSC10 5600, Albuquerque, NM 87131 USA.	rustdave@hotmail.com					ABULABAN RB, 1991, CAN MED ASSOC J, V145, P1097; Aschauer E, 2007, UNFALLCHIRURG, V110, P301, DOI 10.1007/s00113-007-1263-1; Bergstrom KA, 1999, SCAND J MED SCI SPOR, V9, P110; BLADIN C, 1993, AM J SPORT MED, V21, P701, DOI 10.1177/036354659302100511; Cusimano MD, 2010, BRIT J SPORT MED, V44, P781, DOI 10.1136/bjsm.2009.070573; Florenes TW, 2012, SCAND J MED SCI SPOR, V22, P58, DOI 10.1111/j.1600-0838.2010.01147.x; Hasler RM, 2010, BRIT J SPORT MED, V44, P816, DOI 10.1136/bjsm.2010.071357; Hayes JR, 2008, J PEDIATR SURG, V43, P928, DOI 10.1016/j.jpedsurg.2007.12.041; Idzikowski JR, 2000, AM J SPORT MED, V28, P825, DOI 10.1177/03635465000280061001; Kim S, 2012, AM J SPORT MED, V40, P770, DOI 10.1177/0363546511433279; Kroneke EL, 2008, CLIN J SPORT MED, V18, P38, DOI 10.1097/JSM.0b013e318160c044; Made C, 2004, SCAND J MED SCI SPOR, V14, P128, DOI 10.1111/j.1600-0838.2003.00342.x; Matsunaga T, 2004, BRIT J SPORT MED, V38, P80, DOI 10.1136/bjsm.2002.001578; Moffat C, 2009, WEST J EMERG MED, V10, P257; O'Neill DF, 1999, AM J SPORT MED, V27, P94; Olsson H, 2009, NY TIMES, pD6; PINO EC, 1989, AM J SPORT MED, V17, P778, DOI 10.1177/036354658901700610; Russell K, 2007, CLIN J SPORT MED, V17, P145, DOI 10.1097/JSM.0b013e31803f901b; Sacco DE, 1998, J TRAUMA, V44, P654, DOI 10.1097/00005373-199804000-00016; Schoffl V, 2011, WILD ENVIRON MED, V22, P46, DOI 10.1016/j.wem.2010.11.008; Schoffl V, 2010, SPORTS MED, V40, P657, DOI 10.2165/11533690-000000000-00000; SnowSports Industries America, 2012, 2012 SNOW SPORTS PAR; Wakahara K, 2006, AM J SPORT MED, V34, P1670, DOI 10.1177/0363546506288113; Wasden CC, 2009, J TRAUMA, V67, P1022, DOI 10.1097/TA.0b013e3181b0d559	24	18	18	0	11	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0363-5465	1552-3365		AM J SPORT MED	Am. J. Sports Med.	MAR	2013	41	3					652	656		10.1177/0363546512472045			5	Orthopedics; Sport Sciences	Orthopedics; Sport Sciences	098QG	WOS:000315563200024	23324432				2021-06-18	
J	Smania, N; Avesani, R; Roncari, L; Ianes, P; Girardi, P; Varalta, V; Gambini, MG; Fiaschi, A; Gandolfi, M				Smania, Nicola; Avesani, Renato; Roncari, Laura; Ianes, Patrizia; Girardi, Paolo; Varalta, Valentina; Gambini, Maria Grazia; Fiaschi, Antonio; Gandolfi, Marialuisa			Factors Predicting Functional and Cognitive Recovery Following Severe Traumatic, Anoxic, and Cerebrovascular Brain Damage	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						Disability Rating Scale; discharge destination; outcome assessment; predictive factors; prognosis; rehabilitation	DISABILITY RATING-SCALE; GLASGOW OUTCOME SCALE; SEVERE HEAD-INJURY; INDEPENDENCE MEASURE; INPATIENT REHABILITATION; DISCHARGE DESTINATION; STROKE; MODERATE; RELIABILITY; POPULATION	Objectives: To compare demographic data, clinical data, and rate of functional and cognitive recovery in patients with severe traumatic, cerebrovascular, or anoxic acquired brain injury (ABI) and to identify factors predicting discharge home. Participants: Three hundred twenty-nine patients with severe ABI (192 with traumatic, 104 with cerebrovascular, and 33 with anoxic brain injury). Design: Longitudinal prospective study of inpatients attending the intensive Rehabilitation Department of the "Sacro Cuore" Don Calabria Hospital (Negrar, Verona, Italy). Main measures: Etiology, sex, age, rehabilitation admission interval, rehabilitation length of stay, discharge destination, Glasgow Coma Scale, Disability Rating Scale (DRS), Glasgow Outcome Scale, Levels of Cognitive Functioning, and Functional Independence Measure. Results: Predominant etiology was traumatic; male gender was prevalent in all the etiologic groups; patients with traumatic brain injury were younger than the patients in the other groups and had shorter rehabilitation admission interval, greater functional and cognitive outcomes on all considered scales, and a higher frequency of returning home. Patients with anoxic brain injury achieved the lowest grade of functional and cognitive recovery. Age, etiology, and admission DRS score predicted return home. Conclusions: Patients with traumatic brain injury achieved greater functional and cognitive improvements than patients with cerebrovascular and anoxic ABI. Age, etiology, and admission DRS score can assist in predicting discharge destination.	[Smania, Nicola; Roncari, Laura; Ianes, Patrizia; Varalta, Valentina; Fiaschi, Antonio; Gandolfi, Marialuisa] Univ Verona, Dept Neurol Neuropsychol Morphol & Movement Sci, Venice, Italy; [Roncari, Laura] Univ Verona, Sch Specializat Phys Med & Rehabil, Venice, Italy; [Girardi, Paolo] Univ Verona, Dept Med & Publ Hlth, Unit Epidemiol & Med Stat, Venice, Italy; [Smania, Nicola; Ianes, Patrizia; Varalta, Valentina; Gandolfi, Marialuisa] Sacro Cuore Don Calabria, Neuromotor & Cognit Rehabil Res Ctr CRRNC, Verona, Italy; [Avesani, Renato; Gambini, Maria Grazia] Sacro Cuore Don Calabria, Rehabil Dept, Verona, Italy; [Fiaschi, Antonio] IRCCS Osped San Camillo Venezia Lido, Venice, Italy	Smania, N (corresponding author), Azienda Osped Univ Integrata Verona, Dept Neurol Neuropsychol Morphol & Movement Sci, S Riabilitaz Neurol, GB Rossi Univ Hosp, Via LA Scuro 10, I-37134 Verona, Italy.	nicola.smania@univr.it	Gandolfi, Marialuisa/J-7033-2018; Varalta, Valentina/AAB-2055-2019	Gandolfi, Marialuisa/0000-0002-0877-4807; Gambini, Maria Grazia/0000-0002-6211-2169; girardi, Paolo/0000-0001-8330-9414	Cari Verona Foundation (Mosaico), Verona, Italy	A grant from the Cari Verona Foundation (Mosaico), Verona, Italy, supported this study.	ALEXANDER MP, 1994, STROKE, V25, P128, DOI 10.1161/01.STR.25.1.128; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boake C, 2000, PHYS MED REHABILITAT, P1073; Burke DT, 2005, BRAIN INJURY, V19, P675, DOI 10.1080/02699050400024953; Cifu DX, 1996, ARCH PHYS MED REHAB, V77, P883, DOI 10.1016/S0003-9993(96)90274-9; Colantonio A, 2011, J REHABIL MED, V43, P311, DOI 10.2340/16501977-0783; COWEN TD, 1995, ARCH PHYS MED REHAB, V76, P797, DOI 10.1016/S0003-9993(95)80542-7; Cullen NK, 2011, BRAIN INJURY, V25, P35, DOI 10.3109/02699052.2010.531691; Cullen NK, 2009, PM&R, V1, P1069, DOI 10.1016/j.pmrj.2009.09.013; Cullen NK, 2008, BRAIN INJURY, V22, P1013, DOI 10.1080/02699050802530581; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Eilander HJ, 2007, BRAIN INJURY, V21, P53, DOI 10.1080/02699050601151795; ELIASON MR, 1984, PHYS THER, V64, P1357, DOI 10.1093/ptj/64.9.1357; Fertl E, 2000, RESUSCITATION, V47, P231, DOI 10.1016/S0300-9572(00)00239-2; Flanagan SR, 2008, ARCH PHYS MED REHAB, V89, pS9, DOI 10.1016/j.apmr.2007.12.010; FLEMING JM, 1994, ARCH PHYS MED REHAB, V75, P156; Formisano R, 2005, ACT NEUR S, V93, P201; Fragala MA, 2002, BRAIN INJURY, V16, P149, DOI 10.1080/02699050110103328; GOUVIER WD, 1987, ARCH PHYS MED REHAB, V68, P94; Gray DS, 2000, ARCH PHYS MED REHAB, V81, P1447, DOI 10.1053/apmr.2000.16343; GROSWASSER Z, 1989, ARCH PHYS MED REHAB, V70, P186; Hagen C, 1979, REHABILITATION HEAD, P87; HALL K, 1985, ARCH PHYS MED REHAB, V66, P35; Hall KM, 1996, J HEAD TRAUMA REHAB, V11, P27, DOI 10.1097/00001199-199610000-00004; Hammond FM, 2001, J HEAD TRAUMA REHAB, V16, P318, DOI 10.1097/00001199-200108000-00003; Hillen T, 2000, STROKE, V31, P469, DOI 10.1161/01.STR.31.2.469; Husson EC, 2010, J REHABIL MED, V42, P425, DOI 10.2340/16501977-0566; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Kothari S, 2008, ARCH PHYS MED REHAB, V89, pS27, DOI 10.1016/j.apmr.2007.12.014; Kwasnica C, 2008, ARCH PHYS MED REHAB, V89, pS15, DOI 10.1016/j.apmr.2007.12.006; Lippert-Gruener M, 2007, BRAIN INJURY, V21, P1001, DOI 10.1080/02699050701468933; Malec JF, 1996, ARCH PHYS MED REHAB, V77, P198, DOI 10.1016/S0003-9993(96)90168-9; MARSHALL LF, 1991, J NEUROSURG S, V75, P28; OCZKOWSKI WJ, 1993, ARCH PHYS MED REHAB, V74, P1291, DOI 10.1016/0003-9993(93)90081-K; Ottenbacher KJ, 1996, ARCH PHYS MED REHAB, V77, P1226, DOI 10.1016/S0003-9993(96)90184-7; Paolucci S, 2003, STROKE, V34, P2861, DOI 10.1161/01.STR.0000102902.39759.D3; RAPPAPORT M, 1989, ARCH PHYS MED REHAB, V70, P885; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Riachy M, 2008, BMC NEUROL, V26, P8; Rosen DS, 2005, NEUROCRIT CARE, V2, P110, DOI 10.1385/NCC:2:2:110; Sandstrom R, 1998, ARCH PHYS MED REHAB, V79, P762, DOI 10.1016/S0003-9993(98)90353-7; SAZBON L, 1993, J NEUROL NEUROSUR PS, V56, P407, DOI 10.1136/jnnp.56.4.407; Schmidt JG, 1997, J NEUROL REHABIL, V11, P189; Shah MK, 2004, BRAIN INJURY, V18, P111, DOI 10.1080/0269905031000149551; Shah MK, 2007, J NEUROL SCI, V260, P95, DOI 10.1016/j.jns.2007.04.012; Stucki G, 2005, DISABIL REHABIL, V27, P353, DOI 10.1080/09638280400014105; Taricco M, 2006, Eura Medicophys, V42, P73; Teasell R, 2007, BRAIN INJURY, V21, P107, DOI 10.1080/02699050701201524; Tooth L, 2001, BRAIN INJURY, V15, P613, DOI 10.1080/02699050010013923; ZAMPOLINI M, 2003, ITAL J REHABIL MED M, V17, P15	50	18	18	0	16	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2013	28	2					131	140		10.1097/HTR.0b013e31823c0127			10	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	105HU	WOS:000316058300007	22333677				2021-06-18	
J	Tang, DD; Hu, L; Li, H; Zhang, QL; Chen, AT				Tang, Dandan; Hu, Li; Li, Hong; Zhang, Qinglin; Chen, Antao			The Neural Dynamics of Conflict Adaptation within a Look-to-Do Transition	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; COGNITIVE CONTROL MECHANISMS; TRAUMATIC BRAIN-INJURY; INDUCED BEHAVIORAL-ADJUSTMENT; STROOP TASK; SEQUENTIAL MODULATIONS; PREFRONTAL CORTEX; RESPONSE CONFLICT; EXECUTIVE CONTROL; DECISION-MAKING	Background: For optimal performance in conflict situations, conflict adaptation (conflict detection and adjustment) is necessary. However, the neural dynamics of conflict adaptation is still unclear. Methods: In the present study, behavioral and electroencephalography (EEG) data were recorded from seventeen healthy participants during performance of a color-word Stroop task with a novel look-to-do transition. Within this transition, participants looked at the Stroop stimuli but no responses were required in the 'look' trials; or made manual responses to the Stroop stimuli in the 'do' trials. Results: In the 'look' trials, the amplitude modulation of N450 occurred exclusively in the right-frontal region. Subsequently, the amplitude modulation of sustained potential (SP) emerged in the posterior parietal and right-frontal regions. A significantly positive correlation between the modulation of reconfiguration in the 'look' trials and the behavioral conflict adaptation in the 'do' trials was observed. Specially, a stronger information flow from right-frontal region to posterior parietal region in the beta band was observed for incongruent condition than for congruent condition. In the 'do' trials, the conflict of 'look' trials enhanced the amplitude modulations of N450 in the right-frontal and posterior parietal regions, but decreased the amplitude modulations of SP in these regions. Uniquely, a stronger information flow from centro-parietal region to right-frontal region in the theta band was observed for il condition than for cl condition. Conclusion: All these findings showed that top-down conflict adaptation is implemented by: (1) enhancing the sensitivity to conflict detection and the adaptation to conflict resolution; (2) modulating the effective connectivity between parietal region and right-frontal region.	[Tang, Dandan; Hu, Li; Zhang, Qinglin; Chen, Antao] Southwest Univ, Key Lab Cognit & Personal, Minist Educ, Fac Psychol, Chongqing, Peoples R China; [Li, Hong; Chen, Antao] Liaoning Normal Univ, Res Ctr Psychol Dev & Educ, Dalian, Liaoning, Peoples R China	Chen, AT (corresponding author), Southwest Univ, Key Lab Cognit & Personal, Minist Educ, Fac Psychol, Chongqing, Peoples R China.	xscat@swu.edu.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [31170980, 81271477]; Foundation for the Author of National Excellent Doctoral Dissertation of PR ChinaFoundation for the Author of National Excellent Doctoral Dissertation of China [201107]; New Century Excellent Talents in UniversityProgram for New Century Excellent Talents in University (NCET) [NCET-11-0698]; Fundamental Research Funds for the Central UniversitiesFundamental Research Funds for the Central Universities [SWU1009001]	Funding support was provided by the National Natural Science Foundation of China (31170980, 81271477), the Foundation for the Author of National Excellent Doctoral Dissertation of PR China (201107), the New Century Excellent Talents in University (NCET-11-0698), and the Fundamental Research Funds for the Central Universities (SWU1009001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akcay C, 2007, PSYCHON B REV, V14, P742, DOI 10.3758/BF03196831; Andersen RA, 2002, ANNU REV NEUROSCI, V25, P189, DOI 10.1146/annurev.neuro.25.112701.142922; Appelbaum LG, 2009, CEREB CORTEX, V19, P2508, DOI 10.1093/cercor/bhp036; Baccala LA, 2001, BIOL CYBERN, V84, P463, DOI 10.1007/PL00007990; Badre D, 2004, NEURON, V41, P473, DOI 10.1016/S0896-6273(03)00851-1; Botvinick M, 1999, NATURE, V402, P179, DOI 10.1038/46035; Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Carter CS, 2007, COGN AFFECT BEHAV NE, V7, P367, DOI 10.3758/CABN.7.4.367; Chen AT, 2011, INT J PSYCHOPHYSIOL, V80, P129, DOI 10.1016/j.ijpsycho.2011.02.012; Clayson PE, 2011, PSYCHOPHYSIOLOGY, V48, P1621, DOI 10.1111/j.1469-8986.2011.01265.x; Clayson PE, 2011, NEUROPSYCHOLOGIA, V49, P1953, DOI 10.1016/j.neuropsychologia.2011.03.023; di Pellegrino G, 2007, J COGNITIVE NEUROSCI, V19, P275, DOI 10.1162/jocn.2007.19.2.275; Donohue SE, 2011, COGN AFFECT BEHAV NE, P1; Egner T, 2005, NAT NEUROSCI, V8, P1784, DOI 10.1038/nn1594; Egner T, 2005, NEUROIMAGE, V24, P539, DOI 10.1016/j.neuroimage.2004.09.007; Egner T., 2007, HYPNOSIS CONSCIOUS S, P29; Engel AK, 2010, CURR OPIN NEUROBIOL, V20, P156, DOI 10.1016/j.conb.2010.02.015; Fan J, 2003, NEUROIMAGE, V18, P42, DOI 10.1006/nimg.2002.1319; Fellows LK, 2005, CEREB CORTEX, V15, P58, DOI 10.1093/cercor/bhh108; Freitas AL, 2007, PSYCHOL SCI, V18, P1040, DOI 10.1111/j.1467-9280.2007.02022.x; Friston KJ, 2003, NEUROIMAGE, V19, P1273, DOI 10.1016/S1053-8119(03)00202-7; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; GRATTON G, 1992, J EXP PSYCHOL GEN, V121, P480, DOI 10.1037/0096-3445.121.4.480; Hanslmayr S, 2008, J COGNITIVE NEUROSCI, V20, P215, DOI 10.1162/jocn.2008.20020; Hazeltine E, 2011, J EXP PSYCHOL HUMAN, V37, P1898, DOI 10.1037/a0024662; Hommel B, 2004, PSYCHOL RES-PSYCH FO, V68, P1, DOI 10.1007/s00426-003-0132-y; Hu L, 2012, NEUROIMAGE, V62, P217, DOI 10.1016/j.neuroimage.2012.03.094; Hwang K, 2010, J NEUROSCI, V30, P15535, DOI 10.1523/JNEUROSCI.2825-10.2010; Iyer A, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000444; Kennerley SW, 2006, NAT NEUROSCI, V9, P940, DOI 10.1038/nn1724; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; Kim C, 2010, NEUROSCI LETT, V476, P156, DOI 10.1016/j.neulet.2010.04.019; Lamers MJM, 2011, Q J EXP PSYCHOL, V64, P1056, DOI 10.1080/17470218.2010.523792; Larson MJ, 2012, DEV NEUROPSYCHOL, V37, P343, DOI 10.1080/87565641.2011.650337; Larson MJ, 2012, J INT NEUROPSYCH SOC, V18, P323, DOI 10.1017/S1355617711001779; Larson MJ, 2012, NEUROPSYCHOLOGIA, V50, P426, DOI 10.1016/j.neuropsychologia.2011.12.021; Larson MJ, 2011, INT J PSYCHOPHYSIOL, V82, P69, DOI 10.1016/j.ijpsycho.2011.02.018; Larson MJ, 2009, J INT NEUROPSYCH SOC, V15, P927, DOI 10.1017/S1355617709990701; Larson MJ, 2009, NEUROPSYCHOLOGIA, V47, P663, DOI 10.1016/j.neuropsychologia.2008.11.013; Liotti M, 2000, NEUROPSYCHOLOGIA, V38, P701, DOI 10.1016/S0028-3932(99)00106-2; Liston C, 2006, NEURON, V50, P643, DOI 10.1016/j.neuron.2006.04.015; Liu PD, 2012, J COGN PSYCHOL, V24, P457, DOI 10.1080/20445911.2011.651080; Mansouri FA, 2007, SCIENCE, V318, P987, DOI 10.1126/science.1146384; Mansouri FA, 2009, NAT REV NEUROSCI, V10, P141, DOI 10.1038/nrn2538; Markela-Lerenc J, 2004, COGNITIVE BRAIN RES, V18, P278, DOI 10.1016/j.cogbrainres.2003.10.013; Mayr U, 2003, NAT NEUROSCI, V6, P450, DOI 10.1038/nn1051; Mayr U, 2009, PSYCHOL RES-PSYCH FO, V73, P794, DOI 10.1007/s00426-008-0191-1; Milde T, 2010, NEUROIMAGE, V50, P960, DOI 10.1016/j.neuroimage.2009.12.110; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; MULLER HJ, 1989, J EXP PSYCHOL HUMAN, V15, P315, DOI 10.1037/0096-1523.15.2.315; Nieuwenhuis S, 2006, MEM COGNITION, V34, P1260, DOI 10.3758/BF03193270; Notebaert W, 2006, PSYCHON B REV, V13, P112, DOI 10.3758/BF03193821; Peng WW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034163; Perlstein WM, 2006, NEUROPSYCHOLOGIA, V44, P260, DOI 10.1016/j.neuropsychologia.2005.05.009; Posner M.I., 1975, INFORM PROCESSING CO, P55; Posner MI, 1998, ROYAL SOC, V353, P1915; Purmann S, 2009, PSYCHON B REV, V16, P350, DOI 10.3758/PBR.16.2.350; Roelofs A, 2006, P NATL ACAD SCI USA, V103, P13884, DOI 10.1073/pnas.0606265103; Sauseng P, 2008, NEUROSCI BIOBEHAV R, V32, P1001, DOI 10.1016/j.neubiorev.2008.03.014; Sheth SA, 2012, NATURE, V488, P218, DOI 10.1038/nature11239; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Sturmer B, 2002, J EXP PSYCHOL HUMAN, V28, P1345, DOI 10.1037//0096-1523.28.6.1345; Ullsperger M, 2005, COGN AFFECT BEHAV NE, V5, P467, DOI 10.3758/CABN.5.4.467; van Veen V, 2002, J COGNITIVE NEUROSCI, V14, P593, DOI 10.1162/08989290260045837; Verguts T, 2008, PSYCHOL REV, V115, P518, DOI 10.1037/0033-295X.115.2.518; West R, 1999, COGNITIVE BRAIN RES, V8, P157, DOI 10.1016/S0926-6410(99)00017-8; West R, 2005, EXP BRAIN RES, V167, P38, DOI 10.1007/s00221-005-2366-y; West R, 2004, PSYCHOPHYSIOLOGY, V41, P739, DOI 10.1111/j.1469-8986.2004.00205.x; West R, 2003, NEUROPSYCHOLOGIA, V41, P1122, DOI 10.1016/S0028-3932(02)00297-X; West R, 2000, CEREB CORTEX, V10, P748, DOI 10.1093/cercor/10.8.748; Zysset S, 2001, NEUROIMAGE, V13, P29, DOI 10.1006/nimg.2000.0665	72	18	20	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57912	10.1371/journal.pone.0057912			9	Multidisciplinary Sciences	Science & Technology - Other Topics	098DA	WOS:000315524900197	23469102	DOAJ Gold, Green Published			2021-06-18	
J	Alharfi, IM; Stewart, TC; Foster, J; Morrison, GC; Fraser, DD				Alharfi, Ibrahim M.; Stewart, Tanya Charyk; Foster, Jennifer; Morrison, Gavin C.; Fraser, Douglas D.			Central Diabetes Insipidus in Pediatric Severe Traumatic Brain Injury	PEDIATRIC CRITICAL CARE MEDICINE			English	Article						children; diabetes insipidus; mortality; traumatic brain injury	SEVERE HEAD-INJURY; PREDICTIVE FACTORS; CHILDREN; DEATH; DYSFUNCTION; MORTALITY; OUTCOMES	Objectives: To determine the occurrence rate of central diabetes insipidus in pediatric patients with severe traumatic brain injury and to describe the clinical, injury, biochemical, imaging, and intervention variables associated with mortality. Design: Retrospective chart and imaging review. Setting: Children's Hospital, level 1 trauma center. Patients: Severely injured (Injury Severity Score >= 12) pediatric trauma patients (>1 month and <18 yr) with severe traumatic brain injury (presedation Glasgow Coma Scale <= 8 and head Maximum Abbreviated Injury Scale >= 4) that developed acute central diabetes insipidus between January 2000 and December 2011. Measurements and Main Results: Of 818 severely injured trauma patients, 180 had severe traumatic brain injury with an overall mortality rate of 27.2%. Thirty-two of the severe traumatic brain injury patients developed acute central diabetes insipidus that responded to desamino-8-D-arginine vasopressin and/or vasopressin infusion, providing an occurrence rate of 18%. At the time of central diabetes insipidus diagnosis, median urine output and serum sodium were 6.8 ml/kg/hr (interquartile range = 5-11) and 154 mmol/L (interquartile range = 149-159), respectively. The mortality rate of central diabetes insipidus patients was 87.5%, with 71.4% declared brain dead after central diabetes insipidus diagnosis. Early central diabetes insipidus onset, within the first 2 days of severe traumatic brain injury, was strongly associated with mortality (p < 0.001), as were a lower presedation Glasgow Coma Scale (p = 0.03), a lower motor Glasgow Coma Scale (p = 0.01), an occurrence of fixed pupils (p = 0.04), and a prolonged partial thromboplastin time (p = 0.04). Cerebral edema on the initial computed tomography, obtained in the first 24 hrs after injury, was the only imaging finding associated with death (p = 0.002). Survivors of central diabetes insipidus were more likely to have intracranial pressure monitoring (p = 0.03), have thiopental administered to induce coma (p = 0.04) and have received a decompressive craniectomy for elevated intracranial pressure (p = 0.04). Conclusions: The incidence of central diabetes insipidus in pediatric patients with severe traumatic brain injury is 18%. Mortality was associated with early central diabetes insipidus onset and cerebral edema on head computed tomography. Central diabetes insipidus nonsurvivors were less likely to have received intracranial pressure monitoring, thiopental coma and decompressive craniectomy. (Pediatr Crit Care Med 2013; 14:203-209)	[Alharfi, Ibrahim M.; Foster, Jennifer; Morrison, Gavin C.; Fraser, Douglas D.] Univ Western Ontario, Dept Pediat, London, ON N6A 3K7, Canada; [Alharfi, Ibrahim M.] King Fahad Med City, Dept Pediat Crit Care, Childrens Hosp, Riyadh, Saudi Arabia; [Stewart, Tanya Charyk] Univ Western Ontario, Dept Surg, London, ON N6A 3K7, Canada; [Stewart, Tanya Charyk] London Hlth Sci Ctr, Trauma Program, London, ON, Canada; [Fraser, Douglas D.] Translat Res Ctr, London, ON, Canada; [Foster, Jennifer; Fraser, Douglas D.] Childrens Hlth Res Inst, London, ON, Canada; [Fraser, Douglas D.] Univ Western Ontario, London, ON, Canada; [Fraser, Douglas D.] Ctr Crit Illness Res, London, ON, Canada	Fraser, DD (corresponding author), Univ Western Ontario, Dept Pediat, London, ON N6A 3K7, Canada.	douglas.fraser@lhsc.on.ca		Foster, Jennifer/0000-0001-8919-9383			Agha A, 2005, EUR J ENDOCRINOL, V152, P371, DOI 10.1530/eje.1.01861; Agha A, 2004, J CLIN ENDOCR METAB, V89, P5987, DOI 10.1210/jc.2004-1058; Agha A, 2004, CLIN ENDOCRINOL, V60, P584, DOI 10.1111/j.1365-2265.2004.02023.x; ALBERICO AM, 1987, J NEUROSURG, V67, P648, DOI 10.3171/jns.1987.67.5.0648; Alharfi IM, 2012, J NEUROTRAUMA; [Anonymous], 1987, PEDIATR NEUROL, V3, P242; Bajpai A, 2008, INDIAN PEDIATR, V45, P463; BARZILAY Z, 1988, J MED, V19, P47; Boughey JC, 2004, AM SURGEON, V70, P500; Chiaretti A, 2001, PEDIATR NEUROSURG, V34, P131, DOI 10.1159/000056008; Chou YC, 2009, BRAIN INJURY, V23, P1095, DOI 10.3109/02699050903379396; Einaudi S, 2006, J PEDIATR ENDOCR MET, V19, P691; Fiser DH, 2000, CRIT CARE MED, V28, P2616, DOI 10.1097/00003246-200007000-00072; FISER DH, 1987, CRIT CARE MED, V15, P551, DOI 10.1097/00003246-198706000-00002; Hadjizacharia P, 2008, J AM COLL SURGEONS, V207, P477, DOI 10.1016/j.jamcollsurg.2008.04.017; HARPER CG, 1986, J CLIN PATHOL, V39, P769, DOI 10.1136/jcp.39.7.769; Hutchison J, 2006, DEV NEUROSCI-BASEL, V28, P291, DOI 10.1159/000094155; Jagannathan J, 2008, J NEUROSURG-PEDIATR, V2, P240, DOI 10.3171/PED.2008.2.10.240; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Kouvarellis AJ, 2011, CHILD NERV SYST, V27, P1139, DOI 10.1007/s00381-011-1464-3; KAHLER O M, 1948, Med Klin, V43, P58; Lekmanov A. U., 2010, Anesteziologiya i Reanimatologiya, P41; MAZUREK A, 1994, INT ANESTHESIOL CLIN, V32, P11; Mishra Garima, 2011, Indian J Endocrinol Metab, V15 Suppl 3, pS180, DOI 10.4103/2230-8210.84858; Nakagawa TA, 2011, CRIT CARE MED, V39, P2139, DOI 10.1097/CCM.0b013e31821f0d4f; NEVTONOVA G A, 1950, Khirurgiia (Mosk), V6, P68; Ngo QN, 2009, PEDIATR CRIT CARE ME, V10, P346, DOI 10.1097/PCC.0b013e3181a320cd; OUTWATER KM, 1984, NEUROLOGY, V34, P1243, DOI 10.1212/WNL.34.9.1243; PORTER RJ, 1948, J NEUROL NEUROSUR PS, V11, P258, DOI 10.1136/jnnp.11.4.258; Report of Special Task Force. Guidelines for the determination of brain death in children, 1987, PEDIATRICS, V80, P298; Scavarda D, 2010, CHILD NERV SYST, V26, P1555, DOI 10.1007/s00381-010-1150-x; Shemie SD, 2006, CAN MED ASSOC J, V175, pS1, DOI 10.1503/cmaj.060895; STAWORN D, 1994, CRIT CARE MED, V22, P1301, DOI 10.1097/00003246-199408000-00014; Melo JRT, 2010, NEUROSURGERY, V67, P1542, DOI 10.1227/NEU.0b013e3181fa7049; Melo JRT, 2009, CHILD NERV SYST, V25, P1077, DOI 10.1007/s00381-009-0924-5; WANG LC, 1994, PEDIATR NEUROL, V11, P273, DOI 10.1016/0887-8994(94)90001-9; Wise-Faberowski L, 2004, J NEUROSURG ANESTH, V16, P220, DOI 10.1097/00008506-200407000-00006; Yang YH, 2011, PEDIATR NEUROL, V45, P377, DOI 10.1016/j.pediatrneurol.2011.09.002	38	18	20	0	9	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1529-7535	1947-3893		PEDIATR CRIT CARE ME	Pediatr. Crit. Care Med.	FEB	2013	14	2					203	209		10.1097/PCC.0b013e31827127b5			7	Critical Care Medicine; Pediatrics	General & Internal Medicine; Pediatrics	088GC	WOS:000314820800018	23314181				2021-06-18	
J	Chen, MF; Huang, TY; Kuo, YM; Yu, L; Chen, HI; Jen, CYJ				Chen, Mei-Feng; Huang, Tung-Yi; Kuo, Yu-Min; Yu, Lung; Chen, Hsiun-ing; Jen, Chauying J.			Early postinjury exercise reverses memory deficits and retards the progression of closed-head injury in mice	JOURNAL OF PHYSIOLOGY-LONDON			English	Article							TRAUMATIC BRAIN-INJURY; NEUROTROPHIC FACTOR; COGNITIVE DEFICITS; TREADMILL EXERCISE; MOUSE MODEL; RAT HIPPOCAMPUS; DYNAMIC CHANGES; UP-REGULATION; CELLS; INFLAMMATION	Closed-head injury (CHI) usually involves both physical damage of neurons and neuroinflammation. Although exercise promotes neuronal repair and suppresses neuroinflammation, CHI patients currently often remain resting during the post-traumatic period. This study aimed to investigate whether and how postinjury exercise benefited the brain structure and function in mice after CHI. Closed-head injury immediately caused an elevated neurological severity score, with rapid loss of object recognition memory, followed by progressive location-dependent brain damage (neuronal loss and activation of microglia in the cortex and hippocampus). An early exercise protocol at moderate intensity (starting 2 days postimpact and lasting for 7 or 14 days) effectively restored the object recognition memory and prevented the progressive neuronal loss and activation of microglia. However, if the exercise started 9 days postimpact, it was unable to recover recognition memory deficits. In parallel, early exercise intervention drastically promoted neurite regeneration, while late exercise intervention was much less effective. We also tested the possible involvement of brain-derived neurotrophic factor (BDNF) and mitogen-activated protein kinase phosphatase-1 (MKP-1) in the exercise-induced beneficial effects. Exercise gradually restored the impact-abolished hippocampal expression of BDNF and MPK-1, while oral administration of triptolide (a synthesis inhibitor of MKP-1 and an antagonist of nuclear factor-B) before each bout of exercise blocked the restorative effects of exercise on MKP-1 and recognition memory, as well as the exercise-induced retardation of neuronal loss. Although triptolide treatment alone inhibited activation of microglia and maintained neuronal numbers, it did not recover the injury-hampered recognition memory. Overall, moderate exercise shortly after CHI reversed the deficits in recognition memory and prevented the progression of brain injury.	[Chen, Mei-Feng; Kuo, Yu-Min; Yu, Lung; Chen, Hsiun-ing; Jen, Chauying J.] Natl Cheng Kung Univ, Coll Med, Inst Basic Med Sci, Tainan 70101, Taiwan; [Huang, Tung-Yi; Chen, Hsiun-ing; Jen, Chauying J.] Natl Cheng Kung Univ, Coll Med, Dept Physiol, Tainan 70101, Taiwan; [Kuo, Yu-Min] Natl Cheng Kung Univ, Coll Med, Dept Cell Biol & Anat, Tainan 70101, Taiwan; [Yu, Lung] Natl Cheng Kung Univ, Coll Med, Inst Behav Med, Tainan 70101, Taiwan	Jen, CYJ (corresponding author), Natl Cheng Kung Univ, Coll Med, Dept Physiol, Tainan 70101, Taiwan.	jen@mail.ncku.edu.tw	Kuo, Yu-Min/A-9050-2013; Chen, Mei Feng/I-2763-2016; Huang, Troy/I-6395-2019	Kuo, Yu-Min/0000-0003-4867-2482; Chen, Mei Feng/0000-0002-7170-0843; 	National Science Council, TaiwanMinistry of Science and Technology, Taiwan [NSC 98-2320-B-006-019-MY3, NSC 98-2320-B-006-028-MY3]	We thank Mr Ju-San Chen in the Department of Mechanical Engineering for constructing the closed-head injury set-up and Dr Paul R. Saunders for critically reading the manuscript. This study was supported by grants from the National Science Council, Taiwan (NSC 98-2320-B-006-019-MY3 and NSC 98-2320-B-006-028-MY3).	Biegon A, 2004, P NATL ACAD SCI USA, V101, P5117, DOI 10.1073/pnas.0305741101; Chen MF, 2010, MED SCI SPORT EXER, V42, P2173, DOI 10.1249/MSS.0b013e3181e2158d; Chen PL, 2002, J IMMUNOL, V169, P6408, DOI 10.4049/jimmunol.169.11.6408; Chen Y, 1996, J NEUROTRAUM, V13, P557, DOI 10.1089/neu.1996.13.557; Eljaschewitsch E, 2006, NEURON, V49, P67, DOI 10.1016/j.neuron.2005.11.027; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; Feliciano DV, 2008, TRAUMA; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Ginsberg MD, 1997, AM J PHYSIOL-HEART C, V272, pH2859; Gobbo OL, 2005, BEHAV BRAIN RES, V159, P21, DOI 10.1016/j.bbr.2004.09.021; Griesbach GS, 2007, J NEUROTRAUM, V24, P1161, DOI 10.1089/neu.2006.0255; Griesbach GS, 2009, BRAIN RES, V1288, P105, DOI 10.1016/j.brainres.2009.06.045; Griesbach GS, 2004, NEUROSCIENCE, V125, P129, DOI 10.1016/j.neuroscience.2004.01.030; Grossman R, 2003, NEUROIMAGE, V20, P1971, DOI 10.1016/j.neuroimage.2003.06.003; Huang AM, 2006, J NEURAL TRANSM, V113, P803, DOI 10.1007/s00702-005-0359-4; Israelsson C, 2009, J NEUROTRAUM, V26, P1307, DOI [10.1089/neu.2008.0676, 10.1089/neu.2008-0676]; Jeanneteau F, 2010, NAT NEUROSCI, V13, P1373, DOI 10.1038/nn.2655; Kim DH, 2010, PHYSIOL BEHAV, V101, P660, DOI 10.1016/j.physbeh.2010.09.021; Kim HJ, 2010, J NEUROTRAUM, V27, P131, DOI [10.1089/neu.2008.0818, 10.1089/neu.2008-0818]; Lammie GA, 1999, J NEUROTRAUM, V16, P603, DOI 10.1089/neu.1999.16.603; Lang R, 2006, J IMMUNOL, V177, P7497, DOI 10.4049/jimmunol.177.11.7497; Leddy JJ, 2007, NEUROREHABILITATION, V22, P199; Leem YH, 2011, BIOCHEM BIOPH RES CO, V406, P359, DOI 10.1016/j.bbrc.2011.02.046; Lin N, 2007, BIOCHEM PHARMACOL, V73, P136, DOI 10.1016/j.bcp.2006.08.027; Liu YF, 2008, NEUROBIOL LEARN MEM, V90, P81, DOI 10.1016/j.nlm.2008.02.005; Liu YF, 2009, J PHYSIOL-LONDON, V587, P3221, DOI 10.1113/jphysiol.2009.173088; Mahmood A, 2004, J NEUROTRAUM, V21, P33, DOI 10.1089/089771504772695922; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; Moore AH, 2000, J CEREBR BLOOD F MET, V20, P1492, DOI 10.1097/00004647-200010000-00011; Myer DJ, 2006, BRAIN, V129, P2761, DOI 10.1093/brain/awl165; O'Callaghan RM, 2009, HIPPOCAMPUS, V19, P1019, DOI 10.1002/hipo.20591; Pace CJ, 2002, J NEUROSCI METH, V119, P23, DOI 10.1016/S0165-0270(02)00152-8; Paxinos G., 2004, MOUSE BRAIN STEREOTA; Qiu DM, 1999, J BIOL CHEM, V274, P13443, DOI 10.1074/jbc.274.19.13443; Reeves TM, 2000, J NEUROSCI RES, V60, P370, DOI 10.1002/(SICI)1097-4547(20000501)60:3<370::AID-JNR12>3.3.CO;2-2; Seo TB, 2010, NEUROSCI LETT, V481, P178, DOI 10.1016/j.neulet.2010.06.087; SHAPIRA Y, 1993, ANESTH ANALG, V77, P141; SHAPIRA Y, 1988, CRIT CARE MED, V16, P258, DOI 10.1097/00003246-198803000-00010; Su ZD, 2010, GLIA, V58, P901, DOI 10.1002/glia.20972; Tang YP, 1997, J NEUROTRAUM, V14, P863, DOI 10.1089/neu.1997.14.863; Tang YP, 1997, J NEUROTRAUM, V14, P851, DOI 10.1089/neu.1997.14.851; Vasilevskis EE, 2010, CRIT CARE MED, V38, pS683, DOI 10.1097/CCM.0b013e3181f245d3; Vaynman S, 2005, NEUROREHAB NEURAL RE, V19, P283, DOI 10.1177/1545968305280753; Wu CW, 2007, J NEUROCHEM, V103, P2471, DOI 10.1111/j.1471-4159.2007.04987.x; Wu SY, 2011, BRAIN BEHAV IMMUN, V25, P135, DOI 10.1016/j.bbi.2010.09.006; Yaka R, 2007, FASEB J, V21, P2033, DOI 10.1096/fj.06-7856com; YANG KY, 1993, J NEUROTRAUM, V10, P287, DOI 10.1089/neu.1993.10.287; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K; Zohar O, 2003, NEUROSCIENCE, V118, P949, DOI 10.1016/S0306-4522(03)00048-4	50	18	18	0	8	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3751			J PHYSIOL-LONDON	J. Physiol.-London	FEB	2013	591	4					985	1000		10.1113/jphysiol.2012.241125			16	Neurosciences; Physiology	Neurosciences & Neurology; Physiology	092VB	WOS:000315150000020	23184513	Green Published			2021-06-18	
J	Schneider, JC; Gerrard, P; Goldstein, R; Divita, MA; Niewczyk, P; Ryan, CM; Kowalske, K; Zafonte, R				Schneider, Jeffrey C.; Gerrard, Paul; Goldstein, Richard; Divita, Margaret A.; Niewczyk, Paulette; Ryan, Colleen M.; Kowalske, Karen; Zafonte, Ross			The Impact of Comorbidities and Complications on Burn Injury Inpatient Rehabilitation Outcomes	PM&R			English	Article							TRAUMATIC BRAIN-INJURY; SPINAL-CORD-INJURY; LENGTH-OF-STAY; RISK-FACTORS; ACUTE-CARE; MORTALITY; PERFORMANCE; ELIXHAUSER; PREDICTION; RECOVERY	Objective: To examine the impact of comorbidities and complications on burn inpatient rehabilitation facilities (IRE) outcomes. Design: A retrospective cross-sectional study. Setting: Inpatient rehabilitation hospitals. Patients: A total of 4572 patients with a primary diagnosis of burn injury from the Uniform Data System for Medical Rehabilitation database from 2002 to 2010. Methods or Interventions: Regression analyses were used to determine whether 3 different comorbidity measures (Charlson Comorbidity Index, Elixhauser Comoribidity Index, Centers for Medicare and Medicaid Services Comorbidity Tiers) and 1 complication measure improved the predictive model (c-statistic) for each outcome measure. Main Outcome Measurements: Community discharge, Functional Independence Measure (FIM) gain, length of stay efficiency, transfer to acute care within the first 3 days of IRE stay, and transfer to acute care for all time periods. Results: For all outcomes, there was no difference between the Standard Model and the models that include the comorbidity and complication variables as measured by the c-statistic confidence intervals. Conclusions: Comorbidities and complications did not significantly affect burn IRE outcomes. Future research is needed to examine the impact of comorbidities and complications on outcomes of other IRE populations to better understand the implications for current and future health care policy. PM R2013;5:114-121	[Schneider, Jeffrey C.; Gerrard, Paul; Goldstein, Richard; Zafonte, Ross] Harvard Univ, Sch Med, Dept Phys Med & Rehabil, Spaulding Rehabil Hosp, Boston, MA 02114 USA; [Divita, Margaret A.; Niewczyk, Paulette] Uniform Data Syst Med Rehabilitat, Amherst, NY USA; [Niewczyk, Paulette] Daemen Coll, Hlth Care Studies Dept, Amherst, NY USA; [Ryan, Colleen M.] Shriners Hosp Children Boston, Dept Surg, Boston, MA USA; [Ryan, Colleen M.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Sumner Redstone Burn Ctr,Surg Serv, Boston, MA 02114 USA; [Kowalske, Karen] Univ Texas SW Med Ctr Dallas, Dept Phys Med & Rehabil, Dallas, TX 75390 USA	Schneider, JC (corresponding author), Harvard Univ, Sch Med, Dept Phys Med & Rehabil, Spaulding Rehabil Hosp, 125 Nashua St, Boston, MA 02114 USA.	jcschneider@partners.org	Schneider, Jeffrey/AAO-2126-2020	Ryan, Colleen/0000-0002-6455-936X; Gerrard, Paul/0000-0003-0654-5354; DiVita, Margaret/0000-0002-4878-2959	Department of DefenseUnited States Department of Defense	grant, Department of Defense	Alam E, 2008, ARCH PHYS MED REHAB, V89, P1284, DOI 10.1016/j.apmr.2008.01.014; Baldwin LM, 2006, MED CARE, V44, P745, DOI 10.1097/01.mlr.0000223475.70440.07; Black K, 2000, BRAIN INJURY, V14, P141, DOI 10.1080/026990500120808; CARTER GM, 2002, EXECUTIVE SUMMARY AN; Carter GM, 2002, ANAL INITIAL IMPLEME, P99; CARTER GM, 2002, ANAL INITIAL IMPLEME; Centers for Medicare and Medicaid Services, 2011, FED REGISTER, V76, P24214; Centers for Medicare & Medicaid Services (CMS) HHS, 2011, Fed Regist, V76, P47836; CHARLSON M, 1994, J CLIN EPIDEMIOL, V47, P1245, DOI 10.1016/0895-4356(94)90129-5; CMS, 2001, FED REGISTER, V66, P41316; Covinsky KE, 1997, J GEN INTERN MED, V12, P203, DOI 10.1007/s11606-006-5041-5; de Groot V, 2003, J CLIN EPIDEMIOL, V56, P221, DOI 10.1016/S0895-4356(02)00585-1; Deshpande AA, 1997, ARCH PHYS MED REHAB, V78, P350, DOI 10.1016/S0003-9993(97)90224-0; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Eastwood EA, 1999, ARCH PHYS MED REHAB, V80, P1457, DOI 10.1016/S0003-9993(99)90258-7; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; FILLENBAUM GG, 1981, J GERONTOL, V36, P428, DOI 10.1093/geronj/36.4.428; Gerrard P, 2011, PM&R, V3, pS259; Gijsen R, 2001, J CLIN EPIDEMIOL, V54, P661, DOI 10.1016/S0895-4356(00)00363-2; Gomez M, 2008, J BURN CARE RES, V29, P130, DOI [10.1097/BCR.0b013e31815f6efd, 1097/BCR.0b013e31815f6efd]; GRANGER CV, 1992, STROKE, V23, P978, DOI 10.1161/01.STR.23.7.978; GREENFIELD S, 1988, JAMA-J AM MED ASSOC, V260, P2253, DOI 10.1001/jama.260.15.2253; GREENFIELD S, 1993, MED CARE, V31, P141, DOI 10.1097/00005650-199302000-00005; Guo Y, 2008, AM J PHYS MED REHAB, V87, P647, DOI 10.1097/PHM.0b013e31817fb94e; Humphries KH, 2000, J CLIN EPIDEMIOL, V53, P343, DOI 10.1016/S0895-4356(99)00188-2; Hurria A, 2011, J CLIN ONCOL, V29, P4217, DOI 10.1200/JCO.2011.37.5717; IEZZONI LI, 1992, JAMA-J AM MED ASSOC, V267, P2197, DOI 10.1001/jama.267.16.2197; Kansagara D, 2011, JAMA-J AM MED ASSOC, V306, P1688, DOI 10.1001/jama.2011.1515; KATZ DI, 1994, ARCH NEUROL-CHICAGO, V51, P661, DOI 10.1001/archneur.1994.00540190041013; Li B, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-12; Lo A, 2012, INT J STROKE, V7, P118, DOI 10.1111/j.1747-4949.2011.00694.x; MALEC J, 1983, ARCH PHYS MED REHAB, V64, P359; NORRISBAKER C, 1981, ARCH PHYS MED REHAB, V62, P602; Ottenbacher KJ, 2004, JAMA-J AM MED ASSOC, V292, P1687, DOI 10.1001/jama.292.14.1687; Post MWM, 1998, ARCH PHYS MED REHAB, V79, P395, DOI 10.1016/S0003-9993(98)90139-3; Roth EJ, 2001, STROKE, V32, P523, DOI 10.1161/01.STR.32.2.523; Schneider J, 2010, AM J PHYS MED REHABI, V89, pS36; Southern DA, 2004, MED CARE, V42, P355, DOI 10.1097/01.mlr.0000118861.56848.ee; Stillman G, 2009, PM&R, V1, P234, DOI 10.1016/j.pmrj.2008.10.014; Stineman MG, 2003, ARCH PHYS MED REHAB, V84, P712, DOI 10.1016/S0003-9993(03)04850-5; Stukenborg GJ, 2001, MED CARE, V39, P727, DOI 10.1097/00005650-200107000-00009; Tan WH, 2012, J BURN CARE RES, V33, P110, DOI 10.1097/BCR.0b013e318234d91a; Thombs BD, 2007, ANN SURG, V245, P629, DOI 10.1097/01.sla.0000250422.36168.67; Uniform Data System for Medical Rehabilitation, ALPHAFIMADVANTAGE; Wolff JL, 2002, ARCH INTERN MED, V162, P2269, DOI 10.1001/archinte.162.20.2269; Wright RE, 1996, ARCH PHYS MED REHAB, V77, P1049, DOI 10.1016/S0003-9993(96)90067-2	46	18	18	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1934-1482	1934-1563		PM&R	PM&R	FEB	2013	5	2					114	121		10.1016/j.pmrj.2012.07.014			8	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	095VP	WOS:000315363400005	22981003				2021-06-18	
J	Tajuddin, NF; Przybycien-Szymanska, MM; Pak, TR; Neafsey, EJ; Collins, MA				Tajuddin, Nuzhath F.; Przybycien-Szymanska, Magdalena M.; Pak, Toni R.; Neafsey, Edward J.; Collins, Michael A.			Effect of repetitive daily ethanol intoxication on adult rat brain: Significant changes in phospholipase A2 enzyme levels in association with increased PARP-1 indicate neuroinflammatory pathway activation	ALCOHOL			English	Article						Alcohol; Neuroinflammation; PLA2; AQP4; Neurodegeneration; Arachidonic acid; PARP-1; Parthanatos	ALCOHOL-RELATED DEMENTIA; NF-KAPPA-B; DOCOSAHEXAENOIC ACID; SLICE CULTURES; CELL-DEATH; IN-VIVO; NEURONAL DEGENERATION; LIPID-PEROXIDATION; INDUCED APOPTOSIS; OXIDATIVE STRESS	Collaborating on studies of subchronic daily intoxication in juvenile and adult rats, we examined whether the repetitive ethanol treatments at these two life stages altered levels of key neuroinflammation-associated proteins-aquaporin-4 (AQP4), certain phospholipase A2 (PLA2) enzymes, PARP-1 and caspase-3-in hippocampus (HC) and entorhinal cortex (EC). Significant changes in the proteins could implicate activation of specific neuroinflammatory signaling pathways in these rats as well as in severely binge-intoxicated adult animals that are reported to incur degeneration of vulnerable neurons in HC and EC. Male Wistar rats, ethanol-intoxicated (3 g/kg i.p.) once daily for 6 days over an 8-day interval beginning at 37 days old and repeated at age 68-75 days, were sacrificed 1 h after the day 75 dose (blood ethanol, 200-230 mg/dl). Analysis of HC with an immunoblot technique showed that AQP4, Ca+2-dependent PLA2 (cPLA2 IVA), phosphorylated (activated) p-cPLA2, cleaved (89 kD) PARP (c-PARP), and caspase-3 levels were significantly elevated over controls, whereas Ca+2-independent PLA2 (iPLA2 VIA) was reduced similar to 70%; however, cleaved caspase-3 was undetectable. In the EC, AQP4 was unchanged, but cPLA2 and p-cPLA2 were significantly increased while iPLA2 levels were diminished (similar to 40%) similar to HC, although just outside statistical significance (p = 0.06). In addition, EC levels of PARP-1 and c-PARP were significantly increased. The ethanol-induced activation of cPLA2 in association with reduced iPLA2 mirrors PLA2 changes in reports of neurotrauma and also of dietary omega-3 fatty acid depletion. Furthermore, the robust PARP-1 elevations accompanied by negligible caspase-3 activation indicate that repetitive ethanol intoxication may be potentiating non-apoptotic neurodegenerative processes such as parthanatos. Overall, the repetitive ethanol treatments appeared to instigate previously unappreciated neuroinflammatory pathways in vivo. The data provide insights into mechanisms of binge ethanol abuse that might suggest new therapeutic approaches to counter neurodegeneration and dementia. (C) 2013 Elsevier Inc. All rights reserved.	[Tajuddin, Nuzhath F.; Neafsey, Edward J.; Collins, Michael A.] Loyola Univ, Dept Mol Pharmacol & Therapeut, Stritch Sch Med, Maywood, IL 60153 USA; [Przybycien-Szymanska, Magdalena M.; Pak, Toni R.] Loyola Univ, Dept Cell & Mol Physiol, Stritch Sch Med, Maywood, IL 60153 USA	Collins, MA (corresponding author), Loyola Univ, Dept Mol Pharmacol & Therapeut, Stritch Sch Med, 2160 S 1st Ave, Maywood, IL 60153 USA.	mcollin@lumc.edu			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [U01AA018279, R01AG033605, R21AA018398]; Loyola Alcohol Research Program [T32AA013527]; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG033605] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISMUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [R21AA018398, T32AA013527, U01AA018279] Funding Source: NIH RePORTER	The research was supported by NIH U01AA018279, R01AG033605, R21AA018398, and Loyola Alcohol Research Program (T32AA013527). Robert M. Mitchell, Ph.D., is acknowledged for helpful discussions and initial technical assistance. Grace Sun, Ph.D. is thanked for recommendations concerning PLA2 antibodies.	ADACHI J, 1991, J STUD ALCOHOL, V52, P448, DOI 10.15288/jsa.1991.52.448; Adibhatla RM, 2008, BMB REP, V41, P560, DOI 10.5483/BMBRep.2008.41.8.560; Adibhatla RM, 2007, BRAIN RES, V1134, P199, DOI 10.1016/j.brainres.2006.11.080; Alfonso-Loeches S, 2010, J NEUROSCI, V30, P8285, DOI 10.1523/JNEUROSCI.0976-10.2010; Andrabi SA, 2011, NAT MED, V17, P692, DOI 10.1038/nm.2387; Basavarajappa BS, 1998, BIOCHEM PHARMACOL, V55, P515, DOI 10.1016/S0006-2952(97)00501-7; Basavarajappa BS, 1997, ALCOHOL CLIN EXP RES, V21, P1199, DOI 10.1111/j.1530-0277.1997.tb04438.x; Bazan NG, 2011, ANNU REV NUTR, V31, P321, DOI 10.1146/annurev.nutr.012809.104635; Bobba A, 2008, INT J MOL MED, V21, P737; Brown J, 2009, NEUROCHEM RES, V34, P260, DOI 10.1007/s11064-008-9765-y; CARLEN PL, 1994, ALCOHOL CLIN EXP RES, V18, P1330, DOI 10.1111/j.1530-0277.1994.tb01432.x; Chaitanya GV, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-31; Cippitelli A, 2010, NEUROBIOL LEARN MEM, V94, P538, DOI 10.1016/j.nlm.2010.09.006; Collins MA, 1996, ALCOHOL CLIN EXP RES, V20, P284, DOI 10.1111/j.1530-0277.1996.tb01641.x; Collins MA, 1998, FASEB J, V12, P221; Collins Michael A, 2012, Front Biosci (Elite Ed), V4, P1358; Collins MA, 2012, NEUROTOX RES, V21, P70, DOI 10.1007/s12640-011-9276-5; Crews FT, 2011, BRAIN BEHAV IMMUN, V25, pS4, DOI 10.1016/j.bbi.2011.03.003; Dana R, 1998, J BIOL CHEM, V273, P441, DOI 10.1074/jbc.273.1.441; David KK, 2009, FRONT BIOSCI-LANDMRK, V14, P1116, DOI 10.2741/3297; ECKARDT MJ, 1986, ALCOHOL CLIN EXP RES, V10, P123, DOI 10.1111/j.1530-0277.1986.tb05058.x; Floreani NA, 2010, J NEUROIMMUNE PHARM, V5, P533, DOI 10.1007/s11481-010-9213-z; Friis MB, 2008, AM J PHYSIOL-CELL PH, V294, pC1552, DOI 10.1152/ajpcell.00571.2007; Galluzzi L, 2012, CELL DEATH DIFFER, V19, P107, DOI 10.1038/cdd.2011.96; Goracci G, 2010, MOL NEUROBIOL, V41, P274, DOI 10.1007/s12035-010-8108-6; Gotz ME, 2001, ALCOHOL CLIN EXP RES, V25, P717, DOI 10.1111/j.1530-0277.2001.tb02272.x; Gunnarson E, 2004, NEUROSCIENCE, V129, P947, DOI 10.1016/j.neuroscience.2004.08.022; Gupta S, 2008, BRIT J PSYCHIAT, V193, P351, DOI 10.1192/bjp.bp.108.051425; Hassa PO, 2002, CELL MOL LIFE SCI, V59, P1534, DOI 10.1007/s00018-002-8527-2; Hernandez M, 1998, J BIOL CHEM, V273, P606, DOI 10.1074/jbc.273.1.606; Kim HW, 2012, PSYCHOPHARMACOLOGY, V222, P663, DOI 10.1007/s00213-012-2671-7; Kinsey GR, 2008, J LIPID RES, V49, P1477, DOI 10.1194/jlr.M800030-JLR200; Koivusalo M, 2009, J BIOL CHEM, V284, P6595, DOI 10.1074/jbc.R800049200; Kolko M, 2003, NEUROSCI LETT, V338, P164, DOI 10.1016/S0304-3940(02)01385-X; Kramer RM, 1996, J LIPID MEDIAT CELL, V14, P3, DOI 10.1016/0929-7855(96)01501-5; Lambert IH, 2006, ACTA PHYSIOL, V187, P75, DOI 10.1111/j.1748-1716.2006.01557.x; LEHTONEN JYA, 1995, BIOPHYS J, V68, P1888, DOI 10.1016/S0006-3495(95)80366-8; Li LH, 2011, FASEB J, V25, P1556, DOI 10.1096/fj.10-177279; Luo J, 2001, J NEUROCHEM, V76, P1354, DOI 10.1046/j.1471-4159.2001.00129.x; Ma MT, 2011, NEUROCHEM RES, V36, P347, DOI 10.1007/s11064-010-0340-y; MAJCHROWICZ E, 1975, PSYCHOPHARMACOLOGIA, V43, P245, DOI 10.1007/BF00429258; Manley GT, 2000, NAT MED, V6, P159, DOI 10.1038/72256; Moses G. S., 2006, J NEUROINFLAMM, P3; Obernier JA, 2002, PHARMACOL BIOCHEM BE, V72, P521, DOI 10.1016/S0091-3057(02)00715-3; Obernier JA, 2002, ALCOHOL CLIN EXP RES, V26, P547, DOI 10.1111/j.1530-0277.2002.tb02573.x; Ong WY, 2010, CURR MED CHEM, V17, P2746, DOI 10.2174/092986710791859289; Pacher P, 2008, AM J PATHOL, V173, P2, DOI 10.2353/ajpath.2008.080019; Przybycien-Szymanska MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018350; Rao JS, 2007, MOL PSYCHIATR, V12, P151, DOI 10.1038/sj.mp.4001887; Roberta A, 2010, CURR NEUROPHARMACOL, V8, P84, DOI 10.2174/157015910791233178; Saadoun S, 2010, NEUROSCIENCE, V168, P1036, DOI 10.1016/j.neuroscience.2009.08.019; Seleznev K, 2006, J BIOL CHEM, V281, P22275, DOI 10.1074/jbc.M604330200; Shinzawa K, 2008, J NEUROSCI, V28, P2212, DOI 10.1523/JNEUROSCI.4354-07.2008; Simonyi A, 2002, ALCOHOL CLIN EXP RES, V26, P352, DOI 10.1111/j.1530-0277.2002.tb02545.x; Sripathirathan K, 2009, J NEUROTRAUM, V26, P261, DOI 10.1089/neu.2008.0682; Strokin M, 2006, NEUROSCIENCE, V140, P547, DOI 10.1016/j.neuroscience.2006.02.026; Sun GY, 2010, NEUROMOL MED, V12, P133, DOI 10.1007/s12017-009-8092-z; Switzer R. C., 1982, ANAT REC, V202, p186A; Tomas-Camardiel M, 2004, J NEUROCHEM, V91, P891, DOI 10.1111/j.1471-4159.2004.02759.x; Wang YF, 2009, EXP NEUROL, V218, P193, DOI 10.1016/j.expneurol.2009.03.020; Wu AG, 2011, J NEUROTRAUM, V28, P2113, DOI 10.1089/neu.2011.1872; Yang HC, 1999, J NEUROCHEM, V73, P1278, DOI 10.1046/j.1471-4159.1999.0731278.x; Zou J, 2010, ALCOHOL CLIN EXP RES, V34, P777, DOI 10.1111/j.1530-0277.2010.01150.x	63	18	19	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0741-8329			ALCOHOL	Alcohol	FEB	2013	47	1					39	45		10.1016/j.alcohol.2012.09.003			7	Substance Abuse; Pharmacology & Pharmacy; Toxicology	Substance Abuse; Pharmacology & Pharmacy; Toxicology	083UC	WOS:000314489700009	23102656	Green Accepted			2021-06-18	
J	Wang, JW; Wang, HD; Cong, ZX; Zhang, XS; Zhou, XM; Zhang, DD				Wang, Jia-Wei; Wang, Han-Dong; Cong, Zi-Xiang; Zhang, Xiang-Sheng; Zhou, Xiao-Ming; Zhang, Ding-Ding			Activation of metabotropic glutamate receptor 5 reduces the secondary brain injury after traumatic brain injury in rats	BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS			English	Article						Traumatic brain injury; Metabotropic glutamate receptor 5; Inflammation	CEREBRAL-ISCHEMIA; CELL-DEATH; PATHOPHYSIOLOGY; NEUROPROTECTION; NEUROTOXICITY; STRATEGIES; MICROGLIA; APOPTOSIS	A wealth of evidence has shown that microglia-associated neuro-inflammation is involved in the secondary brain injury contributed to the poor outcome after traumatic brain injury (TBI). In vitro studies were reported that activation of metabotropic glutamate receptor 5 (mGluR5) could inhibit the microglia-associated inflammation in response to lipopolysaccharide and our previous study indicated that mGluR5 was expressed in activated microglia following TBI. However, there is little known about whether mGluR5 activation can provide neuro-protection and reduce microglia-associated neuro-inflammation in rats after TBI. The goal of the present study was to investigate the effects of mGluR5 activation with selective agonist CHPG, on cerebral edema, neuronal degeneration, microglia activation and the releasing of pro-inflammatory cytokines, in a rat model of TBI. Rats were randomly distributed into various subgroups undergoing the sham surgery or TBI procedures, and 250 nmol of CHPG or equal volume vehicle was given through intracerebroventricular injection at 30 mm post-TBI. All rats were sacrificed at 24 h after TBI for the further measurements. Our data indicated that post-TBI treatment with CHPG could significantly reduce the secondary brain injury characterized by the cerebral edema and neuronal degeneration, lead to the inhibition of microglia activation and decrease the expression of pro-inflammatory cytokines in both mRNA transcription and protein synthesis. These results provide the substantial evidence that activation of mGluR5 reduces the secondary brain injury after TBI, in part, through modulating microglia-associated neuro-inflammation. (C) 2012 Elsevier Inc. All rights reserved.	[Wang, Jia-Wei; Wang, Han-Dong; Cong, Zi-Xiang; Zhang, Ding-Ding] Nanjing Univ, Sch Med, Jinling Hosp, Dept Neurosurg, Nanjing 210008, Jiangsu, Peoples R China; [Zhang, Xiang-Sheng; Zhou, Xiao-Ming] Second Mil Med Univ, Dept Neurosurg, Jinling Hosp, Sch Med, Nanjing, Jiangsu, Peoples R China	Wang, HD (corresponding author), Jinling Hosp, Dept Neurosurg, 305 E Zhongshan Rd, Nanjing 210002, Jiangsu, Peoples R China.	hdwang_nj@yahoo.com.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81070974]; Key Subject of Jiangsu Province [X4200722]	This work was supported by grants from National Natural Science Foundation of China (No. 81070974), and the Key Subject of Jiangsu Province (X4200722).	Allen JW, 2000, CELL DEATH DIFFER, V7, P470, DOI 10.1038/sj.cdd.4400678; Bao WL, 2001, BRAIN RES, V922, P173, DOI 10.1016/S0006-8993(01)03062-1; Baskaya MK, 2000, J NEUROTRAUM, V17, P93, DOI 10.1089/neu.2000.17.93; Bramlett HM, 2007, PROG BRAIN RES, V161, P125, DOI 10.1016/S0079-6123(06)61009-1; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Byrnes KR, 2009, ANN NEUROL, V66, P63, DOI 10.1002/ana.21673; Byrnes KR, 2009, NEUROTHERAPEUTICS, V6, P94, DOI 10.1016/j.nurt.2008.10.038; Byrnes KR, 2009, GLIA, V57, P550, DOI 10.1002/glia.20783; Chen G, 2009, EXP NEUROL, V216, P398, DOI 10.1016/j.expneurol.2008.12.019; Conn PJ, 1997, ANNU REV PHARMACOL, V37, P205, DOI 10.1146/annurev.pharmtox.37.1.205; d'Avila JC, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-31; Graeber MB, 2010, SCIENCE, V330, P783, DOI 10.1126/science.1190929; Hunter AJ, 1998, TRENDS PHARMACOL SCI, V19, P59, DOI 10.1016/S0165-6147(97)01157-7; Lea PM, 2005, BRIT J PHARMACOL, V145, P527, DOI 10.1038/sj.bjp.0706219; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Loane DJ, 2009, J BIOL CHEM, V284, P15629, DOI 10.1074/jbc.M806139200; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Morganti-Kossmann MC, 2007, INJURY, V38, P1392, DOI 10.1016/j.injury.2007.10.005; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; Movsesyan VA, 2004, J NEUROCHEM, V89, P1528, DOI 10.1111/j.1471-4159.2004.02451.x; Schmued LC, 2005, BRAIN RES, V1035, P24, DOI 10.1016/j.brainres.2004.11.054; Wang JW, 2012, BRAIN RES, V1464, P73, DOI 10.1016/j.brainres.2012.05.014; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131	24	18	18	0	7	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0006-291X	1090-2104		BIOCHEM BIOPH RES CO	Biochem. Biophys. Res. Commun.	JAN 18	2013	430	3					1016	1021		10.1016/j.bbrc.2012.12.046			6	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	082EW	WOS:000314376100025	23261470				2021-06-18	
J	Bonova, P; Burda, J; Danielisova, V; Nemethova, M; Gottlieb, M				Bonova, Petra; Burda, Jozef; Danielisova, Viera; Nemethova, Miroslava; Gottlieb, Miroslav			Development of a pattern in biochemical parameters in the core and penumbra during infarct evolution after transient MCAO in rats	NEUROCHEMISTRY INTERNATIONAL			English	Article						MCAO; Ischaemia; Reperfusion; SOD; Glutamate; Translation activity	MANGANESE-SUPEROXIDE-DISMUTASE; FOCAL CEREBRAL-ISCHEMIA; UNFOLDED PROTEIN RESPONSE; GLOBAL FOREBRAIN ISCHEMIA; TRAUMATIC BRAIN-INJURY; OXIDATIVE STRESS; AMINO-ACIDS; CELL-DEATH; MITOCHONDRIAL DYSFUNCTION; ANTIOXIDANT ENZYMES	The period from stroke initiation to the cessation of penumbra damage spread represents a therapeutic window when expansion can be alleviated. In the present work, we studied some biochemical parameters helpful for the estimation of infarct progression and thus for the application of interventions. We designed four groups: the control group and three groups of animals after middle cerebral artery occlusion with reperfusion periods of 2 h, 1 day or 3 days. In the ischaemic core and penumbra, fluorimetric and spectrophotometric methods for investigating total MnSOD and MAO-A/B activity as well as level of the glutamate were used. Protein synthesis was assessed by in vitro measurements of C-14-leucine incorporation. Noticeable differences between core and penumbra biochemical parameters were shown. In the core, protein synthesis was transiently inhibited two hours and three days after ischaemia (36%). Glutamate and total SOD activity peaked on the first day, but on the third day after MCAO, rapidly decreased by about 44% and 33.6%, respectively. In the penumbra, ischaemia led to higher protein synthesis (78%), elevations in glutamate and rapid activation of MnSOD (by about 884%) one day after insult. On the third day, protein synthesis and MnSOD were still significantly elevated (36% and 388%, respectively), while glutamate levels returned to baseline. In addition, the impact of ischaemia on MAO-A/B activity in the penumbra was confirmed. In conclusion, biochemical parameter screening could be helpful to assess cell damage progress and the possibility of rescue. These regions reflect different biochemical patterns that seem to be clearly established on the first day after transient MCAO. Moreover, the first day of post-ischaemic reperfusion in the present model of stroke seems to be the breakpoint, i.e. the time at which expanding cell death from the infarct core to the penumbra can be at least partially eliminated. (C) 2012 Elsevier Ltd. All rights reserved.	[Bonova, Petra; Burda, Jozef; Danielisova, Viera; Nemethova, Miroslava; Gottlieb, Miroslav] Slovak Acad Sci, Inst Neurobiol, SK-04001 Kosice, Slovakia	Bonova, P (corresponding author), Slovak Acad Sci, Inst Neurobiol, Soltesovej 4-6, SK-04001 Kosice, Slovakia.	kravcukova@saske.sk	Jozef, Burda/F-6058-2011; Nemethova, Miroslava/AAD-9106-2020; Nemethova, Miroslava/F-1506-2018; Bonova, Petra/F-2887-2018	Nemethova, Miroslava/0000-0002-2841-8009; Nemethova, Miroslava/0000-0002-2841-8009; Bonova, Petra/0000-0002-5427-8126	Slovak Grant Agencies [VEGA 2/0092/12, VEGA 2/0148/12, VEGA 2/0066/12]	The authors gratefully acknowledge the excellent technical assistance of Dana Jurusova. This study was supported by the Slovak Grant Agencies VEGA 2/0092/12, VEGA 2/0148/12 and VEGA 2/0066/12.	Abou-Sleiman PM, 2006, NAT REV NEUROSCI, V7, P207, DOI 10.1038/nrn1868; Adachi N, 2005, BRAIN RES REV, V50, P275, DOI 10.1016/j.brainresrev.2005.08.002; Aggoun-Zouaoui D, 1998, APOPTOSIS, V3, P133, DOI 10.1023/A:1009653126347; ANDINE P, 1991, J NEUROCHEM, V57, P222, DOI 10.1111/j.1471-4159.1991.tb02119.x; Arundine M, 2004, CELL MOL LIFE SCI, V61, P657, DOI 10.1007/s00018-003-3319-x; Ashafaq M, 2012, NUTR RES, V32, P133, DOI 10.1016/j.nutres.2011.12.014; Ashwal S, 1998, STROKE, V29, P1037, DOI 10.1161/01.STR.29.5.1037; ASTRUP J, 1981, STROKE, V12, P723, DOI 10.1161/01.STR.12.6.723; Back T, 1998, CELL MOL NEUROBIOL, V18, P621, DOI 10.1023/A:1020265701407; BEAUCHAM.C, 1971, ANAL BIOCHEM, V44, P276, DOI 10.1016/0003-2697(71)90370-8; BEDERSON JB, 1986, STROKE, V17, P472, DOI 10.1161/01.STR.17.3.472; Bidmon HJ, 1998, STROKE, V29, P203, DOI 10.1161/01.STR.29.1.203; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burda J, 2006, CELL MOL NEUROBIOL, V26, P1141, DOI 10.1007/s10571-006-9036-x; Chan PH, 1996, STROKE, V27, P1124, DOI 10.1161/01.STR.27.6.1124; CLEMENS JA, 1988, LIFE SCI, V42, P707, DOI 10.1016/0024-3205(88)90463-8; COOPER HK, 1977, ACTA NEUROL SCAND, V56, P130; Danielisova V, 2005, NEUROCHEM RES, V30, P559, DOI 10.1007/s11064-005-2690-4; Danielisova V, 2009, CELL MOL NEUROBIOL, V29, P871, DOI 10.1007/s10571-009-9369-3; Du C, 1996, J CEREBR BLOOD F MET, V16, P195, DOI 10.1097/00004647-199603000-00003; Edmondson DE, 2004, CURR MED CHEM, V11, P1983, DOI 10.2174/0929867043364784; Endres H, 1998, J CEREBR BLOOD F MET, V18, P238, DOI 10.1097/00004647-199803000-00002; Garcia L, 2004, J NEUROSCI RES, V77, P292, DOI 10.1002/jnr.20140; GRAHAM LT, 1966, ANAL BIOCHEM, V15, P487, DOI 10.1016/0003-2697(66)90110-2; Ha JS, 2006, NEUROSCI LETT, V393, P165, DOI 10.1016/j.neulet.2005.09.056; Harding HP, 2002, ANNU REV CELL DEV BI, V18, P575, DOI 10.1146/annurev.cellbio.18.011402.160624; Hossmann KA, 2012, J CEREBR BLOOD F MET, V32, P1310, DOI 10.1038/jcbfm.2011.186; Huang HF, 2012, CNS NEUROSCI THER, V18, P811, DOI 10.1111/j.1755-5949.2012.00380.x; HYSLOP PA, 1995, BRAIN RES, V671, P181, DOI 10.1016/0006-8993(94)01291-O; KATO H, 1995, BRAIN RES BULL, V36, P205, DOI 10.1016/0361-9230(94)00191-3; Kawase M, 1999, STROKE, V30, P1962, DOI 10.1161/01.STR.30.9.1962; Keller JN, 1998, J NEUROSCI, V18, P687; Khan MM, 2009, BRAIN RES, V1292, P123, DOI 10.1016/j.brainres.2009.07.026; KLEIHUES P, 1975, BRAIN RES, V95, P61, DOI 10.1016/0006-8993(75)90207-3; Kokubo Y, 2003, NEUROSURGERY, V53, P186, DOI 10.1227/01.NEU.0000069023.01440.D6; Kravcukova P, 2009, CELL MOL NEUROBIOL, V29, P887, DOI 10.1007/s10571-009-9371-9; Lang D, 2011, BRAIN RES, V1425, P155, DOI 10.1016/j.brainres.2011.10.005; Li JS, 2008, BRAIN RES, V1210, P223, DOI 10.1016/j.brainres.2008.03.007; Li YB, 1998, BRAIN RES, V814, P164, DOI 10.1016/S0006-8993(98)01082-8; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; MAKER HS, 1981, J NEUROCHEM, V36, P589, DOI 10.1111/j.1471-4159.1981.tb01631.x; MANS RJ, 1961, ARCH BIOCHEM BIOPHYS, V94, P48, DOI 10.1016/0003-9861(61)90009-1; Mehta SL, 2007, BRAIN RES REV, V54, P34, DOI 10.1016/j.brainresrev.2006.11.003; MICHAELS RL, 1990, J NEUROSCI, V10, P283; Molchanova S, 2004, NEUROCHEM RES, V29, P1519, DOI 10.1023/B:NERE.0000029564.98905.5c; Mrsic-Pelcic J., 2012, CELL BIOCH FUNCT; Murakami K, 1998, J NEUROSCI, V18, P205; Negovskii V.A., 1962, RESUSCITATION ARTIFI, P290; PHEBUS LA, 1989, LIFE SCI, V44, P1335, DOI 10.1016/0024-3205(89)90390-1; Popp A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004764; Sacco RL, 2006, STROKE, V37, P577, DOI 10.1161/01.STR.0000199147.30016.74; Sun M, 2009, NEUROCHEM INT, V54, P339, DOI 10.1016/j.neuint.2008.12.017; Sun PZ, 2007, J CEREBR BLOOD F MET, V27, P1129, DOI 10.1038/sj.jcbfm.9600424; SUN Y, 1988, CLIN CHEM, V34, P497; Tipton KF, 2004, CURR MED CHEM, V11, P1965, DOI 10.2174/0929867043364810; Uchida H, 2010, CELL MOL NEUROBIOL, V30, P1125, DOI 10.1007/s10571-010-9545-5; Yang Y, 2001, NEUROPATHOLOGY, V21, P181, DOI 10.1046/j.1440-1789.2001.00397.x; Yao H, 2001, MOL BRAIN RES, V91, P112, DOI 10.1016/S0169-328X(01)00135-8; Yi JH, 2006, NEUROCHEM INT, V48, P394, DOI 10.1016/j.neuint.2005.12.001; Zhang KZ, 2006, NEUROLOGY, V66, pS102, DOI 10.1212/01.wnl.0000192306.98198.ec; Zhang YH, 2008, EXP NEUROL, V210, P514, DOI 10.1016/j.expneurol.2007.11.027; Zhao H, 2012, CURR DRUG TARGETS, V13, P173, DOI 10.2174/138945012799201621; Zhao H, 2009, J CEREBR BLOOD F MET, V29, P873, DOI 10.1038/jcbfm.2009.13	63	18	18	0	21	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0197-0186	1872-9754		NEUROCHEM INT	Neurochem. Int.	JAN	2013	62	1					8	14		10.1016/j.neuint.2012.10.015			7	Biochemistry & Molecular Biology; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	083EJ	WOS:000314445200002	23142152				2021-06-18	
J	De La Rue-Evans, L; Nesbitt, K; Oka, RK				De La Rue-Evans, Linda; Nesbitt, Karen; Oka, Roberta K.			Sleep Hygiene Program Implementation in Patients with Traumatic Brain Injury	REHABILITATION NURSING			English	Article						brain injury; evidence-based practice; quality improvement	LONG-TERM DISABILITY; UNITED-STATES; DISTURBANCE; VETERANS; INSOMNIA; STROKE	Purpose Traumatic brain injury (TBI) is a serious public health problem. The impact of TBI on the individual is multifaceted and includes neurocognitive, behavioral, and psychiatric disturbances as well as greater predisposition for dementia. A common but significant problem reported by patients after TBI is sleep disturbance. The purpose of this manuscript is twofold: (1) to describe our experience with implementation of the newly developed sleep hygiene guidelines; and (2) to report our preliminary results of implementation of the sleep hygiene guidelines on TBI patient outcomes. Methods A mixed methods approach was used to assess implementation of sleep hygiene guidelines and to gather preliminary data on outcomes. Results Although not statistically significant, the average self-reported sleep duration of these TBI patients was slightly higher in 2010 than 2009, with a FIM score that was similar for both time points. In 2009, the mean change in functional independence measure (FIM) score (n=34) was 1.44. In 2010, the mean change in FIM score (n=33) was 1.42. In 2009, most patients (n=13) admitted to the hospital continued to take medications and were discharged with a sleep aid. In 2010, most patients reported a change in their sleep medication prescriptions (on medications at admission and none at discharge) or had continued to take their prescribed sleep medications from admission to discharge (n=12). Conclusion Sleep disorders have a major impact on health outcomes in patients with TBI. To optimize rehabilitation and ultimately improve functional outcomes of patients with TBI, implementation of evidence-based clinical guidelines for sleep is imperative. We report our initial experience with implementation of sleep guidelines.	[De La Rue-Evans, Linda; Nesbitt, Karen; Oka, Roberta K.] VA Palo Alto Hlth Care Syst, Dept Nursing, Palo Alto, CA USA	Oka, RK (corresponding author), VA HCS Palo Alto, 3801 Miranda Ave,MS 118, Palo Alto, CA 94304 USA.	roberta.oka@va.gov					Buxton OM, 2012, ANN INTERN MED, V157, P170, DOI [10.7326/0003-4819-156-12-201208070-00472, 10.7326/0003-4819-157-3-201208070-00472]; Capaldi VF, 2011, MIL MED, V176, P879, DOI 10.7205/MILMED-D-10-00440; Castriotta RJ, 2011, CNS DRUGS, V25, P175, DOI 10.2165/11584870-000000000-00000; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Corso P, 2006, INJURY PREV, V12, P212, DOI 10.1136/ip.2005.010983; DeKosky ST, 2010, NEW ENGL J MED, V363, P1293, DOI 10.1056/NEJMp1007051; DODDS TA, 1993, ARCH PHYS MED REHAB, V74, P531, DOI 10.1016/0003-9993(93)90119-U; Dromerick AW, 2003, J REHABIL RES DEV, V40, P1, DOI 10.1682/JRRD.2003.01.0001; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Fischer H., 2010, CRS REPORT C, P1; Hsueh IP, 2002, J NEUROL NEUROSUR PS, V73, P188, DOI 10.1136/jnnp.73.2.188; Keith R A, 1987, Adv Clin Rehabil, V1, P6; Lew HL, 2010, AM J PHYS MED REHAB, V89, P437, DOI 10.1097/PHM.0b013e3181ddd301; Mitchell MD, 2012, BMC FAM PRACT, V13, DOI 10.1186/1471-2296-13-40; O'Hara R, 2009, J REHABIL RES DEV, V46, P837, DOI 10.1682/JRRD.2008.10.0140; Orff HJ, 2009, J HEAD TRAUMA REHAB, V24, P155, DOI 10.1097/HTR.0b013e3181a0b281; Rosenfeld JV, 2010, INJURY, V41, P437, DOI 10.1016/j.injury.2009.11.018; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac; Zeitzer JM, 2009, J REHABIL RES DEV, V46, P827, DOI 10.1682/JRRD.2008.08.0099	20	18	19	0	20	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0278-4807			REHABIL NURS	Rehabil. Nurs.	JAN-FEB	2013	38	1					2	10		10.1002/rnj.66			9	Nursing; Rehabilitation	Nursing; Rehabilitation	084EY	WOS:000314521600002	23365000				2021-06-18	
J	Eastvold, AD; Walker, WC; Curtiss, G; Schwab, K; Vanderploeg, RD				Eastvold, Angela D.; Walker, William C.; Curtiss, Glenn; Schwab, Karen; Vanderploeg, Rodney D.			The Differential Contributions of Posttraumatic Amnesia Duration and Time Since Injury in Prediction of Functional Outcomes Following Moderate-to-Severe Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						acute hospitalization; independence; outcome prediction; PTA; rehabilitation; return-to-work; TBI	HEAD-INJURY; COMMUNITY INTEGRATION; RETURN; MULTICENTER; EMPLOYMENT; WORK; REHABILITATION; PRODUCTIVITY; UTILITY; STATE	Objective: To examine the relative contributions of preinjury, injury severity, and acute postinjury variables in predicting outcomes at 1 year following moderate-severe traumatic brain injury (TBI). Design: Secondary analysis of a prospective longitudinal cohort study. Setting: Four Veterans Affairs Medical Center acute inpatient rehabilitation programs. Participants: Active duty military or veterans with a nonpenetrating moderate-to-severe TBI. Main outcome measures: Independent living status (N = 280) and work status (N = 248) at one year postinjury. Results: Preinjury characteristics as a group accounted for the largest amount of variance in independent living status at 1 year; however, posttraumatic amnesia (PTA) uniquely explained the largest amount of variance (8.8%). Those with less than 60 days PTA were 9 times more likely to be independent; those with less than 30 days PTA were 3 times more likely to be independent. In contrast, acute postinjury characteristics accounted for the largest amount of variance in work status, with time to rehabilitation explaining the most unique variance (10.4%). Those with less than 48 days time to rehabilitation were 2.4 times more likely to be productive. Conclusions: This study highlights the differential contribution of variables in the prediction of 2 specific functional outcomes in a military sample, adding to our current body of knowledge to assist clinicians, patients and their families following TBI.	[Eastvold, Angela D.; Curtiss, Glenn; Vanderploeg, Rodney D.] James A Haley Vet Affairs Med Ctr, Tampa, FL USA; [Walker, William C.] Hunter H McGuire Vet Affairs Med Ctr, Richmond, VA USA; [Walker, William C.] Def & Vet Brain Injury Ctr, Richmond, VA USA; [Walker, William C.] Virginia Commonwealth Univ, Sch Med, Dept Phys Med & Rehabil, Richmond, VA USA; [Schwab, Karen] Def & Vet Brain Injury Ctr, Bethesda, MD USA; [Schwab, Karen] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA; [Curtiss, Glenn; Vanderploeg, Rodney D.] Univ S Florida, Dept Psychiat & Neurosci, Tampa, FL USA; [Curtiss, Glenn] Univ S Florida, Dept Aging & Mental Hlth Dispar, Tampa, FL USA; [Vanderploeg, Rodney D.] Def & Vet Brain Injury Ctr, Tampa, FL USA; [Vanderploeg, Rodney D.] Univ S Florida, Dept Psychol, Tampa, FL 33620 USA	Eastvold, AD (corresponding author), Univ Utah, Sch Med, Dept Neurol, 650 Komas Ave,106A, Salt Lake City, UT 84108 USA.	angela.eastvold@hsc.utah.edu	Walker, William C/N-3162-2014; Curtiss, Glenn/ABB-5566-2020		Department of Defense through the Henry Jackson Foundation [MDA 905-03-2-0003]; Department of Veterans Affairs, Veterans Health Administration (VHA), Defense and Veterans Brain Injury Center, Uniformed Services University of the Health Sciences, Bethesda, MD	The research reported here was originally supported by the Department of Veterans Affairs, Veterans Health Administration (VHA), Defense and Veterans Brain Injury Center, Uniformed Services University of the Health Sciences, Bethesda, MD, and a Department of Defense award administered through the Henry Jackson Foundation (grant MDA 905-03-2-0003). Further support was provided by the VHA Medical Center in Tampa, Florida.	Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P194, DOI 10.1017/S1355617709990841; BISHARA S N, 1992, Brain Injury, V6, P373, DOI 10.3109/02699059209034952; Brown AW, 2010, BRAIN INJURY, V24, P472, DOI 10.3109/02699051003610466; Brown AW, 2005, J NEUROTRAUM, V22, P1040, DOI 10.1089/neu.2005.22.1040; Centers for Disease Contol and Prevention, TBI BRAIN INJ; Chandler SK, 1993, VOCATIONAL EVALUATIO, P161; Cifu DX, 1997, ARCH PHYS MED REHAB, V78, P125, DOI 10.1016/S0003-9993(97)90252-5; CREPEAU F, 1993, NEUROPSYCHOL REHABIL, V3, P5; Dawson DR, 2004, BRAIN INJURY, V18, P221, DOI 10.1080/02699050310001617406; DeMaris A, 2002, SOCIOL METHOD RES, V31, P27, DOI 10.1177/0049124102031001002; Fleming J, 1999, BRAIN INJURY, V13, P417; Friedland JF, 2001, J NERV MENT DIS, V189, P426, DOI 10.1097/00005053-200107000-00003; Gary KW, 2009, ARCH PHYS MED REHAB, V90, P1699, DOI 10.1016/j.apmr.2009.04.014; Granger CV, 1998, ARCH PHYS MED REHAB, V79, P235, DOI 10.1016/S0003-9993(98)90000-4; Green RE, 2008, ARCH PHYS MED REHAB, V89, pS51, DOI 10.1016/j.apmr.2008.09.552; Hoofien D, 2001, BRAIN INJURY, V15, P189; JENNETT B, 1975, LANCET, V1, P480; Johnstone B, 2003, ARCH PHYS MED REHAB, V84, P161, DOI 10.1053/apmr.2003.50098; KATZ DI, 1994, ARCH NEUROL-CHICAGO, V51, P661, DOI 10.1001/archneur.1994.00540190041013; Keyser-Marcus LA, 2002, ARCH PHYS MED REHAB, V83, P635, DOI 10.1053/apmr.2002.31605; McCrimmon S, 2006, BRAIN INJURY, V20, P1037, DOI 10.1080/02699050600909656; MCKELVEY RD, 1975, J MATH SOCIOL, V4, P103, DOI 10.1080/0022250X.1975.9989847; MCMORDIE W R, 1990, Brain Injury, V4, P57, DOI 10.3109/02699059009026149; Nakase-Richardson R, 2009, ARCH PHYS MED REHAB, V90, P17, DOI 10.1016/j.apmr.2008.06.030; Nightingale EJ, 2007, BRAIN IMPAIR, V8, P101, DOI [10.1375/brim.8.2.101, DOI 10.1375/BRIM.8.2.101]; Ownsworth T, 2004, DISABIL REHABIL, V26, P765, DOI 10.1080/09638280410001696700; Rush BK, 2006, REHABIL PSYCHOL, V51, P257, DOI 10.1037/0090-5550.51.3.257; Sander AM, 1996, J HEAD TRAUMA REHAB, V11, P70, DOI 10.1097/00001199-199610000-00007; Sherer M, 2003, J HEAD TRAUMA REHAB, V18, P408, DOI 10.1097/00001199-200309000-00003; Sherer M, 2002, CLIN NEUROPSYCHOL, V16, P157, DOI 10.1076/clin.16.2.157.13238; STAMBROOK M, 1990, Brain Injury, V4, P183, DOI 10.3109/02699059009026164; Tate R., 2005, BRAIN IMPAIR, V6, P75, DOI DOI 10.1375/BRIM.2005.6.2.75; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207; Vanderploeg RD, 2008, ARCH PHYS MED REHAB, V89, P2227, DOI 10.1016/j.apmr.2008.06.015; Vogenthaler D R, 1989, Brain Inj, V3, P355, DOI 10.3109/02699058909004560; Vogenthaler D R, 1989, Brain Inj, V3, P369, DOI 10.3109/02699058909004561; Walker WC, 2010, J NEUROL NEUROSUR PS, V81, P87, DOI 10.1136/jnnp.2008.161570; Whelan-Goodinson R, 2008, J REHABIL MED, V40, P850, DOI 10.2340/16501977-0271; Wilson JTL, 2000, J NEUROL NEUROSUR PS, V69, P204, DOI 10.1136/jnnp.69.2.204; WILSON JTL, 1994, J NEUROL NEUROSUR PS, V57, P198, DOI 10.1136/jnnp.57.2.198	41	18	18	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2013	28	1					48	58		10.1097/HTR.0b013e31823c9317			11	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	070ZW	WOS:000313555400006	22333678				2021-06-18	
J	Mendez, MF; Owens, EM; Jimenez, EE; Peppers, D; Licht, EA				Mendez, Mario F.; Owens, Emily M.; Jimenez, Elvira E.; Peppers, Dominique; Licht, Eliot A.			Changes in personality after mild traumatic brain injury from primary blast vs. blunt forces	BRAIN INJURY			English	Article						Traumatic brain injury; concussion; blast forces; blunt forces; personality	POSTTRAUMATIC-STRESS-DISORDER; SYSTEMS BEHAVIOR SCALE; POSTCONCUSSIVE SYMPTOMS; INTERPERSONAL-BEHAVIOR; SERVICE MEMBERS; MECHANISMS; INVENTORY; IRAQ; PTSD; TBI	Introduction: Injuries from explosive devices can cause blast-force injuries, including mild traumatic brain injury (mTBI). Objective: This study investigated changes in personality from blast-force mTBI in comparison to blunt-force mTBI. Methods: Clinicians and significant others assessed US veterans who sustained pure blast-force mTBI (n = 12), as compared to those who sustained pure blunt-force mTBI (n = 12). Inclusion criteria included absence of any mixed blast-blunt trauma and absence of post-traumatic stress disorder. Measures included the Interpersonal Measure of Psychopathy (IMP), the Big Five Inventory (BFI), the Interpersonal Adjectives Scale (IAS) and the Frontal Systems Behaviour Scale (FrSBe). Results: There were no group differences on demographic or TBI-related variables. Compared to the Blunt Group, the Blast Group had more psychopathy on the IM-P, with anger, frustration, toughness and boundary violations and tended to more neuroticism on the BFI. When pre-TBI and post-TBI assessments were compared on the IAS and FrSBe, only the patients with blast force mTBI had become more cold-hearted, aloof-introverted and apathetic. Conclusion: These results suggest that blast forces alone can cause negativistic behavioural changes when evaluated with selected measures of personality. Further research on isolated blast-force mTBI should focus on these personality changes and their relationship to blast over-pressure.	[Mendez, Mario F.; Owens, Emily M.; Jimenez, Elvira E.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; [Mendez, Mario F.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA; [Mendez, Mario F.; Licht, Eliot A.] VA Greater Los Angeles Healthcare Ctr, Neurol Sect, Los Angeles, CA 90073 USA; [Peppers, Dominique] VA Greater Los Angeles Healthcare Ctr, Sect Phys Med & Rehabil, Los Angeles, CA 90073 USA	Mendez, MF (corresponding author), VA Greater Los Angeles Healthcare Ctr, Neurobehav Unit 691 116AF, 11301 Wilshire Blvd, Los Angeles, CA 90073 USA.	mmendez@UCLA.edu			Veterans Affairs AdministrationUS Department of Veterans Affairs	This research was made possible by a grant from the Veterans Affairs Administration.	ALDEN LE, 1990, J PERS ASSESS, V55, P521, DOI 10.1207/s15327752jpa5503&4_10; Arbisi PA, 2011, PSYCHOL ASSESSMENT, V23, P203, DOI 10.1037/a0021339; Bauman RA, 2009, J NEUROTRAUM, V26, P841, DOI 10.1089/neu.2009-0898; Belanger HG, 2011, CLIN NEUROPSYCHOL, V25, P702, DOI 10.1080/13854046.2011.566892; Belanger HG, 2009, J INT NEUROPSYCH SOC, V15, P1, DOI 10.1017/S1355617708090036; Belanger HG, 2005, J REHABIL RES DEV, V42, P403, DOI 10.1682/JRRD.2004.08.0095; Brenner LA, 2010, J HEAD TRAUMA REHAB, V25, P307, DOI 10.1097/HTR.0b013e3181cada03; Brenner LA, 2010, NEUROPSYCHOLOGY, V24, P160, DOI 10.1037/a0017966; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; Chavko M, 2007, J NEUROSCI METH, V159, P277, DOI 10.1016/j.jneumeth.2006.07.018; Chen Y, 2011, BRAIN INJURY, V25, P641, DOI 10.3109/02699052.2011.580313; Cooper DB, 2011, BRAIN INJURY, V25, P1, DOI 10.3109/02699052.2010.531692; Courtney MW, 2011, NEUROIMAGE, V54, pS55, DOI 10.1016/j.neuroimage.2010.05.025; Demakis GJ, 2007, ARCH CLIN NEUROPSYCH, V22, P123, DOI 10.1016/j.acn.2006.09.004; Drake AI, 2010, NEUROREHABILITATION, V26, P183, DOI 10.3233/NRE-2010-0554; Elder GA, 2009, MT SINAI J MED, V76, P111, DOI 10.1002/msj.20098; Fear NT, 2009, PSYCHOL MED, V39, P1379, DOI 10.1017/S0033291708004595; Foley J, 2006, INT J NEUROSCI, V116, P1377, DOI 10.1080/00207450500514334; French LM, 2010, ANN NY ACAD SCI, V1208, P38, DOI 10.1111/j.1749-6632.2010.05696.x; Garden N, 2010, NEUROPSYCHOLOGY, V24, P168, DOI 10.1037/a0017431; Grace J, 1999, ASSESSMENT, V6, P269, DOI 10.1177/107319119900600307; Gracia-Garcia P, 2011, J NEUROPSYCH CLIN N, V23, pE14, DOI 10.1176/appi.neuropsych.23.2.E14; Heltemes KJ, 2012, INJURY; HENRY GK, 1994, J NEUROPSYCH CLIN N, V6, P58; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Jones E, 2007, AM J PSYCHIAT, V164, P1641, DOI 10.1176/appi.ajp.2007.07071180; Kennedy JE, 2010, NEUROREHABILITATION, V26, P223, DOI 10.3233/NRE-2010-0558; King NS, 2008, BRAIN INJURY, V22, P1, DOI 10.1080/02699050701829696; Kosson DS, 1997, PSYCHOL ASSESSMENT, V9, P89, DOI 10.1037/1040-3590.9.2.89; Kozminski M, 2010, J AM OSTEOPATH ASSOC, V110, P514; Kurtz JE, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199806000-00002; Labuschagne I, 2012, INT J NEUROPSYCHOPH, V15, P883, DOI 10.1017/S1461145711001489; Lannoo E, 1997, J PSYCHOSOM RES, V43, P505, DOI 10.1016/S0022-3999(97)00152-9; Levin HS, 2010, J NEUROTRAUM, V27, P683, DOI 10.1089/neu.2009.1073; Lew HL, 2005, J REHABIL RES DEV, V42, pXIII, DOI 10.1682/JRRD.2005.07.0124; Lew HL, 2008, CLIN PSYCHOL REV, V45, pxi; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Lippa SM, 2010, J INT NEUROPSYCH SOC, V16, P856, DOI 10.1017/S1355617710000743; Matthews SC, 2011, NEUROIMAGE, V54, pS69, DOI 10.1016/j.neuroimage.2010.04.269; Max JE, 2006, J NEUROPSYCH CLIN N, V18, P21, DOI 10.1176/appi.neuropsych.18.1.21; McAllister TW, 2010, ANN NY ACAD SCI, V1208, P46, DOI 10.1111/j.1749-6632.2010.05720.x; Meares S, 2011, NEUROPSYCHOLOGY, V25, P454, DOI 10.1037/a0022580; Mendez MF, 2008, INT J GERIATR PSYCH, V23, P1203, DOI 10.1002/gps.2019; Miller JD, 2011, ASSESSMENT, V18, P335, DOI 10.1177/1073191111411671; Moss WC, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.108702; Nyein MK, 2010, P NATL ACAD SCI USA, V107, P20703, DOI 10.1073/pnas.1014786107; Obonsawin MC, 2007, J NEUROL NEUROSUR PS, V78, P1239, DOI 10.1136/jnnp.2004.052654; Peskind ER, 2011, NEUROIMAGE, V54, pS76, DOI 10.1016/j.neuroimage.2010.04.008; Ramanathan DM, 2011, BRAIN INJURY, V25, P328, DOI 10.3109/02699052.2011.554336; Risling M, 2011, NEUROIMAGE, V54, pS89, DOI 10.1016/j.neuroimage.2010.05.031; Rogers JM, 2007, BRAIN INJURY, V21, P1321, DOI 10.1080/02699050701765700; Ruocco AC, 2007, BRAIN INJURY, V21, P1233, DOI 10.1080/02699050701716919; Saljo A, 2011, NEUROIMAGE, V54, pS83, DOI 10.1016/j.neuroimage.2010.05.050; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Simmons AN, 2012, NEUROPHARMACOLOGY, V62, P598, DOI 10.1016/j.neuropharm.2011.03.016; Sponheim SR, 2011, NEUROIMAGE, V54, pS21, DOI 10.1016/j.neuroimage.2010.09.007; Stout JC, 2003, AM J GERIAT PSYCHIAT, V11, P683; Stout JC, 2003, ASSESSMENT, V10, P79, DOI 10.1177/1073191102250339; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Trudeau DL, 1998, J NEUROPSYCH CLIN N, V10, P308, DOI 10.1176/jnp.10.3.308; Velikonja D, 2010, J CLIN EXP NEUROPSYC, V32, P610, DOI 10.1080/13803390903401302; Vitacco MJ, 2010, PSYCHOL ASSESSMENT, V22, P638, DOI 10.1037/a0019780; Weddell RA, 2006, BRAIN INJURY, V20, P1221, DOI 10.1080/02699050601049783; WIGGINS JS, 1988, MULTIVAR BEHAV RES, V23, P517, DOI 10.1207/s15327906mbr2304_8; Wilk JE, 2010, J HEAD TRAUMA REHAB, V25, P9, DOI 10.1097/HTR.0b013e3181bd090f; Yeates GN, 2008, NEUROPSYCHOL REHABIL, V18, P566, DOI 10.1080/09602010802151532; Zhang JY, 2009, STAPP CAR CRASH JO, V53, P215; Zolondek S, 2006, ASSESSMENT, V13, P470, DOI 10.1177/1073191106289861	68	18	19	0	49	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JAN	2013	27	1					10	18		10.3109/02699052.2012.722252			9	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	059IY	WOS:000312699300002	23252434				2021-06-18	
J	Ragan, DK; McKinstry, R; Benzinger, T; Leonard, JR; Pineda, JA				Ragan, Dustin K.; McKinstry, Robert; Benzinger, Tammie; Leonard, Jeffrey R.; Pineda, Jose A.			Alterations in cerebral oxygen metabolism after traumatic brain injury in children	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						brain imaging; brain trauma; cerebral blood flow	POSITRON-EMISSION-TOMOGRAPHY; BLOOD-FLOW MEASUREMENTS; QUANTITATIVE-EVALUATION; PERFUSION; MR; ISCHEMIA; CONSUMPTION; EXTRACTION; HUMANS; RAT	Traumatic brain injury (TBI) is the most common cause of acquired disability in children. Metabolic defects, and in particular mitochondrial dysfunction, are important contributors to brain injury after TBI. Studies of metabolic dysfunction are limited, but magnetic resonance methods suitable for use in children are overcoming this limitation. We performed noninvasive measurements of cerebral blood flow and oxygen metabolic index (ON) to assess metabolic dysfunction in children with severe TBI. Cerebral blood flow is variable after TBI but hypoperfusion and low OMI are predominant, supporting metabolic dysfunction. This finding is consistent with preclinical and adult clinical studies of brain metabolism and mitochondrial dysfunction after TBI. Journal of Cerebral Blood Flow & Metabolism (2013) 33, 48-52; doi:10.1038/jcbfm.2012.130; published online 12 September 2012	[Ragan, Dustin K.; Pineda, Jose A.] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; [McKinstry, Robert; Benzinger, Tammie] Washington Univ, Sch Med, Dept Radiol, St Louis, MO 63110 USA; [Leonard, Jeffrey R.] Washington Univ, Sch Med, Dept Neurosurg, St Louis, MO 63110 USA	Pineda, JA (corresponding author), Washington Univ, Sch Med, Dept Pediat & Neurol, Div Crit Care Med, Campus Box 8116,1 Childrens Pl,NWT-10, St Louis, MO 63110 USA.	pineda_j@kids.wustl.edu	Pineda, Jose/W-2806-2019; Benzinger, Tammie/L-6104-2013; Benzinger, Tammie L. S./ABA-8534-2020	Benzinger, Tammie L. S./0000-0002-8114-0552	Robert Wood Johnson FoundationRobert Wood Johnson Foundation (RWJF); American Heart AssociationAmerican Heart Association; Washington University Institute of Clinical and Translational Sciences [KL2 RRO24994, 12POST8860002, UL1 RR024992]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000448] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [KL2RR024994, UL1RR024992] Funding Source: NIH RePORTER	Financial support was received from the Robert Wood Johnson Foundation, the American Heart Association and from the Washington University Institute of Clinical and Translational Sciences (KL2 RRO24994, 12POST8860002, and UL1 RR024992).	Adelson PD, 2011, CHILD NERV SYST, V27, P1465, DOI 10.1007/s00381-011-1476-z; Adelson PD, 1996, J NEUROSURG, V85, P877, DOI 10.3171/jns.1996.85.5.0877; Aliefendioglu D, 2007, J PEDIAT HEMATOL ONC, V29, P747, DOI 10.1097/MPH.0b013e318157fd85; An HY, 2009, STROKE, V40, P2165, DOI 10.1161/STROKEAHA.108.540864; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; BUCHWEITZ E, 1980, SCIENCE, V209, P499, DOI 10.1126/science.7394515; Clausen T, 2001, BRAIN RES, V908, P35, DOI 10.1016/S0006-8993(01)02566-5; Coles JP, 2004, J CEREBR BLOOD F MET, V24, P202, DOI 10.1097/01.WCB.0000103022.98348.24; DETRE JA, 1992, MAGNET RESON MED, V23, P37, DOI 10.1002/mrm.1910230106; Detre JA, 1999, EUR J RADIOL, V30, P115, DOI 10.1016/S0720-048X(99)00050-9; Diringer MN, 2002, J NEUROSURG, V96, P103, DOI 10.3171/jns.2002.96.1.0103; Diringer MN, 2000, J NEUROSURG, V92, P7, DOI 10.3171/jns.2000.92.1.0007; Faul M., 2010, CTR DIS CONTROL PREV; Fernandez-Seara MA, 2006, MAGN RESON MED, V55, P967, DOI 10.1002/mrm.20892; Fujima N, 2011, NEUROIMAGE, V54, P344, DOI 10.1016/j.neuroimage.2010.08.020; Haacke EM, 2010, J MAGN RESON IMAGING, V32, P663, DOI 10.1002/jmri.22276; HARPER AM, 1966, J NEUROL NEUROSUR PS, V29, P398, DOI 10.1136/jnnp.29.5.398; Henriksen OM, 2012, J MAGN RESON IMAGING, V35, P1290, DOI 10.1002/jmri.23579; HOFFMAN WE, 1986, ANESTH ANALG, V65, P729; Hopkins RO, 2005, NEUROPSYCHOLOGY, V19, P233, DOI 10.1037/0894-4105.19.2.233; Jain V, 2012, RADIOLOGY, V263, P527, DOI 10.1148/radiol.12111509; Jain V, 2011, J CEREBR BLOOD F MET, V31, P1504, DOI 10.1038/jcbfm.2011.34; Jain V, 2010, J CEREBR BLOOD F MET, V30, P1598, DOI 10.1038/jcbfm.2010.49; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Kaloostian P, 2012, J NEUROTRAUM, V29, P727, DOI 10.1089/neu.2011.2147; Kelly DF, 1997, J NEUROSURG, V86, P633, DOI 10.3171/jns.1997.86.4.0633; Kissack CM, 2005, J CEREBR BLOOD F MET, V25, P545, DOI 10.1038/sj.jcbfm.9600046; LEBRUNGRANDIE P, 1983, ARCH NEUROL-CHICAGO, V40, P230, DOI 10.1001/archneur.1983.04050040060010; Lifshitz J, 2003, J CEREBR BLOOD F MET, V23, P219, DOI 10.1097/01.WCB.0000040581.43808.03; Lu HZ, 2008, MAGN RESON MED, V60, P357, DOI 10.1002/mrm.21627; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; MICHENFELDER JD, 1971, BRIT J ANAESTH, V43, P630, DOI 10.1093/bja/43.7.630; Nortje J, 2008, CRIT CARE MED, V36, P273, DOI 10.1097/01.CCM.0000292014.60835.15; OBRIST WD, 1979, J NEUROSURG, V51, P292, DOI 10.3171/jns.1979.51.3.0292; Poncelet BP, 1999, MAGN RESON MED, V41, P510, DOI 10.1002/(SICI)1522-2594(199903)41:3<510::AID-MRM13>3.0.CO;2-G; Qiu ML, 2010, MAGN RESON MED, V63, P374, DOI 10.1002/mrm.22218; Ragan DK, 2012, PEDIATR RES, V71, P199, DOI 10.1038/pr.2011.31; Raynaud JS, 2001, MAGN RESON MED, V46, P305, DOI 10.1002/mrm.1192; Signoretti S, 2008, J NEUROSURG, V108, P42, DOI 10.3171/JNS/2008/108/01/0042; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Taki Y, 2011, HUM BRAIN MAPP, V32, P1973, DOI 10.1002/hbm.21163; TENJIN H, 1990, NEUROSURGERY, V26, P971, DOI 10.1227/00006123-199006000-00009; Tisdall MM, 2008, J NEUROSURG, V109, P424, DOI 10.3171/JNS/2008/109/9/0424; Verweij BH, 2000, J NEUROSURG, V93, P815, DOI 10.3171/jns.2000.93.5.0815; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Wang Z, 2008, MAGN RESON IMAGING, V26, P261, DOI 10.1016/j.mri.2007.07.003; Wu WC, 2007, MAGN RESON MED, V58, P1020, DOI 10.1002/mrm.21403; Xiong Y, 1997, J NEUROTRAUM, V14, P23, DOI 10.1089/neu.1997.14.23; Xu GF, 2010, NMR BIOMED, V23, P286, DOI 10.1002/nbm.1462; Xu YQ, 2010, J CEREBR BLOOD F MET, V30, P883, DOI 10.1038/jcbfm.2009.263; YAMAKAMI I, 1991, J CEREBR BLOOD F MET, V11, P655, DOI 10.1038/jcbfm.1991.117; YAMAKAMI I, 1989, J CEREBR BLOOD F MET, V9, P117, DOI 10.1038/jcbfm.1989.16; Ye FQ, 2000, MAGNET RESON MED, V44, P450, DOI 10.1002/1522-2594(200009)44:3<450::AID-MRM16>3.3.CO;2-S; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	54	18	18	0	5	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	JAN	2013	33	1					48	52		10.1038/jcbfm.2012.130			5	Endocrinology & Metabolism; Hematology; Neurosciences	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	066MJ	WOS:000313224600006	22968318	Green Published, Bronze			2021-06-18	
J	Self, M; Driver, S; Stevens, L; Warren, AM				Self, Megan; Driver, Simon; Stevens, Laurel; Warren, Ann Marie			Physical Activity Experiences of Individuals Living With a Traumatic Brain Injury: A Qualitative Research Exploration	ADAPTED PHYSICAL ACTIVITY QUARTERLY			English	Article						health promotion; group interviews; rehabilitation; needs assessment	HEALTH-PROMOTION INTERVENTION; ACTIVITY PARTICIPATION; PUBLIC-HEALTH; PEOPLE; ADULTS; DISABILITY; REHABILITATION; DEPRESSION; BEHAVIORS; AQUATICS	Traumatic brain injury (TBI) is a significant public health issue due to the incidence, complexity, and cost associated with treatment. The purpose of this study was to determine physical activity (PA) knowledge, attitudes, intentions, and barriers among individuals with a TBI undergoing outpatient rehabilitation. Seventeen participants completed a series of group interviews regarding their PA needs. A qualitative research design was adopted and trustworthiness was established through investigator triangulation of data. A cross-case analysis was completed to identify themes and conceptual patterns. The main themes identified were (a) an inability to differentiate between PA and physical therapy, (b) a limited knowledge of PA health benefits and the relationship to rehabilitation, and (c) an interest in participating in a PA based health promotion program. Future interventions should educate individuals about PA, the associated health benefits, and the role PA plays in the rehabilitation process.	[Self, Megan] Univ N Texas, Denton, TX 76203 USA; [Driver, Simon] Oregon State Univ, Sch Biol & Populat Hlth Sci, Corvallis, OR 97331 USA; [Stevens, Laurel] Baylor Inst Rehabil, Dallas, TX USA; [Warren, Ann Marie] Baylor Univ, Med Ctr, Dallas, TX USA	Self, M (corresponding author), Univ N Texas, Denton, TX 76203 USA.			driver, simon/0000-0003-2356-432X; Warren, Ann Marie/0000-0002-3753-5573			Abdullah N, 2004, CALIF J HLTH PROMOT, V2, P42, DOI DOI 10.32398/cjhp.v2isi.909; [Anonymous], 1998, NIH Consens Statement, V16, P1; ARMSTRONG C, 1991, J REHABIL, V57, P15; Bateman A, 2001, ARCH PHYS MED REHAB, V82, P174, DOI 10.1053/apmr.2001.19744; Brain Injury Association of America, 2012, BIAA AD NEW TBI DEF; Centers for Disease Control and Prevention, 2010, TRAUM BRAIN INJ; Centers for Disease Control and Prevention, 2011, DAT 2012 HLTH PEOPL; Chogahara M, 1998, J AGING PHYS ACTIV, V6, P1, DOI 10.1123/japa.6.1.1; Cresswell J, 1998, QUALITATIVE INQUIRY; Dalton C, 2012, CLIN REHABIL, V26, P165, DOI 10.1177/0269215511405230; Driver S, 2006, ADAPT PHYS ACT Q, V23, P148, DOI 10.1123/apaq.23.2.148; Driver S, 2006, BRAIN INJURY, V20, P133, DOI 10.1080/02699050500443822; Driver S, 2005, BRAIN INJURY, V19, P1067, DOI 10.1080/02699050500149338; Driver S, 2004, BRAIN INJURY, V18, P847, DOI 10.1080/02699050410001671856; DRIVER S, 2003, J COGNITIVE REHABILI, V21, P26; Driver S., 2009, J COGNITIVE REHABILI, V33, P4, DOI DOI 10.1519/SSC.0B013E318211F99D; Driver S, 2008, ADAPT PHYS ACT Q, V25, P289, DOI 10.1123/apaq.25.4.289; Driver S, 2012, BRAIN INJURY, V26, P1482, DOI 10.3109/02699052.2012.694568; Driver S, 2012, DISABIL HEALTH J, V5, P117, DOI 10.1016/j.dhjo.2011.11.002; Driver S, 2009, BRAIN INJURY, V23, P203, DOI 10.1080/02699050802695574; Driver SJ, 2007, ADAPT PHYS ACT Q, V24, P160, DOI 10.1123/apaq.24.2.160; Fines L., 1994, J COGNITIVE REHABILI, V12, P10; Finkelstein EA., 2006, INCIDENCE EC BURDEN; Finset A, 2000, BRAIN INJURY, V14, P887; FINSET A, 1995, BRAIN INJURY, V9, P141, DOI 10.3109/02699059509008187; Fleming J, 2011, BRAIN INJURY, V25, P806, DOI 10.3109/02699052.2011.585508; Glaser B. G., 1967, DISCOVERY GROUNDED T; Goodwin DL, 2004, ADAPT PHYS ACT Q, V21, P122, DOI 10.1123/apaq.21.2.122; Harter S., 1987, CONT TOPICS DEV PSYC, P219; Henwood T, 2011, AGEING SOC, V31, P1330, DOI 10.1017/S0144686X10001406; Irwin K, 2011, STRENGTH COND J, V33, P43, DOI 10.1519/SSC.0b013e318210e899; Jones David B, 2009, Res Q Exerc Sport, V80, P710; Kahn EB, 2002, AM J PREV MED, V22, P73, DOI 10.1016/S0749-3797(02)00434-8; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Leech NL, 2007, SCHOOL PSYCHOL QUART, V22, P557, DOI 10.1037/1045-3830.22.4.557; Lollar DJ, 2003, ANNU REV PUBL HEALTH, V24, P195, DOI 10.1146/annurev.publhealth.24.100901.140844; LOX CL, 2003, PSYCHOL EXERCISE INT; McPherson KM, 2009, CLIN REHABIL, V23, P296, DOI 10.1177/0269215509102980; MEADOWS LM, 2001, NATURE QUALITATIVE E; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; National Institute of Neurological Disorders and Stroke, 2002, NIH PUBL; PROCHASKA JO, 1983, J CONSULT CLIN PSYCH, V51, P390, DOI 10.1037//0022-006X.51.3.390; Ravesloot C, 2005, REHABIL PSYCHOL, V50, P239, DOI 10.1037/0090-5550.50.3.239; Ravesloot CH, 2007, HEALTH EDUC RES, V22, P522, DOI 10.1093/her/cyl114; Reavenall S, 2010, INT J THER REHABIL, V17, P360, DOI 10.12968/ijtr.2010.17.7.48893; Rimmer JH, 2008, AM J LIFESTYLE MED, V2, P409, DOI 10.1177/1559827608317397; Rimmer JH, 2000, AM J PREV MED, V18, P332, DOI 10.1016/S0749-3797(00)00129-X; Stuijbergen AK, 2003, ARCH PHYS MED REHAB, V84, P467, DOI 10.1053/apmr.2003.50028; Thomas DR, 2003, GEN INDUCTIVE APPROA; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Todd Zazie, 2004, MIXING METHODS PSYCH; U. S. Department of Health and Human Services, 2010, HLTH PEOPL 2020 ROAD; U.S. Department of Health and Human Services, 2010, PROM PHYS ACT GUID C; Wise EK, 2010, ARCH PHYS MED REHAB, V91, P1357, DOI 10.1016/j.apmr.2010.06.009; Ylvisaker M, 2003, J HEAD TRAUMA REHAB, V18, P7, DOI 10.1097/00001199-200301000-00005; YLVISAKER M, 1999, COLLABORATIVE BRAIN; Zhang Y, 2012, FUNGAL DIVERS, V53, P1, DOI 10.1007/s13225-011-0117-x	57	18	18	0	28	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	0736-5829	1543-2777		ADAPT PHYS ACT Q	Adapt. Phys. Act. Q.	JAN	2013	30	1					20	39		10.1123/apaq.30.1.20			20	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	074XM	WOS:000313848400002	23283024				2021-06-18	
J	Mao, ZQ; Wang, N; Hussain, M; Li, M; Zhang, HQ; Zhang, QH; Zhang, P; Zhi, XL; Ling, F				Mao, Zhiqi; Wang, Ning; Hussain, Mohammed; Li, Meng; Zhang, Hongqi; Zhang, Qiuhang; Zhang, Peng; Zhi, Xinglong; Ling, Feng			Traumatic intracranial aneurysms due to blunt brain injury-a single center experience	ACTA NEUROCHIRURGICA			English	Article						Cerebrovascular trauma; Intracranial aneurysm; Brain injuries	INTERNAL CAROTID-ARTERY; CEREBELLAR ARTERY; VERTEBRAL ARTERY; MANAGEMENT; CHILDHOOD; INFANCY; WOUNDS	Traumatic intracranial aneurysms (TICAs) have previously been described in literature. However, the evidence of TICAs secondary to blunt brain injury have not been elucidated well, with most of the conclusions coming from isolated case reports. We have attempted to examine the epidemiology, classification, clinical presentation, therapeutic modalities, and outcomes of TICAs with our series of patients at the neurosurgery department of Xuanwu Hospital, China. We reviewed our aneurysm database from January 1, 2005 to December 31, 2011. In particular, patients with TICAs secondary to blunt brain injury were reviewed. Variables assessed included age, sex, causes of blunt brain injury, skull fracture, location, classification, clinical presentation, time elapsed to arrive at diagnoses, treatment, and eventual outcome. Based on our assessment, we arrived at a modified classification scheme to categorize these aneurysms. We reviewed 2335 patients with cerebral aneurysm from January 1, 2005 to December 31, 2011. Of these, 15 patients (0.64 %) with traumatic aneurysms secondary to blunt brain injury were identified.Motor vehicle accidents (MVA) were observed to be the most common cause of injury (10 patients, 66.7 %), followed by TICAs sustained after falling down (5 patients, 33.3 %). The most common symptom at presentation was epistaxis (6 patients, 40 %), followed by ophthalmic problems (6 patients, 40 %), with both presentations seen in 1 patient. The most common diagnostic modality used was DSA in 12 patients (80 %) followed by CTA in 2 patients (13.3 %). Infraclinoid TICAs were seen in 9 patients (60 %), whereas supraclinoid TICAs were seen in 5 patients (33.3 %), with perifalx TICAs seen in 1 patient. Endovascular intervention therapies were performed in 11 patients (73.3 %), bypass surgery and trapping in 2 (13.3 %), transnasal endoscopic approach in combination with balloon assisted in 2 patients. At discharge, 2 patients had poor clinical outcomes (13.3 %), 5 had fair (33.3 %),and 8 resulted with good outcomes (53.3 %). TICAs arising secondary to blunt brain injury account for 0.64 % of all cerebral aneurysms. Infraclinoid, supraclinoid ICA and perifalx TICAs are the most common aneurysms arising from blunt brain injury. Our study further shows that traumatic patients presenting with recurrent epistaxis, oculomotor nerve palsy, and delayed intracranial hemorrhage should receive cerebroangiography as soon as possible. An early diagnosis and proper treatment could prove to be helpful in terms of improving final clinical outcome.	[Mao, Zhiqi; Wang, Ning; Li, Meng; Zhang, Hongqi; Zhang, Qiuhang; Zhang, Peng; Zhi, Xinglong; Ling, Feng] Capital Med Univ, Xuanwu Hosp, Dept Neurosurg, Beijing 100053, Peoples R China; [Hussain, Mohammed] Wayne State Univ, Dept Neurosurg, Detroit, MI USA	Ling, F (corresponding author), Capital Med Univ, Xuanwu Hosp, Dept Neurosurg, 45 Changchun St, Beijing 100053, Peoples R China.	dr.lingfeng@gmail.com	Zhiqi, Mao/V-5983-2017	Zhiqi, Mao/0000-0002-8535-4531			Allison JW, 1998, PEDIATR RADIOL, V28, P223, DOI 10.1007/s002470050336; Bell RS, 2010, NEUROSURGERY, V66, P66, DOI 10.1227/01.NEU.0000361285.50218.A8; Bhatia S, 2011, ACTA NEUROCHIR, V153, P905, DOI 10.1007/s00701-010-0846-8; BUCKINGHAM MJ, 1988, NEUROSURGERY, V22, P398, DOI 10.1227/00006123-198802000-00022; CASEY ATH, 1994, BRIT J NEUROSURG, V8, P97, DOI 10.3109/02688699409002401; COGBILL TH, 1994, J TRAUMA, V37, P473, DOI 10.1097/00005373-199409000-00024; Cohen JE, 2005, J NEUROSURG, V102, P555, DOI 10.3171/jns.2005.102.3.0555; Cohen JE, 2008, NEUROSURGERY, V63, P476, DOI 10.1227/01.NEU.0000324995.57376.79; Dario A, 1997, J Neurosurg Sci, V41, P195; Dubey A, 2008, J CLIN NEUROSCI, V15, P609, DOI 10.1016/j.jocn.2007.11.006; DUTREVOU MD, 1992, NEUROSURGERY, V31, P905, DOI 10.1227/00006123-199211000-00012; ENDO S, 1980, CHILD BRAIN, V6, P131; Fusco MR, 2011, NEUROSURGERY, V68, P517, DOI 10.1227/NEU.0b013e3181fe2fda; GEORGE B, 1987, NEUROSURGERY, V20, P821; HOLMES B, 1993, J TRAUMA, V35, P855, DOI 10.1097/00005373-199312000-00009; Horowitz MB, 1999, SURG NEUROL, V51, P31, DOI 10.1016/S0090-3019(98)00029-9; JAKOBSSON KE, 1984, ACTA NEUROCHIR, V71, P91, DOI 10.1007/BF01401153; Larson P S, 2000, Neurosurg Focus, V8, pe4; Lath R, 2002, J CLIN NEUROSCI, V9, P466, DOI 10.1054/jocn.2001.1050; Martin E M, 1986, J Neurosci Nurs, V18, P89; NAKSTAD P, 1986, NEURORADIOLOGY, V28, P335, DOI 10.1007/BF00333440; NORDBY HK, 1984, ACTA NEUROCHIR, V72, P157, DOI 10.1007/BF01406868; PARKINSON D, 1985, SURG NEUROL, V23, P453, DOI 10.1016/0090-3019(85)90236-8; POZZATI E, 1982, J NEUROSURG, V57, P418, DOI 10.3171/jns.1982.57.3.0418; QUATTROCCHI KB, 1990, NEUROSURGERY, V27, P476, DOI 10.1227/00006123-199009000-00025; Sakamoto S, 2009, ACTA NEUROCHIR, V151, P1531, DOI 10.1007/s00701-009-0285-6; Schuster JM, 1999, NEUROSURGERY, V45, P1465, DOI 10.1097/00006123-199912000-00039; Stein DM, 2009, J TRAUMA, V66, P132, DOI 10.1097/TA.0b013e318142d146; Tan TC, 2001, BRIT J NEUROSURG, V15, P137; Tureyen K, 2001, BRIT J NEUROSURG, V15, P429, DOI 10.1080/02688690120082440; Uzan M, 1998, NEUROSURGERY, V43, P1314, DOI 10.1097/00006123-199812000-00024; VENTUREYRA ECG, 1994, CHILD NERV SYST, V10, P361, DOI 10.1007/BF00335125; WANG AN, 1986, SURG NEUROL, V25, P77, DOI 10.1016/0090-3019(86)90120-5; Wang X, 2008, NEUROL INDIA, V56, P47, DOI 10.4103/0028-3886.39312; WIENER I, 1984, J TRAUMA, V24, P346, DOI 10.1097/00005373-198404000-00012; Yang TC, 2007, EUR NEUROL, V58, P239, DOI 10.1159/000107970; YAZBAK PA, 1995, PEDIATR NEUROSURG, V22, P15, DOI 10.1159/000121294; Zhang C, 2011, NEUROPEDIATRICS, V42, P204, DOI 10.1055/s-0031-1291221	38	18	21	0	12	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268			ACTA NEUROCHIR	Acta Neurochir.	DEC	2012	154	12					2187	2193		10.1007/s00701-012-1487-x			7	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	040XJ	WOS:000311359500008	22975866				2021-06-18	
J	O'Callaghan, A; McAllister, L; Wilson, L				O'Callaghan, Anna; McAllister, Lindy; Wilson, Linda			Insight vs readiness: Factors affecting engagement in therapy from the perspectives of adults with TBI and their significant others	BRAIN INJURY			English	Article						Readiness for therapy; acceptance of impairments; engagement with therapy	TRAUMATIC BRAIN-INJURY; COMMUNITY INTEGRATION QUESTIONNAIRE; WORKING ALLIANCE; PATIENT COMPLIANCE; SELF-AWARENESS; REHABILITATION; PARTICIPATION; RECOVERY; SEVERITY; MODEL	Introduction: Adults sustain significant, often irreversible impairments following brain injury. The process they go through coming to terms with these impairments can seriously interfere with their readiness to engage in rehabilitation. Aim: This study aimed to look beyond the development of self-awareness and insight in order to explore the concept of readiness as it relates to clients' experiences of engaging with therapy. Method: Sixteen in-depth interviews were conducted with 14 adults with a moderate-severe traumatic brain injury (TBI) and nine of their significant others. These participants were asked to speak about the continuum of care they experienced and the factors that effected their engagement with care. Results: The results of this study indicated that participants believed their ability to engage in therapy was related to the degree to which they were aware of and accepted their impairments and motivated to engage in rehabilitation. Participants reported that the rate and degree to which they developed awareness varied according to the type of impairments they experienced (i.e. physical vs cognitive). Participants also stated that one way to augment their awareness was to compare their new vs old selves and to compare their recovery to those of others with a similar impairment. Finally, participants reported that it was important to be able to access services when they had accepted their impairment and were ready to engage in therapy. Conclusion: The clinical implications for considering the degree of awareness of impairments and readiness for engagement in care of an adult with a moderate-severe TBI are discussed in relation to future services planning.	[O'Callaghan, Anna] Univ Queensland, Brisbane, Qld, Australia; [McAllister, Lindy] Univ Sydney, Sydney, NSW 2006, Australia; [Wilson, Linda] Charles Sturt Univ, Albury, NSW, Australia	O'Callaghan, A (corresponding author), Univ Queensland, Div Speech Pathol, Sch Hlth & Rehabil Sci, St Lucia, Qld 4072, Australia.	annamocallaghan@gmail.com	Wilson, Linda/P-8523-2015	Wilson, Linda/0000-0003-4175-7125	Speech Pathology Australia Postgraduate Student Research Grant	This research was partially funded through a Speech Pathology Australia Postgraduate Student Research Grant. The authors report no conflicts of interest. The authors alone were responsible for the content and writing of the paper.	Attride-Stirling J., 2001, QUAL RES, V1, P385, DOI [DOI 10.1177/146879410100100307, 10.1177/146879410100100307]; Avesani R, 2005, BRAIN INJURY, V19, P933, DOI 10.1080/02699050400002371; Bombardier CH, 1997, ARCH PHYS MED REHAB, V78, P592, DOI 10.1016/S0003-9993(97)90424-X; Bowling A., 2002, RES METHODS HLTH INV, V2nd edn; British Society of Rehabilitation Medicine Royal College of Physicians, 2003, REH FOLL ACQ BRAIN I; Bush BA, 2003, ARCH PHYS MED REHAB, V84, P1803, DOI 10.1016/S0003-9993(03)00367-8; Charmaz K, 1995, SOCIOL QUART, V36, P657, DOI 10.1111/j.1533-8525.1995.tb00459.x; Charmaz Kathy, 1997, GOOD DAYS BAD DAYS S; Cheng SKW, 2006, BRAIN INJURY, V20, P621, DOI 10.1080/02699050600677196; Cicerone KD, 2004, ARCH PHYS MED REHAB, V85, P943, DOI 10.1016/j.apmr.2003.07.019; Commonwealth Department of Health and Aged Care, 2001, MEAS REM ACC REM IND; Dumont C, 2004, J HEAD TRAUMA REHAB, V19, P431, DOI 10.1097/00001199-200411000-00002; Durgin CJ, 2000, J HEAD TRAUMA REHAB, V15, P1195, DOI 10.1097/00001199-200012000-00002; Fearnside MR, 1997, MED J AUSTRALIA, V167, P293, DOI 10.5694/j.1326-5377.1997.tb125070.x; Felmingham KL, 2001, ARCH PHYS MED REHAB, V82, P435, DOI 10.1053/apmr.2001.21985; Fleming J, 1999, BRAIN INJURY, V13, P417; Fleming JM, 1998, J HEAD TRAUMA REHAB, V13, P39, DOI 10.1097/00001199-199810000-00006; Foster M, 2004, SOC SCI MED, V59, P1867, DOI 10.1016/j.socscimed.2004.02.017; Gentleman D, 2001, TRAUMA, V3, P193; Goranson TE, 2003, BRAIN INJURY, V17, P759, DOI 10.1080/0269905031000088513; Gray DS, 2000, BRAIN INJURY, V14, P1003, DOI 10.1080/02699050050191940; Grbich C, 1999, HDB RES METHODS HLTH; Greenwood K., 1999, HDB RES METHODS HLTH; Hughes P, 2003, DOING EARLY CHILDHOO; Isaki E, 2000, BRAIN INJURY, V14, P441; Kaplan CP, 2001, BRAIN INJURY, V15, P725, DOI 10.1080/02699050010005913; KATZ DI, 1994, ARCH NEUROL-CHICAGO, V51, P661, DOI 10.1001/archneur.1994.00540190041013; Khan F, 2003, MED J AUSTRALIA, V178, P290, DOI 10.5694/j.1326-5377.2003.tb05199.x; Llewellyn G, 1999, HDB RES METHODS HLTH, P174; MACKAY LE, 1992, ARCH PHYS MED REHAB, V73, P635; MacLennan DL, 2008, NEUROREHABILITATION, V23, P521; Malec JF, 2001, ARCH PHYS MED REHAB, V82, P885, DOI 10.1053/apmr.2001.23895; Minichiello V., 1999, HDB RES METHODS HLTH, P35; Morse JM., 1995, QUALITATIVE RES METH, V2; New Zealand Guidelines Group, 2006, TRAUM BRAIN INJ DIAG; Newberry L, 2001, NEW DIRECTION FOLLW; Novack TA, 2001, ARCH PHYS MED REHAB, V82, P300, DOI 10.1053/apmr.2001.18222; O'Callaghan C, 2006, NEUROPSYCHOL REHABIL, V16, P579, DOI 10.1080/09602010500368834; Satz P, 1998, BRAIN INJURY, V12, P537, DOI 10.1080/026990598122313; Schonberger M, 2006, NEUROPSYCHOL REHABIL, V16, P561, DOI 10.1080/09602010500263084; Schonberger M, 2006, NEUROPSYCHOL REHABIL, V16, P298, DOI 10.1080/09602010500176476; Schonberger M, 2006, BRAIN INJURY, V20, P445, DOI 10.1080/02699050600664772; Schonberger M, 2006, BRAIN INJURY, V20, P1271, DOI 10.1080/02699050601049395; Schwandt TA., 2000, HDB QUALITATIVE RES, V2nd ed., P189; Seale GS, 2002, BRAIN INJURY, V16, P955, DOI 10.1080/02699050210155258; Sherer M, 1998, J HEAD TRAUMA REHAB, V13, P52, DOI 10.1097/00001199-199810000-00007; Tuel SM, 1992, BRAIN INJURY, V6, P337; van den Broek MD, 2005, J HEAD TRAUMA REHAB, V20, P464, DOI 10.1097/00001199-200509000-00007; Wagner AK, 2000, J TRAUMA, V49, P411, DOI 10.1097/00005373-200009000-00005; Winkler D, 2006, J HEAD TRAUMA REHAB, V21, P8, DOI 10.1097/00001199-200601000-00002	50	18	18	0	19	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	DEC	2012	26	13-14					1599	1610		10.3109/02699052.2012.698788			12	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	041RU	WOS:000311419700006	22738228				2021-06-18	
J	Orman, JA; Geyer, D; Jones, J; Schneider, EB; Grafman, J; Pugh, MJ; DuBose, J				Orman, Jean A.; Geyer, Dennis; Jones, John; Schneider, Eric B.; Grafman, Jordan; Pugh, Mary Jo; DuBose, Joseph			Epidemiology of moderate-to-severe penetrating versus closed traumatic brain injury in the Iraq and Afghanistan wars	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Traumatic and penetrating brain injury; military; epidemiology; Operation Enduring Freedom/Iraqi Freedom; Operation New Dawn	COMBAT WOUNDS; FREEDOM; HOSPITALIZATIONS; BATTLEFIELD	BACKGROUND: US combat operations in Iraq and Afghanistan have resulted in a greater proportion of service members with head and neck wounds caused by explosions compared with that of previous wars. Although penetrating traumatic brain injury (TBI) is frequently associated with these wounds, the epidemiology of penetrating TBI from these conflicts has not been well described. METHODS: The Joint Theater Trauma Registry was queried for January 2003 through December 2010 to identify all patients with moderate-to-severe brain injury with a maximum Abbreviated Injury Scale (AIS) score of the head of 3 or greater and a diagnosis of penetrating or closed TBI in accordance with the Department of Defense Traumatic Brain Injury Surveillance definition. The epidemiology of these injuries was examined, including demographics, TBI severity, overall injury severity, and surgical interventions provided. RESULTS: A total of 1,255 TBI patients (774 penetrating, 481 closed) meeting criteria were identified. Penetrating brain injuries were more severe, more likely to be battle related, and less likely to be isolated injuries than a group of moderate-to-severe closed TBIs within the same range of anatomic injury severity. During the 5-year period of the Iraq war with the largest numbers of TBIs (2004-2008), the numbers of penetrating TBIs exceeded closed TBIs by a ratio of 2:1. During the 3-year period of the Afghanistan war with the greatest numbers of TBIs (2008-2010), the ratio of penetrating to closed TBIs was substantially lower, approximately 1.3:1. CONCLUSION: This study represents the first comprehensive report on the epidemiology of moderate-to-severe penetrating and closed TBIs resulting from the wars in Iraq and Afghanistan using Joint Theater Trauma Registry data. With the maturing theater of conflicts, penetrating TBIs were substantially less predominant compared with closed TBIs. While this finding may reflect changes in the use of protective measures and tactics or improvements in diagnosis of closed TBIs, additional research is needed to identify the reason for this shift and the subsequent effect on outcome after combat-related TBIs. (J Trauma Acute Care Surg. 2012;73: S496-S502. Copyright (C) 2012 by Lippincott Williams & Wilkins)	[Orman, Jean A.] USA, Inst Surg Res, ATTN MCMR SRR, Ft Sam Houston, TX 78234 USA; [Orman, Jean A.; Pugh, Mary Jo] Univ Texas Hlth Sci Ctr San Antonio, Dept Epidemiol & Biostat, San Antonio, TX 78229 USA; [Geyer, Dennis] San Antonio Mil Med Ctr, Dept Surg, Neurosurg Serv, San Antonio, TX USA; [Pugh, Mary Jo] S Texas Vet Hlth Care Syst, San Antonio, TX USA; [Schneider, Eric B.] Johns Hopkins Sch Med, Ctr Surg Trials & Outcomes Res, Baltimore, MD USA; [DuBose, Joseph] Univ Maryland Med Syst, R Adams Cowley Shock Trauma Ctr, Baltimore, MD USA; [Jones, John] Northwestern Univ, Rehabil Inst Chicago, Chicago, IL 60611 USA; [Grafman, Jordan] Northwestern Univ, Dept Phys Med & Rehabil, Chicago, IL 60611 USA	Orman, JA (corresponding author), USA, Inst Surg Res, ATTN MCMR SRR, 3698 Chambers Pass, Ft Sam Houston, TX 78234 USA.	Jean.A.Orman@amedd.army.mil	Pugh, Mary Jo/K-5336-2019	Pugh, Mary Jo/0000-0003-4196-7763; Grafman, Jordan H./0000-0001-8645-4457	South Texas Veterans Healthcare System; Veterans AffairsUS Department of Veterans Affairs [I01HX000329] Funding Source: NIH RePORTER	We acknowledge JTTR for providing data for this study and Ms. Susan West and Ms. Celina Garcia of the JTTR staff for their invaluable assistance in preparing the data set. Some work for this study was supported by resources of the South Texas Veterans Healthcare System.	Aarabi B, 2000, NEUROSURG FOCUS, V8, P1, DOI DOI 10.3171/FOC.2000.8.1.155; [Anonymous], 2010, 09033 DEP DEF; Armed Forces Health Surveillance Center, NEUROLOGY; Army Dismounted Complex Blast Injury Task Force, 2011, DISM COMPL BLAST INJ; *ASS ADV AUT MED C, 1990, ABBR INJ SCAL 1990 R; BELASCO AMY, 2009, TROOP LEVELS AFGHAN; Bell RS, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.2.FOCUS1022; Bell RS, 2009, J TRAUMA, V66, pS104, DOI 10.1097/TA.0b013e31819d88c8; Belmont PJ, 2012, J TRAUMA ACUTE CARE, V73, P3, DOI 10.1097/TA.0b013e318250bfb4; Belmont PJ, 2010, J TRAUMA, V68, P204, DOI 10.1097/TA.0b013e3181bdcf95; Burrelli DF, 2012, WOMEN COMBAT ISSUES; Carey ME, 2000, NEUROSURGERY, V47, P678, DOI 10.1097/00006123-200009000-00031; Centers for Disease Control and Prevention, 2012, DRG INT CLASS DIS 9; Champion HR, 2009, J TRAUMA, V66, P1468, DOI 10.1097/TA.0b013e3181a27e7f; Department of Defense, DOD WORLDW NUMB TBI; DuBose JJ, 2011, J TRAUMA, V70, P11, DOI 10.1097/TA.0b013e318207c563; Duckworth JL, 2012, PATHOPHYSIO IN PRESS; Eastridge BJ, 2011, J TRAUMA, V71, pS4, DOI 10.1097/TA.0b013e318221147b; Ecker RD, 2011, J NEUROSURG, V115, P124, DOI 10.3171/2011.2.JNS101490; Eisenburg MF, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.2.FOCUS108; Feickert Andrew, 2008, MINE RESISTANT AMBUS; Galarneau MR, 2008, J NEUROSURG, V108, P950, DOI 10.3171/JNS/2008/108/5/0950; Glenn Michael Alan, 2008, J Trauma Nurs, V15, P181, DOI 10.1097/01.JTN.0000343323.47463.aa; Heltemes KJ, 2011, MIL MED, V176, P132, DOI 10.7205/MILMED-D-09-00238; Institute of Medicine, 2009, GULF WAR HLTH, V7; Jaffee MS, 2009, SYSTEMS ENG IMPROVE; Joint Theater Trauma System, 2007, CLIN PRACTICE GUIDEL; Lanska DJ, 2009, ANN NEUROL, V66, P444, DOI 10.1002/ana.21822; Ling GSF, 2011, CURR OPIN ANESTHESIO, V24, P124, DOI 10.1097/ACO.0b013e32834458da; Ling GSF, 2010, ANNU REV MED, V61, P457, DOI 10.1146/annurev.med.60.071207.140903; Mabry RL, 2000, J TRAUMA, V49, P515, DOI 10.1097/00005373-200009000-00021; MacGregor AJ, 2011, J HEAD TRAUMA REHAB, V26, P312, DOI 10.1097/HTR.0b013e3181e94404; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Ramasamy A, 2008, J TRAUMA, V65, P910, DOI 10.1097/TA.0b013e3181848cf6; Raymont Vanessa, 2011, Front Neurol, V2, P15, DOI 10.3389/fneur.2011.00015; SALAZAR AM, 1985, NEUROLOGY, V35, P1406, DOI 10.1212/WNL.35.10.1406; Santiago LA, 2012, BRAIN INJURY, V26, P107, DOI 10.3109/02699052.2011.635363; Wojcik BE, 2010, AM J PREV MED, V38, pS108, DOI 10.1016/j.amepre.2009.10.006	38	18	21	0	9	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	DEC	2012	73			5			S496	S502		10.1097/TA.0b013e318275473c			7	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	056QT	WOS:000312506900020	23192076				2021-06-18	
J	Tanriverdi, F; De Bellis, A; Teksahin, H; Alp, E; Bizzarro, A; Sinisi, AA; Bellastella, G; Paglionico, VA; Bellastella, A; Unluhizarci, K; Doganay, M; Kelestimur, F				Tanriverdi, F.; De Bellis, A.; Teksahin, H.; Alp, E.; Bizzarro, A.; Sinisi, A. A.; Bellastella, G.; Paglionico, V. A.; Bellastella, A.; Unluhizarci, K.; Doganay, M.; Kelestimur, F.			Prospective investigation of pituitary functions in patients with acute infectious meningitis: is acute meningitis induced pituitary dysfunction associated with autoimmunity?	PITUITARY			English	Article						Meningitis; Pituitary; Hypopituitarism; Growth hormone; Autoimmunity	TRAUMATIC BRAIN-INJURY; GH REPLACEMENT THERAPY; SERUM IGF-I; GROWTH-HORMONE; ANTIPITUITARY ANTIBODIES; TUBERCULOUS MENINGITIS; SHEEHANS-SYNDROME; BODY-COMPOSITION; AMATEUR BOXERS; HYPOPITUITARISM	Previous case reports and retrospective studies suggest that pituitary dysfunction may occur after acute bacterial or viral meningitis. In this prospective study we assessed the pituitary functions, lipid profile and anthropometric measures in adults with acute bacterial or viral meningitis. Moreover, in order to investigate whether autoimmune mechanisms could play a role in the pathogenesis of acute meningitis-induced hypopituitarism we also investigated the anti-pituitary antibodies (APA) and anti-hypothalamus antibodies (AHA) prospectively. Sixteen patients (10 males, 6 females; mean +/- A SD age 40.9 +/- A 15.9) with acute infectious meningitis were included and the patients were evaluated in the acute phase, and at 6 and 12 months after the acute meningitis. In the acute phase 18.7% of the patients had GH deficiency, 12.5% had ACTH and FSH/LH deficiencies. At 12 months after acute meningitis 6 of 14 patients (42.8%) had GH deficiency, 1 of 14 patients (7.1%) had ACTH and FSH/LH deficiencies. Two of 14 patients (14.3%) had combined hormone deficiencies and four patients (28.6%) had isolated hormone deficiencies at 12 months. Four of 9 (44.4%) hormone deficiencies at 6 months were recovered at 12 months, and 3 of 8 (37.5%) hormone deficiencies at 12 months were new-onset hormone deficiencies. At 12 months there were significant negative correlations between IGF-I level vs. LDL-C, and IGF-I level vs. total cholesterol. The frequency of AHA and APA positivity was substantially high, ranging from 35 to 50% of the patients throughout the 12 months period. However there were no significant correlations between AHA or APA positivity and hypopituitarism. The risk of hypopituitarism, GH deficiency in particular, is substantially high in the acute phase, after 6 and 12 months of the acute infectious meningitis. Moreover we found that 6th month after meningitis is too early to make a decision for pituitary dysfunction and these patients should be screened for at least 12 months. In addition, the occurrence of AHA and APA positivity due to acute infectious meningitis was demonstrated for the first time. Further longer-term prospective investigations need to be carried out on a larger cohort of patients to understand the role of autoimmunity in the pathogenesis of late hypopituitarism after acute infectious meningitis.	[Tanriverdi, F.; Teksahin, H.; Unluhizarci, K.; Kelestimur, F.] Erciyes Univ, Sch Med, Dept Endocrinol, TR-38039 Kayseri, Turkey; [De Bellis, A.; Sinisi, A. A.; Bellastella, G.; Paglionico, V. A.; Bellastella, A.] Univ Naples 2, Dept Endocrinol, I-80131 Naples, Italy; [Alp, E.; Doganay, M.] Erciyes Univ, Sch Med, Dept Infect Dis, TR-38039 Kayseri, Turkey; [Bizzarro, A.] Univ Naples 2, Dept Immunol, I-80131 Naples, Italy	Kelestimur, F (corresponding author), Erciyes Univ, Sch Med, Dept Endocrinol, TR-38039 Kayseri, Turkey.	fktimur@erciyes.edu.tr	Doganay, Mehmet/G-4250-2019	Doganay, Mehmet/0000-0003-3922-4901; DE BELLIS, Annamaria/0000-0002-0611-4506			Aimaretti G, 2005, J CLIN ENDOCR METAB, V90, P6085, DOI 10.1210/jc.2005-0504; AMATO G, 1993, J CLIN ENDOCR METAB, V77, P1671, DOI 10.1210/jc.77.6.1671; Bellastella G, 2010, J CLIN ENDOCR METAB, V95, P3750, DOI 10.1210/jc.2010-0551; BURKE CW, 1992, CLIN ENDOCRINOL, V36, P133, DOI 10.1111/j.1365-2265.1992.tb00946.x; De Bellis A, 2008, EUR J ENDOCRINOL, V158, P147, DOI 10.1530/EJE-07-0647; DRURY MI, 1968, BRIT MED J, V1, P842, DOI 10.1136/bmj.1.5595.842; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gomez JM, 2002, CLIN ENDOCRINOL, V56, P329, DOI 10.1046/j.1365-2265.2002.01472.x; HAGG E, 1978, ACTA MED SCAND, V203, P231; HASLAM RHA, 1969, AM J DIS CHILD, V118, P903, DOI 10.1001/archpedi.1969.02100040905017; JEW K, 1984, NEUROSURGERY, V14, P567, DOI 10.1227/00006123-198405000-00008; Karaca Z, 2011, PITUITARY, V14, P134, DOI 10.1007/s11102-010-0270-3; Kasturi BS, 2009, J NEUROTRAUM, V26, P1315, DOI [10.1089/neu.2008.0751, 10.1089/neu.2008-0751]; Kunitomi M, 2002, INT J OBESITY, V26, P361, DOI 10.1038/sj.ijo.0801899; KUPARI M, 1980, ACTA ENDOCRINOL-COP, V94, P433, DOI 10.1530/acta.0.0940433; LAM KSL, 1993, ANN INTERN MED, V118, P701, DOI 10.7326/0003-4819-118-9-199305010-00007; Lamberts SWJ, 1998, LANCET, V352, P127; LEVIN AR, 1959, BRIT MED J, V2, P1061, DOI 10.1136/bmj.2.5159.1061; LICHTENSTEIN MJ, 1982, J ENDOCRINOL INVEST, V5, P111, DOI 10.1007/BF03350501; Lynch C, 2007, BRIT J HOSP MED, V68, P272, DOI 10.12968/hmed.2007.68.5.23336; Molitch ME, 2011, J CLIN ENDOCR METAB, V96, P1587, DOI 10.1210/jc.2011-0179; Muraoka A, 1989, Nihon Naika Gakkai Zasshi, V78, P684; PAI KG, 1976, J PEDIATR-US, V88, P289, DOI 10.1016/S0022-3476(76)81002-5; Schaefer S, 2008, EUR J ENDOCRINOL, V158, P3, DOI 10.1530/EJE-07-0484; Schneider HJ, 2006, EUR J ENDOCRINOL, V154, P259, DOI 10.1530/eje.1.02071; Tanriverdi F, 2008, J ENDOCRINOL INVEST, V31, P489, DOI 10.1007/BF03346395; Tanriverdi F, 2005, GROWTH HORM IGF RES, V15, P231, DOI 10.1016/j.ghir.2005.03.005; Tanriverdi F, 2008, J NEUROTRAUM, V25, P1071, DOI 10.1089/neu.2007.0456; Tanriverdi Fatih, 2006, Expert Rev Pharmacoecon Outcomes Res, V6, P131, DOI 10.1586/14737167.6.2.131; Tanriverdi F, 2008, OBES METAB-MILAN, V4, P118; Tanriverdi F, 2008, EUR J ENDOCRINOL, V159, P7, DOI 10.1530/EJE-08-0050; Tanriverdi F, 2007, CLIN ENDOCRINOL, V66, P360, DOI 10.1111/j.1365-2265.2006.02737.x; Tanriverdi F, 2006, J CLIN ENDOCR METAB, V91, P2105, DOI 10.1210/jc.2005-2476; Tanriverdi F, 2010, EUR J ENDOCRINOL, V162, P861, DOI 10.1530/EJE-09-1024; Tanriverdi F, 2010, J NEUROTRAUM, V27, P301, DOI 10.1089/neu.2009.1102; Tsiakalos A, 2010, J CLIN ENDOCR METAB, V95, P3277, DOI 10.1210/jc.2010-0144; TUNKEL AR, 2005, PRINCIPLES PRACTICE, P1083	37	18	18	0	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1386-341X	1573-7403		PITUITARY	Pituitary	DEC	2012	15	4					579	588		10.1007/s11102-011-0371-7			10	Endocrinology & Metabolism	Endocrinology & Metabolism	034UM	WOS:000310898400017	22228382				2021-06-18	
J	Tuominen, R; Joelsson, P; Tenovuo, O				Tuominen, Risto; Joelsson, Petteri; Tenovuo, Olli			Treatment costs and productivity losses caused by traumatic brain injuries	BRAIN INJURY			English	Article						traumatic brain injury; treatment costs; productivity losses	ECONOMIC BURDEN; HEAD-INJURIES; EPIDEMIOLOGY; EUROPE; TRENDS	Objective: To estimate the magnitude and relative importance of hospital treatment costs and productivity losses caused by traumatic brain injuries (TBIs). Patients: A total of 155 patients with new TBI diagnoses admitted to Turku University Hospital were systematically sampled. Methods: Hospital costs were determined by collecting detailed data from patient records and applying the actual cost from the hospital administration. For estimating the productivity losses, the age of retirement was adjusted according to the age- and sex-specific retirement probability. Results: Median treatment costs per TBI patient were (sic)5429, surgery (sic)1600 and other costs (sic)3651. Overall treatment costs for severe brain injuries were significantly (p < 0.01) higher than for less severe cases. Median production losses due to early retirement were estimated to be (sic)1.19 million per TBI patient, significantly (p < 0.03) lower among less severe than among the severe cases. Age, sex and severity of TBI could explain only 9% of the variation in treatment costs, but explained 73% of the variation in production losses. Conclusions: Indirect productivity losses form the great majority of the overall economic burden of TBI to society. The direct treatment costs in tertiary level hospitals also impose a considerable burden on the healthcare sector.	[Tuominen, Risto; Joelsson, Petteri] Univ Turku, Dept Publ Hlth, SF-20014 Turku, Finland; [Tuominen, Risto] Turku Univ Hosp, Primary Hlth Care Unit, Turku, Finland; [Joelsson, Petteri; Tenovuo, Olli] Univ Turku, Dept Neurol, SF-20014 Turku, Finland	Tuominen, R (corresponding author), Univ Turku, Dept Publ Hlth, Lemminkaisenkatu 1, SF-20014 Turku, Finland.	risto.tuominen@utu.fi			Hospital District of Southwest Finland	The authors report no conflicts of interest. The Hospital District of Southwest Finland supported this study.	Baechli H, 2004, NEUROSURG REV, V27, P263, DOI 10.1007/s10143-004-0337-6; Berg J, 2005, EUR J NEUROL, V12, P85, DOI 10.1111/j.1468-1331.2005.01200.x; Berg Jenny, 2004, Eur J Health Econ, V5 Suppl 1, pS84, DOI 10.1007/s10198-005-0293-2; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Davis KL, 2007, J TRAUMA, V62, P622, DOI 10.1097/TA.0b013e318031afe3; DIKMEN SS, 1994, ARCH NEUROL-CHICAGO, V51, P177, DOI 10.1001/archneur.1994.00540140087018; Hashimoto K, 2006, J REHABIL MED, V38, P141, DOI 10.1080/16501970500441690; Heidi Nyman and Statistical Group, 2010, STAT YB PENS FINL 20, P42; Himanen L, 2011, BRAIN INJURY, V25, P443, DOI 10.3109/02699052.2011.556580; Kayani NA, 2009, PUBLIC HEALTH REP, V124, P551, DOI 10.1177/003335490912400412; Koskinen S, 2008, BRAIN INJURY, V22, P205, DOI 10.1080/02699050801938975; Kreutzer JS, 2003, J HEAD TRAUMA REHAB, V18, P128, DOI 10.1097/00001199-200303000-00004; Langlois JA, 2006, TRAUMATIC BRAIN INJU; MacKenzie E., 1991, J HEAD TRAUMA REHAB, V6, P76, DOI [10.1097/00001199-199106000-00010, DOI 10.1097/00001199-199106000-00010]; McGarry LJ, 2002, J TRAUMA, V53, P1152, DOI 10.1097/00005373-200212000-00020; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Moss NEG, 1996, INJURY, V27, P159, DOI 10.1016/0020-1383(95)00217-0; Powell JM, 2008, ARCH PHYS MED REHAB, V89, P1550, DOI 10.1016/j.apmr.2007.12.035; Shames J, 2007, DISABIL REHABIL, V29, P1387, DOI 10.1080/09638280701315011; Son AHPWV, 2007, CLIN REHABIL, V21, P1024, DOI 10.1177/0269215507077603; Statistics Board, 2010, POP STRUCT 2009; Steudel WI, 2005, ACTA NEUROCHIR, V147, P231, DOI 10.1007/s00701-004-0441-y; Sundstrom T, 2007, J NEUROTRAUM, V24, P147, DOI 10.1089/neu.2006.0099; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Thompson K, 2001, N C Med J, V62, P376; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; Walker WC, 2006, ARCH PHYS MED REHAB, V87, P1576, DOI 10.1016/j.apmr.2006.08.335; Zitnay GA, 2008, J NEUROTRAUM, V25, P1135, DOI 10.1089/neu.2008.0599	28	18	18	0	7	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	DEC	2012	26	13-14					1697	1701		10.3109/02699052.2012.722256			5	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	041RU	WOS:000311419700015	23163250				2021-06-18	
J	Wang, Y; Guo, F; Pan, CF; Lou, YL; Zhang, PQ; Guo, SC; Yin, JH; Deng, ZF				Wang, Yang; Guo, Fei; Pan, Changfu; Lou, Yuanlei; Zhang, Pengqi; Guo, Shangchun; Yin, Junhui; Deng, Zhifeng			Effects of low temperatures on proliferation-related signaling pathways in the hippocampus after traumatic brain injury	EXPERIMENTAL BIOLOGY AND MEDICINE			English	Article						miRNA; microarray; neurogenesis; traumatic brain injury; low-temperature exposure	CLOSED-HEAD INJURY; MICRORNA EXPRESSION; RAT; NEUROGENESIS; NEURONS; CELLS; HYPOTHERMIA; NOTCH; MICE	To evaluate the influence of low temperatures on the proliferation of neural stem cells (NSCs) and the regulation of their signaling pathways after brain trauma, we examined changes in the expression levels of specific miRNAs and their target genes. We also evaluated NSC proliferation in the hippocampus after brain trauma under low-temperature conditions. We found that the expression profile of miRNAs in the hippocampus after trauma changed at both normal and low temperatures, and the expression of miR-34a decreased significantly lower in rats exposed to low temperatures. There was significant proliferation of endogenous NSCs in the hippocampus after brain trauma at both temperatures, but NSC proliferation was slower at low temperatures. In addition, the expression of Notch1 significantly increased in the hippocampus after brain trauma at both temperatures. However, at low temperatures, the degree of up-regulation of Notch signaling molecules was significantly lower. We conclude that low-temperature environments can inhibit the proliferation of endogenous NSCs in the hippocampus, possibly by alleviating the effects of miR-34a down-regulation and Notch signaling up-regulation induced by traumatic brain injury.	[Wang, Yang; Guo, Shangchun; Yin, Junhui] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Inst Orthopaed Surg, Shanghai 200233, Peoples R China; [Wang, Yang; Guo, Fei; Lou, Yuanlei] Nanchang Univ, Inst Urol, Nanchang 330006, Peoples R China; [Pan, Changfu; Deng, Zhifeng] Nanchang Univ, Affiliated Hosp 3, Dept Neurosurg, Nanchang 330006, Peoples R China; [Zhang, Pengqi; Deng, Zhifeng] Shanghai Jiao Tong Univ, Dept Neurosurg, Affiliated Peoples Hosp 6, Shanghai 200233, Peoples R China	Deng, ZF (corresponding author), Nanchang Univ, Affiliated Hosp 3, Dept Neurosurg, Nanchang 330006, Peoples R China.	dengzf63@126.com	Guo, Shang-Chun/M-6246-2018	Guo, Shang-Chun/0000-0001-6285-6750; , Fei/0000-0003-2397-8629	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81160154]; National Key Technology RD ProgramNational Key Technology R&D Program [2008BAI68B06]	This work was supported by the National Natural Science Foundation of China (81160154) and the National Key Technology R&D Program (2008BAI68B06).	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Beni-Adani L, 2001, J PHARMACOL EXP THER, V296, P57; Chen Y, 1996, J NEUROTRAUM, V13, P557, DOI 10.1089/neu.1996.13.557; Fineberg SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038562; Golant A, 2008, J AM ACAD ORTHOP SUR, V16, P704, DOI 10.5435/00124635-200812000-00003; Han Y, 2008, CHIN OCCUP MED, V35, P515; Jeyaseelan K, 2008, STROKE, V39, P959, DOI 10.1161/STROKEAHA.107.500736; Ji Q, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006816; Kanagawa T, 2006, BRAIN RES, V1111, P36, DOI 10.1016/j.brainres.2006.06.112; Lei P, 2009, BRAIN RES, V1284, P191, DOI 10.1016/j.brainres.2009.05.074; Martin RS, 2005, SHOCK, V24, P114, DOI 10.1097/01.shk.0000169726.25189.b1; Nagao M, 2007, MOL CELL BIOL, V27, P3982, DOI 10.1128/MCB.00170-07; Oya S, 2009, NEUROSCIENCE, V158, P683, DOI 10.1016/j.neuroscience.2008.10.043; Redell JB, 2009, J NEUROSCI RES, V87, P1435, DOI 10.1002/jnr.21945; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Richardson RM, 2007, NEUROSURG CLIN N AM, V18, P169, DOI 10.1016/j.nec.2006.10.007; Richardson RM, 2010, J NEUROSURG, V112, P1125, DOI 10.3171/2009.4.JNS081087; Stefani G, 2008, NAT REV MOL CELL BIO, V9, P219, DOI 10.1038/nrm2347; Sun D, 2007, EXP NEUROL, V204, P264, DOI 10.1016/j.expneurol.2006.11.005; Urrea C, 2007, RESTOR NEUROL NEUROS, V25, P65; Wang XM, 2009, J CEREBR BLOOD F MET, V29, P1644, DOI 10.1038/jcbfm.2009.83	21	18	19	0	15	ROYAL SOC MEDICINE PRESS LTD	LONDON	1 WIMPOLE STREET, LONDON W1G 0AE, ENGLAND	1535-3702			EXP BIOL MED	Exp. Biol. Med.	DEC	2012	237	12					1424	1432		10.1258/ebm.2012.012123			9	Medicine, Research & Experimental	Research & Experimental Medicine	082GS	WOS:000314380900007	23354401				2021-06-18	
J	Martinez-Vargas, M; Rojo, FE; Tabla-Ramon, E; Navarro-Arguelles, H; Ortiz-Lailzon, N; Hernandez-Chavez, A; Solis, B; Tapia, RM; Arredondo, AP; Morales-Gomez, J; Gonzalez-Rivera, R; Nava-Talavera, K; Navarro, L				Martinez-Vargas, Marina; Estrada Rojo, Francisco; Tabla-Ramon, Erika; Navarro-Argueelles, Hilda; Ortiz-Lailzon, Nathan; Hernandez-Chavez, Alejandro; Solis, Barbara; Martinez Tapia, Ricardo; Perez Arredondo, Adan; Morales-Gomez, Julio; Gonzalez-Rivera, Ruben; Nava-Talavera, Karen; Navarro, Luz			Sleep deprivation has a neuroprotective role in a traumatic brain injury of the rat	NEUROSCIENCE LETTERS			English	Article						Traumatic brain injury; Sleep deprivation; Neuroprotection	CEREBRAL-ISCHEMIA; GENE-EXPRESSION; GROWTH-FACTOR; INCREASES; GLUTAMATE; RECOVERY; STROKE; CORTEX; EEG	During the process of a brain injury, responses to produce damage and cell death are activated, but self-protective responses that attempt to maintain the integrity and functionality of the brain are also activated. We have previously reported that the recovery from a traumatic brain injury (TBI) is better in rats if it occurs during the dark phase of the diurnal cycle when rats are in the waking period. This suggests that wakefulness causes a neuroprotective role in this type of injury. Here we report that 24 h of total sleep deprivation after a TBI reduces the morphological damage and enhances the recovery of the rats, as seen on a neurobiological scale. (C) 2012 Elsevier Ireland Ltd. All rights reserved.	[Martinez-Vargas, Marina; Estrada Rojo, Francisco; Tabla-Ramon, Erika; Navarro-Argueelles, Hilda; Ortiz-Lailzon, Nathan; Hernandez-Chavez, Alejandro; Solis, Barbara; Martinez Tapia, Ricardo; Perez Arredondo, Adan; Morales-Gomez, Julio; Nava-Talavera, Karen; Navarro, Luz] Univ Nacl Autonoma Mexico Apdo, Depto Fisiol, Fac Med, Mexico City 04510, DF, Mexico	Navarro, L (corresponding author), Univ Nacl Autonoma Mexico Apdo, Depto Fisiol, Fac Med, Postal 70-250, Mexico City 04510, DF, Mexico.	lnavarro@servidor.unam.mx	Navarro, Luz/A-4983-2013; Navarro, Luz/Q-9086-2019; Martinez-Tapia, Ricardo Jesus/AAU-4219-2020	Martinez-Tapia, Ricardo Jesus/0000-0003-3460-7065; HERNANDEZ CHAVEZ, ALEJANDRO/0000-0002-9876-0600; MARTINEZ-VARGAS, MARINA/0000-0002-3729-2161; Perez-Arredondo, Adan/0000-0002-0479-6734	PAPIITPrograma de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT) [IN 222209, IN221212]	Supported by grants PAPIIT IN 222209 and IN221212. Thanks to Dr. Ellis Glazier for editing this English-language text.	Barriga-Ibars C, 2005, REV NEUROLOGIA, V40, P548, DOI 10.33588/rn.4009.2005250; Bettendorff L, 1996, SLEEP, V19, P65, DOI 10.1093/sleep/19.1.65; Brandt JA, 2001, BRAIN RES, V898, P105, DOI 10.1016/S0006-8993(01)02149-7; COHEN HB, 1965, SCIENCE, V150, P1318, DOI 10.1126/science.150.3701.1318; Corbett D, 1998, PROG NEUROBIOL, V54, P531, DOI 10.1016/S0301-0082(97)00078-6; Dash MB, 2009, J NEUROSCI, V29, P580, DOI 10.1523/JNEUROSCI.5486-08.2009; Endo T, 1997, PSYCHIAT RES, V66, P97, DOI 10.1016/S0165-1781(96)03029-6; EVERSON CA, 1989, SLEEP, V12, P13, DOI 10.1093/sleep/12.1.13; Ezpleta S.D., APUNTES NEUROLOGIA; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Feinberg I, 1999, SLEEP, V22, P1021, DOI 10.1093/sleep/22.8.1021; Gao B, 2010, SLEEP, V33, P879, DOI 10.1093/sleep/33.7.879; Hsu JC, 2003, BRAIN RES, V984, P170, DOI 10.1016/S0006-8993(03)03128-7; Hunter AJ, 2000, NEUROPHARMACOLOGY, V39, P806, DOI 10.1016/S0028-3908(99)00262-2; IYER KS, 1988, P NATL ACAD SCI USA, V85, P3653, DOI 10.1073/pnas.85.10.3653; Junek A, 2010, NEUROSCIENCE, V170, P1140, DOI 10.1016/j.neuroscience.2010.08.018; Kazanis I, 2003, BRAIN RES, V991, P34, DOI 10.1016/S0006-8993(03)03525-X; KUSHIDA CA, 1989, SLEEP, V12, P22, DOI 10.1093/sleep/12.1.22; Leker RR, 2002, BRAIN RES REV, V39, P55, DOI 10.1016/S0165-0173(02)00157-1; Martinez-Vargas M, 2003, NEUROSCIENCE, V117, P197, DOI 10.1016/S0306-4522(02)00820-5; Martinez-Vargas M, 2006, NEUROSCI LETT, V400, P21, DOI 10.1016/j.neulet.2006.02.010; Moldovan M, 2010, EXP NEUROL, V222, P135, DOI 10.1016/j.expneurol.2009.12.023; Montes-Rodriguez CJ, 2004, NEUROSCI LETT, V360, P133, DOI 10.1016/j.neulet.2004.02.053; RECHTSCHAFFEN A, 1983, SCIENCE, V221, P182, DOI 10.1126/science.6857280; Rechtschaffen A, 1999, SLEEP, V22, P11, DOI 10.1093/sleep/22.1.11; Salgado-Delgado R, 2008, NEUROSCIENCE, V154, P922, DOI 10.1016/j.neuroscience.2008.03.066; Scheepens A, 2000, J PEDIATR ENDOCR MET, V13, P1483; Schwierin B, 1999, NEUROSCI LETT, V261, P61, DOI 10.1016/S0304-3940(98)01006-4; Spiegel K, 2003, REV NEUROL-FRANCE, V159, pS11; Sritharan K, 2009, BRIT J HOSP MED, V70, pM156, DOI 10.12968/hmed.2009.70.Sup10.44641; Tononi G, 2001, NEUROPSYCHOPHARMACOL, V25, pS28, DOI 10.1016/S0893-133X(01)00322-0; Toppila J, 1996, J SLEEP RES, V5, P115, DOI 10.1046/j.1365-2869.1996.d01-66.x; Wang Sheng-Xu, 2002, Di Yi Jun Yi Da Xue Xue Bao, V22, P888; Weil ZM, 2009, EXP NEUROL, V218, P129, DOI 10.1016/j.expneurol.2009.04.018; WIRZJUSTICE A, 1981, PSYCHIAT RES, V5, P67, DOI 10.1016/0165-1781(81)90062-7; Zhang F, 2010, MOLECULES, V15, P5246, DOI 10.3390/molecules15085246; Zucconi GG, 2006, BRAIN RES BULL, V69, P375, DOI 10.1016/j.brainresbull.2006.01.009; Zunzunegui C, 2011, SLEEP, V34, P1261, DOI 10.5665/SLEEP.1252	38	18	18	0	12	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	NOV 7	2012	529	2					118	122		10.1016/j.neulet.2012.09.037			5	Neurosciences	Neurosciences & Neurology	039RK	WOS:000311264000004	23022503				2021-06-18	
J	Fogelman, D; Zafonte, R				Fogelman, David; Zafonte, Ross			Exercise to Enhance Neurocognitive Function After Traumatic Brain Injury	PM&R			English	Article							PLASTICITY-RELATED PROTEINS; HIPPOCAMPAL NEUROGENESIS; SYNAPTIC PLASTICITY; VOLUNTARY EXERCISE; PHYSICAL-ACTIVITY; UP-REGULATION; BED REST; CONCUSSION; SPORTS; PATHOPHYSIOLOGY	Vigorous exercise has long been associated with improved health in many domains. Results of clinical observation have suggested that neurocognitive performance also is improved by vigorous exercise. Data derived from animal model based research have been emerging that show molecular and neuroanatomic mechanisms that may explain how exercise improves cognition, particularly after traumatic brain injury. This article will summarize the current state of the basic science and clinical literature regarding exercise as an intervention, both independently and in conjunction with other modalities, for brain injury rehabilitation. A key principle is the factor of timing of the initiation of exercise after mild traumatic brain injury, balancing potentially favorable and detrimental effects on recovery. PM R 2012;4:908-913	[Zafonte, Ross] Harvard Univ, Sch Med, Spaulding Rehabil Hosp, Massachusetts Gen Hosp,Dept Phys Med & Rehabil, Cambridge, MA 02138 USA	Fogelman, D (corresponding author), 125 Nashua St, Boston, MA 02114 USA.	rzafonte@partners.org					ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; Chalder M, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2758; Churchill JD, 2002, NEUROBIOL AGING, V23, P941, DOI 10.1016/S0197-4580(02)00028-3; de Kruijk JR, 2002, J NEUROL NEUROSUR PS, V73, P167, DOI 10.1136/jnnp.73.2.167; Devine JM, 2009, PM&R, V1, P560, DOI 10.1016/j.pmrj.2009.03.015; Ding QX, 2006, EUR J NEUROSCI, V24, P1265, DOI 10.1111/j.1460-9568.2006.05026.x; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Farmer J, 2004, NEUROSCIENCE, V124, P71, DOI 10.1016/j.neuroscience.2003.09.029; Gagnon I, 2009, BRAIN INJURY, V23, P956, DOI 10.3109/02699050903373477; Giza CC, 2001, J ATHL TRAINING, V36, P228; Gordon WA, 1998, J HEAD TRAUMA REHAB, V13, P58, DOI 10.1097/00001199-199808000-00006; Gould E, 1999, P NATL ACAD SCI USA, V96, P5263, DOI 10.1073/pnas.96.9.5263; Grealy MA, 1999, ARCH PHYS MED REHAB, V80, P661, DOI 10.1016/S0003-9993(99)90169-7; Griesbach GS, 2004, BRAIN RES, V1016, P154, DOI 10.1016/j.brainres.2004.04.079; Griesbach GS, 2004, NEUROSCIENCE, V125, P129, DOI 10.1016/j.neuroscience.2004.01.030; Hanna-Pladdy B, 2001, CLIN NEUROPSYCHOL, V15, P289, DOI 10.1076/clin.15.3.289.10272; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI 10.1249/mss.0b013e3180616b27; Hassett LM, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006123.pub2; Iverson G.L., 2007, BRAIN INJURY MED PRI; Jantzen KJ, 2010, J HEAD TRAUMA REHAB, V25, P256, DOI 10.1097/HTR.0b013e3181e5477c; Jovanovic JN, 2000, NAT NEUROSCI, V3, P323; Leddy JJ, 2010, CLIN J SPORT MED, V20, P21, DOI 10.1097/JSM.0b013e3181c6c22c; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; Marlatt MW, 2010, BRAIN RES, V1341, P93, DOI 10.1016/j.brainres.2010.03.086; McCrea M, 2009, NEUROSURGERY, V65, P876, DOI 10.1227/01.NEU.0000350155.89800.00; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McMillan T, 2002, NEUROPSYCHOL REHABIL, V12, P117, DOI 10.1080/09602010143000202; Molteni R, 2002, EUR J NEUROSCI, V16, P1107, DOI 10.1046/j.1460-9568.2002.02158.x; Moser RS, 2012, J PEDIAT; Pereira AC, 2007, P NATL ACAD SCI USA, V104, P5638, DOI 10.1073/pnas.0611721104; Richards M, 2003, SOC SCI MED, V56, P785, DOI 10.1016/S0277-9536(02)00075-8; Signoretti S, 2011, PM&R, V3, pS359, DOI 10.1016/j.pmrj.2011.07.018; Silverberg ND, 2012, J HEAD TRAUMA REHABI; Solomon GS, 2007, J NEUROPSYCH CLIN N, V19, P195, DOI 10.1176/appi.neuropsych.19.2.195; vanBoxtel MPJ, 1997, MED SCI SPORT EXER, V29, P1357, DOI 10.1097/00005768-199710000-00013; Vaynman S, 2004, EUR J NEUROSCI, V20, P2580, DOI 10.1111/j.1460-9568.2004.03720.x; Williamson GM, 2000, HEALTH PSYCHOL, V19, P339, DOI 10.1037//0278-6133.19.4.339; Winkelman C, 2009, AACN ADV CRIT CARE, V20, P254, DOI 10.1097/NCI.0b013e3181ac838d	39	18	18	0	36	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1934-1482	1934-1563		PM&R	PM&R	NOV	2012	4	11					908	913		10.1016/j.pmrj.2012.09.028			6	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	048AU	WOS:000311883400019	23174558				2021-06-18	
J	Forman, JL; Lopez-Valdes, FJ; Pollack, K; Heredero-Ordoyo, R; Molinero, A; Mansilla, A; Fildes, B; Segui-Gomez, M				Forman, Jason L.; Lopez-Valdes, Francisco J.; Pollack, Keshia; Heredero-Ordoyo, Rafael; Molinero, Aquilino; Mansilla, Alberto; Fildes, Brian; Segui-Gomez, Maria			Injuries among powered two-wheeler users in eight European countries: A descriptive analysis of hospital discharge data	ACCIDENT ANALYSIS AND PREVENTION			English	Article						Motorcycles; Two-wheelers; Hospital discharge; Epidemiology; Injury; Biomechanics	PATTERNS; TRAUMA	Powered two-wheelers (PTWs - mopeds, motorcycles, and scooters) remain the most dangerous form of travel on today's roads. This study used hospital discharge data from eight European countries to examine the frequencies and patterns of injury among PM users (age >= 14 years), the predicted incidence of the loss of functional ability, and the mechanisms of the head injuries observed (all in light of increased helmet use). Of 977,557 injured patients discharged in 2004, 12,994 were identified as having been injured in PTW collisions. Lower extremity injuries accounted for 26% (25.6-26.7, 95% C.I.) of the total injuries, followed by upper extremity injuries (20.7%: 20.3-21.2), traumatic brain injuries (TBI) (18.5%: 18-19), and thoracic injuries (8.2%: 7.8-8.5). Approximately 80% of the lower extremity injury cases were expected to exhibit some functional disability one year following discharge (predicted Functional Capacity Index, pFCI-AIS98 < 100), compared to 47% of the upper extremity injury cases and 24% of the TBI cases. Although it occurred less frequently, patients that were expected to experience some functional limitation from TBI were predicted to fair worse on average (lose more functional ability) than patients expected to have functional limitations from extremity injuries. Cerebral concussion was the most common head injury observed (occurring in 56% of head injury cases), with most concussion cases (78%) exhibiting no other head injury. Among the AIS3+ head injuries that could be mapped to an injury mechanism, 48% of these were associated with a translational-impact mechanism, and 37% were associated with a rotational mechanism. The observation of high rates of expected long-term disability suggests that future efforts aim to mitigate lower and upper extremity injuries among PTW users. Likewise, the high rates of concussion and head injuries associated with a rotational mechanism provide goals for the next phase of PTW user head protection. (C) 2011 Elsevier Ltd. All rights reserved.	[Forman, Jason L.; Lopez-Valdes, Francisco J.; Heredero-Ordoyo, Rafael; Segui-Gomez, Maria] Univ Navarra, ECIP, Navarra 31080, Spain; [Pollack, Keshia; Segui-Gomez, Maria] Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Injury Res & Policy, Baltimore, MD USA; [Lopez-Valdes, Francisco J.; Segui-Gomez, Maria] Univ Virginia, Ctr Appl Biomech, Charlottesville, VA 22911 USA; [Molinero, Aquilino] Fdn CIDAUT, Boecillo 47151, Castilla, Spain; [Molinero, Aquilino] Fdn CIDAUT, Leon 47151, Spain; [Mansilla, Alberto] Univ Valladolid, E-47011 Valladolid, Spain; [Fildes, Brian] Monash Univ, MUARC Europe, Prato Ctr, I-59100 Prato, Italy	Forman, JL (corresponding author), Univ Navarra, ECIP, Irunlarrea 1,Ed Castanos, Navarra 31080, Spain.	jlf3m@virginia.edu; fjl2j@virginia.edu; kpollack@jhsph.edu; rhereder@unav.es; aqumol@cidaut.es; albman@eis.uva.es; Brian.Fildes@muarc.monash.edu.au; msegui@unav.es	Lopez-Valdes, Francisco/AAG-5519-2019; Lopez-Valdes, Francisco J/I-3649-2012	Lopez-Valdes, Francisco J/0000-0003-3167-5732			AAAM, 2008, ABBR INJ SEV SCAL AI; AAAM, 1998, ABBR INJ SEV SCAL AI; ACEM, 2008, 20 ACEM, P16; Arbogast K.B., 2005, P INT RES COUNC BIOM; Arregui-Dalmases C, 2010, ACCIDENT ANAL PREV, V42, P1164, DOI 10.1016/j.aap.2010.01.005; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Barell V, 2002, INJ PREV, V8, P91, DOI 10.1136/ip.8.2.91; Barnes Jo, 2009, Ann Adv Automot Med, V53, P195; Center for Injury Research and Policy of the Johns Hopkins University School of Public Health and Trianalytics Inc., 1998, ICDMAP 90 PROGR MAP; Coben JH, 2004, AM J PREV MED, V27, P355, DOI 10.1016/j.amepre.2004.08.002; European Center for Injury Prevention at Universidad de Navarra, 2007, ALG CALC FUNCT CAP I; European Center for Injury Prevention at Universidad de Navarra, 2007, ALG TRANSL ICD 10 CO; European Center for Injury Prevention at Universidad de Navarra, 2007, ALG CALC BAR MATR IC; European Center for Injury Prevention at Universidad de Navarra, 2008, ALG EST TYP FORC REL; Fingerhut LA, 2006, INJURY PREV, V12, P24, DOI 10.1136/ip.2005.009076; Fitzharris M, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-11; Gennarelli Thomas A., 1993, Journal of Emergency Medicine, V11, P5; Hinds JD, 2007, INJURY, V38, P1131, DOI 10.1016/j.injury.2007.06.012; LaTorre G, 2002, EUR J PUBLIC HEALTH, V12, P99, DOI 10.1093/eurpub/12.2.99; Liu BC, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004333.pub3; MACKENZIE EJ, 1989, MED CARE, V27, P412, DOI 10.1097/00005650-198904000-00008; MacKenzie EJ, 1996, J TRAUMA, V41, P799, DOI 10.1097/00005373-199611000-00006; MacKenzie EJ, 2002, QUAL LIFE RES, V11, P797, DOI 10.1023/A:1020820017658; MacKenzie EJ, 1986, P AAAM, V30, P135; MARGANITT B, 1990, AM J PUBLIC HEALTH, V80, P1463, DOI 10.2105/AJPH.80.12.1463; Martin P., 2003, P 31 INT WORKSH INJ; Monk JP, 2009, CAN J SURG, V52, pE235; Robertson A, 2002, SPINE, V27, P2825, DOI 10.1097/00007632-200212150-00019; SafetyNet, 2009, POW 2 WHEEL; Schuller E., 1984, P 26 STAPP CAR CRASH, P259; Segui-Gomez M, 2007, INJURY PREV, V13, P429, DOI 10.1136/ip.2007.017475; Segui-Gomez M, 2008, INJURY RELATED HOSPI; WHO. Geneva: World Health Organisation, 2004, WORLD REP ROAD TRAFF; WHO (World Health Organization), 1992, INT CLASS DIS V 10 I; World Health Organization, 2009, GLOB STAT REP ROAD S; ZETTAS JP, 1979, J TRAUMA, V19, P833, DOI 10.1097/00005373-197911000-00007	36	18	18	0	15	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0001-4575	1879-2057		ACCIDENT ANAL PREV	Accid. Anal. Prev.	NOV	2012	49				SI		229	236		10.1016/j.aap.2011.02.020			8	Ergonomics; Public, Environmental & Occupational Health; Social Sciences, Interdisciplinary; Transportation	Engineering; Public, Environmental & Occupational Health; Social Sciences - Other Topics; Transportation	074WI	WOS:000313845300027	23036399				2021-06-18	
J	Genet, F; Chehensse, C; Jourdan, C; Lautridou, C; Denormandie, P; Schnitzler, A				Genet, Francois; Chehensse, Clement; Jourdan, Claire; Lautridou, Christine; Denormandie, Philippe; Schnitzler, Alexis			Impact of the Operative Delay and the Degree of Neurologic Sequelae on Recurrence of Excised Heterotopic Ossification in Patients With Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						heterotopic ossification; recurrence; traumatic brain injury	SPINAL-CORD; BONE-FORMATION; HEAD-INJURY; ELBOW; RESECTION; HIP; REHABILITATION; STROKE; JOINT; KNEE	The timing of surgery with regard to recurrence risk after neurologic heterotopic ossification (HO) excision is still debated. This study investigated the association between recurrence risk after HO excision in traumatic brain injury (TBI) patients and (1) the operative delay and (2) the degree of neurologic sequelae (Garland status). A case-control study was performed. Patients who developed troublesome HO requiring surgery after TBI with (case, n = 16) or without recurrence (control, n = 64) were retrospectively included. Other matching criteria were sex and age at the time of surgery (+/- 4 years). The median delay for first HO surgery was 13.7 months (interquartile range: 9.0-37.1) for the case group and 13.2 months (interquartile range: 7.8-30.0) for the control group. No significant link was found between recurrence and operative delay (P = .54), even after inclusion of all matching factors (P = .53), or Garland status (P = .81). The inclusion of Garland status into the model did not change this result (P = .64). After TBI, no link was found between HO operative delay and recurrence. In spite of a common notion of a relationship between initial severity of TBI and HO development, no link was found between HO recurrence risk and the severity of sequelae.	[Genet, Francois; Chehensse, Clement; Jourdan, Claire; Schnitzler, Alexis] CHU R Poincare, Serv Med Phys & Readaptat, Garches, France; [Lautridou, Christine; Denormandie, Philippe] CHU R Poincare, Serv Chirurg Orthoped, Garches, France	Genet, F (corresponding author), Hop Raymond Poincare, Serv Med Phys & Readaptat, 104 Bld Raymond Poincare, F-92380 Garches, France.	francois.genet@rpc.aphp.fr					Borg J, 2011, AM J PHYS MED REHAB, V90, P65, DOI 10.1097/PHM.0b013e3181fc80e7; Carlier RY, 2005, J BONE JOINT SURG BR, V87B, P301, DOI 10.1302/0301-620X.87B3.14737; Chalidis B, 2007, J NEUROTRAUM, V24, P1675, DOI 10.1089/neu.2007.0342; Charnley G, 1996, INJURY, V27, P125, DOI 10.1016/0020-1383(95)00180-8; Cipriano Cara, 2009, Orthopedics, V32, DOI 10.3928/01477447-20090728-33; Denormandie P, 1999, Chir Main, V18, P99; ENNEKING WF, 1972, CLIN ORTHOP RELAT R, P28; Frischhut B, 1993, Acta Neurol (Napoli), V15, P114; Fuller DA, 2005, CLIN ORTHOP RELAT R, P197, DOI 10.1097/01.blo.0000170718.86747.da; GACON G, 1978, REV CHIR ORTHOP, V64, P375; GARLAND DE, 1989, CLIN ORTHOP RELAT R, P169; GARLAND DE, 1988, CLIN ORTHOP RELAT R, P86; GARLAND DE, 1985, J BONE JOINT SURG AM, V67A, P1261, DOI 10.2106/00004623-198567080-00019; GARLAND DE, 1991, CLIN ORTHOP RELAT R, P13; Genet F, 2009, J BONE JOINT SURG BR, V91B, P1493, DOI 10.1302/0301-620X.91B11.22305; Genet F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016632; HSU JD, 1975, CLIN ORTHOP RELAT R, P165; Ippolito E, 1999, J HAND SURG-AM, V24A, P546; Ippolito E, 1999, CLIN ORTHOP RELAT R, P130, DOI 10.1097/00003086-199908000-00018; Lazarus MD, 1999, NEUROREHABILITATION, V12, P145; McAuliffe JA, 1997, J BONE JOINT SURG AM, V79A, P749, DOI 10.2106/00004623-199705000-00015; Melamed E, 2002, AM J PHYS MED REHAB, V81, P670, DOI 10.1097/00002060-200209000-00006; Moore T J, 1993, J Orthop Trauma, V7, P11, DOI 10.1097/00005131-199302000-00003; Narmoneva DA, 2002, J ORTHOP RES, V20, P83, DOI 10.1016/S0736-0266(01)00076-6; ORZEL JA, 1985, J NUCL MED, V26, P125; Paolucci S, 2000, ARCH PHYS MED REHAB, V81, P695, DOI 10.1053/apmr.2000.5583; ROBERTS JB, 1979, J BONE JOINT SURG AM, V61, P760, DOI 10.2106/00004623-197961050-00018; Rossier A B, 1973, Paraplegia, V11, P38; Sarafis KA, 1999, J TRAUMA, V46, P104, DOI 10.1097/00005373-199901000-00017; Sorriaux G, 2005, REV CHIR ORTHOP, V91, P415, DOI 10.1016/S0035-1040(05)84358-2; STOVER SL, 1976, J BONE JOINT SURG AM, V58, P683, DOI 10.2106/00004623-197658050-00019; STOVER SL, 1991, CLIN ORTHOP RELAT R, P71; TANAKA T, 1977, RADIOLOGY, V123, P217, DOI 10.1148/123.1.217; WADE DT, 1985, J NEUROL NEUROSUR PS, V48, P7, DOI 10.1136/jnnp.48.1.7; WHARTON GW, 1970, J BONE JOINT SURG AM, VA 52, P105, DOI 10.2106/00004623-197052010-00010	35	18	19	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2012	27	6					443	448		10.1097/HTR.0b013e31822b54ba			6	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	039CU	WOS:000311221200015	22495100				2021-06-18	
J	Honeybul, S; Gillett, G; Ho, K; Lind, C				Honeybul, Stephen; Gillett, Grant; Ho, Kwok; Lind, Christopher			Ethical considerations for performing decompressive craniectomy as a life-saving intervention for severe traumatic brain injury	JOURNAL OF MEDICAL ETHICS			English	Article								In all fields of clinical medicine, there is an increasing awareness that outcome must be assessed in terms of quality of life and cost effectiveness, rather than merely length of survival. This is especially the case when considering decompressive craniectomy for severe traumatic brain injury. The procedure itself is technically straightforward and involves temporarily removing a large section of the skull vault in order to provide extra space into which the injured brain can expand. A number of studies have demonstrated many patients going on to make a good long-term functional recovery, however, this is not always the case and a significant number survive but are left with severe neurocognitive impairment. Unfortunately, many of these patients are young adults who were previously fit and well and are, therefore, likely to spend many years in a condition that they may feel to be unacceptable, and this raises a number of ethical issues regarding consent and resource allocation. In an attempt to address these issues, we have used the analytical framework proposed by Jonsen, that requires systematic consideration of medical indications, patient preferences, quality of life and contextual features.	[Honeybul, Stephen] Sir Charles Gairdner Hosp, Dept Neurosurg, Perth, WA 6009, Australia; [Gillett, Grant] Univ Otago, Bioeth Ctr, Dunedin Hosp & Otago, Dunedin, Otago, New Zealand; [Ho, Kwok] Univ Western Australia, Dept Intens Care Med, Perth, WA 6009, Australia; [Ho, Kwok] Univ Western Australia, Sch Populat Hlth, Perth, WA 6009, Australia; [Lind, Christopher] Univ Western Australia, Sch Surg, Perth, WA 6009, Australia	Honeybul, S (corresponding author), Sir Charles Gairdner Hosp, Dept Neurosurg, Hosp Ave, Perth, WA 6009, Australia.	stephen.honeybul@health.wa.gov.au	Lind, Christopher/K-3629-2012; Ho, Kwok M./E-3546-2010	Lind, Christopher/0000-0001-9991-1725; Ho, Kwok M./0000-0002-6705-6004			Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Beauchamp TL, 2001, PRINCIPLES BIOMEDICA, P69; Boddington Paula, 1992, Bioethics, V6, P201, DOI 10.1111/j.1467-8519.1992.tb00198.x; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Fagerlin A, 2004, HASTINGS CENT REP, V34, P30, DOI 10.2307/3527683; Fins JJ, 2009, ANN NY ACAD SCI, V1157, P131, DOI 10.1111/j.1749-6632.2009.04473.x; Ho KM, 2011, J TRAUMA, V71, P1637, DOI 10.1097/TA.0b013e31823a08f1; Ho KM, 2011, CRIT CARE MED, V39, P2495, DOI 10.1097/CCM.0b013e318225764e; Honeybul S, 2011, J MED ETHICS, V37, P707, DOI 10.1136/medethics-2011-100081; Honeybul S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032375; Honeybul S, 2011, J NEUROTRAUM, V28, P2199, DOI 10.1089/neu.2011.1907; Honeybul S, 2011, J NEUROTRAUM, V28, P929, DOI 10.1089/neu.2010.1612; Honeybul S, 2011, J NEUROTRAUM, V28, P13, DOI 10.1089/neu.2010.1584; Honeybul S, 2010, J NEUROTRAUM, V27, P1225, DOI 10.1089/neu.2010.1316; Hutchinson PJ, 2006, ACTA NEUROCHIR SUPPL, V96, P17; Jonsen A R, 1986, Law Med Health Care, V14, P172; Jonsen AR, 2006, CLIN OTHICS PRACTICA; Kerridge IH, 1999, MED J AUSTRALIA, V171, P239, DOI 10.5694/j.1326-5377.1999.tb123629.x; Kiphuth IC, 2010, NEUROCRIT CARE, V13, P380, DOI 10.1007/s12028-010-9449-8; KNAUS WA, 1995, JAMA-J AM MED ASSOC, V274, P1591, DOI 10.1001/jama.1995.03530200027032; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/s0140-6736(04)17188-2; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Perkins HS, 2007, ANN INTERN MED, V147, P51, DOI 10.7326/0003-4819-147-1-200707030-00008; Polin RS, 1997, NEUROSURGERY, V41, P84, DOI 10.1097/00006123-199707000-00018; Romero CM, 2011, NEW ENGL J MED, V365, P373, DOI 10.1056/NEJMc1106421; Schiff ND, 2005, NEUROLOGY, V64, P514, DOI 10.1212/01.WNL.0000150883.10285.44; Schiff ND, 2002, BRAIN, V125, P1210, DOI 10.1093/brain/awf131; Wood RL, 2006, J NEUROL NEUROSUR PS, V77, P71, DOI 10.1136/jnnp.2005.065540	28	18	18	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-6800	1473-4257		J MED ETHICS	J. Med. Ethics	NOV	2012	38	11					657	661		10.1136/medethics-2012-100672			5	Ethics; Medical Ethics; Social Issues; Social Sciences, Biomedical	Social Sciences - Other Topics; Medical Ethics; Social Issues; Biomedical Social Sciences	030PE	WOS:000310581800004	22807572				2021-06-18	
J	Gregson, BA; Rowan, EN; Mitchell, PM; Unterberg, A; McColl, EM; Chambers, IR; McNamee, P; Mendelow, AD				Gregson, Barbara A.; Rowan, Elise N.; Mitchell, Patrick M.; Unterberg, Andy; McColl, Elaine M.; Chambers, Iain R.; McNamee, Paul; Mendelow, A. David			Surgical trial in traumatic intracerebral hemorrhage (STITCH(Trauma)): study protocol for a randomized controlled trial	TRIALS			English	Article						Head injury; Traumatic intracerebral hemorrhage; Hematoma; Early surgery	HEMATOMAS; SURGERY	Background: Intracranial hemorrhage occurs in over 60% of severe head injuries in one of three types: extradural (EDH); subdural (SDH); and intraparenchymal (TICH). Prompt surgical removal of significant SDH and EDH is established and widely accepted. However, TICH is more common and is found in more than 40% of severe head injuries. It is associated with a worse outcome but the role for surgical removal remains undefined. Surgical practice in the treatment of TICHs differs widely around the world. The aim of early surgery in TICH removal is to prevent secondary brain injury. There have been trials of surgery for spontaneous ICH (including the STICH II trial), but none so far of surgery for TICH. Methods/Design: The UK National Institutes of Health Research has funded STITCH(Trauma) to determine whether a policy of early surgery in patients with TICH improves outcome compared to a policy of initial conservative treatment. It will include a health economics component and carry out a subgroup analysis of patients undergoing invasive monitoring. This is an international multicenter pragmatic randomized controlled trial. Patients are eligible if: they are within 48 h of injury; they have evidence of TICH on CT scan with a confluent volume of attenuation significantly raised above that of the background white and grey matter that has a total volume >10 mL; and their treating neurosurgeon is in equipoise. Patients will be ineligible if they have: a significant surface hematoma (EDH or SDH) requiring surgery; a hemorrhage/contusion located in the cerebellum; three or more separate hematomas fulfilling inclusion criteria; or severe pre-existing physical or mental disability or severe co-morbidity which would lead to poor outcome even if the patient made a full recovery from the head injury. Patients will be randomized via an independent service. Patients randomized to surgery receive surgery within 12 h. Both groups will be monitored according to standard neurosurgical practice. All patients have a CT scan at 5 days (+/-2 days) to assess changes in hematoma size. Follow-up is by postal questionnaire at 6 and 12 months. The recruitment target is 840 patients.	[Gregson, Barbara A.; Rowan, Elise N.; Mitchell, Patrick M.; Mendelow, A. David] Newcastle Univ, Neurosurg Trials Unit, Newcastle Upon Tyne NE2 4AE, Tyne & Wear, England; [Unterberg, Andy] Heidelberg Univ, Dept Neurosurg, D-69120 Heidelberg, Germany; [McColl, Elaine M.] Newcastle CTU, Sch Med, Inst Hlth & Soc, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Chambers, Iain R.] James Cook Univ Hosp, Middlesbrough TS4 3BW, Cleveland, England; [McNamee, Paul] Univ Aberdeen, Hlth Econ Res Unit, Inst Appl Hlth Sci, Aberdeen AB25 2ZD, Scotland	Rowan, EN (corresponding author), Newcastle Univ, Neurosurg Trials Unit, 3-4 Claremont Terrace, Newcastle Upon Tyne NE2 4AE, Tyne & Wear, England.	e.n.rowan@ncl.ac.uk	McColl, Elaine/V-9906-2019; Abdullah, J/C-2828-2011	McColl, Elaine/0000-0001-8300-3204; Abdullah, J/0000-0002-0258-7410; Gregson, Barbara/0000-0003-4868-9137	NIHR Health Technology Assessment program [07/37/16]; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0501444] Funding Source: researchfish	This project is funded by the NIHR Health Technology Assessment program (project number 07/37/16). The views and opinions expressed therein are those of the authors and do not necessarily reflect those of the HTA program, NIHR, NHS, or the Department of Health.	Boto GR, 2001, J NEUROSURG, V94, P224, DOI 10.3171/jns.2001.94.2.0224; Chambers IR, 2006, J NEUROL NEUROSUR PS, V77, P234, DOI 10.1136/jnnp.2005.072215; CHOKSEY M, 1993, BRIT J NEUROSURG, V7, P611, DOI 10.3109/02688699308995090; D'Avella D, 2001, J Neurosurg Sci, V45, P29; Fairbank J, 2005, BRIT MED J, V330, P1485; Marion DW, 2006, NEUROSURGERY, V58, P655; Mathiesen T, 1995, ACTA NEUROCHIR, V137, P155, DOI 10.1007/BF02187188; Mendelow AD, 2005, LANCET, V365, P387; Mendelow AD, 2003, ACTA NEUROCHIR, V145, P679, DOI 10.1007/s00701-003-0063-9; Mendelow AD, 2003, ACTA NEUROCHIR WIEN, P681; Murray GD, 2005, J NEUROTRAUM, V22, P511, DOI 10.1089/neu.2005.22.511; Pettigrew LEL, 1998, J NEUROSURG, V89, P939, DOI 10.3171/jns.1998.89.6.0939; Prasad K, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002244.pub3; Siddique MS, 2002, J NEUROSURG, V96, P86, DOI 10.3171/jns.2002.96.1.0086; Weinstein JN, 2006, JAMA-J AM MED ASSOC, V296, P2441, DOI 10.1001/jama.296.20.2441; ZUMKELLER M, 1992, NEUROSURG REV, V15, P33, DOI 10.1007/BF02352065	16	18	21	0	3	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1745-6215			TRIALS	Trials	OCT 16	2012	13								193	10.1186/1745-6215-13-193			11	Medicine, Research & Experimental	Research & Experimental Medicine	032SW	WOS:000310740400001	23072576	DOAJ Gold, Green Published			2021-06-18	
J	Rashid, B; Destrade, M; Gilchrist, MD				Rashid, Badar; Destrade, Michel; Gilchrist, Michael D.			Temperature effects on brain tissue in compression	JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS			English	Article						Traumatic brain injury (TBI); Body temperature; Room temperature; Ogden model; Compression	MODEL; BEHAVIOR; STRETCH; INJURY	Extensive research has been carried out for at least 50 years to understand the mechanical properties of brain tissue in order to understand the mechanisms of traumatic brain injury (TBI). The observed large variability in experimental results may be due to the inhomogeneous nature of brain tissue and to the broad range of test conditions. However, test temperature is also considered as one of the factors influencing the properties of brain tissue. In this research, the mechanical properties of porcine brain have been investigated at 22 degrees C (room temperature), and at 37 degrees C (body temperature) while maintaining a constant preservation temperature of approximately 4-5 degrees C. Unconfined compression tests were performed at dynamic strain rates of 30 and 50 s(-1) using a custom made test apparatus. There was no significant difference (p = 0.8559-0.9290) between the average engineering stresses of the brain tissue at the two different temperature conditions. The results of this study should help to understand the behavior of brain tissue at different temperature conditions, particularly in unconfined compression tests. (C) 2012 Elsevier Ltd. All rights reserved.	[Rashid, Badar; Destrade, Michel; Gilchrist, Michael D.] Univ Coll Dublin, Sch Mech & Mat Engn, Dublin 4, Ireland; [Destrade, Michel] Natl Univ Ireland Galway, Sch Math Stat & Appl Math, Galway, Ireland	Gilchrist, MD (corresponding author), Univ Coll Dublin, Sch Mech & Mat Engn, Dublin 4, Ireland.	Badar.Rashid@ucdconnect.ie; michel.destrade@nuigalway.ie; michael.gilchrist@ucd.ie	Destrade, Michel/O-5825-2019; Gilchrist, Michael D/B-6100-2017	Destrade, Michel/0000-0002-6266-1221; Gilchrist, Michael D/0000-0003-1765-429X	Irish Research Council for Science, Engineering and Technology (IRCSET), IrelandIrish Research Council for Science, Engineering and Technology	The authors thank John Gahan, Tony Dennis and Pat McNally for their assistance in machining components and developing electronic circuits for the experimental setup. This work was supported for the first author by a Postgraduate Research Scholarship awarded by the Irish Research Council for Science, Engineering and Technology (IRCSET), Ireland.	Franceschini G, 2006, J MECH PHYS SOLIDS, V54, P2592, DOI 10.1016/j.jmps.2006.05.004; Ho J, 2009, J BIOMECH, V42, P2074, DOI 10.1016/j.jbiomech.2009.06.051; Horgan TJ, 2003, INT J CRASHWORTHINES, V8, P353, DOI 10.1533/cras.8.4.353.19278; Hrapko M, 2006, BIORHEOLOGY, V43, P623; Hrapko M, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2907746; Huang CY, 2009, J BIOMECH, V42, P546, DOI 10.1016/j.jbiomech.2008.11.013; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; MARGULIES SS, 1990, J BIOMECH, V23, P823, DOI 10.1016/0021-9290(90)90029-3; Meaney D.F., 1990, INT C BIOM IMP; Miller K, 1997, J BIOMECH, V30, P1115, DOI 10.1016/S0021-9290(97)00092-4; Miller K, 2002, J BIOMECH, V35, P483, DOI 10.1016/S0021-9290(01)00234-2; Morrison B, 2006, J NEUROSCI METH, V150, P192, DOI 10.1016/j.jneumeth.2005.06.014; Morrison B, 2000, J BIOMECH ENG-T ASME, V122, P224, DOI 10.1115/1.429650; Morrison B., 2003, STAPP CAR CRASH J, V47, P93; Nicolle S, 2005, BIORHEOLOGY, V42, P209; Nicolle Stephane, 2004, Stapp Car Crash J, V48, P239; Ning XG, 2006, J BIOMECH ENG-T ASME, V128, P925, DOI 10.1115/1.2354208; Pervin F, 2009, J BIOMECH, V42, P731, DOI 10.1016/j.jbiomech.2009.01.023; Peters GWM, 1997, BIORHEOLOGY, V34, P127, DOI 10.1016/S0006-355X(97)00009-7; Pfister BJ, 2003, ANN BIOMED ENG, V31, P589, DOI 10.1114/1.1566445; Prange MT, 2002, J BIOMECH ENG-T ASME, V124, P244, DOI 10.1115/1.1449907; RUAN JS, 1994, J BIOMECH ENG-T ASME, V116, P44, DOI 10.1115/1.2895703; Shen F, 2006, J BIOMECH ENG-T ASME, V128, P797, DOI 10.1115/1.2264393; SHUCK LZ, 1972, J BASIC ENG-T ASME, V94, P905, DOI 10.1115/1.3425588; TAKHOUNTS EG, 1999, P 27 INT WORKSH, P141; Tamura A, 2007, J BIOMECH SCI ENG, V2, P115, DOI [10.1299/jbse.2.115, DOI 10.1299/JBSE.2.115]; Tamura A., 2008, J BIOMECH SCI ENG, V3, P263, DOI DOI 10.1299/JBSE.3.263; Thibault KL, 1998, J BIOMECH, V31, P1119, DOI 10.1016/S0021-9290(98)00122-5; Velardi F, 2006, BIOMECH MODEL MECHAN, V5, P53, DOI 10.1007/s10237-005-0007-9; Zhang JY, 2011, J BIOMECH, V44, P391, DOI 10.1016/j.jbiomech.2010.10.024; Zhang L, 2001, Stapp Car Crash J, V45, P369	31	18	18	0	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	1751-6161	1878-0180		J MECH BEHAV BIOMED	J. Mech. Behav. Biomed. Mater.	OCT	2012	14						113	118		10.1016/j.jmbbm.2012.04.005			6	Engineering, Biomedical; Materials Science, Biomaterials	Engineering; Materials Science	073SB	WOS:000313761700012	23022565				2021-06-18	
J	Saadat, SMS; Bidabadi, E; Saadat, SNS; Mashouf, M; Salamat, F; Yousefzadeh, S				Saadat, Seyed Mohammad Seyed; Bidabadi, Elham; Saadat, Seyedeh Nazanin Seyed; Mashouf, Mehryar; Salamat, Fatemeh; Yousefzadeh, Shahrokh			Association of persistent hyperglycemia with outcome of severe traumatic brain injury in pediatric population	CHILDS NERVOUS SYSTEM			English	Article						Brain injury; Hyperglycemia; Mortality; Child	SEVERE HEAD-INJURY; PREDICTOR; CHILDREN	Hyperglycemia is a common secondary insult associated with an increased risk of mortality and poor outcome in traumatic brain injury (TBI), but the effect of hyperglycemia on outcomes of severe TBI in children and adolescents is less apparent. The aim of this study was to evaluate the association of hyperglycemia with mortality in pediatric patients with severe TBI. In this cross-sectional study, data of all children and adolescents with severe TBI admitted to Poursina Hospital in Rasht, including age, gender, Glasgow Coma Scale (GCS) upon admission, mortality rate, hospital length of stay, and serial blood glucose during the first three consecutive ICU days following admission, were reviewed from April 2007 to May 2011. After univariate analysis and adjustment for related covariates, logistic regression model was established to determine the association between persistent hyperglycemia and outcome. One-hundred and twenty-two children were included with a median admission GCS of 6 (interquartile range (IQR) 5-7) and a median age of 13 years (IQR 7.75-17). Among them, 91 were boys (74.6 %) and 31 were girls (26.6 %); the overall mortality was 40.2 % (n = 49). Patients who died had a significantly greater blood glucose levels than survivors for the first 3 days of admission (P = 0.003, P < 0.001, P = 0.001, respectively). Moreover, persistent hyperglycemia during the first 3 days of admission had an adjusted odds ratio of 11.11 for mortality (P < 0.001). Early hyperglycemia is associated with poor outcome, and persistent hyperglycemia is a powerful and independent predictor of mortality in children and adolescents with severe TBI.	[Saadat, Seyed Mohammad Seyed; Bidabadi, Elham; Saadat, Seyedeh Nazanin Seyed; Salamat, Fatemeh] Guilan Univ Med Sci, Med Students Res Comm, Rasht 4165855695, Iran; [Mashouf, Mehryar] Arya Hosp, Dept Neurosurg, Rasht, Iran; [Yousefzadeh, Shahrokh] Poursina Hosp, Dept Neurosurg, Rasht, Iran	Bidabadi, E (corresponding author), Guilan Univ Med Sci, Med Students Res Comm, 15-135 Ave Golsar, Rasht 4165855695, Iran.	mashoof@mail.com	Bidabadi, Elham/D-2879-2019	Yousefzadeh-Chabok, Shahrokh/0000-0002-8825-3015; Seyed Saadat, Seyed Mohammad/0000-0001-8188-3455; Seyedsaadat, Seyed Mohammad/0000-0002-8219-6144; Bidabadi, Elham/0000-0002-1067-3335			Asilioglu N, 2011, J PEDIAT-BRAZIL, V87, P325, DOI [10.2223/JPED.2097, 10.1590/S0021-75572011000400009]; Carrick MM, 2005, J TRAUMA, V58, P725, DOI 10.1097/01.TA.0000159249.68363.78; Cochran A, 2003, J TRAUMA, V55, P1035, DOI 10.1097/01.TA.0000031175.96507.48; Griesdale DEG, 2009, NEUROCRIT CARE, V11, P311, DOI 10.1007/s12028-009-9249-1; Jeremitsky E, 2005, J TRAUMA, V58, P47, DOI 10.1097/01.TA.0000135158.42242.B1; Kan CH, 2009, MALAYS J MED SCI, V16, P25; Kreutziger J, 2009, J TRAUMA, V67, P704, DOI 10.1097/TA.0b013e3181b22e37; Krug EG, 2000, AM J PUBLIC HEALTH, V90, P523, DOI 10.2105/AJPH.90.4.523; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Marton E, 2007, CHILD NERV SYST, V23, P873, DOI 10.1007/s00381-007-0314-9; Melo JRT, 2010, ACTA NEUROCHIR, V152, P1559, DOI 10.1007/s00701-010-0680-z; PARISH RA, 1988, J TRAUMA, V28, P517, DOI 10.1097/00005373-198804000-00017; Salim A, 2009, AM SURGEON, V75, P25; Melo JRT, 2009, ARQ NEURO-PSIQUIAT, V67, P804, DOI 10.1590/S0004-282X2009000500004	14	18	19	0	4	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0256-7040			CHILD NERV SYST	Childs Nerv. Syst.	OCT	2012	28	10					1773	1777		10.1007/s00381-012-1753-5			5	Clinical Neurology; Pediatrics; Surgery	Neurosciences & Neurology; Pediatrics; Surgery	010YW	WOS:000309131400016	22526446				2021-06-18	
J	Singh, R; Squires, J; Fromkin, JB; Berger, RP				Singh, Ranjodh; Squires, Janet; Fromkin, Janet B.; Berger, Rachel P.			Assessing the use of follow-up skeletal surveys in children with suspected physical abuse	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Skeletal survey; child physical abuse	TRAUMATIC BRAIN-INJURY; INFANTS; FRACTURES; BRUISE; SERUM	BACKGROUND: Child physical abuse is an important cause of morbidity and mortality in young children. The skeletal survey (SS) is considered a mandatory part of the evaluation for suspected physical abuse in young children. Literature suggests that a follow-up SS performed 10 to 21 days after the initial SS can provide important additional information, but previous studies evaluating the follow-up SS have been small and included very selective patient populations. METHODS: A retrospective descriptive study of a consecutive sample of children who underwent an initial SS and a follow-up SS at a single children's hospital during a 7-year period. Data on demographics, clinical presentation, results, and effect of the follow-up SS on clinical diagnosis were collected. RESULTS: Of the 1470 children who underwent an initial SS, 11% (169 of 1470 children) also underwent a follow-up SS. The mean age of the children who underwent both an initial SS and a follow-up SS was 5.8 months. Fourteen percent of the follow-up SS identified previously unrecognized fractures; all of which were healing. There were eight children in whom the information obtained from the follow-up SS resulted in a diagnosis of definite physical abuse; all eight children were younger than 12 months, and in six of these cases, the initial SS did not demonstrate any fractures. CONCLUSION: Only a small proportion of children who undergo an initial SS also undergo a follow-up SS. The relatively high proportion of follow-up SS that demonstrated previously unrecognized fracture(s), the young age of children undergoing the follow-up SS, and the high morbidity and mortality of unrecognized/missed child physical abuse in this age group suggest that the follow-up SS should be a routine part of the evaluation of child physical abuse. (J Trauma Acute Care Surg. 2012; 73: 972-976. Copyright (C) 2012 by Lippincott Williams & Wilkins)	[Squires, Janet; Fromkin, Janet B.; Berger, Rachel P.] Univ Pittsburgh, Med Ctr, Childrens Hosp Pittsburgh, Dept Pediat, Pittsburgh, PA 15224 USA; [Singh, Ranjodh] Univ Pittsburgh, Pittsburgh, PA 15224 USA	Berger, RP (corresponding author), Univ Pittsburgh, Med Ctr, Childrens Hosp Pittsburgh, Dept Pediat, 4417 Penn Ave, Pittsburgh, PA 15224 USA.	Rachel.Berger@chp.edu			Pediatric Clinical and Translational Research Center at the Children's Hospital of Pittsburgh of University of Pittsburgh Medical Center; University of PittsburghUniversity of Pittsburgh	R. Singh received funding from the Summer Student Research Training Program of the Pediatric Clinical and Translational Research Center at the Children's Hospital of Pittsburgh of University of Pittsburgh Medical Center and the Brackenridge Summer Fellowship of the University of Pittsburgh. The remaining authors declare no conflicts of interest.	Belfer RA, 2001, AM J EMERG MED, V19, P122, DOI 10.1053/ajem.2001.21345; Bennett Berkeley L, 2011, BMC Res Notes, V4, P354, DOI 10.1186/1756-0500-4-354; Berger RP, 2006, DEV NEUROSCI-BASEL, V28, P327, DOI 10.1159/000094158; Berger RP, 2006, PEDIATRICS, V117, P325, DOI 10.1542/peds.2005-0711; Campbell KA, 2006, ARCH PEDIAT ADOL MED, V160, P1241, DOI 10.1001/archpedi.160.12.1241; Day Fiona, 2006, J Clin Forensic Med, V13, P55, DOI 10.1016/j.jcfm.2005.08.001; Di Pietro MA, 2009, PEDIATRICS, V123, P1430, DOI 10.1542/peds.2009-0558; Duffy SO, 2011, PEDIATRICS, V127, pE47, DOI 10.1542/peds.2010-0298; Hamilton-Giachritsis CE, 2005, J FAM PSYCHOL, V19, P619, DOI 10.1037/0893-3200.19.4.619; Hansen KK, 2009, CHILD ABUSE NEGLECT, V33, P278, DOI 10.1016/j.chiabu.2008.10.002; Harlan SR, 2009, PEDIATR RADIOL, V39, P962, DOI 10.1007/s00247-009-1313-7; Keenan HT, 2003, JAMA-J AM MED ASSOC, V290, P621, DOI 10.1001/jama.290.5.621; King WK, 2006, PEDIATR EMERG CARE, V22, P211, DOI 10.1097/01.pec.0000208180.94166.dd; Kleinman PK, 1996, AM J ROENTGENOL, V167, P893, DOI 10.2214/ajr.167.4.8819377; Leventhal JM, 2008, PEDIATRICS, V122, P599, DOI 10.1542/peds.2007-1959; Nimkin K, 2001, RADIOL CLIN N AM, V39, P843, DOI 10.1016/S0033-8389(05)70314-6; Oral R, 2008, PEDIATR EMERG CARE, V24, P816, DOI 10.1097/PEC.0b013e31818e9f5d; Pierce MC, 2009, PEDIATR EMERG CARE, V25, P845, DOI 10.1097/PEC.0b013e3181c06217; Sonik A, 2010, CHILD ABUSE NEGLECT, V34, P804, DOI 10.1016/j.chiabu.2010.03.002; Sugar NF, 1999, ARCH PEDIAT ADOL MED, V153, P399, DOI 10.1001/archpedi.153.4.399; Talvik I, 2008, ACTA PAEDIATR, V97, P782, DOI 10.1111/j.1651-2227.2008.00778.x; US Department of Health and Human Services Administration for Children Youth and Families, 2010, CHILD MALTR 2009; Wood JN, 2009, PEDIATRICS, V123, pE247, DOI 10.1542/peds.2008-2467; Zimmerman S, 2005, CHILD ABUSE NEGLECT, V29, P1075, DOI 10.1016/j.chiabu.2004.08.012	24	18	18	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	2163-0755			J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	OCT	2012	73	4					972	976		10.1097/TA.0b013e31825a773d			5	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	029OL	WOS:000310505100030	22902733	Green Accepted			2021-06-18	
J	Viscomi, MT; D'Amelio, M				Viscomi, Maria Teresa; D'Amelio, Marcello			The "Janus-Faced Role" of Autophagy in Neuronal Sickness: Focus on Neurodegeneration	MOLECULAR NEUROBIOLOGY			English	Article						Autophagosomes; Autophagic flux; Cell death; Acute brain damage; Neuronal recovery	TRAUMATIC BRAIN-INJURY; CHAPERONE-MEDIATED AUTOPHAGY; NEONATAL HYPOXIA-ISCHEMIA; FOCAL CEREBRAL-ISCHEMIA; SPINAL-CORD-INJURY; CELL-DEATH; ALPHA-SYNUCLEIN; PARKINSONS-DISEASE; ALZHEIMERS-DISEASE; MUTANT HUNTINGTIN	The mature brain is a highly dynamic organ that constantly changes its organization by destroying and forming new connections. Collectively, these changes are referred to as brain plasticity and are associated with functional changes, such as memory, addiction, and recovery of function after brain damage. Neuronal plasticity is sustained by the fine regulation of protein synthesis and organelle biogenesis and their degradation to ensure efficient turnover. Thus, autophagy, as quality control mechanism of proteins and organelles in neurons, is essential to their physiology and pathology. Here, we review recent several findings proving that defects in autophagy affect neuronal function and impair functional recovery after brain insults, contributing to neurodegeneration, in chronic and acute neurological disorders. Thus, an understanding of the molecular mechanisms by which the autophagy machinery is finely regulated might accelerate the development of therapeutic interventions in many neurological disorders for which no cure is available.	[Viscomi, Maria Teresa; D'Amelio, Marcello] IRCCS S Lucia Fdn, Dept Expt Neurosci, I-00143 Rome, Italy; [D'Amelio, Marcello] Univ Campus Biomed, I-00128 Rome, Italy	Viscomi, MT (corresponding author), IRCCS S Lucia Fdn, Dept Expt Neurosci, Via Fosso di Fiorano 65, I-00143 Rome, Italy.	mt.viscomi@hsantalucia.it; m.damelio@hsantalucia.it	Viscomi, Maria Teresa/G-4173-2011; Viscomi, Maria Teresa/AAL-6625-2021	Viscomi, Maria Teresa/0000-0002-9096-4967; D'Amelio, Marcello/0000-0001-6526-1832	Wings for Life Spinal Cord Research Foundation [WFL1-2011]; Projects for Research of National Interest (PRIN); Alzheimer's AssociationAlzheimer's Association [NIRG-11-204588]	This work was supported by Wings for Life Spinal Cord Research Foundation (WFL1-2011) (M. T. V.), by Projects for Research of National Interest (PRIN 2009), and by grant from the Alzheimer's Association (NIRG-11-204588) (M.DA). We thank Prof. M. Molinari and Prof. G. Bernardi for their continuous support and encouragement. The professional editorial work of Blue Pencil Science is also acknowledged.	Adhami F, 2007, AUTOPHAGY, V3, P42, DOI 10.4161/auto.3412; Adhami F, 2006, AM J PATHOL, V169, P566, DOI 10.2353/ajpath.2006.051066; Bauer PO, 2010, NAT BIOTECHNOL, V28, P256, DOI 10.1038/nbt.1608; Binkofski F, 1996, ANN NEUROL, V39, P460, DOI 10.1002/ana.410390408; Carloni S, 2012, NEUROSCIENCE, V203, P160, DOI 10.1016/j.neuroscience.2011.12.021; Carloni S, 2010, AUTOPHAGY, V6, P366, DOI 10.4161/auto.6.3.11261; Carloni S, 2008, NEUROBIOL DIS, V32, P329, DOI 10.1016/j.nbd.2008.07.022; Chang YY, 2009, MOL BIOL CELL, V20, P2004, DOI 10.1091/mbc.E08-12-1250; Clark RSB, 2008, AUTOPHAGY, V4, P88, DOI 10.4161/auto.5173; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; Di Bartolomeo S, 2010, J CELL BIOL, V191, P155, DOI 10.1083/jcb.201002100; Erlich S, 2007, NEUROBIOL DIS, V26, P86, DOI 10.1016/j.nbd.2006.12.003; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; Fimia GM, 2007, NATURE, V447, P1121, DOI 10.1038/nature05925; Furuta N, 2010, MOL BIOL CELL, V21, P1001, DOI 10.1091/mbc.E09-08-0693; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Ginet V, 2009, AM J PATHOL, V175, P1962, DOI 10.2353/ajpath.2009.090463; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Inoue Y, 2010, SEMIN CELL DEV BIOL, V21, P664, DOI 10.1016/j.semcdb.2010.03.009; Johansen T, 2011, AUTOPHAGY, V7, P279, DOI 10.4161/auto.7.3.14487; Kaminskyy V, 2012, BBA-PROTEINS PROTEOM, V1824, P44, DOI 10.1016/j.bbapap.2011.05.013; Kanno H, 2011, SPINE, V36, pE1427, DOI 10.1097/BRS.0b013e3182028c3a; Kanno H, 2009, NEUROBIOL DIS, V33, P143, DOI 10.1016/j.nbd.2008.09.009; Koike M, 2008, AM J PATHOL, V172, P454, DOI 10.2353/ajpath.2008.070876; Lai YC, 2008, J CEREBR BLOOD F MET, V28, P540, DOI 10.1038/sj.jcbfm.9600551; Lesage S, 2009, HUM MOL GENET, V18, pR48, DOI 10.1093/hmg/ddp012; Liang CY, 2008, NAT CELL BIOL, V10, P776, DOI 10.1038/ncb1740; Liu CL, 2008, J CEREBR BLOOD F MET, V28, P674, DOI 10.1038/sj.jcbfm.9600587; Luo CL, 2011, NEUROSCIENCE, V184, P54, DOI 10.1016/j.neuroscience.2011.03.021; Luzio JP, 2007, NAT REV MOL CELL BIO, V8, P622, DOI 10.1038/nrm2217; Martinez-Vicente M, 2008, J CLIN INVEST, V118, P777, DOI 10.1172/JCI32806; Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140; McAllister Thomas W, 2011, Dialogues Clin Neurosci, V13, P287; Mizushima N, 2003, J CELL SCI, V116, P1679, DOI 10.1242/jcs.00381; Mizushima N, 1998, J BIOL CHEM, V273, P33889, DOI 10.1074/jbc.273.51.33889; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2007, ANNU REV NUTR, V27, P19, DOI 10.1146/annurev.nutr.27.061406.093749; Mizushima N, 2010, CURR OPIN CELL BIOL, V22, P132, DOI 10.1016/j.ceb.2009.12.004; Moreau K, 2011, CELL, V146, P303, DOI 10.1016/j.cell.2011.06.023; Mueller-Steiner S, 2006, NEURON, V51, P703, DOI 10.1016/j.neuron.2006.07.027; Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Nixon RA, 2005, J NEUROPATH EXP NEUR, V64, P113, DOI 10.1093/jnen/64.2.113; Nixon RA, 2011, NEUROBIOL DIS, V43, P38, DOI 10.1016/j.nbd.2011.01.021; Pickford F, 2008, J CLIN INVEST, V118, P2190, DOI 10.1172/JCI33585; Pimplikar SW, 2010, J NEUROSCI, V30, P14946, DOI 10.1523/JNEUROSCI.4305-10.2010; Puyal J, 2012, NEUROSCIENTIST, V18, P224, DOI 10.1177/1073858411404948; Puyal J, 2009, AUTOPHAGY, V5, P1060, DOI 10.4161/auto.5.7.9728; Rami A, 2008, NEUROBIOL DIS, V29, P132, DOI 10.1016/j.nbd.2007.08.005; Rami A, 2008, AUTOPHAGY, V4, P227, DOI 10.4161/auto.5339; Ravikumar B, 2002, HUM MOL GENET, V11, P1107, DOI 10.1093/hmg/11.9.1107; Ravikumar B, 2010, PHYSIOL REV, V90, P1383, DOI 10.1152/physrev.00030.2009; Repnik U, 2012, BBA-PROTEINS PROTEOM, V1824, P22, DOI 10.1016/j.bbapap.2011.08.016; Sadasivan S, 2008, BIOCHEM BIOPH RES CO, V373, P478, DOI 10.1016/j.bbrc.2008.05.031; Sarkar S, 2007, J BIOL CHEM, V282, P5641, DOI 10.1074/jbc.M609532200; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; Sekiguchi A, 2012, J NEUROTRAUM, V29, P946, DOI 10.1089/neu.2011.1919; Shibata M, 2006, J BIOL CHEM, V281, P14474, DOI 10.1074/jbc.M600364200; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; TELLEZNAGEL I, 1974, J NEUROPATH EXP NEUR, V33, P308, DOI 10.1097/00005072-197404000-00008; Thomas B, 2009, ANTIOXID REDOX SIGN, V11, P2077, DOI 10.1089/ars.2009.2697; Uchiyama Y, 2008, AUTOPHAGY, V4, P404, DOI 10.4161/auto.5598; Viscomi MT, 2009, CEREBELLUM, V8, P184, DOI 10.1007/s12311-009-0107-7; Viscomi MT, 2012, AUTOPHAGY, V8, P222, DOI 10.4161/auto.8.2.18599; Wen YD, 2008, AUTOPHAGY, V4, P762, DOI 10.4161/auto.6412; Winslow AR, 2010, J CELL BIOL, V190, P1023, DOI 10.1083/jcb.201003122; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; Xu M, 2011, ACTA PHARMACOL SIN, V32, P1089, DOI 10.1038/aps.2011.50; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33; Yang DS, 2011, BRAIN, V134, P258, DOI 10.1093/brain/awq341; Yang ZF, 2010, CURR OPIN CELL BIOL, V22, P124, DOI 10.1016/j.ceb.2009.11.014; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028; Zhu C, 2005, CELL DEATH DIFFER, V12, P162, DOI 10.1038/sj.cdd.4401545; Zhu CL, 2006, J NEUROCHEM, V96, P1016, DOI 10.1111/j.1471-4159.2005.03639.x	76	18	18	0	11	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	0893-7648	1559-1182		MOL NEUROBIOL	Mol. Neurobiol.	OCT	2012	46	2					513	521		10.1007/s12035-012-8296-3			9	Neurosciences	Neurosciences & Neurology	013YF	WOS:000309341500019	22773113				2021-06-18	
J	Malec, JF; Hammond, FM; Giacino, JT; Whyte, J; Wright, J				Malec, James F.; Hammond, Flora M.; Giacino, Joseph T.; Whyte, John; Wright, Jerry			Structured Interview to Improve the Reliability and Psychometric Integrity of the Disability Rating Scale	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injuries; Outcomes assessment; Rehabilitation	TRAUMATIC BRAIN-INJURY; GLASGOW OUTCOME SCALE; FUNCTIONAL INDEPENDENCE MEASURE; COMMUNITY	Malec JF, Hammond FM, Giacino JT, Whyte J, Wright J. Structured interview to improve the reliability and psychometric integrity of the Disability Rating Scale. Arch Phys Med Rehabil 2012;93: 1603-8. Objectives: To (1) develop a standardized interview for telephone administration, (2) assess the psychometric properties of this interview format (Disability Rating Scale-Postacute Interview [DRS-PI]), and (3) identify additional items to reduce skew. Design: Prospective cohort assessment study. Setting: Not applicable. Participants: Participants (N=406; 287 individuals with traumatic brain injury [TBI], 1.19 caregivers) in the U.S. TBI Model Systems national database during 1- to 20-year telephone follow-up. Interventions: Not applicable. Main Outcome Measures: Original Disability Rating Scale (DRS) and DRS-PI variations. DRS-PI questions were developed by consensus of the study investigators; item scores were derived from responses to questions by algorithm. Unnecessary questions were pruned. Results: The DRS-PI correlated highly with the original DRS (intraclass correlation, .91) and demonstrated satisfactory construct validity and internal consistency (person separation/reliability, 2.51/.86; item separation/reliability, 16.72/1.00; Cronbach alpha=.83). Both versions showed substantial skew. For the original DRS, 42% of scores were 0 or 1; for DRS-PI, 44%. Adding several items to the DRS-PI including actual employment status further improved its psychometric properties (person separation/reliability, 3.10/.91; item separation/reliability, 21.42/1.00; Cronbach alpha=.92) and reduced skew. For the Expanded DRS-PI, 18% of scores were 0 or 1. Conclusions: The DRS-PI provides an efficient method to ensure standardized administration of, and correlates highly with, the original DRS. The addition of several new items including actual employment status mitigates skew in postacute samples.	[Malec, James F.] IUSM, Dept Phys Med & Rehabil, PM&R, Indianapolis, IN 46254 USA; [Malec, James F.; Hammond, Flora M.] Rehabil Hosp Indiana, Indianapolis, IN 46254 USA; [Hammond, Flora M.] Carolinas HealthCare Syst, Carolinas Rehabil, Charlotte, NC USA; [Giacino, Joseph T.] Harvard Univ, Sch Med, Dept Phys Med & Rehabil, Boston, MA USA; [Giacino, Joseph T.] Spaulding Rehabil Hosp, Boston, MA USA; [Whyte, John] Moss Rehabil Res Inst, Philadelphia, PA USA; [Wright, Jerry] Santa Clara Valley Med Ctr, San Jose, CA 95128 USA	Malec, JF (corresponding author), IUSM, Dept Phys Med & Rehabil, PM&R, 4141 Shore Dr, Indianapolis, IN 46254 USA.	jmalec@rhin.com	Giacino, Joseph/AAF-1952-2021	Giacino, Joseph/0000-0002-7916-9698; Whyte, John/0000-0002-4381-1474	National Institute on Disability and Rehabilitation Research [H133A070042]	Supported by a TBI Model System supplemental grant (no. H133A070042) from the National Institute on Disability and Rehabilitation Research.	CORRIGAN JD, 1995, J HEAD TRAUMA REHAB, V10, P41, DOI 10.1097/00001199-199508000-00005; GRANGER CV, 1993, AM J PHYS MED REHAB, V72, P84, DOI 10.1097/00002060-199304000-00005; Graves DE, 2011, ARCH PHYS MED REHA S, V92, pSI; HALL K, 1985, ARCH PHYS MED REHAB, V66, P35; Hall KM, 2001, ARCH PHYS MED REHAB, V82, P367, DOI 10.1053/apmr.2001.21525; Hall KM., 1993, J HEAD TRAUMA REHAB, V8, DOI [DOI 10.1097/00001199-199308020-00008, 10.1097/00001199-199308020-00008]; Levin HS, 2001, J NEUROTRAUM, V18, P575, DOI 10.1089/089771501750291819; LINACRE JM, 1994, ARCH PHYS MED REHAB, V75, P127; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Whiteneck GG, 2011, ARCH PHYS MED REHAB, V92, P542, DOI 10.1016/j.apmr.2010.08.002; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	12	18	18	0	3	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	SEP	2012	93	9					1603	1608		10.1016/j.apmr.2012.04.003			6	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	001IL	WOS:000308453800013	22510680				2021-06-18	
J	McIntosh, AS				McIntosh, Andrew S.			Biomechanical considerations in the design of equipment to prevent sports injury	PROCEEDINGS OF THE INSTITUTION OF MECHANICAL ENGINEERS PART P-JOURNAL OF SPORTS ENGINEERING AND TECHNOLOGY			English	Article						Biomechanics; equipment; sports injury; injury prevention	RANDOMIZED CONTROLLED-TRIAL; RUGBY UNION FOOTBALL; RISK COMPENSATION; HEAD; RECONSTRUCTION; EPIDEMIOLOGY; CONCUSSION; IMPACTS	The international market for sports equipment is enormous. One component of that market is explicitly equipment to prevent injury, and ideally all equipment should enable performance without causing injury. This paper will describe a biomechanical approach to the design of equipment to prevent sports injury. Elements in this approach include understanding and applying: injury risk management methods to set objectives; injury mechanisms; human tolerance to loads; range of sports loads (normal and abnormal); objectives of sport and sports skills; efficacy and effectiveness of current and past equipment; user expectations (usability, mass, aesthetics); standards requirements; setting performance objectives; identifying and testing materials; assessing materials and component testing; prototype testing; final product; and product evaluation and continuous control.	[McIntosh, Andrew S.] Univ New S Wales, Fac Sci, Sydney, NSW 2052, Australia; [McIntosh, Andrew S.] Monash Univ, Australian Ctr Res Sports Injury & Its Prevent AC, Clayton, Vic 3800, Australia	McIntosh, AS (corresponding author), Univ New S Wales, Fac Sci, Sydney, NSW 2052, Australia.	a.mcintosh@unsw.edu.au					[Anonymous], 2005, 145722005 BSIEN; [Anonymous], 2008, 2063 ASNZS; Bahr R, 2005, BRIT J SPORT MED, V39, P324, DOI 10.1136/bjsm.2005.018341; Balendra G, 2008, BRIT J SPORT MED, V42, DOI 10.1136/bjsm.2007.038950; Benson BW, 2009, BRIT J SPORT MED, V43, pI56, DOI 10.1136/bjsm.2009.058271; Daly RM, 2001, BRIT J SPORT MED, V35, P8, DOI 10.1136/bjsm.35.1.8; Emery CA, 2010, BRIT J SPORT MED, V44, P555, DOI 10.1136/bjsm.2010.074377; Finch C, 2005, INJURY PREV, V11, P242, DOI 10.1136/ip.2004.006882; Finch CF, 2011, SPORTS MED, V41, P59, DOI 10.2165/11537260-000000000-00000; Finch CF, 2004, SPORTS SAFETY AUSTR; Frechede B, 2009, MED SCI SPORT EXER, V41, P390, DOI 10.1249/MSS.0b013e318186b1c5; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; Hagel B, 2004, CLIN J SPORT MED, V14, P193, DOI 10.1097/00042752-200407000-00001; Hootman JM, 2007, J ATHL TRAINING, V42, P311; ISO AN, 2009, 31000 ISO AN ASNZS; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Larkins PA, 2003, SPORTS INJURIES REPO; MARGULIES SS, 1992, J BIOMECH, V25, P917, DOI 10.1016/0021-9290(92)90231-O; McBain K, 2012, BRIT J SPORT MED, V46, P174, DOI 10.1136/bjsm.2010.081182; McIntosh A, 1995, P 37 STAPP CAR CRASH; McIntosh AS, 2009, MED SCI SPORT EXER, V41, P306, DOI 10.1249/MSS.0b013e3181864bee; McIntosh AS, 2000, BRIT J SPORT MED, V34, P337, DOI 10.1136/bjsm.34.5.337; McIntosh AS, 2005, SOLID MECH APPL, V124, P231; McIntosh AS, 2005, BRIT J SPORT MED, V39, P314, DOI 10.1136/bjsm.2005.018200; McIntosh AS, 2005, BRIT J SPORT MED, V39, P2, DOI 10.1136/bjsm.2004.016188; Olsen OE, 2003, SCAND J MED SCI SPOR, V13, P299, DOI 10.1034/j.1600-0838.2003.00329.x; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Prasad P., 1985, SAE TECHNICAL PAPER; Quarrie KL, 2005, BRIT J SPORT MED, V39, P650, DOI 10.1136/bjsm.2004.016022; Rowson S, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3130454; Sulheim S, 2006, JAMA-J AM MED ASSOC, V295, P919, DOI 10.1001/jama.295.8.919; Usman J, 2011, J SCI MED SPORT, V14, P547, DOI 10.1016/j.jsams.2011.05.006; Verhagen EALM, 2010, BRIT J SPORT MED, V44, P1082, DOI 10.1136/bjsm.2010.076406	33	18	19	0	41	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1754-3371			P I MECH ENG P-J SPO	Proc. Inst. Mech. Eng. Part P-J. Sport. Eng. Technol.	SEP-DEC	2012	226	P3-4			SI		193	199		10.1177/1754337111431024			7	Engineering, Mechanical; Sport Sciences	Engineering; Sport Sciences	999NH	WOS:000308320000006					2021-06-18	
J	Ooi, YC; Dagi, TF; Maltenfort, M; Rincon, F; Vibbert, M; Jabbour, P; Gonzalez, LF; Rosenwasser, R; Jallo, J				Ooi, Yinn Cher; Dagi, T. Forcht; Maltenfort, Mitchell; Rincon, Fred; Vibbert, Matthew; Jabbour, Pascal; Gonzalez, L. Fernando; Rosenwasser, Robert; Jallo, Jack			Tight Glycemic Control Reduces Infection and Improves Neurological Outcome in Critically Ill Neurosurgical and Neurological Patients	NEUROSURGERY			English	Article						Hyperglycemia; Intensive insulin therapy; Tight glycemic control	INTENSIVE INSULIN THERAPY; TRAUMATIC BRAIN-INJURY; ANEURYSMAL SUBARACHNOID HEMORRHAGE; CARDIAC SURGICAL-PROCEDURES; BLOOD-GLUCOSE CONCENTRATION; STERNAL WOUND-INFECTION; DIABETES-MELLITUS; ISCHEMIC-STROKE; MEDICAL ICU; HEAD-INJURY	BACKGROUND: Tight glycemic control (TGC) may improve outcomes in hyperglycemic neurosurgical patients. The adoption of TGC has been limited by a lack of adequate data on optimal insulin delivery protocols and serum glucose concentration and by concerns about the risks of hypoglycemia. OBJECTIVE: This study was designed as a meta-analysis of outcomes to compare intensive insulin therapy and TGC with conventional insulin therapy and conventional glucose control. The secondary objective was to determine retrospectively whether a particular glucose range correlates with better outcomes. METHODS: Using electronic databases, we retrieved all English language studies published between January 1997 and December 2010 reporting outcomes in neurological and neurosurgical patients as a function of glucose levels and insulin protocols. We conducted a meta-analysis around 4 outcome measures: infection, neurological outcome, hypoglycemia, and mortality. Effect sizes in each study were individually correlated with target intensive insulin therapy glucose levels. Individual studies were assessed for quality by use of the Jadad scale. RESULTS: Nine studies reporting on 1459 patients met the inclusion criteria. Five were restricted to neurosurgical patients. Four included neurological patients. Compared with conventional glucose control, TGC lowered infection rates (odds ratio, 0.59; 95% confidence interval, 0.47-0.76; P < .001) and yielded better neurological outcomes (odds ratio, 1.72; 95% confidence interval, 1.36-2.16; P < .001). Beneficial effects increased as glucose limits tightened and study quality improved (R-2 > 0.9 for both). TGC resulted in a higher rate of hypoglycemic events (odds ratio, 8.04; 95% confidence interval, 4.85-13.31; P < .001). Mortality was not affected. CONCLUSION: TGC reduced infection risk and improved neurological outcome despite increased rates of hypoglycemic events. An optimal target for serum glucose concentrations could not be determined.	[Ooi, Yinn Cher] Univ Calif Los Angeles, Dept Neurol Surg, Los Angeles, CA USA; [Maltenfort, Mitchell; Rincon, Fred; Vibbert, Matthew; Jabbour, Pascal; Gonzalez, L. Fernando; Rosenwasser, Robert; Jallo, Jack] Thomas Jefferson Univ Hosp, Dept Neurol Surg, Philadelphia, PA 19107 USA; [Dagi, T. Forcht] Harvard MIT Program Hlth Sci & Technol, Div Hlth Sci & Technol, Boston, MA USA	Jallo, J (corresponding author), 909 Walnut St, Philadelphia, PA 19107 USA.	jack.jallo@jefferson.edu	ROSENWASSER, ROBERT H/L-2482-2014	Jallo, Jack/0000-0002-5512-1729; Rincon, Fred/0000-0002-8510-118X	Nuvasive	Dr Jallo receives research support in the form of a grant from Nuvasive. The other authors have no personal financial or institutional interest in any of the drugs, materials, or devices described in this article.	Anderson RE, 1999, STROKE, V30, P160, DOI 10.1161/01.STR.30.1.160; Bhalla A, 2003, EUR J NEUROL, V10, P25, DOI 10.1046/j.1468-1331.2003.00504.x; Bilotta F, 2008, NEUROCRIT CARE, V9, P159, DOI 10.1007/s12028-008-9084-9; Bilotta Federico, 2007, J Neurosurg Anesthesiol, V19, P156, DOI 10.1097/ANA.0b013e3180338e69; Bilotta F, 2009, ANESTHESIOLOGY, V110, P611, DOI 10.1097/ALN.0b013e318198004b; BONITA R, 1988, STROKE, V19, P1497, DOI 10.1161/01.STR.19.12.1497; Brunkhorst FM, 2008, NEW ENGL J MED, V358, P125, DOI 10.1056/NEJMoa070716; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Culliford AT, 1999, ANN THORAC SURG, V67, P360; DECOURTENMYERS GM, 1994, J CEREBR BLOOD F MET, V14, P227, DOI 10.1038/jcbfm.1994.29; Egi M, 2006, ANESTHESIOLOGY, V105, P244, DOI 10.1097/00000542-200608000-00006; Finney SJ, 2003, JAMA-J AM MED ASSOC, V290, P2041, DOI 10.1001/jama.290.15.2041; Furnary AP, 1999, ANN THORAC SURG, V67, P352, DOI 10.1016/S0003-4975(99)00014-4; Gale SC, 2007, AM SURGEON, V73, P454; Grey Neil J, 2004, Endocr Pract, V10 Suppl 2, P46; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; JENNETT B, 1975, LANCET, V1, P480; Kimura K, 2007, J NEUROL SCI, V255, P90, DOI 10.1016/j.jns.2007.02.005; Krinsley JS, 2004, MAYO CLIN PROC, V79, P992, DOI 10.4065/79.8.992; LAM AM, 1991, J NEUROSURG, V75, P545, DOI 10.3171/jns.1991.75.4.0545; Latorre JGS, 2009, STROKE, V40, P1644, DOI 10.1161/STROKEAHA.108.535534; LI PA, 1994, NEUROSCI LETT, V177, P63, DOI 10.1016/0304-3940(94)90045-0; Lukins MB, 2005, ANESTH ANALG, V100, P1129, DOI 10.1213/01.ANE.0000146943.45445.55; McCowen KC, 2001, CRIT CARE CLIN, V17, P107, DOI 10.1016/S0749-0704(05)70154-8; Mebis L, 2007, CURR OPIN CRIT CARE, V13, P392, DOI 10.1097/MCC.0b013e3281c1c9c8; Mechanick JI, 2007, CURR OPIN CLIN NUTR, V10, P193, DOI 10.1097/MCO.0b013e32802b7016; Moghissie ES, ACP HOSP S; Parsons MW, 2002, ANN NEUROL, V52, P20, DOI 10.1002/ana.10241; Pasternak JJ, 2004, J NEUROSURG ANESTH, V16, P122, DOI 10.1097/00008506-200404000-00003; Pittas AG, 2004, ARCH INTERN MED, V164, P2005, DOI 10.1001/archinte.164.18.2005; PULSINELLI WA, 1983, AM J MED, V74, P540, DOI 10.1016/0002-9343(83)91007-0; RANKIN J, 1957, Scott Med J, V2, P200; Schlenk F, 2009, NEUROCRIT CARE, V11, P56, DOI 10.1007/s12028-009-9222-z; Schlenk F, 2008, CRIT CARE, V12, DOI 10.1186/cc6776; Scott JF, 1999, STROKE, V30, P793, DOI 10.1161/01.STR.30.4.793; Wiener RS, 2008, JAMA-J AM MED ASSOC, V300, P933, DOI 10.1001/jama.300.8.933; Thomas G, 2007, NEPHROL DIAL TRANSPL, V22, P2849, DOI 10.1093/ndt/gfm401; Timmer JR, 2004, AM HEART J, V148, P399, DOI 10.1016/j.ahj.2004.04.007; Todd MM, 2005, NEW ENGL J MED, V352, P135, DOI 10.1056/NEJMoa040975; Van den Berghe G, 2005, NEUROLOGY, V64, P1348, DOI 10.1212/01.WNL.0000158442.08857.FC; Van den Berghe G, 2006, NEW ENGL J MED, V354, P449, DOI 10.1056/NEJMoa052521; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; Vespa P, 2006, CRIT CARE MED, V34, P850, DOI 10.1097/01.CCM.0000201875.12245.6F; Vespa PM, 2008, CRIT CARE, V12, DOI 10.1186/cc6986; Walia S, 2002, INJURY, V33, P339, DOI 10.1016/S0020-1383(02)00053-0; Wass CT, 1996, MAYO CLIN PROC, V71, P801; WIDOM B, 1990, ANN INTERN MED, V112, P904, DOI 10.7326/0003-4819-112-12-904; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Yamada K, 2007, CRIT CARE, V11, DOI 10.1186/cc5953; Yang M, 2009, INT J NURS STUD, V46, P753, DOI 10.1016/j.ijnurstu.2009.01.004; Zygun DA, 2004, NEUROSURGERY, V55, P877, DOI 10.1227/01.NEU.0000137658.14906.E4	52	18	18	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0148-396X			NEUROSURGERY	Neurosurgery	SEP	2012	71	3					692	702		10.1227/NEU.0b013e3182631eb4			11	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	996HB	WOS:000308074400038	22688953				2021-06-18	
J	Vidal, PG; Goodman, AM; Colin, A; Leddy, JJ; Grady, MF				Vidal, Paul G.; Goodman, Arlene M.; Colin, Amy; Leddy, John J.; Grady, Matthew F.			Rehabilitation Strategies for Prolonged Recovery in Pediatric and Adolescent Concussion	PEDIATRIC ANNALS			English	Article							SPORTS-RELATED CONCUSSION; CEREBRAL CONCUSSION; POSTURAL CONTROL; EXERCISE; HEADACHE		[Vidal, Paul G.] Specialized Phys Therapy LLC, Cherry Hill, NJ 08003 USA; [Goodman, Arlene M.] Childrens Hosp Philadelphia, Div Orthopaed Surg, Philadelphia, PA USA; [Goodman, Arlene M.] Childrens Hosp Philadelphia, Dept Pediat, Philadelphia, PA USA; [Colin, Amy] Childrens Hosp Philadelphia, Dept Speech Language Pathol, Philadelphia, PA USA; [Leddy, John J.] SUNY Buffalo, UB Orthopaed & Sports Med, Buffalo, NY 14260 USA; [Grady, Matthew F.] Childrens Hosp Philadelphia, Philadelphia, PA USA; [Grady, Matthew F.] Univ Penn, Div Pediat Orthoped & Sports Med, Dept Surg, Philadelphia, PA 19104 USA; [Grady, Matthew F.] Univ Penn, Div Pediat Orthoped & Sports Med, Dept Pediat, Philadelphia, PA 19104 USA	Vidal, PG (corresponding author), Specialized Phys Therapy LLC, 1919 Greentree Rd, Cherry Hill, NJ 08003 USA.	specializedpt@verizon.net					Cavanaugh JT, 2006, J ATHL TRAINING, V41, P305; Cavanaugh JT, 2005, BRIT J SPORT MED, V39, P805, DOI 10.1136/bjsm.2004.015909; Children's Hospital of Philadelphia, CONC CAR KIDS MINDS; Gagnon I, 2009, BRAIN INJURY, V23, P956, DOI 10.3109/02699050903373477; Galetta KM, 2011, J NEUROL SCI, V309, P34, DOI 10.1016/j.jns.2011.07.039; Gottshall Kim R, 2005, Int Tinnitus J, V11, P81; Griesbach GS, 2004, NEUROSCIENCE, V125, P129, DOI 10.1016/j.neuroscience.2004.01.030; Herdman S J, 2007, VESTIBULAR REHABILIT; Herdman SJ, 2003, ARCH OTOLARYNGOL, V129, P819, DOI 10.1001/archotol.129.8.819; Jull G, 2002, SPINE, V27, P1835, DOI 10.1097/00007632-200209010-00004; Leddy JJ, 2007, NEUROREHABILITATION, V22, P199; Leddy JJ, 2011, CLIN J SPORT MED, V21, P89, DOI 10.1097/JSM.0b013e3181fdc721; Leddy JJ, 2010, CLIN J SPORT MED, V20, P21, DOI 10.1097/JSM.0b013e3181c6c22c; Maugans TA, 2012, PEDIATRICS, V129, P28, DOI 10.1542/peds.2011-2083; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; Register-Mihalik JK, 2008, NEUROSURGERY, V63, P76, DOI 10.1227/01.NEU.0000335073.39728.CE; Scheiman M, 2002, OPTOMETRY VISION SCI, V79, P151, DOI 10.1097/00006324-200203000-00009; Working Group on Cognitive-Communication Disorders of ASHA's Special Interest Division I Language Learning and Education; and Division 2 Neurophysiology and Neurogenic Speech and Language Disorders, ROL SPEECH LANG PATH; Wrisley DM, 2000, J ORTHOP SPORT PHYS, V30, P755, DOI 10.2519/jospt.2000.30.12.755; Yeates KO, 2010, J INT NEUROPSYCH SOC, V16, P953, DOI 10.1017/S1355617710000986	20	18	18	0	17	SLACK INC	THOROFARE	6900 GROVE RD, THOROFARE, NJ 08086 USA	0090-4481	1938-2359		PEDIATR ANN	Pediatr. Annu.	SEP	2012	41	9					E186	E191		10.3928/00904481-20120827-10			6	Pediatrics	Pediatrics	082NM	WOS:000314398700003	22953976				2021-06-18	
J	Rapp, PE; Curley, KC				Rapp, Paul E.; Curley, Kenneth C.			Is a diagnosis of "mild traumatic brain injury" a category mistake?	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article; Proceedings Paper	Advanced Technology Applications for Combat Casualty Care Conference (ATACCC)	AUG 15-18, 2011	Fort Lauderdale, FL			Diagnosis; mild TBI; nosology	TEST-RETEST RELIABILITY; POSTTRAUMATIC-STRESS-DISORDER; POST-CONCUSSION SYMPTOMS; EYE-TARGET SYNCHRONIZATION; EVENT-RELATED POTENTIALS; COMPLAINT BASE RATES; HEAD-INJURY; QUANTITATIVE EEG; AMERICAN ACADEMY; POSTCONCUSSIONAL SYMPTOMS	BACKGROUND: Efforts to produce definitions and diagnostic standards for mild traumatic brain injury (TBI) have a long and complex history. The diagnosis of TBI must be considered in the larger context of neuropsychiatric diagnosis. A major reconceptualization of diagnosis is now underway in which the classical syndrome conceptualization is being discarded. We address the question, what are the implications of this revision of thinking in the specific context of TBI? METHODS: A recent literature on logical structures for neuropsychiatric disorders was reviewed. The symptom pattern of TBI was identified, and a literature survey determined the frequency of these symptom patterns in other disorders and in healthy control populations. RESULTS: The frequency of symptom endorsement in populations without a history of TBI can be equal to endorsement frequencies in populations with a history of mild TBI. In some studies, the frequency of symptom endorsement in healthy controls having no history of head injury actually exceeded the endorsement rates in a comparison group with a history mild TBI. CONCLUSION: The heterogeneity of this clinical population and their clinical presentations, the absence of a unitary etiology of postinjury deficits, and the complex idiosyncratic time course of the appearance of these deficits argue against the valid implementation of the classical model of diagnosis. In addition, the accepted criteria of diagnostic utility are not satisfied. TBI is not a disease; it is an event. More precisely, TBI is an event or a sequence of events that can, in some instances, lead to a diagnosable neurological or psychiatric disorder. (J Trauma Acute Care Surg. 2012;73:S13-S23. Copyright (c) 2012 by Lippincott Williams & Wilkins)	[Rapp, Paul E.] Uniformed Serv Univ Hlth Sci, Dept Mil & Emergency Med, Traumat Injury Res Program, Bethesda, MD 20814 USA; [Curley, Kenneth C.] USA, Med Res & Mat Command, Combat Casualty Care Directorate, Ft Detrick, MD USA	Rapp, PE (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Mil & Emergency Med, Traumat Injury Res Program, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	prapp@usuhs.mil					American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Anderson T, 2006, PRACT NEUROL, V6, P342, DOI DOI 10.1136/JNNP.2006.106583; Andrich D, 1988, RASCH MODELS MEASURE; Arciniegas David B, 2004, Phys Med Rehabil Clin N Am, V15, P177, DOI 10.1016/S1047-9651(03)00104-9; Arlinghaus KA, 2004, TXB TRAUMATIC BRAIN, P59; Bardel A, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-37; Barr WB, BRAIN INJ, V26, P58; Belanger HG, 2007, J NEUROPSYCH CLIN N, V19, P5, DOI 10.1176/appi.neuropsych.19.1.5; Bigler ED, 2010, NEUROLOGY, V74, P626, DOI 10.1212/WNL.0b013e3181d3e43a; Bleiberg J, 1997, NEUROPSY NEUROPSY BE, V10, P247; Boake C, 2005, J NEUROPSYCH CLIN N, V17, P350, DOI 10.1176/appi.neuropsych.17.3.350; Boake C, 2004, J NEUROPSYCH CLIN N, V16, P493, DOI 10.1176/appi.neuropsych.16.4.493; Broglio SP, 2009, J NEUROTRAUM, V26, P1463, DOI [10.1089/neu.2008.0766, 10.1089/neu.2008-0766]; Caeyenberghs K, 2010, NEUROPSYCHOLOGIA, V48, P1472, DOI 10.1016/j.neuropsychologia.2010.01.017; Cantu R, 2006, Foundations of Sport-Related Brain Injuries, P87, DOI 10.1007/0-387-32565-4_5; Catani C., 2003, THESIS U KONSTANZ KO; Chakraborty K, 2012, INT J SOC PSYCHIATR, V58, P87, DOI 10.1177/0020764010387065; Chan RCK, 2001, CLIN REHABIL, V15, P266, DOI 10.1191/026921501675253420; Contreras R, 2011, BRAIN RES, V1398, P55, DOI 10.1016/j.brainres.2011.05.004; Contreras R, 2008, J BIOL PHYS, V34, P381, DOI 10.1007/s10867-008-9092-1; De Beaumont L, 2007, BRAIN INJURY, V21, P631, DOI 10.1080/02699050701426931; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; Dean PJA, 2012, BRAIN INJURY, V26, P14, DOI 10.3109/02699052.2011.635354; Department of Veterans Affairs, 2007, VET HLTH ADM DIR VHA; Donnelly KT, 2011, J HEAD TRAUMA REHAB, V26, P439, DOI 10.1097/HTR.0b013e3182005de3; DUNN JT, 1995, J CLIN PSYCHOL, V51, P577, DOI 10.1002/1097-4679(199507)51:4<577::AID-JCLP2270510418>3.0.CO;2-E; Eyres S, 2005, CLIN REHABIL, V19, P878, DOI 10.1191/0269215505cr905oa; Fuerst DR, 2007, PSYCHOPHYSIOLOGY, V44, P620, DOI 10.1111/j.1469-8986.2007.00524.x; Gaetz M, 2001, J HEAD TRAUMA REHAB, V16, P386, DOI 10.1097/00001199-200108000-00008; GOUVIER WD, 1992, ARCH CLIN NEUROPSYCH, V7, P193, DOI 10.1016/0887-6177(92)90162-G; Greenwald BA, 2003, ARCH PHYS MED REHAB, V84, pS3, DOI 10.1053/apmr.2003.50052; Grouvier WD, 1988, ARCH CLIN NEUROPSYCH, V3, P273; HAGLUND Y, 1990, ACTA NEUROL SCAND, V82, P353; Halbauer JD, 2009, J REHABIL RES DEV, V46, P757, DOI 10.1682/JRRD.2008.08.0119; Harvey AG, 2003, J INT NEUROPSYCH SOC, V9, P663, DOI 10.1017/S1355617703940069; Hawley CA, 2004, J NEUROL NEUROSUR PS, V75, P737, DOI 10.1136/jnnp.2003.020651; Head H., 1926, APHASIA KINDRED DISO; Heitger MH, 2006, BRAIN INJURY, V20, P807, DOI 10.1080/02699050600676354; Heitger MH, 2009, BRAIN, V132, P2850, DOI 10.1093/brain/awp181; Heitger MH, 2004, BRAIN, V127, P575, DOI 10.1093/brain/awh066; Heitger MH, 2002, PROG BRAIN RES, V140, P433; Hetherington CR, 1996, BRAIN INJURY, V10, P473, DOI 10.1080/026990596124197; Hickling EJ, 1998, BRAIN INJURY, V12, P265, DOI 10.1080/026990598122566; Hoffman DA, 1999, J NEUROPSYCH CLIN N, V11, P401, DOI 10.1176/jnp.11.3.401; Hughlings-Jackson J., 1882, SELECTED WRITINGS J, V2, P29; Ingebrigtsen T, 1998, J NEUROL, V245, P609, DOI 10.1007/s004150050254; Iverson GL, 1997, BRAIN INJURY, V11, P783, DOI 10.1080/026990597122990; Kendell R, 2003, AM J PSYCHIAT, V160, P4, DOI 10.1176/appi.ajp.160.1.4; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kobeissy FH, 2008, PROTEOM CLIN APPL, V2, P10; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Kupfer DJ, 2002, RESEARCH AGENDA FOR DSM-V, pXV; LEESHALEY PR, 1993, ARCH CLIN NEUROPSYCH, V8, P203, DOI 10.1016/0887-6177(93)90036-Z; Lew HL, 2006, J HEAD TRAUMA REHAB, V21, P430, DOI 10.1097/00001199-200609000-00050; Lew HL, 2006, J HEAD TRAUMA REHAB, V21, P350, DOI 10.1097/00001199-200607000-00006; Lew HL, 2005, J REHABIL RES DEV, V42, P29, DOI 10.1682/JRRD.2004.05.0056; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; McCrea M, 2008, MILD TRAUMATIC BRAIN; McCrea M, 2010, J HEAD TRAUMA REHAB, V25, P283, DOI 10.1097/HTR.0b013e3181e67923; McMillan TM, 1996, BRAIN INJURY, V10, P749, DOI 10.1080/026990596124016; Mondello S, 2011, EXPERT REV MOL DIAGN, V11, P65, DOI 10.1586/ERM.10.104; Mullins-Sweatt SN, 2009, PSYCHOL ASSESSMENT, V21, P302, DOI 10.1037/a0016607; Naunheim RS, 2011, AM J EMERG MED, V29, P845, DOI 10.1016/j.ajem.2010.03.010; Naunheim RS, 2010, BRAIN INJURY, V24, P1324, DOI 10.3109/02699052.2010.506862; Naunheim RS, 2010, AM J EMERG MED, V28, p386e1; Nuwer M, 1997, NEUROLOGY, V49, P277, DOI 10.1212/WNL.49.1.277; Nuwer MR, 2005, CLIN NEUROPHYSIOL, V116, P2001, DOI 10.1016/j.clinph.2005.05.008; ODDY M, 1978, J NEUROL NEUROSUR PS, V41, P611, DOI 10.1136/jnnp.41.7.611; Papa Linda, 2008, Expert Opin Med Diagn, V2, P937, DOI 10.1517/17530059.2.8.937; PERSONS JB, 1986, AM PSYCHOL, V41, P1252, DOI 10.1037/0003-066X.41.11.1252; Potter S, 2006, J NEUROL, V253, P1603, DOI 10.1007/s00415-006-0275-z; RADANOV BP, 1992, SPINE, V17, P127, DOI 10.1097/00007632-199202000-00001; Rao V, 2000, PSYCHOSOMATICS, V41, P95, DOI 10.1176/appi.psy.41.2.95; Rapp PE, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-119; Rentzsch J, 2008, INT J PSYCHOPHYSIOL, V67, P81, DOI 10.1016/j.ijpsycho.2007.10.006; Rizzo PA, 1983, NEUROPSYCHOBIOLOGY, V9, P72; Rosenblum MG, 1996, PHYS REV LETT, V76, P1804, DOI 10.1103/PhysRevLett.76.1804; Rosenblum MG, 1997, PHYS REV LETT, V78, P4193, DOI 10.1103/PhysRevLett.78.4193; Ruff Robert L, 2010, F1000 Med Rep, V2, P64, DOI 10.3410/M2-64; Ryle T, 1949, CONCEPT MIND; Sawchyn JM, 2000, ARCH CLIN NEUROPSYCH, V15, P1, DOI 10.1016/S0887-6177(98)00041-9; SBORDONE RJ, 1995, BRAIN INJURY, V9, P405, DOI 10.3109/02699059509005780; Sbordone RJ, 2010, PSYCHOL INJ LAW, V3, P63, DOI 10.1007/s12207-010-9066-z; SCHOENHUBER R, 1986, NEUROSURGERY, V19, P532, DOI 10.1227/00006123-198610000-00006; SINHA R, 1992, BIOL PSYCHIAT, V32, P992; Smith DH, 2006, PSYCHOSOMATICS, V47, P271, DOI 10.1176/appi.psy.47.3.271; Smith GT, 2009, PSYCHOL ASSESSMENT, V21, P272, DOI 10.1037/a0016699; Smith GT, 2009, PSYCHOL ASSESSMENT, V21, P241, DOI 10.1037/a0016919; Solbakk AK, 2005, J CLIN EXP NEUROPSYC, V27, P205, DOI 10.1080/13803390490515739; Sterr A, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-7; STUSS DT, 1989, J NEUROL NEUROSUR PS, V52, P742, DOI 10.1136/jnnp.52.6.742; Suh M, 2006, NEUROSCI LETT, V401, P108, DOI 10.1016/j.neulet.2006.02.074; Sumpter RE, 2006, BRAIN INJURY, V20, P93, DOI 10.1080/02699050500394090; Sumpter RE, 2005, BRIT J PSYCHIAT, V186, P423, DOI 10.1192/bjp.186.5.423; Thatcher R. W., 1989, ELECTROENCEPHALOGR C, V73, DOI [10.1016/0013-4694(89)90188-0, DOI 10.1016/0013-4694(89)90188-0, https://doi.org/10.1016/0013-4694(89)90188-0]; Thatcher RW, 2003, CLIN ELECTROENCEPHAL, V34, P39, DOI 10.1177/155005940303400203; Thatcher RW, 2001, J NEUROPSYCH CLIN N, V13, P77, DOI 10.1176/appi.neuropsych.13.1.77; Thatcher RW, 1999, CLIN ELECTROENCEPHAL, V30, P94, DOI 10.1177/155005949903000304; Trahan DE, 2001, ARCH CLIN NEUROPSYCH, V16, P435, DOI 10.1016/S0887-6177(00)00051-2; TUKEY JW, 1979, J AM STAT ASSOC, V74, P786, DOI 10.2307/2286400; US Government Accountability Office, 2008, VA HLTH CAR MILD TRA; Van Dyke SA, 2010, MIL MED, V175, P947, DOI 10.7205/MILMED-D-10-00337; Viera AJ, 2005, FAM MED, V37, P360; Vila M, 2009, J PEDIATR PSYCHOL, V34, P989, DOI 10.1093/jpepsy/jsp005; Wagner AK, 2011, J NEUROTRAUM, V28, P871, DOI 10.1089/neu.2010.1586; Walhovd KB, 2002, INT J PSYCHOPHYSIOL, V46, P29, DOI 10.1016/S0167-8760(02)00039-9; Wallace BE, 2001, J HEAD TRAUMA REHAB, V16, P165, DOI 10.1097/00001199-200104000-00006; Weinberg A, 2011, PSYCHOPHYSIOLOGY, V48, P1420, DOI 10.1111/j.1469-8986.2011.01206.x; WERNER RA, 1991, ARCH PHYS MED REHAB, V72, P31; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; WONG JL, 1994, ARCH CLIN NEUROPSYCH, V9, P411, DOI 10.1016/0887-6177(94)90004-3; World Health Organization, 1992, ICD 10 INT STAT CLAS; Wylie SA, 2009, NEUROPSYCHOLOGIA, V47, P1844, DOI 10.1016/j.neuropsychologia.2009.02.025; Wylie SA, 2009, NEUROPSYCHOLOGIA, V47, P145, DOI 10.1016/j.neuropsychologia.2008.08.001; Zhou WD, 2008, J NEUROTRAUM, V25, P279, DOI 10.1089/neu.2007.0489; Zolog TC, 2011, J COGN BEHAV PSYCHOT, V11, P191	119	18	18	0	21	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	AUG	2012	73			1			S13	S23		10.1097/TA.0b013e318260604b			11	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	992VP	WOS:000307808500004	22847083	Green Published			2021-06-18	
J	Walter, KH; Barnes, SM; Chard, KM				Walter, Kristen H.; Barnes, Sean M.; Chard, Kathleen M.			The influence of comorbid MDD on outcome after residential treatment for veterans with PTSD and a history of TBI	JOURNAL OF TRAUMATIC STRESS			English	Article							POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN-INJURY; DIAGNOSIS; SYMPTOMS; IRAQ; ASSOCIATIONS; AFGHANISTAN; DEPLOYMENT; VICTIMS	Among military personnel, posttraumatic stress disorder (PTSD), major depressive disorder (MDD), and a history of traumatic brain injury (TBI) are frequently reported, highlighting the need for treatment outcome research with this population. This study examined the influence of the presence or absence of comorbid MDD on the outcome of a residential treatment program at the midpoint and end of the program for 47 male veterans with PTSD and a history of TBI. Results demonstrated significant decreases of self-reported symptoms on the PTSD Checklist-Stressor Specific Version (PCL-S; MDD, d = 1.19; No MDD, d = 1.17) and the Beck Depression InventoryII (BDI-II; MDD, d = 0.98; No MDD, d = 1.09) following treatment for both groups. There were no differences in the rate of symptom reduction between groups. Individuals who also met criteria for MDD at pretreatment, however, evidenced higher scores on symptom measures at all assessment time points (ds = 0.601.25).	[Walter, Kristen H.; Barnes, Sean M.; Chard, Kathleen M.] Cincinnati VA Med Ctr, PTSD & Anxiety Disorders Clin, Cincinnati, OH 45220 USA; [Chard, Kathleen M.] Univ Cincinnati, Sch Med, Dept Psychiat, Cincinnati, OH USA; [Barnes, Sean M.] VA Eastern Colorado Hlth Care Syst, VISN Mental Illness Res Educ & Clin Ctr 19, Denver, CO USA	Chard, KM (corresponding author), Cincinnati VA Med Ctr, PTSD & Anxiety Disorders Clin, 3200 Vine St, Cincinnati, OH 45220 USA.	Kathleen.Chard@va.gov	Walter, Kristen H/S-1827-2019				American Psychiatric Association, 2000, DIAGN STAT MAN MENT, DOI [10.1176/appi.books.9780890423349, DOI 10.1176/APPI.BOOKS.9780890423349]; Beck A.T., 1996, MANUAL BECK DEPRESSI; Blake D. D., 1990, CLIN ADM PTSD SCALE, VIV; BLANCHARD EB, 1995, BEHAV RES THER, V33, P471, DOI 10.1016/0005-7967(94)00064-Q; Brenner LA, 2009, REHABIL PSYCHOL, V54, P239, DOI 10.1037/a0016908; Campbell I, 2007, STAT MED, V26, P3661, DOI 10.1002/sim.2832; Carlson KF, 2010, J TRAUMA STRESS, V23, P17, DOI 10.1002/jts.20483; Chard KM, 2011, J TRAUMA STRESS, V24, P347, DOI 10.1002/jts.20644; Chard KM, 2008, COGNITIVE PROCESSING; Ehlers A, 2000, BEHAV RES THER, V38, P319, DOI 10.1016/S0005-7967(99)00123-0; Ehlers A, 1995, Behav Cogn Psychother, V23, P217, DOI 10.1017/S135246580001585X; First M.B., 1996, STRUCTURED CLIN INTE; FOA EB, 1989, BEHAV THER, V20, P155, DOI 10.1016/S0005-7894(89)80067-X; Foa EB, 2007, PROLONGED EXPOSURE T; Henning KR, 1997, J CLIN PSYCHOL, V53, P801, DOI 10.1002/(SICI)1097-4679(199712)53:8<801::AID-JCLP3>3.3.CO;2-V; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hudak AM, 2012, J HEAD TRAUMA REHAB, V27, P87, DOI 10.1097/HTR.0b013e3182114efd; Karlin BE, 2010, J TRAUMA STRESS, V23, P663, DOI 10.1002/jts.20588; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Linehan MM., 1993, COGNITIVE BEHAV TREA; Lobbestael J, 2011, CLIN PSYCHOL PSYCHOT, V18, P75, DOI 10.1002/cpp.693; Lowe B, 2004, J AFFECT DISORDERS, V78, P131, DOI 10.1016/S0165-0327(02)00237-9; MERTON RK, 1968, SCIENCE, V159, P56, DOI 10.1126/science.159.3810.56; Nixon RDV, 2011, J TRAUMA STRESS, V24, P451, DOI 10.1002/jts.20654; Resick P. A, 2007, COGNITIVE PROCESSING; Resick PA, 2002, J CONSULT CLIN PSYCH, V70, P867, DOI 10.1037//0022-006X.70.4.867; Rizvi SL, 2009, BEHAV RES THER, V47, P737, DOI 10.1016/j.brat.2009.06.003; Schell T.L., 2008, INVISIBLE WOUNDS WAR, DOI [10.7249/mg720-1ccf.12, DOI 10.7249/MG720-1CCF.12]; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; Shear MK, 2000, AM J PSYCHIAT, V157, P581, DOI 10.1176/appi.ajp.157.4.581; Tanielian T, 2008, INVISIBLE WOUNDS WAR; Twamley E. W., 2008, COGNITIVE SYMP UNPUB; United States Department of Veterans Affairs & Department of Defense, 2009, VA DOD CLIN PRACT GU; Vanderploeg RD, 2009, ARCH PHYS MED REHAB, V90, P1084, DOI 10.1016/j.apmr.2009.01.023; Weathers F., 1991, PTSD CHECKLIST MILIT; Weathers F. W., 1993, 9 ANN M INT SOC TRAU; Williams AD, 2007, BEHAV RES THER, V45, P1141, DOI 10.1016/j.brat.2006.09.005	37	18	18	0	5	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0894-9867			J TRAUMA STRESS	J. Trauma Stress	AUG	2012	25	4					426	432		10.1002/jts.21722			7	Psychology, Clinical; Psychiatry	Psychology; Psychiatry	983HI	WOS:000307110000009	22821663				2021-06-18	
J	McNamee, S; Howe, L; Nakase-Richardson, R; Peterson, M				McNamee, Shane; Howe, Laura; Nakase-Richardson, Risa; Peterson, Michelle			Treatment of Disorders of Consciousness in the Veterans Health Administration Polytrauma Centers	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						brain injury; disorders of consciousness; rehabilitation	TRAUMATIC BRAIN-INJURY; VEGETATIVE STATE; SENSORY STIMULATION; AMANTADINE; METHYLPHENIDATE; MANAGEMENT; AWAKENINGS; CHILDREN; RECOVERY; FAMILY	This article describes the evolution of the emerging consciousness programs and the approach to care for veterans and active duty service members with disorders of consciousness (DOC) at the 4 polytrauma rehabilitation centers of the Veterans Health Administration. Compared to traditional rehabilitation patients, DOC patients have unique recovery patterns and rehabilitative needs, and they require an intensive medical and nursing support structure. This requires closely integrated rehabilitation and acute medical care to ensure the highest level of outcomes. Unfortunately, little information exists in the literature to establish best practices for the rehabilitation of this population. It is the authors' intentions to bridge the literature gap in regard to programmatic structure, treatment approaches for those with DOC, and support of their caregivers. This article includes descriptions of medical care protocols, review of stimulation approaches (environmental and pharmacologic) caregiver support, and monitoring of recovery patterns.	[McNamee, Shane] Hunter Holmes McGuire VA Hosp, Phys Med & Rehabil Serv, Richmond, VA USA; [McNamee, Shane] Virginia Commonwealth Univ, Dept PM&R, Richmond, VA 23284 USA; [Howe, Laura] VA Palo Alto Hlth Care Syst, Psychol Serv, Palo Alto, CA USA; [Nakase-Richardson, Risa] James A Haley Vet Hosp, Mental Hlth & Behav Sci Serv, Phys Med & Rehabil Serv, Tampa, FL 33612 USA; [Nakase-Richardson, Risa] Ctr Excellence Maximizing Rehabil Outcomes, Tampa, FL USA; [Peterson, Michelle] Minneapolis VA Hlth Care Syst, Phys Med & Rehabil Serv, Minneapolis, VA USA	McNamee, S (corresponding author), Hunter Holmes McGuire Med Ctr, Dept Vet Affairs, 1201 Broad Rock Blvd, Richmond, VA 23249 USA.	Shane.McNamee@va.gov					Abbasi M, 2011, J MAGN RESON IMAGING, V34, P429; Andrews K, 1996, BRAIN INJURY, V10, P797, DOI 10.1080/026990596123918; [Anonymous], FAM CAR MAP POL SYST; [Anonymous], 2008, EM CONSC PROGR VHA P; ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; Ashwal S, 2003, BRAIN DEV-JPN, V25, P535, DOI 10.1016/S0387-7604(03)00095-0; Berube J, 2006, MOHONK REPORT REPORT; Blatow M, 2011, J MAGN RESON IMAGING, V34, P429, DOI 10.1002/jmri.22629; Boss P., 2006, LOSS TRAUMA RESILIEN; Challman TD, 2000, MAYO CLIN PROC, V75, P711; Chew E, 2009, J REHABIL RES DEV, V46, P851, DOI 10.1682/JRRD.2008.09.0120; CHILDS NL, 1993, NEUROLOGY, V43, P1465, DOI 10.1212/WNL.43.8.1465; Cotman CW, 1978, NEURONAL PLASTICITY; DeMarchi R, 2005, CAN J NEUROL SCI, V32, P4, DOI 10.1017/S0317167100016826; Duff Diane, 2006, Axone, V27, P9; Eickhoff SB, 2008, EXP NEUROL, V214, P240, DOI 10.1016/j.expneurol.2008.08.007; Ferraro L, 1999, NEUROPSYCHOPHARMACOL, V20, P346, DOI 10.1016/S0893-133X(98)00085-2; Georgiopoulos M, 2010, STEREOT FUNCT NEUROS, V88, P199, DOI 10.1159/000314354; Giacino JT, 2012, NEW ENGL J MED, V366, P819, DOI 10.1056/NEJMoa1102609; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; GIACINO JT, 1995, ARCH PHYS MED REHAB, V76, P205; Giacino JT, 1996, NEUROREHABILITATION, V6, P69, DOI 10.3233/NRE-1996-6108; Giacino JT, 2005, REHABILITATION TRAUM, P305; HAIG AJ, 1990, ARCH PHYS MED REHAB, V71, P1081; Haler EM, 2010, PHYS MED REHABILITAT, P1249; Han L, 2001, ARCH INTERN MED, V161, P1099, DOI 10.1001/archinte.161.8.1099; JACKSON RD, 1989, AM J PHYS MED REHAB, V68, P18, DOI 10.1097/00002060-198902000-00006; Krimchansky BZ, 2004, BRAIN INJURY, V18, P1099, DOI 10.1080/02699050310001646206; Magnuson B, 2011, NUTR CLIN PRACT, V26, P253, DOI 10.1177/0884533611405673; Marks Jean P, 2006, J Neurosci Nurs, V38, P84; Martin RT, 2007, AM J PHYS MED REHAB, V86, P613, DOI 10.1097/PHM.0b013e3181154a84; Matsuda W, 2005, NEUROPSYCHOL REHABIL, V15, P414, DOI 10.1080/09602010443000588; Matsuda W, 2003, J NEUROL NEUROSUR PS, V74, P1571, DOI 10.1136/jnnp.74.11.1571; McMahon MA, 2009, AM J PHYS MED REHAB, V88, P525, DOI 10.1097/PHM.0b013e3181a5ade3; Nakase-Richardson R, 2010, AM C REH MED ANN C M; NICKELS JL, 1994, BRAIN INJURY, V8, P709, DOI 10.3109/02699059409151025; Oliveira L, 2011, BRAIN INJURY, V25, P315, DOI 10.3109/02699052.2011.556103; Pangilinan PH, 2010, PM&R, V2, P1127, DOI 10.1016/j.pmrj.2010.07.007; Passler MA, 2001, ARCH PHYS MED REHAB, V82, P311, DOI 10.1053/apmr.2001.20831; Perlesz A, 1999, REHABIL PSYCHOL, V44, P6, DOI 10.1037/0090-5550.44.1.6; Pistoia F, 2010, CNS DRUGS, V24, P625, DOI 10.2165/11535940-000000000-00000; Polytrauma Emerging Consciousness Program Scope of Services, 2007, EM CONSC PROGR VHA P; Polytrauma/TBI System of Care, FAM CAR SUPP TRAIN E; RAISMAN G, 1969, BRAIN RES, V14, P25, DOI 10.1016/0006-8993(69)90029-8; Sayer NA, 2009, PM&R, V1, P23, DOI 10.1016/j.pmrj.2008.10.003; Schiff ND, 2005, NEUROLOGY, V64, P514, DOI 10.1212/01.WNL.0000150883.10285.44; Schiff ND, 2002, BRAIN, V125, P1210, DOI 10.1093/brain/awf131; Schnakers C, 2008, J NEUROL NEUROSUR PS, V79, DOI 10.1136/jnnp.2007.124099; Seel RT, 2010, ARCH PHYS MED REHAB, V91, P1795, DOI 10.1016/j.apmr.2010.07.218; SERIO CD, 1995, J HEAD TRAUMA REHAB, V10, P32, DOI 10.1097/00001199-199504000-00005; Spellman NT, 2000, TXB MILITARY MED, V2, P741; STEWARD O, 1989, Journal of Neurotrauma, V6, P99, DOI 10.1089/neu.1989.6.99; Strauss DJ, 2000, PEDIATR NEUROL, V23, P312, DOI 10.1016/S0887-8994(00)00194-6; Thaxton L, 2002, J HEAD TRAUMA REHAB, V17, P335, DOI 10.1097/00001199-200208000-00007; TRESCH DD, 1991, ARCH INTERN MED, V151, P930, DOI 10.1001/archinte.151.5.930; VALACH J, 1950, Slov Lek, V12, P380; Walker WC, 1999, BRAIN INJURY, V10, P65; Wood R L, 1992, Brain Inj, V6, P411, DOI 10.3109/02699059209008137; WOOD R L, 1991, Brain Injury, V5, P401, DOI 10.3109/02699059109008113; Worzniak M, 1997, J FAM PRACTICE, V44, P495; Zafonte RD, 1998, BRAIN INJURY, V12, P617; Zhu JH, 2009, J NEUROTRAUM, V26, P677, DOI 10.1089/neu.2008.0691	62	18	18	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUL-AUG	2012	27	4					244	252		10.1097/HTR.0b013e31825e12c8			9	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	975PJ	WOS:000306523000002	22767072				2021-06-18	
J	Roussel, M; Dujardin, K; Henon, H; Godefroy, O				Roussel, Martine; Dujardin, Kathy; Henon, Hilde; Godefroy, Olivier			Is the frontal dysexecutive syndrome due to a working memory deficit? Evidence from patients with stroke	BRAIN			English	Article						brain injury; ischaemic stroke; frontal lobe; executive functions; working memory	DUAL-TASK PERFORMANCE; TRAUMATIC BRAIN-INJURY; COGNITIVE IMPAIRMENT; EXECUTIVE FUNCTIONS; ALZHEIMERS-DISEASE; REHEARSAL; DEMENTIA; SYSTEM; INTERFERENCE; COMPONENT	Although frontal dysexecutive disorders are frequently considered to be due to working memory deficit, this has not been systematically examined and very little evidence is available for impairment of working memory in frontal damage. The objective of this study was to examine the components of working memory, their anatomy and the relations with executive functions in patients with stroke involving the frontal or posterior cortex. The study population consisted of 29 patients (frontal: n = 17; posterior: n = 12) and 29 matched controls. Phonological loop (letter and word spans, phonological store; rehearsal process), visuospatial sketchpad (visuospatial span) and the central executive (working memory span, dual task and updating process) were examined. The group comparison analysis showed impairment in the frontal group of: (i) verbal spans (P < 0.03); (ii) with a deficit of the rehearsal process (P = 0.006); (iii) visuospatial span (P = 0.04); (iv) working memory span (P = 0.001) that disappeared after controlling for verbal span and (v) running memory (P = 0.05) unrelated to updating conditions. The clinical anatomical correlation study showed that impairment of the central executive depended on frontal and posterior lesion. Cognitive dysexecutive disorders were observed in 11/20 patients with central executive deficit and an inverse dissociation was observed in two patients. Receiver operating characteristic curve analysis indicated that cognitive dysexecutive disorders had the highest ability to discriminate frontal lesions (area under curve = 0.844, 95% confidence interval: 0.74-0.95; P = 0.0001; central executive impairment: area under curve = 0.732, 95% confidence interval: 0.57-0.82; P = 0.006). This study reveals that frontal lesions induce mild impairment of short-term memory associated with a deficit of the rehearsal process supporting the role of the frontal lobe in this process; the central executive depends on lesions in the frontal lobe and posterior regions accounting for its low frequency and the negative results of group studies. Finally, the frontal dysexecutive syndrome cannot be attributed to central executive impairment, although it may contribute to some dysexecutive disorders.	[Roussel, Martine; Godefroy, Olivier] Univ Hosp Amiens, Lab Funct Neurosci EA4559, Dept Neurol, F-80054 Amiens, France; [Dujardin, Kathy; Henon, Hilde] Univ Hosp Lille, Dept Neurol, F-59037 Lille, France	Roussel, M (corresponding author), Hop Nord Amiens, Serv Neurol, F-80054 Amiens, France.	roussel.martine@chu-amiens.fr	DUJARDIN, Kathy/H-5037-2011	DUJARDIN, Kathy/0000-0002-0110-574X; Godefroy, Olivier/0000-0001-6789-6620			Anastasi A., 1988, PSYCHOL TESTING; Andres P, 2002, NEUROPSYCHOLOGIA, V40, P835, DOI 10.1016/S0028-3932(01)00182-8; Awh E, 1996, PSYCHOL SCI, V7, P25, DOI 10.1111/j.1467-9280.1996.tb00662.x; Azouvi P, 2009, PROG BRAIN RES, V177, P89, DOI 10.1016/S0079-6123(09)17708-7; Baddeley A, 1996, Q J EXP PSYCHOL-A, V49, P5; BADDELEY A, 1986, Q J EXP PSYCHOL-A, V38, P603, DOI 10.1080/14640748608401616; BADDELEY A, 1988, BRAIN COGNITION, V7, P212, DOI 10.1016/0278-2626(88)90031-0; Baddeley A, 1997, NEUROPSYCHOLOGY, V11, P187, DOI 10.1037/0894-4105.11.2.187; Baddeley A, 2000, TRENDS COGN SCI, V4, P417, DOI 10.1016/S1364-6613(00)01538-2; Baddeley A. D., 1986, WORKING MEMORY; BADDELEY AD, 1991, BRAIN, V114, P2521, DOI 10.1093/brain/114.6.2521; Baddeley A, 2010, CURR BIOL, V20, pR136, DOI 10.1016/j.cub.2009.12.014; Barbey AK, 2011, CEREB CORTEX, V21, P789, DOI 10.1093/cercor/bhq153; Bates E, 2003, NAT NEUROSCI, V6, P448, DOI 10.1038/nn1050; Beato R, 2008, ARQ NEURO-PSIQUIAT, V66, P147, DOI 10.1590/S0004-282X2008000200001; Beauregard J, 1971, TEST AUTOMATISMES VE; Belleville S, 1996, NEUROPSYCHOLOGIA, V34, P195, DOI 10.1016/0028-3932(95)00097-6; BELLEVILLE S, 1992, BRAIN LANG, V43, P713, DOI 10.1016/0093-934X(92)90092-S; Collette F, 1999, NEUROPSYCHOLOGIA, V37, P905, DOI 10.1016/S0028-3932(98)00148-1; Collette F, 2002, NEUROSCI BIOBEHAV R, V26, P105, DOI 10.1016/S0149-7634(01)00063-X; Cowey CM, 1996, MEMORY, V4, P19, DOI 10.1080/741940668; D'Esposito M, 2006, J INT NEUROPSYCH SOC, V12, P248, DOI 10.1017/S1355617706060322; D'Esposito M, 2000, EXP BRAIN RES, V133, P3, DOI 10.1007/s002210000395; D'Esposito M, 1999, NEUROPSYCHOLOGIA, V37, P1303, DOI 10.1016/S0028-3932(99)00021-4; D'Esposito M, 2007, PHILOS T R SOC B, V362, P761, DOI 10.1098/rstb.2007.2086; De Renzi E, 1975, Cortex, V11, P341; DESPOSITO M, 1995, NATURE, V378, P279, DOI 10.1038/378279a0; ESLINGER PJ, 1985, NEUROLOGY, V35, P1731, DOI 10.1212/WNL.35.12.1731; FAZEKAS F, 1987, AM J ROENTGENOL, V149, P351, DOI 10.2214/ajr.149.2.351; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Godefroy O, 1996, BRAIN, V119, P191, DOI 10.1093/brain/119.1.191; Godefroy O, 1999, CORTEX, V35, P1, DOI 10.1016/S0010-9452(08)70782-2; Godefroy O, 2002, NEUROPSYCHOLOGIA, V40, P2234, DOI 10.1016/S0028-3932(02)00109-4; Godefroy O, 1998, BRAIN, V121, P1545, DOI 10.1093/brain/121.8.1545; Godefroy O, 2010, ANN NEUROL, V68, P855, DOI 10.1002/ana.22117; Goldman-Rakic P. S., 1987, NERVOUS SYSTEM, P373, DOI DOI 10.1002/CPHY.CP010509; Hillary FG, 2011, BRAIN, V134, P1555, DOI 10.1093/brain/awr043; Huntley JD, 2010, INT J GERIATR PSYCH, V25, P121, DOI 10.1002/gps.2314; Leclercq M, 2000, J CLIN EXP NEUROPSYC, V22, P339, DOI 10.1076/1380-3395(200006)22:3;1-V;FT339; LEZAK MD, 1982, INT J PSYCHOL, V17, P281, DOI 10.1080/00207598208247445; Luria A. R., 1966, HIGHER CORTICAL FUNC; McDowell S, 1997, NEUROPSYCHOLOGIA, V35, P1341, DOI 10.1016/S0028-3932(97)00082-1; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Miyake A., 1999, MODELS WORKING MEMOR, P442, DOI [DOI 10.1017/CBO9781139174909.016, 10.1017/CBO9781139174909.016]; MORRIS N, 1990, BRIT J PSYCHOL, V81, P111, DOI 10.1111/j.2044-8295.1990.tb02349.x; MORRIS RG, 1988, J NEUROL NEUROSUR PS, V51, P757, DOI 10.1136/jnnp.51.6.757; Muller NG, 2006, NEUROSCIENCE, V139, P51, DOI 10.1016/j.neuroscience.2005.09.018; NELSON HE, 1976, CORTEX, V12, P313, DOI 10.1016/S0010-9452(76)80035-4; NORMAN DA, 1986, CONSCIOUSNESS SELF R, P1, DOI DOI 10.1007/978-1-4757-0629-1_1; OWEN AM, 1990, NEUROPSYCHOLOGIA, V28, P1021, DOI 10.1016/0028-3932(90)90137-D; PAULESU E, 1993, NATURE, V362, P342, DOI 10.1038/362342a0; Pillon B., 2001, HDB NEUROPSYCHOLOGY, Vsecond, P311; POLLACK I, 1959, J EXP PSYCHOL, V57, P137, DOI 10.1037/h0046137; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Raven J. C., 1965, GUIDE USING COLOURED; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Sachdev PS, 2004, NEUROLOGY, V62, P912, DOI 10.1212/01.WNL.0000115108.65264.4B; SHALLICE T, 1982, PHILOS T ROY SOC B, V298, P199, DOI 10.1098/rstb.1982.0082; Shallice T., 1990, NEUROPSYCHOLOGICAL I, P11, DOI [10.1017/CBO9780511665547.003, DOI 10.1017/CBO9780511665547.003]; Signoret JL, 1991, BATTERIE EVALUATION; Stablum F, 2000, PSYCHOL RES-PSYCH FO, V63, P265, DOI 10.1007/s004269900002; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; TATEMICHI TK, 1994, J NEUROL NEUROSUR PS, V57, P202, DOI 10.1136/jnnp.57.2.202; Vallar G, 1997, NEUROPSYCHOLOGIA, V35, P795, DOI 10.1016/S0028-3932(96)00127-3; Vilkki J, 1996, NEUROPSYCHOLOGIA, V34, P1051, DOI 10.1016/0028-3932(96)00028-0; Vilkki JA, 2002, NEUROPSYCHOLOGIA, V40, P340, DOI 10.1016/S0028-3932(01)00090-2; WARRINGTON EK, 1969, BRAIN, V92, P885, DOI 10.1093/brain/92.4.885; Waters GS, 1996, Q J EXP PSYCHOL-A, V49, P51, DOI 10.1080/027249896392801; WATERS GS, 1992, J MEM LANG, V31, P54, DOI 10.1016/0749-596X(92)90005-I; Wechsler D, 1989, WAISR ECHELLE INTELL	70	18	18	1	18	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0006-8950	1460-2156		BRAIN	Brain	JUL	2012	135		7				2192	2201		10.1093/brain/aws132			10	Clinical Neurology; Neurosciences	Neurosciences & Neurology	966GQ	WOS:000305826300018	22637543	Bronze			2021-06-18	
J	Arango-Lasprilla, JC; Ketchum, JM; Drew, A; Hammond, F; Powell, JM; Kreutzer, J; Lim, PC; Carr, C				Arango-Lasprilla, Juan Carlos; Ketchum, Jessica M.; Drew, Allison; Hammond, Flora; Powell, Janet M.; Kreutzer, Jeffrey; Lim, P. Chuwn; Carr, Caroline			Neurobehavioural symptoms 1 year after traumatic brain injury: A preliminary study of the relationship between race/ethnicity and symptoms	BRAIN INJURY			English	Article						Brain injuries; minority health; depression; memory; attention; communication; neurobehavioural manifestations	NEUROPSYCHOLOGICAL TEST-PERFORMANCE; RACIAL/ETHNIC DIFFERENCES; FUNCTIONING INVENTORY; MINORITY STATUS; DEPRESSION; OUTCOMES; REHABILITATION; DISPARITIES; ADULTS; RATES	Objective: To investigate whether White, African American and Hispanic individuals with a traumatic brain injury (TBI) express differences in neurobehavioural symptoms at 1 year post-injury after adjusting for demographic and injury characteristics. Design: Retrospective study. Participants: One thousand, three hundred and thirty-nine individuals from the TBI Model Systems National Database with primarily moderate-to-severe TBI (978 White, 288 African American and 73 Hispanic) hospitalized between 1996 and 2001. Main outcome measures: Neurobehavioural Functioning Inventory (NFI) at 1 year post-injury. Results: There were significant differences in NFI scores among the races/ethnicities for the depression, somatic, memory/attention, communication and motor subscales, after adjusting for demographic and injury characteristics; there were not significant differences in the aggression sub-scale. Hispanics had higher levels of symptom reporting than African Americans and Whites, while differences between African Americans and Whites were not significant. Conclusions: Hispanics scored significantly higher than Whites and African Americans on the sub-scales of the NFI, indicating more problems in these areas. Future research should focus on identifying factors that may contribute to the difference between the groups and treatment interventions should be implemented accordingly.	[Arango-Lasprilla, Juan Carlos; Drew, Allison; Kreutzer, Jeffrey] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Richmond, VA 23298 USA; [Ketchum, Jessica M.; Carr, Caroline] Virginia Commonwealth Univ, Dept Biostat, Richmond, VA 23298 USA; [Ketchum, Jessica M.; Carr, Caroline] Virginia Commonwealth Univ, Ctr Rehabil Sci & Engn, Richmond, VA 23298 USA; [Hammond, Flora] Indiana Univ Sch Med, Indianapolis, IN USA; [Hammond, Flora] Carolinas Rehabil, Charlotte, NC USA; [Powell, Janet M.] Univ Washington, Dept Rehabil Med, Div Occupat Therapy, Seattle, WA 98195 USA	Arango-Lasprilla, JC (corresponding author), Virginia Commonwealth Univ, VCU W Hosp, Dept Phys Med & Rehabil, 3rd Floor,Room 3-102,1200 E Broad St, Richmond, VA 23298 USA.	jcarangolasp@vcu.edu	Ketchum, Jessica/AAE-8200-2020	Ketchum, Jessica/0000-0002-5566-3691	National Institute on Disability and Rehabilitation Research, United States Department of EducationUS Department of Education [H133A070036, H133A21943-16, H133A070032]	This research was supported by grants H133A070036, H133A21943-16 and H133A070032 from the National Institute on Disability and Rehabilitation Research, United States Department of Education.	Aguilar-Gaxiola SA, 2008, ISSUES CHILD FAM LIV, P3, DOI 10.1007/978-0-387-78512-7_1; Arango-Lasprilla JC, 2007, BRAIN INJURY, V21, P701, DOI 10.1080/02699050701481597; Arango-Lasprilla JC, 2007, ARCH PHYS MED REHAB, V88, P11, DOI 10.1016/j.apmr.2006.10.029; Arango-Lasprilla JC, 2009, NEUROREHABILITATION, V24, P5, DOI 10.3233/NRE-2009-0449; Baguley IJ, 2006, J HEAD TRAUMA REHAB, V21, P45, DOI 10.1097/00001199-200601000-00005; Bowman SM, 2007, MED CARE, V45, P686, DOI 10.1097/MLR.0b013e31803dcdf3; Burnett DM, 2003, ARCH PHYS MED REHAB, V84, P263, DOI 10.1053/apmr.2003.50091; Dahmer E., 1993, J HEAD TRAUMA REHAB, V8, P12, DOI [10.1097/00001199-199308020-00004, DOI 10.1097/00001199-199308020-00004]; Donders J, 2004, ASSESSMENT, V11, P275, DOI 10.1177/1073191104268914; Dunlop DD, 2003, AM J PUBLIC HEALTH, V93, P1945, DOI 10.2105/AJPH.93.11.1945; Gary KW, 2009, BRAIN INJURY, V23, P775, DOI 10.1080/02699050903200563; Greenspan AI, 2006, BRAIN INJURY, V20, P733, DOI 10.1080/02699050600773276; Gureje O, 1997, AM J PSYCHIAT, V154, P989; JORGE RE, 1994, J NEUROSURG, V81, P726, DOI 10.3171/jns.1994.81.5.0726; Kennedy RE, 2005, J HEAD TRAUMA REHAB, V20, P512, DOI 10.1097/00001199-200511000-00004; Kennepohl S, 2004, J INT NEUROPSYCH SOC, V10, P566, DOI 10.1017/S1355617704104128; Kersel DA, 2001, BRAIN INJURY, V15, P283, DOI 10.1080/02699050010005887; Kreutzer JS, 1996, ARCH PHYS MED REHAB, V77, P116, DOI 10.1016/S0003-9993(96)90155-0; Kreutzer JS, 2001, BRAIN INJURY, V15, P563, DOI 10.1080/02699050010009108; Kreutzer JS., 1999, NEUROBEHAVIORAL FUNC; Perez JE, 2008, ISSUES CHILD FAM LIV, P117, DOI 10.1007/978-0-387-78512-7_6; Rosenthal M, 1996, J HEAD TRAUMA REHAB, V11, P40, DOI 10.1097/00001199-199610000-00005; Seel RT, 1997, ARCH PHYS MED REHAB, V78, P1254, DOI 10.1016/S0003-9993(97)90340-3; Seel RT, 2003, ARCH PHYS MED REHAB, V84, P177, DOI 10.1053/apmr.2003.50106; Shafi S, 2007, J TRAUMA, V63, P1138, DOI 10.1097/TA.0b013e3181568cd4	25	18	18	0	14	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	JUN	2012	26	6					814	824		10.3109/02699052.2012.655360			11	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	943EO	WOS:000304103500003	22583172				2021-06-18	
J	Covassin, T; Bay, E				Covassin, Tracey; Bay, Esther			Are There Gender Differences in Cognitive Function, Chronic Stress, and Neurobehavioral Symptoms After Mild-to-Moderate Traumatic Brain Injury?	JOURNAL OF NEUROSCIENCE NURSING			English	Article							SEX-DIFFERENCES; ALLOSTATIC LOAD; DEPRESSIVE SYMPTOMS; RISK-FACTORS; HEAD-INJURY; CONCUSSION; IMPACT; HIPPOCAMPUS; EPIDEMIOLOGY; METAANALYSIS	Research is inconclusive on whether gender differences exist in cognitive function in persons who sustain a mild-to-moderate traumatic brain injury (TBI). Furthermore, it is also unclear whether there is a relationship between chronic stress and cognitive function in these persons. The purpose of this integrative review is to determine whether gender differences exist in cognitive function, neurobehavioral symptoms, and chronic stress levels after a mild-to-moderate TBI. Participants (n = 72) were recruited from eight outpatient rehabilitation centers. Participants completed the demographic questions, the Immediate Postconcussion Assessment Cognitive Testing neurocognitive test battery, the Perceived Stress Scale-14, and the Neurobehavioral Functioning Inventory (NFI). Gender differences were present on verbal memory composite scores (p = .033), with women performing worse than men. There were no other between-gender differences on cognitive tasks, neurobehavioral symptoms, or chronic stress. Higher chronic stress levels result in a decrease in verbal memory (p = .015) and motor processing speed (p = .006) and slower reaction time (p = .007) for women. As male NFI cognition scores increased, motor processing speed scores decreased (p = .012) and reaction time got slower (p = .019), whereas women exhibited decreased verbal memory (p = .017) and slower reaction time (p =.034). As NFI motor symptoms increased, men exhibited decreased verbal memory (p = .005), visual memory (p = .002), and motor processing speed (p =.002) and slower reaction time (p = .002). Overall, this study only found gender differences on verbal memory composite scores, whereas the remaining cognitive tasks, neurobehavioral symptoms, and chronic stress did not indicate gender differences. Correlations between chronic stress, neurobehavioral symptoms, and cognitive function differed in both men and women with TBI. Persons in the chronic phase of recovery from a TBI may benefit from training in compensatory strategies for verbal memory deficits and stress management.	[Covassin, Tracey] Michigan State Univ, Dept Kinesiol, E Lansing, MI 48824 USA; [Bay, Esther] Univ Michigan, Dept Phys Med & Rehabil, Ann Arbor, MI 48109 USA	Covassin, T (corresponding author), Michigan State Univ, Dept Kinesiol, E Lansing, MI 48824 USA.	covassin@msu.edu			Michigan State University Office of the Vice President for Research	Funding to conduct this study was given to Esther Bay from the Michigan State University Office of the Vice President for Research.	Bangasser DA, 2010, NEUROSCI BIOBEHAV R, V34, P1223, DOI 10.1016/j.neubiorev.2010.02.002; Bay E, 2002, J NURS SCHOLARSHIP, V34, P221, DOI 10.1111/j.1547-5069.2002.00221.x; Bay E, 2008, BRAIN INJURY, V22, P233, DOI 10.1080/02699050801953073; Bay E, 2009, J NEUROSCI NURS, V41, P298, DOI 10.1097/JNN.0b013e3181b6be81; Bazarian JJ, 2010, J NEUROTRAUM, V27, P527, DOI 10.1089/neu.2009.1068; Bazarian JJ, 1999, BRAIN INJURY, V13, P173, DOI 10.1080/026990599121692; Bazarian JJ, 2001, ACAD EMERG MED, V8, P788, DOI 10.1111/j.1553-2712.2001.tb00208.x; Bruce-Keller AJ, 2007, J NEUROTRAUM, V24, P203, DOI 10.1089/neu.2006.0163; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; Cohen S., 1995, MEASURING STRESS GUI; Covassin T, 2007, NEUROSURGERY, V61, P345, DOI 10.1227/01.NEU.0000279972.95060.CB; EMERSON CS, 1993, BRAIN RES, V608, P95, DOI 10.1016/0006-8993(93)90778-L; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Faul M.D., 2010, TRAUMATIC BRAIN INJU; FENTON G, 1993, BRIT J PSYCHIAT, V162, P493, DOI 10.1192/bjp.162.4.493; Gianaros PJ, 2007, NEUROIMAGE, V35, P795, DOI 10.1016/j.neuroimage.2006.10.045; Groswasser Z, 1998, BRAIN INJURY, V12, P805, DOI 10.1080/026990598122197; Hughes RB, 2005, WOMEN HEALTH ISS, V15, P14, DOI 10.1016/j.whi.2004.09.001; Iverson GL, 2004, ARCH CLIN NEUROPSYCH, V19, P961; Iverson GL, 2002, ARCH CLIN NEUROPSYCH, V17, P770; Kajantie E, 2006, PSYCHONEUROENDOCRINO, V31, P151, DOI 10.1016/j.psyneuen.2005.07.002; Kessels RPC, 2001, BRAIN RES REV, V35, P295, DOI 10.1016/S0165-0173(01)00058-3; Kreutzer JS, 1996, ARCH PHYS MED REHAB, V77, P116, DOI 10.1016/S0003-9993(96)90155-0; Kreutzer JS., 1999, NEUROBEHAVIORAL FUNC; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lovell M. R., 2008, IMPACT 2006 5 0 CLIN; Lovell MR, 2001, IMMEDIATE POSTCONCUS; McCauley SR, 2001, J CLIN EXP NEUROPSYC, V23, P792, DOI 10.1076/jcen.23.6.792.1016; McEwen BS, 2003, BIOL PSYCHIAT, V54, P200, DOI 10.1016/S0006-3223(03)00177-X; McEwen BS, 2002, NEUROBIOL AGING, V23, P921, DOI 10.1016/S0197-4580(02)00027-1; McEwen BS, 2001, ANN NY ACAD SCI, V933, P265, DOI 10.1111/j.1749-6632.2001.tb05830.x; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; NeuroHealth Systems, 2001, IMM POSTC ASS COGN T; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Raskin SA, 1998, CLIN NEUROPSYCHOL, V12, P21, DOI 10.1076/clin.12.1.21.1724; Ratcliff JJ, 2007, BRAIN INJURY, V21, P1023, DOI 10.1080/02699050701633072; RUTHERFORD WH, 1979, INJURY, V10, P225, DOI 10.1016/0020-1383(79)90015-9; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Schopp LH, 2001, J CLIN PSYCHOL MED S, V8, P181, DOI 10.1023/A:1011369620254; Slewa-Younan S, 2008, J NEUROL NEUROSUR PS, V79, P1197, DOI 10.1136/jnnp.2008.147983; TEASDALE G, 1974, LANCET, V2, P81; Tsushima WT, 2009, BRAIN INJURY, V23, P809, DOI 10.1080/02699050903200530; Weiss EM, 2003, PERS INDIV DIFFER, V35, P863, DOI 10.1016/S0191-8869(02)00288-X; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Wood RL, 2004, BRAIN INJURY, V18, P1135, DOI 10.1080/02699050410001675906; World Health Organisation, 1993, ICD 10 CLASSIFICATIO	47	18	18	0	19	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0888-0395			J NEUROSCI NURS	J. Neurosci. Nurs.	JUN	2012	44	3					124	133		10.1097/JNN.0b013e318252737d			10	Clinical Neurology; Nursing	Neurosciences & Neurology; Nursing	937QZ	WOS:000303674600004	22555349				2021-06-18	
J	Hassanpour, K; Hotz-Boendermaker, S; Dokladal, P; Curt, A				Hassanpour, Katayun; Hotz-Boendermaker, Sabina; Dokladal, Petra; Curt, Armin		European Multictr Study Human	Low depressive symptoms in acute spinal cord injury compared to other neurological disorders	JOURNAL OF NEUROLOGY			English	Article						Depressive symptoms; Spinal cord injury; Beck Depression Inventory; ASIA; Neurological disorders	INVENTORY-FAST SCREEN; MAJOR DEPRESSION; CHRONIC PAIN; STROKE; PREVALENCE; PEOPLE; INDIVIDUALS; SITUATION; DISTRESS; VALIDITY	The aim of the study was to reveal the incidence and time course of depressive symptoms following acute spinal cord injury (SCI) in relation to clinical outcomes for comparison to other neurological disorders with severe impairment. In patients with acute traumatic SCI (n = 130), combined follow up assessments of neurological and functional outcomes, pain and patient-rated affective factors (e.g. mood, anxiety) were prospectively (1, 3, 6, 12 months after injury) collected during rehabilitation and follow up in out-patient clinics. We related these to the severity of depressive symptoms (no, mild, moderate and severe) based on the Beck Depression Inventory (BDI) scores. The mean 65% of patients showed no depressive symptoms and 30% mild depressive symptoms, while less than 5% presented moderate to severe depressive symptoms. The group findings and symptoms in individual patients remained stable over 1 year though patients revealed significant clinical recovery. Although two-thirds of the patients experienced pain, BDI scores were not related to pain intensity. BDI mean scores were only slightly higher than in control populations, but rather low compared to patients with other neurological disorders (e.g. stroke and multiple sclerosis) that are also associated with severe functional impairment. The prevalence of depressive symptoms following acute SCI is rather low and remains stable within the first year after injury despite the severe neurological impairment and loss of independency. In comparison to other neurological disorders that also involve brain function SCI patients seem to be less challenged by depressive symptoms that constitute additional burdens to respond to the severe functional impairments.	[Hassanpour, Katayun; Hotz-Boendermaker, Sabina; Dokladal, Petra; Curt, Armin] Balgrist Univ Hosp, Spinal Cord Injury Ctr, CH-8008 Zurich, Switzerland	Hotz-Boendermaker, S (corresponding author), Balgrist Univ Hosp, Spinal Cord Injury Ctr, Forchstr 340, CH-8008 Zurich, Switzerland.	shotz@paralab.balgrist.ch	Hotz, S/AAL-7043-2020	Hotz, S/0000-0001-9455-6074	International Foundation for Research in Paraplegia (IFP); International Spinal Research Trust (ISRT) [CLI006]; Swiss National Science Foundation (SNF)Swiss National Science Foundation (SNSF) [PMPDP3-124282]	We would like to thank the EM-SCI study group, especially Rene Koller from Zurich and Dr. F. Rohrich of the Berufsgenossenschaftliche Kliniken Bergmannstrost, Halle (Germany). The following centers participated in this study: K. Rohl, MD, Berufsgenossenschaftliche Kliniken Bergmannstrost, Halle (Germany); N. Weidner and R. Rupp, University Clinic of Heidelberg (Germany); R. D. Sambale, MD, Orthopadische Klinik Hessisch-Lichtenau (Germany); J. Harms, MD, SRH Klinikum Karlsbad-Langensteinbach (Germany); D. Maier, MD, Berufsgenossenschaftliche Klinik in Murnau (Germany), Y.-B. Kalke, MD, Rehabilitationskrankhaus Ulm (Germany) and, M. Schubert, MD, Balgrist University Hospital, Zurich (Switzerland). We are grateful to Boris Quednow, MD, Psychiatric University Hospital Zurich, for his helpful comments on the manuscript. We would also like to thank all the patients for their willingness to invest their time in this study. Supported by the International Foundation for Research in Paraplegia (IFP) and the International Spinal Research Trust (ISRT; Stage II of the Clinical Initiative: CLI006) and the Swiss National Science Foundation (SNF, PMPDP3-124282).	Alajbegovic A, 2009, ACTA CLIN CROAT, V48, P3; ASIA, 2003, INT STAND NEUR CLASS; Ayuso-Mateos JL, 2001, BRIT J PSYCHIAT, V179, P308, DOI 10.1192/bjp.179.4.308; Benedict RHB, 2003, MULT SCLER J, V9, P393, DOI 10.1191/1352458503ms902oa; Binks TM, 1997, ANN NY ACAD SCI, V821, P430, DOI 10.1111/j.1749-6632.1997.tb48297.x; Boekamp JR, 1996, INT J PSYCHIAT MED, V26, P329, DOI 10.2190/CMU6-24AH-E4JG-8KBN; Bombardier CH, 2004, ARCH PHYS MED REHAB, V85, P1749, DOI 10.1016/j.apmr.2004.07.348; Cairns DM, 1996, ARCH PHYS MED REHAB, V77, P329, DOI 10.1016/S0003-9993(96)90079-9; Consortium for Spinal Cord Medicine, 1998, J SPINAL CORD MED, V21, P248, DOI DOI 10.1080/10790268.1998.11719536; Craig A, 2009, SPINAL CORD, V47, P108, DOI 10.1038/sc.2008.115; Elliott TR, 1996, ARCH PHYS MED REHAB, V77, P816, DOI 10.1016/S0003-9993(96)90263-4; Erban P, 2006, CLIN NEUROL NEUROSUR, V108, P384, DOI 10.1016/j.clineuro.2005.06.008; FRANK RG, 1985, AM J PSYCHIAT, V142, P252; Hackett ML, 2005, STROKE, V36, P2296, DOI 10.1161/01.STR.0000183622.75135.a4; Healey AK, 2008, INT J GERIATR PSYCH, V23, P531, DOI 10.1002/gps.1933; Hoffman JM, 2011, ARCH PHYS MED REHAB, V92, P411, DOI 10.1016/j.apmr.2010.10.036; HOHMANN GW, 1975, CLIN ORTHOP RELAT R, P81; HOUSE A, 1991, BRIT J PSYCHIAT, V158, P83, DOI 10.1192/bjp.158.1.83; Jensen MP, 2005, SPINAL CORD, V43, P704, DOI 10.1038/sj.sc.3101777; Kemp BJ, 2004, J SPINAL CORD MED, V27, P22, DOI 10.1080/10790268.2004.11753726; KENDALL PC, 1987, COGNITIVE THER RES, V11, P289, DOI 10.1007/BF01186280; Kennedy P, 2000, SPINAL CORD, V38, P498, DOI 10.1038/sj.sc.3101021; Kennedy P, 2000, ARCH PHYS MED REHAB, V81, P932, DOI 10.1053/apmr.2000.5580; Klose L, 2011, KLIN PSYCHIAT PSYCHO; Kotila M, 1998, STROKE, V29, P368, DOI 10.1161/01.STR.29.2.368; Lincoln NB, 2003, STROKE, V34, P111, DOI 10.1161/01.STR.0000044167.44670.55; Lude P, 2005, SPINAL CORD, V43, P102, DOI 10.1038/sj.sc.3101688; Merrick Daniel, 2010, BMC Res Notes, V3, P190, DOI 10.1186/1756-0500-3-190; Osteraker AL, 2005, SPINAL CORD, V43, P223, DOI 10.1038/sj.sc.3101703; Rampello L, 2004, PSYCHOPHARMACOLOGY, V173, P73, DOI 10.1007/s00213-003-1698-1; Saikkonen J, 2004, SPINAL CORD, V42, P459, DOI 10.1038/sj.sc.3101618; Siddall PJ, 2003, PAIN, V103, P249, DOI 10.1016/S0304-3959(02)00452-9; SILLER J, 1969, REHABIL LIT, V30, P290; Taylor L, 2010, EUR J NEUROL, V17, P1047, DOI 10.1111/j.1468-1331.2010.02960.x; Tedman BM, 1997, J NEUROL SCI, V152, pS75, DOI 10.1016/S0022-510X(97)00249-9; Tirch D, 1999, J Spinal Cord Med, V22, P284; van Hedel HJ, 2011, NEUROREHABIL NE 0602; Widerstrom-Noga EG, 2003, SPINAL CORD, V41, P600, DOI 10.1038/sj.sc.3101511; Wittchen HU, 2005, EUR NEUROPSYCHOPHARM, V15, P357, DOI 10.1016/j.euroneuro.2005.04.012	39	18	18	0	9	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0340-5354	1432-1459		J NEUROL	J. Neurol.	JUN	2012	259	6					1142	1150		10.1007/s00415-011-6316-2			9	Clinical Neurology	Neurosciences & Neurology	953IB	WOS:000304859300019	22095042	Green Accepted			2021-06-18	
J	Zhao, YQ; Wu, HL; Wang, XL; Li, JG; Zhang, S				Zhao, Yongqing; Wu, Huili; Wang, Xueling; Li, Jianguo; Zhang, Sai			Clinical epidemiology of posttraumatic epilepsy in a group of Chinese patients	SEIZURE-EUROPEAN JOURNAL OF EPILEPSY			English	Article						Traumatic brain injury; Posttraumatic epilepsy; Epidemiology; Risk factor	TRAUMATIC BRAIN-INJURY; RISK-FACTORS; SEIZURES	Objective: To explore the incidence, types of onset, and risk factors of posttraumatic epilepsy (PTE). Methods: This is a retrospective follow-up study of patients discharged from the Affiliated Hospital of the Medical College of the Chinese People's Armed Police Forces between September 2004 and September 2008 with a diagnosis of traumatic brain injury (TBI). Results: Complete clinical information was available on 2826 patients. Of the 2826 TBI patients, 141 developed PTE, providing an incidence rate of 5.0%. Twenty-four cases (0.8%) had posttraumatic seizures (PTS), of which 16 (66.7%) continued to experience after the acute phase of their TBI, accounting for 5.0% of the total PTE cases. A total of 125 cases (88.7%) were diagnosed as presenting with late-stage seizures, occurring from 10 days to three years after TBI (93/141 (66.0%) presented within six months after the TBI, 14/141 (9.9%) between six and twelve months, 22/141 (15.7%) between one and two years and only 12/141 (8.5%) between two and three years after the TBI. The severity of PTE was rated mild, medium, and severe in 3.6%, 6.9%, and 17% of the TBI patients. Multiple regression analysis was carried out to identify factors contributing to the risk of developing PTE. Five parameters contributed to the model: Older age, greater severity of brain injury, abnormal neuroimaging, surgical treatment, and early-stage seizures. Conclusion: Age, severity of brain injury, neuroimaging results, treatment methods, and early-stage seizures are independent risk factors of PTE. (C) 2012 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.	[Zhao, Yongqing; Wu, Huili; Wang, Xueling; Li, Jianguo; Zhang, Sai] Chinese Peoples Armed Police Forces, Hosp Med Coll, Comprehens Epilepsy Ctr, Neurol & Neurosurg Ctr, Tianjin 300162, Peoples R China	Zhao, YQ (corresponding author), Chinese Peoples Armed Police Forces, Hosp Med Coll, Comprehens Epilepsy Ctr, Neurol & Neurosurg Ctr, Tianjin 300162, Peoples R China.	yongqing6509@yahoo.com.cn			Medical College of Chinese People's Armed Police Forces	This work was financially supported by the Doctor Fund of the Medical College of Chinese People's Armed Police Forces.	Annegers JF, 2000, SEIZURE-EUR J EPILEP, V9, P453, DOI 10.1053/seiz.2000.0458; Asikainen I, 1999, EPILEPSIA, V40, P584, DOI 10.1111/j.1528-1157.1999.tb05560.x; Chengyun D, 2006, CHIN J NEUROSURG, V22, P541; Christensen J, 2009, LANCET, V373, P1105, DOI 10.1016/S0140-6736(09)60214-2; DEVINSKY O, 1995, EPILEPSIA, V36, P1089, DOI 10.1111/j.1528-1157.1995.tb00467.x; Englander J, 2003, ARCH PHYS MED REHAB, V84, P365, DOI 10.1053/apmr.2003.50022; Ferguson PL, 2010, EPILEPSIA, V51, P891, DOI 10.1111/j.1528-1167.2009.02384.x; Frey LC, 2003, EPILEPSIA, V44, P11, DOI 10.1046/j.1528-1157.44.s10.4.x; HAUSER WA, 1984, NEUROLOGY, V34, P746, DOI 10.1212/WNL.34.6.746; Hillbom E., 1959, ACTA PSYCHIAT NEUROL, V34, P7; Jyoti A, 2009, NEUROSCI LETT, V453, P86, DOI 10.1016/j.neulet.2009.01.082; Qifu T, 2006, EPILEPSY SURG, P538; Schutze M, 1999, ZBL NEUROCHIR, V60, P163; Shengyu Y, 2000, DIAGNOSIS TREATMENT, P133; Wang HC, 2008, J TRAUMA, V64, P883, DOI 10.1097/TA.0b013e31804a7fa4; WEISS GH, 1983, ARCH NEUROL-CHICAGO, V40, P7, DOI 10.1001/archneur.1983.04050010027006; Zhongcheng W, 1998, NEUROSURGERY, P365	17	18	21	0	10	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	1059-1311			SEIZURE-EUR J EPILEP	Seizure	JUN	2012	21	5					322	326		10.1016/j.seizure.2012.02.007			5	Clinical Neurology; Neurosciences	Neurosciences & Neurology	948RT	WOS:000304521000003	22425008	Bronze			2021-06-18	
J	Griesbach, GS; Vincelli, J; Tio, DL; Hovda, DA				Griesbach, G. S.; Vincelli, J.; Tio, D. L.; Hovda, D. A.			EFFECTS OF ACUTE RESTRAINT-INDUCED STRESS ON GLUCOCORTICOID RECEPTORS AND BRAIN-DERIVED NEUROTROPHIC FACTOR AFTER MILD TRAUMATIC BRAIN INJURY	NEUROSCIENCE			English	Article						traumatic brain injury; stress; brain-derived neurotrophic factor; glucocorticoid receptor	PITUITARY-ADRENAL AXIS; PRIMED BURST POTENTIATION; MESSENGER-RNA EXPRESSION; LATERAL FLUID PERCUSSION; RAT HIPPOCAMPUS; GENE-EXPRESSION; DENTATE GYRUS; ADRENOCORTICAL AXIS; CORTICOSTERONE; BDNF	We have previously reported that experimental mild traumatic brain injury results in increased sensitivity to stressful events during the first post-injury weeks, as determined by analyzing the hypothalamic-pituitary-adrenal (HPA) axis regulation following restraint-induced stress. This is the same time period when rehabilitative exercise has proven to be ineffective after a mild fluid-percussion injury (FPI). Here we evaluated effects of stress on neuroplasticity. Adult male rats underwent either an FPI or sham injury. Additional rats were only exposed to anesthesia. Rats were exposed to 30 min of restraint stress, followed by tail vein blood collection at post-injury days (PID) 1, 7, and 14. The response to dexamethasone (DEX) was also evaluated. Hippocampal tissue was collected 120 min after stress onset. Brain-derived neurotrophic factor (BDNF) along with glucocorticoid (GR) and mineralocorticoid (MR) receptors was determined by Western blot analysis. Results indicated injury-dependent changes in glucocorticoid and mineralocorticoid receptors that were influenced by the presence of dexamethasone. Control and FPI rats responded differentially to DEX in that GR increases after receiving the lower dose of DEX were longer lasting in the FPI group. A suppression of MR was found at PID 1 in vehicle-treated FPI and Sham groups. Decreases in the precursor form of BDNF were observed in different FPI groups at PIDs 7 and 14. These findings suggest that the increased sensitivity to stressful events during the first post-injury weeks, after a mild FPI, has an impact on hippocampal neuroplasticity. (c) 2012 IBRO. Published by Elsevier Ltd. All rights reserved.	[Griesbach, G. S.; Vincelli, J.; Hovda, D. A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, Los Angeles, CA 90095 USA; [Tio, D. L.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA; [Hovda, D. A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacolp, Los Angeles, CA 90095 USA	Griesbach, GS (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, Los Angeles, CA 90095 USA.	ggriesbach@mednet.ucla.edu			NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS6190]; UCLA Brain Injury Research Center; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS061960] Funding Source: NIH RePORTER	This study was supported by NINDS award NS6190 (G.S.G.) and the UCLA Brain Injury Research Center. We thank David Garfinkel for his excellent technical help.	Ashman TA, 2006, MT SINAI J MED, V73, P999; Avramescu S, 2008, J NEUROSCI, V28, P6760, DOI 10.1523/JNEUROSCI.0643-08.2008; Barco A, 2005, NEURON, V48, P123, DOI 10.1016/j.neuron.2005.09.005; Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; Bay E, 2009, WESTERN J NURS RES, V31, P731, DOI 10.1177/0193945909334856; Bazarian JJ, 2006, ACAD EMERG MED, V13, P199, DOI 10.1197/j.aem.2005.07.031; Cernak I, 1999, BRAIN INJURY, V13, P1005; Cole JT, 2011, J NEUROTRAUM, V28, P359, DOI 10.1089/neu.2010.1427; Conway-Campbell BL, 2010, J NEUROENDOCRINOL, V22, P1093, DOI 10.1111/j.1365-2826.2010.02051.x; DALLMAN MF, 1987, ANN NY ACAD SCI, V512, P402, DOI 10.1111/j.1749-6632.1987.tb24976.x; de Kloet ER, 2000, EUR J PHARMACOL, V405, P187, DOI 10.1016/S0014-2999(00)00552-5; de Quervain DJF, 2000, NAT NEUROSCI, V3, P313, DOI 10.1038/73873; DeKeyser FG, 2000, NEUROIMMUNOMODULAT, V7, P182, DOI 10.1159/000026437; DIAMOND DM, 1994, BEHAV BRAIN RES, V62, P1, DOI 10.1016/0166-4328(94)90032-9; DIAMOND DM, 1992, HIPPOCAMPUS, V2, P421, DOI 10.1002/hipo.450020409; Englander J, 2010, BRAIN INJURY, V24, P1379, DOI 10.3109/02699052.2010.523041; Fujikawa T, 2000, BRAIN RES, V874, P186, DOI 10.1016/S0006-8993(00)02576-2; Furay AR, 2008, ENDOCRINOLOGY, V149, P5482, DOI 10.1210/en.2008-0642; Golding EM, 1999, AM J PHYSIOL-HEART C, V277, pH1457; Goodman YD, 1996, J NEUROCHEM, V66, P1836; Griesbach GS, 2011, NEUROSCIENCE, V178, P147, DOI 10.1016/j.neuroscience.2011.01.028; Griesbach GS, 2007, J NEUROTRAUM, V24, P1161, DOI 10.1089/neu.2006.0255; Griesbach GS, 2012, J NEUROTRAUM, V29, P1426, DOI 10.1089/neu.2011.2229; Griesbach GS, 2009, BRAIN RES, V1288, P105, DOI 10.1016/j.brainres.2009.06.045; Griesbach GS, 2004, NEUROSCIENCE, V125, P129, DOI 10.1016/j.neuroscience.2004.01.030; Gronli J, 2006, PHARMACOL BIOCHEM BE, V85, P842, DOI 10.1016/j.pbb.2006.11.021; Gurkoff GG, 2006, BRAIN RES, V1077, P24, DOI 10.1016/j.brainres.2006.01.011; Hall ED, 2008, J NEUROTRAUM, V25, P235, DOI 10.1089/neu.2007.0383; Han JS, 2002, EUR J NEUROSCI, V16, P1399, DOI 10.1046/j.1460-9568.2002.02191.x; Hansson AC, 2000, EUR J NEUROSCI, V12, P2918, DOI 10.1046/j.1460-9568.2000.00185.x; Hansson AC, 2006, J NEUROENDOCRINOL, V18, P104, DOI 10.1111/j.1365-2826.2005.01390.x; Harris JL, 2009, J NEUROTRAUM, V26, P1669, DOI [10.1089/neu.2009.0875, 10.1089/neu.2009-0875]; Herman JP, 1998, J NEUROSCI, V18, P7462; Hirasawa K, 2000, J NEUROSURG, V93, P581, DOI 10.3171/jns.2000.93.4.0581; Houshyar H, 2001, J NEUROENDOCRINOL, V13, P875, DOI 10.1046/j.1365-2826.2001.00714.x; Ising M, 2005, PROG NEURO-PSYCHOPH, V29, P1085, DOI 10.1016/j.pnpbp.2005.03.014; JACOBSON L, 1991, ENDOCR REV, V12, P118, DOI 10.1210/edrv-12-2-118; Jeanneteau FD, 2012, P NATL ACAD SCI USA, V109, P1305, DOI 10.1073/pnas.1114122109; JOELS M, 1992, TRENDS NEUROSCI, V15, P25, DOI 10.1016/0166-2236(92)90345-9; JOELS M, 1994, PROG NEUROBIOL, V43, P1, DOI 10.1016/0301-0082(94)90014-0; Jorge RE, 2007, BIOL PSYCHIAT, V62, P332, DOI 10.1016/j.biopsych.2006.07.024; Kitraki E, 1999, NEUROENDOCRINOLOGY, V69, P331, DOI 10.1159/000054435; LOWENSTEIN DH, 1994, MOL BRAIN RES, V22, P299, DOI 10.1016/0169-328X(94)90058-2; Lu B, 2003, NEURON, V39, P735, DOI 10.1016/S0896-6273(03)00538-5; Lupien SJ, 1998, NAT NEUROSCI, V1, P69, DOI 10.1038/271; McCullers DL, 2002, BRAIN RES, V947, P41, DOI 10.1016/S0006-8993(02)02904-9; McEwen BS, 2001, HUM PSYCHOPHARM CLIN, V16, pS7, DOI 10.1002/hup.266; McEwen BS, 1999, ANNU REV NEUROSCI, V22, P105, DOI 10.1146/annurev.neuro.22.1.105; Meyer A, 1996, BRAIN RES, V732, P121, DOI 10.1016/0006-8993(96)00502-1; Morales DM, 2005, NEUROSCIENCE, V136, P971, DOI 10.1016/j.neuroscience.2005.08.030; Murakami S, 2005, NEUROSCI RES, V53, P129, DOI 10.1016/j.neures.2005.06.008; Neigh GN, 2009, J CEREBR BLOOD F MET, V29, P1673, DOI 10.1038/jcbfm.2009.85; Newcomer JW, 1999, ARCH GEN PSYCHIAT, V56, P527, DOI 10.1001/archpsyc.56.6.527; Osteen CL, 2001, J NEUROTRAUM, V18, P141, DOI 10.1089/08977150150502587; Paskitti ME, 2000, MOL BRAIN RES, V80, P142, DOI 10.1016/S0169-328X(00)00121-2; REUL JMHM, 1985, ENDOCRINOLOGY, V117, P2505, DOI 10.1210/endo-117-6-2505; Revest JM, 2010, MOL PSYCHIATR, V15, P1140, DOI 10.1038/mp.2010.40; Sapolsky RM, 2000, ARCH GEN PSYCHIAT, V57, P925, DOI 10.1001/archpsyc.57.10.925; SAPOLSKY RM, 1984, ENDOCRINOLOGY, V114, P287, DOI 10.1210/endo-114-1-287; Sapolsky RM, 1999, EXP GERONTOL, V34, P721, DOI 10.1016/S0531-5565(99)00047-9; Schaaf MJM, 1998, BRAIN RES, V813, P112, DOI 10.1016/S0006-8993(98)01010-5; Schaaf MJM, 1997, J NEUROSCI RES, V48, P334, DOI 10.1002/(SICI)1097-4547(19970515)48:4<334::AID-JNR5>3.3.CO;2-F; Seidah NG, 1996, FEBS LETT, V379, P247, DOI 10.1016/0014-5793(95)01520-5; SHENKIN HA, 1971, J NEUROSURG, V34, P657, DOI 10.3171/jns.1971.34.5.0657; Spyrka J, 2010, BRAIN RES, V1320, P28, DOI 10.1016/j.brainres.2010.01.031; STEINBOK P, 1979, NEUROSURGERY, V5, P559, DOI 10.1227/00006123-197911000-00003; Taylor AN, 2008, J NEUROTRAUM, V25, P311, DOI 10.1089/neu.2007.0486; Taylor AN, 2010, J NEUROTRAUM, V27, P1081, DOI 10.1089/neu.2009.1252; Vreeburg SA, 2009, ARCH GEN PSYCHIAT, V66, P617, DOI 10.1001/archgenpsychiatry.2009.50; Xu L, 1998, P NATL ACAD SCI USA, V95, P3204, DOI 10.1073/pnas.95.6.3204	70	18	19	0	15	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	MAY 17	2012	210						393	402		10.1016/j.neuroscience.2012.03.005			10	Neurosciences	Neurosciences & Neurology	951ON	WOS:000304730000037	22445725	Green Accepted			2021-06-18	
J	Franssen, RA; Rzucidlo, AM; Franssen, CL; Hampton, JE; Benkovic, SA; Bardi, M; Kinsley, CH; Lambert, KG				Franssen, R. Adam; Rzucidlo, Amanda M.; Franssen, Catherine L.; Hampton, J. Ezekiel; Benkovic, Stanley A., Jr.; Bardi, Massimo; Kinsley, Craig H.; Lambert, Kelly G.			Reproductive experience facilitates recovery from kainic acid-induced neural insult in female Long-Evans rats	BRAIN RESEARCH			English	Article						Traumatic brain injury; Maternal behavior; Memory; Neurotoxicity; Gliosis	RECEPTOR ISOFORMS EXPRESSION; REACTIVE ASTROCYTES; BRAIN-INJURY; PROGESTERONE; HIPPOCAMPUS; NEUROPROTECTION; MOTHERHOOD; MEMORY; EXCITOTOXICITY; LACTATION	The hormones of pregnancy and lactation (e.g., estrogen, progesterone, and oxytocin) have been shown to modulate learning, memory, and the restructuring of brain areas not traditionally associated with maternal behavior. Given the impact of reproductive experience on plasticity of brain areas such as the hippocampus, kainic acid (KA) was used in the current study to induce hippocampal-specific neurotoxic insult in adult multiparous and virgin Long-Evans rats. In Experiment I, Fluoro-Jade B, an indicant of degenerating cells, revealed significant neuronal damage in KA-treated hippocampi at 16 h post-injection in both maternal and virgin rats. In Experiment H, maternal and virgin rats were assessed in spatial and novel object preference tasks to determine the effects of KA on subsequent behavioral and cognitive responses. Twenty-four hours post injection, saline maternal animals exhibited superior memory in a spatial task. Further, maternal saline-injected rats were more similar to maternal KA-injected rats than both the virgin groups. Forty-eight hours following the KA or saline injection, compared to virgins, maternal animals demonstrated enhanced memory in the novel object memory test, regardless of type of injection. Further, neurobiological assessments in Experiment II indicated that virgin KA exposed rats had significantly more glial fibrillary acidic protein (GFAP)-immunoreactivity in the hippocampus, suggesting that they were in an earlier stage of neural recovery compared to maternal animals or, alternatively, may have exhibited more trauma than maternal animals. Together, these data suggest that the previously reported plasticity of the maternal brain may facilitate neural and behavioral recovery from neural insults. (c) 2012 Elsevier B.V. All rights reserved.	[Lambert, Kelly G.] Randolph Macon Coll, Dept Psychol, Copley Sci Ctr 138, Ashland, VA 23005 USA; [Franssen, R. Adam] Longwood Univ, Dept Biol & Environm Sci, Farmville, VA 23909 USA; [Benkovic, Stanley A., Jr.] Neurosci Associates, Knoxville, TN 37934 USA; [Kinsley, Craig H.] Univ Richmond, Dept Psychol, Richmond, VA 23173 USA; [Bardi, Massimo] Marshall Univ, Dept Psychol, Huntington, WV 25575 USA	Lambert, KG (corresponding author), Randolph Macon Coll, Dept Psychol, Copley Sci Ctr 138, 304 Caroline St, Ashland, VA 23005 USA.	klambert@rmc.edu		Lambert, Kelly/0000-0003-1626-5129	R-MC Psychology Department; Joan and Macon Brock Professorship; Schapiro Undergraduate Research Fellowship program	This research was funded by the R-MC Psychology Department, the Joan and Macon Brock Professorship, and the Schapiro Undergraduate Research Fellowship program. Appreciation is also extended to the valuable contributions of Anya Baranova, Ph.D. and Eleanor Shea.	Azcoitia I., 2011, TRENDS ENDOCRIN MET, V119, P1084; Azcoitia I, 2010, EUR J NEUROSCI, V32, P1995, DOI 10.1111/j.1460-9568.2010.07516.x; Barha CK, 2011, EXP NEUROL, V231, P72, DOI 10.1016/j.expneurol.2011.05.016; Barker GRI, 2007, J NEUROSCI, V27, P2948, DOI 10.1523/JNEUROSCI.5289-06.2007; Barreto G, 2009, ENDOCRINOLOGY, V150, P5010, DOI 10.1210/en.2009-0352; Baulieu EE, 2000, STEROIDS, V65, P605, DOI 10.1016/S0039-128X(00)00173-2; Benkovic SA, 2004, BRAIN RES, V1024, P59, DOI 10.1016/j.brainres.2004.07.021; BOUMA GJ, 1992, J NEUROTRAUM, V9, pS333; Cabrera V, 2009, NEUROSCI LETT, V461, P136, DOI 10.1016/j.neulet.2009.06.017; Carroll JC, 2007, J NEUROSCI, V27, P13357, DOI 10.1523/JNEUROSCI.2718-07.2007; Chen YM, 2003, J CEREBR BLOOD F MET, V23, P137, DOI 10.1097/01.WCB.0000044631.80210.3C; Franssen CL, 2011, J NEUROENDOCRINOL, V23, P1177, DOI 10.1111/j.1365-2826.2011.02225.x; Gatewood JD, 2005, BRAIN RES BULL, V66, P91, DOI 10.1016/j.brainresbull.2005.03.016; Gennarelli T. A., 2005, TXB TRAUMATIC BRAIN, P27; Gibson CL, 2005, EXP NEUROL, V193, P522, DOI 10.1016/j.expneurol.2005.01.009; Guerra-Araiza C, 2003, J NEUROENDOCRINOL, V15, P984, DOI 10.1046/j.1365-2826.2003.01088.x; Guerra-Araiza C, 2000, LIFE SCI, V66, P1743, DOI 10.1016/S0024-3205(00)00497-5; Guerra-Araiza C, 2001, BRAIN RES BULL, V54, P13, DOI 10.1016/S0361-9230(00)00410-X; He J, 2004, EXP NEUROL, V189, P404, DOI 10.1016/j.expneurol.2004.06.008; Hilton GD, 2006, ENDOCRINOLOGY, V147, P1246, DOI 10.1210/en.2005-1258; Irwin RW, 2008, ENDOCRINOLOGY, V149, P3167, DOI 10.1210/en.2007-1227; KESSLAK JP, 1986, BEHAV NEUROSCI, V100, P280, DOI 10.1037/0735-7044.100.2.280; Kinsley CH, 2006, SCI AM, V294, P72, DOI 10.1038/scientificamerican0106-72; Kinsley CH, 2006, HORM BEHAV, V49, P131, DOI 10.1016/j.yhbeh.2005.05.017; Kinsley CH, 1999, NATURE, V402, P137; Kinsley CH, 2008, J NEUROENDOCRINOL, V20, P515, DOI 10.1111/j.1365-2826.2008.01667.x; Kinsley CH, 2008, ARCH SEX BEHAV, V37, P43, DOI 10.1007/s10508-007-9277-x; Krajewska M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024341; Lambert KG, 2005, PHYSIOL BEHAV, V84, P799, DOI 10.1016/j.physbeh.2005.03.012; Lambert KG., 2008, PARENTAL BRAIN; Love G, 2005, BEHAV NEUROSCI, V119, P1084, DOI 10.1037/0735-7044.119.4.1084; MCINTOSH TK, 1994, CEREBROVAS BRAIN MET, V6, P109; Morales T, 2011, J NEUROENDOCRINOL, V23, P994, DOI 10.1111/j.1365-2826.2011.02141.x; NADLER JV, 1978, NATURE, V271, P676, DOI 10.1038/271676a0; Nilsen J, 2003, P NATL ACAD SCI USA, V100, P10506, DOI 10.1073/pnas.1334098100; Nilsen J, 2002, ENDOCRINOLOGY, V143, P205, DOI 10.1210/en.143.1.205; OLNEY JW, 1979, BRAIN RES, V176, P91, DOI 10.1016/0006-8993(79)90872-2; Otani N, 2006, J CLIN NEUROSCI, V13, P934, DOI 10.1016/j.jocn.2005.10.018; Panter S. S., 1992, PRINCIPLES PRACTICE, P32; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Ridet JL, 1997, TRENDS NEUROSCI, V20, P570, DOI 10.1016/S0166-2236(97)01139-9; ROOF RL, 1993, BRAIN RES, V607, P333, DOI 10.1016/0006-8993(93)91526-X; Salmaso N, 2005, NEUROSCIENCE, V134, P1431, DOI 10.1016/j.neuroscience.2005.05.038; Schmued LC, 2000, BRAIN RES, V874, P123, DOI 10.1016/S0006-8993(00)02513-0; Schumacher M, 2007, PHARMACOL THERAPEUT, V116, P77, DOI 10.1016/j.pharmthera.2007.06.001; Sofroniew MV, 2005, NEUROSCIENTIST, V11, P400, DOI 10.1177/1073858405278321; SPERK G, 1983, NEUROSCIENCE, V10, P1301, DOI 10.1016/0306-4522(83)90113-6; Stein DG, 2008, BRAIN RES REV, V57, P386, DOI 10.1016/j.brainresrev.2007.06.012; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Vanoye-Carlo A, 2008, HORM BEHAV, V53, P112, DOI 10.1016/j.yhbeh.2007.09.004; Warner R. C., 2007, APPL STAT	51	18	18	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	MAY 15	2012	1454						80	89		10.1016/j.brainres.2012.03.028			10	Neurosciences	Neurosciences & Neurology	944GB	WOS:000304186200007	22483962				2021-06-18	
J	Kosty, J; Macyszyn, L; Lai, K; McCroskery, J; Park, HR; Stein, SC				Kosty, Jennifer; Macyszyn, Luke; Lai, Kevin; McCroskery, James; Park, Hae-Ran; Stein, Sherman C.			Relating Quality of Life to Glasgow Outcome Scale Health States	JOURNAL OF NEUROTRAUMA			English	Article						comparative effectiveness research; decision analysis; Glasgow Outcome Scale; standard gamble; quality of life	TRAUMATIC BRAIN-INJURY; 1ST 5 YEARS; HEAD-INJURY; QOLIBRI; UTILITY; SATISFACTION; DISABILITY; INTERVIEWS; MANAGEMENT; MORTALITY	There has recently been a call for the adoption of comparative effectiveness research (CER) and related research approaches for studying traumatic brain injury (TBI). These methods allow researchers to compare the effectiveness of different therapies in producing patient-oriented outcomes of interest. Heretofore, the only measures by which to compare such therapies have been mortality and rate of poor outcome. Better comparisons can be made if parametric, preference-based quality-of-life (QOL) values are available for intermediate outcomes, such as those described by the Glasgow Outcome Scale Extended (GOSE). Our objective was therefore to determine QOL for the health states described by the GOSE. We interviewed community members at least 18 years of age using the standard gamble method to assess QOL for descriptions of GOSE scores of 2-7 derived from the structured interview. Linear regression analysis was also performed to assess the effect of age, gender, and years of education on QOL. One hundred and one participants between the ages of 18 and 83 were interviewed (mean age 40 +/- 19 years), including 55 men and 46 women. Functional impairment and QOL showed a strong inverse relationship, as assessed by both linear regression and the Spearman rank order coefficient. No consistent effect or age, gender, or years of education was seen. As expected, QOL decreased with functional outcome as described by the GOSE. The results of this study will provide the groundwork for future groups seeking to apply CER methods to clinical studies of TBI.	[Kosty, Jennifer; Macyszyn, Luke; Lai, Kevin; McCroskery, James; Park, Hae-Ran; Stein, Sherman C.] Univ Penn, Dept Neurosurg, Philadelphia, PA 19104 USA	Stein, SC (corresponding author), Univ Penn, Dept Neurosurg, 3400 Spruce St, Philadelphia, PA 19104 USA.	sherman.stein@uphs.upenn.edu					Aoki N, 1998, MED DECIS MAKING, V18, P357, DOI 10.1177/0272989X9801800401; Baumann CR, 2007, BRAIN, V130, P1873, DOI 10.1093/brain/awm109; Branca B, 2004, J HEAD TRAUMA REHAB, V19, P40, DOI 10.1097/00001199-200401000-00005; Cantor JB, 2008, J HEAD TRAUMA REHAB, V23, P41, DOI 10.1097/01.HTR.0000308720.70288.af; Colantonio A, 1998, ARCH PHYS MED REHAB, V79, P550, DOI 10.1016/S0003-9993(98)90072-7; COLOHAN ART, 1989, J NEUROSURG, V71, P202, DOI 10.3171/jns.1989.71.2.0202; Corrigan JD, 1998, ARCH PHYS MED REHAB, V79, P298, DOI 10.1016/S0003-9993(98)90010-7; Drummond J., 2000, METHODS EC EVALUATIO; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Findler M, 2001, BRAIN INJURY, V15, P715, DOI 10.1080/02699050010013941; Finkelstein EA., 2006, INCIDENCE EC BURDEN; GELPKE GJ, 1983, J NEUROSURG, V59, P745, DOI 10.3171/jns.1983.59.5.0745; Gold M., 1996, Cost-Effectiveness in Health and Medicine.; Guilfoyle MR, 2010, J NEUROTRAUM, V27, P2173, DOI 10.1089/neu.2010.1353; Hallan S, 1999, J INTERN MED, V246, P309, DOI 10.1046/j.1365-2796.1999.00531.x; Hawthorne G, 2011, J CLIN NEUROSCI, V18, P197, DOI 10.1016/j.jocn.2010.06.015; Hibbard MR, 2004, ARCH PHYS MED REHAB, V85, pS43, DOI 10.1016/j.apmr.2003.08.116; Hillier SL, 1997, BRAIN INJURY, V11, P661; HOFFMANN KJ, 1984, EUR J DRUG METAB PH, V9, P215, DOI 10.1007/BF03189644; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Kinsella G, 1989, Int Disabil Stud, V11, P9; Kreuter M, 1998, SPINAL CORD, V36, P252, DOI 10.1038/sj.sc.3100592; LANGFITT TW, 1978, J NEUROSURG, V48, P673, DOI 10.3171/jns.1978.48.5.0673; Lingsma HF, 2011, NEUROSURGERY, V68, P601, DOI 10.1227/NEU.0b013e318209333b; Lu J, 2005, ACT NEUR S, V95, P281; Maas A., 2011, J NEUROTRAUM, V28, P1; Maas AIR, 2010, NEUROTHERAPEUTICS, V7, P115, DOI 10.1016/j.nurt.2009.10.022; Mailhan L, 2005, BRAIN INJURY, V19, P227, DOI 10.1080/02699050410001720149; McCarthy ML, 2006, ARCH PHYS MED REHAB, V87, P953, DOI 10.1016/j.apmr.2006.03.007; O'CARROLL R E, 1991, Brain Injury, V5, P303, DOI 10.3109/02699059109008100; Paniak C, 1999, J HEAD TRAUMA REHAB, V14, P211, DOI 10.1097/00001199-199906000-00002; Post PN, 2001, STROKE, V32, P1425, DOI 10.1161/01.STR.32.6.1425; Resch JA, 2009, REHABIL PSYCHOL, V54, P51, DOI 10.1037/a0015051; RICHARDSON J, 1994, SOC SCI MED, V39, P7, DOI 10.1016/0277-9536(94)90162-7; Rosen AB, 2003, MED DECIS MAKING, V23, P511, DOI 10.1177/0272989X03258431; ROSSER R, 1978, INT J EPIDEMIOL, V7, P347, DOI 10.1093/ije/7.4.347; SACKETT DL, 1978, J CHRON DIS, V31, P697, DOI 10.1016/0021-9681(78)90072-3; Sox HC, 2007, MED DECISION MAKING; Stein S. C., 1996, NEUROTRAUMA, P31; Stein SC, 2010, J NEUROTRAUM, V27, P1343, DOI 10.1089/neu.2009.1206; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; TEMKIN N, 1988, J CLIN EPIDEMIOL, V41, P47, DOI 10.1016/0895-4356(88)90008-X; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; TORRANCE GW, 1986, J HEALTH ECON, V5, P1, DOI 10.1016/0167-6296(86)90020-2; Truelle JL, 2008, ACTA NEUROCHIR SUPPL, V101, P125; Truelle JL, 2010, BRAIN INJURY, V24, P1272, DOI 10.3109/02699052.2010.506865; Van Wijck EEE, 1998, MED DECIS MAKING, V18, P400, DOI 10.1177/0272989X9801800407; Von Neumann J., 1953, THEORY GAMES EC BEHA, V3d; von Steinbuechel N, 2005, ACTA NEUROCHIR SUPPL, V93, P43; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1167, DOI 10.1089/neu.2009.1076; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1157, DOI 10.1089/neu.2009.1077; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	54	18	20	0	14	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAY	2012	29	7					1322	1327		10.1089/neu.2011.2222			6	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	933TC	WOS:000303384600005	22339668				2021-06-18	
J	Pignolo, L; Rogano, S; Quintieri, M; Leto, E; Dolce, G				Pignolo, Loris; Rogano, Stefania; Quintieri, Maria; Leto, Elio; Dolce, Giuliano			DECREASING INCIDENCE OF PAROXYSMAL SYMPATHETIC HYPERACTIVITY SYNDROME IN THE VEGETATIVE STATE	JOURNAL OF REHABILITATION MEDICINE			English	Article; Proceedings Paper	Workshop on Consciousness and the Vegetative State - Today/2nd Conference on Consciousness and Coma	JUL 06, 2010	Salerno, ITALY			paroxysmal sympathetic hyperactivity; dysautonomia; incidence; vegetative state; outcome	TRAUMATIC BRAIN-INJURY; GLASGOW OUTCOME SCALE; DYSAUTONOMIA; DAMAGE; COMA; MANAGEMENT; DISABILITY; DISORDERS	Objective: To update knowledge of the incidence of paroxysmal sympathetic hyperactivity (PSH, also referred to as dysautonomia), an emergency condition tentatively attributed to sympathetic paroxysms or diencephalic-hypothalamic disarrangement associated with severe diffuse brain axonal damage or hypoxia. This condition is reportedly common in the vegetative state, threatens survival and affects outcome. Methods: The results of a retrospective study on 333 subjects in a vegetative state admitted to a dedicated unit in 1998-2005 are compared with a survey on patients admitted to the same unit in 2006-2010. Results and comment: In the 1998-2005 period, the incidence of PSH was 32% and 16% in post-traumatic and non-traumatic patients, respectively. It decreased to 18% and 7% in the 2006-2010 period. The PSH duration and the time spent in emergency units before admission and in the dedicated unit for the vegetative state after admission also decreased significantly. Incidence was greater among post-traumatic patients; its effect on outcome does not appear to have changed.	[Pignolo, Loris] S Anna Inst, Crotone, Italy; [Pignolo, Loris] RAN, Crotone, Italy	Pignolo, L (corresponding author), S Anna Inst, Crotone, Italy.	l.pignolo@istitutosantanna.it					ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; Baguley IJ, 2008, NEUROCRIT CARE, V8, P293, DOI 10.1007/s12028-007-9021-3; Baguley IJ, 2008, MED HYPOTHESES, V70, P26, DOI 10.1016/j.mehy.2007.04.037; Baguley IJ, 2006, BRAIN INJURY, V20, P437, DOI 10.1080/02699050600664715; Baguley IJ, 2009, ARCH PHYS MED REHAB, V90, P580, DOI 10.1016/j.apmr.2008.10.020; Baguley IJ, 1999, J NEUROL NEUROSUR PS, V67, P39, DOI 10.1136/jnnp.67.1.39; Baguley IJ, 2005, BRAIN INJURY, V19, P545, DOI 10.1080/02699050400025075; Baguley IJ, 2004, BRAIN INJURY, V18, P409, DOI 10.1080/02699050310001645775; Baguley IJ, 1999, MAYO CLIN PROC, V74, P105, DOI 10.4065/74.1.105; Borer-Alafi N, 2002, BRAIN INJURY, V16, P593, DOI 10.1080/02699050110119484; Dolce G., 2002; Dolce G, 2021, J NEUROTRAUM, V38, P1441, DOI 10.1089/neu.2008.0536; GENNARELLI TA, 1986, J HEAD TRAUMA REHAB, V1, P23; Giacino JT, 1997, J HEAD TRAUMA REHAB, V12, P36, DOI 10.1097/00001199-199708000-00005; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Hagen C., 1972, LEVELS COGNITIVE FUN; Hendricks HT, 2010, EUR J NEUROL, V17, P1172, DOI 10.1111/j.1468-1331.2010.02989.x; JENNETT B, 1972, LANCET, V1, P734; JENNETT B, 1975, LANCET, V1, P480; Jennett B, 2002, J NEUROL NEUROSUR PS, V73, P355, DOI 10.1136/jnnp.73.4.355; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Kang YM, 2004, INT J NEUROSCI, V114, P299, DOI 10.1080/00207450490264115; Laureys S, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-68; Luther MS, 2007, BRAIN INJURY, V21, P763, DOI 10.1080/02699050701481639; Metz SA, 1978, ANNS INT MED, V88, P89; O'Brien PB, 2006, CRIT CARE RESUSC, V8, P200; Ong J, 2005, CNS DRUG REV, V11, P317; Perkes I, 2010, ANN NEUROL, V68, P126, DOI 10.1002/ana.22066; Pignolo L, 2009, BRAIN INJURY, V23, P1, DOI 10.1080/02699050802595873; Rabinstein AA, 2007, NEUROL RES, V29, P680, DOI 10.1179/016164107X240071; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; TALMAN WT, 1988, ARCH NEUROL-CHICAGO, V45, P1037, DOI 10.1001/archneur.1988.00520330129022; Whyte J, 2005, ARCH PHYS MED REHAB, V86, P453, DOI 10.1016/j.apmr.2004.05.016; Wijdicks Eelco F M, 2006, Rev Neurol Dis, V3, P109; Young GB, 2004, J CLIN NEUROPHYSIOL, V21, P379; Zandbergen EGJ, 2001, INTENS CARE MED, V27, P1661, DOI 10.1007/s001340101076	36	18	19	0	5	FOUNDATION REHABILITATION INFORMATION	UPPSALA	TRADGARDSGATAN 14, UPPSALA, SE-753 09, SWEDEN	1650-1977			J REHABIL MED	J. Rehabil. Med.	MAY	2012	44	6			SI		502	504		10.2340/16501977-0981			3	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	956TW	WOS:000305113000005	22661000	DOAJ Gold			2021-06-18	
J	Sinopoli, KJ; Dennis, M				Sinopoli, Katia J.; Dennis, Maureen			Inhibitory control after traumatic brain injury in children	INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE			English	Article						TBI; Inhibitory control; Effortful inhibition; Effortless inhibition	ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; CLOSED-HEAD INJURY; DEFICIT HYPERACTIVITY DISORDER; EVENT-RELATED FMRI; GO/NOGO RESPONSE-INHIBITION; COLOR-OBJECT INTERFERENCE; STOP-SIGNAL PARADIGM; COGNITIVE CONTROL; EXECUTIVE FUNCTIONS; ANTERIOR CINGULATE	Inhibitory control describes a number of distinct processes. Effortless inhibition refers to acts of control that are automatic and reflexive. Effortful inhibition refers to voluntary, goal-directed acts of control such as response flexibility, interference control, cancellation inhibition, and restraint inhibition. Disruptions to a number of inhibitory control processes occur as a consequence of childhood traumatic brain injury (TBI). This paper reviews the current knowledge of inhibition deficits following childhood TB!, and includes an overview of the inhibition construct and a discussion of the specific deficits shown by children and adolescents with TBI and the factors that mediate the expression of these deficits, including injury-related variables and the expression of pre- and post-injury attention-deficit/hyperactivity disorder. The review illustrates that inhibitory control processes differ in terms of measurement, assessment, and neurological underpinnings, and also that childhood TBI may selectively disrupt particular forms of inhibition. (C) 2011 ISDN. Published by Elsevier Ltd. All rights reserved.	[Sinopoli, Katia J.; Dennis, Maureen] Univ Toronto, BrainFit Lab, Fac Med, Toronto, ON M5G 1V7, Canada; [Sinopoli, Katia J.] Hosp Sick Children, Dept Psychol, Toronto, ON M5G 1X8, Canada; [Dennis, Maureen] Univ Toronto, Dept Psychol, Toronto, ON M5G 1V7, Canada	Sinopoli, KJ (corresponding author), Univ Toronto, BrainFit Lab, Fac Med, 160-500 Univ Ave, Toronto, ON M5G 1V7, Canada.	katia.sinopoli@sickkids.ca	Sinopoli, Katia/AAO-7803-2020		Ontario Neurotrauma Foundation [2007-ABI-PHD-565]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [HD04946]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD048946] Funding Source: NIH RePORTER	Funding to Katia J. Sinopoli was provided by the Ontario Neurotrauma Foundation to (2007-ABI-PHD-565, The Regulation of Thoughts and Actions in Children Following Traumatic Brain Injury). This research was also supported by an NIH 1RO1 grant to Keith O. Yeates and Maureen Dennis (HD04946, Social Outcomes in Pediatric Traumatic Brain Injury).	Adams ZW, 2008, DEV DISABIL RES REV, V14, P268, DOI 10.1002/ddrr.37; Adleman NE, 2002, NEUROIMAGE, V16, P61, DOI 10.1006/nimg.2001.1046; Aron AR, 2005, BIOL PSYCHIAT, V57, P1285, DOI 10.1016/j.biopsych.2004.10.026; Aron AR, 2003, NAT NEUROSCI, V6, P115, DOI 10.1038/nn1003; Bate AJ, 2001, J CLIN EXP NEUROPSYC, V23, P386, DOI 10.1076/jcen.23.3.386.1190; Bedard AC, 2003, J ABNORM CHILD PSYCH, V31, P315, DOI 10.1023/A:1023285614844; Berg EA, 1948, J GEN PSYCHOL, V39, P15, DOI 10.1080/00221309.1948.9918159; Bigler ED, 2006, AM J PHYS MED REHAB, V85, P793, DOI 10.1097/01.phm.0000237873.26250.e1; Bissett PG, 2011, J EXP PSYCHOL LEARN, V37, P392, DOI 10.1037/a0021800; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Bujoreanu IS, 2008, DEV NEUROPSYCHOL, V33, P584, DOI 10.1080/87565640802254364; Bush G, 2003, MOL PSYCHIATR, V8, P60, DOI 10.1038/sj.mp.4001217; Chevrier AD, 2007, HUM BRAIN MAPP, V28, P1347, DOI 10.1002/hbm.20355; Chikazoe J, 2009, J NEUROSCI, V29, P15870, DOI 10.1523/JNEUROSCI.3645-09.2009; Clohessy AB, 2001, ACTA PSYCHOL, V106, P51, DOI 10.1016/S0001-6918(00)00026-3; Crosbie J, 2008, NEUROSCI BIOBEHAV R, V32, P40, DOI 10.1016/j.neubiorev.2007.05.002; Dennis M, 2001, J INT NEUROPSYCH SOC, V7, P683, DOI 10.1017/S1355617701766040; Dennis M., 1995, TRAUMATIC HEAD INJUR, P165; Desman C, 2008, CHILD NEUROPSYCHOL, V14, P483, DOI 10.1080/09297040701625831; Diamond A, 2005, DEV PSYCHOPATHOL, V17, P807, DOI 10.1017/S0954579405050388; Downar J, 2002, J NEUROPHYSIOL, V87, P615, DOI 10.1152/jn.00636.2001; ERIKSEN BA, 1974, PERCEPT PSYCHOPHYS, V16, P143, DOI 10.3758/BF03203267; Ewing-Cobbs L, 2004, DEV NEUROPSYCHOL, V26, P487, DOI 10.1207/s15326942dn2601_7; Ewing-Cobbs L, 2008, NEUROIMAGE, V42, P1305, DOI 10.1016/j.neuroimage.2008.06.031; Floden D, 2006, J COGNITIVE NEUROSCI, V18, P1843, DOI 10.1162/jocn.2006.18.11.1843; Fuster JM, 2002, J NEUROCYTOL, V31, P373, DOI 10.1023/A:1024190429920; Ganesalingam K, 2007, J INT NEUROPSYCH SOC, V13, P298, DOI 10.1017/S1355617707070324; Garavan H, 2002, NEUROIMAGE, V17, P1820, DOI 10.1006/nimg.2002.1326; Geier C, 2009, PHARMACOL BIOCHEM BE, V93, P212, DOI 10.1016/j.pbb.2009.01.021; Gerring J, 2000, BRAIN INJURY, V14, P205; Gerring JP, 1998, J AM ACAD CHILD PSY, V37, P647, DOI 10.1097/00004583-199806000-00015; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; Gordon M., 1983, GORDON DIAGNOSTIC SY; Herskovits EH, 1999, RADIOLOGY, V213, P389, DOI 10.1148/radiology.213.2.r99nv45389; Horneman G, 2009, BRAIN INJURY, V23, P907, DOI 10.1080/02699050903283239; Horvitz JC, 2002, BEHAV BRAIN RES, V137, P65, DOI 10.1016/S0166-4328(02)00285-1; Huang-Pollock CL, 2007, J CLIN CHILD ADOLESC, V36, P127, DOI 10.1080/15374410701274124; JOHNSON MH, 1995, DEV PSYCHOBIOL, V28, P281, DOI 10.1002/dev.420280504; Johnstone SJ, 2007, INT J PSYCHOPHYSIOL, V63, P25, DOI 10.1016/j.ijpsycho.2006.07.001; Jonsson CA, 2009, BRAIN INJURY, V23, P1008, DOI 10.3109/02699050903379354; Kaufmann L, 2005, NEUROIMAGE, V25, P888, DOI 10.1016/j.neuroimage.2004.12.041; Kelly AMC, 2004, EUR J NEUROSCI, V19, P3105, DOI 10.1111/j.0953-816X.2004.03429.x; Klein C, 2001, PSYCHOPHYSIOLOGY, V38, P179; Klein RM, 2000, TRENDS COGN SCI, V4, P138, DOI 10.1016/S1364-6613(00)01452-2; Konishi S, 1999, BRAIN, V122, P981, DOI 10.1093/brain/122.5.981; Konrad K, 2000, CHILD NEUROPSYCHOL, V6, P286, DOI 10.1076/chin.6.4.286.3145; Konrad KN, 2000, BRAIN INJURY, V14, P859; Kraus MF, 2007, COGN BEHAV NEUROL, V20, P170, DOI 10.1097/WNN.0b013e318142badb; La Heij W, 2011, J EXP CHILD PSYCHOL, V108, P156, DOI 10.1016/j.jecp.2010.08.007; Larsson H, 2011, J CHILD PSYCHOL PSYC, V52, P954, DOI 10.1111/j.1469-7610.2011.02379.x; Leblanc N, 2005, DEV NEUROPSYCHOL, V28, P829, DOI 10.1207/s15326942dn2803_5; Levin H, 2007, J DEV BEHAV PEDIATR, V28, P108, DOI 10.1097/01.DBP.0000267559.26576.cd; Levin HS, 2008, J HEAD TRAUMA REHAB, V23, P197, DOI 10.1097/01.HTR.0000327252.54128.7c; Levin HS, 2004, J CLIN EXP NEUROPSYC, V26, P589, DOI 10.1080/13803390490504434; LEVIN HS, 1993, ARCH NEUROL-CHICAGO, V50, P897, DOI 10.1001/archneur.1993.00540090008004; Liston C, 2006, CEREB CORTEX, V16, P553, DOI 10.1093/cercor/bhj003; LOGAN GD, 1984, PSYCHOL REV, V91, P295, DOI 10.1037/0033-295X.91.3.295; Logan Gordon D., 1994, P189; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; MACLEOD CM, 1991, PSYCHOL BULL, V109, P163, DOI 10.1037/0033-2909.109.2.163; Max JE, 2005, J AM ACAD CHILD PSY, V44, P1032, DOI 10.1097/01.chi.0000173293.05817.b1; Max JE, 2005, J AM ACAD CHILD PSY, V44, P1041, DOI 10.1097/01.chi.0000173292.05817.f8; Max JE, 1998, BRAIN INJURY, V12, P41; Mayer AR, 2009, HUM BRAIN MAPP, V30, P4152, DOI 10.1002/hbm.20836; Menon V, 2001, HUM BRAIN MAPP, V12, P131, DOI 10.1002/1097-0193(200103)12:3<131::AID-HBM1010>3.0.CO;2-C; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Mincic AM, 2010, ACTA NEUROBIOL EXP, V70, P406; Mink JW, 1996, PROG NEUROBIOL, V50, P381, DOI 10.1016/S0301-0082(96)00042-1; Munoz DP, 2004, NAT REV NEUROSCI, V5, P218, DOI 10.1038/nrn1345; Ochsner KN, 2009, J COGNITIVE NEUROSCI, V21, P1841, DOI 10.1162/jocn.2009.21129; Padmala S, 2010, NEUROPSYCHOLOGIA, V48, P558, DOI 10.1016/j.neuropsychologia.2009.10.017; Picton TW, 2007, CEREB CORTEX, V17, P826, DOI 10.1093/cercor/bhk031; Prevor MB, 2005, COGNITIVE DEV, V20, P256, DOI 10.1016/j.cogdev.2005.04.001; Rhodes SM, 2005, PSYCHOL MED, V35, P1109, DOI 10.1017/S0033291705004599; Ridderinkhof KR, 1997, J EXP CHILD PSYCHOL, V65, P315, DOI 10.1006/jecp.1997.2367; Rieger M, 2003, NEUROPSYCHOLOGY, V17, P272, DOI 10.1037/0894-4105.17.2.272; Rubia K, 2007, HUM BRAIN MAPP, V28, P1163, DOI 10.1002/hbm.20347; Rubia K, 2006, HUM BRAIN MAPP, V27, P973, DOI 10.1002/hbm.20237; Rueda MR, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-39; Schachar R, 2004, DEV NEUROPSYCHOL, V25, P179, DOI 10.1207/s15326942dn2501&2_10; Schachar R, 2007, J ABNORM CHILD PSYCH, V35, P229, DOI 10.1007/s10802-006-9075-2; Schatz J, 2001, J INT NEUROPSYCH SOC, V7, P275, DOI 10.1017/S1355617701733012; Scheres A, 2001, CHILD NEUROPSYCHOL, V7, P172, DOI 10.1076/chin.7.3.172.8746; Sinopoli KJ, 2011, J CLIN EXP NEUROPSYC, V33, P805, DOI 10.1080/13803395.2011.562864; Sinopoli KJ, 2011, DEV PSYCHOL, V47, P1479, DOI 10.1037/a0024440; Slomine BS, 2005, J INT NEUROPSYCH SOC, V11, P645, DOI 10.1017/S1355617705050769; Smith EE, 1998, P NATL ACAD SCI USA, V95, P12061, DOI 10.1073/pnas.95.20.12061; Solanto MV, 2002, BEHAV BRAIN RES, V130, P65, DOI 10.1016/S0166-4328(01)00431-4; Somsen RJM, 2007, DEVELOPMENTAL SCI, V10, P664, DOI 10.1111/j.1467-7687.2007.00613.x; Sowell ER, 1999, NAT NEUROSCI, V2, P859, DOI 10.1038/13154; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; TEASDALE G, 1974, LANCET, V2, P81; Velanova K, 2009, J NEUROSCI, V29, P12558, DOI 10.1523/JNEUROSCI.1579-09.2009; Verbruggen F, 2009, J EXP PSYCHOL HUMAN, V35, P835, DOI 10.1037/a0012726; Ward H, 2007, CHILD NEUROPSYCHOL, V13, P219, DOI 10.1080/09297040600910003; Wassenberg R, 2004, BRAIN INJURY, V18, P751, DOI 10.1080/02699050410001671775; Watanabe J, 2002, NEUROIMAGE, V17, P1207, DOI 10.1006/nimg.2002.1198; Willcutt EG, 2005, BIOL PSYCHIAT, V57, P1336, DOI 10.1016/j.biopsych.2005.02.006; Williams BR, 1999, DEV PSYCHOL, V35, P205, DOI 10.1037/0012-1649.35.1.205; Yeates KO, 2005, J AM ACAD CHILD PSY, V44, P574, DOI 10.1097/01.chi.0000159947.50523.64; Yeates KO, 2000, SCI PRACT NEUROPSYCH, P92; Zelazo PD, 2006, NAT PROTOC, V1, P297, DOI 10.1038/nprot.2006.46	103	18	18	0	13	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0736-5748	1873-474X		INT J DEV NEUROSCI	Int. J. Dev. Neurosci.	MAY	2012	30	3			SI		207	215		10.1016/j.ijdevneu.2011.08.006			9	Developmental Biology; Neurosciences	Developmental Biology; Neurosciences & Neurology	936XH	WOS:000303622800006	22100363	Green Accepted			2021-06-18	
J	Teranishi, K; Scultetus, A; Haque, A; Stern, S; Philbin, N; Rice, J; Johnson, T; Auker, C; McCarron, R; Freilich, D; Arnaud, F				Teranishi, Kohsuke; Scultetus, Anke; Haque, Ashraful; Stern, Susan; Philbin, Nora; Rice, Jennifer; Johnson, Todd; Auker, Charles; McCarron, Richard; Freilich, Daniel; Arnaud, Francoise			Traumatic brain injury and severe uncontrolled haemorrhage with short delay pre-hospital resuscitation in a swine model	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Haemoglobin-based oxygen carrier; Polytrauma; Haemorrhagic shock; Traumatic brain injury; Resuscitation	CEREBRAL BLOOD-FLOW; POLYMERIZED HEMOGLOBIN HBOC-201; CARRYING SOLUTION HBOC-201; LOW-VOLUME RESUSCITATION; INTRACRANIAL-PRESSURE; OXYGEN CARRIER; FLUID RESUSCITATION; PORCINE MODEL; HEAD-INJURY; SHOCK	Introduction: Unavailability of blood (and oxygen delivery) for pre-hospital resuscitation in haemorrhagic shock patients are major problems, supporting the importance for novel resuscitation strategies. In a combined polytrauma model of uncontrolled haemorrhage and traumatic brain injury (TBI) in swine, we investigated if pre-hospital administration of the haemoglobin based oxygen carrier HBOC-201 will improve tissue oxygenation and physiologic parameters compared to Lactated Ringer's (LR) solution. Materials and methods: Anaesthetised Yorkshire swine underwent fluid-percussion TBI and Grade III liver laceration. During a 30-min pre-hospital phase, the animals were resuscitated with a single infusion of HBOC-201, LR solution, or nothing (NON). Upon hospital arrival, the animals were given blood or normal saline as needed. Surviving animals were euthanised 6 h post-injury. Cerebral blood flow was measured by microsphere injection, and pathology was assessed by gross observation and immunohistochemical analysis. Results: Mean TBI force (2.4 +/- 0.1 atm) (means +/- standard error of the mean) and blood loss (22.5 +/- 1.7 mL/kg) were similar between groups. Survival at the 6 h endpoint was similar in all groups (similar to 50%). Cerebral perfusion pressure (CPP) and brain tissue oxygen tension were significantly greater in HBOC-201 as compared with LR animals (p < 0.005). Mean arterial pressure (MAP) and mean pulmonary artery pressure (MPAP) were not significantly different amongst groups. Blood transfusion requirements were delayed in HBOC-201 animals. Animals treated with HBOC-201 or LR showed no immunohistopathological differences in glial fibrillary acidic protein (GFAP) and microtubule-associated protein 2 (MAP-2). Severity of subarachnoid and intraparenchymal haemorrhages were similar for HBOC and LR groups. Conclusion: In this polytrauma swine model of uncontrolled haemorrhage and TBI with a 30-min delay to hospital arrival, pre-hospital resuscitation with one bolus of HBOC-201 indicated short term benefits in systemic and cerebrovascular physiological parameters. True clinical benefits of this strategy need to be confirmed on TBI and haemorrhagic shock patients. (C) 2010 Elsevier Ltd. All rights reserved.	[Arnaud, Francoise] USN, Med Res Ctr, Operat & Undersea Med Directorate, NeuroTrauma Dept, Silver Spring, MD 20910 USA; [Teranishi, Kohsuke] Juntendo Univ, Sch Med, Dept Neurosurg, Tokyo 113, Japan; [Scultetus, Anke; McCarron, Richard; Freilich, Daniel; Arnaud, Francoise] Uniformed Serv Univ Hlth Sci, Dept Surg, Bethesda, MD 20814 USA; [Stern, Susan] Univ Washington, Dept Emergency, Seattle, WA 98195 USA; [Johnson, Todd] Walter Reed Army Inst Res, Dept Pathol, Silver Spring, MD USA	Arnaud, F (corresponding author), USN, Med Res Ctr, Operat & Undersea Med Directorate, NeuroTrauma Dept, 503 Robert Grant Ave, Silver Spring, MD 20910 USA.	Francoise.Arnaud@med.navy.mil			Naval Medical Research Center, Silver Spring, MD; DoD Work Unit [604771N.9737.001.A0315]	This work was performed at Naval Medical Research Center, Silver Spring, MD and was supported by funding from DoD Work Unit No. 604771N.9737.001.A0315. The views expressed in this article are those of the authors and do not necessarily reflect the official policy or position of the Department of the Navy, Department of Defense, nor the U. S. Government.	*AM ASS NEUR SURG, 1995, GUID MAN SEV HEAD IN; Arnaud F, 2007, TRANSFUSION, V47, P2098, DOI 10.1111/j.1537-2995.2007.01435.x; Asano Y, 1998, AM J PHYSIOL-HEART C, V275, pH1313; BICKELL WH, 1994, NEW ENGL J MED, V331, P1105, DOI 10.1056/NEJM199410273311701; Bullock R., 1996, EUR J EMERG MED, V3, P109, DOI 10.1097/00063110-199606000-00010; DEWITT DS, 1992, J NEUROSURG, V76, P812, DOI 10.3171/jns.1992.76.5.0812; GENNARELLI TA, 1994, J TRAUMA, V37, P962, DOI 10.1097/00005373-199412000-00016; GUNNAR W, 1988, SURGERY, V103, P398; Gurney J, 2004, J TRAUMA, V57, P726, DOI 10.1097/01.TA.0000147520.84792.B4; HARIRI RJ, 1993, J NEUROSURG, V79, P421, DOI 10.3171/jns.1993.79.3.0421; Katz LM, 2002, RESUSCITATION, V54, P77, DOI 10.1016/S0300-9572(02)00053-9; Kelly JF, 2008, J TRAUMA, V64, pS21, DOI 10.1097/TA.0b013e318160b9fb; Kerby JD, 2007, SHOCK, V27, P652, DOI 10.1097/01.shk.0000248584.10400.dc; King DR, 2005, J TRAUMA, V59, P553, DOI 10.1097/01.ta.0000177711.52191.62; KOWALENKO T, 1992, J TRAUMA, V33, P349, DOI 10.1097/00005373-199209000-00003; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lee SK, 2002, ACAD EMERG MED, V9, P969; McMahon CG, 1999, J TRAUMA, V47, P891, DOI 10.1097/00005373-199911000-00013; MILLER JD, 1978, JAMA-J AM MED ASSOC, V240, P439, DOI 10.1001/jama.240.5.439; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Ortegon DP, 2002, J TRAUMA, V53, P1068, DOI 10.1097/00005373-200212000-00007; Patel MB, 2006, J TRAUMA, V61, P46, DOI 10.1097/01.ta.0000219730.71206.3a; RAMMING S, 1994, J TRAUMA, V37, P705, DOI 10.1097/00005373-199411000-00003; Rebel A, 2002, AM J PHYSIOL-HEART C, V282, pH832, DOI 10.1152/ajpheart.00880.2001; Rice J, 2008, J TRAUMA, V64, P1240, DOI 10.1097/TA.0b013e318058245e; Rice J, 2006, J TRAUMA, V61, P1085, DOI 10.1097/01.ta.0000236640.62893.fa; Rosenthal G, 2008, J NEUROSURG, V108, P575, DOI 10.3171/JNS/2008/108/3/0575; Sampson JB, 2003, J TRAUMA, V55, P747, DOI 10.1097/01.TA.0000084519.47163.77; SHACKFORD SR, 1992, J NEUROSURG, V76, P91, DOI 10.3171/jns.1992.76.1.0091; SIEGEL JH, 1995, J NEUROTRAUM, V12, P579, DOI 10.1089/neu.1995.12.579; Stern S, 2008, SHOCK; STERN S, 1996, ACAD EMERG MED, V3, P545; STERN SA, 1995, ACAD EMERG MED, V2, P89, DOI 10.1111/j.1553-2712.1995.tb03167.x; Stern SA, 2000, J NEUROSURG, V93, P305, DOI 10.3171/jns.2000.93.2.0305; Talmor D, 1999, ANESTH ANALG, V89, P950, DOI 10.1097/00000539-199910000-00024; WALD SL, 1993, J TRAUMA, V34, P377, DOI 10.1097/00005373-199303000-00012; York GB, 2003, J TRAUMA, V55, P873, DOI 10.1097/01.TA.0000092681.17874.6F; YUAN XQ, 1991, J NEUROSURG, V75, P408, DOI 10.3171/jns.1991.75.3.0408	38	18	19	0	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	MAY	2012	43	5					585	593		10.1016/j.injury.2010.09.042			9	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	918RC	WOS:000302267100008	21036354				2021-06-18	
J	Triebel, KL; Martin, RC; Novack, TA; Dreer, L; Turner, C; Pritchard, PR; Raman, R; Marson, DC				Triebel, K. L.; Martin, R. C.; Novack, T. A.; Dreer, L.; Turner, C.; Pritchard, P. R.; Raman, R.; Marson, D. C.			Treatment consent capacity in patients with traumatic brain injury across a range of injury severity	NEUROLOGY			English	Article							DECISION-MAKING CAPACITY; MILD HEAD-INJURY; PERFUSION; AMNESIA; IMPAIRMENT; CONCUSSION; RECOVERY; 3T; CT	Objective: To investigate medical decision-making capacity (MDC) in patients with acute traumatic brain injury (TBI) across a range of injury severity. Methods: We evaluated MDC cross-sectionally 1 month after injury in 40 healthy controls and 86 patients with TBI stratified by injury severity (28 mild [mTBI], 15 complicated mild [cmTBI], 43 moderate/severe [msevTBI]). We compared group performance on the Capacity to Consent to Treatment Instrument and its 5 consent standards (expressing choice, reasonable choice, appreciation, reasoning, understanding). Capacity impairment ratings (no impairment, mild/moderate impairment, severe impairment) on the consent standards were also assigned to each participant with TBI using cut scores referenced to control performance. Results: One month after injury, the mTBI group performed equivalently to controls on all consent standards. In contrast, the cmTBI group was impaired relative to controls on the understanding standard. No differences emerged between the mTBI and cmTBI groups. The msevTBI group was impaired on almost all standards relative to both control and mTBI groups, and on the understanding standard relative to the cmTBI group. Capacity compromise (mild/moderate or severe impairment ratings) on the 3 clinically complex standards (understanding, reasoning, appreciation) occurred in 10%-30% of patients with mTBI, 50% of patients with cmTBI, and 50%-80% of patients with msevTBI. Conclusions: One month following injury, MDC is largely intact in patients with mTBI, but is impaired in patients with cmTBI and msevTBI. Impaired MDC is prevalent in acute TBI and is strongly related to injury severity. Neurology (R) 2012;78:1472-1478	[Triebel, K. L.; Martin, R. C.; Turner, C.; Marson, D. C.] Univ Alabama Birmingham, Dept Neurol, Div Neuropsychol, Birmingham, AL 35294 USA; [Novack, T. A.] Univ Alabama Birmingham, Dept Phys Med & Rehabil, Birmingham, AL USA; [Dreer, L.] Univ Alabama Birmingham, Dept Ophthalmol, Birmingham, AL USA; [Pritchard, P. R.] Univ Alabama Birmingham, Dept Surg, Div Neurosurg, Birmingham, AL USA; [Raman, R.] UCSD, Dept Family & Prevent Med, San Diego, CA USA	Marson, DC (corresponding author), Univ Alabama Birmingham, Dept Neurol, Div Neuropsychol, Birmingham, AL 35294 USA.	dmarson@uab.edu	triebel, kristen/A-6569-2019	triebel, kristen/0000-0001-9161-7847	National Institute on Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [1R01HD053074]; NIH (NICHD)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [1R01 HD053074, 2R01 AG021927-06A1, CDC MM-1042, NIA 2R01 AG021927-06A1]; National Institute on AgingUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30 AG031054, R01 AG021927, 1P50 AG16582, 1R01 AG021927, P30AG031054]; NIH for NICHD [1R01 HD053074]; National Eye InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [K23 EY017327]; EyeSight Foundation of Alabama; Research to Prevent BlindnessResearch to Prevent Blindness (RPB); Medtronic Spine LLC; NIH (NIA)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [AG021927, AG16582, AG24904, AG10483]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD053074] Funding Source: NIH RePORTER	Supported by the National Institute on Child Health and Human Development (1R01HD053074) (Dr. Marson, PI).; Dr. Triebel receives research support from the NIH (NICHD 1R01 HD053074 and 2R01 AG021927-06A1) and has received research support from the National Institute on Aging (P30 AG031054 and R01 AG021927). Dr. Martin receives research support from the NIH (NICHD 1R01 HD053074, 2R01 AG021927-06A1, and CDC MM-1042) and has received research support from the NIA (1P50 AG16582 and 1R01 AG021927). Dr. Novack receives research support from the NIH for NICHD 1R01 HD053074. Dr. Dreer receives research support from the National Eye Institute (K23 EY017327), the EyeSight Foundation of Alabama, and Research to Prevent Blindness, and has received research support from the National Institute on Aging (P30AG031054). Ms. Turner receives research support from the NIH for NICHD 1R01 HD053074. Dr. Pritchard receives research support from the NIH for NICHD 1R01 HD053074 and from Medtronic Spine LLC, and has served as a training and educational consultant for Medtronic/Kyphon. Dr. Marson serves as a consultant to Medivation, Inc. and for the American Bar Association and American Psychological Association; receives research support from the NIH (NICHD 1R01 HD053074 and NIA 2R01 AG021927-06A1); has received research support from the NIH (NIA AG021927, AG16582, NIA Director's Supplementary Reserve, AG24904, and AG10483); and receives royalty payments as coinventor of CCTI assessment instrument, which is owned by UAB Research Foundation (since 1996). Go to Neurology.org for full disclosures.	American Congress of Rehabilitation Medicine, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; APPELBAUM PS, 1988, NEW ENGL J MED, V319, P1635, DOI 10.1056/NEJM198812223192504; Borgaro SR, 2003, BRAIN INJURY, V17, P189, DOI 10.1080/0269905021000013183; Bushnik T, 2008, ARCH PHYS MED REHAB, V89, P894, DOI 10.1016/j.apmr.2008.03.001; Dahmer E., 1993, J HEAD TRAUMA REHAB, V8, P12, DOI [10.1097/00001199-199308020-00004, DOI 10.1097/00001199-199308020-00004]; de Guise E, 2010, CLIN NEUROPSYCHOL, V24, P1113, DOI 10.1080/13854046.2010.506199; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Dreer LE, 2008, REHABIL PSYCHOL, V53, P486, DOI 10.1037/a0013798; Dymek MP, 1999, J FORENSIC NEUROPSYC, V1, P27, DOI DOI 10.1300/J151V01N01_; Ge YL, 2009, BRAIN INJURY, V23, P666, DOI 10.1080/02699050903014899; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Iverson GL, 2006, BRAIN INJURY, V20, P1335, DOI 10.1080/02699050601082156; Kraus J, 2009, J HEAD TRAUMA REHAB, V24, P344, DOI 10.1097/HTR.0b013e3181ae35fd; Lee H, 2008, J NEUROTRAUM, V25, P1049, DOI 10.1089/neu.2008.0566; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Marson DC, 2005, ARCH PHYS MED REHAB, V86, P889, DOI 10.1016/j.apmr.2004.09.020; MARSON DC, 1995, ARCH NEUROL-CHICAGO, V52, P949, DOI 10.1001/archneur.1995.00540340029010; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea MA, 2007, MILD TRAUMATIC BRAIN; McKinlay W, 1999, REHABILITATION ADULT, V3, P74; Metting Z, 2010, J NEUROTRAUM, V27, P2183, DOI 10.1089/neu.2010.1395; Metting Z, 2009, ANN NEUROL, V66, P809, DOI 10.1002/ana.21785; MILLER JD, 1993, J NEUROL NEUROSUR PS, V56, P440, DOI 10.1136/jnnp.56.5.440; Okonkwo O, 2007, NEUROLOGY, V69, P1528, DOI 10.1212/01.wnl.0000277639.90611.d9; Pentland B, 1999, REHABILITATION ADULT, P42; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Rosenthal M, 2000, HANDBOOK OF REHABILITATION PSYCHOLOGY, P49, DOI 10.1037/10361-003; RUSSELL WR, 1961, ARCH NEUROL-CHICAGO, V5, P4, DOI 10.1001/archneur.1961.00450130006002; SPSS, 2004, STAT PACK SOC SCI SP; Sterr A, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-7; Triebel KL, 2009, NEUROLOGY, V73, P2086, DOI 10.1212/WNL.0b013e3181c67bce; Vanderploeg RD, 2005, J INT NEUROPSYCH SOC, V11, P228, DOI 10.1017/S1355617705050289	34	18	18	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0028-3878			NEUROLOGY	Neurology	MAY	2012	78	19					1472	1478		10.1212/WNL.0b013e3182553c38			7	Clinical Neurology	Neurosciences & Neurology	939AW	WOS:000303776900008	22496195	Green Published			2021-06-18	
J	Courtney, AC; Andrusiv, LP; Courtney, MW				Courtney, Amy C.; Andrusiv, Lubov P.; Courtney, Michael W.			Oxy-acetylene driven laboratory scale shock tubes for studying blast wave effects	REVIEW OF SCIENTIFIC INSTRUMENTS			English	Article							TRAUMATIC BRAIN-INJURY; MODEL	This paper describes the development and characterization of modular, oxy-acetylene driven laboratory scale shock tubes. Such tools are needed to produce realistic blast waves in a laboratory setting. The pressure-time profiles measured at 1 MHz using high-speed piezoelectric pressure sensors have relevant durations and show a true shock front and exponential decay characteristic of free-field blast waves. Descriptions are included for shock tube diameters of 27-79 mm. A range of peak pressures from 204 kPa to 1187 kPa (with 0.5-5.6% standard error of the mean) were produced by selection of the driver section diameter and distance from the shock tube opening. The peak pressures varied predictably with distance from the shock tube opening while maintaining both a true blast wave profile and relevant pulse duration for distances up to about one diameter from the shock tube opening. This shock tube design provides a more realistic blast profile than current compression-driven shock tubes, and it does not have a large jet effect. In addition, operation does not require specialized personnel or facilities like most blast-driven shock tubes, which reduces operating costs and effort and permits greater throughput and accessibility. It is expected to be useful in assessing the response of various sensors to shock wave loading; assessing the reflection, transmission, and absorption properties of candidate armor materials; assessing material properties at high rates of loading; assessing the response of biological materials to shock wave exposure; and providing a means to validate numerical models of the interaction of shock waves with structures. All of these activities have been difficult to pursue in a laboratory setting due in part to lack of appropriate means to produce a realistic blast loading profile. (C) 2012 American Institute of Physics. [http://dx.doi.org/10.1063/1.3702803]	[Courtney, Amy C.] Force Protect Ind Inc, R&D, Ladson, SC 29456 USA; [Andrusiv, Lubov P.; Courtney, Michael W.] USAF Acad, Colorado Springs, CO 80840 USA	Courtney, AC (corresponding author), Force Protect Ind Inc, R&D, 9801 Highway 78, Ladson, SC 29456 USA.	amy_courtney@post.harvard.edu		Courtney, Amy/0000-0002-1925-8736	BTG Research	This work was supported in part by BTG Research, www.btgresearch.org.	Alley M., 2009, THESIS PURDUE U W LA; Arun P, 2011, NEUROREPORT, V22, P379, DOI 10.1097/WNR.0b013e328346b138; Bauman RA, 2009, J NEUROTRAUM, V26, P841, DOI 10.1089/neu.2009-0898; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; Chavko M, 2007, J NEUROSCI METH, V159, P277, DOI 10.1016/j.jneumeth.2006.07.018; Chavko M, 2011, J NEUROSCI METH, V195, P61, DOI 10.1016/j.jneumeth.2010.11.019; Chen YC, 2009, J NEUROTRAUM, V26, P861, DOI 10.1089/neu.2008.0645; Courtney MW, 2010, REV SCI INSTRUM, V81, DOI 10.1063/1.3518970; DUFF RE, 1966, REV SCI INSTRUM, V37, P579, DOI 10.1063/1.1720256; Henshall B. D., 1957, AERONAUTICAL RES COU; Nakagawa A, 2011, J NEUROTRAUM, V28, P1101, DOI 10.1089/neu.2010.1442; Reneer DV, 2011, J NEUROTRAUM, V28, P95, DOI 10.1089/neu.2010.1513; Richmond D. R., 1966, 1854 DASA; Risling Marten, 2010, Front Neurol, V1, P1, DOI 10.3389/fneur.2010.00001; Segars R. A., 2008, NATICKTR09010 US ARM; SNYDER AD, 1965, AFAPLTR6593; Wang ZG, 1998, CHINESE MED J-PEKING, V111, P109	17	18	20	1	15	AMER INST PHYSICS	MELVILLE	CIRCULATION & FULFILLMENT DIV, 2 HUNTINGTON QUADRANGLE, STE 1 N O 1, MELVILLE, NY 11747-4501 USA	0034-6748			REV SCI INSTRUM	Rev. Sci. Instrum.	APR	2012	83	4							045111	10.1063/1.3702803			7	Instruments & Instrumentation; Physics, Applied	Instruments & Instrumentation; Physics	934BO	WOS:000303415300073	22559580				2021-06-18	
J	Helton, WS; Head, J				Helton, William S.; Head, James			Earthquakes on the Mind: Implications of Disasters for Human Performance	HUMAN FACTORS			English	Article						attention; disaster; earthquake; response inhibition; stress; sustained attention; vigilance	TRAUMATIC BRAIN-INJURY; SUSTAINED ATTENTION; TARGET DETECTION; TASK; VIGILANCE; DEPRESSION; DISORDER; FAILURES; VALIDITY; STIMULI	Objective: The present study explored the impact a natural disaster has on human performance. Background: Previous research indicates that traffic accidents increase after disasters. A plausible explanation for this finding is that disasters induce cognitive disruption and this disruption negatively affects performance (e.g., driving quality). Method: A total of 16 participants (7 men and 9 women) performed a sustained-attention-to-response task before and after a 7.1-magnitude earthquake. Performance (errors of omission, errors of commission, and reaction time) was compared before and after the earthquake. Results: Errors of omission increased after the earthquake. Changes in errors of commission and reaction times were, however, dependent on individual differences in stress response to the earthquake. Conclusion: The results indicate that natural disasters may have a negative impact on performance. Application: Communities need to be aware of the increased risk of accidents following disasters and develop countermeasures, including individualized assessment tools.	[Helton, William S.] Univ Canterbury, Dept Psychol, Christchurch 8140, New Zealand	Helton, WS (corresponding author), Univ Canterbury, Dept Psychol, Private Bag 4800, Christchurch 8140, New Zealand.	Deak.Helton@canterbury.ac.nz					Bergiannaki JD, 2003, ACTA PSYCHIAT SCAND, V107, P18, DOI 10.1034/j.1600-0447.2003.01467.x; CARDENA E, 1993, AM J PSYCHIAT, V150, P474; Chan RCK, 2001, BRAIN INJURY, V15, P819, DOI 10.1080/02699050119721; Cheyne JA, 2009, COGNITION, V111, P98, DOI 10.1016/j.cognition.2008.12.009; Cheyne JA, 2006, CONSCIOUS COGN, V15, P578, DOI 10.1016/j.concog.2005.11.009; COLQUHOUN WP, 1970, HUM FACTORS, V12, P537, DOI 10.1177/001872087001200603; Dockree PM, 2006, EXP BRAIN RES, V168, P218, DOI 10.1007/s00221-005-0079-x; Dockree PM, 2004, COGNITIVE BRAIN RES, V20, P403, DOI 10.1016/j.cogbrainres.2004.03.019; Eysenck MW, 2007, EMOTION, V7, P336, DOI 10.1037/1528-3542.7.2.336; Gigerenzer G, 2004, PSYCHOL SCI, V15, P286, DOI 10.1111/j.0956-7976.2004.00668.x; Gosling SD, 2003, J RES PERS, V37, P504, DOI 10.1016/S0092-6566(03)00046-1; Helton WS, 2008, ACTA PSYCHOL, V129, P18, DOI 10.1016/j.actpsy.2008.04.002; Helton WS, 2011, HUM FACTORS, V53, P132, DOI 10.1177/0018720811401385; Helton WS, 2011, EXP BRAIN RES, V209, P401, DOI 10.1007/s00221-011-2563-9; Helton WS, 2010, BRAIN COGNITION, V74, P75, DOI 10.1016/j.bandc.2010.06.008; Helton WS, 2010, CONSCIOUS COGN, V19, P77, DOI 10.1016/j.concog.2010.01.006; Helton WS, 2009, CONSCIOUS COGN, V18, P600, DOI 10.1016/j.concog.2009.06.002; Helton WS, 2009, J CLIN EXP NEUROPSYC, V31, P39, DOI 10.1080/13803390801978856; Henry JD, 2005, BRIT J CLIN PSYCHOL, V44, P227, DOI 10.1348/014466505X29657; Johnson KA, 2007, NEUROPSYCHOLOGIA, V45, P630, DOI 10.1016/j.neuropsychologia.2006.03.034; Kemp S., AUSTR J DIS IN PRESS; Mcvay JC, 2010, PSYCHOL BULL, V136, P188, DOI 10.1037/a0018298; Neria Y, 2008, PSYCHOL MED, V38, P467, DOI 10.1017/S0033291707001353; NOLENHOEKSEMA S, 1991, J PERS SOC PSYCHOL, V61, P115, DOI 10.1037/0022-3514.61.1.115; Ossowski U, 2011, CONSCIOUS COGN, V20, P1649, DOI 10.1016/j.concog.2011.08.015; PARASURAMAN R, 1991, PSYCHOL AGING, V6, P155, DOI 10.1037/0882-7974.6.2.155; Peebles D, 2004, PROCEEDINGS OF THE SIXTH INTERNATIONAL CONFERENCE ON COGNITIVE MODELING, P231; Robertson IH, 1997, NEUROPSYCHOLOGIA, V35, P747, DOI 10.1016/S0028-3932(97)00015-8; Smallwood J, 2004, CONSCIOUS COGN, V13, P657, DOI 10.1016/j.concog.2004.06.003; Smallwood JM, 2003, CONSCIOUS COGN, V12, P452, DOI 10.1016/S1053-8100(03)00018-7; Smallwood J, 2006, PSYCHOL BULL, V132, P946, DOI 10.1037/0033-2909.132.6.946; Smallwood J, 2010, PSYCHOL BULL, V136, P202, DOI 10.1037/a0018673; Smallwood J, 2009, EMOTION, V9, P271, DOI 10.1037/a0014855; Smilek D, 2010, NEUROPSYCHOLOGIA, V48, P2564, DOI 10.1016/j.neuropsychologia.2010.05.002; Stecklov G, 2004, P NATL ACAD SCI USA, V101, P14551, DOI 10.1073/pnas.0402483101; Su JC, 2009, PSYCHOL SCI, V20, P59, DOI 10.1111/j.1467-9280.2008.02257.x; Whyte J, 2006, NEUROPSYCHOLOGIA, V44, P2007, DOI 10.1016/j.neuropsychologia.2006.02.012	37	18	18	0	13	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0018-7208	1547-8181		HUM FACTORS	Hum. Factors	APR	2012	54	2					189	194		10.1177/0018720811430503			6	Behavioral Sciences; Engineering, Industrial; Ergonomics; Psychology, Applied; Psychology	Behavioral Sciences; Engineering; Psychology	915FJ	WOS:000302009200003	22624286				2021-06-18	
J	LaPar, DJ; Rosenberger, LH; Walters, DM; Hedrick, TL; Swenson, BR; Young, JS; Dossett, LA; May, AK; Sawyer, RG				LaPar, Damien J.; Rosenberger, Laura H.; Walters, Dustin M.; Hedrick, Traci L.; Swenson, Brian R.; Young, Jeffrey S.; Dossett, Lesly A.; May, Addison K.; Sawyer, Robert G.			Severe Traumatic Head Injury Affects Systemic Cytokine Expression	JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS			English	Article; Proceedings Paper	123rd Annual Meeting of the Southern-Surgical-Association	DEC, 2011	Hot Springs, VA	So Surg Assoc			TUMOR-NECROSIS-FACTOR; BRAIN-INJURY; CEREBROSPINAL-FLUID; INTERLEUKIN-6; PATHOGENESIS; INFLAMMATION; DYSFUNCTION; SURVIVAL; ALPHA; CELLS	BACKGROUND: The neuroimmunologic effect of traumatic head injury remains ill-defined. This study aimed to characterize systemic cytokine profiles among traumatically injured patients to assess the effect of traumatic head injury on the systemic inflammatory response. STUDY DESIGN: For 5 years, 1,022 patients were evaluated from a multi-institutional Trauma Immunomodulatory Database. Patients were stratified by presence of severe head injury (SHI; head Injury Severity Score >= 4, n = 335) vs nonsevere head injury (NHI; head Injury Severity Score <= 3, n = 687). Systemic cytokine expression was quantified by ELISA within 72 hours of admission. Patient factors, outcomes, and cytokine profiles were compared by univariate analyses. RESULTS: SHI patients were more severely injured with higher mortality, despite similar ICU infection and ventilator-associated pneumonia rates. Expression of early proinflammatory cytokines, interleukin-6 (p < 0.001) and tumor necrosis factor-alpha (p = 0.02), was higher among NHI patients, and expression of immunomodulatory cytokines, interferon-gamma (p = 0.01) and interleukin-12 (p = 0.003), was higher in SHI patients. High tumor necrosis factor-alpha levels in NHI patients were associated with mortality (p = 0.01), increased mechanical ventilation (p = 0.02), and development of ventilator-associated pneumonia (p = 0.01). Alternatively, among SHI patients, high interleukin-2 levels were associated with survival, decreased mechanical ventilation, and absence of ventilator-associated pneumonia. CONCLUSIONS: The presence of severe traumatic head injury significantly alters systemic cytokine expression and exerts an immunomodulatory effect. Early recognition of these profiles can allow for targeted intervention to reduce patient morbidity and mortality. (J Am Coll Surg 2012;214:478-488. (C) 2012 by the American College of Surgeons)	[LaPar, Damien J.; Rosenberger, Laura H.; Walters, Dustin M.; Hedrick, Traci L.; Swenson, Brian R.; Young, Jeffrey S.; Sawyer, Robert G.] Univ Virginia, Dept Surg, Div Trauma & Surg Crit Care, Charlottesville, VA 22903 USA; [Dossett, Lesly A.; May, Addison K.] Vanderbilt Univ, Dept Surg, Med Ctr, Div Trauma & Surg Crit Care, Nashville, TN 37240 USA	LaPar, DJ (corresponding author), Univ Virginia, Dept Surg, Div Trauma & Surg Crit Care, POB 800681, Charlottesville, VA 22903 USA.	djl8w@virginia.edu	Dossett, Lesly/I-8881-2019; Hedrick, Traci/AAG-9788-2019	Dossett, Lesly/0000-0001-8060-1073; Sawyer, Robert/0000-0002-8155-2661	NHLBI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [T32 HL007849-11A1, T32 HL007849] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [T32HL007849] Funding Source: NIH RePORTER		BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Boddie DE, 2003, BRIT J NEUROSURG, V17, P405, DOI 10.1080/02688690310001611198; BONE RC, 1991, ANN INTERN MED, V115, P457, DOI 10.7326/0003-4819-115-6-457; Bone RC, 1997, CHEST, V112, P235, DOI 10.1378/chest.112.1.235; *CDCP, 2010, NAT VIT STAT REP, V58; Correale J, 2004, J NEUROL, V251, P1304, DOI 10.1007/s00415-004-0649-z; Csuka E, 1999, J NEUROIMMUNOL, V101, P211, DOI 10.1016/S0165-5728(99)00148-4; Delgado-Rodriguez M, 1999, J HOSP INFECT, V41, P203, DOI 10.1016/S0195-6701(99)90017-8; Fan L, 1996, MOL BRAIN RES, V36, P287, DOI 10.1016/0169-328X(95)00274-V; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; GOODMAN JC, 1990, J NEUROIMMUNOL, V30, P213; HAMA T, 1989, NEUROSCI LETT, V104, P340, DOI 10.1016/0304-3940(89)90600-9; HELLING TS, 1988, J TRAUMA, V28, P1575, DOI 10.1097/00005373-198811000-00009; Helmy A, 2011, PROG NEUROBIOL, V95, P352, DOI 10.1016/j.pneurobio.2011.09.003; Hranjec T, 2010, J AM COLL SURGEONS, V210, P833, DOI 10.1016/j.jamcollsurg.2009.12.042; Jones NC, 2005, EUR J NEUROSCI, V22, P72, DOI 10.1111/j.1460-9568.2005.04221.x; Kadhim Hazim J, 2008, J Intensive Care Med, V23, P236, DOI 10.1177/0885066608318458; KOSSMANN T, 1995, SHOCK, V4, P311, DOI 10.1097/00024382-199511000-00001; Kossmann T, 1996, BRAIN RES, V713, P143, DOI 10.1016/0006-8993(95)01501-9; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; MILLER C H, 1991, Neurological Research, V13, P117; Morganti-Kossmann MC, 2007, INJURY, V38, P1392, DOI 10.1016/j.injury.2007.10.005; Morganti-Kossmann MC, 2001, SHOCK, V16, P165, DOI 10.1097/00024382-200116030-00001; MorgantiKossman MC, 1997, MOL PSYCHIATR, V2, P133, DOI 10.1038/sj.mp.4000227; OTT L, 1994, J NEUROTRAUM, V11, P447, DOI 10.1089/neu.1994.11.447; QUATTROCCHI K B, 1991, Neurological Research, V13, P13; QUATTROCCHI KB, 1991, J NEUROSURG, V75, P766, DOI 10.3171/jns.1991.75.5.0766; Sanderson KL, 1999, J CEREBR BLOOD F MET, V19, P1118, DOI 10.1097/00004647-199910000-00008; SATOH T, 1988, MOL CELL BIOL, V8, P3546, DOI 10.1128/MCB.8.8.3546; TAUPIN V, 1993, J NEUROIMMUNOL, V42, P177, DOI 10.1016/0165-5728(93)90008-M; Whalen MJ, 2000, CRIT CARE MED, V28, P929, DOI 10.1097/00003246-200004000-00003; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	32	18	21	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1072-7515	1879-1190		J AM COLL SURGEONS	J. Am. Coll. Surg.	APR	2012	214	4					478	486		10.1016/j.jamcollsurg.2011.12.015			9	Surgery	Surgery	921NW	WOS:000302485300019	22342787	Green Accepted			2021-06-18	
J	Arazpour, M; Chitsazan, A; Hutchins, SW; Ghomshe, FT; Mousavi, ME; Takamjani, EE; Aminian, G; Rahgozar, M; Bani, MA				Arazpour, Mokhtar; Chitsazan, Ahmad; Hutchins, Stephen W.; Ghomshe, Farhad Tabatabai; Mousavi, Mohammad Ebrahim; Takamjani, Esmaeil Ebrahimi; Aminian, Gholamreza; Rahgozar, Mehdi; Bani, Monireh Ahmadi			Design and simulation of a new powered gait orthosis for paraplegic patients	PROSTHETICS AND ORTHOTICS INTERNATIONAL			English	Article						Fabrication techniques; lower limb orthotics; paraplegia	FUNCTIONAL ELECTRICAL-STIMULATION; CONTROL WBC ORTHOSIS; SPINAL-CORD-INJURY; ENERGY-EXPENDITURE; WALKING; HIP; AMBULATION; PERFORMANCE; SYSTEM; JOINT	Background and Aim: This article describes the development and testing of a new powered gait orthosis to potentially assist spinal cord injury patients to walk by producing synchronized hip and knee joint movements. Technique: The first evaluation of the orthosis was performed without users, and was followed by evaluation of the orthosis performance using three healthy subjects to test the structure under weight-bearing conditions. The orthosis was primarily evaluated to ascertain its ability to generate appropriate hip and knee motion during walking. The walking experiments replicated the flexion and extension of both the hip and knee produced by the actuators which had previously been demonstrated during the initial computer simulations. Discussion: The results suggest that this new orthosis could be used to assist paraplegic subjects who have adequate ranges of motion and also with weakness or reduced tone to ambulate, and may also be suitable for other subjects with impaired lower limb function (e.g. stroke, poliomyelitis, myelomeningocele and traumatic brain injury provided they do not have increased tone or movement disorders.	[Arazpour, Mokhtar; Ghomshe, Farhad Tabatabai; Mousavi, Mohammad Ebrahim; Aminian, Gholamreza; Rahgozar, Mehdi; Bani, Monireh Ahmadi] Univ Social Welf & Rehabil Sci, Tehran, Iran; [Chitsazan, Ahmad] Amirkabir Univ Technol, Tehran, Iran; [Hutchins, Stephen W.] Univ Salford, Fac Hlth & Social Care, IHSCR, Salford M5 4WT, Lancs, England; [Takamjani, Esmaeil Ebrahimi] Univ Tehran Med Sci, Tehran, Iran	Arazpour, M (corresponding author), Univ Social Welf & Rehabil Sci, Tehran, Iran.	M.Arazpour@uswr.ac.ir	rahgozar, mehdi/P-4913-2017; aminian, gholamreza/D-9106-2017; arazpour, Mokhtar/D-9132-2017; Bani, Monireh Ahmadi/D-9121-2017; Ebrahimi-Takamjani, Ismail/P-3602-2018	ebrahimi, ismail/0000-0003-1784-0244; Tabatabai Ghomsheh, Farhad/0000-0002-0754-0814; Ebrahimi-Takamjani, Ismail/0000-0002-5855-8432			Audu ML, 2010, IEEE T NEUR SYS REH, V18, P610, DOI 10.1109/TNSRE.2010.2047594; BERNARDI M, 1995, PARAPLEGIA, V33, P409, DOI 10.1038/sc.1995.91; Dall PM, 1999, PROSTHET ORTHOT INT, V23, P152; Dollar AM, 2008, IEEE T ROBOT, V24, P144, DOI 10.1109/TRO.2008.915453; Franceschini M, 1997, ARCH PHYS MED REHAB, V78, P582, DOI 10.1016/S0003-9993(97)90422-6; GELLMAN H, 1988, J BONE JOINT SURG AM, V70A, P517, DOI 10.2106/00004623-198870040-00006; Genda E, 2004, PROSTHET ORTHOT INT, V28, P69; Harvey LA, 1998, ARCH PHYS MED REHAB, V79, P945, DOI 10.1016/S0003-9993(98)90092-2; HIROKAWA S, 1990, ARCH PHYS MED REHAB, V71, P687; Jaspers P, 1997, SPINAL CORD, V35, P585, DOI 10.1038/sj.sc.3100462; Kang S, 2007, IFMBE PROC, V14, P2889; Kawashima N, 2003, SPINAL CORD, V41, P506, DOI 10.1038/sj.sc.3101494; Kirtley C, 1992, 7 WORLD C INT SOC PR; Leung A, 2009, PROSTHET ORTHOT INT, V33, P61, DOI 10.1080/03093640802562368; Lissons M, 1992, 7 WORLD C INT SOC PR; Massucci M, 1998, SPINAL CORD, V36, P223, DOI 10.1038/sj.sc.3100564; Motlock WM, 1992, P 7 WORLD C INT SOC, P28; NENE AV, 1990, ARCH PHYS MED REHAB, V71, P116; Ohta Y, 2007, P I MECH ENG H, V221, P629, DOI 10.1243/09544119JEIM55; PHILLIPS CA, 1991, PARAPLEGIA, V29, P268, DOI 10.1038/sc.1991.38; Ruthenberg BJ, 1997, J REHABIL RES DEV, V34, P203; Saitoh E, 1996, AM J PHYS MED REHAB, V75, P198, DOI 10.1097/00002060-199605000-00010; Solomonow M, 1988, IEEE ENG MED BIOL SO, V10, P1672; SYKES L, 1995, ARCH PHYS MED REHAB, V76, P779, DOI 10.1016/S0003-9993(95)80534-6; TASHMAN S, 1995, J BIOMECH ENG-T ASME, V117, P300, DOI 10.1115/1.2794185; WINCHESTER PK, 1993, PROSTHET ORTHOT INT, V17, P101; Yakimovich T, 2009, J REHABIL RES DEV, V46, P257, DOI 10.1682/JRRD.2008.02.0024; Yang L, 1996, J BIOMECH, V29, P217, DOI 10.1016/0021-9290(95)00018-6; Yang L, 1997, ARTIF ORGANS, V21, P183, DOI 10.1111/j.1525-1594.1997.tb04648.x; Yano H, 1997, PROSTHET ORTHOT INT, V21, P222	30	18	18	0	18	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0309-3646	1746-1553		PROSTHET ORTHOT INT	Prosthet. Orthot. Int.	MAR	2012	36	1					125	130		10.1177/0309364611431481			6	Orthopedics; Rehabilitation	Orthopedics; Rehabilitation	962TQ	WOS:000305568400016	22235109	Bronze			2021-06-18	
J	Blyth, T; Scott, A; Bond, A; Paul, E				Blyth, Tanya; Scott, Amanda; Bond, Annabelle; Paul, Eldho			A comparison of two assessments of high level cognitive communication disorders in mild traumatic brain injury	BRAIN INJURY			English	Article						Assessment; closed head injury; cognitive; language	STATUS EXAMINATION COGNISTAT	Primary objectives: Individuals with traumatic brain injury (TBI) frequently encounter cognitive communication disorders. Deficits can be subtle but can seriously influence an individual's ability to achieve life goals. Feedback from rehabilitation facilities indicated that high level cognitive communication disorders are not consistently identified in the acute setting. This study aimed to compare the cognitive communication results from two screening assessments, the Cognistat and the Cognitive Linguistic Quick Test (CLQT), in participants with a mild traumatic brain injury and to relate these findings to a range of prognostic indicators. Methods: Eighty-three adults post-TBI (16-81 years; 79.5% males) were recruited at an acute trauma centre. The language components of the two tests were analysed. Main outcomes and results: The CLQT identified more participants with an impairment in language than the Cognistat, 19.3% compared to 1.2% (p < 0.001). No clinical variables relating to the participants' brain injury were found to be associated with language impairment. Conclusions: This study found that the CLQT identified more individuals with high level cognitive communication deficits than the Cognistat in the acute setting.	[Blyth, Tanya; Scott, Amanda] The Alfred, Speech Pathol Dept, Melbourne, Vic, Australia; [Bond, Annabelle] The Alfred, Occupat Therapy Dept, Melbourne, Vic, Australia; [Paul, Eldho] Monash Univ, Dept Epidemiol & Preventat Med, Melbourne, Vic 3004, Australia	Blyth, T (corresponding author), The Alfred, POB 315, Prahran, Vic 3181, Australia.	t.blyth@alfred.org.au		Paul, Eldho/0000-0003-1263-7255	Royal Automobile Club of Victoria; Sir Edmund Herring Scholarship	This research was funded by the Royal Automobile Club of Victoria with the Sir Edmund Herring Scholarship.	Bara BG, 2001, BRAIN LANG, V77, P72, DOI 10.1006/brln.2000.2430; Bergeron E, 2003, EUR J TRAUMA, V29, P85; Borgaro SR, 2003, BRAIN INJURY, V17, P189, DOI 10.1080/0269905021000013183; Doninger NA, 2000, J HEAD TRAUMA REHAB, V15, P683, DOI 10.1097/00001199-200002000-00007; Doninger NA, 2006, REHABIL PSYCHOL, V51, P281, DOI 10.1037/0090-5550.51.4.281; Duff MC, 2002, BRAIN INJURY, V16, P773, DOI 10.1080/02699050210128870; Hart T, 2003, ARCH PHYS MED REHAB, V84, P221, DOI 10.1053/apmr.2003.50023; Helm-Estabrooks N., 2001, COGNITIVE LINGUISTIC; Hinchliffe FJ, 2001, TRAUMATIC BRAIN INJU, P199; LeBlanc J, 2006, BRAIN INJURY, V20, P1391, DOI 10.1080/02699050601081927; Lee H, 2008, J NEUROTRAUM, V25, P1049, DOI 10.1089/neu.2008.0566; Lynch WJ, 2002, J HEAD TRAUMA REHAB, V17, P66, DOI 10.1097/00001199-200202000-00009; Malojcic B, 2008, J NEUROTRAUM, V25, P30, DOI 10.1089/neu.2007.0384; Marosszeky NEV, 1997, PTA PROTOCOL GUIDELI; Mittenberg W, 2000, J HEAD TRAUMA REHAB, V15, P783, DOI 10.1097/00001199-200004000-00003; Morarty J, 2005, 6 WORLD C BRAIN INJ; Mueller J., 2007, COGNISTAT MANUAL; Nabors NA, 1997, J HEAD TRAUMA REHAB, V12, P79, DOI 10.1097/00001199-199706000-00008; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P1; Shames J, 2007, DISABIL REHABIL, V29, P1387, DOI 10.1080/09638280701315011; Tate RL, 2008, AUSTR NZ J PUBLIC HL, V22, P419; Whelan BM, 2006, BRAIN LANG, V99, P183, DOI 10.1016/j.bandl.2006.06.100; Ylvisaker M, 2000, LANGUAGE INTERVENTIO, P745	24	18	18	1	15	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	MAR	2012	26	3					234	240		10.3109/02699052.2012.654587			7	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	899XD	WOS:000300849100004	22372411				2021-06-18	
J	Bramley, H; Kroft, C; Polk, D; Newberry, T; Silvis, M				Bramley, Harry; Kroft, Christopher; Polk, David; Newberry, Ty; Silvis, Matthew			Do Youth Hockey Coaches Allow Players With a Known Concussion to Participate in a Game?	CLINICAL PEDIATRICS			English	Article						concussion; traumatic brain injury; head injuries; pediatrics; hockey	SPORT-RELATED CONCUSSION; CLINICAL VIGNETTES; PHYSICIAN PRACTICE; UNITED-STATES; BRAIN-INJURY; QUALITY; IMPACT; RISK	Ice hockey is a high-risk sport for concussion. It is important that coaches have an understanding of concussion, although previous studies have demonstrated poor knowledge of concussion recognition and management by youth coaches. A cross-sectional survey with 7 case scenarios was completed by 314 youth hockey coaches. Each case scenario described a player with a concussion during a game, and scores reflected how the coach would respond to each scenario. Although most coaches would not allow a player to continue participating in a game after suffering a concussion, there was a small percentage that would. Statistical analysis found an inverse relationship between the coaches' age and consideration of continued participation. This places athletes at significant risk for further injury and is not consistent with current concussion guidelines. USA Hockey should provide additional concussion training for their coaches as well as mandatory health care clearance following a concussion.	[Bramley, Harry] Penn State Milton S Hershey Med Ctr, Dept Pediat, Hershey, PA 17033 USA; [Kroft, Christopher; Polk, David] York Coll Penn, York, PA USA; [Newberry, Ty] USA Hockey, Washington, DC USA	Bramley, H (corresponding author), Penn State Milton S Hershey Med Ctr, Dept Pediat, Mail Code H085,500 Univ Dr, Hershey, PA 17033 USA.	hbramley@hmc.psu.edu					*BOST U CTR STUD T, CAS STUD; CANTU RC, 1995, PHYSICIAN SPORTSMED, V23, P27, DOI 10.1080/00913847.1995.11947799; *CDCP, 1997, MMWR-MORBID MORTAL W, V46, P224; Emery CA, 2010, JAMA-J AM MED ASSOC, V303, P2265, DOI 10.1001/jama.2010.755; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; HockeyCanada, HOCK CAN ANN REP 200; Jotwani V, 2010, CURR SPORT MED REP, V9, P21, DOI 10.1249/JSR.0b013e3181ccb55e; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; McCrory P, 2001, CLIN J SPORT MED, V11, P144, DOI 10.1097/00042752-200107000-00004; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; McLeod TCV, 2007, CLIN J SPORT MED, V17, P140; National Federation of State High School Association, CONC SPORT WHAT YOU; Peabody JW, 2004, ANN INTERN MED, V141, P771, DOI 10.7326/0003-4819-141-10-200411160-00008; Pham T, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-128; Pittsburgh Amateur Hockey League, RUL REG 2010 2011 SE; Roberts WO, 1999, MED SCI SPORT EXER, V31, P46, DOI 10.1097/00005768-199901000-00009; Sosin DM, 1996, BRAIN INJURY, V10, P47; US Department of Health and Human Services Centers for Disease Control and Prevention, 2005, HEADS TOOLK; USA Hockey, USA HOCK BOARD DIR A; USAHockey, 2009, USA HOCK ANN C REG R; *WA STAT DEP HLTH, CONC MAN SCH SPORTS	23	18	18	0	10	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0009-9228			CLIN PEDIATR	Clin. Pediatr.	MAR	2012	51	3					283	287		10.1177/0009922811422434			5	Pediatrics	Pediatrics	899AB	WOS:000300782400014	21937746				2021-06-18	
J	Loske, P; Boato, F; Hendrix, S; Piepgras, J; Just, I; Ahnert-Hilger, G; Holtje, M				Loske, Peter; Boato, Francesco; Hendrix, Sven; Piepgras, Johannes; Just, Ingo; Ahnert-Hilger, Gudrun; Hoeltje, Markus			Minimal essential length of Clostridium botulinum C3 peptides to enhance neuronal regenerative growth and connectivity in a non-enzymatic mode	JOURNAL OF NEUROCHEMISTRY			English	Article						C3 transferase; regeneration; RhoA; spinal cord injury	SPINAL-CORD-INJURY; RHO; RECEPTOR; PROTEIN; OUTGROWTH; MOTONEURONS; INHIBITOR; EXOENZYME; RECOVERY; INSIGHTS	C3 ADP-ribosyltransferase is a valuable tool to study Rho-dependent cellular processes. In the current study we investigated the impact of enzyme-deficient peptides derived from Clostridium botulinum C3 transferase in the context of neuronal process elongation and branching, synaptic connectivity, and putative beneficial effects on functional outcome following traumatic injury to the CNS. By screening a range of peptidic fragments, we identified three short peptides from C3bot that promoted axon and dendrite outgrowth in cultivated hippocampal neurons. Furthermore, one of these fragments, a 26-amino acid peptide covering the residues 156181 enhanced synaptic connectivity in primary hippocampal culture. This peptide was also effective to foster axon outgrowth and re-innervation in organotypical brain slice culture. To evaluate the potential of the 26mer to foster repair mechanisms after CNS injury we applied this peptide to mice subjected to spinal cord injury by either compression impact or hemisection. A single local administration at the site of the lesion improved locomotor recovery. In addition, histological analysis revealed an increased serotonergic input to lumbar motoneurons in treated compared with control mice. Pull-down assays showed that lesion-induced up-regulation of RhoA activity within the spinal cord was largely blocked by C3bot peptides despite the lack of enzymatic activity.	[Hoeltje, Markus] Charite, Inst Integrat Neuroanat, Ctr Anat, D-10115 Berlin, Germany; [Boato, Francesco; Hendrix, Sven] Hasselt Univ, Dept Morphol, Hasselt, Belgium; [Boato, Francesco; Hendrix, Sven] Hasselt Univ, Inst Biomed, Hasselt, Belgium; [Just, Ingo] Hannover Med Sch MHH, Inst Toxicol, Hannover, Germany	Holtje, M (corresponding author), Charite, Inst Integrat Neuroanat, Ctr Anat, Philippstr 12, D-10115 Berlin, Germany.	markus.hoeltje@charite.de	Hendrix, Sven/F-4059-2010	Hendrix, Sven/0000-0003-2344-7369; Boato, Francesco/0000-0001-9741-8021	Deutsche Forschungsgemeinschaft (DFG)German Research Foundation (DFG) [HO 3249/2-1, JU 231/5-1, SPP1394]; Berlin-Brandenburg Center for Regenerative Therapies; Flemish Research Council (FWO)FWO	The authors are indebted to Birgit Metze, Annemarie Lochner and Julia Konig for their engaged and skillful technical assistance. Work was supported by grants from the Deutsche Forschungsgemeinschaft (DFG) to MH and GAH (HO 3249/2-1), IJ (JU 231/5-1) and SH (SPP1394). This study was also supported in part by grants from the Berlin-Brandenburg Center for Regenerative Therapies and the Flemish Research Council (FWO) to SH. All authors declare no conflicts of interest.	Ahnert-Hilger G, 2004, J NEUROCHEM, V90, P9, DOI 10.1111/j.1471-4159.2004.02475.x; Aktories K, 2005, CURR TOP MICROBIOL, V291, P113; Albertinazzi C, 1998, J CELL BIOL, V142, P815, DOI 10.1083/jcb.142.3.815; Basso DM, 2006, J NEUROTRAUM, V23, P635, DOI 10.1089/neu.2006.23.635; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Bertrand J, 2007, NEUROBIOL DIS, V25, P65, DOI 10.1016/j.nbd.2006.08.008; Boato F, 2010, J CELL SCI, V123, P1652, DOI 10.1242/jcs.066050; Boido M, 2009, EUR J NEUROSCI, V30, P833, DOI 10.1111/j.1460-9568.2009.06879.x; Chen HX, 2007, J NEUROSCI, V27, P8378, DOI 10.1523/JNEUROSCI.0872-07.2007; Conrad S, 2005, J COMP NEUROL, V487, P166, DOI 10.1002/cne.20561; Dergham P, 2002, J NEUROSCI, V22, P6570; Dubreuil CI, 2003, J CELL BIOL, V162, P233, DOI 10.1083/jcb.200301080; Hall A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001818; Han SI, 2001, J MOL BIOL, V305, P95, DOI 10.1006/jmbi.2000.4292; Harvey PJ, 2006, J NEUROPHYSIOL, V96, P1158, DOI 10.1152/jn.01088.2005; Hechler D, 2006, BRAIN RES REV, V52, P160, DOI 10.1016/j.brainresrev.2006.01.005; Hechler D, 2010, EXP BRAIN RES, V205, P215, DOI 10.1007/s00221-010-2355-7; Henneberger C, 2005, EUR J NEUROSCI, V21, P431, DOI 10.1111/j.1460-9568.2005.03869.x; Holtje M, 2009, FASEB J, V23, P1115, DOI 10.1096/fj.08-116855; Jin Z, 1997, J NEUROSCI, V17, P6256; Just I, 2011, N-S ARCH PHARMACOL, V383, P247, DOI 10.1007/s00210-010-0589-3; Kakimoto T, 2006, J BIOL CHEM, V281, P29042, DOI 10.1074/jbc.M604025200; Kalil K, 2000, J NEUROBIOL, V44, P145, DOI 10.1002/1097-4695(200008)44:2<145::AID-NEU5>3.3.CO;2-O; Lehmann M, 1999, J NEUROSCI, V19, P7537, DOI 10.1523/JNEUROSCI.19-17-07537.1999; Li X, 2007, J NEUROPHYSIOL, V97, P1236, DOI 10.1152/jn.00995.2006; McKerracher L, 2006, J NEUROTRAUM, V23, P309, DOI 10.1089/neu.2006.23.309; Menetry J, 2008, PROTEIN SCI, V17, P878, DOI 10.1110/ps.073398508; Mullner A, 2008, EUR J NEUROSCI, V27, P326, DOI 10.1111/j.1460-9568.2007.06006.x; Murray KC, 2010, NAT MED, V16, P694, DOI 10.1038/nm.2160; Rekling JC, 2000, PHYSIOL REV, V80, P767; Schmitt KRL, 2007, NEUROSCI RES, V59, P68, DOI 10.1016/j.neures.2007.05.011; Schmitt KRL, 2010, BRAIN PATHOL, V20, P771, DOI 10.1111/j.1750-3639.2009.00358.x; Schweigreiter R, 2004, MOL CELL NEUROSCI, V27, P163, DOI 10.1016/j.mcn.2004.06.004; Sekhon LHS, 2001, SPINE, V26, pS2, DOI 10.1097/00007632-200112151-00002; Shen YJ, 2009, SCIENCE, V326, P592, DOI 10.1126/science.1178310; Sheng HX, 2004, J NEUROTRAUM, V21, P595, DOI 10.1089/089771504774129928; Sieber-Blum M, 2006, MOL CELL NEUROSCI, V32, P67, DOI 10.1016/j.mcn.2006.02.003; Simonen M, 2003, NEURON, V38, P201, DOI 10.1016/S0896-6273(03)00226-5; Ung RV, 2008, EUR J NEUROSCI, V28, P2231, DOI 10.1111/j.1460-9568.2008.06508.x; Vogelsgesang M, 2007, N-S ARCH PHARMACOL, V374, P347, DOI 10.1007/s00210-006-0113-y; Wilde C, 2002, J BIOL CHEM, V277, P14771, DOI 10.1074/jbc.M201072200; Yamashita T, 2003, NAT NEUROSCI, V6, P461, DOI 10.1038/nn1045	42	18	19	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3042	1471-4159		J NEUROCHEM	J. Neurochem.	MAR	2012	120	6					1084	1096		10.1111/j.1471-4159.2012.07657.x			13	Biochemistry & Molecular Biology; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	903JL	WOS:000301112500020	22239108	Bronze			2021-06-18	
J	Rayan, N; Barnes, S; Fleming, N; Kudyakov, R; Ballard, D; Gentilello, LM; Shafi, S				Rayan, Nadine; Barnes, Sunni; Fleming, Neil; Kudyakov, Rustam; Ballard, David; Gentilello, Larry M.; Shafi, Shahid			Barriers to compliance with evidence-based care in trauma	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Quality improvement; practice guidelines; innovation diffusion	QUALITY; MORTALITY; SYSTEMS	BACKGROUND: We have preciously demonstrated that trauma patients receive less than two-thirds of the care recommended by evidence-based medicine. The purpose of this study was to identify patients least likely to receive optimal care. METHODS: Records of a random sample of 774 patients admitted to a Level I trauma center (2006-2008) with moderate to severe injuries (Abbreviated Injury Scale score >= 3) were reviewed for compliance with 25 trauma-specific processes of care (T-POC) endorsed by Advanced Trauma Life Support, Eastern Association for the Surgery of Trauma, the Brain Trauma Foundation, Surgical Care Improvement Project, and the Glue Grant Consortium based on evidence or consensus. These encompassed all aspects of trauma care, including initial evaluation, resuscitation, operative care, critical care, rehabilitation, and injury prevention. Multivariate logistic regression was used to identify patients likely to receive recommended care. RESULTS: Study patients were eligible for a total of 2,603 T-POC, of which only 1,515 (58%) were provided to the patient. Compliance was highest for T-POC involving resuscitation (83%) and was lowest for neurosurgical interventions (17%). Increasing severity of head injuries was associated with lower compliance, while intensive care unit stay was associated with higher compliance. There was no relationship between compliance and patient demographics, socioeconomic status, overall injury severity, or daily volume of trauma admissions. CONCLUSION: Little over half of recommended care was delivered to trauma patients with moderate to severe injuries. Patients with increasing severity of traumatic brain injuries were least likely to receive optimal care. However, differences among patient subgroups are small in relation to the overall gap between observed and recommended care. (J Trauma. 2012; 72: 585-593. Copyright (C) 2012 by Lippincott Williams & Wilkins)	[Rayan, Nadine; Barnes, Sunni; Fleming, Neil; Kudyakov, Rustam; Ballard, David; Shafi, Shahid] Baylor Hlth Care Syst, Inst Hlth Care Res & Improvement, Dallas, TX USA; [Gentilello, Larry M.] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA	Shafi, S (corresponding author), Baylor Hlth Care Syst, 1600 W Coll St,Suite LL 10, Grapevine, TX 76051 USA.	shahid.shafi@baylorhealth.edu			Agency for Healthcare Research and Quality (AHRQ)United States Department of Health & Human ServicesAgency for Healthcare Research & Quality [1R01HS017718-01A1]; Seeger Foundation of the Baylor University Medical Center, Dallas, TX; AGENCY FOR HEALTHCARE RESEARCH AND QUALITYUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality [R01HS017718] Funding Source: NIH RePORTER	Supported in part by Agency for Healthcare Research and Quality (AHRQ grant #1R01HS017718-01A1) and the Seeger Foundation of the Baylor University Medical Center, Dallas, TX.	American College of Surgeons, 2008, ATLS DOCT STUD MAN; Balas E A, 2000, Yearb Med Inform, P65; Berwick DM, 2003, JAMA-J AM MED ASSOC, V289, P1969, DOI 10.1001/jama.289.15.1969; BROOS PLO, 1993, INJURY, V24, P365, DOI 10.1016/0020-1383(93)90096-O; Centers for Disease Control and Prevention, INJ PREV CONTR DAT S; DONABEDIAN A, 1966, MILBANK FUND Q, V44, P166, DOI 10.2307/3348969; Gurses AP, 2008, QUAL SAF HEALTH CARE, V17, P351, DOI 10.1136/qshc.2006.021709; Hemmila MR, 2010, J TRAUMA, V68, P253, DOI 10.1097/TA.0b013e3181cfc8e6; Ingraham AM, 2010, ANN SURG, V252, P358, DOI 10.1097/SLA.0b013e3181e623bf; Kalhan R, 2006, CRIT CARE MED, V34, P300, DOI 10.1097/01.CCM.0000198328.83571.4A; MACKENZIE EJ, 1990, J TRAUMA, V30, P1096, DOI 10.1097/00005373-199009000-00005; McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615; Nathens AB, 2008, J TRAUMA, V65, P628, DOI 10.1097/TA.0b013e3181837994; QualityNet, SCIP PROJ INF; Scott IA, 2005, MED J AUSTRALIA, V182, P325, DOI 10.5694/j.1326-5377.2005.tb06729.x; Shafi S, J TRAUMA IN PRESS; Shafi S, 2008, J TRAUMA, V64, P599, DOI 10.1097/TA.0b013e31816533f9; Shafi S, 2010, J TRAUMA, V68, P771, DOI 10.1097/TA.0b013e3181d03a20; Shafi S, 2009, J AM COLL SURGEONS, V209, P521, DOI 10.1016/j.jamcollsurg.2009.07.001; Shafi S, 2008, ARCH SURG-CHICAGO, V143, P1057, DOI 10.1001/archsurg.143.11.1057; Vogeli C, 2009, MED CARE, V47, P591, DOI 10.1097/MLR.0b013e31819432cd	21	18	18	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	MAR	2012	72	3					585	592		10.1097/TA.0b013e318243da4d			8	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	906TR	WOS:000301371100014	22491540				2021-06-18	
J	Talving, P; Lustenberger, T; Inaba, K; Lam, L; Mohseni, S; Chan, LD; Demetriades, D				Talving, Peep; Lustenberger, Thomas; Inaba, Kenji; Lam, Lydia; Mohseni, Shahin; Chan, Linda; Demetriades, Demetrios			Erythropoiesis-Stimulating Agent Administration and Survival After Severe Traumatic Brain Injury A Prospective Study	ARCHIVES OF SURGERY			English	Article							RECOMBINANT-HUMAN-ERYTHROPOIETIN; NEUROPROTECTION; ANGIOGENESIS; EFFICACY; HEALTH; ALPHA	Objective: To validate previous findings of the effects of erythropoiesis-stimulating agent (ESA) administration following severe traumatic brain injury. Design: Prospective observational study of all patients with severe traumatic brain injury admitted to the surgical intensive care unit (SICU) at our institution from January 1, 2009, to December 31, 2010 (head Abbreviated Injury Scale score >= 3). Propensity scores were calculated to match patients who received ESA within 30 days after admission to patients who did not receive ESA. Patients: A total of 566 patients with severe traumatic brain injury were admitted to the SICU. After matching in a 1:1 ratio, 75 matched pairs were analyzed. Main Outcome Measures: A Glasgow Coma Scale score (difference between admission and SICU discharge), in-hospital morbidity, and mortality. Results: Patients who received ESA and control subjects who did not receive ESA had similar age, mechanisms of injury, vital signs on admission, Abbreviated Injury Scale scores, Injury Severity Scores, and specific intracranial injuries. Patients who received ESA experienced significantly longer lengths of stay in the SICU (mean [SD], 16.1 [1.3] days vs 8.6 [0.8] days; P < .001) and comparable SICU-free days. There was no statistically significant difference in the incidence of major in-hospital complications including deep venous thrombosis and pulmonary embolism when comparing the 2 study cohorts. The Delta Glasgow Coma Scale mean [standard error of the mean] score was 3.0 [0.4] and 2.4 [0.5] in patients who received ESA and those who did not, respectively (P=.33). However, in-hospital mortality was significantly lower for patients who received ESA compared with those who did not (9.3% vs 25.3%; odds ratio, 0.25; 95% CI, 0.08-0.75; P=.012). Conclusions: Erythropoiesis-stimulating agent administration demonstrates a significant survival advantage without an increase in morbidity in patients with severe traumatic brain injury.	[Talving, Peep] Univ So Calif, Keck Sch Med, Div Acute Care Surg, Dept Surg, Los Angeles, CA 90033 USA	Talving, P (corresponding author), Univ So Calif, Keck Sch Med, Div Acute Care Surg, Dept Surg, 1200 N State St,C5L100, Los Angeles, CA 90033 USA.	peep.talving@surgery.usc.edu	Talving, Peep/E-6015-2013; Talving, Peep/G-8621-2015	Talving, Peep/0000-0002-9741-2073			ANAGNOSTOU A, 1994, P NATL ACAD SCI USA, V91, P3974, DOI 10.1073/pnas.91.9.3974; Bennett CL, 2008, JAMA-J AM MED ASSOC, V299, P914, DOI 10.1001/jama.299.8.914; Brines ML, 2000, P NATL ACAD SCI USA, V97, P10526, DOI 10.1073/pnas.97.19.10526; Caucio L, 2008, J TRAUMA, V65, P297; Chong ZZ, 2003, J CEREBR BLOOD F MET, V23, P320, DOI 10.1097/01.WCB.0000050061.57184.AE; Chong ZZ, 2002, J HEMATOTH STEM CELL, V11, P863, DOI 10.1089/152581602321080529; Chong ZZ, 2002, CIRCULATION, V106, P2973, DOI 10.1161/01.CIR.0000039103.58920.1F; Chong ZZ, 2002, J CEREBR BLOOD F MET, V22, P503, DOI 10.1097/00004647-200205000-00001; Corwin HL, 2006, TRANSFUS MED REV, V20, P27, DOI 10.1016/j.tmrv.2005.08.002; Corwin HL, 2002, JAMA-J AM MED ASSOC, V288, P2827, DOI 10.1001/jama.288.22.2827; Corwin HL, 2007, NEW ENGL J MED, V357, P965, DOI 10.1056/NEJMoa071533; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Ehrenreich H, 2009, STROKE, V40, pE647, DOI 10.1161/STROKEAHA.109.564872; Fauchere JC, 2008, PEDIATRICS, V122, P375, DOI 10.1542/peds.2007-2591; Genc S, 2004, RESTOR NEUROL NEUROS, V22, P105; Grasso G, 2002, P NATL ACAD SCI USA, V99, P5627, DOI 10.1073/pnas.082097299; Grasso G, 2007, BRAIN RES, V1182, P99, DOI 10.1016/j.brainres.2007.08.078; Grasso G, 2009, NEUROSURGERY, V65, P763, DOI 10.1227/01.NEU.0000347475.73347.5F; Gross CP, 1999, NEW ENGL J MED, V340, P1881, DOI 10.1056/NEJM199906173402406; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Juul SE, 2008, PEDIATRICS, V122, P383, DOI 10.1542/peds.2007-2711; Maiese K, 2004, RESTOR NEUROL NEUROS, V22, P87; Maiese K, 2005, JAMA-J AM MED ASSOC, V293, P90, DOI 10.1001/jama.293.1.90; Myburgh JA, 2008, J TRAUMA, V64, P854, DOI 10.1097/TA.0b013e3180340e77; Napolitano LM, 2008, J TRAUMA, V65, P285, DOI 10.1097/TA.0b013e31817f2c6e; Nichol AD, 2009, INJURY, V40, P471, DOI 10.1016/j.injury.2009.01.002; Sakamaki K, 2004, CURR NEUROVASC RES, V1, P305, DOI 10.2174/1567202043362072; Shingo T, 2001, J NEUROSCI, V21, P9733, DOI 10.1523/JNEUROSCI.21-24-09733.2001; Talving P, 2010, ANN SURG, V251, P1, DOI 10.1097/SLA.0b013e3181b844fa; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009	30	18	21	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0004-0010	1538-3644		ARCH SURG-CHICAGO	Arch. Surg.	MAR	2012	147	3					251	255		10.1001/archsurg.2011.1838			5	Surgery	Surgery	910LC	WOS:000301637200011	22430906	Bronze			2021-06-18	
J	Boselli, M; Aquilani, R; Baiardi, P; Dioguardi, FS; Guarnaschelli, C; Achilli, MP; Arrigoni, N; Iadarola, P; Verri, M; Viglio, S; Barbieri, A; Boschi, F				Boselli, Mirella; Aquilani, Roberto; Baiardi, Paola; Dioguardi, Francesco Saverio; Guarnaschelli, Caterina; Achilli, Maria Pia; Arrigoni, Nadia; Iadarola, Paolo; Verri, Manuela; Viglio, Simona; Barbieri, Annalisa; Boschi, Federica			Supplementation of Essential Amino Acids May Reduce the Occurrence of Infections in Rehabilitation Patients With Brain Injury	NUTRITION IN CLINICAL PRACTICE			English	Article						amino acids; essential; infection; brain injuries	C-REACTIVE PROTEIN; SUBARACHNOID HEMORRHAGE; ISCHEMIC-STROKE; MEDICAL COMPLICATIONS; COGNITIVE RECOVERY; RESPONSE SYNDROME; BODY-COMPOSITION; RISK-FACTOR; MUSCLE; IMMUNE	Background: To investigate whether supplementation with oral essential amino acids (EAAs) may reduce the occurrence of nosocomial infection among patients with brain injury (BI: stroke, trauma, anoxic coma). Methods: Patients (n = 125; 77 men, 48 women; mean age 63 +/- 15 years) with stroke (68.8%), subarachnoid hemorrhage (17.6%), traumatic BI (7.2%), and anoxic BI (6.4%) 88 +/- 15days after the index event. Patients were randomly assigned to 2 months of oral EAAs (n = 63; 8 g/d) or placebo (n = 62). Results: Over the first month of rehabilitation, there were 60 infections in the whole population of 125 patients (48%); however, the rate was 23.2% lower in the EAA group (23 episodes/63 patients; 36.5%) than in the placebo group (37 episodes/62 patients; 59.7%) (P < .01). The types of infection were similarly distributed between the 2 groups. Serum levels of prealbumin < 20 mg/dL and C-reactive protein (CRP) > 0.3 mg/dL were the best predictors of future infection (prealbumin: odds ratio [OR] = 4.17, confidence interval [CI] 1.84-9.45, P < .001; CRP: OR = 3.8, CI 1.71-8.44, P < .001). Conclusion: Supplementary EAAs may reduce the occurrence of nosocomial infections in rehabilitation patients with BI. Prealbumin and CRP are the best predictors of future infections. (Nutr Clin Pract. 2012; 27: 99-114)	[Barbieri, Annalisa; Boschi, Federica] Univ Pavia, Dipartimento Sci Farmaco, I-27100 Pavia, Italy; [Boselli, Mirella; Guarnaschelli, Caterina; Achilli, Maria Pia; Arrigoni, Nadia] Ist Sci Montescano, IRCCS, Fdn S Maugeri,Unita Riabilitaz Neuromotoria, Unita Gravi Cerebrolesioni Acquisite, Pavia, Italy; [Aquilani, Roberto] Ist Sci Montescano, IRCCS, Fdn S Maugeri, Serv Fisiopatol Metab Nutr & Nutr Clin, Pavia, Italy; [Baiardi, Paola] Univ Pavia, Fdn S Maugeri, Consorzio Valutaz Biol & Farmacol, I-27100 Pavia, Italy; [Dioguardi, Francesco Saverio] Univ Milan, Dipartimento Med Interna, Milan, Italy; [Iadarola, Paolo; Viglio, Simona] Univ Pavia, Dipartimento Biochim A Castellani, I-27100 Pavia, Italy; [Verri, Manuela] Univ Pavia, Dipartimento Med Legale Sci Forensi & Farmacotoss, Sez Sci Farmacol & Tossicol, I-27100 Pavia, Italy	Boschi, F (corresponding author), Univ Pavia, Dipartimento Sci Farmaco, Viale Taramelli 12, I-27100 Pavia, Italy.	federica.boschi@unipv.it	Saverio, Francesco/B-4422-2017; Baiardi, Paola/AAB-9060-2020; Achilli, Maria Pia/AAE-1142-2021	Saverio, Francesco/0000-0003-0445-3106; Baiardi, Paola/0000-0002-1622-8400; Viglio, Simona/0000-0001-5020-478X; Achilli, Maria Pia/0000-0003-1918-2388; Boselli, Mirella/0000-0003-4545-5271			Alpers D. H., 1988, MANUAL NUTR THERAPEU; Aquilani R, 2005, ARCH PHYS MED REHAB, V86, P1729, DOI 10.1016/j.apmr.2005.03.022; Aquilani R, 1999, EUR HEART J, V20, P1020, DOI 10.1053/euhj.1999.1402; Aquilani R, 2008, ARCH PHYS MED REHAB, V89, P1642, DOI 10.1016/j.apmr.2008.02.023; Aquilani R, 2011, ARCH GERONTOL GERIAT, V52, pE123, DOI 10.1016/j.archger.2010.09.005; Aquilani R, 2010, NUTR NEUROSCI, V13, P129, DOI 10.1179/147683010X12611460764002; Aquilani R, 2009, NUTR NEUROSCI, V12, P219, DOI 10.1179/147683009X423445; Aquilani R, 2008, NUTR NEUROSCI, V11, P235, DOI 10.1179/147683008X301586; Aquilani R, 2008, CLIN REHABIL, V22, P1042, DOI 10.1177/0269215508094244; Arenillas JF, 2003, STROKE, V34, P2463, DOI 10.1161/01.STR.0000089920.93927.A7; Badjatia N, 2010, JPEN-PARENTER ENTER, V34, P64, DOI 10.1177/0148607109348797; Belayev L, 2005, STROKE, V36, P118, DOI 10.1161/01.STR.0000149620.74770.2e; Berenholtz SM, 2004, CRIT CARE MED, V32, P2014, DOI 10.1097/01.CCM.0000142399.70913.2F; Bradshaw RA, 1998, TRENDS BIOCHEM SCI, V23, P263, DOI 10.1016/S0968-0004(98)01227-4; Calder PC, 2007, BRIT J NUTR, V98, pS133, DOI 10.1017/S0007114507832909; Chandra RK, 2002, EUR J CLIN NUTR, V56, pS73, DOI 10.1038/sj.ejcn.1601492; CHUMLEA WC, 1985, J AM GERIATR SOC, V33, P116, DOI 10.1111/j.1532-5415.1985.tb02276.x; de Maat MPM, 2004, CURR OPIN LIPIDOL, V15, P651, DOI 10.1097/00041433-200412000-00005; Dhar R, 2008, NEUROCRIT CARE, V8, P404, DOI 10.1007/s12028-008-9054-2; Droge W, 2002, EXP GERONTOL, V37, P1333, DOI 10.1016/S0531-5565(02)00175-4; Esper DH, 2006, JPEN-PARENTER ENTER, V30, P71, DOI 10.1177/014860710603000271; Fafournoux P, 2000, BIOCHEM J, V351, P1, DOI 10.1042/0264-6021:3510001; Ferrucci L, 2000, J AM GERIATR SOC, V48, P1102, DOI 10.1111/j.1532-5415.2000.tb04787.x; Frontera JA, 2008, NEUROSURGERY, V62, P80, DOI 10.1227/01.NEU.0000311064.18368.EA; FUGAZZA G, 1998, EUROPA MEDICOPHYSICA, V34, P125; GOUVIER WD, 1987, ARCH PHYS MED REHAB, V68, P94; Gussekloo J, 2000, ARTERIOSCL THROM VAS, V20, P1047, DOI 10.1161/01.ATV.20.4.1047; HERSIO K, 1990, ACTA NEUROCHIR, V106, P13, DOI 10.1007/BF01809327; Hill AG, 1998, BRIT J SURG, V85, P884; Hugonnet S, 2004, EMERG INFECT DIS, V10, P76, DOI 10.3201/eid1001.030407; *I SUP NAZ NUTR, 1989, TAB COMP AL; KALRA L, 1995, STROKE, V26, P990, DOI 10.1161/01.STR.26.6.990; Keel M, 2005, INJURY, V36, P691, DOI 10.1016/j.injury.2004.12.037; Keith R A, 1987, Adv Clin Rehabil, V1, P6; KISHIMOTO T, 1989, BLOOD, V74, P1, DOI 10.1182/blood.V74.1.1.1; Kuptniratsaikul V, 2009, AM J PHYS MED REHAB, V88, P92, DOI 10.1097/PHM.0b013e3181909d5f; Laviano A, 2011, NEUROCRIT CARE, V14, P44, DOI 10.1007/s12028-010-9461-z; LESOURD B, 1995, NUTR REV, V53, pS86; Lesourd B, 1995, NUTR REV, V53, pS92; Liong MT, 2006, J DAIRY SCI, V89, P1390, DOI 10.3168/jds.S0022-0302(06)72207-X; Liu ZQ, 2006, J NUTR, V136, p212S, DOI 10.1093/jn/136.1.212S; Lombardo A, 2004, CIRCULATION, V109, P3158, DOI 10.1161/01.CIR.0000130786.28008.56; Lynch CJ, 2002, AM J PHYSIOL-ENDOC M, V283, pE503, DOI 10.1152/ajpendo.00084.2002; Martindale RG, 2005, JPEN-PARENTER ENTER, V29, pS53, DOI 10.1177/01486071050290S1S53; Meisel C, 2005, NAT REV NEUROSCI, V6, P775, DOI 10.1038/nrn1765; Mendez Christian M, 2005, Nutr Clin Pract, V20, P314, DOI 10.1177/0115426505020003314; Mermel LA, 2000, ANN INTERN MED, V133, P395; Mokart D, 2002, BRIT J SURG, V89, P1450, DOI 10.1046/j.1365-2168.2002.02218.x; Molls RR, 2005, J NUTR, V135, P2644; Mylotte JM, 2001, INFECT CONT HOSP EP, V22, P83, DOI 10.1086/501868; NIELSEN HJ, 1995, BRIT J SURG, V82, P582, DOI 10.1002/bjs.1800820505; Olano-Martin E, 2000, BRIT J NUTR, V83, P247, DOI 10.1017/S0007114500000325; Rello J, 2001, CHEST, V120, P955, DOI 10.1378/chest.120.3.955; Rennie MJ, 2006, J NUTR, V136, p264S, DOI 10.1093/jn/136.1.264S; Roth EJ, 2001, STROKE, V32, P523, DOI 10.1161/01.STR.32.2.523; Roth E, 2007, CLIN NUTR, V26, P535, DOI 10.1016/j.clnu.2007.05.007; RUDERMAN NB, 1975, ANNU REV MED, V26, P245, DOI 10.1146/annurev.me.26.020175.001333; Selim MH, 2004, AGEING RES REV, V3, P345, DOI 10.1016/j.arr.2004.04.001; Silva Y, 2005, STROKE, V36, P86, DOI 10.1161/01.STR.0000149615.51204.0b; Sorbello D, 2009, CEREBROVASC DIS, V28, P378, DOI 10.1159/000230712; TOUHO H, 1990, J NEUROSURG, V72, P710, DOI 10.3171/jns.1990.72.5.0710; Tracey KJ, 2002, NATURE, V420, P853, DOI 10.1038/nature01321; Verma S, 2002, CIRCULATION, V106, P913, DOI 10.1161/01.CIR.0000029802.88087.5E; Vila N, 2000, STROKE, V31, P2325, DOI 10.1161/01.STR.31.10.2325; Visser M, 2005, AM J CLIN NUTR, V82, P531; Wartenberg KE, 2006, CRIT CARE MED, V34, P617, DOI 10.1097/01.CCM.0000201903.46435.35; Wichienchot S., 2006, Current Issues in Intestinal Microbiology, V7, P7; Winbeck K, 2002, STROKE, V33, P2459, DOI 10.1161/01.STR.0000029828.51413.82; Wu AW, 2000, J AM GERIATR SOC, V48, pS6, DOI 10.1111/j.1532-5415.2000.tb03142.x; Yoshimoto Y, 2001, STROKE, V32, P1989, DOI 10.1161/hs0901.095646; Zuliani G, 2001, J GERONTOL A-BIOL, V56, pM212, DOI 10.1093/gerona/56.4.M212	71	18	18	0	7	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0884-5336			NUTR CLIN PRACT	Nutr. Clin. Pract.	FEB	2012	27	1					99	113		10.1177/0884533611431068			15	Nutrition & Dietetics	Nutrition & Dietetics	886IU	WOS:000299848900012	22307494				2021-06-18	
J	Xu, JF; Liu, WG; Dong, XQ; Yang, SB; Fan, J				Xu, Jin-Fang; Liu, Wei-Guo; Dong, Xiao-Qiao; Yang, Song-Bin; Fan, Jing			Change in plasma gelsolin level after traumatic brain injury	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Gelsolin; traumatic brain injury; mortality; prognosis	SCAVENGER SYSTEM; HEAD-INJURY; ACTIN; SERUM; DEPRESSION; PREDICTOR; MORTALITY; PROTECTS; OUTCOMES; S100B	BACKGROUND: Plasma gelsolin depletion has been associated with poor outcome of critically ill patients. However, there is a paucity of data available on circulating plasma gelsolin concentration in traumatic brain injury (TBI). Thus, we sought to investigate change in plasma gelsolin level after TBI and to evaluate its relation with disease outcome. METHODS: Fifty healthy controls and 94 patients with acute severe TBI were included. Plasma samples were obtained on admission and at days 1, 2, 3, 5, and 7. Its concentration was measured by enzyme-linked immunosorbent assay. RESULTS: Twenty-six patients (27.7%) died from TBI in a month. After TBI, plasma gelsolin level in patients decreased during the 6-hour period immediately, was at the nadir in 24 hours, increased gradually thereafter, and was substantially lower than that in healthy controls during the 7-day period. A multivariate analysis showed plasma gelsolin level was an independent predictor for 1-month mortality (odds ratio, 0.941; 95% confidence interval, 0.895-0.989; p = 0.017) and positively associated with Glasgow Coma Scale (GCS) score (t = 6.538, p < 0.001). A receiver operating characteristic curve identified that a baseline plasma gelsolin level <52.7 mg/L predicted 1-month mortality with 88.5% sensitivity and 79.4% specificity (area under the curve, 0.869; 95% confidence interval, 0.783-0.930). The predictive value of the gelsolin concentration was thus similar to that of GCS scores (p = 0.185). However, gelsolin did not statistically significantly improve the area under the curve of GCS scores (p = 0.517). CONCLUSIONS: Decreased plasma gelsolin level is associated with GCS scores and an independent prognostic marker of mortality after TBI. Reversing plasma gelsolin deficiency may be an effective treatment for TBI. (J Trauma. 2012; 72: 491-496. Copyright (C) 2012 by Lippincott Williams & Wilkins)	[Xu, Jin-Fang; Liu, Wei-Guo; Fan, Jing] Zhejiang Univ, Dept Neurosurg, Affiliated Hosp 2, Sch Med, Hangzhou 310000, Zhejiang, Peoples R China; [Dong, Xiao-Qiao] Nanjing Med Univ, Hangzhou Municipal Peoples Hosp 1, Dept Neurosurg, Hangzhou, Zhejiang, Peoples R China; [Yang, Song-Bin] Shengzhou Peoples Hosp, Dept Neurosurg, Shenzhou, Peoples R China	Liu, WG (corresponding author), Zhejiang Univ, Dept Neurosurg, Affiliated Hosp 2, Sch Med, 88 Jiefang Rd, Hangzhou 310000, Zhejiang, Peoples R China.	lwgxjf@163.com					Bernard F, 2008, J TRAUMA, V64, P872, DOI 10.1097/TA.0b013e31803428cc; Bucki R, 2005, BIOCHEMISTRY-US, V44, P9590, DOI 10.1021/bi0503504; Christofidou-Solomidou M, 2002, LUNG, V180, P91, DOI 10.1007/s004080000084; Christofidou-Solomidou M, 2002, J INVEST MED, V50, P54, DOI 10.2310/6650.2002.33518; Dahl B, 1999, SHOCK, V12, P102, DOI 10.1097/00024382-199908000-00002; DiNubile MJ, 2002, BLOOD, V100, P4367, DOI 10.1182/blood-2002-06-1672; Endres M, 1999, J CLIN INVEST, V103, P347, DOI 10.1172/JCI4953; Goetzl EJ, 2000, J BIOL CHEM, V275, P14573, DOI 10.1074/jbc.275.19.14573; GORDON E, 1995, J NEUROSURG ANESTH, V7, P235, DOI 10.1097/00008506-199510000-00001; Guntert A, 2010, J ALZHEIMERS DIS, V21, P585, DOI 10.3233/JAD-2010-100279; HADDAD JG, 1990, P NATL ACAD SCI USA, V87, P1381, DOI 10.1073/pnas.87.4.1381; Huang S, 1997, CLIN INFECT DIS, V24, P951, DOI 10.1093/clinids/24.5.951; ITO H, 1992, GASTROENTEROLOGY, V102, P1686, DOI 10.1016/0016-5085(92)91731-I; JANMEY PA, 1987, BLOOD, V70, P524; Juul N, 2000, J NEUROSURG, V92, P1, DOI 10.3171/jns.2000.92.1.0001; KWIATKOWSKI DJ, 1988, J BIOL CHEM, V263, P8239; KWIATKOWSKI DJ, 1986, NATURE, V323, P455, DOI 10.1038/323455a0; Laird AM, 2004, J TRAUMA, V56, P1058, DOI 10.1097/01.TA.0000123267.39011.9F; Lee PS, 2007, CRIT CARE MED, V35, P849, DOI 10.1097/01.CCM.0000253815.26311.24; Lee PS, 2006, ANN SURG, V243, P399, DOI 10.1097/01.sla.0000201798.77133.55; LEE WM, 1992, NEW ENGL J MED, V326, P1335; Lesko MM, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-72; LIND SE, 1986, J CLIN INVEST, V78, P736, DOI 10.1172/JCI112634; LIND SE, 1988, AM REV RESPIR DIS, V138, P429, DOI 10.1164/ajrccm/138.2.429; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Moppett IK, 2007, BRIT J ANAESTH, V99, P18, DOI 10.1093/bja/aem128; Mounzer KC, 1999, AM J RESP CRIT CARE, V160, P1673, DOI 10.1164/ajrccm.160.5.9807137; Nakamura N, 2006, NEUROL MED-CHIR, V46, P567, DOI 10.2176/nmc.46.567; Osborn TM, 2007, AM J PHYSIOL-CELL PH, V292, pC1323, DOI 10.1152/ajpcell.00510.2006; Petzold A, 2002, CRIT CARE MED, V30, P2705, DOI 10.1097/00003246-200212000-00015; Rosengart MR, 2002, SHOCK, V17, P109, DOI 10.1097/00024382-200202000-00005; Rothenbach PA, 2004, J APPL PHYSIOL, V96, P25, DOI 10.1152/japplphysiol.01074.2002; Silacci P, 2004, CELL MOL LIFE SCI, V61, P2614, DOI 10.1007/s00018-004-4225-6; Spiotta AM, 2010, J NEUROSURG, V113, P571, DOI 10.3171/2010.1.JNS09506; Suhler E, 1997, CRIT CARE MED, V25, P594, DOI 10.1097/00003246-199704000-00007; Timofeev I, 2011, BRAIN, V134, P484, DOI 10.1093/brain/awq353; Van den Berghe G, 2005, NEUROLOGY, V64, P1348, DOI 10.1212/01.WNL.0000158442.08857.FC; Vos PE, 2010, NEUROLOGY, V75, P1786, DOI 10.1212/WNL.0b013e3181fd62d2; Wang HH, 2008, CRIT CARE, V12, DOI 10.1186/cc6988; Yildirim F, 2008, EXP NEUROL, V210, P531, DOI 10.1016/j.expneurol.2007.11.031; YIN HL, 1979, NATURE, V281, P583, DOI 10.1038/281583a0	41	18	19	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	FEB	2012	72	2					491	496		10.1097/TA.0b013e318226ec39			6	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	898ZN	WOS:000300781000049	22439219				2021-06-18	
J	Valiyaveettil, M; Alamneh, Y; Oguntayo, S; Wei, YL; Wang, Y; Arun, P; Nambiar, MP				Valiyaveettil, Manojkumar; Alamneh, Yonas; Oguntayo, Samuel; Wei, Yanling; Wang, Ying; Arun, Peethambaran; Nambiar, Madhusoodana P.			Regional specific alterations in brain acetylcholinesterase activity after repeated blast exposures in mice	NEUROSCIENCE LETTERS			English	Article						Blast injury; Acetylcholinesterase; Cholinergic pathway; Traumatic brain injury; Repeated blast exposure	REDUCED EVOKED RELEASE; CLOSED-HEAD INJURY; CHOLINERGIC DYSFUNCTION; COGNITIVE IMPAIRMENT; STRESS; RATS; MODEL; DEFICITS; BLOOD; OVERPRESSURE	Acetylcholinesterase (AChE) which catalyzes the hydrolysis of the neurotransmitter acetylcholine has been recognized as one of the major regulators of stress responses after traumatic brain injury (TBI). Repeated blast exposure induces TBI (blast TBI) with a variable neuropathology at different brain regions. Since AChE inhibitors are being used as a line of treatment for TBI, we sought to determine the time course of AChE activity in the blood and different brain regions after repeated blast exposures using modified Ellman assay. Our data showed that repeated blast exposures significantly reduced AChE activity in the whole-blood and erythrocytes by 3-6 h, while plasma AChE activity was significantly increased by 3 h post-blast. In the brain, significant increase in AChE activity was observed at 6 h in the frontal cortex, while hind cortex and hippocampus showed a significant decrease at 6 h post-blast, which returned to normal levels by 7 days. AChE activity in the cerebellum and mid brain showed a decrease at 6 h, followed by significant increase at 3 days and that was decreased significantly at 14 days post-blast. Medulla region showed decreased AChE activity at 24 h post-blast, which was significantly increased at 14 days. These results suggest that there are brain regional and time-related changes in AChE activity after tightly coupled repeated blast exposures in mice. In summary, acute and chronic regional specific changes in the AChE activity after repeated blast exposures warrant systematic evaluation of the possibility of AChE inhibitor therapeutics against blast TBI. Published by Elsevier Ireland Ltd.	[Valiyaveettil, Manojkumar; Alamneh, Yonas; Oguntayo, Samuel; Wei, Yanling; Wang, Ying; Arun, Peethambaran; Nambiar, Madhusoodana P.] Walter Reed Army Inst Res, Ctr Mil Psychiat & Neurosci, Blast Induced Neurotrauma Branch, Silver Spring, MD 20910 USA	Valiyaveettil, M (corresponding author), Walter Reed Army Inst Res, Ctr Mil Psychiat & Neurosci, Blast Induced Neurotrauma Branch, Silver Spring, MD 20910 USA.	m.valiyaveettil@amedd.army.mil; madhusoodana.nambiar@amedd.army.mil					Arciniegas DB, 2011, J HEAD TRAUMA REHAB, V26, P319, DOI 10.1097/HTR.0b013e31821ebfb3; Armonda RA, 2006, NEUROSURGERY, V59, P1215, DOI 10.1227/01.NEU.0000249190.46033.94; Arun P, 2011, NEUROREPORT, V22, P379, DOI 10.1097/WNR.0b013e328346b138; AUGUSTINSSON KB, 1978, CLIN CHIM ACTA, V89, P239, DOI 10.1016/0009-8981(78)90322-4; Bauman RA, 2009, J NEUROTRAUM, V26, P841, DOI 10.1089/neu.2009-0898; Chen Y, 1998, J NEUROTRAUM, V15, P231, DOI 10.1089/neu.1998.15.231; Dixon CE, 1997, BRAIN RES, V749, P127, DOI 10.1016/S0006-8993(96)01310-8; Dixon CE, 1996, PHARMACOL BIOCHEM BE, V53, P679, DOI 10.1016/0091-3057(95)02069-1; DIXON CE, 1995, NEUROSCI LETT, V198, P111, DOI 10.1016/0304-3940(95)11979-7; Donat CK, 2008, BRAIN RES, V1246, P167, DOI 10.1016/j.brainres.2008.09.059; Donat CK, 2007, BRAIN INJURY, V21, P1031, DOI 10.1080/02699050701630359; DONOVAN DA, 1994, J WILDLIFE DIS, V30, P234, DOI 10.7589/0090-3558-30.2.234; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; French LM, 2010, ANN NY ACAD SCI, V1208, P38, DOI 10.1111/j.1749-6632.2010.05696.x; Friedman A, 1996, NAT MED, V2, P1382, DOI 10.1038/nm1296-1382; Fujiki M, 2008, J CLIN NEUROSCI, V15, P791, DOI 10.1016/j.jocn.2007.07.002; Gorman LK, 1996, J NEUROTRAUM, V13, P457, DOI 10.1089/neu.1996.13.457; Griffin SL, 2003, J NEUROPSYCH CLIN N, V15, P17, DOI 10.1176/appi.neuropsych.15.1.17; Grisaru D, 1999, EUR J BIOCHEM, V264, P672, DOI 10.1046/j.1432-1327.1999.00693.x; Hicks RR, 2010, J TRAUMA, V68, P1257, DOI 10.1097/TA.0b013e3181d8956d; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Kaufer D, 1998, NATURE, V393, P373, DOI 10.1038/30741; Levin H S, 1986, Cent Nerv Syst Trauma, V3, P333; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Meshorer E, 2002, SCIENCE, V295, P508, DOI 10.1126/science.1066752; Ostberg A, 2011, NEUROLOGY, V76, P1046, DOI 10.1212/WNL.0b013e318211c1c4; Pavlov VA, 2003, MOL MED, V9, P125, DOI 10.1007/BF03402177; Readnower RD, 2010, J NEUROSCI RES, V88, P3530, DOI 10.1002/jnr.22510; SAIJA A, 1988, BRAIN RES, V452, P303, DOI 10.1016/0006-8993(88)90034-0; Scremin OU, 2006, BRAIN RES, V1124, P155, DOI 10.1016/j.brainres.2006.09.062; Shaked I, 2008, ANN NY ACAD SCI, V1148, P269, DOI 10.1196/annals.1410.001; Shohami E, 2000, J MOL MED-JMM, V78, P228, DOI 10.1007/s001090000104; Sklan EH, 2006, BIOL PSYCHIAT, V60, P741, DOI 10.1016/j.biopsych.2006.03.080; Svetlov SI, 2010, J TRAUMA, V69, P795, DOI 10.1097/TA.0b013e3181bbd885; Tenovuo O, 2005, PROG NEURO-PSYCHOPH, V29, P61, DOI 10.1016/j.pnpbp.2004.10.006; Tomkins O, 2001, CELL MOL NEUROBIOL, V21, P675, DOI 10.1023/A:1015147920283; Wang LS, 2002, BRAIN RES, V949, P162, DOI 10.1016/S0006-8993(02)02977-3; Wang Y, 2011, J NEUROTRAUM, V28, P2171, DOI 10.1089/neu.2011.1990; Writer BW, 2009, J NEUROPSYCH CLIN N, V21, P362, DOI 10.1176/appi.neuropsych.21.4.362	40	18	18	0	7	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940			NEUROSCI LETT	Neurosci. Lett.	JAN 6	2012	506	1					141	145		10.1016/j.neulet.2011.10.067			5	Neurosciences	Neurosciences & Neurology	891GK	WOS:000300205000029	22079491				2021-06-18	
J	Budinich, CS; Chen, HZ; Lowe, D; Rosenberger, JG; Bernstock, JD; McCabe, JT				Budinich, Craig S.; Chen, HuaZhen; Lowe, Dennell; Rosenberger, John G.; Bernstock, Joshua D.; McCabe, Joseph T.			Mouse Brain PSA-NCAM Levels Are Altered by Graded-Controlled Cortical Impact Injury	NEURAL PLASTICITY			English	Article							CELL-ADHESION MOLECULE; CENTRAL-NERVOUS-SYSTEM; FOCAL CEREBRAL-ISCHEMIA; POLYSIALIC ACID; STRUCTURAL BIOLOGY; PROGENITOR CELLS; ADULT-RAT; IN-VITRO; EXPRESSION; NEUROGENESIS	Traumatic brain injury (TBI) is a worldwide endemic that results in unacceptably high morbidity and mortality. Secondary injury processes following primary injury are composed of intricate interactions between assorted molecules that ultimately dictate the degree of longer-term neurological deficits. One comparatively unexplored molecule that may contribute to exacerbation of injury or enhancement of recovery is the posttranslationally modified polysialic acid form of neural cell adhesion molecule, PSA-NCAM. This molecule is a critical modulator of central nervous system plasticity and reorganization after injury. In this study, we used controlled cortical impact (CCI) to produce moderate or severe TBI in the mouse. Immunoblotting and immunohistochemical analysis were used to track the early (2, 24, and 48 hour) and late (1 and 3 week) time course and location of changes in the levels of PSA-NCAM after TBI. Variable and heterogeneous short-and long-term increases or decreases in expression were found. In general, alterations in PSA-NCAM levels were seen in the cerebral cortex immediately after injury, and these reductions persisted in brain regions distal to the primary injury site, especially after severe injury. This information provides a starting point to dissect the role of PSA-NCAM in TBI-related pathology and recovery.	[Budinich, Craig S.; McCabe, Joseph T.] Uniformed Serv Univ Hlth Sci, Grad Program Neurosci, FE Hebert Sch Med, Bethesda, MD 20814 USA; [Chen, HuaZhen; Lowe, Dennell; Rosenberger, John G.; McCabe, Joseph T.] Uniformed Serv Univ Hlth Sci, Dept Anat Physiol & Genet, FE Hebert Sch Med, Bethesda, MD 20814 USA; [Bernstock, Joshua D.; McCabe, Joseph T.] Uniformed Serv Univ Hlth Sci, Grad Program Mol & Cell Biol, FE Hebert Sch Med, Bethesda, MD 20814 USA; [McCabe, Joseph T.] Uniformed Serv Univ Hlth Sci, Ctr Neurosci & Regenerat Med, FE Hebert Sch Med, Bethesda, MD 20814 USA	McCabe, JT (corresponding author), Uniformed Serv Univ Hlth Sci, Grad Program Neurosci, FE Hebert Sch Med, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	jmccabe@usuhs.mil	McCabe, Joseph/J-6293-2014	McCabe, Joseph/0000-0002-1159-7442; Bernstock, Joshua/0000-0002-7814-3867	TriService Nursing Research Program [N10-P09]; US Army Medical Research and Materiel CommandU.S. Army Medical Research & Materiel Command (USAMRMC) [W81XWH-09-2-0147]; USUHS Concept Award [RO704B]	This work was supported by TriService Nursing Research Program Grant N10-P09 to C. S. Budinich and US Army Medical Research and Materiel Command grant W81XWH-09-2-0147 and a USUHS Concept Award RO704B to J. T. MCabe. The experiments were conducted according to the principles set forth in the Guide for Care and Use of Laboratory Animals, ILAR, National Research Council, DHEW Publication no. (NIH) 73-23. The opinions, interpretations, conclusions and recommendations are those of the authors and are not necessarily endorsed by the US Army, Department of Defense, the US government, or the Uniformed Services University of the Health Sciences. The use of trade names does not constitute an official endorsement or approval of the use of such reagents or commercial hardware or software. This paper may not be cited for purposes of advertisement. The investigators appreciated utilization of the preclinical core facilities of the Center for Neuroscience and Regenerative Medicine, USUHS. The authors thank Mr. Eric Prager for assistance with the construction of Figure 7.	Amoureux MC, 2000, J NEUROSCI, V20, P3631; Asher R A, 2001, Prog Brain Res, V132, P611; Bachelin C, 2010, BRAIN, V133, P406, DOI 10.1093/brain/awp256; Belanger HG, 2009, J INT NEUROPSYCH SOC, V15, P1, DOI 10.1017/S1355617708090036; BONFANTI L, 1992, NEUROSCIENCE, V49, P419, DOI 10.1016/0306-4522(92)90107-D; Bonfanti L, 2006, PROG NEUROBIOL, V80, P129, DOI 10.1016/j.pneurobio.2006.08.003; Brody DL, 2007, J NEUROTRAUM, V24, P657, DOI 10.1089/neu.2006.0011; Brown S, 2011, BRAIN INJURY, V25, P453, DOI 10.3109/02699052.2011.556581; Cassens C, 2010, J BIOL CHEM, V285, P28959, DOI 10.1074/jbc.M110.114835; *CDC, 2011, INJ PREV CONTR TRAUM; CHUONG CM, 1984, J NEUROSCI, V4, P2354; Cox ET, 2009, NEUROSCIENCE, V162, P96, DOI 10.1016/j.neuroscience.2009.04.037; Culmsee C, 2005, J NEUROSCI, V25, P10262, DOI 10.1523/JNEUROSCI.2818-05.2005; Ditlevsen DK, 2008, J NEUROSCI RES, V86, P727, DOI 10.1002/jnr.21551; Dominguez MI, 2003, BRAIN RES, V966, P206, DOI 10.1016/S0006-8993(02)04164-1; Duveau V, 2007, NEUROBIOL DIS, V26, P385, DOI 10.1016/j.nbd.2007.01.007; Duveau V, 2010, EUR J NEUROSCI, V32, P89, DOI 10.1111/j.1460-9568.2010.07272.x; El Maarouf A, 2006, P NATL ACAD SCI USA, V103, P16989, DOI 10.1073/pnas.0608036103; El Maarouf A, 2010, ADV EXP MED BIOL, V663, P137, DOI 10.1007/978-1-4419-1170-4_9; Gascon E, 2007, BRAIN RES REV, V56, P101, DOI 10.1016/j.brainresrev.2007.05.014; Gascon E, 2007, DEVELOPMENT, V134, P1181, DOI 10.1242/dev.02808; Gascon E, 2010, ADV EXP MED BIOL, V663, P127, DOI 10.1007/978-1-4419-1170-4_8; Hammond MSL, 2006, J BIOL CHEM, V281, P34859, DOI 10.1074/jbc.M602568200; Hampton T, 2011, JAMA-J AM MED ASSOC, V306, P477, DOI 10.1001/jama.2011.1092; Huh JW, 2008, EXP NEUROL, V213, P84, DOI 10.1016/j.expneurol.2008.05.009; Kaplan GB, 2010, BEHAV PHARMACOL, V21, P427, DOI 10.1097/FBP.0b013e32833d8bc9; Kiselyov VV, 2010, ADV EXP MED BIOL, V663, P67, DOI 10.1007/978-1-4419-1170-4_4; Kiselyov VV, 2005, J NEUROCHEM, V94, P1169, DOI 10.1111/j.1471-4159.2005.03284.x; Lavdas AA, 2006, GLIA, V53, P868, DOI 10.1002/glia.20340; Lee E, 2009, BMB REP, V42, P239, DOI 10.5483/BMBRep.2009.42.5.239; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Maas AIR, 2010, NEUROTHERAPEUTICS, V7, P115, DOI 10.1016/j.nurt.2009.10.022; Morel MP, 2002, J NEUROCYTOL, V31, P633, DOI 10.1023/A:1025739511646; Nacher J, 2002, BRAIN RES, V927, P111, DOI 10.1016/S0006-8993(01)03241-3; Nielsen J, 2010, ADV EXP MED BIOL, V663, P23, DOI 10.1007/978-1-4419-1170-4_2; NOBLE M, 1985, NATURE, V316, P725, DOI 10.1038/316725a0; Nykjaer A, 2005, CURR OPIN NEUROBIOL, V15, P49, DOI 10.1016/j.conb.2005.01.004; Pertab JL, 2009, BRAIN INJURY, V23, P498, DOI 10.1080/02699050902927984; Petridis AK, 2004, DEV DYNAM, V230, P675, DOI 10.1002/dvdy.20094; Plesnila N, 2001, P NATL ACAD SCI USA, V98, P15318, DOI 10.1073/pnas.261323298; Prosser RA, 2003, J NEUROSCI, V23, P652; Rao V, 2002, PSYCHIAT CLIN N AM, V25, P43, DOI 10.1016/S0193-953X(03)00052-2; RUTISHAUSER U, 1976, P NATL ACAD SCI USA, V73, P577, DOI 10.1073/pnas.73.2.577; Rutishauser U, 2008, NAT REV NEUROSCI, V9, P26, DOI 10.1038/nrn2285; Saatman KE, 2006, J NEUROTRAUM, V23, P1241, DOI 10.1089/neu.2006.23.1241; Seidenfaden R, 2006, NEUROCHEM INT, V49, P1, DOI 10.1016/j.neuint.2005.12.011; Soares S, 2000, J NEUROSCI, V20, P2551; Soroka V, 2010, ADV EXP MED BIOL, V663, P3, DOI 10.1007/978-1-4419-1170-4_1; Spijker S, 2011, NEUROMETHODS, V57, P13, DOI 10.1007/978-1-61779-111-6_2; Vink R, 2009, NEUROTHERAPEUTICS, V6, P28, DOI 10.1016/j.nurt.2008.10.036; Vutskits L, 2006, NEUROCHEM RES, V31, P215, DOI 10.1007/s11064-005-9021-7; Vutskits L, 2003, EUR J NEUROSCI, V17, P2119, DOI 10.1046/j.1460-9568.2003.02660.x; WATSON RE, 1986, PEPTIDES, V7, P155, DOI 10.1016/0196-9781(86)90076-8; Zhang Y, 2007, EUR J NEUROSCI, V25, P351, DOI 10.1111/j.1460-9568.2007.05311.x; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	56	18	18	0	1	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	2090-5904	1687-5443		NEURAL PLAST	Neural. Plast.		2012	2012								378307	10.1155/2012/378307			13	Neurosciences	Neurosciences & Neurology	989UN	WOS:000307586400001	22848850	DOAJ Gold, Green Published			2021-06-18	
J	Henry, JA; Zaugg, TL; Myers, PJ; Schmidt, CJ; Griest, S; Legro, MW; Kaelin, C; Thielman, EJ; Storzbach, DM; McMillan, GP; Carlson, KF				Henry, James A.; Zaugg, Tara L.; Myers, Paula J.; Schmidt, Caroline J.; Griest, Susan; Legro, Marcia W.; Kaelin, Christine; Thielman, Emily J.; Storzbach, Daniel M.; McMillan, Garnett P.; Carlson, Kathleen F.			Pilot study to develop telehealth tinnitus management for persons with and without traumatic brain injury	JOURNAL OF REHABILITATION RESEARCH AND DEVELOPMENT			English	Article						blast injury; clinical trial; cognitive-behavioral therapy; education; hearing disorders; military Veterans; rehabilitation; telehealth; tinnitus; traumatic brain injury	TELEPHONE PSYCHOTHERAPY; HOSPITAL ANXIETY; WAR VETERANS; DEPRESSION; HEALTH; PREVALENCE; MODERATE; BLAST; IRAQ; CARE	Tinnitus, or "ringing in the ears," affects 10%-15% of adults; cases can be problematic and require lifelong management. Many people who have experienced traumatic brain injury (TBI) also experience tinnitus. We developed Progressive Tinnitus Management (PTM), which uses education and counseling to help patients learn how to self-manage their reactions to tinnitus. We adapted PTM by delivering the intervention via telephone and by adding cognitive-behavioral therapy. A pilot study was conducted to evaluate the feasibility and potential efficacy of this approach for individuals with and without TBI. Participants with clinically significant tinnitus were recruited into three groups: probable symptomatic mild TBI (n = 15), moderate to severe TBI (n = 9), and no symptomatic TBI (72 = 12). Participants received telephone counseling (six sessions over 6 months) by an audiologist and a psychologist. Questionnaires were completed at baseline, 12 weeks, and 24 weeks. All groups showed trends reflecting improvement in self-perceived functional limitations due to tinnitus. A follow-up randomized clinical study is underway.	[Henry, James A.; Zaugg, Tara L.; Griest, Susan; Legro, Marcia W.; Kaelin, Christine; Thielman, Emily J.; McMillan, Garnett P.] VA Med Ctr, Dept Vet Affairs VA Rehabil Res & Dev Natl Ctr Re, Portland, OR USA; [Henry, James A.; Griest, Susan] Oregon Hlth & Sci Univ, Dept Otolaryngol Head & Neck Surg, Portland, OR 97201 USA; [Myers, Paula J.] James A Haley Vet Hosp, Tampa, FL 33612 USA; [Schmidt, Caroline J.] VA Connecticut Healthcare Syst, West Haven, CT USA; [Schmidt, Caroline J.] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT USA; [Storzbach, Daniel M.] VA Med Ctr, Neuropsychol Clin, Portland, OR USA; [Storzbach, Daniel M.] Oregon Hlth & Sci Univ, Dept Psychiat, Portland, OR 97201 USA; [Storzbach, Daniel M.] Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR 97201 USA; [Carlson, Kathleen F.] VA Med Ctr, VA Hlth Serv Res & Dev Portland Ctr Study Chron C, Portland, OR USA; [Carlson, Kathleen F.] Oregon Hlth & Sci Univ, Dept Publ Hlth & Prevent Med, Portland, OR 97201 USA	Henry, JA (corresponding author), VA Med Ctr NCRAR, POB 1034, Portland, OR 97207 USA.	james.henry@va.gov			VA, VHA, Rehabilitation Research and Development Service [C6770R, F7070S, C2659C]; VA, VHA, Health Services Research and Development Career Development Award Program [08-025]	This material was based on work supported by the VA, VHA, Rehabilitation Research and Development Service (grants C6770R, F7070S, C2659C). Dr. Carlson's efforts were supported by the VA, VHA, Health Services Research and Development Career Development Award Program (grant 08-025).	Andersson G, 2002, CLIN PSYCHOL REV, V22, P977, DOI 10.1016/S0272-7358(01)00124-6; Beck J.S., 1995, COGNITIVE THERAPY BA; Bell KR, 2005, ARCH PHYS MED REHAB, V86, P851, DOI 10.1016/j.apmr.2004.09.015; Bliese PD, 2008, J CONSULT CLIN PSYCH, V76, P272, DOI 10.1037/0022-006X.76.2.272; Borges G, 2010, J CLIN PSYCHIAT, V71, P1617, DOI 10.4088/JCP.08m04967blu; Carlson KF, 2011, J HEAD TRAUMA REHAB, V26, P103, DOI 10.1097/HTR.0b013e3181e50ef1; Carlson KF, 2010, J TRAUMA STRESS, V23, P17, DOI 10.1002/jts.20483; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Cave KM, 2007, MIL MED, V172, P726, DOI 10.7205/MILMED.172.7.726; Chandler D W, 1997, J Am Acad Audiol, V8, P81; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd; Crocetti A, 2009, OTOLARYNG HEAD NECK, V140, P403, DOI 10.1016/j.otohns.2008.11.036; DelliFraine JL, 2008, J TELEMED TELECARE, V14, P62, DOI 10.1258/jtt.2007.070709; Fann JR, 2009, J NEUROTRAUM, V26, P2383, DOI 10.1089/neu.2009.1091; Godleski L, 2008, BEHAV SCI LAW, V26, P271, DOI 10.1002/bsl.811; Halbauer JD, 2009, J REHABIL RES DEV, V46, P757, DOI 10.1682/JRRD.2008.08.0119; Henry J, 1998, TINNITUS TREATMENT R, P99; Henry J. A., 2010, MANAGE YOUR TINNITUS; HENRY JA, PROGR TINNITUS MANAG, P44760; HENRY JA, 2008, MANAGE YOUR TINNITUS; HENRY JA, 2009, MANAGE YOUR TINNITUS, P44760; Henry JA, 2007, J REHABIL RES DEV, V44, P21, DOI 10.1682/JRRD.2006.02.0018; Henry JA, 2010, J FAM PRACTICE, V59, P389; Henry JA, 2009, NOISE HEALTH, V11, P33, DOI 10.4103/1463-1741.45311; Henry James A, 2008, Trends Amplif, V12, P170, DOI 10.1177/1084713808319941; Hersh WR, 2006, AHRQ PUBLICATION; Hoge CW, 2009, NEW ENGL J MED, V360, P1588, DOI 10.1056/NEJMp0810606; Iverson G.L., 2006, BRAIN INJURY MED PRI, P333; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kendall C. J., 2010, PROGR TINNITUS MANAG; KRUMM M, 2008, AUDIOLOGY TODAY, V20, P36; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Lew HL, 2007, J REHABIL RES DEV, V44, P921, DOI 10.1682/JRRD.2007.09.0140; Lew HL, 2006, J REHABIL RES DEV, V43, pVII, DOI 10.1682/JRRD.2006.05.0054; Lipsey M. W., 1990, DESIGN SENSITIVITY S; Martinez Devesa P, 2007, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD005233.PUB2; McCrea M, 2008, MILD TRAUMATIC BRAIN; Moldover JE, 2004, NEUROPSYCHOL REV, V14, P143, DOI 10.1023/B:NERV.0000048181.46159.61; MYERS P, 2003, WRITTEN MAT RESOURCE, P44760; Newman C W, 1998, J Am Acad Audiol, V9, P153; Newman C. W., 2004, TINNITUS THEORY MANA, P237; Newman CW, 1996, ARCH OTOLARYNGOL, V122, P143; Orff HJ, 2009, J HEAD TRAUMA REHAB, V24, P155, DOI 10.1097/HTR.0b013e3181a0b281; Ouellet MC, 2004, NEUROREHAB NEURAL RE, V18, P187, DOI 10.1177/1545968304271405; Prins A, 2003, PRIMARY CARE PSYCHIA, V9, P9; Rosenfeld JV, 2010, INJURY, V41, P437, DOI 10.1016/j.injury.2009.11.018; Shargorodsky J, 2010, AM J MED, V123, P711, DOI 10.1016/j.amjmed.2010.02.015; Simon GE, 2009, ARCH GEN PSYCHIAT, V66, P1081, DOI 10.1001/archgenpsychiatry.2009.123; Snow GW, 2004, TINNITUS THEORY MANA, P16; Soo C, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005239.pub2; Stetler CB, 2006, J GEN INTERN MED, V21, pS1, DOI [10.1111/j.1525-1497.2006.00355.x, 10.1007/s11606-006-0267-9]; SWEETOW RW, 2000, TINNITUS HDB, P297; Tanielian T, 2008, INVISIBLE WOUNDS WAR; TELEHEALTH WBJ, 2001, J GERONTOL NURS, V27, P9; Tuerk PW, 2010, TELEMED J E-HEALTH, V16, P115, DOI 10.1089/tmj.2009.0144; Tutty S, 2005, GEN HOSP PSYCHIAT, V27, P400, DOI 10.1016/j.genhosppsych.2005.06.009; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; WILKINSON MJB, 1988, J ROY COLL GEN PRACT, V38, P311; ZAUGG TL, 2003, P 7 INT TINN SEM 200, P226; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; Zoger S, 2001, AUDIOLOGY, V40, P133	61	18	19	1	17	JOURNAL REHAB RES & DEV	BALTIMORE	DEPT OF VETERANS AFFAIRS REHABIL RES & DEVELOP CTR 103 SOUTH GAY STREET, BALTIMORE, MD 21202-4051 USA	0748-7711	1938-1352		J REHABIL RES DEV	J. Rehabil. Res. Dev.		2012	49	7					1025	1042		10.1682/JRRD.2010.07.0125			18	Rehabilitation	Rehabilitation	149EZ	WOS:000319303100007	23341277	Bronze			2021-06-18	
S	Larson, AN; McIntosh, AL		Heggie, TW; Caine, DJ		Larson, A. Noelle; McIntosh, Amy L.			The Epidemiology of Injury in ATV and Motocross Sports	EPIDEMIOLOGY OF INJURY IN ADVENTURE AND EXTREME SPORTS	Medicine and Sport Science		English	Article; Book Chapter							ALL-TERRAIN-VEHICLE; TRAUMA CENTERS; CHILDREN; ADOLESCENTS; CONCUSSION; PREVENTION; SEVERITY; CRASHES; HELMETS; RIDERS	Off-road motorsports are popular in rural and suburban areas, and allow for racing, recreation, and easy access to backcountry destinations. This chapter will review the incidence and types of injuries sustained in off-road motorsports. We completed a structured review of motocross and all-terrain vehicle (ATV) injuries, assessing for injury rates, risk factors, and mortality figures. Information for this study was obtained from a PubMed search under the terms 'motocross', 'motorcross', 'all-terrain vehicies', 'injury', 'motorcycle', 'ATV'. Abstracts and articles in the English language from 1980 onward were reviewed. Further statistics were obtained from the US Consumer Product Safety Commission publications. Operating vehicles off-road requires coordination, experience, and training. Motocross is an organized sport with national associations governing the competition of highly trained athletes. ATVs are used both recreationally and commercially, typically for farming and ranching. ATV use appears more dangerous that motocross, with a higher mortality rate, disproportionately for children. Both sports continue to have high rates of head, spinal cord, and extremity injury. Future prospective studies in off-road motorsports should evaluate the risk factors for injury and target specific areas for injury prevention. Improved training programs, use and improvement of safety helmets, and for ATV use, limiting access to minors, may improve the overall safety of off-road motorsports. Copyright (C) 2012 S. Karger AG, Basel	[Larson, A. Noelle; McIntosh, Amy L.] Mayo Clin, Div Pediat Orthoped Surg, Rochester, MN 55905 USA	Larson, AN (corresponding author), Mayo Clin, Div Pediat Orthoped Surg, 200 1st St SW, Rochester, MN 55905 USA.	larson.noelle@mayo.edu	Larson, A. Noelle/AAC-7158-2019	Larson, A. Noelle/0000-0001-6542-6975; McIntosh, Amy/0000-0002-3660-4901			Alawi Khalid, 2006, CJEM, V8, P277; American Academy of Orthopaedic Surgeons, POS STAT ALL TERR VE; [Anonymous], 2007, CONSUMER PRODUCT SAF, V11, P2; [Anonymous], 2000, PEDIATRICS, V105, P1352; Ascensao A, 2008, J SPORT MED PHYS FIT, V48, P311; Barnett TM, 2008, FOOT ANKLE INT, V29, P245, DOI 10.3113/FAI.2008.0245; Bizzarri F, 2008, J CARDIOTHORAC SURG, V3, DOI 10.1186/1749-8090-3-23; Bougard C, 2008, ACCIDENT ANAL PREV, V40, P635, DOI 10.1016/j.aap.2007.09.002; Bougard C, 2012, EUR J APPL PHYSIOL, V112, P59, DOI 10.1007/s00421-011-1948-6; Bowman SM, 2009, INJURY PREV, V15, P3, DOI 10.1136/ip.2008.019372; Brandenburg MA, 2007, J TRAUMA, V63, P994, DOI 10.1097/TA.0b013e31814b91fe; Brown RL, 2002, J PEDIATR SURG, V37, P375, DOI 10.1053/jpsu.2002.30826; Burns BJ, 2011, PREHOSP EMERG CARE, V15, P414, DOI 10.3109/10903127.2011.561416; Colburn NT, 2003, INJURY, V34, P207, DOI 10.1016/S0020-1383(02)00039-6; Commission, 2007, COM2007725 COMM EUR, P5; Cvijanovich NZ, 2001, PEDIATRICS, V108, P631, DOI 10.1542/peds.108.3.631; Garland Sara, 2010, 2009 ANN REPORT ATV; Gielen JL, 2009, SKELETAL RADIOL, V38, P1153, DOI 10.1007/s00256-009-0746-2; Gittelman MA, 2006, PEDIATRICS, V117, P2190, DOI 10.1542/peds.2005-2603; Gobbi A, 2004, KNEE SURG SPORT TR A, V12, P574, DOI 10.1007/s00167-004-0510-z; Gorski TF, 2003, AM SURGEON, V69, P895; Grange JT, 2009, CURR SPORT MED REP, V8, P125, DOI 10.1249/JSR.0b013e3181a61e95; Hall AJ, 2009, AM J PREV MED, V36, P311, DOI 10.1016/j.amepre.2008.11.019; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Helmkamp JC, 2007, INJURY PREV, V13, P426, DOI 10.1136/ip.2007.016030; Kirkpatrick R, 2007, J PEDIATR ORTHOPED, V27, P725, DOI 10.1097/BPO.0b013e3181558856; Konttinen T, 2008, J STRENGTH COND RES, V22, P202, DOI 10.1519/JSC.0b013e31815f5831; Konttinen T, 2007, J SPORT SCI, V25, P995, DOI 10.1080/02640410600944584; Larson AN, 2009, J PEDIATR ORTHOPED, V29, P847, DOI 10.1097/BPO.0b013e3181c1e2fa; Lister DG, 1998, J PEDIATR SURG, V33, P1081, DOI 10.1016/S0022-3468(98)90535-8; Lynch JM, 1998, J PEDIATR SURG, V33, P329, DOI 10.1016/S0022-3468(98)90456-0; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McIntosh AL, 2011, CONCUSSIVE INJURIES; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Mullins RJ, 2007, J AM COLL SURGEONS, V204, P216, DOI 10.1016/j.jamcollsurg.2006.10.025; Rodgers GB, 2001, AM J EPIDEMIOL, V153, P1112, DOI 10.1093/aje/153.11.1112; RODGERS GB, 1993, ACCIDENT ANAL PREV, V25, P335, DOI 10.1016/0001-4575(93)90027-T; Sawyer JR, 2011, J PEDIATR ORTHOPED, V31, P623, DOI 10.1097/BPO.0b013e31822a2f0f; Scutchfield SB, 2003, CLIN ORTHOP RELAT R, P61, DOI 10.1097/01.blo.0000060441.40507.3e; Smith LM, 2005, J TRAUMA, V58, P783, DOI 10.1097/01.TA.0000158252.11002.6E; STREETER R, 2008, ANN REPORT ATV RELAT; Tomida Y, 2005, BRIT J SPORT MED, V39, P508, DOI 10.1136/bjsm.2004.013722; White S L, 1999, J Foot Ankle Surg, V38, P214	43	18	19	1	9	KARGER	BASEL	POSTFACH, CH-4009 BASEL, SWITZERLAND	0254-5020		978-3-318-02164-6	MED SPORT SCI	Med.Sport Sci.		2012	58						158	172					15	Hospitality, Leisure, Sport & Tourism; Sport Sciences	Social Sciences - Other Topics; Sport Sciences	BCI64	WOS:000310249000010	22824845				2021-06-18	
J	Laursen, B; Helweg-Larsen, K				Laursen, Bjarne; Helweg-Larsen, Karin			Health service use in adults 20-64 years with traumatic brain injury, spinal cord injury or pelvic fracture. A cohort study with 9-year follow-up	BMJ OPEN			English	Article							CARE UTILIZATION; DISABILITY; REGISTER	Objectives: To estimate the health service use over 9 years after the injury year for patients with traumatic brain injury (TBI), spinal cord injury (SCI) and pelvic fracture (PF), and compare with non-injured. Design: A register-based cohort design with a 9-year follow-up period. Setting: The Danish population. Participants: The study included 434, 100 and 278 hospital-treated incident patients with TBI, SCI and PF, respectively, among 20-year-olds to 64-year-olds identified using the National Patient Register. Controls for each patient group were drawn from the population register, matched by age, sex and health service use during 1995. All were followed during 1996-2005 by linkage to national health registers. The observations were excluded when the patients left Denmark or died. Outcome measures: The use of hospital treatments, contacts with general practitioners and the use of physiotherapy. Results: Compared to the controls, more patients with TBI and SCI were hospital admitted all 9 years after the injury year, on average 0.36 and 0.50 times annually, respectively. For patients with PF hospital admissions returned to baseline year 2 after the injury year. For patients with SCI the use of general practitioner services remained at an increased level year 9 after the injury year, while it returned to baseline level year 4 after the injury year for patients with TBI and year 2 for patients with PF. For patients with SCI physiotherapy use remained increased over 9 years after the injury year, while it returned to baseline the fifth year for patients with TBI and the third year after for patients with PF. Conclusions: TBI and SCI increase the use of health services over 9 years after the injury year, while most health service use after PF returned to baseline 2 years after the injury year.	[Laursen, Bjarne; Helweg-Larsen, Karin] Univ So Denmark, Natl Inst Publ Hlth, Copenhagen, Denmark	Laursen, B (corresponding author), Univ So Denmark, Natl Inst Publ Hlth, Copenhagen, Denmark.	bla@niph.dk		Laursen, Bjarne/0000-0003-0121-9891	TrygFonden [7585-07]	This work was supported by TrygFonden, grant no. 7585-07.	Becker DJ, 2010, J GERONTOL A-BIOL, V65, P1012, DOI 10.1093/gerona/glq093; Borg T, 2010, INJURY, V41, P400, DOI 10.1016/j.injury.2009.11.006; Braithwaite IJ, 1998, INJURY, V29, P55; Dijkers MP, 2004, ARCH PHYS MED REHAB, V85, pS21, DOI 10.1016/j.apmr.2003.08.119; Dryden DM, 2004, SPINAL CORD, V42, P513, DOI 10.1038/sj.sc.3101629; Guilcher SJT, 2010, SPINAL CORD, V48, P45, DOI 10.1038/sc.2009.78; Haagsma JA, 2012, B WORLD HEALTH ORGAN, V90, P513, DOI 10.2471/BLT.11.095109; Hall KM, 1999, ARCH PHYS MED REHAB, V80, P1507, DOI 10.1016/S0003-9993(99)90265-4; Kiely N, 1996, INJURY, V27, P45, DOI 10.1016/0020-1383(95)00161-1; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Munce SEP, 2009, SPINAL CORD, V47, P470, DOI 10.1038/sc.2008.173; NAAM NH, 1983, ARCH SURG-CHICAGO, V118, P610; National Board of Health Denmark, ACTIVITY AT HOSPITAL; Nickelsen T N, 2001, Ugeskr Laeger, V164, P33; Polinder S, 2007, J TRAUMA, V62, P133, DOI 10.1097/TA.0b013e31802b71c9; SAHL AJ, 2011, SCAND J PUBLIC HLT S, V39, P34, DOI DOI 10.1177/1403494810394718; Slomine BS, 2006, PEDIATRICS, V117, pE663, DOI 10.1542/peds.2005-1892; Toft AMH, 2010, J TRAUMA, V69, P26, DOI 10.1097/TA.0b013e3181d3cbf2; Wrona RM, 2010, DISABIL REHABIL, V32, P650, DOI 10.3109/09638280903186327	20	18	18	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2044-6055			BMJ OPEN	BMJ Open		2012	2	5							e001521	10.1136/bmjopen-2012-001521			6	Medicine, General & Internal	General & Internal Medicine	091MN	WOS:000315053900080	23103605	DOAJ Gold, Green Published			2021-06-18	
S	Ono, T; Galanopoulou, AS		Ahmad, SI		Ono, Tomonori; Galanopoulou, Aristea S.			EPILEPSY AND EPILEPTIC SYNDROME	NEURODEGENERATIVE DISEASES	Advances in Experimental Medicine and Biology		English	Article; Book Chapter							TEMPORAL-LOBE EPILEPSY; ELECTRICAL STATUS EPILEPTICUS; TUBEROUS SCLEROSIS COMPLEX; MAGNETIC-RESONANCE-SPECTROSCOPY; MULTICENTER RANDOMIZED-TRIAL; REDUCES SPONTANEOUS SEIZURES; LITHIUM-PILOCARPINE MODEL; PROGRESSIVE NEURONAL LOSS; TRAUMATIC BRAIN-INJURY; HIPPOCAMPAL SCLEROSIS	Epilepsy is one of the most common neurological disorders. In most patients with epilepsy, seizures respond to available medications. However, a significant number of patients, especially in the setting of medically-intractable epilepsies, may experience different degrees of memory or cognitive impairment, behavioral abnormalities or psychiatric symptoms, which may limit their daily functioning. As a result, in many patients, epilepsy may resemble a neurodegenerative disease. Epileptic seizures and their potential impact on brain development, the progressive nature of epileptogenesis that may functionally alter brain regions involved in cognitive processing, neurodegenerative processes that relate to the underlying etiology, comorbid conditions or epigenetic factors, such as stress, medications, social factors, may all contribute to the progessive nature of epilepsy. Clinical and experimental studies have addressed the pathogenetic mechanisms underlying epileptogenesis and neurodegeneration. We will primarily focus on the findings derived from studies on one of the most common causes of focal onset epilepsy, the temporal lobe epilepsy, which indicate that both processes are progressive and utilize common or interacting pathways. In this chapter we will discuss some of these studies, the potential candidate targets for neuroprotective therapies as well as the attempts to identify early biomarkers of progression and epileptogenesis, so as to implement therapies with early-onset disease-modifying effects.	[Ono, Tomonori; Galanopoulou, Aristea S.] Albert Einstein Coll Med, Saul R Korey Dept Neurol, Bronx, NY 10467 USA; [Galanopoulou, Aristea S.] Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, Bronx, NY 10467 USA	Galanopoulou, AS (corresponding author), Albert Einstein Coll Med, Saul R Korey Dept Neurol, Bronx, NY 10467 USA.	aristea.galanopoulou@einstein.yu.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R56NS020253, K02NS062947, R01NS020253] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K02 NS062947, NS20253, NS62947] Funding Source: Medline		Agrawal A, 2006, CLIN NEUROL NEUROSUR, V108, P433, DOI 10.1016/j.clineuro.2005.09.001; ALBALA BJ, 1984, DEV BRAIN RES, V13, P139, DOI 10.1016/0165-3806(84)90085-3; Andersson-Roswall L, 2010, NEUROLOGY, V74, P1977, DOI 10.1212/WNL.0b013e3181e39684; Andre VM, 2010, EPILEPSIA, V51, P166, DOI 10.1111/j.1528-1167.2010.02634.x; [Anonymous], 1989, EPILEPSIA, V30, P389, DOI 10.1111/j.1528-1157.1989.tb05316.x; Badawy RAB, 2009, J CLIN NEUROSCI, V16, P485, DOI 10.1016/j.jocn.2008.10.001; Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920; Ben-Ari Y, 2006, LANCET NEUROL, V5, P1055, DOI 10.1016/S1474-4422(06)70626-3; Bengzon J, 1997, P NATL ACAD SCI USA, V94, P10432, DOI 10.1073/pnas.94.19.10432; Berg AT, 2010, EPILEPSIA, V51, P676, DOI 10.1111/j.1528-1167.2010.02522.x; Berg AT, 2001, NEUROLOGY, V56, P1445, DOI 10.1212/WNL.56.11.1445; Berg AT, 2010, OPTN SRTR ANN REP, P9; Beume LA, 2010, NEUROPEDIATRICS, V41, P135, DOI 10.1055/s-0030-1263155; Bittigau P, 2003, ANN NY ACAD SCI, V993, P103, DOI 10.1111/j.1749-6632.2003.tb07517.x; Blumcke I, 1999, J COMP NEUROL, V414, P437, DOI 10.1002/(SICI)1096-9861(19991129)414:4<437::AID-CNE2>3.0.CO;2-3; Blumenfeld H, 2008, EPILEPSIA, V49, P400, DOI 10.1111/j.1528-1167.2007.01458.x; Boyett JM, 2001, HIPPOCAMPUS, V11, P418, DOI 10.1002/hipo.1056.abs; Brodie MJ, 2005, ACTA NEUROL SCAND, V112, P36, DOI 10.1111/j.1600-0404.2005.00507.x; Brooks-Kayal AR, 2009, NEUROTHERAPEUTICS, V6, P312, DOI 10.1016/j.nurt.2009.01.019; Buckmaster PS, 1999, J NEUROPHYSIOL, V81, P712; Cancedda L, 2007, J NEUROSCI, V27, P5224, DOI 10.1523/JNEUROSCI.5169-06.2007; CAVAZOS JE, 1990, BRAIN RES, V527, P1, DOI 10.1016/0006-8993(90)91054-K; CAVAZOS JE, 1994, J NEUROSCI, V14, P3106; Cavazos JE, 2006, EPILEPSY BEHAV, V8, P483, DOI 10.1016/j.yebeh.2006.01.011; CENDES F, 1993, ANN NEUROL, V34, P795, DOI 10.1002/ana.410340607; Cepeda C, 2010, EPILEPSIA, V51, P160, DOI 10.1111/j.1528-1167.2010.02633.x; Chen CM, 2008, J NEUROSCI RES, V86, P2696, DOI 10.1002/jnr.21706; Connelly A, 1998, NEUROLOGY, V51, P61, DOI 10.1212/WNL.51.1.61; Coulter DA, 1996, EPILEPSY RES, V26, P81, DOI 10.1016/S0920-1211(96)00044-7; Darke K, 2010, ARCH DIS CHILD, V95, P382, DOI 10.1136/adc.2009.160606; de Lanerolle NC, 2010, NEUROTHERAPEUTICS, V7, P424, DOI 10.1016/j.nurt.2010.08.002; Dhanushkodi A, 2008, NEUROSCI BIOBEHAV R, V32, P657, DOI 10.1016/j.neubiorev.2007.10.004; Dube C, 2004, ANN NEUROL, V56, P709, DOI 10.1002/ana.20266; Elliott-Hunt CR, 2002, J NEUROCHEM, V80, P416, DOI 10.1046/j.0022-3042.2001.00712.x; Elsharkawy AE, 2009, EPILEPSY RES, V86, P191, DOI 10.1016/j.eplepsyres.2009.06.008; Engel J, 1996, EPILEPSY RES, V26, P141, DOI 10.1016/S0920-1211(96)00043-5; Engel J, 2001, NEUROSCIENTIST, V7, P340, DOI 10.1177/107385840100700410; Engel J, 2001, EPILEPSIA, V42, P796, DOI 10.1046/j.1528-1157.2001.10401.x; Engel J, 2005, ADV BEHAV BIOL, V55, P371; Engel J, 2010, EPILEPSIA, V51, P2363, DOI 10.1111/j.1528-1167.2010.02701.x; Escayg A, 2010, EPILEPSIA, V51, P1650, DOI 10.1111/j.1528-1167.2010.02640.x; Fisher RS, 2005, EPILEPSIA, V46, P470, DOI 10.1111/j.0013-9580.2005.66104.x; FRENCH JA, 1993, ANN NEUROL, V34, P774, DOI 10.1002/ana.410340604; Galanopoulou AS, 2008, CURR NEUROPHARMACOL, V6, P1, DOI 10.2174/157015908783769653; Galanopoulou AS, 2008, J NEUROSCI, V28, P1557, DOI 10.1523/JNEUROSCI.5180-07.2008; Galanopoulou AS, 2009, EPILEPSIA, V50, P37, DOI 10.1111/j.1528-1167.2009.02217.x; Galanopoulou AS, 2002, DEV NEUROSCI-BASEL, V24, P355, DOI 10.1159/000069047; Galanopoulou AS, 2003, NEUROSCI LETT, V342, P201, DOI 10.1016/S0304-3940(03)00282-9; Galanopoulou AS, 2000, BRAIN DEV-JPN, V22, P279, DOI 10.1016/S0387-7604(00)00127-3; Giblin KA, 2010, NEUROSCIENTIST, V16, P253, DOI 10.1177/1073858409354385; Gleissner U, 2005, BRAIN, V128, P2822, DOI 10.1093/brain/awh597; Goffin K, 2009, EXP NEUROL, V217, P205, DOI 10.1016/j.expneurol.2009.02.008; Gomes WA, 2007, MAGN RESON MED, V58, P230, DOI 10.1002/mrm.21310; Guo X, 2001, EUR J NEUROSCI, V13, P1683, DOI 10.1046/j.0953-816x.2001.01542.x; Guo Y, 2009, NEUROSCIENCE, V162, P972, DOI 10.1016/j.neuroscience.2009.05.041; Hamed SA, 2010, RESTOR NEUROL NEUROS, V28, P323, DOI 10.3233/RNN-2010-0537; Hermann B, 2002, EPILEPSIA, V43, P1062, DOI 10.1046/j.1528-1157.2002.49901.x; Hirtz D, 2007, NEUROLOGY, V68, P326, DOI 10.1212/01.wnl.0000252807.38124.a3; Holmes GL, 2007, EPILEPSIA, V48, P617, DOI 10.1111/j.1528-1167.2007.01035.x; Hrachovy RA, 2003, J CLIN NEUROPHYSIOL, V20, P408, DOI 10.1097/00004691-200311000-00004; Isaeva E, 2006, EUR J NEUROSCI, V23, P1559, DOI 10.1111/j.1460-9568.2006.04693.x; JAMBAQUE I, 1993, NEUROPSYCHOLOGIA, V31, P1321, DOI 10.1016/0028-3932(93)90101-5; Jonas R, 2004, NEUROLOGY, V62, P1712, DOI 10.1212/01.WNL.0000127109.14569.C3; Jupp B, 2007, EPILEPSIA, V48, P82, DOI 10.1111/j.1528-1167.2007.01245.x; Kabuto H, 1998, EPILEPSIA, V39, P237, DOI 10.1111/j.1528-1157.1998.tb01367.x; Kalviainen R, 1998, NEUROLOGY, V50, P1377, DOI 10.1212/WNL.50.5.1377; Kamida T, 2009, SEIZURE-EUR J EPILEP, V18, P71, DOI 10.1016/j.seizure.2008.06.012; Kim CH, 2010, EPILEPSY RES, V90, P21, DOI 10.1016/j.eplepsyres.2010.03.002; Kivity S, 2004, EPILEPSIA, V45, P255, DOI 10.1111/j.0013-9580.2004.30503.x; Knudsen EI, 2004, J COGNITIVE NEUROSCI, V16, P1412, DOI 10.1162/0898929042304796; Komatsu M, 2000, EPILEPSIA, V41, P1091, DOI 10.1111/j.1528-1157.2000.tb00312.x; KOO B, 1993, NEUROLOGY, V43, P2322, DOI 10.1212/WNL.43.11.2322; Kotloski R, 2002, PROG BRAIN RES, V135, P95; Kuster GW, 2007, ARQ NEURO-PSIQUIAT, V65, P1101, DOI 10.1590/S0004-282X2007000700002; Kwan P, 2000, NEW ENGL J MED, V342, P314, DOI 10.1056/NEJM200002033420503; Kwan P, 2001, LANCET, V357, P216, DOI 10.1016/S0140-6736(00)03600-X; Larner AJ, 2010, NEUROMOL MED, V12, P71, DOI 10.1007/s12017-009-8076-z; Liacu D, 2010, NEUROPHYSIOL CLIN, V40, P151, DOI 10.1016/j.neucli.2010.01.003; Ljungberg MC, 2009, DIS MODEL MECH, V2, P389, DOI 10.1242/dmm.002386; LOMBROSO CT, 1983, EPILEPSIA, V24, P135, DOI 10.1111/j.1528-1157.1983.tb04874.x; Lopantsev V, 2009, EUR J NEUROSCI, V29, P1153, DOI 10.1111/j.1460-9568.2009.06663.x; Lowenstein DH, 2009, EPILEPSIA, V50, P4, DOI 10.1111/j.1528-1167.2008.02004.x; Lux AL, 2005, LANCET NEUROL, V4, P712, DOI 10.1016/S1474-4422(05)70199-X; Macdonald RL, 2010, J PHYSIOL-LONDON, V588, P1861, DOI 10.1113/jphysiol.2010.186999; Mathern GW, 2002, PROG BRAIN RES, V135, P237; Mathern GW, 1997, HIPPOCAMPAL SCLEROSI, P133; McVicar KA, 2004, MENT RETARD DEV D R, V10, P144, DOI 10.1002/mrdd.20028; Mendez MF, 2003, DRUG AGING, V20, P791, DOI 10.2165/00002512-200320110-00001; Meyerhoff JL, 2004, BRAIN RES, V1016, P139, DOI 10.1016/j.brainres.2004.03.019; Minkeviciene R, 2009, J NEUROSCI, V29, P3453, DOI 10.1523/JNEUROSCI.5215-08.2009; Mirrione MM, 2006, SYNAPSE, V59, P119, DOI 10.1002/syn.20216; Miyamoto R, 2008, BRAIN RES, V1209, P85, DOI 10.1016/j.brainres.2008.02.064; Moldrich RX, 2003, EUR J PHARMACOL, V476, P3, DOI 10.1016/S0014-2999(03)02149-6; Mori A, 2004, ACTA MED OKAYAMA, V58, P111; Motamedi G, 2003, EPILEPSY BEHAV, V4, pS25, DOI 10.1016/j.yebeh.2003.07.004; Muller-Schwarze AB, 1999, NEUROREPORT, V10, P1517, DOI 10.1097/00001756-199905140-00023; Naegele JR, 2007, EPILEPSIA, V48, P107, DOI 10.1111/j.1528-1167.2007.01071.x; Naegele JR, 2010, NEUROPHARMACOLOGY, V58, P855, DOI 10.1016/j.neuropharm.2010.01.019; Nairismagi J, 2004, EPILEPSIA, V45, P1024, DOI 10.1111/j.0013-9580.2004.08904.x; Napolioni V, 2009, BRAIN DEV-JPN, V31, P104, DOI 10.1016/j.braindev.2008.09.013; Noe F, 2007, PEPTIDES, V28, P377, DOI 10.1016/j.peptides.2006.07.025; Nordli DR, 2010, BRAIN DEV-JPN, V32, P37, DOI 10.1016/j.braindev.2009.09.015; O'Reilly RC, 2006, SCIENCE, V314, P91, DOI 10.1126/science.1127242; OLEARY DS, 1983, J NERV MENT DIS, V171, P624, DOI 10.1097/00005053-198310000-00006; Palop JJ, 2007, NEURON, V55, P697, DOI 10.1016/j.neuron.2007.07.025; Paradiso B, 2009, P NATL ACAD SCI USA, V106, P7191, DOI 10.1073/pnas.0810710106; Partikian A, 2010, J CHILD NEUROL, V25, P423, DOI 10.1177/0883073809341664; Pellock JM, 2010, EPILEPSIA, V51, P2175, DOI 10.1111/j.1528-1167.2010.02657.x; Pitkanen A, 2006, J NEUROTRAUM, V23, P241, DOI 10.1089/neu.2006.23.241; Pitkanen A, 2004, EXPERT OPIN PHARMACO, V5, P777, DOI 10.1517/14656566.5.4.777; Pitkanen A, 2002, LANCET NEUROL, V1, P173, DOI 10.1016/S1474-4422(02)00073-X; Pitkanen A, 2010, EPILEPSIA, V51, P2, DOI 10.1111/j.1528-1167.2010.02602.x; Pitkanen A, 2009, EPILEPSIA, V50, P21, DOI 10.1111/j.1528-1167.2008.02007.x; Pretel S, 1997, ACTA HISTOCHEM, V99, P71, DOI 10.1016/S0065-1281(97)80010-4; Rakhade SN, 2009, NAT REV NEUROL, V5, P380, DOI 10.1038/nrneurol.2009.80; Raol YSH, 2003, ANN NEUROL, V53, P503, DOI 10.1002/ana.10490; Reeves TM, 1997, BRAIN RES, V757, P119, DOI 10.1016/S0006-8993(97)00170-4; Reilly PL, 2001, J CLIN NEUROSCI, V8, P398, DOI 10.1054/jocn.2001.0916; Rener-Primec Z, 2006, EPILEPSIA, V47, P2202, DOI 10.1111/j.1528-1167.2006.00888.x; Riikonen RS, 2010, EUR J PAEDIATR NEURO, V14, P13, DOI 10.1016/j.ejpn.2009.03.004; Rivera C, 2004, J NEUROSCI, V24, P4683, DOI 10.1523/JNEUROSCI.5265-03.2004; Roch C, 2002, EPILEPSIA, V43, P1129, DOI 10.1046/j.1528-1157.2002.17802.x; Roch C, 2002, EPILEPSIA, V43, P325, DOI 10.1046/j.1528-1157.2002.11301.x; Rugg-Gunn FJ, 2001, BRAIN, V124, P627, DOI 10.1093/brain/124.3.627; Salmenpera T, 2001, EPILEPSY RES, V46, P69, DOI 10.1016/S0920-1211(01)00258-3; Sanchez RM, 2001, J NEUROSCI, V21, P8154; Shapiro LA, 2008, EPILEPSIA, V49, P33, DOI 10.1111/j.1528-1167.2008.01491.x; Sharma V, 2007, SEIZURE-EUR J EPILEP, V16, P680, DOI 10.1016/j.seizure.2007.05.012; Shen J, 2009, J INT MED RES, V37, P1211, DOI 10.1177/147323000903700428; Shih JJ, 2004, EPILEPSIA, V45, P223, DOI 10.1111/j.0013-9580.2004.13503.x; Shinnar S, 2008, NEUROLOGY, V71, P170, DOI 10.1212/01.wnl.0000310774.01185.97; SHINNAR S, 1994, EPILEPSIA, V35, P471, DOI 10.1111/j.1528-1157.1994.tb02464.x; Shinnar S, 1996, PEDIATRICS, V98, P216; Shon YM, 2010, EPILEPSIA, V51, P529, DOI 10.1111/j.1528-1167.2009.02327.x; Spanaki MV, 2000, EPILEPSIA, V41, P1227, DOI 10.1111/j.1528-1157.2000.tb00330.x; Spooner CG, 2006, NEUROLOGY, V67, P2147, DOI 10.1212/01.wnl.0000248189.93630.4f; STAFSTROM CE, 1992, DEV BRAIN RES, V65, P227, DOI 10.1016/0165-3806(92)90184-X; SUTULA T, 1992, J NEUROSCI, V12, P4173; Sutula Thomas, 2002, Epilepsy Curr, V2, P86, DOI 10.1046/j.1535-7597.2002.00032.x; Sutula TP, 2003, CURR OPIN NEUROL, V16, P189, DOI 10.1097/00019052-200304000-00012; Swann JW, 2007, DEV NEUROSCI-BASEL, V29, P168, DOI 10.1159/000096221; Tasch E, 1999, ANN NEUROL, V45, P568, DOI 10.1002/1531-8249(199905)45:5<568::AID-ANA4>3.0.CO;2-P; TASSINARI CA, 1992, EPILEPSY RES, P111; Tassinari CA, 2006, EPILEPSIA, V47, P40, DOI 10.1111/j.1528-1167.2006.00686.x; Theodore WH, 1999, NEUROLOGY, V52, P132, DOI 10.1212/WNL.52.1.132; Thom M, 2002, J NEUROPATH EXP NEUR, V61, P510, DOI 10.1093/jnen/61.6.510; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Tokumitsu T, 1997, BRAIN RES, V744, P57, DOI 10.1016/S0006-8993(96)01071-2; Tubbs RS, 2005, CHILD NERV SYST, V21, P461, DOI 10.1007/s00381-005-1136-2; VanLandingham KE, 1998, ANN NEUROL, V43, P413, DOI 10.1002/ana.410430403; Veliskova J, 2001, ANN NEUROL, V50, P596, DOI 10.1002/ana.1248; Vezzani A, 2008, EPILEPSIA, V49, P24, DOI 10.1111/j.1528-1167.2008.01490.x; Wang DD, 2008, J NEUROSCI, V28, P5547, DOI 10.1523/JNEUROSCI.5599-07.2008; Wang YY, 2010, BRAIN PATHOL, V20, P1, DOI 10.1111/j.1750-3639.2008.00254.x; WHO, 2009, EP FACT SHEET 2009; Wieshmann UC, 1997, EPILEPSIA, V38, P1238, DOI 10.1111/j.1528-1157.1997.tb01222.x; Willmore LJ, 2009, NEUROCHEM RES, V34, P688, DOI 10.1007/s11064-008-9841-3; WILLMORE LJ, 1978, ANN NEUROL, V4, P329, DOI 10.1002/ana.410040408; Woermann FG, 1999, ANN NEUROL, V45, P369, DOI 10.1002/1531-8249(199903)45:3<369::AID-ANA13>3.0.CO;2-Q; Wong M, 2008, EPILEPSIA, V49, P8, DOI 10.1111/j.1528-1167.2007.01270.x; Yan HD, 2005, EPILEPSIA, V46, P1170, DOI 10.1111/j.1528-1167.2005.35204.x; Yang TH, 2010, J NEUROL SCI, V296, P1, DOI 10.1016/j.jns.2010.06.002; YOKOI I, 1995, FREE RADICAL BIO MED, V19, P473, DOI 10.1016/0891-5849(95)00050-8; Zeng LH, 2009, J NEUROSCI, V29, P6964, DOI 10.1523/JNEUROSCI.0066-09.2009; Zhang G, 2004, NEUROSCIENCE, V125, P299, DOI 10.1016/j.neuroscience.2004.01.040	165	18	19	0	9	SPRINGER	NEW YORK	233 SPRING STREET, NEW YORK, NY 10013, UNITED STATES	0065-2598	2214-8019	978-1-4614-0652-5; 978-1-4614-0653-2	ADV EXP MED BIOL	Adv.Exp.Med.Biol.		2012	724						99	113			10.1007/978-1-4614-0653-2		15	Medicine, Research & Experimental; Clinical Neurology; Neurosciences	Research & Experimental Medicine; Neurosciences & Neurology	BA2XJ	WOS:000333978900010	22411237	Green Published			2021-06-18	
J	Wilde, EA; Hunter, JV; Bigler, ED				Wilde, Elisabeth A.; Hunter, Jill V.; Bigler, Erin D.			Pediatric traumatic brain injury: Neuroimaging and neurorehabilitation outcome	NEUROREHABILITATION			English	Article						Neuroimaging; neurorehabilitation; diffusion tensor imaging (DTI); magnetic resonance imaging (MRI); computed tomography (CT); children	DIFFUSE AXONAL INJURY; WORKING-MEMORY; CORTICAL THICKNESS; HEAD-INJURY; CHILDREN; MODERATE; ADOLESCENTS; ACTIVATION; CHILDHOOD; LESIONS	Brain injury in the pediatric patient not only occurs in an immature brain, but potentially influences all subsequent brain and neurodevelopmental maturation. This presents unique challenges in neuroimaging the developing central nervous system, which is reviewed herein. The most significant neuroimaging advances in assessing pediatric traumatic brain injury (TBI) have occurred with magnetic resonance imaging (MRI), particularly diffusion tensor imaging and the multiple emerging techniques using functional MRI (fMRI). Pediatric neuroimaging findings of TBI are discussed in terms of techniques that can assess underlying neural networks and provide information about neuroplasticity of recovery. Neuroimaging methods also provide insights into the complexities of brain injury, cognitive and neurobehavioral recovery, and how multimodality contemporary neuroimaging methods best demonstrate underlying neuropathology that affects outcome.	[Wilde, Elisabeth A.] Baylor Coll Med, Cognit Neurosci Lab, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Wilde, Elisabeth A.] Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; [Wilde, Elisabeth A.; Hunter, Jill V.] Baylor Coll Med, Dept Radiol, Houston, TX 77030 USA; [Wilde, Elisabeth A.] Michael E DeBakey VA Med Ctr, Houston, TX USA; [Hunter, Jill V.] Texas Childrens Hosp, Dept Pediat Radiol, Houston, TX 77030 USA; [Bigler, Erin D.] Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA; [Bigler, Erin D.] Brigham Young Univ, Ctr Neurosci, Provo, UT 84602 USA; [Bigler, Erin D.] Univ Utah, Inst Brain, Salt Lake City, UT USA; [Bigler, Erin D.] Univ Utah, Dept Psychiat, Salt Lake City, UT USA	Wilde, EA (corresponding author), Baylor Coll Med, Cognit Neurosci Lab, Dept Phys Med & Rehabil, Houston, TX 77030 USA.	ewilde@bcm.edu			National Institute Neurological Disorders and Stroke grant [R01-NS21889, 1 RO1-HD-04946]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS021889] Funding Source: NIH RePORTER	This work was supported by the National Institute Neurological Disorders and Stroke grant R01-NS21889 ("Neurobehavioral outcome of head injury in children") and 1 RO1-HD-04946 (Social Outcomes in Pediatric Traumatic Brain Injury). We gratefully acknowledge the contribution of Tracy Abildskov in manuscript preparation. The content of this manuscript is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anderson SW, 2000, DEV NEUROPSYCHOL, V18, P281, DOI 10.1207/S1532694202Anderson; Anderson V., 2010, PEDIAT TRAUMATIC BRA; Anderson V, 2012, INT J DEV NEUROSCI, V30, P217, DOI 10.1016/j.ijdevneu.2011.09.008; Babikian T, 2005, PEDIATR NEUROL, V33, P184, DOI 10.1016/j.pediatrneurol.2005.03.015; Beaulieu CL, 2002, SURG CLIN N AM, V82, P393, DOI 10.1016/S0039-6109(02)00009-9; Bigler ED, 2007, NEUROPSYCHOLOGY, V21, P515, DOI 10.1037/0894-4105.21.5.515; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Caeyenberghs K, 2012, BRAIN, V135, P1293, DOI 10.1093/brain/aws048; Catroppa C, 2009, DEV NEUROREHABIL, V12, P53, DOI 10.1080/17518420802634476; Courchesne E, 2000, RADIOLOGY, V216, P672, DOI 10.1148/radiology.216.3.r00au37672; Dennis M, 2010, CORTEX, V46, P1043, DOI 10.1016/j.cortex.2009.10.008; Ewing-Cobbs L, 2008, NEUROIMAGE, V42, P1305, DOI 10.1016/j.neuroimage.2008.06.031; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Gale SD, 2010, J HEAD TRAUMA REHAB, V25, P15, DOI 10.1097/HTR.0b013e3181c39960; Giedd JN, 2010, NEUROPSYCHOL REV, V20, P349, DOI 10.1007/s11065-010-9151-9; Giza CC, 2006, DEV NEUROSCI-BASEL, V28, P364, DOI 10.1159/000094163; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; Gorman S., 2011, J INT NEUROPSYCH SOC, V17, P1; Hanten G, 2008, NEUROPSYCHOLOGY, V22, P357, DOI 10.1037/0894-4105.22.3.357; Hasan KM, 2010, BRAIN STRUCT FUNCT, V214, P361, DOI 10.1007/s00429-009-0238-0; Hunter JV, 2012, J NEUROTRAUM, V29, P654, DOI 10.1089/neu.2011.1906; Irimia A, 2011, J NEUROTRAUM, V28, P2287, DOI 10.1089/neu.2011.1920; Jernigan TL, 2011, PROG BRAIN RES, V189, P77, DOI 10.1016/B978-0-444-53884-0.00019-1; Johnson CP, 2011, J INT NEUROPSYCH SOC, P1; Karunanayaka PR, 2007, NEUROREHABILITATION, V22, P355; Knickmeyer RC, 2008, J NEUROSCI, V28, P12176, DOI 10.1523/JNEUROSCI.3479-08.2008; Koepsell TD, 2011, PEDIATRICS, V128, P946, DOI 10.1542/peds.2010-2259; Kou ZF, 2010, J HEAD TRAUMA REHAB, V25, P267, DOI 10.1097/HTR.0b013e3181e54793; Lajiness-O'Neill R, 2011, APPL NEUROPSYCHOL, V18, P298, DOI 10.1080/09084282.2011.595457; Lajiness-O'Neill R, 2010, APPL NEUROPSYCHOL, V17, P83, DOI 10.1080/09084281003708837; Levin HS, 2001, NEUROPSYCHOLOGIA, V39, P122, DOI 10.1016/S0028-3932(00)00111-1; Mandalis A, 2007, DEV NEUROPSYCHOL, V32, P683, DOI 10.1080/87565640701376045; Merkley TL, 2008, J NEUROTRAUM, V25, P1343, DOI 10.1089/neu.2008.0615; Newsome MR, 2007, NEUROCASE, V13, P16, DOI 10.1080/13554790601186629; Newsome MR, 2012, INT J DEV NEUROSCI, V30, P255, DOI 10.1016/j.ijdevneu.2011.10.008; Newsome MR, 2010, NEUROPSYCHOLOGY, V24, P139, DOI 10.1037/a0017432; Prins ML, 2010, DEV NEUROSCI-BASEL, V32, P510, DOI 10.1159/000316800; Scheibel RS, 2011, SOC NEUROSCI-UK, V6, P582, DOI 10.1080/17470919.2011.588844; Spanos GK, 2007, AM J NEURORADIOL, V28, P537; Stiles J, 2010, NEUROPSYCHOL REV, V20, P327, DOI 10.1007/s11065-010-9148-4; Suskauer SJ, 2009, DEV DISABIL RES REV, V15, P117, DOI 10.1002/ddrr.62; Tavano A, 2009, BRAIN INJURY, V23, P167, DOI 10.1080/02699050802657012; Thurman DJ, 2007, BRAIN INJURY MED PRI, P45; Tong KA, 2008, AM J NEURORADIOL, V29, P9, DOI 10.3174/ajnr.A0786; Tong KA, 2004, ANN NEUROL, V56, P36, DOI 10.1002/ana.20123; Tong KA, 2003, RADIOLOGY, V227, P332, DOI 10.1148/radiol.2272020176; Tymofiyeva O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031029; van den Heuvel MP, 2011, J NEUROSCI, V31, P15775, DOI 10.1523/JNEUROSCI.3539-11.2011; Van Essen DC, 2012, NEUROIMAGE; Vogel AC, 2010, NEUROPSYCHOL REV, V20, P362, DOI 10.1007/s11065-010-9145-7; Wilde E. A., 2012, BRAIN IMAGING BEHAV; Wilde EA, 2005, J NEUROTRAUM, V22, P333, DOI 10.1089/neu.2005.22.333; Wilde EA, 2007, DEV MED CHILD NEUROL, V49, P294, DOI 10.1111/j.1469-8749.2007.00294.x; Wilde EA, 2006, J CHILD NEUROL, V21, P769, DOI 10.1177/08830738060210090201; Wilde EA, 2012, INT J DEV NEUROSCI, V30, P267, DOI 10.1016/j.ijdevneu.2012.01.003; Wilde EA, 2011, INT J PSYCHOPHYSIOL, V82, P86, DOI 10.1016/j.ijpsycho.2011.04.006; Wilde EA, 2010, DEV NEUROPSYCHOL, V35, P333, DOI 10.1080/87565641003696940; Wozniak JR, 2007, ARCH CLIN NEUROPSYCH, V22, P555, DOI 10.1016/j.acn.2007.03.004	58	18	18	1	30	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2012	31	3					245	260		10.3233/NRE-2012-0794			16	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	028QC	WOS:000310436200003	23093453				2021-06-18	
J	Zampolini, M; Zaccaria, B; Tolli, V; Frustaci, A; Franceschini, M				Zampolini, M.; Zaccaria, B.; Tolli, V.; Frustaci, A.; Franceschini, M.		GISCAR Grp	Rehabilitation of traumatic brain injury in Italy: A multi-centred study	BRAIN INJURY			English	Article						Closed head injury; rehabilitation; persistent vegetative state; outcome	LENGTH-OF-STAY; EPIDEMIOLOGY; PREDICTORS; OUTCOMES; IMPACT	Objectives: The aims of this study were to analyse TBI rehabilitation in Italy, identifying the main factors conditioning motor and functional recovery and destination upon discharge of traumatic severe acquired brain injury (sABI) patients who had undergone intensive rehabilitative treatment. Design: An observational prospective study of 863 consecutive patients admitted to 52 Rehabilitation Centres from January 2001 to December 2003. Results: The main cause of trauma was road accidents (79.8%), the mean length of stay was 87.31 +/- 77.26 days and 40.4% access to rehabilitation facilities after a month. Pressure sore rates fell from 26.1% to 6.6% during the rehabilitation programme. After discharge 615 patients returned home, whilst 212 were admitted to other health facilities. Discussion: This study highlights some major criticisms of rehabilitation of TBI. The delay of admission and evitable complications such as pressure sores are correlated to a worse outcome. While LOS causes a problem of cost-effectiveness, the rate of home discharge is prevalent and very high compared with other studies.	[Zampolini, M.] ASL N 3, Dept Rehabil, Umbria, Italy; [Zaccaria, B.] Univ Hosp, Dept Rehabil, Parma, Italy; [Tolli, V.] Inst San Raffaele Velletri, Rehabil Unit, Rome, Italy; [Franceschini, M.] IRCCS San Raffaele Pisana, Dept Neurorehabil, Rome, Italy	Zampolini, M (corresponding author), Foligno Hosp, Via M Arcamone, I-06034 Foligno, PG, Italy.	mauro.zampolini@tin.it	Zampolini, Mauro/B-7749-2009; Castelli, Enrico/J-1887-2012; Frustaci, Alessandra/I-9378-2012	Franceschini, Marco/0000-0002-2131-1583	'La Regione d'Umbria', Italy	Financial disclosure statements have been obtained and no conflicts of interest have been reported by the authors or by any individuals in control of the content of this article. This study has been carried out with funds provided by 'La Regione d'Umbria', Italy. The authors do not have economic benefits from this study. Preliminary data from this study has been presented at various meetings and congresses.	Arango-Lasprilla JC, 2007, ARCH PHYS MED REHAB, V88, P11, DOI 10.1016/j.apmr.2006.10.029; Bushnik T, 2003, ARCH PHYS MED REHAB, V84, P255, DOI 10.1053/apmr.2003.50092; Bushnik T, 2003, ARCH PHYS MED REHAB, V84, P151, DOI 10.1053/apmr.2003.50123; Choi JH, 2008, J TRAUMA, V65, P1028, DOI 10.1097/TA.0b013e31815eba9b; COWEN TD, 1995, ARCH PHYS MED REHAB, V76, P797, DOI 10.1016/S0003-9993(95)80542-7; De Silva MJ, 2009, INT J EPIDEMIOL, V38, P452, DOI 10.1093/ije/dyn189; Granger CV, 2010, AM J PHYS MED REHAB, V89, P265, DOI 10.1097/PHM.0b013e3181d3eb20; Green RE, 2008, ARCH PHYS MED REHAB, V89, pS51, DOI 10.1016/j.apmr.2008.09.552; High WM, 2006, ARCH PHYS MED REHAB, V87, P334, DOI 10.1016/j.apmr.2005.11.028; Mammi P, 2006, Eura Medicophys, V42, P17; Mauritz W, 2008, EUR J PUBLIC HEALTH, V18, P575, DOI 10.1093/eurpub/ckn079; Ottenbacher KJ, 2004, JAMA-J AM MED ASSOC, V292, P1687, DOI 10.1001/jama.292.14.1687; Safaz I, 2008, BRAIN INJURY, V22, P733, DOI 10.1080/02699050802304714; Sandhaug M, 2010, BRAIN INJURY, V24, P740, DOI 10.3109/02699051003652849; Simonsen LL, 2007, INJURY, V38, P1146, DOI 10.1016/j.injury.2007.03.019; Sirois MJ, 2004, ARCH PHYS MED REHAB, V85, P184, DOI 10.1016/j.apmr.2003.06.009; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; von Wild K R, 2000, Neurol Neurochir Pol, V34, P138; Zampolini M., 2003, GIORNALE ITALIANO ME, V17, P15; ZAMPOLINI M, 2001, 4 WORLD C BRAIN INJ, P427	20	18	18	0	14	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JAN	2012	26	1					27	35		10.3109/02699052.2011.635358			9	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	858HY	WOS:000297787900003	22149442				2021-06-18	
J	Arango-Lasprilla, JC; Ketchum, JM; Lewis, AN; Krch, D; Gary, KW; Dodd, BA				Arango-Lasprilla, Juan Carlos; Ketchum, Jessica M.; Lewis, Allen N.; Krch, Denise; Gary, Kelli W.; Dodd, Brett Anthony, Jr.			Racial and Ethnic Disparities in Employment Outcomes for Persons With Traumatic Brain Injury: A Longitudinal Investigation 1-5 Years After Injury	PM&R			English	Article							COMMUNITY INTEGRATION; ACUTE PREDICTORS; HEAD TRAUMA; RETURN; WORK; DISABILITY; REHABILITATION; POPULATION; PREVALENCE; LIFE	Objective: To determine whether differences exist in employment rates between whites, blacks, and Hispanics with traumatic brain injury (TBI) at 1, 2, or 5 years after injury; to determine whether changes occur in postinjury employment rates over time for whites, blacks, and Hispanics; and to determine whether changes in postinjury employment rates over time are different for whites, blacks, and Hispanics. Setting: Sixteen TBI Model System centers. Patients or Other Participants: Persons (3,940) with moderate-to-severe TBI who self-reported as white, black, or Hispanic. Main Outcome Measurements: Employment status dichotomized as competitively employed versus not competitively employed. Results: The odds of competitive employment were significantly greater for whites versus blacks at 1, 2, and 5 years after injury and were greater for whites versus Hispanics at 1 and 2 years after injury; whites and Hispanics did not differ significantly at 5 years after injury; and blacks and Hispanics were not significantly different at 1, 2, or 5 years after injury. The odds of employment increased significantly from 1-2, 2-5, and 1-5 years after injury for whites and Hispanics, whereas the odds of employment increased from 2-5 and 1-5 years after injury for blacks, with no significant difference between 1 and 2 years after injury for blacks. No evidence was found that the changes in employment rates over time were significantly different among the race and/or ethnicity groups. Conclusion: Future researchers should seek to identify causative factors for employment disparities, and rehabilitation professionals should work to mitigate inequalities in employment among racial and ethnic groups with TBI. PM R 2011;3:1083-1091	[Arango-Lasprilla, Juan Carlos] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Sch Med, Richmond, VA 23219 USA; [Ketchum, Jessica M.] Virginia Commonwealth Univ, Dept Biostat, Richmond, VA 23219 USA; [Ketchum, Jessica M.] Virginia Commonwealth Univ, Ctr Rehabil Sci & Engn, Richmond, VA 23219 USA; [Lewis, Allen N.] Virginia Commonwealth Univ, Dept Rehabil Counseling, Richmond, VA 23219 USA; [Krch, Denise] Kessler Fdn, Res Ctr, W Orange, NJ USA; [Gary, Kelli W.] Virginia Commonwealth Univ, Dept Occupat Therapy, Richmond, VA 23219 USA; [Dodd, Brett Anthony, Jr.] Regents Univ, Sch Psychol & Counseling, Virginia Beach, VA USA	Arango-Lasprilla, JC (corresponding author), Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Sch Med, Richmond, VA 23219 USA.	jcarangolasp@vcu.edu	Ketchum, Jessica/AAE-8200-2020	Ketchum, Jessica/0000-0002-5566-3691	National Institute of Disability and Rehabilitation Research [H133A070036]; United States Department of EducationUS Department of Education [H133A080060]; Department of Education, NIDRR [H133P090009]	This work was supported by the National Institute of Disability and Rehabilitation Research (grant H133A070036) and the United States Department of Education (grant H133A080060).; The contents of this article were developed partially under a grant from the Department of Education, NIDRR grant number H133P090009. However, those contents do not necessarily represent the policy of the Department of Education, and you should not assume endorsement by the Federal Government.	Anson K, 2006, J HEAD TRAUMA REHAB, V21, P248, DOI 10.1097/00001199-200605000-00005; Arango-Lasprilla JC, 2008, ARCH PHYS MED REHAB, V89, P988, DOI 10.1016/j.apmr.2008.02.012; Arango-Lasprilla JC, 2009, PM&R, V1, P41, DOI 10.1016/j.pmrj.2008.07.001; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Cifu DX, 1997, ARCH PHYS MED REHAB, V78, P125, DOI 10.1016/S0003-9993(97)90252-5; COOPER K D, 1983, Neuroepidemiology, V2, P70, DOI 10.1159/000110512; Corrigan JD, 2007, ARCH PHYS MED REHAB, V88, P1400, DOI 10.1016/j.apmr.2007.08.006; Cardoso EDS, 2007, J HEAD TRAUMA REHAB, V22, P85; Doctor JN, 2005, J INT NEUROPSYCH SOC, V11, P747, DOI 10.1017/S1355617705050836; Felmingham KL, 2001, ARCH PHYS MED REHAB, V82, P435, DOI 10.1053/apmr.2001.21985; Fleming J, 1999, BRAIN INJURY, V13, P417; Fleminger S, 2005, BRIT MED J, V331, P1419, DOI 10.1136/bmj.331.7530.1419; FRANKOWSKI RF, 1985, CENTRAL NERVOUS SYST; Gamboa AM, 2006, NEUROREHABILITATION, V21, P327; Gary KW, 2010, J VOCAT REHABIL, V33, P65, DOI 10.3233/JVR-2010-0516; Gary KW, 2009, ARCH PHYS MED REHAB, V90, P1699, DOI 10.1016/j.apmr.2009.04.014; Gollaher K, 1998, BRAIN INJURY, V12, P255, DOI 10.1080/026990598122557; Hosmer D. W., 2000, APPL LOGISTIC REGRES; Izaute M, 2008, BRAIN INJURY, V22, P758, DOI 10.1080/02699050802366002; Johansson U, 2003, BRAIN INJURY, V17, P991, DOI 10.1080/0269905031000110508; Johnstone B, 2003, ARCH PHYS MED REHAB, V84, P238, DOI 10.1053/apmr.2003.50097; Kersel DA, 2001, BRAIN INJURY, V15, P683, DOI 10.1080/02699050010013662; Keyser-Marcus LA, 2002, ARCH PHYS MED REHAB, V83, P635, DOI 10.1053/apmr.2002.31605; Kreutzer JS, 2003, J HEAD TRAUMA REHAB, V18, P128, DOI 10.1097/00001199-200303000-00004; Kreutzer JS, 2001, BRAIN INJURY, V15, P563, DOI 10.1080/02699050010009108; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Lewis A, 2009, DISABIL REHABIL, V31, P1136, DOI 10.1080/09638280902773737; McCrimmon S, 2006, BRAIN INJURY, V20, P1037, DOI 10.1080/02699050600909656; O'Neill J, 1998, J HEAD TRAUMA REHAB, V13, P68, DOI 10.1097/00001199-199808000-00007; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Safaz I, 2008, BRAIN INJURY, V22, P733, DOI 10.1080/02699050802304714; Shames J, 2007, DISABIL REHABIL, V29, P1387, DOI 10.1080/09638280701315011; Sherer M, 2003, J HEAD TRAUMA REHAB, V18, P408, DOI 10.1097/00001199-200309000-00003; *STAT U NEW YORK B, 1997, GUID UN DAT SET MED; Tsaousides T, 2008, REHABIL PSYCHOL, V53, P456, DOI 10.1037/a0012579; US Census Bureau, AM COMM SURV 5 YEAR; Wallister TW, 2008, WORLD PSYCHIATRY, V7, P3; WHITMAN S, 1984, AM J EPIDEMIOL, V119, P570, DOI 10.1093/oxfordjournals.aje.a113774; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac	39	18	18	0	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1934-1482	1934-1563		PM&R	PM&R	DEC	2011	3	12					1083	1091		10.1016/j.pmrj.2011.05.023			9	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	966YG	WOS:000305872700002	21872550				2021-06-18	
J	Konstantinidis, A; Inaba, K; Dubose, J; Barmparas, G; Talving, P; David, JS; Lam, L; Demetriades, D				Konstantinidis, Agathoklis; Inaba, Kenji; Dubose, Joe; Barmparas, Galinos; Talving, Peep; David, Jean-Stephane; Lam, Lydia; Demetriades, Demetrios			The Impact of Nontherapeutic Hypothermia on Outcomes After Severe Traumatic Brain Injury	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						Hypothermia; Trauma; Severe brain injury; Mortality; Intensive care unit; Admission	SEVERE HEAD-INJURY; ADMISSION HYPOTHERMIA; MODERATE HYPOTHERMIA; COAGULOPATHY; COAGULATION; HYPOTENSION; MANAGEMENT; HEMORRHAGE; PREDICTOR; MORTALITY	Introduction: In patients with isolated severe traumatic brain injury (TBI), the effect of controlled, therapeutic hypothermia on outcomes has been studied extensively. What is not well understood, however, and the purpose of this study, was to examine the impact of noninduced, nontherapeutic hypothermia on outcomes in these patients. Methods: A retrospective review of the institutional trauma registry at the Los Angeles County + University of Southern California Medical Center was performed to identify all trauma patients admitted to the surgical intensive care unit (SICU) with isolated severe TBI from January 2000 to December 2008. Patients were classified as hypothermic (core temperature [Tc] <= 35 degrees C) or normothermic (Tc >35 degrees C) based on their first Tc recorded on SICU admission. The primary outcome measure was in-hospital mortality, and secondary outcomes included SICU and hospital length of stay. Results: During the study period, 1,403 patients sustaining an isolated severe TBI were admitted to the SICU. After excluding 122 patients with missing temperature data, 1,281 patients were analyzed. Hypothermia (Tc <35 degrees C) on SICU admission was identified in 10.9% (n = 140) of the study population, with the remaining 89.1% (n = 1,141) being normothermic (Tc >35 degrees C). After adjusting for differences in baseline characteristics between the two groups, patients who were hypothermic on SICU admission were found to be significantly less likely to survive (odds ratio, 2.9; 95% confidence interval, 1.3, 6.7; p < 0.013). A penetrating mechanism of injury, Injury Severity Score >= 25, and undergoing an exploratory laparotomy before admission were found to be independent risk factors for the development of hypothermia on SICU admission. Conclusion: For patients who have sustained isolated severe TBI, the presence of noninduced, nontherapeutic hypothermia on SICU admission is associated with a significant increase in mortality. The impact of preventative measures used to avoid the development of hypothermia and the effectiveness of measures for restoring normothermia warrant further investigation.	[Konstantinidis, Agathoklis; Inaba, Kenji; Barmparas, Galinos; Talving, Peep; Lam, Lydia; Demetriades, Demetrios] Univ So Calif, Div Trauma Surg & Surg Crit Care, Los Angeles Cty Med Ctr, Los Angeles, CA 90033 USA; [Dubose, Joe] Univ Maryland Med Syst, R Adams Cowley Shock Trauma Ctr, Baltimore, MD USA; Univ Lyon 1, F-69365 Lyon, France; [David, Jean-Stephane] HCL, Lyon Sud Hosp, Dept Anesthesiol & Crit Care, Lyon, France	Inaba, K (corresponding author), Univ So Calif, Div Trauma Surg & Surg Crit Care, USC LAC Mad Ctr, 1200 N State St,Inpatient Tower C,Room C5L100, Los Angeles, CA 90033 USA.	kinaba@surgery.usc.edu	INABA, KENJI/AAC-8532-2020; Talving, Peep/E-6015-2013; David, Jean Stephane/H-9399-2019; Talving, Peep/G-8621-2015; Barmparas, Galinos/L-6530-2019	David, Jean Stephane/0000-0001-6274-7044; Talving, Peep/0000-0002-9741-2073; 			*AM COLL SURG, 2008, AM COLL SURG COMM TR; Arthurs Z, 2006, AM J SURG, V191, P610, DOI 10.1016/j.amjsurg.2006.02.010; Bergstein JM, 1996, ANN EMERG MED, V27, P39, DOI 10.1016/S0196-0644(96)70294-9; BERNABEI AF, 1992, J TRAUMA, V33, P835, DOI 10.1097/00005373-199212000-00007; BEST R, 1985, AM J EMERG MED, V3, P48, DOI 10.1016/0735-6757(85)90013-0; Carrick MM, 2005, J TRAUMA, V58, P725, DOI 10.1097/01.TA.0000159249.68363.78; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Clifton GL, 2002, J NEUROTRAUM, V19, P293, DOI 10.1089/089771502753594864; CLIFTON GL, 1993, J NEUROTRAUM, V10, P263, DOI 10.1089/neu.1993.10.263; FRIED SJ, 1986, J TRAUMA, V26, P183, DOI 10.1097/00005373-198602000-00016; Gentilello LM, 1997, ANN SURG, V226, P439, DOI 10.1097/00000658-199710000-00005; GREGORY JS, 1991, J TRAUMA, V31, P795, DOI 10.1097/00005373-199106000-00009; Harris OA, 2002, ARCH NEUROL-CHICAGO, V59, P1077, DOI 10.1001/archneur.59.7.1077; Harris OA, 2009, J NEUROSURG, V110, P1256, DOI 10.3171/2009.1.JNS081320; Hildebrand F, 2009, UNFALLCHIRURG, V112, P959, DOI 10.1007/s00113-009-1683-1; Hutchison JS, 2008, NEW ENGL J MED, V358, P2447, DOI 10.1056/NEJMoa0706930; Inaba K, 2009, WORLD J SURG, V33, P864, DOI 10.1007/s00268-009-9936-2; JURKOVICH GJ, 1987, J TRAUMA, V27, P1019, DOI 10.1097/00005373-198709000-00011; KEIMOWITZ RM, 1973, J NEUROSURG, V39, P178, DOI 10.3171/jns.1973.39.2.0178; Kirkpatrick AW, 1999, CAN J SURG, V42, P333; Kongsayreepong S, 2003, ANESTH ANALG, V96, P826, DOI 10.1213/01.ANE.0000048822.27698.28; Kushimoto S, 2003, J NEUROTRAUM, V20, P357, DOI 10.1089/089771503765172318; Lenhardt Rainer, 2010, Front Biosci (Schol Ed), V2, P1145; Lewis FR, 1997, ANN SURG, V226, P447; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; Martin RS, 2005, SHOCK, V24, P114, DOI 10.1097/01.shk.0000169726.25189.b1; Metz C, 1996, J NEUROSURG, V85, P533, DOI 10.3171/jns.1996.85.4.0533; Murshid WR, 2002, BRIT J NEUROSURG, V16, P362, DOI 10.1080/0268869021000007597; NICODEMUS HF, 1981, CRIT CARE MED, V9, P325, DOI 10.1097/00003246-198104000-00009; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; PALLADINO WG, 1983, J SURG RES, V34, P388, DOI 10.1016/0022-4804(83)90087-2; Polderman KH, 2002, INTENS CARE MED, V28, P1563, DOI 10.1007/s00134-002-1511-3; ROBERTS S, 1994, UROLOGY, V44, P832, DOI 10.1016/S0090-4295(94)80166-5; Scherer RU, 1998, CRIT CARE MED, V26, P149, DOI 10.1097/00003246-199801000-00031; Shafi S, 2005, J TRAUMA, V59, P1081, DOI 10.1097/01.ta.0000188647.03665.fd; SHIOZAKI T, 1993, J NEUROSURG, V79, P363, DOI 10.3171/jns.1993.79.3.0363; STEIN SC, 1992, NEUROSURGERY, V30, P160, DOI 10.1227/00006123-199202000-00002; STEINEMANN S, 1990, J TRAUMA, V30, P200, DOI 10.1097/00005373-199002000-00011; STONER HB, 1980, CLIN SCI, V59, P19, DOI 10.1042/cs0590019; Talving P, 2009, J TRAUMA, V66, P55, DOI 10.1097/TA.0b013e318190c3c0; TOUHO H, 1986, NEUROSURGERY, V19, P523, DOI 10.1227/00006123-198610000-00005; Wafaisade A, 2010, NEUROCRIT CARE, V12, P211, DOI 10.1007/s12028-009-9281-1; Wang HE, 2005, CRIT CARE MED, V33, P1296, DOI 10.1097/01.CCM.0000165965.31895.80; Zehtabchi S, 2008, RESUSCITATION, V76, P52, DOI 10.1016/j.resuscitation.2007.06.024	44	18	20	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	DEC	2011	71	6					1627	1631		10.1097/TA.0b013e3182159e31			5	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	869RT	WOS:000298616400033	21537207				2021-06-18	
J	McCartney, A; Butler, C; Acreman, S				McCartney, Aileen; Butler, Claire; Acreman, Sue			Exploring access to rehabilitation services from allied health professionals for patients with primary high-grade brain tumours	PALLIATIVE MEDICINE			English	Article						Allied health professionals; brain tumours; health services access; rehabilitation	INPATIENT REHABILITATION; LUNG-CANCER; FUNCTIONAL OUTCOMES; BREATHLESSNESS; INTERVENTION; BARRIERS; INJURY; UK	Primary brain tumours account for less than 2% of cancer diagnoses in the UK but more people under 40 die from a brain tumour than from any other cancer. Despite developments in some treatment options, survival remains poor and patients suffer with considerable functional and cognitive deficits. Rehabilitation for patients with primary brain tumours produces statistically and clinically significant improvements in function. When compared, similar functional gains are made following rehabilitation for brain tumour patients and for those following stroke and traumatic brain injury. There have been very few studies looking at access to rehabilitation for this group of patients as a primary objective. However, existing studies and clinical experience suggest that patients with brain tumours do not access rehabilitation services frequently or easily, either locally or nationally. Therefore, this qualitative study addressed the reasons for this through semi-structured interviews of healthcare professionals, investigating their experiences of rehabilitation for this patient group and describing commonly identified barriers under key themes. The interviews gauged the views of eight healthcare professionals representing three professions in different settings, including hospital and community based. The resultant barriers fell under the following themes: professional knowledge and behaviours; services and systems; and the disease and its effects. Suggested solutions were wide ranging and included education, multidisciplinary meetings and specialist clinicians to co-ordinate care. The barriers to accessing rehabilitation for this group of patients are complex, but some of the solutions could be reached through education and co-ordination of services. Further research into the benefits of, and access to, rehabilitation for this group of patients is essential to ensure that patients with brain tumours are given opportunity to gain from the benefits of rehabilitation in the same way as other diagnoses, both cancer and non-cancer.	[McCartney, Aileen] Wisdom Hosp, Rochester ME1 2NU, Kent, England; [Acreman, Sue] Velindre Canc Ctr, Cardiff, S Glam, Wales	McCartney, A (corresponding author), Wisdom Hosp, Rochester ME1 2NU, Kent, England.	aileenmccartney@nhs.net					Bell KR, 1998, ARCH PHYS MED REHAB, V79, pS37, DOI 10.1016/S0003-9993(98)90120-4; BERGLUND G, 1994, EUR J CANCER, V30A, P1744, DOI 10.1016/0959-8049(94)00330-8; Bredin M, 1999, BMJ-BRIT MED J, V318, P901, DOI 10.1136/bmj.318.7188.901; *CANC RES UK, 2004, CANC STATS MON 2004; *CANC RES UK, 2008, BRAIN TUM RISKS CAUS; Cheville AL, 2007, J SURG ONCOL, V95, P409, DOI 10.1002/jso.20782; Corner J, 2006, SOC SCI MED, V62, P1381, DOI 10.1016/j.socscimed.2005.08.012; Corner J, 1996, PALLIATIVE MED, V10, P299, DOI 10.1177/026921639601000405; Cramp F, 2008, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD006145.PUB2; Ezzy D., 2002, QUALITATIVE ANAL PRA; Geler-Kulcu D, 2009, J CLIN NEUROSCI, V16, P74, DOI 10.1016/j.jocn.2008.04.014; GUERRERO D, 1998, NEUROONCOLOGY NURSES; Hackman D, 2011, PHYSIOTHER RES INT, V16, P201, DOI 10.1002/pri.506; Holley S, 2001, Oncol Nurs Forum, V28, P1393; Huang ME, 1998, ARCH PHYS MED REHAB, V79, P1386, DOI 10.1016/S0003-9993(98)90232-5; Huang ME, 2000, AM J PHYS MED REHAB, V79, P327, DOI 10.1097/00002060-200007000-00003; Kirshblum S, 2001, CANCER, V92, P1029, DOI 10.1002/1097-0142(20010815)92:4+<1029::AID-CNCR1416>3.0.CO;2-P; Marciniak CM, 2001, ARCH PHYS MED REHAB, V82, P457, DOI 10.1053/apmr.2001.21862; Miller M, 2000, Eur J Oncol Nurs, V4, P233, DOI 10.1054/ejon.2000.0109; MUKAND JA, 2001, AM J PHYS MED REHAB, V80, P346; Mulholland PJ, 2004, MIMS ADV NEURO ONCOL, V1, P1; *NAT I HLTH, 2006, SERV GUID IMPR OUTC; National Council for Hospice and Specialist Palliative Care Services (NCHSPCS), 2000, FULF LIV REH PALL CA; National Institute for Health and Clinical Excellence, 2004, IMPR SUPP PALL CAR A; O'Dell MW, 1998, ARCH PHYS MED REHAB, V79, P1530, DOI 10.1016/S0003-9993(98)90414-2; Osoba D, 2000, NEURO-ONCOLOGY, V2, P221, DOI 10.1093/neuonc/2.4.221; Patton M.Q., 2002, QUALITATIVE RES EVAL; Rodriguez-Bigas MA, 2007, J SURG ONCOL, V95, P400, DOI 10.1002/jso.20778; Rubin IS., 1995, QUALITATIVE INTERVIE; Salander P, 2002, PALLIATIVE MED, V16, P305, DOI 10.1191/0269216302pm569oa; Sherer M, 1997, CANCER, V80, P250, DOI 10.1002/(SICI)1097-0142(19970715)80:2<250::AID-CNCR13>3.3.CO;2-T; Stevinson C, 2005, EUR J CANCER CARE, V14, P63, DOI 10.1111/j.1365-2354.2005.00514.x	32	18	18	0	4	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0269-2163			PALLIATIVE MED	Palliat. Med.	DEC	2011	25	8			SI		788	796		10.1177/0269216311398699			9	Health Care Sciences & Services; Public, Environmental & Occupational Health; Medicine, General & Internal	Health Care Sciences & Services; Public, Environmental & Occupational Health; General & Internal Medicine	854EP	WOS:000297478100009	21393353				2021-06-18	
J	Tseng, WC; Shih, HM; Su, YC; Chen, HW; Hsiao, KY; Chen, IC				Tseng, Wei-Chun; Shih, Hong-Mo; Su, Yi-Chun; Chen, Hong-Wen; Hsiao, Kuang-Yu; Chen, I-Chuan			The Association Between Skull Bone Fractures and Outcomes in Patients With Severe Traumatic Brain Injury	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						Traumatic brain injury; Mortality; Risk factors; Skull bone fracture; Subarachnoid hemorrhage; Subdural hemorrhage	MODERATE HEAD-INJURY; SUBARACHNOID HEMORRHAGE; HYPOTENSION; SCAN; EPIDEMIOLOGY; MULTICENTER; PROGRESSION; PREDICTORS; MORTALITY	Background: In traumatic brain injury (TBI), computed tomography (CT) provides a good assessment of anatomic pathologic findings and the prognostic value of CT characteristics has been well discussed. However, few studies have focused on skull bone fracture and its clinical prognostic importance. Hence, this study aims to evaluate the effects of skull bone fracture on patients with severe TBI admitted to the emergency unit. Methods: We reviewed the medical records of patients with isolated severe TBI admitted to the emergency unit of a university hospital from July 2003 to June 2008. Patients were divided into two groups based on the presence of skull bone fracture identified by the CT scan while in the emergency unit. Mann-Whitney U test and a Student's t test were used to identify the differences between the two groups, whereas logistic regression was applied to determine any significant differences found in the statistical analysis. Results: A total of 197 patients were signed up in our study. Based on the presence of skull bone fracture on CT scan at emergency department, 92 patients (46.7%) comprised the skull bone fracture group and 59 patients (64.1%) of these died. One hundred five patients (53.3%) comprised the nonskull bone fracture group, of which 33 patients (31.4%) died. There is significant difference between the two groups (p = 0.004). Conclusion: This study shows that skull bone fracture is a mortality risk factor for patients with isolated severe blunt TBI.	[Chen, I-Chuan] Chang Gung Mem Hosp, Dept Emergency Med, Puzih City 613, Chiayi County, Taiwan; Chang Gung Univ, Coll Med, Dept Med, Gueishan Township, Taoyuan County, Taiwan	Chen, IC (corresponding author), Chang Gung Mem Hosp, Dept Emergency Med, 6 W Sec,Jiapu Rd, Puzih City 613, Chiayi County, Taiwan.	giomacky@gmail.com		Shih, Hong-Mo/0000-0001-7732-3594			Bahloul M, 2004, J TRAUMA, V57, P255, DOI 10.1097/01.TA.0000083004.35231.1E; Bjerke HS, 2000, J TRAUMA, V48, P1037; Chang EF, 2006, NEUROSURGERY, V58, P647, DOI 10.1227/01.NEU.0000197101.68538.E6; Chesnut RM, 1997, J TRAUMA, V42, pS4, DOI 10.1097/00005373-199705001-00002; Chieregato A, 2005, NEUROSURGERY, V56, P671, DOI 10.1227/01.NEU.0000156200.76331.7A; Choi JH, 2008, J TRAUMA, V65, P1028, DOI 10.1097/TA.0b013e31815eba9b; Compagnone C, 2009, NEUROSURGERY, V64, P690, DOI 10.1227/01.NEU.0000340796.18738.F7; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; Fabbri A, 2008, J NEUROL NEUROSUR PS, V79, P567, DOI 10.1136/jnnp.2007.120162; Fainardi E, 2004, ACTA NEUROCHIR, V146, P257, DOI 10.1007/s00701-003-0207-y; Franklin GA, 2000, J TRAUMA, V48, P1034, DOI 10.1097/00005373-200006000-00006; Hsiao KY, 2008, EMERG MED J, V25, P670, DOI 10.1136/emj.2007.053405; Jeremitsky E, 2003, J TRAUMA, V54, P312, DOI 10.1097/01.TA.0000037876.37236.D6; KAKARIEKA A, 1994, ACTA NEUROCHIR, V129, P1, DOI 10.1007/BF01400864; KRAUS JF, 1984, AM J EPIDEMIOL, V119, P186, DOI 10.1093/oxfordjournals.aje.a113737; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maas AIR, 2007, J NEUROTRAUM, V24, P303, DOI 10.1089/neu.2006.0033; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Masson F, 2001, J TRAUMA, V51, P481, DOI 10.1097/00005373-200109000-00010; Mattioli C, 2003, J NEUROSURG, V98, P37, DOI 10.3171/jns.2003.98.1.0037; Servadei E, 2000, BRIT J NEUROSURG, V14, P110; Servadei F, 2002, ACT NEUR S, V81, P81; Servadei F, 2002, NEUROSURGERY, V50, P261, DOI 10.1097/00006123-200202000-00006; Shapiro MB, 2002, J TRAUMA, V53, P236; Siegel S., 1988, NONPARAMETRIC STAT B; TEASDALE G, 1982, BRIT MED J, V285, P1695, DOI 10.1136/bmj.285.6356.1695; TIRET L, 1990, INT J EPIDEMIOL, V19, P133, DOI 10.1093/ije/19.1.133; Wong GKC, 2011, J NEUROSURG, V114, P1510, DOI 10.3171/2011.1.JNS101102; Zenati MS, 2002, J TRAUMA, V53, P232, DOI 10.1097/00005373-200208000-00007; Zygun DA, 2005, CAN J NEUROL SCI, V32, P87, DOI 10.1017/S0317167100016930	30	18	19	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	DEC	2011	71	6					1611	1614		10.1097/TA.0b013e31823a8a60			4	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	869RT	WOS:000298616400029	22182871				2021-06-18	
J	Wei, XE; Wang, D; Li, MH; Zhang, YZ; Li, YH; Li, WB				Wei, Xiao-Er; Wang, Dan; Li, Ming-Hua; Zhang, Yu-Zhen; Li, Yue-Hua; Li, Wen-Bin			A Useful Tool for the Initial Assessment of Blood-Brain Barrier Permeability After Traumatic Brain Injury in Rabbits: Dynamic Contrast-Enhanced Magnetic Resonance Imaging	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						Dynamic contrast-enhanced MRI; T2-weighted imaging; Blood-brain barrier; Traumatic brain injury; Rabbit	CLOSED-HEAD INJURY; T-1-WEIGHTED MRI; LESION VOLUME; ACUTE STROKE; IN-VIVO; DISRUPTION; RAT; DYSFUNCTION; DISEASE; MODELS	Objective: The aim of this study was to evaluate the role of dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) and its quantitative coefficient (K(trans)) in the assessment of the extent of traumatic brain injury (TBI) in a rabbit model. Methods: A weight-drop device (height, 20 cm) was used with varying impact force, 30-, 60-, or 90-g weight, to induce mild, moderate, or severe TBI, respectively. DCE-MRI and T2-weighted MRI was used to examine the injured groups and a sham group 1 day after TBI. We analyzed the relationship between K(trans) and the lesion volume on the basis of T2-weighted images in each group. Results: The lesion volumes in both the severe and the moderate injury groups were greater than those observed in the mild injury group (p < 0.01). Furthermore, the lesion volumes in the severe injury group tended to be greater than those seen in the moderate injury group (p = 0.053). The K(trans) values in all injury groups were greater than those observed in the sham group (p < 0.01). In addition, the K(trans) values in the severe and moderate injury groups were greater than those of the mild injury group (p < 0.01), and the values seen in the severe injury group tended to be greater than those of the moderate injury group (p = 0.08). Moreover, we observed a correlation between the K(trans) value and lesion volume in all injury groups (mild injury group: r = 0.766, p = 0.01; moderate injury group: r = 0.731, p = 0.04; and severe injury group: r = 0.886, p = 0.019). Conclusions: DCE-MRI and its quantitative coefficient, K(trans), have the potential to accurately assess the blood-brain barrier and the extent of injury in an in vivo model of TBI.	[Wei, Xiao-Er; Wang, Dan; Li, Ming-Hua; Zhang, Yu-Zhen; Li, Yue-Hua; Li, Wen-Bin] Shanghai Jiao Tong Univ, Dept Intervent & Diagnost Radiol, Affiliated Peoples Hosp 6, Shanghai 200030, Peoples R China	Li, WB (corresponding author), 600 Yi Shan Rd, Shanghai 200233, Peoples R China.	liwenbin@sh163.net			Science and Technology Commission of Shanghai Municipality, ShanghaiScience & Technology Commission of Shanghai Municipality (STCSM) [08411951200]	Supported by a grant part from Science and Technology Commission of Shanghai Municipality, Shanghai (Grant No. 08411951200).	Abo-Ramadan U, 2009, EXP NEUROL, V219, P328, DOI 10.1016/j.expneurol.2009.06.002; Adelson PD, 1998, ACT NEUR S, V71, P104; Armitage PA, 2011, MAGN RESON IMAGING, V29, P305, DOI 10.1016/j.mri.2010.09.002; Barrett KM, 2009, STROKE, V40, P2422, DOI 10.1161/STROKEAHA.109.548933; Bartels AL, 2008, J NEURAL TRANSM, V115, P1001, DOI 10.1007/s00702-008-0030-y; Biegon A, 2004, P NATL ACAD SCI USA, V101, P5117, DOI 10.1073/pnas.0305741101; Bowman GL, 2007, NEUROLOGY, V68, P1809, DOI 10.1212/01.wnl.0000262031.18018.1a; Chastain CA, 2009, J NEUROTRAUM, V26, P1183, DOI 10.1089/neu.2008.0650; Darling WG, 2009, EXP NEUROL, V220, P90, DOI 10.1016/j.expneurol.2009.07.034; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Immonen RJ, 2009, NEUROIMAGE, V45, P1, DOI 10.1016/j.neuroimage.2008.11.022; Ishrat T, 2010, EXP NEUROL, V226, P183, DOI 10.1016/j.expneurol.2010.08.023; Kharatishvili I, 2009, EXP NEUROL, V217, P154, DOI 10.1016/j.expneurol.2009.01.026; Korn A, 2005, J CLIN NEUROPHYSIOL, V22, P1, DOI 10.1097/01.WNP.0000150973.24324.A7; Kortekaas R, 2005, ANN NEUROL, V57, P176, DOI 10.1002/ana.20369; Larsson HBW, 2009, MAGN RESON MED, V62, P1270, DOI 10.1002/mrm.22136; Laurer HL, 1999, CURR OPIN NEUROL, V12, P715, DOI 10.1097/00019052-199912000-00010; Lemasson B, 2010, RADIOLOGY, V257, P342, DOI 10.1148/radiol.10092343; Lorberboym M, 2003, J NUCL MED, V44, P1898; Lu DY, 2007, NEUROSURGERY, V61, P596, DOI 10.1227/01.NEU.0000290908.38438.B2; Marchi N, 2007, EPILEPSIA, V48, P732, DOI 10.1111/j.1528-1167.2007.00988.x; Noworolski SM, 2008, MAGN RESON IMAGING, V26, P1071, DOI 10.1016/j.mri.2008.01.033; Oby E, 2006, EPILEPSIA, V47, P1761, DOI 10.1111/j.1528-1167.2006.00817.x; Onyszchuk G, 2007, J NEUROSCI METH, V160, P187, DOI 10.1016/j.jneumeth.2006.09.007; Rite I, 2007, J NEUROCHEM, V101, P1567, DOI 10.1111/j.1471-4159.2007.04567.x; Rodriguez-Baeza A, 2003, ANAT REC PART A, V273A, P583, DOI 10.1002/ar.a.10069; Seiffert E, 2004, J NEUROSCI, V24, P7829, DOI 10.1523/JNEUROSCI.1751-04.2004; Sharma HS, 2007, ANN NY ACAD SCI, V1122, P295, DOI 10.1196/annals.1403.022; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Song SK, 2011, NEUROBIOL AGING, V32, P2183, DOI 10.1016/j.neurobiolaging.2009.12.017; Thijs VN, 2000, STROKE, V31, P2597, DOI 10.1161/01.STR.31.11.2597; Tofts PS, 1999, J MAGN RESON IMAGING, V10, P223, DOI 10.1002/(SICI)1522-2586(199909)10:3<223::AID-JMRI2>3.0.CO;2-S; TOFTS PS, 1991, MAGNET RESON MED, V17, P357, DOI 10.1002/mrm.1910170208; Tomkins O, 2007, NEUROBIOL DIS, V25, P367, DOI 10.1016/j.nbd.2006.10.006; Turkbey B, 2010, DIAGN INTERV RADIOL, V16, P186, DOI 10.4261/1305-3825.DIR.2537-08.1; Vidarsson L, 2009, MAGN RESON IMAGING, V27, P1216, DOI 10.1016/j.mri.2009.01.019; Wang GM, 2009, BRAIN RES, V1294, P183, DOI 10.1016/j.brainres.2009.07.070; Wang HL, 2006, J MAGN RESON IMAGING, V24, P695, DOI 10.1002/jmri.20669; Wuerfel E, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-70; Yang FY, 2010, J MAGN RESON IMAGING, V32, P593, DOI 10.1002/jmri.22297; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003	41	18	21	1	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0022-5282			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	DEC	2011	71	6					1645	1650		10.1097/TA.0b013e31823498eb			6	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	869RT	WOS:000298616400037	22182873				2021-06-18	
J	Wen, L; Wang, H; Wang, F; Gong, JB; Li, G; Huang, X; Zhan, RY; Yang, XF				Wen, L.; Wang, H.; Wang, F.; Gong, J. B.; Li, G.; Huang, X.; Zhan, R. Y.; Yang, X. F.			A prospective study of early versus late craniectomy after traumatic brain injury	BRAIN INJURY			English	Article						decompressive craniectomy; outcome; traumatic brain injury	EARLY DECOMPRESSIVE CRANIECTOMY; SURGICAL-MANAGEMENT; HEAD-INJURY	Background: Decompressive craniectomy is an important method for managing traumatic brain injury (TBI). At present, controversies about this procedure exist, especially about the optimum operative time for patients with TBI. Methods: A prospective study was performed at the First Affiliated Hospital, College of Medicine, Zhejiang University. From January 2008 to December 2009, 25 patients who underwent early decompressive craniectomy were included in the study group, and 19 patients who underwent "late'' decompressive craniectomy as a second-tier therapy for intracranial hypertension were included as a comparison group. Results: The 30-day mortality after the operation was 16% in the study group. The overall mortality rate was 20% at the 6-month follow-up. A total of 52% of the patients (13 patients) had good outcomes, and 7 patients remained in a severely disabled or vegetative state. In the comparison group, 4 patients died, and 12 had good outcomes at the 6-month follow-up. The remaining 3 patients had poor outcomes. The study group was well matched with the comparison group. However, the outcomes in the study group were not better than those in the comparison group, as evaluated by the 6-month GOS score. Conclusion: Early decompressive craniectomy as a first-tier therapy for intracranial hypertension did not improve patient outcome when compared with "late'' decompressive craniectomy for managing TBI.	[Yang, X. F.] Zhejiang Univ, Coll Med, Dept Neurosurg, Affiliated Hosp 1, Hangzhou 310003, Zhejiang, Peoples R China	Yang, XF (corresponding author), Zhejiang Univ, Coll Med, Dept Neurosurg, Affiliated Hosp 1, 79 Qingchun Rd, Hangzhou 310003, Zhejiang, Peoples R China.	jediwen@163.com					Akyuz M, 2010, TURK NEUROSURG, V20, P382, DOI 10.5137/1019-5149.JTN.2785-09.1; Boret H, 2006, ACTA ANAESTH SCAND, V50, P252, DOI 10.1111/j.1399-6576.2005.00862.x; Cavusoglu H, 2010, ULUS TRAVMA ACIL CER, V16, P119; Compagnone C, 2005, NEUROSURGERY, V57, P1183; Cooper DJ, 2008, J CRIT CARE, V23, P387, DOI 10.1016/j.jcrc.2007.05.002; HASE U, 1978, ACTA NEUROCHIR, V45, P1, DOI 10.1007/BF01774379; Leitgeb J, 2007, WIEN KLIN WOCHENSCHR, V119, P56, DOI 10.1007/s00508-006-0764-1; Maas AIR, 1997, ACTA NEUROCHIR, V139, P286, DOI 10.1007/BF01808823; Piek Jurgen, 2002, Curr Opin Crit Care, V8, P134, DOI 10.1097/00075198-200204000-00008; Rubiano AM, 2009, ULUS TRAVMA ACIL CER, V15, P28; Schneider GH, 2002, ACT NEUR S, V81, P77; Timofeev I, 2006, INJURY, V37, P1125, DOI 10.1016/j.injury.2006.07.031; Yang XF, 2008, ACTA NEUROCHIR, V150, P1241, DOI 10.1007/s00701-008-0145-9; 2000, J NEUROTRAUMA, V17, P457	14	18	19	0	8	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	DEC	2011	25	13-14					1318	1324		10.3109/02699052.2011.608214			7	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	847MI	WOS:000296976600007	21902550				2021-06-18	
J	Appelboom, G; Zoller, SD; Piazza, MA; Szpalski, C; Bruce, SS; McDowell, MM; Vaughan, KA; Zacharia, BE; Hickman, Z; D'Ambrosio, A; Feldstein, NA; Anderson, RCE				Appelboom, Geoffrey; Zoller, Stephen D.; Piazza, Matthew A.; Szpalski, Caroline; Bruce, Samuel S.; McDowell, Michael M.; Vaughan, Kerry A.; Zacharia, Brad E.; Hickman, Zachary; D'Ambrosio, Anthony; Feldstein, Neil A.; Anderson, Richard C. E.			Traumatic brain injury in pediatric patients: evidence for the effectiveness of decompressive surgery	NEUROSURGICAL FOCUS			English	Article						clinical trial; pediatric; traumatic brain injury; decompressive surgery	CEREBRAL-BLOOD-FLOW; SEVERE HEAD-INJURY; LONG-TERM POTENTIATION; INTRACRANIAL HYPERTENSION; PERFUSION-PRESSURE; CHILDREN; CRANIECTOMY; IMPACT; ADULT; METABOLISM	Traumatic brain injury (TBI) is the current leading cause of death in children over 1 year of age. Adequate management and care of pediatric patients is critical to ensure the best functional outcome in this population. In their controversial trial, Cooper et al. concluded that decompressive craniectomy following TBI did not improve clinical outcome of the analyzed adult population. While the study did not target pediatric populations, the results do raise important and timely clinical questions regarding the effectiveness of decompressive surgery in pediatric patients. There is still a paucity of evidence regarding the effectiveness of this therapy in a pediatric population, and there is an especially noticeable knowledge gap surrounding age-stratified interventions in pediatric trauma. The purposes of this review are to first explore the anatomical variations between pediatric and adult populations in the setting of TBI. Second, the authors assess how these differences between adult and pediatric populations could translate into differences in the impact of decompressive surgery following TBI. (DOI: 10.3171/2011.8.FOCUS11177)	[Appelboom, Geoffrey; Zoller, Stephen D.; Piazza, Matthew A.; Bruce, Samuel S.; McDowell, Michael M.; Vaughan, Kerry A.; Zacharia, Brad E.; Hickman, Zachary; D'Ambrosio, Anthony; Feldstein, Neil A.; Anderson, Richard C. E.] Columbia Univ Coll Phys & Surg, Dept Neurol Surg, Neurol Inst, New York, NY 10032 USA; [Szpalski, Caroline] NYU, Dept Plast & Craniofacial Surg, New York, NY USA	Appelboom, G (corresponding author), Columbia Univ Coll Phys & Surg, Dept Neurol Surg, Neurol Inst, 710 W 168th St,Room 431, New York, NY 10032 USA.	ga2294@columbia.edu	Zacharia, Brad/P-1726-2019; Hickman, Zachary L./O-6335-2017	Hickman, Zachary L./0000-0001-5535-0268; Zacharia, Brad/0000-0002-2078-7635; Zoller, Stephen/0000-0002-6581-8159			*AANS CNS BRAIN TR, 2007, J NEUROTRAUMA S1, V24, pS55; Abdullah Jafri Malin, 2005, Asian J Surg, V28, P163, DOI 10.1016/S1015-9584(09)60334-1; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS25; Anderson VA, 2005, J NEUROL NEUROSUR PS, V76, P401, DOI 10.1136/jnnp.2003.019174; Anderson V, 2009, J HEAD TRAUMA REHAB, V24, P303, DOI 10.1097/HTR.0b013e3181ada830; Aya-ay J, 2005, EXP NEUROL, V193, P149, DOI 10.1016/j.expneurol.2004.11.021; Bauer R, 1999, PEDIATR NEUROSURG, V30, P62, DOI 10.1159/000028765; Bayir H, 2009, CRIT CARE MED, V37, P689, DOI 10.1097/CCM.0b013e318194abf2; BERGER MS, 1985, J NEUROSURG, V62, P194, DOI 10.3171/jns.1985.62.2.0194; Bittigau D, 1999, ANN NEUROL, V45, P724, DOI 10.1002/1531-8249(199906)45:6<724::AID-ANA6>3.0.CO;2-P; Bullock R, 1996, Eur J Emerg Med, V3, P109, DOI 10.1097/00063110-199606000-00010; Carter BG, 1999, INTENS CARE MED, V25, P722, DOI 10.1007/s001340050936; Chambers IR, 2006, J NEUROL NEUROSUR PS, V77, P234, DOI 10.1136/jnnp.2005.072215; Cho DY, 1995, PEDIATR NEUROSURG, V23, P192, DOI 10.1159/000120958; Coles JP, 2002, CRIT CARE MED, V30, P1950, DOI 10.1097/00003246-200209000-00002; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; D'Ambrosio R, 1998, BRAIN RES, V786, P64, DOI 10.1016/S0006-8993(97)01412-1; Danton GH, 2003, J NEUROPATH EXP NEUR, V62, P127, DOI 10.1093/jnen/62.2.127; ESPARZA J, 1985, CHILD NERV SYST, V1, P109, DOI 10.1007/BF00706691; GAAB MR, 1990, ACT NEUR S, V51, P326; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; Giza CC, 2006, J NEUROTRAUM, V23, P950, DOI 10.1089/neu.2006.23.950; Giza CC, 2006, DEV NEUROSCI-BASEL, V28, P364, DOI 10.1159/000094163; Guerra WKW, 1999, INTENS CARE MED, V25, P1327; Hieu PD, 1996, CHILD NERV SYST, V12, P270; Hutchinson PJ, 2006, ACTA NEUROCHIR SUPPL, V96, P17; Kan P, 2006, J NEUROSURG, V105, P337, DOI 10.3171/ped.2006.105.5.337; Keenan HT, 2006, DEV NEUROSCI-BASEL, V28, P256, DOI 10.1159/000094152; KERR FWL, 1968, MAYO CLIN PROC, V43, P852; KRAUS JF, 1990, AM J DIS CHILD, V144, P684, DOI 10.1001/archpedi.1990.02150300082022; Kunze E, 1998, ACT NEUR S, V71, P16; LEVIN HS, 1992, NEUROSURGERY, V31, P435, DOI 10.1227/00006123-199209000-00008; Maas AIR, 2010, NEUROTHERAPEUTICS, V7, P127, DOI 10.1016/j.nurt.2009.10.020; Madikians A, 2009, CURR TREAT OPTION NE, V11, P393, DOI 10.1007/s11940-009-0044-2; Margulies SS, 2000, J BIOMECH ENG-T ASME, V122, P364, DOI 10.1115/1.1287160; Marmarou A, 2007, J NEUROTRAUM, V24, P270, DOI 10.1089/neu.2006.0029; Olivecrona M, 2007, J NEUROTRAUM, V24, P927, DOI 10.1089/neu.2005.356E; OMMAYA AK, 1971, J BIOMECH, V4, P13, DOI 10.1016/0021-9290(71)90011-X; Ommaya AK, 2002, BRIT J NEUROSURG, V16, P220, DOI 10.1080/02688690220148824; PFENNINGER J, 1983, INTENS CARE MED, V9, P13, DOI 10.1007/BF01693699; Pizzorusso T, 2002, SCIENCE, V298, P1248, DOI 10.1126/science.1072699; Polin RS, 1997, NEUROSURGERY, V41, P84, DOI 10.1097/00006123-199707000-00018; Prins ML, 2001, J NEUROTRAUM, V18, P31, DOI 10.1089/089771501750055758; REEVES TM, 1995, EXP BRAIN RES, V106, P248; SETTERGREN G, 1980, ACTA PAEDIATR SCAND, V69, P457, DOI 10.1111/j.1651-2227.1980.tb07114.x; SHARPLES PM, 1995, J NEUROL NEUROSUR PS, V58, P145, DOI 10.1136/jnnp.58.2.145; STRINGER WA, 1993, AM J NEURORADIOL, V14, P475; Taylor A, 2001, CHILD NERV SYST, V17, P154, DOI 10.1007/s003810000410; Timofeev I, 2006, ACTA NEUROCHIR SUPPL, V96, P11; Timofeev I, 2008, J NEUROSURG, V108, P66, DOI 10.3171/JNS/2008/108/01/0066; Tropea D, 2003, J NEUROSCI, V23, P7034, DOI 10.1523/JNEUROSCI.23-18-07034.2003; Vavilala Monica S, 2002, Int Anesthesiol Clin, V40, P69; Venkatesh B, 2004, INTENS CARE MED, V30, P510, DOI 10.1007/s00134-003-2102-7	53	18	19	0	1	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1092-0684			NEUROSURG FOCUS	Neurosurg. Focus	NOV	2011	31	5							E5	10.3171/2011.8.FOCUS11177			8	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	844QL	WOS:000296762300006	22044104				2021-06-18	
J	Bao, YJ; Li, LZ; Li, XG; Wang, YJ				Bao, Yi-Jun; Li, Li-Zhuo; Li, Xin-Guo; Wang, Yun-Jie			17Beta-estradiol differentially protects cortical pericontusional zone from programmed cell death after traumatic cerebral contusion at distinct stages via non-genomic and genomic pathways	MOLECULAR AND CELLULAR NEUROSCIENCE			English	Article						Akt; 17Beta-estradiol; Caspase-3; Cortical pericontusional zone; ERK1/2; Survivin	ESTROGEN-RECEPTOR-ALPHA; BRAIN-INJURY; INDUCED NEUROPROTECTION; HIPPOCAMPAL-NEURONS; ENDOTHELIAL-CELLS; PLASMA-MEMBRANE; KINASE PATHWAYS; RAT HIPPOCAMPUS; ACTIVATION; PHOSPHORYLATION	Pericontusional zone (PCZ) of traumatic cerebral contusion is a target of pharmacological intervention. Our previous study indicated that 17beta-estradiol has a protective role in PCZ after traumatic cerebral contusion via the upregulation of estrogen receptor (ER) alpha mRNA induction and protein expression as well as inhibition of caspase-3 activation, suggesting that genomic signaling pathway is implicated in the protective effect of 17beta-estrodiol. Recent findings demonstrated that 17beta-estradiol also acts on the extranuclear/membrane ER to activate non-genomic signaling pathway to regulate cellular functions and exert the protective effect in the brain. It is still unclear how and whether genomic and non-genomic pathways of 17beta-estradiol are involved in the neuroprotection in PCZ. Our current study demonstrates that 17beta-estradiol activates ERK1/2 and Akt at the early stage and induces ERalpha and survivin mRNA at the late stage to modulate its protection via the suppression of caspase-3 activation in PCZ. These findings suggest that 17beta-estrodiol differentially plays its protective roles via genomic and non-genomic signaling pathways in PCZ after traumatic cerebral contusion. (C) 2011 Elsevier Inc. All rights reserved.	[Bao, Yi-Jun; Li, Xin-Guo; Wang, Yun-Jie] China Med Univ, Hosp 1, Dept Neurosurg, Shenyang 110001, Liaoning, Peoples R China; [Li, Li-Zhuo] China Med Univ, Shengjing Hosp, Emergency Dept, Shenyang 110004, Peoples R China	Bao, YJ (corresponding author), China Med Univ, Hosp 1, Dept Neurosurg, 155 Nanjingbei St, Shenyang 110001, Liaoning, Peoples R China.	neurobao3@hotmail.com; wyj024@vip.sina.com			Natural Science Foundation of Liaoning Provincial Science and Technology Commission, Liaoning, China [20071051]	This study was supported by Grant from Natural Science Foundation of Liaoning Provincial Science and Technology Commission, Liaoning, China (No. 20071051).	Azcoitia I, 1999, GLIA, V26, P260; Bekinschtein P, 2008, P NATL ACAD SCI USA, V105, P2711, DOI 10.1073/pnas.0711863105; BINDER M, 1984, HISTOCHEM J, V16, P1003, DOI 10.1007/BF01003854; Chaban VV, 2004, ENDOCRINOLOGY, V145, P3788, DOI 10.1210/en.2004-0149; Chen SH, 2009, CRIT CARE MED, V37, P3097, DOI 10.1097/CCM.0b013e3181bc7986; Choi YC, 2004, FUND CLIN PHARMACOL, V18, P547, DOI 10.1111/j.1472-8206.2004.00284.x; Dressler J, 2007, INT J LEGAL MED, V121, P365, DOI 10.1007/s00414-006-0126-6; Dubal DB, 1999, J NEUROSCI, V19, P6385; Dubal DB, 2001, P NATL ACAD SCI USA, V98, P1952, DOI 10.1073/pnas.041483198; Filardo E, 2007, ENDOCRINOLOGY, V148, P3236, DOI 10.1210/en.2006-1605; Funakoshi T, 2006, BIOCHEM BIOPH RES CO, V346, P904, DOI 10.1016/j.bbrc.2006.05.191; Gorosito SV, 2008, NEUROSCIENCE, V154, P1173, DOI 10.1016/j.neuroscience.2008.05.001; Green PS, 2000, INT J DEV NEUROSCI, V18, P347, DOI 10.1016/S0736-5748(00)00017-4; Ho KJ, 2002, ARTERIOSCL THROM VAS, V22, P1952, DOI 10.1161/01.ATV.0000041200.85946.4A; Johnson EA, 2005, EXP BRAIN RES, V167, P17, DOI 10.1007/s00221-005-2362-2; Jover-Mengual T, 2007, ENDOCRINOLOGY, V148, P1131, DOI 10.1210/en.2006-1137; Kelly MJ, 2009, MOL CELL ENDOCRINOL, V308, P17, DOI 10.1016/j.mce.2009.03.008; Kow LM, 2004, P NATL ACAD SCI USA, V101, P12354, DOI 10.1073/pnas.0404889101; Lee SJ, 2001, ANNU REV PHARMACOL, V41, P569, DOI 10.1146/annurev.pharmtox.41.1.569; Li LZ, 2011, NEUROCHEM INT, V58, P126, DOI 10.1016/j.neuint.2010.11.006; Liu M, 2010, MINERVA ENDOCRINOL, V35, P127; Madak-Erdogan Z, 2008, MOL ENDOCRINOL, V22, P2116, DOI 10.1210/me.2008-0059; Marin R, 2009, J STEROID BIOCHEM, V114, P2, DOI 10.1016/j.jsbmb.2008.12.014; Milner TA, 2001, J COMP NEUROL, V429, P355; Minambres E, 2008, J NEUROTRAUM, V25, P581, DOI 10.1089/neu.2007.0398; Nakajo Y, 2008, BRAIN RES, V1241, P103, DOI 10.1016/j.brainres.2008.08.080; Nishio M, 2004, NEUROSCI LETT, V355, P109, DOI 10.1016/j.neulet.2003.10.064; Noshita N, 2002, NEUROBIOL DIS, V9, P294, DOI 10.1006/nbdi.2002.0482; Otani N, 2002, J NEUROTRAUM, V19, P1587, DOI 10.1089/089771502762300247; Otani N, 2002, J CEREBR BLOOD F MET, V22, P327, DOI 10.1097/00004647-200203000-00010; Raz L, 2008, NEUROSIGNALS, V16, P140, DOI 10.1159/000111559; Razandi M, 1999, MOL ENDOCRINOL, V13, P307, DOI 10.1210/me.13.2.307; Russell KS, 2000, P NATL ACAD SCI USA, V97, P5930, DOI 10.1073/pnas.97.11.5930; SCHRODER ML, 1995, J NEUROSURG, V82, P966, DOI 10.3171/jns.1995.82.6.0966; Simoncini T, 2004, STEROIDS, V69, P537, DOI 10.1016/j.steroids.2004.05.009; Simoncini T, 2003, EUR J ENDOCRINOL, V148, P281, DOI 10.1530/eje.0.1480281; Singer CA, 1999, J NEUROSCI, V19, P2455; Singh M, 1999, J NEUROSCI, V19, P1179; Singh M, 2001, ENDOCRINE, V14, P407, DOI 10.1385/ENDO:14:3:407; Sullivan PG, 2002, BRAIN RES, V949, P88, DOI 10.1016/S0006-8993(02)02968-2; Taguchi Yasuto, 2004, Nucl Recept, V2, P5, DOI 10.1186/1478-1336-2-5; Vasudevan N, 2007, ENDOCR REV, V28, P1, DOI 10.1210/er.2005-0021; Wu TW, 2005, NEUROSCIENCE, V135, P59, DOI 10.1016/j.neuroscience.2004.12.027; Yang LC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009851; Zhang QG, 2008, J NEUROSCI, V28, P8430, DOI 10.1523/JNEUROSCI.2752-08.2008; Zhang QG, 2006, J NEUROCHEM, V98, P1886, DOI 10.1111/j.1471-4159.2006.04020.x; Zhang QG, 2009, J NEUROSCI, V29, P13823, DOI 10.1523/JNEUROSCI.3574-09.2009; Zhao LZ, 2007, BRAIN RES, V1172, P48, DOI 10.1016/j.brainres.2007.06.092	48	18	18	0	4	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1044-7431			MOL CELL NEUROSCI	Mol. Cell. Neurosci.	NOV	2011	48	3					185	194		10.1016/j.mcn.2011.07.004			10	Neurosciences	Neurosciences & Neurology	836AF	WOS:000296077700001	21803156				2021-06-18	
J	Meoded, A; Singhi, S; Poretti, A; Tekes, A; Tekes, A; Huisman, TAGM				Meoded, A.; Singhi, S.; Poretti, A.; Eran, A.; Tekes, A.; Huisman, T. A. G. M.			Tectorial Membrane Injury: Frequently Overlooked in Pediatric Traumatic Head Injury	AMERICAN JOURNAL OF NEURORADIOLOGY			English	Article							RETROCLIVAL EPIDURAL HEMATOMA; EXTRADURAL HEMATOMA; CLIVUS; TOMOGRAPHY; CHILDREN	REHs and tectorial membrane injuries are rare complications of pediatric head and neck injuries. We aim to describe the neuroimaging findings in pediatric REHs, to summarize the mechanism of injury, and to correlate the imaging findings with the clinical presentation. We retrospectively evaluated CT and/or MR imaging studies of 10 children with traumatic REH. Most patients were involved in MVAs. The tectorial membrane was injured in 70% of patients, and REHs were medium to large in 80%. None of the patients had a focal spinal cord or brain stem injury, craniocervical junction dislocation, or vertebral fractures. Tectorial membrane disruption was diagnosed in most patients without craniocervical junction related symptoms. Tectorial membrane lesions and REHs were seen in young children who sustained high-speed head and neck injuries. Clinical symptoms may be minimal or misleading. The radiologist should be aware of these injuries in children, MR imaging appears to be more sensitive than CT.	[Huisman, T. A. G. M.] Johns Hopkins Univ Hosp, Div Pediat Radiol, Russell H Morgan Dept Radiol & Radiol Sci, Baltimore, MD 21287 USA; Johns Hopkins Univ Hosp, Div Neuroradiol, Russell H Morgan Dept Radiol & Radiol Sci, Baltimore, MD 21287 USA	Huisman, TAGM (corresponding author), Johns Hopkins Univ Hosp, Div Pediat Radiol, Russell H Morgan Dept Radiol & Radiol Sci, 600 N Wolfe St,B-173, Baltimore, MD 21287 USA.	thuisma1@jhmi.edu	Poretti, Andrea/H-6269-2019	Poretti, Andrea/0000-0002-9594-3858			Agrawal D, 2006, CHILD NERV SYST, V22, P670, DOI 10.1007/s00381-006-0059-x; Benedetti PF, 2000, AM J ROENTGENOL, V175, P661, DOI 10.2214/ajr.175.3.1750661; Coleman CC, 1941, ANN SURG, V113, P712, DOI 10.1097/00000658-194105000-00008; CORDOBES F, 1981, J NEUROSURG, V54, P179, DOI 10.3171/jns.1981.54.2.0179; HOOPER R, 1959, BRIT J SURG, V47, P71, DOI 10.1002/bjs.18004720114; JAMIESON KG, 1968, J NEUROSURG, V29, P13, DOI 10.3171/jns.1968.29.1.0013; Kwon TH, 2008, NEUROL MED-CHIR, V48, P347, DOI 10.2176/nmc.48.347; MCKISSOCK W, 1960, BRIT J SURG, V48, P155, DOI 10.1002/bjs.18004820814; Mizushima H, 1998, J NEUROSURG, V88, P590, DOI 10.3171/jns.1998.88.3.0590; Ratilal B, 2006, SURG NEUROL, V66, P200, DOI 10.1016/j.surneu.2005.11.030; Sun PP, 2000, J NEUROSURG, V93, P28, DOI 10.3171/spi.2000.93.1.0028; Tubbs RS, 2010, NEUROSURGERY, V67, P404, DOI 10.1227/01.NEU.0000372085.70895.E7; WERNE SVEN, 1957, ACTA ORTHOPAED SCAND SUPPL, V23, P1; Yama N, 2007, J TRAUMA, V62, P898, DOI 10.1097/01.ta.0000221058.72995.c9	14	18	19	0	2	AMER SOC NEURORADIOLOGY	OAK BROOK	2210 MIDWEST RD, OAK BROOK, IL 60521 USA	0195-6108			AM J NEURORADIOL	Am. J. Neuroradiol.	NOV	2011	32	10					1806	1811		10.3174/ajnr.A2606			6	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	859PM	WOS:000297888300009	21852371	Green Published, Other Gold			2021-06-18	
J	Rockenstein, E; Ubhi, K; Pham, E; Michael, S; Doppler, E; Novak, P; Inglis, C; Mante, M; Adame, A; Alvarez, XA; Moessler, H; Masliah, E				Rockenstein, Edward; Ubhi, Kiren; Pham, Emiley; Michael, Sarah; Doppler, Edith; Novak, Philipp; Inglis, Chandra; Mante, Michael; Adame, Anthony; Alvarez, X. Anton; Moessler, Herbert; Masliah, Eliezer			Beneficial Effects of a Neurotrophic Peptidergic Mixture Persist for a Prolonged Period Following Treatment Interruption in a Transgenic Model of Alzheimer's Disease	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article						amyloid precursor protein; neurodegeneration; synapses; water maze; Cerebrolysin	NERVE GROWTH-FACTOR; NOOTROPIC DRUG CEREBROLYSIN; FIMBRIA-FORNIX TRANSECTION; SPATIAL MEMORY IMPAIRMENT; TRAUMATIC BRAIN-INJURY; FACTOR GENE-THERAPY; SHORT-TERM; NEURODEGENERATIVE DISEASES; FUNCTIONAL RECOVERY; BASAL FOREBRAIN	Neurodegenerative disorders such as Alzheimer's disease (AD) are characterized by the loss of neurotrophic factors, and experimental therapeutical approaches to AD have investigated the efficacy of replacing or augmenting neurotrophic factor activity. Cerebrolysin, a peptide mixture with neurotrophic-like effects, has been shown to improve cognition in patients with AD and to reduce synaptic and behavioral deficits in transgenic (tg) mice overexpressing the amyloid precursor protein (APP). However, it is unclear how long-lasting the beneficial effects of Cerebrolysin are and whether or not behavioral and neuropathological alterations will reappear following treatment interruption. The objective of the present study was to investigate the consequences of interrupting Cerebrolysin treatment (washout effect) 3 and 6 months after the completion of a 3-month treatment period in APP tg mice. We demonstrate that, in APP tg mice, Cerebrolysin-induced amelioration of memory deficits in the water maze and reduction of neurodegenerative pathology persist for 3 months after treatment interruption; however, these effects dissipate 6 months following treatment termination. Immunohistochemical analysis demonstrated that the decrease in neocortical and hippocampal amyloid plaque load observed in Cerebrolysin-treated APP tg mice immediately after treatment was no longer apparent at 3 months after treatment interruption, indicating that the beneficial effects of Cerebrolysin at this time point were independent of its effect on amyloid-beta deposition. In conclusion, the results demonstrate that the effects of Cerebrolysin persist for a significant period of time following treatment termination and suggest that this prolonged effect may involve the neurotrophic factor-like activity of Cerebrolysin. (C) 2011 Wiley-Liss, Inc.	[Rockenstein, Edward; Ubhi, Kiren; Pham, Emiley; Michael, Sarah; Inglis, Chandra; Mante, Michael; Adame, Anthony; Masliah, Eliezer] Univ Calif San Diego, Dept Neurosci, Sch Med, La Jolla, CA 92093 USA; [Doppler, Edith; Novak, Philipp; Moessler, Herbert] EVER Neuro Pharma, Div Res, Unterach, Austria; [Alvarez, X. Anton] EuroEspes Biomed Res Ctr, Dept Neuropharmacol, La Coruna, Spain; [Masliah, Eliezer] Univ Calif San Diego, Dept Pathol, Sch Med, La Jolla, CA 92093 USA	Masliah, E (corresponding author), Univ Calif San Diego, Dept Neurosci, Sch Med, La Jolla, CA 92093 USA.	emasliah@ucsd.edu			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [AG05131]; EVER Pharma; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P50AG005131, R37AG018440] Funding Source: NIH RePORTER	Contract grant sponsor: NIH; Contract grant number: AG05131; Contract grant sponsor: EVER Pharma.	Alvarez XA, 2011, EUR J NEUROL, V18, P59, DOI 10.1111/j.1468-1331.2010.03092.x; Alvarez XA, 2006, EUR J NEUROL, V13, P43, DOI 10.1111/j.1468-1331.2006.01222.x; Alvarez XA, 2003, INT CLIN PSYCHOPHARM, V18, P271, DOI 10.1097/07.yic.0000085765.24936.9a; Alvarez XA, 2000, J NEURAL TRANSM-SUPP, P315; Alvarez XA, 2008, J NEURAL TRANSM, V115, P683, DOI 10.1007/s00702-008-0024-9; Chana G, 2006, NEUROLOGY, V67, P1486, DOI 10.1212/01.wnl.0000240066.02404.e6; Chana G, 2003, BIOL PSYCHIAT, V53, P1086, DOI 10.1016/S0006-3223(03)00114-8; Chen HH, 2007, NEUROBIOL AGING, V28, P1148, DOI 10.1016/j.neurobiolaging.2006.05.036; CHEN KS, 1995, J NEUROSCI, V15, P2819; Deigner HP, 2000, EXPERT OPIN INV DRUG, V9, P747, DOI 10.1517/13543784.9.4.747; DeKosky ST, 1996, NEURODEGENERATION, V5, P417, DOI 10.1006/neur.1996.0056; EBEWENeuroPharmaGmbH, 2009, CER SOL INJ SUMM PRO; FISCHER W, 1987, NATURE, V329, P65, DOI 10.1038/329065a0; FrancisTurner L, 1996, NEUROSCI LETT, V202, P193, DOI 10.1016/0304-3940(95)12240-0; FrancisTurner L, 1996, J NEURAL TRANSM-SUPP, P277; Funke M, 1998, J NEURAL TRANSM-SUPP, P385; HEFTI F, 1986, J NEUROSCI, V6, P2155; KROMER LF, 1987, SCIENCE, V235, P214, DOI 10.1126/science.3798108; LEVIMONTALCINI R, 1951, J EXP ZOOL, V116, P321, DOI 10.1002/jez.1401160206; Mallory M, 1999, ACTA NEUROPATHOL, V97, P437, DOI 10.1007/s004010051012; MARKOWSKA AL, 1994, J NEUROSCI, V14, P4815; MartinezSerrano A, 1996, P NATL ACAD SCI USA, V93, P6355, DOI 10.1073/pnas.93.13.6355; Masliah E, 2001, NEUROLOGY, V56, P127, DOI 10.1212/WNL.56.1.127; MASLIAH E, 1995, HISTOL HISTOPATHOL, V10, P509; Masliah E, 1999, PHARMACOL BIOCHEM BE, V62, P239, DOI 10.1016/S0091-3057(98)00144-0; Masliah E, 2006, J ALZHEIMERS DIS, V9, P91; MASLOW K, 2010, ALZHEIMERS DEMENT, V6, P158; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; MUFSON EJ, 1995, NEUROREPORT, V6, P1063, DOI 10.1097/00001756-199505090-00028; Muresanu DF, 2008, J NEUROL SCI, V267, P112, DOI 10.1016/j.jns.2007.10.016; Nagahara AH, 2009, NAT MED, V15, P331, DOI 10.1038/nm.1912; Onose G, 2009, J Med Life, V2, P350; Pham E, 2010, FEBS J, V277, P3051, DOI 10.1111/j.1742-4658.2010.07719.x; Plosker GL, 2010, CNS DRUGS, V24, P263, DOI 10.2165/11204820-000000000-00000; Plosker GL, 2009, DRUG AGING, V26, P893, DOI 10.2165/11203320-000000000-00000; Reinprecht I, 1999, HISTOCHEM J, V31, P394; Rockenstein E, 2005, J BIOL CHEM, V280, P32957, DOI 10.1074/jbc.M507016200; Rockenstein E, 2005, J NEURAL TRANSM, V112, P269, DOI 10.1007/s00702-004-0181-4; Rockenstein E, 2003, J NEURAL TRANSM, V110, P1313, DOI 10.1007/s00702-003-0025-7; Rockenstein E, 2002, J NEURAL TRANSM-SUPP, P327; Rockenstein E, 2001, J NEUROSCI RES, V66, P573, DOI 10.1002/jnr.1247; Rockenstein E, 2007, ADV DRUG DELIVER REV, V59, P1093, DOI 10.1016/j.addr.2007.08.013; Rockenstein E, 2007, J NEUROSCI, V27, P1981, DOI 10.1523/JNEUROSCI.4321-06.2007; Rockenstein E, 2007, ACTA NEUROPATHOL, V113, P265, DOI 10.1007/s00401-006-0166-5; Rockenstein E, 2006, J NEUROSCI RES, V83, P1252, DOI 10.1002/jnr.20818; ROCKENSTEIN EM, 1995, J BIOL CHEM, V270, P28257; RUTHER E, 1994, PHARMACOPSYCHIATRY, V27, P32, DOI 10.1055/s-2007-1014271; Ruther E, 2000, J NEURAL TRANSM, V107, P815, DOI 10.1007/s007020070061; Satou T, 2000, J NEURAL TRANSM, V107, P1253, DOI 10.1007/s007020070015; SCHEFF SW, 1990, NEUROBIOL AGING, V11, P29, DOI 10.1016/0197-4580(90)90059-9; SCOTT SA, 1995, J NEUROSCI, V15, P6213; Spencer B, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-109; SVENDSEN CN, 1991, ANN NY ACAD SCI, V640, P91; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; TROJANOWSKI JQ, 1995, NEUROBIOL AGING, V16, P335, DOI 10.1016/0197-4580(94)00176-2; Tuszynski MH, 2007, ALZ DIS ASSOC DIS, V21, P179, DOI 10.1097/WAD.0b013e318068d6d2; Tuszynski MH, 2005, NAT MED, V11, P551, DOI 10.1038/nm1239; TUSZYNSKI MH, 1995, P NATL ACAD SCI USA, V92, P4621, DOI 10.1073/pnas.92.10.4621; Ubhi K, 2009, ACTA NEUROPATHOL, V117, P699, DOI 10.1007/s00401-009-0505-4; Valouskova V, 1996, J NEURAL TRANSM-SUPP, P280; Veinbergs I, 2000, J NEURAL TRANSM-SUPP, P273; WILLIAMS LR, 1991, CAN J NEUROL SCI, V18, P403, DOI 10.1017/S0317167100032546; WILLIAMS LR, 1986, P NATL ACAD SCI USA, V83, P9231, DOI 10.1073/pnas.83.23.9231; Windisch M, 1998, J NEURAL TRANSM-SUPP, P289; Wronski R, 2000, J NEURAL TRANSM, V107, P145, DOI 10.1007/s007020050013; Zhang CL, 2010, J NEUROSCI RES, V88, P3275, DOI 10.1002/jnr.22495	66	18	22	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0360-4012	1097-4547		J NEUROSCI RES	J. Neurosci. Res.	NOV	2011	89	11					1812	1821		10.1002/jnr.22712			10	Neurosciences	Neurosciences & Neurology	827LN	WOS:000295430100011	21793038	Green Accepted			2021-06-18	
J	Sayer, NA; Nelson, D; Nugent, S				Sayer, Nina A.; Nelson, Dave; Nugent, Sean			Evaluation of the Veterans Health Administration Traumatic Brain Injury Screening Program in the Upper Midwest	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						Department of Veterans Affairs; health services needs and demands; rehabilitation; screening; traumatic brain injury	POSTTRAUMATIC-STRESS-DISORDER; COLLEGIATE FOOTBALL PLAYERS; ENDURING FREEDOM; NCAA CONCUSSION; BLAST INJURIES; IRAQI FREEDOM; MEDICAL-CARE; AFGHANISTAN; IMPAIRMENT; EXPLOSIONS	Objective: To evaluate the Veterans Health Administration's traumatic brain injury (TBI) screening program in terms of predictors of screening and positive-screen follow-up. Design: Retrospective administrative data study. Multiple logistic regression analyses were used to estimate the odds of TBI screening at a given appointment and among those screening positive, follow-up in a TBI/polytrauma specialty clinic. Participants: A total of 15 973 Iraq and Afghanistan war veterans treated at a Veterans Affairs medical center in the upper Midwest during the first 18 months of the TBI screening program. Results: Almost 90% of Iraq and Afghanistan veteran patients were offered TBI screening and 17% screened positive. Screening rates increased over time and varied by facility. Appointment type predicted screening with increased likelihood of screening during primary care and TBI/polytrauma clinic appointments. Younger, male, and army veterans without psychiatric diagnoses were more likely to be screened. Fifty-two percent of positive TBI screens had subsequent appointments in a TBI/polytrauma specialty clinic during the study period. Rates of follow-up in the clinic increased over time and varied by facility and patient characteristics. Conclusions: Within the upper Midwest, Veterans Health Administration has had greater success implementing TBI screening than ensuring follow-up of positive screens in a specialty clinic. Research is needed on barriers to follow-up of positive screens and the outcomes of TBI screening and subsequent specialty care.	[Sayer, Nina A.; Nelson, Dave; Nugent, Sean] Ctr Chron Dis Outcomes Res, VA Med Ctr, Minneapolis, MN 55417 USA; [Sayer, Nina A.; Nelson, Dave] Univ Minnesota, Dept Med, Minneapolis, MN 55455 USA	Sayer, NA (corresponding author), Ctr Chron Dis Outcomes Res, VA Med Ctr, 152-2E,1 Vet Dr, Minneapolis, MN 55417 USA.	nina.sayer@va.gov	Sayer, Nina/E-3249-2016		Department of Veterans Affairs (VA) Health Services Research and Development (HSR&D) Quality Enhancement Research Initiative (QUERI) [QUERI LIP PLY 05-403-5]	This article represents original and valid research that has not been previously published and is not under consideration for publication elsewhere. This research was supported by a Department of Veterans Affairs (VA) Health Services Research and Development (HSR&D) Quality Enhancement Research Initiative (QUERI) locally initiated project (QUERI LIP PLY 05-403-5). The content of this article presents the findings and conclusions of the authors and does not necessarily represent the VA or HSR&D. Portions of these data were presented at the VA HSR&D, 2008, QUERI national meeting in Phoenix, Arizona.	American Congress of Rehabilitation Medicine, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; ANDERSEN R, 1973, MILBANK FUND Q, V51, P95, DOI 10.2307/3349613; ANDERSEN RM, 1995, J HEALTH SOC BEHAV, V36, P1, DOI 10.2307/2137284; Babcock-Parziale JL, 2009, EVALUATION VAS TBI C; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Bhattacharjee Y, 2008, SCIENCE, V319, P406, DOI 10.1126/science.319.5862.406; Brahm KD, 2009, OPTOMETRY VISION SCI, V86, P817, DOI 10.1097/OPX.0b013e3181adff2d; Carlson KF, 2010, J TRAUMA STRESS, V23, P17, DOI 10.1002/jts.20483; Carlson KF, 2010, 08025 HSR D CDA; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Centers for Disease Control and Prevention, 2003, EXPL BLAST INJ PRIM; Clark ME, 2007, J REHABIL RES DEV, V44, P179, DOI 10.1682/JRRD.2006.05.0057; DePalma RG, 2005, NEW ENGL J MED, V352, P1335, DOI 10.1056/NEJMra042083; Department of Veterans Affairs Office of Quality and Performance and Department of Defense Quality Management Directorate USAMC, 2009, VA DOD CLIN PRACT GU; Department of Veterans Affairs Veterans Health Administration, 2009, POL TRUAM BRAIN INJ; Department of Veterans Affairs Veterans Health Administration, 2010, SCREEN EV POSS TRAUM; Department of Veterans Affairs VHA Support Services Center, 2009, COMPR TBI EV SUMM RE; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352; Jaycox L, 2008, INVISIBLE WOUNDS WAR; Kluger Y, 2003, ISRAEL MED ASSOC J, V5, P235; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Leibovici D, 1996, J TRAUMA, V41, P1030, DOI 10.1097/00005373-199612000-00015; Lew HL, 2007, J REHABIL RES DEV, V44, P1027, DOI 10.1682/JRRD.2007.05.0073; Lew HL, 2009, J REHABIL RES DEV, V46, P819, DOI 10.1682/JRRD.2008.09.0129; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2008, MILD TRAUMATIC BRAIN; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; RICCITIELLO R, 2006, NEWSWEEK        0317; Sayer NA, 2009, J REHABIL RES DEV, V46, P703, DOI 10.1682/JRRD.2009.01.0008; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; Scott SG, 2006, J AM OSTEOPATH ASSOC, V106, P265; Seal KH, 2008, AM J PUBLIC HEALTH, V98, P714, DOI 10.2105/AJPH.2007.115519; Sigford BJ, 2008, ARCH PHYS MED REHAB, V89, P160, DOI 10.1016/j.apmr.2007.09.015; Stein MB, 2009, AM J PSYCHIAT, V166, P768, DOI 10.1176/appi.ajp.2009.08101604; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; *US GOV ACC OFF, 2008, GAO08276; VA Office of Inspector General, 2010, 0902093211 VA OFF IN; Vanderploeg RD, 2009, TBI SCREENING INSTRU; VHA Health Information Management Office of Health Data and Informatics, 2008, FACT SHEET INT COD G; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Wojcik BE, 2010, AM J PREV MED, V38, pS108, DOI 10.1016/j.amepre.2009.10.006	46	18	18	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2011	26	6					454	467		10.1097/HTR.0b013e3181ff393c			14	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	859AC	WOS:000297845000002	22094545				2021-06-18	
J	Yokobori, S; Watanabe, A; Matsumoto, G; Onda, H; Masuno, T; Fuse, A; Kushimoto, S; Yokota, H				Yokobori, Shoji; Watanabe, Akihiro; Matsumoto, Gaku; Onda, Hidetaka; Masuno, Tomohiko; Fuse, Akira; Kushimoto, Shigeki; Yokota, Hiroyuki			Time Course of Recovery From Cerebral Vulnerability After Severe Traumatic Brain Injury: A Microdialysis Study	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						Severe brain injury; Biomarker; Microdialysis; Cerebral vascular autoregulation; Neurointensive care	BLOOD-FLOW; HEAD-INJURY; INTRACEREBRAL MICRODIALYSIS; METABOLISM; CARE; HYPOPERFUSION; CIRCULATION; FRACTURES; VASOSPASM; FIXATION	Background: The aim of this study was to evaluate the time course of recovery from cerebral vulnerability, using microdialysis (MD) technique and cerebral vascular autoregulation measurement, to clarify the appropriate timing of subsequent major surgical procedures, and to minimize the possibility of secondary brain injury in patients with severe traumatic brain injury (STBI). Methods: In 3,470 MD samples of 25 patients with STBI, cerebral extracellular biomarkers (glucose, lactate, pyruvate, glycerol, and glutamate) were measured. In addition, to estimate cerebral vascular autoregulaton, the pressure reactivity index (PRx) was calculated with intracranial pressure (ICP) and mean arterial pressure. The data with ICP, cerebral perfusion pressure (CPP), and PRx were collected hourly for 7 days after injury and they were compared with MD biomarkers daily. Results: During the study period, the average ICP and CPP remained stable and were within the threshold of STBI treatment guidelines. After injury, the extracellular glucose concentration decreased, and the levels of glycerol, glutamate, and lactate/pyruvate ratio (LPR), which indicate cerebral ischemia and neural cell damage, increased. On the fourth day after injury, the extracellular glucose concentration improved, and the value of LPR decreased. The average PRx decreased daily and became negative on the fifth day after injury. Conclusion: Our results indicated that cerebral vascular autoregulation would recover on the fourth day after STBI, and cerebral perfusion might be increased by recovery of autoregulation. Thus, subsequent nonemergent surgery should be performed at least 4 days after STBI to prevent secondary brain injury. In addition, we should keep in mind that the cerebral vulnerability might persist for 4 days after suffering STBI.	[Yokobori, Shoji; Watanabe, Akihiro; Matsumoto, Gaku; Onda, Hidetaka; Masuno, Tomohiko; Fuse, Akira; Kushimoto, Shigeki; Yokota, Hiroyuki] Nippon Med Sch, Dept Emergency & Crit Care Med, Tokyo 113, Japan	Yokobori, S (corresponding author), Univ Miami, Miller Sch Med, Miami Project Cure Paralysis, Lois Pope LIFE Ctr Ee 3 25, 1095 NW 14th Terrace, Miami, FL 33136 USA.	SYokobori@med.miami.edu			Mitsui Sumitomo Insurance Welfare FoundationMitsui Sumitomo Insurance Welfare Foundation	Supported by a grant from Mitsui Sumitomo Insurance Welfare Foundation.	Bellander BM, 2004, INTENS CARE MED, V30, P2166, DOI 10.1007/s00134-004-2461-8; BOUMA GJ, 1992, J NEUROSURG, V77, P360, DOI 10.3171/jns.1992.77.3.0360; Chamoun R, 2010, J NEUROSURG, V113, P564, DOI 10.3171/2009.12.JNS09689; Czosnyka M, 1996, STROKE, V27, P1829, DOI 10.1161/01.STR.27.10.1829; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Diedler J, 2010, J NEUROL SCI, V295, P16, DOI 10.1016/j.jns.2010.05.027; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Giannoudis PV, 2002, AM J SURG, V183, P261, DOI 10.1016/S0002-9610(02)00783-3; Hlatky R, 2004, NEUROCRIT CARE, V1, P69, DOI 10.1385/NCC:1:1:69; Japan Society of Neurotraumatology Committee of Guidelines for the Treatment and Management of Severe Traumatic Brain Injury, 2006, NEUROTRAUMATOLOGY S, V29, P15; Jeremitsky E, 2003, J TRAUMA, V54, P312, DOI 10.1097/01.TA.0000037876.37236.D6; Kalb DC, 1998, SURGERY, V124, P739, DOI 10.1067/msy.1998.91395; Kelly DF, 1997, J NEUROSURG, V86, P633, DOI 10.3171/jns.1997.86.4.0633; Martin NA, 1997, J NEUROSURG, V87, P9, DOI 10.3171/jns.1997.87.1.0009; MILLER JD, 1985, BRIT J ANAESTH, V57, P120, DOI 10.1093/bja/57.1.120; MUIZELAAR JP, 1989, J NEUROSURG, V71, P63, DOI 10.3171/jns.1989.71.1.0063; Nordstrom CH, 2010, CHILD NERV SYST, V26, P465, DOI 10.1007/s00381-009-1035-z; OBRIST WD, 1979, J NEUROSURG, V51, P292, DOI 10.3171/jns.1979.51.3.0292; Oertel M, 2005, J NEUROSURG, V103, P812, DOI 10.3171/jns.2005.103.5.0812; OVERGAARD J, 1981, J NEUROSURG, V55, P63, DOI 10.3171/jns.1981.55.1.0063; OVERGAARD J, 1983, J NEUROSURG, V59, P439, DOI 10.3171/jns.1983.59.3.0439; PERSSON L, 1992, J NEUROSURG, V76, P72, DOI 10.3171/jns.1992.76.1.0072; Reinstrup P, 2000, NEUROSURGERY, V47, P701, DOI 10.1097/00006123-200009000-00035; ROBERTSON CS, 1992, J NEUROL NEUROSUR PS, V55, P594, DOI 10.1136/jnnp.55.7.594; Samuelsson C, 2009, J NEUROSURG, V111, P910, DOI 10.3171/2008.8.JNS0889; Soustiel JF, 2007, NEUROL RES, V29, P654, DOI 10.1179/016164107X240017; Stahl M., 2002, Current Pharmaceutical Biotechnology, V3, P165, DOI 10.2174/1389201023378373; Sviri GE, 2009, J NEUROSURG, V111, P695, DOI 10.3171/2008.10.17686; The Brain Trauma Foundation, 2007, J NEUROTRAUM, V24, P7; Tuttle MS, 2009, J TRAUMA, V67, P602, DOI 10.1097/TA.0b013e3181aa21c0; Vespa PM, 2003, J CEREBR BLOOD F MET, V23, P865, DOI 10.1097/01.WCB.0000076701.45782.EF; Yokota H, 2007, NEUROL MED-CHIR, V47, P383, DOI 10.2176/nmc.47.383	32	18	19	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	NOV	2011	71	5					1235	1240		10.1097/TA.0b013e3182140dd7			6	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	849IG	WOS:000297118600030	21502877				2021-06-18	
J	Zhou, ND; Windmiller, JR; Valdes-Ramirez, G; Zhou, M; Halamek, J; Katz, E; Wang, J				Zhou, Nandi; Windmiller, Joshua R.; Valdes-Ramirez, Gabriela; Zhou, Ming; Halamek, Jan; Katz, Evgeny; Wang, Joseph			Enzyme-based NAND gate for rapid electrochemical screening of traumatic brain injury in serum	ANALYTICA CHIMICA ACTA			English	Article						Glutamate; Lactate dehydrogenase; Traumatic brain injury; Assay; Electrochemical sensor; Amperometry	EXCITATORY AMINO-ACIDS; CEREBROSPINAL-FLUID; GLUTAMATE; HUMANS	We report on the development of a rapid enzyme logic gate-based electrochemical assay for the assessment of traumatic brain injury (TBI). The concept harnesses a biocatalytic cascade that emulates the functionality of a Boolean NAND gate in order to process relevant physiological parameters in the biochemical domain. The enzymatic backbone ensures that a high-fidelity diagnosis of traumatic brain injury can be tendered in a rapid fashion when the concentrations of key serum-based biomarkers reach pathological levels. The excitatory neurotransmitter glutamate and the enzyme lactate dehydrogenase were used here as clinically-relevant input TBI biomarkers, in connection to the low-potential detection of the NADH product in the presence of methylene green at a glassy carbon electrode. A systematic optimization of the gate and the entire protocol has resulted in the effective discrimination between the physiological and pathological logic levels. Owing to its robust design, the enzyme-based logic gate mitigates potential interferences from both physiological and electroactive sources and is able to perform direct measurements in human serum samples. Granted further detailed clinical validation, this proof-of-concept study demonstrates the potential of the electrochemical assay to aid in the rapid and decentralized diagnosis of TBI. (C) 2011 Elsevier B.V. All rights reserved.	[Zhou, Nandi; Windmiller, Joshua R.; Valdes-Ramirez, Gabriela; Zhou, Ming; Wang, Joseph] Univ Calif San Diego, Dept NanoEngn, La Jolla, CA 92093 USA; [Halamek, Jan; Katz, Evgeny] Clarkson Univ, Dept Chem & Biomol Sci, Potsdam, NY 13699 USA	Katz, E (corresponding author), Clarkson Univ, Dept Chem & Biomol Sci, Potsdam, NY 13699 USA.	ekatz@clarkson.edu; josephwang@ucsd.edu	Zhou, Nandi/C-5111-2011; Valdes-Ramirez, Gabriela/D-2053-2012; Zhou, Ming/B-7451-2009; Wang, Joseph/C-6175-2011	Zhou, Nandi/0000-0002-2906-7781; Zhou, Ming/0000-0003-2239-9342; Valdes Ramirez, Gabriela/0000-0002-9566-930X	Office of Naval Research (ONR)Office of Naval Research [N00014-08-1-1202]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [20805020]; Chinese Ministry of EducationMinistry of Education, China [109079]; CONACyT from the Mexican government	This work was supported by the Office of Naval Research (ONR Award #N00014-08-1-1202). N.Z. acknowledges support from the National Natural Science Foundation of China (Award no. 20805020) and the Key Project of the Chinese Ministry of Education (Award no. 109079). G.V.R. acknowledges a CONACyT post-doctoral fellowship from the Mexican government.	BAKAY RAE, 1983, J NEUROSURG, V58, P27, DOI 10.3171/jns.1983.58.1.0027; BAKER AJ, 1993, J NEUROSURG, V79, P369, DOI 10.3171/jns.1993.79.3.0369; BERGMEYER HU, 1978, CLIN CHEM, V24, P58; Brown JIM, 1998, J NEUROTRAUM, V15, P253, DOI 10.1089/neu.1998.15.253; Choi D. W, 1990, BRAIN METAB REV, V2, P105; DeKosky ST, 2010, NEW ENGL J MED, V363, P1293, DOI 10.1056/NEJMp1007051; GAY RJ, 1968, CLIN CHEM, V14, P740; GREENAMYRE JT, 1989, NEUROBIOL AGING, V10, P593, DOI 10.1016/0197-4580(89)90143-7; GRIFFITHS T, 1984, J NEUROTRAUM, V15, P253; Halamek J, 2010, MOL BIOSYST, V6, P2554, DOI 10.1039/c0mb00153h; Halamek J, 2010, ANALYST, V135, P2249, DOI 10.1039/c0an00270d; Hara I, 1997, Int J Urol, V4, P202, DOI 10.1111/j.1442-2042.1997.tb00171.x; Ingebrigtsen T, 2002, J TRAUMA, V52, P798, DOI 10.1097/00005373-200204000-00038; Kratz A, 2004, NEW ENGL J MED, V351, P1548, DOI 10.1056/NEJMcpc049016; Meldrum BS, 2000, J NUTR, V130, p1007S, DOI 10.1093/jn/130.4.1007S; Melnikov D, 2010, J PHYS CHEM B, V114, P12166, DOI 10.1021/jp105912e; Opitz T, 1994, NEUROPSYCHOPHARMACOL, V11, P278; PALMER AM, 1993, J NEUROCHEM, V61, P2015, DOI 10.1111/j.1471-4159.1993.tb07437.x; Sammour T, 2009, INJURY, V40, P104, DOI 10.1016/j.injury.2008.07.032; Suzuki M, 2002, J NEUROTRAUM, V19, P285, DOI 10.1089/08977150252807027; Wang J, 2008, CHEM REV, V108, P814, DOI 10.1021/cr068123a; Wang J, 2010, ANAL BIOANAL CHEM, V398, P1591, DOI 10.1007/s00216-010-3746-0; Windmiller JR, 2011, SENSOR ACTUAT B-CHEM, V155, P206, DOI 10.1016/j.snb.2010.11.048; Windmiller JR, 2010, SENSOR ACTUAT B-CHEM, V150, P285, DOI 10.1016/j.snb.2010.07.001; YAO T, 1990, ANAL CHIM ACTA, V231, P121, DOI 10.1016/S0003-2670(00)86405-3; Zhou JA, 2011, TALANTA, V83, P955, DOI 10.1016/j.talanta.2010.10.057	26	18	18	0	30	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0003-2670			ANAL CHIM ACTA	Anal. Chim. Acta	OCT 3	2011	703	1					94	100		10.1016/j.aca.2011.07.023			7	Chemistry, Analytical	Chemistry	829EP	WOS:000295561700012	21843680				2021-06-18	
J	Guskiewicz, KM; Register-Mihalik, JK				Guskiewicz, Kevin M.; Register-Mihalik, Johna K.			Postconcussive Impairment Differences Across a Multifaceted Concussion Assessment Protocol	PM&R			English	Article							SPORTS-RELATED CONCUSSION; MILD HEAD-INJURY; POSTURAL STABILITY; NEUROPSYCHOLOGICAL ASSESSMENT; RELIABLE CHANGE; SYMPTOM SCALE; SENSITIVITY; RECOVERY; VALIDITY; DEFICITS	Objective: To examine the proportion of athletes with concussion and with impairment disagreements across various clinical concussion assessment measures. Design: Quasi-experimental repeated measures design. Setting: Clinical research laboratory. Participants: A sample of 100 collegiate-aged athletes participated in the study (mean [SD] age, 18.5 +/- 1.1 years; mean [SD] height, 180.6 +/- 9.9 cm; mean [SD] weight, 84.1 +/- 20.6 kg). Methods or Interventions: Participants completed preseason baseline and postconcussive injury assessments on a clinical assessment battery, including a 17-item graded symptom checklist, a computerized neurocognitive assessment, and a balance performance assessment. Main Outcome Measurements: Symptom severity total score, 8 cognitive domain scores from the Automated Neuropsychological Assessment Metrics, and the composite balance score obtained from the Sensory Organization Test served as outcome measures for the study. McNemar tests of paired proportions were then used to analyze impairment disagreements (where one measure identified impairments not identified by the other) between the study outcome measures. The a level was set to .05 a priori. Results: We observed significant disagreements between symptom severity total scores, and all other measures used in the study in which symptom severity total scores identified more impairments than all other measures. In addition, we observed significant disagreements for half of the clinical measures used in the study, with disagreement proportions that ranged from 22%-52%. Conclusions: Our study underscores the importance of using a multifaceted approach for management of concussion that includes assessment of symptom severity, cognitive function, and balance. Use of this multifaceted approach also can aid clinicians in understanding other comorbidities that may complicate the management of concussion. PM R 2011;3:S445-S451	[Guskiewicz, Kevin M.; Register-Mihalik, Johna K.] Univ N Carolina, Matthew Gfeller Sport Related Traumat Brain Injur, Dept Exercise & Sport Sci, Chapel Hill, NC 27599 USA	Guskiewicz, KM (corresponding author), Univ N Carolina, Matthew Gfeller Sport Related Traumat Brain Injur, Dept Exercise & Sport Sci, CB 8700,209 Fetzer Hall, Chapel Hill, NC 27599 USA.	gus@email.unc.edu		Guskiewicz, Kevin/0000-0002-8682-2130; Register-Mihalik, Johna/0000-0002-4229-4743			Bleiberg J, 1998, J HEAD TRAUMA REHAB, V13, P36, DOI 10.1097/00001199-199804000-00006; Bleiberg J, 2004, NEUROSURGERY, V54, P1073, DOI 10.1227/01.NEU.0000118820.33396.6A; Broglio SP, 2008, CLIN J SPORT MED, V18, P148, DOI 10.1097/JSM.0b013e318164f42a; Broglio SP, 2007, NEUROSURGERY, V60, P1050, DOI 10.1227/01.NEU.0000255479.90999.C0; Brown CN, 2007, J ATHL TRAINING, V42, P515; Cernich A, 2007, ARCH CLIN NEUROPSYCH, V22, pS101, DOI 10.1016/j.acn.2006.10.008; Giza CC, 2001, J ATHL TRAINING, V36, P228; Guskiewicz KM, 1996, J ATHL TRAINING, V31, P300; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Kuehl MD, 2010, CLIN J SPORT MED, V20, P86, DOI 10.1097/JSM.0b013e3181cf4534; Lau BC, 2011, AM J SPORT MED, V39, P1209, DOI 10.1177/0363546510392016; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Mailer BJ, 2008, J SPORT REHABIL, V17, P11, DOI 10.1123/jsr.17.1.11; McCrea M, 2005, J INT NEUROPSYCH SOC, V11, P58, DOI 10.1017/S1355617705050083; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2009, PM&R, V1, P406, DOI 10.1016/j.pmrj.2009.03.010; Moser RS, 2005, NEUROSURGERY, V57, P300, DOI 10.1227/01.NEU.0000166663.98616.E4; Notebaert AJ, 2005, J ATHL TRAINING, V40, P320; Parsons TD, 2009, INT J NEUROSCI, V119, P492, DOI 10.1080/00207450802330876; Patel AV, 2007, J ATHL TRAINING, V42, P66; Peterson CL, 2003, CLIN J SPORT MED, V13, P230, DOI 10.1097/00042752-200307000-00006; Piland SG, 2006, MED SCI SPORT EXER, V38, P27, DOI 10.1249/01.mss.0000183186.98212.d5; Piland SG, 2003, J ATHL TRAINING, V38, P104; Register-Mihalik J, 2007, CLIN J SPORT MED, V17, P282, DOI 10.1097/JSM.0b013e31804ca68a; Register-Mihalik JK, 2008, NEUROSURGERY, V63, P76, DOI 10.1227/01.NEU.0000335073.39728.CE; Register-Mihalik JK, 2009, SPORTS HEALTH, V1, P61, DOI 10.1177/1941738108325920; Riemann BL, 1999, J SPORT REHABIL, V8, P71, DOI 10.1123/jsr.8.2.71; Riemann BL, 2000, J ATHL TRAINING, V35, P19	29	18	18	0	14	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1934-1482	1934-1563		PM&R	PM&R	OCT	2011	3	10		3			S445	S451		10.1016/j.pmrj.2011.08.009			7	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	966YK	WOS:000305873100013	22035688				2021-06-18	
J	Higgins, AZ; Cullen, DK; LaPlaca, MC; Karlsson, JOM				Higgins, Adam Z.; Cullen, D. Kacy; LaPlaca, Michelle C.; Karlsson, Jens O. M.			Effects of freezing profile parameters on the survival of cryopreserved rat embryonic neural cells	JOURNAL OF NEUROSCIENCE METHODS			English	Article						Cryopreservation; Controlled-rate freezing; Intracellular ice formation; Solutions effects; Optimization	TRAUMATIC BRAIN-INJURY; PARKINSONS-DISEASE; DOPAMINE NEURONS; FETAL-BRAIN; HIPPOCAMPAL-NEURONS; TISSUE-CULTURE; TRANSPLANTATION; GRAFTS; MATURATION; VIABILITY	The ability to successfully cryopreserve neural cells would represent an important advance with benefits to neural tissue engineering, neural transplantation, and neuroscience research. We have examined key factors responsible for damage to rat embryonic neural cells during cryopreservation using a two-step temperature profile, with an emphasis on the effects of cooling rate and plunge temperature. Our results indicate that the initial addition of 8% dimethyl sulfoxide (DMSO) and seeding of extracellular ice do not significantly decrease viable cell yield. However, subsequent freezing resulted in significant cell losses for all profile parameter combinations examined. A maximum post-thaw survival of 56% (compared to unfrozen controls) was observed after cooling at 2 degrees C/min to -80 degrees C followed by direct immersion in liquid nitrogen. Single-step removal of DMSO after thawing was associated with an additional 40-70% loss of viable cells, and the number of viable cells was further reduced by approximately 70% after 2 days of cell culture (resulting in a net viable cell yield of 9.6 +/- 0.4%). Nonetheless, the cryopreserved neurons that did survive displayed a normal morphology, including formation of neurites. Trends in neuronal viability conformed with predictions of existing theoretical models of cell freezing, with reduced survival for rapid cooling rates or high plunge temperatures (attributable to intracellular ice formation), and decreasing viability with increasing profile duration (consistent with the known effects of cell dehydration at suboptimal cooling rates). These observations suggest that neural cells are good candidates for further refinement of freezing profile design using a physics-based approach to parameter optimization. (C) 2011 Elsevier B.V. All rights reserved.	[Higgins, Adam Z.; Cullen, D. Kacy; LaPlaca, Michelle C.] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; [Karlsson, Jens O. M.] Georgia Inst Technol, George W Woodruff Sch Mech Engn, Atlanta, GA 30332 USA	Karlsson, JOM (corresponding author), Villanova Univ, Dept Mech Engn, 800 Lancaster Ave, Villanova, PA 19085 USA.	karlsson@alum.mit.edu			National Science Foundation (NSF)National Science Foundation (NSF); Howard Hughes Medical InstituteHoward Hughes Medical Institute; Medtronic Foundation; George Family Foundation; Georgia Tech/Emory Center for the Engineering of Living Tissues; NSF Engineering Research CenterNational Science Foundation (NSF) [EEC-9731643]	Fellowship support (for AZH) was provided by the National Science Foundation (NSF), the Howard Hughes Medical Institute, the Medtronic Foundation and the George Family Foundation. The work was performed using facilities that were funded in part by the Georgia Tech/Emory Center for the Engineering of Living Tissues, an NSF Engineering Research Center (EEC-9731643).	ARCHER DR, 1994, EXP NEUROL, V125, P268, DOI 10.1006/exnr.1994.1029; Baust JM, 2000, IN VITRO CELL DEV-AN, V36, P262; Ben-Hur T, 2005, CURR DRUG TARGETS, V6, P3, DOI 10.2174/1389450053345000; Ben-Hur T, 2004, STEM CELLS, V22, P1246, DOI 10.1634/stemcells.2004-0094; BOND NW, 1989, BIOL PSYCHOL, V28, P67, DOI 10.1016/0301-0511(89)90111-7; Brundin P, 2000, CELL TRANSPLANT, V9, P179, DOI 10.1177/096368970000900205; Cameron DF, 1997, CELL TRANSPLANT, V6, P185, DOI 10.1016/S0963-6897(97)00022-5; Cancedda L, 2007, J NEUROSCI, V27, P5224, DOI 10.1523/JNEUROSCI.5169-06.2007; COLLIER TJ, 1987, BRAIN RES, V436, P363, DOI 10.1016/0006-8993(87)91680-5; COLLIER TJ, 1993, BRAIN RES, V623, P249, DOI 10.1016/0006-8993(93)91435-U; COLLIER TJ, 1988, PROG BRAIN RES, V78, P631; Cullen DK, 2010, BRAIN RES, V1359, P44, DOI 10.1016/j.brainres.2010.08.058; DAS GD, 1983, J NEUROSCI METH, V8, P1, DOI 10.1016/0165-0270(83)90047-X; Decherchi P, 1997, CRYOBIOLOGY, V34, P214, DOI 10.1006/cryo.1997.2003; Deng L, 2007, J NEUROSCI, V27, P10860, DOI 10.1523/JNEUROSCI.2744-07.2007; DILLER KR, 1975, CRYOBIOLOGY, V12, P480, DOI 10.1016/0011-2240(75)90029-2; Dinsmore J H, 1998, Expert Opin Investig Drugs, V7, P527, DOI 10.1517/13543784.7.4.527; DONG JF, 1993, BRAIN RES, V621, P242, DOI 10.1016/0006-8993(93)90112-Z; Inden M, 2005, NEUROSCI LETT, V387, P151, DOI 10.1016/j.neulet.2005.06.029; JENSEN S, 1984, J COMP NEUROL, V227, P558, DOI 10.1002/cne.902270407; JUN F, 1992, CRYOBIOLOGY, V29, P267, DOI 10.1016/0011-2240(92)90025-W; Karlsson J.O., 2000, PRINCIPLES TISSUE EN, Vsecond, P293, DOI [10.1007/11749219, DOI 10.1007/11749219]; Karlsson JOM, 2010, CRYOBIOLOGY, V60, P43, DOI 10.1016/j.cryobiol.2009.07.004; Karlsson JOM, 2009, MOL REPROD DEV, V76, P321, DOI 10.1002/mrd.20956; Karlsson JOM, 1996, BIOMATERIALS, V17, P243, DOI 10.1016/0142-9612(96)85562-1; Karlsson JOM, 2001, CRYOBIOLOGY, V42, P154, DOI 10.1006/cryo.2001.2318; Karlsson JOM, 1996, HUM REPROD, V11, P1296; KARLSSON JOM, 1993, BIOPHYS J, V65, P2524, DOI 10.1016/S0006-3495(93)81319-5; KAWAMOTO JC, 1986, BRAIN RES, V384, P84, DOI 10.1016/0006-8993(86)91222-9; LINDVALL O, 1990, SCIENCE, V247, P574, DOI 10.1126/science.2105529; Lindvall Olle, 2004, NeuroRx, V1, P379, DOI 10.1602/neurorx.1.4.379; MATTSON MP, 1988, INT J DEV NEUROSCI, V6, P439, DOI 10.1016/0736-5748(88)90050-0; MATTSON MP, 1990, BRAIN RES, V522, P204, DOI 10.1016/0006-8993(90)91462-P; MAZUR P, 1984, AM J PHYSIOL, V247, pC125; MAZUR P, 1970, SCIENCE, V168, P939, DOI 10.1126/science.168.3934.939; MAZUR P, 1972, EXP CELL RES, V71, P345, DOI 10.1016/0014-4827(72)90303-5; Muir JK, 1999, J NEUROTRAUM, V16, P403, DOI 10.1089/neu.1999.16.403; Negishi T, 2002, EXP ANIM TOKYO, V51, P383, DOI 10.1538/expanim.51.383; Oliveira Alcyr A. Jr, 2005, Current Alzheimer Research, V2, P79, DOI 10.2174/1567205052772759; Otto F, 2003, J NEUROSCI METH, V128, P173, DOI 10.1016/S0165-0270(03)00186-9; Paynter SJ, 2009, CRYOBIOLOGY, V58, P308, DOI 10.1016/j.cryobiol.2009.02.008; Paynter SJ, 2008, BRAIN RES BULL, V75, P1, DOI 10.1016/j.brainresbull.2007.08.004; SAUER H, 1992, EXP BRAIN RES, V90, P54, DOI 10.1007/BF00229256; Sautter J, 1996, J NEUROSCI METH, V64, P173, DOI 10.1016/0165-0270(95)00130-1; Sautter J, 2000, EXP NEUROL, V164, P121, DOI 10.1006/exnr.2000.7410; Seggio AM, 2008, J NEUROSCI METH, V173, P67, DOI 10.1016/j.jneumeth.2008.05.017; Shear DA, 2004, BRAIN RES, V1026, P11, DOI 10.1016/j.brainres.2004.07.087; Soares HD, 1995, J NEUROTRAUM, V12, P1059, DOI 10.1089/neu.1995.12.1059; SORENSEN T, 1986, J COMP NEUROL, V252, P468, DOI 10.1002/cne.902520404; Steinschneider R, 1996, DEV BRAIN RES, V95, P15, DOI 10.1016/0165-3806(96)00052-1; SWETT JW, 1994, EXP NEUROL, V129, P330, DOI 10.1006/exnr.1994.1175; TONER M, 1990, J APPL PHYS, V67, P1582, DOI 10.1063/1.345670; Totoiu MO, 2004, EXP NEUROL, V187, P254, DOI 10.1016/j.expneurol.2004.01.028; Walker PA, 2009, DIS MODEL MECH, V2, P23, DOI 10.1242/dmm.001198; Watts C, 2000, CELL TRANSPLANT, V9, P223, DOI 10.1177/096368970000900208; Wernig M, 2008, P NATL ACAD SCI USA, V105, P5856, DOI 10.1073/pnas.0801677105	56	18	18	0	8	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-0270	1872-678X		J NEUROSCI METH	J. Neurosci. Methods	SEP 30	2011	201	1					9	16		10.1016/j.jneumeth.2011.06.033			8	Biochemical Research Methods; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	828LY	WOS:000295503700002	21816171				2021-06-18	
J	Holschneider, DP; Guo, YM; Roch, M; Norman, KM; Scremin, OU				Holschneider, Daniel P.; Guo, Yumei; Roch, Margareth; Norman, Keith M.; Scremin, Oscar U.			Acetylcholinesterase Inhibition and Locomotor Function after Motor-Sensory Cortex Impact Injury	JOURNAL OF NEUROTRAUMA			English	Article						acetylcholinesterase; cholinergic; motor function; neurorehabilitation; TBI	TRAUMATIC BRAIN-INJURY; ORAL PHYSOSTIGMINE; MEMORY DEFICITS; WORKING MEMORY; HEAD-INJURY; LONG-TERM; RECOVERY; RATS; RIVASTIGMINE; DONEPEZIL	Traumatic brain injury (TBI) induces transient or persistent dysfunction of gait and balance. Enhancement of cholinergic transmission has been reported to accelerate recovery of cognitive function after TBI, but the effects of this intervention on locomotor activity remain largely unexplored. The hypothesis that enhancement of cholinergic function by inhibition of acetylcholinesterase (AChE) improves locomotion following TBI was tested in Sprague-Dawley male rats after a unilateral controlled cortical impact (CCI) injury of the motor-sensory cortex. Locomotion was tested by time to fall on the constant speed and accelerating Rotarod, placement errors and time to cross while walking through a horizontal ladder, activity monitoring in the home cages, and rearing behavior. Assessments were performed the 1st and 2nd day and the 1st, 2nd, and 3rd week after TBI. The AChE inhibitor physostigmine hemisulfate (PHY) was administered continuously via osmotic minipumps implanted subcutaneously at the rates of 1.6-12.8 mu mol/kg/day. All measures of locomotion were impaired by TBI and recovered to initial levels between 1 and 3 weeks post-TBI, with the exception of the maximum speed achievable on the accelerating Rotarod, as well as rearing in the open field. PHY improved performance in the accelerating Rotarod at 1.6 and 3.2 mu mol/kg/day (AChE activity 95 and 78% of control, respectively), however, higher doses induced progressive deterioration. No effect or worsening of outcomes was observed at all PHY doses for home cage activity, rearing, and horizontal ladder walking. Potential benefits of cholinesterase inhibition on locomotor function have to be weighed against the evidence of the narrow range of useful doses.	[Holschneider, Daniel P.; Guo, Yumei] Univ So Calif, USC Keck Sch Med, Dept Psychiat & Behav Sci, Los Angeles, CA 90033 USA; [Holschneider, Daniel P.] Univ So Calif, USC Keck Sch Med, Dept Neurol, Los Angeles, CA 90033 USA; [Holschneider, Daniel P.] Univ So Calif, USC Keck Sch Med, Dept Cell & Neurobiol, Los Angeles, CA 90033 USA; [Holschneider, Daniel P.; Roch, Margareth; Norman, Keith M.; Scremin, Oscar U.] Vet Affairs Greater Los Angeles Healthcare Syst, Res Serv, Los Angeles, CA USA; [Scremin, Oscar U.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Los Angeles, CA 90095 USA	Holschneider, DP (corresponding author), Univ So Calif, USC Keck Sch Med, Dept Psychiat & Behav Sci, 1333 San Pablo St,BMT 403,MC9112, Los Angeles, CA 90033 USA.	holschne@usc.edu			Department of Veterans Affairs Rehabilitation Research & Development Merit Review (VA RRD) [B5089R]	This work was supported by a Department of Veterans Affairs Rehabilitation Research & Development Merit Review (VA RR&D) #B5089R and a VA RR&D Research Career Scientist award (O.U.S).	Allen AR, 1914, J NERV MENT DIS, V41, P141, DOI 10.1097/00005053-191403000-00002; Arciniegas David B, 2004, Phys Med Rehabil Clin N Am, V15, P177, DOI 10.1016/S1047-9651(03)00104-9; Arciniegas David B, 2003, Curr Psychiatry Rep, V5, P391, DOI 10.1007/s11920-003-0074-5; ARCINIEGAS DB, 2004, PHYS MED REH CLIN N, V50, pR8; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; CARDENAS DD, 1994, BRAIN INJURY, V8, P579, DOI 10.3109/02699059409151010; Chen Y, 1998, J NEUROTRAUM, V15, P231, DOI 10.1089/neu.1998.15.231; CHROBAK JJ, 1988, BRAIN RES, V463, P107, DOI 10.1016/0006-8993(88)90532-X; DAWSON GR, 1991, PHARMACOL BIOCHEM BE, V39, P865, DOI 10.1016/0091-3057(91)90045-4; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; FIBIGER HC, 1971, PSYCHOPHARMACOLOGIA, V20, P366, DOI 10.1007/BF00403568; GEFFEN GM, 1991, NEUROREPORT, V2, P105, DOI 10.1097/00001756-199102000-00010; GUALTIERI T, 1991, Brain Injury, V5, P219, DOI 10.3109/02699059109008093; Hasselmo ME, 2011, NEUROPSYCHOPHARMACOL, V36, P52, DOI 10.1038/npp.2010.104; Hoane MR, 2008, OXID MED CELL LONGEV, V1, P46, DOI 10.4161/oxim.1.1.6694; Hoane MR, 2002, PHYSIOL BEHAV, V76, P271, DOI 10.1016/S0031-9384(02)00714-X; Holschneider DP, 2003, J CEREBR BLOOD F MET, V23, P925, DOI 10.1097/01.WCB.0000072797.66873.6A; Jang SH, 2009, NEUROREHABILITATION, V24, P349, DOI 10.3233/NRE-2009-0489; JANOWSKY DS, 1972, LANCET, V2, P632; Katz DI, 2004, ARCH PHYS MED REHAB, V85, P865, DOI 10.1016/j.apmr.2003.11.020; Khateb A, 2005, EUR NEUROL, V54, P39, DOI 10.1159/000087718; LUINE V, 1990, BRAIN RES, V523, P321, DOI 10.1016/0006-8993(90)91507-D; MACCIOCCHI SN, 1993, CURR OPIN NEUROL, V6, P773, DOI 10.1097/00019052-199310000-00016; MUIR JL, 1995, PSYCHOPHARMACOLOGY, V118, P82; Riggio S, 2009, MT SINAI J MED, V76, P163, DOI 10.1002/msj.20097; SASAKI M, 1987, Brain and Nerve (Tokyo), V39, P983; Scremin OU, 2007, BRAIN RES, V1141, P235, DOI 10.1016/j.brainres.2007.01.006; Scremin OU, 2006, BRAIN RES, V1124, P155, DOI 10.1016/j.brainres.2006.09.062; SCREMIN OU, 1990, J NEUROSCI RES, V26, P188, DOI 10.1002/jnr.490260208; Scremin OU, 1997, J NEUROTRAUM, V14, P573, DOI 10.1089/neu.1997.14.573; Sharma HS, 2006, ACTA NEUROCHIR SUPPL, V96, P288; Silver JM, 2006, NEUROLOGY, V67, P748, DOI 10.1212/01.wnl.0000234062.98062.e9; Silver JM, 2009, BRAIN INJURY, V23, P123, DOI 10.1080/02699050802649696; STERN Y, 1987, ANN NEUROL, V22, P306, DOI 10.1002/ana.410220305; Taverni JP, 1998, BRAIN INJURY, V12, P77; Tenovuo O, 2005, PROG NEURO-PSYCHOPH, V29, P61, DOI 10.1016/j.pnpbp.2004.10.006; Vallee M, 2006, ARCH PHYS MED REHAB, V87, P806, DOI 10.1016/j.apmr.2006.02.031; WALKER GC, 1991, ARCH PHYS MED REHAB, V72, P469; Wright LKM, 2010, NEUROTOXICOL TERATOL, V32, P329, DOI 10.1016/j.ntt.2009.12.006; Zhang L, 2004, ARCH PHYS MED REHAB, V85, P1050, DOI 10.1016/j.apmr.2003.10.014	42	18	18	0	4	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	SEP	2011	28	9					1909	1919		10.1089/neu.2011.1978			11	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	821AK	WOS:000294947000020	21787180				2021-06-18	
J	Purcell, L; LeBlanc, CMA; McCambridge, TM; Brenner, JS; Benjamin, HJ; Cappetta, CT; Demorest, RA; Halstead, ME; Koutures, CG; LaBella, CR; Labotz, M; Loud, K; Martin, SS; Weiss-Kelly, A				Purcell, Laura; LeBlanc, Claire M. A.; McCambridge, Teri M.; Brenner, Joel S.; Benjamin, Holly J.; Cappetta, Charles T.; Demorest, Rebecca A.; Halstead, Mark E.; Koutures, Chris G.; LaBella, Cynthia R.; Labotz, Michele; Loud, Keith; Martin, Stephanie S.; Weiss-Kelly, Amanda			Policy Statement-Boxing Participation by Children and Adolescents	PEDIATRICS			English	Article						boxing; youth; children and adolescents; head injuries; concussion	TRAUMATIC BRAIN-INJURY; SPORT-RELATED CONCUSSION; HIGH-SCHOOL; AMATEUR BOXERS; RECOVERY; ADULTS	Thousands of boys and girls younger than 19 years participate in boxing in North America. Although boxing provides benefits for participants, including exercise, self-discipline, and self-confidence, the sport of boxing encourages and rewards deliberate blows to the head and face. Participants in boxing are at risk of head, face, and neck injuries, including chronic and even fatal neurologic injuries. Concussions are one of the most common injuries that occur with boxing. Because of the risk of head and facial injuries, the American Academy of Pediatrics and the Canadian Paediatric Society oppose boxing as a sport for children and adolescents. These organizations recommend that physicians vigorously oppose boxing in youth and encourage patients to participate in alternative sports in which intentional head blows are not central to the sport. Pediatrics 2011; 128: 617-623					Houghton, Kristin/0000-0001-7174-1007			[American Academy of Pediatrics Committee on Sports Medicine and Fitness], 2006, PEDIATRICS, V117, P1467; American Medical Association, H 470 963 BOX INJ; Australian Medical Association, BOX 1997 REAFF 2007; Bianco M, 2005, BRIT J SPORT MED, V39, P532, DOI 10.1136/bjsm.2004.014365; Bianco M, 2005, BRIT J SPORT MED, V39, P70, DOI 10.1136/bjsm.2003.006643; British Medical Association, BOX BMAS POS; [Canadian Medical Association Office for Public Health], BOX; Canadian Pediatric Society, 2006, PAEDIAT CHILD HLTH, V11, P420; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Gambrell Robert C, 2007, Curr Sports Med Rep, V6, P317; HAGLUND Y, 1993, AM J SPORT MED, V21, P97, DOI 10.1177/036354659302100117; Hahnel S, 2008, AM J NEURORADIOL, V29, P388, DOI 10.3174/ajnr.A0799; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; HEILBRONNER RL, 1991, AM J SPORT MED, V19, P376, DOI 10.1177/036354659101900409; Jako P, 2002, BRIT J SPORT MED, V36, P394, DOI 10.1136/bjsm.36.6.394; Jordan BD, 2000, SEMIN NEUROL, V20, P179, DOI 10.1055/s-2000-9826; Knapik JJ, 2007, SPORTS MED, V37, P117, DOI 10.2165/00007256-200737020-00003; Loosemore M, 2007, BMJ-BRIT MED J, V335, P809, DOI 10.1136/bmj.39342.690220.55; Matser EJT, 2000, PHYSICIAN SPORTSMED, V28, P87, DOI 10.3810/psm.2000.01.645; McCrory P, 2004, BRIT J SPORT MED, V38, P516, DOI 10.1136/bjsm.2004.014811; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; Moriarity J, 2004, NEUROLOGY, V62, P1497, DOI 10.1212/WNL.62.9.1497; Moser RS, 2005, NEUROSURGERY, V57, P300, DOI 10.1227/01.NEU.0000166663.98616.E4; Pearn J, 1998, J PAEDIATR CHILD H, V34, P311, DOI 10.1046/j.1440-1754.1998.00231.x; Porter M, 1996, CLIN J SPORT MED, V6, P97, DOI 10.1097/00042752-199604000-00006; Porter MD, 2003, CLIN J SPORT MED, V13, P339, DOI 10.1097/00042752-200311000-00002; [Public Health Agency of Canada Health Surveillance and Epidemiology Division], 2008, INJ ASS FORM BOX CAN; Rabadi MH, 2001, CLIN J SPORT MED, V11, P194, DOI 10.1097/00042752-200107000-00011; Risser WL, 1997, PEDIATRICS, V99, P134; Ryan AJ, 1998, CLIN SPORT MED, V17, P155, DOI 10.1016/S0278-5919(05)70070-3; Sim A, 2008, J NEUROSURG, V108, P511, DOI 10.3171/JNS/2008/108/3/0511; Sokol DK, 2004, J MED ETHICS, V30, P513, DOI 10.1136/jme.2003.004952; Toth C, 2005, SPORTS MED, V35, P685, DOI 10.2165/00007256-200535080-00003; US Consumer Product Safety Commission, 2007, NEISS DAT HIGHL 2007; USA Boxing, 2008 US BOX RUL; USA Boxing, BOX BAS; Washington RL, 2005, PEDIATRICS, V116, P1557, DOI 10.1542/peds.2005-2314; World Medical Association, WMA STAT BOX; Zazryn T, 2006, BRIT J SPORT MED, V40, P670, DOI 10.1136/bjsm.2006.025924; Zazryn TR, 2008, NEUROL CLIN, V26, P257, DOI 10.1016/j.ncl.2007.11.004; Zazryn T, 2007, SPORTS MED, V37, P467; Zetterberg H, 2006, ARCH NEUROL-CHICAGO, V63, P1277, DOI 10.1001/archneur.63.9.1277	43	18	19	0	8	AMER ACAD PEDIATRICS	ELK GROVE VILLAGE	141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA	0031-4005	1098-4275		PEDIATRICS	Pediatrics	SEP	2011	128	3					617	623		10.1542/peds.2011-1165			7	Pediatrics	Pediatrics	827DB	WOS:000295406100061	21873697	Bronze			2021-06-18	
J	Silva, J; Ownsworth, T; Shields, C; Fleming, J				Silva, Jennifer; Ownsworth, Tamara; Shields, Cassandra; Fleming, Jennifer			Enhanced Appreciation of Life Following Acquired Brain Injury: Posttraumatic Growth at 6 Months Postdischarge	BRAIN IMPAIRMENT			English	Article						brain injury; posttraumatic growth; subjective impairment; depressive symptoms	PSYCHOMETRIC EVALUATION; POSITIVE CONSEQUENCES; 2-COMPONENT MODEL; TUMOR PATIENTS; BREAST-CANCER; BENEFIT; DEPRESSION; ADVERSITY; STROKE; SENSE	preliminary research supports that acquired brain injury (ABI) can act as a catalyst for positive psychological changes, and that such posttraumatic growth (PIG) increases with time since injury. In this study, posttraumatic growth refers to positive psychological changes in domains including interpersonal relationships, new possibilities, personal strength, spirituality and appreciation for life. This study aimed to identify associations between levels of subjective impairment and depressive symptoms at discharge, and PTG at 6-months postdischarge following ABI. Sixty participants (73% male) with ABI (Mean days of hospitalisation = 32.92, SD = 40.74) were consecutively recruited from an inpatient rehabilitation unit at discharge and were administered measures of subjective impairment (Mayo-Portland Adaptability Index-4; MPAI-4) and depression (Depression, Anxiety Stress Scales; DASS). Participants were followed up at 6-months postdischarge and administered the Post-Traumatic Growth Inventory, DASS and MPAI-4. The results indicated that levels of PIG reported at six months postdischarge were relatively modest and ranged between no to very small degree of change ('spirituality') and a small to moderate degree of change ('a greater appreciation of life'). Level of subjective impairment at discharge significantly predicted overall level of PIG at 6-months follow-up (beta=.40, p<.05, sr(2)=.28). Further, at 6-months postdischarge, individuals with a greater appreciation for life reported significantly higher levels of subjective impairment (r=.35; p<.01) and depressive symptoms (r=.34, p<.01) at that time point These findings indicate that individuals who perceive greater functional consequences of their ABI are more likely to experience PIG. Further, the process of reevaluating priorities and values in life after ABI may be associated with emotional distress during the early stages of community reintegration.	[Silva, Jennifer; Ownsworth, Tamara; Shields, Cassandra] Griffith Univ, Sch Psychol, Mt Gravatt, Qld 4122, Australia; [Silva, Jennifer; Ownsworth, Tamara; Shields, Cassandra] Griffith Inst Hlth, Nathan, Qld, Australia; [Fleming, Jennifer] Univ Queensland, Brisbane, Qld 4072, Australia; [Fleming, Jennifer] Princess Alexandra Hosp, Brisbane, Qld 4102, Australia; [Fleming, Jennifer] Metro S Hlth Serv Dist, Ctr Functioning & Hlth Res, Brisbane, Qld, Australia	Ownsworth, T (corresponding author), Griffith Univ, Sch Psychol, Mt Gravatt, Qld 4122, Australia.	t.ownsworth@griffith.edu.au		Ownsworth, Tamara/0000-0003-1835-7094	Department of Communities (Disability Services); Acquired Brain Injury Outreach Services; Australian Research CouncilAustralian Research Council [LP0776294]	We would like to acknowledge the funding and support for this project from the Department of Communities (Disability Services), Acquired Brain Injury Outreach Services and the Australian Research Council (LP0776294). We are grateful to the occupational therapists and medical directors of the Brain Injury Rehabilitation Unit and Acute Neurosciences Ward at the Princess Alexandra Hospital. We would also like to thank Emily Nalder, Petrea Cornwell, Terrence Haines, Melissa Kendall, Professor Linda Worrall and Professor Lesley Chenoweth for their involvement in the broader project.	Adelbratt S, 2000, PALLIATIVE MED, V14, P499, DOI 10.1191/026921600701536426; ALDWIN CM, 1987, J PERS SOC PSYCHOL, V53, P337, DOI 10.1037/0022-3514.53.2.337; Calhoun LG, 2000, J TRAUMA STRESS, V13, P521, DOI 10.1023/A:1007745627077; Caplan G., 1964, PRINCIPLES PREVENTIV; Davis CG, 1998, J PERS SOC PSYCHOL, V75, P561, DOI 10.1037/0022-3514.75.2.561; Frankl V.E, 1963, MANS SEARCH MEANING; Frazier P, 2001, J CONSULT CLIN PSYCH, V69, P1048, DOI 10.1037//0022-006X.69.6.1048; Gangstad B, 2009, REHABIL PSYCHOL, V54, P69, DOI 10.1037/a0014639; Gillen G, 2005, AM J OCCUP THER, V59, P346, DOI 10.5014/ajot.59.3.346; Harrington S, 2008, J PSYCHOSOC ONCOL, V26, P43, DOI 10.1080/07347330802115848; Hawley CA, 2008, BRAIN INJURY, V22, P427, DOI 10.1080/02699050802064607; Hayes AM, 2007, CLIN PSYCHOL REV, V27, P715, DOI 10.1016/j.cpr.2007.01.008; Hefferon K, 2009, BRIT J HEALTH PSYCH, V14, P343, DOI 10.1348/135910708X332936; Helgeson VS, 2006, J CONSULT CLIN PSYCH, V74, P797, DOI 10.1037/0022-006X.74.5.797; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Joseph S, 2005, PSYCHOL ASSESSMENT, V17, P70, DOI 10.1037/1040-3590.17.1.70; Joseph S, 2006, CLIN PSYCHOL REV, V26, P1041, DOI 10.1016/j.cpr.2005.12.006; Kendall E, 2009, SOC SCI MED, V69, P947, DOI 10.1016/j.socscimed.2009.06.021; Kim Y, 2007, PSYCHOSOM MED, V69, P283, DOI 10.1097/PSY.0b013e3180417cf4; Lazarus R.S., 1984, STRESS APPRAISAL COP; Linley PA, 2004, J TRAUMA STRESS, V17, P11, DOI 10.1023/B:JOTS.0000014671.27856.7e; Lovibond S.H., 1995, MANUAL DEPRESSION AN; Maercker A, 2004, PSYCHOL INQ, V15, P41; Malec JF, 2007, J HEAD TRAUMA REHAB, V22, P156, DOI 10.1097/01.HTR.0000271116.12028.af; Malec JF, 2010, ARCH PHYS MED REHAB, V91, P1087, DOI 10.1016/j.apmr.2010.04.002; Malec JF, 2003, J HEAD TRAUMA REHAB, V18, P479, DOI 10.1097/00001199-200311000-00002; Malec JF., 2005, The Mayo-Portland Adaptability Inventory; MCGRATH JC, 2008, TRAUMA RECOVERY GROW, P259; McGrath JC, 2006, BRAIN INJURY, V20, P767, DOI 10.1080/02699050600664566; Mols F, 2009, PSYCHOL HEALTH, V24, P583, DOI 10.1080/08870440701671362; Nietzsche Friedrich, 1955, BEYOND GOOD EVIL; Nochi M, 2000, SOC SCI MED, V51, P1795, DOI 10.1016/S0277-9536(00)00111-8; Ownsworth T., 2005, NEUROPSYCHOANALYSIS, V7, P83; Ownsworth T, 2008, BRAIN INJURY, V22, P858, DOI 10.1080/02699050802446697; Ownsworth T, 2011, J INT NEUROPSYCH SOC, V17, P112, DOI 10.1017/S1355617710001311; Park CL, 1996, J PERS, V64, P71, DOI 10.1111/j.1467-6494.1996.tb00815.x; PARK CL, 1997, REV GEN PSYCHOL, V0002, P00115, DOI DOI 10.1037/1089-2680.1.2.115; Park CL, 2010, PSYCHOL BULL, V136, P257, DOI 10.1037/a0018301; PEARLIN LI, 1978, J HEALTH SOC BEHAV, V19, P2, DOI 10.2307/2136319; Powell T, 2007, BRAIN INJURY, V21, P31, DOI 10.1080/02699050601106245; Sears SR, 2003, HEALTH PSYCHOL, V22, P487, DOI 10.1037/0278-6133.22.5.487; Seligman MEP, 2000, AM PSYCHOL, V55, P5, DOI 10.1037/0003-066X.55.1.5; Soo C, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005239.pub2; Strang S, 2001, PALLIATIVE MED, V15, P127, DOI 10.1191/026921601670322085; Tate RL, 1999, PSYCHOL MED, V29, P713, DOI 10.1017/S0033291799008466; Tedeschi RG, 2004, PSYCHOL INQ, V15, P1, DOI 10.1207/s15327965pli1501_01; Tedeschi RG, 1996, J TRAUMA STRESS, V9, P455, DOI 10.1007/BF02103658; THOMPSON SC, 1991, BASIC APPL SOC PSYCH, V12, P81, DOI 10.1207/s15324834basp1201_6; THOMPSON SC, 1988, J SOC CLIN PSYCHOL, V7, P260, DOI 10.1521/jscp.1988.7.2-3.260; TOMICH PL, 2004, ANN M SOC BEH MED BA; Turner B, 2011, NEUROPSYCHOL REHABIL, V21, P64, DOI 10.1080/09602011.2010.527747; Warren D., 2008, THESIS U ROCKIES; Yalom I., 1980, EXISTENTIAL PSYCHOTH; Zoellner T, 2006, CLIN PSYCHOL REV, V26, P626, DOI 10.1016/j.cpr.2006.01.008	54	18	19	0	17	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1443-9646	1839-5252		BRAIN IMPAIR	Brain Impair.	SEP	2011	12	2			SI		93	104		10.1375/brim.12.2.93			12	Clinical Neurology; Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	837BH	WOS:000296165600003		Green Published			2021-06-18	
J	Chang, YJ; Yeh, ML; Li, YC; Hsu, CY; Lin, CC; Hsu, MS; Chiu, WT				Chang, Ying-Jui; Yeh, Min-Li; Li, Yu-Chuan; Hsu, Chien-Yeh; Lin, Chao-Cheng; Hsu, Meng-Shiuan; Chiu, Wen-Ta			Predicting Hospital-Acquired Infections by Scoring System with Simple Parameters	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; BLOOD-STREAM INFECTIONS; ADMINISTRATIVE CODING DATA; TRAUMATIC BRAIN-INJURY; NOSOCOMIAL INFECTIONS; RISK-FACTORS; SURVEILLANCE; PREVENTION; MORTALITY; COSTS	Background: Hospital-acquired infections (HAI) are associated with increased attributable morbidity, mortality, prolonged hospitalization, and economic costs. A simple, reliable prediction model for HAI has great clinical relevance. The objective of this study is to develop a scoring system to predict HAI that was derived from Logistic Regression (LR) and validated by Artificial Neural Networks (ANN) simultaneously. Methodology/Principal Findings: A total of 476 patients from all the 806 HAI inpatients were included for the study between 2004 and 2005. A sample of 1,376 non-HAI inpatients was randomly drawn from all the admitted patients in the same period of time as the control group. External validation of 2,500 patients was abstracted from another academic teaching center. Sixteen variables were extracted from the Electronic Health Records (EHR) and fed into ANN and LR models. With stepwise selection, the following seven variables were identified by LR models as statistically significant: Foley catheterization, central venous catheterization, arterial line, nasogastric tube, hemodialysis, stress ulcer prophylaxes and systemic glucocorticosteroids. Both ANN and LR models displayed excellent discrimination (area under the receiver operating characteristic curve [AUC]: 0.964 versus 0.969, p = 0.507) to identify infection in internal validation. During external validation, high AUC was obtained from both models (AUC: 0.850 versus 0.870, p = 0.447). The scoring system also performed extremely well in the internal (AUC: 0.965) and external (AUC: 0.871) validations. Conclusions: We developed a scoring system to predict HAI with simple parameters validated with ANN and LR models. Armed with this scoring system, infectious disease specialists can more efficiently identify patients at high risk for HAI during hospitalization. Further, using parameters either by observation of medical devices used or data obtained from EHR also provided good prediction outcome that can be utilized in different clinical settings.	[Chang, Ying-Jui; Yeh, Min-Li] Taipei Med Univ, Coll Med, Grad Inst Med Sci, Taipei, Taiwan; [Chang, Ying-Jui] Far Eastern Mem Hosp, Dept Dermatol, New Taipei, Taiwan; [Yeh, Min-Li] Oriental Inst Technol, Dept Nursing, New Taipei, Taiwan; [Li, Yu-Chuan] Taipei Med Univ, Dept Dermatol, Wan Fang Hosp, Taipei, Taiwan; [Li, Yu-Chuan; Hsu, Chien-Yeh] Taipei Med Univ, Grad Inst Biomed Informat, Coll Med Sci & Technol, Taipei, Taiwan; [Hsu, Chien-Yeh] Taipei Med Univ, CECR, Taipei, Taiwan; [Lin, Chao-Cheng] Natl Taiwan Univ Hosp, Dept Psychiat, Taipei, Taiwan; [Hsu, Meng-Shiuan] Far Eastern Mem Hosp, Infect Dis Sect, Dept Internal Med, New Taipei, Taiwan; [Chiu, Wen-Ta] Taipei Med Univ, Grad Inst Injury Prevent & Control, Taipei, Taiwan	Chang, YJ (corresponding author), Taipei Med Univ, Coll Med, Grad Inst Med Sci, Taipei, Taiwan.	jack@tmu.edu.tw; cyhsu@tmu.edu.tw		Li, Yu-Chuan (Jack)/0000-0001-6497-4232; Chang, Ying-Jui/0000-0003-0294-4657; Hsu, Chien-Yeh/0000-0001-8233-6461			Archibald LK, 2007, BENNETT BRACHMANS HO, P483; Artigas AT, 2001, CRIT CARE MED, V29, P304, DOI 10.1097/00003246-200102000-00015; Cardo D, 2004, AM J INFECT CONTROL, V32, P470, DOI 10.1016/j.ajic.2004.10.001; Cevik MA, 2005, J HOSP INFECT, V59, P324, DOI 10.1016/j.jhin.2004.10.012; Chong Chee-Fah, 2003, AMIA Annu Symp Proc, P160; D'Agata EMC, 2000, AM J KIDNEY DIS, V35, P1083, DOI 10.1016/S0272-6386(00)70044-8; Darouiche RO, 2001, CLIN INFECT DIS, V33, P1567, DOI 10.1086/323130; Department of Health EY Taiwan, 2010, EL MED REC; DiGiovine B, 1999, AM J RESP CRIT CARE, V160, P976, DOI 10.1164/ajrccm.160.3.9808145; Dreiseitl S, 2002, J BIOMED INFORM, V35, P352, DOI 10.1016/S1532-0464(03)00034-0; EMORI TG, 1991, AM J INFECT CONTROL, V19, P19, DOI 10.1016/0196-6553(91)90157-8; Escolano S, 2000, STAT MED, V19, P3465, DOI 10.1002/1097-0258(20001230)19:24&lt;3465::AID-SIM658&gt;3.0.CO;2-6; Ferrer M, 1999, ANN INTERN MED, V130, P991, DOI 10.7326/0003-4819-130-12-199906150-00007; GARNER JS, 1988, AM J INFECT CONTROL, V16, P128, DOI 10.1016/0196-6553(88)90053-3; Girou E, 1998, AM J RESP CRIT CARE, V157, P1151, DOI 10.1164/ajrccm.157.4.9701129; Goldstein MM, 2010, PERSPECT HLTH INF MA, V7; HALEY RW, 1985, AM J EPIDEMIOL, V121, P159, DOI 10.1093/oxfordjournals.aje.a113988; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Jhung MA, 2009, CLIN INFECT DIS, V49, P949, DOI 10.1086/605086; Kallen AJ, 2010, CLIN INFECT DIS, V51, P335, DOI 10.1086/653942; Kamp-Hopmans TEM, 2003, INFECT CONT HOSP EP, V24, P584, DOI 10.1086/502258; Kostadima E, 2006, EUR RESPIR J, V27, P437, DOI 10.1183/09031936.06.00127405; Leblebicioglu H, 2007, J HOSP INFECT, V65, P251, DOI 10.1016/j.jhin.2006.10.012; Li YC, 2000, INT J MED INFORM, V57, P1, DOI 10.1016/S1386-5056(99)00054-4; Lin CC, 2008, COMPUT METH PROG BIO, V91, P91, DOI 10.1016/j.cmpb.2008.02.004; Mahieu LM, 2001, J HOSP INFECT, V47, P223, DOI 10.1053/jhin.2000.0852; McGovern B, 2010, J HOSP INFECT, V75, P138, DOI 10.1016/j.jhin.2009.12.008; Richards MJ, 2000, INFECT CONT HOSP EP, V21, P510, DOI 10.1086/501795; Saint S, 2009, ANN INTERN MED, V150, P877, DOI 10.7326/0003-4819-150-12-200906160-00013; Shang J S, 2000, Health Care Manag Sci, V3, P287, DOI 10.1023/A:1019018129822; Sheng WH, 2005, J HOSP INFECT, V59, P205, DOI 10.1016/j.jhin.2004.06.003; Stevenson KB, 2008, AM J INFECT CONTROL, V36, P155, DOI 10.1016/j.ajic.2008.01.004; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Strand K, 2008, ACTA ANAESTH SCAND, V52, P467, DOI 10.1111/j.1399-6576.2008.01586.x; Taylor G, 2002, INFECT CONT HOSP EP, V23, P716, DOI 10.1086/501999; Teramoto S, 2006, EUR RESPIR J, V27, P436, DOI 10.1183/09031936.06.00113405; VINCENT JL, 1995, JAMA-J AM MED ASSOC, V274, P639, DOI 10.1001/jama.274.8.639; Vincent JL, 2003, LANCET, V361, P2068, DOI 10.1016/S0140-6736(03)13644-6; Vonberg RP, 2006, INFECT CONT HOSP EP, V27, P357, DOI 10.1086/503339; Wald HL, 2007, JAMA-J AM MED ASSOC, V298, P2782, DOI 10.1001/jama.298.23.2782; Wilson JS, 2010, INT J HEALTH GEOGR, V9, DOI 10.1186/1476-072X-9-47; Woeltje KF, 2010, CRIT CARE MED, V38, pS399, DOI 10.1097/CCM.0b013e3181e6d11d	42	18	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2011	6	8							e23137	10.1371/journal.pone.0023137			11	Multidisciplinary Sciences	Science & Technology - Other Topics	832TW	WOS:000295832000008	21887234	DOAJ Gold, Green Published			2021-06-18	
J	Prieto, R; Tavazzi, B; Taya, K; Barrios, L; Amorini, AM; Di Pietro, V; Pascual, JM; Marmarou, A; Marmarou, CR				Prieto, Ruth; Tavazzi, Barbara; Taya, Keisuke; Barrios, Laura; Amorini, Angela M.; Di Pietro, Valentina; Pascual, Jose M.; Marmarou, Anthony; Marmarou, Christina R.			Brain energy depletion in a rodent model of diffuse traumatic brain injury is not prevented with administration of sodium lactate	BRAIN RESEARCH			English	Article						ATP; Brain trauma; Energy metabolism; Lactate; Mitochondria; Cerebral metabolism	TRICARBOXYLIC-ACID CYCLE; MITOCHONDRIAL DYSFUNCTION; MAGNETIC-RESONANCE; NAD(+) DEPLETION; PERMEABILITY TRANSITION; COGNITIVE DEFICITS; OXIDATIVE STRESS; RAT; METABOLISM; ASTROCYTES	Lactate has been identified as an alternative fuel for the brain in situations of increased energy demand, as following a traumatic brain injury (TBI). This study investigates the effect of treatment with sodium lactate (NaLac) on the changes in brain energy state induced by a severe diffuse TBI. Rats were assigned to one of the eight groups (n=10 per group): 1 sham, normal saline; 2 TBI, normal saline; 3 TBI, hypertonic saline; 4 TBI, 100 mM NaLac, 5 TB!, 500 mM NaLac; 6 TBI, 1280 mM NaLac; 7 TBI, 2000 mM NaLac and 8-TBI-500 mM NaLac+magnesium sulfate. Cerebrums were removed 6 h after trauma. Metabolites representative of the energy state (ATP, ATP-catabolites), N-acetylaspartate (NAA), antioxidant defenses (ascorbic acid, glutathione), markers of oxidative stress (malondialdehyde, ADP-ribose) and nicotinic coenzymes (NAD(+)) were measured by HPLC. TBI induced a marked decrease in the cerebral levels of ATP, NAA, ascorbic acid, glutathione and NAD(+) and a significant rise in the content of ATP-catabolites, malondialdehyde and ADP-ribose. These alterations were not ameliorated with NaLac infusion. We observed a significant reduction in cerebral NAD(+), an essential co-enzyme for mitochondrial lactate-dehydrogenase that converts lactate into pyruvate and thus replenishes the tricarboxylic acid cycle. These results suggest that the metabolic pathway necessary to consume lactate may be compromised following a severe diffuse TBI in rats. (C) 2011 Elsevier B.V. All rights reserved.	[Prieto, Ruth] Clin San Carlos Univ Hosp, Dept Neurosurg, Madrid 28040, Spain; [Prieto, Ruth; Taya, Keisuke; Marmarou, Anthony; Marmarou, Christina R.] Virginia Commonwealth Univ, Dept Neurosurg, Richmond, VA 23298 USA; [Tavazzi, Barbara; Amorini, Angela M.; Di Pietro, Valentina] Univ Cattolica Sacro Cuore, Inst Biochem & Clin Biochem, Rome, Italy; [Taya, Keisuke] Jikei Univ Hosp, Dept Neurosurg, Tokyo, Japan; [Barrios, Laura] CSIC, Dept Stat, Comp Tech Ctr, Madrid, Spain; [Pascual, Jose M.] La Princesa Univ Hosp, Dept Neurosurg, Madrid, Spain	Prieto, R (corresponding author), Clin San Carlos Univ Hosp, Dept Neurosurg, Prof Martin Lagos S-N, Madrid 28040, Spain.	rprieto29@hotmail.com; btavazzi@rm.unicatt.it; K_taya2004@yahoo.co.jp; laura@cti.csic.es; amorini@unict.it; valentina.dipietro@rm.unicatt.it; jmpasncj@hotmail.com; crmarmar@vcu.edu	TAVAZZI, BARBARA/AAB-9830-2019	TAVAZZI, BARBARA/0000-0001-8743-0895; Di Pietro, Valentina/0000-0001-9430-4723; AMORINI, Angela Maria/0000-0003-3525-9955	National Institutes of Health, BethesdaUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [RO1 NS12587, RO1 NS19235]; Johnson & Johnson Medical Company; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS012587, R01NS019235] Funding Source: NIH RePORTER	This research was supported by grants RO1 NS12587 and RO1 NS19235 from the National Institutes of Health, Bethesda and by the scholarship provided to R.P. by Johnson & Johnson Medical Company. The contents are the sole responsibility of the authors and do not necessarily represent the official views of the Fund or the Advisory Board.	Ahmed SM, 2000, J NEUROCHEM, V74, P1951, DOI 10.1046/j.1471-4159.2000.741951000000000.x; Alano CC, 2004, J BIOL CHEM, V279, P18895, DOI 10.1074/jbc.M313329200; Ang BT, 2003, J NEUROSURG, V99, P125, DOI 10.3171/jns.2003.99.1.0125; Barzo P, 1996, J NEUROSURG, V85, P1113, DOI 10.3171/jns.1996.85.6.1113; Bergersen LH, 2007, NEUROSCIENCE, V145, P11, DOI 10.1016/j.neuroscience.2006.11.062; Bernardi P, 1999, PHYSIOL REV, V79, P1127; Cecil KM, 1998, J NEUROSURG, V88, P795, DOI 10.3171/jns.1998.88.5.0795; Cernak I, 2000, J NEUROTRAUM, V17, P53, DOI 10.1089/neu.2000.17.53; Chen T, 2000, J NEUROTRAUM, V17, P135, DOI 10.1089/neu.2000.17.135; Chen T, 2000, BRAIN RES, V861, P281, DOI 10.1016/S0006-8993(00)01992-2; Clark JB, 1998, DEV NEUROSCI-BASEL, V20, P271, DOI 10.1159/000017321; Clark RSB, 2007, J NEUROTRAUM, V24, P1399, DOI 10.1089/neu.2007.0305; Fink EL, 2008, J CEREBR BLOOD F MET, V28, P1523, DOI 10.1038/jcbfm.2008.52; Fukushima M, 2009, J NEUROTRAUM, V26, P1095, DOI 10.1089/neu.2008.0771; Gallagher CN, 2009, BRAIN, V132, P2839, DOI 10.1093/brain/awp202; Holloway R, 2007, ACTA NEUROCHIR, V149, P919, DOI 10.1007/s00701-007-1241-y; Ichai C, 2009, INTENS CARE MED, V35, P471, DOI 10.1007/s00134-008-1283-5; Ide K, 2000, J PHYSIOL-LONDON, V522, P159, DOI 10.1111/j.1469-7793.2000.t01-2-00159.xm; IZUMI Y, 1994, NEUROREPORT, V5, P617, DOI 10.1097/00001756-199401000-00021; KOWALCHUK JM, 1988, J APPL PHYSIOL, V65, P2080; Lai Y, 2008, J NEUROCHEM, V104, P1700, DOI 10.1111/j.1471-4159.2007.05114.x; Lazzarino G, 2003, ANAL BIOCHEM, V322, P51, DOI 10.1016/j.ab.2003.07.013; Levasseur JE, 2006, NEUROSURGERY, V59, P1122, DOI 10.1227/01.NEU.0000245581.00908.AF; MARAN A, 1994, LANCET, V343, P16, DOI 10.1016/S0140-6736(94)90876-1; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Pascual JM, 2007, J NEUROTRAUM, V24, P944, DOI 10.1089/neu.2006.0190; PELLERIN L, 1994, P NATL ACAD SCI USA, V91, P10625, DOI 10.1073/pnas.91.22.10625; Rice AC, 2002, BRAIN RES, V928, P156, DOI 10.1016/S0006-8993(01)03299-1; Ros J, 2001, J NEUROSCI RES, V66, P790, DOI 10.1002/jnr.10043; Satchell MA, 2003, J NEUROCHEM, V85, P697, DOI 10.1046/j.1471-4159.2003.01707.x; Schuck Otto, 2005, Biomedical Papers (Olomouc), V149, P69; Schurr A, 1999, J NEUROSCI, V19, P34; SHACKFORD SR, 1992, J NEUROSURG, V76, P91, DOI 10.3171/jns.1992.76.1.0091; Sharma Pushpa, 2009, J Emerg Trauma Shock, V2, P67, DOI 10.4103/0974-2700.50739; Signoretti S, 2001, J NEUROTRAUM, V18, P977, DOI 10.1089/08977150152693683; Smith D, 2003, J CEREBR BLOOD F MET, V23, P658, DOI 10.1097/01.WCB.0000063991.19746.11; Tavazzi B, 2005, CLIN BIOCHEM, V38, P997, DOI 10.1016/j.clinbiochem.2005.08.002; Tavazzi B, 2005, NEUROSURGERY, V56, P582, DOI 10.1227/01.NEU.0000156715.04900.E6; Vagnozzi R, 1999, J NEUROTRAUM, V16, P903, DOI 10.1089/neu.1999.16.903; Ying WH, 2002, J CEREBR BLOOD F MET, V22, P774, DOI 10.1097/00004647-200207000-00002	40	18	19	0	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	AUG 2	2011	1404						39	49		10.1016/j.brainres.2011.06.006			11	Neurosciences	Neurosciences & Neurology	802DP	WOS:000293489800005	21723535	Green Accepted			2021-06-18	
J	Clune-Ryberg, M; Blanco-Campal, A; Carton, S; Pender, N; O'Brien, D; Phillips, J; Delargy, M; Burke, T				Clune-Ryberg, Melanie; Blanco-Campal, Alberto; Carton, Simone; Pender, Niall; O'Brien, Donncha; Phillips, Jack; Delargy, Mark; Burke, Teresa			The contribution of retrospective memory, attention and executive functions to the prospective and retrospective components of prospective memory following TBI	BRAIN INJURY			English	Article						Memory disorders; neuropsychological test; process approach; cognitive rehabilitation; delayed intentions; traumatic brain injury	TRAUMATIC BRAIN-INJURY; PERFORMANCE; REALIZATION; INTENTIONS	Primary objective: Despite the prevalence of prospective memory (PM) problems, relatively little is known about the processes underlying impairment following TBI. This study sought to examine PM performance, using a multiple-task, multiple-response video-based paradigm in which initial encoding of the cue-action associations was ensured (Video-Assessment of Prospective Memory; VAPM). Research design: VAPM was designed to allow easy identification of reasons for failure (i.e. cue detection and/or specific action retrieval). Patients with moderate/severe TBI (n == 32) and matched controls (n == 16) also completed standardized neuropsychological assessment including evaluation of episodic retrospective memory (RM), attention, information processing, executive functions and mood. Main outcomes and results: As a group, those with TBI were impaired on PM tasks with 50%% failing to complete at least 2/6 required tasks despite near perfect performance by controls. Individual profile analyses revealed different reasons for impairment, with RM contributing significantly to both the prospective and retrospective components. This was supported by correlational analyses illustrating a significant relationship between cue detection and RM measures, in addition to measures of executive functions and attention. Conclusions: The contribution of RM to both components of PM, along with the finding of heterogeneity in performance among participants have important implications for theoretical understanding and clinical practice.	[Clune-Ryberg, Melanie; Blanco-Campal, Alberto; Burke, Teresa] Univ Coll Dublin, Sch Psychol, Dublin 4, Ireland; [Carton, Simone] DunLaoghaire Co, Natl Rehabil Hosp, Dept Clin Psychol, Dublin, Ireland; [Pender, Niall] Beaumont Hosp, Dept Clin Psychol, Dublin 9, Ireland; [O'Brien, Donncha] Beaumont Hosp, Dept Neurosurg, Dublin 9, Ireland; [Phillips, Jack] Beaumont Private Clin, Dublin, Ireland; [Delargy, Mark] DunLaoghaire Co, Natl Rehabil Hosp, Rehabil Med, Dublin, Ireland	Burke, T (corresponding author), Univ Coll Dublin, Sch Psychol, Dublin 4, Ireland.	evelyn.burke@ucd.ie		Pender, Niall/0000-0002-4172-0704; Burke, Teresa/0000-0001-8093-9912	Irish Research Council for the Humanities and Social Sciences (IRCHSS)Irish Research Council for Science, Engineering and Technology	Funding for this research was provided by the Irish Research Council for the Humanities and Social Sciences (IRCHSS), a postgraduate research scholarship to the first author. The authors report no conflicts of interest.	Altgassen M, 2008, J CLIN EXP NEUROPSYC, V30, P777, DOI 10.1080/13803390701779552; Baddeley A., 1994, DOORS PEOPLE TEST TE; Baddeley A.D., 1992, SPEED CAPACITY LANGU; Bravin JH, 2000, J CLIN EXP NEUROPSYC, V22, P418, DOI 10.1076/1380-3395(200006)22:3;1-V;FT418; Burgess P. W., 1997, COGNITIVE MODELS MEM, P247; Burgess PW, 2011, NEUROPSYCHOLOGIA, V49, P2246, DOI 10.1016/j.neuropsychologia.2011.02.014; Burgess PW, 2001, NEUROPSYCHOLOGIA, V39, P545, DOI 10.1016/S0028-3932(00)00149-4; BURKE T, 2010, P 3 INT C PROSP MEM; Carlesimo GA, 2004, J INT NEUROPSYCH SOC, V10, P679, DOI 10.1017/S1355617704105079; CLUNE M, 2008, VIDEO ASSESSMENT PRO; CLUNE M, 2008, THESIS U COLL DUBLIN; Crawford JR, 2003, MEMORY, V11, P261, DOI 10.1080/09658210244000027; Delis D.C., 2001, DELIS KAPLAN D KEFS; Einstein, 2007, PROSPECTIVE MEMORY O, DOI [10.4135/9781452225913, DOI 10.4135/9781452225913]; Einstein G., 1996, PROSPECTIVE MEMORY T, P115; Elliott J, 2008, POPULAR FEMINIST FICTION AS AMERICAN ALLEGORY: REPRESENTING NATIONAL TIME, P1, DOI 10.1057/9780230612808; Ellis J, 2000, APPL COGNITIVE PSYCH, V14, pS1, DOI 10.1002/acp.767; Ellis JA., 1996, PROSPECTIVE MEMORY T, P1; Fish J, 2010, NEUROPSYCHOL REHABIL, V20, P161, DOI 10.1080/09602010903126029; Kinch J., 2001, BRAIN IMPAIR, V2, P119, DOI [10.1375/brim.2.2.119, DOI 10.1375/BRIM.2.2.119]; Kinsella GJ, 2009, BRAIN IMPAIR, V10, P45, DOI 10.1375/brim.10.1.45; Kliegel M, 2004, BRAIN COGNITION, V56, P43, DOI 10.1016/j.bandc.2004.05.005; Kliegel M, 2002, PSYCHOL BEITR, V44, P303, DOI DOI 10.1037/0012-1649.44.2.612; Kliegel M, 2007, INT J PSYCHOPHYSIOL, V64, P226, DOI 10.1016/j.ijpsycho.2006.09.007; Kliegel M, 2011, NEUROPSYCHOLOGIA, V49, P2166, DOI 10.1016/j.neuropsychologia.2011.01.024; Knight RG, 2005, BRAIN INJURY, V19, P19, DOI 10.1080/02699050410001720022; Lezak M.D., 2004, NEUROPSYCHOLOGICAL A, Vfourth; Manly T, 1999, NEUROPSYCHOLOGIA, V37, P661, DOI 10.1016/S0028-3932(98)00127-4; Marsh RL, 1998, MEM COGNITION, V26, P633, DOI 10.3758/BF03211383; Mateer C.A., 1987, J HEAD TRAUMA REHAB, V2, P74, DOI [10.1097/00001199-198709000-00009, DOI 10.1097/00001199-198709000-00009]; McDaniel MA, 2004, J EXP PSYCHOL LEARN, V30, P605, DOI 10.1037/0278-7393.30.3.605; McDaniel MA, 2000, APPL COGNITIVE PSYCH, V14, pS127, DOI 10.1002/acp.775; Okuda J, 1998, NEUROSCI LETT, V253, P127, DOI 10.1016/S0304-3940(98)00628-4; Palmer HM, 2000, BRAIN COGNITION, V44, P103; Potvin MJ, 2011, BRAIN INJURY, V25, P192, DOI 10.3109/02699052.2010.541896; RASKIN S, 1998, P COGN NEUR SOC ANN; Raskin SA, 2009, BRAIN IMPAIR, V10, P76, DOI 10.1375/brim.10.1.76; Rey A, 1964, EXAMEN CLIN PSYCHOL; Robertson IH, 1997, NEUROPSYCHOLOGIA, V35, P747, DOI 10.1016/S0028-3932(97)00015-8; Schmidt M., 1996, REY AUDITORY VERBAL; Shum D, 2011, NEUROPSYCHOLOGIA, V49, P2156, DOI 10.1016/j.neuropsychologia.2011.02.006; Simons JS, 2006, NEUROPSYCHOLOGIA, V44, P1388, DOI 10.1016/j.neuropsychologia.2006.01.005; Smith G, 2000, MEMORY, V8, P311, DOI 10.1080/09658210050117735; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Titov N, 2000, BRAIN INJURY, V14, P877; Wechsler D., 1997, WMS 3 WECHSLER MEMOR; Wechsler D, 1997, WAIS 3 ADM SCORING M; West R, 2002, NEUROSCI BIOBEHAV R, V26, P827, DOI 10.1016/S0149-7634(02)00069-6; West R, 2000, APPL COGNITIVE PSYCH, V14, pS115, DOI 10.1002/acp.774; West R, 2001, COGNITIVE BRAIN RES, V12, P1, DOI 10.1016/S0926-6410(01)00014-3; WILSON BA, 2005, PROSPECTIVE MEMORY T; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	52	18	21	1	12	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	AUG	2011	25	9					819	831		10.3109/02699052.2011.589790			13	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	790CY	WOS:000292567300003	21721845				2021-06-18	
J	Zehr, EP				Zehr, E. Paul			Evidence-based risk assessment and recommendations for physical activity clearance: stroke and spinal cord injury	APPLIED PHYSIOLOGY NUTRITION AND METABOLISM			English	Article						rehabilitation; physical therapy; neurotrauma; functional capacity; safety	BODY-WEIGHT SUPPORT; CLINICAL-PRACTICE GUIDELINES; RANDOMIZED CONTROLLED-TRIAL; HEMIPARETIC STROKE; EXERCISE RECOMMENDATIONS; CEREBROVASCULAR-DISEASE; POSTSTROKE HEMIPLEGIA; SCIENTIFIC STATEMENT; AEROBIC EXERCISE; IMPROVES WALKING	Physical activity (PA) has potential benefits after stroke or spinal cord injury (SCI), especially in improving efficiency and functional capacity in activities of daily living. Currently, many who could benefit from PA may be routinely excluded from participation because of myths related to functional capacity and the concern for harm. The purpose of this review was to evaluate the literature for reports of adverse events during exercise after stroke or SCI, and to provide recommendations regarding exercise participation in supervised and unsupervised environments. Studies were evaluated for quality, and the summary level and quality of evidence were evaluated using the AGREE rubric, modified to address the main outcome measure of adverse events. Levels of exercise stress were evaluated for aerobic activities, using an established rubric. Included in the current analysis were 32 studies for stroke and 4 for SCI. In aggregate, this yielded a total of 730 experimental participants with stroke and 143 with SCI. It should be noted that almost all studies were not designed to examine naturally occurring adverse events from PA. Significant contraindications to unsupervised exercise include manifestation of autonomic dysreflexia in SCI and cardiovascular comorbidity after stroke. There are clear benefits of exercise training on physiological outcomes in stroke and SCI, but the relation between outcomes and safety remains unclear. However, taken on balance, the risk-to-benefit ratio favors the recommendation of exercise. This recommendation is based on studies in which participants were almost universally screened for participation in supervised environments. Thus, the grading of evidence for finding adverse events to support this conclusion is inadequate.	[Zehr, E. Paul] Univ Victoria, Rehabil Neurosci Lab, Victoria, BC V8W 3P1, Canada; [Zehr, E. Paul] Int Collaborat Repair Discoveries ICORD, Vancouver, BC, Canada; [Zehr, E. Paul] Univ Victoria, Ctr Biomed Res, Victoria, BC V8W 3P1, Canada; [Zehr, E. Paul] Univ Victoria, Div Med Sci, Victoria, BC V8W 3P1, Canada; [Zehr, E. Paul] Univ Victoria, Sch Exercise Sci Phys & Hlth Educ, Victoria, BC V8W 3P1, Canada	Zehr, EP (corresponding author), Univ Victoria, Rehabil Neurosci Lab, POB 3015 STN CSC, Victoria, BC V8W 3P1, Canada.	pzehr@uvic.ca					Ada L, 2003, ARCH PHYS MED REHAB, V84, P1486, DOI 10.1016/S0003-9993(03)00349-6; ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Adams RJ, 2003, CIRCULATION, V108, P1278, DOI 10.1161/01.CIR.0000090444.87006.CF; AGREE Collaboration, 2001, APPR GUID RES EV AGR; American Spinal Injury Association, 2002, INT STAND NEUR CLASS; [Anonymous], 1993, Schweiz Z Sportmed, V41, P127; Badics E, 2002, NEUROREHABILITATION, V17, P211; Barzi Y, 2008, CLIN NEUROPHYSIOL, V119, P1443, DOI 10.1016/j.clinph.2008.02.016; Bourbonnais D, 2002, AM J PHYS MED REHAB, V81, P890, DOI 10.1097/00002060-200212000-00002; Brosseau L, 2006, TOP STROKE REHABIL, V13, P1, DOI 10.1310/3TKX-7XEC-2DTG-XQKH; BUTEFISCH C, 1995, J NEUROL SCI, V130, P59, DOI 10.1016/0022-510X(95)00003-K; Cluzeau F, 2003, QUAL SAF HEALTH CARE, V12, P18; Corcoran P J, 1970, Arch Phys Med Rehabil, V51, P69; CUVIELLOPALMER ED, 1988, THESIS TEXAS WOMENS; da Cunha IT, 2002, ARCH PHYS MED REHAB, V83, P1258, DOI 10.1053/apmr.2002.34267; Dean CM, 2000, ARCH PHYS MED REHAB, V81, P409, DOI 10.1053/mr.2000.3839; Dobkin B, 2006, NEUROLOGY, V66, P484, DOI 10.1212/01.wnl.0000202600.72018.39; Dobrovolny CL, 2003, ARCH PHYS MED REHAB, V84, P1308, DOI 10.1016/S0003-9993(03)00150-3; Downs SH, 1998, J EPIDEMIOL COMMUN H, V52, P377, DOI 10.1136/jech.52.6.377; Duncan P, 1998, STROKE, V29, P2055, DOI 10.1161/01.STR.29.10.2055; Eich HJ, 2004, CLIN REHABIL, V18, P640, DOI 10.1191/0269215504cr779oa; ENGARDT M, 1995, ARCH PHYS MED REHAB, V76, P419, DOI 10.1016/S0003-9993(95)80570-2; Farry, 2010, INCIDENCE PREVALENCE; Farry A., 2010, SPINAL CORD INJURY C; Field-Fote Edelle C, 2005, J Neurol Phys Ther, V29, P127; Figoni S.F., 2002, ACSMS RESOURCES CLIN, P48; GERSTEN J W, 1971, Scandinavian Journal of Rehabilitation Medicine, V3, P85; Giuliani CA, 1992, P FORUM STROKE REHAB, P49; GLASSER L, 1986, PHYS THER, V66, P673, DOI 10.1093/ptj/66.5.673; Gordon NF, 2004, CIRCULATION, V109, P2031, DOI 10.1161/01.CIR.0000126280.65777.A4; Heart and Stroke Foundation, 2010, STROK STAT; HERTZER NR, 1985, ARCH INTERN MED, V145, P849, DOI 10.1001/archinte.145.5.849; Inaba M, 1973, Phys Ther, V53, P28; Ivey F M, 2005, Top Stroke Rehabil, V12, P1; Ivey FM, 2008, J CARDIOPULM REHABIL, V28, P2, DOI 10.1097/01.HCR.0000311501.57022.a8; Ivey Frederick M, 2006, NeuroRx, V3, P439, DOI 10.1016/j.nurx.2006.07.011; Jacobs PL, 2004, SPORTS MED, V34, P727, DOI 10.2165/00007256-200434110-00003; Jaffe DL, 2004, J REHABIL RES DEV, V41, P283, DOI 10.1682/JRRD.2004.03.0283; Karimi H., THESIS QUEENS U KING; Kelly Brian M, 2007, Phys Med Rehabil Clin N Am, V18, P631, DOI 10.1016/j.pmr.2007.07.006; Kim C M, 2001, J Stroke Cerebrovasc Dis, V10, P265, DOI 10.1053/jscd.2001.123775; Kosak MC, 2000, NEUROREHAB NEURAL RE, V14, P13, DOI 10.1177/154596830001400102; Krassioukov A, 2009, ARCH PHYS MED REHAB, V90, P682, DOI 10.1016/j.apmr.2008.10.017; Lau DCW, 2007, CAN MED ASSOC J, V176, P1103, DOI 10.1503/cmaj.070306; Laufer Y, 2001, J REHABIL RES DEV, V38, P69; Liston R, 2000, AGE AGEING, V29, P311, DOI 10.1093/ageing/29.4.311; Macko R.F., 2008, ARCH PHYS M IN PRESS; Macko RF, 1997, STROKE, V28, P988, DOI 10.1161/01.STR.28.5.988; Meek C, 2003, CLIN REHABIL, V17, P6, DOI 10.1191/0269215503cr579oa; Mehrholz J., 2008, COCHRANE DB SYST REV, V10; Morris SL, 2004, CLIN REHABIL, V18, P27, DOI 10.1191/0269215504cr699oa; Moseley AM, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.cd002840.pub2; Myers J, 2007, AM J PHYS MED REHAB, V86, P142, DOI 10.1097/PHM.0b013e31802f0247; NAKAJIMA A, 1988, PARAPLEGIA, V26, P165, DOI 10.1038/sc.1988.27; Nilsson L, 2001, CLIN REHABIL, V15, P515, DOI 10.1191/026921501680425234; Ouellette MM, 2004, STROKE, V35, P1404, DOI 10.1161/01.STR.0000127785.73065.34; Patten C, 2004, J REHABIL RES DEV, V41, P293, DOI 10.1682/JRRD.2004.03.0293; Pohl M, 2002, STROKE, V33, P553, DOI 10.1161/hs0202.102365; Postans NJ, 2004, ARCH PHYS MED REHAB, V85, P604, DOI 10.1016/j.apmr.2003.08.083; Potempa K, 1996, SPORTS MED, V21, P337, DOI 10.2165/00007256-199621050-00003; POTEMPA K, 1995, STROKE, V26, P101, DOI 10.1161/01.STR.26.1.101; Ramas J, 2007, Ann Readapt Med Phys, V50, P438, DOI 10.1016/j.annrmp.2007.04.005; RICHARDS CL, 1993, ARCH PHYS MED REHAB, V74, P612, DOI 10.1016/0003-9993(93)90159-8; Rosamond W, 2008, CIRCULATION, V117, pE25, DOI 10.1161/CIRCULATIONAHA.107.187998; ROTH EJ, 1993, ARCH PHYS MED REHAB, V74, P752, DOI 10.1016/0003-9993(93)90038-C; Saunders DH, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003316.pub3; Scheidtmann K, 1999, NEUROL REHABIL, V5, P198; Sharp SA, 1997, ARCH PHYS MED REHAB, V78, P1231, DOI 10.1016/S0003-9993(97)90337-3; Teixeira-Salmela LF, 1999, ARCH PHYS MED REHAB, V80, P1211, DOI 10.1016/S0003-9993(99)90018-7; van de Port IGL, 2007, AM J PHYS MED REHAB, V86, P935, DOI 10.1097/PHM.0b013e31802ee464; Visintin M, 1998, STROKE, V29, P1122, DOI 10.1161/01.STR.29.6.1122; Warburton Darren E R, 2007, Top Spinal Cord Inj Rehabil, V13, P98, DOI 10.1310/sci1301-98; Warburton DER, 2006, CAN MED ASSOC J, V174, P961, DOI 10.1503/cmaj.1040750; Warburton DER, 2006, CAN MED ASSOC J, V174, P801, DOI 10.1503/cmaj.051351; Weiss A, 2000, AM J PHYS MED REHAB, V79, P369, DOI 10.1097/00002060-200007000-00009; Werner C, 2002, EUR J NEUROL, V9, P639, DOI 10.1046/j.1468-1331.2002.00492.x; Winstein CJ, 2004, ARCH PHYS MED REHAB, V85, P620, DOI 10.1016/j.apmr.2003.06.027; Zehr E.P., CLIN NEUROP IN PRESS	78	18	19	0	15	CANADIAN SCIENCE PUBLISHING, NRC RESEARCH PRESS	OTTAWA	65 AURIGA DR, SUITE 203, OTTAWA, ON K2E 7W6, CANADA	1715-5312	1715-5320		APPL PHYSIOL NUTR ME	Appl. Physiol. Nutr. Metab.	JUL	2011	36			1			S214	S231		10.1139/H11-055			18	Nutrition & Dietetics; Physiology; Sport Sciences	Nutrition & Dietetics; Physiology; Sport Sciences	885JM	WOS:000299775200011	21800943	Bronze			2021-06-18	
J	Contreras, R; Ghajar, J; Bahar, S; Suh, M				Contreras, R.; Ghajar, J.; Bahar, S.; Suh, M.			Effect of cognitive load on eye-target synchronization during smooth pursuit eye movement	BRAIN RESEARCH			English	Article						Mild traumatic brain injury (mTBI); Smooth pursuit eye movement; Phase synchronization; Diffuse axonal injury; Eye tracking	BRAIN; ATTENTION; DEFICITS	In mild traumatic brain injury (mTBI), the fiber tracts that connect the frontal cortex with the cerebellum may suffer shear damage, leading to attention deficits and performance variability. This damage also disrupts the enhancement of eye-target synchronization that can be affected by cognitive load when subjects are tested using a concurrent eye-tracking test and word-recall test. We investigated the effect of cognitive load on eye-target synchronization in normal and mTBI patients using the nonlinear dynamical technique of stochastic phase synchronization. Results demonstrate that eye-target synchronization was negatively affected by cognitive load in mTBI subjects. In contrast, eye-target synchronization improved under intermediate cognitive load in young (<= 40 years old) normal subjects. (C) 2011 Elsevier B.V. All rights reserved.	[Contreras, R.; Bahar, S.] Univ Missouri, Dept Phys & Astron, St Louis, MO 63121 USA; [Contreras, R.; Bahar, S.] Univ Missouri, Ctr Neurodynam, St Louis, MO 63121 USA; [Ghajar, J.] Brain Trauma Fdn, New York, NY USA; [Ghajar, J.] Weill Cornell Med Coll, Dept Neurol Surg, New York, NY USA; [Suh, M.] Sungkyunkwan Univ, Dept Biol Sci, Suwon, South Korea; [Suh, M.] Sungkyunkwan Univ, Sch Med, Samsung Adv Inst Hlth Sci & Technol, Grad Program Hlth Sci & Technol, Seoul, South Korea	Bahar, S (corresponding author), Univ Missouri, Dept Phys & Astron, St Louis, MO 63121 USA.	bahars@umsl.edu; minahsuh@skku.edu			James S. McDonnell Foundation; NSFNational Science Foundation (NSF) [PHY-0547647]; National Research Foundation (NRF) [2010-0000571]	This work was supported by James S. McDonnell Foundation grant for the Cognitive Neurobiological Research Consortium in Traumatic Brain Injury. The authors thank Rachel Kolster and Ranjeeta Sarkar for technical assistance with eye movement and cognitive testing. SB and RC acknowledge NSF CAREER Grant No. PHY-0547647 (to SB) for additional support. MS also acknowledge the National Research Foundation (NRF) Grant No. 2010-0000571 (to MS) by the Korean government (MEST).	Bahar S, 2004, FLUCT NOISE LETT, V4, pL87, DOI 10.1142/S0219477504001690; Chen Y, 2002, PROG BRAIN RES, V140, P255; COLLEWIJN H, 1984, J PHYSIOL-LONDON, V351, P217, DOI 10.1113/jphysiol.1984.sp015242; Contreras R, 2008, J BIOL PHYS, V34, P381, DOI 10.1007/s10867-008-9092-1; Dockree PM, 2006, EXP BRAIN RES, V168, P218, DOI 10.1007/s00221-005-0079-x; Gross J, 2000, J PHYSIOL-LONDON, V527, P623, DOI 10.1111/j.1469-7793.2000.00623.x; Hetherington CR, 1996, BRAIN INJURY, V10, P473, DOI 10.1080/026990596124197; Hultsch D.F., 2004, NEW FRONTIERS COGNIT, P65, DOI DOI 10.1093/ACPROF:OSO/9780198525691.003.0004; Hutton SB, 2005, EXP BRAIN RES, V163, P306, DOI 10.1007/s00221-004-2171-z; KOWLER E, 1989, VISION RES, V29, P1049, DOI 10.1016/0042-6989(89)90052-7; Lencer R, 2008, BRAIN COGNITION, V68, P219, DOI 10.1016/j.bandc.2008.08.013; Maruta J, 2010, J HEAD TRAUMA REHAB, V25, P293, DOI 10.1097/HTR.0b013e3181e67936; Pikovsky A., 2001, SYNCHRONIZATION; Robertson IH, 1997, NEUROPSYCHOLOGIA, V35, P747, DOI 10.1016/S0028-3932(97)00015-8; Stuss DT, 1994, NEUROPSYCHOLOGY, V8, P316, DOI DOI 10.1037/0894-4105.8.3.316; Suh M, 2006, NEUROSCI LETT, V410, P203, DOI 10.1016/j.neulet.2006.10.001; Suh M, 2006, NEUROSCI LETT, V401, P108, DOI 10.1016/j.neulet.2006.02.074; Suh M, 2008, J KOREAN PHYS SOC, V53, P3468, DOI 10.3938/jkps.53.3468; Takeshita D, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.051925; Tass P, 1998, PHYS REV LETT, V81, P3291, DOI 10.1103/PhysRevLett.81.3291; Tass PA, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.088101; Van Donkelaar P, 2002, PROG BRAIN RES, V140, P267; Vanderploeg RD, 2005, J INT NEUROPSYCH SOC, V11, P228, DOI 10.1017/S1355617705050289	23	18	18	0	17	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	JUN 29	2011	1398						55	63		10.1016/j.brainres.2011.05.004			9	Neurosciences	Neurosciences & Neurology	788GZ	WOS:000292434700006	21620377				2021-06-18	
J	Hare, GMT; Baker, JE; Pavenski, K				Hare, Gregory M. T.; Baker, James E.; Pavenski, Katerina			Assessment and treatment of preoperative anemia: Continuing Professional Development	CANADIAN JOURNAL OF ANESTHESIA-JOURNAL CANADIEN D ANESTHESIE			English	Article							RED-BLOOD-CELL; ERYTHROPOIETIC STIMULATING AGENTS; RECOMBINANT-HUMAN-ERYTHROPOIETIN; RANDOMIZED CONTROLLED-TRIAL; SEVERE ISOVOLEMIC ANEMIA; TRAUMATIC BRAIN-INJURY; IRON-DEFICIENCY ANEMIA; CARDIAC-SURGERY; INTRAVENOUS IRON; TRANSFUSION REQUIREMENTS	The purpose of this continuing professional development (CPD) module is to review the risk of anemia and transfusion in perioperative patients and to propose an approach for the diagnosis and treatment of preoperative anemia. Preoperative anemia has been associated with increased transfusion of red blood cells, organ injury, and mortality. Postoperative anemia has also been associated with impaired recovery from surgery. Transfusion also increases the risk of infection, organ injury, and mortality. Preoperatively, iron deficiency anemia can be corrected with oral or intravenous iron; certain types of patients might respond to administration of erythrocyte stimulating agents (ESAs). With ESAs, the increased risk of thrombosis should be balanced against the expected benefit. Preoperative diagnosis and treatment of anemia may reduce the risk of morbidity and mortality associated with both anemia and transfusion.	[Hare, Gregory M. T.] Univ Toronto, St Michaels Hosp, Dept Anesthesia & Physiol, Keenan Res Ctr,Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada; [Baker, James E.] Univ Toronto, St Michaels Hosp, Dept Anesthesia, Toronto, ON M5B 1W8, Canada; [Pavenski, Katerina] Univ Toronto, St Michaels Hosp, Dept Lab Med, Toronto, ON M5B 1W8, Canada	Hare, GMT (corresponding author), Univ Toronto, St Michaels Hosp, Dept Anesthesia & Physiol, Keenan Res Ctr,Li Ka Shing Knowledge Inst, 30 Bond St, Toronto, ON M5B 1W8, Canada.	hareg@smh.ca	Hare, Greg/AAM-5599-2021		Department of Anesthesia, St. Michael's Hospital, University of Toronto	Department of Anesthesia, St. Michael's Hospital, University of Toronto.	Alghamdi AA, 2006, J CARDIAC SURG, V21, P320, DOI 10.1111/j.1540-8191.2006.00241.x; [Anonymous], 1825, LANCET, V4, P342; Auerbach M, 2007, LANCET, V369, P1502, DOI 10.1016/S0140-6736(07)60689-8; Beattie WS, 2010, ANESTHESIOLOGY, V112, P25, DOI 10.1097/ALN.0b013e3181c5dd81; Beattie WS, 2009, ANESTHESIOLOGY, V110, P574, DOI 10.1097/ALN.0b013e31819878d3; Beris P, 2008, BRIT J ANAESTH, V100, P599, DOI 10.1093/bja/aen054; Bierbaum BE, 1999, J BONE JOINT SURG AM, V81A, P2, DOI 10.2106/00004623-199901000-00002; CHAPLER CK, 1986, CAN J PHYSIOL PHARM, V64, P7, DOI 10.1139/y86-002; Conlon NP, 2008, ANESTH ANALG, V106, P1056, DOI 10.1213/ane.0b013e318164f114; Creteur J, 2009, CRIT CARE, V13, DOI 10.1186/cc8009; da Silveira AD, 2008, CORONARY ARTERY DIS, V19, P21, DOI 10.1097/MCA.0b013e3282f27c0a; de Andrade JR, 1999, ORTHOPEDICS, V22, pS113; Devereaux PJ, 2008, LANCET, V371, P1839, DOI 10.1016/S0140-6736(08)60601-7; Dhar R, 2009, STROKE, V40, P3039, DOI 10.1161/STROKEAHA.109.556159; Dunkelgrun M, 2008, AM J CARDIOL, V101, P526, DOI 10.1016/j.amjcard.2007.09.103; Feagan BG, 2000, ANN INTERN MED, V133, P845, DOI 10.7326/0003-4819-133-11-200012050-00008; Garcia-Erce JA, 2009, VOX SANG, V97, P260, DOI 10.1111/j.1423-0410.2009.01200.x; Gray C, 1998, CAN MED ASSOC J, V158, P89; Guralnik JM, 2004, BLOOD, V104, P2263, DOI 10.1182/blood-2004-05-1812; Hajjar LA, 2010, JAMA-J AM MED ASSOC, V304, P1559, DOI 10.1001/jama.2010.1446; Halm EA, 2004, J ORTHOP TRAUMA, V18, P369, DOI 10.1097/00005131-200407000-00007; Hare GMT, 2006, BRIT J ANAESTH, V97, P617, DOI 10.1093/bja/ael238; Hare GMT, 2009, CAN J ANAESTH, V56, P183, DOI 10.1007/s12630-009-9051-8; Hebert PC, 2001, CRIT CARE MED, V29, P227, DOI 10.1097/00003246-200102000-00001; Hebert PC, 1999, NEW ENGL J MED, V340, P409, DOI 10.1056/NEJM199902113400601; Karkouti K, 2005, ANN THORAC SURG, V80, P1381, DOI 10.1016/j.athoracsur.2005.03.137; Karkouti K, 2005, J THORAC CARDIOV SUR, V129, P391, DOI 10.1016/j.jtcvs.2004.06.028; Karkouti K, 2008, CIRCULATION, V117, P478, DOI 10.1161/CIRCULATIONAHA.107.718353; Khorana AA, 2008, ARCH INTERN MED, V168, P2377, DOI 10.1001/archinte.168.21.2377; Kiraly LN, 2009, J TRAUMA, V67, P29, DOI 10.1097/TA.0b013e3181af6a8c; Koch CG, 2006, CRIT CARE MED, V34, P1608, DOI 10.1097/01.CCM.0000217920.48559.D8; Koch CG, 2008, NEW ENGL J MED, V358, P1229, DOI 10.1056/NEJMoa070403; Kulier A, 2007, CIRCULATION, V116, P471, DOI 10.1161/CIRCULATIONAHA.106.653501; Lasocki S, 2011, ANESTHESIOLOGY, V114, P688, DOI 10.1097/ALN.0b013e3182065c57; Marik PE, 2008, CRIT CARE MED, V36, P2667, DOI 10.1097/CCM.0b013e3181844677; McIntyre LA, 2006, NEUROCRIT CARE, V5, P4, DOI 10.1385/NCC:5:1:4; McLaren AT, 2007, AM J PHYSIOL-REG I, V292, pR403, DOI 10.1152/ajpregu.00403.2006; Na HS, 2011, TRANSFUSION, V51, P118, DOI 10.1111/j.1537-2995.2010.02783.x; O'Brien SF, 2007, TRANSFUSION, V47, P316, DOI 10.1111/j.1537-2995.2007.01108.x; Pasricha SRS, 2010, MED J AUSTRALIA, V193, P525, DOI 10.5694/j.1326-5377.2010.tb04038.x; Pfeffer MA, 2009, NEW ENGL J MED, V361, P2019, DOI 10.1056/NEJMoa0907845; Ragoonanan TE, 2009, ANESTHESIOLOGY, V111, P988, DOI 10.1097/ALN.0b013e3181b87f0e; Rao SV, 2004, JAMA-J AM MED ASSOC, V292, P1555, DOI 10.1001/jama.292.13.1555; Rizzo JD, 2008, BLOOD, V111, P25, DOI 10.1182/blood-2007-08-109488; Saleh E, 2007, BRIT J ANAESTH, V99, P801, DOI 10.1093/bja/aem299; Shander A, 2010, TRANSFUSION, V50, P719, DOI 10.1111/j.1537-2995.2009.02492.x; Shehata N, 2011, JAMA-J AM MED ASSOC, V305, P357, DOI 10.1001/jama.2011.14; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Stowell CP, 2009, SPINE, V34, P2479, DOI 10.1097/BRS.0b013e3181bd163f; Testa U, 2010, EXPERT OPIN EMERG DR, V15, P119, DOI 10.1517/14728210903499273; Theusinger OM, 2007, ANESTHESIOLOGY, V107, P923, DOI 10.1097/01.anes.0000291441.10704.82; Tsui AKY, 2010, CAN J ANESTH, V57, P779, DOI 10.1007/s12630-010-9329-x; Vamvakas EC, 2001, BLOOD, V97, P1180, DOI 10.1182/blood.V97.5.1180; Vamvakas EC, 2009, BLOOD, V113, P3406, DOI 10.1182/blood-2008-10-167643; van Klei WA, 2009, ANESTHESIOLOGY, V111, P717, DOI 10.1097/ALN.0b013e3181b6a761; Weiskopf RB, 1998, JAMA-J AM MED ASSOC, V279, P217, DOI 10.1001/jama.279.3.217; Weiskopf RB, 2000, ANESTHESIOLOGY, V92, P1646, DOI 10.1097/00000542-200006000-00023; Weiss G, 2005, NEW ENGL J MED, V352, P1011, DOI 10.1056/NEJMra041809; Wu WC, 2010, ANN SURG, V252, P11, DOI 10.1097/SLA.0b013e3181e3e43f; Zygun DA, 2009, CRIT CARE MED, V37, P1074, DOI 10.1097/CCM.0b013e318194ad22	60	18	18	0	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0832-610X	1496-8975		CAN J ANESTH	Can. J. Anesth.	JUN	2011	58	6					569	581		10.1007/s12630-011-9498-2			13	Anesthesiology	Anesthesiology	765SY	WOS:000290730100012	21484608	Bronze			2021-06-18	
J	Lin, YW; Hsieh, CL				Lin, Yi-Wen; Hsieh, Ching-Liang			Oral Uncaria rhynchophylla (UR) reduces kainic acid-induced epileptic seizures and neuronal death accompanied by attenuating glial cell proliferation and S100B proteins in rats	JOURNAL OF ETHNOPHARMACOLOGY			English	Article						Epileptic seizures; Hippocampus; GFAP; S100B; Traditional Chinese Medicine; Uncaria rhynchophylla	TEMPORAL-LOBE EPILEPSY; TRAUMATIC BRAIN-INJURY; TREATED RATS; HIPPOCAMPAL SLICES; GABA(A) RECEPTORS; S-100 PROTEIN; ANIMAL-MODEL; S100-BETA; EXPRESSION; EPILEPTOGENESIS	Aim of the study: Epilepsy is a common clinical syndrome with recurrent neuronal discharges in cerebral cortex and hippocampus. Here we aim to determine the protective role of Uncaria rhynchophylla (UR), an herbal drug belong to Traditional Chinese Medicine (TCM), on epileptic rats. Materials and methods: To address this issue, we tested the effect of UR on kainic acid (KA)-induced epileptic seizures and further investigate the underlying mechanisms. Results: Oral UR successfully decreased neuronal death and discharges in hippocampal CA1 pyramidal neurons. The population spikes (PSs) were decreased from 4.1 +/- 0.4 mV to 2.1 +/- 0.3 mV in MA-induced epileptic seizures and UR-treated groups, respectively. Oral UR protected animals from neuronal death induced by MA treatment (from 34 +/- 4.6 to 191.7 +/- 48.6 neurons/field) through attenuating glial cell proliferation and S100B protein expression but not GABAA and TRPV1 receptors. Conclusions: The above results provide detail mechanisms underlying the neuroprotective action of UR on MA-induced epileptic seizure in hippocampal CA1 neurons. Crown Copyright (C) 2011 Published by Elsevier Ireland Ltd. All rights reserved.	[Lin, Yi-Wen; Hsieh, Ching-Liang] China Med Univ, Grad Inst Acupuncture Sci, Taichung 40402, Taiwan; [Lin, Yi-Wen; Hsieh, Ching-Liang] China Med Univ, Acupuncture Res Ctr, Taichung 40402, Taiwan; [Hsieh, Ching-Liang] China Med Univ Hosp, Dept Chinese Med, Taichung, Taiwan	Hsieh, CL (corresponding author), China Med Univ, Grad Inst Acupuncture Sci, 91 Hsueh Shih Rd, Taichung 40402, Taiwan.	clhsieh@mail.cmuh.org.tw	Lin, Yi-Wen/O-3541-2015	Lin, Yi-Wen/0000-0001-7204-8837	National Science Council, Taiwan, R. O. C.Ministry of Science and Technology, Taiwan [NSC 97-2320-B-039-011-MY3]; Taiwan Department of Health Clinical Trial and Research Center of Excellence [DOH100-TD-B-111-004]	This study was supported by grant NSC 97-2320-B-039-011-MY3 from the National Science Council, Taiwan, R. O. C. and was also supported in part by Taiwan Department of Health Clinical Trial and Research Center of Excellence (DOH100-TD-B-111-004).	Antonucci F, 2009, EPILEPSIA, V50, P963, DOI 10.1111/j.1528-1167.2008.01983.x; BARGER SW, 1992, J BIOL CHEM, V267, P9689; BARNES JM, 1992, PROG NEUROBIOL, V39, P113, DOI 10.1016/0301-0082(92)90007-2; Bhaskaran MD, 2010, EXP NEUROL, V223, P529, DOI 10.1016/j.expneurol.2010.01.021; Birder LA, 2002, NAT NEUROSCI, V5, P856, DOI 10.1038/nn902; Brenner RP, 2004, J CLIN NEUROPHYSIOL, V21, P319; Chaves ML, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-6; Cohen AS, 2003, EUR J NEUROSCI, V17, P1607, DOI 10.1046/j.1460-9568.2003.02597.x; Coulter DA, 1996, EPILEPSY RES, V26, P81, DOI 10.1016/S0920-1211(96)00044-7; de Oliveira DL, 2008, EPILEPSIA, V49, P842, DOI 10.1111/j.1528-1167.2007.01484.x; Donato R, 1999, BBA-MOL CELL RES, V1450, P191, DOI 10.1016/S0167-4889(99)00058-0; Dudek FE, 2010, EPILEPSIA, V51, P126, DOI 10.1111/j.1528-1167.2010.02626.x; Fu M, 2009, MED HYPOTHESES, V73, P100, DOI 10.1016/j.mehy.2009.01.005; Golarai G, 2001, J NEUROSCI, V21, P8523; GRIFFIN WST, 1995, J NEUROCHEM, V65, P228; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; HOUSER CR, 1990, BRAIN RES, V535, P195, DOI 10.1016/0006-8993(90)91601-C; Hsieh CL, 2009, AM J CHINESE MED, V37, P351, DOI 10.1142/S0192415X09006898; Hsieh CL, 1999, AM J CHINESE MED, V27, P257, DOI 10.1142/S0192415X9900029X; Hughes PE, 1996, NEUROSCIENCE, V74, P1143, DOI 10.1016/S0306-4522(96)00174-1; Ichikawa H, 1997, BRAIN RES, V748, P253, DOI 10.1016/S0006-8993(96)01364-9; ISOBE T, 1981, J NEUROCHEM, V37, P522, DOI 10.1111/j.1471-4159.1981.tb00488.x; Kang JQ, 2009, TRENDS MOL MED, V15, P430, DOI 10.1016/j.molmed.2009.07.003; Kang N, 2004, J NEUROPHYSIOL, V92, P873, DOI 10.1152/jn.01231.2003; Kang TH, 2002, EUR J PHARMACOL, V455, P27, DOI 10.1016/S0014-2999(02)02581-5; Kapur J, 1997, J NEUROSCI, V17, P7532, DOI 10.1523/jneurosci.17-19-07532.1997; KAPUR N, 1994, NEUROPSYCHOLOGIA, V32, P23, DOI 10.1016/0028-3932(94)90066-3; Kim YB, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-42; Kohling R, 2000, J NEUROSCI, V20, P6820, DOI 10.1523/JNEUROSCI.20-18-06820.2000; Lee J, 2003, NEUROSCI LETT, V348, P51, DOI 10.1016/S0304-3940(03)00613-X; Llinas RR, 1999, P NATL ACAD SCI USA, V96, P15222, DOI 10.1073/pnas.96.26.15222; Marsch R, 2007, J NEUROSCI, V27, P832, DOI 10.1523/JNEUROSCI.3303-06.2007; MOORE BW, 1965, BIOCHEM BIOPH RES CO, V19, P739, DOI 10.1016/0006-291X(65)90320-7; Morochovic R, 2009, EUR J NEUROL, V16, P1112, DOI 10.1111/j.1468-1331.2009.02653.x; Nadkarni Suhita, 2005, Journal of Integrative Neuroscience, V4, P207, DOI 10.1142/S0219635205000811; Qi JS, 2006, J PHYSIOL-LONDON, V577, P579, DOI 10.1113/jphysiol.2006.113134; Raedt R, 2009, ACTA NEUROL SCAND, V119, P293, DOI 10.1111/j.1600-0404.2008.01108.x; Rao MS, 2006, J NEUROSCI RES, V83, P1088, DOI 10.1002/jnr.20802; Rathore C, 2009, EPILEPSIA, V50, P2249, DOI 10.1111/j.1528-1167.2009.02300.x; RICKMANN M, 1995, NEUROSCIENCE, V67, P977, DOI 10.1016/0306-4522(94)00615-C; Rubenstein JLR, 2003, GENES BRAIN BEHAV, V2, P255, DOI 10.1034/j.1601-183X.2003.00037.x; Sakatani S, 2007, EUR J NEUROSCI, V25, P1144, DOI 10.1111/j.1460-9568.2007.05337.x; Schramm J, 2008, NEUROSURGERY, V62, P463, DOI [10.1227/01.neu.0000316250.69898.23, 10.1227/01.NEU.0000297106.65002.1F]; SELINFREUND RH, 1991, P NATL ACAD SCI USA, V88, P3554, DOI 10.1073/pnas.88.9.3554; Shan Y, 1997, EXP NEUROL, V144, P406, DOI 10.1006/exnr.1997.6427; SHASHOUA VE, 1984, J NEUROCHEM, V42, P1536, DOI 10.1111/j.1471-4159.1984.tb12739.x; Shimada Y, 1999, J PHARM PHARMACOL, V51, P715, DOI 10.1211/0022357991772853; Sieghart W., 2002, Current Topics in Medicinal Chemistry, V2, P795, DOI 10.2174/1568026023393507; Talathi SS, 2009, NEUROSCI LETT, V455, P145, DOI 10.1016/j.neulet.2009.03.057; Tang NY, 2010, AM J CHINESE MED, V38, P251, DOI 10.1142/S0192415X10007828; TAUCK DL, 1985, J NEUROSCI, V5, P1016; Wassef A, 2003, J CLIN PSYCHOPHARM, V23, P601, DOI 10.1097/01.jcp.0000095349.32154.a5; WILLIAMS S, 1993, NEUROSCIENCE, V52, P541, DOI 10.1016/0306-4522(93)90404-4; WINNINGHAMMAJOR F, 1989, J CELL BIOL, V109, P3063, DOI 10.1083/jcb.109.6.3063	54	18	19	0	17	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0378-8741			J ETHNOPHARMACOL	J. Ethnopharmacol.	MAY 17	2011	135	2					313	320		10.1016/j.jep.2011.03.018			8	Plant Sciences; Chemistry, Medicinal; Integrative & Complementary Medicine; Pharmacology & Pharmacy	Plant Sciences; Pharmacology & Pharmacy; Integrative & Complementary Medicine	778PG	WOS:000291716000013	21402140				2021-06-18	
J	Barry, CM; Helps, SC; van den Heuvel, C; Vink, R				Barry, Christine M.; Helps, Stephen C.; van den Heuvel, Corinna; Vink, Robert			Characterizing the role of the neuropeptide substance P in experimental subarachnoid hemorrhage	BRAIN RESEARCH			English	Article						Subarachnoid hemorrhage; Brain edema; Substance P; Neurological outcome; Intracranial pressure	TRAUMATIC BRAIN-INJURY; FUNCTIONAL DEFICITS; HYPERBARIC-OXYGEN; RAT MODEL; EDEMA; STROKE	Background: Raised intracranial pressure (ICP) following SAH predicts poor outcome and is due to hemorrhage volume and possibly, brain edema, hydrocephalus and increased volume of circulating intracranial blood. Interventions that reduce edema may therefore reduce ICP and improve outcome. The neuropeptide substance P (SP) mediates vasogenic edema formation in animal models of ischemic stroke, intracerebral hemorrhage and brain trauma, and may contribute to development of increased ICP. SP (NK1 tachykinin receptor) blockade using n-acetyl-1-tryptophan (NAT) reduces edema and improves outcome in these models. This study therefore assessed whether SP mediates edema formation in experimental SAH. Methods: SAH was induced in rats by either injection of autologous blood into the prechiasmatic cistern (injection SAN) or by arterial puncture of the Circle of Willis (filament SAN). NAT was injected (i.v.) 30 min after SAH induction. Subgroups were assessed for brain water content, SP and albumin immunoreactivity, and functional outcome at 5, 24 and 48 h or ICP over 5 h. Results: A secondary ICP increase occurred within 2 h of SAH. Brain edema followed filament SAH (p < 0.001) and correlated with functional deficits (r = 0.8, p < 0.01). Increased albumin immunoreactivity (p < 0.001) indicated vasogenic edema. However, NAT treatment did not improve ICP, edema or outcome. Conclusions: Experimental SAN produced secondary ICP elevation, vasogenic brain edema and functional deficits, although it is unclear if edema contributed to ICP. Blockade of SP did not improve any outcome parameters, suggesting that neurogenic inflammation may be less critical than other factors in these models. (C) 2011 Elsevier B.V. All rights reserved.	[Barry, Christine M.] Univ Adelaide, Sch Med Sci, Discipline Anat & Pathol, Adelaide, SA 5005, Australia; Univ Adelaide, Sch Med Sci, Adelaide Ctr Neurosci Res, Adelaide, SA 5005, Australia	Barry, CM (corresponding author), Univ Adelaide, Sch Med Sci, Discipline Anat & Pathol, Adelaide, SA 5005, Australia.	Christine.barry@adelaide.edu.au	Vink, Robert/J-7351-2012; AM, Robert Vink/S-5616-2019; Barry, Christine/M-6775-2018	Vink, Robert/0000-0002-4885-0667; AM, Robert Vink/0000-0002-4885-0667; Barry, Christine/0000-0002-5227-3524	Neurosurgical Research Foundation (Australia); National Stroke Foundation of Australia	Supported, in part, by the Neurosurgical Research Foundation (Australia) and the National Stroke Foundation of Australia.	BEDERSON JB, 1986, STROKE, V17, P472, DOI 10.1161/01.STR.17.3.472; BEDERSON JB, 1995, STROKE, V26, P1086, DOI 10.1161/01.STR.26.6.1086; Claassen J, 2002, STROKE, V33, P1225, DOI 10.1161/01.STR.0000015624.29071.1F; Donkin JJ, 2009, J CEREBR BLOOD F MET, V29, P1388, DOI 10.1038/jcbfm.2009.63; DONKIN JJ, 2006, DISCIPLINE PATHOLOGY, P308; Gao C, 2008, AUTON NEUROSCI-BASIC, V141, P22, DOI 10.1016/j.autneu.2008.04.007; Huang J, 2002, NEUROSURGERY, V51, P1101, DOI 10.1097/00006123-200211000-00001; Huang ZX, 2007, BRAIN RES, V1153, P204, DOI 10.1016/j.brainres.2007.03.061; Ingall T, 2000, STROKE, V31, P1054, DOI 10.1161/01.STR.31.5.1054; JOHSHITA H, 1990, STROKE, V21, P1051, DOI 10.1161/01.STR.21.7.1051; Kleinig TJ, 2010, STROKE, V41, pE212; Li ZQ, 2009, BRAIN RES, V1264, P98, DOI 10.1016/j.brainres.2009.01.055; Nimmo AJ, 2004, NEUROPEPTIDES, V38, P40, DOI 10.1016/j.npep.2003.12.003; O'Connor CA, 2005, BRAIN RES, V1062, P171, DOI 10.1016/j.brainres.2005.09.011; Ostrowski RP, 2005, J CEREBR BLOOD F MET, V25, P554, DOI 10.1038/sj.jcbfm.9600048; Park S, 2004, STROKE, V35, P2412, DOI 10.1161/01.STR.0000141162.29864.e9; Prunell GF, 2002, NEUROREPORT, V13, P2553, DOI 10.1097/00001756-200212200-00034; Ruifrok AC, 2001, ANAL QUANT CYTOL, V23, P291; Scholler K, 2007, BRAIN RES, V1142, P237, DOI 10.1016/j.brainres.2007.01.034; THAL SC, 2009, J NEUROSURG; Thal SC, 2008, J NEUROL SCI, V268, P150, DOI 10.1016/j.jns.2007.12.002; Turner RJ, 2006, ACTA NEUROCHIR SUPPL, V96, P263; Vink R, 2010, NEUROTHERAPEUTICS, V7, P74, DOI 10.1016/j.nurt.2009.10.018; Yatsushige H, 2007, J NEUROSCI RES, V85, P1436, DOI 10.1002/jnr.21281; Yatsushige H, 2006, J NEUROTRAUM, V23, P1874, DOI 10.1089/neu.2006.23.1874	25	18	18	0	8	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993			BRAIN RES	Brain Res.	MAY 10	2011	1389						143	151		10.1016/j.brainres.2011.02.082			9	Neurosciences	Neurosciences & Neurology	767VK	WOS:000290886300015	21377453				2021-06-18	
J	Darling, SR; Schaubel, DE; Baker, JG; Leddy, JJ; Bisson, LJ; Willer, B				Darling, Scott R.; Schaubel, Douglas E.; Baker, John G.; Leddy, John J.; Bisson, Leslie J.; Willer, Barry			Intentional versus unintentional contact as a mechanism of injury in youth ice hockey	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article							BODY-CHECKING; HIGH-SCHOOL; RATES; BODYCHECKING; SPORTS; SAFETY; RISK	Background Youth ice hockey injury rates and mechanisms have been described by various classification systems. Intentional versus unintentional contact was used to classify mechanisms of injuries. All injuries (n=247) in one youth hockey programme over a 5-year period were recorded and included in the analysis. Purpose To evaluate youth ice hockey injuries and compare programmes that allow body checking versus programmes that do not allow body checking. A primary goal was to determine whether programmes that allow body checking have increased injury rates from intentional body contact. Another goal was to describe the rates of injury across ages, levels of competitive play and during games versus practices. Methods Rates of injury were compared for three levels of competition (house, select and representative) for approximately 3000 boys aged 4-18 years over a 5-year period. This represents 13 292 player years. Data were collected prospectively in this cohort study. All injuries were reported prospectively by a designated team official and verified by a physician. The log injury rate (per 1000 player hours) was modelled via Poisson regression with log player hours used as an offset. Rate ratio was used to explain the covariate-adjusted injury rate for each of three groups (all injuries, intentional injuries, unintentional injuries). Results Unintentional contacts accounted for 66.0% of overall injuries (95% CI 60.0 to 72.0), compared with 34.0% from intentional contacts (p < 0.001; Z=5.25). Serious injuries (fractures, dislocations, concussions) resulted more often from unintentional collisions (p=0.04). Players in more competitive leagues that allow body checking had a greater incidence of total injuries than less competitive leagues. Conclusions Most injuries in the youth hockey programme studied were the result of unintentional contact, and were generally more severe. These findings were not expected given previously published research.	[Darling, Scott R.] SUNY Buffalo, Dept Orthopaed, Buffalo, NY 14214 USA; [Schaubel, Douglas E.] Univ Michigan, Ann Arbor, MI 48109 USA	Darling, SR (corresponding author), SUNY Buffalo, Dept Orthopaed, 160 Farber Hall,3435 Main St, Buffalo, NY 14214 USA.	sdarling@buffalo.edu			Burlington Lions Optimists Minor Hockey Association officials	The authors wish to acknowledge the support of the Burlington Lions Optimists Minor Hockey Association officials, parents and players for allowing access to injury reports. The authors also want to acknowledge this organisation and Hockey Canada for their commitment to the culture of safety in hockey.	Anderson AJ, 2000, PEDIATRICS, V105, P657; Benson Brian W, 2005, Med Sport Sci, V49, P86, DOI 10.1159/000085393; Cantu RC, 1999, PHYSICIAN SPORTSMED, V27, P35, DOI 10.3810/psm.1999.08.945; Cheng T L, 1999, Inj Prev, V5, P59; DAFFNER RH, 1977, J FAM PRACTICE, V4, P225; Emery CA, 2006, AM J SPORT MED, V34, P1960, DOI 10.1177/0363546506290061; GERBERICH SG, 1987, CHILD NERV SYST, V3, P59, DOI 10.1007/BF00271123; Hagel BE, 2006, CAN MED ASSOC J, V175, P155, DOI 10.1503/cmaj.051531; Koh JO, 2003, BRAIN INJURY, V17, P901, DOI 10.1080/0269905031000088869; Macpherson A, 2006, PEDIATRICS, V117, pE143, DOI 10.1542/peds.2005-1163; Marchie A, 2003, CAN MED ASSOC J, V169, P124; Roberts WO, 1999, PHYSICIAN SPORTSMED, V27, P35, DOI 10.3810/psm.1999.11.1102; Roberts WO, 1999, MED SCI SPORT EXER, V31, P46, DOI 10.1097/00005768-199901000-00009; STUART M, 2000, PRINCIPLES ICE HOCKE, P19; STUART MJ, 1995, MAYO CLIN PROC, V70, P350, DOI 10.4065/70.4.350; Sutherland G W, 1976, Am J Sports Med, V4, P264, DOI 10.1177/036354657600400605; Willer B, 2005, MED SCI SPORT EXER, V37, P1658, DOI 10.1249/01.mss.0000181839.86170.06	17	18	18	0	9	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674			BRIT J SPORT MED	Br. J. Sports Med.	MAY	2011	45	6					492	U194		10.1136/bjsm.2009.063693			6	Sport Sciences	Sport Sciences	746XM	WOS:000289282900008	20484317				2021-06-18	
J	Oliva, AA; Kang, Y; Truettner, JS; Sanchez-Molano, J; Furones, C; Yool, AJ; Atkins, CM				Oliva, A. A., Jr.; Kang, Y.; Truettner, J. S.; Sanchez-Molano, J.; Furones, C.; Yool, A. J.; Atkins, C. M.			FLUID-PERCUSSION BRAIN INJURY INDUCES CHANGES IN AQUAPORIN CHANNEL EXPRESSION	NEUROSCIENCE			English	Article						aquaporin; edema; fluid-percussion; traumatic brain injury; water channel	AQP4 EXPRESSION; WATER TRANSPORT; RAT-BRAIN; EDEMA; LACTATE; HOMEOSTASIS; ASTROCYTE; TRAUMA; CELLS; MODEL	Edema, the accumulation of excess fluid, is a major pathological change in the brain that contributes significantly to pathology and mortality after moderate to severe brain injury. Edema is regulated by aquaporin (AQP) channels which transport water across cellular membranes. Six AQPs are found in the brain (1, 3, 4, 5, 8, and 9), and previous studies have found that AQP4 is regulated after traumatic brain injury (TBI). To further understand how AQPs contribute to brain edema, we investigated whether expression of AQP1, 3, and 9 are also regulated after TBI. Adult male Sprague Dawley rats received moderate parasagittal fluid-percussion brain injury (FPI) or sham surgery. After induction of FPI, the injured, ipsilateral parietal cortex and hippocampus were dissected and analyzed by Western blotting. We observed a small decrease in AQP3 and 4 levels at 7 days after FPI in the ipsilateral, parietal cortex. Both AQP1 and 9 significantly increased within 30 min post-injury and remained elevated for up to 6 h in the ipsilateral, parietal cortex. Aqp1 and 9 mRNA levels were also significantly increased at 30 min post-FPI. Administration of an AQP1 and 4 antagonist, AqB013, non-significantly increased brain water content in sham, non-injured animals, and did not prevent edema formation 24 h after trauma in either the parietal cortex or hippocampus. These results indicate that Aqp1 and 9 mRNA and protein levels increase after moderate parasagittal FPI and that an inhibitor of AQP1 and 4 does not decrease edema after moderate parasagittal FPI. (c) 2011 IBRO. Published by Elsevier Ltd. All rights reserved.	[Atkins, C. M.] Univ Miami, Miller Sch Med, Miami Project Cure Paralysis, Dept Neurol Surg, Miami, FL 33136 USA; [Yool, A. J.] Univ Adelaide, Sch Mol & Biomed Sci, Discipline Physiol, Adelaide, SA, Australia	Atkins, CM (corresponding author), Univ Miami, Miller Sch Med, Miami Project Cure Paralysis, Dept Neurol Surg, POB 016960 R-48, Miami, FL 33136 USA.	catkins@med.miami.edu	Yool, Andrea/AAK-9907-2020	Yool, Andrea/0000-0003-1283-585X; Atkins, Coleen/0000-0003-4718-7493	The Miami Project to Cure Paralysis; The Buoniconti Fund to Cure Paralysis; the Channel 7 Children's Research Foundation, Australia	This work was supported by The Miami Project to Cure Paralysis, The Buoniconti Fund to Cure Paralysis, and the Channel 7 Children's Research Foundation, Australia. We thank Dr. C. Falo for scientific input, Dr. G. Flynn for providing AqB013, and Drs. Helen Bramlett and Michael Norenberg for critical reading of the manuscript.	Agre P, 2004, NEUROSCIENCE, V129, P849, DOI 10.1016/j.neuroscience.2004.10.001; Arima H, 2003, J BIOL CHEM, V278, P44525, DOI 10.1074/jbc.M304368200; Badaut J, 2004, NEUROSCIENCE, V129, P971, DOI 10.1016/j.neuroscience.2004.06.035; Badaut J, 2004, NEUROSCIENCE, V128, P27, DOI 10.1016/j.neuroscience.2004.05.042; Badaut J, 2001, J CEREBR BLOOD F MET, V21, P477, DOI 10.1097/00004647-200105000-00001; Chen T, 2000, ACT NEUR S, V76, P359; D'Ambrosio R, 1999, J NEUROSCI, V19, P8152; Ding JY, 2009, NEUROSCI LETT, V453, P68, DOI 10.1016/j.neulet.2009.01.077; Donkin JJ, 2010, CURR OPIN NEUROL, V23, P293, DOI 10.1097/WCO.0b013e328337f451; Elkjaer ML, 2000, BIOCHEM BIOPH RES CO, V276, P1118, DOI 10.1006/bbrc.2000.3505; Guo QM, 2006, EXP NEUROL, V198, P469, DOI 10.1016/j.expneurol.2005.12.013; Higashida T, 2011, J NEUROSURG, V114, P92, DOI 10.3171/2010.6.JNS10207; Hwang IK, 2007, J NEUROSCI RES, V85, P2470, DOI 10.1002/jnr.21381; KAWAMATA T, 1995, BRAIN RES, V674, P196, DOI 10.1016/0006-8993(94)01444-M; Ke CS, 2001, NEUROSCI LETT, V301, P21, DOI 10.1016/S0304-3940(01)01589-0; Kiening KL, 2002, NEUROSCI LETT, V324, P105, DOI 10.1016/S0304-3940(02)00180-5; Kim SW, 2001, J AM SOC NEPHROL, V12, P2019, DOI 10.1681/ASN.V12102019; Lescot T, 2010, J NEUROTRAUM, V27, P85, DOI 10.1089/neu.2009.0982; Levasseur JE, 2006, NEUROSURGERY, V59, P1122, DOI 10.1227/01.NEU.0000245581.00908.AF; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Manley GT, 2000, NAT MED, V6, P159, DOI 10.1038/72256; Manley GT, 2004, NEUROSCIENCE, V129, P983, DOI 10.1016/j.neuroscience.2004.06.088; Marcoux J, 2008, CRIT CARE MED, V36, P2871, DOI 10.1097/CCM.0b013e318186a4a0; Marmarou A, 2006, J NEUROSURG, V104, P720, DOI 10.3171/jns.2006.104.5.720; Marmarou Anthony, 2007, Neurosurg Focus, V22, pE1; Matsuzaki T, 1999, J HISTOCHEM CYTOCHEM, V47, P1275, DOI 10.1177/002215549904701007; Migliati E, 2009, MOL PHARMACOL, V76, P105, DOI 10.1124/mol.108.053744; Misawa T, 2008, ACTA NEUROPATHOL, V116, P247, DOI 10.1007/s00401-008-0387-x; Nesic O, 2008, J NEUROCHEM, V105, P628, DOI 10.1111/j.1471-4159.2007.05177.x; Newcombe VFJ, 2008, ACTA NEUROCHIR SUPPL, V102, P247, DOI 10.1007/978-3-211-85578-2_47; Nielsen S, 1997, J NEUROSCI, V17, P171; Papadopoulos MC, 2004, FASEB J, V18, P1291, DOI 10.1096/fj.04-1723fje; Park E, 2009, J CEREBR BLOOD F MET, V29, P575, DOI 10.1038/jcbfm.2008.151; Pasco A, 2007, J NEUROTRAUM, V24, P1321, DOI 10.1089/neu.2006.0136; Rash JE, 1998, P NATL ACAD SCI USA, V95, P11981, DOI 10.1073/pnas.95.20.11981; Rojek AM, 2007, P NATL ACAD SCI USA, V104, P3609, DOI 10.1073/pnas.0610894104; Roudier N, 1998, J BIOL CHEM, V273, P8407, DOI 10.1074/jbc.273.14.8407; Speake T, 2003, BBA-BIOMEMBRANES, V1609, P80, DOI 10.1016/S0005-2736(02)00658-2; Stein SC, 2010, J NEUROTRAUM, V27, P1343, DOI 10.1089/neu.2009.1206; Sun MC, 2003, J NEUROSURG, V98, P565, DOI 10.3171/jns.2003.98.3.0565; Taya K, 2008, ACTA NEUROCHIR SUPPL, V102, P425, DOI 10.1007/978-3-211-85578-2_83; Tomura S, 2011, J NEUROTRAUM, V28, P237, DOI 10.1089/neu.2010.1443; Tran ND, 2010, J NEUROSURG, V112, P1095, DOI 10.3171/2009.8.JNS081704; Umenishi F, 2003, J BIOL CHEM, V278, P15765, DOI 10.1074/jbc.M209980200; Venero JL, 2001, PROG NEUROBIOL, V63, P321, DOI 10.1016/S0301-0082(00)00035-6; Verkman AS, 2006, BBA-BIOMEMBRANES, V1758, P1085, DOI 10.1016/j.bbamem.2006.02.018; Wilson AJ, 2010, CELL TISSUE RES, V340, P159, DOI 10.1007/s00441-010-0927-2; Zhang GW, 2010, J ETHNOPHARMACOL, V128, P433, DOI 10.1016/j.jep.2010.01.032; Zhao J, 2005, J NEUROSCI RES, V82, P499, DOI 10.1002/jnr.20649; Zhou SN, 2008, NEUROL RES, V30, P400, DOI 10.1179/174313208X300431	50	18	18	1	4	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	APR 28	2011	180						272	279		10.1016/j.neuroscience.2011.02.020			8	Neurosciences	Neurosciences & Neurology	748MV	WOS:000289395600028	21329742				2021-06-18	
J	Zhao, J; Redell, JB; Moore, AN; Dash, PK				Zhao, Jing; Redell, John B.; Moore, Anthony N.; Dash, Pramod K.			A novel strategy to activate cytoprotective genes in the injured brain	BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS			English	Article						Blood-brain barrier; Cytoprotective genes; Keap1; Nrf2; Peptide-based therapy; TBI	CORTICAL IMPACT MODEL; INDUCED AXONAL INJURY; CLOSED-HEAD INJURY; MU-CALPAIN; PROTEOLYSIS; PROTECTS; NRF2; RAT; EXPRESSION; INDUCTION	The transcription factor nuclear factor E2-related factor 2 (Nrf2) regulates the expression of multiple cytoprotective genes that have been shown to offer protection in response to a number of insults. The present study describes a novel strategy to increase expression of Nrf2-responsive genes in brain injured mice. Under normal conditions, the adapter protein Kelch-like ECH-associated protein 1 (Keap1) binds to Nrf2 and promotes its proteosomal degradation in the cytoplasm. The amino acid sequence DEETGE, located at amino acid 77-82 of Nrf2, is critical for Nr12-Keap1 interaction, and synthetic peptides containing this sequence can be used to disrupt the complex in vitro. We observed that intracerebroventricular (i.c.v.) infusion of a peptide containing the DEETGE sequence along with the cell transduction domain of the HIV-TAT protein (TAT-DEETGE) into brain-injured mice did not increase the mRNA levels for Nrf2-driven genes. However, when a calpain cleavage sequence was introduced between the TAT sequence and the DEETGE sequence, the new peptide (TAT-CAL-DEETGE) increased the mRNA levels of these genes. Increased gene expression was not observed when the TAT-CAL-DEETGE peptide was injected into uninjured animals. Furthermore, injection of TAT-CAL-DEETGE peptides before or after brain injury reduced blood-brain barrier compromise, a prominent secondary pathology that negatively influences outcome. The present strategy to increase Nrf2-responsive gene expression can be adapted to treat other insults or diseases based on their underlying mechanism(s) of cellular damage. (C) 2011 Elsevier Inc. All rights reserved.	[Zhao, Jing; Redell, John B.; Moore, Anthony N.; Dash, Pramod K.] Univ Texas Med Sch, Dept Neurobiol & Anat, Houston, TX 77225 USA	Dash, PK (corresponding author), Univ Texas Med Sch, Dept Neurobiol & Anat, POB 20708, Houston, TX 77225 USA.	Jing.Zhao@uth.tmc.edu; John.B.Redell@uth.tmc.edu; Anthony.N.Moore@uth.tmc.edu; p.dash@uth.tmc.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS049160, NS053588, MH072933]; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH072933] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS049160, R01NS053588] Funding Source: NIH RePORTER	The authors thank the members of the Dash Laboratory for their insightful comments, suggestions and critical reading of the manuscript. This work was supported by research grants (NS049160, NS053588 and MH072933) from the National Institutes of Health. The sponsors had no role in the study design, in the collection, analysis or interpretation of data, nor did they have any influence on the decision to submit our findings for publication.	Buki A, 2003, J NEUROTRAUM, V20, P261, DOI 10.1089/089771503321532842; Buki A, 1999, J NEUROPATH EXP NEUR, V58, P365; Cuerrier D, 2005, J BIOL CHEM, V280, P40632, DOI 10.1074/jbc.M506870200; DASH PK, 1995, J NEUROSCI, V15, P2030; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Ho A, 2001, CANCER RES, V61, P474; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Kampfl A, 1997, J NEUROTRAUM, V14, P121, DOI 10.1089/neu.1997.14.121; Kampfl A, 1996, J NEUROCHEM, V67, P1575; Kang MI, 2004, P NATL ACAD SCI USA, V101, P2046, DOI 10.1073/pnas.0308347100; Lo SC, 2006, EMBO J, V25, P3605, DOI 10.1038/sj.emboj.7601243; MEANEY DF, 1994, J NEUROTRAUM, V11, P599, DOI 10.1089/neu.1994.11.599; Okonkwo DO, 1999, NEUROREPORT, V10, P353, DOI 10.1097/00001756-199902050-00026; Pike BR, 1998, NEUROREPORT, V9, P2437, DOI 10.1097/00001756-199808030-00002; Ping Z, 2010, BRAIN RES, V1343, P178, DOI 10.1016/j.brainres.2010.04.036; Ray SK, 2003, CNS NEUROL DISORD-DR, V2, P173, DOI 10.2174/1568007033482887; Redell JB, 2003, EXP BIOL MED, V228, P261; Saatman KE, 2010, NEUROTHERAPEUTICS, V7, P31, DOI 10.1016/j.nurt.2009.11.002; SHAPIRA Y, 1993, ANESTH ANALG, V77, P141; SHOHAMI E, 1994, ACTA NEUROCHIR, P443; Son TG, 2010, J NEUROCHEM, V112, P1316, DOI 10.1111/j.1471-4159.2009.06552.x; Yang CH, 2009, BRAIN RES, V1282, P133, DOI 10.1016/j.brainres.2009.05.009; Zhao J, 2007, J NEUROSCI, V27, P10240, DOI 10.1523/JNEUROSCI.1683-07.2007; Zhao XR, 2007, STROKE, V38, P3280, DOI 10.1161/STROKEAHA.107.486506	24	18	18	0	6	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0006-291X	1090-2104		BIOCHEM BIOPH RES CO	Biochem. Biophys. Res. Commun.	APR 15	2011	407	3					501	506		10.1016/j.bbrc.2011.03.046			6	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	755TB	WOS:000289958500011	21414291	Green Accepted			2021-06-18	
J	Fahlenkamp, AV; Coburn, M; Czaplik, M; Ryang, YM; Kipp, M; Rossaint, R; Beyer, C				Fahlenkamp, Astrid V.; Coburn, Mark; Czaplik, Michael; Ryang, Yu-Mi; Kipp, Markus; Rossaint, Rolf; Beyer, Cordian			Expression analysis of the early chemokine response 4 h after in vitro traumatic brain injury	INFLAMMATION RESEARCH			English	Article						Brain trauma; Neuroinflammation; Cytokines; Chemokines; Array	ENDOTHELIAL-CELLS; SLICE CULTURES; RAT; PATHOPHYSIOLOGY; CYTOKINES; MCP-1; MODEL	The importance of cytokine- and chemokine-mediated neuroinflammation in the progress of brain injury is becoming increasingly evident. We investigated the early local cytokine and chemokine expression and the development of tissue injury after moderate mechanical hippocampus trauma. Mouse organotypic hippocampal slice cultures. Drop-weight trauma in the CA1 region of the hippocampus. Staining of necrotic tissue, PCR array and evaluation, real-time PCR, statistical analysis with a two-tailed, independent t test. At 12 and 24 h after trauma, the tissue injury spread from the primary mechanical lesion to the entire hippocampal formation. A pronounced up-regulation of distinct chemokine transcripts was found 4 h after in vitro traumatic brain injury which preceded the development of the secondary injury. The enhanced expression of inflammatory genes might contribute to the development of the secondary trauma and could pinpoint future neuroinflammatory and neuroprotective targets for research and treatment.	[Fahlenkamp, Astrid V.; Coburn, Mark; Czaplik, Michael; Rossaint, Rolf] Rhein Westfal TH Aachen, Univ Hosp Aachen, Dept Anesthesiol, D-52074 Aachen, Germany; [Fahlenkamp, Astrid V.; Kipp, Markus; Beyer, Cordian] Rhein Westfal TH Aachen, Fac Med, Inst Neuroanat, D-52074 Aachen, Germany; [Ryang, Yu-Mi] Tech Univ Munich, Dept Neurosurg, Klinikum Rechts Isar, D-81675 Munich, Germany	Coburn, M (corresponding author), Rhein Westfal TH Aachen, Univ Hosp Aachen, Dept Anesthesiol, Pauwelsstr 30, D-52074 Aachen, Germany.	mcoburn@ukaachen.de	Czaplik, Michael/G-1120-2012; Kipp, Markus/K-2694-2015; Ryang, Yu-Mi/Q-8373-2016	Ryang, Yu-Mi/0000-0002-9045-5038; Coburn, Mark/0000-0002-7930-0270	AVF (Forschungsrotation); AVF (START)Austrian Science Fund (FWF)	We would like to thank J. Hoffmann and R. Blaumeiser-Debarry for their excellent technical assistance. The study was supported by two grants allocated to AVF (Forschungsrotation and START, both RWTH Aachen University) and two grants allocated to MK (Hertie-Stiftung; START, RWTH Aachen University).	Adamchik Y, 2000, BRAIN RES PROTOC, V5, P153, DOI 10.1016/S1385-299X(00)00007-6; [Anonymous], IMAGEJ IMAGE PROCESS; Babcock AA, 2003, J NEUROSCI, V23, P7922; Coburn M, 2008, CRIT CARE MED, V36, P588, DOI 10.1097/01.CCM.0B013E3181611F8A6; Cross AK, 1999, J NEUROSCI RES, V55, P17, DOI 10.1002/(SICI)1097-4547(19990101)55:1<17::AID-JNR3>3.0.CO;2-J; Di Pietro V, 2010, J NEUROTRAUM, V27, P349, DOI 10.1089/neu.2009.1095; Fahlenkamp AV, 2011, J MOL NEUROSCI, V45, P48, DOI 10.1007/s12031-010-9432-z; Ghirnikar RS, 1998, NEUROCHEM RES, V23, P329, DOI 10.1023/A:1022453332560; Ghirnikar RS, 1996, J NEUROSCI RES, V46, P727; Israelsson C, 2008, J NEUROTRAUM, V25, P959, DOI 10.1089/neu.2008.0562; Israelsson C, 2010, EUR J NEUROSCI, V31, P852, DOI 10.1111/j.1460-9568.2010.07105.x; Loetscher PD, 2009, CRIT CARE, V13, DOI 10.1186/cc8214; Lumpkins K, 2008, J TRAUMA, V64, P358, DOI 10.1097/TA.0b013e318160df9b; Morganti-Kossmann MC, 2007, INJURY, V38, P1392, DOI 10.1016/j.injury.2007.10.005; Morrison B, 1998, J NEUROTRAUM, V15, P911, DOI 10.1089/neu.1998.15.911; Morrison B, 2000, NEUROSCIENCE, V96, P131, DOI 10.1016/S0306-4522(99)00537-0; Omari KM, 2004, J NEUROIMMUNOL, V146, P203, DOI 10.1016/j.jneuroim.2003.10.032; Rhodes JKJ, 2009, J NEUROTRAUM, V26, P507, DOI 10.1089/neu.2008.0686; Rossaint J, 2009, CRIT CARE, V13, DOI 10.1186/cc7795; *SABIOSCIENCES, SABIOSCIENCES WEB BA; Semple BD, 2010, J CEREBR BLOOD F MET, V30, P769, DOI 10.1038/jcbfm.2009.262; Stefini R, 2008, J NEUROSURG, V108, P958, DOI 10.3171/JNS/2008/108/5/0958; Szczucinski A, 2007, EUR NEUROL, V58, P228, DOI 10.1159/000107945; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Woller G, 2008, J LEUKOCYTE BIOL, V83, P936, DOI 10.1189/jlb.0907592; Yates CC, 2008, AM J PATHOL, V173, P643, DOI 10.2353/ajpath.2008.070990; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	27	18	18	0	4	SPRINGER BASEL AG	BASEL	PICASSOPLATZ 4, BASEL, 4052, SWITZERLAND	1023-3830			INFLAMM RES	Inflamm. Res.	APR	2011	60	4					379	387		10.1007/s00011-010-0281-6			9	Cell Biology; Immunology	Cell Biology; Immunology	735XZ	WOS:000288455400009	21104293				2021-06-18	
J	Guillamondegui, OD; Richards, JE; Ely, EW; Jackson, JC; Archer-Swygert, K; Norris, PR; Obremskey, WT				Guillamondegui, Oscar D.; Richards, Justin E.; Ely, E. Wesley; Jackson, James C.; Archer-Swygert, Kristin; Norris, Patrick R.; Obremskey, William T.			Does Hypoxia Affect Intensive Care Unit Delirium or Long-Term Cognitive Impairment After Multiple Trauma Without Intracranial Hemorrhage?	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article; Proceedings Paper	69th Annual Meeting of the American-Association-for-the-Surgery-of-Trauma	SEP 22-25, 2010	Boston, MA	Amer Assoc Surg Trauma (AAST)		Hypoxia; Delirium; Cognitive impairment; Traumatic brain injury	BRAIN-INJURY; RISK-FACTORS; SURVIVORS; OUTCOMES; DECLINE	Background: Within the traumatic brain injury population, outcomes are affected by hypoxic events in the early injury period. Previous work shows a high prevalence of cognitive deficits in patients with multiple injuries who do not have intracranial hemorrhage identified on admission head computed tomography scan. We hypothesize that intensive care unit (ICU) delirium and long-term cognitive impairment (LTCI) are more likely in patients who have a hypoxic event within the first 48 hours of ICU admission. Methods: A total of 173 patients with multiple injuries (Injury Severity Score [ISS] > 15) who presented to a Level I trauma center from July 2006 to July 2007 were enrolled in a study on long-term cognitive deficit. Ninety-seven patients required ICU management and all had continuous oxygen saturation data collected. The Confusion Assessment Method for the ICU was collected twice a day on all patients in ICU. Of the total enrolled population, 108 (62%) were evaluated 12 months after discharge by neuropsychological tests. Cognitive impairment was defined as having 2 neuropsychological test scores, 1.5 standard deviations below the mean or 1 neuropsychological test score, and 2 standard deviations below the mean. Demographic data, ISS, initial 24-hour blood requirements, presence of hypoxia (SpO(2) <90% and <85%) or hypotension (systolic blood pressure <90 mm Hg), emergency department (ED) pulse, Glasgow Coma Scale score, ventilator and ICU days were recorded. Significant univariate identification of clinical variables was used for multivariate analysis. Results: Fifty-five of 97 ICU patients (57%) were Confusion Assessment Method-ICU positive for delirium and 59 of 108 (55%) demonstrated cognitive impairment at 12-month follow-up. There was no significant association between hypoxia and ICU delirium (74.5% vs. 74%; p = 0.9) or LTCI (89% vs. 83%; p = 0.5). Ventilator days (8.7 +/- 8.9 vs. 2.9 +/- 4.6; p < 0.0001), ED pulse (109 +/- 28.5 vs. 94 +/- 22.8; p = 0.01), and blood transfusions (10 U +/- 10.8 U vs. 5 U +/- 5.3 U; p = 0.015) were significant independent predictors of delirium. Ventilator days (odds ratio, 1.16; 95% confidence interval, 1.05-1.29; p = 0.004) and ED pulse (odds ratio, 1.02; 95% confidence interval, 1.00-1.04; p = 0.03) remained significant predictors of ICU delirium after adjusting for ISS, hypoxic state, blood transfusions, and ED blood pressure. Among ED Glasgow Coma Scale score (10.5 +/- 5.1 vs. 11.4 +/- 5.5; p = 0.7), ISS (33.3 +/- 10.1 vs. 32.2 +/- 9.0; p = 0.5), ventilator days (6.5 +/- 7.5 vs. 6.2 +/- 8.8; p = 0.4), blood transfusions (8.1 +/- 6.8 vs. 9.4 +/- 8.1; p = 0.4), and delirium (62% vs. 62.5%; p = 0.9), there were no significant univariate associations with LTCI. Conclusions: Hypoxic events in the ICU do not have a direct correlation with ICU delirium or LTCI in the patients with multiple injuries without evidence of intracranial hemorrhage.	[Guillamondegui, Oscar D.; Norris, Patrick R.] Vanderbilt Univ, Med Ctr, Div Trauma & Surg Crit Care, Nashville, TN USA; [Richards, Justin E.; Archer-Swygert, Kristin; Obremskey, William T.] Vanderbilt Univ, Med Ctr, Div Orthopaed Trauma, Dept Orthopaed & Rehabil, Nashville, TN USA; [Ely, E. Wesley; Jackson, James C.] Vanderbilt Univ, Med Ctr, Div Allergy Pulm Crit Care Med, Nashville, TN USA; [Guillamondegui, Oscar D.] Tennessee Valley Healthcare Syst Nashville VA, Nashville, TN USA	Guillamondegui, OD (corresponding author), 1211 21st Ave S,404 Med Arts Bldg, Nashville, TN 37212 USA.	oscar.guillamondegui@vanderbilt.edu	Ely, E. Wesley/Z-2018-2019	Ely, E. Wesley/0000-0003-3957-2172			ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Angles EM, 2008, AM J SURG, V196, P864, DOI 10.1016/j.amjsurg.2008.07.037; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Colantonio A, 2004, DISABIL REHABIL, V26, P253, DOI 10.1080/09638280310001639722; Control NCfIPa, 2003, REP C MILD TRAUM BRA; Dubois MJ, 2001, INTENS CARE MED, V27, P1297, DOI 10.1007/s001340101017; Ely EW, 2001, JAMA-J AM MED ASSOC, V286, P2703, DOI 10.1001/jama.286.21.2703; Hilsabeck RC, 2002, HEPATOLOGY, V35, P440, DOI 10.1053/jhep.2002.31257; Hoge CW, 2009, NEW ENGL J MED, V360, P1588, DOI 10.1056/NEJMp0810606; Jackson JC, 2007, J TRAUMA, V62, P80, DOI 10.1097/TA.0b013e31802ce9bd; Jackson JC, 2004, NEUROPSYCHOL REV, V14, P87, DOI 10.1023/B:NERV.0000028080.39602.17; Jackson JC, 2004, INTENS CARE MED, V30, P2009, DOI 10.1007/s00134-004-2422-2; JORM AF, 1994, PSYCHOL MED, V24, P145, DOI 10.1017/S003329170002691X; Kushner D, 1998, ARCH INTERN MED, V158, P1617, DOI 10.1001/archinte.158.15.1617; Norris PR, 2010, J HEALTHC ENG, V1, P315, DOI 10.1260/2040-2295.1.3.315; Ouimet S, 2007, INTENS CARE MED, V33, P66, DOI 10.1007/s00134-006-0399-8; Pandharipande P, 2008, J TRAUMA, V65, P34, DOI 10.1097/TA.0b013e31814b2c4d; Powell JM, 2008, ARCH PHYS MED REHAB, V89, P1550, DOI 10.1016/j.apmr.2007.12.035; Sigurdardottir S, 2009, J INT NEUROPSYCH SOC, V15, P740, DOI 10.1017/S1355617709990452; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009	21	18	22	0	9	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	APR	2011	70	4					910	913		10.1097/TA.0b013e3182114f18			4	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	750OV	WOS:000289558700031	21610396				2021-06-18	
J	Kuo, JR; Lo, CJ; Lu, CL; Chio, CC; Wang, CC; Lin, KC				Kuo, Jinn-Rung; Lo, Chong-Jeh; Lu, Chin-Li; Chio, Chung-Ching; Wang, Che-Chuan; Lin, Kao-Chang			Prognostic Predictors of Outcome in an Operative Series in Traumatic Brain Injury Patients	JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION			English	Article						craniectomy; injury severity score; prognostic factors; pupillary reaction; traumatic brain injury	SEVERE HEAD-INJURY; ACUTE SUBDURAL-HEMATOMA; DECOMPRESSIVE CRANIECTOMY; INTRACRANIAL-PRESSURE; COMA; MULTICENTER; SCALE	Background: Although several prognostic factors for traumatic brain injury (TBI) have been evaluated, a useful predictive scoring model for outcome has yet to be developed for TBI patients. The aim of this study was to determine independent predictors and develop a multivariate logistic regression equation to determine prognosis in TBI patients. Methods: A total of 13 different variables were evaluated. All 84 patients in this study were retrospectively evaluated between October 2003 and January 2008 and all underwent craniectomy or craniotomy for hematoma removal and were fitted with intracranial pressure (ICP) microsensor monitors. By using univariate, multiple logistic regression and prognostic regression scoring equations it was possible to draw Receiver-Operating Characteristic curves (ROC) to predict Glasgow Outcome Scale (GOS) 6 months after TBI. Results: We found that patients over 40 years of age (p<0.001), unresponsive pre-op pupil reaction (p=0.001), pre-op midline shift (p=0.008), higher injury severity score (ISS; p=0.007), and craniectomy (p<0.05) were associated with poor outcome in patients with TBI. Using ROC curve to predict the probability of unfavorable outcome, the sensitivity was 97.5% and the specificity was 90.7%. Conclusion: In our preliminary findings, five variables to predict poor outcomes 6 months after TB! were useful. These sensitive variables can be used as a referential guideline in our daily practice to decide whether or not to perform advanced management or avoid decompressive craniectomy.	[Lin, Kao-Chang] Chi Mei Med Ctr, Dept Neurol, Yung Kang 710, Tainan, Taiwan; [Kuo, Jinn-Rung] Natl Cheng Kung Univ, Sch Med, Inst Clin Med, Tainan 70101, Taiwan; [Kuo, Jinn-Rung; Chio, Chung-Ching; Wang, Che-Chuan] Chi Mei Med Ctr, Dept Neurosurg, Tainan, Taiwan; [Lu, Chin-Li] Chi Mei Med Ctr, Clin Res Inst, Tainan, Taiwan; [Kuo, Jinn-Rung; Lin, Kao-Chang] So Taiwan Univ, Dept Biotechnol, Tainan, Taiwan; [Lo, Chong-Jeh] Chang Gung Mem Hosp, Div Trauma & Emergency Surg, Kaohsiung, Taiwan; [Lo, Chong-Jeh] Kaohsiung Med Ctr, Kaohsiung, Taiwan	Lin, KC (corresponding author), Chi Mei Med Ctr, Dept Neurol, 901 Chung Hwa Rd, Yung Kang 710, Tainan, Taiwan.	kuo.ox@msa.hinet.net		Lu, Chin-Li/0000-0002-0818-4823			Adekoya Nelson, 2002, MMWR Surveill Summ, V51, P1; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Balestreri M, 2004, J NEUROL NEUROSUR PS, V75, P161; Carter BG, 2007, ANAESTH INTENS CARE, V35, P984, DOI 10.1177/0310057X0703500623; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; Howard JL, 2008, J TRAUMA, V65, P380, DOI 10.1097/TA.0b013e31817c50d4; JENNETT B, 1975, LANCET, V1, P480; Jiang JY, 2005, J NEUROTRAUM, V22, P623, DOI 10.1089/neu.2005.22.623; Kuo JR, 2007, EUR J NEUROL, V14, P1073, DOI 10.1111/j.1468-1331.2007.01908.x; Kuo JR, 2006, J CLIN NEUROSCI, V13, P218, DOI 10.1016/j.jocn.2005.01.012; Kuo JR, 2004, J CLIN NEUROSCI, V11, P710, DOI 10.1016/j.jocn.2003.10.011; LOBATO RD, 1991, J NEUROSURG, V75, P256, DOI 10.3171/jns.1991.75.2.0256; MARSHALL LF, 1991, J NEUROSURG, V75, pS28, DOI 10.3171/sup.1991.75.1s.0s28; Mass AIR, 2007, J TRAUMA, V24, P303; Mosenthal AC, 2004, J TRAUMA, V56, P1042, DOI 10.1097/01.TA.0000127767.83267.33; Ono J, 2001, J CLIN NEUROSCI, V8, P120, DOI 10.1054/jocn.2000.0732; PHUENPATHOM N, 1993, SURG NEUROL, V40, P22, DOI 10.1016/0090-3019(93)90164-V; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; Signorini DF, 1999, J NEUROL NEUROSUR PS, V66, P20, DOI 10.1136/jnnp.66.1.20; Skoglund TS, 2006, J NEUROTRAUM, V23, P1502, DOI 10.1089/neu.2006.23.1502; The Brain Trauma Foundation, 2000, J NEUROTRAUM, V17, P583; Timofeev I, 2008, J NEUROSURG, V108, P66, DOI 10.3171/JNS/2008/108/01/0066; Ucar T, 2005, J NEUROTRAUM, V22, P1311, DOI 10.1089/neu.2005.22.1311; WRONSKI J, 2000, NEUROL NEUROCHIR PSY, V6, P80; ZWEIG MH, 1993, CLIN CHEM, V39, P561	25	18	20	0	3	ELSEVIER TAIWAN	TAIPEI	RM N-412, 4F, CHIA HSIN BUILDING 11, NO 96, ZHONG SHAN N ROAD SEC 2, TAIPEI, 10449, TAIWAN	0929-6646			J FORMOS MED ASSOC	J. Formos. Med. Assoc.	APR	2011	110	4					258	264		10.1016/S0929-6646(11)60038-7			7	Medicine, General & Internal	General & Internal Medicine	764QB	WOS:000290645900007	21540008				2021-06-18	
J	Ouckama, R; Pearsall, DJ				Ouckama, Ryan; Pearsall, David J.			Evaluation of a flexible force sensor for measurement of helmet foam impact performance	JOURNAL OF BIOMECHANICS			English	Article						Impact biomechanics; Head injury; Helmets; Concussion; Material testing	TRAUMATIC BRAIN-INJURY; HEAD-INJURY; INTRACRANIAL-PRESSURE; ACCELERATION; EPIDEMIOLOGY; BIOMECHANICS; CONCUSSION; FOOTBALL; CRITERIA	The association between translational head acceleration and concussion remains unclear and provides a weak predictive measure for this type of injury; thus, alternative methods of helmet evaluation are warranted. Recent finite element analysis studies suggest that better estimates of concussion risk can be obtained when regional parameters of the cranium, brain and surrounding tissues are included. Lacking, however, are empirical data at the head-helmet interface with regards to contact area and force. Hence, the purpose of this study was to evaluate a system to capture the impact force distribution of helmet foams. Thirteen Flexiforce (R) sensors were arranged in a 5 x 5 cm array, secured to a load cell. Three densities of foam were repeatedly impacted with 5J of energy during ambient (20 degrees C) and cold (-25 degrees C) conditions. RMS error, calculated relative to the global force registered by the load cell, was < 1.5% of the measurement range during individual calibration of the Flexiforce (R) sensors. RMS error was 5% of the measured range for the global force estimated by the sensor array. Load distribution measurement revealed significant differences between repeated impacts of cold temperature foams for which acceleration results were non-significant. The sensor array, covering only 36% of the total area, possessed sufficient spatial and temporal resolution to capture dynamic load distribution patterns. Implementation of this force mapping system is not limited to helmet testing. Indeed it may be adopted to assess other body regions vulnerable to contact injuries (e.g., chest, hip and shin protectors). (c) 2010 Elsevier Ltd. All rights reserved.	[Ouckama, Ryan; Pearsall, David J.] McGill Univ, Dept Kinesiol & Phys Educ, Ice Hockey Res Grp IHRG, Montreal, PQ H2W 1S4, Canada	Ouckama, R (corresponding author), McGill Univ, Dept Kinesiol & Phys Educ, Ice Hockey Res Grp IHRG, 475 Pine Ave W, Montreal, PQ H2W 1S4, Canada.	ryan.ouckama@mail.mcgill.ca	Pearsall, David/C-9353-2014	Pearsall, David/0000-0002-4382-3504	Natural Sciences and Engineering Research Council of Canada (NSERC)Natural Sciences and Engineering Research Council of Canada (NSERC); Le Fonds Quebecois de la Recherche sur la Nature et les Technologies (FQRNT)FQRNT; Bauer Hockey Corporation in St-Jerome, Quebec	This study was supported by the Industrial Innovation Scholarship from the Natural Sciences and Engineering Research Council of Canada (NSERC), Le Fonds Quebecois de la Recherche sur la Nature et les Technologies (FQRNT) and the Bauer Hockey Corporation in St-Jerome, Quebec.	[Anonymous], 2007, F104507 ASTM; [Anonymous], 2009, Z262109 CSA; Bishop PJ, 1993, SAFETY ICE HOCKEY, P175; Bland JM, 2010, INT J NURS STUD, V47, P931, DOI 10.1016/j.ijnurstu.2009.10.001; Cui L, 2009, MATER DESIGN, V30, P3414, DOI 10.1016/j.matdes.2009.03.044; Faul M.D., 2010, TRAUMATIC BRAIN INJU; FORERO R, 2009, OPTIMISATION ENERG 1; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; GURDJIAN ES, 1966, J TRAUM, V6, P600, DOI 10.1097/00005373-196609000-00005; Hardy WN, 2007, STAPP CAR CRASH JO, V51, P17; Hootman JM, 2007, J ATHL TRAINING, V42, P311; ISO, 2003, 10256 ISO; King AI, 2000, ANNU REV BIOMED ENG, V2, P55, DOI 10.1146/annurev.bioeng.2.1.55; Kleiven S, 2006, INT J CRASHWORTHINES, V11, P65, DOI 10.1533/ijcr.2005.0384; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Marjoux D, 2008, ACCIDENT ANAL PREV, V40, P1135, DOI 10.1016/j.aap.2007.12.006; McCrory P, 2009, PHYSICIAN SPORTSMED, V37, P141, DOI 10.3810/psm.2009.06.1721; Mueller FO, 1998, CLIN SPORT MED, V17, P169, DOI 10.1016/S0278-5919(05)70071-5; TEKSCAN I, 2009, FLEXIFORCE SENSOR US; Tommasone BA, 2006, J ATHL TRAINING, V41, P470; Viano DC, 2005, NEUROSURGERY, V56, P266, DOI 10.1227/01.neu.0000150035.54230.3C; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zhang LY, 2001, J NEUROTRAUM, V18, P21, DOI 10.1089/089771501750055749	23	18	18	2	35	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0021-9290			J BIOMECH	J. Biomech.	MAR 15	2011	44	5					904	909		10.1016/j.jbiomech.2010.11.035			6	Biophysics; Engineering, Biomedical	Biophysics; Engineering	742FD	WOS:000288925800018	21194694				2021-06-18	
J	Armstead, WM; Kiessling, JW; Cines, DB; Higazi, AA				Armstead, William M.; Kiessling, J. Willis; Cines, Douglas B.; Higazi, Abd Al-Roof			Glucagon Protects Against Impaired NMDA-Mediated Cerebrovasodilation and Cerebral Autoregulation during Hypotension after Brain Injury by Activating cAMP Protein Kinase A and Inhibiting Upregulation of tPA	JOURNAL OF NEUROTRAUMA			English	Article						autoregulation; cerebral circulation; glucagon; NMDA; signal transduction; tPA; traumatic brain injury	TISSUE-PLASMINOGEN ACTIVATOR; CEREBROSPINAL-FLUID; BLOOD-FLOW; HEMODYNAMICS; MODULATION; RECEPTOR; INSULIN	Outcome of traumatic brain injury (TBI) is impaired by hyperglycemia, hypotension, and glutamate, and improved by insulin. Insulin reduces glutamate concentration, making it uncertain whether its beneficial effect accrues from euglycemia. Glucagon decreases CNS glutamate, lessens neuronal cell injury, and improves neurological scores in mice after TBI. In vitro, glucagon limits NMDA-mediated excitotoxicity by increasing cAMP and protein kinase A (PKA). NMDA receptor activation couples cerebral blood flow (CBF) to metabolism. Dilation induced by NMDA is impaired after fluid percussion brain injury (FPI) due to upregulation of endogenous tPA, which further disturbs cerebral autoregulation during hypotension after fluid percussion injury (FPI). We hypothesized that glucagon prevents impaired NMDA receptor-mediated dilation after FPI by upregulating cAMP, which decreases release of tPA. NMDA-induced pial artery dilation (PAD) was reversed to vasoconstriction after FPI. Glucagon 30 min before or 30 min after FPI blocked NMDA-mediated vasoconstriction and restored the response to vasodilation. PAD during hypotension was blunted after FPI, but protected by glucagon. Glucagon prevented FPI-induced reductions in CSF cAMP, yielding a net increase in cAMP, and blocked FPI-induced elevation of CSF tPA. Co-administration of the PKA antagonist Rp 8Br cAMPs prevented glucagon-mediated preservation of NMDA-mediated dilation after FPI. The pKA agonist Sp 8Br cAMPs prevented impairment of NMDA-induced dilation. These data indicate that glucagon protects against impaired cerebrovasodilation by upregulating cAMP, which decreases release of tPA, suggesting that it may provide neuroprotection when given after TBI, or prior to certain neurosurgical or cardiac interventions in which the incidence of perioperative ischemia is high.	[Armstead, William M.; Kiessling, J. Willis] Univ Penn, Dept Anesthesiol & Crit Care, Philadelphia, PA 19104 USA; [Armstead, William M.] Univ Penn, Dept Pharmacol, Philadelphia, PA 19104 USA; [Cines, Douglas B.; Higazi, Abd Al-Roof] Univ Penn, Dept Pathol, Philadelphia, PA 19104 USA; [Higazi, Abd Al-Roof] Hadassah Univ Hosp, Dept Clin Biochem, IL-91120 Jerusalem, Israel; [Higazi, Abd Al-Roof] Hebrew Univ Jerusalem, Hadassah Med Sch, IL-91010 Jerusalem, Israel	Armstead, WM (corresponding author), Univ Penn, Dept Anesthesiol & Crit Care, 3620 Hamilton Walk,JM3, Philadelphia, PA 19104 USA.	armsteaw@uphs.upenn.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS53410, HD57355, HL76406, CA83121, HL76206, HL07971, HL81864, HL77760, HL82545]; University of Pennsylvania Institute for Translational Medicine and Therapeutics; Israeli Science FoundationIsrael Science Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD057355] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R01CA083121] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R21HL081864, T32HL007971, R01HL077760, R01HL076206, P01HL076406] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS053410] Funding Source: NIH RePORTER	This research was supported by grants from the National Institutes of Health (NS53410 and HD57355 to W. M. A.; HL76406, CA83121, HL76206, HL07971, and HL81864 to D. B. C.; and HL77760 and HL82545 to A. A. R. H.), the University of Pennsylvania Institute for Translational Medicine and Therapeutics (to D. B. C.), and the Israeli Science Foundation (to A.A.R.H.).	Armstead WM, 2011, NEUROL RES, V33, P726, DOI 10.1179/016164110X12807570509853; Armstead WM, 2009, J CEREBR BLOOD F MET, V29, P524, DOI 10.1038/jcbfm.2008.142; Armstead WM, 2005, DEV BRAIN RES, V156, P139, DOI 10.1016/j.devbraines.2005.02.012; Armstead WM, 2002, DEV BRAIN RES, V139, P19, DOI 10.1016/S0165-3806(02)00511-4; Armstead WM, 1997, BRAIN RES, V768, P177, DOI 10.1016/S0006-8993(97)00641-0; Atkins CM, 2007, EXP NEUROL, V208, P145, DOI 10.1016/j.expneurol.2007.08.011; Bilotta F, 2008, NEUROCRIT CARE, V9, P159, DOI 10.1007/s12028-008-9084-9; BROCKMAN RP, 1975, AM J PHYSIOL, V229, P1344; Fanne Rami Abu, 2011, J Neurosurg, V114, P85, DOI 10.3171/2010.4.JNS10263; Faraci FM, 1998, PHYSIOL REV, V78, P53; Gottlieb M, 2003, J NEUROCHEM, V87, P119, DOI 10.1046/j.1471-4159.2003.01972.x; LAPTOOK AR, 1983, BRAIN RES, V276, P51, DOI 10.1016/0006-8993(83)90547-4; LEFFLER CW, 1989, AM J PHYSIOL, V257, pH1917; LEFFLER CW, 1985, PEDIATR RES, V19, P1160, DOI 10.1203/00006450-198511000-00009; Liu-DeRyke X, 2009, NEUROCRIT CARE, V11, P151, DOI 10.1007/s12028-009-9228-6; Lovshin JA, 2004, ENDOCRINOLOGY, V145, P3495, DOI 10.1210/en.2004-0100; Nelson D, 2005, PRINCIPLES BIOCH, P543; Nicole O, 2001, NAT MED, V7, P59; Park L, 2008, P NATL ACAD SCI USA, V105, P1073, DOI 10.1073/pnas.0708823105; Pawlak R, 2005, P NATL ACAD SCI USA, V102, P443, DOI 10.1073/pnas.0406454102; Salim A, 2009, AM SURGEON, V75, P25; TSIRKA SE, 1995, NATURE, V377, P340, DOI 10.1038/377340a0; Wang YMF, 1998, NAT MED, V4, P228, DOI 10.1038/nm0298-228; WEI EP, 1980, CIRC RES, V46, P37, DOI 10.1161/01.RES.46.1.37; Zhang H, 2001, CLIN CHEM, V47, P1458	25	18	18	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAR	2011	28	3					451	457		10.1089/neu.2010.1659			7	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	734WD	WOS:000288370600010	21375400	Green Published			2021-06-18	
J	Lammert, A; Bode, H; Hammes, HP; Birck, R; Fatar, M; Zohsel, K; Braun, J; Schmieder, K; Diepers, M; Schubert, GA; Barth, M; Thome, C; Seiz, M				Lammert, A.; Bode, H.; Hammes, H. -P.; Birck, R.; Fatar, M.; Zohsel, K.; Braun, J.; Schmieder, K.; Diepers, M.; Schubert, G. A.; Barth, M.; Thome, C.; Seiz, M.			Neuro-Endocrine and Neuropsychological Outcome After Aneurysmal Subarachnoid Hemorrhage (aSAH): A Prospective Cohort Study	EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES			English	Article						hypopituitarism; aneurysmal subarachnoid hemorrhage; neuropsychological deficit	TRAUMATIC BRAIN-INJURY; CRITICAL ILLNESS; HYPOPITUITARISM; DYSFUNCTION; DEFICIENCY	Objective: Neuropsychological sequelae are common after aneurysmal subarachnoid hemorrhage (aSAH) and may be associated with or caused by supposed hypothalamic-pituitary dysfunction. We evaluated the incidence of neuroendocrine and neuropsychological deficits after aSAH and their interrelations in a standardized manner. Methods: 26 patients (20 females) were prospectively screened for neuro-endocrine and neuropsychological deficits 3 and 6 months after aSAH. We measured GH, IGF-1, prolactin, LH, FSH, estradiol, TSH, fT4, total T3, testosterone, ACTH as well as cortisol before and after ACTH-stimulation. Neuropsychological analysis covered verbal comprehension, short term and working memory, visuospatial construction, figural memory, psychomotor speed, attention, and concentration. Results: After 3 months central hypogonadism was observed in 2 patients accompanied by central hypothyroidism in 1 male subject. Central hypogonadism resolved spontaneously after 6 months in both. After 3 months, neuropsychological deficits were detected in 57% of the examined patients (44% attention deficits, 38% memory impairment, 12% psychomotor deficits). Neuropsychological deficits were still present in 53% after 6 months. Conclusion: We found a low prevalence of neuro-endocrine and a high prevalence of neuropsychological deficits in patients 3 and 6 months after aSAH. Thus, the absent co-incidence of central hormonal and psychological dysfunction leaves a causal association questionable.	[Lammert, A.; Bode, H.; Hammes, H. -P.; Birck, R.] Univ Med Ctr Mannheim, Dept Med 5, D-68167 Mannheim, Germany; [Fatar, M.; Zohsel, K.] Univ Med Ctr Mannheim, Dept Neurol, D-68167 Mannheim, Germany; [Braun, J.; Schmieder, K.; Schubert, G. A.; Barth, M.; Thome, C.; Seiz, M.] Univ Med Ctr Mannheim, Dept Neurosurg, D-68167 Mannheim, Germany; [Diepers, M.] Univ Med Ctr Mannheim, Dept Neuroradiol, D-68167 Mannheim, Germany; [Thome, C.; Seiz, M.] Med Univ Innsbruck, Dept Neurosurg, Innsbruck, Austria	Lammert, A (corresponding author), Univ Med Ctr Mannheim, Dept Med 5, Theodor Kutzer Ufer 1-3, D-68167 Mannheim, Germany.	alexander.lammert@umm.de	Barth, Martin/E-8265-2014; Schubert, Gerrit Alexander/Q-9192-2017; Fatar, Marc/E-6892-2015; Hammes, Hans-Peter/S-3719-2019	Schubert, Gerrit Alexander/0000-0001-9135-6042; 			Aimaretti G, 2005, J CLIN ENDOCR METAB, V90, P6085, DOI 10.1210/jc.2005-0504; Aimaretti G, 2004, CLIN ENDOCRINOL, V61, P320, DOI 10.1111/j.1365-2265.2004.02094.x; Anderson SW, 2006, ANN NEUROL, V60, P518, DOI 10.1002/ana.21018; Bederson JB, 2009, STROKE, V40, P994, DOI 10.1161/STROKEAHA.108.191395; Bellebaum C, 2004, J CLIN EXP NEUROPSYC, V26, P1081, DOI 10.1080/13803390490515342; Berry E, 1997, BRIT J NEUROSURG, V11, P378; Brabant G, 2007, J CLIN ENDOCR METAB, V92, P2604, DOI 10.1210/jc.2007-0153; Dimopoulou I, 2004, STROKE, V35, P2884, DOI 10.1161/01.STR.0000147716.45571.45; Israel E, 2000, J CLIN ENDOCR METAB, V85, P3990; KOKSHOORN N, 2009, EUR J ENDOCRINOL; Kreitschmann-Andermahr I, 2004, J CLIN ENDOCR METAB, V89, P4986, DOI 10.1210/jc.2004-0146; LINDHOLM J, 1987, CLIN ENDOCRINOL, V26, P53, DOI 10.1111/j.1365-2265.1987.tb03638.x; OGDEN JA, 1993, NEUROSURGERY, V33, P572, DOI 10.1227/00006123-199310000-00004; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; SIEVERS C, 2009, CLIN ENDOCRINOL OXF; Suarez JI, 2006, NEW ENGL J MED, V354, P387, DOI 10.1056/NEJMra052732; Van den Berghe G, 2001, J CLIN ENDOCR METAB, V86, P3217, DOI 10.1210/jc.86.7.3217; Van den Berghe G, 2000, EUR J ENDOCRINOL, V143, P1, DOI 10.1530/eje.0.1430001	18	18	18	1	4	JOHANN AMBROSIUS BARTH VERLAG MEDIZINVERLAGE HEIDELBERG GMBH	STUTTGART	RUEDIGERSTR 14, D-70469 STUTTGART, GERMANY	0947-7349	1439-3646		EXP CLIN ENDOCR DIAB	Exp. Clin. Endocrinol. Diabet.	FEB	2011	119	2					111	116		10.1055/s-0030-1262815			6	Endocrinology & Metabolism	Endocrinology & Metabolism	742CX	WOS:000288918100008	20690074				2021-06-18	
J	Chang, WH; Park, YH; Ohn, SH; Park, CH; Lee, PKW; Kim, YH				Chang, Won Hyuk; Park, Yun H.; Ohn, Suk Hoon; Park, Chang-hyun; Lee, Peter K. W.; Kim, Yun-Hee			Neural correlates of donepezil-induced cognitive improvement in patients with right hemisphere stroke: A pilot study	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Donepezil; Stroke; Cognitive impairment; functional MRI	TRAUMATIC BRAIN-INJURY; VASCULAR DEMENTIA; POSTSTROKE APHASIA; ALZHEIMERS-DISEASE; OPEN-LABEL; INTELLIGENCE; REHABILITATION; 24-WEEK; SYSTEM; TRIAL	Donepezil has been proven effective in the treatment of Alzheimer's disease and vascular dementia. However, its effects on the cognitive neural network have not been fully investigated. The purpose of this study was to evaluate the effect of donepezil on reorganisation of the cognitive neural network in patients with post-stroke cognitive impairment using functional MRI (fMRI). Fourteen patients with stroke in the right hemisphere were enrolled. Participants were randomly assigned to the experimental or the control group. Donepezil (5 mg) or placebo was administered daily for four weeks. Cognitive function assessment was performed before and immediately after treatment, and repeated one month after cessation of treatment. fMRI was performed before and after treatment. Ten out of 14 patients (six in the experimental group, four in the control group) successfully completed all experimental processes. The experimental group showed significant improvements in the Mini-Mental Status Examination during the post-treatment evaluation and one-month follow-up compared to the pre-treatment evaluation (p < .05). No improvement was observed in the control group. In the experimental group fMRI showed increased activation in both prefrontal areas, both inferior frontal lobes, and in the left inferior parietal lobe. Increased recruitment of the parieto-frontal networks in the selected patients was considered to be a neural correlate of cognitive improvement induced by donepezil.	[Kim, Yun-Hee] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Phys Med & Rehabil,Div Neurorehabil Stroke &, Seoul 135710, South Korea; [Ohn, Suk Hoon] Hallym Univ, Hallym Sacred Heart Hosp, Sch Med, Dept Phys Med & Rehabil, Kyounggido, South Korea	Kim, YH (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Phys Med & Rehabil,Div Neurorehabil Stroke &, 50 Irwon Dong, Seoul 135710, South Korea.	yunkim@skku.edu	Park, Chang-hyun/I-2217-2016; Kim, Yun Hee/F-4600-2014		KOSEFKorea Science and Engineering Foundation; Korean GovernmentKorean Government [M10644000022-06N4400-02210]; Clinical Medical Research Center; Samsung Medical Center; IN-SUNG Foundation for Medical Research	This study was supported by a KOSEF grant funded by the Korean Government (no. M10644000022-06N4400-02210), Clinical Medical Research Center, Samsung Medical Center, and IN-SUNG Foundation for Medical Research.	Ballard C, 2003, INT PSYCHOGERIATR, V15, P123, DOI 10.1017/S1041610203009074; Berthier ML, 2005, DRUG AGING, V22, P163, DOI 10.2165/00002512-200522020-00006; Berthier ML, 2003, NEUROLOGY, V60, P1218, DOI 10.1212/01.WNL.0000055871.82308.41; Black S, 2003, STROKE, V34, P2323, DOI 10.1161/01.STR.0000091396.95360.E1; BOIVIN MJ, 1992, CORTEX, V28, P231, DOI 10.1016/S0010-9452(13)80051-2; Court J. A., 2002, VASCULAR COGNITIVE I; Cummings JL, 2000, AM J GERIAT PSYCHIAT, V8, P134, DOI 10.1176/appi.ajgp.8.2.134; Esposito G, 1999, BRAIN, V122, P963, DOI 10.1093/brain/122.5.963; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; GOTTFRIES CG, 1994, DEMENTIA, V5, P163, DOI 10.1159/000106715; Gray JR, 2004, NAT REV NEUROSCI, V5, P471, DOI 10.1038/nrn1405; Gray JR, 2003, NAT NEUROSCI, V6, P316, DOI 10.1038/nn1014; Kim Y.H., 2001, J KOREAN ACAD REHABI, V25, P209; Lee KH, 2006, NEUROIMAGE, V29, P578, DOI 10.1016/j.neuroimage.2005.07.036; Masanic CA, 2001, ARCH PHYS MED REHAB, V82, P896, DOI 10.1053/apmr.2001.23833; Mesulam M, 2003, NEUROLOGY, V60, P1183, DOI 10.1212/01.WNL.0000055927.22611.EB; Robertson IH, 1999, PSYCHOL BULL, V125, P544, DOI 10.1037/0033-2909.125.5.544; Rogers SL, 1998, NEUROLOGY, V50, P136, DOI 10.1212/WNL.50.1.136; Roman GC, 2006, NEUROBIOL AGING, V27, P1769, DOI 10.1016/j.neurobiolaging.2005.10.004; Somerville J, 2000, J CLIN EXP NEUROPSYC, V22, P613, DOI 10.1076/1380-3395(200010)22:5;1-9;FT613; STARKSTEIN SE, 1993, STROKE, V24, P1625, DOI 10.1161/01.STR.24.11.1625; Swartz Richard H, 2003, J Stroke Cerebrovasc Dis, V12, P29, DOI 10.1053/jscd.2003.5; Taverni JP, 1998, BRAIN INJURY, V12, P77; Vinters HV, 2000, J NEUROPATH EXP NEUR, V59, P931, DOI 10.1093/jnen/59.11.931; Wilkinson D, 2003, NEUROLOGY, V61, P479, DOI 10.1212/01.WNL.0000078943.50032.FC	25	18	20	0	8	PSYCHOLOGY PRESS	HOVE	27 CHURCH RD, HOVE BN3 2FA, EAST SUSSEX, ENGLAND	0960-2011			NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.		2011	21	4					502	514		10.1080/09602011.2011.582708			13	Neurosciences; Psychology	Neurosciences & Neurology; Psychology	885OO	WOS:000299788700004	21714757				2021-06-18	
J	Chauhan, NB; Gatto, R				Chauhan, Neelima B.; Gatto, Rodolfo			Restoration of cognitive deficits after statin feeding in TBI	RESTORATIVE NEUROLOGY AND NEUROSCIENCE			English	Article						Traumatic brain injury; controlled cortical impact injury; simvastatin; lovastatin; pravastatin; spontaneous exploratory working memory; learning and memory; morris water maze; Y-maze	TRAUMATIC BRAIN-INJURY; DELAYED NEURONAL DEATH; NITRIC-OXIDE SYNTHASE; BEHAVIORAL DEFICITS; REDUCTASE INHIBITOR; FUNCTIONAL OUTCOMES; ISCHEMIC BRAIN; FOCAL ISCHEMIA; SIMVASTATIN; RATS	Purpose: Traumatic brain injury (TBI) is a global health concern and growing socio-economic burden with limited treatment options. Behavioral assessment in experimental TBI with candidate therapeutic interventions is critical in order to expedite clinical translation. Statins constitute one of the potential treatment options based on their proven beneficial effects in various models of neurotrauma. We compared functional outcome after dietary intervention with representative hydrophilic Pravastatin or lipophilic Simvastatin and Lovastatin to test if different statins will differentially affect cognitive outcomes after injury in a controlled cortical impact injury (CCI) mouse model of TBI. Methods: Mice were subjected to TBI with a controlled cortical impact produced on the left somatosensory-parietal cortex between bregma -1.82 and -2.06, fed with Simvastatin/Lovastatin/Pravastatin (2 mg/kg) for 8 weeks, evaluated for learning, memory and spontaneous exploration behavior followed by immunocytochemistry of an axonal marker. Results: Results indicate that feeding of TBI mice with Simvastatin and Lovastatin significantly improved spatial learning and memory, restored spontaneous exploration and restored axonal integrity (Simvastatin > Lovastatin). On the other hand, Pravastatin failed to improve spatial learning or memory or exploration or axonal damage. Conclusions: Current findings confirm maximum benefits rendered by Simvastatin and reinforce Simvastatin as the candidate therapy for treating TBI.	[Chauhan, Neelima B.; Gatto, Rodolfo] Jesse Brown VA Med Ctr, Chicago, IL 60612 USA; [Chauhan, Neelima B.; Gatto, Rodolfo] Westside Inst Sci & Educ Chicago, Chicago, IL USA; [Chauhan, Neelima B.] Univ Illinois, Dept Pediat, Chicago, IL USA; [Chauhan, Neelima B.] Univ Illinois, Dept Anat & Cell Biol, Chicago, IL USA; [Gatto, Rodolfo] Univ Illinois, Dept BioEngn, Chicago, IL USA	Chauhan, NB (corresponding author), Jesse Brown VA Med Ctr, R&D 537-151,820 S Damen Ave, Chicago, IL 60612 USA.	nchauhan@uic.edu	Gatto, Rodolfo Gabriel/R-7155-2018	Gatto, Rodolfo Gabriel/0000-0003-2170-6662	Department of Veterans AffairsUS Department of Veterans Affairs [B6285R]; Westside Institute for Science and Education, Chicago; Department of Pediatrics, University of Illinois at Chicago; Department of Anatomy & Cell Biology, University of Illinois at Chicago; Department of BioEngineering, University of Illinois at Chicago; Veterans AffairsUS Department of Veterans Affairs [I01RX000880] Funding Source: NIH RePORTER	This work was supported by the Department of Veterans Affairs (VA MERIT Grant #B6285R, Chauhan NB). Authors are thankful for the support provided by the Westside Institute for Science and Education, Chicago; and by the Departments of Pediatrics, Anatomy & Cell Biology, and BioEngineering, University of Illinois at Chicago.	Balduini W, 2003, STROKE, V34, P2007, DOI 10.1161/01.STR.0000080677.24419.88; Cekic M, 2010, NEUROTHERAPEUTICS, V7, P81, DOI 10.1016/j.nurt.2009.10.017; Chauhan NB, 2004, NEUROCHEM RES, V29, P1897, DOI 10.1023/B:NERE.0000042217.90204.8d; Chauhan NB, 2007, PHYTOTHER RES, V21, P629, DOI 10.1002/ptr.2122; Chauhan NB, 2010, J NEUROSCI METH, V190, P1, DOI 10.1016/j.jneumeth.2010.04.004; Chen G, 2009, EXP NEUROL, V216, P398, DOI 10.1016/j.expneurol.2008.12.019; Chen SF, 2007, LIFE SCI, V81, P288, DOI 10.1016/j.lfs.2007.05.023; Cheng Y, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-156; Cimino A, 2005, NEUROTOXICOLOGY, V26, P929, DOI 10.1016/j.neuro.2005.03.009; Cimino M, 2007, NEUROSCIENTIST, V13, P208, DOI 10.1177/1073858406297121; Daimon M, 2004, NEUROSCI LETT, V362, P122, DOI 10.1016/j.neulet.2004.03.012; Farrell R, 2001, NEUROSCIENCE, V107, P585, DOI 10.1016/S0306-4522(01)00386-4; FRANKLIN KBJ, 1998, MOUSE BRAIN STEREOTA; Fujimoto ST, 2004, NEUROSCI BIOBEHAV R, V28, P365, DOI 10.1016/j.neubiorev.2004.06.002; Guyton JR, 2006, AM J CARDIOL, V97, p95C, DOI 10.1016/j.amjcard.2005.12.016; Kasturi BS, 2009, RESTOR NEUROL NEUROS, V27, P265, DOI [10.3233/RNN-2009-0475, 10.3233/RNN-2009-0476]; Laufs U, 2002, BRAIN RES, V942, P23, DOI 10.1016/S0006-8993(02)02649-5; Li B, 2009, NEUROSURGERY, V65, P179, DOI 10.1227/01.NEU.0000346272.76537.DC; Liao JK, 2005, ANNU REV PHARMACOL, V45, P89, DOI 10.1146/annurev.pharmtox.45.120403.095748; Lu DY, 2007, J NEUROTRAUM, V24, P1132, DOI 10.1089/neu.2007.0288; Mammis A, 2009, SURG NEUROL, V71, P527, DOI 10.1016/j.surneu.2008.02.040; MONTGOMERY KS, 2007, NEUROBIOL AGING; Neal MD, 2009, J TRAUMA, V67, P476, DOI 10.1097/TA.0b013e3181ad66bb; Orr JD, 2008, CURR ATHEROSCLER REP, V10, P11; QUION JA, 2003, CLIN PHARMACOKINET, V27, P94; Richardson RM, 2010, J NEUROSURG, V112, P1125, DOI 10.3171/2009.4.JNS081087; Sironi L, 2006, NEUROBIOL DIS, V22, P445, DOI 10.1016/j.nbd.2005.12.004; Sironi L, 2003, ARTERIOSCL THROM VAS, V23, P322, DOI 10.1161/01.ATV.0000044458.23905.3B; Stein DG, 2010, AM J ROENTGENOL, V194, P20, DOI 10.2214/AJR.09.3407; Stepien K, 2005, PHARMACOL REP, V57, P561; Tanaka K, 2009, NEUROSCI LETT, V462, P235, DOI 10.1016/j.neulet.2009.07.024; Turkoglu OF, 2009, SURG NEUROL, V72, P146, DOI 10.1016/j.surneu.2008.07.004; Vaishnavi S, 2009, PSYCHOSOMATICS, V50, P198, DOI 10.1176/appi.psy.50.3.198; van der Most PJ, 2009, PROG NEUROBIOL, V88, P64, DOI 10.1016/j.pneurobio.2009.02.002; Vink R, 2009, NEUROTHERAPEUTICS, V6, P28, DOI 10.1016/j.nurt.2008.10.036; Vree Tom B, 2003, ScientificWorldJournal, V3, P1332; Vuletic S, 2006, DEMENT GERIATR COGN, V22, P392, DOI 10.1159/000095679; Wang HC, 2007, EXP NEUROL, V206, P59, DOI 10.1016/j.expneurol.2007.03.031; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Wierzbicki AS, 2003, PHARMACOL THERAPEUT, V99, P95, DOI 10.1016/S0163-7258(03)00055-X; Wu HT, 2008, J NEUROSURG, V109, P691, DOI 10.3171/JNS/2008/109/10/0691; Wu HT, 2008, J NEUROTRAUM, V25, P130, DOI 10.1089/neu.2007.0369; Xiong Y, 2010, J NEUROTRAUM, V27, P205, DOI 10.1089/neu.2009.1001; Xiong Y, 2009, EXPERT OPIN EMERG DR, V14, P67, DOI [10.1517/14728210902769601, 10.1517/14728210902769601 ]; Yu SJ, 2009, BRAIN RES, V1287, P157, DOI 10.1016/j.brainres.2009.06.067	45	18	18	1	4	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	0922-6028	1878-3627		RESTOR NEUROL NEUROS	Restor. Neurol. Neurosci.		2011	29	1					23	34		10.3233/RNN-2011-0573			12	Neurosciences	Neurosciences & Neurology	722ZZ	WOS:000287476200003	21335666				2021-06-18	
J	Davies, SR; Field, ARJ; Andersen, T; Pestell, C				Davies, Simon R.; Field, Alan R. J.; Andersen, Thorvald; Pestell, Carmela			The ecological validity of the Rey-Osterrieth Complex Figure: Predicting everyday problems in children with neuropsychological disorders	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Rey-Osterrieth Complex Figure; Ecological validity; Child neuropsychological disorders; Parent rating questionnaires; Behavioral executive dysfunction	BEHAVIOR RATING INVENTORY; ACUTE LYMPHOBLASTIC-LEUKEMIA; QUALITATIVE SCORING SYSTEM; TRAUMATIC BRAIN-INJURY; EXECUTIVE FUNCTION; ORGANIZATIONAL APPROACH; PERFORMANCE; CHILDHOOD; MEMORY; ADOLESCENTS	Despite its extensive use, the validity of the Rey Complex Figure in predicting everyday behavioral executive dysfunction displayed by children with various neuropsychological disorders is unknown. The copied figures of 263 children aged 6 to 17 years were rescored using an accuracy approach that measured visuospatial ability and three process approaches developed to measure executive functioning. Controlling for age and IQ, partial correlations between scores derived by all scoring methods and the parent ratings on an executive function inventory were zero. In contrast, all four scoring approaches were associated with parent ratings on questionnaires that indexed children's academic achievement, developmental status, and adaptive ability. The findings suggest that the ecological validity of the Rey Complex Figure for children with various central nervous system disorders is more associated with visual-motor integration skills than executive functioning.	[Davies, Simon R.] N Metropolitan Area Mental Hlth Serv, Neurosci Unit, Graylands Selby Lemnos Serv, Claremont, WA 6190, Australia; [Davies, Simon R.; Field, Alan R. J.; Andersen, Thorvald] Murdoch Univ, Dept Psychol, Murdoch, WA 6150, Australia; [Pestell, Carmela] CAHDS, Joondalup, WA, Australia; [Davies, Simon R.] N Metropolitan Area Mental Hlth Serv, Neurosci Unit, Special Care Hlth Serv, Claremont, WA 6190, Australia	Davies, SR (corresponding author), N Metropolitan Area Mental Hlth Serv, Neurosci Unit, Graylands Selby Lemnos Serv, Private Bag 1, Claremont, WA 6190, Australia.	simon.davies@health.wa.gov.au		Pestell, Carmela/0000-0002-1737-7774			AKSHOOMOFF NA, 1995, NEUROPSYCHOLOGY, V9, P364, DOI 10.1037/0894-4105.9.3.364; Anderson P, 2001, CLIN NEUROPSYCHOL, V15, P81, DOI 10.1076/clin.15.1.81.1905; Anderson V, 2005, BRAIN INJURY, V19, P459, DOI 10.1080/02699050400004823; Anderson VA, 2002, CHILD NEUROPSYCHOL, V8, P231, DOI 10.1076/chin.8.4.231.13509; Anderson VA, 2001, DEV NEUROPSYCHOL, V20, P385, DOI 10.1207/S15326942DN2001_5; Baron I., 2004, NEUROPSYCHOLOGICAL E; Bart O, 2007, INFANT CHILD DEV, V16, P597, DOI 10.1002/icd.514; Beebe DW, 2004, APPL NEUROPSYCHOL, V11, P91, DOI 10.1207/s15324826an1102_4; Beery K., 1989, DEV TEST VISUAL MOTO; Bennett PC, 2005, J INT NEUROPSYCH SOC, V11, P606, DOI 10.1017/S1355617705050721; Bernstein JH., 1996, DEV SCORING SYSTEM R; Bodnar LE, 2007, CHILD NEUROPSYCHOL, V13, P345, DOI 10.1080/09297040600899867; Boone KB, 2000, J CLIN EXP NEUROPSYC, V22, P430; Cahn DA, 1996, CLIN NEUROPSYCHOL, V10, P397, DOI 10.1080/13854049608406700; Chaytor N, 2006, ARCH CLIN NEUROPSYCH, V21, P217, DOI 10.1016/j.acn.2005.12.002; Chaytor N, 2003, NEUROPSYCHOL REV, V13, P181, DOI 10.1023/B:NERV.0000009483.91468.fb; Deckersbach T, 2000, J CLIN EXP NEUROPSYC, V22, P640, DOI 10.1076/1380-3395(200010)22:5;1-9;FT640; Demsky Y, 2000, PERCEPT MOTOR SKILL, V91, P311, DOI 10.2466/PMS.91.5.311-321; Denckla MB, 2002, CHILD NEUROPSYCHOL, V8, P304, DOI 10.1076/chin.8.4.304.13512; DUFFEY JB, 1976, PERCEPT MOTOR SKILL, V43, P543, DOI 10.2466/pms.1976.43.2.543; Elliot C.D, 1990, DIFFERENTIAL ABILITY; Emslie H., 2003, CHILD NEUROPSYCHOL, V13, P539; Franzen M.D., 1996, ECOLOGICAL VALIDITY, P91; Frisk V, 2005, CHILD NEUROPSYCHOL, V11, P135, DOI 10.1080/092970490911289; Garth J, 1997, Pediatr Rehabil, V1, P99; Gioia GA, 2004, DEV NEUROPSYCHOL, V25, P135, DOI 10.1207/s15326942dn2501&2_8; Gioia GA, 2000, CHILD NEUROPSYCHOL, V6, P235, DOI 10.1076/chin.6.3.235.3152; Goulden LG, 1997, ARCH CLIN NEUROPSYCH, V12, P326, DOI 10.1093/arclin/12.4.326; Green P, 2003, CHILD NEUROPSYCHOL, V9, P189, DOI 10.1076/chin.9.3.189.16460; GRIMWOOD K, 1995, PEDIATRICS, V95, P646; Harris N. S., 1999, J INT NEUROPSYCH SOC, V5, P119; HEINRICHS RW, 1990, PROF PSYCHOL-RES PR, V21, P171, DOI 10.1037/0735-7028.21.3.171; Kirk U, 1985, HEMISPHERIC FUNCTION, P193; Kirkwood MW, 2001, CLIN NEUROPSYCHOL, V15, P345, DOI 10.1076/clin.15.3.345.10268; KLICPERA C, 1983, ACTA PAEDOPSYCHIATR, V49, P73; Knight J., 2003, HDB REY OSTERRIETH C; LACHAR D, 2004, COMPREHENSIVE HDB PS, V2, P192; Lachar D., 2001, PERSONALITY INVENTOR; Lawrence Vivienne, 2004, J Atten Disord, V7, P137, DOI 10.1177/108705470400700302; Lezak M.D., 2004, NEUROPSYCHOLOGICAL A, Vfourth; Mahone EM, 2002, CHILD NEUROPSYCHOL, V8, P52, DOI 10.1076/chin.8.1.52.8719; Mahone EM, 2002, ARCH CLIN NEUROPSYCH, V17, P643, DOI 10.1016/S0887-6177(01)00168-8; Mangeot S, 2002, CHILD NEUROPSYCHOL, V8, P271, DOI 10.1076/chin.8.4.271.13503; Mayes S. D., 2009, LEARN INDIVID DIFFER, V19, P239; MCHALE K, 1992, AM J OCCUP THER, V46, P898, DOI 10.5014/ajot.46.10.898; Molho CE, 1997, ARCH CLIN NEUROPSYCH, V12, P370, DOI 10.1093/arclin/12.4.370a; Nakano K, 2006, BRAIN DEV-JPN, V28, P641, DOI 10.1016/j.braindev.2006.04.011; Osterrieth P, 1944, ARCH PSYCHOL, V20, P206; Parrish J, 2007, DEV MED CHILD NEUROL, V49, P412, DOI 10.1111/j.1469-8749.2007.00412.x; POULTON RG, 1995, ARCH CLIN NEUROPSYCH, V10, P47, DOI 10.1016/0887-6177(93)E0003-T; Rabin LA, 2005, ARCH CLIN NEUROPSYCH, V20, P33, DOI 10.1016/j.acn.2004.02.005; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; Savage CR, 1999, BIOL PSYCHIAT, V45, P905, DOI 10.1016/S0006-3223(98)00278-9; Sbordone R. J., 1996, ECOLOGICAL VALIDITY, P1; Sbordone R. J., 1996, ECOLOGICAL VALIDITY, P15; Seidman LJ, 1995, J CHILD PSYCHOL PSYC, V36, P1459, DOI 10.1111/j.1469-7610.1995.tb01675.x; Seidman LJ, 1997, J CONSULT CLIN PSYCH, V65, P150, DOI 10.1037/0022-006X.65.1.150; Silver CH, 2000, J HEAD TRAUMA REHAB, V15, P973, DOI 10.1097/00001199-200008000-00002; Smith SR, 2006, CHILD NEUROPSYCHOL, V12, P383, DOI 10.1080/09297040500350953; STERN RA, 1999, BOSTON QUALITATIVE S; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Taylor E.M., 1959, PSYCHOL APPRAISAL CH; Tupper D. E., 1991, NEUROPSYCHOLOGY EVER, P1; Vriezen ER, 2002, CHILD NEUROPSYCHOL, V8, P296, DOI 10.1076/chin.8.4.296.13505; WABER DP, 1992, DEV NEUROPSYCHOL, V8, P1, DOI 10.1080/87565649209540512; WABER DP, 1994, DEV NEUROPSYCHOL, V10, P349, DOI 10.1080/87565649409540589; WABER DP, 1995, DEV NEUROPSYCHOL, V11, P237, DOI 10.1080/87565649509540616; WABER DP, 1985, J CLIN EXP NEUROPSYC, V7, P264, DOI 10.1080/01688638508401259; Watanabe K, 2005, BRAIN DEV-JPN, V27, P564, DOI 10.1016/j.braindev.2005.02.007; Wechsler D., 2003, WECHSLER INTELLIGENC; World Health Organization, 2007, INT STAT CLASS DIS R	71	18	18	0	27	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.		2011	33	7					820	831		10.1080/13803395.2011.574608			12	Psychology, Clinical; Clinical Neurology; Psychology	Psychology; Neurosciences & Neurology	882HE	WOS:000299553600009	21957867				2021-06-18	
B	Garcia, P		Rosen, J; Hannaford, B; Satava, RM		Garcia, Pablo			Telemedicine for the Battlefield: Present and Future Technologies	SURGICAL ROBOTICS: SYSTEMS APPLICATIONS AND VISIONS			English	Article; Book Chapter							SURGERY; ROBOTICS	Providing medical care in the field is very challenging because of the limited availability of medical resources. The current practice in military operations is to stabilize patients far forward and evacuate them to better equipped medical facilities, such as combat field hospital: This strategy has proven very successful in recent conflicts. However, it is possible to save more lives and ameliorate the consequences of long term injuries by providing an accurate diagnosis earlier, specialized surgical care faster and more sophisticated intensive care during transport. This chapter focuses on technologies that allow augmenting the diagnostics and treatment capabilities of medical teams in the field. The decisions made by the first responders are critical for the patient chances of survival and they are done with very little information on the real status of the patient. For example, recognizing an internal head injury or abdominal bleeding is critical to determine where the patient should be evacuated but this information is currently not available. Once a patient is evacuated to a medical facility it is impossible to provide all specialties required to treat complex injuries (it is not uncommon for general trauma surgeons to conduct head procedures because they do not have a neurosurgeon in the staff). Finally, once patients are stable enough to transport them outside the country they are taken on long transcontinental flights with a small team of nurses and doctors who have limited means to react to adverse conditions in patients. Technology can be used to force multiply the capabilities of the medical personnel in the field by allowing them to perform more sophisticated diagnosis and treatments closed to the point of injury. Figure 3.1 illustrates the different layers of technology which can be used to treat patients in the field. Each additional layer adds a level of sophistication to the one below but is applicable to a smaller pool of patients.	SRI Int, Menlo Pk, CA 94025 USA	Garcia, P (corresponding author), SRI Int, 333 Ravenswood Ave, Menlo Pk, CA 94025 USA.	pablo.garcia@sri.com					AMIR Y, 2004, IEEE T PARALLEL DIST, V15; Ballantyne GH, 2002, SURG LAPARO ENDO PER, V12, P1, DOI 10.1097/00129689-200202000-00001; Blum AL, 1997, ARTIF INTELL, V90, P281, DOI 10.1016/S0004-3702(96)00047-1; Buess GF, 2000, ARCH SURG-CHICAGO, V135, P229, DOI 10.1001/archsurg.135.2.229; Cleary K, 2001, Comput Aided Surg, V6, P312, DOI 10.3109/10929080109146301; GREEN PS, 1995, IEEE ENG MED BIOL, V14, P324, DOI 10.1109/51.391769; HARDEN T, 2005, P ASME 2005 DES ENG; Howe RD, 1999, ANNU REV BIOMED ENG, V1, P211, DOI 10.1146/annurev.bioeng.1.1.211; KAPOOR C, 1998, P 12 CSIM IFTOMM S T; KAPOOR C, 2006, IND ROBOT INT J, V33; Nau D, 2005, IEEE INTELL SYST, V20, P34, DOI 10.1109/MIS.2005.20; PHOLSIRI C, 2005, P ASME 2005 DES ENG; Rosen J, 2006, IEEE SPECTRUM, V43, P34, DOI 10.1109/MSPEC.2006.1705774; Satava RM, 2003, SURG ENDOSC, V17, P104, DOI 10.1007/s00464-002-0018-x; Speich J.E., 2004, ENCY BIOMATERIALS BI, P983, DOI DOI 10.1081/E-EBBE-120024154; TAYLOR RH, 1999, HDB IND ROBOTICS, P1213	16	18	18	0	1	SPRINGER-VERLAG BERLIN	BERLIN	HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY			978-1-4419-1125-4				2011							33	68		10.1007/978-1-4419-1126-1_3	10.1007/978-1-4419-1126-1		36	Computer Science, Artificial Intelligence; Engineering, Electrical & Electronic; Robotics; Surgery	Computer Science; Engineering; Robotics; Surgery	BSX98	WOS:000286092400003					2021-06-18	
J	Griffen, JA; Rapport, LJ; Bryer, RC; Bieliauskas, LA; Burt, C				Griffen, Julie A.; Rapport, Lisa J.; Bryer, Renee Coleman; Bieliauskas, Linas A.; Burt, Cynthia			Awareness of Deficits and On-Road Driving Performance	CLINICAL NEUROPSYCHOLOGIST			English	Article						Driving; Awareness of deficit; Acquired brain injury	TRAUMATIC BRAIN-INJURY; COMMUNITY INTEGRATION; NEUROPSYCHOLOGICAL ASPECTS; SELF-AWARENESS; OLDER-ADULTS; ABILITY; STROKE; PREDICTORS; FITNESS; REHABILITATION	This study examined the relationship of neuropsychological and on-road driving evaluations among adults with acquired brain injury (ABI), and the extent to which that relationship is moderated by awareness of deficit. Participants were 62 pairs of adults with ABI and significant-other informants and 40 healthy controls (N = 102). Adults with ABI and controls completed neuropsychological and on-road evaluations. Multiple regression indicated that neuropsychological performance and the interaction between awareness of deficit and neuropsychological performance each explained significant variance in driving performance (i.e., the relationship between neuropsychological performance and on-road outcome depends on level of awareness). The moderation effect was illustrated by different relationships between neuropsychological and on-road performances among awareness groups: Among adults with impaired awareness (n = 21), neuropsychological functioning was substantially related to driving outcomes; in contrast, driving outcome showed weak relation to neuropsychological functioning among those with intact awareness (n = 24) or hypervigilance (n = 17) toward deficits. An exception was that processing speed showed modest relation to on-road outcome for all groups, including controls. Awareness of deficit has a considerable influence on driving outcomes both directly and as a moderator between the relationship of neuropsychological functioning and driving performance. When adults with ABI lack appreciation for their impairments, their neuropsychological status is especially important in predicting driving outcomes.	[Griffen, Julie A.; Rapport, Lisa J.; Bryer, Renee Coleman; Burt, Cynthia] Wayne State Univ, Dept Psychol, Detroit, MI 48202 USA; [Bieliauskas, Linas A.] Univ Michigan, Psychol Serv, VA Med Ctr, Ann Arbor, MI 48109 USA	Rapport, LJ (corresponding author), Wayne State Univ, Dept Psychol, 7th Floor,5057 Woodward Ave, Detroit, MI 48202 USA.	rapport@wayne.edu			US Department of Education - National Institute of Disability Research and RehabilitationUS Department of Education [H133G050134]; Wayne State University	This research was supported by grants from the US Department of Education - National Institute of Disability Research and Rehabilitation (H133G050134, L.J. Rapport) and Wayne State University (J.A. Griffen).	Anstey KJ, 2006, J AM GERIATR SOC, V54, P121, DOI 10.1111/j.1532-5415.2005.00471.x; Anstey KJ, 2005, CLIN PSYCHOL REV, V25, P45, DOI 10.1016/j.cpr.2004.07.008; Association for Driver Rehabilitation Specialists (ADED), 2002, MOD PRACT DRIV REH I; Association for Driver Rehabilitation Specialists (ADED), 2009, BEST PRACT DEV DRIV; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Benton A., 1978, CLIN NEUROPSYCHOL, V10, P80; Bieliauskas LA, 1998, CLIN NEUROPSYCHOL, V12, P206, DOI 10.1076/clin.12.2.206.1994; Brouwer W H, 1994, Disabil Rehabil, V16, P149; Clay OJ, 2005, OPTOMETRY VISION SCI, V82, P724, DOI 10.1097/01.opx.0000175009.08626.65; Cohen J., 1965, HDB CLIN PSYCHOL, P95; Coleman BR., 2005, DRIVER REHABILITATIO, P165; Coleman RD, 2002, ARCH PHYS MED REHAB, V83, P1415, DOI 10.1053/apmr.2002.35111; Edwards JD, 2009, GERONTOLOGIST, V49, P485, DOI 10.1093/geront/gnp042; Fisk GD, 1998, BRAIN INJURY, V12, P683; FITTEN LJ, 1995, JAMA-J AM MED ASSOC, V273, P1360, DOI 10.1001/jama.273.17.1360; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; FORDYCE DJ, 1986, REHABIL PSYCHOL, V31, P217, DOI 10.1037//0090-5550.31.4.217; Fox GK, 1997, J AM GERIATR SOC, V45, P949, DOI 10.1111/j.1532-5415.1997.tb02965.x; Fox GK, 1998, ARCH PHYS MED REHAB, V79, P1288, DOI 10.1016/S0003-9993(98)90277-5; GALSKI T, 1992, AM J OCCUP THER, V46, P324, DOI 10.5014/ajot.46.4.324; Golden C., 1978, STROOP COLOR WORD TE; Griffen JA, 2009, TOP STROKE REHABIL, V16, P212, DOI 10.1310/tsr1603-212; Hedges LV., 1981, J EDUC STAT, V6, P107; Heikkila VM, 1999, ACTA NEUROL SCAND, V99, P349, DOI 10.1111/j.1600-0404.1999.tb07363.x; Korteling JE, 1996, ARCH PHYS MED REHAB, V77, P138, DOI 10.1016/S0003-9993(96)90158-6; Lundqvist A, 2001, NEUROPSYCHOL REHABIL, V11, P171, DOI 10.1080/09602010042000240; Lundqvist A, 2000, APPL COGNITIVE PSYCH, V14, P135, DOI 10.1002/(SICI)1099-0720(200003/04)14:2<135::AID-ACP628>3.0.CO;2-S; Lundqvist A, 2007, BRAIN INJURY, V21, P1109, DOI 10.1080/02699050701651660; Lundqvist A, 1997, APPL NEUROPSYCHOL, V4, P220, DOI 10.1207/s15324826an0404_3; Marcotte TD, 2000, J INT NEUROPSYCH SOC, V6, P233; Marshall SC, 2007, TOP STROKE REHABIL, V14, P98, DOI 10.1310/tsr1401-98; Mazer BL, 1998, ARCH PHYS MED REHAB, V79, P743, DOI 10.1016/S0003-9993(98)90350-1; Michon J.A., 1985, HUMAN BEHAV TRAFFIC, P485, DOI [10.1007/978-1-4613-2173-6 19, DOI 10.1007/978-1-4613-2173-619]; Orfei MD, 2008, NEUROSCIENTIST, V14, P203, DOI 10.1177/1073858407309995; Ott BR, 2003, J GERIATR PSYCH NEUR, V16, P151, DOI 10.1177/0891988703255688; Ownsworth T, 2005, J HEAD TRAUMA REHAB, V20, P315, DOI 10.1097/00001199-200507000-00004; Prigatano GP, 2005, J HEAD TRAUMA REHAB, V20, P19, DOI 10.1097/00001199-200501000-00004; Radford KA, 2004, ARCH PHYS MED REHAB, V85, P324, DOI 10.1016/S0003-9993(03)00765-2; Rapport L, 2006, J HEAD TRAUMA REHAB, V21, P34, DOI 10.1097/00001199-200601000-00004; Rapport LJ, 2008, ARCH PHYS MED REHAB, V89, P922, DOI 10.1016/j.apmr.2008.01.009; RAPPORT LJ, 1993, ARCH PHYS MED REHAB, V74, P621, DOI 10.1016/0003-9993(93)90160-C; Reger MA, 2004, NEUROPSYCHOLOGY, V18, P85, DOI 10.1037/0894-4105.18.1.85; Reitan R., 1988, HALSTEAD REITAN NEUR; Ryan KA, 2009, J CLIN EXP NEUROPSYC, V31, P126, DOI 10.1080/13803390802119922; Schanke AK, 2000, SCAND J PSYCHOL, V41, P113, DOI 10.1111/1467-9450.00179; Schultheis MT, 2002, J HEAD TRAUMA REHAB, V17, P38, DOI 10.1097/00001199-200202000-00006; Shallice, 1997, HAYLING BRIXTON TEST; Sherer M, 1998, BRAIN INJURY, V12, P63, DOI 10.1080/026990598122863; Sherer M, 1998, J HEAD TRAUMA REHAB, V13, P52, DOI 10.1097/00001199-199810000-00007; Smith A., 1973, SYMBOL DIGIT MODALIT; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Tabachnick B. G., 2006, USING MULTIVARIATE S; Trobe JD, 1996, ARCH NEUROL-CHICAGO, V53, P411, DOI 10.1001/archneur.1996.00550050033021; VANZOMEREN AH, 1988, ARCH PHYS MED REHAB, V69, P90; VANZOMEREN AH, 1987, ARCH PHYS MED REHAB, V68, P697; Waldron-Perrine B, 2009, CLIN NEUROPSYCHOL, V23, P462, DOI 10.1080/13854040802279683; Wechsler D, 1997, WAIS 3 ADM SCORING M; Withaar FK, 2000, J INT NEUROPSYCH SOC, V6, P480, DOI 10.1017/S1355617700644065	58	18	18	0	3	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.		2011	25	7					1158	1178		10.1080/13854046.2011.609841			21	Psychology, Clinical; Clinical Neurology; Psychology	Psychology; Neurosciences & Neurology	882JJ	WOS:000299559600005	21951140				2021-06-18	
J	Le, K; Coelho, C; Mozeiko, J; Krueger, F; Grafman, J				Le, Karen; Coelho, Carl; Mozeiko, Jennifer; Krueger, Frank; Grafman, Jordan			Measuring goodness of story narratives: Implications for traumatic brain injury	APHASIOLOGY			English	Article; Proceedings Paper	40th Clinical Aphasiology Conference (CAC)	MAY 23-27, 2010	Isle of Palms, SC			Discourse production; Narrative discourse; Traumatic brain injury; Discourse analysis; Penetrating head injury; Story narratives	CLOSED-HEAD-INJURY; PRAGMATIC LANGUAGE-SKILLS; DISCOURSE PRODUCTION; WORKING-MEMORY; CHILDREN; ADULTS; COMPREHENSION; ABILITY; NEEDS	Background: This study examined the utility of story ogoodnesso, a measure of organisation and completeness, in quantifying narrative discourse deficits following traumatic brain injury (TBI). In an initial study, the story goodness measure demonstrated sensitivity and reliability in distinguishing individuals who had TBI from those who were non-brain-injured. Aims: The purpose of the current study was to validate previous findings of the story goodness index, specifically in discriminating performance between groups and identifying performance subgroups, in a larger sample of participants with TBI. Methods Procedures: A total of 46 non-brain-injured adults and 171 adults with TBI participated. Story retellings were analysed for story grammar and story completeness. The two discourse scores were then plotted as coordinates, which allowed for quantification of story goodness. Statistical analyses included a multivariate analysis of variance and calculation of Pearson correlation coefficients for the discourse measures. Outcomes Results: Results indicated that participants' scores clustered differentially across quadrants between groups and discriminated groups into four distinct categories of story ogoodnesso. Conclusions: Findings paralleled those found in the initial study, suggesting that story goodness is a sensitive measure for examining the discourse of individuals with TBI. The story goodness has potential clinical utility and may have implications for investigation of discourse impairments in other clinical populations and treatment of discourse deficits.	[Grafman, Jordan] NINDS, Cognit Neurosci Sect, Magnuson Clin Ctr, Bethesda, MD 20892 USA; [Le, Karen; Coelho, Carl; Mozeiko, Jennifer] Univ Connecticut, Dept Commun Sci, Storrs, CT 06268 USA	Grafman, J (corresponding author), NINDS, Cognit Neurosci Sect, Magnuson Clin Ctr, Bldg 10,7D43,MSC 1440,10 Ctr Dr, Bethesda, MD 20892 USA.	GrafmanJ@ninds.nih.gov		Grafman, Jordan H./0000-0001-8645-4457			Barrett J., 1998, OLD MCDONALD HAD APA; Biddle KR, 1996, J COMMUN DISORD, V29, P447, DOI 10.1016/0021-9924(95)00038-0; Body R, 2004, BRAIN INJURY, V18, P707, DOI 10.1080/02699050310001596914; Brookshire BL, 2000, J INT NEUROPSYCH SOC, V6, P741, DOI 10.1017/S1355617700677019; Chapman SB, 2006, BRAIN LANG, V97, P178, DOI 10.1016/j.bandl.2005.10.002; CHAPMAN SB, 1992, BRAIN LANG, V43, P42, DOI 10.1016/0093-934X(92)90020-F; Chapman SB, 2001, J HEAD TRAUMA REHAB, V16, P441, DOI 10.1097/00001199-200110000-00004; Coelho CA, 2003, APHASIOLOGY, V17, P499, DOI 10.1080/02687030344000111; Coelho CA, 2002, J SPEECH LANG HEAR R, V45, P1232, DOI 10.1044/1092-4388(2002/099); Coelho Carl A., 2007, Seminars in Speech and Language, V28, P122, DOI 10.1055/s-2007-970570; DERENZI E, 1962, BRAIN, V85, P665, DOI 10.1093/brain/85.4.665; Ewing-Cobbs L, 1998, BRAIN LANG, V61, P395, DOI 10.1006/brln.1997.1884; GLOSSER G, 1991, BRAIN LANG, V40, P67, DOI 10.1016/0093-934X(91)90117-J; HARTLEY L L, 1992, Brain Injury, V6, P271, DOI 10.3109/02699059209029669; Hay E, 2005, AM J SPEECH-LANG PAT, V14, P324, DOI 10.1044/1058-0360(2005/031); HEILMAN KM, 1971, J NEUROL NEUROSUR PS, V34, P265, DOI 10.1136/jnnp.34.3.265; Hunt K. W, 1965, 3 NCTE; Jorgensen M, 2009, BRAIN INJURY, V23, P727, DOI 10.1080/02699050903133954; Kaplan E., 1983, BOSTON NAMING TEST; Le K, 2011, J SPEECH LANG HEAR R, V54, P118, DOI 10.1044/1092-4388(2010/09-0022); LILES BZ, 1989, J SPEECH HEAR DISORD, V54, P356, DOI 10.1044/jshd.5403.356; Mar RA, 2004, NEUROPSYCHOLOGIA, V42, P1414, DOI 10.1016/j.neuropsychologia.2003.12.016; MCDONALD S, 1993, BRAIN LANG, V44, P28, DOI 10.1006/brln.1993.1003; MCDONALD S, 1995, BRAIN INJURY, V9, P255, DOI 10.3109/02699059509008197; MERRITT DD, 1987, J SPEECH HEAR RES, V30, P539, DOI 10.1044/jshr.3004.539; PLAG JA, 1967, PERS PSYCHOL, V20, P323, DOI 10.1111/j.1744-6570.1967.tb01527.x; Snow P, 1997, APHASIOLOGY, V11, P947, DOI 10.1080/02687039708249421; Tucker FM, 1998, BRAIN INJURY, V12, P783, DOI 10.1080/026990598122179; U. S. Department of Defense, 1984, TEST MAN ARM SERV VO; Youse KM, 2005, BRAIN INJURY, V19, P1001, DOI 10.1080/02699050500109951	30	18	18	0	10	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0268-7038	1464-5041		APHASIOLOGY	Aphasiology		2011	25	6-7					748	760	PII 938548156	10.1080/02687038.2010.539696			13	Audiology & Speech-Language Pathology; Linguistics; Clinical Neurology; Rehabilitation	Audiology & Speech-Language Pathology; Linguistics; Neurosciences & Neurology; Rehabilitation	775XO	WOS:000291497000008					2021-06-18	
B	Lester, P; Leskin, G; Woodward, K; Saltzman, W; Nash, W; Mogil, C; Paley, B; Beardslee, W		Wadsworth, SM; Riggs, D		Lester, Patricia; Leskin, Gregory; Woodward, Kirsten; Saltzman, William; Nash, William; Mogil, Catherine; Paley, Blair; Beardslee, William			Wartime Deployment and Military Children: Applying Prevention Science to Enhance Family Resilience	RISK AND RESILIENCE IN U S MILITARY FAMILIES			English	Article; Book Chapter							POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN-INJURY; MENTAL-HEALTH PROBLEMS; ADOLESCENT CHILDREN; VIETNAM VETERANS; COMBAT VETERANS; LOW-INCOME; PARENTS; INTERVENTION; IMPACT	During wartime, military families and children make extraordinary sacrifices for their country. This chapter reviews the impact of wartime deployments and parental combat-related mental health problems on military children, as well as risk and protective factors that may serve to guide preventive interventions for military families facing multiple deployments, combat operational stress, and psychological injuries. Using a public health prevention approach, we describe the adaptation of evidence-based interventions to support psychological health in military families. This adaptation is FOCUS (Families Over Coming Under Stress), a family-centered preventive intervention designed to enhance the strengths of family members, manage deployment-related stressors and reminders, and maintain positive family growth and psychological adjustment throughout the stages of deployment. Supported by the U.S. Bureau of Navy Medicine and Surgery (BUMED), military leadership, community providers, and families, this intervention has been implemented through a large-scale service demonstration project to support military families.	[Lester, Patricia; Leskin, Gregory; Saltzman, William; Mogil, Catherine] Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, FOCUS, Los Angeles, CA 90095 USA; [Leskin, Gregory] Natl Ctr PTSD VA Palo Alto, Palo Alto, CA USA; [Woodward, Kirsten] USN, Wounded & Injured Support Directorate 3, Bur Med & Surg, Washington, DC USA; [Saltzman, William] Calif State Univ Long Beach, Long Beach, CA 90840 USA; [Paley, Blair] Univ Calif Los Angeles, David Geffen Sch Med, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA; [Beardslee, William] Harvard Univ, Sch Med, Boston, MA USA; [Beardslee, William] Childrens Hosp, Dept Psychiat, Baer Prevent Initiat, Boston, MA 02115 USA	Lester, P (corresponding author), Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, FOCUS, Los Angeles, CA 90095 USA.	plester@mednet.ucla.edu					Ahnert L, 2004, CHILD DEV, V75, P639, DOI 10.1111/j.1467-8624.2004.00698.x; *AM AC PED, 2009, MIL YOUTH COP SEP FA; American Psychological Association, 2007, PSYCH NEEDS US MIL S; Baker DG, 2009, MIL MED, V174, P773; Beardslee WR, 2007, J FAM PSYCHOL, V21, P703, DOI 10.1037/0893-3200.21.4.703; BEARDSLEE WR, 1988, AM J PSYCHIAT, V145, P63; Beardslee WR, 2003, PEDIATRICS, V112, pE119, DOI 10.1542/peds.112.2.e119; BEARDSLEE WR, 1984, PEDIATR ANN, V13, P32; Beardslee WR, 2009, ZERO 3, V29, P34; BEARDSLEE WR, 1994, HDB DEPRESSION CHILD, P463; Belsky J, 2002, DEV PSYCHOPATHOL, V14, P293, DOI 10.1017/S0954579402002067; Bonds DD, 2007, J FAM PSYCHOL, V21, P288, DOI 10.1037/0893-3200.21.2.288; Bourg C, 1999, ARMED FORCES SOC, V25, P633, DOI 10.1177/0095327X9902500406; Bowlby J., 1973, ATTACHMENT LOSS, VII; Bowlby J., 1980, ATTACHMENT LOSS; Bowlby J., 1988, SECURE BASE PARENT C; Bowlby J., 1969, ATTACHMENT LOSS ATTA, V1; Burrell LM, 2006, ARMED FORCES SOC, V33, P43, DOI 10.1177/0002764206288804; CARROLL EM, 1985, J ABNORM PSYCHOL, V94, P329, DOI 10.1037/0021-843X.94.3.329; Chandra A., 2008, UNDERSTANDING IMPACT; Chartrand MM, 2008, ARCH PEDIAT ADOL MED, V162, P1009, DOI 10.1001/archpedi.162.11.1009; Compas BE, 1989, PRIMARY PREVENTION P, P60; Cox M. J., 2001, INTERPARENTAL CONFLI, P249, DOI DOI 10.1017/CBO9780511527838.011; Cox MJ, 1997, ANNU REV PSYCHOL, V48, P243, DOI 10.1146/annurev.psych.48.1.243; D'Angelo EJ, 2009, FAM PROCESS, V48, P269, DOI 10.1111/j.1545-5300.2009.01281.x; Davidson AC, 2001, AUST NZ J PSYCHIAT, V35, P345, DOI 10.1046/j.1440-1614.2001.00897.x; Dekel R, 2008, AM J ORTHOPSYCHIAT, V78, P281, DOI 10.1037/a0013955; Dybdahl R, 2001, CHILD DEV, V72, P1214, DOI 10.1111/1467-8624.00343; Eaton KM, 2008, MIL MED, V173, P1051, DOI 10.7205/MILMED.173.11.1051; Erbes C, 2007, MIL MED, V172, P359, DOI 10.7205/MILMED.172.4.359; EREL O, 1995, PSYCHOL BULL, V118, P108, DOI 10.1037/0033-2909.118.1.108; Faber AJ, 2008, J FAM PSYCHOL, V22, P222, DOI 10.1037/0893-3200.22.2.222; Feinberg ME, 2008, J FAM PSYCHOL, V22, P253, DOI 10.1037/0893-3200.22.2.253; Feinberg ME, 2002, CLIN CHILD FAM PSYCH, V5, P173, DOI 10.1023/A:1019695015110; Flake EM, 2009, J DEV BEHAV PEDIATR, V30, P271, DOI 10.1097/DBP.0b013e3181aac6e4; Friedman MJ, 2006, AM J PSYCHIAT, V163, P586, DOI 10.1176/appi.ajp.163.4.586; Galovski T, 2004, AGGRESS VIOLENT BEH, V9, P477, DOI 10.1016/S1359-1789(03)00045-4; Gibbs DA, 2007, JAMA-J AM MED ASSOC, V298, P528, DOI 10.1001/jama.298.5.528; GONZALEZ S, 1989, FAM PROCESS, V28, P69, DOI 10.1111/j.1545-5300.1989.00069.x; Hoge CQ, 2004, NEW ENGL J MED, V351, P2471; Hosek J., 2006, DEPLOYMENTS AFFECT S; Huebner AJ, 2007, FAM RELAT, V56, P112, DOI 10.1111/j.1741-3729.2007.00445.x; *I MED NAT RES COU, 2009, DEPR PAR PAR CHILDR; Jensen PS, 1996, J AM ACAD CHILD PSY, V35, P433, DOI 10.1097/00004583-199604000-00009; Kang HK, 2005, NEW ENGL J MED, V352, P1289, DOI 10.1056/NEJMp058024; Laor N, 2001, AM J PSYCHIAT, V158, P1020, DOI 10.1176/appi.ajp.158.7.1020; Layne CM, 2008, J AM ACAD CHILD PSY, V47, P1048, DOI 10.1097/CHI.0b013e31817eecae; LAYNE CM, 1999, TRAUMA GRIEF FOCUSED; LAYNE CM, 2002, UCLA TRAUMA GR UNPUB; LEE MB, 2002, CLIN CHILD PSYCHOL P, V7, P71, DOI DOI 10.1177/1359104502007001006; Lester P, 2003, J DEV BEHAV PEDIATR, V24, P242, DOI 10.1097/00004703-200308000-00004; LESTER P, 2001, AM AC CHILD AD PSYCH; LESTER P, 2008, EVIDENCE BASED TREAT, P170; Lester P, 2010, J AM ACAD CHILD PSY, V49, P310, DOI 10.1016/j.jaac.2010.01.003; Lew HL, 2006, J REHABIL RES DEV, V43, pVII, DOI 10.1682/JRRD.2006.05.0054; Lincoln A, 2008, J CLIN PSYCHOL, V64, P984, DOI 10.1002/jclp.20520; Luthar S, 2006, DEV PSYCHOPATHOL, V3, P740; Matsakis A., 1988, VIETNAM WIVES; McCarroll JE, 2008, CHILD ABUSE REV, V17, P108, DOI 10.1002/car.986; McFarlane AC, 2009, CURR OPIN PSYCHIATR, V22, P369, DOI 10.1097/YCO.0b013e32832c9064; *MIL CHILD ED COAL, 2007, MIL CHILD FACTS 2007; Milliken CS, 2007, JAMA-J AM MED ASSOC, V298, P2141, DOI 10.1001/jama.298.18.2141; Minuchin S., 1981, FAMILY THERAPY TECHN; Murray John S, 2002, J Spec Pediatr Nurs, V7, P127; Nachmias M, 1996, CHILD DEV, V67, P508, DOI 10.2307/1131829; Nash WP, OPERATIONAL IN PRESS; NASH WP, 2007, COMBAT STRESS INJURI, P103; O'Connor E, 2007, J APPL DEV PSYCHOL, V28, P458, DOI 10.1016/j.appdev.2007.06.007; OCONNELL ME, 1994, BOARD CHILDREN YOUTH; Office of the Deputy Under Secretary of Defense, 2007, DEM 2007 PROF MIL CO; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Palmer C, 2008, MIL PSYCHOL, V20, P205, DOI 10.1080/08995600802118858; PATTERSON JM, 1987, J ADOLESCENCE, V10, P163, DOI 10.1016/S0140-1971(87)80086-6; PEARROW M, 2009, COMMUNICATION DISORD, V30, P77, DOI DOI 10.1177/1525740108328227; Podorefsky DL, 2001, J AM ACAD CHILD PSY, V40, P879, DOI 10.1097/00004583-200108000-00008; Reger GM, 2009, TELEMED J E-HEALTH, V15, P101, DOI 10.1089/tmj.2008.0050; Rentz ED, 2007, AM J EPIDEMIOL, V165, P1199, DOI 10.1093/aje/kwm008; Riggs DS, 1998, J TRAUMA STRESS, V11, P87, DOI 10.1023/A:1024409200155; ROSEN LN, 1993, MIL MED, V158, P465; Rotheram-Borus MJ, 2004, ARCH PEDIAT ADOL MED, V158, P742, DOI 10.1001/archpedi.158.8.742; Rotheram-Borus MJ, 2001, J CONSULT CLIN PSYCH, V69, P763, DOI 10.1037//0022-006X.69.5.763; Rotherarn-Borus MJ, 2003, AIDS, V17, P1217, DOI 10.1097/01.aids.0000060337.12269.1d; Ruscio AM, 2002, J TRAUMA STRESS, V15, P351, DOI 10.1023/A:1020125006371; RUTTER M, 1984, PSYCHOL MED, V14, P853, DOI 10.1017/S0033291700019838; RUTTER M, 1966, I PSYCHIAT MAUDSLEY, V16; Saltzman W. R., 2002, CHILD CHILD PSYCHIAT, V12, P319; Saltzman William R., 2009, FOCUS MILITARY FAMIL; Saltzman WR, 2001, GROUP DYN-THEOR RES, V5, P291, DOI 10.1037/1089-2699.5.4.291; SALTZMAN WR, 2007, PROJECT FOCUS MILITA; SALTZMAN WR, 2008, TREATING TRAUMATIZED; Schoppe-Sullivan SJ, 2009, J CHILD PSYCHOL PSYC, V50, P698, DOI 10.1111/j.1469-7610.2008.02009.x; Seal KH, 2009, AM J PUBLIC HEALTH, V99, P1651, DOI 10.2105/AJPH.2008.150284; SEGAL MW, 1986, ARMED FORCES SOC, V13, P9, DOI 10.1177/0095327X8601300101; SOLANTAUS T, INT J MENTA IN PRESS, V11, P15; Spoth Richard L, 2002, Prev Sci, V3, P145, DOI 10.1023/A:1019924615322; Sroufe LA, 2005, ATTACH HUM DEV, V7, P349, DOI 10.1080/14616730500365928; Stein JA, 1999, FAM PROCESS, V38, P193, DOI 10.1111/j.1545-5300.1999.00193.x; *US MAR CORPS, 2006, MCRP611CNTTP115M MAR; Waldrep DA, 2004, IRAQ WAR CLIN GUIDE, P83; Walsh F, 2007, FAM PROCESS, V46, P207, DOI 10.1111/j.1545-5300.2007.00205.x; Westerink J, 1999, AUST NZ J PSYCHIAT, V33, P841, DOI 10.1046/j.1440-1614.1999.00638.x	101	18	18	0	9	SPRINGER	NEW YORK	233 SPRING STREET, NEW YORK, NY 10013, UNITED STATES			978-1-4419-7063-3				2011							149	173		10.1007/978-1-4419-7064-0_8	10.1007/978-1-4419-7064-0		25	Psychology, Clinical; Psychology, Developmental	Psychology	BSJ70	WOS:000284727200008					2021-06-18	
J	Li, LZ; Bao, YJ; Zhao, M				Li, Li-Zhuo; Bao, Yi-Jun; Zhao, Min			17Beta-estradiol attenuates programmed cell death in cortical pericontusional zone following traumatic brain injury via upregulation of ERalpha and inhibition of caspase-3 activation	NEUROCHEMISTRY INTERNATIONAL			English	Article						17Beta-estradiol; Cortical pericontusional zone; Estrogen receptor; Caspase-3	ESTROGEN-RECEPTOR-ALPHA; ESTRADIOL-MEDIATED PROTECTION; CENTRAL-NERVOUS-SYSTEM; CEREBRAL-ISCHEMIA; FOCAL ISCHEMIA; APOPTOSIS; RAT; BETA; PROGESTERONE; CONTUSIONS	Pericontusional zone (PCZ) of traumatic cerebral contusion is a target of pharmacological intervention. It is well studied that 17beta-estradiol has a protective role in ischemic brain injury, but its role in brain protection of traumatic brain damage deserves further investigation, especially in pericontusional zone. Here we show that 17beta-estradiol enhances the protein expression and mRNA induction of estrogen alpha receptor (ERalpha) and prevents from programmed cell death in cortical pericontusional zone. ERalpha specific antagonist blocks this protective effect of 17beta-estradiol. Caspase-3 activation occurs in cortical pericontusional zone of the oil-treated injured rat brain and its activation is inhibited by 17beta-estradiol treatment. Additionally. ERalpha specific antagonist reverses this inhibition. Pan-caspase inhibitor also protect cortical pericontusional zone from programmed cell death. Our present study indicates 17beta-estradiol protects from programmed cell death in cortical pericontusional zone via enhancement of ERalpha and decrease of caspase-3 activation. (C) 2010 Elsevier Ltd. All rights reserved.	[Li, Li-Zhuo; Zhao, Min] China Med Univ, Emergency Dept, Shengjing Hosp, Shenyang 110004, Liaoning, Peoples R China; [Bao, Yi-Jun] China Med Univ, Dept Neurosurg, Hosp 1, Shenyang 110004, Liaoning, Peoples R China	Li, LZ (corresponding author), China Med Univ, Emergency Dept, Shengjing Hosp, 36 Sanhao St, Shenyang 110004, Liaoning, Peoples R China.	lilizhuo1@hotmail.com			Natural Science Foundation of Liaoning Provincial Science and Technology Commission, Liaoning, China [20071051]	This study was supported by Grant from Natural Science Foundation of Liaoning Provincial Science and Technology Commission, Liaoning, China (No. 20071051).	BECKER DP, 1977, J NEUROSURG, V47, P491, DOI 10.3171/jns.1977.47.4.0491; Bruce-Keller AJ, 2007, J NEUROTRAUM, V24, P203, DOI 10.1089/neu.2006.0163; Chen G, 2008, ANN CLIN LAB SCI, V38, P65; Chen SH, 2009, CRIT CARE MED, V37, P3097, DOI 10.1097/CCM.0b013e3181bc7986; Davoli MA, 2002, NEUROSCIENCE, V115, P125, DOI 10.1016/S0306-4522(02)00376-7; Dubal DB, 1999, J NEUROSCI, V19, P6385; Dubal DB, 1998, J CEREBR BLOOD F MET, V18, P1253, DOI 10.1097/00004647-199811000-00012; Dubal DB, 2001, P NATL ACAD SCI USA, V98, P1952, DOI 10.1073/pnas.041483198; Dubal DB, 2006, ENDOCRINOLOGY, V147, P3076, DOI 10.1210/en.2005-1177; Duran-Vilaregut J, 2010, NEUROCHEM INT, V56, P443, DOI 10.1016/j.neuint.2009.12.001; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Goodman YD, 1996, J NEUROCHEM, V66, P1836; Green PS, 2000, INT J DEV NEUROSCI, V18, P347, DOI 10.1016/S0736-5748(00)00017-4; Harms C, 2001, J NEUROSCI, V21, P2600, DOI 10.1523/JNEUROSCI.21-08-02600.2001; Hewitt SC, 2000, BREAST CANCER RES, V2, P345, DOI 10.1186/bcr79; Kuiper GGJM, 1997, ENDOCRINOLOGY, V138, P863, DOI 10.1210/en.138.3.863; Kushi H, 2003, ACTA NEUROCHIR SUPPL, V86, P339; LANDERS J P, 1992, Critical Reviews in Eukaryotic Gene Expression, V2, P19; Lebesgue D, 2006, J NEUROTRAUM, V23, P1814, DOI 10.1089/neu.2006.23.1814; Minambres E, 2008, J NEUROTRAUM, V25, P581, DOI 10.1089/neu.2007.0398; Namura S, 1998, J NEUROSCI, V18, P3659; Ng I, 2000, NEUROSURGERY, V46, P949, DOI 10.1097/00006123-200004000-00034; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; Nilsen J, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-74; O'Connor CA, 2005, BRAIN RES, V1062, P171, DOI 10.1016/j.brainres.2005.09.011; Raghupathi R, 2000, J NEUROTRAUM, V17, P927, DOI 10.1089/neu.2000.17.927; Roof RL, 2000, J NEUROTRAUM, V17, P367, DOI 10.1089/neu.2000.17.367; SCHRODER ML, 1995, J NEUROSURG, V82, P966, DOI 10.3171/jns.1995.82.6.0966; Shughrue PJ, 1997, J COMP NEUROL, V388, P507, DOI 10.1002/(SICI)1096-9861(19971201)388:4<507::AID-CNE1>3.0.CO;2-6; Simpkins JW, 1997, J NEUROSURG, V87, P724, DOI 10.3171/jns.1997.87.5.0724; Soustiel JF, 2005, J NEUROTRAUM, V22, P345, DOI 10.1089/neu.2005.22.345; Springer JE, 2001, CLIN CHEM LAB MED, V39, P299, DOI 10.1515/CCLM.2001.046; Suzuki S, 2007, P NATL ACAD SCI USA, V104, P6013, DOI 10.1073/pnas.0610394104; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Vegeto E, 2003, P NATL ACAD SCI USA, V100, P9614, DOI 10.1073/pnas.1531957100; Willingham MC, 1999, J HISTOCHEM CYTOCHEM, V47, P1101, DOI 10.1177/002215549904700901; Wise PM, 2001, FRONT NEUROENDOCRIN, V22, P33, DOI 10.1006/frne.2000.0207; Woolley CS, 1999, CURR OPIN NEUROBIOL, V9, P349, DOI 10.1016/S0959-4388(99)80051-8; Yakovlev AG, 2001, MOL NEUROBIOL, V24, P131	39	18	19	0	4	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0197-0186	1872-9754		NEUROCHEM INT	Neurochem. Int.	JAN	2011	58	1					126	133		10.1016/j.neuint.2010.11.006			8	Biochemistry & Molecular Biology; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	718HM	WOS:000287111700017	21093516				2021-06-18	
J	McFadden, KL; Healy, KM; Dettmann, ML; Kaye, JT; Ito, TA; Hernandez, TD				McFadden, Kristina L.; Healy, Kyle M.; Dettmann, Miranda L.; Kaye, Jesse T.; Ito, Tiffany A.; Hernandez, Theresa D.			Acupressure as a Non-Pharmacological Intervention for Traumatic Brain Injury (TBI)	JOURNAL OF NEUROTRAUMA			English	Article						ERPs; neuropsychological assessment; oddball task; placebo-controlled; Stroop task	MILD HEAD-INJURY; UNITED-STATES; TRANSCENDENTAL-MEDITATION; COGNITIVE FUNCTION; SYMPTOMS; POTENTIALS; SEQUELAE; OPTIMISM; SMOKING; STRESS	Acupressure is a complementary and alternative medicine (CAM) treatment using fingertips to stimulate acupoints on the skin. Although suggested to improve cognitive function, acupressure has not been previously investigated with a controlled design in traumatic brain injury (TBI) survivors, who could particularly benefit from a non-pharmacological intervention for cognitive impairment. A randomized, placebo-controlled, single-blind design assessed the effects of acupressure (eight treatments over 4 weeks) on cognitive impairment and state of being following TBI, including assessment of event-related potentials (ERPs) during Stroop and auditory oddball tasks. It was hypothesized that active acupressure treatments would confer greater cognitive improvement than placebo treatments, perhaps because of enhanced relaxation response induction and resulting stress reduction. Significant treatment effects were found comparing pre- to post-treatment change between groups. During the Stroop task, the active-treatment group showed greater reduction in both P300 latency (p = 0.010, partial eta(2)=0.26) and amplitude (p=0.011, partial eta(2)=0.26), as well as a reduced Stroop effect on accuracy (p = 0.008, partial eta(2)=0.21) than did the placebo group. Additionally, the active-treatment group improved more than did the placebo group on the digit span test (p = 0.043, Cohen's d = 0.68). Together, these results suggest an enhancement in working memory function associated with active treatments. Because acupressure emphasizes self-care and can be taught to novice individuals, it warrants further study as an adjunct treatment for TBI.	[McFadden, Kristina L.; Healy, Kyle M.; Dettmann, Miranda L.; Kaye, Jesse T.; Ito, Tiffany A.; Hernandez, Theresa D.] Univ Colorado, Dept Psychol & Neurosci, Boulder, CO 80309 USA	Hernandez, TD (corresponding author), Univ Colorado, Dept Psychol & Neurosci, 1905 Colorado Ave, Boulder, CO 80309 USA.	Theresa.Hernandez@colorado.edu	Kaye, Jesse T./H-6042-2019; Legget, Kristina/AAU-8563-2020	Kaye, Jesse T./0000-0001-6350-4247; Legget, Kristina/0000-0002-2948-506X	Colorado Traumatic Brain Injury Trust	We thank Jin Shin (acupressure) practitioners Christine Palafox, B.A., C.M.T., N.C.T.M.B. and Tara Dempsey, B.A., and all study participants. We also thank professional research assistant Kate Hoversten, B.A. for help with data collection; undergraduate research assistants D. Frank Distel and Samantha Kile for help with data acquisition/entry; undergraduate research assistant Nathan Faes for help with data entry; and professional research assistant Jessica Sannan, B.S. and departmental information technology specialist Jon Roberts, M.A. for technical support. This work was supported by funding from the Colorado Traumatic Brain Injury Trust Fund.	Arciniegas DB, 2006, BEHAV NEUROL, V17, P25, DOI 10.1155/2006/460592; Bagiella E, 2010, J HEAD TRAUMA REHAB, V25, P375, DOI 10.1097/HTR.0b013e3181d27fe3; Belanger HG, 2007, J NEUROPSYCH CLIN N, V19, P5, DOI 10.1176/appi.neuropsych.19.1.5; BENSON H, 1974, PSYCHIATRY, V37, P37, DOI 10.1080/00332747.1974.11023785; BLAIR SN, 1985, AM J EPIDEMIOL, V122, P794, DOI 10.1093/oxfordjournals.aje.a114163; BOHNEN N, 1992, ACTA NEUROL SCAND, V85, P116, DOI 10.1111/j.1600-0404.1992.tb04009.x; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; BURMEISTER AJ, 1997, JIN SHIN IYUTSU TOUC; Canter PH, 2003, WIEN KLIN WOCHENSCHR, V115, P758, DOI 10.1007/BF03040500; Cantor JB, 2004, ARCH PHYS MED REHAB, V85, pS54, DOI 10.1016/j.apmr.2003.08.113; CLANCY D, 1996, ALTERNATIVE COMPLEME, V2, P173; COHEN J, 1993, BEHAV RES METH INSTR, V25, P257, DOI 10.3758/BF03204507; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; DIKMEN S, 1983, ARCH NEUROL-CHICAGO, V40, P333, DOI 10.1001/archneur.1983.04050060033004; Dikmen SS, 2000, NEUROLOGY, V54, P895, DOI 10.1212/WNL.54.4.895; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; DIKMEN SS, 1991, JAMA-J AM MED ASSOC, V265, P1271, DOI 10.1001/jama.265.10.1271; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Ernst M, 2001, NEUROPSYCHOPHARMACOL, V25, P313, DOI 10.1016/S0893-133X(01)00257-3; Esch Tobias, 2003, Med Sci Monit, V9, pRA23; EWING R, 1980, Journal of Clinical Neuropsychology, V2, P147, DOI 10.1080/01688638008403789; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Felhendler D, 1999, Complement Ther Med, V7, P231, DOI 10.1016/S0965-2299(99)80007-7; GILSON BS, 1975, AM J PUBLIC HEALTH, V65, P1304, DOI 10.2105/AJPH.65.12.1304; Gordon WA, 2000, BRAIN INJURY, V14, P21, DOI 10.1080/026990500120907; GOUVIER WD, 1992, ARCH CLIN NEUROPSYCH, V7, P193, DOI 10.1016/0887-6177(92)90162-G; Hanna-Pladdy B, 2001, CLIN NEUROPSYCHOL, V15, P289, DOI 10.1076/clin.15.3.289.10272; Harris RE, 2005, J ALTERN COMPLEM MED, V11, P673, DOI 10.1089/acm.2005.11.673; HERNANDEZ TD, 2003, SOC AC RES ABSTR, V43; Hillary FG, 2010, BRAIN IMAGING BEHAV, V4, P141, DOI 10.1007/s11682-010-9094-z; Hruby T, 2003, ACTA NEUROBIOL EXP, V63, P55; Ilan AB, 2001, INT J PSYCHOPHYSIOL, V40, P109, DOI 10.1016/S0167-8760(00)00156-2; Katayama J, 1998, PSYCHOPHYSIOLOGY, V35, P23, DOI 10.1017/S0048577298961479; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; Kok A, 2001, PSYCHOPHYSIOLOGY, V38, P557, DOI 10.1017/S0048577201990559; KRAUS JF, 2005, TXB TRAUMATIC BRAIN, P3; KREBS C, 1998, REVOLUTIONARY WAY TH; Kubota JT, 2007, J EXP SOC PSYCHOL, V43, P738, DOI 10.1016/j.jesp.2006.10.023; Larson MJ, 2009, J INT NEUROPSYCH SOC, V15, P927, DOI 10.1017/S1355617709990701; Lesak MD, 2004, NEUROPSYCHOLOGICAL A; MARSH NV, 1995, BRAIN INJURY, V9, P553, DOI 10.3109/02699059509008214; McCrea M, 2008, MILD TRAUMATIC BRAIN; McFadden KL, 2010, EXPLORE-NY, V6, P380, DOI 10.1016/j.explore.2010.08.004; McFadden KL, 2010, COMPLEMENT THER MED, V18, P42, DOI 10.1016/j.ctim.2010.01.001; MINES S, 2003, WE ARE ALL SHOCK OVE; Mines S., 1982, WELLSPRING, V11, P16; Myers SS, 2008, J GEN INTERN MED, V23, P148, DOI 10.1007/s11606-007-0460-5; Nakamura T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008220; Newberg AB, 2010, J ALZHEIMERS DIS, V20, P517, DOI 10.3233/JAD-2010-1391; Oken BS, 2006, ALTERN THER HEALTH M, V12, P40; Pagulayan KF, 2006, ARCH PHYS MED REHAB, V87, P611, DOI 10.1016/j.apmr.2006.01.018; Polich John, 2004, Phys Med Rehabil Clin N Am, V15, P133, DOI 10.1016/S1047-9651(03)00109-8; Potter DD, 2002, J INT NEUROPSYCH SOC, V8, P828, DOI 10.1017/S1355617702860118; Potter DD, 1999, J PSYCHOPHYSIOL, V13, P173, DOI 10.1027//0269-8803.13.3.173; Price DD, 2008, ANNU REV PSYCHOL, V59, P565, DOI 10.1146/annurev.psych.59.113006.095941; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Reitan RM., 1969, MANUAL ADM NEUROPSYC; Reynolds C.R., 2002, COMPREHENSIVE TRAIL; Riggio S, 2009, MT SINAI J MED, V76, P163, DOI 10.1002/msj.20097; RUGG MD, 1993, NEUROPSYCHOLOGIA, V31, P373, DOI 10.1016/0028-3932(93)90161-R; Russell DW, 1996, J PERS ASSESS, V66, P20, DOI 10.1207/s15327752jpa6601_2; SCHEIER MF, 1994, J PERS SOC PSYCHOL, V67, P1063, DOI 10.1037/0022-3514.67.6.1063; SCHEIER MF, 1992, COGNITIVE THER RES, V16, P201, DOI 10.1007/BF01173489; SEMLITSCH HV, 1986, PSYCHOPHYSIOLOGY, V23, P695, DOI 10.1111/j.1469-8986.1986.tb00696.x; SHAPIRO DA, 1981, BRIT J CLIN PSYCHOL, V20, P111, DOI 10.1111/j.2044-8260.1981.tb00504.x; Sivak S, 2008, BRAIN INJURY, V22, P193, DOI 10.1080/02699050801895431; So KT, 2001, INTELLIGENCE, V29, P419, DOI 10.1016/S0160-2896(01)00070-8; Sosin DM, 1996, BRAIN INJURY, V10, P47; Spielberger C.D., 1970, STATE TRAIT ANXIETY; Spikman JM, 2004, J INT NEUROPSYCH SOC, V10, P851, DOI 10.1017/S1355617704106061; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Subramanya P, 2009, BIOPSYCHOSOC MED, V3, DOI 10.1186/1751-0759-3-8; Sugiura Toshifumi, 2007, Journal of Physiological Anthropology, V26, P257, DOI 10.2114/jpa2.26.257; Summers CR, 2009, MT SINAI J MED, V76, P105, DOI 10.1002/msj.20100; Temkin NR, 2007, LANCET NEUROL, V6, P29, DOI 10.1016/S1474-4422(06)70630-5; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Thurman DJ, 2007, BRAIN INJURY MED PRI, P45; Tosevski DL, 2010, CURR OPIN PSYCHIATR, V23, P48, DOI 10.1097/YCO.0b013e328333d625; Tsay SL, 2004, INT J NURS STUD, V41, P99, DOI 10.1016/S0020-7489(03)00079-8; Vanderhasselt MA, 2009, BIOL PSYCHOL, V81, P169, DOI 10.1016/j.biopsycho.2009.03.009; Verbois SL, 2003, NEUROSCIENCE, V119, P1199, DOI 10.1016/S0306-4522(03)00206-9; Wang MC, 2007, J TRAUMA, V62, P1250, DOI 10.1097/01.ta.0000215581.50234.56; Wechsler D, 2008, WECHSLER ADULT INTEL, V4th; Zasler N. D., 2007, BRAIN INJURY MED PRI, P779	84	18	18	0	16	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN	2011	28	1					21	34		10.1089/neu.2010.1515			14	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	710DT	WOS:000286491800003	20979460				2021-06-18	
J	Sundin, J; Forbes, H; Fear, NT; Dandeker, C; Wessely, S				Sundin, Josefin; Forbes, Harriet; Fear, Nicola T.; Dandeker, Christopher; Wessely, Simon			The impact of the conflicts of Iraq and Afghanistan: A UK perspective	INTERNATIONAL REVIEW OF PSYCHIATRY			English	Article							MENTAL-HEALTH PROBLEMS; POSTTRAUMATIC-STRESS-DISORDER; ARMED-FORCES PERSONNEL; TRAUMATIC BRAIN-INJURY; MILITARY PERSONNEL; DEPLOYMENT LENGTH; RISK-FACTORS; WAR; SOLDIERS; SYMPTOMS	Concerns about the mental health of military personnel deployed to Iraq and Afghanistan has led to a new generation of research. This review is an examination of the UK literature on the mental health consequences of deployment of armed forces personnel to Iraq and Afghanistan. As yet, deployment to Iraq or Afghanistan has not been associated with a general increase in mental health problems for the UK Armed Forces. However, research has highlighted certain problems that continue to need to be addressed. Whilst, the rate of post-traumatic stress disorder (PTSD) is low in the UK Armed Forces (1.6-6%), deployment to Iraq or Afghanistan is associated with an increased risk of PTSD for reserve personnel. In contrast to PTSD, the rate of alcohol misuse is high in the UK Armed Forces (between 16-20%), and has been associated with deployment to Iraq or Afghanistan for regular personnel. As the UK military engagement in Afghanistan continues and more personnel are deployed, the demand for help from military health services, the NHS and the service charities will increase.	[Sundin, Josefin] Kings Coll London, Acad Ctr Def Mental Hlth, Weston Educ Ctr, London SE5 9RJ, England; [Forbes, Harriet; Dandeker, Christopher; Wessely, Simon] Kings Coll London, Kings Ctr Mil Hlth Res, London SE5 9RJ, England	Sundin, J (corresponding author), Kings Coll London, Acad Ctr Def Mental Hlth, Weston Educ Ctr, 10 Cutcombe Rd, London SE5 9RJ, England.	Josefin.sundin@kcl.ac.uk	Fear, Nicola/A-1917-2012; Wessely, Simon C/A-8713-2008; Sundin, Josefin/B-9666-2012	Fear, Nicola/0000-0002-5792-2925; Wessely, Simon Charles/0000-0002-6743-9929; Forbes, Harriet/0000-0001-6888-2212; Sundin, Josefin/0000-0002-0609-586X			Adler AB, 2005, J OCCUP HEALTH PSYCH, V10, P121, DOI 10.1037/1076-8998.10.2.121; Basoglu M, 2005, JAMA-J AM MED ASSOC, V294, P580, DOI 10.1001/jama.294.5.580; Browne T, 2008, OCCUP ENVIRON MED, V65, P628, DOI 10.1136/oem.2007.036830; Browne T, 2007, BRIT J PSYCHIAT, V190, P484, DOI 10.1192/bjp.bp.106.030544; Buckman JEJ, 2011, OCCUP ENVIRON MED, V68, P69, DOI 10.1136/oem.2009.054692; Burbeck R, 2002, EMERG MED J, V19, P234, DOI 10.1136/emj.19.3.234; Collins PA, 2003, OCCUP MED-OXFORD, V53, P256, DOI 10.1093/occmed/kqg061; Dandeker C, 2010, ARMED FORCES SOC, V36, P264, DOI 10.1177/0095327X09344068; *DASA, 2010, UK ARM FORC PSYCH MO; *DASA, 2009, UK ARM FORC PSYCH MO; Dedert EA, 2009, J PSYCHIATR RES, V43, P830, DOI 10.1016/j.jpsychires.2009.01.004; Dikel TN, 2005, J TRAUMA STRESS, V18, P69, DOI 10.1002/jts.20002; *DIR RES FORC CAD, 2005, FUT US UK RES FORC; Dohrenwend BP, 2006, SCIENCE, V313, P979, DOI 10.1126/science.1128944; Fear NT, 2009, PSYCHOL MED, V39, P1379, DOI 10.1017/S0033291708004595; Fear NT, 2007, ADDICTION, V102, P1749, DOI 10.1111/j.1360-0443.2007.01978.x; Fear NT, 2010, LANCET, V375, P1783, DOI 10.1016/S0140-6736(10)60672-1; Fear NT, 2009, INT J OCCUP ENV HEAL, V15, P291; Gould M, 2010, J ROY SOC MED, V103, P148, DOI 10.1258/jrsm.2010.090426; Grieger TA, 2006, AM J PSYCHIAT, V163, P1777, DOI 10.1176/appi.ajp.163.10.1777; *HC DEF COMM, 2004, 3 HOUS COMM DEF COMM; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Horn O, 2006, LANCET, V367, P1742, DOI 10.1016/S0140-6736(06)68661-3; Hotopf M, 2006, LANCET, V367, P1731, DOI 10.1016/S0140-6736(06)68662-5; Hughes JH, 2005, BRIT J PSYCHIAT, V186, P536, DOI 10.1192/bjp.186.6.536; Iversen AC, 2008, PSYCHOL MED, V38, P511, DOI 10.1017/S0033291708002778; Iversen AC, 2009, BMC PSYCHIATRY, V9, DOI 10.1186/1471-244X-9-68; Kang HK, 2005, NEW ENGL J MED, V352, P1289, DOI 10.1056/NEJMp058024; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; Langston V, 2007, MIL MED, V172, P931, DOI 10.7205/MILMED.172.9.931; Langston V, 2010, J MENT HEALTH, V19, P8, DOI 10.3109/09638230802522999; Milliken CS, 2007, JAMA-J AM MED ASSOC, V298, P2141, DOI 10.1001/jama.298.18.2141; Mulligan K, 2010, BRIT J PSYCHIAT, V197, P405, DOI 10.1192/bjp.bp.110.077263; National Audit Office, 2006, 16331 HC NAT AUD OFF, P2005; *NCCMH NICE, 2005, 26 NCCMHNICE ROYAL C; Perrin MA, 2007, AM J PSYCHIAT, V164, P1385, DOI 10.1176/appi.ajp.2007.06101645; Rona RJ, 2007, BRIT MED J, V335, P603, DOI 10.1136/bmj.39274.585752.BE; Rona RJ, 2006, BMJ-BRIT MED J, V333, P991, DOI 10.1136/BMJ.38985.610949.55; Rona RJ, 2009, J TRAUMA STRESS, V22, P11, DOI 10.1002/jts.20383; Sundin J, 2010, OCCUP MED-OXFORD, V60, P552, DOI 10.1093/occmed/kqq129; Sundin J, 2010, PSYCHOL MED, V40, P367, DOI 10.1017/S0033291709990791; Sundin J, 2010, INT ARCH OCC ENV HEA, V83, P653, DOI 10.1007/s00420-009-0504-8; SWEENEY M, 2007, GUARDIAN        0405; Thomas JL, 2010, ARCH GEN PSYCHIAT, V67, P614, DOI 10.1001/archgenpsychiatry.2010.54; Turner MA, 2005, BRIT J PSYCHIAT, V186, P476, DOI 10.1192/bjp.186.6.476; Unwin C, 1999, LANCET, V353, P169, DOI 10.1016/S0140-6736(98)11338-7; Vasterling JJ, 2010, J TRAUMA STRESS, V23, P41, DOI 10.1002/jts.20487; 2010, DEFENCE POLICY BUSIN	50	18	18	0	11	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0954-0261			INT REV PSYCHIATR	Int. Rev. Psych.		2011	23	2					153	159		10.3109/09540261.2011.561303			7	Psychiatry	Psychiatry	755PO	WOS:000289946800005	21521084				2021-06-18	
J	Baralic, I; Savic, S; Alempijevic, DM; Jecmenica, DS; Sbutega-Milosevic, G; Obradovic, M				Baralic, Ivanka; Savic, Slobodan; Alempijevic, Djordje M.; Jecmenica, Dragan S.; Sbutega-Milosevic, Gorica; Obradovic, Miroljub			Child homicide on the territory of Belgrade	CHILD ABUSE & NEGLECT			English	Article						Children; Homicide; Neonaticide; Fatal child abuse; Forensic pathology	INFANTICIDE; WALES; FILICIDE; ENGLAND; DEATHS	Objective: This study examines the incidence and other epidemiological and medico-legal characteristics of child homicide in the territory of Belgrade, Republic of Serbia. Methods: We performed a retrospective analysis of all autopsies carried out at the Institute of Forensic Medicine in Belgrade during a 15 year period between 1991 and 2005, focusing on homicide cases of victims aged 0-14 years. These were then analyzed in terms of number of deaths, mortality rates, age, and sex of the victim, relation to the perpetrator, and cause of death and injury. Results: Forty-six homicides were identified where the victims were aged 0-14 years. These included 24 girls and 22 boys. In 32 cases (69.6%) the perpetrator was one of the child's birth parents, more frequently the mother. Blunt head trauma was the most frequent cause of death, followed by exsanguination. In 9 cases (19.5%) there was evidence of physical abuse; 16 children died in the setting of multiple homicide and/or murder/suicide. In 4 cases (8.7%) there was evidence of neglect which contributed to the fatal outcome. There were 10 cases of neonaticide within the 46 homicides. There were, however, 49 further cases where bodies of newborn infants were discovered after having been disposed of in suspicious circumstances. Conclusions: Proportionally, the largest number of victims fell within the 1-4 years age group, with a slight preponderance of females, most of them killed at home by a close family member, usually the mother. Blunt head trauma was the single most frequent cause of death. Injury patterns consistent with child abuse were identified among 20% of the study group. (C) 2010 Elsevier Ltd. All rights reserved.	[Baralic, Ivanka; Savic, Slobodan; Alempijevic, Djordje M.; Jecmenica, Dragan S.; Obradovic, Miroljub] Univ Belgrade, Inst Forens Med, Sch Med, Belgrade 11000, Serbia; [Sbutega-Milosevic, Gorica] Univ Belgrade, Inst Hyg & Med Ecol, Sch Med, Belgrade 11000, Serbia	Alempijevic, DM (corresponding author), Univ Belgrade, Inst Forens Med, Sch Med, Deligradska 31A, Belgrade 11000, Serbia.		Alempijevic, Djordje/H-1128-2014	Alempijevic, Djordje/0000-0002-0810-9559			Alempijevic Djordje, 2006, Srp Arh Celok Lek, V134 Suppl 2, P135; Bohnert M, 2005, INT J LEGAL MED, V119, P31, DOI 10.1007/s00414-004-0458-z; Bourget D, 2002, J AM ACAD PSYCHIATRY, V30, P345; Brookman F, 2006, J INTERPERS VIOLENCE, V21, P869, DOI 10.1177/0886260506288935; BYARD WR, 2004, FORENSIC PATHOLOGY R, V1, P171; *CDCP, 1997, JAMA-J AM MED ASSOC, V277, P704; Cordner S M, 2001, Leg Med (Tokyo), V3, P95, DOI 10.1016/S1344-6223(01)00016-5; DICKEMANN M, 2008, INFANTICIDE COMP EVO, P427; DiMaio Vjm, 2001, FORENSIC PATHOLOGY; Dix J, 1998, AM J FOREN MED PATH, V19, P321, DOI 10.1097/00000433-199812000-00005; Flynn SM, 2007, J CLIN PSYCHIAT, V68, P1501, DOI 10.4088/JCP.v68n1005; Friedman SH, 2005, AM J PSYCHIAT, V162, P1578, DOI 10.1176/appi.ajp.162.9.1578; Goldfrank LR, 1998, GOLDFRANKS TOXICOLOG; Hadareanu V, 2007, ROM J LEG MED, V15, P278; Karakus M, 2003, CROAT MED J, V44, P592; KASIM MS, 1995, CHILD ABUSE NEGLECT, V19, P847, DOI 10.1016/0145-2134(95)00046-B; KEELING WJ, 2009, PAEDIAT FORENSIC MED, P180; Knight B, 1996, FORENSIC PATHOLOGY; LAZIN D, 2006, KRIVICNI ZAKONIK OBR; Lucas DR, 2002, CHILD ABUSE NEGLECT, V26, P167, DOI 10.1016/S0145-2134(01)00315-5; Lyman JM, 2003, CHILD ABUSE NEGLECT, V27, P1063, DOI 10.1016/S0145-2134(03)00166-2; Marcikic M, 2006, COLLEGIUM ANTROPOL, V30, P437; MARKS MN, 1993, MED SCI LAW, V33, P329, DOI 10.1177/002580249303300411; MASON JK, 1989, PAEDIAT FORENSIC MED; Meadow R, 1999, ARCH DIS CHILD, V80, P7, DOI 10.1136/adc.80.1.7; Moniruzzaman S, 2005, SCAND J PUBLIC HEALT, V33, P464, DOI 10.1080/14034940510006021; Mujkic A, 2008, ARCH PEDIAT ADOL MED, V162, P140, DOI 10.1001/archpediatrics.2007.31; Nielssen OB, 2009, MED J AUSTRALIA, V190, P7, DOI 10.5694/j.1326-5377.2009.tb02252.x; PATTON SB, 2003, TOPICS ADV PRACTICE, V3; Pearson J, 2009, BMC PEDIATR, V9, DOI 10.1186/1471-2431-9-26; Romain N, 2003, MED SCI LAW, V43, P203, DOI 10.1258/rsmmsl.43.3.203; Rouge-Maillart C, 2005, AM J FOREN MED PATH, V26, P320, DOI 10.1097/01.paf.0000188085.11961.b2; *ROYAL COLL PAED C, 2004, SUDD UNEXP DEATH INF; *STAT ANN BELGR, 2008, BELGR BUR INF STAT; WEEKESSHACKELFO.VA, 2004, METHODS, V19, P75	35	18	18	0	8	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0145-2134			CHILD ABUSE NEGLECT	Child Abuse Negl.	DEC	2010	34	12					935	942		10.1016/j.chiabu.2010.06.003			8	Family Studies; Psychology, Social; Social Work	Family Studies; Psychology; Social Work	704FX	WOS:000286037600005	21030080				2021-06-18	
J	Ranaivo, HR; Patel, F; Wainwright, MS				Ranaivo, Hantamalala Ralay; Patel, Fatima; Wainwright, Mark S.			Albumin activates the canonical TGF receptor-smad signaling pathway but this is not required for activation of astrocytes	EXPERIMENTAL NEUROLOGY			English	Article						Albumin; Astrocyte; Cytokines; TGF beta receptor; Smads	TRAUMATIC BRAIN-INJURY; GROWTH-FACTOR-BETA; NITRIC-OXIDE SYNTHASE; REDUCES NEUROLOGICAL DEFICIT; MATRIX-METALLOPROTEINASE-9 EXPRESSION; TRANSFORMING GROWTH-FACTOR-BETA-1; RAT; CYTOKINE; CELLS; NEUROTOXICITY	The use of albumin as a resuscitation fluid is considered safe for most critically ill patients. However, clinical data suggest albumin may increase mortality in neurotrauma, but improve outcome after stroke. Albumin has been shown to activate glia, and to play a role in the mechanisms of epileptogenesis via the TGF beta-receptor (TGF beta R). We have previously shown that albumin induces the production of inflammatory mediators including IL-1 beta via activation of MAPK pathways in primary astrocytes and microglia. The extracellular signaling mechanisms leading to the activation of glial cells in response to albumin are not well understood. Here, we investigated the role of the TGF beta R and the canonical TGF beta receptor-smad signaling pathway in astrocyte activation by albumin. In primary astrocyte cultures, albumin activated the smad pathway downstream of the TGF beta R by increasing the phosphorylation of smad2, and in the level of smad3 and smad4 translocated to the nucleus. Albumin produced an increase in IL-1 beta which was not dependent on smad activation, but was prevented by blockade of the TGF beta R. Increase in the chemokine CX3CL1, and the decrease in S100B produced by albumin were independent of the TGF beta R and smad activation. Albumin induced an increase in LDH release that was inhibited by blockade of the TGF beta R and by inhibition of smad activation. These findings show that albumin activates the canonical TGF beta receptor-smad signaling pathway. The albumin-induced increase in the pro-epileptogenic cytokine IL-1 beta involves the TGF beta R, but is independent of smad activation. Taken together, the effects of albumin on both IL-1 beta and activation of the TGF beta R pathway are further evidence for a role for albumin in neurotrauma-related epileptogenesis. (c) 2010 Elsevier Inc. All rights reserved.	[Ranaivo, Hantamalala Ralay; Patel, Fatima; Wainwright, Mark S.] Northwestern Univ, Dept Pediat, Div Neurol, Feinberg Sch Med, Chicago, IL 60611 USA; [Ranaivo, Hantamalala Ralay; Patel, Fatima; Wainwright, Mark S.] Northwestern Univ, Ctr Interdisciplinary Res Pediat Crit Illness & I, Feinberg Sch Med, Chicago, IL 60611 USA	Wainwright, MS (corresponding author), Childrens Mem Hosp, Div Neurol 51, 2300 Childrens Plaza, Chicago, IL 60614 USA.	m-wainwright@northwestern.edu			Davee Foundation; Medical Research Junior Board Foundation; Lyndsey Whittingham Foundation	Dr. Wainwright is supported by the Davee Foundation, the Medical Research Junior Board Foundation, and by the Lyndsey Whittingham Foundation.	Allan SM, 2005, NAT REV IMMUNOL, V5, P629, DOI 10.1038/nri1664; Balosso S, 2008, BRAIN, V131, P3256, DOI 10.1093/brain/awn271; Belayev L, 2005, STROKE, V36, P326, DOI 10.1161/01.STR.0000152949.31366.3d; Belayev L, 1999, J NEUROTRAUM, V16, P445, DOI 10.1089/neu.1999.16.445; Belayev L, 1999, BRAIN RES, V845, P107, DOI 10.1016/S0006-8993(99)01952-6; Boldt J, 2010, BRIT J ANAESTH, V104, P276, DOI 10.1093/bja/aep393; Buisson A, 2003, CELL MOL NEUROBIOL, V23, P539, DOI 10.1023/A:1025072013107; Buttram SDW, 2007, J NEUROTRAUM, V24, P1707, DOI 10.1089/neu.2007.0349; Cacheaux LP, 2009, J NEUROSCI, V29, P8927, DOI 10.1523/JNEUROSCI.0430-09.2009; Calvo CF, 2005, J NEUROSCI RES, V80, P707, DOI 10.1002/jnr.20511; Docagne F, 2002, MOL CELL NEUROSCI, V21, P634, DOI 10.1006/mcne.2002.1206; ELLIS EF, 1995, J NEUROTRAUM, V12, P325, DOI 10.1089/neu.1995.12.325; Ginsberg MD, 2006, BIOCHEM SOC T, V34, P1323, DOI 10.1042/BST0341323; Hooper C, 2005, J NEUROCHEM, V92, P1363, DOI 10.1111/j.1471-4159.2005.02982.x; Hooper C, 2009, J NEUROCHEM, V109, P694, DOI 10.1111/j.1471-4159.2009.05953.x; Hu JG, 1996, J BIOL CHEM, V271, P2543, DOI 10.1074/jbc.271.5.2543; Hu JR, 1997, J NEUROCHEM, V69, P2294; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Ivens S, 2007, BRAIN, V130, P535, DOI 10.1093/brain/awl317; Jinnin M, 2006, MOL PHARMACOL, V69, P597, DOI 10.1124/mol.105.017483; Jones NC, 2004, J NEUROPATH EXP NEUR, V63, P708, DOI 10.1093/jnen/63.7.708; Kinoshita K, 2002, NEUROSURGERY, V51, P195, DOI 10.1097/00006123-200207000-00027; Kozuka N, 2007, NEUROSCIENCE, V144, P911, DOI 10.1016/j.neuroscience.2006.10.040; Ledeboer A, 2000, GLIA, V30, P134, DOI 10.1002/(SICI)1098-1136(200004)30:2<134::AID-GLIA3>3.0.CO;2-3; Louin G, 2006, NEUROPHARMACOLOGY, V50, P182, DOI 10.1016/j.neuropharm.2005.08.020; Morganti-Kossmann MC, 1999, J NEUROTRAUM, V16, P617, DOI 10.1089/neu.1999.16.617; Mrak RE, 2005, NEUROBIOL AGING, V26, P349, DOI 10.1016/j.neurobiolaging.2004.05.010; Myburgh J, 2007, NEW ENGL J MED, V357, P874; NADAL A, 2001, BRAIN RES, V132, P367; Palesch YY, 2006, STROKE, V37, P2107, DOI 10.1161/01.STR.0000231389.34701.b5; PREHN JHM, 1993, J CEREBR BLOOD F MET, V13, P521, DOI 10.1038/jcbfm.1993.67; Ranaivo HR, 2010, BRAIN RES, V1313, P222, DOI 10.1016/j.brainres.2009.11.063; Re DB, 2006, NAT NEUROSCI, V9, P859; Ruocco A, 1999, J CEREBR BLOOD F MET, V19, P1345, DOI 10.1097/00004647-199912000-00008; Schmierer B, 2007, NAT REV MOL CELL BIO, V8, P970, DOI 10.1038/nrm2297; Si QS, 1997, GLIA, V21, P413, DOI 10.1002/(SICI)1098-1136(199712)21:4<413::AID-GLIA9>3.0.CO;2-3; Siddiqui SS, 2004, AM J PHYSIOL-LUNG C, V286, pL1016, DOI 10.1152/ajplung.00356.2003; Sinz EH, 1999, J CLIN INVEST, V104, P647, DOI 10.1172/JCI6670; Tabernero A, 2002, J BIOL CHEM, V277, P4240, DOI 10.1074/jbc.M108760200; Takekawa M, 2002, EMBO J, V21, P6473, DOI 10.1093/emboj/cdf643; Tehranian R, 2002, J NEUROTRAUM, V19, P939, DOI 10.1089/089771502320317096; Thornton P, 2008, MOL CELL NEUROSCI, V37, P135, DOI 10.1016/j.mcn.2007.09.002; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Vecil GG, 2000, J NEUROSCI RES, V61, P212, DOI 10.1002/1097-4547(20000715)61:2<212::AID-JNR12>3.0.CO;2-9; Wang Y, 2007, EXP NEUROL, V203, P168, DOI 10.1016/j.expneurol.2006.08.006; Wu CY, 2004, J NEUROCHEM, V90, P1477, DOI 10.1111/j.1471-4159.2004.02682.x; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328; Zhao TZ, 2009, NEUROL SCI, V30, P379, DOI 10.1007/s10072-009-0123-x; Zujovic V, 2000, GLIA, V29, P305, DOI 10.1002/(SICI)1098-1136(20000215)29:4<305::AID-GLIA2>3.0.CO;2-V	49	18	18	0	9	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	DEC	2010	226	2					310	319		10.1016/j.expneurol.2010.09.005			10	Neurosciences	Neurosciences & Neurology	675MW	WOS:000283835800007	20854815				2021-06-18	
J	Wang, DM; Hazel, AS				Wang, Dongmei; Hazel, Alan S.			Microglial activation is a major contributor to neurologic dysfunction in thiamine deficiency	BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS			English	Article						Wernicke encephalopathy; Inflammation; Microglia; Vitamin B-1; Neurologic dysfunction; Oxidative stress	TRAUMATIC BRAIN-INJURY; GLUTAMATE TRANSPORTERS; INDUCED APOPTOSIS; OXIDATIVE STRESS; N-ACETYLCYSTEINE; MILD IMPAIRMENT; GENE-EXPRESSION; MEDIAL THALAMUS; DOWN-REGULATION; MINOCYCLINE	In Wernicke's encephalopathy and thiamine deficiency (TD), the cause of this brain disorder, development of inflammation is an important aspect of the disease process. How this pathological mechanism relates to the neurologic impairment associated with TD, however, remains unclear. A key feature of the inflammatory process is the activation of microglia. In the present study, we evaluated the role of microglial activation in the pathophysiology of TD by examining the relationship between levels of CD11b/c and CD68, two proteins associated with microglial activation, and neurological dysfunction under conditions of TD. Rats with TD showed large increases in expression of both CD11b/c and CD68 in the vulnerable thalamus and inferior colliculus, with no change in mRNA levels in the relatively non-vulnerable frontal cortex. These alterations in CD11b/c and CD68 expression were reflected in dramatic upregulation of both proteins by immunoblotting and immunohistochemical methods. Co-treatment of rats with TD and the anti-inflammatory drug minocycline prevented microglial activation, and onset of neurological changes, including loss of righting reflex, was delayed by approximately 39 h, compared to animals with TD alone. In addition, co-treatment of rats with TD and N-acetylcysteine prevented the increase in CD11b/c and CD68, but did not alter the onset of neurological impairment. These results suggest that microglial activation plays a role in the development of neurological impairment in TD and possibly Wernicke's encephalopathy, and that while development of oxidative stress may be involved in microglial activation, the basis of this neurologic dysfunction is likely to be multifactorial in nature. (C) 2010 Elsevier Inc. All rights reserved.	[Wang, Dongmei; Hazel, Alan S.] Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada	Hazel, AS (corresponding author), Hop St Luc CHUM, NeuroRescue Lab, 1058 St Denis, Montreal, PQ H2X 3J4, Canada.	alan.stewart.hazell@umontreal.ca			Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [MOP-84497]	This study was supported by a grant from The Canadian Institutes of Health Research (MOP-84497).	Bye N, 2007, EXP NEUROL, V204, P220, DOI 10.1016/j.expneurol.2006.10.013; Calingasan NY, 1999, J NEUROPATH EXP NEUR, V58, P946, DOI 10.1097/00005072-199909000-00005; Carmichael EA, 1931, BRAIN, V54, P189, DOI 10.1093/brain/54.2.189; Chornyy S, 2007, ACTA BIOCHIM POL, V54, P315, DOI 10.18388/abp.2007_3252; COLLINS GH, 1967, AM J PATHOL, V50, P791; Dringen R, 2005, ANTIOXID REDOX SIGN, V7, P1223, DOI 10.1089/ars.2005.7.1223; GIULIAN D, 1989, J NEUROSCI, V9, P4416; Hazell AS, 2010, GLIA, V58, P148, DOI 10.1002/glia.20908; Hazell AS, 2005, J NEUROSCI RES, V79, P200, DOI 10.1002/jnr.20278; Hazell AS, 2001, J NEUROCHEM, V78, P560, DOI 10.1046/j.1471-4159.2001.00436.x; Karuppagounder SS, 2007, NEUROBIOL DIS, V26, P353, DOI 10.1016/j.nbd.2007.01.011; Ke ZJ, 2006, NEUROCHEM INT, V49, P548, DOI 10.1016/j.neuint.2006.04.011; Kruse M, 2004, NEUROCHEM INT, V45, P49, DOI 10.1016/j.neuint.2003.12.007; Langlais PJ, 1997, METAB BRAIN DIS, V12, P137, DOI 10.1023/B:MEBR.0000007108.14989.e8; Lee SM, 2003, J NEUROTRAUM, V20, P1017, DOI 10.1089/089771503770195867; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Matsushima K, 1997, NEUROREPORT, V8, P867; MCGEER PL, 1988, NEUROLOGY, V38, P1285, DOI 10.1212/WNL.38.8.1285; Morimoto N, 2005, BRAIN RES, V1044, P8, DOI 10.1016/j.brainres.2005.02.062; MORIOKA T, 1991, J CEREBR BLOOD F MET, V11, P966, DOI 10.1038/jcbfm.1991.162; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Pi RB, 2004, J NEUROCHEM, V91, P1219, DOI 10.1111/j.1471-4159.2004.02796.x; Raivich G, 1999, ACTA NEUROCHIR SUPPL, V73, P21; ROBERTSON DM, 1975, AM J PATHOL, V79, P107; Rozen S, 2000, Methods Mol Biol, V132, P365; Todd KG, 1999, GLIA, V25, P190, DOI 10.1002/(SICI)1098-1136(19990115)25:2<190::AID-GLIA9>3.0.CO;2-B; Vemuganti R, 2006, EUR J NEUROSCI, V23, P1172, DOI 10.1111/j.1460-9568.2006.04651.x; Victor M, 1989, WERNICKE KORSAKOFF S; Wang JJL, 2000, J NUTR BIOCHEM, V11, P208, DOI 10.1016/S0955-2863(00)00067-X; Xiong Y, 1999, J NEUROTRAUM, V16, P1067, DOI 10.1089/neu.1999.16.1067; Yrjanheikki J, 1999, P NATL ACAD SCI USA, V96, P13496, DOI 10.1073/pnas.96.23.13496	31	18	21	0	2	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0006-291X	1090-2104		BIOCHEM BIOPH RES CO	Biochem. Biophys. Res. Commun.	NOV 5	2010	402	1					123	128		10.1016/j.bbrc.2010.09.128			6	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	679TB	WOS:000284182600022	20932820				2021-06-18	
J	Kubota, M; Kasahara, T; Iwamoto, K; Komori, A; Ishiwata, M; Miyauchi, T; Kato, T				Kubota, Mie; Kasahara, Takaoki; Iwamoto, Kazuya; Komori, Atsuko; Ishiwata, Mizuho; Miyauchi, Taeko; Kato, Tadafumi			Therapeutic implications of down-regulation of cyclophilin D in bipolar disorder	INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY			English	Article						Bipolar disorder; cyclophilin D; DNA microarray; mtDNA; NIM811	MITOCHONDRIAL PERMEABILITY TRANSITION; MAGNETIC-RESONANCE-SPECTROSCOPY; FOCAL CEREBRAL-ISCHEMIA; TRAUMATIC BRAIN-INJURY; CELL-DEATH; CYCLOSPORINE-A; DNA MUTATIONS; GENE-EXPRESSION; MOOD STABILIZER; SPLICING FACTOR	We previously reported that neuron-specific mutant Polg1 (mitochondrial DNA polymerase) transgenic (Tg) mice exhibited bipolar disorder (BD)-like phenotypes such as periodic activity change and altered circadian rhythm. In this study, we re-evaluated two datasets resulting from DNA microarray analysis to estimate a biological pathway associated with the disorder. The gene lists were derived from the comparison between post-mortem brains of BD patients and control subjects, and from the comparison between the brains of Tg and wild-type mice. Gene ontology analysis showed that 16 categories overlapped in the altered gene expression profiles of BD patients and the mouse model. In the brains of Tg mice, 33 genes showed similar changes in the frontal cortex and hippocampus compared to wild-type mice. Among the 33 genes, SFPQ and PPIF were differentially expressed in post-mortem brains of BD patients compared to control subjects. The only gene consistently down-regulated in both patients and the mouse model was PPIF, which encodes cyclophilin D (CypD), a component of the mitochondrial permeability transition pore. A blood-brain barrier-permeable CypD inhibitor significantly improved the abnormal behaviour of Tg mice at 40 mg/kg.d. These findings collectively suggest that CypD is a promising target for a new drug for BD.	[Kubota, Mie; Kasahara, Takaoki; Iwamoto, Kazuya; Komori, Atsuko; Ishiwata, Mizuho; Miyauchi, Taeko; Kato, Tadafumi] RIKEN Brain Sci Inst, Lab Mol Dynam Mental Disorders, Wako, Saitama 3510198, Japan	Kato, T (corresponding author), RIKEN Brain Sci Inst, Lab Mol Dynam Mental Disorders, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	kato@brain.riken.jp	Kato, Tadafumi/J-3583-2014; Kasahara, Takaoki/AAJ-5367-2020	Kato, Tadafumi/0000-0001-7856-3952; Kasahara, Takaoki/0000-0002-0953-5146	RIKEN BSI; Japanese Ministry of Health and Labor; Japanese Ministry of Education, Culture, Sports, Science and TechnologyMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT); Grants-in-Aid for Scientific ResearchMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI) [20689022] Funding Source: KAKEN	Post-mortem brains were donated by the Stanley Foundation Brain Collection, courtesy of Drs Michael B. Knable, E. Fuller Torrey, Maree J. Webster, and Robert H. Yolken. We are grateful to staff members of the BSI Research Resource Center for technical assistance and for microarray analysis. We also thank BoldFace Editors, Inc., for language editing of the manuscript. This work was supported by grants to the Laboratory for Molecular Dynamics of Mental Disorders, RIKEN BSI, a Grant-in-Aid from the Japanese Ministry of Health and Labor, and Grants-in-Aid from the Japanese Ministry of Education, Culture, Sports, Science and Technology. NIM 811 was provided by Novartis Pharma.	Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Basso E, 2005, J BIOL CHEM, V280, P18558, DOI 10.1074/jbc.C500089200; Billups B, 2002, J NEUROSCI, V22, P5840; Boyle MP, 2005, P NATL ACAD SCI USA, V102, P473, DOI 10.1073/pnas.0406458102; Chanas-Sacre G, 1999, J NEUROSCI RES, V57, P62, DOI 10.1002/(SICI)1097-4547(19990701)57:1<62::AID-JNR7>3.0.CO;2-Y; Chen G, 1999, J NEUROCHEM, V72, P879, DOI 10.1046/j.1471-4159.1999.720879.x; Corson TW, 2004, EUR NEUROPSYCHOPHARM, V14, P143, DOI 10.1016/S0924-977X(03)00102-0; Dager SR, 2004, ARCH GEN PSYCHIAT, V61, P450, DOI 10.1001/archpsyc.61.5.450; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Du H, 2008, NAT MED, V14, P1097, DOI 10.1038/nm.1868; Ferreira MAR, 2008, NAT GENET, V40, P1056, DOI 10.1038/ng.209; Forte M, 2007, P NATL ACAD SCI USA, V104, P7558, DOI 10.1073/pnas.0702228104; Glatt S. J., 2009, Current Pharmacogenomics & Personalized Medicine, V7, P164; Hansson MJ, 2004, J BIOENERG BIOMEMBR, V36, P407, DOI 10.1023/B:JOBB.0000041776.31885.45; HERMAN JP, 1995, NEUROENDOCRINOLOGY, V61, P180, DOI 10.1159/000126839; Hiroi T, 2005, PHARMACOGENOMICS J, V5, P102, DOI 10.1038/sj.tpj.6500296; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Iacobazzi V, 2005, BIOCHEM J, V391, P613, DOI 10.1042/BJ20050776; Iwamoto K, 2005, HUM MOL GENET, V14, P241, DOI 10.1093/hmg/ddi022; Jeong MR, 2003, FEBS LETT, V542, P74, DOI 10.1016/S0014-5793(03)00350-8; Kakiuchi C, 2003, NAT GENET, V35, P171, DOI 10.1038/ng1235; Kasahara T, 2006, MOL PSYCHIATR, V11, P577, DOI 10.1038/sj.mp.4001824; KATO T, 1994, J AFFECT DISORDERS, V31, P125, DOI 10.1016/0165-0327(94)90116-3; KATO T, 1993, J AFFECT DISORDERS, V27, P53, DOI 10.1016/0165-0327(93)90097-4; Kato T, 2000, BIPOLAR DISORD, V2, P180, DOI 10.1034/j.1399-5618.2000.020305.x; Kato T, 2008, TRENDS NEUROSCI, V31, P495, DOI 10.1016/j.tins.2008.07.007; Kato T, 2007, CNS DRUGS, V21, P1, DOI 10.2165/00023210-200721010-00001; Kim MH, 2005, J NEUROSCI, V25, P6057, DOI 10.1523/JNEUROSCI.0454-05.2005; Kitraki E, 1999, NEUROENDOCRINOLOGY, V69, P331, DOI 10.1159/000054435; Korde AS, 2007, J NEUROTRAUM, V24, P895, DOI 10.1089/neu.2006.0122; Kubota M, 2006, J NEUROSCI, V26, P12314, DOI 10.1523/JNEUROSCI.3933-06.2006; Le-Niculescu H, 2008, AM J MED GENET B, V147B, P134, DOI 10.1002/ajmg.b.30707; Leung AWC, 2008, J BIOL CHEM, V283, P26312, DOI 10.1074/jbc.M805235200; Li JZ, 2004, HUM MOL GENET, V13, P609, DOI 10.1093/hmg/ddh065; Lowery LA, 2007, DEV DYNAM, V236, P1347, DOI 10.1002/dvdy.21132; Luvisetto S, 2008, NEUROSCIENCE, V155, P585, DOI 10.1016/j.neuroscience.2008.06.030; Mbye LH, 2008, EXP NEUROL, V209, P243, DOI 10.1016/j.expneurol.2007.09.025; Millay DP, 2008, NAT MED, V14, P442, DOI 10.1038/nm1736; Mott JL, 2004, BIOCHEM BIOPH RES CO, V319, P1210, DOI 10.1016/j.bbrc.2004.05.104; Mott JL, 2001, MUTAT RES-FUND MOL M, V474, P35, DOI 10.1016/S0027-5107(00)00159-7; Mott JL, 2006, BBA-BIOENERGETICS, V1757, P596, DOI 10.1016/j.bbabio.2006.04.014; Mouri A, 2010, HIPPOCAMPUS, V20, P293, DOI 10.1002/hipo.20625; Naga KK, 2007, J NEUROSCI, V27, P7469, DOI 10.1523/JNEUROSCI.0646-07.2007; Nakagawa T, 2005, NATURE, V434, P652, DOI 10.1038/nature03317; Nakatani N, 2006, HUM MOL GENET, V15, P1949, DOI 10.1093/hmg/ddl118; Nonaka S, 1998, P NATL ACAD SCI USA, V95, P2642, DOI 10.1073/pnas.95.5.2642; Palma E, 2009, HUM MOL GENET, V18, P2024, DOI 10.1093/hmg/ddp126; Qing H, 2003, EUR J NEUROSCI, V17, P1563, DOI 10.1046/j.1460-9568.2003.02590.x; Rasmussen A, 1996, TRANSPLANTATION, V62, P1031, DOI 10.1097/00007890-199610150-00026; Ravikumar R, 2007, J NEUROTRAUM, V24, P1618, DOI 10.1089/neu.2007.0329; Regenold WT, 2009, BIOL PSYCHIAT, V65, P489, DOI 10.1016/j.biopsych.2008.11.010; SAKATA A, 1994, BIOCHEM PHARMACOL, V48, P1989, DOI 10.1016/0006-2952(94)90601-7; Schinzel AC, 2005, P NATL ACAD SCI USA, V102, P12005, DOI 10.1073/pnas.0505294102; Shimizu S, 1998, P NATL ACAD SCI USA, V95, P1455, DOI 10.1073/pnas.95.4.1455; Stork C, 2005, MOL PSYCHIATR, V10, P900, DOI 10.1038/sj.mp.4001711; Sullivan PG, 2000, NEUROSCIENCE, V101, P289, DOI 10.1016/S0306-4522(00)00380-8; SUOMALAINEN A, 1992, J CLIN INVEST, V90, P61, DOI 10.1172/JCI115856; Tomita H, 2004, BIOL PSYCHIAT, V55, P346, DOI 10.1016/j.biopsych.2003.10.013; Waldmeier PC, 2002, MOL PHARMACOL, V62, P22, DOI 10.1124/mol.62.1.22; Watanuki T, 2008, J AFFECT DISORDERS, V110, P62, DOI 10.1016/j.jad.2008.01.003; Zhang DX, 2005, AM J PHYSIOL-HEART C, V288, pH302, DOI 10.1152/ajpheart.00661.2004	61	18	19	1	6	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1461-1457			INT J NEUROPSYCHOPH	Int. J. Neuropsychopharmacol.	NOV	2010	13	10					1355	1368		10.1017/S1461145710000362			14	Clinical Neurology; Neurosciences; Pharmacology & Pharmacy; Psychiatry	Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry	674WH	WOS:000283780600006	20392297	Bronze			2021-06-18	
J	Eckroth-Bucher, M				Eckroth-Bucher, Margie			Self-Awareness A Review and Analysis of a Basic Nursing Concept	ADVANCES IN NURSING SCIENCE			English	Article						convictions; intrapersonal; introspection; presence; process; self-awareness; understanding; values	TRAUMATIC BRAIN-INJURY; EDUCATION	Self-awareness has long been addressed as fundamental for the professional nurse with the accepted view that self-awareness will lead to greater competence. Therefore, it is important to understand the historical evolution of the concept, attributes, antecedents, and consequences. Rodgers' evolutionary method was used for critical analysis of nursing, social sciences, and education literature. Analysis indicates that self-awareness is a dynamic, transformative process of self. Ultimately, self-awareness is the use of self-insights and presence knowingly to guide behavior that is genuine and authentic to create a healing interpersonal environment. Future research areas within practice and education are identified.	Bloomsburg Univ, Dept Nursing, McCormick Ctr Human Serv 3203, Bloomsburg, PA 17815 USA	Eckroth-Bucher, M (corresponding author), Bloomsburg Univ, Dept Nursing, McCormick Ctr Human Serv 3203, 400 E 2nd St, Bloomsburg, PA 17815 USA.	meckroth@bloomu.edu					Abu Baker K, 1999, FAM PROCESS, V38, P55, DOI 10.1111/j.1545-5300.1999.00055.x; ARNOLD EC, 2007, INTERPERSONAL RELATI, P91; Baumeister R. F., 1995, ADV SOCIAL PSYCHOL, P51; Burnard P, 1984, Nurs Mirror, V158, P30; BURNARD P, 1986, SELF AWARENESS NURSE; Campbell J, 1980, ANS Adv Nurs Sci, V2, P15; Cook SH, 1999, J ADV NURS, V29, P1292, DOI 10.1046/j.1365-2648.1999.01014.x; Demaree HA, 1997, NEUROPSYCHOL REV, V7, P171, DOI 10.1023/B:NERV.0000005908.72548.10; Dirette DK, 2007, BRAIN INJURY, V21, P1131, DOI 10.1080/02699050701687326; Drew N, 1997, J Holist Nurs, V15, P406, DOI 10.1177/089801019701500407; Eckroth-Bucher M, 2001, J Psychosoc Nurs Ment Health Serv, V39, P32; Engin E, 2009, ARCH PSYCHIAT NURS, V23, P148, DOI 10.1016/j.apnu.2008.05.003; FENIGSTEIN A, 1975, J CONSULT CLIN PSYCH, V43, P522, DOI 10.1037/h0076760; Ferrari M, 1998, SELF-AWARENESS, P387; Fleming JM, 1998, J HEAD TRAUMA REHAB, V13, P39, DOI 10.1097/00001199-199810000-00006; Foster Tom, 2005, Br J Nurs, V14, P698; Freshwater Dawn, 2004, Nurs Inq, V11, P91, DOI 10.1111/j.1440-1800.2004.00198.x; Gooch Sally, 2006, Nurs Stand, V20, P20; Harris MS, 1997, SMITH COLL STUD SOC, V67, P587, DOI 10.1080/00377319709517508; Jarvis P, 1995, NURS EDUC TODAY, V15, P414, DOI 10.1016/S0260-6917(95)80052-2; Jerome A M, 1992, Pediatr Nurs, V18, P153; Kondrat ME, 1999, SOC SERV REV, V73, P451, DOI 10.1086/514441; Lauterbach S. S., 2005, INT J HUMAN CARING, V9, P29; Maslow A., 1954, MOTIVATION PERSONALI; MILLER JK, 2008, MENT HLTH PRACT, V12, P31; Moch S D, 1990, Sch Inq Nurs Pract, V4, P155; Moore C, 2007, INFANCY, V11, P157, DOI 10.1111/j.1532-7078.2007.tb00220.x; Morrison J, 2008, J NURS MANAGE, V16, P974, DOI 10.1111/j.1365-2834.2008.00876.x; Parks P, 1997, J HUMANIST PSYCHOL, V37, P67, DOI 10.1177/00221678970372010; Peplau H.E., 1952, INTERPERSONAL RELATI; Rawlinson J W, 1990, Nurse Educ Today, V10, P111, DOI 10.1016/0260-6917(90)90205-5; RIDLEY DS, 1991, J EXP EDUC, V60, P31; Rodgers BL, 2000, CONCEPT DEV NURSING, P77; Rogers CR, 2007, PSYCHOTHERAPY, V44, P240, DOI 10.1037/0033-3204.44.3.240; Rungapadiachy D. M., 1999, INTERPERSONAL COMMUN; *SIGM THET TAU INT, 2005, SCHOL REFL PRACT; SMITH J, 2007, NURSING STANDARD, V21, P47; SMOYAK S, 1999, INTERPERSONAL RRELAT, P41; SORENSEN KC, 1979, BASIC NURSING PSYCHO; Stolder ME, 2007, J TRANSCULT NURS, V18, P265, DOI 10.1177/1043659607301295; Stumpf S. E, 1994, PHILOS HIST PROBLEMS; SWEENEY NM, 1994, J ADV NURS, V20, P917, DOI 10.1046/j.1365-2648.1994.20050917.x; TAYLOR CM, 1990, ESSENTIALS PSYCHIAT, P41; Tiuraniemi J, 2008, ADMIN SOC WORK, V32, P23, DOI 10.1080/03643100802293824; Vorauer JD, 1999, J EXP SOC PSYCHOL, V35, P415, DOI 10.1006/jesp.1999.1388; WANSOR CT, 1991, ENGL J, V21, P41; WARELOW E, 2008, HOLIST NURS PRACT, V22, P146; Weierter SJM, 1999, J APPL SOC PSYCHOL, V29, P1246, DOI 10.1111/j.1559-1816.1999.tb02038.x; Wertz FJ, 1998, J HUMANIST PSYCHOL, V38, P42, DOI 10.1177/00221678980381006; Wicklund, 1972, THEORY OBJECTIVE SEL	50	18	20	1	26	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0161-9268	1550-5014		ADV NURS SCI	Adv. Nurs. Sci.	OCT-DEC	2010	33	4					297	309		10.1097/ANS.0b013e3181fb2e4c			13	Nursing	Nursing	678SY	WOS:000284102100007	21068551				2021-06-18	
J	Iselin, G; Le Brocque, R; Kenardy, J; Anderson, V; McKinlay, L				Iselin, Greg; Le Brocque, Robyne; Kenardy, Justin; Anderson, Vicki; McKinlay, Lynne			Which method of posttraumatic stress disorder classification best predicts psychosocial function in children with traumatic brain injury?	JOURNAL OF ANXIETY DISORDERS			English	Article						PTSD; Diagnostic criteria; Classification; Pediatrics; Traumatic brain injury	HEAD-INJURY; PTSD; SYMPTOMS; DIAGNOSIS; QUESTIONNAIRE; VALIDITY; CRITERIA	Controversy surrounds the classification of posttraumatic stress disorder (PTSD), particularly in children and adolescents with traumatic brain injury (TBI). In these populations, it is difficult to differentiate TBI-related organic memory loss from dissociative amnesia. Several alternative PTSD classification algorithms have been proposed for use with children. This paper investigates DSM-IV-TR and alternative PTSD classification algorithms, including and excluding the dissociative amnesia item, in terms of their ability to predict psychosocial function following pediatric TBI. A sample of 184 children aged 6-14 years were recruited following emergency department presentation and/or hospital admission for TBI. PTSD was assessed via semi-structured clinical interview (CAPS-CA) with the child at 3 months post-injury. Psychosocial function was assessed using the parent report CHQ-PF50. Two alternative classification algorithms, the PTSD-AA and 2 of 3 algorithms, reached statistical significance. While the inclusion of the dissociative amnesia item increased prevalence rates across algorithms, it generally resulted in weaker associations with psychosocial function. The PTSD-AA algorithm appears to have the strongest association with psychosocial function following TBI in children and adolescents. Removing the dissociative amnesia item from the diagnostic algorithm generally results in improved validity. (C) 2010 Elsevier Ltd. All rights reserved.	[Iselin, Greg; Le Brocque, Robyne; Kenardy, Justin] Univ Queensland, Sch Med, Ctr Natl Res Disabil & Rehabil Med CONROD, Herston, Qld 4006, Australia; [Anderson, Vicki] Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; [McKinlay, Lynne] Royal Childrens Hosp, Queensland Paediat Rehabil Serv, Herston, Qld 4006, Australia	Kenardy, J (corresponding author), Univ Queensland, Sch Med, Ctr Natl Res Disabil & Rehabil Med CONROD, Herston Rd, Herston, Qld 4006, Australia.	j.kenardy@uq.edu.au	Le Brocque, Robyne/F-4848-2010; Kenardy, Justin/F-2085-2010; Kenardy, Justin A/H-6603-2014	Le Brocque, Robyne/0000-0002-4574-1254; Kenardy, Justin A/0000-0001-9475-8450; McKinlay, Lynne/0000-0002-6677-0628			Aaron J, 1999, J PEDIATR PSYCHOL, V24, P335, DOI 10.1093/jpepsy/24.4.335; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Bedard-Gilligan M, 2008, BEHAV RES THER, V46, P1062, DOI 10.1016/j.brat.2008.06.009; Bryant RA, 1998, AM J PSYCHIAT, V155, P625, DOI 10.1176/ajp.155.5.625; Bryant RA, 1999, BRAIN INJURY, V13, P15, DOI 10.1080/026990599121836; Carrion VG, 2002, J AM ACAD CHILD PSY, V41, P166, DOI 10.1097/00004583-200202000-00010; Chalton LD, 2009, BRAIN INJURY, V23, P77, DOI 10.1080/02699050802635273; Cohen JA, 1998, J AM ACAD CHILD PSY, V37, p4S, DOI 10.1097/00004583-199810001-00002; Cohen Judith A, 2009, Dialogues Clin Neurosci, V11, P91; Cook NR, 2008, CLIN CHEM, V54, P17, DOI 10.1373/clinchem.2007.096529; Daviss WB, 2000, J AM ACAD CHILD PSY, V39, P576, DOI 10.1097/00004583-200005000-00011; de Vries APJ, 1999, PEDIATRICS, V104, P1293, DOI 10.1542/peds.104.6.1293; Gerring JP, 2002, J AM ACAD CHILD PSY, V41, P157, DOI 10.1097/00004583-200202000-00009; Kassam-Adams N, 2004, J AM ACAD CHILD PSY, V43, P403, DOI 10.1097/00004583-200404000-00006; Kenardy J, 2007, J ANXIETY DISORD, V21, P456, DOI 10.1016/j.janxdis.2006.05.007; KILPATRICK DG, 1998, DSM 4 SOURCEBOOK, V4, P803; King NS, 2008, BRAIN INJURY, V22, P1, DOI 10.1080/02699050701829696; KING NS, 2008, PSYCHOL APPROACHES R, P294; Landgraf JM, 1996, CHILD HLTH QUESTIONN, V1st; Langeland W, 2008, NEUROSCI BIOBEHAV R, V32, P161, DOI 10.1016/j.neubiorev.2007.07.002; Levi RB, 1999, J CLIN CHILD PSYCHOL, V28, P232, DOI 10.1207/s15374424jccp2802_10; Mather FJ, 2003, BRAIN INJURY, V17, P1077, DOI 10.1080/0269905031000114045; McKinnon AC, 2008, BEHAV RES THER, V46, P766, DOI 10.1016/j.brat.2008.02.008; McMillan TM, 2001, BRAIN INJURY, V15, P39, DOI 10.1080/02699050150209110; Meiser-Stedman R, 2008, AM J PSYCHIAT, V165, P1326, DOI 10.1176/appi.ajp.2008.07081282; Nader K., 1996, CLIN ADM PTSD SCALE; Orr SP, 1997, ANN NY ACAD SCI, V821, P114, DOI 10.1111/j.1749-6632.1997.tb48273.x; Salmon K, 2002, CLIN PSYCHOL REV, V22, P163, DOI 10.1016/S0272-7358(01)00086-1; Scheeringa M, 2003, J AM ACAD CHILD PSY, V42, P561, DOI 10.1097/01.CHI.0000046822.95464.14; Scheeringa MS, 2006, AM J PSYCHIAT, V163, P644, DOI 10.1176/appi.ajp.163.4.644; Scheeringa MS, 2005, J AM ACAD CHILD PSY, V44, P899, DOI 10.1097/01.chi.0000169013.81536.71; Scheeringa MS, 1995, INF MENTAL HLTH J, V16, P259, DOI 10.1002/1097-0355(199524)16:4<259::AID-IMHJ2280160403>3.0.CO;2-T; Stallard P, 1998, BRIT MED J, V317, P1619, DOI 10.1136/bmj.317.7173.1619; Stallard P, 2007, J CHILD PSYCHOL PSYC, V48, P194, DOI 10.1111/j.1469-7610.2006.01692.x; Stallard P, 2003, BEHAV COGN PSYCHOTH, V31, P337, DOI 10.1017/S1352465803003084; Stein MB, 2009, AM J PSYCHIAT, V166, P768, DOI 10.1176/appi.ajp.2009.08101604; Turnbull SJ, 2001, BRAIN INJURY, V15, P775, DOI 10.1080/02699050110034334; Waters E, 2000, AUST NZ J PUBL HEAL, V24, P207, DOI 10.1111/j.1467-842X.2000.tb00145.x; Winston FK, 2003, JAMA-J AM MED ASSOC, V290, P643, DOI 10.1001/jama.290.5.643; *ZER 3, 1994, DIAGN CLASS MENT HLT	40	18	18	0	7	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0887-6185	1873-7897		J ANXIETY DISORD	J. Anxiety Disord.	OCT	2010	24	7					774	779		10.1016/j.janxdis.2010.05.011			6	Psychology, Clinical; Psychiatry	Psychology; Psychiatry	643UT	WOS:000281325600017	20541906				2021-06-18	
J	Gyorgy, AB; Walker, J; Wingo, D; Eidelman, O; Pollard, HB; Molnar, A; Agoston, DV				Gyorgy, Andrea B.; Walker, John; Wingo, Dan; Eidelman, Ofer; Pollard, Harvey B.; Molnar, Andras; Agoston, Denes V.			Reverse phase protein microarray technology in traumatic brain injury	JOURNAL OF NEUROSCIENCE METHODS			English	Article						Antibody specificity; Reverse phase protein microarray; Bioinformatics; Traumatic brain injury	VALIDATION; CANCER; PROTEOMICS; PATHWAYS; MEDICINE; ANTIBODY; TISSUE	Antibody based, high throughput proteomics technology represents an exciting new approach in understanding the pathobiologies of complex disorders such as cancer, stroke and traumatic brain injury. Reverse phase protein microarray (RPPA) can complement the classical methods based on mass spectrometry as a high throughput validation and quantification method. RPPA technology can address problematic issues, such as sample complexity, sensitivity, quantification, reproducibility and throughput, which are currently associated with mass spectrometry-based approaches. However, there are technical challenges, predominantly associated with the selection and use of antibodies, preparation and representation of samples and with analyzing and quantifying primary RPPA data. Here we present ways to identify and overcome some of the current issues associated with RPPA. We believe that using stringent quality controls, improved bioinformatics analysis and interpretation of primary RPPA data, this method will significantly contribute in generating new level of understanding about complex disorders at the level of systems biology. Published by Elsevier B.V.	[Gyorgy, Andrea B.; Walker, John; Wingo, Dan; Eidelman, Ofer; Pollard, Harvey B.; Molnar, Andras; Agoston, Denes V.] Uniformed Serv Univ Hlth Sci, Sch Med, Dept Anat Physiol & Genet, Bethesda, MD 20814 USA	Gyorgy, AB (corresponding author), USU, Dept Anat Physiol & Genet, Program Neurosci, Neurosurg Program Natl Capital Consortium,Sch Med, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	agyorgy@usuhs.mil			Defense Advanced Research Projects Agency (DARPA)United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)	The work was funded by Defense Advanced Research Projects Agency (DARPA) Preventing Violent Explosive Neurologic Trauma (PREVENT) program. We thank Members of the PREVENT Team for providing the biosamples for our analysis and Ms. Nicole Draghic for her editorial assistance.	AGOSTON DV, 2009, J NEUROTRAUMA; Aguilar-Mahecha A, 2006, OMICS, V10, P311, DOI 10.1089/omi.2006.10.311; ANDERSON T, 2009, PROTEOMICS; BAUMAN RA, 2009, J NEUROTRAUMA; Belluco C, 2005, CLIN CHIM ACTA, V357, P180, DOI 10.1016/j.cccn.2005.03.024; Bjorling E, 2008, MOL CELL PROTEOMICS, V7, P2028, DOI 10.1074/mcp.M800264-MCP200; Bordeaux J, 2010, BIOTECHNIQUES, V48, P197, DOI 10.2144/000113382; Breitling R, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-100; Chan SM, 2004, NAT MED, V10, P1390, DOI 10.1038/nm1139; Espina V, 2003, PROTEOMICS, V3, P2091, DOI 10.1002/pmic.200300592; Espina Virginia, 2007, V383, P321, DOI 10.1007/978-1-59745-335-6_21; Espina V, 2009, CLIN LAB MED, V29, P1, DOI 10.1016/j.cll.2009.03.001; Espina Virginia, 2009, V520, P89, DOI 10.1007/978-1-60327-811-9_7; GYORGY A, J NEUROTRAUMA UNPUB; Kricka LJ, 2008, MOL BIOTECHNOL, V38, P19, DOI 10.1007/s12033-007-0066-5; Kumble KD, 2003, ANAL BIOANAL CHEM, V377, P812, DOI 10.1007/s00216-003-2088-6; Liotta LA, 2003, NATURE, V425, P905, DOI 10.1038/425905a; Liotta LA, 2003, CANCER CELL, V3, P317, DOI 10.1016/S1535-6108(03)00086-2; Liotta Lance A, 2003, Clin Adv Hematol Oncol, V1, P460; MacBeath G, 2002, NAT GENET, V32, P526, DOI 10.1038/ng1037; Madoz-Gurpide J, 2001, PROTEOMICS, V1, P1279, DOI 10.1002/1615-9861(200110)1:10<1279::AID-PROT1279>3.0.CO;2-W; Marina O, 2008, J PROTEOME RES, V7, P2059, DOI 10.1021/pr700892h; Nishizuka S, 2008, CURR OPIN BIOTECH, V19, P41, DOI 10.1016/j.copbio.2007.11.007; Paweletz CP, 2001, ONCOGENE, V20, P1981, DOI 10.1038/sj.onc.1204265; Poetz O, 2005, MECH AGEING DEV, V126, P161, DOI 10.1016/j.mad.2004.09.030; Pollard HB, 2007, PROTEOM CLIN APPL, V1, P934, DOI 10.1002/prca.200700154; Ramaswamy Anitha, 2005, Proteome Sci, V3, P9, DOI 10.1186/1477-5956-3-9; Schweitzer B, 2002, CURR OPIN BIOTECH, V13, P14, DOI 10.1016/S0958-1669(02)00278-1; Shingyoji M, 2005, TALANTA, V67, P472, DOI 10.1016/j.talanta.2005.06.064; Spurrier B, 2008, NAT PROTOC, V3, P1796, DOI 10.1038/nprot.2008.179; VanMeter A, 2007, EXPERT REV MOL DIAGN, V7, P625, DOI 10.1586/14737159.7.5.625; Wulfkuhle JD, 2006, NAT CLIN PRACT ONCOL, V3, P256, DOI 10.1038/ncponc0485; Zong Yaping, 2007, V381, P363	33	18	18	0	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-0270			J NEUROSCI METH	J. Neurosci. Methods	SEP 30	2010	192	1					96	101		10.1016/j.jneumeth.2010.07.029			6	Biochemical Research Methods; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	671CM	WOS:000283477500012	20674607				2021-06-18	
J	Klin, Y; Zlotnik, A; Boyko, M; Ohayon, S; Shapira, Y; Teichberg, VI				Klin, Yael; Zlotnik, Alexander; Boyko, Matthew; Ohayon, Sharon; Shapira, Yoram; Teichberg, Vivian I.			Distribution of radiolabeled L-glutamate and D-aspartate from blood into peripheral tissues in naive rats: Significance for brain neuroprotection	BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS			English	Article						Brain; Glutamate; Blood; Organ distribution; Neuroprotection	HUMAN HEAD-INJURY; EXCITATORY AMINO-ACIDS; CEREBROSPINAL-FLUID; ISCHEMIC-STROKE; NEURONAL DEATH; RELEASE; METABOLISM; TRANSPORTERS; BARRIER; HUMANS	Excess L-glutamate (glutamate) levels in brain interstitial and cerebrospinal fluids (ISF and CSF, respectively) are the hallmark of several neurodegenerative conditions such as stroke, traumatic brain injury or amyotrophic lateral sclerosis. Its removal could prevent the glutamate excitotoxicity that causes long-lasting neurological deficits. As in previous studies, we have established the role of blood glutamate levels in brain neuroprotection, we have now investigated the contribution of the peripheral organs to the homeostasis of glutamate in blood. We have administered naive rats with intravenous injections of either L-[1-C-14]Glutamic acid (L-[1-C-14] Glu), L-[G-H-3] Glutamic acid (L-[G-H-3] Glu) or D-[2,3-H-3] Aspartic acid (D-[2,3-H-3] Asp), a non-metabolized analog of glutamate, and have followed their distribution into peripheral organs. We have observed that the decay of the radioactivity associated with 01-14C1 Glu and L-[G-H-3] Glu was faster than that associated with glutamate non-metabolized analog, D-[2,3-H-3] Asp. L-[1-C-14] Glu was subjected in blood to a rapid decarboxylation with the loss of (CO2)-C-14. The three major sequestrating organs, serving as depots for the eliminated glutamate and/or its metabolites were skeletal muscle, liver and gut, contributing together 92% or 87% of total L-[U-C-14] Glu or D-[2,3-H-3] Asp radioactivity capture. L-[U-C-14] Glu and D-[2,3-H-3] Asp showed a different organ sequestration pattern. We conclude that glutamate is rapidly eliminated from the blood into peripheral tissues, mainly in non-metabolized form. The liver plays a central role in glutamate metabolism and serves as an origin for glutamate metabolites that redistribute into skeletal muscle and gut. The findings of this study suggest now that pharmacological manipulations that reduce the liver glutamate release rate or cause a boosting of the skeletal muscle glutamate pumping rate are likely to cause brain neuroprotection. (C) 2010 Elsevier Inc. All rights reserved.	[Klin, Yael; Teichberg, Vivian I.] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel; [Zlotnik, Alexander; Boyko, Matthew; Ohayon, Sharon; Shapira, Yoram] Soroka Med Ctr, Div Anesthesiol, IL-84101 Beer Sheva, Israel; [Zlotnik, Alexander; Boyko, Matthew; Ohayon, Sharon; Shapira, Yoram] Ben Gurion Univ Negev, IL-84105 Beer Sheva, Israel	Teichberg, VI (corresponding author), Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel.	Vivian.teichberg@weizmann.ac.il		Boyko, Matthew/0000-0003-3116-1643	Braintact Ltd	V.I.T. has received a grant from Braintact Ltd. as well as consultancy fees.	BAKER AJ, 1993, J NEUROSURG, V79, P369, DOI 10.3171/jns.1993.79.3.0369; Bullock R, 1998, J NEUROSURG, V89, P507, DOI 10.3171/jns.1998.89.4.0507; Camacho A, 2006, ARCH MED RES, V37, P11, DOI 10.1016/j.arcmed.2005.05.014; Castillo J, 1997, LANCET, V349, P79, DOI 10.1016/S0140-6736(96)04453-4; Castillo J, 1996, STROKE, V27, P1060, DOI 10.1161/01.STR.27.6.1060; Castillo J, 2002, NEUROLOGY, V58, P624, DOI 10.1212/WNL.58.4.624; CHEN M, 1991, ANN NEUROL, V30, P62, DOI 10.1002/ana.410300112; CHOI DW, 1990, ANNU REV NEUROSCI, V13, P171, DOI 10.1146/annurev.neuro.13.1.171; CHOI DW, 1994, PROG BRAIN RES, V100, P47; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Davalos A, 1997, STROKE, V28, P708, DOI 10.1161/01.STR.28.4.708; EGER EI, 1974, UPTAKE INHALED ANEST; Gottlieb M, 2003, J NEUROCHEM, V87, P119, DOI 10.1046/j.1471-4159.2003.01972.x; Graham TE, 2000, AM J PHYSIOL-ENDOC M, V278, pE83; Hediger MA, 1999, AM J PHYSIOL-RENAL, V277, pF477; Johnston MV, 2001, PEDIATR RES, V49, P735, DOI 10.1203/00006450-200106000-00003; Koura SS, 1998, ACT NEUR S, V71, P244; LAJTHA A, 1959, J NEUROCHEM, V3, P322, DOI 10.1111/j.1471-4159.1959.tb12638.x; Mate M, 2009, EUR J PHARMACOL, V604, P51, DOI 10.1016/j.ejphar.2008.12.022; MATTHEWS JC, 2005, EXPRESSION NONORGANE; Nagy D, 2009, CELL MOL NEUROBIOL, V29, P827, DOI 10.1007/s10571-009-9364-8; O'Kane RL, 1999, J BIOL CHEM, V274, P31891, DOI 10.1074/jbc.274.45.31891; PALMER AM, 1993, J NEUROCHEM, V61, P2015, DOI 10.1111/j.1471-4159.1993.tb07437.x; Patterson BW, 2002, AM J PHYSIOL-ENDOC M, V282, pE931, DOI 10.1152/ajpendo.00359.2001; PETROFF CP, 1965, INT J APPL RADIAT IS, V16, P599, DOI 10.1016/0020-708X(65)90096-7; Richards DA, 2003, PHARMACOL RES, V48, P101, DOI 10.1016/S1043-6618(03)00081-1; Rose ME, 2002, BRAIN RES, V943, P15, DOI 10.1016/S0006-8993(02)02471-X; RUTTEN MJ, 1987, BRAIN RES, V425, P301, DOI 10.1016/0006-8993(87)90513-0; Serena J, 2001, STROKE, V32, P1154, DOI 10.1161/01.STR.32.5.1154; Teichberg VI, 2009, NEUROSCIENCE, V158, P301, DOI 10.1016/j.neuroscience.2008.02.075; Teichberg VI, 2007, P NATL ACAD SCI USA, V104, P7315, DOI 10.1073/pnas.0702450104; THOMASSEN A, 1991, METABOLISM, V40, P378, DOI 10.1016/0026-0495(91)90148-P; Vesce S, 2007, INT REV NEUROBIOL, V82, P57, DOI 10.1016/S0074-7742(07)82003-4; Wieraszko A, 2009, NEUROSCI LETT, V458, P19, DOI 10.1016/j.neulet.2009.04.024; Zauner A, 1996, ACT NEUR S, V67, P40; Zhang H, 2001, CLIN CHEM, V47, P1458; Zlotnik A, 2007, EXP NEUROL, V203, P213, DOI 10.1016/j.expneurol.2006.08.021; Zlotnik A, 2009, J NEUROSURG ANESTH, V21, P235, DOI 10.1097/ANA.0b013e3181a2bf0b	38	18	20	0	5	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0006-291X	1090-2104		BIOCHEM BIOPH RES CO	Biochem. Biophys. Res. Commun.	SEP 3	2010	399	4					694	698		10.1016/j.bbrc.2010.07.144			5	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	650HQ	WOS:000281840200040	20691657				2021-06-18	
J	Kulbatski, I				Kulbatski, Iris			Stem/Precursor Cell-Based CNS Therapy: The Importance of Circumventing Immune Suppression by Transplanting Autologous Cells	STEM CELL REVIEWS AND REPORTS			English	Article						Stem/precursor cells; Central nervous system; Transplantation; Autologous; Immunosuppresion; Immunomodulation; Neural repair; Bone marrow stromal cells; Neurotrauma; Neurodegeneration	PLURIPOTENT STEM-CELLS; SPINAL-CORD-INJURY; TRAUMATIC BRAIN-INJURY; MICROGLIAL CELLS; STROMAL CELLS; AUTOIMMUNE ENCEPHALOMYELITIS; FUNCTIONAL RECOVERY; MULTIPLE-SCLEROSIS; PROGENITOR-CELLS; NEUROPROTECTION	Stem/precursor cell (SPC) therapy for neuro-degeneration and neurotrauma has enormous therapeutic potential, but despite ongoing research efforts the success of clinical trials remains limited. Therapies that utilize immune suppression in combination with SPC transplantation have thus far failed to consider the beneficial role of the immune system in central nervous system (CNS) recovery. Systemic immune suppression may prevent neural repair, and in some cases exacerbate the underlying disorder. Until about a decade ago, immunosuppression for CNS disorders was viewed as a therapeutic target, based on the perception that all immune activity in the CNS was destructive. However, recent studies show that the infiltration of blood-borne immune cells into the CNS following neurotrauma and during chronic neurodegeneration promote CNS protection and regeneration. In the context of SPC therapies, although immune suppression prevents rejection of non-autologous cell grafts, it also prevents the restorative immune response by eliminating the immune mediated guidance cues that are required for SPCs to migrate to the location they are needed, and preventing SPC-mediated immunomodulation. This article argues in favor of transplanting autologous SPCs, particularly bone marrow derived cells. The therapeutic use of autologous SPCs for neural repair circumvents the need for concomitant immune suppression, exploits the immunomodulatory capacity of these cells, and maintains the immune niche that supports neural repair and is required to guide these cells to their appropriate locations. Overall, such an approach accommodates the requirements for translational therapeutics, and provides a standardized platform for reconciling the inherent controversies in the science.	Cedars Sinai Med Ctr, Maxine Dunitz Neurosurg Inst, Los Angeles, CA 90048 USA	Kulbatski, I (corresponding author), Cedars Sinai Med Ctr, Maxine Dunitz Neurosurg Inst, Davis Res Bldg 2029,8700 Beverly Blvd, Los Angeles, CA 90048 USA.	iris.kulbatski@sympatico.ca					Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; Ajami B, 2007, NAT NEUROSCI, V10, P1538, DOI 10.1038/nn2014; Amariglio N, 2009, PLOS MED, V6, P221, DOI 10.1371/journal.pmed.1000029; ARMSTRONG RC, 1990, J NEUROSCI RES, V27, P400, DOI 10.1002/jnr.490270319; Baker M, 2009, NATURE, V457, P941, DOI 10.1038/457941a; Bechmann I, 2001, RESTOR NEUROL NEUROS, V19, P189; Beers DR, 2008, P NATL ACAD SCI USA, V105, P15558, DOI 10.1073/pnas.0807419105; Belmadani A, 2006, J NEUROSCI, V26, P3182, DOI 10.1523/JNEUROSCI.0156-06.2006; Ben-Hur T, 2003, MOL CELL NEUROSCI, V24, P623, DOI 10.1016/S1044-7431(03)00218-5; Ben-Hur T, 2008, J NEUROL SCI, V265, P102, DOI 10.1016/j.jns.2007.05.007; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Butovsky O, 2007, EUR J NEUROSCI, V26, P413, DOI 10.1111/j.1460-9568.2007.05652.x; Cao QL, 2001, EXP NEUROL, V167, P48, DOI 10.1006/exnr.2000.7536; CHAO CC, 1992, J IMMUNOL, V149, P2736; Chiu IM, 2008, P NATL ACAD SCI USA, V105, P17913, DOI 10.1073/pnas.0804610105; Dunn GP, 2002, NAT IMMUNOL, V3, P991, DOI 10.1038/ni1102-991; Einstein O, 2007, ANN NEUROL, V61, P209, DOI 10.1002/ana.21033; Glezer I, 2007, NEUROSCIENCE, V147, P867, DOI 10.1016/j.neuroscience.2007.02.055; Gris D, 2004, J NEUROSCI, V24, P4043, DOI 10.1523/JNEUROSCI.5343-03.2004; Himes BT, 2006, NEUROREHAB NEURAL RE, V20, P278, DOI 10.1177/1545968306286976; Hofstetter HH, 2003, J NEUROIMMUNOL, V134, P25, DOI 10.1016/S0165-5728(02)00358-2; Horner PJ, 2000, J NEUROSCI, V20, P2218; Hyun I, 2008, CELL STEM CELL, V3, P607, DOI 10.1016/j.stem.2008.11.009; Imitola J, 2004, P NATL ACAD SCI USA, V101, P18117, DOI 10.1073/pnas.0408258102; Jalving M, 2009, CURR OPIN MOL THER, V11, P383; Johansson CB, 1999, EXP CELL RES, V253, P733, DOI 10.1006/excr.1999.4678; Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3; Karussis D, 2008, J NEUROL SCI, V265, P131, DOI 10.1016/j.jns.2007.05.005; Kulbatski I, 2005, CURR DRUG TARGETS, V6, P111, DOI 10.2174/1389450053345037; Lalive PH, 2005, EUR J IMMUNOL, V35, P727, DOI 10.1002/eji.200425430; Le Blanc K, 2004, SCAND J IMMUNOL, V60, P307, DOI 10.1111/j.0300-9475.2004.01483.x; Lee H, 2009, REGEN MED, V4, P759, DOI 10.2217/RME.09.46; Leon S, 2000, J NEUROSCI, V20, P4615, DOI 10.1523/JNEUROSCI.20-12-04615.2000; Li Y, 2009, NEUROSCI LETT, V456, P120, DOI 10.1016/j.neulet.2008.03.096; LININGTON C, 1993, EUR J IMMUNOL, V23, P1364, DOI 10.1002/eji.1830230627; Mabon PJ, 2000, EXP NEUROL, V166, P52, DOI 10.1006/exnr.2000.7488; Mahmood A, 2005, NEUROSURGERY, V57, P1026, DOI 10.1227/01.NEU.0000181369.76323.50; Mahmood A, 2003, NEUROSURGERY, V53, P697, DOI 10.1227/01.NEU.0000079333.61863.AA; Majed HH, 2006, J NEUROSCI, V26, P1730, DOI 10.1523/JNEUROSCI.0702-05.2006; Malm TM, 2005, NEUROBIOL DIS, V18, P134, DOI 10.1016/j.nbd.2004.09.009; Mansilla E, 2005, TRANSPL P, V37, P292, DOI 10.1016/j.transproceed.2005.01.070; Mathews DJH, 2008, NEUROLOGY, V71, P288, DOI 10.1212/01.wnl.0000316436.13659.80; McDonald JW, 2004, J NEUROTRAUM, V21, P383, DOI 10.1089/089771504323004539; MEDA L, 1995, NATURE, V374, P647, DOI 10.1038/374647a0; Mildner A, 2007, NAT NEUROSCI, V10, P1544, DOI 10.1038/nn2015; Moalem G, 1999, NAT MED, V5, P49, DOI 10.1038/4734; Namiki J, 1999, J NEUROPATH EXP NEUR, V58, P489, DOI 10.1097/00005072-199905000-00008; Nasef A, 2008, REGEN MED, V3, P531, DOI 10.2217/17460751.3.4.531; Neumann J, 2006, FASEB J, V20, P714, DOI 10.1096/fj.05-4882fje; Park HC, 2005, TISSUE ENG, V11, P913, DOI 10.1089/ten.2005.11.913; Parr AM, 2007, BONE MARROW TRANSPL, V40, P609, DOI 10.1038/sj.bmt.1705757; Polazzi E, 2001, GLIA, V36, P271, DOI 10.1002/glia.1115; Popovich PG, 1999, EXP NEUROL, V158, P351, DOI 10.1006/exnr.1999.7118; Popovich PG, 2001, J NEUROPATH EXP NEUR, V60, P676, DOI 10.1093/jnen/60.7.676; Popovich PG, 2002, J NEUROPATH EXP NEUR, V61, P623, DOI 10.1093/jnen/61.7.623; Rapalino O, 1998, NAT MED, V4, P814, DOI 10.1038/nm0798-814; Rolletschek A, 2009, BIOL CHEM, V390, P845, DOI 10.1515/BC.2009.103; Schwartz M, 2001, J NEUROIMMUNOL, V113, P185, DOI 10.1016/S0165-5728(00)00447-1; Schwartz M, 2008, TRENDS PHARMACOL SCI, V29, P287, DOI 10.1016/j.tips.2008.03.006; Shihabuddin LS, 2000, J NEUROSCI, V20, P8727; Simard AR, 2006, NEURON, V49, P489, DOI 10.1016/j.neuron.2006.01.022; Slavin S, 2008, CLIN NEUROL NEUROSUR, V110, P943, DOI 10.1016/j.clineuro.2008.01.014; Smyth MJ, 2006, ADV IMMUNOL, V90, P1, DOI 10.1016/S0065-2776(06)90001-7; Stirling DP, 2004, J NEUROSCI, V24, P2182, DOI 10.1523/JNEUROSCI.5275-03.2004; Suhonen JO, 1996, NATURE, V383, P624, DOI 10.1038/383624a0; Sykova E, 2006, CELL TRANSPLANT, V15, P675, DOI 10.3727/000000006783464381; Tator CH, 2006, NEUROSURGERY, V59, P957, DOI 10.1227/01.NEU.0000245591.16087.89; Temple S, 1999, CURR OPIN NEUROBIOL, V9, P135, DOI 10.1016/S0959-4388(99)80017-8; Ting AE, 2008, CRIT REV ONCOL HEMAT, V65, P81, DOI 10.1016/j.critrevonc.2007.09.007; Uccelli A, 2006, EXPERT OPIN BIOL TH, V6, P17, DOI 10.1517/14712598.6.1.17; Weiss S, 1996, J NEUROSCI, V16, P7599; Zappia E, 2005, BLOOD, V106, P1755, DOI 10.1182/blood-2005-04-1496; Zhang J, 2005, EXP NEUROL, V195, P16, DOI 10.1016/j.expneurol.2005.03.018; Zhang SC, 2003, J HEMATOTH STEM CELL, V12, P625, DOI 10.1089/15258160360732650; Ziv Y, 2006, NAT NEUROSCI, V9, P268, DOI 10.1038/nn1629; Ziv Y, 2006, P NATL ACAD SCI USA, V103, P13174, DOI 10.1073/pnas.0603747103	76	18	18	0	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	2629-3269	2629-3277		STEM CELL REV REP	Stem Cell Rev. Rep.	FAL	2010	6	3					405	410		10.1007/s12015-010-9141-6			6	Cell & Tissue Engineering; Cell Biology; Medicine, Research & Experimental	Cell Biology; Research & Experimental Medicine	647WD	WOS:000281649900009	20300887				2021-06-18	
J	Eastman, CL; Verley, DR; Fender, JS; Temkin, NR; D'Ambrosio, R				Eastman, Clifford L.; Verley, Derek R.; Fender, Jason S.; Temkin, Nancy R.; D'Ambrosio, Raimondo			ECoG studies of valproate, carbamazepine and halothane in frontal-lobe epilepsy induced by head injury in the rat	EXPERIMENTAL NEUROLOGY			English	Article						Posttraumatic epilepsy; Neocortical epilepsy; Trauma; Screening; In vivo; EEG; Partial seizure; Pharmacoresistance; Fluid percussion injury; Remission; Bootstrap	COMPLEX PARTIAL SEIZURES; FLUID PERCUSSION INJURY; ANTIEPILEPTIC DRUGS; CROSS-TOLERANCE; BRAIN-INJURY; MODEL; RESISTANCE; IDENTIFICATION; LEVETIRACETAM; PROGRESSION	The use of electrocorticography (ECoG) with etiologically realistic epilepsy models promises to facilitate the discovery of better anti-epileptic drugs (AEDs). However, this novel approach is labor intensive, and must be optimized. To this end, we employed rostral parasagittal fluid percussion injury (rpFPI) in the adolescent rat, which closely replicates human contusive closed head injury and results in posttraumatic epilepsy (PTE). We systematically examined variables affecting the power to detect anti-epileptic effects by ECoG and used a non-parametric bootstrap strategy to test several different statistics, study designs, statistical tests, and impact of non-responders. We found that logarithmically transformed data acquired in repeated-measures experiments provided the greatest statistical power to detect decreases in seizure frequencies of preclinical interest with just 8 subjects and with up to similar to 40% non-responders. We then used this optimized design to study the anti-epileptic effects of acute exposure to halothane, and chronic (1 week) exposures to carbamazepine (CBZ) and valproate (VPA) 1 month post-injury. While CBZ was ineffective in all animals, VPA induced, during treatment, a progressive decrease in seizure frequency in animals primarily suffering from non-spreading neocortical seizures, but was ineffective in animals with a high frequency of spreading seizures. Halothane powerfully blocked all seizure activity. The data show that rpFPI and chronic ECoG can conveniently be employed for the evaluation of AEDs, suggest that VPA may be more effective than CBZ to treat some forms of PTE, and support the theory that pharmacoresistance may depend on the severity of epilepsy. The data also demonstrate the utility of chronic exposures to experimental drugs in preclinical studies and highlight the need for greater attention to etiology in clinical studies of AEDs. (C) 2010 Elsevier Inc. All rights reserved.	[Eastman, Clifford L.; Verley, Derek R.; Fender, Jason S.; Temkin, Nancy R.; D'Ambrosio, Raimondo] Univ Washington, Sch Med, Dept Neurol Surg, Seattle, WA 98104 USA; [Temkin, Nancy R.] Univ Washington, Sch Med, Dept Biostat, Seattle, WA 98104 USA; [D'Ambrosio, Raimondo] Univ Washington, Sch Med, Dept Neurol, Seattle, WA 98104 USA; [D'Ambrosio, Raimondo] Univ Washington, Sch Med, Reg Epilepsy Ctr, Seattle, WA 98104 USA	D'Ambrosio, R (corresponding author), Harborview Med Ctr, UW Dept Neurosurg, Box 359915,325 9th Ave, Seattle, WA 98104 USA.	raid@u.washington.edu	Verley, Derek/J-4550-2015	Verley, Derek/0000-0002-2670-6568	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS053928]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS053928] Funding Source: NIH RePORTER	This work was supported by National Institutes of Health [NS053928 to RD]. We thank Drs. Shahin Hakimian, John W. Miller and Emilio Perucca for helpful discussion and review of the manuscript.	Arida RM, 1999, EPILEPSY RES, V34, P99, DOI 10.1016/S0920-1211(98)00092-8; BALISH M, 1991, EPILEPSIA, V32, P642, DOI 10.1111/j.1528-1157.1991.tb04703.x; Bancaud J, 1992, Adv Neurol, V57, P3; Bauer J, 2001, SEIZURE-EUR J EPILEP, V10, P239, DOI 10.1053/seiz.2000.0499; BEGHI E, 1992, EPILEPSIA, V33, P45; Berg AT, 2001, NEUROLOGY, V56, P1445, DOI 10.1212/WNL.56.11.1445; Bethmann K, 2007, EPILEPSIA, V48, P816, DOI 10.1111/j.1528-1167.2007.00980.x; Blum DE, 1996, NEUROLOGY, V47, P260, DOI 10.1212/WNL.47.1.260; Callaghan BC, 2007, ANN NEUROL, V62, P382, DOI 10.1002/ana.21166; D'Ambrosio R, 2005, BRAIN, V128, P174, DOI 10.1093/brain/awh337; D'Ambrosio R, 2004, BRAIN, V127, P304, DOI 10.1093/brain/awh038; D'Ambrosio R, 2010, EPILEPSY CURR, V10, P61, DOI 10.1111/j.1535-7511.2010.01358.x; D'Ambrosio R, 2009, BRAIN, V132, P2805, DOI 10.1093/brain/awp217; DELGADOESCUETA AV, 1982, NEW ENGL J MED, V306, P1337, DOI 10.1056/NEJM198206033062205; DELGADOESCUETA AV, 1983, NEW ENGL J MED, V308, P1576, DOI 10.1056/NEJM198306303082607; Dube C, 2006, BRAIN, V129, P911, DOI 10.1093/brain/awl018; Duncan JS, 2006, LANCET, V367, P1087, DOI 10.1016/S0140-6736(06)68477-8; Efron B., 1998, INTRO BOOTSTRAP; French JA, 2007, EPILEPSIA, V48, P3, DOI 10.1111/j.1528-1167.2007.00992.x; Gilliam F, 2004, NEUROLOGY, V63, pS9, DOI 10.1212/WNL.63.10_suppl_4.S9; Grabenstatter HL, 2005, EPILEPSIA, V46, P8, DOI 10.1111/j.0013-9580.2005.13404.x; Haut SR, 2005, EPILEPSIA, V46, P146, DOI 10.1111/j.0013-9580.2005.29004.x; Hitiris N, 2007, EPILEPSY RES, V75, P192, DOI 10.1016/j.eplepsyres.2007.06.003; JUULJENSEN P, 1986, INTRACTABLE EPILEPSY, P5; Karceski S, 2005, EPILEPSY BEHAV, V7, pS1, DOI 10.1016/j.yebeh.2005.06.001; Kelly KM, 2001, EPILEPSY RES, V47, P189, DOI 10.1016/S0920-1211(01)00294-7; Kharlamov EA, 2003, EPILEPSY RES, V56, P185, DOI 10.1016/j.eplepsyres.2003.09.005; Klein PM, 2009, EPILEPSIA, V50, P385; Kraus J, 2000, HEAD INJURY, P1; Krupp E, 2000, EXP NEUROL, V162, P278, DOI 10.1006/exnr.1999.7343; Kwan P, 2003, NEUROLOGY, V60, pS2, DOI 10.1212/WNL.60.11_suppl_4.S2; LANGENDORF FG, 2008, EPILEPSY COMPREHENSI, P2537; LEITE JP, 1995, EPILEPSY RES, V20, P93, DOI 10.1016/0920-1211(94)00070-D; Loscher W, 2007, EPILEPSIA, V48, P1245, DOI 10.1111/j.1528-1167.2007.01093.x; Loscher W, 2004, EPILEPSY RES, V60, P77, DOI 10.1016/j.eplepsyres.2004.06.004; LOSCHER W, 1995, EPILEPSIA, V36, P929, DOI 10.1111/j.1528-1157.1995.tb01637.x; Loscher W, 2002, CNS DRUGS, V16, P669; Luders H O, 1992, Adv Neurol, V57, P149; Luna-Tortos C, 2008, NEUROPHARMACOLOGY, V55, P1364, DOI 10.1016/j.neuropharm.2008.08.032; MATTSON RH, 1992, NEW ENGL J MED, V327, P765, DOI 10.1056/NEJM199209103271104; Mattson RH, 1996, NEUROLOGY, V47, P68, DOI 10.1212/WNL.47.1.68; Meldrum B, 2002, EPILEPSY RES, V50, P33, DOI 10.1016/S0920-1211(02)00066-9; Minicucci F, 2006, EPILEPSIA, V47, P9, DOI 10.1111/j.1528-1167.2006.00870.x; Murao Kohei, 2002, J Anesth, V16, P34, DOI 10.1007/s540-002-8092-0; Nissinen J, 2007, EPILEPSY RES, V73, P181, DOI 10.1016/j.eplepsyres.2006.10.003; Oakley JC, 2009, P NATL ACAD SCI USA, V106, P3994, DOI 10.1073/pnas.0813330106; Remy S, 2003, ANN NEUROL, V53, P469, DOI 10.1002/ana.10473; Rogawski Michael A, 2008, Epilepsy Curr, V8, P127, DOI 10.1111/j.1535-7511.2008.00272.x; ROPPER AH, 1986, ANN NEUROL, V19, P98, DOI 10.1002/ana.410190124; Schmidt D, 2002, EPILEPSY RES, V50, P71, DOI 10.1016/S0920-1211(02)00070-0; Schmidt D, 2009, EPILEPSY CURR, V9, P47, DOI 10.1111/j.1535-7511.2008.01289.x; Semah F, 1998, NEUROLOGY, V51, P1256, DOI 10.1212/WNL.51.5.1256; Sloviter RS, 2005, CR BIOL, V328, P143, DOI 10.1016/j.crvi.2004.10.010; Stables James P., 2002, Epilepsia, V43, P1410, DOI 10.1046/j.1528-1157.2002.06702.x; Tatum WO, 2001, J CLIN NEUROPHYSIOL, V18, P14, DOI 10.1097/00004691-200101000-00004; Temkin NR, 2009, EPILEPSIA, V50, P10, DOI 10.1111/j.1528-1167.2008.02005.x; Temkin NR, 2001, EPILEPSIA, V42, P515, DOI 10.1046/j.1528-1157.2001.28900.x; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; van Vliet EA, 2008, EPILEPSIA, V49, P1151, DOI 10.1111/j.1528-1167.2007.01516.x; Vezzani A, 2005, EPILEPSIA, V46, P1724, DOI 10.1111/j.1528-1167.2005.00298.x; White HS, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s7.10.x; White HS, 2002, NEUROLOGY, V59, pS7, DOI 10.1212/WNL.59.9_suppl_5.S7; White HS, 1998, NEUROPHARMACOLOGY ME, P27; Williams PA, 2007, NEUROSCIENCE, V149, P943, DOI 10.1016/j.neuroscience.2007.07.067; WILLIAMSON PD, 1986, EPILEPSIA, V27, pS46, DOI 10.1111/j.1528-1157.1986.tb05740.x; WILLIAMSON PD, 1985, ANN NEUROL, V18, P497, DOI 10.1002/ana.410180413; Zhang ZJ, 2003, EPILEPSIA, V44, P1487, DOI 10.1111/j.0013-9580.2003.34803.x	67	18	18	0	3	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	AUG	2010	224	2					369	388		10.1016/j.expneurol.2010.04.013			20	Neurosciences	Neurosciences & Neurology	631II	WOS:000280339600007	20420832	Green Accepted			2021-06-18	
J	Colley, BS; Phillips, LL; Reeves, TM				Colley, Beverly S.; Phillips, Linda L.; Reeves, Thomas M.			The effects of cyclosporin-A on axonal conduction deficits following traumatic brain injury in adult rats	EXPERIMENTAL NEUROLOGY			English	Article						Cyclosporin-A; Compound action potentials; Traumatic brain injury; Neuroprotection; Corpus callosum; Rat	FLUID PERCUSSION INJURY; CORD WHITE-MATTER; ACUTE MITOCHONDRIAL DYSFUNCTION; TRANSIENT FOREBRAIN ISCHEMIA; VISUAL CALLOSAL AXONS; CORPUS-CALLOSUM; SPINAL-CORD; NEUROFILAMENT COMPACTION; UNMYELINATED AXONS; TACROLIMUS FK506	Immunophilin ligands, including cyclosporin-A (CsA), have been shown to be neuroprotective in experimental models of traumatic brain injury (TBI) and to attenuate the severity of traumatic axonal injury. Prior studies have documented CsA treatment to reduce essential components of posttraumatic axonal pathology, including impaired axoplasmic transport, spectrin proteolysis, and axonal swelling. However, the effects of CsA administration on axonal function, following TBI, have not been evaluated. The present study assessed the effects of CsA treatment on compound action potentials (CAPs) evoked in corpus callosum of adult rats following midline fluid percussion injury. Rats received a 20 mg/kg bolus of CsA, or cremaphor vehicle, at either 15 min or 1 h postinjury, and at 24 h postinjury CAP recording was conducted in coronal brain slices. To elucidate how injury and CsA treatments affect specific populations of axons, CAP waveforms generated largely by myelinated axons (N1) were analyzed separately from the CAP signal, which predominantly reflects activity in unmyelinated axons (N2). CsA administration at 15 min postinjury resulted in significant protection of CAP area, and this effect was more pronounced in N1, than in the N2, CAP component. This treatment also significantly protected against TBI-induced reductions in high-frequency responding of the N1 CAP signal. In contrast, CsA treatment at 1 h did not significantly protect CAPs but was associated with atypical waveforms in N1 CAPs, including decreased CAP duration and reduced refractoriness. The present findings also support growing evidence that myelinated and unmyelinated axons respond differentially to injury and neuroprotective compounds. (C) 2010 Elsevier Inc. All rights reserved.	[Colley, Beverly S.; Phillips, Linda L.; Reeves, Thomas M.] Virginia Commonwealth Univ, Dept Anat & Neurobiol, Sch Med, Med Ctr, Richmond, VA 23298 USA	Reeves, TM (corresponding author), Virginia Commonwealth Univ, Dept Anat & Neurobiol, Sch Med, Med Ctr, 1217 E Marshall St,Room 740,MCV Campus Box 980709, Richmond, VA 23298 USA.	tmreeves@vcu.edu			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS-057758, NS-056247]; Virginia Commonwealth Neurotrauma Initiative [07-302F]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS057758, R01NS056247] Funding Source: NIH RePORTER	The authors gratefully acknowledge the expert technical assistance of Nancy Lee and Terry Smith. This study was supported by NIH research grants NS-057758 (T.M.R.) and NS-056247 (L.L.P.) and by a Virginia Commonwealth Neurotrauma Initiative Award 07-302F (T.M.R.).	Agrawal SK, 2000, NEUROSCIENCE, V99, P179, DOI 10.1016/S0306-4522(00)00165-2; Ai JL, 2007, J NEUROTRAUM, V24, P960, DOI 10.1089/neu.2006.0224; Albensi BC, 2000, EXP NEUROL, V162, P385, DOI 10.1006/exnr.1999.7338; Alessandri B, 2002, J NEUROTRAUM, V19, P829, DOI 10.1089/08977150260190429; Baker AJ, 2002, J NEUROTRAUM, V19, P587, DOI 10.1089/089771502753754064; BEMENT SL, 1969, EXP NEUROL, V24, P147, DOI 10.1016/0014-4886(69)90012-0; BLACK JA, 1982, BRAIN RES, V250, P1, DOI 10.1016/0006-8993(82)90948-9; Buki A, 1999, J NEUROTRAUM, V16, P511, DOI 10.1089/neu.1999.16.511; Crawford DK, 2009, J NEUROSCI METH, V182, P25, DOI 10.1016/j.jneumeth.2009.05.013; Deng Y, 2007, EXP NEUROL, V205, P154, DOI 10.1016/j.expneurol.2007.01.023; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; FAMIGLIO L, 1989, TRANSPLANTATION, V48, P316, DOI 10.1097/00007890-198908000-00025; Kaminska B, 2004, J CELL MOL MED, V8, P45, DOI 10.1111/j.1582-4934.2004.tb00259.x; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; Marmarou CR, 2006, EXP NEUROL, V197, P353, DOI 10.1016/j.expneurol.2005.10.003; Maxwell WL, 2003, J NEUROTRAUM, V20, P151, DOI 10.1089/08977150360547071; MAXWELL WL, 1993, ACTA NEUROPATHOL, V86, P136, DOI 10.1007/BF00334880; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; Mazzeo AT, 2009, J NEUROTRAUM, V26, P2195, DOI 10.1089/neu.2009.1012; Mazzeo AT, 2009, EXP NEUROL, V218, P363, DOI 10.1016/j.expneurol.2009.05.026; Mbye LH, 2008, EXP NEUROL, V209, P243, DOI 10.1016/j.expneurol.2007.09.025; Mbye LH, 2009, J CEREBR BLOOD F MET, V29, P87, DOI 10.1038/jcbfm.2008.93; Mobley Lloyd W 3rd, 2003, Spine J, V3, P11, DOI 10.1016/S1529-9430(02)00442-4; Nashmi R, 2001, NEUROSCIENCE, V104, P235, DOI 10.1016/S0306-4522(01)00009-4; Okonkwo DO, 1999, NEUROREPORT, V10, P353, DOI 10.1097/00001756-199902050-00026; Okonkwo DO, 1999, J CEREBR BLOOD F MET, V19, P443, DOI 10.1097/00004647-199904000-00010; Partadiredja G, 2003, J NEUROCYTOL, V32, P1165, DOI 10.1023/B:NEUR.0000021910.65920.41; Peasley MA, 2002, AM J PHYSIOL-CELL PH, V283, pC980, DOI 10.1152/ajpcell.00591.2001; POVLISHOCK JT, 1992, J NEUROTRAUM, V9, pS189; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; PRESTON RJ, 1983, EXP NEUROL, V79, P808, DOI 10.1016/0014-4886(83)90044-4; Pryor J, 2006, SPINAL CORD, V44, P653, DOI 10.1038/sj.sc.3101901; Pyrzynska B, 2001, NEUROCHEM INT, V38, P409, DOI 10.1016/S0197-0186(00)00105-4; RACUSEN LC, 1990, LIFE SCI, V46, P1021, DOI 10.1016/0024-3205(90)90026-N; Reeves TM, 2007, BRAIN RES, V1154, P225, DOI 10.1016/j.brainres.2007.04.002; Reeves TM, 2005, EXP NEUROL, V196, P126, DOI 10.1016/j.expneurol.2005.07.014; Riess P, 2001, RESTOR NEUROL NEUROS, V18, P1; Saatman KE, 1998, J NEUROTRAUM, V15, P1047, DOI 10.1089/neu.1998.15.1047; Sato M, 2001, BRAIN RES, V917, P45, DOI 10.1016/S0006-8993(01)02905-5; Scheff SW, 1999, J NEUROTRAUM, V16, P783, DOI 10.1089/neu.1999.16.783; Setkowicz Z, 2007, ACTA NEUROBIOL EXP, V67, P399; Singleton RH, 2001, J NEUROTRAUM, V18, P607, DOI 10.1089/089771501750291846; Smith DH, 2000, NEUROSCIENTIST, V6, P483, DOI 10.1177/107385840000600611; Smith DH, 1999, J NEUROPATH EXP NEUR, V58, P982, DOI 10.1097/00005072-199909000-00008; Stone JR, 2000, BRAIN RES, V871, P288, DOI 10.1016/S0006-8993(00)02485-9; Stone JR, 2001, EXP NEUROL, V172, P320, DOI 10.1006/exnr.2001.7818; Stover JF, 2001, J NEUROSURG, V94, P782, DOI 10.3171/jns.2001.94.5.0782; Sullivan PG, 2000, NEUROSCIENCE, V101, P289, DOI 10.1016/S0306-4522(00)00380-8; Sullivan PG, 1999, EXP NEUROL, V160, P226, DOI 10.1006/exnr.1999.7197; Sullivan PG, 2000, EXP NEUROL, V161, P631, DOI 10.1006/exnr.1999.7282; SWADLOW HA, 1976, EXP NEUROL, V53, P128, DOI 10.1016/0014-4886(76)90288-0; Swanson TH, 1998, BRAIN RES, V784, P188, DOI 10.1016/S0006-8993(97)01323-1; Uchino H, 1995, ACTA PHYSIOL SCAND, V155, P469, DOI 10.1111/j.1748-1716.1995.tb09999.x; Uchino H, 1998, BRAIN RES, V812, P216, DOI 10.1016/S0006-8993(98)00902-0; WALKER RW, 1988, NEUROL CLIN, V6, P261, DOI 10.1016/S0733-8619(18)30869-7; WAXMAN SG, 1992, BRAIN RES, V574, P105, DOI 10.1016/0006-8993(92)90806-K; WAXMAN SG, 1976, EXP NEUROL, V53, P115, DOI 10.1016/0014-4886(76)90287-9; WEST DC, 1983, J PHYSIOL-LONDON, V337, P37, DOI 10.1113/jphysiol.1983.sp014610; Zawadzka M, 2003, MOL CELL NEUROSCI, V22, P202, DOI 10.1016/S1044-7431(03)00036-8	60	18	18	0	2	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	JUL	2010	224	1			SI		241	251		10.1016/j.expneurol.2010.03.026			11	Neurosciences	Neurosciences & Neurology	615IO	WOS:000279128400027	20362574	Green Accepted			2021-06-18	
J	Hoenig, H; Lee, J; Stineman, M				Hoenig, Helen; Lee, Jeanne; Stineman, Margaret			Conceptual Overview of Frameworks for Measuring Quality in Rehabilitation	TOPICS IN STROKE REHABILITATION			English	Article						outcome and process assessment; quality of care; rehabilitation	SKILLED NURSING FACILITIES; TRAUMATIC BRAIN-INJURY; OF-THE-SCIENCE; STROKE REHABILITATION; RANDOMIZED-TRIAL; INPATIENT REHABILITATION; GERIATRIC EVALUATION; OUTCOMES RESEARCH; PATIENT OUTCOMES; POSTACUTE CARE	This article reviews theories and conceptual models that may be helpful in evaluating quality of care in rehabilitation, with a focus on the seminal Donabedian model of structure, process, and outcomes. In addition, this article reviews a variety of new theories and conceptual models that have been developed to expand the Donabedian model in areas specific to rehabilitation (eg, the multidisciplinary team, assistive technology), and it covers new approaches developed to help with implementing changes to improve quality. Directions for future research and development are identified, including the need for consensus and consistent use of terminology and measures and the need for quality measures with greater breadth, depth, and granularity that capture the complex interactions between the structure and processes of care unique to rehabilitation of physical disability.	[Hoenig, Helen; Lee, Jeanne] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Hoenig, Helen] Durham VA Med Ctr, Phys Med & Rehabil Serv, Durham, NC USA; [Stineman, Margaret] Univ Penn, Dept Phys Med & Rehabil, Philadelphia, PA 19104 USA	Hoenig, H (corresponding author), Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA.				Agency for Healthcare Research and Quality (AHRQ) Comparative Effectiveness of Alternative Levels of Stroke RehabilitationUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality [1-R01 HS018540-01]; Veterans Health Administration Rehabilitation Research and Development (RRD) [042251]; National Institute on Disability and Rehabilitation Research of the US Department of Education [H133E080003]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITYUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality [R01HS018540] Funding Source: NIH RePORTER	M. Stineman was supported in part through the Agency for Healthcare Research and Quality (AHRQ) Comparative Effectiveness of Alternative Levels of Stroke Rehabilitation grant 1-R01 HS018540-01.; H. Hoenig received support from the Veterans Health Administration Rehabilitation Research and Development (RR&D) grant 042251 and by the Mobility Rehabilitation and Engineering Research Center, which is funded by the National Institute on Disability and Rehabilitation Research of the US Department of Education under grant H133E080003. The views of the authors do not necessarily reflect the views of the funding agencies.	*ACRM TAX TASK FOR, 2005, RES AG DEV REH TAX; *AG HEALTHC RES QU, 2006, INTR AHRQ QUAL IND; [Anonymous], 2017, CONC MOD; *ASKOXFORD, COMP OXF ENGL DICT P; Berlowitz DR, 2010, TOP STROKE REHABIL, V17, P252, DOI 10.1310/tsr1704-252; Bettger JAP, 2007, ARCH PHYS MED REHAB, V88, P1526, DOI 10.1016/j.apmr.2007.06.768; *BUS EXC, TOT QUAL MAN TOOLS B; CHIODO LK, 1992, PHYS THER, V72, P168, DOI 10.1093/ptj/72.3.168; CHIODO LK, 1992, PHYS THER, V72, P174, DOI 10.1093/ptj/72.3.174; Cohen HJ, 2002, NEW ENGL J MED, V346, P905, DOI 10.1056/NEJMsa010285; Crawford VLS, 2009, STROKE, V40, P2143, DOI 10.1161/STROKEAHA.108.545376; Daugherty EL, 2009, CRIT CARE MED, V37, P1210, DOI [10.1097/CCM.0b013e3181b6fa29, 10.1097/CCM.0b013e31819d67b5]; DEANE JP, 2004, THESIS U FLORIDA GAI; DeJong G, 2005, ARCH PHYS MED REHAB, V86, pS1, DOI 10.1016/j.apmr.2005.09.003; DeJong G, 2004, ARCH PHYS MED REHAB, V85, P678, DOI 10.1016/j.apmr.2003.06.033; DeJong G, 2009, ARCH PHYS MED REHAB, V90, P1269, DOI 10.1016/j.apmr.2008.11.021; DONABEDIAN A, 1988, JAMA-J AM MED ASSOC, V260, P1743, DOI 10.1001/jama.260.12.1743; Duncan PW, 2002, STROKE, V33, P167, DOI 10.1161/hs0102.101014; FUHRER MJ, 1987, OVERVIEW OUTCOME ANA, P1; Gage B, 2007, ARCH PHYS MED REHAB, V88, P1737, DOI 10.1016/j.apmr.2007.09.025; Goldstein LB, 2003, NEUROLOGY, V61, P792, DOI 10.1212/01.WNL.0000082724.77447.3A; Hoenig H, 2005, J AM GERIATR SOC, V53, P1712, DOI 10.1111/j.1532-5415.2005.53502.x; Hoenig H, 2002, MED CARE, V40, P1036, DOI 10.1097/00005650-200211000-00005; Hoenig H, 2001, HEALTH SERV RES, V35, P1293; Hoenig H, 1999, J REHABIL RES DEV, V36, P19; Hoenig H, 2000, ARCH PHYS MED REHAB, V81, P853, DOI 10.1053/apmr.2000.5569; Horn SD, 2005, ARCH PHYS MED REHAB, V86, pS101, DOI 10.1016/j.apmr.2005.09.016; HUGHES SL, 1990, MED CARE, V28, P135, DOI 10.1097/00005650-199002000-00004; Jette DU, 2005, ARCH PHYS MED REHAB, V86, P373, DOI 10.1016/j.apmr.2004.10.018; Kirschner KL, 2009, PM&R, V1, P957, DOI 10.1016/j.pmrj.2009.09.001; Lemieux-Charles L, 2006, MED CARE RES REV, V63, P263, DOI 10.1177/1077558706287003; Lenker JA, 2003, ASSIST TECHNOL, V15, P1, DOI 10.1080/10400435.2003.10131885; Michie S, 2005, QUAL SAF HEALTH CARE, V14, P26, DOI 10.1136/qshc.2004.011155; Michie S, 2004, PSYCHOL HEALTH, V19, P29, DOI 10.1080/0887044031000141199; Needham DM, 2010, TOP STROKE REHABIL, V17, P271, DOI 10.1310/tsr1704-271; *OFF QUAL PERF DEP, PERF MEAS; OTTENBACHER KJ, 1993, ARCH NEUROL-CHICAGO, V50, P37, DOI 10.1001/archneur.1993.00540010033014; Pegg PO, 2005, REHABIL PSYCHOL, V50, P366, DOI 10.1037/0090-5550.50.4.366; Phibbs CS, 2006, MED CARE, V44, P91, DOI 10.1097/01.mlr.0000188981.06522.e0; Pound P, 1999, AGE AGEING, V28, P433, DOI 10.1093/ageing/28.5.433; Pound P, 2000, SOC SCI MED, V51, P1437, DOI 10.1016/S0277-9536(00)00040-X; Pronovost P, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1714; Reker DM, 2000, J REHABIL RES DEV, V37, P483; Reker DM, 2002, ARCH PHYS MED REHAB, V83, P750, DOI 10.1053/apmr.2002.99736; Rodkey GV, 2009, AM J SURG, V198, pS3, DOI 10.1016/j.amjsurg.2009.08.004; ROSE SS, 2003, THESIS U ARIZONA TUC; Rubenstein LZ, 2007, J AM GERIATR SOC, V55, P166, DOI 10.1111/j.1532-5415.2007.01044.x; RUBENSTEIN LZ, 1988, J CLIN EPIDEMIOL, V41, P441, DOI 10.1016/0895-4356(88)90045-5; RUBENSTEIN LZ, 1995, AGING-CLIN EXP RES, V7, P212, DOI 10.1007/BF03324318; Salazar AM, 2000, JAMA-J AM MED ASSOC, V283, P3075, DOI 10.1001/jama.283.23.3075; Shoemaker LL, 2009, AM J PHYS MED REHAB, V88, P1020, DOI 10.1097/PHM.0b013e3181bc0d55; SIVENIUS J, 1985, STROKE, V16, P928, DOI 10.1161/01.STR.16.6.928; Stineman M G, 2001, Top Stroke Rehabil, V8, P34; Stineman MG, 2008, ARCH PHYS MED REHAB, V89, P1863, DOI 10.1016/j.apmr.2008.03.013; Stineman MG, 2007, DISABIL REHABIL, V29, P1165, DOI 10.1080/09638280600976145; Stineman MG, 2010, TOP STROKE REHABIL, V17, P262, DOI 10.1310/tsr1704-262; Stineman MG, 2010, PM&R, V2, P232, DOI 10.1016/j.pmrj.2010.01.012; Stineman MG, 1997, MED CARE, V35, pJS90, DOI 10.1097/00005650-199706001-00018; Stineman MG, 1997, MED CARE, V35, pJS106; Strasser DC, 2008, ARCH PHYS MED REHAB, V89, P10, DOI 10.1016/j.apmr.2007.08.127; Strasser DC, 2010, TOP STROKE REHABIL, V17, P225, DOI 10.1310/tsr1704-225; Strasser DC, 2005, ARCH PHYS MED REHAB, V86, P403, DOI 10.1016/j.apmr.2004.04.046; Van Craen K, 2010, J AM GERIATR SOC, V58, P83, DOI 10.1111/j.1532-5415.2009.02621.x; *VET HLTH ADM, QUERI IMPL GUID; Walsh K, 2002, POSTGRAD MED J, V78, P322, DOI 10.1136/pmj.78.920.322; Wang YC, 2008, J REHABIL RES DEV, V45, P1065, DOI 10.1682/JRRD.2007.12.0211; WIELAND D, 1986, JAMA-J AM MED ASSOC, V255, P2622, DOI 10.1001/jama.255.19.2622; WINKLER SLH, J REHABIL RES UNPUB; World Health Organization, 2001, INT CLASS FUNCT DIS; Yagura H, 2005, CEREBROVASC DIS, V20, P258, DOI 10.1159/000087708	70	18	20	0	10	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1074-9357	1945-5119		TOP STROKE REHABIL	Top. Stroke Rehabil.	JUL-AUG	2010	17	4					239	251		10.1310/tsr1704-239			13	Rehabilitation	Rehabilitation	654FD	WOS:000282153000003	20826412				2021-06-18	
J	Mandell, SP; Kaufman, R; Mack, CD; Bulger, EM				Mandell, Samuel P.; Kaufman, Robert; Mack, Christopher D.; Bulger, Eileen M.			Mortality and injury patterns associated with roof crush in rollover crashes	ACCIDENT ANALYSIS AND PREVENTION			English	Article						Rollover; Roof crush; Roof intrusion; Occupant safety	OCCUPANT	Background: In the United States, a significant number of spine injuries, traumatic brain injuries (TBI), and deaths result from motor vehicle rollover crashes each year though they make up a small percentage of total crashes. We sought to explore the relationship between these injuries and the degree of roof crush. Methods: We searched the NASS CDS database for belted, adult (>= 16), non-middle seat passengers involved in rollover crashes from 1993 to 2006. We also searched the CIREN database for illustrative cases. Logistic regression was used to evaluate the relationship between different levels of roof crush and mortality, severe injury (AIS >= 3) to the spine, spinal cord, and head injury. Results: The risk of mortality, TBI, and spine injury all increased as the degree of roof crush increased. For mortality increased risk occurred at >15 cm [15-30 cm: OR 2.089 (95% CI: 1.461-2.987); >30 cm: OR 6.301 (95% CI: 4.369-9.087)]. For TBI, increased risk was seen above 15 cm crush [15-30cm: OR 1.52(95% CI: 1.045-2.21); >30 cm: OR 3.672 (95% CI: 2.456-5.490)]. For spine injury increased risk was seen above 8 cm crush [8-15 cm: OR 1.968(95% CI 1.273-3.043); 15-30 cm: OR 2.530 (95% CI 1.634-3.917); >= 30 cm OR 2.682 (95% CI 1.474, 4.877). Results were similar across the different statistical models. Conclusion: There is an association between the degree of roof crush and mortality, spine injury, and head injury in rollover crashes. (C) 2010 Elsevier Ltd. All rights reserved.	[Mandell, Samuel P.; Bulger, Eileen M.] Univ Washington, Harborview Med Ctr, Dept Trauma Surg, Seattle, WA 98104 USA; [Kaufman, Robert; Mack, Christopher D.] Univ Washington, Harborview Injury Prevent & Res Ctr, Seattle, WA 98104 USA	Mandell, SP (corresponding author), Univ Washington, Harborview Med Ctr, Dept Trauma Surg, 325 9th Ave, Seattle, WA 98104 USA.	mandells@u.washington.edu	Mandell, Samuel/AAM-4647-2021				[Anonymous], 2009, FED REG; BAHLING GS, 1995, J TRAUMA, V38, P557, DOI 10.1097/00005373-199504000-00015; Bidez MW, 2007, ANN BIOMED ENG, V35, P1973, DOI 10.1007/s10439-007-9355-1; Brumbelow M., 2008, ROOF STRENGTH INJURY; BURNS SP, INJURY PREVENT UNPUB; BURNS SP, J SPINAL CORD UNPUB; FRIEDMAN D, 2005, 050417 CTR INJ RES; Grzebieta R. H., 2007, P AUSTR ROAD SAF RES; GRZEBIETA RH, 2007, ROLLOVER CRASHES DIV; Hu Jingwen, 2005, Annu Proc Assoc Adv Automot Med, V49, P119; Jehle D, 2007, ACAD EMERG MED, V14, P899, DOI 10.1197/j.aem.2007.06.029; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Moffatt E.A, 2005, 2005010942 SAE; MOFFATT EA, 1975, 19 C AM ASS AUT MED; NHTSA, 2005, 810631 NHTSA DOT HS; Revell M, 2003, TRAUMA, V5, P61, DOI [10.1191/1460408603ta268oa, DOI 10.1191/1460408603TA268OA]; RIDELLA S, 2008, INT IRCOBI C BIM INJ, P33; STRASHNY A, 2007, ROLE VERTICAL ROOF I, V216; Viano David C, 2007, Traffic Inj Prev, V8, P382, DOI 10.1080/15389580701583379; VIANO DC, 2006, ANAL REPORTS LIT HEA; Young D, 2007, INT J CRASHWORTHINES, V12, P609, DOI 10.1080/13588260701497946; YOUNG DGR, 2008, ACCIDENT RECONSTRUCT, V10; 2005, AAAM ABBREVIATED INJ	23	18	19	0	7	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0001-4575			ACCIDENT ANAL PREV	Accid. Anal. Prev.	JUL	2010	42	4					1326	1331		10.1016/j.aap.2010.02.013			6	Ergonomics; Public, Environmental & Occupational Health; Social Sciences, Interdisciplinary; Transportation	Engineering; Public, Environmental & Occupational Health; Social Sciences - Other Topics; Transportation	607LD	WOS:000278504700046	20441849				2021-06-18	
J	Palijan, TZ; Radeljak, S; Kovac, M; Kovacevic, D				Palijan, Tija Zarkovic; Radeljak, Sanja; Kovac, Marina; Kovacevic, Drazen			RELATIONSHIP BETWEEN COMORBIDITY AND VIOLENCE RISK ASSESMENT IN FORENSIC PSYCHIATRY - THE IMPLICATON OF NEUROIMAGING STUDIES	PSYCHIATRIA DANUBINA			English	Article; Proceedings Paper	24th Danube Congress of Psychiatry	MAY 05-08, 2010	Zagreb, CROATIA	Danubian Psychiat Assoc		comorbidity; violence risk assessment; neuroimaging; forensic psychiatry	DOUBLE-BLIND; DEPRESSION; PREVALENCE; ADULTS; THERAPY	Violence is an important social problem. Violence in the community has important social relevance for the political, criminal justice, and health care systems. Studies of homicide offenders have suggested a high prevalence of neurologic dysfunction due to organic brain damage such as traumatic brain injury, epilepsy and dementia have been observed to exhibit excessive violence. Moreover, violence in the mentally ill can be viewed as an important medical and mental health problem with significant implications for forensic psychiatry and the community. Although numerous previous studies showed that rate of violent behavior in the community is not much higher in patients with serious mental disorders (schizophrenia) than in healthy controls, that rate is substantially higher in patients with psychiatric comorbidity and substance abuse. A high proportion of patients in forensic psychiatric facilities are diagnosed with comorbidity, most often with schizophrenia, paranoid psychosis, organic brain syndrome, various personality disorders and comorbid substance abuse. These patients represent a high risk group for violence within forensic psychiatric facilities, and repetitive violent behavior in the community. Understanding the neurobiological basis of aggressive behavior clearly has important social and clinical implications. By introduction of neuroimaging studies (MU, fMRI, PET, SPECT) as a useful tool in forensic psychiatry, the neurobiological aspect of violence is better understood. Previous studies have shown that individuals with frontotemporal brain dysfunction are frequently displaying antisocial behavior (disinhibition, impulsivity, lack of empathy) that justify the diagnosis of "acquired sociopathy/psychopathy". A correlation between the potential for impulsive aggression mediated by limbic brain structures, and the control of the aggression by frontotemporal brain regions has been shown. The individuals with such brain dysfunction have an increased risk of violent behavior and scored high on the Webster's and Hare's violence risk assessment scale. This article reviews the relationship between psychiatric comorbidity, violence risk assessment and neuro imaging in forensic psychiatry and showing the useful directions for future research, screening and prevention of violent behavior among mentally ill criminal offenders.	[Palijan, Tija Zarkovic; Radeljak, Sanja; Kovac, Marina; Kovacevic, Drazen] Neuropsychiat Hosp Dr Ivan Barbot, Dept Forens Psychiat, Popovaca 44317, Croatia	Palijan, TZ (corresponding author), Neuropsychiat Hosp Dr Ivan Barbot, Dept Forens Psychiat, Jelengradska 1, Popovaca 44317, Croatia.	tija.zarkovic-palijan@npbp.hr					Anderson RJ, 2000, DIABETES, V49, pA64; Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069; Brown LC, 2008, DIABETES RES CLIN PR, V79, P61, DOI 10.1016/j.diabres.2007.07.009; DiMatteo MR, 2000, ARCH INTERN MED, V160, P2101, DOI 10.1001/archinte.160.14.2101; Egede LE, 2005, PSYCHOSOM MED, V67, P46, DOI 10.1097/01.psy.0000149260.82006.fb; Egede LE, 2004, DIABETES CARE, V27, P421, DOI 10.2337/diacare.27.2.421; Egede LE, 2002, DIABETES EDUCATOR, V28, P258, DOI 10.1177/014572170202800211; Filakovic P., 2004, MEDICUS, V13, P59; Filipcic I, 2007, COLLEGIUM ANTROPOL, V31, P139; Gonzalez JS, 2007, DIABETES CARE, V30, P2222, DOI 10.2337/dc07-0158; Katon W, 2004, DIABETES CARE, V27, P914, DOI 10.2337/diacare.27.4.914; Katon WJ, 2005, DIABETES CARE, V28, P2668, DOI 10.2337/diacare.28.11.2668; Lustman Patrick J, 2008, Curr Psychiatry Rep, V10, P495, DOI 10.1007/s11892-007-0020-8; Lustman PJ, 2006, ARCH GEN PSYCHIAT, V63, P521, DOI 10.1001/archpsyc.63.5.521; Lustman PJ, 1997, PSYCHOSOM MED, V59, P241, DOI 10.1097/00006842-199705000-00007; Lustman PJ, 2000, DIABETES CARE, V23, P934, DOI 10.2337/diacare.23.7.934; Paile-Hyvarinen M, 2007, BMC FAM PRACT, V8, DOI 10.1186/1471-2296-8-34; Pibernik-Okanovic M, 2005, DIABETIC MED, V22, P942, DOI 10.1111/j.1464-5491.2005.01528.x; Pibernik-Okanovic M, 1998, PHARMACOECONOMICS, V14, P201, DOI 10.2165/00019053-199814020-00008	19	18	19	6	39	MEDICINSKA NAKLADA	ZAGREB	VLASKA 69, HR-10000 ZAGREB, CROATIA	0353-5053			PSYCHIAT DANUB	Psychiatr. Danub.	JUN	2010	22	2					253	256					4	Psychiatry	Psychiatry	616JT	WOS:000279206200019	20562756				2021-06-18	
J	Bottari, C; Dassa, C; Rainville, C; Dutil, E				Bottari, Carolina; Dassa, Clement; Rainville, Constant; Dutil, Elisabeth			A Generalizability Study of the Instrumental Activities of Daily Living Profile	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Activities of daily living; Brain injuries; Cognition; Psychometrics; Rehabilitation	TRAUMATIC BRAIN-INJURY; RELIABILITY; IMPAIRMENTS; COGNITION; DEFICITS; MODERATE; OUTCOMES; CONTEXT; DAMAGE	Objective: To establish generalizability estimates of the Instrumental Activities of Daily Living (IADL) Profile when administered to persons with a moderate or severe traumatic brain injury (TB!) within their home and community environment. Design: Generalizability theory was used to estimate generalizability and dependability coefficients as well as the relative contribution of identified sources of measurement error to total measurement error. Decision studies were used to enable the investigators to determine the optimal measurement design. Setting: The IADL Profile was administered in subjects' homes and community environments. Participants: Convenience sample of adults with a moderate or severe TBI (N=30, aged 16-65y). Interventions: Not applicable. Main Outcome Measures: IADL Profile scores include 6 factor scores (going to the grocery store/shopping for groceries, having a meal with guests/cleaning up, putting on outdoor clothing, obtaining information, making a budget, and preparing a hot meal) and I total score. Results: The greatest sources of measurement error were the subject-item interactions (3-random-facet design) and the subject-rater interactions (2-random-facet design). One hundred percent of generalizability coefficients of factor scores indicated acceptable to excellent reliability. Indices of dependability confirmed that 1 evaluator could reliably score the tool on a single occasion after having received a 3-day training workshop. Conclusions: The IADL Profile administered to persons with a moderate or severe TB I provides occupational therapists with a reliable set of measures of IADL independence capable of both capturing and analyzing the complex interactions between personal and environmental factors.	[Bottari, Carolina; Dutil, Elisabeth] Univ Montreal, Sch Rehabil, Montreal, PQ, Canada; [Dassa, Clement] Univ Montreal, Dept Social & Prevent Med, Montreal, PQ, Canada; [Rainville, Constant] Univ Montreal, Dept Psychol, Montreal, PQ H3C 3J7, Canada; [Bottari, Carolina; Rainville, Constant; Dutil, Elisabeth] Ctr Interdisciplinary Res Rehabil, Montreal, PQ, Canada; [Dassa, Clement] Interdisciplinary Res Grp Hlth, Montreal, PQ, Canada	Bottari, C (corresponding author), Univ Montreal, Ecole Readaptat, 7077 Parc, Montreal, PQ, Canada.	carolina.bottari@umontreal.ca			Fonds de la recherche en sante du Quebec (FRSQ)Fonds de la Recherche en Sante du Quebec [6623]; Association quebecoise d'etablissements de sante et de services sociaux; Association des etablissements de readaptation du Quebec; Societe d'assurance automobile du Quebec; Quebec Rehabilitation Research Network; Canadian Occupational Therapy Foundation	Supported by the Fonds de la recherche en sante du Quebec (FRSQ) (grant no. 6623). The study was financed pursuant to a jointly cooperative arrangement between the FRSQ, the Association quebecoise d'etablissements de sante et de services sociaux, the Association des etablissements de readaptation du Quebec, the Societe d'assurance automobile du Quebec, and the Quebec Rehabilitation Research Network. Also supported by the Canadian Occupational Therapy Foundation.	BAIN D, 1996, EVALUER VOS EVALUATI, P125; Bao S, 2009, HUM FACTORS, V51, P292, DOI 10.1177/0018720809340273; Bottari C., 2008, BRAIN INJ S1, V22, P33; BOTTARI C, 2009, BRAIN INJURY, V23, P1; Bottari C, 2001, PERCEPTION EXPERTS C; BOTTARI C, 2008, BRAIN INJ S1, V22, P34; Bottari C, 2006, AUST OCCUP THER J, V53, P98, DOI DOI 10.1111/J.1440-1630.2006.00547.X; Bottari C, 2009, NEUROPSYCHOL REHABIL, V19, P177, DOI 10.1080/09602010802188435; Bottari CL, 2010, CAN J OCCUP THER, V77, P90, DOI 10.2182/cjot.2010.77.2.5; Brennan R. L., 2001, GEN THEORY; Brentnall J, 2009, OTJR-OCCUP PART HEAL, V29, P63, DOI 10.3928/15394492-20090301-01; Brzuzy S, 1996, J HEAD TRAUMA REHAB, V11, P74, DOI 10.1097/00001199-199606000-00011; Burgess PW, 2006, J INT NEUROPSYCH SOC, V12, P194, DOI 10.1017/S1355617706060310; Burgess PW, 2000, PSYCHOL RES-PSYCH FO, V63, P279, DOI 10.1007/s004269900006; CARDINET J, 1985, ASSURER MESURE; Chevignard M, 2000, CORTEX, V36, P649, DOI 10.1016/S0010-9452(08)70543-4; Colantonio A, 2004, DISABIL REHABIL, V26, P253, DOI 10.1080/09638280310001639722; Crocker L., 1986, INTRO CLASSICAL MODE; CRONBACH LJ, 1972, MULTIFACET CONCEPT O, P1; DAWSON DR, 1995, BRAIN INJURY, V9, P339, DOI 10.3109/02699059509005774; DONNER A, 1987, STAT MED, V6, P441, DOI 10.1002/sim.4780060404; DUTIL E, 1990, Occupational Therapy in Health Care, V7, P7, DOI 10.1080/J003v07n01_03; Dutil E, 2005, ADL PROFILE DESCRIPT; ESLINGER PJ, 1985, NEUROLOGY, V35, P1731, DOI 10.1212/WNL.35.12.1731; Fisher AG, 2003, ASSESSMENT MOTOR PRO, V1; Fortin S, 2003, CORTEX, V39, P273, DOI 10.1016/S0010-9452(08)70109-6; Fougeyrollas P, 1998, INT J REHABIL RES, V21, P127, DOI 10.1097/00004356-199806000-00002; GERVAIS N, 1995, COMP PROFIL AVQ MESU; Gitlin LN, 2003, GERONTOLOGIST, V43, P628, DOI 10.1093/geront/43.5.628; Golden C., 1978, STROOP COLOR WORD TE; Gordon WA, 2006, AM J PHYS MED REHAB, V85, P343, DOI 10.1097/01.phm.0000202106.01654.61; Humphreys GW, 1998, COGN NEUROPSYCHOL, V15, P771; KASINDI G, 1998, COMP DEUX OUTILS SER; Klein Sheryl, 2008, Can J Occup Ther, V75, P69; Knight C, 2002, NEUROPSYCHOL REHABIL, V12, P231, DOI 10.1080/09602010244000039; Kozlowski O., 2002, Annales de Readaptation et de Medecine Physique, V45, P466, DOI 10.1016/S0168-6054(02)00297-0; Le Thiec F., 1999, Annales de Readaptation et de Medecine Physique, V42, P1, DOI 10.1016/S0168-6054(99)80030-0; Lezak M.D., 1983, NEUROPSYCHOLOGICAL A; Lezak M. D., 1989, ASSESSMENT BEHAV CON, P113; Lezak M.D., 2004, NEUROPSYCHOLOGICAL A, Vfourth; Luria, 1973, WORKING BRAIN INTRO; Luria A. R., 1966, HIGHER CORTICAL FUNC; Martin K, 2009, PEDIATR PHYS THER, V21, P261, DOI 10.1097/PEP.0b013e3181b13bca; Nunnally J.C., 1978, PSYCHOMETRIC THEORY; Pedhazur E. J., 1991, MEASUREMENTS DESIGN; Ponsford J., 1995, TRAUMATIC BRAIN INJU; Rabbitt P., 1997, METHODOLOGY FRONTAL, P1; RAINVILLE C, 2005, COMMUNICATION DEMENC, P137; Rempfer MV, 2003, PSYCHIAT RES, V117, P103, DOI 10.1016/S0165-1781(02)00318-9; ROGERS JC, 1982, AM J OCCUP THER, V36, P709, DOI 10.5014/ajot.36.11.709; Rousseau J., 1994, CANADIAN J OCCUPATIO, V61, P149, DOI DOI 10.1177/000841749406100304; ROUSSEAU J, 1994, CANADIAN J OCCUPATIO, V61, P159, DOI DOI 10.1177/000841749406100305; Schwartz MF, 2002, NEUROPSYCHOL REHABIL, V12, P311, DOI 10.1080/09602010244000084; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; SHALLICE T, 1982, PHILOS T ROY SOC B, V298, P199, DOI 10.1098/rstb.1982.0082; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Stuss D.T., 1986, FRONTAL LOBES; TEASDALE G, 1974, LANCET, V2, P81; Vangeneugden T, 2005, BIOMETRICS, V61, P295, DOI 10.1111/j.0006-341X.2005.031040.x; VONCRAMON DY, 1994, NEUROPSYCHOL REHABIL, V4, P399, DOI 10.1080/09602019408401608; WALSH WB, 1995, TESTS ASSESSMENT; Wechsler D., 1997, WMS 3 WECHSLER MEMOR; Whiteneck G, 2004, ARCH PHYS MED REHAB, V85, pS73, DOI 10.1016/j.apmr.2003.08.107; Zalla T, 2001, NEUROPSYCHOLOGIA, V39, P759, DOI 10.1016/S0028-3932(01)00019-7	64	18	18	0	6	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	MAY	2010	91	5					734	742		10.1016/j.apmr.2009.12.023			9	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	594LK	WOS:000277539000010	20434611				2021-06-18	
J	Johnson, CL; Resch, JA; Elliott, TR; Villarreal, V; Kwok, OM; Berry, JW; Underhill, AT				Johnson, Caitlin L.; Resch, J. Aaron; Elliott, Timothy R.; Villarreal, Victor; Kwok, Oi-Man; Berry, Jack W.; Underhill, Andrea T.			Family Satisfaction Predicts Life Satisfaction Trajectories Over the First 5 Years After Traumatic Brain Injury	REHABILITATION PSYCHOLOGY			English	Article						traumatic brain injury; family satisfaction; life satisfaction; modeling	SET-POINT MODEL; QUALITY-OF-LIFE; SELF-EFFICACY; SPINAL-CORD; RELIABILITY; ADAPTATION; HAPPINESS; INDIVIDUALS; DISABILITY; ADJUSTMENT	Objectives: Examined the influence of functional impairment, stable marital status, and family satisfaction on life satisfaction trajectories for 609 individuals (435 men, 174 women) over the first 5 years after traumatic brain injury (TB!). Measures: Participants completed the Family Satisfaction Scale (FSS), Functional Independence Measure (FIM), and the Life Satisfaction Index (LSI) at years I. 2, 4, and 5 after sustaining a TBI. Results: Trajectory modeling revealed that higher family satisfaction was associated with increases in life satisfaction for individuals with less functional impairment. Stable marital status was not significantly associated with life satisfaction trajectories. Implications: Family satisfaction appears to have pronounced beneficial effects on life satisfaction for persons with less functional impairment after TBI regardless of marital status. In contrast, a stable marriage appears to have no apparent benefits to self-reported life satisfaction over the first 5 years post-TBI. Theoretical and clinical implications of these results are discussed.	[Elliott, Timothy R.] Texas A&M Univ, Dept Educ Psychol, College Stn, TX 77845 USA; [Berry, Jack W.] Samford Univ, Homewood, AL USA; [Underhill, Andrea T.] Univ Alabama Birmingham, Birmingham, AL USA	Elliott, TR (corresponding author), Texas A&M Univ, Dept Educ Psychol, 4225 TAMU, College Stn, TX 77845 USA.	telliott@tamu.edu	Elliott, Timothy R./I-5301-2012	Elliott, Timothy R./0000-0002-6608-7714; Kwok, Oiman/0000-0002-4617-4562	NCIPC CDC HHS [R49-CE000191] Funding Source: Medline; NATIONAL CENTER FOR INJURY PREVENTION AND CONTROLUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49CE000191] Funding Source: NIH RePORTER		ADAMS DL, 1969, J GERONTOL, V24, P470, DOI 10.1093/geronj/24.4.470; Arango-Lasprilla JC, 2008, BRAIN INJURY, V22, P565, DOI 10.1080/02699050802172004; Bond T.G., 2001, APPL RASCH MODEL FUN; Cicerone KD, 2007, J HEAD TRAUMA REHAB, V22, P257, DOI 10.1097/01.HTR.0000290970.56130.81; *COMM INJ SCAL, 1985, ABBR INJ SCAL 1985 R; Corrigan JD, 2001, J HEAD TRAUMA REHAB, V16, P543, DOI 10.1097/00001199-200112000-00003; Corrigan JD, 2007, ARCH PHYS MED REHAB, V88, P1400, DOI 10.1016/j.apmr.2007.08.006; Cumsille P.E., 1994, J FAM PSYCHOL, V8, P202, DOI [10.1037/0893-3200.8.2.202., DOI 10.1037/0893-3200.8.2.202, 10.1037/0893-3200.8.2.202]; Diener E, 2006, AM PSYCHOL, V61, P305, DOI 10.1037/0003-066X.61.4.305; Diener E, 1999, PSYCHOL BULL, V125, P276, DOI 10.1037//0033-2909.125.2.276; Dijkers MP, 2004, ARCH PHYS MED REHAB, V85, pS21, DOI 10.1016/j.apmr.2003.08.119; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Dunn DS, 2008, REHABIL PSYCHOL, V53, P413, DOI 10.1037/a0013749; Elliott T. R., 2002, HDB POSITIVE PSYCHOL, P687; Elliott T. R., 2009, OXFORD HDB POSITIVE, V2, P651, DOI DOI 10.1093/OXFORDHB/9780195187243.013.0062; ELLIOTT TR, 2007, PSYCHOL MANAGEMENT P, P16; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Fisher G. H., 1976, ADV PSYCHOL ED MEASU, P97; Frederick S., 1999, WELL BEING FDN HEDON, P302; Hicken BL, 2002, J REHABIL RES DEV, V39, P359; Johnston MV, 2002, ARCH PHYS MED REHAB, V83, pS26, DOI 10.1053/apmr.2002.37100; Kaplan RM, 2005, ANNU REV CLIN PSYCHO, V1, P525, DOI 10.1146/annurev.clinpsy.1.102803.144118; Keith R A, 1987, Adv Clin Rehabil, V1, P6; Kosciulek JF, 1996, J REHABIL, V62, P49; Kosciulek JF, 1999, BRAIN INJURY, V13, P245, DOI 10.1080/026990599121610; Kreuter M, 1998, SPINAL CORD, V36, P252, DOI 10.1038/sj.sc.3100592; Kwok OM, 2008, REHABIL PSYCHOL, V53, P370, DOI 10.1037/a0012765; Lightsey OR, 2008, FAM J, V16, P212, DOI 10.1177/1066480708317503; Linacre JM, 2003, USERS GUIDE WINSTEPS; Lobello SG, 2004, BRAIN INJURY, V18, P1127, DOI 10.1080/02699050410001672378; Lucas RE, 2003, J PERS SOC PSYCHOL, V84, P527, DOI 10.1037/0022-3514.84.3.527; Lucas RE, 2007, J PERS SOC PSYCHOL, V92, P717, DOI 10.1037/0022-3514.92.4.717; Lucas RE, 2007, CURR DIR PSYCHOL SCI, V16, P75, DOI 10.1111/j.1467-8721.2007.00479.x; Lyubomirsky S, 2005, REV GEN PSYCHOL, V9, P111, DOI 10.1037/1089-2680.9.2.111; MACKENZIE EJ, 1989, MED CARE, V27, P412, DOI 10.1097/00005650-198904000-00008; Mailhan L, 2005, BRAIN INJURY, V19, P227, DOI 10.1080/02699050410001720149; NEUGARTEN BL, 1961, J GERONTOL, V16, P134, DOI 10.1093/geronj/16.2.134; Olson D. H., 1983, CIRCUMPLEX MODEL SYS; Olson D.H., 1982, FAMILY INVENTORIES I, P25; Perlesz A, 1999, REHABIL PSYCHOL, V44, P6, DOI 10.1037/0090-5550.44.1.6; Perlesz A, 2000, J HEAD TRAUMA REHAB, V15, P909, DOI 10.1097/00001199-200006000-00005; Pierce CA, 2006, AM J PHYS MED REHAB, V85, P889, DOI 10.1097/01.phm.0000242615.43129.ae; RAO VN, 1982, INT J AGING HUM DEV, V14, P55, DOI 10.2190/DWM4-E05K-CNTD-XNAA; Raudenbush SW., 2002, HIERARCHICAL LINEAR, V2nd ed; Resch JA, 2009, REHABIL PSYCHOL, V54, P51, DOI 10.1037/a0015051; Rotondi AJ, 2007, J HEAD TRAUMA REHAB, V22, P14, DOI 10.1097/00001199-200701000-00002; Rutterford NA, 2006, J INT NEUROPSYCH SOC, V12, P359, DOI 10.1017/S1355617706060450; Stalnacke BM, 2007, BRAIN INJURY, V21, P933, DOI 10.1080/02699050701553189; Strauss DJ, 1998, ARCH PHYS MED REHAB, V79, P1095, DOI 10.1016/S0003-9993(98)90177-0; Testa JA, 2005, ARCH PHYS MED REHAB, V86, P1815, DOI 10.1016/j.apmr.2005.03.010; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Underhill AT, 2004, J REHABIL RES DEV, V41, P603, DOI 10.1682/JRRD.2003.06.0094; Wallace KA, 2002, EDUC PSYCHOL MEAS, V62, P674, DOI 10.1177/0013164402062004009; Warren L, 1996, J REHABIL RES DEV, V33, P404; WEBB CR, 1995, ARCH PHYS MED REHAB, V76, P1113, DOI 10.1016/S0003-9993(95)80118-9; Wood RL, 2008, EUR J ANAESTH, V25, P115, DOI 10.1017/S0265021507003432; Wood RL, 2006, J NEUROL NEUROSUR PS, V77, P71, DOI 10.1136/jnnp.2005.065540	57	18	18	0	12	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550	1939-1544		REHABIL PSYCHOL	Rehabil. Psychol.	MAY	2010	55	2					180	187		10.1037/a0019480			8	Psychology, Clinical; Rehabilitation	Psychology; Rehabilitation	604KX	WOS:000278279000008	20496972				2021-06-18	
J	O'Callaghan, AM; McAllister, L; Wilson, L				O'Callaghan, Anna Mary; McAllister, Lindy; Wilson, Linda			Experiences of care reported by adults with traumatic brain injury	INTERNATIONAL JOURNAL OF SPEECH-LANGUAGE PATHOLOGY			English	Article; Proceedings Paper	Speech Pathology Australia National Conference	MAY 17-21, 2009	Adelaide, AUSTRALIA			Traumatic brain injury (TBI); best practice; consumer preferences; clinical care guidelines; healthcare funding	CLINICAL-PRACTICE GUIDELINES; SEVERE HEAD-INJURY; CAREGIVER BURDEN; CONSUMER PARTICIPATION; RELATIVES VIEW; OUTCOMES; REHABILITATION; MANAGEMENT; REINTEGRATION; INDIVIDUALS	This paper investigates the continuum of care experienced by adults and their significant others following a moderate to severe traumatic brain injury (TBI) in Victoria, Australia. Clinical care guidelines exist defining best practice in TBI rehabilitation, but little is currently known about the experiences of those who sustain a TBI their needs and the barriers they encounter when attempting to access services. This paper presents the journeys of 202 Victorians admitted for acute care following a moderate to severe TBI over 4 years. Results of this study indicate very few participants report receiving services in line with recommendations made in clinical care guidelines. In addition reported access to services was noted to vary according to allocated healthcare funding (i.e., compensable vs. private vs. public). Clinicians' consideration of healthcare consumers' experiences are essential if services provided are to match consumers' needs.	[Wilson, Linda] Charles Sturt Univ, Sch Community Hlth, Albury, NSW 2640, Australia	Wilson, L (corresponding author), Charles Sturt Univ, Sch Community Hlth, POB 789, Albury, NSW 2640, Australia.	liwilson@csu.edu.au	Copley, Anna/D-1067-2011; McAllister, Lindy/C-8027-2009; Wilson, Linda/P-8523-2015	Copley, Anna/0000-0003-1784-9070; Wilson, Linda/0000-0003-4175-7125			*ACC COMP CORP NZ, 2004, TRAUM BRAIN INJ REH; *ACC REH COMP INS, 1998, MED J AUSTRALIA, V167, P293; [Anonymous], 2008, GUID PREH MAN SEV TR; Avesani R, 2005, BRAIN INJURY, V19, P933, DOI 10.1080/02699050400002371; Bastian H, 1996, INT J QUAL HEALTH C, V8, P485, DOI 10.1093/intqhc/8.5.485; *BRAIN TRAUM FDN, 2007, J NEUROTRAUMA S, V1; *BRAIN TRAUM FDN, 2006, NEUROSURGERY S   MAR; BROOKS DN, 1983, J NEUROL NEUROSUR PS, V46, P336, DOI 10.1136/jnnp.46.4.336; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; Brooks N., 1987, J HEAD TRAUMA REHABI, V2, P1, DOI [10.1097/00001199-198709000-00003, DOI 10.1097/00001199-198709000-00003]; Bulger EM, 2002, CRIT CARE MED, V30, P1870, DOI 10.1097/00003246-200208000-00033; Bushnik T, 2003, ARCH PHYS MED REHAB, V84, P151, DOI 10.1053/apmr.2003.50123; Cabana MD, 1999, JAMA-J AM MED ASSOC, V282, P1458, DOI 10.1001/jama.282.15.1458; Coetzer R, 2005, INT J REHABIL RES, V28, P361, DOI 10.1097/00004356-200512000-00010; Ergh TC, 2002, J HEAD TRAUMA REHAB, V17, P155, DOI 10.1097/00001199-200204000-00006; Fakhry SM, 2004, J TRAUMA, V56, P492, DOI 10.1097/01.TA.0000115650.07193.66; Faul M, 2007, J TRAUMA, V63, P1271, DOI 10.1097/TA.0b013e3181493080; Feild M, 1990, CLIN PRACTICE GUIDEL; Frattali C, 2003, J MED SPEECH-LANG PA, V11, pIX; Gillham B., 2000, DEV QUESTIONNAIRE; Hodgkinson A, 2000, J HEAD TRAUMA REHAB, V15, P1208, DOI 10.1097/00001199-200012000-00003; HUMPHREYS J, 1997, 4 NAT RUR HLTH C; Humphreys JS, 1997, MED J AUSTRALIA, V166, P577, DOI 10.5694/j.1326-5377.1997.tb123267.x; *I MED, 1992, GUID CLIN PRACT DEV; *I TRAUM HLTH INJ, 2006, IN MAN CLOS HEAD INJ; Jackson C. J, 2000, DESIGNING ANAL QUEST; Kaplan CP, 2001, BRAIN INJURY, V15, P725, DOI 10.1080/02699050010005913; KAPLAN SH, 1989, MED CARE, V27, pS110, DOI 10.1097/00005650-198903001-00010; Karlovits T, 1999, BRAIN INJURY, V13, P845; Khan F, 2003, MED J AUSTRALIA, V178, P290, DOI 10.5694/j.1326-5377.2003.tb05199.x; Lefebvre H, 2005, BRAIN INJURY, V19, P585, DOI 10.1080/02699050400025026; Maas AIR, 1997, ACTA NEUROCHIR, V139, P286, DOI 10.1007/BF01808823; Maas AIR, 2002, NEUROL RES, V24, P19, DOI 10.1179/016164102101199495; MACPHAIL M, 1998, ACCOMMODATION SUPPOR; Marsh NV, 1998, BRAIN INJURY, V12, P225, DOI 10.1080/026990598122700; Marsh NV, 2002, J CLIN EXP NEUROPSYC, V24, P434, DOI 10.1076/jcen.24.4.434.1030; MCAULEY I, 2007, HLTH POLICY AUSTR RE; Mcilvoy L, 2001, J Neurosci Nurs, V33, P72; McNaughton H., 2004, TRAUMATIC BRAIN INJU; Motor Accidents Authority NSW, 2008, GUID MILD TRAUM BRAI; Muus K, 2006, J HEAD TRAUMA REHAB, V21, P431, DOI 10.1097/00001199-200609000-00052; Nabors N, 2002, BRAIN INJURY, V16, P1039, DOI 10.1080/02699050210155285; National Institute for Clinical Excellence, 2007, HEAD INJ TRIAG ASS I; Nelson William A, 2007, Healthc Exec, V22, P36; New Zealand Guidelines Group, 2006, TRAUM BRAIN INJ DIAG; NEWBERRY L, 2001, NEW DIRECTION FOLLOW; OCONNOR P, 2002, 43 INJCAT AUSTR I HL; PENCHANSKY R, 1981, MED CARE, V19, P127, DOI 10.1097/00005650-198102000-00001; Rankin N, 2000, EUR J CANCER CARE, V9, P97; RAO JN, 1995, BRIT MED J, V311, P1023; Rosenthal M, 1996, J HEAD TRAUMA REHAB, V11, P40, DOI 10.1097/00001199-199610000-00005; Royal College of Physicians and British Society of Rehabilitation Medicine, 2003, REH FOLL ACQ BRAIN I; Schootman M, 2000, BRAIN INJURY, V14, P373; SELIGMAN M, 1993, PSYCHOL TODAY    SPR; Spain DA, 1998, J TRAUMA, V45, P101, DOI 10.1097/00005373-199807000-00022; Stringer K, 1999, STUDY ACCOMMODATION; Tooth L, 2001, BRAIN INJURY, V15, P613, DOI 10.1080/02699050010013923; *TRAFF ACC COMM, 2003, CLIENT INF; TREVENA L, 2004, CLIN PRACTICE GUIDEL; Turkstra L. S., 2008, ASHA LEADER      JUL, P10; TURNERSTOKES L, 2005, COCHRANE COLLABORATI, V4, P1; World Health Organization Commission on the Social Determinants of Health, 2008, CLOS GAP GEN HLTH EQ	62	18	18	0	5	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1754-9507	1754-9515		INT J SPEECH-LANG PA	Int. J. Speech-Lang. Pathol.	APR	2010	12	2			SI		107	123		10.3109/17549500903431774			17	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	581GW	WOS:000276510800005	20420352				2021-06-18	
J	Alachini, B; Pisoni, C; Cieza, A; Cazzulani, B; Giustini, A; Pistarini, C				Alachini, B.; Pisoni, C.; Cieza, A.; Cazzulani, B.; Giustini, A.; Pistarini, C.		Italian Network	Developing ICF core set for subjects with traumatic brain injury: an Italian clinical perspective	EUROPEAN JOURNAL OF PHYSICAL AND REHABILITATION MEDICINE			English	Article						Brain injury; Disability evaluation; Cross sectional studies	QUALITY-OF-LIFE; INTERNATIONAL CLASSIFICATION; HEALTH ICF; DISABILITY; REHABILITATION; MODERATE; MODEL	Aim. The objective of this empirical study is to describe functioning and health of individuals with traumatic brain injury (TBI) and to identify the most common problems using the International Classification of Functioning Disability and Health (ICF). The specific aims are to describe the prevalence of problems in functioning as defined by the ICF of individuals with TBI, and to identify categories that explain most of the variance of the external standards. Methods. 261 TBI patients from 24 Italian centres members of the Italian Network were consecutively enrolled into the study between July 2008 and January 2009. The study was conducted as an empirical cross-sectional study. Results. The Extended ICF checklist captures the problems of TBI patients: many problems were reported within body function and body structure, but the most impaired categories were in Activity and Participation domain: the impaired categories reflect restrictions in challenging activities or activities related to later stages of recovery. The Environmental Factors in ICF were most frequently scored as facilitators: the support of the family is the most important environmental factor emerged, together with health professional. Conclusion. This study describes and identifies the most common problems in functioning of persons with TBI in an Italian sample. It emphasizes the importance of approaching the description of functioning and disability from a comprehensive perspective including not only body functions and structures but also activities and participation domains and environmental factors.	[Alachini, B.; Pisoni, C.; Pistarini, C.] Salvatore Maugeri Fdn, IRCCS, Sci Inst Pavia, Neurorehabil Unit, Pavia, Italy; [Cieza, A.] Univ Munich, Dept Phys Med & Rehabil, WHO FIC CC DIMDI, Munich, Germany; [Cazzulani, B.] Univ Pavia, Dept Phys Med & Rehabil, I-27100 Pavia, Italy; [Giustini, A.] San Pancrazio Rehabil Hosp, HSS Santo Stefano Grp, Trento, Italy	Pistarini, C (corresponding author), Fdn Salvatore Maugeri, IRCCS, Ist Sci Pavia, Operat Unit Neurorehabil, Via Salvatore Maugeri 10, I-27100 Pavia, Italy.	caterina.pistarini@fsm.it	Cazzulani, Benedetta/AAC-1818-2020; Pistarini, CATERINA/K-5234-2018; Pisoni, Camilla/P-8491-2019	Cazzulani, Benedetta/0000-0002-1219-9163; Pistarini, CATERINA/0000-0001-8925-0484; Pisoni, Camilla/0000-0001-9292-9682			Bernabeu M, 2009, NEUROREHAB NEURAL RE, V23, P464, DOI 10.1177/1545968308328725; Bilbao A, 2003, NEUROREHABILITATION, V18, P239; Cieza A, 2005, J REHABIL MED, V37, P212, DOI 10.1080/16501970510040263; Cieza A, 2004, J REHABIL MED, V36, P9, DOI 10.1080/16501960410015353; Cieza A, 2002, J REHABIL MED, V34, P205, DOI 10.1080/165019702760279189; Crooks Carol Y, 2007, Phys Med Rehabil Clin N Am, V18, P681, DOI 10.1016/j.pmr.2007.06.005; Grill E, 2005, DISABIL REHABIL, V27, P459, DOI 10.1080/09638280400014063; Grimes DA, 2002, LANCET, V359, P57, DOI 10.1016/S0140-6736(02)07283-5; Heegaard W, 2007, EMERG MED CLIN N AM, V25, P655, DOI 10.1016/j.emc.2007.07.001; Koskinen S, 2007, J REHABIL MED, V39, P467, DOI 10.2340/16501977-0077; Lovasik D, 2001, Crit Care Nurs Q, V23, P24; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; McArthur DL, 2004, BRAIN PATHOL, V14, P185, DOI 10.1111/j.1750-3639.2004.tb00052.x; Pagulayan KF, 2006, ARCH PHYS MED REHAB, V87, P611, DOI 10.1016/j.apmr.2006.01.018; Parikh S, 2007, INT ANESTHESIOL CLIN, V45, P119, DOI 10.1097/AIA.0b013e318078cfe7; Petchprapai Nutthita, 2007, J Neurosci Nurs, V39, P260; Pierce CA, 2006, AM J PHYS MED REHAB, V85, P889, DOI 10.1097/01.phm.0000242615.43129.ae; Pisoni C, 2008, EUR J PHYS REHAB MED, V44, P377; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; Ragnarsson KT, 2002, RESTOR NEUROL NEUROS, V20, P103; Sangha O, 2003, ARTHRIT RHEUM-ARTHR, V49, P156, DOI 10.1002/art.10993; Simpson G, 2000, BRAIN INJURY, V14, P125, DOI 10.1080/026990500120790; Stucki G, 2005, AM J PHYS MED REHAB, V84, P733, DOI 10.1097/01.phm.0000179521.70639.83; Stucki G, 2002, DISABIL REHABIL, V24, P932, DOI 10.1080/09638280210148594; Stucki G, 2002, DISABIL REHABIL, V24, P281, DOI 10.1080/09638280110105222; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; von Steinbuechel N, 2005, ACTA NEUROCHIR SUPPL, V93, P43; *WHOQOL GROUP, 1994, INT J MENTAL HLTH, V23; World Health Organization, 2001, INT CLASS FUNCT DIS; World Health Organization, INT CLASS FUNCT DIS	30	18	19	0	0	EDIZIONI MINERVA MEDICA	TURIN	CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY	1973-9087	1973-9095		EUR J PHYS REHAB MED	Eur. J. Phys. Rehabil. Med.	MAR	2010	46	1					27	36					10	Rehabilitation	Rehabilitation	578JR	WOS:000276290100005	20332723				2021-06-18	
J	Brown, AW; Malec, JF; Mandrekar, J; Diehl, NN; Dikmen, SS; Sherer, M; Hart, T; Novack, TA				Brown, Allen W.; Malec, James F.; Mandrekar, Jay; Diehl, Nancy N.; Dikmen, Sureyya S.; Sherer, Mark; Hart, Tessa; Novack, Thomas A.			Predictive utility of weekly post-traumatic amnesia assessments after brain injury: A multicentre analysis	BRAIN INJURY			English	Article						Outcome; rehabilitation; measurement	GLASGOW OUTCOME SCALE; CLOSED-HEAD INJURY; FUNCTIONAL INDEPENDENCE; GALVESTON ORIENTATION; REHABILITATION; SEVERITY; LOG; COMPLAINTS; RECOVERY; DURATION	Primary objective: To consider the duration of post-traumatic amnesia (PTA) as a single predictor variable to determine whether categories of PTA duration exist that predict 1-year outcomes after traumatic brain injury (TBI). Research design: Using the TBI Model System database (n=5250), the duration of PTA that predicts 1-year outcomes was calculated. Logistic regression was used to determine whether a single predictive threshold value existed. Classification and regression tree analysis then determined whether multiple threshold values existed. The area under the ROC curve and percentage correct classification were also calculated to discriminate classification accuracy and choose the best predictive thresholds. Results: A single threshold value of PTA days was identified for all variables. At 1 year, PTA that extended into week 7 after injury predicted total FIM(TM) and FIM(TM) sub-scales. One-year employment and global outcomes were predicted by PTA extending into week 4 after injury. Independent living was predicted by PTA extending into the 8th week after injury. Conclusion: After moderate-to-severe TBI, determining the presence of PTA at weekly intervals can efficiently determine injury severity while providing meaningful precision when used in research and clinical outcome prediction.	[Brown, Allen W.; Mandrekar, Jay] Mayo Clin, Rochester, MN 55905 USA; [Malec, James F.] Rehab Hosp Indiana, Indianapolis, IN USA; [Diehl, Nancy N.] Mayo Clin, Jacksonville, FL 32224 USA; [Dikmen, Sureyya S.] Univ Washington, Seattle, WA 98195 USA; [Sherer, Mark] TIRR Mem Hermann, Houston, TX USA; [Hart, Tessa] Moss Rehabil Res Inst, Elkins Pk, PA USA; [Novack, Thomas A.] Univ Alabama, Birmingham, AL USA	Brown, AW (corresponding author), Mayo Clin, 100 1st St SW, Rochester, MN 55905 USA.	brown.allen@mayo.edu		Brown, Allen W./0000-0001-7228-3351	National Institute on Disability and Rehabilitation Research, United States Department of EducationUS Department of Education	We gratefully acknowledge the assistance of the Traumatic Brain Injury National Data and Statistical Centre located at Craig Hospital in Englewood, Colorado. This work was supported by Traumatic Brain Injury Model Systems grants from the National Institute on Disability and Rehabilitation Research, United States Department of Education.	American Congress of Rehabilitation Medicine, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; BISHARA S N, 1992, Brain Injury, V6, P373, DOI 10.3109/02699059209034952; Boake C, 1996, ARCH PHYS MED REHAB, V77, P765, DOI 10.1016/S0003-9993(96)90254-3; Bode RK, 2000, J HEAD TRAUMA REHAB, V15, P637, DOI 10.1097/00001199-200002000-00004; Brown AW, 2005, J NEUROTRAUM, V22, P1040, DOI 10.1089/neu.2005.22.1040; Corrigan JD, 2003, ARCH PHYS MED REHAB, V84, P153, DOI 10.1053/apmr.2003.50093; De Guise E, 2005, BRAIN INJURY, V19, P1087, DOI 10.1080/02699050500149882; DEIRDRE RD, 2004, BRAIN INJURY, V18, P221; DODDS TA, 1993, ARCH PHYS MED REHAB, V74, P531, DOI 10.1016/0003-9993(93)90119-U; Ellenberg JH, 1996, ARCH NEUROL-CHICAGO, V53, P782, DOI 10.1001/archneur.1996.00550080104018; Frey KL, 2007, BRAIN INJURY, V21, P513, DOI 10.1080/02699050701311026; GRANGER CV, 1990, ARCH PHYS MED REHAB, V71, P870; Jackson WT, 1998, ARCH PHYS MED REHAB, V79, P718, DOI 10.1016/S0003-9993(98)90051-X; KATZ DI, 1994, ARCH NEUROL-CHICAGO, V51, P661, DOI 10.1001/archneur.1994.00540190041013; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; LINACRE JM, 1994, ARCH PHYS MED REHAB, V75, P127; McMillan TM, 1996, J NEUROL NEUROSUR PS, V60, P422, DOI 10.1136/jnnp.60.4.422; Nakase-Richardson R, 2007, J NEUROL NEUROSUR PS, V78, P872, DOI 10.1136/jnnp.2006.104190; Nakase-Richardson R, 2009, ARCH PHYS MED REHAB, V90, P17, DOI 10.1016/j.apmr.2008.06.030; Novack TA, 2000, J HEAD TRAUMA REHAB, V15, P957, DOI 10.1097/00001199-200006000-00008; Ponsford J, 2004, BRAIN INJURY, V18, P603, DOI 10.1080/02699050310001646152; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Russell WR, 1932, BRAIN, V55, P549, DOI 10.1093/brain/55.4.549; RUSSELL WR, 1961, ARCH NEUROL-CHICAGO, V5, P16, DOI DOI 10.1001/ARCHNEUR.1961.00450130006002; Sherer M, 2002, ARCH PHYS MED REHAB, V83, P183, DOI 10.1053/apmr.2002.28802; Tate RL, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.074989; Tate RL, 2000, J NEUROL NEUROSUR PS, V68, P178, DOI 10.1136/jnnp.68.2.178; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Therneau TM., 1997, INTRO RECURSIVE PART, V61; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21; Wilde EA, 2006, BRAIN INJURY, V20, P695, DOI 10.1080/02699050600744079; Williams B.A., 2006, FINDING OPTIMAL CUTP, V79; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Zafonte RD, 1997, ARCH PHYS MED REHAB, V78, P1103, DOI 10.1016/S0003-9993(97)90135-0	35	18	18	0	4	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	MAR	2010	24	3					472	478		10.3109/02699051003610466			7	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	574JR	WOS:000275985800003	20184404				2021-06-18	
J	Coben, R; Myers, TE				Coben, Robert; Myers, Thomas E.			The Relative Efficacy of Connectivity Guided and Symptom Based EEG Biofeedback for Autistic Disorders	APPLIED PSYCHOPHYSIOLOGY AND BIOFEEDBACK			English	Article						Autism; Quantitative EEG; Neurofeedback; Assessment; Efficacy	ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; TRAUMATIC BRAIN-INJURY; CORPUS-CALLOSUM; SPECTRUM DISORDER; FUNCTIONAL CONNECTIVITY; NEUROFEEDBACK TREATMENT; RESONANCE SPECTROSCOPY; CORTICAL CONNECTIVITY; EXECUTIVE FUNCTION; INFANTILE-AUTISM	Autism is a neurodevelopmental disorder characterized by deficits in communication, social interaction, and a limited range of interests with repetitive stereotypical behavior. Various abnormalities have been documented in the brains of individuals with autism, both anatomically and functionally. The connectivity theory of autism is a recently developed theory of the neurobiological cause of autisic symptoms. Different patterns of hyper- and hypo-connectivity have been identified with the use of quantitative electroencephalogray (QEEG), which may be amenable to neurofeedback. In this study, we compared the results of two published controlled studies examining the efficacy of neurofeedback in the treatment of autism. Specifically, we examined whether a symptom based approach or an assessment/connectivity guided based approach was more effective. Although both methods demonstrated significant improvement in symptoms of autism, connectivity guided neurofeedback demonstrated greater reduction on various subscales of the Autism Treatment Evaluation Checklist (ATEC). Furthermore, when individuals were matched for severity of symptoms, the amount of change per session was significantly higher in the Coben and Padolsky (J Neurother 11:5-23, 2007) study for all five measures of the ATEC. Our findings suggest that an approach guided by QEEG based connectivity assessment may be more efficacious in the treatment of autism. This permits the targeting and amelioration of abnormal connectivity patterns in the brains of people who are autistic.	[Coben, Robert; Myers, Thomas E.] Neurorehabil Serv, Massapequa Pk, NY 11762 USA; [Coben, Robert; Myers, Thomas E.] Neuropsychol Serv, Massapequa Pk, NY 11762 USA	Coben, R (corresponding author), Neurorehabil Serv, 1035 Pk Blvd,Suite 2B, Massapequa Pk, NY 11762 USA.	robcoben@optonline.net					Alexander AL, 2007, NEUROIMAGE, V34, P61, DOI 10.1016/j.neuroimage.2006.08.032; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Attwood T, 1998, ASPERGERS SYNDROME G; AYERS M, 1995, BIOFEEDBACK SELF-REG, V20, P309; BAILEY A, 1993, LANCET, V341, P1225, DOI 10.1016/0140-6736(93)91065-T; Bailey A, 1998, BRAIN, V121, P889, DOI 10.1093/brain/121.5.889; Bernier R, 2007, BRAIN COGNITION, V64, P228, DOI 10.1016/j.bandc.2007.03.004; Boddaert N, 2002, J RADIOL, V83, P1829; Boger-Megiddo I, 2006, J AUTISM DEV DISORD, V36, P733, DOI 10.1007/s10803-006-0121-2; BYERS AP, 1995, J NEUROTHERAPY, V1, P22, DOI DOI 10.1300/J184V01N01_; CANTOR DS, 1986, J AUTISM DEV DISORD, V16, P169, DOI 10.1007/BF01531728; Casanova MF, 2002, J CHILD NEUROL, V17, P692, DOI 10.1177/088307380201700908; *CDCP, 2006, COMM AR AUT SPECTR D; Cherkassky VL, 2006, NEUROREPORT, V17, P1687, DOI 10.1097/01.wnr.0000239956.45448.4c; Chung MK, 2004, NEUROIMAGE, V23, P242, DOI 10.1016/j.neuroimage.2004.04.037; COBEN R, 2009, J NEUROTHERAPY; Coben R., 2007, BIOFEEDBACK, V35, P131, DOI DOI 10.1300/J184V11N01; Coben R, 2008, CLIN NEUROPHYSIOL, V119, P1002, DOI 10.1016/j.clinph.2008.01.013; Courchesne E, 2005, DEV PSYCHOPATHOL, V17, P577, DOI 10.1017/S0954579405050285; Courchesne E, 2005, CURR OPIN NEUROBIOL, V15, P225, DOI 10.1016/j.conb.2005.03.001; Courchesne E, 2004, MENT RETARD DEV D R, V10, P106, DOI 10.1002/mrdd.20020; Courchesne E, 2003, JAMA-J AM MED ASSOC, V290, P337, DOI 10.1001/jama.290.3.337; Courchesne E, 1999, NEUROLOGY, V52, P1057, DOI 10.1212/WNL.52.5.1057; Courchesne E, 2001, NEUROLOGY, V57, P245, DOI 10.1212/WNL.57.2.245; COURCHESNE E, 1993, AM J ROENTGENOL, V160, P387, DOI 10.2214/ajr.160.2.8424359; COWAN J, 1994, ANN M ASS APPL PSYCH; Davidovitch M, 1996, J CHILD NEUROL, V11, P389, DOI 10.1177/088307389601100509; FILIPEK PA, 1992, ANN NEUROL, V32, P475; Frith C, 2003, NOVART FDN SYMP, V251, P149; Fuchs T, 2003, APPL PSYCHOPHYS BIOF, V28, P1, DOI 10.1023/A:1022353731579; Hamilton L. M., 2000, FACING AUTISM GIVING; Hammond D. C., 2004, Journal of Neurotherapy, V8, P5, DOI 10.1300/J184v08n01_02; Hammond D. C., 2003, J NEUROTHERAPY, V7, P25, DOI DOI 10.1300/J184V07N02_; Heinrich H, 2004, BIOL PSYCHIAT, V55, P772, DOI 10.1016/j.biopsych.2003.11.013; Herbert MR, 2005, NEUROSCIENTIST, V11, P417, DOI 10.1177/0091270005278866; Herbert MR, 2004, ANN NEUROL, V55, P530, DOI 10.1002/ana.20032; Herbert MR, 2003, BRAIN, V126, P1182, DOI 10.1093/brain/awg110; HOFFMAN DA, 1996, CLIN ELECTROENCEPHAL, V27, P6; Huang-Storms L., 2007, J NEUROTHERAPY, V10, P3; Hughes JR, 2007, EPILEPSY BEHAV, V11, P20, DOI 10.1016/j.yebeh.2007.03.010; Jarusiewicz B., 2002, J NEUROTHER, V6, P39, DOI [DOI 10.1300/J184V06N04_05, 10.1300/J184v06n04_05]; Just MA, 2004, BRAIN, V127, P1811, DOI 10.1093/brain/awh199; Just MA, 2007, CEREB CORTEX, V17, P951, DOI 10.1093/cercor/bhl006; Kanner L, 1943, NERV CHILD, V2, P217; KELLER I, 2001, J NEUROTHERAPY, V51, P19; Kemper TL, 1998, J NEUROPATH EXP NEUR, V57, P645, DOI 10.1097/00005072-199807000-00001; La Vaque TJ, 2002, APPL PSYCHOPHYS BIOF, V27, P273, DOI 10.1023/A:1021061318355; LUBAR JF, 1981, ARCH NEUROL-CHICAGO, V38, P700, DOI 10.1001/archneur.1981.00510110060009; LUBAR JO, 1984, BIOFEEDBACK SELF-REG, V9, P1, DOI 10.1007/BF00998842; McAlonan GM, 2005, BRAIN, V128, P268, DOI 10.1093/brain/awh332; MCCANDLESS J, 2005, CHILDREN STARVING BR; Mizuno A, 2006, BRAIN RES, V1104, P160, DOI 10.1016/j.brainres.2006.05.064; Monderer RS, 2002, EPILEPSY BEHAV, V3, P214, DOI 10.1016/S1525-5050(02)00001-X; Moore NC, 2000, CLIN ELECTROENCEPHAL, V31, P1, DOI 10.1177/155005940003100105; Murias M, 2007, BIOL PSYCHIAT, V62, P270, DOI 10.1016/j.biopsych.2006.11.012; Murphy DGM, 2002, ARCH GEN PSYCHIAT, V59, P885, DOI 10.1001/archpsyc.59.10.885; Nunez P.L., 2006, ELECT FIELDS BRAIN N, V2nd; Nunez P. L., 1995, NEOCORTICAL DYNAMICS; OTHMER S, 1997, ASSESSMENT EEG SPECT; Padolsky J., 2007, J NEUROTHERAPY, V11, P5, DOI DOI 10.1300/J184V11N01_02; Page LA, 2006, AM J PSYCHIAT, V163, P2189, DOI 10.1176/appi.ajp.163.12.2189; Piven J, 1997, AM J PSYCHIAT, V154, P1051; Piven J, 1996, J AM ACAD CHILD PSY, V35, P530, DOI 10.1097/00004583-199604000-00020; Schmitz N, 2006, BIOL PSYCHIAT, V59, P7, DOI 10.1016/j.biopsych.2005.06.007; Schoenberger NE, 2001, J HEAD TRAUMA REHAB, V16, P260, DOI 10.1097/00001199-200106000-00005; Sicile-Kira Chantal, 2004, AUTISM SPECTRUM DISO; SIEGEL B, 1996, WORLD AUTISTIC CHILD; STERMAN MB, 1972, ELECTROEN CLIN NEURO, V33, P89, DOI 10.1016/0013-4694(72)90028-4; Sterman MB, 2000, CLIN ELECTROENCEPHAL, V31, P45, DOI 10.1177/155005940003100111; Thornton KE, 2005, CHILD ADOL PSYCH CL, V14, P137, DOI 10.1016/j.chc.2004.07.001; Tidmarsh L, 2003, CAN J PSYCHIAT, V48, P517, DOI 10.1177/070674370304800803; Trudeau DL, 2005, CHILD ADOL PSYCH CL, V14, P125, DOI 10.1016/j.chc.2004.07.006; Vidal CN, 2006, BIOL PSYCHIAT, V60, P218, DOI 10.1016/j.biopsych.2005.11.011; Walker J.E., 2002, J NEUROTHER, V6, P31, DOI [10.1300/J184v06n02_05, DOI 10.1300/J184v06n02_05, DOI 10.1300/J184V06N02_]; Walker JE, 2005, CHILD ADOL PSYCH CL, V14, P163, DOI 10.1016/j.chc.2004.07.009; Wickelgren A, 2005, SCIENCE, V308, P1856, DOI 10.1126/science.308.5730.1856	76	18	21	2	31	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1090-0586	1573-3270		APPL PSYCHOPHYS BIOF	Appl. Psychophysiol. Biofeedback	MAR	2010	35	1					13	23		10.1007/s10484-009-9102-5			11	Psychology, Clinical	Psychology	534PV	WOS:000272910500004	19649702				2021-06-18	
J	Colantonio, A; Mroczek, D; Patel, J; Lewko, J; Fergenbaum, J; Brison, R				Colantonio, Angela; Mroczek, David; Patel, Jigisha; Lewko, John; Fergenbaum, Jennifer; Brison, Robert			Examining Occupational Traumatic Brain Injury in Ontario	CANADIAN JOURNAL OF PUBLIC HEALTH-REVUE CANADIENNE DE SANTE PUBLIQUE			English	Article						Traumatic brain injury; epidemiology; workplace		Objective: Occupational traumatic brain injuries disrupt the lives of workers and carry major economic repercussions. To date, there has been limited information on brain injuries that occur at work across injury severity levels in Canada. The aim of this study was to provide an overview of occupational traumatic brain injuries in Ontario, with a focus on the sex of the workers. Methods: For this cross-sectional study, data from the Ontario Workplace Safety and Insurance Board were used. A retrospective chart review was conducted of over 1,500 claim files from the year 2004 with the diagnostic codes of concussion and intracranial injury. Severity was assessed according to data on days off work. Results: The average age of those injured was 37.8 years. The breakdown by sex shows that 57.8% of claims for occupational traumatic brain injury involved males. The most common mechanism of injury was being "struck by or against", followed by "falls". Most of the occupational traumatic brain injuries were from the manufacturing, and government and related services sectors. The highest rate, however, was shown for transportation and storage (81.5/100,000), followed by government and related services (56.6/100,000) and primary industries (47/100,000). Conclusions: An examination of occupational traumatic brain injuries across a range of severities reveals a profile that is different from that associated with more severely injured workers: there were many more women in particular industries who were injured and more injuries involving being struck by an object. This paper provides data on key industries, mechanisms and contributing factors involved in work-related traumatic brain injury that result in claims to the Workplace Safety and Insurance Board.	[Colantonio, Angela] Univ Toronto, Toronto Rehabil Inst, Dept Occupat Sci, Toronto, ON M5G 1V7, Canada; [Lewko, John] Laurentian Univ, Sudbury, ON P3E 2C6, Canada; [Brison, Robert] Queens Univ, Dept Emergency Med, Kingston, ON, Canada	Colantonio, A (corresponding author), Univ Toronto, Toronto Rehabil Inst, Dept Occupat Sci, 160-500 Univ Ave, Toronto, ON M5G 1V7, Canada.	Angela.colantonio@utoronto.ca		Colantonio, Angela/0000-0003-2094-4765			Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; Colantonio A, 2009, BRAIN INJURY, V23, P873, DOI 10.1080/02699050903036033; de Guise E, 2005, CAN J NEUROL SCI, V32, P186, DOI 10.1017/S0317167100003954; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; HEYER NJ, 1994, AM J PUBLIC HEALTH, V84, P1106, DOI 10.2105/AJPH.84.7.1106; Kim H, 2006, NEUROREHABILITATION, V21, P269; KISNER SM, 1994, J OCCUP ENVIRON MED, V36, P137, DOI 10.1097/00043764-199402000-00008; Kristman VL, 2008, BRAIN INJURY, V22, P51, DOI 10.1080/02699050701849991; Lett Ronald, 2002, Inj Control Saf Promot, V9, P199, DOI 10.1076/icsp.9.3.199.8708; McCrory P, 2009, PHYSICIAN SPORTSMED, V37, P141, DOI 10.3810/psm.2009.06.1721; O'Connor C, 2005, PSYCHOL REP, V97, P169, DOI 10.2466/PR0.97.5.169-179; Smith JR, 2004, MACROMOL RAPID COMM, V25, P127, DOI 10.1002/marc.200300193; Tricco AC, 2006, BRAIN INJURY, V20, P719, DOI 10.1080/02699050600664640; *WSIB, 2004, STAT SUPPL 2004 ANN	14	18	18	0	3	SPRINGER INTERNATIONAL PUBLISHING AG	CHAM	GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND	0008-4263	1920-7476		CAN J PUBLIC HEALTH	Can. J. Public Health-Rev. Can. Sante Publ.	MAR-APR	2010	101			1			S58	S62		10.1007/BF03403848			5	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	602II	WOS:000278132300010	20629449	Green Published			2021-06-18	
J	Hu, SL; Li, F; Luo, HS; Xia, YZ; Zhang, JQ; Hu, R; Cui, GY; Meng, H; Feng, H				Hu, Shengli; Li, Fei; Luo, Haishui; Xia, Yongzhi; Zhang, Jiuquan; Hu, Rong; Cui, Gaoyu; Meng, Hui; Feng, Hua			Amelioration of rCBF and PbtO(2) following TBI at high altitude by hyperbaric oxygen pre-conditioning	NEUROLOGICAL RESEARCH			English	Article						High altitude; hyperbaric oxygen; pre-conditioning; traumatic brain injury	ISCHEMIA-REPERFUSION INJURY; CEREBRAL-ARTERY OCCLUSION; ACUTE MOUNTAIN-SICKNESS; BLOOD-FLOW; TOLERANCE	Objectives: Hypobaric hypoxia at high altitude can lead to brain damage and pre-conditioning with hyperbaric oxygen (HBO) can reduce ischemic/hypoxic brain injury. This study investigates the effects of high altitude on traumatic brain injury (TBI) and examines the neuroprotection provided by HBO preconditioning against TBI. Methods: Rats were randomly divided into four groups: HBO pre-conditioning group (HBOP, n=10), high altitude group (HA, n=10), plain control group (PC, n=10) and plain sham operation group (sham, n=10). All groups were subjected to head trauma by weight drop device except for the sham group. Rats from each group were examined for neurological function, regional cerebral blood flow (rCBF) and brain tissue oxygen pressure (PbtO(2)) and were killed for analysis by transmission electron microscope. Results: The score of neurological deficits in the HA group was highest, followed by the HBOP group and the PC group, respectively. Both rCBF and PbtO(2) were the lowest in the HA group. Brain morphology and structure seen via the transmission electron microscope was diminished in the HA group, while fewer pathological injuries occurred in the HBOP and PC groups. Conclusions: High altitude aggravates TBI significantly and HBO pre-conditioning can attenuate TBI in rats at high altitude by improvement of rCBF and PbtO(2). Pre-treatment with HBO might be beneficial for people traveling to high altitude locations.	[Hu, Shengli; Li, Fei; Luo, Haishui; Xia, Yongzhi; Zhang, Jiuquan; Hu, Rong; Cui, Gaoyu; Meng, Hui; Feng, Hua] Third Mil Med Univ, Southwest Hosp, Dept Neurosurg, Chongqing 400038, Peoples R China	Feng, H (corresponding author), Third Mil Med Univ, Southwest Hosp, Dept Neurosurg, Gaotanyan 29, Chongqing 400038, Peoples R China.	fenghua8888@yahoo.com.cn	ZHANG, JIUQUAN/X-8389-2019	Zhang, Jiuquan/0000-0003-0239-6988	PLA in China [06MB241, 01L049]	This work was supported by the medical research program of PLA in China (nos. 06MB241 and 01L049). The authors thank Jiasi Bai (Department of Central laboratory, Southwest Hospital), Shibing Zhang and Quan Xie (Hyperbaric Oxygen Center, Southwest Hospital) for technical assistance.	Akca O, 1999, LANCET, V354, P41, DOI 10.1016/S0140-6736(99)00874-0; Basnyat B, 2003, LANCET, V361, P1967, DOI 10.1016/S0140-6736(03)13591-X; Clarke C, 2006, POSTGRAD MED J, V82, P748, DOI 10.1136/pgmj.2006.047662; Dong HL, 2002, ANESTHESIOLOGY, V96, P907, DOI 10.1097/00000542-200204000-00018; FAYED N, 2006, AM J MED, V119; Freiberger JJ, 2006, BRAIN RES, V1075, P213, DOI 10.1016/j.brainres.2005.12.088; Gallagher SA, 2004, EMERG MED CLIN N AM, V22, P329, DOI 10.1016/j.emc.2004.02.001; Gertsch JH, 2002, HIGH ALT MED BIOL, V3, P29, DOI 10.1089/152702902753639522; Gurer A, 2006, TRANSPL P, V38, P3337, DOI 10.1016/j.transproceed.2006.10.184; HACKETT PH, 1976, LANCET, V2, P1149; Hackett PH, 2001, NEW ENGL J MED, V345, P107, DOI 10.1056/NEJM200107123450206; Inoue Y, 2005, J NEUROTRAUM, V22, P1411, DOI 10.1089/neu.2005.22.1411; Kelly DF, 1997, J NEUROSURG, V86, P633, DOI 10.3171/jns.1997.86.4.0633; Lim YJ, 2004, ANESTHESIOLOGY, V100, P562, DOI 10.1097/00000542-200403000-00015; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Pettigrew LC, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-47; Prass K, 2000, BRAIN RES, V871, P146, DOI 10.1016/S0006-8993(00)02264-2; Qin Zhiyong, 2007, Neurosurg Focus, V22, pE13, DOI 10.3171/foc.2007.22.5.14; Queen SA, 1997, BRAIN RES, V777, P42, DOI 10.1016/S0006-8993(97)00717-8; Schoch HJ, 2002, BRAIN, V125, P2549, DOI 10.1093/brain/awf257; Wada K, 2001, NEUROSURGERY, V49, P160; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Xiong LZ, 2000, CHINESE MED J-PEKING, V113, P836; Yogaratnam JZ, 2006, CARDIOVASC REVASCULA, V7, P146, DOI 10.1016/j.carrev.2006.04.006; Yu SY, 2005, J SURG RES, V128, P28, DOI 10.1016/j.jss.2005.04.025	25	18	25	0	4	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.	MAR	2010	32	2					173	178		10.1179/174313209X414524			6	Clinical Neurology; Neurosciences	Neurosciences & Neurology	558XJ	WOS:000274781900011	20158955				2021-06-18	
J	James, SE; Dunham, M; Carrion-Jones, M; Murashov, A; Lu, Q				James, Sarah E.; Dunham, Mayisha; Carrion-Jones, Monica; Murashov, Alexander; Lu, Qun			Rho kinase inhibitor Y-27632 facilitates recovery from experimental peripheral neuropathy induced by anti-cancer drug cisplatin	NEUROTOXICOLOGY			English	Article						Cisplatin; Peripheral neuropathy; Regeneration; Rho GTPases; Y-27632	SPINAL-CORD-INJURY; TRAUMATIC BRAIN-INJURY; DORSAL-ROOT GANGLIA; HIPPOCAMPAL-NEURONS; NEURITE OUTGROWTH; TESTICULAR CANCER; ACTIVATION; GTPASES; NEUROTOXICITY; DNA	Chemotherapy drugs have neurotoxicity associated with treatment, which can become a dose-limiting problem when clinical presentation is severe. However, there is no effective therapy to circumvent the neurotoxicity of anti-cancer drug treatment. In this study, we utilized a newly designed mouse model of cisplatin-induced peripheral neuropathy to determine both the severity of neurotoxicity induced by drug treatment and the effectiveness of the Rho kinase inhibitor Y-27632 in post-treatment recovery. Sensory nerve conduction studies revealed a significant increase in mean distal (peak) latency with cisplatin treatment, indicating a deterioration of sensory nerve function. Also, hind paw touch sensitivity decreased steadily with increasing cumulative dose of cisplatin. Histological and immunohistochemical analyses of the sural nerve using neuronal marker protein gene product 9.5 (PGP 9.5) demonstrated abnormal nerve fiber morphology in cisplatin-treated mice. Remarkably, post-treatment with Y-27632 improved the sural nerve distal (peak) latency and sensory threshold to return to pre-treatment levels. Sural nerve histology worsened in the absence of Y-27632 during recovery. These studies suggest that Rho kinase inhibitor Y-27632 can initiate regeneration of damaged nerves following cisplatin treatment. (C) 2010 Elsevier Inc. All rights reserved.	[James, Sarah E.; Lu, Qun] E Carolina Univ, Dept Anat & Cell Biol, Leo Jenkins Canc Ctr, Brody Sch Med, Greenville, NC 27834 USA; [Lu, Qun] E Carolina Univ, Dept Med, Brody Sch Med, Greenville, NC 27834 USA; [Dunham, Mayisha; Carrion-Jones, Monica] E Carolina Univ, Dept Phys Med & Rehabil, Brody Sch Med, Greenville, NC 27834 USA; [Murashov, Alexander] E Carolina Univ, Dept Physiol, Brody Sch Med, Greenville, NC 27834 USA	Lu, Q (corresponding author), E Carolina Univ, Dept Anat & Cell Biol, Leo Jenkins Canc Ctr, Brody Sch Med, 7N84 Brody Sci Bldg,600 Moye Blvd, Greenville, NC 27834 USA.	luq@ecu.edu	Murashov, Alexander K/F-2241-2011; Murashov, Alexander/ABB-2151-2020	Murashov, Alexander K/0000-0002-8912-5891; Murashov, Alexander/0000-0002-8912-5891	National Institute on AgingUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [AG026630]; National Cancer InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [CA111891]; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R01CA111891] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R03AG026630] Funding Source: NIH RePORTER	The authors wish to thank Melissa Clark and Joani Zary for technical assistance and Dr. Teresa Lever for helpful discussions. This study was supported in part by grants from National Institute on Aging AG026630 and National Cancer Institute CA111891 (Q.L.).	Akahori H, 2004, DIABETES RES CLIN PR, V64, P153, DOI 10.1016/j.diabres.2003.10.012; Alaedini A, 2008, EXP NEUROL, V210, P368, DOI 10.1016/j.expneurol.2007.11.018; Aquino JB, 2006, BRAIN RES, V1117, P80, DOI 10.1016/j.brainres.2006.02.045; Brabeck C, 2004, J NEUROTRAUM, V21, P697, DOI 10.1089/0897715041269597; Cepeda V, 2007, ANTI-CANCER AGENT ME, V7, P3, DOI 10.2174/187152007779314044; Dergham P, 2002, J NEUROSCI, V22, P6570; Dubreuil CI, 2006, EXP NEUROL, V198, P361, DOI 10.1016/j.expneurol.2005.12.002; Dubreuil CI, 2003, J CELL BIOL, V162, P233, DOI 10.1083/jcb.200301080; Dunham MW, 2009, AM J PHYS MED REHAB, V88, P542, DOI 10.1097/PHM.0b013e31819c575b; Einhorn LH, 2002, P NATL ACAD SCI USA, V99, P4592, DOI 10.1073/pnas.072067999; Ellezam B, 2002, PROG BRAIN RES, V137, P371; Feldman DR, 2008, JAMA-J AM MED ASSOC, V299, P672, DOI 10.1001/jama.299.6.672; Gnad R, 2001, EXP CELL RES, V264, P244, DOI 10.1006/excr.2001.5165; James SE, 2008, NEUROTOXICOLOGY, V29, P605, DOI 10.1016/j.neuro.2008.04.008; Jones SB, 2004, J NEUROSCI, V24, P8510, DOI 10.1523/JNEUROSCI.1264-04.2004; Kelland L, 2007, NAT REV CANCER, V7, P573, DOI 10.1038/nrc2167; Kim JH, 2006, NEUROBIOL DIS, V21, P626, DOI 10.1016/j.nbd.2005.09.009; Madura T, 2004, EMBO REP, V5, P412, DOI 10.1038/sj.embor.7400117; McDonald ES, 2005, NEUROBIOL DIS, V18, P305, DOI 10.1016/j.nbd.2004.09.013; Meijer C, 1999, NEUROTOXICOLOGY, V20, P883; Mong PY, 2008, J IMMUNOL, V180, P550, DOI 10.4049/jimmunol.180.1.550; Negishi M, 2005, NEUROSCIENTIST, V11, P187, DOI 10.1177/1073858404268768; Neumann H, 2002, J NEUROSCI, V22, P854, DOI 10.1523/JNEUROSCI.22-03-00854.2002; Nikolic M, 2002, INT J BIOCHEM CELL B, V34, P731, DOI 10.1016/S1357-2725(01)00167-4; Quasthoff S, 2002, J NEUROL, V249, P9, DOI 10.1007/PL00007853; ROSENBERG B, 1969, NATURE, V222, P385, DOI 10.1038/222385a0; Sedletska Yuliya, 2005, Current Medicinal Chemistry - Anti-Cancer Agents, V5, P251, DOI 10.2174/1568011053765967; Sung JK, 2003, BRAIN RES, V959, P29, DOI 10.1016/S0006-8993(02)03717-4; Ta LE, 2006, NEUROTOXICOLOGY, V27, P992, DOI 10.1016/j.neuro.2006.04.010; Wilder-Smith EP, 2007, HISTOPATHOLOGY, V51, P674, DOI 10.1111/j.1365-2559.2007.02851.x; Yuan Z, 2009, CANCER CHEMOTH PHARM, V65, P13, DOI 10.1007/s00280-009-0998-5	31	18	19	0	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0161-813X	1872-9711		NEUROTOXICOLOGY	Neurotoxicology	MAR	2010	31	2					188	194		10.1016/j.neuro.2009.12.010			7	Neurosciences; Pharmacology & Pharmacy; Toxicology	Neurosciences & Neurology; Pharmacology & Pharmacy; Toxicology	574KF	WOS:000275987300003	20060419	Green Accepted			2021-06-18	
J	Karam, YR; Traynelis, VC				Karam, Youssef R.; Traynelis, Vincent C.			Occipital Condyle Fractures	NEUROSURGERY			English	Article						Basilar cranial fracture; Cranial trauma; Craniovertebral junction; Occipital condyle; Occipitocervical fusion	COLLET-SICARD-SYNDROME; CLOSED-HEAD-INJURY; OCCIPITOATLANTOAXIAL COMPLEX; CRANIOVERTEBRAL JUNCTION; FORGOTTEN CONDYLE; LIGAMENT INJURY; CT; TRAUMA; BIOMECHANICS; MORPHOLOGY	OBJECTIVE: The anatomy, clinical presentation, radiologic evaluation, treatment, and outcome of occipital condyle fractures are reviewed. METHODS: We review and discuss the literature on occipital condyle fractures. RESULTS: Occipital condyle fractures are best diagnosed with computed tomography. The neurologic presentation is variable. The majority of these injuries may be treated non-operatively, but an occipitocervical fusion is necessary to restore stability across the craniovertebral junction. CONCLUSION: Occipital condyle fractures are a rare but serious injury that requires prompt diagnosis and treatment.	[Karam, Youssef R.; Traynelis, Vincent C.] Univ Iowa Hosp & Clin, Dept Neurosurg, Iowa City, IA 52242 USA	Traynelis, VC (corresponding author), Rush Univ, Med Ctr, Dept Neurosurg, 1725 W Harrison 1115, Chicago, IL 60612 USA.	vincent_traynelis@rush.edu					Alcelik I, 2006, J BONE JOINT SURG BR, V88B, P665, DOI 10.1302/0301-620X.88B5.16598; ANDERSON PA, 1988, SPINE, V13, P731, DOI 10.1097/00007632-198807000-00004; Aran E, 2001, NEUROCIRUGIA, V12, P517; BELL C, 1817, MIDDLESEX HOSP J, P4469; BLACKSIN MF, 1995, AM J ROENTGENOL, V165, P1201, DOI 10.2214/ajr.165.5.7572503; Bloom AI, 1997, CLIN RADIOL, V52, P198, DOI 10.1016/S0009-9260(97)80273-5; Bloom AI, 1996, PEDIATR RADIOL, V26, P786, DOI 10.1007/BF01396202; BOLENDER N, 1978, AM J ROENTGENOL, V131, P729, DOI 10.2214/ajr.131.4.729; BUCHOLZ RW, 1979, J BONE JOINT SURG AM, V61, P248, DOI 10.2106/00004623-197961020-00014; Chen JY, 2006, EMERG RADIOL, V12, P192, DOI 10.1007/s10140-006-0471-2; Chou CW, 2008, J CLIN NEUROSCI, V15, P920, DOI 10.1016/j.jocn.2007.03.014; CLAYMAN DA, 1994, AM J NEURORADIOL, V15, P1309; COHEN A, 1991, Pediatric Emergency Care, V7, P24, DOI 10.1097/00006565-199102000-00007; Cottalorda J, 1996, J PEDIATR ORTHOP B, V5, P61, DOI 10.1097/01202412-199605010-00013; Dashti R, 2007, EUR SPINE J, V16, pS261, DOI 10.1007/s00586-006-0270-1; De Wyngaert R, 2006, EMERG RADIOL, V13, P79, DOI 10.1007/s10140-006-0516-6; Demisch S, 1998, CLIN NEUROL NEUROSUR, V100, P44, DOI 10.1016/S0303-8467(97)00111-X; DESAI SS, 1990, J TRAUMA, V30, P240, DOI 10.1097/00005373-199002000-00023; DVORAK J, 1988, J ORTHOP RES, V6, P452, DOI 10.1002/jor.1100060317; Erol FS, 2007, YONSEI MED J, V48, P120, DOI 10.3349/ymj.2007.48.1.120; Freeman BJC, 2005, INJURY, V36, P207, DOI 10.1016/j.injury.2004.05.026; HAAS LL, 1957, RADIOLOGY, V69, P546, DOI 10.1148/69.4.546; HARRIS MB, 1993, J SPINAL DISORD, V6, P5; HASHIMOTO T, 1988, NEUROSURGERY, V23, P367, DOI 10.1227/00006123-198809000-00015; LEVENTHAL MR, 1992, ORTHOPEDICS, V15, P944; LEVINE AM, 1989, CLIN ORTHOP RELAT R, P53; LINK TM, 1995, RADIOLOGY, V196, P741, DOI 10.1148/radiology.196.3.7644638; Liu JK, 2004, SURG NEUROL, V61, P255, DOI 10.1016/S0090-3019(03)00422-1; Miyazaki C, 2000, CLIN NEUROL NEUROSUR, V102, P255, DOI 10.1016/S0303-8467(00)00109-8; Muthukumar N, 2002, J CLIN NEUROSCI, V9, P580, DOI 10.1054/jocn.2001.1067; Noble ER, 1996, AM J NEURORADIOL, V17, P507; ORBAY T, 1989, SURG NEUROL, V31, P402, DOI 10.1016/0090-3019(89)90076-1; Payer M, 2004, J CLIN NEUROSCI, V11, P211, DOI 10.1016/j.jocn.2003.02.010; Rhoton AL, 2000, NEUROSURGERY, V47, pS155, DOI 10.1097/00006123-200009001-00017; Rhoton AL, 2000, NEUROSURGERY, V47, pS195, DOI 10.1097/00006123-200009001-00020; Schrodel MH, 2002, SKULL BASE-INTERD AP, V12, P93, DOI 10.1055/s-2002-31571-1; SHARMA BS, 1994, CLIN NEUROL NEUROSUR, V96, P197, DOI 10.1016/0303-8467(94)90063-9; Shin H, 2006, J NEUROSURG-SPINE, V4, P137, DOI 10.3171/spi.2006.4.2.137; SPENCER JA, 1984, NEUROSURGERY, V15, P101, DOI 10.1227/00006123-198407000-00019; STANDRING S, 2005, GRAYS ANATOMY, P463; STROOBANTS J, 1994, J NEUROSURG, V81, P137, DOI 10.3171/jns.1994.81.1.0137; Tubbs RS, 2000, J NEUROSURG, V92, P197, DOI 10.3171/spi.2000.92.2.0197; Tuli S, 1997, NEUROSURGERY, V41, P368, DOI 10.1097/00006123-199708000-00006; Urculo E, 1996, J NEUROSURG, V84, P522, DOI 10.3171/jns.1996.84.3.0522; Vishteh AG, 1999, J NEUROSURG, V90, P91, DOI 10.3171/spi.1999.90.1.0091; WANI MA, 1991, J TRAUMA, V31, P1437, DOI 10.1097/00005373-199110000-00025; WERNE SVEN, 1957, ACTA ORTHOPAED SCAND SUPPL, V23, P1; WHITE AA, 1978, ORTHOP CLIN N AM, V9, P867; WIESEL S, 1978, ORTHOP CLIN N AM, V9, P969; WIESEL S W, 1979, Spine, V4, P187, DOI 10.1097/00007632-197905000-00001; YOUNG WF, 1994, NEUROSURGERY, V34, P257, DOI 10.1227/00006123-199402000-00008	51	18	18	0	5	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	MAR	2010	66	3		S			A56	A59		10.1227/01.NEU.0000365751.84075.66			4	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	559BY	WOS:000274796000009	20173528				2021-06-18	
J	Vannorsdall, TD; Cascella, NG; Rao, V; Pearlson, GD; Gordon, B; Schretlen, DJ				Vannorsdall, Tracy D.; Cascella, Nicola G.; Rao, Vani; Pearlson, Godfrey D.; Gordon, Barry; Schretlen, David J.			A Morphometric Analysis of Neuroanatomic Abnormalities in Traumatic Brain Injury	JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Article							VOXEL-BASED MORPHOMETRY; UNITED-STATES; HEAD-INJURY; SEVERITY; NEUROPATHOLOGY; MATTER; COMA	Cognitive and structural brain abnormalities are common following traumatic brain injury (TBI). The authors compared cognition and brain structure in 14 TBI survivors and 28 matched healthy comparison subjects. TBI survivors showed reduced cerebral volume, due mainly to white matter changes, and poorer attention, psychomotor speed, and memory. Severity of white matter abnormality correlated with worse performance on several cognitive measures that distinguished between groups. Using voxel-based morphometry, regions of reduced white matter concentration were found throughout the cerebrum along with more localized gray matter reductions. Findings suggest that diffuse rather than focal aspects of TBI contribute most to cognitive outcome. (The Journal of Neuropsychiatry and Clinical Neurosciences 2010; 22: 173-181)	[Vannorsdall, Tracy D.; Cascella, Nicola G.; Rao, Vani; Pearlson, Godfrey D.; Gordon, Barry; Schretlen, David J.] Johns Hopkins Univ, Sch Med, Baltimore, MD USA	Schretlen, DJ (corresponding author), Johns Hopkins Univ Hosp, 600 N Wolfe St,Meyer 218, Baltimore, MD 21287 USA.	dschret@jhmi.edu					Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Benedict HR., 1997, BRIEF VISUOSPATIAL M; Bigler ED, 2001, J HEAD TRAUMA REHAB, V16, P117, DOI 10.1097/00001199-200104000-00003; Bigler ED, 2007, NEUROPSYCHOLOGY, V21, P515, DOI 10.1037/0894-4105.21.5.515; Blair JR., 1989, CLIN NEUROPSYCHOL, V3, P129; Blatter DD, 1997, AM J NEURORADIOL, V18, P1; Brandt J., 2001, HOPKINS VERBAL LEARN; Gale SD, 2005, J NEUROL NEUROSUR PS, V76, P984, DOI 10.1136/jnnp.2004.036210; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Heaton R. K, 1981, WISCONSIN CARD SORTI; Kim J, 2008, NEUROIMAGE, V39, P1014, DOI 10.1016/j.neuroimage.2007.10.005; KlOve H, 1963, MED CLIN N AM; Levine B, 2008, NEUROLOGY, V70, P771, DOI 10.1212/01.wnl.0000304108.32283.aa; MacKenzie JD, 2002, AM J NEURORADIOL, V23, P1509; *MATHWORKS INC, 2005, MATL; NELSON HE, 1976, CORTEX, V11, P918; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Rey A., 1941, ARCH PSYCHOL, V28, P215; Rey A., 1993, CLIN NEUROPSYCHOL, V7, P4; ROSS BL, 1994, AM J PHYS MED REHAB, V73, P341, DOI 10.1097/00002060-199409000-00007; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Salmond CH, 2005, BRAIN, V128, P189, DOI 10.1093/brain/awh352; Schretlen D, 1997, BRIEF TEST ATTENTION; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Smith CD, 2007, NEUROBIOL AGING, V28, P1075, DOI 10.1016/j.neurobiolaging.2006.05.018; *SPSS, 2007, SPSS WIND REL 15 0; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Tomaiuolo F, 2005, J NEUROTRAUM, V22, P76, DOI 10.1089/neu.2005.22.76; Trivedi MA, 2007, J NEUROTRAUM, V24, P766, DOI 10.1089/neu.2006.0205	31	18	18	0	7	AMER PSYCHIATRIC PUBLISHING, INC	WASHINGTON	800 MAINE AVE SW, SUITE 900, WASHINGTON, DC 20024 USA	0895-0172	1545-7222		J NEUROPSYCH CLIN N	J. Neuropsychiatr. Clin. Neurosci.	SPR	2010	22	2					173	181					9	Clinical Neurology; Neurosciences; Psychiatry	Neurosciences & Neurology; Psychiatry	595ZY	WOS:000277654200005	20463111				2021-06-18	
J	van Oorsouw, K; Merckelbach, H				van Oorsouw, Kim; Merckelbach, Harald			Detecting malingered memory problems in the civil and criminal arena	LEGAL AND CRIMINOLOGICAL PSYCHOLOGY			English	Article							TRAUMATIC BRAIN-INJURY; SYMPTOM VALIDITY TEST; SIMULATING AMNESIA; SCALE; DISSOCIATION; PSYCHOPATHY; ALCOHOL; MMPI-2; VALIDATION; ACCURACY	Feigning a psychiatric or neurological disorder may be an attractive strategy to obtain all sorts of privileges or disability benefits. In the criminal arena, feigning memory loss for a crime (crime-related amnesia) may be a way for defendants to gain sympathy or to promote a diminished capacity defence. Although crime-related amnesia may, under some circumstances, be genuine, in many cases it is more likely to be malingered. Malingered memory problems are a subtle form of deception and what is true for deceptive behaviour in general is also true for malingering memory loss: on the basis of clinical intuition alone, it is difficult to detect. Fortunately, there are methods and tools to evaluate the authenticity of memory problems. It is important that forensic and clinical psychologists familiarize themselves with these techniques.	[van Oorsouw, Kim; Merckelbach, Harald] Maastricht Univ, Dept Clin Psychol Sci, NL-6200 MD Maastricht, Netherlands	van Oorsouw, K (corresponding author), Maastricht Univ, Dept Clin Psychol Sci, POB 616, NL-6200 MD Maastricht, Netherlands.	K.vanOorsouw@psychology.unimaas.nl					Arbisi PA, 1995, PSYCHOL ASSESSMENT, V7, P424, DOI 10.1037/1040-3590.7.4.424; Assefi SL, 2003, PSYCHOL SCI, V14, P77, DOI 10.1111/1467-9280.01422; Axelrod BN, 2006, CLIN NEUROPSYCHOL, V20, P513, DOI 10.1080/13854040590967117; Berry D., 2008, CLIN ASSESSMENT MALI, P237; BERRY DTR, 2002, CLIN PERSONALITY ASS, P269; Bigler ED, 2001, ARCH CLIN NEUROPSYCH, V16, P95; Boone KB, 2002, J CLIN EXP NEUROPSYC, V24, P561, DOI 10.1076/jcen.24.5.561.1004; Bourget D, 2007, J AM ACAD PSYCHIATRY, V35, P469; Brown S.C., 2000, OXFORD HDB MEMORY, P93, DOI DOI 10.1016/J.ADOLESCENCE.2017.05.018; Butcher JN, 1989, MANUAL ADM SCORING M; Cassidy JD, 2000, NEW ENGL J MED, V342, P1179, DOI 10.1056/NEJM200004203421606; Christianson S. A., 2004, DETECTION DECEPTION, P195, DOI [DOI 10.1017/CBO9780511490071.009, 10.1017/CBO9780511490071.009]; Christianson SA, 1999, APPL COGNITIVE PSYCH, V13, P495, DOI 10.1002/(SICI)1099-0720(199912)13:6<495::AID-ACP615>3.0.CO;2-0; CHRISTIANSON SA, 2006, REACTIVE INSTRUMENTA; Christianson SA, 2006, WITNESS TESTIMONY PS, P105; Cima M, 2004, INT J LAW PSYCHIAT, V27, P215, DOI 10.1016/j.ijlp.2004.03.007; Cima M, 2003, CLIN NEUROPSYCHOL, V17, P235, DOI 10.1076/clin.17.2.235.16507; Cima M., 2003, FAKING GOOD BAD UGLY; COOPER BS, 2005, THESIS U BRIT COLUMB; CRITCHLOW B, 1986, AM PSYCHOL, V41, P751, DOI 10.1037/0003-066X.41.7.751; Denney RL, 2000, J HEAD TRAUMA REHAB, V15, P804, DOI 10.1097/00001199-200004000-00005; Denney RL, 1996, ARCH CLIN NEUROPSYCH, V11, P589, DOI 10.1016/0887-6177(95)00042-9; Dickens S. E., 1992, STRUCTURED INTERVIEW; Dunn TM, 2003, ARCH CLIN NEUROPSYCH, V18, P121, DOI 10.1016/S0887-6177(01)00188-3; FAUST D, 1995, MALINGERING CONVERSI, V13, P225; FAUST D, 1996, NEUROPSYCHIATRY; FLOREZ JA, 2002, CURRENT OPINION PSYC, V15, P569; GACONO CB, 1995, B AM ACAD PSYCH LAW, V23, P387; GERSON AR, 2002, AM J FORENSIC PSYCH, V20, P57; Gervais RO, 2007, ASSESSMENT, V14, P196, DOI 10.1177/1073191106295861; GILBERT GM, 1971, NURNBERGER TAGEBUCH; Gorny I., 2005, J FORENSIC NEUROPSYC, V4, P71, DOI DOI 10.1300/J151V04N04_05; Green P., 2003, J FORENSIC NEUROPSYC, V2, P97, DOI DOI 10.1300/J151V02N03_05; Green P., 2007, ASSESSMENT FEIGNED C, P50; Greiffenstein MF, 2006, LEGAL CRIMINOL PSYCH, V11, P131, DOI 10.1348/135532505X49828; Greiffenstein MF, 2001, CLIN NEUROPSYCHOL, V15, P162, DOI 10.1076/clin.15.2.162.1895; Greve KW, 2006, J CLIN EXP NEUROPSYC, V28, P1176, DOI 10.1080/13803390500263550; Haque Q., 2003, ADV PSYCHIAT TREATME, V9, P144; Holmes EA, 2005, CLIN PSYCHOL REV, V25, P1, DOI 10.1016/j.cpr.2004.08.006; Hopwood JS, 1933, J MENT SCI, V79, P27; IVERSON GL, 1995, BRAIN INJURY, V9, P35, DOI 10.3109/02699059509004569; Jelicic M, 2007, NETHERLANDS J PSYCHO, V63, P107; Jelicic M., 2007, OFFENDERS MEMORIES V, P215, DOI 10.1002/9780470713082.ch9; JELICIC M, 2004, J CREDIBILITY ASSESS, V5, P1; Jureidini J, 2004, PSYCHOPATHOLOGY, V37, P259, DOI 10.1159/000081981; KALANT H, 1996, CONTEMP DRUG PROBL, V23, P631; Kopelman MD, 2000, COGNITIVE NEUROPSYCH, V17, P585, DOI 10.1080/026432900750002172; Kopelman MD, 1995, HDB MEMORY DISORDERS, P427; Kucharski LT, 2006, BEHAV SCI LAW, V24, P633, DOI 10.1002/bsl.661; Kvavilashvili L, 1999, MEMORY, V7, P421, DOI 10.1080/741944922; LEESHALEY PR, 1991, PSYCHOL REP, V68, P203, DOI 10.2466/PR0.68.1.203-210; Lezak MD, 1995, NEUROPSYCHOLOGICAL A; Lilienfeld SO, 1996, J PERS ASSESS, V66, P488, DOI 10.1207/s15327752jpa6603_3; MacNeil BM, 2006, PERS INDIV DIFFER, V41, P641, DOI 10.1016/j.paid.2006.03.004; MALLESON A, 2002, DUBIOUS DIAGNOSES WH; Marshall WL, 2005, SEX ABUSE-J RES TR, V17, P31; McSherry B, 2004, INT J LAW PSYCHIAT, V27, P445, DOI 10.1016/j.ijlp.2004.06.002; Meijer EH, 2007, PSYCHOPHYSIOLOGY, V44, P814, DOI 10.1111/j.1469-8986.2007.00543.x; Merckelbach H, 2003, BEHAV RES THER, V41, P351, DOI 10.1016/S0005-7967(02)00019-0; Merckelbach H, 2003, ARCH CLIN NEUROPSYCH, V18, P145, DOI 10.1016/S0887-6177(01)00191-3; Merckelbach H, 2003, COMPR PSYCHIAT, V44, P65, DOI 10.1053/comp.2003.50011; Merckelbach Harald, 2007, OFFENDERS MEMORIES V, P165, DOI DOI 10.1002/9780470713082.CH7; MILLER H, 1961, BRIT MED J, V1, P992, DOI 10.1136/bmj.1.5231.992; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; MITTENBERG W, 1993, PSYCHOL ASSESSMENT, V5, P34, DOI DOI 10.1037/1040-3590.5.1.34; Morel KR, 2008, J ANXIETY DISORD, V22, P1297, DOI 10.1016/j.janxdis.2008.01.011; Nairne JS, 2008, CURR DIR PSYCHOL SCI, V17, P239, DOI 10.1111/j.1467-8721.2008.00582.x; PAYNE JD, 2004, MEMORY EMOTION, P42; Pollock P.H., 1999, LEGAL CRIMINOL PSYCH, V4, DOI [DOI 10.1348/135532599167842, 10.1348/135532599167842]; Porter S, 2001, INT J LAW PSYCHIAT, V24, P23, DOI 10.1016/S0160-2527(00)00066-2; Porter S., 2006, HDB PSYCHOPATHY, P481; Porter S, 2007, LAW HUMAN BEHAV, V31, P91, DOI 10.1007/s10979-006-9033-0; Pressman MR, 2007, J SLEEP RES, V16, P198, DOI 10.1111/j.1365-2869.2007.00586.x; Pyszora NM, 2003, J FORENSIC PSYCHI PS, V14, P475, DOI 10.1080/14789940310001599785; Rassin E, 1999, BEHAV SCI LAW, V17, P237, DOI 10.1002/(SICI)1099-0798(199904/06)17:2<237::AID-BSL342>3.0.CO;2-5; Rivard JM, 2002, J FORENSIC SCI, V47, P1093; Rogers R., 2008, CLIN ASSESSMENT MALI, P301; Rogers R, 2008, CLIN ASSESSMENT MALI, V3rd, P3; Rosen GM, 2004, J AM ACAD PSYCHIATRY, V32, P132; Rosen GM, 2003, J ANXIETY DISORD, V17, P361, DOI 10.1016/S0887-6185(02)00200-1; Ruiz MA, 2002, PROF PSYCHOL-RES PR, V33, P294, DOI 10.1037//0735-7028.33.3.294; Salekin R. T., 2007, CLIN ASSESSMENT MALI, P343; Schagen S, 1997, J CLIN EXP NEUROPSYC, V19, P43, DOI 10.1080/01688639708403835; Schmand B, 1998, J NEUROL NEUROSUR PS, V64, P339, DOI 10.1136/jnnp.64.3.339; SMITH GP, 1992, J AM ACAD PSYCHIAT L, V25, P183; Sweet J.J., 2008, CLIN ASSESSMENT MALI, P218; Swihart G, 1999, INT J LAW PSYCHIAT, V22, P199, DOI 10.1016/S0160-2527(99)00005-9; Tombaugh TN, 1996, TEST MEMORY MALINGER; Tysse J. E., 2005, W MITCHELL LAW REV, V32, P353; van Oorsouw K, 2004, J AM ACAD PSYCHIATRY, V32, P364; van Oorsouw K, 2004, APPL COGNITIVE PSYCH, V18, P505, DOI 10.1002/acp.999; Van Oorsouw K., 2007, OFFENDERS MEMORIES V, P191; Van Oorsouw K, 2007, AM J PSYCHOL, V120, P287, DOI 10.2307/20445399; Van Oorsouw K, 2006, PSYCHOL CRIME LAW, V12, P261, DOI 10.1080/10683160500224477; Vanderploeg RD, 2003, J HEAD TRAUMA REHAB, V18, P148, DOI 10.1097/00001199-200303000-00006; Wechsler D, 2008, WECHSLER ADULT INTEL, V4th; Wechsler D., 1997, WMS 3 WECHSLER MEMOR; Woodworth M, 2002, J ABNORM PSYCHOL, V111, P436, DOI 10.1037//0021-843X.111.3.436	98	18	18	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1355-3259	2044-8333		LEGAL CRIMINOL PSYCH	Legal Criminol. Psychol.	FEB	2010	15	1			SI		97	114		10.1348/135532509X451304			18	Criminology & Penology; Law; Psychology, Multidisciplinary	Criminology & Penology; Government & Law; Psychology	560RN	WOS:000274919900007					2021-06-18	
J	Ahmed, M; Mostafa, S; Fisher, G; Reynolds, TM				Ahmed, M.; Mostafa, S.; Fisher, G.; Reynolds, T. M.			Comparison between transcutaneous bilirubinometry and total serum bilirubin measurements in preterm infants < 35 weeks gestation	ANNALS OF CLINICAL BIOCHEMISTRY			English	Article							PHOTOTHERAPY; TERM	Background: Neonatal hyperbilirubinaemia is a common treatable cause of brain injury. The treatment for this condition is phototherapy. The decision whether to use phototherapy is currently dependent upon serum bilirubin assay results. However, repeated blood sampling is not only traumatic but may also be a cause of anaemia in neonates. We evaluated a transcutaneous bilirubin assay method to determine whether it was suitable for routine use in preterm infants. Methods: One hundred and eighty-three transcutaneous bilirubin measurements were taken contemporaneously with blood samples for laboratory measurement of serum bilirubin. The study was carried out with informed parental consent and approval by the local research ethics committee. Results: The transcutaneous bilirubin method (BiliChek (R)) exhibited a consistent positive bias compared with the laboratory bilirubin assay. Consequently, for a given detection rate, the transcutaneous method had a higher screen positive rate, i.e. more neonates would be given phototherapy if transcutaneous bilirubin results were used to decide. There was a margin of safety in the transcutaneous bilirubin assay calibration. Conclusion: The BiliChek transcutaneous bilirubin assay is a safe alternative to laboratory bilirubin assay in deciding whether to give preterm neonates phototherapy.	[Ahmed, M.; Mostafa, S.] Queens Hosp, Dept Paediat, Burton Upon Trent, Staffs, England; [Fisher, G.] Queens Hosp, Dept Biochem, Burton Upon Trent, Staffs, England; [Reynolds, T. M.] Univ Leicester, Leicester Med Sch, Leicester, Leics, England	Ahmed, M (corresponding author), Queens Hosp, Belvedere Rd, Burton Upon Trent DE13 0RB, Staffs, England.	mansoor.ahmed@burtonh-tr.wmids.nhs.uk	Reynolds, Tim/AAW-5715-2020	Reynolds, Tim/0000-0002-9729-4775	RD budget	No external financial support was received for this project (BiliChek disposable probe tips were financed from the R&D budget).	Beck M, 2003, ARCH DIS CHILD-FETAL, V88, P350; Bhutani VK, 2000, PEDIATRICS, V106, DOI 10.1542/peds.106.2.e17; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Brister BS, 2002, AAPG BULL, V86, P1; De Luca D, 2008, ARCH DIS CHILD-FETAL, V93, pF135, DOI 10.1136/adc.2007.121053; Hinds LE, 2007, ARCH DIS CHILD-FETAL, V92, P378, DOI 10.1136/adc.2006.107771; Knupfer M, 2001, ACTA PAEDIATR, V90, P899; Lin JC, 2000, PEDIATRICS, V106, part. no., DOI 10.1542/peds.106.2.e19; Maisels MJ, 2004, PEDIATRICS, V114, P297; Maisels MJ, 2004, PEDIATRICS, V113, P1628, DOI 10.1542/peds.113.6.1628; Maisels MJ., 1993, EFFECTIVE CARE NEWBO, P507; Payne RB, 1997, ANN CLIN BIOCHEM, V34, P319, DOI 10.1177/000456329703400317; Rennie JM, 2009, ARCH DIS CHILD-FETAL, V94, pF323, DOI 10.1136/adc.2008.147686; Rubaltelli FF, 2001, PEDIATRICS, V107, P1264, DOI 10.1542/peds.107.6.1264; Sarici SU, 2000, J TROP PEDIATRICS, V46, P36, DOI 10.1093/tropej/46.1.36; Thayyil S, 2005, ARCH DIS CHILD, V90, P1311, DOI 10.1136/adc.2004.070292; Twomey PJ, 2006, ANN CLIN BIOCHEM, V43, P124, DOI 10.1258/000456306776021616; Willems W A, 2004, J Matern Fetal Neonatal Med, V16, P209; Wong CM, 2002, ARCH DIS CHILD-FETAL, V87, pF137, DOI 10.1136/fn.87.2.F137	19	18	18	0	4	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0004-5632	1758-1001		ANN CLIN BIOCHEM	Ann. Clin. Biochem.	JAN	2010	47		1				72	77		10.1258/acb.2009.009072			6	Medical Laboratory Technology	Medical Laboratory Technology	567XQ	WOS:000275482400013	19940207	Bronze			2021-06-18	
J	Bales, JW; Ma, XC; Yan, HQ; Jenkins, LW; Dixon, CE				Bales, James W.; Ma, Xiecheng; Yan, Hong Q.; Jenkins, Larry W.; Dixon, C. Edward			Expression of Protein Phosphatase 2B (Calcineurin) Subunit A Isoforms in Rat Hippocampus after Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						calcineurin; hippocampus; traumatic brain injury	LONG-TERM POTENTIATION; CONTROLLED CORTICAL IMPACT; FLUID PERCUSSION INJURY; SYNAPTIC PLASTICITY; CYCLOSPORINE-A; RECEPTOR FUNCTION; WORKING-MEMORY; IN-VIVO; DEFICITS; CALCIUM	Calcineurin (CaN) is a calcium/calmodulin-dependent phosphatase directly activated by calcium as a result of neuronal activation that is important for neuronal function. CaN subunit isoforms are implicated in long-term potentiation (LTP), long-term depression (LTD), and structural plasticity. CaN inhibitors are also beneficial to cognitive outcomes in animal models of traumatic brain injury (TBI). There are known changes in the CaN A (CnA) subunit following fluid percussion injury (FPI). The CnA subunit has two isoforms: CnA alpha and CnA beta. The effect of moderate controlled cortical impact (CCI) on distribution of CnA isoforms was examined at 2 h and 2 weeks post-injury. CnA distribution was assayed by immunohistochemistry and graded for non-parametric analysis. Acutely CnA isoforms showed reduced immunoreactivity in stratum radiatum processes of the ipsilateral CA1 and CA1-2. There was also a significant alteration in the immunoreactivity of both CnA isoforms in the ipsilateral dentate gyrus, predominantly within the hidden blade. Alterations in CnA isoform regional distribution within the CA1, CA1-2, and dentate gyrus may have significant implications for persistent hippocampal dysfunction following TBI, including dysfunction in hippocampal plasticity. Understanding alterations in CnA isoform distribution may help improve the targeting of current therapeutic interventions and/or the development of new treatments for TBI.	[Dixon, C. Edward] Univ Pittsburgh, Dept Neurol Surg, Brain Trauma Res Ctr, Pittsburgh, PA 15260 USA; [Bales, James W.; Dixon, C. Edward] Univ Pittsburgh, Ctr Neurosci, Pittsburgh, PA 15260 USA; [Bales, James W.] Univ Pittsburgh, Ctr Neural Basis Cognit, Pittsburgh, PA 15260 USA	Dixon, CE (corresponding author), Univ Pittsburgh, Dept Neurol Surg, Brain Trauma Res Ctr, 201 Hill Bldg,3434 5th Ave, Pittsburgh, PA 15260 USA.	dixonec@upmc.edu			NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS060672-01A2, P50 NS030318-150014, R01 NS060672, P50 NS030318] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS060672, P50NS030318] Funding Source: NIH RePORTER		Albensi BC, 2000, EXP NEUROL, V162, P385, DOI 10.1006/exnr.1999.7338; Asai A, 1999, J BIOL CHEM, V274, P34450, DOI 10.1074/jbc.274.48.34450; Banke TG, 2000, J NEUROSCI, V20, P89, DOI 10.1523/JNEUROSCI.20-01-00089.2000; Beattie EC, 2000, NAT NEUROSCI, V3, P1291; Butcher SP, 1997, J NEUROSCI, V17, P6939; Buzsaki G, 1996, CEREB CORTEX, V6, P81, DOI 10.1093/cercor/6.2.81; D'Ambrosio R, 1998, BRAIN RES, V786, P64, DOI 10.1016/S0006-8993(97)01412-1; Dell'Acqua ML, 2006, EUR J CELL BIOL, V85, P627, DOI 10.1016/j.ejcb.2006.01.010; Deshpande LS, 2008, NEUROSCI LETT, V441, P115, DOI 10.1016/j.neulet.2008.05.113; Dixon CE, 1997, J NEUROTRAUM, V14, P161, DOI 10.1089/neu.1997.14.161; Dixon CE, 1996, PHARMACOL BIOCHEM BE, V53, P679, DOI 10.1016/0091-3057(95)02069-1; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Eastwood SL, 2005, EUR J NEUROSCI, V22, P3017, DOI 10.1111/j.1460-9568.2005.04518.x; FINEMAN I, 1993, BRAIN RES, V624, P94, DOI 10.1016/0006-8993(93)90064-T; Friberg H, 1998, J NEUROSCI, V18, P5151; Groth RD, 2003, BIOCHEM BIOPH RES CO, V311, P1159, DOI 10.1016/j.bbrc.2003.09.002; Hall ED, 2008, J NEUROTRAUM, V25, P235, DOI 10.1089/neu.2007.0383; Hamm RJ, 1996, J NEUROTRAUM, V13, P317, DOI 10.1089/neu.1996.13.317; Hashimoto T, 1998, J NEUROCHEM, V70, P1289; HOVDA DA, 1992, J NEUROTRAUM, V9, pS47; HOVDA DA, 1990, ACT NEUR S, V51, P331; Huang RQ, 1998, J PHARMACOL EXP THER, V286, P243; Kayyali US, 1997, J NEUROCHEM, V68, P1668; KLEE CB, 1979, P NATL ACAD SCI USA, V76, P6270, DOI 10.1073/pnas.76.12.6270; Kline AE, 2000, NEUROSCI LETT, V280, P163, DOI 10.1016/S0304-3940(00)00797-7; Kline AE, 2002, J NEUROTRAUM, V19, P415, DOI 10.1089/08977150252932370; Kurz JE, 2005, BRAIN RES, V1048, P153, DOI 10.1016/j.brainres.2005.04.062; Kurz JE, 2005, J NEUROTRAUM, V22, P476, DOI 10.1089/neu.2005.22.476; Lee HK, 2003, CELL, V112, P631, DOI 10.1016/S0092-8674(03)00122-3; Lee SH, 2002, NEURON, V36, P661, DOI 10.1016/S0896-6273(02)01024-3; Lemon N, 2006, J NEUROSCI, V26, P7723, DOI 10.1523/JNEUROSCI.1454-06.2006; Li SM, 2003, NAT NEUROSCI, V6, P526, DOI 10.1038/nn1049; Liu YL, 2007, MOL PSYCHIATR, V12, P966, DOI 10.1038/sj.mp.4001977; Lu YM, 2000, NEURON, V26, P197, DOI 10.1016/S0896-6273(00)81150-2; MANALAN AS, 1983, P NATL ACAD SCI-BIOL, V80, P4291, DOI 10.1073/pnas.80.14.4291; Mbye LH, 2009, J CEREBR BLOOD F MET, V29, P87, DOI 10.1038/jcbfm.2008.93; Morioka M, 1999, PROG NEUROBIOL, V58, P1, DOI 10.1016/S0301-0082(98)00073-2; Muller RU, 1996, J GEN PHYSIOL, V107, P663, DOI 10.1085/jgp.107.6.663; Okonkwo DO, 2003, NEUROREPORT, V14, P463, DOI 10.1097/01.wnr.0000058958.85541.d3; Okonkwo DO, 1999, NEUROREPORT, V10, P353, DOI 10.1097/00001756-199902050-00026; REEVES TM, 1995, EXP BRAIN RES, V106, P248; Rusnak F, 2000, PHYSIOL REV, V80, P1483; Sanders MJ, 2000, BRAIN RES, V861, P69, DOI 10.1016/S0006-8993(00)01986-7; Scheff SW, 1997, J NEUROTRAUM, V14, P615, DOI 10.1089/neu.1997.14.615; SHAPIRA Y, 1989, Neurological Research, V11, P169; Sick TJ, 1998, BRAIN RES, V785, P287, DOI 10.1016/S0006-8993(97)01418-2; Sun DA, 2008, EUR J NEUROSCI, V27, P1659, DOI 10.1111/j.1460-9568.2008.06156.x; TONG G, 1995, SCIENCE, V267, P1510, DOI 10.1126/science.7878472; Uchino H, 2008, J ANESTH, V22, P253, DOI 10.1007/s00540-008-0617-3; VICTOR RG, 1995, P NATL ACAD SCI USA, V92, P6269, DOI 10.1073/pnas.92.14.6269; Wang HG, 1999, SCIENCE, V284, P339, DOI 10.1126/science.284.5412.339; Wang JH, 1996, LEARN MEMORY, V3, P170, DOI 10.1101/lm.3.2-3.170; Winder DG, 2001, NAT REV NEUROSCI, V2, P461, DOI 10.1038/35081514; Wu HY, 2004, J BIOL CHEM, V279, P4929, DOI 10.1074/jbc.M309767200; Yakel JL, 1997, TRENDS PHARMACOL SCI, V18, P124, DOI 10.1016/S0165-6147(97)01046-8; Yan HQ, 2000, BRAIN RES, V887, P134, DOI 10.1016/S0006-8993(00)03002-X; Yang SA, 2000, BIOCHEMISTRY-US, V39, P16147, DOI 10.1021/bi001321q; Zeng HK, 2001, CELL, V107, P617, DOI 10.1016/S0092-8674(01)00585-2; Zhuo M, 1999, P NATL ACAD SCI USA, V96, P4650, DOI 10.1073/pnas.96.8.4650	59	18	18	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN	2010	27	1					109	120		10.1089/neu.2009.1072			12	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	548RF	WOS:000273983200009	19751097	Green Accepted, Green Published			2021-06-18	
J	Bootes, K; Chapparo, C				Bootes, Kylie; Chapparo, Christine			Difficulties with multitasking on return to work after TBI: A critical case study	WORK-A JOURNAL OF PREVENTION ASSESSMENT & REHABILITATION			English	Article							STRATEGY APPLICATION; BRAIN INJURY; INTERVENTION	Work performance research highlights that psychometric cognitive measures and cognitive component information processing measures are strong predictors of success in multitasking work environments [14]. People with a mild to moderate traumatic brain injury (TBI) returning to a job requiring multitasking, may have difficulty succeeding despite pre-morbid equivalent cognitive scores. A critical case study is presented to begin to determine what aspects of information processing contribute to difficulties in multitasking work performance, for people with a TBI. The Perceive Recall Plan and Perform (PRPP) System of Task Analysis: Workplace Interview (i.e. PRPP@WORK) is used with the employer to obtain information processing scores. Results indicate substantial information processing deficits were perceived by the employer for the employee with a TBI. Future larger studies of people with a TBI who return to work that requires multitasking are needed to more clearly indicate: the level of multitasking they perform; what aspects of information processing hinder their work performance; the impact on performance of perceived cognitive load by the person with a TBI and the type and impact of support provided to improve their work performance.	[Chapparo, Christine] Univ Sydney, Fac Hlth Sci, Discipline Occupat Therapy, Lidcombe, NSW 1825, Australia	Chapparo, C (corresponding author), Univ Sydney, Fac Hlth Sci, Discipline Occupat Therapy, POB 170, Lidcombe, NSW 1825, Australia.	c.chapparo@usyd.edu.au					Barshi I., 2009, MULTITASKING MYTH HA; BOOTES K, 2003, PRPP SYSTEM WORKPLAC; Bootes Kylie, 2002, Work, V19, P255; Burgess PW, 2000, PSYCHOL RES-PSYCH FO, V63, P279, DOI 10.1007/s004269900006; BURGESS PW, PROSPECTIVE MEMORY, P236; Chan D, 2002, HUM PERFORM, V15, P233, DOI 10.1207/S15327043HUP1503_01; CHAPPARO C, 1997, MONOGRAPH OCCUPATION, V1, P189; Clark R.C., 2006, EFFICIENCY LEARNING; Fleming J, 1999, BRAIN INJURY, V13, P417; Fry K, 2002, AUSTR OCCUPATIONAL T, V49, P182, DOI 10.1046/j.1440-1630.2002.00337.x; HAMBLETON RK, 2003, APPL PSYCH MEAS, V7, P33; HOCKSTAFF JE, 1991, 5 NAT FOR ISS VOC AS, P185; Huffcutt AI, 2001, J APPL PSYCHOL, V86, P897, DOI 10.1037//0021-9010.86.5.897; Kinney T.B., 2008, 23 ANN C SOC IND ORG; Lautamo, 2006, AUSTRALIAN OCCUPATIO, V0, DOI [https://doi.org/10.1111/j.1440-1630.2006.00540.x, DOI 10.1111/J.1440-1630.2006.00540.X, 10.1111/j.1440-1630.2006.00540.x]; LOHRI J, 2004, THESIS U SYDNEY LIDC; Mateer CA, 2006, NEUROREHABILITATION, V21, P315; Nott MT, 2008, BRAIN INJURY, V22, P669, DOI 10.1080/02699050802227170; Nott MT, 2009, AUST OCCUP THER J, V56, P307, DOI 10.1111/j.1440-1630.2008.00763.x; NOTT MT, 2007, AUSTR OCCUPATIONAL T, V55, P199; Paas F, 2003, EDUC PSYCHOL-US, V38, P63, DOI 10.1207/S15326985EP3801_8; PONSFORD JL, 1995, BRAIN INJURY, V9, P1, DOI 10.3109/02699059509004565; PONSFORD JL, 1993, NEUROPSYCHOL REHABIL, V3, P5; Ree MJ, 2002, HUM PERFORM, V15, P3; Gouveia PAR, 2007, BRAIN COGNITION, V63, P240, DOI 10.1016/j.bandc.2006.09.001; Romiszowski A, 1984, DESIGNING INSTRUCTIO; Sbordone RJ, 2001, NEUROREHABILITATION, V16, P199; Schmidt FL, 1998, PSYCHOL BULL, V124, P262, DOI 10.1037/0033-2909.124.2.262; Schraagen J. M., 2000, COGNITIVE TASK ANAL; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; SHAW L, 2008, ERGONOMICS THERAPIST, P103; Slifer KJ, 1997, BRAIN INJURY, V11, P877; STAKE RE, 2005, ART CASE STUDY; Swan L, 2004, BRAIN INJURY, V18, P143, DOI 10.1080/02699050310001596923; Tenopyr ML, 2002, HUM PERFORM, V15, P107, DOI 10.1207/S15327043HUP1501&02_07; Wei J, 2003, HUM FACTORS ERGONOM, V13, P59, DOI 10.1002/hfm.10028; Yin R., 2002, APPL SOCIAL RES METH, V5	37	18	19	0	6	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1051-9815	1875-9270		WORK	Work		2010	36	2					207	216		10.3233/WOR-2010-01021			10	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	629FW	WOS:000280181500009	20634614				2021-06-18	
J	Chang, MC; Jang, SH				Chang, Min Cheol; Jang, Sung Ho			Corpus callosum injury in patients with diffuse axonal injury: A diffusion tensor imaging study	NEUROREHABILITATION			English	Article						Diffuse axonal injury; diffuse tensor imaging; corpus callosum; brain injury	TRAUMATIC BRAIN-INJURY; WHITE-MATTER INJURY; CLOSED-HEAD TRAUMA; CORTICOSPINAL TRACT; MR; INTEGRITY; LESIONS; TRACTOGRAPHY; FEATURES; MODERATE	Little is known about diffusion tensor image (DTI) findings of corpus callosum (CC) injury in patients with diffuse axonal injury (DAI). In the present study, we investigated the presence and extent of CC injury in patients with DAI. Twenty patients with DAI and 20 age-and sex-matched normal healthy controls subjects were recruited. Patients were divided into two groups according to the presence of a CC lesion on conventional brain MRI, namely, the CC (+) group (8 patients) and the CC (-) group (12 patients). DTIs were acquired using a sensitivity-encoding head coil at 1.5 T. The CC was divided into six mid-sagittal segments: the genu, rostral midbody, anterior midbody, posterior midbody, isthmus, and splenium. Fractional anisotropies (FA) and apparent diffusion coefficients (ADCs) were measured. FA values of all CC segments in DAI patients were significantly lower than those of controls (p < 0.001); whereas ADC values were either similar or marginally higher. FA values of the six sagittal segments in the CC (-) and (+) groups were significantly lower than those of controls, and ADC values were slightly higher, or showed no change. CC lesions may be present in DAI patients, irrespective of detection on conventional brain MRI. The authors suggest the probability that in cases of corpus callosum injury, DTI can offer a powerful means of detecting DAI.	[Chang, Min Cheol; Jang, Sung Ho] Yeungnam Univ, Coll Med, Dept Phys Med & Rehabil, Taegu 705717, South Korea	Jang, SH (corresponding author), Yeungnam Univ, Coll Med, Dept Phys Med & Rehabil, 317-1 Daemyungdong, Taegu 705717, South Korea.	strokerehab@hanmail.net					ADAMS JH, 1977, BRAIN, V100, P489, DOI 10.1093/brain/100.3.489; ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; Ahn YH, 2006, NEUROREHABILITATION, V21, P239; Alexander AL, 2007, NEUROTHERAPEUTICS, V4, P316, DOI 10.1016/j.nurt.2007.05.011; Assaf Y, 2008, J MOL NEUROSCI, V34, P51, DOI 10.1007/s12031-007-0029-0; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI 10.1016/j.jmr.2011.09.022; Beaulieu C, 1996, MAGNET RESON MED, V36, P627, DOI 10.1002/mrm.1910360419; BIEGON A, 1994, NEUROBIOL AGING, V15, P393, DOI 10.1016/0197-4580(94)90070-1; GENTRY LR, 1988, AM J NEURORADIOL, V9, P101, DOI 10.2214/ajr.150.3.663; GENTRY LR, 1989, RADIOLOGY, V171, P177, DOI 10.1148/radiology.171.1.2928523; GENTRY LR, 1988, AM J ROENTGENOL, V150, P673, DOI 10.2214/ajr.150.3.673; Godefroy O, 2003, J NEUROL, V250, P1, DOI 10.1007/s00415-003-0918-2; GRAHAM DI, 1997, GREENFIELDS NEUROPAT, P104; Han BS, 2007, NEUROREHABILITATION, V22, P151; Hong JH, 2009, BRAIN RES BULL, V80, P30, DOI 10.1016/j.brainresbull.2009.05.021; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Kuroki N, 2006, BIOL PSYCHIAT, V60, P22, DOI 10.1016/j.biopsych.2005.09.021; LEVIN H, 1994, J NEUROPSYCH CLIN N, V6, P443; Mazziotta J, 2001, J AM MED INFORM ASSN, V8, P401, DOI 10.1136/jamia.2001.0080401; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Miller EK, 2000, NAT REV NEUROSCI, V1, P59, DOI 10.1038/35036228; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Nakayama N, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.077875; Neil JJ, 2008, J MAGN RESON IMAGING, V27, P1, DOI 10.1002/jmri.21087; Parizel PM, 1998, EUR RADIOL, V8, P960, DOI 10.1007/s003300050496; Pierpaoli C, 1996, RADIOLOGY, V201, P637, DOI 10.1148/radiology.201.3.8939209; Ptak T, 2003, AM J ROENTGENOL, V181, P1401, DOI 10.2214/ajr.181.5.1811401; Rugg-Gunn FJ, 2001, J NEUROL NEUROSUR PS, V70, P530, DOI 10.1136/jnnp.70.4.530; Rutgers DR, 2008, AM J NEURORADIOL, V29, P1730, DOI 10.3174/ajnr.A1213; SUGIYAMA K, J NEUROTRAUMA; Sugiyama K, 2007, BRAIN INJURY, V21, P413, DOI 10.1080/02699050701311042; Takei K, 2008, SCHIZOPHR RES, V103, P52, DOI 10.1016/j.schres.2008.03.008; Wang JY, 2008, ARCH NEUROL-CHICAGO, V65, P619, DOI 10.1001/archneur.65.5.619; Wilde EA, 2006, J NEUROTRAUM, V23, P1412, DOI 10.1089/neu.2006.23.1412; WITELSON SF, 1989, BRAIN, V112, P799, DOI 10.1093/brain/112.3.799; Xu J, 2007, J NEUROTRAUM, V24, P753, DOI 10.1089/neu.2006.0208	39	18	19	0	3	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2010	26	4					339	345		10.3233/NRE-2010-0571			7	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	632NE	WOS:000280430600007	20555157				2021-06-18	
J	Cosentino, G; Giglia, G; Palermo, A; Panetta, ML; Lo Baido, R; Brighina, F; Fierro, B				Cosentino, G.; Giglia, G.; Palermo, A.; Panetta, M. L.; Lo Baido, R.; Brighina, F.; Fierro, B.			A case of post-traumatic complex auditory hallucinosis treated with rTMS	NEUROCASE			English	Article						Auditory hallucinosis; rTMS; Functional disruption; Therapeutic role of TMS; Right posterior temporal region	TRANSCRANIAL MAGNETIC STIMULATION; MUSICAL HALLUCINATIONS; ACQUIRED DEAFNESS; FRONTOTEMPORAL DEMENTIA; SCHIZOPHRENIA; TINNITUS; DEPRESSION; METABOLISM; APHASIA; CORTEX	Previous studies of auditory hallucinations in schizophrenia found that the hallucinations were reduced by the application of transcranial magnetic stimulation (rTMS). Here we describe a case of traumatic brain injury associated with continuous music hallucinations. An MRI scan showed a structural lesion of the right temporal pole and a PET scan indicated a hyperactive area of the posterior right temporal lobe. We hypothesized that rTMS applied to the right temporal area would reduce this activity and the corresponding hallucinations. The patient's music hallucinations were significantly reduced by rTMS treatment. A PET scan following treatment also indicated that rTMS treatment reduced brain activity in the right temporal lobe. This case provides initial evidence that rTMS may be a successful treatment of syndromes associated with hyperactive brain areas.	[Cosentino, G.; Palermo, A.; Panetta, M. L.; Lo Baido, R.; Brighina, F.; Fierro, B.] Univ Palermo, Dept Clin Neurosci, Palermo, Italy; [Giglia, G.] Casa Cura R Pacis, San Cataldo CL, Sicily, Italy	Brighina, F (corresponding author), Univ Palermo, Dept Clin Neurosci, Palermo, Italy.	fbrighina@unipa.it	Brighina, Filippo/K-9864-2016; Giglia, Giuseppe/M-7100-2016	Brighina, Filippo/0000-0001-5875-3126; Giglia, Giuseppe/0000-0001-5616-3595			AIZENBERG D, 1986, J NERV MENT DIS, V174, P309, DOI 10.1097/00005053-198605000-00008; BERRIOS GE, 1990, BRIT J PSYCHIAT, V156, P188, DOI 10.1192/bjp.156.2.188; Boellaard R, 2004, J NUCL MED, V45, P1519; Brighina F, 2003, NEUROSCI LETT, V336, P131, DOI 10.1016/S0304-3940(02)01283-1; Burt T, 2002, INT J NEUROPSYCHOPH, V5, P73, DOI 10.1017/S1461145702002791; Chen R, 1997, NEUROLOGY, V48, P1398, DOI 10.1212/WNL.48.5.1398; d'Alfonso AAL, 2002, J NEUROPSYCH CLIN N, V14, P77, DOI 10.1176/appi.neuropsych.14.1.77; Daniele O, 2003, J NEUROL, V250, P761, DOI 10.1007/s00415-003-1080-6; Evers S, 2004, J NEUROL SCI, V227, P55, DOI 10.1016/j.jns.2004.08.004; Finocchiaro C, 2006, NEUROCASE, V12, P317, DOI 10.1080/13554790601126203; Griffiths TD, 2000, BRAIN, V123, P2065, DOI 10.1093/brain/123.10.2065; Halpern AR, 2001, ANN NY ACAD SCI, V930, P179, DOI 10.1111/j.1749-6632.2001.tb05733.x; HAMMEKE TA, 1983, J NEUROL NEUROSUR PS, V46, P570, DOI 10.1136/jnnp.46.6.570; Harris JA, 2008, J COGNITIVE NEUROSCI, V20, P734, DOI 10.1162/jocn.2008.20048; Hoffman RE, 2000, LANCET, V355, P1073, DOI 10.1016/S0140-6736(00)02043-2; Horacek J, 2007, NEUROPSYCHOBIOLOGY, V55, P132, DOI 10.1159/000106055; LENNOX G, 1988, BRIT J PSYCHIAT, V153, P713; Lockwood AH, 1999, SCAND AUDIOL, V28, P47; Londero A, 2006, NEUROPHYSIOL CLIN, V36, P145, DOI 10.1016/j.neucli.2006.08.001; Miller BL, 2000, BRIT J PSYCHIAT, V176, P458, DOI 10.1192/bjp.176.5.458; Miller BL, 1998, NEUROLOGY, V51, P978, DOI 10.1212/WNL.51.4.978; Naeser MA, 2005, BRAIN LANG, V93, P95, DOI 10.1016/j.bandl.2004.08.004; Reyes SA, 2002, HEARING RES, V171, P43, DOI 10.1016/S0378-5955(02)00346-5; Rossi S, 2007, J NEUROL NEUROSUR PS, V78, P857, DOI 10.1136/jnnp.2006.105007; Schielke E, 2000, NEUROLOGY, V55, P454, DOI 10.1212/WNL.55.3.454; SILBERSWEIG DA, 1995, NATURE, V378, P176, DOI 10.1038/378176a0; THEODORE WH, 1988, NEUROLOGY, V38, P1201, DOI 10.1212/WNL.38.8.1201; Thie JA, 2004, J NUCL MED, V45, P1431; ZATORRE RJ, 1994, J NEUROSCI, V14, P1908, DOI 10.1523/jneurosci.14-04-01908.1994	29	18	18	0	12	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1355-4794	1465-3656		NEUROCASE	Neurocase		2010	16	3					267	272	PII 918839701	10.1080/13554790903456191			6	Clinical Neurology; Psychiatry; Psychology	Neurosciences & Neurology; Psychiatry; Psychology	602FQ	WOS:000278124300006	20104391				2021-06-18	
J	FitzGerald, A; Aditya, H; Prior, A; McNeill, E; Pentland, B				FitzGerald, Alasdair; Aditya, Hosakere; Prior, Anthony; McNeill, Ewan; Pentland, Brian			Anoxic brain injury: Clinical patterns and functional outcomes. A study of 93 cases	BRAIN INJURY			English	Article						Anoxia-hypoxia; brain injury; functional outcome; cognition; rehabilitation	CARDIAC-ARREST; DEMOGRAPHIC-VARIABLES; CEREBRAL HYPOXIA; ADULT SURVIVORS; ENCEPHALOPATHY; REHABILITATION; MYOCLONUS; EPILEPSY; SEQUELAE; MEMORY	Background: Anoxic brain injury (ABI) is a syndrome of diverse aetiology, most case series published to date being confined to ABI of a single aetiology or to a limited numbers of patients. Methods: This study performed a retrospective analysis on all patients admitted for rehabilitation following ABI over a 14-year period. It identified 93 cases and presents a summary of their clinical patterns and functional and psychometric outcome measures. In addition a database involving 584 patients admitted for rehabilitation following traumatic brain injury (TBI) during the same time interval was used to compare demographic, functional and cognitive patterns. Conclusions: Relative to TBI, there was a peak frequency of ABI in males aged 60 years and in females in their late 20s. ABI patients were referred later for rehabilitation, had similar lengths of stay, but made slower progress, with poorer outcomes and were more likely to be transferred to residential care. Those with ABI had more severe impairments on cognitive assessment relative to those with TBI, being particularly susceptible to impairments in memory, especially visual memory or short-term memory. Neurological impairments of speech and language were present in 72 patients; visual field loss in eight and cortical blindness in 10; six suffered myoclonus and 10 late epilepsy.	[FitzGerald, Alasdair; Pentland, Brian] Astley Ainslie Hosp, Dept Neurorehabil, Edinburgh EH3 9HL, Midlothian, Scotland; [Aditya, Hosakere] St Johns Hosp, Dept Psychiat, Livingston, Scotland; [Prior, Anthony; McNeill, Ewan] Astley Ainslie Hosp, Dept Neuropsychol, Edinburgh EH3 9HL, Midlothian, Scotland; [Pentland, Brian] Univ Edinburgh, Dept Rehabil Studies, Edinburgh EH8 9YL, Midlothian, Scotland	FitzGerald, A (corresponding author), Astley Ainslie Hosp, Dept Neurorehabil, Edinburgh EH3 9HL, Midlothian, Scotland.	alasdair.fitzgerald@nhs.net					Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Auer R., 2002, GREENFIELDS NEUROPAT, V7th, P233; Benton A, 1989, MULTILINGUAL APHASIA; BEREK K, 1995, STROKE, V26, P543, DOI 10.1161/01.STR.26.4.543; BHATIA KP, 1994, BRAIN, V117, P859, DOI 10.1093/brain/117.4.859; BHATT MH, 1993, NEUROLOGY, V43, P314, DOI 10.1212/WNL.43.2.314; Bigler E D, 1988, Arch Clin Neuropsychol, V3, P383, DOI 10.1016/0887-6177(88)90052-2; Burkala EJ, 2005, AIDS, V19, P675, DOI 10.1097/01.aids.0000166090.31693.aa; Caine D, 2000, J INT NEUROPSYCH SOC, V6, P86, DOI 10.1017/S1355617700611116; Christensen J, 2009, LANCET, V373, P1105, DOI 10.1016/S0140-6736(09)60214-2; CORKIN S, 1985, ANN NY ACAD SCI, V444, P10, DOI 10.1111/j.1749-6632.1985.tb37577.x; CORWIN J, 1993, CLIN NEUROPSYCHOL, V7, P3, DOI 10.1080/13854049308401883; Coughlan AK, 1986, ADULT MEMORY INFORM; Crawford JR, 1997, CLIN NEUROPSYCHOL, V11, P192, DOI 10.1080/13854049708407050; Crawford JR, 2001, BRIT J CLIN PSYCHOL, V40, P97, DOI 10.1348/014466501163517; CUMMINGS JL, 1993, ARCH NEUROL-CHICAGO, V50, P873, DOI 10.1001/archneur.1993.00540080076020; Fertl E, 2000, RESUSCITATION, V47, P231, DOI 10.1016/S0300-9572(00)00239-2; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gale SD, 1999, BRAIN INJURY, V13, P229, DOI 10.1080/026990599121601; Garcia-Molina A, 2006, BRAIN INJURY, V20, P1139, DOI 10.1080/02699050600983248; Hall KM., 1993, J HEAD TRAUMA REHAB, V8, DOI [DOI 10.1097/00001199-199308020-00008, 10.1097/00001199-199308020-00008]; Herman ST, 2002, NEUROLOGY, V59, pS21, DOI 10.1212/WNL.59.9_suppl_5.S21; HOPKINS RO, 1995, BRAIN COGNITION, V27, P180, DOI 10.1006/brcg.1995.1016; Hopkins RO, 2005, NEUROPSYCHOLOGY, V19, P233, DOI 10.1037/0894-4105.19.2.233; Hopkins RO, 2004, J INT NEUROPSYCH SOC, V10, P957, DOI 10.1017/S1355617704107108; HORN S, 1992, Brain Injury, V6, P321, DOI 10.3109/02699059209034946; Kandiah P, 2006, SEMIN NEUROL, V26, P413, DOI 10.1055/s-2006-948322; Khot S, 2006, SEMIN NEUROL, V26, P422, DOI 10.1055/s-2006-948323; LANCE JW, 1963, BRAIN, V86, P111, DOI 10.1093/brain/86.1.111; LEVY DE, 1985, JAMA-J AM MED ASSOC, V253, P1420, DOI 10.1001/jama.253.10.1420; Lim C, 2004, NEUROLOGY, V63, P1774, DOI 10.1212/01.WNL.0000144189.83077.8E; Lishman WA, 1998, PSYCHOL CONSEQUENCES, P546; Middelkamp W, 2007, CLIN REHABIL, V21, P425, DOI 10.1177/0269215507075307; RANDOLPH C, 1998, REPEATABLE BATTERY N; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Schmidt JG, 1997, J NEUROL REHABIL, V11, P189; Shah MK, 2004, BRAIN INJURY, V18, P111, DOI 10.1080/0269905031000149551; Shah MK, 2007, J NEUROL SCI, V260, P95, DOI 10.1016/j.jns.2007.04.012; Shallice, 1997, HAYLING BRIXTON TEST; Sivan AB., 1992, BENTON VISUAL RETENT; SNYDER BD, 2003, NEUROLOGY CLIN PRACT, P1665; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; TRESPASSER Z, 1989, ARCH PHYS MED REHAB, V70, P186; VOLPE BT, 1983, ARCH NEUROL-CHICAGO, V40, P436, DOI 10.1001/archneur.1983.04050070066017; Wechsler D., 1997, WMS 3 WECHSLER MEMOR; Wechsler D, 1997, WAIS 3 ADM SCORING M; Wechsler D., 1997, WECHSLER TEST ADULT; WIJDICKS EFM, 1994, ANN NEUROL, V35, P239, DOI 10.1002/ana.410350219; Wilson, 1991, NATL ADULT READING T; Wilson BA, 1996, BRAIN INJURY, V10, P863, DOI 10.1080/026990596123846; Wilson FC, 2003, NEUROREHABILITATION, V18, P291	52	18	18	1	16	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.		2010	24	11					1311	1323		10.3109/02699052.2010.506864			13	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	667MY	WOS:000283198800005	20722503				2021-06-18	
J	Gauvin-Lepage, J; Lefebvre, H				Gauvin-Lepage, Jerome; Lefebvre, Helene			Social inclusion of persons with moderate head injuries: The points of view of adolescents with brain injuries, their parents and professionals	BRAIN INJURY			English	Article						Traumatic brain injury; social inclusion; adolescents; perceptions; qualitative study	REHABILITATION; CHILDREN; FAMILY; BEHAVIOR; SCHOOL; TERM	Primary objective: This study explores the perceptions of adolescents, their parents and professionals as to the social inclusion of adolescents who have suffered a moderate traumatic brain injury (TBI). Research design: Exploratory descriptive qualitative study. Methods and procedures: Semi-structured interviews were conducted with three adolescents who had suffered a moderate TBI and with their parents. In addition, a focus group was conducted with four professionals. Main outcomes and results: The results show that the perceptions of adolescents, as well as their parents, affect different aspects of their lives, such as the adolescent's personal experiences, the family, friends, the environment and school. A great number of repercussions were indeed noted, which facilitate and sometimes limit the social inclusion of these adolescents. In general, the professionals shared the same perceptions, but added some ideas that did not come up in interviews with the adolescents and their parents. Conclusions: The results of this study should enable health professionals to better understand the social inclusion experienced by these people. They should also provide professionals with guidelines on how to better support the social inclusion of adolescents with TBIs and help families cope with this difficult situation.	[Gauvin-Lepage, Jerome] Jewish Rehabil Hosp, Laval, PQ H7N 1R2, Canada; [Gauvin-Lepage, Jerome; Lefebvre, Helene] Univ Montreal, Fac Nursing, Montreal, PQ, Canada; [Gauvin-Lepage, Jerome; Lefebvre, Helene] Montreal Ctr Interdisciplinary Res Rehabil, Montreal, PQ, Canada	Gauvin-Lepage, J (corresponding author), Jewish Rehabil Hosp, 3205 Alton Goldbloom Pl,Nursing Adm B-1127, Laval, PQ H7N 1R2, Canada.	jerome.gauvin-lepage@umontreal.ca	Gauvin-Lepage, Jerome/AAD-6699-2020				ALBRECHT SL, 1986, SOCIAL PSYCHOL, P696; ALVIN P, 2005, ANNONCE HANDICAP ADO, P127; Anderson VA, 2005, J NEUROL NEUROSUR PS, V76, P401, DOI 10.1136/jnnp.2003.019174; BEE HL, 2008, AGES VIE PSYCHOL DEV, P468; BELANGER ME, 2000, MED QUEBEC, V35, P91; BOURQUE C, 2000, CADRE REFERENCE CLIN, P108; Braga LW, 2005, BRAIN INJURY, V19, P819, DOI 10.1080/02699050500110165; Bragg RM, 1992, J HEAD TRAUMA REHAB, V7, P94; BRONFENBRENNER U, 1986, DEV PSYCHOL, V22, P723, DOI 10.1037/0012-1649.22.6.723; Bronfenbrenner U, 1979, ECOLOGY HUMAN DEV EX, p[xv, 330]; BURNS N, 2009, PRACTICE NURSING RES, P750; Cimon L., 2000, PARTENARIAT RECHERCH, P47; Colantonio A, 1998, ARCH PHYS MED REHAB, V79, P550, DOI 10.1016/S0003-9993(98)90072-7; Crotty M., 1998, FDN SOCIAL RES MEANI, P248; Denzin NK, 2008, COLLECTING INTERPRET, Vx, P701; DePalma J A, 2001, Crit Care Nurs Q, V23, P42; DUBE C, 2001, QUEBEC SCI, V39, P22; EWINGCOBBS L, 1994, NEUROSURGERY, V35, P225, DOI 10.1227/00006123-199408000-00007; Farmer JE, 1996, J LEARN DISABIL-US, V29, P532, DOI 10.1177/002221949602900508; FAWCETT J, 1999, RELATIONSHIP THEORY, P398; FORTIN MF, 2006, FONDEMENTS ETAPES PR, P485; Francois N., 2005, ANNONCE HANDICAP ADO, P58; FRASER SN, 2006, DISS ABSTR INT B, V67, P253; FRIEDMAN D, 1999, COMPRENDRE NEUROTRAU, P43; GARCIA JG, 1998, PROFESSIONAL SCH COU, V2, P33; Guba EG, 1989, 4 GENERATION EVALUAT, P294; Guba EG, 1985, NATURALISTIC INQUIRY, P416; Hanks RA, 1999, ARCH PHYS MED REHAB, V80, P991, DOI 10.1016/S0003-9993(99)90049-7; Hawley CA, 2004, ARCH DIS CHILD, V89, P136, DOI 10.1136/adc.2002.025577; HEISS I, 1993, SOCIAL ROLES CONFORM, P11; Khan F, 2003, MED J AUSTRALIA, V178, P290, DOI 10.5694/j.1326-5377.2003.tb05199.x; Laloua F., 2006, EVALUATION TROUBLES, P109; Lefebvre H., 2004, RECHERCHE SOINS INFI, V78, P14; Lefebvre H., 2002, FAMILLE SITUATION HA, P27; Lefebvre H., 2005, FRONTIERES, V17, P77; Leon-Carrion J, 2006, STUD NEUROPSYCH DEV, P513; LEPAGE C, 2000, PARTENARIAT RECHERCH, P35; Levin HS, 2005, PEDIATR NEUROL, V33, P79, DOI 10.1016/j.pediatrneurol.2005.02.002; Light R, 1998, J CONSULT CLIN PSYCH, V66, P1023; Loiselle CG, 2007, METHODES RECHERCHE S, P591; Lovasik D, 2001, Crit Care Nurs Q, V23, P24; MALEC EA, 1993, DISS ABSTR INT B, V55, P222; MCLEAN A, 1993, ARCH PHYS MED REHAB, V74, P1041, DOI 10.1016/0003-9993(93)90059-J; Mucchielli A., 2009, DICT METHODES QUALIT, P303; NEUMAN W, 2006, SOCIAL RES METHODS Q, P592; OLDS SW, 2005, DEV PERSONNE ADAPTAT, P399; Paquet M, 2005, J ADV NURS, V51, P567, DOI 10.1111/j.1365-2648.2005.03544.x; Patton M.Q., 2002, QUALITATIVE RES EVAL, V3rd ed., P598; PELCHAT D, 2004, APPRENDRE ENSEMBLE P, P196; Ponsford J, 1999, J HEAD TRAUMA REHAB, V14, P360, DOI 10.1097/00001199-199908000-00005; Poupart J., 1997, RECHERCHE QUALITATIV, P405; PRADATDIEHL P, 2006, EVALUATION TROUBLES, P162; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; SCHWANDT TA, 2001, DICT QUALITATIVE INQ, P322; Shanmukhi S, 2003, NEUROL INDIA, V51, P518; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; Thompson Matthew D, 2003, Semin Pediatr Neurol, V10, P130, DOI 10.1016/S1071-9091(03)00021-4; TOCHON FV, 1996, REV SCI ED, V22, P467, DOI DOI 10.7202/031889AR; Wong SY, 2006, J INTELLECT DISABILI, V10, P165, DOI 10.1177/1744629506064012; Yazicioglu K, 2006, MIL MED, V171, P1083, DOI 10.7205/MILMED.171.11.1083	60	18	18	0	9	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2010	24	9					1087	1097		10.3109/02699052.2010.494593			11	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	636RH	WOS:000280756700005	20569044				2021-06-18	
J	Hansen, TS; Jakobsen, D				Hansen, Trine S.; Jakobsen, Daniela			A decision-algorithm defining the rehabilitation approach: 'Facial oral tract therapy'(R)	DISABILITY AND REHABILITATION			English	Article						Rehabilitation research; therapeutic methods; practice guideline	TRAUMATIC BRAIN-INJURY; HYPOTHESIS-ORIENTED ALGORITHM; BLACK-BOX; SWALLOWING DISORDERS; CHIN-TUCK; STROKE; COORDINATION; PATIENT; INTERVENTIONS; PSYCHOTHERAPY	Aim. The aim of this study was to describe and define the rehabilitation approach: 'Facial Oral Tract Therapy' (F.O.T.T.)(R). Method. We defined the content and process of the rehabilitation approach (F.O.T.T.)(R) in a decision-algorithm supported by a manual with supplementary material. The algorithm was developed by a research occupational therapist and an F.O.T.T.(R) senior instructor. We used an inductive approach combining existing knowledge from: F.O.T.T.(R) instructors, therapists trained in using the F.O.T.T.(R) approach, and existing literature. A group of F.O.T.T.(R) instructors and the originator of the treatment approach Mrs. Kay Coombes has given comments to and approved the algorithm. Result. The algorithm consist of five flowcharts: 'one assessment' chart guiding the therapist in the examination of the patient and four 'treatment charts', one for each of the four areas of F.O.T.T.(R): swallowing and eating; oral hygiene; breathing, voice, and speech articulation; facial expression, giving guidance on interventions. The algorithm outlines all important components in the treatment that the therapist should decide to use or not to use in the intervention. The algorithm is supported by a manual with criteria of when to use which components. Conclusion. This algorithm is designed to be a practical guideline to therapists using F.O.T.T.(R) in clinical practice and in educational settings. The use of this algorithm may support standardization of F.O.T.T.(R) and thereby promote and maintain the quality in the treatment. This in turn will facilitate research that addresses F.O.T.T.(R) and outcomes.	[Hansen, Trine S.; Jakobsen, Daniela] Univ Copenhagen, Hvidovre Hosp, Brain Injury Unit, Dept Neurorehabil, DK-2760 Hvidovre, Denmark; [Hansen, Trine S.; Jakobsen, Daniela] Univ Copenhagen, Hvidovre Hosp, Dept Occupat Therapy, DK-2760 Hvidovre, Denmark	Hansen, TS (corresponding author), Univ Copenhagen, Hvidovre Hosp, Brain Injury Unit, Dept Neurorehabil, Kettegaard Alle 30,2650, DK-2760 Hvidovre, Denmark.	trine.schow@gmail.com					Addis ME, 1999, CLIN PSYCHOL-SCI PR, V6, P430, DOI 10.1093/clipsy/6.4.430; Affolter F., 1991, PERCEPTION INTERACTI; AFFOLTER F, 2000, CLIN IMPLICATIONS; Alaverdashvili M, 2008, BEHAV BRAIN RES, V188, P281, DOI 10.1016/j.bbr.2007.11.007; *ARCOS, FAC OR TRACT THER FO; Ayuse T, 2006, J ORAL REHABIL, V33, P402, DOI 10.1111/j.1365-2842.2005.01586.x; Ballinger C, 1999, CLIN REHABIL, V13, P301, DOI 10.1191/026921599673198490; BOBATH B, 1978, HEMIPLEGIA EVALUATIO; Calhoun KS, 1998, J CONSULT CLIN PSYCH, V66, P151, DOI 10.1037/0022-006X.66.1.151; Carney N, 1999, J HEAD TRAUMA REHAB, V14, P277, DOI 10.1097/00001199-199906000-00008; Carroll KM, 2002, CLIN PSYCHOL-SCI PR, V9, P396, DOI 10.1093/clipsy/9.4.396; COOMBES K, 2001, FACIAL ORAL TRACT TH; COOMBES KFO, 2008, IADH MAGAZINE; DAVIES PM, 2000, STEPS FOLLOW; DAVIES PM, 1994, STARTING AGAIN EARLY; De Mayo T, 2005, J ORAL REHABIL, V32, P487, DOI 10.1111/j.1365-2842.2005.01453.x; DeJong G, 2005, ARCH PHYS MED REHAB, V86, pS1, DOI 10.1016/j.apmr.2005.09.003; DeJong G, 2004, ARCH PHYS MED REHAB, V85, P678, DOI 10.1016/j.apmr.2003.06.033; ECHTERNACH JL, 1989, PHYS THER, V69, P559, DOI 10.1093/ptj/69.7.559; FRANK JS, 1990, PHYS THER, V70, P855, DOI 10.1093/ptj/70.12.855; Hansen TS, 2008, ARCH PHYS MED REHAB, V89, P1556, DOI 10.1016/j.apmr.2007.11.063; HARRINGTON R, 1975, J AM GERIATR SOC, V23, P254, DOI 10.1111/j.1532-5415.1975.tb00314.x; Hart T, 2009, NEUROPSYCHOL REHABIL, V19, P161, DOI 10.1080/09602010802188393; HENRY WP, 1993, J CONSULT CLIN PSYCH, V61, P434, DOI 10.1037/0022-006X.61.3.434; *IB, THEOR ASS; *IB, THEOR ASS CLIN PRACT; KATHLEEN M, 2002, CLIN PSYCHOL-SCI PR, V9, P396; KJAERSGAARD A, 2005, MUND SVAELG; Langmore S E, 1988, Dysphagia, V2, P216, DOI 10.1007/BF02414429; Law M., 1996, CANADIAN J OCCUPATIO, V63, P9, DOI [10.1177/000841749606300103, DOI 10.1177/000841749606300103]; LAZARUS C, 1987, ARCH PHYS MED REHAB, V68, P79; LOGEMANN JA, 1983, EVALUATION TREATMENT, V2; Mackay LE, 1999, ARCH PHYS MED REHAB, V80, P365, DOI 10.1016/S0003-9993(99)90271-X; MARTIN BJW, 1994, J APPL PHYSIOL, V76, P714; MAYSTON M, 2001, NEUROLOGICAL PHYSIOT; Miller R M, 1999, Phys Med Rehabil Clin N Am, V10, P925; MONCHER FJ, 1991, CLIN PSYCHOL REV, V11, P247, DOI 10.1016/0272-7358(91)90103-2; MULDER T, 1993, BAILLIERE CLIN NEUR, V2, P1; Mulder Theo, 2001, Neural Plasticity, V8, P131, DOI 10.1155/NP.2001.131; Nezu A., 2008, EVIDENCE BASED OUTCO; Nudo Randolph J, 2006, NeuroRx, V3, P420; Nudo Randolph J, 2003, Phys Med Rehabil Clin N Am, V14, pS57, DOI 10.1016/S1047-9651(02)00054-2; Nudo RJ, 2007, BRAIN INJURY MED PRI, P913; NUSSERMULLER B, 2004, THERAPIE FACIO ORALE; *NUSSERMULLERBU, 2007, THERAPIE FACIO ORALE, V2; NUSSERMULLERBUS.R, 2007, KONSENSUSEMPFEHLUNGE; Raine S, 2006, PHYSIOTHER RES INT, V11, P4, DOI 10.1002/pri.35; Rothstein JM, 2003, PHYS THER, V83, P455, DOI 10.1093/ptj/83.5.455; ROTHSTEIN JM, 1986, PHYS THER, V66, P1388, DOI 10.1093/ptj/66.9.1388; Rozet I, 2007, BEST PRACT RES-CLIN, V21, P465, DOI 10.1016/j.bpa.2007.07.001; Sataloff RT, 2007, OTOLARYNG CLIN N AM, V40, P909, DOI 10.1016/j.otc.2007.05.002; Schenkman M, 2006, PHYS THER, V86, P1681, DOI 10.2522/ptj.20050260; Seidl RO, 2007, CLIN REHABIL, V21, P686, DOI 10.1177/0269215507076393; Smithard DG, 1996, STROKE, V27, P1200, DOI 10.1161/01.STR.27.7.1200; Talbot Ana, 2005, Gerodontology, V22, P77, DOI 10.1111/j.1741-2358.2005.00049.x; Tinetti ME, 2008, J AM GERIATR SOC, V56, P730, DOI 10.1111/j.1532-5415.2007.01627.x; TINETTI ME, 1989, SEMIN NEUROL, V9, P39, DOI 10.1055/s-2008-1041303; Ward EC, 2007, J HEAD TRAUMA REHAB, V22, P184, DOI 10.1097/01.HTR.0000271119.96780.f5; WELCH MV, 1993, ARCH PHYS MED REHAB, V74, P178; WHO, 2006, INT CLASS FUNCT DIS; Whyte J, 2003, AM J PHYS MED REHAB, V82, pS16, DOI 10.1097/01.PHM.0000086992.95121.C2; Whyte J, 2003, AM J PHYS MED REHAB, V82, P639, DOI 10.1097/01.PHM.0000078200.61840.2D; Whyte J, 2009, NEUROPSYCHOL REHABIL, V19, P807, DOI 10.1080/09602010903031146; World Health Organization, WHO INT CLASS FUNCT	64	18	18	0	18	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.		2010	32	17					1447	1460		10.3109/09638280903556482			14	Rehabilitation	Rehabilitation	636QX	WOS:000280755100008	20624108				2021-06-18	
J	Horton, AM; Soper, HV; Reynolds, CR				Horton, Arthur MacNeill, Jr.; Soper, Henry V.; Reynolds, Cecil R.			Executive Functions in Children with Traumatic Brain Injury	APPLIED NEUROPSYCHOLOGY			English	Article						children; executive functioning; neuropsychology; traumatic brain injury	ATTENTIONAL DEFICITS; TASK-PERFORMANCE; EARLY-CHILDHOOD; HEAD-INJURY; DAMAGE; TRAIL; TBI	The maturational course of the development of executive functioning abilities is dependent on the functional capacity of the human brain. Unfortunately, there is a dearth of standardized functional assessments of executive functioning abilities for children. The present article describes neurodevelopment of executive functioning and several recent measures of executive functioning that have been developed to assess maturational periods of specific executive functions. Clinical implications of these results for traumatically brain-injured children are described.	[Horton, Arthur MacNeill, Jr.] Psych Associates Maryland, Bethesda, MD USA; [Soper, Henry V.] Fielding Grad Univ, Psychol Program, Santa Barbara, CA USA; [Reynolds, Cecil R.] Texas A&M Univ, Dept Educ Psychol, Bastrop, TX USA	Horton, AM (corresponding author), 5903 Lone Oak Dr, Bethesda, MD 20814 USA.	drmachorton@hotmail.com					Anderson SW, 2000, DEV NEUROPSYCHOL, V18, P281, DOI 10.1207/S1532694202Anderson; Anderson V, 2005, BRAIN INJURY, V19, P699, DOI 10.1080/02699050400025281; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Benton A, 1989, MULTILINGUAL APHASIA; BENTON AL, 1968, NEUROPSYCHOLOGIA, V6, P53, DOI 10.1016/0028-3932(68)90038-9; Campbell CGN, 2004, CAN J NEUROL SCI, V31, P213, DOI 10.1017/S0317167100053853; Catroppa C, 2003, DEV NEUROPSYCHOL, V23, P359, DOI 10.1207/S15326942DN2303_3; Catroppa C, 2007, J PEDIATR PSYCHOL, V32, P354, DOI 10.1093/jpepsy/jsl019; Chan RCK, 2001, BRAIN INJURY, V15, P71, DOI 10.1080/02699050118215; Christodoulou C, 2001, J NEUROL NEUROSUR PS, V71, P161, DOI 10.1136/jnnp.71.2.161; Cicerone KD, 1996, BRAIN INJURY, V10, P79, DOI 10.1080/026990596124566; ESTES WK, 1974, AM PSYCHOL, V29, P740, DOI 10.1037/h0037458; Fenwick T, 1999, CHILD NEUROPSYCHOL, V5, P213, DOI 10.1076/0929-7049(199912)05:04;1-R;FT213; GRANT DA, 1948, J EXP PSYCHOL, V38, P404, DOI 10.1037/h0059831; Hartlage L. C., 1975, PEDIAT PSYCHOL, V3, P23; HARTLAGE LC, 1986, NEUROPSYCHOLOGY HDB, P441; Heaton R., 1993, WISCONSIN CARD SORTI; Heaton R. K, 1981, WISCONSIN CARD SORTI; High WM, 2005, REHABILITATION TRAUM; HORTON AM, 1994, BEHAV INTERVENTIONS; HORTON AM, 2008, NEUROPSYCHOLOGY HDB, P3; Horton AM, 1986, CHILD NEUROPSYCHOL, V2, P299; HYND GW, 1988, PEDIAT NEUROPSYCHOLO; Kolb B., 1989, HDB CLIN CHILD NEURO, P17; Kraus JF, 1995, TRAUMATIC HEAD INJUR, P22; Leclercq M, 2000, J CLIN EXP NEUROPSYC, V22, P339, DOI 10.1076/1380-3395(200006)22:3;1-V;FT339; Levine B, 2005, COGN BEHAV NEUROL, V18, P45, DOI 10.1097/01.wnn.0000152227.13001.c3; Levine B., 2002, PRINCIPLES FRONTAL L, P448; Lezak MD, 1995, NEUROPSYCHOLOGICAL A; Luria A. R., 1966, HIGHER CORTICAL FUNC; MILNER B, 1963, ARCH NEUROL-CHICAGO, V9, P90, DOI 10.1001/archneur.1963.00460070100010; Mitrushina M., 1999, HDB NORMATIVE DATA N; Morgan JE, 2008, TXB CLIN NEUROPSYCHO, P158; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; Reitan R, 1974, CLIN NEUROPSYCHOLOGY; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Reitan RM, 1955, J CONSULT PSYCHOL, V19, P393, DOI 10.1037/h0044509; Reynolds C. R., 2003, COMPREHENSIVE TRAIL; Reynolds C. R., 2006, TEST VERBAL CONCEPTU; REYNOLDS CR, 1997, HDB CLIN CHILD NEURO; Romine CB, 2005, APPL NEUROPSYCHOL, V12, P190, DOI 10.1207/s15324826an1204_2; ROSEN W G, 1980, Journal of Clinical Neuropsychology, V2, P135, DOI 10.1080/01688638008403788; ROTH RM, 2008, NEUROPSYCHOLOGY HDB, P217; Stuss DT, 2001, PSYCHOL ASSESSMENT, V13, P230, DOI 10.1037//1040-3590.13.2.230; STUSS DT, 1989, J NEUROL NEUROSUR PS, V52, P742, DOI 10.1136/jnnp.52.6.742; Verdejo-Garcia A, 2006, J INT NEUROPSYCH SOC, V12, P405, DOI 10.1017/S1355617706060486; Wolfson D., 1993, HALSTEAD REITAN NEUR; Yeates KO, 2005, J AM ACAD CHILD PSY, V44, P574, DOI 10.1097/01.chi.0000159947.50523.64; Ylvisaker M., 1998, TRAUMATIC BRAIN INJU; Zillmer E. A., 2001, PRINCIPLES NEUROPSYC	50	18	18	1	23	PSYCHOLOGY PRESS	HOVE	27 CHURCH RD, HOVE BN3 2FA, EAST SUSSEX, ENGLAND	0908-4282			APPL NEUROPSYCHOL	Appl. Neuropsychol.		2010	17	2					99	103	PII 922163073	10.1080/09084281003708944			5	Clinical Neurology; Psychology	Neurosciences & Neurology; Psychology	596CX	WOS:000277662800004	20467949				2021-06-18	
J	Leung, AWS; Cheng, SKW; Mak, AKY; Leung, KK; Li, LSW; Lee, TMC				Leung, Ada W. S.; Cheng, Stephen K. W.; Mak, Amanda K. Y.; Leung, Kwok-Keung; Li, Leonard S. W.; Lee, Tatia M. C.			Functional gain in hemorrhagic stroke patients is predicted by functional level and cognitive abilities measured at hospital admission	NEUROREHABILITATION			English	Article						Stroke; FIM; functional recovery; learning; memory	TRAUMATIC BRAIN-INJURY; NEUROPSYCHOLOGICAL DEFICITS; SUBARACHNOID HEMORRHAGE; INDEPENDENCE MEASURE; ISCHEMIC-STROKE; RECOVERY; REHABILITATION; POSTSTROKE; MILD; SYMPTOMS	Background and purpose: Few studies have addressed factors that contribute to functional recovery in people with hemorrhagic stroke. We assessed the value of using pre-training functional level and cognitive abilities measured at admission in order to predict functional gain in a sample of stroke patients. Methods: The Functional Independence Measure (FIM) was administered to 85 hemorrhagic stroke patients. Three multiple regression models were constructed using total gain in FIM scores, gain in scores in the cognitive domain of FIM, and gain in scores in the motor domain of FIM as outcome variables. Predictor variables were age; scores on the Digit Span Forward Test (DSF), Digit Span Backward Test (DSB). and Chinese Auditory Verbal Learning Test (CAVLT); and the FIM scores measured at admission. Results: All regression models were significant, Ps < 0.001, and each explained over 73% of the variance in the FIM gains. Age and admission FIM scores were both significant predictors in each of the three models. The DSB span score was a significant predictor of the total FIM and the cognitive FIM gains. The CAVLT recognition score was also a significant predictor of the cognitive FIM gain. Conclusions: Functional improvement in patients with hemorrhagic stroke after in-patient rehabilitation was predicted by age, pre-training functional level, and cognitive abilities measured at admission.	[Leung, Ada W. S.; Mak, Amanda K. Y.; Leung, Kwok-Keung; Lee, Tatia M. C.] Univ Hong Kong, Neuropsychol Lab, Hong Kong, Hong Kong, Peoples R China; [Cheng, Stephen K. W.] MacLehose Med Rehabil Ctr, Occupat Therapy Dept, Hong Kong, Hong Kong, Peoples R China; [Mak, Amanda K. Y.; Leung, Kwok-Keung; Li, Leonard S. W.; Lee, Tatia M. C.] MacLehose Med Rehabil Ctr, Inst Clin Neuropsychol, Hong Kong, Hong Kong, Peoples R China; [Li, Leonard S. W.] Tung Wah Hosp, Dept Rehabil Med, Hong Kong, Hong Kong, Peoples R China	Lee, TMC (corresponding author), Univ Hong Kong, Neuropsychol Lab, K610,Knowles Bldg,Pokfulam Rd, Hong Kong, Hong Kong, Peoples R China.	tmclee@hkusua.hku.hk					BIRKETT DP, 2008, PSYCHIAT STROKE, P5; BLACK FW, 1986, J CLIN PSYCHOL, V42, P770, DOI 10.1002/1097-4679(198609)42:5<770::AID-JCLP2270420516>3.0.CO;2-P; de Freitas GR, 2000, ARCH NEUROL-CHICAGO, V57, P513, DOI 10.1001/archneur.57.4.513; Denti L, 2008, EUR J PHYS REHAB MED, V44, P3; HUTTER BO, 1993, NEUROSURGERY, V33, P999; Kashluba S, 2008, ARCH PHYS MED REHAB, V89, P904, DOI 10.1016/j.apmr.2007.12.029; Katrak PH, 2009, PM&R, V1, P427, DOI 10.1016/j.pmrj.2009.03.002; Kelly PJ, 2003, ARCH PHYS MED REHAB, V84, P968, DOI 10.1016/S0003-9993(03)00040-6; Kelly PJ, 2001, STROKE, V32, P530, DOI 10.1161/01.STR.32.2.530; KIDD D, 1995, DISABIL REHABIL, V17, P10, DOI 10.3109/09638289509166622; Kwakkel G, 2004, RESTOR NEUROL NEUROS, V22, P281; Lee TMC, 2004, INT J GERIATR PSYCH, V19, P216, DOI 10.1002/gps.1053; LEININGER BE, 1990, J NEUROL NEUROSUR PS, V53, P293, DOI 10.1136/jnnp.53.4.293; Leskela M, 1999, EUR J NEUROL, V6, P653, DOI 10.1046/j.1468-1331.1999.660653.x; LINACRE JM, 1994, ARCH PHYS MED REHAB, V75, P127; Lipson DM, 2005, INT J REHABIL RES, V28, P303, DOI 10.1097/00004356-200512000-00002; MORROW LA, 1992, NEUROPSYCHOLOGIA, V30, P911, DOI 10.1016/0028-3932(92)90035-K; Nedeltchev K, 2007, STROKE, V38, P2531, DOI 10.1161/STROKEAHA.107.482554; O'Dell MW, 2002, ARCH PHYS MED REHAB, V83, P678, DOI 10.1053/apmr.2002.32305; Ozdemir F, 2001, AM J PHYS MED REHAB, V80, P410, DOI 10.1097/00002060-200106000-00003; PULLICINO P, 1992, STROKE, V23, P919, DOI 10.1161/str.23.6.919a; Rey A., 1959, ARCH PSYCHOL, V37, P126; Ross S R, 1997, Appl Neuropsychol, V4, P165, DOI 10.1207/s15324826an0403_4; Schepers V, 2009, J REHABIL MED, V41, P930, DOI 10.2340/16501977-0446; Schepers VPM, 2008, J REHABIL MED, V40, P487, DOI 10.2340/16501977-0198; Schepers VP, 2006, ARCH PHYS MED REHAB, V87, P184, DOI 10.1016/j.apmr.2005.10.005; Schepers VP, 2005, ARCH PHYS MED REHAB, V86, P1472, DOI 10.1016/j.apmr.2004.11.039; Su CY, 2000, ARCH PHYS MED REHAB, V81, P706, DOI 10.1053/apmr.2000.4437; TIDSWELL P, 1995, NEUROLOGY, V45, P875; Till C, 2008, ARCH PHYS MED REHAB, V89, pS25, DOI 10.1016/j.apmr.2008.07.004	30	18	19	0	7	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2010	27	4					351	358		10.3233/NRE-2010-0619			8	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	723XJ	WOS:000287540400008	21160125				2021-06-18	
